AGE,CI_LOWER,CI_UPPER,COUNT,EVENT_TYPE,POPULATION,RACE,RATE,SEX,SITE,YEAR
1-4,20.2,22.3,1658,Incidence,7805332,All Races,21.2,Female,All Cancer Sites Combined,2016
1-4,4.0,4.9,344,Incidence,7805332,All Races,4.4,Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Cervix,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Esophagus,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Female Breast,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Kaposi Sarcoma,2016
1-4,1.8,2.4,164,Incidence,7805332,All Races,2.1,Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Larynx,2016
1-4,7.7,9.0,650,Incidence,7805332,All Races,8.3,Female,Leukemias,2016
1-4,0.4,0.7,41,Incidence,7805332,All Races,0.5,Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Mesothelioma,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Myeloma,2016
1-4,0.3,0.7,37,Incidence,7805332,All Races,0.5,Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Ovary,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Pancreas,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Stomach,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Thyroid,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Female,Urinary Bladder,2016
10-14,14.8,16.3,1568,Incidence,10104766,All Races,15.5,Female,All Cancer Sites Combined,2016
10-14,2.4,3.1,279,Incidence,10104766,All Races,2.8,Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Cervix,2016
10-14,0.6,0.9,74,Incidence,10104766,All Races,0.7,Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Esophagus,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Female Breast,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,"Female Breast, <i>in situ</i>",2016
10-14,1.0,1.4,117,Incidence,10104766,All Races,1.2,Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Kaposi Sarcoma,2016
10-14,0.1,0.3,21,Incidence,10104766,All Races,0.2,Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Larynx,2016
10-14,3.0,3.7,338,Incidence,10104766,All Races,3.3,Female,Leukemias,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Lung and Bronchus,2016
10-14,0.2,0.4,27,Incidence,10104766,All Races,0.3,Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Mesothelioma,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Myeloma,2016
10-14,0.9,1.3,106,Incidence,10104766,All Races,1.0,Female,Non-Hodgkin Lymphoma,2016
10-14,0.2,0.5,33,Incidence,10104766,All Races,0.3,Female,Oral Cavity and Pharynx,2016
10-14,0.6,0.9,72,Incidence,10104766,All Races,0.7,Female,Ovary,2016
10-14,0.1,0.3,19,Incidence,10104766,All Races,0.2,Female,Pancreas,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Stomach,2016
10-14,1.1,1.6,133,Incidence,10104766,All Races,1.3,Female,Thyroid,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Female,Urinary Bladder,2016
15-19,23.2,25.2,2500,Incidence,10335334,All Races,24.2,Female,All Cancer Sites Combined,2016
15-19,1.7,2.3,207,Incidence,10335334,All Races,2.0,Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Cervix,2016
15-19,1.4,1.9,167,Incidence,10335334,All Races,1.6,Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Esophagus,2016
15-19,0.1,0.3,20,Incidence,10335334,All Races,0.2,Female,Female Breast,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,"Female Breast, <i>in situ</i>",2016
15-19,3.0,3.7,345,Incidence,10335334,All Races,3.3,Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Kaposi Sarcoma,2016
15-19,0.1,0.3,24,Incidence,10335334,All Races,0.2,Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Larynx,2016
15-19,2.2,2.8,253,Incidence,10335334,All Races,2.4,Female,Leukemias,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Lung and Bronchus,2016
15-19,1.0,1.4,121,Incidence,10335334,All Races,1.2,Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Mesothelioma,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Myeloma,2016
15-19,1.2,1.6,142,Incidence,10335334,All Races,1.4,Female,Non-Hodgkin Lymphoma,2016
15-19,0.4,0.7,57,Incidence,10335334,All Races,0.6,Female,Oral Cavity and Pharynx,2016
15-19,1.1,1.5,131,Incidence,10335334,All Races,1.3,Female,Ovary,2016
15-19,0.1,0.3,24,Incidence,10335334,All Races,0.2,Female,Pancreas,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Stomach,2016
15-19,5.4,6.3,605,Incidence,10335334,All Races,5.9,Female,Thyroid,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Female,Urinary Bladder,2016
20-24,37.8,40.2,4243,Incidence,10880883,All Races,39.0,Female,All Cancer Sites Combined,2016
20-24,1.5,2.1,194,Incidence,10880883,All Races,1.8,Female,Brain and Other Nervous System,2016
20-24,0.7,1.0,91,Incidence,10880883,All Races,0.8,Female,Cervix,2016
20-24,2.1,2.7,257,Incidence,10880883,All Races,2.4,Female,Colon and Rectum,2016
20-24,0.4,0.7,61,Incidence,10880883,All Races,0.6,Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,10880883,All Races,~,Female,Esophagus,2016
20-24,1.5,2.0,192,Incidence,10880883,All Races,1.8,Female,Female Breast,2016
20-24,0.1,0.3,21,Incidence,10880883,All Races,0.2,Female,"Female Breast, <i>in situ</i>",2016
20-24,3.9,4.7,468,Incidence,10880883,All Races,4.3,Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,10880883,All Races,~,Female,Kaposi Sarcoma,2016
20-24,0.4,0.7,60,Incidence,10880883,All Races,0.6,Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,10880883,All Races,~,Female,Larynx,2016
20-24,1.9,2.5,241,Incidence,10880883,All Races,2.2,Female,Leukemias,2016
20-24,0.1,0.3,24,Incidence,10880883,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2016
20-24,0.2,0.5,37,Incidence,10880883,All Races,0.3,Female,Lung and Bronchus,2016
20-24,3.5,4.2,420,Incidence,10880883,All Races,3.9,Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,10880883,All Races,~,Female,Mesothelioma,2016
20-24,~,~,~,Incidence,10880883,All Races,~,Female,Myeloma,2016
20-24,1.8,2.3,221,Incidence,10880883,All Races,2.0,Female,Non-Hodgkin Lymphoma,2016
20-24,0.5,0.8,65,Incidence,10880883,All Races,0.6,Female,Oral Cavity and Pharynx,2016
20-24,1.5,2.1,194,Incidence,10880883,All Races,1.8,Female,Ovary,2016
20-24,0.2,0.4,29,Incidence,10880883,All Races,0.3,Female,Pancreas,2016
20-24,0.1,0.3,25,Incidence,10880883,All Races,0.2,Female,Stomach,2016
20-24,10.5,11.8,1212,Incidence,10880883,All Races,11.1,Female,Thyroid,2016
20-24,0.1,0.3,18,Incidence,10880883,All Races,0.2,Female,Urinary Bladder,2016
25-29,71.6,74.8,8249,Incidence,11271329,All Races,73.2,Female,All Cancer Sites Combined,2016
25-29,2.1,2.7,270,Incidence,11271329,All Races,2.4,Female,Brain and Other Nervous System,2016
25-29,5.1,5.9,618,Incidence,11271329,All Races,5.5,Female,Cervix,2016
25-29,3.4,4.1,423,Incidence,11271329,All Races,3.8,Female,Colon and Rectum,2016
25-29,1.8,2.4,234,Incidence,11271329,All Races,2.1,Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,11271329,All Races,~,Female,Esophagus,2016
25-29,10.1,11.3,1201,Incidence,11271329,All Races,10.7,Female,Female Breast,2016
25-29,0.7,1.0,91,Incidence,11271329,All Races,0.8,Female,"Female Breast, <i>in situ</i>",2016
25-29,3.4,4.1,423,Incidence,11271329,All Races,3.8,Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,11271329,All Races,~,Female,Kaposi Sarcoma,2016
25-29,1.2,1.7,161,Incidence,11271329,All Races,1.4,Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,11271329,All Races,~,Female,Larynx,2016
25-29,2.2,2.8,279,Incidence,11271329,All Races,2.5,Female,Leukemias,2016
25-29,0.2,0.4,30,Incidence,11271329,All Races,0.3,Female,Liver and Intrahepatic Bile Duct,2016
25-29,0.4,0.7,62,Incidence,11271329,All Races,0.6,Female,Lung and Bronchus,2016
25-29,8.0,9.1,965,Incidence,11271329,All Races,8.6,Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,11271329,All Races,~,Female,Mesothelioma,2016
25-29,~,~,~,Incidence,11271329,All Races,~,Female,Myeloma,2016
25-29,2.0,2.6,260,Incidence,11271329,All Races,2.3,Female,Non-Hodgkin Lymphoma,2016
25-29,0.8,1.2,112,Incidence,11271329,All Races,1.0,Female,Oral Cavity and Pharynx,2016
25-29,1.9,2.5,249,Incidence,11271329,All Races,2.2,Female,Ovary,2016
25-29,0.4,0.7,61,Incidence,11271329,All Races,0.5,Female,Pancreas,2016
25-29,0.3,0.5,44,Incidence,11271329,All Races,0.4,Female,Stomach,2016
25-29,18.4,20.0,2162,Incidence,11271329,All Races,19.2,Female,Thyroid,2016
25-29,0.3,0.5,40,Incidence,11271329,All Races,0.4,Female,Urinary Bladder,2016
30-34,128.4,132.7,14149,Incidence,10837503,All Races,130.6,Female,All Cancer Sites Combined,2016
30-34,2.8,3.4,334,Incidence,10837503,All Races,3.1,Female,Brain and Other Nervous System,2016
30-34,10.3,11.5,1181,Incidence,10837503,All Races,10.9,Female,Cervix,2016
30-34,5.9,6.9,689,Incidence,10837503,All Races,6.4,Female,Colon and Rectum,2016
30-34,5.2,6.1,611,Incidence,10837503,All Races,5.6,Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,10837503,All Races,~,Female,Esophagus,2016
30-34,30.2,32.3,3388,Incidence,10837503,All Races,31.3,Female,Female Breast,2016
30-34,2.8,3.5,338,Incidence,10837503,All Races,3.1,Female,"Female Breast, <i>in situ</i>",2016
30-34,3.3,4.0,397,Incidence,10837503,All Races,3.7,Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,10837503,All Races,~,Female,Kaposi Sarcoma,2016
30-34,2.6,3.3,318,Incidence,10837503,All Races,2.9,Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,10837503,All Races,~,Female,Larynx,2016
30-34,3.3,4.0,391,Incidence,10837503,All Races,3.6,Female,Leukemias,2016
30-34,0.4,0.7,56,Incidence,10837503,All Races,0.5,Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.0,1.5,133,Incidence,10837503,All Races,1.2,Female,Lung and Bronchus,2016
30-34,12.4,13.8,1417,Incidence,10837503,All Races,13.1,Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,10837503,All Races,~,Female,Mesothelioma,2016
30-34,0.2,0.5,37,Incidence,10837503,All Races,0.3,Female,Myeloma,2016
30-34,4.0,4.8,472,Incidence,10837503,All Races,4.4,Female,Non-Hodgkin Lymphoma,2016
30-34,1.6,2.1,195,Incidence,10837503,All Races,1.8,Female,Oral Cavity and Pharynx,2016
30-34,3.2,3.9,384,Incidence,10837503,All Races,3.5,Female,Ovary,2016
30-34,0.5,0.8,73,Incidence,10837503,All Races,0.7,Female,Pancreas,2016
30-34,0.9,1.3,115,Incidence,10837503,All Races,1.1,Female,Stomach,2016
30-34,26.1,28.1,2932,Incidence,10837503,All Races,27.1,Female,Thyroid,2016
30-34,0.4,0.7,56,Incidence,10837503,All Races,0.5,Female,Urinary Bladder,2016
35-39,199.2,204.7,21002,Incidence,10399494,All Races,202.0,Female,All Cancer Sites Combined,2016
35-39,3.1,3.8,357,Incidence,10399494,All Races,3.4,Female,Brain and Other Nervous System,2016
35-39,14.7,16.2,1601,Incidence,10399494,All Races,15.4,Female,Cervix,2016
35-39,11.0,12.3,1207,Incidence,10399494,All Races,11.6,Female,Colon and Rectum,2016
35-39,10.0,11.3,1104,Incidence,10399494,All Races,10.6,Female,"Corpus and Uterus, NOS",2016
35-39,0.1,0.3,22,Incidence,10399494,All Races,0.2,Female,Esophagus,2016
35-39,62.3,65.3,6633,Incidence,10399494,All Races,63.8,Female,Female Breast,2016
35-39,8.1,9.2,901,Incidence,10399494,All Races,8.7,Female,"Female Breast, <i>in situ</i>",2016
35-39,2.4,3.1,287,Incidence,10399494,All Races,2.8,Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,10399494,All Races,~,Female,Kaposi Sarcoma,2016
35-39,4.9,5.8,559,Incidence,10399494,All Races,5.4,Female,Kidney and Renal Pelvis,2016
35-39,0.1,0.3,21,Incidence,10399494,All Races,0.2,Female,Larynx,2016
35-39,3.5,4.2,400,Incidence,10399494,All Races,3.8,Female,Leukemias,2016
35-39,0.8,1.1,97,Incidence,10399494,All Races,0.9,Female,Liver and Intrahepatic Bile Duct,2016
35-39,2.5,3.1,291,Incidence,10399494,All Races,2.8,Female,Lung and Bronchus,2016
35-39,15.4,17.0,1685,Incidence,10399494,All Races,16.2,Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,10399494,All Races,~,Female,Mesothelioma,2016
35-39,0.7,1.1,96,Incidence,10399494,All Races,0.9,Female,Myeloma,2016
35-39,5.6,6.6,636,Incidence,10399494,All Races,6.1,Female,Non-Hodgkin Lymphoma,2016
35-39,2.1,2.7,252,Incidence,10399494,All Races,2.4,Female,Oral Cavity and Pharynx,2016
35-39,4.6,5.5,521,Incidence,10399494,All Races,5.0,Female,Ovary,2016
35-39,1.5,2.0,177,Incidence,10399494,All Races,1.7,Female,Pancreas,2016
35-39,1.7,2.2,201,Incidence,10399494,All Races,1.9,Female,Stomach,2016
35-39,32.0,34.2,3442,Incidence,10399494,All Races,33.1,Female,Thyroid,2016
35-39,1.0,1.4,120,Incidence,10399494,All Races,1.2,Female,Urinary Bladder,2016
40-44,309.4,316.4,31009,Incidence,9910118,All Races,312.9,Female,All Cancer Sites Combined,2016
40-44,3.1,3.9,344,Incidence,9910118,All Races,3.5,Female,Brain and Other Nervous System,2016
40-44,15.2,16.8,1583,Incidence,9910118,All Races,16.0,Female,Cervix,2016
40-44,19.2,21.0,1992,Incidence,9910118,All Races,20.1,Female,Colon and Rectum,2016
40-44,16.6,18.3,1730,Incidence,9910118,All Races,17.5,Female,"Corpus and Uterus, NOS",2016
40-44,0.2,0.5,32,Incidence,9910118,All Races,0.3,Female,Esophagus,2016
40-44,122.8,127.2,12382,Incidence,9910118,All Races,124.9,Female,Female Breast,2016
40-44,38.2,40.7,3908,Incidence,9910118,All Races,39.4,Female,"Female Breast, <i>in situ</i>",2016
40-44,1.9,2.5,219,Incidence,9910118,All Races,2.2,Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,9910118,All Races,~,Female,Kaposi Sarcoma,2016
40-44,8.1,9.3,859,Incidence,9910118,All Races,8.7,Female,Kidney and Renal Pelvis,2016
40-44,0.2,0.5,32,Incidence,9910118,All Races,0.3,Female,Larynx,2016
40-44,5.3,6.3,572,Incidence,9910118,All Races,5.8,Female,Leukemias,2016
40-44,1.1,1.6,132,Incidence,9910118,All Races,1.3,Female,Liver and Intrahepatic Bile Duct,2016
40-44,7.0,8.1,749,Incidence,9910118,All Races,7.6,Female,Lung and Bronchus,2016
40-44,19.0,20.8,1973,Incidence,9910118,All Races,19.9,Female,Melanomas of the Skin,2016
40-44,0.1,0.3,19,Incidence,9910118,All Races,0.2,Female,Mesothelioma,2016
40-44,1.9,2.5,214,Incidence,9910118,All Races,2.2,Female,Myeloma,2016
40-44,8.0,9.1,844,Incidence,9910118,All Races,8.5,Female,Non-Hodgkin Lymphoma,2016
40-44,3.6,4.3,390,Incidence,9910118,All Races,3.9,Female,Oral Cavity and Pharynx,2016
40-44,8.1,9.3,860,Incidence,9910118,All Races,8.7,Female,Ovary,2016
40-44,2.4,3.1,272,Incidence,9910118,All Races,2.7,Female,Pancreas,2016
40-44,2.6,3.3,291,Incidence,9910118,All Races,2.9,Female,Stomach,2016
40-44,34.2,36.6,3507,Incidence,9910118,All Races,35.4,Female,Thyroid,2016
40-44,1.5,2.0,169,Incidence,9910118,All Races,1.7,Female,Urinary Bladder,2016
45-49,449.5,457.7,47857,Incidence,10550885,All Races,453.6,Female,All Cancer Sites Combined,2016
45-49,4.0,4.8,465,Incidence,10550885,All Races,4.4,Female,Brain and Other Nervous System,2016
45-49,13.7,15.2,1525,Incidence,10550885,All Races,14.5,Female,Cervix,2016
45-49,31.0,33.2,3389,Incidence,10550885,All Races,32.1,Female,Colon and Rectum,2016
45-49,26.3,28.3,2877,Incidence,10550885,All Races,27.3,Female,"Corpus and Uterus, NOS",2016
45-49,0.7,1.1,93,Incidence,10550885,All Races,0.9,Female,Esophagus,2016
45-49,189.8,195.1,20304,Incidence,10550885,All Races,192.4,Female,Female Breast,2016
45-49,55.5,58.4,6010,Incidence,10550885,All Races,57.0,Female,"Female Breast, <i>in situ</i>",2016
45-49,1.9,2.4,225,Incidence,10550885,All Races,2.1,Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,10550885,All Races,~,Female,Kaposi Sarcoma,2016
45-49,11.6,12.9,1291,Incidence,10550885,All Races,12.2,Female,Kidney and Renal Pelvis,2016
45-49,0.9,1.3,118,Incidence,10550885,All Races,1.1,Female,Larynx,2016
45-49,7.0,8.0,792,Incidence,10550885,All Races,7.5,Female,Leukemias,2016
45-49,1.8,2.3,215,Incidence,10550885,All Races,2.0,Female,Liver and Intrahepatic Bile Duct,2016
45-49,18.1,19.7,1992,Incidence,10550885,All Races,18.9,Female,Lung and Bronchus,2016
45-49,23.9,25.8,2619,Incidence,10550885,All Races,24.8,Female,Melanomas of the Skin,2016
45-49,0.2,0.5,34,Incidence,10550885,All Races,0.3,Female,Mesothelioma,2016
45-49,3.6,4.4,422,Incidence,10550885,All Races,4.0,Female,Myeloma,2016
45-49,11.6,12.9,1289,Incidence,10550885,All Races,12.2,Female,Non-Hodgkin Lymphoma,2016
45-49,5.6,6.5,637,Incidence,10550885,All Races,6.0,Female,Oral Cavity and Pharynx,2016
45-49,12.8,14.2,1424,Incidence,10550885,All Races,13.5,Female,Ovary,2016
45-49,5.4,6.4,622,Incidence,10550885,All Races,5.9,Female,Pancreas,2016
45-49,3.6,4.4,419,Incidence,10550885,All Races,4.0,Female,Stomach,2016
45-49,35.7,38.0,3883,Incidence,10550885,All Races,36.8,Female,Thyroid,2016
45-49,3.0,3.7,347,Incidence,10550885,All Races,3.3,Female,Urinary Bladder,2016
5-9,11.8,13.2,1245,Incidence,10008005,All Races,12.4,Female,All Cancer Sites Combined,2016
5-9,3.0,3.7,333,Incidence,10008005,All Races,3.3,Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Cervix,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Esophagus,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Female Breast,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Kaposi Sarcoma,2016
5-9,0.7,1.0,83,Incidence,10008005,All Races,0.8,Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Larynx,2016
5-9,3.5,4.3,390,Incidence,10008005,All Races,3.9,Female,Leukemias,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Mesothelioma,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Myeloma,2016
5-9,0.5,0.9,70,Incidence,10008005,All Races,0.7,Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Oral Cavity and Pharynx,2016
5-9,0.2,0.5,32,Incidence,10008005,All Races,0.3,Female,Ovary,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Pancreas,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Stomach,2016
5-9,0.1,0.3,23,Incidence,10008005,All Races,0.2,Female,Thyroid,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Female,Urinary Bladder,2016
50-54,624.2,633.6,69727,Incidence,11087512,All Races,628.9,Female,All Cancer Sites Combined,2016
50-54,5.8,6.8,697,Incidence,11087512,All Races,6.3,Female,Brain and Other Nervous System,2016
50-54,12.2,13.6,1430,Incidence,11087512,All Races,12.9,Female,Cervix,2016
50-54,54.9,57.7,6242,Incidence,11087512,All Races,56.3,Female,Colon and Rectum,2016
50-54,47.6,50.2,5421,Incidence,11087512,All Races,48.9,Female,"Corpus and Uterus, NOS",2016
50-54,1.7,2.2,215,Incidence,11087512,All Races,1.9,Female,Esophagus,2016
50-54,228.5,234.1,25643,Incidence,11087512,All Races,231.3,Female,Female Breast,2016
50-54,64.4,67.5,7310,Incidence,11087512,All Races,65.9,Female,"Female Breast, <i>in situ</i>",2016
50-54,1.5,2.0,191,Incidence,11087512,All Races,1.7,Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,11087512,All Races,~,Female,Kaposi Sarcoma,2016
50-54,16.6,18.1,1922,Incidence,11087512,All Races,17.3,Female,Kidney and Renal Pelvis,2016
50-54,2.3,2.9,283,Incidence,11087512,All Races,2.6,Female,Larynx,2016
50-54,10.2,11.5,1201,Incidence,11087512,All Races,10.8,Female,Leukemias,2016
50-54,4.3,5.1,523,Incidence,11087512,All Races,4.7,Female,Liver and Intrahepatic Bile Duct,2016
50-54,47.5,50.1,5407,Incidence,11087512,All Races,48.8,Female,Lung and Bronchus,2016
50-54,28.3,30.3,3243,Incidence,11087512,All Races,29.2,Female,Melanomas of the Skin,2016
50-54,0.2,0.3,26,Incidence,11087512,All Races,0.2,Female,Mesothelioma,2016
50-54,6.4,7.4,768,Incidence,11087512,All Races,6.9,Female,Myeloma,2016
50-54,18.3,19.9,2116,Incidence,11087512,All Races,19.1,Female,Non-Hodgkin Lymphoma,2016
50-54,9.8,11.0,1150,Incidence,11087512,All Races,10.4,Female,Oral Cavity and Pharynx,2016
50-54,17.1,18.7,1982,Incidence,11087512,All Races,17.9,Female,Ovary,2016
50-54,10.1,11.4,1190,Incidence,11087512,All Races,10.7,Female,Pancreas,2016
50-54,5.6,6.5,671,Incidence,11087512,All Races,6.1,Female,Stomach,2016
50-54,35.2,37.5,4029,Incidence,11087512,All Races,36.3,Female,Thyroid,2016
50-54,6.5,7.4,769,Incidence,11087512,All Races,6.9,Female,Urinary Bladder,2016
55-59,814.2,824.7,92407,Incidence,11276769,All Races,819.4,Female,All Cancer Sites Combined,2016
55-59,7.6,8.6,910,Incidence,11276769,All Races,8.1,Female,Brain and Other Nervous System,2016
55-59,12.0,13.4,1430,Incidence,11276769,All Races,12.7,Female,Cervix,2016
55-59,55.5,58.3,6415,Incidence,11276769,All Races,56.9,Female,Colon and Rectum,2016
55-59,77.9,81.2,8964,Incidence,11276769,All Races,79.5,Female,"Corpus and Uterus, NOS",2016
55-59,3.3,4.0,406,Incidence,11276769,All Races,3.6,Female,Esophagus,2016
55-59,265.8,271.8,30311,Incidence,11276769,All Races,268.8,Female,Female Breast,2016
55-59,66.8,69.9,7706,Incidence,11276769,All Races,68.3,Female,"Female Breast, <i>in situ</i>",2016
55-59,1.7,2.2,215,Incidence,11276769,All Races,1.9,Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,11276769,All Races,~,Female,Kaposi Sarcoma,2016
55-59,23.3,25.1,2727,Incidence,11276769,All Races,24.2,Female,Kidney and Renal Pelvis,2016
55-59,3.6,4.3,447,Incidence,11276769,All Races,4.0,Female,Larynx,2016
55-59,15.0,16.5,1777,Incidence,11276769,All Races,15.8,Female,Leukemias,2016
55-59,9.5,10.7,1138,Incidence,11276769,All Races,10.1,Female,Liver and Intrahepatic Bile Duct,2016
55-59,92.6,96.2,10642,Incidence,11276769,All Races,94.4,Female,Lung and Bronchus,2016
55-59,31.8,33.9,3702,Incidence,11276769,All Races,32.8,Female,Melanomas of the Skin,2016
55-59,0.4,0.7,63,Incidence,11276769,All Races,0.6,Female,Mesothelioma,2016
55-59,9.8,11.0,1175,Incidence,11276769,All Races,10.4,Female,Myeloma,2016
55-59,25.3,27.2,2955,Incidence,11276769,All Races,26.2,Female,Non-Hodgkin Lymphoma,2016
55-59,14.5,15.9,1715,Incidence,11276769,All Races,15.2,Female,Oral Cavity and Pharynx,2016
55-59,21.7,23.5,2548,Incidence,11276769,All Races,22.6,Female,Ovary,2016
55-59,17.4,19.0,2047,Incidence,11276769,All Races,18.2,Female,Pancreas,2016
55-59,7.7,8.8,931,Incidence,11276769,All Races,8.3,Female,Stomach,2016
55-59,34.1,36.3,3968,Incidence,11276769,All Races,35.2,Female,Thyroid,2016
55-59,11.5,12.8,1374,Incidence,11276769,All Races,12.2,Female,Urinary Bladder,2016
60-64,1048.2,1060.8,107068,Incidence,10153415,All Races,1054.5,Female,All Cancer Sites Combined,2016
60-64,10.0,11.3,1080,Incidence,10153415,All Races,10.6,Female,Brain and Other Nervous System,2016
60-64,11.3,12.6,1212,Incidence,10153415,All Races,11.9,Female,Cervix,2016
60-64,71.3,74.7,7412,Incidence,10153415,All Races,73.0,Female,Colon and Rectum,2016
60-64,101.9,105.8,10543,Incidence,10153415,All Races,103.8,Female,"Corpus and Uterus, NOS",2016
60-64,4.5,5.3,497,Incidence,10153415,All Races,4.9,Female,Esophagus,2016
60-64,332.7,339.8,34137,Incidence,10153415,All Races,336.2,Female,Female Breast,2016
60-64,78.4,81.8,8131,Incidence,10153415,All Races,80.1,Female,"Female Breast, <i>in situ</i>",2016
60-64,1.7,2.3,203,Incidence,10153415,All Races,2.0,Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,10153415,All Races,~,Female,Kaposi Sarcoma,2016
60-64,30.0,32.1,3152,Incidence,10153415,All Races,31.0,Female,Kidney and Renal Pelvis,2016
60-64,4.0,4.8,445,Incidence,10153415,All Races,4.4,Female,Larynx,2016
60-64,19.8,21.6,2101,Incidence,10153415,All Races,20.7,Female,Leukemias,2016
60-64,14.8,16.4,1584,Incidence,10153415,All Races,15.6,Female,Liver and Intrahepatic Bile Duct,2016
60-64,132.4,136.9,13672,Incidence,10153415,All Races,134.7,Female,Lung and Bronchus,2016
60-64,38.2,40.6,3997,Incidence,10153415,All Races,39.4,Female,Melanomas of the Skin,2016
60-64,0.7,1.0,84,Incidence,10153415,All Races,0.8,Female,Mesothelioma,2016
60-64,14.2,15.7,1518,Incidence,10153415,All Races,15.0,Female,Myeloma,2016
60-64,36.3,38.7,3804,Incidence,10153415,All Races,37.5,Female,Non-Hodgkin Lymphoma,2016
60-64,17.5,19.1,1857,Incidence,10153415,All Races,18.3,Female,Oral Cavity and Pharynx,2016
60-64,25.9,27.9,2728,Incidence,10153415,All Races,26.9,Female,Ovary,2016
60-64,26.6,28.6,2803,Incidence,10153415,All Races,27.6,Female,Pancreas,2016
60-64,9.7,10.9,1044,Incidence,10153415,All Races,10.3,Female,Stomach,2016
60-64,32.1,34.4,3377,Incidence,10153415,All Races,33.3,Female,Thyroid,2016
60-64,18.0,19.7,1908,Incidence,10153415,All Races,18.8,Female,Urinary Bladder,2016
65-69,1371.7,1387.1,122411,Incidence,8874413,All Races,1379.4,Female,All Cancer Sites Combined,2016
65-69,13.3,14.9,1247,Incidence,8874413,All Races,14.1,Female,Brain and Other Nervous System,2016
65-69,10.4,11.7,979,Incidence,8874413,All Races,11.0,Female,Cervix,2016
65-69,96.7,100.9,8766,Incidence,8874413,All Races,98.8,Female,Colon and Rectum,2016
65-69,115.0,119.5,10402,Incidence,8874413,All Races,117.2,Female,"Corpus and Uterus, NOS",2016
65-69,6.0,7.0,576,Incidence,8874413,All Races,6.5,Female,Esophagus,2016
65-69,423.3,431.9,37946,Incidence,8874413,All Races,427.6,Female,Female Breast,2016
65-69,94.5,98.6,8566,Incidence,8874413,All Races,96.5,Female,"Female Breast, <i>in situ</i>",2016
65-69,2.3,3.0,235,Incidence,8874413,All Races,2.6,Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,8874413,All Races,~,Female,Kaposi Sarcoma,2016
65-69,41.5,44.2,3799,Incidence,8874413,All Races,42.8,Female,Kidney and Renal Pelvis,2016
65-69,4.4,5.3,432,Incidence,8874413,All Races,4.9,Female,Larynx,2016
65-69,28.8,31.1,2659,Incidence,8874413,All Races,30.0,Female,Leukemias,2016
65-69,17.3,19.1,1617,Incidence,8874413,All Races,18.2,Female,Liver and Intrahepatic Bile Duct,2016
65-69,199.7,205.7,17986,Incidence,8874413,All Races,202.7,Female,Lung and Bronchus,2016
65-69,44.7,47.5,4091,Incidence,8874413,All Races,46.1,Female,Melanomas of the Skin,2016
65-69,1.1,1.6,117,Incidence,8874413,All Races,1.3,Female,Mesothelioma,2016
65-69,22.0,24.0,2039,Incidence,8874413,All Races,23.0,Female,Myeloma,2016
65-69,51.3,54.3,4685,Incidence,8874413,All Races,52.8,Female,Non-Hodgkin Lymphoma,2016
65-69,20.0,21.9,1858,Incidence,8874413,All Races,20.9,Female,Oral Cavity and Pharynx,2016
65-69,31.0,33.4,2854,Incidence,8874413,All Races,32.2,Female,Ovary,2016
65-69,39.4,42.1,3616,Incidence,8874413,All Races,40.7,Female,Pancreas,2016
65-69,13.4,14.9,1255,Incidence,8874413,All Races,14.1,Female,Stomach,2016
65-69,32.8,35.3,3020,Incidence,8874413,All Races,34.0,Female,Thyroid,2016
65-69,28.3,30.6,2611,Incidence,8874413,All Races,29.4,Female,Urinary Bladder,2016
70-74,1649.8,1669.8,105347,Incidence,6347009,All Races,1659.8,Female,All Cancer Sites Combined,2016
70-74,14.7,16.6,991,Incidence,6347009,All Races,15.6,Female,Brain and Other Nervous System,2016
70-74,8.9,10.5,613,Incidence,6347009,All Races,9.7,Female,Cervix,2016
70-74,121.3,126.8,7874,Incidence,6347009,All Races,124.1,Female,Colon and Rectum,2016
70-74,104.8,109.9,6812,Incidence,6347009,All Races,107.3,Female,"Corpus and Uterus, NOS",2016
70-74,7.6,9.0,526,Incidence,6347009,All Races,8.3,Female,Esophagus,2016
70-74,465.8,476.5,29903,Incidence,6347009,All Races,471.1,Female,Female Breast,2016
70-74,97.4,102.3,6334,Incidence,6347009,All Races,99.8,Female,"Female Breast, <i>in situ</i>",2016
70-74,2.8,3.7,205,Incidence,6347009,All Races,3.2,Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,6347009,All Races,~,Female,Kaposi Sarcoma,2016
70-74,45.8,49.2,3013,Incidence,6347009,All Races,47.5,Female,Kidney and Renal Pelvis,2016
70-74,4.2,5.3,298,Incidence,6347009,All Races,4.7,Female,Larynx,2016
70-74,39.7,42.9,2619,Incidence,6347009,All Races,41.3,Female,Leukemias,2016
70-74,19.5,21.7,1305,Incidence,6347009,All Races,20.6,Female,Liver and Intrahepatic Bile Duct,2016
70-74,296.8,305.3,19106,Incidence,6347009,All Races,301.0,Female,Lung and Bronchus,2016
70-74,48.8,52.3,3206,Incidence,6347009,All Races,50.5,Female,Melanomas of the Skin,2016
70-74,1.4,2.1,108,Incidence,6347009,All Races,1.7,Female,Mesothelioma,2016
70-74,28.1,30.7,1865,Incidence,6347009,All Races,29.4,Female,Myeloma,2016
70-74,67.4,71.5,4408,Incidence,6347009,All Races,69.5,Female,Non-Hodgkin Lymphoma,2016
70-74,24.2,26.7,1614,Incidence,6347009,All Races,25.4,Female,Oral Cavity and Pharynx,2016
70-74,35.6,38.6,2352,Incidence,6347009,All Races,37.1,Female,Ovary,2016
70-74,53.2,56.8,3489,Incidence,6347009,All Races,55.0,Female,Pancreas,2016
70-74,17.9,20.0,1200,Incidence,6347009,All Races,18.9,Female,Stomach,2016
70-74,27.8,30.5,1849,Incidence,6347009,All Races,29.1,Female,Thyroid,2016
70-74,42.9,46.2,2828,Incidence,6347009,All Races,44.6,Female,Urinary Bladder,2016
75-79,1834.3,1859.1,85727,Incidence,4642235,All Races,1846.7,Female,All Cancer Sites Combined,2016
75-79,17.3,19.8,860,Incidence,4642235,All Races,18.5,Female,Brain and Other Nervous System,2016
75-79,8.8,10.6,450,Incidence,4642235,All Races,9.7,Female,Cervix,2016
75-79,161.7,169.1,7677,Incidence,4642235,All Races,165.4,Female,Colon and Rectum,2016
75-79,90.4,96.0,4325,Incidence,4642235,All Races,93.2,Female,"Corpus and Uterus, NOS",2016
75-79,8.8,10.6,448,Incidence,4642235,All Races,9.7,Female,Esophagus,2016
75-79,448.8,461.1,21120,Incidence,4642235,All Races,455.0,Female,Female Breast,2016
75-79,80.2,85.5,3845,Incidence,4642235,All Races,82.8,Female,"Female Breast, <i>in situ</i>",2016
75-79,2.6,3.6,143,Incidence,4642235,All Races,3.1,Female,Hodgkin Lymphoma,2016
75-79,0.3,0.7,23,Incidence,4642235,All Races,0.5,Female,Kaposi Sarcoma,2016
75-79,49.8,53.9,2405,Incidence,4642235,All Races,51.8,Female,Kidney and Renal Pelvis,2016
75-79,4.2,5.4,221,Incidence,4642235,All Races,4.8,Female,Larynx,2016
75-79,50.6,54.8,2443,Incidence,4642235,All Races,52.6,Female,Leukemias,2016
75-79,23.5,26.4,1157,Incidence,4642235,All Races,24.9,Female,Liver and Intrahepatic Bile Duct,2016
75-79,345.5,356.3,16288,Incidence,4642235,All Races,350.9,Female,Lung and Bronchus,2016
75-79,52.9,57.2,2556,Incidence,4642235,All Races,55.1,Female,Melanomas of the Skin,2016
75-79,2.0,2.9,112,Incidence,4642235,All Races,2.4,Female,Mesothelioma,2016
75-79,32.7,36.1,1596,Incidence,4642235,All Races,34.4,Female,Myeloma,2016
75-79,82.1,87.4,3932,Incidence,4642235,All Races,84.7,Female,Non-Hodgkin Lymphoma,2016
75-79,24.9,27.9,1223,Incidence,4642235,All Races,26.3,Female,Oral Cavity and Pharynx,2016
75-79,38.5,42.2,1873,Incidence,4642235,All Races,40.3,Female,Ovary,2016
75-79,69.7,74.6,3348,Incidence,4642235,All Races,72.1,Female,Pancreas,2016
75-79,23.3,26.2,1146,Incidence,4642235,All Races,24.7,Female,Stomach,2016
75-79,22.4,25.2,1104,Incidence,4642235,All Races,23.8,Female,Thyroid,2016
75-79,53.9,58.2,2602,Incidence,4642235,All Races,56.1,Female,Urinary Bladder,2016
80-84,1915.0,1944.5,65909,Incidence,3415481,All Races,1929.7,Female,All Cancer Sites Combined,2016
80-84,16.5,19.3,610,Incidence,3415481,All Races,17.9,Female,Brain and Other Nervous System,2016
80-84,8.1,10.2,311,Incidence,3415481,All Races,9.1,Female,Cervix,2016
80-84,200.7,210.3,7018,Incidence,3415481,All Races,205.5,Female,Colon and Rectum,2016
80-84,71.9,77.8,2555,Incidence,3415481,All Races,74.8,Female,"Corpus and Uterus, NOS",2016
80-84,11.5,13.9,432,Incidence,3415481,All Races,12.6,Female,Esophagus,2016
80-84,401.8,415.4,13955,Incidence,3415481,All Races,408.6,Female,Female Breast,2016
80-84,51.3,56.2,1835,Incidence,3415481,All Races,53.7,Female,"Female Breast, <i>in situ</i>",2016
80-84,2.7,3.9,111,Incidence,3415481,All Races,3.2,Female,Hodgkin Lymphoma,2016
80-84,0.3,0.9,19,Incidence,3415481,All Races,0.6,Female,Kaposi Sarcoma,2016
80-84,49.1,53.9,1757,Incidence,3415481,All Races,51.4,Female,Kidney and Renal Pelvis,2016
80-84,3.6,5.0,146,Incidence,3415481,All Races,4.3,Female,Larynx,2016
80-84,60.7,66.1,2165,Incidence,3415481,All Races,63.4,Female,Leukemias,2016
80-84,26.1,29.7,951,Incidence,3415481,All Races,27.8,Female,Liver and Intrahepatic Bile Duct,2016
80-84,340.9,353.5,11857,Incidence,3415481,All Races,347.2,Female,Lung and Bronchus,2016
80-84,57.3,62.5,2045,Incidence,3415481,All Races,59.9,Female,Melanomas of the Skin,2016
80-84,2.5,3.7,103,Incidence,3415481,All Races,3.0,Female,Mesothelioma,2016
80-84,34.0,38.0,1228,Incidence,3415481,All Races,36.0,Female,Myeloma,2016
80-84,93.9,100.5,3318,Incidence,3415481,All Races,97.1,Female,Non-Hodgkin Lymphoma,2016
80-84,25.8,29.3,939,Incidence,3415481,All Races,27.5,Female,Oral Cavity and Pharynx,2016
80-84,42.6,47.1,1530,Incidence,3415481,All Races,44.8,Female,Ovary,2016
80-84,82.7,88.9,2930,Incidence,3415481,All Races,85.8,Female,Pancreas,2016
80-84,26.6,30.2,970,Incidence,3415481,All Races,28.4,Female,Stomach,2016
80-84,17.3,20.3,641,Incidence,3415481,All Races,18.8,Female,Thyroid,2016
80-84,66.3,71.9,2359,Incidence,3415481,All Races,69.1,Female,Urinary Bladder,2016
85+,1736.6,1762.1,72567,Incidence,4148383,All Races,1749.3,Female,All Cancer Sites Combined,2016
85+,13.7,16.1,616,Incidence,4148383,All Races,14.8,Female,Brain and Other Nervous System,2016
85+,6.7,8.4,312,Incidence,4148383,All Races,7.5,Female,Cervix,2016
85+,226.5,235.7,9585,Incidence,4148383,All Races,231.1,Female,Colon and Rectum,2016
85+,48.1,52.4,2084,Incidence,4148383,All Races,50.2,Female,"Corpus and Uterus, NOS",2016
85+,11.4,13.6,516,Incidence,4148383,All Races,12.4,Female,Esophagus,2016
85+,318.9,329.8,13454,Incidence,4148383,All Races,324.3,Female,Female Breast,2016
85+,21.7,24.6,959,Incidence,4148383,All Races,23.1,Female,"Female Breast, <i>in situ</i>",2016
85+,2.2,3.2,111,Incidence,4148383,All Races,2.7,Female,Hodgkin Lymphoma,2016
85+,0.6,1.1,34,Incidence,4148383,All Races,0.8,Female,Kaposi Sarcoma,2016
85+,37.8,41.7,1648,Incidence,4148383,All Races,39.7,Female,Kidney and Renal Pelvis,2016
85+,2.3,3.4,117,Incidence,4148383,All Races,2.8,Female,Larynx,2016
85+,65.0,70.0,2799,Incidence,4148383,All Races,67.5,Female,Leukemias,2016
85+,24.2,27.3,1065,Incidence,4148383,All Races,25.7,Female,Liver and Intrahepatic Bile Duct,2016
85+,243.0,252.6,10278,Incidence,4148383,All Races,247.8,Female,Lung and Bronchus,2016
85+,60.4,65.3,2605,Incidence,4148383,All Races,62.8,Female,Melanomas of the Skin,2016
85+,2.2,3.2,111,Incidence,4148383,All Races,2.7,Female,Mesothelioma,2016
85+,29.0,32.4,1274,Incidence,4148383,All Races,30.7,Female,Myeloma,2016
85+,83.3,89.0,3571,Incidence,4148383,All Races,86.1,Female,Non-Hodgkin Lymphoma,2016
85+,28.0,31.3,1229,Incidence,4148383,All Races,29.6,Female,Oral Cavity and Pharynx,2016
85+,35.8,39.6,1562,Incidence,4148383,All Races,37.7,Female,Ovary,2016
85+,90.1,96.0,3859,Incidence,4148383,All Races,93.0,Female,Pancreas,2016
85+,28.9,32.3,1267,Incidence,4148383,All Races,30.5,Female,Stomach,2016
85+,8.9,10.9,410,Incidence,4148383,All Races,9.9,Female,Thyroid,2016
85+,74.0,79.3,3178,Incidence,4148383,All Races,76.6,Female,Urinary Bladder,2016
<1,24.3,29.0,515,Incidence,1937196,All Races,26.6,Female,All Cancer Sites Combined,2016
<1,3.5,5.4,85,Incidence,1937196,All Races,4.4,Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Cervix,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Colon and Rectum,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Esophagus,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Female Breast,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Kaposi Sarcoma,2016
<1,1.5,2.8,40,Incidence,1937196,All Races,2.1,Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Larynx,2016
<1,3.3,5.2,81,Incidence,1937196,All Races,4.2,Female,Leukemias,2016
<1,1.3,2.5,35,Incidence,1937196,All Races,1.8,Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Mesothelioma,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Myeloma,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Ovary,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Pancreas,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Stomach,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Thyroid,2016
<1,~,~,~,Incidence,1937196,All Races,~,Female,Urinary Bladder,2016
1-4,23.3,25.4,1986,Incidence,8168137,All Races,24.3,Male,All Cancer Sites Combined,2016
1-4,4.6,5.6,417,Incidence,8168137,All Races,5.1,Male,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Colon and Rectum,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Esophagus,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Kaposi Sarcoma,2016
1-4,1.3,1.9,130,Incidence,8168137,All Races,1.6,Male,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Larynx,2016
1-4,8.8,10.1,772,Incidence,8168137,All Races,9.5,Male,Leukemias,2016
1-4,0.5,0.9,57,Incidence,8168137,All Races,0.7,Male,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Lung and Bronchus,2016
1-4,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Mesothelioma,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Myeloma,2016
1-4,0.8,1.2,80,Incidence,8168137,All Races,1.0,Male,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Pancreas,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Prostate,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Stomach,2016
1-4,0.3,0.6,38,Incidence,8168137,All Races,0.5,Male,Testis,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Thyroid,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male,Urinary Bladder,2016
10-14,15.8,17.4,1744,Incidence,10529234,All Races,16.6,Male,All Cancer Sites Combined,2016
10-14,2.8,3.5,330,Incidence,10529234,All Races,3.1,Male,Brain and Other Nervous System,2016
10-14,0.3,0.6,49,Incidence,10529234,All Races,0.5,Male,Colon and Rectum,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Esophagus,2016
10-14,1.2,1.7,155,Incidence,10529234,All Races,1.5,Male,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Kaposi Sarcoma,2016
10-14,0.1,0.3,21,Incidence,10529234,All Races,0.2,Male,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Larynx,2016
10-14,3.5,4.3,409,Incidence,10529234,All Races,3.9,Male,Leukemias,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Lung and Bronchus,2016
10-14,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
10-14,0.2,0.4,27,Incidence,10529234,All Races,0.3,Male,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Mesothelioma,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Myeloma,2016
10-14,1.6,2.2,199,Incidence,10529234,All Races,1.9,Male,Non-Hodgkin Lymphoma,2016
10-14,0.1,0.3,23,Incidence,10529234,All Races,0.2,Male,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Pancreas,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Prostate,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Stomach,2016
10-14,0.2,0.4,25,Incidence,10529234,All Races,0.2,Male,Testis,2016
10-14,0.3,0.5,41,Incidence,10529234,All Races,0.4,Male,Thyroid,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male,Urinary Bladder,2016
15-19,24.1,26.0,2708,Incidence,10804809,All Races,25.1,Male,All Cancer Sites Combined,2016
15-19,1.9,2.5,236,Incidence,10804809,All Races,2.2,Male,Brain and Other Nervous System,2016
15-19,1.1,1.5,136,Incidence,10804809,All Races,1.3,Male,Colon and Rectum,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Esophagus,2016
15-19,2.8,3.5,343,Incidence,10804809,All Races,3.2,Male,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Kaposi Sarcoma,2016
15-19,0.1,0.3,21,Incidence,10804809,All Races,0.2,Male,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Larynx,2016
15-19,3.6,4.4,428,Incidence,10804809,All Races,4.0,Male,Leukemias,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Liver and Intrahepatic Bile Duct,2016
15-19,0.1,0.3,17,Incidence,10804809,All Races,0.2,Male,Lung and Bronchus,2016
15-19,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
15-19,0.6,0.9,76,Incidence,10804809,All Races,0.7,Male,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Mesothelioma,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Myeloma,2016
15-19,2.3,2.9,278,Incidence,10804809,All Races,2.6,Male,Non-Hodgkin Lymphoma,2016
15-19,0.3,0.6,49,Incidence,10804809,All Races,0.5,Male,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Pancreas,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Prostate,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Stomach,2016
15-19,3.2,3.9,381,Incidence,10804809,All Races,3.5,Male,Testis,2016
15-19,1.0,1.4,124,Incidence,10804809,All Races,1.1,Male,Thyroid,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male,Urinary Bladder,2016
20-24,34.6,36.8,4101,Incidence,11486770,All Races,35.7,Male,All Cancer Sites Combined,2016
20-24,2.3,2.9,298,Incidence,11486770,All Races,2.6,Male,Brain and Other Nervous System,2016
20-24,1.2,1.6,161,Incidence,11486770,All Races,1.4,Male,Colon and Rectum,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male,Esophagus,2016
20-24,3.4,4.1,432,Incidence,11486770,All Races,3.8,Male,Hodgkin Lymphoma,2016
20-24,0.2,0.5,38,Incidence,11486770,All Races,0.3,Male,Kaposi Sarcoma,2016
20-24,0.4,0.7,63,Incidence,11486770,All Races,0.5,Male,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male,Larynx,2016
20-24,2.9,3.6,370,Incidence,11486770,All Races,3.2,Male,Leukemias,2016
20-24,0.1,0.3,20,Incidence,11486770,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2016
20-24,0.2,0.4,34,Incidence,11486770,All Races,0.3,Male,Lung and Bronchus,2016
20-24,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
20-24,1.5,2.0,201,Incidence,11486770,All Races,1.7,Male,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male,Mesothelioma,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male,Myeloma,2016
20-24,2.6,3.2,330,Incidence,11486770,All Races,2.9,Male,Non-Hodgkin Lymphoma,2016
20-24,0.6,0.9,84,Incidence,11486770,All Races,0.7,Male,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male,Pancreas,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male,Prostate,2016
20-24,0.2,0.3,27,Incidence,11486770,All Races,0.2,Male,Stomach,2016
20-24,10.0,11.2,1216,Incidence,11486770,All Races,10.6,Male,Testis,2016
20-24,2.1,2.7,276,Incidence,11486770,All Races,2.4,Male,Thyroid,2016
20-24,0.2,0.4,35,Incidence,11486770,All Races,0.3,Male,Urinary Bladder,2016
25-29,50.5,53.1,6047,Incidence,11668343,All Races,51.8,Male,All Cancer Sites Combined,2016
25-29,3.0,3.7,389,Incidence,11668343,All Races,3.3,Male,Brain and Other Nervous System,2016
25-29,2.9,3.5,374,Incidence,11668343,All Races,3.2,Male,Colon and Rectum,2016
25-29,~,~,~,Incidence,11668343,All Races,~,Male,Esophagus,2016
25-29,4.0,4.8,514,Incidence,11668343,All Races,4.4,Male,Hodgkin Lymphoma,2016
25-29,0.8,1.2,118,Incidence,11668343,All Races,1.0,Male,Kaposi Sarcoma,2016
25-29,1.4,1.8,187,Incidence,11668343,All Races,1.6,Male,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,11668343,All Races,~,Male,Larynx,2016
25-29,3.0,3.6,385,Incidence,11668343,All Races,3.3,Male,Leukemias,2016
25-29,0.3,0.6,49,Incidence,11668343,All Races,0.4,Male,Liver and Intrahepatic Bile Duct,2016
25-29,0.4,0.7,60,Incidence,11668343,All Races,0.5,Male,Lung and Bronchus,2016
25-29,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
25-29,3.1,3.8,397,Incidence,11668343,All Races,3.4,Male,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,11668343,All Races,~,Male,Mesothelioma,2016
25-29,~,~,~,Incidence,11668343,All Races,~,Male,Myeloma,2016
25-29,3.6,4.4,466,Incidence,11668343,All Races,4.0,Male,Non-Hodgkin Lymphoma,2016
25-29,0.9,1.3,131,Incidence,11668343,All Races,1.1,Male,Oral Cavity and Pharynx,2016
25-29,0.2,0.4,35,Incidence,11668343,All Races,0.3,Male,Pancreas,2016
25-29,~,~,~,Incidence,11668343,All Races,~,Male,Prostate,2016
25-29,0.4,0.7,67,Incidence,11668343,All Races,0.6,Male,Stomach,2016
25-29,13.8,15.2,1686,Incidence,11668343,All Races,14.4,Male,Testis,2016
25-29,3.4,4.1,441,Incidence,11668343,All Races,3.8,Male,Thyroid,2016
25-29,0.4,0.7,62,Incidence,11668343,All Races,0.5,Male,Urinary Bladder,2016
30-34,71.2,74.4,8010,Incidence,10997952,All Races,72.8,Male,All Cancer Sites Combined,2016
30-34,4.0,4.8,485,Incidence,10997952,All Races,4.4,Male,Brain and Other Nervous System,2016
30-34,5.6,6.6,668,Incidence,10997952,All Races,6.1,Male,Colon and Rectum,2016
30-34,0.3,0.5,39,Incidence,10997952,All Races,0.4,Male,Esophagus,2016
30-34,3.4,4.1,410,Incidence,10997952,All Races,3.7,Male,Hodgkin Lymphoma,2016
30-34,1.1,1.5,138,Incidence,10997952,All Races,1.3,Male,Kaposi Sarcoma,2016
30-34,3.7,4.5,451,Incidence,10997952,All Races,4.1,Male,Kidney and Renal Pelvis,2016
30-34,0.1,0.2,17,Incidence,10997952,All Races,0.2,Male,Larynx,2016
30-34,3.8,4.5,455,Incidence,10997952,All Races,4.1,Male,Leukemias,2016
30-34,0.6,0.9,77,Incidence,10997952,All Races,0.7,Male,Liver and Intrahepatic Bile Duct,2016
30-34,1.0,1.4,128,Incidence,10997952,All Races,1.2,Male,Lung and Bronchus,2016
30-34,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
30-34,6.5,7.5,770,Incidence,10997952,All Races,7.0,Male,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,10997952,All Races,~,Male,Mesothelioma,2016
30-34,0.4,0.6,52,Incidence,10997952,All Races,0.5,Male,Myeloma,2016
30-34,5.1,6.0,607,Incidence,10997952,All Races,5.5,Male,Non-Hodgkin Lymphoma,2016
30-34,1.7,2.2,210,Incidence,10997952,All Races,1.9,Male,Oral Cavity and Pharynx,2016
30-34,0.4,0.7,64,Incidence,10997952,All Races,0.6,Male,Pancreas,2016
30-34,~,~,~,Incidence,10997952,All Races,~,Male,Prostate,2016
30-34,0.9,1.2,114,Incidence,10997952,All Races,1.0,Male,Stomach,2016
30-34,14.7,16.1,1693,Incidence,10997952,All Races,15.4,Male,Testis,2016
30-34,5.4,6.3,643,Incidence,10997952,All Races,5.8,Male,Thyroid,2016
30-34,0.7,1.1,99,Incidence,10997952,All Races,0.9,Male,Urinary Bladder,2016
35-39,98.2,102.1,10400,Incidence,10385679,All Races,100.1,Male,All Cancer Sites Combined,2016
35-39,4.1,4.9,468,Incidence,10385679,All Races,4.5,Male,Brain and Other Nervous System,2016
35-39,10.7,12.0,1173,Incidence,10385679,All Races,11.3,Male,Colon and Rectum,2016
35-39,0.5,0.9,71,Incidence,10385679,All Races,0.7,Male,Esophagus,2016
35-39,3.1,3.9,362,Incidence,10385679,All Races,3.5,Male,Hodgkin Lymphoma,2016
35-39,0.8,1.2,102,Incidence,10385679,All Races,1.0,Male,Kaposi Sarcoma,2016
35-39,7.7,8.9,861,Incidence,10385679,All Races,8.3,Male,Kidney and Renal Pelvis,2016
35-39,0.3,0.5,38,Incidence,10385679,All Races,0.4,Male,Larynx,2016
35-39,4.9,5.8,557,Incidence,10385679,All Races,5.4,Male,Leukemias,2016
35-39,0.9,1.3,115,Incidence,10385679,All Races,1.1,Male,Liver and Intrahepatic Bile Duct,2016
35-39,2.4,3.1,286,Incidence,10385679,All Races,2.8,Male,Lung and Bronchus,2016
35-39,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
35-39,9.5,10.7,1045,Incidence,10385679,All Races,10.1,Male,Melanomas of the Skin,2016
35-39,0.1,0.3,17,Incidence,10385679,All Races,0.2,Male,Mesothelioma,2016
35-39,0.9,1.3,114,Incidence,10385679,All Races,1.1,Male,Myeloma,2016
35-39,7.6,8.7,840,Incidence,10385679,All Races,8.1,Male,Non-Hodgkin Lymphoma,2016
35-39,3.3,4.0,379,Incidence,10385679,All Races,3.6,Male,Oral Cavity and Pharynx,2016
35-39,1.5,2.0,177,Incidence,10385679,All Races,1.7,Male,Pancreas,2016
35-39,0.5,0.8,64,Incidence,10385679,All Races,0.6,Male,Prostate,2016
35-39,1.8,2.4,218,Incidence,10385679,All Races,2.1,Male,Stomach,2016
35-39,11.9,13.2,1303,Incidence,10385679,All Races,12.5,Male,Testis,2016
35-39,7.6,8.7,844,Incidence,10385679,All Races,8.1,Male,Thyroid,2016
35-39,1.8,2.4,219,Incidence,10385679,All Races,2.1,Male,Urinary Bladder,2016
40-44,153.5,158.5,15235,Incidence,9768609,All Races,156.0,Male,All Cancer Sites Combined,2016
40-44,4.6,5.5,490,Incidence,9768609,All Races,5.0,Male,Brain and Other Nervous System,2016
40-44,20.3,22.1,2070,Incidence,9768609,All Races,21.2,Male,Colon and Rectum,2016
40-44,1.5,2.0,168,Incidence,9768609,All Races,1.7,Male,Esophagus,2016
40-44,2.6,3.3,285,Incidence,9768609,All Races,2.9,Male,Hodgkin Lymphoma,2016
40-44,0.8,1.2,95,Incidence,9768609,All Races,1.0,Male,Kaposi Sarcoma,2016
40-44,14.5,16.1,1491,Incidence,9768609,All Races,15.3,Male,Kidney and Renal Pelvis,2016
40-44,1.2,1.7,137,Incidence,9768609,All Races,1.4,Male,Larynx,2016
40-44,7.1,8.2,743,Incidence,9768609,All Races,7.6,Male,Leukemias,2016
40-44,1.8,2.4,201,Incidence,9768609,All Races,2.1,Male,Liver and Intrahepatic Bile Duct,2016
40-44,6.1,7.2,649,Incidence,9768609,All Races,6.6,Male,Lung and Bronchus,2016
40-44,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
40-44,14.0,15.5,1442,Incidence,9768609,All Races,14.8,Male,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,9768609,All Races,~,Male,Mesothelioma,2016
40-44,2.4,3.0,263,Incidence,9768609,All Races,2.7,Male,Myeloma,2016
40-44,10.4,11.8,1082,Incidence,9768609,All Races,11.1,Male,Non-Hodgkin Lymphoma,2016
40-44,8.0,9.2,839,Incidence,9768609,All Races,8.6,Male,Oral Cavity and Pharynx,2016
40-44,3.2,3.9,344,Incidence,9768609,All Races,3.5,Male,Pancreas,2016
40-44,6.2,7.2,656,Incidence,9768609,All Races,6.7,Male,Prostate,2016
40-44,3.2,3.9,345,Incidence,9768609,All Races,3.5,Male,Stomach,2016
40-44,8.1,9.3,850,Incidence,9768609,All Races,8.7,Male,Testis,2016
40-44,9.4,10.6,974,Incidence,9768609,All Races,10.0,Male,Thyroid,2016
40-44,4.4,5.3,472,Incidence,9768609,All Races,4.8,Male,Urinary Bladder,2016
45-49,262.0,268.2,27453,Incidence,10356168,All Races,265.1,Male,All Cancer Sites Combined,2016
45-49,5.6,6.6,630,Incidence,10356168,All Races,6.1,Male,Brain and Other Nervous System,2016
45-49,36.9,39.3,3940,Incidence,10356168,All Races,38.0,Male,Colon and Rectum,2016
45-49,3.3,4.1,383,Incidence,10356168,All Races,3.7,Male,Esophagus,2016
45-49,2.5,3.2,293,Incidence,10356168,All Races,2.8,Male,Hodgkin Lymphoma,2016
45-49,0.9,1.3,111,Incidence,10356168,All Races,1.1,Male,Kaposi Sarcoma,2016
45-49,22.9,24.8,2466,Incidence,10356168,All Races,23.8,Male,Kidney and Renal Pelvis,2016
45-49,2.7,3.3,310,Incidence,10356168,All Races,3.0,Male,Larynx,2016
45-49,9.5,10.7,1047,Incidence,10356168,All Races,10.1,Male,Leukemias,2016
45-49,5.2,6.1,582,Incidence,10356168,All Races,5.6,Male,Liver and Intrahepatic Bile Duct,2016
45-49,15.7,17.3,1704,Incidence,10356168,All Races,16.5,Male,Lung and Bronchus,2016
45-49,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
45-49,20.1,21.9,2176,Incidence,10356168,All Races,21.0,Male,Melanomas of the Skin,2016
45-49,0.2,0.4,26,Incidence,10356168,All Races,0.3,Male,Mesothelioma,2016
45-49,4.4,5.3,501,Incidence,10356168,All Races,4.8,Male,Myeloma,2016
45-49,15.2,16.7,1651,Incidence,10356168,All Races,15.9,Male,Non-Hodgkin Lymphoma,2016
45-49,17.5,19.2,1897,Incidence,10356168,All Races,18.3,Male,Oral Cavity and Pharynx,2016
45-49,6.4,7.4,715,Incidence,10356168,All Races,6.9,Male,Pancreas,2016
45-49,28.7,30.8,3075,Incidence,10356168,All Races,29.7,Male,Prostate,2016
45-49,5.3,6.2,597,Incidence,10356168,All Races,5.8,Male,Stomach,2016
45-49,5.6,6.6,632,Incidence,10356168,All Races,6.1,Male,Testis,2016
45-49,11.2,12.6,1230,Incidence,10356168,All Races,11.9,Male,Thyroid,2016
45-49,8.1,9.3,898,Incidence,10356168,All Races,8.7,Male,Urinary Bladder,2016
5-9,14.2,15.6,1555,Incidence,10442552,All Races,14.9,Male,All Cancer Sites Combined,2016
5-9,3.4,4.1,390,Incidence,10442552,All Races,3.7,Male,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Colon and Rectum,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Esophagus,2016
5-9,0.4,0.7,56,Incidence,10442552,All Races,0.5,Male,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Kaposi Sarcoma,2016
5-9,0.4,0.7,60,Incidence,10442552,All Races,0.6,Male,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Larynx,2016
5-9,4.3,5.1,492,Incidence,10442552,All Races,4.7,Male,Leukemias,2016
5-9,0.1,0.3,18,Incidence,10442552,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Lung and Bronchus,2016
5-9,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
5-9,0.1,0.3,20,Incidence,10442552,All Races,0.2,Male,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Mesothelioma,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Myeloma,2016
5-9,1.3,1.8,165,Incidence,10442552,All Races,1.6,Male,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Pancreas,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Prostate,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Stomach,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Testis,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Thyroid,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male,Urinary Bladder,2016
50-54,526.3,535.0,56825,Incidence,10708723,All Races,530.6,Male,All Cancer Sites Combined,2016
50-54,8.4,9.6,962,Incidence,10708723,All Races,9.0,Male,Brain and Other Nervous System,2016
50-54,70.2,73.4,7689,Incidence,10708723,All Races,71.8,Male,Colon and Rectum,2016
50-54,8.4,9.6,962,Incidence,10708723,All Races,9.0,Male,Esophagus,2016
50-54,2.8,3.5,332,Incidence,10708723,All Races,3.1,Male,Hodgkin Lymphoma,2016
50-54,0.8,1.2,103,Incidence,10708723,All Races,1.0,Male,Kaposi Sarcoma,2016
50-54,35.3,37.6,3900,Incidence,10708723,All Races,36.4,Male,Kidney and Renal Pelvis,2016
50-54,7.6,8.7,876,Incidence,10708723,All Races,8.2,Male,Larynx,2016
50-54,15.4,16.9,1728,Incidence,10708723,All Races,16.1,Male,Leukemias,2016
50-54,16.2,17.7,1815,Incidence,10708723,All Races,16.9,Male,Liver and Intrahepatic Bile Duct,2016
50-54,46.4,49.0,5109,Incidence,10708723,All Races,47.7,Male,Lung and Bronchus,2016
50-54,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
50-54,31.3,33.5,3465,Incidence,10708723,All Races,32.4,Male,Melanomas of the Skin,2016
50-54,0.3,0.6,46,Incidence,10708723,All Races,0.4,Male,Mesothelioma,2016
50-54,8.5,9.7,974,Incidence,10708723,All Races,9.1,Male,Myeloma,2016
50-54,23.8,25.7,2653,Incidence,10708723,All Races,24.8,Male,Non-Hodgkin Lymphoma,2016
50-54,32.2,34.4,3562,Incidence,10708723,All Races,33.3,Male,Oral Cavity and Pharynx,2016
50-54,13.8,15.2,1551,Incidence,10708723,All Races,14.5,Male,Pancreas,2016
50-54,109.9,113.9,11978,Incidence,10708723,All Races,111.9,Male,Prostate,2016
50-54,8.8,10.0,1009,Incidence,10708723,All Races,9.4,Male,Stomach,2016
50-54,4.4,5.2,511,Incidence,10708723,All Races,4.8,Male,Testis,2016
50-54,11.0,12.3,1251,Incidence,10708723,All Races,11.7,Male,Thyroid,2016
50-54,19.3,21.0,2157,Incidence,10708723,All Races,20.1,Male,Urinary Bladder,2016
55-59,895.7,907.1,96124,Incidence,10663988,All Races,901.4,Male,All Cancer Sites Combined,2016
55-59,11.8,13.2,1330,Incidence,10663988,All Races,12.5,Male,Brain and Other Nervous System,2016
55-59,81.4,84.9,8865,Incidence,10663988,All Races,83.1,Male,Colon and Rectum,2016
55-59,14.8,16.3,1657,Incidence,10663988,All Races,15.5,Male,Esophagus,2016
55-59,2.9,3.6,343,Incidence,10663988,All Races,3.2,Male,Hodgkin Lymphoma,2016
55-59,0.6,0.9,81,Incidence,10663988,All Races,0.8,Male,Kaposi Sarcoma,2016
55-59,50.9,53.6,5572,Incidence,10663988,All Races,52.3,Male,Kidney and Renal Pelvis,2016
55-59,13.1,14.5,1473,Incidence,10663988,All Races,13.8,Male,Larynx,2016
55-59,23.7,25.6,2623,Incidence,10663988,All Races,24.6,Male,Leukemias,2016
55-59,37.5,39.9,4125,Incidence,10663988,All Races,38.7,Male,Liver and Intrahepatic Bile Duct,2016
55-59,104.0,107.9,11293,Incidence,10663988,All Races,105.9,Male,Lung and Bronchus,2016
55-59,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
55-59,45.6,48.2,4997,Incidence,10663988,All Races,46.9,Male,Melanomas of the Skin,2016
55-59,0.9,1.3,120,Incidence,10663988,All Races,1.1,Male,Mesothelioma,2016
55-59,14.2,15.7,1590,Incidence,10663988,All Races,14.9,Male,Myeloma,2016
55-59,34.6,36.9,3807,Incidence,10663988,All Races,35.7,Male,Non-Hodgkin Lymphoma,2016
55-59,50.1,52.9,5490,Incidence,10663988,All Races,51.5,Male,Oral Cavity and Pharynx,2016
55-59,23.4,25.2,2590,Incidence,10663988,All Races,24.3,Male,Pancreas,2016
55-59,239.5,245.4,25856,Incidence,10663988,All Races,242.5,Male,Prostate,2016
55-59,14.5,15.9,1619,Incidence,10663988,All Races,15.2,Male,Stomach,2016
55-59,2.8,3.5,334,Incidence,10663988,All Races,3.1,Male,Testis,2016
55-59,14.1,15.5,1578,Incidence,10663988,All Races,14.8,Male,Thyroid,2016
55-59,39.6,42.1,4354,Incidence,10663988,All Races,40.8,Male,Urinary Bladder,2016
60-64,1360.6,1375.7,127204,Incidence,9297699,All Races,1368.1,Male,All Cancer Sites Combined,2016
60-64,15.6,17.2,1525,Incidence,9297699,All Races,16.4,Male,Brain and Other Nervous System,2016
60-64,106.8,111.0,10124,Incidence,9297699,All Races,108.9,Male,Colon and Rectum,2016
60-64,23.8,25.8,2307,Incidence,9297699,All Races,24.8,Male,Esophagus,2016
60-64,2.7,3.5,286,Incidence,9297699,All Races,3.1,Male,Hodgkin Lymphoma,2016
60-64,0.6,1.0,74,Incidence,9297699,All Races,0.8,Male,Kaposi Sarcoma,2016
60-64,64.7,68.0,6165,Incidence,9297699,All Races,66.3,Male,Kidney and Renal Pelvis,2016
60-64,17.5,19.2,1705,Incidence,9297699,All Races,18.3,Male,Larynx,2016
60-64,36.2,38.7,3482,Incidence,9297699,All Races,37.5,Male,Leukemias,2016
60-64,60.5,63.7,5769,Incidence,9297699,All Races,62.0,Male,Liver and Intrahepatic Bile Duct,2016
60-64,170.1,175.4,16061,Incidence,9297699,All Races,172.7,Male,Lung and Bronchus,2016
60-64,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
60-64,65.7,69.1,6266,Incidence,9297699,All Races,67.4,Male,Melanomas of the Skin,2016
60-64,1.9,2.5,200,Incidence,9297699,All Races,2.2,Male,Mesothelioma,2016
60-64,21.5,23.5,2091,Incidence,9297699,All Races,22.5,Male,Myeloma,2016
60-64,49.3,52.3,4722,Incidence,9297699,All Races,50.8,Male,Non-Hodgkin Lymphoma,2016
60-64,62.5,65.8,5964,Incidence,9297699,All Races,64.1,Male,Oral Cavity and Pharynx,2016
60-64,39.4,42.0,3780,Incidence,9297699,All Races,40.7,Male,Pancreas,2016
60-64,408.9,417.2,38400,Incidence,9297699,All Races,413.0,Male,Prostate,2016
60-64,20.5,22.4,1995,Incidence,9297699,All Races,21.5,Male,Stomach,2016
60-64,1.9,2.5,202,Incidence,9297699,All Races,2.2,Male,Testis,2016
60-64,15.2,16.8,1484,Incidence,9297699,All Races,16.0,Male,Thyroid,2016
60-64,67.5,70.9,6436,Incidence,9297699,All Races,69.2,Male,Urinary Bladder,2016
65-69,1927.7,1947.1,153588,Incidence,7927580,All Races,1937.4,Male,All Cancer Sites Combined,2016
65-69,19.3,21.3,1609,Incidence,7927580,All Races,20.3,Male,Brain and Other Nervous System,2016
65-69,138.7,144.0,11206,Incidence,7927580,All Races,141.4,Male,Colon and Rectum,2016
65-69,31.6,34.2,2607,Incidence,7927580,All Races,32.9,Male,Esophagus,2016
65-69,3.4,4.3,306,Incidence,7927580,All Races,3.9,Male,Hodgkin Lymphoma,2016
65-69,0.7,1.1,67,Incidence,7927580,All Races,0.8,Male,Kaposi Sarcoma,2016
65-69,85.6,89.8,6951,Incidence,7927580,All Races,87.7,Male,Kidney and Renal Pelvis,2016
65-69,21.8,23.9,1811,Incidence,7927580,All Races,22.8,Male,Larynx,2016
65-69,52.6,55.8,4294,Incidence,7927580,All Races,54.2,Male,Leukemias,2016
65-69,61.2,64.7,4988,Incidence,7927580,All Races,62.9,Male,Liver and Intrahepatic Bile Duct,2016
65-69,260.0,267.1,20892,Incidence,7927580,All Races,263.5,Male,Lung and Bronchus,2016
65-69,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
65-69,95.4,99.8,7736,Incidence,7927580,All Races,97.6,Male,Melanomas of the Skin,2016
65-69,3.5,4.4,315,Incidence,7927580,All Races,4.0,Male,Mesothelioma,2016
65-69,33.1,35.7,2724,Incidence,7927580,All Races,34.4,Male,Myeloma,2016
65-69,70.3,74.0,5717,Incidence,7927580,All Races,72.1,Male,Non-Hodgkin Lymphoma,2016
65-69,67.5,71.2,5497,Incidence,7927580,All Races,69.3,Male,Oral Cavity and Pharynx,2016
65-69,55.6,59.0,4540,Incidence,7927580,All Races,57.3,Male,Pancreas,2016
65-69,616.7,627.7,49325,Incidence,7927580,All Races,622.2,Male,Prostate,2016
65-69,28.5,30.9,2355,Incidence,7927580,All Races,29.7,Male,Stomach,2016
65-69,1.2,1.8,118,Incidence,7927580,All Races,1.5,Male,Testis,2016
65-69,18.0,20.0,1506,Incidence,7927580,All Races,19.0,Male,Thyroid,2016
65-69,111.9,116.6,9057,Incidence,7927580,All Races,114.2,Male,Urinary Bladder,2016
70-74,2355.1,2380.9,128916,Incidence,5444125,All Races,2368.0,Male,All Cancer Sites Combined,2016
70-74,21.0,23.6,1213,Incidence,5444125,All Races,22.3,Male,Brain and Other Nervous System,2016
70-74,168.5,175.4,9360,Incidence,5444125,All Races,171.9,Male,Colon and Rectum,2016
70-74,39.1,42.5,2220,Incidence,5444125,All Races,40.8,Male,Esophagus,2016
70-74,4.4,5.6,273,Incidence,5444125,All Races,5.0,Male,Hodgkin Lymphoma,2016
70-74,0.4,0.8,32,Incidence,5444125,All Races,0.6,Male,Kaposi Sarcoma,2016
70-74,97.7,103.0,5461,Incidence,5444125,All Races,100.3,Male,Kidney and Renal Pelvis,2016
70-74,24.7,27.4,1415,Incidence,5444125,All Races,26.0,Male,Larynx,2016
70-74,72.5,77.1,4071,Incidence,5444125,All Races,74.8,Male,Leukemias,2016
70-74,52.6,56.5,2967,Incidence,5444125,All Races,54.5,Male,Liver and Intrahepatic Bile Duct,2016
70-74,383.2,393.7,21148,Incidence,5444125,All Races,388.5,Male,Lung and Bronchus,2016
70-74,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
70-74,124.3,130.3,6929,Incidence,5444125,All Races,127.3,Male,Melanomas of the Skin,2016
70-74,7.0,8.5,420,Incidence,5444125,All Races,7.7,Male,Mesothelioma,2016
70-74,42.6,46.2,2415,Incidence,5444125,All Races,44.4,Male,Myeloma,2016
70-74,99.3,104.7,5552,Incidence,5444125,All Races,102.0,Male,Non-Hodgkin Lymphoma,2016
70-74,68.6,73.1,3854,Incidence,5444125,All Races,70.8,Male,Oral Cavity and Pharynx,2016
70-74,73.8,78.5,4145,Incidence,5444125,All Races,76.1,Male,Pancreas,2016
70-74,630.9,644.3,34712,Incidence,5444125,All Races,637.6,Male,Prostate,2016
70-74,39.5,42.9,2240,Incidence,5444125,All Races,41.1,Male,Stomach,2016
70-74,0.7,1.3,54,Incidence,5444125,All Races,1.0,Male,Testis,2016
70-74,16.9,19.2,980,Incidence,5444125,All Races,18.0,Male,Thyroid,2016
70-74,177.7,184.8,9866,Incidence,5444125,All Races,181.2,Male,Urinary Bladder,2016
75-79,2671.2,2704.6,100028,Incidence,3721492,All Races,2687.8,Male,All Cancer Sites Combined,2016
75-79,25.3,28.6,1001,Incidence,3721492,All Races,26.9,Male,Brain and Other Nervous System,2016
75-79,209.5,219.0,7972,Incidence,3721492,All Races,214.2,Male,Colon and Rectum,2016
75-79,40.6,44.9,1589,Incidence,3721492,All Races,42.7,Male,Esophagus,2016
75-79,4.3,5.8,186,Incidence,3721492,All Races,5.0,Male,Hodgkin Lymphoma,2016
75-79,0.8,1.6,43,Incidence,3721492,All Races,1.2,Male,Kaposi Sarcoma,2016
75-79,101.2,107.8,3887,Incidence,3721492,All Races,104.4,Male,Kidney and Renal Pelvis,2016
75-79,25.4,28.8,1008,Incidence,3721492,All Races,27.1,Male,Larynx,2016
75-79,96.5,103.0,3710,Incidence,3721492,All Races,99.7,Male,Leukemias,2016
75-79,53.5,58.4,2081,Incidence,3721492,All Races,55.9,Male,Liver and Intrahepatic Bile Duct,2016
75-79,471.7,485.8,17815,Incidence,3721492,All Races,478.7,Male,Lung and Bronchus,2016
75-79,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
75-79,151.6,159.6,5790,Incidence,3721492,All Races,155.6,Male,Melanomas of the Skin,2016
75-79,10.8,13.0,442,Incidence,3721492,All Races,11.9,Male,Mesothelioma,2016
75-79,51.4,56.1,2000,Incidence,3721492,All Races,53.7,Male,Myeloma,2016
75-79,124.0,131.3,4749,Incidence,3721492,All Races,127.6,Male,Non-Hodgkin Lymphoma,2016
75-79,67.5,73.0,2613,Incidence,3721492,All Races,70.2,Male,Oral Cavity and Pharynx,2016
75-79,87.8,93.9,3379,Incidence,3721492,All Races,90.8,Male,Pancreas,2016
75-79,559.1,574.4,21090,Incidence,3721492,All Races,566.7,Male,Prostate,2016
75-79,47.4,51.9,1847,Incidence,3721492,All Races,49.6,Male,Stomach,2016
75-79,0.8,1.5,40,Incidence,3721492,All Races,1.1,Male,Testis,2016
75-79,17.5,20.4,704,Incidence,3721492,All Races,18.9,Male,Thyroid,2016
75-79,239.6,249.7,9104,Incidence,3721492,All Races,244.6,Male,Urinary Bladder,2016
80-84,2838.8,2881.2,70158,Incidence,2453136,All Races,2859.9,Male,All Cancer Sites Combined,2016
80-84,25.8,30.0,683,Incidence,2453136,All Races,27.8,Male,Brain and Other Nervous System,2016
80-84,240.3,252.8,6047,Incidence,2453136,All Races,246.5,Male,Colon and Rectum,2016
80-84,43.9,49.4,1143,Incidence,2453136,All Races,46.6,Male,Esophagus,2016
80-84,4.2,6.0,123,Incidence,2453136,All Races,5.0,Male,Hodgkin Lymphoma,2016
80-84,1.1,2.2,39,Incidence,2453136,All Races,1.6,Male,Kaposi Sarcoma,2016
80-84,97.0,105.0,2476,Incidence,2453136,All Races,100.9,Male,Kidney and Renal Pelvis,2016
80-84,24.1,28.2,640,Incidence,2453136,All Races,26.1,Male,Larynx,2016
80-84,114.7,123.4,2919,Incidence,2453136,All Races,119.0,Male,Leukemias,2016
80-84,52.8,58.8,1368,Incidence,2453136,All Races,55.8,Male,Liver and Intrahepatic Bile Duct,2016
80-84,490.7,508.4,12254,Incidence,2453136,All Races,499.5,Male,Lung and Bronchus,2016
80-84,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
80-84,181.5,192.3,4583,Incidence,2453136,All Races,186.8,Male,Melanomas of the Skin,2016
80-84,15.8,19.1,426,Incidence,2453136,All Races,17.4,Male,Mesothelioma,2016
80-84,60.4,66.8,1559,Incidence,2453136,All Races,63.6,Male,Myeloma,2016
80-84,140.0,149.6,3550,Incidence,2453136,All Races,144.7,Male,Non-Hodgkin Lymphoma,2016
80-84,65.3,71.9,1681,Incidence,2453136,All Races,68.5,Male,Oral Cavity and Pharynx,2016
80-84,98.5,106.5,2513,Incidence,2453136,All Races,102.4,Male,Pancreas,2016
80-84,425.5,442.0,10639,Incidence,2453136,All Races,433.7,Male,Prostate,2016
80-84,52.2,58.1,1351,Incidence,2453136,All Races,55.1,Male,Stomach,2016
80-84,~,~,~,Incidence,2453136,All Races,~,Male,Testis,2016
80-84,13.4,16.4,364,Incidence,2453136,All Races,14.8,Male,Thyroid,2016
80-84,315.1,329.3,7902,Incidence,2453136,All Races,322.1,Male,Urinary Bladder,2016
85+,2783.8,2827.8,62697,Incidence,2234625,All Races,2805.7,Male,All Cancer Sites Combined,2016
85+,21.5,25.5,524,Incidence,2234625,All Races,23.4,Male,Brain and Other Nervous System,2016
85+,265.0,278.7,6073,Incidence,2234625,All Races,271.8,Male,Colon and Rectum,2016
85+,40.1,45.6,956,Incidence,2234625,All Races,42.8,Male,Esophagus,2016
85+,2.8,4.5,80,Incidence,2234625,All Races,3.6,Male,Hodgkin Lymphoma,2016
85+,1.4,2.6,44,Incidence,2234625,All Races,2.0,Male,Kaposi Sarcoma,2016
85+,77.8,85.4,1822,Incidence,2234625,All Races,81.5,Male,Kidney and Renal Pelvis,2016
85+,20.9,24.9,511,Incidence,2234625,All Races,22.9,Male,Larynx,2016
85+,125.3,134.8,2904,Incidence,2234625,All Races,130.0,Male,Leukemias,2016
85+,46.2,52.1,1097,Incidence,2234625,All Races,49.1,Male,Liver and Intrahepatic Bile Duct,2016
85+,406.3,423.3,9268,Incidence,2234625,All Races,414.7,Male,Lung and Bronchus,2016
85+,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
85+,196.7,208.5,4526,Incidence,2234625,All Races,202.5,Male,Melanomas of the Skin,2016
85+,15.3,18.8,380,Incidence,2234625,All Races,17.0,Male,Mesothelioma,2016
85+,53.9,60.2,1274,Incidence,2234625,All Races,57.0,Male,Myeloma,2016
85+,136.9,146.8,3169,Incidence,2234625,All Races,141.8,Male,Non-Hodgkin Lymphoma,2016
85+,57.7,64.2,1361,Incidence,2234625,All Races,60.9,Male,Oral Cavity and Pharynx,2016
85+,101.4,110.0,2361,Incidence,2234625,All Races,105.7,Male,Pancreas,2016
85+,369.9,386.1,8446,Incidence,2234625,All Races,378.0,Male,Prostate,2016
85+,57.5,64.0,1356,Incidence,2234625,All Races,60.7,Male,Stomach,2016
85+,0.6,1.4,21,Incidence,2234625,All Races,0.9,Male,Testis,2016
85+,7.6,10.1,197,Incidence,2234625,All Races,8.8,Male,Thyroid,2016
85+,340.9,356.4,7789,Incidence,2234625,All Races,348.6,Male,Urinary Bladder,2016
<1,26.7,31.5,588,Incidence,2026072,All Races,29.0,Male,All Cancer Sites Combined,2016
<1,3.3,5.1,84,Incidence,2026072,All Races,4.1,Male,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Colon and Rectum,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Esophagus,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Kaposi Sarcoma,2016
<1,0.7,1.7,23,Incidence,2026072,All Races,1.1,Male,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Larynx,2016
<1,3.5,5.4,89,Incidence,2026072,All Races,4.4,Male,Leukemias,2016
<1,1.4,2.7,40,Incidence,2026072,All Races,2.0,Male,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Lung and Bronchus,2016
<1,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Melanomas of the Skin,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Mesothelioma,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Myeloma,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Pancreas,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Prostate,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Stomach,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Testis,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Thyroid,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male,Urinary Bladder,2016
1-4,22.1,23.6,3644,Incidence,15973469,All Races,22.8,Male and Female,All Cancer Sites Combined,2016
1-4,4.4,5.1,761,Incidence,15973469,All Races,4.8,Male and Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,Cervix,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Esophagus,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,Female Breast,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Kaposi Sarcoma,2016
1-4,1.6,2.1,294,Incidence,15973469,All Races,1.8,Male and Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Larynx,2016
1-4,8.4,9.4,1422,Incidence,15973469,All Races,8.9,Male and Female,Leukemias,2016
1-4,0.5,0.7,98,Incidence,15973469,All Races,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
1-4,0.1,0.2,17,Incidence,15973469,All Races,0.1,Male and Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,Male and Female Breast,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
1-4,0.1,0.2,16,Incidence,15973469,All Races,0.1,Male and Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Mesothelioma,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Myeloma,2016
1-4,0.6,0.9,117,Incidence,15973469,All Races,0.7,Male and Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,7805332,All Races,~,Male and Female,Ovary,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Pancreas,2016
1-4,~,~,~,Incidence,8168137,All Races,~,Male and Female,Prostate,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Stomach,2016
1-4,0.3,0.6,38,Incidence,8168137,All Races,0.5,Male and Female,Testis,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Thyroid,2016
1-4,~,~,~,Incidence,15973469,All Races,~,Male and Female,Urinary Bladder,2016
10-14,15.5,16.6,3312,Incidence,20634000,All Races,16.1,Male and Female,All Cancer Sites Combined,2016
10-14,2.7,3.2,609,Incidence,20634000,All Races,3.0,Male and Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Male and Female,Cervix,2016
10-14,0.5,0.7,123,Incidence,20634000,All Races,0.6,Male and Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Male and Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Esophagus,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Male and Female,Female Breast,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2016
10-14,1.2,1.5,272,Incidence,20634000,All Races,1.3,Male and Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Kaposi Sarcoma,2016
10-14,0.1,0.3,42,Incidence,20634000,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Larynx,2016
10-14,3.4,3.9,747,Incidence,20634000,All Races,3.6,Male and Female,Leukemias,2016
10-14,0.1,0.2,21,Incidence,20634000,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Male and Female,Male and Female Breast,2016
10-14,~,~,~,Incidence,10104766,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
10-14,0.2,0.3,54,Incidence,20634000,All Races,0.3,Male and Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Mesothelioma,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Myeloma,2016
10-14,1.3,1.7,305,Incidence,20634000,All Races,1.5,Male and Female,Non-Hodgkin Lymphoma,2016
10-14,0.2,0.4,56,Incidence,20634000,All Races,0.3,Male and Female,Oral Cavity and Pharynx,2016
10-14,0.6,0.9,72,Incidence,10104766,All Races,0.7,Male and Female,Ovary,2016
10-14,0.1,0.2,24,Incidence,20634000,All Races,0.1,Male and Female,Pancreas,2016
10-14,~,~,~,Incidence,10529234,All Races,~,Male and Female,Prostate,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Stomach,2016
10-14,0.2,0.4,25,Incidence,10529234,All Races,0.2,Male and Female,Testis,2016
10-14,0.7,1.0,174,Incidence,20634000,All Races,0.8,Male and Female,Thyroid,2016
10-14,~,~,~,Incidence,20634000,All Races,~,Male and Female,Urinary Bladder,2016
15-19,24.0,25.3,5208,Incidence,21140143,All Races,24.6,Male and Female,All Cancer Sites Combined,2016
15-19,1.9,2.3,443,Incidence,21140143,All Races,2.1,Male and Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Male and Female,Cervix,2016
15-19,1.3,1.6,303,Incidence,21140143,All Races,1.4,Male and Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Male and Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,21140143,All Races,~,Male and Female,Esophagus,2016
15-19,0.1,0.3,20,Incidence,10335334,All Races,0.2,Male and Female,Female Breast,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2016
15-19,3.0,3.5,688,Incidence,21140143,All Races,3.3,Male and Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,21140143,All Races,~,Male and Female,Kaposi Sarcoma,2016
15-19,0.2,0.3,45,Incidence,21140143,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,21140143,All Races,~,Male and Female,Larynx,2016
15-19,3.0,3.5,681,Incidence,21140143,All Races,3.2,Male and Female,Leukemias,2016
15-19,0.1,0.2,26,Incidence,21140143,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
15-19,0.1,0.2,30,Incidence,21140143,All Races,0.1,Male and Female,Lung and Bronchus,2016
15-19,0.1,0.3,20,Incidence,10335334,All Races,0.2,Male and Female,Male and Female Breast,2016
15-19,~,~,~,Incidence,10335334,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
15-19,0.8,1.1,197,Incidence,21140143,All Races,0.9,Male and Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,21140143,All Races,~,Male and Female,Mesothelioma,2016
15-19,~,~,~,Incidence,21140143,All Races,~,Male and Female,Myeloma,2016
15-19,1.8,2.2,420,Incidence,21140143,All Races,2.0,Male and Female,Non-Hodgkin Lymphoma,2016
15-19,0.4,0.6,106,Incidence,21140143,All Races,0.5,Male and Female,Oral Cavity and Pharynx,2016
15-19,1.1,1.5,131,Incidence,10335334,All Races,1.3,Male and Female,Ovary,2016
15-19,0.1,0.2,33,Incidence,21140143,All Races,0.2,Male and Female,Pancreas,2016
15-19,~,~,~,Incidence,10804809,All Races,~,Male and Female,Prostate,2016
15-19,0.1,0.1,18,Incidence,21140143,All Races,0.1,Male and Female,Stomach,2016
15-19,3.2,3.9,381,Incidence,10804809,All Races,3.5,Male and Female,Testis,2016
15-19,3.2,3.7,729,Incidence,21140143,All Races,3.4,Male and Female,Thyroid,2016
15-19,~,~,~,Incidence,21140143,All Races,~,Male and Female,Urinary Bladder,2016
20-24,36.5,38.1,8344,Incidence,22367653,All Races,37.3,Male and Female,All Cancer Sites Combined,2016
20-24,2.0,2.4,492,Incidence,22367653,All Races,2.2,Male and Female,Brain and Other Nervous System,2016
20-24,0.7,1.0,91,Incidence,10880883,All Races,0.8,Male and Female,Cervix,2016
20-24,1.7,2.1,418,Incidence,22367653,All Races,1.9,Male and Female,Colon and Rectum,2016
20-24,0.4,0.7,61,Incidence,10880883,All Races,0.6,Male and Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,22367653,All Races,~,Male and Female,Esophagus,2016
20-24,1.5,2.0,192,Incidence,10880883,All Races,1.8,Male and Female,Female Breast,2016
20-24,0.1,0.3,21,Incidence,10880883,All Races,0.2,Male and Female,"Female Breast, <i>in situ</i>",2016
20-24,3.8,4.3,900,Incidence,22367653,All Races,4.0,Male and Female,Hodgkin Lymphoma,2016
20-24,0.1,0.2,39,Incidence,22367653,All Races,0.2,Male and Female,Kaposi Sarcoma,2016
20-24,0.5,0.7,123,Incidence,22367653,All Races,0.5,Male and Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,22367653,All Races,~,Male and Female,Larynx,2016
20-24,2.5,3.0,611,Incidence,22367653,All Races,2.7,Male and Female,Leukemias,2016
20-24,0.1,0.3,44,Incidence,22367653,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
20-24,0.2,0.4,71,Incidence,22367653,All Races,0.3,Male and Female,Lung and Bronchus,2016
20-24,1.5,2.0,192,Incidence,10880883,All Races,1.8,Male and Female,Male and Female Breast,2016
20-24,0.1,0.3,21,Incidence,10880883,All Races,0.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
20-24,2.6,3.0,621,Incidence,22367653,All Races,2.8,Male and Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,22367653,All Races,~,Male and Female,Mesothelioma,2016
20-24,~,~,~,Incidence,22367653,All Races,~,Male and Female,Myeloma,2016
20-24,2.3,2.7,551,Incidence,22367653,All Races,2.5,Male and Female,Non-Hodgkin Lymphoma,2016
20-24,0.6,0.8,149,Incidence,22367653,All Races,0.7,Male and Female,Oral Cavity and Pharynx,2016
20-24,1.5,2.1,194,Incidence,10880883,All Races,1.8,Male and Female,Ovary,2016
20-24,0.1,0.2,39,Incidence,22367653,All Races,0.2,Male and Female,Pancreas,2016
20-24,~,~,~,Incidence,11486770,All Races,~,Male and Female,Prostate,2016
20-24,0.2,0.3,52,Incidence,22367653,All Races,0.2,Male and Female,Stomach,2016
20-24,10.0,11.2,1216,Incidence,11486770,All Races,10.6,Male and Female,Testis,2016
20-24,6.3,7.0,1488,Incidence,22367653,All Races,6.7,Male and Female,Thyroid,2016
20-24,0.2,0.3,53,Incidence,22367653,All Races,0.2,Male and Female,Urinary Bladder,2016
25-29,61.3,63.4,14296,Incidence,22939672,All Races,62.3,Male and Female,All Cancer Sites Combined,2016
25-29,2.7,3.1,659,Incidence,22939672,All Races,2.9,Male and Female,Brain and Other Nervous System,2016
25-29,5.1,5.9,618,Incidence,11271329,All Races,5.5,Male and Female,Cervix,2016
25-29,3.2,3.7,797,Incidence,22939672,All Races,3.5,Male and Female,Colon and Rectum,2016
25-29,1.8,2.4,234,Incidence,11271329,All Races,2.1,Male and Female,"Corpus and Uterus, NOS",2016
25-29,0.1,0.1,21,Incidence,22939672,All Races,0.1,Male and Female,Esophagus,2016
25-29,10.1,11.3,1201,Incidence,11271329,All Races,10.7,Male and Female,Female Breast,2016
25-29,0.7,1.0,91,Incidence,11271329,All Races,0.8,Male and Female,"Female Breast, <i>in situ</i>",2016
25-29,3.8,4.4,937,Incidence,22939672,All Races,4.1,Male and Female,Hodgkin Lymphoma,2016
25-29,0.4,0.6,121,Incidence,22939672,All Races,0.5,Male and Female,Kaposi Sarcoma,2016
25-29,1.4,1.7,348,Incidence,22939672,All Races,1.5,Male and Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,22939672,All Races,~,Male and Female,Larynx,2016
25-29,2.7,3.1,664,Incidence,22939672,All Races,2.9,Male and Female,Leukemias,2016
25-29,0.3,0.4,79,Incidence,22939672,All Races,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2016
25-29,0.4,0.6,122,Incidence,22939672,All Races,0.5,Male and Female,Lung and Bronchus,2016
25-29,10.1,11.3,1201,Incidence,11271329,All Races,10.7,Male and Female,Male and Female Breast,2016
25-29,0.7,1.0,91,Incidence,11271329,All Races,0.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
25-29,5.6,6.3,1362,Incidence,22939672,All Races,5.9,Male and Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,22939672,All Races,~,Male and Female,Mesothelioma,2016
25-29,0.0,0.1,19,Incidence,22939672,All Races,0.1,Male and Female,Myeloma,2016
25-29,2.9,3.4,726,Incidence,22939672,All Races,3.2,Male and Female,Non-Hodgkin Lymphoma,2016
25-29,0.9,1.2,243,Incidence,22939672,All Races,1.1,Male and Female,Oral Cavity and Pharynx,2016
25-29,1.9,2.5,249,Incidence,11271329,All Races,2.2,Male and Female,Ovary,2016
25-29,0.3,0.5,96,Incidence,22939672,All Races,0.4,Male and Female,Pancreas,2016
25-29,~,~,~,Incidence,11668343,All Races,~,Male and Female,Prostate,2016
25-29,0.4,0.6,111,Incidence,22939672,All Races,0.5,Male and Female,Stomach,2016
25-29,13.8,15.2,1686,Incidence,11668343,All Races,14.4,Male and Female,Testis,2016
25-29,10.9,11.8,2603,Incidence,22939672,All Races,11.3,Male and Female,Thyroid,2016
25-29,0.4,0.5,102,Incidence,22939672,All Races,0.4,Male and Female,Urinary Bladder,2016
30-34,100.1,102.8,22159,Incidence,21835455,All Races,101.5,Male and Female,All Cancer Sites Combined,2016
30-34,3.5,4.0,819,Incidence,21835455,All Races,3.8,Male and Female,Brain and Other Nervous System,2016
30-34,10.3,11.5,1181,Incidence,10837503,All Races,10.9,Male and Female,Cervix,2016
30-34,5.9,6.6,1357,Incidence,21835455,All Races,6.2,Male and Female,Colon and Rectum,2016
30-34,5.2,6.1,611,Incidence,10837503,All Races,5.6,Male and Female,"Corpus and Uterus, NOS",2016
30-34,0.2,0.3,45,Incidence,21835455,All Races,0.2,Male and Female,Esophagus,2016
30-34,30.2,32.3,3388,Incidence,10837503,All Races,31.3,Male and Female,Female Breast,2016
30-34,2.8,3.5,338,Incidence,10837503,All Races,3.1,Male and Female,"Female Breast, <i>in situ</i>",2016
30-34,3.4,4.0,807,Incidence,21835455,All Races,3.7,Male and Female,Hodgkin Lymphoma,2016
30-34,0.5,0.8,139,Incidence,21835455,All Races,0.6,Male and Female,Kaposi Sarcoma,2016
30-34,3.3,3.8,769,Incidence,21835455,All Races,3.5,Male and Female,Kidney and Renal Pelvis,2016
30-34,0.1,0.2,28,Incidence,21835455,All Races,0.1,Male and Female,Larynx,2016
30-34,3.6,4.1,846,Incidence,21835455,All Races,3.9,Male and Female,Leukemias,2016
30-34,0.5,0.7,133,Incidence,21835455,All Races,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.1,1.3,261,Incidence,21835455,All Races,1.2,Male and Female,Lung and Bronchus,2016
30-34,30.2,32.3,3388,Incidence,10837503,All Races,31.3,Male and Female,Male and Female Breast,2016
30-34,2.8,3.5,338,Incidence,10837503,All Races,3.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
30-34,9.6,10.4,2187,Incidence,21835455,All Races,10.0,Male and Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,21835455,All Races,~,Male and Female,Mesothelioma,2016
30-34,0.3,0.5,89,Incidence,21835455,All Races,0.4,Male and Female,Myeloma,2016
30-34,4.7,5.2,1079,Incidence,21835455,All Races,4.9,Male and Female,Non-Hodgkin Lymphoma,2016
30-34,1.7,2.0,405,Incidence,21835455,All Races,1.9,Male and Female,Oral Cavity and Pharynx,2016
30-34,3.2,3.9,384,Incidence,10837503,All Races,3.5,Male and Female,Ovary,2016
30-34,0.5,0.7,137,Incidence,21835455,All Races,0.6,Male and Female,Pancreas,2016
30-34,~,~,~,Incidence,10997952,All Races,~,Male and Female,Prostate,2016
30-34,0.9,1.2,229,Incidence,21835455,All Races,1.0,Male and Female,Stomach,2016
30-34,14.7,16.1,1693,Incidence,10997952,All Races,15.4,Male and Female,Testis,2016
30-34,15.8,16.9,3575,Incidence,21835455,All Races,16.4,Male and Female,Thyroid,2016
30-34,0.6,0.8,155,Incidence,21835455,All Races,0.7,Male and Female,Urinary Bladder,2016
35-39,149.4,152.8,31402,Incidence,20785173,All Races,151.1,Male and Female,All Cancer Sites Combined,2016
35-39,3.7,4.2,825,Incidence,20785173,All Races,4.0,Male and Female,Brain and Other Nervous System,2016
35-39,14.7,16.2,1601,Incidence,10399494,All Races,15.4,Male and Female,Cervix,2016
35-39,11.0,11.9,2380,Incidence,20785173,All Races,11.5,Male and Female,Colon and Rectum,2016
35-39,10.0,11.3,1104,Incidence,10399494,All Races,10.6,Male and Female,"Corpus and Uterus, NOS",2016
35-39,0.4,0.5,93,Incidence,20785173,All Races,0.4,Male and Female,Esophagus,2016
35-39,62.3,65.3,6633,Incidence,10399494,All Races,63.8,Male and Female,Female Breast,2016
35-39,8.1,9.2,901,Incidence,10399494,All Races,8.7,Male and Female,"Female Breast, <i>in situ</i>",2016
35-39,2.9,3.4,649,Incidence,20785173,All Races,3.1,Male and Female,Hodgkin Lymphoma,2016
35-39,0.4,0.6,104,Incidence,20785173,All Races,0.5,Male and Female,Kaposi Sarcoma,2016
35-39,6.5,7.2,1420,Incidence,20785173,All Races,6.8,Male and Female,Kidney and Renal Pelvis,2016
35-39,0.2,0.4,59,Incidence,20785173,All Races,0.3,Male and Female,Larynx,2016
35-39,4.3,4.9,957,Incidence,20785173,All Races,4.6,Male and Female,Leukemias,2016
35-39,0.9,1.2,212,Incidence,20785173,All Races,1.0,Male and Female,Liver and Intrahepatic Bile Duct,2016
35-39,2.6,3.0,577,Incidence,20785173,All Races,2.8,Male and Female,Lung and Bronchus,2016
35-39,62.3,65.3,6633,Incidence,10399494,All Races,63.8,Male and Female,Male and Female Breast,2016
35-39,8.1,9.2,901,Incidence,10399494,All Races,8.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
35-39,12.6,13.6,2730,Incidence,20785173,All Races,13.1,Male and Female,Melanomas of the Skin,2016
35-39,0.1,0.2,25,Incidence,20785173,All Races,0.1,Male and Female,Mesothelioma,2016
35-39,0.9,1.2,210,Incidence,20785173,All Races,1.0,Male and Female,Myeloma,2016
35-39,6.7,7.5,1476,Incidence,20785173,All Races,7.1,Male and Female,Non-Hodgkin Lymphoma,2016
35-39,2.8,3.3,631,Incidence,20785173,All Races,3.0,Male and Female,Oral Cavity and Pharynx,2016
35-39,4.6,5.5,521,Incidence,10399494,All Races,5.0,Male and Female,Ovary,2016
35-39,1.5,1.9,354,Incidence,20785173,All Races,1.7,Male and Female,Pancreas,2016
35-39,0.5,0.8,64,Incidence,10385679,All Races,0.6,Male and Female,Prostate,2016
35-39,1.8,2.2,419,Incidence,20785173,All Races,2.0,Male and Female,Stomach,2016
35-39,11.9,13.2,1303,Incidence,10385679,All Races,12.5,Male and Female,Testis,2016
35-39,20.0,21.2,4286,Incidence,20785173,All Races,20.6,Male and Female,Thyroid,2016
35-39,1.5,1.8,339,Incidence,20785173,All Races,1.6,Male and Female,Urinary Bladder,2016
40-44,232.9,237.1,46244,Incidence,19678727,All Races,235.0,Male and Female,All Cancer Sites Combined,2016
40-44,4.0,4.5,834,Incidence,19678727,All Races,4.2,Male and Female,Brain and Other Nervous System,2016
40-44,15.2,16.8,1583,Incidence,9910118,All Races,16.0,Male and Female,Cervix,2016
40-44,20.0,21.3,4062,Incidence,19678727,All Races,20.6,Male and Female,Colon and Rectum,2016
40-44,16.6,18.3,1730,Incidence,9910118,All Races,17.5,Male and Female,"Corpus and Uterus, NOS",2016
40-44,0.9,1.2,200,Incidence,19678727,All Races,1.0,Male and Female,Esophagus,2016
40-44,122.8,127.2,12382,Incidence,9910118,All Races,124.9,Male and Female,Female Breast,2016
40-44,38.2,40.7,3908,Incidence,9910118,All Races,39.4,Male and Female,"Female Breast, <i>in situ</i>",2016
40-44,2.3,2.8,504,Incidence,19678727,All Races,2.6,Male and Female,Hodgkin Lymphoma,2016
40-44,0.4,0.6,99,Incidence,19678727,All Races,0.5,Male and Female,Kaposi Sarcoma,2016
40-44,11.5,12.4,2350,Incidence,19678727,All Races,11.9,Male and Female,Kidney and Renal Pelvis,2016
40-44,0.7,1.0,169,Incidence,19678727,All Races,0.9,Male and Female,Larynx,2016
40-44,6.3,7.1,1315,Incidence,19678727,All Races,6.7,Male and Female,Leukemias,2016
40-44,1.5,1.9,333,Incidence,19678727,All Races,1.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
40-44,6.7,7.5,1398,Incidence,19678727,All Races,7.1,Male and Female,Lung and Bronchus,2016
40-44,122.8,127.2,12382,Incidence,9910118,All Races,124.9,Male and Female,Male and Female Breast,2016
40-44,38.2,40.7,3908,Incidence,9910118,All Races,39.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
40-44,16.8,17.9,3415,Incidence,19678727,All Races,17.4,Male and Female,Melanomas of the Skin,2016
40-44,0.1,0.2,30,Incidence,19678727,All Races,0.2,Male and Female,Mesothelioma,2016
40-44,2.2,2.7,477,Incidence,19678727,All Races,2.4,Male and Female,Myeloma,2016
40-44,9.4,10.2,1926,Incidence,19678727,All Races,9.8,Male and Female,Non-Hodgkin Lymphoma,2016
40-44,5.9,6.6,1229,Incidence,19678727,All Races,6.2,Male and Female,Oral Cavity and Pharynx,2016
40-44,8.1,9.3,860,Incidence,9910118,All Races,8.7,Male and Female,Ovary,2016
40-44,2.9,3.4,616,Incidence,19678727,All Races,3.1,Male and Female,Pancreas,2016
40-44,6.2,7.2,656,Incidence,9768609,All Races,6.7,Male and Female,Prostate,2016
40-44,3.0,3.5,636,Incidence,19678727,All Races,3.2,Male and Female,Stomach,2016
40-44,8.1,9.3,850,Incidence,9768609,All Races,8.7,Male and Female,Testis,2016
40-44,22.1,23.4,4481,Incidence,19678727,All Races,22.8,Male and Female,Thyroid,2016
40-44,3.0,3.5,641,Incidence,19678727,All Races,3.3,Male and Female,Urinary Bladder,2016
45-49,357.6,362.8,75310,Incidence,20907053,All Races,360.2,Male and Female,All Cancer Sites Combined,2016
45-49,4.9,5.6,1095,Incidence,20907053,All Races,5.2,Male and Female,Brain and Other Nervous System,2016
45-49,13.7,15.2,1525,Incidence,10550885,All Races,14.5,Male and Female,Cervix,2016
45-49,34.3,35.9,7329,Incidence,20907053,All Races,35.1,Male and Female,Colon and Rectum,2016
45-49,26.3,28.3,2877,Incidence,10550885,All Races,27.3,Male and Female,"Corpus and Uterus, NOS",2016
45-49,2.1,2.5,476,Incidence,20907053,All Races,2.3,Male and Female,Esophagus,2016
45-49,189.8,195.1,20304,Incidence,10550885,All Races,192.4,Male and Female,Female Breast,2016
45-49,55.5,58.4,6010,Incidence,10550885,All Races,57.0,Male and Female,"Female Breast, <i>in situ</i>",2016
45-49,2.3,2.7,518,Incidence,20907053,All Races,2.5,Male and Female,Hodgkin Lymphoma,2016
45-49,0.4,0.6,112,Incidence,20907053,All Races,0.5,Male and Female,Kaposi Sarcoma,2016
45-49,17.4,18.6,3757,Incidence,20907053,All Races,18.0,Male and Female,Kidney and Renal Pelvis,2016
45-49,1.9,2.3,428,Incidence,20907053,All Races,2.0,Male and Female,Larynx,2016
45-49,8.4,9.2,1839,Incidence,20907053,All Races,8.8,Male and Female,Leukemias,2016
45-49,3.6,4.1,797,Incidence,20907053,All Races,3.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
45-49,17.1,18.3,3696,Incidence,20907053,All Races,17.7,Male and Female,Lung and Bronchus,2016
45-49,189.8,195.1,20304,Incidence,10550885,All Races,192.4,Male and Female,Male and Female Breast,2016
45-49,55.5,58.4,6010,Incidence,10550885,All Races,57.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
45-49,22.3,23.6,4795,Incidence,20907053,All Races,22.9,Male and Female,Melanomas of the Skin,2016
45-49,0.2,0.4,60,Incidence,20907053,All Races,0.3,Male and Female,Mesothelioma,2016
45-49,4.1,4.7,923,Incidence,20907053,All Races,4.4,Male and Female,Myeloma,2016
45-49,13.6,14.6,2940,Incidence,20907053,All Races,14.1,Male and Female,Non-Hodgkin Lymphoma,2016
45-49,11.7,12.6,2534,Incidence,20907053,All Races,12.1,Male and Female,Oral Cavity and Pharynx,2016
45-49,12.8,14.2,1424,Incidence,10550885,All Races,13.5,Male and Female,Ovary,2016
45-49,6.1,6.7,1337,Incidence,20907053,All Races,6.4,Male and Female,Pancreas,2016
45-49,28.7,30.8,3075,Incidence,10356168,All Races,29.7,Male and Female,Prostate,2016
45-49,4.6,5.2,1016,Incidence,20907053,All Races,4.9,Male and Female,Stomach,2016
45-49,5.6,6.6,632,Incidence,10356168,All Races,6.1,Male and Female,Testis,2016
45-49,23.8,25.1,5113,Incidence,20907053,All Races,24.5,Male and Female,Thyroid,2016
45-49,5.6,6.3,1245,Incidence,20907053,All Races,6.0,Male and Female,Urinary Bladder,2016
5-9,13.2,14.2,2800,Incidence,20450557,All Races,13.7,Male and Female,All Cancer Sites Combined,2016
5-9,3.3,3.8,723,Incidence,20450557,All Races,3.5,Male and Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Male and Female,Cervix,2016
5-9,0.0,0.1,16,Incidence,20450557,All Races,0.1,Male and Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Male and Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Esophagus,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Male and Female,Female Breast,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2016
5-9,0.3,0.4,68,Incidence,20450557,All Races,0.3,Male and Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Kaposi Sarcoma,2016
5-9,0.6,0.8,143,Incidence,20450557,All Races,0.7,Male and Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Larynx,2016
5-9,4.0,4.6,882,Incidence,20450557,All Races,4.3,Male and Female,Leukemias,2016
5-9,0.1,0.2,28,Incidence,20450557,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Male and Female,Male and Female Breast,2016
5-9,~,~,~,Incidence,10008005,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
5-9,0.1,0.2,29,Incidence,20450557,All Races,0.1,Male and Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Mesothelioma,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Myeloma,2016
5-9,1.0,1.3,235,Incidence,20450557,All Races,1.1,Male and Female,Non-Hodgkin Lymphoma,2016
5-9,0.1,0.2,21,Incidence,20450557,All Races,0.1,Male and Female,Oral Cavity and Pharynx,2016
5-9,0.2,0.5,32,Incidence,10008005,All Races,0.3,Male and Female,Ovary,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Pancreas,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male and Female,Prostate,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Stomach,2016
5-9,~,~,~,Incidence,10442552,All Races,~,Male and Female,Testis,2016
5-9,0.1,0.2,32,Incidence,20450557,All Races,0.2,Male and Female,Thyroid,2016
5-9,~,~,~,Incidence,20450557,All Races,~,Male and Female,Urinary Bladder,2016
50-54,577.4,583.8,126552,Incidence,21796235,All Races,580.6,Male and Female,All Cancer Sites Combined,2016
50-54,7.2,8.0,1659,Incidence,21796235,All Races,7.6,Male and Female,Brain and Other Nervous System,2016
50-54,12.2,13.6,1430,Incidence,11087512,All Races,12.9,Male and Female,Cervix,2016
50-54,62.9,65.0,13931,Incidence,21796235,All Races,63.9,Male and Female,Colon and Rectum,2016
50-54,47.6,50.2,5421,Incidence,11087512,All Races,48.9,Male and Female,"Corpus and Uterus, NOS",2016
50-54,5.1,5.7,1177,Incidence,21796235,All Races,5.4,Male and Female,Esophagus,2016
50-54,228.5,234.1,25643,Incidence,11087512,All Races,231.3,Male and Female,Female Breast,2016
50-54,64.4,67.5,7310,Incidence,11087512,All Races,65.9,Male and Female,"Female Breast, <i>in situ</i>",2016
50-54,2.2,2.6,523,Incidence,21796235,All Races,2.4,Male and Female,Hodgkin Lymphoma,2016
50-54,0.4,0.6,111,Incidence,21796235,All Races,0.5,Male and Female,Kaposi Sarcoma,2016
50-54,26.0,27.4,5822,Incidence,21796235,All Races,26.7,Male and Female,Kidney and Renal Pelvis,2016
50-54,5.0,5.6,1159,Incidence,21796235,All Races,5.3,Male and Female,Larynx,2016
50-54,13.0,13.9,2929,Incidence,21796235,All Races,13.4,Male and Female,Leukemias,2016
50-54,10.3,11.2,2338,Incidence,21796235,All Races,10.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
50-54,47.3,49.2,10516,Incidence,21796235,All Races,48.2,Male and Female,Lung and Bronchus,2016
50-54,228.5,234.1,25643,Incidence,11087512,All Races,231.3,Male and Female,Male and Female Breast,2016
50-54,64.4,67.5,7310,Incidence,11087512,All Races,65.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
50-54,30.0,31.5,6708,Incidence,21796235,All Races,30.8,Male and Female,Melanomas of the Skin,2016
50-54,0.3,0.4,72,Incidence,21796235,All Races,0.3,Male and Female,Mesothelioma,2016
50-54,7.6,8.4,1742,Incidence,21796235,All Races,8.0,Male and Female,Myeloma,2016
50-54,21.3,22.5,4769,Incidence,21796235,All Races,21.9,Male and Female,Non-Hodgkin Lymphoma,2016
50-54,21.0,22.2,4712,Incidence,21796235,All Races,21.6,Male and Female,Oral Cavity and Pharynx,2016
50-54,17.1,18.7,1982,Incidence,11087512,All Races,17.9,Male and Female,Ovary,2016
50-54,12.1,13.1,2741,Incidence,21796235,All Races,12.6,Male and Female,Pancreas,2016
50-54,109.9,113.9,11978,Incidence,10708723,All Races,111.9,Male and Female,Prostate,2016
50-54,7.3,8.1,1680,Incidence,21796235,All Races,7.7,Male and Female,Stomach,2016
50-54,4.4,5.2,511,Incidence,10708723,All Races,4.8,Male and Female,Testis,2016
50-54,23.6,24.9,5280,Incidence,21796235,All Races,24.2,Male and Female,Thyroid,2016
50-54,12.9,13.9,2926,Incidence,21796235,All Races,13.4,Male and Female,Urinary Bladder,2016
55-59,855.4,863.2,188531,Incidence,21940757,All Races,859.3,Male and Female,All Cancer Sites Combined,2016
55-59,9.8,10.6,2240,Incidence,21940757,All Races,10.2,Male and Female,Brain and Other Nervous System,2016
55-59,12.0,13.4,1430,Incidence,11276769,All Races,12.7,Male and Female,Cervix,2016
55-59,68.5,70.8,15280,Incidence,21940757,All Races,69.6,Male and Female,Colon and Rectum,2016
55-59,77.9,81.2,8964,Incidence,11276769,All Races,79.5,Male and Female,"Corpus and Uterus, NOS",2016
55-59,9.0,9.8,2063,Incidence,21940757,All Races,9.4,Male and Female,Esophagus,2016
55-59,265.8,271.8,30311,Incidence,11276769,All Races,268.8,Male and Female,Female Breast,2016
55-59,66.8,69.9,7706,Incidence,11276769,All Races,68.3,Male and Female,"Female Breast, <i>in situ</i>",2016
55-59,2.3,2.8,558,Incidence,21940757,All Races,2.5,Male and Female,Hodgkin Lymphoma,2016
55-59,0.3,0.5,85,Incidence,21940757,All Races,0.4,Male and Female,Kaposi Sarcoma,2016
55-59,37.0,38.6,8299,Incidence,21940757,All Races,37.8,Male and Female,Kidney and Renal Pelvis,2016
55-59,8.4,9.2,1920,Incidence,21940757,All Races,8.8,Male and Female,Larynx,2016
55-59,19.5,20.7,4400,Incidence,21940757,All Races,20.1,Male and Female,Leukemias,2016
55-59,23.3,24.6,5263,Incidence,21940757,All Races,24.0,Male and Female,Liver and Intrahepatic Bile Duct,2016
55-59,98.7,101.3,21935,Incidence,21940757,All Races,100.0,Male and Female,Lung and Bronchus,2016
55-59,265.8,271.8,30311,Incidence,11276769,All Races,268.8,Male and Female,Male and Female Breast,2016
55-59,66.8,69.9,7706,Incidence,11276769,All Races,68.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
55-59,38.8,40.5,8699,Incidence,21940757,All Races,39.6,Male and Female,Melanomas of the Skin,2016
55-59,0.7,1.0,183,Incidence,21940757,All Races,0.8,Male and Female,Mesothelioma,2016
55-59,12.1,13.1,2765,Incidence,21940757,All Races,12.6,Male and Female,Myeloma,2016
55-59,30.1,31.6,6762,Incidence,21940757,All Races,30.8,Male and Female,Non-Hodgkin Lymphoma,2016
55-59,32.1,33.6,7205,Incidence,21940757,All Races,32.8,Male and Female,Oral Cavity and Pharynx,2016
55-59,21.7,23.5,2548,Incidence,11276769,All Races,22.6,Male and Female,Ovary,2016
55-59,20.5,21.8,4637,Incidence,21940757,All Races,21.1,Male and Female,Pancreas,2016
55-59,239.5,245.4,25856,Incidence,10663988,All Races,242.5,Male and Female,Prostate,2016
55-59,11.2,12.1,2550,Incidence,21940757,All Races,11.6,Male and Female,Stomach,2016
55-59,2.8,3.5,334,Incidence,10663988,All Races,3.1,Male and Female,Testis,2016
55-59,24.6,26.0,5546,Incidence,21940757,All Races,25.3,Male and Female,Thyroid,2016
55-59,25.4,26.8,5728,Incidence,21940757,All Races,26.1,Male and Female,Urinary Bladder,2016
60-64,1199.5,1209.3,234272,Incidence,19451114,All Races,1204.4,Male and Female,All Cancer Sites Combined,2016
60-64,12.9,13.9,2605,Incidence,19451114,All Races,13.4,Male and Female,Brain and Other Nervous System,2016
60-64,11.3,12.6,1212,Incidence,10153415,All Races,11.9,Male and Female,Cervix,2016
60-64,88.8,91.5,17536,Incidence,19451114,All Races,90.2,Male and Female,Colon and Rectum,2016
60-64,101.9,105.8,10543,Incidence,10153415,All Races,103.8,Male and Female,"Corpus and Uterus, NOS",2016
60-64,13.9,15.0,2804,Incidence,19451114,All Races,14.4,Male and Female,Esophagus,2016
60-64,332.7,339.8,34137,Incidence,10153415,All Races,336.2,Male and Female,Female Breast,2016
60-64,78.4,81.8,8131,Incidence,10153415,All Races,80.1,Male and Female,"Female Breast, <i>in situ</i>",2016
60-64,2.3,2.7,489,Incidence,19451114,All Races,2.5,Male and Female,Hodgkin Lymphoma,2016
60-64,0.3,0.5,77,Incidence,19451114,All Races,0.4,Male and Female,Kaposi Sarcoma,2016
60-64,46.9,48.9,9317,Incidence,19451114,All Races,47.9,Male and Female,Kidney and Renal Pelvis,2016
60-64,10.6,11.5,2150,Incidence,19451114,All Races,11.1,Male and Female,Larynx,2016
60-64,28.0,29.5,5583,Incidence,19451114,All Races,28.7,Male and Female,Leukemias,2016
60-64,36.9,38.7,7353,Incidence,19451114,All Races,37.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
60-64,151.1,154.6,29733,Incidence,19451114,All Races,152.9,Male and Female,Lung and Bronchus,2016
60-64,332.7,339.8,34137,Incidence,10153415,All Races,336.2,Male and Female,Male and Female Breast,2016
60-64,78.4,81.8,8131,Incidence,10153415,All Races,80.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
60-64,51.7,53.8,10263,Incidence,19451114,All Races,52.8,Male and Female,Melanomas of the Skin,2016
60-64,1.3,1.6,284,Incidence,19451114,All Races,1.5,Male and Female,Mesothelioma,2016
60-64,18.0,19.2,3609,Incidence,19451114,All Races,18.6,Male and Female,Myeloma,2016
60-64,42.9,44.8,8526,Incidence,19451114,All Races,43.8,Male and Female,Non-Hodgkin Lymphoma,2016
60-64,39.3,41.1,7821,Incidence,19451114,All Races,40.2,Male and Female,Oral Cavity and Pharynx,2016
60-64,25.9,27.9,2728,Incidence,10153415,All Races,26.9,Male and Female,Ovary,2016
60-64,33.0,34.7,6583,Incidence,19451114,All Races,33.8,Male and Female,Pancreas,2016
60-64,408.9,417.2,38400,Incidence,9297699,All Races,413.0,Male and Female,Prostate,2016
60-64,15.1,16.2,3039,Incidence,19451114,All Races,15.6,Male and Female,Stomach,2016
60-64,1.9,2.5,202,Incidence,9297699,All Races,2.2,Male and Female,Testis,2016
60-64,24.3,25.7,4861,Incidence,19451114,All Races,25.0,Male and Female,Thyroid,2016
60-64,42.0,43.8,8344,Incidence,19451114,All Races,42.9,Male and Female,Urinary Bladder,2016
65-69,1636.5,1648.8,275999,Incidence,16801993,All Races,1642.7,Male and Female,All Cancer Sites Combined,2016
65-69,16.4,17.6,2856,Incidence,16801993,All Races,17.0,Male and Female,Brain and Other Nervous System,2016
65-69,10.4,11.7,979,Incidence,8874413,All Races,11.0,Male and Female,Cervix,2016
65-69,117.2,120.5,19972,Incidence,16801993,All Races,118.9,Male and Female,Colon and Rectum,2016
65-69,115.0,119.5,10402,Incidence,8874413,All Races,117.2,Male and Female,"Corpus and Uterus, NOS",2016
65-69,18.3,19.6,3183,Incidence,16801993,All Races,18.9,Male and Female,Esophagus,2016
65-69,423.3,431.9,37946,Incidence,8874413,All Races,427.6,Male and Female,Female Breast,2016
65-69,94.5,98.6,8566,Incidence,8874413,All Races,96.5,Male and Female,"Female Breast, <i>in situ</i>",2016
65-69,3.0,3.5,541,Incidence,16801993,All Races,3.2,Male and Female,Hodgkin Lymphoma,2016
65-69,0.4,0.6,79,Incidence,16801993,All Races,0.5,Male and Female,Kaposi Sarcoma,2016
65-69,62.8,65.2,10750,Incidence,16801993,All Races,64.0,Male and Female,Kidney and Renal Pelvis,2016
65-69,12.8,13.9,2243,Incidence,16801993,All Races,13.3,Male and Female,Larynx,2016
65-69,40.4,42.4,6953,Incidence,16801993,All Races,41.4,Male and Female,Leukemias,2016
65-69,38.4,40.3,6605,Incidence,16801993,All Races,39.3,Male and Female,Liver and Intrahepatic Bile Duct,2016
65-69,229.1,233.7,38878,Incidence,16801993,All Races,231.4,Male and Female,Lung and Bronchus,2016
65-69,423.3,431.9,37946,Incidence,8874413,All Races,427.6,Male and Female,Male and Female Breast,2016
65-69,94.5,98.6,8566,Incidence,8874413,All Races,96.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
65-69,69.1,71.7,11827,Incidence,16801993,All Races,70.4,Male and Female,Melanomas of the Skin,2016
65-69,2.3,2.8,432,Incidence,16801993,All Races,2.6,Male and Female,Mesothelioma,2016
65-69,27.5,29.2,4763,Incidence,16801993,All Races,28.3,Male and Female,Myeloma,2016
65-69,60.7,63.1,10402,Incidence,16801993,All Races,61.9,Male and Female,Non-Hodgkin Lymphoma,2016
65-69,42.8,44.8,7355,Incidence,16801993,All Races,43.8,Male and Female,Oral Cavity and Pharynx,2016
65-69,31.0,33.4,2854,Incidence,8874413,All Races,32.2,Male and Female,Ovary,2016
65-69,47.5,49.6,8156,Incidence,16801993,All Races,48.5,Male and Female,Pancreas,2016
65-69,616.7,627.7,49325,Incidence,7927580,All Races,622.2,Male and Female,Prostate,2016
65-69,20.8,22.2,3610,Incidence,16801993,All Races,21.5,Male and Female,Stomach,2016
65-69,1.2,1.8,118,Incidence,7927580,All Races,1.5,Male and Female,Testis,2016
65-69,26.2,27.7,4526,Incidence,16801993,All Races,26.9,Male and Female,Thyroid,2016
65-69,68.2,70.7,11668,Incidence,16801993,All Races,69.4,Male and Female,Urinary Bladder,2016
70-74,1978.7,1994.8,234263,Incidence,11791134,All Races,1986.8,Male and Female,All Cancer Sites Combined,2016
70-74,17.9,19.5,2204,Incidence,11791134,All Races,18.7,Male and Female,Brain and Other Nervous System,2016
70-74,8.9,10.5,613,Incidence,6347009,All Races,9.7,Male and Female,Cervix,2016
70-74,144.0,148.4,17234,Incidence,11791134,All Races,146.2,Male and Female,Colon and Rectum,2016
70-74,104.8,109.9,6812,Incidence,6347009,All Races,107.3,Male and Female,"Corpus and Uterus, NOS",2016
70-74,22.4,24.2,2746,Incidence,11791134,All Races,23.3,Male and Female,Esophagus,2016
70-74,465.8,476.5,29903,Incidence,6347009,All Races,471.1,Male and Female,Female Breast,2016
70-74,97.4,102.3,6334,Incidence,6347009,All Races,99.8,Male and Female,"Female Breast, <i>in situ</i>",2016
70-74,3.7,4.4,478,Incidence,11791134,All Races,4.1,Male and Female,Hodgkin Lymphoma,2016
70-74,0.2,0.5,39,Incidence,11791134,All Races,0.3,Male and Female,Kaposi Sarcoma,2016
70-74,70.3,73.4,8474,Incidence,11791134,All Races,71.9,Male and Female,Kidney and Renal Pelvis,2016
70-74,13.8,15.2,1713,Incidence,11791134,All Races,14.5,Male and Female,Larynx,2016
70-74,55.4,58.1,6690,Incidence,11791134,All Races,56.7,Male and Female,Leukemias,2016
70-74,35.2,37.3,4272,Incidence,11791134,All Races,36.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
70-74,338.1,344.7,40254,Incidence,11791134,All Races,341.4,Male and Female,Lung and Bronchus,2016
70-74,465.8,476.5,29903,Incidence,6347009,All Races,471.1,Male and Female,Male and Female Breast,2016
70-74,97.4,102.3,6334,Incidence,6347009,All Races,99.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
70-74,84.3,87.6,10135,Incidence,11791134,All Races,86.0,Male and Female,Melanomas of the Skin,2016
70-74,4.1,4.9,528,Incidence,11791134,All Races,4.5,Male and Female,Mesothelioma,2016
70-74,35.2,37.4,4280,Incidence,11791134,All Races,36.3,Male and Female,Myeloma,2016
70-74,82.8,86.1,9960,Incidence,11791134,All Races,84.5,Male and Female,Non-Hodgkin Lymphoma,2016
70-74,45.2,47.6,5468,Incidence,11791134,All Races,46.4,Male and Female,Oral Cavity and Pharynx,2016
70-74,35.6,38.6,2352,Incidence,6347009,All Races,37.1,Male and Female,Ovary,2016
70-74,63.3,66.2,7634,Incidence,11791134,All Races,64.7,Male and Female,Pancreas,2016
70-74,630.9,644.3,34712,Incidence,5444125,All Races,637.6,Male and Female,Prostate,2016
70-74,28.2,30.2,3440,Incidence,11791134,All Races,29.2,Male and Female,Stomach,2016
70-74,0.7,1.3,54,Incidence,5444125,All Races,1.0,Male and Female,Testis,2016
70-74,23.1,24.9,2829,Incidence,11791134,All Races,24.0,Male and Female,Thyroid,2016
70-74,105.8,109.5,12694,Incidence,11791134,All Races,107.7,Male and Female,Urinary Bladder,2016
75-79,2210.9,2231.1,185755,Incidence,8363727,All Races,2221.0,Male and Female,All Cancer Sites Combined,2016
75-79,21.3,23.3,1861,Incidence,8363727,All Races,22.3,Male and Female,Brain and Other Nervous System,2016
75-79,8.8,10.6,450,Incidence,4642235,All Races,9.7,Male and Female,Cervix,2016
75-79,184.2,190.1,15649,Incidence,8363727,All Races,187.1,Male and Female,Colon and Rectum,2016
75-79,90.4,96.0,4325,Incidence,4642235,All Races,93.2,Male and Female,"Corpus and Uterus, NOS",2016
75-79,23.3,25.4,2037,Incidence,8363727,All Races,24.4,Male and Female,Esophagus,2016
75-79,448.8,461.1,21120,Incidence,4642235,All Races,455.0,Male and Female,Female Breast,2016
75-79,80.2,85.5,3845,Incidence,4642235,All Races,82.8,Male and Female,"Female Breast, <i>in situ</i>",2016
75-79,3.5,4.4,329,Incidence,8363727,All Races,3.9,Male and Female,Hodgkin Lymphoma,2016
75-79,0.6,1.0,66,Incidence,8363727,All Races,0.8,Male and Female,Kaposi Sarcoma,2016
75-79,73.4,77.1,6292,Incidence,8363727,All Races,75.2,Male and Female,Kidney and Renal Pelvis,2016
75-79,13.9,15.5,1229,Incidence,8363727,All Races,14.7,Male and Female,Larynx,2016
75-79,71.7,75.4,6153,Incidence,8363727,All Races,73.6,Male and Female,Leukemias,2016
75-79,37.4,40.1,3238,Incidence,8363727,All Races,38.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
75-79,403.4,412.1,34103,Incidence,8363727,All Races,407.7,Male and Female,Lung and Bronchus,2016
75-79,448.8,461.1,21120,Incidence,4642235,All Races,455.0,Male and Female,Male and Female Breast,2016
75-79,80.2,85.5,3845,Incidence,4642235,All Races,82.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
75-79,97.7,102.0,8346,Incidence,8363727,All Races,99.8,Male and Female,Melanomas of the Skin,2016
75-79,6.1,7.2,554,Incidence,8363727,All Races,6.6,Male and Female,Mesothelioma,2016
75-79,41.6,44.4,3596,Incidence,8363727,All Races,43.0,Male and Female,Myeloma,2016
75-79,101.6,106.0,8681,Incidence,8363727,All Races,103.8,Male and Female,Non-Hodgkin Lymphoma,2016
75-79,44.4,47.3,3836,Incidence,8363727,All Races,45.9,Male and Female,Oral Cavity and Pharynx,2016
75-79,38.5,42.2,1873,Incidence,4642235,All Races,40.3,Male and Female,Ovary,2016
75-79,78.5,82.4,6727,Incidence,8363727,All Races,80.4,Male and Female,Pancreas,2016
75-79,559.1,574.4,21090,Incidence,3721492,All Races,566.7,Male and Female,Prostate,2016
75-79,34.5,37.1,2993,Incidence,8363727,All Races,35.8,Male and Female,Stomach,2016
75-79,0.8,1.5,40,Incidence,3721492,All Races,1.1,Male and Female,Testis,2016
75-79,20.6,22.6,1808,Incidence,8363727,All Races,21.6,Male and Female,Thyroid,2016
75-79,137.4,142.5,11706,Incidence,8363727,All Races,140.0,Male and Female,Urinary Bladder,2016
80-84,2306.2,2330.9,136067,Incidence,5868617,All Races,2318.6,Male and Female,All Cancer Sites Combined,2016
80-84,20.8,23.3,1293,Incidence,5868617,All Races,22.0,Male and Female,Brain and Other Nervous System,2016
80-84,8.1,10.2,311,Incidence,3415481,All Races,9.1,Male and Female,Cervix,2016
80-84,218.8,226.5,13065,Incidence,5868617,All Races,222.6,Male and Female,Colon and Rectum,2016
80-84,71.9,77.8,2555,Incidence,3415481,All Races,74.8,Male and Female,"Corpus and Uterus, NOS",2016
80-84,25.5,28.2,1575,Incidence,5868617,All Races,26.8,Male and Female,Esophagus,2016
80-84,401.8,415.4,13955,Incidence,3415481,All Races,408.6,Male and Female,Female Breast,2016
80-84,51.3,56.2,1835,Incidence,3415481,All Races,53.7,Male and Female,"Female Breast, <i>in situ</i>",2016
80-84,3.5,4.5,234,Incidence,5868617,All Races,4.0,Male and Female,Hodgkin Lymphoma,2016
80-84,0.8,1.3,58,Incidence,5868617,All Races,1.0,Male and Female,Kaposi Sarcoma,2016
80-84,70.0,74.3,4233,Incidence,5868617,All Races,72.1,Male and Female,Kidney and Renal Pelvis,2016
80-84,12.5,14.4,786,Incidence,5868617,All Races,13.4,Male and Female,Larynx,2016
80-84,84.3,89.0,5084,Incidence,5868617,All Races,86.6,Male and Female,Leukemias,2016
80-84,37.9,41.2,2319,Incidence,5868617,All Races,39.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
80-84,405.7,416.1,24111,Incidence,5868617,All Races,410.8,Male and Female,Lung and Bronchus,2016
80-84,401.8,415.4,13955,Incidence,3415481,All Races,408.6,Male and Female,Male and Female Breast,2016
80-84,51.3,56.2,1835,Incidence,3415481,All Races,53.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
80-84,110.2,115.7,6628,Incidence,5868617,All Races,112.9,Male and Female,Melanomas of the Skin,2016
80-84,8.3,9.8,529,Incidence,5868617,All Races,9.0,Male and Female,Mesothelioma,2016
80-84,45.7,49.3,2787,Incidence,5868617,All Races,47.5,Male and Female,Myeloma,2016
80-84,114.3,119.8,6868,Incidence,5868617,All Races,117.0,Male and Female,Non-Hodgkin Lymphoma,2016
80-84,43.0,46.4,2620,Incidence,5868617,All Races,44.6,Male and Female,Oral Cavity and Pharynx,2016
80-84,42.6,47.1,1530,Incidence,3415481,All Races,44.8,Male and Female,Ovary,2016
80-84,90.3,95.2,5443,Incidence,5868617,All Races,92.7,Male and Female,Pancreas,2016
80-84,425.5,442.0,10639,Incidence,2453136,All Races,433.7,Male and Female,Prostate,2016
80-84,38.0,41.2,2321,Incidence,5868617,All Races,39.5,Male and Female,Stomach,2016
80-84,~,~,~,Incidence,2453136,All Races,~,Male and Female,Testis,2016
80-84,16.1,18.2,1005,Incidence,5868617,All Races,17.1,Male and Female,Thyroid,2016
80-84,171.5,178.3,10261,Incidence,5868617,All Races,174.8,Male and Female,Urinary Bladder,2016
85+,2107.8,2130.4,135264,Incidence,6383008,All Races,2119.1,Male and Female,All Cancer Sites Combined,2016
85+,16.8,18.9,1140,Incidence,6383008,All Races,17.9,Male and Female,Brain and Other Nervous System,2016
85+,6.7,8.4,312,Incidence,4148383,All Races,7.5,Male and Female,Cervix,2016
85+,241.5,249.2,15658,Incidence,6383008,All Races,245.3,Male and Female,Colon and Rectum,2016
85+,48.1,52.4,2084,Incidence,4148383,All Races,50.2,Male and Female,"Corpus and Uterus, NOS",2016
85+,21.9,24.3,1472,Incidence,6383008,All Races,23.1,Male and Female,Esophagus,2016
85+,318.9,329.8,13454,Incidence,4148383,All Races,324.3,Male and Female,Female Breast,2016
85+,21.7,24.6,959,Incidence,4148383,All Races,23.1,Male and Female,"Female Breast, <i>in situ</i>",2016
85+,2.6,3.4,191,Incidence,6383008,All Races,3.0,Male and Female,Hodgkin Lymphoma,2016
85+,1.0,1.5,78,Incidence,6383008,All Races,1.2,Male and Female,Kaposi Sarcoma,2016
85+,52.6,56.2,3470,Incidence,6383008,All Races,54.4,Male and Female,Kidney and Renal Pelvis,2016
85+,9.1,10.6,628,Incidence,6383008,All Races,9.8,Male and Female,Larynx,2016
85+,87.0,91.7,5703,Incidence,6383008,All Races,89.3,Male and Female,Leukemias,2016
85+,32.5,35.3,2162,Incidence,6383008,All Races,33.9,Male and Female,Liver and Intrahepatic Bile Duct,2016
85+,301.9,310.5,19546,Incidence,6383008,All Races,306.2,Male and Female,Lung and Bronchus,2016
85+,318.9,329.8,13454,Incidence,4148383,All Races,324.3,Male and Female,Male and Female Breast,2016
85+,21.7,24.6,959,Incidence,4148383,All Races,23.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
85+,109.1,114.3,7131,Incidence,6383008,All Races,111.7,Male and Female,Melanomas of the Skin,2016
85+,7.0,8.4,491,Incidence,6383008,All Races,7.7,Male and Female,Mesothelioma,2016
85+,38.4,41.5,2548,Incidence,6383008,All Races,39.9,Male and Female,Myeloma,2016
85+,103.1,108.1,6740,Incidence,6383008,All Races,105.6,Male and Female,Non-Hodgkin Lymphoma,2016
85+,39.0,42.2,2590,Incidence,6383008,All Races,40.6,Male and Female,Oral Cavity and Pharynx,2016
85+,35.8,39.6,1562,Incidence,4148383,All Races,37.7,Male and Female,Ovary,2016
85+,95.0,99.9,6220,Incidence,6383008,All Races,97.4,Male and Female,Pancreas,2016
85+,369.9,386.1,8446,Incidence,2234625,All Races,378.0,Male and Female,Prostate,2016
85+,39.5,42.7,2623,Incidence,6383008,All Races,41.1,Male and Female,Stomach,2016
85+,0.6,1.4,21,Incidence,2234625,All Races,0.9,Male and Female,Testis,2016
85+,8.8,10.3,607,Incidence,6383008,All Races,9.5,Male and Female,Thyroid,2016
85+,168.6,175.1,10967,Incidence,6383008,All Races,171.8,Male and Female,Urinary Bladder,2016
<1,26.2,29.5,1103,Incidence,3963268,All Races,27.8,Male and Female,All Cancer Sites Combined,2016
<1,3.6,5.0,169,Incidence,3963268,All Races,4.3,Male and Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,Cervix,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Colon and Rectum,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Esophagus,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,Female Breast,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Kaposi Sarcoma,2016
<1,1.2,2.0,63,Incidence,3963268,All Races,1.6,Male and Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Larynx,2016
<1,3.7,5.0,170,Incidence,3963268,All Races,4.3,Male and Female,Leukemias,2016
<1,1.5,2.4,75,Incidence,3963268,All Races,1.9,Male and Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,Male and Female Breast,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Mesothelioma,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Myeloma,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,1937196,All Races,~,Male and Female,Ovary,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Pancreas,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male and Female,Prostate,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Stomach,2016
<1,~,~,~,Incidence,2026072,All Races,~,Male and Female,Testis,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Thyroid,2016
<1,~,~,~,Incidence,3963268,All Races,~,Male and Female,Urinary Bladder,2016
1-4,19.1,23.2,417,Incidence,1975266,Hispanic of any race,21.1,Female,All Cancer Sites Combined,2016
1-4,3.4,5.3,85,Incidence,1975266,Hispanic of any race,4.3,Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Cervix,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Esophagus,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Female Breast,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
1-4,1.3,2.5,36,Incidence,1975266,Hispanic of any race,1.8,Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Larynx,2016
1-4,7.5,10.2,174,Incidence,1975266,Hispanic of any race,8.8,Female,Leukemias,2016
1-4,0.6,1.5,19,Incidence,1975266,Hispanic of any race,1.0,Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Mesothelioma,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Myeloma,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Ovary,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Pancreas,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Stomach,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Thyroid,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Female,Urinary Bladder,2016
10-14,15.0,18.2,409,Incidence,2472211,Hispanic of any race,16.5,Female,All Cancer Sites Combined,2016
10-14,1.7,2.9,56,Incidence,2472211,Hispanic of any race,2.3,Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Cervix,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Esophagus,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Female Breast,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
10-14,1.0,1.9,34,Incidence,2472211,Hispanic of any race,1.4,Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Larynx,2016
10-14,4.3,6.1,127,Incidence,2472211,Hispanic of any race,5.1,Female,Leukemias,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Mesothelioma,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Myeloma,2016
10-14,0.7,1.5,25,Incidence,2472211,Hispanic of any race,1.0,Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
10-14,0.4,1.2,18,Incidence,2472211,Hispanic of any race,0.7,Female,Ovary,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Pancreas,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Stomach,2016
10-14,1.1,2.2,39,Incidence,2472211,Hispanic of any race,1.6,Female,Thyroid,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Female,Urinary Bladder,2016
15-19,19.3,23.0,495,Incidence,2349375,Hispanic of any race,21.1,Female,All Cancer Sites Combined,2016
15-19,0.7,1.6,25,Incidence,2349375,Hispanic of any race,1.1,Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Cervix,2016
15-19,0.9,1.8,30,Incidence,2349375,Hispanic of any race,1.3,Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Esophagus,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Female Breast,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
15-19,1.7,3.0,53,Incidence,2349375,Hispanic of any race,2.3,Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Larynx,2016
15-19,2.7,4.2,79,Incidence,2349375,Hispanic of any race,3.4,Female,Leukemias,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Mesothelioma,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Myeloma,2016
15-19,1.2,2.3,40,Incidence,2349375,Hispanic of any race,1.7,Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
15-19,0.9,1.9,32,Incidence,2349375,Hispanic of any race,1.4,Female,Ovary,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Pancreas,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Stomach,2016
15-19,4.4,6.3,125,Incidence,2349375,Hispanic of any race,5.3,Female,Thyroid,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Female,Urinary Bladder,2016
20-24,30.1,34.8,750,Incidence,2315935,Hispanic of any race,32.4,Female,All Cancer Sites Combined,2016
20-24,1.0,2.0,33,Incidence,2315935,Hispanic of any race,1.4,Female,Brain and Other Nervous System,2016
20-24,0.4,1.2,17,Incidence,2315935,Hispanic of any race,0.7,Female,Cervix,2016
20-24,1.3,2.5,43,Incidence,2315935,Hispanic of any race,1.9,Female,Colon and Rectum,2016
20-24,0.7,1.5,24,Incidence,2315935,Hispanic of any race,1.0,Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Esophagus,2016
20-24,1.1,2.1,35,Incidence,2315935,Hispanic of any race,1.5,Female,Female Breast,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
20-24,2.6,4.2,77,Incidence,2315935,Hispanic of any race,3.3,Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Larynx,2016
20-24,2.0,3.4,61,Incidence,2315935,Hispanic of any race,2.6,Female,Leukemias,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Lung and Bronchus,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Mesothelioma,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Myeloma,2016
20-24,1.1,2.2,37,Incidence,2315935,Hispanic of any race,1.6,Female,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
20-24,1.4,2.6,45,Incidence,2315935,Hispanic of any race,1.9,Female,Ovary,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Pancreas,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Stomach,2016
20-24,9.1,11.8,240,Incidence,2315935,Hispanic of any race,10.4,Female,Thyroid,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Female,Urinary Bladder,2016
25-29,58.4,65.0,1356,Incidence,2201631,Hispanic of any race,61.6,Female,All Cancer Sites Combined,2016
25-29,1.1,2.3,36,Incidence,2201631,Hispanic of any race,1.6,Female,Brain and Other Nervous System,2016
25-29,4.8,6.9,127,Incidence,2201631,Hispanic of any race,5.8,Female,Cervix,2016
25-29,2.7,4.3,76,Incidence,2201631,Hispanic of any race,3.5,Female,Colon and Rectum,2016
25-29,2.0,3.5,59,Incidence,2201631,Hispanic of any race,2.7,Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Esophagus,2016
25-29,7.9,10.4,200,Incidence,2201631,Hispanic of any race,9.1,Female,Female Breast,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
25-29,2.2,3.7,64,Incidence,2201631,Hispanic of any race,2.9,Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
25-29,0.8,1.7,26,Incidence,2201631,Hispanic of any race,1.2,Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Larynx,2016
25-29,2.2,3.7,63,Incidence,2201631,Hispanic of any race,2.9,Female,Leukemias,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Lung and Bronchus,2016
25-29,0.9,1.9,29,Incidence,2201631,Hispanic of any race,1.3,Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Mesothelioma,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Myeloma,2016
25-29,1.6,2.9,48,Incidence,2201631,Hispanic of any race,2.2,Female,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
25-29,1.6,2.9,48,Incidence,2201631,Hispanic of any race,2.2,Female,Ovary,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Pancreas,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Stomach,2016
25-29,16.9,20.6,412,Incidence,2201631,Hispanic of any race,18.7,Female,Thyroid,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Female,Urinary Bladder,2016
30-34,101.2,110.0,2246,Incidence,2128673,Hispanic of any race,105.5,Female,All Cancer Sites Combined,2016
30-34,1.3,2.6,40,Incidence,2128673,Hispanic of any race,1.9,Female,Brain and Other Nervous System,2016
30-34,10.5,13.4,253,Incidence,2128673,Hispanic of any race,11.9,Female,Cervix,2016
30-34,4.8,6.9,123,Incidence,2128673,Hispanic of any race,5.8,Female,Colon and Rectum,2016
30-34,6.6,9.0,165,Incidence,2128673,Hispanic of any race,7.8,Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Esophagus,2016
30-34,22.0,26.2,511,Incidence,2128673,Hispanic of any race,24.0,Female,Female Breast,2016
30-34,2.2,3.6,60,Incidence,2128673,Hispanic of any race,2.8,Female,"Female Breast, <i>in situ</i>",2016
30-34,1.7,3.0,49,Incidence,2128673,Hispanic of any race,2.3,Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
30-34,2.2,3.7,61,Incidence,2128673,Hispanic of any race,2.9,Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Larynx,2016
30-34,3.3,5.0,87,Incidence,2128673,Hispanic of any race,4.1,Female,Leukemias,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
30-34,0.5,1.4,19,Incidence,2128673,Hispanic of any race,0.9,Female,Lung and Bronchus,2016
30-34,1.7,3.1,50,Incidence,2128673,Hispanic of any race,2.3,Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Mesothelioma,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Myeloma,2016
30-34,2.9,4.5,77,Incidence,2128673,Hispanic of any race,3.6,Female,Non-Hodgkin Lymphoma,2016
30-34,0.6,1.5,20,Incidence,2128673,Hispanic of any race,0.9,Female,Oral Cavity and Pharynx,2016
30-34,2.6,4.3,72,Incidence,2128673,Hispanic of any race,3.4,Female,Ovary,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Pancreas,2016
30-34,1.4,2.7,42,Incidence,2128673,Hispanic of any race,2.0,Female,Stomach,2016
30-34,21.1,25.2,492,Incidence,2128673,Hispanic of any race,23.1,Female,Thyroid,2016
30-34,~,~,~,Incidence,2128673,Hispanic of any race,~,Female,Urinary Bladder,2016
35-39,158.4,169.4,3400,Incidence,2075190,Hispanic of any race,163.8,Female,All Cancer Sites Combined,2016
35-39,1.9,3.3,53,Incidence,2075190,Hispanic of any race,2.6,Female,Brain and Other Nervous System,2016
35-39,16.2,19.8,372,Incidence,2075190,Hispanic of any race,17.9,Female,Cervix,2016
35-39,8.3,11.1,200,Incidence,2075190,Hispanic of any race,9.6,Female,Colon and Rectum,2016
35-39,11.0,14.0,258,Incidence,2075190,Hispanic of any race,12.4,Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,2075190,Hispanic of any race,~,Female,Esophagus,2016
35-39,44.4,50.4,982,Incidence,2075190,Hispanic of any race,47.3,Female,Female Breast,2016
35-39,6.1,8.4,149,Incidence,2075190,Hispanic of any race,7.2,Female,"Female Breast, <i>in situ</i>",2016
35-39,1.2,2.3,35,Incidence,2075190,Hispanic of any race,1.7,Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,2075190,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
35-39,4.5,6.6,114,Incidence,2075190,Hispanic of any race,5.5,Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,2075190,Hispanic of any race,~,Female,Larynx,2016
35-39,3.0,4.7,78,Incidence,2075190,Hispanic of any race,3.8,Female,Leukemias,2016
35-39,~,~,~,Incidence,2075190,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
35-39,1.5,2.7,42,Incidence,2075190,Hispanic of any race,2.0,Female,Lung and Bronchus,2016
35-39,2.3,3.8,62,Incidence,2075190,Hispanic of any race,3.0,Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,2075190,Hispanic of any race,~,Female,Mesothelioma,2016
35-39,0.5,1.4,18,Incidence,2075190,Hispanic of any race,0.9,Female,Myeloma,2016
35-39,4.7,6.8,117,Incidence,2075190,Hispanic of any race,5.6,Female,Non-Hodgkin Lymphoma,2016
35-39,0.9,2.0,28,Incidence,2075190,Hispanic of any race,1.3,Female,Oral Cavity and Pharynx,2016
35-39,4.0,5.9,101,Incidence,2075190,Hispanic of any race,4.9,Female,Ovary,2016
35-39,0.7,1.7,23,Incidence,2075190,Hispanic of any race,1.1,Female,Pancreas,2016
35-39,2.4,4.0,65,Incidence,2075190,Hispanic of any race,3.1,Female,Stomach,2016
35-39,27.6,32.4,621,Incidence,2075190,Hispanic of any race,29.9,Female,Thyroid,2016
35-39,0.5,1.3,17,Incidence,2075190,Hispanic of any race,0.8,Female,Urinary Bladder,2016
40-44,243.4,257.6,4861,Incidence,1941080,Hispanic of any race,250.4,Female,All Cancer Sites Combined,2016
40-44,2.0,3.6,53,Incidence,1941080,Hispanic of any race,2.7,Female,Brain and Other Nervous System,2016
40-44,16.3,20.2,353,Incidence,1941080,Hispanic of any race,18.2,Female,Cervix,2016
40-44,14.3,17.9,311,Incidence,1941080,Hispanic of any race,16.0,Female,Colon and Rectum,2016
40-44,16.3,20.2,353,Incidence,1941080,Hispanic of any race,18.2,Female,"Corpus and Uterus, NOS",2016
40-44,~,~,~,Incidence,1941080,Hispanic of any race,~,Female,Esophagus,2016
40-44,92.9,101.7,1887,Incidence,1941080,Hispanic of any race,97.2,Female,Female Breast,2016
40-44,25.8,30.6,546,Incidence,1941080,Hispanic of any race,28.1,Female,"Female Breast, <i>in situ</i>",2016
40-44,1.0,2.2,30,Incidence,1941080,Hispanic of any race,1.5,Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,1941080,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
40-44,7.9,10.6,178,Incidence,1941080,Hispanic of any race,9.2,Female,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,1941080,Hispanic of any race,~,Female,Larynx,2016
40-44,4.2,6.3,100,Incidence,1941080,Hispanic of any race,5.2,Female,Leukemias,2016
40-44,0.7,1.7,21,Incidence,1941080,Hispanic of any race,1.1,Female,Liver and Intrahepatic Bile Duct,2016
40-44,2.8,4.6,70,Incidence,1941080,Hispanic of any race,3.6,Female,Lung and Bronchus,2016
40-44,3.4,5.3,83,Incidence,1941080,Hispanic of any race,4.3,Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,1941080,Hispanic of any race,~,Female,Mesothelioma,2016
40-44,1.2,2.4,34,Incidence,1941080,Hispanic of any race,1.8,Female,Myeloma,2016
40-44,6.4,8.9,147,Incidence,1941080,Hispanic of any race,7.6,Female,Non-Hodgkin Lymphoma,2016
40-44,1.5,2.8,40,Incidence,1941080,Hispanic of any race,2.1,Female,Oral Cavity and Pharynx,2016
40-44,7.2,9.8,164,Incidence,1941080,Hispanic of any race,8.4,Female,Ovary,2016
40-44,1.4,2.7,39,Incidence,1941080,Hispanic of any race,2.0,Female,Pancreas,2016
40-44,4.5,6.6,106,Incidence,1941080,Hispanic of any race,5.5,Female,Stomach,2016
40-44,28.2,33.2,594,Incidence,1941080,Hispanic of any race,30.6,Female,Thyroid,2016
40-44,~,~,~,Incidence,1941080,Hispanic of any race,~,Female,Urinary Bladder,2016
45-49,345.3,363.0,6191,Incidence,1748512,Hispanic of any race,354.1,Female,All Cancer Sites Combined,2016
45-49,2.8,4.7,64,Incidence,1748512,Hispanic of any race,3.7,Female,Brain and Other Nervous System,2016
45-49,15.0,18.9,295,Incidence,1748512,Hispanic of any race,16.9,Female,Cervix,2016
45-49,23.1,27.9,445,Incidence,1748512,Hispanic of any race,25.5,Female,Colon and Rectum,2016
45-49,27.1,32.2,517,Incidence,1748512,Hispanic of any race,29.6,Female,"Corpus and Uterus, NOS",2016
45-49,~,~,~,Incidence,1748512,Hispanic of any race,~,Female,Esophagus,2016
45-49,135.9,147.1,2473,Incidence,1748512,Hispanic of any race,141.4,Female,Female Breast,2016
45-49,36.7,42.6,692,Incidence,1748512,Hispanic of any race,39.6,Female,"Female Breast, <i>in situ</i>",2016
45-49,1.1,2.3,28,Incidence,1748512,Hispanic of any race,1.6,Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,1748512,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
45-49,10.9,14.3,219,Incidence,1748512,Hispanic of any race,12.5,Female,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,1748512,Hispanic of any race,~,Female,Larynx,2016
45-49,6.5,9.2,136,Incidence,1748512,Hispanic of any race,7.8,Female,Leukemias,2016
45-49,1.9,3.4,45,Incidence,1748512,Hispanic of any race,2.6,Female,Liver and Intrahepatic Bile Duct,2016
45-49,6.7,9.4,140,Incidence,1748512,Hispanic of any race,8.0,Female,Lung and Bronchus,2016
45-49,5.0,7.4,107,Incidence,1748512,Hispanic of any race,6.1,Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,1748512,Hispanic of any race,~,Female,Mesothelioma,2016
45-49,2.6,4.4,60,Incidence,1748512,Hispanic of any race,3.4,Female,Myeloma,2016
45-49,9.3,12.4,188,Incidence,1748512,Hispanic of any race,10.8,Female,Non-Hodgkin Lymphoma,2016
45-49,2.2,3.9,52,Incidence,1748512,Hispanic of any race,3.0,Female,Oral Cavity and Pharynx,2016
45-49,10.0,13.2,201,Incidence,1748512,Hispanic of any race,11.5,Female,Ovary,2016
45-49,3.6,5.7,80,Incidence,1748512,Hispanic of any race,4.6,Female,Pancreas,2016
45-49,5.3,7.8,113,Incidence,1748512,Hispanic of any race,6.5,Female,Stomach,2016
45-49,33.3,39.0,630,Incidence,1748512,Hispanic of any race,36.0,Female,Thyroid,2016
45-49,0.9,2.1,25,Incidence,1748512,Hispanic of any race,1.4,Female,Urinary Bladder,2016
5-9,11.0,13.7,316,Incidence,2573720,Hispanic of any race,12.3,Female,All Cancer Sites Combined,2016
5-9,2.1,3.4,70,Incidence,2573720,Hispanic of any race,2.7,Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Cervix,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Esophagus,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Female Breast,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
5-9,0.4,1.0,16,Incidence,2573720,Hispanic of any race,0.6,Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Larynx,2016
5-9,4.0,5.7,123,Incidence,2573720,Hispanic of any race,4.8,Female,Leukemias,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Mesothelioma,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Myeloma,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Ovary,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Pancreas,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Stomach,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Thyroid,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Female,Urinary Bladder,2016
50-54,487.8,510.2,7673,Incidence,1538011,Hispanic of any race,498.9,Female,All Cancer Sites Combined,2016
50-54,4.2,6.5,81,Incidence,1538011,Hispanic of any race,5.3,Female,Brain and Other Nervous System,2016
50-54,14.6,18.7,255,Incidence,1538011,Hispanic of any race,16.6,Female,Cervix,2016
50-54,46.7,53.8,771,Incidence,1538011,Hispanic of any race,50.1,Female,Colon and Rectum,2016
50-54,43.5,50.4,720,Incidence,1538011,Hispanic of any race,46.8,Female,"Corpus and Uterus, NOS",2016
50-54,~,~,~,Incidence,1538011,Hispanic of any race,~,Female,Esophagus,2016
50-54,170.3,183.7,2721,Incidence,1538011,Hispanic of any race,176.9,Female,Female Breast,2016
50-54,46.0,53.1,761,Incidence,1538011,Hispanic of any race,49.5,Female,"Female Breast, <i>in situ</i>",2016
50-54,1.1,2.4,25,Incidence,1538011,Hispanic of any race,1.6,Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,1538011,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
50-54,16.4,20.7,284,Incidence,1538011,Hispanic of any race,18.5,Female,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,1538011,Hispanic of any race,~,Female,Larynx,2016
50-54,7.6,10.7,139,Incidence,1538011,Hispanic of any race,9.0,Female,Leukemias,2016
50-54,3.6,5.8,71,Incidence,1538011,Hispanic of any race,4.6,Female,Liver and Intrahepatic Bile Duct,2016
50-54,18.7,23.4,322,Incidence,1538011,Hispanic of any race,20.9,Female,Lung and Bronchus,2016
50-54,5.7,8.4,107,Incidence,1538011,Hispanic of any race,7.0,Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,1538011,Hispanic of any race,~,Female,Mesothelioma,2016
50-54,4.8,7.3,92,Incidence,1538011,Hispanic of any race,6.0,Female,Myeloma,2016
50-54,16.9,21.3,292,Incidence,1538011,Hispanic of any race,19.0,Female,Non-Hodgkin Lymphoma,2016
50-54,4.0,6.3,77,Incidence,1538011,Hispanic of any race,5.0,Female,Oral Cavity and Pharynx,2016
50-54,16.5,20.9,286,Incidence,1538011,Hispanic of any race,18.6,Female,Ovary,2016
50-54,7.1,10.1,131,Incidence,1538011,Hispanic of any race,8.5,Female,Pancreas,2016
50-54,7.7,10.7,140,Incidence,1538011,Hispanic of any race,9.1,Female,Stomach,2016
50-54,34.4,40.6,575,Incidence,1538011,Hispanic of any race,37.4,Female,Thyroid,2016
50-54,2.7,4.7,55,Incidence,1538011,Hispanic of any race,3.6,Female,Urinary Bladder,2016
55-59,633.7,661.6,8286,Incidence,1279624,Hispanic of any race,647.5,Female,All Cancer Sites Combined,2016
55-59,6.0,9.1,95,Incidence,1279624,Hispanic of any race,7.4,Female,Brain and Other Nervous System,2016
55-59,14.5,19.0,213,Incidence,1279624,Hispanic of any race,16.6,Female,Cervix,2016
55-59,47.6,55.5,658,Incidence,1279624,Hispanic of any race,51.4,Female,Colon and Rectum,2016
55-59,67.8,77.2,926,Incidence,1279624,Hispanic of any race,72.4,Female,"Corpus and Uterus, NOS",2016
55-59,1.1,2.6,22,Incidence,1279624,Hispanic of any race,1.7,Female,Esophagus,2016
55-59,202.5,218.5,2692,Incidence,1279624,Hispanic of any race,210.4,Female,Female Breast,2016
55-59,49.7,57.8,686,Incidence,1279624,Hispanic of any race,53.6,Female,"Female Breast, <i>in situ</i>",2016
55-59,1.3,2.9,25,Incidence,1279624,Hispanic of any race,2.0,Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,1279624,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
55-59,23.7,29.5,339,Incidence,1279624,Hispanic of any race,26.5,Female,Kidney and Renal Pelvis,2016
55-59,0.8,2.1,17,Incidence,1279624,Hispanic of any race,1.3,Female,Larynx,2016
55-59,11.2,15.3,168,Incidence,1279624,Hispanic of any race,13.1,Female,Leukemias,2016
55-59,10.5,14.4,158,Incidence,1279624,Hispanic of any race,12.3,Female,Liver and Intrahepatic Bile Duct,2016
55-59,29.9,36.3,422,Incidence,1279624,Hispanic of any race,33.0,Female,Lung and Bronchus,2016
55-59,6.1,9.2,97,Incidence,1279624,Hispanic of any race,7.6,Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,1279624,Hispanic of any race,~,Female,Mesothelioma,2016
55-59,8.6,12.2,132,Incidence,1279624,Hispanic of any race,10.3,Female,Myeloma,2016
55-59,22.3,27.9,320,Incidence,1279624,Hispanic of any race,25.0,Female,Non-Hodgkin Lymphoma,2016
55-59,5.7,8.6,90,Incidence,1279624,Hispanic of any race,7.0,Female,Oral Cavity and Pharynx,2016
55-59,19.8,25.0,285,Incidence,1279624,Hispanic of any race,22.3,Female,Ovary,2016
55-59,15.3,20.0,224,Incidence,1279624,Hispanic of any race,17.5,Female,Pancreas,2016
55-59,10.7,14.7,161,Incidence,1279624,Hispanic of any race,12.6,Female,Stomach,2016
55-59,36.2,43.1,506,Incidence,1279624,Hispanic of any race,39.5,Female,Thyroid,2016
55-59,4.2,6.8,69,Incidence,1279624,Hispanic of any race,5.4,Female,Urinary Bladder,2016
60-64,829.0,865.1,8490,Incidence,1002477,Hispanic of any race,846.9,Female,All Cancer Sites Combined,2016
60-64,8.5,12.6,104,Incidence,1002477,Hispanic of any race,10.4,Female,Brain and Other Nervous System,2016
60-64,14.3,19.5,168,Incidence,1002477,Hispanic of any race,16.8,Female,Cervix,2016
60-64,62.3,72.6,675,Incidence,1002477,Hispanic of any race,67.3,Female,Colon and Rectum,2016
60-64,77.6,89.0,834,Incidence,1002477,Hispanic of any race,83.2,Female,"Corpus and Uterus, NOS",2016
60-64,1.4,3.3,22,Incidence,1002477,Hispanic of any race,2.2,Female,Esophagus,2016
60-64,256.5,276.8,2672,Incidence,1002477,Hispanic of any race,266.5,Female,Female Breast,2016
60-64,57.0,66.8,619,Incidence,1002477,Hispanic of any race,61.7,Female,"Female Breast, <i>in situ</i>",2016
60-64,1.5,3.6,24,Incidence,1002477,Hispanic of any race,2.4,Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,1002477,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
60-64,30.5,37.8,341,Incidence,1002477,Hispanic of any race,34.0,Female,Kidney and Renal Pelvis,2016
60-64,2.0,4.3,30,Incidence,1002477,Hispanic of any race,3.0,Female,Larynx,2016
60-64,13.8,18.8,162,Incidence,1002477,Hispanic of any race,16.2,Female,Leukemias,2016
60-64,19.8,25.8,227,Incidence,1002477,Hispanic of any race,22.6,Female,Liver and Intrahepatic Bile Duct,2016
60-64,53.1,62.7,579,Incidence,1002477,Hispanic of any race,57.8,Female,Lung and Bronchus,2016
60-64,9.4,13.7,114,Incidence,1002477,Hispanic of any race,11.4,Female,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,1002477,Hispanic of any race,~,Female,Mesothelioma,2016
60-64,14.0,19.2,165,Incidence,1002477,Hispanic of any race,16.5,Female,Myeloma,2016
60-64,33.5,41.2,373,Incidence,1002477,Hispanic of any race,37.2,Female,Non-Hodgkin Lymphoma,2016
60-64,10.0,14.4,121,Incidence,1002477,Hispanic of any race,12.1,Female,Oral Cavity and Pharynx,2016
60-64,22.6,29.0,257,Incidence,1002477,Hispanic of any race,25.6,Female,Ovary,2016
60-64,23.2,29.6,263,Incidence,1002477,Hispanic of any race,26.2,Female,Pancreas,2016
60-64,15.2,20.5,177,Incidence,1002477,Hispanic of any race,17.7,Female,Stomach,2016
60-64,34.9,42.6,387,Incidence,1002477,Hispanic of any race,38.6,Female,Thyroid,2016
60-64,8.3,12.4,102,Incidence,1002477,Hispanic of any race,10.2,Female,Urinary Bladder,2016
65-69,1091.4,1138.9,8514,Incidence,763582,Hispanic of any race,1115.0,Female,All Cancer Sites Combined,2016
65-69,8.8,13.6,84,Incidence,763582,Hispanic of any race,11.0,Female,Brain and Other Nervous System,2016
65-69,11.8,17.4,110,Incidence,763582,Hispanic of any race,14.4,Female,Cervix,2016
65-69,89.5,103.6,736,Incidence,763582,Hispanic of any race,96.4,Female,Colon and Rectum,2016
65-69,88.3,102.3,726,Incidence,763582,Hispanic of any race,95.1,Female,"Corpus and Uterus, NOS",2016
65-69,2.8,5.8,31,Incidence,763582,Hispanic of any race,4.1,Female,Esophagus,2016
65-69,321.4,347.4,2552,Incidence,763582,Hispanic of any race,334.2,Female,Female Breast,2016
65-69,70.9,83.5,588,Incidence,763582,Hispanic of any race,77.0,Female,"Female Breast, <i>in situ</i>",2016
65-69,2.4,5.3,28,Incidence,763582,Hispanic of any race,3.7,Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,763582,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
65-69,44.3,54.3,375,Incidence,763582,Hispanic of any race,49.1,Female,Kidney and Renal Pelvis,2016
65-69,~,~,~,Incidence,763582,Hispanic of any race,~,Female,Larynx,2016
65-69,22.3,29.7,197,Incidence,763582,Hispanic of any race,25.8,Female,Leukemias,2016
65-69,30.9,39.4,267,Incidence,763582,Hispanic of any race,35.0,Female,Liver and Intrahepatic Bile Duct,2016
65-69,87.2,101.0,717,Incidence,763582,Hispanic of any race,93.9,Female,Lung and Bronchus,2016
65-69,11.5,16.9,107,Incidence,763582,Hispanic of any race,14.0,Female,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,763582,Hispanic of any race,~,Female,Mesothelioma,2016
65-69,20.6,27.7,183,Incidence,763582,Hispanic of any race,24.0,Female,Myeloma,2016
65-69,46.6,57.0,394,Incidence,763582,Hispanic of any race,51.6,Female,Non-Hodgkin Lymphoma,2016
65-69,13.0,18.8,120,Incidence,763582,Hispanic of any race,15.7,Female,Oral Cavity and Pharynx,2016
65-69,27.8,35.9,242,Incidence,763582,Hispanic of any race,31.7,Female,Ovary,2016
65-69,32.3,40.9,278,Incidence,763582,Hispanic of any race,36.4,Female,Pancreas,2016
65-69,21.3,28.5,189,Incidence,763582,Hispanic of any race,24.8,Female,Stomach,2016
65-69,36.6,45.8,313,Incidence,763582,Hispanic of any race,41.0,Female,Thyroid,2016
65-69,12.0,17.5,111,Incidence,763582,Hispanic of any race,14.5,Female,Urinary Bladder,2016
70-74,1243.0,1303.6,6817,Incidence,535497,Hispanic of any race,1273.0,Female,All Cancer Sites Combined,2016
70-74,10.0,16.3,69,Incidence,535497,Hispanic of any race,12.9,Female,Brain and Other Nervous System,2016
70-74,13.0,20.0,87,Incidence,535497,Hispanic of any race,16.2,Female,Cervix,2016
70-74,97.9,115.6,570,Incidence,535497,Hispanic of any race,106.4,Female,Colon and Rectum,2016
70-74,76.1,91.8,448,Incidence,535497,Hispanic of any race,83.7,Female,"Corpus and Uterus, NOS",2016
70-74,2.6,6.2,22,Incidence,535497,Hispanic of any race,4.1,Female,Esophagus,2016
70-74,332.1,363.9,1862,Incidence,535497,Hispanic of any race,347.7,Female,Female Breast,2016
70-74,71.3,86.5,421,Incidence,535497,Hispanic of any race,78.6,Female,"Female Breast, <i>in situ</i>",2016
70-74,2.1,5.5,19,Incidence,535497,Hispanic of any race,3.5,Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,535497,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
70-74,38.8,50.3,237,Incidence,535497,Hispanic of any race,44.3,Female,Kidney and Renal Pelvis,2016
70-74,~,~,~,Incidence,535497,Hispanic of any race,~,Female,Larynx,2016
70-74,30.6,40.9,190,Incidence,535497,Hispanic of any race,35.5,Female,Leukemias,2016
70-74,34.3,45.1,211,Incidence,535497,Hispanic of any race,39.4,Female,Liver and Intrahepatic Bile Duct,2016
70-74,134.9,155.5,776,Incidence,535497,Hispanic of any race,144.9,Female,Lung and Bronchus,2016
70-74,12.7,19.6,85,Incidence,535497,Hispanic of any race,15.9,Female,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,535497,Hispanic of any race,~,Female,Mesothelioma,2016
70-74,21.7,30.4,138,Incidence,535497,Hispanic of any race,25.8,Female,Myeloma,2016
70-74,60.3,74.3,359,Incidence,535497,Hispanic of any race,67.0,Female,Non-Hodgkin Lymphoma,2016
70-74,12.3,19.2,83,Incidence,535497,Hispanic of any race,15.5,Female,Oral Cavity and Pharynx,2016
70-74,29.1,39.1,181,Incidence,535497,Hispanic of any race,33.8,Female,Ovary,2016
70-74,46.3,58.8,280,Incidence,535497,Hispanic of any race,52.3,Female,Pancreas,2016
70-74,25.6,35.1,161,Incidence,535497,Hispanic of any race,30.1,Female,Stomach,2016
70-74,29.7,39.9,185,Incidence,535497,Hispanic of any race,34.5,Female,Thyroid,2016
70-74,22.5,31.5,143,Incidence,535497,Hispanic of any race,26.7,Female,Urinary Bladder,2016
75-79,1391.4,1467.1,5510,Incidence,385618,Hispanic of any race,1428.9,Female,All Cancer Sites Combined,2016
75-79,14.2,22.9,70,Incidence,385618,Hispanic of any race,18.2,Female,Brain and Other Nervous System,2016
75-79,13.2,21.8,66,Incidence,385618,Hispanic of any race,17.1,Female,Cervix,2016
75-79,125.0,148.6,526,Incidence,385618,Hispanic of any race,136.4,Female,Colon and Rectum,2016
75-79,72.2,90.4,312,Incidence,385618,Hispanic of any race,80.9,Female,"Corpus and Uterus, NOS",2016
75-79,4.2,9.6,25,Incidence,385618,Hispanic of any race,6.5,Female,Esophagus,2016
75-79,301.6,337.6,1231,Incidence,385618,Hispanic of any race,319.2,Female,Female Breast,2016
75-79,53.2,69.0,234,Incidence,385618,Hispanic of any race,60.7,Female,"Female Breast, <i>in situ</i>",2016
75-79,2.6,7.1,17,Incidence,385618,Hispanic of any race,4.4,Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,385618,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
75-79,44.7,59.3,199,Incidence,385618,Hispanic of any race,51.6,Female,Kidney and Renal Pelvis,2016
75-79,~,~,~,Incidence,385618,Hispanic of any race,~,Female,Larynx,2016
75-79,34.6,47.6,157,Incidence,385618,Hispanic of any race,40.7,Female,Leukemias,2016
75-79,36.3,49.6,164,Incidence,385618,Hispanic of any race,42.5,Female,Liver and Intrahepatic Bile Duct,2016
75-79,158.6,185.0,661,Incidence,385618,Hispanic of any race,171.4,Female,Lung and Bronchus,2016
75-79,10.5,18.3,54,Incidence,385618,Hispanic of any race,14.0,Female,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,385618,Hispanic of any race,~,Female,Mesothelioma,2016
75-79,29.8,42.0,137,Incidence,385618,Hispanic of any race,35.5,Female,Myeloma,2016
75-79,76.3,95.1,329,Incidence,385618,Hispanic of any race,85.3,Female,Non-Hodgkin Lymphoma,2016
75-79,16.5,25.8,80,Incidence,385618,Hispanic of any race,20.7,Female,Oral Cavity and Pharynx,2016
75-79,26.5,38.1,123,Incidence,385618,Hispanic of any race,31.9,Female,Ovary,2016
75-79,64.4,81.6,280,Incidence,385618,Hispanic of any race,72.6,Female,Pancreas,2016
75-79,30.8,43.1,141,Incidence,385618,Hispanic of any race,36.6,Female,Stomach,2016
75-79,25.8,37.2,120,Incidence,385618,Hispanic of any race,31.1,Female,Thyroid,2016
75-79,27.2,38.9,126,Incidence,385618,Hispanic of any race,32.7,Female,Urinary Bladder,2016
80-84,1438.3,1530.2,4043,Incidence,272495,Hispanic of any race,1483.7,Female,All Cancer Sites Combined,2016
80-84,11.7,21.7,44,Incidence,272495,Hispanic of any race,16.1,Female,Brain and Other Nervous System,2016
80-84,8.0,16.6,32,Incidence,272495,Hispanic of any race,11.7,Female,Cervix,2016
80-84,147.4,178.1,442,Incidence,272495,Hispanic of any race,162.2,Female,Colon and Rectum,2016
80-84,45.9,63.8,148,Incidence,272495,Hispanic of any race,54.3,Female,"Corpus and Uterus, NOS",2016
80-84,5.1,12.2,22,Incidence,272495,Hispanic of any race,8.1,Female,Esophagus,2016
80-84,254.8,294.5,747,Incidence,272495,Hispanic of any race,274.1,Female,Female Breast,2016
80-84,28.5,43.0,96,Incidence,272495,Hispanic of any race,35.2,Female,"Female Breast, <i>in situ</i>",2016
80-84,3.4,9.5,16,Incidence,272495,Hispanic of any race,5.9,Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,272495,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
80-84,38.5,55.1,126,Incidence,272495,Hispanic of any race,46.2,Female,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,272495,Hispanic of any race,~,Female,Larynx,2016
80-84,38.5,55.1,126,Incidence,272495,Hispanic of any race,46.2,Female,Leukemias,2016
80-84,46.9,65.0,151,Incidence,272495,Hispanic of any race,55.4,Female,Liver and Intrahepatic Bile Duct,2016
80-84,171.6,204.5,511,Incidence,272495,Hispanic of any race,187.5,Female,Lung and Bronchus,2016
80-84,14.6,25.4,53,Incidence,272495,Hispanic of any race,19.4,Female,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,272495,Hispanic of any race,~,Female,Mesothelioma,2016
80-84,29.5,44.2,99,Incidence,272495,Hispanic of any race,36.3,Female,Myeloma,2016
80-84,85.9,109.7,265,Incidence,272495,Hispanic of any race,97.2,Female,Non-Hodgkin Lymphoma,2016
80-84,12.0,22.1,45,Incidence,272495,Hispanic of any race,16.5,Female,Oral Cavity and Pharynx,2016
80-84,34.5,50.3,114,Incidence,272495,Hispanic of any race,41.8,Female,Ovary,2016
80-84,80.7,103.9,250,Incidence,272495,Hispanic of any race,91.7,Female,Pancreas,2016
80-84,41.5,58.6,135,Incidence,272495,Hispanic of any race,49.5,Female,Stomach,2016
80-84,17.4,29.2,62,Incidence,272495,Hispanic of any race,22.8,Female,Thyroid,2016
80-84,30.5,45.4,102,Incidence,272495,Hispanic of any race,37.4,Female,Urinary Bladder,2016
85+,1385.9,1475.8,3929,Incidence,274694,Hispanic of any race,1430.3,Female,All Cancer Sites Combined,2016
85+,9.2,18.1,36,Incidence,274694,Hispanic of any race,13.1,Female,Brain and Other Nervous System,2016
85+,13.5,24.0,50,Incidence,274694,Hispanic of any race,18.2,Female,Cervix,2016
85+,172.3,205.2,517,Incidence,274694,Hispanic of any race,188.2,Female,Colon and Rectum,2016
85+,37.2,53.4,123,Incidence,274694,Hispanic of any race,44.8,Female,"Corpus and Uterus, NOS",2016
85+,6.2,13.9,26,Incidence,274694,Hispanic of any race,9.5,Female,Esophagus,2016
85+,217.0,253.6,645,Incidence,274694,Hispanic of any race,234.8,Female,Female Breast,2016
85+,13.5,24.0,50,Incidence,274694,Hispanic of any race,18.2,Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,274694,Hispanic of any race,~,Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,274694,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
85+,31.3,46.3,105,Incidence,274694,Hispanic of any race,38.2,Female,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,274694,Hispanic of any race,~,Female,Larynx,2016
85+,40.5,57.4,133,Incidence,274694,Hispanic of any race,48.4,Female,Leukemias,2016
85+,47.9,66.0,155,Incidence,274694,Hispanic of any race,56.4,Female,Liver and Intrahepatic Bile Duct,2016
85+,143.1,173.2,433,Incidence,274694,Hispanic of any race,157.6,Female,Lung and Bronchus,2016
85+,13.8,24.4,51,Incidence,274694,Hispanic of any race,18.6,Female,Melanomas of the Skin,2016
85+,~,~,~,Incidence,274694,Hispanic of any race,~,Female,Mesothelioma,2016
85+,17.0,28.5,61,Incidence,274694,Hispanic of any race,22.2,Female,Myeloma,2016
85+,66.5,87.5,210,Incidence,274694,Hispanic of any race,76.4,Female,Non-Hodgkin Lymphoma,2016
85+,13.2,23.6,49,Incidence,274694,Hispanic of any race,17.8,Female,Oral Cavity and Pharynx,2016
85+,26.3,40.3,90,Incidence,274694,Hispanic of any race,32.8,Female,Ovary,2016
85+,81.1,104.2,253,Incidence,274694,Hispanic of any race,92.1,Female,Pancreas,2016
85+,43.5,60.9,142,Incidence,274694,Hispanic of any race,51.7,Female,Stomach,2016
85+,9.2,18.1,36,Incidence,274694,Hispanic of any race,13.1,Female,Thyroid,2016
85+,39.9,56.6,131,Incidence,274694,Hispanic of any race,47.7,Female,Urinary Bladder,2016
<1,19.9,28.7,119,Incidence,495790,Hispanic of any race,24.0,Female,All Cancer Sites Combined,2016
<1,3.6,7.9,27,Incidence,495790,Hispanic of any race,5.4,Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Cervix,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Colon and Rectum,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Esophagus,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Female Breast,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Larynx,2016
<1,3.4,7.7,26,Incidence,495790,Hispanic of any race,5.2,Female,Leukemias,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Mesothelioma,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Myeloma,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Ovary,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Pancreas,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Stomach,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Thyroid,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Female,Urinary Bladder,2016
1-4,21.8,26.0,489,Incidence,2052941,Hispanic of any race,23.8,Male,All Cancer Sites Combined,2016
1-4,3.1,4.9,81,Incidence,2052941,Hispanic of any race,3.9,Male,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Colon and Rectum,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Esophagus,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
1-4,0.7,1.6,22,Incidence,2052941,Hispanic of any race,1.1,Male,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Larynx,2016
1-4,9.9,12.9,232,Incidence,2052941,Hispanic of any race,11.3,Male,Leukemias,2016
1-4,0.5,1.4,18,Incidence,2052941,Hispanic of any race,0.9,Male,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Lung and Bronchus,2016
1-4,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Mesothelioma,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Myeloma,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Pancreas,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Prostate,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Stomach,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Testis,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Thyroid,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male,Urinary Bladder,2016
10-14,14.8,18.0,419,Incidence,2563326,Hispanic of any race,16.3,Male,All Cancer Sites Combined,2016
10-14,1.5,2.7,53,Incidence,2563326,Hispanic of any race,2.1,Male,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Colon and Rectum,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Esophagus,2016
10-14,0.5,1.3,21,Incidence,2563326,Hispanic of any race,0.8,Male,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Larynx,2016
10-14,4.6,6.5,141,Incidence,2563326,Hispanic of any race,5.5,Male,Leukemias,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Lung and Bronchus,2016
10-14,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Mesothelioma,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Myeloma,2016
10-14,1.0,2.0,38,Incidence,2563326,Hispanic of any race,1.5,Male,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Pancreas,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Prostate,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Stomach,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Testis,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Thyroid,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male,Urinary Bladder,2016
15-19,24.1,28.2,640,Incidence,2452213,Hispanic of any race,26.1,Male,All Cancer Sites Combined,2016
15-19,1.1,2.1,38,Incidence,2452213,Hispanic of any race,1.5,Male,Brain and Other Nervous System,2016
15-19,0.8,1.7,30,Incidence,2452213,Hispanic of any race,1.2,Male,Colon and Rectum,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Esophagus,2016
15-19,1.9,3.2,61,Incidence,2452213,Hispanic of any race,2.5,Male,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Larynx,2016
15-19,5.0,6.9,144,Incidence,2452213,Hispanic of any race,5.9,Male,Leukemias,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Lung and Bronchus,2016
15-19,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Mesothelioma,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Myeloma,2016
15-19,1.7,3.0,56,Incidence,2452213,Hispanic of any race,2.3,Male,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Pancreas,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Prostate,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Stomach,2016
15-19,4.6,6.5,135,Incidence,2452213,Hispanic of any race,5.5,Male,Testis,2016
15-19,0.6,1.5,24,Incidence,2452213,Hispanic of any race,1.0,Male,Thyroid,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male,Urinary Bladder,2016
20-24,31.0,35.6,824,Incidence,2481254,Hispanic of any race,33.2,Male,All Cancer Sites Combined,2016
20-24,1.3,2.3,43,Incidence,2481254,Hispanic of any race,1.7,Male,Brain and Other Nervous System,2016
20-24,0.8,1.7,30,Incidence,2481254,Hispanic of any race,1.2,Male,Colon and Rectum,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Esophagus,2016
20-24,1.6,2.7,52,Incidence,2481254,Hispanic of any race,2.1,Male,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Larynx,2016
20-24,3.2,4.9,99,Incidence,2481254,Hispanic of any race,4.0,Male,Leukemias,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Lung and Bronchus,2016
20-24,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Mesothelioma,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Myeloma,2016
20-24,1.5,2.6,49,Incidence,2481254,Hispanic of any race,2.0,Male,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Pancreas,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Prostate,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Stomach,2016
20-24,12.3,15.3,341,Incidence,2481254,Hispanic of any race,13.7,Male,Testis,2016
20-24,1.5,2.7,50,Incidence,2481254,Hispanic of any race,2.0,Male,Thyroid,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male,Urinary Bladder,2016
25-29,40.9,46.2,1061,Incidence,2437400,Hispanic of any race,43.5,Male,All Cancer Sites Combined,2016
25-29,1.7,3.0,56,Incidence,2437400,Hispanic of any race,2.3,Male,Brain and Other Nervous System,2016
25-29,1.8,3.0,57,Incidence,2437400,Hispanic of any race,2.3,Male,Colon and Rectum,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Esophagus,2016
25-29,2.1,3.4,65,Incidence,2437400,Hispanic of any race,2.7,Male,Hodgkin Lymphoma,2016
25-29,0.7,1.5,25,Incidence,2437400,Hispanic of any race,1.0,Male,Kaposi Sarcoma,2016
25-29,0.9,1.8,31,Incidence,2437400,Hispanic of any race,1.3,Male,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Larynx,2016
25-29,3.0,4.5,90,Incidence,2437400,Hispanic of any race,3.7,Male,Leukemias,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Lung and Bronchus,2016
25-29,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
25-29,0.5,1.2,19,Incidence,2437400,Hispanic of any race,0.8,Male,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Mesothelioma,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Myeloma,2016
25-29,2.5,3.9,76,Incidence,2437400,Hispanic of any race,3.1,Male,Non-Hodgkin Lymphoma,2016
25-29,0.6,1.4,22,Incidence,2437400,Hispanic of any race,0.9,Male,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Pancreas,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Prostate,2016
25-29,0.6,1.4,23,Incidence,2437400,Hispanic of any race,0.9,Male,Stomach,2016
25-29,13.2,16.3,359,Incidence,2437400,Hispanic of any race,14.7,Male,Testis,2016
25-29,1.8,3.1,58,Incidence,2437400,Hispanic of any race,2.4,Male,Thyroid,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male,Urinary Bladder,2016
30-34,51.5,57.5,1277,Incidence,2345972,Hispanic of any race,54.4,Male,All Cancer Sites Combined,2016
30-34,2.3,3.7,69,Incidence,2345972,Hispanic of any race,2.9,Male,Brain and Other Nervous System,2016
30-34,3.2,4.8,92,Incidence,2345972,Hispanic of any race,3.9,Male,Colon and Rectum,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Esophagus,2016
30-34,1.7,3.0,54,Incidence,2345972,Hispanic of any race,2.3,Male,Hodgkin Lymphoma,2016
30-34,1.2,2.3,40,Incidence,2345972,Hispanic of any race,1.7,Male,Kaposi Sarcoma,2016
30-34,2.8,4.3,82,Incidence,2345972,Hispanic of any race,3.5,Male,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Larynx,2016
30-34,3.9,5.7,111,Incidence,2345972,Hispanic of any race,4.7,Male,Leukemias,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Lung and Bronchus,2016
30-34,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
30-34,0.6,1.5,23,Incidence,2345972,Hispanic of any race,1.0,Male,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Mesothelioma,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Myeloma,2016
30-34,3.9,5.7,111,Incidence,2345972,Hispanic of any race,4.7,Male,Non-Hodgkin Lymphoma,2016
30-34,0.8,1.8,29,Incidence,2345972,Hispanic of any race,1.2,Male,Oral Cavity and Pharynx,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Pancreas,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Prostate,2016
30-34,1.0,2.0,34,Incidence,2345972,Hispanic of any race,1.4,Male,Stomach,2016
30-34,12.0,15.0,316,Incidence,2345972,Hispanic of any race,13.5,Male,Testis,2016
30-34,3.2,4.9,93,Incidence,2345972,Hispanic of any race,4.0,Male,Thyroid,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male,Urinary Bladder,2016
35-39,68.1,75.2,1587,Incidence,2215514,Hispanic of any race,71.6,Male,All Cancer Sites Combined,2016
35-39,2.2,3.6,63,Incidence,2215514,Hispanic of any race,2.8,Male,Brain and Other Nervous System,2016
35-39,6.4,8.8,167,Incidence,2215514,Hispanic of any race,7.5,Male,Colon and Rectum,2016
35-39,~,~,~,Incidence,2215514,Hispanic of any race,~,Male,Esophagus,2016
35-39,1.9,3.3,56,Incidence,2215514,Hispanic of any race,2.5,Male,Hodgkin Lymphoma,2016
35-39,0.6,1.4,21,Incidence,2215514,Hispanic of any race,0.9,Male,Kaposi Sarcoma,2016
35-39,6.0,8.3,157,Incidence,2215514,Hispanic of any race,7.1,Male,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,2215514,Hispanic of any race,~,Male,Larynx,2016
35-39,4.1,6.0,110,Incidence,2215514,Hispanic of any race,5.0,Male,Leukemias,2016
35-39,0.5,1.3,18,Incidence,2215514,Hispanic of any race,0.8,Male,Liver and Intrahepatic Bile Duct,2016
35-39,1.0,2.0,31,Incidence,2215514,Hispanic of any race,1.4,Male,Lung and Bronchus,2016
35-39,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
35-39,0.8,1.8,28,Incidence,2215514,Hispanic of any race,1.3,Male,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,2215514,Hispanic of any race,~,Male,Mesothelioma,2016
35-39,0.7,1.6,24,Incidence,2215514,Hispanic of any race,1.1,Male,Myeloma,2016
35-39,6.2,8.5,161,Incidence,2215514,Hispanic of any race,7.3,Male,Non-Hodgkin Lymphoma,2016
35-39,1.5,2.8,46,Incidence,2215514,Hispanic of any race,2.1,Male,Oral Cavity and Pharynx,2016
35-39,1.0,2.0,31,Incidence,2215514,Hispanic of any race,1.4,Male,Pancreas,2016
35-39,~,~,~,Incidence,2215514,Hispanic of any race,~,Male,Prostate,2016
35-39,3.1,4.8,87,Incidence,2215514,Hispanic of any race,3.9,Male,Stomach,2016
35-39,8.0,10.6,205,Incidence,2215514,Hispanic of any race,9.3,Male,Testis,2016
35-39,4.6,6.6,122,Incidence,2215514,Hispanic of any race,5.5,Male,Thyroid,2016
35-39,0.7,1.7,25,Incidence,2215514,Hispanic of any race,1.1,Male,Urinary Bladder,2016
40-44,105.2,114.5,2193,Incidence,1997480,Hispanic of any race,109.8,Male,All Cancer Sites Combined,2016
40-44,2.8,4.5,72,Incidence,1997480,Hispanic of any race,3.6,Male,Brain and Other Nervous System,2016
40-44,13.7,17.1,306,Incidence,1997480,Hispanic of any race,15.3,Male,Colon and Rectum,2016
40-44,0.8,1.8,24,Incidence,1997480,Hispanic of any race,1.2,Male,Esophagus,2016
40-44,1.8,3.2,48,Incidence,1997480,Hispanic of any race,2.4,Male,Hodgkin Lymphoma,2016
40-44,0.9,2.0,28,Incidence,1997480,Hispanic of any race,1.4,Male,Kaposi Sarcoma,2016
40-44,12.0,15.2,270,Incidence,1997480,Hispanic of any race,13.5,Male,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,1997480,Hispanic of any race,~,Male,Larynx,2016
40-44,5.9,8.3,141,Incidence,1997480,Hispanic of any race,7.1,Male,Leukemias,2016
40-44,1.4,2.7,40,Incidence,1997480,Hispanic of any race,2.0,Male,Liver and Intrahepatic Bile Duct,2016
40-44,2.5,4.1,65,Incidence,1997480,Hispanic of any race,3.3,Male,Lung and Bronchus,2016
40-44,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
40-44,2.1,3.6,56,Incidence,1997480,Hispanic of any race,2.8,Male,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,1997480,Hispanic of any race,~,Male,Mesothelioma,2016
40-44,2.0,3.5,54,Incidence,1997480,Hispanic of any race,2.7,Male,Myeloma,2016
40-44,9.2,12.1,212,Incidence,1997480,Hispanic of any race,10.6,Male,Non-Hodgkin Lymphoma,2016
40-44,3.7,5.6,92,Incidence,1997480,Hispanic of any race,4.6,Male,Oral Cavity and Pharynx,2016
40-44,1.6,2.9,43,Incidence,1997480,Hispanic of any race,2.2,Male,Pancreas,2016
40-44,2.9,4.7,74,Incidence,1997480,Hispanic of any race,3.7,Male,Prostate,2016
40-44,4.1,6.1,100,Incidence,1997480,Hispanic of any race,5.0,Male,Stomach,2016
40-44,4.6,6.7,111,Incidence,1997480,Hispanic of any race,5.6,Male,Testis,2016
40-44,6.0,8.4,142,Incidence,1997480,Hispanic of any race,7.1,Male,Thyroid,2016
40-44,1.3,2.5,36,Incidence,1997480,Hispanic of any race,1.8,Male,Urinary Bladder,2016
45-49,170.2,182.5,3163,Incidence,1794358,Hispanic of any race,176.3,Male,All Cancer Sites Combined,2016
45-49,3.5,5.5,80,Incidence,1794358,Hispanic of any race,4.5,Male,Brain and Other Nervous System,2016
45-49,24.6,29.5,484,Incidence,1794358,Hispanic of any race,27.0,Male,Colon and Rectum,2016
45-49,1.1,2.3,29,Incidence,1794358,Hispanic of any race,1.6,Male,Esophagus,2016
45-49,1.9,3.4,46,Incidence,1794358,Hispanic of any race,2.6,Male,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,1794358,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
45-49,19.2,23.5,381,Incidence,1794358,Hispanic of any race,21.2,Male,Kidney and Renal Pelvis,2016
45-49,0.9,2.1,26,Incidence,1794358,Hispanic of any race,1.4,Male,Larynx,2016
45-49,7.4,10.2,157,Incidence,1794358,Hispanic of any race,8.7,Male,Leukemias,2016
45-49,7.1,9.8,150,Incidence,1794358,Hispanic of any race,8.4,Male,Liver and Intrahepatic Bile Duct,2016
45-49,5.3,7.8,116,Incidence,1794358,Hispanic of any race,6.5,Male,Lung and Bronchus,2016
45-49,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
45-49,2.8,4.7,66,Incidence,1794358,Hispanic of any race,3.7,Male,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,1794358,Hispanic of any race,~,Male,Mesothelioma,2016
45-49,3.7,5.8,84,Incidence,1794358,Hispanic of any race,4.7,Male,Myeloma,2016
45-49,12.0,15.5,245,Incidence,1794358,Hispanic of any race,13.7,Male,Non-Hodgkin Lymphoma,2016
45-49,6.7,9.3,142,Incidence,1794358,Hispanic of any race,7.9,Male,Oral Cavity and Pharynx,2016
45-49,4.0,6.2,90,Incidence,1794358,Hispanic of any race,5.0,Male,Pancreas,2016
45-49,12.5,16.0,254,Incidence,1794358,Hispanic of any race,14.2,Male,Prostate,2016
45-49,6.3,8.8,134,Incidence,1794358,Hispanic of any race,7.5,Male,Stomach,2016
45-49,2.3,3.9,54,Incidence,1794358,Hispanic of any race,3.0,Male,Testis,2016
45-49,7.7,10.5,162,Incidence,1794358,Hispanic of any race,9.0,Male,Thyroid,2016
45-49,2.6,4.4,62,Incidence,1794358,Hispanic of any race,3.5,Male,Urinary Bladder,2016
5-9,12.3,15.2,366,Incidence,2674058,Hispanic of any race,13.7,Male,All Cancer Sites Combined,2016
5-9,1.9,3.1,66,Incidence,2674058,Hispanic of any race,2.5,Male,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Colon and Rectum,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Esophagus,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Larynx,2016
5-9,4.9,6.7,153,Incidence,2674058,Hispanic of any race,5.7,Male,Leukemias,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Lung and Bronchus,2016
5-9,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Mesothelioma,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Myeloma,2016
5-9,0.6,1.3,24,Incidence,2674058,Hispanic of any race,0.9,Male,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Pancreas,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Prostate,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Stomach,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Testis,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Thyroid,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male,Urinary Bladder,2016
50-54,347.1,365.9,5515,Incidence,1547353,Hispanic of any race,356.4,Male,All Cancer Sites Combined,2016
50-54,5.3,7.9,100,Incidence,1547353,Hispanic of any race,6.5,Male,Brain and Other Nervous System,2016
50-54,55.0,62.7,909,Incidence,1547353,Hispanic of any race,58.7,Male,Colon and Rectum,2016
50-54,3.4,5.5,67,Incidence,1547353,Hispanic of any race,4.3,Male,Esophagus,2016
50-54,1.9,3.6,41,Incidence,1547353,Hispanic of any race,2.6,Male,Hodgkin Lymphoma,2016
50-54,0.8,2.1,21,Incidence,1547353,Hispanic of any race,1.4,Male,Kaposi Sarcoma,2016
50-54,29.4,35.1,498,Incidence,1547353,Hispanic of any race,32.2,Male,Kidney and Renal Pelvis,2016
50-54,3.5,5.7,70,Incidence,1547353,Hispanic of any race,4.5,Male,Larynx,2016
50-54,9.4,12.8,170,Incidence,1547353,Hispanic of any race,11.0,Male,Leukemias,2016
50-54,26.3,31.7,447,Incidence,1547353,Hispanic of any race,28.9,Male,Liver and Intrahepatic Bile Duct,2016
50-54,12.9,16.8,228,Incidence,1547353,Hispanic of any race,14.7,Male,Lung and Bronchus,2016
50-54,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
50-54,4.2,6.5,81,Incidence,1547353,Hispanic of any race,5.2,Male,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,1547353,Hispanic of any race,~,Male,Mesothelioma,2016
50-54,7.0,9.9,129,Incidence,1547353,Hispanic of any race,8.3,Male,Myeloma,2016
50-54,20.9,25.7,359,Incidence,1547353,Hispanic of any race,23.2,Male,Non-Hodgkin Lymphoma,2016
50-54,12.9,16.8,229,Incidence,1547353,Hispanic of any race,14.8,Male,Oral Cavity and Pharynx,2016
50-54,10.8,14.4,193,Incidence,1547353,Hispanic of any race,12.5,Male,Pancreas,2016
50-54,60.2,68.2,992,Incidence,1547353,Hispanic of any race,64.1,Male,Prostate,2016
50-54,9.9,13.3,178,Incidence,1547353,Hispanic of any race,11.5,Male,Stomach,2016
50-54,2.0,3.7,43,Incidence,1547353,Hispanic of any race,2.8,Male,Testis,2016
50-54,6.5,9.4,122,Incidence,1547353,Hispanic of any race,7.9,Male,Thyroid,2016
50-54,8.0,11.2,147,Incidence,1547353,Hispanic of any race,9.5,Male,Urinary Bladder,2016
55-59,604.2,632.0,7624,Incidence,1233636,Hispanic of any race,618.0,Male,All Cancer Sites Combined,2016
55-59,6.5,9.8,99,Incidence,1233636,Hispanic of any race,8.0,Male,Brain and Other Nervous System,2016
55-59,68.3,78.0,901,Incidence,1233636,Hispanic of any race,73.0,Male,Colon and Rectum,2016
55-59,6.2,9.4,95,Incidence,1233636,Hispanic of any race,7.7,Male,Esophagus,2016
55-59,1.9,3.9,34,Incidence,1233636,Hispanic of any race,2.8,Male,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,1233636,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
55-59,43.2,50.9,579,Incidence,1233636,Hispanic of any race,46.9,Male,Kidney and Renal Pelvis,2016
55-59,6.0,9.1,92,Incidence,1233636,Hispanic of any race,7.5,Male,Larynx,2016
55-59,12.8,17.1,183,Incidence,1233636,Hispanic of any race,14.8,Male,Leukemias,2016
55-59,50.5,58.8,673,Incidence,1233636,Hispanic of any race,54.6,Male,Liver and Intrahepatic Bile Duct,2016
55-59,39.6,47.0,533,Incidence,1233636,Hispanic of any race,43.2,Male,Lung and Bronchus,2016
55-59,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
55-59,6.4,9.6,97,Incidence,1233636,Hispanic of any race,7.9,Male,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,1233636,Hispanic of any race,~,Male,Mesothelioma,2016
55-59,11.1,15.2,161,Incidence,1233636,Hispanic of any race,13.1,Male,Myeloma,2016
55-59,28.4,34.7,388,Incidence,1233636,Hispanic of any race,31.5,Male,Non-Hodgkin Lymphoma,2016
55-59,21.1,26.6,293,Incidence,1233636,Hispanic of any race,23.8,Male,Oral Cavity and Pharynx,2016
55-59,16.2,21.1,229,Incidence,1233636,Hispanic of any race,18.6,Male,Pancreas,2016
55-59,161.4,175.9,2079,Incidence,1233636,Hispanic of any race,168.5,Male,Prostate,2016
55-59,14.7,19.4,209,Incidence,1233636,Hispanic of any race,16.9,Male,Stomach,2016
55-59,0.8,2.2,17,Incidence,1233636,Hispanic of any race,1.4,Male,Testis,2016
55-59,9.8,13.7,144,Incidence,1233636,Hispanic of any race,11.7,Male,Thyroid,2016
55-59,15.6,20.4,221,Incidence,1233636,Hispanic of any race,17.9,Male,Urinary Bladder,2016
60-64,963.0,1003.8,8932,Incidence,908424,Hispanic of any race,983.2,Male,All Cancer Sites Combined,2016
60-64,10.3,15.0,113,Incidence,908424,Hispanic of any race,12.4,Male,Brain and Other Nervous System,2016
60-64,98.0,111.4,950,Incidence,908424,Hispanic of any race,104.6,Male,Colon and Rectum,2016
60-64,11.0,15.8,120,Incidence,908424,Hispanic of any race,13.2,Male,Esophagus,2016
60-64,2.5,5.1,33,Incidence,908424,Hispanic of any race,3.6,Male,Hodgkin Lymphoma,2016
60-64,1.2,3.1,18,Incidence,908424,Hispanic of any race,2.0,Male,Kaposi Sarcoma,2016
60-64,59.3,69.8,585,Incidence,908424,Hispanic of any race,64.4,Male,Kidney and Renal Pelvis,2016
60-64,11.0,15.8,120,Incidence,908424,Hispanic of any race,13.2,Male,Larynx,2016
60-64,19.5,25.8,204,Incidence,908424,Hispanic of any race,22.5,Male,Leukemias,2016
60-64,79.0,91.1,771,Incidence,908424,Hispanic of any race,84.9,Male,Liver and Intrahepatic Bile Duct,2016
60-64,72.5,84.1,710,Incidence,908424,Hispanic of any race,78.2,Male,Lung and Bronchus,2016
60-64,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
60-64,9.1,13.5,101,Incidence,908424,Hispanic of any race,11.1,Male,Melanomas of the Skin,2016
60-64,1.4,3.5,21,Incidence,908424,Hispanic of any race,2.3,Male,Mesothelioma,2016
60-64,18.4,24.5,193,Incidence,908424,Hispanic of any race,21.2,Male,Myeloma,2016
60-64,38.8,47.4,390,Incidence,908424,Hispanic of any race,42.9,Male,Non-Hodgkin Lymphoma,2016
60-64,29.9,37.6,305,Incidence,908424,Hispanic of any race,33.6,Male,Oral Cavity and Pharynx,2016
60-64,28.9,36.4,295,Incidence,908424,Hispanic of any race,32.5,Male,Pancreas,2016
60-64,287.9,310.6,2717,Incidence,908424,Hispanic of any race,299.1,Male,Prostate,2016
60-64,21.4,28.0,223,Incidence,908424,Hispanic of any race,24.5,Male,Stomach,2016
60-64,~,~,~,Incidence,908424,Hispanic of any race,~,Male,Testis,2016
60-64,8.6,12.9,96,Incidence,908424,Hispanic of any race,10.6,Male,Thyroid,2016
60-64,31.1,38.8,316,Incidence,908424,Hispanic of any race,34.8,Male,Urinary Bladder,2016
65-69,1472.0,1531.5,9851,Incidence,656076,Hispanic of any race,1501.5,Male,All Cancer Sites Combined,2016
65-69,12.5,18.7,101,Incidence,656076,Hispanic of any race,15.4,Male,Brain and Other Nervous System,2016
65-69,144.4,163.6,1009,Incidence,656076,Hispanic of any race,153.8,Male,Colon and Rectum,2016
65-69,18.1,25.3,141,Incidence,656076,Hispanic of any race,21.5,Male,Esophagus,2016
65-69,3.8,7.6,36,Incidence,656076,Hispanic of any race,5.5,Male,Hodgkin Lymphoma,2016
65-69,1.9,4.7,20,Incidence,656076,Hispanic of any race,3.0,Male,Kaposi Sarcoma,2016
65-69,78.9,93.2,563,Incidence,656076,Hispanic of any race,85.8,Male,Kidney and Renal Pelvis,2016
65-69,13.9,20.4,111,Incidence,656076,Hispanic of any race,16.9,Male,Larynx,2016
65-69,28.0,36.8,211,Incidence,656076,Hispanic of any race,32.2,Male,Leukemias,2016
65-69,93.4,108.9,662,Incidence,656076,Hispanic of any race,100.9,Male,Liver and Intrahepatic Bile Duct,2016
65-69,130.0,148.2,911,Incidence,656076,Hispanic of any race,138.9,Male,Lung and Bronchus,2016
65-69,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
65-69,16.7,23.7,131,Incidence,656076,Hispanic of any race,20.0,Male,Melanomas of the Skin,2016
65-69,2.6,5.8,26,Incidence,656076,Hispanic of any race,4.0,Male,Mesothelioma,2016
65-69,28.3,37.1,213,Incidence,656076,Hispanic of any race,32.5,Male,Myeloma,2016
65-69,54.3,66.3,394,Incidence,656076,Hispanic of any race,60.1,Male,Non-Hodgkin Lymphoma,2016
65-69,37.0,47.0,274,Incidence,656076,Hispanic of any race,41.8,Male,Oral Cavity and Pharynx,2016
65-69,45.3,56.4,332,Incidence,656076,Hispanic of any race,50.6,Male,Pancreas,2016
65-69,477.4,511.6,3243,Incidence,656076,Hispanic of any race,494.3,Male,Prostate,2016
65-69,31.5,40.9,236,Incidence,656076,Hispanic of any race,36.0,Male,Stomach,2016
65-69,~,~,~,Incidence,656076,Hispanic of any race,~,Male,Testis,2016
65-69,13.6,20.0,109,Incidence,656076,Hispanic of any race,16.6,Male,Thyroid,2016
65-69,59.1,71.6,427,Incidence,656076,Hispanic of any race,65.1,Male,Urinary Bladder,2016
70-74,1810.9,1893.1,7846,Incidence,423727,Hispanic of any race,1851.7,Male,All Cancer Sites Combined,2016
70-74,15.2,23.8,81,Incidence,423727,Hispanic of any race,19.1,Male,Brain and Other Nervous System,2016
70-74,157.5,182.6,719,Incidence,423727,Hispanic of any race,169.7,Male,Colon and Rectum,2016
70-74,20.9,30.8,108,Incidence,423727,Hispanic of any race,25.5,Male,Esophagus,2016
70-74,5.2,10.7,32,Incidence,423727,Hispanic of any race,7.6,Male,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,423727,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
70-74,91.9,111.3,429,Incidence,423727,Hispanic of any race,101.2,Male,Kidney and Renal Pelvis,2016
70-74,18.8,28.2,98,Incidence,423727,Hispanic of any race,23.1,Male,Larynx,2016
70-74,44.2,58.0,215,Incidence,423727,Hispanic of any race,50.7,Male,Leukemias,2016
70-74,80.4,98.7,378,Incidence,423727,Hispanic of any race,89.2,Male,Liver and Intrahepatic Bile Duct,2016
70-74,211.8,240.6,957,Incidence,423727,Hispanic of any race,225.9,Male,Lung and Bronchus,2016
70-74,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
70-74,18.6,27.9,97,Incidence,423727,Hispanic of any race,22.9,Male,Melanomas of the Skin,2016
70-74,3.8,8.7,25,Incidence,423727,Hispanic of any race,5.9,Male,Mesothelioma,2016
70-74,40.7,54.0,199,Incidence,423727,Hispanic of any race,47.0,Male,Myeloma,2016
70-74,83.8,102.4,393,Incidence,423727,Hispanic of any race,92.7,Male,Non-Hodgkin Lymphoma,2016
70-74,40.4,53.7,198,Incidence,423727,Hispanic of any race,46.7,Male,Oral Cavity and Pharynx,2016
70-74,49.9,64.5,241,Incidence,423727,Hispanic of any race,56.9,Male,Pancreas,2016
70-74,516.5,560.9,2281,Incidence,423727,Hispanic of any race,538.3,Male,Prostate,2016
70-74,50.1,64.8,242,Incidence,423727,Hispanic of any race,57.1,Male,Stomach,2016
70-74,~,~,~,Incidence,423727,Hispanic of any race,~,Male,Testis,2016
70-74,14.3,22.7,77,Incidence,423727,Hispanic of any race,18.2,Male,Thyroid,2016
70-74,94.4,114.0,440,Incidence,423727,Hispanic of any race,103.8,Male,Urinary Bladder,2016
75-79,2107.3,2216.0,6117,Incidence,283048,Hispanic of any race,2161.1,Male,All Cancer Sites Combined,2016
75-79,15.6,26.5,58,Incidence,283048,Hispanic of any race,20.5,Male,Brain and Other Nervous System,2016
75-79,187.9,221.6,578,Incidence,283048,Hispanic of any race,204.2,Male,Colon and Rectum,2016
75-79,21.8,34.4,78,Incidence,283048,Hispanic of any race,27.6,Male,Esophagus,2016
75-79,6.0,13.5,26,Incidence,283048,Hispanic of any race,9.2,Male,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,283048,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
75-79,97.0,121.7,308,Incidence,283048,Hispanic of any race,108.8,Male,Kidney and Renal Pelvis,2016
75-79,21.2,33.6,76,Incidence,283048,Hispanic of any race,26.9,Male,Larynx,2016
75-79,58.6,78.1,192,Incidence,283048,Hispanic of any race,67.8,Male,Leukemias,2016
75-79,81.4,104.1,261,Incidence,283048,Hispanic of any race,92.2,Male,Liver and Intrahepatic Bile Duct,2016
75-79,291.4,332.9,882,Incidence,283048,Hispanic of any race,311.6,Male,Lung and Bronchus,2016
75-79,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
75-79,20.8,33.2,75,Incidence,283048,Hispanic of any race,26.5,Male,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,283048,Hispanic of any race,~,Male,Mesothelioma,2016
75-79,42.6,59.5,143,Incidence,283048,Hispanic of any race,50.5,Male,Myeloma,2016
75-79,98.0,122.8,311,Incidence,283048,Hispanic of any race,109.9,Male,Non-Hodgkin Lymphoma,2016
75-79,40.3,56.8,136,Incidence,283048,Hispanic of any race,48.0,Male,Oral Cavity and Pharynx,2016
75-79,66.5,87.2,216,Incidence,283048,Hispanic of any race,76.3,Male,Pancreas,2016
75-79,507.9,562.2,1513,Incidence,283048,Hispanic of any race,534.5,Male,Prostate,2016
75-79,60.5,80.4,198,Incidence,283048,Hispanic of any race,70.0,Male,Stomach,2016
75-79,~,~,~,Incidence,283048,Hispanic of any race,~,Male,Testis,2016
75-79,14.0,24.5,53,Incidence,283048,Hispanic of any race,18.7,Male,Thyroid,2016
75-79,118.1,145.1,371,Incidence,283048,Hispanic of any race,131.1,Male,Urinary Bladder,2016
80-84,2208.6,2347.3,4175,Incidence,183346,Hispanic of any race,2277.1,Male,All Cancer Sites Combined,2016
80-84,15.1,29.1,39,Incidence,183346,Hispanic of any race,21.3,Male,Brain and Other Nervous System,2016
80-84,201.5,245.2,408,Incidence,183346,Hispanic of any race,222.5,Male,Colon and Rectum,2016
80-84,31.2,50.1,73,Incidence,183346,Hispanic of any race,39.8,Male,Esophagus,2016
80-84,5.4,14.8,17,Incidence,183346,Hispanic of any race,9.3,Male,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,183346,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
80-84,89.9,120.0,191,Incidence,183346,Hispanic of any race,104.2,Male,Kidney and Renal Pelvis,2016
80-84,21.2,37.2,52,Incidence,183346,Hispanic of any race,28.4,Male,Larynx,2016
80-84,69.2,96.0,150,Incidence,183346,Hispanic of any race,81.8,Male,Leukemias,2016
80-84,73.3,100.7,158,Incidence,183346,Hispanic of any race,86.2,Male,Liver and Intrahepatic Bile Duct,2016
80-84,277.0,327.8,553,Incidence,183346,Hispanic of any race,301.6,Male,Lung and Bronchus,2016
80-84,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
80-84,27.8,45.8,66,Incidence,183346,Hispanic of any race,36.0,Male,Melanomas of the Skin,2016
80-84,5.8,15.5,18,Incidence,183346,Hispanic of any race,9.8,Male,Mesothelioma,2016
80-84,45.4,67.5,102,Incidence,183346,Hispanic of any race,55.6,Male,Myeloma,2016
80-84,106.2,138.7,223,Incidence,183346,Hispanic of any race,121.6,Male,Non-Hodgkin Lymphoma,2016
80-84,41.4,62.7,94,Incidence,183346,Hispanic of any race,51.3,Male,Oral Cavity and Pharynx,2016
80-84,81.3,110.1,174,Incidence,183346,Hispanic of any race,94.9,Male,Pancreas,2016
80-84,409.3,470.5,805,Incidence,183346,Hispanic of any race,439.1,Male,Prostate,2016
80-84,56.8,81.2,125,Incidence,183346,Hispanic of any race,68.2,Male,Stomach,2016
80-84,~,~,~,Incidence,183346,Hispanic of any race,~,Male,Testis,2016
80-84,10.6,22.7,29,Incidence,183346,Hispanic of any race,15.8,Male,Thyroid,2016
80-84,180.2,221.7,367,Incidence,183346,Hispanic of any race,200.2,Male,Urinary Bladder,2016
85+,2155.8,2304.9,3465,Incidence,155424,Hispanic of any race,2229.4,Male,All Cancer Sites Combined,2016
85+,8.9,21.4,22,Incidence,155424,Hispanic of any race,14.2,Male,Brain and Other Nervous System,2016
85+,217.5,267.0,375,Incidence,155424,Hispanic of any race,241.3,Male,Colon and Rectum,2016
85+,23.9,42.4,50,Incidence,155424,Hispanic of any race,32.2,Male,Esophagus,2016
85+,~,~,~,Incidence,155424,Hispanic of any race,~,Male,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,155424,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
85+,75.8,106.3,140,Incidence,155424,Hispanic of any race,90.1,Male,Kidney and Renal Pelvis,2016
85+,12.5,26.8,29,Incidence,155424,Hispanic of any race,18.7,Male,Larynx,2016
85+,78.1,109.1,144,Incidence,155424,Hispanic of any race,92.6,Male,Leukemias,2016
85+,75.8,106.3,140,Incidence,155424,Hispanic of any race,90.1,Male,Liver and Intrahepatic Bile Duct,2016
85+,274.4,329.7,468,Incidence,155424,Hispanic of any race,301.1,Male,Lung and Bronchus,2016
85+,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
85+,41.4,64.8,81,Incidence,155424,Hispanic of any race,52.1,Male,Melanomas of the Skin,2016
85+,5.9,16.7,16,Incidence,155424,Hispanic of any race,10.3,Male,Mesothelioma,2016
85+,46.0,70.5,89,Incidence,155424,Hispanic of any race,57.3,Male,Myeloma,2016
85+,101.3,136.1,183,Incidence,155424,Hispanic of any race,117.7,Male,Non-Hodgkin Lymphoma,2016
85+,39.1,61.9,77,Incidence,155424,Hispanic of any race,49.5,Male,Oral Cavity and Pharynx,2016
85+,81.7,113.2,150,Incidence,155424,Hispanic of any race,96.5,Male,Pancreas,2016
85+,324.3,384.0,549,Incidence,155424,Hispanic of any race,353.2,Male,Prostate,2016
85+,78.7,109.8,145,Incidence,155424,Hispanic of any race,93.3,Male,Stomach,2016
85+,~,~,~,Incidence,155424,Hispanic of any race,~,Male,Testis,2016
85+,~,~,~,Incidence,155424,Hispanic of any race,~,Male,Thyroid,2016
85+,180.3,225.7,314,Incidence,155424,Hispanic of any race,202.0,Male,Urinary Bladder,2016
<1,16.8,24.8,106,Incidence,516455,Hispanic of any race,20.5,Male,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Colon and Rectum,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Esophagus,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Larynx,2016
<1,2.1,5.5,18,Incidence,516455,Hispanic of any race,3.5,Male,Leukemias,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Lung and Bronchus,2016
<1,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Melanomas of the Skin,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Mesothelioma,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Myeloma,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Pancreas,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Prostate,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Stomach,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Testis,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Thyroid,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male,Urinary Bladder,2016
1-4,21.1,24.0,906,Incidence,4028207,Hispanic of any race,22.5,Male and Female,All Cancer Sites Combined,2016
1-4,3.5,4.8,166,Incidence,4028207,Hispanic of any race,4.1,Male and Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,Cervix,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Esophagus,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,Female Breast,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
1-4,1.1,1.9,58,Incidence,4028207,Hispanic of any race,1.4,Male and Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Larynx,2016
1-4,9.1,11.1,406,Incidence,4028207,Hispanic of any race,10.1,Male and Female,Leukemias,2016
1-4,0.6,1.3,37,Incidence,4028207,Hispanic of any race,0.9,Male and Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,Male and Female Breast,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Mesothelioma,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Myeloma,2016
1-4,0.4,1.0,27,Incidence,4028207,Hispanic of any race,0.7,Male and Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,1975266,Hispanic of any race,~,Male and Female,Ovary,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Pancreas,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male and Female,Prostate,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Stomach,2016
1-4,~,~,~,Incidence,2052941,Hispanic of any race,~,Male and Female,Testis,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Thyroid,2016
1-4,~,~,~,Incidence,4028207,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
10-14,15.3,17.6,828,Incidence,5035537,Hispanic of any race,16.4,Male and Female,All Cancer Sites Combined,2016
10-14,1.8,2.6,109,Incidence,5035537,Hispanic of any race,2.2,Male and Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Male and Female,Cervix,2016
10-14,0.3,0.7,24,Incidence,5035537,Hispanic of any race,0.5,Male and Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Esophagus,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Male and Female,Female Breast,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
10-14,0.8,1.4,55,Incidence,5035537,Hispanic of any race,1.1,Male and Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Larynx,2016
10-14,4.7,6.0,268,Incidence,5035537,Hispanic of any race,5.3,Male and Female,Leukemias,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Male and Female,Male and Female Breast,2016
10-14,~,~,~,Incidence,2472211,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Mesothelioma,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Myeloma,2016
10-14,1.0,1.6,63,Incidence,5035537,Hispanic of any race,1.3,Male and Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2016
10-14,0.4,1.2,18,Incidence,2472211,Hispanic of any race,0.7,Male and Female,Ovary,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Pancreas,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male and Female,Prostate,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Stomach,2016
10-14,~,~,~,Incidence,2563326,Hispanic of any race,~,Male and Female,Testis,2016
10-14,0.7,1.2,47,Incidence,5035537,Hispanic of any race,0.9,Male and Female,Thyroid,2016
10-14,~,~,~,Incidence,5035537,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
15-19,22.3,25.1,1135,Incidence,4801588,Hispanic of any race,23.6,Male and Female,All Cancer Sites Combined,2016
15-19,1.0,1.7,63,Incidence,4801588,Hispanic of any race,1.3,Male and Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Male and Female,Cervix,2016
15-19,1.0,1.6,60,Incidence,4801588,Hispanic of any race,1.2,Male and Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Esophagus,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Male and Female,Female Breast,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
15-19,2.0,2.9,114,Incidence,4801588,Hispanic of any race,2.4,Male and Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Larynx,2016
15-19,4.1,5.3,223,Incidence,4801588,Hispanic of any race,4.6,Male and Female,Leukemias,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Male and Female,Male and Female Breast,2016
15-19,~,~,~,Incidence,2349375,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Mesothelioma,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Myeloma,2016
15-19,1.6,2.4,96,Incidence,4801588,Hispanic of any race,2.0,Male and Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2016
15-19,0.9,1.9,32,Incidence,2349375,Hispanic of any race,1.4,Male and Female,Ovary,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Pancreas,2016
15-19,~,~,~,Incidence,2452213,Hispanic of any race,~,Male and Female,Prostate,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Stomach,2016
15-19,4.6,6.5,135,Incidence,2452213,Hispanic of any race,5.5,Male and Female,Testis,2016
15-19,2.6,3.6,149,Incidence,4801588,Hispanic of any race,3.1,Male and Female,Thyroid,2016
15-19,~,~,~,Incidence,4801588,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
20-24,31.2,34.5,1574,Incidence,4797189,Hispanic of any race,32.8,Male and Female,All Cancer Sites Combined,2016
20-24,1.2,2.0,76,Incidence,4797189,Hispanic of any race,1.6,Male and Female,Brain and Other Nervous System,2016
20-24,0.4,1.2,17,Incidence,2315935,Hispanic of any race,0.7,Male and Female,Cervix,2016
20-24,1.2,1.9,73,Incidence,4797189,Hispanic of any race,1.5,Male and Female,Colon and Rectum,2016
20-24,0.7,1.5,24,Incidence,2315935,Hispanic of any race,1.0,Male and Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Esophagus,2016
20-24,1.1,2.1,35,Incidence,2315935,Hispanic of any race,1.5,Male and Female,Female Breast,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
20-24,2.2,3.2,129,Incidence,4797189,Hispanic of any race,2.7,Male and Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
20-24,0.4,0.9,29,Incidence,4797189,Hispanic of any race,0.6,Male and Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Larynx,2016
20-24,2.8,3.9,160,Incidence,4797189,Hispanic of any race,3.3,Male and Female,Leukemias,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Lung and Bronchus,2016
20-24,1.1,2.1,35,Incidence,2315935,Hispanic of any race,1.5,Male and Female,Male and Female Breast,2016
20-24,~,~,~,Incidence,2315935,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
20-24,0.3,0.6,20,Incidence,4797189,Hispanic of any race,0.4,Male and Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Mesothelioma,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Myeloma,2016
20-24,1.4,2.2,86,Incidence,4797189,Hispanic of any race,1.8,Male and Female,Non-Hodgkin Lymphoma,2016
20-24,0.3,0.7,23,Incidence,4797189,Hispanic of any race,0.5,Male and Female,Oral Cavity and Pharynx,2016
20-24,1.4,2.6,45,Incidence,2315935,Hispanic of any race,1.9,Male and Female,Ovary,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Pancreas,2016
20-24,~,~,~,Incidence,2481254,Hispanic of any race,~,Male and Female,Prostate,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Stomach,2016
20-24,12.3,15.3,341,Incidence,2481254,Hispanic of any race,13.7,Male and Female,Testis,2016
20-24,5.4,6.8,290,Incidence,4797189,Hispanic of any race,6.0,Male and Female,Thyroid,2016
20-24,~,~,~,Incidence,4797189,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
25-29,50.0,54.2,2417,Incidence,4639031,Hispanic of any race,52.1,Male and Female,All Cancer Sites Combined,2016
25-29,1.6,2.4,92,Incidence,4639031,Hispanic of any race,2.0,Male and Female,Brain and Other Nervous System,2016
25-29,4.8,6.9,127,Incidence,2201631,Hispanic of any race,5.8,Male and Female,Cervix,2016
25-29,2.4,3.4,133,Incidence,4639031,Hispanic of any race,2.9,Male and Female,Colon and Rectum,2016
25-29,2.0,3.5,59,Incidence,2201631,Hispanic of any race,2.7,Male and Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,4639031,Hispanic of any race,~,Male and Female,Esophagus,2016
25-29,7.9,10.4,200,Incidence,2201631,Hispanic of any race,9.1,Male and Female,Female Breast,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
25-29,2.3,3.3,129,Incidence,4639031,Hispanic of any race,2.8,Male and Female,Hodgkin Lymphoma,2016
25-29,0.3,0.8,25,Incidence,4639031,Hispanic of any race,0.5,Male and Female,Kaposi Sarcoma,2016
25-29,0.9,1.6,57,Incidence,4639031,Hispanic of any race,1.2,Male and Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,4639031,Hispanic of any race,~,Male and Female,Larynx,2016
25-29,2.8,3.9,153,Incidence,4639031,Hispanic of any race,3.3,Male and Female,Leukemias,2016
25-29,0.2,0.6,17,Incidence,4639031,Hispanic of any race,0.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
25-29,0.2,0.6,19,Incidence,4639031,Hispanic of any race,0.4,Male and Female,Lung and Bronchus,2016
25-29,7.9,10.4,200,Incidence,2201631,Hispanic of any race,9.1,Male and Female,Male and Female Breast,2016
25-29,~,~,~,Incidence,2201631,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
25-29,0.8,1.4,48,Incidence,4639031,Hispanic of any race,1.0,Male and Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,4639031,Hispanic of any race,~,Male and Female,Mesothelioma,2016
25-29,~,~,~,Incidence,4639031,Hispanic of any race,~,Male and Female,Myeloma,2016
25-29,2.2,3.2,124,Incidence,4639031,Hispanic of any race,2.7,Male and Female,Non-Hodgkin Lymphoma,2016
25-29,0.5,1.0,34,Incidence,4639031,Hispanic of any race,0.7,Male and Female,Oral Cavity and Pharynx,2016
25-29,1.6,2.9,48,Incidence,2201631,Hispanic of any race,2.2,Male and Female,Ovary,2016
25-29,0.2,0.6,19,Incidence,4639031,Hispanic of any race,0.4,Male and Female,Pancreas,2016
25-29,~,~,~,Incidence,2437400,Hispanic of any race,~,Male and Female,Prostate,2016
25-29,0.6,1.1,37,Incidence,4639031,Hispanic of any race,0.8,Male and Female,Stomach,2016
25-29,13.2,16.3,359,Incidence,2437400,Hispanic of any race,14.7,Male and Female,Testis,2016
25-29,9.2,11.1,470,Incidence,4639031,Hispanic of any race,10.1,Male and Female,Thyroid,2016
25-29,0.3,0.7,21,Incidence,4639031,Hispanic of any race,0.5,Male and Female,Urinary Bladder,2016
30-34,76.2,81.4,3523,Incidence,4474645,Hispanic of any race,78.7,Male and Female,All Cancer Sites Combined,2016
30-34,2.0,2.9,109,Incidence,4474645,Hispanic of any race,2.4,Male and Female,Brain and Other Nervous System,2016
30-34,10.5,13.4,253,Incidence,2128673,Hispanic of any race,11.9,Male and Female,Cervix,2016
30-34,4.2,5.5,215,Incidence,4474645,Hispanic of any race,4.8,Male and Female,Colon and Rectum,2016
30-34,6.6,9.0,165,Incidence,2128673,Hispanic of any race,7.8,Male and Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,4474645,Hispanic of any race,~,Male and Female,Esophagus,2016
30-34,22.0,26.2,511,Incidence,2128673,Hispanic of any race,24.0,Male and Female,Female Breast,2016
30-34,2.2,3.6,60,Incidence,2128673,Hispanic of any race,2.8,Male and Female,"Female Breast, <i>in situ</i>",2016
30-34,1.9,2.8,103,Incidence,4474645,Hispanic of any race,2.3,Male and Female,Hodgkin Lymphoma,2016
30-34,0.7,1.2,41,Incidence,4474645,Hispanic of any race,0.9,Male and Female,Kaposi Sarcoma,2016
30-34,2.7,3.8,143,Incidence,4474645,Hispanic of any race,3.2,Male and Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,4474645,Hispanic of any race,~,Male and Female,Larynx,2016
30-34,3.8,5.1,198,Incidence,4474645,Hispanic of any race,4.4,Male and Female,Leukemias,2016
30-34,0.2,0.6,17,Incidence,4474645,Hispanic of any race,0.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
30-34,0.5,1.0,30,Incidence,4474645,Hispanic of any race,0.7,Male and Female,Lung and Bronchus,2016
30-34,22.0,26.2,511,Incidence,2128673,Hispanic of any race,24.0,Male and Female,Male and Female Breast,2016
30-34,2.2,3.6,60,Incidence,2128673,Hispanic of any race,2.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
30-34,1.3,2.1,73,Incidence,4474645,Hispanic of any race,1.6,Male and Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,4474645,Hispanic of any race,~,Male and Female,Mesothelioma,2016
30-34,0.2,0.6,16,Incidence,4474645,Hispanic of any race,0.4,Male and Female,Myeloma,2016
30-34,3.6,4.8,188,Incidence,4474645,Hispanic of any race,4.2,Male and Female,Non-Hodgkin Lymphoma,2016
30-34,0.8,1.4,49,Incidence,4474645,Hispanic of any race,1.1,Male and Female,Oral Cavity and Pharynx,2016
30-34,2.6,4.3,72,Incidence,2128673,Hispanic of any race,3.4,Male and Female,Ovary,2016
30-34,0.3,0.7,21,Incidence,4474645,Hispanic of any race,0.5,Male and Female,Pancreas,2016
30-34,~,~,~,Incidence,2345972,Hispanic of any race,~,Male and Female,Prostate,2016
30-34,1.3,2.1,76,Incidence,4474645,Hispanic of any race,1.7,Male and Female,Stomach,2016
30-34,12.0,15.0,316,Incidence,2345972,Hispanic of any race,13.5,Male and Female,Testis,2016
30-34,12.0,14.2,585,Incidence,4474645,Hispanic of any race,13.1,Male and Female,Thyroid,2016
30-34,~,~,~,Incidence,4474645,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
35-39,113.0,119.5,4987,Incidence,4290704,Hispanic of any race,116.2,Male and Female,All Cancer Sites Combined,2016
35-39,2.2,3.2,116,Incidence,4290704,Hispanic of any race,2.7,Male and Female,Brain and Other Nervous System,2016
35-39,16.2,19.8,372,Incidence,2075190,Hispanic of any race,17.9,Male and Female,Cervix,2016
35-39,7.7,9.5,367,Incidence,4290704,Hispanic of any race,8.6,Male and Female,Colon and Rectum,2016
35-39,11.0,14.0,258,Incidence,2075190,Hispanic of any race,12.4,Male and Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,4290704,Hispanic of any race,~,Male and Female,Esophagus,2016
35-39,44.4,50.4,982,Incidence,2075190,Hispanic of any race,47.3,Male and Female,Female Breast,2016
35-39,6.1,8.4,149,Incidence,2075190,Hispanic of any race,7.2,Male and Female,"Female Breast, <i>in situ</i>",2016
35-39,1.7,2.6,91,Incidence,4290704,Hispanic of any race,2.1,Male and Female,Hodgkin Lymphoma,2016
35-39,0.3,0.7,21,Incidence,4290704,Hispanic of any race,0.5,Male and Female,Kaposi Sarcoma,2016
35-39,5.6,7.1,271,Incidence,4290704,Hispanic of any race,6.3,Male and Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,4290704,Hispanic of any race,~,Male and Female,Larynx,2016
35-39,3.8,5.1,188,Incidence,4290704,Hispanic of any race,4.4,Male and Female,Leukemias,2016
35-39,0.5,1.1,32,Incidence,4290704,Hispanic of any race,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
35-39,1.3,2.1,73,Incidence,4290704,Hispanic of any race,1.7,Male and Female,Lung and Bronchus,2016
35-39,44.4,50.4,982,Incidence,2075190,Hispanic of any race,47.3,Male and Female,Male and Female Breast,2016
35-39,6.1,8.4,149,Incidence,2075190,Hispanic of any race,7.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
35-39,1.7,2.6,90,Incidence,4290704,Hispanic of any race,2.1,Male and Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,4290704,Hispanic of any race,~,Male and Female,Mesothelioma,2016
35-39,0.7,1.3,42,Incidence,4290704,Hispanic of any race,1.0,Male and Female,Myeloma,2016
35-39,5.7,7.3,278,Incidence,4290704,Hispanic of any race,6.5,Male and Female,Non-Hodgkin Lymphoma,2016
35-39,1.4,2.2,74,Incidence,4290704,Hispanic of any race,1.7,Male and Female,Oral Cavity and Pharynx,2016
35-39,4.0,5.9,101,Incidence,2075190,Hispanic of any race,4.9,Male and Female,Ovary,2016
35-39,0.9,1.6,54,Incidence,4290704,Hispanic of any race,1.3,Male and Female,Pancreas,2016
35-39,~,~,~,Incidence,2215514,Hispanic of any race,~,Male and Female,Prostate,2016
35-39,3.0,4.2,152,Incidence,4290704,Hispanic of any race,3.5,Male and Female,Stomach,2016
35-39,8.0,10.6,205,Incidence,2215514,Hispanic of any race,9.3,Male and Female,Testis,2016
35-39,16.1,18.6,743,Incidence,4290704,Hispanic of any race,17.3,Male and Female,Thyroid,2016
35-39,0.7,1.3,42,Incidence,4290704,Hispanic of any race,1.0,Male and Female,Urinary Bladder,2016
40-44,174.9,183.3,7054,Incidence,3938560,Hispanic of any race,179.1,Male and Female,All Cancer Sites Combined,2016
40-44,2.6,3.8,125,Incidence,3938560,Hispanic of any race,3.2,Male and Female,Brain and Other Nervous System,2016
40-44,16.3,20.2,353,Incidence,1941080,Hispanic of any race,18.2,Male and Female,Cervix,2016
40-44,14.5,17.0,617,Incidence,3938560,Hispanic of any race,15.7,Male and Female,Colon and Rectum,2016
40-44,16.3,20.2,353,Incidence,1941080,Hispanic of any race,18.2,Male and Female,"Corpus and Uterus, NOS",2016
40-44,0.5,1.1,30,Incidence,3938560,Hispanic of any race,0.8,Male and Female,Esophagus,2016
40-44,92.9,101.7,1887,Incidence,1941080,Hispanic of any race,97.2,Male and Female,Female Breast,2016
40-44,25.8,30.6,546,Incidence,1941080,Hispanic of any race,28.1,Male and Female,"Female Breast, <i>in situ</i>",2016
40-44,1.6,2.5,78,Incidence,3938560,Hispanic of any race,2.0,Male and Female,Hodgkin Lymphoma,2016
40-44,0.5,1.1,29,Incidence,3938560,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2016
40-44,10.3,12.5,448,Incidence,3938560,Hispanic of any race,11.4,Male and Female,Kidney and Renal Pelvis,2016
40-44,0.2,0.7,16,Incidence,3938560,Hispanic of any race,0.4,Male and Female,Larynx,2016
40-44,5.4,6.9,241,Incidence,3938560,Hispanic of any race,6.1,Male and Female,Leukemias,2016
40-44,1.2,2.0,61,Incidence,3938560,Hispanic of any race,1.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
40-44,2.9,4.1,135,Incidence,3938560,Hispanic of any race,3.4,Male and Female,Lung and Bronchus,2016
40-44,92.9,101.7,1887,Incidence,1941080,Hispanic of any race,97.2,Male and Female,Male and Female Breast,2016
40-44,25.8,30.6,546,Incidence,1941080,Hispanic of any race,28.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
40-44,3.0,4.2,139,Incidence,3938560,Hispanic of any race,3.5,Male and Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,3938560,Hispanic of any race,~,Male and Female,Mesothelioma,2016
40-44,1.8,2.8,88,Incidence,3938560,Hispanic of any race,2.2,Male and Female,Myeloma,2016
40-44,8.2,10.1,359,Incidence,3938560,Hispanic of any race,9.1,Male and Female,Non-Hodgkin Lymphoma,2016
40-44,2.8,4.0,132,Incidence,3938560,Hispanic of any race,3.4,Male and Female,Oral Cavity and Pharynx,2016
40-44,7.2,9.8,164,Incidence,1941080,Hispanic of any race,8.4,Male and Female,Ovary,2016
40-44,1.7,2.6,82,Incidence,3938560,Hispanic of any race,2.1,Male and Female,Pancreas,2016
40-44,2.9,4.7,74,Incidence,1997480,Hispanic of any race,3.7,Male and Female,Prostate,2016
40-44,4.5,6.0,206,Incidence,3938560,Hispanic of any race,5.2,Male and Female,Stomach,2016
40-44,4.6,6.7,111,Incidence,1997480,Hispanic of any race,5.6,Male and Female,Testis,2016
40-44,17.4,20.1,736,Incidence,3938560,Hispanic of any race,18.7,Male and Female,Thyroid,2016
40-44,1.0,1.7,51,Incidence,3938560,Hispanic of any race,1.3,Male and Female,Urinary Bladder,2016
45-49,258.7,269.4,9354,Incidence,3542870,Hispanic of any race,264.0,Male and Female,All Cancer Sites Combined,2016
45-49,3.4,4.8,144,Incidence,3542870,Hispanic of any race,4.1,Male and Female,Brain and Other Nervous System,2016
45-49,15.0,18.9,295,Incidence,1748512,Hispanic of any race,16.9,Male and Female,Cervix,2016
45-49,24.6,28.0,929,Incidence,3542870,Hispanic of any race,26.2,Male and Female,Colon and Rectum,2016
45-49,27.1,32.2,517,Incidence,1748512,Hispanic of any race,29.6,Male and Female,"Corpus and Uterus, NOS",2016
45-49,0.7,1.3,34,Incidence,3542870,Hispanic of any race,1.0,Male and Female,Esophagus,2016
45-49,135.9,147.1,2473,Incidence,1748512,Hispanic of any race,141.4,Male and Female,Female Breast,2016
45-49,36.7,42.6,692,Incidence,1748512,Hispanic of any race,39.6,Male and Female,"Female Breast, <i>in situ</i>",2016
45-49,1.6,2.6,74,Incidence,3542870,Hispanic of any race,2.1,Male and Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,3542870,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
45-49,15.6,18.3,600,Incidence,3542870,Hispanic of any race,16.9,Male and Female,Kidney and Renal Pelvis,2016
45-49,0.7,1.3,34,Incidence,3542870,Hispanic of any race,1.0,Male and Female,Larynx,2016
45-49,7.4,9.3,293,Incidence,3542870,Hispanic of any race,8.3,Male and Female,Leukemias,2016
45-49,4.8,6.3,195,Incidence,3542870,Hispanic of any race,5.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
45-49,6.4,8.2,256,Incidence,3542870,Hispanic of any race,7.2,Male and Female,Lung and Bronchus,2016
45-49,135.9,147.1,2473,Incidence,1748512,Hispanic of any race,141.4,Male and Female,Male and Female Breast,2016
45-49,36.7,42.6,692,Incidence,1748512,Hispanic of any race,39.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
45-49,4.2,5.7,173,Incidence,3542870,Hispanic of any race,4.9,Male and Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,3542870,Hispanic of any race,~,Male and Female,Mesothelioma,2016
45-49,3.4,4.8,144,Incidence,3542870,Hispanic of any race,4.1,Male and Female,Myeloma,2016
45-49,11.1,13.4,433,Incidence,3542870,Hispanic of any race,12.2,Male and Female,Non-Hodgkin Lymphoma,2016
45-49,4.7,6.3,194,Incidence,3542870,Hispanic of any race,5.5,Male and Female,Oral Cavity and Pharynx,2016
45-49,10.0,13.2,201,Incidence,1748512,Hispanic of any race,11.5,Male and Female,Ovary,2016
45-49,4.1,5.6,170,Incidence,3542870,Hispanic of any race,4.8,Male and Female,Pancreas,2016
45-49,12.5,16.0,254,Incidence,1794358,Hispanic of any race,14.2,Male and Female,Prostate,2016
45-49,6.1,7.9,247,Incidence,3542870,Hispanic of any race,7.0,Male and Female,Stomach,2016
45-49,2.3,3.9,54,Incidence,1794358,Hispanic of any race,3.0,Male and Female,Testis,2016
45-49,20.8,24.0,792,Incidence,3542870,Hispanic of any race,22.4,Male and Female,Thyroid,2016
45-49,2.0,3.0,87,Incidence,3542870,Hispanic of any race,2.5,Male and Female,Urinary Bladder,2016
5-9,12.0,14.0,682,Incidence,5247778,Hispanic of any race,13.0,Male and Female,All Cancer Sites Combined,2016
5-9,2.2,3.1,136,Incidence,5247778,Hispanic of any race,2.6,Male and Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,Cervix,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Esophagus,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,Female Breast,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
5-9,0.4,0.8,28,Incidence,5247778,Hispanic of any race,0.5,Male and Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Larynx,2016
5-9,4.7,5.9,276,Incidence,5247778,Hispanic of any race,5.3,Male and Female,Leukemias,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,Male and Female Breast,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Mesothelioma,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Myeloma,2016
5-9,0.5,1.0,37,Incidence,5247778,Hispanic of any race,0.7,Male and Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,2573720,Hispanic of any race,~,Male and Female,Ovary,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Pancreas,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male and Female,Prostate,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Stomach,2016
5-9,~,~,~,Incidence,2674058,Hispanic of any race,~,Male and Female,Testis,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Thyroid,2016
5-9,~,~,~,Incidence,5247778,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
50-54,420.2,434.8,13188,Incidence,3085364,Hispanic of any race,427.4,Male and Female,All Cancer Sites Combined,2016
50-54,5.0,6.8,181,Incidence,3085364,Hispanic of any race,5.9,Male and Female,Brain and Other Nervous System,2016
50-54,14.6,18.7,255,Incidence,1538011,Hispanic of any race,16.6,Male and Female,Cervix,2016
50-54,51.9,57.1,1680,Incidence,3085364,Hispanic of any race,54.5,Male and Female,Colon and Rectum,2016
50-54,43.5,50.4,720,Incidence,1538011,Hispanic of any race,46.8,Male and Female,"Corpus and Uterus, NOS",2016
50-54,2.1,3.3,81,Incidence,3085364,Hispanic of any race,2.6,Male and Female,Esophagus,2016
50-54,170.3,183.7,2721,Incidence,1538011,Hispanic of any race,176.9,Male and Female,Female Breast,2016
50-54,46.0,53.1,761,Incidence,1538011,Hispanic of any race,49.5,Male and Female,"Female Breast, <i>in situ</i>",2016
50-54,1.7,2.7,66,Incidence,3085364,Hispanic of any race,2.1,Male and Female,Hodgkin Lymphoma,2016
50-54,0.4,1.0,21,Incidence,3085364,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2016
50-54,23.6,27.2,782,Incidence,3085364,Hispanic of any race,25.3,Male and Female,Kidney and Renal Pelvis,2016
50-54,2.0,3.2,79,Incidence,3085364,Hispanic of any race,2.6,Male and Female,Larynx,2016
50-54,8.9,11.2,309,Incidence,3085364,Hispanic of any race,10.0,Male and Female,Leukemias,2016
50-54,15.4,18.3,518,Incidence,3085364,Hispanic of any race,16.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
50-54,16.4,19.4,550,Incidence,3085364,Hispanic of any race,17.8,Male and Female,Lung and Bronchus,2016
50-54,170.3,183.7,2721,Incidence,1538011,Hispanic of any race,176.9,Male and Female,Male and Female Breast,2016
50-54,46.0,53.1,761,Incidence,1538011,Hispanic of any race,49.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
50-54,5.3,7.0,188,Incidence,3085364,Hispanic of any race,6.1,Male and Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,3085364,Hispanic of any race,~,Male and Female,Mesothelioma,2016
50-54,6.2,8.2,221,Incidence,3085364,Hispanic of any race,7.2,Male and Female,Myeloma,2016
50-54,19.5,22.8,651,Incidence,3085364,Hispanic of any race,21.1,Male and Female,Non-Hodgkin Lymphoma,2016
50-54,8.8,11.1,306,Incidence,3085364,Hispanic of any race,9.9,Male and Female,Oral Cavity and Pharynx,2016
50-54,16.5,20.9,286,Incidence,1538011,Hispanic of any race,18.6,Male and Female,Ovary,2016
50-54,9.4,11.7,324,Incidence,3085364,Hispanic of any race,10.5,Male and Female,Pancreas,2016
50-54,60.2,68.2,992,Incidence,1547353,Hispanic of any race,64.1,Male and Female,Prostate,2016
50-54,9.2,11.5,318,Incidence,3085364,Hispanic of any race,10.3,Male and Female,Stomach,2016
50-54,2.0,3.7,43,Incidence,1547353,Hispanic of any race,2.8,Male and Female,Testis,2016
50-54,20.9,24.3,697,Incidence,3085364,Hispanic of any race,22.6,Male and Female,Thyroid,2016
50-54,5.7,7.5,202,Incidence,3085364,Hispanic of any race,6.5,Male and Female,Urinary Bladder,2016
55-59,623.2,643.0,15910,Incidence,2513260,Hispanic of any race,633.0,Male and Female,All Cancer Sites Combined,2016
55-59,6.7,8.9,194,Incidence,2513260,Hispanic of any race,7.7,Male and Female,Brain and Other Nervous System,2016
55-59,14.5,19.0,213,Incidence,1279624,Hispanic of any race,16.6,Male and Female,Cervix,2016
55-59,59.0,65.2,1559,Incidence,2513260,Hispanic of any race,62.0,Male and Female,Colon and Rectum,2016
55-59,67.8,77.2,926,Incidence,1279624,Hispanic of any race,72.4,Male and Female,"Corpus and Uterus, NOS",2016
55-59,3.9,5.6,117,Incidence,2513260,Hispanic of any race,4.7,Male and Female,Esophagus,2016
55-59,202.5,218.5,2692,Incidence,1279624,Hispanic of any race,210.4,Male and Female,Female Breast,2016
55-59,49.7,57.8,686,Incidence,1279624,Hispanic of any race,53.6,Male and Female,"Female Breast, <i>in situ</i>",2016
55-59,1.8,3.0,59,Incidence,2513260,Hispanic of any race,2.3,Male and Female,Hodgkin Lymphoma,2016
55-59,0.4,1.1,17,Incidence,2513260,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2016
55-59,34.2,39.0,918,Incidence,2513260,Hispanic of any race,36.5,Male and Female,Kidney and Renal Pelvis,2016
55-59,3.6,5.2,109,Incidence,2513260,Hispanic of any race,4.3,Male and Female,Larynx,2016
55-59,12.5,15.5,351,Incidence,2513260,Hispanic of any race,14.0,Male and Female,Leukemias,2016
55-59,30.9,35.4,831,Incidence,2513260,Hispanic of any race,33.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
55-59,35.6,40.5,955,Incidence,2513260,Hispanic of any race,38.0,Male and Female,Lung and Bronchus,2016
55-59,202.5,218.5,2692,Incidence,1279624,Hispanic of any race,210.4,Male and Female,Male and Female Breast,2016
55-59,49.7,57.8,686,Incidence,1279624,Hispanic of any race,53.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
55-59,6.7,8.9,194,Incidence,2513260,Hispanic of any race,7.7,Male and Female,Melanomas of the Skin,2016
55-59,0.6,1.4,24,Incidence,2513260,Hispanic of any race,1.0,Male and Female,Mesothelioma,2016
55-59,10.4,13.1,293,Incidence,2513260,Hispanic of any race,11.7,Male and Female,Myeloma,2016
55-59,26.1,30.3,708,Incidence,2513260,Hispanic of any race,28.2,Male and Female,Non-Hodgkin Lymphoma,2016
55-59,13.8,16.8,383,Incidence,2513260,Hispanic of any race,15.2,Male and Female,Oral Cavity and Pharynx,2016
55-59,19.8,25.0,285,Incidence,1279624,Hispanic of any race,22.3,Male and Female,Ovary,2016
55-59,16.4,19.8,453,Incidence,2513260,Hispanic of any race,18.0,Male and Female,Pancreas,2016
55-59,161.4,175.9,2079,Incidence,1233636,Hispanic of any race,168.5,Male and Female,Prostate,2016
55-59,13.3,16.3,370,Incidence,2513260,Hispanic of any race,14.7,Male and Female,Stomach,2016
55-59,0.8,2.2,17,Incidence,1233636,Hispanic of any race,1.4,Male and Female,Testis,2016
55-59,23.9,27.9,650,Incidence,2513260,Hispanic of any race,25.9,Male and Female,Thyroid,2016
55-59,10.2,12.9,290,Incidence,2513260,Hispanic of any race,11.5,Male and Female,Urinary Bladder,2016
60-64,898.2,925.4,17422,Incidence,1910901,Hispanic of any race,911.7,Male and Female,All Cancer Sites Combined,2016
60-64,9.9,13.0,217,Incidence,1910901,Hispanic of any race,11.4,Male and Female,Brain and Other Nervous System,2016
60-64,14.3,19.5,168,Incidence,1002477,Hispanic of any race,16.8,Male and Female,Cervix,2016
60-64,81.0,89.3,1625,Incidence,1910901,Hispanic of any race,85.0,Male and Female,Colon and Rectum,2016
60-64,77.6,89.0,834,Incidence,1002477,Hispanic of any race,83.2,Male and Female,"Corpus and Uterus, NOS",2016
60-64,6.3,8.8,142,Incidence,1910901,Hispanic of any race,7.4,Male and Female,Esophagus,2016
60-64,256.5,276.8,2672,Incidence,1002477,Hispanic of any race,266.5,Male and Female,Female Breast,2016
60-64,57.0,66.8,619,Incidence,1002477,Hispanic of any race,61.7,Male and Female,"Female Breast, <i>in situ</i>",2016
60-64,2.3,3.9,57,Incidence,1910901,Hispanic of any race,3.0,Male and Female,Hodgkin Lymphoma,2016
60-64,0.6,1.5,18,Incidence,1910901,Hispanic of any race,0.9,Male and Female,Kaposi Sarcoma,2016
60-64,45.4,51.7,926,Incidence,1910901,Hispanic of any race,48.5,Male and Female,Kidney and Renal Pelvis,2016
60-64,6.6,9.2,150,Incidence,1910901,Hispanic of any race,7.8,Male and Female,Larynx,2016
60-64,17.2,21.2,366,Incidence,1910901,Hispanic of any race,19.2,Male and Female,Leukemias,2016
60-64,49.0,55.6,998,Incidence,1910901,Hispanic of any race,52.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
60-64,63.8,71.2,1289,Incidence,1910901,Hispanic of any race,67.5,Male and Female,Lung and Bronchus,2016
60-64,256.5,276.8,2672,Incidence,1002477,Hispanic of any race,266.5,Male and Female,Male and Female Breast,2016
60-64,57.0,66.8,619,Incidence,1002477,Hispanic of any race,61.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
60-64,9.8,12.9,215,Incidence,1910901,Hispanic of any race,11.3,Male and Female,Melanomas of the Skin,2016
60-64,1.1,2.2,30,Incidence,1910901,Hispanic of any race,1.6,Male and Female,Mesothelioma,2016
60-64,16.8,20.8,358,Incidence,1910901,Hispanic of any race,18.7,Male and Female,Myeloma,2016
60-64,37.1,42.9,763,Incidence,1910901,Hispanic of any race,39.9,Male and Female,Non-Hodgkin Lymphoma,2016
60-64,20.2,24.5,426,Incidence,1910901,Hispanic of any race,22.3,Male and Female,Oral Cavity and Pharynx,2016
60-64,22.6,29.0,257,Incidence,1002477,Hispanic of any race,25.6,Male and Female,Ovary,2016
60-64,26.8,31.7,558,Incidence,1910901,Hispanic of any race,29.2,Male and Female,Pancreas,2016
60-64,287.9,310.6,2717,Incidence,908424,Hispanic of any race,299.1,Male and Female,Prostate,2016
60-64,18.9,23.1,400,Incidence,1910901,Hispanic of any race,20.9,Male and Female,Stomach,2016
60-64,~,~,~,Incidence,908424,Hispanic of any race,~,Male and Female,Testis,2016
60-64,23.1,27.6,483,Incidence,1910901,Hispanic of any race,25.3,Male and Female,Thyroid,2016
60-64,19.8,24.1,418,Incidence,1910901,Hispanic of any race,21.9,Male and Female,Urinary Bladder,2016
65-69,1275.0,1312.5,18365,Incidence,1419658,Hispanic of any race,1293.6,Male and Female,All Cancer Sites Combined,2016
65-69,11.2,15.1,185,Incidence,1419658,Hispanic of any race,13.0,Male and Female,Brain and Other Nervous System,2016
65-69,11.8,17.4,110,Incidence,763582,Hispanic of any race,14.4,Male and Female,Cervix,2016
65-69,117.2,128.8,1745,Incidence,1419658,Hispanic of any race,122.9,Male and Female,Colon and Rectum,2016
65-69,88.3,102.3,726,Incidence,763582,Hispanic of any race,95.1,Male and Female,"Corpus and Uterus, NOS",2016
65-69,10.4,14.1,172,Incidence,1419658,Hispanic of any race,12.1,Male and Female,Esophagus,2016
65-69,321.4,347.4,2552,Incidence,763582,Hispanic of any race,334.2,Male and Female,Female Breast,2016
65-69,70.9,83.5,588,Incidence,763582,Hispanic of any race,77.0,Male and Female,"Female Breast, <i>in situ</i>",2016
65-69,3.5,5.8,64,Incidence,1419658,Hispanic of any race,4.5,Male and Female,Hodgkin Lymphoma,2016
65-69,1.1,2.6,25,Incidence,1419658,Hispanic of any race,1.8,Male and Female,Kaposi Sarcoma,2016
65-69,61.9,70.4,938,Incidence,1419658,Hispanic of any race,66.1,Male and Female,Kidney and Renal Pelvis,2016
65-69,7.1,10.2,121,Incidence,1419658,Hispanic of any race,8.5,Male and Female,Larynx,2016
65-69,26.0,31.7,408,Incidence,1419658,Hispanic of any race,28.7,Male and Female,Leukemias,2016
65-69,61.3,69.8,929,Incidence,1419658,Hispanic of any race,65.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
65-69,109.2,120.4,1628,Incidence,1419658,Hispanic of any race,114.7,Male and Female,Lung and Bronchus,2016
65-69,321.4,347.4,2552,Incidence,763582,Hispanic of any race,334.2,Male and Female,Male and Female Breast,2016
65-69,70.9,83.5,588,Incidence,763582,Hispanic of any race,77.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
65-69,14.7,19.0,238,Incidence,1419658,Hispanic of any race,16.8,Male and Female,Melanomas of the Skin,2016
65-69,1.7,3.4,35,Incidence,1419658,Hispanic of any race,2.5,Male and Female,Mesothelioma,2016
65-69,25.2,30.8,396,Incidence,1419658,Hispanic of any race,27.9,Male and Female,Myeloma,2016
65-69,51.7,59.5,788,Incidence,1419658,Hispanic of any race,55.5,Male and Female,Non-Hodgkin Lymphoma,2016
65-69,25.1,30.6,394,Incidence,1419658,Hispanic of any race,27.8,Male and Female,Oral Cavity and Pharynx,2016
65-69,27.8,35.9,242,Incidence,763582,Hispanic of any race,31.7,Male and Female,Ovary,2016
65-69,39.6,46.5,610,Incidence,1419658,Hispanic of any race,43.0,Male and Female,Pancreas,2016
65-69,477.4,511.6,3243,Incidence,656076,Hispanic of any race,494.3,Male and Female,Prostate,2016
65-69,27.2,32.9,425,Incidence,1419658,Hispanic of any race,29.9,Male and Female,Stomach,2016
65-69,~,~,~,Incidence,656076,Hispanic of any race,~,Male and Female,Testis,2016
65-69,27.0,32.7,422,Incidence,1419658,Hispanic of any race,29.7,Male and Female,Thyroid,2016
65-69,34.8,41.2,538,Incidence,1419658,Hispanic of any race,37.9,Male and Female,Urinary Bladder,2016
70-74,1504.0,1553.6,14663,Incidence,959224,Hispanic of any race,1528.6,Male and Female,All Cancer Sites Combined,2016
70-74,13.2,18.3,150,Incidence,959224,Hispanic of any race,15.6,Male and Female,Brain and Other Nervous System,2016
70-74,13.0,20.0,87,Incidence,535497,Hispanic of any race,16.2,Male and Female,Cervix,2016
70-74,127.1,141.9,1289,Incidence,959224,Hispanic of any race,134.4,Male and Female,Colon and Rectum,2016
70-74,76.1,91.8,448,Incidence,535497,Hispanic of any race,83.7,Male and Female,"Corpus and Uterus, NOS",2016
70-74,11.3,16.1,130,Incidence,959224,Hispanic of any race,13.6,Male and Female,Esophagus,2016
70-74,332.1,363.9,1862,Incidence,535497,Hispanic of any race,347.7,Male and Female,Female Breast,2016
70-74,71.3,86.5,421,Incidence,535497,Hispanic of any race,78.6,Male and Female,"Female Breast, <i>in situ</i>",2016
70-74,4.0,7.0,51,Incidence,959224,Hispanic of any race,5.3,Male and Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,959224,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
70-74,64.3,74.9,666,Incidence,959224,Hispanic of any race,69.4,Male and Female,Kidney and Renal Pelvis,2016
70-74,9.7,14.2,113,Incidence,959224,Hispanic of any race,11.8,Male and Female,Larynx,2016
70-74,38.2,46.5,405,Incidence,959224,Hispanic of any race,42.2,Male and Female,Leukemias,2016
70-74,56.5,66.6,589,Incidence,959224,Hispanic of any race,61.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
70-74,172.3,189.4,1733,Incidence,959224,Hispanic of any race,180.7,Male and Female,Lung and Bronchus,2016
70-74,332.1,363.9,1862,Incidence,535497,Hispanic of any race,347.7,Male and Female,Male and Female Breast,2016
70-74,71.3,86.5,421,Incidence,535497,Hispanic of any race,78.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
70-74,16.3,21.9,182,Incidence,959224,Hispanic of any race,19.0,Male and Female,Melanomas of the Skin,2016
70-74,2.4,4.8,33,Incidence,959224,Hispanic of any race,3.4,Male and Female,Mesothelioma,2016
70-74,31.5,39.1,337,Incidence,959224,Hispanic of any race,35.1,Male and Female,Myeloma,2016
70-74,72.9,84.2,752,Incidence,959224,Hispanic of any race,78.4,Male and Female,Non-Hodgkin Lymphoma,2016
70-74,26.0,32.9,281,Incidence,959224,Hispanic of any race,29.3,Male and Female,Oral Cavity and Pharynx,2016
70-74,29.1,39.1,181,Incidence,535497,Hispanic of any race,33.8,Male and Female,Ovary,2016
70-74,49.8,59.2,521,Incidence,959224,Hispanic of any race,54.3,Male and Female,Pancreas,2016
70-74,516.5,560.9,2281,Incidence,423727,Hispanic of any race,538.3,Male and Female,Prostate,2016
70-74,38.0,46.3,403,Incidence,959224,Hispanic of any race,42.0,Male and Female,Stomach,2016
70-74,~,~,~,Incidence,423727,Hispanic of any race,~,Male and Female,Testis,2016
70-74,24.1,30.8,262,Incidence,959224,Hispanic of any race,27.3,Male and Female,Thyroid,2016
70-74,55.9,65.9,583,Incidence,959224,Hispanic of any race,60.8,Male and Female,Urinary Bladder,2016
75-79,1707.4,1770.7,11627,Incidence,668666,Hispanic of any race,1738.8,Male and Female,All Cancer Sites Combined,2016
75-79,16.0,22.8,128,Incidence,668666,Hispanic of any race,19.1,Male and Female,Brain and Other Nervous System,2016
75-79,13.2,21.8,66,Incidence,385618,Hispanic of any race,17.1,Male and Female,Cervix,2016
75-79,155.5,175.1,1104,Incidence,668666,Hispanic of any race,165.1,Male and Female,Colon and Rectum,2016
75-79,72.2,90.4,312,Incidence,385618,Hispanic of any race,80.9,Male and Female,"Corpus and Uterus, NOS",2016
75-79,12.6,18.7,103,Incidence,668666,Hispanic of any race,15.4,Male and Female,Esophagus,2016
75-79,301.6,337.6,1231,Incidence,385618,Hispanic of any race,319.2,Male and Female,Female Breast,2016
75-79,53.2,69.0,234,Incidence,385618,Hispanic of any race,60.7,Male and Female,"Female Breast, <i>in situ</i>",2016
75-79,4.7,8.7,43,Incidence,668666,Hispanic of any race,6.4,Male and Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,668666,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
75-79,69.4,82.7,507,Incidence,668666,Hispanic of any race,75.8,Male and Female,Kidney and Renal Pelvis,2016
75-79,10.6,16.2,88,Incidence,668666,Hispanic of any race,13.2,Male and Female,Larynx,2016
75-79,46.9,58.0,349,Incidence,668666,Hispanic of any race,52.2,Male and Female,Leukemias,2016
75-79,57.7,69.9,425,Incidence,668666,Hispanic of any race,63.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
75-79,219.4,242.6,1543,Incidence,668666,Hispanic of any race,230.8,Male and Female,Lung and Bronchus,2016
75-79,301.6,337.6,1231,Incidence,385618,Hispanic of any race,319.2,Male and Female,Male and Female Breast,2016
75-79,53.2,69.0,234,Incidence,385618,Hispanic of any race,60.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
75-79,16.1,22.9,129,Incidence,668666,Hispanic of any race,19.3,Male and Female,Melanomas of the Skin,2016
75-79,2.2,5.2,23,Incidence,668666,Hispanic of any race,3.4,Male and Female,Mesothelioma,2016
75-79,37.1,47.1,280,Incidence,668666,Hispanic of any race,41.9,Male and Female,Myeloma,2016
75-79,88.4,103.4,640,Incidence,668666,Hispanic of any race,95.7,Male and Female,Non-Hodgkin Lymphoma,2016
75-79,28.1,36.9,216,Incidence,668666,Hispanic of any race,32.3,Male and Female,Oral Cavity and Pharynx,2016
75-79,26.5,38.1,123,Incidence,385618,Hispanic of any race,31.9,Male and Female,Ovary,2016
75-79,67.8,81.0,496,Incidence,668666,Hispanic of any race,74.2,Male and Female,Pancreas,2016
75-79,507.9,562.2,1513,Incidence,283048,Hispanic of any race,534.5,Male and Female,Prostate,2016
75-79,45.4,56.4,339,Incidence,668666,Hispanic of any race,50.7,Male and Female,Stomach,2016
75-79,~,~,~,Incidence,283048,Hispanic of any race,~,Male and Female,Testis,2016
75-79,22.2,30.0,173,Incidence,668666,Hispanic of any race,25.9,Male and Female,Thyroid,2016
75-79,67.9,81.2,497,Incidence,668666,Hispanic of any race,74.3,Male and Female,Urinary Bladder,2016
80-84,1764.1,1842.2,8218,Incidence,455841,Hispanic of any race,1802.8,Male and Female,All Cancer Sites Combined,2016
80-84,14.5,22.6,83,Incidence,455841,Hispanic of any race,18.2,Male and Female,Brain and Other Nervous System,2016
80-84,8.0,16.6,32,Incidence,272495,Hispanic of any race,11.7,Male and Female,Cervix,2016
80-84,174.1,199.4,850,Incidence,455841,Hispanic of any race,186.5,Male and Female,Colon and Rectum,2016
80-84,45.9,63.8,148,Incidence,272495,Hispanic of any race,54.3,Male and Female,"Corpus and Uterus, NOS",2016
80-84,16.9,25.5,95,Incidence,455841,Hispanic of any race,20.8,Male and Female,Esophagus,2016
80-84,254.8,294.5,747,Incidence,272495,Hispanic of any race,274.1,Male and Female,Female Breast,2016
80-84,28.5,43.0,96,Incidence,272495,Hispanic of any race,35.2,Male and Female,"Female Breast, <i>in situ</i>",2016
80-84,5.0,10.2,33,Incidence,455841,Hispanic of any race,7.2,Male and Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,455841,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
80-84,62.1,77.6,317,Incidence,455841,Hispanic of any race,69.5,Male and Female,Kidney and Renal Pelvis,2016
80-84,10.2,17.2,61,Incidence,455841,Hispanic of any race,13.4,Male and Female,Larynx,2016
80-84,53.6,68.1,276,Incidence,455841,Hispanic of any race,60.5,Male and Female,Leukemias,2016
80-84,60.4,75.8,309,Incidence,455841,Hispanic of any race,67.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
80-84,219.6,247.9,1064,Incidence,455841,Hispanic of any race,233.4,Male and Female,Lung and Bronchus,2016
80-84,254.8,294.5,747,Incidence,272495,Hispanic of any race,274.1,Male and Female,Male and Female Breast,2016
80-84,28.5,43.0,96,Incidence,272495,Hispanic of any race,35.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
80-84,21.6,31.2,119,Incidence,455841,Hispanic of any race,26.1,Male and Female,Melanomas of the Skin,2016
80-84,2.9,7.0,21,Incidence,455841,Hispanic of any race,4.6,Male and Female,Mesothelioma,2016
80-84,38.2,50.6,201,Incidence,455841,Hispanic of any race,44.1,Male and Female,Myeloma,2016
80-84,97.8,117.0,488,Incidence,455841,Hispanic of any race,107.1,Male and Female,Non-Hodgkin Lymphoma,2016
80-84,25.6,36.0,139,Incidence,455841,Hispanic of any race,30.5,Male and Female,Oral Cavity and Pharynx,2016
80-84,34.5,50.3,114,Incidence,272495,Hispanic of any race,41.8,Male and Female,Ovary,2016
80-84,84.4,102.3,424,Incidence,455841,Hispanic of any race,93.0,Male and Female,Pancreas,2016
80-84,409.3,470.5,805,Incidence,183346,Hispanic of any race,439.1,Male and Female,Prostate,2016
80-84,50.3,64.4,260,Incidence,455841,Hispanic of any race,57.0,Male and Female,Stomach,2016
80-84,~,~,~,Incidence,183346,Hispanic of any race,~,Male and Female,Testis,2016
80-84,16.1,24.5,91,Incidence,455841,Hispanic of any race,20.0,Male and Female,Thyroid,2016
80-84,93.8,112.6,469,Incidence,455841,Hispanic of any race,102.9,Male and Female,Urinary Bladder,2016
85+,1680.1,1758.7,7394,Incidence,430118,Hispanic of any race,1719.1,Male and Female,All Cancer Sites Combined,2016
85+,10.2,17.4,58,Incidence,430118,Hispanic of any race,13.5,Male and Female,Brain and Other Nervous System,2016
85+,13.5,24.0,50,Incidence,274694,Hispanic of any race,18.2,Male and Female,Cervix,2016
85+,194.0,221.5,892,Incidence,430118,Hispanic of any race,207.4,Male and Female,Colon and Rectum,2016
85+,37.2,53.4,123,Incidence,274694,Hispanic of any race,44.8,Male and Female,"Corpus and Uterus, NOS",2016
85+,13.9,22.1,76,Incidence,430118,Hispanic of any race,17.7,Male and Female,Esophagus,2016
85+,217.0,253.6,645,Incidence,274694,Hispanic of any race,234.8,Male and Female,Female Breast,2016
85+,13.5,24.0,50,Incidence,274694,Hispanic of any race,18.2,Male and Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,430118,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,430118,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
85+,50.1,64.6,245,Incidence,430118,Hispanic of any race,57.0,Male and Female,Kidney and Renal Pelvis,2016
85+,6.1,11.9,37,Incidence,430118,Hispanic of any race,8.6,Male and Female,Larynx,2016
85+,57.0,72.4,277,Incidence,430118,Hispanic of any race,64.4,Male and Female,Leukemias,2016
85+,61.0,76.9,295,Incidence,430118,Hispanic of any race,68.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
85+,196.0,223.6,901,Incidence,430118,Hispanic of any race,209.5,Male and Female,Lung and Bronchus,2016
85+,217.0,253.6,645,Incidence,274694,Hispanic of any race,234.8,Male and Female,Male and Female Breast,2016
85+,13.5,24.0,50,Incidence,274694,Hispanic of any race,18.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
85+,25.7,36.4,132,Incidence,430118,Hispanic of any race,30.7,Male and Female,Melanomas of the Skin,2016
85+,3.0,7.5,21,Incidence,430118,Hispanic of any race,4.9,Male and Female,Mesothelioma,2016
85+,29.5,40.9,150,Incidence,430118,Hispanic of any race,34.9,Male and Female,Myeloma,2016
85+,82.6,100.9,393,Incidence,430118,Hispanic of any race,91.4,Male and Female,Non-Hodgkin Lymphoma,2016
85+,24.4,34.9,126,Incidence,430118,Hispanic of any race,29.3,Male and Female,Oral Cavity and Pharynx,2016
85+,26.3,40.3,90,Incidence,274694,Hispanic of any race,32.8,Male and Female,Ovary,2016
85+,84.8,103.3,403,Incidence,430118,Hispanic of any race,93.7,Male and Female,Pancreas,2016
85+,324.3,384.0,549,Incidence,155424,Hispanic of any race,353.2,Male and Female,Prostate,2016
85+,59.2,74.9,287,Incidence,430118,Hispanic of any race,66.7,Male and Female,Stomach,2016
85+,~,~,~,Incidence,155424,Hispanic of any race,~,Male and Female,Testis,2016
85+,8.6,15.3,50,Incidence,430118,Hispanic of any race,11.6,Male and Female,Thyroid,2016
85+,94.1,113.5,445,Incidence,430118,Hispanic of any race,103.5,Male and Female,Urinary Bladder,2016
<1,19.4,25.3,225,Incidence,1012245,Hispanic of any race,22.2,Male and Female,All Cancer Sites Combined,2016
<1,2.8,5.4,40,Incidence,1012245,Hispanic of any race,4.0,Male and Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,Cervix,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Colon and Rectum,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Esophagus,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,Female Breast,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Larynx,2016
<1,3.2,5.8,44,Incidence,1012245,Hispanic of any race,4.3,Male and Female,Leukemias,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,Male and Female Breast,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Mesothelioma,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Myeloma,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,495790,Hispanic of any race,~,Male and Female,Ovary,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Pancreas,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male and Female,Prostate,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Stomach,2016
<1,~,~,~,Incidence,516455,Hispanic of any race,~,Male and Female,Testis,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Thyroid,2016
<1,~,~,~,Incidence,1012245,Hispanic of any race,~,Male and Female,Urinary Bladder,2016
1-4,12.0,34.2,16,Incidence,76000,Non-Hispanic American Indian/Alaska Native,21.1,Female,All Cancer Sites Combined,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
15-19,9.0,25.5,16,Incidence,102084,Non-Hispanic American Indian/Alaska Native,15.7,Female,All Cancer Sites Combined,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
20-24,23.4,46.3,36,Incidence,107654,Non-Hispanic American Indian/Alaska Native,33.4,Female,All Cancer Sites Combined,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
25-29,45.6,76.2,62,Incidence,104267,Non-Hispanic American Indian/Alaska Native,59.5,Female,All Cancer Sites Combined,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
25-29,8.8,24.9,16,Incidence,104267,Non-Hispanic American Indian/Alaska Native,15.3,Female,Thyroid,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
30-34,121.8,172.2,134,Incidence,92175,Non-Hispanic American Indian/Alaska Native,145.4,Female,All Cancer Sites Combined,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
30-34,19.3,42.6,27,Incidence,92175,Non-Hispanic American Indian/Alaska Native,29.3,Female,Female Breast,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
30-34,22.0,46.5,30,Incidence,92175,Non-Hispanic American Indian/Alaska Native,32.5,Female,Thyroid,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
35-39,184.0,247.4,182,Incidence,85074,Non-Hispanic American Indian/Alaska Native,213.9,Female,All Cancer Sites Combined,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
35-39,14.4,36.3,20,Incidence,85074,Non-Hispanic American Indian/Alaska Native,23.5,Female,Cervix,2016
35-39,11.6,32.0,17,Incidence,85074,Non-Hispanic American Indian/Alaska Native,20.0,Female,Colon and Rectum,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
35-39,41.6,74.8,48,Incidence,85074,Non-Hispanic American Indian/Alaska Native,56.4,Female,Female Breast,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
35-39,22.8,49.0,29,Incidence,85074,Non-Hispanic American Indian/Alaska Native,34.1,Female,Thyroid,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
40-44,333.5,420.2,296,Incidence,78941,Non-Hispanic American Indian/Alaska Native,375.0,Female,All Cancer Sites Combined,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
40-44,25.6,54.3,30,Incidence,78941,Non-Hispanic American Indian/Alaska Native,38.0,Female,Colon and Rectum,2016
40-44,31.9,63.1,36,Incidence,78941,Non-Hispanic American Indian/Alaska Native,45.6,Female,"Corpus and Uterus, NOS",2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
40-44,103.1,154.1,100,Incidence,78941,Non-Hispanic American Indian/Alaska Native,126.7,Female,Female Breast,2016
40-44,23.6,51.3,28,Incidence,78941,Non-Hispanic American Indian/Alaska Native,35.5,Female,"Female Breast, <i>in situ</i>",2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
40-44,18.5,43.7,23,Incidence,78941,Non-Hispanic American Indian/Alaska Native,29.1,Female,Thyroid,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
45-49,424.9,519.7,389,Incidence,82677,Non-Hispanic American Indian/Alaska Native,470.5,Female,All Cancer Sites Combined,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
45-49,30.5,60.3,36,Incidence,82677,Non-Hispanic American Indian/Alaska Native,43.5,Female,Colon and Rectum,2016
45-49,17.6,41.7,23,Incidence,82677,Non-Hispanic American Indian/Alaska Native,27.8,Female,"Corpus and Uterus, NOS",2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
45-49,136.9,193.3,135,Incidence,82677,Non-Hispanic American Indian/Alaska Native,163.3,Female,Female Breast,2016
45-49,24.5,51.8,30,Incidence,82677,Non-Hispanic American Indian/Alaska Native,36.3,Female,"Female Breast, <i>in situ</i>",2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
45-49,18.6,43.2,24,Incidence,82677,Non-Hispanic American Indian/Alaska Native,29.0,Female,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
45-49,14.8,37.4,20,Incidence,82677,Non-Hispanic American Indian/Alaska Native,24.2,Female,Lung and Bronchus,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
45-49,24.5,51.8,30,Incidence,82677,Non-Hispanic American Indian/Alaska Native,36.3,Female,Thyroid,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
50-54,552.3,654.8,542,Incidence,90039,Non-Hispanic American Indian/Alaska Native,602.0,Female,All Cancer Sites Combined,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
50-54,10.2,28.9,16,Incidence,90039,Non-Hispanic American Indian/Alaska Native,17.8,Female,Cervix,2016
50-54,54.7,90.8,64,Incidence,90039,Non-Hispanic American Indian/Alaska Native,71.1,Female,Colon and Rectum,2016
50-54,47.0,80.8,56,Incidence,90039,Non-Hispanic American Indian/Alaska Native,62.2,Female,"Corpus and Uterus, NOS",2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
50-54,147.1,202.7,156,Incidence,90039,Non-Hispanic American Indian/Alaska Native,173.3,Female,Female Breast,2016
50-54,26.2,52.8,34,Incidence,90039,Non-Hispanic American Indian/Alaska Native,37.8,Female,"Female Breast, <i>in situ</i>",2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
50-54,13.6,34.3,20,Incidence,90039,Non-Hispanic American Indian/Alaska Native,22.2,Female,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
50-54,41.2,73.2,50,Incidence,90039,Non-Hispanic American Indian/Alaska Native,55.5,Female,Lung and Bronchus,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
50-54,10.2,28.9,16,Incidence,90039,Non-Hispanic American Indian/Alaska Native,17.8,Female,Non-Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
50-54,11.0,30.2,17,Incidence,90039,Non-Hispanic American Indian/Alaska Native,18.9,Female,Ovary,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
50-54,20.7,44.9,28,Incidence,90039,Non-Hispanic American Indian/Alaska Native,31.1,Female,Thyroid,2016
50-54,~,~,~,Incidence,90039,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
55-59,765.9,885.5,744,Incidence,90281,Non-Hispanic American Indian/Alaska Native,824.1,Female,All Cancer Sites Combined,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
55-59,69.3,109.1,79,Incidence,90281,Non-Hispanic American Indian/Alaska Native,87.5,Female,Colon and Rectum,2016
55-59,54.6,90.5,64,Incidence,90281,Non-Hispanic American Indian/Alaska Native,70.9,Female,"Corpus and Uterus, NOS",2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
55-59,216.7,282.8,224,Incidence,90281,Non-Hispanic American Indian/Alaska Native,248.1,Female,Female Breast,2016
55-59,32.6,61.6,41,Incidence,90281,Non-Hispanic American Indian/Alaska Native,45.4,Female,"Female Breast, <i>in situ</i>",2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
55-59,27.0,53.9,35,Incidence,90281,Non-Hispanic American Indian/Alaska Native,38.8,Female,Kidney and Renal Pelvis,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
55-59,16.1,38.2,23,Incidence,90281,Non-Hispanic American Indian/Alaska Native,25.5,Female,Liver and Intrahepatic Bile Duct,2016
55-59,81.2,123.8,91,Incidence,90281,Non-Hispanic American Indian/Alaska Native,100.8,Female,Lung and Bronchus,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
55-59,14.4,35.6,21,Incidence,90281,Non-Hispanic American Indian/Alaska Native,23.3,Female,Non-Hodgkin Lymphoma,2016
55-59,12.7,32.9,19,Incidence,90281,Non-Hispanic American Indian/Alaska Native,21.0,Female,Oral Cavity and Pharynx,2016
55-59,14.4,35.6,21,Incidence,90281,Non-Hispanic American Indian/Alaska Native,23.3,Female,Ovary,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
55-59,10.1,28.8,16,Incidence,90281,Non-Hispanic American Indian/Alaska Native,17.7,Female,Stomach,2016
55-59,12.7,32.9,19,Incidence,90281,Non-Hispanic American Indian/Alaska Native,21.0,Female,Thyroid,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
60-64,857.1,995.4,700,Incidence,75728,Non-Hispanic American Indian/Alaska Native,924.4,Female,All Cancer Sites Combined,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
60-64,67.4,110.9,66,Incidence,75728,Non-Hispanic American Indian/Alaska Native,87.2,Female,Colon and Rectum,2016
60-64,45.6,82.5,47,Incidence,75728,Non-Hispanic American Indian/Alaska Native,62.1,Female,"Corpus and Uterus, NOS",2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
60-64,230.0,304.8,201,Incidence,75728,Non-Hispanic American Indian/Alaska Native,265.4,Female,Female Breast,2016
60-64,44.5,81.0,46,Incidence,75728,Non-Hispanic American Indian/Alaska Native,60.7,Female,"Female Breast, <i>in situ</i>",2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
60-64,23.5,51.9,27,Incidence,75728,Non-Hispanic American Indian/Alaska Native,35.7,Female,Kidney and Renal Pelvis,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
60-64,23.5,51.9,27,Incidence,75728,Non-Hispanic American Indian/Alaska Native,35.7,Female,Liver and Intrahepatic Bile Duct,2016
60-64,106.3,159.2,99,Incidence,75728,Non-Hispanic American Indian/Alaska Native,130.7,Female,Lung and Bronchus,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
60-64,13.1,35.9,17,Incidence,75728,Non-Hispanic American Indian/Alaska Native,22.4,Female,Myeloma,2016
60-64,20.3,47.2,24,Incidence,75728,Non-Hispanic American Indian/Alaska Native,31.7,Female,Non-Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
60-64,18.2,44.0,22,Incidence,75728,Non-Hispanic American Indian/Alaska Native,29.1,Female,Ovary,2016
60-64,14.1,37.6,18,Incidence,75728,Non-Hispanic American Indian/Alaska Native,23.8,Female,Pancreas,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
60-64,25.6,55.0,29,Incidence,75728,Non-Hispanic American Indian/Alaska Native,38.3,Female,Thyroid,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
65-69,1146.6,1327.6,729,Incidence,59048,Non-Hispanic American Indian/Alaska Native,1234.6,Female,All Cancer Sites Combined,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
65-69,82.0,136.5,63,Incidence,59048,Non-Hispanic American Indian/Alaska Native,106.7,Female,Colon and Rectum,2016
65-69,57.0,103.9,46,Incidence,59048,Non-Hispanic American Indian/Alaska Native,77.9,Female,"Corpus and Uterus, NOS",2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
65-69,329.7,430.6,223,Incidence,59048,Non-Hispanic American Indian/Alaska Native,377.7,Female,Female Breast,2016
65-69,55.6,102.0,45,Incidence,59048,Non-Hispanic American Indian/Alaska Native,76.2,Female,"Female Breast, <i>in situ</i>",2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
65-69,41.3,82.4,35,Incidence,59048,Non-Hispanic American Indian/Alaska Native,59.3,Female,Kidney and Renal Pelvis,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
65-69,22.0,54.4,21,Incidence,59048,Non-Hispanic American Indian/Alaska Native,35.6,Female,Liver and Intrahepatic Bile Duct,2016
65-69,180.8,257.7,128,Incidence,59048,Non-Hispanic American Indian/Alaska Native,216.8,Female,Lung and Bronchus,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
65-69,30.1,66.5,27,Incidence,59048,Non-Hispanic American Indian/Alaska Native,45.7,Female,Non-Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
65-69,16.8,46.1,17,Incidence,59048,Non-Hispanic American Indian/Alaska Native,28.8,Female,Ovary,2016
65-69,24.7,58.4,23,Incidence,59048,Non-Hispanic American Indian/Alaska Native,39.0,Female,Pancreas,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
70-74,1281.2,1520.9,534,Incidence,38219,Non-Hispanic American Indian/Alaska Native,1397.2,Female,All Cancer Sites Combined,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
70-74,113.0,193.2,57,Incidence,38219,Non-Hispanic American Indian/Alaska Native,149.1,Female,Colon and Rectum,2016
70-74,42.3,96.6,25,Incidence,38219,Non-Hispanic American Indian/Alaska Native,65.4,Female,"Corpus and Uterus, NOS",2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
70-74,286.6,406.7,131,Incidence,38219,Non-Hispanic American Indian/Alaska Native,342.8,Female,Female Breast,2016
70-74,32.0,80.8,20,Incidence,38219,Non-Hispanic American Indian/Alaska Native,52.3,Female,"Female Breast, <i>in situ</i>",2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
70-74,38.1,90.3,23,Incidence,38219,Non-Hispanic American Indian/Alaska Native,60.2,Female,Kidney and Renal Pelvis,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
70-74,246.0,358.3,114,Incidence,38219,Non-Hispanic American Indian/Alaska Native,298.3,Female,Lung and Bronchus,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
70-74,32.0,80.8,20,Incidence,38219,Non-Hispanic American Indian/Alaska Native,52.3,Female,Non-Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
70-74,27.9,74.4,18,Incidence,38219,Non-Hispanic American Indian/Alaska Native,47.1,Female,Ovary,2016
70-74,23.9,68.0,16,Incidence,38219,Non-Hispanic American Indian/Alaska Native,41.9,Female,Pancreas,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
75-79,1559.1,1882.1,444,Incidence,25891,Non-Hispanic American Indian/Alaska Native,1714.9,Female,All Cancer Sites Combined,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
75-79,146.7,259.0,51,Incidence,25891,Non-Hispanic American Indian/Alaska Native,197.0,Female,Colon and Rectum,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
75-79,283.0,431.5,91,Incidence,25891,Non-Hispanic American Indian/Alaska Native,351.5,Female,Female Breast,2016
75-79,53.3,128.6,22,Incidence,25891,Non-Hispanic American Indian/Alaska Native,85.0,Female,"Female Breast, <i>in situ</i>",2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
75-79,38.2,105.1,17,Incidence,25891,Non-Hispanic American Indian/Alaska Native,65.7,Female,Kidney and Renal Pelvis,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
75-79,310.8,465.5,99,Incidence,25891,Non-Hispanic American Indian/Alaska Native,382.4,Female,Lung and Bronchus,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
75-79,62.5,142.5,25,Incidence,25891,Non-Hispanic American Indian/Alaska Native,96.6,Female,Non-Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
80-84,1551.5,1961.5,288,Incidence,16480,Non-Hispanic American Indian/Alaska Native,1747.6,Female,All Cancer Sites Combined,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
80-84,137.8,281.2,33,Incidence,16480,Non-Hispanic American Indian/Alaska Native,200.2,Female,Colon and Rectum,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
80-84,235.7,413.8,52,Incidence,16480,Non-Hispanic American Indian/Alaska Native,315.5,Female,Female Breast,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
80-84,240.9,420.7,53,Incidence,16480,Non-Hispanic American Indian/Alaska Native,321.6,Female,Lung and Bronchus,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
80-84,60.1,165.2,17,Incidence,16480,Non-Hispanic American Indian/Alaska Native,103.2,Female,Non-Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
80-84,55.5,157.7,16,Incidence,16480,Non-Hispanic American Indian/Alaska Native,97.1,Female,Pancreas,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
85+,1217.4,1591.0,222,Incidence,15915,Non-Hispanic American Indian/Alaska Native,1394.9,Female,All Cancer Sites Combined,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
85+,111.8,246.8,27,Incidence,15915,Non-Hispanic American Indian/Alaska Native,169.7,Female,Colon and Rectum,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
85+,158.4,313.2,36,Incidence,15915,Non-Hispanic American Indian/Alaska Native,226.2,Female,Female Breast,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
85+,147.9,298.5,34,Incidence,15915,Non-Hispanic American Indian/Alaska Native,213.6,Female,Lung and Bronchus,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
85+,67.0,178.7,18,Incidence,15915,Non-Hispanic American Indian/Alaska Native,113.1,Female,Pancreas,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2016
1-4,18.5,43.8,23,Incidence,78822,Non-Hispanic American Indian/Alaska Native,29.2,Male,All Cancer Sites Combined,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
1-4,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
10-14,9.0,25.6,16,Incidence,101551,Non-Hispanic American Indian/Alaska Native,15.8,Male,All Cancer Sites Combined,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
10-14,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
15-19,15.4,35.2,25,Incidence,104721,Non-Hispanic American Indian/Alaska Native,23.9,Male,All Cancer Sites Combined,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
15-19,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
20-24,26.3,49.8,41,Incidence,111704,Non-Hispanic American Indian/Alaska Native,36.7,Male,All Cancer Sites Combined,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
20-24,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
20-24,9.6,25.5,18,Incidence,111704,Non-Hispanic American Indian/Alaska Native,16.1,Male,Testis,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
25-29,44.4,74.2,62,Incidence,107154,Non-Hispanic American Indian/Alaska Native,57.9,Male,All Cancer Sites Combined,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
25-29,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
25-29,10.0,26.5,18,Incidence,107154,Non-Hispanic American Indian/Alaska Native,16.8,Male,Testis,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
30-34,58.2,95.0,68,Incidence,90714,Non-Hispanic American Indian/Alaska Native,75.0,Male,All Cancer Sites Combined,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
30-34,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
30-34,10.9,30.0,17,Incidence,90714,Non-Hispanic American Indian/Alaska Native,18.7,Male,Testis,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
35-39,97.6,146.2,99,Incidence,82423,Non-Hispanic American Indian/Alaska Native,120.1,Male,All Cancer Sites Combined,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
35-39,11.1,31.5,16,Incidence,82423,Non-Hispanic American Indian/Alaska Native,19.4,Male,Colon and Rectum,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
35-39,12.0,33.0,17,Incidence,82423,Non-Hispanic American Indian/Alaska Native,20.6,Male,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
35-39,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
40-44,119.6,175.4,110,Incidence,75606,Non-Hispanic American Indian/Alaska Native,145.5,Male,All Cancer Sites Combined,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
40-44,17.2,42.5,21,Incidence,75606,Non-Hispanic American Indian/Alaska Native,27.8,Male,Colon and Rectum,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
40-44,13.1,36.0,17,Incidence,75606,Non-Hispanic American Indian/Alaska Native,22.5,Male,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
40-44,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
45-49,231.7,305.3,209,Incidence,78399,Non-Hispanic American Indian/Alaska Native,266.6,Male,All Cancer Sites Combined,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
45-49,32.2,63.6,36,Incidence,78399,Non-Hispanic American Indian/Alaska Native,45.9,Male,Colon and Rectum,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
45-49,31.1,62.1,35,Incidence,78399,Non-Hispanic American Indian/Alaska Native,44.6,Male,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
45-49,13.6,36.3,18,Incidence,78399,Non-Hispanic American Indian/Alaska Native,23.0,Male,Lung and Bronchus,2016
45-49,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
45-49,14.6,37.8,19,Incidence,78399,Non-Hispanic American Indian/Alaska Native,24.2,Male,Prostate,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
5-9,15.1,35.1,24,Incidence,101595,Non-Hispanic American Indian/Alaska Native,23.6,Male,All Cancer Sites Combined,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
5-9,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
50-54,463.6,561.9,426,Incidence,83362,Non-Hispanic American Indian/Alaska Native,511.0,Male,All Cancer Sites Combined,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
50-54,71.8,114.1,76,Incidence,83362,Non-Hispanic American Indian/Alaska Native,91.2,Male,Colon and Rectum,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
50-54,44.5,79.1,50,Incidence,83362,Non-Hispanic American Indian/Alaska Native,60.0,Male,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
50-54,24.3,51.4,30,Incidence,83362,Non-Hispanic American Indian/Alaska Native,36.0,Male,Liver and Intrahepatic Bile Duct,2016
50-54,23.3,50.0,29,Incidence,83362,Non-Hispanic American Indian/Alaska Native,34.8,Male,Lung and Bronchus,2016
50-54,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
50-54,12.8,34.1,18,Incidence,83362,Non-Hispanic American Indian/Alaska Native,21.6,Male,Non-Hodgkin Lymphoma,2016
50-54,24.3,51.4,30,Incidence,83362,Non-Hispanic American Indian/Alaska Native,36.0,Male,Oral Cavity and Pharynx,2016
50-54,14.7,37.1,20,Incidence,83362,Non-Hispanic American Indian/Alaska Native,24.0,Male,Pancreas,2016
50-54,47.6,83.2,53,Incidence,83362,Non-Hispanic American Indian/Alaska Native,63.6,Male,Prostate,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
55-59,729.4,853.5,635,Incidence,80418,Non-Hispanic American Indian/Alaska Native,789.6,Male,All Cancer Sites Combined,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
55-59,74.5,118.3,76,Incidence,80418,Non-Hispanic American Indian/Alaska Native,94.5,Male,Colon and Rectum,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
55-59,61.3,101.6,64,Incidence,80418,Non-Hispanic American Indian/Alaska Native,79.6,Male,Kidney and Renal Pelvis,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
55-59,13.3,35.4,18,Incidence,80418,Non-Hispanic American Indian/Alaska Native,22.4,Male,Leukemias,2016
55-59,63.5,104.4,66,Incidence,80418,Non-Hispanic American Indian/Alaska Native,82.1,Male,Liver and Intrahepatic Bile Duct,2016
55-59,71.2,114.1,73,Incidence,80418,Non-Hispanic American Indian/Alaska Native,90.8,Male,Lung and Bronchus,2016
55-59,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
55-59,14.2,36.9,19,Incidence,80418,Non-Hispanic American Indian/Alaska Native,23.6,Male,Non-Hodgkin Lymphoma,2016
55-59,31.4,62.0,36,Incidence,80418,Non-Hispanic American Indian/Alaska Native,44.8,Male,Oral Cavity and Pharynx,2016
55-59,18.1,42.9,23,Incidence,80418,Non-Hispanic American Indian/Alaska Native,28.6,Male,Pancreas,2016
55-59,115.8,168.9,113,Incidence,80418,Non-Hispanic American Indian/Alaska Native,140.5,Male,Prostate,2016
55-59,11.4,32.3,16,Incidence,80418,Non-Hispanic American Indian/Alaska Native,19.9,Male,Stomach,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
55-59,29.3,59.1,34,Incidence,80418,Non-Hispanic American Indian/Alaska Native,42.3,Male,Urinary Bladder,2016
60-64,1066.2,1231.5,753,Incidence,65671,Non-Hispanic American Indian/Alaska Native,1146.6,Male,All Cancer Sites Combined,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
60-64,117.0,176.8,95,Incidence,65671,Non-Hispanic American Indian/Alaska Native,144.7,Male,Colon and Rectum,2016
60-64,19.8,48.9,21,Incidence,65671,Non-Hispanic American Indian/Alaska Native,32.0,Male,Esophagus,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
60-64,55.2,98.6,49,Incidence,65671,Non-Hispanic American Indian/Alaska Native,74.6,Male,Kidney and Renal Pelvis,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
60-64,17.4,45.2,19,Incidence,65671,Non-Hispanic American Indian/Alaska Native,28.9,Male,Leukemias,2016
60-64,75.1,124.4,64,Incidence,65671,Non-Hispanic American Indian/Alaska Native,97.5,Male,Liver and Intrahepatic Bile Duct,2016
60-64,146.0,211.9,116,Incidence,65671,Non-Hispanic American Indian/Alaska Native,176.6,Male,Lung and Bronchus,2016
60-64,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
60-64,22.2,52.6,23,Incidence,65671,Non-Hispanic American Indian/Alaska Native,35.0,Male,Non-Hodgkin Lymphoma,2016
60-64,35.9,72.3,34,Incidence,65671,Non-Hispanic American Indian/Alaska Native,51.8,Male,Oral Cavity and Pharynx,2016
60-64,27.1,59.8,27,Incidence,65671,Non-Hispanic American Indian/Alaska Native,41.1,Male,Pancreas,2016
60-64,198.9,274.6,154,Incidence,65671,Non-Hispanic American Indian/Alaska Native,234.5,Male,Prostate,2016
60-64,18.6,47.0,20,Incidence,65671,Non-Hispanic American Indian/Alaska Native,30.5,Male,Stomach,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
60-64,22.2,52.6,23,Incidence,65671,Non-Hispanic American Indian/Alaska Native,35.0,Male,Urinary Bladder,2016
65-69,1441.0,1655.9,810,Incidence,52405,Non-Hispanic American Indian/Alaska Native,1545.7,Male,All Cancer Sites Combined,2016
65-69,17.5,49.6,16,Incidence,52405,Non-Hispanic American Indian/Alaska Native,30.5,Male,Brain and Other Nervous System,2016
65-69,117.7,185.8,78,Incidence,52405,Non-Hispanic American Indian/Alaska Native,148.8,Male,Colon and Rectum,2016
65-69,21.8,56.6,19,Incidence,52405,Non-Hispanic American Indian/Alaska Native,36.3,Male,Esophagus,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
65-69,87.4,147.4,60,Incidence,52405,Non-Hispanic American Indian/Alaska Native,114.5,Male,Kidney and Renal Pelvis,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
65-69,21.8,56.6,19,Incidence,52405,Non-Hispanic American Indian/Alaska Native,36.3,Male,Leukemias,2016
65-69,80.7,138.8,56,Incidence,52405,Non-Hispanic American Indian/Alaska Native,106.9,Male,Liver and Intrahepatic Bile Duct,2016
65-69,160.4,238.4,103,Incidence,52405,Non-Hispanic American Indian/Alaska Native,196.5,Male,Lung and Bronchus,2016
65-69,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
65-69,30.9,70.4,25,Incidence,52405,Non-Hispanic American Indian/Alaska Native,47.7,Male,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
65-69,27.8,65.9,23,Incidence,52405,Non-Hispanic American Indian/Alaska Native,43.9,Male,Non-Hodgkin Lymphoma,2016
65-69,32.4,72.7,26,Incidence,52405,Non-Hispanic American Indian/Alaska Native,49.6,Male,Oral Cavity and Pharynx,2016
65-69,21.8,56.6,19,Incidence,52405,Non-Hispanic American Indian/Alaska Native,36.3,Male,Pancreas,2016
65-69,367.9,481.1,221,Incidence,52405,Non-Hispanic American Indian/Alaska Native,421.7,Male,Prostate,2016
65-69,17.5,49.6,16,Incidence,52405,Non-Hispanic American Indian/Alaska Native,30.5,Male,Stomach,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
65-69,59.4,110.5,43,Incidence,52405,Non-Hispanic American Indian/Alaska Native,82.1,Male,Urinary Bladder,2016
70-74,1738.2,2038.9,616,Incidence,32696,Non-Hispanic American Indian/Alaska Native,1884.0,Male,All Cancer Sites Combined,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
70-74,137.4,232.8,59,Incidence,32696,Non-Hispanic American Indian/Alaska Native,180.5,Male,Colon and Rectum,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
70-74,77.1,152.4,36,Incidence,32696,Non-Hispanic American Indian/Alaska Native,110.1,Male,Kidney and Renal Pelvis,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
70-74,69.5,141.7,33,Incidence,32696,Non-Hispanic American Indian/Alaska Native,100.9,Male,Liver and Intrahepatic Bile Duct,2016
70-74,246.1,368.6,99,Incidence,32696,Non-Hispanic American Indian/Alaska Native,302.8,Male,Lung and Bronchus,2016
70-74,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
70-74,39.8,98.2,21,Incidence,32696,Non-Hispanic American Indian/Alaska Native,64.2,Male,Non-Hodgkin Lymphoma,2016
70-74,44.6,105.6,23,Incidence,32696,Non-Hispanic American Indian/Alaska Native,70.3,Male,Oral Cavity and Pharynx,2016
70-74,49.5,112.9,25,Incidence,32696,Non-Hispanic American Indian/Alaska Native,76.5,Male,Pancreas,2016
70-74,337.8,478.8,132,Incidence,32696,Non-Hispanic American Indian/Alaska Native,403.7,Male,Prostate,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
70-74,84.8,163.1,39,Incidence,32696,Non-Hispanic American Indian/Alaska Native,119.3,Male,Urinary Bladder,2016
75-79,1979.3,2385.8,451,Incidence,20731,Non-Hispanic American Indian/Alaska Native,2175.5,Male,All Cancer Sites Combined,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
75-79,166.6,301.5,47,Incidence,20731,Non-Hispanic American Indian/Alaska Native,226.7,Male,Colon and Rectum,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
75-79,47.8,131.3,17,Incidence,20731,Non-Hispanic American Indian/Alaska Native,82.0,Male,Kidney and Renal Pelvis,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
75-79,62.7,154.8,21,Incidence,20731,Non-Hispanic American Indian/Alaska Native,101.3,Male,Liver and Intrahepatic Bile Duct,2016
75-79,327.5,507.0,85,Incidence,20731,Non-Hispanic American Indian/Alaska Native,410.0,Male,Lung and Bronchus,2016
75-79,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
75-79,55.2,143.1,19,Incidence,20731,Non-Hispanic American Indian/Alaska Native,91.7,Male,Non-Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
75-79,331.8,512.3,86,Incidence,20731,Non-Hispanic American Indian/Alaska Native,414.8,Male,Prostate,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
75-79,125.7,246.0,37,Incidence,20731,Non-Hispanic American Indian/Alaska Native,178.5,Male,Urinary Bladder,2016
80-84,2345.4,2943.0,307,Incidence,11666,Non-Hispanic American Indian/Alaska Native,2631.6,Male,All Cancer Sites Combined,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
80-84,216.1,427.2,36,Incidence,11666,Non-Hispanic American Indian/Alaska Native,308.6,Male,Colon and Rectum,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
80-84,98.1,254.3,19,Incidence,11666,Non-Hispanic American Indian/Alaska Native,162.9,Male,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
80-84,340.3,594.3,53,Incidence,11666,Non-Hispanic American Indian/Alaska Native,454.3,Male,Lung and Bronchus,2016
80-84,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
80-84,84.9,233.3,17,Incidence,11666,Non-Hispanic American Indian/Alaska Native,145.7,Male,Pancreas,2016
80-84,325.5,574.8,51,Incidence,11666,Non-Hispanic American Indian/Alaska Native,437.2,Male,Prostate,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
80-84,84.9,233.3,17,Incidence,11666,Non-Hispanic American Indian/Alaska Native,145.7,Male,Urinary Bladder,2016
85+,1607.4,2188.0,168,Incidence,8931,Non-Hispanic American Indian/Alaska Native,1881.1,Male,All Cancer Sites Combined,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
85+,110.9,304.8,17,Incidence,8931,Non-Hispanic American Indian/Alaska Native,190.3,Male,Colon and Rectum,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
85+,136.8,345.9,20,Incidence,8931,Non-Hispanic American Indian/Alaska Native,223.9,Male,Lung and Bronchus,2016
85+,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
85+,273.0,545.0,35,Incidence,8931,Non-Hispanic American Indian/Alaska Native,391.9,Male,Prostate,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
85+,128.1,332.2,19,Incidence,8931,Non-Hispanic American Indian/Alaska Native,212.7,Male,Urinary Bladder,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2016
<1,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2016
1-4,17.9,34.4,39,Incidence,154822,Non-Hispanic American Indian/Alaska Native,25.2,Male and Female,All Cancer Sites Combined,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
1-4,6.9,18.4,18,Incidence,154822,Non-Hispanic American Indian/Alaska Native,11.6,Male and Female,Leukemias,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,76000,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
1-4,~,~,~,Incidence,78822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
1-4,~,~,~,Incidence,154822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
10-14,8.5,19.0,26,Incidence,200577,Non-Hispanic American Indian/Alaska Native,13.0,Male and Female,All Cancer Sites Combined,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,99026,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
10-14,~,~,~,Incidence,101551,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
10-14,~,~,~,Incidence,200577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
15-19,14.2,26.9,41,Incidence,206805,Non-Hispanic American Indian/Alaska Native,19.8,Male and Female,All Cancer Sites Combined,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,102084,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
15-19,~,~,~,Incidence,104721,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
15-19,~,~,~,Incidence,206805,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
20-24,27.7,43.9,77,Incidence,219358,Non-Hispanic American Indian/Alaska Native,35.1,Male and Female,All Cancer Sites Combined,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,107654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
20-24,~,~,~,Incidence,111704,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
20-24,9.6,25.5,18,Incidence,111704,Non-Hispanic American Indian/Alaska Native,16.1,Male and Female,Testis,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
20-24,~,~,~,Incidence,219358,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
25-29,48.8,69.9,124,Incidence,211421,Non-Hispanic American Indian/Alaska Native,58.7,Male and Female,All Cancer Sites Combined,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,104267,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
25-29,~,~,~,Incidence,107154,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
25-29,10.0,26.5,18,Incidence,107154,Non-Hispanic American Indian/Alaska Native,16.8,Male and Female,Testis,2016
25-29,6.9,16.3,23,Incidence,211421,Non-Hispanic American Indian/Alaska Native,10.9,Male and Female,Thyroid,2016
25-29,~,~,~,Incidence,211421,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
30-34,95.7,126.8,202,Incidence,182889,Non-Hispanic American Indian/Alaska Native,110.4,Male and Female,All Cancer Sites Combined,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
30-34,5.8,15.6,18,Incidence,182889,Non-Hispanic American Indian/Alaska Native,9.8,Male and Female,Colon and Rectum,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
30-34,19.3,42.6,27,Incidence,92175,Non-Hispanic American Indian/Alaska Native,29.3,Male and Female,Female Breast,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
30-34,5.4,14.9,17,Incidence,182889,Non-Hispanic American Indian/Alaska Native,9.3,Male and Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
30-34,19.3,42.6,27,Incidence,92175,Non-Hispanic American Indian/Alaska Native,29.3,Male and Female,Male and Female Breast,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
30-34,~,~,~,Incidence,92175,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
30-34,~,~,~,Incidence,90714,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
30-34,10.9,30.0,17,Incidence,90714,Non-Hispanic American Indian/Alaska Native,18.7,Male and Female,Testis,2016
30-34,13.8,27.3,36,Incidence,182889,Non-Hispanic American Indian/Alaska Native,19.7,Male and Female,Thyroid,2016
30-34,~,~,~,Incidence,182889,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
35-39,148.7,188.6,281,Incidence,167497,Non-Hispanic American Indian/Alaska Native,167.8,Male and Female,All Cancer Sites Combined,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
35-39,14.4,36.3,20,Incidence,85074,Non-Hispanic American Indian/Alaska Native,23.5,Male and Female,Cervix,2016
35-39,13.6,27.7,33,Incidence,167497,Non-Hispanic American Indian/Alaska Native,19.7,Male and Female,Colon and Rectum,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
35-39,41.6,74.8,48,Incidence,85074,Non-Hispanic American Indian/Alaska Native,56.4,Male and Female,Female Breast,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
35-39,13.1,27.0,32,Incidence,167497,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
35-39,41.6,74.8,48,Incidence,85074,Non-Hispanic American Indian/Alaska Native,56.4,Male and Female,Male and Female Breast,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
35-39,~,~,~,Incidence,85074,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
35-39,~,~,~,Incidence,82423,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
35-39,15.1,29.8,36,Incidence,167497,Non-Hispanic American Indian/Alaska Native,21.5,Male and Female,Thyroid,2016
35-39,~,~,~,Incidence,167497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
40-44,237.8,289.5,406,Incidence,154547,Non-Hispanic American Indian/Alaska Native,262.7,Male and Female,All Cancer Sites Combined,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
40-44,24.6,43.4,51,Incidence,154547,Non-Hispanic American Indian/Alaska Native,33.0,Male and Female,Colon and Rectum,2016
40-44,31.9,63.1,36,Incidence,78941,Non-Hispanic American Indian/Alaska Native,45.6,Male and Female,"Corpus and Uterus, NOS",2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
40-44,103.1,154.1,100,Incidence,78941,Non-Hispanic American Indian/Alaska Native,126.7,Male and Female,Female Breast,2016
40-44,23.6,51.3,28,Incidence,78941,Non-Hispanic American Indian/Alaska Native,35.5,Male and Female,"Female Breast, <i>in situ</i>",2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
40-44,12.0,26.2,28,Incidence,154547,Non-Hispanic American Indian/Alaska Native,18.1,Male and Female,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
40-44,103.1,154.1,100,Incidence,78941,Non-Hispanic American Indian/Alaska Native,126.7,Male and Female,Male and Female Breast,2016
40-44,23.6,51.3,28,Incidence,78941,Non-Hispanic American Indian/Alaska Native,35.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
40-44,8.4,20.8,21,Incidence,154547,Non-Hispanic American Indian/Alaska Native,13.6,Male and Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
40-44,~,~,~,Incidence,78941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
40-44,~,~,~,Incidence,75606,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
40-44,12.6,26.9,29,Incidence,154547,Non-Hispanic American Indian/Alaska Native,18.8,Male and Female,Thyroid,2016
40-44,~,~,~,Incidence,154547,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
45-49,342.1,402.2,598,Incidence,161076,Non-Hispanic American Indian/Alaska Native,371.3,Male and Female,All Cancer Sites Combined,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
45-49,35.0,56.3,72,Incidence,161076,Non-Hispanic American Indian/Alaska Native,44.7,Male and Female,Colon and Rectum,2016
45-49,17.6,41.7,23,Incidence,82677,Non-Hispanic American Indian/Alaska Native,27.8,Male and Female,"Corpus and Uterus, NOS",2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
45-49,136.9,193.3,135,Incidence,82677,Non-Hispanic American Indian/Alaska Native,163.3,Male and Female,Female Breast,2016
45-49,24.5,51.8,30,Incidence,82677,Non-Hispanic American Indian/Alaska Native,36.3,Male and Female,"Female Breast, <i>in situ</i>",2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
45-49,27.9,47.2,59,Incidence,161076,Non-Hispanic American Indian/Alaska Native,36.6,Male and Female,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
45-49,6.1,16.9,17,Incidence,161076,Non-Hispanic American Indian/Alaska Native,10.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
45-49,16.7,32.4,38,Incidence,161076,Non-Hispanic American Indian/Alaska Native,23.6,Male and Female,Lung and Bronchus,2016
45-49,136.9,193.3,135,Incidence,82677,Non-Hispanic American Indian/Alaska Native,163.3,Male and Female,Male and Female Breast,2016
45-49,24.5,51.8,30,Incidence,82677,Non-Hispanic American Indian/Alaska Native,36.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
45-49,6.1,16.9,17,Incidence,161076,Non-Hispanic American Indian/Alaska Native,10.6,Male and Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
45-49,8.6,20.7,22,Incidence,161076,Non-Hispanic American Indian/Alaska Native,13.7,Male and Female,Non-Hodgkin Lymphoma,2016
45-49,6.1,16.9,17,Incidence,161076,Non-Hispanic American Indian/Alaska Native,10.6,Male and Female,Oral Cavity and Pharynx,2016
45-49,~,~,~,Incidence,82677,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
45-49,14.6,37.8,19,Incidence,78399,Non-Hispanic American Indian/Alaska Native,24.2,Male and Female,Prostate,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
45-49,~,~,~,Incidence,78399,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
45-49,15.1,30.2,35,Incidence,161076,Non-Hispanic American Indian/Alaska Native,21.7,Male and Female,Thyroid,2016
45-49,~,~,~,Incidence,161076,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
5-9,12.5,24.8,36,Incidence,201058,Non-Hispanic American Indian/Alaska Native,17.9,Male and Female,All Cancer Sites Combined,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,99463,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
5-9,~,~,~,Incidence,101595,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
5-9,~,~,~,Incidence,201058,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
50-54,523.6,594.5,968,Incidence,173401,Non-Hispanic American Indian/Alaska Native,558.2,Male and Female,All Cancer Sites Combined,2016
50-54,~,~,~,Incidence,173401,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
50-54,10.2,28.9,16,Incidence,90039,Non-Hispanic American Indian/Alaska Native,17.8,Male and Female,Cervix,2016
50-54,67.9,95.3,140,Incidence,173401,Non-Hispanic American Indian/Alaska Native,80.7,Male and Female,Colon and Rectum,2016
50-54,47.0,80.8,56,Incidence,90039,Non-Hispanic American Indian/Alaska Native,62.2,Male and Female,"Corpus and Uterus, NOS",2016
50-54,~,~,~,Incidence,173401,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
50-54,147.1,202.7,156,Incidence,90039,Non-Hispanic American Indian/Alaska Native,173.3,Male and Female,Female Breast,2016
50-54,26.2,52.8,34,Incidence,90039,Non-Hispanic American Indian/Alaska Native,37.8,Male and Female,"Female Breast, <i>in situ</i>",2016
50-54,~,~,~,Incidence,173401,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,173401,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
50-54,31.5,51.0,70,Incidence,173401,Non-Hispanic American Indian/Alaska Native,40.4,Male and Female,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,173401,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
50-54,8.0,19.2,22,Incidence,173401,Non-Hispanic American Indian/Alaska Native,12.7,Male and Female,Leukemias,2016
50-54,16.5,31.4,40,Incidence,173401,Non-Hispanic American Indian/Alaska Native,23.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
50-54,36.1,56.8,79,Incidence,173401,Non-Hispanic American Indian/Alaska Native,45.6,Male and Female,Lung and Bronchus,2016
50-54,147.1,202.7,156,Incidence,90039,Non-Hispanic American Indian/Alaska Native,173.3,Male and Female,Male and Female Breast,2016
50-54,26.2,52.8,34,Incidence,90039,Non-Hispanic American Indian/Alaska Native,37.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
50-54,6.6,17.1,19,Incidence,173401,Non-Hispanic American Indian/Alaska Native,11.0,Male and Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,173401,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
50-54,6.2,16.4,18,Incidence,173401,Non-Hispanic American Indian/Alaska Native,10.4,Male and Female,Myeloma,2016
50-54,13.6,27.4,34,Incidence,173401,Non-Hispanic American Indian/Alaska Native,19.6,Male and Female,Non-Hodgkin Lymphoma,2016
50-54,16.5,31.4,40,Incidence,173401,Non-Hispanic American Indian/Alaska Native,23.1,Male and Female,Oral Cavity and Pharynx,2016
50-54,11.0,30.2,17,Incidence,90039,Non-Hispanic American Indian/Alaska Native,18.9,Male and Female,Ovary,2016
50-54,12.6,26.1,32,Incidence,173401,Non-Hispanic American Indian/Alaska Native,18.5,Male and Female,Pancreas,2016
50-54,47.6,83.2,53,Incidence,83362,Non-Hispanic American Indian/Alaska Native,63.6,Male and Female,Prostate,2016
50-54,6.2,16.4,18,Incidence,173401,Non-Hispanic American Indian/Alaska Native,10.4,Male and Female,Stomach,2016
50-54,~,~,~,Incidence,83362,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
50-54,14.1,28.1,35,Incidence,173401,Non-Hispanic American Indian/Alaska Native,20.2,Male and Female,Thyroid,2016
50-54,5.7,15.7,17,Incidence,173401,Non-Hispanic American Indian/Alaska Native,9.8,Male and Female,Urinary Bladder,2016
55-59,765.8,851.6,1379,Incidence,170699,Non-Hispanic American Indian/Alaska Native,807.9,Male and Female,All Cancer Sites Combined,2016
55-59,~,~,~,Incidence,170699,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
55-59,~,~,~,Incidence,90281,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
55-59,77.1,106.3,155,Incidence,170699,Non-Hispanic American Indian/Alaska Native,90.8,Male and Female,Colon and Rectum,2016
55-59,54.6,90.5,64,Incidence,90281,Non-Hispanic American Indian/Alaska Native,70.9,Male and Female,"Corpus and Uterus, NOS",2016
55-59,8.1,19.5,22,Incidence,170699,Non-Hispanic American Indian/Alaska Native,12.9,Male and Female,Esophagus,2016
55-59,216.7,282.8,224,Incidence,90281,Non-Hispanic American Indian/Alaska Native,248.1,Male and Female,Female Breast,2016
55-59,32.6,61.6,41,Incidence,90281,Non-Hispanic American Indian/Alaska Native,45.4,Male and Female,"Female Breast, <i>in situ</i>",2016
55-59,~,~,~,Incidence,170699,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,170699,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
55-59,47.1,70.6,99,Incidence,170699,Non-Hispanic American Indian/Alaska Native,58.0,Male and Female,Kidney and Renal Pelvis,2016
55-59,~,~,~,Incidence,170699,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
55-59,11.4,24.4,29,Incidence,170699,Non-Hispanic American Indian/Alaska Native,17.0,Male and Female,Leukemias,2016
55-59,41.9,64.2,89,Incidence,170699,Non-Hispanic American Indian/Alaska Native,52.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
55-59,81.9,112.0,164,Incidence,170699,Non-Hispanic American Indian/Alaska Native,96.1,Male and Female,Lung and Bronchus,2016
55-59,216.7,282.8,224,Incidence,90281,Non-Hispanic American Indian/Alaska Native,248.1,Male and Female,Male and Female Breast,2016
55-59,32.6,61.6,41,Incidence,90281,Non-Hispanic American Indian/Alaska Native,45.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
55-59,7.2,18.1,20,Incidence,170699,Non-Hispanic American Indian/Alaska Native,11.7,Male and Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,170699,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
55-59,8.1,19.5,22,Incidence,170699,Non-Hispanic American Indian/Alaska Native,12.9,Male and Female,Myeloma,2016
55-59,16.7,31.9,40,Incidence,170699,Non-Hispanic American Indian/Alaska Native,23.4,Male and Female,Non-Hodgkin Lymphoma,2016
55-59,24.3,41.9,55,Incidence,170699,Non-Hispanic American Indian/Alaska Native,32.2,Male and Female,Oral Cavity and Pharynx,2016
55-59,14.4,35.6,21,Incidence,90281,Non-Hispanic American Indian/Alaska Native,23.3,Male and Female,Ovary,2016
55-59,12.3,25.8,31,Incidence,170699,Non-Hispanic American Indian/Alaska Native,18.2,Male and Female,Pancreas,2016
55-59,115.8,168.9,113,Incidence,80418,Non-Hispanic American Indian/Alaska Native,140.5,Male and Female,Prostate,2016
55-59,12.8,26.5,32,Incidence,170699,Non-Hispanic American Indian/Alaska Native,18.7,Male and Female,Stomach,2016
55-59,~,~,~,Incidence,80418,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
55-59,7.6,18.8,21,Incidence,170699,Non-Hispanic American Indian/Alaska Native,12.3,Male and Female,Thyroid,2016
55-59,17.7,33.3,42,Incidence,170699,Non-Hispanic American Indian/Alaska Native,24.6,Male and Female,Urinary Bladder,2016
60-64,975.4,1081.8,1453,Incidence,141399,Non-Hispanic American Indian/Alaska Native,1027.6,Male and Female,All Cancer Sites Combined,2016
60-64,~,~,~,Incidence,141399,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
60-64,~,~,~,Incidence,75728,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
60-64,97.0,132.9,161,Incidence,141399,Non-Hispanic American Indian/Alaska Native,113.9,Male and Female,Colon and Rectum,2016
60-64,45.6,82.5,47,Incidence,75728,Non-Hispanic American Indian/Alaska Native,62.1,Male and Female,"Corpus and Uterus, NOS",2016
60-64,12.6,27.8,27,Incidence,141399,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Esophagus,2016
60-64,230.0,304.8,201,Incidence,75728,Non-Hispanic American Indian/Alaska Native,265.4,Male and Female,Female Breast,2016
60-64,44.5,81.0,46,Incidence,75728,Non-Hispanic American Indian/Alaska Native,60.7,Male and Female,"Female Breast, <i>in situ</i>",2016
60-64,~,~,~,Incidence,141399,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,141399,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
60-64,42.3,67.3,76,Incidence,141399,Non-Hispanic American Indian/Alaska Native,53.7,Male and Female,Kidney and Renal Pelvis,2016
60-64,7.0,19.2,17,Incidence,141399,Non-Hispanic American Indian/Alaska Native,12.0,Male and Female,Larynx,2016
60-64,13.7,29.5,29,Incidence,141399,Non-Hispanic American Indian/Alaska Native,20.5,Male and Female,Leukemias,2016
60-64,51.8,79.0,91,Incidence,141399,Non-Hispanic American Indian/Alaska Native,64.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
60-64,132.4,173.8,215,Incidence,141399,Non-Hispanic American Indian/Alaska Native,152.1,Male and Female,Lung and Bronchus,2016
60-64,230.0,304.8,201,Incidence,75728,Non-Hispanic American Indian/Alaska Native,265.4,Male and Female,Male and Female Breast,2016
60-64,44.5,81.0,46,Incidence,75728,Non-Hispanic American Indian/Alaska Native,60.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
60-64,9.2,22.7,21,Incidence,141399,Non-Hispanic American Indian/Alaska Native,14.9,Male and Female,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,141399,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
60-64,12.6,27.8,27,Incidence,141399,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Myeloma,2016
60-64,24.4,44.2,47,Incidence,141399,Non-Hispanic American Indian/Alaska Native,33.2,Male and Female,Non-Hodgkin Lymphoma,2016
60-64,23.8,43.4,46,Incidence,141399,Non-Hispanic American Indian/Alaska Native,32.5,Male and Female,Oral Cavity and Pharynx,2016
60-64,18.2,44.0,22,Incidence,75728,Non-Hispanic American Indian/Alaska Native,29.1,Male and Female,Ovary,2016
60-64,23.2,42.6,45,Incidence,141399,Non-Hispanic American Indian/Alaska Native,31.8,Male and Female,Pancreas,2016
60-64,198.9,274.6,154,Incidence,65671,Non-Hispanic American Indian/Alaska Native,234.5,Male and Female,Prostate,2016
60-64,14.9,31.1,31,Incidence,141399,Non-Hispanic American Indian/Alaska Native,21.9,Male and Female,Stomach,2016
60-64,~,~,~,Incidence,65671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
60-64,17.8,35.2,36,Incidence,141399,Non-Hispanic American Indian/Alaska Native,25.5,Male and Female,Thyroid,2016
60-64,15.5,31.9,32,Incidence,141399,Non-Hispanic American Indian/Alaska Native,22.6,Male and Female,Urinary Bladder,2016
65-69,1312.7,1451.6,1539,Incidence,111453,Non-Hispanic American Indian/Alaska Native,1380.9,Male and Female,All Cancer Sites Combined,2016
65-69,12.4,29.9,22,Incidence,111453,Non-Hispanic American Indian/Alaska Native,19.7,Male and Female,Brain and Other Nervous System,2016
65-69,~,~,~,Incidence,59048,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
65-69,106.5,149.2,141,Incidence,111453,Non-Hispanic American Indian/Alaska Native,126.5,Male and Female,Colon and Rectum,2016
65-69,57.0,103.9,46,Incidence,59048,Non-Hispanic American Indian/Alaska Native,77.9,Male and Female,"Corpus and Uterus, NOS",2016
65-69,16.7,36.3,28,Incidence,111453,Non-Hispanic American Indian/Alaska Native,25.1,Male and Female,Esophagus,2016
65-69,329.7,430.6,223,Incidence,59048,Non-Hispanic American Indian/Alaska Native,377.7,Male and Female,Female Breast,2016
65-69,55.6,102.0,45,Incidence,59048,Non-Hispanic American Indian/Alaska Native,76.2,Male and Female,"Female Breast, <i>in situ</i>",2016
65-69,~,~,~,Incidence,111453,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,111453,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
65-69,69.0,104.2,95,Incidence,111453,Non-Hispanic American Indian/Alaska Native,85.2,Male and Female,Kidney and Renal Pelvis,2016
65-69,~,~,~,Incidence,111453,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
65-69,16.7,36.3,28,Incidence,111453,Non-Hispanic American Indian/Alaska Native,25.1,Male and Female,Leukemias,2016
65-69,54.5,86.3,77,Incidence,111453,Non-Hispanic American Indian/Alaska Native,69.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
65-69,181.4,235.8,231,Incidence,111453,Non-Hispanic American Indian/Alaska Native,207.3,Male and Female,Lung and Bronchus,2016
65-69,329.7,430.6,223,Incidence,59048,Non-Hispanic American Indian/Alaska Native,377.7,Male and Female,Male and Female Breast,2016
65-69,55.6,102.0,45,Incidence,59048,Non-Hispanic American Indian/Alaska Native,76.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
65-69,18.9,39.5,31,Incidence,111453,Non-Hispanic American Indian/Alaska Native,27.8,Male and Female,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,111453,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
65-69,9.6,25.5,18,Incidence,111453,Non-Hispanic American Indian/Alaska Native,16.2,Male and Female,Myeloma,2016
65-69,33.3,59.1,50,Incidence,111453,Non-Hispanic American Indian/Alaska Native,44.9,Male and Female,Non-Hodgkin Lymphoma,2016
65-69,21.1,42.6,34,Incidence,111453,Non-Hispanic American Indian/Alaska Native,30.5,Male and Female,Oral Cavity and Pharynx,2016
65-69,16.8,46.1,17,Incidence,59048,Non-Hispanic American Indian/Alaska Native,28.8,Male and Female,Ovary,2016
65-69,27.2,50.9,42,Incidence,111453,Non-Hispanic American Indian/Alaska Native,37.7,Male and Female,Pancreas,2016
65-69,367.9,481.1,221,Incidence,52405,Non-Hispanic American Indian/Alaska Native,421.7,Male and Female,Prostate,2016
65-69,18.2,38.4,30,Incidence,111453,Non-Hispanic American Indian/Alaska Native,26.9,Male and Female,Stomach,2016
65-69,~,~,~,Incidence,52405,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
65-69,13.1,31.0,23,Incidence,111453,Non-Hispanic American Indian/Alaska Native,20.6,Male and Female,Thyroid,2016
65-69,34.8,61.2,52,Incidence,111453,Non-Hispanic American Indian/Alaska Native,46.7,Male and Female,Urinary Bladder,2016
70-74,1529.3,1718.2,1150,Incidence,70915,Non-Hispanic American Indian/Alaska Native,1621.7,Male and Female,All Cancer Sites Combined,2016
70-74,~,~,~,Incidence,70915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
70-74,~,~,~,Incidence,38219,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
70-74,135.2,196.2,116,Incidence,70915,Non-Hispanic American Indian/Alaska Native,163.6,Male and Female,Colon and Rectum,2016
70-74,42.3,96.6,25,Incidence,38219,Non-Hispanic American Indian/Alaska Native,65.4,Male and Female,"Corpus and Uterus, NOS",2016
70-74,~,~,~,Incidence,70915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
70-74,286.6,406.7,131,Incidence,38219,Non-Hispanic American Indian/Alaska Native,342.8,Male and Female,Female Breast,2016
70-74,32.0,80.8,20,Incidence,38219,Non-Hispanic American Indian/Alaska Native,52.3,Male and Female,"Female Breast, <i>in situ</i>",2016
70-74,~,~,~,Incidence,70915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,70915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
70-74,63.3,107.3,59,Incidence,70915,Non-Hispanic American Indian/Alaska Native,83.2,Male and Female,Kidney and Renal Pelvis,2016
70-74,~,~,~,Incidence,70915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
70-74,23.9,53.7,26,Incidence,70915,Non-Hispanic American Indian/Alaska Native,36.7,Male and Female,Leukemias,2016
70-74,46.3,84.9,45,Incidence,70915,Non-Hispanic American Indian/Alaska Native,63.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
70-74,261.4,343.5,213,Incidence,70915,Non-Hispanic American Indian/Alaska Native,300.4,Male and Female,Lung and Bronchus,2016
70-74,286.6,406.7,131,Incidence,38219,Non-Hispanic American Indian/Alaska Native,342.8,Male and Female,Male and Female Breast,2016
70-74,32.0,80.8,20,Incidence,38219,Non-Hispanic American Indian/Alaska Native,52.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
70-74,14.0,38.4,17,Incidence,70915,Non-Hispanic American Indian/Alaska Native,24.0,Male and Female,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,70915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
70-74,20.6,48.7,23,Incidence,70915,Non-Hispanic American Indian/Alaska Native,32.4,Male and Female,Myeloma,2016
70-74,41.5,78.4,41,Incidence,70915,Non-Hispanic American Indian/Alaska Native,57.8,Male and Female,Non-Hodgkin Lymphoma,2016
70-74,32.0,65.4,33,Incidence,70915,Non-Hispanic American Indian/Alaska Native,46.5,Male and Female,Oral Cavity and Pharynx,2016
70-74,27.9,74.4,18,Incidence,38219,Non-Hispanic American Indian/Alaska Native,47.1,Male and Female,Ovary,2016
70-74,41.5,78.4,41,Incidence,70915,Non-Hispanic American Indian/Alaska Native,57.8,Male and Female,Pancreas,2016
70-74,337.8,478.8,132,Incidence,32696,Non-Hispanic American Indian/Alaska Native,403.7,Male and Female,Prostate,2016
70-74,18.3,45.3,21,Incidence,70915,Non-Hispanic American Indian/Alaska Native,29.6,Male and Female,Stomach,2016
70-74,~,~,~,Incidence,32696,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
70-74,12.9,36.6,16,Incidence,70915,Non-Hispanic American Indian/Alaska Native,22.6,Male and Female,Thyroid,2016
70-74,48.7,88.1,47,Incidence,70915,Non-Hispanic American Indian/Alaska Native,66.3,Male and Female,Urinary Bladder,2016
75-79,1796.0,2049.7,895,Incidence,46622,Non-Hispanic American Indian/Alaska Native,1919.7,Male and Female,All Cancer Sites Combined,2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
75-79,170.7,256.2,98,Incidence,46622,Non-Hispanic American Indian/Alaska Native,210.2,Male and Female,Colon and Rectum,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
75-79,283.0,431.5,91,Incidence,25891,Non-Hispanic American Indian/Alaska Native,351.5,Male and Female,Female Breast,2016
75-79,53.3,128.6,22,Incidence,25891,Non-Hispanic American Indian/Alaska Native,85.0,Male and Female,"Female Breast, <i>in situ</i>",2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
75-79,50.5,101.9,34,Incidence,46622,Non-Hispanic American Indian/Alaska Native,72.9,Male and Female,Kidney and Renal Pelvis,2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
75-79,21.2,58.4,17,Incidence,46622,Non-Hispanic American Indian/Alaska Native,36.5,Male and Female,Leukemias,2016
75-79,52.3,104.4,35,Incidence,46622,Non-Hispanic American Indian/Alaska Native,75.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
75-79,339.7,456.0,184,Incidence,46622,Non-Hispanic American Indian/Alaska Native,394.7,Male and Female,Lung and Bronchus,2016
75-79,283.0,431.5,91,Incidence,25891,Non-Hispanic American Indian/Alaska Native,351.5,Male and Female,Male and Female Breast,2016
75-79,53.3,128.6,22,Incidence,25891,Non-Hispanic American Indian/Alaska Native,85.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
75-79,22.9,61.0,18,Incidence,46622,Non-Hispanic American Indian/Alaska Native,38.6,Male and Female,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
75-79,22.9,61.0,18,Incidence,46622,Non-Hispanic American Indian/Alaska Native,38.6,Male and Female,Myeloma,2016
75-79,68.6,126.7,44,Incidence,46622,Non-Hispanic American Indian/Alaska Native,94.4,Male and Female,Non-Hodgkin Lymphoma,2016
75-79,24.5,63.6,19,Incidence,46622,Non-Hispanic American Indian/Alaska Native,40.8,Male and Female,Oral Cavity and Pharynx,2016
75-79,~,~,~,Incidence,25891,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
75-79,43.4,91.9,30,Incidence,46622,Non-Hispanic American Indian/Alaska Native,64.3,Male and Female,Pancreas,2016
75-79,331.8,512.3,86,Incidence,20731,Non-Hispanic American Indian/Alaska Native,414.8,Male and Female,Prostate,2016
75-79,24.5,63.6,19,Incidence,46622,Non-Hispanic American Indian/Alaska Native,40.8,Male and Female,Stomach,2016
75-79,~,~,~,Incidence,20731,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
75-79,~,~,~,Incidence,46622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
75-79,72.2,131.6,46,Incidence,46622,Non-Hispanic American Indian/Alaska Native,98.7,Male and Female,Urinary Bladder,2016
80-84,1947.5,2290.9,595,Incidence,28146,Non-Hispanic American Indian/Alaska Native,2114.0,Male and Female,All Cancer Sites Combined,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
80-84,190.7,310.3,69,Incidence,28146,Non-Hispanic American Indian/Alaska Native,245.2,Male and Female,Colon and Rectum,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
80-84,235.7,413.8,52,Incidence,16480,Non-Hispanic American Indian/Alaska Native,315.5,Male and Female,Female Breast,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
80-84,80.7,164.7,33,Incidence,28146,Non-Hispanic American Indian/Alaska Native,117.2,Male and Female,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
80-84,37.9,101.1,18,Incidence,28146,Non-Hispanic American Indian/Alaska Native,64.0,Male and Female,Leukemias,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
80-84,308.3,455.5,106,Incidence,28146,Non-Hispanic American Indian/Alaska Native,376.6,Male and Female,Lung and Bronchus,2016
80-84,235.7,413.8,52,Incidence,16480,Non-Hispanic American Indian/Alaska Native,315.5,Male and Female,Male and Female Breast,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
80-84,74.8,156.3,31,Incidence,28146,Non-Hispanic American Indian/Alaska Native,110.1,Male and Female,Non-Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
80-84,~,~,~,Incidence,16480,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
80-84,80.7,164.7,33,Incidence,28146,Non-Hispanic American Indian/Alaska Native,117.2,Male and Female,Pancreas,2016
80-84,325.5,574.8,51,Incidence,11666,Non-Hispanic American Indian/Alaska Native,437.2,Male and Female,Prostate,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
80-84,~,~,~,Incidence,11666,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
80-84,~,~,~,Incidence,28146,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
80-84,66.1,143.8,28,Incidence,28146,Non-Hispanic American Indian/Alaska Native,99.5,Male and Female,Urinary Bladder,2016
85+,1417.7,1733.5,390,Incidence,24846,Non-Hispanic American Indian/Alaska Native,1569.7,Male and Female,All Cancer Sites Combined,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
85+,128.7,237.7,44,Incidence,24846,Non-Hispanic American Indian/Alaska Native,177.1,Male and Female,Colon and Rectum,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
85+,158.4,313.2,36,Incidence,15915,Non-Hispanic American Indian/Alaska Native,226.2,Male and Female,Female Breast,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
85+,42.9,114.5,18,Incidence,24846,Non-Hispanic American Indian/Alaska Native,72.4,Male and Female,Leukemias,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
85+,163.3,283.6,54,Incidence,24846,Non-Hispanic American Indian/Alaska Native,217.3,Male and Female,Lung and Bronchus,2016
85+,158.4,313.2,36,Incidence,15915,Non-Hispanic American Indian/Alaska Native,226.2,Male and Female,Male and Female Breast,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
85+,~,~,~,Incidence,15915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
85+,65.1,148.5,25,Incidence,24846,Non-Hispanic American Indian/Alaska Native,100.6,Male and Female,Pancreas,2016
85+,273.0,545.0,35,Incidence,8931,Non-Hispanic American Indian/Alaska Native,391.9,Male and Female,Prostate,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
85+,~,~,~,Incidence,8931,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
85+,~,~,~,Incidence,24846,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
85+,68.4,153.3,26,Incidence,24846,Non-Hispanic American Indian/Alaska Native,104.6,Male and Female,Urinary Bladder,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,18402,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2016
<1,~,~,~,Incidence,18972,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2016
<1,~,~,~,Incidence,37374,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2016
1-4,15.3,23.2,94,Incidence,496765,Non-Hispanic Asian/Pacific Islander,18.9,Female,All Cancer Sites Combined,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
1-4,6.6,12.1,45,Incidence,496765,Non-Hispanic Asian/Pacific Islander,9.1,Female,Leukemias,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
10-14,11.4,17.7,85,Incidence,593259,Non-Hispanic Asian/Pacific Islander,14.3,Female,All Cancer Sites Combined,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
15-19,16.9,24.3,121,Incidence,595764,Non-Hispanic Asian/Pacific Islander,20.3,Female,All Cancer Sites Combined,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
15-19,4.5,8.8,38,Incidence,595764,Non-Hispanic Asian/Pacific Islander,6.4,Female,Thyroid,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
20-24,25.2,33.4,201,Incidence,690687,Non-Hispanic Asian/Pacific Islander,29.1,Female,All Cancer Sites Combined,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
20-24,2.2,5.2,24,Incidence,690687,Non-Hispanic Asian/Pacific Islander,3.5,Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
20-24,1.5,4.1,18,Incidence,690687,Non-Hispanic Asian/Pacific Islander,2.6,Female,Ovary,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
20-24,8.2,13.1,72,Incidence,690687,Non-Hispanic Asian/Pacific Islander,10.4,Female,Thyroid,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
25-29,46.4,56.2,437,Incidence,854771,Non-Hispanic Asian/Pacific Islander,51.1,Female,All Cancer Sites Combined,2016
25-29,1.1,3.0,16,Incidence,854771,Non-Hispanic Asian/Pacific Islander,1.9,Female,Brain and Other Nervous System,2016
25-29,1.7,4.0,23,Incidence,854771,Non-Hispanic Asian/Pacific Islander,2.7,Female,Cervix,2016
25-29,1.1,3.0,16,Incidence,854771,Non-Hispanic Asian/Pacific Islander,1.9,Female,Colon and Rectum,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
25-29,6.9,11.0,75,Incidence,854771,Non-Hispanic Asian/Pacific Islander,8.8,Female,Female Breast,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
25-29,1.1,3.0,16,Incidence,854771,Non-Hispanic Asian/Pacific Islander,1.9,Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
25-29,2.0,4.5,26,Incidence,854771,Non-Hispanic Asian/Pacific Islander,3.0,Female,Leukemias,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
25-29,1.9,4.3,25,Incidence,854771,Non-Hispanic Asian/Pacific Islander,2.9,Female,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
25-29,14.6,20.3,148,Incidence,854771,Non-Hispanic Asian/Pacific Islander,17.3,Female,Thyroid,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
30-34,97.2,110.8,917,Incidence,883243,Non-Hispanic Asian/Pacific Islander,103.8,Female,All Cancer Sites Combined,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
30-34,5.3,8.9,61,Incidence,883243,Non-Hispanic Asian/Pacific Islander,6.9,Female,Cervix,2016
30-34,2.5,5.1,32,Incidence,883243,Non-Hispanic Asian/Pacific Islander,3.6,Female,Colon and Rectum,2016
30-34,3.5,6.6,43,Incidence,883243,Non-Hispanic Asian/Pacific Islander,4.9,Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
30-34,24.5,31.6,246,Incidence,883243,Non-Hispanic Asian/Pacific Islander,27.9,Female,Female Breast,2016
30-34,1.4,3.5,20,Incidence,883243,Non-Hispanic Asian/Pacific Islander,2.3,Female,"Female Breast, <i>in situ</i>",2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
30-34,2.6,5.2,33,Incidence,883243,Non-Hispanic Asian/Pacific Islander,3.7,Female,Leukemias,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.3,3.4,19,Incidence,883243,Non-Hispanic Asian/Pacific Islander,2.2,Female,Lung and Bronchus,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
30-34,3.2,6.2,40,Incidence,883243,Non-Hispanic Asian/Pacific Islander,4.5,Female,Non-Hodgkin Lymphoma,2016
30-34,1.1,3.1,17,Incidence,883243,Non-Hispanic Asian/Pacific Islander,1.9,Female,Oral Cavity and Pharynx,2016
30-34,2.3,4.8,30,Incidence,883243,Non-Hispanic Asian/Pacific Islander,3.4,Female,Ovary,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
30-34,26.1,33.4,261,Incidence,883243,Non-Hispanic Asian/Pacific Islander,29.6,Female,Thyroid,2016
30-34,~,~,~,Incidence,883243,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
35-39,145.3,162.3,1279,Incidence,832670,Non-Hispanic Asian/Pacific Islander,153.6,Female,All Cancer Sites Combined,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
35-39,6.8,10.9,72,Incidence,832670,Non-Hispanic Asian/Pacific Islander,8.6,Female,Cervix,2016
35-39,6.4,10.5,69,Incidence,832670,Non-Hispanic Asian/Pacific Islander,8.3,Female,Colon and Rectum,2016
35-39,7.4,11.7,78,Incidence,832670,Non-Hispanic Asian/Pacific Islander,9.4,Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
35-39,51.2,61.5,468,Incidence,832670,Non-Hispanic Asian/Pacific Islander,56.2,Female,Female Breast,2016
35-39,6.8,10.9,72,Incidence,832670,Non-Hispanic Asian/Pacific Islander,8.6,Female,"Female Breast, <i>in situ</i>",2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
35-39,1.8,4.3,24,Incidence,832670,Non-Hispanic Asian/Pacific Islander,2.9,Female,Leukemias,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
35-39,1.8,4.3,24,Incidence,832670,Non-Hispanic Asian/Pacific Islander,2.9,Female,Lung and Bronchus,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
35-39,3.8,7.1,44,Incidence,832670,Non-Hispanic Asian/Pacific Islander,5.3,Female,Non-Hodgkin Lymphoma,2016
35-39,2.4,5.1,30,Incidence,832670,Non-Hispanic Asian/Pacific Islander,3.6,Female,Oral Cavity and Pharynx,2016
35-39,2.7,5.6,33,Incidence,832670,Non-Hispanic Asian/Pacific Islander,4.0,Female,Ovary,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
35-39,1.6,3.9,21,Incidence,832670,Non-Hispanic Asian/Pacific Islander,2.5,Female,Stomach,2016
35-39,28.8,36.7,271,Incidence,832670,Non-Hispanic Asian/Pacific Islander,32.5,Female,Thyroid,2016
35-39,~,~,~,Incidence,832670,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
40-44,240.7,262.7,2022,Incidence,803986,Non-Hispanic Asian/Pacific Islander,251.5,Female,All Cancer Sites Combined,2016
40-44,1.1,3.2,16,Incidence,803986,Non-Hispanic Asian/Pacific Islander,2.0,Female,Brain and Other Nervous System,2016
40-44,8.9,13.6,89,Incidence,803986,Non-Hispanic Asian/Pacific Islander,11.1,Female,Cervix,2016
40-44,9.3,14.2,93,Incidence,803986,Non-Hispanic Asian/Pacific Islander,11.6,Female,Colon and Rectum,2016
40-44,13.7,19.5,132,Incidence,803986,Non-Hispanic Asian/Pacific Islander,16.4,Female,"Corpus and Uterus, NOS",2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
40-44,111.5,126.7,956,Incidence,803986,Non-Hispanic Asian/Pacific Islander,118.9,Female,Female Breast,2016
40-44,39.7,49.0,355,Incidence,803986,Non-Hispanic Asian/Pacific Islander,44.2,Female,"Female Breast, <i>in situ</i>",2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
40-44,1.5,3.8,20,Incidence,803986,Non-Hispanic Asian/Pacific Islander,2.5,Female,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
40-44,2.3,5.0,28,Incidence,803986,Non-Hispanic Asian/Pacific Islander,3.5,Female,Leukemias,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
40-44,5.4,9.2,57,Incidence,803986,Non-Hispanic Asian/Pacific Islander,7.1,Female,Lung and Bronchus,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
40-44,4.9,8.6,53,Incidence,803986,Non-Hispanic Asian/Pacific Islander,6.6,Female,Non-Hodgkin Lymphoma,2016
40-44,3.1,6.2,36,Incidence,803986,Non-Hispanic Asian/Pacific Islander,4.5,Female,Oral Cavity and Pharynx,2016
40-44,5.7,9.6,60,Incidence,803986,Non-Hispanic Asian/Pacific Islander,7.5,Female,Ovary,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
40-44,2.5,5.3,30,Incidence,803986,Non-Hispanic Asian/Pacific Islander,3.7,Female,Stomach,2016
40-44,32.5,41.0,294,Incidence,803986,Non-Hispanic Asian/Pacific Islander,36.6,Female,Thyroid,2016
40-44,~,~,~,Incidence,803986,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
45-49,362.3,390.5,2750,Incidence,730975,Non-Hispanic Asian/Pacific Islander,376.2,Female,All Cancer Sites Combined,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
45-49,9.8,15.0,89,Incidence,730975,Non-Hispanic Asian/Pacific Islander,12.2,Female,Cervix,2016
45-49,22.2,29.7,188,Incidence,730975,Non-Hispanic Asian/Pacific Islander,25.7,Female,Colon and Rectum,2016
45-49,24.5,32.3,206,Incidence,730975,Non-Hispanic Asian/Pacific Islander,28.2,Female,"Corpus and Uterus, NOS",2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
45-49,175.2,195.1,1352,Incidence,730975,Non-Hispanic Asian/Pacific Islander,185.0,Female,Female Breast,2016
45-49,62.4,74.5,499,Incidence,730975,Non-Hispanic Asian/Pacific Islander,68.3,Female,"Female Breast, <i>in situ</i>",2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
45-49,3.2,6.5,34,Incidence,730975,Non-Hispanic Asian/Pacific Islander,4.7,Female,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
45-49,3.4,6.8,36,Incidence,730975,Non-Hispanic Asian/Pacific Islander,4.9,Female,Leukemias,2016
45-49,2.0,4.7,23,Incidence,730975,Non-Hispanic Asian/Pacific Islander,3.1,Female,Liver and Intrahepatic Bile Duct,2016
45-49,10.4,15.7,94,Incidence,730975,Non-Hispanic Asian/Pacific Islander,12.9,Female,Lung and Bronchus,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
45-49,6.5,10.9,62,Incidence,730975,Non-Hispanic Asian/Pacific Islander,8.5,Female,Non-Hodgkin Lymphoma,2016
45-49,5.1,9.0,50,Incidence,730975,Non-Hispanic Asian/Pacific Islander,6.8,Female,Oral Cavity and Pharynx,2016
45-49,12.9,18.7,114,Incidence,730975,Non-Hispanic Asian/Pacific Islander,15.6,Female,Ovary,2016
45-49,2.9,6.0,31,Incidence,730975,Non-Hispanic Asian/Pacific Islander,4.2,Female,Pancreas,2016
45-49,3.9,7.5,40,Incidence,730975,Non-Hispanic Asian/Pacific Islander,5.5,Female,Stomach,2016
45-49,31.1,39.9,258,Incidence,730975,Non-Hispanic Asian/Pacific Islander,35.3,Female,Thyroid,2016
45-49,~,~,~,Incidence,730975,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
5-9,7.7,13.0,60,Incidence,591894,Non-Hispanic Asian/Pacific Islander,10.1,Female,All Cancer Sites Combined,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
5-9,2.3,5.6,22,Incidence,591894,Non-Hispanic Asian/Pacific Islander,3.7,Female,Leukemias,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
50-54,477.9,512.1,3244,Incidence,655608,Non-Hispanic Asian/Pacific Islander,494.8,Female,All Cancer Sites Combined,2016
50-54,2.7,6.0,27,Incidence,655608,Non-Hispanic Asian/Pacific Islander,4.1,Female,Brain and Other Nervous System,2016
50-54,8.5,13.7,71,Incidence,655608,Non-Hispanic Asian/Pacific Islander,10.8,Female,Cervix,2016
50-54,41.2,51.7,303,Incidence,655608,Non-Hispanic Asian/Pacific Islander,46.2,Female,Colon and Rectum,2016
50-54,43.9,54.8,322,Incidence,655608,Non-Hispanic Asian/Pacific Islander,49.1,Female,"Corpus and Uterus, NOS",2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
50-54,185.9,207.5,1288,Incidence,655608,Non-Hispanic Asian/Pacific Islander,196.5,Female,Female Breast,2016
50-54,68.9,82.3,494,Incidence,655608,Non-Hispanic Asian/Pacific Islander,75.3,Female,"Female Breast, <i>in situ</i>",2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
50-54,4.7,8.8,43,Incidence,655608,Non-Hispanic Asian/Pacific Islander,6.6,Female,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
50-54,4.7,8.8,43,Incidence,655608,Non-Hispanic Asian/Pacific Islander,6.6,Female,Leukemias,2016
50-54,4.2,8.1,39,Incidence,655608,Non-Hispanic Asian/Pacific Islander,5.9,Female,Liver and Intrahepatic Bile Duct,2016
50-54,25.3,33.7,192,Incidence,655608,Non-Hispanic Asian/Pacific Islander,29.3,Female,Lung and Bronchus,2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
50-54,2.7,6.0,27,Incidence,655608,Non-Hispanic Asian/Pacific Islander,4.1,Female,Myeloma,2016
50-54,12.4,18.6,100,Incidence,655608,Non-Hispanic Asian/Pacific Islander,15.3,Female,Non-Hodgkin Lymphoma,2016
50-54,7.5,12.5,64,Incidence,655608,Non-Hispanic Asian/Pacific Islander,9.8,Female,Oral Cavity and Pharynx,2016
50-54,19.5,27.0,151,Incidence,655608,Non-Hispanic Asian/Pacific Islander,23.0,Female,Ovary,2016
50-54,5.5,9.9,49,Incidence,655608,Non-Hispanic Asian/Pacific Islander,7.5,Female,Pancreas,2016
50-54,5.8,10.2,51,Incidence,655608,Non-Hispanic Asian/Pacific Islander,7.8,Female,Stomach,2016
50-54,37.4,47.5,277,Incidence,655608,Non-Hispanic Asian/Pacific Islander,42.3,Female,Thyroid,2016
50-54,~,~,~,Incidence,655608,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
55-59,553.3,591.7,3443,Incidence,601633,Non-Hispanic Asian/Pacific Islander,572.3,Female,All Cancer Sites Combined,2016
55-59,2.4,5.7,23,Incidence,601633,Non-Hispanic Asian/Pacific Islander,3.8,Female,Brain and Other Nervous System,2016
55-59,8.6,14.1,67,Incidence,601633,Non-Hispanic Asian/Pacific Islander,11.1,Female,Cervix,2016
55-59,38.1,48.8,260,Incidence,601633,Non-Hispanic Asian/Pacific Islander,43.2,Female,Colon and Rectum,2016
55-59,59.0,72.1,393,Incidence,601633,Non-Hispanic Asian/Pacific Islander,65.3,Female,"Corpus and Uterus, NOS",2016
55-59,~,~,~,Incidence,601633,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
55-59,211.4,235.5,1343,Incidence,601633,Non-Hispanic Asian/Pacific Islander,223.2,Female,Female Breast,2016
55-59,64.7,78.4,429,Incidence,601633,Non-Hispanic Asian/Pacific Islander,71.3,Female,"Female Breast, <i>in situ</i>",2016
55-59,~,~,~,Incidence,601633,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,601633,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
55-59,6.0,10.8,49,Incidence,601633,Non-Hispanic Asian/Pacific Islander,8.1,Female,Kidney and Renal Pelvis,2016
55-59,~,~,~,Incidence,601633,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
55-59,7.2,12.3,57,Incidence,601633,Non-Hispanic Asian/Pacific Islander,9.5,Female,Leukemias,2016
55-59,7.9,13.2,62,Incidence,601633,Non-Hispanic Asian/Pacific Islander,10.3,Female,Liver and Intrahepatic Bile Duct,2016
55-59,36.9,47.4,252,Incidence,601633,Non-Hispanic Asian/Pacific Islander,41.9,Female,Lung and Bronchus,2016
55-59,~,~,~,Incidence,601633,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,601633,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
55-59,3.2,6.9,29,Incidence,601633,Non-Hispanic Asian/Pacific Islander,4.8,Female,Myeloma,2016
55-59,13.5,20.2,100,Incidence,601633,Non-Hispanic Asian/Pacific Islander,16.6,Female,Non-Hodgkin Lymphoma,2016
55-59,8.3,13.8,65,Incidence,601633,Non-Hispanic Asian/Pacific Islander,10.8,Female,Oral Cavity and Pharynx,2016
55-59,16.7,24.0,121,Incidence,601633,Non-Hispanic Asian/Pacific Islander,20.1,Female,Ovary,2016
55-59,7.3,12.5,58,Incidence,601633,Non-Hispanic Asian/Pacific Islander,9.6,Female,Pancreas,2016
55-59,11.1,17.3,84,Incidence,601633,Non-Hispanic Asian/Pacific Islander,14.0,Female,Stomach,2016
55-59,32.5,42.4,224,Incidence,601633,Non-Hispanic Asian/Pacific Islander,37.2,Female,Thyroid,2016
55-59,3.6,7.5,32,Incidence,601633,Non-Hispanic Asian/Pacific Islander,5.3,Female,Urinary Bladder,2016
60-64,713.6,759.7,3951,Incidence,536573,Non-Hispanic Asian/Pacific Islander,736.3,Female,All Cancer Sites Combined,2016
60-64,3.9,8.2,31,Incidence,536573,Non-Hispanic Asian/Pacific Islander,5.8,Female,Brain and Other Nervous System,2016
60-64,9.8,16.1,68,Incidence,536573,Non-Hispanic Asian/Pacific Islander,12.7,Female,Cervix,2016
60-64,49.4,62.2,298,Incidence,536573,Non-Hispanic Asian/Pacific Islander,55.5,Female,Colon and Rectum,2016
60-64,62.3,76.5,371,Incidence,536573,Non-Hispanic Asian/Pacific Islander,69.1,Female,"Corpus and Uterus, NOS",2016
60-64,~,~,~,Incidence,536573,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
60-64,255.2,283.2,1443,Incidence,536573,Non-Hispanic Asian/Pacific Islander,268.9,Female,Female Breast,2016
60-64,68.8,83.8,408,Incidence,536573,Non-Hispanic Asian/Pacific Islander,76.0,Female,"Female Breast, <i>in situ</i>",2016
60-64,~,~,~,Incidence,536573,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,536573,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
60-64,12.3,19.2,83,Incidence,536573,Non-Hispanic Asian/Pacific Islander,15.5,Female,Kidney and Renal Pelvis,2016
60-64,~,~,~,Incidence,536573,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
60-64,8.0,13.8,57,Incidence,536573,Non-Hispanic Asian/Pacific Islander,10.6,Female,Leukemias,2016
60-64,12.7,19.6,85,Incidence,536573,Non-Hispanic Asian/Pacific Islander,15.8,Female,Liver and Intrahepatic Bile Duct,2016
60-64,69.7,84.8,413,Incidence,536573,Non-Hispanic Asian/Pacific Islander,77.0,Female,Lung and Bronchus,2016
60-64,~,~,~,Incidence,536573,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,536573,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
60-64,5.6,10.6,42,Incidence,536573,Non-Hispanic Asian/Pacific Islander,7.8,Female,Myeloma,2016
60-64,24.7,34.0,156,Incidence,536573,Non-Hispanic Asian/Pacific Islander,29.1,Female,Non-Hodgkin Lymphoma,2016
60-64,10.2,16.5,70,Incidence,536573,Non-Hispanic Asian/Pacific Islander,13.0,Female,Oral Cavity and Pharynx,2016
60-64,18.7,26.9,121,Incidence,536573,Non-Hispanic Asian/Pacific Islander,22.6,Female,Ovary,2016
60-64,15.5,23.1,102,Incidence,536573,Non-Hispanic Asian/Pacific Islander,19.0,Female,Pancreas,2016
60-64,12.0,18.8,81,Incidence,536573,Non-Hispanic Asian/Pacific Islander,15.1,Female,Stomach,2016
60-64,33.7,44.4,208,Incidence,536573,Non-Hispanic Asian/Pacific Islander,38.8,Female,Thyroid,2016
60-64,5.3,10.2,40,Incidence,536573,Non-Hispanic Asian/Pacific Islander,7.5,Female,Urinary Bladder,2016
65-69,840.1,894.9,3880,Incidence,447405,Non-Hispanic Asian/Pacific Islander,867.2,Female,All Cancer Sites Combined,2016
65-69,4.2,9.0,28,Incidence,447405,Non-Hispanic Asian/Pacific Islander,6.3,Female,Brain and Other Nervous System,2016
65-69,7.0,12.9,43,Incidence,447405,Non-Hispanic Asian/Pacific Islander,9.6,Female,Cervix,2016
65-69,72.2,89.0,359,Incidence,447405,Non-Hispanic Asian/Pacific Islander,80.2,Female,Colon and Rectum,2016
65-69,62.2,77.9,312,Incidence,447405,Non-Hispanic Asian/Pacific Islander,69.7,Female,"Corpus and Uterus, NOS",2016
65-69,~,~,~,Incidence,447405,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
65-69,279.8,311.8,1322,Incidence,447405,Non-Hispanic Asian/Pacific Islander,295.5,Female,Female Breast,2016
65-69,87.5,105.9,431,Incidence,447405,Non-Hispanic Asian/Pacific Islander,96.3,Female,"Female Breast, <i>in situ</i>",2016
65-69,~,~,~,Incidence,447405,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,447405,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
65-69,13.6,21.5,77,Incidence,447405,Non-Hispanic Asian/Pacific Islander,17.2,Female,Kidney and Renal Pelvis,2016
65-69,~,~,~,Incidence,447405,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
65-69,9.5,16.3,56,Incidence,447405,Non-Hispanic Asian/Pacific Islander,12.5,Female,Leukemias,2016
65-69,20.6,30.1,112,Incidence,447405,Non-Hispanic Asian/Pacific Islander,25.0,Female,Liver and Intrahepatic Bile Duct,2016
65-69,91.5,110.3,450,Incidence,447405,Non-Hispanic Asian/Pacific Islander,100.6,Female,Lung and Bronchus,2016
65-69,~,~,~,Incidence,447405,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,447405,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
65-69,11.6,19.0,67,Incidence,447405,Non-Hispanic Asian/Pacific Islander,15.0,Female,Myeloma,2016
65-69,26.1,36.7,139,Incidence,447405,Non-Hispanic Asian/Pacific Islander,31.1,Female,Non-Hodgkin Lymphoma,2016
65-69,12.6,20.3,72,Incidence,447405,Non-Hispanic Asian/Pacific Islander,16.1,Female,Oral Cavity and Pharynx,2016
65-69,18.6,27.7,102,Incidence,447405,Non-Hispanic Asian/Pacific Islander,22.8,Female,Ovary,2016
65-69,22.8,32.8,123,Incidence,447405,Non-Hispanic Asian/Pacific Islander,27.5,Female,Pancreas,2016
65-69,17.4,26.2,96,Incidence,447405,Non-Hispanic Asian/Pacific Islander,21.5,Female,Stomach,2016
65-69,30.2,41.5,159,Incidence,447405,Non-Hispanic Asian/Pacific Islander,35.5,Female,Thyroid,2016
65-69,7.7,14.0,47,Incidence,447405,Non-Hispanic Asian/Pacific Islander,10.5,Female,Urinary Bladder,2016
70-74,967.7,1039.9,2994,Incidence,298413,Non-Hispanic Asian/Pacific Islander,1003.3,Female,All Cancer Sites Combined,2016
70-74,4.6,11.2,22,Incidence,298413,Non-Hispanic Asian/Pacific Islander,7.4,Female,Brain and Other Nervous System,2016
70-74,6.0,13.2,27,Incidence,298413,Non-Hispanic Asian/Pacific Islander,9.0,Female,Cervix,2016
70-74,88.8,111.9,298,Incidence,298413,Non-Hispanic Asian/Pacific Islander,99.9,Female,Colon and Rectum,2016
70-74,52.5,70.5,182,Incidence,298413,Non-Hispanic Asian/Pacific Islander,61.0,Female,"Corpus and Uterus, NOS",2016
70-74,~,~,~,Incidence,298413,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
70-74,285.8,325.8,911,Incidence,298413,Non-Hispanic Asian/Pacific Islander,305.3,Female,Female Breast,2016
70-74,81.3,103.4,274,Incidence,298413,Non-Hispanic Asian/Pacific Islander,91.8,Female,"Female Breast, <i>in situ</i>",2016
70-74,~,~,~,Incidence,298413,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,298413,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
70-74,17.4,28.5,67,Incidence,298413,Non-Hispanic Asian/Pacific Islander,22.5,Female,Kidney and Renal Pelvis,2016
70-74,~,~,~,Incidence,298413,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
70-74,11.6,20.9,47,Incidence,298413,Non-Hispanic Asian/Pacific Islander,15.7,Female,Leukemias,2016
70-74,25.5,38.5,94,Incidence,298413,Non-Hispanic Asian/Pacific Islander,31.5,Female,Liver and Intrahepatic Bile Duct,2016
70-74,114.9,140.8,380,Incidence,298413,Non-Hispanic Asian/Pacific Islander,127.3,Female,Lung and Bronchus,2016
70-74,~,~,~,Incidence,298413,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,298413,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
70-74,12.7,22.5,51,Incidence,298413,Non-Hispanic Asian/Pacific Islander,17.1,Female,Myeloma,2016
70-74,40.4,56.4,143,Incidence,298413,Non-Hispanic Asian/Pacific Islander,47.9,Female,Non-Hodgkin Lymphoma,2016
70-74,15.3,25.9,60,Incidence,298413,Non-Hispanic Asian/Pacific Islander,20.1,Female,Oral Cavity and Pharynx,2016
70-74,21.9,34.1,82,Incidence,298413,Non-Hispanic Asian/Pacific Islander,27.5,Female,Ovary,2016
70-74,35.5,50.6,127,Incidence,298413,Non-Hispanic Asian/Pacific Islander,42.6,Female,Pancreas,2016
70-74,20.7,32.6,78,Incidence,298413,Non-Hispanic Asian/Pacific Islander,26.1,Female,Stomach,2016
70-74,26.4,39.7,97,Incidence,298413,Non-Hispanic Asian/Pacific Islander,32.5,Female,Thyroid,2016
70-74,9.9,18.6,41,Incidence,298413,Non-Hispanic Asian/Pacific Islander,13.7,Female,Urinary Bladder,2016
75-79,1084.1,1175.0,2396,Incidence,212250,Non-Hispanic Asian/Pacific Islander,1128.9,Female,All Cancer Sites Combined,2016
75-79,5.4,14.0,19,Incidence,212250,Non-Hispanic Asian/Pacific Islander,9.0,Female,Brain and Other Nervous System,2016
75-79,8.0,17.9,26,Incidence,212250,Non-Hispanic Asian/Pacific Islander,12.2,Female,Cervix,2016
75-79,105.8,135.8,255,Incidence,212250,Non-Hispanic Asian/Pacific Islander,120.1,Female,Colon and Rectum,2016
75-79,33.3,51.1,88,Incidence,212250,Non-Hispanic Asian/Pacific Islander,41.5,Female,"Corpus and Uterus, NOS",2016
75-79,~,~,~,Incidence,212250,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
75-79,246.5,291.0,569,Incidence,212250,Non-Hispanic Asian/Pacific Islander,268.1,Female,Female Breast,2016
75-79,57.2,79.9,144,Incidence,212250,Non-Hispanic Asian/Pacific Islander,67.8,Female,"Female Breast, <i>in situ</i>",2016
75-79,~,~,~,Incidence,212250,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,212250,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
75-79,21.6,36.4,60,Incidence,212250,Non-Hispanic Asian/Pacific Islander,28.3,Female,Kidney and Renal Pelvis,2016
75-79,~,~,~,Incidence,212250,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
75-79,13.1,25.1,39,Incidence,212250,Non-Hispanic Asian/Pacific Islander,18.4,Female,Leukemias,2016
75-79,33.3,51.1,88,Incidence,212250,Non-Hispanic Asian/Pacific Islander,41.5,Female,Liver and Intrahepatic Bile Duct,2016
75-79,170.9,208.4,401,Incidence,212250,Non-Hispanic Asian/Pacific Islander,188.9,Female,Lung and Bronchus,2016
75-79,~,~,~,Incidence,212250,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,212250,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
75-79,15.1,27.8,44,Incidence,212250,Non-Hispanic Asian/Pacific Islander,20.7,Female,Myeloma,2016
75-79,51.6,73.2,131,Incidence,212250,Non-Hispanic Asian/Pacific Islander,61.7,Female,Non-Hodgkin Lymphoma,2016
75-79,11.9,23.5,36,Incidence,212250,Non-Hispanic Asian/Pacific Islander,17.0,Female,Oral Cavity and Pharynx,2016
75-79,17.5,31.1,50,Incidence,212250,Non-Hispanic Asian/Pacific Islander,23.6,Female,Ovary,2016
75-79,50.7,72.2,129,Incidence,212250,Non-Hispanic Asian/Pacific Islander,60.8,Female,Pancreas,2016
75-79,34.1,52.1,90,Incidence,212250,Non-Hispanic Asian/Pacific Islander,42.4,Female,Stomach,2016
75-79,16.7,30.0,48,Incidence,212250,Non-Hispanic Asian/Pacific Islander,22.6,Female,Thyroid,2016
75-79,16.3,29.4,47,Incidence,212250,Non-Hispanic Asian/Pacific Islander,22.1,Female,Urinary Bladder,2016
80-84,1220.3,1336.9,1866,Incidence,146057,Non-Hispanic Asian/Pacific Islander,1277.6,Female,All Cancer Sites Combined,2016
80-84,10.5,24.4,24,Incidence,146057,Non-Hispanic Asian/Pacific Islander,16.4,Female,Brain and Other Nervous System,2016
80-84,6.8,18.6,17,Incidence,146057,Non-Hispanic Asian/Pacific Islander,11.6,Female,Cervix,2016
80-84,137.8,179.2,230,Incidence,146057,Non-Hispanic Asian/Pacific Islander,157.5,Female,Colon and Rectum,2016
80-84,34.9,57.5,66,Incidence,146057,Non-Hispanic Asian/Pacific Islander,45.2,Female,"Corpus and Uterus, NOS",2016
80-84,~,~,~,Incidence,146057,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
80-84,196.4,245.2,321,Incidence,146057,Non-Hispanic Asian/Pacific Islander,219.8,Female,Female Breast,2016
80-84,31.9,53.6,61,Incidence,146057,Non-Hispanic Asian/Pacific Islander,41.8,Female,"Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,146057,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,146057,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
80-84,21.9,40.4,44,Incidence,146057,Non-Hispanic Asian/Pacific Islander,30.1,Female,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,146057,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
80-84,21.9,40.4,44,Incidence,146057,Non-Hispanic Asian/Pacific Islander,30.1,Female,Leukemias,2016
80-84,48.3,74.2,88,Incidence,146057,Non-Hispanic Asian/Pacific Islander,60.3,Female,Liver and Intrahepatic Bile Duct,2016
80-84,179.6,226.4,295,Incidence,146057,Non-Hispanic Asian/Pacific Islander,202.0,Female,Lung and Bronchus,2016
80-84,~,~,~,Incidence,146057,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,146057,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
80-84,12.7,27.7,28,Incidence,146057,Non-Hispanic Asian/Pacific Islander,19.2,Female,Myeloma,2016
80-84,54.5,81.8,98,Incidence,146057,Non-Hispanic Asian/Pacific Islander,67.1,Female,Non-Hodgkin Lymphoma,2016
80-84,15.0,30.9,32,Incidence,146057,Non-Hispanic Asian/Pacific Islander,21.9,Female,Oral Cavity and Pharynx,2016
80-84,21.9,40.4,44,Incidence,146057,Non-Hispanic Asian/Pacific Islander,30.1,Female,Ovary,2016
80-84,66.2,96.0,117,Incidence,146057,Non-Hispanic Asian/Pacific Islander,80.1,Female,Pancreas,2016
80-84,37.4,60.6,70,Incidence,146057,Non-Hispanic Asian/Pacific Islander,47.9,Female,Stomach,2016
80-84,13.9,29.3,30,Incidence,146057,Non-Hispanic Asian/Pacific Islander,20.5,Female,Thyroid,2016
80-84,23.1,42.0,46,Incidence,146057,Non-Hispanic Asian/Pacific Islander,31.5,Female,Urinary Bladder,2016
85+,1192.4,1303.7,1951,Incidence,156445,Non-Hispanic Asian/Pacific Islander,1247.1,Female,All Cancer Sites Combined,2016
85+,6.8,18.2,18,Incidence,156445,Non-Hispanic Asian/Pacific Islander,11.5,Female,Brain and Other Nervous System,2016
85+,5.8,16.6,16,Incidence,156445,Non-Hispanic Asian/Pacific Islander,10.2,Female,Cervix,2016
85+,156.8,199.2,277,Incidence,156445,Non-Hispanic Asian/Pacific Islander,177.1,Female,Colon and Rectum,2016
85+,23.7,42.1,50,Incidence,156445,Non-Hispanic Asian/Pacific Islander,32.0,Female,"Corpus and Uterus, NOS",2016
85+,~,~,~,Incidence,156445,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
85+,171.3,215.4,301,Incidence,156445,Non-Hispanic Asian/Pacific Islander,192.4,Female,Female Breast,2016
85+,14.5,29.6,33,Incidence,156445,Non-Hispanic Asian/Pacific Islander,21.1,Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,156445,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,156445,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
85+,16.7,32.6,37,Incidence,156445,Non-Hispanic Asian/Pacific Islander,23.7,Female,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,156445,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
85+,28.2,47.9,58,Incidence,156445,Non-Hispanic Asian/Pacific Islander,37.1,Female,Leukemias,2016
85+,46.3,70.7,90,Incidence,156445,Non-Hispanic Asian/Pacific Islander,57.5,Female,Liver and Intrahepatic Bile Duct,2016
85+,191.2,237.7,334,Incidence,156445,Non-Hispanic Asian/Pacific Islander,213.5,Female,Lung and Bronchus,2016
85+,~,~,~,Incidence,156445,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
85+,~,~,~,Incidence,156445,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
85+,11.9,25.9,28,Incidence,156445,Non-Hispanic Asian/Pacific Islander,17.9,Female,Myeloma,2016
85+,42.8,66.5,84,Incidence,156445,Non-Hispanic Asian/Pacific Islander,53.7,Female,Non-Hodgkin Lymphoma,2016
85+,15.1,30.4,34,Incidence,156445,Non-Hispanic Asian/Pacific Islander,21.7,Female,Oral Cavity and Pharynx,2016
85+,14.5,29.6,33,Incidence,156445,Non-Hispanic Asian/Pacific Islander,21.1,Female,Ovary,2016
85+,56.1,82.6,107,Incidence,156445,Non-Hispanic Asian/Pacific Islander,68.4,Female,Pancreas,2016
85+,49.1,74.2,95,Incidence,156445,Non-Hispanic Asian/Pacific Islander,60.7,Female,Stomach,2016
85+,7.8,19.7,20,Incidence,156445,Non-Hispanic Asian/Pacific Islander,12.8,Female,Thyroid,2016
85+,24.3,42.9,51,Incidence,156445,Non-Hispanic Asian/Pacific Islander,32.6,Female,Urinary Bladder,2016
<1,21.0,41.4,36,Incidence,120326,Non-Hispanic Asian/Pacific Islander,29.9,Female,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2016
1-4,19.3,27.7,122,Incidence,525990,Non-Hispanic Asian/Pacific Islander,23.2,Male,All Cancer Sites Combined,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
1-4,7.1,12.5,50,Incidence,525990,Non-Hispanic Asian/Pacific Islander,9.5,Male,Leukemias,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
1-4,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
10-14,13.1,19.7,97,Incidence,599298,Non-Hispanic Asian/Pacific Islander,16.2,Male,All Cancer Sites Combined,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
10-14,3.0,6.6,27,Incidence,599298,Non-Hispanic Asian/Pacific Islander,4.5,Male,Leukemias,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
10-14,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
15-19,15.5,22.6,114,Incidence,605933,Non-Hispanic Asian/Pacific Islander,18.8,Male,All Cancer Sites Combined,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
15-19,2.1,5.3,21,Incidence,605933,Non-Hispanic Asian/Pacific Islander,3.5,Male,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
15-19,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
20-24,21.2,28.6,177,Incidence,717911,Non-Hispanic Asian/Pacific Islander,24.7,Male,All Cancer Sites Combined,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
20-24,1.9,4.6,22,Incidence,717911,Non-Hispanic Asian/Pacific Islander,3.1,Male,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
20-24,3.2,6.5,33,Incidence,717911,Non-Hispanic Asian/Pacific Islander,4.6,Male,Leukemias,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
20-24,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
20-24,1.9,4.6,22,Incidence,717911,Non-Hispanic Asian/Pacific Islander,3.1,Male,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
20-24,2.4,5.3,26,Incidence,717911,Non-Hispanic Asian/Pacific Islander,3.6,Male,Testis,2016
20-24,1.3,3.6,16,Incidence,717911,Non-Hispanic Asian/Pacific Islander,2.2,Male,Thyroid,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
25-29,31.3,39.5,292,Incidence,829071,Non-Hispanic Asian/Pacific Islander,35.2,Male,All Cancer Sites Combined,2016
25-29,1.6,3.9,21,Incidence,829071,Non-Hispanic Asian/Pacific Islander,2.5,Male,Brain and Other Nervous System,2016
25-29,1.1,3.1,16,Incidence,829071,Non-Hispanic Asian/Pacific Islander,1.9,Male,Colon and Rectum,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
25-29,1.3,3.4,18,Incidence,829071,Non-Hispanic Asian/Pacific Islander,2.2,Male,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
25-29,1.5,3.7,20,Incidence,829071,Non-Hispanic Asian/Pacific Islander,2.4,Male,Leukemias,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
25-29,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
25-29,3.1,6.2,37,Incidence,829071,Non-Hispanic Asian/Pacific Islander,4.5,Male,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
25-29,4.5,8.0,50,Incidence,829071,Non-Hispanic Asian/Pacific Islander,6.0,Male,Testis,2016
25-29,2.3,5.0,29,Incidence,829071,Non-Hispanic Asian/Pacific Islander,3.5,Male,Thyroid,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
30-34,42.2,51.7,379,Incidence,810445,Non-Hispanic Asian/Pacific Islander,46.8,Male,All Cancer Sites Combined,2016
30-34,1.8,4.3,23,Incidence,810445,Non-Hispanic Asian/Pacific Islander,2.8,Male,Brain and Other Nervous System,2016
30-34,2.5,5.3,30,Incidence,810445,Non-Hispanic Asian/Pacific Islander,3.7,Male,Colon and Rectum,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
30-34,1.8,4.3,23,Incidence,810445,Non-Hispanic Asian/Pacific Islander,2.8,Male,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
30-34,2.0,4.6,25,Incidence,810445,Non-Hispanic Asian/Pacific Islander,3.1,Male,Leukemias,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
30-34,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
30-34,2.7,5.6,32,Incidence,810445,Non-Hispanic Asian/Pacific Islander,3.9,Male,Non-Hodgkin Lymphoma,2016
30-34,2.0,4.6,25,Incidence,810445,Non-Hispanic Asian/Pacific Islander,3.1,Male,Oral Cavity and Pharynx,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
30-34,4.5,8.0,49,Incidence,810445,Non-Hispanic Asian/Pacific Islander,6.0,Male,Testis,2016
30-34,4.6,8.1,50,Incidence,810445,Non-Hispanic Asian/Pacific Islander,6.2,Male,Thyroid,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
35-39,67.8,80.4,543,Incidence,734466,Non-Hispanic Asian/Pacific Islander,73.9,Male,All Cancer Sites Combined,2016
35-39,2.5,5.5,28,Incidence,734466,Non-Hispanic Asian/Pacific Islander,3.8,Male,Brain and Other Nervous System,2016
35-39,8.0,12.8,75,Incidence,734466,Non-Hispanic Asian/Pacific Islander,10.2,Male,Colon and Rectum,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
35-39,2.2,5.0,25,Incidence,734466,Non-Hispanic Asian/Pacific Islander,3.4,Male,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
35-39,3.4,6.8,36,Incidence,734466,Non-Hispanic Asian/Pacific Islander,4.9,Male,Leukemias,2016
35-39,2.0,4.7,23,Incidence,734466,Non-Hispanic Asian/Pacific Islander,3.1,Male,Liver and Intrahepatic Bile Duct,2016
35-39,1.3,3.7,17,Incidence,734466,Non-Hispanic Asian/Pacific Islander,2.3,Male,Lung and Bronchus,2016
35-39,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
35-39,5.6,9.7,55,Incidence,734466,Non-Hispanic Asian/Pacific Islander,7.5,Male,Non-Hodgkin Lymphoma,2016
35-39,3.2,6.5,34,Incidence,734466,Non-Hispanic Asian/Pacific Islander,4.6,Male,Oral Cavity and Pharynx,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
35-39,2.1,4.9,24,Incidence,734466,Non-Hispanic Asian/Pacific Islander,3.3,Male,Stomach,2016
35-39,3.3,6.6,35,Incidence,734466,Non-Hispanic Asian/Pacific Islander,4.8,Male,Testis,2016
35-39,8.4,13.3,78,Incidence,734466,Non-Hispanic Asian/Pacific Islander,10.6,Male,Thyroid,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
40-44,93.2,108.0,713,Incidence,710146,Non-Hispanic Asian/Pacific Islander,100.4,Male,All Cancer Sites Combined,2016
40-44,1.9,4.7,22,Incidence,710146,Non-Hispanic Asian/Pacific Islander,3.1,Male,Brain and Other Nervous System,2016
40-44,15.8,22.3,134,Incidence,710146,Non-Hispanic Asian/Pacific Islander,18.9,Male,Colon and Rectum,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
40-44,5.3,9.4,51,Incidence,710146,Non-Hispanic Asian/Pacific Islander,7.2,Male,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
40-44,3.7,7.2,37,Incidence,710146,Non-Hispanic Asian/Pacific Islander,5.2,Male,Leukemias,2016
40-44,4.3,8.0,42,Incidence,710146,Non-Hispanic Asian/Pacific Islander,5.9,Male,Liver and Intrahepatic Bile Duct,2016
40-44,5.0,9.0,48,Incidence,710146,Non-Hispanic Asian/Pacific Islander,6.8,Male,Lung and Bronchus,2016
40-44,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
40-44,5.3,9.4,51,Incidence,710146,Non-Hispanic Asian/Pacific Islander,7.2,Male,Non-Hodgkin Lymphoma,2016
40-44,6.3,10.7,59,Incidence,710146,Non-Hispanic Asian/Pacific Islander,8.3,Male,Oral Cavity and Pharynx,2016
40-44,1.4,3.8,17,Incidence,710146,Non-Hispanic Asian/Pacific Islander,2.4,Male,Pancreas,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
40-44,2.5,5.5,27,Incidence,710146,Non-Hispanic Asian/Pacific Islander,3.8,Male,Stomach,2016
40-44,2.1,4.9,23,Incidence,710146,Non-Hispanic Asian/Pacific Islander,3.2,Male,Testis,2016
40-44,7.3,12.0,67,Incidence,710146,Non-Hispanic Asian/Pacific Islander,9.4,Male,Thyroid,2016
40-44,1.5,4.0,18,Incidence,710146,Non-Hispanic Asian/Pacific Islander,2.5,Male,Urinary Bladder,2016
45-49,161.9,182.3,1106,Incidence,643461,Non-Hispanic Asian/Pacific Islander,171.9,Male,All Cancer Sites Combined,2016
45-49,2.3,5.4,23,Incidence,643461,Non-Hispanic Asian/Pacific Islander,3.6,Male,Brain and Other Nervous System,2016
45-49,26.1,34.7,194,Incidence,643461,Non-Hispanic Asian/Pacific Islander,30.1,Male,Colon and Rectum,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
45-49,6.6,11.3,56,Incidence,643461,Non-Hispanic Asian/Pacific Islander,8.7,Male,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
45-49,4.7,8.8,42,Incidence,643461,Non-Hispanic Asian/Pacific Islander,6.5,Male,Leukemias,2016
45-49,11.0,16.8,88,Incidence,643461,Non-Hispanic Asian/Pacific Islander,13.7,Male,Liver and Intrahepatic Bile Duct,2016
45-49,11.1,17.0,89,Incidence,643461,Non-Hispanic Asian/Pacific Islander,13.8,Male,Lung and Bronchus,2016
45-49,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
45-49,8.6,13.9,71,Incidence,643461,Non-Hispanic Asian/Pacific Islander,11.0,Male,Non-Hodgkin Lymphoma,2016
45-49,14.8,21.5,115,Incidence,643461,Non-Hispanic Asian/Pacific Islander,17.9,Male,Oral Cavity and Pharynx,2016
45-49,4.8,9.0,43,Incidence,643461,Non-Hispanic Asian/Pacific Islander,6.7,Male,Pancreas,2016
45-49,6.4,11.1,55,Incidence,643461,Non-Hispanic Asian/Pacific Islander,8.5,Male,Prostate,2016
45-49,4.2,8.1,38,Incidence,643461,Non-Hispanic Asian/Pacific Islander,5.9,Male,Stomach,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
45-49,10.6,16.3,85,Incidence,643461,Non-Hispanic Asian/Pacific Islander,13.2,Male,Thyroid,2016
45-49,3.1,6.7,30,Incidence,643461,Non-Hispanic Asian/Pacific Islander,4.7,Male,Urinary Bladder,2016
5-9,8.0,13.3,64,Incidence,615144,Non-Hispanic Asian/Pacific Islander,10.4,Male,All Cancer Sites Combined,2016
5-9,1.5,4.2,16,Incidence,615144,Non-Hispanic Asian/Pacific Islander,2.6,Male,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
5-9,2.2,5.4,22,Incidence,615144,Non-Hispanic Asian/Pacific Islander,3.6,Male,Leukemias,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
5-9,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
50-54,286.9,315.4,1733,Incidence,575973,Non-Hispanic Asian/Pacific Islander,300.9,Male,All Cancer Sites Combined,2016
50-54,3.2,7.0,28,Incidence,575973,Non-Hispanic Asian/Pacific Islander,4.9,Male,Brain and Other Nervous System,2016
50-54,58.7,72.0,375,Incidence,575973,Non-Hispanic Asian/Pacific Islander,65.1,Male,Colon and Rectum,2016
50-54,2.3,5.6,21,Incidence,575973,Non-Hispanic Asian/Pacific Islander,3.6,Male,Esophagus,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
50-54,14.4,21.5,102,Incidence,575973,Non-Hispanic Asian/Pacific Islander,17.7,Male,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
50-54,6.0,10.9,47,Incidence,575973,Non-Hispanic Asian/Pacific Islander,8.2,Male,Leukemias,2016
50-54,18.5,26.4,128,Incidence,575973,Non-Hispanic Asian/Pacific Islander,22.2,Male,Liver and Intrahepatic Bile Duct,2016
50-54,25.1,34.1,169,Incidence,575973,Non-Hispanic Asian/Pacific Islander,29.3,Male,Lung and Bronchus,2016
50-54,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
50-54,3.2,7.0,28,Incidence,575973,Non-Hispanic Asian/Pacific Islander,4.9,Male,Myeloma,2016
50-54,14.0,20.9,99,Incidence,575973,Non-Hispanic Asian/Pacific Islander,17.2,Male,Non-Hodgkin Lymphoma,2016
50-54,18.7,26.6,129,Incidence,575973,Non-Hispanic Asian/Pacific Islander,22.4,Male,Oral Cavity and Pharynx,2016
50-54,7.3,12.6,56,Incidence,575973,Non-Hispanic Asian/Pacific Islander,9.7,Male,Pancreas,2016
50-54,29.1,38.8,194,Incidence,575973,Non-Hispanic Asian/Pacific Islander,33.7,Male,Prostate,2016
50-54,8.7,14.4,65,Incidence,575973,Non-Hispanic Asian/Pacific Islander,11.3,Male,Stomach,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
50-54,7.9,13.4,60,Incidence,575973,Non-Hispanic Asian/Pacific Islander,10.4,Male,Thyroid,2016
50-54,6.6,11.6,51,Incidence,575973,Non-Hispanic Asian/Pacific Islander,8.9,Male,Urinary Bladder,2016
55-59,490.6,530.0,2603,Incidence,510408,Non-Hispanic Asian/Pacific Islander,510.0,Male,All Cancer Sites Combined,2016
55-59,5.3,10.2,38,Incidence,510408,Non-Hispanic Asian/Pacific Islander,7.4,Male,Brain and Other Nervous System,2016
55-59,67.2,82.3,380,Incidence,510408,Non-Hispanic Asian/Pacific Islander,74.5,Male,Colon and Rectum,2016
55-59,4.6,9.3,34,Incidence,510408,Non-Hispanic Asian/Pacific Islander,6.7,Male,Esophagus,2016
55-59,~,~,~,Incidence,510408,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,510408,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
55-59,19.0,27.5,117,Incidence,510408,Non-Hispanic Asian/Pacific Islander,22.9,Male,Kidney and Renal Pelvis,2016
55-59,1.9,5.3,17,Incidence,510408,Non-Hispanic Asian/Pacific Islander,3.3,Male,Larynx,2016
55-59,9.8,16.2,65,Incidence,510408,Non-Hispanic Asian/Pacific Islander,12.7,Male,Leukemias,2016
55-59,44.2,56.7,256,Incidence,510408,Non-Hispanic Asian/Pacific Islander,50.2,Male,Liver and Intrahepatic Bile Duct,2016
55-59,50.8,64.2,292,Incidence,510408,Non-Hispanic Asian/Pacific Islander,57.2,Male,Lung and Bronchus,2016
55-59,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
55-59,~,~,~,Incidence,510408,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,510408,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
55-59,4.8,9.5,35,Incidence,510408,Non-Hispanic Asian/Pacific Islander,6.9,Male,Myeloma,2016
55-59,18.8,27.3,116,Incidence,510408,Non-Hispanic Asian/Pacific Islander,22.7,Male,Non-Hodgkin Lymphoma,2016
55-59,26.7,36.6,160,Incidence,510408,Non-Hispanic Asian/Pacific Islander,31.3,Male,Oral Cavity and Pharynx,2016
55-59,12.4,19.5,80,Incidence,510408,Non-Hispanic Asian/Pacific Islander,15.7,Male,Pancreas,2016
55-59,87.1,104.3,487,Incidence,510408,Non-Hispanic Asian/Pacific Islander,95.4,Male,Prostate,2016
55-59,20.9,29.8,128,Incidence,510408,Non-Hispanic Asian/Pacific Islander,25.1,Male,Stomach,2016
55-59,~,~,~,Incidence,510408,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
55-59,11.6,18.4,75,Incidence,510408,Non-Hispanic Asian/Pacific Islander,14.7,Male,Thyroid,2016
55-59,15.4,23.2,97,Incidence,510408,Non-Hispanic Asian/Pacific Islander,19.0,Male,Urinary Bladder,2016
60-64,767.6,820.7,3461,Incidence,435984,Non-Hispanic Asian/Pacific Islander,793.8,Male,All Cancer Sites Combined,2016
60-64,7.7,14.1,46,Incidence,435984,Non-Hispanic Asian/Pacific Islander,10.6,Male,Brain and Other Nervous System,2016
60-64,91.3,110.3,438,Incidence,435984,Non-Hispanic Asian/Pacific Islander,100.5,Male,Colon and Rectum,2016
60-64,10.5,17.7,60,Incidence,435984,Non-Hispanic Asian/Pacific Islander,13.8,Male,Esophagus,2016
60-64,~,~,~,Incidence,435984,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,435984,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
60-64,28.9,40.1,149,Incidence,435984,Non-Hispanic Asian/Pacific Islander,34.2,Male,Kidney and Renal Pelvis,2016
60-64,3.5,8.2,24,Incidence,435984,Non-Hispanic Asian/Pacific Islander,5.5,Male,Larynx,2016
60-64,15.0,23.3,82,Incidence,435984,Non-Hispanic Asian/Pacific Islander,18.8,Male,Leukemias,2016
60-64,57.8,73.2,284,Incidence,435984,Non-Hispanic Asian/Pacific Islander,65.1,Male,Liver and Intrahepatic Bile Duct,2016
60-64,98.7,118.5,472,Incidence,435984,Non-Hispanic Asian/Pacific Islander,108.3,Male,Lung and Bronchus,2016
60-64,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
60-64,~,~,~,Incidence,435984,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,435984,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
60-64,10.3,17.5,59,Incidence,435984,Non-Hispanic Asian/Pacific Islander,13.5,Male,Myeloma,2016
60-64,30.4,41.9,156,Incidence,435984,Non-Hispanic Asian/Pacific Islander,35.8,Male,Non-Hodgkin Lymphoma,2016
60-64,28.9,40.1,149,Incidence,435984,Non-Hispanic Asian/Pacific Islander,34.2,Male,Oral Cavity and Pharynx,2016
60-64,19.5,28.9,104,Incidence,435984,Non-Hispanic Asian/Pacific Islander,23.9,Male,Pancreas,2016
60-64,177.0,203.1,827,Incidence,435984,Non-Hispanic Asian/Pacific Islander,189.7,Male,Prostate,2016
60-64,26.0,36.7,135,Incidence,435984,Non-Hispanic Asian/Pacific Islander,31.0,Male,Stomach,2016
60-64,~,~,~,Incidence,435984,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
60-64,14.5,22.8,80,Incidence,435984,Non-Hispanic Asian/Pacific Islander,18.3,Male,Thyroid,2016
60-64,25.5,36.2,133,Incidence,435984,Non-Hispanic Asian/Pacific Islander,30.5,Male,Urinary Bladder,2016
65-69,1068.7,1138.0,3923,Incidence,355697,Non-Hispanic Asian/Pacific Islander,1102.9,Male,All Cancer Sites Combined,2016
65-69,8.0,15.3,40,Incidence,355697,Non-Hispanic Asian/Pacific Islander,11.2,Male,Brain and Other Nervous System,2016
65-69,99.6,121.7,392,Incidence,355697,Non-Hispanic Asian/Pacific Islander,110.2,Male,Colon and Rectum,2016
65-69,9.5,17.2,46,Incidence,355697,Non-Hispanic Asian/Pacific Islander,12.9,Male,Esophagus,2016
65-69,~,~,~,Incidence,355697,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,355697,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
65-69,31.0,44.0,132,Incidence,355697,Non-Hispanic Asian/Pacific Islander,37.1,Male,Kidney and Renal Pelvis,2016
65-69,5.0,11.0,27,Incidence,355697,Non-Hispanic Asian/Pacific Islander,7.6,Male,Larynx,2016
65-69,19.3,29.9,86,Incidence,355697,Non-Hispanic Asian/Pacific Islander,24.2,Male,Leukemias,2016
65-69,69.5,88.2,279,Incidence,355697,Non-Hispanic Asian/Pacific Islander,78.4,Male,Liver and Intrahepatic Bile Duct,2016
65-69,148.7,175.4,575,Incidence,355697,Non-Hispanic Asian/Pacific Islander,161.7,Male,Lung and Bronchus,2016
65-69,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
65-69,2.6,7.3,16,Incidence,355697,Non-Hispanic Asian/Pacific Islander,4.5,Male,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,355697,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
65-69,15.1,24.6,69,Incidence,355697,Non-Hispanic Asian/Pacific Islander,19.4,Male,Myeloma,2016
65-69,49.8,65.8,204,Incidence,355697,Non-Hispanic Asian/Pacific Islander,57.4,Male,Non-Hodgkin Lymphoma,2016
65-69,34.4,48.0,145,Incidence,355697,Non-Hispanic Asian/Pacific Islander,40.8,Male,Oral Cavity and Pharynx,2016
65-69,29.8,42.5,127,Incidence,355697,Non-Hispanic Asian/Pacific Islander,35.7,Male,Pancreas,2016
65-69,304.3,342.0,1148,Incidence,355697,Non-Hispanic Asian/Pacific Islander,322.7,Male,Prostate,2016
65-69,34.7,48.3,146,Incidence,355697,Non-Hispanic Asian/Pacific Islander,41.0,Male,Stomach,2016
65-69,~,~,~,Incidence,355697,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
65-69,12.1,20.8,57,Incidence,355697,Non-Hispanic Asian/Pacific Islander,16.0,Male,Thyroid,2016
65-69,34.1,47.7,144,Incidence,355697,Non-Hispanic Asian/Pacific Islander,40.5,Male,Urinary Bladder,2016
70-74,1339.1,1433.6,3336,Incidence,240733,Non-Hispanic Asian/Pacific Islander,1385.8,Male,All Cancer Sites Combined,2016
70-74,6.4,14.8,24,Incidence,240733,Non-Hispanic Asian/Pacific Islander,10.0,Male,Brain and Other Nervous System,2016
70-74,158.2,192.0,420,Incidence,240733,Non-Hispanic Asian/Pacific Islander,174.5,Male,Colon and Rectum,2016
70-74,14.3,26.0,47,Incidence,240733,Non-Hispanic Asian/Pacific Islander,19.5,Male,Esophagus,2016
70-74,~,~,~,Incidence,240733,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,240733,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
70-74,42.8,61.4,124,Incidence,240733,Non-Hispanic Asian/Pacific Islander,51.5,Male,Kidney and Renal Pelvis,2016
70-74,5.1,12.8,20,Incidence,240733,Non-Hispanic Asian/Pacific Islander,8.3,Male,Larynx,2016
70-74,36.4,53.7,107,Incidence,240733,Non-Hispanic Asian/Pacific Islander,44.4,Male,Leukemias,2016
70-74,72.4,95.9,201,Incidence,240733,Non-Hispanic Asian/Pacific Islander,83.5,Male,Liver and Intrahepatic Bile Duct,2016
70-74,213.0,251.8,558,Incidence,240733,Non-Hispanic Asian/Pacific Islander,231.8,Male,Lung and Bronchus,2016
70-74,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
70-74,~,~,~,Incidence,240733,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,240733,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
70-74,15.1,26.9,49,Incidence,240733,Non-Hispanic Asian/Pacific Islander,20.4,Male,Myeloma,2016
70-74,50.1,70.0,143,Incidence,240733,Non-Hispanic Asian/Pacific Islander,59.4,Male,Non-Hodgkin Lymphoma,2016
70-74,29.7,45.5,89,Incidence,240733,Non-Hispanic Asian/Pacific Islander,37.0,Male,Oral Cavity and Pharynx,2016
70-74,40.6,58.7,118,Incidence,240733,Non-Hispanic Asian/Pacific Islander,49.0,Male,Pancreas,2016
70-74,324.1,371.6,836,Incidence,240733,Non-Hispanic Asian/Pacific Islander,347.3,Male,Prostate,2016
70-74,48.5,68.2,139,Incidence,240733,Non-Hispanic Asian/Pacific Islander,57.7,Male,Stomach,2016
70-74,~,~,~,Incidence,240733,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
70-74,8.7,18.3,31,Incidence,240733,Non-Hispanic Asian/Pacific Islander,12.9,Male,Thyroid,2016
70-74,55.0,75.8,156,Incidence,240733,Non-Hispanic Asian/Pacific Islander,64.8,Male,Urinary Bladder,2016
75-79,1638.9,1763.6,2884,Incidence,169608,Non-Hispanic Asian/Pacific Islander,1700.4,Male,All Cancer Sites Combined,2016
75-79,9.1,21.1,24,Incidence,169608,Non-Hispanic Asian/Pacific Islander,14.2,Male,Brain and Other Nervous System,2016
75-79,147.4,186.8,282,Incidence,169608,Non-Hispanic Asian/Pacific Islander,166.3,Male,Colon and Rectum,2016
75-79,11.0,23.9,28,Incidence,169608,Non-Hispanic Asian/Pacific Islander,16.5,Male,Esophagus,2016
75-79,~,~,~,Incidence,169608,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,169608,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
75-79,41.1,63.3,87,Incidence,169608,Non-Hispanic Asian/Pacific Islander,51.3,Male,Kidney and Renal Pelvis,2016
75-79,5.8,16.0,17,Incidence,169608,Non-Hispanic Asian/Pacific Islander,10.0,Male,Larynx,2016
75-79,42.1,64.6,89,Incidence,169608,Non-Hispanic Asian/Pacific Islander,52.5,Male,Leukemias,2016
75-79,85.7,116.5,170,Incidence,169608,Non-Hispanic Asian/Pacific Islander,100.2,Male,Liver and Intrahepatic Bile Duct,2016
75-79,278.0,331.0,515,Incidence,169608,Non-Hispanic Asian/Pacific Islander,303.6,Male,Lung and Bronchus,2016
75-79,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
75-79,7.2,18.2,20,Incidence,169608,Non-Hispanic Asian/Pacific Islander,11.8,Male,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,169608,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
75-79,21.9,38.9,50,Incidence,169608,Non-Hispanic Asian/Pacific Islander,29.5,Male,Myeloma,2016
75-79,68.4,96.1,138,Incidence,169608,Non-Hispanic Asian/Pacific Islander,81.4,Male,Non-Hodgkin Lymphoma,2016
75-79,30.6,50.2,67,Incidence,169608,Non-Hispanic Asian/Pacific Islander,39.5,Male,Oral Cavity and Pharynx,2016
75-79,60.8,87.2,124,Incidence,169608,Non-Hispanic Asian/Pacific Islander,73.1,Male,Pancreas,2016
75-79,336.2,394.3,618,Incidence,169608,Non-Hispanic Asian/Pacific Islander,364.4,Male,Prostate,2016
75-79,74.9,103.8,150,Incidence,169608,Non-Hispanic Asian/Pacific Islander,88.4,Male,Stomach,2016
75-79,~,~,~,Incidence,169608,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
75-79,10.0,22.5,26,Incidence,169608,Non-Hispanic Asian/Pacific Islander,15.3,Male,Thyroid,2016
75-79,105.4,139.2,206,Incidence,169608,Non-Hispanic Asian/Pacific Islander,121.5,Male,Urinary Bladder,2016
80-84,1697.9,1860.0,1870,Incidence,105202,Non-Hispanic Asian/Pacific Islander,1777.5,Male,All Cancer Sites Combined,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
80-84,171.8,226.5,208,Incidence,105202,Non-Hispanic Asian/Pacific Islander,197.7,Male,Colon and Rectum,2016
80-84,20.0,41.8,31,Incidence,105202,Non-Hispanic Asian/Pacific Islander,29.5,Male,Esophagus,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
80-84,36.1,63.7,51,Incidence,105202,Non-Hispanic Asian/Pacific Islander,48.5,Male,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
80-84,31.2,57.2,45,Incidence,105202,Non-Hispanic Asian/Pacific Islander,42.8,Male,Leukemias,2016
80-84,74.8,112.5,97,Incidence,105202,Non-Hispanic Asian/Pacific Islander,92.2,Male,Liver and Intrahepatic Bile Duct,2016
80-84,303.3,374.4,355,Incidence,105202,Non-Hispanic Asian/Pacific Islander,337.4,Male,Lung and Bronchus,2016
80-84,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
80-84,30.4,56.1,44,Incidence,105202,Non-Hispanic Asian/Pacific Islander,41.8,Male,Myeloma,2016
80-84,57.8,91.5,77,Incidence,105202,Non-Hispanic Asian/Pacific Islander,73.2,Male,Non-Hodgkin Lymphoma,2016
80-84,26.4,50.7,39,Incidence,105202,Non-Hispanic Asian/Pacific Islander,37.1,Male,Oral Cavity and Pharynx,2016
80-84,73.1,110.4,95,Incidence,105202,Non-Hispanic Asian/Pacific Islander,90.3,Male,Pancreas,2016
80-84,269.1,336.4,317,Incidence,105202,Non-Hispanic Asian/Pacific Islander,301.3,Male,Prostate,2016
80-84,72.2,109.3,94,Incidence,105202,Non-Hispanic Asian/Pacific Islander,89.4,Male,Stomach,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
80-84,120.7,167.3,150,Incidence,105202,Non-Hispanic Asian/Pacific Islander,142.6,Male,Urinary Bladder,2016
85+,1722.4,1898.0,1650,Incidence,91230,Non-Hispanic Asian/Pacific Islander,1808.6,Male,All Cancer Sites Combined,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
85+,164.5,222.4,175,Incidence,91230,Non-Hispanic Asian/Pacific Islander,191.8,Male,Colon and Rectum,2016
85+,19.5,43.1,27,Incidence,91230,Non-Hispanic Asian/Pacific Islander,29.6,Male,Esophagus,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
85+,30.4,58.4,39,Incidence,91230,Non-Hispanic Asian/Pacific Islander,42.7,Male,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
85+,35.0,64.7,44,Incidence,91230,Non-Hispanic Asian/Pacific Islander,48.2,Male,Leukemias,2016
85+,72.5,112.8,83,Incidence,91230,Non-Hispanic Asian/Pacific Islander,91.0,Male,Liver and Intrahepatic Bile Duct,2016
85+,318.6,397.2,325,Incidence,91230,Non-Hispanic Asian/Pacific Islander,356.2,Male,Lung and Bronchus,2016
85+,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
85+,13.4,33.9,20,Incidence,91230,Non-Hispanic Asian/Pacific Islander,21.9,Male,Myeloma,2016
85+,87.2,130.9,98,Incidence,91230,Non-Hispanic Asian/Pacific Islander,107.4,Male,Non-Hodgkin Lymphoma,2016
85+,26.7,53.4,35,Incidence,91230,Non-Hispanic Asian/Pacific Islander,38.4,Male,Oral Cavity and Pharynx,2016
85+,65.6,104.3,76,Incidence,91230,Non-Hispanic Asian/Pacific Islander,83.3,Male,Pancreas,2016
85+,214.4,279.9,224,Incidence,91230,Non-Hispanic Asian/Pacific Islander,245.5,Male,Prostate,2016
85+,75.4,116.4,86,Incidence,91230,Non-Hispanic Asian/Pacific Islander,94.3,Male,Stomach,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
85+,149.3,204.8,160,Incidence,91230,Non-Hispanic Asian/Pacific Islander,175.4,Male,Urinary Bladder,2016
<1,16.5,34.5,31,Incidence,127483,Non-Hispanic Asian/Pacific Islander,24.3,Male,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2016
<1,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2016
1-4,18.4,24.1,216,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,All Cancer Sites Combined,2016
1-4,1.7,3.8,27,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
1-4,7.5,11.4,95,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Leukemias,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,496765,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
1-4,~,~,~,Incidence,525990,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2016
1-4,~,~,~,Incidence,1022755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
10-14,13.1,17.6,182,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,15.3,Male and Female,All Cancer Sites Combined,2016
10-14,1.6,3.4,28,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
10-14,2.5,4.8,42,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Leukemias,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,593259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
10-14,~,~,~,Incidence,599298,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
10-14,0.8,2.2,16,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Thyroid,2016
10-14,~,~,~,Incidence,1192557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
15-19,17.1,22.2,235,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,19.6,Male and Female,All Cancer Sites Combined,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
15-19,2.0,4.0,34,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
15-19,1.6,3.5,29,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Leukemias,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
15-19,1.1,2.8,22,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,1.8,Male and Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,595764,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
15-19,~,~,~,Incidence,605933,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
15-19,2.8,5.1,46,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Thyroid,2016
15-19,~,~,~,Incidence,1201697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
20-24,24.2,29.7,378,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,26.8,Male and Female,All Cancer Sites Combined,2016
20-24,0.8,2.0,18,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
20-24,2.4,4.4,46,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
20-24,2.4,4.4,46,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Leukemias,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2016
20-24,~,~,~,Incidence,690687,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
20-24,1.6,3.3,33,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2016
20-24,1.5,4.1,18,Incidence,690687,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Ovary,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
20-24,~,~,~,Incidence,717911,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
20-24,2.4,5.3,26,Incidence,717911,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Testis,2016
20-24,5.0,7.7,88,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,6.2,Male and Female,Thyroid,2016
20-24,~,~,~,Incidence,1408598,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
25-29,40.2,46.6,729,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,43.3,Male and Female,All Cancer Sites Combined,2016
25-29,1.5,3.0,37,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Brain and Other Nervous System,2016
25-29,1.7,4.0,23,Incidence,854771,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Cervix,2016
25-29,1.3,2.7,32,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Colon and Rectum,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
25-29,6.9,11.0,75,Incidence,854771,Non-Hispanic Asian/Pacific Islander,8.8,Male and Female,Female Breast,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
25-29,1.4,2.8,34,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
25-29,2.0,3.6,46,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Leukemias,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
25-29,6.9,11.0,75,Incidence,854771,Non-Hispanic Asian/Pacific Islander,8.8,Male and Female,Male and Female Breast,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
25-29,2.8,4.7,62,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Non-Hodgkin Lymphoma,2016
25-29,1.1,2.3,27,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,854771,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
25-29,~,~,~,Incidence,829071,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
25-29,4.5,8.0,50,Incidence,829071,Non-Hispanic Asian/Pacific Islander,6.0,Male and Female,Testis,2016
25-29,9.0,12.2,177,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,10.5,Male and Female,Thyroid,2016
25-29,~,~,~,Incidence,1683842,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
30-34,72.4,80.8,1296,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,76.5,Male and Female,All Cancer Sites Combined,2016
30-34,1.3,2.7,33,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Brain and Other Nervous System,2016
30-34,5.3,8.9,61,Incidence,883243,Non-Hispanic Asian/Pacific Islander,6.9,Male and Female,Cervix,2016
30-34,2.8,4.7,62,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Colon and Rectum,2016
30-34,3.5,6.6,43,Incidence,883243,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
30-34,24.5,31.6,246,Incidence,883243,Non-Hispanic Asian/Pacific Islander,27.9,Male and Female,Female Breast,2016
30-34,1.4,3.5,20,Incidence,883243,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,"Female Breast, <i>in situ</i>",2016
30-34,1.0,2.2,25,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,1.5,Male and Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
30-34,1.3,2.7,32,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
30-34,2.6,4.4,58,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Leukemias,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.3,2.7,32,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Lung and Bronchus,2016
30-34,24.5,31.6,246,Incidence,883243,Non-Hispanic Asian/Pacific Islander,27.9,Male and Female,Male and Female Breast,2016
30-34,1.4,3.5,20,Incidence,883243,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
30-34,3.3,5.4,72,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Non-Hodgkin Lymphoma,2016
30-34,1.8,3.4,42,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Oral Cavity and Pharynx,2016
30-34,2.3,4.8,30,Incidence,883243,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Ovary,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
30-34,~,~,~,Incidence,810445,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
30-34,1.1,2.3,27,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Stomach,2016
30-34,4.5,8.0,49,Incidence,810445,Non-Hispanic Asian/Pacific Islander,6.0,Male and Female,Testis,2016
30-34,16.4,20.5,311,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,18.4,Male and Female,Thyroid,2016
30-34,~,~,~,Incidence,1693688,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
35-39,111.0,121.7,1822,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,116.3,Male and Female,All Cancer Sites Combined,2016
35-39,1.7,3.3,38,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Brain and Other Nervous System,2016
35-39,6.8,10.9,72,Incidence,832670,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Cervix,2016
35-39,7.7,10.8,144,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,9.2,Male and Female,Colon and Rectum,2016
35-39,7.4,11.7,78,Incidence,832670,Non-Hispanic Asian/Pacific Islander,9.4,Male and Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
35-39,51.2,61.5,468,Incidence,832670,Non-Hispanic Asian/Pacific Islander,56.2,Male and Female,Female Breast,2016
35-39,6.8,10.9,72,Incidence,832670,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,"Female Breast, <i>in situ</i>",2016
35-39,0.7,1.8,18,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
35-39,1.8,3.4,39,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
35-39,2.9,4.9,60,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Leukemias,2016
35-39,1.5,3.0,34,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
35-39,1.9,3.5,41,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Lung and Bronchus,2016
35-39,51.2,61.5,468,Incidence,832670,Non-Hispanic Asian/Pacific Islander,56.2,Male and Female,Male and Female Breast,2016
35-39,6.8,10.9,72,Incidence,832670,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
35-39,5.1,7.7,99,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Non-Hodgkin Lymphoma,2016
35-39,3.1,5.2,64,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,Oral Cavity and Pharynx,2016
35-39,2.7,5.6,33,Incidence,832670,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Ovary,2016
35-39,0.8,2.0,21,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Pancreas,2016
35-39,~,~,~,Incidence,734466,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
35-39,2.1,3.8,45,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Stomach,2016
35-39,3.3,6.6,35,Incidence,734466,Non-Hispanic Asian/Pacific Islander,4.8,Male and Female,Testis,2016
35-39,20.0,24.7,349,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,22.3,Male and Female,Thyroid,2016
35-39,~,~,~,Incidence,1567136,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
40-44,173.9,187.5,2735,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,180.6,Male and Female,All Cancer Sites Combined,2016
40-44,1.8,3.4,38,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Brain and Other Nervous System,2016
40-44,8.9,13.6,89,Incidence,803986,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Cervix,2016
40-44,13.1,17.1,227,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,15.0,Male and Female,Colon and Rectum,2016
40-44,13.7,19.5,132,Incidence,803986,Non-Hispanic Asian/Pacific Islander,16.4,Male and Female,"Corpus and Uterus, NOS",2016
40-44,~,~,~,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
40-44,111.5,126.7,956,Incidence,803986,Non-Hispanic Asian/Pacific Islander,118.9,Male and Female,Female Breast,2016
40-44,39.7,49.0,355,Incidence,803986,Non-Hispanic Asian/Pacific Islander,44.2,Male and Female,"Female Breast, <i>in situ</i>",2016
40-44,0.7,1.8,17,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
40-44,3.7,5.9,71,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,4.7,Male and Female,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
40-44,3.3,5.5,65,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Leukemias,2016
40-44,2.7,4.7,55,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
40-44,5.7,8.4,105,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,6.9,Male and Female,Lung and Bronchus,2016
40-44,111.5,126.7,956,Incidence,803986,Non-Hispanic Asian/Pacific Islander,118.9,Male and Female,Male and Female Breast,2016
40-44,39.7,49.0,355,Incidence,803986,Non-Hispanic Asian/Pacific Islander,44.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
40-44,0.7,1.8,17,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
40-44,~,~,~,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
40-44,5.6,8.3,104,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,6.9,Male and Female,Non-Hodgkin Lymphoma,2016
40-44,5.1,7.7,95,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Oral Cavity and Pharynx,2016
40-44,5.7,9.6,60,Incidence,803986,Non-Hispanic Asian/Pacific Islander,7.5,Male and Female,Ovary,2016
40-44,1.4,2.9,31,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Pancreas,2016
40-44,~,~,~,Incidence,710146,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
40-44,2.9,4.9,57,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Stomach,2016
40-44,2.1,4.9,23,Incidence,710146,Non-Hispanic Asian/Pacific Islander,3.2,Male and Female,Testis,2016
40-44,21.4,26.4,361,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,23.8,Male and Female,Thyroid,2016
40-44,1.2,2.6,27,Incidence,1514132,Non-Hispanic Asian/Pacific Islander,1.8,Male and Female,Urinary Bladder,2016
45-49,271.8,289.5,3856,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,280.6,Male and Female,All Cancer Sites Combined,2016
45-49,1.9,3.7,37,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Brain and Other Nervous System,2016
45-49,9.8,15.0,89,Incidence,730975,Non-Hispanic Asian/Pacific Islander,12.2,Male and Female,Cervix,2016
45-49,25.1,30.7,382,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,27.8,Male and Female,Colon and Rectum,2016
45-49,24.5,32.3,206,Incidence,730975,Non-Hispanic Asian/Pacific Islander,28.2,Male and Female,"Corpus and Uterus, NOS",2016
45-49,~,~,~,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
45-49,175.2,195.1,1352,Incidence,730975,Non-Hispanic Asian/Pacific Islander,185.0,Male and Female,Female Breast,2016
45-49,62.4,74.5,499,Incidence,730975,Non-Hispanic Asian/Pacific Islander,68.3,Male and Female,"Female Breast, <i>in situ</i>",2016
45-49,~,~,~,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
45-49,5.3,8.0,90,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,6.5,Male and Female,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
45-49,4.5,7.1,78,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,Leukemias,2016
45-49,6.6,9.7,111,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,8.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
45-49,11.5,15.4,183,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,13.3,Male and Female,Lung and Bronchus,2016
45-49,175.2,195.1,1352,Incidence,730975,Non-Hispanic Asian/Pacific Islander,185.0,Male and Female,Male and Female Breast,2016
45-49,62.4,74.5,499,Incidence,730975,Non-Hispanic Asian/Pacific Islander,68.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
45-49,~,~,~,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
45-49,1.4,2.9,28,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Myeloma,2016
45-49,8.1,11.5,133,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,9.7,Male and Female,Non-Hodgkin Lymphoma,2016
45-49,10.2,14.0,165,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,12.0,Male and Female,Oral Cavity and Pharynx,2016
45-49,12.9,18.7,114,Incidence,730975,Non-Hispanic Asian/Pacific Islander,15.6,Male and Female,Ovary,2016
45-49,4.2,6.8,74,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,5.4,Male and Female,Pancreas,2016
45-49,6.4,11.1,55,Incidence,643461,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Prostate,2016
45-49,4.5,7.1,78,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,Stomach,2016
45-49,~,~,~,Incidence,643461,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
45-49,22.4,27.7,343,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,25.0,Male and Female,Thyroid,2016
45-49,1.8,3.6,36,Incidence,1374436,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Urinary Bladder,2016
5-9,8.5,12.2,124,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,10.3,Male and Female,All Cancer Sites Combined,2016
5-9,1.6,3.5,29,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
5-9,2.6,4.9,44,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Leukemias,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,591894,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
5-9,~,~,~,Incidence,615144,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2016
5-9,~,~,~,Incidence,1207038,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
50-54,393.0,415.5,4977,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,404.1,Male and Female,All Cancer Sites Combined,2016
50-54,3.4,5.8,55,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,4.5,Male and Female,Brain and Other Nervous System,2016
50-54,8.5,13.7,71,Incidence,655608,Non-Hispanic Asian/Pacific Islander,10.8,Male and Female,Cervix,2016
50-54,51.0,59.4,678,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,55.1,Male and Female,Colon and Rectum,2016
50-54,43.9,54.8,322,Incidence,655608,Non-Hispanic Asian/Pacific Islander,49.1,Male and Female,"Corpus and Uterus, NOS",2016
50-54,1.4,3.1,26,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Esophagus,2016
50-54,185.9,207.5,1288,Incidence,655608,Non-Hispanic Asian/Pacific Islander,196.5,Male and Female,Female Breast,2016
50-54,68.9,82.3,494,Incidence,655608,Non-Hispanic Asian/Pacific Islander,75.3,Male and Female,"Female Breast, <i>in situ</i>",2016
50-54,~,~,~,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
50-54,9.9,13.9,145,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,11.8,Male and Female,Kidney and Renal Pelvis,2016
50-54,~,~,~,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
50-54,5.9,9.0,90,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,7.3,Male and Female,Leukemias,2016
50-54,11.6,15.8,167,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,13.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
50-54,26.4,32.5,361,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,29.3,Male and Female,Lung and Bronchus,2016
50-54,185.9,207.5,1288,Incidence,655608,Non-Hispanic Asian/Pacific Islander,196.5,Male and Female,Male and Female Breast,2016
50-54,68.9,82.3,494,Incidence,655608,Non-Hispanic Asian/Pacific Islander,75.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
50-54,~,~,~,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
50-54,3.4,5.8,55,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,4.5,Male and Female,Myeloma,2016
50-54,14.0,18.6,199,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,16.2,Male and Female,Non-Hodgkin Lymphoma,2016
50-54,13.5,18.0,193,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,15.7,Male and Female,Oral Cavity and Pharynx,2016
50-54,19.5,27.0,151,Incidence,655608,Non-Hispanic Asian/Pacific Islander,23.0,Male and Female,Ovary,2016
50-54,7.0,10.3,105,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Pancreas,2016
50-54,29.1,38.8,194,Incidence,575973,Non-Hispanic Asian/Pacific Islander,33.7,Male and Female,Prostate,2016
50-54,7.8,11.3,116,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,9.4,Male and Female,Stomach,2016
50-54,~,~,~,Incidence,575973,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
50-54,24.5,30.4,337,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,27.4,Male and Female,Thyroid,2016
50-54,4.1,6.7,65,Incidence,1231581,Non-Hispanic Asian/Pacific Islander,5.3,Male and Female,Urinary Bladder,2016
55-59,530.1,557.6,6046,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,543.7,Male and Female,All Cancer Sites Combined,2016
55-59,4.2,7.0,61,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,5.5,Male and Female,Brain and Other Nervous System,2016
55-59,8.6,14.1,67,Incidence,601633,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Cervix,2016
55-59,53.2,62.2,640,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,57.6,Male and Female,Colon and Rectum,2016
55-59,59.0,72.1,393,Incidence,601633,Non-Hispanic Asian/Pacific Islander,65.3,Male and Female,"Corpus and Uterus, NOS",2016
55-59,2.5,4.8,39,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Esophagus,2016
55-59,211.4,235.5,1343,Incidence,601633,Non-Hispanic Asian/Pacific Islander,223.2,Male and Female,Female Breast,2016
55-59,64.7,78.4,429,Incidence,601633,Non-Hispanic Asian/Pacific Islander,71.3,Male and Female,"Female Breast, <i>in situ</i>",2016
55-59,~,~,~,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
55-59,12.7,17.4,166,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,14.9,Male and Female,Kidney and Renal Pelvis,2016
55-59,1.0,2.7,19,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Larynx,2016
55-59,9.1,13.1,122,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,11.0,Male and Female,Leukemias,2016
55-59,25.5,31.9,318,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,28.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
55-59,44.9,53.2,544,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,48.9,Male and Female,Lung and Bronchus,2016
55-59,211.4,235.5,1343,Incidence,601633,Non-Hispanic Asian/Pacific Islander,223.2,Male and Female,Male and Female Breast,2016
55-59,64.7,78.4,429,Incidence,601633,Non-Hispanic Asian/Pacific Islander,71.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
55-59,1.5,3.4,26,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
55-59,4.4,7.3,64,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Myeloma,2016
55-59,16.9,22.2,216,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,19.4,Male and Female,Non-Hodgkin Lymphoma,2016
55-59,17.7,23.1,225,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,20.2,Male and Female,Oral Cavity and Pharynx,2016
55-59,16.7,24.0,121,Incidence,601633,Non-Hispanic Asian/Pacific Islander,20.1,Male and Female,Ovary,2016
55-59,10.4,14.7,138,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,12.4,Male and Female,Pancreas,2016
55-59,87.1,104.3,487,Incidence,510408,Non-Hispanic Asian/Pacific Islander,95.4,Male and Female,Prostate,2016
55-59,16.6,21.8,212,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,19.1,Male and Female,Stomach,2016
55-59,~,~,~,Incidence,510408,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
55-59,23.9,30.1,299,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,26.9,Male and Female,Thyroid,2016
55-59,9.7,13.8,129,Incidence,1112041,Non-Hispanic Asian/Pacific Islander,11.6,Male and Female,Urinary Bladder,2016
60-64,744.9,779.7,7412,Incidence,972557,Non-Hispanic Asian/Pacific Islander,762.1,Male and Female,All Cancer Sites Combined,2016
60-64,6.2,9.9,77,Incidence,972557,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Brain and Other Nervous System,2016
60-64,9.8,16.1,68,Incidence,536573,Non-Hispanic Asian/Pacific Islander,12.7,Male and Female,Cervix,2016
60-64,70.3,81.3,736,Incidence,972557,Non-Hispanic Asian/Pacific Islander,75.7,Male and Female,Colon and Rectum,2016
60-64,62.3,76.5,371,Incidence,536573,Non-Hispanic Asian/Pacific Islander,69.1,Male and Female,"Corpus and Uterus, NOS",2016
60-64,5.4,8.9,68,Incidence,972557,Non-Hispanic Asian/Pacific Islander,7.0,Male and Female,Esophagus,2016
60-64,255.2,283.2,1443,Incidence,536573,Non-Hispanic Asian/Pacific Islander,268.9,Male and Female,Female Breast,2016
60-64,68.8,83.8,408,Incidence,536573,Non-Hispanic Asian/Pacific Islander,76.0,Male and Female,"Female Breast, <i>in situ</i>",2016
60-64,~,~,~,Incidence,972557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,972557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
60-64,20.9,27.1,232,Incidence,972557,Non-Hispanic Asian/Pacific Islander,23.9,Male and Female,Kidney and Renal Pelvis,2016
60-64,1.7,3.9,26,Incidence,972557,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Larynx,2016
60-64,12.0,16.9,139,Incidence,972557,Non-Hispanic Asian/Pacific Islander,14.3,Male and Female,Leukemias,2016
60-64,34.2,42.0,369,Incidence,972557,Non-Hispanic Asian/Pacific Islander,37.9,Male and Female,Liver and Intrahepatic Bile Duct,2016
60-64,85.1,97.2,885,Incidence,972557,Non-Hispanic Asian/Pacific Islander,91.0,Male and Female,Lung and Bronchus,2016
60-64,255.2,283.2,1443,Incidence,536573,Non-Hispanic Asian/Pacific Islander,268.9,Male and Female,Male and Female Breast,2016
60-64,68.8,83.8,408,Incidence,536573,Non-Hispanic Asian/Pacific Islander,76.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
60-64,1.2,3.1,19,Incidence,972557,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,972557,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
60-64,8.5,12.6,101,Incidence,972557,Non-Hispanic Asian/Pacific Islander,10.4,Male and Female,Myeloma,2016
60-64,28.6,35.8,312,Incidence,972557,Non-Hispanic Asian/Pacific Islander,32.1,Male and Female,Non-Hodgkin Lymphoma,2016
60-64,19.6,25.7,219,Incidence,972557,Non-Hispanic Asian/Pacific Islander,22.5,Male and Female,Oral Cavity and Pharynx,2016
60-64,18.7,26.9,121,Incidence,536573,Non-Hispanic Asian/Pacific Islander,22.6,Male and Female,Ovary,2016
60-64,18.4,24.3,206,Incidence,972557,Non-Hispanic Asian/Pacific Islander,21.2,Male and Female,Pancreas,2016
60-64,177.0,203.1,827,Incidence,435984,Non-Hispanic Asian/Pacific Islander,189.7,Male and Female,Prostate,2016
60-64,19.3,25.4,216,Incidence,972557,Non-Hispanic Asian/Pacific Islander,22.2,Male and Female,Stomach,2016
60-64,~,~,~,Incidence,435984,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
60-64,26.3,33.2,288,Incidence,972557,Non-Hispanic Asian/Pacific Islander,29.6,Male and Female,Thyroid,2016
60-64,15.2,20.6,173,Incidence,972557,Non-Hispanic Asian/Pacific Islander,17.8,Male and Female,Urinary Bladder,2016
65-69,950.2,993.4,7803,Incidence,803102,Non-Hispanic Asian/Pacific Islander,971.6,Male and Female,All Cancer Sites Combined,2016
65-69,6.6,10.7,68,Incidence,803102,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Brain and Other Nervous System,2016
65-69,7.0,12.9,43,Incidence,447405,Non-Hispanic Asian/Pacific Islander,9.6,Male and Female,Cervix,2016
65-69,86.9,100.4,751,Incidence,803102,Non-Hispanic Asian/Pacific Islander,93.5,Male and Female,Colon and Rectum,2016
65-69,62.2,77.9,312,Incidence,447405,Non-Hispanic Asian/Pacific Islander,69.7,Male and Female,"Corpus and Uterus, NOS",2016
65-69,5.2,8.9,55,Incidence,803102,Non-Hispanic Asian/Pacific Islander,6.8,Male and Female,Esophagus,2016
65-69,279.8,311.8,1322,Incidence,447405,Non-Hispanic Asian/Pacific Islander,295.5,Male and Female,Female Breast,2016
65-69,87.5,105.9,431,Incidence,447405,Non-Hispanic Asian/Pacific Islander,96.3,Male and Female,"Female Breast, <i>in situ</i>",2016
65-69,~,~,~,Incidence,803102,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,803102,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
65-69,22.6,29.8,209,Incidence,803102,Non-Hispanic Asian/Pacific Islander,26.0,Male and Female,Kidney and Renal Pelvis,2016
65-69,2.5,5.3,30,Incidence,803102,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Larynx,2016
65-69,14.9,20.8,142,Incidence,803102,Non-Hispanic Asian/Pacific Islander,17.7,Male and Female,Leukemias,2016
65-69,44.0,53.8,391,Incidence,803102,Non-Hispanic Asian/Pacific Islander,48.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
65-69,119.9,135.7,1025,Incidence,803102,Non-Hispanic Asian/Pacific Islander,127.6,Male and Female,Lung and Bronchus,2016
65-69,279.8,311.8,1322,Incidence,447405,Non-Hispanic Asian/Pacific Islander,295.5,Male and Female,Male and Female Breast,2016
65-69,87.5,105.9,431,Incidence,447405,Non-Hispanic Asian/Pacific Islander,96.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
65-69,2.3,5.0,28,Incidence,803102,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,803102,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
65-69,14.2,20.0,136,Incidence,803102,Non-Hispanic Asian/Pacific Islander,16.9,Male and Female,Myeloma,2016
65-69,38.3,47.5,343,Incidence,803102,Non-Hispanic Asian/Pacific Islander,42.7,Male and Female,Non-Hodgkin Lymphoma,2016
65-69,23.5,30.9,217,Incidence,803102,Non-Hispanic Asian/Pacific Islander,27.0,Male and Female,Oral Cavity and Pharynx,2016
65-69,18.6,27.7,102,Incidence,447405,Non-Hispanic Asian/Pacific Islander,22.8,Male and Female,Ovary,2016
65-69,27.4,35.2,250,Incidence,803102,Non-Hispanic Asian/Pacific Islander,31.1,Male and Female,Pancreas,2016
65-69,304.3,342.0,1148,Incidence,355697,Non-Hispanic Asian/Pacific Islander,322.7,Male and Female,Prostate,2016
65-69,26.5,34.2,242,Incidence,803102,Non-Hispanic Asian/Pacific Islander,30.1,Male and Female,Stomach,2016
65-69,~,~,~,Incidence,355697,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
65-69,23.4,30.7,216,Incidence,803102,Non-Hispanic Asian/Pacific Islander,26.9,Male and Female,Thyroid,2016
65-69,20.5,27.4,191,Incidence,803102,Non-Hispanic Asian/Pacific Islander,23.8,Male and Female,Urinary Bladder,2016
70-74,1145.3,1203.4,6330,Incidence,539146,Non-Hispanic Asian/Pacific Islander,1174.1,Male and Female,All Cancer Sites Combined,2016
70-74,6.2,11.4,46,Incidence,539146,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Brain and Other Nervous System,2016
70-74,6.0,13.2,27,Incidence,298413,Non-Hispanic Asian/Pacific Islander,9.0,Male and Female,Cervix,2016
70-74,123.6,143.3,718,Incidence,539146,Non-Hispanic Asian/Pacific Islander,133.2,Male and Female,Colon and Rectum,2016
70-74,52.5,70.5,182,Incidence,298413,Non-Hispanic Asian/Pacific Islander,61.0,Male and Female,"Corpus and Uterus, NOS",2016
70-74,8.5,14.3,60,Incidence,539146,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Esophagus,2016
70-74,285.8,325.8,911,Incidence,298413,Non-Hispanic Asian/Pacific Islander,305.3,Male and Female,Female Breast,2016
70-74,81.3,103.4,274,Incidence,298413,Non-Hispanic Asian/Pacific Islander,91.8,Male and Female,"Female Breast, <i>in situ</i>",2016
70-74,~,~,~,Incidence,539146,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,539146,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
70-74,30.6,40.8,191,Incidence,539146,Non-Hispanic Asian/Pacific Islander,35.4,Male and Female,Kidney and Renal Pelvis,2016
70-74,3.3,7.3,27,Incidence,539146,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Larynx,2016
70-74,24.2,33.4,154,Incidence,539146,Non-Hispanic Asian/Pacific Islander,28.6,Male and Female,Leukemias,2016
70-74,48.6,61.3,295,Incidence,539146,Non-Hispanic Asian/Pacific Islander,54.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
70-74,163.0,185.5,938,Incidence,539146,Non-Hispanic Asian/Pacific Islander,174.0,Male and Female,Lung and Bronchus,2016
70-74,285.8,325.8,911,Incidence,298413,Non-Hispanic Asian/Pacific Islander,305.3,Male and Female,Male and Female Breast,2016
70-74,81.3,103.4,274,Incidence,298413,Non-Hispanic Asian/Pacific Islander,91.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
70-74,3.3,7.3,27,Incidence,539146,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,539146,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
70-74,15.1,22.6,100,Incidence,539146,Non-Hispanic Asian/Pacific Islander,18.5,Male and Female,Myeloma,2016
70-74,47.1,59.6,286,Incidence,539146,Non-Hispanic Asian/Pacific Islander,53.0,Male and Female,Non-Hodgkin Lymphoma,2016
70-74,23.4,32.4,149,Incidence,539146,Non-Hispanic Asian/Pacific Islander,27.6,Male and Female,Oral Cavity and Pharynx,2016
70-74,21.9,34.1,82,Incidence,298413,Non-Hispanic Asian/Pacific Islander,27.5,Male and Female,Ovary,2016
70-74,39.9,51.5,245,Incidence,539146,Non-Hispanic Asian/Pacific Islander,45.4,Male and Female,Pancreas,2016
70-74,324.1,371.6,836,Incidence,240733,Non-Hispanic Asian/Pacific Islander,347.3,Male and Female,Prostate,2016
70-74,35.1,46.0,217,Incidence,539146,Non-Hispanic Asian/Pacific Islander,40.2,Male and Female,Stomach,2016
70-74,~,~,~,Incidence,240733,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
70-74,19.8,28.2,128,Incidence,539146,Non-Hispanic Asian/Pacific Islander,23.7,Male and Female,Thyroid,2016
70-74,31.6,42.0,197,Incidence,539146,Non-Hispanic Asian/Pacific Islander,36.5,Male and Female,Urinary Bladder,2016
75-79,1345.7,1420.5,5280,Incidence,381858,Non-Hispanic Asian/Pacific Islander,1382.7,Male and Female,All Cancer Sites Combined,2016
75-79,8.1,15.2,43,Incidence,381858,Non-Hispanic Asian/Pacific Islander,11.3,Male and Female,Brain and Other Nervous System,2016
75-79,8.0,17.9,26,Incidence,212250,Non-Hispanic Asian/Pacific Islander,12.2,Male and Female,Cervix,2016
75-79,129.0,153.0,537,Incidence,381858,Non-Hispanic Asian/Pacific Islander,140.6,Male and Female,Colon and Rectum,2016
75-79,33.3,51.1,88,Incidence,212250,Non-Hispanic Asian/Pacific Islander,41.5,Male and Female,"Corpus and Uterus, NOS",2016
75-79,7.7,14.6,41,Incidence,381858,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,Esophagus,2016
75-79,246.5,291.0,569,Incidence,212250,Non-Hispanic Asian/Pacific Islander,268.1,Male and Female,Female Breast,2016
75-79,57.2,79.9,144,Incidence,212250,Non-Hispanic Asian/Pacific Islander,67.8,Male and Female,"Female Breast, <i>in situ</i>",2016
75-79,~,~,~,Incidence,381858,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,381858,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
75-79,32.5,45.2,147,Incidence,381858,Non-Hispanic Asian/Pacific Islander,38.5,Male and Female,Kidney and Renal Pelvis,2016
75-79,2.8,7.4,18,Incidence,381858,Non-Hispanic Asian/Pacific Islander,4.7,Male and Female,Larynx,2016
75-79,28.0,39.9,128,Incidence,381858,Non-Hispanic Asian/Pacific Islander,33.5,Male and Female,Leukemias,2016
75-79,59.6,76.3,258,Incidence,381858,Non-Hispanic Asian/Pacific Islander,67.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
75-79,224.6,255.9,916,Incidence,381858,Non-Hispanic Asian/Pacific Islander,239.9,Male and Female,Lung and Bronchus,2016
75-79,246.5,291.0,569,Incidence,212250,Non-Hispanic Asian/Pacific Islander,268.1,Male and Female,Male and Female Breast,2016
75-79,57.2,79.9,144,Incidence,212250,Non-Hispanic Asian/Pacific Islander,67.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
75-79,5.3,11.2,30,Incidence,381858,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,381858,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
75-79,19.9,30.1,94,Incidence,381858,Non-Hispanic Asian/Pacific Islander,24.6,Male and Female,Myeloma,2016
75-79,62.3,79.4,269,Incidence,381858,Non-Hispanic Asian/Pacific Islander,70.4,Male and Female,Non-Hodgkin Lymphoma,2016
75-79,22.0,32.7,103,Incidence,381858,Non-Hispanic Asian/Pacific Islander,27.0,Male and Female,Oral Cavity and Pharynx,2016
75-79,17.5,31.1,50,Incidence,212250,Non-Hispanic Asian/Pacific Islander,23.6,Male and Female,Ovary,2016
75-79,58.3,74.9,253,Incidence,381858,Non-Hispanic Asian/Pacific Islander,66.3,Male and Female,Pancreas,2016
75-79,336.2,394.3,618,Incidence,169608,Non-Hispanic Asian/Pacific Islander,364.4,Male and Female,Prostate,2016
75-79,55.1,71.3,240,Incidence,381858,Non-Hispanic Asian/Pacific Islander,62.9,Male and Female,Stomach,2016
75-79,~,~,~,Incidence,169608,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
75-79,15.2,24.3,74,Incidence,381858,Non-Hispanic Asian/Pacific Islander,19.4,Male and Female,Thyroid,2016
75-79,58.3,74.9,253,Incidence,381858,Non-Hispanic Asian/Pacific Islander,66.3,Male and Female,Urinary Bladder,2016
80-84,1439.6,1535.4,3736,Incidence,251259,Non-Hispanic Asian/Pacific Islander,1486.9,Male and Female,All Cancer Sites Combined,2016
80-84,10.4,20.3,37,Incidence,251259,Non-Hispanic Asian/Pacific Islander,14.7,Male and Female,Brain and Other Nervous System,2016
80-84,6.8,18.6,17,Incidence,146057,Non-Hispanic Asian/Pacific Islander,11.6,Male and Female,Cervix,2016
80-84,158.4,191.4,438,Incidence,251259,Non-Hispanic Asian/Pacific Islander,174.3,Male and Female,Colon and Rectum,2016
80-84,34.9,57.5,66,Incidence,146057,Non-Hispanic Asian/Pacific Islander,45.2,Male and Female,"Corpus and Uterus, NOS",2016
80-84,13.1,24.0,45,Incidence,251259,Non-Hispanic Asian/Pacific Islander,17.9,Male and Female,Esophagus,2016
80-84,196.4,245.2,321,Incidence,146057,Non-Hispanic Asian/Pacific Islander,219.8,Male and Female,Female Breast,2016
80-84,31.9,53.6,61,Incidence,146057,Non-Hispanic Asian/Pacific Islander,41.8,Male and Female,"Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,251259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,251259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
80-84,30.6,46.2,95,Incidence,251259,Non-Hispanic Asian/Pacific Islander,37.8,Male and Female,Kidney and Renal Pelvis,2016
80-84,~,~,~,Incidence,251259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
80-84,28.4,43.6,89,Incidence,251259,Non-Hispanic Asian/Pacific Islander,35.4,Male and Female,Leukemias,2016
80-84,63.4,85.0,185,Incidence,251259,Non-Hispanic Asian/Pacific Islander,73.6,Male and Female,Liver and Intrahepatic Bile Duct,2016
80-84,239.2,279.4,650,Incidence,251259,Non-Hispanic Asian/Pacific Islander,258.7,Male and Female,Lung and Bronchus,2016
80-84,196.4,245.2,321,Incidence,146057,Non-Hispanic Asian/Pacific Islander,219.8,Male and Female,Male and Female Breast,2016
80-84,31.9,53.6,61,Incidence,146057,Non-Hispanic Asian/Pacific Islander,41.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
80-84,3.6,10.3,16,Incidence,251259,Non-Hispanic Asian/Pacific Islander,6.4,Male and Female,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,251259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
80-84,22.4,36.1,72,Incidence,251259,Non-Hispanic Asian/Pacific Islander,28.7,Male and Female,Myeloma,2016
80-84,59.7,80.8,175,Incidence,251259,Non-Hispanic Asian/Pacific Islander,69.6,Male and Female,Non-Hodgkin Lymphoma,2016
80-84,22.1,35.6,71,Incidence,251259,Non-Hispanic Asian/Pacific Islander,28.3,Male and Female,Oral Cavity and Pharynx,2016
80-84,21.9,40.4,44,Incidence,146057,Non-Hispanic Asian/Pacific Islander,30.1,Male and Female,Ovary,2016
80-84,73.4,96.5,212,Incidence,251259,Non-Hispanic Asian/Pacific Islander,84.4,Male and Female,Pancreas,2016
80-84,269.1,336.4,317,Incidence,105202,Non-Hispanic Asian/Pacific Islander,301.3,Male and Female,Prostate,2016
80-84,55.7,76.1,164,Incidence,251259,Non-Hispanic Asian/Pacific Islander,65.3,Male and Female,Stomach,2016
80-84,~,~,~,Incidence,105202,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
80-84,13.1,24.0,45,Incidence,251259,Non-Hispanic Asian/Pacific Islander,17.9,Male and Female,Thyroid,2016
80-84,67.5,89.7,196,Incidence,251259,Non-Hispanic Asian/Pacific Islander,78.0,Male and Female,Urinary Bladder,2016
85+,1406.8,1502.2,3601,Incidence,247675,Non-Hispanic Asian/Pacific Islander,1453.9,Male and Female,All Cancer Sites Combined,2016
85+,7.5,16.3,28,Incidence,247675,Non-Hispanic Asian/Pacific Islander,11.3,Male and Female,Brain and Other Nervous System,2016
85+,5.8,16.6,16,Incidence,156445,Non-Hispanic Asian/Pacific Islander,10.2,Male and Female,Cervix,2016
85+,166.1,200.1,452,Incidence,247675,Non-Hispanic Asian/Pacific Islander,182.5,Male and Female,Colon and Rectum,2016
85+,23.7,42.1,50,Incidence,156445,Non-Hispanic Asian/Pacific Islander,32.0,Male and Female,"Corpus and Uterus, NOS",2016
85+,11.9,22.5,41,Incidence,247675,Non-Hispanic Asian/Pacific Islander,16.6,Male and Female,Esophagus,2016
85+,171.3,215.4,301,Incidence,156445,Non-Hispanic Asian/Pacific Islander,192.4,Male and Female,Female Breast,2016
85+,14.5,29.6,33,Incidence,156445,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,247675,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,247675,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
85+,24.2,38.4,76,Incidence,247675,Non-Hispanic Asian/Pacific Islander,30.7,Male and Female,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,247675,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
85+,33.6,50.0,102,Incidence,247675,Non-Hispanic Asian/Pacific Islander,41.2,Male and Female,Leukemias,2016
85+,59.8,81.1,173,Incidence,247675,Non-Hispanic Asian/Pacific Islander,69.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
85+,246.1,287.2,659,Incidence,247675,Non-Hispanic Asian/Pacific Islander,266.1,Male and Female,Lung and Bronchus,2016
85+,171.3,215.4,301,Incidence,156445,Non-Hispanic Asian/Pacific Islander,192.4,Male and Female,Male and Female Breast,2016
85+,14.5,29.6,33,Incidence,156445,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
85+,4.3,11.5,18,Incidence,247675,Non-Hispanic Asian/Pacific Islander,7.3,Male and Female,Melanomas of the Skin,2016
85+,~,~,~,Incidence,247675,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
85+,14.3,25.7,48,Incidence,247675,Non-Hispanic Asian/Pacific Islander,19.4,Male and Female,Myeloma,2016
85+,63.2,85.0,182,Incidence,247675,Non-Hispanic Asian/Pacific Islander,73.5,Male and Female,Non-Hodgkin Lymphoma,2016
85+,21.7,35.3,69,Incidence,247675,Non-Hispanic Asian/Pacific Islander,27.9,Male and Female,Oral Cavity and Pharynx,2016
85+,14.5,29.6,33,Incidence,156445,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,Ovary,2016
85+,63.6,85.4,183,Incidence,247675,Non-Hispanic Asian/Pacific Islander,73.9,Male and Female,Pancreas,2016
85+,214.4,279.9,224,Incidence,91230,Non-Hispanic Asian/Pacific Islander,245.5,Male and Female,Prostate,2016
85+,62.8,84.5,181,Incidence,247675,Non-Hispanic Asian/Pacific Islander,73.1,Male and Female,Stomach,2016
85+,~,~,~,Incidence,91230,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
85+,7.2,15.9,27,Incidence,247675,Non-Hispanic Asian/Pacific Islander,10.9,Male and Female,Thyroid,2016
85+,74.1,97.5,211,Incidence,247675,Non-Hispanic Asian/Pacific Islander,85.2,Male and Female,Urinary Bladder,2016
<1,21.0,34.3,67,Incidence,247809,Non-Hispanic Asian/Pacific Islander,27.0,Male and Female,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Leukemias,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,120326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2016
<1,~,~,~,Incidence,127483,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2016
<1,~,~,~,Incidence,247809,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2016
1-4,12.6,17.0,177,Incidence,1203317,Non-Hispanic Black,14.7,Female,All Cancer Sites Combined,2016
1-4,2.4,4.6,41,Incidence,1203317,Non-Hispanic Black,3.4,Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Cervix,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Esophagus,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Female Breast,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
1-4,1.1,2.7,21,Incidence,1203317,Non-Hispanic Black,1.7,Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Larynx,2016
1-4,4.1,6.8,64,Incidence,1203317,Non-Hispanic Black,5.3,Female,Leukemias,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Mesothelioma,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Myeloma,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Ovary,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Pancreas,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Stomach,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Thyroid,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Female,Urinary Bladder,2016
10-14,10.2,13.7,178,Incidence,1504204,Non-Hispanic Black,11.8,Female,All Cancer Sites Combined,2016
10-14,1.0,2.4,24,Incidence,1504204,Non-Hispanic Black,1.6,Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Cervix,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Esophagus,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Female Breast,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Larynx,2016
10-14,1.5,3.0,32,Incidence,1504204,Non-Hispanic Black,2.1,Female,Leukemias,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Mesothelioma,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Myeloma,2016
10-14,0.7,1.8,17,Incidence,1504204,Non-Hispanic Black,1.1,Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Ovary,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Pancreas,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Stomach,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Thyroid,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Female,Urinary Bladder,2016
15-19,13.9,17.9,249,Incidence,1579189,Non-Hispanic Black,15.8,Female,All Cancer Sites Combined,2016
15-19,1.3,2.8,31,Incidence,1579189,Non-Hispanic Black,2.0,Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Cervix,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Esophagus,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Female Breast,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2016
15-19,1.5,3.0,34,Incidence,1579189,Non-Hispanic Black,2.2,Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Larynx,2016
15-19,1.1,2.5,27,Incidence,1579189,Non-Hispanic Black,1.7,Female,Leukemias,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Mesothelioma,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Myeloma,2016
15-19,0.7,1.8,18,Incidence,1579189,Non-Hispanic Black,1.1,Female,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2016
15-19,0.6,1.7,17,Incidence,1579189,Non-Hispanic Black,1.1,Female,Ovary,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Pancreas,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Stomach,2016
15-19,1.3,2.7,30,Incidence,1579189,Non-Hispanic Black,1.9,Female,Thyroid,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Female,Urinary Bladder,2016
20-24,24.9,29.9,468,Incidence,1714858,Non-Hispanic Black,27.3,Female,All Cancer Sites Combined,2016
20-24,1.1,2.4,28,Incidence,1714858,Non-Hispanic Black,1.6,Female,Brain and Other Nervous System,2016
20-24,0.7,1.8,20,Incidence,1714858,Non-Hispanic Black,1.2,Female,Cervix,2016
20-24,0.9,2.1,24,Incidence,1714858,Non-Hispanic Black,1.4,Female,Colon and Rectum,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Esophagus,2016
20-24,2.4,4.1,54,Incidence,1714858,Non-Hispanic Black,3.1,Female,Female Breast,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2016
20-24,2.5,4.3,57,Incidence,1714858,Non-Hispanic Black,3.3,Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Larynx,2016
20-24,0.9,2.1,24,Incidence,1714858,Non-Hispanic Black,1.4,Female,Leukemias,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Mesothelioma,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Myeloma,2016
20-24,1.9,3.4,44,Incidence,1714858,Non-Hispanic Black,2.6,Female,Non-Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2016
20-24,1.1,2.4,29,Incidence,1714858,Non-Hispanic Black,1.7,Female,Ovary,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Pancreas,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Stomach,2016
20-24,2.5,4.3,57,Incidence,1714858,Non-Hispanic Black,3.3,Female,Thyroid,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Female,Urinary Bladder,2016
25-29,52.2,59.4,953,Incidence,1710998,Non-Hispanic Black,55.7,Female,All Cancer Sites Combined,2016
25-29,1.1,2.4,28,Incidence,1710998,Non-Hispanic Black,1.6,Female,Brain and Other Nervous System,2016
25-29,3.7,5.8,80,Incidence,1710998,Non-Hispanic Black,4.7,Female,Cervix,2016
25-29,2.6,4.4,59,Incidence,1710998,Non-Hispanic Black,3.4,Female,Colon and Rectum,2016
25-29,1.5,2.9,36,Incidence,1710998,Non-Hispanic Black,2.1,Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Esophagus,2016
25-29,11.5,15.0,225,Incidence,1710998,Non-Hispanic Black,13.2,Female,Female Breast,2016
25-29,0.6,1.7,18,Incidence,1710998,Non-Hispanic Black,1.1,Female,"Female Breast, <i>in situ</i>",2016
25-29,2.8,4.7,63,Incidence,1710998,Non-Hispanic Black,3.7,Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
25-29,1.3,2.7,33,Incidence,1710998,Non-Hispanic Black,1.9,Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Larynx,2016
25-29,1.1,2.4,29,Incidence,1710998,Non-Hispanic Black,1.7,Female,Leukemias,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Mesothelioma,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Myeloma,2016
25-29,1.7,3.2,40,Incidence,1710998,Non-Hispanic Black,2.3,Female,Non-Hodgkin Lymphoma,2016
25-29,0.5,1.5,16,Incidence,1710998,Non-Hispanic Black,0.9,Female,Oral Cavity and Pharynx,2016
25-29,1.5,2.9,36,Incidence,1710998,Non-Hispanic Black,2.1,Female,Ovary,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Pancreas,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Stomach,2016
25-29,7.1,9.9,144,Incidence,1710998,Non-Hispanic Black,8.4,Female,Thyroid,2016
25-29,~,~,~,Incidence,1710998,Non-Hispanic Black,~,Female,Urinary Bladder,2016
30-34,108.4,119.2,1706,Incidence,1500649,Non-Hispanic Black,113.7,Female,All Cancer Sites Combined,2016
30-34,1.1,2.5,26,Incidence,1500649,Non-Hispanic Black,1.7,Female,Brain and Other Nervous System,2016
30-34,8.1,11.3,144,Incidence,1500649,Non-Hispanic Black,9.6,Female,Cervix,2016
30-34,5.7,8.4,104,Incidence,1500649,Non-Hispanic Black,6.9,Female,Colon and Rectum,2016
30-34,4.5,6.9,84,Incidence,1500649,Non-Hispanic Black,5.6,Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Esophagus,2016
30-34,36.7,43.1,597,Incidence,1500649,Non-Hispanic Black,39.8,Female,Female Breast,2016
30-34,2.2,4.0,45,Incidence,1500649,Non-Hispanic Black,3.0,Female,"Female Breast, <i>in situ</i>",2016
30-34,2.8,4.8,55,Incidence,1500649,Non-Hispanic Black,3.7,Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
30-34,1.8,3.5,38,Incidence,1500649,Non-Hispanic Black,2.5,Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Larynx,2016
30-34,3.2,5.4,63,Incidence,1500649,Non-Hispanic Black,4.2,Female,Leukemias,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Mesothelioma,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Myeloma,2016
30-34,4.2,6.6,79,Incidence,1500649,Non-Hispanic Black,5.3,Female,Non-Hodgkin Lymphoma,2016
30-34,1.3,2.8,29,Incidence,1500649,Non-Hispanic Black,1.9,Female,Oral Cavity and Pharynx,2016
30-34,1.7,3.3,36,Incidence,1500649,Non-Hispanic Black,2.4,Female,Ovary,2016
30-34,0.9,2.1,21,Incidence,1500649,Non-Hispanic Black,1.4,Female,Pancreas,2016
30-34,0.7,1.9,18,Incidence,1500649,Non-Hispanic Black,1.2,Female,Stomach,2016
30-34,12.2,16.0,210,Incidence,1500649,Non-Hispanic Black,14.0,Female,Thyroid,2016
30-34,~,~,~,Incidence,1500649,Non-Hispanic Black,~,Female,Urinary Bladder,2016
35-39,181.0,195.2,2719,Incidence,1446307,Non-Hispanic Black,188.0,Female,All Cancer Sites Combined,2016
35-39,1.4,3.0,30,Incidence,1446307,Non-Hispanic Black,2.1,Female,Brain and Other Nervous System,2016
35-39,11.3,15.1,190,Incidence,1446307,Non-Hispanic Black,13.1,Female,Cervix,2016
35-39,9.9,13.5,168,Incidence,1446307,Non-Hispanic Black,11.6,Female,Colon and Rectum,2016
35-39,7.1,10.2,124,Incidence,1446307,Non-Hispanic Black,8.6,Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,1446307,Non-Hispanic Black,~,Female,Esophagus,2016
35-39,73.0,82.2,1121,Incidence,1446307,Non-Hispanic Black,77.5,Female,Female Breast,2016
35-39,8.9,12.3,152,Incidence,1446307,Non-Hispanic Black,10.5,Female,"Female Breast, <i>in situ</i>",2016
35-39,3.3,5.5,62,Incidence,1446307,Non-Hispanic Black,4.3,Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,1446307,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
35-39,3.9,6.3,72,Incidence,1446307,Non-Hispanic Black,5.0,Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,1446307,Non-Hispanic Black,~,Female,Larynx,2016
35-39,2.9,4.9,55,Incidence,1446307,Non-Hispanic Black,3.8,Female,Leukemias,2016
35-39,0.7,1.9,17,Incidence,1446307,Non-Hispanic Black,1.2,Female,Liver and Intrahepatic Bile Duct,2016
35-39,2.3,4.2,46,Incidence,1446307,Non-Hispanic Black,3.2,Female,Lung and Bronchus,2016
35-39,~,~,~,Incidence,1446307,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,1446307,Non-Hispanic Black,~,Female,Mesothelioma,2016
35-39,1.8,3.5,37,Incidence,1446307,Non-Hispanic Black,2.6,Female,Myeloma,2016
35-39,6.0,8.9,106,Incidence,1446307,Non-Hispanic Black,7.3,Female,Non-Hodgkin Lymphoma,2016
35-39,1.7,3.4,35,Incidence,1446307,Non-Hispanic Black,2.4,Female,Oral Cavity and Pharynx,2016
35-39,4.0,6.4,74,Incidence,1446307,Non-Hispanic Black,5.1,Female,Ovary,2016
35-39,1.7,3.4,36,Incidence,1446307,Non-Hispanic Black,2.5,Female,Pancreas,2016
35-39,1.8,3.5,37,Incidence,1446307,Non-Hispanic Black,2.6,Female,Stomach,2016
35-39,15.8,20.2,259,Incidence,1446307,Non-Hispanic Black,17.9,Female,Thyroid,2016
35-39,~,~,~,Incidence,1446307,Non-Hispanic Black,~,Female,Urinary Bladder,2016
40-44,286.4,304.8,4000,Incidence,1353723,Non-Hispanic Black,295.5,Female,All Cancer Sites Combined,2016
40-44,1.7,3.5,34,Incidence,1353723,Non-Hispanic Black,2.5,Female,Brain and Other Nervous System,2016
40-44,14.2,18.6,221,Incidence,1353723,Non-Hispanic Black,16.3,Female,Cervix,2016
40-44,18.7,23.6,285,Incidence,1353723,Non-Hispanic Black,21.1,Female,Colon and Rectum,2016
40-44,11.9,15.9,187,Incidence,1353723,Non-Hispanic Black,13.8,Female,"Corpus and Uterus, NOS",2016
40-44,~,~,~,Incidence,1353723,Non-Hispanic Black,~,Female,Esophagus,2016
40-44,129.4,141.9,1835,Incidence,1353723,Non-Hispanic Black,135.6,Female,Female Breast,2016
40-44,31.3,37.6,465,Incidence,1353723,Non-Hispanic Black,34.3,Female,"Female Breast, <i>in situ</i>",2016
40-44,1.8,3.6,35,Incidence,1353723,Non-Hispanic Black,2.6,Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,1353723,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
40-44,8.0,11.4,130,Incidence,1353723,Non-Hispanic Black,9.6,Female,Kidney and Renal Pelvis,2016
40-44,~,~,~,Incidence,1353723,Non-Hispanic Black,~,Female,Larynx,2016
40-44,4.8,7.5,82,Incidence,1353723,Non-Hispanic Black,6.1,Female,Leukemias,2016
40-44,1.0,2.5,22,Incidence,1353723,Non-Hispanic Black,1.6,Female,Liver and Intrahepatic Bile Duct,2016
40-44,4.4,6.9,75,Incidence,1353723,Non-Hispanic Black,5.5,Female,Lung and Bronchus,2016
40-44,~,~,~,Incidence,1353723,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,1353723,Non-Hispanic Black,~,Female,Mesothelioma,2016
40-44,4.8,7.5,82,Incidence,1353723,Non-Hispanic Black,6.1,Female,Myeloma,2016
40-44,7.8,11.1,126,Incidence,1353723,Non-Hispanic Black,9.3,Female,Non-Hodgkin Lymphoma,2016
40-44,3.3,5.6,59,Incidence,1353723,Non-Hispanic Black,4.4,Female,Oral Cavity and Pharynx,2016
40-44,5.8,8.7,97,Incidence,1353723,Non-Hispanic Black,7.2,Female,Ovary,2016
40-44,2.7,4.9,50,Incidence,1353723,Non-Hispanic Black,3.7,Female,Pancreas,2016
40-44,2.2,4.2,42,Incidence,1353723,Non-Hispanic Black,3.1,Female,Stomach,2016
40-44,18.9,23.9,288,Incidence,1353723,Non-Hispanic Black,21.3,Female,Thyroid,2016
40-44,~,~,~,Incidence,1353723,Non-Hispanic Black,~,Female,Urinary Bladder,2016
45-49,407.7,429.2,5872,Incidence,1403701,Non-Hispanic Black,418.3,Female,All Cancer Sites Combined,2016
45-49,1.9,3.7,38,Incidence,1403701,Non-Hispanic Black,2.7,Female,Brain and Other Nervous System,2016
45-49,11.9,15.8,193,Incidence,1403701,Non-Hispanic Black,13.7,Female,Cervix,2016
45-49,33.3,39.7,511,Incidence,1403701,Non-Hispanic Black,36.4,Female,Colon and Rectum,2016
45-49,17.9,22.7,283,Incidence,1403701,Non-Hispanic Black,20.2,Female,"Corpus and Uterus, NOS",2016
45-49,~,~,~,Incidence,1403701,Non-Hispanic Black,~,Female,Esophagus,2016
45-49,180.8,195.2,2637,Incidence,1403701,Non-Hispanic Black,187.9,Female,Female Breast,2016
45-49,43.3,50.5,657,Incidence,1403701,Non-Hispanic Black,46.8,Female,"Female Breast, <i>in situ</i>",2016
45-49,2.2,4.0,42,Incidence,1403701,Non-Hispanic Black,3.0,Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,1403701,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
45-49,10.7,14.5,175,Incidence,1403701,Non-Hispanic Black,12.5,Female,Kidney and Renal Pelvis,2016
45-49,~,~,~,Incidence,1403701,Non-Hispanic Black,~,Female,Larynx,2016
45-49,6.2,9.1,106,Incidence,1403701,Non-Hispanic Black,7.6,Female,Leukemias,2016
45-49,1.6,3.2,32,Incidence,1403701,Non-Hispanic Black,2.3,Female,Liver and Intrahepatic Bile Duct,2016
45-49,15.7,20.2,251,Incidence,1403701,Non-Hispanic Black,17.9,Female,Lung and Bronchus,2016
45-49,~,~,~,Incidence,1403701,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,1403701,Non-Hispanic Black,~,Female,Mesothelioma,2016
45-49,8.8,12.2,146,Incidence,1403701,Non-Hispanic Black,10.4,Female,Myeloma,2016
45-49,12.0,16.0,195,Incidence,1403701,Non-Hispanic Black,13.9,Female,Non-Hodgkin Lymphoma,2016
45-49,4.5,7.1,80,Incidence,1403701,Non-Hispanic Black,5.7,Female,Oral Cavity and Pharynx,2016
45-49,8.7,12.2,145,Incidence,1403701,Non-Hispanic Black,10.3,Female,Ovary,2016
45-49,6.6,9.7,113,Incidence,1403701,Non-Hispanic Black,8.1,Female,Pancreas,2016
45-49,4.4,6.9,78,Incidence,1403701,Non-Hispanic Black,5.6,Female,Stomach,2016
45-49,21.1,26.3,331,Incidence,1403701,Non-Hispanic Black,23.6,Female,Thyroid,2016
45-49,1.0,2.5,23,Incidence,1403701,Non-Hispanic Black,1.6,Female,Urinary Bladder,2016
5-9,9.2,12.5,165,Incidence,1536668,Non-Hispanic Black,10.7,Female,All Cancer Sites Combined,2016
5-9,2.6,4.5,53,Incidence,1536668,Non-Hispanic Black,3.4,Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Cervix,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Esophagus,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Female Breast,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Larynx,2016
5-9,1.8,3.5,39,Incidence,1536668,Non-Hispanic Black,2.5,Female,Leukemias,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Mesothelioma,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Myeloma,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Ovary,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Pancreas,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Stomach,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Thyroid,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Female,Urinary Bladder,2016
50-54,605.6,631.3,8968,Incidence,1450267,Non-Hispanic Black,618.4,Female,All Cancer Sites Combined,2016
50-54,3.4,5.6,64,Incidence,1450267,Non-Hispanic Black,4.4,Female,Brain and Other Nervous System,2016
50-54,14.3,18.6,237,Incidence,1450267,Non-Hispanic Black,16.3,Female,Cervix,2016
50-54,72.5,81.6,1116,Incidence,1450267,Non-Hispanic Black,77.0,Female,Colon and Rectum,2016
50-54,33.0,39.2,522,Incidence,1450267,Non-Hispanic Black,36.0,Female,"Corpus and Uterus, NOS",2016
50-54,2.0,3.8,41,Incidence,1450267,Non-Hispanic Black,2.8,Female,Esophagus,2016
50-54,223.4,239.1,3352,Incidence,1450267,Non-Hispanic Black,231.1,Female,Female Breast,2016
50-54,57.2,65.3,887,Incidence,1450267,Non-Hispanic Black,61.2,Female,"Female Breast, <i>in situ</i>",2016
50-54,2.0,3.8,40,Incidence,1450267,Non-Hispanic Black,2.8,Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,1450267,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
50-54,16.5,21.0,270,Incidence,1450267,Non-Hispanic Black,18.6,Female,Kidney and Renal Pelvis,2016
50-54,2.6,4.6,51,Incidence,1450267,Non-Hispanic Black,3.5,Female,Larynx,2016
50-54,9.5,13.0,162,Incidence,1450267,Non-Hispanic Black,11.2,Female,Leukemias,2016
50-54,5.2,7.9,93,Incidence,1450267,Non-Hispanic Black,6.4,Female,Liver and Intrahepatic Bile Duct,2016
50-54,45.6,52.8,712,Incidence,1450267,Non-Hispanic Black,49.1,Female,Lung and Bronchus,2016
50-54,0.8,2.0,19,Incidence,1450267,Non-Hispanic Black,1.3,Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,1450267,Non-Hispanic Black,~,Female,Mesothelioma,2016
50-54,14.7,18.9,242,Incidence,1450267,Non-Hispanic Black,16.7,Female,Myeloma,2016
50-54,15.4,19.8,254,Incidence,1450267,Non-Hispanic Black,17.5,Female,Non-Hodgkin Lymphoma,2016
50-54,8.1,11.3,139,Incidence,1450267,Non-Hispanic Black,9.6,Female,Oral Cavity and Pharynx,2016
50-54,12.3,16.2,205,Incidence,1450267,Non-Hispanic Black,14.1,Female,Ovary,2016
50-54,12.3,16.3,206,Incidence,1450267,Non-Hispanic Black,14.2,Female,Pancreas,2016
50-54,8.5,11.8,146,Incidence,1450267,Non-Hispanic Black,10.1,Female,Stomach,2016
50-54,22.5,27.7,362,Incidence,1450267,Non-Hispanic Black,25.0,Female,Thyroid,2016
50-54,3.8,6.2,71,Incidence,1450267,Non-Hispanic Black,4.9,Female,Urinary Bladder,2016
55-59,823.7,854.0,11843,Incidence,1412034,Non-Hispanic Black,838.7,Female,All Cancer Sites Combined,2016
55-59,3.4,5.6,62,Incidence,1412034,Non-Hispanic Black,4.4,Female,Brain and Other Nervous System,2016
55-59,13.7,17.9,221,Incidence,1412034,Non-Hispanic Black,15.7,Female,Cervix,2016
55-59,71.2,80.3,1068,Incidence,1412034,Non-Hispanic Black,75.6,Female,Colon and Rectum,2016
55-59,64.0,72.7,964,Incidence,1412034,Non-Hispanic Black,68.3,Female,"Corpus and Uterus, NOS",2016
55-59,4.0,6.4,72,Incidence,1412034,Non-Hispanic Black,5.1,Female,Esophagus,2016
55-59,276.1,293.8,4022,Incidence,1412034,Non-Hispanic Black,284.8,Female,Female Breast,2016
55-59,66.9,75.8,1006,Incidence,1412034,Non-Hispanic Black,71.2,Female,"Female Breast, <i>in situ</i>",2016
55-59,1.6,3.3,33,Incidence,1412034,Non-Hispanic Black,2.3,Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,1412034,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
55-59,24.9,30.5,390,Incidence,1412034,Non-Hispanic Black,27.6,Female,Kidney and Renal Pelvis,2016
55-59,3.7,6.1,68,Incidence,1412034,Non-Hispanic Black,4.8,Female,Larynx,2016
55-59,11.9,15.9,195,Incidence,1412034,Non-Hispanic Black,13.8,Female,Leukemias,2016
55-59,11.7,15.7,192,Incidence,1412034,Non-Hispanic Black,13.6,Female,Liver and Intrahepatic Bile Duct,2016
55-59,104.2,115.2,1548,Incidence,1412034,Non-Hispanic Black,109.6,Female,Lung and Bronchus,2016
55-59,1.1,2.5,24,Incidence,1412034,Non-Hispanic Black,1.7,Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,1412034,Non-Hispanic Black,~,Female,Mesothelioma,2016
55-59,20.1,25.1,318,Incidence,1412034,Non-Hispanic Black,22.5,Female,Myeloma,2016
55-59,20.0,25.0,316,Incidence,1412034,Non-Hispanic Black,22.4,Female,Non-Hodgkin Lymphoma,2016
55-59,11.3,15.1,185,Incidence,1412034,Non-Hispanic Black,13.1,Female,Oral Cavity and Pharynx,2016
55-59,17.4,22.1,278,Incidence,1412034,Non-Hispanic Black,19.7,Female,Ovary,2016
55-59,20.8,25.9,328,Incidence,1412034,Non-Hispanic Black,23.2,Female,Pancreas,2016
55-59,12.3,16.3,200,Incidence,1412034,Non-Hispanic Black,14.2,Female,Stomach,2016
55-59,22.5,27.7,353,Incidence,1412034,Non-Hispanic Black,25.0,Female,Thyroid,2016
55-59,8.6,12.0,144,Incidence,1412034,Non-Hispanic Black,10.2,Female,Urinary Bladder,2016
60-64,1084.1,1122.0,13123,Incidence,1189828,Non-Hispanic Black,1102.9,Female,All Cancer Sites Combined,2016
60-64,5.9,9.0,87,Incidence,1189828,Non-Hispanic Black,7.3,Female,Brain and Other Nervous System,2016
60-64,14.8,19.6,203,Incidence,1189828,Non-Hispanic Black,17.1,Female,Cervix,2016
60-64,91.1,102.4,1150,Incidence,1189828,Non-Hispanic Black,96.7,Female,Colon and Rectum,2016
60-64,108.1,120.3,1357,Incidence,1189828,Non-Hispanic Black,114.1,Female,"Corpus and Uterus, NOS",2016
60-64,6.4,9.7,94,Incidence,1189828,Non-Hispanic Black,7.9,Female,Esophagus,2016
60-64,333.0,354.2,4087,Incidence,1189828,Non-Hispanic Black,343.5,Female,Female Breast,2016
60-64,91.1,102.3,1149,Incidence,1189828,Non-Hispanic Black,96.6,Female,"Female Breast, <i>in situ</i>",2016
60-64,2.0,4.0,34,Incidence,1189828,Non-Hispanic Black,2.9,Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,1189828,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
60-64,35.8,43.0,467,Incidence,1189828,Non-Hispanic Black,39.2,Female,Kidney and Renal Pelvis,2016
60-64,5.5,8.6,82,Incidence,1189828,Non-Hispanic Black,6.9,Female,Larynx,2016
60-64,17.0,22.1,231,Incidence,1189828,Non-Hispanic Black,19.4,Female,Leukemias,2016
60-64,26.7,33.0,354,Incidence,1189828,Non-Hispanic Black,29.8,Female,Liver and Intrahepatic Bile Duct,2016
60-64,129.1,142.4,1614,Incidence,1189828,Non-Hispanic Black,135.6,Female,Lung and Bronchus,2016
60-64,1.2,2.9,23,Incidence,1189828,Non-Hispanic Black,1.9,Female,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,1189828,Non-Hispanic Black,~,Female,Mesothelioma,2016
60-64,30.3,37.0,399,Incidence,1189828,Non-Hispanic Black,33.5,Female,Myeloma,2016
60-64,28.3,34.8,374,Incidence,1189828,Non-Hispanic Black,31.4,Female,Non-Hodgkin Lymphoma,2016
60-64,13.2,17.7,182,Incidence,1189828,Non-Hispanic Black,15.3,Female,Oral Cavity and Pharynx,2016
60-64,20.4,25.9,274,Incidence,1189828,Non-Hispanic Black,23.0,Female,Ovary,2016
60-64,35.1,42.3,459,Incidence,1189828,Non-Hispanic Black,38.6,Female,Pancreas,2016
60-64,16.3,21.3,222,Incidence,1189828,Non-Hispanic Black,18.7,Female,Stomach,2016
60-64,21.8,27.5,292,Incidence,1189828,Non-Hispanic Black,24.5,Female,Thyroid,2016
60-64,12.1,16.5,169,Incidence,1189828,Non-Hispanic Black,14.2,Female,Urinary Bladder,2016
65-69,1386.2,1434.2,13339,Incidence,945997,Non-Hispanic Black,1410.0,Female,All Cancer Sites Combined,2016
65-69,4.6,7.8,57,Incidence,945997,Non-Hispanic Black,6.0,Female,Brain and Other Nervous System,2016
65-69,13.1,18.3,147,Incidence,945997,Non-Hispanic Black,15.5,Female,Cervix,2016
65-69,122.7,137.3,1228,Incidence,945997,Non-Hispanic Black,129.8,Female,Colon and Rectum,2016
65-69,137.9,153.3,1376,Incidence,945997,Non-Hispanic Black,145.5,Female,"Corpus and Uterus, NOS",2016
65-69,7.0,10.9,83,Incidence,945997,Non-Hispanic Black,8.8,Female,Esophagus,2016
65-69,410.6,436.9,4007,Incidence,945997,Non-Hispanic Black,423.6,Female,Female Breast,2016
65-69,113.5,127.6,1139,Incidence,945997,Non-Hispanic Black,120.4,Female,"Female Breast, <i>in situ</i>",2016
65-69,1.3,3.3,20,Incidence,945997,Non-Hispanic Black,2.1,Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,945997,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
65-69,48.9,58.4,506,Incidence,945997,Non-Hispanic Black,53.5,Female,Kidney and Renal Pelvis,2016
65-69,4.3,7.4,54,Incidence,945997,Non-Hispanic Black,5.7,Female,Larynx,2016
65-69,22.7,29.2,244,Incidence,945997,Non-Hispanic Black,25.8,Female,Leukemias,2016
65-69,23.2,29.8,249,Incidence,945997,Non-Hispanic Black,26.3,Female,Liver and Intrahepatic Bile Duct,2016
65-69,187.3,205.2,1855,Incidence,945997,Non-Hispanic Black,196.1,Female,Lung and Bronchus,2016
65-69,1.2,3.1,19,Incidence,945997,Non-Hispanic Black,2.0,Female,Melanomas of the Skin,2016
65-69,~,~,~,Incidence,945997,Non-Hispanic Black,~,Female,Mesothelioma,2016
65-69,45.8,54.9,475,Incidence,945997,Non-Hispanic Black,50.2,Female,Myeloma,2016
65-69,33.3,41.2,351,Incidence,945997,Non-Hispanic Black,37.1,Female,Non-Hodgkin Lymphoma,2016
65-69,13.9,19.2,155,Incidence,945997,Non-Hispanic Black,16.4,Female,Oral Cavity and Pharynx,2016
65-69,22.8,29.4,245,Incidence,945997,Non-Hispanic Black,25.9,Female,Ovary,2016
65-69,49.9,59.5,516,Incidence,945997,Non-Hispanic Black,54.5,Female,Pancreas,2016
65-69,16.7,22.5,184,Incidence,945997,Non-Hispanic Black,19.5,Female,Stomach,2016
65-69,25.9,32.9,277,Incidence,945997,Non-Hispanic Black,29.3,Female,Thyroid,2016
65-69,20.2,26.4,219,Incidence,945997,Non-Hispanic Black,23.2,Female,Urinary Bladder,2016
70-74,1567.4,1630.4,9947,Incidence,622205,Non-Hispanic Black,1598.7,Female,All Cancer Sites Combined,2016
70-74,7.8,13.0,63,Incidence,622205,Non-Hispanic Black,10.1,Female,Brain and Other Nervous System,2016
70-74,14.4,21.1,109,Incidence,622205,Non-Hispanic Black,17.5,Female,Cervix,2016
70-74,136.1,155.2,905,Incidence,622205,Non-Hispanic Black,145.5,Female,Colon and Rectum,2016
70-74,119.0,137.0,795,Incidence,622205,Non-Hispanic Black,127.8,Female,"Corpus and Uterus, NOS",2016
70-74,6.5,11.3,54,Incidence,622205,Non-Hispanic Black,8.7,Female,Esophagus,2016
70-74,423.1,456.2,2734,Incidence,622205,Non-Hispanic Black,439.4,Female,Female Breast,2016
70-74,118.4,136.3,791,Incidence,622205,Non-Hispanic Black,127.1,Female,"Female Breast, <i>in situ</i>",2016
70-74,1.6,4.4,17,Incidence,622205,Non-Hispanic Black,2.7,Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,622205,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
70-74,55.4,67.9,382,Incidence,622205,Non-Hispanic Black,61.4,Female,Kidney and Renal Pelvis,2016
70-74,3.0,6.5,28,Incidence,622205,Non-Hispanic Black,4.5,Female,Larynx,2016
70-74,30.7,40.2,219,Incidence,622205,Non-Hispanic Black,35.2,Female,Leukemias,2016
70-74,18.2,25.7,135,Incidence,622205,Non-Hispanic Black,21.7,Female,Liver and Intrahepatic Bile Duct,2016
70-74,249.2,274.8,1629,Incidence,622205,Non-Hispanic Black,261.8,Female,Lung and Bronchus,2016
70-74,1.7,4.6,18,Incidence,622205,Non-Hispanic Black,2.9,Female,Melanomas of the Skin,2016
70-74,~,~,~,Incidence,622205,Non-Hispanic Black,~,Female,Mesothelioma,2016
70-74,61.0,74.1,419,Incidence,622205,Non-Hispanic Black,67.3,Female,Myeloma,2016
70-74,43.7,54.8,305,Incidence,622205,Non-Hispanic Black,49.0,Female,Non-Hodgkin Lymphoma,2016
70-74,15.0,21.8,113,Incidence,622205,Non-Hispanic Black,18.2,Female,Oral Cavity and Pharynx,2016
70-74,29.0,38.3,208,Incidence,622205,Non-Hispanic Black,33.4,Female,Ovary,2016
70-74,53.6,65.8,370,Incidence,622205,Non-Hispanic Black,59.5,Female,Pancreas,2016
70-74,24.9,33.5,180,Incidence,622205,Non-Hispanic Black,28.9,Female,Stomach,2016
70-74,23.1,31.4,168,Incidence,622205,Non-Hispanic Black,27.0,Female,Thyroid,2016
70-74,26.5,35.4,191,Incidence,622205,Non-Hispanic Black,30.7,Female,Urinary Bladder,2016
75-79,1704.3,1781.9,7801,Incidence,447611,Non-Hispanic Black,1742.8,Female,All Cancer Sites Combined,2016
75-79,8.3,14.7,50,Incidence,447611,Non-Hispanic Black,11.2,Female,Brain and Other Nervous System,2016
75-79,17.0,25.7,94,Incidence,447611,Non-Hispanic Black,21.0,Female,Cervix,2016
75-79,163.3,188.1,785,Incidence,447611,Non-Hispanic Black,175.4,Female,Colon and Rectum,2016
75-79,100.2,119.8,491,Incidence,447611,Non-Hispanic Black,109.7,Female,"Corpus and Uterus, NOS",2016
75-79,7.9,14.2,48,Incidence,447611,Non-Hispanic Black,10.7,Female,Esophagus,2016
75-79,413.0,451.8,1934,Incidence,447611,Non-Hispanic Black,432.1,Female,Female Breast,2016
75-79,96.4,115.6,473,Incidence,447611,Non-Hispanic Black,105.7,Female,"Female Breast, <i>in situ</i>",2016
75-79,~,~,~,Incidence,447611,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,447611,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
75-79,52.9,67.5,268,Incidence,447611,Non-Hispanic Black,59.9,Female,Kidney and Renal Pelvis,2016
75-79,3.6,8.2,25,Incidence,447611,Non-Hispanic Black,5.6,Female,Larynx,2016
75-79,36.4,48.7,189,Incidence,447611,Non-Hispanic Black,42.2,Female,Leukemias,2016
75-79,15.2,23.5,85,Incidence,447611,Non-Hispanic Black,19.0,Female,Liver and Intrahepatic Bile Duct,2016
75-79,287.0,319.5,1356,Incidence,447611,Non-Hispanic Black,302.9,Female,Lung and Bronchus,2016
75-79,3.3,7.7,23,Incidence,447611,Non-Hispanic Black,5.1,Female,Melanomas of the Skin,2016
75-79,~,~,~,Incidence,447611,Non-Hispanic Black,~,Female,Mesothelioma,2016
75-79,70.4,87.1,351,Incidence,447611,Non-Hispanic Black,78.4,Female,Myeloma,2016
75-79,43.1,56.3,221,Incidence,447611,Non-Hispanic Black,49.4,Female,Non-Hodgkin Lymphoma,2016
75-79,12.4,20.0,71,Incidence,447611,Non-Hispanic Black,15.9,Female,Oral Cavity and Pharynx,2016
75-79,27.5,38.4,146,Incidence,447611,Non-Hispanic Black,32.6,Female,Ovary,2016
75-79,78.5,96.0,389,Incidence,447611,Non-Hispanic Black,86.9,Female,Pancreas,2016
75-79,34.8,46.8,181,Incidence,447611,Non-Hispanic Black,40.4,Female,Stomach,2016
75-79,15.8,24.2,88,Incidence,447611,Non-Hispanic Black,19.7,Female,Thyroid,2016
75-79,42.5,55.6,218,Incidence,447611,Non-Hispanic Black,48.7,Female,Urinary Bladder,2016
80-84,1733.2,1826.5,5629,Incidence,316344,Non-Hispanic Black,1779.4,Female,All Cancer Sites Combined,2016
80-84,6.7,13.9,31,Incidence,316344,Non-Hispanic Black,9.8,Female,Brain and Other Nervous System,2016
80-84,15.0,25.1,62,Incidence,316344,Non-Hispanic Black,19.6,Female,Cervix,2016
80-84,190.3,222.2,651,Incidence,316344,Non-Hispanic Black,205.8,Female,Colon and Rectum,2016
80-84,76.7,97.5,274,Incidence,316344,Non-Hispanic Black,86.6,Female,"Corpus and Uterus, NOS",2016
80-84,6.9,14.3,32,Incidence,316344,Non-Hispanic Black,10.1,Female,Esophagus,2016
80-84,379.4,423.8,1269,Incidence,316344,Non-Hispanic Black,401.1,Female,Female Breast,2016
80-84,56.2,74.3,205,Incidence,316344,Non-Hispanic Black,64.8,Female,"Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,316344,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,316344,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
80-84,51.8,69.2,190,Incidence,316344,Non-Hispanic Black,60.1,Female,Kidney and Renal Pelvis,2016
80-84,3.1,8.6,17,Incidence,316344,Non-Hispanic Black,5.4,Female,Larynx,2016
80-84,42.8,58.7,159,Incidence,316344,Non-Hispanic Black,50.3,Female,Leukemias,2016
80-84,19.8,31.1,79,Incidence,316344,Non-Hispanic Black,25.0,Female,Liver and Intrahepatic Bile Duct,2016
80-84,272.0,309.9,919,Incidence,316344,Non-Hispanic Black,290.5,Female,Lung and Bronchus,2016
80-84,~,~,~,Incidence,316344,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
80-84,~,~,~,Incidence,316344,Non-Hispanic Black,~,Female,Mesothelioma,2016
80-84,62.1,81.1,225,Incidence,316344,Non-Hispanic Black,71.1,Female,Myeloma,2016
80-84,47.1,63.8,174,Incidence,316344,Non-Hispanic Black,55.0,Female,Non-Hodgkin Lymphoma,2016
80-84,10.6,19.4,46,Incidence,316344,Non-Hispanic Black,14.5,Female,Oral Cavity and Pharynx,2016
80-84,33.8,48.1,128,Incidence,316344,Non-Hispanic Black,40.5,Female,Ovary,2016
80-84,82.3,103.9,293,Incidence,316344,Non-Hispanic Black,92.6,Female,Pancreas,2016
80-84,41.3,57.0,154,Incidence,316344,Non-Hispanic Black,48.7,Female,Stomach,2016
80-84,12.5,21.9,53,Incidence,316344,Non-Hispanic Black,16.8,Female,Thyroid,2016
80-84,42.2,58.0,157,Incidence,316344,Non-Hispanic Black,49.6,Female,Urinary Bladder,2016
85+,1604.5,1692.1,5476,Incidence,332306,Non-Hispanic Black,1647.9,Female,All Cancer Sites Combined,2016
85+,6.8,13.9,33,Incidence,332306,Non-Hispanic Black,9.9,Female,Brain and Other Nervous System,2016
85+,11.9,20.9,53,Incidence,332306,Non-Hispanic Black,15.9,Female,Cervix,2016
85+,202.3,234.3,724,Incidence,332306,Non-Hispanic Black,217.9,Female,Colon and Rectum,2016
85+,49.6,66.2,191,Incidence,332306,Non-Hispanic Black,57.5,Female,"Corpus and Uterus, NOS",2016
85+,6.6,13.6,32,Incidence,332306,Non-Hispanic Black,9.6,Female,Esophagus,2016
85+,322.8,362.9,1138,Incidence,332306,Non-Hispanic Black,342.5,Female,Female Breast,2016
85+,23.9,35.9,98,Incidence,332306,Non-Hispanic Black,29.5,Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,332306,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,332306,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
85+,39.6,54.6,155,Incidence,332306,Non-Hispanic Black,46.6,Female,Kidney and Renal Pelvis,2016
85+,~,~,~,Incidence,332306,Non-Hispanic Black,~,Female,Larynx,2016
85+,45.4,61.4,176,Incidence,332306,Non-Hispanic Black,53.0,Female,Leukemias,2016
85+,20.2,31.3,84,Incidence,332306,Non-Hispanic Black,25.3,Female,Liver and Intrahepatic Bile Duct,2016
85+,212.4,245.2,759,Incidence,332306,Non-Hispanic Black,228.4,Female,Lung and Bronchus,2016
85+,3.9,9.7,21,Incidence,332306,Non-Hispanic Black,6.3,Female,Melanomas of the Skin,2016
85+,~,~,~,Incidence,332306,Non-Hispanic Black,~,Female,Mesothelioma,2016
85+,58.9,76.8,224,Incidence,332306,Non-Hispanic Black,67.4,Female,Myeloma,2016
85+,41.0,56.2,160,Incidence,332306,Non-Hispanic Black,48.1,Female,Non-Hodgkin Lymphoma,2016
85+,16.2,26.3,69,Incidence,332306,Non-Hispanic Black,20.8,Female,Oral Cavity and Pharynx,2016
85+,28.6,41.5,115,Incidence,332306,Non-Hispanic Black,34.6,Female,Ovary,2016
85+,93.7,116.0,347,Incidence,332306,Non-Hispanic Black,104.4,Female,Pancreas,2016
85+,49.9,66.6,192,Incidence,332306,Non-Hispanic Black,57.8,Female,Stomach,2016
85+,5.4,11.8,27,Incidence,332306,Non-Hispanic Black,8.1,Female,Thyroid,2016
85+,62.0,80.4,235,Incidence,332306,Non-Hispanic Black,70.7,Female,Urinary Bladder,2016
<1,15.1,25.5,59,Incidence,298319,Non-Hispanic Black,19.8,Female,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Cervix,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Colon and Rectum,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Esophagus,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Female Breast,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Larynx,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Leukemias,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Mesothelioma,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Myeloma,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Ovary,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Pancreas,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Stomach,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Thyroid,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Female,Urinary Bladder,2016
1-4,15.5,20.3,221,Incidence,1243824,Non-Hispanic Black,17.8,Male,All Cancer Sites Combined,2016
1-4,3.1,5.4,51,Incidence,1243824,Non-Hispanic Black,4.1,Male,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Colon and Rectum,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Esophagus,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
1-4,0.9,2.3,18,Incidence,1243824,Non-Hispanic Black,1.4,Male,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Larynx,2016
1-4,4.0,6.7,65,Incidence,1243824,Non-Hispanic Black,5.2,Male,Leukemias,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
1-4,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Mesothelioma,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Myeloma,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Pancreas,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Prostate,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Stomach,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Testis,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Thyroid,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male,Urinary Bladder,2016
10-14,12.8,16.6,226,Incidence,1548466,Non-Hispanic Black,14.6,Male,All Cancer Sites Combined,2016
10-14,1.8,3.4,39,Incidence,1548466,Non-Hispanic Black,2.5,Male,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Colon and Rectum,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Esophagus,2016
10-14,1.0,2.3,24,Incidence,1548466,Non-Hispanic Black,1.5,Male,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Larynx,2016
10-14,2.3,4.1,48,Incidence,1548466,Non-Hispanic Black,3.1,Male,Leukemias,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
10-14,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Mesothelioma,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Myeloma,2016
10-14,1.6,3.2,36,Incidence,1548466,Non-Hispanic Black,2.3,Male,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Pancreas,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Prostate,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Stomach,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Testis,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Thyroid,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male,Urinary Bladder,2016
15-19,16.3,20.5,299,Incidence,1630512,Non-Hispanic Black,18.3,Male,All Cancer Sites Combined,2016
15-19,1.2,2.6,29,Incidence,1630512,Non-Hispanic Black,1.8,Male,Brain and Other Nervous System,2016
15-19,0.6,1.6,16,Incidence,1630512,Non-Hispanic Black,1.0,Male,Colon and Rectum,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Esophagus,2016
15-19,1.9,3.5,42,Incidence,1630512,Non-Hispanic Black,2.6,Male,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Larynx,2016
15-19,2.1,3.8,47,Incidence,1630512,Non-Hispanic Black,2.9,Male,Leukemias,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
15-19,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Mesothelioma,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Myeloma,2016
15-19,2.1,3.8,46,Incidence,1630512,Non-Hispanic Black,2.8,Male,Non-Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Pancreas,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Prostate,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Stomach,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Testis,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Thyroid,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male,Urinary Bladder,2016
20-24,19.0,23.3,373,Incidence,1771515,Non-Hispanic Black,21.1,Male,All Cancer Sites Combined,2016
20-24,0.9,2.1,25,Incidence,1771515,Non-Hispanic Black,1.4,Male,Brain and Other Nervous System,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Colon and Rectum,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Esophagus,2016
20-24,1.7,3.2,42,Incidence,1771515,Non-Hispanic Black,2.4,Male,Hodgkin Lymphoma,2016
20-24,0.8,1.9,22,Incidence,1771515,Non-Hispanic Black,1.2,Male,Kaposi Sarcoma,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Larynx,2016
20-24,2.0,3.7,49,Incidence,1771515,Non-Hispanic Black,2.8,Male,Leukemias,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
20-24,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Mesothelioma,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Myeloma,2016
20-24,1.9,3.5,47,Incidence,1771515,Non-Hispanic Black,2.7,Male,Non-Hodgkin Lymphoma,2016
20-24,0.6,1.5,17,Incidence,1771515,Non-Hispanic Black,1.0,Male,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Pancreas,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Prostate,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Stomach,2016
20-24,1.1,2.3,28,Incidence,1771515,Non-Hispanic Black,1.6,Male,Testis,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Thyroid,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male,Urinary Bladder,2016
25-29,34.5,40.4,629,Incidence,1685032,Non-Hispanic Black,37.3,Male,All Cancer Sites Combined,2016
25-29,1.6,3.2,39,Incidence,1685032,Non-Hispanic Black,2.3,Male,Brain and Other Nervous System,2016
25-29,1.7,3.3,41,Incidence,1685032,Non-Hispanic Black,2.4,Male,Colon and Rectum,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Esophagus,2016
25-29,4.0,6.2,84,Incidence,1685032,Non-Hispanic Black,5.0,Male,Hodgkin Lymphoma,2016
25-29,3.1,5.0,67,Incidence,1685032,Non-Hispanic Black,4.0,Male,Kaposi Sarcoma,2016
25-29,1.3,2.6,31,Incidence,1685032,Non-Hispanic Black,1.8,Male,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Larynx,2016
25-29,2.5,4.2,55,Incidence,1685032,Non-Hispanic Black,3.3,Male,Leukemias,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
25-29,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Mesothelioma,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Myeloma,2016
25-29,4.1,6.4,87,Incidence,1685032,Non-Hispanic Black,5.2,Male,Non-Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Pancreas,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Prostate,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Stomach,2016
25-29,2.0,3.7,47,Incidence,1685032,Non-Hispanic Black,2.8,Male,Testis,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Thyroid,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male,Urinary Bladder,2016
30-34,54.4,62.4,816,Incidence,1399601,Non-Hispanic Black,58.3,Male,All Cancer Sites Combined,2016
30-34,1.9,3.6,37,Incidence,1399601,Non-Hispanic Black,2.6,Male,Brain and Other Nervous System,2016
30-34,5.0,7.7,88,Incidence,1399601,Non-Hispanic Black,6.3,Male,Colon and Rectum,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Esophagus,2016
30-34,3.2,5.4,59,Incidence,1399601,Non-Hispanic Black,4.2,Male,Hodgkin Lymphoma,2016
30-34,3.2,5.4,59,Incidence,1399601,Non-Hispanic Black,4.2,Male,Kaposi Sarcoma,2016
30-34,3.3,5.5,60,Incidence,1399601,Non-Hispanic Black,4.3,Male,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Larynx,2016
30-34,3.0,5.1,55,Incidence,1399601,Non-Hispanic Black,3.9,Male,Leukemias,2016
30-34,1.1,2.6,24,Incidence,1399601,Non-Hispanic Black,1.7,Male,Liver and Intrahepatic Bile Duct,2016
30-34,1.4,3.1,30,Incidence,1399601,Non-Hispanic Black,2.1,Male,Lung and Bronchus,2016
30-34,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Mesothelioma,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Myeloma,2016
30-34,5.4,8.1,93,Incidence,1399601,Non-Hispanic Black,6.6,Male,Non-Hodgkin Lymphoma,2016
30-34,1.2,2.6,25,Incidence,1399601,Non-Hispanic Black,1.8,Male,Oral Cavity and Pharynx,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Pancreas,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Prostate,2016
30-34,1.0,2.5,23,Incidence,1399601,Non-Hispanic Black,1.6,Male,Stomach,2016
30-34,2.3,4.3,45,Incidence,1399601,Non-Hispanic Black,3.2,Male,Testis,2016
30-34,1.4,3.0,29,Incidence,1399601,Non-Hispanic Black,2.1,Male,Thyroid,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male,Urinary Bladder,2016
35-39,85.5,95.9,1183,Incidence,1305398,Non-Hispanic Black,90.6,Male,All Cancer Sites Combined,2016
35-39,2.1,4.1,39,Incidence,1305398,Non-Hispanic Black,3.0,Male,Brain and Other Nervous System,2016
35-39,9.9,13.6,152,Incidence,1305398,Non-Hispanic Black,11.6,Male,Colon and Rectum,2016
35-39,~,~,~,Incidence,1305398,Non-Hispanic Black,~,Male,Esophagus,2016
35-39,3.5,5.9,60,Incidence,1305398,Non-Hispanic Black,4.6,Male,Hodgkin Lymphoma,2016
35-39,2.4,4.5,44,Incidence,1305398,Non-Hispanic Black,3.4,Male,Kaposi Sarcoma,2016
35-39,7.6,11.0,120,Incidence,1305398,Non-Hispanic Black,9.2,Male,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,1305398,Non-Hispanic Black,~,Male,Larynx,2016
35-39,5.1,7.9,83,Incidence,1305398,Non-Hispanic Black,6.4,Male,Leukemias,2016
35-39,1.2,2.7,24,Incidence,1305398,Non-Hispanic Black,1.8,Male,Liver and Intrahepatic Bile Duct,2016
35-39,3.6,6.0,61,Incidence,1305398,Non-Hispanic Black,4.7,Male,Lung and Bronchus,2016
35-39,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
35-39,~,~,~,Incidence,1305398,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,1305398,Non-Hispanic Black,~,Male,Mesothelioma,2016
35-39,1.7,3.5,32,Incidence,1305398,Non-Hispanic Black,2.5,Male,Myeloma,2016
35-39,8.9,12.5,138,Incidence,1305398,Non-Hispanic Black,10.6,Male,Non-Hodgkin Lymphoma,2016
35-39,1.7,3.5,32,Incidence,1305398,Non-Hispanic Black,2.5,Male,Oral Cavity and Pharynx,2016
35-39,1.0,2.5,21,Incidence,1305398,Non-Hispanic Black,1.6,Male,Pancreas,2016
35-39,1.2,2.7,24,Incidence,1305398,Non-Hispanic Black,1.8,Male,Prostate,2016
35-39,1.7,3.5,32,Incidence,1305398,Non-Hispanic Black,2.5,Male,Stomach,2016
35-39,2.9,5.1,51,Incidence,1305398,Non-Hispanic Black,3.9,Male,Testis,2016
35-39,2.2,4.2,40,Incidence,1305398,Non-Hispanic Black,3.1,Male,Thyroid,2016
35-39,1.4,3.0,27,Incidence,1305398,Non-Hispanic Black,2.1,Male,Urinary Bladder,2016
40-44,154.3,168.8,1938,Incidence,1200661,Non-Hispanic Black,161.4,Male,All Cancer Sites Combined,2016
40-44,2.5,4.6,41,Incidence,1200661,Non-Hispanic Black,3.4,Male,Brain and Other Nervous System,2016
40-44,20.0,25.5,272,Incidence,1200661,Non-Hispanic Black,22.7,Male,Colon and Rectum,2016
40-44,~,~,~,Incidence,1200661,Non-Hispanic Black,~,Male,Esophagus,2016
40-44,2.7,5.0,45,Incidence,1200661,Non-Hispanic Black,3.7,Male,Hodgkin Lymphoma,2016
40-44,1.5,3.4,28,Incidence,1200661,Non-Hispanic Black,2.3,Male,Kaposi Sarcoma,2016
40-44,15.2,20.0,210,Incidence,1200661,Non-Hispanic Black,17.5,Male,Kidney and Renal Pelvis,2016
40-44,1.0,2.5,19,Incidence,1200661,Non-Hispanic Black,1.6,Male,Larynx,2016
40-44,5.0,7.9,76,Incidence,1200661,Non-Hispanic Black,6.3,Male,Leukemias,2016
40-44,1.8,3.8,32,Incidence,1200661,Non-Hispanic Black,2.7,Male,Liver and Intrahepatic Bile Duct,2016
40-44,7.6,11.1,111,Incidence,1200661,Non-Hispanic Black,9.2,Male,Lung and Bronchus,2016
40-44,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
40-44,~,~,~,Incidence,1200661,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,1200661,Non-Hispanic Black,~,Male,Mesothelioma,2016
40-44,5.3,8.3,80,Incidence,1200661,Non-Hispanic Black,6.7,Male,Myeloma,2016
40-44,11.6,15.8,163,Incidence,1200661,Non-Hispanic Black,13.6,Male,Non-Hodgkin Lymphoma,2016
40-44,6.1,9.3,91,Incidence,1200661,Non-Hispanic Black,7.6,Male,Oral Cavity and Pharynx,2016
40-44,3.8,6.4,60,Incidence,1200661,Non-Hispanic Black,5.0,Male,Pancreas,2016
40-44,16.3,21.3,224,Incidence,1200661,Non-Hispanic Black,18.7,Male,Prostate,2016
40-44,3.4,5.9,54,Incidence,1200661,Non-Hispanic Black,4.5,Male,Stomach,2016
40-44,2.8,5.1,46,Incidence,1200661,Non-Hispanic Black,3.8,Male,Testis,2016
40-44,4.5,7.3,69,Incidence,1200661,Non-Hispanic Black,5.7,Male,Thyroid,2016
40-44,2.7,4.9,44,Incidence,1200661,Non-Hispanic Black,3.7,Male,Urinary Bladder,2016
45-49,292.0,311.4,3748,Incidence,1242948,Non-Hispanic Black,301.5,Male,All Cancer Sites Combined,2016
45-49,3.1,5.5,52,Incidence,1242948,Non-Hispanic Black,4.2,Male,Brain and Other Nervous System,2016
45-49,40.3,47.8,546,Incidence,1242948,Non-Hispanic Black,43.9,Male,Colon and Rectum,2016
45-49,1.6,3.4,30,Incidence,1242948,Non-Hispanic Black,2.4,Male,Esophagus,2016
45-49,2.6,4.8,44,Incidence,1242948,Non-Hispanic Black,3.5,Male,Hodgkin Lymphoma,2016
45-49,1.8,3.6,32,Incidence,1242948,Non-Hispanic Black,2.6,Male,Kaposi Sarcoma,2016
45-49,23.5,29.2,326,Incidence,1242948,Non-Hispanic Black,26.2,Male,Kidney and Renal Pelvis,2016
45-49,2.9,5.2,49,Incidence,1242948,Non-Hispanic Black,3.9,Male,Larynx,2016
45-49,8.3,11.9,124,Incidence,1242948,Non-Hispanic Black,10.0,Male,Leukemias,2016
45-49,4.2,6.9,68,Incidence,1242948,Non-Hispanic Black,5.5,Male,Liver and Intrahepatic Bile Duct,2016
45-49,14.7,19.3,210,Incidence,1242948,Non-Hispanic Black,16.9,Male,Lung and Bronchus,2016
45-49,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
45-49,~,~,~,Incidence,1242948,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,1242948,Non-Hispanic Black,~,Male,Mesothelioma,2016
45-49,7.6,11.0,114,Incidence,1242948,Non-Hispanic Black,9.2,Male,Myeloma,2016
45-49,15.3,20.0,218,Incidence,1242948,Non-Hispanic Black,17.5,Male,Non-Hodgkin Lymphoma,2016
45-49,12.9,17.3,186,Incidence,1242948,Non-Hispanic Black,15.0,Male,Oral Cavity and Pharynx,2016
45-49,7.1,10.4,107,Incidence,1242948,Non-Hispanic Black,8.6,Male,Pancreas,2016
45-49,75.8,85.8,1003,Incidence,1242948,Non-Hispanic Black,80.7,Male,Prostate,2016
45-49,7.1,10.4,107,Incidence,1242948,Non-Hispanic Black,8.6,Male,Stomach,2016
45-49,1.2,2.9,24,Incidence,1242948,Non-Hispanic Black,1.9,Male,Testis,2016
45-49,4.6,7.4,73,Incidence,1242948,Non-Hispanic Black,5.9,Male,Thyroid,2016
45-49,3.3,5.8,55,Incidence,1242948,Non-Hispanic Black,4.4,Male,Urinary Bladder,2016
5-9,10.7,14.3,197,Incidence,1586975,Non-Hispanic Black,12.4,Male,All Cancer Sites Combined,2016
5-9,2.4,4.3,52,Incidence,1586975,Non-Hispanic Black,3.3,Male,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Colon and Rectum,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Esophagus,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Larynx,2016
5-9,2.1,3.9,46,Incidence,1586975,Non-Hispanic Black,2.9,Male,Leukemias,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
5-9,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Mesothelioma,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Myeloma,2016
5-9,1.2,2.6,29,Incidence,1586975,Non-Hispanic Black,1.8,Male,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Pancreas,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Prostate,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Stomach,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Testis,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Thyroid,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male,Urinary Bladder,2016
50-54,639.8,668.0,8344,Incidence,1276248,Non-Hispanic Black,653.8,Male,All Cancer Sites Combined,2016
50-54,5.0,7.9,81,Incidence,1276248,Non-Hispanic Black,6.3,Male,Brain and Other Nervous System,2016
50-54,82.0,92.3,1111,Incidence,1276248,Non-Hispanic Black,87.1,Male,Colon and Rectum,2016
50-54,6.6,9.8,103,Incidence,1276248,Non-Hispanic Black,8.1,Male,Esophagus,2016
50-54,4.1,6.7,67,Incidence,1276248,Non-Hispanic Black,5.2,Male,Hodgkin Lymphoma,2016
50-54,1.1,2.6,22,Incidence,1276248,Non-Hispanic Black,1.7,Male,Kaposi Sarcoma,2016
50-54,39.9,47.2,554,Incidence,1276248,Non-Hispanic Black,43.4,Male,Kidney and Renal Pelvis,2016
50-54,7.4,10.8,115,Incidence,1276248,Non-Hispanic Black,9.0,Male,Larynx,2016
50-54,10.8,14.8,162,Incidence,1276248,Non-Hispanic Black,12.7,Male,Leukemias,2016
50-54,15.1,19.8,221,Incidence,1276248,Non-Hispanic Black,17.3,Male,Liver and Intrahepatic Bile Duct,2016
50-54,60.4,69.3,826,Incidence,1276248,Non-Hispanic Black,64.7,Male,Lung and Bronchus,2016
50-54,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
50-54,~,~,~,Incidence,1276248,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,1276248,Non-Hispanic Black,~,Male,Mesothelioma,2016
50-54,16.9,21.8,246,Incidence,1276248,Non-Hispanic Black,19.3,Male,Myeloma,2016
50-54,20.9,26.3,300,Incidence,1276248,Non-Hispanic Black,23.5,Male,Non-Hodgkin Lymphoma,2016
50-54,22.8,28.5,326,Incidence,1276248,Non-Hispanic Black,25.5,Male,Oral Cavity and Pharynx,2016
50-54,15.0,19.7,220,Incidence,1276248,Non-Hispanic Black,17.2,Male,Pancreas,2016
50-54,225.9,242.8,2989,Incidence,1276248,Non-Hispanic Black,234.2,Male,Prostate,2016
50-54,11.5,15.6,171,Incidence,1276248,Non-Hispanic Black,13.4,Male,Stomach,2016
50-54,~,~,~,Incidence,1276248,Non-Hispanic Black,~,Male,Testis,2016
50-54,4.0,6.6,66,Incidence,1276248,Non-Hispanic Black,5.2,Male,Thyroid,2016
50-54,10.3,14.2,155,Incidence,1276248,Non-Hispanic Black,12.1,Male,Urinary Bladder,2016
55-59,1144.2,1182.6,14140,Incidence,1215543,Non-Hispanic Black,1163.3,Male,All Cancer Sites Combined,2016
55-59,6.7,10.0,100,Incidence,1215543,Non-Hispanic Black,8.2,Male,Brain and Other Nervous System,2016
55-59,97.1,108.5,1248,Incidence,1215543,Non-Hispanic Black,102.7,Male,Colon and Rectum,2016
55-59,12.9,17.3,182,Incidence,1215543,Non-Hispanic Black,15.0,Male,Esophagus,2016
55-59,2.3,4.4,39,Incidence,1215543,Non-Hispanic Black,3.2,Male,Hodgkin Lymphoma,2016
55-59,0.8,2.1,16,Incidence,1215543,Non-Hispanic Black,1.3,Male,Kaposi Sarcoma,2016
55-59,57.1,66.0,747,Incidence,1215543,Non-Hispanic Black,61.5,Male,Kidney and Renal Pelvis,2016
55-59,16.7,21.7,232,Incidence,1215543,Non-Hispanic Black,19.1,Male,Larynx,2016
55-59,16.1,21.0,224,Incidence,1215543,Non-Hispanic Black,18.4,Male,Leukemias,2016
55-59,52.9,61.5,694,Incidence,1215543,Non-Hispanic Black,57.1,Male,Liver and Intrahepatic Bile Duct,2016
55-59,140.0,153.7,1784,Incidence,1215543,Non-Hispanic Black,146.8,Male,Lung and Bronchus,2016
55-59,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
55-59,1.2,2.8,23,Incidence,1215543,Non-Hispanic Black,1.9,Male,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,1215543,Non-Hispanic Black,~,Male,Mesothelioma,2016
55-59,24.5,30.4,332,Incidence,1215543,Non-Hispanic Black,27.3,Male,Myeloma,2016
55-59,27.2,33.4,367,Incidence,1215543,Non-Hispanic Black,30.2,Male,Non-Hodgkin Lymphoma,2016
55-59,37.4,44.7,498,Incidence,1215543,Non-Hispanic Black,41.0,Male,Oral Cavity and Pharynx,2016
55-59,29.1,35.5,391,Incidence,1215543,Non-Hispanic Black,32.2,Male,Pancreas,2016
55-59,455.4,479.8,5682,Incidence,1215543,Non-Hispanic Black,467.4,Male,Prostate,2016
55-59,22.3,28.0,304,Incidence,1215543,Non-Hispanic Black,25.0,Male,Stomach,2016
55-59,~,~,~,Incidence,1215543,Non-Hispanic Black,~,Male,Testis,2016
55-59,7.3,10.7,108,Incidence,1215543,Non-Hispanic Black,8.9,Male,Thyroid,2016
55-59,24.8,30.8,336,Incidence,1215543,Non-Hispanic Black,27.6,Male,Urinary Bladder,2016
60-64,1762.4,1815.7,17367,Incidence,970841,Non-Hispanic Black,1788.9,Male,All Cancer Sites Combined,2016
60-64,7.9,12.0,95,Incidence,970841,Non-Hispanic Black,9.8,Male,Brain and Other Nervous System,2016
60-64,138.9,154.2,1421,Incidence,970841,Non-Hispanic Black,146.4,Male,Colon and Rectum,2016
60-64,19.1,25.1,213,Incidence,970841,Non-Hispanic Black,21.9,Male,Esophagus,2016
60-64,1.3,3.2,20,Incidence,970841,Non-Hispanic Black,2.1,Male,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,970841,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
60-64,73.7,85.0,769,Incidence,970841,Non-Hispanic Black,79.2,Male,Kidney and Renal Pelvis,2016
60-64,26.2,33.2,287,Incidence,970841,Non-Hispanic Black,29.6,Male,Larynx,2016
60-64,24.1,30.8,265,Incidence,970841,Non-Hispanic Black,27.3,Male,Leukemias,2016
60-64,102.8,116.1,1061,Incidence,970841,Non-Hispanic Black,109.3,Male,Liver and Intrahepatic Bile Duct,2016
60-64,223.2,242.5,2259,Incidence,970841,Non-Hispanic Black,232.7,Male,Lung and Bronchus,2016
60-64,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
60-64,1.0,2.8,17,Incidence,970841,Non-Hispanic Black,1.8,Male,Melanomas of the Skin,2016
60-64,~,~,~,Incidence,970841,Non-Hispanic Black,~,Male,Mesothelioma,2016
60-64,41.4,50.0,442,Incidence,970841,Non-Hispanic Black,45.5,Male,Myeloma,2016
60-64,39.0,47.4,418,Incidence,970841,Non-Hispanic Black,43.1,Male,Non-Hodgkin Lymphoma,2016
60-64,45.4,54.4,483,Incidence,970841,Non-Hispanic Black,49.8,Male,Oral Cavity and Pharynx,2016
60-64,56.1,66.0,591,Incidence,970841,Non-Hispanic Black,60.9,Male,Pancreas,2016
60-64,720.8,755.1,7163,Incidence,970841,Non-Hispanic Black,737.8,Male,Prostate,2016
60-64,30.3,37.8,329,Incidence,970841,Non-Hispanic Black,33.9,Male,Stomach,2016
60-64,~,~,~,Incidence,970841,Non-Hispanic Black,~,Male,Testis,2016
60-64,7.0,10.8,85,Incidence,970841,Non-Hispanic Black,8.8,Male,Thyroid,2016
60-64,41.2,49.8,440,Incidence,970841,Non-Hispanic Black,45.3,Male,Urinary Bladder,2016
65-69,2398.1,2469.7,17799,Incidence,731351,Non-Hispanic Black,2433.7,Male,All Cancer Sites Combined,2016
65-69,10.6,16.0,96,Incidence,731351,Non-Hispanic Black,13.1,Male,Brain and Other Nervous System,2016
65-69,177.7,197.7,1371,Incidence,731351,Non-Hispanic Black,187.5,Male,Colon and Rectum,2016
65-69,23.6,31.3,199,Incidence,731351,Non-Hispanic Black,27.2,Male,Esophagus,2016
65-69,1.5,3.9,18,Incidence,731351,Non-Hispanic Black,2.5,Male,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,731351,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
65-69,104.4,119.9,819,Incidence,731351,Non-Hispanic Black,112.0,Male,Kidney and Renal Pelvis,2016
65-69,32.0,40.9,265,Incidence,731351,Non-Hispanic Black,36.2,Male,Larynx,2016
65-69,39.3,49.1,322,Incidence,731351,Non-Hispanic Black,44.0,Male,Leukemias,2016
65-69,107.6,123.3,843,Incidence,731351,Non-Hispanic Black,115.3,Male,Liver and Intrahepatic Bile Duct,2016
65-69,320.8,347.4,2442,Incidence,731351,Non-Hispanic Black,333.9,Male,Lung and Bronchus,2016
65-69,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
65-69,2.5,5.5,28,Incidence,731351,Non-Hispanic Black,3.8,Male,Melanomas of the Skin,2016
65-69,1.6,4.1,19,Incidence,731351,Non-Hispanic Black,2.6,Male,Mesothelioma,2016
65-69,64.9,77.2,518,Incidence,731351,Non-Hispanic Black,70.8,Male,Myeloma,2016
65-69,46.3,56.9,376,Incidence,731351,Non-Hispanic Black,51.4,Male,Non-Hodgkin Lymphoma,2016
65-69,53.0,64.2,427,Incidence,731351,Non-Hispanic Black,58.4,Male,Oral Cavity and Pharynx,2016
65-69,64.3,76.6,514,Incidence,731351,Non-Hispanic Black,70.3,Male,Pancreas,2016
65-69,1017.8,1064.7,7614,Incidence,731351,Non-Hispanic Black,1041.1,Male,Prostate,2016
65-69,41.0,51.0,335,Incidence,731351,Non-Hispanic Black,45.8,Male,Stomach,2016
65-69,~,~,~,Incidence,731351,Non-Hispanic Black,~,Male,Testis,2016
65-69,9.4,14.5,86,Incidence,731351,Non-Hispanic Black,11.8,Male,Thyroid,2016
65-69,57.4,69.1,461,Incidence,731351,Non-Hispanic Black,63.0,Male,Urinary Bladder,2016
70-74,2568.5,2663.3,11751,Incidence,449274,Non-Hispanic Black,2615.6,Male,All Cancer Sites Combined,2016
70-74,8.3,14.7,50,Incidence,449274,Non-Hispanic Black,11.1,Male,Brain and Other Nervous System,2016
70-74,190.5,217.1,914,Incidence,449274,Non-Hispanic Black,203.4,Male,Colon and Rectum,2016
70-74,25.6,36.0,137,Incidence,449274,Non-Hispanic Black,30.5,Male,Esophagus,2016
70-74,~,~,~,Incidence,449274,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,449274,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
70-74,104.7,124.7,514,Incidence,449274,Non-Hispanic Black,114.4,Male,Kidney and Renal Pelvis,2016
70-74,35.3,47.3,184,Incidence,449274,Non-Hispanic Black,41.0,Male,Larynx,2016
70-74,51.3,65.6,261,Incidence,449274,Non-Hispanic Black,58.1,Male,Leukemias,2016
70-74,64.3,80.2,323,Incidence,449274,Non-Hispanic Black,71.9,Male,Liver and Intrahepatic Bile Duct,2016
70-74,450.0,490.4,2111,Incidence,449274,Non-Hispanic Black,469.9,Male,Lung and Bronchus,2016
70-74,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
70-74,2.4,6.3,18,Incidence,449274,Non-Hispanic Black,4.0,Male,Melanomas of the Skin,2016
70-74,4.5,9.5,30,Incidence,449274,Non-Hispanic Black,6.7,Male,Mesothelioma,2016
70-74,72.9,89.8,364,Incidence,449274,Non-Hispanic Black,81.0,Male,Myeloma,2016
70-74,61.7,77.4,311,Incidence,449274,Non-Hispanic Black,69.2,Male,Non-Hodgkin Lymphoma,2016
70-74,52.7,67.2,268,Incidence,449274,Non-Hispanic Black,59.7,Male,Oral Cavity and Pharynx,2016
70-74,87.5,105.9,433,Incidence,449274,Non-Hispanic Black,96.4,Male,Pancreas,2016
70-74,908.5,965.4,4208,Incidence,449274,Non-Hispanic Black,936.6,Male,Prostate,2016
70-74,58.2,73.4,294,Incidence,449274,Non-Hispanic Black,65.4,Male,Stomach,2016
70-74,~,~,~,Incidence,449274,Non-Hispanic Black,~,Male,Testis,2016
70-74,8.6,15.2,52,Incidence,449274,Non-Hispanic Black,11.6,Male,Thyroid,2016
70-74,98.3,117.8,484,Incidence,449274,Non-Hispanic Black,107.7,Male,Urinary Bladder,2016
75-79,2583.7,2701.5,7774,Incidence,294237,Non-Hispanic Black,2642.1,Male,All Cancer Sites Combined,2016
75-79,6.3,13.8,28,Incidence,294237,Non-Hispanic Black,9.5,Male,Brain and Other Nervous System,2016
75-79,237.0,273.8,750,Incidence,294237,Non-Hispanic Black,254.9,Male,Colon and Rectum,2016
75-79,26.1,39.5,95,Incidence,294237,Non-Hispanic Black,32.3,Male,Esophagus,2016
75-79,~,~,~,Incidence,294237,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,294237,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
75-79,105.8,131.0,347,Incidence,294237,Non-Hispanic Black,117.9,Male,Kidney and Renal Pelvis,2016
75-79,32.3,46.9,115,Incidence,294237,Non-Hispanic Black,39.1,Male,Larynx,2016
75-79,66.5,86.8,224,Incidence,294237,Non-Hispanic Black,76.1,Male,Leukemias,2016
75-79,42.8,59.5,149,Incidence,294237,Non-Hispanic Black,50.6,Male,Liver and Intrahepatic Bile Duct,2016
75-79,500.2,553.0,1548,Incidence,294237,Non-Hispanic Black,526.1,Male,Lung and Bronchus,2016
75-79,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
75-79,5.0,11.7,23,Incidence,294237,Non-Hispanic Black,7.8,Male,Melanomas of the Skin,2016
75-79,3.4,9.3,17,Incidence,294237,Non-Hispanic Black,5.8,Male,Mesothelioma,2016
75-79,81.1,103.4,270,Incidence,294237,Non-Hispanic Black,91.8,Male,Myeloma,2016
75-79,67.4,87.9,227,Incidence,294237,Non-Hispanic Black,77.1,Male,Non-Hodgkin Lymphoma,2016
75-79,42.5,59.1,148,Incidence,294237,Non-Hispanic Black,50.3,Male,Oral Cavity and Pharynx,2016
75-79,86.6,109.5,287,Incidence,294237,Non-Hispanic Black,97.5,Male,Pancreas,2016
75-79,747.4,811.5,2292,Incidence,294237,Non-Hispanic Black,779.0,Male,Prostate,2016
75-79,73.5,94.7,246,Incidence,294237,Non-Hispanic Black,83.6,Male,Stomach,2016
75-79,~,~,~,Incidence,294237,Non-Hispanic Black,~,Male,Testis,2016
75-79,8.3,16.5,35,Incidence,294237,Non-Hispanic Black,11.9,Male,Thyroid,2016
75-79,118.7,145.3,387,Incidence,294237,Non-Hispanic Black,131.5,Male,Urinary Bladder,2016
80-84,2446.5,2593.3,4562,Incidence,181095,Non-Hispanic Black,2519.1,Male,All Cancer Sites Combined,2016
80-84,8.9,20.4,25,Incidence,181095,Non-Hispanic Black,13.8,Male,Brain and Other Nervous System,2016
80-84,254.5,303.7,504,Incidence,181095,Non-Hispanic Black,278.3,Male,Colon and Rectum,2016
80-84,29.2,47.6,68,Incidence,181095,Non-Hispanic Black,37.5,Male,Esophagus,2016
80-84,~,~,~,Incidence,181095,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,181095,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
80-84,79.8,108.5,169,Incidence,181095,Non-Hispanic Black,93.3,Male,Kidney and Renal Pelvis,2016
80-84,26.2,43.9,62,Incidence,181095,Non-Hispanic Black,34.2,Male,Larynx,2016
80-84,63.5,89.4,137,Incidence,181095,Non-Hispanic Black,75.7,Male,Leukemias,2016
80-84,40.0,61.1,90,Incidence,181095,Non-Hispanic Black,49.7,Male,Liver and Intrahepatic Bile Duct,2016
80-84,457.6,522.6,886,Incidence,181095,Non-Hispanic Black,489.2,Male,Lung and Bronchus,2016
80-84,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
80-84,~,~,~,Incidence,181095,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
80-84,7.2,17.7,21,Incidence,181095,Non-Hispanic Black,11.6,Male,Mesothelioma,2016
80-84,107.0,139.8,222,Incidence,181095,Non-Hispanic Black,122.6,Male,Myeloma,2016
80-84,60.5,85.8,131,Incidence,181095,Non-Hispanic Black,72.3,Male,Non-Hodgkin Lymphoma,2016
80-84,31.6,50.7,73,Incidence,181095,Non-Hispanic Black,40.3,Male,Oral Cavity and Pharynx,2016
80-84,85.4,115.0,180,Incidence,181095,Non-Hispanic Black,99.4,Male,Pancreas,2016
80-84,536.2,606.3,1033,Incidence,181095,Non-Hispanic Black,570.4,Male,Prostate,2016
80-84,81.8,110.9,173,Incidence,181095,Non-Hispanic Black,95.5,Male,Stomach,2016
80-84,~,~,~,Incidence,181095,Non-Hispanic Black,~,Male,Testis,2016
80-84,~,~,~,Incidence,181095,Non-Hispanic Black,~,Male,Thyroid,2016
80-84,143.3,180.8,292,Incidence,181095,Non-Hispanic Black,161.2,Male,Urinary Bladder,2016
85+,2314.2,2476.9,3361,Incidence,140363,Non-Hispanic Black,2394.5,Male,All Cancer Sites Combined,2016
85+,11.0,25.4,24,Incidence,140363,Non-Hispanic Black,17.1,Male,Brain and Other Nervous System,2016
85+,244.2,299.4,380,Incidence,140363,Non-Hispanic Black,270.7,Male,Colon and Rectum,2016
85+,24.0,43.7,46,Incidence,140363,Non-Hispanic Black,32.8,Male,Esophagus,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
85+,68.9,99.9,117,Incidence,140363,Non-Hispanic Black,83.4,Male,Kidney and Renal Pelvis,2016
85+,14.4,30.5,30,Incidence,140363,Non-Hispanic Black,21.4,Male,Larynx,2016
85+,68.9,99.9,117,Incidence,140363,Non-Hispanic Black,83.4,Male,Leukemias,2016
85+,35.1,58.2,64,Incidence,140363,Non-Hispanic Black,45.6,Male,Liver and Intrahepatic Bile Duct,2016
85+,372.1,439.4,568,Incidence,140363,Non-Hispanic Black,404.7,Male,Lung and Bronchus,2016
85+,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male,Mesothelioma,2016
85+,88.5,123.1,147,Incidence,140363,Non-Hispanic Black,104.7,Male,Myeloma,2016
85+,55.4,83.5,96,Incidence,140363,Non-Hispanic Black,68.4,Male,Non-Hodgkin Lymphoma,2016
85+,26.4,47.0,50,Incidence,140363,Non-Hispanic Black,35.6,Male,Oral Cavity and Pharynx,2016
85+,95.7,131.5,158,Incidence,140363,Non-Hispanic Black,112.6,Male,Pancreas,2016
85+,490.6,567.3,741,Incidence,140363,Non-Hispanic Black,527.9,Male,Prostate,2016
85+,85.2,119.2,142,Incidence,140363,Non-Hispanic Black,101.2,Male,Stomach,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male,Testis,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male,Thyroid,2016
85+,164.7,210.7,262,Incidence,140363,Non-Hispanic Black,186.7,Male,Urinary Bladder,2016
<1,23.0,35.3,88,Incidence,306801,Non-Hispanic Black,28.7,Male,All Cancer Sites Combined,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Colon and Rectum,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Esophagus,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Larynx,2016
<1,3.2,8.9,17,Incidence,306801,Non-Hispanic Black,5.5,Male,Leukemias,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Lung and Bronchus,2016
<1,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Melanomas of the Skin,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Mesothelioma,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Myeloma,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Pancreas,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Prostate,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Stomach,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Testis,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Thyroid,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male,Urinary Bladder,2016
1-4,14.7,17.9,398,Incidence,2447141,Non-Hispanic Black,16.3,Male and Female,All Cancer Sites Combined,2016
1-4,3.0,4.6,92,Incidence,2447141,Non-Hispanic Black,3.8,Male and Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,Cervix,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Esophagus,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,Female Breast,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
1-4,1.1,2.2,39,Incidence,2447141,Non-Hispanic Black,1.6,Male and Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Larynx,2016
1-4,4.4,6.3,129,Incidence,2447141,Non-Hispanic Black,5.3,Male and Female,Leukemias,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Myeloma,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,1203317,Non-Hispanic Black,~,Male and Female,Ovary,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Pancreas,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male and Female,Prostate,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Stomach,2016
1-4,~,~,~,Incidence,1243824,Non-Hispanic Black,~,Male and Female,Testis,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Thyroid,2016
1-4,~,~,~,Incidence,2447141,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
10-14,12.0,14.6,404,Incidence,3052670,Non-Hispanic Black,13.2,Male and Female,All Cancer Sites Combined,2016
10-14,1.6,2.6,63,Incidence,3052670,Non-Hispanic Black,2.1,Male and Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,Cervix,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Esophagus,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,Female Breast,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2016
10-14,0.8,1.6,35,Incidence,3052670,Non-Hispanic Black,1.1,Male and Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Larynx,2016
10-14,2.1,3.3,80,Incidence,3052670,Non-Hispanic Black,2.6,Male and Female,Leukemias,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Myeloma,2016
10-14,1.3,2.3,53,Incidence,3052670,Non-Hispanic Black,1.7,Male and Female,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,1504204,Non-Hispanic Black,~,Male and Female,Ovary,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Pancreas,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male and Female,Prostate,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Stomach,2016
10-14,~,~,~,Incidence,1548466,Non-Hispanic Black,~,Male and Female,Testis,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Thyroid,2016
10-14,~,~,~,Incidence,3052670,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
15-19,15.7,18.6,548,Incidence,3209701,Non-Hispanic Black,17.1,Male and Female,All Cancer Sites Combined,2016
15-19,1.4,2.4,60,Incidence,3209701,Non-Hispanic Black,1.9,Male and Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Male and Female,Cervix,2016
15-19,0.4,1.0,21,Incidence,3209701,Non-Hispanic Black,0.7,Male and Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Esophagus,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Male and Female,Female Breast,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2016
15-19,1.9,3.0,76,Incidence,3209701,Non-Hispanic Black,2.4,Male and Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Larynx,2016
15-19,1.8,2.9,74,Incidence,3209701,Non-Hispanic Black,2.3,Male and Female,Leukemias,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2016
15-19,~,~,~,Incidence,1579189,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Myeloma,2016
15-19,1.5,2.5,64,Incidence,3209701,Non-Hispanic Black,2.0,Male and Female,Non-Hodgkin Lymphoma,2016
15-19,0.5,1.1,24,Incidence,3209701,Non-Hispanic Black,0.7,Male and Female,Oral Cavity and Pharynx,2016
15-19,0.6,1.7,17,Incidence,1579189,Non-Hispanic Black,1.1,Male and Female,Ovary,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Pancreas,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male and Female,Prostate,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Stomach,2016
15-19,~,~,~,Incidence,1630512,Non-Hispanic Black,~,Male and Female,Testis,2016
15-19,0.9,1.7,39,Incidence,3209701,Non-Hispanic Black,1.2,Male and Female,Thyroid,2016
15-19,~,~,~,Incidence,3209701,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
20-24,22.5,25.8,841,Incidence,3486373,Non-Hispanic Black,24.1,Male and Female,All Cancer Sites Combined,2016
20-24,1.1,2.0,53,Incidence,3486373,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2016
20-24,0.7,1.8,20,Incidence,1714858,Non-Hispanic Black,1.2,Male and Female,Cervix,2016
20-24,0.8,1.5,39,Incidence,3486373,Non-Hispanic Black,1.1,Male and Female,Colon and Rectum,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Esophagus,2016
20-24,2.4,4.1,54,Incidence,1714858,Non-Hispanic Black,3.1,Male and Female,Female Breast,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2016
20-24,2.3,3.5,99,Incidence,3486373,Non-Hispanic Black,2.8,Male and Female,Hodgkin Lymphoma,2016
20-24,0.4,1.0,23,Incidence,3486373,Non-Hispanic Black,0.7,Male and Female,Kaposi Sarcoma,2016
20-24,0.4,0.9,21,Incidence,3486373,Non-Hispanic Black,0.6,Male and Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Larynx,2016
20-24,1.6,2.6,73,Incidence,3486373,Non-Hispanic Black,2.1,Male and Female,Leukemias,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2016
20-24,2.4,4.1,54,Incidence,1714858,Non-Hispanic Black,3.1,Male and Female,Male and Female Breast,2016
20-24,~,~,~,Incidence,1714858,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Myeloma,2016
20-24,2.1,3.2,91,Incidence,3486373,Non-Hispanic Black,2.6,Male and Female,Non-Hodgkin Lymphoma,2016
20-24,0.5,1.2,28,Incidence,3486373,Non-Hispanic Black,0.8,Male and Female,Oral Cavity and Pharynx,2016
20-24,1.1,2.4,29,Incidence,1714858,Non-Hispanic Black,1.7,Male and Female,Ovary,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Pancreas,2016
20-24,~,~,~,Incidence,1771515,Non-Hispanic Black,~,Male and Female,Prostate,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Stomach,2016
20-24,1.1,2.3,28,Incidence,1771515,Non-Hispanic Black,1.6,Male and Female,Testis,2016
20-24,1.5,2.5,69,Incidence,3486373,Non-Hispanic Black,2.0,Male and Female,Thyroid,2016
20-24,~,~,~,Incidence,3486373,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
25-29,44.3,48.9,1582,Incidence,3396030,Non-Hispanic Black,46.6,Male and Female,All Cancer Sites Combined,2016
25-29,1.5,2.5,67,Incidence,3396030,Non-Hispanic Black,2.0,Male and Female,Brain and Other Nervous System,2016
25-29,3.7,5.8,80,Incidence,1710998,Non-Hispanic Black,4.7,Male and Female,Cervix,2016
25-29,2.4,3.6,100,Incidence,3396030,Non-Hispanic Black,2.9,Male and Female,Colon and Rectum,2016
25-29,1.5,2.9,36,Incidence,1710998,Non-Hispanic Black,2.1,Male and Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Esophagus,2016
25-29,11.5,15.0,225,Incidence,1710998,Non-Hispanic Black,13.2,Male and Female,Female Breast,2016
25-29,0.6,1.7,18,Incidence,1710998,Non-Hispanic Black,1.1,Male and Female,"Female Breast, <i>in situ</i>",2016
25-29,3.7,5.1,147,Incidence,3396030,Non-Hispanic Black,4.3,Male and Female,Hodgkin Lymphoma,2016
25-29,1.6,2.5,68,Incidence,3396030,Non-Hispanic Black,2.0,Male and Female,Kaposi Sarcoma,2016
25-29,1.5,2.4,64,Incidence,3396030,Non-Hispanic Black,1.9,Male and Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Larynx,2016
25-29,2.0,3.1,84,Incidence,3396030,Non-Hispanic Black,2.5,Male and Female,Leukemias,2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
25-29,0.3,0.8,17,Incidence,3396030,Non-Hispanic Black,0.5,Male and Female,Lung and Bronchus,2016
25-29,11.5,15.0,225,Incidence,1710998,Non-Hispanic Black,13.2,Male and Female,Male and Female Breast,2016
25-29,0.6,1.7,18,Incidence,1710998,Non-Hispanic Black,1.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Myeloma,2016
25-29,3.1,4.4,127,Incidence,3396030,Non-Hispanic Black,3.7,Male and Female,Non-Hodgkin Lymphoma,2016
25-29,0.6,1.3,30,Incidence,3396030,Non-Hispanic Black,0.9,Male and Female,Oral Cavity and Pharynx,2016
25-29,1.5,2.9,36,Incidence,1710998,Non-Hispanic Black,2.1,Male and Female,Ovary,2016
25-29,0.3,0.8,18,Incidence,3396030,Non-Hispanic Black,0.5,Male and Female,Pancreas,2016
25-29,~,~,~,Incidence,1685032,Non-Hispanic Black,~,Male and Female,Prostate,2016
25-29,0.3,0.9,19,Incidence,3396030,Non-Hispanic Black,0.6,Male and Female,Stomach,2016
25-29,2.0,3.7,47,Incidence,1685032,Non-Hispanic Black,2.8,Male and Female,Testis,2016
25-29,3.9,5.4,156,Incidence,3396030,Non-Hispanic Black,4.6,Male and Female,Thyroid,2016
25-29,~,~,~,Incidence,3396030,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
30-34,83.6,90.4,2522,Incidence,2900250,Non-Hispanic Black,87.0,Male and Female,All Cancer Sites Combined,2016
30-34,1.7,2.8,63,Incidence,2900250,Non-Hispanic Black,2.2,Male and Female,Brain and Other Nervous System,2016
30-34,8.1,11.3,144,Incidence,1500649,Non-Hispanic Black,9.6,Male and Female,Cervix,2016
30-34,5.7,7.6,192,Incidence,2900250,Non-Hispanic Black,6.6,Male and Female,Colon and Rectum,2016
30-34,4.5,6.9,84,Incidence,1500649,Non-Hispanic Black,5.6,Male and Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,2900250,Non-Hispanic Black,~,Male and Female,Esophagus,2016
30-34,36.7,43.1,597,Incidence,1500649,Non-Hispanic Black,39.8,Male and Female,Female Breast,2016
30-34,2.2,4.0,45,Incidence,1500649,Non-Hispanic Black,3.0,Male and Female,"Female Breast, <i>in situ</i>",2016
30-34,3.2,4.7,114,Incidence,2900250,Non-Hispanic Black,3.9,Male and Female,Hodgkin Lymphoma,2016
30-34,1.5,2.6,59,Incidence,2900250,Non-Hispanic Black,2.0,Male and Female,Kaposi Sarcoma,2016
30-34,2.7,4.1,98,Incidence,2900250,Non-Hispanic Black,3.4,Male and Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,2900250,Non-Hispanic Black,~,Male and Female,Larynx,2016
30-34,3.4,4.9,118,Incidence,2900250,Non-Hispanic Black,4.1,Male and Female,Leukemias,2016
30-34,0.8,1.7,35,Incidence,2900250,Non-Hispanic Black,1.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.1,2.1,45,Incidence,2900250,Non-Hispanic Black,1.6,Male and Female,Lung and Bronchus,2016
30-34,36.7,43.1,597,Incidence,1500649,Non-Hispanic Black,39.8,Male and Female,Male and Female Breast,2016
30-34,2.2,4.0,45,Incidence,1500649,Non-Hispanic Black,3.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
30-34,~,~,~,Incidence,2900250,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,2900250,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
30-34,0.5,1.1,22,Incidence,2900250,Non-Hispanic Black,0.8,Male and Female,Myeloma,2016
30-34,5.1,6.9,172,Incidence,2900250,Non-Hispanic Black,5.9,Male and Female,Non-Hodgkin Lymphoma,2016
30-34,1.4,2.4,54,Incidence,2900250,Non-Hispanic Black,1.9,Male and Female,Oral Cavity and Pharynx,2016
30-34,1.7,3.3,36,Incidence,1500649,Non-Hispanic Black,2.4,Male and Female,Ovary,2016
30-34,0.8,1.6,32,Incidence,2900250,Non-Hispanic Black,1.1,Male and Female,Pancreas,2016
30-34,~,~,~,Incidence,1399601,Non-Hispanic Black,~,Male and Female,Prostate,2016
30-34,1.0,1.9,41,Incidence,2900250,Non-Hispanic Black,1.4,Male and Female,Stomach,2016
30-34,2.3,4.3,45,Incidence,1399601,Non-Hispanic Black,3.2,Male and Female,Testis,2016
30-34,7.2,9.4,239,Incidence,2900250,Non-Hispanic Black,8.2,Male and Female,Thyroid,2016
30-34,~,~,~,Incidence,2900250,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
35-39,137.4,146.3,3902,Incidence,2751705,Non-Hispanic Black,141.8,Male and Female,All Cancer Sites Combined,2016
35-39,2.0,3.2,69,Incidence,2751705,Non-Hispanic Black,2.5,Male and Female,Brain and Other Nervous System,2016
35-39,11.3,15.1,190,Incidence,1446307,Non-Hispanic Black,13.1,Male and Female,Cervix,2016
35-39,10.4,13.0,320,Incidence,2751705,Non-Hispanic Black,11.6,Male and Female,Colon and Rectum,2016
35-39,7.1,10.2,124,Incidence,1446307,Non-Hispanic Black,8.6,Male and Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,2751705,Non-Hispanic Black,~,Male and Female,Esophagus,2016
35-39,73.0,82.2,1121,Incidence,1446307,Non-Hispanic Black,77.5,Male and Female,Female Breast,2016
35-39,8.9,12.3,152,Incidence,1446307,Non-Hispanic Black,10.5,Male and Female,"Female Breast, <i>in situ</i>",2016
35-39,3.7,5.3,122,Incidence,2751705,Non-Hispanic Black,4.4,Male and Female,Hodgkin Lymphoma,2016
35-39,1.2,2.2,46,Incidence,2751705,Non-Hispanic Black,1.7,Male and Female,Kaposi Sarcoma,2016
35-39,6.0,8.0,192,Incidence,2751705,Non-Hispanic Black,7.0,Male and Female,Kidney and Renal Pelvis,2016
35-39,~,~,~,Incidence,2751705,Non-Hispanic Black,~,Male and Female,Larynx,2016
35-39,4.2,5.9,138,Incidence,2751705,Non-Hispanic Black,5.0,Male and Female,Leukemias,2016
35-39,1.1,2.0,41,Incidence,2751705,Non-Hispanic Black,1.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
35-39,3.2,4.7,107,Incidence,2751705,Non-Hispanic Black,3.9,Male and Female,Lung and Bronchus,2016
35-39,73.0,82.2,1121,Incidence,1446307,Non-Hispanic Black,77.5,Male and Female,Male and Female Breast,2016
35-39,8.9,12.3,152,Incidence,1446307,Non-Hispanic Black,10.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
35-39,~,~,~,Incidence,2751705,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,2751705,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
35-39,2.0,3.2,69,Incidence,2751705,Non-Hispanic Black,2.5,Male and Female,Myeloma,2016
35-39,7.8,10.1,244,Incidence,2751705,Non-Hispanic Black,8.9,Male and Female,Non-Hodgkin Lymphoma,2016
35-39,1.9,3.1,67,Incidence,2751705,Non-Hispanic Black,2.4,Male and Female,Oral Cavity and Pharynx,2016
35-39,4.0,6.4,74,Incidence,1446307,Non-Hispanic Black,5.1,Male and Female,Ovary,2016
35-39,1.6,2.7,57,Incidence,2751705,Non-Hispanic Black,2.1,Male and Female,Pancreas,2016
35-39,1.2,2.7,24,Incidence,1305398,Non-Hispanic Black,1.8,Male and Female,Prostate,2016
35-39,2.0,3.2,69,Incidence,2751705,Non-Hispanic Black,2.5,Male and Female,Stomach,2016
35-39,2.9,5.1,51,Incidence,1305398,Non-Hispanic Black,3.9,Male and Female,Testis,2016
35-39,9.7,12.2,299,Incidence,2751705,Non-Hispanic Black,10.9,Male and Female,Thyroid,2016
35-39,0.9,1.8,36,Incidence,2751705,Non-Hispanic Black,1.3,Male and Female,Urinary Bladder,2016
40-44,226.6,238.5,5938,Incidence,2554384,Non-Hispanic Black,232.5,Male and Female,All Cancer Sites Combined,2016
40-44,2.3,3.7,75,Incidence,2554384,Non-Hispanic Black,2.9,Male and Female,Brain and Other Nervous System,2016
40-44,14.2,18.6,221,Incidence,1353723,Non-Hispanic Black,16.3,Male and Female,Cervix,2016
40-44,20.0,23.7,557,Incidence,2554384,Non-Hispanic Black,21.8,Male and Female,Colon and Rectum,2016
40-44,11.9,15.9,187,Incidence,1353723,Non-Hispanic Black,13.8,Male and Female,"Corpus and Uterus, NOS",2016
40-44,0.5,1.3,21,Incidence,2554384,Non-Hispanic Black,0.8,Male and Female,Esophagus,2016
40-44,129.4,141.9,1835,Incidence,1353723,Non-Hispanic Black,135.6,Male and Female,Female Breast,2016
40-44,31.3,37.6,465,Incidence,1353723,Non-Hispanic Black,34.3,Male and Female,"Female Breast, <i>in situ</i>",2016
40-44,2.5,3.9,80,Incidence,2554384,Non-Hispanic Black,3.1,Male and Female,Hodgkin Lymphoma,2016
40-44,0.8,1.7,30,Incidence,2554384,Non-Hispanic Black,1.2,Male and Female,Kaposi Sarcoma,2016
40-44,11.9,14.8,340,Incidence,2554384,Non-Hispanic Black,13.3,Male and Female,Kidney and Renal Pelvis,2016
40-44,0.5,1.2,20,Incidence,2554384,Non-Hispanic Black,0.8,Male and Female,Larynx,2016
40-44,5.3,7.2,158,Incidence,2554384,Non-Hispanic Black,6.2,Male and Female,Leukemias,2016
40-44,1.6,2.8,54,Incidence,2554384,Non-Hispanic Black,2.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
40-44,6.3,8.4,186,Incidence,2554384,Non-Hispanic Black,7.3,Male and Female,Lung and Bronchus,2016
40-44,129.4,141.9,1835,Incidence,1353723,Non-Hispanic Black,135.6,Male and Female,Male and Female Breast,2016
40-44,31.3,37.6,465,Incidence,1353723,Non-Hispanic Black,34.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
40-44,~,~,~,Incidence,2554384,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,2554384,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
40-44,5.4,7.4,162,Incidence,2554384,Non-Hispanic Black,6.3,Male and Female,Myeloma,2016
40-44,10.0,12.7,289,Incidence,2554384,Non-Hispanic Black,11.3,Male and Female,Non-Hodgkin Lymphoma,2016
40-44,5.0,6.9,150,Incidence,2554384,Non-Hispanic Black,5.9,Male and Female,Oral Cavity and Pharynx,2016
40-44,5.8,8.7,97,Incidence,1353723,Non-Hispanic Black,7.2,Male and Female,Ovary,2016
40-44,3.5,5.2,110,Incidence,2554384,Non-Hispanic Black,4.3,Male and Female,Pancreas,2016
40-44,16.3,21.3,224,Incidence,1200661,Non-Hispanic Black,18.7,Male and Female,Prostate,2016
40-44,3.0,4.6,96,Incidence,2554384,Non-Hispanic Black,3.8,Male and Female,Stomach,2016
40-44,2.8,5.1,46,Incidence,1200661,Non-Hispanic Black,3.8,Male and Female,Testis,2016
40-44,12.6,15.5,357,Incidence,2554384,Non-Hispanic Black,14.0,Male and Female,Thyroid,2016
40-44,1.8,3.0,59,Incidence,2554384,Non-Hispanic Black,2.3,Male and Female,Urinary Bladder,2016
45-49,356.3,370.8,9620,Incidence,2646649,Non-Hispanic Black,363.5,Male and Female,All Cancer Sites Combined,2016
45-49,2.7,4.2,90,Incidence,2646649,Non-Hispanic Black,3.4,Male and Female,Brain and Other Nervous System,2016
45-49,11.9,15.8,193,Incidence,1403701,Non-Hispanic Black,13.7,Male and Female,Cervix,2016
45-49,37.6,42.4,1057,Incidence,2646649,Non-Hispanic Black,39.9,Male and Female,Colon and Rectum,2016
45-49,17.9,22.7,283,Incidence,1403701,Non-Hispanic Black,20.2,Male and Female,"Corpus and Uterus, NOS",2016
45-49,1.1,2.1,42,Incidence,2646649,Non-Hispanic Black,1.6,Male and Female,Esophagus,2016
45-49,180.8,195.2,2637,Incidence,1403701,Non-Hispanic Black,187.9,Male and Female,Female Breast,2016
45-49,43.3,50.5,657,Incidence,1403701,Non-Hispanic Black,46.8,Male and Female,"Female Breast, <i>in situ</i>",2016
45-49,2.6,4.0,86,Incidence,2646649,Non-Hispanic Black,3.2,Male and Female,Hodgkin Lymphoma,2016
45-49,0.9,1.8,33,Incidence,2646649,Non-Hispanic Black,1.2,Male and Female,Kaposi Sarcoma,2016
45-49,17.3,20.7,501,Incidence,2646649,Non-Hispanic Black,18.9,Male and Female,Kidney and Renal Pelvis,2016
45-49,1.8,3.0,63,Incidence,2646649,Non-Hispanic Black,2.4,Male and Female,Larynx,2016
45-49,7.6,9.9,230,Incidence,2646649,Non-Hispanic Black,8.7,Male and Female,Leukemias,2016
45-49,3.1,4.6,100,Incidence,2646649,Non-Hispanic Black,3.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
45-49,15.9,19.1,461,Incidence,2646649,Non-Hispanic Black,17.4,Male and Female,Lung and Bronchus,2016
45-49,180.8,195.2,2637,Incidence,1403701,Non-Hispanic Black,187.9,Male and Female,Male and Female Breast,2016
45-49,43.3,50.5,657,Incidence,1403701,Non-Hispanic Black,46.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
45-49,0.5,1.3,22,Incidence,2646649,Non-Hispanic Black,0.8,Male and Female,Melanomas of the Skin,2016
45-49,~,~,~,Incidence,2646649,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
45-49,8.7,11.1,260,Incidence,2646649,Non-Hispanic Black,9.8,Male and Female,Myeloma,2016
45-49,14.1,17.2,413,Incidence,2646649,Non-Hispanic Black,15.6,Male and Female,Non-Hodgkin Lymphoma,2016
45-49,8.9,11.3,266,Incidence,2646649,Non-Hispanic Black,10.1,Male and Female,Oral Cavity and Pharynx,2016
45-49,8.7,12.2,145,Incidence,1403701,Non-Hispanic Black,10.3,Male and Female,Ovary,2016
45-49,7.3,9.5,220,Incidence,2646649,Non-Hispanic Black,8.3,Male and Female,Pancreas,2016
45-49,75.8,85.8,1003,Incidence,1242948,Non-Hispanic Black,80.7,Male and Female,Prostate,2016
45-49,6.0,8.1,185,Incidence,2646649,Non-Hispanic Black,7.0,Male and Female,Stomach,2016
45-49,1.2,2.9,24,Incidence,1242948,Non-Hispanic Black,1.9,Male and Female,Testis,2016
45-49,13.8,16.8,404,Incidence,2646649,Non-Hispanic Black,15.3,Male and Female,Thyroid,2016
45-49,2.3,3.7,78,Incidence,2646649,Non-Hispanic Black,2.9,Male and Female,Urinary Bladder,2016
5-9,10.4,12.8,362,Incidence,3123643,Non-Hispanic Black,11.6,Male and Female,All Cancer Sites Combined,2016
5-9,2.7,4.1,105,Incidence,3123643,Non-Hispanic Black,3.4,Male and Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,Cervix,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Esophagus,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,Female Breast,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
5-9,0.4,1.0,20,Incidence,3123643,Non-Hispanic Black,0.6,Male and Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Larynx,2016
5-9,2.2,3.4,85,Incidence,3123643,Non-Hispanic Black,2.7,Male and Female,Leukemias,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Myeloma,2016
5-9,1.0,1.9,43,Incidence,3123643,Non-Hispanic Black,1.4,Male and Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,1536668,Non-Hispanic Black,~,Male and Female,Ovary,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Pancreas,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male and Female,Prostate,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Stomach,2016
5-9,~,~,~,Incidence,1586975,Non-Hispanic Black,~,Male and Female,Testis,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Thyroid,2016
5-9,~,~,~,Incidence,3123643,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
50-54,625.5,644.5,17312,Incidence,2726515,Non-Hispanic Black,634.9,Male and Female,All Cancer Sites Combined,2016
50-54,4.5,6.3,145,Incidence,2726515,Non-Hispanic Black,5.3,Male and Female,Brain and Other Nervous System,2016
50-54,14.3,18.6,237,Incidence,1450267,Non-Hispanic Black,16.3,Male and Female,Cervix,2016
50-54,78.3,85.1,2227,Incidence,2726515,Non-Hispanic Black,81.7,Male and Female,Colon and Rectum,2016
50-54,33.0,39.2,522,Incidence,1450267,Non-Hispanic Black,36.0,Male and Female,"Corpus and Uterus, NOS",2016
50-54,4.5,6.2,144,Incidence,2726515,Non-Hispanic Black,5.3,Male and Female,Esophagus,2016
50-54,223.4,239.1,3352,Incidence,1450267,Non-Hispanic Black,231.1,Male and Female,Female Breast,2016
50-54,57.2,65.3,887,Incidence,1450267,Non-Hispanic Black,61.2,Male and Female,"Female Breast, <i>in situ</i>",2016
50-54,3.2,4.7,107,Incidence,2726515,Non-Hispanic Black,3.9,Male and Female,Hodgkin Lymphoma,2016
50-54,0.6,1.4,26,Incidence,2726515,Non-Hispanic Black,1.0,Male and Female,Kaposi Sarcoma,2016
50-54,28.2,32.4,824,Incidence,2726515,Non-Hispanic Black,30.2,Male and Female,Kidney and Renal Pelvis,2016
50-54,5.2,7.1,166,Incidence,2726515,Non-Hispanic Black,6.1,Male and Female,Larynx,2016
50-54,10.6,13.3,324,Incidence,2726515,Non-Hispanic Black,11.9,Male and Female,Leukemias,2016
50-54,10.3,12.9,314,Incidence,2726515,Non-Hispanic Black,11.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
50-54,53.6,59.3,1538,Incidence,2726515,Non-Hispanic Black,56.4,Male and Female,Lung and Bronchus,2016
50-54,223.4,239.1,3352,Incidence,1450267,Non-Hispanic Black,231.1,Male and Female,Male and Female Breast,2016
50-54,57.2,65.3,887,Incidence,1450267,Non-Hispanic Black,61.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
50-54,0.7,1.6,30,Incidence,2726515,Non-Hispanic Black,1.1,Male and Female,Melanomas of the Skin,2016
50-54,~,~,~,Incidence,2726515,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
50-54,16.3,19.6,488,Incidence,2726515,Non-Hispanic Black,17.9,Male and Female,Myeloma,2016
50-54,18.7,22.1,554,Incidence,2726515,Non-Hispanic Black,20.3,Male and Female,Non-Hodgkin Lymphoma,2016
50-54,15.5,18.7,465,Incidence,2726515,Non-Hispanic Black,17.1,Male and Female,Oral Cavity and Pharynx,2016
50-54,12.3,16.2,205,Incidence,1450267,Non-Hispanic Black,14.1,Male and Female,Ovary,2016
50-54,14.2,17.2,426,Incidence,2726515,Non-Hispanic Black,15.6,Male and Female,Pancreas,2016
50-54,225.9,242.8,2989,Incidence,1276248,Non-Hispanic Black,234.2,Male and Female,Prostate,2016
50-54,10.4,13.0,317,Incidence,2726515,Non-Hispanic Black,11.6,Male and Female,Stomach,2016
50-54,~,~,~,Incidence,1276248,Non-Hispanic Black,~,Male and Female,Testis,2016
50-54,14.2,17.3,428,Incidence,2726515,Non-Hispanic Black,15.7,Male and Female,Thyroid,2016
50-54,7.2,9.4,226,Incidence,2726515,Non-Hispanic Black,8.3,Male and Female,Urinary Bladder,2016
55-59,976.9,1001.0,25983,Incidence,2627577,Non-Hispanic Black,988.9,Male and Female,All Cancer Sites Combined,2016
55-59,5.3,7.2,162,Incidence,2627577,Non-Hispanic Black,6.2,Male and Female,Brain and Other Nervous System,2016
55-59,13.7,17.9,221,Incidence,1412034,Non-Hispanic Black,15.7,Male and Female,Cervix,2016
55-59,84.6,91.8,2316,Incidence,2627577,Non-Hispanic Black,88.1,Male and Female,Colon and Rectum,2016
55-59,64.0,72.7,964,Incidence,1412034,Non-Hispanic Black,68.3,Male and Female,"Corpus and Uterus, NOS",2016
55-59,8.5,10.9,254,Incidence,2627577,Non-Hispanic Black,9.7,Male and Female,Esophagus,2016
55-59,276.1,293.8,4022,Incidence,1412034,Non-Hispanic Black,284.8,Male and Female,Female Breast,2016
55-59,66.9,75.8,1006,Incidence,1412034,Non-Hispanic Black,71.2,Male and Female,"Female Breast, <i>in situ</i>",2016
55-59,2.1,3.5,72,Incidence,2627577,Non-Hispanic Black,2.7,Male and Female,Hodgkin Lymphoma,2016
55-59,0.4,1.0,17,Incidence,2627577,Non-Hispanic Black,0.6,Male and Female,Kaposi Sarcoma,2016
55-59,40.8,45.9,1137,Incidence,2627577,Non-Hispanic Black,43.3,Male and Female,Kidney and Renal Pelvis,2016
55-59,10.2,12.8,300,Incidence,2627577,Non-Hispanic Black,11.4,Male and Female,Larynx,2016
55-59,14.5,17.5,419,Incidence,2627577,Non-Hispanic Black,15.9,Male and Female,Leukemias,2016
55-59,31.5,36.0,886,Incidence,2627577,Non-Hispanic Black,33.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
55-59,122.5,131.2,3332,Incidence,2627577,Non-Hispanic Black,126.8,Male and Female,Lung and Bronchus,2016
55-59,276.1,293.8,4022,Incidence,1412034,Non-Hispanic Black,284.8,Male and Female,Male and Female Breast,2016
55-59,66.9,75.8,1006,Incidence,1412034,Non-Hispanic Black,71.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
55-59,1.3,2.4,47,Incidence,2627577,Non-Hispanic Black,1.8,Male and Female,Melanomas of the Skin,2016
55-59,~,~,~,Incidence,2627577,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
55-59,22.9,26.7,650,Incidence,2627577,Non-Hispanic Black,24.7,Male and Female,Myeloma,2016
55-59,24.1,28.0,683,Incidence,2627577,Non-Hispanic Black,26.0,Male and Female,Non-Hodgkin Lymphoma,2016
55-59,24.1,28.0,683,Incidence,2627577,Non-Hispanic Black,26.0,Male and Female,Oral Cavity and Pharynx,2016
55-59,17.4,22.1,278,Incidence,1412034,Non-Hispanic Black,19.7,Male and Female,Ovary,2016
55-59,25.4,29.4,719,Incidence,2627577,Non-Hispanic Black,27.4,Male and Female,Pancreas,2016
55-59,455.4,479.8,5682,Incidence,1215543,Non-Hispanic Black,467.4,Male and Female,Prostate,2016
55-59,17.5,20.9,504,Incidence,2627577,Non-Hispanic Black,19.2,Male and Female,Stomach,2016
55-59,~,~,~,Incidence,1215543,Non-Hispanic Black,~,Male and Female,Testis,2016
55-59,16.0,19.2,461,Incidence,2627577,Non-Hispanic Black,17.5,Male and Female,Thyroid,2016
55-59,16.7,20.0,480,Incidence,2627577,Non-Hispanic Black,18.3,Male and Female,Urinary Bladder,2016
60-64,1395.3,1427.1,30490,Incidence,2160669,Non-Hispanic Black,1411.1,Male and Female,All Cancer Sites Combined,2016
60-64,7.2,9.7,182,Incidence,2160669,Non-Hispanic Black,8.4,Male and Female,Brain and Other Nervous System,2016
60-64,14.8,19.6,203,Incidence,1189828,Non-Hispanic Black,17.1,Male and Female,Cervix,2016
60-64,114.4,123.7,2571,Incidence,2160669,Non-Hispanic Black,119.0,Male and Female,Colon and Rectum,2016
60-64,108.1,120.3,1357,Incidence,1189828,Non-Hispanic Black,114.1,Male and Female,"Corpus and Uterus, NOS",2016
60-64,12.7,15.9,307,Incidence,2160669,Non-Hispanic Black,14.2,Male and Female,Esophagus,2016
60-64,333.0,354.2,4087,Incidence,1189828,Non-Hispanic Black,343.5,Male and Female,Female Breast,2016
60-64,91.1,102.3,1149,Incidence,1189828,Non-Hispanic Black,96.6,Male and Female,"Female Breast, <i>in situ</i>",2016
60-64,1.9,3.3,54,Incidence,2160669,Non-Hispanic Black,2.5,Male and Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,2160669,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
60-64,54.1,60.5,1236,Incidence,2160669,Non-Hispanic Black,57.2,Male and Female,Kidney and Renal Pelvis,2016
60-64,15.4,18.9,369,Incidence,2160669,Non-Hispanic Black,17.1,Male and Female,Larynx,2016
60-64,21.0,25.1,496,Incidence,2160669,Non-Hispanic Black,23.0,Male and Female,Leukemias,2016
60-64,62.1,69.0,1415,Incidence,2160669,Non-Hispanic Black,65.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
60-64,173.6,185.0,3873,Incidence,2160669,Non-Hispanic Black,179.3,Male and Female,Lung and Bronchus,2016
60-64,333.0,354.2,4087,Incidence,1189828,Non-Hispanic Black,343.5,Male and Female,Male and Female Breast,2016
60-64,91.1,102.3,1149,Incidence,1189828,Non-Hispanic Black,96.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
60-64,1.3,2.5,40,Incidence,2160669,Non-Hispanic Black,1.9,Male and Female,Melanomas of the Skin,2016
60-64,0.5,1.3,17,Incidence,2160669,Non-Hispanic Black,0.8,Male and Female,Mesothelioma,2016
60-64,36.3,41.6,841,Incidence,2160669,Non-Hispanic Black,38.9,Male and Female,Myeloma,2016
60-64,34.1,39.3,792,Incidence,2160669,Non-Hispanic Black,36.7,Male and Female,Non-Hodgkin Lymphoma,2016
60-64,28.5,33.2,665,Incidence,2160669,Non-Hispanic Black,30.8,Male and Female,Oral Cavity and Pharynx,2016
60-64,20.4,25.9,274,Incidence,1189828,Non-Hispanic Black,23.0,Male and Female,Ovary,2016
60-64,45.7,51.6,1050,Incidence,2160669,Non-Hispanic Black,48.6,Male and Female,Pancreas,2016
60-64,720.8,755.1,7163,Incidence,970841,Non-Hispanic Black,737.8,Male and Female,Prostate,2016
60-64,23.4,27.7,551,Incidence,2160669,Non-Hispanic Black,25.5,Male and Female,Stomach,2016
60-64,~,~,~,Incidence,970841,Non-Hispanic Black,~,Male and Female,Testis,2016
60-64,15.7,19.3,377,Incidence,2160669,Non-Hispanic Black,17.4,Male and Female,Thyroid,2016
60-64,26.0,30.5,609,Incidence,2160669,Non-Hispanic Black,28.2,Male and Female,Urinary Bladder,2016
65-69,1835.8,1877.1,31138,Incidence,1677348,Non-Hispanic Black,1856.4,Male and Female,All Cancer Sites Combined,2016
65-69,7.7,10.7,153,Incidence,1677348,Non-Hispanic Black,9.1,Male and Female,Brain and Other Nervous System,2016
65-69,13.1,18.3,147,Incidence,945997,Non-Hispanic Black,15.5,Male and Female,Cervix,2016
65-69,149.0,161.0,2599,Incidence,1677348,Non-Hispanic Black,154.9,Male and Female,Colon and Rectum,2016
65-69,137.9,153.3,1376,Incidence,945997,Non-Hispanic Black,145.5,Male and Female,"Corpus and Uterus, NOS",2016
65-69,14.9,18.9,282,Incidence,1677348,Non-Hispanic Black,16.8,Male and Female,Esophagus,2016
65-69,410.6,436.9,4007,Incidence,945997,Non-Hispanic Black,423.6,Male and Female,Female Breast,2016
65-69,113.5,127.6,1139,Incidence,945997,Non-Hispanic Black,120.4,Male and Female,"Female Breast, <i>in situ</i>",2016
65-69,1.6,3.1,38,Incidence,1677348,Non-Hispanic Black,2.3,Male and Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,1677348,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
65-69,74.8,83.4,1325,Incidence,1677348,Non-Hispanic Black,79.0,Male and Female,Kidney and Renal Pelvis,2016
65-69,17.0,21.2,319,Incidence,1677348,Non-Hispanic Black,19.0,Male and Female,Larynx,2016
65-69,31.0,36.6,566,Incidence,1677348,Non-Hispanic Black,33.7,Male and Female,Leukemias,2016
65-69,61.3,69.1,1092,Incidence,1677348,Non-Hispanic Black,65.1,Male and Female,Liver and Intrahepatic Bile Duct,2016
65-69,248.6,264.0,4297,Incidence,1677348,Non-Hispanic Black,256.2,Male and Female,Lung and Bronchus,2016
65-69,410.6,436.9,4007,Incidence,945997,Non-Hispanic Black,423.6,Male and Female,Male and Female Breast,2016
65-69,113.5,127.6,1139,Incidence,945997,Non-Hispanic Black,120.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
65-69,2.1,3.7,47,Incidence,1677348,Non-Hispanic Black,2.8,Male and Female,Melanomas of the Skin,2016
65-69,0.8,2.0,22,Incidence,1677348,Non-Hispanic Black,1.3,Male and Female,Mesothelioma,2016
65-69,55.6,63.0,993,Incidence,1677348,Non-Hispanic Black,59.2,Male and Female,Myeloma,2016
65-69,40.2,46.6,727,Incidence,1677348,Non-Hispanic Black,43.3,Male and Female,Non-Hodgkin Lymphoma,2016
65-69,31.9,37.6,582,Incidence,1677348,Non-Hispanic Black,34.7,Male and Female,Oral Cavity and Pharynx,2016
65-69,22.8,29.4,245,Incidence,945997,Non-Hispanic Black,25.9,Male and Female,Ovary,2016
65-69,57.7,65.3,1030,Incidence,1677348,Non-Hispanic Black,61.4,Male and Female,Pancreas,2016
65-69,1017.8,1064.7,7614,Incidence,731351,Non-Hispanic Black,1041.1,Male and Female,Prostate,2016
65-69,28.3,33.7,519,Incidence,1677348,Non-Hispanic Black,30.9,Male and Female,Stomach,2016
65-69,~,~,~,Incidence,731351,Non-Hispanic Black,~,Male and Female,Testis,2016
65-69,19.5,24.0,363,Incidence,1677348,Non-Hispanic Black,21.6,Male and Female,Thyroid,2016
65-69,37.5,43.7,680,Incidence,1677348,Non-Hispanic Black,40.5,Male and Female,Urinary Bladder,2016
70-74,1998.2,2052.2,21698,Incidence,1071479,Non-Hispanic Black,2025.1,Male and Female,All Cancer Sites Combined,2016
70-74,8.7,12.7,113,Incidence,1071479,Non-Hispanic Black,10.5,Male and Female,Brain and Other Nervous System,2016
70-74,14.4,21.1,109,Incidence,622205,Non-Hispanic Black,17.5,Male and Female,Cervix,2016
70-74,162.1,177.8,1819,Incidence,1071479,Non-Hispanic Black,169.8,Male and Female,Colon and Rectum,2016
70-74,119.0,137.0,795,Incidence,622205,Non-Hispanic Black,127.8,Male and Female,"Corpus and Uterus, NOS",2016
70-74,15.4,20.5,191,Incidence,1071479,Non-Hispanic Black,17.8,Male and Female,Esophagus,2016
70-74,423.1,456.2,2734,Incidence,622205,Non-Hispanic Black,439.4,Male and Female,Female Breast,2016
70-74,118.4,136.3,791,Incidence,622205,Non-Hispanic Black,127.1,Male and Female,"Female Breast, <i>in situ</i>",2016
70-74,1.8,3.9,29,Incidence,1071479,Non-Hispanic Black,2.7,Male and Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,1071479,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
70-74,78.2,89.3,896,Incidence,1071479,Non-Hispanic Black,83.6,Male and Female,Kidney and Renal Pelvis,2016
70-74,17.2,22.6,212,Incidence,1071479,Non-Hispanic Black,19.8,Male and Female,Larynx,2016
70-74,40.9,49.0,480,Incidence,1071479,Non-Hispanic Black,44.8,Male and Female,Leukemias,2016
70-74,38.9,46.8,458,Incidence,1071479,Non-Hispanic Black,42.7,Male and Female,Liver and Intrahepatic Bile Duct,2016
70-74,338.0,360.4,3740,Incidence,1071479,Non-Hispanic Black,349.1,Male and Female,Lung and Bronchus,2016
70-74,423.1,456.2,2734,Incidence,622205,Non-Hispanic Black,439.4,Male and Female,Male and Female Breast,2016
70-74,118.4,136.3,791,Incidence,622205,Non-Hispanic Black,127.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
70-74,2.4,4.7,36,Incidence,1071479,Non-Hispanic Black,3.4,Male and Female,Melanomas of the Skin,2016
70-74,2.2,4.4,34,Incidence,1071479,Non-Hispanic Black,3.2,Male and Female,Mesothelioma,2016
70-74,68.0,78.4,783,Incidence,1071479,Non-Hispanic Black,73.1,Male and Female,Myeloma,2016
70-74,53.0,62.2,616,Incidence,1071479,Non-Hispanic Black,57.5,Male and Female,Non-Hodgkin Lymphoma,2016
70-74,32.1,39.3,381,Incidence,1071479,Non-Hispanic Black,35.6,Male and Female,Oral Cavity and Pharynx,2016
70-74,29.0,38.3,208,Incidence,622205,Non-Hispanic Black,33.4,Male and Female,Ovary,2016
70-74,69.8,80.3,803,Incidence,1071479,Non-Hispanic Black,74.9,Male and Female,Pancreas,2016
70-74,908.5,965.4,4208,Incidence,449274,Non-Hispanic Black,936.6,Male and Female,Prostate,2016
70-74,40.3,48.4,474,Incidence,1071479,Non-Hispanic Black,44.2,Male and Female,Stomach,2016
70-74,~,~,~,Incidence,449274,Non-Hispanic Black,~,Male and Female,Testis,2016
70-74,17.9,23.4,220,Incidence,1071479,Non-Hispanic Black,20.5,Male and Female,Thyroid,2016
70-74,58.3,67.9,675,Incidence,1071479,Non-Hispanic Black,63.0,Male and Female,Urinary Bladder,2016
75-79,2066.6,2132.7,15575,Incidence,741848,Non-Hispanic Black,2099.5,Male and Female,All Cancer Sites Combined,2016
75-79,8.3,13.1,78,Incidence,741848,Non-Hispanic Black,10.5,Male and Female,Brain and Other Nervous System,2016
75-79,17.0,25.7,94,Incidence,447611,Non-Hispanic Black,21.0,Male and Female,Cervix,2016
75-79,196.7,217.5,1535,Incidence,741848,Non-Hispanic Black,206.9,Male and Female,Colon and Rectum,2016
75-79,100.2,119.8,491,Incidence,447611,Non-Hispanic Black,109.7,Male and Female,"Corpus and Uterus, NOS",2016
75-79,16.2,22.7,143,Incidence,741848,Non-Hispanic Black,19.3,Male and Female,Esophagus,2016
75-79,413.0,451.8,1934,Incidence,447611,Non-Hispanic Black,432.1,Male and Female,Female Breast,2016
75-79,96.4,115.6,473,Incidence,447611,Non-Hispanic Black,105.7,Male and Female,"Female Breast, <i>in situ</i>",2016
75-79,1.3,3.7,17,Incidence,741848,Non-Hispanic Black,2.3,Male and Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,741848,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
75-79,76.5,89.7,615,Incidence,741848,Non-Hispanic Black,82.9,Male and Female,Kidney and Renal Pelvis,2016
75-79,15.9,22.3,140,Incidence,741848,Non-Hispanic Black,18.9,Male and Female,Larynx,2016
75-79,50.4,61.3,413,Incidence,741848,Non-Hispanic Black,55.7,Male and Female,Leukemias,2016
75-79,27.6,35.9,234,Incidence,741848,Non-Hispanic Black,31.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
75-79,377.3,406.0,2904,Incidence,741848,Non-Hispanic Black,391.5,Male and Female,Lung and Bronchus,2016
75-79,413.0,451.8,1934,Incidence,447611,Non-Hispanic Black,432.1,Male and Female,Male and Female Breast,2016
75-79,96.4,115.6,473,Incidence,447611,Non-Hispanic Black,105.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
75-79,4.5,8.3,46,Incidence,741848,Non-Hispanic Black,6.2,Male and Female,Melanomas of the Skin,2016
75-79,1.8,4.3,21,Incidence,741848,Non-Hispanic Black,2.8,Male and Female,Mesothelioma,2016
75-79,77.3,90.6,621,Incidence,741848,Non-Hispanic Black,83.7,Male and Female,Myeloma,2016
75-79,54.9,66.2,448,Incidence,741848,Non-Hispanic Black,60.4,Male and Female,Non-Hodgkin Lymphoma,2016
75-79,25.7,33.7,219,Incidence,741848,Non-Hispanic Black,29.5,Male and Female,Oral Cavity and Pharynx,2016
75-79,27.5,38.4,146,Incidence,447611,Non-Hispanic Black,32.6,Male and Female,Ovary,2016
75-79,84.4,98.3,676,Incidence,741848,Non-Hispanic Black,91.1,Male and Female,Pancreas,2016
75-79,747.4,811.5,2292,Incidence,294237,Non-Hispanic Black,779.0,Male and Female,Prostate,2016
75-79,52.2,63.3,427,Incidence,741848,Non-Hispanic Black,57.6,Male and Female,Stomach,2016
75-79,~,~,~,Incidence,294237,Non-Hispanic Black,~,Male and Female,Testis,2016
75-79,13.8,19.8,123,Incidence,741848,Non-Hispanic Black,16.6,Male and Female,Thyroid,2016
75-79,75.2,88.3,605,Incidence,741848,Non-Hispanic Black,81.6,Male and Female,Urinary Bladder,2016
80-84,2009.1,2088.9,10191,Incidence,497439,Non-Hispanic Black,2048.7,Male and Female,All Cancer Sites Combined,2016
80-84,8.5,14.6,56,Incidence,497439,Non-Hispanic Black,11.3,Male and Female,Brain and Other Nervous System,2016
80-84,15.0,25.1,62,Incidence,316344,Non-Hispanic Black,19.6,Male and Female,Cervix,2016
80-84,219.0,246.0,1155,Incidence,497439,Non-Hispanic Black,232.2,Male and Female,Colon and Rectum,2016
80-84,76.7,97.5,274,Incidence,316344,Non-Hispanic Black,86.6,Male and Female,"Corpus and Uterus, NOS",2016
80-84,16.4,24.5,100,Incidence,497439,Non-Hispanic Black,20.1,Male and Female,Esophagus,2016
80-84,379.4,423.8,1269,Incidence,316344,Non-Hispanic Black,401.1,Male and Female,Female Breast,2016
80-84,56.2,74.3,205,Incidence,316344,Non-Hispanic Black,64.8,Male and Female,"Female Breast, <i>in situ</i>",2016
80-84,~,~,~,Incidence,497439,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,497439,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
80-84,64.9,80.0,359,Incidence,497439,Non-Hispanic Black,72.2,Male and Female,Kidney and Renal Pelvis,2016
80-84,12.6,19.8,79,Incidence,497439,Non-Hispanic Black,15.9,Male and Female,Larynx,2016
80-84,52.9,66.7,296,Incidence,497439,Non-Hispanic Black,59.5,Male and Female,Leukemias,2016
80-84,29.0,39.5,169,Incidence,497439,Non-Hispanic Black,34.0,Male and Female,Liver and Intrahepatic Bile Duct,2016
80-84,346.3,380.0,1805,Incidence,497439,Non-Hispanic Black,362.9,Male and Female,Lung and Bronchus,2016
80-84,379.4,423.8,1269,Incidence,316344,Non-Hispanic Black,401.1,Male and Female,Male and Female Breast,2016
80-84,56.2,74.3,205,Incidence,316344,Non-Hispanic Black,64.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
80-84,3.1,7.2,24,Incidence,497439,Non-Hispanic Black,4.8,Male and Female,Melanomas of the Skin,2016
80-84,2.8,6.7,22,Incidence,497439,Non-Hispanic Black,4.4,Male and Female,Mesothelioma,2016
80-84,81.7,98.6,447,Incidence,497439,Non-Hispanic Black,89.9,Male and Female,Myeloma,2016
80-84,54.6,68.6,305,Incidence,497439,Non-Hispanic Black,61.3,Male and Female,Non-Hodgkin Lymphoma,2016
80-84,19.8,28.6,119,Incidence,497439,Non-Hispanic Black,23.9,Male and Female,Oral Cavity and Pharynx,2016
80-84,33.8,48.1,128,Incidence,316344,Non-Hispanic Black,40.5,Male and Female,Ovary,2016
80-84,86.7,104.1,473,Incidence,497439,Non-Hispanic Black,95.1,Male and Female,Pancreas,2016
80-84,536.2,606.3,1033,Incidence,181095,Non-Hispanic Black,570.4,Male and Female,Prostate,2016
80-84,58.8,73.3,327,Incidence,497439,Non-Hispanic Black,65.7,Male and Female,Stomach,2016
80-84,~,~,~,Incidence,181095,Non-Hispanic Black,~,Male and Female,Testis,2016
80-84,10.3,16.9,66,Incidence,497439,Non-Hispanic Black,13.3,Male and Female,Thyroid,2016
80-84,82.1,99.0,449,Incidence,497439,Non-Hispanic Black,90.3,Male and Female,Urinary Bladder,2016
85+,1830.8,1909.0,8837,Incidence,472669,Non-Hispanic Black,1869.6,Male and Female,All Cancer Sites Combined,2016
85+,9.1,15.6,57,Incidence,472669,Non-Hispanic Black,12.1,Male and Female,Brain and Other Nervous System,2016
85+,11.9,20.9,53,Incidence,332306,Non-Hispanic Black,15.9,Male and Female,Cervix,2016
85+,220.0,247.8,1104,Incidence,472669,Non-Hispanic Black,233.6,Male and Female,Colon and Rectum,2016
85+,49.6,66.2,191,Incidence,332306,Non-Hispanic Black,57.5,Male and Female,"Corpus and Uterus, NOS",2016
85+,13.0,20.6,78,Incidence,472669,Non-Hispanic Black,16.5,Male and Female,Esophagus,2016
85+,322.8,362.9,1138,Incidence,332306,Non-Hispanic Black,342.5,Male and Female,Female Breast,2016
85+,23.9,35.9,98,Incidence,332306,Non-Hispanic Black,29.5,Male and Female,"Female Breast, <i>in situ</i>",2016
85+,~,~,~,Incidence,472669,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2016
85+,~,~,~,Incidence,472669,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
85+,50.9,64.8,272,Incidence,472669,Non-Hispanic Black,57.5,Male and Female,Kidney and Renal Pelvis,2016
85+,6.9,12.7,45,Incidence,472669,Non-Hispanic Black,9.5,Male and Female,Larynx,2016
85+,55.1,69.5,293,Incidence,472669,Non-Hispanic Black,62.0,Male and Female,Leukemias,2016
85+,26.5,36.8,148,Incidence,472669,Non-Hispanic Black,31.3,Male and Female,Liver and Intrahepatic Bile Duct,2016
85+,265.8,296.3,1327,Incidence,472669,Non-Hispanic Black,280.7,Male and Female,Lung and Bronchus,2016
85+,322.8,362.9,1138,Incidence,332306,Non-Hispanic Black,342.5,Male and Female,Male and Female Breast,2016
85+,23.9,35.9,98,Incidence,332306,Non-Hispanic Black,29.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
85+,4.8,9.8,33,Incidence,472669,Non-Hispanic Black,7.0,Male and Female,Melanomas of the Skin,2016
85+,2.1,5.8,17,Incidence,472669,Non-Hispanic Black,3.6,Male and Female,Mesothelioma,2016
85+,70.7,86.9,371,Incidence,472669,Non-Hispanic Black,78.5,Male and Female,Myeloma,2016
85+,47.7,61.2,256,Incidence,472669,Non-Hispanic Black,54.2,Male and Female,Non-Hodgkin Lymphoma,2016
85+,20.9,30.1,119,Incidence,472669,Non-Hispanic Black,25.2,Male and Female,Oral Cavity and Pharynx,2016
85+,28.6,41.5,115,Incidence,332306,Non-Hispanic Black,34.6,Male and Female,Ovary,2016
85+,97.7,116.6,505,Incidence,472669,Non-Hispanic Black,106.8,Male and Female,Pancreas,2016
85+,490.6,567.3,741,Incidence,140363,Non-Hispanic Black,527.9,Male and Female,Prostate,2016
85+,63.3,78.7,334,Incidence,472669,Non-Hispanic Black,70.7,Male and Female,Stomach,2016
85+,~,~,~,Incidence,140363,Non-Hispanic Black,~,Male and Female,Testis,2016
85+,4.8,9.8,33,Incidence,472669,Non-Hispanic Black,7.0,Male and Female,Thyroid,2016
85+,96.1,114.8,497,Incidence,472669,Non-Hispanic Black,105.1,Male and Female,Urinary Bladder,2016
<1,20.5,28.6,147,Incidence,605120,Non-Hispanic Black,24.3,Male and Female,All Cancer Sites Combined,2016
<1,2.0,5.1,20,Incidence,605120,Non-Hispanic Black,3.3,Male and Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,Cervix,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Esophagus,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,Female Breast,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Larynx,2016
<1,2.5,5.9,24,Incidence,605120,Non-Hispanic Black,4.0,Male and Female,Leukemias,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Mesothelioma,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Myeloma,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,298319,Non-Hispanic Black,~,Male and Female,Ovary,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Pancreas,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male and Female,Prostate,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Stomach,2016
<1,~,~,~,Incidence,306801,Non-Hispanic Black,~,Male and Female,Testis,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Thyroid,2016
<1,~,~,~,Incidence,605120,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2016
1-4,21.5,24.5,927,Incidence,4032894,Non-Hispanic White,23.0,Female,All Cancer Sites Combined,2016
1-4,4.2,5.5,194,Incidence,4032894,Non-Hispanic White,4.8,Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Cervix,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Esophagus,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Female Breast,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
1-4,2.0,3.0,101,Incidence,4032894,Non-Hispanic White,2.5,Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Larynx,2016
1-4,7.8,9.6,350,Incidence,4032894,Non-Hispanic White,8.7,Female,Leukemias,2016
1-4,0.2,0.6,16,Incidence,4032894,Non-Hispanic White,0.4,Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Mesothelioma,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Myeloma,2016
1-4,0.3,0.7,19,Incidence,4032894,Non-Hispanic White,0.5,Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Ovary,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Pancreas,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Stomach,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Thyroid,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Female,Urinary Bladder,2016
10-14,14.8,16.9,858,Incidence,5413785,Non-Hispanic White,15.8,Female,All Cancer Sites Combined,2016
10-14,2.8,3.8,177,Incidence,5413785,Non-Hispanic White,3.3,Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Cervix,2016
10-14,0.8,1.3,56,Incidence,5413785,Non-Hispanic White,1.0,Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Esophagus,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Female Breast,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2016
10-14,0.9,1.5,64,Incidence,5413785,Non-Hispanic White,1.2,Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Larynx,2016
10-14,2.4,3.4,156,Incidence,5413785,Non-Hispanic White,2.9,Female,Leukemias,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Lung and Bronchus,2016
10-14,0.2,0.5,18,Incidence,5413785,Non-Hispanic White,0.3,Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Mesothelioma,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Myeloma,2016
10-14,0.8,1.4,57,Incidence,5413785,Non-Hispanic White,1.1,Female,Non-Hodgkin Lymphoma,2016
10-14,0.2,0.5,18,Incidence,5413785,Non-Hispanic White,0.3,Female,Oral Cavity and Pharynx,2016
10-14,0.5,0.9,35,Incidence,5413785,Non-Hispanic White,0.6,Female,Ovary,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Pancreas,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Stomach,2016
10-14,1.1,1.7,75,Incidence,5413785,Non-Hispanic White,1.4,Female,Thyroid,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Female,Urinary Bladder,2016
15-19,26.4,29.2,1578,Incidence,5686035,Non-Hispanic White,27.8,Female,All Cancer Sites Combined,2016
15-19,2.1,2.9,141,Incidence,5686035,Non-Hispanic White,2.5,Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Cervix,2016
15-19,1.8,2.6,126,Incidence,5686035,Non-Hispanic White,2.2,Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Esophagus,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Female Breast,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2016
15-19,3.7,4.8,238,Incidence,5686035,Non-Hispanic White,4.2,Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Larynx,2016
15-19,1.9,2.7,127,Incidence,5686035,Non-Hispanic White,2.2,Female,Leukemias,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Lung and Bronchus,2016
15-19,1.4,2.1,99,Incidence,5686035,Non-Hispanic White,1.7,Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Mesothelioma,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Myeloma,2016
15-19,1.0,1.6,72,Incidence,5686035,Non-Hispanic White,1.3,Female,Non-Hodgkin Lymphoma,2016
15-19,0.4,0.9,36,Incidence,5686035,Non-Hispanic White,0.6,Female,Oral Cavity and Pharynx,2016
15-19,1.0,1.6,70,Incidence,5686035,Non-Hispanic White,1.2,Female,Ovary,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Pancreas,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Stomach,2016
15-19,6.4,7.8,403,Incidence,5686035,Non-Hispanic White,7.1,Female,Thyroid,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Female,Urinary Bladder,2016
20-24,43.0,46.4,2690,Incidence,6020463,Non-Hispanic White,44.7,Female,All Cancer Sites Combined,2016
20-24,1.7,2.4,123,Incidence,6020463,Non-Hispanic White,2.0,Female,Brain and Other Nervous System,2016
20-24,0.6,1.1,48,Incidence,6020463,Non-Hispanic White,0.8,Female,Cervix,2016
20-24,2.6,3.5,182,Incidence,6020463,Non-Hispanic White,3.0,Female,Colon and Rectum,2016
20-24,0.3,0.6,25,Incidence,6020463,Non-Hispanic White,0.4,Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Esophagus,2016
20-24,1.2,1.8,87,Incidence,6020463,Non-Hispanic White,1.4,Female,Female Breast,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2016
20-24,4.5,5.6,302,Incidence,6020463,Non-Hispanic White,5.0,Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
20-24,0.3,0.7,29,Incidence,6020463,Non-Hispanic White,0.5,Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Larynx,2016
20-24,1.9,2.7,139,Incidence,6020463,Non-Hispanic White,2.3,Female,Leukemias,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2016
20-24,0.3,0.6,26,Incidence,6020463,Non-Hispanic White,0.4,Female,Lung and Bronchus,2016
20-24,5.8,7.0,384,Incidence,6020463,Non-Hispanic White,6.4,Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Mesothelioma,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Myeloma,2016
20-24,1.7,2.5,124,Incidence,6020463,Non-Hispanic White,2.1,Female,Non-Hodgkin Lymphoma,2016
20-24,0.4,0.8,36,Incidence,6020463,Non-Hispanic White,0.6,Female,Oral Cavity and Pharynx,2016
20-24,1.3,1.9,95,Incidence,6020463,Non-Hispanic White,1.6,Female,Ovary,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Pancreas,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Stomach,2016
20-24,12.5,14.4,807,Incidence,6020463,Non-Hispanic White,13.4,Female,Thyroid,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Female,Urinary Bladder,2016
25-29,80.3,84.8,5257,Incidence,6372444,Non-Hispanic White,82.5,Female,All Cancer Sites Combined,2016
25-29,2.5,3.3,184,Incidence,6372444,Non-Hispanic White,2.9,Female,Brain and Other Nervous System,2016
25-29,5.2,6.4,369,Incidence,6372444,Non-Hispanic White,5.8,Female,Cervix,2016
25-29,3.7,4.7,265,Incidence,6372444,Non-Hispanic White,4.2,Female,Colon and Rectum,2016
25-29,1.5,2.2,115,Incidence,6372444,Non-Hispanic White,1.8,Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,6372444,Non-Hispanic White,~,Female,Esophagus,2016
25-29,9.9,11.6,684,Incidence,6372444,Non-Hispanic White,10.7,Female,Female Breast,2016
25-29,0.6,1.1,52,Incidence,6372444,Non-Hispanic White,0.8,Female,"Female Breast, <i>in situ</i>",2016
25-29,3.8,4.8,272,Incidence,6372444,Non-Hispanic White,4.3,Female,Hodgkin Lymphoma,2016
25-29,~,~,~,Incidence,6372444,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
25-29,1.2,1.9,97,Incidence,6372444,Non-Hispanic White,1.5,Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,6372444,Non-Hispanic White,~,Female,Larynx,2016
25-29,1.9,2.7,147,Incidence,6372444,Non-Hispanic White,2.3,Female,Leukemias,2016
25-29,0.2,0.5,19,Incidence,6372444,Non-Hispanic White,0.3,Female,Liver and Intrahepatic Bile Duct,2016
25-29,0.5,0.9,42,Incidence,6372444,Non-Hispanic White,0.7,Female,Lung and Bronchus,2016
25-29,12.8,14.6,870,Incidence,6372444,Non-Hispanic White,13.7,Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,6372444,Non-Hispanic White,~,Female,Mesothelioma,2016
25-29,~,~,~,Incidence,6372444,Non-Hispanic White,~,Female,Myeloma,2016
25-29,1.9,2.6,141,Incidence,6372444,Non-Hispanic White,2.2,Female,Non-Hodgkin Lymphoma,2016
25-29,0.8,1.4,68,Incidence,6372444,Non-Hispanic White,1.1,Female,Oral Cavity and Pharynx,2016
25-29,1.9,2.7,146,Incidence,6372444,Non-Hispanic White,2.3,Female,Ovary,2016
25-29,0.3,0.6,28,Incidence,6372444,Non-Hispanic White,0.4,Female,Pancreas,2016
25-29,0.1,0.4,16,Incidence,6372444,Non-Hispanic White,0.3,Female,Stomach,2016
25-29,20.8,23.1,1399,Incidence,6372444,Non-Hispanic White,22.0,Female,Thyroid,2016
25-29,0.3,0.6,27,Incidence,6372444,Non-Hispanic White,0.4,Female,Urinary Bladder,2016
30-34,139.6,145.5,8847,Incidence,6207696,Non-Hispanic White,142.5,Female,All Cancer Sites Combined,2016
30-34,3.5,4.5,245,Incidence,6207696,Non-Hispanic White,3.9,Female,Brain and Other Nervous System,2016
30-34,10.4,12.0,694,Incidence,6207696,Non-Hispanic White,11.2,Female,Cervix,2016
30-34,5.9,7.2,405,Incidence,6207696,Non-Hispanic White,6.5,Female,Colon and Rectum,2016
30-34,4.3,5.4,301,Incidence,6207696,Non-Hispanic White,4.8,Female,"Corpus and Uterus, NOS",2016
30-34,~,~,~,Incidence,6207696,Non-Hispanic White,~,Female,Esophagus,2016
30-34,30.3,33.1,1967,Incidence,6207696,Non-Hispanic White,31.7,Female,Female Breast,2016
30-34,2.9,3.8,206,Incidence,6207696,Non-Hispanic White,3.3,Female,"Female Breast, <i>in situ</i>",2016
30-34,3.8,4.8,267,Incidence,6207696,Non-Hispanic White,4.3,Female,Hodgkin Lymphoma,2016
30-34,~,~,~,Incidence,6207696,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
30-34,2.8,3.7,198,Incidence,6207696,Non-Hispanic White,3.2,Female,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,6207696,Non-Hispanic White,~,Female,Larynx,2016
30-34,2.7,3.6,197,Incidence,6207696,Non-Hispanic White,3.2,Female,Leukemias,2016
30-34,0.3,0.7,31,Incidence,6207696,Non-Hispanic White,0.5,Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.0,1.6,77,Incidence,6207696,Non-Hispanic White,1.2,Female,Lung and Bronchus,2016
30-34,19.2,21.4,1260,Incidence,6207696,Non-Hispanic White,20.3,Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,6207696,Non-Hispanic White,~,Female,Mesothelioma,2016
30-34,0.1,0.4,16,Incidence,6207696,Non-Hispanic White,0.3,Female,Myeloma,2016
30-34,3.8,4.8,265,Incidence,6207696,Non-Hispanic White,4.3,Female,Non-Hodgkin Lymphoma,2016
30-34,1.7,2.4,125,Incidence,6207696,Non-Hispanic White,2.0,Female,Oral Cavity and Pharynx,2016
30-34,3.4,4.4,241,Incidence,6207696,Non-Hispanic White,3.9,Female,Ovary,2016
30-34,0.4,0.7,32,Incidence,6207696,Non-Hispanic White,0.5,Female,Pancreas,2016
30-34,0.4,0.9,39,Incidence,6207696,Non-Hispanic White,0.6,Female,Stomach,2016
30-34,29.1,31.9,1893,Incidence,6207696,Non-Hispanic White,30.5,Female,Thyroid,2016
30-34,0.5,1.0,46,Incidence,6207696,Non-Hispanic White,0.7,Female,Urinary Bladder,2016
35-39,215.9,223.4,13041,Incidence,5938427,Non-Hispanic White,219.6,Female,All Cancer Sites Combined,2016
35-39,3.8,4.9,258,Incidence,5938427,Non-Hispanic White,4.3,Female,Brain and Other Nervous System,2016
35-39,14.7,16.7,930,Incidence,5938427,Non-Hispanic White,15.7,Female,Cervix,2016
35-39,11.5,13.3,734,Incidence,5938427,Non-Hispanic White,12.4,Female,Colon and Rectum,2016
35-39,9.6,11.3,620,Incidence,5938427,Non-Hispanic White,10.4,Female,"Corpus and Uterus, NOS",2016
35-39,~,~,~,Incidence,5938427,Non-Hispanic White,~,Female,Esophagus,2016
35-39,64.1,68.3,3931,Incidence,5938427,Non-Hispanic White,66.2,Female,Female Breast,2016
35-39,7.8,9.3,506,Incidence,5938427,Non-Hispanic White,8.5,Female,"Female Breast, <i>in situ</i>",2016
35-39,2.6,3.5,182,Incidence,5938427,Non-Hispanic White,3.1,Female,Hodgkin Lymphoma,2016
35-39,~,~,~,Incidence,5938427,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
35-39,5.1,6.3,339,Incidence,5938427,Non-Hispanic White,5.7,Female,Kidney and Renal Pelvis,2016
35-39,0.2,0.5,19,Incidence,5938427,Non-Hispanic White,0.3,Female,Larynx,2016
35-39,3.4,4.4,231,Incidence,5938427,Non-Hispanic White,3.9,Female,Leukemias,2016
35-39,0.7,1.2,54,Incidence,5938427,Non-Hispanic White,0.9,Female,Liver and Intrahepatic Bile Duct,2016
35-39,2.5,3.4,174,Incidence,5938427,Non-Hispanic White,2.9,Female,Lung and Bronchus,2016
35-39,23.9,26.4,1493,Incidence,5938427,Non-Hispanic White,25.1,Female,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,5938427,Non-Hispanic White,~,Female,Mesothelioma,2016
35-39,0.4,0.8,35,Incidence,5938427,Non-Hispanic White,0.6,Female,Myeloma,2016
35-39,5.4,6.7,356,Incidence,5938427,Non-Hispanic White,6.0,Female,Non-Hodgkin Lymphoma,2016
35-39,2.2,3.0,152,Incidence,5938427,Non-Hispanic White,2.6,Female,Oral Cavity and Pharynx,2016
35-39,4.5,5.7,303,Incidence,5938427,Non-Hispanic White,5.1,Female,Ovary,2016
35-39,1.4,2.1,103,Incidence,5938427,Non-Hispanic White,1.7,Female,Pancreas,2016
35-39,1.0,1.6,75,Incidence,5938427,Non-Hispanic White,1.3,Female,Stomach,2016
35-39,35.7,38.8,2210,Incidence,5938427,Non-Hispanic White,37.2,Female,Thyroid,2016
35-39,1.2,1.8,86,Incidence,5938427,Non-Hispanic White,1.4,Female,Urinary Bladder,2016
40-44,334.3,343.9,19375,Incidence,5713844,Non-Hispanic White,339.1,Female,All Cancer Sites Combined,2016
40-44,3.7,4.7,238,Incidence,5713844,Non-Hispanic White,4.2,Female,Brain and Other Nervous System,2016
40-44,14.6,16.7,893,Incidence,5713844,Non-Hispanic White,15.6,Female,Cervix,2016
40-44,20.6,23.1,1246,Incidence,5713844,Non-Hispanic White,21.8,Female,Colon and Rectum,2016
40-44,16.5,18.7,1005,Incidence,5713844,Non-Hispanic White,17.6,Female,"Corpus and Uterus, NOS",2016
40-44,0.2,0.5,18,Incidence,5713844,Non-Hispanic White,0.3,Female,Esophagus,2016
40-44,128.0,134.0,7483,Incidence,5713844,Non-Hispanic White,131.0,Female,Female Breast,2016
40-44,41.6,45.0,2472,Incidence,5713844,Non-Hispanic White,43.3,Female,"Female Breast, <i>in situ</i>",2016
40-44,2.1,2.9,142,Incidence,5713844,Non-Hispanic White,2.5,Female,Hodgkin Lymphoma,2016
40-44,~,~,~,Incidence,5713844,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
40-44,8.2,9.8,512,Incidence,5713844,Non-Hispanic White,9.0,Female,Kidney and Renal Pelvis,2016
40-44,0.3,0.7,26,Incidence,5713844,Non-Hispanic White,0.5,Female,Larynx,2016
40-44,5.5,6.7,347,Incidence,5713844,Non-Hispanic White,6.1,Female,Leukemias,2016
40-44,1.0,1.6,75,Incidence,5713844,Non-Hispanic White,1.3,Female,Liver and Intrahepatic Bile Duct,2016
40-44,8.5,10.1,532,Incidence,5713844,Non-Hispanic White,9.3,Female,Lung and Bronchus,2016
40-44,29.2,32.1,1748,Incidence,5713844,Non-Hispanic White,30.6,Female,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,5713844,Non-Hispanic White,~,Female,Mesothelioma,2016
40-44,1.2,1.9,87,Incidence,5713844,Non-Hispanic White,1.5,Female,Myeloma,2016
40-44,8.0,9.5,499,Incidence,5713844,Non-Hispanic White,8.7,Female,Non-Hodgkin Lymphoma,2016
40-44,3.8,4.9,245,Incidence,5713844,Non-Hispanic White,4.3,Female,Oral Cavity and Pharynx,2016
40-44,8.3,9.9,519,Incidence,5713844,Non-Hispanic White,9.1,Female,Ovary,2016
40-44,2.5,3.4,165,Incidence,5713844,Non-Hispanic White,2.9,Female,Pancreas,2016
40-44,1.4,2.1,101,Incidence,5713844,Non-Hispanic White,1.8,Female,Stomach,2016
40-44,37.8,41.1,2253,Incidence,5713844,Non-Hispanic White,39.4,Female,Thyroid,2016
40-44,1.8,2.6,125,Incidence,5713844,Non-Hispanic White,2.2,Female,Urinary Bladder,2016
45-49,482.6,493.3,32037,Incidence,6565689,Non-Hispanic White,487.9,Female,All Cancer Sites Combined,2016
45-49,4.6,5.8,340,Incidence,6565689,Non-Hispanic White,5.2,Female,Brain and Other Nervous System,2016
45-49,13.1,14.9,916,Incidence,6565689,Non-Hispanic White,14.0,Female,Cervix,2016
45-49,31.6,34.4,2167,Incidence,6565689,Non-Hispanic White,33.0,Female,Colon and Rectum,2016
45-49,26.5,29.0,1820,Incidence,6565689,Non-Hispanic White,27.7,Female,"Corpus and Uterus, NOS",2016
45-49,0.8,1.3,66,Incidence,6565689,Non-Hispanic White,1.0,Female,Esophagus,2016
45-49,202.5,209.4,13520,Incidence,6565689,Non-Hispanic White,205.9,Female,Female Breast,2016
45-49,60.1,63.9,4069,Incidence,6565689,Non-Hispanic White,62.0,Female,"Female Breast, <i>in situ</i>",2016
45-49,1.9,2.6,148,Incidence,6565689,Non-Hispanic White,2.3,Female,Hodgkin Lymphoma,2016
45-49,~,~,~,Incidence,6565689,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
45-49,11.8,13.5,828,Incidence,6565689,Non-Hispanic White,12.6,Female,Kidney and Renal Pelvis,2016
45-49,1.1,1.7,92,Incidence,6565689,Non-Hispanic White,1.4,Female,Larynx,2016
45-49,6.9,8.3,499,Incidence,6565689,Non-Hispanic White,7.6,Female,Leukemias,2016
45-49,1.4,2.0,109,Incidence,6565689,Non-Hispanic White,1.7,Female,Liver and Intrahepatic Bile Duct,2016
45-49,21.3,23.6,1475,Incidence,6565689,Non-Hispanic White,22.5,Female,Lung and Bronchus,2016
45-49,34.0,36.9,2329,Incidence,6565689,Non-Hispanic White,35.5,Female,Melanomas of the Skin,2016
45-49,0.2,0.5,22,Incidence,6565689,Non-Hispanic White,0.3,Female,Mesothelioma,2016
45-49,2.6,3.4,196,Incidence,6565689,Non-Hispanic White,3.0,Female,Myeloma,2016
45-49,11.6,13.3,814,Incidence,6565689,Non-Hispanic White,12.4,Female,Non-Hodgkin Lymphoma,2016
45-49,6.1,7.3,439,Incidence,6565689,Non-Hispanic White,6.7,Female,Oral Cavity and Pharynx,2016
45-49,13.4,15.3,942,Incidence,6565689,Non-Hispanic White,14.3,Female,Ovary,2016
45-49,5.3,6.4,383,Incidence,6565689,Non-Hispanic White,5.8,Female,Pancreas,2016
45-49,2.4,3.2,182,Incidence,6565689,Non-Hispanic White,2.8,Female,Stomach,2016
45-49,37.8,40.8,2580,Incidence,6565689,Non-Hispanic White,39.3,Female,Thyroid,2016
45-49,3.9,4.9,285,Incidence,6565689,Non-Hispanic White,4.3,Female,Urinary Bladder,2016
5-9,11.9,13.9,666,Incidence,5181945,Non-Hispanic White,12.9,Female,All Cancer Sites Combined,2016
5-9,3.1,4.2,188,Incidence,5181945,Non-Hispanic White,3.6,Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Cervix,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Esophagus,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Female Breast,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
5-9,0.6,1.2,46,Incidence,5181945,Non-Hispanic White,0.9,Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Larynx,2016
5-9,3.3,4.3,195,Incidence,5181945,Non-Hispanic White,3.8,Female,Leukemias,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Mesothelioma,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Myeloma,2016
5-9,0.5,1.0,38,Incidence,5181945,Non-Hispanic White,0.7,Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Ovary,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Pancreas,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Stomach,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Thyroid,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Female,Urinary Bladder,2016
50-54,655.4,667.2,48482,Incidence,7331432,Non-Hispanic White,661.3,Female,All Cancer Sites Combined,2016
50-54,6.5,7.7,518,Incidence,7331432,Non-Hispanic White,7.1,Female,Brain and Other Nervous System,2016
50-54,10.6,12.2,834,Incidence,7331432,Non-Hispanic White,11.4,Female,Cervix,2016
50-54,51.5,54.8,3894,Incidence,7331432,Non-Hispanic White,53.1,Female,Colon and Rectum,2016
50-54,49.4,52.7,3744,Incidence,7331432,Non-Hispanic White,51.1,Female,"Corpus and Uterus, NOS",2016
50-54,1.8,2.4,153,Incidence,7331432,Non-Hispanic White,2.1,Female,Esophagus,2016
50-54,240.5,247.7,17897,Incidence,7331432,Non-Hispanic White,244.1,Female,Female Breast,2016
50-54,67.1,70.9,5058,Incidence,7331432,Non-Hispanic White,69.0,Female,"Female Breast, <i>in situ</i>",2016
50-54,1.4,2.0,122,Incidence,7331432,Non-Hispanic White,1.7,Female,Hodgkin Lymphoma,2016
50-54,~,~,~,Incidence,7331432,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
50-54,16.7,18.6,1291,Incidence,7331432,Non-Hispanic White,17.6,Female,Kidney and Renal Pelvis,2016
50-54,2.6,3.4,220,Incidence,7331432,Non-Hispanic White,3.0,Female,Larynx,2016
50-54,10.5,12.1,827,Incidence,7331432,Non-Hispanic White,11.3,Female,Leukemias,2016
50-54,3.7,4.7,306,Incidence,7331432,Non-Hispanic White,4.2,Female,Liver and Intrahepatic Bile Duct,2016
50-54,54.3,57.8,4108,Incidence,7331432,Non-Hispanic White,56.0,Female,Lung and Bronchus,2016
50-54,38.8,41.7,2949,Incidence,7331432,Non-Hispanic White,40.2,Female,Melanomas of the Skin,2016
50-54,0.2,0.4,20,Incidence,7331432,Non-Hispanic White,0.3,Female,Mesothelioma,2016
50-54,4.9,6.0,396,Incidence,7331432,Non-Hispanic White,5.4,Female,Myeloma,2016
50-54,18.3,20.4,1418,Incidence,7331432,Non-Hispanic White,19.3,Female,Non-Hodgkin Lymphoma,2016
50-54,10.8,12.3,845,Incidence,7331432,Non-Hispanic White,11.5,Female,Oral Cavity and Pharynx,2016
50-54,16.9,18.8,1308,Incidence,7331432,Non-Hispanic White,17.8,Female,Ovary,2016
50-54,9.9,11.5,783,Incidence,7331432,Non-Hispanic White,10.7,Female,Pancreas,2016
50-54,3.9,4.9,319,Incidence,7331432,Non-Hispanic White,4.4,Female,Stomach,2016
50-54,36.0,38.8,2741,Incidence,7331432,Non-Hispanic White,37.4,Female,Thyroid,2016
50-54,7.7,9.0,612,Incidence,7331432,Non-Hispanic White,8.3,Female,Urinary Bladder,2016
55-59,846.5,859.5,67118,Incidence,7868576,Non-Hispanic White,853.0,Female,All Cancer Sites Combined,2016
55-59,8.5,9.8,717,Incidence,7868576,Non-Hispanic White,9.1,Female,Brain and Other Nervous System,2016
55-59,10.7,12.2,900,Incidence,7868576,Non-Hispanic White,11.4,Female,Cervix,2016
55-59,52.6,55.8,4262,Incidence,7868576,Non-Hispanic White,54.2,Female,Colon and Rectum,2016
55-59,80.9,84.9,6522,Incidence,7868576,Non-Hispanic White,82.9,Female,"Corpus and Uterus, NOS",2016
55-59,3.4,4.2,298,Incidence,7868576,Non-Hispanic White,3.8,Female,Esophagus,2016
55-59,273.3,280.7,21797,Incidence,7868576,Non-Hispanic White,277.0,Female,Female Breast,2016
55-59,67.8,71.5,5476,Incidence,7868576,Non-Hispanic White,69.6,Female,"Female Breast, <i>in situ</i>",2016
55-59,1.6,2.2,149,Incidence,7868576,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2016
55-59,~,~,~,Incidence,7868576,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
55-59,23.0,25.2,1895,Incidence,7868576,Non-Hispanic White,24.1,Female,Kidney and Renal Pelvis,2016
55-59,4.1,5.0,358,Incidence,7868576,Non-Hispanic White,4.5,Female,Larynx,2016
55-59,15.8,17.7,1316,Incidence,7868576,Non-Hispanic White,16.7,Female,Leukemias,2016
55-59,8.2,9.5,696,Incidence,7868576,Non-Hispanic White,8.8,Female,Liver and Intrahepatic Bile Duct,2016
55-59,103.0,107.6,8284,Incidence,7868576,Non-Hispanic White,105.3,Female,Lung and Bronchus,2016
55-59,41.4,44.3,3370,Incidence,7868576,Non-Hispanic White,42.8,Female,Melanomas of the Skin,2016
55-59,0.4,0.8,48,Incidence,7868576,Non-Hispanic White,0.6,Female,Mesothelioma,2016
55-59,8.0,9.3,678,Incidence,7868576,Non-Hispanic White,8.6,Female,Myeloma,2016
55-59,26.3,28.6,2161,Incidence,7868576,Non-Hispanic White,27.5,Female,Non-Hodgkin Lymphoma,2016
55-59,16.1,17.9,1335,Incidence,7868576,Non-Hispanic White,17.0,Female,Oral Cavity and Pharynx,2016
55-59,22.1,24.3,1823,Incidence,7868576,Non-Hispanic White,23.2,Female,Ovary,2016
55-59,17.1,19.0,1416,Incidence,7868576,Non-Hispanic White,18.0,Female,Pancreas,2016
55-59,5.3,6.4,462,Incidence,7868576,Non-Hispanic White,5.9,Female,Stomach,2016
55-59,34.6,37.2,2822,Incidence,7868576,Non-Hispanic White,35.9,Female,Thyroid,2016
55-59,13.3,14.9,1108,Incidence,7868576,Non-Hispanic White,14.1,Female,Urinary Bladder,2016
60-64,1081.4,1096.5,79782,Incidence,7326732,Non-Hispanic White,1088.9,Female,All Cancer Sites Combined,2016
60-64,10.8,12.4,847,Incidence,7326732,Non-Hispanic White,11.6,Female,Brain and Other Nervous System,2016
60-64,9.6,11.0,753,Incidence,7326732,Non-Hispanic White,10.3,Female,Cervix,2016
60-64,68.2,72.0,5136,Incidence,7326732,Non-Hispanic White,70.1,Female,Colon and Rectum,2016
60-64,104.6,109.4,7837,Incidence,7326732,Non-Hispanic White,107.0,Female,"Corpus and Uterus, NOS",2016
60-64,4.5,5.5,366,Incidence,7326732,Non-Hispanic White,5.0,Female,Esophagus,2016
60-64,343.3,351.9,25465,Incidence,7326732,Non-Hispanic White,347.6,Female,Female Breast,2016
60-64,77.6,81.7,5836,Incidence,7326732,Non-Hispanic White,79.7,Female,"Female Breast, <i>in situ</i>",2016
60-64,1.6,2.3,140,Incidence,7326732,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2016
60-64,~,~,~,Incidence,7326732,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
60-64,29.0,31.5,2215,Incidence,7326732,Non-Hispanic White,30.2,Female,Kidney and Renal Pelvis,2016
60-64,4.0,5.0,326,Incidence,7326732,Non-Hispanic White,4.4,Female,Larynx,2016
60-64,20.9,23.0,1607,Incidence,7326732,Non-Hispanic White,21.9,Female,Leukemias,2016
60-64,11.3,12.9,884,Incidence,7326732,Non-Hispanic White,12.1,Female,Liver and Intrahepatic Bile Duct,2016
60-64,146.2,151.8,10913,Incidence,7326732,Non-Hispanic White,148.9,Female,Lung and Bronchus,2016
60-64,48.4,51.6,3662,Incidence,7326732,Non-Hispanic White,50.0,Female,Melanomas of the Skin,2016
60-64,0.7,1.2,69,Incidence,7326732,Non-Hispanic White,0.9,Female,Mesothelioma,2016
60-64,11.3,12.9,883,Incidence,7326732,Non-Hispanic White,12.1,Female,Myeloma,2016
60-64,37.4,40.2,2842,Incidence,7326732,Non-Hispanic White,38.8,Female,Non-Hodgkin Lymphoma,2016
60-64,18.8,20.8,1450,Incidence,7326732,Non-Hispanic White,19.8,Female,Oral Cavity and Pharynx,2016
60-64,26.6,29.0,2033,Incidence,7326732,Non-Hispanic White,27.7,Female,Ovary,2016
60-64,25.5,27.9,1954,Incidence,7326732,Non-Hispanic White,26.7,Female,Pancreas,2016
60-64,6.8,8.1,545,Incidence,7326732,Non-Hispanic White,7.4,Female,Stomach,2016
60-64,31.9,34.5,2432,Incidence,7326732,Non-Hispanic White,33.2,Female,Thyroid,2016
60-64,20.3,22.4,1562,Incidence,7326732,Non-Hispanic White,21.3,Female,Urinary Bladder,2016
65-69,1419.8,1438.0,94895,Incidence,6641207,Non-Hispanic White,1428.9,Female,All Cancer Sites Combined,2016
65-69,15.1,17.0,1063,Incidence,6641207,Non-Hispanic White,16.0,Female,Brain and Other Nervous System,2016
65-69,9.3,10.9,668,Incidence,6641207,Non-Hispanic White,10.1,Female,Cervix,2016
65-69,92.8,97.5,6315,Incidence,6641207,Non-Hispanic White,95.1,Female,Colon and Rectum,2016
65-69,116.0,121.2,7876,Incidence,6641207,Non-Hispanic White,118.6,Female,"Corpus and Uterus, NOS",2016
65-69,6.0,7.3,441,Incidence,6641207,Non-Hispanic White,6.6,Female,Esophagus,2016
65-69,440.1,450.2,29562,Incidence,6641207,Non-Hispanic White,445.1,Female,Female Breast,2016
65-69,92.6,97.3,6306,Incidence,6641207,Non-Hispanic White,95.0,Female,"Female Breast, <i>in situ</i>",2016
65-69,2.3,3.1,178,Incidence,6641207,Non-Hispanic White,2.7,Female,Hodgkin Lymphoma,2016
65-69,~,~,~,Incidence,6641207,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
65-69,40.3,43.4,2778,Incidence,6641207,Non-Hispanic White,41.8,Female,Kidney and Renal Pelvis,2016
65-69,4.9,6.0,360,Incidence,6641207,Non-Hispanic White,5.4,Female,Larynx,2016
65-69,30.5,33.2,2113,Incidence,6641207,Non-Hispanic White,31.8,Female,Leukemias,2016
65-69,13.6,15.5,964,Incidence,6641207,Non-Hispanic White,14.5,Female,Liver and Intrahepatic Bile Duct,2016
65-69,218.8,225.9,14765,Incidence,6641207,Non-Hispanic White,222.3,Female,Lung and Bronchus,2016
65-69,55.1,58.7,3778,Incidence,6641207,Non-Hispanic White,56.9,Female,Melanomas of the Skin,2016
65-69,1.3,1.9,103,Incidence,6641207,Non-Hispanic White,1.6,Female,Mesothelioma,2016
65-69,18.4,20.5,1290,Incidence,6641207,Non-Hispanic White,19.4,Female,Myeloma,2016
65-69,54.1,57.7,3712,Incidence,6641207,Non-Hispanic White,55.9,Female,Non-Hodgkin Lymphoma,2016
65-69,21.3,23.6,1489,Incidence,6641207,Non-Hispanic White,22.4,Female,Oral Cavity and Pharynx,2016
65-69,32.3,35.1,2238,Incidence,6641207,Non-Hispanic White,33.7,Female,Ovary,2016
65-69,38.5,41.6,2658,Incidence,6641207,Non-Hispanic White,40.0,Female,Pancreas,2016
65-69,10.5,12.2,753,Incidence,6641207,Non-Hispanic White,11.3,Female,Stomach,2016
65-69,32.1,34.8,2220,Incidence,6641207,Non-Hispanic White,33.4,Female,Thyroid,2016
65-69,31.6,34.4,2192,Incidence,6641207,Non-Hispanic White,33.0,Female,Urinary Bladder,2016
70-74,1727.4,1750.9,84180,Incidence,4840380,Non-Hispanic White,1739.1,Female,All Cancer Sites Combined,2016
70-74,16.0,18.3,828,Incidence,4840380,Non-Hispanic White,17.1,Female,Brain and Other Nervous System,2016
70-74,7.1,8.7,383,Incidence,4840380,Non-Hispanic White,7.9,Female,Cervix,2016
70-74,120.3,126.6,5974,Incidence,4840380,Non-Hispanic White,123.4,Female,Colon and Rectum,2016
70-74,106.9,112.9,5318,Incidence,4840380,Non-Hispanic White,109.9,Female,"Corpus and Uterus, NOS",2016
70-74,8.1,9.8,432,Incidence,4840380,Non-Hispanic White,8.9,Female,Esophagus,2016
70-74,490.6,503.1,24048,Incidence,4840380,Non-Hispanic White,496.8,Female,Female Breast,2016
70-74,96.1,101.7,4785,Incidence,4840380,Non-Hispanic White,98.9,Female,"Female Breast, <i>in situ</i>",2016
70-74,2.9,3.9,164,Incidence,4840380,Non-Hispanic White,3.4,Female,Hodgkin Lymphoma,2016
70-74,~,~,~,Incidence,4840380,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
70-74,45.5,49.4,2294,Incidence,4840380,Non-Hispanic White,47.4,Female,Kidney and Renal Pelvis,2016
70-74,4.4,5.7,242,Incidence,4840380,Non-Hispanic White,5.0,Female,Larynx,2016
70-74,41.8,45.6,2113,Incidence,4840380,Non-Hispanic White,43.7,Female,Leukemias,2016
70-74,16.3,18.7,847,Incidence,4840380,Non-Hispanic White,17.5,Female,Liver and Intrahepatic Bile Duct,2016
70-74,327.8,338.2,16117,Incidence,4840380,Non-Hispanic White,333.0,Female,Lung and Bronchus,2016
70-74,59.1,63.5,2967,Incidence,4840380,Non-Hispanic White,61.3,Female,Melanomas of the Skin,2016
70-74,1.5,2.2,88,Incidence,4840380,Non-Hispanic White,1.8,Female,Mesothelioma,2016
70-74,23.9,26.8,1225,Incidence,4840380,Non-Hispanic White,25.3,Female,Myeloma,2016
70-74,70.5,75.4,3529,Incidence,4840380,Non-Hispanic White,72.9,Female,Non-Hodgkin Lymphoma,2016
70-74,26.1,29.1,1333,Incidence,4840380,Non-Hispanic White,27.5,Female,Oral Cavity and Pharynx,2016
70-74,36.5,40.0,1851,Incidence,4840380,Non-Hispanic White,38.2,Female,Ovary,2016
70-74,53.2,57.4,2676,Incidence,4840380,Non-Hispanic White,55.3,Female,Pancreas,2016
70-74,14.7,17.0,765,Incidence,4840380,Non-Hispanic White,15.8,Female,Stomach,2016
70-74,26.9,29.9,1372,Incidence,4840380,Non-Hispanic White,28.3,Female,Thyroid,2016
70-74,47.9,51.9,2416,Incidence,4840380,Non-Hispanic White,49.9,Female,Urinary Bladder,2016
75-79,1921.4,1950.3,68937,Incidence,3561135,Non-Hispanic White,1935.8,Female,All Cancer Sites Combined,2016
75-79,18.6,21.5,713,Incidence,3561135,Non-Hispanic White,20.0,Female,Brain and Other Nervous System,2016
75-79,6.4,8.2,260,Incidence,3561135,Non-Hispanic White,7.3,Female,Cervix,2016
75-79,164.6,173.1,6012,Incidence,3561135,Non-Hispanic White,168.8,Female,Colon and Rectum,2016
75-79,92.2,98.7,3397,Incidence,3561135,Non-Hispanic White,95.4,Female,"Corpus and Uterus, NOS",2016
75-79,9.0,11.1,357,Incidence,3561135,Non-Hispanic White,10.0,Female,Esophagus,2016
75-79,474.5,489.0,17154,Incidence,3561135,Non-Hispanic White,481.7,Female,Female Breast,2016
75-79,79.6,85.6,2939,Incidence,3561135,Non-Hispanic White,82.5,Female,"Female Breast, <i>in situ</i>",2016
75-79,2.5,3.7,108,Incidence,3561135,Non-Hispanic White,3.0,Female,Hodgkin Lymphoma,2016
75-79,~,~,~,Incidence,3561135,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
75-79,49.6,54.3,1849,Incidence,3561135,Non-Hispanic White,51.9,Female,Kidney and Renal Pelvis,2016
75-79,4.3,5.8,180,Incidence,3561135,Non-Hispanic White,5.1,Female,Larynx,2016
75-79,54.4,59.4,2024,Incidence,3561135,Non-Hispanic White,56.8,Female,Leukemias,2016
75-79,20.9,24.0,798,Incidence,3561135,Non-Hispanic White,22.4,Female,Liver and Intrahepatic Bile Duct,2016
75-79,378.6,391.5,13710,Incidence,3561135,Non-Hispanic White,385.0,Female,Lung and Bronchus,2016
75-79,63.7,69.1,2364,Incidence,3561135,Non-Hispanic White,66.4,Female,Melanomas of the Skin,2016
75-79,2.3,3.4,100,Incidence,3561135,Non-Hispanic White,2.8,Female,Mesothelioma,2016
75-79,27.4,31.0,1038,Incidence,3561135,Non-Hispanic White,29.1,Female,Myeloma,2016
75-79,86.6,92.8,3192,Incidence,3561135,Non-Hispanic White,89.6,Female,Non-Hodgkin Lymphoma,2016
75-79,26.9,30.4,1018,Incidence,3561135,Non-Hispanic White,28.6,Female,Oral Cavity and Pharynx,2016
75-79,41.1,45.5,1540,Incidence,3561135,Non-Hispanic White,43.2,Female,Ovary,2016
75-79,68.1,73.7,2523,Incidence,3561135,Non-Hispanic White,70.8,Female,Pancreas,2016
75-79,18.9,21.9,726,Incidence,3561135,Non-Hispanic White,20.4,Female,Stomach,2016
75-79,21.9,25.1,834,Incidence,3561135,Non-Hispanic White,23.4,Female,Thyroid,2016
75-79,58.3,63.5,2168,Incidence,3561135,Non-Hispanic White,60.9,Female,Urinary Bladder,2016
80-84,2000.0,2034.2,53564,Incidence,2655629,Non-Hispanic White,2017.0,Female,All Cancer Sites Combined,2016
80-84,17.3,20.7,503,Incidence,2655629,Non-Hispanic White,18.9,Female,Brain and Other Nervous System,2016
80-84,6.4,8.5,196,Incidence,2655629,Non-Hispanic White,7.4,Female,Cervix,2016
80-84,205.7,216.8,5608,Incidence,2655629,Non-Hispanic White,211.2,Female,Colon and Rectum,2016
80-84,73.4,80.1,2036,Incidence,2655629,Non-Hispanic White,76.7,Female,"Corpus and Uterus, NOS",2016
80-84,12.2,15.0,359,Incidence,2655629,Non-Hispanic White,13.5,Female,Esophagus,2016
80-84,423.5,439.4,11456,Incidence,2655629,Non-Hispanic White,431.4,Female,Female Breast,2016
80-84,51.8,57.4,1448,Incidence,2655629,Non-Hispanic White,54.5,Female,"Female Breast, <i>in situ</i>",2016
80-84,2.7,4.2,90,Incidence,2655629,Non-Hispanic White,3.4,Female,Hodgkin Lymphoma,2016
80-84,~,~,~,Incidence,2655629,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
80-84,49.0,54.5,1374,Incidence,2655629,Non-Hispanic White,51.7,Female,Kidney and Renal Pelvis,2016
80-84,3.6,5.2,116,Incidence,2655629,Non-Hispanic White,4.4,Female,Larynx,2016
80-84,64.8,71.1,1804,Incidence,2655629,Non-Hispanic White,67.9,Female,Leukemias,2016
80-84,21.6,25.3,621,Incidence,2655629,Non-Hispanic White,23.4,Female,Liver and Intrahepatic Bile Duct,2016
80-84,370.8,385.6,10042,Incidence,2655629,Non-Hispanic White,378.1,Female,Lung and Bronchus,2016
80-84,68.3,74.7,1897,Incidence,2655629,Non-Hispanic White,71.4,Female,Melanomas of the Skin,2016
80-84,3.0,4.5,98,Incidence,2655629,Non-Hispanic White,3.7,Female,Mesothelioma,2016
80-84,30.3,34.7,862,Incidence,2655629,Non-Hispanic White,32.5,Female,Myeloma,2016
80-84,99.5,107.2,2743,Incidence,2655629,Non-Hispanic White,103.3,Female,Non-Hodgkin Lymphoma,2016
80-84,28.2,32.4,804,Incidence,2655629,Non-Hispanic White,30.3,Female,Oral Cavity and Pharynx,2016
80-84,43.5,48.7,1224,Incidence,2655629,Non-Hispanic White,46.1,Female,Ovary,2016
80-84,80.9,88.0,2241,Incidence,2655629,Non-Hispanic White,84.4,Female,Pancreas,2016
80-84,20.8,24.4,599,Incidence,2655629,Non-Hispanic White,22.6,Female,Stomach,2016
80-84,16.7,20.0,485,Incidence,2655629,Non-Hispanic White,18.3,Female,Thyroid,2016
80-84,72.8,79.5,2021,Incidence,2655629,Non-Hispanic White,76.1,Female,Urinary Bladder,2016
85+,1788.2,1817.0,60510,Incidence,3356860,Non-Hispanic White,1802.6,Female,All Cancer Sites Combined,2016
85+,14.3,17.0,525,Incidence,3356860,Non-Hispanic White,15.6,Female,Brain and Other Nervous System,2016
85+,4.9,6.5,189,Incidence,3356860,Non-Hispanic White,5.6,Female,Cervix,2016
85+,232.5,243.0,7980,Incidence,3356860,Non-Hispanic White,237.7,Female,Colon and Rectum,2016
85+,48.4,53.3,1706,Incidence,3356860,Non-Hispanic White,50.8,Female,"Corpus and Uterus, NOS",2016
85+,11.9,14.4,439,Incidence,3356860,Non-Hispanic White,13.1,Female,Esophagus,2016
85+,328.9,341.3,11248,Incidence,3356860,Non-Hispanic White,335.1,Female,Female Breast,2016
85+,21.1,24.4,763,Incidence,3356860,Non-Hispanic White,22.7,Female,"Female Breast, <i>in situ</i>",2016
85+,2.3,3.5,96,Incidence,3356860,Non-Hispanic White,2.9,Female,Hodgkin Lymphoma,2016
85+,0.5,1.2,27,Incidence,3356860,Non-Hispanic White,0.8,Female,Kaposi Sarcoma,2016
85+,37.7,42.0,1335,Incidence,3356860,Non-Hispanic White,39.8,Female,Kidney and Renal Pelvis,2016
85+,2.2,3.3,91,Incidence,3356860,Non-Hispanic White,2.7,Female,Larynx,2016
85+,68.7,74.4,2401,Incidence,3356860,Non-Hispanic White,71.5,Female,Leukemias,2016
85+,20.1,23.3,726,Incidence,3356860,Non-Hispanic White,21.6,Female,Liver and Intrahepatic Bile Duct,2016
85+,253.1,264.0,8679,Incidence,3356860,Non-Hispanic White,258.5,Female,Lung and Bronchus,2016
85+,70.4,76.2,2458,Incidence,3356860,Non-Hispanic White,73.2,Female,Melanomas of the Skin,2016
85+,2.5,3.7,101,Incidence,3356860,Non-Hispanic White,3.0,Female,Mesothelioma,2016
85+,26.5,30.1,949,Incidence,3356860,Non-Hispanic White,28.3,Female,Myeloma,2016
85+,88.5,95.0,3078,Incidence,3356860,Non-Hispanic White,91.7,Female,Non-Hodgkin Lymphoma,2016
85+,29.8,33.7,1065,Incidence,3356860,Non-Hispanic White,31.7,Female,Oral Cavity and Pharynx,2016
85+,37.1,41.3,1314,Incidence,3356860,Non-Hispanic White,39.1,Female,Ovary,2016
85+,89.7,96.2,3118,Incidence,3356860,Non-Hispanic White,92.9,Female,Pancreas,2016
85+,22.8,26.2,822,Incidence,3356860,Non-Hispanic White,24.5,Female,Stomach,2016
85+,8.6,10.7,323,Incidence,3356860,Non-Hispanic White,9.6,Female,Thyroid,2016
85+,78.4,84.6,2735,Incidence,3356860,Non-Hispanic White,81.5,Female,Urinary Bladder,2016
<1,24.8,31.5,280,Incidence,998887,Non-Hispanic White,28.0,Female,All Cancer Sites Combined,2016
<1,3.4,6.1,46,Incidence,998887,Non-Hispanic White,4.6,Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Cervix,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Colon and Rectum,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Esophagus,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Female Breast,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Kaposi Sarcoma,2016
<1,1.2,3.1,20,Incidence,998887,Non-Hispanic White,2.0,Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Larynx,2016
<1,2.8,5.3,39,Incidence,998887,Non-Hispanic White,3.9,Female,Leukemias,2016
<1,1.0,2.7,17,Incidence,998887,Non-Hispanic White,1.7,Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Mesothelioma,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Myeloma,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Ovary,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Pancreas,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Stomach,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Thyroid,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Female,Urinary Bladder,2016
1-4,24.1,27.2,1086,Incidence,4244572,Non-Hispanic White,25.6,Male,All Cancer Sites Combined,2016
1-4,5.4,6.9,258,Incidence,4244572,Non-Hispanic White,6.1,Male,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Colon and Rectum,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Esophagus,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Kaposi Sarcoma,2016
1-4,1.5,2.3,79,Incidence,4244572,Non-Hispanic White,1.9,Male,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Larynx,2016
1-4,8.5,10.4,401,Incidence,4244572,Non-Hispanic White,9.4,Male,Leukemias,2016
1-4,0.4,0.9,26,Incidence,4244572,Non-Hispanic White,0.6,Male,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Lung and Bronchus,2016
1-4,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Mesothelioma,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Myeloma,2016
1-4,0.9,1.5,49,Incidence,4244572,Non-Hispanic White,1.2,Male,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Pancreas,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Prostate,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Stomach,2016
1-4,0.3,0.7,18,Incidence,4244572,Non-Hispanic White,0.4,Male,Testis,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Thyroid,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male,Urinary Bladder,2016
10-14,15.6,17.8,949,Incidence,5693299,Non-Hispanic White,16.7,Male,All Cancer Sites Combined,2016
10-14,3.2,4.3,212,Incidence,5693299,Non-Hispanic White,3.7,Male,Brain and Other Nervous System,2016
10-14,0.3,0.7,29,Incidence,5693299,Non-Hispanic White,0.5,Male,Colon and Rectum,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Esophagus,2016
10-14,1.4,2.1,97,Incidence,5693299,Non-Hispanic White,1.7,Male,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Kaposi Sarcoma,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Larynx,2016
10-14,2.7,3.7,182,Incidence,5693299,Non-Hispanic White,3.2,Male,Leukemias,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Lung and Bronchus,2016
10-14,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
10-14,0.2,0.6,22,Incidence,5693299,Non-Hispanic White,0.4,Male,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Mesothelioma,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Myeloma,2016
10-14,1.5,2.3,107,Incidence,5693299,Non-Hispanic White,1.9,Male,Non-Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Pancreas,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Prostate,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Stomach,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Testis,2016
10-14,0.2,0.6,22,Incidence,5693299,Non-Hispanic White,0.4,Male,Thyroid,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male,Urinary Bladder,2016
15-19,25.1,27.7,1580,Incidence,5986474,Non-Hispanic White,26.4,Male,All Cancer Sites Combined,2016
15-19,2.2,3.1,157,Incidence,5986474,Non-Hispanic White,2.6,Male,Brain and Other Nervous System,2016
15-19,1.1,1.7,84,Incidence,5986474,Non-Hispanic White,1.4,Male,Colon and Rectum,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Esophagus,2016
15-19,3.1,4.1,214,Incidence,5986474,Non-Hispanic White,3.6,Male,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Kaposi Sarcoma,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Larynx,2016
15-19,3.1,4.0,211,Incidence,5986474,Non-Hispanic White,3.5,Male,Leukemias,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Lung and Bronchus,2016
15-19,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
15-19,0.9,1.4,68,Incidence,5986474,Non-Hispanic White,1.1,Male,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Mesothelioma,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Myeloma,2016
15-19,2.2,3.0,154,Incidence,5986474,Non-Hispanic White,2.6,Male,Non-Hodgkin Lymphoma,2016
15-19,0.3,0.6,25,Incidence,5986474,Non-Hispanic White,0.4,Male,Oral Cavity and Pharynx,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Pancreas,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Prostate,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Stomach,2016
15-19,3.1,4.1,216,Incidence,5986474,Non-Hispanic White,3.6,Male,Testis,2016
15-19,1.0,1.6,78,Incidence,5986474,Non-Hispanic White,1.3,Male,Thyroid,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male,Urinary Bladder,2016
20-24,39.3,42.5,2603,Incidence,6368513,Non-Hispanic White,40.9,Male,All Cancer Sites Combined,2016
20-24,2.9,3.9,215,Incidence,6368513,Non-Hispanic White,3.4,Male,Brain and Other Nervous System,2016
20-24,1.4,2.0,106,Incidence,6368513,Non-Hispanic White,1.7,Male,Colon and Rectum,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Esophagus,2016
20-24,4.2,5.3,302,Incidence,6368513,Non-Hispanic White,4.7,Male,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Kaposi Sarcoma,2016
20-24,0.4,0.8,37,Incidence,6368513,Non-Hispanic White,0.6,Male,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Larynx,2016
20-24,2.4,3.2,175,Incidence,6368513,Non-Hispanic White,2.7,Male,Leukemias,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2016
20-24,0.2,0.5,19,Incidence,6368513,Non-Hispanic White,0.3,Male,Lung and Bronchus,2016
20-24,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
20-24,2.5,3.3,184,Incidence,6368513,Non-Hispanic White,2.9,Male,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Mesothelioma,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Myeloma,2016
20-24,2.8,3.7,203,Incidence,6368513,Non-Hispanic White,3.2,Male,Non-Hodgkin Lymphoma,2016
20-24,0.5,0.9,43,Incidence,6368513,Non-Hispanic White,0.7,Male,Oral Cavity and Pharynx,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Pancreas,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Prostate,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male,Stomach,2016
20-24,11.4,13.2,781,Incidence,6368513,Non-Hispanic White,12.3,Male,Testis,2016
20-24,2.6,3.5,191,Incidence,6368513,Non-Hispanic White,3.0,Male,Thyroid,2016
20-24,0.2,0.5,23,Incidence,6368513,Non-Hispanic White,0.4,Male,Urinary Bladder,2016
25-29,57.1,60.8,3875,Incidence,6576326,Non-Hispanic White,58.9,Male,All Cancer Sites Combined,2016
25-29,3.6,4.5,265,Incidence,6576326,Non-Hispanic White,4.0,Male,Brain and Other Nervous System,2016
25-29,3.4,4.3,252,Incidence,6576326,Non-Hispanic White,3.8,Male,Colon and Rectum,2016
25-29,~,~,~,Incidence,6576326,Non-Hispanic White,~,Male,Esophagus,2016
25-29,4.6,5.8,341,Incidence,6576326,Non-Hispanic White,5.2,Male,Hodgkin Lymphoma,2016
25-29,0.2,0.5,21,Incidence,6576326,Non-Hispanic White,0.3,Male,Kaposi Sarcoma,2016
25-29,1.5,2.1,116,Incidence,6576326,Non-Hispanic White,1.8,Male,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,6576326,Non-Hispanic White,~,Male,Larynx,2016
25-29,2.8,3.7,212,Incidence,6576326,Non-Hispanic White,3.2,Male,Leukemias,2016
25-29,0.2,0.4,17,Incidence,6576326,Non-Hispanic White,0.3,Male,Liver and Intrahepatic Bile Duct,2016
25-29,0.4,0.7,35,Incidence,6576326,Non-Hispanic White,0.5,Male,Lung and Bronchus,2016
25-29,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
25-29,4.7,5.8,346,Incidence,6576326,Non-Hispanic White,5.3,Male,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,6576326,Non-Hispanic White,~,Male,Mesothelioma,2016
25-29,~,~,~,Incidence,6576326,Non-Hispanic White,~,Male,Myeloma,2016
25-29,3.4,4.3,252,Incidence,6576326,Non-Hispanic White,3.8,Male,Non-Hodgkin Lymphoma,2016
25-29,0.8,1.3,70,Incidence,6576326,Non-Hispanic White,1.1,Male,Oral Cavity and Pharynx,2016
25-29,0.2,0.5,22,Incidence,6576326,Non-Hispanic White,0.3,Male,Pancreas,2016
25-29,~,~,~,Incidence,6576326,Non-Hispanic White,~,Male,Prostate,2016
25-29,0.2,0.5,22,Incidence,6576326,Non-Hispanic White,0.3,Male,Stomach,2016
25-29,16.9,19.0,1179,Incidence,6576326,Non-Hispanic White,17.9,Male,Testis,2016
25-29,4.4,5.5,326,Incidence,6576326,Non-Hispanic White,5.0,Male,Thyroid,2016
25-29,0.5,0.9,42,Incidence,6576326,Non-Hispanic White,0.6,Male,Urinary Bladder,2016
30-34,81.6,86.1,5298,Incidence,6321910,Non-Hispanic White,83.8,Male,All Cancer Sites Combined,2016
30-34,5.0,6.1,350,Incidence,6321910,Non-Hispanic White,5.5,Male,Brain and Other Nervous System,2016
30-34,6.4,7.7,442,Incidence,6321910,Non-Hispanic White,7.0,Male,Colon and Rectum,2016
30-34,0.4,0.8,34,Incidence,6321910,Non-Hispanic White,0.5,Male,Esophagus,2016
30-34,3.9,5.0,279,Incidence,6321910,Non-Hispanic White,4.4,Male,Hodgkin Lymphoma,2016
30-34,0.3,0.7,32,Incidence,6321910,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2016
30-34,3.8,4.9,274,Incidence,6321910,Non-Hispanic White,4.3,Male,Kidney and Renal Pelvis,2016
30-34,~,~,~,Incidence,6321910,Non-Hispanic White,~,Male,Larynx,2016
30-34,3.5,4.5,253,Incidence,6321910,Non-Hispanic White,4.0,Male,Leukemias,2016
30-34,0.3,0.7,30,Incidence,6321910,Non-Hispanic White,0.5,Male,Liver and Intrahepatic Bile Duct,2016
30-34,0.9,1.4,71,Incidence,6321910,Non-Hispanic White,1.1,Male,Lung and Bronchus,2016
30-34,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
30-34,10.1,11.7,688,Incidence,6321910,Non-Hispanic White,10.9,Male,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,6321910,Non-Hispanic White,~,Male,Mesothelioma,2016
30-34,0.3,0.6,28,Incidence,6321910,Non-Hispanic White,0.4,Male,Myeloma,2016
30-34,5.0,6.2,355,Incidence,6321910,Non-Hispanic White,5.6,Male,Non-Hodgkin Lymphoma,2016
30-34,1.6,2.3,121,Incidence,6321910,Non-Hispanic White,1.9,Male,Oral Cavity and Pharynx,2016
30-34,0.4,0.8,37,Incidence,6321910,Non-Hispanic White,0.6,Male,Pancreas,2016
30-34,~,~,~,Incidence,6321910,Non-Hispanic White,~,Male,Prostate,2016
30-34,0.5,0.9,43,Incidence,6321910,Non-Hispanic White,0.7,Male,Stomach,2016
30-34,18.5,20.7,1236,Incidence,6321910,Non-Hispanic White,19.6,Male,Testis,2016
30-34,6.5,7.8,450,Incidence,6321910,Non-Hispanic White,7.1,Male,Thyroid,2016
30-34,0.8,1.3,67,Incidence,6321910,Non-Hispanic White,1.1,Male,Urinary Bladder,2016
35-39,109.3,114.6,6741,Incidence,6022757,Non-Hispanic White,111.9,Male,All Cancer Sites Combined,2016
35-39,4.9,6.1,329,Incidence,6022757,Non-Hispanic White,5.5,Male,Brain and Other Nervous System,2016
35-39,11.5,13.3,746,Incidence,6022757,Non-Hispanic White,12.4,Male,Colon and Rectum,2016
35-39,0.6,1.1,51,Incidence,6022757,Non-Hispanic White,0.8,Male,Esophagus,2016
35-39,3.3,4.3,227,Incidence,6022757,Non-Hispanic White,3.8,Male,Hodgkin Lymphoma,2016
35-39,0.4,0.8,33,Incidence,6022757,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2016
35-39,8.1,9.6,529,Incidence,6022757,Non-Hispanic White,8.8,Male,Kidney and Renal Pelvis,2016
35-39,0.3,0.7,27,Incidence,6022757,Non-Hispanic White,0.4,Male,Larynx,2016
35-39,4.7,5.8,314,Incidence,6022757,Non-Hispanic White,5.2,Male,Leukemias,2016
35-39,0.6,1.0,47,Incidence,6022757,Non-Hispanic White,0.8,Male,Liver and Intrahepatic Bile Duct,2016
35-39,2.5,3.4,174,Incidence,6022757,Non-Hispanic White,2.9,Male,Lung and Bronchus,2016
35-39,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
35-39,14.9,16.9,955,Incidence,6022757,Non-Hispanic White,15.9,Male,Melanomas of the Skin,2016
35-39,~,~,~,Incidence,6022757,Non-Hispanic White,~,Male,Mesothelioma,2016
35-39,0.5,0.9,42,Incidence,6022757,Non-Hispanic White,0.7,Male,Myeloma,2016
35-39,6.9,8.4,459,Incidence,6022757,Non-Hispanic White,7.6,Male,Non-Hodgkin Lymphoma,2016
35-39,3.6,4.7,249,Incidence,6022757,Non-Hispanic White,4.1,Male,Oral Cavity and Pharynx,2016
35-39,1.5,2.3,113,Incidence,6022757,Non-Hispanic White,1.9,Male,Pancreas,2016
35-39,0.3,0.7,28,Incidence,6022757,Non-Hispanic White,0.5,Male,Prostate,2016
35-39,0.9,1.5,71,Incidence,6022757,Non-Hispanic White,1.2,Male,Stomach,2016
35-39,15.0,17.0,964,Incidence,6022757,Non-Hispanic White,16.0,Male,Testis,2016
35-39,8.8,10.4,575,Incidence,6022757,Non-Hispanic White,9.5,Male,Thyroid,2016
35-39,2.2,3.0,154,Incidence,6022757,Non-Hispanic White,2.6,Male,Urinary Bladder,2016
40-44,169.7,176.5,9974,Incidence,5763946,Non-Hispanic White,173.0,Male,All Cancer Sites Combined,2016
40-44,5.4,6.7,345,Incidence,5763946,Non-Hispanic White,6.0,Male,Brain and Other Nervous System,2016
40-44,21.4,23.9,1304,Incidence,5763946,Non-Hispanic White,22.6,Male,Colon and Rectum,2016
40-44,1.8,2.6,124,Incidence,5763946,Non-Hispanic White,2.2,Male,Esophagus,2016
40-44,2.7,3.6,178,Incidence,5763946,Non-Hispanic White,3.1,Male,Hodgkin Lymphoma,2016
40-44,0.4,0.9,36,Incidence,5763946,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2016
40-44,15.1,17.2,929,Incidence,5763946,Non-Hispanic White,16.1,Male,Kidney and Renal Pelvis,2016
40-44,1.4,2.1,99,Incidence,5763946,Non-Hispanic White,1.7,Male,Larynx,2016
40-44,7.5,9.0,472,Incidence,5763946,Non-Hispanic White,8.2,Male,Leukemias,2016
40-44,1.1,1.8,82,Incidence,5763946,Non-Hispanic White,1.4,Male,Liver and Intrahepatic Bile Duct,2016
40-44,6.6,8.0,419,Incidence,5763946,Non-Hispanic White,7.3,Male,Lung and Bronchus,2016
40-44,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
40-44,21.0,23.5,1281,Incidence,5763946,Non-Hispanic White,22.2,Male,Melanomas of the Skin,2016
40-44,~,~,~,Incidence,5763946,Non-Hispanic White,~,Male,Mesothelioma,2016
40-44,1.8,2.5,122,Incidence,5763946,Non-Hispanic White,2.1,Male,Myeloma,2016
40-44,10.1,11.9,632,Incidence,5763946,Non-Hispanic White,11.0,Male,Non-Hodgkin Lymphoma,2016
40-44,9.1,10.8,572,Incidence,5763946,Non-Hispanic White,9.9,Male,Oral Cavity and Pharynx,2016
40-44,3.3,4.4,221,Incidence,5763946,Non-Hispanic White,3.8,Male,Pancreas,2016
40-44,5.1,6.3,328,Incidence,5763946,Non-Hispanic White,5.7,Male,Prostate,2016
40-44,2.3,3.2,157,Incidence,5763946,Non-Hispanic White,2.7,Male,Stomach,2016
40-44,10.4,12.2,649,Incidence,5763946,Non-Hispanic White,11.3,Male,Testis,2016
40-44,10.8,12.6,674,Incidence,5763946,Non-Hispanic White,11.7,Male,Thyroid,2016
40-44,5.5,6.8,353,Incidence,5763946,Non-Hispanic White,6.1,Male,Urinary Bladder,2016
45-49,281.3,289.5,18767,Incidence,6576298,Non-Hispanic White,285.4,Male,All Cancer Sites Combined,2016
45-49,6.5,7.8,467,Incidence,6576298,Non-Hispanic White,7.1,Male,Brain and Other Nervous System,2016
45-49,38.6,41.6,2636,Incidence,6576298,Non-Hispanic White,40.1,Male,Colon and Rectum,2016
45-49,4.2,5.2,307,Incidence,6576298,Non-Hispanic White,4.7,Male,Esophagus,2016
45-49,2.5,3.4,194,Incidence,6576298,Non-Hispanic White,2.9,Male,Hodgkin Lymphoma,2016
45-49,0.6,1.1,53,Incidence,6576298,Non-Hispanic White,0.8,Male,Kaposi Sarcoma,2016
45-49,23.9,26.4,1652,Incidence,6576298,Non-Hispanic White,25.1,Male,Kidney and Renal Pelvis,2016
45-49,3.0,3.9,224,Incidence,6576298,Non-Hispanic White,3.4,Male,Larynx,2016
45-49,9.8,11.4,695,Incidence,6576298,Non-Hispanic White,10.6,Male,Leukemias,2016
45-49,3.5,4.5,262,Incidence,6576298,Non-Hispanic White,4.0,Male,Liver and Intrahepatic Bile Duct,2016
45-49,18.1,20.2,1260,Incidence,6576298,Non-Hispanic White,19.2,Male,Lung and Bronchus,2016
45-49,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
45-49,28.7,31.3,1971,Incidence,6576298,Non-Hispanic White,30.0,Male,Melanomas of the Skin,2016
45-49,0.2,0.5,19,Incidence,6576298,Non-Hispanic White,0.3,Male,Mesothelioma,2016
45-49,3.7,4.7,277,Incidence,6576298,Non-Hispanic White,4.2,Male,Myeloma,2016
45-49,15.5,17.5,1083,Incidence,6576298,Non-Hispanic White,16.5,Male,Non-Hodgkin Lymphoma,2016
45-49,20.6,22.8,1425,Incidence,6576298,Non-Hispanic White,21.7,Male,Oral Cavity and Pharynx,2016
45-49,6.4,7.7,461,Incidence,6576298,Non-Hispanic White,7.0,Male,Pancreas,2016
45-49,24.5,26.9,1689,Incidence,6576298,Non-Hispanic White,25.7,Male,Prostate,2016
45-49,4.2,5.3,309,Incidence,6576298,Non-Hispanic White,4.7,Male,Stomach,2016
45-49,7.3,8.7,527,Incidence,6576298,Non-Hispanic White,8.0,Male,Testis,2016
45-49,12.6,14.4,885,Incidence,6576298,Non-Hispanic White,13.5,Male,Thyroid,2016
45-49,10.2,11.8,720,Incidence,6576298,Non-Hispanic White,10.9,Male,Urinary Bladder,2016
5-9,14.9,17.1,870,Incidence,5439329,Non-Hispanic White,16.0,Male,All Cancer Sites Combined,2016
5-9,3.9,5.0,239,Incidence,5439329,Non-Hispanic White,4.4,Male,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Colon and Rectum,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Esophagus,2016
5-9,0.4,0.8,31,Incidence,5439329,Non-Hispanic White,0.6,Male,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Kaposi Sarcoma,2016
5-9,0.4,0.9,34,Incidence,5439329,Non-Hispanic White,0.6,Male,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Larynx,2016
5-9,4.1,5.3,254,Incidence,5439329,Non-Hispanic White,4.7,Male,Leukemias,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Lung and Bronchus,2016
5-9,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Mesothelioma,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Myeloma,2016
5-9,1.5,2.3,102,Incidence,5439329,Non-Hispanic White,1.9,Male,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Pancreas,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Prostate,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Stomach,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Testis,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Thyroid,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male,Urinary Bladder,2016
50-54,547.6,558.4,39830,Incidence,7202789,Non-Hispanic White,553.0,Male,All Cancer Sites Combined,2016
50-54,9.6,11.1,745,Incidence,7202789,Non-Hispanic White,10.3,Male,Brain and Other Nervous System,2016
50-54,68.7,72.6,5090,Incidence,7202789,Non-Hispanic White,70.7,Male,Colon and Rectum,2016
50-54,9.8,11.3,758,Incidence,7202789,Non-Hispanic White,10.5,Male,Esophagus,2016
50-54,2.5,3.4,211,Incidence,7202789,Non-Hispanic White,2.9,Male,Hodgkin Lymphoma,2016
50-54,0.5,0.9,52,Incidence,7202789,Non-Hispanic White,0.7,Male,Kaposi Sarcoma,2016
50-54,35.6,38.4,2663,Incidence,7202789,Non-Hispanic White,37.0,Male,Kidney and Renal Pelvis,2016
50-54,8.6,10.1,672,Incidence,7202789,Non-Hispanic White,9.3,Male,Larynx,2016
50-54,17.1,19.1,1304,Incidence,7202789,Non-Hispanic White,18.1,Male,Leukemias,2016
50-54,12.7,14.4,975,Incidence,7202789,Non-Hispanic White,13.5,Male,Liver and Intrahepatic Bile Duct,2016
50-54,51.6,54.9,3834,Incidence,7202789,Non-Hispanic White,53.2,Male,Lung and Bronchus,2016
50-54,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
50-54,42.4,45.5,3165,Incidence,7202789,Non-Hispanic White,43.9,Male,Melanomas of the Skin,2016
50-54,0.4,0.8,41,Incidence,7202789,Non-Hispanic White,0.6,Male,Mesothelioma,2016
50-54,7.0,8.2,546,Incidence,7202789,Non-Hispanic White,7.6,Male,Myeloma,2016
50-54,24.3,26.6,1832,Incidence,7202789,Non-Hispanic White,25.4,Male,Non-Hodgkin Lymphoma,2016
50-54,37.6,40.5,2812,Incidence,7202789,Non-Hispanic White,39.0,Male,Oral Cavity and Pharynx,2016
50-54,13.8,15.6,1055,Incidence,7202789,Non-Hispanic White,14.6,Male,Pancreas,2016
50-54,101.0,105.7,7444,Incidence,7202789,Non-Hispanic White,103.3,Male,Prostate,2016
50-54,7.4,8.7,577,Incidence,7202789,Non-Hispanic White,8.0,Male,Stomach,2016
50-54,5.5,6.6,433,Incidence,7202789,Non-Hispanic White,6.0,Male,Testis,2016
50-54,12.8,14.5,982,Incidence,7202789,Non-Hispanic White,13.6,Male,Thyroid,2016
50-54,23.3,25.5,1756,Incidence,7202789,Non-Hispanic White,24.4,Male,Urinary Bladder,2016
55-59,909.2,922.8,69599,Incidence,7598544,Non-Hispanic White,916.0,Male,All Cancer Sites Combined,2016
55-59,13.4,15.1,1078,Incidence,7598544,Non-Hispanic White,14.2,Male,Brain and Other Nervous System,2016
55-59,78.7,82.7,6129,Incidence,7598544,Non-Hispanic White,80.7,Male,Colon and Rectum,2016
55-59,16.5,18.4,1325,Incidence,7598544,Non-Hispanic White,17.4,Male,Esophagus,2016
55-59,3.0,3.8,256,Incidence,7598544,Non-Hispanic White,3.4,Male,Hodgkin Lymphoma,2016
55-59,0.4,0.8,46,Incidence,7598544,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2016
55-59,51.3,54.5,4018,Incidence,7598544,Non-Hispanic White,52.9,Male,Kidney and Renal Pelvis,2016
55-59,13.8,15.6,1116,Incidence,7598544,Non-Hispanic White,14.7,Male,Larynx,2016
55-59,26.4,28.8,2095,Incidence,7598544,Non-Hispanic White,27.6,Male,Leukemias,2016
55-59,30.6,33.2,2421,Incidence,7598544,Non-Hispanic White,31.9,Male,Liver and Intrahepatic Bile Duct,2016
55-59,110.3,115.1,8559,Incidence,7598544,Non-Hispanic White,112.6,Male,Lung and Bronchus,2016
55-59,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
55-59,58.5,62.0,4580,Incidence,7598544,Non-Hispanic White,60.3,Male,Melanomas of the Skin,2016
55-59,0.9,1.4,89,Incidence,7598544,Non-Hispanic White,1.2,Male,Mesothelioma,2016
55-59,12.9,14.5,1039,Incidence,7598544,Non-Hispanic White,13.7,Male,Myeloma,2016
55-59,36.5,39.2,2874,Incidence,7598544,Non-Hispanic White,37.8,Male,Non-Hodgkin Lymphoma,2016
55-59,57.0,60.5,4461,Incidence,7598544,Non-Hispanic White,58.7,Male,Oral Cavity and Pharynx,2016
55-59,23.4,25.6,1859,Incidence,7598544,Non-Hispanic White,24.5,Male,Pancreas,2016
55-59,218.6,225.4,16867,Incidence,7598544,Non-Hispanic White,222.0,Male,Prostate,2016
55-59,11.7,13.3,950,Incidence,7598544,Non-Hispanic White,12.5,Male,Stomach,2016
55-59,3.4,4.3,294,Incidence,7598544,Non-Hispanic White,3.9,Male,Testis,2016
55-59,15.2,17.0,1221,Incidence,7598544,Non-Hispanic White,16.1,Male,Thyroid,2016
55-59,45.8,48.9,3598,Incidence,7598544,Non-Hispanic White,47.4,Male,Urinary Bladder,2016
60-64,1364.9,1382.4,94695,Incidence,6893729,Non-Hispanic White,1373.6,Male,All Cancer Sites Combined,2016
60-64,17.2,19.3,1256,Incidence,6893729,Non-Hispanic White,18.2,Male,Brain and Other Nervous System,2016
60-64,100.5,105.3,7094,Incidence,6893729,Non-Hispanic White,102.9,Male,Colon and Rectum,2016
60-64,26.1,28.5,1881,Incidence,6893729,Non-Hispanic White,27.3,Male,Esophagus,2016
60-64,2.8,3.7,224,Incidence,6893729,Non-Hispanic White,3.2,Male,Hodgkin Lymphoma,2016
60-64,0.4,0.8,41,Incidence,6893729,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2016
60-64,64.3,68.2,4567,Incidence,6893729,Non-Hispanic White,66.2,Male,Kidney and Renal Pelvis,2016
60-64,17.1,19.1,1247,Incidence,6893729,Non-Hispanic White,18.1,Male,Larynx,2016
60-64,39.9,43.0,2855,Incidence,6893729,Non-Hispanic White,41.4,Male,Leukemias,2016
60-64,50.0,53.4,3560,Incidence,6893729,Non-Hispanic White,51.6,Male,Liver and Intrahepatic Bile Duct,2016
60-64,176.9,183.3,12415,Incidence,6893729,Non-Hispanic White,180.1,Male,Lung and Bronchus,2016
60-64,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
60-64,83.2,87.6,5887,Incidence,6893729,Non-Hispanic White,85.4,Male,Melanomas of the Skin,2016
60-64,1.9,2.6,155,Incidence,6893729,Non-Hispanic White,2.2,Male,Mesothelioma,2016
60-64,18.8,20.9,1367,Incidence,6893729,Non-Hispanic White,19.8,Male,Myeloma,2016
60-64,51.7,55.2,3683,Incidence,6893729,Non-Hispanic White,53.4,Male,Non-Hodgkin Lymphoma,2016
60-64,69.6,73.6,4935,Incidence,6893729,Non-Hispanic White,71.6,Male,Oral Cavity and Pharynx,2016
60-64,38.4,41.4,2749,Incidence,6893729,Non-Hispanic White,39.9,Male,Pancreas,2016
60-64,380.4,389.7,26545,Incidence,6893729,Non-Hispanic White,385.1,Male,Prostate,2016
60-64,17.6,19.6,1279,Incidence,6893729,Non-Hispanic White,18.6,Male,Stomach,2016
60-64,2.2,3.0,176,Incidence,6893729,Non-Hispanic White,2.6,Male,Testis,2016
60-64,16.5,18.5,1202,Incidence,6893729,Non-Hispanic White,17.4,Male,Thyroid,2016
60-64,76.6,80.8,5426,Incidence,6893729,Non-Hispanic White,78.7,Male,Urinary Bladder,2016
65-69,1933.3,1955.5,118882,Incidence,6114175,Non-Hispanic White,1944.4,Male,All Cancer Sites Combined,2016
65-69,20.9,23.2,1346,Incidence,6114175,Non-Hispanic White,22.0,Male,Brain and Other Nervous System,2016
65-69,132.1,137.9,8251,Incidence,6114175,Non-Hispanic White,134.9,Male,Colon and Rectum,2016
65-69,34.3,37.3,2188,Incidence,6114175,Non-Hispanic White,35.8,Male,Esophagus,2016
65-69,3.4,4.4,238,Incidence,6114175,Non-Hispanic White,3.9,Male,Hodgkin Lymphoma,2016
65-69,0.3,0.7,31,Incidence,6114175,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2016
65-69,84.8,89.5,5329,Incidence,6114175,Non-Hispanic White,87.2,Male,Kidney and Renal Pelvis,2016
65-69,21.5,23.9,1387,Incidence,6114175,Non-Hispanic White,22.7,Male,Larynx,2016
65-69,56.8,60.7,3589,Incidence,6114175,Non-Hispanic White,58.7,Male,Leukemias,2016
65-69,49.3,52.9,3121,Incidence,6114175,Non-Hispanic White,51.0,Male,Liver and Intrahepatic Bile Duct,2016
65-69,269.7,278.1,16745,Incidence,6114175,Non-Hispanic White,273.9,Male,Lung and Bronchus,2016
65-69,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
65-69,116.2,121.7,7269,Incidence,6114175,Non-Hispanic White,118.9,Male,Melanomas of the Skin,2016
65-69,3.8,4.8,262,Incidence,6114175,Non-Hispanic White,4.3,Male,Mesothelioma,2016
65-69,29.5,32.3,1890,Incidence,6114175,Non-Hispanic White,30.9,Male,Myeloma,2016
65-69,73.9,78.2,4648,Incidence,6114175,Non-Hispanic White,76.0,Male,Non-Hodgkin Lymphoma,2016
65-69,72.6,76.9,4570,Incidence,6114175,Non-Hispanic White,74.7,Male,Oral Cavity and Pharynx,2016
65-69,55.8,59.6,3526,Incidence,6114175,Non-Hispanic White,57.7,Male,Pancreas,2016
65-69,580.6,592.8,35870,Incidence,6114175,Non-Hispanic White,586.7,Male,Prostate,2016
65-69,25.0,27.6,1604,Incidence,6114175,Non-Hispanic White,26.2,Male,Stomach,2016
65-69,1.3,2.0,99,Incidence,6114175,Non-Hispanic White,1.6,Male,Testis,2016
65-69,19.1,21.4,1235,Incidence,6114175,Non-Hispanic White,20.2,Male,Thyroid,2016
65-69,125.9,131.6,7868,Incidence,6114175,Non-Hispanic White,128.7,Male,Urinary Bladder,2016
70-74,2401.4,2430.9,103560,Incidence,4286186,Non-Hispanic White,2416.1,Male,All Cancer Sites Combined,2016
70-74,22.9,25.9,1043,Incidence,4286186,Non-Hispanic White,24.3,Male,Brain and Other Nervous System,2016
70-74,163.6,171.4,7177,Incidence,4286186,Non-Hispanic White,167.4,Male,Colon and Rectum,2016
70-74,42.4,46.4,1902,Incidence,4286186,Non-Hispanic White,44.4,Male,Esophagus,2016
70-74,4.5,5.9,220,Incidence,4286186,Non-Hispanic White,5.1,Male,Hodgkin Lymphoma,2016
70-74,0.2,0.6,16,Incidence,4286186,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2016
70-74,97.9,104.0,4326,Incidence,4286186,Non-Hispanic White,100.9,Male,Kidney and Renal Pelvis,2016
70-74,24.1,27.2,1097,Incidence,4286186,Non-Hispanic White,25.6,Male,Larynx,2016
70-74,77.2,82.6,3424,Incidence,4286186,Non-Hispanic White,79.9,Male,Leukemias,2016
70-74,45.2,49.3,2023,Incidence,4286186,Non-Hispanic White,47.2,Male,Liver and Intrahepatic Bile Duct,2016
70-74,397.9,409.9,17311,Incidence,4286186,Non-Hispanic White,403.9,Male,Lung and Bronchus,2016
70-74,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
70-74,149.6,157.0,6569,Incidence,4286186,Non-Hispanic White,153.3,Male,Melanomas of the Skin,2016
70-74,7.4,9.1,351,Incidence,4286186,Non-Hispanic White,8.2,Male,Mesothelioma,2016
70-74,39.6,43.4,1777,Incidence,4286186,Non-Hispanic White,41.5,Male,Myeloma,2016
70-74,104.9,111.2,4629,Incidence,4286186,Non-Hispanic White,108.0,Male,Non-Hodgkin Lymphoma,2016
70-74,73.2,78.5,3249,Incidence,4286186,Non-Hispanic White,75.8,Male,Oral Cavity and Pharynx,2016
70-74,74.3,79.5,3295,Incidence,4286186,Non-Hispanic White,76.9,Male,Pancreas,2016
70-74,607.3,622.2,26349,Incidence,4286186,Non-Hispanic White,614.7,Male,Prostate,2016
70-74,34.1,37.7,1539,Incidence,4286186,Non-Hispanic White,35.9,Male,Stomach,2016
70-74,0.7,1.4,44,Incidence,4286186,Non-Hispanic White,1.0,Male,Testis,2016
70-74,17.4,20.1,802,Incidence,4286186,Non-Hispanic White,18.7,Male,Thyroid,2016
70-74,197.1,205.6,8630,Incidence,4286186,Non-Hispanic White,201.3,Male,Urinary Bladder,2016
75-79,2749.3,2787.3,81546,Incidence,2945779,Non-Hispanic White,2768.2,Male,All Cancer Sites Combined,2016
75-79,28.2,32.2,887,Incidence,2945779,Non-Hispanic White,30.1,Male,Brain and Other Nervous System,2016
75-79,207.4,218.0,6265,Incidence,2945779,Non-Hispanic White,212.7,Male,Colon and Rectum,2016
75-79,44.1,49.1,1371,Incidence,2945779,Non-Hispanic White,46.5,Male,Esophagus,2016
75-79,4.2,5.9,148,Incidence,2945779,Non-Hispanic White,5.0,Male,Hodgkin Lymphoma,2016
75-79,0.6,1.3,26,Incidence,2945779,Non-Hispanic White,0.9,Male,Kaposi Sarcoma,2016
75-79,101.5,108.9,3097,Incidence,2945779,Non-Hispanic White,105.1,Male,Kidney and Renal Pelvis,2016
75-79,24.8,28.5,784,Incidence,2945779,Non-Hispanic White,26.6,Male,Larynx,2016
75-79,103.2,110.7,3148,Incidence,2945779,Non-Hispanic White,106.9,Male,Leukemias,2016
75-79,47.3,52.4,1467,Incidence,2945779,Non-Hispanic White,49.8,Male,Liver and Intrahepatic Bile Duct,2016
75-79,491.6,507.7,14717,Incidence,2945779,Non-Hispanic White,499.6,Male,Lung and Bronchus,2016
75-79,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
75-79,182.2,192.1,5512,Incidence,2945779,Non-Hispanic White,187.1,Male,Melanomas of the Skin,2016
75-79,12.2,14.9,398,Incidence,2945779,Non-Hispanic White,13.5,Male,Mesothelioma,2016
75-79,48.9,54.1,1515,Incidence,2945779,Non-Hispanic White,51.4,Male,Myeloma,2016
75-79,132.2,140.6,4017,Incidence,2945779,Non-Hispanic White,136.4,Male,Non-Hodgkin Lymphoma,2016
75-79,72.5,78.8,2226,Incidence,2945779,Non-Hispanic White,75.6,Male,Oral Cavity and Pharynx,2016
75-79,88.9,95.9,2720,Incidence,2945779,Non-Hispanic White,92.3,Male,Pancreas,2016
75-79,534.6,551.5,15995,Incidence,2945779,Non-Hispanic White,543.0,Male,Prostate,2016
75-79,39.5,44.2,1230,Incidence,2945779,Non-Hispanic White,41.8,Male,Stomach,2016
75-79,0.9,1.7,36,Incidence,2945779,Non-Hispanic White,1.2,Male,Testis,2016
75-79,18.3,21.5,585,Incidence,2945779,Non-Hispanic White,19.9,Male,Thyroid,2016
75-79,265.9,277.8,8006,Incidence,2945779,Non-Hispanic White,271.8,Male,Urinary Bladder,2016
80-84,2951.2,2999.5,58487,Incidence,1965779,Non-Hispanic White,2975.3,Male,All Cancer Sites Combined,2016
80-84,28.1,33.0,599,Incidence,1965779,Non-Hispanic White,30.5,Male,Brain and Other Nervous System,2016
80-84,240.2,254.1,4857,Incidence,1965779,Non-Hispanic White,247.1,Male,Colon and Rectum,2016
80-84,46.0,52.2,964,Incidence,1965779,Non-Hispanic White,49.0,Male,Esophagus,2016
80-84,3.9,5.9,95,Incidence,1965779,Non-Hispanic White,4.8,Male,Hodgkin Lymphoma,2016
80-84,0.7,1.7,22,Incidence,1965779,Non-Hispanic White,1.1,Male,Kaposi Sarcoma,2016
80-84,99.3,108.3,2039,Incidence,1965779,Non-Hispanic White,103.7,Male,Kidney and Renal Pelvis,2016
80-84,23.7,28.2,509,Incidence,1965779,Non-Hispanic White,25.9,Male,Larynx,2016
80-84,124.3,134.4,2541,Incidence,1965779,Non-Hispanic White,129.3,Male,Leukemias,2016
80-84,48.2,54.5,1008,Incidence,1965779,Non-Hispanic White,51.3,Male,Liver and Intrahepatic Bile Duct,2016
80-84,516.8,537.1,10357,Incidence,1965779,Non-Hispanic White,526.9,Male,Lung and Bronchus,2016
80-84,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
80-84,216.9,230.2,4393,Incidence,1965779,Non-Hispanic White,223.5,Male,Melanomas of the Skin,2016
80-84,17.4,21.4,380,Incidence,1965779,Non-Hispanic White,19.3,Male,Mesothelioma,2016
80-84,56.4,63.2,1174,Incidence,1965779,Non-Hispanic White,59.7,Male,Myeloma,2016
80-84,151.1,162.2,3078,Incidence,1965779,Non-Hispanic White,156.6,Male,Non-Hodgkin Lymphoma,2016
80-84,69.8,77.4,1445,Incidence,1965779,Non-Hispanic White,73.5,Male,Oral Cavity and Pharynx,2016
80-84,98.6,107.6,2025,Incidence,1965779,Non-Hispanic White,103.0,Male,Pancreas,2016
80-84,405.4,423.5,8146,Incidence,1965779,Non-Hispanic White,414.4,Male,Prostate,2016
80-84,45.1,51.3,946,Incidence,1965779,Non-Hispanic White,48.1,Male,Stomach,2016
80-84,~,~,~,Incidence,1965779,Non-Hispanic White,~,Male,Testis,2016
80-84,13.8,17.4,305,Incidence,1965779,Non-Hispanic White,15.5,Male,Thyroid,2016
80-84,347.8,364.6,7001,Incidence,1965779,Non-Hispanic White,356.1,Male,Urinary Bladder,2016
85+,2896.0,2945.6,53515,Incidence,1832246,Non-Hispanic White,2920.7,Male,All Cancer Sites Combined,2016
85+,23.0,27.7,463,Incidence,1832246,Non-Hispanic White,25.3,Male,Brain and Other Nervous System,2016
85+,270.0,285.3,5086,Incidence,1832246,Non-Hispanic White,277.6,Male,Colon and Rectum,2016
85+,41.8,48.0,821,Incidence,1832246,Non-Hispanic White,44.8,Male,Esophagus,2016
85+,3.0,4.8,70,Incidence,1832246,Non-Hispanic White,3.8,Male,Hodgkin Lymphoma,2016
85+,1.1,2.4,31,Incidence,1832246,Non-Hispanic White,1.7,Male,Kaposi Sarcoma,2016
85+,78.3,86.6,1509,Incidence,1832246,Non-Hispanic White,82.4,Male,Kidney and Renal Pelvis,2016
85+,21.8,26.3,439,Incidence,1832246,Non-Hispanic White,24.0,Male,Larynx,2016
85+,134.9,145.8,2570,Incidence,1832246,Non-Hispanic White,140.3,Male,Leukemias,2016
85+,40.6,46.7,798,Incidence,1832246,Non-Hispanic White,43.6,Male,Liver and Intrahepatic Bile Duct,2016
85+,418.7,437.7,7844,Incidence,1832246,Non-Hispanic White,428.1,Male,Lung and Bronchus,2016
85+,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
85+,231.1,245.2,4362,Incidence,1832246,Non-Hispanic White,238.1,Male,Melanomas of the Skin,2016
85+,16.8,20.8,343,Incidence,1832246,Non-Hispanic White,18.7,Male,Mesothelioma,2016
85+,51.7,58.6,1009,Incidence,1832246,Non-Hispanic White,55.1,Male,Myeloma,2016
85+,145.0,156.3,2758,Incidence,1832246,Non-Hispanic White,150.5,Male,Non-Hodgkin Lymphoma,2016
85+,60.7,68.1,1179,Incidence,1832246,Non-Hispanic White,64.3,Male,Oral Cavity and Pharynx,2016
85+,102.5,112.0,1964,Incidence,1832246,Non-Hispanic White,107.2,Male,Pancreas,2016
85+,359.4,377.0,6745,Incidence,1832246,Non-Hispanic White,368.1,Male,Prostate,2016
85+,49.9,56.6,974,Incidence,1832246,Non-Hispanic White,53.2,Male,Stomach,2016
85+,0.5,1.4,16,Incidence,1832246,Non-Hispanic White,0.9,Male,Testis,2016
85+,7.8,10.7,168,Incidence,1832246,Non-Hispanic White,9.2,Male,Thyroid,2016
85+,371.6,389.6,6972,Incidence,1832246,Non-Hispanic White,380.5,Male,Urinary Bladder,2016
<1,28.8,35.8,338,Incidence,1050522,Non-Hispanic White,32.2,Male,All Cancer Sites Combined,2016
<1,3.5,6.3,50,Incidence,1050522,Non-Hispanic White,4.8,Male,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Colon and Rectum,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Esophagus,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Kaposi Sarcoma,2016
<1,0.9,2.5,16,Incidence,1050522,Non-Hispanic White,1.5,Male,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Larynx,2016
<1,3.2,5.8,46,Incidence,1050522,Non-Hispanic White,4.4,Male,Leukemias,2016
<1,1.4,3.3,23,Incidence,1050522,Non-Hispanic White,2.2,Male,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Lung and Bronchus,2016
<1,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Melanomas of the Skin,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Mesothelioma,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Myeloma,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Pancreas,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Prostate,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Stomach,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Testis,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Thyroid,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male,Urinary Bladder,2016
1-4,23.3,25.4,2013,Incidence,8277466,Non-Hispanic White,24.3,Male and Female,All Cancer Sites Combined,2016
1-4,5.0,6.0,452,Incidence,8277466,Non-Hispanic White,5.5,Male and Female,Brain and Other Nervous System,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,Cervix,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Colon and Rectum,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Esophagus,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,Female Breast,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2016
1-4,1.9,2.5,180,Incidence,8277466,Non-Hispanic White,2.2,Male and Female,Kidney and Renal Pelvis,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Larynx,2016
1-4,8.4,9.7,751,Incidence,8277466,Non-Hispanic White,9.1,Male and Female,Leukemias,2016
1-4,0.4,0.7,42,Incidence,8277466,Non-Hispanic White,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,Male and Female Breast,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Myeloma,2016
1-4,0.6,1.0,68,Incidence,8277466,Non-Hispanic White,0.8,Male and Female,Non-Hodgkin Lymphoma,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2016
1-4,~,~,~,Incidence,4032894,Non-Hispanic White,~,Male and Female,Ovary,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Pancreas,2016
1-4,~,~,~,Incidence,4244572,Non-Hispanic White,~,Male and Female,Prostate,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Stomach,2016
1-4,0.3,0.7,18,Incidence,4244572,Non-Hispanic White,0.4,Male and Female,Testis,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Thyroid,2016
1-4,~,~,~,Incidence,8277466,Non-Hispanic White,~,Male and Female,Urinary Bladder,2016
10-14,15.5,17.0,1807,Incidence,11107084,Non-Hispanic White,16.3,Male and Female,All Cancer Sites Combined,2016
10-14,3.2,3.9,389,Incidence,11107084,Non-Hispanic White,3.5,Male and Female,Brain and Other Nervous System,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Male and Female,Cervix,2016
10-14,0.6,0.9,85,Incidence,11107084,Non-Hispanic White,0.8,Male and Female,Colon and Rectum,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Esophagus,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Male and Female,Female Breast,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2016
10-14,1.2,1.7,161,Incidence,11107084,Non-Hispanic White,1.4,Male and Female,Hodgkin Lymphoma,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2016
10-14,0.1,0.2,17,Incidence,11107084,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Larynx,2016
10-14,2.7,3.4,338,Incidence,11107084,Non-Hispanic White,3.0,Male and Female,Leukemias,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Male and Female,Male and Female Breast,2016
10-14,~,~,~,Incidence,5413785,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
10-14,0.3,0.5,40,Incidence,11107084,Non-Hispanic White,0.4,Male and Female,Melanomas of the Skin,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Myeloma,2016
10-14,1.3,1.7,164,Incidence,11107084,Non-Hispanic White,1.5,Male and Female,Non-Hodgkin Lymphoma,2016
10-14,0.2,0.4,32,Incidence,11107084,Non-Hispanic White,0.3,Male and Female,Oral Cavity and Pharynx,2016
10-14,0.5,0.9,35,Incidence,5413785,Non-Hispanic White,0.6,Male and Female,Ovary,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Pancreas,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male and Female,Prostate,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Stomach,2016
10-14,~,~,~,Incidence,5693299,Non-Hispanic White,~,Male and Female,Testis,2016
10-14,0.7,1.1,97,Incidence,11107084,Non-Hispanic White,0.9,Male and Female,Thyroid,2016
10-14,~,~,~,Incidence,11107084,Non-Hispanic White,~,Male and Female,Urinary Bladder,2016
15-19,26.1,28.0,3158,Incidence,11672509,Non-Hispanic White,27.1,Male and Female,All Cancer Sites Combined,2016
15-19,2.3,2.9,298,Incidence,11672509,Non-Hispanic White,2.6,Male and Female,Brain and Other Nervous System,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Male and Female,Cervix,2016
15-19,1.6,2.1,210,Incidence,11672509,Non-Hispanic White,1.8,Male and Female,Colon and Rectum,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Esophagus,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Male and Female,Female Breast,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2016
15-19,3.5,4.2,452,Incidence,11672509,Non-Hispanic White,3.9,Male and Female,Hodgkin Lymphoma,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2016
15-19,0.1,0.3,22,Incidence,11672509,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Larynx,2016
15-19,2.6,3.2,338,Incidence,11672509,Non-Hispanic White,2.9,Male and Female,Leukemias,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2016
15-19,0.1,0.2,16,Incidence,11672509,Non-Hispanic White,0.1,Male and Female,Lung and Bronchus,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Male and Female,Male and Female Breast,2016
15-19,~,~,~,Incidence,5686035,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
15-19,1.2,1.7,167,Incidence,11672509,Non-Hispanic White,1.4,Male and Female,Melanomas of the Skin,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Myeloma,2016
15-19,1.7,2.2,226,Incidence,11672509,Non-Hispanic White,1.9,Male and Female,Non-Hodgkin Lymphoma,2016
15-19,0.4,0.7,61,Incidence,11672509,Non-Hispanic White,0.5,Male and Female,Oral Cavity and Pharynx,2016
15-19,1.0,1.6,70,Incidence,5686035,Non-Hispanic White,1.2,Male and Female,Ovary,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Pancreas,2016
15-19,~,~,~,Incidence,5986474,Non-Hispanic White,~,Male and Female,Prostate,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Stomach,2016
15-19,3.1,4.1,216,Incidence,5986474,Non-Hispanic White,3.6,Male and Female,Testis,2016
15-19,3.8,4.5,481,Incidence,11672509,Non-Hispanic White,4.1,Male and Female,Thyroid,2016
15-19,~,~,~,Incidence,11672509,Non-Hispanic White,~,Male and Female,Urinary Bladder,2016
20-24,41.6,43.9,5293,Incidence,12388976,Non-Hispanic White,42.7,Male and Female,All Cancer Sites Combined,2016
20-24,2.4,3.0,338,Incidence,12388976,Non-Hispanic White,2.7,Male and Female,Brain and Other Nervous System,2016
20-24,0.6,1.1,48,Incidence,6020463,Non-Hispanic White,0.8,Male and Female,Cervix,2016
20-24,2.1,2.6,288,Incidence,12388976,Non-Hispanic White,2.3,Male and Female,Colon and Rectum,2016
20-24,0.3,0.6,25,Incidence,6020463,Non-Hispanic White,0.4,Male and Female,"Corpus and Uterus, NOS",2016
20-24,~,~,~,Incidence,12388976,Non-Hispanic White,~,Male and Female,Esophagus,2016
20-24,1.2,1.8,87,Incidence,6020463,Non-Hispanic White,1.4,Male and Female,Female Breast,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2016
20-24,4.5,5.3,604,Incidence,12388976,Non-Hispanic White,4.9,Male and Female,Hodgkin Lymphoma,2016
20-24,~,~,~,Incidence,12388976,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2016
20-24,0.4,0.7,66,Incidence,12388976,Non-Hispanic White,0.5,Male and Female,Kidney and Renal Pelvis,2016
20-24,~,~,~,Incidence,12388976,Non-Hispanic White,~,Male and Female,Larynx,2016
20-24,2.3,2.8,314,Incidence,12388976,Non-Hispanic White,2.5,Male and Female,Leukemias,2016
20-24,0.1,0.2,20,Incidence,12388976,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
20-24,0.3,0.5,45,Incidence,12388976,Non-Hispanic White,0.4,Male and Female,Lung and Bronchus,2016
20-24,1.2,1.8,87,Incidence,6020463,Non-Hispanic White,1.4,Male and Female,Male and Female Breast,2016
20-24,~,~,~,Incidence,6020463,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
20-24,4.2,5.0,568,Incidence,12388976,Non-Hispanic White,4.6,Male and Female,Melanomas of the Skin,2016
20-24,~,~,~,Incidence,12388976,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
20-24,~,~,~,Incidence,12388976,Non-Hispanic White,~,Male and Female,Myeloma,2016
20-24,2.4,2.9,327,Incidence,12388976,Non-Hispanic White,2.6,Male and Female,Non-Hodgkin Lymphoma,2016
20-24,0.5,0.8,79,Incidence,12388976,Non-Hispanic White,0.6,Male and Female,Oral Cavity and Pharynx,2016
20-24,1.3,1.9,95,Incidence,6020463,Non-Hispanic White,1.6,Male and Female,Ovary,2016
20-24,0.1,0.2,19,Incidence,12388976,Non-Hispanic White,0.2,Male and Female,Pancreas,2016
20-24,~,~,~,Incidence,6368513,Non-Hispanic White,~,Male and Female,Prostate,2016
20-24,0.1,0.3,24,Incidence,12388976,Non-Hispanic White,0.2,Male and Female,Stomach,2016
20-24,11.4,13.2,781,Incidence,6368513,Non-Hispanic White,12.3,Male and Female,Testis,2016
20-24,7.6,8.6,998,Incidence,12388976,Non-Hispanic White,8.1,Male and Female,Thyroid,2016
20-24,0.2,0.4,35,Incidence,12388976,Non-Hispanic White,0.3,Male and Female,Urinary Bladder,2016
25-29,69.1,72.0,9132,Incidence,12948770,Non-Hispanic White,70.5,Male and Female,All Cancer Sites Combined,2016
25-29,3.2,3.8,449,Incidence,12948770,Non-Hispanic White,3.5,Male and Female,Brain and Other Nervous System,2016
25-29,5.2,6.4,369,Incidence,6372444,Non-Hispanic White,5.8,Male and Female,Cervix,2016
25-29,3.7,4.4,517,Incidence,12948770,Non-Hispanic White,4.0,Male and Female,Colon and Rectum,2016
25-29,1.5,2.2,115,Incidence,6372444,Non-Hispanic White,1.8,Male and Female,"Corpus and Uterus, NOS",2016
25-29,~,~,~,Incidence,12948770,Non-Hispanic White,~,Male and Female,Esophagus,2016
25-29,9.9,11.6,684,Incidence,6372444,Non-Hispanic White,10.7,Male and Female,Female Breast,2016
25-29,0.6,1.1,52,Incidence,6372444,Non-Hispanic White,0.8,Male and Female,"Female Breast, <i>in situ</i>",2016
25-29,4.4,5.1,613,Incidence,12948770,Non-Hispanic White,4.7,Male and Female,Hodgkin Lymphoma,2016
25-29,0.1,0.3,23,Incidence,12948770,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2016
25-29,1.4,1.9,213,Incidence,12948770,Non-Hispanic White,1.6,Male and Female,Kidney and Renal Pelvis,2016
25-29,~,~,~,Incidence,12948770,Non-Hispanic White,~,Male and Female,Larynx,2016
25-29,2.5,3.1,359,Incidence,12948770,Non-Hispanic White,2.8,Male and Female,Leukemias,2016
25-29,0.2,0.4,36,Incidence,12948770,Non-Hispanic White,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2016
25-29,0.5,0.7,77,Incidence,12948770,Non-Hispanic White,0.6,Male and Female,Lung and Bronchus,2016
25-29,9.9,11.6,684,Incidence,6372444,Non-Hispanic White,10.7,Male and Female,Male and Female Breast,2016
25-29,0.6,1.1,52,Incidence,6372444,Non-Hispanic White,0.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
25-29,8.9,9.9,1216,Incidence,12948770,Non-Hispanic White,9.4,Male and Female,Melanomas of the Skin,2016
25-29,~,~,~,Incidence,12948770,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
25-29,~,~,~,Incidence,12948770,Non-Hispanic White,~,Male and Female,Myeloma,2016
25-29,2.7,3.4,393,Incidence,12948770,Non-Hispanic White,3.0,Male and Female,Non-Hodgkin Lymphoma,2016
25-29,0.9,1.3,138,Incidence,12948770,Non-Hispanic White,1.1,Male and Female,Oral Cavity and Pharynx,2016
25-29,1.9,2.7,146,Incidence,6372444,Non-Hispanic White,2.3,Male and Female,Ovary,2016
25-29,0.3,0.5,50,Incidence,12948770,Non-Hispanic White,0.4,Male and Female,Pancreas,2016
25-29,~,~,~,Incidence,6576326,Non-Hispanic White,~,Male and Female,Prostate,2016
25-29,0.2,0.4,38,Incidence,12948770,Non-Hispanic White,0.3,Male and Female,Stomach,2016
25-29,16.9,19.0,1179,Incidence,6576326,Non-Hispanic White,17.9,Male and Female,Testis,2016
25-29,12.7,14.0,1725,Incidence,12948770,Non-Hispanic White,13.3,Male and Female,Thyroid,2016
25-29,0.4,0.7,69,Incidence,12948770,Non-Hispanic White,0.5,Male and Female,Urinary Bladder,2016
30-34,111.0,114.8,14145,Incidence,12529606,Non-Hispanic White,112.9,Male and Female,All Cancer Sites Combined,2016
30-34,4.4,5.1,595,Incidence,12529606,Non-Hispanic White,4.7,Male and Female,Brain and Other Nervous System,2016
30-34,10.4,12.0,694,Incidence,6207696,Non-Hispanic White,11.2,Male and Female,Cervix,2016
30-34,6.3,7.2,847,Incidence,12529606,Non-Hispanic White,6.8,Male and Female,Colon and Rectum,2016
30-34,4.3,5.4,301,Incidence,6207696,Non-Hispanic White,4.8,Male and Female,"Corpus and Uterus, NOS",2016
30-34,0.2,0.4,38,Incidence,12529606,Non-Hispanic White,0.3,Male and Female,Esophagus,2016
30-34,30.3,33.1,1967,Incidence,6207696,Non-Hispanic White,31.7,Male and Female,Female Breast,2016
30-34,2.9,3.8,206,Incidence,6207696,Non-Hispanic White,3.3,Male and Female,"Female Breast, <i>in situ</i>",2016
30-34,4.0,4.7,546,Incidence,12529606,Non-Hispanic White,4.4,Male and Female,Hodgkin Lymphoma,2016
30-34,0.2,0.4,32,Incidence,12529606,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2016
30-34,3.4,4.1,472,Incidence,12529606,Non-Hispanic White,3.8,Male and Female,Kidney and Renal Pelvis,2016
30-34,0.1,0.3,23,Incidence,12529606,Non-Hispanic White,0.2,Male and Female,Larynx,2016
30-34,3.3,3.9,450,Incidence,12529606,Non-Hispanic White,3.6,Male and Female,Leukemias,2016
30-34,0.4,0.6,61,Incidence,12529606,Non-Hispanic White,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2016
30-34,1.0,1.4,148,Incidence,12529606,Non-Hispanic White,1.2,Male and Female,Lung and Bronchus,2016
30-34,30.3,33.1,1967,Incidence,6207696,Non-Hispanic White,31.7,Male and Female,Male and Female Breast,2016
30-34,2.9,3.8,206,Incidence,6207696,Non-Hispanic White,3.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
30-34,14.9,16.3,1948,Incidence,12529606,Non-Hispanic White,15.5,Male and Female,Melanomas of the Skin,2016
30-34,~,~,~,Incidence,12529606,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
30-34,0.3,0.5,44,Incidence,12529606,Non-Hispanic White,0.4,Male and Female,Myeloma,2016
30-34,4.6,5.4,620,Incidence,12529606,Non-Hispanic White,4.9,Male and Female,Non-Hodgkin Lymphoma,2016
30-34,1.7,2.2,246,Incidence,12529606,Non-Hispanic White,2.0,Male and Female,Oral Cavity and Pharynx,2016
30-34,3.4,4.4,241,Incidence,6207696,Non-Hispanic White,3.9,Male and Female,Ovary,2016
30-34,0.4,0.7,69,Incidence,12529606,Non-Hispanic White,0.6,Male and Female,Pancreas,2016
30-34,~,~,~,Incidence,6321910,Non-Hispanic White,~,Male and Female,Prostate,2016
30-34,0.5,0.8,82,Incidence,12529606,Non-Hispanic White,0.7,Male and Female,Stomach,2016
30-34,18.5,20.7,1236,Incidence,6321910,Non-Hispanic White,19.6,Male and Female,Testis,2016
30-34,18.0,19.5,2343,Incidence,12529606,Non-Hispanic White,18.7,Male and Female,Thyroid,2016
30-34,0.7,1.1,113,Incidence,12529606,Non-Hispanic White,0.9,Male and Female,Urinary Bladder,2016
35-39,163.1,167.7,19782,Incidence,11961184,Non-Hispanic White,165.4,Male and Female,All Cancer Sites Combined,2016
35-39,4.5,5.3,587,Incidence,11961184,Non-Hispanic White,4.9,Male and Female,Brain and Other Nervous System,2016
35-39,14.7,16.7,930,Incidence,5938427,Non-Hispanic White,15.7,Male and Female,Cervix,2016
35-39,11.8,13.0,1480,Incidence,11961184,Non-Hispanic White,12.4,Male and Female,Colon and Rectum,2016
35-39,9.6,11.3,620,Incidence,5938427,Non-Hispanic White,10.4,Male and Female,"Corpus and Uterus, NOS",2016
35-39,0.4,0.7,65,Incidence,11961184,Non-Hispanic White,0.5,Male and Female,Esophagus,2016
35-39,64.1,68.3,3931,Incidence,5938427,Non-Hispanic White,66.2,Male and Female,Female Breast,2016
35-39,7.8,9.3,506,Incidence,5938427,Non-Hispanic White,8.5,Male and Female,"Female Breast, <i>in situ</i>",2016
35-39,3.1,3.8,409,Incidence,11961184,Non-Hispanic White,3.4,Male and Female,Hodgkin Lymphoma,2016
35-39,0.2,0.4,33,Incidence,11961184,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2016
35-39,6.8,7.8,868,Incidence,11961184,Non-Hispanic White,7.3,Male and Female,Kidney and Renal Pelvis,2016
35-39,0.3,0.5,46,Incidence,11961184,Non-Hispanic White,0.4,Male and Female,Larynx,2016
35-39,4.2,5.0,545,Incidence,11961184,Non-Hispanic White,4.6,Male and Female,Leukemias,2016
35-39,0.7,1.0,101,Incidence,11961184,Non-Hispanic White,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
35-39,2.6,3.2,348,Incidence,11961184,Non-Hispanic White,2.9,Male and Female,Lung and Bronchus,2016
35-39,64.1,68.3,3931,Incidence,5938427,Non-Hispanic White,66.2,Male and Female,Male and Female Breast,2016
35-39,7.8,9.3,506,Incidence,5938427,Non-Hispanic White,8.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
35-39,19.7,21.3,2448,Incidence,11961184,Non-Hispanic White,20.5,Male and Female,Melanomas of the Skin,2016
35-39,0.1,0.2,17,Incidence,11961184,Non-Hispanic White,0.1,Male and Female,Mesothelioma,2016
35-39,0.5,0.8,77,Incidence,11961184,Non-Hispanic White,0.6,Male and Female,Myeloma,2016
35-39,6.4,7.3,815,Incidence,11961184,Non-Hispanic White,6.8,Male and Female,Non-Hodgkin Lymphoma,2016
35-39,3.0,3.7,401,Incidence,11961184,Non-Hispanic White,3.4,Male and Female,Oral Cavity and Pharynx,2016
35-39,4.5,5.7,303,Incidence,5938427,Non-Hispanic White,5.1,Male and Female,Ovary,2016
35-39,1.6,2.1,216,Incidence,11961184,Non-Hispanic White,1.8,Male and Female,Pancreas,2016
35-39,0.3,0.7,28,Incidence,6022757,Non-Hispanic White,0.5,Male and Female,Prostate,2016
35-39,1.0,1.4,146,Incidence,11961184,Non-Hispanic White,1.2,Male and Female,Stomach,2016
35-39,15.0,17.0,964,Incidence,6022757,Non-Hispanic White,16.0,Male and Female,Testis,2016
35-39,22.4,24.2,2785,Incidence,11961184,Non-Hispanic White,23.3,Male and Female,Thyroid,2016
35-39,1.8,2.3,240,Incidence,11961184,Non-Hispanic White,2.0,Male and Female,Urinary Bladder,2016
40-44,252.8,258.6,29349,Incidence,11477790,Non-Hispanic White,255.7,Male and Female,All Cancer Sites Combined,2016
40-44,4.7,5.5,583,Incidence,11477790,Non-Hispanic White,5.1,Male and Female,Brain and Other Nervous System,2016
40-44,14.6,16.7,893,Incidence,5713844,Non-Hispanic White,15.6,Male and Female,Cervix,2016
40-44,21.4,23.1,2550,Incidence,11477790,Non-Hispanic White,22.2,Male and Female,Colon and Rectum,2016
40-44,16.5,18.7,1005,Incidence,5713844,Non-Hispanic White,17.6,Male and Female,"Corpus and Uterus, NOS",2016
40-44,1.0,1.5,142,Incidence,11477790,Non-Hispanic White,1.2,Male and Female,Esophagus,2016
40-44,128.0,134.0,7483,Incidence,5713844,Non-Hispanic White,131.0,Male and Female,Female Breast,2016
40-44,41.6,45.0,2472,Incidence,5713844,Non-Hispanic White,43.3,Male and Female,"Female Breast, <i>in situ</i>",2016
40-44,2.5,3.1,320,Incidence,11477790,Non-Hispanic White,2.8,Male and Female,Hodgkin Lymphoma,2016
40-44,0.2,0.4,37,Incidence,11477790,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2016
40-44,11.9,13.2,1441,Incidence,11477790,Non-Hispanic White,12.6,Male and Female,Kidney and Renal Pelvis,2016
40-44,0.9,1.3,125,Incidence,11477790,Non-Hispanic White,1.1,Male and Female,Larynx,2016
40-44,6.7,7.6,819,Incidence,11477790,Non-Hispanic White,7.1,Male and Female,Leukemias,2016
40-44,1.2,1.6,157,Incidence,11477790,Non-Hispanic White,1.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
40-44,7.8,8.8,951,Incidence,11477790,Non-Hispanic White,8.3,Male and Female,Lung and Bronchus,2016
40-44,128.0,134.0,7483,Incidence,5713844,Non-Hispanic White,131.0,Male and Female,Male and Female Breast,2016
40-44,41.6,45.0,2472,Incidence,5713844,Non-Hispanic White,43.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
40-44,25.5,27.3,3029,Incidence,11477790,Non-Hispanic White,26.4,Male and Female,Melanomas of the Skin,2016
40-44,0.1,0.3,20,Incidence,11477790,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2016
40-44,1.6,2.1,209,Incidence,11477790,Non-Hispanic White,1.8,Male and Female,Myeloma,2016
40-44,9.3,10.4,1131,Incidence,11477790,Non-Hispanic White,9.9,Male and Female,Non-Hodgkin Lymphoma,2016
40-44,6.6,7.6,817,Incidence,11477790,Non-Hispanic White,7.1,Male and Female,Oral Cavity and Pharynx,2016
40-44,8.3,9.9,519,Incidence,5713844,Non-Hispanic White,9.1,Male and Female,Ovary,2016
40-44,3.0,3.7,386,Incidence,11477790,Non-Hispanic White,3.4,Male and Female,Pancreas,2016
40-44,5.1,6.3,328,Incidence,5763946,Non-Hispanic White,5.7,Male and Female,Prostate,2016
40-44,2.0,2.5,258,Incidence,11477790,Non-Hispanic White,2.2,Male and Female,Stomach,2016
40-44,10.4,12.2,649,Incidence,5763946,Non-Hispanic White,11.3,Male and Female,Testis,2016
40-44,24.6,26.4,2927,Incidence,11477790,Non-Hispanic White,25.5,Male and Female,Thyroid,2016
40-44,3.8,4.6,478,Incidence,11477790,Non-Hispanic White,4.2,Male and Female,Urinary Bladder,2016
45-49,383.2,390.0,50804,Incidence,13141987,Non-Hispanic White,386.6,Male and Female,All Cancer Sites Combined,2016
45-49,5.7,6.6,807,Incidence,13141987,Non-Hispanic White,6.1,Male and Female,Brain and Other Nervous System,2016
45-49,13.1,14.9,916,Incidence,6565689,Non-Hispanic White,14.0,Male and Female,Cervix,2016
45-49,35.5,37.6,4803,Incidence,13141987,Non-Hispanic White,36.5,Male and Female,Colon and Rectum,2016
45-49,26.5,29.0,1820,Incidence,6565689,Non-Hispanic White,27.7,Male and Female,"Corpus and Uterus, NOS",2016
45-49,2.6,3.1,373,Incidence,13141987,Non-Hispanic White,2.8,Male and Female,Esophagus,2016
45-49,202.5,209.4,13520,Incidence,6565689,Non-Hispanic White,205.9,Male and Female,Female Breast,2016
45-49,60.1,63.9,4069,Incidence,6565689,Non-Hispanic White,62.0,Male and Female,"Female Breast, <i>in situ</i>",2016
45-49,2.3,2.9,342,Incidence,13141987,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2016
45-49,0.3,0.5,53,Incidence,13141987,Non-Hispanic White,0.4,Male and Female,Kaposi Sarcoma,2016
45-49,18.1,19.6,2480,Incidence,13141987,Non-Hispanic White,18.9,Male and Female,Kidney and Renal Pelvis,2016
45-49,2.1,2.7,316,Incidence,13141987,Non-Hispanic White,2.4,Male and Female,Larynx,2016
45-49,8.6,9.6,1194,Incidence,13141987,Non-Hispanic White,9.1,Male and Female,Leukemias,2016
45-49,2.5,3.1,371,Incidence,13141987,Non-Hispanic White,2.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
45-49,20.0,21.6,2735,Incidence,13141987,Non-Hispanic White,20.8,Male and Female,Lung and Bronchus,2016
45-49,202.5,209.4,13520,Incidence,6565689,Non-Hispanic White,205.9,Male and Female,Male and Female Breast,2016
45-49,60.1,63.9,4069,Incidence,6565689,Non-Hispanic White,62.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
45-49,31.7,33.7,4300,Incidence,13141987,Non-Hispanic White,32.7,Male and Female,Melanomas of the Skin,2016
45-49,0.2,0.4,41,Incidence,13141987,Non-Hispanic White,0.3,Male and Female,Mesothelioma,2016
45-49,3.3,3.9,473,Incidence,13141987,Non-Hispanic White,3.6,Male and Female,Myeloma,2016
45-49,13.8,15.1,1897,Incidence,13141987,Non-Hispanic White,14.4,Male and Female,Non-Hodgkin Lymphoma,2016
45-49,13.5,14.8,1864,Incidence,13141987,Non-Hispanic White,14.2,Male and Female,Oral Cavity and Pharynx,2016
45-49,13.4,15.3,942,Incidence,6565689,Non-Hispanic White,14.3,Male and Female,Ovary,2016
45-49,6.0,6.9,844,Incidence,13141987,Non-Hispanic White,6.4,Male and Female,Pancreas,2016
45-49,24.5,26.9,1689,Incidence,6576298,Non-Hispanic White,25.7,Male and Female,Prostate,2016
45-49,3.4,4.1,491,Incidence,13141987,Non-Hispanic White,3.7,Male and Female,Stomach,2016
45-49,7.3,8.7,527,Incidence,6576298,Non-Hispanic White,8.0,Male and Female,Testis,2016
45-49,25.5,27.3,3465,Incidence,13141987,Non-Hispanic White,26.4,Male and Female,Thyroid,2016
45-49,7.2,8.1,1005,Incidence,13141987,Non-Hispanic White,7.6,Male and Female,Urinary Bladder,2016
5-9,13.7,15.2,1536,Incidence,10621274,Non-Hispanic White,14.5,Male and Female,All Cancer Sites Combined,2016
5-9,3.6,4.4,427,Incidence,10621274,Non-Hispanic White,4.0,Male and Female,Brain and Other Nervous System,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,Cervix,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Colon and Rectum,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Esophagus,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,Female Breast,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2016
5-9,0.3,0.5,38,Incidence,10621274,Non-Hispanic White,0.4,Male and Female,Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2016
5-9,0.6,0.9,80,Incidence,10621274,Non-Hispanic White,0.8,Male and Female,Kidney and Renal Pelvis,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Larynx,2016
5-9,3.8,4.6,449,Incidence,10621274,Non-Hispanic White,4.2,Male and Female,Leukemias,2016
5-9,0.1,0.3,18,Incidence,10621274,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,Male and Female Breast,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
5-9,0.1,0.3,19,Incidence,10621274,Non-Hispanic White,0.2,Male and Female,Melanomas of the Skin,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Myeloma,2016
5-9,1.1,1.6,140,Incidence,10621274,Non-Hispanic White,1.3,Male and Female,Non-Hodgkin Lymphoma,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2016
5-9,~,~,~,Incidence,5181945,Non-Hispanic White,~,Male and Female,Ovary,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Pancreas,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male and Female,Prostate,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Stomach,2016
5-9,~,~,~,Incidence,5439329,Non-Hispanic White,~,Male and Female,Testis,2016
5-9,0.1,0.3,18,Incidence,10621274,Non-Hispanic White,0.2,Male and Female,Thyroid,2016
5-9,~,~,~,Incidence,10621274,Non-Hispanic White,~,Male and Female,Urinary Bladder,2016
50-54,603.6,611.6,88312,Incidence,14534221,Non-Hispanic White,607.6,Male and Female,All Cancer Sites Combined,2016
50-54,8.2,9.2,1263,Incidence,14534221,Non-Hispanic White,8.7,Male and Female,Brain and Other Nervous System,2016
50-54,10.6,12.2,834,Incidence,7331432,Non-Hispanic White,11.4,Male and Female,Cervix,2016
50-54,60.5,63.1,8984,Incidence,14534221,Non-Hispanic White,61.8,Male and Female,Colon and Rectum,2016
50-54,49.4,52.7,3744,Incidence,7331432,Non-Hispanic White,51.1,Male and Female,"Corpus and Uterus, NOS",2016
50-54,5.9,6.7,911,Incidence,14534221,Non-Hispanic White,6.3,Male and Female,Esophagus,2016
50-54,240.5,247.7,17897,Incidence,7331432,Non-Hispanic White,244.1,Male and Female,Female Breast,2016
50-54,67.1,70.9,5058,Incidence,7331432,Non-Hispanic White,69.0,Male and Female,"Female Breast, <i>in situ</i>",2016
50-54,2.1,2.6,333,Incidence,14534221,Non-Hispanic White,2.3,Male and Female,Hodgkin Lymphoma,2016
50-54,0.3,0.5,55,Incidence,14534221,Non-Hispanic White,0.4,Male and Female,Kaposi Sarcoma,2016
50-54,26.4,28.1,3954,Incidence,14534221,Non-Hispanic White,27.2,Male and Female,Kidney and Renal Pelvis,2016
50-54,5.7,6.6,892,Incidence,14534221,Non-Hispanic White,6.1,Male and Female,Larynx,2016
50-54,14.0,15.3,2131,Incidence,14534221,Non-Hispanic White,14.7,Male and Female,Leukemias,2016
50-54,8.3,9.3,1281,Incidence,14534221,Non-Hispanic White,8.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
50-54,53.4,55.9,7942,Incidence,14534221,Non-Hispanic White,54.6,Male and Female,Lung and Bronchus,2016
50-54,240.5,247.7,17897,Incidence,7331432,Non-Hispanic White,244.1,Male and Female,Male and Female Breast,2016
50-54,67.1,70.9,5058,Incidence,7331432,Non-Hispanic White,69.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
50-54,41.0,43.1,6114,Incidence,14534221,Non-Hispanic White,42.1,Male and Female,Melanomas of the Skin,2016
50-54,0.3,0.5,61,Incidence,14534221,Non-Hispanic White,0.4,Male and Female,Mesothelioma,2016
50-54,6.1,6.9,942,Incidence,14534221,Non-Hispanic White,6.5,Male and Female,Myeloma,2016
50-54,21.6,23.1,3250,Incidence,14534221,Non-Hispanic White,22.4,Male and Female,Non-Hodgkin Lymphoma,2016
50-54,24.4,26.0,3657,Incidence,14534221,Non-Hispanic White,25.2,Male and Female,Oral Cavity and Pharynx,2016
50-54,16.9,18.8,1308,Incidence,7331432,Non-Hispanic White,17.8,Male and Female,Ovary,2016
50-54,12.1,13.2,1838,Incidence,14534221,Non-Hispanic White,12.6,Male and Female,Pancreas,2016
50-54,101.0,105.7,7444,Incidence,7202789,Non-Hispanic White,103.3,Male and Female,Prostate,2016
50-54,5.8,6.6,896,Incidence,14534221,Non-Hispanic White,6.2,Male and Female,Stomach,2016
50-54,5.5,6.6,433,Incidence,7202789,Non-Hispanic White,6.0,Male and Female,Testis,2016
50-54,24.8,26.5,3723,Incidence,14534221,Non-Hispanic White,25.6,Male and Female,Thyroid,2016
50-54,15.6,17.0,2368,Incidence,14534221,Non-Hispanic White,16.3,Male and Female,Urinary Bladder,2016
55-59,879.2,888.6,136717,Incidence,15467120,Non-Hispanic White,883.9,Male and Female,All Cancer Sites Combined,2016
55-59,11.1,12.2,1795,Incidence,15467120,Non-Hispanic White,11.6,Male and Female,Brain and Other Nervous System,2016
55-59,10.7,12.2,900,Incidence,7868576,Non-Hispanic White,11.4,Male and Female,Cervix,2016
55-59,65.9,68.5,10391,Incidence,15467120,Non-Hispanic White,67.2,Male and Female,Colon and Rectum,2016
55-59,80.9,84.9,6522,Incidence,7868576,Non-Hispanic White,82.9,Male and Female,"Corpus and Uterus, NOS",2016
55-59,10.0,11.0,1623,Incidence,15467120,Non-Hispanic White,10.5,Male and Female,Esophagus,2016
55-59,273.3,280.7,21797,Incidence,7868576,Non-Hispanic White,277.0,Male and Female,Female Breast,2016
55-59,67.8,71.5,5476,Incidence,7868576,Non-Hispanic White,69.6,Male and Female,"Female Breast, <i>in situ</i>",2016
55-59,2.4,2.9,405,Incidence,15467120,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2016
55-59,0.2,0.4,47,Incidence,15467120,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2016
55-59,37.3,39.2,5913,Incidence,15467120,Non-Hispanic White,38.2,Male and Female,Kidney and Renal Pelvis,2016
55-59,9.0,10.0,1474,Incidence,15467120,Non-Hispanic White,9.5,Male and Female,Larynx,2016
55-59,21.3,22.8,3411,Incidence,15467120,Non-Hispanic White,22.1,Male and Female,Leukemias,2016
55-59,19.5,20.9,3117,Incidence,15467120,Non-Hispanic White,20.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
55-59,107.3,110.6,16843,Incidence,15467120,Non-Hispanic White,108.9,Male and Female,Lung and Bronchus,2016
55-59,273.3,280.7,21797,Incidence,7868576,Non-Hispanic White,277.0,Male and Female,Male and Female Breast,2016
55-59,67.8,71.5,5476,Incidence,7868576,Non-Hispanic White,69.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
55-59,50.3,52.5,7950,Incidence,15467120,Non-Hispanic White,51.4,Male and Female,Melanomas of the Skin,2016
55-59,0.7,1.0,137,Incidence,15467120,Non-Hispanic White,0.9,Male and Female,Mesothelioma,2016
55-59,10.6,11.6,1717,Incidence,15467120,Non-Hispanic White,11.1,Male and Female,Myeloma,2016
55-59,31.7,33.5,5035,Incidence,15467120,Non-Hispanic White,32.6,Male and Female,Non-Hodgkin Lymphoma,2016
55-59,36.5,38.5,5796,Incidence,15467120,Non-Hispanic White,37.5,Male and Female,Oral Cavity and Pharynx,2016
55-59,22.1,24.3,1823,Incidence,7868576,Non-Hispanic White,23.2,Male and Female,Ovary,2016
55-59,20.5,21.9,3275,Incidence,15467120,Non-Hispanic White,21.2,Male and Female,Pancreas,2016
55-59,218.6,225.4,16867,Incidence,7598544,Non-Hispanic White,222.0,Male and Female,Prostate,2016
55-59,8.7,9.6,1412,Incidence,15467120,Non-Hispanic White,9.1,Male and Female,Stomach,2016
55-59,3.4,4.3,294,Incidence,7598544,Non-Hispanic White,3.9,Male and Female,Testis,2016
55-59,25.3,27.0,4043,Incidence,15467120,Non-Hispanic White,26.1,Male and Female,Thyroid,2016
55-59,29.6,31.3,4706,Incidence,15467120,Non-Hispanic White,30.4,Male and Female,Urinary Bladder,2016
60-64,1221.2,1232.7,174477,Incidence,14220461,Non-Hispanic White,1226.9,Male and Female,All Cancer Sites Combined,2016
60-64,14.2,15.4,2103,Incidence,14220461,Non-Hispanic White,14.8,Male and Female,Brain and Other Nervous System,2016
60-64,9.6,11.0,753,Incidence,7326732,Non-Hispanic White,10.3,Male and Female,Cervix,2016
60-64,84.5,87.5,12230,Incidence,14220461,Non-Hispanic White,86.0,Male and Female,Colon and Rectum,2016
60-64,104.6,109.4,7837,Incidence,7326732,Non-Hispanic White,107.0,Male and Female,"Corpus and Uterus, NOS",2016
60-64,15.2,16.5,2247,Incidence,14220461,Non-Hispanic White,15.8,Male and Female,Esophagus,2016
60-64,343.3,351.9,25465,Incidence,7326732,Non-Hispanic White,347.6,Male and Female,Female Breast,2016
60-64,77.6,81.7,5836,Incidence,7326732,Non-Hispanic White,79.7,Male and Female,"Female Breast, <i>in situ</i>",2016
60-64,2.3,2.8,364,Incidence,14220461,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2016
60-64,0.2,0.4,43,Incidence,14220461,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2016
60-64,46.6,48.8,6782,Incidence,14220461,Non-Hispanic White,47.7,Male and Female,Kidney and Renal Pelvis,2016
60-64,10.5,11.6,1573,Incidence,14220461,Non-Hispanic White,11.1,Male and Female,Larynx,2016
60-64,30.5,32.3,4462,Incidence,14220461,Non-Hispanic White,31.4,Male and Female,Leukemias,2016
60-64,30.3,32.2,4444,Incidence,14220461,Non-Hispanic White,31.3,Male and Female,Liver and Intrahepatic Bile Duct,2016
60-64,161.9,166.2,23328,Incidence,14220461,Non-Hispanic White,164.0,Male and Female,Lung and Bronchus,2016
60-64,343.3,351.9,25465,Incidence,7326732,Non-Hispanic White,347.6,Male and Female,Male and Female Breast,2016
60-64,77.6,81.7,5836,Incidence,7326732,Non-Hispanic White,79.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
60-64,65.8,68.5,9549,Incidence,14220461,Non-Hispanic White,67.1,Male and Female,Melanomas of the Skin,2016
60-64,1.4,1.8,224,Incidence,14220461,Non-Hispanic White,1.6,Male and Female,Mesothelioma,2016
60-64,15.2,16.5,2250,Incidence,14220461,Non-Hispanic White,15.8,Male and Female,Myeloma,2016
60-64,44.8,47.0,6525,Incidence,14220461,Non-Hispanic White,45.9,Male and Female,Non-Hodgkin Lymphoma,2016
60-64,43.8,46.0,6385,Incidence,14220461,Non-Hispanic White,44.9,Male and Female,Oral Cavity and Pharynx,2016
60-64,26.6,29.0,2033,Incidence,7326732,Non-Hispanic White,27.7,Male and Female,Ovary,2016
60-64,32.1,34.0,4703,Incidence,14220461,Non-Hispanic White,33.1,Male and Female,Pancreas,2016
60-64,380.4,389.7,26545,Incidence,6893729,Non-Hispanic White,385.1,Male and Female,Prostate,2016
60-64,12.2,13.4,1824,Incidence,14220461,Non-Hispanic White,12.8,Male and Female,Stomach,2016
60-64,2.2,3.0,176,Incidence,6893729,Non-Hispanic White,2.6,Male and Female,Testis,2016
60-64,24.7,26.4,3634,Incidence,14220461,Non-Hispanic White,25.6,Male and Female,Thyroid,2016
60-64,48.0,50.3,6988,Incidence,14220461,Non-Hispanic White,49.1,Male and Female,Urinary Bladder,2016
65-69,1668.9,1683.1,213777,Incidence,12755382,Non-Hispanic White,1676.0,Male and Female,All Cancer Sites Combined,2016
65-69,18.1,19.7,2409,Incidence,12755382,Non-Hispanic White,18.9,Male and Female,Brain and Other Nervous System,2016
65-69,9.3,10.9,668,Incidence,6641207,Non-Hispanic White,10.1,Male and Female,Cervix,2016
65-69,112.3,116.1,14566,Incidence,12755382,Non-Hispanic White,114.2,Male and Female,Colon and Rectum,2016
65-69,116.0,121.2,7876,Incidence,6641207,Non-Hispanic White,118.6,Male and Female,"Corpus and Uterus, NOS",2016
65-69,19.8,21.4,2629,Incidence,12755382,Non-Hispanic White,20.6,Male and Female,Esophagus,2016
65-69,440.1,450.2,29562,Incidence,6641207,Non-Hispanic White,445.1,Male and Female,Female Breast,2016
65-69,92.6,97.3,6306,Incidence,6641207,Non-Hispanic White,95.0,Male and Female,"Female Breast, <i>in situ</i>",2016
65-69,3.0,3.6,416,Incidence,12755382,Non-Hispanic White,3.3,Male and Female,Hodgkin Lymphoma,2016
65-69,0.2,0.4,37,Incidence,12755382,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2016
65-69,62.2,65.0,8107,Incidence,12755382,Non-Hispanic White,63.6,Male and Female,Kidney and Renal Pelvis,2016
65-69,13.1,14.4,1747,Incidence,12755382,Non-Hispanic White,13.7,Male and Female,Larynx,2016
65-69,43.5,45.9,5702,Incidence,12755382,Non-Hispanic White,44.7,Male and Female,Leukemias,2016
65-69,31.1,33.0,4085,Incidence,12755382,Non-Hispanic White,32.0,Male and Female,Liver and Intrahepatic Bile Duct,2016
65-69,244.3,249.8,31510,Incidence,12755382,Non-Hispanic White,247.0,Male and Female,Lung and Bronchus,2016
65-69,440.1,450.2,29562,Incidence,6641207,Non-Hispanic White,445.1,Male and Female,Male and Female Breast,2016
65-69,92.6,97.3,6306,Incidence,6641207,Non-Hispanic White,95.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
65-69,85.0,88.2,11047,Incidence,12755382,Non-Hispanic White,86.6,Male and Female,Melanomas of the Skin,2016
65-69,2.6,3.2,365,Incidence,12755382,Non-Hispanic White,2.9,Male and Female,Mesothelioma,2016
65-69,24.1,25.8,3180,Incidence,12755382,Non-Hispanic White,24.9,Male and Female,Myeloma,2016
65-69,64.1,67.0,8360,Incidence,12755382,Non-Hispanic White,65.5,Male and Female,Non-Hodgkin Lymphoma,2016
65-69,46.3,48.7,6059,Incidence,12755382,Non-Hispanic White,47.5,Male and Female,Oral Cavity and Pharynx,2016
65-69,32.3,35.1,2238,Incidence,6641207,Non-Hispanic White,33.7,Male and Female,Ovary,2016
65-69,47.3,49.7,6184,Incidence,12755382,Non-Hispanic White,48.5,Male and Female,Pancreas,2016
65-69,580.6,592.8,35870,Incidence,6114175,Non-Hispanic White,586.7,Male and Female,Prostate,2016
65-69,17.7,19.2,2357,Incidence,12755382,Non-Hispanic White,18.5,Male and Female,Stomach,2016
65-69,1.3,2.0,99,Incidence,6114175,Non-Hispanic White,1.6,Male and Female,Testis,2016
65-69,26.2,28.0,3455,Incidence,12755382,Non-Hispanic White,27.1,Male and Female,Thyroid,2016
65-69,77.3,80.4,10060,Incidence,12755382,Non-Hispanic White,78.9,Male and Female,Urinary Bladder,2016
70-74,2047.8,2066.4,187740,Incidence,9126566,Non-Hispanic White,2057.1,Male and Female,All Cancer Sites Combined,2016
70-74,19.6,21.5,1871,Incidence,9126566,Non-Hispanic White,20.5,Male and Female,Brain and Other Nervous System,2016
70-74,7.1,8.7,383,Incidence,4840380,Non-Hispanic White,7.9,Male and Female,Cervix,2016
70-74,141.6,146.6,13151,Incidence,9126566,Non-Hispanic White,144.1,Male and Female,Colon and Rectum,2016
70-74,106.9,112.9,5318,Incidence,4840380,Non-Hispanic White,109.9,Male and Female,"Corpus and Uterus, NOS",2016
70-74,24.5,26.6,2334,Incidence,9126566,Non-Hispanic White,25.6,Male and Female,Esophagus,2016
70-74,490.6,503.1,24048,Incidence,4840380,Non-Hispanic White,496.8,Male and Female,Female Breast,2016
70-74,96.1,101.7,4785,Incidence,4840380,Non-Hispanic White,98.9,Male and Female,"Female Breast, <i>in situ</i>",2016
70-74,3.8,4.7,384,Incidence,9126566,Non-Hispanic White,4.2,Male and Female,Hodgkin Lymphoma,2016
70-74,0.1,0.3,20,Incidence,9126566,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2016
70-74,70.8,74.3,6620,Incidence,9126566,Non-Hispanic White,72.5,Male and Female,Kidney and Renal Pelvis,2016
70-74,13.9,15.5,1339,Incidence,9126566,Non-Hispanic White,14.7,Male and Female,Larynx,2016
70-74,59.1,62.3,5537,Incidence,9126566,Non-Hispanic White,60.7,Male and Female,Leukemias,2016
70-74,30.3,32.6,2870,Incidence,9126566,Non-Hispanic White,31.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
70-74,362.4,370.2,33428,Incidence,9126566,Non-Hispanic White,366.3,Male and Female,Lung and Bronchus,2016
70-74,490.6,503.1,24048,Incidence,4840380,Non-Hispanic White,496.8,Male and Female,Male and Female Breast,2016
70-74,96.1,101.7,4785,Incidence,4840380,Non-Hispanic White,98.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
70-74,102.4,106.6,9536,Incidence,9126566,Non-Hispanic White,104.5,Male and Female,Melanomas of the Skin,2016
70-74,4.4,5.3,439,Incidence,9126566,Non-Hispanic White,4.8,Male and Female,Mesothelioma,2016
70-74,31.7,34.1,3002,Incidence,9126566,Non-Hispanic White,32.9,Male and Female,Myeloma,2016
70-74,87.5,91.3,8158,Incidence,9126566,Non-Hispanic White,89.4,Male and Female,Non-Hodgkin Lymphoma,2016
70-74,48.8,51.7,4582,Incidence,9126566,Non-Hispanic White,50.2,Male and Female,Oral Cavity and Pharynx,2016
70-74,36.5,40.0,1851,Incidence,4840380,Non-Hispanic White,38.2,Male and Female,Ovary,2016
70-74,63.8,67.1,5971,Incidence,9126566,Non-Hispanic White,65.4,Male and Female,Pancreas,2016
70-74,607.3,622.2,26349,Incidence,4286186,Non-Hispanic White,614.7,Male and Female,Prostate,2016
70-74,24.2,26.3,2304,Incidence,9126566,Non-Hispanic White,25.2,Male and Female,Stomach,2016
70-74,0.7,1.4,44,Incidence,4286186,Non-Hispanic White,1.0,Male and Female,Testis,2016
70-74,22.8,24.8,2174,Incidence,9126566,Non-Hispanic White,23.8,Male and Female,Thyroid,2016
70-74,118.8,123.3,11046,Incidence,9126566,Non-Hispanic White,121.0,Male and Female,Urinary Bladder,2016
75-79,2301.0,2324.4,150483,Incidence,6506914,Non-Hispanic White,2312.7,Male and Female,All Cancer Sites Combined,2016
75-79,23.4,25.8,1600,Incidence,6506914,Non-Hispanic White,24.6,Male and Female,Brain and Other Nervous System,2016
75-79,6.4,8.2,260,Incidence,3561135,Non-Hispanic White,7.3,Male and Female,Cervix,2016
75-79,185.4,192.0,12277,Incidence,6506914,Non-Hispanic White,188.7,Male and Female,Colon and Rectum,2016
75-79,92.2,98.7,3397,Incidence,3561135,Non-Hispanic White,95.4,Male and Female,"Corpus and Uterus, NOS",2016
75-79,25.3,27.8,1728,Incidence,6506914,Non-Hispanic White,26.6,Male and Female,Esophagus,2016
75-79,474.5,489.0,17154,Incidence,3561135,Non-Hispanic White,481.7,Male and Female,Female Breast,2016
75-79,79.6,85.6,2939,Incidence,3561135,Non-Hispanic White,82.5,Male and Female,"Female Breast, <i>in situ</i>",2016
75-79,3.5,4.4,256,Incidence,6506914,Non-Hispanic White,3.9,Male and Female,Hodgkin Lymphoma,2016
75-79,0.4,0.8,40,Incidence,6506914,Non-Hispanic White,0.6,Male and Female,Kaposi Sarcoma,2016
75-79,73.9,78.2,4946,Incidence,6506914,Non-Hispanic White,76.0,Male and Female,Kidney and Renal Pelvis,2016
75-79,13.9,15.8,964,Incidence,6506914,Non-Hispanic White,14.8,Male and Female,Larynx,2016
75-79,77.3,81.7,5172,Incidence,6506914,Non-Hispanic White,79.5,Male and Female,Leukemias,2016
75-79,33.4,36.3,2265,Incidence,6506914,Non-Hispanic White,34.8,Male and Female,Liver and Intrahepatic Bile Duct,2016
75-79,431.8,442.0,28427,Incidence,6506914,Non-Hispanic White,436.9,Male and Female,Lung and Bronchus,2016
75-79,474.5,489.0,17154,Incidence,3561135,Non-Hispanic White,481.7,Male and Female,Male and Female Breast,2016
75-79,79.6,85.6,2939,Incidence,3561135,Non-Hispanic White,82.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
75-79,118.4,123.7,7876,Incidence,6506914,Non-Hispanic White,121.0,Male and Female,Melanomas of the Skin,2016
75-79,7.0,8.4,498,Incidence,6506914,Non-Hispanic White,7.7,Male and Female,Mesothelioma,2016
75-79,37.7,40.8,2553,Incidence,6506914,Non-Hispanic White,39.2,Male and Female,Myeloma,2016
75-79,108.2,113.4,7209,Incidence,6506914,Non-Hispanic White,110.8,Male and Female,Non-Hodgkin Lymphoma,2016
75-79,48.2,51.6,3244,Incidence,6506914,Non-Hispanic White,49.9,Male and Female,Oral Cavity and Pharynx,2016
75-79,41.1,45.5,1540,Incidence,3561135,Non-Hispanic White,43.2,Male and Female,Ovary,2016
75-79,78.4,82.8,5243,Incidence,6506914,Non-Hispanic White,80.6,Male and Female,Pancreas,2016
75-79,534.6,551.5,15995,Incidence,2945779,Non-Hispanic White,543.0,Male and Female,Prostate,2016
75-79,28.7,31.4,1956,Incidence,6506914,Non-Hispanic White,30.1,Male and Female,Stomach,2016
75-79,0.9,1.7,36,Incidence,2945779,Non-Hispanic White,1.2,Male and Female,Testis,2016
75-79,20.7,23.0,1419,Incidence,6506914,Non-Hispanic White,21.8,Male and Female,Thyroid,2016
75-79,153.3,159.4,10174,Incidence,6506914,Non-Hispanic White,156.4,Male and Female,Urinary Bladder,2016
80-84,2410.4,2438.8,112051,Incidence,4621408,Non-Hispanic White,2424.6,Male and Female,All Cancer Sites Combined,2016
80-84,22.5,25.3,1102,Incidence,4621408,Non-Hispanic White,23.8,Male and Female,Brain and Other Nervous System,2016
80-84,6.4,8.5,196,Incidence,2655629,Non-Hispanic White,7.4,Male and Female,Cervix,2016
80-84,222.1,230.8,10465,Incidence,4621408,Non-Hispanic White,226.4,Male and Female,Colon and Rectum,2016
80-84,73.4,80.1,2036,Incidence,2655629,Non-Hispanic White,76.7,Male and Female,"Corpus and Uterus, NOS",2016
80-84,27.1,30.2,1323,Incidence,4621408,Non-Hispanic White,28.6,Male and Female,Esophagus,2016
80-84,423.5,439.4,11456,Incidence,2655629,Non-Hispanic White,431.4,Male and Female,Female Breast,2016
80-84,51.8,57.4,1448,Incidence,2655629,Non-Hispanic White,54.5,Male and Female,"Female Breast, <i>in situ</i>",2016
80-84,3.4,4.6,185,Incidence,4621408,Non-Hispanic White,4.0,Male and Female,Hodgkin Lymphoma,2016
80-84,0.5,1.1,35,Incidence,4621408,Non-Hispanic White,0.8,Male and Female,Kaposi Sarcoma,2016
80-84,71.4,76.4,3413,Incidence,4621408,Non-Hispanic White,73.9,Male and Female,Kidney and Renal Pelvis,2016
80-84,12.5,14.6,625,Incidence,4621408,Non-Hispanic White,13.5,Male and Female,Larynx,2016
80-84,91.2,96.9,4345,Incidence,4621408,Non-Hispanic White,94.0,Male and Female,Leukemias,2016
80-84,33.6,37.0,1629,Incidence,4621408,Non-Hispanic White,35.2,Male and Female,Liver and Intrahepatic Bile Duct,2016
80-84,435.4,447.5,20399,Incidence,4621408,Non-Hispanic White,441.4,Male and Female,Lung and Bronchus,2016
80-84,423.5,439.4,11456,Incidence,2655629,Non-Hispanic White,431.4,Male and Female,Male and Female Breast,2016
80-84,51.8,57.4,1448,Incidence,2655629,Non-Hispanic White,54.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
80-84,132.8,139.5,6290,Incidence,4621408,Non-Hispanic White,136.1,Male and Female,Melanomas of the Skin,2016
80-84,9.4,11.3,478,Incidence,4621408,Non-Hispanic White,10.3,Male and Female,Mesothelioma,2016
80-84,42.2,46.0,2036,Incidence,4621408,Non-Hispanic White,44.1,Male and Female,Myeloma,2016
80-84,122.7,129.2,5821,Incidence,4621408,Non-Hispanic White,126.0,Male and Female,Non-Hodgkin Lymphoma,2016
80-84,46.7,50.7,2249,Incidence,4621408,Non-Hispanic White,48.7,Male and Female,Oral Cavity and Pharynx,2016
80-84,43.5,48.7,1224,Incidence,2655629,Non-Hispanic White,46.1,Male and Female,Ovary,2016
80-84,89.6,95.1,4266,Incidence,4621408,Non-Hispanic White,92.3,Male and Female,Pancreas,2016
80-84,405.4,423.5,8146,Incidence,1965779,Non-Hispanic White,414.4,Male and Female,Prostate,2016
80-84,31.8,35.1,1545,Incidence,4621408,Non-Hispanic White,33.4,Male and Female,Stomach,2016
80-84,~,~,~,Incidence,1965779,Non-Hispanic White,~,Male and Female,Testis,2016
80-84,15.9,18.3,790,Incidence,4621408,Non-Hispanic White,17.1,Male and Female,Thyroid,2016
80-84,191.2,199.3,9022,Incidence,4621408,Non-Hispanic White,195.2,Male and Female,Urinary Bladder,2016
85+,2184.7,2210.2,114025,Incidence,5189106,Non-Hispanic White,2197.4,Male and Female,All Cancer Sites Combined,2016
85+,17.9,20.3,988,Incidence,5189106,Non-Hispanic White,19.0,Male and Female,Brain and Other Nervous System,2016
85+,4.9,6.5,189,Incidence,3356860,Non-Hispanic White,5.6,Male and Female,Cervix,2016
85+,247.5,256.2,13066,Incidence,5189106,Non-Hispanic White,251.8,Male and Female,Colon and Rectum,2016
85+,48.4,53.3,1706,Incidence,3356860,Non-Hispanic White,50.8,Male and Female,"Corpus and Uterus, NOS",2016
85+,23.0,25.7,1260,Incidence,5189106,Non-Hispanic White,24.3,Male and Female,Esophagus,2016
85+,328.9,341.3,11248,Incidence,3356860,Non-Hispanic White,335.1,Male and Female,Female Breast,2016
85+,21.1,24.4,763,Incidence,3356860,Non-Hispanic White,22.7,Male and Female,"Female Breast, <i>in situ</i>",2016
85+,2.7,3.7,166,Incidence,5189106,Non-Hispanic White,3.2,Male and Female,Hodgkin Lymphoma,2016
85+,0.8,1.4,58,Incidence,5189106,Non-Hispanic White,1.1,Male and Female,Kaposi Sarcoma,2016
85+,52.8,56.9,2844,Incidence,5189106,Non-Hispanic White,54.8,Male and Female,Kidney and Renal Pelvis,2016
85+,9.4,11.1,530,Incidence,5189106,Non-Hispanic White,10.2,Male and Female,Larynx,2016
85+,93.2,98.5,4971,Incidence,5189106,Non-Hispanic White,95.8,Male and Female,Leukemias,2016
85+,27.9,30.9,1524,Incidence,5189106,Non-Hispanic White,29.4,Male and Female,Liver and Intrahepatic Bile Duct,2016
85+,313.6,323.3,16523,Incidence,5189106,Non-Hispanic White,318.4,Male and Female,Lung and Bronchus,2016
85+,328.9,341.3,11248,Incidence,3356860,Non-Hispanic White,335.1,Male and Female,Male and Female Breast,2016
85+,21.1,24.4,763,Incidence,3356860,Non-Hispanic White,22.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
85+,128.3,134.6,6820,Incidence,5189106,Non-Hispanic White,131.4,Male and Female,Melanomas of the Skin,2016
85+,7.8,9.4,444,Incidence,5189106,Non-Hispanic White,8.6,Male and Female,Mesothelioma,2016
85+,36.1,39.4,1958,Incidence,5189106,Non-Hispanic White,37.7,Male and Female,Myeloma,2016
85+,109.6,115.4,5836,Incidence,5189106,Non-Hispanic White,112.5,Male and Female,Non-Hodgkin Lymphoma,2016
85+,41.5,45.1,2244,Incidence,5189106,Non-Hispanic White,43.2,Male and Female,Oral Cavity and Pharynx,2016
85+,37.1,41.3,1314,Incidence,3356860,Non-Hispanic White,39.1,Male and Female,Ovary,2016
85+,95.3,100.7,5082,Incidence,5189106,Non-Hispanic White,97.9,Male and Female,Pancreas,2016
85+,359.4,377.0,6745,Incidence,1832246,Non-Hispanic White,368.1,Male and Female,Prostate,2016
85+,33.0,36.2,1796,Incidence,5189106,Non-Hispanic White,34.6,Male and Female,Stomach,2016
85+,0.5,1.4,16,Incidence,1832246,Non-Hispanic White,0.9,Male and Female,Testis,2016
85+,8.6,10.3,491,Incidence,5189106,Non-Hispanic White,9.5,Male and Female,Thyroid,2016
85+,183.4,190.8,9707,Incidence,5189106,Non-Hispanic White,187.1,Male and Female,Urinary Bladder,2016
<1,27.8,32.6,618,Incidence,2049409,Non-Hispanic White,30.2,Male and Female,All Cancer Sites Combined,2016
<1,3.8,5.7,96,Incidence,2049409,Non-Hispanic White,4.7,Male and Female,Brain and Other Nervous System,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,Cervix,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Colon and Rectum,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Esophagus,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,Female Breast,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2016
<1,1.2,2.4,36,Incidence,2049409,Non-Hispanic White,1.8,Male and Female,Kidney and Renal Pelvis,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Larynx,2016
<1,3.3,5.1,85,Incidence,2049409,Non-Hispanic White,4.1,Male and Female,Leukemias,2016
<1,1.4,2.7,40,Incidence,2049409,Non-Hispanic White,2.0,Male and Female,Liver and Intrahepatic Bile Duct,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,Male and Female Breast,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Mesothelioma,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Myeloma,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Non-Hodgkin Lymphoma,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2016
<1,~,~,~,Incidence,998887,Non-Hispanic White,~,Male and Female,Ovary,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Pancreas,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male and Female,Prostate,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Stomach,2016
<1,~,~,~,Incidence,1050522,Non-Hispanic White,~,Male and Female,Testis,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Thyroid,2016
<1,~,~,~,Incidence,2049409,Non-Hispanic White,~,Male and Female,Urinary Bladder,2016
1-4,20.6,22.7,1694,Incidence,7825088,All Races,21.6,Female,All Cancer Sites Combined,2017
1-4,4.2,5.2,365,Incidence,7825088,All Races,4.7,Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Cervix,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Esophagus,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Female Breast,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Kaposi Sarcoma,2017
1-4,1.8,2.5,165,Incidence,7825088,All Races,2.1,Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Larynx,2017
1-4,7.4,8.7,627,Incidence,7825088,All Races,8.0,Female,Leukemias,2017
1-4,0.5,0.8,49,Incidence,7825088,All Races,0.6,Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Mesothelioma,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Myeloma,2017
1-4,0.4,0.7,42,Incidence,7825088,All Races,0.5,Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Ovary,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Pancreas,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Stomach,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Thyroid,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Female,Urinary Bladder,2017
10-14,14.1,15.6,1507,Incidence,10174304,All Races,14.8,Female,All Cancer Sites Combined,2017
10-14,2.6,3.2,295,Incidence,10174304,All Races,2.9,Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Cervix,2017
10-14,0.6,0.9,75,Incidence,10174304,All Races,0.7,Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Esophagus,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Female Breast,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,"Female Breast, <i>in situ</i>",2017
10-14,1.0,1.5,125,Incidence,10174304,All Races,1.2,Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Kaposi Sarcoma,2017
10-14,0.1,0.3,23,Incidence,10174304,All Races,0.2,Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Larynx,2017
10-14,2.5,3.1,283,Incidence,10174304,All Races,2.8,Female,Leukemias,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Lung and Bronchus,2017
10-14,0.1,0.3,21,Incidence,10174304,All Races,0.2,Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Mesothelioma,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Myeloma,2017
10-14,0.7,1.1,92,Incidence,10174304,All Races,0.9,Female,Non-Hodgkin Lymphoma,2017
10-14,0.2,0.4,30,Incidence,10174304,All Races,0.3,Female,Oral Cavity and Pharynx,2017
10-14,0.7,1.1,88,Incidence,10174304,All Races,0.9,Female,Ovary,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Pancreas,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Stomach,2017
10-14,1.1,1.5,129,Incidence,10174304,All Races,1.3,Female,Thyroid,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Female,Urinary Bladder,2017
15-19,22.7,24.6,2440,Incidence,10322453,All Races,23.6,Female,All Cancer Sites Combined,2017
15-19,2.0,2.6,235,Incidence,10322453,All Races,2.3,Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Cervix,2017
15-19,1.1,1.5,135,Incidence,10322453,All Races,1.3,Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Esophagus,2017
15-19,0.1,0.3,21,Incidence,10322453,All Races,0.2,Female,Female Breast,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,"Female Breast, <i>in situ</i>",2017
15-19,3.1,3.9,361,Incidence,10322453,All Races,3.5,Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Kaposi Sarcoma,2017
15-19,0.1,0.3,23,Incidence,10322453,All Races,0.2,Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Larynx,2017
15-19,2.1,2.7,243,Incidence,10322453,All Races,2.4,Female,Leukemias,2017
15-19,0.1,0.3,17,Incidence,10322453,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Lung and Bronchus,2017
15-19,0.8,1.2,99,Incidence,10322453,All Races,1.0,Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Mesothelioma,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Myeloma,2017
15-19,1.1,1.5,131,Incidence,10322453,All Races,1.3,Female,Non-Hodgkin Lymphoma,2017
15-19,0.4,0.7,60,Incidence,10322453,All Races,0.6,Female,Oral Cavity and Pharynx,2017
15-19,1.0,1.4,123,Incidence,10322453,All Races,1.2,Female,Ovary,2017
15-19,0.1,0.3,22,Incidence,10322453,All Races,0.2,Female,Pancreas,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Stomach,2017
15-19,4.9,5.8,547,Incidence,10322453,All Races,5.3,Female,Thyroid,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Female,Urinary Bladder,2017
20-24,38.0,40.4,4210,Incidence,10747498,All Races,39.2,Female,All Cancer Sites Combined,2017
20-24,1.7,2.3,214,Incidence,10747498,All Races,2.0,Female,Brain and Other Nervous System,2017
20-24,0.6,0.9,76,Incidence,10747498,All Races,0.7,Female,Cervix,2017
20-24,2.1,2.7,260,Incidence,10747498,All Races,2.4,Female,Colon and Rectum,2017
20-24,0.3,0.6,49,Incidence,10747498,All Races,0.5,Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,10747498,All Races,~,Female,Esophagus,2017
20-24,1.5,2.0,186,Incidence,10747498,All Races,1.7,Female,Female Breast,2017
20-24,0.1,0.3,23,Incidence,10747498,All Races,0.2,Female,"Female Breast, <i>in situ</i>",2017
20-24,4.1,4.9,479,Incidence,10747498,All Races,4.5,Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,10747498,All Races,~,Female,Kaposi Sarcoma,2017
20-24,0.5,0.8,66,Incidence,10747498,All Races,0.6,Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,10747498,All Races,~,Female,Larynx,2017
20-24,2.0,2.6,248,Incidence,10747498,All Races,2.3,Female,Leukemias,2017
20-24,0.1,0.3,21,Incidence,10747498,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2017
20-24,0.3,0.5,40,Incidence,10747498,All Races,0.4,Female,Lung and Bronchus,2017
20-24,3.2,3.9,378,Incidence,10747498,All Races,3.5,Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,10747498,All Races,~,Female,Mesothelioma,2017
20-24,~,~,~,Incidence,10747498,All Races,~,Female,Myeloma,2017
20-24,1.9,2.5,234,Incidence,10747498,All Races,2.2,Female,Non-Hodgkin Lymphoma,2017
20-24,0.5,0.7,63,Incidence,10747498,All Races,0.6,Female,Oral Cavity and Pharynx,2017
20-24,1.6,2.2,204,Incidence,10747498,All Races,1.9,Female,Ovary,2017
20-24,0.2,0.4,33,Incidence,10747498,All Races,0.3,Female,Pancreas,2017
20-24,0.2,0.3,25,Incidence,10747498,All Races,0.2,Female,Stomach,2017
20-24,10.1,11.3,1149,Incidence,10747498,All Races,10.7,Female,Thyroid,2017
20-24,~,~,~,Incidence,10747498,All Races,~,Female,Urinary Bladder,2017
25-29,70.5,73.6,8259,Incidence,11463708,All Races,72.0,Female,All Cancer Sites Combined,2017
25-29,2.4,3.0,312,Incidence,11463708,All Races,2.7,Female,Brain and Other Nervous System,2017
25-29,4.3,5.2,543,Incidence,11463708,All Races,4.7,Female,Cervix,2017
25-29,3.4,4.1,425,Incidence,11463708,All Races,3.7,Female,Colon and Rectum,2017
25-29,1.9,2.5,253,Incidence,11463708,All Races,2.2,Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,11463708,All Races,~,Female,Esophagus,2017
25-29,9.9,11.1,1206,Incidence,11463708,All Races,10.5,Female,Female Breast,2017
25-29,0.6,1.0,92,Incidence,11463708,All Races,0.8,Female,"Female Breast, <i>in situ</i>",2017
25-29,3.6,4.3,449,Incidence,11463708,All Races,3.9,Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,11463708,All Races,~,Female,Kaposi Sarcoma,2017
25-29,1.1,1.6,153,Incidence,11463708,All Races,1.3,Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,11463708,All Races,~,Female,Larynx,2017
25-29,2.4,3.0,306,Incidence,11463708,All Races,2.7,Female,Leukemias,2017
25-29,0.2,0.3,27,Incidence,11463708,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2017
25-29,0.4,0.7,60,Incidence,11463708,All Races,0.5,Female,Lung and Bronchus,2017
25-29,7.5,8.6,922,Incidence,11463708,All Races,8.0,Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,11463708,All Races,~,Female,Mesothelioma,2017
25-29,0.1,0.2,17,Incidence,11463708,All Races,0.1,Female,Myeloma,2017
25-29,2.4,3.1,314,Incidence,11463708,All Races,2.7,Female,Non-Hodgkin Lymphoma,2017
25-29,1.0,1.4,133,Incidence,11463708,All Races,1.2,Female,Oral Cavity and Pharynx,2017
25-29,2.1,2.7,277,Incidence,11463708,All Races,2.4,Female,Ovary,2017
25-29,0.3,0.6,52,Incidence,11463708,All Races,0.5,Female,Pancreas,2017
25-29,0.4,0.6,57,Incidence,11463708,All Races,0.5,Female,Stomach,2017
25-29,16.7,18.3,2005,Incidence,11463708,All Races,17.5,Female,Thyroid,2017
25-29,0.2,0.4,28,Incidence,11463708,All Races,0.2,Female,Urinary Bladder,2017
30-34,124.9,129.1,13815,Incidence,10877130,All Races,127.0,Female,All Cancer Sites Combined,2017
30-34,2.8,3.4,334,Incidence,10877130,All Races,3.1,Female,Brain and Other Nervous System,2017
30-34,10.9,12.1,1249,Incidence,10877130,All Races,11.5,Female,Cervix,2017
30-34,5.8,6.8,686,Incidence,10877130,All Races,6.3,Female,Colon and Rectum,2017
30-34,5.2,6.1,611,Incidence,10877130,All Races,5.6,Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,10877130,All Races,~,Female,Esophagus,2017
30-34,29.4,31.5,3309,Incidence,10877130,All Races,30.4,Female,Female Breast,2017
30-34,2.4,3.0,292,Incidence,10877130,All Races,2.7,Female,"Female Breast, <i>in situ</i>",2017
30-34,3.0,3.7,367,Incidence,10877130,All Races,3.4,Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,10877130,All Races,~,Female,Kaposi Sarcoma,2017
30-34,2.5,3.1,305,Incidence,10877130,All Races,2.8,Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,10877130,All Races,~,Female,Larynx,2017
30-34,3.2,3.9,381,Incidence,10877130,All Races,3.5,Female,Leukemias,2017
30-34,0.3,0.6,51,Incidence,10877130,All Races,0.5,Female,Liver and Intrahepatic Bile Duct,2017
30-34,1.2,1.7,155,Incidence,10877130,All Races,1.4,Female,Lung and Bronchus,2017
30-34,12.4,13.8,1423,Incidence,10877130,All Races,13.1,Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,10877130,All Races,~,Female,Mesothelioma,2017
30-34,0.2,0.4,34,Incidence,10877130,All Races,0.3,Female,Myeloma,2017
30-34,3.4,4.2,410,Incidence,10877130,All Races,3.8,Female,Non-Hodgkin Lymphoma,2017
30-34,1.4,1.9,183,Incidence,10877130,All Races,1.7,Female,Oral Cavity and Pharynx,2017
30-34,2.7,3.4,327,Incidence,10877130,All Races,3.0,Female,Ovary,2017
30-34,0.7,1.1,100,Incidence,10877130,All Races,0.9,Female,Pancreas,2017
30-34,1.0,1.4,126,Incidence,10877130,All Races,1.2,Female,Stomach,2017
30-34,24.2,26.1,2730,Incidence,10877130,All Races,25.1,Female,Thyroid,2017
30-34,0.4,0.7,55,Incidence,10877130,All Races,0.5,Female,Urinary Bladder,2017
35-39,193.8,199.1,20810,Incidence,10594335,All Races,196.4,Female,All Cancer Sites Combined,2017
35-39,3.0,3.7,357,Incidence,10594335,All Races,3.4,Female,Brain and Other Nervous System,2017
35-39,13.4,14.8,1493,Incidence,10594335,All Races,14.1,Female,Cervix,2017
35-39,10.6,11.9,1187,Incidence,10594335,All Races,11.2,Female,Colon and Rectum,2017
35-39,10.1,11.4,1140,Incidence,10594335,All Races,10.8,Female,"Corpus and Uterus, NOS",2017
35-39,0.1,0.3,20,Incidence,10594335,All Races,0.2,Female,Esophagus,2017
35-39,61.1,64.2,6637,Incidence,10594335,All Races,62.6,Female,Female Breast,2017
35-39,8.6,9.7,968,Incidence,10594335,All Races,9.1,Female,"Female Breast, <i>in situ</i>",2017
35-39,2.2,2.8,262,Incidence,10594335,All Races,2.5,Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,10594335,All Races,~,Female,Kaposi Sarcoma,2017
35-39,4.8,5.6,550,Incidence,10594335,All Races,5.2,Female,Kidney and Renal Pelvis,2017
35-39,0.2,0.4,27,Incidence,10594335,All Races,0.3,Female,Larynx,2017
35-39,3.9,4.7,452,Incidence,10594335,All Races,4.3,Female,Leukemias,2017
35-39,0.6,1.0,83,Incidence,10594335,All Races,0.8,Female,Liver and Intrahepatic Bile Duct,2017
35-39,2.6,3.2,304,Incidence,10594335,All Races,2.9,Female,Lung and Bronchus,2017
35-39,15.1,16.6,1677,Incidence,10594335,All Races,15.8,Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,10594335,All Races,~,Female,Mesothelioma,2017
35-39,0.9,1.3,115,Incidence,10594335,All Races,1.1,Female,Myeloma,2017
35-39,5.2,6.1,593,Incidence,10594335,All Races,5.6,Female,Non-Hodgkin Lymphoma,2017
35-39,2.4,3.1,291,Incidence,10594335,All Races,2.7,Female,Oral Cavity and Pharynx,2017
35-39,4.9,5.8,567,Incidence,10594335,All Races,5.4,Female,Ovary,2017
35-39,1.4,1.8,168,Incidence,10594335,All Races,1.6,Female,Pancreas,2017
35-39,1.7,2.2,204,Incidence,10594335,All Races,1.9,Female,Stomach,2017
35-39,29.8,31.9,3267,Incidence,10594335,All Races,30.8,Female,Thyroid,2017
35-39,0.7,1.1,94,Incidence,10594335,All Races,0.9,Female,Urinary Bladder,2017
40-44,308.0,315.0,30704,Incidence,9857600,All Races,311.5,Female,All Cancer Sites Combined,2017
40-44,3.4,4.2,374,Incidence,9857600,All Races,3.8,Female,Brain and Other Nervous System,2017
40-44,14.6,16.2,1515,Incidence,9857600,All Races,15.4,Female,Cervix,2017
40-44,18.7,20.5,1933,Incidence,9857600,All Races,19.6,Female,Colon and Rectum,2017
40-44,16.5,18.2,1710,Incidence,9857600,All Races,17.3,Female,"Corpus and Uterus, NOS",2017
40-44,0.3,0.6,42,Incidence,9857600,All Races,0.4,Female,Esophagus,2017
40-44,125.3,129.8,12570,Incidence,9857600,All Races,127.5,Female,Female Breast,2017
40-44,37.4,39.9,3809,Incidence,9857600,All Races,38.6,Female,"Female Breast, <i>in situ</i>",2017
40-44,1.9,2.5,220,Incidence,9857600,All Races,2.2,Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,9857600,All Races,~,Female,Kaposi Sarcoma,2017
40-44,8.6,9.9,910,Incidence,9857600,All Races,9.2,Female,Kidney and Renal Pelvis,2017
40-44,0.4,0.7,50,Incidence,9857600,All Races,0.5,Female,Larynx,2017
40-44,5.4,6.4,577,Incidence,9857600,All Races,5.9,Female,Leukemias,2017
40-44,1.1,1.6,135,Incidence,9857600,All Races,1.4,Female,Liver and Intrahepatic Bile Duct,2017
40-44,6.4,7.4,681,Incidence,9857600,All Races,6.9,Female,Lung and Bronchus,2017
40-44,18.7,20.4,1926,Incidence,9857600,All Races,19.5,Female,Melanomas of the Skin,2017
40-44,0.1,0.3,18,Incidence,9857600,All Races,0.2,Female,Mesothelioma,2017
40-44,2.0,2.6,225,Incidence,9857600,All Races,2.3,Female,Myeloma,2017
40-44,7.6,8.7,801,Incidence,9857600,All Races,8.1,Female,Non-Hodgkin Lymphoma,2017
40-44,3.3,4.0,358,Incidence,9857600,All Races,3.6,Female,Oral Cavity and Pharynx,2017
40-44,7.3,8.4,775,Incidence,9857600,All Races,7.9,Female,Ovary,2017
40-44,2.4,3.0,264,Incidence,9857600,All Races,2.7,Female,Pancreas,2017
40-44,2.8,3.6,314,Incidence,9857600,All Races,3.2,Female,Stomach,2017
40-44,32.8,35.1,3345,Incidence,9857600,All Races,33.9,Female,Thyroid,2017
40-44,1.4,1.9,159,Incidence,9857600,All Races,1.6,Female,Urinary Bladder,2017
45-49,448.1,456.3,47693,Incidence,10547318,All Races,452.2,Female,All Cancer Sites Combined,2017
45-49,4.3,5.2,499,Incidence,10547318,All Races,4.7,Female,Brain and Other Nervous System,2017
45-49,13.0,14.4,1446,Incidence,10547318,All Races,13.7,Female,Cervix,2017
45-49,30.7,32.9,3351,Incidence,10547318,All Races,31.8,Female,Colon and Rectum,2017
45-49,25.1,27.1,2752,Incidence,10547318,All Races,26.1,Female,"Corpus and Uterus, NOS",2017
45-49,0.7,1.0,86,Incidence,10547318,All Races,0.8,Female,Esophagus,2017
45-49,193.2,198.6,20663,Incidence,10547318,All Races,195.9,Female,Female Breast,2017
45-49,55.3,58.1,5979,Incidence,10547318,All Races,56.7,Female,"Female Breast, <i>in situ</i>",2017
45-49,1.7,2.3,210,Incidence,10547318,All Races,2.0,Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,10547318,All Races,~,Female,Kaposi Sarcoma,2017
45-49,12.8,14.2,1422,Incidence,10547318,All Races,13.5,Female,Kidney and Renal Pelvis,2017
45-49,0.9,1.3,116,Incidence,10547318,All Races,1.1,Female,Larynx,2017
45-49,7.0,8.1,797,Incidence,10547318,All Races,7.6,Female,Leukemias,2017
45-49,1.8,2.4,220,Incidence,10547318,All Races,2.1,Female,Liver and Intrahepatic Bile Duct,2017
45-49,17.2,18.8,1895,Incidence,10547318,All Races,18.0,Female,Lung and Bronchus,2017
45-49,23.8,25.7,2607,Incidence,10547318,All Races,24.7,Female,Melanomas of the Skin,2017
45-49,0.2,0.4,27,Incidence,10547318,All Races,0.3,Female,Mesothelioma,2017
45-49,3.7,4.4,425,Incidence,10547318,All Races,4.0,Female,Myeloma,2017
45-49,11.5,12.8,1277,Incidence,10547318,All Races,12.1,Female,Non-Hodgkin Lymphoma,2017
45-49,5.8,6.8,664,Incidence,10547318,All Races,6.3,Female,Oral Cavity and Pharynx,2017
45-49,12.0,13.3,1333,Incidence,10547318,All Races,12.6,Female,Ovary,2017
45-49,5.1,6.0,579,Incidence,10547318,All Races,5.5,Female,Pancreas,2017
45-49,4.0,4.8,467,Incidence,10547318,All Races,4.4,Female,Stomach,2017
45-49,33.2,35.4,3615,Incidence,10547318,All Races,34.3,Female,Thyroid,2017
45-49,3.0,3.7,356,Incidence,10547318,All Races,3.4,Female,Urinary Bladder,2017
5-9,11.4,12.8,1199,Incidence,9948106,All Races,12.1,Female,All Cancer Sites Combined,2017
5-9,3.1,3.9,346,Incidence,9948106,All Races,3.5,Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Cervix,2017
5-9,0.1,0.3,16,Incidence,9948106,All Races,0.2,Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Esophagus,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Female Breast,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,"Female Breast, <i>in situ</i>",2017
5-9,0.1,0.3,20,Incidence,9948106,All Races,0.2,Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Kaposi Sarcoma,2017
5-9,0.6,1.0,78,Incidence,9948106,All Races,0.8,Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Larynx,2017
5-9,3.1,3.8,344,Incidence,9948106,All Races,3.5,Female,Leukemias,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Lung and Bronchus,2017
5-9,0.1,0.3,16,Incidence,9948106,All Races,0.2,Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Mesothelioma,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Myeloma,2017
5-9,0.6,0.9,72,Incidence,9948106,All Races,0.7,Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Oral Cavity and Pharynx,2017
5-9,0.2,0.4,25,Incidence,9948106,All Races,0.3,Female,Ovary,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Pancreas,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Stomach,2017
5-9,0.1,0.3,21,Incidence,9948106,All Races,0.2,Female,Thyroid,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Female,Urinary Bladder,2017
50-54,618.3,627.7,67563,Incidence,10844299,All Races,623.0,Female,All Cancer Sites Combined,2017
50-54,5.5,6.4,640,Incidence,10844299,All Races,5.9,Female,Brain and Other Nervous System,2017
50-54,12.4,13.7,1413,Incidence,10844299,All Races,13.0,Female,Cervix,2017
50-54,52.8,55.6,5873,Incidence,10844299,All Races,54.2,Female,Colon and Rectum,2017
50-54,47.5,50.2,5296,Incidence,10844299,All Races,48.8,Female,"Corpus and Uterus, NOS",2017
50-54,1.6,2.1,198,Incidence,10844299,All Races,1.8,Female,Esophagus,2017
50-54,231.6,237.4,25430,Incidence,10844299,All Races,234.5,Female,Female Breast,2017
50-54,65.5,68.6,7266,Incidence,10844299,All Races,67.0,Female,"Female Breast, <i>in situ</i>",2017
50-54,1.5,2.0,193,Incidence,10844299,All Races,1.8,Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,10844299,All Races,~,Female,Kaposi Sarcoma,2017
50-54,17.6,19.2,1994,Incidence,10844299,All Races,18.4,Female,Kidney and Renal Pelvis,2017
50-54,2.3,2.9,276,Incidence,10844299,All Races,2.5,Female,Larynx,2017
50-54,10.8,12.1,1241,Incidence,10844299,All Races,11.4,Female,Leukemias,2017
50-54,4.5,5.4,535,Incidence,10844299,All Races,4.9,Female,Liver and Intrahepatic Bile Duct,2017
50-54,44.3,46.9,4942,Incidence,10844299,All Races,45.6,Female,Lung and Bronchus,2017
50-54,27.9,29.9,3135,Incidence,10844299,All Races,28.9,Female,Melanomas of the Skin,2017
50-54,0.3,0.5,41,Incidence,10844299,All Races,0.4,Female,Mesothelioma,2017
50-54,6.0,6.9,699,Incidence,10844299,All Races,6.4,Female,Myeloma,2017
50-54,17.7,19.3,2003,Incidence,10844299,All Races,18.5,Female,Non-Hodgkin Lymphoma,2017
50-54,9.6,10.8,1103,Incidence,10844299,All Races,10.2,Female,Oral Cavity and Pharynx,2017
50-54,17.4,19.0,1968,Incidence,10844299,All Races,18.1,Female,Ovary,2017
50-54,9.4,10.6,1087,Incidence,10844299,All Races,10.0,Female,Pancreas,2017
50-54,5.6,6.6,662,Incidence,10844299,All Races,6.1,Female,Stomach,2017
50-54,32.7,34.9,3665,Incidence,10844299,All Races,33.8,Female,Thyroid,2017
50-54,6.2,7.2,728,Incidence,10844299,All Races,6.7,Female,Urinary Bladder,2017
55-59,812.3,822.8,92176,Incidence,11274831,All Races,817.5,Female,All Cancer Sites Combined,2017
55-59,7.9,9.0,950,Incidence,11274831,All Races,8.4,Female,Brain and Other Nervous System,2017
55-59,11.8,13.1,1403,Incidence,11274831,All Races,12.4,Female,Cervix,2017
55-59,55.2,58.0,6381,Incidence,11274831,All Races,56.6,Female,Colon and Rectum,2017
55-59,76.2,79.5,8773,Incidence,11274831,All Races,77.8,Female,"Corpus and Uterus, NOS",2017
55-59,3.1,3.8,390,Incidence,11274831,All Races,3.5,Female,Esophagus,2017
55-59,267.3,273.3,30474,Incidence,11274831,All Races,270.3,Female,Female Breast,2017
55-59,66.4,69.4,7656,Incidence,11274831,All Races,67.9,Female,"Female Breast, <i>in situ</i>",2017
55-59,1.6,2.2,213,Incidence,11274831,All Races,1.9,Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,11274831,All Races,~,Female,Kaposi Sarcoma,2017
55-59,23.7,25.6,2779,Incidence,11274831,All Races,24.6,Female,Kidney and Renal Pelvis,2017
55-59,3.6,4.4,451,Incidence,11274831,All Races,4.0,Female,Larynx,2017
55-59,14.9,16.4,1766,Incidence,11274831,All Races,15.7,Female,Leukemias,2017
55-59,9.0,10.2,1081,Incidence,11274831,All Races,9.6,Female,Liver and Intrahepatic Bile Duct,2017
55-59,92.6,96.2,10640,Incidence,11274831,All Races,94.4,Female,Lung and Bronchus,2017
55-59,33.7,35.9,3920,Incidence,11274831,All Races,34.8,Female,Melanomas of the Skin,2017
55-59,0.4,0.7,61,Incidence,11274831,All Races,0.5,Female,Mesothelioma,2017
55-59,9.5,10.7,1133,Incidence,11274831,All Races,10.0,Female,Myeloma,2017
55-59,25.6,27.5,2991,Incidence,11274831,All Races,26.5,Female,Non-Hodgkin Lymphoma,2017
55-59,14.2,15.6,1677,Incidence,11274831,All Races,14.9,Female,Oral Cavity and Pharynx,2017
55-59,21.5,23.2,2516,Incidence,11274831,All Races,22.3,Female,Ovary,2017
55-59,17.6,19.1,2067,Incidence,11274831,All Races,18.3,Female,Pancreas,2017
55-59,7.5,8.5,901,Incidence,11274831,All Races,8.0,Female,Stomach,2017
55-59,32.6,34.7,3792,Incidence,11274831,All Races,33.6,Female,Thyroid,2017
55-59,11.2,12.5,1336,Incidence,11274831,All Races,11.8,Female,Urinary Bladder,2017
60-64,1046.0,1058.5,109424,Incidence,10398926,All Races,1052.3,Female,All Cancer Sites Combined,2017
60-64,10.0,11.3,1105,Incidence,10398926,All Races,10.6,Female,Brain and Other Nervous System,2017
60-64,11.1,12.4,1224,Incidence,10398926,All Races,11.8,Female,Cervix,2017
60-64,68.8,72.0,7321,Incidence,10398926,All Races,70.4,Female,Colon and Rectum,2017
60-64,101.0,104.9,10702,Incidence,10398926,All Races,102.9,Female,"Corpus and Uterus, NOS",2017
60-64,4.8,5.7,543,Incidence,10398926,All Races,5.2,Female,Esophagus,2017
60-64,332.0,339.0,34887,Incidence,10398926,All Races,335.5,Female,Female Breast,2017
60-64,79.0,82.5,8393,Incidence,10398926,All Races,80.7,Female,"Female Breast, <i>in situ</i>",2017
60-64,1.9,2.5,226,Incidence,10398926,All Races,2.2,Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,10398926,All Races,~,Female,Kaposi Sarcoma,2017
60-64,30.3,32.5,3266,Incidence,10398926,All Races,31.4,Female,Kidney and Renal Pelvis,2017
60-64,4.2,5.0,475,Incidence,10398926,All Races,4.6,Female,Larynx,2017
60-64,20.9,22.7,2261,Incidence,10398926,All Races,21.7,Female,Leukemias,2017
60-64,14.9,16.4,1624,Incidence,10398926,All Races,15.6,Female,Liver and Intrahepatic Bile Duct,2017
60-64,135.4,139.9,14314,Incidence,10398926,All Races,137.6,Female,Lung and Bronchus,2017
60-64,39.2,41.7,4207,Incidence,10398926,All Races,40.5,Female,Melanomas of the Skin,2017
60-64,0.6,0.9,79,Incidence,10398926,All Races,0.8,Female,Mesothelioma,2017
60-64,14.5,16.0,1585,Incidence,10398926,All Races,15.2,Female,Myeloma,2017
60-64,33.9,36.2,3644,Incidence,10398926,All Races,35.0,Female,Non-Hodgkin Lymphoma,2017
60-64,17.4,19.1,1897,Incidence,10398926,All Races,18.2,Female,Oral Cavity and Pharynx,2017
60-64,25.3,27.2,2728,Incidence,10398926,All Races,26.2,Female,Ovary,2017
60-64,27.7,29.8,2985,Incidence,10398926,All Races,28.7,Female,Pancreas,2017
60-64,9.4,10.7,1044,Incidence,10398926,All Races,10.0,Female,Stomach,2017
60-64,29.4,31.5,3168,Incidence,10398926,All Races,30.5,Female,Thyroid,2017
60-64,18.4,20.1,1999,Incidence,10398926,All Races,19.2,Female,Urinary Bladder,2017
65-69,1369.6,1385.1,122369,Incidence,8884407,All Races,1377.3,Female,All Cancer Sites Combined,2017
65-69,12.0,13.5,1129,Incidence,8884407,All Races,12.7,Female,Brain and Other Nervous System,2017
65-69,10.1,11.5,960,Incidence,8884407,All Races,10.8,Female,Cervix,2017
65-69,95.1,99.2,8631,Incidence,8884407,All Races,97.1,Female,Colon and Rectum,2017
65-69,113.3,117.8,10264,Incidence,8884407,All Races,115.5,Female,"Corpus and Uterus, NOS",2017
65-69,5.6,6.7,545,Incidence,8884407,All Races,6.1,Female,Esophagus,2017
65-69,426.7,435.3,38291,Incidence,8884407,All Races,431.0,Female,Female Breast,2017
65-69,97.2,101.3,8816,Incidence,8884407,All Races,99.2,Female,"Female Breast, <i>in situ</i>",2017
65-69,2.3,3.0,238,Incidence,8884407,All Races,2.7,Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,8884407,All Races,~,Female,Kaposi Sarcoma,2017
65-69,42.1,44.8,3858,Incidence,8884407,All Races,43.4,Female,Kidney and Renal Pelvis,2017
65-69,4.0,4.9,392,Incidence,8884407,All Races,4.4,Female,Larynx,2017
65-69,29.5,31.8,2720,Incidence,8884407,All Races,30.6,Female,Leukemias,2017
65-69,19.4,21.3,1805,Incidence,8884407,All Races,20.3,Female,Liver and Intrahepatic Bile Duct,2017
65-69,199.5,205.5,17989,Incidence,8884407,All Races,202.5,Female,Lung and Bronchus,2017
65-69,46.5,49.4,4256,Incidence,8884407,All Races,47.9,Female,Melanomas of the Skin,2017
65-69,0.9,1.4,101,Incidence,8884407,All Races,1.1,Female,Mesothelioma,2017
65-69,21.4,23.4,1988,Incidence,8884407,All Races,22.4,Female,Myeloma,2017
65-69,48.7,51.6,4455,Incidence,8884407,All Races,50.1,Female,Non-Hodgkin Lymphoma,2017
65-69,20.9,22.8,1938,Incidence,8884407,All Races,21.8,Female,Oral Cavity and Pharynx,2017
65-69,30.5,32.9,2816,Incidence,8884407,All Races,31.7,Female,Ovary,2017
65-69,40.2,42.8,3686,Incidence,8884407,All Races,41.5,Female,Pancreas,2017
65-69,13.5,15.0,1265,Incidence,8884407,All Races,14.2,Female,Stomach,2017
65-69,29.7,32.0,2742,Incidence,8884407,All Races,30.9,Female,Thyroid,2017
65-69,28.2,30.5,2607,Incidence,8884407,All Races,29.3,Female,Urinary Bladder,2017
70-74,1631.4,1650.5,112920,Incidence,6881542,All Races,1640.9,Female,All Cancer Sites Combined,2017
70-74,14.8,16.6,1079,Incidence,6881542,All Races,15.7,Female,Brain and Other Nervous System,2017
70-74,9.6,11.2,713,Incidence,6881542,All Races,10.4,Female,Cervix,2017
70-74,116.0,121.2,8159,Incidence,6881542,All Races,118.6,Female,Colon and Rectum,2017
70-74,107.6,112.6,7574,Incidence,6881542,All Races,110.1,Female,"Corpus and Uterus, NOS",2017
70-74,7.3,8.6,544,Incidence,6881542,All Races,7.9,Female,Esophagus,2017
70-74,468.5,478.8,32590,Incidence,6881542,All Races,473.6,Female,Female Breast,2017
70-74,98.0,102.8,6908,Incidence,6881542,All Races,100.4,Female,"Female Breast, <i>in situ</i>",2017
70-74,3.0,3.9,239,Incidence,6881542,All Races,3.5,Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,6881542,All Races,~,Female,Kaposi Sarcoma,2017
70-74,47.3,50.6,3367,Incidence,6881542,All Races,48.9,Female,Kidney and Renal Pelvis,2017
70-74,4.4,5.5,340,Incidence,6881542,All Races,4.9,Female,Larynx,2017
70-74,39.3,42.3,2805,Incidence,6881542,All Races,40.8,Female,Leukemias,2017
70-74,20.3,22.5,1469,Incidence,6881542,All Races,21.3,Female,Liver and Intrahepatic Bile Duct,2017
70-74,289.2,297.3,20181,Incidence,6881542,All Races,293.3,Female,Lung and Bronchus,2017
70-74,51.1,54.6,3637,Incidence,6881542,All Races,52.9,Female,Melanomas of the Skin,2017
70-74,1.5,2.2,126,Incidence,6881542,All Races,1.8,Female,Mesothelioma,2017
70-74,27.0,29.5,1942,Incidence,6881542,All Races,28.2,Female,Myeloma,2017
70-74,64.5,68.3,4569,Incidence,6881542,All Races,66.4,Female,Non-Hodgkin Lymphoma,2017
70-74,21.8,24.1,1577,Incidence,6881542,All Races,22.9,Female,Oral Cavity and Pharynx,2017
70-74,34.3,37.1,2457,Incidence,6881542,All Races,35.7,Female,Ovary,2017
70-74,53.3,56.9,3791,Incidence,6881542,All Races,55.1,Female,Pancreas,2017
70-74,17.0,19.1,1240,Incidence,6881542,All Races,18.0,Female,Stomach,2017
70-74,26.0,28.5,1875,Incidence,6881542,All Races,27.2,Female,Thyroid,2017
70-74,41.3,44.4,2948,Incidence,6881542,All Races,42.8,Female,Urinary Bladder,2017
75-79,1831.9,1856.2,89125,Incidence,4833186,All Races,1844.0,Female,All Cancer Sites Combined,2017
75-79,16.0,18.4,830,Incidence,4833186,All Races,17.2,Female,Brain and Other Nervous System,2017
75-79,9.0,10.8,479,Incidence,4833186,All Races,9.9,Female,Cervix,2017
75-79,152.0,159.0,7513,Incidence,4833186,All Races,155.4,Female,Colon and Rectum,2017
75-79,90.0,95.5,4482,Incidence,4833186,All Races,92.7,Female,"Corpus and Uterus, NOS",2017
75-79,9.1,10.9,483,Incidence,4833186,All Races,10.0,Female,Esophagus,2017
75-79,452.0,464.1,22137,Incidence,4833186,All Races,458.0,Female,Female Breast,2017
75-79,80.0,85.2,3990,Incidence,4833186,All Races,82.6,Female,"Female Breast, <i>in situ</i>",2017
75-79,2.6,3.7,151,Incidence,4833186,All Races,3.1,Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,4833186,All Races,~,Female,Kaposi Sarcoma,2017
75-79,51.3,55.4,2578,Incidence,4833186,All Races,53.3,Female,Kidney and Renal Pelvis,2017
75-79,3.8,5.0,211,Incidence,4833186,All Races,4.4,Female,Larynx,2017
75-79,51.9,56.1,2610,Incidence,4833186,All Races,54.0,Female,Leukemias,2017
75-79,25.6,28.5,1306,Incidence,4833186,All Races,27.0,Female,Liver and Intrahepatic Bile Duct,2017
75-79,350.9,361.6,17216,Incidence,4833186,All Races,356.2,Female,Lung and Bronchus,2017
75-79,55.3,59.6,2776,Incidence,4833186,All Races,57.4,Female,Melanomas of the Skin,2017
75-79,2.1,3.1,124,Incidence,4833186,All Races,2.6,Female,Mesothelioma,2017
75-79,32.3,35.7,1642,Incidence,4833186,All Races,34.0,Female,Myeloma,2017
75-79,81.4,86.6,4058,Incidence,4833186,All Races,84.0,Female,Non-Hodgkin Lymphoma,2017
75-79,25.6,28.6,1308,Incidence,4833186,All Races,27.1,Female,Oral Cavity and Pharynx,2017
75-79,38.4,42.0,1943,Incidence,4833186,All Races,40.2,Female,Ovary,2017
75-79,72.3,77.2,3612,Incidence,4833186,All Races,74.7,Female,Pancreas,2017
75-79,21.1,23.8,1084,Incidence,4833186,All Races,22.4,Female,Stomach,2017
75-79,21.8,24.5,1117,Incidence,4833186,All Races,23.1,Female,Thyroid,2017
75-79,54.6,58.8,2739,Incidence,4833186,All Races,56.7,Female,Urinary Bladder,2017
80-84,1892.1,1921.2,65883,Incidence,3455501,All Races,1906.6,Female,All Cancer Sites Combined,2017
80-84,15.9,18.8,598,Incidence,3455501,All Races,17.3,Female,Brain and Other Nervous System,2017
80-84,8.2,10.2,317,Incidence,3455501,All Races,9.2,Female,Cervix,2017
80-84,192.9,202.3,6826,Incidence,3455501,All Races,197.5,Female,Colon and Rectum,2017
80-84,73.5,79.3,2639,Incidence,3455501,All Races,76.4,Female,"Corpus and Uterus, NOS",2017
80-84,10.5,12.8,401,Incidence,3455501,All Races,11.6,Female,Esophagus,2017
80-84,398.9,412.4,14015,Incidence,3455501,All Races,405.6,Female,Female Breast,2017
80-84,51.6,56.5,1867,Incidence,3455501,All Races,54.0,Female,"Female Breast, <i>in situ</i>",2017
80-84,2.7,4.0,114,Incidence,3455501,All Races,3.3,Female,Hodgkin Lymphoma,2017
80-84,0.4,0.9,20,Incidence,3455501,All Races,0.6,Female,Kaposi Sarcoma,2017
80-84,48.5,53.3,1758,Incidence,3455501,All Races,50.9,Female,Kidney and Renal Pelvis,2017
80-84,3.4,4.8,140,Incidence,3455501,All Races,4.1,Female,Larynx,2017
80-84,58.4,63.6,2106,Incidence,3455501,All Races,60.9,Female,Leukemias,2017
80-84,25.5,29.0,940,Incidence,3455501,All Races,27.2,Female,Liver and Intrahepatic Bile Duct,2017
80-84,340.6,353.0,11983,Incidence,3455501,All Races,346.8,Female,Lung and Bronchus,2017
80-84,61.2,66.5,2205,Incidence,3455501,All Races,63.8,Female,Melanomas of the Skin,2017
80-84,2.9,4.2,122,Incidence,3455501,All Races,3.5,Female,Mesothelioma,2017
80-84,37.5,41.7,1367,Incidence,3455501,All Races,39.6,Female,Myeloma,2017
80-84,90.3,96.8,3231,Incidence,3455501,All Races,93.5,Female,Non-Hodgkin Lymphoma,2017
80-84,26.9,30.5,989,Incidence,3455501,All Races,28.6,Female,Oral Cavity and Pharynx,2017
80-84,40.3,44.6,1465,Incidence,3455501,All Races,42.4,Female,Ovary,2017
80-84,82.3,88.5,2950,Incidence,3455501,All Races,85.4,Female,Pancreas,2017
80-84,26.6,30.2,980,Incidence,3455501,All Races,28.4,Female,Stomach,2017
80-84,14.9,17.6,560,Incidence,3455501,All Races,16.2,Female,Thyroid,2017
80-84,65.1,70.6,2344,Incidence,3455501,All Races,67.8,Female,Urinary Bladder,2017
85+,1699.8,1724.9,71604,Incidence,4181647,All Races,1712.3,Female,All Cancer Sites Combined,2017
85+,14.0,16.4,635,Incidence,4181647,All Races,15.2,Female,Brain and Other Nervous System,2017
85+,7.0,8.7,327,Incidence,4181647,All Races,7.8,Female,Cervix,2017
85+,221.4,230.6,9449,Incidence,4181647,All Races,226.0,Female,Colon and Rectum,2017
85+,47.8,52.1,2089,Incidence,4181647,All Races,50.0,Female,"Corpus and Uterus, NOS",2017
85+,10.5,12.6,483,Incidence,4181647,All Races,11.6,Female,Esophagus,2017
85+,308.6,319.3,13127,Incidence,4181647,All Races,313.9,Female,Female Breast,2017
85+,21.5,24.4,959,Incidence,4181647,All Races,22.9,Female,"Female Breast, <i>in situ</i>",2017
85+,1.6,2.5,83,Incidence,4181647,All Races,2.0,Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,4181647,All Races,~,Female,Kaposi Sarcoma,2017
85+,39.5,43.4,1731,Incidence,4181647,All Races,41.4,Female,Kidney and Renal Pelvis,2017
85+,2.0,3.0,104,Incidence,4181647,All Races,2.5,Female,Larynx,2017
85+,62.5,67.4,2714,Incidence,4181647,All Races,64.9,Female,Leukemias,2017
85+,24.1,27.1,1069,Incidence,4181647,All Races,25.6,Female,Liver and Intrahepatic Bile Duct,2017
85+,240.2,249.7,10242,Incidence,4181647,All Races,244.9,Female,Lung and Bronchus,2017
85+,59.0,63.8,2566,Incidence,4181647,All Races,61.4,Female,Melanomas of the Skin,2017
85+,2.2,3.2,113,Incidence,4181647,All Races,2.7,Female,Mesothelioma,2017
85+,28.8,32.2,1274,Incidence,4181647,All Races,30.5,Female,Myeloma,2017
85+,79.0,84.5,3418,Incidence,4181647,All Races,81.7,Female,Non-Hodgkin Lymphoma,2017
85+,28.0,31.3,1237,Incidence,4181647,All Races,29.6,Female,Oral Cavity and Pharynx,2017
85+,34.8,38.5,1531,Incidence,4181647,All Races,36.6,Female,Ovary,2017
85+,89.0,94.8,3841,Incidence,4181647,All Races,91.9,Female,Pancreas,2017
85+,26.5,29.7,1174,Incidence,4181647,All Races,28.1,Female,Stomach,2017
85+,8.2,10.1,381,Incidence,4181647,All Races,9.1,Female,Thyroid,2017
85+,69.6,74.8,3017,Incidence,4181647,All Races,72.1,Female,Urinary Bladder,2017
<1,22.8,27.3,474,Incidence,1896804,All Races,25.0,Female,All Cancer Sites Combined,2017
<1,2.6,4.4,65,Incidence,1896804,All Races,3.4,Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Cervix,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Colon and Rectum,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Esophagus,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Female Breast,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Kaposi Sarcoma,2017
<1,1.0,2.2,29,Incidence,1896804,All Races,1.5,Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Larynx,2017
<1,3.5,5.5,84,Incidence,1896804,All Races,4.4,Female,Leukemias,2017
<1,0.6,1.6,20,Incidence,1896804,All Races,1.1,Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Mesothelioma,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Myeloma,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Ovary,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Pancreas,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Stomach,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Thyroid,2017
<1,~,~,~,Incidence,1896804,All Races,~,Female,Urinary Bladder,2017
1-4,22.9,25.1,1963,Incidence,8187491,All Races,24.0,Male,All Cancer Sites Combined,2017
1-4,4.4,5.4,397,Incidence,8187491,All Races,4.8,Male,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Colon and Rectum,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Esophagus,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Kaposi Sarcoma,2017
1-4,1.4,2.0,140,Incidence,8187491,All Races,1.7,Male,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Larynx,2017
1-4,8.8,10.1,773,Incidence,8187491,All Races,9.4,Male,Leukemias,2017
1-4,0.5,0.9,58,Incidence,8187491,All Races,0.7,Male,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Lung and Bronchus,2017
1-4,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Mesothelioma,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Myeloma,2017
1-4,0.6,1.0,66,Incidence,8187491,All Races,0.8,Male,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Pancreas,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Prostate,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Stomach,2017
1-4,0.2,0.4,21,Incidence,8187491,All Races,0.3,Male,Testis,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Thyroid,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male,Urinary Bladder,2017
10-14,15.6,17.1,1734,Incidence,10609152,All Races,16.3,Male,All Cancer Sites Combined,2017
10-14,3.2,4.0,382,Incidence,10609152,All Races,3.6,Male,Brain and Other Nervous System,2017
10-14,0.3,0.6,47,Incidence,10609152,All Races,0.4,Male,Colon and Rectum,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Esophagus,2017
10-14,1.1,1.5,134,Incidence,10609152,All Races,1.3,Male,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Kaposi Sarcoma,2017
10-14,0.1,0.3,20,Incidence,10609152,All Races,0.2,Male,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Larynx,2017
10-14,3.4,4.2,404,Incidence,10609152,All Races,3.8,Male,Leukemias,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Lung and Bronchus,2017
10-14,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Mesothelioma,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Myeloma,2017
10-14,1.4,2.0,179,Incidence,10609152,All Races,1.7,Male,Non-Hodgkin Lymphoma,2017
10-14,0.2,0.4,33,Incidence,10609152,All Races,0.3,Male,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Pancreas,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Prostate,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Stomach,2017
10-14,0.2,0.3,25,Incidence,10609152,All Races,0.2,Male,Testis,2017
10-14,0.2,0.4,33,Incidence,10609152,All Races,0.3,Male,Thyroid,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male,Urinary Bladder,2017
15-19,22.9,24.8,2571,Incidence,10783133,All Races,23.8,Male,All Cancer Sites Combined,2017
15-19,2.4,3.1,296,Incidence,10783133,All Races,2.7,Male,Brain and Other Nervous System,2017
15-19,1.0,1.4,127,Incidence,10783133,All Races,1.2,Male,Colon and Rectum,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Esophagus,2017
15-19,2.5,3.1,299,Incidence,10783133,All Races,2.8,Male,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Kaposi Sarcoma,2017
15-19,0.1,0.3,21,Incidence,10783133,All Races,0.2,Male,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Larynx,2017
15-19,3.3,4.0,392,Incidence,10783133,All Races,3.6,Male,Leukemias,2017
15-19,0.1,0.2,16,Incidence,10783133,All Races,0.1,Male,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Lung and Bronchus,2017
15-19,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
15-19,0.4,0.7,59,Incidence,10783133,All Races,0.5,Male,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Mesothelioma,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Myeloma,2017
15-19,2.3,2.9,277,Incidence,10783133,All Races,2.6,Male,Non-Hodgkin Lymphoma,2017
15-19,0.2,0.4,33,Incidence,10783133,All Races,0.3,Male,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Pancreas,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Prostate,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male,Stomach,2017
15-19,3.0,3.8,365,Incidence,10783133,All Races,3.4,Male,Testis,2017
15-19,0.8,1.2,107,Incidence,10783133,All Races,1.0,Male,Thyroid,2017
15-19,0.1,0.2,16,Incidence,10783133,All Races,0.1,Male,Urinary Bladder,2017
20-24,34.6,36.8,4040,Incidence,11314113,All Races,35.7,Male,All Cancer Sites Combined,2017
20-24,1.9,2.5,246,Incidence,11314113,All Races,2.2,Male,Brain and Other Nervous System,2017
20-24,1.7,2.2,222,Incidence,11314113,All Races,2.0,Male,Colon and Rectum,2017
20-24,~,~,~,Incidence,11314113,All Races,~,Male,Esophagus,2017
20-24,3.7,4.5,463,Incidence,11314113,All Races,4.1,Male,Hodgkin Lymphoma,2017
20-24,0.2,0.5,37,Incidence,11314113,All Races,0.3,Male,Kaposi Sarcoma,2017
20-24,0.4,0.6,55,Incidence,11314113,All Races,0.5,Male,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,11314113,All Races,~,Male,Larynx,2017
20-24,2.8,3.4,348,Incidence,11314113,All Races,3.1,Male,Leukemias,2017
20-24,0.1,0.3,22,Incidence,11314113,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2017
20-24,0.2,0.3,27,Incidence,11314113,All Races,0.2,Male,Lung and Bronchus,2017
20-24,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
20-24,1.3,1.8,172,Incidence,11314113,All Races,1.5,Male,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,11314113,All Races,~,Male,Mesothelioma,2017
20-24,~,~,~,Incidence,11314113,All Races,~,Male,Myeloma,2017
20-24,2.7,3.4,341,Incidence,11314113,All Races,3.0,Male,Non-Hodgkin Lymphoma,2017
20-24,0.4,0.7,64,Incidence,11314113,All Races,0.6,Male,Oral Cavity and Pharynx,2017
20-24,0.1,0.3,23,Incidence,11314113,All Races,0.2,Male,Pancreas,2017
20-24,~,~,~,Incidence,11314113,All Races,~,Male,Prostate,2017
20-24,0.1,0.3,22,Incidence,11314113,All Races,0.2,Male,Stomach,2017
20-24,10.2,11.4,1223,Incidence,11314113,All Races,10.8,Male,Testis,2017
20-24,1.9,2.4,244,Incidence,11314113,All Races,2.2,Male,Thyroid,2017
20-24,0.2,0.3,27,Incidence,11314113,All Races,0.2,Male,Urinary Bladder,2017
25-29,48.3,50.9,5898,Incidence,11897087,All Races,49.6,Male,All Cancer Sites Combined,2017
25-29,2.5,3.1,334,Incidence,11897087,All Races,2.8,Male,Brain and Other Nervous System,2017
25-29,2.7,3.3,357,Incidence,11897087,All Races,3.0,Male,Colon and Rectum,2017
25-29,~,~,~,Incidence,11897087,All Races,~,Male,Esophagus,2017
25-29,3.6,4.3,472,Incidence,11897087,All Races,4.0,Male,Hodgkin Lymphoma,2017
25-29,0.8,1.1,110,Incidence,11897087,All Races,0.9,Male,Kaposi Sarcoma,2017
25-29,1.2,1.6,168,Incidence,11897087,All Races,1.4,Male,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,11897087,All Races,~,Male,Larynx,2017
25-29,2.8,3.5,373,Incidence,11897087,All Races,3.1,Male,Leukemias,2017
25-29,0.3,0.6,53,Incidence,11897087,All Races,0.4,Male,Liver and Intrahepatic Bile Duct,2017
25-29,0.5,0.7,70,Incidence,11897087,All Races,0.6,Male,Lung and Bronchus,2017
25-29,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
25-29,2.7,3.3,357,Incidence,11897087,All Races,3.0,Male,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,11897087,All Races,~,Male,Mesothelioma,2017
25-29,~,~,~,Incidence,11897087,All Races,~,Male,Myeloma,2017
25-29,3.4,4.2,451,Incidence,11897087,All Races,3.8,Male,Non-Hodgkin Lymphoma,2017
25-29,0.9,1.3,127,Incidence,11897087,All Races,1.1,Male,Oral Cavity and Pharynx,2017
25-29,0.1,0.3,27,Incidence,11897087,All Races,0.2,Male,Pancreas,2017
25-29,~,~,~,Incidence,11897087,All Races,~,Male,Prostate,2017
25-29,0.3,0.6,50,Incidence,11897087,All Races,0.4,Male,Stomach,2017
25-29,14.3,15.7,1785,Incidence,11897087,All Races,15.0,Male,Testis,2017
25-29,3.2,3.9,422,Incidence,11897087,All Races,3.5,Male,Thyroid,2017
25-29,0.3,0.6,55,Incidence,11897087,All Races,0.5,Male,Urinary Bladder,2017
30-34,68.3,71.4,7740,Incidence,11081933,All Races,69.8,Male,All Cancer Sites Combined,2017
30-34,3.9,4.7,473,Incidence,11081933,All Races,4.3,Male,Brain and Other Nervous System,2017
30-34,5.9,6.8,705,Incidence,11081933,All Races,6.4,Male,Colon and Rectum,2017
30-34,0.2,0.4,33,Incidence,11081933,All Races,0.3,Male,Esophagus,2017
30-34,3.4,4.1,412,Incidence,11081933,All Races,3.7,Male,Hodgkin Lymphoma,2017
30-34,0.8,1.2,110,Incidence,11081933,All Races,1.0,Male,Kaposi Sarcoma,2017
30-34,3.1,3.8,385,Incidence,11081933,All Races,3.5,Male,Kidney and Renal Pelvis,2017
30-34,0.1,0.3,21,Incidence,11081933,All Races,0.2,Male,Larynx,2017
30-34,3.7,4.4,445,Incidence,11081933,All Races,4.0,Male,Leukemias,2017
30-34,0.5,0.8,70,Incidence,11081933,All Races,0.6,Male,Liver and Intrahepatic Bile Duct,2017
30-34,1.0,1.4,134,Incidence,11081933,All Races,1.2,Male,Lung and Bronchus,2017
30-34,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
30-34,5.8,6.8,697,Incidence,11081933,All Races,6.3,Male,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,11081933,All Races,~,Male,Mesothelioma,2017
30-34,0.4,0.6,53,Incidence,11081933,All Races,0.5,Male,Myeloma,2017
30-34,5.1,6.0,612,Incidence,11081933,All Races,5.5,Male,Non-Hodgkin Lymphoma,2017
30-34,1.5,2.0,193,Incidence,11081933,All Races,1.7,Male,Oral Cavity and Pharynx,2017
30-34,0.6,0.9,82,Incidence,11081933,All Races,0.7,Male,Pancreas,2017
30-34,~,~,~,Incidence,11081933,All Races,~,Male,Prostate,2017
30-34,0.9,1.3,116,Incidence,11081933,All Races,1.0,Male,Stomach,2017
30-34,13.7,15.1,1598,Incidence,11081933,All Races,14.4,Male,Testis,2017
30-34,5.4,6.3,645,Incidence,11081933,All Races,5.8,Male,Thyroid,2017
30-34,0.8,1.2,106,Incidence,11081933,All Races,1.0,Male,Urinary Bladder,2017
35-39,97.4,101.2,10524,Incidence,10596983,All Races,99.3,Male,All Cancer Sites Combined,2017
35-39,4.4,5.2,505,Incidence,10596983,All Races,4.8,Male,Brain and Other Nervous System,2017
35-39,11.8,13.2,1325,Incidence,10596983,All Races,12.5,Male,Colon and Rectum,2017
35-39,0.5,0.9,72,Incidence,10596983,All Races,0.7,Male,Esophagus,2017
35-39,2.9,3.6,339,Incidence,10596983,All Races,3.2,Male,Hodgkin Lymphoma,2017
35-39,0.7,1.0,89,Incidence,10596983,All Races,0.8,Male,Kaposi Sarcoma,2017
35-39,7.1,8.2,809,Incidence,10596983,All Races,7.6,Male,Kidney and Renal Pelvis,2017
35-39,0.4,0.6,51,Incidence,10596983,All Races,0.5,Male,Larynx,2017
35-39,4.7,5.5,540,Incidence,10596983,All Races,5.1,Male,Leukemias,2017
35-39,1.0,1.5,130,Incidence,10596983,All Races,1.2,Male,Liver and Intrahepatic Bile Duct,2017
35-39,2.2,2.8,259,Incidence,10596983,All Races,2.4,Male,Lung and Bronchus,2017
35-39,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
35-39,9.8,11.1,1104,Incidence,10596983,All Races,10.4,Male,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,10596983,All Races,~,Male,Mesothelioma,2017
35-39,0.9,1.3,115,Incidence,10596983,All Races,1.1,Male,Myeloma,2017
35-39,7.0,8.1,798,Incidence,10596983,All Races,7.5,Male,Non-Hodgkin Lymphoma,2017
35-39,3.4,4.2,403,Incidence,10596983,All Races,3.8,Male,Oral Cavity and Pharynx,2017
35-39,1.3,1.8,163,Incidence,10596983,All Races,1.5,Male,Pancreas,2017
35-39,0.5,0.8,66,Incidence,10596983,All Races,0.6,Male,Prostate,2017
35-39,1.7,2.2,203,Incidence,10596983,All Races,1.9,Male,Stomach,2017
35-39,11.2,12.5,1254,Incidence,10596983,All Races,11.8,Male,Testis,2017
35-39,7.6,8.7,867,Incidence,10596983,All Races,8.2,Male,Thyroid,2017
35-39,1.7,2.3,213,Incidence,10596983,All Races,2.0,Male,Urinary Bladder,2017
40-44,147.8,152.7,14599,Incidence,9718987,All Races,150.2,Male,All Cancer Sites Combined,2017
40-44,4.4,5.3,467,Incidence,9718987,All Races,4.8,Male,Brain and Other Nervous System,2017
40-44,20.3,22.1,2061,Incidence,9718987,All Races,21.2,Male,Colon and Rectum,2017
40-44,1.6,2.1,176,Incidence,9718987,All Races,1.8,Male,Esophagus,2017
40-44,2.8,3.5,302,Incidence,9718987,All Races,3.1,Male,Hodgkin Lymphoma,2017
40-44,0.7,1.1,85,Incidence,9718987,All Races,0.9,Male,Kaposi Sarcoma,2017
40-44,14.2,15.7,1449,Incidence,9718987,All Races,14.9,Male,Kidney and Renal Pelvis,2017
40-44,0.9,1.3,103,Incidence,9718987,All Races,1.1,Male,Larynx,2017
40-44,6.4,7.5,676,Incidence,9718987,All Races,7.0,Male,Leukemias,2017
40-44,2.1,2.7,229,Incidence,9718987,All Races,2.4,Male,Liver and Intrahepatic Bile Duct,2017
40-44,6.0,7.0,633,Incidence,9718987,All Races,6.5,Male,Lung and Bronchus,2017
40-44,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
40-44,13.5,15.0,1385,Incidence,9718987,All Races,14.3,Male,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,9718987,All Races,~,Male,Mesothelioma,2017
40-44,2.4,3.1,266,Incidence,9718987,All Races,2.7,Male,Myeloma,2017
40-44,10.1,11.4,1044,Incidence,9718987,All Races,10.7,Male,Non-Hodgkin Lymphoma,2017
40-44,7.6,8.7,789,Incidence,9718987,All Races,8.1,Male,Oral Cavity and Pharynx,2017
40-44,3.1,3.8,336,Incidence,9718987,All Races,3.5,Male,Pancreas,2017
40-44,5.4,6.3,567,Incidence,9718987,All Races,5.8,Male,Prostate,2017
40-44,3.3,4.1,358,Incidence,9718987,All Races,3.7,Male,Stomach,2017
40-44,8.0,9.2,837,Incidence,9718987,All Races,8.6,Male,Testis,2017
40-44,8.5,9.8,888,Incidence,9718987,All Races,9.1,Male,Thyroid,2017
40-44,3.7,4.5,395,Incidence,9718987,All Races,4.1,Male,Urinary Bladder,2017
45-49,267.1,273.4,27968,Incidence,10349982,All Races,270.2,Male,All Cancer Sites Combined,2017
45-49,6.1,7.1,683,Incidence,10349982,All Races,6.6,Male,Brain and Other Nervous System,2017
45-49,38.8,41.2,4141,Incidence,10349982,All Races,40.0,Male,Colon and Rectum,2017
45-49,3.6,4.4,416,Incidence,10349982,All Races,4.0,Male,Esophagus,2017
45-49,2.8,3.5,324,Incidence,10349982,All Races,3.1,Male,Hodgkin Lymphoma,2017
45-49,0.8,1.1,97,Incidence,10349982,All Races,0.9,Male,Kaposi Sarcoma,2017
45-49,23.3,25.2,2509,Incidence,10349982,All Races,24.2,Male,Kidney and Renal Pelvis,2017
45-49,2.8,3.5,328,Incidence,10349982,All Races,3.2,Male,Larynx,2017
45-49,9.7,11.0,1070,Incidence,10349982,All Races,10.3,Male,Leukemias,2017
45-49,5.3,6.2,593,Incidence,10349982,All Races,5.7,Male,Liver and Intrahepatic Bile Duct,2017
45-49,15.2,16.8,1652,Incidence,10349982,All Races,16.0,Male,Lung and Bronchus,2017
45-49,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
45-49,20.8,22.6,2241,Incidence,10349982,All Races,21.7,Male,Melanomas of the Skin,2017
45-49,0.2,0.4,25,Incidence,10349982,All Races,0.2,Male,Mesothelioma,2017
45-49,5.2,6.1,581,Incidence,10349982,All Races,5.6,Male,Myeloma,2017
45-49,16.0,17.6,1735,Incidence,10349982,All Races,16.8,Male,Non-Hodgkin Lymphoma,2017
45-49,17.4,19.1,1889,Incidence,10349982,All Races,18.3,Male,Oral Cavity and Pharynx,2017
45-49,7.0,8.1,777,Incidence,10349982,All Races,7.5,Male,Pancreas,2017
45-49,28.6,30.7,3069,Incidence,10349982,All Races,29.7,Male,Prostate,2017
45-49,5.4,6.4,607,Incidence,10349982,All Races,5.9,Male,Stomach,2017
45-49,5.8,6.8,650,Incidence,10349982,All Races,6.3,Male,Testis,2017
45-49,9.7,11.0,1068,Incidence,10349982,All Races,10.3,Male,Thyroid,2017
45-49,8.5,9.7,939,Incidence,10349982,All Races,9.1,Male,Urinary Bladder,2017
5-9,13.5,14.9,1471,Incidence,10382200,All Races,14.2,Male,All Cancer Sites Combined,2017
5-9,3.7,4.5,424,Incidence,10382200,All Races,4.1,Male,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Colon and Rectum,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Esophagus,2017
5-9,0.4,0.7,59,Incidence,10382200,All Races,0.6,Male,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Kaposi Sarcoma,2017
5-9,0.4,0.7,52,Incidence,10382200,All Races,0.5,Male,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Larynx,2017
5-9,3.9,4.7,443,Incidence,10382200,All Races,4.3,Male,Leukemias,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Lung and Bronchus,2017
5-9,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Mesothelioma,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Myeloma,2017
5-9,1.2,1.7,150,Incidence,10382200,All Races,1.4,Male,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Pancreas,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Prostate,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Stomach,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Testis,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Thyroid,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male,Urinary Bladder,2017
50-54,520.0,528.8,54982,Incidence,10485450,All Races,524.4,Male,All Cancer Sites Combined,2017
50-54,8.4,9.6,944,Incidence,10485450,All Races,9.0,Male,Brain and Other Nervous System,2017
50-54,69.7,72.9,7472,Incidence,10485450,All Races,71.3,Male,Colon and Rectum,2017
50-54,7.9,9.0,881,Incidence,10485450,All Races,8.4,Male,Esophagus,2017
50-54,2.7,3.4,316,Incidence,10485450,All Races,3.0,Male,Hodgkin Lymphoma,2017
50-54,0.7,1.0,89,Incidence,10485450,All Races,0.8,Male,Kaposi Sarcoma,2017
50-54,34.5,36.8,3738,Incidence,10485450,All Races,35.6,Male,Kidney and Renal Pelvis,2017
50-54,7.0,8.1,792,Incidence,10485450,All Races,7.6,Male,Larynx,2017
50-54,14.9,16.5,1646,Incidence,10485450,All Races,15.7,Male,Leukemias,2017
50-54,14.5,16.0,1602,Incidence,10485450,All Races,15.3,Male,Liver and Intrahepatic Bile Duct,2017
50-54,43.9,46.5,4737,Incidence,10485450,All Races,45.2,Male,Lung and Bronchus,2017
50-54,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
50-54,30.9,33.1,3354,Incidence,10485450,All Races,32.0,Male,Melanomas of the Skin,2017
50-54,0.4,0.7,53,Incidence,10485450,All Races,0.5,Male,Mesothelioma,2017
50-54,8.6,9.8,962,Incidence,10485450,All Races,9.2,Male,Myeloma,2017
50-54,23.4,25.3,2556,Incidence,10485450,All Races,24.4,Male,Non-Hodgkin Lymphoma,2017
50-54,32.7,35.0,3549,Incidence,10485450,All Races,33.8,Male,Oral Cavity and Pharynx,2017
50-54,13.7,15.1,1508,Incidence,10485450,All Races,14.4,Male,Pancreas,2017
50-54,112.4,116.5,12000,Incidence,10485450,All Races,114.4,Male,Prostate,2017
50-54,8.4,9.5,935,Incidence,10485450,All Races,8.9,Male,Stomach,2017
50-54,3.7,4.5,428,Incidence,10485450,All Races,4.1,Male,Testis,2017
50-54,11.5,12.8,1275,Incidence,10485450,All Races,12.2,Male,Thyroid,2017
50-54,18.5,20.2,2025,Incidence,10485450,All Races,19.3,Male,Urinary Bladder,2017
55-59,894.0,905.4,96002,Incidence,10670828,All Races,899.7,Male,All Cancer Sites Combined,2017
55-59,11.4,12.7,1283,Incidence,10670828,All Races,12.0,Male,Brain and Other Nervous System,2017
55-59,81.1,84.6,8841,Incidence,10670828,All Races,82.9,Male,Colon and Rectum,2017
55-59,15.1,16.6,1694,Incidence,10670828,All Races,15.9,Male,Esophagus,2017
55-59,2.9,3.6,347,Incidence,10670828,All Races,3.3,Male,Hodgkin Lymphoma,2017
55-59,0.5,0.8,67,Incidence,10670828,All Races,0.6,Male,Kaposi Sarcoma,2017
55-59,48.3,51.0,5295,Incidence,10670828,All Races,49.6,Male,Kidney and Renal Pelvis,2017
55-59,12.7,14.1,1431,Incidence,10670828,All Races,13.4,Male,Larynx,2017
55-59,23.0,24.8,2547,Incidence,10670828,All Races,23.9,Male,Leukemias,2017
55-59,35.5,37.8,3905,Incidence,10670828,All Races,36.6,Male,Liver and Intrahepatic Bile Duct,2017
55-59,100.5,104.4,10930,Incidence,10670828,All Races,102.4,Male,Lung and Bronchus,2017
55-59,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
55-59,46.2,48.8,5067,Incidence,10670828,All Races,47.5,Male,Melanomas of the Skin,2017
55-59,0.8,1.1,100,Incidence,10670828,All Races,0.9,Male,Mesothelioma,2017
55-59,14.3,15.8,1603,Incidence,10670828,All Races,15.0,Male,Myeloma,2017
55-59,34.2,36.5,3771,Incidence,10670828,All Races,35.3,Male,Non-Hodgkin Lymphoma,2017
55-59,49.8,52.5,5453,Incidence,10670828,All Races,51.1,Male,Oral Cavity and Pharynx,2017
55-59,24.8,26.7,2747,Incidence,10670828,All Races,25.7,Male,Pancreas,2017
55-59,252.8,258.9,27302,Incidence,10670828,All Races,255.9,Male,Prostate,2017
55-59,14.3,15.8,1605,Incidence,10670828,All Races,15.0,Male,Stomach,2017
55-59,2.8,3.5,336,Incidence,10670828,All Races,3.1,Male,Testis,2017
55-59,13.3,14.8,1498,Incidence,10670828,All Races,14.0,Male,Thyroid,2017
55-59,36.8,39.2,4052,Incidence,10670828,All Races,38.0,Male,Urinary Bladder,2017
60-64,1364.6,1379.5,130741,Incidence,9529117,All Races,1372.0,Male,All Cancer Sites Combined,2017
60-64,15.4,17.1,1548,Incidence,9529117,All Races,16.2,Male,Brain and Other Nervous System,2017
60-64,104.3,108.5,10139,Incidence,9529117,All Races,106.4,Male,Colon and Rectum,2017
60-64,23.1,25.1,2293,Incidence,9529117,All Races,24.1,Male,Esophagus,2017
60-64,2.9,3.6,310,Incidence,9529117,All Races,3.3,Male,Hodgkin Lymphoma,2017
60-64,0.5,0.8,58,Incidence,9529117,All Races,0.6,Male,Kaposi Sarcoma,2017
60-64,65.2,68.5,6373,Incidence,9529117,All Races,66.9,Male,Kidney and Renal Pelvis,2017
60-64,18.6,20.4,1857,Incidence,9529117,All Races,19.5,Male,Larynx,2017
60-64,35.2,37.6,3469,Incidence,9529117,All Races,36.4,Male,Leukemias,2017
60-64,56.5,59.6,5532,Incidence,9529117,All Races,58.1,Male,Liver and Intrahepatic Bile Duct,2017
60-64,166.9,172.1,16150,Incidence,9529117,All Races,169.5,Male,Lung and Bronchus,2017
60-64,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
60-64,64.9,68.2,6339,Incidence,9529117,All Races,66.5,Male,Melanomas of the Skin,2017
60-64,1.5,2.0,164,Incidence,9529117,All Races,1.7,Male,Mesothelioma,2017
60-64,20.8,22.6,2067,Incidence,9529117,All Races,21.7,Male,Myeloma,2017
60-64,48.8,51.6,4783,Incidence,9529117,All Races,50.2,Male,Non-Hodgkin Lymphoma,2017
60-64,61.2,64.4,5985,Incidence,9529117,All Races,62.8,Male,Oral Cavity and Pharynx,2017
60-64,38.1,40.6,3746,Incidence,9529117,All Races,39.3,Male,Pancreas,2017
60-64,431.1,439.5,41477,Incidence,9529117,All Races,435.3,Male,Prostate,2017
60-64,20.5,22.3,2039,Incidence,9529117,All Races,21.4,Male,Stomach,2017
60-64,2.0,2.6,215,Incidence,9529117,All Races,2.3,Male,Testis,2017
60-64,14.4,15.9,1441,Incidence,9529117,All Races,15.1,Male,Thyroid,2017
60-64,67.0,70.4,6545,Incidence,9529117,All Races,68.7,Male,Urinary Bladder,2017
65-69,1963.9,1983.5,156101,Incidence,7909189,All Races,1973.7,Male,All Cancer Sites Combined,2017
65-69,18.4,20.3,1529,Incidence,7909189,All Races,19.3,Male,Brain and Other Nervous System,2017
65-69,138.5,143.7,11158,Incidence,7909189,All Races,141.1,Male,Colon and Rectum,2017
65-69,31.6,34.2,2602,Incidence,7909189,All Races,32.9,Male,Esophagus,2017
65-69,3.6,4.5,319,Incidence,7909189,All Races,4.0,Male,Hodgkin Lymphoma,2017
65-69,0.4,0.7,43,Incidence,7909189,All Races,0.5,Male,Kaposi Sarcoma,2017
65-69,86.6,90.8,7013,Incidence,7909189,All Races,88.7,Male,Kidney and Renal Pelvis,2017
65-69,20.9,23.0,1737,Incidence,7909189,All Races,22.0,Male,Larynx,2017
65-69,49.3,52.4,4020,Incidence,7909189,All Races,50.8,Male,Leukemias,2017
65-69,63.9,67.5,5195,Incidence,7909189,All Races,65.7,Male,Liver and Intrahepatic Bile Duct,2017
65-69,257.1,264.3,20618,Incidence,7909189,All Races,260.7,Male,Lung and Bronchus,2017
65-69,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
65-69,96.7,101.1,7824,Incidence,7909189,All Races,98.9,Male,Melanomas of the Skin,2017
65-69,3.3,4.2,295,Incidence,7909189,All Races,3.7,Male,Mesothelioma,2017
65-69,32.0,34.5,2629,Incidence,7909189,All Races,33.2,Male,Myeloma,2017
65-69,71.5,75.3,5801,Incidence,7909189,All Races,73.3,Male,Non-Hodgkin Lymphoma,2017
65-69,67.9,71.6,5517,Incidence,7909189,All Races,69.8,Male,Oral Cavity and Pharynx,2017
65-69,57.5,60.9,4680,Incidence,7909189,All Races,59.2,Male,Pancreas,2017
65-69,651.4,662.7,51965,Incidence,7909189,All Races,657.0,Male,Prostate,2017
65-69,28.5,30.9,2348,Incidence,7909189,All Races,29.7,Male,Stomach,2017
65-69,1.1,1.6,106,Incidence,7909189,All Races,1.3,Male,Testis,2017
65-69,16.8,18.7,1405,Incidence,7909189,All Races,17.8,Male,Thyroid,2017
65-69,115.6,120.4,9335,Incidence,7909189,All Races,118.0,Male,Urinary Bladder,2017
70-74,2352.4,2377.2,140258,Incidence,5931096,All Races,2364.8,Male,All Cancer Sites Combined,2017
70-74,22.1,24.5,1380,Incidence,5931096,All Races,23.3,Male,Brain and Other Nervous System,2017
70-74,159.7,166.3,9666,Incidence,5931096,All Races,163.0,Male,Colon and Rectum,2017
70-74,39.2,42.4,2419,Incidence,5931096,All Races,40.8,Male,Esophagus,2017
70-74,4.0,5.1,268,Incidence,5931096,All Races,4.5,Male,Hodgkin Lymphoma,2017
70-74,0.6,1.1,48,Incidence,5931096,All Races,0.8,Male,Kaposi Sarcoma,2017
70-74,98.3,103.4,5980,Incidence,5931096,All Races,100.8,Male,Kidney and Renal Pelvis,2017
70-74,24.1,26.7,1503,Incidence,5931096,All Races,25.3,Male,Larynx,2017
70-74,70.8,75.2,4330,Incidence,5931096,All Races,73.0,Male,Leukemias,2017
70-74,54.3,58.1,3331,Incidence,5931096,All Races,56.2,Male,Liver and Intrahepatic Bile Duct,2017
70-74,365.9,375.7,21989,Incidence,5931096,All Races,370.7,Male,Lung and Bronchus,2017
70-74,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
70-74,125.0,130.8,7586,Incidence,5931096,All Races,127.9,Male,Melanomas of the Skin,2017
70-74,7.0,8.4,453,Incidence,5931096,All Races,7.6,Male,Mesothelioma,2017
70-74,40.5,43.8,2500,Incidence,5931096,All Races,42.2,Male,Myeloma,2017
70-74,97.8,102.9,5952,Incidence,5931096,All Races,100.4,Male,Non-Hodgkin Lymphoma,2017
70-74,68.3,72.6,4178,Incidence,5931096,All Races,70.4,Male,Oral Cavity and Pharynx,2017
70-74,74.5,78.9,4547,Incidence,5931096,All Races,76.7,Male,Pancreas,2017
70-74,665.3,678.5,39847,Incidence,5931096,All Races,671.8,Male,Prostate,2017
70-74,37.6,40.8,2323,Incidence,5931096,All Races,39.2,Male,Stomach,2017
70-74,0.8,1.4,64,Incidence,5931096,All Races,1.1,Male,Testis,2017
70-74,16.1,18.2,1015,Incidence,5931096,All Races,17.1,Male,Thyroid,2017
70-74,172.4,179.2,10424,Incidence,5931096,All Races,175.8,Male,Urinary Bladder,2017
75-79,2681.7,2714.4,104940,Incidence,3889506,All Races,2698.0,Male,All Cancer Sites Combined,2017
75-79,24.3,27.6,1008,Incidence,3889506,All Races,25.9,Male,Brain and Other Nervous System,2017
75-79,202.2,211.3,8040,Incidence,3889506,All Races,206.7,Male,Colon and Rectum,2017
75-79,41.0,45.1,1673,Incidence,3889506,All Races,43.0,Male,Esophagus,2017
75-79,4.1,5.5,184,Incidence,3889506,All Races,4.7,Male,Hodgkin Lymphoma,2017
75-79,0.7,1.4,39,Incidence,3889506,All Races,1.0,Male,Kaposi Sarcoma,2017
75-79,105.3,111.9,4222,Incidence,3889506,All Races,108.5,Male,Kidney and Renal Pelvis,2017
75-79,22.5,25.6,935,Incidence,3889506,All Races,24.0,Male,Larynx,2017
75-79,92.3,98.5,3708,Incidence,3889506,All Races,95.3,Male,Leukemias,2017
75-79,56.3,61.2,2284,Incidence,3889506,All Races,58.7,Male,Liver and Intrahepatic Bile Duct,2017
75-79,455.5,469.0,17978,Incidence,3889506,All Races,462.2,Male,Lung and Bronchus,2017
75-79,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
75-79,159.8,167.8,6369,Incidence,3889506,All Races,163.7,Male,Melanomas of the Skin,2017
75-79,11.4,13.7,487,Incidence,3889506,All Races,12.5,Male,Mesothelioma,2017
75-79,51.1,55.7,2075,Incidence,3889506,All Races,53.3,Male,Myeloma,2017
75-79,124.4,131.5,4974,Incidence,3889506,All Races,127.9,Male,Non-Hodgkin Lymphoma,2017
75-79,66.7,72.0,2697,Incidence,3889506,All Races,69.3,Male,Oral Cavity and Pharynx,2017
75-79,91.8,98.0,3689,Incidence,3889506,All Races,94.8,Male,Pancreas,2017
75-79,582.3,597.6,22946,Incidence,3889506,All Races,589.9,Male,Prostate,2017
75-79,47.5,52.0,1934,Incidence,3889506,All Races,49.7,Male,Stomach,2017
75-79,0.6,1.2,34,Incidence,3889506,All Races,0.9,Male,Testis,2017
75-79,16.4,19.0,687,Incidence,3889506,All Races,17.7,Male,Thyroid,2017
75-79,238.5,248.4,9468,Incidence,3889506,All Races,243.4,Male,Urinary Bladder,2017
80-84,2843.2,2885.2,71726,Incidence,2504286,All Races,2864.1,Male,All Cancer Sites Combined,2017
80-84,26.7,31.0,721,Incidence,2504286,All Races,28.8,Male,Brain and Other Nervous System,2017
80-84,240.2,252.5,6168,Incidence,2504286,All Races,246.3,Male,Colon and Rectum,2017
80-84,44.7,50.1,1185,Incidence,2504286,All Races,47.3,Male,Esophagus,2017
80-84,4.0,5.8,122,Incidence,2504286,All Races,4.9,Male,Hodgkin Lymphoma,2017
80-84,1.0,1.9,35,Incidence,2504286,All Races,1.4,Male,Kaposi Sarcoma,2017
80-84,96.3,104.2,2509,Incidence,2504286,All Races,100.2,Male,Kidney and Renal Pelvis,2017
80-84,25.0,29.1,675,Incidence,2504286,All Races,27.0,Male,Larynx,2017
80-84,115.7,124.4,3005,Incidence,2504286,All Races,120.0,Male,Leukemias,2017
80-84,55.6,61.6,1466,Incidence,2504286,All Races,58.5,Male,Liver and Intrahepatic Bile Duct,2017
80-84,485.7,503.1,12380,Incidence,2504286,All Races,494.4,Male,Lung and Bronchus,2017
80-84,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
80-84,188.1,199.0,4845,Incidence,2504286,All Races,193.5,Male,Melanomas of the Skin,2017
80-84,13.9,17.0,386,Incidence,2504286,All Races,15.4,Male,Mesothelioma,2017
80-84,58.9,65.1,1551,Incidence,2504286,All Races,61.9,Male,Myeloma,2017
80-84,143.6,153.2,3715,Incidence,2504286,All Races,148.3,Male,Non-Hodgkin Lymphoma,2017
80-84,63.7,70.1,1674,Incidence,2504286,All Races,66.8,Male,Oral Cavity and Pharynx,2017
80-84,103.2,111.4,2686,Incidence,2504286,All Races,107.3,Male,Pancreas,2017
80-84,437.1,453.7,11152,Incidence,2504286,All Races,445.3,Male,Prostate,2017
80-84,53.9,59.9,1424,Incidence,2504286,All Races,56.9,Male,Stomach,2017
80-84,0.7,1.5,26,Incidence,2504286,All Races,1.0,Male,Testis,2017
80-84,13.2,16.3,368,Incidence,2504286,All Races,14.7,Male,Thyroid,2017
80-84,306.8,320.7,7855,Incidence,2504286,All Races,313.7,Male,Urinary Bladder,2017
85+,2724.4,2767.4,62806,Incidence,2287279,All Races,2745.9,Male,All Cancer Sites Combined,2017
85+,20.7,24.6,516,Incidence,2287279,All Races,22.6,Male,Brain and Other Nervous System,2017
85+,248.8,261.9,5839,Incidence,2287279,All Races,255.3,Male,Colon and Rectum,2017
85+,37.4,42.6,913,Incidence,2287279,All Races,39.9,Male,Esophagus,2017
85+,3.2,4.8,90,Incidence,2287279,All Races,3.9,Male,Hodgkin Lymphoma,2017
85+,1.3,2.5,42,Incidence,2287279,All Races,1.8,Male,Kaposi Sarcoma,2017
85+,79.9,87.4,1912,Incidence,2287279,All Races,83.6,Male,Kidney and Renal Pelvis,2017
85+,19.5,23.4,489,Incidence,2287279,All Races,21.4,Male,Larynx,2017
85+,124.7,134.1,2958,Incidence,2287279,All Races,129.3,Male,Leukemias,2017
85+,44.7,50.4,1086,Incidence,2287279,All Races,47.5,Male,Liver and Intrahepatic Bile Duct,2017
85+,403.0,419.7,9408,Incidence,2287279,All Races,411.3,Male,Lung and Bronchus,2017
85+,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
85+,198.7,210.5,4679,Incidence,2287279,All Races,204.6,Male,Melanomas of the Skin,2017
85+,15.2,18.6,386,Incidence,2287279,All Races,16.9,Male,Mesothelioma,2017
85+,50.3,56.3,1218,Incidence,2287279,All Races,53.3,Male,Myeloma,2017
85+,135.7,145.5,3215,Incidence,2287279,All Races,140.6,Male,Non-Hodgkin Lymphoma,2017
85+,59.2,65.8,1428,Incidence,2287279,All Races,62.4,Male,Oral Cavity and Pharynx,2017
85+,97.4,105.7,2321,Incidence,2287279,All Races,101.5,Male,Pancreas,2017
85+,357.4,373.1,8353,Incidence,2287279,All Races,365.2,Male,Prostate,2017
85+,52.1,58.2,1260,Incidence,2287279,All Races,55.1,Male,Stomach,2017
85+,0.4,1.2,17,Incidence,2287279,All Races,0.7,Male,Testis,2017
85+,7.5,9.9,197,Incidence,2287279,All Races,8.6,Male,Thyroid,2017
85+,335.2,350.4,7839,Incidence,2287279,All Races,342.7,Male,Urinary Bladder,2017
<1,25.7,30.4,555,Incidence,1985633,All Races,28.0,Male,All Cancer Sites Combined,2017
<1,3.2,5.1,81,Incidence,1985633,All Races,4.1,Male,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Colon and Rectum,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Esophagus,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Kaposi Sarcoma,2017
<1,1.1,2.3,33,Incidence,1985633,All Races,1.7,Male,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Larynx,2017
<1,3.1,4.9,78,Incidence,1985633,All Races,3.9,Male,Leukemias,2017
<1,1.0,2.2,30,Incidence,1985633,All Races,1.5,Male,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Lung and Bronchus,2017
<1,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Melanomas of the Skin,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Mesothelioma,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Myeloma,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Pancreas,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Prostate,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Stomach,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Testis,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Thyroid,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male,Urinary Bladder,2017
1-4,22.1,23.6,3657,Incidence,16012579,All Races,22.8,Male and Female,All Cancer Sites Combined,2017
1-4,4.4,5.1,762,Incidence,16012579,All Races,4.8,Male and Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,Cervix,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Esophagus,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,Female Breast,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Kaposi Sarcoma,2017
1-4,1.7,2.1,305,Incidence,16012579,All Races,1.9,Male and Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Larynx,2017
1-4,8.3,9.2,1400,Incidence,16012579,All Races,8.7,Male and Female,Leukemias,2017
1-4,0.5,0.8,107,Incidence,16012579,All Races,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2017
1-4,0.1,0.2,16,Incidence,16012579,All Races,0.1,Male and Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,Male and Female Breast,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Mesothelioma,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Myeloma,2017
1-4,0.6,0.8,108,Incidence,16012579,All Races,0.7,Male and Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,7825088,All Races,~,Male and Female,Ovary,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Pancreas,2017
1-4,~,~,~,Incidence,8187491,All Races,~,Male and Female,Prostate,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Stomach,2017
1-4,0.2,0.4,21,Incidence,8187491,All Races,0.3,Male and Female,Testis,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Thyroid,2017
1-4,~,~,~,Incidence,16012579,All Races,~,Male and Female,Urinary Bladder,2017
10-14,15.1,16.1,3241,Incidence,20783456,All Races,15.6,Male and Female,All Cancer Sites Combined,2017
10-14,3.0,3.5,677,Incidence,20783456,All Races,3.3,Male and Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Male and Female,Cervix,2017
10-14,0.5,0.7,122,Incidence,20783456,All Races,0.6,Male and Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Male and Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Esophagus,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Male and Female,Female Breast,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2017
10-14,1.1,1.4,259,Incidence,20783456,All Races,1.2,Male and Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Kaposi Sarcoma,2017
10-14,0.1,0.3,43,Incidence,20783456,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Larynx,2017
10-14,3.1,3.6,687,Incidence,20783456,All Races,3.3,Male and Female,Leukemias,2017
10-14,0.0,0.1,17,Incidence,20783456,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Male and Female,Male and Female Breast,2017
10-14,~,~,~,Incidence,10174304,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
10-14,0.1,0.2,36,Incidence,20783456,All Races,0.2,Male and Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Mesothelioma,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Myeloma,2017
10-14,1.2,1.5,271,Incidence,20783456,All Races,1.3,Male and Female,Non-Hodgkin Lymphoma,2017
10-14,0.2,0.4,63,Incidence,20783456,All Races,0.3,Male and Female,Oral Cavity and Pharynx,2017
10-14,0.7,1.1,88,Incidence,10174304,All Races,0.9,Male and Female,Ovary,2017
10-14,0.1,0.1,18,Incidence,20783456,All Races,0.1,Male and Female,Pancreas,2017
10-14,~,~,~,Incidence,10609152,All Races,~,Male and Female,Prostate,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Stomach,2017
10-14,0.2,0.3,25,Incidence,10609152,All Races,0.2,Male and Female,Testis,2017
10-14,0.7,0.9,162,Incidence,20783456,All Races,0.8,Male and Female,Thyroid,2017
10-14,~,~,~,Incidence,20783456,All Races,~,Male and Female,Urinary Bladder,2017
15-19,23.1,24.4,5011,Incidence,21105586,All Races,23.7,Male and Female,All Cancer Sites Combined,2017
15-19,2.3,2.7,531,Incidence,21105586,All Races,2.5,Male and Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Male and Female,Cervix,2017
15-19,1.1,1.4,262,Incidence,21105586,All Races,1.2,Male and Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Male and Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,21105586,All Races,~,Male and Female,Esophagus,2017
15-19,0.1,0.3,21,Incidence,10322453,All Races,0.2,Male and Female,Female Breast,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2017
15-19,2.9,3.4,660,Incidence,21105586,All Races,3.1,Male and Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,21105586,All Races,~,Male and Female,Kaposi Sarcoma,2017
15-19,0.2,0.3,44,Incidence,21105586,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,21105586,All Races,~,Male and Female,Larynx,2017
15-19,2.8,3.3,635,Incidence,21105586,All Races,3.0,Male and Female,Leukemias,2017
15-19,0.1,0.2,33,Incidence,21105586,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
15-19,0.1,0.2,22,Incidence,21105586,All Races,0.1,Male and Female,Lung and Bronchus,2017
15-19,0.1,0.3,21,Incidence,10322453,All Races,0.2,Male and Female,Male and Female Breast,2017
15-19,~,~,~,Incidence,10322453,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
15-19,0.6,0.9,158,Incidence,21105586,All Races,0.7,Male and Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,21105586,All Races,~,Male and Female,Mesothelioma,2017
15-19,~,~,~,Incidence,21105586,All Races,~,Male and Female,Myeloma,2017
15-19,1.8,2.1,408,Incidence,21105586,All Races,1.9,Male and Female,Non-Hodgkin Lymphoma,2017
15-19,0.4,0.5,93,Incidence,21105586,All Races,0.4,Male and Female,Oral Cavity and Pharynx,2017
15-19,1.0,1.4,123,Incidence,10322453,All Races,1.2,Male and Female,Ovary,2017
15-19,0.1,0.2,30,Incidence,21105586,All Races,0.1,Male and Female,Pancreas,2017
15-19,~,~,~,Incidence,10783133,All Races,~,Male and Female,Prostate,2017
15-19,0.0,0.1,17,Incidence,21105586,All Races,0.1,Male and Female,Stomach,2017
15-19,3.0,3.8,365,Incidence,10783133,All Races,3.4,Male and Female,Testis,2017
15-19,2.9,3.3,654,Incidence,21105586,All Races,3.1,Male and Female,Thyroid,2017
15-19,0.1,0.1,20,Incidence,21105586,All Races,0.1,Male and Female,Urinary Bladder,2017
20-24,36.6,38.2,8250,Incidence,22061611,All Races,37.4,Male and Female,All Cancer Sites Combined,2017
20-24,1.9,2.3,460,Incidence,22061611,All Races,2.1,Male and Female,Brain and Other Nervous System,2017
20-24,0.6,0.9,76,Incidence,10747498,All Races,0.7,Male and Female,Cervix,2017
20-24,2.0,2.4,482,Incidence,22061611,All Races,2.2,Male and Female,Colon and Rectum,2017
20-24,0.3,0.6,49,Incidence,10747498,All Races,0.5,Male and Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,22061611,All Races,~,Male and Female,Esophagus,2017
20-24,1.5,2.0,186,Incidence,10747498,All Races,1.7,Male and Female,Female Breast,2017
20-24,0.1,0.3,23,Incidence,10747498,All Races,0.2,Male and Female,"Female Breast, <i>in situ</i>",2017
20-24,4.0,4.6,942,Incidence,22061611,All Races,4.3,Male and Female,Hodgkin Lymphoma,2017
20-24,0.1,0.2,38,Incidence,22061611,All Races,0.2,Male and Female,Kaposi Sarcoma,2017
20-24,0.5,0.7,121,Incidence,22061611,All Races,0.5,Male and Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,22061611,All Races,~,Male and Female,Larynx,2017
20-24,2.5,2.9,596,Incidence,22061611,All Races,2.7,Male and Female,Leukemias,2017
20-24,0.1,0.3,43,Incidence,22061611,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
20-24,0.2,0.4,67,Incidence,22061611,All Races,0.3,Male and Female,Lung and Bronchus,2017
20-24,1.5,2.0,186,Incidence,10747498,All Races,1.7,Male and Female,Male and Female Breast,2017
20-24,0.1,0.3,23,Incidence,10747498,All Races,0.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
20-24,2.3,2.7,550,Incidence,22061611,All Races,2.5,Male and Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,22061611,All Races,~,Male and Female,Mesothelioma,2017
20-24,0.0,0.1,16,Incidence,22061611,All Races,0.1,Male and Female,Myeloma,2017
20-24,2.4,2.8,575,Incidence,22061611,All Races,2.6,Male and Female,Non-Hodgkin Lymphoma,2017
20-24,0.5,0.7,127,Incidence,22061611,All Races,0.6,Male and Female,Oral Cavity and Pharynx,2017
20-24,1.6,2.2,204,Incidence,10747498,All Races,1.9,Male and Female,Ovary,2017
20-24,0.2,0.3,56,Incidence,22061611,All Races,0.3,Male and Female,Pancreas,2017
20-24,~,~,~,Incidence,11314113,All Races,~,Male and Female,Prostate,2017
20-24,0.2,0.3,47,Incidence,22061611,All Races,0.2,Male and Female,Stomach,2017
20-24,10.2,11.4,1223,Incidence,11314113,All Races,10.8,Male and Female,Testis,2017
20-24,6.0,6.7,1393,Incidence,22061611,All Races,6.3,Male and Female,Thyroid,2017
20-24,0.1,0.2,37,Incidence,22061611,All Races,0.2,Male and Female,Urinary Bladder,2017
25-29,59.6,61.6,14157,Incidence,23360795,All Races,60.6,Male and Female,All Cancer Sites Combined,2017
25-29,2.6,3.0,646,Incidence,23360795,All Races,2.8,Male and Female,Brain and Other Nervous System,2017
25-29,4.3,5.2,543,Incidence,11463708,All Races,4.7,Male and Female,Cervix,2017
25-29,3.1,3.6,782,Incidence,23360795,All Races,3.3,Male and Female,Colon and Rectum,2017
25-29,1.9,2.5,253,Incidence,11463708,All Races,2.2,Male and Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,23360795,All Races,~,Male and Female,Esophagus,2017
25-29,9.9,11.1,1206,Incidence,11463708,All Races,10.5,Male and Female,Female Breast,2017
25-29,0.6,1.0,92,Incidence,11463708,All Races,0.8,Male and Female,"Female Breast, <i>in situ</i>",2017
25-29,3.7,4.2,921,Incidence,23360795,All Races,3.9,Male and Female,Hodgkin Lymphoma,2017
25-29,0.4,0.6,113,Incidence,23360795,All Races,0.5,Male and Female,Kaposi Sarcoma,2017
25-29,1.2,1.5,321,Incidence,23360795,All Races,1.4,Male and Female,Kidney and Renal Pelvis,2017
25-29,0.0,0.1,19,Incidence,23360795,All Races,0.1,Male and Female,Larynx,2017
25-29,2.7,3.1,679,Incidence,23360795,All Races,2.9,Male and Female,Leukemias,2017
25-29,0.3,0.4,80,Incidence,23360795,All Races,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
25-29,0.5,0.7,130,Incidence,23360795,All Races,0.6,Male and Female,Lung and Bronchus,2017
25-29,9.9,11.1,1206,Incidence,11463708,All Races,10.5,Male and Female,Male and Female Breast,2017
25-29,0.6,1.0,92,Incidence,11463708,All Races,0.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
25-29,5.2,5.8,1279,Incidence,23360795,All Races,5.5,Male and Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,23360795,All Races,~,Male and Female,Mesothelioma,2017
25-29,0.1,0.2,31,Incidence,23360795,All Races,0.1,Male and Female,Myeloma,2017
25-29,3.0,3.5,765,Incidence,23360795,All Races,3.3,Male and Female,Non-Hodgkin Lymphoma,2017
25-29,1.0,1.3,260,Incidence,23360795,All Races,1.1,Male and Female,Oral Cavity and Pharynx,2017
25-29,2.1,2.7,277,Incidence,11463708,All Races,2.4,Male and Female,Ovary,2017
25-29,0.3,0.4,79,Incidence,23360795,All Races,0.3,Male and Female,Pancreas,2017
25-29,~,~,~,Incidence,11897087,All Races,~,Male and Female,Prostate,2017
25-29,0.4,0.6,107,Incidence,23360795,All Races,0.5,Male and Female,Stomach,2017
25-29,14.3,15.7,1785,Incidence,11897087,All Races,15.0,Male and Female,Testis,2017
25-29,10.0,10.8,2427,Incidence,23360795,All Races,10.4,Male and Female,Thyroid,2017
25-29,0.3,0.4,83,Incidence,23360795,All Races,0.4,Male and Female,Urinary Bladder,2017
30-34,96.9,99.5,21555,Incidence,21959063,All Races,98.2,Male and Female,All Cancer Sites Combined,2017
30-34,3.4,3.9,807,Incidence,21959063,All Races,3.7,Male and Female,Brain and Other Nervous System,2017
30-34,10.9,12.1,1249,Incidence,10877130,All Races,11.5,Male and Female,Cervix,2017
30-34,6.0,6.7,1391,Incidence,21959063,All Races,6.3,Male and Female,Colon and Rectum,2017
30-34,5.2,6.1,611,Incidence,10877130,All Races,5.6,Male and Female,"Corpus and Uterus, NOS",2017
30-34,0.1,0.3,44,Incidence,21959063,All Races,0.2,Male and Female,Esophagus,2017
30-34,29.4,31.5,3309,Incidence,10877130,All Races,30.4,Male and Female,Female Breast,2017
30-34,2.4,3.0,292,Incidence,10877130,All Races,2.7,Male and Female,"Female Breast, <i>in situ</i>",2017
30-34,3.3,3.8,779,Incidence,21959063,All Races,3.5,Male and Female,Hodgkin Lymphoma,2017
30-34,0.5,0.7,121,Incidence,21959063,All Races,0.6,Male and Female,Kaposi Sarcoma,2017
30-34,2.9,3.4,690,Incidence,21959063,All Races,3.1,Male and Female,Kidney and Renal Pelvis,2017
30-34,0.1,0.2,35,Incidence,21959063,All Races,0.2,Male and Female,Larynx,2017
30-34,3.5,4.0,826,Incidence,21959063,All Races,3.8,Male and Female,Leukemias,2017
30-34,0.5,0.7,121,Incidence,21959063,All Races,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
30-34,1.2,1.5,289,Incidence,21959063,All Races,1.3,Male and Female,Lung and Bronchus,2017
30-34,29.4,31.5,3309,Incidence,10877130,All Races,30.4,Male and Female,Male and Female Breast,2017
30-34,2.4,3.0,292,Incidence,10877130,All Races,2.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
30-34,9.2,10.1,2120,Incidence,21959063,All Races,9.7,Male and Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,21959063,All Races,~,Male and Female,Mesothelioma,2017
30-34,0.3,0.5,87,Incidence,21959063,All Races,0.4,Male and Female,Myeloma,2017
30-34,4.4,4.9,1022,Incidence,21959063,All Races,4.7,Male and Female,Non-Hodgkin Lymphoma,2017
30-34,1.5,1.9,376,Incidence,21959063,All Races,1.7,Male and Female,Oral Cavity and Pharynx,2017
30-34,2.7,3.4,327,Incidence,10877130,All Races,3.0,Male and Female,Ovary,2017
30-34,0.7,1.0,182,Incidence,21959063,All Races,0.8,Male and Female,Pancreas,2017
30-34,~,~,~,Incidence,11081933,All Races,~,Male and Female,Prostate,2017
30-34,1.0,1.3,242,Incidence,21959063,All Races,1.1,Male and Female,Stomach,2017
30-34,13.7,15.1,1598,Incidence,11081933,All Races,14.4,Male and Female,Testis,2017
30-34,14.9,15.9,3375,Incidence,21959063,All Races,15.4,Male and Female,Thyroid,2017
30-34,0.6,0.9,161,Incidence,21959063,All Races,0.7,Male and Female,Urinary Bladder,2017
35-39,146.2,149.5,31334,Incidence,21191318,All Races,147.9,Male and Female,All Cancer Sites Combined,2017
35-39,3.8,4.3,862,Incidence,21191318,All Races,4.1,Male and Female,Brain and Other Nervous System,2017
35-39,13.4,14.8,1493,Incidence,10594335,All Races,14.1,Male and Female,Cervix,2017
35-39,11.4,12.3,2512,Incidence,21191318,All Races,11.9,Male and Female,Colon and Rectum,2017
35-39,10.1,11.4,1140,Incidence,10594335,All Races,10.8,Male and Female,"Corpus and Uterus, NOS",2017
35-39,0.3,0.5,92,Incidence,21191318,All Races,0.4,Male and Female,Esophagus,2017
35-39,61.1,64.2,6637,Incidence,10594335,All Races,62.6,Male and Female,Female Breast,2017
35-39,8.6,9.7,968,Incidence,10594335,All Races,9.1,Male and Female,"Female Breast, <i>in situ</i>",2017
35-39,2.6,3.1,601,Incidence,21191318,All Races,2.8,Male and Female,Hodgkin Lymphoma,2017
35-39,0.4,0.6,96,Incidence,21191318,All Races,0.5,Male and Female,Kaposi Sarcoma,2017
35-39,6.1,6.8,1359,Incidence,21191318,All Races,6.4,Male and Female,Kidney and Renal Pelvis,2017
35-39,0.3,0.5,78,Incidence,21191318,All Races,0.4,Male and Female,Larynx,2017
35-39,4.4,5.0,992,Incidence,21191318,All Races,4.7,Male and Female,Leukemias,2017
35-39,0.9,1.1,213,Incidence,21191318,All Races,1.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
35-39,2.4,2.9,563,Incidence,21191318,All Races,2.7,Male and Female,Lung and Bronchus,2017
35-39,61.1,64.2,6637,Incidence,10594335,All Races,62.6,Male and Female,Male and Female Breast,2017
35-39,8.6,9.7,968,Incidence,10594335,All Races,9.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
35-39,12.6,13.6,2781,Incidence,21191318,All Races,13.1,Male and Female,Melanomas of the Skin,2017
35-39,0.0,0.1,17,Incidence,21191318,All Races,0.1,Male and Female,Mesothelioma,2017
35-39,0.9,1.2,230,Incidence,21191318,All Races,1.1,Male and Female,Myeloma,2017
35-39,6.2,6.9,1391,Incidence,21191318,All Races,6.6,Male and Female,Non-Hodgkin Lymphoma,2017
35-39,3.0,3.5,694,Incidence,21191318,All Races,3.3,Male and Female,Oral Cavity and Pharynx,2017
35-39,4.9,5.8,567,Incidence,10594335,All Races,5.4,Male and Female,Ovary,2017
35-39,1.4,1.7,331,Incidence,21191318,All Races,1.6,Male and Female,Pancreas,2017
35-39,0.5,0.8,66,Incidence,10596983,All Races,0.6,Male and Female,Prostate,2017
35-39,1.7,2.1,407,Incidence,21191318,All Races,1.9,Male and Female,Stomach,2017
35-39,11.2,12.5,1254,Incidence,10596983,All Races,11.8,Male and Female,Testis,2017
35-39,18.9,20.1,4134,Incidence,21191318,All Races,19.5,Male and Female,Thyroid,2017
35-39,1.3,1.6,307,Incidence,21191318,All Races,1.4,Male and Female,Urinary Bladder,2017
40-44,229.3,233.6,45303,Incidence,19576587,All Races,231.4,Male and Female,All Cancer Sites Combined,2017
40-44,4.0,4.6,841,Incidence,19576587,All Races,4.3,Male and Female,Brain and Other Nervous System,2017
40-44,14.6,16.2,1515,Incidence,9857600,All Races,15.4,Male and Female,Cervix,2017
40-44,19.8,21.0,3994,Incidence,19576587,All Races,20.4,Male and Female,Colon and Rectum,2017
40-44,16.5,18.2,1710,Incidence,9857600,All Races,17.3,Male and Female,"Corpus and Uterus, NOS",2017
40-44,1.0,1.3,218,Incidence,19576587,All Races,1.1,Male and Female,Esophagus,2017
40-44,125.3,129.8,12570,Incidence,9857600,All Races,127.5,Male and Female,Female Breast,2017
40-44,37.4,39.9,3809,Incidence,9857600,All Races,38.6,Male and Female,"Female Breast, <i>in situ</i>",2017
40-44,2.4,2.9,522,Incidence,19576587,All Races,2.7,Male and Female,Hodgkin Lymphoma,2017
40-44,0.4,0.6,89,Incidence,19576587,All Races,0.5,Male and Female,Kaposi Sarcoma,2017
40-44,11.6,12.5,2359,Incidence,19576587,All Races,12.1,Male and Female,Kidney and Renal Pelvis,2017
40-44,0.7,0.9,153,Incidence,19576587,All Races,0.8,Male and Female,Larynx,2017
40-44,6.1,6.8,1253,Incidence,19576587,All Races,6.4,Male and Female,Leukemias,2017
40-44,1.7,2.1,364,Incidence,19576587,All Races,1.9,Male and Female,Liver and Intrahepatic Bile Duct,2017
40-44,6.4,7.1,1314,Incidence,19576587,All Races,6.7,Male and Female,Lung and Bronchus,2017
40-44,125.3,129.8,12570,Incidence,9857600,All Races,127.5,Male and Female,Male and Female Breast,2017
40-44,37.4,39.9,3809,Incidence,9857600,All Races,38.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
40-44,16.3,17.5,3311,Incidence,19576587,All Races,16.9,Male and Female,Melanomas of the Skin,2017
40-44,0.1,0.2,30,Incidence,19576587,All Races,0.2,Male and Female,Mesothelioma,2017
40-44,2.3,2.7,491,Incidence,19576587,All Races,2.5,Male and Female,Myeloma,2017
40-44,9.0,9.9,1845,Incidence,19576587,All Races,9.4,Male and Female,Non-Hodgkin Lymphoma,2017
40-44,5.5,6.2,1147,Incidence,19576587,All Races,5.9,Male and Female,Oral Cavity and Pharynx,2017
40-44,7.3,8.4,775,Incidence,9857600,All Races,7.9,Male and Female,Ovary,2017
40-44,2.8,3.3,600,Incidence,19576587,All Races,3.1,Male and Female,Pancreas,2017
40-44,5.4,6.3,567,Incidence,9718987,All Races,5.8,Male and Female,Prostate,2017
40-44,3.2,3.7,672,Incidence,19576587,All Races,3.4,Male and Female,Stomach,2017
40-44,8.0,9.2,837,Incidence,9718987,All Races,8.6,Male and Female,Testis,2017
40-44,21.0,22.3,4233,Incidence,19576587,All Races,21.6,Male and Female,Thyroid,2017
40-44,2.6,3.1,554,Incidence,19576587,All Races,2.8,Male and Female,Urinary Bladder,2017
45-49,359.5,364.7,75661,Incidence,20897300,All Races,362.1,Male and Female,All Cancer Sites Combined,2017
45-49,5.3,6.0,1182,Incidence,20897300,All Races,5.7,Male and Female,Brain and Other Nervous System,2017
45-49,13.0,14.4,1446,Incidence,10547318,All Races,13.7,Male and Female,Cervix,2017
45-49,35.0,36.7,7492,Incidence,20897300,All Races,35.9,Male and Female,Colon and Rectum,2017
45-49,25.1,27.1,2752,Incidence,10547318,All Races,26.1,Male and Female,"Corpus and Uterus, NOS",2017
45-49,2.2,2.6,502,Incidence,20897300,All Races,2.4,Male and Female,Esophagus,2017
45-49,193.2,198.6,20663,Incidence,10547318,All Races,195.9,Male and Female,Female Breast,2017
45-49,55.3,58.1,5979,Incidence,10547318,All Races,56.7,Male and Female,"Female Breast, <i>in situ</i>",2017
45-49,2.3,2.8,534,Incidence,20897300,All Races,2.6,Male and Female,Hodgkin Lymphoma,2017
45-49,0.4,0.6,100,Incidence,20897300,All Races,0.5,Male and Female,Kaposi Sarcoma,2017
45-49,18.2,19.4,3931,Incidence,20897300,All Races,18.8,Male and Female,Kidney and Renal Pelvis,2017
45-49,1.9,2.3,444,Incidence,20897300,All Races,2.1,Male and Female,Larynx,2017
45-49,8.5,9.3,1867,Incidence,20897300,All Races,8.9,Male and Female,Leukemias,2017
45-49,3.6,4.2,813,Incidence,20897300,All Races,3.9,Male and Female,Liver and Intrahepatic Bile Duct,2017
45-49,16.4,17.5,3547,Incidence,20897300,All Races,17.0,Male and Female,Lung and Bronchus,2017
45-49,193.2,198.6,20663,Incidence,10547318,All Races,195.9,Male and Female,Male and Female Breast,2017
45-49,55.3,58.1,5979,Incidence,10547318,All Races,56.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
45-49,22.6,23.9,4848,Incidence,20897300,All Races,23.2,Male and Female,Melanomas of the Skin,2017
45-49,0.2,0.3,52,Incidence,20897300,All Races,0.2,Male and Female,Mesothelioma,2017
45-49,4.5,5.1,1006,Incidence,20897300,All Races,4.8,Male and Female,Myeloma,2017
45-49,13.9,14.9,3012,Incidence,20897300,All Races,14.4,Male and Female,Non-Hodgkin Lymphoma,2017
45-49,11.7,12.7,2553,Incidence,20897300,All Races,12.2,Male and Female,Oral Cavity and Pharynx,2017
45-49,12.0,13.3,1333,Incidence,10547318,All Races,12.6,Male and Female,Ovary,2017
45-49,6.1,6.8,1356,Incidence,20897300,All Races,6.5,Male and Female,Pancreas,2017
45-49,28.6,30.7,3069,Incidence,10349982,All Races,29.7,Male and Female,Prostate,2017
45-49,4.8,5.5,1074,Incidence,20897300,All Races,5.1,Male and Female,Stomach,2017
45-49,5.8,6.8,650,Incidence,10349982,All Races,6.3,Male and Female,Testis,2017
45-49,21.8,23.1,4683,Incidence,20897300,All Races,22.4,Male and Female,Thyroid,2017
45-49,5.9,6.5,1295,Incidence,20897300,All Races,6.2,Male and Female,Urinary Bladder,2017
5-9,12.6,13.6,2670,Incidence,20330306,All Races,13.1,Male and Female,All Cancer Sites Combined,2017
5-9,3.5,4.1,770,Incidence,20330306,All Races,3.8,Male and Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Male and Female,Cervix,2017
5-9,0.1,0.2,20,Incidence,20330306,All Races,0.1,Male and Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Male and Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Esophagus,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Male and Female,Female Breast,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2017
5-9,0.3,0.5,79,Incidence,20330306,All Races,0.4,Male and Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Kaposi Sarcoma,2017
5-9,0.5,0.8,130,Incidence,20330306,All Races,0.6,Male and Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Larynx,2017
5-9,3.6,4.2,787,Incidence,20330306,All Races,3.9,Male and Female,Leukemias,2017
5-9,0.1,0.2,25,Incidence,20330306,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Male and Female,Male and Female Breast,2017
5-9,~,~,~,Incidence,9948106,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
5-9,0.1,0.2,22,Incidence,20330306,All Races,0.1,Male and Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Mesothelioma,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Myeloma,2017
5-9,1.0,1.2,222,Incidence,20330306,All Races,1.1,Male and Female,Non-Hodgkin Lymphoma,2017
5-9,0.1,0.1,18,Incidence,20330306,All Races,0.1,Male and Female,Oral Cavity and Pharynx,2017
5-9,0.2,0.4,25,Incidence,9948106,All Races,0.3,Male and Female,Ovary,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Pancreas,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male and Female,Prostate,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Stomach,2017
5-9,~,~,~,Incidence,10382200,All Races,~,Male and Female,Testis,2017
5-9,0.1,0.2,29,Incidence,20330306,All Races,0.1,Male and Female,Thyroid,2017
5-9,~,~,~,Incidence,20330306,All Races,~,Male and Female,Urinary Bladder,2017
50-54,571.3,577.8,122545,Incidence,21329749,All Races,574.5,Male and Female,All Cancer Sites Combined,2017
50-54,7.1,7.8,1584,Incidence,21329749,All Races,7.4,Male and Female,Brain and Other Nervous System,2017
50-54,12.4,13.7,1413,Incidence,10844299,All Races,13.0,Male and Female,Cervix,2017
50-54,61.5,63.6,13345,Incidence,21329749,All Races,62.6,Male and Female,Colon and Rectum,2017
50-54,47.5,50.2,5296,Incidence,10844299,All Races,48.8,Male and Female,"Corpus and Uterus, NOS",2017
50-54,4.8,5.4,1079,Incidence,21329749,All Races,5.1,Male and Female,Esophagus,2017
50-54,231.6,237.4,25430,Incidence,10844299,All Races,234.5,Male and Female,Female Breast,2017
50-54,65.5,68.6,7266,Incidence,10844299,All Races,67.0,Male and Female,"Female Breast, <i>in situ</i>",2017
50-54,2.2,2.6,509,Incidence,21329749,All Races,2.4,Male and Female,Hodgkin Lymphoma,2017
50-54,0.4,0.5,95,Incidence,21329749,All Races,0.4,Male and Female,Kaposi Sarcoma,2017
50-54,26.2,27.6,5732,Incidence,21329749,All Races,26.9,Male and Female,Kidney and Renal Pelvis,2017
50-54,4.7,5.3,1068,Incidence,21329749,All Races,5.0,Male and Female,Larynx,2017
50-54,13.0,14.0,2887,Incidence,21329749,All Races,13.5,Male and Female,Leukemias,2017
50-54,9.6,10.5,2137,Incidence,21329749,All Races,10.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
50-54,44.5,46.3,9679,Incidence,21329749,All Races,45.4,Male and Female,Lung and Bronchus,2017
50-54,231.6,237.4,25430,Incidence,10844299,All Races,234.5,Male and Female,Male and Female Breast,2017
50-54,65.5,68.6,7266,Incidence,10844299,All Races,67.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
50-54,29.7,31.2,6489,Incidence,21329749,All Races,30.4,Male and Female,Melanomas of the Skin,2017
50-54,0.4,0.5,94,Incidence,21329749,All Races,0.4,Male and Female,Mesothelioma,2017
50-54,7.4,8.2,1661,Incidence,21329749,All Races,7.8,Male and Female,Myeloma,2017
50-54,20.8,22.0,4559,Incidence,21329749,All Races,21.4,Male and Female,Non-Hodgkin Lymphoma,2017
50-54,21.2,22.4,4652,Incidence,21329749,All Races,21.8,Male and Female,Oral Cavity and Pharynx,2017
50-54,17.4,19.0,1968,Incidence,10844299,All Races,18.1,Male and Female,Ovary,2017
50-54,11.7,12.6,2595,Incidence,21329749,All Races,12.2,Male and Female,Pancreas,2017
50-54,112.4,116.5,12000,Incidence,10485450,All Races,114.4,Male and Female,Prostate,2017
50-54,7.1,7.9,1597,Incidence,21329749,All Races,7.5,Male and Female,Stomach,2017
50-54,3.7,4.5,428,Incidence,10485450,All Races,4.1,Male and Female,Testis,2017
50-54,22.5,23.8,4940,Incidence,21329749,All Races,23.2,Male and Female,Thyroid,2017
50-54,12.4,13.4,2753,Incidence,21329749,All Races,12.9,Male and Female,Urinary Bladder,2017
55-59,853.6,861.4,188178,Incidence,21945659,All Races,857.5,Male and Female,All Cancer Sites Combined,2017
55-59,9.8,10.6,2233,Incidence,21945659,All Races,10.2,Male and Female,Brain and Other Nervous System,2017
55-59,11.8,13.1,1403,Incidence,11274831,All Races,12.4,Male and Female,Cervix,2017
55-59,68.3,70.5,15222,Incidence,21945659,All Races,69.4,Male and Female,Colon and Rectum,2017
55-59,76.2,79.5,8773,Incidence,11274831,All Races,77.8,Male and Female,"Corpus and Uterus, NOS",2017
55-59,9.1,9.9,2084,Incidence,21945659,All Races,9.5,Male and Female,Esophagus,2017
55-59,267.3,273.3,30474,Incidence,11274831,All Races,270.3,Male and Female,Female Breast,2017
55-59,66.4,69.4,7656,Incidence,11274831,All Races,67.9,Male and Female,"Female Breast, <i>in situ</i>",2017
55-59,2.3,2.8,560,Incidence,21945659,All Races,2.6,Male and Female,Hodgkin Lymphoma,2017
55-59,0.3,0.4,72,Incidence,21945659,All Races,0.3,Male and Female,Kaposi Sarcoma,2017
55-59,36.0,37.6,8074,Incidence,21945659,All Races,36.8,Male and Female,Kidney and Renal Pelvis,2017
55-59,8.2,9.0,1882,Incidence,21945659,All Races,8.6,Male and Female,Larynx,2017
55-59,19.1,20.2,4313,Incidence,21945659,All Races,19.7,Male and Female,Leukemias,2017
55-59,22.1,23.4,4986,Incidence,21945659,All Races,22.7,Male and Female,Liver and Intrahepatic Bile Duct,2017
55-59,97.0,99.6,21570,Incidence,21945659,All Races,98.3,Male and Female,Lung and Bronchus,2017
55-59,267.3,273.3,30474,Incidence,11274831,All Races,270.3,Male and Female,Male and Female Breast,2017
55-59,66.4,69.4,7656,Incidence,11274831,All Races,67.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
55-59,40.1,41.8,8987,Incidence,21945659,All Races,41.0,Male and Female,Melanomas of the Skin,2017
55-59,0.6,0.9,161,Incidence,21945659,All Races,0.7,Male and Female,Mesothelioma,2017
55-59,12.0,12.9,2736,Incidence,21945659,All Races,12.5,Male and Female,Myeloma,2017
55-59,30.1,31.6,6762,Incidence,21945659,All Races,30.8,Male and Female,Non-Hodgkin Lymphoma,2017
55-59,31.7,33.3,7130,Incidence,21945659,All Races,32.5,Male and Female,Oral Cavity and Pharynx,2017
55-59,21.5,23.2,2516,Incidence,11274831,All Races,22.3,Male and Female,Ovary,2017
55-59,21.3,22.6,4814,Incidence,21945659,All Races,21.9,Male and Female,Pancreas,2017
55-59,252.8,258.9,27302,Incidence,10670828,All Races,255.9,Male and Female,Prostate,2017
55-59,11.0,11.9,2506,Incidence,21945659,All Races,11.4,Male and Female,Stomach,2017
55-59,2.8,3.5,336,Incidence,10670828,All Races,3.1,Male and Female,Testis,2017
55-59,23.5,24.8,5290,Incidence,21945659,All Races,24.1,Male and Female,Thyroid,2017
55-59,23.9,25.2,5388,Incidence,21945659,All Races,24.6,Male and Female,Urinary Bladder,2017
60-64,1200.3,1210.0,240165,Incidence,19928043,All Races,1205.2,Male and Female,All Cancer Sites Combined,2017
60-64,12.8,13.8,2653,Incidence,19928043,All Races,13.3,Male and Female,Brain and Other Nervous System,2017
60-64,11.1,12.4,1224,Incidence,10398926,All Races,11.8,Male and Female,Cervix,2017
60-64,86.3,88.9,17460,Incidence,19928043,All Races,87.6,Male and Female,Colon and Rectum,2017
60-64,101.0,104.9,10702,Incidence,10398926,All Races,102.9,Male and Female,"Corpus and Uterus, NOS",2017
60-64,13.7,14.8,2836,Incidence,19928043,All Races,14.2,Male and Female,Esophagus,2017
60-64,332.0,339.0,34887,Incidence,10398926,All Races,335.5,Male and Female,Female Breast,2017
60-64,79.0,82.5,8393,Incidence,10398926,All Races,80.7,Male and Female,"Female Breast, <i>in situ</i>",2017
60-64,2.5,2.9,536,Incidence,19928043,All Races,2.7,Male and Female,Hodgkin Lymphoma,2017
60-64,0.2,0.4,64,Incidence,19928043,All Races,0.3,Male and Female,Kaposi Sarcoma,2017
60-64,47.4,49.3,9639,Incidence,19928043,All Races,48.4,Male and Female,Kidney and Renal Pelvis,2017
60-64,11.2,12.2,2332,Incidence,19928043,All Races,11.7,Male and Female,Larynx,2017
60-64,28.0,29.5,5730,Incidence,19928043,All Races,28.8,Male and Female,Leukemias,2017
60-64,35.1,36.8,7156,Incidence,19928043,All Races,35.9,Male and Female,Liver and Intrahepatic Bile Duct,2017
60-64,151.2,154.6,30464,Incidence,19928043,All Races,152.9,Male and Female,Lung and Bronchus,2017
60-64,332.0,339.0,34887,Incidence,10398926,All Races,335.5,Male and Female,Male and Female Breast,2017
60-64,79.0,82.5,8393,Incidence,10398926,All Races,80.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
60-64,51.9,53.9,10546,Incidence,19928043,All Races,52.9,Male and Female,Melanomas of the Skin,2017
60-64,1.1,1.4,243,Incidence,19928043,All Races,1.2,Male and Female,Mesothelioma,2017
60-64,17.7,18.9,3652,Incidence,19928043,All Races,18.3,Male and Female,Myeloma,2017
60-64,41.4,43.2,8427,Incidence,19928043,All Races,42.3,Male and Female,Non-Hodgkin Lymphoma,2017
60-64,38.7,40.4,7882,Incidence,19928043,All Races,39.6,Male and Female,Oral Cavity and Pharynx,2017
60-64,25.3,27.2,2728,Incidence,10398926,All Races,26.2,Male and Female,Ovary,2017
60-64,33.0,34.6,6731,Incidence,19928043,All Races,33.8,Male and Female,Pancreas,2017
60-64,431.1,439.5,41477,Incidence,9529117,All Races,435.3,Male and Female,Prostate,2017
60-64,14.9,16.0,3083,Incidence,19928043,All Races,15.5,Male and Female,Stomach,2017
60-64,2.0,2.6,215,Incidence,9529117,All Races,2.3,Male and Female,Testis,2017
60-64,22.5,23.8,4609,Incidence,19928043,All Races,23.1,Male and Female,Thyroid,2017
60-64,42.0,43.8,8544,Incidence,19928043,All Races,42.9,Male and Female,Urinary Bladder,2017
65-69,1652.0,1664.4,278470,Incidence,16793596,All Races,1658.2,Male and Female,All Cancer Sites Combined,2017
65-69,15.2,16.4,2658,Incidence,16793596,All Races,15.8,Male and Female,Brain and Other Nervous System,2017
65-69,10.1,11.5,960,Incidence,8884407,All Races,10.8,Male and Female,Cervix,2017
65-69,116.2,119.5,19789,Incidence,16793596,All Races,117.8,Male and Female,Colon and Rectum,2017
65-69,113.3,117.8,10264,Incidence,8884407,All Races,115.5,Male and Female,"Corpus and Uterus, NOS",2017
65-69,18.1,19.4,3147,Incidence,16793596,All Races,18.7,Male and Female,Esophagus,2017
65-69,426.7,435.3,38291,Incidence,8884407,All Races,431.0,Male and Female,Female Breast,2017
65-69,97.2,101.3,8816,Incidence,8884407,All Races,99.2,Male and Female,"Female Breast, <i>in situ</i>",2017
65-69,3.0,3.6,557,Incidence,16793596,All Races,3.3,Male and Female,Hodgkin Lymphoma,2017
65-69,0.2,0.4,55,Incidence,16793596,All Races,0.3,Male and Female,Kaposi Sarcoma,2017
65-69,63.5,66.0,10871,Incidence,16793596,All Races,64.7,Male and Female,Kidney and Renal Pelvis,2017
65-69,12.1,13.2,2129,Incidence,16793596,All Races,12.7,Male and Female,Larynx,2017
65-69,39.2,41.1,6740,Incidence,16793596,All Races,40.1,Male and Female,Leukemias,2017
65-69,40.7,42.7,7000,Incidence,16793596,All Races,41.7,Male and Female,Liver and Intrahepatic Bile Duct,2017
65-69,227.6,232.2,38607,Incidence,16793596,All Races,229.9,Male and Female,Lung and Bronchus,2017
65-69,426.7,435.3,38291,Incidence,8884407,All Races,431.0,Male and Female,Male and Female Breast,2017
65-69,97.2,101.3,8816,Incidence,8884407,All Races,99.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
65-69,70.7,73.2,12080,Incidence,16793596,All Races,71.9,Male and Female,Melanomas of the Skin,2017
65-69,2.1,2.6,396,Incidence,16793596,All Races,2.4,Male and Female,Mesothelioma,2017
65-69,26.7,28.3,4617,Incidence,16793596,All Races,27.5,Male and Female,Myeloma,2017
65-69,59.9,62.3,10256,Incidence,16793596,All Races,61.1,Male and Female,Non-Hodgkin Lymphoma,2017
65-69,43.4,45.4,7455,Incidence,16793596,All Races,44.4,Male and Female,Oral Cavity and Pharynx,2017
65-69,30.5,32.9,2816,Incidence,8884407,All Races,31.7,Male and Female,Ovary,2017
65-69,48.8,50.9,8366,Incidence,16793596,All Races,49.8,Male and Female,Pancreas,2017
65-69,651.4,662.7,51965,Incidence,7909189,All Races,657.0,Male and Female,Prostate,2017
65-69,20.8,22.2,3613,Incidence,16793596,All Races,21.5,Male and Female,Stomach,2017
65-69,1.1,1.6,106,Incidence,7909189,All Races,1.3,Male and Female,Testis,2017
65-69,23.9,25.5,4147,Incidence,16793596,All Races,24.7,Male and Female,Thyroid,2017
65-69,69.8,72.4,11942,Incidence,16793596,All Races,71.1,Male and Female,Urinary Bladder,2017
70-74,1968.3,1983.7,253178,Incidence,12812638,All Races,1976.0,Male and Female,All Cancer Sites Combined,2017
70-74,18.4,20.0,2459,Incidence,12812638,All Races,19.2,Male and Female,Brain and Other Nervous System,2017
70-74,9.6,11.2,713,Incidence,6881542,All Races,10.4,Male and Female,Cervix,2017
70-74,137.1,141.2,17825,Incidence,12812638,All Races,139.1,Male and Female,Colon and Rectum,2017
70-74,107.6,112.6,7574,Incidence,6881542,All Races,110.1,Male and Female,"Corpus and Uterus, NOS",2017
70-74,22.3,24.0,2963,Incidence,12812638,All Races,23.1,Male and Female,Esophagus,2017
70-74,468.5,478.8,32590,Incidence,6881542,All Races,473.6,Male and Female,Female Breast,2017
70-74,98.0,102.8,6908,Incidence,6881542,All Races,100.4,Male and Female,"Female Breast, <i>in situ</i>",2017
70-74,3.6,4.3,507,Incidence,12812638,All Races,4.0,Male and Female,Hodgkin Lymphoma,2017
70-74,0.3,0.6,58,Incidence,12812638,All Races,0.5,Male and Female,Kaposi Sarcoma,2017
70-74,71.5,74.4,9347,Incidence,12812638,All Races,73.0,Male and Female,Kidney and Renal Pelvis,2017
70-74,13.7,15.1,1843,Incidence,12812638,All Races,14.4,Male and Female,Larynx,2017
70-74,54.4,57.0,7135,Incidence,12812638,All Races,55.7,Male and Female,Leukemias,2017
70-74,36.4,38.5,4800,Incidence,12812638,All Races,37.5,Male and Female,Liver and Intrahepatic Bile Duct,2017
70-74,326.0,332.3,42170,Incidence,12812638,All Races,329.1,Male and Female,Lung and Bronchus,2017
70-74,468.5,478.8,32590,Incidence,6881542,All Races,473.6,Male and Female,Male and Female Breast,2017
70-74,98.0,102.8,6908,Incidence,6881542,All Races,100.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
70-74,86.0,89.2,11223,Incidence,12812638,All Races,87.6,Male and Female,Melanomas of the Skin,2017
70-74,4.2,4.9,579,Incidence,12812638,All Races,4.5,Male and Female,Mesothelioma,2017
70-74,33.7,35.7,4442,Incidence,12812638,All Races,34.7,Male and Female,Myeloma,2017
70-74,80.6,83.7,10521,Incidence,12812638,All Races,82.1,Male and Female,Non-Hodgkin Lymphoma,2017
70-74,43.8,46.1,5755,Incidence,12812638,All Races,44.9,Male and Female,Oral Cavity and Pharynx,2017
70-74,34.3,37.1,2457,Incidence,6881542,All Races,35.7,Male and Female,Ovary,2017
70-74,63.7,66.5,8338,Incidence,12812638,All Races,65.1,Male and Female,Pancreas,2017
70-74,665.3,678.5,39847,Incidence,5931096,All Races,671.8,Male and Female,Prostate,2017
70-74,26.9,28.7,3563,Incidence,12812638,All Races,27.8,Male and Female,Stomach,2017
70-74,0.8,1.4,64,Incidence,5931096,All Races,1.1,Male and Female,Testis,2017
70-74,21.7,23.4,2890,Incidence,12812638,All Races,22.6,Male and Female,Thyroid,2017
70-74,102.6,106.1,13372,Incidence,12812638,All Races,104.4,Male and Female,Urinary Bladder,2017
75-79,2214.9,2234.8,194065,Incidence,8722692,All Races,2224.8,Male and Female,All Cancer Sites Combined,2017
75-79,20.1,22.1,1838,Incidence,8722692,All Races,21.1,Male and Female,Brain and Other Nervous System,2017
75-79,9.0,10.8,479,Incidence,4833186,All Races,9.9,Male and Female,Cervix,2017
75-79,175.5,181.1,15553,Incidence,8722692,All Races,178.3,Male and Female,Colon and Rectum,2017
75-79,90.0,95.5,4482,Incidence,4833186,All Races,92.7,Male and Female,"Corpus and Uterus, NOS",2017
75-79,23.7,25.8,2156,Incidence,8722692,All Races,24.7,Male and Female,Esophagus,2017
75-79,452.0,464.1,22137,Incidence,4833186,All Races,458.0,Male and Female,Female Breast,2017
75-79,80.0,85.2,3990,Incidence,4833186,All Races,82.6,Male and Female,"Female Breast, <i>in situ</i>",2017
75-79,3.4,4.3,335,Incidence,8722692,All Races,3.8,Male and Female,Hodgkin Lymphoma,2017
75-79,0.5,0.8,54,Incidence,8722692,All Races,0.6,Male and Female,Kaposi Sarcoma,2017
75-79,76.1,79.8,6800,Incidence,8722692,All Races,78.0,Male and Female,Kidney and Renal Pelvis,2017
75-79,12.4,13.9,1146,Incidence,8722692,All Races,13.1,Male and Female,Larynx,2017
75-79,70.7,74.2,6318,Incidence,8722692,All Races,72.4,Male and Female,Leukemias,2017
75-79,39.8,42.5,3590,Incidence,8722692,All Races,41.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
75-79,399.3,407.7,35194,Incidence,8722692,All Races,403.5,Male and Female,Lung and Bronchus,2017
75-79,452.0,464.1,22137,Incidence,4833186,All Races,458.0,Male and Female,Male and Female Breast,2017
75-79,80.0,85.2,3990,Incidence,4833186,All Races,82.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
75-79,102.7,107.0,9145,Incidence,8722692,All Races,104.8,Male and Female,Melanomas of the Skin,2017
75-79,6.5,7.6,611,Incidence,8722692,All Races,7.0,Male and Female,Mesothelioma,2017
75-79,41.3,44.0,3717,Incidence,8722692,All Races,42.6,Male and Female,Myeloma,2017
75-79,101.4,105.7,9032,Incidence,8722692,All Races,103.5,Male and Female,Non-Hodgkin Lymphoma,2017
75-79,44.5,47.4,4005,Incidence,8722692,All Races,45.9,Male and Female,Oral Cavity and Pharynx,2017
75-79,38.4,42.0,1943,Incidence,4833186,All Races,40.2,Male and Female,Ovary,2017
75-79,81.8,85.6,7301,Incidence,8722692,All Races,83.7,Male and Female,Pancreas,2017
75-79,582.3,597.6,22946,Incidence,3889506,All Races,589.9,Male and Female,Prostate,2017
75-79,33.4,35.9,3018,Incidence,8722692,All Races,34.6,Male and Female,Stomach,2017
75-79,0.6,1.2,34,Incidence,3889506,All Races,0.9,Male and Female,Testis,2017
75-79,19.7,21.7,1804,Incidence,8722692,All Races,20.7,Male and Female,Thyroid,2017
75-79,137.5,142.5,12207,Incidence,8722692,All Races,139.9,Male and Female,Urinary Bladder,2017
80-84,2296.8,2321.2,137609,Incidence,5959787,All Races,2309.0,Male and Female,All Cancer Sites Combined,2017
80-84,21.0,23.4,1319,Incidence,5959787,All Races,22.1,Male and Female,Brain and Other Nervous System,2017
80-84,8.2,10.2,317,Incidence,3455501,All Races,9.2,Male and Female,Cervix,2017
80-84,214.3,221.8,12994,Incidence,5959787,All Races,218.0,Male and Female,Colon and Rectum,2017
80-84,73.5,79.3,2639,Incidence,3455501,All Races,76.4,Male and Female,"Corpus and Uterus, NOS",2017
80-84,25.3,28.0,1586,Incidence,5959787,All Races,26.6,Male and Female,Esophagus,2017
80-84,398.9,412.4,14015,Incidence,3455501,All Races,405.6,Male and Female,Female Breast,2017
80-84,51.6,56.5,1867,Incidence,3455501,All Races,54.0,Male and Female,"Female Breast, <i>in situ</i>",2017
80-84,3.5,4.5,236,Incidence,5959787,All Races,4.0,Male and Female,Hodgkin Lymphoma,2017
80-84,0.7,1.2,55,Incidence,5959787,All Races,0.9,Male and Female,Kaposi Sarcoma,2017
80-84,69.5,73.8,4267,Incidence,5959787,All Races,71.6,Male and Female,Kidney and Renal Pelvis,2017
80-84,12.8,14.6,815,Incidence,5959787,All Races,13.7,Male and Female,Larynx,2017
80-84,83.4,88.1,5111,Incidence,5959787,All Races,85.8,Male and Female,Leukemias,2017
80-84,38.8,42.0,2406,Incidence,5959787,All Races,40.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
80-84,403.7,414.0,24363,Incidence,5959787,All Races,408.8,Male and Female,Lung and Bronchus,2017
80-84,398.9,412.4,14015,Incidence,3455501,All Races,405.6,Male and Female,Male and Female Breast,2017
80-84,51.6,56.5,1867,Incidence,3455501,All Races,54.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
80-84,115.5,121.1,7050,Incidence,5959787,All Races,118.3,Male and Female,Melanomas of the Skin,2017
80-84,7.8,9.3,508,Incidence,5959787,All Races,8.5,Male and Female,Mesothelioma,2017
80-84,47.2,50.8,2918,Incidence,5959787,All Races,49.0,Male and Female,Myeloma,2017
80-84,113.8,119.3,6946,Incidence,5959787,All Races,116.5,Male and Female,Non-Hodgkin Lymphoma,2017
80-84,43.0,46.4,2663,Incidence,5959787,All Races,44.7,Male and Female,Oral Cavity and Pharynx,2017
80-84,40.3,44.6,1465,Incidence,3455501,All Races,42.4,Male and Female,Ovary,2017
80-84,92.1,97.1,5636,Incidence,5959787,All Races,94.6,Male and Female,Pancreas,2017
80-84,437.1,453.7,11152,Incidence,2504286,All Races,445.3,Male and Female,Prostate,2017
80-84,38.7,42.0,2404,Incidence,5959787,All Races,40.3,Male and Female,Stomach,2017
80-84,0.7,1.5,26,Incidence,2504286,All Races,1.0,Male and Female,Testis,2017
80-84,14.6,16.6,928,Incidence,5959787,All Races,15.6,Male and Female,Thyroid,2017
80-84,167.8,174.5,10199,Incidence,5959787,All Races,171.1,Male and Female,Urinary Bladder,2017
85+,2066.7,2088.9,134410,Incidence,6468926,All Races,2077.8,Male and Female,All Cancer Sites Combined,2017
85+,16.8,18.9,1151,Incidence,6468926,All Races,17.8,Male and Female,Brain and Other Nervous System,2017
85+,7.0,8.7,327,Incidence,4181647,All Races,7.8,Male and Female,Cervix,2017
85+,232.6,240.1,15288,Incidence,6468926,All Races,236.3,Male and Female,Colon and Rectum,2017
85+,47.8,52.1,2089,Incidence,4181647,All Races,50.0,Male and Female,"Corpus and Uterus, NOS",2017
85+,20.5,22.7,1396,Incidence,6468926,All Races,21.6,Male and Female,Esophagus,2017
85+,308.6,319.3,13127,Incidence,4181647,All Races,313.9,Male and Female,Female Breast,2017
85+,21.5,24.4,959,Incidence,4181647,All Races,22.9,Male and Female,"Female Breast, <i>in situ</i>",2017
85+,2.3,3.1,173,Incidence,6468926,All Races,2.7,Male and Female,Hodgkin Lymphoma,2017
85+,0.7,1.1,57,Incidence,6468926,All Races,0.9,Male and Female,Kaposi Sarcoma,2017
85+,54.5,58.2,3643,Incidence,6468926,All Races,56.3,Male and Female,Kidney and Renal Pelvis,2017
85+,8.4,9.9,593,Incidence,6468926,All Races,9.2,Male and Female,Larynx,2017
85+,85.4,90.0,5672,Incidence,6468926,All Races,87.7,Male and Female,Leukemias,2017
85+,31.9,34.7,2155,Incidence,6468926,All Races,33.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
85+,299.5,308.0,19650,Incidence,6468926,All Races,303.8,Male and Female,Lung and Bronchus,2017
85+,308.6,319.3,13127,Incidence,4181647,All Races,313.9,Male and Female,Male and Female Breast,2017
85+,21.5,24.4,959,Incidence,4181647,All Races,22.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
85+,109.4,114.6,7245,Incidence,6468926,All Races,112.0,Male and Female,Melanomas of the Skin,2017
85+,7.1,8.4,499,Incidence,6468926,All Races,7.7,Male and Female,Mesothelioma,2017
85+,37.0,40.1,2492,Incidence,6468926,All Races,38.5,Male and Female,Myeloma,2017
85+,100.1,105.0,6633,Incidence,6468926,All Races,102.5,Male and Female,Non-Hodgkin Lymphoma,2017
85+,39.6,42.8,2665,Incidence,6468926,All Races,41.2,Male and Female,Oral Cavity and Pharynx,2017
85+,34.8,38.5,1531,Incidence,4181647,All Races,36.6,Male and Female,Ovary,2017
85+,92.9,97.7,6162,Incidence,6468926,All Races,95.3,Male and Female,Pancreas,2017
85+,357.4,373.1,8353,Incidence,2287279,All Races,365.2,Male and Female,Prostate,2017
85+,36.1,39.2,2434,Incidence,6468926,All Races,37.6,Male and Female,Stomach,2017
85+,0.4,1.2,17,Incidence,2287279,All Races,0.7,Male and Female,Testis,2017
85+,8.2,9.7,578,Incidence,6468926,All Races,8.9,Male and Female,Thyroid,2017
85+,164.7,171.0,10856,Incidence,6468926,All Races,167.8,Male and Female,Urinary Bladder,2017
<1,24.9,28.2,1029,Incidence,3882437,All Races,26.5,Male and Female,All Cancer Sites Combined,2017
<1,3.2,4.4,146,Incidence,3882437,All Races,3.8,Male and Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,Cervix,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Colon and Rectum,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Esophagus,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,Female Breast,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Kaposi Sarcoma,2017
<1,1.2,2.0,62,Incidence,3882437,All Races,1.6,Male and Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Larynx,2017
<1,3.6,4.9,162,Incidence,3882437,All Races,4.2,Male and Female,Leukemias,2017
<1,1.0,1.7,50,Incidence,3882437,All Races,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,Male and Female Breast,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Mesothelioma,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Myeloma,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,1896804,All Races,~,Male and Female,Ovary,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Pancreas,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male and Female,Prostate,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Stomach,2017
<1,~,~,~,Incidence,1985633,All Races,~,Male and Female,Testis,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Thyroid,2017
<1,~,~,~,Incidence,3882437,All Races,~,Male and Female,Urinary Bladder,2017
1-4,18.4,22.4,405,Incidence,1988966,Hispanic of any race,20.4,Female,All Cancer Sites Combined,2017
1-4,2.8,4.5,71,Incidence,1988966,Hispanic of any race,3.6,Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Cervix,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Esophagus,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Female Breast,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
1-4,1.4,2.7,39,Incidence,1988966,Hispanic of any race,2.0,Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Larynx,2017
1-4,7.3,9.9,169,Incidence,1988966,Hispanic of any race,8.5,Female,Leukemias,2017
1-4,0.5,1.4,18,Incidence,1988966,Hispanic of any race,0.9,Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Mesothelioma,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Myeloma,2017
1-4,0.5,1.3,16,Incidence,1988966,Hispanic of any race,0.8,Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Ovary,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Pancreas,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Stomach,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Thyroid,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Female,Urinary Bladder,2017
10-14,13.2,16.3,372,Incidence,2533728,Hispanic of any race,14.7,Female,All Cancer Sites Combined,2017
10-14,1.9,3.2,64,Incidence,2533728,Hispanic of any race,2.5,Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Cervix,2017
10-14,0.5,1.2,19,Incidence,2533728,Hispanic of any race,0.7,Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Esophagus,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Female Breast,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
10-14,0.6,1.4,23,Incidence,2533728,Hispanic of any race,0.9,Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Larynx,2017
10-14,3.0,4.6,95,Incidence,2533728,Hispanic of any race,3.7,Female,Leukemias,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Mesothelioma,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Myeloma,2017
10-14,0.5,1.3,21,Incidence,2533728,Hispanic of any race,0.8,Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2017
10-14,0.8,1.6,29,Incidence,2533728,Hispanic of any race,1.1,Female,Ovary,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Pancreas,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Stomach,2017
10-14,0.8,1.7,30,Incidence,2533728,Hispanic of any race,1.2,Female,Thyroid,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Female,Urinary Bladder,2017
15-19,18.6,22.3,487,Incidence,2390957,Hispanic of any race,20.4,Female,All Cancer Sites Combined,2017
15-19,1.3,2.4,42,Incidence,2390957,Hispanic of any race,1.8,Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Cervix,2017
15-19,0.9,1.9,32,Incidence,2390957,Hispanic of any race,1.3,Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Esophagus,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Female Breast,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
15-19,1.8,3.1,57,Incidence,2390957,Hispanic of any race,2.4,Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Larynx,2017
15-19,2.1,3.4,64,Incidence,2390957,Hispanic of any race,2.7,Female,Leukemias,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Mesothelioma,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Myeloma,2017
15-19,0.8,1.8,30,Incidence,2390957,Hispanic of any race,1.3,Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2017
15-19,0.8,1.7,29,Incidence,2390957,Hispanic of any race,1.2,Female,Ovary,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Pancreas,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Stomach,2017
15-19,4.0,5.8,115,Incidence,2390957,Hispanic of any race,4.8,Female,Thyroid,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Female,Urinary Bladder,2017
20-24,28.5,33.0,714,Incidence,2325062,Hispanic of any race,30.7,Female,All Cancer Sites Combined,2017
20-24,0.8,1.7,28,Incidence,2325062,Hispanic of any race,1.2,Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Cervix,2017
20-24,1.7,3.0,53,Incidence,2325062,Hispanic of any race,2.3,Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Esophagus,2017
20-24,1.3,2.4,41,Incidence,2325062,Hispanic of any race,1.8,Female,Female Breast,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
20-24,1.8,3.1,56,Incidence,2325062,Hispanic of any race,2.4,Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Larynx,2017
20-24,1.9,3.2,58,Incidence,2325062,Hispanic of any race,2.5,Female,Leukemias,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Lung and Bronchus,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Mesothelioma,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Myeloma,2017
20-24,1.3,2.4,42,Incidence,2325062,Hispanic of any race,1.8,Female,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2017
20-24,1.9,3.2,57,Incidence,2325062,Hispanic of any race,2.5,Female,Ovary,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Pancreas,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Stomach,2017
20-24,7.9,10.4,211,Incidence,2325062,Hispanic of any race,9.1,Female,Thyroid,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Female,Urinary Bladder,2017
25-29,57.1,63.6,1370,Incidence,2273007,Hispanic of any race,60.3,Female,All Cancer Sites Combined,2017
25-29,0.9,1.9,31,Incidence,2273007,Hispanic of any race,1.4,Female,Brain and Other Nervous System,2017
25-29,3.6,5.4,101,Incidence,2273007,Hispanic of any race,4.4,Female,Cervix,2017
25-29,2.8,4.3,79,Incidence,2273007,Hispanic of any race,3.5,Female,Colon and Rectum,2017
25-29,2.3,3.7,67,Incidence,2273007,Hispanic of any race,2.9,Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Esophagus,2017
25-29,7.4,9.8,194,Incidence,2273007,Hispanic of any race,8.5,Female,Female Breast,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
25-29,2.1,3.5,63,Incidence,2273007,Hispanic of any race,2.8,Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
25-29,1.1,2.2,36,Incidence,2273007,Hispanic of any race,1.6,Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Larynx,2017
25-29,2.6,4.1,74,Incidence,2273007,Hispanic of any race,3.3,Female,Leukemias,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Lung and Bronchus,2017
25-29,1.3,2.4,41,Incidence,2273007,Hispanic of any race,1.8,Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Mesothelioma,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Myeloma,2017
25-29,2.2,3.7,66,Incidence,2273007,Hispanic of any race,2.9,Female,Non-Hodgkin Lymphoma,2017
25-29,0.5,1.3,18,Incidence,2273007,Hispanic of any race,0.8,Female,Oral Cavity and Pharynx,2017
25-29,2.1,3.5,62,Incidence,2273007,Hispanic of any race,2.7,Female,Ovary,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Pancreas,2017
25-29,0.4,1.1,16,Incidence,2273007,Hispanic of any race,0.7,Female,Stomach,2017
25-29,14.6,17.9,368,Incidence,2273007,Hispanic of any race,16.2,Female,Thyroid,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Female,Urinary Bladder,2017
30-34,102.0,110.8,2271,Incidence,2135897,Hispanic of any race,106.3,Female,All Cancer Sites Combined,2017
30-34,1.5,2.8,44,Incidence,2135897,Hispanic of any race,2.1,Female,Brain and Other Nervous System,2017
30-34,10.3,13.2,250,Incidence,2135897,Hispanic of any race,11.7,Female,Cervix,2017
30-34,4.7,6.8,122,Incidence,2135897,Hispanic of any race,5.7,Female,Colon and Rectum,2017
30-34,6.2,8.5,156,Incidence,2135897,Hispanic of any race,7.3,Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Esophagus,2017
30-34,22.1,26.3,516,Incidence,2135897,Hispanic of any race,24.2,Female,Female Breast,2017
30-34,1.4,2.6,41,Incidence,2135897,Hispanic of any race,1.9,Female,"Female Breast, <i>in situ</i>",2017
30-34,1.5,2.8,45,Incidence,2135897,Hispanic of any race,2.1,Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
30-34,2.2,3.7,61,Incidence,2135897,Hispanic of any race,2.9,Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Larynx,2017
30-34,2.8,4.5,76,Incidence,2135897,Hispanic of any race,3.6,Female,Leukemias,2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
30-34,0.7,1.6,23,Incidence,2135897,Hispanic of any race,1.1,Female,Lung and Bronchus,2017
30-34,2.1,3.6,59,Incidence,2135897,Hispanic of any race,2.8,Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Mesothelioma,2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Myeloma,2017
30-34,2.8,4.5,76,Incidence,2135897,Hispanic of any race,3.6,Female,Non-Hodgkin Lymphoma,2017
30-34,0.6,1.5,21,Incidence,2135897,Hispanic of any race,1.0,Female,Oral Cavity and Pharynx,2017
30-34,2.5,4.0,68,Incidence,2135897,Hispanic of any race,3.2,Female,Ovary,2017
30-34,0.9,2.0,30,Incidence,2135897,Hispanic of any race,1.4,Female,Pancreas,2017
30-34,1.6,2.9,46,Incidence,2135897,Hispanic of any race,2.2,Female,Stomach,2017
30-34,20.7,24.8,485,Incidence,2135897,Hispanic of any race,22.7,Female,Thyroid,2017
30-34,~,~,~,Incidence,2135897,Hispanic of any race,~,Female,Urinary Bladder,2017
35-39,159.1,170.1,3476,Incidence,2112661,Hispanic of any race,164.5,Female,All Cancer Sites Combined,2017
35-39,2.2,3.7,60,Incidence,2112661,Hispanic of any race,2.8,Female,Brain and Other Nervous System,2017
35-39,14.2,17.7,336,Incidence,2112661,Hispanic of any race,15.9,Female,Cervix,2017
35-39,7.6,10.2,187,Incidence,2112661,Hispanic of any race,8.9,Female,Colon and Rectum,2017
35-39,11.8,15.0,282,Incidence,2112661,Hispanic of any race,13.3,Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,2112661,Hispanic of any race,~,Female,Esophagus,2017
35-39,46.0,52.0,1033,Incidence,2112661,Hispanic of any race,48.9,Female,Female Breast,2017
35-39,5.9,8.2,148,Incidence,2112661,Hispanic of any race,7.0,Female,"Female Breast, <i>in situ</i>",2017
35-39,1.5,2.7,43,Incidence,2112661,Hispanic of any race,2.0,Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,2112661,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
35-39,4.4,6.4,113,Incidence,2112661,Hispanic of any race,5.3,Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,2112661,Hispanic of any race,~,Female,Larynx,2017
35-39,3.9,5.9,102,Incidence,2112661,Hispanic of any race,4.8,Female,Leukemias,2017
35-39,0.5,1.4,19,Incidence,2112661,Hispanic of any race,0.9,Female,Liver and Intrahepatic Bile Duct,2017
35-39,1.1,2.2,34,Incidence,2112661,Hispanic of any race,1.6,Female,Lung and Bronchus,2017
35-39,2.9,4.6,78,Incidence,2112661,Hispanic of any race,3.7,Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,2112661,Hispanic of any race,~,Female,Mesothelioma,2017
35-39,~,~,~,Incidence,2112661,Hispanic of any race,~,Female,Myeloma,2017
35-39,4.0,6.0,104,Incidence,2112661,Hispanic of any race,4.9,Female,Non-Hodgkin Lymphoma,2017
35-39,1.4,2.6,40,Incidence,2112661,Hispanic of any race,1.9,Female,Oral Cavity and Pharynx,2017
35-39,4.2,6.2,108,Incidence,2112661,Hispanic of any race,5.1,Female,Ovary,2017
35-39,1.2,2.3,35,Incidence,2112661,Hispanic of any race,1.7,Female,Pancreas,2017
35-39,3.0,4.7,79,Incidence,2112661,Hispanic of any race,3.7,Female,Stomach,2017
35-39,25.5,30.0,585,Incidence,2112661,Hispanic of any race,27.7,Female,Thyroid,2017
35-39,~,~,~,Incidence,2112661,Hispanic of any race,~,Female,Urinary Bladder,2017
40-44,242.2,256.2,4914,Incidence,1972195,Hispanic of any race,249.2,Female,All Cancer Sites Combined,2017
40-44,2.4,4.0,61,Incidence,1972195,Hispanic of any race,3.1,Female,Brain and Other Nervous System,2017
40-44,14.5,18.1,320,Incidence,1972195,Hispanic of any race,16.2,Female,Cervix,2017
40-44,15.3,19.0,337,Incidence,1972195,Hispanic of any race,17.1,Female,Colon and Rectum,2017
40-44,15.6,19.4,344,Incidence,1972195,Hispanic of any race,17.4,Female,"Corpus and Uterus, NOS",2017
40-44,~,~,~,Incidence,1972195,Hispanic of any race,~,Female,Esophagus,2017
40-44,93.3,102.1,1926,Incidence,1972195,Hispanic of any race,97.7,Female,Female Breast,2017
40-44,23.7,28.3,511,Incidence,1972195,Hispanic of any race,25.9,Female,"Female Breast, <i>in situ</i>",2017
40-44,1.0,2.2,30,Incidence,1972195,Hispanic of any race,1.5,Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,1972195,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
40-44,8.5,11.3,193,Incidence,1972195,Hispanic of any race,9.8,Female,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,1972195,Hispanic of any race,~,Female,Larynx,2017
40-44,4.8,6.9,114,Incidence,1972195,Hispanic of any race,5.8,Female,Leukemias,2017
40-44,0.6,1.5,19,Incidence,1972195,Hispanic of any race,1.0,Female,Liver and Intrahepatic Bile Duct,2017
40-44,3.1,4.9,77,Incidence,1972195,Hispanic of any race,3.9,Female,Lung and Bronchus,2017
40-44,3.0,4.8,75,Incidence,1972195,Hispanic of any race,3.8,Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,1972195,Hispanic of any race,~,Female,Mesothelioma,2017
40-44,1.4,2.8,40,Incidence,1972195,Hispanic of any race,2.0,Female,Myeloma,2017
40-44,5.2,7.4,123,Incidence,1972195,Hispanic of any race,6.2,Female,Non-Hodgkin Lymphoma,2017
40-44,1.4,2.6,38,Incidence,1972195,Hispanic of any race,1.9,Female,Oral Cavity and Pharynx,2017
40-44,5.3,7.6,126,Incidence,1972195,Hispanic of any race,6.4,Female,Ovary,2017
40-44,1.8,3.2,47,Incidence,1972195,Hispanic of any race,2.4,Female,Pancreas,2017
40-44,4.8,6.9,114,Incidence,1972195,Hispanic of any race,5.8,Female,Stomach,2017
40-44,28.4,33.3,607,Incidence,1972195,Hispanic of any race,30.8,Female,Thyroid,2017
40-44,0.6,1.6,20,Incidence,1972195,Hispanic of any race,1.0,Female,Urinary Bladder,2017
45-49,346.6,364.1,6403,Incidence,1802374,Hispanic of any race,355.3,Female,All Cancer Sites Combined,2017
45-49,2.8,4.7,66,Incidence,1802374,Hispanic of any race,3.7,Female,Brain and Other Nervous System,2017
45-49,14.0,17.7,284,Incidence,1802374,Hispanic of any race,15.8,Female,Cervix,2017
45-49,22.1,26.7,439,Incidence,1802374,Hispanic of any race,24.4,Female,Colon and Rectum,2017
45-49,23.2,27.9,459,Incidence,1802374,Hispanic of any race,25.5,Female,"Corpus and Uterus, NOS",2017
45-49,~,~,~,Incidence,1802374,Hispanic of any race,~,Female,Esophagus,2017
45-49,143.0,154.3,2677,Incidence,1802374,Hispanic of any race,148.5,Female,Female Breast,2017
45-49,39.3,45.3,761,Incidence,1802374,Hispanic of any race,42.2,Female,"Female Breast, <i>in situ</i>",2017
45-49,0.9,2.0,24,Incidence,1802374,Hispanic of any race,1.3,Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,1802374,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
45-49,11.5,14.9,237,Incidence,1802374,Hispanic of any race,13.1,Female,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,1802374,Hispanic of any race,~,Female,Larynx,2017
45-49,6.2,8.7,133,Incidence,1802374,Hispanic of any race,7.4,Female,Leukemias,2017
45-49,1.5,3.0,39,Incidence,1802374,Hispanic of any race,2.2,Female,Liver and Intrahepatic Bile Duct,2017
45-49,6.7,9.3,143,Incidence,1802374,Hispanic of any race,7.9,Female,Lung and Bronchus,2017
45-49,4.6,6.8,101,Incidence,1802374,Hispanic of any race,5.6,Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,1802374,Hispanic of any race,~,Female,Mesothelioma,2017
45-49,2.6,4.4,62,Incidence,1802374,Hispanic of any race,3.4,Female,Myeloma,2017
45-49,10.0,13.2,207,Incidence,1802374,Hispanic of any race,11.5,Female,Non-Hodgkin Lymphoma,2017
45-49,2.4,4.1,57,Incidence,1802374,Hispanic of any race,3.2,Female,Oral Cavity and Pharynx,2017
45-49,10.4,13.7,216,Incidence,1802374,Hispanic of any race,12.0,Female,Ovary,2017
45-49,3.8,5.8,85,Incidence,1802374,Hispanic of any race,4.7,Female,Pancreas,2017
45-49,5.8,8.3,126,Incidence,1802374,Hispanic of any race,7.0,Female,Stomach,2017
45-49,31.3,36.8,612,Incidence,1802374,Hispanic of any race,34.0,Female,Thyroid,2017
45-49,1.5,2.9,38,Incidence,1802374,Hispanic of any race,2.1,Female,Urinary Bladder,2017
5-9,9.6,12.2,277,Incidence,2561602,Hispanic of any race,10.8,Female,All Cancer Sites Combined,2017
5-9,1.9,3.2,64,Incidence,2561602,Hispanic of any race,2.5,Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Cervix,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Esophagus,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Female Breast,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Larynx,2017
5-9,3.0,4.5,94,Incidence,2561602,Hispanic of any race,3.7,Female,Leukemias,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Mesothelioma,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Myeloma,2017
5-9,0.5,1.3,22,Incidence,2561602,Hispanic of any race,0.9,Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Ovary,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Pancreas,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Stomach,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Thyroid,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Female,Urinary Bladder,2017
50-54,486.3,508.4,7822,Incidence,1572985,Hispanic of any race,497.3,Female,All Cancer Sites Combined,2017
50-54,4.1,6.4,81,Incidence,1572985,Hispanic of any race,5.1,Female,Brain and Other Nervous System,2017
50-54,13.3,17.2,238,Incidence,1572985,Hispanic of any race,15.1,Female,Cervix,2017
50-54,39.6,46.1,672,Incidence,1572985,Hispanic of any race,42.7,Female,Colon and Rectum,2017
50-54,42.9,49.6,726,Incidence,1572985,Hispanic of any race,46.2,Female,"Corpus and Uterus, NOS",2017
50-54,~,~,~,Incidence,1572985,Hispanic of any race,~,Female,Esophagus,2017
50-54,174.2,187.5,2843,Incidence,1572985,Hispanic of any race,180.7,Female,Female Breast,2017
50-54,47.2,54.3,797,Incidence,1572985,Hispanic of any race,50.7,Female,"Female Breast, <i>in situ</i>",2017
50-54,1.3,2.8,31,Incidence,1572985,Hispanic of any race,2.0,Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,1572985,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
50-54,17.5,21.9,308,Incidence,1572985,Hispanic of any race,19.6,Female,Kidney and Renal Pelvis,2017
50-54,0.7,1.8,18,Incidence,1572985,Hispanic of any race,1.1,Female,Larynx,2017
50-54,8.0,11.1,148,Incidence,1572985,Hispanic of any race,9.4,Female,Leukemias,2017
50-54,5.2,7.7,100,Incidence,1572985,Hispanic of any race,6.4,Female,Liver and Intrahepatic Bile Duct,2017
50-54,14.0,18.1,251,Incidence,1572985,Hispanic of any race,16.0,Female,Lung and Bronchus,2017
50-54,6.6,9.5,125,Incidence,1572985,Hispanic of any race,7.9,Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,1572985,Hispanic of any race,~,Female,Mesothelioma,2017
50-54,4.9,7.4,95,Incidence,1572985,Hispanic of any race,6.0,Female,Myeloma,2017
50-54,16.9,21.3,299,Incidence,1572985,Hispanic of any race,19.0,Female,Non-Hodgkin Lymphoma,2017
50-54,4.8,7.3,94,Incidence,1572985,Hispanic of any race,6.0,Female,Oral Cavity and Pharynx,2017
50-54,16.6,20.9,293,Incidence,1572985,Hispanic of any race,18.6,Female,Ovary,2017
50-54,7.2,10.2,135,Incidence,1572985,Hispanic of any race,8.6,Female,Pancreas,2017
50-54,8.2,11.3,152,Incidence,1572985,Hispanic of any race,9.7,Female,Stomach,2017
50-54,34.9,41.1,596,Incidence,1572985,Hispanic of any race,37.9,Female,Thyroid,2017
50-54,2.2,4.0,48,Incidence,1572985,Hispanic of any race,3.1,Female,Urinary Bladder,2017
55-59,618.5,645.6,8397,Incidence,1328754,Hispanic of any race,631.9,Female,All Cancer Sites Combined,2017
55-59,4.8,7.5,80,Incidence,1328754,Hispanic of any race,6.0,Female,Brain and Other Nervous System,2017
55-59,14.4,18.9,220,Incidence,1328754,Hispanic of any race,16.6,Female,Cervix,2017
55-59,44.8,52.4,644,Incidence,1328754,Hispanic of any race,48.5,Female,Colon and Rectum,2017
55-59,59.0,67.6,840,Incidence,1328754,Hispanic of any race,63.2,Female,"Corpus and Uterus, NOS",2017
55-59,1.0,2.5,22,Incidence,1328754,Hispanic of any race,1.7,Female,Esophagus,2017
55-59,202.4,218.1,2792,Incidence,1328754,Hispanic of any race,210.1,Female,Female Breast,2017
55-59,47.3,55.1,679,Incidence,1328754,Hispanic of any race,51.1,Female,"Female Breast, <i>in situ</i>",2017
55-59,1.2,2.8,25,Incidence,1328754,Hispanic of any race,1.9,Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,1328754,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
55-59,26.1,31.9,384,Incidence,1328754,Hispanic of any race,28.9,Female,Kidney and Renal Pelvis,2017
55-59,~,~,~,Incidence,1328754,Hispanic of any race,~,Female,Larynx,2017
55-59,9.5,13.2,149,Incidence,1328754,Hispanic of any race,11.2,Female,Leukemias,2017
55-59,12.5,16.6,192,Incidence,1328754,Hispanic of any race,14.4,Female,Liver and Intrahepatic Bile Duct,2017
55-59,31.9,38.3,465,Incidence,1328754,Hispanic of any race,35.0,Female,Lung and Bronchus,2017
55-59,8.1,11.5,129,Incidence,1328754,Hispanic of any race,9.7,Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,1328754,Hispanic of any race,~,Female,Mesothelioma,2017
55-59,8.3,11.8,132,Incidence,1328754,Hispanic of any race,9.9,Female,Myeloma,2017
55-59,22.1,27.5,328,Incidence,1328754,Hispanic of any race,24.7,Female,Non-Hodgkin Lymphoma,2017
55-59,6.4,9.5,104,Incidence,1328754,Hispanic of any race,7.8,Female,Oral Cavity and Pharynx,2017
55-59,19.7,24.9,295,Incidence,1328754,Hispanic of any race,22.2,Female,Ovary,2017
55-59,13.5,17.8,206,Incidence,1328754,Hispanic of any race,15.5,Female,Pancreas,2017
55-59,10.6,14.5,165,Incidence,1328754,Hispanic of any race,12.4,Female,Stomach,2017
55-59,37.1,44.1,538,Incidence,1328754,Hispanic of any race,40.5,Female,Thyroid,2017
55-59,4.3,6.9,73,Incidence,1328754,Hispanic of any race,5.5,Female,Urinary Bladder,2017
60-64,818.1,853.0,8836,Incidence,1057711,Hispanic of any race,835.4,Female,All Cancer Sites Combined,2017
60-64,6.8,10.5,90,Incidence,1057711,Hispanic of any race,8.5,Female,Brain and Other Nervous System,2017
60-64,14.3,19.3,176,Incidence,1057711,Hispanic of any race,16.6,Female,Cervix,2017
60-64,64.5,74.6,734,Incidence,1057711,Hispanic of any race,69.4,Female,Colon and Rectum,2017
60-64,82.3,93.7,929,Incidence,1057711,Hispanic of any race,87.8,Female,"Corpus and Uterus, NOS",2017
60-64,1.8,3.8,28,Incidence,1057711,Hispanic of any race,2.6,Female,Esophagus,2017
60-64,256.2,276.0,2813,Incidence,1057711,Hispanic of any race,266.0,Female,Female Breast,2017
60-64,63.7,73.8,726,Incidence,1057711,Hispanic of any race,68.6,Female,"Female Breast, <i>in situ</i>",2017
60-64,1.3,3.1,22,Incidence,1057711,Hispanic of any race,2.1,Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,1057711,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
60-64,29.9,36.9,352,Incidence,1057711,Hispanic of any race,33.3,Female,Kidney and Renal Pelvis,2017
60-64,1.7,3.7,27,Incidence,1057711,Hispanic of any race,2.6,Female,Larynx,2017
60-64,14.9,20.0,183,Incidence,1057711,Hispanic of any race,17.3,Female,Leukemias,2017
60-64,19.8,25.6,239,Incidence,1057711,Hispanic of any race,22.6,Female,Liver and Intrahepatic Bile Duct,2017
60-64,52.8,62.0,606,Incidence,1057711,Hispanic of any race,57.3,Female,Lung and Bronchus,2017
60-64,8.4,12.3,108,Incidence,1057711,Hispanic of any race,10.2,Female,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,1057711,Hispanic of any race,~,Female,Mesothelioma,2017
60-64,13.7,18.6,169,Incidence,1057711,Hispanic of any race,16.0,Female,Myeloma,2017
60-64,31.8,39.0,373,Incidence,1057711,Hispanic of any race,35.3,Female,Non-Hodgkin Lymphoma,2017
60-64,8.5,12.5,110,Incidence,1057711,Hispanic of any race,10.4,Female,Oral Cavity and Pharynx,2017
60-64,21.3,27.4,256,Incidence,1057711,Hispanic of any race,24.2,Female,Ovary,2017
60-64,19.7,25.5,238,Incidence,1057711,Hispanic of any race,22.5,Female,Pancreas,2017
60-64,14.9,20.0,183,Incidence,1057711,Hispanic of any race,17.3,Female,Stomach,2017
60-64,31.8,39.0,373,Incidence,1057711,Hispanic of any race,35.3,Female,Thyroid,2017
60-64,9.3,13.5,119,Incidence,1057711,Hispanic of any race,11.3,Female,Urinary Bladder,2017
65-69,1070.5,1116.6,8688,Incidence,794602,Hispanic of any race,1093.4,Female,All Cancer Sites Combined,2017
65-69,9.3,14.2,92,Incidence,794602,Hispanic of any race,11.6,Female,Brain and Other Nervous System,2017
65-69,11.1,16.4,108,Incidence,794602,Hispanic of any race,13.6,Female,Cervix,2017
65-69,86.5,100.1,740,Incidence,794602,Hispanic of any race,93.1,Female,Colon and Rectum,2017
65-69,85.6,99.0,732,Incidence,794602,Hispanic of any race,92.1,Female,"Corpus and Uterus, NOS",2017
65-69,1.3,3.6,18,Incidence,794602,Hispanic of any race,2.3,Female,Esophagus,2017
65-69,313.3,338.5,2588,Incidence,794602,Hispanic of any race,325.7,Female,Female Breast,2017
65-69,75.0,87.7,645,Incidence,794602,Hispanic of any race,81.2,Female,"Female Breast, <i>in situ</i>",2017
65-69,2.9,5.8,33,Incidence,794602,Hispanic of any race,4.2,Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,794602,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
65-69,44.1,53.9,388,Incidence,794602,Hispanic of any race,48.8,Female,Kidney and Renal Pelvis,2017
65-69,1.3,3.6,18,Incidence,794602,Hispanic of any race,2.3,Female,Larynx,2017
65-69,21.9,29.0,201,Incidence,794602,Hispanic of any race,25.3,Female,Leukemias,2017
65-69,34.8,43.6,310,Incidence,794602,Hispanic of any race,39.0,Female,Liver and Intrahepatic Bile Duct,2017
65-69,83.5,96.8,715,Incidence,794602,Hispanic of any race,90.0,Female,Lung and Bronchus,2017
65-69,11.0,16.3,107,Incidence,794602,Hispanic of any race,13.5,Female,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,794602,Hispanic of any race,~,Female,Mesothelioma,2017
65-69,21.1,28.1,194,Incidence,794602,Hispanic of any race,24.4,Female,Myeloma,2017
65-69,48.4,58.7,424,Incidence,794602,Hispanic of any race,53.4,Female,Non-Hodgkin Lymphoma,2017
65-69,12.4,17.9,119,Incidence,794602,Hispanic of any race,15.0,Female,Oral Cavity and Pharynx,2017
65-69,25.9,33.6,235,Incidence,794602,Hispanic of any race,29.6,Female,Ovary,2017
65-69,36.1,45.1,321,Incidence,794602,Hispanic of any race,40.4,Female,Pancreas,2017
65-69,21.7,28.8,199,Incidence,794602,Hispanic of any race,25.0,Female,Stomach,2017
65-69,34.3,43.1,306,Incidence,794602,Hispanic of any race,38.5,Female,Thyroid,2017
65-69,13.0,18.6,124,Incidence,794602,Hispanic of any race,15.6,Female,Urinary Bladder,2017
70-74,1261.0,1319.9,7427,Incidence,575661,Hispanic of any race,1290.2,Female,All Cancer Sites Combined,2017
70-74,12.6,19.2,90,Incidence,575661,Hispanic of any race,15.6,Female,Brain and Other Nervous System,2017
70-74,11.0,17.3,80,Incidence,575661,Hispanic of any race,13.9,Female,Cervix,2017
70-74,106.9,124.6,665,Incidence,575661,Hispanic of any race,115.5,Female,Colon and Rectum,2017
70-74,74.8,89.7,472,Incidence,575661,Hispanic of any race,82.0,Female,"Corpus and Uterus, NOS",2017
70-74,2.3,5.6,21,Incidence,575661,Hispanic of any race,3.6,Female,Esophagus,2017
70-74,339.7,370.6,2043,Incidence,575661,Hispanic of any race,354.9,Female,Female Breast,2017
70-74,75.1,90.1,474,Incidence,575661,Hispanic of any race,82.3,Female,"Female Breast, <i>in situ</i>",2017
70-74,3.0,6.6,26,Incidence,575661,Hispanic of any race,4.5,Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,575661,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
70-74,46.7,58.7,302,Incidence,575661,Hispanic of any race,52.5,Female,Kidney and Renal Pelvis,2017
70-74,1.6,4.5,16,Incidence,575661,Hispanic of any race,2.8,Female,Larynx,2017
70-74,23.7,32.5,160,Incidence,575661,Hispanic of any race,27.8,Female,Leukemias,2017
70-74,34.6,45.1,228,Incidence,575661,Hispanic of any race,39.6,Female,Liver and Intrahepatic Bile Duct,2017
70-74,136.4,156.3,841,Incidence,575661,Hispanic of any race,146.1,Female,Lung and Bronchus,2017
70-74,13.0,19.8,93,Incidence,575661,Hispanic of any race,16.2,Female,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,575661,Hispanic of any race,~,Female,Mesothelioma,2017
70-74,22.7,31.3,154,Incidence,575661,Hispanic of any race,26.8,Female,Myeloma,2017
70-74,62.7,76.5,399,Incidence,575661,Hispanic of any race,69.3,Female,Non-Hodgkin Lymphoma,2017
70-74,12.4,19.0,89,Incidence,575661,Hispanic of any race,15.5,Female,Oral Cavity and Pharynx,2017
70-74,26.5,35.8,178,Incidence,575661,Hispanic of any race,30.9,Female,Ovary,2017
70-74,45.4,57.3,294,Incidence,575661,Hispanic of any race,51.1,Female,Pancreas,2017
70-74,25.3,34.3,170,Incidence,575661,Hispanic of any race,29.5,Female,Stomach,2017
70-74,30.3,40.1,201,Incidence,575661,Hispanic of any race,34.9,Female,Thyroid,2017
70-74,22.5,31.1,153,Incidence,575661,Hispanic of any race,26.6,Female,Urinary Bladder,2017
75-79,1399.3,1473.6,5788,Incidence,403044,Hispanic of any race,1436.1,Female,All Cancer Sites Combined,2017
75-79,14.9,23.6,76,Incidence,403044,Hispanic of any race,18.9,Female,Brain and Other Nervous System,2017
75-79,12.0,20.0,63,Incidence,403044,Hispanic of any race,15.6,Female,Cervix,2017
75-79,125.1,148.1,549,Incidence,403044,Hispanic of any race,136.2,Female,Colon and Rectum,2017
75-79,61.3,77.8,279,Incidence,403044,Hispanic of any race,69.2,Female,"Corpus and Uterus, NOS",2017
75-79,5.2,10.9,31,Incidence,403044,Hispanic of any race,7.7,Female,Esophagus,2017
75-79,309.4,344.9,1317,Incidence,403044,Hispanic of any race,326.8,Female,Female Breast,2017
75-79,59.0,75.2,269,Incidence,403044,Hispanic of any race,66.7,Female,"Female Breast, <i>in situ</i>",2017
75-79,2.6,7.1,18,Incidence,403044,Hispanic of any race,4.5,Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,403044,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
75-79,43.0,57.0,200,Incidence,403044,Hispanic of any race,49.6,Female,Kidney and Renal Pelvis,2017
75-79,~,~,~,Incidence,403044,Hispanic of any race,~,Female,Larynx,2017
75-79,32.9,45.3,156,Incidence,403044,Hispanic of any race,38.7,Female,Leukemias,2017
75-79,52.5,67.8,241,Incidence,403044,Hispanic of any race,59.8,Female,Liver and Intrahepatic Bile Duct,2017
75-79,158.9,184.7,691,Incidence,403044,Hispanic of any race,171.4,Female,Lung and Bronchus,2017
75-79,15.3,24.2,78,Incidence,403044,Hispanic of any race,19.4,Female,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,403044,Hispanic of any race,~,Female,Mesothelioma,2017
75-79,26.0,37.2,126,Incidence,403044,Hispanic of any race,31.3,Female,Myeloma,2017
75-79,78.4,97.0,352,Incidence,403044,Hispanic of any race,87.3,Female,Non-Hodgkin Lymphoma,2017
75-79,13.5,21.9,70,Incidence,403044,Hispanic of any race,17.4,Female,Oral Cavity and Pharynx,2017
75-79,28.5,40.2,137,Incidence,403044,Hispanic of any race,34.0,Female,Ovary,2017
75-79,68.8,86.2,311,Incidence,403044,Hispanic of any race,77.2,Female,Pancreas,2017
75-79,32.9,45.3,156,Incidence,403044,Hispanic of any race,38.7,Female,Stomach,2017
75-79,25.6,36.7,124,Incidence,403044,Hispanic of any race,30.8,Female,Thyroid,2017
75-79,26.7,38.0,129,Incidence,403044,Hispanic of any race,32.0,Female,Urinary Bladder,2017
80-84,1380.2,1468.4,4044,Incidence,284031,Hispanic of any race,1423.8,Female,All Cancer Sites Combined,2017
80-84,7.7,15.9,32,Incidence,284031,Hispanic of any race,11.3,Female,Brain and Other Nervous System,2017
80-84,9.5,18.4,38,Incidence,284031,Hispanic of any race,13.4,Female,Cervix,2017
80-84,134.1,162.7,420,Incidence,284031,Hispanic of any race,147.9,Female,Colon and Rectum,2017
80-84,54.8,73.7,181,Incidence,284031,Hispanic of any race,63.7,Female,"Corpus and Uterus, NOS",2017
80-84,4.9,11.7,22,Incidence,284031,Hispanic of any race,7.7,Female,Esophagus,2017
80-84,245.8,284.0,751,Incidence,284031,Hispanic of any race,264.4,Female,Female Breast,2017
80-84,32.8,47.8,113,Incidence,284031,Hispanic of any race,39.8,Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,284031,Hispanic of any race,~,Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,284031,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
80-84,41.1,57.8,139,Incidence,284031,Hispanic of any race,48.9,Female,Kidney and Renal Pelvis,2017
80-84,~,~,~,Incidence,284031,Hispanic of any race,~,Female,Larynx,2017
80-84,32.1,47.1,111,Incidence,284031,Hispanic of any race,39.1,Female,Leukemias,2017
80-84,40.8,57.4,138,Incidence,284031,Hispanic of any race,48.6,Female,Liver and Intrahepatic Bile Duct,2017
80-84,174.4,206.9,540,Incidence,284031,Hispanic of any race,190.1,Female,Lung and Bronchus,2017
80-84,11.9,21.6,46,Incidence,284031,Hispanic of any race,16.2,Female,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,284031,Hispanic of any race,~,Female,Mesothelioma,2017
80-84,27.7,41.7,97,Incidence,284031,Hispanic of any race,34.2,Female,Myeloma,2017
80-84,70.5,91.8,229,Incidence,284031,Hispanic of any race,80.6,Female,Non-Hodgkin Lymphoma,2017
80-84,21.4,33.9,77,Incidence,284031,Hispanic of any race,27.1,Female,Oral Cavity and Pharynx,2017
80-84,36.0,51.7,123,Incidence,284031,Hispanic of any race,43.3,Female,Ovary,2017
80-84,73.8,95.5,239,Incidence,284031,Hispanic of any race,84.1,Female,Pancreas,2017
80-84,33.7,49.0,116,Incidence,284031,Hispanic of any race,40.8,Female,Stomach,2017
80-84,11.6,21.2,45,Incidence,284031,Hispanic of any race,15.8,Female,Thyroid,2017
80-84,32.1,47.1,111,Incidence,284031,Hispanic of any race,39.1,Female,Urinary Bladder,2017
85+,1399.6,1487.2,4201,Incidence,291150,Hispanic of any race,1442.9,Female,All Cancer Sites Combined,2017
85+,11.9,21.5,47,Incidence,291150,Hispanic of any race,16.1,Female,Brain and Other Nervous System,2017
85+,11.0,20.3,44,Incidence,291150,Hispanic of any race,15.1,Female,Cervix,2017
85+,170.5,202.2,541,Incidence,291150,Hispanic of any race,185.8,Female,Colon and Rectum,2017
85+,29.5,43.7,105,Incidence,291150,Hispanic of any race,36.1,Female,"Corpus and Uterus, NOS",2017
85+,6.4,13.9,28,Incidence,291150,Hispanic of any race,9.6,Female,Esophagus,2017
85+,215.0,250.4,676,Incidence,291150,Hispanic of any race,232.2,Female,Female Breast,2017
85+,11.9,21.5,47,Incidence,291150,Hispanic of any race,16.1,Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,291150,Hispanic of any race,~,Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,291150,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
85+,34.5,49.7,121,Incidence,291150,Hispanic of any race,41.6,Female,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,291150,Hispanic of any race,~,Female,Larynx,2017
85+,41.1,57.5,142,Incidence,291150,Hispanic of any race,48.8,Female,Leukemias,2017
85+,48.0,65.6,164,Incidence,291150,Hispanic of any race,56.3,Female,Liver and Intrahepatic Bile Duct,2017
85+,144.9,174.2,463,Incidence,291150,Hispanic of any race,159.0,Female,Lung and Bronchus,2017
85+,12.5,22.2,49,Incidence,291150,Hispanic of any race,16.8,Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,291150,Hispanic of any race,~,Female,Mesothelioma,2017
85+,25.8,39.1,93,Incidence,291150,Hispanic of any race,31.9,Female,Myeloma,2017
85+,73.9,95.4,245,Incidence,291150,Hispanic of any race,84.1,Female,Non-Hodgkin Lymphoma,2017
85+,16.6,27.7,63,Incidence,291150,Hispanic of any race,21.6,Female,Oral Cavity and Pharynx,2017
85+,27.9,41.8,100,Incidence,291150,Hispanic of any race,34.3,Female,Ovary,2017
85+,77.8,99.7,257,Incidence,291150,Hispanic of any race,88.3,Female,Pancreas,2017
85+,44.9,61.9,154,Incidence,291150,Hispanic of any race,52.9,Female,Stomach,2017
85+,6.4,13.9,28,Incidence,291150,Hispanic of any race,9.6,Female,Thyroid,2017
85+,39.5,55.6,137,Incidence,291150,Hispanic of any race,47.1,Female,Urinary Bladder,2017
<1,17.9,26.5,107,Incidence,488567,Hispanic of any race,21.9,Female,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Cervix,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Colon and Rectum,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Esophagus,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Female Breast,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Larynx,2017
<1,3.6,8.0,27,Incidence,488567,Hispanic of any race,5.5,Female,Leukemias,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Mesothelioma,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Myeloma,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Ovary,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Pancreas,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Stomach,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Thyroid,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Female,Urinary Bladder,2017
1-4,20.5,24.7,466,Incidence,2068309,Hispanic of any race,22.5,Male,All Cancer Sites Combined,2017
1-4,3.3,5.1,85,Incidence,2068309,Hispanic of any race,4.1,Male,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Colon and Rectum,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Esophagus,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
1-4,0.8,1.8,25,Incidence,2068309,Hispanic of any race,1.2,Male,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Larynx,2017
1-4,8.8,11.6,210,Incidence,2068309,Hispanic of any race,10.2,Male,Leukemias,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Lung and Bronchus,2017
1-4,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Mesothelioma,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Myeloma,2017
1-4,0.4,1.3,16,Incidence,2068309,Hispanic of any race,0.8,Male,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Pancreas,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Prostate,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Stomach,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Testis,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Thyroid,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male,Urinary Bladder,2017
10-14,15.7,18.9,454,Incidence,2631174,Hispanic of any race,17.3,Male,All Cancer Sites Combined,2017
10-14,2.2,3.5,74,Incidence,2631174,Hispanic of any race,2.8,Male,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Colon and Rectum,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Esophagus,2017
10-14,0.7,1.5,28,Incidence,2631174,Hispanic of any race,1.1,Male,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Larynx,2017
10-14,5.1,7.1,159,Incidence,2631174,Hispanic of any race,6.0,Male,Leukemias,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Lung and Bronchus,2017
10-14,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Mesothelioma,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Myeloma,2017
10-14,0.7,1.5,27,Incidence,2631174,Hispanic of any race,1.0,Male,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Pancreas,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Prostate,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Stomach,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Testis,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Thyroid,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male,Urinary Bladder,2017
15-19,22.0,25.8,594,Incidence,2491246,Hispanic of any race,23.8,Male,All Cancer Sites Combined,2017
15-19,1.3,2.4,44,Incidence,2491246,Hispanic of any race,1.8,Male,Brain and Other Nervous System,2017
15-19,0.6,1.4,23,Incidence,2491246,Hispanic of any race,0.9,Male,Colon and Rectum,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Esophagus,2017
15-19,1.5,2.6,50,Incidence,2491246,Hispanic of any race,2.0,Male,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Larynx,2017
15-19,4.5,6.4,135,Incidence,2491246,Hispanic of any race,5.4,Male,Leukemias,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Lung and Bronchus,2017
15-19,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Mesothelioma,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Myeloma,2017
15-19,1.5,2.6,49,Incidence,2491246,Hispanic of any race,2.0,Male,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Pancreas,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Prostate,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Stomach,2017
15-19,4.3,6.2,129,Incidence,2491246,Hispanic of any race,5.2,Male,Testis,2017
15-19,0.6,1.4,23,Incidence,2491246,Hispanic of any race,0.9,Male,Thyroid,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male,Urinary Bladder,2017
20-24,33.7,38.5,892,Incidence,2474168,Hispanic of any race,36.1,Male,All Cancer Sites Combined,2017
20-24,1.1,2.2,39,Incidence,2474168,Hispanic of any race,1.6,Male,Brain and Other Nervous System,2017
20-24,1.4,2.6,48,Incidence,2474168,Hispanic of any race,1.9,Male,Colon and Rectum,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Esophagus,2017
20-24,2.2,3.6,70,Incidence,2474168,Hispanic of any race,2.8,Male,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Larynx,2017
20-24,3.3,5.0,101,Incidence,2474168,Hispanic of any race,4.1,Male,Leukemias,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Lung and Bronchus,2017
20-24,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Mesothelioma,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Myeloma,2017
20-24,2.2,3.6,71,Incidence,2474168,Hispanic of any race,2.9,Male,Non-Hodgkin Lymphoma,2017
20-24,0.4,1.1,16,Incidence,2474168,Hispanic of any race,0.6,Male,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Pancreas,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Prostate,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Stomach,2017
20-24,13.2,16.3,363,Incidence,2474168,Hispanic of any race,14.7,Male,Testis,2017
20-24,1.1,2.2,39,Incidence,2474168,Hispanic of any race,1.6,Male,Thyroid,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male,Urinary Bladder,2017
25-29,42.5,47.8,1125,Incidence,2497112,Hispanic of any race,45.1,Male,All Cancer Sites Combined,2017
25-29,2.0,3.3,64,Incidence,2497112,Hispanic of any race,2.6,Male,Brain and Other Nervous System,2017
25-29,2.0,3.3,64,Incidence,2497112,Hispanic of any race,2.6,Male,Colon and Rectum,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Esophagus,2017
25-29,1.7,2.9,55,Incidence,2497112,Hispanic of any race,2.2,Male,Hodgkin Lymphoma,2017
25-29,0.6,1.4,24,Incidence,2497112,Hispanic of any race,1.0,Male,Kaposi Sarcoma,2017
25-29,0.8,1.7,30,Incidence,2497112,Hispanic of any race,1.2,Male,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Larynx,2017
25-29,3.3,4.9,100,Incidence,2497112,Hispanic of any race,4.0,Male,Leukemias,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Lung and Bronchus,2017
25-29,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Mesothelioma,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Myeloma,2017
25-29,2.4,3.8,75,Incidence,2497112,Hispanic of any race,3.0,Male,Non-Hodgkin Lymphoma,2017
25-29,0.4,1.1,17,Incidence,2497112,Hispanic of any race,0.7,Male,Oral Cavity and Pharynx,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Pancreas,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Prostate,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Stomach,2017
25-29,15.9,19.2,436,Incidence,2497112,Hispanic of any race,17.5,Male,Testis,2017
25-29,2.0,3.4,66,Incidence,2497112,Hispanic of any race,2.6,Male,Thyroid,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male,Urinary Bladder,2017
30-34,52.0,58.0,1299,Incidence,2364118,Hispanic of any race,54.9,Male,All Cancer Sites Combined,2017
30-34,2.4,3.8,72,Incidence,2364118,Hispanic of any race,3.0,Male,Brain and Other Nervous System,2017
30-34,4.2,6.1,120,Incidence,2364118,Hispanic of any race,5.1,Male,Colon and Rectum,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Esophagus,2017
30-34,1.9,3.2,58,Incidence,2364118,Hispanic of any race,2.5,Male,Hodgkin Lymphoma,2017
30-34,0.8,1.8,29,Incidence,2364118,Hispanic of any race,1.2,Male,Kaposi Sarcoma,2017
30-34,2.0,3.4,62,Incidence,2364118,Hispanic of any race,2.6,Male,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Larynx,2017
30-34,3.4,5.1,100,Incidence,2364118,Hispanic of any race,4.2,Male,Leukemias,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Lung and Bronchus,2017
30-34,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
30-34,0.6,1.5,23,Incidence,2364118,Hispanic of any race,1.0,Male,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Mesothelioma,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Myeloma,2017
30-34,4.2,6.0,119,Incidence,2364118,Hispanic of any race,5.0,Male,Non-Hodgkin Lymphoma,2017
30-34,0.8,1.7,27,Incidence,2364118,Hispanic of any race,1.1,Male,Oral Cavity and Pharynx,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Pancreas,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Prostate,2017
30-34,1.4,2.6,46,Incidence,2364118,Hispanic of any race,1.9,Male,Stomach,2017
30-34,11.9,14.9,316,Incidence,2364118,Hispanic of any race,13.4,Male,Testis,2017
30-34,3.9,5.7,112,Incidence,2364118,Hispanic of any race,4.7,Male,Thyroid,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male,Urinary Bladder,2017
35-39,68.5,75.6,1631,Incidence,2265508,Hispanic of any race,72.0,Male,All Cancer Sites Combined,2017
35-39,2.6,4.1,75,Incidence,2265508,Hispanic of any race,3.3,Male,Brain and Other Nervous System,2017
35-39,8.3,10.9,217,Incidence,2265508,Hispanic of any race,9.6,Male,Colon and Rectum,2017
35-39,~,~,~,Incidence,2265508,Hispanic of any race,~,Male,Esophagus,2017
35-39,1.5,2.8,47,Incidence,2265508,Hispanic of any race,2.1,Male,Hodgkin Lymphoma,2017
35-39,0.8,1.7,27,Incidence,2265508,Hispanic of any race,1.2,Male,Kaposi Sarcoma,2017
35-39,5.7,7.9,153,Incidence,2265508,Hispanic of any race,6.8,Male,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,2265508,Hispanic of any race,~,Male,Larynx,2017
35-39,3.9,5.7,107,Incidence,2265508,Hispanic of any race,4.7,Male,Leukemias,2017
35-39,0.6,1.5,22,Incidence,2265508,Hispanic of any race,1.0,Male,Liver and Intrahepatic Bile Duct,2017
35-39,0.7,1.6,24,Incidence,2265508,Hispanic of any race,1.1,Male,Lung and Bronchus,2017
35-39,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
35-39,1.3,2.4,40,Incidence,2265508,Hispanic of any race,1.8,Male,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,2265508,Hispanic of any race,~,Male,Mesothelioma,2017
35-39,0.6,1.5,23,Incidence,2265508,Hispanic of any race,1.0,Male,Myeloma,2017
35-39,5.8,8.1,156,Incidence,2265508,Hispanic of any race,6.9,Male,Non-Hodgkin Lymphoma,2017
35-39,1.2,2.3,38,Incidence,2265508,Hispanic of any race,1.7,Male,Oral Cavity and Pharynx,2017
35-39,0.8,1.7,27,Incidence,2265508,Hispanic of any race,1.2,Male,Pancreas,2017
35-39,~,~,~,Incidence,2265508,Hispanic of any race,~,Male,Prostate,2017
35-39,2.5,4.0,72,Incidence,2265508,Hispanic of any race,3.2,Male,Stomach,2017
35-39,7.6,10.1,200,Incidence,2265508,Hispanic of any race,8.8,Male,Testis,2017
35-39,4.5,6.5,123,Incidence,2265508,Hispanic of any race,5.4,Male,Thyroid,2017
35-39,0.8,1.8,28,Incidence,2265508,Hispanic of any race,1.2,Male,Urinary Bladder,2017
40-44,100.7,109.7,2140,Incidence,2035927,Hispanic of any race,105.1,Male,All Cancer Sites Combined,2017
40-44,2.9,4.7,76,Incidence,2035927,Hispanic of any race,3.7,Male,Brain and Other Nervous System,2017
40-44,13.5,17.0,309,Incidence,2035927,Hispanic of any race,15.2,Male,Colon and Rectum,2017
40-44,0.6,1.6,21,Incidence,2035927,Hispanic of any race,1.0,Male,Esophagus,2017
40-44,1.4,2.7,40,Incidence,2035927,Hispanic of any race,2.0,Male,Hodgkin Lymphoma,2017
40-44,0.8,1.8,24,Incidence,2035927,Hispanic of any race,1.2,Male,Kaposi Sarcoma,2017
40-44,12.5,15.8,286,Incidence,2035927,Hispanic of any race,14.0,Male,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,2035927,Hispanic of any race,~,Male,Larynx,2017
40-44,5.7,8.1,139,Incidence,2035927,Hispanic of any race,6.8,Male,Leukemias,2017
40-44,1.4,2.6,39,Incidence,2035927,Hispanic of any race,1.9,Male,Liver and Intrahepatic Bile Duct,2017
40-44,2.2,3.7,58,Incidence,2035927,Hispanic of any race,2.8,Male,Lung and Bronchus,2017
40-44,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
40-44,1.3,2.6,38,Incidence,2035927,Hispanic of any race,1.9,Male,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,2035927,Hispanic of any race,~,Male,Mesothelioma,2017
40-44,1.7,3.1,48,Incidence,2035927,Hispanic of any race,2.4,Male,Myeloma,2017
40-44,7.2,9.8,171,Incidence,2035927,Hispanic of any race,8.4,Male,Non-Hodgkin Lymphoma,2017
40-44,3.1,4.8,79,Incidence,2035927,Hispanic of any race,3.9,Male,Oral Cavity and Pharynx,2017
40-44,2.6,4.3,69,Incidence,2035927,Hispanic of any race,3.4,Male,Pancreas,2017
40-44,2.1,3.6,56,Incidence,2035927,Hispanic of any race,2.8,Male,Prostate,2017
40-44,4.0,6.0,101,Incidence,2035927,Hispanic of any race,5.0,Male,Stomach,2017
40-44,5.4,7.7,132,Incidence,2035927,Hispanic of any race,6.5,Male,Testis,2017
40-44,5.4,7.6,131,Incidence,2035927,Hispanic of any race,6.4,Male,Thyroid,2017
40-44,1.2,2.4,35,Incidence,2035927,Hispanic of any race,1.7,Male,Urinary Bladder,2017
45-49,172.8,185.1,3297,Incidence,1843110,Hispanic of any race,178.9,Male,All Cancer Sites Combined,2017
45-49,4.0,6.1,91,Incidence,1843110,Hispanic of any race,4.9,Male,Brain and Other Nervous System,2017
45-49,27.8,32.8,557,Incidence,1843110,Hispanic of any race,30.2,Male,Colon and Rectum,2017
45-49,1.5,2.9,39,Incidence,1843110,Hispanic of any race,2.1,Male,Esophagus,2017
45-49,1.8,3.3,45,Incidence,1843110,Hispanic of any race,2.4,Male,Hodgkin Lymphoma,2017
45-49,1.1,2.3,29,Incidence,1843110,Hispanic of any race,1.6,Male,Kaposi Sarcoma,2017
45-49,19.3,23.6,394,Incidence,1843110,Hispanic of any race,21.4,Male,Kidney and Renal Pelvis,2017
45-49,1.1,2.3,30,Incidence,1843110,Hispanic of any race,1.6,Male,Larynx,2017
45-49,5.8,8.3,128,Incidence,1843110,Hispanic of any race,6.9,Male,Leukemias,2017
45-49,6.5,9.1,143,Incidence,1843110,Hispanic of any race,7.8,Male,Liver and Intrahepatic Bile Duct,2017
45-49,4.9,7.2,110,Incidence,1843110,Hispanic of any race,6.0,Male,Lung and Bronchus,2017
45-49,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
45-49,3.1,4.9,72,Incidence,1843110,Hispanic of any race,3.9,Male,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,1843110,Hispanic of any race,~,Male,Mesothelioma,2017
45-49,3.0,4.9,71,Incidence,1843110,Hispanic of any race,3.9,Male,Myeloma,2017
45-49,13.2,16.8,275,Incidence,1843110,Hispanic of any race,14.9,Male,Non-Hodgkin Lymphoma,2017
45-49,7.4,10.1,160,Incidence,1843110,Hispanic of any race,8.7,Male,Oral Cavity and Pharynx,2017
45-49,4.7,6.9,105,Incidence,1843110,Hispanic of any race,5.7,Male,Pancreas,2017
45-49,12.1,15.6,254,Incidence,1843110,Hispanic of any race,13.8,Male,Prostate,2017
45-49,7.4,10.2,161,Incidence,1843110,Hispanic of any race,8.7,Male,Stomach,2017
45-49,2.8,4.6,67,Incidence,1843110,Hispanic of any race,3.6,Male,Testis,2017
45-49,6.5,9.1,142,Incidence,1843110,Hispanic of any race,7.7,Male,Thyroid,2017
45-49,3.5,5.5,82,Incidence,1843110,Hispanic of any race,4.4,Male,Urinary Bladder,2017
5-9,12.6,15.5,372,Incidence,2659980,Hispanic of any race,14.0,Male,All Cancer Sites Combined,2017
5-9,2.3,3.7,78,Incidence,2659980,Hispanic of any race,2.9,Male,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Colon and Rectum,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Esophagus,2017
5-9,0.5,1.2,21,Incidence,2659980,Hispanic of any race,0.8,Male,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Larynx,2017
5-9,4.9,6.8,155,Incidence,2659980,Hispanic of any race,5.8,Male,Leukemias,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Lung and Bronchus,2017
5-9,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Mesothelioma,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Myeloma,2017
5-9,0.7,1.6,29,Incidence,2659980,Hispanic of any race,1.1,Male,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Pancreas,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Prostate,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Stomach,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Testis,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Thyroid,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male,Urinary Bladder,2017
50-54,333.9,352.1,5441,Incidence,1586728,Hispanic of any race,342.9,Male,All Cancer Sites Combined,2017
50-54,5.2,7.7,101,Incidence,1586728,Hispanic of any race,6.4,Male,Brain and Other Nervous System,2017
50-54,51.0,58.3,866,Incidence,1586728,Hispanic of any race,54.6,Male,Colon and Rectum,2017
50-54,4.3,6.7,86,Incidence,1586728,Hispanic of any race,5.4,Male,Esophagus,2017
50-54,1.9,3.5,41,Incidence,1586728,Hispanic of any race,2.6,Male,Hodgkin Lymphoma,2017
50-54,1.0,2.3,24,Incidence,1586728,Hispanic of any race,1.5,Male,Kaposi Sarcoma,2017
50-54,27.6,33.1,480,Incidence,1586728,Hispanic of any race,30.3,Male,Kidney and Renal Pelvis,2017
50-54,2.6,4.5,55,Incidence,1586728,Hispanic of any race,3.5,Male,Larynx,2017
50-54,9.3,12.6,172,Incidence,1586728,Hispanic of any race,10.8,Male,Leukemias,2017
50-54,21.7,26.6,382,Incidence,1586728,Hispanic of any race,24.1,Male,Liver and Intrahepatic Bile Duct,2017
50-54,13.6,17.5,245,Incidence,1586728,Hispanic of any race,15.4,Male,Lung and Bronchus,2017
50-54,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
50-54,4.1,6.3,81,Incidence,1586728,Hispanic of any race,5.1,Male,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,1586728,Hispanic of any race,~,Male,Mesothelioma,2017
50-54,7.7,10.7,144,Incidence,1586728,Hispanic of any race,9.1,Male,Myeloma,2017
50-54,18.7,23.3,332,Incidence,1586728,Hispanic of any race,20.9,Male,Non-Hodgkin Lymphoma,2017
50-54,12.7,16.5,230,Incidence,1586728,Hispanic of any race,14.5,Male,Oral Cavity and Pharynx,2017
50-54,10.0,13.5,185,Incidence,1586728,Hispanic of any race,11.7,Male,Pancreas,2017
50-54,59.8,67.7,1010,Incidence,1586728,Hispanic of any race,63.7,Male,Prostate,2017
50-54,9.2,12.5,170,Incidence,1586728,Hispanic of any race,10.7,Male,Stomach,2017
50-54,1.6,3.1,36,Incidence,1586728,Hispanic of any race,2.3,Male,Testis,2017
50-54,8.5,11.6,158,Incidence,1586728,Hispanic of any race,10.0,Male,Thyroid,2017
50-54,7.4,10.4,140,Incidence,1586728,Hispanic of any race,8.8,Male,Urinary Bladder,2017
55-59,597.9,625.0,7876,Incidence,1288402,Hispanic of any race,611.3,Male,All Cancer Sites Combined,2017
55-59,8.3,11.8,128,Incidence,1288402,Hispanic of any race,9.9,Male,Brain and Other Nervous System,2017
55-59,66.7,76.0,918,Incidence,1288402,Hispanic of any race,71.3,Male,Colon and Rectum,2017
55-59,7.9,11.4,123,Incidence,1288402,Hispanic of any race,9.5,Male,Esophagus,2017
55-59,1.7,3.5,32,Incidence,1288402,Hispanic of any race,2.5,Male,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,1288402,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
55-59,40.9,48.3,573,Incidence,1288402,Hispanic of any race,44.5,Male,Kidney and Renal Pelvis,2017
55-59,7.2,10.5,112,Incidence,1288402,Hispanic of any race,8.7,Male,Larynx,2017
55-59,13.2,17.6,197,Incidence,1288402,Hispanic of any race,15.3,Male,Leukemias,2017
55-59,50.2,58.3,698,Incidence,1288402,Hispanic of any race,54.2,Male,Liver and Intrahepatic Bile Duct,2017
55-59,34.0,40.7,480,Incidence,1288402,Hispanic of any race,37.3,Male,Lung and Bronchus,2017
55-59,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
55-59,7.3,10.6,114,Incidence,1288402,Hispanic of any race,8.8,Male,Melanomas of the Skin,2017
55-59,0.8,2.2,18,Incidence,1288402,Hispanic of any race,1.4,Male,Mesothelioma,2017
55-59,11.9,16.0,178,Incidence,1288402,Hispanic of any race,13.8,Male,Myeloma,2017
55-59,27.7,33.8,395,Incidence,1288402,Hispanic of any race,30.7,Male,Non-Hodgkin Lymphoma,2017
55-59,23.8,29.5,342,Incidence,1288402,Hispanic of any race,26.5,Male,Oral Cavity and Pharynx,2017
55-59,18.1,23.1,264,Incidence,1288402,Hispanic of any race,20.5,Male,Pancreas,2017
55-59,155.8,169.8,2096,Incidence,1288402,Hispanic of any race,162.7,Male,Prostate,2017
55-59,15.9,20.6,234,Incidence,1288402,Hispanic of any race,18.2,Male,Stomach,2017
55-59,1.6,3.3,30,Incidence,1288402,Hispanic of any race,2.3,Male,Testis,2017
55-59,9.3,13.0,142,Incidence,1288402,Hispanic of any race,11.0,Male,Thyroid,2017
55-59,14.7,19.3,218,Incidence,1288402,Hispanic of any race,16.9,Male,Urinary Bladder,2017
60-64,949.5,988.9,9335,Incidence,963291,Hispanic of any race,969.1,Male,All Cancer Sites Combined,2017
60-64,9.2,13.5,108,Incidence,963291,Hispanic of any race,11.2,Male,Brain and Other Nervous System,2017
60-64,98.9,111.9,1014,Incidence,963291,Hispanic of any race,105.3,Male,Colon and Rectum,2017
60-64,9.6,14.0,112,Incidence,963291,Hispanic of any race,11.6,Male,Esophagus,2017
60-64,1.8,4.1,27,Incidence,963291,Hispanic of any race,2.8,Male,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,963291,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
60-64,59.2,69.4,618,Incidence,963291,Hispanic of any race,64.2,Male,Kidney and Renal Pelvis,2017
60-64,10.5,15.1,122,Incidence,963291,Hispanic of any race,12.7,Male,Larynx,2017
60-64,19.0,25.0,210,Incidence,963291,Hispanic of any race,21.8,Male,Leukemias,2017
60-64,72.3,83.5,749,Incidence,963291,Hispanic of any race,77.8,Male,Liver and Intrahepatic Bile Duct,2017
60-64,68.6,79.5,712,Incidence,963291,Hispanic of any race,73.9,Male,Lung and Bronchus,2017
60-64,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
60-64,9.5,13.9,111,Incidence,963291,Hispanic of any race,11.5,Male,Melanomas of the Skin,2017
60-64,1.1,3.0,18,Incidence,963291,Hispanic of any race,1.9,Male,Mesothelioma,2017
60-64,17.8,23.6,198,Incidence,963291,Hispanic of any race,20.6,Male,Myeloma,2017
60-64,40.8,49.4,433,Incidence,963291,Hispanic of any race,45.0,Male,Non-Hodgkin Lymphoma,2017
60-64,27.1,34.2,294,Incidence,963291,Hispanic of any race,30.5,Male,Oral Cavity and Pharynx,2017
60-64,27.0,34.1,293,Incidence,963291,Hispanic of any race,30.4,Male,Pancreas,2017
60-64,290.2,312.2,2900,Incidence,963291,Hispanic of any race,301.1,Male,Prostate,2017
60-64,25.1,31.9,273,Incidence,963291,Hispanic of any race,28.3,Male,Stomach,2017
60-64,~,~,~,Incidence,963291,Hispanic of any race,~,Male,Testis,2017
60-64,10.7,15.3,124,Incidence,963291,Hispanic of any race,12.9,Male,Thyroid,2017
60-64,30.9,38.4,332,Incidence,963291,Hispanic of any race,34.5,Male,Urinary Bladder,2017
65-69,1447.5,1505.2,10108,Incidence,684755,Hispanic of any race,1476.1,Male,All Cancer Sites Combined,2017
65-69,11.6,17.4,98,Incidence,684755,Hispanic of any race,14.3,Male,Brain and Other Nervous System,2017
65-69,142.9,161.5,1041,Incidence,684755,Hispanic of any race,152.0,Male,Colon and Rectum,2017
65-69,15.2,21.7,125,Incidence,684755,Hispanic of any race,18.3,Male,Esophagus,2017
65-69,3.3,6.8,33,Incidence,684755,Hispanic of any race,4.8,Male,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,684755,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
65-69,79.1,93.1,588,Incidence,684755,Hispanic of any race,85.9,Male,Kidney and Renal Pelvis,2017
65-69,14.8,21.3,122,Incidence,684755,Hispanic of any race,17.8,Male,Larynx,2017
65-69,24.5,32.6,194,Incidence,684755,Hispanic of any race,28.3,Male,Leukemias,2017
65-69,90.2,105.1,667,Incidence,684755,Hispanic of any race,97.4,Male,Liver and Intrahepatic Bile Duct,2017
65-69,119.0,136.1,872,Incidence,684755,Hispanic of any race,127.3,Male,Lung and Bronchus,2017
65-69,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
65-69,14.8,21.3,122,Incidence,684755,Hispanic of any race,17.8,Male,Melanomas of the Skin,2017
65-69,3.6,7.1,35,Incidence,684755,Hispanic of any race,5.1,Male,Mesothelioma,2017
65-69,25.8,34.2,204,Incidence,684755,Hispanic of any race,29.8,Male,Myeloma,2017
65-69,59.1,71.3,445,Incidence,684755,Hispanic of any race,65.0,Male,Non-Hodgkin Lymphoma,2017
65-69,36.5,46.3,282,Incidence,684755,Hispanic of any race,41.2,Male,Oral Cavity and Pharynx,2017
65-69,41.5,51.8,318,Incidence,684755,Hispanic of any race,46.4,Male,Pancreas,2017
65-69,500.5,534.7,3543,Incidence,684755,Hispanic of any race,517.4,Male,Prostate,2017
65-69,34.0,43.5,264,Incidence,684755,Hispanic of any race,38.6,Male,Stomach,2017
65-69,~,~,~,Incidence,684755,Hispanic of any race,~,Male,Testis,2017
65-69,11.5,17.3,97,Incidence,684755,Hispanic of any race,14.2,Male,Thyroid,2017
65-69,48.7,59.8,370,Incidence,684755,Hispanic of any race,54.0,Male,Urinary Bladder,2017
70-74,1739.2,1816.5,8176,Incidence,459963,Hispanic of any race,1777.5,Male,All Cancer Sites Combined,2017
70-74,11.7,19.0,69,Incidence,459963,Hispanic of any race,15.0,Male,Brain and Other Nervous System,2017
70-74,151.8,175.4,751,Incidence,459963,Hispanic of any race,163.3,Male,Colon and Rectum,2017
70-74,19.7,28.8,110,Incidence,459963,Hispanic of any race,23.9,Male,Esophagus,2017
70-74,3.7,8.3,26,Incidence,459963,Hispanic of any race,5.7,Male,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,459963,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
70-74,85.9,103.9,435,Incidence,459963,Hispanic of any race,94.6,Male,Kidney and Renal Pelvis,2017
70-74,18.3,27.2,103,Incidence,459963,Hispanic of any race,22.4,Male,Larynx,2017
70-74,36.5,48.5,194,Incidence,459963,Hispanic of any race,42.2,Male,Leukemias,2017
70-74,79.7,97.1,405,Incidence,459963,Hispanic of any race,88.1,Male,Liver and Intrahepatic Bile Duct,2017
70-74,184.4,210.2,906,Incidence,459963,Hispanic of any race,197.0,Male,Lung and Bronchus,2017
70-74,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
70-74,15.1,23.3,87,Incidence,459963,Hispanic of any race,18.9,Male,Melanomas of the Skin,2017
70-74,3.0,7.2,22,Incidence,459963,Hispanic of any race,4.8,Male,Mesothelioma,2017
70-74,33.2,44.8,178,Incidence,459963,Hispanic of any race,38.7,Male,Myeloma,2017
70-74,84.0,101.8,426,Incidence,459963,Hispanic of any race,92.6,Male,Non-Hodgkin Lymphoma,2017
70-74,38.1,50.4,202,Incidence,459963,Hispanic of any race,43.9,Male,Oral Cavity and Pharynx,2017
70-74,58.7,73.7,303,Incidence,459963,Hispanic of any race,65.9,Male,Pancreas,2017
70-74,533.5,576.8,2552,Incidence,459963,Hispanic of any race,554.8,Male,Prostate,2017
70-74,51.3,65.4,267,Incidence,459963,Hispanic of any race,58.0,Male,Stomach,2017
70-74,~,~,~,Incidence,459963,Hispanic of any race,~,Male,Testis,2017
70-74,8.8,15.3,54,Incidence,459963,Hispanic of any race,11.7,Male,Thyroid,2017
70-74,83.8,101.6,425,Incidence,459963,Hispanic of any race,92.4,Male,Urinary Bladder,2017
75-79,2039.2,2143.6,6200,Incidence,296517,Hispanic of any race,2090.9,Male,All Cancer Sites Combined,2017
75-79,15.7,26.4,61,Incidence,296517,Hispanic of any race,20.6,Male,Brain and Other Nervous System,2017
75-79,176.4,208.3,569,Incidence,296517,Hispanic of any race,191.9,Male,Colon and Rectum,2017
75-79,21.7,34.0,81,Incidence,296517,Hispanic of any race,27.3,Male,Esophagus,2017
75-79,4.1,10.4,20,Incidence,296517,Hispanic of any race,6.7,Male,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,296517,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
75-79,94.8,118.6,315,Incidence,296517,Hispanic of any race,106.2,Male,Kidney and Renal Pelvis,2017
75-79,20.2,32.1,76,Incidence,296517,Hispanic of any race,25.6,Male,Larynx,2017
75-79,58.1,77.1,199,Incidence,296517,Hispanic of any race,67.1,Male,Leukemias,2017
75-79,92.6,116.1,308,Incidence,296517,Hispanic of any race,103.9,Male,Liver and Intrahepatic Bile Duct,2017
75-79,258.3,296.5,821,Incidence,296517,Hispanic of any race,276.9,Male,Lung and Bronchus,2017
75-79,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
75-79,18.1,29.4,69,Incidence,296517,Hispanic of any race,23.3,Male,Melanomas of the Skin,2017
75-79,4.6,11.2,22,Incidence,296517,Hispanic of any race,7.4,Male,Mesothelioma,2017
75-79,39.7,55.7,140,Incidence,296517,Hispanic of any race,47.2,Male,Myeloma,2017
75-79,91.6,115.1,305,Incidence,296517,Hispanic of any race,102.9,Male,Non-Hodgkin Lymphoma,2017
75-79,43.7,60.5,153,Incidence,296517,Hispanic of any race,51.6,Male,Oral Cavity and Pharynx,2017
75-79,66.9,87.2,227,Incidence,296517,Hispanic of any race,76.6,Male,Pancreas,2017
75-79,506.2,559.1,1578,Incidence,296517,Hispanic of any race,532.2,Male,Prostate,2017
75-79,61.9,81.4,211,Incidence,296517,Hispanic of any race,71.2,Male,Stomach,2017
75-79,~,~,~,Incidence,296517,Hispanic of any race,~,Male,Testis,2017
75-79,11.4,20.7,46,Incidence,296517,Hispanic of any race,15.5,Male,Thyroid,2017
75-79,118.5,144.9,389,Incidence,296517,Hispanic of any race,131.2,Male,Urinary Bladder,2017
80-84,2223.7,2359.5,4402,Incidence,192157,Hispanic of any race,2290.8,Male,All Cancer Sites Combined,2017
80-84,24.7,41.4,62,Incidence,192157,Hispanic of any race,32.3,Male,Brain and Other Nervous System,2017
80-84,203.6,246.5,431,Incidence,192157,Hispanic of any race,224.3,Male,Colon and Rectum,2017
80-84,23.8,40.2,60,Incidence,192157,Hispanic of any race,31.2,Male,Esophagus,2017
80-84,~,~,~,Incidence,192157,Hispanic of any race,~,Male,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,192157,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
80-84,91.6,121.2,203,Incidence,192157,Hispanic of any race,105.6,Male,Kidney and Renal Pelvis,2017
80-84,19.3,34.3,50,Incidence,192157,Hispanic of any race,26.0,Male,Larynx,2017
80-84,71.8,98.3,162,Incidence,192157,Hispanic of any race,84.3,Male,Leukemias,2017
80-84,80.5,108.4,180,Incidence,192157,Hispanic of any race,93.7,Male,Liver and Intrahepatic Bile Duct,2017
80-84,313.8,366.4,652,Incidence,192157,Hispanic of any race,339.3,Male,Lung and Bronchus,2017
80-84,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
80-84,29.3,47.2,72,Incidence,192157,Hispanic of any race,37.5,Male,Melanomas of the Skin,2017
80-84,8.0,18.6,24,Incidence,192157,Hispanic of any race,12.5,Male,Mesothelioma,2017
80-84,44.2,65.6,104,Incidence,192157,Hispanic of any race,54.1,Male,Myeloma,2017
80-84,130.6,165.5,283,Incidence,192157,Hispanic of any race,147.3,Male,Non-Hodgkin Lymphoma,2017
80-84,38.1,58.1,91,Incidence,192157,Hispanic of any race,47.4,Male,Oral Cavity and Pharynx,2017
80-84,75.2,102.3,169,Incidence,192157,Hispanic of any race,87.9,Male,Pancreas,2017
80-84,396.0,454.8,816,Incidence,192157,Hispanic of any race,424.7,Male,Prostate,2017
80-84,63.2,88.2,144,Incidence,192157,Hispanic of any race,74.9,Male,Stomach,2017
80-84,~,~,~,Incidence,192157,Hispanic of any race,~,Male,Testis,2017
80-84,12.7,25.3,35,Incidence,192157,Hispanic of any race,18.2,Male,Thyroid,2017
80-84,173.9,213.8,371,Incidence,192157,Hispanic of any race,193.1,Male,Urinary Bladder,2017
85+,2076.1,2218.0,3548,Incidence,165318,Hispanic of any race,2146.2,Male,All Cancer Sites Combined,2017
85+,13.2,27.3,32,Incidence,165318,Hispanic of any race,19.4,Male,Brain and Other Nervous System,2017
85+,220.0,268.1,402,Incidence,165318,Hispanic of any race,243.2,Male,Colon and Rectum,2017
85+,25.6,44.0,56,Incidence,165318,Hispanic of any race,33.9,Male,Esophagus,2017
85+,~,~,~,Incidence,165318,Hispanic of any race,~,Male,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,165318,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
85+,76.2,105.8,149,Incidence,165318,Hispanic of any race,90.1,Male,Kidney and Renal Pelvis,2017
85+,9.8,22.3,25,Incidence,165318,Hispanic of any race,15.1,Male,Larynx,2017
85+,68.5,96.7,135,Incidence,165318,Hispanic of any race,81.7,Male,Leukemias,2017
85+,67.9,96.0,134,Incidence,165318,Hispanic of any race,81.1,Male,Liver and Intrahepatic Bile Duct,2017
85+,265.5,318.2,481,Incidence,165318,Hispanic of any race,291.0,Male,Lung and Bronchus,2017
85+,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
85+,28.8,48.1,62,Incidence,165318,Hispanic of any race,37.5,Male,Melanomas of the Skin,2017
85+,6.0,16.5,17,Incidence,165318,Hispanic of any race,10.3,Male,Mesothelioma,2017
85+,40.5,62.9,84,Incidence,165318,Hispanic of any race,50.8,Male,Myeloma,2017
85+,96.4,129.2,185,Incidence,165318,Hispanic of any race,111.9,Male,Non-Hodgkin Lymphoma,2017
85+,36.8,58.2,77,Incidence,165318,Hispanic of any race,46.6,Male,Oral Cavity and Pharynx,2017
85+,72.9,101.9,143,Incidence,165318,Hispanic of any race,86.5,Male,Pancreas,2017
85+,315.9,373.0,568,Incidence,165318,Hispanic of any race,343.6,Male,Prostate,2017
85+,72.9,101.9,143,Incidence,165318,Hispanic of any race,86.5,Male,Stomach,2017
85+,~,~,~,Incidence,165318,Hispanic of any race,~,Male,Testis,2017
85+,8.3,20.1,22,Incidence,165318,Hispanic of any race,13.3,Male,Thyroid,2017
85+,191.8,237.0,353,Incidence,165318,Hispanic of any race,213.5,Male,Urinary Bladder,2017
<1,21.1,30.0,128,Incidence,506984,Hispanic of any race,25.2,Male,All Cancer Sites Combined,2017
<1,2.3,5.9,19,Incidence,506984,Hispanic of any race,3.7,Male,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Colon and Rectum,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Esophagus,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Larynx,2017
<1,2.4,6.1,20,Incidence,506984,Hispanic of any race,3.9,Male,Leukemias,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Lung and Bronchus,2017
<1,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Melanomas of the Skin,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Mesothelioma,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Myeloma,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Pancreas,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Prostate,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Stomach,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Testis,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Thyroid,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male,Urinary Bladder,2017
1-4,20.1,22.9,871,Incidence,4057275,Hispanic of any race,21.5,Male and Female,All Cancer Sites Combined,2017
1-4,3.3,4.5,156,Incidence,4057275,Hispanic of any race,3.8,Male and Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,Cervix,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Esophagus,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,Female Breast,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
1-4,1.2,2.0,64,Incidence,4057275,Hispanic of any race,1.6,Male and Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Larynx,2017
1-4,8.4,10.3,379,Incidence,4057275,Hispanic of any race,9.3,Male and Female,Leukemias,2017
1-4,0.6,1.1,33,Incidence,4057275,Hispanic of any race,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,Male and Female Breast,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Mesothelioma,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Myeloma,2017
1-4,0.5,1.1,32,Incidence,4057275,Hispanic of any race,0.8,Male and Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,1988966,Hispanic of any race,~,Male and Female,Ovary,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Pancreas,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male and Female,Prostate,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Stomach,2017
1-4,~,~,~,Incidence,2068309,Hispanic of any race,~,Male and Female,Testis,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Thyroid,2017
1-4,~,~,~,Incidence,4057275,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
10-14,14.9,17.1,826,Incidence,5164902,Hispanic of any race,16.0,Male and Female,All Cancer Sites Combined,2017
10-14,2.2,3.2,138,Incidence,5164902,Hispanic of any race,2.7,Male and Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Male and Female,Cervix,2017
10-14,0.3,0.6,22,Incidence,5164902,Hispanic of any race,0.4,Male and Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Esophagus,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Male and Female,Female Breast,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
10-14,0.7,1.3,51,Incidence,5164902,Hispanic of any race,1.0,Male and Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Larynx,2017
10-14,4.3,5.6,254,Incidence,5164902,Hispanic of any race,4.9,Male and Female,Leukemias,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Male and Female,Male and Female Breast,2017
10-14,~,~,~,Incidence,2533728,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Mesothelioma,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Myeloma,2017
10-14,0.7,1.2,48,Incidence,5164902,Hispanic of any race,0.9,Male and Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2017
10-14,0.8,1.6,29,Incidence,2533728,Hispanic of any race,1.1,Male and Female,Ovary,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Pancreas,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male and Female,Prostate,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Stomach,2017
10-14,~,~,~,Incidence,2631174,Hispanic of any race,~,Male and Female,Testis,2017
10-14,0.5,1.0,39,Incidence,5164902,Hispanic of any race,0.8,Male and Female,Thyroid,2017
10-14,~,~,~,Incidence,5164902,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
15-19,20.8,23.5,1081,Incidence,4882203,Hispanic of any race,22.1,Male and Female,All Cancer Sites Combined,2017
15-19,1.4,2.2,86,Incidence,4882203,Hispanic of any race,1.8,Male and Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Male and Female,Cervix,2017
15-19,0.8,1.5,55,Incidence,4882203,Hispanic of any race,1.1,Male and Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Esophagus,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Male and Female,Female Breast,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
15-19,1.8,2.6,107,Incidence,4882203,Hispanic of any race,2.2,Male and Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Larynx,2017
15-19,3.5,4.7,199,Incidence,4882203,Hispanic of any race,4.1,Male and Female,Leukemias,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Male and Female,Male and Female Breast,2017
15-19,~,~,~,Incidence,2390957,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Mesothelioma,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Myeloma,2017
15-19,1.3,2.0,79,Incidence,4882203,Hispanic of any race,1.6,Male and Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2017
15-19,0.8,1.7,29,Incidence,2390957,Hispanic of any race,1.2,Male and Female,Ovary,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Pancreas,2017
15-19,~,~,~,Incidence,2491246,Hispanic of any race,~,Male and Female,Prostate,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Stomach,2017
15-19,4.3,6.2,129,Incidence,2491246,Hispanic of any race,5.2,Male and Female,Testis,2017
15-19,2.4,3.3,138,Incidence,4882203,Hispanic of any race,2.8,Male and Female,Thyroid,2017
15-19,~,~,~,Incidence,4882203,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
20-24,31.8,35.1,1606,Incidence,4799230,Hispanic of any race,33.5,Male and Female,All Cancer Sites Combined,2017
20-24,1.1,1.8,67,Incidence,4799230,Hispanic of any race,1.4,Male and Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Male and Female,Cervix,2017
20-24,1.7,2.6,101,Incidence,4799230,Hispanic of any race,2.1,Male and Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Esophagus,2017
20-24,1.3,2.4,41,Incidence,2325062,Hispanic of any race,1.8,Male and Female,Female Breast,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
20-24,2.2,3.1,126,Incidence,4799230,Hispanic of any race,2.6,Male and Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
20-24,0.3,0.7,23,Incidence,4799230,Hispanic of any race,0.5,Male and Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Larynx,2017
20-24,2.8,3.9,159,Incidence,4799230,Hispanic of any race,3.3,Male and Female,Leukemias,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Lung and Bronchus,2017
20-24,1.3,2.4,41,Incidence,2325062,Hispanic of any race,1.8,Male and Female,Male and Female Breast,2017
20-24,~,~,~,Incidence,2325062,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Mesothelioma,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Myeloma,2017
20-24,1.9,2.8,113,Incidence,4799230,Hispanic of any race,2.4,Male and Female,Non-Hodgkin Lymphoma,2017
20-24,0.3,0.8,25,Incidence,4799230,Hispanic of any race,0.5,Male and Female,Oral Cavity and Pharynx,2017
20-24,1.9,3.2,57,Incidence,2325062,Hispanic of any race,2.5,Male and Female,Ovary,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Pancreas,2017
20-24,~,~,~,Incidence,2474168,Hispanic of any race,~,Male and Female,Prostate,2017
20-24,0.2,0.6,17,Incidence,4799230,Hispanic of any race,0.4,Male and Female,Stomach,2017
20-24,13.2,16.3,363,Incidence,2474168,Hispanic of any race,14.7,Male and Female,Testis,2017
20-24,4.6,5.9,250,Incidence,4799230,Hispanic of any race,5.2,Male and Female,Thyroid,2017
20-24,~,~,~,Incidence,4799230,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
25-29,50.3,54.4,2495,Incidence,4770119,Hispanic of any race,52.3,Male and Female,All Cancer Sites Combined,2017
25-29,1.6,2.4,95,Incidence,4770119,Hispanic of any race,2.0,Male and Female,Brain and Other Nervous System,2017
25-29,3.6,5.4,101,Incidence,2273007,Hispanic of any race,4.4,Male and Female,Cervix,2017
25-29,2.5,3.5,143,Incidence,4770119,Hispanic of any race,3.0,Male and Female,Colon and Rectum,2017
25-29,2.3,3.7,67,Incidence,2273007,Hispanic of any race,2.9,Male and Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,4770119,Hispanic of any race,~,Male and Female,Esophagus,2017
25-29,7.4,9.8,194,Incidence,2273007,Hispanic of any race,8.5,Male and Female,Female Breast,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
25-29,2.0,3.0,118,Incidence,4770119,Hispanic of any race,2.5,Male and Female,Hodgkin Lymphoma,2017
25-29,0.3,0.7,24,Incidence,4770119,Hispanic of any race,0.5,Male and Female,Kaposi Sarcoma,2017
25-29,1.1,1.8,66,Incidence,4770119,Hispanic of any race,1.4,Male and Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,4770119,Hispanic of any race,~,Male and Female,Larynx,2017
25-29,3.1,4.2,174,Incidence,4770119,Hispanic of any race,3.6,Male and Female,Leukemias,2017
25-29,0.2,0.6,18,Incidence,4770119,Hispanic of any race,0.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
25-29,0.3,0.7,23,Incidence,4770119,Hispanic of any race,0.5,Male and Female,Lung and Bronchus,2017
25-29,7.4,9.8,194,Incidence,2273007,Hispanic of any race,8.5,Male and Female,Male and Female Breast,2017
25-29,~,~,~,Incidence,2273007,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
25-29,0.7,1.3,48,Incidence,4770119,Hispanic of any race,1.0,Male and Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,4770119,Hispanic of any race,~,Male and Female,Mesothelioma,2017
25-29,~,~,~,Incidence,4770119,Hispanic of any race,~,Male and Female,Myeloma,2017
25-29,2.5,3.5,141,Incidence,4770119,Hispanic of any race,3.0,Male and Female,Non-Hodgkin Lymphoma,2017
25-29,0.5,1.0,35,Incidence,4770119,Hispanic of any race,0.7,Male and Female,Oral Cavity and Pharynx,2017
25-29,2.1,3.5,62,Incidence,2273007,Hispanic of any race,2.7,Male and Female,Ovary,2017
25-29,0.2,0.6,17,Incidence,4770119,Hispanic of any race,0.4,Male and Female,Pancreas,2017
25-29,~,~,~,Incidence,2497112,Hispanic of any race,~,Male and Female,Prostate,2017
25-29,0.4,0.8,28,Incidence,4770119,Hispanic of any race,0.6,Male and Female,Stomach,2017
25-29,15.9,19.2,436,Incidence,2497112,Hispanic of any race,17.5,Male and Female,Testis,2017
25-29,8.3,10.0,434,Incidence,4770119,Hispanic of any race,9.1,Male and Female,Thyroid,2017
25-29,~,~,~,Incidence,4770119,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
30-34,76.8,82.0,3570,Incidence,4500015,Hispanic of any race,79.3,Male and Female,All Cancer Sites Combined,2017
30-34,2.1,3.1,116,Incidence,4500015,Hispanic of any race,2.6,Male and Female,Brain and Other Nervous System,2017
30-34,10.3,13.2,250,Incidence,2135897,Hispanic of any race,11.7,Male and Female,Cervix,2017
30-34,4.7,6.1,242,Incidence,4500015,Hispanic of any race,5.4,Male and Female,Colon and Rectum,2017
30-34,6.2,8.5,156,Incidence,2135897,Hispanic of any race,7.3,Male and Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,4500015,Hispanic of any race,~,Male and Female,Esophagus,2017
30-34,22.1,26.3,516,Incidence,2135897,Hispanic of any race,24.2,Male and Female,Female Breast,2017
30-34,1.4,2.6,41,Incidence,2135897,Hispanic of any race,1.9,Male and Female,"Female Breast, <i>in situ</i>",2017
30-34,1.9,2.8,103,Incidence,4500015,Hispanic of any race,2.3,Male and Female,Hodgkin Lymphoma,2017
30-34,0.5,1.0,32,Incidence,4500015,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2017
30-34,2.3,3.3,123,Incidence,4500015,Hispanic of any race,2.7,Male and Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,4500015,Hispanic of any race,~,Male and Female,Larynx,2017
30-34,3.4,4.5,176,Incidence,4500015,Hispanic of any race,3.9,Male and Female,Leukemias,2017
30-34,0.3,0.7,19,Incidence,4500015,Hispanic of any race,0.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
30-34,0.5,1.1,35,Incidence,4500015,Hispanic of any race,0.8,Male and Female,Lung and Bronchus,2017
30-34,22.1,26.3,516,Incidence,2135897,Hispanic of any race,24.2,Male and Female,Male and Female Breast,2017
30-34,1.4,2.6,41,Incidence,2135897,Hispanic of any race,1.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
30-34,1.4,2.3,82,Incidence,4500015,Hispanic of any race,1.8,Male and Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,4500015,Hispanic of any race,~,Male and Female,Mesothelioma,2017
30-34,0.2,0.6,18,Incidence,4500015,Hispanic of any race,0.4,Male and Female,Myeloma,2017
30-34,3.7,5.0,195,Incidence,4500015,Hispanic of any race,4.3,Male and Female,Non-Hodgkin Lymphoma,2017
30-34,0.8,1.4,48,Incidence,4500015,Hispanic of any race,1.1,Male and Female,Oral Cavity and Pharynx,2017
30-34,2.5,4.0,68,Incidence,2135897,Hispanic of any race,3.2,Male and Female,Ovary,2017
30-34,0.7,1.3,45,Incidence,4500015,Hispanic of any race,1.0,Male and Female,Pancreas,2017
30-34,~,~,~,Incidence,2364118,Hispanic of any race,~,Male and Female,Prostate,2017
30-34,1.6,2.5,92,Incidence,4500015,Hispanic of any race,2.0,Male and Female,Stomach,2017
30-34,11.9,14.9,316,Incidence,2364118,Hispanic of any race,13.4,Male and Female,Testis,2017
30-34,12.2,14.4,597,Incidence,4500015,Hispanic of any race,13.3,Male and Female,Thyroid,2017
30-34,0.3,0.7,22,Incidence,4500015,Hispanic of any race,0.5,Male and Female,Urinary Bladder,2017
35-39,113.5,119.9,5107,Incidence,4378169,Hispanic of any race,116.6,Male and Female,All Cancer Sites Combined,2017
35-39,2.6,3.6,135,Incidence,4378169,Hispanic of any race,3.1,Male and Female,Brain and Other Nervous System,2017
35-39,14.2,17.7,336,Incidence,2112661,Hispanic of any race,15.9,Male and Female,Cervix,2017
35-39,8.3,10.2,404,Incidence,4378169,Hispanic of any race,9.2,Male and Female,Colon and Rectum,2017
35-39,11.8,15.0,282,Incidence,2112661,Hispanic of any race,13.3,Male and Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,4378169,Hispanic of any race,~,Male and Female,Esophagus,2017
35-39,46.0,52.0,1033,Incidence,2112661,Hispanic of any race,48.9,Male and Female,Female Breast,2017
35-39,5.9,8.2,148,Incidence,2112661,Hispanic of any race,7.0,Male and Female,"Female Breast, <i>in situ</i>",2017
35-39,1.7,2.5,90,Incidence,4378169,Hispanic of any race,2.1,Male and Female,Hodgkin Lymphoma,2017
35-39,0.4,0.9,28,Incidence,4378169,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2017
35-39,5.4,6.9,266,Incidence,4378169,Hispanic of any race,6.1,Male and Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,4378169,Hispanic of any race,~,Male and Female,Larynx,2017
35-39,4.1,5.5,209,Incidence,4378169,Hispanic of any race,4.8,Male and Female,Leukemias,2017
35-39,0.7,1.3,41,Incidence,4378169,Hispanic of any race,0.9,Male and Female,Liver and Intrahepatic Bile Duct,2017
35-39,1.0,1.7,58,Incidence,4378169,Hispanic of any race,1.3,Male and Female,Lung and Bronchus,2017
35-39,46.0,52.0,1033,Incidence,2112661,Hispanic of any race,48.9,Male and Female,Male and Female Breast,2017
35-39,5.9,8.2,148,Incidence,2112661,Hispanic of any race,7.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
35-39,2.2,3.2,118,Incidence,4378169,Hispanic of any race,2.7,Male and Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,4378169,Hispanic of any race,~,Male and Female,Mesothelioma,2017
35-39,0.5,1.1,33,Incidence,4378169,Hispanic of any race,0.8,Male and Female,Myeloma,2017
35-39,5.2,6.7,260,Incidence,4378169,Hispanic of any race,5.9,Male and Female,Non-Hodgkin Lymphoma,2017
35-39,1.4,2.2,78,Incidence,4378169,Hispanic of any race,1.8,Male and Female,Oral Cavity and Pharynx,2017
35-39,4.2,6.2,108,Incidence,2112661,Hispanic of any race,5.1,Male and Female,Ovary,2017
35-39,1.1,1.8,62,Incidence,4378169,Hispanic of any race,1.4,Male and Female,Pancreas,2017
35-39,~,~,~,Incidence,2265508,Hispanic of any race,~,Male and Female,Prostate,2017
35-39,2.9,4.0,151,Incidence,4378169,Hispanic of any race,3.4,Male and Female,Stomach,2017
35-39,7.6,10.1,200,Incidence,2265508,Hispanic of any race,8.8,Male and Female,Testis,2017
35-39,15.0,17.4,708,Incidence,4378169,Hispanic of any race,16.2,Male and Female,Thyroid,2017
35-39,0.7,1.3,41,Incidence,4378169,Hispanic of any race,0.9,Male and Female,Urinary Bladder,2017
40-44,171.9,180.1,7054,Incidence,4008122,Hispanic of any race,176.0,Male and Female,All Cancer Sites Combined,2017
40-44,2.9,4.0,137,Incidence,4008122,Hispanic of any race,3.4,Male and Female,Brain and Other Nervous System,2017
40-44,14.5,18.1,320,Incidence,1972195,Hispanic of any race,16.2,Male and Female,Cervix,2017
40-44,14.9,17.4,646,Incidence,4008122,Hispanic of any race,16.1,Male and Female,Colon and Rectum,2017
40-44,15.6,19.4,344,Incidence,1972195,Hispanic of any race,17.4,Male and Female,"Corpus and Uterus, NOS",2017
40-44,0.4,0.9,24,Incidence,4008122,Hispanic of any race,0.6,Male and Female,Esophagus,2017
40-44,93.3,102.1,1926,Incidence,1972195,Hispanic of any race,97.7,Male and Female,Female Breast,2017
40-44,23.7,28.3,511,Incidence,1972195,Hispanic of any race,25.9,Male and Female,"Female Breast, <i>in situ</i>",2017
40-44,1.4,2.2,70,Incidence,4008122,Hispanic of any race,1.7,Male and Female,Hodgkin Lymphoma,2017
40-44,0.4,0.9,25,Incidence,4008122,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2017
40-44,10.9,13.1,479,Incidence,4008122,Hispanic of any race,12.0,Male and Female,Kidney and Renal Pelvis,2017
40-44,0.2,0.7,17,Incidence,4008122,Hispanic of any race,0.4,Male and Female,Larynx,2017
40-44,5.6,7.1,253,Incidence,4008122,Hispanic of any race,6.3,Male and Female,Leukemias,2017
40-44,1.1,1.9,58,Incidence,4008122,Hispanic of any race,1.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
40-44,2.8,4.0,135,Incidence,4008122,Hispanic of any race,3.4,Male and Female,Lung and Bronchus,2017
40-44,93.3,102.1,1926,Incidence,1972195,Hispanic of any race,97.7,Male and Female,Male and Female Breast,2017
40-44,23.7,28.3,511,Incidence,1972195,Hispanic of any race,25.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
40-44,2.3,3.4,113,Incidence,4008122,Hispanic of any race,2.8,Male and Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,4008122,Hispanic of any race,~,Male and Female,Mesothelioma,2017
40-44,1.8,2.7,88,Incidence,4008122,Hispanic of any race,2.2,Male and Female,Myeloma,2017
40-44,6.5,8.2,294,Incidence,4008122,Hispanic of any race,7.3,Male and Female,Non-Hodgkin Lymphoma,2017
40-44,2.4,3.5,117,Incidence,4008122,Hispanic of any race,2.9,Male and Female,Oral Cavity and Pharynx,2017
40-44,5.3,7.6,126,Incidence,1972195,Hispanic of any race,6.4,Male and Female,Ovary,2017
40-44,2.4,3.5,116,Incidence,4008122,Hispanic of any race,2.9,Male and Female,Pancreas,2017
40-44,2.1,3.6,56,Incidence,2035927,Hispanic of any race,2.8,Male and Female,Prostate,2017
40-44,4.7,6.1,215,Incidence,4008122,Hispanic of any race,5.4,Male and Female,Stomach,2017
40-44,5.4,7.7,132,Incidence,2035927,Hispanic of any race,6.5,Male and Female,Testis,2017
40-44,17.1,19.8,738,Incidence,4008122,Hispanic of any race,18.4,Male and Female,Thyroid,2017
40-44,1.0,1.8,55,Incidence,4008122,Hispanic of any race,1.4,Male and Female,Urinary Bladder,2017
45-49,260.8,271.4,9700,Incidence,3645484,Hispanic of any race,266.1,Male and Female,All Cancer Sites Combined,2017
45-49,3.7,5.0,157,Incidence,3645484,Hispanic of any race,4.3,Male and Female,Brain and Other Nervous System,2017
45-49,14.0,17.7,284,Incidence,1802374,Hispanic of any race,15.8,Male and Female,Cervix,2017
45-49,25.7,29.1,996,Incidence,3645484,Hispanic of any race,27.3,Male and Female,Colon and Rectum,2017
45-49,23.2,27.9,459,Incidence,1802374,Hispanic of any race,25.5,Male and Female,"Corpus and Uterus, NOS",2017
45-49,0.9,1.7,46,Incidence,3645484,Hispanic of any race,1.3,Male and Female,Esophagus,2017
45-49,143.0,154.3,2677,Incidence,1802374,Hispanic of any race,148.5,Male and Female,Female Breast,2017
45-49,39.3,45.3,761,Incidence,1802374,Hispanic of any race,42.2,Male and Female,"Female Breast, <i>in situ</i>",2017
45-49,1.5,2.4,69,Incidence,3645484,Hispanic of any race,1.9,Male and Female,Hodgkin Lymphoma,2017
45-49,0.5,1.1,29,Incidence,3645484,Hispanic of any race,0.8,Male and Female,Kaposi Sarcoma,2017
45-49,16.0,18.7,631,Incidence,3645484,Hispanic of any race,17.3,Male and Female,Kidney and Renal Pelvis,2017
45-49,0.7,1.4,37,Incidence,3645484,Hispanic of any race,1.0,Male and Female,Larynx,2017
45-49,6.3,8.1,261,Incidence,3645484,Hispanic of any race,7.2,Male and Female,Leukemias,2017
45-49,4.3,5.8,182,Incidence,3645484,Hispanic of any race,5.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
45-49,6.1,7.9,253,Incidence,3645484,Hispanic of any race,6.9,Male and Female,Lung and Bronchus,2017
45-49,143.0,154.3,2677,Incidence,1802374,Hispanic of any race,148.5,Male and Female,Male and Female Breast,2017
45-49,39.3,45.3,761,Incidence,1802374,Hispanic of any race,42.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
45-49,4.1,5.5,173,Incidence,3645484,Hispanic of any race,4.7,Male and Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,3645484,Hispanic of any race,~,Male and Female,Mesothelioma,2017
45-49,3.1,4.3,133,Incidence,3645484,Hispanic of any race,3.6,Male and Female,Myeloma,2017
45-49,12.1,14.5,482,Incidence,3645484,Hispanic of any race,13.2,Male and Female,Non-Hodgkin Lymphoma,2017
45-49,5.2,6.8,217,Incidence,3645484,Hispanic of any race,6.0,Male and Female,Oral Cavity and Pharynx,2017
45-49,10.4,13.7,216,Incidence,1802374,Hispanic of any race,12.0,Male and Female,Ovary,2017
45-49,4.5,6.0,190,Incidence,3645484,Hispanic of any race,5.2,Male and Female,Pancreas,2017
45-49,12.1,15.6,254,Incidence,1843110,Hispanic of any race,13.8,Male and Female,Prostate,2017
45-49,7.0,8.8,287,Incidence,3645484,Hispanic of any race,7.9,Male and Female,Stomach,2017
45-49,2.8,4.6,67,Incidence,1843110,Hispanic of any race,3.6,Male and Female,Testis,2017
45-49,19.2,22.2,754,Incidence,3645484,Hispanic of any race,20.7,Male and Female,Thyroid,2017
45-49,2.7,3.9,120,Incidence,3645484,Hispanic of any race,3.3,Male and Female,Urinary Bladder,2017
5-9,11.5,13.4,649,Incidence,5221582,Hispanic of any race,12.4,Male and Female,All Cancer Sites Combined,2017
5-9,2.3,3.2,142,Incidence,5221582,Hispanic of any race,2.7,Male and Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,Cervix,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Esophagus,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,Female Breast,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
5-9,0.3,0.7,25,Incidence,5221582,Hispanic of any race,0.5,Male and Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
5-9,0.2,0.6,21,Incidence,5221582,Hispanic of any race,0.4,Male and Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Larynx,2017
5-9,4.2,5.4,249,Incidence,5221582,Hispanic of any race,4.8,Male and Female,Leukemias,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,Male and Female Breast,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Mesothelioma,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Myeloma,2017
5-9,0.7,1.3,51,Incidence,5221582,Hispanic of any race,1.0,Male and Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,2561602,Hispanic of any race,~,Male and Female,Ovary,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Pancreas,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male and Female,Prostate,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Stomach,2017
5-9,~,~,~,Incidence,2659980,Hispanic of any race,~,Male and Female,Testis,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Thyroid,2017
5-9,~,~,~,Incidence,5221582,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
50-54,412.6,427.0,13263,Incidence,3159713,Hispanic of any race,419.8,Male and Female,All Cancer Sites Combined,2017
50-54,5.0,6.7,182,Incidence,3159713,Hispanic of any race,5.8,Male and Female,Brain and Other Nervous System,2017
50-54,13.3,17.2,238,Incidence,1572985,Hispanic of any race,15.1,Male and Female,Cervix,2017
50-54,46.3,51.2,1538,Incidence,3159713,Hispanic of any race,48.7,Male and Female,Colon and Rectum,2017
50-54,42.9,49.6,726,Incidence,1572985,Hispanic of any race,46.2,Male and Female,"Corpus and Uterus, NOS",2017
50-54,2.5,3.7,97,Incidence,3159713,Hispanic of any race,3.1,Male and Female,Esophagus,2017
50-54,174.2,187.5,2843,Incidence,1572985,Hispanic of any race,180.7,Male and Female,Female Breast,2017
50-54,47.2,54.3,797,Incidence,1572985,Hispanic of any race,50.7,Male and Female,"Female Breast, <i>in situ</i>",2017
50-54,1.8,2.9,72,Incidence,3159713,Hispanic of any race,2.3,Male and Female,Hodgkin Lymphoma,2017
50-54,0.5,1.1,24,Incidence,3159713,Hispanic of any race,0.8,Male and Female,Kaposi Sarcoma,2017
50-54,23.2,26.7,788,Incidence,3159713,Hispanic of any race,24.9,Male and Female,Kidney and Renal Pelvis,2017
50-54,1.8,2.9,73,Incidence,3159713,Hispanic of any race,2.3,Male and Female,Larynx,2017
50-54,9.0,11.3,320,Incidence,3159713,Hispanic of any race,10.1,Male and Female,Leukemias,2017
50-54,13.9,16.7,482,Incidence,3159713,Hispanic of any race,15.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
50-54,14.3,17.1,496,Incidence,3159713,Hispanic of any race,15.7,Male and Female,Lung and Bronchus,2017
50-54,174.2,187.5,2843,Incidence,1572985,Hispanic of any race,180.7,Male and Female,Male and Female Breast,2017
50-54,47.2,54.3,797,Incidence,1572985,Hispanic of any race,50.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
50-54,5.7,7.5,206,Incidence,3159713,Hispanic of any race,6.5,Male and Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,3159713,Hispanic of any race,~,Male and Female,Mesothelioma,2017
50-54,6.6,8.6,239,Incidence,3159713,Hispanic of any race,7.6,Male and Female,Myeloma,2017
50-54,18.4,21.6,631,Incidence,3159713,Hispanic of any race,20.0,Male and Female,Non-Hodgkin Lymphoma,2017
50-54,9.2,11.4,324,Incidence,3159713,Hispanic of any race,10.3,Male and Female,Oral Cavity and Pharynx,2017
50-54,16.6,20.9,293,Incidence,1572985,Hispanic of any race,18.6,Male and Female,Ovary,2017
50-54,9.0,11.3,320,Incidence,3159713,Hispanic of any race,10.1,Male and Female,Pancreas,2017
50-54,59.8,67.7,1010,Incidence,1586728,Hispanic of any race,63.7,Male and Female,Prostate,2017
50-54,9.1,11.4,322,Incidence,3159713,Hispanic of any race,10.2,Male and Female,Stomach,2017
50-54,1.6,3.1,36,Incidence,1586728,Hispanic of any race,2.3,Male and Female,Testis,2017
50-54,22.2,25.6,754,Incidence,3159713,Hispanic of any race,23.9,Male and Female,Thyroid,2017
50-54,5.1,6.9,188,Incidence,3159713,Hispanic of any race,5.9,Male and Female,Urinary Bladder,2017
55-59,612.3,631.4,16273,Incidence,2617156,Hispanic of any race,621.8,Male and Female,All Cancer Sites Combined,2017
55-59,6.9,9.1,208,Incidence,2617156,Hispanic of any race,7.9,Male and Female,Brain and Other Nervous System,2017
55-59,14.4,18.9,220,Incidence,1328754,Hispanic of any race,16.6,Male and Female,Cervix,2017
55-59,56.8,62.7,1562,Incidence,2617156,Hispanic of any race,59.7,Male and Female,Colon and Rectum,2017
55-59,59.0,67.6,840,Incidence,1328754,Hispanic of any race,63.2,Male and Female,"Corpus and Uterus, NOS",2017
55-59,4.7,6.5,145,Incidence,2617156,Hispanic of any race,5.5,Male and Female,Esophagus,2017
55-59,202.4,218.1,2792,Incidence,1328754,Hispanic of any race,210.1,Male and Female,Female Breast,2017
55-59,47.3,55.1,679,Incidence,1328754,Hispanic of any race,51.1,Male and Female,"Female Breast, <i>in situ</i>",2017
55-59,1.6,2.8,57,Incidence,2617156,Hispanic of any race,2.2,Male and Female,Hodgkin Lymphoma,2017
55-59,0.4,1.0,17,Incidence,2617156,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2017
55-59,34.3,39.0,957,Incidence,2617156,Hispanic of any race,36.6,Male and Female,Kidney and Renal Pelvis,2017
55-59,4.0,5.7,125,Incidence,2617156,Hispanic of any race,4.8,Male and Female,Larynx,2017
55-59,11.9,14.7,346,Incidence,2617156,Hispanic of any race,13.2,Male and Female,Leukemias,2017
55-59,31.8,36.3,890,Incidence,2617156,Hispanic of any race,34.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
55-59,33.8,38.5,945,Incidence,2617156,Hispanic of any race,36.1,Male and Female,Lung and Bronchus,2017
55-59,202.4,218.1,2792,Incidence,1328754,Hispanic of any race,210.1,Male and Female,Male and Female Breast,2017
55-59,47.3,55.1,679,Incidence,1328754,Hispanic of any race,51.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
55-59,8.2,10.5,243,Incidence,2617156,Hispanic of any race,9.3,Male and Female,Melanomas of the Skin,2017
55-59,0.7,1.5,27,Incidence,2617156,Hispanic of any race,1.0,Male and Female,Mesothelioma,2017
55-59,10.6,13.2,310,Incidence,2617156,Hispanic of any race,11.8,Male and Female,Myeloma,2017
55-59,25.6,29.7,723,Incidence,2617156,Hispanic of any race,27.6,Male and Female,Non-Hodgkin Lymphoma,2017
55-59,15.5,18.7,446,Incidence,2617156,Hispanic of any race,17.0,Male and Female,Oral Cavity and Pharynx,2017
55-59,19.7,24.9,295,Incidence,1328754,Hispanic of any race,22.2,Male and Female,Ovary,2017
55-59,16.4,19.7,470,Incidence,2617156,Hispanic of any race,18.0,Male and Female,Pancreas,2017
55-59,155.8,169.8,2096,Incidence,1288402,Hispanic of any race,162.7,Male and Female,Prostate,2017
55-59,13.8,16.8,399,Incidence,2617156,Hispanic of any race,15.2,Male and Female,Stomach,2017
55-59,1.6,3.3,30,Incidence,1288402,Hispanic of any race,2.3,Male and Female,Testis,2017
55-59,24.1,28.0,680,Incidence,2617156,Hispanic of any race,26.0,Male and Female,Thyroid,2017
55-59,9.9,12.5,291,Incidence,2617156,Hispanic of any race,11.1,Male and Female,Urinary Bladder,2017
60-64,886.1,912.3,18171,Incidence,2021002,Hispanic of any race,899.1,Male and Female,All Cancer Sites Combined,2017
60-64,8.5,11.3,198,Incidence,2021002,Hispanic of any race,9.8,Male and Female,Brain and Other Nervous System,2017
60-64,14.3,19.3,176,Incidence,1057711,Hispanic of any race,16.6,Male and Female,Cervix,2017
60-64,82.5,90.6,1748,Incidence,2021002,Hispanic of any race,86.5,Male and Female,Colon and Rectum,2017
60-64,82.3,93.7,929,Incidence,1057711,Hispanic of any race,87.8,Male and Female,"Corpus and Uterus, NOS",2017
60-64,5.8,8.2,140,Incidence,2021002,Hispanic of any race,6.9,Male and Female,Esophagus,2017
60-64,256.2,276.0,2813,Incidence,1057711,Hispanic of any race,266.0,Male and Female,Female Breast,2017
60-64,63.7,73.8,726,Incidence,1057711,Hispanic of any race,68.6,Male and Female,"Female Breast, <i>in situ</i>",2017
60-64,1.8,3.2,49,Incidence,2021002,Hispanic of any race,2.4,Male and Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,2021002,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
60-64,45.0,51.1,970,Incidence,2021002,Hispanic of any race,48.0,Male and Female,Kidney and Renal Pelvis,2017
60-64,6.2,8.7,149,Incidence,2021002,Hispanic of any race,7.4,Male and Female,Larynx,2017
60-64,17.6,21.5,393,Incidence,2021002,Hispanic of any race,19.4,Male and Female,Leukemias,2017
60-64,45.9,52.0,988,Incidence,2021002,Hispanic of any race,48.9,Male and Female,Liver and Intrahepatic Bile Duct,2017
60-64,61.7,68.8,1318,Incidence,2021002,Hispanic of any race,65.2,Male and Female,Lung and Bronchus,2017
60-64,256.2,276.0,2813,Incidence,1057711,Hispanic of any race,266.0,Male and Female,Male and Female Breast,2017
60-64,63.7,73.8,726,Incidence,1057711,Hispanic of any race,68.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
60-64,9.4,12.4,219,Incidence,2021002,Hispanic of any race,10.8,Male and Female,Melanomas of the Skin,2017
60-64,0.9,2.0,28,Incidence,2021002,Hispanic of any race,1.4,Male and Female,Mesothelioma,2017
60-64,16.3,20.1,367,Incidence,2021002,Hispanic of any race,18.2,Male and Female,Myeloma,2017
60-64,37.2,42.7,806,Incidence,2021002,Hispanic of any race,39.9,Male and Female,Non-Hodgkin Lymphoma,2017
60-64,18.1,22.0,404,Incidence,2021002,Hispanic of any race,20.0,Male and Female,Oral Cavity and Pharynx,2017
60-64,21.3,27.4,256,Incidence,1057711,Hispanic of any race,24.2,Male and Female,Ovary,2017
60-64,24.1,28.6,531,Incidence,2021002,Hispanic of any race,26.3,Male and Female,Pancreas,2017
60-64,290.2,312.2,2900,Incidence,963291,Hispanic of any race,301.1,Male and Female,Prostate,2017
60-64,20.5,24.7,456,Incidence,2021002,Hispanic of any race,22.6,Male and Female,Stomach,2017
60-64,~,~,~,Incidence,963291,Hispanic of any race,~,Male and Female,Testis,2017
60-64,22.5,26.9,497,Incidence,2021002,Hispanic of any race,24.6,Male and Female,Thyroid,2017
60-64,20.3,24.5,451,Incidence,2021002,Hispanic of any race,22.3,Male and Female,Urinary Bladder,2017
65-69,1252.5,1288.8,18796,Incidence,1479357,Hispanic of any race,1270.6,Male and Female,All Cancer Sites Combined,2017
65-69,11.1,14.8,190,Incidence,1479357,Hispanic of any race,12.8,Male and Female,Brain and Other Nervous System,2017
65-69,11.1,16.4,108,Incidence,794602,Hispanic of any race,13.6,Male and Female,Cervix,2017
65-69,114.9,126.1,1781,Incidence,1479357,Hispanic of any race,120.4,Male and Female,Colon and Rectum,2017
65-69,85.6,99.0,732,Incidence,794602,Hispanic of any race,92.1,Male and Female,"Corpus and Uterus, NOS",2017
65-69,8.1,11.4,143,Incidence,1479357,Hispanic of any race,9.7,Male and Female,Esophagus,2017
65-69,313.3,338.5,2588,Incidence,794602,Hispanic of any race,325.7,Male and Female,Female Breast,2017
65-69,75.0,87.7,645,Incidence,794602,Hispanic of any race,81.2,Male and Female,"Female Breast, <i>in situ</i>",2017
65-69,3.5,5.7,66,Incidence,1479357,Hispanic of any race,4.5,Male and Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,1479357,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
65-69,61.9,70.2,976,Incidence,1479357,Hispanic of any race,66.0,Male and Female,Kidney and Renal Pelvis,2017
65-69,8.0,11.2,140,Incidence,1479357,Hispanic of any race,9.5,Male and Female,Larynx,2017
65-69,24.1,29.5,395,Incidence,1479357,Hispanic of any race,26.7,Male and Female,Leukemias,2017
65-69,62.0,70.3,977,Incidence,1479357,Hispanic of any race,66.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
65-69,102.1,112.7,1587,Incidence,1479357,Hispanic of any race,107.3,Male and Female,Lung and Bronchus,2017
65-69,313.3,338.5,2588,Incidence,794602,Hispanic of any race,325.7,Male and Female,Male and Female Breast,2017
65-69,75.0,87.7,645,Incidence,794602,Hispanic of any race,81.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
65-69,13.5,17.6,229,Incidence,1479357,Hispanic of any race,15.5,Male and Female,Melanomas of the Skin,2017
65-69,2.5,4.5,50,Incidence,1479357,Hispanic of any race,3.4,Male and Female,Mesothelioma,2017
65-69,24.3,29.7,398,Incidence,1479357,Hispanic of any race,26.9,Male and Female,Myeloma,2017
65-69,54.9,62.8,869,Incidence,1479357,Hispanic of any race,58.7,Male and Female,Non-Hodgkin Lymphoma,2017
65-69,24.5,29.9,401,Incidence,1479357,Hispanic of any race,27.1,Male and Female,Oral Cavity and Pharynx,2017
65-69,25.9,33.6,235,Incidence,794602,Hispanic of any race,29.6,Male and Female,Ovary,2017
65-69,39.9,46.7,639,Incidence,1479357,Hispanic of any race,43.2,Male and Female,Pancreas,2017
65-69,500.5,534.7,3543,Incidence,684755,Hispanic of any race,517.4,Male and Female,Prostate,2017
65-69,28.5,34.3,463,Incidence,1479357,Hispanic of any race,31.3,Male and Female,Stomach,2017
65-69,~,~,~,Incidence,684755,Hispanic of any race,~,Male and Female,Testis,2017
65-69,24.6,30.0,403,Incidence,1479357,Hispanic of any race,27.2,Male and Female,Thyroid,2017
65-69,30.5,36.5,494,Incidence,1479357,Hispanic of any race,33.4,Male and Female,Urinary Bladder,2017
70-74,1483.1,1530.5,15603,Incidence,1035624,Hispanic of any race,1506.6,Male and Female,All Cancer Sites Combined,2017
70-74,13.1,17.9,159,Incidence,1035624,Hispanic of any race,15.4,Male and Female,Brain and Other Nervous System,2017
70-74,11.0,17.3,80,Incidence,575661,Hispanic of any race,13.9,Male and Female,Cervix,2017
70-74,129.7,144.0,1416,Incidence,1035624,Hispanic of any race,136.7,Male and Female,Colon and Rectum,2017
70-74,74.8,89.7,472,Incidence,575661,Hispanic of any race,82.0,Male and Female,"Corpus and Uterus, NOS",2017
70-74,10.6,15.0,131,Incidence,1035624,Hispanic of any race,12.6,Male and Female,Esophagus,2017
70-74,339.7,370.6,2043,Incidence,575661,Hispanic of any race,354.9,Male and Female,Female Breast,2017
70-74,75.1,90.1,474,Incidence,575661,Hispanic of any race,82.3,Male and Female,"Female Breast, <i>in situ</i>",2017
70-74,3.8,6.6,52,Incidence,1035624,Hispanic of any race,5.0,Male and Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,1035624,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
70-74,66.1,76.5,737,Incidence,1035624,Hispanic of any race,71.2,Male and Female,Kidney and Renal Pelvis,2017
70-74,9.5,13.8,119,Incidence,1035624,Hispanic of any race,11.5,Male and Female,Larynx,2017
70-74,30.7,37.9,354,Incidence,1035624,Hispanic of any race,34.2,Male and Female,Leukemias,2017
70-74,56.5,66.1,633,Incidence,1035624,Hispanic of any race,61.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
70-74,160.9,176.8,1747,Incidence,1035624,Hispanic of any race,168.7,Male and Female,Lung and Bronchus,2017
70-74,339.7,370.6,2043,Incidence,575661,Hispanic of any race,354.9,Male and Female,Male and Female Breast,2017
70-74,75.1,90.1,474,Incidence,575661,Hispanic of any race,82.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
70-74,14.9,20.1,180,Incidence,1035624,Hispanic of any race,17.4,Male and Female,Melanomas of the Skin,2017
70-74,2.0,4.1,30,Incidence,1035624,Hispanic of any race,2.9,Male and Female,Mesothelioma,2017
70-74,28.7,35.7,332,Incidence,1035624,Hispanic of any race,32.1,Male and Female,Myeloma,2017
70-74,74.3,85.3,825,Incidence,1035624,Hispanic of any race,79.7,Male and Female,Non-Hodgkin Lymphoma,2017
70-74,25.0,31.5,291,Incidence,1035624,Hispanic of any race,28.1,Male and Female,Oral Cavity and Pharynx,2017
70-74,26.5,35.8,178,Incidence,575661,Hispanic of any race,30.9,Male and Female,Ovary,2017
70-74,53.1,62.5,597,Incidence,1035624,Hispanic of any race,57.6,Male and Female,Pancreas,2017
70-74,533.5,576.8,2552,Incidence,459963,Hispanic of any race,554.8,Male and Female,Prostate,2017
70-74,38.3,46.3,437,Incidence,1035624,Hispanic of any race,42.2,Male and Female,Stomach,2017
70-74,~,~,~,Incidence,459963,Hispanic of any race,~,Male and Female,Testis,2017
70-74,21.7,27.8,255,Incidence,1035624,Hispanic of any race,24.6,Male and Female,Thyroid,2017
70-74,51.4,60.6,578,Incidence,1035624,Hispanic of any race,55.8,Male and Female,Urinary Bladder,2017
75-79,1683.1,1744.6,11988,Incidence,699561,Hispanic of any race,1713.6,Male and Female,All Cancer Sites Combined,2017
75-79,16.4,23.2,137,Incidence,699561,Hispanic of any race,19.6,Male and Female,Brain and Other Nervous System,2017
75-79,12.0,20.0,63,Incidence,403044,Hispanic of any race,15.6,Male and Female,Cervix,2017
75-79,150.6,169.5,1118,Incidence,699561,Hispanic of any race,159.8,Male and Female,Colon and Rectum,2017
75-79,61.3,77.8,279,Incidence,403044,Hispanic of any race,69.2,Male and Female,"Corpus and Uterus, NOS",2017
75-79,13.2,19.3,112,Incidence,699561,Hispanic of any race,16.0,Male and Female,Esophagus,2017
75-79,309.4,344.9,1317,Incidence,403044,Hispanic of any race,326.8,Male and Female,Female Breast,2017
75-79,59.0,75.2,269,Incidence,403044,Hispanic of any race,66.7,Male and Female,"Female Breast, <i>in situ</i>",2017
75-79,3.8,7.5,38,Incidence,699561,Hispanic of any race,5.4,Male and Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,699561,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
75-79,67.4,80.3,515,Incidence,699561,Hispanic of any race,73.6,Male and Female,Kidney and Renal Pelvis,2017
75-79,10.1,15.5,88,Incidence,699561,Hispanic of any race,12.6,Male and Female,Larynx,2017
75-79,45.6,56.3,355,Incidence,699561,Hispanic of any race,50.7,Male and Female,Leukemias,2017
75-79,72.0,85.3,549,Incidence,699561,Hispanic of any race,78.5,Male and Female,Liver and Intrahepatic Bile Duct,2017
75-79,205.4,227.3,1512,Incidence,699561,Hispanic of any race,216.1,Male and Female,Lung and Bronchus,2017
75-79,309.4,344.9,1317,Incidence,403044,Hispanic of any race,326.8,Male and Female,Male and Female Breast,2017
75-79,59.0,75.2,269,Incidence,403044,Hispanic of any race,66.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
75-79,17.8,24.7,147,Incidence,699561,Hispanic of any race,21.0,Male and Female,Melanomas of the Skin,2017
75-79,2.8,6.0,29,Incidence,699561,Hispanic of any race,4.1,Male and Female,Mesothelioma,2017
75-79,33.6,42.9,266,Incidence,699561,Hispanic of any race,38.0,Male and Female,Myeloma,2017
75-79,86.9,101.4,657,Incidence,699561,Hispanic of any race,93.9,Male and Female,Non-Hodgkin Lymphoma,2017
75-79,27.8,36.3,223,Incidence,699561,Hispanic of any race,31.9,Male and Female,Oral Cavity and Pharynx,2017
75-79,28.5,40.2,137,Incidence,403044,Hispanic of any race,34.0,Male and Female,Ovary,2017
75-79,70.5,83.7,538,Incidence,699561,Hispanic of any race,76.9,Male and Female,Pancreas,2017
75-79,506.2,559.1,1578,Incidence,296517,Hispanic of any race,532.2,Male and Female,Prostate,2017
75-79,47.2,58.1,367,Incidence,699561,Hispanic of any race,52.5,Male and Female,Stomach,2017
75-79,~,~,~,Incidence,296517,Hispanic of any race,~,Male and Female,Testis,2017
75-79,20.8,28.2,170,Incidence,699561,Hispanic of any race,24.3,Male and Female,Thyroid,2017
75-79,67.8,80.7,518,Incidence,699561,Hispanic of any race,74.0,Male and Female,Urinary Bladder,2017
80-84,1736.0,1811.9,8446,Incidence,476188,Hispanic of any race,1773.7,Male and Female,All Cancer Sites Combined,2017
80-84,16.0,24.2,94,Incidence,476188,Hispanic of any race,19.7,Male and Female,Brain and Other Nervous System,2017
80-84,9.5,18.4,38,Incidence,284031,Hispanic of any race,13.4,Male and Female,Cervix,2017
80-84,166.9,191.1,851,Incidence,476188,Hispanic of any race,178.7,Male and Female,Colon and Rectum,2017
80-84,54.8,73.7,181,Incidence,284031,Hispanic of any race,63.7,Male and Female,"Corpus and Uterus, NOS",2017
80-84,13.7,21.4,82,Incidence,476188,Hispanic of any race,17.2,Male and Female,Esophagus,2017
80-84,245.8,284.0,751,Incidence,284031,Hispanic of any race,264.4,Male and Female,Female Breast,2017
80-84,32.8,47.8,113,Incidence,284031,Hispanic of any race,39.8,Male and Female,"Female Breast, <i>in situ</i>",2017
80-84,3.2,7.5,24,Incidence,476188,Hispanic of any race,5.0,Male and Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,476188,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
80-84,64.4,79.9,342,Incidence,476188,Hispanic of any race,71.8,Male and Female,Kidney and Renal Pelvis,2017
80-84,9.2,15.7,58,Incidence,476188,Hispanic of any race,12.2,Male and Female,Larynx,2017
80-84,50.7,64.6,273,Incidence,476188,Hispanic of any race,57.3,Male and Female,Leukemias,2017
80-84,59.6,74.5,318,Incidence,476188,Hispanic of any race,66.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
80-84,236.3,264.9,1192,Incidence,476188,Hispanic of any race,250.3,Male and Female,Lung and Bronchus,2017
80-84,245.8,284.0,751,Incidence,284031,Hispanic of any race,264.4,Male and Female,Male and Female Breast,2017
80-84,32.8,47.8,113,Incidence,284031,Hispanic of any race,39.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
80-84,20.5,29.7,118,Incidence,476188,Hispanic of any race,24.8,Male and Female,Melanomas of the Skin,2017
80-84,4.3,9.0,30,Incidence,476188,Hispanic of any race,6.3,Male and Female,Mesothelioma,2017
80-84,36.6,48.5,201,Incidence,476188,Hispanic of any race,42.2,Male and Female,Myeloma,2017
80-84,98.4,117.3,512,Incidence,476188,Hispanic of any race,107.5,Male and Female,Non-Hodgkin Lymphoma,2017
80-84,30.1,41.0,168,Incidence,476188,Hispanic of any race,35.3,Male and Female,Oral Cavity and Pharynx,2017
80-84,36.0,51.7,123,Incidence,284031,Hispanic of any race,43.3,Male and Female,Ovary,2017
80-84,77.6,94.4,408,Incidence,476188,Hispanic of any race,85.7,Male and Female,Pancreas,2017
80-84,396.0,454.8,816,Incidence,192157,Hispanic of any race,424.7,Male and Female,Prostate,2017
80-84,48.2,61.7,260,Incidence,476188,Hispanic of any race,54.6,Male and Female,Stomach,2017
80-84,~,~,~,Incidence,192157,Hispanic of any race,~,Male and Female,Testis,2017
80-84,13.3,20.9,80,Incidence,476188,Hispanic of any race,16.8,Male and Female,Thyroid,2017
80-84,92.4,110.7,482,Incidence,476188,Hispanic of any race,101.2,Male and Female,Urinary Bladder,2017
85+,1660.0,1735.8,7749,Incidence,456468,Hispanic of any race,1697.6,Male and Female,All Cancer Sites Combined,2017
85+,13.7,21.6,79,Incidence,456468,Hispanic of any race,17.3,Male and Female,Brain and Other Nervous System,2017
85+,11.0,20.3,44,Incidence,291150,Hispanic of any race,15.1,Male and Female,Cervix,2017
85+,193.6,220.2,943,Incidence,456468,Hispanic of any race,206.6,Male and Female,Colon and Rectum,2017
85+,29.5,43.7,105,Incidence,291150,Hispanic of any race,36.1,Male and Female,"Corpus and Uterus, NOS",2017
85+,14.7,22.8,84,Incidence,456468,Hispanic of any race,18.4,Male and Female,Esophagus,2017
85+,215.0,250.4,676,Incidence,291150,Hispanic of any race,232.2,Male and Female,Female Breast,2017
85+,11.9,21.5,47,Incidence,291150,Hispanic of any race,16.1,Male and Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,456468,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,456468,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
85+,52.3,66.6,270,Incidence,456468,Hispanic of any race,59.1,Male and Female,Kidney and Renal Pelvis,2017
85+,5.5,10.9,36,Incidence,456468,Hispanic of any race,7.9,Male and Female,Larynx,2017
85+,53.7,68.3,277,Incidence,456468,Hispanic of any race,60.7,Male and Female,Leukemias,2017
85+,58.1,73.1,298,Incidence,456468,Hispanic of any race,65.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
85+,193.8,220.4,944,Incidence,456468,Hispanic of any race,206.8,Male and Female,Lung and Bronchus,2017
85+,215.0,250.4,676,Incidence,291150,Hispanic of any race,232.2,Male and Female,Male and Female Breast,2017
85+,11.9,21.5,47,Incidence,291150,Hispanic of any race,16.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
85+,20.0,29.3,111,Incidence,456468,Hispanic of any race,24.3,Male and Female,Melanomas of the Skin,2017
85+,2.7,6.8,20,Incidence,456468,Hispanic of any race,4.4,Male and Female,Mesothelioma,2017
85+,33.3,44.9,177,Incidence,456468,Hispanic of any race,38.8,Male and Female,Myeloma,2017
85+,85.5,103.5,430,Incidence,456468,Hispanic of any race,94.2,Male and Female,Non-Hodgkin Lymphoma,2017
85+,25.8,36.2,140,Incidence,456468,Hispanic of any race,30.7,Male and Female,Oral Cavity and Pharynx,2017
85+,27.9,41.8,100,Incidence,291150,Hispanic of any race,34.3,Male and Female,Ovary,2017
85+,79.3,96.7,400,Incidence,456468,Hispanic of any race,87.6,Male and Female,Pancreas,2017
85+,315.9,373.0,568,Incidence,165318,Hispanic of any race,343.6,Male and Female,Prostate,2017
85+,57.9,72.9,297,Incidence,456468,Hispanic of any race,65.1,Male and Female,Stomach,2017
85+,~,~,~,Incidence,165318,Hispanic of any race,~,Male and Female,Testis,2017
85+,8.1,14.4,50,Incidence,456468,Hispanic of any race,11.0,Male and Female,Thyroid,2017
85+,98.1,117.3,490,Incidence,456468,Hispanic of any race,107.3,Male and Female,Urinary Bladder,2017
<1,20.7,26.8,235,Incidence,995551,Hispanic of any race,23.6,Male and Female,All Cancer Sites Combined,2017
<1,2.0,4.2,29,Incidence,995551,Hispanic of any race,2.9,Male and Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,Cervix,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Colon and Rectum,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Esophagus,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,Female Breast,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Larynx,2017
<1,3.5,6.3,47,Incidence,995551,Hispanic of any race,4.7,Male and Female,Leukemias,2017
<1,0.9,2.6,16,Incidence,995551,Hispanic of any race,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,Male and Female Breast,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Mesothelioma,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Myeloma,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,488567,Hispanic of any race,~,Male and Female,Ovary,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Pancreas,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male and Female,Prostate,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Stomach,2017
<1,~,~,~,Incidence,506984,Hispanic of any race,~,Male and Female,Testis,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Thyroid,2017
<1,~,~,~,Incidence,995551,Hispanic of any race,~,Male and Female,Urinary Bladder,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
15-19,17.6,38.8,27,Incidence,101367,Non-Hispanic American Indian/Alaska Native,26.6,Female,All Cancer Sites Combined,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
20-24,17.7,38.5,28,Incidence,105050,Non-Hispanic American Indian/Alaska Native,26.7,Female,All Cancer Sites Combined,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
25-29,66.2,101.5,89,Incidence,107898,Non-Hispanic American Indian/Alaska Native,82.5,Female,All Cancer Sites Combined,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
25-29,9.2,25.2,17,Incidence,107898,Non-Hispanic American Indian/Alaska Native,15.8,Female,Female Breast,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
25-29,11.3,28.6,20,Incidence,107898,Non-Hispanic American Indian/Alaska Native,18.5,Female,Thyroid,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
30-34,124.1,174.6,138,Incidence,93391,Non-Hispanic American Indian/Alaska Native,147.8,Female,All Cancer Sites Combined,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
30-34,26.1,52.1,35,Incidence,93391,Non-Hispanic American Indian/Alaska Native,37.5,Female,Female Breast,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
30-34,13.1,33.1,20,Incidence,93391,Non-Hispanic American Indian/Alaska Native,21.4,Female,Thyroid,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
35-39,192.3,256.5,192,Incidence,86234,Non-Hispanic American Indian/Alaska Native,222.6,Female,All Cancer Sites Combined,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
35-39,11.5,31.6,17,Incidence,86234,Non-Hispanic American Indian/Alaska Native,19.7,Female,Cervix,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
35-39,42.0,75.1,49,Incidence,86234,Non-Hispanic American Indian/Alaska Native,56.8,Female,Female Breast,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
35-39,27.3,55.1,34,Incidence,86234,Non-Hispanic American Indian/Alaska Native,39.4,Female,Thyroid,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
40-44,319.2,404.3,284,Incidence,78915,Non-Hispanic American Indian/Alaska Native,359.9,Female,All Cancer Sites Combined,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
40-44,17.5,42.2,22,Incidence,78915,Non-Hispanic American Indian/Alaska Native,27.9,Female,Cervix,2017
40-44,17.5,42.2,22,Incidence,78915,Non-Hispanic American Indian/Alaska Native,27.9,Female,Colon and Rectum,2017
40-44,26.7,55.8,31,Incidence,78915,Non-Hispanic American Indian/Alaska Native,39.3,Female,"Corpus and Uterus, NOS",2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
40-44,105.4,156.9,102,Incidence,78915,Non-Hispanic American Indian/Alaska Native,129.3,Female,Female Breast,2017
40-44,20.5,46.8,25,Incidence,78915,Non-Hispanic American Indian/Alaska Native,31.7,Female,"Female Breast, <i>in situ</i>",2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
40-44,20.5,46.8,25,Incidence,78915,Non-Hispanic American Indian/Alaska Native,31.7,Female,Thyroid,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
45-49,397.6,489.7,363,Incidence,82156,Non-Hispanic American Indian/Alaska Native,441.8,Female,All Cancer Sites Combined,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
45-49,23.6,50.7,29,Incidence,82156,Non-Hispanic American Indian/Alaska Native,35.3,Female,Colon and Rectum,2017
45-49,18.7,43.5,24,Incidence,82156,Non-Hispanic American Indian/Alaska Native,29.2,Female,"Corpus and Uterus, NOS",2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
45-49,126.6,181.3,125,Incidence,82156,Non-Hispanic American Indian/Alaska Native,152.1,Female,Female Breast,2017
45-49,18.7,43.5,24,Incidence,82156,Non-Hispanic American Indian/Alaska Native,29.2,Female,"Female Breast, <i>in situ</i>",2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
45-49,15.8,39.1,21,Incidence,82156,Non-Hispanic American Indian/Alaska Native,25.6,Female,Lung and Bronchus,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
45-49,21.7,47.8,27,Incidence,82156,Non-Hispanic American Indian/Alaska Native,32.9,Female,Thyroid,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
5-9,10.9,28.9,18,Incidence,98293,Non-Hispanic American Indian/Alaska Native,18.3,Female,All Cancer Sites Combined,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
50-54,538.8,641.6,515,Incidence,87510,Non-Hispanic American Indian/Alaska Native,588.5,Female,All Cancer Sites Combined,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
50-54,58.3,96.0,66,Incidence,87510,Non-Hispanic American Indian/Alaska Native,75.4,Female,Colon and Rectum,2017
50-54,30.7,59.6,38,Incidence,87510,Non-Hispanic American Indian/Alaska Native,43.4,Female,"Corpus and Uterus, NOS",2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
50-54,141.9,197.4,147,Incidence,87510,Non-Hispanic American Indian/Alaska Native,168.0,Female,Female Breast,2017
50-54,27.9,55.6,35,Incidence,87510,Non-Hispanic American Indian/Alaska Native,40.0,Female,"Female Breast, <i>in situ</i>",2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
50-54,26.9,54.3,34,Incidence,87510,Non-Hispanic American Indian/Alaska Native,38.9,Female,Kidney and Renal Pelvis,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
50-54,37.5,68.8,45,Incidence,87510,Non-Hispanic American Indian/Alaska Native,51.4,Female,Lung and Bronchus,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
50-54,18.5,42.2,25,Incidence,87510,Non-Hispanic American Indian/Alaska Native,28.6,Female,Thyroid,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
55-59,655.3,765.9,644,Incidence,90832,Non-Hispanic American Indian/Alaska Native,709.0,Female,All Cancer Sites Combined,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
55-59,10.1,28.6,16,Incidence,90832,Non-Hispanic American Indian/Alaska Native,17.6,Female,Cervix,2017
55-59,57.2,93.7,67,Incidence,90832,Non-Hispanic American Indian/Alaska Native,73.8,Female,Colon and Rectum,2017
55-59,48.5,82.5,58,Incidence,90832,Non-Hispanic American Indian/Alaska Native,63.9,Female,"Corpus and Uterus, NOS",2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
55-59,168.2,227.0,178,Incidence,90832,Non-Hispanic American Indian/Alaska Native,196.0,Female,Female Breast,2017
55-59,39.0,70.1,48,Incidence,90832,Non-Hispanic American Indian/Alaska Native,52.8,Female,"Female Breast, <i>in situ</i>",2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
55-59,20.5,44.6,28,Incidence,90832,Non-Hispanic American Indian/Alaska Native,30.8,Female,Kidney and Renal Pelvis,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
55-59,69.8,109.6,80,Incidence,90832,Non-Hispanic American Indian/Alaska Native,88.1,Female,Lung and Bronchus,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
55-59,10.1,28.6,16,Incidence,90832,Non-Hispanic American Indian/Alaska Native,17.6,Female,Non-Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
55-59,13.4,34.0,20,Incidence,90832,Non-Hispanic American Indian/Alaska Native,22.0,Female,Ovary,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
55-59,19.6,43.2,27,Incidence,90832,Non-Hispanic American Indian/Alaska Native,29.7,Female,Thyroid,2017
55-59,~,~,~,Incidence,90832,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
60-64,929.4,1070.4,785,Incidence,78654,Non-Hispanic American Indian/Alaska Native,998.0,Female,All Cancer Sites Combined,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
60-64,73.9,118.1,74,Incidence,78654,Non-Hispanic American Indian/Alaska Native,94.1,Female,Colon and Rectum,2017
60-64,51.6,89.6,54,Incidence,78654,Non-Hispanic American Indian/Alaska Native,68.7,Female,"Corpus and Uterus, NOS",2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
60-64,257.0,334.1,231,Incidence,78654,Non-Hispanic American Indian/Alaska Native,293.7,Female,Female Breast,2017
60-64,41.7,76.6,45,Incidence,78654,Non-Hispanic American Indian/Alaska Native,57.2,Female,"Female Breast, <i>in situ</i>",2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
60-64,45.0,80.9,48,Incidence,78654,Non-Hispanic American Indian/Alaska Native,61.0,Female,Kidney and Renal Pelvis,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
60-64,27.8,57.4,32,Incidence,78654,Non-Hispanic American Indian/Alaska Native,40.7,Female,Liver and Intrahepatic Bile Duct,2017
60-64,131.1,188.0,124,Incidence,78654,Non-Hispanic American Indian/Alaska Native,157.7,Female,Lung and Bronchus,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
60-64,13.6,36.2,18,Incidence,78654,Non-Hispanic American Indian/Alaska Native,22.9,Female,Non-Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
60-64,20.6,46.9,25,Incidence,78654,Non-Hispanic American Indian/Alaska Native,31.8,Female,Pancreas,2017
60-64,11.6,33.0,16,Incidence,78654,Non-Hispanic American Indian/Alaska Native,20.3,Female,Stomach,2017
60-64,12.6,34.6,17,Incidence,78654,Non-Hispanic American Indian/Alaska Native,21.6,Female,Thyroid,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
65-69,1158.8,1338.3,755,Incidence,60588,Non-Hispanic American Indian/Alaska Native,1246.1,Female,All Cancer Sites Combined,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
65-69,84.2,138.6,66,Incidence,60588,Non-Hispanic American Indian/Alaska Native,108.9,Female,Colon and Rectum,2017
65-69,59.8,106.9,49,Incidence,60588,Non-Hispanic American Indian/Alaska Native,80.9,Female,"Corpus and Uterus, NOS",2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
65-69,312.1,409.1,217,Incidence,60588,Non-Hispanic American Indian/Alaska Native,358.2,Female,Female Breast,2017
65-69,44.4,86.1,38,Incidence,60588,Non-Hispanic American Indian/Alaska Native,62.7,Female,"Female Breast, <i>in situ</i>",2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
65-69,36.1,74.6,32,Incidence,60588,Non-Hispanic American Indian/Alaska Native,52.8,Female,Kidney and Renal Pelvis,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
65-69,22.8,55.0,22,Incidence,60588,Non-Hispanic American Indian/Alaska Native,36.3,Female,Liver and Intrahepatic Bile Duct,2017
65-69,191.4,269.1,138,Incidence,60588,Non-Hispanic American Indian/Alaska Native,227.8,Female,Lung and Bronchus,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
65-69,32.1,68.7,29,Incidence,60588,Non-Hispanic American Indian/Alaska Native,47.9,Female,Non-Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
65-69,17.6,47.0,18,Incidence,60588,Non-Hispanic American Indian/Alaska Native,29.7,Female,Ovary,2017
65-69,21.5,53.0,21,Incidence,60588,Non-Hispanic American Indian/Alaska Native,34.7,Female,Pancreas,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
70-74,1365.4,1600.4,622,Incidence,42043,Non-Hispanic American Indian/Alaska Native,1479.4,Female,All Cancer Sites Combined,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
70-74,121.4,199.7,66,Incidence,42043,Non-Hispanic American Indian/Alaska Native,157.0,Female,Colon and Rectum,2017
70-74,58.0,115.8,35,Incidence,42043,Non-Hispanic American Indian/Alaska Native,83.2,Female,"Corpus and Uterus, NOS",2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
70-74,306.3,423.8,152,Incidence,42043,Non-Hispanic American Indian/Alaska Native,361.5,Female,Female Breast,2017
70-74,52.1,107.4,32,Incidence,42043,Non-Hispanic American Indian/Alaska Native,76.1,Female,"Female Breast, <i>in situ</i>",2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
70-74,50.1,104.7,31,Incidence,42043,Non-Hispanic American Indian/Alaska Native,73.7,Female,Kidney and Renal Pelvis,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
70-74,23.6,64.7,17,Incidence,42043,Non-Hispanic American Indian/Alaska Native,40.4,Female,Liver and Intrahepatic Bile Duct,2017
70-74,247.5,354.2,125,Incidence,42043,Non-Hispanic American Indian/Alaska Native,297.3,Female,Lung and Bronchus,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
70-74,25.4,67.7,18,Incidence,42043,Non-Hispanic American Indian/Alaska Native,42.8,Female,Myeloma,2017
70-74,42.3,93.4,27,Incidence,42043,Non-Hispanic American Indian/Alaska Native,64.2,Female,Non-Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
70-74,23.6,64.7,17,Incidence,42043,Non-Hispanic American Indian/Alaska Native,40.4,Female,Ovary,2017
70-74,27.2,70.6,19,Incidence,42043,Non-Hispanic American Indian/Alaska Native,45.2,Female,Pancreas,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
75-79,1489.2,1796.6,447,Incidence,27297,Non-Hispanic American Indian/Alaska Native,1637.5,Female,All Cancer Sites Combined,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
75-79,132.8,237.3,49,Incidence,27297,Non-Hispanic American Indian/Alaska Native,179.5,Female,Colon and Rectum,2017
75-79,39.1,104.2,18,Incidence,27297,Non-Hispanic American Indian/Alaska Native,65.9,Female,"Corpus and Uterus, NOS",2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
75-79,284.9,429.5,96,Incidence,27297,Non-Hispanic American Indian/Alaska Native,351.7,Female,Female Breast,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
75-79,36.3,99.7,17,Incidence,27297,Non-Hispanic American Indian/Alaska Native,62.3,Female,Kidney and Renal Pelvis,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
75-79,36.3,99.7,17,Incidence,27297,Non-Hispanic American Indian/Alaska Native,62.3,Female,Leukemias,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
75-79,288.2,433.5,97,Incidence,27297,Non-Hispanic American Indian/Alaska Native,355.4,Female,Lung and Bronchus,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
75-79,33.5,95.2,16,Incidence,27297,Non-Hispanic American Indian/Alaska Native,58.6,Female,Non-Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
80-84,1531.7,1929.3,297,Incidence,17248,Non-Hispanic American Indian/Alaska Native,1721.9,Female,All Cancer Sites Combined,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
80-84,112.6,241.5,29,Incidence,17248,Non-Hispanic American Indian/Alaska Native,168.1,Female,Colon and Rectum,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
80-84,245.3,421.6,56,Incidence,17248,Non-Hispanic American Indian/Alaska Native,324.7,Female,Female Breast,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
80-84,290.8,480.3,65,Incidence,17248,Non-Hispanic American Indian/Alaska Native,376.9,Female,Lung and Bronchus,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
80-84,66.3,172.0,19,Incidence,17248,Non-Hispanic American Indian/Alaska Native,110.2,Female,Non-Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
85+,1311.1,1685.0,252,Incidence,16921,Non-Hispanic American Indian/Alaska Native,1489.3,Female,All Cancer Sites Combined,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
85+,154.0,301.4,37,Incidence,16921,Non-Hispanic American Indian/Alaska Native,218.7,Female,Colon and Rectum,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
85+,178.9,335.5,42,Incidence,16921,Non-Hispanic American Indian/Alaska Native,248.2,Female,Female Breast,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
85+,149.0,294.5,36,Incidence,16921,Non-Hispanic American Indian/Alaska Native,212.8,Female,Lung and Bronchus,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2017
1-4,17.7,42.7,22,Incidence,77963,Non-Hispanic American Indian/Alaska Native,28.2,Male,All Cancer Sites Combined,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
1-4,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
10-14,9.7,26.7,17,Incidence,101869,Non-Hispanic American Indian/Alaska Native,16.7,Male,All Cancer Sites Combined,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
10-14,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
15-19,9.5,26.2,17,Incidence,103958,Non-Hispanic American Indian/Alaska Native,16.4,Male,All Cancer Sites Combined,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
15-19,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
20-24,22.5,44.9,35,Incidence,108361,Non-Hispanic American Indian/Alaska Native,32.3,Male,All Cancer Sites Combined,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
20-24,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
25-29,38.0,65.3,56,Incidence,111297,Non-Hispanic American Indian/Alaska Native,50.3,Male,All Cancer Sites Combined,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
25-29,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
25-29,8.2,23.3,16,Incidence,111297,Non-Hispanic American Indian/Alaska Native,14.4,Male,Testis,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
30-34,63.0,100.7,74,Incidence,92260,Non-Hispanic American Indian/Alaska Native,80.2,Male,All Cancer Sites Combined,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
30-34,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
30-34,10.7,29.5,17,Incidence,92260,Non-Hispanic American Indian/Alaska Native,18.4,Male,Testis,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
35-39,88.4,134.5,92,Incidence,83862,Non-Hispanic American Indian/Alaska Native,109.7,Male,All Cancer Sites Combined,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
35-39,15.5,38.3,21,Incidence,83862,Non-Hispanic American Indian/Alaska Native,25.0,Male,Colon and Rectum,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
35-39,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
40-44,131.6,189.8,120,Incidence,75597,Non-Hispanic American Indian/Alaska Native,158.7,Male,All Cancer Sites Combined,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
40-44,15.1,39.2,19,Incidence,75597,Non-Hispanic American Indian/Alaska Native,25.1,Male,Colon and Rectum,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
40-44,16.2,40.9,20,Incidence,75597,Non-Hispanic American Indian/Alaska Native,26.5,Male,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
40-44,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
45-49,243.2,318.6,218,Incidence,78133,Non-Hispanic American Indian/Alaska Native,279.0,Male,All Cancer Sites Combined,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
45-49,40.9,75.6,44,Incidence,78133,Non-Hispanic American Indian/Alaska Native,56.3,Male,Colon and Rectum,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
45-49,24.9,53.3,29,Incidence,78133,Non-Hispanic American Indian/Alaska Native,37.1,Male,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
45-49,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
45-49,12.7,34.8,17,Incidence,78133,Non-Hispanic American Indian/Alaska Native,21.8,Male,Oral Cavity and Pharynx,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
5-9,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
50-54,443.0,540.7,397,Incidence,81011,Non-Hispanic American Indian/Alaska Native,490.1,Male,All Cancer Sites Combined,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
50-54,79.4,124.3,81,Incidence,81011,Non-Hispanic American Indian/Alaska Native,100.0,Male,Colon and Rectum,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
50-54,33.2,64.4,38,Incidence,81011,Non-Hispanic American Indian/Alaska Native,46.9,Male,Kidney and Renal Pelvis,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
50-54,20.0,45.6,25,Incidence,81011,Non-Hispanic American Indian/Alaska Native,30.9,Male,Liver and Intrahepatic Bile Duct,2017
50-54,38.4,71.5,43,Incidence,81011,Non-Hispanic American Indian/Alaska Native,53.1,Male,Lung and Bronchus,2017
50-54,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
50-54,14.1,36.6,19,Incidence,81011,Non-Hispanic American Indian/Alaska Native,23.5,Male,Oral Cavity and Pharynx,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
50-54,60.8,100.9,64,Incidence,81011,Non-Hispanic American Indian/Alaska Native,79.0,Male,Prostate,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
55-59,695.4,816.2,611,Incidence,81035,Non-Hispanic American Indian/Alaska Native,754.0,Male,All Cancer Sites Combined,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
55-59,70.6,113.3,73,Incidence,81035,Non-Hispanic American Indian/Alaska Native,90.1,Male,Colon and Rectum,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
55-59,70.6,113.3,73,Incidence,81035,Non-Hispanic American Indian/Alaska Native,90.1,Male,Kidney and Renal Pelvis,2017
55-59,11.3,32.1,16,Incidence,81035,Non-Hispanic American Indian/Alaska Native,19.7,Male,Larynx,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
55-59,50.1,86.9,54,Incidence,81035,Non-Hispanic American Indian/Alaska Native,66.6,Male,Liver and Intrahepatic Bile Duct,2017
55-59,56.5,95.3,60,Incidence,81035,Non-Hispanic American Indian/Alaska Native,74.0,Male,Lung and Bronchus,2017
55-59,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
55-59,29.1,58.6,34,Incidence,81035,Non-Hispanic American Indian/Alaska Native,42.0,Male,Oral Cavity and Pharynx,2017
55-59,13.2,35.1,18,Incidence,81035,Non-Hispanic American Indian/Alaska Native,22.2,Male,Pancreas,2017
55-59,145.3,203.9,140,Incidence,81035,Non-Hispanic American Indian/Alaska Native,172.8,Male,Prostate,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
55-59,19.0,44.1,24,Incidence,81035,Non-Hispanic American Indian/Alaska Native,29.6,Male,Urinary Bladder,2017
60-64,1133.5,1300.3,830,Incidence,68325,Non-Hispanic American Indian/Alaska Native,1214.8,Male,All Cancer Sites Combined,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
60-64,94.1,147.3,81,Incidence,68325,Non-Hispanic American Indian/Alaska Native,118.6,Male,Colon and Rectum,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
60-64,74.7,122.9,66,Incidence,68325,Non-Hispanic American Indian/Alaska Native,96.6,Male,Kidney and Renal Pelvis,2017
60-64,16.7,43.4,19,Incidence,68325,Non-Hispanic American Indian/Alaska Native,27.8,Male,Larynx,2017
60-64,20.2,48.7,22,Incidence,68325,Non-Hispanic American Indian/Alaska Native,32.2,Male,Leukemias,2017
60-64,70.9,118.0,63,Incidence,68325,Non-Hispanic American Indian/Alaska Native,92.2,Male,Liver and Intrahepatic Bile Duct,2017
60-64,133.6,195.6,111,Incidence,68325,Non-Hispanic American Indian/Alaska Native,162.5,Male,Lung and Bronchus,2017
60-64,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
60-64,14.5,39.8,17,Incidence,68325,Non-Hispanic American Indian/Alaska Native,24.9,Male,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
60-64,23.7,54.0,25,Incidence,68325,Non-Hispanic American Indian/Alaska Native,36.6,Male,Non-Hodgkin Lymphoma,2017
60-64,49.3,89.8,46,Incidence,68325,Non-Hispanic American Indian/Alaska Native,67.3,Male,Oral Cavity and Pharynx,2017
60-64,22.5,52.3,24,Incidence,68325,Non-Hispanic American Indian/Alaska Native,35.1,Male,Pancreas,2017
60-64,265.8,350.3,209,Incidence,68325,Non-Hispanic American Indian/Alaska Native,305.9,Male,Prostate,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
60-64,29.6,62.7,30,Incidence,68325,Non-Hispanic American Indian/Alaska Native,43.9,Male,Urinary Bladder,2017
65-69,1497.3,1715.2,847,Incidence,52823,Non-Hispanic American Indian/Alaska Native,1603.5,Male,All Cancer Sites Combined,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
65-69,120.1,188.5,80,Incidence,52823,Non-Hispanic American Indian/Alaska Native,151.4,Male,Colon and Rectum,2017
65-69,21.7,56.2,19,Incidence,52823,Non-Hispanic American Indian/Alaska Native,36.0,Male,Esophagus,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
65-69,81.7,139.8,57,Incidence,52823,Non-Hispanic American Indian/Alaska Native,107.9,Male,Kidney and Renal Pelvis,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
65-69,20.2,53.9,18,Incidence,52823,Non-Hispanic American Indian/Alaska Native,34.1,Male,Leukemias,2017
65-69,105.0,169.5,71,Incidence,52823,Non-Hispanic American Indian/Alaska Native,134.4,Male,Liver and Intrahepatic Bile Duct,2017
65-69,207.4,294.3,131,Incidence,52823,Non-Hispanic American Indian/Alaska Native,248.0,Male,Lung and Bronchus,2017
65-69,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
65-69,21.7,56.2,19,Incidence,52823,Non-Hispanic American Indian/Alaska Native,36.0,Male,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
65-69,24.6,60.8,21,Incidence,52823,Non-Hispanic American Indian/Alaska Native,39.8,Male,Myeloma,2017
65-69,38.3,81.1,30,Incidence,52823,Non-Hispanic American Indian/Alaska Native,56.8,Male,Non-Hodgkin Lymphoma,2017
65-69,33.7,74.4,27,Incidence,52823,Non-Hispanic American Indian/Alaska Native,51.1,Male,Oral Cavity and Pharynx,2017
65-69,20.2,53.9,18,Incidence,52823,Non-Hispanic American Indian/Alaska Native,34.1,Male,Pancreas,2017
65-69,361.5,473.3,219,Incidence,52823,Non-Hispanic American Indian/Alaska Native,414.6,Male,Prostate,2017
65-69,21.7,56.2,19,Incidence,52823,Non-Hispanic American Indian/Alaska Native,36.0,Male,Stomach,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
65-69,41.4,85.5,32,Incidence,52823,Non-Hispanic American Indian/Alaska Native,60.6,Male,Urinary Bladder,2017
70-74,1714.8,1998.6,668,Incidence,36057,Non-Hispanic American Indian/Alaska Native,1852.6,Male,All Cancer Sites Combined,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
70-74,112.5,195.4,54,Incidence,36057,Non-Hispanic American Indian/Alaska Native,149.8,Male,Colon and Rectum,2017
70-74,25.4,72.1,16,Incidence,36057,Non-Hispanic American Indian/Alaska Native,44.4,Male,Esophagus,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
70-74,74.6,144.7,38,Incidence,36057,Non-Hispanic American Indian/Alaska Native,105.4,Male,Kidney and Renal Pelvis,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
70-74,40.4,95.7,23,Incidence,36057,Non-Hispanic American Indian/Alaska Native,63.8,Male,Leukemias,2017
70-74,72.3,141.4,37,Incidence,36057,Non-Hispanic American Indian/Alaska Native,102.6,Male,Liver and Intrahepatic Bile Duct,2017
70-74,308.8,437.1,133,Incidence,36057,Non-Hispanic American Indian/Alaska Native,368.9,Male,Lung and Bronchus,2017
70-74,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
70-74,29.6,78.9,18,Incidence,36057,Non-Hispanic American Indian/Alaska Native,49.9,Male,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
70-74,36.1,89.0,21,Incidence,36057,Non-Hispanic American Indian/Alaska Native,58.2,Male,Non-Hodgkin Lymphoma,2017
70-74,38.2,92.4,22,Incidence,36057,Non-Hispanic American Indian/Alaska Native,61.0,Male,Oral Cavity and Pharynx,2017
70-74,31.7,82.3,19,Incidence,36057,Non-Hispanic American Indian/Alaska Native,52.7,Male,Pancreas,2017
70-74,354.7,491.2,151,Incidence,36057,Non-Hispanic American Indian/Alaska Native,418.8,Male,Prostate,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
70-74,84.0,157.5,42,Incidence,36057,Non-Hispanic American Indian/Alaska Native,116.5,Male,Urinary Bladder,2017
75-79,2051.4,2450.7,497,Incidence,22144,Non-Hispanic American Indian/Alaska Native,2244.4,Male,All Cancer Sites Combined,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
75-79,148.2,271.9,45,Incidence,22144,Non-Hispanic American Indian/Alaska Native,203.2,Male,Colon and Rectum,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
75-79,91.4,193.4,30,Incidence,22144,Non-Hispanic American Indian/Alaska Native,135.5,Male,Kidney and Renal Pelvis,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
75-79,48.2,128.5,18,Incidence,22144,Non-Hispanic American Indian/Alaska Native,81.3,Male,Leukemias,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
75-79,339.0,514.5,93,Incidence,22144,Non-Hispanic American Indian/Alaska Native,420.0,Male,Lung and Bronchus,2017
75-79,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
75-79,41.3,117.3,16,Incidence,22144,Non-Hispanic American Indian/Alaska Native,72.3,Male,Myeloma,2017
75-79,41.3,117.3,16,Incidence,22144,Non-Hispanic American Indian/Alaska Native,72.3,Male,Non-Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
75-79,428.8,623.4,115,Incidence,22144,Non-Hispanic American Indian/Alaska Native,519.3,Male,Prostate,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
75-79,95.1,198.7,31,Incidence,22144,Non-Hispanic American Indian/Alaska Native,140.0,Male,Urinary Bladder,2017
80-84,2073.3,2617.9,291,Incidence,12469,Non-Hispanic American Indian/Alaska Native,2333.8,Male,All Cancer Sites Combined,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
80-84,168.9,352.9,31,Incidence,12469,Non-Hispanic American Indian/Alaska Native,248.6,Male,Colon and Rectum,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
80-84,339.3,583.2,56,Incidence,12469,Non-Hispanic American Indian/Alaska Native,449.1,Male,Lung and Bronchus,2017
80-84,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
80-84,73.3,208.4,16,Incidence,12469,Non-Hispanic American Indian/Alaska Native,128.3,Male,Pancreas,2017
80-84,277.0,501.2,47,Incidence,12469,Non-Hispanic American Indian/Alaska Native,376.9,Male,Prostate,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
80-84,195.5,390.4,35,Incidence,12469,Non-Hispanic American Indian/Alaska Native,280.7,Male,Urinary Bladder,2017
85+,1372.6,1892.7,155,Incidence,9585,Non-Hispanic American Indian/Alaska Native,1617.1,Male,All Cancer Sites Combined,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
85+,103.3,284.0,17,Incidence,9585,Non-Hispanic American Indian/Alaska Native,177.4,Male,Colon and Rectum,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
85+,168.8,385.0,25,Incidence,9585,Non-Hispanic American Indian/Alaska Native,260.8,Male,Lung and Bronchus,2017
85+,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
85+,211.2,446.8,30,Incidence,9585,Non-Hispanic American Indian/Alaska Native,313.0,Male,Prostate,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2017
<1,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2017
1-4,15.9,31.8,35,Incidence,153051,Non-Hispanic American Indian/Alaska Native,22.9,Male and Female,All Cancer Sites Combined,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,75088,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
1-4,~,~,~,Incidence,77963,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
1-4,~,~,~,Incidence,153051,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
10-14,10.0,21.2,30,Incidence,201540,Non-Hispanic American Indian/Alaska Native,14.9,Male and Female,All Cancer Sites Combined,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,99671,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
10-14,~,~,~,Incidence,101869,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
10-14,~,~,~,Incidence,201540,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
15-19,15.6,28.8,44,Incidence,205325,Non-Hispanic American Indian/Alaska Native,21.4,Male and Female,All Cancer Sites Combined,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,101367,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
15-19,~,~,~,Incidence,103958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
15-19,~,~,~,Incidence,205325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
20-24,22.7,37.8,63,Incidence,213411,Non-Hispanic American Indian/Alaska Native,29.5,Male and Female,All Cancer Sites Combined,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,105050,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
20-24,~,~,~,Incidence,108361,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
20-24,~,~,~,Incidence,213411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
25-29,55.8,77.8,145,Incidence,219195,Non-Hispanic American Indian/Alaska Native,66.2,Male and Female,All Cancer Sites Combined,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
25-29,9.2,25.2,17,Incidence,107898,Non-Hispanic American Indian/Alaska Native,15.8,Male and Female,Female Breast,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
25-29,9.2,25.2,17,Incidence,107898,Non-Hispanic American Indian/Alaska Native,15.8,Male and Female,Male and Female Breast,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
25-29,~,~,~,Incidence,107898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
25-29,~,~,~,Incidence,111297,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
25-29,8.2,23.3,16,Incidence,111297,Non-Hispanic American Indian/Alaska Native,14.4,Male and Female,Testis,2017
25-29,6.7,15.7,23,Incidence,219195,Non-Hispanic American Indian/Alaska Native,10.5,Male and Female,Thyroid,2017
25-29,~,~,~,Incidence,219195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
30-34,99.3,130.6,212,Incidence,185651,Non-Hispanic American Indian/Alaska Native,114.2,Male and Female,All Cancer Sites Combined,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
30-34,5.3,14.7,17,Incidence,185651,Non-Hispanic American Indian/Alaska Native,9.2,Male and Female,Colon and Rectum,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
30-34,26.1,52.1,35,Incidence,93391,Non-Hispanic American Indian/Alaska Native,37.5,Male and Female,Female Breast,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
30-34,26.1,52.1,35,Incidence,93391,Non-Hispanic American Indian/Alaska Native,37.5,Male and Female,Male and Female Breast,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
30-34,~,~,~,Incidence,93391,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
30-34,~,~,~,Incidence,92260,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
30-34,10.7,29.5,17,Incidence,92260,Non-Hispanic American Indian/Alaska Native,18.4,Male and Female,Testis,2017
30-34,8.7,19.9,25,Incidence,185651,Non-Hispanic American Indian/Alaska Native,13.5,Male and Female,Thyroid,2017
30-34,~,~,~,Incidence,185651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
35-39,148.1,187.6,284,Incidence,170096,Non-Hispanic American Indian/Alaska Native,167.0,Male and Female,All Cancer Sites Combined,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
35-39,11.5,31.6,17,Incidence,86234,Non-Hispanic American Indian/Alaska Native,19.7,Male and Female,Cervix,2017
35-39,13.4,27.2,33,Incidence,170096,Non-Hispanic American Indian/Alaska Native,19.4,Male and Female,Colon and Rectum,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
35-39,42.0,75.1,49,Incidence,86234,Non-Hispanic American Indian/Alaska Native,56.8,Male and Female,Female Breast,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
35-39,6.3,16.7,18,Incidence,170096,Non-Hispanic American Indian/Alaska Native,10.6,Male and Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
35-39,42.0,75.1,49,Incidence,86234,Non-Hispanic American Indian/Alaska Native,56.8,Male and Female,Male and Female Breast,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
35-39,~,~,~,Incidence,86234,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
35-39,~,~,~,Incidence,83862,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
35-39,17.3,32.7,41,Incidence,170096,Non-Hispanic American Indian/Alaska Native,24.1,Male and Female,Thyroid,2017
35-39,~,~,~,Incidence,170096,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
40-44,236.6,288.3,404,Incidence,154512,Non-Hispanic American Indian/Alaska Native,261.5,Male and Female,All Cancer Sites Combined,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
40-44,17.5,42.2,22,Incidence,78915,Non-Hispanic American Indian/Alaska Native,27.9,Male and Female,Cervix,2017
40-44,19.0,36.0,41,Incidence,154512,Non-Hispanic American Indian/Alaska Native,26.5,Male and Female,Colon and Rectum,2017
40-44,26.7,55.8,31,Incidence,78915,Non-Hispanic American Indian/Alaska Native,39.3,Male and Female,"Corpus and Uterus, NOS",2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
40-44,105.4,156.9,102,Incidence,78915,Non-Hispanic American Indian/Alaska Native,129.3,Male and Female,Female Breast,2017
40-44,20.5,46.8,25,Incidence,78915,Non-Hispanic American Indian/Alaska Native,31.7,Male and Female,"Female Breast, <i>in situ</i>",2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
40-44,14.2,29.2,32,Incidence,154512,Non-Hispanic American Indian/Alaska Native,20.7,Male and Female,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
40-44,105.4,156.9,102,Incidence,78915,Non-Hispanic American Indian/Alaska Native,129.3,Male and Female,Male and Female Breast,2017
40-44,20.5,46.8,25,Incidence,78915,Non-Hispanic American Indian/Alaska Native,31.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
40-44,~,~,~,Incidence,78915,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
40-44,~,~,~,Incidence,75597,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
40-44,13.6,28.5,31,Incidence,154512,Non-Hispanic American Indian/Alaska Native,20.1,Male and Female,Thyroid,2017
40-44,~,~,~,Incidence,154512,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
45-49,333.6,393.2,581,Incidence,160289,Non-Hispanic American Indian/Alaska Native,362.5,Male and Female,All Cancer Sites Combined,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
45-49,35.7,57.3,73,Incidence,160289,Non-Hispanic American Indian/Alaska Native,45.5,Male and Female,Colon and Rectum,2017
45-49,18.7,43.5,24,Incidence,82156,Non-Hispanic American Indian/Alaska Native,29.2,Male and Female,"Corpus and Uterus, NOS",2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
45-49,126.6,181.3,125,Incidence,82156,Non-Hispanic American Indian/Alaska Native,152.1,Male and Female,Female Breast,2017
45-49,18.7,43.5,24,Incidence,82156,Non-Hispanic American Indian/Alaska Native,29.2,Male and Female,"Female Breast, <i>in situ</i>",2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
45-49,18.9,35.4,42,Incidence,160289,Non-Hispanic American Indian/Alaska Native,26.2,Male and Female,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
45-49,8.6,20.8,22,Incidence,160289,Non-Hispanic American Indian/Alaska Native,13.7,Male and Female,Leukemias,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
45-49,14.2,28.9,33,Incidence,160289,Non-Hispanic American Indian/Alaska Native,20.6,Male and Female,Lung and Bronchus,2017
45-49,126.6,181.3,125,Incidence,82156,Non-Hispanic American Indian/Alaska Native,152.1,Male and Female,Male and Female Breast,2017
45-49,18.7,43.5,24,Incidence,82156,Non-Hispanic American Indian/Alaska Native,29.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
45-49,8.1,20.0,21,Incidence,160289,Non-Hispanic American Indian/Alaska Native,13.1,Male and Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
45-49,10.1,23.0,25,Incidence,160289,Non-Hispanic American Indian/Alaska Native,15.6,Male and Female,Non-Hodgkin Lymphoma,2017
45-49,10.1,23.0,25,Incidence,160289,Non-Hispanic American Indian/Alaska Native,15.6,Male and Female,Oral Cavity and Pharynx,2017
45-49,~,~,~,Incidence,82156,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
45-49,5.7,16.2,16,Incidence,160289,Non-Hispanic American Indian/Alaska Native,10.0,Male and Female,Pancreas,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
45-49,~,~,~,Incidence,78133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
45-49,14.2,28.9,33,Incidence,160289,Non-Hispanic American Indian/Alaska Native,20.6,Male and Female,Thyroid,2017
45-49,~,~,~,Incidence,160289,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
5-9,9.3,20.3,28,Incidence,199011,Non-Hispanic American Indian/Alaska Native,14.1,Male and Female,All Cancer Sites Combined,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,98293,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
5-9,~,~,~,Incidence,100718,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
5-9,~,~,~,Incidence,199011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
50-54,506.6,577.5,912,Incidence,168521,Non-Hispanic American Indian/Alaska Native,541.2,Male and Female,All Cancer Sites Combined,2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
50-54,73.7,102.5,147,Incidence,168521,Non-Hispanic American Indian/Alaska Native,87.2,Male and Female,Colon and Rectum,2017
50-54,30.7,59.6,38,Incidence,87510,Non-Hispanic American Indian/Alaska Native,43.4,Male and Female,"Corpus and Uterus, NOS",2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
50-54,141.9,197.4,147,Incidence,87510,Non-Hispanic American Indian/Alaska Native,168.0,Male and Female,Female Breast,2017
50-54,27.9,55.6,35,Incidence,87510,Non-Hispanic American Indian/Alaska Native,40.0,Male and Female,"Female Breast, <i>in situ</i>",2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
50-54,33.4,53.8,72,Incidence,168521,Non-Hispanic American Indian/Alaska Native,42.7,Male and Female,Kidney and Renal Pelvis,2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
50-54,6.8,17.6,19,Incidence,168521,Non-Hispanic American Indian/Alaska Native,11.3,Male and Female,Leukemias,2017
50-54,13.5,27.5,33,Incidence,168521,Non-Hispanic American Indian/Alaska Native,19.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
50-54,41.9,64.3,88,Incidence,168521,Non-Hispanic American Indian/Alaska Native,52.2,Male and Female,Lung and Bronchus,2017
50-54,141.9,197.4,147,Incidence,87510,Non-Hispanic American Indian/Alaska Native,168.0,Male and Female,Male and Female Breast,2017
50-54,27.9,55.6,35,Incidence,87510,Non-Hispanic American Indian/Alaska Native,40.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
50-54,8.2,19.8,22,Incidence,168521,Non-Hispanic American Indian/Alaska Native,13.1,Male and Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
50-54,9.1,21.2,24,Incidence,168521,Non-Hispanic American Indian/Alaska Native,14.2,Male and Female,Non-Hodgkin Lymphoma,2017
50-54,9.6,21.9,25,Incidence,168521,Non-Hispanic American Indian/Alaska Native,14.8,Male and Female,Oral Cavity and Pharynx,2017
50-54,~,~,~,Incidence,87510,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
50-54,7.2,18.3,20,Incidence,168521,Non-Hispanic American Indian/Alaska Native,11.9,Male and Female,Pancreas,2017
50-54,60.8,100.9,64,Incidence,81011,Non-Hispanic American Indian/Alaska Native,79.0,Male and Female,Prostate,2017
50-54,8.7,20.5,23,Incidence,168521,Non-Hispanic American Indian/Alaska Native,13.6,Male and Female,Stomach,2017
50-54,~,~,~,Incidence,81011,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
50-54,12.5,26.1,31,Incidence,168521,Non-Hispanic American Indian/Alaska Native,18.4,Male and Female,Thyroid,2017
50-54,~,~,~,Incidence,168521,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
55-59,690.4,771.8,1255,Incidence,171867,Non-Hispanic American Indian/Alaska Native,730.2,Male and Female,All Cancer Sites Combined,2017
55-59,~,~,~,Incidence,171867,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
55-59,10.1,28.6,16,Incidence,90832,Non-Hispanic American Indian/Alaska Native,17.6,Male and Female,Cervix,2017
55-59,68.5,96.1,140,Incidence,171867,Non-Hispanic American Indian/Alaska Native,81.5,Male and Female,Colon and Rectum,2017
55-59,48.5,82.5,58,Incidence,90832,Non-Hispanic American Indian/Alaska Native,63.9,Male and Female,"Corpus and Uterus, NOS",2017
55-59,~,~,~,Incidence,171867,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
55-59,168.2,227.0,178,Incidence,90832,Non-Hispanic American Indian/Alaska Native,196.0,Male and Female,Female Breast,2017
55-59,39.0,70.1,48,Incidence,90832,Non-Hispanic American Indian/Alaska Native,52.8,Male and Female,"Female Breast, <i>in situ</i>",2017
55-59,~,~,~,Incidence,171867,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,171867,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
55-59,47.9,71.4,101,Incidence,171867,Non-Hispanic American Indian/Alaska Native,58.8,Male and Female,Kidney and Renal Pelvis,2017
55-59,8.0,19.4,22,Incidence,171867,Non-Hispanic American Indian/Alaska Native,12.8,Male and Female,Larynx,2017
55-59,8.9,20.8,24,Incidence,171867,Non-Hispanic American Indian/Alaska Native,14.0,Male and Female,Leukemias,2017
55-59,28.7,47.6,64,Incidence,171867,Non-Hispanic American Indian/Alaska Native,37.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
55-59,68.5,96.1,140,Incidence,171867,Non-Hispanic American Indian/Alaska Native,81.5,Male and Female,Lung and Bronchus,2017
55-59,168.2,227.0,178,Incidence,90832,Non-Hispanic American Indian/Alaska Native,196.0,Male and Female,Male and Female Breast,2017
55-59,39.0,70.1,48,Incidence,90832,Non-Hispanic American Indian/Alaska Native,52.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
55-59,8.9,20.8,24,Incidence,171867,Non-Hispanic American Indian/Alaska Native,14.0,Male and Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,171867,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
55-59,~,~,~,Incidence,171867,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
55-59,12.3,25.6,31,Incidence,171867,Non-Hispanic American Indian/Alaska Native,18.0,Male and Female,Non-Hodgkin Lymphoma,2017
55-59,18.6,34.4,44,Incidence,171867,Non-Hispanic American Indian/Alaska Native,25.6,Male and Female,Oral Cavity and Pharynx,2017
55-59,13.4,34.0,20,Incidence,90832,Non-Hispanic American Indian/Alaska Native,22.0,Male and Female,Ovary,2017
55-59,10.8,23.5,28,Incidence,171867,Non-Hispanic American Indian/Alaska Native,16.3,Male and Female,Pancreas,2017
55-59,145.3,203.9,140,Incidence,81035,Non-Hispanic American Indian/Alaska Native,172.8,Male and Female,Prostate,2017
55-59,5.3,15.1,16,Incidence,171867,Non-Hispanic American Indian/Alaska Native,9.3,Male and Female,Stomach,2017
55-59,~,~,~,Incidence,81035,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
55-59,12.7,26.3,32,Incidence,171867,Non-Hispanic American Indian/Alaska Native,18.6,Male and Female,Thyroid,2017
55-59,12.3,25.6,31,Incidence,171867,Non-Hispanic American Indian/Alaska Native,18.0,Male and Female,Urinary Bladder,2017
60-64,1045.9,1153.7,1615,Incidence,146979,Non-Hispanic American Indian/Alaska Native,1098.8,Male and Female,All Cancer Sites Combined,2017
60-64,~,~,~,Incidence,146979,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
60-64,89.5,123.4,155,Incidence,146979,Non-Hispanic American Indian/Alaska Native,105.5,Male and Female,Colon and Rectum,2017
60-64,51.6,89.6,54,Incidence,78654,Non-Hispanic American Indian/Alaska Native,68.7,Male and Female,"Corpus and Uterus, NOS",2017
60-64,7.8,20.2,19,Incidence,146979,Non-Hispanic American Indian/Alaska Native,12.9,Male and Female,Esophagus,2017
60-64,257.0,334.1,231,Incidence,78654,Non-Hispanic American Indian/Alaska Native,293.7,Male and Female,Female Breast,2017
60-64,41.7,76.6,45,Incidence,78654,Non-Hispanic American Indian/Alaska Native,57.2,Male and Female,"Female Breast, <i>in situ</i>",2017
60-64,~,~,~,Incidence,146979,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,146979,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
60-64,64.0,93.2,114,Incidence,146979,Non-Hispanic American Indian/Alaska Native,77.6,Male and Female,Kidney and Renal Pelvis,2017
60-64,9.4,22.7,22,Incidence,146979,Non-Hispanic American Indian/Alaska Native,15.0,Male and Female,Larynx,2017
60-64,14.3,29.9,31,Incidence,146979,Non-Hispanic American Indian/Alaska Native,21.1,Male and Female,Leukemias,2017
60-64,52.3,79.0,95,Incidence,146979,Non-Hispanic American Indian/Alaska Native,64.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
60-64,140.1,181.7,235,Incidence,146979,Non-Hispanic American Indian/Alaska Native,159.9,Male and Female,Lung and Bronchus,2017
60-64,257.0,334.1,231,Incidence,78654,Non-Hispanic American Indian/Alaska Native,293.7,Male and Female,Male and Female Breast,2017
60-64,41.7,76.6,45,Incidence,78654,Non-Hispanic American Indian/Alaska Native,57.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
60-64,10.5,24.3,24,Incidence,146979,Non-Hispanic American Indian/Alaska Native,16.3,Male and Female,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,146979,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
60-64,7.3,19.4,18,Incidence,146979,Non-Hispanic American Indian/Alaska Native,12.2,Male and Female,Myeloma,2017
60-64,21.2,39.4,43,Incidence,146979,Non-Hispanic American Indian/Alaska Native,29.3,Male and Female,Non-Hodgkin Lymphoma,2017
60-64,31.7,53.3,61,Incidence,146979,Non-Hispanic American Indian/Alaska Native,41.5,Male and Female,Oral Cavity and Pharynx,2017
60-64,~,~,~,Incidence,78654,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
60-64,24.7,44.1,49,Incidence,146979,Non-Hispanic American Indian/Alaska Native,33.3,Male and Female,Pancreas,2017
60-64,265.8,350.3,209,Incidence,68325,Non-Hispanic American Indian/Alaska Native,305.9,Male and Female,Prostate,2017
60-64,12.7,27.5,28,Incidence,146979,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Stomach,2017
60-64,~,~,~,Incidence,68325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
60-64,11.0,25.1,25,Incidence,146979,Non-Hispanic American Indian/Alaska Native,17.0,Male and Female,Thyroid,2017
60-64,19.4,37.1,40,Incidence,146979,Non-Hispanic American Indian/Alaska Native,27.2,Male and Female,Urinary Bladder,2017
65-69,1344.2,1483.5,1602,Incidence,113411,Non-Hispanic American Indian/Alaska Native,1412.6,Male and Female,All Cancer Sites Combined,2017
65-69,~,~,~,Incidence,113411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
65-69,~,~,~,Incidence,60588,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
65-69,108.7,151.4,146,Incidence,113411,Non-Hispanic American Indian/Alaska Native,128.7,Male and Female,Colon and Rectum,2017
65-69,59.8,106.9,49,Incidence,60588,Non-Hispanic American Indian/Alaska Native,80.9,Male and Female,"Corpus and Uterus, NOS",2017
65-69,12.2,29.4,22,Incidence,113411,Non-Hispanic American Indian/Alaska Native,19.4,Male and Female,Esophagus,2017
65-69,312.1,409.1,217,Incidence,60588,Non-Hispanic American Indian/Alaska Native,358.2,Male and Female,Female Breast,2017
65-69,44.4,86.1,38,Incidence,60588,Non-Hispanic American Indian/Alaska Native,62.7,Male and Female,"Female Breast, <i>in situ</i>",2017
65-69,~,~,~,Incidence,113411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,113411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
65-69,63.0,96.6,89,Incidence,113411,Non-Hispanic American Indian/Alaska Native,78.5,Male and Female,Kidney and Renal Pelvis,2017
65-69,~,~,~,Incidence,113411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
65-69,17.1,36.7,29,Incidence,113411,Non-Hispanic American Indian/Alaska Native,25.6,Male and Female,Leukemias,2017
65-69,66.2,100.5,93,Incidence,113411,Non-Hispanic American Indian/Alaska Native,82.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
65-69,209.7,267.3,269,Incidence,113411,Non-Hispanic American Indian/Alaska Native,237.2,Male and Female,Lung and Bronchus,2017
65-69,312.1,409.1,217,Incidence,60588,Non-Hispanic American Indian/Alaska Native,358.2,Male and Female,Male and Female Breast,2017
65-69,44.4,86.1,38,Incidence,60588,Non-Hispanic American Indian/Alaska Native,62.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
65-69,18.6,38.8,31,Incidence,113411,Non-Hispanic American Indian/Alaska Native,27.3,Male and Female,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,113411,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
65-69,21.5,42.9,35,Incidence,113411,Non-Hispanic American Indian/Alaska Native,30.9,Male and Female,Myeloma,2017
65-69,39.6,67.1,59,Incidence,113411,Non-Hispanic American Indian/Alaska Native,52.0,Male and Female,Non-Hodgkin Lymphoma,2017
65-69,26.7,50.1,42,Incidence,113411,Non-Hispanic American Indian/Alaska Native,37.0,Male and Female,Oral Cavity and Pharynx,2017
65-69,17.6,47.0,18,Incidence,60588,Non-Hispanic American Indian/Alaska Native,29.7,Male and Female,Ovary,2017
65-69,24.5,47.0,39,Incidence,113411,Non-Hispanic American Indian/Alaska Native,34.4,Male and Female,Pancreas,2017
65-69,361.5,473.3,219,Incidence,52823,Non-Hispanic American Indian/Alaska Native,414.6,Male and Female,Prostate,2017
65-69,18.6,38.8,31,Incidence,113411,Non-Hispanic American Indian/Alaska Native,27.3,Male and Female,Stomach,2017
65-69,~,~,~,Incidence,52823,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
65-69,10.8,27.2,20,Incidence,113411,Non-Hispanic American Indian/Alaska Native,17.6,Male and Female,Thyroid,2017
65-69,28.9,53.1,45,Incidence,113411,Non-Hispanic American Indian/Alaska Native,39.7,Male and Female,Urinary Bladder,2017
70-74,1562.8,1744.4,1290,Incidence,78100,Non-Hispanic American Indian/Alaska Native,1651.7,Male and Female,All Cancer Sites Combined,2017
70-74,~,~,~,Incidence,78100,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
70-74,~,~,~,Incidence,42043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
70-74,127.4,183.7,120,Incidence,78100,Non-Hispanic American Indian/Alaska Native,153.6,Male and Female,Colon and Rectum,2017
70-74,58.0,115.8,35,Incidence,42043,Non-Hispanic American Indian/Alaska Native,83.2,Male and Female,"Corpus and Uterus, NOS",2017
70-74,11.7,33.3,16,Incidence,78100,Non-Hispanic American Indian/Alaska Native,20.5,Male and Female,Esophagus,2017
70-74,306.3,423.8,152,Incidence,42043,Non-Hispanic American Indian/Alaska Native,361.5,Male and Female,Female Breast,2017
70-74,52.1,107.4,32,Incidence,42043,Non-Hispanic American Indian/Alaska Native,76.1,Male and Female,"Female Breast, <i>in situ</i>",2017
70-74,~,~,~,Incidence,78100,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,78100,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
70-74,68.7,111.8,69,Incidence,78100,Non-Hispanic American Indian/Alaska Native,88.3,Male and Female,Kidney and Renal Pelvis,2017
70-74,11.7,33.3,16,Incidence,78100,Non-Hispanic American Indian/Alaska Native,20.5,Male and Female,Larynx,2017
70-74,34.4,66.8,38,Incidence,78100,Non-Hispanic American Indian/Alaska Native,48.7,Male and Female,Leukemias,2017
70-74,51.9,90.2,54,Incidence,78100,Non-Hispanic American Indian/Alaska Native,69.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
70-74,291.3,373.2,258,Incidence,78100,Non-Hispanic American Indian/Alaska Native,330.3,Male and Female,Lung and Bronchus,2017
70-74,306.3,423.8,152,Incidence,42043,Non-Hispanic American Indian/Alaska Native,361.5,Male and Female,Male and Female Breast,2017
70-74,52.1,107.4,32,Incidence,42043,Non-Hispanic American Indian/Alaska Native,76.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
70-74,19.7,45.7,24,Incidence,78100,Non-Hispanic American Indian/Alaska Native,30.7,Male and Female,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,78100,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
70-74,24.9,53.3,29,Incidence,78100,Non-Hispanic American Indian/Alaska Native,37.1,Male and Female,Myeloma,2017
70-74,45.3,81.5,48,Incidence,78100,Non-Hispanic American Indian/Alaska Native,61.5,Male and Female,Non-Hodgkin Lymphoma,2017
70-74,31.2,62.3,35,Incidence,78100,Non-Hispanic American Indian/Alaska Native,44.8,Male and Female,Oral Cavity and Pharynx,2017
70-74,23.6,64.7,17,Incidence,42043,Non-Hispanic American Indian/Alaska Native,40.4,Male and Female,Ovary,2017
70-74,34.4,66.8,38,Incidence,78100,Non-Hispanic American Indian/Alaska Native,48.7,Male and Female,Pancreas,2017
70-74,354.7,491.2,151,Incidence,36057,Non-Hispanic American Indian/Alaska Native,418.8,Male and Female,Prostate,2017
70-74,15.6,39.5,20,Incidence,78100,Non-Hispanic American Indian/Alaska Native,25.6,Male and Female,Stomach,2017
70-74,~,~,~,Incidence,36057,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
70-74,~,~,~,Incidence,78100,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
70-74,44.2,80.0,47,Incidence,78100,Non-Hispanic American Indian/Alaska Native,60.2,Male and Female,Urinary Bladder,2017
75-79,1789.5,2035.1,944,Incidence,49441,Non-Hispanic American Indian/Alaska Native,1909.3,Male and Female,All Cancer Sites Combined,2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
75-79,153.6,232.7,94,Incidence,49441,Non-Hispanic American Indian/Alaska Native,190.1,Male and Female,Colon and Rectum,2017
75-79,39.1,104.2,18,Incidence,27297,Non-Hispanic American Indian/Alaska Native,65.9,Male and Female,"Corpus and Uterus, NOS",2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
75-79,284.9,429.5,96,Incidence,27297,Non-Hispanic American Indian/Alaska Native,351.7,Male and Female,Female Breast,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
75-79,69.8,126.4,47,Incidence,49441,Non-Hispanic American Indian/Alaska Native,95.1,Male and Female,Kidney and Renal Pelvis,2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
75-79,49.3,98.5,35,Incidence,49441,Non-Hispanic American Indian/Alaska Native,70.8,Male and Female,Leukemias,2017
75-79,32.7,74.6,25,Incidence,49441,Non-Hispanic American Indian/Alaska Native,50.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
75-79,331.6,443.0,190,Incidence,49441,Non-Hispanic American Indian/Alaska Native,384.3,Male and Female,Lung and Bronchus,2017
75-79,284.9,429.5,96,Incidence,27297,Non-Hispanic American Indian/Alaska Native,351.7,Male and Female,Male and Female Breast,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
75-79,34.4,77.1,26,Incidence,49441,Non-Hispanic American Indian/Alaska Native,52.6,Male and Female,Myeloma,2017
75-79,44.3,91.4,32,Incidence,49441,Non-Hispanic American Indian/Alaska Native,64.7,Male and Female,Non-Hodgkin Lymphoma,2017
75-79,27.9,67.4,22,Incidence,49441,Non-Hispanic American Indian/Alaska Native,44.5,Male and Female,Oral Cavity and Pharynx,2017
75-79,~,~,~,Incidence,27297,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
75-79,36.0,79.5,27,Incidence,49441,Non-Hispanic American Indian/Alaska Native,54.6,Male and Female,Pancreas,2017
75-79,428.8,623.4,115,Incidence,22144,Non-Hispanic American Indian/Alaska Native,519.3,Male and Female,Prostate,2017
75-79,24.7,62.5,20,Incidence,49441,Non-Hispanic American Indian/Alaska Native,40.5,Male and Female,Stomach,2017
75-79,~,~,~,Incidence,22144,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
75-79,~,~,~,Incidence,49441,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
75-79,64.7,119.5,44,Incidence,49441,Non-Hispanic American Indian/Alaska Native,89.0,Male and Female,Urinary Bladder,2017
80-84,1821.9,2145.3,588,Incidence,29717,Non-Hispanic American Indian/Alaska Native,1978.7,Male and Female,All Cancer Sites Combined,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
80-84,154.1,259.9,60,Incidence,29717,Non-Hispanic American Indian/Alaska Native,201.9,Male and Female,Colon and Rectum,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
80-84,245.3,421.6,56,Incidence,17248,Non-Hispanic American Indian/Alaska Native,324.7,Male and Female,Female Breast,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
80-84,54.4,124.2,25,Incidence,29717,Non-Hispanic American Indian/Alaska Native,84.1,Male and Female,Kidney and Renal Pelvis,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
80-84,337.9,486.5,121,Incidence,29717,Non-Hispanic American Indian/Alaska Native,407.2,Male and Female,Lung and Bronchus,2017
80-84,245.3,421.6,56,Incidence,17248,Non-Hispanic American Indian/Alaska Native,324.7,Male and Female,Male and Female Breast,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
80-84,38.5,99.8,19,Incidence,29717,Non-Hispanic American Indian/Alaska Native,63.9,Male and Female,Myeloma,2017
80-84,70.9,148.1,31,Incidence,29717,Non-Hispanic American Indian/Alaska Native,104.3,Male and Female,Non-Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
80-84,~,~,~,Incidence,17248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
80-84,54.4,124.2,25,Incidence,29717,Non-Hispanic American Indian/Alaska Native,84.1,Male and Female,Pancreas,2017
80-84,277.0,501.2,47,Incidence,12469,Non-Hispanic American Indian/Alaska Native,376.9,Male and Female,Prostate,2017
80-84,43.7,108.0,21,Incidence,29717,Non-Hispanic American Indian/Alaska Native,70.7,Male and Female,Stomach,2017
80-84,~,~,~,Incidence,12469,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
80-84,~,~,~,Incidence,29717,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
80-84,101.9,191.0,42,Incidence,29717,Non-Hispanic American Indian/Alaska Native,141.3,Male and Female,Urinary Bladder,2017
85+,1389.9,1692.2,407,Incidence,26506,Non-Hispanic American Indian/Alaska Native,1535.5,Male and Female,All Cancer Sites Combined,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
85+,153.0,265.8,54,Incidence,26506,Non-Hispanic American Indian/Alaska Native,203.7,Male and Female,Colon and Rectum,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
85+,178.9,335.5,42,Incidence,16921,Non-Hispanic American Indian/Alaska Native,248.2,Male and Female,Female Breast,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
85+,34.5,98.0,16,Incidence,26506,Non-Hispanic American Indian/Alaska Native,60.4,Male and Female,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
85+,37.4,102.7,17,Incidence,26506,Non-Hispanic American Indian/Alaska Native,64.1,Male and Female,Leukemias,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
85+,176.0,295.6,61,Incidence,26506,Non-Hispanic American Indian/Alaska Native,230.1,Male and Female,Lung and Bronchus,2017
85+,178.9,335.5,42,Incidence,16921,Non-Hispanic American Indian/Alaska Native,248.2,Male and Female,Male and Female Breast,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
85+,~,~,~,Incidence,16921,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
85+,43.2,111.9,19,Incidence,26506,Non-Hispanic American Indian/Alaska Native,71.7,Male and Female,Pancreas,2017
85+,211.2,446.8,30,Incidence,9585,Non-Hispanic American Indian/Alaska Native,313.0,Male and Female,Prostate,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
85+,~,~,~,Incidence,9585,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
85+,~,~,~,Incidence,26506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
85+,61.0,139.2,25,Incidence,26506,Non-Hispanic American Indian/Alaska Native,94.3,Male and Female,Urinary Bladder,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,17763,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2017
<1,~,~,~,Incidence,18370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2017
<1,~,~,~,Incidence,36133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2017
1-4,15.9,23.8,99,Incidence,506520,Non-Hispanic Asian/Pacific Islander,19.5,Female,All Cancer Sites Combined,2017
1-4,2.3,5.9,19,Incidence,506520,Non-Hispanic Asian/Pacific Islander,3.8,Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
1-4,5.5,10.5,39,Incidence,506520,Non-Hispanic Asian/Pacific Islander,7.7,Female,Leukemias,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
10-14,10.2,16.1,78,Incidence,603049,Non-Hispanic Asian/Pacific Islander,12.9,Female,All Cancer Sites Combined,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
10-14,1.5,4.3,16,Incidence,603049,Non-Hispanic Asian/Pacific Islander,2.7,Female,Leukemias,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
10-14,1.5,4.3,16,Incidence,603049,Non-Hispanic Asian/Pacific Islander,2.7,Female,Thyroid,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
15-19,16.9,24.2,123,Incidence,605391,Non-Hispanic Asian/Pacific Islander,20.3,Female,All Cancer Sites Combined,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
15-19,3.9,7.8,34,Incidence,605391,Non-Hispanic Asian/Pacific Islander,5.6,Female,Thyroid,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
20-24,30.3,39.2,240,Incidence,694292,Non-Hispanic Asian/Pacific Islander,34.6,Female,All Cancer Sites Combined,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
20-24,2.1,5.0,23,Incidence,694292,Non-Hispanic Asian/Pacific Islander,3.3,Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
20-24,1.4,3.9,17,Incidence,694292,Non-Hispanic Asian/Pacific Islander,2.4,Female,Leukemias,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
20-24,1.8,4.4,20,Incidence,694292,Non-Hispanic Asian/Pacific Islander,2.9,Female,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2017
20-24,1.4,3.9,17,Incidence,694292,Non-Hispanic Asian/Pacific Islander,2.4,Female,Ovary,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
20-24,9.3,14.5,81,Incidence,694292,Non-Hispanic Asian/Pacific Islander,11.7,Female,Thyroid,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
25-29,49.4,59.3,474,Incidence,874308,Non-Hispanic Asian/Pacific Islander,54.2,Female,All Cancer Sites Combined,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
25-29,1.1,3.1,17,Incidence,874308,Non-Hispanic Asian/Pacific Islander,1.9,Female,Cervix,2017
25-29,1.5,3.7,21,Incidence,874308,Non-Hispanic Asian/Pacific Islander,2.4,Female,Colon and Rectum,2017
25-29,1.3,3.4,19,Incidence,874308,Non-Hispanic Asian/Pacific Islander,2.2,Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
25-29,6.1,10.0,69,Incidence,874308,Non-Hispanic Asian/Pacific Islander,7.9,Female,Female Breast,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
25-29,1.6,3.8,22,Incidence,874308,Non-Hispanic Asian/Pacific Islander,2.5,Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
25-29,1.2,3.3,18,Incidence,874308,Non-Hispanic Asian/Pacific Islander,2.1,Female,Leukemias,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
25-29,1.4,3.5,20,Incidence,874308,Non-Hispanic Asian/Pacific Islander,2.3,Female,Non-Hodgkin Lymphoma,2017
25-29,1.1,3.1,17,Incidence,874308,Non-Hispanic Asian/Pacific Islander,1.9,Female,Oral Cavity and Pharynx,2017
25-29,1.9,4.4,26,Incidence,874308,Non-Hispanic Asian/Pacific Islander,3.0,Female,Ovary,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
25-29,16.0,21.9,164,Incidence,874308,Non-Hispanic Asian/Pacific Islander,18.8,Female,Thyroid,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
30-34,84.7,97.2,817,Incidence,899891,Non-Hispanic Asian/Pacific Islander,90.8,Female,All Cancer Sites Combined,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
30-34,4.0,7.2,49,Incidence,899891,Non-Hispanic Asian/Pacific Islander,5.4,Female,Cervix,2017
30-34,2.7,5.4,35,Incidence,899891,Non-Hispanic Asian/Pacific Islander,3.9,Female,Colon and Rectum,2017
30-34,4.3,7.6,52,Incidence,899891,Non-Hispanic Asian/Pacific Islander,5.8,Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
30-34,21.3,27.9,220,Incidence,899891,Non-Hispanic Asian/Pacific Islander,24.4,Female,Female Breast,2017
30-34,2.3,4.9,31,Incidence,899891,Non-Hispanic Asian/Pacific Islander,3.4,Female,"Female Breast, <i>in situ</i>",2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
30-34,1.0,2.9,16,Incidence,899891,Non-Hispanic Asian/Pacific Islander,1.8,Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
30-34,2.0,4.4,27,Incidence,899891,Non-Hispanic Asian/Pacific Islander,3.0,Female,Leukemias,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
30-34,2.2,4.8,30,Incidence,899891,Non-Hispanic Asian/Pacific Islander,3.3,Female,Non-Hodgkin Lymphoma,2017
30-34,1.5,3.7,22,Incidence,899891,Non-Hispanic Asian/Pacific Islander,2.4,Female,Oral Cavity and Pharynx,2017
30-34,1.8,4.1,25,Incidence,899891,Non-Hispanic Asian/Pacific Islander,2.8,Female,Ovary,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
30-34,20.7,27.2,214,Incidence,899891,Non-Hispanic Asian/Pacific Islander,23.8,Female,Thyroid,2017
30-34,~,~,~,Incidence,899891,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
35-39,147.4,164.2,1344,Incidence,863725,Non-Hispanic Asian/Pacific Islander,155.6,Female,All Cancer Sites Combined,2017
35-39,1.4,3.6,20,Incidence,863725,Non-Hispanic Asian/Pacific Islander,2.3,Female,Brain and Other Nervous System,2017
35-39,7.0,11.1,77,Incidence,863725,Non-Hispanic Asian/Pacific Islander,8.9,Female,Cervix,2017
35-39,5.6,9.3,63,Incidence,863725,Non-Hispanic Asian/Pacific Islander,7.3,Female,Colon and Rectum,2017
35-39,8.1,12.4,87,Incidence,863725,Non-Hispanic Asian/Pacific Islander,10.1,Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
35-39,51.5,61.6,487,Incidence,863725,Non-Hispanic Asian/Pacific Islander,56.4,Female,Female Breast,2017
35-39,8.2,12.6,88,Incidence,863725,Non-Hispanic Asian/Pacific Islander,10.2,Female,"Female Breast, <i>in situ</i>",2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
35-39,2.0,4.4,26,Incidence,863725,Non-Hispanic Asian/Pacific Islander,3.0,Female,Leukemias,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
35-39,3.3,6.3,40,Incidence,863725,Non-Hispanic Asian/Pacific Islander,4.6,Female,Lung and Bronchus,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
35-39,3.8,7.0,45,Incidence,863725,Non-Hispanic Asian/Pacific Islander,5.2,Female,Non-Hodgkin Lymphoma,2017
35-39,2.1,4.5,27,Incidence,863725,Non-Hispanic Asian/Pacific Islander,3.1,Female,Oral Cavity and Pharynx,2017
35-39,4.4,7.8,51,Incidence,863725,Non-Hispanic Asian/Pacific Islander,5.9,Female,Ovary,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
35-39,27.6,35.2,270,Incidence,863725,Non-Hispanic Asian/Pacific Islander,31.3,Female,Thyroid,2017
35-39,~,~,~,Incidence,863725,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
40-44,245.4,267.5,2083,Incidence,812907,Non-Hispanic Asian/Pacific Islander,256.2,Female,All Cancer Sites Combined,2017
40-44,2.1,4.7,26,Incidence,812907,Non-Hispanic Asian/Pacific Islander,3.2,Female,Brain and Other Nervous System,2017
40-44,7.4,11.7,76,Incidence,812907,Non-Hispanic Asian/Pacific Islander,9.3,Female,Cervix,2017
40-44,10.9,16.0,108,Incidence,812907,Non-Hispanic Asian/Pacific Islander,13.3,Female,Colon and Rectum,2017
40-44,14.0,19.8,136,Incidence,812907,Non-Hispanic Asian/Pacific Islander,16.7,Female,"Corpus and Uterus, NOS",2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
40-44,117.2,132.7,1014,Incidence,812907,Non-Hispanic Asian/Pacific Islander,124.7,Female,Female Breast,2017
40-44,43.9,53.6,395,Incidence,812907,Non-Hispanic Asian/Pacific Islander,48.6,Female,"Female Breast, <i>in situ</i>",2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
40-44,1.6,3.9,21,Incidence,812907,Non-Hispanic Asian/Pacific Islander,2.6,Female,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
40-44,3.3,6.4,38,Incidence,812907,Non-Hispanic Asian/Pacific Islander,4.7,Female,Leukemias,2017
40-44,1.4,3.6,19,Incidence,812907,Non-Hispanic Asian/Pacific Islander,2.3,Female,Liver and Intrahepatic Bile Duct,2017
40-44,5.3,9.1,57,Incidence,812907,Non-Hispanic Asian/Pacific Islander,7.0,Female,Lung and Bronchus,2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
40-44,3.6,6.8,41,Incidence,812907,Non-Hispanic Asian/Pacific Islander,5.0,Female,Non-Hodgkin Lymphoma,2017
40-44,3.6,6.8,41,Incidence,812907,Non-Hispanic Asian/Pacific Islander,5.0,Female,Oral Cavity and Pharynx,2017
40-44,6.1,10.1,64,Incidence,812907,Non-Hispanic Asian/Pacific Islander,7.9,Female,Ovary,2017
40-44,1.2,3.3,17,Incidence,812907,Non-Hispanic Asian/Pacific Islander,2.1,Female,Pancreas,2017
40-44,1.7,4.1,22,Incidence,812907,Non-Hispanic Asian/Pacific Islander,2.7,Female,Stomach,2017
40-44,32.2,40.5,294,Incidence,812907,Non-Hispanic Asian/Pacific Islander,36.2,Female,Thyroid,2017
40-44,~,~,~,Incidence,812907,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
45-49,384.9,413.3,3053,Incidence,765384,Non-Hispanic Asian/Pacific Islander,398.9,Female,All Cancer Sites Combined,2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
45-49,10.6,15.9,100,Incidence,765384,Non-Hispanic Asian/Pacific Islander,13.1,Female,Cervix,2017
45-49,23.4,30.9,206,Incidence,765384,Non-Hispanic Asian/Pacific Islander,26.9,Female,Colon and Rectum,2017
45-49,25.7,33.5,225,Incidence,765384,Non-Hispanic Asian/Pacific Islander,29.4,Female,"Corpus and Uterus, NOS",2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
45-49,190.3,210.4,1532,Incidence,765384,Non-Hispanic Asian/Pacific Islander,200.2,Female,Female Breast,2017
45-49,65.1,77.2,543,Incidence,765384,Non-Hispanic Asian/Pacific Islander,70.9,Female,"Female Breast, <i>in situ</i>",2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
45-49,4.1,7.6,43,Incidence,765384,Non-Hispanic Asian/Pacific Islander,5.6,Female,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
45-49,3.4,6.7,37,Incidence,765384,Non-Hispanic Asian/Pacific Islander,4.8,Female,Leukemias,2017
45-49,1.3,3.6,17,Incidence,765384,Non-Hispanic Asian/Pacific Islander,2.2,Female,Liver and Intrahepatic Bile Duct,2017
45-49,10.9,16.2,102,Incidence,765384,Non-Hispanic Asian/Pacific Islander,13.3,Female,Lung and Bronchus,2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
45-49,1.6,4.0,20,Incidence,765384,Non-Hispanic Asian/Pacific Islander,2.6,Female,Myeloma,2017
45-49,6.9,11.3,68,Incidence,765384,Non-Hispanic Asian/Pacific Islander,8.9,Female,Non-Hodgkin Lymphoma,2017
45-49,3.5,6.8,38,Incidence,765384,Non-Hispanic Asian/Pacific Islander,5.0,Female,Oral Cavity and Pharynx,2017
45-49,12.6,18.3,117,Incidence,765384,Non-Hispanic Asian/Pacific Islander,15.3,Female,Ovary,2017
45-49,2.6,5.6,30,Incidence,765384,Non-Hispanic Asian/Pacific Islander,3.9,Female,Pancreas,2017
45-49,5.3,9.2,54,Incidence,765384,Non-Hispanic Asian/Pacific Islander,7.1,Female,Stomach,2017
45-49,33.4,42.2,288,Incidence,765384,Non-Hispanic Asian/Pacific Islander,37.6,Female,Thyroid,2017
45-49,~,~,~,Incidence,765384,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
5-9,6.1,10.9,50,Incidence,605531,Non-Hispanic Asian/Pacific Islander,8.3,Female,All Cancer Sites Combined,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
5-9,1.9,4.9,19,Incidence,605531,Non-Hispanic Asian/Pacific Islander,3.1,Female,Leukemias,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
50-54,485.2,519.4,3341,Incidence,665473,Non-Hispanic Asian/Pacific Islander,502.0,Female,All Cancer Sites Combined,2017
50-54,2.6,5.7,26,Incidence,665473,Non-Hispanic Asian/Pacific Islander,3.9,Female,Brain and Other Nervous System,2017
50-54,8.6,13.8,73,Incidence,665473,Non-Hispanic Asian/Pacific Islander,11.0,Female,Cervix,2017
50-54,45.9,57.0,341,Incidence,665473,Non-Hispanic Asian/Pacific Islander,51.2,Female,Colon and Rectum,2017
50-54,46.2,57.3,343,Incidence,665473,Non-Hispanic Asian/Pacific Islander,51.5,Female,"Corpus and Uterus, NOS",2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
50-54,208.3,230.9,1460,Incidence,665473,Non-Hispanic Asian/Pacific Islander,219.4,Female,Female Breast,2017
50-54,64.7,77.6,472,Incidence,665473,Non-Hispanic Asian/Pacific Islander,70.9,Female,"Female Breast, <i>in situ</i>",2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
50-54,6.6,11.3,58,Incidence,665473,Non-Hispanic Asian/Pacific Islander,8.7,Female,Kidney and Renal Pelvis,2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
50-54,4.2,8.0,39,Incidence,665473,Non-Hispanic Asian/Pacific Islander,5.9,Female,Leukemias,2017
50-54,2.9,6.3,29,Incidence,665473,Non-Hispanic Asian/Pacific Islander,4.4,Female,Liver and Intrahepatic Bile Duct,2017
50-54,20.9,28.6,163,Incidence,665473,Non-Hispanic Asian/Pacific Islander,24.5,Female,Lung and Bronchus,2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
50-54,2.9,6.3,29,Incidence,665473,Non-Hispanic Asian/Pacific Islander,4.4,Female,Myeloma,2017
50-54,9.9,15.5,83,Incidence,665473,Non-Hispanic Asian/Pacific Islander,12.5,Female,Non-Hodgkin Lymphoma,2017
50-54,4.4,8.4,41,Incidence,665473,Non-Hispanic Asian/Pacific Islander,6.2,Female,Oral Cavity and Pharynx,2017
50-54,13.6,19.9,110,Incidence,665473,Non-Hispanic Asian/Pacific Islander,16.5,Female,Ovary,2017
50-54,4.7,8.7,43,Incidence,665473,Non-Hispanic Asian/Pacific Islander,6.5,Female,Pancreas,2017
50-54,5.6,9.9,50,Incidence,665473,Non-Hispanic Asian/Pacific Islander,7.5,Female,Stomach,2017
50-54,34.5,44.1,260,Incidence,665473,Non-Hispanic Asian/Pacific Islander,39.1,Female,Thyroid,2017
50-54,~,~,~,Incidence,665473,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
55-59,591.2,630.5,3735,Incidence,611716,Non-Hispanic Asian/Pacific Islander,610.6,Female,All Cancer Sites Combined,2017
55-59,2.6,6.0,25,Incidence,611716,Non-Hispanic Asian/Pacific Islander,4.1,Female,Brain and Other Nervous System,2017
55-59,11.8,18.1,90,Incidence,611716,Non-Hispanic Asian/Pacific Islander,14.7,Female,Cervix,2017
55-59,39.0,49.7,270,Incidence,611716,Non-Hispanic Asian/Pacific Islander,44.1,Female,Colon and Rectum,2017
55-59,64.6,78.1,435,Incidence,611716,Non-Hispanic Asian/Pacific Islander,71.1,Female,"Corpus and Uterus, NOS",2017
55-59,~,~,~,Incidence,611716,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
55-59,224.4,248.9,1446,Incidence,611716,Non-Hispanic Asian/Pacific Islander,236.4,Female,Female Breast,2017
55-59,67.7,81.5,455,Incidence,611716,Non-Hispanic Asian/Pacific Islander,74.4,Female,"Female Breast, <i>in situ</i>",2017
55-59,~,~,~,Incidence,611716,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,611716,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
55-59,10.5,16.5,81,Incidence,611716,Non-Hispanic Asian/Pacific Islander,13.2,Female,Kidney and Renal Pelvis,2017
55-59,~,~,~,Incidence,611716,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
55-59,6.8,11.7,55,Incidence,611716,Non-Hispanic Asian/Pacific Islander,9.0,Female,Leukemias,2017
55-59,5.1,9.5,43,Incidence,611716,Non-Hispanic Asian/Pacific Islander,7.0,Female,Liver and Intrahepatic Bile Duct,2017
55-59,40.0,50.8,276,Incidence,611716,Non-Hispanic Asian/Pacific Islander,45.1,Female,Lung and Bronchus,2017
55-59,~,~,~,Incidence,611716,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,611716,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
55-59,5.1,9.5,43,Incidence,611716,Non-Hispanic Asian/Pacific Islander,7.0,Female,Myeloma,2017
55-59,15.2,22.2,113,Incidence,611716,Non-Hispanic Asian/Pacific Islander,18.5,Female,Non-Hodgkin Lymphoma,2017
55-59,6.8,11.7,55,Incidence,611716,Non-Hispanic Asian/Pacific Islander,9.0,Female,Oral Cavity and Pharynx,2017
55-59,19.3,27.0,140,Incidence,611716,Non-Hispanic Asian/Pacific Islander,22.9,Female,Ovary,2017
55-59,11.0,17.0,84,Incidence,611716,Non-Hispanic Asian/Pacific Islander,13.7,Female,Pancreas,2017
55-59,8.9,14.5,70,Incidence,611716,Non-Hispanic Asian/Pacific Islander,11.4,Female,Stomach,2017
55-59,34.6,44.7,241,Incidence,611716,Non-Hispanic Asian/Pacific Islander,39.4,Female,Thyroid,2017
55-59,2.1,5.2,21,Incidence,611716,Non-Hispanic Asian/Pacific Islander,3.4,Female,Urinary Bladder,2017
60-64,724.9,770.5,4153,Incidence,555612,Non-Hispanic Asian/Pacific Islander,747.5,Female,All Cancer Sites Combined,2017
60-64,3.5,7.5,29,Incidence,555612,Non-Hispanic Asian/Pacific Islander,5.2,Female,Brain and Other Nervous System,2017
60-64,12.7,19.5,88,Incidence,555612,Non-Hispanic Asian/Pacific Islander,15.8,Female,Cervix,2017
60-64,53.3,66.4,331,Incidence,555612,Non-Hispanic Asian/Pacific Islander,59.6,Female,Colon and Rectum,2017
60-64,67.5,82.0,414,Incidence,555612,Non-Hispanic Asian/Pacific Islander,74.5,Female,"Corpus and Uterus, NOS",2017
60-64,1.6,4.7,16,Incidence,555612,Non-Hispanic Asian/Pacific Islander,2.9,Female,Esophagus,2017
60-64,262.3,290.1,1533,Incidence,555612,Non-Hispanic Asian/Pacific Islander,275.9,Female,Female Breast,2017
60-64,77.3,92.8,471,Incidence,555612,Non-Hispanic Asian/Pacific Islander,84.8,Female,"Female Breast, <i>in situ</i>",2017
60-64,~,~,~,Incidence,555612,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,555612,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
60-64,12.5,19.3,87,Incidence,555612,Non-Hispanic Asian/Pacific Islander,15.7,Female,Kidney and Renal Pelvis,2017
60-64,~,~,~,Incidence,555612,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
60-64,9.0,14.9,65,Incidence,555612,Non-Hispanic Asian/Pacific Islander,11.7,Female,Leukemias,2017
60-64,13.7,20.7,94,Incidence,555612,Non-Hispanic Asian/Pacific Islander,16.9,Female,Liver and Intrahepatic Bile Duct,2017
60-64,65.1,79.4,400,Incidence,555612,Non-Hispanic Asian/Pacific Islander,72.0,Female,Lung and Bronchus,2017
60-64,1.9,5.1,18,Incidence,555612,Non-Hispanic Asian/Pacific Islander,3.2,Female,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,555612,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
60-64,5.0,9.6,39,Incidence,555612,Non-Hispanic Asian/Pacific Islander,7.0,Female,Myeloma,2017
60-64,19.7,28.0,131,Incidence,555612,Non-Hispanic Asian/Pacific Islander,23.6,Female,Non-Hodgkin Lymphoma,2017
60-64,11.6,18.1,81,Incidence,555612,Non-Hispanic Asian/Pacific Islander,14.6,Female,Oral Cavity and Pharynx,2017
60-64,17.1,24.8,115,Incidence,555612,Non-Hispanic Asian/Pacific Islander,20.7,Female,Ovary,2017
60-64,16.8,24.5,113,Incidence,555612,Non-Hispanic Asian/Pacific Islander,20.3,Female,Pancreas,2017
60-64,15.1,22.5,103,Incidence,555612,Non-Hispanic Asian/Pacific Islander,18.5,Female,Stomach,2017
60-64,30.5,40.6,196,Incidence,555612,Non-Hispanic Asian/Pacific Islander,35.3,Female,Thyroid,2017
60-64,5.9,10.8,45,Incidence,555612,Non-Hispanic Asian/Pacific Islander,8.1,Female,Urinary Bladder,2017
65-69,859.3,913.5,4130,Incidence,466093,Non-Hispanic Asian/Pacific Islander,886.1,Female,All Cancer Sites Combined,2017
65-69,2.8,6.9,21,Incidence,466093,Non-Hispanic Asian/Pacific Islander,4.5,Female,Brain and Other Nervous System,2017
65-69,7.2,13.2,46,Incidence,466093,Non-Hispanic Asian/Pacific Islander,9.9,Female,Cervix,2017
65-69,72.1,88.6,373,Incidence,466093,Non-Hispanic Asian/Pacific Islander,80.0,Female,Colon and Rectum,2017
65-69,64.4,80.0,335,Incidence,466093,Non-Hispanic Asian/Pacific Islander,71.9,Female,"Corpus and Uterus, NOS",2017
65-69,4.0,8.7,28,Incidence,466093,Non-Hispanic Asian/Pacific Islander,6.0,Female,Esophagus,2017
65-69,283.6,315.2,1394,Incidence,466093,Non-Hispanic Asian/Pacific Islander,299.1,Female,Female Breast,2017
65-69,88.9,107.0,455,Incidence,466093,Non-Hispanic Asian/Pacific Islander,97.6,Female,"Female Breast, <i>in situ</i>",2017
65-69,~,~,~,Incidence,466093,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,466093,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
65-69,17.7,26.3,101,Incidence,466093,Non-Hispanic Asian/Pacific Islander,21.7,Female,Kidney and Renal Pelvis,2017
65-69,~,~,~,Incidence,466093,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
65-69,12.1,19.5,72,Incidence,466093,Non-Hispanic Asian/Pacific Islander,15.4,Female,Leukemias,2017
65-69,22.7,32.4,127,Incidence,466093,Non-Hispanic Asian/Pacific Islander,27.2,Female,Liver and Intrahepatic Bile Duct,2017
65-69,95.4,114.2,487,Incidence,466093,Non-Hispanic Asian/Pacific Islander,104.5,Female,Lung and Bronchus,2017
65-69,~,~,~,Incidence,466093,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,466093,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
65-69,8.9,15.4,55,Incidence,466093,Non-Hispanic Asian/Pacific Islander,11.8,Female,Myeloma,2017
65-69,25.1,35.2,139,Incidence,466093,Non-Hispanic Asian/Pacific Islander,29.8,Female,Non-Hodgkin Lymphoma,2017
65-69,15.1,23.3,88,Incidence,466093,Non-Hispanic Asian/Pacific Islander,18.9,Female,Oral Cavity and Pharynx,2017
65-69,20.6,29.9,116,Incidence,466093,Non-Hispanic Asian/Pacific Islander,24.9,Female,Ovary,2017
65-69,22.5,32.2,126,Incidence,466093,Non-Hispanic Asian/Pacific Islander,27.0,Female,Pancreas,2017
65-69,17.5,26.1,100,Incidence,466093,Non-Hispanic Asian/Pacific Islander,21.5,Female,Stomach,2017
65-69,28.2,38.9,155,Incidence,466093,Non-Hispanic Asian/Pacific Islander,33.3,Female,Thyroid,2017
65-69,9.6,16.3,59,Incidence,466093,Non-Hispanic Asian/Pacific Islander,12.7,Female,Urinary Bladder,2017
70-74,961.1,1030.1,3223,Incidence,323869,Non-Hispanic Asian/Pacific Islander,995.2,Female,All Cancer Sites Combined,2017
70-74,4.0,9.9,21,Incidence,323869,Non-Hispanic Asian/Pacific Islander,6.5,Female,Brain and Other Nervous System,2017
70-74,6.5,13.6,31,Incidence,323869,Non-Hispanic Asian/Pacific Islander,9.6,Female,Cervix,2017
70-74,72.3,92.3,265,Incidence,323869,Non-Hispanic Asian/Pacific Islander,81.8,Female,Colon and Rectum,2017
70-74,55.2,72.9,206,Incidence,323869,Non-Hispanic Asian/Pacific Islander,63.6,Female,"Corpus and Uterus, NOS",2017
70-74,3.8,9.5,20,Incidence,323869,Non-Hispanic Asian/Pacific Islander,6.2,Female,Esophagus,2017
70-74,299.5,338.7,1032,Incidence,323869,Non-Hispanic Asian/Pacific Islander,318.6,Female,Female Breast,2017
70-74,88.9,110.9,322,Incidence,323869,Non-Hispanic Asian/Pacific Islander,99.4,Female,"Female Breast, <i>in situ</i>",2017
70-74,~,~,~,Incidence,323869,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,323869,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
70-74,17.9,28.7,74,Incidence,323869,Non-Hispanic Asian/Pacific Islander,22.8,Female,Kidney and Renal Pelvis,2017
70-74,~,~,~,Incidence,323869,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
70-74,17.7,28.3,73,Incidence,323869,Non-Hispanic Asian/Pacific Islander,22.5,Female,Leukemias,2017
70-74,24.3,36.5,97,Incidence,323869,Non-Hispanic Asian/Pacific Islander,30.0,Female,Liver and Intrahepatic Bile Duct,2017
70-74,130.5,156.9,464,Incidence,323869,Non-Hispanic Asian/Pacific Islander,143.3,Female,Lung and Bronchus,2017
70-74,~,~,~,Incidence,323869,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,323869,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
70-74,13.3,22.8,57,Incidence,323869,Non-Hispanic Asian/Pacific Islander,17.6,Female,Myeloma,2017
70-74,36.9,51.7,142,Incidence,323869,Non-Hispanic Asian/Pacific Islander,43.8,Female,Non-Hodgkin Lymphoma,2017
70-74,13.3,22.8,57,Incidence,323869,Non-Hispanic Asian/Pacific Islander,17.6,Female,Oral Cavity and Pharynx,2017
70-74,12.0,21.1,52,Incidence,323869,Non-Hispanic Asian/Pacific Islander,16.1,Female,Ovary,2017
70-74,34.7,49.0,134,Incidence,323869,Non-Hispanic Asian/Pacific Islander,41.4,Female,Pancreas,2017
70-74,21.5,33.1,87,Incidence,323869,Non-Hispanic Asian/Pacific Islander,26.9,Female,Stomach,2017
70-74,22.6,34.5,91,Incidence,323869,Non-Hispanic Asian/Pacific Islander,28.1,Female,Thyroid,2017
70-74,10.1,18.6,45,Incidence,323869,Non-Hispanic Asian/Pacific Islander,13.9,Female,Urinary Bladder,2017
75-79,1064.9,1152.3,2500,Incidence,225641,Non-Hispanic Asian/Pacific Islander,1108.0,Female,All Cancer Sites Combined,2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
75-79,9.7,20.0,32,Incidence,225641,Non-Hispanic Asian/Pacific Islander,14.2,Female,Cervix,2017
75-79,92.1,119.3,237,Incidence,225641,Non-Hispanic Asian/Pacific Islander,105.0,Female,Colon and Rectum,2017
75-79,40.1,58.8,110,Incidence,225641,Non-Hispanic Asian/Pacific Islander,48.8,Female,"Corpus and Uterus, NOS",2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
75-79,255.7,299.6,625,Incidence,225641,Non-Hispanic Asian/Pacific Islander,277.0,Female,Female Breast,2017
75-79,57.1,79.0,152,Incidence,225641,Non-Hispanic Asian/Pacific Islander,67.4,Female,"Female Breast, <i>in situ</i>",2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
75-79,20.7,34.7,61,Incidence,225641,Non-Hispanic Asian/Pacific Islander,27.0,Female,Kidney and Renal Pelvis,2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
75-79,17.6,30.7,53,Incidence,225641,Non-Hispanic Asian/Pacific Islander,23.5,Female,Leukemias,2017
75-79,43.3,62.6,118,Incidence,225641,Non-Hispanic Asian/Pacific Islander,52.3,Female,Liver and Intrahepatic Bile Duct,2017
75-79,166.6,202.5,415,Incidence,225641,Non-Hispanic Asian/Pacific Islander,183.9,Female,Lung and Bronchus,2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,225641,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
75-79,12.3,23.6,39,Incidence,225641,Non-Hispanic Asian/Pacific Islander,17.3,Female,Myeloma,2017
75-79,40.9,59.7,112,Incidence,225641,Non-Hispanic Asian/Pacific Islander,49.6,Female,Non-Hodgkin Lymphoma,2017
75-79,13.0,24.7,41,Incidence,225641,Non-Hispanic Asian/Pacific Islander,18.2,Female,Oral Cavity and Pharynx,2017
75-79,20.3,34.2,60,Incidence,225641,Non-Hispanic Asian/Pacific Islander,26.6,Female,Ovary,2017
75-79,46.1,66.0,125,Incidence,225641,Non-Hispanic Asian/Pacific Islander,55.4,Female,Pancreas,2017
75-79,29.7,46.1,84,Incidence,225641,Non-Hispanic Asian/Pacific Islander,37.2,Female,Stomach,2017
75-79,15.3,27.7,47,Incidence,225641,Non-Hispanic Asian/Pacific Islander,20.8,Female,Thyroid,2017
75-79,16.8,29.7,51,Incidence,225641,Non-Hispanic Asian/Pacific Islander,22.6,Female,Urinary Bladder,2017
80-84,1183.6,1295.6,1903,Incidence,153633,Non-Hispanic Asian/Pacific Islander,1238.7,Female,All Cancer Sites Combined,2017
80-84,6.9,18.5,18,Incidence,153633,Non-Hispanic Asian/Pacific Islander,11.7,Female,Brain and Other Nervous System,2017
80-84,10.5,24.0,25,Incidence,153633,Non-Hispanic Asian/Pacific Islander,16.3,Female,Cervix,2017
80-84,137.1,177.3,240,Incidence,153633,Non-Hispanic Asian/Pacific Islander,156.2,Female,Colon and Rectum,2017
80-84,27.0,46.6,55,Incidence,153633,Non-Hispanic Asian/Pacific Islander,35.8,Female,"Corpus and Uterus, NOS",2017
80-84,~,~,~,Incidence,153633,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
80-84,207.0,255.7,354,Incidence,153633,Non-Hispanic Asian/Pacific Islander,230.4,Female,Female Breast,2017
80-84,35.5,57.6,70,Incidence,153633,Non-Hispanic Asian/Pacific Islander,45.6,Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,153633,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,153633,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
80-84,20.3,37.7,43,Incidence,153633,Non-Hispanic Asian/Pacific Islander,28.0,Female,Kidney and Renal Pelvis,2017
80-84,~,~,~,Incidence,153633,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
80-84,18.6,35.5,40,Incidence,153633,Non-Hispanic Asian/Pacific Islander,26.0,Female,Leukemias,2017
80-84,39.6,62.6,77,Incidence,153633,Non-Hispanic Asian/Pacific Islander,50.1,Female,Liver and Intrahepatic Bile Duct,2017
80-84,192.2,239.3,330,Incidence,153633,Non-Hispanic Asian/Pacific Islander,214.8,Female,Lung and Bronchus,2017
80-84,~,~,~,Incidence,153633,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,153633,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
80-84,14.8,30.2,33,Incidence,153633,Non-Hispanic Asian/Pacific Islander,21.5,Female,Myeloma,2017
80-84,39.0,61.9,76,Incidence,153633,Non-Hispanic Asian/Pacific Islander,49.5,Female,Non-Hodgkin Lymphoma,2017
80-84,11.6,25.6,27,Incidence,153633,Non-Hispanic Asian/Pacific Islander,17.6,Female,Oral Cavity and Pharynx,2017
80-84,18.1,34.7,39,Incidence,153633,Non-Hispanic Asian/Pacific Islander,25.4,Female,Ovary,2017
80-84,58.8,86.3,110,Incidence,153633,Non-Hispanic Asian/Pacific Islander,71.6,Female,Pancreas,2017
80-84,41.3,64.8,80,Incidence,153633,Non-Hispanic Asian/Pacific Islander,52.1,Female,Stomach,2017
80-84,13.7,28.6,31,Incidence,153633,Non-Hispanic Asian/Pacific Islander,20.2,Female,Thyroid,2017
80-84,25.8,45.1,53,Incidence,153633,Non-Hispanic Asian/Pacific Islander,34.5,Female,Urinary Bladder,2017
85+,1134.7,1239.6,1986,Incidence,167411,Non-Hispanic Asian/Pacific Islander,1186.3,Female,All Cancer Sites Combined,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
85+,149.9,189.9,283,Incidence,167411,Non-Hispanic Asian/Pacific Islander,169.0,Female,Colon and Rectum,2017
85+,21.1,38.0,48,Incidence,167411,Non-Hispanic Asian/Pacific Islander,28.7,Female,"Corpus and Uterus, NOS",2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
85+,148.2,188.0,280,Incidence,167411,Non-Hispanic Asian/Pacific Islander,167.3,Female,Female Breast,2017
85+,13.6,27.7,33,Incidence,167411,Non-Hispanic Asian/Pacific Islander,19.7,Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
85+,15.1,29.8,36,Incidence,167411,Non-Hispanic Asian/Pacific Islander,21.5,Female,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
85+,20.6,37.3,47,Incidence,167411,Non-Hispanic Asian/Pacific Islander,28.1,Female,Leukemias,2017
85+,37.9,59.5,80,Incidence,167411,Non-Hispanic Asian/Pacific Islander,47.8,Female,Liver and Intrahepatic Bile Duct,2017
85+,173.6,216.4,325,Incidence,167411,Non-Hispanic Asian/Pacific Islander,194.1,Female,Lung and Bronchus,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
85+,12.1,25.6,30,Incidence,167411,Non-Hispanic Asian/Pacific Islander,17.9,Female,Myeloma,2017
85+,45.4,68.7,94,Incidence,167411,Non-Hispanic Asian/Pacific Islander,56.1,Female,Non-Hodgkin Lymphoma,2017
85+,13.6,27.7,33,Incidence,167411,Non-Hispanic Asian/Pacific Islander,19.7,Female,Oral Cavity and Pharynx,2017
85+,14.1,28.4,34,Incidence,167411,Non-Hispanic Asian/Pacific Islander,20.3,Female,Ovary,2017
85+,73.6,102.6,146,Incidence,167411,Non-Hispanic Asian/Pacific Islander,87.2,Female,Pancreas,2017
85+,52.9,77.9,108,Incidence,167411,Non-Hispanic Asian/Pacific Islander,64.5,Female,Stomach,2017
85+,7.3,18.5,20,Incidence,167411,Non-Hispanic Asian/Pacific Islander,11.9,Female,Thyroid,2017
85+,33.7,54.2,72,Incidence,167411,Non-Hispanic Asian/Pacific Islander,43.0,Female,Urinary Bladder,2017
<1,13.1,29.8,25,Incidence,123650,Non-Hispanic Asian/Pacific Islander,20.2,Female,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2017
1-4,18.7,26.9,121,Incidence,537159,Non-Hispanic Asian/Pacific Islander,22.5,Male,All Cancer Sites Combined,2017
1-4,3.3,7.3,27,Incidence,537159,Non-Hispanic Asian/Pacific Islander,5.0,Male,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
1-4,7.6,13.1,54,Incidence,537159,Non-Hispanic Asian/Pacific Islander,10.1,Male,Leukemias,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
1-4,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
10-14,12.5,18.9,95,Incidence,613603,Non-Hispanic Asian/Pacific Islander,15.5,Male,All Cancer Sites Combined,2017
10-14,2.1,5.2,21,Incidence,613603,Non-Hispanic Asian/Pacific Islander,3.4,Male,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
10-14,3.8,7.7,34,Incidence,613603,Non-Hispanic Asian/Pacific Islander,5.5,Male,Leukemias,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
10-14,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
15-19,16.8,24.1,124,Incidence,614135,Non-Hispanic Asian/Pacific Islander,20.2,Male,All Cancer Sites Combined,2017
15-19,1.7,4.6,18,Incidence,614135,Non-Hispanic Asian/Pacific Islander,2.9,Male,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
15-19,1.9,4.8,19,Incidence,614135,Non-Hispanic Asian/Pacific Islander,3.1,Male,Leukemias,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
15-19,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
20-24,23.3,31.0,194,Incidence,719208,Non-Hispanic Asian/Pacific Islander,27.0,Male,All Cancer Sites Combined,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
20-24,1.7,4.3,20,Incidence,719208,Non-Hispanic Asian/Pacific Islander,2.8,Male,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
20-24,2.4,5.3,26,Incidence,719208,Non-Hispanic Asian/Pacific Islander,3.6,Male,Leukemias,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
20-24,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
20-24,1.6,4.1,19,Incidence,719208,Non-Hispanic Asian/Pacific Islander,2.6,Male,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
20-24,3.4,6.8,35,Incidence,719208,Non-Hispanic Asian/Pacific Islander,4.9,Male,Testis,2017
20-24,2.2,5.1,25,Incidence,719208,Non-Hispanic Asian/Pacific Islander,3.5,Male,Thyroid,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
25-29,30.8,38.8,296,Incidence,853898,Non-Hispanic Asian/Pacific Islander,34.7,Male,All Cancer Sites Combined,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2017
25-29,1.8,4.2,24,Incidence,853898,Non-Hispanic Asian/Pacific Islander,2.8,Male,Colon and Rectum,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
25-29,2.8,5.6,34,Incidence,853898,Non-Hispanic Asian/Pacific Islander,4.0,Male,Leukemias,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
25-29,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
25-29,1.9,4.3,25,Incidence,853898,Non-Hispanic Asian/Pacific Islander,2.9,Male,Non-Hodgkin Lymphoma,2017
25-29,1.1,3.0,16,Incidence,853898,Non-Hispanic Asian/Pacific Islander,1.9,Male,Oral Cavity and Pharynx,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
25-29,4.0,7.3,47,Incidence,853898,Non-Hispanic Asian/Pacific Islander,5.5,Male,Testis,2017
25-29,3.1,6.0,37,Incidence,853898,Non-Hispanic Asian/Pacific Islander,4.3,Male,Thyroid,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
30-34,41.3,50.7,382,Incidence,833496,Non-Hispanic Asian/Pacific Islander,45.8,Male,All Cancer Sites Combined,2017
30-34,1.8,4.3,24,Incidence,833496,Non-Hispanic Asian/Pacific Islander,2.9,Male,Brain and Other Nervous System,2017
30-34,3.5,6.7,41,Incidence,833496,Non-Hispanic Asian/Pacific Islander,4.9,Male,Colon and Rectum,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
30-34,1.3,3.4,18,Incidence,833496,Non-Hispanic Asian/Pacific Islander,2.2,Male,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
30-34,1.8,4.3,24,Incidence,833496,Non-Hispanic Asian/Pacific Islander,2.9,Male,Leukemias,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
30-34,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
30-34,2.3,5.0,29,Incidence,833496,Non-Hispanic Asian/Pacific Islander,3.5,Male,Non-Hodgkin Lymphoma,2017
30-34,1.7,4.1,23,Incidence,833496,Non-Hispanic Asian/Pacific Islander,2.8,Male,Oral Cavity and Pharynx,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
30-34,4.2,7.6,48,Incidence,833496,Non-Hispanic Asian/Pacific Islander,5.8,Male,Testis,2017
30-34,4.9,8.5,54,Incidence,833496,Non-Hispanic Asian/Pacific Islander,6.5,Male,Thyroid,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
35-39,58.7,70.2,493,Incidence,767638,Non-Hispanic Asian/Pacific Islander,64.2,Male,All Cancer Sites Combined,2017
35-39,2.5,5.4,29,Incidence,767638,Non-Hispanic Asian/Pacific Islander,3.8,Male,Brain and Other Nervous System,2017
35-39,6.6,10.9,66,Incidence,767638,Non-Hispanic Asian/Pacific Islander,8.6,Male,Colon and Rectum,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
35-39,2.7,5.7,31,Incidence,767638,Non-Hispanic Asian/Pacific Islander,4.0,Male,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
35-39,2.4,5.3,28,Incidence,767638,Non-Hispanic Asian/Pacific Islander,3.6,Male,Leukemias,2017
35-39,2.4,5.3,28,Incidence,767638,Non-Hispanic Asian/Pacific Islander,3.6,Male,Liver and Intrahepatic Bile Duct,2017
35-39,1.9,4.5,23,Incidence,767638,Non-Hispanic Asian/Pacific Islander,3.0,Male,Lung and Bronchus,2017
35-39,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
35-39,3.8,7.2,41,Incidence,767638,Non-Hispanic Asian/Pacific Islander,5.3,Male,Non-Hodgkin Lymphoma,2017
35-39,5.1,8.9,52,Incidence,767638,Non-Hispanic Asian/Pacific Islander,6.8,Male,Oral Cavity and Pharynx,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
35-39,1.7,4.2,21,Incidence,767638,Non-Hispanic Asian/Pacific Islander,2.7,Male,Testis,2017
35-39,6.2,10.4,62,Incidence,767638,Non-Hispanic Asian/Pacific Islander,8.1,Male,Thyroid,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
40-44,87.5,101.9,676,Incidence,715179,Non-Hispanic Asian/Pacific Islander,94.5,Male,All Cancer Sites Combined,2017
40-44,2.2,5.0,24,Incidence,715179,Non-Hispanic Asian/Pacific Islander,3.4,Male,Brain and Other Nervous System,2017
40-44,11.1,16.7,98,Incidence,715179,Non-Hispanic Asian/Pacific Islander,13.7,Male,Colon and Rectum,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
40-44,4.2,7.9,42,Incidence,715179,Non-Hispanic Asian/Pacific Islander,5.9,Male,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
40-44,2.4,5.3,26,Incidence,715179,Non-Hispanic Asian/Pacific Islander,3.6,Male,Leukemias,2017
40-44,4.2,7.9,42,Incidence,715179,Non-Hispanic Asian/Pacific Islander,5.9,Male,Liver and Intrahepatic Bile Duct,2017
40-44,3.4,6.8,35,Incidence,715179,Non-Hispanic Asian/Pacific Islander,4.9,Male,Lung and Bronchus,2017
40-44,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
40-44,6.3,10.6,59,Incidence,715179,Non-Hispanic Asian/Pacific Islander,8.2,Male,Non-Hodgkin Lymphoma,2017
40-44,7.3,11.9,67,Incidence,715179,Non-Hispanic Asian/Pacific Islander,9.4,Male,Oral Cavity and Pharynx,2017
40-44,1.5,4.0,18,Incidence,715179,Non-Hispanic Asian/Pacific Islander,2.5,Male,Pancreas,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
40-44,2.8,6.0,30,Incidence,715179,Non-Hispanic Asian/Pacific Islander,4.2,Male,Stomach,2017
40-44,2.2,5.0,24,Incidence,715179,Non-Hispanic Asian/Pacific Islander,3.4,Male,Testis,2017
40-44,7.9,12.7,72,Incidence,715179,Non-Hispanic Asian/Pacific Islander,10.1,Male,Thyroid,2017
40-44,1.7,4.3,20,Incidence,715179,Non-Hispanic Asian/Pacific Islander,2.8,Male,Urinary Bladder,2017
45-49,162.4,182.4,1159,Incidence,673131,Non-Hispanic Asian/Pacific Islander,172.2,Male,All Cancer Sites Combined,2017
45-49,4.1,7.9,39,Incidence,673131,Non-Hispanic Asian/Pacific Islander,5.8,Male,Brain and Other Nervous System,2017
45-49,25.6,34.0,199,Incidence,673131,Non-Hispanic Asian/Pacific Islander,29.6,Male,Colon and Rectum,2017
45-49,~,~,~,Incidence,673131,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
45-49,~,~,~,Incidence,673131,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,673131,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
45-49,10.9,16.6,91,Incidence,673131,Non-Hispanic Asian/Pacific Islander,13.5,Male,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,673131,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
45-49,5.5,9.8,50,Incidence,673131,Non-Hispanic Asian/Pacific Islander,7.4,Male,Leukemias,2017
45-49,11.6,17.4,96,Incidence,673131,Non-Hispanic Asian/Pacific Islander,14.3,Male,Liver and Intrahepatic Bile Duct,2017
45-49,9.8,15.3,83,Incidence,673131,Non-Hispanic Asian/Pacific Islander,12.3,Male,Lung and Bronchus,2017
45-49,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
45-49,~,~,~,Incidence,673131,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,673131,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
45-49,1.8,4.6,20,Incidence,673131,Non-Hispanic Asian/Pacific Islander,3.0,Male,Myeloma,2017
45-49,8.8,14.0,75,Incidence,673131,Non-Hispanic Asian/Pacific Islander,11.1,Male,Non-Hodgkin Lymphoma,2017
45-49,11.6,17.4,96,Incidence,673131,Non-Hispanic Asian/Pacific Islander,14.3,Male,Oral Cavity and Pharynx,2017
45-49,2.5,5.7,26,Incidence,673131,Non-Hispanic Asian/Pacific Islander,3.9,Male,Pancreas,2017
45-49,6.5,11.1,58,Incidence,673131,Non-Hispanic Asian/Pacific Islander,8.6,Male,Prostate,2017
45-49,6.7,11.3,59,Incidence,673131,Non-Hispanic Asian/Pacific Islander,8.8,Male,Stomach,2017
45-49,1.7,4.4,19,Incidence,673131,Non-Hispanic Asian/Pacific Islander,2.8,Male,Testis,2017
45-49,9.3,14.6,79,Incidence,673131,Non-Hispanic Asian/Pacific Islander,11.7,Male,Thyroid,2017
45-49,2.9,6.2,29,Incidence,673131,Non-Hispanic Asian/Pacific Islander,4.3,Male,Urinary Bladder,2017
5-9,10.8,16.7,85,Incidence,630904,Non-Hispanic Asian/Pacific Islander,13.5,Male,All Cancer Sites Combined,2017
5-9,2.1,5.1,21,Incidence,630904,Non-Hispanic Asian/Pacific Islander,3.3,Male,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
5-9,2.8,6.2,27,Incidence,630904,Non-Hispanic Asian/Pacific Islander,4.3,Male,Leukemias,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
5-9,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
50-54,288.2,316.5,1763,Incidence,583581,Non-Hispanic Asian/Pacific Islander,302.1,Male,All Cancer Sites Combined,2017
50-54,3.3,7.1,29,Incidence,583581,Non-Hispanic Asian/Pacific Islander,5.0,Male,Brain and Other Nervous System,2017
50-54,52.4,65.0,341,Incidence,583581,Non-Hispanic Asian/Pacific Islander,58.4,Male,Colon and Rectum,2017
50-54,2.4,5.7,22,Incidence,583581,Non-Hispanic Asian/Pacific Islander,3.8,Male,Esophagus,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
50-54,17.2,24.8,121,Incidence,583581,Non-Hispanic Asian/Pacific Islander,20.7,Male,Kidney and Renal Pelvis,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
50-54,5.2,9.7,42,Incidence,583581,Non-Hispanic Asian/Pacific Islander,7.2,Male,Leukemias,2017
50-54,18.5,26.3,129,Incidence,583581,Non-Hispanic Asian/Pacific Islander,22.1,Male,Liver and Intrahepatic Bile Duct,2017
50-54,30.3,40.1,204,Incidence,583581,Non-Hispanic Asian/Pacific Islander,35.0,Male,Lung and Bronchus,2017
50-54,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
50-54,3.8,7.7,32,Incidence,583581,Non-Hispanic Asian/Pacific Islander,5.5,Male,Myeloma,2017
50-54,12.9,19.5,93,Incidence,583581,Non-Hispanic Asian/Pacific Islander,15.9,Male,Non-Hodgkin Lymphoma,2017
50-54,17.0,24.6,120,Incidence,583581,Non-Hispanic Asian/Pacific Islander,20.6,Male,Oral Cavity and Pharynx,2017
50-54,7.5,12.8,58,Incidence,583581,Non-Hispanic Asian/Pacific Islander,9.9,Male,Pancreas,2017
50-54,31.9,41.9,214,Incidence,583581,Non-Hispanic Asian/Pacific Islander,36.7,Male,Prostate,2017
50-54,6.7,11.7,52,Incidence,583581,Non-Hispanic Asian/Pacific Islander,8.9,Male,Stomach,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
50-54,9.8,15.7,73,Incidence,583581,Non-Hispanic Asian/Pacific Islander,12.5,Male,Thyroid,2017
50-54,7.5,12.8,58,Incidence,583581,Non-Hispanic Asian/Pacific Islander,9.9,Male,Urinary Bladder,2017
55-59,477.7,516.2,2589,Incidence,521260,Non-Hispanic Asian/Pacific Islander,496.7,Male,All Cancer Sites Combined,2017
55-59,4.4,8.9,33,Incidence,521260,Non-Hispanic Asian/Pacific Islander,6.3,Male,Brain and Other Nervous System,2017
55-59,70.5,85.8,406,Incidence,521260,Non-Hispanic Asian/Pacific Islander,77.9,Male,Colon and Rectum,2017
55-59,5.5,10.4,40,Incidence,521260,Non-Hispanic Asian/Pacific Islander,7.7,Male,Esophagus,2017
55-59,~,~,~,Incidence,521260,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,521260,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
55-59,20.0,28.6,125,Incidence,521260,Non-Hispanic Asian/Pacific Islander,24.0,Male,Kidney and Renal Pelvis,2017
55-59,2.2,5.7,19,Incidence,521260,Non-Hispanic Asian/Pacific Islander,3.6,Male,Larynx,2017
55-59,7.1,12.6,50,Incidence,521260,Non-Hispanic Asian/Pacific Islander,9.6,Male,Leukemias,2017
55-59,34.3,45.3,206,Incidence,521260,Non-Hispanic Asian/Pacific Islander,39.5,Male,Liver and Intrahepatic Bile Duct,2017
55-59,54.7,68.3,319,Incidence,521260,Non-Hispanic Asian/Pacific Islander,61.2,Male,Lung and Bronchus,2017
55-59,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
55-59,~,~,~,Incidence,521260,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,521260,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
55-59,7.3,12.9,51,Incidence,521260,Non-Hispanic Asian/Pacific Islander,9.8,Male,Myeloma,2017
55-59,17.3,25.4,110,Incidence,521260,Non-Hispanic Asian/Pacific Islander,21.1,Male,Non-Hodgkin Lymphoma,2017
55-59,24.0,33.4,148,Incidence,521260,Non-Hispanic Asian/Pacific Islander,28.4,Male,Oral Cavity and Pharynx,2017
55-59,13.7,21.0,89,Incidence,521260,Non-Hispanic Asian/Pacific Islander,17.1,Male,Pancreas,2017
55-59,88.4,105.5,504,Incidence,521260,Non-Hispanic Asian/Pacific Islander,96.7,Male,Prostate,2017
55-59,16.5,24.4,105,Incidence,521260,Non-Hispanic Asian/Pacific Islander,20.1,Male,Stomach,2017
55-59,~,~,~,Incidence,521260,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
55-59,9.6,15.9,65,Incidence,521260,Non-Hispanic Asian/Pacific Islander,12.5,Male,Thyroid,2017
55-59,13.4,20.6,87,Incidence,521260,Non-Hispanic Asian/Pacific Islander,16.7,Male,Urinary Bladder,2017
60-64,740.2,791.4,3471,Incidence,453438,Non-Hispanic Asian/Pacific Islander,765.5,Male,All Cancer Sites Combined,2017
60-64,7.1,13.0,44,Incidence,453438,Non-Hispanic Asian/Pacific Islander,9.7,Male,Brain and Other Nervous System,2017
60-64,81.0,98.7,406,Incidence,453438,Non-Hispanic Asian/Pacific Islander,89.5,Male,Colon and Rectum,2017
60-64,6.9,12.8,43,Incidence,453438,Non-Hispanic Asian/Pacific Islander,9.5,Male,Esophagus,2017
60-64,~,~,~,Incidence,453438,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,453438,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
60-64,27.4,38.1,147,Incidence,453438,Non-Hispanic Asian/Pacific Islander,32.4,Male,Kidney and Renal Pelvis,2017
60-64,2.9,7.1,21,Incidence,453438,Non-Hispanic Asian/Pacific Islander,4.6,Male,Larynx,2017
60-64,11.8,19.3,69,Incidence,453438,Non-Hispanic Asian/Pacific Islander,15.2,Male,Leukemias,2017
60-64,56.8,71.8,290,Incidence,453438,Non-Hispanic Asian/Pacific Islander,64.0,Male,Liver and Intrahepatic Bile Duct,2017
60-64,88.2,106.5,440,Incidence,453438,Non-Hispanic Asian/Pacific Islander,97.0,Male,Lung and Bronchus,2017
60-64,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
60-64,~,~,~,Incidence,453438,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,453438,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
60-64,10.1,17.0,60,Incidence,453438,Non-Hispanic Asian/Pacific Islander,13.2,Male,Myeloma,2017
60-64,31.9,43.3,169,Incidence,453438,Non-Hispanic Asian/Pacific Islander,37.3,Male,Non-Hodgkin Lymphoma,2017
60-64,29.0,40.0,155,Incidence,453438,Non-Hispanic Asian/Pacific Islander,34.2,Male,Oral Cavity and Pharynx,2017
60-64,18.5,27.5,103,Incidence,453438,Non-Hispanic Asian/Pacific Islander,22.7,Male,Pancreas,2017
60-64,188.3,214.6,912,Incidence,453438,Non-Hispanic Asian/Pacific Islander,201.1,Male,Prostate,2017
60-64,25.0,35.2,135,Incidence,453438,Non-Hispanic Asian/Pacific Islander,29.8,Male,Stomach,2017
60-64,~,~,~,Incidence,453438,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
60-64,12.2,19.8,71,Incidence,453438,Non-Hispanic Asian/Pacific Islander,15.7,Male,Thyroid,2017
60-64,24.2,34.3,131,Incidence,453438,Non-Hispanic Asian/Pacific Islander,28.9,Male,Urinary Bladder,2017
65-69,1161.9,1232.8,4414,Incidence,368763,Non-Hispanic Asian/Pacific Islander,1197.0,Male,All Cancer Sites Combined,2017
65-69,8.2,15.4,42,Incidence,368763,Non-Hispanic Asian/Pacific Islander,11.4,Male,Brain and Other Nervous System,2017
65-69,111.8,134.7,453,Incidence,368763,Non-Hispanic Asian/Pacific Islander,122.8,Male,Colon and Rectum,2017
65-69,9.8,17.6,49,Incidence,368763,Non-Hispanic Asian/Pacific Islander,13.3,Male,Esophagus,2017
65-69,~,~,~,Incidence,368763,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,368763,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
65-69,40.7,55.0,175,Incidence,368763,Non-Hispanic Asian/Pacific Islander,47.5,Male,Kidney and Renal Pelvis,2017
65-69,8.0,15.1,41,Incidence,368763,Non-Hispanic Asian/Pacific Islander,11.1,Male,Larynx,2017
65-69,22.6,33.6,102,Incidence,368763,Non-Hispanic Asian/Pacific Islander,27.7,Male,Leukemias,2017
65-69,74.5,93.4,308,Incidence,368763,Non-Hispanic Asian/Pacific Islander,83.5,Male,Liver and Intrahepatic Bile Duct,2017
65-69,152.8,179.4,611,Incidence,368763,Non-Hispanic Asian/Pacific Islander,165.7,Male,Lung and Bronchus,2017
65-69,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
65-69,3.7,9.0,22,Incidence,368763,Non-Hispanic Asian/Pacific Islander,6.0,Male,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,368763,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
65-69,14.3,23.4,68,Incidence,368763,Non-Hispanic Asian/Pacific Islander,18.4,Male,Myeloma,2017
65-69,45.5,60.6,194,Incidence,368763,Non-Hispanic Asian/Pacific Islander,52.6,Male,Non-Hodgkin Lymphoma,2017
65-69,32.2,45.1,141,Incidence,368763,Non-Hispanic Asian/Pacific Islander,38.2,Male,Oral Cavity and Pharynx,2017
65-69,35.2,48.6,153,Incidence,368763,Non-Hispanic Asian/Pacific Islander,41.5,Male,Pancreas,2017
65-69,338.1,377.0,1317,Incidence,368763,Non-Hispanic Asian/Pacific Islander,357.1,Male,Prostate,2017
65-69,33.2,46.3,145,Incidence,368763,Non-Hispanic Asian/Pacific Islander,39.3,Male,Stomach,2017
65-69,~,~,~,Incidence,368763,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
65-69,12.7,21.2,61,Incidence,368763,Non-Hispanic Asian/Pacific Islander,16.5,Male,Thyroid,2017
65-69,44.5,59.4,190,Incidence,368763,Non-Hispanic Asian/Pacific Islander,51.5,Male,Urinary Bladder,2017
70-74,1366.5,1458.2,3669,Incidence,259886,Non-Hispanic Asian/Pacific Islander,1411.8,Male,All Cancer Sites Combined,2017
70-74,6.2,14.2,25,Incidence,259886,Non-Hispanic Asian/Pacific Islander,9.6,Male,Brain and Other Nervous System,2017
70-74,120.9,149.5,350,Incidence,259886,Non-Hispanic Asian/Pacific Islander,134.7,Male,Colon and Rectum,2017
70-74,15.9,27.5,55,Incidence,259886,Non-Hispanic Asian/Pacific Islander,21.2,Male,Esophagus,2017
70-74,~,~,~,Incidence,259886,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,259886,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
70-74,41.8,59.4,130,Incidence,259886,Non-Hispanic Asian/Pacific Islander,50.0,Male,Kidney and Renal Pelvis,2017
70-74,5.3,12.8,22,Incidence,259886,Non-Hispanic Asian/Pacific Islander,8.5,Male,Larynx,2017
70-74,34.1,50.2,108,Incidence,259886,Non-Hispanic Asian/Pacific Islander,41.6,Male,Leukemias,2017
70-74,72.0,94.6,215,Incidence,259886,Non-Hispanic Asian/Pacific Islander,82.7,Male,Liver and Intrahepatic Bile Duct,2017
70-74,219.0,256.9,617,Incidence,259886,Non-Hispanic Asian/Pacific Islander,237.4,Male,Lung and Bronchus,2017
70-74,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
70-74,~,~,~,Incidence,259886,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,259886,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
70-74,21.7,34.9,72,Incidence,259886,Non-Hispanic Asian/Pacific Islander,27.7,Male,Myeloma,2017
70-74,50.6,69.8,155,Incidence,259886,Non-Hispanic Asian/Pacific Islander,59.6,Male,Non-Hodgkin Lymphoma,2017
70-74,24.8,38.7,81,Incidence,259886,Non-Hispanic Asian/Pacific Islander,31.2,Male,Oral Cavity and Pharynx,2017
70-74,43.9,61.9,136,Incidence,259886,Non-Hispanic Asian/Pacific Islander,52.3,Male,Pancreas,2017
70-74,355.7,403.4,985,Incidence,259886,Non-Hispanic Asian/Pacific Islander,379.0,Male,Prostate,2017
70-74,51.3,70.6,157,Incidence,259886,Non-Hispanic Asian/Pacific Islander,60.4,Male,Stomach,2017
70-74,~,~,~,Incidence,259886,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
70-74,8.7,17.8,33,Incidence,259886,Non-Hispanic Asian/Pacific Islander,12.7,Male,Thyroid,2017
70-74,62.7,83.9,189,Incidence,259886,Non-Hispanic Asian/Pacific Islander,72.7,Male,Urinary Bladder,2017
75-79,1639.5,1760.8,3048,Incidence,179363,Non-Hispanic Asian/Pacific Islander,1699.3,Male,All Cancer Sites Combined,2017
75-79,8.6,19.9,24,Incidence,179363,Non-Hispanic Asian/Pacific Islander,13.4,Male,Brain and Other Nervous System,2017
75-79,155.7,194.9,313,Incidence,179363,Non-Hispanic Asian/Pacific Islander,174.5,Male,Colon and Rectum,2017
75-79,18.3,33.6,45,Incidence,179363,Non-Hispanic Asian/Pacific Islander,25.1,Male,Esophagus,2017
75-79,~,~,~,Incidence,179363,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,179363,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
75-79,40.8,62.3,91,Incidence,179363,Non-Hispanic Asian/Pacific Islander,50.7,Male,Kidney and Renal Pelvis,2017
75-79,5.1,14.5,16,Incidence,179363,Non-Hispanic Asian/Pacific Islander,8.9,Male,Larynx,2017
75-79,42.9,64.7,95,Incidence,179363,Non-Hispanic Asian/Pacific Islander,53.0,Male,Leukemias,2017
75-79,85.7,115.5,179,Incidence,179363,Non-Hispanic Asian/Pacific Islander,99.8,Male,Liver and Intrahepatic Bile Duct,2017
75-79,255.4,304.9,501,Incidence,179363,Non-Hispanic Asian/Pacific Islander,279.3,Male,Lung and Bronchus,2017
75-79,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
75-79,~,~,~,Incidence,179363,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,179363,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
75-79,22.6,39.3,54,Incidence,179363,Non-Hispanic Asian/Pacific Islander,30.1,Male,Myeloma,2017
75-79,76.4,104.7,161,Incidence,179363,Non-Hispanic Asian/Pacific Islander,89.8,Male,Non-Hodgkin Lymphoma,2017
75-79,31.9,51.2,73,Incidence,179363,Non-Hispanic Asian/Pacific Islander,40.7,Male,Oral Cavity and Pharynx,2017
75-79,53.9,78.2,117,Incidence,179363,Non-Hispanic Asian/Pacific Islander,65.2,Male,Pancreas,2017
75-79,367.8,426.6,711,Incidence,179363,Non-Hispanic Asian/Pacific Islander,396.4,Male,Prostate,2017
75-79,62.1,87.9,133,Incidence,179363,Non-Hispanic Asian/Pacific Islander,74.2,Male,Stomach,2017
75-79,~,~,~,Incidence,179363,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
75-79,11.7,24.5,31,Incidence,179363,Non-Hispanic Asian/Pacific Islander,17.3,Male,Thyroid,2017
75-79,98.1,129.9,203,Incidence,179363,Non-Hispanic Asian/Pacific Islander,113.2,Male,Urinary Bladder,2017
80-84,1733.0,1890.8,2046,Incidence,113003,Non-Hispanic Asian/Pacific Islander,1810.6,Male,All Cancer Sites Combined,2017
80-84,10.8,27.3,20,Incidence,113003,Non-Hispanic Asian/Pacific Islander,17.7,Male,Brain and Other Nervous System,2017
80-84,154.1,204.2,201,Incidence,113003,Non-Hispanic Asian/Pacific Islander,177.9,Male,Colon and Rectum,2017
80-84,13.6,31.6,24,Incidence,113003,Non-Hispanic Asian/Pacific Islander,21.2,Male,Esophagus,2017
80-84,~,~,~,Incidence,113003,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,113003,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
80-84,41.3,69.3,61,Incidence,113003,Non-Hispanic Asian/Pacific Islander,54.0,Male,Kidney and Renal Pelvis,2017
80-84,10.1,26.3,19,Incidence,113003,Non-Hispanic Asian/Pacific Islander,16.8,Male,Larynx,2017
80-84,39.0,66.4,58,Incidence,113003,Non-Hispanic Asian/Pacific Islander,51.3,Male,Leukemias,2017
80-84,84.8,123.1,116,Incidence,113003,Non-Hispanic Asian/Pacific Islander,102.7,Male,Liver and Intrahepatic Bile Duct,2017
80-84,324.3,395.1,405,Incidence,113003,Non-Hispanic Asian/Pacific Islander,358.4,Male,Lung and Bronchus,2017
80-84,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
80-84,~,~,~,Incidence,113003,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,113003,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
80-84,29.0,53.3,45,Incidence,113003,Non-Hispanic Asian/Pacific Islander,39.8,Male,Myeloma,2017
80-84,105.0,147.2,141,Incidence,113003,Non-Hispanic Asian/Pacific Islander,124.8,Male,Non-Hodgkin Lymphoma,2017
80-84,30.6,55.3,47,Incidence,113003,Non-Hispanic Asian/Pacific Islander,41.6,Male,Oral Cavity and Pharynx,2017
80-84,46.7,76.3,68,Incidence,113003,Non-Hispanic Asian/Pacific Islander,60.2,Male,Pancreas,2017
80-84,259.7,323.4,328,Incidence,113003,Non-Hispanic Asian/Pacific Islander,290.3,Male,Prostate,2017
80-84,71.2,106.7,99,Incidence,113003,Non-Hispanic Asian/Pacific Islander,87.6,Male,Stomach,2017
80-84,~,~,~,Incidence,113003,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
80-84,14.3,32.7,25,Incidence,113003,Non-Hispanic Asian/Pacific Islander,22.1,Male,Thyroid,2017
80-84,109.9,152.9,147,Incidence,113003,Non-Hispanic Asian/Pacific Islander,130.1,Male,Urinary Bladder,2017
85+,1691.8,1859.3,1745,Incidence,98362,Non-Hispanic Asian/Pacific Islander,1774.1,Male,All Cancer Sites Combined,2017
85+,9.3,26.4,16,Incidence,98362,Non-Hispanic Asian/Pacific Islander,16.3,Male,Brain and Other Nervous System,2017
85+,171.4,228.1,195,Incidence,98362,Non-Hispanic Asian/Pacific Islander,198.2,Male,Colon and Rectum,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
85+,27.3,53.0,38,Incidence,98362,Non-Hispanic Asian/Pacific Islander,38.6,Male,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
85+,59.1,94.4,74,Incidence,98362,Non-Hispanic Asian/Pacific Islander,75.2,Male,Leukemias,2017
85+,65.4,102.4,81,Incidence,98362,Non-Hispanic Asian/Pacific Islander,82.3,Male,Liver and Intrahepatic Bile Duct,2017
85+,307.0,381.2,337,Incidence,98362,Non-Hispanic Asian/Pacific Islander,342.6,Male,Lung and Bronchus,2017
85+,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
85+,27.3,53.0,38,Incidence,98362,Non-Hispanic Asian/Pacific Islander,38.6,Male,Myeloma,2017
85+,71.8,110.2,88,Incidence,98362,Non-Hispanic Asian/Pacific Islander,89.5,Male,Non-Hodgkin Lymphoma,2017
85+,36.0,64.7,48,Incidence,98362,Non-Hispanic Asian/Pacific Islander,48.8,Male,Oral Cavity and Pharynx,2017
85+,67.2,104.6,83,Incidence,98362,Non-Hispanic Asian/Pacific Islander,84.4,Male,Pancreas,2017
85+,207.4,269.3,233,Incidence,98362,Non-Hispanic Asian/Pacific Islander,236.9,Male,Prostate,2017
85+,72.7,111.3,89,Incidence,98362,Non-Hispanic Asian/Pacific Islander,90.5,Male,Stomach,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2017
85+,116.9,164.7,137,Incidence,98362,Non-Hispanic Asian/Pacific Islander,139.3,Male,Urinary Bladder,2017
<1,19.1,37.7,36,Incidence,132082,Non-Hispanic Asian/Pacific Islander,27.3,Male,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2017
<1,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2017
1-4,18.4,24.1,220,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,All Cancer Sites Combined,2017
1-4,3.2,5.9,46,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
1-4,7.2,10.9,93,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,8.9,Male and Female,Leukemias,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,506520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
1-4,~,~,~,Incidence,537159,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2017
1-4,~,~,~,Incidence,1043679,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
10-14,12.2,16.5,173,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,14.2,Male and Female,All Cancer Sites Combined,2017
10-14,1.7,3.5,30,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
10-14,3.1,5.4,50,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,Leukemias,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
10-14,0.8,2.1,16,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,603049,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
10-14,~,~,~,Incidence,613603,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
10-14,0.8,2.2,17,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Thyroid,2017
10-14,~,~,~,Incidence,1216652,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
15-19,17.8,22.9,247,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,20.3,Male and Female,All Cancer Sites Combined,2017
15-19,1.5,3.3,28,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
15-19,1.3,2.9,24,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
15-19,1.6,3.4,29,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Leukemias,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
15-19,1.1,2.6,21,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,605391,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
15-19,~,~,~,Incidence,614135,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
15-19,2.6,4.7,43,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Thyroid,2017
15-19,~,~,~,Incidence,1219526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
20-24,27.9,33.7,434,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,30.7,Male and Female,All Cancer Sites Combined,2017
20-24,0.8,2.1,19,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
20-24,1.0,2.4,22,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
20-24,2.2,4.1,43,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
20-24,2.2,4.1,43,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Leukemias,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2017
20-24,~,~,~,Incidence,694292,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
20-24,2.0,3.8,39,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2017
20-24,1.4,3.9,17,Incidence,694292,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Ovary,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
20-24,~,~,~,Incidence,719208,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
20-24,3.4,6.8,35,Incidence,719208,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,Testis,2017
20-24,6.1,9.1,106,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,7.5,Male and Female,Thyroid,2017
20-24,~,~,~,Incidence,1413500,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
25-29,41.5,47.8,770,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,44.6,Male and Female,All Cancer Sites Combined,2017
25-29,1.0,2.3,27,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Brain and Other Nervous System,2017
25-29,1.1,3.1,17,Incidence,874308,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Cervix,2017
25-29,1.9,3.5,45,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Colon and Rectum,2017
25-29,1.3,3.4,19,Incidence,874308,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
25-29,6.1,10.0,69,Incidence,874308,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Female Breast,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
25-29,1.5,3.0,37,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
25-29,2.2,3.9,52,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Leukemias,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
25-29,6.1,10.0,69,Incidence,874308,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Male and Female Breast,2017
25-29,~,~,~,Incidence,874308,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
25-29,1.9,3.5,45,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Non-Hodgkin Lymphoma,2017
25-29,1.3,2.7,33,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Oral Cavity and Pharynx,2017
25-29,1.9,4.4,26,Incidence,874308,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Ovary,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
25-29,~,~,~,Incidence,853898,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
25-29,4.0,7.3,47,Incidence,853898,Non-Hispanic Asian/Pacific Islander,5.5,Male and Female,Testis,2017
25-29,10.1,13.4,201,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,11.6,Male and Female,Thyroid,2017
25-29,~,~,~,Incidence,1728206,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
30-34,65.3,73.2,1199,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,69.2,Male and Female,All Cancer Sites Combined,2017
30-34,1.5,2.9,37,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Brain and Other Nervous System,2017
30-34,4.0,7.2,49,Incidence,899891,Non-Hispanic Asian/Pacific Islander,5.4,Male and Female,Cervix,2017
30-34,3.5,5.5,76,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Colon and Rectum,2017
30-34,4.3,7.6,52,Incidence,899891,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
30-34,21.3,27.9,220,Incidence,899891,Non-Hispanic Asian/Pacific Islander,24.4,Male and Female,Female Breast,2017
30-34,2.3,4.9,31,Incidence,899891,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,"Female Breast, <i>in situ</i>",2017
30-34,1.1,2.3,28,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
30-34,1.4,2.7,34,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
30-34,2.2,3.9,51,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Leukemias,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
30-34,0.9,2.1,24,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Lung and Bronchus,2017
30-34,21.3,27.9,220,Incidence,899891,Non-Hispanic Asian/Pacific Islander,24.4,Male and Female,Male and Female Breast,2017
30-34,2.3,4.9,31,Incidence,899891,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
30-34,2.6,4.4,59,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Non-Hodgkin Lymphoma,2017
30-34,1.9,3.5,45,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Oral Cavity and Pharynx,2017
30-34,1.8,4.1,25,Incidence,899891,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Ovary,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
30-34,~,~,~,Incidence,833496,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
30-34,0.7,1.9,21,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Stomach,2017
30-34,4.2,7.6,48,Incidence,833496,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Testis,2017
30-34,13.7,17.4,268,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,15.5,Male and Female,Thyroid,2017
30-34,~,~,~,Incidence,1733387,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
35-39,107.5,117.9,1837,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,112.6,Male and Female,All Cancer Sites Combined,2017
35-39,2.2,4.0,49,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Brain and Other Nervous System,2017
35-39,7.0,11.1,77,Incidence,863725,Non-Hispanic Asian/Pacific Islander,8.9,Male and Female,Cervix,2017
35-39,6.6,9.4,129,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Colon and Rectum,2017
35-39,8.1,12.4,87,Incidence,863725,Non-Hispanic Asian/Pacific Islander,10.1,Male and Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
35-39,51.5,61.6,487,Incidence,863725,Non-Hispanic Asian/Pacific Islander,56.4,Male and Female,Female Breast,2017
35-39,8.2,12.6,88,Incidence,863725,Non-Hispanic Asian/Pacific Islander,10.2,Male and Female,"Female Breast, <i>in situ</i>",2017
35-39,1.0,2.3,25,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,1.5,Male and Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
35-39,1.8,3.4,41,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
35-39,2.5,4.3,54,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Leukemias,2017
35-39,1.6,3.1,37,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
35-39,3.0,4.9,63,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,3.9,Male and Female,Lung and Bronchus,2017
35-39,51.5,61.6,487,Incidence,863725,Non-Hispanic Asian/Pacific Islander,56.4,Male and Female,Male and Female Breast,2017
35-39,8.2,12.6,88,Incidence,863725,Non-Hispanic Asian/Pacific Islander,10.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
35-39,~,~,~,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
35-39,~,~,~,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
35-39,4.2,6.5,86,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,5.3,Male and Female,Non-Hodgkin Lymphoma,2017
35-39,3.8,6.0,79,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,4.8,Male and Female,Oral Cavity and Pharynx,2017
35-39,4.4,7.8,51,Incidence,863725,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Ovary,2017
35-39,0.7,1.9,20,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Pancreas,2017
35-39,~,~,~,Incidence,767638,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
35-39,0.8,2.0,22,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Stomach,2017
35-39,1.7,4.2,21,Incidence,767638,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Testis,2017
35-39,18.2,22.7,332,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,20.4,Male and Female,Thyroid,2017
35-39,0.7,1.7,18,Incidence,1631363,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Urinary Bladder,2017
40-44,173.9,187.4,2759,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,180.6,Male and Female,All Cancer Sites Combined,2017
40-44,2.4,4.3,50,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Brain and Other Nervous System,2017
40-44,7.4,11.7,76,Incidence,812907,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Cervix,2017
40-44,11.7,15.5,206,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,13.5,Male and Female,Colon and Rectum,2017
40-44,14.0,19.8,136,Incidence,812907,Non-Hispanic Asian/Pacific Islander,16.7,Male and Female,"Corpus and Uterus, NOS",2017
40-44,~,~,~,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
40-44,117.2,132.7,1014,Incidence,812907,Non-Hispanic Asian/Pacific Islander,124.7,Male and Female,Female Breast,2017
40-44,43.9,53.6,395,Incidence,812907,Non-Hispanic Asian/Pacific Islander,48.6,Male and Female,"Female Breast, <i>in situ</i>",2017
40-44,0.8,2.0,20,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
40-44,3.2,5.3,63,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
40-44,3.2,5.3,64,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,4.2,Male and Female,Leukemias,2017
40-44,3.1,5.1,61,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
40-44,4.9,7.4,92,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,6.0,Male and Female,Lung and Bronchus,2017
40-44,117.2,132.7,1014,Incidence,812907,Non-Hispanic Asian/Pacific Islander,124.7,Male and Female,Male and Female Breast,2017
40-44,43.9,53.6,395,Incidence,812907,Non-Hispanic Asian/Pacific Islander,48.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
40-44,~,~,~,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
40-44,~,~,~,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
40-44,5.3,8.0,100,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,6.5,Male and Female,Non-Hodgkin Lymphoma,2017
40-44,5.8,8.5,108,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,7.1,Male and Female,Oral Cavity and Pharynx,2017
40-44,6.1,10.1,64,Incidence,812907,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Ovary,2017
40-44,1.6,3.2,35,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Pancreas,2017
40-44,~,~,~,Incidence,715179,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
40-44,2.5,4.5,52,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Stomach,2017
40-44,2.2,5.0,24,Incidence,715179,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Testis,2017
40-44,21.6,26.5,366,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,24.0,Male and Female,Thyroid,2017
40-44,0.9,2.2,22,Incidence,1528086,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Urinary Bladder,2017
45-49,284.0,301.8,4212,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,292.8,Male and Female,All Cancer Sites Combined,2017
45-49,2.6,4.7,51,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Brain and Other Nervous System,2017
45-49,10.6,15.9,100,Incidence,765384,Non-Hispanic Asian/Pacific Islander,13.1,Male and Female,Cervix,2017
45-49,25.5,31.0,405,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,28.2,Male and Female,Colon and Rectum,2017
45-49,25.7,33.5,225,Incidence,765384,Non-Hispanic Asian/Pacific Islander,29.4,Male and Female,"Corpus and Uterus, NOS",2017
45-49,~,~,~,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
45-49,190.3,210.4,1532,Incidence,765384,Non-Hispanic Asian/Pacific Islander,200.2,Male and Female,Female Breast,2017
45-49,65.1,77.2,543,Incidence,765384,Non-Hispanic Asian/Pacific Islander,70.9,Male and Female,"Female Breast, <i>in situ</i>",2017
45-49,~,~,~,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
45-49,7.8,11.0,134,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Kidney and Renal Pelvis,2017
45-49,~,~,~,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
45-49,4.8,7.5,87,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,6.0,Male and Female,Leukemias,2017
45-49,6.5,9.4,113,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Liver and Intrahepatic Bile Duct,2017
45-49,11.1,14.9,185,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,12.9,Male and Female,Lung and Bronchus,2017
45-49,190.3,210.4,1532,Incidence,765384,Non-Hispanic Asian/Pacific Islander,200.2,Male and Female,Male and Female Breast,2017
45-49,65.1,77.2,543,Incidence,765384,Non-Hispanic Asian/Pacific Islander,70.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
45-49,0.9,2.2,21,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,1.5,Male and Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
45-49,2.0,3.8,40,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Myeloma,2017
45-49,8.4,11.7,143,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,9.9,Male and Female,Non-Hodgkin Lymphoma,2017
45-49,7.8,11.0,134,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Oral Cavity and Pharynx,2017
45-49,12.6,18.3,117,Incidence,765384,Non-Hispanic Asian/Pacific Islander,15.3,Male and Female,Ovary,2017
45-49,2.9,5.1,56,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,3.9,Male and Female,Pancreas,2017
45-49,6.5,11.1,58,Incidence,673131,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Prostate,2017
45-49,6.5,9.4,113,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Stomach,2017
45-49,1.7,4.4,19,Incidence,673131,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Testis,2017
45-49,23.0,28.3,367,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,25.5,Male and Female,Thyroid,2017
45-49,2.2,4.0,43,Incidence,1438515,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Urinary Bladder,2017
5-9,9.2,12.9,135,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,10.9,Male and Female,All Cancer Sites Combined,2017
5-9,1.9,3.8,34,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
5-9,2.7,5.0,46,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Leukemias,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,605531,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
5-9,~,~,~,Incidence,630904,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2017
5-9,~,~,~,Incidence,1236435,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
50-54,397.5,420.0,5104,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,408.6,Male and Female,All Cancer Sites Combined,2017
50-54,3.3,5.7,55,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Brain and Other Nervous System,2017
50-54,8.6,13.8,73,Incidence,665473,Non-Hispanic Asian/Pacific Islander,11.0,Male and Female,Cervix,2017
50-54,50.6,58.9,682,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,54.6,Male and Female,Colon and Rectum,2017
50-54,46.2,57.3,343,Incidence,665473,Non-Hispanic Asian/Pacific Islander,51.5,Male and Female,"Corpus and Uterus, NOS",2017
50-54,1.5,3.2,28,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Esophagus,2017
50-54,208.3,230.9,1460,Incidence,665473,Non-Hispanic Asian/Pacific Islander,219.4,Male and Female,Female Breast,2017
50-54,64.7,77.6,472,Incidence,665473,Non-Hispanic Asian/Pacific Islander,70.9,Male and Female,"Female Breast, <i>in situ</i>",2017
50-54,~,~,~,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
50-54,12.3,16.6,179,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,14.3,Male and Female,Kidney and Renal Pelvis,2017
50-54,~,~,~,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
50-54,5.1,8.1,81,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,6.5,Male and Female,Leukemias,2017
50-54,10.8,14.8,158,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,12.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
50-54,26.5,32.5,367,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,29.4,Male and Female,Lung and Bronchus,2017
50-54,208.3,230.9,1460,Incidence,665473,Non-Hispanic Asian/Pacific Islander,219.4,Male and Female,Male and Female Breast,2017
50-54,64.7,77.6,472,Incidence,665473,Non-Hispanic Asian/Pacific Islander,70.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
50-54,0.9,2.3,18,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
50-54,3.7,6.3,61,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,Myeloma,2017
50-54,12.1,16.3,176,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,14.1,Male and Female,Non-Hodgkin Lymphoma,2017
50-54,11.0,15.0,161,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,12.9,Male and Female,Oral Cavity and Pharynx,2017
50-54,13.6,19.9,110,Incidence,665473,Non-Hispanic Asian/Pacific Islander,16.5,Male and Female,Ovary,2017
50-54,6.6,9.8,101,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,8.1,Male and Female,Pancreas,2017
50-54,31.9,41.9,214,Incidence,583581,Non-Hispanic Asian/Pacific Islander,36.7,Male and Female,Prostate,2017
50-54,6.7,9.9,102,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,8.2,Male and Female,Stomach,2017
50-54,~,~,~,Incidence,583581,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
50-54,23.9,29.7,333,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,26.7,Male and Female,Thyroid,2017
50-54,4.4,7.1,70,Incidence,1249054,Non-Hispanic Asian/Pacific Islander,5.6,Male and Female,Urinary Bladder,2017
55-59,544.5,572.1,6324,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,558.2,Male and Female,All Cancer Sites Combined,2017
55-59,3.9,6.6,58,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,5.1,Male and Female,Brain and Other Nervous System,2017
55-59,11.8,18.1,90,Incidence,611716,Non-Hispanic Asian/Pacific Islander,14.7,Male and Female,Cervix,2017
55-59,55.3,64.3,676,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,59.7,Male and Female,Colon and Rectum,2017
55-59,64.6,78.1,435,Incidence,611716,Non-Hispanic Asian/Pacific Islander,71.1,Male and Female,"Corpus and Uterus, NOS",2017
55-59,3.0,5.4,46,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,Esophagus,2017
55-59,224.4,248.9,1446,Incidence,611716,Non-Hispanic Asian/Pacific Islander,236.4,Male and Female,Female Breast,2017
55-59,67.7,81.5,455,Incidence,611716,Non-Hispanic Asian/Pacific Islander,74.4,Male and Female,"Female Breast, <i>in situ</i>",2017
55-59,~,~,~,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
55-59,15.8,20.8,206,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,18.2,Male and Female,Kidney and Renal Pelvis,2017
55-59,1.3,3.0,23,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Larynx,2017
55-59,7.6,11.2,105,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Leukemias,2017
55-59,19.3,24.9,249,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,22.0,Male and Female,Liver and Intrahepatic Bile Duct,2017
55-59,48.4,56.9,595,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,52.5,Male and Female,Lung and Bronchus,2017
55-59,224.4,248.9,1446,Incidence,611716,Non-Hispanic Asian/Pacific Islander,236.4,Male and Female,Male and Female Breast,2017
55-59,67.7,81.5,455,Incidence,611716,Non-Hispanic Asian/Pacific Islander,74.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
55-59,1.4,3.2,24,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
55-59,6.7,10.2,94,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,8.3,Male and Female,Myeloma,2017
55-59,17.2,22.4,223,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,19.7,Male and Female,Non-Hodgkin Lymphoma,2017
55-59,15.5,20.6,203,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,17.9,Male and Female,Oral Cavity and Pharynx,2017
55-59,19.3,27.0,140,Incidence,611716,Non-Hispanic Asian/Pacific Islander,22.9,Male and Female,Ovary,2017
55-59,13.1,17.7,173,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,15.3,Male and Female,Pancreas,2017
55-59,88.4,105.5,504,Incidence,521260,Non-Hispanic Asian/Pacific Islander,96.7,Male and Female,Prostate,2017
55-59,13.2,17.9,175,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,15.4,Male and Female,Stomach,2017
55-59,~,~,~,Incidence,521260,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
55-59,24.1,30.2,306,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,27.0,Male and Female,Thyroid,2017
55-59,7.8,11.5,108,Incidence,1132976,Non-Hispanic Asian/Pacific Islander,9.5,Male and Female,Urinary Bladder,2017
60-64,738.7,772.7,7624,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,755.6,Male and Female,All Cancer Sites Combined,2017
60-64,5.7,9.1,73,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,7.2,Male and Female,Brain and Other Nervous System,2017
60-64,12.7,19.5,88,Incidence,555612,Non-Hispanic Asian/Pacific Islander,15.8,Male and Female,Cervix,2017
60-64,67.9,78.5,737,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,73.0,Male and Female,Colon and Rectum,2017
60-64,67.5,82.0,414,Incidence,555612,Non-Hispanic Asian/Pacific Islander,74.5,Male and Female,"Corpus and Uterus, NOS",2017
60-64,4.5,7.5,59,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Esophagus,2017
60-64,262.3,290.1,1533,Incidence,555612,Non-Hispanic Asian/Pacific Islander,275.9,Male and Female,Female Breast,2017
60-64,77.3,92.8,471,Incidence,555612,Non-Hispanic Asian/Pacific Islander,84.8,Male and Female,"Female Breast, <i>in situ</i>",2017
60-64,1.1,2.9,19,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
60-64,20.3,26.4,234,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,23.2,Male and Female,Kidney and Renal Pelvis,2017
60-64,1.6,3.7,25,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Larynx,2017
60-64,11.1,15.7,134,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,13.3,Male and Female,Leukemias,2017
60-64,34.3,42.1,384,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,38.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
60-64,77.7,89.1,840,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,83.2,Male and Female,Lung and Bronchus,2017
60-64,262.3,290.1,1533,Incidence,555612,Non-Hispanic Asian/Pacific Islander,275.9,Male and Female,Male and Female Breast,2017
60-64,77.3,92.8,471,Incidence,555612,Non-Hispanic Asian/Pacific Islander,84.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
60-64,2.3,4.6,33,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
60-64,8.0,11.9,99,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,9.8,Male and Female,Myeloma,2017
60-64,26.5,33.3,300,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,29.7,Male and Female,Non-Hodgkin Lymphoma,2017
60-64,20.5,26.6,236,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,23.4,Male and Female,Oral Cavity and Pharynx,2017
60-64,17.1,24.8,115,Incidence,555612,Non-Hispanic Asian/Pacific Islander,20.7,Male and Female,Ovary,2017
60-64,18.6,24.5,216,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,21.4,Male and Female,Pancreas,2017
60-64,188.3,214.6,912,Incidence,453438,Non-Hispanic Asian/Pacific Islander,201.1,Male and Female,Prostate,2017
60-64,20.7,26.8,238,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,23.6,Male and Female,Stomach,2017
60-64,~,~,~,Incidence,453438,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
60-64,23.4,29.8,267,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,26.5,Male and Female,Thyroid,2017
60-64,15.0,20.2,176,Incidence,1009050,Non-Hispanic Asian/Pacific Islander,17.4,Male and Female,Urinary Bladder,2017
65-69,1001.8,1045.3,8544,Incidence,834856,Non-Hispanic Asian/Pacific Islander,1023.4,Male and Female,All Cancer Sites Combined,2017
65-69,5.8,9.7,63,Incidence,834856,Non-Hispanic Asian/Pacific Islander,7.5,Male and Female,Brain and Other Nervous System,2017
65-69,7.2,13.2,46,Incidence,466093,Non-Hispanic Asian/Pacific Islander,9.9,Male and Female,Cervix,2017
65-69,92.3,105.9,826,Incidence,834856,Non-Hispanic Asian/Pacific Islander,98.9,Male and Female,Colon and Rectum,2017
65-69,64.4,80.0,335,Incidence,466093,Non-Hispanic Asian/Pacific Islander,71.9,Male and Female,"Corpus and Uterus, NOS",2017
65-69,7.3,11.5,77,Incidence,834856,Non-Hispanic Asian/Pacific Islander,9.2,Male and Female,Esophagus,2017
65-69,283.6,315.2,1394,Incidence,466093,Non-Hispanic Asian/Pacific Islander,299.1,Male and Female,Female Breast,2017
65-69,88.9,107.0,455,Incidence,466093,Non-Hispanic Asian/Pacific Islander,97.6,Male and Female,"Female Breast, <i>in situ</i>",2017
65-69,~,~,~,Incidence,834856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,834856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
65-69,29.3,37.2,276,Incidence,834856,Non-Hispanic Asian/Pacific Islander,33.1,Male and Female,Kidney and Renal Pelvis,2017
65-69,3.8,7.1,44,Incidence,834856,Non-Hispanic Asian/Pacific Islander,5.3,Male and Female,Larynx,2017
65-69,17.9,24.2,174,Incidence,834856,Non-Hispanic Asian/Pacific Islander,20.8,Male and Female,Leukemias,2017
65-69,47.3,57.2,435,Incidence,834856,Non-Hispanic Asian/Pacific Islander,52.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
65-69,123.9,139.5,1098,Incidence,834856,Non-Hispanic Asian/Pacific Islander,131.5,Male and Female,Lung and Bronchus,2017
65-69,283.6,315.2,1394,Incidence,466093,Non-Hispanic Asian/Pacific Islander,299.1,Male and Female,Male and Female Breast,2017
65-69,88.9,107.0,455,Incidence,466093,Non-Hispanic Asian/Pacific Islander,97.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
65-69,2.6,5.4,32,Incidence,834856,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,834856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
65-69,12.2,17.6,123,Incidence,834856,Non-Hispanic Asian/Pacific Islander,14.7,Male and Female,Myeloma,2017
65-69,35.7,44.4,333,Incidence,834856,Non-Hispanic Asian/Pacific Islander,39.9,Male and Female,Non-Hodgkin Lymphoma,2017
65-69,24.0,31.2,229,Incidence,834856,Non-Hispanic Asian/Pacific Islander,27.4,Male and Female,Oral Cavity and Pharynx,2017
65-69,20.6,29.9,116,Incidence,466093,Non-Hispanic Asian/Pacific Islander,24.9,Male and Female,Ovary,2017
65-69,29.6,37.6,279,Incidence,834856,Non-Hispanic Asian/Pacific Islander,33.4,Male and Female,Pancreas,2017
65-69,338.1,377.0,1317,Incidence,368763,Non-Hispanic Asian/Pacific Islander,357.1,Male and Female,Prostate,2017
65-69,25.8,33.3,245,Incidence,834856,Non-Hispanic Asian/Pacific Islander,29.3,Male and Female,Stomach,2017
65-69,~,~,~,Incidence,368763,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
65-69,22.5,29.6,216,Incidence,834856,Non-Hispanic Asian/Pacific Islander,25.9,Male and Female,Thyroid,2017
65-69,26.2,33.8,249,Incidence,834856,Non-Hispanic Asian/Pacific Islander,29.8,Male and Female,Urinary Bladder,2017
70-74,1152.9,1208.8,6892,Incidence,583755,Non-Hispanic Asian/Pacific Islander,1180.6,Male and Female,All Cancer Sites Combined,2017
70-74,5.8,10.5,46,Incidence,583755,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Brain and Other Nervous System,2017
70-74,6.5,13.6,31,Incidence,323869,Non-Hispanic Asian/Pacific Islander,9.6,Male and Female,Cervix,2017
70-74,97.2,114.0,615,Incidence,583755,Non-Hispanic Asian/Pacific Islander,105.4,Male and Female,Colon and Rectum,2017
70-74,55.2,72.9,206,Incidence,323869,Non-Hispanic Asian/Pacific Islander,63.6,Male and Female,"Corpus and Uterus, NOS",2017
70-74,10.1,16.1,75,Incidence,583755,Non-Hispanic Asian/Pacific Islander,12.8,Male and Female,Esophagus,2017
70-74,299.5,338.7,1032,Incidence,323869,Non-Hispanic Asian/Pacific Islander,318.6,Male and Female,Female Breast,2017
70-74,88.9,110.9,322,Incidence,323869,Non-Hispanic Asian/Pacific Islander,99.4,Male and Female,"Female Breast, <i>in situ</i>",2017
70-74,~,~,~,Incidence,583755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,583755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
70-74,30.3,40.1,204,Incidence,583755,Non-Hispanic Asian/Pacific Islander,34.9,Male and Female,Kidney and Renal Pelvis,2017
70-74,3.0,6.7,27,Incidence,583755,Non-Hispanic Asian/Pacific Islander,4.6,Male and Female,Larynx,2017
70-74,26.7,35.9,181,Incidence,583755,Non-Hispanic Asian/Pacific Islander,31.0,Male and Female,Leukemias,2017
70-74,47.7,59.7,312,Incidence,583755,Non-Hispanic Asian/Pacific Islander,53.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
70-74,174.3,196.6,1081,Incidence,583755,Non-Hispanic Asian/Pacific Islander,185.2,Male and Female,Lung and Bronchus,2017
70-74,299.5,338.7,1032,Incidence,323869,Non-Hispanic Asian/Pacific Islander,318.6,Male and Female,Male and Female Breast,2017
70-74,88.9,110.9,322,Incidence,323869,Non-Hispanic Asian/Pacific Islander,99.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
70-74,2.1,5.3,20,Incidence,583755,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,583755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
70-74,18.4,26.3,129,Incidence,583755,Non-Hispanic Asian/Pacific Islander,22.1,Male and Female,Myeloma,2017
70-74,45.3,57.0,297,Incidence,583755,Non-Hispanic Asian/Pacific Islander,50.9,Male and Female,Non-Hodgkin Lymphoma,2017
70-74,19.9,27.9,138,Incidence,583755,Non-Hispanic Asian/Pacific Islander,23.6,Male and Female,Oral Cavity and Pharynx,2017
70-74,12.0,21.1,52,Incidence,323869,Non-Hispanic Asian/Pacific Islander,16.1,Male and Female,Ovary,2017
70-74,40.9,52.1,270,Incidence,583755,Non-Hispanic Asian/Pacific Islander,46.3,Male and Female,Pancreas,2017
70-74,355.7,403.4,985,Incidence,259886,Non-Hispanic Asian/Pacific Islander,379.0,Male and Female,Prostate,2017
70-74,36.7,47.4,244,Incidence,583755,Non-Hispanic Asian/Pacific Islander,41.8,Male and Female,Stomach,2017
70-74,~,~,~,Incidence,259886,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
70-74,17.7,25.3,124,Incidence,583755,Non-Hispanic Asian/Pacific Islander,21.2,Male and Female,Thyroid,2017
70-74,35.1,45.6,234,Incidence,583755,Non-Hispanic Asian/Pacific Islander,40.1,Male and Female,Urinary Bladder,2017
75-79,1334.1,1406.4,5548,Incidence,405004,Non-Hispanic Asian/Pacific Islander,1369.9,Male and Female,All Cancer Sites Combined,2017
75-79,6.4,12.6,37,Incidence,405004,Non-Hispanic Asian/Pacific Islander,9.1,Male and Female,Brain and Other Nervous System,2017
75-79,9.7,20.0,32,Incidence,225641,Non-Hispanic Asian/Pacific Islander,14.2,Male and Female,Cervix,2017
75-79,124.7,147.6,550,Incidence,405004,Non-Hispanic Asian/Pacific Islander,135.8,Male and Female,Colon and Rectum,2017
75-79,40.1,58.8,110,Incidence,225641,Non-Hispanic Asian/Pacific Islander,48.8,Male and Female,"Corpus and Uterus, NOS",2017
75-79,10.2,17.7,55,Incidence,405004,Non-Hispanic Asian/Pacific Islander,13.6,Male and Female,Esophagus,2017
75-79,255.7,299.6,625,Incidence,225641,Non-Hispanic Asian/Pacific Islander,277.0,Male and Female,Female Breast,2017
75-79,57.1,79.0,152,Incidence,225641,Non-Hispanic Asian/Pacific Islander,67.4,Male and Female,"Female Breast, <i>in situ</i>",2017
75-79,~,~,~,Incidence,405004,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,405004,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
75-79,31.8,44.0,152,Incidence,405004,Non-Hispanic Asian/Pacific Islander,37.5,Male and Female,Kidney and Renal Pelvis,2017
75-79,3.0,7.6,20,Incidence,405004,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,Larynx,2017
75-79,30.9,42.9,148,Incidence,405004,Non-Hispanic Asian/Pacific Islander,36.5,Male and Female,Leukemias,2017
75-79,65.2,82.2,297,Incidence,405004,Non-Hispanic Asian/Pacific Islander,73.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
75-79,211.8,241.3,916,Incidence,405004,Non-Hispanic Asian/Pacific Islander,226.2,Male and Female,Lung and Bronchus,2017
75-79,255.7,299.6,625,Incidence,225641,Non-Hispanic Asian/Pacific Islander,277.0,Male and Female,Male and Female Breast,2017
75-79,57.1,79.0,152,Incidence,225641,Non-Hispanic Asian/Pacific Islander,67.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
75-79,2.4,6.7,17,Incidence,405004,Non-Hispanic Asian/Pacific Islander,4.2,Male and Female,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,405004,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
75-79,18.5,28.1,93,Incidence,405004,Non-Hispanic Asian/Pacific Islander,23.0,Male and Female,Myeloma,2017
75-79,59.6,75.9,273,Incidence,405004,Non-Hispanic Asian/Pacific Islander,67.4,Male and Female,Non-Hodgkin Lymphoma,2017
75-79,23.2,33.8,114,Incidence,405004,Non-Hispanic Asian/Pacific Islander,28.1,Male and Female,Oral Cavity and Pharynx,2017
75-79,20.3,34.2,60,Incidence,225641,Non-Hispanic Asian/Pacific Islander,26.6,Male and Female,Ovary,2017
75-79,52.5,67.8,242,Incidence,405004,Non-Hispanic Asian/Pacific Islander,59.8,Male and Female,Pancreas,2017
75-79,367.8,426.6,711,Incidence,179363,Non-Hispanic Asian/Pacific Islander,396.4,Male and Female,Prostate,2017
75-79,46.7,61.2,217,Incidence,405004,Non-Hispanic Asian/Pacific Islander,53.6,Male and Female,Stomach,2017
75-79,~,~,~,Incidence,179363,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
75-79,15.2,24.0,78,Incidence,405004,Non-Hispanic Asian/Pacific Islander,19.3,Male and Female,Thyroid,2017
75-79,55.2,70.9,254,Incidence,405004,Non-Hispanic Asian/Pacific Islander,62.7,Male and Female,Urinary Bladder,2017
80-84,1435.2,1528.0,3949,Incidence,266636,Non-Hispanic Asian/Pacific Islander,1481.0,Male and Female,All Cancer Sites Combined,2017
80-84,10.1,19.6,38,Incidence,266636,Non-Hispanic Asian/Pacific Islander,14.3,Male and Female,Brain and Other Nervous System,2017
80-84,10.5,24.0,25,Incidence,153633,Non-Hispanic Asian/Pacific Islander,16.3,Male and Female,Cervix,2017
80-84,150.3,181.6,441,Incidence,266636,Non-Hispanic Asian/Pacific Islander,165.4,Male and Female,Colon and Rectum,2017
80-84,27.0,46.6,55,Incidence,153633,Non-Hispanic Asian/Pacific Islander,35.8,Male and Female,"Corpus and Uterus, NOS",2017
80-84,9.8,19.1,37,Incidence,266636,Non-Hispanic Asian/Pacific Islander,13.9,Male and Female,Esophagus,2017
80-84,207.0,255.7,354,Incidence,153633,Non-Hispanic Asian/Pacific Islander,230.4,Male and Female,Female Breast,2017
80-84,35.5,57.6,70,Incidence,153633,Non-Hispanic Asian/Pacific Islander,45.6,Male and Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,266636,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,266636,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
80-84,31.9,47.3,104,Incidence,266636,Non-Hispanic Asian/Pacific Islander,39.0,Male and Female,Kidney and Renal Pelvis,2017
80-84,4.9,12.0,21,Incidence,266636,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Larynx,2017
80-84,29.8,44.8,98,Incidence,266636,Non-Hispanic Asian/Pacific Islander,36.8,Male and Female,Leukemias,2017
80-84,62.5,83.3,193,Incidence,266636,Non-Hispanic Asian/Pacific Islander,72.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
80-84,256.1,296.3,735,Incidence,266636,Non-Hispanic Asian/Pacific Islander,275.7,Male and Female,Lung and Bronchus,2017
80-84,207.0,255.7,354,Incidence,153633,Non-Hispanic Asian/Pacific Islander,230.4,Male and Female,Male and Female Breast,2017
80-84,35.5,57.6,70,Incidence,153633,Non-Hispanic Asian/Pacific Islander,45.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
80-84,5.5,12.9,23,Incidence,266636,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,266636,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
80-84,23.1,36.5,78,Incidence,266636,Non-Hispanic Asian/Pacific Islander,29.3,Male and Female,Myeloma,2017
80-84,70.9,93.0,217,Incidence,266636,Non-Hispanic Asian/Pacific Islander,81.4,Male and Female,Non-Hodgkin Lymphoma,2017
80-84,21.8,34.8,74,Incidence,266636,Non-Hispanic Asian/Pacific Islander,27.8,Male and Female,Oral Cavity and Pharynx,2017
80-84,18.1,34.7,39,Incidence,153633,Non-Hispanic Asian/Pacific Islander,25.4,Male and Female,Ovary,2017
80-84,57.3,77.3,178,Incidence,266636,Non-Hispanic Asian/Pacific Islander,66.8,Male and Female,Pancreas,2017
80-84,259.7,323.4,328,Incidence,113003,Non-Hispanic Asian/Pacific Islander,290.3,Male and Female,Prostate,2017
80-84,57.7,77.7,179,Incidence,266636,Non-Hispanic Asian/Pacific Islander,67.1,Male and Female,Stomach,2017
80-84,~,~,~,Incidence,113003,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
80-84,15.9,27.3,56,Incidence,266636,Non-Hispanic Asian/Pacific Islander,21.0,Male and Female,Thyroid,2017
80-84,65.0,86.2,200,Incidence,266636,Non-Hispanic Asian/Pacific Islander,75.0,Male and Female,Urinary Bladder,2017
85+,1359.1,1449.6,3731,Incidence,265773,Non-Hispanic Asian/Pacific Islander,1403.8,Male and Female,All Cancer Sites Combined,2017
85+,7.0,15.2,28,Incidence,265773,Non-Hispanic Asian/Pacific Islander,10.5,Male and Female,Brain and Other Nervous System,2017
85+,~,~,~,Incidence,167411,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
85+,164.1,196.7,478,Incidence,265773,Non-Hispanic Asian/Pacific Islander,179.9,Male and Female,Colon and Rectum,2017
85+,21.1,38.0,48,Incidence,167411,Non-Hispanic Asian/Pacific Islander,28.7,Male and Female,"Corpus and Uterus, NOS",2017
85+,5.8,13.4,24,Incidence,265773,Non-Hispanic Asian/Pacific Islander,9.0,Male and Female,Esophagus,2017
85+,148.2,188.0,280,Incidence,167411,Non-Hispanic Asian/Pacific Islander,167.3,Male and Female,Female Breast,2017
85+,13.6,27.7,33,Incidence,167411,Non-Hispanic Asian/Pacific Islander,19.7,Male and Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,265773,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,265773,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
85+,21.9,35.0,74,Incidence,265773,Non-Hispanic Asian/Pacific Islander,27.8,Male and Female,Kidney and Renal Pelvis,2017
85+,3.7,10.2,17,Incidence,265773,Non-Hispanic Asian/Pacific Islander,6.4,Male and Female,Larynx,2017
85+,37.8,54.4,121,Incidence,265773,Non-Hispanic Asian/Pacific Islander,45.5,Male and Female,Leukemias,2017
85+,51.6,70.7,161,Incidence,265773,Non-Hispanic Asian/Pacific Islander,60.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
85+,230.5,268.8,662,Incidence,265773,Non-Hispanic Asian/Pacific Islander,249.1,Male and Female,Lung and Bronchus,2017
85+,148.2,188.0,280,Incidence,167411,Non-Hispanic Asian/Pacific Islander,167.3,Male and Female,Male and Female Breast,2017
85+,13.6,27.7,33,Incidence,167411,Non-Hispanic Asian/Pacific Islander,19.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,265773,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,265773,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
85+,19.9,32.4,68,Incidence,265773,Non-Hispanic Asian/Pacific Islander,25.6,Male and Female,Myeloma,2017
85+,58.9,79.2,182,Incidence,265773,Non-Hispanic Asian/Pacific Islander,68.5,Male and Female,Non-Hodgkin Lymphoma,2017
85+,24.2,37.9,81,Incidence,265773,Non-Hispanic Asian/Pacific Islander,30.5,Male and Female,Oral Cavity and Pharynx,2017
85+,14.1,28.4,34,Incidence,167411,Non-Hispanic Asian/Pacific Islander,20.3,Male and Female,Ovary,2017
85+,75.4,98.1,229,Incidence,265773,Non-Hispanic Asian/Pacific Islander,86.2,Male and Female,Pancreas,2017
85+,207.4,269.3,233,Incidence,98362,Non-Hispanic Asian/Pacific Islander,236.9,Male and Female,Prostate,2017
85+,64.1,85.2,197,Incidence,265773,Non-Hispanic Asian/Pacific Islander,74.1,Male and Female,Stomach,2017
85+,~,~,~,Incidence,98362,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
85+,6.7,14.8,27,Incidence,265773,Non-Hispanic Asian/Pacific Islander,10.2,Male and Female,Thyroid,2017
85+,68.3,90.1,209,Incidence,265773,Non-Hispanic Asian/Pacific Islander,78.6,Male and Female,Urinary Bladder,2017
<1,18.2,30.6,61,Incidence,255732,Non-Hispanic Asian/Pacific Islander,23.9,Male and Female,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Leukemias,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,123650,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2017
<1,~,~,~,Incidence,132082,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2017
<1,~,~,~,Incidence,255732,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2017
1-4,13.4,18.0,188,Incidence,1206356,Non-Hispanic Black,15.6,Female,All Cancer Sites Combined,2017
1-4,2.2,4.3,38,Incidence,1206356,Non-Hispanic Black,3.1,Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Cervix,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Esophagus,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Female Breast,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
1-4,1.4,3.2,26,Incidence,1206356,Non-Hispanic Black,2.2,Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Larynx,2017
1-4,3.6,6.1,57,Incidence,1206356,Non-Hispanic Black,4.7,Female,Leukemias,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Mesothelioma,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Myeloma,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Ovary,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Pancreas,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Stomach,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Thyroid,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Female,Urinary Bladder,2017
10-14,9.4,12.8,167,Incidence,1520380,Non-Hispanic Black,11.0,Female,All Cancer Sites Combined,2017
10-14,1.1,2.5,26,Incidence,1520380,Non-Hispanic Black,1.7,Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Cervix,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Esophagus,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Female Breast,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
10-14,1.0,2.3,23,Incidence,1520380,Non-Hispanic Black,1.5,Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Larynx,2017
10-14,1.1,2.4,25,Incidence,1520380,Non-Hispanic Black,1.6,Female,Leukemias,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Mesothelioma,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Myeloma,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2017
10-14,0.7,1.8,17,Incidence,1520380,Non-Hispanic Black,1.1,Female,Ovary,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Pancreas,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Stomach,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Thyroid,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Female,Urinary Bladder,2017
15-19,16.3,20.6,288,Incidence,1571812,Non-Hispanic Black,18.3,Female,All Cancer Sites Combined,2017
15-19,1.5,3.0,34,Incidence,1571812,Non-Hispanic Black,2.2,Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Cervix,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Esophagus,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Female Breast,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
15-19,1.8,3.4,39,Incidence,1571812,Non-Hispanic Black,2.5,Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Larynx,2017
15-19,1.7,3.3,38,Incidence,1571812,Non-Hispanic Black,2.4,Female,Leukemias,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Mesothelioma,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Myeloma,2017
15-19,0.8,2.0,20,Incidence,1571812,Non-Hispanic Black,1.3,Female,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2017
15-19,1.0,2.3,25,Incidence,1571812,Non-Hispanic Black,1.6,Female,Ovary,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Pancreas,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Stomach,2017
15-19,0.8,2.0,20,Incidence,1571812,Non-Hispanic Black,1.3,Female,Thyroid,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Female,Urinary Bladder,2017
20-24,26.1,31.3,479,Incidence,1675544,Non-Hispanic Black,28.6,Female,All Cancer Sites Combined,2017
20-24,1.2,2.5,29,Incidence,1675544,Non-Hispanic Black,1.7,Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Cervix,2017
20-24,0.8,1.9,21,Incidence,1675544,Non-Hispanic Black,1.3,Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Esophagus,2017
20-24,2.2,3.9,50,Incidence,1675544,Non-Hispanic Black,3.0,Female,Female Breast,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
20-24,2.9,4.9,64,Incidence,1675544,Non-Hispanic Black,3.8,Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
20-24,0.7,1.8,20,Incidence,1675544,Non-Hispanic Black,1.2,Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Larynx,2017
20-24,1.5,2.9,35,Incidence,1675544,Non-Hispanic Black,2.1,Female,Leukemias,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Mesothelioma,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Myeloma,2017
20-24,1.5,3.0,36,Incidence,1675544,Non-Hispanic Black,2.1,Female,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2017
20-24,1.0,2.3,26,Incidence,1675544,Non-Hispanic Black,1.6,Female,Ovary,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Pancreas,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Stomach,2017
20-24,2.7,4.5,59,Incidence,1675544,Non-Hispanic Black,3.5,Female,Thyroid,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Female,Urinary Bladder,2017
25-29,49.9,56.7,942,Incidence,1770797,Non-Hispanic Black,53.2,Female,All Cancer Sites Combined,2017
25-29,1.2,2.6,32,Incidence,1770797,Non-Hispanic Black,1.8,Female,Brain and Other Nervous System,2017
25-29,3.3,5.3,75,Incidence,1770797,Non-Hispanic Black,4.2,Female,Cervix,2017
25-29,2.1,3.7,50,Incidence,1770797,Non-Hispanic Black,2.8,Female,Colon and Rectum,2017
25-29,0.9,2.1,25,Incidence,1770797,Non-Hispanic Black,1.4,Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Esophagus,2017
25-29,10.9,14.2,221,Incidence,1770797,Non-Hispanic Black,12.5,Female,Female Breast,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
25-29,2.9,4.7,66,Incidence,1770797,Non-Hispanic Black,3.7,Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
25-29,0.7,1.8,21,Incidence,1770797,Non-Hispanic Black,1.2,Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Larynx,2017
25-29,2.0,3.7,49,Incidence,1770797,Non-Hispanic Black,2.8,Female,Leukemias,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Mesothelioma,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Myeloma,2017
25-29,2.2,3.9,53,Incidence,1770797,Non-Hispanic Black,3.0,Female,Non-Hodgkin Lymphoma,2017
25-29,0.6,1.5,17,Incidence,1770797,Non-Hispanic Black,1.0,Female,Oral Cavity and Pharynx,2017
25-29,1.9,3.5,46,Incidence,1770797,Non-Hispanic Black,2.6,Female,Ovary,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Pancreas,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Stomach,2017
25-29,5.5,8.0,118,Incidence,1770797,Non-Hispanic Black,6.7,Female,Thyroid,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Female,Urinary Bladder,2017
30-34,99.4,109.7,1587,Incidence,1518974,Non-Hispanic Black,104.5,Female,All Cancer Sites Combined,2017
30-34,1.3,2.7,29,Incidence,1518974,Non-Hispanic Black,1.9,Female,Brain and Other Nervous System,2017
30-34,8.2,11.4,148,Incidence,1518974,Non-Hispanic Black,9.7,Female,Cervix,2017
30-34,5.2,7.9,98,Incidence,1518974,Non-Hispanic Black,6.5,Female,Colon and Rectum,2017
30-34,4.1,6.5,79,Incidence,1518974,Non-Hispanic Black,5.2,Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Esophagus,2017
30-34,32.6,38.7,540,Incidence,1518974,Non-Hispanic Black,35.6,Female,Female Breast,2017
30-34,1.9,3.7,41,Incidence,1518974,Non-Hispanic Black,2.7,Female,"Female Breast, <i>in situ</i>",2017
30-34,2.0,3.8,43,Incidence,1518974,Non-Hispanic Black,2.8,Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
30-34,1.8,3.4,38,Incidence,1518974,Non-Hispanic Black,2.5,Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Larynx,2017
30-34,1.8,3.5,39,Incidence,1518974,Non-Hispanic Black,2.6,Female,Leukemias,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
30-34,1.2,2.6,27,Incidence,1518974,Non-Hispanic Black,1.8,Female,Lung and Bronchus,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Mesothelioma,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Myeloma,2017
30-34,3.6,5.8,70,Incidence,1518974,Non-Hispanic Black,4.6,Female,Non-Hodgkin Lymphoma,2017
30-34,1.1,2.5,26,Incidence,1518974,Non-Hispanic Black,1.7,Female,Oral Cavity and Pharynx,2017
30-34,1.7,3.3,36,Incidence,1518974,Non-Hispanic Black,2.4,Female,Ovary,2017
30-34,1.1,2.4,25,Incidence,1518974,Non-Hispanic Black,1.6,Female,Pancreas,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Stomach,2017
30-34,9.0,12.4,161,Incidence,1518974,Non-Hispanic Black,10.6,Female,Thyroid,2017
30-34,~,~,~,Incidence,1518974,Non-Hispanic Black,~,Female,Urinary Bladder,2017
35-39,174.1,188.0,2664,Incidence,1472188,Non-Hispanic Black,181.0,Female,All Cancer Sites Combined,2017
35-39,1.6,3.2,34,Incidence,1472188,Non-Hispanic Black,2.3,Female,Brain and Other Nervous System,2017
35-39,10.6,14.3,182,Incidence,1472188,Non-Hispanic Black,12.4,Female,Cervix,2017
35-39,10.4,14.0,178,Incidence,1472188,Non-Hispanic Black,12.1,Female,Colon and Rectum,2017
35-39,7.9,11.1,139,Incidence,1472188,Non-Hispanic Black,9.4,Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Esophagus,2017
35-39,68.9,77.7,1078,Incidence,1472188,Non-Hispanic Black,73.2,Female,Female Breast,2017
35-39,7.3,10.3,128,Incidence,1472188,Non-Hispanic Black,8.7,Female,"Female Breast, <i>in situ</i>",2017
35-39,2.0,3.8,41,Incidence,1472188,Non-Hispanic Black,2.8,Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
35-39,3.3,5.6,64,Incidence,1472188,Non-Hispanic Black,4.3,Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Larynx,2017
35-39,2.3,4.2,46,Incidence,1472188,Non-Hispanic Black,3.1,Female,Leukemias,2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
35-39,1.9,3.6,39,Incidence,1472188,Non-Hispanic Black,2.6,Female,Lung and Bronchus,2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Mesothelioma,2017
35-39,1.6,3.2,34,Incidence,1472188,Non-Hispanic Black,2.3,Female,Myeloma,2017
35-39,6.1,8.9,109,Incidence,1472188,Non-Hispanic Black,7.4,Female,Non-Hodgkin Lymphoma,2017
35-39,2.1,3.9,43,Incidence,1472188,Non-Hispanic Black,2.9,Female,Oral Cavity and Pharynx,2017
35-39,3.9,6.3,74,Incidence,1472188,Non-Hispanic Black,5.0,Female,Ovary,2017
35-39,1.3,2.7,28,Incidence,1472188,Non-Hispanic Black,1.9,Female,Pancreas,2017
35-39,1.9,3.7,40,Incidence,1472188,Non-Hispanic Black,2.7,Female,Stomach,2017
35-39,15.0,19.3,251,Incidence,1472188,Non-Hispanic Black,17.0,Female,Thyroid,2017
35-39,~,~,~,Incidence,1472188,Non-Hispanic Black,~,Female,Urinary Bladder,2017
40-44,276.5,294.6,3848,Incidence,1348163,Non-Hispanic Black,285.4,Female,All Cancer Sites Combined,2017
40-44,1.7,3.5,34,Incidence,1348163,Non-Hispanic Black,2.5,Female,Brain and Other Nervous System,2017
40-44,12.7,16.9,198,Incidence,1348163,Non-Hispanic Black,14.7,Female,Cervix,2017
40-44,17.7,22.6,270,Incidence,1348163,Non-Hispanic Black,20.0,Female,Colon and Rectum,2017
40-44,11.7,15.8,184,Incidence,1348163,Non-Hispanic Black,13.6,Female,"Corpus and Uterus, NOS",2017
40-44,~,~,~,Incidence,1348163,Non-Hispanic Black,~,Female,Esophagus,2017
40-44,123.7,136.0,1749,Incidence,1348163,Non-Hispanic Black,129.7,Female,Female Breast,2017
40-44,27.5,33.4,409,Incidence,1348163,Non-Hispanic Black,30.3,Female,"Female Breast, <i>in situ</i>",2017
40-44,2.1,4.0,39,Incidence,1348163,Non-Hispanic Black,2.9,Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,1348163,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
40-44,7.1,10.3,116,Incidence,1348163,Non-Hispanic Black,8.6,Female,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,1348163,Non-Hispanic Black,~,Female,Larynx,2017
40-44,5.4,8.3,91,Incidence,1348163,Non-Hispanic Black,6.7,Female,Leukemias,2017
40-44,0.8,2.2,19,Incidence,1348163,Non-Hispanic Black,1.4,Female,Liver and Intrahepatic Bile Duct,2017
40-44,4.3,6.9,74,Incidence,1348163,Non-Hispanic Black,5.5,Female,Lung and Bronchus,2017
40-44,~,~,~,Incidence,1348163,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,1348163,Non-Hispanic Black,~,Female,Mesothelioma,2017
40-44,4.8,7.5,82,Incidence,1348163,Non-Hispanic Black,6.1,Female,Myeloma,2017
40-44,8.6,12.1,138,Incidence,1348163,Non-Hispanic Black,10.2,Female,Non-Hodgkin Lymphoma,2017
40-44,2.0,3.9,38,Incidence,1348163,Non-Hispanic Black,2.8,Female,Oral Cavity and Pharynx,2017
40-44,5.3,8.1,89,Incidence,1348163,Non-Hispanic Black,6.6,Female,Ovary,2017
40-44,3.1,5.3,55,Incidence,1348163,Non-Hispanic Black,4.1,Female,Pancreas,2017
40-44,3.6,6.0,63,Incidence,1348163,Non-Hispanic Black,4.7,Female,Stomach,2017
40-44,17.1,21.9,261,Incidence,1348163,Non-Hispanic Black,19.4,Female,Thyroid,2017
40-44,~,~,~,Incidence,1348163,Non-Hispanic Black,~,Female,Urinary Bladder,2017
45-49,400.2,421.4,5790,Incidence,1409909,Non-Hispanic Black,410.7,Female,All Cancer Sites Combined,2017
45-49,2.7,4.8,51,Incidence,1409909,Non-Hispanic Black,3.6,Female,Brain and Other Nervous System,2017
45-49,10.9,14.7,179,Incidence,1409909,Non-Hispanic Black,12.7,Female,Cervix,2017
45-49,32.7,39.0,504,Incidence,1409909,Non-Hispanic Black,35.7,Female,Colon and Rectum,2017
45-49,17.3,22.0,275,Incidence,1409909,Non-Hispanic Black,19.5,Female,"Corpus and Uterus, NOS",2017
45-49,0.6,1.8,16,Incidence,1409909,Non-Hispanic Black,1.1,Female,Esophagus,2017
45-49,178.2,192.5,2612,Incidence,1409909,Non-Hispanic Black,185.3,Female,Female Breast,2017
45-49,44.9,52.2,683,Incidence,1409909,Non-Hispanic Black,48.4,Female,"Female Breast, <i>in situ</i>",2017
45-49,1.7,3.5,35,Incidence,1409909,Non-Hispanic Black,2.5,Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,1409909,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
45-49,12.7,16.7,206,Incidence,1409909,Non-Hispanic Black,14.6,Female,Kidney and Renal Pelvis,2017
45-49,0.9,2.3,21,Incidence,1409909,Non-Hispanic Black,1.5,Female,Larynx,2017
45-49,5.8,8.7,101,Incidence,1409909,Non-Hispanic Black,7.2,Female,Leukemias,2017
45-49,1.5,3.1,31,Incidence,1409909,Non-Hispanic Black,2.2,Female,Liver and Intrahepatic Bile Duct,2017
45-49,14.5,18.9,234,Incidence,1409909,Non-Hispanic Black,16.6,Female,Lung and Bronchus,2017
45-49,~,~,~,Incidence,1409909,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,1409909,Non-Hispanic Black,~,Female,Mesothelioma,2017
45-49,8.9,12.4,149,Incidence,1409909,Non-Hispanic Black,10.6,Female,Myeloma,2017
45-49,11.7,15.6,191,Incidence,1409909,Non-Hispanic Black,13.5,Female,Non-Hodgkin Lymphoma,2017
45-49,3.9,6.3,70,Incidence,1409909,Non-Hispanic Black,5.0,Female,Oral Cavity and Pharynx,2017
45-49,6.5,9.6,112,Incidence,1409909,Non-Hispanic Black,7.9,Female,Ovary,2017
45-49,7.7,10.9,130,Incidence,1409909,Non-Hispanic Black,9.2,Female,Pancreas,2017
45-49,5.1,7.8,89,Incidence,1409909,Non-Hispanic Black,6.3,Female,Stomach,2017
45-49,18.7,23.6,297,Incidence,1409909,Non-Hispanic Black,21.1,Female,Thyroid,2017
45-49,1.6,3.2,32,Incidence,1409909,Non-Hispanic Black,2.3,Female,Urinary Bladder,2017
5-9,10.9,14.5,193,Incidence,1529319,Non-Hispanic Black,12.6,Female,All Cancer Sites Combined,2017
5-9,3.3,5.5,66,Incidence,1529319,Non-Hispanic Black,4.3,Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Cervix,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Esophagus,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Female Breast,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
5-9,0.9,2.2,22,Incidence,1529319,Non-Hispanic Black,1.4,Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Larynx,2017
5-9,1.7,3.3,37,Incidence,1529319,Non-Hispanic Black,2.4,Female,Leukemias,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Mesothelioma,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Myeloma,2017
5-9,0.6,1.8,17,Incidence,1529319,Non-Hispanic Black,1.1,Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Ovary,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Pancreas,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Stomach,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Thyroid,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Female,Urinary Bladder,2017
50-54,580.5,605.8,8473,Incidence,1428677,Non-Hispanic Black,593.1,Female,All Cancer Sites Combined,2017
50-54,2.1,3.9,41,Incidence,1428677,Non-Hispanic Black,2.9,Female,Brain and Other Nervous System,2017
50-54,13.0,17.1,214,Incidence,1428677,Non-Hispanic Black,15.0,Female,Cervix,2017
50-54,62.6,71.2,954,Incidence,1428677,Non-Hispanic Black,66.8,Female,Colon and Rectum,2017
50-54,29.7,35.7,466,Incidence,1428677,Non-Hispanic Black,32.6,Female,"Corpus and Uterus, NOS",2017
50-54,1.9,3.7,39,Incidence,1428677,Non-Hispanic Black,2.7,Female,Esophagus,2017
50-54,229.7,245.8,3395,Incidence,1428677,Non-Hispanic Black,237.6,Female,Female Breast,2017
50-54,59.6,68.0,910,Incidence,1428677,Non-Hispanic Black,63.7,Female,"Female Breast, <i>in situ</i>",2017
50-54,1.5,3.2,32,Incidence,1428677,Non-Hispanic Black,2.2,Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,1428677,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
50-54,17.1,21.7,276,Incidence,1428677,Non-Hispanic Black,19.3,Female,Kidney and Renal Pelvis,2017
50-54,1.7,3.4,35,Incidence,1428677,Non-Hispanic Black,2.4,Female,Larynx,2017
50-54,9.3,12.8,157,Incidence,1428677,Non-Hispanic Black,11.0,Female,Leukemias,2017
50-54,4.4,7.0,80,Incidence,1428677,Non-Hispanic Black,5.6,Female,Liver and Intrahepatic Bile Duct,2017
50-54,39.7,46.6,615,Incidence,1428677,Non-Hispanic Black,43.0,Female,Lung and Bronchus,2017
50-54,0.6,1.8,16,Incidence,1428677,Non-Hispanic Black,1.1,Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,1428677,Non-Hispanic Black,~,Female,Mesothelioma,2017
50-54,13.2,17.3,216,Incidence,1428677,Non-Hispanic Black,15.1,Female,Myeloma,2017
50-54,15.1,19.4,245,Incidence,1428677,Non-Hispanic Black,17.1,Female,Non-Hodgkin Lymphoma,2017
50-54,7.5,10.7,129,Incidence,1428677,Non-Hispanic Black,9.0,Female,Oral Cavity and Pharynx,2017
50-54,11.4,15.3,189,Incidence,1428677,Non-Hispanic Black,13.2,Female,Ovary,2017
50-54,11.0,14.8,183,Incidence,1428677,Non-Hispanic Black,12.8,Female,Pancreas,2017
50-54,6.5,9.5,113,Incidence,1428677,Non-Hispanic Black,7.9,Female,Stomach,2017
50-54,20.2,25.2,323,Incidence,1428677,Non-Hispanic Black,22.6,Female,Thyroid,2017
50-54,3.5,5.8,65,Incidence,1428677,Non-Hispanic Black,4.5,Female,Urinary Bladder,2017
55-59,818.6,848.7,11822,Incidence,1418292,Non-Hispanic Black,833.5,Female,All Cancer Sites Combined,2017
55-59,4.5,7.1,81,Incidence,1418292,Non-Hispanic Black,5.7,Female,Brain and Other Nervous System,2017
55-59,13.1,17.3,214,Incidence,1418292,Non-Hispanic Black,15.1,Female,Cervix,2017
55-59,70.4,79.5,1062,Incidence,1418292,Non-Hispanic Black,74.9,Female,Colon and Rectum,2017
55-59,68.8,77.8,1038,Incidence,1418292,Non-Hispanic Black,73.2,Female,"Corpus and Uterus, NOS",2017
55-59,4.5,7.1,81,Incidence,1418292,Non-Hispanic Black,5.7,Female,Esophagus,2017
55-59,274.7,292.3,4019,Incidence,1418292,Non-Hispanic Black,283.4,Female,Female Breast,2017
55-59,69.0,78.0,1041,Incidence,1418292,Non-Hispanic Black,73.4,Female,"Female Breast, <i>in situ</i>",2017
55-59,1.8,3.5,36,Incidence,1418292,Non-Hispanic Black,2.5,Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,1418292,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
55-59,25.5,31.1,400,Incidence,1418292,Non-Hispanic Black,28.2,Female,Kidney and Renal Pelvis,2017
55-59,3.1,5.3,58,Incidence,1418292,Non-Hispanic Black,4.1,Female,Larynx,2017
55-59,11.8,15.7,193,Incidence,1418292,Non-Hispanic Black,13.6,Female,Leukemias,2017
55-59,11.5,15.4,189,Incidence,1418292,Non-Hispanic Black,13.3,Female,Liver and Intrahepatic Bile Duct,2017
55-59,98.7,109.4,1474,Incidence,1418292,Non-Hispanic Black,103.9,Female,Lung and Bronchus,2017
55-59,0.9,2.3,21,Incidence,1418292,Non-Hispanic Black,1.5,Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,1418292,Non-Hispanic Black,~,Female,Mesothelioma,2017
55-59,19.4,24.3,308,Incidence,1418292,Non-Hispanic Black,21.7,Female,Myeloma,2017
55-59,18.8,23.7,300,Incidence,1418292,Non-Hispanic Black,21.2,Female,Non-Hodgkin Lymphoma,2017
55-59,11.6,15.5,191,Incidence,1418292,Non-Hispanic Black,13.5,Female,Oral Cavity and Pharynx,2017
55-59,15.3,19.7,247,Incidence,1418292,Non-Hispanic Black,17.4,Female,Ovary,2017
55-59,24.0,29.4,377,Incidence,1418292,Non-Hispanic Black,26.6,Female,Pancreas,2017
55-59,10.5,14.2,174,Incidence,1418292,Non-Hispanic Black,12.3,Female,Stomach,2017
55-59,22.0,27.3,348,Incidence,1418292,Non-Hispanic Black,24.5,Female,Thyroid,2017
55-59,7.1,10.2,121,Incidence,1418292,Non-Hispanic Black,8.5,Female,Urinary Bladder,2017
60-64,1078.0,1115.0,13554,Incidence,1236296,Non-Hispanic Black,1096.3,Female,All Cancer Sites Combined,2017
60-64,4.8,7.6,75,Incidence,1236296,Non-Hispanic Black,6.1,Female,Brain and Other Nervous System,2017
60-64,14.9,19.6,212,Incidence,1236296,Non-Hispanic Black,17.1,Female,Cervix,2017
60-64,86.0,96.7,1128,Incidence,1236296,Non-Hispanic Black,91.2,Female,Colon and Rectum,2017
60-64,114.6,127.0,1492,Incidence,1236296,Non-Hispanic Black,120.7,Female,"Corpus and Uterus, NOS",2017
60-64,6.6,9.8,100,Incidence,1236296,Non-Hispanic Black,8.1,Female,Esophagus,2017
60-64,327.6,348.2,4176,Incidence,1236296,Non-Hispanic Black,337.8,Female,Female Breast,2017
60-64,89.0,99.9,1166,Incidence,1236296,Non-Hispanic Black,94.3,Female,"Female Breast, <i>in situ</i>",2017
60-64,1.8,3.7,33,Incidence,1236296,Non-Hispanic Black,2.7,Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,1236296,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
60-64,36.0,43.1,487,Incidence,1236296,Non-Hispanic Black,39.4,Female,Kidney and Renal Pelvis,2017
60-64,4.3,7.1,69,Incidence,1236296,Non-Hispanic Black,5.6,Female,Larynx,2017
60-64,16.4,21.3,232,Incidence,1236296,Non-Hispanic Black,18.8,Female,Leukemias,2017
60-64,21.4,26.9,297,Incidence,1236296,Non-Hispanic Black,24.0,Female,Liver and Intrahepatic Bile Duct,2017
60-64,138.9,152.4,1799,Incidence,1236296,Non-Hispanic Black,145.5,Female,Lung and Bronchus,2017
60-64,1.2,2.8,23,Incidence,1236296,Non-Hispanic Black,1.9,Female,Melanomas of the Skin,2017
60-64,~,~,~,Incidence,1236296,Non-Hispanic Black,~,Female,Mesothelioma,2017
60-64,30.7,37.3,419,Incidence,1236296,Non-Hispanic Black,33.9,Female,Myeloma,2017
60-64,26.0,32.1,358,Incidence,1236296,Non-Hispanic Black,29.0,Female,Non-Hodgkin Lymphoma,2017
60-64,12.8,17.2,184,Incidence,1236296,Non-Hispanic Black,14.9,Female,Oral Cavity and Pharynx,2017
60-64,18.6,23.7,260,Incidence,1236296,Non-Hispanic Black,21.0,Female,Ovary,2017
60-64,38.3,45.6,517,Incidence,1236296,Non-Hispanic Black,41.8,Female,Pancreas,2017
60-64,11.6,15.8,168,Incidence,1236296,Non-Hispanic Black,13.6,Female,Stomach,2017
60-64,21.6,27.2,300,Incidence,1236296,Non-Hispanic Black,24.3,Female,Thyroid,2017
60-64,12.2,16.5,176,Incidence,1236296,Non-Hispanic Black,14.2,Female,Urinary Bladder,2017
65-69,1399.2,1446.7,13886,Incidence,975957,Non-Hispanic Black,1422.8,Female,All Cancer Sites Combined,2017
65-69,5.6,9.1,70,Incidence,975957,Non-Hispanic Black,7.2,Female,Brain and Other Nervous System,2017
65-69,16.1,21.7,183,Incidence,975957,Non-Hispanic Black,18.8,Female,Cervix,2017
65-69,119.6,133.8,1235,Incidence,975957,Non-Hispanic Black,126.5,Female,Colon and Rectum,2017
65-69,132.3,147.3,1363,Incidence,975957,Non-Hispanic Black,139.7,Female,"Corpus and Uterus, NOS",2017
65-69,5.4,8.8,68,Incidence,975957,Non-Hispanic Black,7.0,Female,Esophagus,2017
65-69,414.0,440.0,4166,Incidence,975957,Non-Hispanic Black,426.9,Female,Female Breast,2017
65-69,117.4,131.5,1213,Incidence,975957,Non-Hispanic Black,124.3,Female,"Female Breast, <i>in situ</i>",2017
65-69,2.5,5.0,35,Incidence,975957,Non-Hispanic Black,3.6,Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,975957,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
65-69,50.5,59.9,537,Incidence,975957,Non-Hispanic Black,55.0,Female,Kidney and Renal Pelvis,2017
65-69,5.1,8.5,65,Incidence,975957,Non-Hispanic Black,6.7,Female,Larynx,2017
65-69,22.2,28.6,246,Incidence,975957,Non-Hispanic Black,25.2,Female,Leukemias,2017
65-69,25.8,32.7,284,Incidence,975957,Non-Hispanic Black,29.1,Female,Liver and Intrahepatic Bile Duct,2017
65-69,189.6,207.4,1936,Incidence,975957,Non-Hispanic Black,198.4,Female,Lung and Bronchus,2017
65-69,2.1,4.4,30,Incidence,975957,Non-Hispanic Black,3.1,Female,Melanomas of the Skin,2017
65-69,~,~,~,Incidence,975957,Non-Hispanic Black,~,Female,Mesothelioma,2017
65-69,41.0,49.5,440,Incidence,975957,Non-Hispanic Black,45.1,Female,Myeloma,2017
65-69,29.8,37.1,325,Incidence,975957,Non-Hispanic Black,33.3,Female,Non-Hodgkin Lymphoma,2017
65-69,12.6,17.6,146,Incidence,975957,Non-Hispanic Black,15.0,Female,Oral Cavity and Pharynx,2017
65-69,26.2,33.1,288,Incidence,975957,Non-Hispanic Black,29.5,Female,Ovary,2017
65-69,52.1,61.7,554,Incidence,975957,Non-Hispanic Black,56.8,Female,Pancreas,2017
65-69,21.9,28.2,243,Incidence,975957,Non-Hispanic Black,24.9,Female,Stomach,2017
65-69,22.8,29.3,253,Incidence,975957,Non-Hispanic Black,25.9,Female,Thyroid,2017
65-69,20.9,27.1,233,Incidence,975957,Non-Hispanic Black,23.9,Female,Urinary Bladder,2017
70-74,1530.2,1590.3,10408,Incidence,667176,Non-Hispanic Black,1560.0,Female,All Cancer Sites Combined,2017
70-74,6.1,10.6,54,Incidence,667176,Non-Hispanic Black,8.1,Female,Brain and Other Nervous System,2017
70-74,14.9,21.5,120,Incidence,667176,Non-Hispanic Black,18.0,Female,Cervix,2017
70-74,134.2,152.5,955,Incidence,667176,Non-Hispanic Black,143.1,Female,Colon and Rectum,2017
70-74,129.4,147.4,922,Incidence,667176,Non-Hispanic Black,138.2,Female,"Corpus and Uterus, NOS",2017
70-74,6.3,10.9,56,Incidence,667176,Non-Hispanic Black,8.4,Female,Esophagus,2017
70-74,417.8,449.6,2892,Incidence,667176,Non-Hispanic Black,433.5,Female,Female Breast,2017
70-74,113.0,129.9,809,Incidence,667176,Non-Hispanic Black,121.3,Female,"Female Breast, <i>in situ</i>",2017
70-74,1.6,4.3,18,Incidence,667176,Non-Hispanic Black,2.7,Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,667176,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
70-74,51.2,62.8,379,Incidence,667176,Non-Hispanic Black,56.8,Female,Kidney and Renal Pelvis,2017
70-74,4.7,8.7,43,Incidence,667176,Non-Hispanic Black,6.4,Female,Larynx,2017
70-74,26.9,35.6,207,Incidence,667176,Non-Hispanic Black,31.0,Female,Leukemias,2017
70-74,18.9,26.2,149,Incidence,667176,Non-Hispanic Black,22.3,Female,Liver and Intrahepatic Bile Duct,2017
70-74,240.5,264.8,1684,Incidence,667176,Non-Hispanic Black,252.4,Female,Lung and Bronchus,2017
70-74,1.5,4.1,17,Incidence,667176,Non-Hispanic Black,2.5,Female,Melanomas of the Skin,2017
70-74,~,~,~,Incidence,667176,Non-Hispanic Black,~,Female,Mesothelioma,2017
70-74,57.2,69.4,421,Incidence,667176,Non-Hispanic Black,63.1,Female,Myeloma,2017
70-74,36.8,46.7,277,Incidence,667176,Non-Hispanic Black,41.5,Female,Non-Hodgkin Lymphoma,2017
70-74,12.2,18.2,100,Incidence,667176,Non-Hispanic Black,15.0,Female,Oral Cavity and Pharynx,2017
70-74,23.5,31.5,182,Incidence,667176,Non-Hispanic Black,27.3,Female,Ovary,2017
70-74,60.8,73.4,446,Incidence,667176,Non-Hispanic Black,66.8,Female,Pancreas,2017
70-74,28.9,37.8,221,Incidence,667176,Non-Hispanic Black,33.1,Female,Stomach,2017
70-74,21.9,29.8,171,Incidence,667176,Non-Hispanic Black,25.6,Female,Thyroid,2017
70-74,27.6,36.4,212,Incidence,667176,Non-Hispanic Black,31.8,Female,Urinary Bladder,2017
75-79,1706.5,1782.7,8098,Incidence,464262,Non-Hispanic Black,1744.3,Female,All Cancer Sites Combined,2017
75-79,6.9,12.7,44,Incidence,464262,Non-Hispanic Black,9.5,Female,Brain and Other Nervous System,2017
75-79,13.9,21.7,81,Incidence,464262,Non-Hispanic Black,17.4,Female,Cervix,2017
75-79,150.2,173.5,750,Incidence,464262,Non-Hispanic Black,161.5,Female,Colon and Rectum,2017
75-79,99.5,118.7,505,Incidence,464262,Non-Hispanic Black,108.8,Female,"Corpus and Uterus, NOS",2017
75-79,8.4,14.7,52,Incidence,464262,Non-Hispanic Black,11.2,Female,Esophagus,2017
75-79,422.2,460.7,2048,Incidence,464262,Non-Hispanic Black,441.1,Female,Female Breast,2017
75-79,96.0,114.9,488,Incidence,464262,Non-Hispanic Black,105.1,Female,"Female Breast, <i>in situ</i>",2017
75-79,~,~,~,Incidence,464262,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,464262,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
75-79,51.6,65.8,271,Incidence,464262,Non-Hispanic Black,58.4,Female,Kidney and Renal Pelvis,2017
75-79,4.0,8.7,28,Incidence,464262,Non-Hispanic Black,6.0,Female,Larynx,2017
75-79,36.3,48.3,195,Incidence,464262,Non-Hispanic Black,42.0,Female,Leukemias,2017
75-79,19.5,28.6,110,Incidence,464262,Non-Hispanic Black,23.7,Female,Liver and Intrahepatic Bile Duct,2017
75-79,288.3,320.2,1411,Incidence,464262,Non-Hispanic Black,303.9,Female,Lung and Bronchus,2017
75-79,3.3,7.7,24,Incidence,464262,Non-Hispanic Black,5.2,Female,Melanomas of the Skin,2017
75-79,~,~,~,Incidence,464262,Non-Hispanic Black,~,Female,Mesothelioma,2017
75-79,64.6,80.3,335,Incidence,464262,Non-Hispanic Black,72.2,Female,Myeloma,2017
75-79,51.4,65.5,270,Incidence,464262,Non-Hispanic Black,58.2,Female,Non-Hodgkin Lymphoma,2017
75-79,13.1,20.7,77,Incidence,464262,Non-Hispanic Black,16.6,Female,Oral Cavity and Pharynx,2017
75-79,30.9,42.1,168,Incidence,464262,Non-Hispanic Black,36.2,Female,Ovary,2017
75-79,82.6,100.2,423,Incidence,464262,Non-Hispanic Black,91.1,Female,Pancreas,2017
75-79,32.9,44.4,178,Incidence,464262,Non-Hispanic Black,38.3,Female,Stomach,2017
75-79,15.2,23.4,88,Incidence,464262,Non-Hispanic Black,19.0,Female,Thyroid,2017
75-79,40.7,53.4,217,Incidence,464262,Non-Hispanic Black,46.7,Female,Urinary Bladder,2017
80-84,1702.8,1794.1,5664,Incidence,324031,Non-Hispanic Black,1748.0,Female,All Cancer Sites Combined,2017
80-84,7.8,15.4,36,Incidence,324031,Non-Hispanic Black,11.1,Female,Brain and Other Nervous System,2017
80-84,14.4,24.2,61,Incidence,324031,Non-Hispanic Black,18.8,Female,Cervix,2017
80-84,170.3,200.3,599,Incidence,324031,Non-Hispanic Black,184.9,Female,Colon and Rectum,2017
80-84,80.7,101.7,294,Incidence,324031,Non-Hispanic Black,90.7,Female,"Corpus and Uterus, NOS",2017
80-84,6.2,13.2,30,Incidence,324031,Non-Hispanic Black,9.3,Female,Esophagus,2017
80-84,380.0,423.9,1301,Incidence,324031,Non-Hispanic Black,401.5,Female,Female Breast,2017
80-84,50.0,66.9,188,Incidence,324031,Non-Hispanic Black,58.0,Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,324031,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,324031,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
80-84,44.0,60.0,167,Incidence,324031,Non-Hispanic Black,51.5,Female,Kidney and Renal Pelvis,2017
80-84,3.1,8.4,17,Incidence,324031,Non-Hispanic Black,5.2,Female,Larynx,2017
80-84,40.9,56.3,156,Incidence,324031,Non-Hispanic Black,48.1,Female,Leukemias,2017
80-84,18.8,29.7,77,Incidence,324031,Non-Hispanic Black,23.8,Female,Liver and Intrahepatic Bile Duct,2017
80-84,249.8,285.7,866,Incidence,324031,Non-Hispanic Black,267.3,Female,Lung and Bronchus,2017
80-84,4.5,10.7,23,Incidence,324031,Non-Hispanic Black,7.1,Female,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,324031,Non-Hispanic Black,~,Female,Mesothelioma,2017
80-84,66.4,85.7,245,Incidence,324031,Non-Hispanic Black,75.6,Female,Myeloma,2017
80-84,49.7,66.6,187,Incidence,324031,Non-Hispanic Black,57.7,Female,Non-Hodgkin Lymphoma,2017
80-84,14.7,24.5,62,Incidence,324031,Non-Hispanic Black,19.1,Female,Oral Cavity and Pharynx,2017
80-84,31.3,45.0,122,Incidence,324031,Non-Hispanic Black,37.7,Female,Ovary,2017
80-84,99.3,122.5,358,Incidence,324031,Non-Hispanic Black,110.5,Female,Pancreas,2017
80-84,41.7,57.3,159,Incidence,324031,Non-Hispanic Black,49.1,Female,Stomach,2017
80-84,12.0,21.0,52,Incidence,324031,Non-Hispanic Black,16.0,Female,Thyroid,2017
80-84,41.5,57.0,158,Incidence,324031,Non-Hispanic Black,48.8,Female,Urinary Bladder,2017
85+,1553.9,1639.0,5442,Incidence,340973,Non-Hispanic Black,1596.0,Female,All Cancer Sites Combined,2017
85+,6.4,13.2,32,Incidence,340973,Non-Hispanic Black,9.4,Female,Brain and Other Nervous System,2017
85+,11.1,19.7,51,Incidence,340973,Non-Hispanic Black,15.0,Female,Cervix,2017
85+,181.3,211.3,668,Incidence,340973,Non-Hispanic Black,195.9,Female,Colon and Rectum,2017
85+,50.8,67.4,200,Incidence,340973,Non-Hispanic Black,58.7,Female,"Corpus and Uterus, NOS",2017
85+,6.9,13.9,34,Incidence,340973,Non-Hispanic Black,10.0,Female,Esophagus,2017
85+,316.9,356.1,1146,Incidence,340973,Non-Hispanic Black,336.1,Female,Female Breast,2017
85+,27.3,39.8,113,Incidence,340973,Non-Hispanic Black,33.1,Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,340973,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,340973,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
85+,38.0,52.6,153,Incidence,340973,Non-Hispanic Black,44.9,Female,Kidney and Renal Pelvis,2017
85+,~,~,~,Incidence,340973,Non-Hispanic Black,~,Female,Larynx,2017
85+,39.1,53.8,157,Incidence,340973,Non-Hispanic Black,46.0,Female,Leukemias,2017
85+,18.6,29.2,80,Incidence,340973,Non-Hispanic Black,23.5,Female,Liver and Intrahepatic Bile Duct,2017
85+,223.5,256.6,817,Incidence,340973,Non-Hispanic Black,239.6,Female,Lung and Bronchus,2017
85+,4.0,9.8,22,Incidence,340973,Non-Hispanic Black,6.5,Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,340973,Non-Hispanic Black,~,Female,Mesothelioma,2017
85+,51.4,68.0,202,Incidence,340973,Non-Hispanic Black,59.2,Female,Myeloma,2017
85+,33.7,47.5,137,Incidence,340973,Non-Hispanic Black,40.2,Female,Non-Hodgkin Lymphoma,2017
85+,12.2,21.0,55,Incidence,340973,Non-Hispanic Black,16.1,Female,Oral Cavity and Pharynx,2017
85+,21.8,33.1,92,Incidence,340973,Non-Hispanic Black,27.0,Female,Ovary,2017
85+,98.0,120.5,371,Incidence,340973,Non-Hispanic Black,108.8,Female,Pancreas,2017
85+,41.0,56.0,164,Incidence,340973,Non-Hispanic Black,48.1,Female,Stomach,2017
85+,6.4,13.2,32,Incidence,340973,Non-Hispanic Black,9.4,Female,Thyroid,2017
85+,58.5,76.1,228,Incidence,340973,Non-Hispanic Black,66.9,Female,Urinary Bladder,2017
<1,12.2,21.9,49,Incidence,296258,Non-Hispanic Black,16.5,Female,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Cervix,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Colon and Rectum,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Esophagus,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Female Breast,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Larynx,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Leukemias,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Mesothelioma,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Myeloma,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Ovary,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Pancreas,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Stomach,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Thyroid,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Female,Urinary Bladder,2017
1-4,16.3,21.1,231,Incidence,1243848,Non-Hispanic Black,18.6,Male,All Cancer Sites Combined,2017
1-4,2.6,4.8,45,Incidence,1243848,Non-Hispanic Black,3.6,Male,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Colon and Rectum,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Esophagus,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
1-4,1.6,3.3,29,Incidence,1243848,Non-Hispanic Black,2.3,Male,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Larynx,2017
1-4,4.0,6.6,64,Incidence,1243848,Non-Hispanic Black,5.1,Male,Leukemias,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
1-4,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Mesothelioma,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Myeloma,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Pancreas,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Prostate,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Stomach,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Testis,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Thyroid,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male,Urinary Bladder,2017
10-14,11.3,14.9,204,Incidence,1567070,Non-Hispanic Black,13.0,Male,All Cancer Sites Combined,2017
10-14,2.1,3.9,46,Incidence,1567070,Non-Hispanic Black,2.9,Male,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Colon and Rectum,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Esophagus,2017
10-14,0.9,2.1,22,Incidence,1567070,Non-Hispanic Black,1.4,Male,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Larynx,2017
10-14,2.1,3.9,46,Incidence,1567070,Non-Hispanic Black,2.9,Male,Leukemias,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
10-14,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Mesothelioma,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Myeloma,2017
10-14,1.0,2.3,24,Incidence,1567070,Non-Hispanic Black,1.5,Male,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Pancreas,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Prostate,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Stomach,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Testis,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Thyroid,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male,Urinary Bladder,2017
15-19,15.0,19.1,275,Incidence,1621518,Non-Hispanic Black,17.0,Male,All Cancer Sites Combined,2017
15-19,1.2,2.6,29,Incidence,1621518,Non-Hispanic Black,1.8,Male,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Colon and Rectum,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Esophagus,2017
15-19,1.9,3.6,43,Incidence,1621518,Non-Hispanic Black,2.7,Male,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Larynx,2017
15-19,1.7,3.3,39,Incidence,1621518,Non-Hispanic Black,2.4,Male,Leukemias,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
15-19,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Mesothelioma,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Myeloma,2017
15-19,2.1,3.8,46,Incidence,1621518,Non-Hispanic Black,2.8,Male,Non-Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Pancreas,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Prostate,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Stomach,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Testis,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Thyroid,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male,Urinary Bladder,2017
20-24,18.7,23.1,360,Incidence,1727835,Non-Hispanic Black,20.8,Male,All Cancer Sites Combined,2017
20-24,0.8,2.0,23,Incidence,1727835,Non-Hispanic Black,1.3,Male,Brain and Other Nervous System,2017
20-24,0.8,1.9,22,Incidence,1727835,Non-Hispanic Black,1.3,Male,Colon and Rectum,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Esophagus,2017
20-24,2.1,3.7,49,Incidence,1727835,Non-Hispanic Black,2.8,Male,Hodgkin Lymphoma,2017
20-24,0.9,2.1,24,Incidence,1727835,Non-Hispanic Black,1.4,Male,Kaposi Sarcoma,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Larynx,2017
20-24,1.7,3.2,41,Incidence,1727835,Non-Hispanic Black,2.4,Male,Leukemias,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
20-24,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Mesothelioma,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Myeloma,2017
20-24,2.5,4.3,57,Incidence,1727835,Non-Hispanic Black,3.3,Male,Non-Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Pancreas,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Prostate,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Stomach,2017
20-24,1.4,2.7,34,Incidence,1727835,Non-Hispanic Black,2.0,Male,Testis,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Thyroid,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male,Urinary Bladder,2017
25-29,31.8,37.3,608,Incidence,1764298,Non-Hispanic Black,34.5,Male,All Cancer Sites Combined,2017
25-29,1.1,2.4,29,Incidence,1764298,Non-Hispanic Black,1.6,Male,Brain and Other Nervous System,2017
25-29,1.8,3.3,44,Incidence,1764298,Non-Hispanic Black,2.5,Male,Colon and Rectum,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Esophagus,2017
25-29,3.1,5.1,71,Incidence,1764298,Non-Hispanic Black,4.0,Male,Hodgkin Lymphoma,2017
25-29,2.9,4.8,66,Incidence,1764298,Non-Hispanic Black,3.7,Male,Kaposi Sarcoma,2017
25-29,1.0,2.2,26,Incidence,1764298,Non-Hispanic Black,1.5,Male,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Larynx,2017
25-29,1.9,3.4,45,Incidence,1764298,Non-Hispanic Black,2.6,Male,Leukemias,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
25-29,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Mesothelioma,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Myeloma,2017
25-29,3.5,5.5,78,Incidence,1764298,Non-Hispanic Black,4.4,Male,Non-Hodgkin Lymphoma,2017
25-29,0.5,1.5,16,Incidence,1764298,Non-Hispanic Black,0.9,Male,Oral Cavity and Pharynx,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Pancreas,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Prostate,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Stomach,2017
25-29,2.4,4.1,56,Incidence,1764298,Non-Hispanic Black,3.2,Male,Testis,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Thyroid,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male,Urinary Bladder,2017
30-34,54.6,62.6,837,Incidence,1430300,Non-Hispanic Black,58.5,Male,All Cancer Sites Combined,2017
30-34,2.2,4.0,43,Incidence,1430300,Non-Hispanic Black,3.0,Male,Brain and Other Nervous System,2017
30-34,5.2,8.0,93,Incidence,1430300,Non-Hispanic Black,6.5,Male,Colon and Rectum,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Esophagus,2017
30-34,2.7,4.7,51,Incidence,1430300,Non-Hispanic Black,3.6,Male,Hodgkin Lymphoma,2017
30-34,2.8,4.9,54,Incidence,1430300,Non-Hispanic Black,3.8,Male,Kaposi Sarcoma,2017
30-34,2.0,3.8,40,Incidence,1430300,Non-Hispanic Black,2.8,Male,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Larynx,2017
30-34,3.2,5.4,60,Incidence,1430300,Non-Hispanic Black,4.2,Male,Leukemias,2017
30-34,1.1,2.5,24,Incidence,1430300,Non-Hispanic Black,1.7,Male,Liver and Intrahepatic Bile Duct,2017
30-34,1.1,2.6,25,Incidence,1430300,Non-Hispanic Black,1.7,Male,Lung and Bronchus,2017
30-34,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Mesothelioma,2017
30-34,0.8,2.1,19,Incidence,1430300,Non-Hispanic Black,1.3,Male,Myeloma,2017
30-34,6.6,9.7,115,Incidence,1430300,Non-Hispanic Black,8.0,Male,Non-Hodgkin Lymphoma,2017
30-34,0.8,2.1,19,Incidence,1430300,Non-Hispanic Black,1.3,Male,Oral Cavity and Pharynx,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Pancreas,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Prostate,2017
30-34,0.9,2.2,20,Incidence,1430300,Non-Hispanic Black,1.4,Male,Stomach,2017
30-34,3.0,5.2,57,Incidence,1430300,Non-Hispanic Black,4.0,Male,Testis,2017
30-34,1.4,2.9,29,Incidence,1430300,Non-Hispanic Black,2.0,Male,Thyroid,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male,Urinary Bladder,2017
35-39,82.1,92.2,1161,Incidence,1334355,Non-Hispanic Black,87.0,Male,All Cancer Sites Combined,2017
35-39,2.0,3.9,38,Incidence,1334355,Non-Hispanic Black,2.8,Male,Brain and Other Nervous System,2017
35-39,10.9,14.8,170,Incidence,1334355,Non-Hispanic Black,12.7,Male,Colon and Rectum,2017
35-39,~,~,~,Incidence,1334355,Non-Hispanic Black,~,Male,Esophagus,2017
35-39,3.0,5.2,53,Incidence,1334355,Non-Hispanic Black,4.0,Male,Hodgkin Lymphoma,2017
35-39,1.2,2.8,25,Incidence,1334355,Non-Hispanic Black,1.9,Male,Kaposi Sarcoma,2017
35-39,7.0,10.2,113,Incidence,1334355,Non-Hispanic Black,8.5,Male,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,1334355,Non-Hispanic Black,~,Male,Larynx,2017
35-39,4.2,6.7,71,Incidence,1334355,Non-Hispanic Black,5.3,Male,Leukemias,2017
35-39,1.2,2.8,25,Incidence,1334355,Non-Hispanic Black,1.9,Male,Liver and Intrahepatic Bile Duct,2017
35-39,3.4,5.8,60,Incidence,1334355,Non-Hispanic Black,4.5,Male,Lung and Bronchus,2017
35-39,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
35-39,~,~,~,Incidence,1334355,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,1334355,Non-Hispanic Black,~,Male,Mesothelioma,2017
35-39,2.0,3.8,37,Incidence,1334355,Non-Hispanic Black,2.8,Male,Myeloma,2017
35-39,7.5,10.8,120,Incidence,1334355,Non-Hispanic Black,9.0,Male,Non-Hodgkin Lymphoma,2017
35-39,3.5,5.9,61,Incidence,1334355,Non-Hispanic Black,4.6,Male,Oral Cavity and Pharynx,2017
35-39,1.2,2.7,24,Incidence,1334355,Non-Hispanic Black,1.8,Male,Pancreas,2017
35-39,0.7,1.9,16,Incidence,1334355,Non-Hispanic Black,1.2,Male,Prostate,2017
35-39,1.5,3.2,30,Incidence,1334355,Non-Hispanic Black,2.2,Male,Stomach,2017
35-39,3.1,5.4,55,Incidence,1334355,Non-Hispanic Black,4.1,Male,Testis,2017
35-39,1.6,3.3,31,Incidence,1334355,Non-Hispanic Black,2.3,Male,Thyroid,2017
35-39,0.7,2.0,17,Incidence,1334355,Non-Hispanic Black,1.3,Male,Urinary Bladder,2017
40-44,150.9,165.2,1888,Incidence,1195509,Non-Hispanic Black,157.9,Male,All Cancer Sites Combined,2017
40-44,2.5,4.7,42,Incidence,1195509,Non-Hispanic Black,3.5,Male,Brain and Other Nervous System,2017
40-44,20.4,25.9,275,Incidence,1195509,Non-Hispanic Black,23.0,Male,Colon and Rectum,2017
40-44,~,~,~,Incidence,1195509,Non-Hispanic Black,~,Male,Esophagus,2017
40-44,3.2,5.6,51,Incidence,1195509,Non-Hispanic Black,4.3,Male,Hodgkin Lymphoma,2017
40-44,1.5,3.3,27,Incidence,1195509,Non-Hispanic Black,2.3,Male,Kaposi Sarcoma,2017
40-44,15.2,20.0,209,Incidence,1195509,Non-Hispanic Black,17.5,Male,Kidney and Renal Pelvis,2017
40-44,~,~,~,Incidence,1195509,Non-Hispanic Black,~,Male,Larynx,2017
40-44,5.6,8.7,84,Incidence,1195509,Non-Hispanic Black,7.0,Male,Leukemias,2017
40-44,2.0,4.1,35,Incidence,1195509,Non-Hispanic Black,2.9,Male,Liver and Intrahepatic Bile Duct,2017
40-44,9.8,13.7,139,Incidence,1195509,Non-Hispanic Black,11.6,Male,Lung and Bronchus,2017
40-44,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
40-44,~,~,~,Incidence,1195509,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,1195509,Non-Hispanic Black,~,Male,Mesothelioma,2017
40-44,5.1,8.0,77,Incidence,1195509,Non-Hispanic Black,6.4,Male,Myeloma,2017
40-44,12.0,16.3,168,Incidence,1195509,Non-Hispanic Black,14.1,Male,Non-Hodgkin Lymphoma,2017
40-44,6.1,9.3,90,Incidence,1195509,Non-Hispanic Black,7.5,Male,Oral Cavity and Pharynx,2017
40-44,2.8,5.1,46,Incidence,1195509,Non-Hispanic Black,3.8,Male,Pancreas,2017
40-44,13.7,18.3,190,Incidence,1195509,Non-Hispanic Black,15.9,Male,Prostate,2017
40-44,3.7,6.3,58,Incidence,1195509,Non-Hispanic Black,4.9,Male,Stomach,2017
40-44,1.7,3.6,30,Incidence,1195509,Non-Hispanic Black,2.5,Male,Testis,2017
40-44,2.4,4.6,40,Incidence,1195509,Non-Hispanic Black,3.3,Male,Thyroid,2017
40-44,2.5,4.7,41,Incidence,1195509,Non-Hispanic Black,3.4,Male,Urinary Bladder,2017
45-49,293.3,312.7,3779,Incidence,1247535,Non-Hispanic Black,302.9,Male,All Cancer Sites Combined,2017
45-49,3.0,5.4,51,Incidence,1247535,Non-Hispanic Black,4.1,Male,Brain and Other Nervous System,2017
45-49,39.0,46.3,531,Incidence,1247535,Non-Hispanic Black,42.6,Male,Colon and Rectum,2017
45-49,2.6,4.7,44,Incidence,1247535,Non-Hispanic Black,3.5,Male,Esophagus,2017
45-49,3.8,6.4,62,Incidence,1247535,Non-Hispanic Black,5.0,Male,Hodgkin Lymphoma,2017
45-49,1.2,2.9,24,Incidence,1247535,Non-Hispanic Black,1.9,Male,Kaposi Sarcoma,2017
45-49,24.5,30.4,341,Incidence,1247535,Non-Hispanic Black,27.3,Male,Kidney and Renal Pelvis,2017
45-49,2.2,4.3,39,Incidence,1247535,Non-Hispanic Black,3.1,Male,Larynx,2017
45-49,8.3,11.9,124,Incidence,1247535,Non-Hispanic Black,9.9,Male,Leukemias,2017
45-49,4.2,6.8,67,Incidence,1247535,Non-Hispanic Black,5.4,Male,Liver and Intrahepatic Bile Duct,2017
45-49,15.2,20.0,218,Incidence,1247535,Non-Hispanic Black,17.5,Male,Lung and Bronchus,2017
45-49,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
45-49,~,~,~,Incidence,1247535,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,1247535,Non-Hispanic Black,~,Male,Mesothelioma,2017
45-49,10.0,13.9,148,Incidence,1247535,Non-Hispanic Black,11.9,Male,Myeloma,2017
45-49,15.6,20.4,223,Incidence,1247535,Non-Hispanic Black,17.9,Male,Non-Hodgkin Lymphoma,2017
45-49,12.9,17.3,187,Incidence,1247535,Non-Hispanic Black,15.0,Male,Oral Cavity and Pharynx,2017
45-49,8.3,11.9,125,Incidence,1247535,Non-Hispanic Black,10.0,Male,Pancreas,2017
45-49,70.9,80.7,944,Incidence,1247535,Non-Hispanic Black,75.7,Male,Prostate,2017
45-49,5.2,8.2,82,Incidence,1247535,Non-Hispanic Black,6.6,Male,Stomach,2017
45-49,0.8,2.2,17,Incidence,1247535,Non-Hispanic Black,1.4,Male,Testis,2017
45-49,4.4,7.2,71,Incidence,1247535,Non-Hispanic Black,5.7,Male,Thyroid,2017
45-49,5.4,8.3,84,Incidence,1247535,Non-Hispanic Black,6.7,Male,Urinary Bladder,2017
5-9,9.0,12.2,166,Incidence,1579103,Non-Hispanic Black,10.5,Male,All Cancer Sites Combined,2017
5-9,2.5,4.4,53,Incidence,1579103,Non-Hispanic Black,3.4,Male,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Colon and Rectum,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Esophagus,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
5-9,0.6,1.6,16,Incidence,1579103,Non-Hispanic Black,1.0,Male,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Larynx,2017
5-9,1.9,3.5,41,Incidence,1579103,Non-Hispanic Black,2.6,Male,Leukemias,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
5-9,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Mesothelioma,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Myeloma,2017
5-9,0.6,1.7,17,Incidence,1579103,Non-Hispanic Black,1.1,Male,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Pancreas,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Prostate,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Stomach,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Testis,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Thyroid,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male,Urinary Bladder,2017
50-54,633.1,661.3,8125,Incidence,1255571,Non-Hispanic Black,647.1,Male,All Cancer Sites Combined,2017
50-54,4.4,7.1,71,Incidence,1255571,Non-Hispanic Black,5.7,Male,Brain and Other Nervous System,2017
50-54,75.9,85.9,1014,Incidence,1255571,Non-Hispanic Black,80.8,Male,Colon and Rectum,2017
50-54,5.2,8.1,82,Incidence,1255571,Non-Hispanic Black,6.5,Male,Esophagus,2017
50-54,3.0,5.3,51,Incidence,1255571,Non-Hispanic Black,4.1,Male,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,1255571,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
50-54,37.2,44.3,510,Incidence,1255571,Non-Hispanic Black,40.6,Male,Kidney and Renal Pelvis,2017
50-54,8.9,12.6,134,Incidence,1255571,Non-Hispanic Black,10.7,Male,Larynx,2017
50-54,13.4,17.9,195,Incidence,1255571,Non-Hispanic Black,15.5,Male,Leukemias,2017
50-54,12.2,16.4,178,Incidence,1255571,Non-Hispanic Black,14.2,Male,Liver and Intrahepatic Bile Duct,2017
50-54,51.2,59.5,694,Incidence,1255571,Non-Hispanic Black,55.3,Male,Lung and Bronchus,2017
50-54,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
50-54,0.8,2.3,18,Incidence,1255571,Non-Hispanic Black,1.4,Male,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,1255571,Non-Hispanic Black,~,Male,Mesothelioma,2017
50-54,18.6,23.8,265,Incidence,1255571,Non-Hispanic Black,21.1,Male,Myeloma,2017
50-54,19.8,25.2,281,Incidence,1255571,Non-Hispanic Black,22.4,Male,Non-Hodgkin Lymphoma,2017
50-54,22.2,27.8,312,Incidence,1255571,Non-Hispanic Black,24.8,Male,Oral Cavity and Pharynx,2017
50-54,16.2,21.0,232,Incidence,1255571,Non-Hispanic Black,18.5,Male,Pancreas,2017
50-54,234.1,251.5,3047,Incidence,1255571,Non-Hispanic Black,242.7,Male,Prostate,2017
50-54,12.2,16.5,179,Incidence,1255571,Non-Hispanic Black,14.3,Male,Stomach,2017
50-54,1.2,2.8,24,Incidence,1255571,Non-Hispanic Black,1.9,Male,Testis,2017
50-54,5.2,8.1,82,Incidence,1255571,Non-Hispanic Black,6.5,Male,Thyroid,2017
50-54,9.7,13.6,145,Incidence,1255571,Non-Hispanic Black,11.5,Male,Urinary Bladder,2017
55-59,1133.1,1171.3,14072,Incidence,1221430,Non-Hispanic Black,1152.1,Male,All Cancer Sites Combined,2017
55-59,5.3,8.2,81,Incidence,1221430,Non-Hispanic Black,6.6,Male,Brain and Other Nervous System,2017
55-59,99.7,111.3,1287,Incidence,1221430,Non-Hispanic Black,105.4,Male,Colon and Rectum,2017
55-59,11.7,15.9,167,Incidence,1221430,Non-Hispanic Black,13.7,Male,Esophagus,2017
55-59,2.7,4.9,45,Incidence,1221430,Non-Hispanic Black,3.7,Male,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,1221430,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
55-59,53.7,62.3,707,Incidence,1221430,Non-Hispanic Black,57.9,Male,Kidney and Renal Pelvis,2017
55-59,18.5,23.8,257,Incidence,1221430,Non-Hispanic Black,21.0,Male,Larynx,2017
55-59,17.7,22.8,246,Incidence,1221430,Non-Hispanic Black,20.1,Male,Leukemias,2017
55-59,45.1,53.0,598,Incidence,1221430,Non-Hispanic Black,49.0,Male,Liver and Intrahepatic Bile Duct,2017
55-59,134.6,148.1,1725,Incidence,1221430,Non-Hispanic Black,141.2,Male,Lung and Bronchus,2017
55-59,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
55-59,0.9,2.4,19,Incidence,1221430,Non-Hispanic Black,1.6,Male,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,1221430,Non-Hispanic Black,~,Male,Mesothelioma,2017
55-59,28.1,34.4,380,Incidence,1221430,Non-Hispanic Black,31.1,Male,Myeloma,2017
55-59,27.5,33.8,373,Incidence,1221430,Non-Hispanic Black,30.5,Male,Non-Hodgkin Lymphoma,2017
55-59,35.6,42.7,477,Incidence,1221430,Non-Hispanic Black,39.1,Male,Oral Cavity and Pharynx,2017
55-59,30.3,36.9,409,Incidence,1221430,Non-Hispanic Black,33.5,Male,Pancreas,2017
55-59,464.4,489.0,5821,Incidence,1221430,Non-Hispanic Black,476.6,Male,Prostate,2017
55-59,19.5,24.8,269,Incidence,1221430,Non-Hispanic Black,22.0,Male,Stomach,2017
55-59,~,~,~,Incidence,1221430,Non-Hispanic Black,~,Male,Testis,2017
55-59,6.2,9.4,94,Incidence,1221430,Non-Hispanic Black,7.7,Male,Thyroid,2017
55-59,20.9,26.4,287,Incidence,1221430,Non-Hispanic Black,23.5,Male,Urinary Bladder,2017
60-64,1737.5,1789.3,17854,Incidence,1012548,Non-Hispanic Black,1763.3,Male,All Cancer Sites Combined,2017
60-64,6.4,10.1,82,Incidence,1012548,Non-Hispanic Black,8.1,Male,Brain and Other Nervous System,2017
60-64,130.5,145.1,1394,Incidence,1012548,Non-Hispanic Black,137.7,Male,Colon and Rectum,2017
60-64,17.2,22.8,201,Incidence,1012548,Non-Hispanic Black,19.9,Male,Esophagus,2017
60-64,2.7,5.2,38,Incidence,1012548,Non-Hispanic Black,3.8,Male,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,1012548,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
60-64,79.8,91.3,865,Incidence,1012548,Non-Hispanic Black,85.4,Male,Kidney and Renal Pelvis,2017
60-64,26.6,33.4,302,Incidence,1012548,Non-Hispanic Black,29.8,Male,Larynx,2017
60-64,25.4,32.1,290,Incidence,1012548,Non-Hispanic Black,28.6,Male,Leukemias,2017
60-64,88.7,100.8,958,Incidence,1012548,Non-Hispanic Black,94.6,Male,Liver and Intrahepatic Bile Duct,2017
60-64,220.2,238.9,2323,Incidence,1012548,Non-Hispanic Black,229.4,Male,Lung and Bronchus,2017
60-64,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
60-64,1.2,3.1,20,Incidence,1012548,Non-Hispanic Black,2.0,Male,Melanomas of the Skin,2017
60-64,0.9,2.6,16,Incidence,1012548,Non-Hispanic Black,1.6,Male,Mesothelioma,2017
60-64,37.3,45.3,417,Incidence,1012548,Non-Hispanic Black,41.2,Male,Myeloma,2017
60-64,38.4,46.5,428,Incidence,1012548,Non-Hispanic Black,42.3,Male,Non-Hodgkin Lymphoma,2017
60-64,41.0,49.4,456,Incidence,1012548,Non-Hispanic Black,45.0,Male,Oral Cavity and Pharynx,2017
60-64,47.0,56.0,520,Incidence,1012548,Non-Hispanic Black,51.4,Male,Pancreas,2017
60-64,750.0,784.2,7766,Incidence,1012548,Non-Hispanic Black,767.0,Male,Prostate,2017
60-64,27.7,34.6,314,Incidence,1012548,Non-Hispanic Black,31.0,Male,Stomach,2017
60-64,~,~,~,Incidence,1012548,Non-Hispanic Black,~,Male,Testis,2017
60-64,7.4,11.3,93,Incidence,1012548,Non-Hispanic Black,9.2,Male,Thyroid,2017
60-64,40.8,49.2,454,Incidence,1012548,Non-Hispanic Black,44.8,Male,Urinary Bladder,2017
65-69,2370.9,2441.2,18069,Incidence,751052,Non-Hispanic Black,2405.8,Male,All Cancer Sites Combined,2017
65-69,8.8,13.7,83,Incidence,751052,Non-Hispanic Black,11.1,Male,Brain and Other Nervous System,2017
65-69,173.1,192.6,1372,Incidence,751052,Non-Hispanic Black,182.7,Male,Colon and Rectum,2017
65-69,23.6,31.2,204,Incidence,751052,Non-Hispanic Black,27.2,Male,Esophagus,2017
65-69,2.5,5.4,28,Incidence,751052,Non-Hispanic Black,3.7,Male,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,751052,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
65-69,93.1,107.5,752,Incidence,751052,Non-Hispanic Black,100.1,Male,Kidney and Renal Pelvis,2017
65-69,28.9,37.3,247,Incidence,751052,Non-Hispanic Black,32.9,Male,Larynx,2017
65-69,34.3,43.3,290,Incidence,751052,Non-Hispanic Black,38.6,Male,Leukemias,2017
65-69,113.9,129.8,914,Incidence,751052,Non-Hispanic Black,121.7,Male,Liver and Intrahepatic Bile Duct,2017
65-69,323.7,350.1,2529,Incidence,751052,Non-Hispanic Black,336.7,Male,Lung and Bronchus,2017
65-69,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
65-69,1.6,4.1,20,Incidence,751052,Non-Hispanic Black,2.7,Male,Melanomas of the Skin,2017
65-69,1.2,3.5,16,Incidence,751052,Non-Hispanic Black,2.1,Male,Mesothelioma,2017
65-69,58.4,70.0,481,Incidence,751052,Non-Hispanic Black,64.0,Male,Myeloma,2017
65-69,47.0,57.5,391,Incidence,751052,Non-Hispanic Black,52.1,Male,Non-Hodgkin Lymphoma,2017
65-69,43.2,53.3,361,Incidence,751052,Non-Hispanic Black,48.1,Male,Oral Cavity and Pharynx,2017
65-69,66.3,78.6,543,Incidence,751052,Non-Hispanic Black,72.3,Male,Pancreas,2017
65-69,1020.0,1066.3,7833,Incidence,751052,Non-Hispanic Black,1042.9,Male,Prostate,2017
65-69,40.8,50.6,342,Incidence,751052,Non-Hispanic Black,45.5,Male,Stomach,2017
65-69,~,~,~,Incidence,751052,Non-Hispanic Black,~,Male,Testis,2017
65-69,9.5,14.6,89,Incidence,751052,Non-Hispanic Black,11.9,Male,Thyroid,2017
65-69,64.6,76.7,529,Incidence,751052,Non-Hispanic Black,70.4,Male,Urinary Bladder,2017
70-74,2559.7,2650.8,12606,Incidence,483929,Non-Hispanic Black,2604.9,Male,All Cancer Sites Combined,2017
70-74,12.2,19.4,75,Incidence,483929,Non-Hispanic Black,15.5,Male,Brain and Other Nervous System,2017
70-74,195.0,220.9,1005,Incidence,483929,Non-Hispanic Black,207.7,Male,Colon and Rectum,2017
70-74,24.5,34.4,141,Incidence,483929,Non-Hispanic Black,29.1,Male,Esophagus,2017
70-74,2.5,6.4,20,Incidence,483929,Non-Hispanic Black,4.1,Male,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,483929,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
70-74,104.5,123.8,551,Incidence,483929,Non-Hispanic Black,113.9,Male,Kidney and Renal Pelvis,2017
70-74,36.4,48.1,203,Incidence,483929,Non-Hispanic Black,41.9,Male,Larynx,2017
70-74,49.3,62.9,270,Incidence,483929,Non-Hispanic Black,55.8,Male,Leukemias,2017
70-74,67.7,83.4,364,Incidence,483929,Non-Hispanic Black,75.2,Male,Liver and Intrahepatic Bile Duct,2017
70-74,420.2,457.8,2123,Incidence,483929,Non-Hispanic Black,438.7,Male,Lung and Bronchus,2017
70-74,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
70-74,2.8,6.9,22,Incidence,483929,Non-Hispanic Black,4.5,Male,Melanomas of the Skin,2017
70-74,2.7,6.6,21,Incidence,483929,Non-Hispanic Black,4.3,Male,Mesothelioma,2017
70-74,79.3,96.1,423,Incidence,483929,Non-Hispanic Black,87.4,Male,Myeloma,2017
70-74,54.4,68.5,296,Incidence,483929,Non-Hispanic Black,61.2,Male,Non-Hodgkin Lymphoma,2017
70-74,50.3,64.0,275,Incidence,483929,Non-Hispanic Black,56.8,Male,Oral Cavity and Pharynx,2017
70-74,79.3,96.1,423,Incidence,483929,Non-Hispanic Black,87.4,Male,Pancreas,2017
70-74,935.3,990.8,4659,Incidence,483929,Non-Hispanic Black,962.7,Male,Prostate,2017
70-74,55.0,69.2,299,Incidence,483929,Non-Hispanic Black,61.8,Male,Stomach,2017
70-74,~,~,~,Incidence,483929,Non-Hispanic Black,~,Male,Testis,2017
70-74,8.4,14.6,54,Incidence,483929,Non-Hispanic Black,11.2,Male,Thyroid,2017
70-74,93.3,111.5,494,Incidence,483929,Non-Hispanic Black,102.1,Male,Urinary Bladder,2017
75-79,2602.5,2718.4,8149,Incidence,306356,Non-Hispanic Black,2660.0,Male,All Cancer Sites Combined,2017
75-79,10.4,19.3,44,Incidence,306356,Non-Hispanic Black,14.4,Male,Brain and Other Nervous System,2017
75-79,243.0,279.5,799,Incidence,306356,Non-Hispanic Black,260.8,Male,Colon and Rectum,2017
75-79,24.5,37.2,93,Incidence,306356,Non-Hispanic Black,30.4,Male,Esophagus,2017
75-79,~,~,~,Incidence,306356,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,306356,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
75-79,109.7,134.8,373,Incidence,306356,Non-Hispanic Black,121.8,Male,Kidney and Renal Pelvis,2017
75-79,28.9,42.6,108,Incidence,306356,Non-Hispanic Black,35.3,Male,Larynx,2017
75-79,51.4,69.0,183,Incidence,306356,Non-Hispanic Black,59.7,Male,Leukemias,2017
75-79,49.9,67.3,178,Incidence,306356,Non-Hispanic Black,58.1,Male,Liver and Intrahepatic Bile Duct,2017
75-79,469.0,519.1,1512,Incidence,306356,Non-Hispanic Black,493.5,Male,Lung and Bronchus,2017
75-79,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
75-79,3.2,8.9,17,Incidence,306356,Non-Hispanic Black,5.5,Male,Melanomas of the Skin,2017
75-79,3.2,8.9,17,Incidence,306356,Non-Hispanic Black,5.5,Male,Mesothelioma,2017
75-79,89.6,112.4,308,Incidence,306356,Non-Hispanic Black,100.5,Male,Myeloma,2017
75-79,62.3,81.6,219,Incidence,306356,Non-Hispanic Black,71.5,Male,Non-Hodgkin Lymphoma,2017
75-79,44.4,61.0,160,Incidence,306356,Non-Hispanic Black,52.2,Male,Oral Cavity and Pharynx,2017
75-79,98.0,121.7,335,Incidence,306356,Non-Hispanic Black,109.3,Male,Pancreas,2017
75-79,756.5,819.7,2413,Incidence,306356,Non-Hispanic Black,787.6,Male,Prostate,2017
75-79,78.9,100.3,273,Incidence,306356,Non-Hispanic Black,89.1,Male,Stomach,2017
75-79,~,~,~,Incidence,306356,Non-Hispanic Black,~,Male,Testis,2017
75-79,9.9,18.5,42,Incidence,306356,Non-Hispanic Black,13.7,Male,Thyroid,2017
75-79,126.2,152.9,426,Incidence,306356,Non-Hispanic Black,139.1,Male,Urinary Bladder,2017
80-84,2454.3,2598.8,4732,Incidence,187347,Non-Hispanic Black,2525.8,Male,All Cancer Sites Combined,2017
80-84,9.9,21.6,28,Incidence,187347,Non-Hispanic Black,14.9,Male,Brain and Other Nervous System,2017
80-84,246.0,293.6,504,Incidence,187347,Non-Hispanic Black,269.0,Male,Colon and Rectum,2017
80-84,21.2,37.0,53,Incidence,187347,Non-Hispanic Black,28.3,Male,Esophagus,2017
80-84,~,~,~,Incidence,187347,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,187347,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
80-84,72.7,99.7,160,Incidence,187347,Non-Hispanic Black,85.4,Male,Kidney and Renal Pelvis,2017
80-84,31.0,49.6,74,Incidence,187347,Non-Hispanic Black,39.5,Male,Larynx,2017
80-84,70.7,97.4,156,Incidence,187347,Non-Hispanic Black,83.3,Male,Leukemias,2017
80-84,35.3,54.9,83,Incidence,187347,Non-Hispanic Black,44.3,Male,Liver and Intrahepatic Bile Duct,2017
80-84,450.5,513.9,902,Incidence,187347,Non-Hispanic Black,481.5,Male,Lung and Bronchus,2017
80-84,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
80-84,~,~,~,Incidence,187347,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
80-84,~,~,~,Incidence,187347,Non-Hispanic Black,~,Male,Mesothelioma,2017
80-84,102.9,134.6,221,Incidence,187347,Non-Hispanic Black,118.0,Male,Myeloma,2017
80-84,68.3,94.5,151,Incidence,187347,Non-Hispanic Black,80.6,Male,Non-Hodgkin Lymphoma,2017
80-84,40.5,61.4,94,Incidence,187347,Non-Hispanic Black,50.2,Male,Oral Cavity and Pharynx,2017
80-84,113.9,147.1,243,Incidence,187347,Non-Hispanic Black,129.7,Male,Pancreas,2017
80-84,545.2,614.7,1085,Incidence,187347,Non-Hispanic Black,579.1,Male,Prostate,2017
80-84,75.1,102.6,165,Incidence,187347,Non-Hispanic Black,88.1,Male,Stomach,2017
80-84,~,~,~,Incidence,187347,Non-Hispanic Black,~,Male,Testis,2017
80-84,5.7,15.2,18,Incidence,187347,Non-Hispanic Black,9.6,Male,Thyroid,2017
80-84,151.1,188.9,317,Incidence,187347,Non-Hispanic Black,169.2,Male,Urinary Bladder,2017
85+,2217.1,2373.2,3347,Incidence,145894,Non-Hispanic Black,2294.1,Male,All Cancer Sites Combined,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male,Brain and Other Nervous System,2017
85+,202.4,252.0,330,Incidence,145894,Non-Hispanic Black,226.2,Male,Colon and Rectum,2017
85+,19.0,36.5,39,Incidence,145894,Non-Hispanic Black,26.7,Male,Esophagus,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
85+,55.2,82.6,99,Incidence,145894,Non-Hispanic Black,67.9,Male,Kidney and Renal Pelvis,2017
85+,16.1,32.6,34,Incidence,145894,Non-Hispanic Black,23.3,Male,Larynx,2017
85+,76.3,108.0,133,Incidence,145894,Non-Hispanic Black,91.2,Male,Leukemias,2017
85+,35.6,58.3,67,Incidence,145894,Non-Hispanic Black,45.9,Male,Liver and Intrahepatic Bile Duct,2017
85+,384.3,451.2,608,Incidence,145894,Non-Hispanic Black,416.7,Male,Lung and Bronchus,2017
85+,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
85+,6.3,17.8,16,Incidence,145894,Non-Hispanic Black,11.0,Male,Melanomas of the Skin,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male,Mesothelioma,2017
85+,85.8,119.2,148,Incidence,145894,Non-Hispanic Black,101.4,Male,Myeloma,2017
85+,55.8,83.4,100,Incidence,145894,Non-Hispanic Black,68.5,Male,Non-Hodgkin Lymphoma,2017
85+,26.0,46.0,51,Incidence,145894,Non-Hispanic Black,35.0,Male,Oral Cavity and Pharynx,2017
85+,72.6,103.6,127,Incidence,145894,Non-Hispanic Black,87.0,Male,Pancreas,2017
85+,448.9,521.0,706,Incidence,145894,Non-Hispanic Black,483.9,Male,Prostate,2017
85+,87.0,120.6,150,Incidence,145894,Non-Hispanic Black,102.8,Male,Stomach,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male,Testis,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male,Thyroid,2017
85+,173.3,219.4,285,Incidence,145894,Non-Hispanic Black,195.3,Male,Urinary Bladder,2017
<1,12.1,21.5,50,Incidence,306592,Non-Hispanic Black,16.3,Male,All Cancer Sites Combined,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Colon and Rectum,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Esophagus,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Larynx,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Leukemias,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Lung and Bronchus,2017
<1,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Melanomas of the Skin,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Mesothelioma,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Myeloma,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Pancreas,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Prostate,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Stomach,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Testis,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Thyroid,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male,Urinary Bladder,2017
1-4,15.5,18.8,419,Incidence,2450204,Non-Hispanic Black,17.1,Male and Female,All Cancer Sites Combined,2017
1-4,2.7,4.2,83,Incidence,2450204,Non-Hispanic Black,3.4,Male and Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,Cervix,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Esophagus,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,Female Breast,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
1-4,1.7,2.9,55,Incidence,2450204,Non-Hispanic Black,2.2,Male and Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Larynx,2017
1-4,4.1,5.9,121,Incidence,2450204,Non-Hispanic Black,4.9,Male and Female,Leukemias,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Myeloma,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,1206356,Non-Hispanic Black,~,Male and Female,Ovary,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Pancreas,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male and Female,Prostate,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Stomach,2017
1-4,~,~,~,Incidence,1243848,Non-Hispanic Black,~,Male and Female,Testis,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Thyroid,2017
1-4,~,~,~,Incidence,2450204,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
10-14,10.8,13.3,371,Incidence,3087450,Non-Hispanic Black,12.0,Male and Female,All Cancer Sites Combined,2017
10-14,1.8,2.9,72,Incidence,3087450,Non-Hispanic Black,2.3,Male and Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Male and Female,Cervix,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Esophagus,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Male and Female,Female Breast,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
10-14,1.1,2.0,45,Incidence,3087450,Non-Hispanic Black,1.5,Male and Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Larynx,2017
10-14,1.8,2.9,71,Incidence,3087450,Non-Hispanic Black,2.3,Male and Female,Leukemias,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2017
10-14,~,~,~,Incidence,1520380,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Myeloma,2017
10-14,0.8,1.6,35,Incidence,3087450,Non-Hispanic Black,1.1,Male and Female,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2017
10-14,0.7,1.8,17,Incidence,1520380,Non-Hispanic Black,1.1,Male and Female,Ovary,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Pancreas,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male and Female,Prostate,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Stomach,2017
10-14,~,~,~,Incidence,1567070,Non-Hispanic Black,~,Male and Female,Testis,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Thyroid,2017
10-14,~,~,~,Incidence,3087450,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
15-19,16.2,19.1,563,Incidence,3193330,Non-Hispanic Black,17.6,Male and Female,All Cancer Sites Combined,2017
15-19,1.5,2.5,63,Incidence,3193330,Non-Hispanic Black,2.0,Male and Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Male and Female,Cervix,2017
15-19,0.3,0.9,18,Incidence,3193330,Non-Hispanic Black,0.6,Male and Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Esophagus,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Male and Female,Female Breast,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
15-19,2.0,3.2,82,Incidence,3193330,Non-Hispanic Black,2.6,Male and Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Larynx,2017
15-19,1.9,3.0,77,Incidence,3193330,Non-Hispanic Black,2.4,Male and Female,Leukemias,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2017
15-19,~,~,~,Incidence,1571812,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Myeloma,2017
15-19,1.6,2.6,66,Incidence,3193330,Non-Hispanic Black,2.1,Male and Female,Non-Hodgkin Lymphoma,2017
15-19,0.4,1.0,22,Incidence,3193330,Non-Hispanic Black,0.7,Male and Female,Oral Cavity and Pharynx,2017
15-19,1.0,2.3,25,Incidence,1571812,Non-Hispanic Black,1.6,Male and Female,Ovary,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Pancreas,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male and Female,Prostate,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Stomach,2017
15-19,~,~,~,Incidence,1621518,Non-Hispanic Black,~,Male and Female,Testis,2017
15-19,0.5,1.1,23,Incidence,3193330,Non-Hispanic Black,0.7,Male and Female,Thyroid,2017
15-19,~,~,~,Incidence,3193330,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
20-24,23.0,26.4,839,Incidence,3403379,Non-Hispanic Black,24.7,Male and Female,All Cancer Sites Combined,2017
20-24,1.1,2.0,52,Incidence,3403379,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Male and Female,Cervix,2017
20-24,0.9,1.7,43,Incidence,3403379,Non-Hispanic Black,1.3,Male and Female,Colon and Rectum,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Esophagus,2017
20-24,2.2,3.9,50,Incidence,1675544,Non-Hispanic Black,3.0,Male and Female,Female Breast,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
20-24,2.7,4.0,113,Incidence,3403379,Non-Hispanic Black,3.3,Male and Female,Hodgkin Lymphoma,2017
20-24,0.5,1.1,25,Incidence,3403379,Non-Hispanic Black,0.7,Male and Female,Kaposi Sarcoma,2017
20-24,0.7,1.4,34,Incidence,3403379,Non-Hispanic Black,1.0,Male and Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Larynx,2017
20-24,1.8,2.8,76,Incidence,3403379,Non-Hispanic Black,2.2,Male and Female,Leukemias,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
20-24,2.2,3.9,50,Incidence,1675544,Non-Hispanic Black,3.0,Male and Female,Male and Female Breast,2017
20-24,~,~,~,Incidence,1675544,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Myeloma,2017
20-24,2.2,3.3,93,Incidence,3403379,Non-Hispanic Black,2.7,Male and Female,Non-Hodgkin Lymphoma,2017
20-24,0.4,1.0,23,Incidence,3403379,Non-Hispanic Black,0.7,Male and Female,Oral Cavity and Pharynx,2017
20-24,1.0,2.3,26,Incidence,1675544,Non-Hispanic Black,1.6,Male and Female,Ovary,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Pancreas,2017
20-24,~,~,~,Incidence,1727835,Non-Hispanic Black,~,Male and Female,Prostate,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Stomach,2017
20-24,1.4,2.7,34,Incidence,1727835,Non-Hispanic Black,2.0,Male and Female,Testis,2017
20-24,1.6,2.5,68,Incidence,3403379,Non-Hispanic Black,2.0,Male and Female,Thyroid,2017
20-24,~,~,~,Incidence,3403379,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
25-29,41.7,46.1,1550,Incidence,3535095,Non-Hispanic Black,43.8,Male and Female,All Cancer Sites Combined,2017
25-29,1.3,2.2,61,Incidence,3535095,Non-Hispanic Black,1.7,Male and Female,Brain and Other Nervous System,2017
25-29,3.3,5.3,75,Incidence,1770797,Non-Hispanic Black,4.2,Male and Female,Cervix,2017
25-29,2.1,3.3,94,Incidence,3535095,Non-Hispanic Black,2.7,Male and Female,Colon and Rectum,2017
25-29,0.9,2.1,25,Incidence,1770797,Non-Hispanic Black,1.4,Male and Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Esophagus,2017
25-29,10.9,14.2,221,Incidence,1770797,Non-Hispanic Black,12.5,Male and Female,Female Breast,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
25-29,3.3,4.6,137,Incidence,3535095,Non-Hispanic Black,3.9,Male and Female,Hodgkin Lymphoma,2017
25-29,1.5,2.4,68,Incidence,3535095,Non-Hispanic Black,1.9,Male and Female,Kaposi Sarcoma,2017
25-29,1.0,1.8,47,Incidence,3535095,Non-Hispanic Black,1.3,Male and Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Larynx,2017
25-29,2.1,3.3,94,Incidence,3535095,Non-Hispanic Black,2.7,Male and Female,Leukemias,2017
25-29,0.3,0.8,18,Incidence,3535095,Non-Hispanic Black,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
25-29,10.9,14.2,221,Incidence,1770797,Non-Hispanic Black,12.5,Male and Female,Male and Female Breast,2017
25-29,~,~,~,Incidence,1770797,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Myeloma,2017
25-29,3.1,4.4,131,Incidence,3535095,Non-Hispanic Black,3.7,Male and Female,Non-Hodgkin Lymphoma,2017
25-29,0.6,1.3,33,Incidence,3535095,Non-Hispanic Black,0.9,Male and Female,Oral Cavity and Pharynx,2017
25-29,1.9,3.5,46,Incidence,1770797,Non-Hispanic Black,2.6,Male and Female,Ovary,2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Pancreas,2017
25-29,~,~,~,Incidence,1764298,Non-Hispanic Black,~,Male and Female,Prostate,2017
25-29,0.5,1.1,28,Incidence,3535095,Non-Hispanic Black,0.8,Male and Female,Stomach,2017
25-29,2.4,4.1,56,Incidence,1764298,Non-Hispanic Black,3.2,Male and Female,Testis,2017
25-29,3.2,4.5,133,Incidence,3535095,Non-Hispanic Black,3.8,Male and Female,Thyroid,2017
25-29,~,~,~,Incidence,3535095,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
30-34,79.0,85.5,2424,Incidence,2949274,Non-Hispanic Black,82.2,Male and Female,All Cancer Sites Combined,2017
30-34,1.9,3.1,72,Incidence,2949274,Non-Hispanic Black,2.4,Male and Female,Brain and Other Nervous System,2017
30-34,8.2,11.4,148,Incidence,1518974,Non-Hispanic Black,9.7,Male and Female,Cervix,2017
30-34,5.6,7.5,191,Incidence,2949274,Non-Hispanic Black,6.5,Male and Female,Colon and Rectum,2017
30-34,4.1,6.5,79,Incidence,1518974,Non-Hispanic Black,5.2,Male and Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,2949274,Non-Hispanic Black,~,Male and Female,Esophagus,2017
30-34,32.6,38.7,540,Incidence,1518974,Non-Hispanic Black,35.6,Male and Female,Female Breast,2017
30-34,1.9,3.7,41,Incidence,1518974,Non-Hispanic Black,2.7,Male and Female,"Female Breast, <i>in situ</i>",2017
30-34,2.6,3.9,94,Incidence,2949274,Non-Hispanic Black,3.2,Male and Female,Hodgkin Lymphoma,2017
30-34,1.6,2.7,61,Incidence,2949274,Non-Hispanic Black,2.1,Male and Female,Kaposi Sarcoma,2017
30-34,2.1,3.3,78,Incidence,2949274,Non-Hispanic Black,2.6,Male and Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,2949274,Non-Hispanic Black,~,Male and Female,Larynx,2017
30-34,2.7,4.1,99,Incidence,2949274,Non-Hispanic Black,3.4,Male and Female,Leukemias,2017
30-34,0.7,1.5,31,Incidence,2949274,Non-Hispanic Black,1.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
30-34,1.3,2.3,52,Incidence,2949274,Non-Hispanic Black,1.8,Male and Female,Lung and Bronchus,2017
30-34,32.6,38.7,540,Incidence,1518974,Non-Hispanic Black,35.6,Male and Female,Male and Female Breast,2017
30-34,1.9,3.7,41,Incidence,1518974,Non-Hispanic Black,2.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
30-34,~,~,~,Incidence,2949274,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,2949274,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
30-34,0.8,1.6,34,Incidence,2949274,Non-Hispanic Black,1.2,Male and Female,Myeloma,2017
30-34,5.4,7.2,185,Incidence,2949274,Non-Hispanic Black,6.3,Male and Female,Non-Hodgkin Lymphoma,2017
30-34,1.1,2.0,45,Incidence,2949274,Non-Hispanic Black,1.5,Male and Female,Oral Cavity and Pharynx,2017
30-34,1.7,3.3,36,Incidence,1518974,Non-Hispanic Black,2.4,Male and Female,Ovary,2017
30-34,0.8,1.6,34,Incidence,2949274,Non-Hispanic Black,1.2,Male and Female,Pancreas,2017
30-34,~,~,~,Incidence,1430300,Non-Hispanic Black,~,Male and Female,Prostate,2017
30-34,0.8,1.6,34,Incidence,2949274,Non-Hispanic Black,1.2,Male and Female,Stomach,2017
30-34,3.0,5.2,57,Incidence,1430300,Non-Hispanic Black,4.0,Male and Female,Testis,2017
30-34,5.6,7.4,190,Incidence,2949274,Non-Hispanic Black,6.4,Male and Female,Thyroid,2017
30-34,~,~,~,Incidence,2949274,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
35-39,132.0,140.7,3825,Incidence,2806543,Non-Hispanic Black,136.3,Male and Female,All Cancer Sites Combined,2017
35-39,2.0,3.2,72,Incidence,2806543,Non-Hispanic Black,2.6,Male and Female,Brain and Other Nervous System,2017
35-39,10.6,14.3,182,Incidence,1472188,Non-Hispanic Black,12.4,Male and Female,Cervix,2017
35-39,11.1,13.8,348,Incidence,2806543,Non-Hispanic Black,12.4,Male and Female,Colon and Rectum,2017
35-39,7.9,11.1,139,Incidence,1472188,Non-Hispanic Black,9.4,Male and Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,2806543,Non-Hispanic Black,~,Male and Female,Esophagus,2017
35-39,68.9,77.7,1078,Incidence,1472188,Non-Hispanic Black,73.2,Male and Female,Female Breast,2017
35-39,7.3,10.3,128,Incidence,1472188,Non-Hispanic Black,8.7,Male and Female,"Female Breast, <i>in situ</i>",2017
35-39,2.7,4.1,94,Incidence,2806543,Non-Hispanic Black,3.3,Male and Female,Hodgkin Lymphoma,2017
35-39,0.8,1.6,31,Incidence,2806543,Non-Hispanic Black,1.1,Male and Female,Kaposi Sarcoma,2017
35-39,5.4,7.3,177,Incidence,2806543,Non-Hispanic Black,6.3,Male and Female,Kidney and Renal Pelvis,2017
35-39,~,~,~,Incidence,2806543,Non-Hispanic Black,~,Male and Female,Larynx,2017
35-39,3.4,5.0,117,Incidence,2806543,Non-Hispanic Black,4.2,Male and Female,Leukemias,2017
35-39,0.9,1.7,35,Incidence,2806543,Non-Hispanic Black,1.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
35-39,2.9,4.3,99,Incidence,2806543,Non-Hispanic Black,3.5,Male and Female,Lung and Bronchus,2017
35-39,68.9,77.7,1078,Incidence,1472188,Non-Hispanic Black,73.2,Male and Female,Male and Female Breast,2017
35-39,7.3,10.3,128,Incidence,1472188,Non-Hispanic Black,8.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
35-39,~,~,~,Incidence,2806543,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,2806543,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
35-39,2.0,3.2,71,Incidence,2806543,Non-Hispanic Black,2.5,Male and Female,Myeloma,2017
35-39,7.1,9.3,229,Incidence,2806543,Non-Hispanic Black,8.2,Male and Female,Non-Hodgkin Lymphoma,2017
35-39,3.0,4.5,104,Incidence,2806543,Non-Hispanic Black,3.7,Male and Female,Oral Cavity and Pharynx,2017
35-39,3.9,6.3,74,Incidence,1472188,Non-Hispanic Black,5.0,Male and Female,Ovary,2017
35-39,1.4,2.4,52,Incidence,2806543,Non-Hispanic Black,1.9,Male and Female,Pancreas,2017
35-39,0.7,1.9,16,Incidence,1334355,Non-Hispanic Black,1.2,Male and Female,Prostate,2017
35-39,1.9,3.2,70,Incidence,2806543,Non-Hispanic Black,2.5,Male and Female,Stomach,2017
35-39,3.1,5.4,55,Incidence,1334355,Non-Hispanic Black,4.1,Male and Female,Testis,2017
35-39,8.9,11.3,282,Incidence,2806543,Non-Hispanic Black,10.0,Male and Female,Thyroid,2017
35-39,0.7,1.4,28,Incidence,2806543,Non-Hispanic Black,1.0,Male and Female,Urinary Bladder,2017
40-44,219.7,231.4,5736,Incidence,2543672,Non-Hispanic Black,225.5,Male and Female,All Cancer Sites Combined,2017
40-44,2.4,3.7,76,Incidence,2543672,Non-Hispanic Black,3.0,Male and Female,Brain and Other Nervous System,2017
40-44,12.7,16.9,198,Incidence,1348163,Non-Hispanic Black,14.7,Male and Female,Cervix,2017
40-44,19.7,23.3,545,Incidence,2543672,Non-Hispanic Black,21.4,Male and Female,Colon and Rectum,2017
40-44,11.7,15.8,184,Incidence,1348163,Non-Hispanic Black,13.6,Male and Female,"Corpus and Uterus, NOS",2017
40-44,0.5,1.3,21,Incidence,2543672,Non-Hispanic Black,0.8,Male and Female,Esophagus,2017
40-44,123.7,136.0,1749,Incidence,1348163,Non-Hispanic Black,129.7,Male and Female,Female Breast,2017
40-44,27.5,33.4,409,Incidence,1348163,Non-Hispanic Black,30.3,Male and Female,"Female Breast, <i>in situ</i>",2017
40-44,2.8,4.3,90,Incidence,2543672,Non-Hispanic Black,3.5,Male and Female,Hodgkin Lymphoma,2017
40-44,0.8,1.6,29,Incidence,2543672,Non-Hispanic Black,1.1,Male and Female,Kaposi Sarcoma,2017
40-44,11.4,14.2,325,Incidence,2543672,Non-Hispanic Black,12.8,Male and Female,Kidney and Renal Pelvis,2017
40-44,0.4,1.1,17,Incidence,2543672,Non-Hispanic Black,0.7,Male and Female,Larynx,2017
40-44,5.9,8.0,175,Incidence,2543672,Non-Hispanic Black,6.9,Male and Female,Leukemias,2017
40-44,1.6,2.8,54,Incidence,2543672,Non-Hispanic Black,2.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
40-44,7.3,9.6,213,Incidence,2543672,Non-Hispanic Black,8.4,Male and Female,Lung and Bronchus,2017
40-44,123.7,136.0,1749,Incidence,1348163,Non-Hispanic Black,129.7,Male and Female,Male and Female Breast,2017
40-44,27.5,33.4,409,Incidence,1348163,Non-Hispanic Black,30.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
40-44,~,~,~,Incidence,2543672,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,2543672,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
40-44,5.3,7.3,159,Incidence,2543672,Non-Hispanic Black,6.3,Male and Female,Myeloma,2017
40-44,10.7,13.5,306,Incidence,2543672,Non-Hispanic Black,12.0,Male and Female,Non-Hodgkin Lymphoma,2017
40-44,4.2,6.0,128,Incidence,2543672,Non-Hispanic Black,5.0,Male and Female,Oral Cavity and Pharynx,2017
40-44,5.3,8.1,89,Incidence,1348163,Non-Hispanic Black,6.6,Male and Female,Ovary,2017
40-44,3.2,4.8,101,Incidence,2543672,Non-Hispanic Black,4.0,Male and Female,Pancreas,2017
40-44,13.7,18.3,190,Incidence,1195509,Non-Hispanic Black,15.9,Male and Female,Prostate,2017
40-44,3.9,5.7,121,Incidence,2543672,Non-Hispanic Black,4.8,Male and Female,Stomach,2017
40-44,1.7,3.6,30,Incidence,1195509,Non-Hispanic Black,2.5,Male and Female,Testis,2017
40-44,10.5,13.2,301,Incidence,2543672,Non-Hispanic Black,11.8,Male and Female,Thyroid,2017
40-44,1.7,2.9,56,Incidence,2543672,Non-Hispanic Black,2.2,Male and Female,Urinary Bladder,2017
45-49,352.9,367.4,9569,Incidence,2657444,Non-Hispanic Black,360.1,Male and Female,All Cancer Sites Combined,2017
45-49,3.1,4.7,102,Incidence,2657444,Non-Hispanic Black,3.8,Male and Female,Brain and Other Nervous System,2017
45-49,10.9,14.7,179,Incidence,1409909,Non-Hispanic Black,12.7,Male and Female,Cervix,2017
45-49,36.6,41.4,1035,Incidence,2657444,Non-Hispanic Black,38.9,Male and Female,Colon and Rectum,2017
45-49,17.3,22.0,275,Incidence,1409909,Non-Hispanic Black,19.5,Male and Female,"Corpus and Uterus, NOS",2017
45-49,1.7,2.9,60,Incidence,2657444,Non-Hispanic Black,2.3,Male and Female,Esophagus,2017
45-49,178.2,192.5,2612,Incidence,1409909,Non-Hispanic Black,185.3,Male and Female,Female Breast,2017
45-49,44.9,52.2,683,Incidence,1409909,Non-Hispanic Black,48.4,Male and Female,"Female Breast, <i>in situ</i>",2017
45-49,3.0,4.5,97,Incidence,2657444,Non-Hispanic Black,3.7,Male and Female,Hodgkin Lymphoma,2017
45-49,0.6,1.4,26,Incidence,2657444,Non-Hispanic Black,1.0,Male and Female,Kaposi Sarcoma,2017
45-49,18.9,22.4,547,Incidence,2657444,Non-Hispanic Black,20.6,Male and Female,Kidney and Renal Pelvis,2017
45-49,1.7,2.9,60,Incidence,2657444,Non-Hispanic Black,2.3,Male and Female,Larynx,2017
45-49,7.4,9.6,225,Incidence,2657444,Non-Hispanic Black,8.5,Male and Female,Leukemias,2017
45-49,3.0,4.5,98,Incidence,2657444,Non-Hispanic Black,3.7,Male and Female,Liver and Intrahepatic Bile Duct,2017
45-49,15.5,18.7,452,Incidence,2657444,Non-Hispanic Black,17.0,Male and Female,Lung and Bronchus,2017
45-49,178.2,192.5,2612,Incidence,1409909,Non-Hispanic Black,185.3,Male and Female,Male and Female Breast,2017
45-49,44.9,52.2,683,Incidence,1409909,Non-Hispanic Black,48.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
45-49,0.5,1.3,23,Incidence,2657444,Non-Hispanic Black,0.9,Male and Female,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,2657444,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
45-49,9.9,12.5,297,Incidence,2657444,Non-Hispanic Black,11.2,Male and Female,Myeloma,2017
45-49,14.1,17.2,414,Incidence,2657444,Non-Hispanic Black,15.6,Male and Female,Non-Hodgkin Lymphoma,2017
45-49,8.5,10.9,257,Incidence,2657444,Non-Hispanic Black,9.7,Male and Female,Oral Cavity and Pharynx,2017
45-49,6.5,9.6,112,Incidence,1409909,Non-Hispanic Black,7.9,Male and Female,Ovary,2017
45-49,8.5,10.8,255,Incidence,2657444,Non-Hispanic Black,9.6,Male and Female,Pancreas,2017
45-49,70.9,80.7,944,Incidence,1247535,Non-Hispanic Black,75.7,Male and Female,Prostate,2017
45-49,5.5,7.5,171,Incidence,2657444,Non-Hispanic Black,6.4,Male and Female,Stomach,2017
45-49,0.8,2.2,17,Incidence,1247535,Non-Hispanic Black,1.4,Male and Female,Testis,2017
45-49,12.5,15.3,368,Incidence,2657444,Non-Hispanic Black,13.8,Male and Female,Thyroid,2017
45-49,3.6,5.2,116,Incidence,2657444,Non-Hispanic Black,4.4,Male and Female,Urinary Bladder,2017
5-9,10.4,12.8,359,Incidence,3108422,Non-Hispanic Black,11.5,Male and Female,All Cancer Sites Combined,2017
5-9,3.2,4.6,119,Incidence,3108422,Non-Hispanic Black,3.8,Male and Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,Cervix,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Esophagus,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,Female Breast,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
5-9,0.9,1.7,38,Incidence,3108422,Non-Hispanic Black,1.2,Male and Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Larynx,2017
5-9,2.0,3.1,78,Incidence,3108422,Non-Hispanic Black,2.5,Male and Female,Leukemias,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Myeloma,2017
5-9,0.8,1.5,34,Incidence,3108422,Non-Hispanic Black,1.1,Male and Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,1529319,Non-Hispanic Black,~,Male and Female,Ovary,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Pancreas,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male and Female,Prostate,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Stomach,2017
5-9,~,~,~,Incidence,1579103,Non-Hispanic Black,~,Male and Female,Testis,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Thyroid,2017
5-9,~,~,~,Incidence,3108422,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
50-54,609.0,627.8,16598,Incidence,2684248,Non-Hispanic Black,618.3,Male and Female,All Cancer Sites Combined,2017
50-54,3.4,5.0,112,Incidence,2684248,Non-Hispanic Black,4.2,Male and Female,Brain and Other Nervous System,2017
50-54,13.0,17.1,214,Incidence,1428677,Non-Hispanic Black,15.0,Male and Female,Cervix,2017
50-54,70.1,76.6,1968,Incidence,2684248,Non-Hispanic Black,73.3,Male and Female,Colon and Rectum,2017
50-54,29.7,35.7,466,Incidence,1428677,Non-Hispanic Black,32.6,Male and Female,"Corpus and Uterus, NOS",2017
50-54,3.7,5.4,121,Incidence,2684248,Non-Hispanic Black,4.5,Male and Female,Esophagus,2017
50-54,229.7,245.8,3395,Incidence,1428677,Non-Hispanic Black,237.6,Male and Female,Female Breast,2017
50-54,59.6,68.0,910,Incidence,1428677,Non-Hispanic Black,63.7,Male and Female,"Female Breast, <i>in situ</i>",2017
50-54,2.5,3.8,83,Incidence,2684248,Non-Hispanic Black,3.1,Male and Female,Hodgkin Lymphoma,2017
50-54,0.4,1.1,18,Incidence,2684248,Non-Hispanic Black,0.7,Male and Female,Kaposi Sarcoma,2017
50-54,27.3,31.4,786,Incidence,2684248,Non-Hispanic Black,29.3,Male and Female,Kidney and Renal Pelvis,2017
50-54,5.4,7.3,169,Incidence,2684248,Non-Hispanic Black,6.3,Male and Female,Larynx,2017
50-54,11.8,14.6,352,Incidence,2684248,Non-Hispanic Black,13.1,Male and Female,Leukemias,2017
50-54,8.5,10.9,258,Incidence,2684248,Non-Hispanic Black,9.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
50-54,46.2,51.5,1309,Incidence,2684248,Non-Hispanic Black,48.8,Male and Female,Lung and Bronchus,2017
50-54,229.7,245.8,3395,Incidence,1428677,Non-Hispanic Black,237.6,Male and Female,Male and Female Breast,2017
50-54,59.6,68.0,910,Incidence,1428677,Non-Hispanic Black,63.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
50-54,0.9,1.8,34,Incidence,2684248,Non-Hispanic Black,1.3,Male and Female,Melanomas of the Skin,2017
50-54,~,~,~,Incidence,2684248,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
50-54,16.4,19.6,481,Incidence,2684248,Non-Hispanic Black,17.9,Male and Female,Myeloma,2017
50-54,18.0,21.3,526,Incidence,2684248,Non-Hispanic Black,19.6,Male and Female,Non-Hodgkin Lymphoma,2017
50-54,14.9,18.0,441,Incidence,2684248,Non-Hispanic Black,16.4,Male and Female,Oral Cavity and Pharynx,2017
50-54,11.4,15.3,189,Incidence,1428677,Non-Hispanic Black,13.2,Male and Female,Ovary,2017
50-54,14.0,17.0,415,Incidence,2684248,Non-Hispanic Black,15.5,Male and Female,Pancreas,2017
50-54,234.1,251.5,3047,Incidence,1255571,Non-Hispanic Black,242.7,Male and Female,Prostate,2017
50-54,9.7,12.2,292,Incidence,2684248,Non-Hispanic Black,10.9,Male and Female,Stomach,2017
50-54,1.2,2.8,24,Incidence,1255571,Non-Hispanic Black,1.9,Male and Female,Testis,2017
50-54,13.7,16.6,405,Incidence,2684248,Non-Hispanic Black,15.1,Male and Female,Thyroid,2017
50-54,6.8,9.0,210,Incidence,2684248,Non-Hispanic Black,7.8,Male and Female,Urinary Bladder,2017
55-59,969.0,993.0,25894,Incidence,2639722,Non-Hispanic Black,980.9,Male and Female,All Cancer Sites Combined,2017
55-59,5.2,7.2,162,Incidence,2639722,Non-Hispanic Black,6.1,Male and Female,Brain and Other Nervous System,2017
55-59,13.1,17.3,214,Incidence,1418292,Non-Hispanic Black,15.1,Male and Female,Cervix,2017
55-59,85.4,92.7,2349,Incidence,2639722,Non-Hispanic Black,89.0,Male and Female,Colon and Rectum,2017
55-59,68.8,77.8,1038,Incidence,1418292,Non-Hispanic Black,73.2,Male and Female,"Corpus and Uterus, NOS",2017
55-59,8.3,10.6,248,Incidence,2639722,Non-Hispanic Black,9.4,Male and Female,Esophagus,2017
55-59,274.7,292.3,4019,Incidence,1418292,Non-Hispanic Black,283.4,Male and Female,Female Breast,2017
55-59,69.0,78.0,1041,Incidence,1418292,Non-Hispanic Black,73.4,Male and Female,"Female Breast, <i>in situ</i>",2017
55-59,2.4,3.8,81,Incidence,2639722,Non-Hispanic Black,3.1,Male and Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,2639722,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
55-59,39.5,44.5,1107,Incidence,2639722,Non-Hispanic Black,41.9,Male and Female,Kidney and Renal Pelvis,2017
55-59,10.7,13.3,315,Incidence,2639722,Non-Hispanic Black,11.9,Male and Female,Larynx,2017
55-59,15.1,18.3,439,Incidence,2639722,Non-Hispanic Black,16.6,Male and Female,Leukemias,2017
55-59,27.8,32.0,787,Incidence,2639722,Non-Hispanic Black,29.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
55-59,117.0,125.5,3199,Incidence,2639722,Non-Hispanic Black,121.2,Male and Female,Lung and Bronchus,2017
55-59,274.7,292.3,4019,Incidence,1418292,Non-Hispanic Black,283.4,Male and Female,Male and Female Breast,2017
55-59,69.0,78.0,1041,Incidence,1418292,Non-Hispanic Black,73.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
55-59,1.1,2.1,40,Incidence,2639722,Non-Hispanic Black,1.5,Male and Female,Melanomas of the Skin,2017
55-59,~,~,~,Incidence,2639722,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
55-59,24.2,28.1,688,Incidence,2639722,Non-Hispanic Black,26.1,Male and Female,Myeloma,2017
55-59,23.6,27.5,673,Incidence,2639722,Non-Hispanic Black,25.5,Male and Female,Non-Hodgkin Lymphoma,2017
55-59,23.4,27.3,668,Incidence,2639722,Non-Hispanic Black,25.3,Male and Female,Oral Cavity and Pharynx,2017
55-59,15.3,19.7,247,Incidence,1418292,Non-Hispanic Black,17.4,Male and Female,Ovary,2017
55-59,27.7,31.9,786,Incidence,2639722,Non-Hispanic Black,29.8,Male and Female,Pancreas,2017
55-59,464.4,489.0,5821,Incidence,1221430,Non-Hispanic Black,476.6,Male and Female,Prostate,2017
55-59,15.3,18.4,443,Incidence,2639722,Non-Hispanic Black,16.8,Male and Female,Stomach,2017
55-59,~,~,~,Incidence,1221430,Non-Hispanic Black,~,Male and Female,Testis,2017
55-59,15.2,18.4,442,Incidence,2639722,Non-Hispanic Black,16.7,Male and Female,Thyroid,2017
55-59,14.0,17.0,408,Incidence,2639722,Non-Hispanic Black,15.5,Male and Female,Urinary Bladder,2017
60-64,1381.2,1412.2,31408,Incidence,2248844,Non-Hispanic Black,1396.6,Male and Female,All Cancer Sites Combined,2017
60-64,5.9,8.2,157,Incidence,2248844,Non-Hispanic Black,7.0,Male and Female,Brain and Other Nervous System,2017
60-64,14.9,19.6,212,Incidence,1236296,Non-Hispanic Black,17.1,Male and Female,Cervix,2017
60-64,107.8,116.6,2522,Incidence,2248844,Non-Hispanic Black,112.1,Male and Female,Colon and Rectum,2017
60-64,114.6,127.0,1492,Incidence,1236296,Non-Hispanic Black,120.7,Male and Female,"Corpus and Uterus, NOS",2017
60-64,11.9,15.0,301,Incidence,2248844,Non-Hispanic Black,13.4,Male and Female,Esophagus,2017
60-64,327.6,348.2,4176,Incidence,1236296,Non-Hispanic Black,337.8,Male and Female,Female Breast,2017
60-64,89.0,99.9,1166,Incidence,1236296,Non-Hispanic Black,94.3,Male and Female,"Female Breast, <i>in situ</i>",2017
60-64,2.5,4.0,71,Incidence,2248844,Non-Hispanic Black,3.2,Male and Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,2248844,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
60-64,57.0,63.4,1352,Incidence,2248844,Non-Hispanic Black,60.1,Male and Female,Kidney and Renal Pelvis,2017
60-64,14.9,18.3,371,Incidence,2248844,Non-Hispanic Black,16.5,Male and Female,Larynx,2017
60-64,21.3,25.3,522,Incidence,2248844,Non-Hispanic Black,23.2,Male and Female,Leukemias,2017
60-64,52.8,59.0,1255,Incidence,2248844,Non-Hispanic Black,55.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
60-64,177.7,189.0,4122,Incidence,2248844,Non-Hispanic Black,183.3,Male and Female,Lung and Bronchus,2017
60-64,327.6,348.2,4176,Incidence,1236296,Non-Hispanic Black,337.8,Male and Female,Male and Female Breast,2017
60-64,89.0,99.9,1166,Incidence,1236296,Non-Hispanic Black,94.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
60-64,1.4,2.6,43,Incidence,2248844,Non-Hispanic Black,1.9,Male and Female,Melanomas of the Skin,2017
60-64,0.6,1.5,22,Incidence,2248844,Non-Hispanic Black,1.0,Male and Female,Mesothelioma,2017
60-64,34.7,39.8,836,Incidence,2248844,Non-Hispanic Black,37.2,Male and Female,Myeloma,2017
60-64,32.6,37.5,786,Incidence,2248844,Non-Hispanic Black,35.0,Male and Female,Non-Hodgkin Lymphoma,2017
60-64,26.3,30.8,640,Incidence,2248844,Non-Hispanic Black,28.5,Male and Female,Oral Cavity and Pharynx,2017
60-64,18.6,23.7,260,Incidence,1236296,Non-Hispanic Black,21.0,Male and Female,Ovary,2017
60-64,43.3,49.0,1037,Incidence,2248844,Non-Hispanic Black,46.1,Male and Female,Pancreas,2017
60-64,750.0,784.2,7766,Incidence,1012548,Non-Hispanic Black,767.0,Male and Female,Prostate,2017
60-64,19.6,23.4,482,Incidence,2248844,Non-Hispanic Black,21.4,Male and Female,Stomach,2017
60-64,~,~,~,Incidence,1012548,Non-Hispanic Black,~,Male and Female,Testis,2017
60-64,15.8,19.3,393,Incidence,2248844,Non-Hispanic Black,17.5,Male and Female,Thyroid,2017
60-64,25.9,30.3,630,Incidence,2248844,Non-Hispanic Black,28.0,Male and Female,Urinary Bladder,2017
65-69,1830.1,1870.7,31955,Incidence,1727009,Non-Hispanic Black,1850.3,Male and Female,All Cancer Sites Combined,2017
65-69,7.5,10.4,153,Incidence,1727009,Non-Hispanic Black,8.9,Male and Female,Brain and Other Nervous System,2017
65-69,16.1,21.7,183,Incidence,975957,Non-Hispanic Black,18.8,Male and Female,Cervix,2017
65-69,145.2,156.9,2607,Incidence,1727009,Non-Hispanic Black,151.0,Male and Female,Colon and Rectum,2017
65-69,132.3,147.3,1363,Incidence,975957,Non-Hispanic Black,139.7,Male and Female,"Corpus and Uterus, NOS",2017
65-69,13.9,17.7,272,Incidence,1727009,Non-Hispanic Black,15.7,Male and Female,Esophagus,2017
65-69,414.0,440.0,4166,Incidence,975957,Non-Hispanic Black,426.9,Male and Female,Female Breast,2017
65-69,117.4,131.5,1213,Incidence,975957,Non-Hispanic Black,124.3,Male and Female,"Female Breast, <i>in situ</i>",2017
65-69,2.8,4.7,63,Incidence,1727009,Non-Hispanic Black,3.6,Male and Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,1727009,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
65-69,70.6,78.8,1289,Incidence,1727009,Non-Hispanic Black,74.6,Male and Female,Kidney and Renal Pelvis,2017
65-69,16.1,20.2,312,Incidence,1727009,Non-Hispanic Black,18.1,Male and Female,Larynx,2017
65-69,28.5,33.8,536,Incidence,1727009,Non-Hispanic Black,31.0,Male and Female,Leukemias,2017
65-69,65.5,73.4,1198,Incidence,1727009,Non-Hispanic Black,69.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
65-69,251.0,266.2,4465,Incidence,1727009,Non-Hispanic Black,258.5,Male and Female,Lung and Bronchus,2017
65-69,414.0,440.0,4166,Incidence,975957,Non-Hispanic Black,426.9,Male and Female,Male and Female Breast,2017
65-69,117.4,131.5,1213,Incidence,975957,Non-Hispanic Black,124.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
65-69,2.1,3.8,50,Incidence,1727009,Non-Hispanic Black,2.9,Male and Female,Melanomas of the Skin,2017
65-69,0.8,2.0,23,Incidence,1727009,Non-Hispanic Black,1.3,Male and Female,Mesothelioma,2017
65-69,49.9,56.9,921,Incidence,1727009,Non-Hispanic Black,53.3,Male and Female,Myeloma,2017
65-69,38.5,44.6,716,Incidence,1727009,Non-Hispanic Black,41.5,Male and Female,Non-Hodgkin Lymphoma,2017
65-69,26.9,32.0,507,Incidence,1727009,Non-Hispanic Black,29.4,Male and Female,Oral Cavity and Pharynx,2017
65-69,26.2,33.1,288,Incidence,975957,Non-Hispanic Black,29.5,Male and Female,Ovary,2017
65-69,59.8,67.4,1097,Incidence,1727009,Non-Hispanic Black,63.5,Male and Female,Pancreas,2017
65-69,1020.0,1066.3,7833,Incidence,751052,Non-Hispanic Black,1042.9,Male and Female,Prostate,2017
65-69,31.2,36.7,585,Incidence,1727009,Non-Hispanic Black,33.9,Male and Female,Stomach,2017
65-69,~,~,~,Incidence,751052,Non-Hispanic Black,~,Male and Female,Testis,2017
65-69,17.8,22.0,342,Incidence,1727009,Non-Hispanic Black,19.8,Male and Female,Thyroid,2017
65-69,41.0,47.4,762,Incidence,1727009,Non-Hispanic Black,44.1,Male and Female,Urinary Bladder,2017
70-74,1973.5,2025.3,23014,Incidence,1151105,Non-Hispanic Black,1999.3,Male and Female,All Cancer Sites Combined,2017
70-74,9.4,13.3,129,Incidence,1151105,Non-Hispanic Black,11.2,Male and Female,Brain and Other Nervous System,2017
70-74,14.9,21.5,120,Incidence,667176,Non-Hispanic Black,18.0,Male and Female,Cervix,2017
70-74,162.8,178.0,1960,Incidence,1151105,Non-Hispanic Black,170.3,Male and Female,Colon and Rectum,2017
70-74,129.4,147.4,922,Incidence,667176,Non-Hispanic Black,138.2,Male and Female,"Corpus and Uterus, NOS",2017
70-74,14.8,19.7,197,Incidence,1151105,Non-Hispanic Black,17.1,Male and Female,Esophagus,2017
70-74,417.8,449.6,2892,Incidence,667176,Non-Hispanic Black,433.5,Male and Female,Female Breast,2017
70-74,113.0,129.9,809,Incidence,667176,Non-Hispanic Black,121.3,Male and Female,"Female Breast, <i>in situ</i>",2017
70-74,2.3,4.5,38,Incidence,1151105,Non-Hispanic Black,3.3,Male and Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,1151105,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
70-74,75.7,86.2,930,Incidence,1151105,Non-Hispanic Black,80.8,Male and Female,Kidney and Renal Pelvis,2017
70-74,18.8,24.2,246,Incidence,1151105,Non-Hispanic Black,21.4,Male and Female,Larynx,2017
70-74,37.8,45.3,477,Incidence,1151105,Non-Hispanic Black,41.4,Male and Female,Leukemias,2017
70-74,40.8,48.6,513,Incidence,1151105,Non-Hispanic Black,44.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
70-74,320.3,341.4,3807,Incidence,1151105,Non-Hispanic Black,330.7,Male and Female,Lung and Bronchus,2017
70-74,417.8,449.6,2892,Incidence,667176,Non-Hispanic Black,433.5,Male and Female,Male and Female Breast,2017
70-74,113.0,129.9,809,Incidence,667176,Non-Hispanic Black,121.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
70-74,2.4,4.6,39,Incidence,1151105,Non-Hispanic Black,3.4,Male and Female,Melanomas of the Skin,2017
70-74,1.3,3.0,23,Incidence,1151105,Non-Hispanic Black,2.0,Male and Female,Mesothelioma,2017
70-74,68.5,78.4,844,Incidence,1151105,Non-Hispanic Black,73.3,Male and Female,Myeloma,2017
70-74,45.8,54.0,573,Incidence,1151105,Non-Hispanic Black,49.8,Male and Female,Non-Hodgkin Lymphoma,2017
70-74,29.4,36.0,375,Incidence,1151105,Non-Hispanic Black,32.6,Male and Female,Oral Cavity and Pharynx,2017
70-74,23.5,31.5,182,Incidence,667176,Non-Hispanic Black,27.3,Male and Female,Ovary,2017
70-74,70.6,80.7,869,Incidence,1151105,Non-Hispanic Black,75.5,Male and Female,Pancreas,2017
70-74,935.3,990.8,4659,Incidence,483929,Non-Hispanic Black,962.7,Male and Female,Prostate,2017
70-74,41.4,49.2,520,Incidence,1151105,Non-Hispanic Black,45.2,Male and Female,Stomach,2017
70-74,~,~,~,Incidence,483929,Non-Hispanic Black,~,Male and Female,Testis,2017
70-74,17.1,22.3,225,Incidence,1151105,Non-Hispanic Black,19.5,Male and Female,Thyroid,2017
70-74,56.9,66.0,706,Incidence,1151105,Non-Hispanic Black,61.3,Male and Female,Urinary Bladder,2017
75-79,2076.0,2141.0,16247,Incidence,770618,Non-Hispanic Black,2108.3,Male and Female,All Cancer Sites Combined,2017
75-79,9.2,14.1,88,Incidence,770618,Non-Hispanic Black,11.4,Male and Female,Brain and Other Nervous System,2017
75-79,13.9,21.7,81,Incidence,464262,Non-Hispanic Black,17.4,Male and Female,Cervix,2017
75-79,191.1,211.3,1549,Incidence,770618,Non-Hispanic Black,201.0,Male and Female,Colon and Rectum,2017
75-79,99.5,118.7,505,Incidence,464262,Non-Hispanic Black,108.8,Male and Female,"Corpus and Uterus, NOS",2017
75-79,15.9,22.1,145,Incidence,770618,Non-Hispanic Black,18.8,Male and Female,Esophagus,2017
75-79,422.2,460.7,2048,Incidence,464262,Non-Hispanic Black,441.1,Male and Female,Female Breast,2017
75-79,96.0,114.9,488,Incidence,464262,Non-Hispanic Black,105.1,Male and Female,"Female Breast, <i>in situ</i>",2017
75-79,1.5,3.9,19,Incidence,770618,Non-Hispanic Black,2.5,Male and Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,770618,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
75-79,77.2,90.3,644,Incidence,770618,Non-Hispanic Black,83.6,Male and Female,Kidney and Renal Pelvis,2017
75-79,14.8,20.9,136,Incidence,770618,Non-Hispanic Black,17.6,Male and Female,Larynx,2017
75-79,44.2,54.3,378,Incidence,770618,Non-Hispanic Black,49.1,Male and Female,Leukemias,2017
75-79,33.2,41.9,288,Incidence,770618,Non-Hispanic Black,37.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
75-79,365.7,393.3,2923,Incidence,770618,Non-Hispanic Black,379.3,Male and Female,Lung and Bronchus,2017
75-79,422.2,460.7,2048,Incidence,464262,Non-Hispanic Black,441.1,Male and Female,Male and Female Breast,2017
75-79,96.0,114.9,488,Incidence,464262,Non-Hispanic Black,105.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
75-79,3.8,7.2,41,Incidence,770618,Non-Hispanic Black,5.3,Male and Female,Melanomas of the Skin,2017
75-79,2.1,4.8,25,Incidence,770618,Non-Hispanic Black,3.2,Male and Female,Mesothelioma,2017
75-79,77.1,90.1,643,Incidence,770618,Non-Hispanic Black,83.4,Male and Female,Myeloma,2017
75-79,58.0,69.3,489,Incidence,770618,Non-Hispanic Black,63.5,Male and Female,Non-Hodgkin Lymphoma,2017
75-79,27.0,34.9,237,Incidence,770618,Non-Hispanic Black,30.8,Male and Female,Oral Cavity and Pharynx,2017
75-79,30.9,42.1,168,Incidence,464262,Non-Hispanic Black,36.2,Male and Female,Ovary,2017
75-79,91.5,105.6,758,Incidence,770618,Non-Hispanic Black,98.4,Male and Female,Pancreas,2017
75-79,756.5,819.7,2413,Incidence,306356,Non-Hispanic Black,787.6,Male and Female,Prostate,2017
75-79,53.2,64.2,451,Incidence,770618,Non-Hispanic Black,58.5,Male and Female,Stomach,2017
75-79,~,~,~,Incidence,306356,Non-Hispanic Black,~,Male and Female,Testis,2017
75-79,14.1,20.0,130,Incidence,770618,Non-Hispanic Black,16.9,Male and Female,Thyroid,2017
75-79,77.1,90.1,643,Incidence,770618,Non-Hispanic Black,83.4,Male and Female,Urinary Bladder,2017
80-84,1994.0,2072.4,10396,Incidence,511378,Non-Hispanic Black,2032.9,Male and Female,All Cancer Sites Combined,2017
80-84,9.6,16.0,64,Incidence,511378,Non-Hispanic Black,12.5,Male and Female,Brain and Other Nervous System,2017
80-84,14.4,24.2,61,Incidence,324031,Non-Hispanic Black,18.8,Male and Female,Cervix,2017
80-84,203.1,228.8,1103,Incidence,511378,Non-Hispanic Black,215.7,Male and Female,Colon and Rectum,2017
80-84,80.7,101.7,294,Incidence,324031,Non-Hispanic Black,90.7,Male and Female,"Corpus and Uterus, NOS",2017
80-84,12.9,20.1,83,Incidence,511378,Non-Hispanic Black,16.2,Male and Female,Esophagus,2017
80-84,380.0,423.9,1301,Incidence,324031,Non-Hispanic Black,401.5,Male and Female,Female Breast,2017
80-84,50.0,66.9,188,Incidence,324031,Non-Hispanic Black,58.0,Male and Female,"Female Breast, <i>in situ</i>",2017
80-84,~,~,~,Incidence,511378,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,511378,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
80-84,57.2,71.3,327,Incidence,511378,Non-Hispanic Black,63.9,Male and Female,Kidney and Renal Pelvis,2017
80-84,14.3,21.8,91,Incidence,511378,Non-Hispanic Black,17.8,Male and Female,Larynx,2017
80-84,54.4,68.2,312,Incidence,511378,Non-Hispanic Black,61.0,Male and Female,Leukemias,2017
80-84,26.6,36.5,160,Incidence,511378,Non-Hispanic Black,31.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
80-84,329.8,362.2,1768,Incidence,511378,Non-Hispanic Black,345.7,Male and Female,Lung and Bronchus,2017
80-84,380.0,423.9,1301,Incidence,324031,Non-Hispanic Black,401.5,Male and Female,Male and Female Breast,2017
80-84,50.0,66.9,188,Incidence,324031,Non-Hispanic Black,58.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
80-84,4.4,9.1,33,Incidence,511378,Non-Hispanic Black,6.5,Male and Female,Melanomas of the Skin,2017
80-84,2.5,6.3,21,Incidence,511378,Non-Hispanic Black,4.1,Male and Female,Mesothelioma,2017
80-84,83.0,99.8,466,Incidence,511378,Non-Hispanic Black,91.1,Male and Female,Myeloma,2017
80-84,59.2,73.5,338,Incidence,511378,Non-Hispanic Black,66.1,Male and Female,Non-Hodgkin Lymphoma,2017
80-84,25.9,35.7,156,Incidence,511378,Non-Hispanic Black,30.5,Male and Female,Oral Cavity and Pharynx,2017
80-84,31.3,45.0,122,Incidence,324031,Non-Hispanic Black,37.7,Male and Female,Ovary,2017
80-84,108.3,127.3,601,Incidence,511378,Non-Hispanic Black,117.5,Male and Female,Pancreas,2017
80-84,545.2,614.7,1085,Incidence,187347,Non-Hispanic Black,579.1,Male and Female,Prostate,2017
80-84,56.6,70.6,324,Incidence,511378,Non-Hispanic Black,63.4,Male and Female,Stomach,2017
80-84,~,~,~,Incidence,187347,Non-Hispanic Black,~,Male and Female,Testis,2017
80-84,10.7,17.3,70,Incidence,511378,Non-Hispanic Black,13.7,Male and Female,Thyroid,2017
80-84,84.7,101.6,475,Incidence,511378,Non-Hispanic Black,92.9,Male and Female,Urinary Bladder,2017
85+,1767.7,1843.4,8789,Incidence,486867,Non-Hispanic Black,1805.2,Male and Female,All Cancer Sites Combined,2017
85+,6.6,12.1,44,Incidence,486867,Non-Hispanic Black,9.0,Male and Female,Brain and Other Nervous System,2017
85+,11.1,19.7,51,Incidence,340973,Non-Hispanic Black,15.0,Male and Female,Cervix,2017
85+,192.5,218.1,998,Incidence,486867,Non-Hispanic Black,205.0,Male and Female,Colon and Rectum,2017
85+,50.8,67.4,200,Incidence,340973,Non-Hispanic Black,58.7,Male and Female,"Corpus and Uterus, NOS",2017
85+,11.8,18.9,73,Incidence,486867,Non-Hispanic Black,15.0,Male and Female,Esophagus,2017
85+,316.9,356.1,1146,Incidence,340973,Non-Hispanic Black,336.1,Male and Female,Female Breast,2017
85+,27.3,39.8,113,Incidence,340973,Non-Hispanic Black,33.1,Male and Female,"Female Breast, <i>in situ</i>",2017
85+,~,~,~,Incidence,486867,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,486867,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
85+,45.6,58.6,252,Incidence,486867,Non-Hispanic Black,51.8,Male and Female,Kidney and Renal Pelvis,2017
85+,6.0,11.4,41,Incidence,486867,Non-Hispanic Black,8.4,Male and Female,Larynx,2017
85+,52.9,66.8,290,Incidence,486867,Non-Hispanic Black,59.6,Male and Female,Leukemias,2017
85+,25.5,35.5,147,Incidence,486867,Non-Hispanic Black,30.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
85+,277.7,308.3,1425,Incidence,486867,Non-Hispanic Black,292.7,Male and Female,Lung and Bronchus,2017
85+,316.9,356.1,1146,Incidence,340973,Non-Hispanic Black,336.1,Male and Female,Male and Female Breast,2017
85+,27.3,39.8,113,Incidence,340973,Non-Hispanic Black,33.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
85+,5.5,10.7,38,Incidence,486867,Non-Hispanic Black,7.8,Male and Female,Melanomas of the Skin,2017
85+,~,~,~,Incidence,486867,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
85+,64.6,79.8,350,Incidence,486867,Non-Hispanic Black,71.9,Male and Female,Myeloma,2017
85+,42.7,55.3,237,Incidence,486867,Non-Hispanic Black,48.7,Male and Female,Non-Hodgkin Lymphoma,2017
85+,17.8,26.3,106,Incidence,486867,Non-Hispanic Black,21.8,Male and Female,Oral Cavity and Pharynx,2017
85+,21.8,33.1,92,Incidence,340973,Non-Hispanic Black,27.0,Male and Female,Ovary,2017
85+,93.5,111.7,498,Incidence,486867,Non-Hispanic Black,102.3,Male and Female,Pancreas,2017
85+,448.9,521.0,706,Incidence,145894,Non-Hispanic Black,483.9,Male and Female,Prostate,2017
85+,57.6,72.0,314,Incidence,486867,Non-Hispanic Black,64.5,Male and Female,Stomach,2017
85+,~,~,~,Incidence,145894,Non-Hispanic Black,~,Male and Female,Testis,2017
85+,6.0,11.4,41,Incidence,486867,Non-Hispanic Black,8.4,Male and Female,Thyroid,2017
85+,96.4,114.9,513,Incidence,486867,Non-Hispanic Black,105.4,Male and Female,Urinary Bladder,2017
<1,13.3,20.0,99,Incidence,602850,Non-Hispanic Black,16.4,Male and Female,All Cancer Sites Combined,2017
<1,2.0,5.1,20,Incidence,602850,Non-Hispanic Black,3.3,Male and Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,Cervix,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Esophagus,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,Female Breast,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Larynx,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Leukemias,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Mesothelioma,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Myeloma,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,296258,Non-Hispanic Black,~,Male and Female,Ovary,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Pancreas,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male and Female,Prostate,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Stomach,2017
<1,~,~,~,Incidence,306592,Non-Hispanic Black,~,Male and Female,Testis,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Thyroid,2017
<1,~,~,~,Incidence,602850,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2017
1-4,22.2,25.2,953,Incidence,4026911,Non-Hispanic White,23.7,Female,All Cancer Sites Combined,2017
1-4,4.8,6.3,222,Incidence,4026911,Non-Hispanic White,5.5,Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Cervix,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Esophagus,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Female Breast,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
1-4,1.8,2.7,89,Incidence,4026911,Non-Hispanic White,2.2,Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Larynx,2017
1-4,7.8,9.6,349,Incidence,4026911,Non-Hispanic White,8.7,Female,Leukemias,2017
1-4,0.4,0.9,24,Incidence,4026911,Non-Hispanic White,0.6,Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Mesothelioma,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Myeloma,2017
1-4,0.3,0.8,22,Incidence,4026911,Non-Hispanic White,0.5,Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Ovary,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Pancreas,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Stomach,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Thyroid,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Female,Urinary Bladder,2017
10-14,14.7,16.9,850,Incidence,5394716,Non-Hispanic White,15.8,Female,All Cancer Sites Combined,2017
10-14,3.0,4.0,188,Incidence,5394716,Non-Hispanic White,3.5,Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Cervix,2017
10-14,0.7,1.2,49,Incidence,5394716,Non-Hispanic White,0.9,Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Esophagus,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Female Breast,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2017
10-14,1.0,1.7,72,Incidence,5394716,Non-Hispanic White,1.3,Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Larynx,2017
10-14,2.1,3.0,138,Incidence,5394716,Non-Hispanic White,2.6,Female,Leukemias,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Lung and Bronchus,2017
10-14,0.2,0.5,17,Incidence,5394716,Non-Hispanic White,0.3,Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Mesothelioma,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Myeloma,2017
10-14,0.7,1.2,48,Incidence,5394716,Non-Hispanic White,0.9,Female,Non-Hodgkin Lymphoma,2017
10-14,0.2,0.5,19,Incidence,5394716,Non-Hispanic White,0.4,Female,Oral Cavity and Pharynx,2017
10-14,0.5,1.0,38,Incidence,5394716,Non-Hispanic White,0.7,Female,Ovary,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Pancreas,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Stomach,2017
10-14,1.0,1.6,69,Incidence,5394716,Non-Hispanic White,1.3,Female,Thyroid,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Female,Urinary Bladder,2017
15-19,24.8,27.4,1468,Incidence,5630193,Non-Hispanic White,26.1,Female,All Cancer Sites Combined,2017
15-19,2.1,3.0,143,Incidence,5630193,Non-Hispanic White,2.5,Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Cervix,2017
15-19,1.2,1.9,86,Incidence,5630193,Non-Hispanic White,1.5,Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Esophagus,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Female Breast,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2017
15-19,3.7,4.8,238,Incidence,5630193,Non-Hispanic White,4.2,Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
15-19,0.2,0.5,16,Incidence,5630193,Non-Hispanic White,0.3,Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Larynx,2017
15-19,1.9,2.7,126,Incidence,5630193,Non-Hispanic White,2.2,Female,Leukemias,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Lung and Bronchus,2017
15-19,1.1,1.7,79,Incidence,5630193,Non-Hispanic White,1.4,Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Mesothelioma,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Myeloma,2017
15-19,1.0,1.6,69,Incidence,5630193,Non-Hispanic White,1.2,Female,Non-Hodgkin Lymphoma,2017
15-19,0.3,0.7,29,Incidence,5630193,Non-Hispanic White,0.5,Female,Oral Cavity and Pharynx,2017
15-19,0.8,1.3,58,Incidence,5630193,Non-Hispanic White,1.0,Female,Ovary,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Pancreas,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Stomach,2017
15-19,5.7,7.1,359,Incidence,5630193,Non-Hispanic White,6.4,Female,Thyroid,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Female,Urinary Bladder,2017
20-24,42.9,46.3,2639,Incidence,5916948,Non-Hispanic White,44.6,Female,All Cancer Sites Combined,2017
20-24,2.1,2.9,144,Incidence,5916948,Non-Hispanic White,2.4,Female,Brain and Other Nervous System,2017
20-24,0.5,0.9,40,Incidence,5916948,Non-Hispanic White,0.7,Female,Cervix,2017
20-24,2.4,3.3,167,Incidence,5916948,Non-Hispanic White,2.8,Female,Colon and Rectum,2017
20-24,0.2,0.5,21,Incidence,5916948,Non-Hispanic White,0.4,Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Esophagus,2017
20-24,1.1,1.7,80,Incidence,5916948,Non-Hispanic White,1.4,Female,Female Breast,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2017
20-24,5.0,6.2,332,Incidence,5916948,Non-Hispanic White,5.6,Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
20-24,0.3,0.7,27,Incidence,5916948,Non-Hispanic White,0.5,Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Larynx,2017
20-24,1.8,2.6,130,Incidence,5916948,Non-Hispanic White,2.2,Female,Leukemias,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2017
20-24,0.3,0.6,26,Incidence,5916948,Non-Hispanic White,0.4,Female,Lung and Bronchus,2017
20-24,5.0,6.2,331,Incidence,5916948,Non-Hispanic White,5.6,Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Mesothelioma,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Myeloma,2017
20-24,1.8,2.6,128,Incidence,5916948,Non-Hispanic White,2.2,Female,Non-Hodgkin Lymphoma,2017
20-24,0.5,0.9,41,Incidence,5916948,Non-Hispanic White,0.7,Female,Oral Cavity and Pharynx,2017
20-24,1.4,2.0,99,Incidence,5916948,Non-Hispanic White,1.7,Female,Ovary,2017
20-24,0.2,0.6,22,Incidence,5916948,Non-Hispanic White,0.4,Female,Pancreas,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Stomach,2017
20-24,12.0,13.9,764,Incidence,5916948,Non-Hispanic White,12.9,Female,Thyroid,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Female,Urinary Bladder,2017
25-29,79.2,83.6,5217,Incidence,6410127,Non-Hispanic White,81.4,Female,All Cancer Sites Combined,2017
25-29,3.1,4.0,224,Incidence,6410127,Non-Hispanic White,3.5,Female,Brain and Other Nervous System,2017
25-29,4.5,5.7,326,Incidence,6410127,Non-Hispanic White,5.1,Female,Cervix,2017
25-29,3.7,4.7,268,Incidence,6410127,Non-Hispanic White,4.2,Female,Colon and Rectum,2017
25-29,1.7,2.5,133,Incidence,6410127,Non-Hispanic White,2.1,Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,6410127,Non-Hispanic White,~,Female,Esophagus,2017
25-29,10.0,11.6,692,Incidence,6410127,Non-Hispanic White,10.8,Female,Female Breast,2017
25-29,0.6,1.0,48,Incidence,6410127,Non-Hispanic White,0.7,Female,"Female Breast, <i>in situ</i>",2017
25-29,4.0,5.1,292,Incidence,6410127,Non-Hispanic White,4.6,Female,Hodgkin Lymphoma,2017
25-29,~,~,~,Incidence,6410127,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
25-29,1.1,1.7,88,Incidence,6410127,Non-Hispanic White,1.4,Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,6410127,Non-Hispanic White,~,Female,Larynx,2017
25-29,2.1,2.9,160,Incidence,6410127,Non-Hispanic White,2.5,Female,Leukemias,2017
25-29,~,~,~,Incidence,6410127,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2017
25-29,0.4,0.8,39,Incidence,6410127,Non-Hispanic White,0.6,Female,Lung and Bronchus,2017
25-29,12.0,13.7,822,Incidence,6410127,Non-Hispanic White,12.8,Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,6410127,Non-Hispanic White,~,Female,Mesothelioma,2017
25-29,~,~,~,Incidence,6410127,Non-Hispanic White,~,Female,Myeloma,2017
25-29,2.3,3.1,169,Incidence,6410127,Non-Hispanic White,2.6,Female,Non-Hodgkin Lymphoma,2017
25-29,0.9,1.5,77,Incidence,6410127,Non-Hispanic White,1.2,Female,Oral Cavity and Pharynx,2017
25-29,1.8,2.5,137,Incidence,6410127,Non-Hispanic White,2.1,Female,Ovary,2017
25-29,0.3,0.7,30,Incidence,6410127,Non-Hispanic White,0.5,Female,Pancreas,2017
25-29,0.2,0.5,23,Incidence,6410127,Non-Hispanic White,0.4,Female,Stomach,2017
25-29,19.2,21.4,1298,Incidence,6410127,Non-Hispanic White,20.2,Female,Thyroid,2017
25-29,0.2,0.4,17,Incidence,6410127,Non-Hispanic White,0.3,Female,Urinary Bladder,2017
30-34,137.9,143.8,8737,Incidence,6204154,Non-Hispanic White,140.8,Female,All Cancer Sites Combined,2017
30-34,3.4,4.4,243,Incidence,6204154,Non-Hispanic White,3.9,Female,Brain and Other Nervous System,2017
30-34,11.5,13.3,768,Incidence,6204154,Non-Hispanic White,12.4,Female,Cervix,2017
30-34,5.9,7.2,406,Incidence,6204154,Non-Hispanic White,6.5,Female,Colon and Rectum,2017
30-34,4.5,5.7,315,Incidence,6204154,Non-Hispanic White,5.1,Female,"Corpus and Uterus, NOS",2017
30-34,~,~,~,Incidence,6204154,Non-Hispanic White,~,Female,Esophagus,2017
30-34,30.2,33.0,1958,Incidence,6204154,Non-Hispanic White,31.6,Female,Female Breast,2017
30-34,2.4,3.3,176,Incidence,6204154,Non-Hispanic White,2.8,Female,"Female Breast, <i>in situ</i>",2017
30-34,3.6,4.6,253,Incidence,6204154,Non-Hispanic White,4.1,Female,Hodgkin Lymphoma,2017
30-34,~,~,~,Incidence,6204154,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
30-34,2.5,3.4,182,Incidence,6204154,Non-Hispanic White,2.9,Female,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,6204154,Non-Hispanic White,~,Female,Larynx,2017
30-34,3.2,4.2,227,Incidence,6204154,Non-Hispanic White,3.7,Female,Leukemias,2017
30-34,0.3,0.7,30,Incidence,6204154,Non-Hispanic White,0.5,Female,Liver and Intrahepatic Bile Duct,2017
30-34,1.2,1.8,89,Incidence,6204154,Non-Hispanic White,1.4,Female,Lung and Bronchus,2017
30-34,19.4,21.7,1272,Incidence,6204154,Non-Hispanic White,20.5,Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,6204154,Non-Hispanic White,~,Female,Mesothelioma,2017
30-34,~,~,~,Incidence,6204154,Non-Hispanic White,~,Female,Myeloma,2017
30-34,3.1,4.1,222,Incidence,6204154,Non-Hispanic White,3.6,Female,Non-Hodgkin Lymphoma,2017
30-34,1.4,2.1,108,Incidence,6204154,Non-Hispanic White,1.7,Female,Oral Cavity and Pharynx,2017
30-34,2.6,3.5,189,Incidence,6204154,Non-Hispanic White,3.0,Female,Ovary,2017
30-34,0.4,0.8,37,Incidence,6204154,Non-Hispanic White,0.6,Female,Pancreas,2017
30-34,0.6,1.1,50,Incidence,6204154,Non-Hispanic White,0.8,Female,Stomach,2017
30-34,27.7,30.4,1800,Incidence,6204154,Non-Hispanic White,29.0,Female,Thyroid,2017
30-34,0.4,0.8,38,Incidence,6204154,Non-Hispanic White,0.6,Female,Urinary Bladder,2017
35-39,207.7,215.1,12759,Incidence,6036831,Non-Hispanic White,211.4,Female,All Cancer Sites Combined,2017
35-39,3.4,4.4,234,Incidence,6036831,Non-Hispanic White,3.9,Female,Brain and Other Nervous System,2017
35-39,13.3,15.2,859,Incidence,6036831,Non-Hispanic White,14.2,Female,Cervix,2017
35-39,11.2,13.0,728,Incidence,6036831,Non-Hispanic White,12.1,Female,Colon and Rectum,2017
35-39,9.3,10.9,608,Incidence,6036831,Non-Hispanic White,10.1,Female,"Corpus and Uterus, NOS",2017
35-39,~,~,~,Incidence,6036831,Non-Hispanic White,~,Female,Esophagus,2017
35-39,62.9,66.9,3916,Incidence,6036831,Non-Hispanic White,64.9,Female,Female Breast,2017
35-39,9.0,10.6,589,Incidence,6036831,Non-Hispanic White,9.8,Female,"Female Breast, <i>in situ</i>",2017
35-39,2.3,3.2,164,Incidence,6036831,Non-Hispanic White,2.7,Female,Hodgkin Lymphoma,2017
35-39,~,~,~,Incidence,6036831,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
35-39,5.2,6.4,348,Incidence,6036831,Non-Hispanic White,5.8,Female,Kidney and Renal Pelvis,2017
35-39,0.2,0.5,20,Incidence,6036831,Non-Hispanic White,0.3,Female,Larynx,2017
35-39,3.8,4.9,262,Incidence,6036831,Non-Hispanic White,4.3,Female,Leukemias,2017
35-39,0.5,1.0,44,Incidence,6036831,Non-Hispanic White,0.7,Female,Liver and Intrahepatic Bile Duct,2017
35-39,2.7,3.6,188,Incidence,6036831,Non-Hispanic White,3.1,Female,Lung and Bronchus,2017
35-39,23.4,25.9,1487,Incidence,6036831,Non-Hispanic White,24.6,Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,6036831,Non-Hispanic White,~,Female,Mesothelioma,2017
35-39,0.8,1.3,63,Incidence,6036831,Non-Hispanic White,1.0,Female,Myeloma,2017
35-39,4.7,5.9,317,Incidence,6036831,Non-Hispanic White,5.3,Female,Non-Hodgkin Lymphoma,2017
35-39,2.5,3.4,176,Incidence,6036831,Non-Hispanic White,2.9,Female,Oral Cavity and Pharynx,2017
35-39,4.7,5.9,317,Incidence,6036831,Non-Hispanic White,5.3,Female,Ovary,2017
35-39,1.2,1.8,87,Incidence,6036831,Non-Hispanic White,1.4,Female,Pancreas,2017
35-39,0.8,1.4,64,Incidence,6036831,Non-Hispanic White,1.1,Female,Stomach,2017
35-39,32.5,35.5,2051,Incidence,6036831,Non-Hispanic White,34.0,Female,Thyroid,2017
35-39,0.8,1.4,65,Incidence,6036831,Non-Hispanic White,1.1,Female,Urinary Bladder,2017
40-44,334.3,344.0,19082,Incidence,5626690,Non-Hispanic White,339.1,Female,All Cancer Sites Combined,2017
40-44,3.9,5.0,249,Incidence,5626690,Non-Hispanic White,4.4,Female,Brain and Other Nervous System,2017
40-44,14.5,16.6,875,Incidence,5626690,Non-Hispanic White,15.6,Female,Cervix,2017
40-44,19.7,22.1,1174,Incidence,5626690,Non-Hispanic White,20.9,Female,Colon and Rectum,2017
40-44,16.6,18.8,992,Incidence,5626690,Non-Hispanic White,17.6,Female,"Corpus and Uterus, NOS",2017
40-44,0.3,0.7,26,Incidence,5626690,Non-Hispanic White,0.5,Female,Esophagus,2017
40-44,132.7,138.8,7636,Incidence,5626690,Non-Hispanic White,135.7,Female,Female Breast,2017
40-44,41.0,44.4,2402,Incidence,5626690,Non-Hispanic White,42.7,Female,"Female Breast, <i>in situ</i>",2017
40-44,2.1,2.9,139,Incidence,5626690,Non-Hispanic White,2.5,Female,Hodgkin Lymphoma,2017
40-44,~,~,~,Incidence,5626690,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
40-44,9.1,10.8,559,Incidence,5626690,Non-Hispanic White,9.9,Female,Kidney and Renal Pelvis,2017
40-44,0.5,0.9,38,Incidence,5626690,Non-Hispanic White,0.7,Female,Larynx,2017
40-44,5.1,6.3,319,Incidence,5626690,Non-Hispanic White,5.7,Female,Leukemias,2017
40-44,1.1,1.7,77,Incidence,5626690,Non-Hispanic White,1.4,Female,Liver and Intrahepatic Bile Duct,2017
40-44,7.5,9.0,463,Incidence,5626690,Non-Hispanic White,8.2,Female,Lung and Bronchus,2017
40-44,29.2,32.1,1725,Incidence,5626690,Non-Hispanic White,30.7,Female,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,5626690,Non-Hispanic White,~,Female,Mesothelioma,2017
40-44,1.3,1.9,89,Incidence,5626690,Non-Hispanic White,1.6,Female,Myeloma,2017
40-44,7.7,9.2,475,Incidence,5626690,Non-Hispanic White,8.4,Female,Non-Hodgkin Lymphoma,2017
40-44,3.6,4.7,231,Incidence,5626690,Non-Hispanic White,4.1,Female,Oral Cavity and Pharynx,2017
40-44,7.8,9.4,482,Incidence,5626690,Non-Hispanic White,8.6,Female,Ovary,2017
40-44,2.1,3.0,142,Incidence,5626690,Non-Hispanic White,2.5,Female,Pancreas,2017
40-44,1.6,2.4,110,Incidence,5626690,Non-Hispanic White,2.0,Female,Stomach,2017
40-44,35.6,38.8,2093,Incidence,5626690,Non-Hispanic White,37.2,Female,Thyroid,2017
40-44,1.7,2.5,116,Incidence,5626690,Non-Hispanic White,2.1,Female,Urinary Bladder,2017
45-49,480.0,490.7,31392,Incidence,6468512,Non-Hispanic White,485.3,Female,All Cancer Sites Combined,2017
45-49,5.0,6.2,362,Incidence,6468512,Non-Hispanic White,5.6,Female,Brain and Other Nervous System,2017
45-49,12.3,14.1,854,Incidence,6468512,Non-Hispanic White,13.2,Female,Cervix,2017
45-49,31.5,34.4,2130,Incidence,6468512,Non-Hispanic White,32.9,Female,Colon and Rectum,2017
45-49,25.5,28.1,1733,Incidence,6468512,Non-Hispanic White,26.8,Female,"Corpus and Uterus, NOS",2017
45-49,0.7,1.2,58,Incidence,6468512,Non-Hispanic White,0.9,Female,Esophagus,2017
45-49,204.8,211.8,13472,Incidence,6468512,Non-Hispanic White,208.3,Female,Female Breast,2017
45-49,58.4,62.2,3898,Incidence,6468512,Non-Hispanic White,60.3,Female,"Female Breast, <i>in situ</i>",2017
45-49,1.9,2.7,147,Incidence,6468512,Non-Hispanic White,2.3,Female,Hodgkin Lymphoma,2017
45-49,~,~,~,Incidence,6468512,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
45-49,13.2,15.0,912,Incidence,6468512,Non-Hispanic White,14.1,Female,Kidney and Renal Pelvis,2017
45-49,1.1,1.6,86,Incidence,6468512,Non-Hispanic White,1.3,Female,Larynx,2017
45-49,7.2,8.5,506,Incidence,6468512,Non-Hispanic White,7.8,Female,Leukemias,2017
45-49,1.6,2.3,126,Incidence,6468512,Non-Hispanic White,1.9,Female,Liver and Intrahepatic Bile Duct,2017
45-49,20.3,22.6,1387,Incidence,6468512,Non-Hispanic White,21.4,Female,Lung and Bronchus,2017
45-49,34.3,37.3,2315,Incidence,6468512,Non-Hispanic White,35.8,Female,Melanomas of the Skin,2017
45-49,0.1,0.4,16,Incidence,6468512,Non-Hispanic White,0.2,Female,Mesothelioma,2017
45-49,2.5,3.4,189,Incidence,6468512,Non-Hispanic White,2.9,Female,Myeloma,2017
45-49,11.2,12.9,779,Incidence,6468512,Non-Hispanic White,12.0,Female,Non-Hodgkin Lymphoma,2017
45-49,6.8,8.1,479,Incidence,6468512,Non-Hispanic White,7.4,Female,Oral Cavity and Pharynx,2017
45-49,12.5,14.3,866,Incidence,6468512,Non-Hispanic White,13.4,Female,Ovary,2017
45-49,4.5,5.6,324,Incidence,6468512,Non-Hispanic White,5.0,Female,Pancreas,2017
45-49,2.6,3.4,192,Incidence,6468512,Non-Hispanic White,3.0,Female,Stomach,2017
45-49,34.7,37.6,2338,Incidence,6468512,Non-Hispanic White,36.1,Female,Thyroid,2017
45-49,3.6,4.6,266,Incidence,6468512,Non-Hispanic White,4.1,Female,Urinary Bladder,2017
5-9,11.6,13.6,646,Incidence,5129054,Non-Hispanic White,12.6,Female,All Cancer Sites Combined,2017
5-9,3.3,4.4,197,Incidence,5129054,Non-Hispanic White,3.8,Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Cervix,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Esophagus,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Female Breast,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
5-9,0.6,1.1,40,Incidence,5129054,Non-Hispanic White,0.8,Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Larynx,2017
5-9,3.1,4.2,185,Incidence,5129054,Non-Hispanic White,3.6,Female,Leukemias,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Mesothelioma,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Myeloma,2017
5-9,0.3,0.8,27,Incidence,5129054,Non-Hispanic White,0.5,Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Ovary,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Pancreas,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Stomach,2017
5-9,0.2,0.5,17,Incidence,5129054,Non-Hispanic White,0.3,Female,Thyroid,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Female,Urinary Bladder,2017
50-54,652.4,664.4,46541,Incidence,7068629,Non-Hispanic White,658.4,Female,All Cancer Sites Combined,2017
50-54,6.3,7.5,484,Incidence,7068629,Non-Hispanic White,6.8,Female,Brain and Other Nervous System,2017
50-54,11.3,12.9,852,Incidence,7068629,Non-Hispanic White,12.1,Female,Cervix,2017
50-54,51.5,55.0,3763,Incidence,7068629,Non-Hispanic White,53.2,Female,Colon and Rectum,2017
50-54,50.1,53.4,3656,Incidence,7068629,Non-Hispanic White,51.7,Female,"Corpus and Uterus, NOS",2017
50-54,1.7,2.3,139,Incidence,7068629,Non-Hispanic White,2.0,Female,Esophagus,2017
50-54,241.5,248.8,17330,Incidence,7068629,Non-Hispanic White,245.2,Female,Female Breast,2017
50-54,68.2,72.1,4955,Incidence,7068629,Non-Hispanic White,70.1,Female,"Female Breast, <i>in situ</i>",2017
50-54,1.4,2.1,123,Incidence,7068629,Non-Hispanic White,1.7,Female,Hodgkin Lymphoma,2017
50-54,~,~,~,Incidence,7068629,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
50-54,17.5,19.5,1304,Incidence,7068629,Non-Hispanic White,18.4,Female,Kidney and Renal Pelvis,2017
50-54,2.6,3.5,215,Incidence,7068629,Non-Hispanic White,3.0,Female,Larynx,2017
50-54,11.5,13.1,868,Incidence,7068629,Non-Hispanic White,12.3,Female,Leukemias,2017
50-54,4.0,5.0,315,Incidence,7068629,Non-Hispanic White,4.5,Female,Liver and Intrahepatic Bile Duct,2017
50-54,52.6,56.1,3839,Incidence,7068629,Non-Hispanic White,54.3,Female,Lung and Bronchus,2017
50-54,38.1,41.1,2799,Incidence,7068629,Non-Hispanic White,39.6,Female,Melanomas of the Skin,2017
50-54,0.3,0.6,28,Incidence,7068629,Non-Hispanic White,0.4,Female,Mesothelioma,2017
50-54,4.4,5.4,344,Incidence,7068629,Non-Hispanic White,4.9,Female,Myeloma,2017
50-54,17.9,19.9,1336,Incidence,7068629,Non-Hispanic White,18.9,Female,Non-Hodgkin Lymphoma,2017
50-54,10.8,12.4,816,Incidence,7068629,Non-Hispanic White,11.5,Female,Oral Cavity and Pharynx,2017
50-54,18.1,20.2,1351,Incidence,7068629,Non-Hispanic White,19.1,Female,Ovary,2017
50-54,9.3,10.8,711,Incidence,7068629,Non-Hispanic White,10.1,Female,Pancreas,2017
50-54,4.1,5.2,327,Incidence,7068629,Non-Hispanic White,4.6,Female,Stomach,2017
50-54,32.7,35.4,2407,Incidence,7068629,Non-Hispanic White,34.1,Female,Thyroid,2017
50-54,7.6,9.0,587,Incidence,7068629,Non-Hispanic White,8.3,Female,Urinary Bladder,2017
55-59,845.2,858.2,66437,Incidence,7800967,Non-Hispanic White,851.7,Female,All Cancer Sites Combined,2017
55-59,8.9,10.3,746,Incidence,7800967,Non-Hispanic White,9.6,Female,Brain and Other Nervous System,2017
55-59,10.1,11.5,840,Incidence,7800967,Non-Hispanic White,10.8,Female,Cervix,2017
55-59,52.8,56.1,4247,Incidence,7800967,Non-Hispanic White,54.4,Female,Colon and Rectum,2017
55-59,78.8,82.8,6302,Incidence,7800967,Non-Hispanic White,80.8,Female,"Corpus and Uterus, NOS",2017
55-59,3.1,3.9,272,Incidence,7800967,Non-Hispanic White,3.5,Female,Esophagus,2017
55-59,275.1,282.5,21749,Incidence,7800967,Non-Hispanic White,278.8,Female,Female Breast,2017
55-59,66.8,70.5,5357,Incidence,7800967,Non-Hispanic White,68.7,Female,"Female Breast, <i>in situ</i>",2017
55-59,1.6,2.2,144,Incidence,7800967,Non-Hispanic White,1.8,Female,Hodgkin Lymphoma,2017
55-59,~,~,~,Incidence,7800967,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
55-59,22.8,25.0,1866,Incidence,7800967,Non-Hispanic White,23.9,Female,Kidney and Renal Pelvis,2017
55-59,4.2,5.2,366,Incidence,7800967,Non-Hispanic White,4.7,Female,Larynx,2017
55-59,16.1,18.0,1327,Incidence,7800967,Non-Hispanic White,17.0,Female,Leukemias,2017
55-59,7.6,8.9,645,Incidence,7800967,Non-Hispanic White,8.3,Female,Liver and Intrahepatic Bile Duct,2017
55-59,104.0,108.6,8289,Incidence,7800967,Non-Hispanic White,106.3,Female,Lung and Bronchus,2017
55-59,43.8,46.8,3532,Incidence,7800967,Non-Hispanic White,45.3,Female,Melanomas of the Skin,2017
55-59,0.5,0.8,48,Incidence,7800967,Non-Hispanic White,0.6,Female,Mesothelioma,2017
55-59,7.6,8.8,638,Incidence,7800967,Non-Hispanic White,8.2,Female,Myeloma,2017
55-59,26.8,29.2,2185,Incidence,7800967,Non-Hispanic White,28.0,Female,Non-Hodgkin Lymphoma,2017
55-59,15.6,17.4,1284,Incidence,7800967,Non-Hispanic White,16.5,Female,Oral Cavity and Pharynx,2017
55-59,22.0,24.2,1799,Incidence,7800967,Non-Hispanic White,23.1,Female,Ovary,2017
55-59,16.8,18.7,1382,Incidence,7800967,Non-Hispanic White,17.7,Female,Pancreas,2017
55-59,5.5,6.6,469,Incidence,7800967,Non-Hispanic White,6.0,Female,Stomach,2017
55-59,31.7,34.3,2575,Incidence,7800967,Non-Hispanic White,33.0,Female,Thyroid,2017
55-59,13.1,14.8,1089,Incidence,7800967,Non-Hispanic White,14.0,Female,Urinary Bladder,2017
60-64,1080.0,1095.0,80999,Incidence,7448062,Non-Hispanic White,1087.5,Female,All Cancer Sites Combined,2017
60-64,11.3,12.9,899,Incidence,7448062,Non-Hispanic White,12.1,Female,Brain and Other Nervous System,2017
60-64,9.0,10.5,725,Incidence,7448062,Non-Hispanic White,9.7,Female,Cervix,2017
60-64,65.2,68.9,4992,Incidence,7448062,Non-Hispanic White,67.0,Female,Colon and Rectum,2017
60-64,101.1,105.8,7704,Incidence,7448062,Non-Hispanic White,103.4,Female,"Corpus and Uterus, NOS",2017
60-64,4.7,5.8,391,Incidence,7448062,Non-Hispanic White,5.2,Female,Esophagus,2017
60-64,342.9,351.4,25853,Incidence,7448062,Non-Hispanic White,347.1,Female,Female Breast,2017
60-64,77.3,81.3,5905,Incidence,7448062,Non-Hispanic White,79.3,Female,"Female Breast, <i>in situ</i>",2017
60-64,1.8,2.5,159,Incidence,7448062,Non-Hispanic White,2.1,Female,Hodgkin Lymphoma,2017
60-64,~,~,~,Incidence,7448062,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
60-64,29.3,31.8,2274,Incidence,7448062,Non-Hispanic White,30.5,Female,Kidney and Renal Pelvis,2017
60-64,4.5,5.5,370,Incidence,7448062,Non-Hispanic White,5.0,Female,Larynx,2017
60-64,22.3,24.5,1738,Incidence,7448062,Non-Hispanic White,23.3,Female,Leukemias,2017
60-64,12.0,13.7,957,Incidence,7448062,Non-Hispanic White,12.8,Female,Liver and Intrahepatic Bile Duct,2017
60-64,149.1,154.7,11312,Incidence,7448062,Non-Hispanic White,151.9,Female,Lung and Bronchus,2017
60-64,49.9,53.2,3839,Incidence,7448062,Non-Hispanic White,51.5,Female,Melanomas of the Skin,2017
60-64,0.6,1.1,63,Incidence,7448062,Non-Hispanic White,0.8,Female,Mesothelioma,2017
60-64,11.7,13.4,934,Incidence,7448062,Non-Hispanic White,12.5,Female,Myeloma,2017
60-64,35.2,37.9,2721,Incidence,7448062,Non-Hispanic White,36.5,Female,Non-Hodgkin Lymphoma,2017
60-64,18.9,21.0,1486,Incidence,7448062,Non-Hispanic White,20.0,Female,Oral Cavity and Pharynx,2017
60-64,26.5,28.9,2064,Incidence,7448062,Non-Hispanic White,27.7,Female,Ovary,2017
60-64,26.7,29.1,2076,Incidence,7448062,Non-Hispanic White,27.9,Female,Pancreas,2017
60-64,7.0,8.2,565,Incidence,7448062,Non-Hispanic White,7.6,Female,Stomach,2017
60-64,28.9,31.4,2246,Incidence,7448062,Non-Hispanic White,30.2,Female,Thyroid,2017
60-64,20.7,22.8,1619,Incidence,7448062,Non-Hispanic White,21.7,Female,Urinary Bladder,2017
65-69,1418.1,1436.4,93765,Incidence,6569590,Non-Hispanic White,1427.3,Female,All Cancer Sites Combined,2017
65-69,13.3,15.2,936,Incidence,6569590,Non-Hispanic White,14.2,Female,Brain and Other Nervous System,2017
65-69,8.6,10.1,611,Incidence,6569590,Non-Hispanic White,9.3,Female,Cervix,2017
65-69,91.1,95.8,6139,Incidence,6569590,Non-Hispanic White,93.4,Female,Colon and Rectum,2017
65-69,114.7,120.0,7707,Incidence,6569590,Non-Hispanic White,117.3,Female,"Corpus and Uterus, NOS",2017
65-69,5.9,7.1,427,Incidence,6569590,Non-Hispanic White,6.5,Female,Esophagus,2017
65-69,446.1,456.4,29641,Incidence,6569590,Non-Hispanic White,451.2,Female,Female Breast,2017
65-69,94.8,99.6,6384,Incidence,6569590,Non-Hispanic White,97.2,Female,"Female Breast, <i>in situ</i>",2017
65-69,2.1,2.8,160,Incidence,6569590,Non-Hispanic White,2.4,Female,Hodgkin Lymphoma,2017
65-69,~,~,~,Incidence,6569590,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
65-69,40.8,43.9,2780,Incidence,6569590,Non-Hispanic White,42.3,Female,Kidney and Renal Pelvis,2017
65-69,4.0,5.1,299,Incidence,6569590,Non-Hispanic White,4.6,Female,Larynx,2017
65-69,31.2,34.0,2141,Incidence,6569590,Non-Hispanic White,32.6,Female,Leukemias,2017
65-69,15.1,17.0,1053,Incidence,6569590,Non-Hispanic White,16.0,Female,Liver and Intrahepatic Bile Duct,2017
65-69,218.8,226.0,14609,Incidence,6569590,Non-Hispanic White,222.4,Female,Lung and Bronchus,2017
65-69,57.9,61.6,3923,Incidence,6569590,Non-Hispanic White,59.7,Female,Melanomas of the Skin,2017
65-69,0.9,1.4,74,Incidence,6569590,Non-Hispanic White,1.1,Female,Mesothelioma,2017
65-69,18.2,20.3,1264,Incidence,6569590,Non-Hispanic White,19.2,Female,Myeloma,2017
65-69,51.2,54.7,3475,Incidence,6569590,Non-Hispanic White,52.9,Female,Non-Hodgkin Lymphoma,2017
65-69,22.4,24.8,1550,Incidence,6569590,Non-Hispanic White,23.6,Female,Oral Cavity and Pharynx,2017
65-69,31.0,33.8,2128,Incidence,6569590,Non-Hispanic White,32.4,Female,Ovary,2017
65-69,38.7,41.8,2641,Incidence,6569590,Non-Hispanic White,40.2,Female,Pancreas,2017
65-69,9.9,11.5,701,Incidence,6569590,Non-Hispanic White,10.7,Female,Stomach,2017
65-69,28.9,31.6,1984,Incidence,6569590,Non-Hispanic White,30.2,Female,Thyroid,2017
65-69,31.2,34.0,2139,Incidence,6569590,Non-Hispanic White,32.6,Female,Urinary Bladder,2017
70-74,1704.5,1726.9,90238,Incidence,5259621,Non-Hispanic White,1715.7,Female,All Cancer Sites Combined,2017
70-74,16.1,18.4,906,Incidence,5259621,Non-Hispanic White,17.2,Female,Brain and Other Nervous System,2017
70-74,8.1,9.8,470,Incidence,5259621,Non-Hispanic White,8.9,Female,Cervix,2017
70-74,113.8,119.6,6137,Incidence,5259621,Non-Hispanic White,116.7,Female,Colon and Rectum,2017
70-74,108.8,114.5,5871,Incidence,5259621,Non-Hispanic White,111.6,Female,"Corpus and Uterus, NOS",2017
70-74,7.7,9.3,444,Incidence,5259621,Non-Hispanic White,8.4,Female,Esophagus,2017
70-74,492.3,504.3,26207,Incidence,5259621,Non-Hispanic White,498.3,Female,Female Breast,2017
70-74,96.3,101.7,5206,Incidence,5259621,Non-Hispanic White,99.0,Female,"Female Breast, <i>in situ</i>",2017
70-74,3.0,4.1,186,Incidence,5259621,Non-Hispanic White,3.5,Female,Hodgkin Lymphoma,2017
70-74,~,~,~,Incidence,5259621,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
70-74,46.7,50.5,2556,Incidence,5259621,Non-Hispanic White,48.6,Female,Kidney and Renal Pelvis,2017
70-74,4.6,5.8,271,Incidence,5259621,Non-Hispanic White,5.2,Female,Larynx,2017
70-74,42.1,45.7,2306,Incidence,5259621,Non-Hispanic White,43.8,Female,Leukemias,2017
70-74,17.3,19.6,968,Incidence,5259621,Non-Hispanic White,18.4,Female,Liver and Intrahepatic Bile Duct,2017
70-74,317.9,327.7,16976,Incidence,5259621,Non-Hispanic White,322.8,Female,Lung and Bronchus,2017
70-74,61.9,66.3,3370,Incidence,5259621,Non-Hispanic White,64.1,Female,Melanomas of the Skin,2017
70-74,1.8,2.6,113,Incidence,5259621,Non-Hispanic White,2.1,Female,Mesothelioma,2017
70-74,22.9,25.6,1273,Incidence,5259621,Non-Hispanic White,24.2,Female,Myeloma,2017
70-74,67.6,72.2,3676,Incidence,5259621,Non-Hispanic White,69.9,Female,Non-Hodgkin Lymphoma,2017
70-74,23.5,26.2,1304,Incidence,5259621,Non-Hispanic White,24.8,Female,Oral Cavity and Pharynx,2017
70-74,36.6,40.0,2014,Incidence,5259621,Non-Hispanic White,38.3,Female,Ovary,2017
70-74,52.7,56.7,2877,Incidence,5259621,Non-Hispanic White,54.7,Female,Pancreas,2017
70-74,13.1,15.2,742,Incidence,5259621,Non-Hispanic White,14.1,Female,Stomach,2017
70-74,24.9,27.7,1382,Incidence,5259621,Non-Hispanic White,26.3,Female,Thyroid,2017
70-74,45.9,49.6,2510,Incidence,5259621,Non-Hispanic White,47.7,Female,Urinary Bladder,2017
75-79,1916.5,1944.9,71495,Incidence,3703126,Non-Hispanic White,1930.7,Female,All Cancer Sites Combined,2017
75-79,17.2,20.0,688,Incidence,3703126,Non-Hispanic White,18.6,Female,Brain and Other Nervous System,2017
75-79,7.2,9.0,298,Incidence,3703126,Non-Hispanic White,8.0,Female,Cervix,2017
75-79,154.2,162.4,5861,Incidence,3703126,Non-Hispanic White,158.3,Female,Colon and Rectum,2017
75-79,92.3,98.6,3533,Incidence,3703126,Non-Hispanic White,95.4,Female,"Corpus and Uterus, NOS",2017
75-79,9.4,11.5,384,Incidence,3703126,Non-Hispanic White,10.4,Female,Esophagus,2017
75-79,476.2,490.4,17896,Incidence,3703126,Non-Hispanic White,483.3,Female,Female Breast,2017
75-79,79.3,85.1,3042,Incidence,3703126,Non-Hispanic White,82.1,Female,"Female Breast, <i>in situ</i>",2017
75-79,2.8,4.0,123,Incidence,3703126,Non-Hispanic White,3.3,Female,Hodgkin Lymphoma,2017
75-79,~,~,~,Incidence,3703126,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
75-79,52.1,56.8,2015,Incidence,3703126,Non-Hispanic White,54.4,Female,Kidney and Renal Pelvis,2017
75-79,3.8,5.2,165,Incidence,3703126,Non-Hispanic White,4.5,Female,Larynx,2017
75-79,55.6,60.5,2149,Incidence,3703126,Non-Hispanic White,58.0,Female,Leukemias,2017
75-79,20.7,23.8,822,Incidence,3703126,Non-Hispanic White,22.2,Female,Liver and Intrahepatic Bile Duct,2017
75-79,385.2,398.0,14500,Incidence,3703126,Non-Hispanic White,391.6,Female,Lung and Bronchus,2017
75-79,66.5,71.9,2561,Incidence,3703126,Non-Hispanic White,69.2,Female,Melanomas of the Skin,2017
75-79,2.3,3.4,104,Incidence,3703126,Non-Hispanic White,2.8,Female,Mesothelioma,2017
75-79,28.4,32.0,1116,Incidence,3703126,Non-Hispanic White,30.1,Female,Myeloma,2017
75-79,85.1,91.2,3264,Incidence,3703126,Non-Hispanic White,88.1,Female,Non-Hodgkin Lymphoma,2017
75-79,27.9,31.4,1096,Incidence,3703126,Non-Hispanic White,29.6,Female,Oral Cavity and Pharynx,2017
75-79,39.7,43.9,1545,Incidence,3703126,Non-Hispanic White,41.7,Female,Ovary,2017
75-79,70.8,76.4,2724,Incidence,3703126,Non-Hispanic White,73.6,Female,Pancreas,2017
75-79,16.2,19.0,650,Incidence,3703126,Non-Hispanic White,17.6,Female,Stomach,2017
75-79,21.3,24.4,844,Incidence,3703126,Non-Hispanic White,22.8,Female,Thyroid,2017
75-79,59.5,64.6,2297,Incidence,3703126,Non-Hispanic White,62.0,Female,Urinary Bladder,2017
80-84,1985.9,2019.9,53439,Incidence,2668102,Non-Hispanic White,2002.9,Female,All Cancer Sites Combined,2017
80-84,17.3,20.7,505,Incidence,2668102,Non-Hispanic White,18.9,Female,Brain and Other Nervous System,2017
80-84,6.1,8.2,190,Incidence,2668102,Non-Hispanic White,7.1,Female,Cervix,2017
80-84,200.5,211.5,5495,Incidence,2668102,Non-Hispanic White,206.0,Female,Colon and Rectum,2017
80-84,74.6,81.4,2080,Incidence,2668102,Non-Hispanic White,78.0,Female,"Corpus and Uterus, NOS",2017
80-84,11.2,14.0,335,Incidence,2668102,Non-Hispanic White,12.6,Female,Esophagus,2017
80-84,421.7,437.5,11460,Incidence,2668102,Non-Hispanic White,429.5,Female,Female Breast,2017
80-84,52.8,58.5,1483,Incidence,2668102,Non-Hispanic White,55.6,Female,"Female Breast, <i>in situ</i>",2017
80-84,2.9,4.4,95,Incidence,2668102,Non-Hispanic White,3.6,Female,Hodgkin Lymphoma,2017
80-84,~,~,~,Incidence,2668102,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
80-84,49.5,55.0,1392,Incidence,2668102,Non-Hispanic White,52.2,Female,Kidney and Renal Pelvis,2017
80-84,3.4,5.0,111,Incidence,2668102,Non-Hispanic White,4.2,Female,Larynx,2017
80-84,63.2,69.4,1768,Incidence,2668102,Non-Hispanic White,66.3,Female,Leukemias,2017
80-84,22.0,25.7,635,Incidence,2668102,Non-Hispanic White,23.8,Female,Liver and Intrahepatic Bile Duct,2017
80-84,372.1,386.9,10125,Incidence,2668102,Non-Hispanic White,379.5,Female,Lung and Bronchus,2017
80-84,73.5,80.2,2050,Incidence,2668102,Non-Hispanic White,76.8,Female,Melanomas of the Skin,2017
80-84,3.2,4.8,105,Incidence,2668102,Non-Hispanic White,3.9,Female,Mesothelioma,2017
80-84,34.1,38.8,971,Incidence,2668102,Non-Hispanic White,36.4,Female,Myeloma,2017
80-84,96.9,104.6,2687,Incidence,2668102,Non-Hispanic White,100.7,Female,Non-Hodgkin Lymphoma,2017
80-84,28.2,32.4,807,Incidence,2668102,Non-Hispanic White,30.2,Female,Oral Cavity and Pharynx,2017
80-84,41.3,46.4,1168,Incidence,2668102,Non-Hispanic White,43.8,Female,Ovary,2017
80-84,79.7,86.6,2217,Incidence,2668102,Non-Hispanic White,83.1,Female,Pancreas,2017
80-84,20.9,24.5,604,Incidence,2668102,Non-Hispanic White,22.6,Female,Stomach,2017
80-84,14.3,17.4,421,Incidence,2668102,Non-Hispanic White,15.8,Female,Thyroid,2017
80-84,71.5,78.1,1994,Incidence,2668102,Non-Hispanic White,74.7,Female,Urinary Bladder,2017
85+,1749.6,1778.1,59138,Incidence,3352877,Non-Hispanic White,1763.8,Female,All Cancer Sites Combined,2017
85+,14.7,17.4,536,Incidence,3352877,Non-Hispanic White,16.0,Female,Brain and Other Nervous System,2017
85+,5.6,7.4,216,Incidence,3352877,Non-Hispanic White,6.4,Female,Cervix,2017
85+,229.2,239.6,7859,Incidence,3352877,Non-Hispanic White,234.4,Female,Colon and Rectum,2017
85+,48.7,53.6,1713,Incidence,3352877,Non-Hispanic White,51.1,Female,"Corpus and Uterus, NOS",2017
85+,10.9,13.3,405,Incidence,3352877,Non-Hispanic White,12.1,Female,Esophagus,2017
85+,318.0,330.2,10865,Incidence,3352877,Non-Hispanic White,324.1,Female,Female Breast,2017
85+,20.9,24.1,753,Incidence,3352877,Non-Hispanic White,22.5,Female,"Female Breast, <i>in situ</i>",2017
85+,1.5,2.5,66,Incidence,3352877,Non-Hispanic White,2.0,Female,Hodgkin Lymphoma,2017
85+,~,~,~,Incidence,3352877,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
85+,39.8,44.2,1407,Incidence,3352877,Non-Hispanic White,42.0,Female,Kidney and Renal Pelvis,2017
85+,1.9,2.9,79,Incidence,3352877,Non-Hispanic White,2.4,Female,Larynx,2017
85+,66.8,72.5,2333,Incidence,3352877,Non-Hispanic White,69.6,Female,Leukemias,2017
85+,20.3,23.5,733,Incidence,3352877,Non-Hispanic White,21.9,Female,Liver and Intrahepatic Bile Duct,2017
85+,249.8,260.6,8556,Incidence,3352877,Non-Hispanic White,255.2,Female,Lung and Bronchus,2017
85+,69.0,74.7,2408,Incidence,3352877,Non-Hispanic White,71.8,Female,Melanomas of the Skin,2017
85+,2.5,3.7,103,Incidence,3352877,Non-Hispanic White,3.1,Female,Mesothelioma,2017
85+,26.0,29.6,931,Incidence,3352877,Non-Hispanic White,27.8,Female,Myeloma,2017
85+,83.3,89.6,2898,Incidence,3352877,Non-Hispanic White,86.4,Female,Non-Hodgkin Lymphoma,2017
85+,29.8,33.6,1061,Incidence,3352877,Non-Hispanic White,31.6,Female,Oral Cavity and Pharynx,2017
85+,36.5,40.7,1293,Incidence,3352877,Non-Hispanic White,38.6,Female,Ovary,2017
85+,87.3,93.8,3034,Incidence,3352877,Non-Hispanic White,90.5,Female,Pancreas,2017
85+,20.4,23.6,735,Incidence,3352877,Non-Hispanic White,21.9,Female,Stomach,2017
85+,7.9,9.9,297,Incidence,3352877,Non-Hispanic White,8.9,Female,Thyroid,2017
85+,73.0,78.9,2546,Incidence,3352877,Non-Hispanic White,75.9,Female,Urinary Bladder,2017
<1,25.2,32.1,275,Incidence,965208,Non-Hispanic White,28.5,Female,All Cancer Sites Combined,2017
<1,2.8,5.4,38,Incidence,965208,Non-Hispanic White,3.9,Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Cervix,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Colon and Rectum,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Esophagus,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Female Breast,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Kaposi Sarcoma,2017
<1,1.3,3.2,20,Incidence,965208,Non-Hispanic White,2.1,Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Larynx,2017
<1,3.0,5.6,40,Incidence,965208,Non-Hispanic White,4.1,Female,Leukemias,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Mesothelioma,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Myeloma,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Ovary,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Pancreas,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Stomach,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Thyroid,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Female,Urinary Bladder,2017
1-4,23.8,26.9,1074,Incidence,4238104,Non-Hispanic White,25.3,Male,All Cancer Sites Combined,2017
1-4,4.7,6.1,228,Incidence,4238104,Non-Hispanic White,5.4,Male,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Colon and Rectum,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Esophagus,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Kaposi Sarcoma,2017
1-4,1.4,2.2,75,Incidence,4238104,Non-Hispanic White,1.8,Male,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Larynx,2017
1-4,8.9,10.9,418,Incidence,4238104,Non-Hispanic White,9.9,Male,Leukemias,2017
1-4,0.6,1.1,35,Incidence,4238104,Non-Hispanic White,0.8,Male,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Lung and Bronchus,2017
1-4,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Mesothelioma,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Myeloma,2017
1-4,0.5,1.1,33,Incidence,4238104,Non-Hispanic White,0.8,Male,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Pancreas,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Prostate,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Stomach,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Testis,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Thyroid,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male,Urinary Bladder,2017
10-14,15.4,17.5,933,Incidence,5671510,Non-Hispanic White,16.5,Male,All Cancer Sites Combined,2017
10-14,3.6,4.7,234,Incidence,5671510,Non-Hispanic White,4.1,Male,Brain and Other Nervous System,2017
10-14,0.5,1.0,40,Incidence,5671510,Non-Hispanic White,0.7,Male,Colon and Rectum,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Esophagus,2017
10-14,1.0,1.6,73,Incidence,5671510,Non-Hispanic White,1.3,Male,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Kaposi Sarcoma,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Larynx,2017
10-14,2.4,3.3,158,Incidence,5671510,Non-Hispanic White,2.8,Male,Leukemias,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Lung and Bronchus,2017
10-14,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Mesothelioma,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Myeloma,2017
10-14,1.6,2.4,111,Incidence,5671510,Non-Hispanic White,2.0,Male,Non-Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Pancreas,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Prostate,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Stomach,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Testis,2017
10-14,0.2,0.5,20,Incidence,5671510,Non-Hispanic White,0.4,Male,Thyroid,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male,Urinary Bladder,2017
15-19,24.5,27.1,1526,Incidence,5927693,Non-Hispanic White,25.7,Male,All Cancer Sites Combined,2017
15-19,2.9,3.8,197,Incidence,5927693,Non-Hispanic White,3.3,Male,Brain and Other Nervous System,2017
15-19,1.2,1.8,89,Incidence,5927693,Non-Hispanic White,1.5,Male,Colon and Rectum,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Esophagus,2017
15-19,2.8,3.7,189,Incidence,5927693,Non-Hispanic White,3.2,Male,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Kaposi Sarcoma,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Larynx,2017
15-19,2.8,3.7,193,Incidence,5927693,Non-Hispanic White,3.3,Male,Leukemias,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Lung and Bronchus,2017
15-19,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
15-19,0.6,1.1,51,Incidence,5927693,Non-Hispanic White,0.9,Male,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Mesothelioma,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Myeloma,2017
15-19,2.4,3.3,167,Incidence,5927693,Non-Hispanic White,2.8,Male,Non-Hodgkin Lymphoma,2017
15-19,0.2,0.5,17,Incidence,5927693,Non-Hispanic White,0.3,Male,Oral Cavity and Pharynx,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Pancreas,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Prostate,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Stomach,2017
15-19,3.2,4.2,216,Incidence,5927693,Non-Hispanic White,3.6,Male,Testis,2017
15-19,0.9,1.5,69,Incidence,5927693,Non-Hispanic White,1.2,Male,Thyroid,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male,Urinary Bladder,2017
20-24,38.1,41.2,2476,Incidence,6249904,Non-Hispanic White,39.6,Male,All Cancer Sites Combined,2017
20-24,2.3,3.2,170,Incidence,6249904,Non-Hispanic White,2.7,Male,Brain and Other Nervous System,2017
20-24,1.9,2.6,138,Incidence,6249904,Non-Hispanic White,2.2,Male,Colon and Rectum,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Esophagus,2017
20-24,4.5,5.6,312,Incidence,6249904,Non-Hispanic White,5.0,Male,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Kaposi Sarcoma,2017
20-24,0.3,0.6,28,Incidence,6249904,Non-Hispanic White,0.4,Male,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Larynx,2017
20-24,2.4,3.2,172,Incidence,6249904,Non-Hispanic White,2.8,Male,Leukemias,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2017
20-24,0.2,0.5,20,Incidence,6249904,Non-Hispanic White,0.3,Male,Lung and Bronchus,2017
20-24,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
20-24,2.0,2.8,149,Incidence,6249904,Non-Hispanic White,2.4,Male,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Mesothelioma,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Myeloma,2017
20-24,2.6,3.4,186,Incidence,6249904,Non-Hispanic White,3.0,Male,Non-Hodgkin Lymphoma,2017
20-24,0.3,0.6,27,Incidence,6249904,Non-Hispanic White,0.4,Male,Oral Cavity and Pharynx,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Pancreas,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Prostate,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male,Stomach,2017
20-24,11.2,12.9,751,Incidence,6249904,Non-Hispanic White,12.0,Male,Testis,2017
20-24,2.3,3.1,166,Incidence,6249904,Non-Hispanic White,2.7,Male,Thyroid,2017
20-24,0.2,0.5,20,Incidence,6249904,Non-Hispanic White,0.3,Male,Urinary Bladder,2017
25-29,53.6,57.2,3676,Incidence,6637083,Non-Hispanic White,55.4,Male,All Cancer Sites Combined,2017
25-29,2.8,3.6,211,Incidence,6637083,Non-Hispanic White,3.2,Male,Brain and Other Nervous System,2017
25-29,2.8,3.7,212,Incidence,6637083,Non-Hispanic White,3.2,Male,Colon and Rectum,2017
25-29,~,~,~,Incidence,6637083,Non-Hispanic White,~,Male,Esophagus,2017
25-29,4.3,5.4,321,Incidence,6637083,Non-Hispanic White,4.8,Male,Hodgkin Lymphoma,2017
25-29,0.2,0.4,18,Incidence,6637083,Non-Hispanic White,0.3,Male,Kaposi Sarcoma,2017
25-29,1.2,1.8,97,Incidence,6637083,Non-Hispanic White,1.5,Male,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,6637083,Non-Hispanic White,~,Male,Larynx,2017
25-29,2.4,3.2,183,Incidence,6637083,Non-Hispanic White,2.8,Male,Leukemias,2017
25-29,0.2,0.4,19,Incidence,6637083,Non-Hispanic White,0.3,Male,Liver and Intrahepatic Bile Duct,2017
25-29,0.5,0.9,43,Incidence,6637083,Non-Hispanic White,0.6,Male,Lung and Bronchus,2017
25-29,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
25-29,4.3,5.4,320,Incidence,6637083,Non-Hispanic White,4.8,Male,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,6637083,Non-Hispanic White,~,Male,Mesothelioma,2017
25-29,~,~,~,Incidence,6637083,Non-Hispanic White,~,Male,Myeloma,2017
25-29,3.4,4.4,259,Incidence,6637083,Non-Hispanic White,3.9,Male,Non-Hodgkin Lymphoma,2017
25-29,0.8,1.3,70,Incidence,6637083,Non-Hispanic White,1.1,Male,Oral Cavity and Pharynx,2017
25-29,0.2,0.4,19,Incidence,6637083,Non-Hispanic White,0.3,Male,Pancreas,2017
25-29,~,~,~,Incidence,6637083,Non-Hispanic White,~,Male,Prostate,2017
25-29,0.2,0.5,24,Incidence,6637083,Non-Hispanic White,0.4,Male,Stomach,2017
25-29,17.0,19.0,1193,Incidence,6637083,Non-Hispanic White,18.0,Male,Testis,2017
25-29,3.9,5.0,293,Incidence,6637083,Non-Hispanic White,4.4,Male,Thyroid,2017
25-29,0.4,0.8,41,Incidence,6637083,Non-Hispanic White,0.6,Male,Urinary Bladder,2017
30-34,76.3,80.7,4969,Incidence,6332751,Non-Hispanic White,78.5,Male,All Cancer Sites Combined,2017
30-34,4.6,5.7,325,Incidence,6332751,Non-Hispanic White,5.1,Male,Brain and Other Nervous System,2017
30-34,6.3,7.6,436,Incidence,6332751,Non-Hispanic White,6.9,Male,Colon and Rectum,2017
30-34,0.2,0.5,23,Incidence,6332751,Non-Hispanic White,0.4,Male,Esophagus,2017
30-34,3.8,4.9,275,Incidence,6332751,Non-Hispanic White,4.3,Male,Hodgkin Lymphoma,2017
30-34,0.2,0.4,18,Incidence,6332751,Non-Hispanic White,0.3,Male,Kaposi Sarcoma,2017
30-34,3.6,4.6,260,Incidence,6332751,Non-Hispanic White,4.1,Male,Kidney and Renal Pelvis,2017
30-34,~,~,~,Incidence,6332751,Non-Hispanic White,~,Male,Larynx,2017
30-34,3.5,4.5,250,Incidence,6332751,Non-Hispanic White,3.9,Male,Leukemias,2017
30-34,0.3,0.6,26,Incidence,6332751,Non-Hispanic White,0.4,Male,Liver and Intrahepatic Bile Duct,2017
30-34,1.1,1.6,84,Incidence,6332751,Non-Hispanic White,1.3,Male,Lung and Bronchus,2017
30-34,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
30-34,9.0,10.6,621,Incidence,6332751,Non-Hispanic White,9.8,Male,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,6332751,Non-Hispanic White,~,Male,Mesothelioma,2017
30-34,0.2,0.4,18,Incidence,6332751,Non-Hispanic White,0.3,Male,Myeloma,2017
30-34,4.6,5.8,327,Incidence,6332751,Non-Hispanic White,5.2,Male,Non-Hodgkin Lymphoma,2017
30-34,1.5,2.2,117,Incidence,6332751,Non-Hispanic White,1.8,Male,Oral Cavity and Pharynx,2017
30-34,0.5,1.0,46,Incidence,6332751,Non-Hispanic White,0.7,Male,Pancreas,2017
30-34,~,~,~,Incidence,6332751,Non-Hispanic White,~,Male,Prostate,2017
30-34,0.5,0.9,41,Incidence,6332751,Non-Hispanic White,0.6,Male,Stomach,2017
30-34,16.6,18.7,1116,Incidence,6332751,Non-Hispanic White,17.6,Male,Testis,2017
30-34,6.1,7.4,425,Incidence,6332751,Non-Hispanic White,6.7,Male,Thyroid,2017
30-34,0.9,1.5,74,Incidence,6332751,Non-Hispanic White,1.2,Male,Urinary Bladder,2017
35-39,110.1,115.5,6902,Incidence,6119766,Non-Hispanic White,112.8,Male,All Cancer Sites Combined,2017
35-39,5.2,6.4,353,Incidence,6119766,Non-Hispanic White,5.8,Male,Brain and Other Nervous System,2017
35-39,12.7,14.5,831,Incidence,6119766,Non-Hispanic White,13.6,Male,Colon and Rectum,2017
35-39,0.7,1.2,54,Incidence,6119766,Non-Hispanic White,0.9,Male,Esophagus,2017
35-39,3.1,4.1,219,Incidence,6119766,Non-Hispanic White,3.6,Male,Hodgkin Lymphoma,2017
35-39,0.4,0.7,32,Incidence,6119766,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2017
35-39,7.4,8.8,495,Incidence,6119766,Non-Hispanic White,8.1,Male,Kidney and Renal Pelvis,2017
35-39,0.4,0.8,36,Incidence,6119766,Non-Hispanic White,0.6,Male,Larynx,2017
35-39,4.7,5.8,320,Incidence,6119766,Non-Hispanic White,5.2,Male,Leukemias,2017
35-39,0.6,1.1,50,Incidence,6119766,Non-Hispanic White,0.8,Male,Liver and Intrahepatic Bile Duct,2017
35-39,2.1,2.9,149,Incidence,6119766,Non-Hispanic White,2.4,Male,Lung and Bronchus,2017
35-39,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
35-39,15.0,17.1,981,Incidence,6119766,Non-Hispanic White,16.0,Male,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,6119766,Non-Hispanic White,~,Male,Mesothelioma,2017
35-39,0.6,1.1,49,Incidence,6119766,Non-Hispanic White,0.8,Male,Myeloma,2017
35-39,6.9,8.3,461,Incidence,6119766,Non-Hispanic White,7.5,Male,Non-Hodgkin Lymphoma,2017
35-39,3.4,4.4,235,Incidence,6119766,Non-Hispanic White,3.8,Male,Oral Cavity and Pharynx,2017
35-39,1.4,2.0,102,Incidence,6119766,Non-Hispanic White,1.7,Male,Pancreas,2017
35-39,0.5,0.9,39,Incidence,6119766,Non-Hispanic White,0.6,Male,Prostate,2017
35-39,1.2,1.8,91,Incidence,6119766,Non-Hispanic White,1.5,Male,Stomach,2017
35-39,14.3,16.3,937,Incidence,6119766,Non-Hispanic White,15.3,Male,Testis,2017
35-39,9.4,11.0,625,Incidence,6119766,Non-Hispanic White,10.2,Male,Thyroid,2017
35-39,2.1,2.9,150,Incidence,6119766,Non-Hispanic White,2.5,Male,Urinary Bladder,2017
40-44,163.4,170.1,9463,Incidence,5675804,Non-Hispanic White,166.7,Male,All Cancer Sites Combined,2017
40-44,5.0,6.2,317,Incidence,5675804,Non-Hispanic White,5.6,Male,Brain and Other Nervous System,2017
40-44,22.3,24.8,1334,Incidence,5675804,Non-Hispanic White,23.5,Male,Colon and Rectum,2017
40-44,1.9,2.7,130,Incidence,5675804,Non-Hispanic White,2.3,Male,Esophagus,2017
40-44,2.8,3.8,187,Incidence,5675804,Non-Hispanic White,3.3,Male,Hodgkin Lymphoma,2017
40-44,0.2,0.6,22,Incidence,5675804,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2017
40-44,14.5,16.5,878,Incidence,5675804,Non-Hispanic White,15.5,Male,Kidney and Renal Pelvis,2017
40-44,1.0,1.6,74,Incidence,5675804,Non-Hispanic White,1.3,Male,Larynx,2017
40-44,6.5,8.0,410,Incidence,5675804,Non-Hispanic White,7.2,Male,Leukemias,2017
40-44,1.5,2.3,107,Incidence,5675804,Non-Hispanic White,1.9,Male,Liver and Intrahepatic Bile Duct,2017
40-44,6.1,7.5,385,Incidence,5675804,Non-Hispanic White,6.8,Male,Lung and Bronchus,2017
40-44,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
40-44,20.9,23.4,1255,Incidence,5675804,Non-Hispanic White,22.1,Male,Melanomas of the Skin,2017
40-44,~,~,~,Incidence,5675804,Non-Hispanic White,~,Male,Mesothelioma,2017
40-44,1.9,2.7,128,Incidence,5675804,Non-Hispanic White,2.3,Male,Myeloma,2017
40-44,10.1,11.8,619,Incidence,5675804,Non-Hispanic White,10.9,Male,Non-Hodgkin Lymphoma,2017
40-44,8.6,10.2,532,Incidence,5675804,Non-Hispanic White,9.4,Male,Oral Cavity and Pharynx,2017
40-44,3.0,4.0,199,Incidence,5675804,Non-Hispanic White,3.5,Male,Pancreas,2017
40-44,4.5,5.7,290,Incidence,5675804,Non-Hispanic White,5.1,Male,Prostate,2017
40-44,2.4,3.3,159,Incidence,5675804,Non-Hispanic White,2.8,Male,Stomach,2017
40-44,10.2,12.0,629,Incidence,5675804,Non-Hispanic White,11.1,Male,Testis,2017
40-44,10.1,11.8,620,Incidence,5675804,Non-Hispanic White,10.9,Male,Thyroid,2017
40-44,4.4,5.6,284,Incidence,5675804,Non-Hispanic White,5.0,Male,Urinary Bladder,2017
45-49,288.9,297.3,19015,Incidence,6487643,Non-Hispanic White,293.1,Male,All Cancer Sites Combined,2017
45-49,6.9,8.3,491,Incidence,6487643,Non-Hispanic White,7.6,Male,Brain and Other Nervous System,2017
45-49,41.1,44.3,2768,Incidence,6487643,Non-Hispanic White,42.7,Male,Colon and Rectum,2017
45-49,4.5,5.6,323,Incidence,6487643,Non-Hispanic White,5.0,Male,Esophagus,2017
45-49,2.7,3.6,201,Incidence,6487643,Non-Hispanic White,3.1,Male,Hodgkin Lymphoma,2017
45-49,0.3,0.7,32,Incidence,6487643,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2017
45-49,23.8,26.3,1625,Incidence,6487643,Non-Hispanic White,25.0,Male,Kidney and Renal Pelvis,2017
45-49,3.4,4.3,249,Incidence,6487643,Non-Hispanic White,3.8,Male,Larynx,2017
45-49,10.5,12.2,735,Incidence,6487643,Non-Hispanic White,11.3,Male,Leukemias,2017
45-49,3.7,4.7,270,Incidence,6487643,Non-Hispanic White,4.2,Male,Liver and Intrahepatic Bile Duct,2017
45-49,17.7,19.8,1217,Incidence,6487643,Non-Hispanic White,18.8,Male,Lung and Bronchus,2017
45-49,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
45-49,29.9,32.6,2027,Incidence,6487643,Non-Hispanic White,31.2,Male,Melanomas of the Skin,2017
45-49,~,~,~,Incidence,6487643,Non-Hispanic White,~,Male,Mesothelioma,2017
45-49,4.5,5.6,329,Incidence,6487643,Non-Hispanic White,5.1,Male,Myeloma,2017
45-49,16.3,18.3,1120,Incidence,6487643,Non-Hispanic White,17.3,Male,Non-Hodgkin Lymphoma,2017
45-49,20.5,22.8,1404,Incidence,6487643,Non-Hispanic White,21.6,Male,Oral Cavity and Pharynx,2017
45-49,7.2,8.5,508,Incidence,6487643,Non-Hispanic White,7.8,Male,Pancreas,2017
45-49,25.4,28.0,1730,Incidence,6487643,Non-Hispanic White,26.7,Male,Prostate,2017
45-49,4.1,5.1,296,Incidence,6487643,Non-Hispanic White,4.6,Male,Stomach,2017
45-49,7.5,9.0,534,Incidence,6487643,Non-Hispanic White,8.2,Male,Testis,2017
45-49,10.7,12.3,745,Incidence,6487643,Non-Hispanic White,11.5,Male,Thyroid,2017
45-49,10.3,12.0,722,Incidence,6487643,Non-Hispanic White,11.1,Male,Urinary Bladder,2017
5-9,14.1,16.2,815,Incidence,5386121,Non-Hispanic White,15.1,Male,All Cancer Sites Combined,2017
5-9,4.3,5.5,261,Incidence,5386121,Non-Hispanic White,4.8,Male,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Colon and Rectum,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Esophagus,2017
5-9,0.3,0.7,25,Incidence,5386121,Non-Hispanic White,0.5,Male,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Kaposi Sarcoma,2017
5-9,0.3,0.7,24,Incidence,5386121,Non-Hispanic White,0.4,Male,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Larynx,2017
5-9,3.4,4.4,209,Incidence,5386121,Non-Hispanic White,3.9,Male,Leukemias,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Lung and Bronchus,2017
5-9,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Mesothelioma,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Myeloma,2017
5-9,1.3,2.0,88,Incidence,5386121,Non-Hispanic White,1.6,Male,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Pancreas,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Prostate,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Stomach,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Testis,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Thyroid,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male,Urinary Bladder,2017
50-54,543.2,554.2,38170,Incidence,6956772,Non-Hispanic White,548.7,Male,All Cancer Sites Combined,2017
50-54,9.7,11.3,730,Incidence,6956772,Non-Hispanic White,10.5,Male,Brain and Other Nervous System,2017
50-54,70.5,74.5,5044,Incidence,6956772,Non-Hispanic White,72.5,Male,Colon and Rectum,2017
50-54,9.0,10.4,673,Incidence,6956772,Non-Hispanic White,9.7,Male,Esophagus,2017
50-54,2.7,3.5,216,Incidence,6956772,Non-Hispanic White,3.1,Male,Hodgkin Lymphoma,2017
50-54,0.5,0.9,47,Incidence,6956772,Non-Hispanic White,0.7,Male,Kaposi Sarcoma,2017
50-54,35.2,38.0,2544,Incidence,6956772,Non-Hispanic White,36.6,Male,Kidney and Renal Pelvis,2017
50-54,7.7,9.1,581,Incidence,6956772,Non-Hispanic White,8.4,Male,Larynx,2017
50-54,16.1,18.1,1187,Incidence,6956772,Non-Hispanic White,17.1,Male,Leukemias,2017
50-54,11.8,13.5,878,Incidence,6956772,Non-Hispanic White,12.6,Male,Liver and Intrahepatic Bile Duct,2017
50-54,49.0,52.4,3524,Incidence,6956772,Non-Hispanic White,50.7,Male,Lung and Bronchus,2017
50-54,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
50-54,42.1,45.2,3036,Incidence,6956772,Non-Hispanic White,43.6,Male,Melanomas of the Skin,2017
50-54,0.4,0.7,37,Incidence,6956772,Non-Hispanic White,0.5,Male,Mesothelioma,2017
50-54,6.6,7.9,505,Incidence,6956772,Non-Hispanic White,7.3,Male,Myeloma,2017
50-54,24.6,27.0,1794,Incidence,6956772,Non-Hispanic White,25.8,Male,Non-Hodgkin Lymphoma,2017
50-54,39.0,42.0,2815,Incidence,6956772,Non-Hispanic White,40.5,Male,Oral Cavity and Pharynx,2017
50-54,13.7,15.5,1014,Incidence,6956772,Non-Hispanic White,14.6,Male,Pancreas,2017
50-54,102.8,107.6,7318,Incidence,6956772,Non-Hispanic White,105.2,Male,Prostate,2017
50-54,6.8,8.1,518,Incidence,6956772,Non-Hispanic White,7.4,Male,Stomach,2017
50-54,4.6,5.6,353,Incidence,6956772,Non-Hispanic White,5.1,Male,Testis,2017
50-54,12.6,14.4,937,Incidence,6956772,Non-Hispanic White,13.5,Male,Thyroid,2017
50-54,22.3,24.6,1628,Incidence,6956772,Non-Hispanic White,23.4,Male,Urinary Bladder,2017
55-59,910.2,923.9,69090,Incidence,7533743,Non-Hispanic White,917.1,Male,All Cancer Sites Combined,2017
55-59,12.7,14.4,1020,Incidence,7533743,Non-Hispanic White,13.5,Male,Brain and Other Nervous System,2017
55-59,78.2,82.2,6040,Incidence,7533743,Non-Hispanic White,80.2,Male,Colon and Rectum,2017
55-59,16.9,18.8,1341,Incidence,7533743,Non-Hispanic White,17.8,Male,Esophagus,2017
55-59,3.0,3.9,258,Incidence,7533743,Non-Hispanic White,3.4,Male,Hodgkin Lymphoma,2017
55-59,0.3,0.7,36,Incidence,7533743,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2017
55-59,48.6,51.8,3778,Incidence,7533743,Non-Hispanic White,50.1,Male,Kidney and Renal Pelvis,2017
55-59,12.7,14.4,1019,Incidence,7533743,Non-Hispanic White,13.5,Male,Larynx,2017
55-59,25.4,27.7,1997,Incidence,7533743,Non-Hispanic White,26.5,Male,Leukemias,2017
55-59,29.6,32.1,2322,Incidence,7533743,Non-Hispanic White,30.8,Male,Liver and Intrahepatic Bile Duct,2017
55-59,107.5,112.3,8279,Incidence,7533743,Non-Hispanic White,109.9,Male,Lung and Bronchus,2017
55-59,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
55-59,60.0,63.5,4650,Incidence,7533743,Non-Hispanic White,61.7,Male,Melanomas of the Skin,2017
55-59,0.7,1.1,68,Incidence,7533743,Non-Hispanic White,0.9,Male,Mesothelioma,2017
55-59,12.0,13.7,967,Incidence,7533743,Non-Hispanic White,12.8,Male,Myeloma,2017
55-59,36.1,38.9,2826,Incidence,7533743,Non-Hispanic White,37.5,Male,Non-Hodgkin Lymphoma,2017
55-59,56.7,60.2,4402,Incidence,7533743,Non-Hispanic White,58.4,Male,Oral Cavity and Pharynx,2017
55-59,24.7,27.1,1950,Incidence,7533743,Non-Hispanic White,25.9,Male,Pancreas,2017
55-59,234.4,241.4,17922,Incidence,7533743,Non-Hispanic White,237.9,Male,Prostate,2017
55-59,12.1,13.7,969,Incidence,7533743,Non-Hispanic White,12.9,Male,Stomach,2017
55-59,3.3,4.2,279,Incidence,7533743,Non-Hispanic White,3.7,Male,Testis,2017
55-59,14.7,16.5,1176,Incidence,7533743,Non-Hispanic White,15.6,Male,Thyroid,2017
55-59,43.1,46.1,3361,Incidence,7533743,Non-Hispanic White,44.6,Male,Urinary Bladder,2017
60-64,1373.4,1390.9,96865,Incidence,7008393,Non-Hispanic White,1382.1,Male,All Cancer Sites Combined,2017
60-64,17.5,19.5,1293,Incidence,7008393,Non-Hispanic White,18.4,Male,Brain and Other Nervous System,2017
60-64,99.2,104.0,7119,Incidence,7008393,Non-Hispanic White,101.6,Male,Colon and Rectum,2017
60-64,26.0,28.4,1906,Incidence,7008393,Non-Hispanic White,27.2,Male,Esophagus,2017
60-64,2.8,3.7,227,Incidence,7008393,Non-Hispanic White,3.2,Male,Hodgkin Lymphoma,2017
60-64,0.3,0.7,35,Incidence,7008393,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2017
60-64,64.0,67.8,4620,Incidence,7008393,Non-Hispanic White,65.9,Male,Kidney and Renal Pelvis,2017
60-64,18.6,20.7,1374,Incidence,7008393,Non-Hispanic White,19.6,Male,Larynx,2017
60-64,38.6,41.6,2807,Incidence,7008393,Non-Hispanic White,40.1,Male,Leukemias,2017
60-64,47.4,50.7,3435,Incidence,7008393,Non-Hispanic White,49.0,Male,Liver and Intrahepatic Bile Duct,2017
60-64,175.2,181.5,12498,Incidence,7008393,Non-Hispanic White,178.3,Male,Lung and Bronchus,2017
60-64,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
60-64,81.8,86.1,5884,Incidence,7008393,Non-Hispanic White,84.0,Male,Melanomas of the Skin,2017
60-64,1.5,2.2,127,Incidence,7008393,Non-Hispanic White,1.8,Male,Mesothelioma,2017
60-64,18.3,20.3,1351,Incidence,7008393,Non-Hispanic White,19.3,Male,Myeloma,2017
60-64,50.5,53.9,3655,Incidence,7008393,Non-Hispanic White,52.2,Male,Non-Hodgkin Lymphoma,2017
60-64,69.0,73.0,4975,Incidence,7008393,Non-Hispanic White,71.0,Male,Oral Cavity and Pharynx,2017
60-64,38.3,41.3,2787,Incidence,7008393,Non-Hispanic White,39.8,Male,Pancreas,2017
60-64,400.9,410.4,28427,Incidence,7008393,Non-Hispanic White,405.6,Male,Prostate,2017
60-64,17.4,19.5,1291,Incidence,7008393,Non-Hispanic White,18.4,Male,Stomach,2017
60-64,2.3,3.1,188,Incidence,7008393,Non-Hispanic White,2.7,Male,Testis,2017
60-64,15.2,17.1,1130,Incidence,7008393,Non-Hispanic White,16.1,Male,Thyroid,2017
60-64,76.2,80.4,5486,Incidence,7008393,Non-Hispanic White,78.3,Male,Urinary Bladder,2017
65-69,1976.9,1999.5,119954,Incidence,6033382,Non-Hispanic White,1988.2,Male,All Cancer Sites Combined,2017
65-69,20.3,22.7,1295,Incidence,6033382,Non-Hispanic White,21.5,Male,Brain and Other Nervous System,2017
65-69,131.3,137.1,8095,Incidence,6033382,Non-Hispanic White,134.2,Male,Colon and Rectum,2017
65-69,34.7,37.7,2182,Incidence,6033382,Non-Hispanic White,36.2,Male,Esophagus,2017
65-69,3.5,4.5,242,Incidence,6033382,Non-Hispanic White,4.0,Male,Hodgkin Lymphoma,2017
65-69,0.2,0.6,23,Incidence,6033382,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2017
65-69,86.9,91.7,5384,Incidence,6033382,Non-Hispanic White,89.2,Male,Kidney and Renal Pelvis,2017
65-69,20.5,22.9,1306,Incidence,6033382,Non-Hispanic White,21.6,Male,Larynx,2017
65-69,53.6,57.4,3348,Incidence,6033382,Non-Hispanic White,55.5,Male,Leukemias,2017
65-69,51.3,55.0,3203,Incidence,6033382,Non-Hispanic White,53.1,Male,Liver and Intrahepatic Bile Duct,2017
65-69,267.0,275.4,16361,Incidence,6033382,Non-Hispanic White,271.2,Male,Lung and Bronchus,2017
65-69,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
65-69,118.6,124.2,7323,Incidence,6033382,Non-Hispanic White,121.4,Male,Melanomas of the Skin,2017
65-69,3.4,4.4,233,Incidence,6033382,Non-Hispanic White,3.9,Male,Mesothelioma,2017
65-69,28.9,31.7,1827,Incidence,6033382,Non-Hispanic White,30.3,Male,Myeloma,2017
65-69,75.4,79.8,4681,Incidence,6033382,Non-Hispanic White,77.6,Male,Non-Hodgkin Lymphoma,2017
65-69,74.6,79.0,4634,Incidence,6033382,Non-Hispanic White,76.8,Male,Oral Cavity and Pharynx,2017
65-69,58.0,62.0,3618,Incidence,6033382,Non-Hispanic White,60.0,Male,Pancreas,2017
65-69,616.7,629.3,37587,Incidence,6033382,Non-Hispanic White,623.0,Male,Prostate,2017
65-69,24.8,27.4,1572,Incidence,6033382,Non-Hispanic White,26.1,Male,Stomach,2017
65-69,1.2,1.9,92,Incidence,6033382,Non-Hispanic White,1.5,Male,Testis,2017
65-69,17.7,19.9,1133,Incidence,6033382,Non-Hispanic White,18.8,Male,Thyroid,2017
65-69,130.9,136.8,8073,Incidence,6033382,Non-Hispanic White,133.8,Male,Urinary Bladder,2017
70-74,2399.6,2427.8,112930,Incidence,4678761,Non-Hispanic White,2413.7,Male,All Cancer Sites Combined,2017
70-74,24.1,27.0,1195,Incidence,4678761,Non-Hispanic White,25.5,Male,Brain and Other Nervous System,2017
70-74,154.8,162.1,7412,Incidence,4678761,Non-Hispanic White,158.4,Male,Colon and Rectum,2017
70-74,42.6,46.5,2082,Incidence,4678761,Non-Hispanic White,44.5,Male,Esophagus,2017
70-74,4.0,5.3,215,Incidence,4678761,Non-Hispanic White,4.6,Male,Hodgkin Lymphoma,2017
70-74,0.4,0.9,28,Incidence,4678761,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2017
70-74,99.6,105.4,4793,Incidence,4678761,Non-Hispanic White,102.4,Male,Kidney and Renal Pelvis,2017
70-74,23.3,26.1,1154,Incidence,4678761,Non-Hispanic White,24.7,Male,Larynx,2017
70-74,75.9,81.0,3667,Incidence,4678761,Non-Hispanic White,78.4,Male,Leukemias,2017
70-74,47.0,51.0,2291,Incidence,4678761,Non-Hispanic White,49.0,Male,Liver and Intrahepatic Bile Duct,2017
70-74,381.2,392.5,18100,Incidence,4678761,Non-Hispanic White,386.9,Male,Lung and Bronchus,2017
70-74,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
70-74,150.8,157.9,7221,Incidence,4678761,Non-Hispanic White,154.3,Male,Melanomas of the Skin,2017
70-74,7.6,9.3,393,Incidence,4678761,Non-Hispanic White,8.4,Male,Mesothelioma,2017
70-74,36.6,40.1,1793,Incidence,4678761,Non-Hispanic White,38.3,Male,Myeloma,2017
70-74,103.6,109.6,4986,Incidence,4678761,Non-Hispanic White,106.6,Male,Non-Hodgkin Lymphoma,2017
70-74,73.6,78.6,3560,Incidence,4678761,Non-Hispanic White,76.1,Male,Oral Cavity and Pharynx,2017
70-74,75.3,80.4,3642,Incidence,4678761,Non-Hispanic White,77.8,Male,Pancreas,2017
70-74,640.4,655.0,30305,Incidence,4678761,Non-Hispanic White,647.7,Male,Prostate,2017
70-74,31.9,35.3,1570,Incidence,4678761,Non-Hispanic White,33.6,Male,Stomach,2017
70-74,0.9,1.6,57,Incidence,4678761,Non-Hispanic White,1.2,Male,Testis,2017
70-74,17.3,19.7,864,Incidence,4678761,Non-Hispanic White,18.5,Male,Thyroid,2017
70-74,191.4,199.4,9140,Incidence,4678761,Non-Hispanic White,195.4,Male,Urinary Bladder,2017
75-79,2761.1,2798.4,85526,Incidence,3076790,Non-Hispanic White,2779.7,Male,All Cancer Sites Combined,2017
75-79,26.3,30.1,866,Incidence,3076790,Non-Hispanic White,28.1,Male,Brain and Other Nervous System,2017
75-79,198.0,208.1,6245,Incidence,3076790,Non-Hispanic White,203.0,Male,Colon and Rectum,2017
75-79,44.5,49.4,1443,Incidence,3076790,Non-Hispanic White,46.9,Male,Esophagus,2017
75-79,3.9,5.5,144,Incidence,3076790,Non-Hispanic White,4.7,Male,Hodgkin Lymphoma,2017
75-79,0.6,1.3,27,Incidence,3076790,Non-Hispanic White,0.9,Male,Kaposi Sarcoma,2017
75-79,106.2,113.7,3381,Incidence,3076790,Non-Hispanic White,109.9,Male,Kidney and Renal Pelvis,2017
75-79,21.8,25.3,724,Incidence,3076790,Non-Hispanic White,23.5,Male,Larynx,2017
75-79,99.1,106.3,3159,Incidence,3076790,Non-Hispanic White,102.7,Male,Leukemias,2017
75-79,49.1,54.2,1588,Incidence,3076790,Non-Hispanic White,51.6,Male,Liver and Intrahepatic Bile Duct,2017
75-79,478.4,494.0,14957,Incidence,3076790,Non-Hispanic White,486.1,Male,Lung and Bronchus,2017
75-79,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
75-79,193.7,203.7,6113,Incidence,3076790,Non-Hispanic White,198.7,Male,Melanomas of the Skin,2017
75-79,12.9,15.6,438,Incidence,3076790,Non-Hispanic White,14.2,Male,Mesothelioma,2017
75-79,47.7,52.7,1544,Incidence,3076790,Non-Hispanic White,50.2,Male,Myeloma,2017
75-79,133.1,141.5,4223,Incidence,3076790,Non-Hispanic White,137.3,Male,Non-Hodgkin Lymphoma,2017
75-79,70.7,76.8,2268,Incidence,3076790,Non-Hispanic White,73.7,Male,Oral Cavity and Pharynx,2017
75-79,93.0,100.0,2967,Incidence,3076790,Non-Hispanic White,96.4,Male,Pancreas,2017
75-79,557.2,574.0,17401,Incidence,3076790,Non-Hispanic White,565.6,Male,Prostate,2017
75-79,39.8,44.4,1295,Incidence,3076790,Non-Hispanic White,42.1,Male,Stomach,2017
75-79,0.5,1.2,25,Incidence,3076790,Non-Hispanic White,0.8,Male,Testis,2017
75-79,16.8,19.8,562,Incidence,3076790,Non-Hispanic White,18.3,Male,Thyroid,2017
75-79,264.2,275.9,8308,Incidence,3076790,Non-Hispanic White,270.0,Male,Urinary Bladder,2017
80-84,2958.0,3006.0,59436,Incidence,1993195,Non-Hispanic White,2981.9,Male,All Cancer Sites Combined,2017
80-84,28.0,32.9,605,Incidence,1993195,Non-Hispanic White,30.4,Male,Brain and Other Nervous System,2017
80-84,242.3,256.2,4966,Incidence,1993195,Non-Hispanic White,249.1,Male,Colon and Rectum,2017
80-84,49.1,55.4,1040,Incidence,1993195,Non-Hispanic White,52.2,Male,Esophagus,2017
80-84,4.2,6.3,103,Incidence,1993195,Non-Hispanic White,5.2,Male,Hodgkin Lymphoma,2017
80-84,0.6,1.5,19,Incidence,1993195,Non-Hispanic White,1.0,Male,Kaposi Sarcoma,2017
80-84,98.6,107.6,2053,Incidence,1993195,Non-Hispanic White,103.0,Male,Kidney and Renal Pelvis,2017
80-84,24.0,28.6,523,Incidence,1993195,Non-Hispanic White,26.2,Male,Larynx,2017
80-84,124.8,134.9,2587,Incidence,1993195,Non-Hispanic White,129.8,Male,Leukemias,2017
80-84,50.7,57.2,1073,Incidence,1993195,Non-Hispanic White,53.8,Male,Liver and Intrahepatic Bile Duct,2017
80-84,506.7,526.7,10298,Incidence,1993195,Non-Hispanic White,516.7,Male,Lung and Bronchus,2017
80-84,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
80-84,226.3,239.7,4643,Incidence,1993195,Non-Hispanic White,232.9,Male,Melanomas of the Skin,2017
80-84,15.2,18.9,339,Incidence,1993195,Non-Hispanic White,17.0,Male,Mesothelioma,2017
80-84,54.8,61.5,1158,Incidence,1993195,Non-Hispanic White,58.1,Male,Myeloma,2017
80-84,149.8,160.8,3094,Incidence,1993195,Non-Hispanic White,155.2,Male,Non-Hodgkin Lymphoma,2017
80-84,67.1,74.6,1411,Incidence,1993195,Non-Hispanic White,70.8,Male,Oral Cavity and Pharynx,2017
80-84,104.8,114.0,2179,Incidence,1993195,Non-Hispanic White,109.3,Male,Pancreas,2017
80-84,421.3,439.5,8577,Incidence,1993195,Non-Hispanic White,430.3,Male,Prostate,2017
80-84,46.8,53.1,994,Incidence,1993195,Non-Hispanic White,49.9,Male,Stomach,2017
80-84,0.7,1.6,21,Incidence,1993195,Non-Hispanic White,1.1,Male,Testis,2017
80-84,12.8,16.2,287,Incidence,1993195,Non-Hispanic White,14.4,Male,Thyroid,2017
80-84,339.5,356.0,6930,Incidence,1993195,Non-Hispanic White,347.7,Male,Urinary Bladder,2017
85+,2842.8,2891.5,53373,Incidence,1861587,Non-Hispanic White,2867.1,Male,All Cancer Sites Combined,2017
85+,22.2,26.8,455,Incidence,1861587,Non-Hispanic White,24.4,Male,Brain and Other Nervous System,2017
85+,253.2,268.0,4850,Incidence,1861587,Non-Hispanic White,260.5,Male,Colon and Rectum,2017
85+,39.6,45.6,791,Incidence,1861587,Non-Hispanic White,42.5,Male,Esophagus,2017
85+,3.2,5.1,75,Incidence,1861587,Non-Hispanic White,4.0,Male,Hodgkin Lymphoma,2017
85+,1.0,2.1,27,Incidence,1861587,Non-Hispanic White,1.5,Male,Kaposi Sarcoma,2017
85+,82.2,90.7,1607,Incidence,1861587,Non-Hispanic White,86.3,Male,Kidney and Renal Pelvis,2017
85+,20.0,24.4,412,Incidence,1861587,Non-Hispanic White,22.1,Male,Larynx,2017
85+,133.2,144.0,2579,Incidence,1861587,Non-Hispanic White,138.5,Male,Leukemias,2017
85+,39.6,45.6,792,Incidence,1861587,Non-Hispanic White,42.5,Male,Liver and Intrahepatic Bile Duct,2017
85+,415.3,434.1,7905,Incidence,1861587,Non-Hispanic White,424.6,Male,Lung and Bronchus,2017
85+,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
85+,233.6,247.7,4478,Incidence,1861587,Non-Hispanic White,240.5,Male,Melanomas of the Skin,2017
85+,17.1,21.1,354,Incidence,1861587,Non-Hispanic White,19.0,Male,Mesothelioma,2017
85+,47.2,53.7,937,Incidence,1861587,Non-Hispanic White,50.3,Male,Myeloma,2017
85+,145.4,156.6,2809,Incidence,1861587,Non-Hispanic White,150.9,Male,Non-Hodgkin Lymphoma,2017
85+,63.0,70.5,1241,Incidence,1861587,Non-Hispanic White,66.7,Male,Oral Cavity and Pharynx,2017
85+,100.3,109.7,1953,Incidence,1861587,Non-Hispanic White,104.9,Male,Pancreas,2017
85+,349.7,366.9,6669,Incidence,1861587,Non-Hispanic White,358.2,Male,Prostate,2017
85+,43.3,49.6,863,Incidence,1861587,Non-Hispanic White,46.4,Male,Stomach,2017
85+,~,~,~,Incidence,1861587,Non-Hispanic White,~,Male,Testis,2017
85+,7.2,9.9,157,Incidence,1861587,Non-Hispanic White,8.4,Male,Thyroid,2017
85+,366.4,384.1,6984,Incidence,1861587,Non-Hispanic White,375.2,Male,Urinary Bladder,2017
<1,28.3,35.4,322,Incidence,1015937,Non-Hispanic White,31.7,Male,All Cancer Sites Combined,2017
<1,3.4,6.2,47,Incidence,1015937,Non-Hispanic White,4.6,Male,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Colon and Rectum,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Esophagus,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Kaposi Sarcoma,2017
<1,1.4,3.3,22,Incidence,1015937,Non-Hispanic White,2.2,Male,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Larynx,2017
<1,3.3,6.0,46,Incidence,1015937,Non-Hispanic White,4.5,Male,Leukemias,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Lung and Bronchus,2017
<1,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Melanomas of the Skin,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Mesothelioma,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Myeloma,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Pancreas,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Prostate,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Stomach,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Testis,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Thyroid,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male,Urinary Bladder,2017
1-4,23.5,25.6,2027,Incidence,8265015,Non-Hispanic White,24.5,Male and Female,All Cancer Sites Combined,2017
1-4,5.0,6.0,450,Incidence,8265015,Non-Hispanic White,5.4,Male and Female,Brain and Other Nervous System,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,Cervix,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Colon and Rectum,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Esophagus,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,Female Breast,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2017
1-4,1.7,2.3,164,Incidence,8265015,Non-Hispanic White,2.0,Male and Female,Kidney and Renal Pelvis,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Larynx,2017
1-4,8.6,10.0,767,Incidence,8265015,Non-Hispanic White,9.3,Male and Female,Leukemias,2017
1-4,0.5,0.9,59,Incidence,8265015,Non-Hispanic White,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,Male and Female Breast,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Myeloma,2017
1-4,0.5,0.9,55,Incidence,8265015,Non-Hispanic White,0.7,Male and Female,Non-Hodgkin Lymphoma,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2017
1-4,~,~,~,Incidence,4026911,Non-Hispanic White,~,Male and Female,Ovary,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Pancreas,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male and Female,Prostate,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Stomach,2017
1-4,~,~,~,Incidence,4238104,Non-Hispanic White,~,Male and Female,Testis,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Thyroid,2017
1-4,~,~,~,Incidence,8265015,Non-Hispanic White,~,Male and Female,Urinary Bladder,2017
10-14,15.4,16.9,1783,Incidence,11066226,Non-Hispanic White,16.1,Male and Female,All Cancer Sites Combined,2017
10-14,3.5,4.2,422,Incidence,11066226,Non-Hispanic White,3.8,Male and Female,Brain and Other Nervous System,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Male and Female,Cervix,2017
10-14,0.6,1.0,89,Incidence,11066226,Non-Hispanic White,0.8,Male and Female,Colon and Rectum,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Esophagus,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Male and Female,Female Breast,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2017
10-14,1.1,1.5,145,Incidence,11066226,Non-Hispanic White,1.3,Male and Female,Hodgkin Lymphoma,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2017
10-14,0.1,0.3,18,Incidence,11066226,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Larynx,2017
10-14,2.4,3.0,296,Incidence,11066226,Non-Hispanic White,2.7,Male and Female,Leukemias,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Male and Female,Male and Female Breast,2017
10-14,~,~,~,Incidence,5394716,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
10-14,0.2,0.4,29,Incidence,11066226,Non-Hispanic White,0.3,Male and Female,Melanomas of the Skin,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Myeloma,2017
10-14,1.2,1.7,159,Incidence,11066226,Non-Hispanic White,1.4,Male and Female,Non-Hodgkin Lymphoma,2017
10-14,0.2,0.4,34,Incidence,11066226,Non-Hispanic White,0.3,Male and Female,Oral Cavity and Pharynx,2017
10-14,0.5,1.0,38,Incidence,5394716,Non-Hispanic White,0.7,Male and Female,Ovary,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Pancreas,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male and Female,Prostate,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Stomach,2017
10-14,~,~,~,Incidence,5671510,Non-Hispanic White,~,Male and Female,Testis,2017
10-14,0.6,1.0,89,Incidence,11066226,Non-Hispanic White,0.8,Male and Female,Thyroid,2017
10-14,~,~,~,Incidence,11066226,Non-Hispanic White,~,Male and Female,Urinary Bladder,2017
15-19,25.0,26.8,2994,Incidence,11557886,Non-Hispanic White,25.9,Male and Female,All Cancer Sites Combined,2017
15-19,2.6,3.3,340,Incidence,11557886,Non-Hispanic White,2.9,Male and Female,Brain and Other Nervous System,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Male and Female,Cervix,2017
15-19,1.3,1.8,175,Incidence,11557886,Non-Hispanic White,1.5,Male and Female,Colon and Rectum,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Esophagus,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Male and Female,Female Breast,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2017
15-19,3.4,4.1,427,Incidence,11557886,Non-Hispanic White,3.7,Male and Female,Hodgkin Lymphoma,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2017
15-19,0.2,0.3,27,Incidence,11557886,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Larynx,2017
15-19,2.5,3.1,319,Incidence,11557886,Non-Hispanic White,2.8,Male and Female,Leukemias,2017
15-19,0.1,0.3,22,Incidence,11557886,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Male and Female,Male and Female Breast,2017
15-19,~,~,~,Incidence,5630193,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
15-19,0.9,1.3,130,Incidence,11557886,Non-Hispanic White,1.1,Male and Female,Melanomas of the Skin,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Myeloma,2017
15-19,1.8,2.3,236,Incidence,11557886,Non-Hispanic White,2.0,Male and Female,Non-Hodgkin Lymphoma,2017
15-19,0.3,0.5,46,Incidence,11557886,Non-Hispanic White,0.4,Male and Female,Oral Cavity and Pharynx,2017
15-19,0.8,1.3,58,Incidence,5630193,Non-Hispanic White,1.0,Male and Female,Ovary,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Pancreas,2017
15-19,~,~,~,Incidence,5927693,Non-Hispanic White,~,Male and Female,Prostate,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Stomach,2017
15-19,3.2,4.2,216,Incidence,5927693,Non-Hispanic White,3.6,Male and Female,Testis,2017
15-19,3.4,4.1,428,Incidence,11557886,Non-Hispanic White,3.7,Male and Female,Thyroid,2017
15-19,~,~,~,Incidence,11557886,Non-Hispanic White,~,Male and Female,Urinary Bladder,2017
20-24,40.9,43.2,5115,Incidence,12166852,Non-Hispanic White,42.0,Male and Female,All Cancer Sites Combined,2017
20-24,2.3,2.9,314,Incidence,12166852,Non-Hispanic White,2.6,Male and Female,Brain and Other Nervous System,2017
20-24,0.5,0.9,40,Incidence,5916948,Non-Hispanic White,0.7,Male and Female,Cervix,2017
20-24,2.2,2.8,305,Incidence,12166852,Non-Hispanic White,2.5,Male and Female,Colon and Rectum,2017
20-24,0.2,0.5,21,Incidence,5916948,Non-Hispanic White,0.4,Male and Female,"Corpus and Uterus, NOS",2017
20-24,~,~,~,Incidence,12166852,Non-Hispanic White,~,Male and Female,Esophagus,2017
20-24,1.1,1.7,80,Incidence,5916948,Non-Hispanic White,1.4,Male and Female,Female Breast,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2017
20-24,4.9,5.7,644,Incidence,12166852,Non-Hispanic White,5.3,Male and Female,Hodgkin Lymphoma,2017
20-24,~,~,~,Incidence,12166852,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2017
20-24,0.3,0.6,55,Incidence,12166852,Non-Hispanic White,0.5,Male and Female,Kidney and Renal Pelvis,2017
20-24,~,~,~,Incidence,12166852,Non-Hispanic White,~,Male and Female,Larynx,2017
20-24,2.2,2.8,302,Incidence,12166852,Non-Hispanic White,2.5,Male and Female,Leukemias,2017
20-24,0.1,0.3,27,Incidence,12166852,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
20-24,0.3,0.5,46,Incidence,12166852,Non-Hispanic White,0.4,Male and Female,Lung and Bronchus,2017
20-24,1.1,1.7,80,Incidence,5916948,Non-Hispanic White,1.4,Male and Female,Male and Female Breast,2017
20-24,~,~,~,Incidence,5916948,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
20-24,3.6,4.3,480,Incidence,12166852,Non-Hispanic White,3.9,Male and Female,Melanomas of the Skin,2017
20-24,~,~,~,Incidence,12166852,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
20-24,~,~,~,Incidence,12166852,Non-Hispanic White,~,Male and Female,Myeloma,2017
20-24,2.3,2.9,314,Incidence,12166852,Non-Hispanic White,2.6,Male and Female,Non-Hodgkin Lymphoma,2017
20-24,0.4,0.7,68,Incidence,12166852,Non-Hispanic White,0.6,Male and Female,Oral Cavity and Pharynx,2017
20-24,1.4,2.0,99,Incidence,5916948,Non-Hispanic White,1.7,Male and Female,Ovary,2017
20-24,0.2,0.4,37,Incidence,12166852,Non-Hispanic White,0.3,Male and Female,Pancreas,2017
20-24,~,~,~,Incidence,6249904,Non-Hispanic White,~,Male and Female,Prostate,2017
20-24,0.1,0.2,17,Incidence,12166852,Non-Hispanic White,0.1,Male and Female,Stomach,2017
20-24,11.2,12.9,751,Incidence,6249904,Non-Hispanic White,12.0,Male and Female,Testis,2017
20-24,7.2,8.2,930,Incidence,12166852,Non-Hispanic White,7.6,Male and Female,Thyroid,2017
20-24,0.2,0.3,29,Incidence,12166852,Non-Hispanic White,0.2,Male and Female,Urinary Bladder,2017
25-29,66.8,69.6,8893,Incidence,13047210,Non-Hispanic White,68.2,Male and Female,All Cancer Sites Combined,2017
25-29,3.0,3.7,435,Incidence,13047210,Non-Hispanic White,3.3,Male and Female,Brain and Other Nervous System,2017
25-29,4.5,5.7,326,Incidence,6410127,Non-Hispanic White,5.1,Male and Female,Cervix,2017
25-29,3.4,4.0,480,Incidence,13047210,Non-Hispanic White,3.7,Male and Female,Colon and Rectum,2017
25-29,1.7,2.5,133,Incidence,6410127,Non-Hispanic White,2.1,Male and Female,"Corpus and Uterus, NOS",2017
25-29,~,~,~,Incidence,13047210,Non-Hispanic White,~,Male and Female,Esophagus,2017
25-29,10.0,11.6,692,Incidence,6410127,Non-Hispanic White,10.8,Male and Female,Female Breast,2017
25-29,0.6,1.0,48,Incidence,6410127,Non-Hispanic White,0.7,Male and Female,"Female Breast, <i>in situ</i>",2017
25-29,4.3,5.1,613,Incidence,13047210,Non-Hispanic White,4.7,Male and Female,Hodgkin Lymphoma,2017
25-29,0.1,0.2,19,Incidence,13047210,Non-Hispanic White,0.1,Male and Female,Kaposi Sarcoma,2017
25-29,1.2,1.6,185,Incidence,13047210,Non-Hispanic White,1.4,Male and Female,Kidney and Renal Pelvis,2017
25-29,~,~,~,Incidence,13047210,Non-Hispanic White,~,Male and Female,Larynx,2017
25-29,2.4,2.9,343,Incidence,13047210,Non-Hispanic White,2.6,Male and Female,Leukemias,2017
25-29,0.2,0.4,33,Incidence,13047210,Non-Hispanic White,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
25-29,0.5,0.8,82,Incidence,13047210,Non-Hispanic White,0.6,Male and Female,Lung and Bronchus,2017
25-29,10.0,11.6,692,Incidence,6410127,Non-Hispanic White,10.8,Male and Female,Male and Female Breast,2017
25-29,0.6,1.0,48,Incidence,6410127,Non-Hispanic White,0.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
25-29,8.3,9.3,1142,Incidence,13047210,Non-Hispanic White,8.8,Male and Female,Melanomas of the Skin,2017
25-29,~,~,~,Incidence,13047210,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
25-29,~,~,~,Incidence,13047210,Non-Hispanic White,~,Male and Female,Myeloma,2017
25-29,3.0,3.6,428,Incidence,13047210,Non-Hispanic White,3.3,Male and Female,Non-Hodgkin Lymphoma,2017
25-29,1.0,1.3,147,Incidence,13047210,Non-Hispanic White,1.1,Male and Female,Oral Cavity and Pharynx,2017
25-29,1.8,2.5,137,Incidence,6410127,Non-Hispanic White,2.1,Male and Female,Ovary,2017
25-29,0.3,0.5,49,Incidence,13047210,Non-Hispanic White,0.4,Male and Female,Pancreas,2017
25-29,~,~,~,Incidence,6637083,Non-Hispanic White,~,Male and Female,Prostate,2017
25-29,0.3,0.5,47,Incidence,13047210,Non-Hispanic White,0.4,Male and Female,Stomach,2017
25-29,17.0,19.0,1193,Incidence,6637083,Non-Hispanic White,18.0,Male and Female,Testis,2017
25-29,11.6,12.8,1591,Incidence,13047210,Non-Hispanic White,12.2,Male and Female,Thyroid,2017
25-29,0.3,0.6,58,Incidence,13047210,Non-Hispanic White,0.4,Male and Female,Urinary Bladder,2017
30-34,107.5,111.2,13706,Incidence,12536905,Non-Hispanic White,109.3,Male and Female,All Cancer Sites Combined,2017
30-34,4.2,4.9,568,Incidence,12536905,Non-Hispanic White,4.5,Male and Female,Brain and Other Nervous System,2017
30-34,11.5,13.3,768,Incidence,6204154,Non-Hispanic White,12.4,Male and Female,Cervix,2017
30-34,6.3,7.2,842,Incidence,12536905,Non-Hispanic White,6.7,Male and Female,Colon and Rectum,2017
30-34,4.5,5.7,315,Incidence,6204154,Non-Hispanic White,5.1,Male and Female,"Corpus and Uterus, NOS",2017
30-34,0.1,0.3,28,Incidence,12536905,Non-Hispanic White,0.2,Male and Female,Esophagus,2017
30-34,30.2,33.0,1958,Incidence,6204154,Non-Hispanic White,31.6,Male and Female,Female Breast,2017
30-34,2.4,3.3,176,Incidence,6204154,Non-Hispanic White,2.8,Male and Female,"Female Breast, <i>in situ</i>",2017
30-34,3.9,4.6,528,Incidence,12536905,Non-Hispanic White,4.2,Male and Female,Hodgkin Lymphoma,2017
30-34,0.1,0.2,18,Incidence,12536905,Non-Hispanic White,0.1,Male and Female,Kaposi Sarcoma,2017
30-34,3.2,3.9,442,Incidence,12536905,Non-Hispanic White,3.5,Male and Female,Kidney and Renal Pelvis,2017
30-34,0.1,0.3,23,Incidence,12536905,Non-Hispanic White,0.2,Male and Female,Larynx,2017
30-34,3.5,4.2,477,Incidence,12536905,Non-Hispanic White,3.8,Male and Female,Leukemias,2017
30-34,0.3,0.6,56,Incidence,12536905,Non-Hispanic White,0.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
30-34,1.2,1.6,173,Incidence,12536905,Non-Hispanic White,1.4,Male and Female,Lung and Bronchus,2017
30-34,30.2,33.0,1958,Incidence,6204154,Non-Hispanic White,31.6,Male and Female,Male and Female Breast,2017
30-34,2.4,3.3,176,Incidence,6204154,Non-Hispanic White,2.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
30-34,14.4,15.8,1893,Incidence,12536905,Non-Hispanic White,15.1,Male and Female,Melanomas of the Skin,2017
30-34,~,~,~,Incidence,12536905,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
30-34,0.2,0.4,32,Incidence,12536905,Non-Hispanic White,0.3,Male and Female,Myeloma,2017
30-34,4.0,4.8,549,Incidence,12536905,Non-Hispanic White,4.4,Male and Female,Non-Hodgkin Lymphoma,2017
30-34,1.6,2.0,225,Incidence,12536905,Non-Hispanic White,1.8,Male and Female,Oral Cavity and Pharynx,2017
30-34,2.6,3.5,189,Incidence,6204154,Non-Hispanic White,3.0,Male and Female,Ovary,2017
30-34,0.5,0.8,83,Incidence,12536905,Non-Hispanic White,0.7,Male and Female,Pancreas,2017
30-34,~,~,~,Incidence,6332751,Non-Hispanic White,~,Male and Female,Prostate,2017
30-34,0.6,0.9,91,Incidence,12536905,Non-Hispanic White,0.7,Male and Female,Stomach,2017
30-34,16.6,18.7,1116,Incidence,6332751,Non-Hispanic White,17.6,Male and Female,Testis,2017
30-34,17.0,18.5,2225,Incidence,12536905,Non-Hispanic White,17.7,Male and Female,Thyroid,2017
30-34,0.7,1.1,112,Incidence,12536905,Non-Hispanic White,0.9,Male and Female,Urinary Bladder,2017
35-39,159.5,164.0,19661,Incidence,12156597,Non-Hispanic White,161.7,Male and Female,All Cancer Sites Combined,2017
35-39,4.4,5.2,587,Incidence,12156597,Non-Hispanic White,4.8,Male and Female,Brain and Other Nervous System,2017
35-39,13.3,15.2,859,Incidence,6036831,Non-Hispanic White,14.2,Male and Female,Cervix,2017
35-39,12.2,13.5,1559,Incidence,12156597,Non-Hispanic White,12.8,Male and Female,Colon and Rectum,2017
35-39,9.3,10.9,608,Incidence,6036831,Non-Hispanic White,10.1,Male and Female,"Corpus and Uterus, NOS",2017
35-39,0.4,0.7,66,Incidence,12156597,Non-Hispanic White,0.5,Male and Female,Esophagus,2017
35-39,62.9,66.9,3916,Incidence,6036831,Non-Hispanic White,64.9,Male and Female,Female Breast,2017
35-39,9.0,10.6,589,Incidence,6036831,Non-Hispanic White,9.8,Male and Female,"Female Breast, <i>in situ</i>",2017
35-39,2.8,3.5,383,Incidence,12156597,Non-Hispanic White,3.2,Male and Female,Hodgkin Lymphoma,2017
35-39,0.2,0.4,32,Incidence,12156597,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2017
35-39,6.5,7.4,843,Incidence,12156597,Non-Hispanic White,6.9,Male and Female,Kidney and Renal Pelvis,2017
35-39,0.3,0.6,56,Incidence,12156597,Non-Hispanic White,0.5,Male and Female,Larynx,2017
35-39,4.4,5.2,582,Incidence,12156597,Non-Hispanic White,4.8,Male and Female,Leukemias,2017
35-39,0.6,0.9,94,Incidence,12156597,Non-Hispanic White,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
35-39,2.5,3.1,337,Incidence,12156597,Non-Hispanic White,2.8,Male and Female,Lung and Bronchus,2017
35-39,62.9,66.9,3916,Incidence,6036831,Non-Hispanic White,64.9,Male and Female,Male and Female Breast,2017
35-39,9.0,10.6,589,Incidence,6036831,Non-Hispanic White,9.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
35-39,19.5,21.1,2468,Incidence,12156597,Non-Hispanic White,20.3,Male and Female,Melanomas of the Skin,2017
35-39,~,~,~,Incidence,12156597,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
35-39,0.8,1.1,112,Incidence,12156597,Non-Hispanic White,0.9,Male and Female,Myeloma,2017
35-39,6.0,6.9,778,Incidence,12156597,Non-Hispanic White,6.4,Male and Female,Non-Hodgkin Lymphoma,2017
35-39,3.1,3.7,411,Incidence,12156597,Non-Hispanic White,3.4,Male and Female,Oral Cavity and Pharynx,2017
35-39,4.7,5.9,317,Incidence,6036831,Non-Hispanic White,5.3,Male and Female,Ovary,2017
35-39,1.3,1.8,189,Incidence,12156597,Non-Hispanic White,1.6,Male and Female,Pancreas,2017
35-39,0.5,0.9,39,Incidence,6119766,Non-Hispanic White,0.6,Male and Female,Prostate,2017
35-39,1.1,1.5,155,Incidence,12156597,Non-Hispanic White,1.3,Male and Female,Stomach,2017
35-39,14.3,16.3,937,Incidence,6119766,Non-Hispanic White,15.3,Male and Female,Testis,2017
35-39,21.2,22.9,2676,Incidence,12156597,Non-Hispanic White,22.0,Male and Female,Thyroid,2017
35-39,1.5,2.0,215,Incidence,12156597,Non-Hispanic White,1.8,Male and Female,Urinary Bladder,2017
40-44,249.6,255.5,28545,Incidence,11302494,Non-Hispanic White,252.6,Male and Female,All Cancer Sites Combined,2017
40-44,4.6,5.4,566,Incidence,11302494,Non-Hispanic White,5.0,Male and Female,Brain and Other Nervous System,2017
40-44,14.5,16.6,875,Incidence,5626690,Non-Hispanic White,15.6,Male and Female,Cervix,2017
40-44,21.3,23.1,2508,Incidence,11302494,Non-Hispanic White,22.2,Male and Female,Colon and Rectum,2017
40-44,16.6,18.8,992,Incidence,5626690,Non-Hispanic White,17.6,Male and Female,"Corpus and Uterus, NOS",2017
40-44,1.2,1.6,156,Incidence,11302494,Non-Hispanic White,1.4,Male and Female,Esophagus,2017
40-44,132.7,138.8,7636,Incidence,5626690,Non-Hispanic White,135.7,Male and Female,Female Breast,2017
40-44,41.0,44.4,2402,Incidence,5626690,Non-Hispanic White,42.7,Male and Female,"Female Breast, <i>in situ</i>",2017
40-44,2.6,3.2,326,Incidence,11302494,Non-Hispanic White,2.9,Male and Female,Hodgkin Lymphoma,2017
40-44,0.1,0.3,23,Incidence,11302494,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2017
40-44,12.1,13.4,1437,Incidence,11302494,Non-Hispanic White,12.7,Male and Female,Kidney and Renal Pelvis,2017
40-44,0.8,1.2,112,Incidence,11302494,Non-Hispanic White,1.0,Male and Female,Larynx,2017
40-44,6.0,6.9,729,Incidence,11302494,Non-Hispanic White,6.4,Male and Female,Leukemias,2017
40-44,1.4,1.9,184,Incidence,11302494,Non-Hispanic White,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
40-44,7.0,8.0,848,Incidence,11302494,Non-Hispanic White,7.5,Male and Female,Lung and Bronchus,2017
40-44,132.7,138.8,7636,Incidence,5626690,Non-Hispanic White,135.7,Male and Female,Male and Female Breast,2017
40-44,41.0,44.4,2402,Incidence,5626690,Non-Hispanic White,42.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
40-44,25.4,27.3,2980,Incidence,11302494,Non-Hispanic White,26.4,Male and Female,Melanomas of the Skin,2017
40-44,0.1,0.3,19,Incidence,11302494,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2017
40-44,1.7,2.2,217,Incidence,11302494,Non-Hispanic White,1.9,Male and Female,Myeloma,2017
40-44,9.1,10.3,1094,Incidence,11302494,Non-Hispanic White,9.7,Male and Female,Non-Hodgkin Lymphoma,2017
40-44,6.3,7.2,763,Incidence,11302494,Non-Hispanic White,6.8,Male and Female,Oral Cavity and Pharynx,2017
40-44,7.8,9.4,482,Incidence,5626690,Non-Hispanic White,8.6,Male and Female,Ovary,2017
40-44,2.7,3.4,341,Incidence,11302494,Non-Hispanic White,3.0,Male and Female,Pancreas,2017
40-44,4.5,5.7,290,Incidence,5675804,Non-Hispanic White,5.1,Male and Female,Prostate,2017
40-44,2.1,2.7,269,Incidence,11302494,Non-Hispanic White,2.4,Male and Female,Stomach,2017
40-44,10.2,12.0,629,Incidence,5675804,Non-Hispanic White,11.1,Male and Female,Testis,2017
40-44,23.1,24.9,2713,Incidence,11302494,Non-Hispanic White,24.0,Male and Female,Thyroid,2017
40-44,3.2,3.9,400,Incidence,11302494,Non-Hispanic White,3.5,Male and Female,Urinary Bladder,2017
45-49,385.7,392.5,50407,Incidence,12956155,Non-Hispanic White,389.1,Male and Female,All Cancer Sites Combined,2017
45-49,6.1,7.0,853,Incidence,12956155,Non-Hispanic White,6.6,Male and Female,Brain and Other Nervous System,2017
45-49,12.3,14.1,854,Incidence,6468512,Non-Hispanic White,13.2,Male and Female,Cervix,2017
45-49,36.8,38.9,4898,Incidence,12956155,Non-Hispanic White,37.8,Male and Female,Colon and Rectum,2017
45-49,25.5,28.1,1733,Incidence,6468512,Non-Hispanic White,26.8,Male and Female,"Corpus and Uterus, NOS",2017
45-49,2.7,3.3,381,Incidence,12956155,Non-Hispanic White,2.9,Male and Female,Esophagus,2017
45-49,204.8,211.8,13472,Incidence,6468512,Non-Hispanic White,208.3,Male and Female,Female Breast,2017
45-49,58.4,62.2,3898,Incidence,6468512,Non-Hispanic White,60.3,Male and Female,"Female Breast, <i>in situ</i>",2017
45-49,2.4,3.0,348,Incidence,12956155,Non-Hispanic White,2.7,Male and Female,Hodgkin Lymphoma,2017
45-49,0.2,0.4,33,Incidence,12956155,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2017
45-49,18.8,20.4,2537,Incidence,12956155,Non-Hispanic White,19.6,Male and Female,Kidney and Renal Pelvis,2017
45-49,2.3,2.9,335,Incidence,12956155,Non-Hispanic White,2.6,Male and Female,Larynx,2017
45-49,9.1,10.1,1241,Incidence,12956155,Non-Hispanic White,9.6,Male and Female,Leukemias,2017
45-49,2.8,3.4,396,Incidence,12956155,Non-Hispanic White,3.1,Male and Female,Liver and Intrahepatic Bile Duct,2017
45-49,19.3,20.9,2604,Incidence,12956155,Non-Hispanic White,20.1,Male and Female,Lung and Bronchus,2017
45-49,204.8,211.8,13472,Incidence,6468512,Non-Hispanic White,208.3,Male and Female,Male and Female Breast,2017
45-49,58.4,62.2,3898,Incidence,6468512,Non-Hispanic White,60.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
45-49,32.5,34.5,4342,Incidence,12956155,Non-Hispanic White,33.5,Male and Female,Melanomas of the Skin,2017
45-49,0.1,0.3,29,Incidence,12956155,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2017
45-49,3.7,4.4,518,Incidence,12956155,Non-Hispanic White,4.0,Male and Female,Myeloma,2017
45-49,14.0,15.3,1899,Incidence,12956155,Non-Hispanic White,14.7,Male and Female,Non-Hodgkin Lymphoma,2017
45-49,13.9,15.2,1883,Incidence,12956155,Non-Hispanic White,14.5,Male and Female,Oral Cavity and Pharynx,2017
45-49,12.5,14.3,866,Incidence,6468512,Non-Hispanic White,13.4,Male and Female,Ovary,2017
45-49,6.0,6.9,832,Incidence,12956155,Non-Hispanic White,6.4,Male and Female,Pancreas,2017
45-49,25.4,28.0,1730,Incidence,6487643,Non-Hispanic White,26.7,Male and Female,Prostate,2017
45-49,3.4,4.1,488,Incidence,12956155,Non-Hispanic White,3.8,Male and Female,Stomach,2017
45-49,7.5,9.0,534,Incidence,6487643,Non-Hispanic White,8.2,Male and Female,Testis,2017
45-49,23.0,24.7,3083,Incidence,12956155,Non-Hispanic White,23.8,Male and Female,Thyroid,2017
45-49,7.2,8.1,988,Incidence,12956155,Non-Hispanic White,7.6,Male and Female,Urinary Bladder,2017
5-9,13.2,14.6,1461,Incidence,10515175,Non-Hispanic White,13.9,Male and Female,All Cancer Sites Combined,2017
5-9,4.0,4.8,458,Incidence,10515175,Non-Hispanic White,4.4,Male and Female,Brain and Other Nervous System,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,Cervix,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Colon and Rectum,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Esophagus,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,Female Breast,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2017
5-9,0.2,0.4,31,Incidence,10515175,Non-Hispanic White,0.3,Male and Female,Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2017
5-9,0.5,0.8,64,Incidence,10515175,Non-Hispanic White,0.6,Male and Female,Kidney and Renal Pelvis,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Larynx,2017
5-9,3.4,4.1,394,Incidence,10515175,Non-Hispanic White,3.7,Male and Female,Leukemias,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,Male and Female Breast,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
5-9,0.1,0.3,17,Incidence,10515175,Non-Hispanic White,0.2,Male and Female,Melanomas of the Skin,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Myeloma,2017
5-9,0.9,1.3,115,Incidence,10515175,Non-Hispanic White,1.1,Male and Female,Non-Hodgkin Lymphoma,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2017
5-9,~,~,~,Incidence,5129054,Non-Hispanic White,~,Male and Female,Ovary,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Pancreas,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male and Female,Prostate,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Stomach,2017
5-9,~,~,~,Incidence,5386121,Non-Hispanic White,~,Male and Female,Testis,2017
5-9,0.1,0.3,22,Incidence,10515175,Non-Hispanic White,0.2,Male and Female,Thyroid,2017
5-9,~,~,~,Incidence,10515175,Non-Hispanic White,~,Male and Female,Urinary Bladder,2017
50-54,599.9,608.1,84711,Incidence,14025401,Non-Hispanic White,604.0,Male and Female,All Cancer Sites Combined,2017
50-54,8.2,9.2,1214,Incidence,14025401,Non-Hispanic White,8.7,Male and Female,Brain and Other Nervous System,2017
50-54,11.3,12.9,852,Incidence,7068629,Non-Hispanic White,12.1,Male and Female,Cervix,2017
50-54,61.5,64.1,8807,Incidence,14025401,Non-Hispanic White,62.8,Male and Female,Colon and Rectum,2017
50-54,50.1,53.4,3656,Incidence,7068629,Non-Hispanic White,51.7,Male and Female,"Corpus and Uterus, NOS",2017
50-54,5.4,6.2,812,Incidence,14025401,Non-Hispanic White,5.8,Male and Female,Esophagus,2017
50-54,241.5,248.8,17330,Incidence,7068629,Non-Hispanic White,245.2,Male and Female,Female Breast,2017
50-54,68.2,72.1,4955,Incidence,7068629,Non-Hispanic White,70.1,Male and Female,"Female Breast, <i>in situ</i>",2017
50-54,2.2,2.7,339,Incidence,14025401,Non-Hispanic White,2.4,Male and Female,Hodgkin Lymphoma,2017
50-54,0.3,0.5,48,Incidence,14025401,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2017
50-54,26.6,28.3,3848,Incidence,14025401,Non-Hispanic White,27.4,Male and Female,Kidney and Renal Pelvis,2017
50-54,5.3,6.1,796,Incidence,14025401,Non-Hispanic White,5.7,Male and Female,Larynx,2017
50-54,14.0,15.3,2055,Incidence,14025401,Non-Hispanic White,14.7,Male and Female,Leukemias,2017
50-54,8.0,9.0,1193,Incidence,14025401,Non-Hispanic White,8.5,Male and Female,Liver and Intrahepatic Bile Duct,2017
50-54,51.3,53.7,7363,Incidence,14025401,Non-Hispanic White,52.5,Male and Female,Lung and Bronchus,2017
50-54,241.5,248.8,17330,Incidence,7068629,Non-Hispanic White,245.2,Male and Female,Male and Female Breast,2017
50-54,68.2,72.1,4955,Incidence,7068629,Non-Hispanic White,70.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
50-54,40.5,42.7,5835,Incidence,14025401,Non-Hispanic White,41.6,Male and Female,Melanomas of the Skin,2017
50-54,0.4,0.6,65,Incidence,14025401,Non-Hispanic White,0.5,Male and Female,Mesothelioma,2017
50-54,5.7,6.5,849,Incidence,14025401,Non-Hispanic White,6.1,Male and Female,Myeloma,2017
50-54,21.5,23.1,3130,Incidence,14025401,Non-Hispanic White,22.3,Male and Female,Non-Hodgkin Lymphoma,2017
50-54,25.1,26.7,3631,Incidence,14025401,Non-Hispanic White,25.9,Male and Female,Oral Cavity and Pharynx,2017
50-54,18.1,20.2,1351,Incidence,7068629,Non-Hispanic White,19.1,Male and Female,Ovary,2017
50-54,11.7,12.9,1725,Incidence,14025401,Non-Hispanic White,12.3,Male and Female,Pancreas,2017
50-54,102.8,107.6,7318,Incidence,6956772,Non-Hispanic White,105.2,Male and Female,Prostate,2017
50-54,5.6,6.4,845,Incidence,14025401,Non-Hispanic White,6.0,Male and Female,Stomach,2017
50-54,4.6,5.6,353,Incidence,6956772,Non-Hispanic White,5.1,Male and Female,Testis,2017
50-54,23.0,24.7,3344,Incidence,14025401,Non-Hispanic White,23.8,Male and Female,Thyroid,2017
50-54,15.1,16.5,2215,Incidence,14025401,Non-Hispanic White,15.8,Male and Female,Urinary Bladder,2017
55-59,879.1,888.5,135527,Incidence,15334710,Non-Hispanic White,883.8,Male and Female,All Cancer Sites Combined,2017
55-59,11.0,12.1,1766,Incidence,15334710,Non-Hispanic White,11.5,Male and Female,Brain and Other Nervous System,2017
55-59,10.1,11.5,840,Incidence,7800967,Non-Hispanic White,10.8,Male and Female,Cervix,2017
55-59,65.8,68.4,10287,Incidence,15334710,Non-Hispanic White,67.1,Male and Female,Colon and Rectum,2017
55-59,78.8,82.8,6302,Incidence,7800967,Non-Hispanic White,80.8,Male and Female,"Corpus and Uterus, NOS",2017
55-59,10.0,11.0,1613,Incidence,15334710,Non-Hispanic White,10.5,Male and Female,Esophagus,2017
55-59,275.1,282.5,21749,Incidence,7800967,Non-Hispanic White,278.8,Male and Female,Female Breast,2017
55-59,66.8,70.5,5357,Incidence,7800967,Non-Hispanic White,68.7,Male and Female,"Female Breast, <i>in situ</i>",2017
55-59,2.4,2.9,402,Incidence,15334710,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2017
55-59,0.2,0.3,39,Incidence,15334710,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2017
55-59,35.9,37.8,5644,Incidence,15334710,Non-Hispanic White,36.8,Male and Female,Kidney and Renal Pelvis,2017
55-59,8.6,9.5,1385,Incidence,15334710,Non-Hispanic White,9.0,Male and Female,Larynx,2017
55-59,20.9,22.4,3324,Incidence,15334710,Non-Hispanic White,21.7,Male and Female,Leukemias,2017
55-59,18.7,20.1,2967,Incidence,15334710,Non-Hispanic White,19.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
55-59,106.4,109.7,16568,Incidence,15334710,Non-Hispanic White,108.0,Male and Female,Lung and Bronchus,2017
55-59,275.1,282.5,21749,Incidence,7800967,Non-Hispanic White,278.8,Male and Female,Male and Female Breast,2017
55-59,66.8,70.5,5357,Incidence,7800967,Non-Hispanic White,68.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
55-59,52.2,54.5,8182,Incidence,15334710,Non-Hispanic White,53.4,Male and Female,Melanomas of the Skin,2017
55-59,0.6,0.9,116,Incidence,15334710,Non-Hispanic White,0.8,Male and Female,Mesothelioma,2017
55-59,10.0,11.0,1605,Incidence,15334710,Non-Hispanic White,10.5,Male and Female,Myeloma,2017
55-59,31.8,33.6,5011,Incidence,15334710,Non-Hispanic White,32.7,Male and Female,Non-Hodgkin Lymphoma,2017
55-59,36.1,38.1,5686,Incidence,15334710,Non-Hispanic White,37.1,Male and Female,Oral Cavity and Pharynx,2017
55-59,22.0,24.2,1799,Incidence,7800967,Non-Hispanic White,23.1,Male and Female,Ovary,2017
55-59,21.0,22.5,3332,Incidence,15334710,Non-Hispanic White,21.7,Male and Female,Pancreas,2017
55-59,234.4,241.4,17922,Incidence,7533743,Non-Hispanic White,237.9,Male and Female,Prostate,2017
55-59,8.9,9.9,1438,Incidence,15334710,Non-Hispanic White,9.4,Male and Female,Stomach,2017
55-59,3.3,4.2,279,Incidence,7533743,Non-Hispanic White,3.7,Male and Female,Testis,2017
55-59,23.7,25.3,3751,Incidence,15334710,Non-Hispanic White,24.5,Male and Female,Thyroid,2017
55-59,28.2,29.9,4450,Incidence,15334710,Non-Hispanic White,29.0,Male and Female,Urinary Bladder,2017
60-64,1224.6,1236.1,177864,Incidence,14456455,Non-Hispanic White,1230.3,Male and Female,All Cancer Sites Combined,2017
60-64,14.5,15.8,2192,Incidence,14456455,Non-Hispanic White,15.2,Male and Female,Brain and Other Nervous System,2017
60-64,9.0,10.5,725,Incidence,7448062,Non-Hispanic White,9.7,Male and Female,Cervix,2017
60-64,82.3,85.3,12111,Incidence,14456455,Non-Hispanic White,83.8,Male and Female,Colon and Rectum,2017
60-64,101.1,105.8,7704,Incidence,7448062,Non-Hispanic White,103.4,Male and Female,"Corpus and Uterus, NOS",2017
60-64,15.2,16.6,2297,Incidence,14456455,Non-Hispanic White,15.9,Male and Female,Esophagus,2017
60-64,342.9,351.4,25853,Incidence,7448062,Non-Hispanic White,347.1,Male and Female,Female Breast,2017
60-64,77.3,81.3,5905,Incidence,7448062,Non-Hispanic White,79.3,Male and Female,"Female Breast, <i>in situ</i>",2017
60-64,2.4,3.0,386,Incidence,14456455,Non-Hispanic White,2.7,Male and Female,Hodgkin Lymphoma,2017
60-64,0.2,0.3,36,Incidence,14456455,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2017
60-64,46.6,48.8,6894,Incidence,14456455,Non-Hispanic White,47.7,Male and Female,Kidney and Renal Pelvis,2017
60-64,11.5,12.6,1744,Incidence,14456455,Non-Hispanic White,12.1,Male and Female,Larynx,2017
60-64,30.5,32.4,4545,Incidence,14456455,Non-Hispanic White,31.4,Male and Female,Leukemias,2017
60-64,29.5,31.3,4392,Incidence,14456455,Non-Hispanic White,30.4,Male and Female,Liver and Intrahepatic Bile Duct,2017
60-64,162.6,166.8,23810,Incidence,14456455,Non-Hispanic White,164.7,Male and Female,Lung and Bronchus,2017
60-64,342.9,351.4,25853,Incidence,7448062,Non-Hispanic White,347.1,Male and Female,Male and Female Breast,2017
60-64,77.3,81.3,5905,Incidence,7448062,Non-Hispanic White,79.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
60-64,65.9,68.6,9723,Incidence,14456455,Non-Hispanic White,67.3,Male and Female,Melanomas of the Skin,2017
60-64,1.1,1.5,190,Incidence,14456455,Non-Hispanic White,1.3,Male and Female,Mesothelioma,2017
60-64,15.2,16.5,2285,Incidence,14456455,Non-Hispanic White,15.8,Male and Female,Myeloma,2017
60-64,43.0,45.2,6376,Incidence,14456455,Non-Hispanic White,44.1,Male and Female,Non-Hodgkin Lymphoma,2017
60-64,43.6,45.8,6461,Incidence,14456455,Non-Hispanic White,44.7,Male and Female,Oral Cavity and Pharynx,2017
60-64,26.5,28.9,2064,Incidence,7448062,Non-Hispanic White,27.7,Male and Female,Ovary,2017
60-64,32.7,34.6,4863,Incidence,14456455,Non-Hispanic White,33.6,Male and Female,Pancreas,2017
60-64,400.9,410.4,28427,Incidence,7008393,Non-Hispanic White,405.6,Male and Female,Prostate,2017
60-64,12.3,13.4,1856,Incidence,14456455,Non-Hispanic White,12.8,Male and Female,Stomach,2017
60-64,2.3,3.1,188,Incidence,7008393,Non-Hispanic White,2.7,Male and Female,Testis,2017
60-64,22.6,24.2,3376,Incidence,14456455,Non-Hispanic White,23.4,Male and Female,Thyroid,2017
60-64,48.0,50.3,7105,Incidence,14456455,Non-Hispanic White,49.1,Male and Female,Urinary Bladder,2017
65-69,1688.6,1703.0,213719,Incidence,12602972,Non-Hispanic White,1695.8,Male and Female,All Cancer Sites Combined,2017
65-69,17.0,18.5,2231,Incidence,12602972,Non-Hispanic White,17.7,Male and Female,Brain and Other Nervous System,2017
65-69,8.6,10.1,611,Incidence,6569590,Non-Hispanic White,9.3,Male and Female,Cervix,2017
65-69,111.1,114.8,14234,Incidence,12602972,Non-Hispanic White,112.9,Male and Female,Colon and Rectum,2017
65-69,114.7,120.0,7707,Incidence,6569590,Non-Hispanic White,117.3,Male and Female,"Corpus and Uterus, NOS",2017
65-69,19.9,21.5,2609,Incidence,12602972,Non-Hispanic White,20.7,Male and Female,Esophagus,2017
65-69,446.1,456.4,29641,Incidence,6569590,Non-Hispanic White,451.2,Male and Female,Female Breast,2017
65-69,94.8,99.6,6384,Incidence,6569590,Non-Hispanic White,97.2,Male and Female,"Female Breast, <i>in situ</i>",2017
65-69,2.9,3.5,402,Incidence,12602972,Non-Hispanic White,3.2,Male and Female,Hodgkin Lymphoma,2017
65-69,0.2,0.3,29,Incidence,12602972,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2017
65-69,63.4,66.2,8164,Incidence,12602972,Non-Hispanic White,64.8,Male and Female,Kidney and Renal Pelvis,2017
65-69,12.1,13.4,1605,Incidence,12602972,Non-Hispanic White,12.7,Male and Female,Larynx,2017
65-69,42.4,44.7,5489,Incidence,12602972,Non-Hispanic White,43.6,Male and Female,Leukemias,2017
65-69,32.8,34.8,4256,Incidence,12602972,Non-Hispanic White,33.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
65-69,243.0,248.5,30970,Incidence,12602972,Non-Hispanic White,245.7,Male and Female,Lung and Bronchus,2017
65-69,446.1,456.4,29641,Incidence,6569590,Non-Hispanic White,451.2,Male and Female,Male and Female Breast,2017
65-69,94.8,99.6,6384,Incidence,6569590,Non-Hispanic White,97.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
65-69,87.6,90.9,11246,Incidence,12602972,Non-Hispanic White,89.2,Male and Female,Melanomas of the Skin,2017
65-69,2.2,2.7,307,Incidence,12602972,Non-Hispanic White,2.4,Male and Female,Mesothelioma,2017
65-69,23.7,25.4,3091,Incidence,12602972,Non-Hispanic White,24.5,Male and Female,Myeloma,2017
65-69,63.3,66.1,8156,Incidence,12602972,Non-Hispanic White,64.7,Male and Female,Non-Hodgkin Lymphoma,2017
65-69,47.9,50.3,6184,Incidence,12602972,Non-Hispanic White,49.1,Male and Female,Oral Cavity and Pharynx,2017
65-69,31.0,33.8,2128,Incidence,6569590,Non-Hispanic White,32.4,Male and Female,Ovary,2017
65-69,48.4,50.9,6259,Incidence,12602972,Non-Hispanic White,49.7,Male and Female,Pancreas,2017
65-69,616.7,629.3,37587,Incidence,6033382,Non-Hispanic White,623.0,Male and Female,Prostate,2017
65-69,17.3,18.8,2273,Incidence,12602972,Non-Hispanic White,18.0,Male and Female,Stomach,2017
65-69,1.2,1.9,92,Incidence,6033382,Non-Hispanic White,1.5,Male and Female,Testis,2017
65-69,23.9,25.6,3117,Incidence,12602972,Non-Hispanic White,24.7,Male and Female,Thyroid,2017
65-69,79.5,82.6,10212,Incidence,12602972,Non-Hispanic White,81.0,Male and Female,Urinary Bladder,2017
70-74,2035.4,2053.2,203168,Incidence,9938382,Non-Hispanic White,2044.3,Male and Female,All Cancer Sites Combined,2017
70-74,20.2,22.1,2101,Incidence,9938382,Non-Hispanic White,21.1,Male and Female,Brain and Other Nervous System,2017
70-74,8.1,9.8,470,Incidence,5259621,Non-Hispanic White,8.9,Male and Female,Cervix,2017
70-74,134.0,138.6,13549,Incidence,9938382,Non-Hispanic White,136.3,Male and Female,Colon and Rectum,2017
70-74,108.8,114.5,5871,Incidence,5259621,Non-Hispanic White,111.6,Male and Female,"Corpus and Uterus, NOS",2017
70-74,24.4,26.4,2526,Incidence,9938382,Non-Hispanic White,25.4,Male and Female,Esophagus,2017
70-74,492.3,504.3,26207,Incidence,5259621,Non-Hispanic White,498.3,Male and Female,Female Breast,2017
70-74,96.3,101.7,5206,Incidence,5259621,Non-Hispanic White,99.0,Male and Female,"Female Breast, <i>in situ</i>",2017
70-74,3.6,4.4,401,Incidence,9938382,Non-Hispanic White,4.0,Male and Female,Hodgkin Lymphoma,2017
70-74,0.2,0.5,34,Incidence,9938382,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2017
70-74,72.3,75.7,7349,Incidence,9938382,Non-Hispanic White,73.9,Male and Female,Kidney and Renal Pelvis,2017
70-74,13.6,15.1,1425,Incidence,9938382,Non-Hispanic White,14.3,Male and Female,Larynx,2017
70-74,58.6,61.6,5973,Incidence,9938382,Non-Hispanic White,60.1,Male and Female,Leukemias,2017
70-74,31.7,33.9,3259,Incidence,9938382,Non-Hispanic White,32.8,Male and Female,Liver and Intrahepatic Bile Duct,2017
70-74,349.3,356.6,35076,Incidence,9938382,Non-Hispanic White,352.9,Male and Female,Lung and Bronchus,2017
70-74,492.3,504.3,26207,Incidence,5259621,Non-Hispanic White,498.3,Male and Female,Male and Female Breast,2017
70-74,96.3,101.7,5206,Incidence,5259621,Non-Hispanic White,99.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
70-74,104.5,108.6,10591,Incidence,9938382,Non-Hispanic White,106.6,Male and Female,Melanomas of the Skin,2017
70-74,4.7,5.6,506,Incidence,9938382,Non-Hispanic White,5.1,Male and Female,Mesothelioma,2017
70-74,29.8,32.0,3066,Incidence,9938382,Non-Hispanic White,30.9,Male and Female,Myeloma,2017
70-74,85.3,89.0,8662,Incidence,9938382,Non-Hispanic White,87.2,Male and Female,Non-Hodgkin Lymphoma,2017
70-74,47.6,50.3,4864,Incidence,9938382,Non-Hispanic White,48.9,Male and Female,Oral Cavity and Pharynx,2017
70-74,36.6,40.0,2014,Incidence,5259621,Non-Hispanic White,38.3,Male and Female,Ovary,2017
70-74,64.0,67.2,6519,Incidence,9938382,Non-Hispanic White,65.6,Male and Female,Pancreas,2017
70-74,640.4,655.0,30305,Incidence,4678761,Non-Hispanic White,647.7,Male and Female,Prostate,2017
70-74,22.3,24.2,2312,Incidence,9938382,Non-Hispanic White,23.3,Male and Female,Stomach,2017
70-74,0.9,1.6,57,Incidence,4678761,Non-Hispanic White,1.2,Male and Female,Testis,2017
70-74,21.7,23.6,2246,Incidence,9938382,Non-Hispanic White,22.6,Male and Female,Thyroid,2017
70-74,115.1,119.4,11650,Incidence,9938382,Non-Hispanic White,117.2,Male and Female,Urinary Bladder,2017
75-79,2304.5,2327.5,157021,Incidence,6779916,Non-Hispanic White,2316.0,Male and Female,All Cancer Sites Combined,2017
75-79,21.8,24.1,1554,Incidence,6779916,Non-Hispanic White,22.9,Male and Female,Brain and Other Nervous System,2017
75-79,7.2,9.0,298,Incidence,3703126,Non-Hispanic White,8.0,Male and Female,Cervix,2017
75-79,175.4,181.8,12106,Incidence,6779916,Non-Hispanic White,178.6,Male and Female,Colon and Rectum,2017
75-79,92.3,98.6,3533,Incidence,3703126,Non-Hispanic White,95.4,Male and Female,"Corpus and Uterus, NOS",2017
75-79,25.7,28.2,1827,Incidence,6779916,Non-Hispanic White,26.9,Male and Female,Esophagus,2017
75-79,476.2,490.4,17896,Incidence,3703126,Non-Hispanic White,483.3,Male and Female,Female Breast,2017
75-79,79.3,85.1,3042,Incidence,3703126,Non-Hispanic White,82.1,Male and Female,"Female Breast, <i>in situ</i>",2017
75-79,3.5,4.4,267,Incidence,6779916,Non-Hispanic White,3.9,Male and Female,Hodgkin Lymphoma,2017
75-79,0.3,0.7,34,Incidence,6779916,Non-Hispanic White,0.5,Male and Female,Kaposi Sarcoma,2017
75-79,77.5,81.7,5396,Incidence,6779916,Non-Hispanic White,79.6,Male and Female,Kidney and Renal Pelvis,2017
75-79,12.3,14.0,889,Incidence,6779916,Non-Hispanic White,13.1,Male and Female,Larynx,2017
75-79,76.2,80.4,5308,Incidence,6779916,Non-Hispanic White,78.3,Male and Female,Leukemias,2017
75-79,34.1,37.0,2410,Incidence,6779916,Non-Hispanic White,35.5,Male and Female,Liver and Intrahepatic Bile Duct,2017
75-79,429.5,439.5,29457,Incidence,6779916,Non-Hispanic White,434.5,Male and Female,Lung and Bronchus,2017
75-79,476.2,490.4,17896,Incidence,3703126,Non-Hispanic White,483.3,Male and Female,Male and Female Breast,2017
75-79,79.3,85.1,3042,Incidence,3703126,Non-Hispanic White,82.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
75-79,125.3,130.7,8674,Incidence,6779916,Non-Hispanic White,127.9,Male and Female,Melanomas of the Skin,2017
75-79,7.3,8.7,542,Incidence,6779916,Non-Hispanic White,8.0,Male and Female,Mesothelioma,2017
75-79,37.8,40.8,2660,Incidence,6779916,Non-Hispanic White,39.2,Male and Female,Myeloma,2017
75-79,107.9,113.0,7487,Incidence,6779916,Non-Hispanic White,110.4,Male and Female,Non-Hodgkin Lymphoma,2017
75-79,48.0,51.3,3364,Incidence,6779916,Non-Hispanic White,49.6,Male and Female,Oral Cavity and Pharynx,2017
75-79,39.7,43.9,1545,Incidence,3703126,Non-Hispanic White,41.7,Male and Female,Ovary,2017
75-79,81.8,86.1,5691,Incidence,6779916,Non-Hispanic White,83.9,Male and Female,Pancreas,2017
75-79,557.2,574.0,17401,Incidence,3076790,Non-Hispanic White,565.6,Male and Female,Prostate,2017
75-79,27.4,30.0,1945,Incidence,6779916,Non-Hispanic White,28.7,Male and Female,Stomach,2017
75-79,0.5,1.2,25,Incidence,3076790,Non-Hispanic White,0.8,Male and Female,Testis,2017
75-79,19.7,21.9,1406,Incidence,6779916,Non-Hispanic White,20.7,Male and Female,Thyroid,2017
75-79,153.5,159.4,10605,Incidence,6779916,Non-Hispanic White,156.4,Male and Female,Urinary Bladder,2017
80-84,2407.4,2435.7,112875,Incidence,4661297,Non-Hispanic White,2421.5,Male and Female,All Cancer Sites Combined,2017
80-84,22.4,25.3,1110,Incidence,4661297,Non-Hispanic White,23.8,Male and Female,Brain and Other Nervous System,2017
80-84,6.1,8.2,190,Incidence,2668102,Non-Hispanic White,7.1,Male and Female,Cervix,2017
80-84,220.1,228.8,10461,Incidence,4661297,Non-Hispanic White,224.4,Male and Female,Colon and Rectum,2017
80-84,74.6,81.4,2080,Incidence,2668102,Non-Hispanic White,78.0,Male and Female,"Corpus and Uterus, NOS",2017
80-84,28.0,31.1,1375,Incidence,4661297,Non-Hispanic White,29.5,Male and Female,Esophagus,2017
80-84,421.7,437.5,11460,Incidence,2668102,Non-Hispanic White,429.5,Male and Female,Female Breast,2017
80-84,52.8,58.5,1483,Incidence,2668102,Non-Hispanic White,55.6,Male and Female,"Female Breast, <i>in situ</i>",2017
80-84,3.7,4.9,198,Incidence,4661297,Non-Hispanic White,4.2,Male and Female,Hodgkin Lymphoma,2017
80-84,0.5,0.9,31,Incidence,4661297,Non-Hispanic White,0.7,Male and Female,Kaposi Sarcoma,2017
80-84,71.5,76.4,3445,Incidence,4661297,Non-Hispanic White,73.9,Male and Female,Kidney and Renal Pelvis,2017
80-84,12.6,14.7,634,Incidence,4661297,Non-Hispanic White,13.6,Male and Female,Larynx,2017
80-84,90.7,96.2,4355,Incidence,4661297,Non-Hispanic White,93.4,Male and Female,Leukemias,2017
80-84,34.9,38.4,1708,Incidence,4661297,Non-Hispanic White,36.6,Male and Female,Liver and Intrahepatic Bile Duct,2017
80-84,432.2,444.2,20423,Incidence,4661297,Non-Hispanic White,438.1,Male and Female,Lung and Bronchus,2017
80-84,421.7,437.5,11460,Incidence,2668102,Non-Hispanic White,429.5,Male and Female,Male and Female Breast,2017
80-84,52.8,58.5,1483,Incidence,2668102,Non-Hispanic White,55.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
80-84,140.2,147.1,6693,Incidence,4661297,Non-Hispanic White,143.6,Male and Female,Melanomas of the Skin,2017
80-84,8.7,10.5,444,Incidence,4661297,Non-Hispanic White,9.5,Male and Female,Mesothelioma,2017
80-84,43.8,47.7,2129,Incidence,4661297,Non-Hispanic White,45.7,Male and Female,Myeloma,2017
80-84,120.8,127.3,5781,Incidence,4661297,Non-Hispanic White,124.0,Male and Female,Non-Hodgkin Lymphoma,2017
80-84,45.6,49.6,2218,Incidence,4661297,Non-Hispanic White,47.6,Male and Female,Oral Cavity and Pharynx,2017
80-84,41.3,46.4,1168,Incidence,2668102,Non-Hispanic White,43.8,Male and Female,Ovary,2017
80-84,91.5,97.1,4396,Incidence,4661297,Non-Hispanic White,94.3,Male and Female,Pancreas,2017
80-84,421.3,439.5,8577,Incidence,1993195,Non-Hispanic White,430.3,Male and Female,Prostate,2017
80-84,32.6,36.0,1598,Incidence,4661297,Non-Hispanic White,34.3,Male and Female,Stomach,2017
80-84,0.7,1.6,21,Incidence,1993195,Non-Hispanic White,1.1,Male and Female,Testis,2017
80-84,14.1,16.4,708,Incidence,4661297,Non-Hispanic White,15.2,Male and Female,Thyroid,2017
80-84,187.5,195.5,8924,Incidence,4661297,Non-Hispanic White,191.4,Male and Female,Urinary Bladder,2017
85+,2145.1,2170.3,112511,Incidence,5214464,Non-Hispanic White,2157.7,Male and Female,All Cancer Sites Combined,2017
85+,17.8,20.2,991,Incidence,5214464,Non-Hispanic White,19.0,Male and Female,Brain and Other Nervous System,2017
85+,5.6,7.4,216,Incidence,3352877,Non-Hispanic White,6.4,Male and Female,Cervix,2017
85+,239.5,248.0,12709,Incidence,5214464,Non-Hispanic White,243.7,Male and Female,Colon and Rectum,2017
85+,48.7,53.6,1713,Incidence,3352877,Non-Hispanic White,51.1,Male and Female,"Corpus and Uterus, NOS",2017
85+,21.7,24.3,1196,Incidence,5214464,Non-Hispanic White,22.9,Male and Female,Esophagus,2017
85+,318.0,330.2,10865,Incidence,3352877,Non-Hispanic White,324.1,Male and Female,Female Breast,2017
85+,20.9,24.1,753,Incidence,3352877,Non-Hispanic White,22.5,Male and Female,"Female Breast, <i>in situ</i>",2017
85+,2.3,3.2,141,Incidence,5214464,Non-Hispanic White,2.7,Male and Female,Hodgkin Lymphoma,2017
85+,0.5,1.0,37,Incidence,5214464,Non-Hispanic White,0.7,Male and Female,Kaposi Sarcoma,2017
85+,55.8,59.9,3014,Incidence,5214464,Non-Hispanic White,57.8,Male and Female,Kidney and Renal Pelvis,2017
85+,8.6,10.3,491,Incidence,5214464,Non-Hispanic White,9.4,Male and Female,Larynx,2017
85+,91.6,96.9,4912,Incidence,5214464,Non-Hispanic White,94.2,Male and Female,Leukemias,2017
85+,27.8,30.8,1525,Incidence,5214464,Non-Hispanic White,29.2,Male and Female,Liver and Intrahepatic Bile Duct,2017
85+,310.9,320.5,16461,Incidence,5214464,Non-Hispanic White,315.7,Male and Female,Lung and Bronchus,2017
85+,318.0,330.2,10865,Incidence,3352877,Non-Hispanic White,324.1,Male and Female,Male and Female Breast,2017
85+,20.9,24.1,753,Incidence,3352877,Non-Hispanic White,22.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
85+,129.0,135.2,6886,Incidence,5214464,Non-Hispanic White,132.1,Male and Female,Melanomas of the Skin,2017
85+,8.0,9.6,457,Incidence,5214464,Non-Hispanic White,8.8,Male and Female,Mesothelioma,2017
85+,34.2,37.5,1868,Incidence,5214464,Non-Hispanic White,35.8,Male and Female,Myeloma,2017
85+,106.6,112.3,5707,Incidence,5214464,Non-Hispanic White,109.4,Male and Female,Non-Hodgkin Lymphoma,2017
85+,42.4,46.0,2302,Incidence,5214464,Non-Hispanic White,44.1,Male and Female,Oral Cavity and Pharynx,2017
85+,36.5,40.7,1293,Incidence,3352877,Non-Hispanic White,38.6,Male and Female,Ovary,2017
85+,93.0,98.3,4987,Incidence,5214464,Non-Hispanic White,95.6,Male and Female,Pancreas,2017
85+,349.7,366.9,6669,Incidence,1861587,Non-Hispanic White,358.2,Male and Female,Prostate,2017
85+,29.2,32.2,1598,Incidence,5214464,Non-Hispanic White,30.6,Male and Female,Stomach,2017
85+,~,~,~,Incidence,1861587,Non-Hispanic White,~,Male and Female,Testis,2017
85+,7.9,9.5,454,Incidence,5214464,Non-Hispanic White,8.7,Male and Female,Thyroid,2017
85+,179.1,186.5,9530,Incidence,5214464,Non-Hispanic White,182.8,Male and Female,Urinary Bladder,2017
<1,27.8,32.7,597,Incidence,1981145,Non-Hispanic White,30.1,Male and Female,All Cancer Sites Combined,2017
<1,3.4,5.3,85,Incidence,1981145,Non-Hispanic White,4.3,Male and Female,Brain and Other Nervous System,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,Cervix,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Colon and Rectum,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Esophagus,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,Female Breast,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2017
<1,1.5,2.9,42,Incidence,1981145,Non-Hispanic White,2.1,Male and Female,Kidney and Renal Pelvis,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Larynx,2017
<1,3.5,5.4,86,Incidence,1981145,Non-Hispanic White,4.3,Male and Female,Leukemias,2017
<1,0.8,1.9,25,Incidence,1981145,Non-Hispanic White,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,Male and Female Breast,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Mesothelioma,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Myeloma,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Non-Hodgkin Lymphoma,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2017
<1,~,~,~,Incidence,965208,Non-Hispanic White,~,Male and Female,Ovary,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Pancreas,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male and Female,Prostate,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Stomach,2017
<1,~,~,~,Incidence,1015937,Non-Hispanic White,~,Male and Female,Testis,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Thyroid,2017
<1,~,~,~,Incidence,1981145,Non-Hispanic White,~,Male and Female,Urinary Bladder,2017
1-4,19.9,21.9,1627,Incidence,7794796,All Races,20.9,Female,All Cancer Sites Combined,2018
1-4,3.7,4.6,323,Incidence,7794796,All Races,4.1,Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Cervix,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Esophagus,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Female Breast,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Kaposi Sarcoma,2018
1-4,1.7,2.3,156,Incidence,7794796,All Races,2.0,Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Larynx,2018
1-4,7.9,9.2,663,Incidence,7794796,All Races,8.5,Female,Leukemias,2018
1-4,0.3,0.7,37,Incidence,7794796,All Races,0.5,Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Mesothelioma,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Myeloma,2018
1-4,0.2,0.5,29,Incidence,7794796,All Races,0.4,Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Ovary,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Pancreas,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Stomach,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Thyroid,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Female,Urinary Bladder,2018
10-14,15.2,16.7,1631,Incidence,10223894,All Races,16.0,Female,All Cancer Sites Combined,2018
10-14,2.6,3.3,301,Incidence,10223894,All Races,2.9,Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Cervix,2018
10-14,0.6,1.0,80,Incidence,10223894,All Races,0.8,Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Esophagus,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Female Breast,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,"Female Breast, <i>in situ</i>",2018
10-14,0.9,1.4,116,Incidence,10223894,All Races,1.1,Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Kaposi Sarcoma,2018
10-14,0.2,0.4,25,Incidence,10223894,All Races,0.2,Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Larynx,2018
10-14,2.8,3.5,322,Incidence,10223894,All Races,3.1,Female,Leukemias,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Lung and Bronchus,2018
10-14,0.2,0.4,29,Incidence,10223894,All Races,0.3,Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Mesothelioma,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Myeloma,2018
10-14,0.9,1.3,107,Incidence,10223894,All Races,1.0,Female,Non-Hodgkin Lymphoma,2018
10-14,0.2,0.4,29,Incidence,10223894,All Races,0.3,Female,Oral Cavity and Pharynx,2018
10-14,0.8,1.2,97,Incidence,10223894,All Races,0.9,Female,Ovary,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Pancreas,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Stomach,2018
10-14,1.4,1.9,171,Incidence,10223894,All Races,1.7,Female,Thyroid,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Female,Urinary Bladder,2018
15-19,23.5,25.4,2523,Incidence,10314076,All Races,24.5,Female,All Cancer Sites Combined,2018
15-19,1.8,2.3,211,Incidence,10314076,All Races,2.0,Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Cervix,2018
15-19,1.3,1.8,162,Incidence,10314076,All Races,1.6,Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Esophagus,2018
15-19,0.1,0.3,21,Incidence,10314076,All Races,0.2,Female,Female Breast,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,"Female Breast, <i>in situ</i>",2018
15-19,3.0,3.7,343,Incidence,10314076,All Races,3.3,Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Kaposi Sarcoma,2018
15-19,0.2,0.4,28,Incidence,10314076,All Races,0.3,Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Larynx,2018
15-19,2.3,2.9,268,Incidence,10314076,All Races,2.6,Female,Leukemias,2018
15-19,0.1,0.3,18,Incidence,10314076,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2018
15-19,0.1,0.3,18,Incidence,10314076,All Races,0.2,Female,Lung and Bronchus,2018
15-19,0.8,1.2,105,Incidence,10314076,All Races,1.0,Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Mesothelioma,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Myeloma,2018
15-19,1.0,1.4,121,Incidence,10314076,All Races,1.2,Female,Non-Hodgkin Lymphoma,2018
15-19,0.3,0.5,41,Incidence,10314076,All Races,0.4,Female,Oral Cavity and Pharynx,2018
15-19,1.0,1.5,129,Incidence,10314076,All Races,1.3,Female,Ovary,2018
15-19,0.2,0.5,34,Incidence,10314076,All Races,0.3,Female,Pancreas,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Stomach,2018
15-19,5.6,6.6,628,Incidence,10314076,All Races,6.1,Female,Thyroid,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Female,Urinary Bladder,2018
20-24,38.7,41.1,4252,Incidence,10652877,All Races,39.9,Female,All Cancer Sites Combined,2018
20-24,1.5,2.0,184,Incidence,10652877,All Races,1.7,Female,Brain and Other Nervous System,2018
20-24,0.5,0.8,64,Incidence,10652877,All Races,0.6,Female,Cervix,2018
20-24,1.8,2.4,220,Incidence,10652877,All Races,2.1,Female,Colon and Rectum,2018
20-24,0.4,0.7,53,Incidence,10652877,All Races,0.5,Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Esophagus,2018
20-24,1.6,2.1,194,Incidence,10652877,All Races,1.8,Female,Female Breast,2018
20-24,0.1,0.3,18,Incidence,10652877,All Races,0.2,Female,"Female Breast, <i>in situ</i>",2018
20-24,3.9,4.7,455,Incidence,10652877,All Races,4.3,Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Kaposi Sarcoma,2018
20-24,0.4,0.7,62,Incidence,10652877,All Races,0.6,Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Larynx,2018
20-24,2.1,2.7,250,Incidence,10652877,All Races,2.3,Female,Leukemias,2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Liver and Intrahepatic Bile Duct,2018
20-24,0.2,0.4,29,Incidence,10652877,All Races,0.3,Female,Lung and Bronchus,2018
20-24,3.3,4.0,384,Incidence,10652877,All Races,3.6,Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Mesothelioma,2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Myeloma,2018
20-24,2.0,2.6,240,Incidence,10652877,All Races,2.3,Female,Non-Hodgkin Lymphoma,2018
20-24,0.5,0.8,65,Incidence,10652877,All Races,0.6,Female,Oral Cavity and Pharynx,2018
20-24,1.7,2.2,205,Incidence,10652877,All Races,1.9,Female,Ovary,2018
20-24,0.4,0.6,52,Incidence,10652877,All Races,0.5,Female,Pancreas,2018
20-24,0.2,0.4,34,Incidence,10652877,All Races,0.3,Female,Stomach,2018
20-24,10.8,12.0,1213,Incidence,10652877,All Races,11.4,Female,Thyroid,2018
20-24,~,~,~,Incidence,10652877,All Races,~,Female,Urinary Bladder,2018
25-29,68.8,71.9,8115,Incidence,11535821,All Races,70.3,Female,All Cancer Sites Combined,2018
25-29,2.5,3.1,321,Incidence,11535821,All Races,2.8,Female,Brain and Other Nervous System,2018
25-29,4.2,5.0,528,Incidence,11535821,All Races,4.6,Female,Cervix,2018
25-29,3.2,3.9,403,Incidence,11535821,All Races,3.5,Female,Colon and Rectum,2018
25-29,1.9,2.4,244,Incidence,11535821,All Races,2.1,Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,11535821,All Races,~,Female,Esophagus,2018
25-29,9.8,11.0,1202,Incidence,11535821,All Races,10.4,Female,Female Breast,2018
25-29,0.5,0.8,71,Incidence,11535821,All Races,0.6,Female,"Female Breast, <i>in situ</i>",2018
25-29,3.5,4.2,446,Incidence,11535821,All Races,3.9,Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,11535821,All Races,~,Female,Kaposi Sarcoma,2018
25-29,1.0,1.4,137,Incidence,11535821,All Races,1.2,Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,11535821,All Races,~,Female,Larynx,2018
25-29,2.4,3.0,306,Incidence,11535821,All Races,2.7,Female,Leukemias,2018
25-29,0.2,0.4,35,Incidence,11535821,All Races,0.3,Female,Liver and Intrahepatic Bile Duct,2018
25-29,0.5,0.8,71,Incidence,11535821,All Races,0.6,Female,Lung and Bronchus,2018
25-29,6.3,7.3,785,Incidence,11535821,All Races,6.8,Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,11535821,All Races,~,Female,Mesothelioma,2018
25-29,~,~,~,Incidence,11535821,All Races,~,Female,Myeloma,2018
25-29,2.5,3.1,319,Incidence,11535821,All Races,2.8,Female,Non-Hodgkin Lymphoma,2018
25-29,0.9,1.3,121,Incidence,11535821,All Races,1.0,Female,Oral Cavity and Pharynx,2018
25-29,2.1,2.6,270,Incidence,11535821,All Races,2.3,Female,Ovary,2018
25-29,0.4,0.6,55,Incidence,11535821,All Races,0.5,Female,Pancreas,2018
25-29,0.4,0.6,56,Incidence,11535821,All Races,0.5,Female,Stomach,2018
25-29,17.0,18.5,2044,Incidence,11535821,All Races,17.7,Female,Thyroid,2018
25-29,0.1,0.3,22,Incidence,11535821,All Races,0.2,Female,Urinary Bladder,2018
30-34,126.0,130.2,14018,Incidence,10945565,All Races,128.1,Female,All Cancer Sites Combined,2018
30-34,2.8,3.5,342,Incidence,10945565,All Races,3.1,Female,Brain and Other Nervous System,2018
30-34,11.0,12.3,1270,Incidence,10945565,All Races,11.6,Female,Cervix,2018
30-34,6.1,7.0,716,Incidence,10945565,All Races,6.5,Female,Colon and Rectum,2018
30-34,5.6,6.6,668,Incidence,10945565,All Races,6.1,Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,10945565,All Races,~,Female,Esophagus,2018
30-34,29.9,32.0,3386,Incidence,10945565,All Races,30.9,Female,Female Breast,2018
30-34,2.6,3.2,318,Incidence,10945565,All Races,2.9,Female,"Female Breast, <i>in situ</i>",2018
30-34,3.0,3.7,361,Incidence,10945565,All Races,3.3,Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,10945565,All Races,~,Female,Kaposi Sarcoma,2018
30-34,2.6,3.2,317,Incidence,10945565,All Races,2.9,Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,10945565,All Races,~,Female,Larynx,2018
30-34,2.9,3.5,348,Incidence,10945565,All Races,3.2,Female,Leukemias,2018
30-34,0.3,0.5,44,Incidence,10945565,All Races,0.4,Female,Liver and Intrahepatic Bile Duct,2018
30-34,1.0,1.5,136,Incidence,10945565,All Races,1.2,Female,Lung and Bronchus,2018
30-34,12.0,13.3,1384,Incidence,10945565,All Races,12.6,Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,10945565,All Races,~,Female,Mesothelioma,2018
30-34,0.2,0.4,34,Incidence,10945565,All Races,0.3,Female,Myeloma,2018
30-34,3.8,4.6,458,Incidence,10945565,All Races,4.2,Female,Non-Hodgkin Lymphoma,2018
30-34,1.3,1.7,162,Incidence,10945565,All Races,1.5,Female,Oral Cavity and Pharynx,2018
30-34,2.9,3.6,353,Incidence,10945565,All Races,3.2,Female,Ovary,2018
30-34,0.8,1.1,103,Incidence,10945565,All Races,0.9,Female,Pancreas,2018
30-34,0.9,1.3,123,Incidence,10945565,All Races,1.1,Female,Stomach,2018
30-34,24.4,26.3,2777,Incidence,10945565,All Races,25.4,Female,Thyroid,2018
30-34,0.4,0.7,61,Incidence,10945565,All Races,0.6,Female,Urinary Bladder,2018
35-39,194.2,199.5,21197,Incidence,10767228,All Races,196.9,Female,All Cancer Sites Combined,2018
35-39,3.0,3.7,356,Incidence,10767228,All Races,3.3,Female,Brain and Other Nervous System,2018
35-39,13.2,14.6,1491,Incidence,10767228,All Races,13.8,Female,Cervix,2018
35-39,10.6,11.8,1203,Incidence,10767228,All Races,11.2,Female,Colon and Rectum,2018
35-39,10.2,11.5,1167,Incidence,10767228,All Races,10.8,Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,10767228,All Races,~,Female,Esophagus,2018
35-39,61.8,64.8,6811,Incidence,10767228,All Races,63.3,Female,Female Breast,2018
35-39,8.3,9.5,958,Incidence,10767228,All Races,8.9,Female,"Female Breast, <i>in situ</i>",2018
35-39,2.4,3.1,295,Incidence,10767228,All Races,2.7,Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,10767228,All Races,~,Female,Kaposi Sarcoma,2018
35-39,5.3,6.2,618,Incidence,10767228,All Races,5.7,Female,Kidney and Renal Pelvis,2018
35-39,0.1,0.2,16,Incidence,10767228,All Races,0.1,Female,Larynx,2018
35-39,3.7,4.5,442,Incidence,10767228,All Races,4.1,Female,Leukemias,2018
35-39,0.6,0.9,80,Incidence,10767228,All Races,0.7,Female,Liver and Intrahepatic Bile Duct,2018
35-39,2.6,3.3,314,Incidence,10767228,All Races,2.9,Female,Lung and Bronchus,2018
35-39,15.4,16.9,1738,Incidence,10767228,All Races,16.1,Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,10767228,All Races,~,Female,Mesothelioma,2018
35-39,0.7,1.0,88,Incidence,10767228,All Races,0.8,Female,Myeloma,2018
35-39,5.1,6.0,598,Incidence,10767228,All Races,5.6,Female,Non-Hodgkin Lymphoma,2018
35-39,2.1,2.7,254,Incidence,10767228,All Races,2.4,Female,Oral Cavity and Pharynx,2018
35-39,4.7,5.5,546,Incidence,10767228,All Races,5.1,Female,Ovary,2018
35-39,1.3,1.8,168,Incidence,10767228,All Races,1.6,Female,Pancreas,2018
35-39,1.9,2.4,231,Incidence,10767228,All Races,2.1,Female,Stomach,2018
35-39,28.7,30.8,3205,Incidence,10767228,All Races,29.8,Female,Thyroid,2018
35-39,0.8,1.2,111,Incidence,10767228,All Races,1.0,Female,Urinary Bladder,2018
40-44,312.4,319.4,31274,Incidence,9901383,All Races,315.9,Female,All Cancer Sites Combined,2018
40-44,3.0,3.8,337,Incidence,9901383,All Races,3.4,Female,Brain and Other Nervous System,2018
40-44,15.2,16.8,1580,Incidence,9901383,All Races,16.0,Female,Cervix,2018
40-44,18.1,19.8,1872,Incidence,9901383,All Races,18.9,Female,Colon and Rectum,2018
40-44,16.5,18.1,1713,Incidence,9901383,All Races,17.3,Female,"Corpus and Uterus, NOS",2018
40-44,0.2,0.4,31,Incidence,9901383,All Races,0.3,Female,Esophagus,2018
40-44,129.3,133.9,13029,Incidence,9901383,All Races,131.6,Female,Female Breast,2018
40-44,37.1,39.6,3798,Incidence,9901383,All Races,38.4,Female,"Female Breast, <i>in situ</i>",2018
40-44,1.9,2.5,216,Incidence,9901383,All Races,2.2,Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,9901383,All Races,~,Female,Kaposi Sarcoma,2018
40-44,8.8,10.0,926,Incidence,9901383,All Races,9.4,Female,Kidney and Renal Pelvis,2018
40-44,0.3,0.5,36,Incidence,9901383,All Races,0.4,Female,Larynx,2018
40-44,4.9,5.8,525,Incidence,9901383,All Races,5.3,Female,Leukemias,2018
40-44,1.2,1.7,140,Incidence,9901383,All Races,1.4,Female,Liver and Intrahepatic Bile Duct,2018
40-44,6.4,7.5,687,Incidence,9901383,All Races,6.9,Female,Lung and Bronchus,2018
40-44,18.1,19.8,1875,Incidence,9901383,All Races,18.9,Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,9901383,All Races,~,Female,Mesothelioma,2018
40-44,2.3,2.9,258,Incidence,9901383,All Races,2.6,Female,Myeloma,2018
40-44,7.5,8.7,800,Incidence,9901383,All Races,8.1,Female,Non-Hodgkin Lymphoma,2018
40-44,3.3,4.0,360,Incidence,9901383,All Races,3.6,Female,Oral Cavity and Pharynx,2018
40-44,7.8,8.9,824,Incidence,9901383,All Races,8.3,Female,Ovary,2018
40-44,2.6,3.3,294,Incidence,9901383,All Races,3.0,Female,Pancreas,2018
40-44,3.3,4.0,358,Incidence,9901383,All Races,3.6,Female,Stomach,2018
40-44,32.5,34.8,3333,Incidence,9901383,All Races,33.7,Female,Thyroid,2018
40-44,1.2,1.7,146,Incidence,9901383,All Races,1.5,Female,Urinary Bladder,2018
45-49,448.9,457.1,47411,Incidence,10466104,All Races,453.0,Female,All Cancer Sites Combined,2018
45-49,4.0,4.8,459,Incidence,10466104,All Races,4.4,Female,Brain and Other Nervous System,2018
45-49,13.7,15.1,1504,Incidence,10466104,All Races,14.4,Female,Cervix,2018
45-49,30.7,32.9,3325,Incidence,10466104,All Races,31.8,Female,Colon and Rectum,2018
45-49,25.9,27.9,2818,Incidence,10466104,All Races,26.9,Female,"Corpus and Uterus, NOS",2018
45-49,0.7,1.1,95,Incidence,10466104,All Races,0.9,Female,Esophagus,2018
45-49,195.4,200.8,20732,Incidence,10466104,All Races,198.1,Female,Female Breast,2018
45-49,56.4,59.3,6056,Incidence,10466104,All Races,57.9,Female,"Female Breast, <i>in situ</i>",2018
45-49,1.6,2.1,190,Incidence,10466104,All Races,1.8,Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,10466104,All Races,~,Female,Kaposi Sarcoma,2018
45-49,12.1,13.5,1342,Incidence,10466104,All Races,12.8,Female,Kidney and Renal Pelvis,2018
45-49,0.8,1.2,105,Incidence,10466104,All Races,1.0,Female,Larynx,2018
45-49,7.0,8.0,785,Incidence,10466104,All Races,7.5,Female,Leukemias,2018
45-49,1.7,2.3,208,Incidence,10466104,All Races,2.0,Female,Liver and Intrahepatic Bile Duct,2018
45-49,16.7,18.4,1836,Incidence,10466104,All Races,17.5,Female,Lung and Bronchus,2018
45-49,22.2,24.0,2418,Incidence,10466104,All Races,23.1,Female,Melanomas of the Skin,2018
45-49,0.2,0.5,34,Incidence,10466104,All Races,0.3,Female,Mesothelioma,2018
45-49,3.8,4.6,438,Incidence,10466104,All Races,4.2,Female,Myeloma,2018
45-49,11.4,12.7,1260,Incidence,10466104,All Races,12.0,Female,Non-Hodgkin Lymphoma,2018
45-49,5.5,6.5,629,Incidence,10466104,All Races,6.0,Female,Oral Cavity and Pharynx,2018
45-49,12.3,13.6,1354,Incidence,10466104,All Races,12.9,Female,Ovary,2018
45-49,5.1,6.0,581,Incidence,10466104,All Races,5.6,Female,Pancreas,2018
45-49,4.2,5.0,482,Incidence,10466104,All Races,4.6,Female,Stomach,2018
45-49,32.9,35.2,3561,Incidence,10466104,All Races,34.0,Female,Thyroid,2018
45-49,2.8,3.5,325,Incidence,10466104,All Races,3.1,Female,Urinary Bladder,2018
5-9,11.2,12.6,1176,Incidence,9888217,All Races,11.9,Female,All Cancer Sites Combined,2018
5-9,3.0,3.8,334,Incidence,9888217,All Races,3.4,Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Cervix,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Esophagus,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Female Breast,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,"Female Breast, <i>in situ</i>",2018
5-9,0.1,0.3,20,Incidence,9888217,All Races,0.2,Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Kaposi Sarcoma,2018
5-9,0.6,1.0,77,Incidence,9888217,All Races,0.8,Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Larynx,2018
5-9,3.4,4.2,372,Incidence,9888217,All Races,3.8,Female,Leukemias,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Mesothelioma,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Myeloma,2018
5-9,0.5,0.8,60,Incidence,9888217,All Races,0.6,Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Oral Cavity and Pharynx,2018
5-9,0.1,0.3,17,Incidence,9888217,All Races,0.2,Female,Ovary,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Pancreas,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Stomach,2018
5-9,0.1,0.3,19,Incidence,9888217,All Races,0.2,Female,Thyroid,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Female,Urinary Bladder,2018
50-54,612.0,621.5,65335,Incidence,10593345,All Races,616.8,Female,All Cancer Sites Combined,2018
50-54,5.2,6.1,598,Incidence,10593345,All Races,5.6,Female,Brain and Other Nervous System,2018
50-54,12.0,13.3,1339,Incidence,10593345,All Races,12.6,Female,Cervix,2018
50-54,53.7,56.6,5840,Incidence,10593345,All Races,55.1,Female,Colon and Rectum,2018
50-54,47.4,50.1,5162,Incidence,10593345,All Races,48.7,Female,"Corpus and Uterus, NOS",2018
50-54,1.7,2.3,213,Incidence,10593345,All Races,2.0,Female,Esophagus,2018
50-54,230.0,235.8,24673,Incidence,10593345,All Races,232.9,Female,Female Breast,2018
50-54,64.2,67.3,6966,Incidence,10593345,All Races,65.8,Female,"Female Breast, <i>in situ</i>",2018
50-54,1.7,2.2,203,Incidence,10593345,All Races,1.9,Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,10593345,All Races,~,Female,Kaposi Sarcoma,2018
50-54,17.0,18.7,1889,Incidence,10593345,All Races,17.8,Female,Kidney and Renal Pelvis,2018
50-54,2.0,2.6,247,Incidence,10593345,All Races,2.3,Female,Larynx,2018
50-54,9.5,10.7,1068,Incidence,10593345,All Races,10.1,Female,Leukemias,2018
50-54,4.2,5.0,488,Incidence,10593345,All Races,4.6,Female,Liver and Intrahepatic Bile Duct,2018
50-54,41.6,44.1,4538,Incidence,10593345,All Races,42.8,Female,Lung and Bronchus,2018
50-54,27.9,29.9,3058,Incidence,10593345,All Races,28.9,Female,Melanomas of the Skin,2018
50-54,0.2,0.4,34,Incidence,10593345,All Races,0.3,Female,Mesothelioma,2018
50-54,6.5,7.5,738,Incidence,10593345,All Races,7.0,Female,Myeloma,2018
50-54,17.6,19.2,1945,Incidence,10593345,All Races,18.4,Female,Non-Hodgkin Lymphoma,2018
50-54,10.0,11.2,1121,Incidence,10593345,All Races,10.6,Female,Oral Cavity and Pharynx,2018
50-54,16.4,18.0,1819,Incidence,10593345,All Races,17.2,Female,Ovary,2018
50-54,10.2,11.4,1142,Incidence,10593345,All Races,10.8,Female,Pancreas,2018
50-54,5.4,6.3,616,Incidence,10593345,All Races,5.8,Female,Stomach,2018
50-54,32.6,34.8,3572,Incidence,10593345,All Races,33.7,Female,Thyroid,2018
50-54,5.9,6.9,674,Incidence,10593345,All Races,6.4,Female,Urinary Bladder,2018
55-59,805.2,815.8,91244,Incidence,11257833,All Races,810.5,Female,All Cancer Sites Combined,2018
55-59,7.8,8.9,940,Incidence,11257833,All Races,8.3,Female,Brain and Other Nervous System,2018
55-59,11.8,13.2,1406,Incidence,11257833,All Races,12.5,Female,Cervix,2018
55-59,54.2,56.9,6253,Incidence,11257833,All Races,55.5,Female,Colon and Rectum,2018
55-59,75.6,78.9,8693,Incidence,11257833,All Races,77.2,Female,"Corpus and Uterus, NOS",2018
55-59,3.2,3.9,395,Incidence,11257833,All Races,3.5,Female,Esophagus,2018
55-59,268.5,274.6,30573,Incidence,11257833,All Races,271.6,Female,Female Breast,2018
55-59,64.6,67.6,7442,Incidence,11257833,All Races,66.1,Female,"Female Breast, <i>in situ</i>",2018
55-59,1.8,2.3,232,Incidence,11257833,All Races,2.1,Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,11257833,All Races,~,Female,Kaposi Sarcoma,2018
55-59,23.4,25.2,2736,Incidence,11257833,All Races,24.3,Female,Kidney and Renal Pelvis,2018
55-59,3.7,4.5,461,Incidence,11257833,All Races,4.1,Female,Larynx,2018
55-59,14.7,16.2,1736,Incidence,11257833,All Races,15.4,Female,Leukemias,2018
55-59,8.9,10.0,1060,Incidence,11257833,All Races,9.4,Female,Liver and Intrahepatic Bile Duct,2018
55-59,89.7,93.3,10301,Incidence,11257833,All Races,91.5,Female,Lung and Bronchus,2018
55-59,32.4,34.6,3770,Incidence,11257833,All Races,33.5,Female,Melanomas of the Skin,2018
55-59,0.4,0.6,53,Incidence,11257833,All Races,0.5,Female,Mesothelioma,2018
55-59,9.5,10.7,1134,Incidence,11257833,All Races,10.1,Female,Myeloma,2018
55-59,25.2,27.1,2945,Incidence,11257833,All Races,26.2,Female,Non-Hodgkin Lymphoma,2018
55-59,14.9,16.4,1762,Incidence,11257833,All Races,15.7,Female,Oral Cavity and Pharynx,2018
55-59,20.0,21.6,2340,Incidence,11257833,All Races,20.8,Female,Ovary,2018
55-59,18.0,19.6,2110,Incidence,11257833,All Races,18.7,Female,Pancreas,2018
55-59,7.7,8.8,925,Incidence,11257833,All Races,8.2,Female,Stomach,2018
55-59,30.8,32.9,3581,Incidence,11257833,All Races,31.8,Female,Thyroid,2018
55-59,10.3,11.6,1232,Incidence,11257833,All Races,10.9,Female,Urinary Bladder,2018
60-64,1043.5,1055.8,111111,Incidence,10585539,All Races,1049.6,Female,All Cancer Sites Combined,2018
60-64,9.3,10.5,1045,Incidence,10585539,All Races,9.9,Female,Brain and Other Nervous System,2018
60-64,10.5,11.8,1176,Incidence,10585539,All Races,11.1,Female,Cervix,2018
60-64,68.3,71.5,7399,Incidence,10585539,All Races,69.9,Female,Colon and Rectum,2018
60-64,99.6,103.5,10746,Incidence,10585539,All Races,101.5,Female,"Corpus and Uterus, NOS",2018
60-64,4.5,5.4,522,Incidence,10585539,All Races,4.9,Female,Esophagus,2018
60-64,331.6,338.6,35472,Incidence,10585539,All Races,335.1,Female,Female Breast,2018
60-64,79.3,82.7,8576,Incidence,10585539,All Races,81.0,Female,"Female Breast, <i>in situ</i>",2018
60-64,1.7,2.2,205,Incidence,10585539,All Races,1.9,Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,10585539,All Races,~,Female,Kaposi Sarcoma,2018
60-64,32.2,34.4,3522,Incidence,10585539,All Races,33.3,Female,Kidney and Renal Pelvis,2018
60-64,3.9,4.7,452,Incidence,10585539,All Races,4.3,Female,Larynx,2018
60-64,19.8,21.5,2183,Incidence,10585539,All Races,20.6,Female,Leukemias,2018
60-64,14.4,15.9,1602,Incidence,10585539,All Races,15.1,Female,Liver and Intrahepatic Bile Duct,2018
60-64,138.7,143.2,14922,Incidence,10585539,All Races,141.0,Female,Lung and Bronchus,2018
60-64,38.8,41.2,4231,Incidence,10585539,All Races,40.0,Female,Melanomas of the Skin,2018
60-64,0.6,1.0,85,Incidence,10585539,All Races,0.8,Female,Mesothelioma,2018
60-64,14.6,16.1,1623,Incidence,10585539,All Races,15.3,Female,Myeloma,2018
60-64,34.8,37.1,3804,Incidence,10585539,All Races,35.9,Female,Non-Hodgkin Lymphoma,2018
60-64,17.4,19.1,1929,Incidence,10585539,All Races,18.2,Female,Oral Cavity and Pharynx,2018
60-64,23.9,25.8,2631,Incidence,10585539,All Races,24.9,Female,Ovary,2018
60-64,27.0,29.0,2960,Incidence,10585539,All Races,28.0,Female,Pancreas,2018
60-64,9.7,11.0,1094,Incidence,10585539,All Races,10.3,Female,Stomach,2018
60-64,28.4,30.5,3117,Incidence,10585539,All Races,29.4,Female,Thyroid,2018
60-64,17.7,19.4,1960,Incidence,10585539,All Races,18.5,Female,Urinary Bladder,2018
65-69,1357.7,1372.9,123439,Incidence,9041390,All Races,1365.3,Female,All Cancer Sites Combined,2018
65-69,12.5,14.0,1196,Incidence,9041390,All Races,13.2,Female,Brain and Other Nervous System,2018
65-69,10.1,11.4,970,Incidence,9041390,All Races,10.7,Female,Cervix,2018
65-69,92.4,96.5,8538,Incidence,9041390,All Races,94.4,Female,Colon and Rectum,2018
65-69,114.7,119.2,10570,Incidence,9041390,All Races,116.9,Female,"Corpus and Uterus, NOS",2018
65-69,5.9,7.0,581,Incidence,9041390,All Races,6.4,Female,Esophagus,2018
65-69,421.3,429.8,38473,Incidence,9041390,All Races,425.5,Female,Female Breast,2018
65-69,96.4,100.5,8904,Incidence,9041390,All Races,98.5,Female,"Female Breast, <i>in situ</i>",2018
65-69,2.1,2.7,217,Incidence,9041390,All Races,2.4,Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,9041390,All Races,~,Female,Kaposi Sarcoma,2018
65-69,41.1,43.8,3836,Incidence,9041390,All Races,42.4,Female,Kidney and Renal Pelvis,2018
65-69,4.2,5.1,422,Incidence,9041390,All Races,4.7,Female,Larynx,2018
65-69,29.4,31.7,2760,Incidence,9041390,All Races,30.5,Female,Leukemias,2018
65-69,19.2,21.1,1823,Incidence,9041390,All Races,20.2,Female,Liver and Intrahepatic Bile Duct,2018
65-69,196.9,202.8,18069,Incidence,9041390,All Races,199.8,Female,Lung and Bronchus,2018
65-69,46.1,48.9,4295,Incidence,9041390,All Races,47.5,Female,Melanomas of the Skin,2018
65-69,0.8,1.2,90,Incidence,9041390,All Races,1.0,Female,Mesothelioma,2018
65-69,21.1,23.0,1994,Incidence,9041390,All Races,22.1,Female,Myeloma,2018
65-69,50.7,53.7,4719,Incidence,9041390,All Races,52.2,Female,Non-Hodgkin Lymphoma,2018
65-69,20.4,22.3,1931,Incidence,9041390,All Races,21.4,Female,Oral Cavity and Pharynx,2018
65-69,28.1,30.4,2644,Incidence,9041390,All Races,29.2,Female,Ovary,2018
65-69,40.9,43.6,3817,Incidence,9041390,All Races,42.2,Female,Pancreas,2018
65-69,13.2,14.7,1259,Incidence,9041390,All Races,13.9,Female,Stomach,2018
65-69,30.2,32.6,2838,Incidence,9041390,All Races,31.4,Female,Thyroid,2018
65-69,26.9,29.1,2530,Incidence,9041390,All Races,28.0,Female,Urinary Bladder,2018
70-74,1630.4,1649.2,117747,Incidence,7180687,All Races,1639.8,Female,All Cancer Sites Combined,2018
70-74,14.7,16.5,1117,Incidence,7180687,All Races,15.6,Female,Brain and Other Nervous System,2018
70-74,9.5,11.0,737,Incidence,7180687,All Races,10.3,Female,Cervix,2018
70-74,115.3,120.4,8460,Incidence,7180687,All Races,117.8,Female,Colon and Rectum,2018
70-74,107.9,112.8,7925,Incidence,7180687,All Races,110.4,Female,"Corpus and Uterus, NOS",2018
70-74,7.6,9.0,596,Incidence,7180687,All Races,8.3,Female,Esophagus,2018
70-74,476.2,486.4,34559,Incidence,7180687,All Races,481.3,Female,Female Breast,2018
70-74,96.8,101.4,7112,Incidence,7180687,All Races,99.0,Female,"Female Breast, <i>in situ</i>",2018
70-74,2.7,3.6,225,Incidence,7180687,All Races,3.1,Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,7180687,All Races,~,Female,Kaposi Sarcoma,2018
70-74,45.8,49.0,3403,Incidence,7180687,All Races,47.4,Female,Kidney and Renal Pelvis,2018
70-74,3.9,4.9,314,Incidence,7180687,All Races,4.4,Female,Larynx,2018
70-74,37.5,40.4,2793,Incidence,7180687,All Races,38.9,Female,Leukemias,2018
70-74,20.6,22.8,1558,Incidence,7180687,All Races,21.7,Female,Liver and Intrahepatic Bile Duct,2018
70-74,283.4,291.3,20633,Incidence,7180687,All Races,287.3,Female,Lung and Bronchus,2018
70-74,51.2,54.6,3796,Incidence,7180687,All Races,52.9,Female,Melanomas of the Skin,2018
70-74,1.5,2.2,132,Incidence,7180687,All Races,1.8,Female,Mesothelioma,2018
70-74,25.6,28.0,1921,Incidence,7180687,All Races,26.8,Female,Myeloma,2018
70-74,64.0,67.8,4729,Incidence,7180687,All Races,65.9,Female,Non-Hodgkin Lymphoma,2018
70-74,22.8,25.1,1721,Incidence,7180687,All Races,24.0,Female,Oral Cavity and Pharynx,2018
70-74,32.4,35.1,2423,Incidence,7180687,All Races,33.7,Female,Ovary,2018
70-74,55.8,59.3,4131,Incidence,7180687,All Races,57.5,Female,Pancreas,2018
70-74,16.9,18.9,1283,Incidence,7180687,All Races,17.9,Female,Stomach,2018
70-74,27.3,29.8,2048,Incidence,7180687,All Races,28.5,Female,Thyroid,2018
70-74,39.3,42.3,2926,Incidence,7180687,All Races,40.7,Female,Urinary Bladder,2018
75-79,1830.2,1853.7,94222,Incidence,5115395,All Races,1841.9,Female,All Cancer Sites Combined,2018
75-79,17.2,19.6,940,Incidence,5115395,All Races,18.4,Female,Brain and Other Nervous System,2018
75-79,8.9,10.6,497,Incidence,5115395,All Races,9.7,Female,Cervix,2018
75-79,150.8,157.6,7887,Incidence,5115395,All Races,154.2,Female,Colon and Rectum,2018
75-79,90.7,96.0,4774,Incidence,5115395,All Races,93.3,Female,"Corpus and Uterus, NOS",2018
75-79,9.6,11.4,538,Incidence,5115395,All Races,10.5,Female,Esophagus,2018
75-79,463.2,475.0,23995,Incidence,5115395,All Races,469.1,Female,Female Breast,2018
75-79,83.1,88.2,4378,Incidence,5115395,All Races,85.6,Female,"Female Breast, <i>in situ</i>",2018
75-79,2.7,3.7,162,Incidence,5115395,All Races,3.2,Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,5115395,All Races,~,Female,Kaposi Sarcoma,2018
75-79,49.3,53.2,2619,Incidence,5115395,All Races,51.2,Female,Kidney and Renal Pelvis,2018
75-79,3.7,4.9,219,Incidence,5115395,All Races,4.3,Female,Larynx,2018
75-79,49.4,53.4,2628,Incidence,5115395,All Races,51.4,Female,Leukemias,2018
75-79,25.7,28.5,1385,Incidence,5115395,All Races,27.1,Female,Liver and Intrahepatic Bile Duct,2018
75-79,342.4,352.6,17773,Incidence,5115395,All Races,347.4,Female,Lung and Bronchus,2018
75-79,54.7,58.9,2903,Incidence,5115395,All Races,56.8,Female,Melanomas of the Skin,2018
75-79,2.1,3.0,127,Incidence,5115395,All Races,2.5,Female,Mesothelioma,2018
75-79,32.9,36.1,1764,Incidence,5115395,All Races,34.5,Female,Myeloma,2018
75-79,81.8,86.8,4312,Incidence,5115395,All Races,84.3,Female,Non-Hodgkin Lymphoma,2018
75-79,26.1,29.0,1410,Incidence,5115395,All Races,27.6,Female,Oral Cavity and Pharynx,2018
75-79,36.1,39.5,1934,Incidence,5115395,All Races,37.8,Female,Ovary,2018
75-79,72.5,77.2,3827,Incidence,5115395,All Races,74.8,Female,Pancreas,2018
75-79,21.6,24.2,1170,Incidence,5115395,All Races,22.9,Female,Stomach,2018
75-79,22.8,25.5,1234,Incidence,5115395,All Races,24.1,Female,Thyroid,2018
75-79,52.6,56.7,2793,Incidence,5115395,All Races,54.6,Female,Urinary Bladder,2018
80-84,1887.8,1916.5,67276,Incidence,3536898,All Races,1902.1,Female,All Cancer Sites Combined,2018
80-84,16.6,19.4,634,Incidence,3536898,All Races,17.9,Female,Brain and Other Nervous System,2018
80-84,7.7,9.7,306,Incidence,3536898,All Races,8.7,Female,Cervix,2018
80-84,191.4,200.6,6931,Incidence,3536898,All Races,196.0,Female,Colon and Rectum,2018
80-84,75.8,81.7,2784,Incidence,3536898,All Races,78.7,Female,"Corpus and Uterus, NOS",2018
80-84,11.3,13.7,441,Incidence,3536898,All Races,12.5,Female,Esophagus,2018
80-84,413.7,427.2,14870,Incidence,3536898,All Races,420.4,Female,Female Breast,2018
80-84,51.8,56.7,1918,Incidence,3536898,All Races,54.2,Female,"Female Breast, <i>in situ</i>",2018
80-84,2.7,4.0,117,Incidence,3536898,All Races,3.3,Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,3536898,All Races,~,Female,Kaposi Sarcoma,2018
80-84,45.9,50.5,1703,Incidence,3536898,All Races,48.1,Female,Kidney and Renal Pelvis,2018
80-84,3.2,4.5,134,Incidence,3536898,All Races,3.8,Female,Larynx,2018
80-84,57.2,62.3,2111,Incidence,3536898,All Races,59.7,Female,Leukemias,2018
80-84,26.7,30.2,1005,Incidence,3536898,All Races,28.4,Female,Liver and Intrahepatic Bile Duct,2018
80-84,332.2,344.4,11964,Incidence,3536898,All Races,338.3,Female,Lung and Bronchus,2018
80-84,60.3,65.5,2224,Incidence,3536898,All Races,62.9,Female,Melanomas of the Skin,2018
80-84,2.7,4.0,117,Incidence,3536898,All Races,3.3,Female,Mesothelioma,2018
80-84,34.6,38.7,1295,Incidence,3536898,All Races,36.6,Female,Myeloma,2018
80-84,87.6,93.9,3208,Incidence,3536898,All Races,90.7,Female,Non-Hodgkin Lymphoma,2018
80-84,28.8,32.4,1081,Incidence,3536898,All Races,30.6,Female,Oral Cavity and Pharynx,2018
80-84,36.9,41.0,1376,Incidence,3536898,All Races,38.9,Female,Ovary,2018
80-84,84.2,90.4,3087,Incidence,3536898,All Races,87.3,Female,Pancreas,2018
80-84,24.3,27.7,917,Incidence,3536898,All Races,25.9,Female,Stomach,2018
80-84,15.7,18.4,601,Incidence,3536898,All Races,17.0,Female,Thyroid,2018
80-84,63.8,69.2,2351,Incidence,3536898,All Races,66.5,Female,Urinary Bladder,2018
85+,1674.5,1699.3,70942,Incidence,4205508,All Races,1686.9,Female,All Cancer Sites Combined,2018
85+,12.3,14.6,565,Incidence,4205508,All Races,13.4,Female,Brain and Other Nervous System,2018
85+,5.8,7.3,274,Incidence,4205508,All Races,6.5,Female,Cervix,2018
85+,215.1,224.0,9232,Incidence,4205508,All Races,219.5,Female,Colon and Rectum,2018
85+,47.6,51.9,2091,Incidence,4205508,All Races,49.7,Female,"Corpus and Uterus, NOS",2018
85+,10.7,12.8,493,Incidence,4205508,All Races,11.7,Female,Esophagus,2018
85+,314.0,324.8,13432,Incidence,4205508,All Races,319.4,Female,Female Breast,2018
85+,21.4,24.3,958,Incidence,4205508,All Races,22.8,Female,"Female Breast, <i>in situ</i>",2018
85+,1.8,2.7,93,Incidence,4205508,All Races,2.2,Female,Hodgkin Lymphoma,2018
85+,0.4,0.9,27,Incidence,4205508,All Races,0.6,Female,Kaposi Sarcoma,2018
85+,37.8,41.6,1669,Incidence,4205508,All Races,39.7,Female,Kidney and Renal Pelvis,2018
85+,2.2,3.2,111,Incidence,4205508,All Races,2.6,Female,Larynx,2018
85+,59.9,64.7,2617,Incidence,4205508,All Races,62.2,Female,Leukemias,2018
85+,23.5,26.6,1053,Incidence,4205508,All Races,25.0,Female,Liver and Intrahepatic Bile Duct,2018
85+,234.5,243.9,10059,Incidence,4205508,All Races,239.2,Female,Lung and Bronchus,2018
85+,58.2,63.0,2547,Incidence,4205508,All Races,60.6,Female,Melanomas of the Skin,2018
85+,2.2,3.2,111,Incidence,4205508,All Races,2.6,Female,Mesothelioma,2018
85+,27.0,30.2,1201,Incidence,4205508,All Races,28.6,Female,Myeloma,2018
85+,79.2,84.7,3443,Incidence,4205508,All Races,81.9,Female,Non-Hodgkin Lymphoma,2018
85+,29.2,32.5,1296,Incidence,4205508,All Races,30.8,Female,Oral Cavity and Pharynx,2018
85+,32.2,35.7,1426,Incidence,4205508,All Races,33.9,Female,Ovary,2018
85+,86.2,91.9,3745,Incidence,4205508,All Races,89.0,Female,Pancreas,2018
85+,25.4,28.5,1132,Incidence,4205508,All Races,26.9,Female,Stomach,2018
85+,8.8,10.7,408,Incidence,4205508,All Races,9.7,Female,Thyroid,2018
85+,72.1,77.3,3141,Incidence,4205508,All Races,74.7,Female,Urinary Bladder,2018
<1,23.3,27.9,478,Incidence,1871130,All Races,25.5,Female,All Cancer Sites Combined,2018
<1,2.4,4.1,59,Incidence,1871130,All Races,3.2,Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Cervix,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Colon and Rectum,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Esophagus,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Female Breast,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Kaposi Sarcoma,2018
<1,0.7,1.8,22,Incidence,1871130,All Races,1.2,Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Larynx,2018
<1,3.4,5.3,80,Incidence,1871130,All Races,4.3,Female,Leukemias,2018
<1,1.1,2.3,30,Incidence,1871130,All Races,1.6,Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Mesothelioma,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Myeloma,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Ovary,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Pancreas,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Stomach,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Thyroid,2018
<1,~,~,~,Incidence,1871130,All Races,~,Female,Urinary Bladder,2018
1-4,22.1,24.2,1883,Incidence,8156823,All Races,23.1,Male,All Cancer Sites Combined,2018
1-4,3.8,4.7,345,Incidence,8156823,All Races,4.2,Male,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Colon and Rectum,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Esophagus,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Kaposi Sarcoma,2018
1-4,1.4,1.9,134,Incidence,8156823,All Races,1.6,Male,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Larynx,2018
1-4,9.2,10.6,804,Incidence,8156823,All Races,9.9,Male,Leukemias,2018
1-4,0.6,1.0,62,Incidence,8156823,All Races,0.8,Male,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Lung and Bronchus,2018
1-4,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Mesothelioma,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Myeloma,2018
1-4,0.6,1.1,68,Incidence,8156823,All Races,0.8,Male,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Pancreas,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Prostate,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Stomach,2018
1-4,0.1,0.4,19,Incidence,8156823,All Races,0.2,Male,Testis,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Thyroid,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male,Urinary Bladder,2018
10-14,15.5,17.0,1733,Incidence,10663948,All Races,16.3,Male,All Cancer Sites Combined,2018
10-14,2.7,3.3,318,Incidence,10663948,All Races,3.0,Male,Brain and Other Nervous System,2018
10-14,0.4,0.7,61,Incidence,10663948,All Races,0.6,Male,Colon and Rectum,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Esophagus,2018
10-14,1.2,1.7,150,Incidence,10663948,All Races,1.4,Male,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Kaposi Sarcoma,2018
10-14,0.1,0.3,21,Incidence,10663948,All Races,0.2,Male,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Larynx,2018
10-14,3.0,3.8,361,Incidence,10663948,All Races,3.4,Male,Leukemias,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Lung and Bronchus,2018
10-14,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
10-14,0.2,0.4,26,Incidence,10663948,All Races,0.2,Male,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Mesothelioma,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Myeloma,2018
10-14,1.7,2.2,205,Incidence,10663948,All Races,1.9,Male,Non-Hodgkin Lymphoma,2018
10-14,0.1,0.3,17,Incidence,10663948,All Races,0.2,Male,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Pancreas,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Prostate,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Stomach,2018
10-14,0.2,0.4,30,Incidence,10663948,All Races,0.3,Male,Testis,2018
10-14,0.3,0.6,47,Incidence,10663948,All Races,0.4,Male,Thyroid,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male,Urinary Bladder,2018
15-19,23.2,25.0,2594,Incidence,10762990,All Races,24.1,Male,All Cancer Sites Combined,2018
15-19,2.2,2.8,264,Incidence,10762990,All Races,2.5,Male,Brain and Other Nervous System,2018
15-19,1.0,1.5,134,Incidence,10762990,All Races,1.2,Male,Colon and Rectum,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Esophagus,2018
15-19,2.7,3.3,320,Incidence,10762990,All Races,3.0,Male,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Kaposi Sarcoma,2018
15-19,0.1,0.3,17,Incidence,10762990,All Races,0.2,Male,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Larynx,2018
15-19,3.7,4.5,437,Incidence,10762990,All Races,4.1,Male,Leukemias,2018
15-19,0.1,0.2,16,Incidence,10762990,All Races,0.1,Male,Liver and Intrahepatic Bile Duct,2018
15-19,0.1,0.3,17,Incidence,10762990,All Races,0.2,Male,Lung and Bronchus,2018
15-19,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
15-19,0.4,0.7,60,Incidence,10762990,All Races,0.6,Male,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Mesothelioma,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Myeloma,2018
15-19,2.1,2.7,253,Incidence,10762990,All Races,2.4,Male,Non-Hodgkin Lymphoma,2018
15-19,0.4,0.6,51,Incidence,10762990,All Races,0.5,Male,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Pancreas,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Prostate,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Stomach,2018
15-19,2.8,3.5,334,Incidence,10762990,All Races,3.1,Male,Testis,2018
15-19,1.2,1.6,147,Incidence,10762990,All Races,1.4,Male,Thyroid,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male,Urinary Bladder,2018
20-24,35.1,37.3,4041,Incidence,11172233,All Races,36.2,Male,All Cancer Sites Combined,2018
20-24,2.1,2.7,268,Incidence,11172233,All Races,2.4,Male,Brain and Other Nervous System,2018
20-24,1.5,2.0,198,Incidence,11172233,All Races,1.8,Male,Colon and Rectum,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male,Esophagus,2018
20-24,3.6,4.3,440,Incidence,11172233,All Races,3.9,Male,Hodgkin Lymphoma,2018
20-24,0.2,0.5,38,Incidence,11172233,All Races,0.3,Male,Kaposi Sarcoma,2018
20-24,0.5,0.8,67,Incidence,11172233,All Races,0.6,Male,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male,Larynx,2018
20-24,2.8,3.5,347,Incidence,11172233,All Races,3.1,Male,Leukemias,2018
20-24,0.1,0.3,18,Incidence,11172233,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2018
20-24,0.2,0.5,37,Incidence,11172233,All Races,0.3,Male,Lung and Bronchus,2018
20-24,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
20-24,1.3,1.7,164,Incidence,11172233,All Races,1.5,Male,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male,Mesothelioma,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male,Myeloma,2018
20-24,2.5,3.1,312,Incidence,11172233,All Races,2.8,Male,Non-Hodgkin Lymphoma,2018
20-24,0.5,0.8,70,Incidence,11172233,All Races,0.6,Male,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male,Pancreas,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male,Prostate,2018
20-24,0.1,0.3,23,Incidence,11172233,All Races,0.2,Male,Stomach,2018
20-24,10.5,11.7,1236,Incidence,11172233,All Races,11.1,Male,Testis,2018
20-24,2.0,2.6,256,Incidence,11172233,All Races,2.3,Male,Thyroid,2018
20-24,0.2,0.4,32,Incidence,11172233,All Races,0.3,Male,Urinary Bladder,2018
25-29,48.4,50.9,5962,Incidence,12011397,All Races,49.6,Male,All Cancer Sites Combined,2018
25-29,2.9,3.6,389,Incidence,12011397,All Races,3.2,Male,Brain and Other Nervous System,2018
25-29,2.9,3.5,384,Incidence,12011397,All Races,3.2,Male,Colon and Rectum,2018
25-29,0.1,0.2,17,Incidence,12011397,All Races,0.1,Male,Esophagus,2018
25-29,3.5,4.2,463,Incidence,12011397,All Races,3.9,Male,Hodgkin Lymphoma,2018
25-29,0.8,1.2,119,Incidence,12011397,All Races,1.0,Male,Kaposi Sarcoma,2018
25-29,1.2,1.7,175,Incidence,12011397,All Races,1.5,Male,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,12011397,All Races,~,Male,Larynx,2018
25-29,3.0,3.7,401,Incidence,12011397,All Races,3.3,Male,Leukemias,2018
25-29,0.2,0.4,30,Incidence,12011397,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2018
25-29,0.5,0.8,72,Incidence,12011397,All Races,0.6,Male,Lung and Bronchus,2018
25-29,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
25-29,2.8,3.4,372,Incidence,12011397,All Races,3.1,Male,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,12011397,All Races,~,Male,Mesothelioma,2018
25-29,0.1,0.2,16,Incidence,12011397,All Races,0.1,Male,Myeloma,2018
25-29,3.7,4.4,485,Incidence,12011397,All Races,4.0,Male,Non-Hodgkin Lymphoma,2018
25-29,0.9,1.3,128,Incidence,12011397,All Races,1.1,Male,Oral Cavity and Pharynx,2018
25-29,0.2,0.4,30,Incidence,12011397,All Races,0.2,Male,Pancreas,2018
25-29,~,~,~,Incidence,12011397,All Races,~,Male,Prostate,2018
25-29,0.4,0.6,57,Incidence,12011397,All Races,0.5,Male,Stomach,2018
25-29,13.1,14.5,1656,Incidence,12011397,All Races,13.8,Male,Testis,2018
25-29,3.4,4.1,450,Incidence,12011397,All Races,3.7,Male,Thyroid,2018
25-29,0.3,0.6,54,Incidence,12011397,All Races,0.4,Male,Urinary Bladder,2018
30-34,68.2,71.3,7798,Incidence,11186277,All Races,69.7,Male,All Cancer Sites Combined,2018
30-34,3.6,4.4,445,Incidence,11186277,All Races,4.0,Male,Brain and Other Nervous System,2018
30-34,6.3,7.3,756,Incidence,11186277,All Races,6.8,Male,Colon and Rectum,2018
30-34,0.2,0.5,39,Incidence,11186277,All Races,0.3,Male,Esophagus,2018
30-34,3.2,3.9,394,Incidence,11186277,All Races,3.5,Male,Hodgkin Lymphoma,2018
30-34,0.9,1.3,117,Incidence,11186277,All Races,1.0,Male,Kaposi Sarcoma,2018
30-34,3.3,4.0,405,Incidence,11186277,All Races,3.6,Male,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,11186277,All Races,~,Male,Larynx,2018
30-34,3.3,4.1,412,Incidence,11186277,All Races,3.7,Male,Leukemias,2018
30-34,0.5,0.8,74,Incidence,11186277,All Races,0.7,Male,Liver and Intrahepatic Bile Duct,2018
30-34,0.7,1.1,100,Incidence,11186277,All Races,0.9,Male,Lung and Bronchus,2018
30-34,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
30-34,5.5,6.4,661,Incidence,11186277,All Races,5.9,Male,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,11186277,All Races,~,Male,Mesothelioma,2018
30-34,0.3,0.6,50,Incidence,11186277,All Races,0.4,Male,Myeloma,2018
30-34,5.0,5.8,602,Incidence,11186277,All Races,5.4,Male,Non-Hodgkin Lymphoma,2018
30-34,1.6,2.2,212,Incidence,11186277,All Races,1.9,Male,Oral Cavity and Pharynx,2018
30-34,0.5,0.8,69,Incidence,11186277,All Races,0.6,Male,Pancreas,2018
30-34,~,~,~,Incidence,11186277,All Races,~,Male,Prostate,2018
30-34,0.9,1.3,120,Incidence,11186277,All Races,1.1,Male,Stomach,2018
30-34,14.7,16.1,1722,Incidence,11186277,All Races,15.4,Male,Testis,2018
30-34,5.1,6.0,617,Incidence,11186277,All Races,5.5,Male,Thyroid,2018
30-34,0.8,1.2,111,Incidence,11186277,All Races,1.0,Male,Urinary Bladder,2018
35-39,97.7,101.5,10736,Incidence,10781732,All Races,99.6,Male,All Cancer Sites Combined,2018
35-39,4.1,4.9,486,Incidence,10781732,All Races,4.5,Male,Brain and Other Nervous System,2018
35-39,11.2,12.5,1276,Incidence,10781732,All Races,11.8,Male,Colon and Rectum,2018
35-39,0.7,1.1,98,Incidence,10781732,All Races,0.9,Male,Esophagus,2018
35-39,3.1,3.9,376,Incidence,10781732,All Races,3.5,Male,Hodgkin Lymphoma,2018
35-39,0.9,1.4,122,Incidence,10781732,All Races,1.1,Male,Kaposi Sarcoma,2018
35-39,7.5,8.6,869,Incidence,10781732,All Races,8.1,Male,Kidney and Renal Pelvis,2018
35-39,0.3,0.5,42,Incidence,10781732,All Races,0.4,Male,Larynx,2018
35-39,5.2,6.1,603,Incidence,10781732,All Races,5.6,Male,Leukemias,2018
35-39,1.0,1.4,129,Incidence,10781732,All Races,1.2,Male,Liver and Intrahepatic Bile Duct,2018
35-39,2.3,2.9,275,Incidence,10781732,All Races,2.6,Male,Lung and Bronchus,2018
35-39,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
35-39,8.9,10.1,1025,Incidence,10781732,All Races,9.5,Male,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,10781732,All Races,~,Male,Mesothelioma,2018
35-39,0.9,1.3,115,Incidence,10781732,All Races,1.1,Male,Myeloma,2018
35-39,7.4,8.5,856,Incidence,10781732,All Races,7.9,Male,Non-Hodgkin Lymphoma,2018
35-39,2.9,3.6,349,Incidence,10781732,All Races,3.2,Male,Oral Cavity and Pharynx,2018
35-39,1.3,1.8,168,Incidence,10781732,All Races,1.6,Male,Pancreas,2018
35-39,0.4,0.7,61,Incidence,10781732,All Races,0.6,Male,Prostate,2018
35-39,1.8,2.3,220,Incidence,10781732,All Races,2.0,Male,Stomach,2018
35-39,12.1,13.4,1374,Incidence,10781732,All Races,12.7,Male,Testis,2018
35-39,7.0,8.1,815,Incidence,10781732,All Races,7.6,Male,Thyroid,2018
35-39,1.8,2.4,226,Incidence,10781732,All Races,2.1,Male,Urinary Bladder,2018
40-44,152.1,157.0,15119,Incidence,9781751,All Races,154.6,Male,All Cancer Sites Combined,2018
40-44,4.8,5.7,509,Incidence,9781751,All Races,5.2,Male,Brain and Other Nervous System,2018
40-44,21.9,23.8,2234,Incidence,9781751,All Races,22.8,Male,Colon and Rectum,2018
40-44,1.7,2.2,189,Incidence,9781751,All Races,1.9,Male,Esophagus,2018
40-44,2.8,3.5,307,Incidence,9781751,All Races,3.1,Male,Hodgkin Lymphoma,2018
40-44,0.6,0.9,74,Incidence,9781751,All Races,0.8,Male,Kaposi Sarcoma,2018
40-44,15.0,16.6,1544,Incidence,9781751,All Races,15.8,Male,Kidney and Renal Pelvis,2018
40-44,1.0,1.5,119,Incidence,9781751,All Races,1.2,Male,Larynx,2018
40-44,6.7,7.8,705,Incidence,9781751,All Races,7.2,Male,Leukemias,2018
40-44,2.0,2.6,226,Incidence,9781751,All Races,2.3,Male,Liver and Intrahepatic Bile Duct,2018
40-44,6.1,7.2,649,Incidence,9781751,All Races,6.6,Male,Lung and Bronchus,2018
40-44,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
40-44,13.7,15.2,1409,Incidence,9781751,All Races,14.4,Male,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,9781751,All Races,~,Male,Mesothelioma,2018
40-44,2.4,3.1,270,Incidence,9781751,All Races,2.8,Male,Myeloma,2018
40-44,10.1,11.4,1054,Incidence,9781751,All Races,10.8,Male,Non-Hodgkin Lymphoma,2018
40-44,7.5,8.6,789,Incidence,9781751,All Races,8.1,Male,Oral Cavity and Pharynx,2018
40-44,3.1,3.8,338,Incidence,9781751,All Races,3.5,Male,Pancreas,2018
40-44,5.4,6.4,578,Incidence,9781751,All Races,5.9,Male,Prostate,2018
40-44,3.1,3.8,337,Incidence,9781751,All Races,3.4,Male,Stomach,2018
40-44,8.5,9.7,893,Incidence,9781751,All Races,9.1,Male,Testis,2018
40-44,8.4,9.6,880,Incidence,9781751,All Races,9.0,Male,Thyroid,2018
40-44,3.7,4.5,397,Incidence,9781751,All Races,4.1,Male,Urinary Bladder,2018
45-49,259.6,265.8,26924,Incidence,10249333,All Races,262.7,Male,All Cancer Sites Combined,2018
45-49,6.6,7.6,729,Incidence,10249333,All Races,7.1,Male,Brain and Other Nervous System,2018
45-49,38.4,40.9,4063,Incidence,10249333,All Races,39.6,Male,Colon and Rectum,2018
45-49,3.4,4.2,388,Incidence,10249333,All Races,3.8,Male,Esophagus,2018
45-49,2.4,3.0,273,Incidence,10249333,All Races,2.7,Male,Hodgkin Lymphoma,2018
45-49,0.7,1.0,85,Incidence,10249333,All Races,0.8,Male,Kaposi Sarcoma,2018
45-49,22.7,24.6,2418,Incidence,10249333,All Races,23.6,Male,Kidney and Renal Pelvis,2018
45-49,2.6,3.3,302,Incidence,10249333,All Races,2.9,Male,Larynx,2018
45-49,9.4,10.7,1029,Incidence,10249333,All Races,10.0,Male,Leukemias,2018
45-49,4.7,5.6,526,Incidence,10249333,All Races,5.1,Male,Liver and Intrahepatic Bile Duct,2018
45-49,14.3,15.8,1543,Incidence,10249333,All Races,15.1,Male,Lung and Bronchus,2018
45-49,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
45-49,19.3,21.0,2066,Incidence,10249333,All Races,20.2,Male,Melanomas of the Skin,2018
45-49,0.2,0.5,33,Incidence,10249333,All Races,0.3,Male,Mesothelioma,2018
45-49,4.3,5.1,482,Incidence,10249333,All Races,4.7,Male,Myeloma,2018
45-49,14.7,16.3,1588,Incidence,10249333,All Races,15.5,Male,Non-Hodgkin Lymphoma,2018
45-49,16.6,18.2,1782,Incidence,10249333,All Races,17.4,Male,Oral Cavity and Pharynx,2018
45-49,6.2,7.3,691,Incidence,10249333,All Races,6.7,Male,Pancreas,2018
45-49,29.3,31.5,3114,Incidence,10249333,All Races,30.4,Male,Prostate,2018
45-49,5.1,6.0,569,Incidence,10249333,All Races,5.6,Male,Stomach,2018
45-49,5.3,6.3,594,Incidence,10249333,All Races,5.8,Male,Testis,2018
45-49,10.6,11.9,1152,Incidence,10249333,All Races,11.2,Male,Thyroid,2018
45-49,7.9,9.0,862,Incidence,10249333,All Races,8.4,Male,Urinary Bladder,2018
5-9,13.6,15.1,1480,Incidence,10324741,All Races,14.3,Male,All Cancer Sites Combined,2018
5-9,3.1,3.9,359,Incidence,10324741,All Races,3.5,Male,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Colon and Rectum,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Esophagus,2018
5-9,0.4,0.7,60,Incidence,10324741,All Races,0.6,Male,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Kaposi Sarcoma,2018
5-9,0.5,0.8,64,Incidence,10324741,All Races,0.6,Male,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Larynx,2018
5-9,4.2,5.0,475,Incidence,10324741,All Races,4.6,Male,Leukemias,2018
5-9,0.1,0.3,18,Incidence,10324741,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Lung and Bronchus,2018
5-9,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Mesothelioma,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Myeloma,2018
5-9,1.3,1.8,156,Incidence,10324741,All Races,1.5,Male,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Pancreas,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Prostate,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Stomach,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Testis,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Thyroid,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male,Urinary Bladder,2018
50-54,512.9,521.7,53092,Incidence,10262878,All Races,517.3,Male,All Cancer Sites Combined,2018
50-54,8.1,9.2,885,Incidence,10262878,All Races,8.6,Male,Brain and Other Nervous System,2018
50-54,71.1,74.4,7468,Incidence,10262878,All Races,72.8,Male,Colon and Rectum,2018
50-54,8.2,9.3,896,Incidence,10262878,All Races,8.7,Male,Esophagus,2018
50-54,2.5,3.1,287,Incidence,10262878,All Races,2.8,Male,Hodgkin Lymphoma,2018
50-54,0.8,1.2,101,Incidence,10262878,All Races,1.0,Male,Kaposi Sarcoma,2018
50-54,34.9,37.3,3703,Incidence,10262878,All Races,36.1,Male,Kidney and Renal Pelvis,2018
50-54,6.3,7.3,698,Incidence,10262878,All Races,6.8,Male,Larynx,2018
50-54,14.5,16.0,1560,Incidence,10262878,All Races,15.2,Male,Leukemias,2018
50-54,13.5,15.0,1458,Incidence,10262878,All Races,14.2,Male,Liver and Intrahepatic Bile Duct,2018
50-54,40.0,42.5,4230,Incidence,10262878,All Races,41.2,Male,Lung and Bronchus,2018
50-54,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
50-54,29.4,31.5,3122,Incidence,10262878,All Races,30.4,Male,Melanomas of the Skin,2018
50-54,0.4,0.7,57,Incidence,10262878,All Races,0.6,Male,Mesothelioma,2018
50-54,8.8,10.0,966,Incidence,10262878,All Races,9.4,Male,Myeloma,2018
50-54,23.5,25.5,2513,Incidence,10262878,All Races,24.5,Male,Non-Hodgkin Lymphoma,2018
50-54,31.6,33.8,3351,Incidence,10262878,All Races,32.7,Male,Oral Cavity and Pharynx,2018
50-54,13.3,14.7,1434,Incidence,10262878,All Races,14.0,Male,Pancreas,2018
50-54,114.2,118.4,11936,Incidence,10262878,All Races,116.3,Male,Prostate,2018
50-54,8.7,9.9,949,Incidence,10262878,All Races,9.2,Male,Stomach,2018
50-54,4.0,4.8,450,Incidence,10262878,All Races,4.4,Male,Testis,2018
50-54,10.8,12.1,1173,Incidence,10262878,All Races,11.4,Male,Thyroid,2018
50-54,17.4,19.1,1874,Incidence,10262878,All Races,18.3,Male,Urinary Bladder,2018
55-59,879.2,890.5,94310,Incidence,10658259,All Races,884.9,Male,All Cancer Sites Combined,2018
55-59,11.2,12.6,1266,Incidence,10658259,All Races,11.9,Male,Brain and Other Nervous System,2018
55-59,79.5,83.0,8659,Incidence,10658259,All Races,81.2,Male,Colon and Rectum,2018
55-59,14.6,16.1,1634,Incidence,10658259,All Races,15.3,Male,Esophagus,2018
55-59,2.7,3.4,327,Incidence,10658259,All Races,3.1,Male,Hodgkin Lymphoma,2018
55-59,0.6,1.0,84,Incidence,10658259,All Races,0.8,Male,Kaposi Sarcoma,2018
55-59,50.2,52.9,5490,Incidence,10658259,All Races,51.5,Male,Kidney and Renal Pelvis,2018
55-59,12.7,14.1,1432,Incidence,10658259,All Races,13.4,Male,Larynx,2018
55-59,22.8,24.7,2529,Incidence,10658259,All Races,23.7,Male,Leukemias,2018
55-59,32.2,34.4,3551,Incidence,10658259,All Races,33.3,Male,Liver and Intrahepatic Bile Duct,2018
55-59,96.1,99.9,10447,Incidence,10658259,All Races,98.0,Male,Lung and Bronchus,2018
55-59,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
55-59,44.3,46.9,4861,Incidence,10658259,All Races,45.6,Male,Melanomas of the Skin,2018
55-59,0.7,1.0,88,Incidence,10658259,All Races,0.8,Male,Mesothelioma,2018
55-59,13.5,14.9,1515,Incidence,10658259,All Races,14.2,Male,Myeloma,2018
55-59,35.2,37.5,3871,Incidence,10658259,All Races,36.3,Male,Non-Hodgkin Lymphoma,2018
55-59,48.6,51.3,5321,Incidence,10658259,All Races,49.9,Male,Oral Cavity and Pharynx,2018
55-59,25.8,27.8,2858,Incidence,10658259,All Races,26.8,Male,Pancreas,2018
55-59,248.9,255.0,26852,Incidence,10658259,All Races,251.9,Male,Prostate,2018
55-59,13.7,15.2,1538,Incidence,10658259,All Races,14.4,Male,Stomach,2018
55-59,3.0,3.7,355,Incidence,10658259,All Races,3.3,Male,Testis,2018
55-59,13.0,14.4,1456,Incidence,10658259,All Races,13.7,Male,Thyroid,2018
55-59,35.5,37.8,3901,Incidence,10658259,All Races,36.6,Male,Urinary Bladder,2018
60-64,1362.7,1377.5,133140,Incidence,9717646,All Races,1370.1,Male,All Cancer Sites Combined,2018
60-64,14.9,16.5,1523,Incidence,9717646,All Races,15.7,Male,Brain and Other Nervous System,2018
60-64,105.3,109.4,10429,Incidence,9717646,All Races,107.3,Male,Colon and Rectum,2018
60-64,24.2,26.2,2447,Incidence,9717646,All Races,25.2,Male,Esophagus,2018
60-64,2.9,3.7,318,Incidence,9717646,All Races,3.3,Male,Hodgkin Lymphoma,2018
60-64,0.5,0.8,58,Incidence,9717646,All Races,0.6,Male,Kaposi Sarcoma,2018
60-64,66.5,69.8,6619,Incidence,9717646,All Races,68.1,Male,Kidney and Renal Pelvis,2018
60-64,18.2,20.0,1855,Incidence,9717646,All Races,19.1,Male,Larynx,2018
60-64,33.9,36.2,3404,Incidence,9717646,All Races,35.0,Male,Leukemias,2018
60-64,55.6,58.6,5544,Incidence,9717646,All Races,57.1,Male,Liver and Intrahepatic Bile Duct,2018
60-64,167.4,172.6,16519,Incidence,9717646,All Races,170.0,Male,Lung and Bronchus,2018
60-64,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
60-64,63.6,66.9,6339,Incidence,9717646,All Races,65.2,Male,Melanomas of the Skin,2018
60-64,1.2,1.6,134,Incidence,9717646,All Races,1.4,Male,Mesothelioma,2018
60-64,20.5,22.4,2083,Incidence,9717646,All Races,21.4,Male,Myeloma,2018
60-64,47.9,50.7,4792,Incidence,9717646,All Races,49.3,Male,Non-Hodgkin Lymphoma,2018
60-64,61.3,64.5,6113,Incidence,9717646,All Races,62.9,Male,Oral Cavity and Pharynx,2018
60-64,39.6,42.1,3970,Incidence,9717646,All Races,40.9,Male,Pancreas,2018
60-64,431.6,439.9,42342,Incidence,9717646,All Races,435.7,Male,Prostate,2018
60-64,20.3,22.1,2060,Incidence,9717646,All Races,21.2,Male,Stomach,2018
60-64,1.9,2.5,209,Incidence,9717646,All Races,2.2,Male,Testis,2018
60-64,15.4,17.1,1578,Incidence,9717646,All Races,16.2,Male,Thyroid,2018
60-64,64.8,68.0,6451,Incidence,9717646,All Races,66.4,Male,Urinary Bladder,2018
65-69,1951.2,1970.6,157321,Incidence,8022909,All Races,1960.9,Male,All Cancer Sites Combined,2018
65-69,18.9,20.8,1592,Incidence,8022909,All Races,19.8,Male,Brain and Other Nervous System,2018
65-69,135.7,140.8,11090,Incidence,8022909,All Races,138.2,Male,Colon and Rectum,2018
65-69,32.8,35.4,2734,Incidence,8022909,All Races,34.1,Male,Esophagus,2018
65-69,3.1,3.9,278,Incidence,8022909,All Races,3.5,Male,Hodgkin Lymphoma,2018
65-69,0.6,1.0,62,Incidence,8022909,All Races,0.8,Male,Kaposi Sarcoma,2018
65-69,85.3,89.4,7004,Incidence,8022909,All Races,87.3,Male,Kidney and Renal Pelvis,2018
65-69,20.4,22.5,1719,Incidence,8022909,All Races,21.4,Male,Larynx,2018
65-69,50.3,53.4,4158,Incidence,8022909,All Races,51.8,Male,Leukemias,2018
65-69,65.6,69.2,5409,Incidence,8022909,All Races,67.4,Male,Liver and Intrahepatic Bile Duct,2018
65-69,248.6,255.5,20221,Incidence,8022909,All Races,252.0,Male,Lung and Bronchus,2018
65-69,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
65-69,92.5,96.8,7593,Incidence,8022909,All Races,94.6,Male,Melanomas of the Skin,2018
65-69,3.0,3.8,272,Incidence,8022909,All Races,3.4,Male,Mesothelioma,2018
65-69,30.6,33.1,2557,Incidence,8022909,All Races,31.9,Male,Myeloma,2018
65-69,69.6,73.3,5731,Incidence,8022909,All Races,71.4,Male,Non-Hodgkin Lymphoma,2018
65-69,70.4,74.1,5794,Incidence,8022909,All Races,72.2,Male,Oral Cavity and Pharynx,2018
65-69,58.6,62.0,4836,Incidence,8022909,All Races,60.3,Male,Pancreas,2018
65-69,661.5,672.9,53527,Incidence,8022909,All Races,667.2,Male,Prostate,2018
65-69,27.3,29.6,2282,Incidence,8022909,All Races,28.4,Male,Stomach,2018
65-69,1.4,2.0,133,Incidence,8022909,All Races,1.7,Male,Testis,2018
65-69,16.7,18.6,1415,Incidence,8022909,All Races,17.6,Male,Thyroid,2018
65-69,108.9,113.6,8924,Incidence,8022909,All Races,111.2,Male,Urinary Bladder,2018
70-74,2318.9,2342.9,144516,Incidence,6200020,All Races,2330.9,Male,All Cancer Sites Combined,2018
70-74,21.7,24.1,1416,Incidence,6200020,All Races,22.8,Male,Brain and Other Nervous System,2018
70-74,157.5,163.8,9959,Incidence,6200020,All Races,160.6,Male,Colon and Rectum,2018
70-74,39.8,43.0,2564,Incidence,6200020,All Races,41.4,Male,Esophagus,2018
70-74,3.7,4.8,263,Incidence,6200020,All Races,4.2,Male,Hodgkin Lymphoma,2018
70-74,0.4,0.9,39,Incidence,6200020,All Races,0.6,Male,Kaposi Sarcoma,2018
70-74,97.4,102.4,6193,Incidence,6200020,All Races,99.9,Male,Kidney and Renal Pelvis,2018
70-74,22.5,25.0,1472,Incidence,6200020,All Races,23.7,Male,Larynx,2018
70-74,69.2,73.5,4422,Incidence,6200020,All Races,71.3,Male,Leukemias,2018
70-74,56.2,60.1,3604,Incidence,6200020,All Races,58.1,Male,Liver and Intrahepatic Bile Duct,2018
70-74,345.4,354.7,21702,Incidence,6200020,All Races,350.0,Male,Lung and Bronchus,2018
70-74,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
70-74,124.4,130.1,7889,Incidence,6200020,All Races,127.2,Male,Melanomas of the Skin,2018
70-74,5.5,6.7,375,Incidence,6200020,All Races,6.0,Male,Mesothelioma,2018
70-74,40.6,43.8,2614,Incidence,6200020,All Races,42.2,Male,Myeloma,2018
70-74,92.0,96.8,5851,Incidence,6200020,All Races,94.4,Male,Non-Hodgkin Lymphoma,2018
70-74,71.8,76.1,4585,Incidence,6200020,All Races,74.0,Male,Oral Cavity and Pharynx,2018
70-74,75.8,80.2,4837,Incidence,6200020,All Races,78.0,Male,Pancreas,2018
70-74,673.2,686.2,42142,Incidence,6200020,All Races,679.7,Male,Prostate,2018
70-74,36.4,39.5,2354,Incidence,6200020,All Races,38.0,Male,Stomach,2018
70-74,1.1,1.7,85,Incidence,6200020,All Races,1.4,Male,Testis,2018
70-74,16.6,18.7,1095,Incidence,6200020,All Races,17.7,Male,Thyroid,2018
70-74,164.6,171.1,10405,Incidence,6200020,All Races,167.8,Male,Urinary Bladder,2018
75-79,2634.9,2666.3,109594,Incidence,4134784,All Races,2650.5,Male,All Cancer Sites Combined,2018
75-79,23.4,26.4,1028,Incidence,4134784,All Races,24.9,Male,Brain and Other Nervous System,2018
75-79,191.7,200.2,8100,Incidence,4134784,All Races,195.9,Male,Colon and Rectum,2018
75-79,43.0,47.2,1863,Incidence,4134784,All Races,45.1,Male,Esophagus,2018
75-79,4.2,5.6,200,Incidence,4134784,All Races,4.8,Male,Hodgkin Lymphoma,2018
75-79,0.8,1.4,44,Incidence,4134784,All Races,1.1,Male,Kaposi Sarcoma,2018
75-79,104.0,110.4,4431,Incidence,4134784,All Races,107.2,Male,Kidney and Renal Pelvis,2018
75-79,23.8,26.9,1046,Incidence,4134784,All Races,25.3,Male,Larynx,2018
75-79,94.1,100.2,4016,Incidence,4134784,All Races,97.1,Male,Leukemias,2018
75-79,57.9,62.7,2492,Incidence,4134784,All Races,60.3,Male,Liver and Intrahepatic Bile Duct,2018
75-79,439.6,452.5,18443,Incidence,4134784,All Races,446.0,Male,Lung and Bronchus,2018
75-79,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
75-79,150.7,158.3,6387,Incidence,4134784,All Races,154.5,Male,Melanomas of the Skin,2018
75-79,9.4,11.4,427,Incidence,4134784,All Races,10.3,Male,Mesothelioma,2018
75-79,52.5,57.0,2261,Incidence,4134784,All Races,54.7,Male,Myeloma,2018
75-79,120.6,127.4,5125,Incidence,4134784,All Races,123.9,Male,Non-Hodgkin Lymphoma,2018
75-79,64.2,69.2,2758,Incidence,4134784,All Races,66.7,Male,Oral Cavity and Pharynx,2018
75-79,91.7,97.7,3914,Incidence,4134784,All Races,94.7,Male,Pancreas,2018
75-79,599.6,614.6,25101,Incidence,4134784,All Races,607.1,Male,Prostate,2018
75-79,44.6,48.8,1930,Incidence,4134784,All Races,46.7,Male,Stomach,2018
75-79,0.6,1.2,37,Incidence,4134784,All Races,0.9,Male,Testis,2018
75-79,15.9,18.5,710,Incidence,4134784,All Races,17.2,Male,Thyroid,2018
75-79,233.5,243.0,9849,Incidence,4134784,All Races,238.2,Male,Urinary Bladder,2018
80-84,2776.2,2817.0,72277,Incidence,2584496,All Races,2796.6,Male,All Cancer Sites Combined,2018
80-84,25.3,29.3,704,Incidence,2584496,All Races,27.2,Male,Brain and Other Nervous System,2018
80-84,233.0,245.0,6176,Incidence,2584496,All Races,239.0,Male,Colon and Rectum,2018
80-84,43.1,48.3,1179,Incidence,2584496,All Races,45.6,Male,Esophagus,2018
80-84,4.5,6.4,139,Incidence,2584496,All Races,5.4,Male,Hodgkin Lymphoma,2018
80-84,0.8,1.6,29,Incidence,2584496,All Races,1.1,Male,Kaposi Sarcoma,2018
80-84,96.5,104.3,2594,Incidence,2584496,All Races,100.4,Male,Kidney and Renal Pelvis,2018
80-84,23.1,27.0,647,Incidence,2584496,All Races,25.0,Male,Larynx,2018
80-84,112.8,121.2,3022,Incidence,2584496,All Races,116.9,Male,Leukemias,2018
80-84,58.2,64.2,1580,Incidence,2584496,All Races,61.1,Male,Liver and Intrahepatic Bile Duct,2018
80-84,453.9,470.5,11943,Incidence,2584496,All Races,462.1,Male,Lung and Bronchus,2018
80-84,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
80-84,182.8,193.4,4860,Incidence,2584496,All Races,188.0,Male,Melanomas of the Skin,2018
80-84,13.8,16.8,394,Incidence,2584496,All Races,15.2,Male,Mesothelioma,2018
80-84,60.1,66.2,1631,Incidence,2584496,All Races,63.1,Male,Myeloma,2018
80-84,140.4,149.7,3748,Incidence,2584496,All Races,145.0,Male,Non-Hodgkin Lymphoma,2018
80-84,65.7,72.2,1781,Incidence,2584496,All Races,68.9,Male,Oral Cavity and Pharynx,2018
80-84,102.4,110.4,2748,Incidence,2584496,All Races,106.3,Male,Pancreas,2018
80-84,446.5,463.0,11752,Incidence,2584496,All Races,454.7,Male,Prostate,2018
80-84,52.4,58.2,1428,Incidence,2584496,All Races,55.3,Male,Stomach,2018
80-84,0.4,1.1,19,Incidence,2584496,All Races,0.7,Male,Testis,2018
80-84,11.6,14.4,334,Incidence,2584496,All Races,12.9,Male,Thyroid,2018
80-84,290.4,303.7,7676,Incidence,2584496,All Races,297.0,Male,Urinary Bladder,2018
85+,2643.4,2685.3,62145,Incidence,2332518,All Races,2664.3,Male,All Cancer Sites Combined,2018
85+,21.2,25.1,538,Incidence,2332518,All Races,23.1,Male,Brain and Other Nervous System,2018
85+,253.6,266.7,6066,Incidence,2332518,All Races,260.1,Male,Colon and Rectum,2018
85+,37.3,42.4,928,Incidence,2332518,All Races,39.8,Male,Esophagus,2018
85+,2.9,4.5,84,Incidence,2332518,All Races,3.6,Male,Hodgkin Lymphoma,2018
85+,1.1,2.2,37,Incidence,2332518,All Races,1.6,Male,Kaposi Sarcoma,2018
85+,74.9,82.2,1831,Incidence,2332518,All Races,78.5,Male,Kidney and Renal Pelvis,2018
85+,19.8,23.6,505,Incidence,2332518,All Races,21.7,Male,Larynx,2018
85+,117.3,126.3,2840,Incidence,2332518,All Races,121.8,Male,Leukemias,2018
85+,47.2,53.0,1168,Incidence,2332518,All Races,50.1,Male,Liver and Intrahepatic Bile Duct,2018
85+,387.0,403.1,9213,Incidence,2332518,All Races,395.0,Male,Lung and Bronchus,2018
85+,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
85+,191.8,203.2,4605,Incidence,2332518,All Races,197.4,Male,Melanomas of the Skin,2018
85+,13.5,16.7,351,Incidence,2332518,All Races,15.0,Male,Mesothelioma,2018
85+,50.2,56.2,1240,Incidence,2332518,All Races,53.2,Male,Myeloma,2018
85+,133.8,143.4,3232,Incidence,2332518,All Races,138.6,Male,Non-Hodgkin Lymphoma,2018
85+,56.0,62.3,1378,Incidence,2332518,All Races,59.1,Male,Oral Cavity and Pharynx,2018
85+,96.0,104.2,2333,Incidence,2332518,All Races,100.0,Male,Pancreas,2018
85+,347.7,363.1,8288,Incidence,2332518,All Races,355.3,Male,Prostate,2018
85+,52.2,58.3,1287,Incidence,2332518,All Races,55.2,Male,Stomach,2018
85+,0.7,1.6,25,Incidence,2332518,All Races,1.1,Male,Testis,2018
85+,8.7,11.3,232,Incidence,2332518,All Races,9.9,Male,Thyroid,2018
85+,325.4,340.3,7762,Incidence,2332518,All Races,332.8,Male,Urinary Bladder,2018
<1,25.3,30.0,539,Incidence,1955778,All Races,27.6,Male,All Cancer Sites Combined,2018
<1,2.1,3.6,54,Incidence,1955778,All Races,2.8,Male,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Colon and Rectum,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Esophagus,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Kaposi Sarcoma,2018
<1,1.2,2.4,33,Incidence,1955778,All Races,1.7,Male,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Larynx,2018
<1,3.5,5.4,86,Incidence,1955778,All Races,4.4,Male,Leukemias,2018
<1,1.2,2.5,35,Incidence,1955778,All Races,1.8,Male,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Lung and Bronchus,2018
<1,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Melanomas of the Skin,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Mesothelioma,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Myeloma,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Pancreas,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Prostate,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Stomach,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Testis,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Thyroid,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male,Urinary Bladder,2018
1-4,21.3,22.7,3510,Incidence,15951619,All Races,22.0,Male and Female,All Cancer Sites Combined,2018
1-4,3.9,4.5,668,Incidence,15951619,All Races,4.2,Male and Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,Cervix,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Esophagus,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,Female Breast,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2018
1-4,0.1,0.2,21,Incidence,15951619,All Races,0.1,Male and Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Kaposi Sarcoma,2018
1-4,1.6,2.0,290,Incidence,15951619,All Races,1.8,Male and Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Larynx,2018
1-4,8.7,9.7,1467,Incidence,15951619,All Races,9.2,Male and Female,Leukemias,2018
1-4,0.5,0.8,99,Incidence,15951619,All Races,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,Male and Female Breast,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
1-4,0.1,0.2,17,Incidence,15951619,All Races,0.1,Male and Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Mesothelioma,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Myeloma,2018
1-4,0.5,0.7,97,Incidence,15951619,All Races,0.6,Male and Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,7794796,All Races,~,Male and Female,Ovary,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Pancreas,2018
1-4,~,~,~,Incidence,8156823,All Races,~,Male and Female,Prostate,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Stomach,2018
1-4,0.1,0.4,19,Incidence,8156823,All Races,0.2,Male and Female,Testis,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Thyroid,2018
1-4,~,~,~,Incidence,15951619,All Races,~,Male and Female,Urinary Bladder,2018
10-14,15.6,16.7,3364,Incidence,20887842,All Races,16.1,Male and Female,All Cancer Sites Combined,2018
10-14,2.7,3.2,619,Incidence,20887842,All Races,3.0,Male and Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Male and Female,Cervix,2018
10-14,0.6,0.8,141,Incidence,20887842,All Races,0.7,Male and Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Male and Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Esophagus,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Male and Female,Female Breast,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2018
10-14,1.1,1.4,266,Incidence,20887842,All Races,1.3,Male and Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Kaposi Sarcoma,2018
10-14,0.2,0.3,46,Incidence,20887842,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Larynx,2018
10-14,3.0,3.5,683,Incidence,20887842,All Races,3.3,Male and Female,Leukemias,2018
10-14,0.1,0.1,19,Incidence,20887842,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Male and Female,Male and Female Breast,2018
10-14,~,~,~,Incidence,10223894,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
10-14,0.2,0.3,55,Incidence,20887842,All Races,0.3,Male and Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Mesothelioma,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Myeloma,2018
10-14,1.3,1.7,312,Incidence,20887842,All Races,1.5,Male and Female,Non-Hodgkin Lymphoma,2018
10-14,0.2,0.3,46,Incidence,20887842,All Races,0.2,Male and Female,Oral Cavity and Pharynx,2018
10-14,0.8,1.2,97,Incidence,10223894,All Races,0.9,Male and Female,Ovary,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Pancreas,2018
10-14,~,~,~,Incidence,10663948,All Races,~,Male and Female,Prostate,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Stomach,2018
10-14,0.2,0.4,30,Incidence,10663948,All Races,0.3,Male and Female,Testis,2018
10-14,0.9,1.2,218,Incidence,20887842,All Races,1.0,Male and Female,Thyroid,2018
10-14,~,~,~,Incidence,20887842,All Races,~,Male and Female,Urinary Bladder,2018
15-19,23.6,25.0,5117,Incidence,21077066,All Races,24.3,Male and Female,All Cancer Sites Combined,2018
15-19,2.1,2.5,475,Incidence,21077066,All Races,2.3,Male and Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Male and Female,Cervix,2018
15-19,1.2,1.6,296,Incidence,21077066,All Races,1.4,Male and Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Male and Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,21077066,All Races,~,Male and Female,Esophagus,2018
15-19,0.1,0.3,21,Incidence,10314076,All Races,0.2,Male and Female,Female Breast,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2018
15-19,2.9,3.4,663,Incidence,21077066,All Races,3.1,Male and Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,21077066,All Races,~,Male and Female,Kaposi Sarcoma,2018
15-19,0.2,0.3,45,Incidence,21077066,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,21077066,All Races,~,Male and Female,Larynx,2018
15-19,3.1,3.6,705,Incidence,21077066,All Races,3.3,Male and Female,Leukemias,2018
15-19,0.1,0.2,34,Incidence,21077066,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
15-19,0.1,0.2,35,Incidence,21077066,All Races,0.2,Male and Female,Lung and Bronchus,2018
15-19,0.1,0.3,21,Incidence,10314076,All Races,0.2,Male and Female,Male and Female Breast,2018
15-19,~,~,~,Incidence,10314076,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
15-19,0.7,0.9,165,Incidence,21077066,All Races,0.8,Male and Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,21077066,All Races,~,Male and Female,Mesothelioma,2018
15-19,~,~,~,Incidence,21077066,All Races,~,Male and Female,Myeloma,2018
15-19,1.6,2.0,374,Incidence,21077066,All Races,1.8,Male and Female,Non-Hodgkin Lymphoma,2018
15-19,0.4,0.5,92,Incidence,21077066,All Races,0.4,Male and Female,Oral Cavity and Pharynx,2018
15-19,1.0,1.5,129,Incidence,10314076,All Races,1.3,Male and Female,Ovary,2018
15-19,0.2,0.3,48,Incidence,21077066,All Races,0.2,Male and Female,Pancreas,2018
15-19,~,~,~,Incidence,10762990,All Races,~,Male and Female,Prostate,2018
15-19,0.1,0.1,19,Incidence,21077066,All Races,0.1,Male and Female,Stomach,2018
15-19,2.8,3.5,334,Incidence,10762990,All Races,3.1,Male and Female,Testis,2018
15-19,3.4,3.9,775,Incidence,21077066,All Races,3.7,Male and Female,Thyroid,2018
15-19,0.1,0.2,22,Incidence,21077066,All Races,0.1,Male and Female,Urinary Bladder,2018
20-24,37.2,38.8,8293,Incidence,21825110,All Races,38.0,Male and Female,All Cancer Sites Combined,2018
20-24,1.9,2.3,452,Incidence,21825110,All Races,2.1,Male and Female,Brain and Other Nervous System,2018
20-24,0.5,0.8,64,Incidence,10652877,All Races,0.6,Male and Female,Cervix,2018
20-24,1.7,2.1,418,Incidence,21825110,All Races,1.9,Male and Female,Colon and Rectum,2018
20-24,0.4,0.7,53,Incidence,10652877,All Races,0.5,Male and Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,21825110,All Races,~,Male and Female,Esophagus,2018
20-24,1.6,2.1,194,Incidence,10652877,All Races,1.8,Male and Female,Female Breast,2018
20-24,0.1,0.3,18,Incidence,10652877,All Races,0.2,Male and Female,"Female Breast, <i>in situ</i>",2018
20-24,3.8,4.4,895,Incidence,21825110,All Races,4.1,Male and Female,Hodgkin Lymphoma,2018
20-24,0.1,0.2,39,Incidence,21825110,All Races,0.2,Male and Female,Kaposi Sarcoma,2018
20-24,0.5,0.7,129,Incidence,21825110,All Races,0.6,Male and Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,21825110,All Races,~,Male and Female,Larynx,2018
20-24,2.5,3.0,597,Incidence,21825110,All Races,2.7,Male and Female,Leukemias,2018
20-24,0.1,0.2,32,Incidence,21825110,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2018
20-24,0.2,0.4,66,Incidence,21825110,All Races,0.3,Male and Female,Lung and Bronchus,2018
20-24,1.6,2.1,194,Incidence,10652877,All Races,1.8,Male and Female,Male and Female Breast,2018
20-24,0.1,0.3,18,Incidence,10652877,All Races,0.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
20-24,2.3,2.7,548,Incidence,21825110,All Races,2.5,Male and Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,21825110,All Races,~,Male and Female,Mesothelioma,2018
20-24,~,~,~,Incidence,21825110,All Races,~,Male and Female,Myeloma,2018
20-24,2.3,2.7,552,Incidence,21825110,All Races,2.5,Male and Female,Non-Hodgkin Lymphoma,2018
20-24,0.5,0.7,135,Incidence,21825110,All Races,0.6,Male and Female,Oral Cavity and Pharynx,2018
20-24,1.7,2.2,205,Incidence,10652877,All Races,1.9,Male and Female,Ovary,2018
20-24,0.2,0.4,67,Incidence,21825110,All Races,0.3,Male and Female,Pancreas,2018
20-24,~,~,~,Incidence,11172233,All Races,~,Male and Female,Prostate,2018
20-24,0.2,0.3,57,Incidence,21825110,All Races,0.3,Male and Female,Stomach,2018
20-24,10.5,11.7,1236,Incidence,11172233,All Races,11.1,Male and Female,Testis,2018
20-24,6.4,7.1,1469,Incidence,21825110,All Races,6.7,Male and Female,Thyroid,2018
20-24,0.2,0.3,47,Incidence,21825110,All Races,0.2,Male and Female,Urinary Bladder,2018
25-29,58.8,60.8,14077,Incidence,23547218,All Races,59.8,Male and Female,All Cancer Sites Combined,2018
25-29,2.8,3.2,710,Incidence,23547218,All Races,3.0,Male and Female,Brain and Other Nervous System,2018
25-29,4.2,5.0,528,Incidence,11535821,All Races,4.6,Male and Female,Cervix,2018
25-29,3.1,3.6,787,Incidence,23547218,All Races,3.3,Male and Female,Colon and Rectum,2018
25-29,1.9,2.4,244,Incidence,11535821,All Races,2.1,Male and Female,"Corpus and Uterus, NOS",2018
25-29,0.1,0.1,22,Incidence,23547218,All Races,0.1,Male and Female,Esophagus,2018
25-29,9.8,11.0,1202,Incidence,11535821,All Races,10.4,Male and Female,Female Breast,2018
25-29,0.5,0.8,71,Incidence,11535821,All Races,0.6,Male and Female,"Female Breast, <i>in situ</i>",2018
25-29,3.6,4.1,909,Incidence,23547218,All Races,3.9,Male and Female,Hodgkin Lymphoma,2018
25-29,0.4,0.6,122,Incidence,23547218,All Races,0.5,Male and Female,Kaposi Sarcoma,2018
25-29,1.2,1.5,312,Incidence,23547218,All Races,1.3,Male and Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,23547218,All Races,~,Male and Female,Larynx,2018
25-29,2.8,3.2,707,Incidence,23547218,All Races,3.0,Male and Female,Leukemias,2018
25-29,0.2,0.4,65,Incidence,23547218,All Races,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
25-29,0.5,0.7,143,Incidence,23547218,All Races,0.6,Male and Female,Lung and Bronchus,2018
25-29,9.8,11.0,1202,Incidence,11535821,All Races,10.4,Male and Female,Male and Female Breast,2018
25-29,0.5,0.8,71,Incidence,11535821,All Races,0.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
25-29,4.6,5.2,1157,Incidence,23547218,All Races,4.9,Male and Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,23547218,All Races,~,Male and Female,Mesothelioma,2018
25-29,0.1,0.2,28,Incidence,23547218,All Races,0.1,Male and Female,Myeloma,2018
25-29,3.2,3.7,804,Incidence,23547218,All Races,3.4,Male and Female,Non-Hodgkin Lymphoma,2018
25-29,0.9,1.2,249,Incidence,23547218,All Races,1.1,Male and Female,Oral Cavity and Pharynx,2018
25-29,2.1,2.6,270,Incidence,11535821,All Races,2.3,Male and Female,Ovary,2018
25-29,0.3,0.4,85,Incidence,23547218,All Races,0.4,Male and Female,Pancreas,2018
25-29,~,~,~,Incidence,12011397,All Races,~,Male and Female,Prostate,2018
25-29,0.4,0.6,113,Incidence,23547218,All Races,0.5,Male and Female,Stomach,2018
25-29,13.1,14.5,1656,Incidence,12011397,All Races,13.8,Male and Female,Testis,2018
25-29,10.2,11.0,2494,Incidence,23547218,All Races,10.6,Male and Female,Thyroid,2018
25-29,0.3,0.4,76,Incidence,23547218,All Races,0.3,Male and Female,Urinary Bladder,2018
30-34,97.3,99.9,21816,Incidence,22131842,All Races,98.6,Male and Female,All Cancer Sites Combined,2018
30-34,3.3,3.8,787,Incidence,22131842,All Races,3.6,Male and Female,Brain and Other Nervous System,2018
30-34,11.0,12.3,1270,Incidence,10945565,All Races,11.6,Male and Female,Cervix,2018
30-34,6.3,7.0,1472,Incidence,22131842,All Races,6.7,Male and Female,Colon and Rectum,2018
30-34,5.6,6.6,668,Incidence,10945565,All Races,6.1,Male and Female,"Corpus and Uterus, NOS",2018
30-34,0.2,0.3,50,Incidence,22131842,All Races,0.2,Male and Female,Esophagus,2018
30-34,29.9,32.0,3386,Incidence,10945565,All Races,30.9,Male and Female,Female Breast,2018
30-34,2.6,3.2,318,Incidence,10945565,All Races,2.9,Male and Female,"Female Breast, <i>in situ</i>",2018
30-34,3.2,3.7,755,Incidence,22131842,All Races,3.4,Male and Female,Hodgkin Lymphoma,2018
30-34,0.4,0.6,119,Incidence,22131842,All Races,0.5,Male and Female,Kaposi Sarcoma,2018
30-34,3.0,3.5,722,Incidence,22131842,All Races,3.3,Male and Female,Kidney and Renal Pelvis,2018
30-34,0.0,0.1,16,Incidence,22131842,All Races,0.1,Male and Female,Larynx,2018
30-34,3.2,3.7,760,Incidence,22131842,All Races,3.4,Male and Female,Leukemias,2018
30-34,0.4,0.6,118,Incidence,22131842,All Races,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.9,1.2,236,Incidence,22131842,All Races,1.1,Male and Female,Lung and Bronchus,2018
30-34,29.9,32.0,3386,Incidence,10945565,All Races,30.9,Male and Female,Male and Female Breast,2018
30-34,2.6,3.2,318,Incidence,10945565,All Races,2.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
30-34,8.8,9.6,2045,Incidence,22131842,All Races,9.2,Male and Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,22131842,All Races,~,Male and Female,Mesothelioma,2018
30-34,0.3,0.5,84,Incidence,22131842,All Races,0.4,Male and Female,Myeloma,2018
30-34,4.5,5.1,1060,Incidence,22131842,All Races,4.8,Male and Female,Non-Hodgkin Lymphoma,2018
30-34,1.5,1.9,374,Incidence,22131842,All Races,1.7,Male and Female,Oral Cavity and Pharynx,2018
30-34,2.9,3.6,353,Incidence,10945565,All Races,3.2,Male and Female,Ovary,2018
30-34,0.7,0.9,172,Incidence,22131842,All Races,0.8,Male and Female,Pancreas,2018
30-34,~,~,~,Incidence,11186277,All Races,~,Male and Female,Prostate,2018
30-34,1.0,1.2,243,Incidence,22131842,All Races,1.1,Male and Female,Stomach,2018
30-34,14.7,16.1,1722,Incidence,11186277,All Races,15.4,Male and Female,Testis,2018
30-34,14.8,15.9,3394,Incidence,22131842,All Races,15.3,Male and Female,Thyroid,2018
30-34,0.7,0.9,172,Incidence,22131842,All Races,0.8,Male and Female,Urinary Bladder,2018
35-39,146.6,149.8,31933,Incidence,21548960,All Races,148.2,Male and Female,All Cancer Sites Combined,2018
35-39,3.6,4.2,842,Incidence,21548960,All Races,3.9,Male and Female,Brain and Other Nervous System,2018
35-39,13.2,14.6,1491,Incidence,10767228,All Races,13.8,Male and Female,Cervix,2018
35-39,11.1,12.0,2479,Incidence,21548960,All Races,11.5,Male and Female,Colon and Rectum,2018
35-39,10.2,11.5,1167,Incidence,10767228,All Races,10.8,Male and Female,"Corpus and Uterus, NOS",2018
35-39,0.4,0.6,112,Incidence,21548960,All Races,0.5,Male and Female,Esophagus,2018
35-39,61.8,64.8,6811,Incidence,10767228,All Races,63.3,Male and Female,Female Breast,2018
35-39,8.3,9.5,958,Incidence,10767228,All Races,8.9,Male and Female,"Female Breast, <i>in situ</i>",2018
35-39,2.9,3.4,671,Incidence,21548960,All Races,3.1,Male and Female,Hodgkin Lymphoma,2018
35-39,0.5,0.7,128,Incidence,21548960,All Races,0.6,Male and Female,Kaposi Sarcoma,2018
35-39,6.6,7.3,1487,Incidence,21548960,All Races,6.9,Male and Female,Kidney and Renal Pelvis,2018
35-39,0.2,0.3,58,Incidence,21548960,All Races,0.3,Male and Female,Larynx,2018
35-39,4.6,5.2,1045,Incidence,21548960,All Races,4.8,Male and Female,Leukemias,2018
35-39,0.8,1.1,209,Incidence,21548960,All Races,1.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
35-39,2.5,3.0,589,Incidence,21548960,All Races,2.7,Male and Female,Lung and Bronchus,2018
35-39,61.8,64.8,6811,Incidence,10767228,All Races,63.3,Male and Female,Male and Female Breast,2018
35-39,8.3,9.5,958,Incidence,10767228,All Races,8.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
35-39,12.3,13.3,2763,Incidence,21548960,All Races,12.8,Male and Female,Melanomas of the Skin,2018
35-39,0.1,0.2,25,Incidence,21548960,All Races,0.1,Male and Female,Mesothelioma,2018
35-39,0.8,1.1,203,Incidence,21548960,All Races,0.9,Male and Female,Myeloma,2018
35-39,6.4,7.1,1454,Incidence,21548960,All Races,6.7,Male and Female,Non-Hodgkin Lymphoma,2018
35-39,2.6,3.0,603,Incidence,21548960,All Races,2.8,Male and Female,Oral Cavity and Pharynx,2018
35-39,4.7,5.5,546,Incidence,10767228,All Races,5.1,Male and Female,Ovary,2018
35-39,1.4,1.7,336,Incidence,21548960,All Races,1.6,Male and Female,Pancreas,2018
35-39,0.4,0.7,61,Incidence,10781732,All Races,0.6,Male and Female,Prostate,2018
35-39,1.9,2.3,451,Incidence,21548960,All Races,2.1,Male and Female,Stomach,2018
35-39,12.1,13.4,1374,Incidence,10781732,All Races,12.7,Male and Female,Testis,2018
35-39,18.1,19.2,4020,Incidence,21548960,All Races,18.7,Male and Female,Thyroid,2018
35-39,1.4,1.7,337,Incidence,21548960,All Races,1.6,Male and Female,Urinary Bladder,2018
40-44,233.6,237.9,46393,Incidence,19683134,All Races,235.7,Male and Female,All Cancer Sites Combined,2018
40-44,4.0,4.6,846,Incidence,19683134,All Races,4.3,Male and Female,Brain and Other Nervous System,2018
40-44,15.2,16.8,1580,Incidence,9901383,All Races,16.0,Male and Female,Cervix,2018
40-44,20.2,21.5,4106,Incidence,19683134,All Races,20.9,Male and Female,Colon and Rectum,2018
40-44,16.5,18.1,1713,Incidence,9901383,All Races,17.3,Male and Female,"Corpus and Uterus, NOS",2018
40-44,1.0,1.3,220,Incidence,19683134,All Races,1.1,Male and Female,Esophagus,2018
40-44,129.3,133.9,13029,Incidence,9901383,All Races,131.6,Male and Female,Female Breast,2018
40-44,37.1,39.6,3798,Incidence,9901383,All Races,38.4,Male and Female,"Female Breast, <i>in situ</i>",2018
40-44,2.4,2.9,523,Incidence,19683134,All Races,2.7,Male and Female,Hodgkin Lymphoma,2018
40-44,0.3,0.5,80,Incidence,19683134,All Races,0.4,Male and Female,Kaposi Sarcoma,2018
40-44,12.1,13.1,2470,Incidence,19683134,All Races,12.5,Male and Female,Kidney and Renal Pelvis,2018
40-44,0.7,0.9,155,Incidence,19683134,All Races,0.8,Male and Female,Larynx,2018
40-44,5.9,6.6,1230,Incidence,19683134,All Races,6.2,Male and Female,Leukemias,2018
40-44,1.7,2.1,366,Incidence,19683134,All Races,1.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
40-44,6.4,7.2,1336,Incidence,19683134,All Races,6.8,Male and Female,Lung and Bronchus,2018
40-44,129.3,133.9,13029,Incidence,9901383,All Races,131.6,Male and Female,Male and Female Breast,2018
40-44,37.1,39.6,3798,Incidence,9901383,All Races,38.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
40-44,16.1,17.3,3284,Incidence,19683134,All Races,16.7,Male and Female,Melanomas of the Skin,2018
40-44,0.1,0.2,27,Incidence,19683134,All Races,0.1,Male and Female,Mesothelioma,2018
40-44,2.5,2.9,528,Incidence,19683134,All Races,2.7,Male and Female,Myeloma,2018
40-44,9.0,9.9,1854,Incidence,19683134,All Races,9.4,Male and Female,Non-Hodgkin Lymphoma,2018
40-44,5.5,6.2,1149,Incidence,19683134,All Races,5.8,Male and Female,Oral Cavity and Pharynx,2018
40-44,7.8,8.9,824,Incidence,9901383,All Races,8.3,Male and Female,Ovary,2018
40-44,3.0,3.5,632,Incidence,19683134,All Races,3.2,Male and Female,Pancreas,2018
40-44,5.4,6.4,578,Incidence,9781751,All Races,5.9,Male and Female,Prostate,2018
40-44,3.3,3.8,695,Incidence,19683134,All Races,3.5,Male and Female,Stomach,2018
40-44,8.5,9.7,893,Incidence,9781751,All Races,9.1,Male and Female,Testis,2018
40-44,20.8,22.1,4213,Incidence,19683134,All Races,21.4,Male and Female,Thyroid,2018
40-44,2.5,3.0,543,Incidence,19683134,All Races,2.8,Male and Female,Urinary Bladder,2018
45-49,356.3,361.4,74335,Incidence,20715437,All Races,358.8,Male and Female,All Cancer Sites Combined,2018
45-49,5.4,6.1,1188,Incidence,20715437,All Races,5.7,Male and Female,Brain and Other Nervous System,2018
45-49,13.7,15.1,1504,Incidence,10466104,All Races,14.4,Male and Female,Cervix,2018
45-49,34.9,36.5,7388,Incidence,20715437,All Races,35.7,Male and Female,Colon and Rectum,2018
45-49,25.9,27.9,2818,Incidence,10466104,All Races,26.9,Male and Female,"Corpus and Uterus, NOS",2018
45-49,2.1,2.5,483,Incidence,20715437,All Races,2.3,Male and Female,Esophagus,2018
45-49,195.4,200.8,20732,Incidence,10466104,All Races,198.1,Male and Female,Female Breast,2018
45-49,56.4,59.3,6056,Incidence,10466104,All Races,57.9,Male and Female,"Female Breast, <i>in situ</i>",2018
45-49,2.0,2.4,463,Incidence,20715437,All Races,2.2,Male and Female,Hodgkin Lymphoma,2018
45-49,0.3,0.5,89,Incidence,20715437,All Races,0.4,Male and Female,Kaposi Sarcoma,2018
45-49,17.6,18.7,3760,Incidence,20715437,All Races,18.2,Male and Female,Kidney and Renal Pelvis,2018
45-49,1.8,2.2,407,Incidence,20715437,All Races,2.0,Male and Female,Larynx,2018
45-49,8.4,9.2,1814,Incidence,20715437,All Races,8.8,Male and Female,Leukemias,2018
45-49,3.3,3.8,734,Incidence,20715437,All Races,3.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
45-49,15.8,16.9,3379,Incidence,20715437,All Races,16.3,Male and Female,Lung and Bronchus,2018
45-49,195.4,200.8,20732,Incidence,10466104,All Races,198.1,Male and Female,Male and Female Breast,2018
45-49,56.4,59.3,6056,Incidence,10466104,All Races,57.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
45-49,21.0,22.3,4484,Incidence,20715437,All Races,21.6,Male and Female,Melanomas of the Skin,2018
45-49,0.3,0.4,67,Incidence,20715437,All Races,0.3,Male and Female,Mesothelioma,2018
45-49,4.2,4.7,920,Incidence,20715437,All Races,4.4,Male and Female,Myeloma,2018
45-49,13.2,14.3,2848,Incidence,20715437,All Races,13.7,Male and Female,Non-Hodgkin Lymphoma,2018
45-49,11.2,12.1,2411,Incidence,20715437,All Races,11.6,Male and Female,Oral Cavity and Pharynx,2018
45-49,12.3,13.6,1354,Incidence,10466104,All Races,12.9,Male and Female,Ovary,2018
45-49,5.8,6.5,1272,Incidence,20715437,All Races,6.1,Male and Female,Pancreas,2018
45-49,29.3,31.5,3114,Incidence,10249333,All Races,30.4,Male and Female,Prostate,2018
45-49,4.8,5.4,1051,Incidence,20715437,All Races,5.1,Male and Female,Stomach,2018
45-49,5.3,6.3,594,Incidence,10249333,All Races,5.8,Male and Female,Testis,2018
45-49,22.1,23.4,4713,Incidence,20715437,All Races,22.8,Male and Female,Thyroid,2018
45-49,5.4,6.1,1187,Incidence,20715437,All Races,5.7,Male and Female,Urinary Bladder,2018
5-9,12.6,13.6,2656,Incidence,20212958,All Races,13.1,Male and Female,All Cancer Sites Combined,2018
5-9,3.2,3.7,693,Incidence,20212958,All Races,3.4,Male and Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Male and Female,Cervix,2018
5-9,0.1,0.2,24,Incidence,20212958,All Races,0.1,Male and Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Male and Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Esophagus,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Male and Female,Female Breast,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2018
5-9,0.3,0.5,80,Incidence,20212958,All Races,0.4,Male and Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Kaposi Sarcoma,2018
5-9,0.6,0.8,141,Incidence,20212958,All Races,0.7,Male and Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Larynx,2018
5-9,3.9,4.5,847,Incidence,20212958,All Races,4.2,Male and Female,Leukemias,2018
5-9,0.1,0.2,24,Incidence,20212958,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Male and Female,Male and Female Breast,2018
5-9,~,~,~,Incidence,9888217,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Mesothelioma,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Myeloma,2018
5-9,0.9,1.2,216,Incidence,20212958,All Races,1.1,Male and Female,Non-Hodgkin Lymphoma,2018
5-9,0.1,0.1,18,Incidence,20212958,All Races,0.1,Male and Female,Oral Cavity and Pharynx,2018
5-9,0.1,0.3,17,Incidence,9888217,All Races,0.2,Male and Female,Ovary,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Pancreas,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male and Female,Prostate,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Stomach,2018
5-9,~,~,~,Incidence,10324741,All Races,~,Male and Female,Testis,2018
5-9,0.1,0.2,32,Incidence,20212958,All Races,0.2,Male and Female,Thyroid,2018
5-9,~,~,~,Incidence,20212958,All Races,~,Male and Female,Urinary Bladder,2018
50-54,564.6,571.1,118427,Incidence,20856223,All Races,567.8,Male and Female,All Cancer Sites Combined,2018
50-54,6.8,7.5,1483,Incidence,20856223,All Races,7.1,Male and Female,Brain and Other Nervous System,2018
50-54,12.0,13.3,1339,Incidence,10593345,All Races,12.6,Male and Female,Cervix,2018
50-54,62.7,64.9,13308,Incidence,20856223,All Races,63.8,Male and Female,Colon and Rectum,2018
50-54,47.4,50.1,5162,Incidence,10593345,All Races,48.7,Male and Female,"Corpus and Uterus, NOS",2018
50-54,5.0,5.6,1109,Incidence,20856223,All Races,5.3,Male and Female,Esophagus,2018
50-54,230.0,235.8,24673,Incidence,10593345,All Races,232.9,Male and Female,Female Breast,2018
50-54,64.2,67.3,6966,Incidence,10593345,All Races,65.8,Male and Female,"Female Breast, <i>in situ</i>",2018
50-54,2.1,2.6,490,Incidence,20856223,All Races,2.3,Male and Female,Hodgkin Lymphoma,2018
50-54,0.4,0.6,105,Incidence,20856223,All Races,0.5,Male and Female,Kaposi Sarcoma,2018
50-54,26.1,27.5,5592,Incidence,20856223,All Races,26.8,Male and Female,Kidney and Renal Pelvis,2018
50-54,4.2,4.8,945,Incidence,20856223,All Races,4.5,Male and Female,Larynx,2018
50-54,12.1,13.1,2628,Incidence,20856223,All Races,12.6,Male and Female,Leukemias,2018
50-54,8.9,9.8,1946,Incidence,20856223,All Races,9.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
50-54,41.2,42.9,8768,Incidence,20856223,All Races,42.0,Male and Female,Lung and Bronchus,2018
50-54,230.0,235.8,24673,Incidence,10593345,All Races,232.9,Male and Female,Male and Female Breast,2018
50-54,64.2,67.3,6966,Incidence,10593345,All Races,65.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
50-54,28.9,30.4,6180,Incidence,20856223,All Races,29.6,Male and Female,Melanomas of the Skin,2018
50-54,0.4,0.5,91,Incidence,20856223,All Races,0.4,Male and Female,Mesothelioma,2018
50-54,7.8,8.6,1704,Incidence,20856223,All Races,8.2,Male and Female,Myeloma,2018
50-54,20.8,22.0,4458,Incidence,20856223,All Races,21.4,Male and Female,Non-Hodgkin Lymphoma,2018
50-54,20.8,22.1,4472,Incidence,20856223,All Races,21.4,Male and Female,Oral Cavity and Pharynx,2018
50-54,16.4,18.0,1819,Incidence,10593345,All Races,17.2,Male and Female,Ovary,2018
50-54,11.9,12.8,2576,Incidence,20856223,All Races,12.4,Male and Female,Pancreas,2018
50-54,114.2,118.4,11936,Incidence,10262878,All Races,116.3,Male and Female,Prostate,2018
50-54,7.1,7.9,1565,Incidence,20856223,All Races,7.5,Male and Female,Stomach,2018
50-54,4.0,4.8,450,Incidence,10262878,All Races,4.4,Male and Female,Testis,2018
50-54,22.1,23.4,4745,Incidence,20856223,All Races,22.8,Male and Female,Thyroid,2018
50-54,11.7,12.7,2548,Incidence,20856223,All Races,12.2,Male and Female,Urinary Bladder,2018
55-59,842.8,850.5,185554,Incidence,21916092,All Races,846.7,Male and Female,All Cancer Sites Combined,2018
55-59,9.6,10.5,2206,Incidence,21916092,All Races,10.1,Male and Female,Brain and Other Nervous System,2018
55-59,11.8,13.2,1406,Incidence,11257833,All Races,12.5,Male and Female,Cervix,2018
55-59,67.0,69.1,14912,Incidence,21916092,All Races,68.0,Male and Female,Colon and Rectum,2018
55-59,75.6,78.9,8693,Incidence,11257833,All Races,77.2,Male and Female,"Corpus and Uterus, NOS",2018
55-59,8.9,9.7,2029,Incidence,21916092,All Races,9.3,Male and Female,Esophagus,2018
55-59,268.5,274.6,30573,Incidence,11257833,All Races,271.6,Male and Female,Female Breast,2018
55-59,64.6,67.6,7442,Incidence,11257833,All Races,66.1,Male and Female,"Female Breast, <i>in situ</i>",2018
55-59,2.3,2.8,559,Incidence,21916092,All Races,2.6,Male and Female,Hodgkin Lymphoma,2018
55-59,0.3,0.5,89,Incidence,21916092,All Races,0.4,Male and Female,Kaposi Sarcoma,2018
55-59,36.7,38.4,8226,Incidence,21916092,All Races,37.5,Male and Female,Kidney and Renal Pelvis,2018
55-59,8.3,9.0,1893,Incidence,21916092,All Races,8.6,Male and Female,Larynx,2018
55-59,18.9,20.1,4265,Incidence,21916092,All Races,19.5,Male and Female,Leukemias,2018
55-59,20.4,21.7,4611,Incidence,21916092,All Races,21.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
55-59,93.4,96.0,20748,Incidence,21916092,All Races,94.7,Male and Female,Lung and Bronchus,2018
55-59,268.5,274.6,30573,Incidence,11257833,All Races,271.6,Male and Female,Male and Female Breast,2018
55-59,64.6,67.6,7442,Incidence,11257833,All Races,66.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
55-59,38.6,40.2,8631,Incidence,21916092,All Races,39.4,Male and Female,Melanomas of the Skin,2018
55-59,0.5,0.8,141,Incidence,21916092,All Races,0.6,Male and Female,Mesothelioma,2018
55-59,11.6,12.6,2649,Incidence,21916092,All Races,12.1,Male and Female,Myeloma,2018
55-59,30.4,31.8,6816,Incidence,21916092,All Races,31.1,Male and Female,Non-Hodgkin Lymphoma,2018
55-59,31.6,33.1,7083,Incidence,21916092,All Races,32.3,Male and Female,Oral Cavity and Pharynx,2018
55-59,20.0,21.6,2340,Incidence,11257833,All Races,20.8,Male and Female,Ovary,2018
55-59,22.0,23.3,4968,Incidence,21916092,All Races,22.7,Male and Female,Pancreas,2018
55-59,248.9,255.0,26852,Incidence,10658259,All Races,251.9,Male and Female,Prostate,2018
55-59,10.8,11.7,2463,Incidence,21916092,All Races,11.2,Male and Female,Stomach,2018
55-59,3.0,3.7,355,Incidence,10658259,All Races,3.3,Male and Female,Testis,2018
55-59,22.4,23.6,5037,Incidence,21916092,All Races,23.0,Male and Female,Thyroid,2018
55-59,22.8,24.1,5133,Incidence,21916092,All Races,23.4,Male and Female,Urinary Bladder,2018
60-64,1198.3,1207.8,244251,Incidence,20303185,All Races,1203.0,Male and Female,All Cancer Sites Combined,2018
60-64,12.2,13.1,2568,Incidence,20303185,All Races,12.6,Male and Female,Brain and Other Nervous System,2018
60-64,10.5,11.8,1176,Incidence,10585539,All Races,11.1,Male and Female,Cervix,2018
60-64,86.5,89.1,17828,Incidence,20303185,All Races,87.8,Male and Female,Colon and Rectum,2018
60-64,99.6,103.5,10746,Incidence,10585539,All Races,101.5,Male and Female,"Corpus and Uterus, NOS",2018
60-64,14.1,15.2,2969,Incidence,20303185,All Races,14.6,Male and Female,Esophagus,2018
60-64,331.6,338.6,35472,Incidence,10585539,All Races,335.1,Male and Female,Female Breast,2018
60-64,79.3,82.7,8576,Incidence,10585539,All Races,81.0,Male and Female,"Female Breast, <i>in situ</i>",2018
60-64,2.4,2.8,523,Incidence,20303185,All Races,2.6,Male and Female,Hodgkin Lymphoma,2018
60-64,0.2,0.4,65,Incidence,20303185,All Races,0.3,Male and Female,Kaposi Sarcoma,2018
60-64,49.0,50.9,10141,Incidence,20303185,All Races,49.9,Male and Female,Kidney and Renal Pelvis,2018
60-64,10.9,11.8,2307,Incidence,20303185,All Races,11.4,Male and Female,Larynx,2018
60-64,26.8,28.2,5587,Incidence,20303185,All Races,27.5,Male and Female,Leukemias,2018
60-64,34.4,36.0,7146,Incidence,20303185,All Races,35.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
60-64,153.2,156.6,31441,Incidence,20303185,All Races,154.9,Male and Female,Lung and Bronchus,2018
60-64,331.6,338.6,35472,Incidence,10585539,All Races,335.1,Male and Female,Male and Female Breast,2018
60-64,79.3,82.7,8576,Incidence,10585539,All Races,81.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
60-64,51.1,53.1,10570,Incidence,20303185,All Races,52.1,Male and Female,Melanomas of the Skin,2018
60-64,0.9,1.2,219,Incidence,20303185,All Races,1.1,Male and Female,Mesothelioma,2018
60-64,17.7,18.9,3706,Incidence,20303185,All Races,18.3,Male and Female,Myeloma,2018
60-64,41.4,43.2,8596,Incidence,20303185,All Races,42.3,Male and Female,Non-Hodgkin Lymphoma,2018
60-64,38.7,40.5,8042,Incidence,20303185,All Races,39.6,Male and Female,Oral Cavity and Pharynx,2018
60-64,23.9,25.8,2631,Incidence,10585539,All Races,24.9,Male and Female,Ovary,2018
60-64,33.3,34.9,6930,Incidence,20303185,All Races,34.1,Male and Female,Pancreas,2018
60-64,431.6,439.9,42342,Incidence,9717646,All Races,435.7,Male and Female,Prostate,2018
60-64,15.0,16.1,3154,Incidence,20303185,All Races,15.5,Male and Female,Stomach,2018
60-64,1.9,2.5,209,Incidence,9717646,All Races,2.2,Male and Female,Testis,2018
60-64,22.5,23.8,4695,Incidence,20303185,All Races,23.1,Male and Female,Thyroid,2018
60-64,40.5,42.3,8411,Incidence,20303185,All Races,41.4,Male and Female,Urinary Bladder,2018
65-69,1639.2,1651.4,280760,Incidence,17064299,All Races,1645.3,Male and Female,All Cancer Sites Combined,2018
65-69,15.7,17.0,2788,Incidence,17064299,All Races,16.3,Male and Female,Brain and Other Nervous System,2018
65-69,10.1,11.4,970,Incidence,9041390,All Races,10.7,Male and Female,Cervix,2018
65-69,113.4,116.6,19628,Incidence,17064299,All Races,115.0,Male and Female,Colon and Rectum,2018
65-69,114.7,119.2,10570,Incidence,9041390,All Races,116.9,Male and Female,"Corpus and Uterus, NOS",2018
65-69,18.8,20.1,3315,Incidence,17064299,All Races,19.4,Male and Female,Esophagus,2018
65-69,421.3,429.8,38473,Incidence,9041390,All Races,425.5,Male and Female,Female Breast,2018
65-69,96.4,100.5,8904,Incidence,9041390,All Races,98.5,Male and Female,"Female Breast, <i>in situ</i>",2018
65-69,2.7,3.2,495,Incidence,17064299,All Races,2.9,Male and Female,Hodgkin Lymphoma,2018
65-69,0.3,0.5,68,Incidence,17064299,All Races,0.4,Male and Female,Kaposi Sarcoma,2018
65-69,62.3,64.7,10840,Incidence,17064299,All Races,63.5,Male and Female,Kidney and Renal Pelvis,2018
65-69,12.0,13.1,2141,Incidence,17064299,All Races,12.5,Male and Female,Larynx,2018
65-69,39.6,41.5,6918,Incidence,17064299,All Races,40.5,Male and Female,Leukemias,2018
65-69,41.4,43.4,7232,Incidence,17064299,All Races,42.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
65-69,222.1,226.6,38290,Incidence,17064299,All Races,224.4,Male and Female,Lung and Bronchus,2018
65-69,421.3,429.8,38473,Incidence,9041390,All Races,425.5,Male and Female,Male and Female Breast,2018
65-69,96.4,100.5,8904,Incidence,9041390,All Races,98.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
65-69,68.4,70.9,11888,Incidence,17064299,All Races,69.7,Male and Female,Melanomas of the Skin,2018
65-69,1.9,2.4,362,Incidence,17064299,All Races,2.1,Male and Female,Mesothelioma,2018
65-69,25.9,27.5,4551,Incidence,17064299,All Races,26.7,Male and Female,Myeloma,2018
65-69,60.1,62.4,10450,Incidence,17064299,All Races,61.2,Male and Female,Non-Hodgkin Lymphoma,2018
65-69,44.3,46.3,7725,Incidence,17064299,All Races,45.3,Male and Female,Oral Cavity and Pharynx,2018
65-69,28.1,30.4,2644,Incidence,9041390,All Races,29.2,Male and Female,Ovary,2018
65-69,49.6,51.8,8653,Incidence,17064299,All Races,50.7,Male and Female,Pancreas,2018
65-69,661.5,672.9,53527,Incidence,8022909,All Races,667.2,Male and Female,Prostate,2018
65-69,20.1,21.4,3541,Incidence,17064299,All Races,20.8,Male and Female,Stomach,2018
65-69,1.4,2.0,133,Incidence,8022909,All Races,1.7,Male and Female,Testis,2018
65-69,24.2,25.7,4253,Incidence,17064299,All Races,24.9,Male and Female,Thyroid,2018
65-69,65.9,68.4,11454,Incidence,17064299,All Races,67.1,Male and Female,Urinary Bladder,2018
70-74,1952.5,1967.5,262263,Incidence,13380707,All Races,1960.0,Male and Female,All Cancer Sites Combined,2018
70-74,18.2,19.7,2533,Incidence,13380707,All Races,18.9,Male and Female,Brain and Other Nervous System,2018
70-74,9.5,11.0,737,Incidence,7180687,All Races,10.3,Male and Female,Cervix,2018
70-74,135.7,139.7,18419,Incidence,13380707,All Races,137.7,Male and Female,Colon and Rectum,2018
70-74,107.9,112.8,7925,Incidence,7180687,All Races,110.4,Male and Female,"Corpus and Uterus, NOS",2018
70-74,22.8,24.5,3160,Incidence,13380707,All Races,23.6,Male and Female,Esophagus,2018
70-74,476.2,486.4,34559,Incidence,7180687,All Races,481.3,Male and Female,Female Breast,2018
70-74,96.8,101.4,7112,Incidence,7180687,All Races,99.0,Male and Female,"Female Breast, <i>in situ</i>",2018
70-74,3.3,4.0,488,Incidence,13380707,All Races,3.6,Male and Female,Hodgkin Lymphoma,2018
70-74,0.3,0.5,52,Incidence,13380707,All Races,0.4,Male and Female,Kaposi Sarcoma,2018
70-74,70.3,73.2,9596,Incidence,13380707,All Races,71.7,Male and Female,Kidney and Renal Pelvis,2018
70-74,12.7,14.0,1786,Incidence,13380707,All Races,13.3,Male and Female,Larynx,2018
70-74,52.7,55.2,7215,Incidence,13380707,All Races,53.9,Male and Female,Leukemias,2018
70-74,37.5,39.6,5162,Incidence,13380707,All Races,38.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
70-74,313.4,319.4,42335,Incidence,13380707,All Races,316.4,Male and Female,Lung and Bronchus,2018
70-74,476.2,486.4,34559,Incidence,7180687,All Races,481.3,Male and Female,Male and Female Breast,2018
70-74,96.8,101.4,7112,Incidence,7180687,All Races,99.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
70-74,85.8,88.9,11685,Incidence,13380707,All Races,87.3,Male and Female,Melanomas of the Skin,2018
70-74,3.5,4.1,507,Incidence,13380707,All Races,3.8,Male and Female,Mesothelioma,2018
70-74,32.9,34.9,4535,Incidence,13380707,All Races,33.9,Male and Female,Myeloma,2018
70-74,77.6,80.6,10580,Incidence,13380707,All Races,79.1,Male and Female,Non-Hodgkin Lymphoma,2018
70-74,46.0,48.3,6306,Incidence,13380707,All Races,47.1,Male and Female,Oral Cavity and Pharynx,2018
70-74,32.4,35.1,2423,Incidence,7180687,All Races,33.7,Male and Female,Ovary,2018
70-74,65.6,68.4,8968,Incidence,13380707,All Races,67.0,Male and Female,Pancreas,2018
70-74,673.2,686.2,42142,Incidence,6200020,All Races,679.7,Male and Female,Prostate,2018
70-74,26.3,28.1,3637,Incidence,13380707,All Races,27.2,Male and Female,Stomach,2018
70-74,1.1,1.7,85,Incidence,6200020,All Races,1.4,Male and Female,Testis,2018
70-74,22.7,24.3,3143,Incidence,13380707,All Races,23.5,Male and Female,Thyroid,2018
70-74,97.9,101.3,13331,Incidence,13380707,All Races,99.6,Male and Female,Urinary Bladder,2018
75-79,2193.8,2213.0,203816,Incidence,9250179,All Races,2203.4,Male and Female,All Cancer Sites Combined,2018
75-79,20.3,22.2,1968,Incidence,9250179,All Races,21.3,Male and Female,Brain and Other Nervous System,2018
75-79,8.9,10.6,497,Incidence,5115395,All Races,9.7,Male and Female,Cervix,2018
75-79,170.2,175.5,15987,Incidence,9250179,All Races,172.8,Male and Female,Colon and Rectum,2018
75-79,90.7,96.0,4774,Incidence,5115395,All Races,93.3,Male and Female,"Corpus and Uterus, NOS",2018
75-79,24.9,27.0,2401,Incidence,9250179,All Races,26.0,Male and Female,Esophagus,2018
75-79,463.2,475.0,23995,Incidence,5115395,All Races,469.1,Male and Female,Female Breast,2018
75-79,83.1,88.2,4378,Incidence,5115395,All Races,85.6,Male and Female,"Female Breast, <i>in situ</i>",2018
75-79,3.5,4.3,362,Incidence,9250179,All Races,3.9,Male and Female,Hodgkin Lymphoma,2018
75-79,0.5,0.8,58,Incidence,9250179,All Races,0.6,Male and Female,Kaposi Sarcoma,2018
75-79,74.4,78.0,7050,Incidence,9250179,All Races,76.2,Male and Female,Kidney and Renal Pelvis,2018
75-79,12.9,14.5,1265,Incidence,9250179,All Races,13.7,Male and Female,Larynx,2018
75-79,70.1,73.6,6644,Incidence,9250179,All Races,71.8,Male and Female,Leukemias,2018
75-79,40.6,43.3,3877,Incidence,9250179,All Races,41.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
75-79,387.5,395.6,36216,Incidence,9250179,All Races,391.5,Male and Female,Lung and Bronchus,2018
75-79,463.2,475.0,23995,Incidence,5115395,All Races,469.1,Male and Female,Male and Female Breast,2018
75-79,83.1,88.2,4378,Incidence,5115395,All Races,85.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
75-79,98.4,102.5,9290,Incidence,9250179,All Races,100.4,Male and Female,Melanomas of the Skin,2018
75-79,5.5,6.5,554,Incidence,9250179,All Races,6.0,Male and Female,Mesothelioma,2018
75-79,42.2,44.9,4025,Incidence,9250179,All Races,43.5,Male and Female,Myeloma,2018
75-79,100.0,104.1,9437,Incidence,9250179,All Races,102.0,Male and Female,Non-Hodgkin Lymphoma,2018
75-79,43.7,46.4,4168,Incidence,9250179,All Races,45.1,Male and Female,Oral Cavity and Pharynx,2018
75-79,36.1,39.5,1934,Incidence,5115395,All Races,37.8,Male and Female,Ovary,2018
75-79,81.8,85.6,7741,Incidence,9250179,All Races,83.7,Male and Female,Pancreas,2018
75-79,599.6,614.6,25101,Incidence,4134784,All Races,607.1,Male and Female,Prostate,2018
75-79,32.3,34.7,3100,Incidence,9250179,All Races,33.5,Male and Female,Stomach,2018
75-79,0.6,1.2,37,Incidence,4134784,All Races,0.9,Male and Female,Testis,2018
75-79,20.1,22.0,1944,Incidence,9250179,All Races,21.0,Male and Female,Thyroid,2018
75-79,134.3,139.1,12642,Incidence,9250179,All Races,136.7,Male and Female,Urinary Bladder,2018
80-84,2267.8,2291.8,139553,Incidence,6121394,All Races,2279.8,Male and Female,All Cancer Sites Combined,2018
80-84,20.7,23.1,1338,Incidence,6121394,All Races,21.9,Male and Female,Brain and Other Nervous System,2018
80-84,7.7,9.7,306,Incidence,3536898,All Races,8.7,Male and Female,Cervix,2018
80-84,210.5,217.8,13107,Incidence,6121394,All Races,214.1,Male and Female,Colon and Rectum,2018
80-84,75.8,81.7,2784,Incidence,3536898,All Races,78.7,Male and Female,"Corpus and Uterus, NOS",2018
80-84,25.2,27.8,1620,Incidence,6121394,All Races,26.5,Male and Female,Esophagus,2018
80-84,413.7,427.2,14870,Incidence,3536898,All Races,420.4,Male and Female,Female Breast,2018
80-84,51.8,56.7,1918,Incidence,3536898,All Races,54.2,Male and Female,"Female Breast, <i>in situ</i>",2018
80-84,3.7,4.7,256,Incidence,6121394,All Races,4.2,Male and Female,Hodgkin Lymphoma,2018
80-84,0.5,0.9,39,Incidence,6121394,All Races,0.6,Male and Female,Kaposi Sarcoma,2018
80-84,68.1,72.3,4297,Incidence,6121394,All Races,70.2,Male and Female,Kidney and Renal Pelvis,2018
80-84,11.9,13.7,781,Incidence,6121394,All Races,12.8,Male and Female,Larynx,2018
80-84,81.6,86.2,5133,Incidence,6121394,All Races,83.9,Male and Female,Leukemias,2018
80-84,40.6,43.9,2585,Incidence,6121394,All Races,42.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
80-84,385.6,395.5,23907,Incidence,6121394,All Races,390.5,Male and Female,Lung and Bronchus,2018
80-84,413.7,427.2,14870,Incidence,3536898,All Races,420.4,Male and Female,Male and Female Breast,2018
80-84,51.8,56.7,1918,Incidence,3536898,All Races,54.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
80-84,113.0,118.5,7084,Incidence,6121394,All Races,115.7,Male and Female,Melanomas of the Skin,2018
80-84,7.6,9.1,511,Incidence,6121394,All Races,8.3,Male and Female,Mesothelioma,2018
80-84,46.1,49.6,2926,Incidence,6121394,All Races,47.8,Male and Female,Myeloma,2018
80-84,111.0,116.3,6956,Incidence,6121394,All Races,113.6,Male and Female,Non-Hodgkin Lymphoma,2018
80-84,45.1,48.5,2862,Incidence,6121394,All Races,46.8,Male and Female,Oral Cavity and Pharynx,2018
80-84,36.9,41.0,1376,Incidence,3536898,All Races,38.9,Male and Female,Ovary,2018
80-84,92.9,97.8,5835,Incidence,6121394,All Races,95.3,Male and Female,Pancreas,2018
80-84,446.5,463.0,11752,Incidence,2584496,All Races,454.7,Male and Female,Prostate,2018
80-84,36.8,39.9,2345,Incidence,6121394,All Races,38.3,Male and Female,Stomach,2018
80-84,0.4,1.1,19,Incidence,2584496,All Races,0.7,Male and Female,Testis,2018
80-84,14.3,16.3,935,Incidence,6121394,All Races,15.3,Male and Female,Thyroid,2018
80-84,160.6,167.0,10027,Incidence,6121394,All Races,163.8,Male and Female,Urinary Bladder,2018
85+,2024.7,2046.5,133087,Incidence,6538026,All Races,2035.6,Male and Female,All Cancer Sites Combined,2018
85+,15.9,17.9,1103,Incidence,6538026,All Races,16.9,Male and Female,Brain and Other Nervous System,2018
85+,5.8,7.3,274,Incidence,4205508,All Races,6.5,Male and Female,Cervix,2018
85+,230.3,237.7,15298,Incidence,6538026,All Races,234.0,Male and Female,Colon and Rectum,2018
85+,47.6,51.9,2091,Incidence,4205508,All Races,49.7,Male and Female,"Corpus and Uterus, NOS",2018
85+,20.6,22.9,1421,Incidence,6538026,All Races,21.7,Male and Female,Esophagus,2018
85+,314.0,324.8,13432,Incidence,4205508,All Races,319.4,Male and Female,Female Breast,2018
85+,21.4,24.3,958,Incidence,4205508,All Races,22.8,Male and Female,"Female Breast, <i>in situ</i>",2018
85+,2.3,3.1,177,Incidence,6538026,All Races,2.7,Male and Female,Hodgkin Lymphoma,2018
85+,0.8,1.3,64,Incidence,6538026,All Races,1.0,Male and Female,Kaposi Sarcoma,2018
85+,51.8,55.3,3500,Incidence,6538026,All Races,53.5,Male and Female,Kidney and Renal Pelvis,2018
85+,8.7,10.2,616,Incidence,6538026,All Races,9.4,Male and Female,Larynx,2018
85+,81.3,85.7,5457,Incidence,6538026,All Races,83.5,Male and Female,Leukemias,2018
85+,32.6,35.4,2221,Incidence,6538026,All Races,34.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
85+,290.6,299.0,19272,Incidence,6538026,All Races,294.8,Male and Female,Lung and Bronchus,2018
85+,314.0,324.8,13432,Incidence,4205508,All Races,319.4,Male and Female,Male and Female Breast,2018
85+,21.4,24.3,958,Incidence,4205508,All Races,22.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
85+,106.9,112.0,7152,Incidence,6538026,All Races,109.4,Male and Female,Melanomas of the Skin,2018
85+,6.4,7.7,462,Incidence,6538026,All Races,7.1,Male and Female,Mesothelioma,2018
85+,35.9,38.8,2441,Incidence,6538026,All Races,37.3,Male and Female,Myeloma,2018
85+,99.7,104.6,6675,Incidence,6538026,All Races,102.1,Male and Female,Non-Hodgkin Lymphoma,2018
85+,39.4,42.5,2674,Incidence,6538026,All Races,40.9,Male and Female,Oral Cavity and Pharynx,2018
85+,32.2,35.7,1426,Incidence,4205508,All Races,33.9,Male and Female,Ovary,2018
85+,90.6,95.3,6078,Incidence,6538026,All Races,93.0,Male and Female,Pancreas,2018
85+,347.7,363.1,8288,Incidence,2332518,All Races,355.3,Male and Female,Prostate,2018
85+,35.5,38.5,2419,Incidence,6538026,All Races,37.0,Male and Female,Stomach,2018
85+,0.7,1.6,25,Incidence,2332518,All Races,1.1,Male and Female,Testis,2018
85+,9.0,10.6,640,Incidence,6538026,All Races,9.8,Male and Female,Thyroid,2018
85+,163.6,169.9,10903,Incidence,6538026,All Races,166.8,Male and Female,Urinary Bladder,2018
<1,25.0,28.3,1017,Incidence,3826908,All Races,26.6,Male and Female,All Cancer Sites Combined,2018
<1,2.4,3.6,113,Incidence,3826908,All Races,3.0,Male and Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,Cervix,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Colon and Rectum,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Esophagus,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,Female Breast,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Kaposi Sarcoma,2018
<1,1.1,1.9,55,Incidence,3826908,All Races,1.4,Male and Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Larynx,2018
<1,3.7,5.1,166,Incidence,3826908,All Races,4.3,Male and Female,Leukemias,2018
<1,1.3,2.2,65,Incidence,3826908,All Races,1.7,Male and Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,Male and Female Breast,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Mesothelioma,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Myeloma,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,1871130,All Races,~,Male and Female,Ovary,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Pancreas,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male and Female,Prostate,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Stomach,2018
<1,~,~,~,Incidence,1955778,All Races,~,Male and Female,Testis,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Thyroid,2018
<1,~,~,~,Incidence,3826908,All Races,~,Male and Female,Urinary Bladder,2018
1-4,17.5,21.4,386,Incidence,1995244,Hispanic of any race,19.3,Female,All Cancer Sites Combined,2018
1-4,2.7,4.4,70,Incidence,1995244,Hispanic of any race,3.5,Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Cervix,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Esophagus,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Female Breast,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
1-4,1.1,2.2,31,Incidence,1995244,Hispanic of any race,1.6,Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Larynx,2018
1-4,7.6,10.3,177,Incidence,1995244,Hispanic of any race,8.9,Female,Leukemias,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Mesothelioma,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Myeloma,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Ovary,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Pancreas,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Stomach,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Thyroid,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Female,Urinary Bladder,2018
10-14,14.8,18.0,423,Incidence,2587209,Hispanic of any race,16.3,Female,All Cancer Sites Combined,2018
10-14,1.5,2.6,51,Incidence,2587209,Hispanic of any race,2.0,Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Cervix,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Esophagus,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Female Breast,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
10-14,0.5,1.2,21,Incidence,2587209,Hispanic of any race,0.8,Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Larynx,2018
10-14,4.1,5.9,128,Incidence,2587209,Hispanic of any race,4.9,Female,Leukemias,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Mesothelioma,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Myeloma,2018
10-14,0.7,1.6,28,Incidence,2587209,Hispanic of any race,1.1,Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2018
10-14,0.9,1.8,34,Incidence,2587209,Hispanic of any race,1.3,Female,Ovary,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Pancreas,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Stomach,2018
10-14,1.5,2.6,52,Incidence,2587209,Hispanic of any race,2.0,Female,Thyroid,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Female,Urinary Bladder,2018
15-19,20.0,23.7,530,Incidence,2433467,Hispanic of any race,21.8,Female,All Cancer Sites Combined,2018
15-19,0.9,1.9,33,Incidence,2433467,Hispanic of any race,1.4,Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Cervix,2018
15-19,0.8,1.7,28,Incidence,2433467,Hispanic of any race,1.2,Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Esophagus,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Female Breast,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
15-19,1.8,3.1,58,Incidence,2433467,Hispanic of any race,2.4,Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Larynx,2018
15-19,2.4,3.9,75,Incidence,2433467,Hispanic of any race,3.1,Female,Leukemias,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Mesothelioma,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Myeloma,2018
15-19,0.5,1.2,19,Incidence,2433467,Hispanic of any race,0.8,Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2018
15-19,0.9,1.9,32,Incidence,2433467,Hispanic of any race,1.3,Female,Ovary,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Pancreas,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Stomach,2018
15-19,5.0,7.0,144,Incidence,2433467,Hispanic of any race,5.9,Female,Thyroid,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Female,Urinary Bladder,2018
20-24,29.2,33.8,737,Incidence,2342184,Hispanic of any race,31.5,Female,All Cancer Sites Combined,2018
20-24,0.7,1.6,25,Incidence,2342184,Hispanic of any race,1.1,Female,Brain and Other Nervous System,2018
20-24,0.6,1.4,21,Incidence,2342184,Hispanic of any race,0.9,Female,Cervix,2018
20-24,1.3,2.5,43,Incidence,2342184,Hispanic of any race,1.8,Female,Colon and Rectum,2018
20-24,0.4,1.1,16,Incidence,2342184,Hispanic of any race,0.7,Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Esophagus,2018
20-24,1.1,2.2,38,Incidence,2342184,Hispanic of any race,1.6,Female,Female Breast,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
20-24,1.7,3.0,53,Incidence,2342184,Hispanic of any race,2.3,Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Larynx,2018
20-24,1.7,3.0,53,Incidence,2342184,Hispanic of any race,2.3,Female,Leukemias,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Lung and Bronchus,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Mesothelioma,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Myeloma,2018
20-24,1.4,2.5,44,Incidence,2342184,Hispanic of any race,1.9,Female,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2018
20-24,1.3,2.5,43,Incidence,2342184,Hispanic of any race,1.8,Female,Ovary,2018
20-24,0.5,1.3,20,Incidence,2342184,Hispanic of any race,0.9,Female,Pancreas,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Stomach,2018
20-24,8.4,10.9,225,Incidence,2342184,Hispanic of any race,9.6,Female,Thyroid,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Female,Urinary Bladder,2018
25-29,58.5,64.9,1436,Incidence,2330911,Hispanic of any race,61.6,Female,All Cancer Sites Combined,2018
25-29,1.4,2.6,46,Incidence,2330911,Hispanic of any race,2.0,Female,Brain and Other Nervous System,2018
25-29,3.8,5.6,109,Incidence,2330911,Hispanic of any race,4.7,Female,Cervix,2018
25-29,2.4,3.8,71,Incidence,2330911,Hispanic of any race,3.0,Female,Colon and Rectum,2018
25-29,2.6,4.1,77,Incidence,2330911,Hispanic of any race,3.3,Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Esophagus,2018
25-29,7.0,9.4,190,Incidence,2330911,Hispanic of any race,8.2,Female,Female Breast,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
25-29,2.0,3.4,61,Incidence,2330911,Hispanic of any race,2.6,Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
25-29,0.8,1.8,29,Incidence,2330911,Hispanic of any race,1.2,Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Larynx,2018
25-29,2.5,3.9,73,Incidence,2330911,Hispanic of any race,3.1,Female,Leukemias,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Lung and Bronchus,2018
25-29,1.0,2.0,33,Incidence,2330911,Hispanic of any race,1.4,Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Mesothelioma,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Myeloma,2018
25-29,2.3,3.8,70,Incidence,2330911,Hispanic of any race,3.0,Female,Non-Hodgkin Lymphoma,2018
25-29,0.6,1.4,22,Incidence,2330911,Hispanic of any race,0.9,Female,Oral Cavity and Pharynx,2018
25-29,1.5,2.7,48,Incidence,2330911,Hispanic of any race,2.1,Female,Ovary,2018
25-29,0.5,1.3,19,Incidence,2330911,Hispanic of any race,0.8,Female,Pancreas,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Stomach,2018
25-29,16.4,19.9,421,Incidence,2330911,Hispanic of any race,18.1,Female,Thyroid,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Female,Urinary Bladder,2018
30-34,105.9,114.8,2372,Incidence,2150706,Hispanic of any race,110.3,Female,All Cancer Sites Combined,2018
30-34,1.7,3.0,49,Incidence,2150706,Hispanic of any race,2.3,Female,Brain and Other Nervous System,2018
30-34,11.2,14.2,272,Incidence,2150706,Hispanic of any race,12.6,Female,Cervix,2018
30-34,5.3,7.5,136,Incidence,2150706,Hispanic of any race,6.3,Female,Colon and Rectum,2018
30-34,7.8,10.4,194,Incidence,2150706,Hispanic of any race,9.0,Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Esophagus,2018
30-34,21.7,25.9,511,Incidence,2150706,Hispanic of any race,23.8,Female,Female Breast,2018
30-34,1.8,3.2,52,Incidence,2150706,Hispanic of any race,2.4,Female,"Female Breast, <i>in situ</i>",2018
30-34,1.7,3.1,50,Incidence,2150706,Hispanic of any race,2.3,Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
30-34,2.3,3.9,65,Incidence,2150706,Hispanic of any race,3.0,Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Larynx,2018
30-34,3.4,5.2,92,Incidence,2150706,Hispanic of any race,4.3,Female,Leukemias,2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.7,1.7,24,Incidence,2150706,Hispanic of any race,1.1,Female,Lung and Bronchus,2018
30-34,1.6,2.9,46,Incidence,2150706,Hispanic of any race,2.1,Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Mesothelioma,2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Myeloma,2018
30-34,3.4,5.1,90,Incidence,2150706,Hispanic of any race,4.2,Female,Non-Hodgkin Lymphoma,2018
30-34,0.8,1.8,27,Incidence,2150706,Hispanic of any race,1.3,Female,Oral Cavity and Pharynx,2018
30-34,2.4,4.0,67,Incidence,2150706,Hispanic of any race,3.1,Female,Ovary,2018
30-34,~,~,~,Incidence,2150706,Hispanic of any race,~,Female,Pancreas,2018
30-34,1.3,2.4,38,Incidence,2150706,Hispanic of any race,1.8,Female,Stomach,2018
30-34,22.7,27.0,533,Incidence,2150706,Hispanic of any race,24.8,Female,Thyroid,2018
30-34,0.4,1.2,16,Incidence,2150706,Hispanic of any race,0.7,Female,Urinary Bladder,2018
35-39,167.6,178.8,3716,Incidence,2146773,Hispanic of any race,173.1,Female,All Cancer Sites Combined,2018
35-39,1.5,2.8,45,Incidence,2146773,Hispanic of any race,2.1,Female,Brain and Other Nervous System,2018
35-39,15.2,18.7,363,Incidence,2146773,Hispanic of any race,16.9,Female,Cervix,2018
35-39,9.2,11.9,225,Incidence,2146773,Hispanic of any race,10.5,Female,Colon and Rectum,2018
35-39,12.3,15.5,297,Incidence,2146773,Hispanic of any race,13.8,Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,2146773,Hispanic of any race,~,Female,Esophagus,2018
35-39,47.4,53.4,1081,Incidence,2146773,Hispanic of any race,50.4,Female,Female Breast,2018
35-39,4.9,7.0,127,Incidence,2146773,Hispanic of any race,5.9,Female,"Female Breast, <i>in situ</i>",2018
35-39,1.2,2.4,37,Incidence,2146773,Hispanic of any race,1.7,Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,2146773,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
35-39,5.7,7.9,144,Incidence,2146773,Hispanic of any race,6.7,Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,2146773,Hispanic of any race,~,Female,Larynx,2018
35-39,3.5,5.3,92,Incidence,2146773,Hispanic of any race,4.3,Female,Leukemias,2018
35-39,~,~,~,Incidence,2146773,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
35-39,1.6,3.0,48,Incidence,2146773,Hispanic of any race,2.2,Female,Lung and Bronchus,2018
35-39,3.3,5.1,88,Incidence,2146773,Hispanic of any race,4.1,Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,2146773,Hispanic of any race,~,Female,Mesothelioma,2018
35-39,0.6,1.4,20,Incidence,2146773,Hispanic of any race,0.9,Female,Myeloma,2018
35-39,4.7,6.7,121,Incidence,2146773,Hispanic of any race,5.6,Female,Non-Hodgkin Lymphoma,2018
35-39,1.3,2.5,40,Incidence,2146773,Hispanic of any race,1.9,Female,Oral Cavity and Pharynx,2018
35-39,3.9,5.8,103,Incidence,2146773,Hispanic of any race,4.8,Female,Ovary,2018
35-39,1.1,2.3,35,Incidence,2146773,Hispanic of any race,1.6,Female,Pancreas,2018
35-39,3.2,4.9,86,Incidence,2146773,Hispanic of any race,4.0,Female,Stomach,2018
35-39,27.5,32.2,639,Incidence,2146773,Hispanic of any race,29.8,Female,Thyroid,2018
35-39,~,~,~,Incidence,2146773,Hispanic of any race,~,Female,Urinary Bladder,2018
40-44,257.0,271.3,5282,Incidence,2000187,Hispanic of any race,264.1,Female,All Cancer Sites Combined,2018
40-44,1.7,3.1,47,Incidence,2000187,Hispanic of any race,2.3,Female,Brain and Other Nervous System,2018
40-44,16.3,20.1,363,Incidence,2000187,Hispanic of any race,18.1,Female,Cervix,2018
40-44,14.2,17.7,317,Incidence,2000187,Hispanic of any race,15.8,Female,Colon and Rectum,2018
40-44,18.3,22.3,404,Incidence,2000187,Hispanic of any race,20.2,Female,"Corpus and Uterus, NOS",2018
40-44,~,~,~,Incidence,2000187,Hispanic of any race,~,Female,Esophagus,2018
40-44,97.9,106.8,2045,Incidence,2000187,Hispanic of any race,102.2,Female,Female Breast,2018
40-44,24.3,28.9,530,Incidence,2000187,Hispanic of any race,26.5,Female,"Female Breast, <i>in situ</i>",2018
40-44,1.3,2.5,36,Incidence,2000187,Hispanic of any race,1.8,Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,2000187,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
40-44,8.8,11.7,204,Incidence,2000187,Hispanic of any race,10.2,Female,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,2000187,Hispanic of any race,~,Female,Larynx,2018
40-44,4.2,6.3,104,Incidence,2000187,Hispanic of any race,5.2,Female,Leukemias,2018
40-44,0.5,1.4,17,Incidence,2000187,Hispanic of any race,0.8,Female,Liver and Intrahepatic Bile Duct,2018
40-44,3.2,5.0,80,Incidence,2000187,Hispanic of any race,4.0,Female,Lung and Bronchus,2018
40-44,3.4,5.3,86,Incidence,2000187,Hispanic of any race,4.3,Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,2000187,Hispanic of any race,~,Female,Mesothelioma,2018
40-44,2.2,3.7,57,Incidence,2000187,Hispanic of any race,2.8,Female,Myeloma,2018
40-44,5.9,8.3,141,Incidence,2000187,Hispanic of any race,7.0,Female,Non-Hodgkin Lymphoma,2018
40-44,1.6,3.0,44,Incidence,2000187,Hispanic of any race,2.2,Female,Oral Cavity and Pharynx,2018
40-44,6.9,9.4,161,Incidence,2000187,Hispanic of any race,8.0,Female,Ovary,2018
40-44,1.9,3.4,51,Incidence,2000187,Hispanic of any race,2.5,Female,Pancreas,2018
40-44,5.3,7.6,128,Incidence,2000187,Hispanic of any race,6.4,Female,Stomach,2018
40-44,29.7,34.7,642,Incidence,2000187,Hispanic of any race,32.1,Female,Thyroid,2018
40-44,0.6,1.5,20,Incidence,2000187,Hispanic of any race,1.0,Female,Urinary Bladder,2018
45-49,347.9,365.2,6590,Incidence,1848577,Hispanic of any race,356.5,Female,All Cancer Sites Combined,2018
45-49,3.2,5.1,76,Incidence,1848577,Hispanic of any race,4.1,Female,Brain and Other Nervous System,2018
45-49,14.4,18.1,299,Incidence,1848577,Hispanic of any race,16.2,Female,Cervix,2018
45-49,23.5,28.2,477,Incidence,1848577,Hispanic of any race,25.8,Female,Colon and Rectum,2018
45-49,23.4,28.1,475,Incidence,1848577,Hispanic of any race,25.7,Female,"Corpus and Uterus, NOS",2018
45-49,~,~,~,Incidence,1848577,Hispanic of any race,~,Female,Esophagus,2018
45-49,141.1,152.2,2709,Incidence,1848577,Hispanic of any race,146.5,Female,Female Breast,2018
45-49,40.5,46.6,804,Incidence,1848577,Hispanic of any race,43.5,Female,"Female Breast, <i>in situ</i>",2018
45-49,0.7,1.7,21,Incidence,1848577,Hispanic of any race,1.1,Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,1848577,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
45-49,11.2,14.6,237,Incidence,1848577,Hispanic of any race,12.8,Female,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,1848577,Hispanic of any race,~,Female,Larynx,2018
45-49,5.1,7.5,115,Incidence,1848577,Hispanic of any race,6.2,Female,Leukemias,2018
45-49,1.3,2.6,35,Incidence,1848577,Hispanic of any race,1.9,Female,Liver and Intrahepatic Bile Duct,2018
45-49,6.6,9.2,144,Incidence,1848577,Hispanic of any race,7.8,Female,Lung and Bronchus,2018
45-49,3.4,5.4,80,Incidence,1848577,Hispanic of any race,4.3,Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,1848577,Hispanic of any race,~,Female,Mesothelioma,2018
45-49,3.0,4.8,71,Incidence,1848577,Hispanic of any race,3.8,Female,Myeloma,2018
45-49,9.9,13.0,210,Incidence,1848577,Hispanic of any race,11.4,Female,Non-Hodgkin Lymphoma,2018
45-49,3.0,4.9,72,Incidence,1848577,Hispanic of any race,3.9,Female,Oral Cavity and Pharynx,2018
45-49,11.4,14.7,240,Incidence,1848577,Hispanic of any race,13.0,Female,Ovary,2018
45-49,3.1,5.0,74,Incidence,1848577,Hispanic of any race,4.0,Female,Pancreas,2018
45-49,7.1,9.8,155,Incidence,1848577,Hispanic of any race,8.4,Female,Stomach,2018
45-49,31.0,36.3,620,Incidence,1848577,Hispanic of any race,33.5,Female,Thyroid,2018
45-49,1.5,2.9,40,Incidence,1848577,Hispanic of any race,2.2,Female,Urinary Bladder,2018
5-9,11.7,14.5,332,Incidence,2546057,Hispanic of any race,13.0,Female,All Cancer Sites Combined,2018
5-9,2.2,3.6,72,Incidence,2546057,Hispanic of any race,2.8,Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Cervix,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Esophagus,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Female Breast,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
5-9,0.6,1.4,23,Incidence,2546057,Hispanic of any race,0.9,Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Larynx,2018
5-9,4.3,6.1,132,Incidence,2546057,Hispanic of any race,5.2,Female,Leukemias,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Mesothelioma,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Myeloma,2018
5-9,0.6,1.4,25,Incidence,2546057,Hispanic of any race,1.0,Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Ovary,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Pancreas,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Stomach,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Thyroid,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Female,Urinary Bladder,2018
50-54,482.2,504.0,7926,Incidence,1607616,Hispanic of any race,493.0,Female,All Cancer Sites Combined,2018
50-54,4.7,7.2,94,Incidence,1607616,Hispanic of any race,5.8,Female,Brain and Other Nervous System,2018
50-54,14.2,18.2,259,Incidence,1607616,Hispanic of any race,16.1,Female,Cervix,2018
50-54,43.7,50.5,756,Incidence,1607616,Hispanic of any race,47.0,Female,Colon and Rectum,2018
50-54,41.9,48.6,726,Incidence,1607616,Hispanic of any race,45.2,Female,"Corpus and Uterus, NOS",2018
50-54,~,~,~,Incidence,1607616,Hispanic of any race,~,Female,Esophagus,2018
50-54,166.9,179.9,2786,Incidence,1607616,Hispanic of any race,173.3,Female,Female Breast,2018
50-54,46.4,53.4,801,Incidence,1607616,Hispanic of any race,49.8,Female,"Female Breast, <i>in situ</i>",2018
50-54,0.8,1.9,20,Incidence,1607616,Hispanic of any race,1.2,Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,1607616,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
50-54,18.9,23.5,339,Incidence,1607616,Hispanic of any race,21.1,Female,Kidney and Renal Pelvis,2018
50-54,0.6,1.6,16,Incidence,1607616,Hispanic of any race,1.0,Female,Larynx,2018
50-54,7.0,9.9,134,Incidence,1607616,Hispanic of any race,8.3,Female,Leukemias,2018
50-54,5.1,7.6,101,Incidence,1607616,Hispanic of any race,6.3,Female,Liver and Intrahepatic Bile Duct,2018
50-54,13.8,17.7,252,Incidence,1607616,Hispanic of any race,15.7,Female,Lung and Bronchus,2018
50-54,4.9,7.4,98,Incidence,1607616,Hispanic of any race,6.1,Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,1607616,Hispanic of any race,~,Female,Mesothelioma,2018
50-54,6.1,8.8,118,Incidence,1607616,Hispanic of any race,7.3,Female,Myeloma,2018
50-54,18.1,22.5,325,Incidence,1607616,Hispanic of any race,20.2,Female,Non-Hodgkin Lymphoma,2018
50-54,5.1,7.6,100,Incidence,1607616,Hispanic of any race,6.2,Female,Oral Cavity and Pharynx,2018
50-54,15.5,19.6,281,Incidence,1607616,Hispanic of any race,17.5,Female,Ovary,2018
50-54,8.4,11.6,159,Incidence,1607616,Hispanic of any race,9.9,Female,Pancreas,2018
50-54,8.0,11.0,151,Incidence,1607616,Hispanic of any race,9.4,Female,Stomach,2018
50-54,36.2,42.4,630,Incidence,1607616,Hispanic of any race,39.2,Female,Thyroid,2018
50-54,2.3,4.1,50,Incidence,1607616,Hispanic of any race,3.1,Female,Urinary Bladder,2018
55-59,629.0,655.8,8879,Incidence,1382392,Hispanic of any race,642.3,Female,All Cancer Sites Combined,2018
55-59,6.6,9.7,111,Incidence,1382392,Hispanic of any race,8.0,Female,Brain and Other Nervous System,2018
55-59,14.7,19.1,232,Incidence,1382392,Hispanic of any race,16.8,Female,Cervix,2018
55-59,48.1,55.7,716,Incidence,1382392,Hispanic of any race,51.8,Female,Colon and Rectum,2018
55-59,65.5,74.4,965,Incidence,1382392,Hispanic of any race,69.8,Female,"Corpus and Uterus, NOS",2018
55-59,1.2,2.8,26,Incidence,1382392,Hispanic of any race,1.9,Female,Esophagus,2018
55-59,201.2,216.5,2886,Incidence,1382392,Hispanic of any race,208.8,Female,Female Breast,2018
55-59,46.5,54.0,693,Incidence,1382392,Hispanic of any race,50.1,Female,"Female Breast, <i>in situ</i>",2018
55-59,1.7,3.4,34,Incidence,1382392,Hispanic of any race,2.5,Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,1382392,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
55-59,25.8,31.5,395,Incidence,1382392,Hispanic of any race,28.6,Female,Kidney and Renal Pelvis,2018
55-59,0.9,2.3,21,Incidence,1382392,Hispanic of any race,1.5,Female,Larynx,2018
55-59,10.2,13.9,165,Incidence,1382392,Hispanic of any race,11.9,Female,Leukemias,2018
55-59,11.5,15.5,185,Incidence,1382392,Hispanic of any race,13.4,Female,Liver and Intrahepatic Bile Duct,2018
55-59,29.7,35.8,451,Incidence,1382392,Hispanic of any race,32.6,Female,Lung and Bronchus,2018
55-59,6.7,9.7,112,Incidence,1382392,Hispanic of any race,8.1,Female,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,1382392,Hispanic of any race,~,Female,Mesothelioma,2018
55-59,8.2,11.6,135,Incidence,1382392,Hispanic of any race,9.8,Female,Myeloma,2018
55-59,22.9,28.3,353,Incidence,1382392,Hispanic of any race,25.5,Female,Non-Hodgkin Lymphoma,2018
55-59,8.4,11.8,138,Incidence,1382392,Hispanic of any race,10.0,Female,Oral Cavity and Pharynx,2018
55-59,18.4,23.2,286,Incidence,1382392,Hispanic of any race,20.7,Female,Ovary,2018
55-59,14.8,19.2,233,Incidence,1382392,Hispanic of any race,16.9,Female,Pancreas,2018
55-59,11.5,15.5,185,Incidence,1382392,Hispanic of any race,13.4,Female,Stomach,2018
55-59,34.5,41.0,520,Incidence,1382392,Hispanic of any race,37.6,Female,Thyroid,2018
55-59,3.8,6.2,68,Incidence,1382392,Hispanic of any race,4.9,Female,Urinary Bladder,2018
60-64,828.4,862.7,9355,Incidence,1106540,Hispanic of any race,845.4,Female,All Cancer Sites Combined,2018
60-64,6.4,9.8,88,Incidence,1106540,Hispanic of any race,8.0,Female,Brain and Other Nervous System,2018
60-64,11.6,16.0,151,Incidence,1106540,Hispanic of any race,13.6,Female,Cervix,2018
60-64,62.6,72.3,745,Incidence,1106540,Hispanic of any race,67.3,Female,Colon and Rectum,2018
60-64,80.9,92.0,955,Incidence,1106540,Hispanic of any race,86.3,Female,"Corpus and Uterus, NOS",2018
60-64,2.4,4.6,37,Incidence,1106540,Hispanic of any race,3.3,Female,Esophagus,2018
60-64,254.7,273.9,2923,Incidence,1106540,Hispanic of any race,264.2,Female,Female Breast,2018
60-64,60.1,69.6,716,Incidence,1106540,Hispanic of any race,64.7,Female,"Female Breast, <i>in situ</i>",2018
60-64,2.0,4.1,32,Incidence,1106540,Hispanic of any race,2.9,Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,1106540,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
60-64,33.2,40.4,406,Incidence,1106540,Hispanic of any race,36.7,Female,Kidney and Renal Pelvis,2018
60-64,1.5,3.3,25,Incidence,1106540,Hispanic of any race,2.3,Female,Larynx,2018
60-64,14.1,19.0,182,Incidence,1106540,Hispanic of any race,16.4,Female,Leukemias,2018
60-64,23.3,29.4,290,Incidence,1106540,Hispanic of any race,26.2,Female,Liver and Intrahepatic Bile Duct,2018
60-64,55.6,64.8,665,Incidence,1106540,Hispanic of any race,60.1,Female,Lung and Bronchus,2018
60-64,9.2,13.2,122,Incidence,1106540,Hispanic of any race,11.0,Female,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,1106540,Hispanic of any race,~,Female,Mesothelioma,2018
60-64,15.8,21.0,202,Incidence,1106540,Hispanic of any race,18.3,Female,Myeloma,2018
60-64,33.0,40.2,403,Incidence,1106540,Hispanic of any race,36.4,Female,Non-Hodgkin Lymphoma,2018
60-64,9.7,13.9,129,Incidence,1106540,Hispanic of any race,11.7,Female,Oral Cavity and Pharynx,2018
60-64,19.5,25.1,245,Incidence,1106540,Hispanic of any race,22.1,Female,Ovary,2018
60-64,21.6,27.5,270,Incidence,1106540,Hispanic of any race,24.4,Female,Pancreas,2018
60-64,14.7,19.7,189,Incidence,1106540,Hispanic of any race,17.1,Female,Stomach,2018
60-64,31.1,38.1,381,Incidence,1106540,Hispanic of any race,34.4,Female,Thyroid,2018
60-64,10.0,14.1,132,Incidence,1106540,Hispanic of any race,11.9,Female,Urinary Bladder,2018
65-69,1078.6,1123.9,9162,Incidence,832099,Hispanic of any race,1101.1,Female,All Cancer Sites Combined,2018
65-69,9.5,14.2,97,Incidence,832099,Hispanic of any race,11.7,Female,Brain and Other Nervous System,2018
65-69,12.6,18.0,126,Incidence,832099,Hispanic of any race,15.1,Female,Cervix,2018
65-69,82.1,95.0,735,Incidence,832099,Hispanic of any race,88.3,Female,Colon and Rectum,2018
65-69,92.7,106.4,827,Incidence,832099,Hispanic of any race,99.4,Female,"Corpus and Uterus, NOS",2018
65-69,3.6,6.8,42,Incidence,832099,Hispanic of any race,5.0,Female,Esophagus,2018
65-69,321.2,346.1,2775,Incidence,832099,Hispanic of any race,333.5,Female,Female Breast,2018
65-69,75.3,87.7,677,Incidence,832099,Hispanic of any race,81.4,Female,"Female Breast, <i>in situ</i>",2018
65-69,1.8,4.1,23,Incidence,832099,Hispanic of any race,2.8,Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,832099,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
65-69,37.7,46.6,349,Incidence,832099,Hispanic of any race,41.9,Female,Kidney and Renal Pelvis,2018
65-69,1.9,4.4,25,Incidence,832099,Hispanic of any race,3.0,Female,Larynx,2018
65-69,21.7,28.6,208,Incidence,832099,Hispanic of any race,25.0,Female,Leukemias,2018
65-69,31.7,40.0,297,Incidence,832099,Hispanic of any race,35.7,Female,Liver and Intrahepatic Bile Duct,2018
65-69,86.5,99.7,773,Incidence,832099,Hispanic of any race,92.9,Female,Lung and Bronchus,2018
65-69,11.4,16.6,115,Incidence,832099,Hispanic of any race,13.8,Female,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,832099,Hispanic of any race,~,Female,Mesothelioma,2018
65-69,18.9,25.4,183,Incidence,832099,Hispanic of any race,22.0,Female,Myeloma,2018
65-69,48.2,58.2,441,Incidence,832099,Hispanic of any race,53.0,Female,Non-Hodgkin Lymphoma,2018
65-69,10.1,15.0,103,Incidence,832099,Hispanic of any race,12.4,Female,Oral Cavity and Pharynx,2018
65-69,24.9,32.2,236,Incidence,832099,Hispanic of any race,28.4,Female,Ovary,2018
65-69,33.3,41.8,311,Incidence,832099,Hispanic of any race,37.4,Female,Pancreas,2018
65-69,18.5,24.9,179,Incidence,832099,Hispanic of any race,21.5,Female,Stomach,2018
65-69,37.2,46.1,345,Incidence,832099,Hispanic of any race,41.5,Female,Thyroid,2018
65-69,14.2,19.9,140,Incidence,832099,Hispanic of any race,16.8,Female,Urinary Bladder,2018
70-74,1254.9,1311.9,7844,Incidence,611300,Hispanic of any race,1283.2,Female,All Cancer Sites Combined,2018
70-74,12.0,18.3,91,Incidence,611300,Hispanic of any race,14.9,Female,Brain and Other Nervous System,2018
70-74,11.8,18.1,90,Incidence,611300,Hispanic of any race,14.7,Female,Cervix,2018
70-74,97.2,113.6,643,Incidence,611300,Hispanic of any race,105.2,Female,Colon and Rectum,2018
70-74,84.2,99.5,560,Incidence,611300,Hispanic of any race,91.6,Female,"Corpus and Uterus, NOS",2018
70-74,2.9,6.4,27,Incidence,611300,Hispanic of any race,4.4,Female,Esophagus,2018
70-74,345.2,375.4,2201,Incidence,611300,Hispanic of any race,360.1,Female,Female Breast,2018
70-74,73.8,88.3,494,Incidence,611300,Hispanic of any race,80.8,Female,"Female Breast, <i>in situ</i>",2018
70-74,2.4,5.6,23,Incidence,611300,Hispanic of any race,3.8,Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,611300,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
70-74,43.7,55.0,300,Incidence,611300,Hispanic of any race,49.1,Female,Kidney and Renal Pelvis,2018
70-74,1.9,4.9,19,Incidence,611300,Hispanic of any race,3.1,Female,Larynx,2018
70-74,26.2,35.1,186,Incidence,611300,Hispanic of any race,30.4,Female,Leukemias,2018
70-74,38.7,49.4,268,Incidence,611300,Hispanic of any race,43.8,Female,Liver and Intrahepatic Bile Duct,2018
70-74,121.8,140.1,799,Incidence,611300,Hispanic of any race,130.7,Female,Lung and Bronchus,2018
70-74,11.1,17.2,85,Incidence,611300,Hispanic of any race,13.9,Female,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,611300,Hispanic of any race,~,Female,Mesothelioma,2018
70-74,22.7,31.1,163,Incidence,611300,Hispanic of any race,26.7,Female,Myeloma,2018
70-74,53.6,66.0,364,Incidence,611300,Hispanic of any race,59.5,Female,Non-Hodgkin Lymphoma,2018
70-74,13.0,19.5,98,Incidence,611300,Hispanic of any race,16.0,Female,Oral Cavity and Pharynx,2018
70-74,26.8,35.8,190,Incidence,611300,Hispanic of any race,31.1,Female,Ovary,2018
70-74,50.2,62.2,342,Incidence,611300,Hispanic of any race,55.9,Female,Pancreas,2018
70-74,25.0,33.7,178,Incidence,611300,Hispanic of any race,29.1,Female,Stomach,2018
70-74,30.0,39.5,211,Incidence,611300,Hispanic of any race,34.5,Female,Thyroid,2018
70-74,22.6,30.9,162,Incidence,611300,Hispanic of any race,26.5,Female,Urinary Bladder,2018
75-79,1397.5,1469.7,6095,Incidence,425242,Hispanic of any race,1433.3,Female,All Cancer Sites Combined,2018
75-79,11.4,19.0,63,Incidence,425242,Hispanic of any race,14.8,Female,Brain and Other Nervous System,2018
75-79,11.6,19.2,64,Incidence,425242,Hispanic of any race,15.1,Female,Cervix,2018
75-79,119.9,141.8,555,Incidence,425242,Hispanic of any race,130.5,Female,Colon and Rectum,2018
75-79,64.8,81.2,309,Incidence,425242,Hispanic of any race,72.7,Female,"Corpus and Uterus, NOS",2018
75-79,5.0,10.3,31,Incidence,425242,Hispanic of any race,7.3,Female,Esophagus,2018
75-79,298.2,332.2,1339,Incidence,425242,Hispanic of any race,314.9,Female,Female Breast,2018
75-79,50.4,65.0,244,Incidence,425242,Hispanic of any race,57.4,Female,"Female Breast, <i>in situ</i>",2018
75-79,2.9,7.3,20,Incidence,425242,Hispanic of any race,4.7,Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,425242,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
75-79,46.7,60.8,227,Incidence,425242,Hispanic of any race,53.4,Female,Kidney and Renal Pelvis,2018
75-79,~,~,~,Incidence,425242,Hispanic of any race,~,Female,Larynx,2018
75-79,34.6,47.0,172,Incidence,425242,Hispanic of any race,40.4,Female,Leukemias,2018
75-79,51.7,66.5,250,Incidence,425242,Hispanic of any race,58.8,Female,Liver and Intrahepatic Bile Duct,2018
75-79,164.7,190.2,753,Incidence,425242,Hispanic of any race,177.1,Female,Lung and Bronchus,2018
75-79,11.6,19.2,64,Incidence,425242,Hispanic of any race,15.1,Female,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,425242,Hispanic of any race,~,Female,Mesothelioma,2018
75-79,32.9,44.9,164,Incidence,425242,Hispanic of any race,38.6,Female,Myeloma,2018
75-79,76.8,94.6,363,Incidence,425242,Hispanic of any race,85.4,Female,Non-Hodgkin Lymphoma,2018
75-79,15.5,24.2,83,Incidence,425242,Hispanic of any race,19.5,Female,Oral Cavity and Pharynx,2018
75-79,30.5,42.2,153,Incidence,425242,Hispanic of any race,36.0,Female,Ovary,2018
75-79,69.9,86.9,332,Incidence,425242,Hispanic of any race,78.1,Female,Pancreas,2018
75-79,29.4,40.9,148,Incidence,425242,Hispanic of any race,34.8,Female,Stomach,2018
75-79,24.9,35.5,127,Incidence,425242,Hispanic of any race,29.9,Female,Thyroid,2018
75-79,25.5,36.3,130,Incidence,425242,Hispanic of any race,30.6,Female,Urinary Bladder,2018
80-84,1423.0,1510.2,4370,Incidence,298067,Hispanic of any race,1466.1,Female,All Cancer Sites Combined,2018
80-84,11.9,21.4,48,Incidence,298067,Hispanic of any race,16.1,Female,Brain and Other Nervous System,2018
80-84,10.7,19.8,44,Incidence,298067,Hispanic of any race,14.8,Female,Cervix,2018
80-84,129.7,157.2,426,Incidence,298067,Hispanic of any race,142.9,Female,Colon and Rectum,2018
80-84,59.1,78.1,203,Incidence,298067,Hispanic of any race,68.1,Female,"Corpus and Uterus, NOS",2018
80-84,4.1,10.4,20,Incidence,298067,Hispanic of any race,6.7,Female,Esophagus,2018
80-84,274.4,313.7,875,Incidence,298067,Hispanic of any race,293.6,Female,Female Breast,2018
80-84,34.0,48.9,122,Incidence,298067,Hispanic of any race,40.9,Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,298067,Hispanic of any race,~,Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,298067,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
80-84,41.4,57.6,146,Incidence,298067,Hispanic of any race,49.0,Female,Kidney and Renal Pelvis,2018
80-84,~,~,~,Incidence,298067,Hispanic of any race,~,Female,Larynx,2018
80-84,36.7,52.2,131,Incidence,298067,Hispanic of any race,43.9,Female,Leukemias,2018
80-84,50.0,67.7,174,Incidence,298067,Hispanic of any race,58.4,Female,Liver and Intrahepatic Bile Duct,2018
80-84,170.1,201.3,552,Incidence,298067,Hispanic of any race,185.2,Female,Lung and Bronchus,2018
80-84,12.2,21.7,49,Incidence,298067,Hispanic of any race,16.4,Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,298067,Hispanic of any race,~,Female,Mesothelioma,2018
80-84,34.9,50.0,125,Incidence,298067,Hispanic of any race,41.9,Female,Myeloma,2018
80-84,73.8,94.9,250,Incidence,298067,Hispanic of any race,83.9,Female,Non-Hodgkin Lymphoma,2018
80-84,20.7,32.7,78,Incidence,298067,Hispanic of any race,26.2,Female,Oral Cavity and Pharynx,2018
80-84,26.1,39.3,96,Incidence,298067,Hispanic of any race,32.2,Female,Ovary,2018
80-84,70.3,91.0,239,Incidence,298067,Hispanic of any race,80.2,Female,Pancreas,2018
80-84,31.5,45.9,114,Incidence,298067,Hispanic of any race,38.2,Female,Stomach,2018
80-84,13.9,24.0,55,Incidence,298067,Hispanic of any race,18.5,Female,Thyroid,2018
80-84,32.8,47.4,118,Incidence,298067,Hispanic of any race,39.6,Female,Urinary Bladder,2018
85+,1355.4,1439.4,4285,Incidence,306741,Hispanic of any race,1396.9,Female,All Cancer Sites Combined,2018
85+,12.4,21.9,51,Incidence,306741,Hispanic of any race,16.6,Female,Brain and Other Nervous System,2018
85+,5.0,11.6,24,Incidence,306741,Hispanic of any race,7.8,Female,Cervix,2018
85+,166.2,196.6,555,Incidence,306741,Hispanic of any race,180.9,Female,Colon and Rectum,2018
85+,30.1,43.9,112,Incidence,306741,Hispanic of any race,36.5,Female,"Corpus and Uterus, NOS",2018
85+,4.2,10.5,21,Incidence,306741,Hispanic of any race,6.8,Female,Esophagus,2018
85+,207.8,241.7,688,Incidence,306741,Hispanic of any race,224.3,Female,Female Breast,2018
85+,15.2,25.5,61,Incidence,306741,Hispanic of any race,19.9,Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,306741,Hispanic of any race,~,Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,306741,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
85+,33.9,48.6,125,Incidence,306741,Hispanic of any race,40.8,Female,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,306741,Hispanic of any race,~,Female,Larynx,2018
85+,37.5,52.8,137,Incidence,306741,Hispanic of any race,44.7,Female,Leukemias,2018
85+,39.9,55.6,145,Incidence,306741,Hispanic of any race,47.3,Female,Liver and Intrahepatic Bile Duct,2018
85+,148.7,177.6,499,Incidence,306741,Hispanic of any race,162.7,Female,Lung and Bronchus,2018
85+,15.2,25.5,61,Incidence,306741,Hispanic of any race,19.9,Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,306741,Hispanic of any race,~,Female,Mesothelioma,2018
85+,28.3,41.8,106,Incidence,306741,Hispanic of any race,34.6,Female,Myeloma,2018
85+,54.1,72.1,192,Incidence,306741,Hispanic of any race,62.6,Female,Non-Hodgkin Lymphoma,2018
85+,17.8,28.8,70,Incidence,306741,Hispanic of any race,22.8,Female,Oral Cavity and Pharynx,2018
85+,20.4,32.1,79,Incidence,306741,Hispanic of any race,25.8,Female,Ovary,2018
85+,79.1,100.6,274,Incidence,306741,Hispanic of any race,89.3,Female,Pancreas,2018
85+,38.7,54.2,141,Incidence,306741,Hispanic of any race,46.0,Female,Stomach,2018
85+,9.3,17.8,40,Incidence,306741,Hispanic of any race,13.0,Female,Thyroid,2018
85+,45.0,61.6,162,Incidence,306741,Hispanic of any race,52.8,Female,Urinary Bladder,2018
<1,17.0,25.4,101,Incidence,483622,Hispanic of any race,20.9,Female,All Cancer Sites Combined,2018
<1,1.9,5.4,16,Incidence,483622,Hispanic of any race,3.3,Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Cervix,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Colon and Rectum,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Esophagus,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Female Breast,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Larynx,2018
<1,2.5,6.4,20,Incidence,483622,Hispanic of any race,4.1,Female,Leukemias,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Mesothelioma,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Myeloma,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Ovary,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Pancreas,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Stomach,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Thyroid,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Female,Urinary Bladder,2018
1-4,19.9,23.9,453,Incidence,2074462,Hispanic of any race,21.8,Male,All Cancer Sites Combined,2018
1-4,2.4,4.0,65,Incidence,2074462,Hispanic of any race,3.1,Male,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Colon and Rectum,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Esophagus,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
1-4,0.9,1.9,27,Incidence,2074462,Hispanic of any race,1.3,Male,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Larynx,2018
1-4,9.2,12.1,219,Incidence,2074462,Hispanic of any race,10.6,Male,Leukemias,2018
1-4,0.5,1.4,18,Incidence,2074462,Hispanic of any race,0.9,Male,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Lung and Bronchus,2018
1-4,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Mesothelioma,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Myeloma,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Pancreas,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Prostate,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Stomach,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Testis,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Thyroid,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male,Urinary Bladder,2018
10-14,14.7,17.8,436,Incidence,2691862,Hispanic of any race,16.2,Male,All Cancer Sites Combined,2018
10-14,1.5,2.6,54,Incidence,2691862,Hispanic of any race,2.0,Male,Brain and Other Nervous System,2018
10-14,0.3,1.0,16,Incidence,2691862,Hispanic of any race,0.6,Male,Colon and Rectum,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Esophagus,2018
10-14,0.9,1.8,34,Incidence,2691862,Hispanic of any race,1.3,Male,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Larynx,2018
10-14,4.1,5.8,131,Incidence,2691862,Hispanic of any race,4.9,Male,Leukemias,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Lung and Bronchus,2018
10-14,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Mesothelioma,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Myeloma,2018
10-14,1.3,2.4,48,Incidence,2691862,Hispanic of any race,1.8,Male,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Pancreas,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Prostate,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Stomach,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Testis,2018
10-14,0.4,1.1,19,Incidence,2691862,Hispanic of any race,0.7,Male,Thyroid,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male,Urinary Bladder,2018
15-19,23.3,27.2,638,Incidence,2531260,Hispanic of any race,25.2,Male,All Cancer Sites Combined,2018
15-19,1.2,2.2,41,Incidence,2531260,Hispanic of any race,1.6,Male,Brain and Other Nervous System,2018
15-19,0.6,1.4,23,Incidence,2531260,Hispanic of any race,0.9,Male,Colon and Rectum,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Esophagus,2018
15-19,1.7,3.0,58,Incidence,2531260,Hispanic of any race,2.3,Male,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Larynx,2018
15-19,5.1,7.0,152,Incidence,2531260,Hispanic of any race,6.0,Male,Leukemias,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Lung and Bronchus,2018
15-19,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Mesothelioma,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Myeloma,2018
15-19,1.6,2.8,54,Incidence,2531260,Hispanic of any race,2.1,Male,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Pancreas,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Prostate,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Stomach,2018
15-19,4.1,5.8,124,Incidence,2531260,Hispanic of any race,4.9,Male,Testis,2018
15-19,0.7,1.5,26,Incidence,2531260,Hispanic of any race,1.0,Male,Thyroid,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male,Urinary Bladder,2018
20-24,36.0,40.9,951,Incidence,2475300,Hispanic of any race,38.4,Male,All Cancer Sites Combined,2018
20-24,1.6,2.8,54,Incidence,2475300,Hispanic of any race,2.2,Male,Brain and Other Nervous System,2018
20-24,0.9,1.9,33,Incidence,2475300,Hispanic of any race,1.3,Male,Colon and Rectum,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Esophagus,2018
20-24,2.0,3.3,63,Incidence,2475300,Hispanic of any race,2.5,Male,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Larynx,2018
20-24,4.2,6.0,125,Incidence,2475300,Hispanic of any race,5.0,Male,Leukemias,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Lung and Bronchus,2018
20-24,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Mesothelioma,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Myeloma,2018
20-24,1.8,3.1,60,Incidence,2475300,Hispanic of any race,2.4,Male,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Pancreas,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Prostate,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Stomach,2018
20-24,14.2,17.4,390,Incidence,2475300,Hispanic of any race,15.8,Male,Testis,2018
20-24,1.7,3.0,57,Incidence,2475300,Hispanic of any race,2.3,Male,Thyroid,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male,Urinary Bladder,2018
25-29,44.6,50.0,1198,Incidence,2537549,Hispanic of any race,47.2,Male,All Cancer Sites Combined,2018
25-29,1.8,3.0,59,Incidence,2537549,Hispanic of any race,2.3,Male,Brain and Other Nervous System,2018
25-29,2.3,3.7,75,Incidence,2537549,Hispanic of any race,3.0,Male,Colon and Rectum,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Esophagus,2018
25-29,2.1,3.4,69,Incidence,2537549,Hispanic of any race,2.7,Male,Hodgkin Lymphoma,2018
25-29,0.9,1.8,33,Incidence,2537549,Hispanic of any race,1.3,Male,Kaposi Sarcoma,2018
25-29,0.8,1.7,30,Incidence,2537549,Hispanic of any race,1.2,Male,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Larynx,2018
25-29,3.3,5.0,104,Incidence,2537549,Hispanic of any race,4.1,Male,Leukemias,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Lung and Bronchus,2018
25-29,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Mesothelioma,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Myeloma,2018
25-29,3.2,4.8,101,Incidence,2537549,Hispanic of any race,4.0,Male,Non-Hodgkin Lymphoma,2018
25-29,0.5,1.3,22,Incidence,2537549,Hispanic of any race,0.9,Male,Oral Cavity and Pharynx,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Pancreas,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Prostate,2018
25-29,0.5,1.3,21,Incidence,2537549,Hispanic of any race,0.8,Male,Stomach,2018
25-29,15.1,18.3,423,Incidence,2537549,Hispanic of any race,16.7,Male,Testis,2018
25-29,2.3,3.6,73,Incidence,2537549,Hispanic of any race,2.9,Male,Thyroid,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male,Urinary Bladder,2018
30-34,52.5,58.5,1323,Incidence,2387145,Hispanic of any race,55.4,Male,All Cancer Sites Combined,2018
30-34,1.7,3.0,55,Incidence,2387145,Hispanic of any race,2.3,Male,Brain and Other Nervous System,2018
30-34,4.5,6.4,128,Incidence,2387145,Hispanic of any race,5.4,Male,Colon and Rectum,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Esophagus,2018
30-34,1.4,2.6,47,Incidence,2387145,Hispanic of any race,2.0,Male,Hodgkin Lymphoma,2018
30-34,1.0,2.0,34,Incidence,2387145,Hispanic of any race,1.4,Male,Kaposi Sarcoma,2018
30-34,2.4,3.9,74,Incidence,2387145,Hispanic of any race,3.1,Male,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Larynx,2018
30-34,3.7,5.4,107,Incidence,2387145,Hispanic of any race,4.5,Male,Leukemias,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
30-34,0.4,1.1,16,Incidence,2387145,Hispanic of any race,0.7,Male,Lung and Bronchus,2018
30-34,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
30-34,0.7,1.6,26,Incidence,2387145,Hispanic of any race,1.1,Male,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Mesothelioma,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Myeloma,2018
30-34,3.4,5.0,99,Incidence,2387145,Hispanic of any race,4.1,Male,Non-Hodgkin Lymphoma,2018
30-34,0.6,1.4,22,Incidence,2387145,Hispanic of any race,0.9,Male,Oral Cavity and Pharynx,2018
30-34,0.4,1.1,16,Incidence,2387145,Hispanic of any race,0.7,Male,Pancreas,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Prostate,2018
30-34,1.4,2.5,45,Incidence,2387145,Hispanic of any race,1.9,Male,Stomach,2018
30-34,12.8,15.9,341,Incidence,2387145,Hispanic of any race,14.3,Male,Testis,2018
30-34,3.0,4.5,88,Incidence,2387145,Hispanic of any race,3.7,Male,Thyroid,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male,Urinary Bladder,2018
35-39,68.3,75.3,1656,Incidence,2308982,Hispanic of any race,71.7,Male,All Cancer Sites Combined,2018
35-39,2.6,4.1,75,Incidence,2308982,Hispanic of any race,3.2,Male,Brain and Other Nervous System,2018
35-39,7.9,10.4,210,Incidence,2308982,Hispanic of any race,9.1,Male,Colon and Rectum,2018
35-39,~,~,~,Incidence,2308982,Hispanic of any race,~,Male,Esophagus,2018
35-39,1.6,2.9,50,Incidence,2308982,Hispanic of any race,2.2,Male,Hodgkin Lymphoma,2018
35-39,1.0,2.1,34,Incidence,2308982,Hispanic of any race,1.5,Male,Kaposi Sarcoma,2018
35-39,6.5,8.8,176,Incidence,2308982,Hispanic of any race,7.6,Male,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,2308982,Hispanic of any race,~,Male,Larynx,2018
35-39,4.4,6.3,122,Incidence,2308982,Hispanic of any race,5.3,Male,Leukemias,2018
35-39,~,~,~,Incidence,2308982,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
35-39,1.3,2.4,41,Incidence,2308982,Hispanic of any race,1.8,Male,Lung and Bronchus,2018
35-39,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
35-39,0.9,1.9,30,Incidence,2308982,Hispanic of any race,1.3,Male,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,2308982,Hispanic of any race,~,Male,Mesothelioma,2018
35-39,0.7,1.5,24,Incidence,2308982,Hispanic of any race,1.0,Male,Myeloma,2018
35-39,6.3,8.5,169,Incidence,2308982,Hispanic of any race,7.3,Male,Non-Hodgkin Lymphoma,2018
35-39,0.9,1.9,30,Incidence,2308982,Hispanic of any race,1.3,Male,Oral Cavity and Pharynx,2018
35-39,0.7,1.6,26,Incidence,2308982,Hispanic of any race,1.1,Male,Pancreas,2018
35-39,~,~,~,Incidence,2308982,Hispanic of any race,~,Male,Prostate,2018
35-39,2.4,3.9,72,Incidence,2308982,Hispanic of any race,3.1,Male,Stomach,2018
35-39,8.1,10.6,215,Incidence,2308982,Hispanic of any race,9.3,Male,Testis,2018
35-39,5.1,7.2,140,Incidence,2308982,Hispanic of any race,6.1,Male,Thyroid,2018
35-39,0.5,1.2,18,Incidence,2308982,Hispanic of any race,0.8,Male,Urinary Bladder,2018
40-44,102.7,111.6,2225,Incidence,2077490,Hispanic of any race,107.1,Male,All Cancer Sites Combined,2018
40-44,2.8,4.4,73,Incidence,2077490,Hispanic of any race,3.5,Male,Brain and Other Nervous System,2018
40-44,14.5,18.0,336,Incidence,2077490,Hispanic of any race,16.2,Male,Colon and Rectum,2018
40-44,0.6,1.5,20,Incidence,2077490,Hispanic of any race,1.0,Male,Esophagus,2018
40-44,1.9,3.3,53,Incidence,2077490,Hispanic of any race,2.6,Male,Hodgkin Lymphoma,2018
40-44,0.6,1.5,20,Incidence,2077490,Hispanic of any race,1.0,Male,Kaposi Sarcoma,2018
40-44,12.4,15.7,291,Incidence,2077490,Hispanic of any race,14.0,Male,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,2077490,Hispanic of any race,~,Male,Larynx,2018
40-44,5.6,7.8,138,Incidence,2077490,Hispanic of any race,6.6,Male,Leukemias,2018
40-44,1.7,3.1,48,Incidence,2077490,Hispanic of any race,2.3,Male,Liver and Intrahepatic Bile Duct,2018
40-44,2.4,3.9,64,Incidence,2077490,Hispanic of any race,3.1,Male,Lung and Bronchus,2018
40-44,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
40-44,1.7,3.1,48,Incidence,2077490,Hispanic of any race,2.3,Male,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,2077490,Hispanic of any race,~,Male,Mesothelioma,2018
40-44,1.8,3.2,51,Incidence,2077490,Hispanic of any race,2.5,Male,Myeloma,2018
40-44,8.1,10.8,195,Incidence,2077490,Hispanic of any race,9.4,Male,Non-Hodgkin Lymphoma,2018
40-44,3.4,5.2,88,Incidence,2077490,Hispanic of any race,4.2,Male,Oral Cavity and Pharynx,2018
40-44,2.2,3.7,60,Incidence,2077490,Hispanic of any race,2.9,Male,Pancreas,2018
40-44,1.8,3.2,50,Incidence,2077490,Hispanic of any race,2.4,Male,Prostate,2018
40-44,3.9,5.8,99,Incidence,2077490,Hispanic of any race,4.8,Male,Stomach,2018
40-44,5.3,7.5,132,Incidence,2077490,Hispanic of any race,6.4,Male,Testis,2018
40-44,5.4,7.6,134,Incidence,2077490,Hispanic of any race,6.5,Male,Thyroid,2018
40-44,1.9,3.3,52,Incidence,2077490,Hispanic of any race,2.5,Male,Urinary Bladder,2018
45-49,174.7,187.0,3399,Incidence,1880270,Hispanic of any race,180.8,Male,All Cancer Sites Combined,2018
45-49,3.8,5.9,90,Incidence,1880270,Hispanic of any race,4.8,Male,Brain and Other Nervous System,2018
45-49,28.1,33.2,575,Incidence,1880270,Hispanic of any race,30.6,Male,Colon and Rectum,2018
45-49,1.4,2.8,38,Incidence,1880270,Hispanic of any race,2.0,Male,Esophagus,2018
45-49,1.7,3.1,44,Incidence,1880270,Hispanic of any race,2.3,Male,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,1880270,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
45-49,18.5,22.7,386,Incidence,1880270,Hispanic of any race,20.5,Male,Kidney and Renal Pelvis,2018
45-49,0.9,2.0,25,Incidence,1880270,Hispanic of any race,1.3,Male,Larynx,2018
45-49,7.3,10.0,162,Incidence,1880270,Hispanic of any race,8.6,Male,Leukemias,2018
45-49,7.1,9.8,157,Incidence,1880270,Hispanic of any race,8.3,Male,Liver and Intrahepatic Bile Duct,2018
45-49,5.5,7.9,124,Incidence,1880270,Hispanic of any race,6.6,Male,Lung and Bronchus,2018
45-49,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
45-49,2.2,3.8,55,Incidence,1880270,Hispanic of any race,2.9,Male,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,1880270,Hispanic of any race,~,Male,Mesothelioma,2018
45-49,3.8,5.8,89,Incidence,1880270,Hispanic of any race,4.7,Male,Myeloma,2018
45-49,12.5,16.0,266,Incidence,1880270,Hispanic of any race,14.1,Male,Non-Hodgkin Lymphoma,2018
45-49,7.1,9.8,158,Incidence,1880270,Hispanic of any race,8.4,Male,Oral Cavity and Pharynx,2018
45-49,4.6,6.8,106,Incidence,1880270,Hispanic of any race,5.6,Male,Pancreas,2018
45-49,14.7,18.4,309,Incidence,1880270,Hispanic of any race,16.4,Male,Prostate,2018
45-49,4.9,7.1,111,Incidence,1880270,Hispanic of any race,5.9,Male,Stomach,2018
45-49,2.7,4.4,65,Incidence,1880270,Hispanic of any race,3.5,Male,Testis,2018
45-49,7.5,10.2,165,Incidence,1880270,Hispanic of any race,8.8,Male,Thyroid,2018
45-49,3.0,4.9,73,Incidence,1880270,Hispanic of any race,3.9,Male,Urinary Bladder,2018
5-9,13.0,16.0,381,Incidence,2640242,Hispanic of any race,14.4,Male,All Cancer Sites Combined,2018
5-9,2.4,3.7,79,Incidence,2640242,Hispanic of any race,3.0,Male,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Colon and Rectum,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Esophagus,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Larynx,2018
5-9,5.1,7.0,157,Incidence,2640242,Hispanic of any race,5.9,Male,Leukemias,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Lung and Bronchus,2018
5-9,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Mesothelioma,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Myeloma,2018
5-9,0.8,1.7,32,Incidence,2640242,Hispanic of any race,1.2,Male,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Pancreas,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Prostate,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Stomach,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Testis,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Thyroid,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male,Urinary Bladder,2018
50-54,334.1,352.1,5587,Incidence,1628702,Hispanic of any race,343.0,Male,All Cancer Sites Combined,2018
50-54,5.1,7.6,102,Incidence,1628702,Hispanic of any race,6.3,Male,Brain and Other Nervous System,2018
50-54,52.4,59.8,912,Incidence,1628702,Hispanic of any race,56.0,Male,Colon and Rectum,2018
50-54,4.0,6.2,82,Incidence,1628702,Hispanic of any race,5.0,Male,Esophagus,2018
50-54,1.5,3.0,35,Incidence,1628702,Hispanic of any race,2.1,Male,Hodgkin Lymphoma,2018
50-54,0.8,2.0,21,Incidence,1628702,Hispanic of any race,1.3,Male,Kaposi Sarcoma,2018
50-54,28.8,34.3,512,Incidence,1628702,Hispanic of any race,31.4,Male,Kidney and Renal Pelvis,2018
50-54,2.5,4.3,54,Incidence,1628702,Hispanic of any race,3.3,Male,Larynx,2018
50-54,8.8,11.9,167,Incidence,1628702,Hispanic of any race,10.3,Male,Leukemias,2018
50-54,20.1,24.8,364,Incidence,1628702,Hispanic of any race,22.3,Male,Liver and Intrahepatic Bile Duct,2018
50-54,12.9,16.7,240,Incidence,1628702,Hispanic of any race,14.7,Male,Lung and Bronchus,2018
50-54,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
50-54,3.4,5.4,70,Incidence,1628702,Hispanic of any race,4.3,Male,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,1628702,Hispanic of any race,~,Male,Mesothelioma,2018
50-54,6.8,9.7,133,Incidence,1628702,Hispanic of any race,8.2,Male,Myeloma,2018
50-54,20.7,25.4,374,Incidence,1628702,Hispanic of any race,23.0,Male,Non-Hodgkin Lymphoma,2018
50-54,13.0,16.9,242,Incidence,1628702,Hispanic of any race,14.9,Male,Oral Cavity and Pharynx,2018
50-54,10.9,14.4,204,Incidence,1628702,Hispanic of any race,12.5,Male,Pancreas,2018
50-54,61.9,69.9,1072,Incidence,1628702,Hispanic of any race,65.8,Male,Prostate,2018
50-54,9.8,13.2,186,Incidence,1628702,Hispanic of any race,11.4,Male,Stomach,2018
50-54,2.1,3.8,47,Incidence,1628702,Hispanic of any race,2.9,Male,Testis,2018
50-54,7.0,9.9,136,Incidence,1628702,Hispanic of any race,8.4,Male,Thyroid,2018
50-54,6.8,9.6,132,Incidence,1628702,Hispanic of any race,8.1,Male,Urinary Bladder,2018
55-59,588.0,614.3,8087,Incidence,1345456,Hispanic of any race,601.1,Male,All Cancer Sites Combined,2018
55-59,8.8,12.3,140,Incidence,1345456,Hispanic of any race,10.4,Male,Brain and Other Nervous System,2018
55-59,66.1,75.2,949,Incidence,1345456,Hispanic of any race,70.5,Male,Colon and Rectum,2018
55-59,6.6,9.7,108,Incidence,1345456,Hispanic of any race,8.0,Male,Esophagus,2018
55-59,2.6,4.6,47,Incidence,1345456,Hispanic of any race,3.5,Male,Hodgkin Lymphoma,2018
55-59,0.9,2.3,20,Incidence,1345456,Hispanic of any race,1.5,Male,Kaposi Sarcoma,2018
55-59,44.2,51.7,644,Incidence,1345456,Hispanic of any race,47.9,Male,Kidney and Renal Pelvis,2018
55-59,5.7,8.6,95,Incidence,1345456,Hispanic of any race,7.1,Male,Larynx,2018
55-59,12.2,16.3,190,Incidence,1345456,Hispanic of any race,14.1,Male,Leukemias,2018
55-59,45.2,52.7,657,Incidence,1345456,Hispanic of any race,48.8,Male,Liver and Intrahepatic Bile Duct,2018
55-59,31.3,37.6,462,Incidence,1345456,Hispanic of any race,34.3,Male,Lung and Bronchus,2018
55-59,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
55-59,5.4,8.2,90,Incidence,1345456,Hispanic of any race,6.7,Male,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,1345456,Hispanic of any race,~,Male,Mesothelioma,2018
55-59,11.8,15.9,185,Incidence,1345456,Hispanic of any race,13.7,Male,Myeloma,2018
55-59,29.9,36.1,442,Incidence,1345456,Hispanic of any race,32.9,Male,Non-Hodgkin Lymphoma,2018
55-59,22.9,28.4,344,Incidence,1345456,Hispanic of any race,25.6,Male,Oral Cavity and Pharynx,2018
55-59,20.8,26.1,314,Incidence,1345456,Hispanic of any race,23.3,Male,Pancreas,2018
55-59,152.5,166.1,2142,Incidence,1345456,Hispanic of any race,159.2,Male,Prostate,2018
55-59,15.7,20.2,240,Incidence,1345456,Hispanic of any race,17.8,Male,Stomach,2018
55-59,0.7,2.0,17,Incidence,1345456,Hispanic of any race,1.3,Male,Testis,2018
55-59,8.7,12.2,139,Incidence,1345456,Hispanic of any race,10.3,Male,Thyroid,2018
55-59,14.7,19.2,227,Incidence,1345456,Hispanic of any race,16.9,Male,Urinary Bladder,2018
60-64,949.0,987.4,9815,Incidence,1013866,Hispanic of any race,968.1,Male,All Cancer Sites Combined,2018
60-64,10.6,15.1,129,Incidence,1013866,Hispanic of any race,12.7,Male,Brain and Other Nervous System,2018
60-64,104.5,117.5,1124,Incidence,1013866,Hispanic of any race,110.9,Male,Colon and Rectum,2018
60-64,14.0,19.1,166,Incidence,1013866,Hispanic of any race,16.4,Male,Esophagus,2018
60-64,3.4,6.2,47,Incidence,1013866,Hispanic of any race,4.6,Male,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,1013866,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
60-64,60.7,70.8,665,Incidence,1013866,Hispanic of any race,65.6,Male,Kidney and Renal Pelvis,2018
60-64,9.3,13.5,114,Incidence,1013866,Hispanic of any race,11.2,Male,Larynx,2018
60-64,16.5,22.0,194,Incidence,1013866,Hispanic of any race,19.1,Male,Leukemias,2018
60-64,72.3,83.2,787,Incidence,1013866,Hispanic of any race,77.6,Male,Liver and Intrahepatic Bile Duct,2018
60-64,62.5,72.7,684,Incidence,1013866,Hispanic of any race,67.5,Male,Lung and Bronchus,2018
60-64,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
60-64,8.3,12.3,103,Incidence,1013866,Hispanic of any race,10.2,Male,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,1013866,Hispanic of any race,~,Male,Mesothelioma,2018
60-64,15.5,20.9,183,Incidence,1013866,Hispanic of any race,18.0,Male,Myeloma,2018
60-64,42.3,50.7,470,Incidence,1013866,Hispanic of any race,46.4,Male,Non-Hodgkin Lymphoma,2018
60-64,27.8,34.8,316,Incidence,1013866,Hispanic of any race,31.2,Male,Oral Cavity and Pharynx,2018
60-64,28.2,35.2,320,Incidence,1013866,Hispanic of any race,31.6,Male,Pancreas,2018
60-64,292.3,313.8,3071,Incidence,1013866,Hispanic of any race,302.9,Male,Prostate,2018
60-64,22.9,29.3,263,Incidence,1013866,Hispanic of any race,25.9,Male,Stomach,2018
60-64,~,~,~,Incidence,1013866,Hispanic of any race,~,Male,Testis,2018
60-64,10.8,15.3,131,Incidence,1013866,Hispanic of any race,12.9,Male,Thyroid,2018
60-64,30.0,37.2,339,Incidence,1013866,Hispanic of any race,33.4,Male,Urinary Bladder,2018
65-69,1455.0,1511.5,10653,Incidence,718321,Hispanic of any race,1483.0,Male,All Cancer Sites Combined,2018
65-69,12.2,18.0,107,Incidence,718321,Hispanic of any race,14.9,Male,Brain and Other Nervous System,2018
65-69,133.8,151.4,1023,Incidence,718321,Hispanic of any race,142.4,Male,Colon and Rectum,2018
65-69,18.3,25.3,155,Incidence,718321,Hispanic of any race,21.6,Male,Esophagus,2018
65-69,3.4,6.8,35,Incidence,718321,Hispanic of any race,4.9,Male,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,718321,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
65-69,81.9,95.8,637,Incidence,718321,Hispanic of any race,88.7,Male,Kidney and Renal Pelvis,2018
65-69,13.9,20.0,120,Incidence,718321,Hispanic of any race,16.7,Male,Larynx,2018
65-69,26.7,35.0,220,Incidence,718321,Hispanic of any race,30.6,Male,Leukemias,2018
65-69,95.2,110.1,736,Incidence,718321,Hispanic of any race,102.5,Male,Liver and Intrahepatic Bile Duct,2018
65-69,120.3,137.1,923,Incidence,718321,Hispanic of any race,128.5,Male,Lung and Bronchus,2018
65-69,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
65-69,12.8,18.8,112,Incidence,718321,Hispanic of any race,15.6,Male,Melanomas of the Skin,2018
65-69,2.4,5.3,26,Incidence,718321,Hispanic of any race,3.6,Male,Mesothelioma,2018
65-69,25.3,33.3,209,Incidence,718321,Hispanic of any race,29.1,Male,Myeloma,2018
65-69,53.1,64.5,421,Incidence,718321,Hispanic of any race,58.6,Male,Non-Hodgkin Lymphoma,2018
65-69,38.2,47.9,308,Incidence,718321,Hispanic of any race,42.9,Male,Oral Cavity and Pharynx,2018
65-69,49.8,60.8,396,Incidence,718321,Hispanic of any race,55.1,Male,Pancreas,2018
65-69,498.4,531.7,3698,Incidence,718321,Hispanic of any race,514.8,Male,Prostate,2018
65-69,30.2,39.0,247,Incidence,718321,Hispanic of any race,34.4,Male,Stomach,2018
65-69,~,~,~,Incidence,718321,Hispanic of any race,~,Male,Testis,2018
65-69,12.5,18.3,109,Incidence,718321,Hispanic of any race,15.2,Male,Thyroid,2018
65-69,53.4,64.8,423,Incidence,718321,Hispanic of any race,58.9,Male,Urinary Bladder,2018
70-74,1762.8,1837.7,8907,Incidence,494846,Hispanic of any race,1800.0,Male,All Cancer Sites Combined,2018
70-74,16.4,24.6,100,Incidence,494846,Hispanic of any race,20.2,Male,Brain and Other Nervous System,2018
70-74,154.6,177.4,820,Incidence,494846,Hispanic of any race,165.7,Male,Colon and Rectum,2018
70-74,21.6,30.8,128,Incidence,494846,Hispanic of any race,25.9,Male,Esophagus,2018
70-74,3.4,7.7,26,Incidence,494846,Hispanic of any race,5.3,Male,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,494846,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
70-74,90.6,108.4,491,Incidence,494846,Hispanic of any race,99.2,Male,Kidney and Renal Pelvis,2018
70-74,16.6,24.8,101,Incidence,494846,Hispanic of any race,20.4,Male,Larynx,2018
70-74,44.6,57.4,251,Incidence,494846,Hispanic of any race,50.7,Male,Leukemias,2018
70-74,87.9,105.4,477,Incidence,494846,Hispanic of any race,96.4,Male,Liver and Intrahepatic Bile Duct,2018
70-74,199.0,224.8,1047,Incidence,494846,Hispanic of any race,211.6,Male,Lung and Bronchus,2018
70-74,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
70-74,13.4,20.8,83,Incidence,494846,Hispanic of any race,16.8,Male,Melanomas of the Skin,2018
70-74,2.8,6.7,22,Incidence,494846,Hispanic of any race,4.4,Male,Mesothelioma,2018
70-74,34.3,45.6,196,Incidence,494846,Hispanic of any race,39.6,Male,Myeloma,2018
70-74,74.5,90.6,407,Incidence,494846,Hispanic of any race,82.2,Male,Non-Hodgkin Lymphoma,2018
70-74,45.2,58.0,254,Incidence,494846,Hispanic of any race,51.3,Male,Oral Cavity and Pharynx,2018
70-74,53.6,67.5,298,Incidence,494846,Hispanic of any race,60.2,Male,Pancreas,2018
70-74,517.7,558.8,2662,Incidence,494846,Hispanic of any race,537.9,Male,Prostate,2018
70-74,46.3,59.3,260,Incidence,494846,Hispanic of any race,52.5,Male,Stomach,2018
70-74,~,~,~,Incidence,494846,Hispanic of any race,~,Male,Testis,2018
70-74,12.1,19.2,76,Incidence,494846,Hispanic of any race,15.4,Male,Thyroid,2018
70-74,83.7,100.8,455,Incidence,494846,Hispanic of any race,91.9,Male,Urinary Bladder,2018
75-79,2025.1,2126.4,6493,Incidence,312877,Hispanic of any race,2075.3,Male,All Cancer Sites Combined,2018
75-79,13.8,23.6,57,Incidence,312877,Hispanic of any race,18.2,Male,Brain and Other Nervous System,2018
75-79,167.2,197.4,569,Incidence,312877,Hispanic of any race,181.9,Male,Colon and Rectum,2018
75-79,18.9,30.0,75,Incidence,312877,Hispanic of any race,24.0,Male,Esophagus,2018
75-79,5.2,11.8,25,Incidence,312877,Hispanic of any race,8.0,Male,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,312877,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
75-79,88.7,111.1,311,Incidence,312877,Hispanic of any race,99.4,Male,Kidney and Renal Pelvis,2018
75-79,17.2,27.9,69,Incidence,312877,Hispanic of any race,22.1,Male,Larynx,2018
75-79,53.0,70.7,192,Incidence,312877,Hispanic of any race,61.4,Male,Leukemias,2018
75-79,85.9,108.0,302,Incidence,312877,Hispanic of any race,96.5,Male,Liver and Intrahepatic Bile Duct,2018
75-79,258.7,295.9,866,Incidence,312877,Hispanic of any race,276.8,Male,Lung and Bronchus,2018
75-79,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
75-79,23.4,35.7,91,Incidence,312877,Hispanic of any race,29.1,Male,Melanomas of the Skin,2018
75-79,3.2,8.7,17,Incidence,312877,Hispanic of any race,5.4,Male,Mesothelioma,2018
75-79,40.3,55.9,149,Incidence,312877,Hispanic of any race,47.6,Male,Myeloma,2018
75-79,96.8,120.2,338,Incidence,312877,Hispanic of any race,108.0,Male,Non-Hodgkin Lymphoma,2018
75-79,37.1,52.1,138,Incidence,312877,Hispanic of any race,44.1,Male,Oral Cavity and Pharynx,2018
75-79,72.1,92.5,256,Incidence,312877,Hispanic of any race,81.8,Male,Pancreas,2018
75-79,529.7,582.2,1738,Incidence,312877,Hispanic of any race,555.5,Male,Prostate,2018
75-79,61.9,80.9,222,Incidence,312877,Hispanic of any race,71.0,Male,Stomach,2018
75-79,~,~,~,Incidence,312877,Hispanic of any race,~,Male,Testis,2018
75-79,13.5,23.2,56,Incidence,312877,Hispanic of any race,17.9,Male,Thyroid,2018
75-79,122.0,148.0,421,Incidence,312877,Hispanic of any race,134.6,Male,Urinary Bladder,2018
80-84,2144.0,2273.9,4479,Incidence,202832,Hispanic of any race,2208.2,Male,All Cancer Sites Combined,2018
80-84,17.0,30.8,47,Incidence,202832,Hispanic of any race,23.2,Male,Brain and Other Nervous System,2018
80-84,209.4,251.6,466,Incidence,202832,Hispanic of any race,229.7,Male,Colon and Rectum,2018
80-84,18.3,32.5,50,Incidence,202832,Hispanic of any race,24.7,Male,Esophagus,2018
80-84,5.3,14.0,18,Incidence,202832,Hispanic of any race,8.9,Male,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,202832,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
80-84,87.2,115.4,204,Incidence,202832,Hispanic of any race,100.6,Male,Kidney and Renal Pelvis,2018
80-84,20.9,35.9,56,Incidence,202832,Hispanic of any race,27.6,Male,Larynx,2018
80-84,76.3,102.7,180,Incidence,202832,Hispanic of any race,88.7,Male,Leukemias,2018
80-84,89.5,118.0,209,Incidence,202832,Hispanic of any race,103.0,Male,Liver and Intrahepatic Bile Duct,2018
80-84,277.3,325.6,610,Incidence,202832,Hispanic of any race,300.7,Male,Lung and Bronchus,2018
80-84,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
80-84,26.9,43.6,70,Incidence,202832,Hispanic of any race,34.5,Male,Melanomas of the Skin,2018
80-84,8.8,19.4,27,Incidence,202832,Hispanic of any race,13.3,Male,Mesothelioma,2018
80-84,51.7,74.0,126,Incidence,202832,Hispanic of any race,62.1,Male,Myeloma,2018
80-84,111.7,143.2,257,Incidence,202832,Hispanic of any race,126.7,Male,Non-Hodgkin Lymphoma,2018
80-84,44.6,65.4,110,Incidence,202832,Hispanic of any race,54.2,Male,Oral Cavity and Pharynx,2018
80-84,79.5,106.4,187,Incidence,202832,Hispanic of any race,92.2,Male,Pancreas,2018
80-84,368.5,423.7,802,Incidence,202832,Hispanic of any race,395.4,Male,Prostate,2018
80-84,68.5,93.7,163,Incidence,202832,Hispanic of any race,80.4,Male,Stomach,2018
80-84,~,~,~,Incidence,202832,Hispanic of any race,~,Male,Testis,2018
80-84,10.4,21.7,31,Incidence,202832,Hispanic of any race,15.3,Male,Thyroid,2018
80-84,153.5,190.1,347,Incidence,202832,Hispanic of any race,171.1,Male,Urinary Bladder,2018
85+,2038.3,2175.1,3670,Incidence,174273,Hispanic of any race,2105.9,Male,All Cancer Sites Combined,2018
85+,14.5,28.6,36,Incidence,174273,Hispanic of any race,20.7,Male,Brain and Other Nervous System,2018
85+,204.3,249.5,394,Incidence,174273,Hispanic of any race,226.1,Male,Colon and Rectum,2018
85+,22.3,39.1,52,Incidence,174273,Hispanic of any race,29.8,Male,Esophagus,2018
85+,~,~,~,Incidence,174273,Hispanic of any race,~,Male,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,174273,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
85+,61.3,87.3,128,Incidence,174273,Hispanic of any race,73.4,Male,Kidney and Renal Pelvis,2018
85+,15.9,30.6,39,Incidence,174273,Hispanic of any race,22.4,Male,Larynx,2018
85+,65.5,92.3,136,Incidence,174273,Hispanic of any race,78.0,Male,Leukemias,2018
85+,80.8,110.3,165,Incidence,174273,Hispanic of any race,94.7,Male,Liver and Intrahepatic Bile Duct,2018
85+,261.8,312.6,499,Incidence,174273,Hispanic of any race,286.3,Male,Lung and Bronchus,2018
85+,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
85+,29.3,48.2,66,Incidence,174273,Hispanic of any race,37.9,Male,Melanomas of the Skin,2018
85+,6.1,16.3,18,Incidence,174273,Hispanic of any race,10.3,Male,Mesothelioma,2018
85+,35.4,55.9,78,Incidence,174273,Hispanic of any race,44.8,Male,Myeloma,2018
85+,101.5,134.3,204,Incidence,174273,Hispanic of any race,117.1,Male,Non-Hodgkin Lymphoma,2018
85+,34.4,54.6,76,Incidence,174273,Hispanic of any race,43.6,Male,Oral Cavity and Pharynx,2018
85+,73.9,102.2,152,Incidence,174273,Hispanic of any race,87.2,Male,Pancreas,2018
85+,313.4,368.8,593,Incidence,174273,Hispanic of any race,340.3,Male,Prostate,2018
85+,71.3,99.1,147,Incidence,174273,Hispanic of any race,84.4,Male,Stomach,2018
85+,~,~,~,Incidence,174273,Hispanic of any race,~,Male,Testis,2018
85+,~,~,~,Incidence,174273,Hispanic of any race,~,Male,Thyroid,2018
85+,172.2,214.0,335,Incidence,174273,Hispanic of any race,192.2,Male,Urinary Bladder,2018
<1,18.0,26.4,110,Incidence,501506,Hispanic of any race,21.9,Male,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Colon and Rectum,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Esophagus,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Larynx,2018
<1,1.8,5.2,16,Incidence,501506,Hispanic of any race,3.2,Male,Leukemias,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Lung and Bronchus,2018
<1,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Melanomas of the Skin,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Mesothelioma,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Myeloma,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Pancreas,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Prostate,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Stomach,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Testis,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Thyroid,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male,Urinary Bladder,2018
1-4,19.2,22.1,839,Incidence,4069706,Hispanic of any race,20.6,Male and Female,All Cancer Sites Combined,2018
1-4,2.8,3.9,135,Incidence,4069706,Hispanic of any race,3.3,Male and Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,Cervix,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Esophagus,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,Female Breast,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
1-4,1.1,1.8,58,Incidence,4069706,Hispanic of any race,1.4,Male and Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Larynx,2018
1-4,8.8,10.7,396,Incidence,4069706,Hispanic of any race,9.7,Male and Female,Leukemias,2018
1-4,0.4,0.9,25,Incidence,4069706,Hispanic of any race,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,Male and Female Breast,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Mesothelioma,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Myeloma,2018
1-4,0.2,0.7,17,Incidence,4069706,Hispanic of any race,0.4,Male and Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,1995244,Hispanic of any race,~,Male and Female,Ovary,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Pancreas,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male and Female,Prostate,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Stomach,2018
1-4,~,~,~,Incidence,2074462,Hispanic of any race,~,Male and Female,Testis,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Thyroid,2018
1-4,~,~,~,Incidence,4069706,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
10-14,15.2,17.4,859,Incidence,5279071,Hispanic of any race,16.3,Male and Female,All Cancer Sites Combined,2018
10-14,1.6,2.4,105,Incidence,5279071,Hispanic of any race,2.0,Male and Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Male and Female,Cervix,2018
10-14,0.3,0.7,27,Incidence,5279071,Hispanic of any race,0.5,Male and Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Esophagus,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Male and Female,Female Breast,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
10-14,0.8,1.4,55,Incidence,5279071,Hispanic of any race,1.0,Male and Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Larynx,2018
10-14,4.3,5.5,259,Incidence,5279071,Hispanic of any race,4.9,Male and Female,Leukemias,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Male and Female,Male and Female Breast,2018
10-14,~,~,~,Incidence,2587209,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Mesothelioma,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Myeloma,2018
10-14,1.1,1.8,76,Incidence,5279071,Hispanic of any race,1.4,Male and Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2018
10-14,0.9,1.8,34,Incidence,2587209,Hispanic of any race,1.3,Male and Female,Ovary,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Pancreas,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male and Female,Prostate,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Stomach,2018
10-14,~,~,~,Incidence,2691862,Hispanic of any race,~,Male and Female,Testis,2018
10-14,1.1,1.7,71,Incidence,5279071,Hispanic of any race,1.3,Male and Female,Thyroid,2018
10-14,~,~,~,Incidence,5279071,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
15-19,22.2,24.9,1168,Incidence,4964727,Hispanic of any race,23.5,Male and Female,All Cancer Sites Combined,2018
15-19,1.2,1.9,74,Incidence,4964727,Hispanic of any race,1.5,Male and Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Male and Female,Cervix,2018
15-19,0.8,1.4,51,Incidence,4964727,Hispanic of any race,1.0,Male and Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Esophagus,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Male and Female,Female Breast,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
15-19,1.9,2.8,116,Incidence,4964727,Hispanic of any race,2.3,Male and Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Larynx,2018
15-19,4.0,5.2,227,Incidence,4964727,Hispanic of any race,4.6,Male and Female,Leukemias,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Male and Female,Male and Female Breast,2018
15-19,~,~,~,Incidence,2433467,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Mesothelioma,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Myeloma,2018
15-19,1.2,1.8,73,Incidence,4964727,Hispanic of any race,1.5,Male and Female,Non-Hodgkin Lymphoma,2018
15-19,0.2,0.6,18,Incidence,4964727,Hispanic of any race,0.4,Male and Female,Oral Cavity and Pharynx,2018
15-19,0.9,1.9,32,Incidence,2433467,Hispanic of any race,1.3,Male and Female,Ovary,2018
15-19,0.2,0.6,18,Incidence,4964727,Hispanic of any race,0.4,Male and Female,Pancreas,2018
15-19,~,~,~,Incidence,2531260,Hispanic of any race,~,Male and Female,Prostate,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Stomach,2018
15-19,4.1,5.8,124,Incidence,2531260,Hispanic of any race,4.9,Male and Female,Testis,2018
15-19,2.9,4.0,170,Incidence,4964727,Hispanic of any race,3.4,Male and Female,Thyroid,2018
15-19,~,~,~,Incidence,4964727,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
20-24,33.4,36.8,1688,Incidence,4817484,Hispanic of any race,35.0,Male and Female,All Cancer Sites Combined,2018
20-24,1.3,2.0,79,Incidence,4817484,Hispanic of any race,1.6,Male and Female,Brain and Other Nervous System,2018
20-24,0.6,1.4,21,Incidence,2342184,Hispanic of any race,0.9,Male and Female,Cervix,2018
20-24,1.2,2.0,76,Incidence,4817484,Hispanic of any race,1.6,Male and Female,Colon and Rectum,2018
20-24,0.4,1.1,16,Incidence,2342184,Hispanic of any race,0.7,Male and Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Esophagus,2018
20-24,1.1,2.2,38,Incidence,2342184,Hispanic of any race,1.6,Male and Female,Female Breast,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
20-24,2.0,2.9,116,Incidence,4817484,Hispanic of any race,2.4,Male and Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
20-24,0.3,0.8,25,Incidence,4817484,Hispanic of any race,0.5,Male and Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Larynx,2018
20-24,3.2,4.3,178,Incidence,4817484,Hispanic of any race,3.7,Male and Female,Leukemias,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
20-24,0.2,0.5,16,Incidence,4817484,Hispanic of any race,0.3,Male and Female,Lung and Bronchus,2018
20-24,1.1,2.2,38,Incidence,2342184,Hispanic of any race,1.6,Male and Female,Male and Female Breast,2018
20-24,~,~,~,Incidence,2342184,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Mesothelioma,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Myeloma,2018
20-24,1.8,2.6,104,Incidence,4817484,Hispanic of any race,2.2,Male and Female,Non-Hodgkin Lymphoma,2018
20-24,0.3,0.7,24,Incidence,4817484,Hispanic of any race,0.5,Male and Female,Oral Cavity and Pharynx,2018
20-24,1.3,2.5,43,Incidence,2342184,Hispanic of any race,1.8,Male and Female,Ovary,2018
20-24,0.3,0.6,20,Incidence,4817484,Hispanic of any race,0.4,Male and Female,Pancreas,2018
20-24,~,~,~,Incidence,2475300,Hispanic of any race,~,Male and Female,Prostate,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Stomach,2018
20-24,14.2,17.4,390,Incidence,2475300,Hispanic of any race,15.8,Male and Female,Testis,2018
20-24,5.2,6.6,282,Incidence,4817484,Hispanic of any race,5.9,Male and Female,Thyroid,2018
20-24,~,~,~,Incidence,4817484,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
25-29,52.1,56.2,2634,Incidence,4868460,Hispanic of any race,54.1,Male and Female,All Cancer Sites Combined,2018
25-29,1.8,2.6,105,Incidence,4868460,Hispanic of any race,2.2,Male and Female,Brain and Other Nervous System,2018
25-29,3.8,5.6,109,Incidence,2330911,Hispanic of any race,4.7,Male and Female,Cervix,2018
25-29,2.5,3.5,146,Incidence,4868460,Hispanic of any race,3.0,Male and Female,Colon and Rectum,2018
25-29,2.6,4.1,77,Incidence,2330911,Hispanic of any race,3.3,Male and Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Esophagus,2018
25-29,7.0,9.4,190,Incidence,2330911,Hispanic of any race,8.2,Male and Female,Female Breast,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
25-29,2.2,3.2,130,Incidence,4868460,Hispanic of any race,2.7,Male and Female,Hodgkin Lymphoma,2018
25-29,0.5,1.0,33,Incidence,4868460,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2018
25-29,0.9,1.6,59,Incidence,4868460,Hispanic of any race,1.2,Male and Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Larynx,2018
25-29,3.1,4.2,177,Incidence,4868460,Hispanic of any race,3.6,Male and Female,Leukemias,2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Lung and Bronchus,2018
25-29,7.0,9.4,190,Incidence,2330911,Hispanic of any race,8.2,Male and Female,Male and Female Breast,2018
25-29,~,~,~,Incidence,2330911,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
25-29,0.7,1.3,48,Incidence,4868460,Hispanic of any race,1.0,Male and Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Mesothelioma,2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Myeloma,2018
25-29,3.0,4.1,171,Incidence,4868460,Hispanic of any race,3.5,Male and Female,Non-Hodgkin Lymphoma,2018
25-29,0.7,1.2,44,Incidence,4868460,Hispanic of any race,0.9,Male and Female,Oral Cavity and Pharynx,2018
25-29,1.5,2.7,48,Incidence,2330911,Hispanic of any race,2.1,Male and Female,Ovary,2018
25-29,0.4,0.8,27,Incidence,4868460,Hispanic of any race,0.6,Male and Female,Pancreas,2018
25-29,~,~,~,Incidence,2537549,Hispanic of any race,~,Male and Female,Prostate,2018
25-29,0.4,0.9,32,Incidence,4868460,Hispanic of any race,0.7,Male and Female,Stomach,2018
25-29,15.1,18.3,423,Incidence,2537549,Hispanic of any race,16.7,Male and Female,Testis,2018
25-29,9.3,11.1,494,Incidence,4868460,Hispanic of any race,10.1,Male and Female,Thyroid,2018
25-29,~,~,~,Incidence,4868460,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
30-34,78.8,84.1,3695,Incidence,4537851,Hispanic of any race,81.4,Male and Female,All Cancer Sites Combined,2018
30-34,1.9,2.8,104,Incidence,4537851,Hispanic of any race,2.3,Male and Female,Brain and Other Nervous System,2018
30-34,11.2,14.2,272,Incidence,2150706,Hispanic of any race,12.6,Male and Female,Cervix,2018
30-34,5.1,6.6,264,Incidence,4537851,Hispanic of any race,5.8,Male and Female,Colon and Rectum,2018
30-34,7.8,10.4,194,Incidence,2150706,Hispanic of any race,9.0,Male and Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,4537851,Hispanic of any race,~,Male and Female,Esophagus,2018
30-34,21.7,25.9,511,Incidence,2150706,Hispanic of any race,23.8,Male and Female,Female Breast,2018
30-34,1.8,3.2,52,Incidence,2150706,Hispanic of any race,2.4,Male and Female,"Female Breast, <i>in situ</i>",2018
30-34,1.7,2.6,97,Incidence,4537851,Hispanic of any race,2.1,Male and Female,Hodgkin Lymphoma,2018
30-34,0.5,1.0,34,Incidence,4537851,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2018
30-34,2.6,3.6,139,Incidence,4537851,Hispanic of any race,3.1,Male and Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,4537851,Hispanic of any race,~,Male and Female,Larynx,2018
30-34,3.8,5.0,199,Incidence,4537851,Hispanic of any race,4.4,Male and Female,Leukemias,2018
30-34,~,~,~,Incidence,4537851,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.6,1.2,40,Incidence,4537851,Hispanic of any race,0.9,Male and Female,Lung and Bronchus,2018
30-34,21.7,25.9,511,Incidence,2150706,Hispanic of any race,23.8,Male and Female,Male and Female Breast,2018
30-34,1.8,3.2,52,Incidence,2150706,Hispanic of any race,2.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
30-34,1.2,2.0,72,Incidence,4537851,Hispanic of any race,1.6,Male and Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,4537851,Hispanic of any race,~,Male and Female,Mesothelioma,2018
30-34,~,~,~,Incidence,4537851,Hispanic of any race,~,Male and Female,Myeloma,2018
30-34,3.6,4.8,189,Incidence,4537851,Hispanic of any race,4.2,Male and Female,Non-Hodgkin Lymphoma,2018
30-34,0.8,1.4,49,Incidence,4537851,Hispanic of any race,1.1,Male and Female,Oral Cavity and Pharynx,2018
30-34,2.4,4.0,67,Incidence,2150706,Hispanic of any race,3.1,Male and Female,Ovary,2018
30-34,0.4,0.9,29,Incidence,4537851,Hispanic of any race,0.6,Male and Female,Pancreas,2018
30-34,~,~,~,Incidence,2387145,Hispanic of any race,~,Male and Female,Prostate,2018
30-34,1.5,2.3,83,Incidence,4537851,Hispanic of any race,1.8,Male and Female,Stomach,2018
30-34,12.8,15.9,341,Incidence,2387145,Hispanic of any race,14.3,Male and Female,Testis,2018
30-34,12.6,14.8,621,Incidence,4537851,Hispanic of any race,13.7,Male and Female,Thyroid,2018
30-34,0.4,0.9,29,Incidence,4537851,Hispanic of any race,0.6,Male and Female,Urinary Bladder,2018
35-39,117.4,123.8,5372,Incidence,4455755,Hispanic of any race,120.6,Male and Female,All Cancer Sites Combined,2018
35-39,2.2,3.2,120,Incidence,4455755,Hispanic of any race,2.7,Male and Female,Brain and Other Nervous System,2018
35-39,15.2,18.7,363,Incidence,2146773,Hispanic of any race,16.9,Male and Female,Cervix,2018
35-39,8.9,10.7,435,Incidence,4455755,Hispanic of any race,9.8,Male and Female,Colon and Rectum,2018
35-39,12.3,15.5,297,Incidence,2146773,Hispanic of any race,13.8,Male and Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,4455755,Hispanic of any race,~,Male and Female,Esophagus,2018
35-39,47.4,53.4,1081,Incidence,2146773,Hispanic of any race,50.4,Male and Female,Female Breast,2018
35-39,4.9,7.0,127,Incidence,2146773,Hispanic of any race,5.9,Male and Female,"Female Breast, <i>in situ</i>",2018
35-39,1.6,2.4,87,Incidence,4455755,Hispanic of any race,2.0,Male and Female,Hodgkin Lymphoma,2018
35-39,0.5,1.1,34,Incidence,4455755,Hispanic of any race,0.8,Male and Female,Kaposi Sarcoma,2018
35-39,6.4,8.0,320,Incidence,4455755,Hispanic of any race,7.2,Male and Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,4455755,Hispanic of any race,~,Male and Female,Larynx,2018
35-39,4.2,5.5,214,Incidence,4455755,Hispanic of any race,4.8,Male and Female,Leukemias,2018
35-39,~,~,~,Incidence,4455755,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
35-39,1.6,2.5,89,Incidence,4455755,Hispanic of any race,2.0,Male and Female,Lung and Bronchus,2018
35-39,47.4,53.4,1081,Incidence,2146773,Hispanic of any race,50.4,Male and Female,Male and Female Breast,2018
35-39,4.9,7.0,127,Incidence,2146773,Hispanic of any race,5.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
35-39,2.2,3.2,118,Incidence,4455755,Hispanic of any race,2.6,Male and Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,4455755,Hispanic of any race,~,Male and Female,Mesothelioma,2018
35-39,0.7,1.3,44,Incidence,4455755,Hispanic of any race,1.0,Male and Female,Myeloma,2018
35-39,5.8,7.3,290,Incidence,4455755,Hispanic of any race,6.5,Male and Female,Non-Hodgkin Lymphoma,2018
35-39,1.2,2.0,70,Incidence,4455755,Hispanic of any race,1.6,Male and Female,Oral Cavity and Pharynx,2018
35-39,3.9,5.8,103,Incidence,2146773,Hispanic of any race,4.8,Male and Female,Ovary,2018
35-39,1.0,1.8,61,Incidence,4455755,Hispanic of any race,1.4,Male and Female,Pancreas,2018
35-39,~,~,~,Incidence,2308982,Hispanic of any race,~,Male and Female,Prostate,2018
35-39,3.0,4.1,158,Incidence,4455755,Hispanic of any race,3.5,Male and Female,Stomach,2018
35-39,8.1,10.6,215,Incidence,2308982,Hispanic of any race,9.3,Male and Female,Testis,2018
35-39,16.3,18.8,779,Incidence,4455755,Hispanic of any race,17.5,Male and Female,Thyroid,2018
35-39,0.5,1.0,31,Incidence,4455755,Hispanic of any race,0.7,Male and Female,Urinary Bladder,2018
40-44,180.0,188.3,7507,Incidence,4077677,Hispanic of any race,184.1,Male and Female,All Cancer Sites Combined,2018
40-44,2.4,3.5,120,Incidence,4077677,Hispanic of any race,2.9,Male and Female,Brain and Other Nervous System,2018
40-44,16.3,20.1,363,Incidence,2000187,Hispanic of any race,18.1,Male and Female,Cervix,2018
40-44,14.8,17.3,653,Incidence,4077677,Hispanic of any race,16.0,Male and Female,Colon and Rectum,2018
40-44,18.3,22.3,404,Incidence,2000187,Hispanic of any race,20.2,Male and Female,"Corpus and Uterus, NOS",2018
40-44,0.4,0.9,24,Incidence,4077677,Hispanic of any race,0.6,Male and Female,Esophagus,2018
40-44,97.9,106.8,2045,Incidence,2000187,Hispanic of any race,102.2,Male and Female,Female Breast,2018
40-44,24.3,28.9,530,Incidence,2000187,Hispanic of any race,26.5,Male and Female,"Female Breast, <i>in situ</i>",2018
40-44,1.8,2.7,89,Incidence,4077677,Hispanic of any race,2.2,Male and Female,Hodgkin Lymphoma,2018
40-44,0.3,0.8,22,Incidence,4077677,Hispanic of any race,0.5,Male and Female,Kaposi Sarcoma,2018
40-44,11.1,13.3,495,Incidence,4077677,Hispanic of any race,12.1,Male and Female,Kidney and Renal Pelvis,2018
40-44,0.3,0.7,18,Incidence,4077677,Hispanic of any race,0.4,Male and Female,Larynx,2018
40-44,5.2,6.7,242,Incidence,4077677,Hispanic of any race,5.9,Male and Female,Leukemias,2018
40-44,1.2,2.0,65,Incidence,4077677,Hispanic of any race,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
40-44,3.0,4.2,144,Incidence,4077677,Hispanic of any race,3.5,Male and Female,Lung and Bronchus,2018
40-44,97.9,106.8,2045,Incidence,2000187,Hispanic of any race,102.2,Male and Female,Male and Female Breast,2018
40-44,24.3,28.9,530,Incidence,2000187,Hispanic of any race,26.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
40-44,2.8,3.9,134,Incidence,4077677,Hispanic of any race,3.3,Male and Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,4077677,Hispanic of any race,~,Male and Female,Mesothelioma,2018
40-44,2.2,3.2,108,Incidence,4077677,Hispanic of any race,2.6,Male and Female,Myeloma,2018
40-44,7.4,9.2,336,Incidence,4077677,Hispanic of any race,8.2,Male and Female,Non-Hodgkin Lymphoma,2018
40-44,2.7,3.8,132,Incidence,4077677,Hispanic of any race,3.2,Male and Female,Oral Cavity and Pharynx,2018
40-44,6.9,9.4,161,Incidence,2000187,Hispanic of any race,8.0,Male and Female,Ovary,2018
40-44,2.2,3.3,111,Incidence,4077677,Hispanic of any race,2.7,Male and Female,Pancreas,2018
40-44,1.8,3.2,50,Incidence,2077490,Hispanic of any race,2.4,Male and Female,Prostate,2018
40-44,4.9,6.3,227,Incidence,4077677,Hispanic of any race,5.6,Male and Female,Stomach,2018
40-44,5.3,7.5,132,Incidence,2077490,Hispanic of any race,6.4,Male and Female,Testis,2018
40-44,17.7,20.4,776,Incidence,4077677,Hispanic of any race,19.0,Male and Female,Thyroid,2018
40-44,1.4,2.2,72,Incidence,4077677,Hispanic of any race,1.8,Male and Female,Urinary Bladder,2018
45-49,262.7,273.2,9989,Incidence,3728847,Hispanic of any race,267.9,Male and Female,All Cancer Sites Combined,2018
45-49,3.8,5.2,166,Incidence,3728847,Hispanic of any race,4.5,Male and Female,Brain and Other Nervous System,2018
45-49,14.4,18.1,299,Incidence,1848577,Hispanic of any race,16.2,Male and Female,Cervix,2018
45-49,26.5,30.0,1052,Incidence,3728847,Hispanic of any race,28.2,Male and Female,Colon and Rectum,2018
45-49,23.4,28.1,475,Incidence,1848577,Hispanic of any race,25.7,Male and Female,"Corpus and Uterus, NOS",2018
45-49,0.9,1.6,45,Incidence,3728847,Hispanic of any race,1.2,Male and Female,Esophagus,2018
45-49,141.1,152.2,2709,Incidence,1848577,Hispanic of any race,146.5,Male and Female,Female Breast,2018
45-49,40.5,46.6,804,Incidence,1848577,Hispanic of any race,43.5,Male and Female,"Female Breast, <i>in situ</i>",2018
45-49,1.3,2.2,65,Incidence,3728847,Hispanic of any race,1.7,Male and Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,3728847,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
45-49,15.4,18.1,623,Incidence,3728847,Hispanic of any race,16.7,Male and Female,Kidney and Renal Pelvis,2018
45-49,0.6,1.2,32,Incidence,3728847,Hispanic of any race,0.9,Male and Female,Larynx,2018
45-49,6.6,8.4,277,Incidence,3728847,Hispanic of any race,7.4,Male and Female,Leukemias,2018
45-49,4.4,5.9,192,Incidence,3728847,Hispanic of any race,5.1,Male and Female,Liver and Intrahepatic Bile Duct,2018
45-49,6.4,8.1,268,Incidence,3728847,Hispanic of any race,7.2,Male and Female,Lung and Bronchus,2018
45-49,141.1,152.2,2709,Incidence,1848577,Hispanic of any race,146.5,Male and Female,Male and Female Breast,2018
45-49,40.5,46.6,804,Incidence,1848577,Hispanic of any race,43.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
45-49,3.0,4.3,135,Incidence,3728847,Hispanic of any race,3.6,Male and Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,3728847,Hispanic of any race,~,Male and Female,Mesothelioma,2018
45-49,3.7,5.0,160,Incidence,3728847,Hispanic of any race,4.3,Male and Female,Myeloma,2018
45-49,11.6,14.0,476,Incidence,3728847,Hispanic of any race,12.8,Male and Female,Non-Hodgkin Lymphoma,2018
45-49,5.4,7.0,230,Incidence,3728847,Hispanic of any race,6.2,Male and Female,Oral Cavity and Pharynx,2018
45-49,11.4,14.7,240,Incidence,1848577,Hispanic of any race,13.0,Male and Female,Ovary,2018
45-49,4.1,5.6,180,Incidence,3728847,Hispanic of any race,4.8,Male and Female,Pancreas,2018
45-49,14.7,18.4,309,Incidence,1880270,Hispanic of any race,16.4,Male and Female,Prostate,2018
45-49,6.3,8.0,266,Incidence,3728847,Hispanic of any race,7.1,Male and Female,Stomach,2018
45-49,2.7,4.4,65,Incidence,1880270,Hispanic of any race,3.5,Male and Female,Testis,2018
45-49,19.6,22.6,785,Incidence,3728847,Hispanic of any race,21.1,Male and Female,Thyroid,2018
45-49,2.5,3.6,113,Incidence,3728847,Hispanic of any race,3.0,Male and Female,Urinary Bladder,2018
5-9,12.8,14.8,713,Incidence,5186299,Hispanic of any race,13.7,Male and Female,All Cancer Sites Combined,2018
5-9,2.5,3.4,151,Incidence,5186299,Hispanic of any race,2.9,Male and Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,Cervix,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Esophagus,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,Female Breast,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
5-9,0.5,1.0,37,Incidence,5186299,Hispanic of any race,0.7,Male and Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Larynx,2018
5-9,4.9,6.3,289,Incidence,5186299,Hispanic of any race,5.6,Male and Female,Leukemias,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,Male and Female Breast,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Mesothelioma,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Myeloma,2018
5-9,0.8,1.4,57,Incidence,5186299,Hispanic of any race,1.1,Male and Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,2546057,Hispanic of any race,~,Male and Female,Ovary,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Pancreas,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male and Female,Prostate,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Stomach,2018
5-9,~,~,~,Incidence,2640242,Hispanic of any race,~,Male and Female,Testis,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Thyroid,2018
5-9,~,~,~,Incidence,5186299,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
50-54,410.5,424.6,13513,Incidence,3236318,Hispanic of any race,417.5,Male and Female,All Cancer Sites Combined,2018
50-54,5.2,7.0,196,Incidence,3236318,Hispanic of any race,6.1,Male and Female,Brain and Other Nervous System,2018
50-54,14.2,18.2,259,Incidence,1607616,Hispanic of any race,16.1,Male and Female,Cervix,2018
50-54,49.1,54.1,1668,Incidence,3236318,Hispanic of any race,51.5,Male and Female,Colon and Rectum,2018
50-54,41.9,48.6,726,Incidence,1607616,Hispanic of any race,45.2,Male and Female,"Corpus and Uterus, NOS",2018
50-54,2.3,3.5,91,Incidence,3236318,Hispanic of any race,2.8,Male and Female,Esophagus,2018
50-54,166.9,179.9,2786,Incidence,1607616,Hispanic of any race,173.3,Male and Female,Female Breast,2018
50-54,46.4,53.4,801,Incidence,1607616,Hispanic of any race,49.8,Male and Female,"Female Breast, <i>in situ</i>",2018
50-54,1.3,2.2,55,Incidence,3236318,Hispanic of any race,1.7,Male and Female,Hodgkin Lymphoma,2018
50-54,0.4,1.0,22,Incidence,3236318,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2018
50-54,24.6,28.1,851,Incidence,3236318,Hispanic of any race,26.3,Male and Female,Kidney and Renal Pelvis,2018
50-54,1.7,2.7,70,Incidence,3236318,Hispanic of any race,2.2,Male and Female,Larynx,2018
50-54,8.3,10.4,301,Incidence,3236318,Hispanic of any race,9.3,Male and Female,Leukemias,2018
50-54,13.1,15.7,465,Incidence,3236318,Hispanic of any race,14.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
50-54,13.9,16.6,492,Incidence,3236318,Hispanic of any race,15.2,Male and Female,Lung and Bronchus,2018
50-54,166.9,179.9,2786,Incidence,1607616,Hispanic of any race,173.3,Male and Female,Male and Female Breast,2018
50-54,46.4,53.4,801,Incidence,1607616,Hispanic of any race,49.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
50-54,4.4,6.0,168,Incidence,3236318,Hispanic of any race,5.2,Male and Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,3236318,Hispanic of any race,~,Male and Female,Mesothelioma,2018
50-54,6.8,8.8,251,Incidence,3236318,Hispanic of any race,7.8,Male and Female,Myeloma,2018
50-54,20.0,23.3,699,Incidence,3236318,Hispanic of any race,21.6,Male and Female,Non-Hodgkin Lymphoma,2018
50-54,9.5,11.7,342,Incidence,3236318,Hispanic of any race,10.6,Male and Female,Oral Cavity and Pharynx,2018
50-54,15.5,19.6,281,Incidence,1607616,Hispanic of any race,17.5,Male and Female,Ovary,2018
50-54,10.1,12.4,363,Incidence,3236318,Hispanic of any race,11.2,Male and Female,Pancreas,2018
50-54,61.9,69.9,1072,Incidence,1628702,Hispanic of any race,65.8,Male and Female,Prostate,2018
50-54,9.3,11.6,337,Incidence,3236318,Hispanic of any race,10.4,Male and Female,Stomach,2018
50-54,2.1,3.8,47,Incidence,1628702,Hispanic of any race,2.9,Male and Female,Testis,2018
50-54,22.0,25.4,766,Incidence,3236318,Hispanic of any race,23.7,Male and Female,Thyroid,2018
50-54,4.8,6.5,182,Incidence,3236318,Hispanic of any race,5.6,Male and Female,Urinary Bladder,2018
55-59,612.6,631.4,16966,Incidence,2727848,Hispanic of any race,622.0,Male and Female,All Cancer Sites Combined,2018
55-59,8.1,10.4,251,Incidence,2727848,Hispanic of any race,9.2,Male and Female,Brain and Other Nervous System,2018
55-59,14.7,19.1,232,Incidence,1382392,Hispanic of any race,16.8,Male and Female,Cervix,2018
55-59,58.1,64.0,1665,Incidence,2727848,Hispanic of any race,61.0,Male and Female,Colon and Rectum,2018
55-59,65.5,74.4,965,Incidence,1382392,Hispanic of any race,69.8,Male and Female,"Corpus and Uterus, NOS",2018
55-59,4.1,5.8,134,Incidence,2727848,Hispanic of any race,4.9,Male and Female,Esophagus,2018
55-59,201.2,216.5,2886,Incidence,1382392,Hispanic of any race,208.8,Male and Female,Female Breast,2018
55-59,46.5,54.0,693,Incidence,1382392,Hispanic of any race,50.1,Male and Female,"Female Breast, <i>in situ</i>",2018
55-59,2.4,3.7,81,Incidence,2727848,Hispanic of any race,3.0,Male and Female,Hodgkin Lymphoma,2018
55-59,0.4,1.1,20,Incidence,2727848,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2018
55-59,35.8,40.5,1039,Incidence,2727848,Hispanic of any race,38.1,Male and Female,Kidney and Renal Pelvis,2018
55-59,3.5,5.1,116,Incidence,2727848,Hispanic of any race,4.3,Male and Female,Larynx,2018
55-59,11.7,14.4,355,Incidence,2727848,Hispanic of any race,13.0,Male and Female,Leukemias,2018
55-59,28.8,33.0,842,Incidence,2727848,Hispanic of any race,30.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
55-59,31.3,35.7,913,Incidence,2727848,Hispanic of any race,33.5,Male and Female,Lung and Bronchus,2018
55-59,201.2,216.5,2886,Incidence,1382392,Hispanic of any race,208.8,Male and Female,Male and Female Breast,2018
55-59,46.5,54.0,693,Incidence,1382392,Hispanic of any race,50.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
55-59,6.4,8.5,202,Incidence,2727848,Hispanic of any race,7.4,Male and Female,Melanomas of the Skin,2018
55-59,0.5,1.2,22,Incidence,2727848,Hispanic of any race,0.8,Male and Female,Mesothelioma,2018
55-59,10.5,13.1,320,Incidence,2727848,Hispanic of any race,11.7,Male and Female,Myeloma,2018
55-59,27.2,31.2,795,Incidence,2727848,Hispanic of any race,29.1,Male and Female,Non-Hodgkin Lymphoma,2018
55-59,16.1,19.3,482,Incidence,2727848,Hispanic of any race,17.7,Male and Female,Oral Cavity and Pharynx,2018
55-59,18.4,23.2,286,Incidence,1382392,Hispanic of any race,20.7,Male and Female,Ovary,2018
55-59,18.4,21.8,547,Incidence,2727848,Hispanic of any race,20.1,Male and Female,Pancreas,2018
55-59,152.5,166.1,2142,Incidence,1345456,Hispanic of any race,159.2,Male and Female,Prostate,2018
55-59,14.1,17.1,425,Incidence,2727848,Hispanic of any race,15.6,Male and Female,Stomach,2018
55-59,0.7,2.0,17,Incidence,1345456,Hispanic of any race,1.3,Male and Female,Testis,2018
55-59,22.3,26.1,659,Incidence,2727848,Hispanic of any race,24.2,Male and Female,Thyroid,2018
55-59,9.6,12.1,295,Incidence,2727848,Hispanic of any race,10.8,Male and Female,Urinary Bladder,2018
60-64,891.3,917.0,19170,Incidence,2120406,Hispanic of any race,904.1,Male and Female,All Cancer Sites Combined,2018
60-64,8.9,11.7,217,Incidence,2120406,Hispanic of any race,10.2,Male and Female,Brain and Other Nervous System,2018
60-64,11.6,16.0,151,Incidence,1106540,Hispanic of any race,13.6,Male and Female,Cervix,2018
60-64,84.2,92.2,1869,Incidence,2120406,Hispanic of any race,88.1,Male and Female,Colon and Rectum,2018
60-64,80.9,92.0,955,Incidence,1106540,Hispanic of any race,86.3,Male and Female,"Corpus and Uterus, NOS",2018
60-64,8.3,11.0,203,Incidence,2120406,Hispanic of any race,9.6,Male and Female,Esophagus,2018
60-64,254.7,273.9,2923,Incidence,1106540,Hispanic of any race,264.2,Male and Female,Female Breast,2018
60-64,60.1,69.6,716,Incidence,1106540,Hispanic of any race,64.7,Male and Female,"Female Breast, <i>in situ</i>",2018
60-64,2.9,4.6,79,Incidence,2120406,Hispanic of any race,3.7,Male and Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,2120406,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
60-64,47.5,53.6,1071,Incidence,2120406,Hispanic of any race,50.5,Male and Female,Kidney and Renal Pelvis,2018
60-64,5.5,7.7,139,Incidence,2120406,Hispanic of any race,6.6,Male and Female,Larynx,2018
60-64,16.0,19.6,376,Incidence,2120406,Hispanic of any race,17.7,Male and Female,Leukemias,2018
60-64,47.8,53.9,1077,Incidence,2120406,Hispanic of any race,50.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
60-64,60.3,67.1,1349,Incidence,2120406,Hispanic of any race,63.6,Male and Female,Lung and Bronchus,2018
60-64,254.7,273.9,2923,Incidence,1106540,Hispanic of any race,264.2,Male and Female,Male and Female Breast,2018
60-64,60.1,69.6,716,Incidence,1106540,Hispanic of any race,64.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
60-64,9.3,12.1,225,Incidence,2120406,Hispanic of any race,10.6,Male and Female,Melanomas of the Skin,2018
60-64,0.7,1.6,23,Incidence,2120406,Hispanic of any race,1.1,Male and Female,Mesothelioma,2018
60-64,16.4,20.1,385,Incidence,2120406,Hispanic of any race,18.2,Male and Female,Myeloma,2018
60-64,38.5,44.0,873,Incidence,2120406,Hispanic of any race,41.2,Male and Female,Non-Hodgkin Lymphoma,2018
60-64,19.1,23.0,445,Incidence,2120406,Hispanic of any race,21.0,Male and Female,Oral Cavity and Pharynx,2018
60-64,19.5,25.1,245,Incidence,1106540,Hispanic of any race,22.1,Male and Female,Ovary,2018
60-64,25.6,30.2,590,Incidence,2120406,Hispanic of any race,27.8,Male and Female,Pancreas,2018
60-64,292.3,313.8,3071,Incidence,1013866,Hispanic of any race,302.9,Male and Female,Prostate,2018
60-64,19.4,23.4,452,Incidence,2120406,Hispanic of any race,21.3,Male and Female,Stomach,2018
60-64,~,~,~,Incidence,1013866,Hispanic of any race,~,Male and Female,Testis,2018
60-64,22.1,26.3,512,Incidence,2120406,Hispanic of any race,24.1,Male and Female,Thyroid,2018
60-64,20.3,24.3,471,Incidence,2120406,Hispanic of any race,22.2,Male and Female,Urinary Bladder,2018
65-69,1260.3,1296.0,19815,Incidence,1550420,Hispanic of any race,1278.0,Male and Female,All Cancer Sites Combined,2018
65-69,11.4,15.1,204,Incidence,1550420,Hispanic of any race,13.2,Male and Female,Brain and Other Nervous System,2018
65-69,12.6,18.0,126,Incidence,832099,Hispanic of any race,15.1,Male and Female,Cervix,2018
65-69,108.1,118.8,1758,Incidence,1550420,Hispanic of any race,113.4,Male and Female,Colon and Rectum,2018
65-69,92.7,106.4,827,Incidence,832099,Hispanic of any race,99.4,Male and Female,"Corpus and Uterus, NOS",2018
65-69,11.0,14.6,197,Incidence,1550420,Hispanic of any race,12.7,Male and Female,Esophagus,2018
65-69,321.2,346.1,2775,Incidence,832099,Hispanic of any race,333.5,Male and Female,Female Breast,2018
65-69,75.3,87.7,677,Incidence,832099,Hispanic of any race,81.4,Male and Female,"Female Breast, <i>in situ</i>",2018
65-69,2.8,4.8,58,Incidence,1550420,Hispanic of any race,3.7,Male and Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,1550420,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
65-69,59.7,67.7,986,Incidence,1550420,Hispanic of any race,63.6,Male and Female,Kidney and Renal Pelvis,2018
65-69,7.9,11.0,145,Incidence,1550420,Hispanic of any race,9.4,Male and Female,Larynx,2018
65-69,25.1,30.3,428,Incidence,1550420,Hispanic of any race,27.6,Male and Female,Leukemias,2018
65-69,62.6,70.8,1033,Incidence,1550420,Hispanic of any race,66.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
65-69,104.2,114.7,1696,Incidence,1550420,Hispanic of any race,109.4,Male and Female,Lung and Bronchus,2018
65-69,321.2,346.1,2775,Incidence,832099,Hispanic of any race,333.5,Male and Female,Male and Female Breast,2018
65-69,75.3,87.7,677,Incidence,832099,Hispanic of any race,81.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
65-69,12.8,16.7,227,Incidence,1550420,Hispanic of any race,14.6,Male and Female,Melanomas of the Skin,2018
65-69,1.8,3.4,39,Incidence,1550420,Hispanic of any race,2.5,Male and Female,Mesothelioma,2018
65-69,22.8,27.9,392,Incidence,1550420,Hispanic of any race,25.3,Male and Female,Myeloma,2018
65-69,51.9,59.4,862,Incidence,1550420,Hispanic of any race,55.6,Male and Female,Non-Hodgkin Lymphoma,2018
65-69,24.0,29.2,411,Incidence,1550420,Hispanic of any race,26.5,Male and Female,Oral Cavity and Pharynx,2018
65-69,24.9,32.2,236,Incidence,832099,Hispanic of any race,28.4,Male and Female,Ovary,2018
65-69,42.3,49.1,707,Incidence,1550420,Hispanic of any race,45.6,Male and Female,Pancreas,2018
65-69,498.4,531.7,3698,Incidence,718321,Hispanic of any race,514.8,Male and Female,Prostate,2018
65-69,24.9,30.2,426,Incidence,1550420,Hispanic of any race,27.5,Male and Female,Stomach,2018
65-69,~,~,~,Incidence,718321,Hispanic of any race,~,Male and Female,Testis,2018
65-69,26.7,32.1,454,Incidence,1550420,Hispanic of any race,29.3,Male and Female,Thyroid,2018
65-69,33.4,39.4,563,Incidence,1550420,Hispanic of any race,36.3,Male and Female,Urinary Bladder,2018
70-74,1491.5,1537.5,16751,Incidence,1106146,Hispanic of any race,1514.4,Male and Female,All Cancer Sites Combined,2018
70-74,14.9,19.9,191,Incidence,1106146,Hispanic of any race,17.3,Male and Female,Brain and Other Nervous System,2018
70-74,11.8,18.1,90,Incidence,611300,Hispanic of any race,14.7,Male and Female,Cervix,2018
70-74,125.6,139.2,1463,Incidence,1106146,Hispanic of any race,132.3,Male and Female,Colon and Rectum,2018
70-74,84.2,99.5,560,Incidence,611300,Hispanic of any race,91.6,Male and Female,"Corpus and Uterus, NOS",2018
70-74,11.9,16.4,155,Incidence,1106146,Hispanic of any race,14.0,Male and Female,Esophagus,2018
70-74,345.2,375.4,2201,Incidence,611300,Hispanic of any race,360.1,Male and Female,Female Breast,2018
70-74,73.8,88.3,494,Incidence,611300,Hispanic of any race,80.8,Male and Female,"Female Breast, <i>in situ</i>",2018
70-74,3.3,5.9,49,Incidence,1106146,Hispanic of any race,4.4,Male and Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,1106146,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
70-74,66.6,76.7,791,Incidence,1106146,Hispanic of any race,71.5,Male and Female,Kidney and Renal Pelvis,2018
70-74,9.0,13.0,120,Incidence,1106146,Hispanic of any race,10.8,Male and Female,Larynx,2018
70-74,35.9,43.4,437,Incidence,1106146,Hispanic of any race,39.5,Male and Female,Leukemias,2018
70-74,62.6,72.4,745,Incidence,1106146,Hispanic of any race,67.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
70-74,159.4,174.7,1846,Incidence,1106146,Hispanic of any race,166.9,Male and Female,Lung and Bronchus,2018
70-74,345.2,375.4,2201,Incidence,611300,Hispanic of any race,360.1,Male and Female,Male and Female Breast,2018
70-74,73.8,88.3,494,Incidence,611300,Hispanic of any race,80.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
70-74,13.0,17.7,168,Incidence,1106146,Hispanic of any race,15.2,Male and Female,Melanomas of the Skin,2018
70-74,2.2,4.4,35,Incidence,1106146,Hispanic of any race,3.2,Male and Female,Mesothelioma,2018
70-74,29.2,36.0,359,Incidence,1106146,Hispanic of any race,32.5,Male and Female,Myeloma,2018
70-74,64.9,74.8,771,Incidence,1106146,Hispanic of any race,69.7,Male and Female,Non-Hodgkin Lymphoma,2018
70-74,28.6,35.3,352,Incidence,1106146,Hispanic of any race,31.8,Male and Female,Oral Cavity and Pharynx,2018
70-74,26.8,35.8,190,Incidence,611300,Hispanic of any race,31.1,Male and Female,Ovary,2018
70-74,53.5,62.5,640,Incidence,1106146,Hispanic of any race,57.9,Male and Female,Pancreas,2018
70-74,517.7,558.8,2662,Incidence,494846,Hispanic of any race,537.9,Male and Female,Prostate,2018
70-74,36.0,43.5,438,Incidence,1106146,Hispanic of any race,39.6,Male and Female,Stomach,2018
70-74,~,~,~,Incidence,494846,Hispanic of any race,~,Male and Female,Testis,2018
70-74,23.0,29.1,287,Incidence,1106146,Hispanic of any race,25.9,Male and Female,Thyroid,2018
70-74,51.5,60.4,617,Incidence,1106146,Hispanic of any race,55.8,Male and Female,Urinary Bladder,2018
75-79,1675.8,1735.5,12588,Incidence,738119,Hispanic of any race,1705.4,Male and Female,All Cancer Sites Combined,2018
75-79,13.5,19.4,120,Incidence,738119,Hispanic of any race,16.3,Male and Female,Brain and Other Nervous System,2018
75-79,11.6,19.2,64,Incidence,425242,Hispanic of any race,15.1,Male and Female,Cervix,2018
75-79,143.5,161.4,1124,Incidence,738119,Hispanic of any race,152.3,Male and Female,Colon and Rectum,2018
75-79,64.8,81.2,309,Incidence,425242,Hispanic of any race,72.7,Male and Female,"Corpus and Uterus, NOS",2018
75-79,11.8,17.4,106,Incidence,738119,Hispanic of any race,14.4,Male and Female,Esophagus,2018
75-79,298.2,332.2,1339,Incidence,425242,Hispanic of any race,314.9,Male and Female,Female Breast,2018
75-79,50.4,65.0,244,Incidence,425242,Hispanic of any race,57.4,Male and Female,"Female Breast, <i>in situ</i>",2018
75-79,4.4,8.2,45,Incidence,738119,Hispanic of any race,6.1,Male and Female,Hodgkin Lymphoma,2018
75-79,1.4,3.9,18,Incidence,738119,Hispanic of any race,2.4,Male and Female,Kaposi Sarcoma,2018
75-79,66.9,79.3,538,Incidence,738119,Hispanic of any race,72.9,Male and Female,Kidney and Renal Pelvis,2018
75-79,8.6,13.5,80,Incidence,738119,Hispanic of any race,10.8,Male and Female,Larynx,2018
75-79,44.4,54.7,364,Incidence,738119,Hispanic of any race,49.3,Male and Female,Leukemias,2018
75-79,68.7,81.3,552,Incidence,738119,Hispanic of any race,74.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
75-79,208.8,230.3,1619,Incidence,738119,Hispanic of any race,219.3,Male and Female,Lung and Bronchus,2018
75-79,298.2,332.2,1339,Incidence,425242,Hispanic of any race,314.9,Male and Female,Male and Female Breast,2018
75-79,50.4,65.0,244,Incidence,425242,Hispanic of any race,57.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
75-79,17.8,24.6,155,Incidence,738119,Hispanic of any race,21.0,Male and Female,Melanomas of the Skin,2018
75-79,2.3,5.2,26,Incidence,738119,Hispanic of any race,3.5,Male and Female,Mesothelioma,2018
75-79,37.8,47.4,313,Incidence,738119,Hispanic of any race,42.4,Male and Female,Myeloma,2018
75-79,88.1,102.3,701,Incidence,738119,Hispanic of any race,95.0,Male and Female,Non-Hodgkin Lymphoma,2018
75-79,26.1,34.2,221,Incidence,738119,Hispanic of any race,29.9,Male and Female,Oral Cavity and Pharynx,2018
75-79,30.5,42.2,153,Incidence,425242,Hispanic of any race,36.0,Male and Female,Ovary,2018
75-79,73.4,86.4,588,Incidence,738119,Hispanic of any race,79.7,Male and Female,Pancreas,2018
75-79,529.7,582.2,1738,Incidence,312877,Hispanic of any race,555.5,Male and Female,Prostate,2018
75-79,45.1,55.5,370,Incidence,738119,Hispanic of any race,50.1,Male and Female,Stomach,2018
75-79,~,~,~,Incidence,312877,Hispanic of any race,~,Male and Female,Testis,2018
75-79,21.3,28.7,183,Incidence,738119,Hispanic of any race,24.8,Male and Female,Thyroid,2018
75-79,68.5,81.2,551,Incidence,738119,Hispanic of any race,74.6,Male and Female,Urinary Bladder,2018
80-84,1730.0,1803.8,8849,Incidence,500899,Hispanic of any race,1766.6,Male and Female,All Cancer Sites Combined,2018
80-84,15.3,23.2,95,Incidence,500899,Hispanic of any race,19.0,Male and Female,Brain and Other Nervous System,2018
80-84,10.7,19.8,44,Incidence,298067,Hispanic of any race,14.8,Male and Female,Cervix,2018
80-84,166.6,190.2,892,Incidence,500899,Hispanic of any race,178.1,Male and Female,Colon and Rectum,2018
80-84,59.1,78.1,203,Incidence,298067,Hispanic of any race,68.1,Male and Female,"Corpus and Uterus, NOS",2018
80-84,10.9,17.7,70,Incidence,500899,Hispanic of any race,14.0,Male and Female,Esophagus,2018
80-84,274.4,313.7,875,Incidence,298067,Hispanic of any race,293.6,Male and Female,Female Breast,2018
80-84,34.0,48.9,122,Incidence,298067,Hispanic of any race,40.9,Male and Female,"Female Breast, <i>in situ</i>",2018
80-84,4.4,9.0,32,Incidence,500899,Hispanic of any race,6.4,Male and Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,500899,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
80-84,62.7,77.6,350,Incidence,500899,Hispanic of any race,69.9,Male and Female,Kidney and Renal Pelvis,2018
80-84,10.2,16.8,66,Incidence,500899,Hispanic of any race,13.2,Male and Female,Larynx,2018
80-84,55.4,69.4,311,Incidence,500899,Hispanic of any race,62.1,Male and Female,Leukemias,2018
80-84,69.0,84.5,383,Incidence,500899,Hispanic of any race,76.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
80-84,218.8,245.7,1162,Incidence,500899,Hispanic of any race,232.0,Male and Female,Lung and Bronchus,2018
80-84,274.4,313.7,875,Incidence,298067,Hispanic of any race,293.6,Male and Female,Male and Female Breast,2018
80-84,34.0,48.9,122,Incidence,298067,Hispanic of any race,40.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
80-84,19.7,28.4,119,Incidence,500899,Hispanic of any race,23.8,Male and Female,Melanomas of the Skin,2018
80-84,4.7,9.5,34,Incidence,500899,Hispanic of any race,6.8,Male and Female,Mesothelioma,2018
80-84,44.1,56.7,251,Incidence,500899,Hispanic of any race,50.1,Male and Female,Myeloma,2018
80-84,92.6,110.4,507,Incidence,500899,Hispanic of any race,101.2,Male and Female,Non-Hodgkin Lymphoma,2018
80-84,32.4,43.3,188,Incidence,500899,Hispanic of any race,37.5,Male and Female,Oral Cavity and Pharynx,2018
80-84,26.1,39.3,96,Incidence,298067,Hispanic of any race,32.2,Male and Female,Ovary,2018
80-84,77.2,93.5,426,Incidence,500899,Hispanic of any race,85.0,Male and Female,Pancreas,2018
80-84,368.5,423.7,802,Incidence,202832,Hispanic of any race,395.4,Male and Female,Prostate,2018
80-84,49.0,62.2,277,Incidence,500899,Hispanic of any race,55.3,Male and Female,Stomach,2018
80-84,~,~,~,Incidence,202832,Hispanic of any race,~,Male and Female,Testis,2018
80-84,13.7,21.2,86,Incidence,500899,Hispanic of any race,17.2,Male and Female,Thyroid,2018
80-84,84.6,101.7,465,Incidence,500899,Hispanic of any race,92.8,Male and Female,Urinary Bladder,2018
85+,1617.7,1690.5,7955,Incidence,481014,Hispanic of any race,1653.8,Male and Female,All Cancer Sites Combined,2018
85+,14.5,22.3,87,Incidence,481014,Hispanic of any race,18.1,Male and Female,Brain and Other Nervous System,2018
85+,5.0,11.6,24,Incidence,306741,Hispanic of any race,7.8,Male and Female,Cervix,2018
85+,184.9,210.3,949,Incidence,481014,Hispanic of any race,197.3,Male and Female,Colon and Rectum,2018
85+,30.1,43.9,112,Incidence,306741,Hispanic of any race,36.5,Male and Female,"Corpus and Uterus, NOS",2018
85+,11.9,19.1,73,Incidence,481014,Hispanic of any race,15.2,Male and Female,Esophagus,2018
85+,207.8,241.7,688,Incidence,306741,Hispanic of any race,224.3,Male and Female,Female Breast,2018
85+,15.2,25.5,61,Incidence,306741,Hispanic of any race,19.9,Male and Female,"Female Breast, <i>in situ</i>",2018
85+,2.7,6.7,21,Incidence,481014,Hispanic of any race,4.4,Male and Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,481014,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
85+,46.3,59.5,253,Incidence,481014,Hispanic of any race,52.6,Male and Female,Kidney and Renal Pelvis,2018
85+,7.5,13.5,49,Incidence,481014,Hispanic of any race,10.2,Male and Female,Larynx,2018
85+,50.2,63.9,273,Incidence,481014,Hispanic of any race,56.8,Male and Female,Leukemias,2018
85+,57.5,72.0,310,Incidence,481014,Hispanic of any race,64.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
85+,194.8,220.8,998,Incidence,481014,Hispanic of any race,207.5,Male and Female,Lung and Bronchus,2018
85+,207.8,241.7,688,Incidence,306741,Hispanic of any race,224.3,Male and Female,Male and Female Breast,2018
85+,15.2,25.5,61,Incidence,306741,Hispanic of any race,19.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
85+,22.0,31.4,127,Incidence,481014,Hispanic of any race,26.4,Male and Female,Melanomas of the Skin,2018
85+,3.2,7.4,24,Incidence,481014,Hispanic of any race,5.0,Male and Female,Mesothelioma,2018
85+,32.9,44.2,184,Incidence,481014,Hispanic of any race,38.3,Male and Female,Myeloma,2018
85+,74.4,90.8,396,Incidence,481014,Hispanic of any race,82.3,Male and Female,Non-Hodgkin Lymphoma,2018
85+,25.6,35.7,146,Incidence,481014,Hispanic of any race,30.4,Male and Female,Oral Cavity and Pharynx,2018
85+,20.4,32.1,79,Incidence,306741,Hispanic of any race,25.8,Male and Female,Ovary,2018
85+,80.4,97.4,426,Incidence,481014,Hispanic of any race,88.6,Male and Female,Pancreas,2018
85+,313.4,368.8,593,Incidence,174273,Hispanic of any race,340.3,Male and Female,Prostate,2018
85+,53.2,67.2,288,Incidence,481014,Hispanic of any race,59.9,Male and Female,Stomach,2018
85+,~,~,~,Incidence,174273,Hispanic of any race,~,Male and Female,Testis,2018
85+,7.2,13.0,47,Incidence,481014,Hispanic of any race,9.8,Male and Female,Thyroid,2018
85+,94.4,112.8,497,Incidence,481014,Hispanic of any race,103.3,Male and Female,Urinary Bladder,2018
<1,18.6,24.5,211,Incidence,985128,Hispanic of any race,21.4,Male and Female,All Cancer Sites Combined,2018
<1,1.4,3.4,22,Incidence,985128,Hispanic of any race,2.2,Male and Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,Cervix,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Colon and Rectum,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Esophagus,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,Female Breast,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Larynx,2018
<1,2.6,5.1,36,Incidence,985128,Hispanic of any race,3.7,Male and Female,Leukemias,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,Male and Female Breast,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Mesothelioma,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Myeloma,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,483622,Hispanic of any race,~,Male and Female,Ovary,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Pancreas,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male and Female,Prostate,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Stomach,2018
<1,~,~,~,Incidence,501506,Hispanic of any race,~,Male and Female,Testis,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Thyroid,2018
<1,~,~,~,Incidence,985128,Hispanic of any race,~,Male and Female,Urinary Bladder,2018
1-4,17.6,43.5,21,Incidence,73762,Non-Hispanic American Indian/Alaska Native,28.5,Female,All Cancer Sites Combined,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
10-14,13.0,32.0,21,Incidence,100346,Non-Hispanic American Indian/Alaska Native,20.9,Female,All Cancer Sites Combined,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
15-19,17.0,38.1,26,Incidence,100037,Non-Hispanic American Indian/Alaska Native,26.0,Female,All Cancer Sites Combined,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
20-24,32.6,59.4,46,Incidence,103307,Non-Hispanic American Indian/Alaska Native,44.5,Female,All Cancer Sites Combined,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
20-24,9.6,26.3,17,Incidence,103307,Non-Hispanic American Indian/Alaska Native,16.5,Female,Thyroid,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
25-29,53.5,85.3,75,Incidence,110194,Non-Hispanic American Indian/Alaska Native,68.1,Female,All Cancer Sites Combined,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
25-29,16.9,36.7,28,Incidence,110194,Non-Hispanic American Indian/Alaska Native,25.4,Female,Thyroid,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
30-34,113.9,162.2,129,Incidence,94525,Non-Hispanic American Indian/Alaska Native,136.5,Female,All Cancer Sites Combined,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
30-34,11.3,30.1,18,Incidence,94525,Non-Hispanic American Indian/Alaska Native,19.0,Female,Cervix,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
30-34,11.3,30.1,18,Incidence,94525,Non-Hispanic American Indian/Alaska Native,19.0,Female,Female Breast,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
30-34,18.0,40.3,26,Incidence,94525,Non-Hispanic American Indian/Alaska Native,27.5,Female,Thyroid,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
35-39,200.8,265.5,204,Incidence,88127,Non-Hispanic American Indian/Alaska Native,231.5,Female,All Cancer Sites Combined,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
35-39,12.1,32.3,18,Incidence,88127,Non-Hispanic American Indian/Alaska Native,20.4,Female,Cervix,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
35-39,16.5,39.2,23,Incidence,88127,Non-Hispanic American Indian/Alaska Native,26.1,Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
35-39,39.2,70.9,47,Incidence,88127,Non-Hispanic American Indian/Alaska Native,53.3,Female,Female Breast,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
35-39,27.7,55.2,35,Incidence,88127,Non-Hispanic American Indian/Alaska Native,39.7,Female,Thyroid,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
40-44,307.4,390.8,275,Incidence,79195,Non-Hispanic American Indian/Alaska Native,347.2,Female,All Cancer Sites Combined,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
40-44,11.5,32.8,16,Incidence,79195,Non-Hispanic American Indian/Alaska Native,20.2,Female,Colon and Rectum,2018
40-44,16.4,40.5,21,Incidence,79195,Non-Hispanic American Indian/Alaska Native,26.5,Female,"Corpus and Uterus, NOS",2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
40-44,107.3,159.1,104,Incidence,79195,Non-Hispanic American Indian/Alaska Native,131.3,Female,Female Breast,2018
40-44,23.5,51.1,28,Incidence,79195,Non-Hispanic American Indian/Alaska Native,35.4,Female,"Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
40-44,32.9,64.4,37,Incidence,79195,Non-Hispanic American Indian/Alaska Native,46.7,Female,Thyroid,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
45-49,406.0,499.4,368,Incidence,81622,Non-Hispanic American Indian/Alaska Native,450.9,Female,All Cancer Sites Combined,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
45-49,15.0,37.8,20,Incidence,81622,Non-Hispanic American Indian/Alaska Native,24.5,Female,Cervix,2018
45-49,36.0,68.1,41,Incidence,81622,Non-Hispanic American Indian/Alaska Native,50.2,Female,Colon and Rectum,2018
45-49,27.8,56.8,33,Incidence,81622,Non-Hispanic American Indian/Alaska Native,40.4,Female,"Corpus and Uterus, NOS",2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
45-49,126.4,181.1,124,Incidence,81622,Non-Hispanic American Indian/Alaska Native,151.9,Female,Female Breast,2018
45-49,21.8,48.1,27,Incidence,81622,Non-Hispanic American Indian/Alaska Native,33.1,Female,"Female Breast, <i>in situ</i>",2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
45-49,15.9,39.3,21,Incidence,81622,Non-Hispanic American Indian/Alaska Native,25.7,Female,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
45-49,20.8,46.7,26,Incidence,81622,Non-Hispanic American Indian/Alaska Native,31.9,Female,Thyroid,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
50-54,566.9,673.9,525,Incidence,84863,Non-Hispanic American Indian/Alaska Native,618.6,Female,All Cancer Sites Combined,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
50-54,44.7,79.0,51,Incidence,84863,Non-Hispanic American Indian/Alaska Native,60.1,Female,Colon and Rectum,2018
50-54,46.8,81.7,53,Incidence,84863,Non-Hispanic American Indian/Alaska Native,62.5,Female,"Corpus and Uterus, NOS",2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
50-54,173.5,235.3,172,Incidence,84863,Non-Hispanic American Indian/Alaska Native,202.7,Female,Female Breast,2018
50-54,26.8,54.6,33,Incidence,84863,Non-Hispanic American Indian/Alaska Native,38.9,Female,"Female Breast, <i>in situ</i>",2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
50-54,22.9,49.1,29,Incidence,84863,Non-Hispanic American Indian/Alaska Native,34.2,Female,Kidney and Renal Pelvis,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
50-54,30.7,60.1,37,Incidence,84863,Non-Hispanic American Indian/Alaska Native,43.6,Female,Lung and Bronchus,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
50-54,22.9,49.1,29,Incidence,84863,Non-Hispanic American Indian/Alaska Native,34.2,Female,Thyroid,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
55-59,717.7,833.2,703,Incidence,90844,Non-Hispanic American Indian/Alaska Native,773.9,Female,All Cancer Sites Combined,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
55-59,51.4,86.3,61,Incidence,90844,Non-Hispanic American Indian/Alaska Native,67.1,Female,Colon and Rectum,2018
55-59,69.8,109.6,80,Incidence,90844,Non-Hispanic American Indian/Alaska Native,88.1,Female,"Corpus and Uterus, NOS",2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
55-59,195.8,258.8,205,Incidence,90844,Non-Hispanic American Indian/Alaska Native,225.7,Female,Female Breast,2018
55-59,17.8,40.6,25,Incidence,90844,Non-Hispanic American Indian/Alaska Native,27.5,Female,"Female Breast, <i>in situ</i>",2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
55-59,26.8,53.6,35,Incidence,90844,Non-Hispanic American Indian/Alaska Native,38.5,Female,Kidney and Renal Pelvis,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
55-59,10.1,28.6,16,Incidence,90844,Non-Hispanic American Indian/Alaska Native,17.6,Female,Leukemias,2018
55-59,15.2,36.7,22,Incidence,90844,Non-Hispanic American Indian/Alaska Native,24.2,Female,Liver and Intrahepatic Bile Duct,2018
55-59,69.8,109.6,80,Incidence,90844,Non-Hispanic American Indian/Alaska Native,88.1,Female,Lung and Bronchus,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
55-59,13.4,34.0,20,Incidence,90844,Non-Hispanic American Indian/Alaska Native,22.0,Female,Non-Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
55-59,13.4,34.0,20,Incidence,90844,Non-Hispanic American Indian/Alaska Native,22.0,Female,Pancreas,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
55-59,17.8,40.6,25,Incidence,90844,Non-Hispanic American Indian/Alaska Native,27.5,Female,Thyroid,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
60-64,930.3,1068.9,811,Incidence,81276,Non-Hispanic American Indian/Alaska Native,997.8,Female,All Cancer Sites Combined,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
60-64,69.3,111.6,72,Incidence,81276,Non-Hispanic American Indian/Alaska Native,88.6,Female,Colon and Rectum,2018
60-64,47.8,83.9,52,Incidence,81276,Non-Hispanic American Indian/Alaska Native,64.0,Female,"Corpus and Uterus, NOS",2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
60-64,259.1,335.1,240,Incidence,81276,Non-Hispanic American Indian/Alaska Native,295.3,Female,Female Breast,2018
60-64,51.0,88.1,55,Incidence,81276,Non-Hispanic American Indian/Alaska Native,67.7,Female,"Female Breast, <i>in situ</i>",2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
60-64,48.8,85.3,53,Incidence,81276,Non-Hispanic American Indian/Alaska Native,65.2,Female,Kidney and Renal Pelvis,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
60-64,14.1,36.5,19,Incidence,81276,Non-Hispanic American Indian/Alaska Native,23.4,Female,Leukemias,2018
60-64,25.9,54.1,31,Incidence,81276,Non-Hispanic American Indian/Alaska Native,38.1,Female,Liver and Intrahepatic Bile Duct,2018
60-64,116.8,169.8,115,Incidence,81276,Non-Hispanic American Indian/Alaska Native,141.5,Female,Lung and Bronchus,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
60-64,16.0,39.5,21,Incidence,81276,Non-Hispanic American Indian/Alaska Native,25.8,Female,Non-Hodgkin Lymphoma,2018
60-64,13.1,35.0,18,Incidence,81276,Non-Hispanic American Indian/Alaska Native,22.1,Female,Oral Cavity and Pharynx,2018
60-64,13.1,35.0,18,Incidence,81276,Non-Hispanic American Indian/Alaska Native,22.1,Female,Ovary,2018
60-64,16.0,39.5,21,Incidence,81276,Non-Hispanic American Indian/Alaska Native,25.8,Female,Pancreas,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
60-64,21.9,48.3,27,Incidence,81276,Non-Hispanic American Indian/Alaska Native,33.2,Female,Thyroid,2018
60-64,12.2,33.5,17,Incidence,81276,Non-Hispanic American Indian/Alaska Native,20.9,Female,Urinary Bladder,2018
65-69,1114.6,1287.3,754,Incidence,62906,Non-Hispanic American Indian/Alaska Native,1198.6,Female,All Cancer Sites Combined,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
65-69,83.9,137.0,68,Incidence,62906,Non-Hispanic American Indian/Alaska Native,108.1,Female,Colon and Rectum,2018
65-69,65.9,113.8,55,Incidence,62906,Non-Hispanic American Indian/Alaska Native,87.4,Female,"Corpus and Uterus, NOS",2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
65-69,256.2,343.1,187,Incidence,62906,Non-Hispanic American Indian/Alaska Native,297.3,Female,Female Breast,2018
65-69,42.7,82.9,38,Incidence,62906,Non-Hispanic American Indian/Alaska Native,60.4,Female,"Female Breast, <i>in situ</i>",2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
65-69,34.8,71.8,32,Incidence,62906,Non-Hispanic American Indian/Alaska Native,50.9,Female,Kidney and Renal Pelvis,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
65-69,18.2,47.2,19,Incidence,62906,Non-Hispanic American Indian/Alaska Native,30.2,Female,Leukemias,2018
65-69,25.7,58.7,25,Incidence,62906,Non-Hispanic American Indian/Alaska Native,39.7,Female,Liver and Intrahepatic Bile Duct,2018
65-69,174.1,247.1,131,Incidence,62906,Non-Hispanic American Indian/Alaska Native,208.2,Female,Lung and Bronchus,2018
65-69,15.7,43.3,17,Incidence,62906,Non-Hispanic American Indian/Alaska Native,27.0,Female,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
65-69,18.2,47.2,19,Incidence,62906,Non-Hispanic American Indian/Alaska Native,30.2,Female,Myeloma,2018
65-69,37.4,75.5,34,Incidence,62906,Non-Hispanic American Indian/Alaska Native,54.0,Female,Non-Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
65-69,17.0,45.2,18,Incidence,62906,Non-Hispanic American Indian/Alaska Native,28.6,Female,Ovary,2018
65-69,23.2,54.9,23,Incidence,62906,Non-Hispanic American Indian/Alaska Native,36.6,Female,Pancreas,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
70-74,1434.2,1666.6,695,Incidence,44922,Non-Hispanic American Indian/Alaska Native,1547.1,Female,All Cancer Sites Combined,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
70-74,107.8,179.4,63,Incidence,44922,Non-Hispanic American Indian/Alaska Native,140.2,Female,Colon and Rectum,2018
70-74,59.9,116.1,38,Incidence,44922,Non-Hispanic American Indian/Alaska Native,84.6,Female,"Corpus and Uterus, NOS",2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
70-74,290.8,401.4,154,Incidence,44922,Non-Hispanic American Indian/Alaska Native,342.8,Female,Female Breast,2018
70-74,32.5,76.8,23,Incidence,44922,Non-Hispanic American Indian/Alaska Native,51.2,Female,"Female Breast, <i>in situ</i>",2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
70-74,54.3,108.4,35,Incidence,44922,Non-Hispanic American Indian/Alaska Native,77.9,Female,Kidney and Renal Pelvis,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
70-74,28.9,71.5,21,Incidence,44922,Non-Hispanic American Indian/Alaska Native,46.7,Female,Liver and Intrahepatic Bile Duct,2018
70-74,266.3,372.6,142,Incidence,44922,Non-Hispanic American Indian/Alaska Native,316.1,Female,Lung and Bronchus,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
70-74,34.2,79.5,24,Incidence,44922,Non-Hispanic American Indian/Alaska Native,53.4,Female,Non-Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
70-74,34.2,79.5,24,Incidence,44922,Non-Hispanic American Indian/Alaska Native,53.4,Female,Ovary,2018
70-74,37.8,84.8,26,Incidence,44922,Non-Hispanic American Indian/Alaska Native,57.9,Female,Pancreas,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
75-79,1467.1,1762.6,467,Incidence,29010,Non-Hispanic American Indian/Alaska Native,1609.8,Female,All Cancer Sites Combined,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
75-79,101.4,191.7,41,Incidence,29010,Non-Hispanic American Indian/Alaska Native,141.3,Female,Colon and Rectum,2018
75-79,34.1,93.8,17,Incidence,29010,Non-Hispanic American Indian/Alaska Native,58.6,Female,"Corpus and Uterus, NOS",2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
75-79,264.9,400.3,95,Incidence,29010,Non-Hispanic American Indian/Alaska Native,327.5,Female,Female Breast,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
75-79,61.3,135.4,27,Incidence,29010,Non-Hispanic American Indian/Alaska Native,93.1,Female,Kidney and Renal Pelvis,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
75-79,44.8,110.7,21,Incidence,29010,Non-Hispanic American Indian/Alaska Native,72.4,Female,Liver and Intrahepatic Bile Duct,2018
75-79,261.8,396.5,94,Incidence,29010,Non-Hispanic American Indian/Alaska Native,324.0,Female,Lung and Bronchus,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
75-79,58.5,131.3,26,Incidence,29010,Non-Hispanic American Indian/Alaska Native,89.6,Female,Non-Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
75-79,42.1,106.5,20,Incidence,29010,Non-Hispanic American Indian/Alaska Native,68.9,Female,Pancreas,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
80-84,1537.7,1923.9,315,Incidence,18285,Non-Hispanic American Indian/Alaska Native,1722.7,Female,All Cancer Sites Combined,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
80-84,137.9,272.6,36,Incidence,18285,Non-Hispanic American Indian/Alaska Native,196.9,Female,Colon and Rectum,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
80-84,274.4,453.1,65,Incidence,18285,Non-Hispanic American Indian/Alaska Native,355.5,Female,Female Breast,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
80-84,293.6,477.6,69,Incidence,18285,Non-Hispanic American Indian/Alaska Native,377.4,Female,Lung and Bronchus,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
80-84,50.0,142.1,16,Incidence,18285,Non-Hispanic American Indian/Alaska Native,87.5,Female,Pancreas,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
85+,1102.9,1436.9,227,Incidence,17992,Non-Hispanic American Indian/Alaska Native,1261.7,Female,All Cancer Sites Combined,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
85+,94.4,211.7,26,Incidence,17992,Non-Hispanic American Indian/Alaska Native,144.5,Female,Colon and Rectum,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
85+,140.1,277.0,36,Incidence,17992,Non-Hispanic American Indian/Alaska Native,200.1,Female,Female Breast,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
85+,168.2,315.5,42,Incidence,17992,Non-Hispanic American Indian/Alaska Native,233.4,Female,Lung and Bronchus,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
85+,50.8,144.4,16,Incidence,17992,Non-Hispanic American Indian/Alaska Native,88.9,Female,Pancreas,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
1-4,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
10-14,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
15-19,14.2,33.5,23,Incidence,102955,Non-Hispanic American Indian/Alaska Native,22.3,Male,All Cancer Sites Combined,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
15-19,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
20-24,15.3,34.8,25,Incidence,105941,Non-Hispanic American Indian/Alaska Native,23.6,Male,All Cancer Sites Combined,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
20-24,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
25-29,41.0,68.9,61,Incidence,113715,Non-Hispanic American Indian/Alaska Native,53.6,Male,All Cancer Sites Combined,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
25-29,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
25-29,10.7,27.2,20,Incidence,113715,Non-Hispanic American Indian/Alaska Native,17.6,Male,Testis,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
30-34,57.0,92.8,69,Incidence,94133,Non-Hispanic American Indian/Alaska Native,73.3,Male,All Cancer Sites Combined,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
30-34,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
30-34,11.3,30.2,18,Incidence,94133,Non-Hispanic American Indian/Alaska Native,19.1,Male,Testis,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
35-39,78.2,121.4,84,Incidence,85685,Non-Hispanic American Indian/Alaska Native,98.0,Male,All Cancer Sites Combined,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
35-39,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
40-44,145.3,206.0,132,Incidence,75999,Non-Hispanic American Indian/Alaska Native,173.7,Male,All Cancer Sites Combined,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
40-44,14.0,37.4,18,Incidence,75999,Non-Hispanic American Indian/Alaska Native,23.7,Male,Colon and Rectum,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
40-44,26.6,56.4,30,Incidence,75999,Non-Hispanic American Indian/Alaska Native,39.5,Male,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
40-44,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
45-49,248.8,325.3,221,Incidence,77506,Non-Hispanic American Indian/Alaska Native,285.1,Male,All Cancer Sites Combined,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
45-49,39.1,73.2,42,Incidence,77506,Non-Hispanic American Indian/Alaska Native,54.2,Male,Colon and Rectum,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
45-49,33.6,65.8,37,Incidence,77506,Non-Hispanic American Indian/Alaska Native,47.7,Male,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
45-49,11.8,33.5,16,Incidence,77506,Non-Hispanic American Indian/Alaska Native,20.6,Male,Lung and Bronchus,2018
45-49,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
5-9,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
50-54,473.1,575.6,410,Incidence,78475,Non-Hispanic American Indian/Alaska Native,522.5,Male,All Cancer Sites Combined,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
50-54,53.9,92.7,56,Incidence,78475,Non-Hispanic American Indian/Alaska Native,71.4,Male,Colon and Rectum,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
50-54,47.3,84.0,50,Incidence,78475,Non-Hispanic American Indian/Alaska Native,63.7,Male,Kidney and Renal Pelvis,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
50-54,16.6,40.9,21,Incidence,78475,Non-Hispanic American Indian/Alaska Native,26.8,Male,Liver and Intrahepatic Bile Duct,2018
50-54,40.7,75.3,44,Incidence,78475,Non-Hispanic American Indian/Alaska Native,56.1,Male,Lung and Bronchus,2018
50-54,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
50-54,13.6,36.3,18,Incidence,78475,Non-Hispanic American Indian/Alaska Native,22.9,Male,Non-Hodgkin Lymphoma,2018
50-54,19.6,45.5,24,Incidence,78475,Non-Hispanic American Indian/Alaska Native,30.6,Male,Oral Cavity and Pharynx,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
50-54,65.0,107.0,66,Incidence,78475,Non-Hispanic American Indian/Alaska Native,84.1,Male,Prostate,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
55-59,702.1,823.1,620,Incidence,81496,Non-Hispanic American Indian/Alaska Native,760.8,Male,All Cancer Sites Combined,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
55-59,75.7,119.5,78,Incidence,81496,Non-Hispanic American Indian/Alaska Native,95.7,Male,Colon and Rectum,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
55-59,47.7,83.7,52,Incidence,81496,Non-Hispanic American Indian/Alaska Native,63.8,Male,Kidney and Renal Pelvis,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
55-59,47.7,83.7,52,Incidence,81496,Non-Hispanic American Indian/Alaska Native,63.8,Male,Liver and Intrahepatic Bile Duct,2018
55-59,76.7,120.8,79,Incidence,81496,Non-Hispanic American Indian/Alaska Native,96.9,Male,Lung and Bronchus,2018
55-59,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
55-59,28.9,58.3,34,Incidence,81496,Non-Hispanic American Indian/Alaska Native,41.7,Male,Non-Hodgkin Lymphoma,2018
55-59,39.2,72.5,44,Incidence,81496,Non-Hispanic American Indian/Alaska Native,54.0,Male,Oral Cavity and Pharynx,2018
55-59,17.9,42.3,23,Incidence,81496,Non-Hispanic American Indian/Alaska Native,28.2,Male,Pancreas,2018
55-59,118.7,172.1,117,Incidence,81496,Non-Hispanic American Indian/Alaska Native,143.6,Male,Prostate,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
60-64,1129.1,1293.0,851,Incidence,70393,Non-Hispanic American Indian/Alaska Native,1208.9,Male,All Cancer Sites Combined,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
60-64,97.7,150.9,86,Incidence,70393,Non-Hispanic American Indian/Alaska Native,122.2,Male,Colon and Rectum,2018
60-64,18.5,45.6,21,Incidence,70393,Non-Hispanic American Indian/Alaska Native,29.8,Male,Esophagus,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
60-64,57.6,100.1,54,Incidence,70393,Non-Hispanic American Indian/Alaska Native,76.7,Male,Kidney and Renal Pelvis,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
60-64,76.3,124.1,69,Incidence,70393,Non-Hispanic American Indian/Alaska Native,98.0,Male,Liver and Intrahepatic Bile Duct,2018
60-64,137.5,199.2,117,Incidence,70393,Non-Hispanic American Indian/Alaska Native,166.2,Male,Lung and Bronchus,2018
60-64,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
60-64,24.1,54.1,26,Incidence,70393,Non-Hispanic American Indian/Alaska Native,36.9,Male,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
60-64,15.2,40.4,18,Incidence,70393,Non-Hispanic American Indian/Alaska Native,25.6,Male,Myeloma,2018
60-64,25.3,55.8,27,Incidence,70393,Non-Hispanic American Indian/Alaska Native,38.4,Male,Non-Hodgkin Lymphoma,2018
60-64,43.0,80.6,42,Incidence,70393,Non-Hispanic American Indian/Alaska Native,59.7,Male,Oral Cavity and Pharynx,2018
60-64,20.7,49.0,23,Incidence,70393,Non-Hispanic American Indian/Alaska Native,32.7,Male,Pancreas,2018
60-64,244.8,324.8,199,Incidence,70393,Non-Hispanic American Indian/Alaska Native,282.7,Male,Prostate,2018
60-64,13.0,36.9,16,Incidence,70393,Non-Hispanic American Indian/Alaska Native,22.7,Male,Stomach,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
60-64,39.4,75.7,39,Incidence,70393,Non-Hispanic American Indian/Alaska Native,55.4,Male,Urinary Bladder,2018
65-69,1403.9,1612.2,817,Incidence,54273,Non-Hispanic American Indian/Alaska Native,1505.4,Male,All Cancer Sites Combined,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
65-69,110.3,175.3,76,Incidence,54273,Non-Hispanic American Indian/Alaska Native,140.0,Male,Colon and Rectum,2018
65-69,28.3,65.8,24,Incidence,54273,Non-Hispanic American Indian/Alaska Native,44.2,Male,Esophagus,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
65-69,71.6,125.6,52,Incidence,54273,Non-Hispanic American Indian/Alaska Native,95.8,Male,Kidney and Renal Pelvis,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
65-69,16.9,47.9,16,Incidence,54273,Non-Hispanic American Indian/Alaska Native,29.5,Male,Leukemias,2018
65-69,58.9,108.8,44,Incidence,54273,Non-Hispanic American Indian/Alaska Native,81.1,Male,Liver and Intrahepatic Bile Duct,2018
65-69,211.9,298.4,137,Incidence,54273,Non-Hispanic American Indian/Alaska Native,252.4,Male,Lung and Bronchus,2018
65-69,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
65-69,25.4,61.4,22,Incidence,54273,Non-Hispanic American Indian/Alaska Native,40.5,Male,Non-Hodgkin Lymphoma,2018
65-69,34.3,74.6,28,Incidence,54273,Non-Hispanic American Indian/Alaska Native,51.6,Male,Oral Cavity and Pharynx,2018
65-69,38.8,81.1,31,Incidence,54273,Non-Hispanic American Indian/Alaska Native,57.1,Male,Pancreas,2018
65-69,338.1,444.9,211,Incidence,54273,Non-Hispanic American Indian/Alaska Native,388.8,Male,Prostate,2018
65-69,19.7,52.4,18,Incidence,54273,Non-Hispanic American Indian/Alaska Native,33.2,Male,Stomach,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
65-69,48.0,94.0,37,Incidence,54273,Non-Hispanic American Indian/Alaska Native,68.2,Male,Urinary Bladder,2018
70-74,1833.4,2116.5,759,Incidence,38506,Non-Hispanic American Indian/Alaska Native,1971.1,Male,All Cancer Sites Combined,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
70-74,128.0,212.2,64,Incidence,38506,Non-Hispanic American Indian/Alaska Native,166.2,Male,Colon and Rectum,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
70-74,109.9,188.9,56,Incidence,38506,Non-Hispanic American Indian/Alaska Native,145.4,Male,Kidney and Renal Pelvis,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
70-74,44.1,98.9,26,Incidence,38506,Non-Hispanic American Indian/Alaska Native,67.5,Male,Leukemias,2018
70-74,63.3,126.4,35,Incidence,38506,Non-Hispanic American Indian/Alaska Native,90.9,Male,Liver and Intrahepatic Bile Duct,2018
70-74,284.4,403.7,131,Incidence,38506,Non-Hispanic American Indian/Alaska Native,340.2,Male,Lung and Bronchus,2018
70-74,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
70-74,25.7,70.7,17,Incidence,38506,Non-Hispanic American Indian/Alaska Native,44.1,Male,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
70-74,39.9,92.7,24,Incidence,38506,Non-Hispanic American Indian/Alaska Native,62.3,Male,Myeloma,2018
70-74,39.9,92.7,24,Incidence,38506,Non-Hispanic American Indian/Alaska Native,62.3,Male,Non-Hodgkin Lymphoma,2018
70-74,44.1,98.9,26,Incidence,38506,Non-Hispanic American Indian/Alaska Native,67.5,Male,Oral Cavity and Pharynx,2018
70-74,42.0,95.8,25,Incidence,38506,Non-Hispanic American Indian/Alaska Native,64.9,Male,Pancreas,2018
70-74,387.2,524.2,174,Incidence,38506,Non-Hispanic American Indian/Alaska Native,451.9,Male,Prostate,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
70-74,65.5,129.4,36,Incidence,38506,Non-Hispanic American Indian/Alaska Native,93.5,Male,Urinary Bladder,2018
75-79,1925.4,2299.4,499,Incidence,23692,Non-Hispanic American Indian/Alaska Native,2106.2,Male,All Cancer Sites Combined,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
75-79,145.8,263.8,47,Incidence,23692,Non-Hispanic American Indian/Alaska Native,198.4,Male,Colon and Rectum,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
75-79,124.2,234.8,41,Incidence,23692,Non-Hispanic American Indian/Alaska Native,173.1,Male,Kidney and Renal Pelvis,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
75-79,51.6,130.4,20,Incidence,23692,Non-Hispanic American Indian/Alaska Native,84.4,Male,Leukemias,2018
75-79,48.3,125.2,19,Incidence,23692,Non-Hispanic American Indian/Alaska Native,80.2,Male,Liver and Intrahepatic Bile Duct,2018
75-79,313.0,476.2,92,Incidence,23692,Non-Hispanic American Indian/Alaska Native,388.3,Male,Lung and Bronchus,2018
75-79,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
75-79,71.7,160.8,26,Incidence,23692,Non-Hispanic American Indian/Alaska Native,109.7,Male,Non-Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
75-79,48.3,125.2,19,Incidence,23692,Non-Hispanic American Indian/Alaska Native,80.2,Male,Pancreas,2018
75-79,339.6,508.7,99,Incidence,23692,Non-Hispanic American Indian/Alaska Native,417.9,Male,Prostate,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
75-79,85.4,180.8,30,Incidence,23692,Non-Hispanic American Indian/Alaska Native,126.6,Male,Urinary Bladder,2018
80-84,1954.6,2465.0,294,Incidence,13371,Non-Hispanic American Indian/Alaska Native,2198.8,Male,All Cancer Sites Combined,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
80-84,163.7,337.9,32,Incidence,13371,Non-Hispanic American Indian/Alaska Native,239.3,Male,Colon and Rectum,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
80-84,85.6,221.9,19,Incidence,13371,Non-Hispanic American Indian/Alaska Native,142.1,Male,Kidney and Renal Pelvis,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
80-84,329.4,560.8,58,Incidence,13371,Non-Hispanic American Indian/Alaska Native,433.8,Male,Lung and Bronchus,2018
80-84,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
80-84,232.7,433.2,43,Incidence,13371,Non-Hispanic American Indian/Alaska Native,321.6,Male,Prostate,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
80-84,145.3,311.5,29,Incidence,13371,Non-Hispanic American Indian/Alaska Native,216.9,Male,Urinary Bladder,2018
85+,1641.5,2181.4,197,Incidence,10384,Non-Hispanic American Indian/Alaska Native,1897.1,Male,All Cancer Sites Combined,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
85+,155.8,355.4,25,Incidence,10384,Non-Hispanic American Indian/Alaska Native,240.8,Male,Colon and Rectum,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
85+,125.2,309.1,21,Incidence,10384,Non-Hispanic American Indian/Alaska Native,202.2,Male,Lung and Bronchus,2018
85+,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
85+,194.9,412.4,30,Incidence,10384,Non-Hispanic American Indian/Alaska Native,288.9,Male,Prostate,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
85+,117.6,297.5,20,Incidence,10384,Non-Hispanic American Indian/Alaska Native,192.6,Male,Urinary Bladder,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2018
<1,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2018
1-4,15.1,30.9,33,Incidence,150147,Non-Hispanic American Indian/Alaska Native,22.0,Male and Female,All Cancer Sites Combined,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,73762,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
1-4,~,~,~,Incidence,76385,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
1-4,~,~,~,Incidence,150147,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
10-14,12.4,24.6,36,Incidence,202761,Non-Hispanic American Indian/Alaska Native,17.8,Male and Female,All Cancer Sites Combined,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,100346,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
10-14,~,~,~,Incidence,102415,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
10-14,~,~,~,Incidence,202761,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
15-19,17.9,31.9,49,Incidence,202992,Non-Hispanic American Indian/Alaska Native,24.1,Male and Female,All Cancer Sites Combined,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,100037,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
15-19,~,~,~,Incidence,102955,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
15-19,~,~,~,Incidence,202992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
20-24,26.5,42.8,71,Incidence,209248,Non-Hispanic American Indian/Alaska Native,33.9,Male and Female,All Cancer Sites Combined,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,103307,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
20-24,~,~,~,Incidence,105941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
20-24,5.5,14.2,19,Incidence,209248,Non-Hispanic American Indian/Alaska Native,9.1,Male and Female,Thyroid,2018
20-24,~,~,~,Incidence,209248,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
25-29,51.0,71.8,136,Incidence,223909,Non-Hispanic American Indian/Alaska Native,60.7,Male and Female,All Cancer Sites Combined,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
25-29,~,~,~,Incidence,110194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
25-29,~,~,~,Incidence,113715,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
25-29,10.7,27.2,20,Incidence,113715,Non-Hispanic American Indian/Alaska Native,17.6,Male and Female,Testis,2018
25-29,9.0,19.1,30,Incidence,223909,Non-Hispanic American Indian/Alaska Native,13.4,Male and Female,Thyroid,2018
25-29,~,~,~,Incidence,223909,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
30-34,90.8,120.6,198,Incidence,188658,Non-Hispanic American Indian/Alaska Native,105.0,Male and Female,All Cancer Sites Combined,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
30-34,11.3,30.1,18,Incidence,94525,Non-Hispanic American Indian/Alaska Native,19.0,Male and Female,Cervix,2018
30-34,5.2,14.4,17,Incidence,188658,Non-Hispanic American Indian/Alaska Native,9.0,Male and Female,Colon and Rectum,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
30-34,11.3,30.1,18,Incidence,94525,Non-Hispanic American Indian/Alaska Native,19.0,Male and Female,Female Breast,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
30-34,4.8,13.8,16,Incidence,188658,Non-Hispanic American Indian/Alaska Native,8.5,Male and Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
30-34,11.3,30.1,18,Incidence,94525,Non-Hispanic American Indian/Alaska Native,19.0,Male and Female,Male and Female Breast,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
30-34,~,~,~,Incidence,94525,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
30-34,~,~,~,Incidence,94133,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
30-34,11.3,30.2,18,Incidence,94133,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Testis,2018
30-34,11.2,23.3,31,Incidence,188658,Non-Hispanic American Indian/Alaska Native,16.4,Male and Female,Thyroid,2018
30-34,~,~,~,Incidence,188658,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
35-39,147.1,186.0,288,Incidence,173812,Non-Hispanic American Indian/Alaska Native,165.7,Male and Female,All Cancer Sites Combined,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
35-39,12.1,32.3,18,Incidence,88127,Non-Hispanic American Indian/Alaska Native,20.4,Male and Female,Cervix,2018
35-39,8.4,19.9,23,Incidence,173812,Non-Hispanic American Indian/Alaska Native,13.2,Male and Female,Colon and Rectum,2018
35-39,16.5,39.2,23,Incidence,88127,Non-Hispanic American Indian/Alaska Native,26.1,Male and Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
35-39,39.2,70.9,47,Incidence,88127,Non-Hispanic American Indian/Alaska Native,53.3,Male and Female,Female Breast,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
35-39,7.9,19.2,22,Incidence,173812,Non-Hispanic American Indian/Alaska Native,12.7,Male and Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
35-39,39.2,70.9,47,Incidence,88127,Non-Hispanic American Indian/Alaska Native,53.3,Male and Female,Male and Female Breast,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
35-39,~,~,~,Incidence,88127,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
35-39,~,~,~,Incidence,85685,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
35-39,16.4,31.3,40,Incidence,173812,Non-Hispanic American Indian/Alaska Native,23.0,Male and Female,Thyroid,2018
35-39,~,~,~,Incidence,173812,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
40-44,237.4,289.0,407,Incidence,155194,Non-Hispanic American Indian/Alaska Native,262.3,Male and Female,All Cancer Sites Combined,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
40-44,15.2,30.6,34,Incidence,155194,Non-Hispanic American Indian/Alaska Native,21.9,Male and Female,Colon and Rectum,2018
40-44,16.4,40.5,21,Incidence,79195,Non-Hispanic American Indian/Alaska Native,26.5,Male and Female,"Corpus and Uterus, NOS",2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
40-44,107.3,159.1,104,Incidence,79195,Non-Hispanic American Indian/Alaska Native,131.3,Male and Female,Female Breast,2018
40-44,23.5,51.1,28,Incidence,79195,Non-Hispanic American Indian/Alaska Native,35.4,Male and Female,"Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
40-44,20.6,38.1,44,Incidence,155194,Non-Hispanic American Indian/Alaska Native,28.4,Male and Female,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
40-44,107.3,159.1,104,Incidence,79195,Non-Hispanic American Indian/Alaska Native,131.3,Male and Female,Male and Female Breast,2018
40-44,23.5,51.1,28,Incidence,79195,Non-Hispanic American Indian/Alaska Native,35.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
40-44,~,~,~,Incidence,79195,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
40-44,~,~,~,Incidence,75999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
40-44,20.1,37.3,43,Incidence,155194,Non-Hispanic American Indian/Alaska Native,27.7,Male and Female,Thyroid,2018
40-44,~,~,~,Incidence,155194,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
45-49,340.8,401.3,589,Incidence,159128,Non-Hispanic American Indian/Alaska Native,370.1,Male and Female,All Cancer Sites Combined,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
45-49,15.0,37.8,20,Incidence,81622,Non-Hispanic American Indian/Alaska Native,24.5,Male and Female,Cervix,2018
45-49,41.5,64.7,83,Incidence,159128,Non-Hispanic American Indian/Alaska Native,52.2,Male and Female,Colon and Rectum,2018
45-49,27.8,56.8,33,Incidence,81622,Non-Hispanic American Indian/Alaska Native,40.4,Male and Female,"Corpus and Uterus, NOS",2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
45-49,126.4,181.1,124,Incidence,81622,Non-Hispanic American Indian/Alaska Native,151.9,Male and Female,Female Breast,2018
45-49,21.8,48.1,27,Incidence,81622,Non-Hispanic American Indian/Alaska Native,33.1,Male and Female,"Female Breast, <i>in situ</i>",2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
45-49,27.7,47.1,58,Incidence,159128,Non-Hispanic American Indian/Alaska Native,36.4,Male and Female,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
45-49,12.7,26.9,30,Incidence,159128,Non-Hispanic American Indian/Alaska Native,18.9,Male and Female,Lung and Bronchus,2018
45-49,126.4,181.1,124,Incidence,81622,Non-Hispanic American Indian/Alaska Native,151.9,Male and Female,Male and Female Breast,2018
45-49,21.8,48.1,27,Incidence,81622,Non-Hispanic American Indian/Alaska Native,33.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
45-49,6.2,17.1,17,Incidence,159128,Non-Hispanic American Indian/Alaska Native,10.7,Male and Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
45-49,5.7,16.3,16,Incidence,159128,Non-Hispanic American Indian/Alaska Native,10.1,Male and Female,Non-Hodgkin Lymphoma,2018
45-49,7.2,18.6,19,Incidence,159128,Non-Hispanic American Indian/Alaska Native,11.9,Male and Female,Oral Cavity and Pharynx,2018
45-49,~,~,~,Incidence,81622,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
45-49,~,~,~,Incidence,77506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
45-49,16.4,32.0,37,Incidence,159128,Non-Hispanic American Indian/Alaska Native,23.3,Male and Female,Thyroid,2018
45-49,~,~,~,Incidence,159128,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
5-9,6.6,16.3,21,Incidence,196738,Non-Hispanic American Indian/Alaska Native,10.7,Male and Female,All Cancer Sites Combined,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,97033,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
5-9,~,~,~,Incidence,99705,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
5-9,~,~,~,Incidence,196738,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
50-54,536.3,610.3,935,Incidence,163338,Non-Hispanic American Indian/Alaska Native,572.4,Male and Female,All Cancer Sites Combined,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
50-54,53.7,79.2,107,Incidence,163338,Non-Hispanic American Indian/Alaska Native,65.5,Male and Female,Colon and Rectum,2018
50-54,46.8,81.7,53,Incidence,84863,Non-Hispanic American Indian/Alaska Native,62.5,Male and Female,"Corpus and Uterus, NOS",2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
50-54,173.5,235.3,172,Incidence,84863,Non-Hispanic American Indian/Alaska Native,202.7,Male and Female,Female Breast,2018
50-54,26.8,54.6,33,Incidence,84863,Non-Hispanic American Indian/Alaska Native,38.9,Male and Female,"Female Breast, <i>in situ</i>",2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
50-54,38.3,60.3,79,Incidence,163338,Non-Hispanic American Indian/Alaska Native,48.4,Male and Female,Kidney and Renal Pelvis,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
50-54,9.9,22.6,25,Incidence,163338,Non-Hispanic American Indian/Alaska Native,15.3,Male and Female,Leukemias,2018
50-54,13.9,28.4,33,Incidence,163338,Non-Hispanic American Indian/Alaska Native,20.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
50-54,39.4,61.6,81,Incidence,163338,Non-Hispanic American Indian/Alaska Native,49.6,Male and Female,Lung and Bronchus,2018
50-54,173.5,235.3,172,Incidence,84863,Non-Hispanic American Indian/Alaska Native,202.7,Male and Female,Male and Female Breast,2018
50-54,26.8,54.6,33,Incidence,84863,Non-Hispanic American Indian/Alaska Native,38.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
50-54,8.0,19.7,21,Incidence,163338,Non-Hispanic American Indian/Alaska Native,12.9,Male and Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
50-54,7.0,18.2,19,Incidence,163338,Non-Hispanic American Indian/Alaska Native,11.6,Male and Female,Myeloma,2018
50-54,12.4,26.2,30,Incidence,163338,Non-Hispanic American Indian/Alaska Native,18.4,Male and Female,Non-Hodgkin Lymphoma,2018
50-54,10.9,24.1,27,Incidence,163338,Non-Hispanic American Indian/Alaska Native,16.5,Male and Female,Oral Cavity and Pharynx,2018
50-54,~,~,~,Incidence,84863,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
50-54,65.0,107.0,66,Incidence,78475,Non-Hispanic American Indian/Alaska Native,84.1,Male and Female,Prostate,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
50-54,~,~,~,Incidence,78475,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
50-54,14.4,29.1,34,Incidence,163338,Non-Hispanic American Indian/Alaska Native,20.8,Male and Female,Thyroid,2018
50-54,~,~,~,Incidence,163338,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
55-59,726.9,810.2,1323,Incidence,172340,Non-Hispanic American Indian/Alaska Native,767.7,Male and Female,All Cancer Sites Combined,2018
55-59,~,~,~,Incidence,172340,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
55-59,67.8,95.2,139,Incidence,172340,Non-Hispanic American Indian/Alaska Native,80.7,Male and Female,Colon and Rectum,2018
55-59,69.8,109.6,80,Incidence,90844,Non-Hispanic American Indian/Alaska Native,88.1,Male and Female,"Corpus and Uterus, NOS",2018
55-59,5.3,15.1,16,Incidence,172340,Non-Hispanic American Indian/Alaska Native,9.3,Male and Female,Esophagus,2018
55-59,195.8,258.8,205,Incidence,90844,Non-Hispanic American Indian/Alaska Native,225.7,Male and Female,Female Breast,2018
55-59,17.8,40.6,25,Incidence,90844,Non-Hispanic American Indian/Alaska Native,27.5,Male and Female,"Female Breast, <i>in situ</i>",2018
55-59,~,~,~,Incidence,172340,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,172340,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
55-59,40.4,62.3,87,Incidence,172340,Non-Hispanic American Indian/Alaska Native,50.5,Male and Female,Kidney and Renal Pelvis,2018
55-59,~,~,~,Incidence,172340,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
55-59,11.7,24.9,30,Incidence,172340,Non-Hispanic American Indian/Alaska Native,17.4,Male and Female,Leukemias,2018
55-59,33.7,53.9,74,Incidence,172340,Non-Hispanic American Indian/Alaska Native,42.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
55-59,78.5,107.8,159,Incidence,172340,Non-Hispanic American Indian/Alaska Native,92.3,Male and Female,Lung and Bronchus,2018
55-59,195.8,258.8,205,Incidence,90844,Non-Hispanic American Indian/Alaska Native,225.7,Male and Female,Male and Female Breast,2018
55-59,17.8,40.6,25,Incidence,90844,Non-Hispanic American Indian/Alaska Native,27.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
55-59,8.0,19.3,22,Incidence,172340,Non-Hispanic American Indian/Alaska Native,12.8,Male and Female,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,172340,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
55-59,5.3,15.1,16,Incidence,172340,Non-Hispanic American Indian/Alaska Native,9.3,Male and Female,Myeloma,2018
55-59,23.5,40.9,54,Incidence,172340,Non-Hispanic American Indian/Alaska Native,31.3,Male and Female,Non-Hodgkin Lymphoma,2018
55-59,23.0,40.2,53,Incidence,172340,Non-Hispanic American Indian/Alaska Native,30.8,Male and Female,Oral Cavity and Pharynx,2018
55-59,~,~,~,Incidence,90844,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
55-59,18.1,33.6,43,Incidence,172340,Non-Hispanic American Indian/Alaska Native,25.0,Male and Female,Pancreas,2018
55-59,118.7,172.1,117,Incidence,81496,Non-Hispanic American Indian/Alaska Native,143.6,Male and Female,Prostate,2018
55-59,8.9,20.7,24,Incidence,172340,Non-Hispanic American Indian/Alaska Native,13.9,Male and Female,Stomach,2018
55-59,~,~,~,Incidence,81496,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
55-59,13.2,26.9,33,Incidence,172340,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Thyroid,2018
55-59,8.0,19.3,22,Incidence,172340,Non-Hispanic American Indian/Alaska Native,12.8,Male and Female,Urinary Bladder,2018
60-64,1043.8,1149.8,1662,Incidence,151669,Non-Hispanic American Indian/Alaska Native,1095.8,Male and Female,All Cancer Sites Combined,2018
60-64,~,~,~,Incidence,151669,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
60-64,~,~,~,Incidence,81276,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
60-64,88.6,121.7,158,Incidence,151669,Non-Hispanic American Indian/Alaska Native,104.2,Male and Female,Colon and Rectum,2018
60-64,47.8,83.9,52,Incidence,81276,Non-Hispanic American Indian/Alaska Native,64.0,Male and Female,"Corpus and Uterus, NOS",2018
60-64,10.7,24.3,25,Incidence,151669,Non-Hispanic American Indian/Alaska Native,16.5,Male and Female,Esophagus,2018
60-64,259.1,335.1,240,Incidence,81276,Non-Hispanic American Indian/Alaska Native,295.3,Male and Female,Female Breast,2018
60-64,51.0,88.1,55,Incidence,81276,Non-Hispanic American Indian/Alaska Native,67.7,Male and Female,"Female Breast, <i>in situ</i>",2018
60-64,~,~,~,Incidence,151669,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,151669,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
60-64,57.8,85.3,107,Incidence,151669,Non-Hispanic American Indian/Alaska Native,70.5,Male and Female,Kidney and Renal Pelvis,2018
60-64,7.0,18.8,18,Incidence,151669,Non-Hispanic American Indian/Alaska Native,11.9,Male and Female,Larynx,2018
60-64,13.9,29.0,31,Incidence,151669,Non-Hispanic American Indian/Alaska Native,20.4,Male and Female,Leukemias,2018
60-64,53.6,80.2,100,Incidence,151669,Non-Hispanic American Indian/Alaska Native,65.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
60-64,133.9,174.0,232,Incidence,151669,Non-Hispanic American Indian/Alaska Native,153.0,Male and Female,Lung and Bronchus,2018
60-64,259.1,335.1,240,Incidence,81276,Non-Hispanic American Indian/Alaska Native,295.3,Male and Female,Male and Female Breast,2018
60-64,51.0,88.1,55,Incidence,81276,Non-Hispanic American Indian/Alaska Native,67.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
60-64,18.8,35.9,40,Incidence,151669,Non-Hispanic American Indian/Alaska Native,26.4,Male and Female,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,151669,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
60-64,12.8,27.5,29,Incidence,151669,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Myeloma,2018
60-64,23.3,42.0,48,Incidence,151669,Non-Hispanic American Indian/Alaska Native,31.6,Male and Female,Non-Hodgkin Lymphoma,2018
60-64,30.2,50.9,60,Incidence,151669,Non-Hispanic American Indian/Alaska Native,39.6,Male and Female,Oral Cavity and Pharynx,2018
60-64,13.1,35.0,18,Incidence,81276,Non-Hispanic American Indian/Alaska Native,22.1,Male and Female,Ovary,2018
60-64,21.1,38.9,44,Incidence,151669,Non-Hispanic American Indian/Alaska Native,29.0,Male and Female,Pancreas,2018
60-64,244.8,324.8,199,Incidence,70393,Non-Hispanic American Indian/Alaska Native,282.7,Male and Female,Prostate,2018
60-64,9.6,22.8,23,Incidence,151669,Non-Hispanic American Indian/Alaska Native,15.2,Male and Female,Stomach,2018
60-64,~,~,~,Incidence,70393,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
60-64,19.4,36.7,41,Incidence,151669,Non-Hispanic American Indian/Alaska Native,27.0,Male and Female,Thyroid,2018
60-64,27.9,47.9,56,Incidence,151669,Non-Hispanic American Indian/Alaska Native,36.9,Male and Female,Urinary Bladder,2018
65-69,1275.2,1408.7,1571,Incidence,117179,Non-Hispanic American Indian/Alaska Native,1340.7,Male and Female,All Cancer Sites Combined,2018
65-69,~,~,~,Incidence,117179,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
65-69,~,~,~,Incidence,62906,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
65-69,103.6,144.7,144,Incidence,117179,Non-Hispanic American Indian/Alaska Native,122.9,Male and Female,Colon and Rectum,2018
65-69,65.9,113.8,55,Incidence,62906,Non-Hispanic American Indian/Alaska Native,87.4,Male and Female,"Corpus and Uterus, NOS",2018
65-69,15.9,34.5,28,Incidence,117179,Non-Hispanic American Indian/Alaska Native,23.9,Male and Female,Esophagus,2018
65-69,256.2,343.1,187,Incidence,62906,Non-Hispanic American Indian/Alaska Native,297.3,Male and Female,Female Breast,2018
65-69,42.7,82.9,38,Incidence,62906,Non-Hispanic American Indian/Alaska Native,60.4,Male and Female,"Female Breast, <i>in situ</i>",2018
65-69,~,~,~,Incidence,117179,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,117179,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
65-69,57.2,88.8,84,Incidence,117179,Non-Hispanic American Indian/Alaska Native,71.7,Male and Female,Kidney and Renal Pelvis,2018
65-69,~,~,~,Incidence,117179,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
65-69,20.8,41.5,35,Incidence,117179,Non-Hispanic American Indian/Alaska Native,29.9,Male and Female,Leukemias,2018
65-69,45.8,74.5,69,Incidence,117179,Non-Hispanic American Indian/Alaska Native,58.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
65-69,202.1,257.8,268,Incidence,117179,Non-Hispanic American Indian/Alaska Native,228.7,Male and Female,Lung and Bronchus,2018
65-69,256.2,343.1,187,Incidence,62906,Non-Hispanic American Indian/Alaska Native,297.3,Male and Female,Male and Female Breast,2018
65-69,42.7,82.9,38,Incidence,62906,Non-Hispanic American Indian/Alaska Native,60.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
65-69,18.7,38.6,32,Incidence,117179,Non-Hispanic American Indian/Alaska Native,27.3,Male and Female,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,117179,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
65-69,18.0,37.6,31,Incidence,117179,Non-Hispanic American Indian/Alaska Native,26.5,Male and Female,Myeloma,2018
65-69,36.1,62.1,56,Incidence,117179,Non-Hispanic American Indian/Alaska Native,47.8,Male and Female,Non-Hodgkin Lymphoma,2018
65-69,22.2,43.5,37,Incidence,117179,Non-Hispanic American Indian/Alaska Native,31.6,Male and Female,Oral Cavity and Pharynx,2018
65-69,17.0,45.2,18,Incidence,62906,Non-Hispanic American Indian/Alaska Native,28.6,Male and Female,Ovary,2018
65-69,34.6,60.1,54,Incidence,117179,Non-Hispanic American Indian/Alaska Native,46.1,Male and Female,Pancreas,2018
65-69,338.1,444.9,211,Incidence,54273,Non-Hispanic American Indian/Alaska Native,388.8,Male and Female,Prostate,2018
65-69,19.4,39.5,33,Incidence,117179,Non-Hispanic American Indian/Alaska Native,28.2,Male and Female,Stomach,2018
65-69,~,~,~,Incidence,54273,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
65-69,10.4,26.4,20,Incidence,117179,Non-Hispanic American Indian/Alaska Native,17.1,Male and Female,Thyroid,2018
65-69,28.0,51.4,45,Incidence,117179,Non-Hispanic American Indian/Alaska Native,38.4,Male and Female,Urinary Bladder,2018
70-74,1654.4,1834.8,1454,Incidence,83428,Non-Hispanic American Indian/Alaska Native,1742.8,Male and Female,All Cancer Sites Combined,2018
70-74,~,~,~,Incidence,83428,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
70-74,~,~,~,Incidence,44922,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
70-74,126.9,181.1,127,Incidence,83428,Non-Hispanic American Indian/Alaska Native,152.2,Male and Female,Colon and Rectum,2018
70-74,59.9,116.1,38,Incidence,44922,Non-Hispanic American Indian/Alaska Native,84.6,Male and Female,"Corpus and Uterus, NOS",2018
70-74,11.0,31.1,16,Incidence,83428,Non-Hispanic American Indian/Alaska Native,19.2,Male and Female,Esophagus,2018
70-74,290.8,401.4,154,Incidence,44922,Non-Hispanic American Indian/Alaska Native,342.8,Male and Female,Female Breast,2018
70-74,32.5,76.8,23,Incidence,44922,Non-Hispanic American Indian/Alaska Native,51.2,Male and Female,"Female Breast, <i>in situ</i>",2018
70-74,~,~,~,Incidence,83428,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,83428,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
70-74,87.8,133.9,91,Incidence,83428,Non-Hispanic American Indian/Alaska Native,109.1,Male and Female,Kidney and Renal Pelvis,2018
70-74,~,~,~,Incidence,83428,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
70-74,34.3,65.3,40,Incidence,83428,Non-Hispanic American Indian/Alaska Native,47.9,Male and Female,Leukemias,2018
70-74,50.7,87.2,56,Incidence,83428,Non-Hispanic American Indian/Alaska Native,67.1,Male and Female,Liver and Intrahepatic Bile Duct,2018
70-74,289.6,368.4,273,Incidence,83428,Non-Hispanic American Indian/Alaska Native,327.2,Male and Female,Lung and Bronchus,2018
70-74,290.8,401.4,154,Incidence,44922,Non-Hispanic American Indian/Alaska Native,342.8,Male and Female,Male and Female Breast,2018
70-74,32.5,76.8,23,Incidence,44922,Non-Hispanic American Indian/Alaska Native,51.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
70-74,23.3,49.9,29,Incidence,83428,Non-Hispanic American Indian/Alaska Native,34.8,Male and Female,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,83428,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
70-74,33.2,63.9,39,Incidence,83428,Non-Hispanic American Indian/Alaska Native,46.7,Male and Female,Myeloma,2018
70-74,42.4,76.3,48,Incidence,83428,Non-Hispanic American Indian/Alaska Native,57.5,Male and Female,Non-Hodgkin Lymphoma,2018
70-74,26.2,54.1,32,Incidence,83428,Non-Hispanic American Indian/Alaska Native,38.4,Male and Female,Oral Cavity and Pharynx,2018
70-74,34.2,79.5,24,Incidence,44922,Non-Hispanic American Indian/Alaska Native,53.4,Male and Female,Ovary,2018
70-74,45.5,80.4,51,Incidence,83428,Non-Hispanic American Indian/Alaska Native,61.1,Male and Female,Pancreas,2018
70-74,387.2,524.2,174,Incidence,38506,Non-Hispanic American Indian/Alaska Native,451.9,Male and Female,Prostate,2018
70-74,22.3,48.5,28,Incidence,83428,Non-Hispanic American Indian/Alaska Native,33.6,Male and Female,Stomach,2018
70-74,~,~,~,Incidence,38506,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
70-74,15.6,38.5,21,Incidence,83428,Non-Hispanic American Indian/Alaska Native,25.2,Male and Female,Thyroid,2018
70-74,35.3,66.7,41,Incidence,83428,Non-Hispanic American Indian/Alaska Native,49.1,Male and Female,Urinary Bladder,2018
75-79,1719.2,1952.3,966,Incidence,52702,Non-Hispanic American Indian/Alaska Native,1832.9,Male and Female,All Cancer Sites Combined,2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
75-79,133.9,205.7,88,Incidence,52702,Non-Hispanic American Indian/Alaska Native,167.0,Male and Female,Colon and Rectum,2018
75-79,34.1,93.8,17,Incidence,29010,Non-Hispanic American Indian/Alaska Native,58.6,Male and Female,"Corpus and Uterus, NOS",2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
75-79,264.9,400.3,95,Incidence,29010,Non-Hispanic American Indian/Alaska Native,327.5,Male and Female,Female Breast,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
75-79,100.2,163.6,68,Incidence,52702,Non-Hispanic American Indian/Alaska Native,129.0,Male and Female,Kidney and Renal Pelvis,2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
75-79,32.2,72.3,26,Incidence,52702,Non-Hispanic American Indian/Alaska Native,49.3,Male and Female,Leukemias,2018
75-79,54.2,103.4,40,Incidence,52702,Non-Hispanic American Indian/Alaska Native,75.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
75-79,304.0,407.5,186,Incidence,52702,Non-Hispanic American Indian/Alaska Native,352.9,Male and Female,Lung and Bronchus,2018
75-79,264.9,400.3,95,Incidence,29010,Non-Hispanic American Indian/Alaska Native,327.5,Male and Female,Male and Female Breast,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
75-79,21.7,56.3,19,Incidence,52702,Non-Hispanic American Indian/Alaska Native,36.1,Male and Female,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
75-79,17.4,49.3,16,Incidence,52702,Non-Hispanic American Indian/Alaska Native,30.4,Male and Female,Myeloma,2018
75-79,73.7,129.4,52,Incidence,52702,Non-Hispanic American Indian/Alaska Native,98.7,Male and Female,Non-Hodgkin Lymphoma,2018
75-79,23.2,58.6,20,Incidence,52702,Non-Hispanic American Indian/Alaska Native,37.9,Male and Female,Oral Cavity and Pharynx,2018
75-79,~,~,~,Incidence,29010,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
75-79,52.6,101.2,39,Incidence,52702,Non-Hispanic American Indian/Alaska Native,74.0,Male and Female,Pancreas,2018
75-79,339.6,508.7,99,Incidence,23692,Non-Hispanic American Indian/Alaska Native,417.9,Male and Female,Prostate,2018
75-79,27.7,65.5,23,Incidence,52702,Non-Hispanic American Indian/Alaska Native,43.6,Male and Female,Stomach,2018
75-79,~,~,~,Incidence,23692,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
75-79,~,~,~,Incidence,52702,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
75-79,47.8,94.6,36,Incidence,52702,Non-Hispanic American Indian/Alaska Native,68.3,Male and Female,Urinary Bladder,2018
80-84,1774.0,2082.9,609,Incidence,31656,Non-Hispanic American Indian/Alaska Native,1923.8,Male and Female,All Cancer Sites Combined,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
80-84,166.8,272.3,68,Incidence,31656,Non-Hispanic American Indian/Alaska Native,214.8,Male and Female,Colon and Rectum,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
80-84,274.4,453.1,65,Incidence,18285,Non-Hispanic American Indian/Alaska Native,355.5,Male and Female,Female Breast,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
80-84,56.2,124.1,27,Incidence,31656,Non-Hispanic American Indian/Alaska Native,85.3,Male and Female,Kidney and Renal Pelvis,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
80-84,38.6,97.6,20,Incidence,31656,Non-Hispanic American Indian/Alaska Native,63.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
80-84,334.5,477.3,127,Incidence,31656,Non-Hispanic American Indian/Alaska Native,401.2,Male and Female,Lung and Bronchus,2018
80-84,274.4,453.1,65,Incidence,18285,Non-Hispanic American Indian/Alaska Native,355.5,Male and Female,Male and Female Breast,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
80-84,53.7,120.3,26,Incidence,31656,Non-Hispanic American Indian/Alaska Native,82.1,Male and Female,Non-Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
80-84,~,~,~,Incidence,18285,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
80-84,36.1,93.7,19,Incidence,31656,Non-Hispanic American Indian/Alaska Native,60.0,Male and Female,Pancreas,2018
80-84,232.7,433.2,43,Incidence,13371,Non-Hispanic American Indian/Alaska Native,321.6,Male and Female,Prostate,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
80-84,~,~,~,Incidence,13371,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
80-84,~,~,~,Incidence,31656,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
80-84,92.9,175.7,41,Incidence,31656,Non-Hispanic American Indian/Alaska Native,129.5,Male and Female,Urinary Bladder,2018
85+,1355.4,1643.4,424,Incidence,28376,Non-Hispanic American Indian/Alaska Native,1494.2,Male and Female,All Cancer Sites Combined,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
85+,133.8,236.3,51,Incidence,28376,Non-Hispanic American Indian/Alaska Native,179.7,Male and Female,Colon and Rectum,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
85+,140.1,277.0,36,Incidence,17992,Non-Hispanic American Indian/Alaska Native,200.1,Male and Female,Female Breast,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
85+,37.6,100.3,18,Incidence,28376,Non-Hispanic American Indian/Alaska Native,63.4,Male and Female,Leukemias,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
85+,170.6,284.1,63,Incidence,28376,Non-Hispanic American Indian/Alaska Native,222.0,Male and Female,Lung and Bronchus,2018
85+,140.1,277.0,36,Incidence,17992,Non-Hispanic American Indian/Alaska Native,200.1,Male and Female,Male and Female Breast,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
85+,48.6,117.4,22,Incidence,28376,Non-Hispanic American Indian/Alaska Native,77.5,Male and Female,Non-Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
85+,~,~,~,Incidence,17992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
85+,51.4,121.6,23,Incidence,28376,Non-Hispanic American Indian/Alaska Native,81.1,Male and Female,Pancreas,2018
85+,194.9,412.4,30,Incidence,10384,Non-Hispanic American Indian/Alaska Native,288.9,Male and Female,Prostate,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
85+,~,~,~,Incidence,10384,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
85+,~,~,~,Incidence,28376,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
85+,57.0,130.1,25,Incidence,28376,Non-Hispanic American Indian/Alaska Native,88.1,Male and Female,Urinary Bladder,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,16767,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2018
<1,~,~,~,Incidence,17237,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2018
<1,~,~,~,Incidence,34004,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2018
1-4,15.7,23.6,99,Incidence,511479,Non-Hispanic Asian/Pacific Islander,19.4,Female,All Cancer Sites Combined,2018
1-4,1.9,5.3,17,Incidence,511479,Non-Hispanic Asian/Pacific Islander,3.3,Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
1-4,6.1,11.3,43,Incidence,511479,Non-Hispanic Asian/Pacific Islander,8.4,Female,Leukemias,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
10-14,10.3,16.2,79,Incidence,607832,Non-Hispanic Asian/Pacific Islander,13.0,Female,All Cancer Sites Combined,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
10-14,2.4,5.7,23,Incidence,607832,Non-Hispanic Asian/Pacific Islander,3.8,Female,Leukemias,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
15-19,17.3,24.7,128,Incidence,616880,Non-Hispanic Asian/Pacific Islander,20.7,Female,All Cancer Sites Combined,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
15-19,4.9,9.2,42,Incidence,616880,Non-Hispanic Asian/Pacific Islander,6.8,Female,Thyroid,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
20-24,29.4,38.2,233,Incidence,693200,Non-Hispanic Asian/Pacific Islander,33.6,Female,All Cancer Sites Combined,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
20-24,1.4,3.9,17,Incidence,693200,Non-Hispanic Asian/Pacific Islander,2.5,Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
20-24,1.3,3.7,16,Incidence,693200,Non-Hispanic Asian/Pacific Islander,2.3,Female,Leukemias,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
20-24,2.3,5.3,25,Incidence,693200,Non-Hispanic Asian/Pacific Islander,3.6,Female,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
20-24,2.6,5.7,27,Incidence,693200,Non-Hispanic Asian/Pacific Islander,3.9,Female,Ovary,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
20-24,8.9,14.0,78,Incidence,693200,Non-Hispanic Asian/Pacific Islander,11.3,Female,Thyroid,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
25-29,49.7,59.6,476,Incidence,873804,Non-Hispanic Asian/Pacific Islander,54.5,Female,All Cancer Sites Combined,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
25-29,1.8,4.1,24,Incidence,873804,Non-Hispanic Asian/Pacific Islander,2.7,Female,Colon and Rectum,2018
25-29,1.2,3.3,18,Incidence,873804,Non-Hispanic Asian/Pacific Islander,2.1,Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
25-29,6.9,10.9,76,Incidence,873804,Non-Hispanic Asian/Pacific Islander,8.7,Female,Female Breast,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
25-29,2.1,4.6,28,Incidence,873804,Non-Hispanic Asian/Pacific Islander,3.2,Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
25-29,1.6,3.8,22,Incidence,873804,Non-Hispanic Asian/Pacific Islander,2.5,Female,Non-Hodgkin Lymphoma,2018
25-29,1.5,3.7,21,Incidence,873804,Non-Hispanic Asian/Pacific Islander,2.4,Female,Oral Cavity and Pharynx,2018
25-29,1.1,3.1,17,Incidence,873804,Non-Hispanic Asian/Pacific Islander,1.9,Female,Ovary,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
25-29,15.7,21.5,161,Incidence,873804,Non-Hispanic Asian/Pacific Islander,18.4,Female,Thyroid,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
30-34,88.5,101.3,864,Incidence,912123,Non-Hispanic Asian/Pacific Islander,94.7,Female,All Cancer Sites Combined,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
30-34,3.2,6.1,41,Incidence,912123,Non-Hispanic Asian/Pacific Islander,4.5,Female,Cervix,2018
30-34,2.8,5.5,36,Incidence,912123,Non-Hispanic Asian/Pacific Islander,3.9,Female,Colon and Rectum,2018
30-34,4.3,7.5,52,Incidence,912123,Non-Hispanic Asian/Pacific Islander,5.7,Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
30-34,22.6,29.3,235,Incidence,912123,Non-Hispanic Asian/Pacific Islander,25.8,Female,Female Breast,2018
30-34,2.9,5.6,37,Incidence,912123,Non-Hispanic Asian/Pacific Islander,4.1,Female,"Female Breast, <i>in situ</i>",2018
30-34,1.3,3.3,19,Incidence,912123,Non-Hispanic Asian/Pacific Islander,2.1,Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
30-34,1.2,3.1,18,Incidence,912123,Non-Hispanic Asian/Pacific Islander,2.0,Female,Leukemias,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
30-34,2.5,5.1,33,Incidence,912123,Non-Hispanic Asian/Pacific Islander,3.6,Female,Non-Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
30-34,2.5,5.1,33,Incidence,912123,Non-Hispanic Asian/Pacific Islander,3.6,Female,Ovary,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
30-34,24.7,31.7,256,Incidence,912123,Non-Hispanic Asian/Pacific Islander,28.1,Female,Thyroid,2018
30-34,~,~,~,Incidence,912123,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
35-39,147.5,164.0,1388,Incidence,892288,Non-Hispanic Asian/Pacific Islander,155.6,Female,All Cancer Sites Combined,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
35-39,4.4,7.6,52,Incidence,892288,Non-Hispanic Asian/Pacific Islander,5.8,Female,Cervix,2018
35-39,4.5,7.9,54,Incidence,892288,Non-Hispanic Asian/Pacific Islander,6.1,Female,Colon and Rectum,2018
35-39,11.6,16.6,124,Incidence,892288,Non-Hispanic Asian/Pacific Islander,13.9,Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
35-39,54.3,64.6,529,Incidence,892288,Non-Hispanic Asian/Pacific Islander,59.3,Female,Female Breast,2018
35-39,8.0,12.3,89,Incidence,892288,Non-Hispanic Asian/Pacific Islander,10.0,Female,"Female Breast, <i>in situ</i>",2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
35-39,1.2,3.2,18,Incidence,892288,Non-Hispanic Asian/Pacific Islander,2.0,Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
35-39,1.5,3.7,22,Incidence,892288,Non-Hispanic Asian/Pacific Islander,2.5,Female,Leukemias,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
35-39,3.2,6.1,40,Incidence,892288,Non-Hispanic Asian/Pacific Islander,4.5,Female,Lung and Bronchus,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
35-39,2.7,5.5,35,Incidence,892288,Non-Hispanic Asian/Pacific Islander,3.9,Female,Non-Hodgkin Lymphoma,2018
35-39,1.9,4.3,26,Incidence,892288,Non-Hispanic Asian/Pacific Islander,2.9,Female,Oral Cavity and Pharynx,2018
35-39,3.6,6.6,44,Incidence,892288,Non-Hispanic Asian/Pacific Islander,4.9,Female,Ovary,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
35-39,1.2,3.2,18,Incidence,892288,Non-Hispanic Asian/Pacific Islander,2.0,Female,Stomach,2018
35-39,29.0,36.6,291,Incidence,892288,Non-Hispanic Asian/Pacific Islander,32.6,Female,Thyroid,2018
35-39,~,~,~,Incidence,892288,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
40-44,263.4,286.2,2247,Incidence,818294,Non-Hispanic Asian/Pacific Islander,274.6,Female,All Cancer Sites Combined,2018
40-44,1.6,3.9,21,Incidence,818294,Non-Hispanic Asian/Pacific Islander,2.6,Female,Brain and Other Nervous System,2018
40-44,7.9,12.3,81,Incidence,818294,Non-Hispanic Asian/Pacific Islander,9.9,Female,Cervix,2018
40-44,12.9,18.5,127,Incidence,818294,Non-Hispanic Asian/Pacific Islander,15.5,Female,Colon and Rectum,2018
40-44,15.4,21.4,149,Incidence,818294,Non-Hispanic Asian/Pacific Islander,18.2,Female,"Corpus and Uterus, NOS",2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
40-44,123.5,139.3,1074,Incidence,818294,Non-Hispanic Asian/Pacific Islander,131.2,Female,Female Breast,2018
40-44,42.1,51.6,382,Incidence,818294,Non-Hispanic Asian/Pacific Islander,46.7,Female,"Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
40-44,2.2,4.8,27,Incidence,818294,Non-Hispanic Asian/Pacific Islander,3.3,Female,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
40-44,2.9,5.8,34,Incidence,818294,Non-Hispanic Asian/Pacific Islander,4.2,Female,Leukemias,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
40-44,5.6,9.4,60,Incidence,818294,Non-Hispanic Asian/Pacific Islander,7.3,Female,Lung and Bronchus,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
40-44,5.0,8.6,54,Incidence,818294,Non-Hispanic Asian/Pacific Islander,6.6,Female,Non-Hodgkin Lymphoma,2018
40-44,3.4,6.5,39,Incidence,818294,Non-Hispanic Asian/Pacific Islander,4.8,Female,Oral Cavity and Pharynx,2018
40-44,7.3,11.6,76,Incidence,818294,Non-Hispanic Asian/Pacific Islander,9.3,Female,Ovary,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
40-44,3.3,6.4,38,Incidence,818294,Non-Hispanic Asian/Pacific Islander,4.6,Female,Stomach,2018
40-44,34.6,43.2,317,Incidence,818294,Non-Hispanic Asian/Pacific Islander,38.7,Female,Thyroid,2018
40-44,~,~,~,Incidence,818294,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
45-49,399.2,427.7,3256,Incidence,787812,Non-Hispanic Asian/Pacific Islander,413.3,Female,All Cancer Sites Combined,2018
45-49,2.3,5.0,27,Incidence,787812,Non-Hispanic Asian/Pacific Islander,3.4,Female,Brain and Other Nervous System,2018
45-49,11.8,17.2,113,Incidence,787812,Non-Hispanic Asian/Pacific Islander,14.3,Female,Cervix,2018
45-49,22.6,29.8,205,Incidence,787812,Non-Hispanic Asian/Pacific Islander,26.0,Female,Colon and Rectum,2018
45-49,27.8,35.8,249,Incidence,787812,Non-Hispanic Asian/Pacific Islander,31.6,Female,"Corpus and Uterus, NOS",2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
45-49,197.1,217.3,1631,Incidence,787812,Non-Hispanic Asian/Pacific Islander,207.0,Female,Female Breast,2018
45-49,68.1,80.3,583,Incidence,787812,Non-Hispanic Asian/Pacific Islander,74.0,Female,"Female Breast, <i>in situ</i>",2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
45-49,4.1,7.5,44,Incidence,787812,Non-Hispanic Asian/Pacific Islander,5.6,Female,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
45-49,3.5,6.8,39,Incidence,787812,Non-Hispanic Asian/Pacific Islander,5.0,Female,Leukemias,2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
45-49,13.2,18.9,125,Incidence,787812,Non-Hispanic Asian/Pacific Islander,15.9,Female,Lung and Bronchus,2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
45-49,1.5,3.8,19,Incidence,787812,Non-Hispanic Asian/Pacific Islander,2.4,Female,Myeloma,2018
45-49,6.7,10.9,68,Incidence,787812,Non-Hispanic Asian/Pacific Islander,8.6,Female,Non-Hodgkin Lymphoma,2018
45-49,4.5,8.1,48,Incidence,787812,Non-Hispanic Asian/Pacific Islander,6.1,Female,Oral Cavity and Pharynx,2018
45-49,14.9,21.0,140,Incidence,787812,Non-Hispanic Asian/Pacific Islander,17.8,Female,Ovary,2018
45-49,4.0,7.4,43,Incidence,787812,Non-Hispanic Asian/Pacific Islander,5.5,Female,Pancreas,2018
45-49,3.8,7.2,42,Incidence,787812,Non-Hispanic Asian/Pacific Islander,5.3,Female,Stomach,2018
45-49,32.5,41.0,288,Incidence,787812,Non-Hispanic Asian/Pacific Islander,36.6,Female,Thyroid,2018
45-49,~,~,~,Incidence,787812,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
5-9,9.3,14.8,73,Incidence,618577,Non-Hispanic Asian/Pacific Islander,11.8,Female,All Cancer Sites Combined,2018
5-9,2.6,6.0,25,Incidence,618577,Non-Hispanic Asian/Pacific Islander,4.0,Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
5-9,2.9,6.4,27,Incidence,618577,Non-Hispanic Asian/Pacific Islander,4.4,Female,Leukemias,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
50-54,493.4,527.7,3438,Incidence,673715,Non-Hispanic Asian/Pacific Islander,510.3,Female,All Cancer Sites Combined,2018
50-54,2.4,5.5,25,Incidence,673715,Non-Hispanic Asian/Pacific Islander,3.7,Female,Brain and Other Nervous System,2018
50-54,8.8,14.0,75,Incidence,673715,Non-Hispanic Asian/Pacific Islander,11.1,Female,Cervix,2018
50-54,44.5,55.3,335,Incidence,673715,Non-Hispanic Asian/Pacific Islander,49.7,Female,Colon and Rectum,2018
50-54,52.8,64.6,394,Incidence,673715,Non-Hispanic Asian/Pacific Islander,58.5,Female,"Corpus and Uterus, NOS",2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
50-54,206.3,228.7,1464,Incidence,673715,Non-Hispanic Asian/Pacific Islander,217.3,Female,Female Breast,2018
50-54,69.8,83.2,514,Incidence,673715,Non-Hispanic Asian/Pacific Islander,76.3,Female,"Female Breast, <i>in situ</i>",2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
50-54,4.4,8.3,41,Incidence,673715,Non-Hispanic Asian/Pacific Islander,6.1,Female,Kidney and Renal Pelvis,2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
50-54,4.1,7.9,39,Incidence,673715,Non-Hispanic Asian/Pacific Islander,5.8,Female,Leukemias,2018
50-54,2.9,6.2,29,Incidence,673715,Non-Hispanic Asian/Pacific Islander,4.3,Female,Liver and Intrahepatic Bile Duct,2018
50-54,23.2,31.2,182,Incidence,673715,Non-Hispanic Asian/Pacific Islander,27.0,Female,Lung and Bronchus,2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
50-54,2.0,4.9,22,Incidence,673715,Non-Hispanic Asian/Pacific Islander,3.3,Female,Myeloma,2018
50-54,11.8,17.7,98,Incidence,673715,Non-Hispanic Asian/Pacific Islander,14.5,Female,Non-Hodgkin Lymphoma,2018
50-54,5.3,9.4,48,Incidence,673715,Non-Hispanic Asian/Pacific Islander,7.1,Female,Oral Cavity and Pharynx,2018
50-54,14.6,21.1,119,Incidence,673715,Non-Hispanic Asian/Pacific Islander,17.7,Female,Ovary,2018
50-54,6.0,10.5,54,Incidence,673715,Non-Hispanic Asian/Pacific Islander,8.0,Female,Pancreas,2018
50-54,4.2,8.1,40,Incidence,673715,Non-Hispanic Asian/Pacific Islander,5.9,Female,Stomach,2018
50-54,37.0,46.9,281,Incidence,673715,Non-Hispanic Asian/Pacific Islander,41.7,Female,Thyroid,2018
50-54,~,~,~,Incidence,673715,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
55-59,568.4,606.5,3683,Incidence,627154,Non-Hispanic Asian/Pacific Islander,587.3,Female,All Cancer Sites Combined,2018
55-59,3.0,6.5,28,Incidence,627154,Non-Hispanic Asian/Pacific Islander,4.5,Female,Brain and Other Nervous System,2018
55-59,8.3,13.6,67,Incidence,627154,Non-Hispanic Asian/Pacific Islander,10.7,Female,Cervix,2018
55-59,39.7,50.4,281,Incidence,627154,Non-Hispanic Asian/Pacific Islander,44.8,Female,Colon and Rectum,2018
55-59,59.8,72.7,414,Incidence,627154,Non-Hispanic Asian/Pacific Islander,66.0,Female,"Corpus and Uterus, NOS",2018
55-59,~,~,~,Incidence,627154,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
55-59,221.9,246.0,1466,Incidence,627154,Non-Hispanic Asian/Pacific Islander,233.8,Female,Female Breast,2018
55-59,67.7,81.4,466,Incidence,627154,Non-Hispanic Asian/Pacific Islander,74.3,Female,"Female Breast, <i>in situ</i>",2018
55-59,~,~,~,Incidence,627154,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,627154,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
55-59,10.7,16.6,84,Incidence,627154,Non-Hispanic Asian/Pacific Islander,13.4,Female,Kidney and Renal Pelvis,2018
55-59,~,~,~,Incidence,627154,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
55-59,7.7,12.9,63,Incidence,627154,Non-Hispanic Asian/Pacific Islander,10.0,Female,Leukemias,2018
55-59,8.0,13.2,65,Incidence,627154,Non-Hispanic Asian/Pacific Islander,10.4,Female,Liver and Intrahepatic Bile Duct,2018
55-59,32.2,41.9,231,Incidence,627154,Non-Hispanic Asian/Pacific Islander,36.8,Female,Lung and Bronchus,2018
55-59,1.6,4.3,17,Incidence,627154,Non-Hispanic Asian/Pacific Islander,2.7,Female,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,627154,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
55-59,1.9,4.9,20,Incidence,627154,Non-Hispanic Asian/Pacific Islander,3.2,Female,Myeloma,2018
55-59,14.7,21.5,112,Incidence,627154,Non-Hispanic Asian/Pacific Islander,17.9,Female,Non-Hodgkin Lymphoma,2018
55-59,8.8,14.3,71,Incidence,627154,Non-Hispanic Asian/Pacific Islander,11.3,Female,Oral Cavity and Pharynx,2018
55-59,16.7,23.9,126,Incidence,627154,Non-Hispanic Asian/Pacific Islander,20.1,Female,Ovary,2018
55-59,9.1,14.6,73,Incidence,627154,Non-Hispanic Asian/Pacific Islander,11.6,Female,Pancreas,2018
55-59,9.0,14.5,72,Incidence,627154,Non-Hispanic Asian/Pacific Islander,11.5,Female,Stomach,2018
55-59,32.7,42.4,234,Incidence,627154,Non-Hispanic Asian/Pacific Islander,37.3,Female,Thyroid,2018
55-59,2.2,5.3,22,Incidence,627154,Non-Hispanic Asian/Pacific Islander,3.5,Female,Urinary Bladder,2018
60-64,686.2,730.0,4046,Incidence,571603,Non-Hispanic Asian/Pacific Islander,707.8,Female,All Cancer Sites Combined,2018
60-64,4.1,8.3,34,Incidence,571603,Non-Hispanic Asian/Pacific Islander,5.9,Female,Brain and Other Nervous System,2018
60-64,9.2,15.1,68,Incidence,571603,Non-Hispanic Asian/Pacific Islander,11.9,Female,Cervix,2018
60-64,47.9,60.1,307,Incidence,571603,Non-Hispanic Asian/Pacific Islander,53.7,Female,Colon and Rectum,2018
60-64,62.6,76.4,396,Incidence,571603,Non-Hispanic Asian/Pacific Islander,69.3,Female,"Corpus and Uterus, NOS",2018
60-64,1.9,5.0,18,Incidence,571603,Non-Hispanic Asian/Pacific Islander,3.1,Female,Esophagus,2018
60-64,250.7,277.5,1508,Incidence,571603,Non-Hispanic Asian/Pacific Islander,263.8,Female,Female Breast,2018
60-64,77.6,92.9,486,Incidence,571603,Non-Hispanic Asian/Pacific Islander,85.0,Female,"Female Breast, <i>in situ</i>",2018
60-64,~,~,~,Incidence,571603,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,571603,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
60-64,12.3,19.0,88,Incidence,571603,Non-Hispanic Asian/Pacific Islander,15.4,Female,Kidney and Renal Pelvis,2018
60-64,~,~,~,Incidence,571603,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
60-64,6.3,11.3,49,Incidence,571603,Non-Hispanic Asian/Pacific Islander,8.6,Female,Leukemias,2018
60-64,13.9,20.9,98,Incidence,571603,Non-Hispanic Asian/Pacific Islander,17.1,Female,Liver and Intrahepatic Bile Duct,2018
60-64,60.6,74.2,384,Incidence,571603,Non-Hispanic Asian/Pacific Islander,67.2,Female,Lung and Bronchus,2018
60-64,~,~,~,Incidence,571603,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,571603,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
60-64,4.9,9.3,39,Incidence,571603,Non-Hispanic Asian/Pacific Islander,6.8,Female,Myeloma,2018
60-64,18.7,26.6,128,Incidence,571603,Non-Hispanic Asian/Pacific Islander,22.4,Female,Non-Hodgkin Lymphoma,2018
60-64,10.8,17.0,78,Incidence,571603,Non-Hispanic Asian/Pacific Islander,13.6,Female,Oral Cavity and Pharynx,2018
60-64,17.7,25.5,122,Incidence,571603,Non-Hispanic Asian/Pacific Islander,21.3,Female,Ovary,2018
60-64,16.1,23.6,112,Incidence,571603,Non-Hispanic Asian/Pacific Islander,19.6,Female,Pancreas,2018
60-64,11.6,18.0,83,Incidence,571603,Non-Hispanic Asian/Pacific Islander,14.5,Female,Stomach,2018
60-64,31.9,42.1,210,Incidence,571603,Non-Hispanic Asian/Pacific Islander,36.7,Female,Thyroid,2018
60-64,6.2,11.1,48,Incidence,571603,Non-Hispanic Asian/Pacific Islander,8.4,Female,Urinary Bladder,2018
65-69,872.3,926.0,4343,Incidence,483188,Non-Hispanic Asian/Pacific Islander,898.8,Female,All Cancer Sites Combined,2018
65-69,5.7,11.0,39,Incidence,483188,Non-Hispanic Asian/Pacific Islander,8.1,Female,Brain and Other Nervous System,2018
65-69,8.6,14.8,55,Incidence,483188,Non-Hispanic Asian/Pacific Islander,11.4,Female,Cervix,2018
65-69,60.3,75.2,326,Incidence,483188,Non-Hispanic Asian/Pacific Islander,67.5,Female,Colon and Rectum,2018
65-69,67.4,83.0,362,Incidence,483188,Non-Hispanic Asian/Pacific Islander,74.9,Female,"Corpus and Uterus, NOS",2018
65-69,~,~,~,Incidence,483188,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
65-69,301.4,333.3,1532,Incidence,483188,Non-Hispanic Asian/Pacific Islander,317.1,Female,Female Breast,2018
65-69,92.6,110.8,490,Incidence,483188,Non-Hispanic Asian/Pacific Islander,101.4,Female,"Female Breast, <i>in situ</i>",2018
65-69,~,~,~,Incidence,483188,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,483188,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
65-69,15.7,23.8,94,Incidence,483188,Non-Hispanic Asian/Pacific Islander,19.5,Female,Kidney and Renal Pelvis,2018
65-69,~,~,~,Incidence,483188,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
65-69,14.4,22.2,87,Incidence,483188,Non-Hispanic Asian/Pacific Islander,18.0,Female,Leukemias,2018
65-69,20.8,29.9,121,Incidence,483188,Non-Hispanic Asian/Pacific Islander,25.0,Female,Liver and Intrahepatic Bile Duct,2018
65-69,92.0,110.2,487,Incidence,483188,Non-Hispanic Asian/Pacific Islander,100.8,Female,Lung and Bronchus,2018
65-69,~,~,~,Incidence,483188,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,483188,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
65-69,7.3,13.2,48,Incidence,483188,Non-Hispanic Asian/Pacific Islander,9.9,Female,Myeloma,2018
65-69,31.1,42.0,175,Incidence,483188,Non-Hispanic Asian/Pacific Islander,36.2,Female,Non-Hodgkin Lymphoma,2018
65-69,10.4,17.1,65,Incidence,483188,Non-Hispanic Asian/Pacific Islander,13.5,Female,Oral Cavity and Pharynx,2018
65-69,19.1,27.9,112,Incidence,483188,Non-Hispanic Asian/Pacific Islander,23.2,Female,Ovary,2018
65-69,23.2,32.8,134,Incidence,483188,Non-Hispanic Asian/Pacific Islander,27.7,Female,Pancreas,2018
65-69,16.3,24.5,97,Incidence,483188,Non-Hispanic Asian/Pacific Islander,20.1,Female,Stomach,2018
65-69,33.5,44.9,188,Incidence,483188,Non-Hispanic Asian/Pacific Islander,38.9,Female,Thyroid,2018
65-69,9.1,15.5,58,Incidence,483188,Non-Hispanic Asian/Pacific Islander,12.0,Female,Urinary Bladder,2018
70-74,989.5,1056.6,3598,Incidence,351849,Non-Hispanic Asian/Pacific Islander,1022.6,Female,All Cancer Sites Combined,2018
70-74,5.3,11.5,28,Incidence,351849,Non-Hispanic Asian/Pacific Islander,8.0,Female,Brain and Other Nervous System,2018
70-74,6.9,13.8,35,Incidence,351849,Non-Hispanic Asian/Pacific Islander,9.9,Female,Cervix,2018
70-74,69.5,88.3,276,Incidence,351849,Non-Hispanic Asian/Pacific Islander,78.4,Female,Colon and Rectum,2018
70-74,53.5,70.1,216,Incidence,351849,Non-Hispanic Asian/Pacific Islander,61.4,Female,"Corpus and Uterus, NOS",2018
70-74,~,~,~,Incidence,351849,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
70-74,325.6,364.7,1213,Incidence,351849,Non-Hispanic Asian/Pacific Islander,344.8,Female,Female Breast,2018
70-74,83.4,103.9,328,Incidence,351849,Non-Hispanic Asian/Pacific Islander,93.2,Female,"Female Breast, <i>in situ</i>",2018
70-74,~,~,~,Incidence,351849,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,351849,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
70-74,18.8,29.2,83,Incidence,351849,Non-Hispanic Asian/Pacific Islander,23.6,Female,Kidney and Renal Pelvis,2018
70-74,~,~,~,Incidence,351849,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
70-74,14.5,23.9,66,Incidence,351849,Non-Hispanic Asian/Pacific Islander,18.8,Female,Leukemias,2018
70-74,26.5,38.6,113,Incidence,351849,Non-Hispanic Asian/Pacific Islander,32.1,Female,Liver and Intrahepatic Bile Duct,2018
70-74,128.0,153.0,493,Incidence,351849,Non-Hispanic Asian/Pacific Islander,140.1,Female,Lung and Bronchus,2018
70-74,~,~,~,Incidence,351849,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,351849,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
70-74,15.5,25.1,70,Incidence,351849,Non-Hispanic Asian/Pacific Islander,19.9,Female,Myeloma,2018
70-74,37.9,52.2,157,Incidence,351849,Non-Hispanic Asian/Pacific Islander,44.6,Female,Non-Hodgkin Lymphoma,2018
70-74,11.3,19.7,53,Incidence,351849,Non-Hispanic Asian/Pacific Islander,15.1,Female,Oral Cavity and Pharynx,2018
70-74,15.8,25.5,71,Incidence,351849,Non-Hispanic Asian/Pacific Islander,20.2,Female,Ovary,2018
70-74,38.4,52.8,159,Incidence,351849,Non-Hispanic Asian/Pacific Islander,45.2,Female,Pancreas,2018
70-74,21.3,32.4,93,Incidence,351849,Non-Hispanic Asian/Pacific Islander,26.4,Female,Stomach,2018
70-74,21.6,32.7,94,Incidence,351849,Non-Hispanic Asian/Pacific Islander,26.7,Female,Thyroid,2018
70-74,12.0,20.7,56,Incidence,351849,Non-Hispanic Asian/Pacific Islander,15.9,Female,Urinary Bladder,2018
75-79,1085.9,1171.7,2681,Incidence,237644,Non-Hispanic Asian/Pacific Islander,1128.2,Female,All Cancer Sites Combined,2018
75-79,4.5,12.0,18,Incidence,237644,Non-Hispanic Asian/Pacific Islander,7.6,Female,Brain and Other Nervous System,2018
75-79,6.8,15.5,25,Incidence,237644,Non-Hispanic Asian/Pacific Islander,10.5,Female,Cervix,2018
75-79,87.8,113.7,238,Incidence,237644,Non-Hispanic Asian/Pacific Islander,100.1,Female,Colon and Rectum,2018
75-79,54.6,75.4,153,Incidence,237644,Non-Hispanic Asian/Pacific Islander,64.4,Female,"Corpus and Uterus, NOS",2018
75-79,3.8,10.9,16,Incidence,237644,Non-Hispanic Asian/Pacific Islander,6.7,Female,Esophagus,2018
75-79,262.6,305.9,674,Incidence,237644,Non-Hispanic Asian/Pacific Islander,283.6,Female,Female Breast,2018
75-79,71.7,95.3,197,Incidence,237644,Non-Hispanic Asian/Pacific Islander,82.9,Female,"Female Breast, <i>in situ</i>",2018
75-79,~,~,~,Incidence,237644,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,237644,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
75-79,16.7,29.2,53,Incidence,237644,Non-Hispanic Asian/Pacific Islander,22.3,Female,Kidney and Renal Pelvis,2018
75-79,~,~,~,Incidence,237644,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
75-79,21.1,34.9,65,Incidence,237644,Non-Hispanic Asian/Pacific Islander,27.4,Female,Leukemias,2018
75-79,31.2,47.5,92,Incidence,237644,Non-Hispanic Asian/Pacific Islander,38.7,Female,Liver and Intrahepatic Bile Duct,2018
75-79,166.2,201.1,435,Incidence,237644,Non-Hispanic Asian/Pacific Islander,183.0,Female,Lung and Bronchus,2018
75-79,3.8,10.9,16,Incidence,237644,Non-Hispanic Asian/Pacific Islander,6.7,Female,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,237644,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
75-79,14.9,26.8,48,Incidence,237644,Non-Hispanic Asian/Pacific Islander,20.2,Female,Myeloma,2018
75-79,46.5,65.9,132,Incidence,237644,Non-Hispanic Asian/Pacific Islander,55.5,Female,Non-Hodgkin Lymphoma,2018
75-79,13.1,24.4,43,Incidence,237644,Non-Hispanic Asian/Pacific Islander,18.1,Female,Oral Cavity and Pharynx,2018
75-79,19.6,33.0,61,Incidence,237644,Non-Hispanic Asian/Pacific Islander,25.7,Female,Ovary,2018
75-79,56.9,78.2,159,Incidence,237644,Non-Hispanic Asian/Pacific Islander,66.9,Female,Pancreas,2018
75-79,24.1,38.6,73,Incidence,237644,Non-Hispanic Asian/Pacific Islander,30.7,Female,Stomach,2018
75-79,17.8,30.6,56,Incidence,237644,Non-Hispanic Asian/Pacific Islander,23.6,Female,Thyroid,2018
75-79,13.5,24.9,44,Incidence,237644,Non-Hispanic Asian/Pacific Islander,18.5,Female,Urinary Bladder,2018
80-84,1220.5,1331.3,2057,Incidence,161331,Non-Hispanic Asian/Pacific Islander,1275.0,Female,All Cancer Sites Combined,2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
80-84,9.5,22.1,24,Incidence,161331,Non-Hispanic Asian/Pacific Islander,14.9,Female,Cervix,2018
80-84,125.9,163.5,232,Incidence,161331,Non-Hispanic Asian/Pacific Islander,143.8,Female,Colon and Rectum,2018
80-84,30.6,50.7,64,Incidence,161331,Non-Hispanic Asian/Pacific Islander,39.7,Female,"Corpus and Uterus, NOS",2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
80-84,233.7,283.9,416,Incidence,161331,Non-Hispanic Asian/Pacific Islander,257.9,Female,Female Breast,2018
80-84,34.9,56.2,72,Incidence,161331,Non-Hispanic Asian/Pacific Islander,44.6,Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
80-84,19.8,36.6,44,Incidence,161331,Non-Hispanic Asian/Pacific Islander,27.3,Female,Kidney and Renal Pelvis,2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
80-84,20.3,37.3,45,Incidence,161331,Non-Hispanic Asian/Pacific Islander,27.9,Female,Leukemias,2018
80-84,42.1,65.1,85,Incidence,161331,Non-Hispanic Asian/Pacific Islander,52.7,Female,Liver and Intrahepatic Bile Duct,2018
80-84,206.0,253.3,369,Incidence,161331,Non-Hispanic Asian/Pacific Islander,228.7,Female,Lung and Bronchus,2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,161331,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
80-84,16.7,32.3,38,Incidence,161331,Non-Hispanic Asian/Pacific Islander,23.6,Female,Myeloma,2018
80-84,47.6,72.0,95,Incidence,161331,Non-Hispanic Asian/Pacific Islander,58.9,Female,Non-Hodgkin Lymphoma,2018
80-84,12.5,26.5,30,Incidence,161331,Non-Hispanic Asian/Pacific Islander,18.6,Female,Oral Cavity and Pharynx,2018
80-84,25.1,43.7,54,Incidence,161331,Non-Hispanic Asian/Pacific Islander,33.5,Female,Ovary,2018
80-84,61.1,88.3,119,Incidence,161331,Non-Hispanic Asian/Pacific Islander,73.8,Female,Pancreas,2018
80-84,41.0,63.8,83,Incidence,161331,Non-Hispanic Asian/Pacific Islander,51.4,Female,Stomach,2018
80-84,11.5,25.1,28,Incidence,161331,Non-Hispanic Asian/Pacific Islander,17.4,Female,Thyroid,2018
80-84,26.2,45.1,56,Incidence,161331,Non-Hispanic Asian/Pacific Islander,34.7,Female,Urinary Bladder,2018
85+,1118.6,1219.2,2094,Incidence,179263,Non-Hispanic Asian/Pacific Islander,1168.1,Female,All Cancer Sites Combined,2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
85+,8.1,19.3,23,Incidence,179263,Non-Hispanic Asian/Pacific Islander,12.8,Female,Cervix,2018
85+,147.4,185.6,297,Incidence,179263,Non-Hispanic Asian/Pacific Islander,165.7,Female,Colon and Rectum,2018
85+,21.7,38.0,52,Incidence,179263,Non-Hispanic Asian/Pacific Islander,29.0,Female,"Corpus and Uterus, NOS",2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
85+,151.1,189.8,304,Incidence,179263,Non-Hispanic Asian/Pacific Islander,169.6,Female,Female Breast,2018
85+,14.1,27.8,36,Incidence,179263,Non-Hispanic Asian/Pacific Islander,20.1,Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
85+,16.9,31.7,42,Incidence,179263,Non-Hispanic Asian/Pacific Islander,23.4,Female,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
85+,19.7,35.5,48,Incidence,179263,Non-Hispanic Asian/Pacific Islander,26.8,Female,Leukemias,2018
85+,39.4,60.5,88,Incidence,179263,Non-Hispanic Asian/Pacific Islander,49.1,Female,Liver and Intrahepatic Bile Duct,2018
85+,176.4,218.0,352,Incidence,179263,Non-Hispanic Asian/Pacific Islander,196.4,Female,Lung and Bronchus,2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,179263,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
85+,9.5,21.3,26,Incidence,179263,Non-Hispanic Asian/Pacific Islander,14.5,Female,Myeloma,2018
85+,45.9,68.5,101,Incidence,179263,Non-Hispanic Asian/Pacific Islander,56.3,Female,Non-Hodgkin Lymphoma,2018
85+,11.7,24.5,31,Incidence,179263,Non-Hispanic Asian/Pacific Islander,17.3,Female,Oral Cavity and Pharynx,2018
85+,15.0,29.1,38,Incidence,179263,Non-Hispanic Asian/Pacific Islander,21.2,Female,Ovary,2018
85+,66.2,92.8,141,Incidence,179263,Non-Hispanic Asian/Pacific Islander,78.7,Female,Pancreas,2018
85+,34.9,54.9,79,Incidence,179263,Non-Hispanic Asian/Pacific Islander,44.1,Female,Stomach,2018
85+,9.0,20.6,25,Incidence,179263,Non-Hispanic Asian/Pacific Islander,13.9,Female,Thyroid,2018
85+,37.9,58.6,85,Incidence,179263,Non-Hispanic Asian/Pacific Islander,47.4,Female,Urinary Bladder,2018
<1,11.6,27.9,22,Incidence,119231,Non-Hispanic Asian/Pacific Islander,18.5,Female,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2018
1-4,21.5,30.2,139,Incidence,543100,Non-Hispanic Asian/Pacific Islander,25.6,Male,All Cancer Sites Combined,2018
1-4,2.4,5.9,21,Incidence,543100,Non-Hispanic Asian/Pacific Islander,3.9,Male,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
1-4,8.1,13.8,58,Incidence,543100,Non-Hispanic Asian/Pacific Islander,10.7,Male,Leukemias,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
1-4,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
10-14,11.2,17.2,87,Incidence,622690,Non-Hispanic Asian/Pacific Islander,14.0,Male,All Cancer Sites Combined,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
10-14,2.9,6.3,27,Incidence,622690,Non-Hispanic Asian/Pacific Islander,4.3,Male,Leukemias,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
10-14,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
15-19,17.8,25.2,133,Incidence,624406,Non-Hispanic Asian/Pacific Islander,21.3,Male,All Cancer Sites Combined,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
15-19,2.0,4.9,20,Incidence,624406,Non-Hispanic Asian/Pacific Islander,3.2,Male,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
15-19,2.7,6.1,26,Incidence,624406,Non-Hispanic Asian/Pacific Islander,4.2,Male,Leukemias,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
15-19,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
15-19,1.7,4.6,18,Incidence,624406,Non-Hispanic Asian/Pacific Islander,2.9,Male,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
20-24,21.5,29.0,179,Incidence,714088,Non-Hispanic Asian/Pacific Islander,25.1,Male,All Cancer Sites Combined,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
20-24,1.4,3.8,17,Incidence,714088,Non-Hispanic Asian/Pacific Islander,2.4,Male,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
20-24,1.5,4.0,18,Incidence,714088,Non-Hispanic Asian/Pacific Islander,2.5,Male,Leukemias,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
20-24,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
20-24,2.3,5.2,25,Incidence,714088,Non-Hispanic Asian/Pacific Islander,3.5,Male,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
20-24,3.5,7.0,36,Incidence,714088,Non-Hispanic Asian/Pacific Islander,5.0,Male,Testis,2018
20-24,1.7,4.3,20,Incidence,714088,Non-Hispanic Asian/Pacific Islander,2.8,Male,Thyroid,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
25-29,26.3,33.7,257,Incidence,860755,Non-Hispanic Asian/Pacific Islander,29.9,Male,All Cancer Sites Combined,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
25-29,1.5,3.7,21,Incidence,860755,Non-Hispanic Asian/Pacific Islander,2.4,Male,Colon and Rectum,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
25-29,1.2,3.2,17,Incidence,860755,Non-Hispanic Asian/Pacific Islander,2.0,Male,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
25-29,2.4,5.0,30,Incidence,860755,Non-Hispanic Asian/Pacific Islander,3.5,Male,Leukemias,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
25-29,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
25-29,2.4,5.1,31,Incidence,860755,Non-Hispanic Asian/Pacific Islander,3.6,Male,Non-Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
25-29,2.5,5.2,32,Incidence,860755,Non-Hispanic Asian/Pacific Islander,3.7,Male,Testis,2018
25-29,3.4,6.5,41,Incidence,860755,Non-Hispanic Asian/Pacific Islander,4.8,Male,Thyroid,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
30-34,42.2,51.5,398,Incidence,852456,Non-Hispanic Asian/Pacific Islander,46.7,Male,All Cancer Sites Combined,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
30-34,3.2,6.1,38,Incidence,852456,Non-Hispanic Asian/Pacific Islander,4.5,Male,Colon and Rectum,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
30-34,1.2,3.2,17,Incidence,852456,Non-Hispanic Asian/Pacific Islander,2.0,Male,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
30-34,1.2,3.2,17,Incidence,852456,Non-Hispanic Asian/Pacific Islander,2.0,Male,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
30-34,2.8,5.6,34,Incidence,852456,Non-Hispanic Asian/Pacific Islander,4.0,Male,Leukemias,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
30-34,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
30-34,3.0,5.8,36,Incidence,852456,Non-Hispanic Asian/Pacific Islander,4.2,Male,Non-Hodgkin Lymphoma,2018
30-34,2.2,4.7,28,Incidence,852456,Non-Hispanic Asian/Pacific Islander,3.3,Male,Oral Cavity and Pharynx,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
30-34,4.1,7.3,47,Incidence,852456,Non-Hispanic Asian/Pacific Islander,5.5,Male,Testis,2018
30-34,4.8,8.3,54,Incidence,852456,Non-Hispanic Asian/Pacific Islander,6.3,Male,Thyroid,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
35-39,58.8,70.1,513,Incidence,798167,Non-Hispanic Asian/Pacific Islander,64.3,Male,All Cancer Sites Combined,2018
35-39,1.6,4.0,21,Incidence,798167,Non-Hispanic Asian/Pacific Islander,2.6,Male,Brain and Other Nervous System,2018
35-39,6.5,10.7,67,Incidence,798167,Non-Hispanic Asian/Pacific Islander,8.4,Male,Colon and Rectum,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
35-39,3.2,6.2,36,Incidence,798167,Non-Hispanic Asian/Pacific Islander,4.5,Male,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
35-39,3.2,6.2,36,Incidence,798167,Non-Hispanic Asian/Pacific Islander,4.5,Male,Leukemias,2018
35-39,1.9,4.5,24,Incidence,798167,Non-Hispanic Asian/Pacific Islander,3.0,Male,Liver and Intrahepatic Bile Duct,2018
35-39,1.1,3.3,16,Incidence,798167,Non-Hispanic Asian/Pacific Islander,2.0,Male,Lung and Bronchus,2018
35-39,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
35-39,3.4,6.5,38,Incidence,798167,Non-Hispanic Asian/Pacific Islander,4.8,Male,Non-Hodgkin Lymphoma,2018
35-39,3.8,7.1,42,Incidence,798167,Non-Hispanic Asian/Pacific Islander,5.3,Male,Oral Cavity and Pharynx,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
35-39,1.4,3.7,19,Incidence,798167,Non-Hispanic Asian/Pacific Islander,2.4,Male,Stomach,2018
35-39,2.4,5.2,29,Incidence,798167,Non-Hispanic Asian/Pacific Islander,3.6,Male,Testis,2018
35-39,6.0,10.0,62,Incidence,798167,Non-Hispanic Asian/Pacific Islander,7.8,Male,Thyroid,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
40-44,96.1,111.1,743,Incidence,718526,Non-Hispanic Asian/Pacific Islander,103.4,Male,All Cancer Sites Combined,2018
40-44,2.7,5.8,29,Incidence,718526,Non-Hispanic Asian/Pacific Islander,4.0,Male,Brain and Other Nervous System,2018
40-44,17.3,24.0,147,Incidence,718526,Non-Hispanic Asian/Pacific Islander,20.5,Male,Colon and Rectum,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
40-44,6.1,10.4,58,Incidence,718526,Non-Hispanic Asian/Pacific Islander,8.1,Male,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
40-44,3.2,6.4,33,Incidence,718526,Non-Hispanic Asian/Pacific Islander,4.6,Male,Leukemias,2018
40-44,4.6,8.4,45,Incidence,718526,Non-Hispanic Asian/Pacific Islander,6.3,Male,Liver and Intrahepatic Bile Duct,2018
40-44,2.7,5.8,29,Incidence,718526,Non-Hispanic Asian/Pacific Islander,4.0,Male,Lung and Bronchus,2018
40-44,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
40-44,5.5,9.6,53,Incidence,718526,Non-Hispanic Asian/Pacific Islander,7.4,Male,Non-Hodgkin Lymphoma,2018
40-44,9.3,14.5,84,Incidence,718526,Non-Hispanic Asian/Pacific Islander,11.7,Male,Oral Cavity and Pharynx,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
40-44,2.6,5.6,28,Incidence,718526,Non-Hispanic Asian/Pacific Islander,3.9,Male,Stomach,2018
40-44,1.8,4.5,21,Incidence,718526,Non-Hispanic Asian/Pacific Islander,2.9,Male,Testis,2018
40-44,9.4,14.6,85,Incidence,718526,Non-Hispanic Asian/Pacific Islander,11.8,Male,Thyroid,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
45-49,154.3,173.5,1135,Incidence,693293,Non-Hispanic Asian/Pacific Islander,163.7,Male,All Cancer Sites Combined,2018
45-49,2.7,5.8,28,Incidence,693293,Non-Hispanic Asian/Pacific Islander,4.0,Male,Brain and Other Nervous System,2018
45-49,27.4,35.9,218,Incidence,693293,Non-Hispanic Asian/Pacific Islander,31.4,Male,Colon and Rectum,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
45-49,9.5,14.8,83,Incidence,693293,Non-Hispanic Asian/Pacific Islander,12.0,Male,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
45-49,3.3,6.7,33,Incidence,693293,Non-Hispanic Asian/Pacific Islander,4.8,Male,Leukemias,2018
45-49,7.7,12.6,69,Incidence,693293,Non-Hispanic Asian/Pacific Islander,10.0,Male,Liver and Intrahepatic Bile Duct,2018
45-49,10.6,16.1,91,Incidence,693293,Non-Hispanic Asian/Pacific Islander,13.1,Male,Lung and Bronchus,2018
45-49,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
45-49,1.4,3.9,17,Incidence,693293,Non-Hispanic Asian/Pacific Islander,2.5,Male,Myeloma,2018
45-49,8.8,13.9,77,Incidence,693293,Non-Hispanic Asian/Pacific Islander,11.1,Male,Non-Hodgkin Lymphoma,2018
45-49,12.9,19.0,109,Incidence,693293,Non-Hispanic Asian/Pacific Islander,15.7,Male,Oral Cavity and Pharynx,2018
45-49,2.3,5.3,25,Incidence,693293,Non-Hispanic Asian/Pacific Islander,3.6,Male,Pancreas,2018
45-49,5.0,9.0,47,Incidence,693293,Non-Hispanic Asian/Pacific Islander,6.8,Male,Prostate,2018
45-49,4.7,8.7,45,Incidence,693293,Non-Hispanic Asian/Pacific Islander,6.5,Male,Stomach,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
45-49,10.3,15.8,89,Incidence,693293,Non-Hispanic Asian/Pacific Islander,12.8,Male,Thyroid,2018
45-49,3.3,6.7,33,Incidence,693293,Non-Hispanic Asian/Pacific Islander,4.8,Male,Urinary Bladder,2018
5-9,9.9,15.5,81,Incidence,648171,Non-Hispanic Asian/Pacific Islander,12.5,Male,All Cancer Sites Combined,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
5-9,2.2,5.3,23,Incidence,648171,Non-Hispanic Asian/Pacific Islander,3.5,Male,Leukemias,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
5-9,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
50-54,290.6,319.0,1794,Incidence,589028,Non-Hispanic Asian/Pacific Islander,304.6,Male,All Cancer Sites Combined,2018
50-54,3.9,7.9,33,Incidence,589028,Non-Hispanic Asian/Pacific Islander,5.6,Male,Brain and Other Nervous System,2018
50-54,60.0,73.3,391,Incidence,589028,Non-Hispanic Asian/Pacific Islander,66.4,Male,Colon and Rectum,2018
50-54,2.3,5.7,22,Incidence,589028,Non-Hispanic Asian/Pacific Islander,3.7,Male,Esophagus,2018
50-54,~,~,~,Incidence,589028,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,589028,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
50-54,12.4,19.0,91,Incidence,589028,Non-Hispanic Asian/Pacific Islander,15.4,Male,Kidney and Renal Pelvis,2018
50-54,~,~,~,Incidence,589028,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
50-54,6.2,11.0,49,Incidence,589028,Non-Hispanic Asian/Pacific Islander,8.3,Male,Leukemias,2018
50-54,18.1,25.8,128,Incidence,589028,Non-Hispanic Asian/Pacific Islander,21.7,Male,Liver and Intrahepatic Bile Duct,2018
50-54,24.4,33.2,168,Incidence,589028,Non-Hispanic Asian/Pacific Islander,28.5,Male,Lung and Bronchus,2018
50-54,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
50-54,1.8,4.8,18,Incidence,589028,Non-Hispanic Asian/Pacific Islander,3.1,Male,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,589028,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
50-54,3.6,7.5,31,Incidence,589028,Non-Hispanic Asian/Pacific Islander,5.3,Male,Myeloma,2018
50-54,12.4,19.0,91,Incidence,589028,Non-Hispanic Asian/Pacific Islander,15.4,Male,Non-Hodgkin Lymphoma,2018
50-54,20.0,28.0,140,Incidence,589028,Non-Hispanic Asian/Pacific Islander,23.8,Male,Oral Cavity and Pharynx,2018
50-54,7.6,12.9,59,Incidence,589028,Non-Hispanic Asian/Pacific Islander,10.0,Male,Pancreas,2018
50-54,32.9,43.0,222,Incidence,589028,Non-Hispanic Asian/Pacific Islander,37.7,Male,Prostate,2018
50-54,9.1,14.8,69,Incidence,589028,Non-Hispanic Asian/Pacific Islander,11.7,Male,Stomach,2018
50-54,~,~,~,Incidence,589028,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
50-54,10.9,17.1,81,Incidence,589028,Non-Hispanic Asian/Pacific Islander,13.8,Male,Thyroid,2018
50-54,4.4,8.7,37,Incidence,589028,Non-Hispanic Asian/Pacific Islander,6.3,Male,Urinary Bladder,2018
55-59,468.8,506.3,2615,Incidence,536659,Non-Hispanic Asian/Pacific Islander,487.3,Male,All Cancer Sites Combined,2018
55-59,5.2,9.9,39,Incidence,536659,Non-Hispanic Asian/Pacific Islander,7.3,Male,Brain and Other Nervous System,2018
55-59,67.4,82.2,400,Incidence,536659,Non-Hispanic Asian/Pacific Islander,74.5,Male,Colon and Rectum,2018
55-59,3.0,6.9,25,Incidence,536659,Non-Hispanic Asian/Pacific Islander,4.7,Male,Esophagus,2018
55-59,~,~,~,Incidence,536659,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,536659,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
55-59,21.4,30.2,137,Incidence,536659,Non-Hispanic Asian/Pacific Islander,25.5,Male,Kidney and Renal Pelvis,2018
55-59,2.6,6.2,22,Incidence,536659,Non-Hispanic Asian/Pacific Islander,4.1,Male,Larynx,2018
55-59,11.3,17.9,77,Incidence,536659,Non-Hispanic Asian/Pacific Islander,14.3,Male,Leukemias,2018
55-59,35.6,46.6,219,Incidence,536659,Non-Hispanic Asian/Pacific Islander,40.8,Male,Liver and Intrahepatic Bile Duct,2018
55-59,52.0,65.2,313,Incidence,536659,Non-Hispanic Asian/Pacific Islander,58.3,Male,Lung and Bronchus,2018
55-59,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
55-59,~,~,~,Incidence,536659,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,536659,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
55-59,6.8,12.1,49,Incidence,536659,Non-Hispanic Asian/Pacific Islander,9.1,Male,Myeloma,2018
55-59,21.4,30.2,137,Incidence,536659,Non-Hispanic Asian/Pacific Islander,25.5,Male,Non-Hodgkin Lymphoma,2018
55-59,21.1,29.8,135,Incidence,536659,Non-Hispanic Asian/Pacific Islander,25.2,Male,Oral Cavity and Pharynx,2018
55-59,12.8,19.8,86,Incidence,536659,Non-Hispanic Asian/Pacific Islander,16.0,Male,Pancreas,2018
55-59,84.8,101.3,498,Incidence,536659,Non-Hispanic Asian/Pacific Islander,92.8,Male,Prostate,2018
55-59,13.2,20.2,88,Incidence,536659,Non-Hispanic Asian/Pacific Islander,16.4,Male,Stomach,2018
55-59,~,~,~,Incidence,536659,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
55-59,11.2,17.7,76,Incidence,536659,Non-Hispanic Asian/Pacific Islander,14.2,Male,Thyroid,2018
55-59,10.8,17.3,74,Incidence,536659,Non-Hispanic Asian/Pacific Islander,13.8,Male,Urinary Bladder,2018
60-64,745.9,796.4,3611,Incidence,468431,Non-Hispanic Asian/Pacific Islander,770.9,Male,All Cancer Sites Combined,2018
60-64,5.6,10.9,37,Incidence,468431,Non-Hispanic Asian/Pacific Islander,7.9,Male,Brain and Other Nervous System,2018
60-64,85.2,102.9,439,Incidence,468431,Non-Hispanic Asian/Pacific Islander,93.7,Male,Colon and Rectum,2018
60-64,8.7,15.0,54,Incidence,468431,Non-Hispanic Asian/Pacific Islander,11.5,Male,Esophagus,2018
60-64,~,~,~,Incidence,468431,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,468431,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
60-64,31.0,42.2,170,Incidence,468431,Non-Hispanic Asian/Pacific Islander,36.3,Male,Kidney and Renal Pelvis,2018
60-64,4.8,9.9,33,Incidence,468431,Non-Hispanic Asian/Pacific Islander,7.0,Male,Larynx,2018
60-64,14.1,22.0,83,Incidence,468431,Non-Hispanic Asian/Pacific Islander,17.7,Male,Leukemias,2018
60-64,56.0,70.6,295,Incidence,468431,Non-Hispanic Asian/Pacific Islander,63.0,Male,Liver and Intrahepatic Bile Duct,2018
60-64,91.7,110.1,471,Incidence,468431,Non-Hispanic Asian/Pacific Islander,100.5,Male,Lung and Bronchus,2018
60-64,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
60-64,~,~,~,Incidence,468431,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,468431,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
60-64,9.2,15.8,57,Incidence,468431,Non-Hispanic Asian/Pacific Islander,12.2,Male,Myeloma,2018
60-64,29.3,40.1,161,Incidence,468431,Non-Hispanic Asian/Pacific Islander,34.4,Male,Non-Hodgkin Lymphoma,2018
60-64,30.4,41.5,167,Incidence,468431,Non-Hispanic Asian/Pacific Islander,35.7,Male,Oral Cavity and Pharynx,2018
60-64,22.4,32.0,126,Incidence,468431,Non-Hispanic Asian/Pacific Islander,26.9,Male,Pancreas,2018
60-64,178.3,203.6,893,Incidence,468431,Non-Hispanic Asian/Pacific Islander,190.6,Male,Prostate,2018
60-64,25.1,35.3,140,Incidence,468431,Non-Hispanic Asian/Pacific Islander,29.9,Male,Stomach,2018
60-64,~,~,~,Incidence,468431,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
60-64,11.5,18.6,69,Incidence,468431,Non-Hispanic Asian/Pacific Islander,14.7,Male,Thyroid,2018
60-64,23.4,33.2,131,Incidence,468431,Non-Hispanic Asian/Pacific Islander,28.0,Male,Urinary Bladder,2018
65-69,1105.5,1173.6,4342,Incidence,381155,Non-Hispanic Asian/Pacific Islander,1139.2,Male,All Cancer Sites Combined,2018
65-69,7.3,14.0,39,Incidence,381155,Non-Hispanic Asian/Pacific Islander,10.2,Male,Brain and Other Nervous System,2018
65-69,110.7,133.1,463,Incidence,381155,Non-Hispanic Asian/Pacific Islander,121.5,Male,Colon and Rectum,2018
65-69,8.8,16.1,46,Incidence,381155,Non-Hispanic Asian/Pacific Islander,12.1,Male,Esophagus,2018
65-69,~,~,~,Incidence,381155,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,381155,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
65-69,30.9,43.3,140,Incidence,381155,Non-Hispanic Asian/Pacific Islander,36.7,Male,Kidney and Renal Pelvis,2018
65-69,7.3,14.0,39,Incidence,381155,Non-Hispanic Asian/Pacific Islander,10.2,Male,Larynx,2018
65-69,19.9,30.2,94,Incidence,381155,Non-Hispanic Asian/Pacific Islander,24.7,Male,Leukemias,2018
65-69,62.6,79.8,270,Incidence,381155,Non-Hispanic Asian/Pacific Islander,70.8,Male,Liver and Intrahepatic Bile Duct,2018
65-69,152.6,178.7,630,Incidence,381155,Non-Hispanic Asian/Pacific Islander,165.3,Male,Lung and Bronchus,2018
65-69,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
65-69,4.5,10.0,26,Incidence,381155,Non-Hispanic Asian/Pacific Islander,6.8,Male,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,381155,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
65-69,16.2,25.5,78,Incidence,381155,Non-Hispanic Asian/Pacific Islander,20.5,Male,Myeloma,2018
65-69,44.2,58.9,195,Incidence,381155,Non-Hispanic Asian/Pacific Islander,51.2,Male,Non-Hodgkin Lymphoma,2018
65-69,32.1,44.8,145,Incidence,381155,Non-Hispanic Asian/Pacific Islander,38.0,Male,Oral Cavity and Pharynx,2018
65-69,36.7,50.1,164,Incidence,381155,Non-Hispanic Asian/Pacific Islander,43.0,Male,Pancreas,2018
65-69,333.0,370.9,1340,Incidence,381155,Non-Hispanic Asian/Pacific Islander,351.6,Male,Prostate,2018
65-69,34.3,47.3,154,Incidence,381155,Non-Hispanic Asian/Pacific Islander,40.4,Male,Stomach,2018
65-69,~,~,~,Incidence,381155,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
65-69,11.1,19.1,56,Incidence,381155,Non-Hispanic Asian/Pacific Islander,14.7,Male,Thyroid,2018
65-69,37.2,50.7,166,Incidence,381155,Non-Hispanic Asian/Pacific Islander,43.6,Male,Urinary Bladder,2018
70-74,1323.9,1410.8,3828,Incidence,280064,Non-Hispanic Asian/Pacific Islander,1366.8,Male,All Cancer Sites Combined,2018
70-74,6.9,14.9,29,Incidence,280064,Non-Hispanic Asian/Pacific Islander,10.4,Male,Brain and Other Nervous System,2018
70-74,117.6,144.8,366,Incidence,280064,Non-Hispanic Asian/Pacific Islander,130.7,Male,Colon and Rectum,2018
70-74,16.0,27.2,59,Incidence,280064,Non-Hispanic Asian/Pacific Islander,21.1,Male,Esophagus,2018
70-74,~,~,~,Incidence,280064,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,280064,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
70-74,33.9,49.3,115,Incidence,280064,Non-Hispanic Asian/Pacific Islander,41.1,Male,Kidney and Renal Pelvis,2018
70-74,6.9,14.9,29,Incidence,280064,Non-Hispanic Asian/Pacific Islander,10.4,Male,Larynx,2018
70-74,28.1,42.3,97,Incidence,280064,Non-Hispanic Asian/Pacific Islander,34.6,Male,Leukemias,2018
70-74,67.8,88.9,218,Incidence,280064,Non-Hispanic Asian/Pacific Islander,77.8,Male,Liver and Intrahepatic Bile Duct,2018
70-74,193.0,227.3,587,Incidence,280064,Non-Hispanic Asian/Pacific Islander,209.6,Male,Lung and Bronchus,2018
70-74,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
70-74,3.8,10.2,18,Incidence,280064,Non-Hispanic Asian/Pacific Islander,6.4,Male,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,280064,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
70-74,13.6,23.9,51,Incidence,280064,Non-Hispanic Asian/Pacific Islander,18.2,Male,Myeloma,2018
70-74,45.7,63.2,151,Incidence,280064,Non-Hispanic Asian/Pacific Islander,53.9,Male,Non-Hodgkin Lymphoma,2018
70-74,36.5,52.4,123,Incidence,280064,Non-Hispanic Asian/Pacific Islander,43.9,Male,Oral Cavity and Pharynx,2018
70-74,43.7,60.9,145,Incidence,280064,Non-Hispanic Asian/Pacific Islander,51.8,Male,Pancreas,2018
70-74,378.6,425.9,1125,Incidence,280064,Non-Hispanic Asian/Pacific Islander,401.7,Male,Prostate,2018
70-74,46.6,64.4,154,Incidence,280064,Non-Hispanic Asian/Pacific Islander,55.0,Male,Stomach,2018
70-74,~,~,~,Incidence,280064,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
70-74,10.5,19.9,41,Incidence,280064,Non-Hispanic Asian/Pacific Islander,14.6,Male,Thyroid,2018
70-74,57.5,77.1,187,Incidence,280064,Non-Hispanic Asian/Pacific Islander,66.8,Male,Urinary Bladder,2018
75-79,1540.2,1654.7,3017,Incidence,188952,Non-Hispanic Asian/Pacific Islander,1596.7,Male,All Cancer Sites Combined,2018
75-79,7.3,17.6,22,Incidence,188952,Non-Hispanic Asian/Pacific Islander,11.6,Male,Brain and Other Nervous System,2018
75-79,120.9,154.8,259,Incidence,188952,Non-Hispanic Asian/Pacific Islander,137.1,Male,Colon and Rectum,2018
75-79,14.2,27.6,38,Incidence,188952,Non-Hispanic Asian/Pacific Islander,20.1,Male,Esophagus,2018
75-79,~,~,~,Incidence,188952,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,188952,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
75-79,37.4,57.4,88,Incidence,188952,Non-Hispanic Asian/Pacific Islander,46.6,Male,Kidney and Renal Pelvis,2018
75-79,8.6,19.5,25,Incidence,188952,Non-Hispanic Asian/Pacific Islander,13.2,Male,Larynx,2018
75-79,38.3,58.5,90,Incidence,188952,Non-Hispanic Asian/Pacific Islander,47.6,Male,Leukemias,2018
75-79,72.6,99.4,161,Incidence,188952,Non-Hispanic Asian/Pacific Islander,85.2,Male,Liver and Intrahepatic Bile Duct,2018
75-79,232.8,278.9,482,Incidence,188952,Non-Hispanic Asian/Pacific Islander,255.1,Male,Lung and Bronchus,2018
75-79,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
75-79,~,~,~,Incidence,188952,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,188952,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
75-79,23.8,40.3,59,Incidence,188952,Non-Hispanic Asian/Pacific Islander,31.2,Male,Myeloma,2018
75-79,71.6,98.3,159,Incidence,188952,Non-Hispanic Asian/Pacific Islander,84.1,Male,Non-Hodgkin Lymphoma,2018
75-79,35.5,55.0,84,Incidence,188952,Non-Hispanic Asian/Pacific Islander,44.5,Male,Oral Cavity and Pharynx,2018
75-79,59.9,84.6,135,Incidence,188952,Non-Hispanic Asian/Pacific Islander,71.4,Male,Pancreas,2018
75-79,361.9,418.7,736,Incidence,188952,Non-Hispanic Asian/Pacific Islander,389.5,Male,Prostate,2018
75-79,57.5,81.7,130,Incidence,188952,Non-Hispanic Asian/Pacific Islander,68.8,Male,Stomach,2018
75-79,~,~,~,Incidence,188952,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
75-79,9.8,21.4,28,Incidence,188952,Non-Hispanic Asian/Pacific Islander,14.8,Male,Thyroid,2018
75-79,88.7,118.2,194,Incidence,188952,Non-Hispanic Asian/Pacific Islander,102.7,Male,Urinary Bladder,2018
80-84,1676.8,1826.8,2117,Incidence,120928,Non-Hispanic Asian/Pacific Islander,1750.6,Male,All Cancer Sites Combined,2018
80-84,9.5,24.5,19,Incidence,120928,Non-Hispanic Asian/Pacific Islander,15.7,Male,Brain and Other Nervous System,2018
80-84,143.3,190.0,200,Incidence,120928,Non-Hispanic Asian/Pacific Islander,165.4,Male,Colon and Rectum,2018
80-84,14.0,31.5,26,Incidence,120928,Non-Hispanic Asian/Pacific Islander,21.5,Male,Esophagus,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
80-84,30.0,53.6,49,Incidence,120928,Non-Hispanic Asian/Pacific Islander,40.5,Male,Kidney and Renal Pelvis,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
80-84,47.3,75.9,73,Incidence,120928,Non-Hispanic Asian/Pacific Islander,60.4,Male,Leukemias,2018
80-84,81.5,117.8,119,Incidence,120928,Non-Hispanic Asian/Pacific Islander,98.4,Male,Liver and Intrahepatic Bile Duct,2018
80-84,306.2,372.6,409,Incidence,120928,Non-Hispanic Asian/Pacific Islander,338.2,Male,Lung and Bronchus,2018
80-84,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
80-84,18.8,38.3,33,Incidence,120928,Non-Hispanic Asian/Pacific Islander,27.3,Male,Myeloma,2018
80-84,89.8,127.6,130,Incidence,120928,Non-Hispanic Asian/Pacific Islander,107.5,Male,Non-Hodgkin Lymphoma,2018
80-84,27.8,50.7,46,Incidence,120928,Non-Hispanic Asian/Pacific Islander,38.0,Male,Oral Cavity and Pharynx,2018
80-84,60.6,92.4,91,Incidence,120928,Non-Hispanic Asian/Pacific Islander,75.3,Male,Pancreas,2018
80-84,277.9,341.4,373,Incidence,120928,Non-Hispanic Asian/Pacific Islander,308.4,Male,Prostate,2018
80-84,70.3,104.2,104,Incidence,120928,Non-Hispanic Asian/Pacific Islander,86.0,Male,Stomach,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
80-84,130.2,174.9,183,Incidence,120928,Non-Hispanic Asian/Pacific Islander,151.3,Male,Urinary Bladder,2018
85+,1614.6,1772.0,1796,Incidence,106150,Non-Hispanic Asian/Pacific Islander,1691.9,Male,All Cancer Sites Combined,2018
85+,13.0,31.4,22,Incidence,106150,Non-Hispanic Asian/Pacific Islander,20.7,Male,Brain and Other Nervous System,2018
85+,165.8,219.4,203,Incidence,106150,Non-Hispanic Asian/Pacific Islander,191.2,Male,Colon and Rectum,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
85+,26.1,50.2,39,Incidence,106150,Non-Hispanic Asian/Pacific Islander,36.7,Male,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
85+,44.8,74.9,62,Incidence,106150,Non-Hispanic Asian/Pacific Islander,58.4,Male,Leukemias,2018
85+,60.6,94.8,81,Incidence,106150,Non-Hispanic Asian/Pacific Islander,76.3,Male,Liver and Intrahepatic Bile Duct,2018
85+,299.7,370.1,354,Incidence,106150,Non-Hispanic Asian/Pacific Islander,333.5,Male,Lung and Bronchus,2018
85+,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
85+,17.5,38.1,28,Incidence,106150,Non-Hispanic Asian/Pacific Islander,26.4,Male,Myeloma,2018
85+,69.0,105.3,91,Incidence,106150,Non-Hispanic Asian/Pacific Islander,85.7,Male,Non-Hodgkin Lymphoma,2018
85+,23.0,45.9,35,Incidence,106150,Non-Hispanic Asian/Pacific Islander,33.0,Male,Oral Cavity and Pharynx,2018
85+,57.2,90.7,77,Incidence,106150,Non-Hispanic Asian/Pacific Islander,72.5,Male,Pancreas,2018
85+,209.0,268.6,252,Incidence,106150,Non-Hispanic Asian/Pacific Islander,237.4,Male,Prostate,2018
85+,72.4,109.4,95,Incidence,106150,Non-Hispanic Asian/Pacific Islander,89.5,Male,Stomach,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
85+,130.0,178.0,162,Incidence,106150,Non-Hispanic Asian/Pacific Islander,152.6,Male,Urinary Bladder,2018
<1,17.8,36.4,33,Incidence,127285,Non-Hispanic Asian/Pacific Islander,25.9,Male,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2018
<1,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2018
1-4,19.8,25.6,238,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,22.6,Male and Female,All Cancer Sites Combined,2018
1-4,2.5,4.9,38,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
1-4,7.8,11.6,101,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,9.6,Male and Female,Leukemias,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,511479,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
1-4,~,~,~,Incidence,543100,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2018
1-4,~,~,~,Incidence,1054579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
10-14,11.5,15.7,166,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,13.5,Male and Female,All Cancer Sites Combined,2018
10-14,1.3,3.0,25,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
10-14,3.0,5.4,50,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,Leukemias,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,607832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
10-14,~,~,~,Incidence,622690,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2018
10-14,~,~,~,Incidence,1230522,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
15-19,18.6,23.7,261,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,21.0,Male and Female,All Cancer Sites Combined,2018
15-19,0.7,2.1,16,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
15-19,1.8,3.6,32,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
15-19,2.4,4.5,41,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Leukemias,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
15-19,1.4,3.2,27,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,616880,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
15-19,~,~,~,Incidence,624406,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
15-19,3.2,5.6,53,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Thyroid,2018
15-19,~,~,~,Incidence,1241286,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
20-24,26.5,32.2,412,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,29.3,Male and Female,All Cancer Sites Combined,2018
20-24,0.8,2.1,19,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
20-24,1.7,3.4,34,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
20-24,1.7,3.4,34,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Leukemias,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2018
20-24,~,~,~,Incidence,693200,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
20-24,2.6,4.7,50,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2018
20-24,2.6,5.7,27,Incidence,693200,Non-Hispanic Asian/Pacific Islander,3.9,Male and Female,Ovary,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
20-24,~,~,~,Incidence,714088,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
20-24,3.5,7.0,36,Incidence,714088,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Testis,2018
20-24,5.7,8.5,98,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,7.0,Male and Female,Thyroid,2018
20-24,~,~,~,Incidence,1407288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
25-29,39.3,45.4,733,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,42.3,Male and Female,All Cancer Sites Combined,2018
25-29,1.1,2.3,28,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Brain and Other Nervous System,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
25-29,1.9,3.5,45,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Colon and Rectum,2018
25-29,1.2,3.3,18,Incidence,873804,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
25-29,6.9,10.9,76,Incidence,873804,Non-Hispanic Asian/Pacific Islander,8.7,Male and Female,Female Breast,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
25-29,1.9,3.5,45,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
25-29,1.8,3.4,44,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Leukemias,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
25-29,6.9,10.9,76,Incidence,873804,Non-Hispanic Asian/Pacific Islander,8.7,Male and Female,Male and Female Breast,2018
25-29,~,~,~,Incidence,873804,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
25-29,2.3,4.0,53,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,3.1,Male and Female,Non-Hodgkin Lymphoma,2018
25-29,1.5,2.9,36,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Oral Cavity and Pharynx,2018
25-29,1.1,3.1,17,Incidence,873804,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Ovary,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
25-29,~,~,~,Incidence,860755,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
25-29,2.5,5.2,32,Incidence,860755,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Testis,2018
25-29,10.1,13.4,202,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,11.6,Male and Female,Thyroid,2018
25-29,~,~,~,Incidence,1734559,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
30-34,67.6,75.6,1262,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,71.5,Male and Female,All Cancer Sites Combined,2018
30-34,0.8,2.0,23,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Brain and Other Nervous System,2018
30-34,3.2,6.1,41,Incidence,912123,Non-Hispanic Asian/Pacific Islander,4.5,Male and Female,Cervix,2018
30-34,3.3,5.3,74,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,4.2,Male and Female,Colon and Rectum,2018
30-34,4.3,7.5,52,Incidence,912123,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
30-34,22.6,29.3,235,Incidence,912123,Non-Hispanic Asian/Pacific Islander,25.8,Male and Female,Female Breast,2018
30-34,2.9,5.6,37,Incidence,912123,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,"Female Breast, <i>in situ</i>",2018
30-34,1.4,2.8,36,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
30-34,0.9,2.1,25,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
30-34,2.2,3.9,52,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Leukemias,2018
30-34,0.6,1.5,17,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,1.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.9,2.1,25,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Lung and Bronchus,2018
30-34,22.6,29.3,235,Incidence,912123,Non-Hispanic Asian/Pacific Islander,25.8,Male and Female,Male and Female Breast,2018
30-34,2.9,5.6,37,Incidence,912123,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
30-34,0.6,1.6,18,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,1.0,Male and Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
30-34,3.0,4.9,69,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,3.9,Male and Female,Non-Hodgkin Lymphoma,2018
30-34,1.7,3.2,41,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Oral Cavity and Pharynx,2018
30-34,2.5,5.1,33,Incidence,912123,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Ovary,2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
30-34,~,~,~,Incidence,852456,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
30-34,0.8,1.9,22,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Stomach,2018
30-34,4.1,7.3,47,Incidence,852456,Non-Hispanic Asian/Pacific Islander,5.5,Male and Female,Testis,2018
30-34,15.7,19.6,310,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,17.6,Male and Female,Thyroid,2018
30-34,~,~,~,Incidence,1764579,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
35-39,107.5,117.6,1901,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,112.5,Male and Female,All Cancer Sites Combined,2018
35-39,1.5,2.9,36,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Brain and Other Nervous System,2018
35-39,4.4,7.6,52,Incidence,892288,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Cervix,2018
35-39,5.9,8.6,121,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,7.2,Male and Female,Colon and Rectum,2018
35-39,11.6,16.6,124,Incidence,892288,Non-Hispanic Asian/Pacific Islander,13.9,Male and Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
35-39,54.3,64.6,529,Incidence,892288,Non-Hispanic Asian/Pacific Islander,59.3,Male and Female,Female Breast,2018
35-39,8.0,12.3,89,Incidence,892288,Non-Hispanic Asian/Pacific Islander,10.0,Male and Female,"Female Breast, <i>in situ</i>",2018
35-39,0.8,2.0,22,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
35-39,2.4,4.2,54,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,3.2,Male and Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
35-39,2.6,4.4,58,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Leukemias,2018
35-39,1.4,2.8,34,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
35-39,2.5,4.3,56,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Lung and Bronchus,2018
35-39,54.3,64.6,529,Incidence,892288,Non-Hispanic Asian/Pacific Islander,59.3,Male and Female,Male and Female Breast,2018
35-39,8.0,12.3,89,Incidence,892288,Non-Hispanic Asian/Pacific Islander,10.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
35-39,3.4,5.4,73,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Non-Hodgkin Lymphoma,2018
35-39,3.1,5.1,68,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Oral Cavity and Pharynx,2018
35-39,3.6,6.6,44,Incidence,892288,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,Ovary,2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
35-39,~,~,~,Incidence,798167,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
35-39,1.5,3.0,37,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Stomach,2018
35-39,2.4,5.2,29,Incidence,798167,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Testis,2018
35-39,18.8,23.2,353,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,20.9,Male and Female,Thyroid,2018
35-39,~,~,~,Incidence,1690455,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
40-44,187.6,201.7,2990,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,194.6,Male and Female,All Cancer Sites Combined,2018
40-44,2.4,4.3,50,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Brain and Other Nervous System,2018
40-44,7.9,12.3,81,Incidence,818294,Non-Hispanic Asian/Pacific Islander,9.9,Male and Female,Cervix,2018
40-44,15.8,20.1,274,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,17.8,Male and Female,Colon and Rectum,2018
40-44,15.4,21.4,149,Incidence,818294,Non-Hispanic Asian/Pacific Islander,18.2,Male and Female,"Corpus and Uterus, NOS",2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
40-44,123.5,139.3,1074,Incidence,818294,Non-Hispanic Asian/Pacific Islander,131.2,Male and Female,Female Breast,2018
40-44,42.1,51.6,382,Incidence,818294,Non-Hispanic Asian/Pacific Islander,46.7,Male and Female,"Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
40-44,4.4,6.8,85,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,5.5,Male and Female,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
40-44,3.4,5.5,67,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Leukemias,2018
40-44,2.8,4.7,56,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
40-44,4.7,7.1,89,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Lung and Bronchus,2018
40-44,123.5,139.3,1074,Incidence,818294,Non-Hispanic Asian/Pacific Islander,131.2,Male and Female,Male and Female Breast,2018
40-44,42.1,51.6,382,Incidence,818294,Non-Hispanic Asian/Pacific Islander,46.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
40-44,5.7,8.4,107,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,7.0,Male and Female,Non-Hodgkin Lymphoma,2018
40-44,6.7,9.5,123,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,8.0,Male and Female,Oral Cavity and Pharynx,2018
40-44,7.3,11.6,76,Incidence,818294,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Ovary,2018
40-44,0.8,2.1,21,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Pancreas,2018
40-44,~,~,~,Incidence,718526,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
40-44,3.3,5.5,66,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Stomach,2018
40-44,1.8,4.5,21,Incidence,718526,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Testis,2018
40-44,23.7,28.8,402,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,26.2,Male and Female,Thyroid,2018
40-44,~,~,~,Incidence,1536820,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
45-49,287.8,305.4,4391,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,296.5,Male and Female,All Cancer Sites Combined,2018
45-49,2.8,4.8,55,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Brain and Other Nervous System,2018
45-49,11.8,17.2,113,Incidence,787812,Non-Hispanic Asian/Pacific Islander,14.3,Male and Female,Cervix,2018
45-49,25.9,31.4,423,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,28.6,Male and Female,Colon and Rectum,2018
45-49,27.8,35.8,249,Incidence,787812,Non-Hispanic Asian/Pacific Islander,31.6,Male and Female,"Corpus and Uterus, NOS",2018
45-49,0.9,2.2,21,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Esophagus,2018
45-49,197.1,217.3,1631,Incidence,787812,Non-Hispanic Asian/Pacific Islander,207.0,Male and Female,Female Breast,2018
45-49,68.1,80.3,583,Incidence,787812,Non-Hispanic Asian/Pacific Islander,74.0,Male and Female,"Female Breast, <i>in situ</i>",2018
45-49,~,~,~,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
45-49,7.1,10.2,127,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
45-49,3.8,6.1,72,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,Leukemias,2018
45-49,4.3,6.7,80,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,5.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
45-49,12.7,16.7,216,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,14.6,Male and Female,Lung and Bronchus,2018
45-49,197.1,217.3,1631,Incidence,787812,Non-Hispanic Asian/Pacific Islander,207.0,Male and Female,Male and Female Breast,2018
45-49,68.1,80.3,583,Incidence,787812,Non-Hispanic Asian/Pacific Islander,74.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
45-49,~,~,~,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
45-49,1.7,3.4,36,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Myeloma,2018
45-49,8.3,11.5,145,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,9.8,Male and Female,Non-Hodgkin Lymphoma,2018
45-49,9.0,12.4,157,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,10.6,Male and Female,Oral Cavity and Pharynx,2018
45-49,14.9,21.0,140,Incidence,787812,Non-Hispanic Asian/Pacific Islander,17.8,Male and Female,Ovary,2018
45-49,3.6,5.8,68,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,4.6,Male and Female,Pancreas,2018
45-49,5.0,9.0,47,Incidence,693293,Non-Hispanic Asian/Pacific Islander,6.8,Male and Female,Prostate,2018
45-49,4.7,7.2,87,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Stomach,2018
45-49,~,~,~,Incidence,693293,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
45-49,22.9,28.2,377,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,25.5,Male and Female,Thyroid,2018
45-49,1.9,3.6,39,Incidence,1481105,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Urinary Bladder,2018
5-9,10.3,14.2,154,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,12.2,Male and Female,All Cancer Sites Combined,2018
5-9,2.2,4.2,39,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,3.1,Male and Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
5-9,2.9,5.2,50,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,3.9,Male and Female,Leukemias,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
5-9,0.7,2.1,16,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,618577,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
5-9,~,~,~,Incidence,648171,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2018
5-9,~,~,~,Incidence,1266748,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
50-54,403.2,425.7,5232,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,414.3,Male and Female,All Cancer Sites Combined,2018
50-54,3.5,5.9,58,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,4.6,Male and Female,Brain and Other Nervous System,2018
50-54,8.8,14.0,75,Incidence,673715,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Cervix,2018
50-54,53.4,61.8,726,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,57.5,Male and Female,Colon and Rectum,2018
50-54,52.8,64.6,394,Incidence,673715,Non-Hispanic Asian/Pacific Islander,58.5,Male and Female,"Corpus and Uterus, NOS",2018
50-54,1.5,3.2,28,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Esophagus,2018
50-54,206.3,228.7,1464,Incidence,673715,Non-Hispanic Asian/Pacific Islander,217.3,Male and Female,Female Breast,2018
50-54,69.8,83.2,514,Incidence,673715,Non-Hispanic Asian/Pacific Islander,76.3,Male and Female,"Female Breast, <i>in situ</i>",2018
50-54,~,~,~,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
50-54,8.7,12.4,132,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,10.5,Male and Female,Kidney and Renal Pelvis,2018
50-54,~,~,~,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
50-54,5.6,8.6,88,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,7.0,Male and Female,Leukemias,2018
50-54,10.6,14.5,157,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,12.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
50-54,24.9,30.8,350,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,27.7,Male and Female,Lung and Bronchus,2018
50-54,206.3,228.7,1464,Incidence,673715,Non-Hispanic Asian/Pacific Islander,217.3,Male and Female,Male and Female Breast,2018
50-54,69.8,83.2,514,Incidence,673715,Non-Hispanic Asian/Pacific Islander,76.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
50-54,1.4,3.1,27,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
50-54,3.1,5.5,53,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,4.2,Male and Female,Myeloma,2018
50-54,12.9,17.3,189,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,15.0,Male and Female,Non-Hodgkin Lymphoma,2018
50-54,12.8,17.2,188,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,14.9,Male and Female,Oral Cavity and Pharynx,2018
50-54,14.6,21.1,119,Incidence,673715,Non-Hispanic Asian/Pacific Islander,17.7,Male and Female,Ovary,2018
50-54,7.4,10.8,113,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,8.9,Male and Female,Pancreas,2018
50-54,32.9,43.0,222,Incidence,589028,Non-Hispanic Asian/Pacific Islander,37.7,Male and Female,Prostate,2018
50-54,7.1,10.4,109,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Stomach,2018
50-54,~,~,~,Incidence,589028,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
50-54,25.8,31.8,362,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,28.7,Male and Female,Thyroid,2018
50-54,3.1,5.4,52,Incidence,1262743,Non-Hispanic Asian/Pacific Islander,4.1,Male and Female,Urinary Bladder,2018
55-59,527.9,554.7,6298,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,541.2,Male and Female,All Cancer Sites Combined,2018
55-59,4.5,7.3,67,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Brain and Other Nervous System,2018
55-59,8.3,13.6,67,Incidence,627154,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,Cervix,2018
55-59,54.2,63.1,681,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,58.5,Male and Female,Colon and Rectum,2018
55-59,59.8,72.7,414,Incidence,627154,Non-Hispanic Asian/Pacific Islander,66.0,Male and Female,"Corpus and Uterus, NOS",2018
55-59,2.2,4.4,37,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,3.2,Male and Female,Esophagus,2018
55-59,221.9,246.0,1466,Incidence,627154,Non-Hispanic Asian/Pacific Islander,233.8,Male and Female,Female Breast,2018
55-59,67.7,81.4,466,Incidence,627154,Non-Hispanic Asian/Pacific Islander,74.3,Male and Female,"Female Breast, <i>in situ</i>",2018
55-59,~,~,~,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
55-59,16.6,21.7,221,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,19.0,Male and Female,Kidney and Renal Pelvis,2018
55-59,1.4,3.2,25,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Larynx,2018
55-59,10.1,14.2,140,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,12.0,Male and Female,Leukemias,2018
55-59,21.6,27.4,284,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,24.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
55-59,42.9,50.8,544,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,46.7,Male and Female,Lung and Bronchus,2018
55-59,221.9,246.0,1466,Incidence,627154,Non-Hispanic Asian/Pacific Islander,233.8,Male and Female,Male and Female Breast,2018
55-59,67.7,81.4,466,Incidence,627154,Non-Hispanic Asian/Pacific Islander,74.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
55-59,1.8,3.8,31,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
55-59,4.6,7.5,69,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Myeloma,2018
55-59,18.8,24.2,249,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,21.4,Male and Female,Non-Hodgkin Lymphoma,2018
55-59,15.4,20.3,206,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,17.7,Male and Female,Oral Cavity and Pharynx,2018
55-59,16.7,23.9,126,Incidence,627154,Non-Hispanic Asian/Pacific Islander,20.1,Male and Female,Ovary,2018
55-59,11.6,16.0,159,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,13.7,Male and Female,Pancreas,2018
55-59,84.8,101.3,498,Incidence,536659,Non-Hispanic Asian/Pacific Islander,92.8,Male and Female,Prostate,2018
55-59,11.7,16.1,160,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,13.7,Male and Female,Stomach,2018
55-59,~,~,~,Incidence,536659,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
55-59,23.8,29.8,310,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,26.6,Male and Female,Thyroid,2018
55-59,6.7,10.1,96,Incidence,1163813,Non-Hispanic Asian/Pacific Islander,8.2,Male and Female,Urinary Bladder,2018
60-64,719.8,752.9,7657,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,736.2,Male and Female,All Cancer Sites Combined,2018
60-64,5.3,8.6,71,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,6.8,Male and Female,Brain and Other Nervous System,2018
60-64,9.2,15.1,68,Incidence,571603,Non-Hispanic Asian/Pacific Islander,11.9,Male and Female,Cervix,2018
60-64,66.7,77.1,746,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,71.7,Male and Female,Colon and Rectum,2018
60-64,62.6,76.4,396,Incidence,571603,Non-Hispanic Asian/Pacific Islander,69.3,Male and Female,"Corpus and Uterus, NOS",2018
60-64,5.4,8.7,72,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,6.9,Male and Female,Esophagus,2018
60-64,250.7,277.5,1508,Incidence,571603,Non-Hispanic Asian/Pacific Islander,263.8,Male and Female,Female Breast,2018
60-64,77.6,92.9,486,Incidence,571603,Non-Hispanic Asian/Pacific Islander,85.0,Male and Female,"Female Breast, <i>in situ</i>",2018
60-64,~,~,~,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
60-64,21.9,28.0,258,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,24.8,Male and Female,Kidney and Renal Pelvis,2018
60-64,2.5,4.9,37,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Larynx,2018
60-64,10.6,15.1,132,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,12.7,Male and Female,Leukemias,2018
60-64,34.1,41.7,393,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,37.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
60-64,76.8,87.9,855,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,82.2,Male and Female,Lung and Bronchus,2018
60-64,250.7,277.5,1508,Incidence,571603,Non-Hispanic Asian/Pacific Islander,263.8,Male and Female,Male and Female Breast,2018
60-64,77.6,92.9,486,Incidence,571603,Non-Hispanic Asian/Pacific Islander,85.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
60-64,1.9,4.0,29,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
60-64,7.5,11.3,96,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,9.2,Male and Female,Myeloma,2018
60-64,24.7,31.2,289,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,27.8,Male and Female,Non-Hodgkin Lymphoma,2018
60-64,20.7,26.7,245,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,23.6,Male and Female,Oral Cavity and Pharynx,2018
60-64,17.7,25.5,122,Incidence,571603,Non-Hispanic Asian/Pacific Islander,21.3,Male and Female,Ovary,2018
60-64,20.1,26.0,238,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,22.9,Male and Female,Pancreas,2018
60-64,178.3,203.6,893,Incidence,468431,Non-Hispanic Asian/Pacific Islander,190.6,Male and Female,Prostate,2018
60-64,18.7,24.4,223,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,21.4,Male and Female,Stomach,2018
60-64,~,~,~,Incidence,468431,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
60-64,23.8,30.2,279,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,26.8,Male and Female,Thyroid,2018
60-64,14.8,19.9,179,Incidence,1040034,Non-Hispanic Asian/Pacific Islander,17.2,Male and Female,Urinary Bladder,2018
65-69,983.8,1026.2,8685,Incidence,864343,Non-Hispanic Asian/Pacific Islander,1004.8,Male and Female,All Cancer Sites Combined,2018
65-69,7.1,11.3,78,Incidence,864343,Non-Hispanic Asian/Pacific Islander,9.0,Male and Female,Brain and Other Nervous System,2018
65-69,8.6,14.8,55,Incidence,483188,Non-Hispanic Asian/Pacific Islander,11.4,Male and Female,Cervix,2018
65-69,85.0,97.9,789,Incidence,864343,Non-Hispanic Asian/Pacific Islander,91.3,Male and Female,Colon and Rectum,2018
65-69,67.4,83.0,362,Incidence,483188,Non-Hispanic Asian/Pacific Islander,74.9,Male and Female,"Corpus and Uterus, NOS",2018
65-69,5.0,8.5,57,Incidence,864343,Non-Hispanic Asian/Pacific Islander,6.6,Male and Female,Esophagus,2018
65-69,301.4,333.3,1532,Incidence,483188,Non-Hispanic Asian/Pacific Islander,317.1,Male and Female,Female Breast,2018
65-69,92.6,110.8,490,Incidence,483188,Non-Hispanic Asian/Pacific Islander,101.4,Male and Female,"Female Breast, <i>in situ</i>",2018
65-69,~,~,~,Incidence,864343,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,864343,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
65-69,23.7,30.8,234,Incidence,864343,Non-Hispanic Asian/Pacific Islander,27.1,Male and Female,Kidney and Renal Pelvis,2018
65-69,3.6,6.7,43,Incidence,864343,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Larynx,2018
65-69,18.0,24.2,181,Incidence,864343,Non-Hispanic Asian/Pacific Islander,20.9,Male and Female,Leukemias,2018
65-69,40.9,50.0,391,Incidence,864343,Non-Hispanic Asian/Pacific Islander,45.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
65-69,121.8,137.0,1117,Incidence,864343,Non-Hispanic Asian/Pacific Islander,129.2,Male and Female,Lung and Bronchus,2018
65-69,301.4,333.3,1532,Incidence,483188,Non-Hispanic Asian/Pacific Islander,317.1,Male and Female,Male and Female Breast,2018
65-69,92.6,110.8,490,Incidence,483188,Non-Hispanic Asian/Pacific Islander,101.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
65-69,2.8,5.6,35,Incidence,864343,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,864343,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
65-69,12.1,17.4,126,Incidence,864343,Non-Hispanic Asian/Pacific Islander,14.6,Male and Female,Myeloma,2018
65-69,38.6,47.4,370,Incidence,864343,Non-Hispanic Asian/Pacific Islander,42.8,Male and Female,Non-Hodgkin Lymphoma,2018
65-69,21.1,27.8,210,Incidence,864343,Non-Hispanic Asian/Pacific Islander,24.3,Male and Female,Oral Cavity and Pharynx,2018
65-69,19.1,27.9,112,Incidence,483188,Non-Hispanic Asian/Pacific Islander,23.2,Male and Female,Ovary,2018
65-69,30.7,38.6,298,Incidence,864343,Non-Hispanic Asian/Pacific Islander,34.5,Male and Female,Pancreas,2018
65-69,333.0,370.9,1340,Incidence,381155,Non-Hispanic Asian/Pacific Islander,351.6,Male and Female,Prostate,2018
65-69,25.6,32.9,251,Incidence,864343,Non-Hispanic Asian/Pacific Islander,29.0,Male and Female,Stomach,2018
65-69,~,~,~,Incidence,381155,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
65-69,24.8,32.0,244,Incidence,864343,Non-Hispanic Asian/Pacific Islander,28.2,Male and Female,Thyroid,2018
65-69,22.6,29.5,224,Incidence,864343,Non-Hispanic Asian/Pacific Islander,25.9,Male and Female,Urinary Bladder,2018
70-74,1148.6,1202.2,7426,Incidence,631913,Non-Hispanic Asian/Pacific Islander,1175.2,Male and Female,All Cancer Sites Combined,2018
70-74,6.8,11.7,57,Incidence,631913,Non-Hispanic Asian/Pacific Islander,9.0,Male and Female,Brain and Other Nervous System,2018
70-74,6.9,13.8,35,Incidence,351849,Non-Hispanic Asian/Pacific Islander,9.9,Male and Female,Cervix,2018
70-74,93.9,109.8,642,Incidence,631913,Non-Hispanic Asian/Pacific Islander,101.6,Male and Female,Colon and Rectum,2018
70-74,53.5,70.1,216,Incidence,351849,Non-Hispanic Asian/Pacific Islander,61.4,Male and Female,"Corpus and Uterus, NOS",2018
70-74,8.9,14.3,72,Incidence,631913,Non-Hispanic Asian/Pacific Islander,11.4,Male and Female,Esophagus,2018
70-74,325.6,364.7,1213,Incidence,351849,Non-Hispanic Asian/Pacific Islander,344.8,Male and Female,Female Breast,2018
70-74,83.4,103.9,328,Incidence,351849,Non-Hispanic Asian/Pacific Islander,93.2,Male and Female,"Female Breast, <i>in situ</i>",2018
70-74,~,~,~,Incidence,631913,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,631913,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
70-74,27.1,36.0,198,Incidence,631913,Non-Hispanic Asian/Pacific Islander,31.3,Male and Female,Kidney and Renal Pelvis,2018
70-74,3.2,6.8,30,Incidence,631913,Non-Hispanic Asian/Pacific Islander,4.7,Male and Female,Larynx,2018
70-74,22.0,30.1,163,Incidence,631913,Non-Hispanic Asian/Pacific Islander,25.8,Male and Female,Leukemias,2018
70-74,46.9,58.3,331,Incidence,631913,Non-Hispanic Asian/Pacific Islander,52.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
70-74,160.9,181.4,1080,Incidence,631913,Non-Hispanic Asian/Pacific Islander,170.9,Male and Female,Lung and Bronchus,2018
70-74,325.6,364.7,1213,Incidence,351849,Non-Hispanic Asian/Pacific Islander,344.8,Male and Female,Male and Female Breast,2018
70-74,83.4,103.9,328,Incidence,351849,Non-Hispanic Asian/Pacific Islander,93.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
70-74,2.8,6.2,27,Incidence,631913,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,631913,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
70-74,15.9,22.9,121,Incidence,631913,Non-Hispanic Asian/Pacific Islander,19.1,Male and Female,Myeloma,2018
70-74,43.4,54.5,308,Incidence,631913,Non-Hispanic Asian/Pacific Islander,48.7,Male and Female,Non-Hodgkin Lymphoma,2018
70-74,23.9,32.3,176,Incidence,631913,Non-Hispanic Asian/Pacific Islander,27.9,Male and Female,Oral Cavity and Pharynx,2018
70-74,15.8,25.5,71,Incidence,351849,Non-Hispanic Asian/Pacific Islander,20.2,Male and Female,Ovary,2018
70-74,42.9,53.8,304,Incidence,631913,Non-Hispanic Asian/Pacific Islander,48.1,Male and Female,Pancreas,2018
70-74,378.6,425.9,1125,Incidence,280064,Non-Hispanic Asian/Pacific Islander,401.7,Male and Female,Prostate,2018
70-74,34.4,44.3,247,Incidence,631913,Non-Hispanic Asian/Pacific Islander,39.1,Male and Female,Stomach,2018
70-74,~,~,~,Incidence,280064,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
70-74,17.9,25.3,135,Incidence,631913,Non-Hispanic Asian/Pacific Islander,21.4,Male and Female,Thyroid,2018
70-74,33.8,43.6,243,Incidence,631913,Non-Hispanic Asian/Pacific Islander,38.5,Male and Female,Urinary Bladder,2018
75-79,1301.2,1370.8,5698,Incidence,426596,Non-Hispanic Asian/Pacific Islander,1335.7,Male and Female,All Cancer Sites Combined,2018
75-79,6.7,12.8,40,Incidence,426596,Non-Hispanic Asian/Pacific Islander,9.4,Male and Female,Brain and Other Nervous System,2018
75-79,6.8,15.5,25,Incidence,237644,Non-Hispanic Asian/Pacific Islander,10.5,Male and Female,Cervix,2018
75-79,106.5,127.2,497,Incidence,426596,Non-Hispanic Asian/Pacific Islander,116.5,Male and Female,Colon and Rectum,2018
75-79,54.6,75.4,153,Incidence,237644,Non-Hispanic Asian/Pacific Islander,64.4,Male and Female,"Corpus and Uterus, NOS",2018
75-79,9.5,16.5,54,Incidence,426596,Non-Hispanic Asian/Pacific Islander,12.7,Male and Female,Esophagus,2018
75-79,262.6,305.9,674,Incidence,237644,Non-Hispanic Asian/Pacific Islander,283.6,Male and Female,Female Breast,2018
75-79,71.7,95.3,197,Incidence,237644,Non-Hispanic Asian/Pacific Islander,82.9,Male and Female,"Female Breast, <i>in situ</i>",2018
75-79,~,~,~,Incidence,426596,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,426596,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
75-79,27.8,39.0,141,Incidence,426596,Non-Hispanic Asian/Pacific Islander,33.1,Male and Female,Kidney and Renal Pelvis,2018
75-79,4.2,9.2,27,Incidence,426596,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Larynx,2018
75-79,30.8,42.5,155,Incidence,426596,Non-Hispanic Asian/Pacific Islander,36.3,Male and Female,Leukemias,2018
75-79,52.2,67.1,253,Incidence,426596,Non-Hispanic Asian/Pacific Islander,59.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
75-79,201.3,229.3,917,Incidence,426596,Non-Hispanic Asian/Pacific Islander,215.0,Male and Female,Lung and Bronchus,2018
75-79,262.6,305.9,674,Incidence,237644,Non-Hispanic Asian/Pacific Islander,283.6,Male and Female,Male and Female Breast,2018
75-79,71.7,95.3,197,Incidence,237644,Non-Hispanic Asian/Pacific Islander,82.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
75-79,4.2,9.2,27,Incidence,426596,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,426596,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
75-79,20.6,30.3,107,Incidence,426596,Non-Hispanic Asian/Pacific Islander,25.1,Male and Female,Myeloma,2018
75-79,60.6,76.5,291,Incidence,426596,Non-Hispanic Asian/Pacific Islander,68.2,Male and Female,Non-Hodgkin Lymphoma,2018
75-79,24.8,35.4,127,Incidence,426596,Non-Hispanic Asian/Pacific Islander,29.8,Male and Female,Oral Cavity and Pharynx,2018
75-79,19.6,33.0,61,Incidence,237644,Non-Hispanic Asian/Pacific Islander,25.7,Male and Female,Ovary,2018
75-79,61.3,77.3,294,Incidence,426596,Non-Hispanic Asian/Pacific Islander,68.9,Male and Female,Pancreas,2018
75-79,361.9,418.7,736,Incidence,188952,Non-Hispanic Asian/Pacific Islander,389.5,Male and Female,Prostate,2018
75-79,41.3,54.6,203,Incidence,426596,Non-Hispanic Asian/Pacific Islander,47.6,Male and Female,Stomach,2018
75-79,~,~,~,Incidence,188952,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
75-79,15.7,24.4,84,Incidence,426596,Non-Hispanic Asian/Pacific Islander,19.7,Male and Female,Thyroid,2018
75-79,48.9,63.3,238,Incidence,426596,Non-Hispanic Asian/Pacific Islander,55.8,Male and Female,Urinary Bladder,2018
80-84,1434.3,1524.3,4174,Incidence,282259,Non-Hispanic Asian/Pacific Islander,1478.8,Male and Female,All Cancer Sites Combined,2018
80-84,7.2,15.2,30,Incidence,282259,Non-Hispanic Asian/Pacific Islander,10.6,Male and Female,Brain and Other Nervous System,2018
80-84,9.5,22.1,24,Incidence,161331,Non-Hispanic Asian/Pacific Islander,14.9,Male and Female,Cervix,2018
80-84,139.0,168.2,432,Incidence,282259,Non-Hispanic Asian/Pacific Islander,153.1,Male and Female,Colon and Rectum,2018
80-84,30.6,50.7,64,Incidence,161331,Non-Hispanic Asian/Pacific Islander,39.7,Male and Female,"Corpus and Uterus, NOS",2018
80-84,8.6,17.2,35,Incidence,282259,Non-Hispanic Asian/Pacific Islander,12.4,Male and Female,Esophagus,2018
80-84,233.7,283.9,416,Incidence,161331,Non-Hispanic Asian/Pacific Islander,257.9,Male and Female,Female Breast,2018
80-84,34.9,56.2,72,Incidence,161331,Non-Hispanic Asian/Pacific Islander,44.6,Male and Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,282259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,282259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
80-84,26.6,40.4,93,Incidence,282259,Non-Hispanic Asian/Pacific Islander,32.9,Male and Female,Kidney and Renal Pelvis,2018
80-84,3.8,10.1,18,Incidence,282259,Non-Hispanic Asian/Pacific Islander,6.4,Male and Female,Larynx,2018
80-84,34.6,50.1,118,Incidence,282259,Non-Hispanic Asian/Pacific Islander,41.8,Male and Female,Leukemias,2018
80-84,62.7,82.9,204,Incidence,282259,Non-Hispanic Asian/Pacific Islander,72.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
80-84,256.6,295.7,778,Incidence,282259,Non-Hispanic Asian/Pacific Islander,275.6,Male and Female,Lung and Bronchus,2018
80-84,233.7,283.9,416,Incidence,161331,Non-Hispanic Asian/Pacific Islander,257.9,Male and Female,Male and Female Breast,2018
80-84,34.9,56.2,72,Incidence,161331,Non-Hispanic Asian/Pacific Islander,44.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
80-84,3.8,10.1,18,Incidence,282259,Non-Hispanic Asian/Pacific Islander,6.4,Male and Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,282259,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
80-84,19.6,31.7,71,Incidence,282259,Non-Hispanic Asian/Pacific Islander,25.2,Male and Female,Myeloma,2018
80-84,69.6,90.8,225,Incidence,282259,Non-Hispanic Asian/Pacific Islander,79.7,Male and Female,Non-Hodgkin Lymphoma,2018
80-84,21.2,33.7,76,Incidence,282259,Non-Hispanic Asian/Pacific Islander,26.9,Male and Female,Oral Cavity and Pharynx,2018
80-84,25.1,43.7,54,Incidence,161331,Non-Hispanic Asian/Pacific Islander,33.5,Male and Female,Ovary,2018
80-84,64.7,85.2,210,Incidence,282259,Non-Hispanic Asian/Pacific Islander,74.4,Male and Female,Pancreas,2018
80-84,277.9,341.4,373,Incidence,120928,Non-Hispanic Asian/Pacific Islander,308.4,Male and Female,Prostate,2018
80-84,57.1,76.5,187,Incidence,282259,Non-Hispanic Asian/Pacific Islander,66.3,Male and Female,Stomach,2018
80-84,~,~,~,Incidence,120928,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
80-84,9.8,18.9,39,Incidence,282259,Non-Hispanic Asian/Pacific Islander,13.8,Male and Female,Thyroid,2018
80-84,74.3,96.1,239,Incidence,282259,Non-Hispanic Asian/Pacific Islander,84.7,Male and Female,Urinary Bladder,2018
85+,1320.4,1406.5,3890,Incidence,285413,Non-Hispanic Asian/Pacific Islander,1362.9,Male and Female,All Cancer Sites Combined,2018
85+,9.1,17.9,37,Incidence,285413,Non-Hispanic Asian/Pacific Islander,13.0,Male and Female,Brain and Other Nervous System,2018
85+,8.1,19.3,23,Incidence,179263,Non-Hispanic Asian/Pacific Islander,12.8,Male and Female,Cervix,2018
85+,160.2,191.2,500,Incidence,285413,Non-Hispanic Asian/Pacific Islander,175.2,Male and Female,Colon and Rectum,2018
85+,21.7,38.0,52,Incidence,179263,Non-Hispanic Asian/Pacific Islander,29.0,Male and Female,"Corpus and Uterus, NOS",2018
85+,6.0,13.3,26,Incidence,285413,Non-Hispanic Asian/Pacific Islander,9.1,Male and Female,Esophagus,2018
85+,151.1,189.8,304,Incidence,179263,Non-Hispanic Asian/Pacific Islander,169.6,Male and Female,Female Breast,2018
85+,14.1,27.8,36,Incidence,179263,Non-Hispanic Asian/Pacific Islander,20.1,Male and Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,285413,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,285413,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
85+,22.5,35.3,81,Incidence,285413,Non-Hispanic Asian/Pacific Islander,28.4,Male and Female,Kidney and Renal Pelvis,2018
85+,3.7,10.0,18,Incidence,285413,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Larynx,2018
85+,31.7,46.5,110,Incidence,285413,Non-Hispanic Asian/Pacific Islander,38.5,Male and Female,Leukemias,2018
85+,50.6,68.8,169,Incidence,285413,Non-Hispanic Asian/Pacific Islander,59.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
85+,229.4,266.3,706,Incidence,285413,Non-Hispanic Asian/Pacific Islander,247.4,Male and Female,Lung and Bronchus,2018
85+,151.1,189.8,304,Incidence,179263,Non-Hispanic Asian/Pacific Islander,169.6,Male and Female,Male and Female Breast,2018
85+,14.1,27.8,36,Incidence,179263,Non-Hispanic Asian/Pacific Islander,20.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,285413,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,285413,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
85+,14.2,24.7,54,Incidence,285413,Non-Hispanic Asian/Pacific Islander,18.9,Male and Female,Myeloma,2018
85+,58.1,77.5,192,Incidence,285413,Non-Hispanic Asian/Pacific Islander,67.3,Male and Female,Non-Hodgkin Lymphoma,2018
85+,17.9,29.4,66,Incidence,285413,Non-Hispanic Asian/Pacific Islander,23.1,Male and Female,Oral Cavity and Pharynx,2018
85+,15.0,29.1,38,Incidence,179263,Non-Hispanic Asian/Pacific Islander,21.2,Male and Female,Ovary,2018
85+,66.6,87.2,218,Incidence,285413,Non-Hispanic Asian/Pacific Islander,76.4,Male and Female,Pancreas,2018
85+,209.0,268.6,252,Incidence,106150,Non-Hispanic Asian/Pacific Islander,237.4,Male and Female,Prostate,2018
85+,52.2,70.7,174,Incidence,285413,Non-Hispanic Asian/Pacific Islander,61.0,Male and Female,Stomach,2018
85+,~,~,~,Incidence,106150,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
85+,8.5,17.1,35,Incidence,285413,Non-Hispanic Asian/Pacific Islander,12.3,Male and Female,Thyroid,2018
85+,76.1,98.0,247,Incidence,285413,Non-Hispanic Asian/Pacific Islander,86.5,Male and Female,Urinary Bladder,2018
<1,16.8,29.0,55,Incidence,246516,Non-Hispanic Asian/Pacific Islander,22.3,Male and Female,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Leukemias,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,119231,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2018
<1,~,~,~,Incidence,127285,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2018
<1,~,~,~,Incidence,246516,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2018
1-4,14.3,19.0,199,Incidence,1205219,Non-Hispanic Black,16.5,Female,All Cancer Sites Combined,2018
1-4,2.4,4.6,41,Incidence,1205219,Non-Hispanic Black,3.4,Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Cervix,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Esophagus,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Female Breast,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
1-4,1.8,3.7,32,Incidence,1205219,Non-Hispanic Black,2.7,Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Larynx,2018
1-4,3.7,6.2,58,Incidence,1205219,Non-Hispanic Black,4.8,Female,Leukemias,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Mesothelioma,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Myeloma,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Ovary,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Pancreas,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Stomach,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Thyroid,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Female,Urinary Bladder,2018
10-14,11.4,15.0,202,Incidence,1542138,Non-Hispanic Black,13.1,Female,All Cancer Sites Combined,2018
10-14,1.4,2.9,32,Incidence,1542138,Non-Hispanic Black,2.1,Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Cervix,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Esophagus,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Female Breast,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
10-14,0.9,2.2,22,Incidence,1542138,Non-Hispanic Black,1.4,Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Larynx,2018
10-14,1.3,2.7,29,Incidence,1542138,Non-Hispanic Black,1.9,Female,Leukemias,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Mesothelioma,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Myeloma,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2018
10-14,0.6,1.8,17,Incidence,1542138,Non-Hispanic Black,1.1,Female,Ovary,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Pancreas,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Stomach,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Thyroid,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Female,Urinary Bladder,2018
15-19,14.4,18.4,254,Incidence,1558365,Non-Hispanic Black,16.3,Female,All Cancer Sites Combined,2018
15-19,0.7,1.9,19,Incidence,1558365,Non-Hispanic Black,1.2,Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Cervix,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Esophagus,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Female Breast,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
15-19,1.9,3.6,42,Incidence,1558365,Non-Hispanic Black,2.7,Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Larynx,2018
15-19,0.9,2.1,22,Incidence,1558365,Non-Hispanic Black,1.4,Female,Leukemias,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Mesothelioma,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Myeloma,2018
15-19,0.7,1.9,19,Incidence,1558365,Non-Hispanic Black,1.2,Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2018
15-19,0.6,1.7,17,Incidence,1558365,Non-Hispanic Black,1.1,Female,Ovary,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Pancreas,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Stomach,2018
15-19,1.2,2.7,29,Incidence,1558365,Non-Hispanic Black,1.9,Female,Thyroid,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Female,Urinary Bladder,2018
20-24,25.0,30.2,452,Incidence,1642648,Non-Hispanic Black,27.5,Female,All Cancer Sites Combined,2018
20-24,0.7,1.9,20,Incidence,1642648,Non-Hispanic Black,1.2,Female,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Cervix,2018
20-24,1.0,2.2,25,Incidence,1642648,Non-Hispanic Black,1.5,Female,Colon and Rectum,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Esophagus,2018
20-24,1.8,3.5,42,Incidence,1642648,Non-Hispanic Black,2.6,Female,Female Breast,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
20-24,2.8,4.8,61,Incidence,1642648,Non-Hispanic Black,3.7,Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Larynx,2018
20-24,1.5,3.0,36,Incidence,1642648,Non-Hispanic Black,2.2,Female,Leukemias,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Mesothelioma,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Myeloma,2018
20-24,1.7,3.3,40,Incidence,1642648,Non-Hispanic Black,2.4,Female,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2018
20-24,0.7,1.9,20,Incidence,1642648,Non-Hispanic Black,1.2,Female,Ovary,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Pancreas,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Stomach,2018
20-24,2.5,4.4,55,Incidence,1642648,Non-Hispanic Black,3.3,Female,Thyroid,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Female,Urinary Bladder,2018
25-29,51.4,58.3,991,Incidence,1808545,Non-Hispanic Black,54.8,Female,All Cancer Sites Combined,2018
25-29,1.0,2.2,28,Incidence,1808545,Non-Hispanic Black,1.5,Female,Brain and Other Nervous System,2018
25-29,4.1,6.2,91,Incidence,1808545,Non-Hispanic Black,5.0,Female,Cervix,2018
25-29,2.5,4.2,59,Incidence,1808545,Non-Hispanic Black,3.3,Female,Colon and Rectum,2018
25-29,0.7,1.8,21,Incidence,1808545,Non-Hispanic Black,1.2,Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Esophagus,2018
25-29,11.6,15.0,239,Incidence,1808545,Non-Hispanic Black,13.2,Female,Female Breast,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
25-29,2.4,4.1,57,Incidence,1808545,Non-Hispanic Black,3.2,Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
25-29,0.9,2.0,24,Incidence,1808545,Non-Hispanic Black,1.3,Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Larynx,2018
25-29,1.6,3.1,41,Incidence,1808545,Non-Hispanic Black,2.3,Female,Leukemias,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Mesothelioma,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Myeloma,2018
25-29,2.1,3.7,51,Incidence,1808545,Non-Hispanic Black,2.8,Female,Non-Hodgkin Lymphoma,2018
25-29,0.8,1.8,22,Incidence,1808545,Non-Hispanic Black,1.2,Female,Oral Cavity and Pharynx,2018
25-29,1.3,2.7,35,Incidence,1808545,Non-Hispanic Black,1.9,Female,Ovary,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Pancreas,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Stomach,2018
25-29,5.7,8.1,123,Incidence,1808545,Non-Hispanic Black,6.8,Female,Thyroid,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Female,Urinary Bladder,2018
30-34,100.1,110.4,1629,Incidence,1549262,Non-Hispanic Black,105.1,Female,All Cancer Sites Combined,2018
30-34,1.6,3.1,35,Incidence,1549262,Non-Hispanic Black,2.3,Female,Brain and Other Nervous System,2018
30-34,7.3,10.3,135,Incidence,1549262,Non-Hispanic Black,8.7,Female,Cervix,2018
30-34,5.6,8.3,106,Incidence,1549262,Non-Hispanic Black,6.8,Female,Colon and Rectum,2018
30-34,3.2,5.3,65,Incidence,1549262,Non-Hispanic Black,4.2,Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Esophagus,2018
30-34,33.2,39.3,560,Incidence,1549262,Non-Hispanic Black,36.1,Female,Female Breast,2018
30-34,2.3,4.2,49,Incidence,1549262,Non-Hispanic Black,3.2,Female,"Female Breast, <i>in situ</i>",2018
30-34,2.5,4.4,52,Incidence,1549262,Non-Hispanic Black,3.4,Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
30-34,1.9,3.6,41,Incidence,1549262,Non-Hispanic Black,2.6,Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Larynx,2018
30-34,2.0,3.7,43,Incidence,1549262,Non-Hispanic Black,2.8,Female,Leukemias,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
30-34,1.0,2.3,24,Incidence,1549262,Non-Hispanic Black,1.5,Female,Lung and Bronchus,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Mesothelioma,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Myeloma,2018
30-34,4.0,6.4,79,Incidence,1549262,Non-Hispanic Black,5.1,Female,Non-Hodgkin Lymphoma,2018
30-34,0.8,2.1,21,Incidence,1549262,Non-Hispanic Black,1.4,Female,Oral Cavity and Pharynx,2018
30-34,1.5,3.0,33,Incidence,1549262,Non-Hispanic Black,2.1,Female,Ovary,2018
30-34,1.1,2.5,27,Incidence,1549262,Non-Hispanic Black,1.7,Female,Pancreas,2018
30-34,0.6,1.8,17,Incidence,1549262,Non-Hispanic Black,1.1,Female,Stomach,2018
30-34,9.9,13.4,179,Incidence,1549262,Non-Hispanic Black,11.6,Female,Thyroid,2018
30-34,~,~,~,Incidence,1549262,Non-Hispanic Black,~,Female,Urinary Bladder,2018
35-39,170.0,183.5,2639,Incidence,1493922,Non-Hispanic Black,176.6,Female,All Cancer Sites Combined,2018
35-39,1.3,2.8,29,Incidence,1493922,Non-Hispanic Black,1.9,Female,Brain and Other Nervous System,2018
35-39,10.1,13.7,176,Incidence,1493922,Non-Hispanic Black,11.8,Female,Cervix,2018
35-39,11.0,14.7,190,Incidence,1493922,Non-Hispanic Black,12.7,Female,Colon and Rectum,2018
35-39,6.8,9.8,123,Incidence,1493922,Non-Hispanic Black,8.2,Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,1493922,Non-Hispanic Black,~,Female,Esophagus,2018
35-39,66.2,74.7,1051,Incidence,1493922,Non-Hispanic Black,70.4,Female,Female Breast,2018
35-39,7.8,10.9,138,Incidence,1493922,Non-Hispanic Black,9.2,Female,"Female Breast, <i>in situ</i>",2018
35-39,2.8,4.8,55,Incidence,1493922,Non-Hispanic Black,3.7,Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,1493922,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
35-39,4.0,6.4,76,Incidence,1493922,Non-Hispanic Black,5.1,Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,1493922,Non-Hispanic Black,~,Female,Larynx,2018
35-39,3.5,5.8,68,Incidence,1493922,Non-Hispanic Black,4.6,Female,Leukemias,2018
35-39,0.9,2.2,22,Incidence,1493922,Non-Hispanic Black,1.5,Female,Liver and Intrahepatic Bile Duct,2018
35-39,2.7,4.7,54,Incidence,1493922,Non-Hispanic Black,3.6,Female,Lung and Bronchus,2018
35-39,~,~,~,Incidence,1493922,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,1493922,Non-Hispanic Black,~,Female,Mesothelioma,2018
35-39,1.2,2.6,27,Incidence,1493922,Non-Hispanic Black,1.8,Female,Myeloma,2018
35-39,5.9,8.7,107,Incidence,1493922,Non-Hispanic Black,7.2,Female,Non-Hodgkin Lymphoma,2018
35-39,1.2,2.7,28,Incidence,1493922,Non-Hispanic Black,1.9,Female,Oral Cavity and Pharynx,2018
35-39,3.3,5.5,64,Incidence,1493922,Non-Hispanic Black,4.3,Female,Ovary,2018
35-39,1.1,2.5,25,Incidence,1493922,Non-Hispanic Black,1.7,Female,Pancreas,2018
35-39,1.9,3.6,39,Incidence,1493922,Non-Hispanic Black,2.6,Female,Stomach,2018
35-39,13.8,17.9,235,Incidence,1493922,Non-Hispanic Black,15.7,Female,Thyroid,2018
35-39,~,~,~,Incidence,1493922,Non-Hispanic Black,~,Female,Urinary Bladder,2018
40-44,288.2,306.6,4025,Incidence,1353771,Non-Hispanic Black,297.3,Female,All Cancer Sites Combined,2018
40-44,1.4,3.0,28,Incidence,1353771,Non-Hispanic Black,2.1,Female,Brain and Other Nervous System,2018
40-44,15.6,20.1,240,Incidence,1353771,Non-Hispanic Black,17.7,Female,Cervix,2018
40-44,18.5,23.4,282,Incidence,1353771,Non-Hispanic Black,20.8,Female,Colon and Rectum,2018
40-44,12.1,16.2,190,Incidence,1353771,Non-Hispanic Black,14.0,Female,"Corpus and Uterus, NOS",2018
40-44,~,~,~,Incidence,1353771,Non-Hispanic Black,~,Female,Esophagus,2018
40-44,127.0,139.4,1802,Incidence,1353771,Non-Hispanic Black,133.1,Female,Female Breast,2018
40-44,31.3,37.6,465,Incidence,1353771,Non-Hispanic Black,34.3,Female,"Female Breast, <i>in situ</i>",2018
40-44,2.2,4.1,41,Incidence,1353771,Non-Hispanic Black,3.0,Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,1353771,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
40-44,7.6,10.8,123,Incidence,1353771,Non-Hispanic Black,9.1,Female,Kidney and Renal Pelvis,2018
40-44,~,~,~,Incidence,1353771,Non-Hispanic Black,~,Female,Larynx,2018
40-44,3.8,6.2,66,Incidence,1353771,Non-Hispanic Black,4.9,Female,Leukemias,2018
40-44,1.3,2.9,27,Incidence,1353771,Non-Hispanic Black,2.0,Female,Liver and Intrahepatic Bile Duct,2018
40-44,5.9,8.8,98,Incidence,1353771,Non-Hispanic Black,7.2,Female,Lung and Bronchus,2018
40-44,~,~,~,Incidence,1353771,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,1353771,Non-Hispanic Black,~,Female,Mesothelioma,2018
40-44,5.1,7.9,87,Incidence,1353771,Non-Hispanic Black,6.4,Female,Myeloma,2018
40-44,7.8,11.2,127,Incidence,1353771,Non-Hispanic Black,9.4,Female,Non-Hodgkin Lymphoma,2018
40-44,3.2,5.5,57,Incidence,1353771,Non-Hispanic Black,4.2,Female,Oral Cavity and Pharynx,2018
40-44,4.9,7.7,84,Incidence,1353771,Non-Hispanic Black,6.2,Female,Ovary,2018
40-44,3.8,6.3,67,Incidence,1353771,Non-Hispanic Black,4.9,Female,Pancreas,2018
40-44,4.0,6.5,69,Incidence,1353771,Non-Hispanic Black,5.1,Female,Stomach,2018
40-44,18.7,23.6,285,Incidence,1353771,Non-Hispanic Black,21.1,Female,Thyroid,2018
40-44,0.8,2.1,18,Incidence,1353771,Non-Hispanic Black,1.3,Female,Urinary Bladder,2018
45-49,401.7,423.0,5800,Incidence,1406972,Non-Hispanic Black,412.2,Female,All Cancer Sites Combined,2018
45-49,2.4,4.4,46,Incidence,1406972,Non-Hispanic Black,3.3,Female,Brain and Other Nervous System,2018
45-49,12.4,16.4,201,Incidence,1406972,Non-Hispanic Black,14.3,Female,Cervix,2018
45-49,32.8,39.1,504,Incidence,1406972,Non-Hispanic Black,35.8,Female,Colon and Rectum,2018
45-49,16.7,21.3,266,Incidence,1406972,Non-Hispanic Black,18.9,Female,"Corpus and Uterus, NOS",2018
45-49,1.0,2.4,22,Incidence,1406972,Non-Hispanic Black,1.6,Female,Esophagus,2018
45-49,183.1,197.6,2677,Incidence,1406972,Non-Hispanic Black,190.3,Female,Female Breast,2018
45-49,46.2,53.7,701,Incidence,1406972,Non-Hispanic Black,49.8,Female,"Female Breast, <i>in situ</i>",2018
45-49,1.9,3.7,38,Incidence,1406972,Non-Hispanic Black,2.7,Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,1406972,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
45-49,9.7,13.4,161,Incidence,1406972,Non-Hispanic Black,11.4,Female,Kidney and Renal Pelvis,2018
45-49,~,~,~,Incidence,1406972,Non-Hispanic Black,~,Female,Larynx,2018
45-49,6.4,9.3,109,Incidence,1406972,Non-Hispanic Black,7.7,Female,Leukemias,2018
45-49,1.9,3.7,38,Incidence,1406972,Non-Hispanic Black,2.7,Female,Liver and Intrahepatic Bile Duct,2018
45-49,12.2,16.3,199,Incidence,1406972,Non-Hispanic Black,14.1,Female,Lung and Bronchus,2018
45-49,~,~,~,Incidence,1406972,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,1406972,Non-Hispanic Black,~,Female,Mesothelioma,2018
45-49,8.8,12.2,146,Incidence,1406972,Non-Hispanic Black,10.4,Female,Myeloma,2018
45-49,10.7,14.5,176,Incidence,1406972,Non-Hispanic Black,12.5,Female,Non-Hodgkin Lymphoma,2018
45-49,3.7,6.0,67,Incidence,1406972,Non-Hispanic Black,4.8,Female,Oral Cavity and Pharynx,2018
45-49,7.8,11.1,132,Incidence,1406972,Non-Hispanic Black,9.4,Female,Ovary,2018
45-49,6.2,9.1,106,Incidence,1406972,Non-Hispanic Black,7.5,Female,Pancreas,2018
45-49,5.0,7.6,87,Incidence,1406972,Non-Hispanic Black,6.2,Female,Stomach,2018
45-49,18.2,23.0,288,Incidence,1406972,Non-Hispanic Black,20.5,Female,Thyroid,2018
45-49,0.9,2.3,21,Incidence,1406972,Non-Hispanic Black,1.5,Female,Urinary Bladder,2018
5-9,7.6,10.7,138,Incidence,1519565,Non-Hispanic Black,9.1,Female,All Cancer Sites Combined,2018
5-9,2.0,3.7,42,Incidence,1519565,Non-Hispanic Black,2.8,Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Cervix,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Esophagus,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Female Breast,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
5-9,0.6,1.7,16,Incidence,1519565,Non-Hispanic Black,1.1,Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Larynx,2018
5-9,1.6,3.2,35,Incidence,1519565,Non-Hispanic Black,2.3,Female,Leukemias,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Mesothelioma,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Myeloma,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Ovary,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Pancreas,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Stomach,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Thyroid,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Female,Urinary Bladder,2018
50-54,577.8,603.3,8298,Incidence,1405345,Non-Hispanic Black,590.5,Female,All Cancer Sites Combined,2018
50-54,3.3,5.5,60,Incidence,1405345,Non-Hispanic Black,4.3,Female,Brain and Other Nervous System,2018
50-54,12.5,16.6,203,Incidence,1405345,Non-Hispanic Black,14.4,Female,Cervix,2018
50-54,65.0,73.8,974,Incidence,1405345,Non-Hispanic Black,69.3,Female,Colon and Rectum,2018
50-54,34.6,41.1,531,Incidence,1405345,Non-Hispanic Black,37.8,Female,"Corpus and Uterus, NOS",2018
50-54,2.0,3.8,39,Incidence,1405345,Non-Hispanic Black,2.8,Female,Esophagus,2018
50-54,222.6,238.6,3239,Incidence,1405345,Non-Hispanic Black,230.5,Female,Female Breast,2018
50-54,59.8,68.2,898,Incidence,1405345,Non-Hispanic Black,63.9,Female,"Female Breast, <i>in situ</i>",2018
50-54,2.3,4.2,44,Incidence,1405345,Non-Hispanic Black,3.1,Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,1405345,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
50-54,15.7,20.2,251,Incidence,1405345,Non-Hispanic Black,17.9,Female,Kidney and Renal Pelvis,2018
50-54,1.5,3.1,31,Incidence,1405345,Non-Hispanic Black,2.2,Female,Larynx,2018
50-54,8.1,11.4,135,Incidence,1405345,Non-Hispanic Black,9.6,Female,Leukemias,2018
50-54,3.6,6.0,66,Incidence,1405345,Non-Hispanic Black,4.7,Female,Liver and Intrahepatic Bile Duct,2018
50-54,35.4,42.0,542,Incidence,1405345,Non-Hispanic Black,38.6,Female,Lung and Bronchus,2018
50-54,0.8,2.1,19,Incidence,1405345,Non-Hispanic Black,1.4,Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,1405345,Non-Hispanic Black,~,Female,Mesothelioma,2018
50-54,15.0,19.4,240,Incidence,1405345,Non-Hispanic Black,17.1,Female,Myeloma,2018
50-54,16.7,21.3,265,Incidence,1405345,Non-Hispanic Black,18.9,Female,Non-Hodgkin Lymphoma,2018
50-54,6.8,9.9,116,Incidence,1405345,Non-Hispanic Black,8.3,Female,Oral Cavity and Pharynx,2018
50-54,11.5,15.4,188,Incidence,1405345,Non-Hispanic Black,13.4,Female,Ovary,2018
50-54,13.4,17.6,216,Incidence,1405345,Non-Hispanic Black,15.4,Female,Pancreas,2018
50-54,8.0,11.3,134,Incidence,1405345,Non-Hispanic Black,9.5,Female,Stomach,2018
50-54,18.5,23.3,292,Incidence,1405345,Non-Hispanic Black,20.8,Female,Thyroid,2018
50-54,2.6,4.7,50,Incidence,1405345,Non-Hispanic Black,3.6,Female,Urinary Bladder,2018
55-59,797.8,827.5,11587,Incidence,1425957,Non-Hispanic Black,812.6,Female,All Cancer Sites Combined,2018
55-59,3.6,6.0,67,Incidence,1425957,Non-Hispanic Black,4.7,Female,Brain and Other Nervous System,2018
55-59,13.7,17.9,224,Incidence,1425957,Non-Hispanic Black,15.7,Female,Cervix,2018
55-59,68.0,76.9,1032,Incidence,1425957,Non-Hispanic Black,72.4,Female,Colon and Rectum,2018
55-59,66.7,75.5,1012,Incidence,1425957,Non-Hispanic Black,71.0,Female,"Corpus and Uterus, NOS",2018
55-59,5.0,7.7,89,Incidence,1425957,Non-Hispanic Black,6.2,Female,Esophagus,2018
55-59,268.8,286.1,3955,Incidence,1425957,Non-Hispanic Black,277.4,Female,Female Breast,2018
55-59,67.5,76.4,1025,Incidence,1425957,Non-Hispanic Black,71.9,Female,"Female Breast, <i>in situ</i>",2018
55-59,1.8,3.6,37,Incidence,1425957,Non-Hispanic Black,2.6,Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,1425957,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
55-59,23.6,29.0,373,Incidence,1425957,Non-Hispanic Black,26.2,Female,Kidney and Renal Pelvis,2018
55-59,4.1,6.6,75,Incidence,1425957,Non-Hispanic Black,5.3,Female,Larynx,2018
55-59,12.5,16.6,206,Incidence,1425957,Non-Hispanic Black,14.4,Female,Leukemias,2018
55-59,11.4,15.2,188,Incidence,1425957,Non-Hispanic Black,13.2,Female,Liver and Intrahepatic Bile Duct,2018
55-59,86.2,96.2,1299,Incidence,1425957,Non-Hispanic Black,91.1,Female,Lung and Bronchus,2018
55-59,0.7,1.9,17,Incidence,1425957,Non-Hispanic Black,1.2,Female,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,1425957,Non-Hispanic Black,~,Female,Mesothelioma,2018
55-59,19.9,24.9,318,Incidence,1425957,Non-Hispanic Black,22.3,Female,Myeloma,2018
55-59,20.4,25.4,325,Incidence,1425957,Non-Hispanic Black,22.8,Female,Non-Hodgkin Lymphoma,2018
55-59,11.2,15.1,186,Incidence,1425957,Non-Hispanic Black,13.0,Female,Oral Cavity and Pharynx,2018
55-59,14.7,19.0,239,Incidence,1425957,Non-Hispanic Black,16.8,Female,Ovary,2018
55-59,25.6,31.2,403,Incidence,1425957,Non-Hispanic Black,28.3,Female,Pancreas,2018
55-59,11.6,15.4,191,Incidence,1425957,Non-Hispanic Black,13.4,Female,Stomach,2018
55-59,20.5,25.6,327,Incidence,1425957,Non-Hispanic Black,22.9,Female,Thyroid,2018
55-59,6.9,10.0,119,Incidence,1425957,Non-Hispanic Black,8.3,Female,Urinary Bladder,2018
60-64,1092.2,1128.9,14123,Incidence,1271822,Non-Hispanic Black,1110.5,Female,All Cancer Sites Combined,2018
60-64,4.7,7.5,76,Incidence,1271822,Non-Hispanic Black,6.0,Female,Brain and Other Nervous System,2018
60-64,13.1,17.5,193,Incidence,1271822,Non-Hispanic Black,15.2,Female,Cervix,2018
60-64,90.3,101.1,1216,Incidence,1271822,Non-Hispanic Black,95.6,Female,Colon and Rectum,2018
60-64,115.9,128.1,1550,Incidence,1271822,Non-Hispanic Black,121.9,Female,"Corpus and Uterus, NOS",2018
60-64,5.1,8.0,82,Incidence,1271822,Non-Hispanic Black,6.4,Female,Esophagus,2018
60-64,326.8,347.1,4284,Incidence,1271822,Non-Hispanic Black,336.8,Female,Female Breast,2018
60-64,93.2,104.2,1254,Incidence,1271822,Non-Hispanic Black,98.6,Female,"Female Breast, <i>in situ</i>",2018
60-64,1.2,2.8,24,Incidence,1271822,Non-Hispanic Black,1.9,Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,1271822,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
60-64,42.1,49.6,582,Incidence,1271822,Non-Hispanic Black,45.8,Female,Kidney and Renal Pelvis,2018
60-64,4.1,6.7,67,Incidence,1271822,Non-Hispanic Black,5.3,Female,Larynx,2018
60-64,18.0,23.0,259,Incidence,1271822,Non-Hispanic Black,20.4,Female,Leukemias,2018
60-64,18.5,23.6,266,Incidence,1271822,Non-Hispanic Black,20.9,Female,Liver and Intrahepatic Bile Duct,2018
60-64,143.9,157.5,1915,Incidence,1271822,Non-Hispanic Black,150.6,Female,Lung and Bronchus,2018
60-64,1.5,3.3,29,Incidence,1271822,Non-Hispanic Black,2.3,Female,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,1271822,Non-Hispanic Black,~,Female,Mesothelioma,2018
60-64,32.9,39.5,459,Incidence,1271822,Non-Hispanic Black,36.1,Female,Myeloma,2018
60-64,26.4,32.4,372,Incidence,1271822,Non-Hispanic Black,29.2,Female,Non-Hodgkin Lymphoma,2018
60-64,13.0,17.3,191,Incidence,1271822,Non-Hispanic Black,15.0,Female,Oral Cavity and Pharynx,2018
60-64,18.8,24.0,271,Incidence,1271822,Non-Hispanic Black,21.3,Female,Ovary,2018
60-64,36.2,43.2,503,Incidence,1271822,Non-Hispanic Black,39.5,Female,Pancreas,2018
60-64,14.2,18.7,208,Incidence,1271822,Non-Hispanic Black,16.4,Female,Stomach,2018
60-64,19.9,25.2,285,Incidence,1271822,Non-Hispanic Black,22.4,Female,Thyroid,2018
60-64,12.5,16.8,185,Incidence,1271822,Non-Hispanic Black,14.5,Female,Urinary Bladder,2018
65-69,1375.7,1422.0,14086,Incidence,1007069,Non-Hispanic Black,1398.7,Female,All Cancer Sites Combined,2018
65-69,6.1,9.7,78,Incidence,1007069,Non-Hispanic Black,7.7,Female,Brain and Other Nervous System,2018
65-69,15.4,20.7,180,Incidence,1007069,Non-Hispanic Black,17.9,Female,Cervix,2018
65-69,111.3,124.8,1187,Incidence,1007069,Non-Hispanic Black,117.9,Female,Colon and Rectum,2018
65-69,141.1,156.3,1496,Incidence,1007069,Non-Hispanic Black,148.5,Female,"Corpus and Uterus, NOS",2018
65-69,5.2,8.6,68,Incidence,1007069,Non-Hispanic Black,6.8,Female,Esophagus,2018
65-69,407.0,432.4,4225,Incidence,1007069,Non-Hispanic Black,419.5,Female,Female Breast,2018
65-69,116.4,130.2,1240,Incidence,1007069,Non-Hispanic Black,123.1,Female,"Female Breast, <i>in situ</i>",2018
65-69,1.4,3.4,23,Incidence,1007069,Non-Hispanic Black,2.3,Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,1007069,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
65-69,54.0,63.6,591,Incidence,1007069,Non-Hispanic Black,58.7,Female,Kidney and Renal Pelvis,2018
65-69,4.8,8.0,63,Incidence,1007069,Non-Hispanic Black,6.3,Female,Larynx,2018
65-69,21.4,27.6,245,Incidence,1007069,Non-Hispanic Black,24.3,Female,Leukemias,2018
65-69,25.2,31.9,286,Incidence,1007069,Non-Hispanic Black,28.4,Female,Liver and Intrahepatic Bile Duct,2018
65-69,182.5,199.7,1923,Incidence,1007069,Non-Hispanic Black,191.0,Female,Lung and Bronchus,2018
65-69,1.2,3.1,20,Incidence,1007069,Non-Hispanic Black,2.0,Female,Melanomas of the Skin,2018
65-69,~,~,~,Incidence,1007069,Non-Hispanic Black,~,Female,Mesothelioma,2018
65-69,46.7,55.6,514,Incidence,1007069,Non-Hispanic Black,51.0,Female,Myeloma,2018
65-69,31.6,39.0,354,Incidence,1007069,Non-Hispanic Black,35.2,Female,Non-Hodgkin Lymphoma,2018
65-69,13.0,17.9,154,Incidence,1007069,Non-Hispanic Black,15.3,Female,Oral Cavity and Pharynx,2018
65-69,24.4,30.9,277,Incidence,1007069,Non-Hispanic Black,27.5,Female,Ovary,2018
65-69,52.5,62.0,575,Incidence,1007069,Non-Hispanic Black,57.1,Female,Pancreas,2018
65-69,20.5,26.6,236,Incidence,1007069,Non-Hispanic Black,23.4,Female,Stomach,2018
65-69,23.2,29.7,265,Incidence,1007069,Non-Hispanic Black,26.3,Female,Thyroid,2018
65-69,18.3,24.1,212,Incidence,1007069,Non-Hispanic Black,21.1,Female,Urinary Bladder,2018
70-74,1558.7,1617.5,11247,Incidence,708287,Non-Hispanic Black,1587.9,Female,All Cancer Sites Combined,2018
70-74,6.5,10.9,60,Incidence,708287,Non-Hispanic Black,8.5,Female,Brain and Other Nervous System,2018
70-74,14.0,20.3,120,Incidence,708287,Non-Hispanic Black,16.9,Female,Cervix,2018
70-74,132.3,149.9,998,Incidence,708287,Non-Hispanic Black,140.9,Female,Colon and Rectum,2018
70-74,125.0,142.2,945,Incidence,708287,Non-Hispanic Black,133.4,Female,"Corpus and Uterus, NOS",2018
70-74,7.8,12.6,71,Incidence,708287,Non-Hispanic Black,10.0,Female,Esophagus,2018
70-74,429.3,460.5,3150,Incidence,708287,Non-Hispanic Black,444.7,Female,Female Breast,2018
70-74,116.6,133.2,883,Incidence,708287,Non-Hispanic Black,124.7,Female,"Female Breast, <i>in situ</i>",2018
70-74,1.3,3.7,16,Incidence,708287,Non-Hispanic Black,2.3,Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,708287,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
70-74,50.8,62.0,398,Incidence,708287,Non-Hispanic Black,56.2,Female,Kidney and Renal Pelvis,2018
70-74,5.0,9.0,48,Incidence,708287,Non-Hispanic Black,6.8,Female,Larynx,2018
70-74,30.5,39.4,246,Incidence,708287,Non-Hispanic Black,34.7,Female,Leukemias,2018
70-74,18.1,25.0,151,Incidence,708287,Non-Hispanic Black,21.3,Female,Liver and Intrahepatic Bile Duct,2018
70-74,255.2,279.4,1892,Incidence,708287,Non-Hispanic Black,267.1,Female,Lung and Bronchus,2018
70-74,1.8,4.5,21,Incidence,708287,Non-Hispanic Black,3.0,Female,Melanomas of the Skin,2018
70-74,~,~,~,Incidence,708287,Non-Hispanic Black,~,Female,Mesothelioma,2018
70-74,54.8,66.4,428,Incidence,708287,Non-Hispanic Black,60.4,Female,Myeloma,2018
70-74,40.4,50.4,320,Incidence,708287,Non-Hispanic Black,45.2,Female,Non-Hodgkin Lymphoma,2018
70-74,13.1,19.2,113,Incidence,708287,Non-Hispanic Black,16.0,Female,Oral Cavity and Pharynx,2018
70-74,21.8,29.4,180,Incidence,708287,Non-Hispanic Black,25.4,Female,Ovary,2018
70-74,69.8,82.8,539,Incidence,708287,Non-Hispanic Black,76.1,Female,Pancreas,2018
70-74,22.6,30.3,186,Incidence,708287,Non-Hispanic Black,26.3,Female,Stomach,2018
70-74,21.4,29.0,177,Incidence,708287,Non-Hispanic Black,25.0,Female,Thyroid,2018
70-74,27.6,36.0,224,Incidence,708287,Non-Hispanic Black,31.6,Female,Urinary Bladder,2018
75-79,1660.8,1734.2,8263,Incidence,486851,Non-Hispanic Black,1697.2,Female,All Cancer Sites Combined,2018
75-79,6.9,12.6,46,Incidence,486851,Non-Hispanic Black,9.4,Female,Brain and Other Nervous System,2018
75-79,13.8,21.4,84,Incidence,486851,Non-Hispanic Black,17.3,Female,Cervix,2018
75-79,156.5,179.7,817,Incidence,486851,Non-Hispanic Black,167.8,Female,Colon and Rectum,2018
75-79,99.0,117.7,526,Incidence,486851,Non-Hispanic Black,108.0,Female,"Corpus and Uterus, NOS",2018
75-79,7.3,13.1,48,Incidence,486851,Non-Hispanic Black,9.9,Female,Esophagus,2018
75-79,404.6,441.4,2058,Incidence,486851,Non-Hispanic Black,422.7,Female,Female Breast,2018
75-79,93.7,111.9,499,Incidence,486851,Non-Hispanic Black,102.5,Female,"Female Breast, <i>in situ</i>",2018
75-79,~,~,~,Incidence,486851,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,486851,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
75-79,55.4,69.7,303,Incidence,486851,Non-Hispanic Black,62.2,Female,Kidney and Renal Pelvis,2018
75-79,3.2,7.3,24,Incidence,486851,Non-Hispanic Black,4.9,Female,Larynx,2018
75-79,32.0,43.0,181,Incidence,486851,Non-Hispanic Black,37.2,Female,Leukemias,2018
75-79,18.8,27.5,111,Incidence,486851,Non-Hispanic Black,22.8,Female,Liver and Intrahepatic Bile Duct,2018
75-79,281.1,311.9,1442,Incidence,486851,Non-Hispanic Black,296.2,Female,Lung and Bronchus,2018
75-79,1.9,5.3,16,Incidence,486851,Non-Hispanic Black,3.3,Female,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,486851,Non-Hispanic Black,~,Female,Mesothelioma,2018
75-79,61.4,76.4,334,Incidence,486851,Non-Hispanic Black,68.6,Female,Myeloma,2018
75-79,41.1,53.5,229,Incidence,486851,Non-Hispanic Black,47.0,Female,Non-Hodgkin Lymphoma,2018
75-79,13.9,21.6,85,Incidence,486851,Non-Hispanic Black,17.5,Female,Oral Cavity and Pharynx,2018
75-79,29.3,39.9,167,Incidence,486851,Non-Hispanic Black,34.3,Female,Ovary,2018
75-79,86.6,104.2,463,Incidence,486851,Non-Hispanic Black,95.1,Female,Pancreas,2018
75-79,32.7,43.9,185,Incidence,486851,Non-Hispanic Black,38.0,Female,Stomach,2018
75-79,15.8,23.9,95,Incidence,486851,Non-Hispanic Black,19.5,Female,Thyroid,2018
75-79,34.4,45.9,194,Incidence,486851,Non-Hispanic Black,39.8,Female,Urinary Bladder,2018
80-84,1737.0,1828.0,5930,Incidence,332756,Non-Hispanic Black,1782.1,Female,All Cancer Sites Combined,2018
80-84,9.1,17.1,42,Incidence,332756,Non-Hispanic Black,12.6,Female,Brain and Other Nervous System,2018
80-84,12.2,21.2,54,Incidence,332756,Non-Hispanic Black,16.2,Female,Cervix,2018
80-84,179.5,209.7,646,Incidence,332756,Non-Hispanic Black,194.1,Female,Colon and Rectum,2018
80-84,90.5,112.4,336,Incidence,332756,Non-Hispanic Black,101.0,Female,"Corpus and Uterus, NOS",2018
80-84,8.1,15.7,38,Incidence,332756,Non-Hispanic Black,11.4,Female,Esophagus,2018
80-84,372.9,415.9,1311,Incidence,332756,Non-Hispanic Black,394.0,Female,Female Breast,2018
80-84,58.2,76.1,222,Incidence,332756,Non-Hispanic Black,66.7,Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,332756,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,332756,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
80-84,44.0,59.7,171,Incidence,332756,Non-Hispanic Black,51.4,Female,Kidney and Renal Pelvis,2018
80-84,4.1,10.0,22,Incidence,332756,Non-Hispanic Black,6.6,Female,Larynx,2018
80-84,31.8,45.4,127,Incidence,332756,Non-Hispanic Black,38.2,Female,Leukemias,2018
80-84,18.3,28.9,77,Incidence,332756,Non-Hispanic Black,23.1,Female,Liver and Intrahepatic Bile Duct,2018
80-84,281.0,318.5,996,Incidence,332756,Non-Hispanic Black,299.3,Female,Lung and Bronchus,2018
80-84,3.0,8.2,17,Incidence,332756,Non-Hispanic Black,5.1,Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,332756,Non-Hispanic Black,~,Female,Mesothelioma,2018
80-84,72.6,92.4,273,Incidence,332756,Non-Hispanic Black,82.0,Female,Myeloma,2018
80-84,45.9,62.0,178,Incidence,332756,Non-Hispanic Black,53.5,Female,Non-Hodgkin Lymphoma,2018
80-84,13.5,22.9,59,Incidence,332756,Non-Hispanic Black,17.7,Female,Oral Cavity and Pharynx,2018
80-84,24.7,36.9,101,Incidence,332756,Non-Hispanic Black,30.4,Female,Ovary,2018
80-84,103.3,126.6,381,Incidence,332756,Non-Hispanic Black,114.5,Female,Pancreas,2018
80-84,42.3,57.8,165,Incidence,332756,Non-Hispanic Black,49.6,Female,Stomach,2018
80-84,10.6,19.1,48,Incidence,332756,Non-Hispanic Black,14.4,Female,Thyroid,2018
80-84,50.9,67.8,196,Incidence,332756,Non-Hispanic Black,58.9,Female,Urinary Bladder,2018
85+,1524.6,1607.7,5491,Incidence,350704,Non-Hispanic Black,1565.7,Female,All Cancer Sites Combined,2018
85+,5.8,12.2,30,Incidence,350704,Non-Hispanic Black,8.6,Female,Brain and Other Nervous System,2018
85+,10.6,18.8,50,Incidence,350704,Non-Hispanic Black,14.3,Female,Cervix,2018
85+,177.4,206.7,672,Incidence,350704,Non-Hispanic Black,191.6,Female,Colon and Rectum,2018
85+,55.5,72.5,223,Incidence,350704,Non-Hispanic Black,63.6,Female,"Corpus and Uterus, NOS",2018
85+,7.2,14.2,36,Incidence,350704,Non-Hispanic Black,10.3,Female,Esophagus,2018
85+,310.9,349.2,1156,Incidence,350704,Non-Hispanic Black,329.6,Female,Female Breast,2018
85+,27.9,40.3,118,Incidence,350704,Non-Hispanic Black,33.6,Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,350704,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,350704,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
85+,35.2,49.0,146,Incidence,350704,Non-Hispanic Black,41.6,Female,Kidney and Renal Pelvis,2018
85+,~,~,~,Incidence,350704,Non-Hispanic Black,~,Female,Larynx,2018
85+,40.1,54.8,165,Incidence,350704,Non-Hispanic Black,47.0,Female,Leukemias,2018
85+,20.1,30.9,88,Incidence,350704,Non-Hispanic Black,25.1,Female,Liver and Intrahepatic Bile Duct,2018
85+,199.4,230.3,752,Incidence,350704,Non-Hispanic Black,214.4,Female,Lung and Bronchus,2018
85+,3.7,9.2,21,Incidence,350704,Non-Hispanic Black,6.0,Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,350704,Non-Hispanic Black,~,Female,Mesothelioma,2018
85+,51.0,67.3,206,Incidence,350704,Non-Hispanic Black,58.7,Female,Myeloma,2018
85+,41.5,56.3,170,Incidence,350704,Non-Hispanic Black,48.5,Female,Non-Hodgkin Lymphoma,2018
85+,13.3,22.3,61,Incidence,350704,Non-Hispanic Black,17.4,Female,Oral Cavity and Pharynx,2018
85+,26.0,38.1,111,Incidence,350704,Non-Hispanic Black,31.7,Female,Ovary,2018
85+,96.9,118.9,377,Incidence,350704,Non-Hispanic Black,107.5,Female,Pancreas,2018
85+,44.6,60.0,182,Incidence,350704,Non-Hispanic Black,51.9,Female,Stomach,2018
85+,3.3,8.5,19,Incidence,350704,Non-Hispanic Black,5.4,Female,Thyroid,2018
85+,53.1,69.8,214,Incidence,350704,Non-Hispanic Black,61.0,Female,Urinary Bladder,2018
<1,15.4,26.0,60,Incidence,297609,Non-Hispanic Black,20.2,Female,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Cervix,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Colon and Rectum,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Esophagus,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Female Breast,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Larynx,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Leukemias,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Mesothelioma,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Myeloma,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Ovary,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Pancreas,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Stomach,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Thyroid,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Female,Urinary Bladder,2018
1-4,13.7,18.2,197,Incidence,1242475,Non-Hispanic Black,15.9,Male,All Cancer Sites Combined,2018
1-4,2.8,5.0,47,Incidence,1242475,Non-Hispanic Black,3.8,Male,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Colon and Rectum,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Esophagus,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
1-4,1.1,2.7,22,Incidence,1242475,Non-Hispanic Black,1.8,Male,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Larynx,2018
1-4,4.1,6.8,66,Incidence,1242475,Non-Hispanic Black,5.3,Male,Leukemias,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
1-4,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Mesothelioma,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Myeloma,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Pancreas,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Prostate,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Stomach,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Testis,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Thyroid,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male,Urinary Bladder,2018
10-14,11.5,15.2,211,Incidence,1589354,Non-Hispanic Black,13.3,Male,All Cancer Sites Combined,2018
10-14,1.5,3.1,35,Incidence,1589354,Non-Hispanic Black,2.2,Male,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Colon and Rectum,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Esophagus,2018
10-14,0.8,1.9,20,Incidence,1589354,Non-Hispanic Black,1.3,Male,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Larynx,2018
10-14,1.4,2.8,32,Incidence,1589354,Non-Hispanic Black,2.0,Male,Leukemias,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
10-14,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Mesothelioma,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Myeloma,2018
10-14,1.6,3.2,37,Incidence,1589354,Non-Hispanic Black,2.3,Male,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Pancreas,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Prostate,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Stomach,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Testis,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Thyroid,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male,Urinary Bladder,2018
15-19,12.9,16.8,237,Incidence,1604823,Non-Hispanic Black,14.8,Male,All Cancer Sites Combined,2018
15-19,1.2,2.5,28,Incidence,1604823,Non-Hispanic Black,1.7,Male,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Colon and Rectum,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Esophagus,2018
15-19,1.2,2.6,29,Incidence,1604823,Non-Hispanic Black,1.8,Male,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Larynx,2018
15-19,1.8,3.4,40,Incidence,1604823,Non-Hispanic Black,2.5,Male,Leukemias,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
15-19,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Mesothelioma,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Myeloma,2018
15-19,1.7,3.3,39,Incidence,1604823,Non-Hispanic Black,2.4,Male,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Pancreas,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Prostate,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Stomach,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Testis,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Thyroid,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male,Urinary Bladder,2018
20-24,18.6,23.0,349,Incidence,1688858,Non-Hispanic Black,20.7,Male,All Cancer Sites Combined,2018
20-24,1.1,2.3,27,Incidence,1688858,Non-Hispanic Black,1.6,Male,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Colon and Rectum,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Esophagus,2018
20-24,1.9,3.5,44,Incidence,1688858,Non-Hispanic Black,2.6,Male,Hodgkin Lymphoma,2018
20-24,0.9,2.0,23,Incidence,1688858,Non-Hispanic Black,1.4,Male,Kaposi Sarcoma,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Larynx,2018
20-24,1.9,3.6,45,Incidence,1688858,Non-Hispanic Black,2.7,Male,Leukemias,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
20-24,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Mesothelioma,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Myeloma,2018
20-24,2.2,4.0,51,Incidence,1688858,Non-Hispanic Black,3.0,Male,Non-Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Pancreas,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Prostate,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Stomach,2018
20-24,0.9,2.0,23,Incidence,1688858,Non-Hispanic Black,1.4,Male,Testis,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Thyroid,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male,Urinary Bladder,2018
25-29,30.7,36.0,606,Incidence,1822382,Non-Hispanic Black,33.3,Male,All Cancer Sites Combined,2018
25-29,1.2,2.5,33,Incidence,1822382,Non-Hispanic Black,1.8,Male,Brain and Other Nervous System,2018
25-29,2.1,3.7,51,Incidence,1822382,Non-Hispanic Black,2.8,Male,Colon and Rectum,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Esophagus,2018
25-29,3.1,5.0,72,Incidence,1822382,Non-Hispanic Black,4.0,Male,Hodgkin Lymphoma,2018
25-29,2.8,4.5,65,Incidence,1822382,Non-Hispanic Black,3.6,Male,Kaposi Sarcoma,2018
25-29,1.1,2.3,29,Incidence,1822382,Non-Hispanic Black,1.6,Male,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Larynx,2018
25-29,2.2,3.9,54,Incidence,1822382,Non-Hispanic Black,3.0,Male,Leukemias,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
25-29,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Mesothelioma,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Myeloma,2018
25-29,3.6,5.6,82,Incidence,1822382,Non-Hispanic Black,4.5,Male,Non-Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Pancreas,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Prostate,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Stomach,2018
25-29,2.1,3.7,52,Incidence,1822382,Non-Hispanic Black,2.9,Male,Testis,2018
25-29,0.7,1.8,21,Incidence,1822382,Non-Hispanic Black,1.2,Male,Thyroid,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male,Urinary Bladder,2018
30-34,49.5,57.0,782,Incidence,1472285,Non-Hispanic Black,53.1,Male,All Cancer Sites Combined,2018
30-34,2.2,4.0,44,Incidence,1472285,Non-Hispanic Black,3.0,Male,Brain and Other Nervous System,2018
30-34,5.2,7.8,94,Incidence,1472285,Non-Hispanic Black,6.4,Male,Colon and Rectum,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Esophagus,2018
30-34,3.1,5.2,60,Incidence,1472285,Non-Hispanic Black,4.1,Male,Hodgkin Lymphoma,2018
30-34,2.8,4.8,54,Incidence,1472285,Non-Hispanic Black,3.7,Male,Kaposi Sarcoma,2018
30-34,1.9,3.6,39,Incidence,1472285,Non-Hispanic Black,2.6,Male,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Larynx,2018
30-34,2.4,4.3,48,Incidence,1472285,Non-Hispanic Black,3.3,Male,Leukemias,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
30-34,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Mesothelioma,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Myeloma,2018
30-34,5.8,8.6,105,Incidence,1472285,Non-Hispanic Black,7.1,Male,Non-Hodgkin Lymphoma,2018
30-34,0.7,1.9,18,Incidence,1472285,Non-Hispanic Black,1.2,Male,Oral Cavity and Pharynx,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Pancreas,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Prostate,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Stomach,2018
30-34,3.1,5.2,60,Incidence,1472285,Non-Hispanic Black,4.1,Male,Testis,2018
30-34,1.3,2.8,29,Incidence,1472285,Non-Hispanic Black,2.0,Male,Thyroid,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male,Urinary Bladder,2018
35-39,84.4,94.5,1215,Incidence,1360080,Non-Hispanic Black,89.3,Male,All Cancer Sites Combined,2018
35-39,2.3,4.3,43,Incidence,1360080,Non-Hispanic Black,3.2,Male,Brain and Other Nervous System,2018
35-39,10.1,13.8,161,Incidence,1360080,Non-Hispanic Black,11.8,Male,Colon and Rectum,2018
35-39,~,~,~,Incidence,1360080,Non-Hispanic Black,~,Male,Esophagus,2018
35-39,3.6,6.0,64,Incidence,1360080,Non-Hispanic Black,4.7,Male,Hodgkin Lymphoma,2018
35-39,2.2,4.1,41,Incidence,1360080,Non-Hispanic Black,3.0,Male,Kaposi Sarcoma,2018
35-39,7.5,10.8,123,Incidence,1360080,Non-Hispanic Black,9.0,Male,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,1360080,Non-Hispanic Black,~,Male,Larynx,2018
35-39,4.5,7.1,77,Incidence,1360080,Non-Hispanic Black,5.7,Male,Leukemias,2018
35-39,1.9,3.7,36,Incidence,1360080,Non-Hispanic Black,2.6,Male,Liver and Intrahepatic Bile Duct,2018
35-39,3.0,5.2,54,Incidence,1360080,Non-Hispanic Black,4.0,Male,Lung and Bronchus,2018
35-39,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
35-39,~,~,~,Incidence,1360080,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,1360080,Non-Hispanic Black,~,Male,Mesothelioma,2018
35-39,1.3,2.9,27,Incidence,1360080,Non-Hispanic Black,2.0,Male,Myeloma,2018
35-39,7.9,11.3,129,Incidence,1360080,Non-Hispanic Black,9.5,Male,Non-Hodgkin Lymphoma,2018
35-39,2.4,4.4,45,Incidence,1360080,Non-Hispanic Black,3.3,Male,Oral Cavity and Pharynx,2018
35-39,0.8,2.2,19,Incidence,1360080,Non-Hispanic Black,1.4,Male,Pancreas,2018
35-39,0.7,1.9,16,Incidence,1360080,Non-Hispanic Black,1.2,Male,Prostate,2018
35-39,1.7,3.5,34,Incidence,1360080,Non-Hispanic Black,2.5,Male,Stomach,2018
35-39,3.3,5.6,59,Incidence,1360080,Non-Hispanic Black,4.3,Male,Testis,2018
35-39,2.0,3.9,39,Incidence,1360080,Non-Hispanic Black,2.9,Male,Thyroid,2018
35-39,0.8,2.1,18,Incidence,1360080,Non-Hispanic Black,1.3,Male,Urinary Bladder,2018
40-44,156.5,171.1,1970,Incidence,1203602,Non-Hispanic Black,163.7,Male,All Cancer Sites Combined,2018
40-44,2.7,4.9,44,Incidence,1203602,Non-Hispanic Black,3.7,Male,Brain and Other Nervous System,2018
40-44,21.5,27.1,291,Incidence,1203602,Non-Hispanic Black,24.2,Male,Colon and Rectum,2018
40-44,1.1,2.8,22,Incidence,1203602,Non-Hispanic Black,1.8,Male,Esophagus,2018
40-44,3.4,5.9,55,Incidence,1203602,Non-Hispanic Black,4.6,Male,Hodgkin Lymphoma,2018
40-44,1.3,3.1,25,Incidence,1203602,Non-Hispanic Black,2.1,Male,Kaposi Sarcoma,2018
40-44,15.5,20.3,214,Incidence,1203602,Non-Hispanic Black,17.8,Male,Kidney and Renal Pelvis,2018
40-44,1.1,2.7,21,Incidence,1203602,Non-Hispanic Black,1.7,Male,Larynx,2018
40-44,6.2,9.4,92,Incidence,1203602,Non-Hispanic Black,7.6,Male,Leukemias,2018
40-44,2.0,3.9,34,Incidence,1203602,Non-Hispanic Black,2.8,Male,Liver and Intrahepatic Bile Duct,2018
40-44,10.0,14.0,143,Incidence,1203602,Non-Hispanic Black,11.9,Male,Lung and Bronchus,2018
40-44,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
40-44,~,~,~,Incidence,1203602,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,1203602,Non-Hispanic Black,~,Male,Mesothelioma,2018
40-44,4.5,7.3,69,Incidence,1203602,Non-Hispanic Black,5.7,Male,Myeloma,2018
40-44,11.3,15.5,160,Incidence,1203602,Non-Hispanic Black,13.3,Male,Non-Hodgkin Lymphoma,2018
40-44,5.9,9.0,88,Incidence,1203602,Non-Hispanic Black,7.3,Male,Oral Cavity and Pharynx,2018
40-44,3.7,6.3,59,Incidence,1203602,Non-Hispanic Black,4.9,Male,Pancreas,2018
40-44,13.9,18.5,193,Incidence,1203602,Non-Hispanic Black,16.0,Male,Prostate,2018
40-44,2.6,4.8,43,Incidence,1203602,Non-Hispanic Black,3.6,Male,Stomach,2018
40-44,2.5,4.7,42,Incidence,1203602,Non-Hispanic Black,3.5,Male,Testis,2018
40-44,2.4,4.6,41,Incidence,1203602,Non-Hispanic Black,3.4,Male,Thyroid,2018
40-44,2.0,3.9,34,Incidence,1203602,Non-Hispanic Black,2.8,Male,Urinary Bladder,2018
45-49,285.4,304.5,3659,Incidence,1241054,Non-Hispanic Black,294.8,Male,All Cancer Sites Combined,2018
45-49,3.6,6.1,59,Incidence,1241054,Non-Hispanic Black,4.8,Male,Brain and Other Nervous System,2018
45-49,40.9,48.4,553,Incidence,1241054,Non-Hispanic Black,44.6,Male,Colon and Rectum,2018
45-49,3.0,5.3,50,Incidence,1241054,Non-Hispanic Black,4.0,Male,Esophagus,2018
45-49,2.2,4.3,39,Incidence,1241054,Non-Hispanic Black,3.1,Male,Hodgkin Lymphoma,2018
45-49,1.1,2.7,22,Incidence,1241054,Non-Hispanic Black,1.8,Male,Kaposi Sarcoma,2018
45-49,24.9,30.8,344,Incidence,1241054,Non-Hispanic Black,27.7,Male,Kidney and Renal Pelvis,2018
45-49,2.9,5.1,48,Incidence,1241054,Non-Hispanic Black,3.9,Male,Larynx,2018
45-49,6.3,9.4,96,Incidence,1241054,Non-Hispanic Black,7.7,Male,Leukemias,2018
45-49,4.0,6.6,64,Incidence,1241054,Non-Hispanic Black,5.2,Male,Liver and Intrahepatic Bile Duct,2018
45-49,12.7,17.0,183,Incidence,1241054,Non-Hispanic Black,14.7,Male,Lung and Bronchus,2018
45-49,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
45-49,~,~,~,Incidence,1241054,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,1241054,Non-Hispanic Black,~,Male,Mesothelioma,2018
45-49,8.3,11.9,124,Incidence,1241054,Non-Hispanic Black,10.0,Male,Myeloma,2018
45-49,14.6,19.3,209,Incidence,1241054,Non-Hispanic Black,16.8,Male,Non-Hodgkin Lymphoma,2018
45-49,12.0,16.3,174,Incidence,1241054,Non-Hispanic Black,14.0,Male,Oral Cavity and Pharynx,2018
45-49,6.8,10.2,104,Incidence,1241054,Non-Hispanic Black,8.4,Male,Pancreas,2018
45-49,71.8,81.6,950,Incidence,1241054,Non-Hispanic Black,76.5,Male,Prostate,2018
45-49,5.6,8.6,87,Incidence,1241054,Non-Hispanic Black,7.0,Male,Stomach,2018
45-49,1.0,2.6,21,Incidence,1241054,Non-Hispanic Black,1.7,Male,Testis,2018
45-49,3.4,5.9,56,Incidence,1241054,Non-Hispanic Black,4.5,Male,Thyroid,2018
45-49,4.5,7.3,72,Incidence,1241054,Non-Hispanic Black,5.8,Male,Urinary Bladder,2018
5-9,9.7,13.1,178,Incidence,1570026,Non-Hispanic Black,11.3,Male,All Cancer Sites Combined,2018
5-9,2.4,4.3,51,Incidence,1570026,Non-Hispanic Black,3.2,Male,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Colon and Rectum,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Esophagus,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Larynx,2018
5-9,1.9,3.5,41,Incidence,1570026,Non-Hispanic Black,2.6,Male,Leukemias,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
5-9,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Mesothelioma,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Myeloma,2018
5-9,0.8,2.0,21,Incidence,1570026,Non-Hispanic Black,1.3,Male,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Pancreas,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Prostate,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Stomach,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Testis,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Thyroid,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male,Urinary Bladder,2018
50-54,623.3,651.6,7863,Incidence,1233707,Non-Hispanic Black,637.3,Male,All Cancer Sites Combined,2018
50-54,5.6,8.6,86,Incidence,1233707,Non-Hispanic Black,7.0,Male,Brain and Other Nervous System,2018
50-54,78.3,88.6,1028,Incidence,1233707,Non-Hispanic Black,83.3,Male,Colon and Rectum,2018
50-54,4.3,7.0,68,Incidence,1233707,Non-Hispanic Black,5.5,Male,Esophagus,2018
50-54,2.4,4.5,41,Incidence,1233707,Non-Hispanic Black,3.3,Male,Hodgkin Lymphoma,2018
50-54,1.6,3.5,30,Incidence,1233707,Non-Hispanic Black,2.4,Male,Kaposi Sarcoma,2018
50-54,36.0,43.1,487,Incidence,1233707,Non-Hispanic Black,39.5,Male,Kidney and Renal Pelvis,2018
50-54,7.6,11.1,114,Incidence,1233707,Non-Hispanic Black,9.2,Male,Larynx,2018
50-54,11.3,15.5,164,Incidence,1233707,Non-Hispanic Black,13.3,Male,Leukemias,2018
50-54,11.0,15.1,160,Incidence,1233707,Non-Hispanic Black,13.0,Male,Liver and Intrahepatic Bile Duct,2018
50-54,47.7,55.8,637,Incidence,1233707,Non-Hispanic Black,51.6,Male,Lung and Bronchus,2018
50-54,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
50-54,~,~,~,Incidence,1233707,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,1233707,Non-Hispanic Black,~,Male,Mesothelioma,2018
50-54,17.0,22.0,239,Incidence,1233707,Non-Hispanic Black,19.4,Male,Myeloma,2018
50-54,21.8,27.4,302,Incidence,1233707,Non-Hispanic Black,24.5,Male,Non-Hodgkin Lymphoma,2018
50-54,20.2,25.6,281,Incidence,1233707,Non-Hispanic Black,22.8,Male,Oral Cavity and Pharynx,2018
50-54,15.2,19.9,215,Incidence,1233707,Non-Hispanic Black,17.4,Male,Pancreas,2018
50-54,235.1,252.6,3007,Incidence,1233707,Non-Hispanic Black,243.7,Male,Prostate,2018
50-54,10.9,15.0,158,Incidence,1233707,Non-Hispanic Black,12.8,Male,Stomach,2018
50-54,~,~,~,Incidence,1233707,Non-Hispanic Black,~,Male,Testis,2018
50-54,5.4,8.3,83,Incidence,1233707,Non-Hispanic Black,6.7,Male,Thyroid,2018
50-54,11.9,16.1,171,Incidence,1233707,Non-Hispanic Black,13.9,Male,Urinary Bladder,2018
55-59,1103.6,1141.2,13765,Incidence,1226520,Non-Hispanic Black,1122.3,Male,All Cancer Sites Combined,2018
55-59,6.1,9.3,93,Incidence,1226520,Non-Hispanic Black,7.6,Male,Brain and Other Nervous System,2018
55-59,96.3,107.6,1249,Incidence,1226520,Non-Hispanic Black,101.8,Male,Colon and Rectum,2018
55-59,10.0,13.9,145,Incidence,1226520,Non-Hispanic Black,11.8,Male,Esophagus,2018
55-59,2.9,5.2,48,Incidence,1226520,Non-Hispanic Black,3.9,Male,Hodgkin Lymphoma,2018
55-59,0.9,2.4,19,Incidence,1226520,Non-Hispanic Black,1.5,Male,Kaposi Sarcoma,2018
55-59,54.1,62.7,715,Incidence,1226520,Non-Hispanic Black,58.3,Male,Kidney and Renal Pelvis,2018
55-59,18.1,23.2,252,Incidence,1226520,Non-Hispanic Black,20.5,Male,Larynx,2018
55-59,17.4,22.5,243,Incidence,1226520,Non-Hispanic Black,19.8,Male,Leukemias,2018
55-59,35.9,43.0,482,Incidence,1226520,Non-Hispanic Black,39.3,Male,Liver and Intrahepatic Bile Duct,2018
55-59,122.0,134.7,1573,Incidence,1226520,Non-Hispanic Black,128.2,Male,Lung and Bronchus,2018
55-59,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
55-59,1.3,3.0,25,Incidence,1226520,Non-Hispanic Black,2.0,Male,Melanomas of the Skin,2018
55-59,~,~,~,Incidence,1226520,Non-Hispanic Black,~,Male,Mesothelioma,2018
55-59,26.6,32.8,363,Incidence,1226520,Non-Hispanic Black,29.6,Male,Myeloma,2018
55-59,29.0,35.5,394,Incidence,1226520,Non-Hispanic Black,32.1,Male,Non-Hodgkin Lymphoma,2018
55-59,34.3,41.3,462,Incidence,1226520,Non-Hispanic Black,37.7,Male,Oral Cavity and Pharynx,2018
55-59,31.1,37.8,421,Incidence,1226520,Non-Hispanic Black,34.3,Male,Pancreas,2018
55-59,457.2,481.5,5755,Incidence,1226520,Non-Hispanic Black,469.2,Male,Prostate,2018
55-59,18.3,23.5,255,Incidence,1226520,Non-Hispanic Black,20.8,Male,Stomach,2018
55-59,~,~,~,Incidence,1226520,Non-Hispanic Black,~,Male,Testis,2018
55-59,6.4,9.6,97,Incidence,1226520,Non-Hispanic Black,7.9,Male,Thyroid,2018
55-59,22.7,28.4,312,Incidence,1226520,Non-Hispanic Black,25.4,Male,Urinary Bladder,2018
60-64,1726.6,1777.4,18353,Incidence,1047632,Non-Hispanic Black,1751.9,Male,All Cancer Sites Combined,2018
60-64,7.4,11.2,96,Incidence,1047632,Non-Hispanic Black,9.2,Male,Brain and Other Nervous System,2018
60-64,125.8,139.8,1390,Incidence,1047632,Non-Hispanic Black,132.7,Male,Colon and Rectum,2018
60-64,17.9,23.5,215,Incidence,1047632,Non-Hispanic Black,20.5,Male,Esophagus,2018
60-64,2.4,4.8,36,Incidence,1047632,Non-Hispanic Black,3.4,Male,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,1047632,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
60-64,78.6,89.8,881,Incidence,1047632,Non-Hispanic Black,84.1,Male,Kidney and Renal Pelvis,2018
60-64,22.7,28.9,269,Incidence,1047632,Non-Hispanic Black,25.7,Male,Larynx,2018
60-64,25.6,32.2,301,Incidence,1047632,Non-Hispanic Black,28.7,Male,Leukemias,2018
60-64,86.1,97.8,962,Incidence,1047632,Non-Hispanic Black,91.8,Male,Liver and Intrahepatic Bile Duct,2018
60-64,222.7,241.3,2429,Incidence,1047632,Non-Hispanic Black,231.9,Male,Lung and Bronchus,2018
60-64,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
60-64,1.2,2.9,20,Incidence,1047632,Non-Hispanic Black,1.9,Male,Melanomas of the Skin,2018
60-64,~,~,~,Incidence,1047632,Non-Hispanic Black,~,Male,Mesothelioma,2018
60-64,38.0,45.9,438,Incidence,1047632,Non-Hispanic Black,41.8,Male,Myeloma,2018
60-64,29.6,36.7,346,Incidence,1047632,Non-Hispanic Black,33.0,Male,Non-Hodgkin Lymphoma,2018
60-64,42.5,50.9,488,Incidence,1047632,Non-Hispanic Black,46.6,Male,Oral Cavity and Pharynx,2018
60-64,48.2,57.1,550,Incidence,1047632,Non-Hispanic Black,52.5,Male,Pancreas,2018
60-64,743.0,776.5,7958,Incidence,1047632,Non-Hispanic Black,759.6,Male,Prostate,2018
60-64,32.2,39.5,374,Incidence,1047632,Non-Hispanic Black,35.7,Male,Stomach,2018
60-64,~,~,~,Incidence,1047632,Non-Hispanic Black,~,Male,Testis,2018
60-64,9.1,13.3,116,Incidence,1047632,Non-Hispanic Black,11.1,Male,Thyroid,2018
60-64,39.8,47.9,458,Incidence,1047632,Non-Hispanic Black,43.7,Male,Urinary Bladder,2018
65-69,2395.7,2465.3,18786,Incidence,772984,Non-Hispanic Black,2430.3,Male,All Cancer Sites Combined,2018
65-69,10.4,15.6,99,Incidence,772984,Non-Hispanic Black,12.8,Male,Brain and Other Nervous System,2018
65-69,170.7,189.8,1392,Incidence,772984,Non-Hispanic Black,180.1,Male,Colon and Rectum,2018
65-69,21.9,29.2,196,Incidence,772984,Non-Hispanic Black,25.4,Male,Esophagus,2018
65-69,1.8,4.3,22,Incidence,772984,Non-Hispanic Black,2.8,Male,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,772984,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
65-69,96.1,110.5,797,Incidence,772984,Non-Hispanic Black,103.1,Male,Kidney and Renal Pelvis,2018
65-69,29.5,37.8,259,Incidence,772984,Non-Hispanic Black,33.5,Male,Larynx,2018
65-69,40.3,49.9,347,Incidence,772984,Non-Hispanic Black,44.9,Male,Leukemias,2018
65-69,111.0,126.4,916,Incidence,772984,Non-Hispanic Black,118.5,Male,Liver and Intrahepatic Bile Duct,2018
65-69,302.5,327.6,2434,Incidence,772984,Non-Hispanic Black,314.9,Male,Lung and Bronchus,2018
65-69,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
65-69,2.8,5.8,32,Incidence,772984,Non-Hispanic Black,4.1,Male,Melanomas of the Skin,2018
65-69,1.2,3.4,16,Incidence,772984,Non-Hispanic Black,2.1,Male,Mesothelioma,2018
65-69,60.5,72.1,511,Incidence,772984,Non-Hispanic Black,66.1,Male,Myeloma,2018
65-69,46.6,56.8,398,Incidence,772984,Non-Hispanic Black,51.5,Male,Non-Hodgkin Lymphoma,2018
65-69,49.1,59.7,419,Incidence,772984,Non-Hispanic Black,54.2,Male,Oral Cavity and Pharynx,2018
65-69,74.3,87.0,622,Incidence,772984,Non-Hispanic Black,80.5,Male,Pancreas,2018
65-69,1044.8,1091.0,8253,Incidence,772984,Non-Hispanic Black,1067.7,Male,Prostate,2018
65-69,38.8,48.2,335,Incidence,772984,Non-Hispanic Black,43.3,Male,Stomach,2018
65-69,~,~,~,Incidence,772984,Non-Hispanic Black,~,Male,Testis,2018
65-69,8.1,12.7,79,Incidence,772984,Non-Hispanic Black,10.2,Male,Thyroid,2018
65-69,69.2,81.5,581,Incidence,772984,Non-Hispanic Black,75.2,Male,Urinary Bladder,2018
70-74,2464.8,2551.5,12921,Incidence,515218,Non-Hispanic Black,2507.9,Male,All Cancer Sites Combined,2018
70-74,11.1,17.8,73,Incidence,515218,Non-Hispanic Black,14.2,Male,Brain and Other Nervous System,2018
70-74,189.0,213.7,1036,Incidence,515218,Non-Hispanic Black,201.1,Male,Colon and Rectum,2018
70-74,22.3,31.4,137,Incidence,515218,Non-Hispanic Black,26.6,Male,Esophagus,2018
70-74,2.4,6.0,20,Incidence,515218,Non-Hispanic Black,3.9,Male,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,515218,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
70-74,96.0,113.8,539,Incidence,515218,Non-Hispanic Black,104.6,Male,Kidney and Renal Pelvis,2018
70-74,28.9,39.2,174,Incidence,515218,Non-Hispanic Black,33.8,Male,Larynx,2018
70-74,43.6,56.0,255,Incidence,515218,Non-Hispanic Black,49.5,Male,Leukemias,2018
70-74,73.2,88.9,416,Incidence,515218,Non-Hispanic Black,80.7,Male,Liver and Intrahepatic Bile Duct,2018
70-74,397.9,433.3,2140,Incidence,515218,Non-Hispanic Black,415.4,Male,Lung and Bronchus,2018
70-74,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
70-74,2.8,6.7,23,Incidence,515218,Non-Hispanic Black,4.5,Male,Melanomas of the Skin,2018
70-74,3.1,7.2,25,Incidence,515218,Non-Hispanic Black,4.9,Male,Mesothelioma,2018
70-74,73.5,89.3,418,Incidence,515218,Non-Hispanic Black,81.1,Male,Myeloma,2018
70-74,50.5,63.8,293,Incidence,515218,Non-Hispanic Black,56.9,Male,Non-Hodgkin Lymphoma,2018
70-74,41.4,53.5,243,Incidence,515218,Non-Hispanic Black,47.2,Male,Oral Cavity and Pharynx,2018
70-74,85.2,102.1,481,Incidence,515218,Non-Hispanic Black,93.4,Male,Pancreas,2018
70-74,936.9,990.7,4964,Incidence,515218,Non-Hispanic Black,963.5,Male,Prostate,2018
70-74,48.5,61.5,282,Incidence,515218,Non-Hispanic Black,54.7,Male,Stomach,2018
70-74,~,~,~,Incidence,515218,Non-Hispanic Black,~,Male,Testis,2018
70-74,8.9,15.0,60,Incidence,515218,Non-Hispanic Black,11.6,Male,Thyroid,2018
70-74,82.4,99.0,466,Incidence,515218,Non-Hispanic Black,90.4,Male,Urinary Bladder,2018
75-79,2523.4,2634.6,8300,Incidence,321888,Non-Hispanic Black,2578.5,Male,All Cancer Sites Combined,2018
75-79,8.9,16.9,40,Incidence,321888,Non-Hispanic Black,12.4,Male,Brain and Other Nervous System,2018
75-79,210.9,244.2,731,Incidence,321888,Non-Hispanic Black,227.1,Male,Colon and Rectum,2018
75-79,18.3,29.2,75,Incidence,321888,Non-Hispanic Black,23.3,Male,Esophagus,2018
75-79,~,~,~,Incidence,321888,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,321888,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
75-79,94.4,117.1,339,Incidence,321888,Non-Hispanic Black,105.3,Male,Kidney and Renal Pelvis,2018
75-79,28.9,42.2,113,Incidence,321888,Non-Hispanic Black,35.1,Male,Larynx,2018
75-79,55.3,73.0,205,Incidence,321888,Non-Hispanic Black,63.7,Male,Leukemias,2018
75-79,51.5,68.7,192,Incidence,321888,Non-Hispanic Black,59.6,Male,Liver and Intrahepatic Bile Duct,2018
75-79,487.9,537.6,1649,Incidence,321888,Non-Hispanic Black,512.3,Male,Lung and Bronchus,2018
75-79,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
75-79,3.8,9.6,20,Incidence,321888,Non-Hispanic Black,6.2,Male,Melanomas of the Skin,2018
75-79,~,~,~,Incidence,321888,Non-Hispanic Black,~,Male,Mesothelioma,2018
75-79,88.8,110.9,320,Incidence,321888,Non-Hispanic Black,99.4,Male,Myeloma,2018
75-79,61.4,80.0,226,Incidence,321888,Non-Hispanic Black,70.2,Male,Non-Hodgkin Lymphoma,2018
75-79,39.4,54.7,150,Incidence,321888,Non-Hispanic Black,46.6,Male,Oral Cavity and Pharynx,2018
75-79,96.2,119.1,345,Incidence,321888,Non-Hispanic Black,107.2,Male,Pancreas,2018
75-79,759.6,821.3,2543,Incidence,321888,Non-Hispanic Black,790.0,Male,Prostate,2018
75-79,66.9,86.3,245,Incidence,321888,Non-Hispanic Black,76.1,Male,Stomach,2018
75-79,~,~,~,Incidence,321888,Non-Hispanic Black,~,Male,Testis,2018
75-79,5.0,11.5,25,Incidence,321888,Non-Hispanic Black,7.8,Male,Thyroid,2018
75-79,109.1,133.5,389,Incidence,321888,Non-Hispanic Black,120.8,Male,Urinary Bladder,2018
80-84,2452.0,2593.9,4888,Incidence,193801,Non-Hispanic Black,2522.2,Male,All Cancer Sites Combined,2018
80-84,9.2,20.3,27,Incidence,193801,Non-Hispanic Black,13.9,Male,Brain and Other Nervous System,2018
80-84,259.1,306.9,547,Incidence,193801,Non-Hispanic Black,282.2,Male,Colon and Rectum,2018
80-84,20.9,36.4,54,Incidence,193801,Non-Hispanic Black,27.9,Male,Esophagus,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
80-84,76.0,103.1,172,Incidence,193801,Non-Hispanic Black,88.8,Male,Kidney and Renal Pelvis,2018
80-84,25.4,42.2,64,Incidence,193801,Non-Hispanic Black,33.0,Male,Larynx,2018
80-84,62.7,87.5,144,Incidence,193801,Non-Hispanic Black,74.3,Male,Leukemias,2018
80-84,36.9,56.5,89,Incidence,193801,Non-Hispanic Black,45.9,Male,Liver and Intrahepatic Bile Duct,2018
80-84,434.5,495.8,900,Incidence,193801,Non-Hispanic Black,464.4,Male,Lung and Bronchus,2018
80-84,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male,Mesothelioma,2018
80-84,95.2,125.1,212,Incidence,193801,Non-Hispanic Black,109.4,Male,Myeloma,2018
80-84,72.2,98.6,164,Incidence,193801,Non-Hispanic Black,84.6,Male,Non-Hodgkin Lymphoma,2018
80-84,36.0,55.4,87,Incidence,193801,Non-Hispanic Black,44.9,Male,Oral Cavity and Pharynx,2018
80-84,105.3,136.7,233,Incidence,193801,Non-Hispanic Black,120.2,Male,Pancreas,2018
80-84,565.6,635.1,1162,Incidence,193801,Non-Hispanic Black,599.6,Male,Prostate,2018
80-84,76.0,103.1,172,Incidence,193801,Non-Hispanic Black,88.8,Male,Stomach,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male,Testis,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male,Thyroid,2018
80-84,143.1,179.3,311,Incidence,193801,Non-Hispanic Black,160.5,Male,Urinary Bladder,2018
85+,2121.6,2271.3,3335,Incidence,151905,Non-Hispanic Black,2195.5,Male,All Cancer Sites Combined,2018
85+,6.5,17.9,17,Incidence,151905,Non-Hispanic Black,11.2,Male,Brain and Other Nervous System,2018
85+,243.8,296.6,409,Incidence,151905,Non-Hispanic Black,269.2,Male,Colon and Rectum,2018
85+,15.0,30.5,33,Incidence,151905,Non-Hispanic Black,21.7,Male,Esophagus,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
85+,47.1,72.1,89,Incidence,151905,Non-Hispanic Black,58.6,Male,Kidney and Renal Pelvis,2018
85+,21.0,38.9,44,Incidence,151905,Non-Hispanic Black,29.0,Male,Larynx,2018
85+,70.9,100.9,129,Incidence,151905,Non-Hispanic Black,84.9,Male,Leukemias,2018
85+,34.2,56.0,67,Incidence,151905,Non-Hispanic Black,44.1,Male,Liver and Intrahepatic Bile Duct,2018
85+,350.1,412.8,578,Incidence,151905,Non-Hispanic Black,380.5,Male,Lung and Bronchus,2018
85+,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male,Mesothelioma,2018
85+,83.0,115.2,149,Incidence,151905,Non-Hispanic Black,98.1,Male,Myeloma,2018
85+,58.3,85.8,108,Incidence,151905,Non-Hispanic Black,71.1,Male,Non-Hodgkin Lymphoma,2018
85+,25.0,44.1,51,Incidence,151905,Non-Hispanic Black,33.6,Male,Oral Cavity and Pharynx,2018
85+,70.9,100.9,129,Incidence,151905,Non-Hispanic Black,84.9,Male,Pancreas,2018
85+,421.6,490.1,691,Incidence,151905,Non-Hispanic Black,454.9,Male,Prostate,2018
85+,77.5,108.8,140,Incidence,151905,Non-Hispanic Black,92.2,Male,Stomach,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male,Testis,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male,Thyroid,2018
85+,149.7,191.9,258,Incidence,151905,Non-Hispanic Black,169.8,Male,Urinary Bladder,2018
<1,14.6,24.8,59,Incidence,307425,Non-Hispanic Black,19.2,Male,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Colon and Rectum,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Esophagus,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Larynx,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Leukemias,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Lung and Bronchus,2018
<1,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Melanomas of the Skin,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Mesothelioma,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Myeloma,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Pancreas,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Prostate,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Stomach,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Testis,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Thyroid,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male,Urinary Bladder,2018
1-4,14.6,17.9,396,Incidence,2447694,Non-Hispanic Black,16.2,Male and Female,All Cancer Sites Combined,2018
1-4,2.9,4.4,88,Incidence,2447694,Non-Hispanic Black,3.6,Male and Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,Cervix,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Esophagus,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,Female Breast,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
1-4,1.7,2.9,54,Incidence,2447694,Non-Hispanic Black,2.2,Male and Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Larynx,2018
1-4,4.2,6.0,124,Incidence,2447694,Non-Hispanic Black,5.1,Male and Female,Leukemias,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Myeloma,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,1205219,Non-Hispanic Black,~,Male and Female,Ovary,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Pancreas,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male and Female,Prostate,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Stomach,2018
1-4,~,~,~,Incidence,1242475,Non-Hispanic Black,~,Male and Female,Testis,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Thyroid,2018
1-4,~,~,~,Incidence,2447694,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
10-14,11.9,14.5,413,Incidence,3131492,Non-Hispanic Black,13.2,Male and Female,All Cancer Sites Combined,2018
10-14,1.7,2.7,67,Incidence,3131492,Non-Hispanic Black,2.1,Male and Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Male and Female,Cervix,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Esophagus,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Male and Female,Female Breast,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
10-14,1.0,1.8,42,Incidence,3131492,Non-Hispanic Black,1.3,Male and Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Larynx,2018
10-14,1.5,2.5,61,Incidence,3131492,Non-Hispanic Black,1.9,Male and Female,Leukemias,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2018
10-14,~,~,~,Incidence,1542138,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Myeloma,2018
10-14,1.2,2.2,52,Incidence,3131492,Non-Hispanic Black,1.7,Male and Female,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2018
10-14,0.6,1.8,17,Incidence,1542138,Non-Hispanic Black,1.1,Male and Female,Ovary,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Pancreas,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male and Female,Prostate,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Stomach,2018
10-14,~,~,~,Incidence,1589354,Non-Hispanic Black,~,Male and Female,Testis,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Thyroid,2018
10-14,~,~,~,Incidence,3131492,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
15-19,14.2,17.0,491,Incidence,3163188,Non-Hispanic Black,15.5,Male and Female,All Cancer Sites Combined,2018
15-19,1.1,2.0,47,Incidence,3163188,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Male and Female,Cervix,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Esophagus,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Male and Female,Female Breast,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
15-19,1.8,2.8,71,Incidence,3163188,Non-Hispanic Black,2.2,Male and Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Larynx,2018
15-19,1.5,2.5,62,Incidence,3163188,Non-Hispanic Black,2.0,Male and Female,Leukemias,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2018
15-19,~,~,~,Incidence,1558365,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Myeloma,2018
15-19,1.4,2.4,58,Incidence,3163188,Non-Hispanic Black,1.8,Male and Female,Non-Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2018
15-19,0.6,1.7,17,Incidence,1558365,Non-Hispanic Black,1.1,Male and Female,Ovary,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Pancreas,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male and Female,Prostate,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Stomach,2018
15-19,~,~,~,Incidence,1604823,Non-Hispanic Black,~,Male and Female,Testis,2018
15-19,0.7,1.5,33,Incidence,3163188,Non-Hispanic Black,1.0,Male and Female,Thyroid,2018
15-19,~,~,~,Incidence,3163188,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
20-24,22.4,25.8,801,Incidence,3331506,Non-Hispanic Black,24.0,Male and Female,All Cancer Sites Combined,2018
20-24,1.0,1.9,47,Incidence,3331506,Non-Hispanic Black,1.4,Male and Female,Brain and Other Nervous System,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Male and Female,Cervix,2018
20-24,0.9,1.6,40,Incidence,3331506,Non-Hispanic Black,1.2,Male and Female,Colon and Rectum,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Esophagus,2018
20-24,1.8,3.5,42,Incidence,1642648,Non-Hispanic Black,2.6,Male and Female,Female Breast,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
20-24,2.6,3.8,105,Incidence,3331506,Non-Hispanic Black,3.2,Male and Female,Hodgkin Lymphoma,2018
20-24,0.5,1.1,24,Incidence,3331506,Non-Hispanic Black,0.7,Male and Female,Kaposi Sarcoma,2018
20-24,0.5,1.1,26,Incidence,3331506,Non-Hispanic Black,0.8,Male and Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Larynx,2018
20-24,1.9,3.0,81,Incidence,3331506,Non-Hispanic Black,2.4,Male and Female,Leukemias,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2018
20-24,1.8,3.5,42,Incidence,1642648,Non-Hispanic Black,2.6,Male and Female,Male and Female Breast,2018
20-24,~,~,~,Incidence,1642648,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Myeloma,2018
20-24,2.2,3.4,91,Incidence,3331506,Non-Hispanic Black,2.7,Male and Female,Non-Hodgkin Lymphoma,2018
20-24,0.3,0.8,17,Incidence,3331506,Non-Hispanic Black,0.5,Male and Female,Oral Cavity and Pharynx,2018
20-24,0.7,1.9,20,Incidence,1642648,Non-Hispanic Black,1.2,Male and Female,Ovary,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Pancreas,2018
20-24,~,~,~,Incidence,1688858,Non-Hispanic Black,~,Male and Female,Prostate,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Stomach,2018
20-24,0.9,2.0,23,Incidence,1688858,Non-Hispanic Black,1.4,Male and Female,Testis,2018
20-24,1.5,2.5,64,Incidence,3331506,Non-Hispanic Black,1.9,Male and Female,Thyroid,2018
20-24,~,~,~,Incidence,3331506,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
25-29,41.9,46.2,1597,Incidence,3630927,Non-Hispanic Black,44.0,Male and Female,All Cancer Sites Combined,2018
25-29,1.3,2.2,61,Incidence,3630927,Non-Hispanic Black,1.7,Male and Female,Brain and Other Nervous System,2018
25-29,4.1,6.2,91,Incidence,1808545,Non-Hispanic Black,5.0,Male and Female,Cervix,2018
25-29,2.5,3.7,110,Incidence,3630927,Non-Hispanic Black,3.0,Male and Female,Colon and Rectum,2018
25-29,0.7,1.8,21,Incidence,1808545,Non-Hispanic Black,1.2,Male and Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Esophagus,2018
25-29,11.6,15.0,239,Incidence,1808545,Non-Hispanic Black,13.2,Male and Female,Female Breast,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
25-29,3.0,4.2,129,Incidence,3630927,Non-Hispanic Black,3.6,Male and Female,Hodgkin Lymphoma,2018
25-29,1.4,2.3,67,Incidence,3630927,Non-Hispanic Black,1.8,Male and Female,Kaposi Sarcoma,2018
25-29,1.1,1.9,53,Incidence,3630927,Non-Hispanic Black,1.5,Male and Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Larynx,2018
25-29,2.1,3.2,95,Incidence,3630927,Non-Hispanic Black,2.6,Male and Female,Leukemias,2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
25-29,0.5,1.1,28,Incidence,3630927,Non-Hispanic Black,0.8,Male and Female,Lung and Bronchus,2018
25-29,11.6,15.0,239,Incidence,1808545,Non-Hispanic Black,13.2,Male and Female,Male and Female Breast,2018
25-29,~,~,~,Incidence,1808545,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Myeloma,2018
25-29,3.1,4.3,133,Incidence,3630927,Non-Hispanic Black,3.7,Male and Female,Non-Hodgkin Lymphoma,2018
25-29,0.7,1.3,35,Incidence,3630927,Non-Hispanic Black,1.0,Male and Female,Oral Cavity and Pharynx,2018
25-29,1.3,2.7,35,Incidence,1808545,Non-Hispanic Black,1.9,Male and Female,Ovary,2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Pancreas,2018
25-29,~,~,~,Incidence,1822382,Non-Hispanic Black,~,Male and Female,Prostate,2018
25-29,0.3,0.8,19,Incidence,3630927,Non-Hispanic Black,0.5,Male and Female,Stomach,2018
25-29,2.1,3.7,52,Incidence,1822382,Non-Hispanic Black,2.9,Male and Female,Testis,2018
25-29,3.3,4.7,144,Incidence,3630927,Non-Hispanic Black,4.0,Male and Female,Thyroid,2018
25-29,~,~,~,Incidence,3630927,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
30-34,76.6,83.0,2411,Incidence,3021547,Non-Hispanic Black,79.8,Male and Female,All Cancer Sites Combined,2018
30-34,2.1,3.3,79,Incidence,3021547,Non-Hispanic Black,2.6,Male and Female,Brain and Other Nervous System,2018
30-34,7.3,10.3,135,Incidence,1549262,Non-Hispanic Black,8.7,Male and Female,Cervix,2018
30-34,5.7,7.6,200,Incidence,3021547,Non-Hispanic Black,6.6,Male and Female,Colon and Rectum,2018
30-34,3.2,5.3,65,Incidence,1549262,Non-Hispanic Black,4.2,Male and Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,3021547,Non-Hispanic Black,~,Male and Female,Esophagus,2018
30-34,33.2,39.3,560,Incidence,1549262,Non-Hispanic Black,36.1,Male and Female,Female Breast,2018
30-34,2.3,4.2,49,Incidence,1549262,Non-Hispanic Black,3.2,Male and Female,"Female Breast, <i>in situ</i>",2018
30-34,3.1,4.5,112,Incidence,3021547,Non-Hispanic Black,3.7,Male and Female,Hodgkin Lymphoma,2018
30-34,1.4,2.4,55,Incidence,3021547,Non-Hispanic Black,1.8,Male and Female,Kaposi Sarcoma,2018
30-34,2.1,3.3,80,Incidence,3021547,Non-Hispanic Black,2.6,Male and Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,3021547,Non-Hispanic Black,~,Male and Female,Larynx,2018
30-34,2.4,3.7,91,Incidence,3021547,Non-Hispanic Black,3.0,Male and Female,Leukemias,2018
30-34,0.5,1.2,24,Incidence,3021547,Non-Hispanic Black,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.8,1.6,36,Incidence,3021547,Non-Hispanic Black,1.2,Male and Female,Lung and Bronchus,2018
30-34,33.2,39.3,560,Incidence,1549262,Non-Hispanic Black,36.1,Male and Female,Male and Female Breast,2018
30-34,2.3,4.2,49,Incidence,1549262,Non-Hispanic Black,3.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
30-34,~,~,~,Incidence,3021547,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,3021547,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
30-34,0.4,1.1,21,Incidence,3021547,Non-Hispanic Black,0.7,Male and Female,Myeloma,2018
30-34,5.2,7.0,184,Incidence,3021547,Non-Hispanic Black,6.1,Male and Female,Non-Hodgkin Lymphoma,2018
30-34,0.9,1.8,39,Incidence,3021547,Non-Hispanic Black,1.3,Male and Female,Oral Cavity and Pharynx,2018
30-34,1.5,3.0,33,Incidence,1549262,Non-Hispanic Black,2.1,Male and Female,Ovary,2018
30-34,0.8,1.6,36,Incidence,3021547,Non-Hispanic Black,1.2,Male and Female,Pancreas,2018
30-34,~,~,~,Incidence,1472285,Non-Hispanic Black,~,Male and Female,Prostate,2018
30-34,0.7,1.5,31,Incidence,3021547,Non-Hispanic Black,1.0,Male and Female,Stomach,2018
30-34,3.1,5.2,60,Incidence,1472285,Non-Hispanic Black,4.1,Male and Female,Testis,2018
30-34,6.0,7.9,208,Incidence,3021547,Non-Hispanic Black,6.9,Male and Female,Thyroid,2018
30-34,~,~,~,Incidence,3021547,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
35-39,130.8,139.4,3854,Incidence,2854002,Non-Hispanic Black,135.0,Male and Female,All Cancer Sites Combined,2018
35-39,2.0,3.2,72,Incidence,2854002,Non-Hispanic Black,2.5,Male and Female,Brain and Other Nervous System,2018
35-39,10.1,13.7,176,Incidence,1493922,Non-Hispanic Black,11.8,Male and Female,Cervix,2018
35-39,11.0,13.7,351,Incidence,2854002,Non-Hispanic Black,12.3,Male and Female,Colon and Rectum,2018
35-39,6.8,9.8,123,Incidence,1493922,Non-Hispanic Black,8.2,Male and Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,2854002,Non-Hispanic Black,~,Male and Female,Esophagus,2018
35-39,66.2,74.7,1051,Incidence,1493922,Non-Hispanic Black,70.4,Male and Female,Female Breast,2018
35-39,7.8,10.9,138,Incidence,1493922,Non-Hispanic Black,9.2,Male and Female,"Female Breast, <i>in situ</i>",2018
35-39,3.5,5.0,119,Incidence,2854002,Non-Hispanic Black,4.2,Male and Female,Hodgkin Lymphoma,2018
35-39,1.2,2.1,45,Incidence,2854002,Non-Hispanic Black,1.6,Male and Female,Kaposi Sarcoma,2018
35-39,6.0,8.0,199,Incidence,2854002,Non-Hispanic Black,7.0,Male and Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,2854002,Non-Hispanic Black,~,Male and Female,Larynx,2018
35-39,4.3,6.0,145,Incidence,2854002,Non-Hispanic Black,5.1,Male and Female,Leukemias,2018
35-39,1.5,2.6,58,Incidence,2854002,Non-Hispanic Black,2.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
35-39,3.1,4.6,108,Incidence,2854002,Non-Hispanic Black,3.8,Male and Female,Lung and Bronchus,2018
35-39,66.2,74.7,1051,Incidence,1493922,Non-Hispanic Black,70.4,Male and Female,Male and Female Breast,2018
35-39,7.8,10.9,138,Incidence,1493922,Non-Hispanic Black,9.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
35-39,~,~,~,Incidence,2854002,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,2854002,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
35-39,1.4,2.5,54,Incidence,2854002,Non-Hispanic Black,1.9,Male and Female,Myeloma,2018
35-39,7.2,9.4,236,Incidence,2854002,Non-Hispanic Black,8.3,Male and Female,Non-Hodgkin Lymphoma,2018
35-39,2.0,3.2,73,Incidence,2854002,Non-Hispanic Black,2.6,Male and Female,Oral Cavity and Pharynx,2018
35-39,3.3,5.5,64,Incidence,1493922,Non-Hispanic Black,4.3,Male and Female,Ovary,2018
35-39,1.1,2.1,44,Incidence,2854002,Non-Hispanic Black,1.5,Male and Female,Pancreas,2018
35-39,0.7,1.9,16,Incidence,1360080,Non-Hispanic Black,1.2,Male and Female,Prostate,2018
35-39,2.0,3.2,73,Incidence,2854002,Non-Hispanic Black,2.6,Male and Female,Stomach,2018
35-39,3.3,5.6,59,Incidence,1360080,Non-Hispanic Black,4.3,Male and Female,Testis,2018
35-39,8.5,10.8,274,Incidence,2854002,Non-Hispanic Black,9.6,Male and Female,Thyroid,2018
35-39,0.7,1.5,29,Incidence,2854002,Non-Hispanic Black,1.0,Male and Female,Urinary Bladder,2018
40-44,228.5,240.4,5995,Incidence,2557373,Non-Hispanic Black,234.4,Male and Female,All Cancer Sites Combined,2018
40-44,2.2,3.5,72,Incidence,2557373,Non-Hispanic Black,2.8,Male and Female,Brain and Other Nervous System,2018
40-44,15.6,20.1,240,Incidence,1353771,Non-Hispanic Black,17.7,Male and Female,Cervix,2018
40-44,20.6,24.3,573,Incidence,2557373,Non-Hispanic Black,22.4,Male and Female,Colon and Rectum,2018
40-44,12.1,16.2,190,Incidence,1353771,Non-Hispanic Black,14.0,Male and Female,"Corpus and Uterus, NOS",2018
40-44,0.7,1.5,27,Incidence,2557373,Non-Hispanic Black,1.1,Male and Female,Esophagus,2018
40-44,127.0,139.4,1802,Incidence,1353771,Non-Hispanic Black,133.1,Male and Female,Female Breast,2018
40-44,31.3,37.6,465,Incidence,1353771,Non-Hispanic Black,34.3,Male and Female,"Female Breast, <i>in situ</i>",2018
40-44,3.0,4.6,96,Incidence,2557373,Non-Hispanic Black,3.8,Male and Female,Hodgkin Lymphoma,2018
40-44,0.7,1.5,27,Incidence,2557373,Non-Hispanic Black,1.1,Male and Female,Kaposi Sarcoma,2018
40-44,11.8,14.7,337,Incidence,2557373,Non-Hispanic Black,13.2,Male and Female,Kidney and Renal Pelvis,2018
40-44,0.6,1.4,25,Incidence,2557373,Non-Hispanic Black,1.0,Male and Female,Larynx,2018
40-44,5.3,7.2,158,Incidence,2557373,Non-Hispanic Black,6.2,Male and Female,Leukemias,2018
40-44,1.8,3.1,61,Incidence,2557373,Non-Hispanic Black,2.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
40-44,8.3,10.7,241,Incidence,2557373,Non-Hispanic Black,9.4,Male and Female,Lung and Bronchus,2018
40-44,127.0,139.4,1802,Incidence,1353771,Non-Hispanic Black,133.1,Male and Female,Male and Female Breast,2018
40-44,31.3,37.6,465,Incidence,1353771,Non-Hispanic Black,34.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
40-44,~,~,~,Incidence,2557373,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,2557373,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
40-44,5.2,7.1,156,Incidence,2557373,Non-Hispanic Black,6.1,Male and Female,Myeloma,2018
40-44,10.0,12.6,287,Incidence,2557373,Non-Hispanic Black,11.2,Male and Female,Non-Hodgkin Lymphoma,2018
40-44,4.8,6.7,145,Incidence,2557373,Non-Hispanic Black,5.7,Male and Female,Oral Cavity and Pharynx,2018
40-44,4.9,7.7,84,Incidence,1353771,Non-Hispanic Black,6.2,Male and Female,Ovary,2018
40-44,4.1,5.9,126,Incidence,2557373,Non-Hispanic Black,4.9,Male and Female,Pancreas,2018
40-44,13.9,18.5,193,Incidence,1203602,Non-Hispanic Black,16.0,Male and Female,Prostate,2018
40-44,3.6,5.3,112,Incidence,2557373,Non-Hispanic Black,4.4,Male and Female,Stomach,2018
40-44,2.5,4.7,42,Incidence,1203602,Non-Hispanic Black,3.5,Male and Female,Testis,2018
40-44,11.4,14.2,326,Incidence,2557373,Non-Hispanic Black,12.7,Male and Female,Thyroid,2018
40-44,1.5,2.7,52,Incidence,2557373,Non-Hispanic Black,2.0,Male and Female,Urinary Bladder,2018
45-49,350.0,364.5,9459,Incidence,2648026,Non-Hispanic Black,357.2,Male and Female,All Cancer Sites Combined,2018
45-49,3.2,4.8,105,Incidence,2648026,Non-Hispanic Black,4.0,Male and Female,Brain and Other Nervous System,2018
45-49,12.4,16.4,201,Incidence,1406972,Non-Hispanic Black,14.3,Male and Female,Cervix,2018
45-49,37.5,42.4,1057,Incidence,2648026,Non-Hispanic Black,39.9,Male and Female,Colon and Rectum,2018
45-49,16.7,21.3,266,Incidence,1406972,Non-Hispanic Black,18.9,Male and Female,"Corpus and Uterus, NOS",2018
45-49,2.1,3.4,72,Incidence,2648026,Non-Hispanic Black,2.7,Male and Female,Esophagus,2018
45-49,183.1,197.6,2677,Incidence,1406972,Non-Hispanic Black,190.3,Male and Female,Female Breast,2018
45-49,46.2,53.7,701,Incidence,1406972,Non-Hispanic Black,49.8,Male and Female,"Female Breast, <i>in situ</i>",2018
45-49,2.3,3.6,77,Incidence,2648026,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2018
45-49,0.6,1.4,26,Incidence,2648026,Non-Hispanic Black,1.0,Male and Female,Kaposi Sarcoma,2018
45-49,17.4,20.8,505,Incidence,2648026,Non-Hispanic Black,19.1,Male and Female,Kidney and Renal Pelvis,2018
45-49,1.8,3.0,61,Incidence,2648026,Non-Hispanic Black,2.3,Male and Female,Larynx,2018
45-49,6.7,8.9,205,Incidence,2648026,Non-Hispanic Black,7.7,Male and Female,Leukemias,2018
45-49,3.1,4.7,102,Incidence,2648026,Non-Hispanic Black,3.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
45-49,13.0,15.9,382,Incidence,2648026,Non-Hispanic Black,14.4,Male and Female,Lung and Bronchus,2018
45-49,183.1,197.6,2677,Incidence,1406972,Non-Hispanic Black,190.3,Male and Female,Male and Female Breast,2018
45-49,46.2,53.7,701,Incidence,1406972,Non-Hispanic Black,49.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
45-49,~,~,~,Incidence,2648026,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
45-49,~,~,~,Incidence,2648026,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
45-49,9.0,11.5,270,Incidence,2648026,Non-Hispanic Black,10.2,Male and Female,Myeloma,2018
45-49,13.1,16.1,385,Incidence,2648026,Non-Hispanic Black,14.5,Male and Female,Non-Hodgkin Lymphoma,2018
45-49,8.0,10.3,241,Incidence,2648026,Non-Hispanic Black,9.1,Male and Female,Oral Cavity and Pharynx,2018
45-49,7.8,11.1,132,Incidence,1406972,Non-Hispanic Black,9.4,Male and Female,Ovary,2018
45-49,6.9,9.1,210,Incidence,2648026,Non-Hispanic Black,7.9,Male and Female,Pancreas,2018
45-49,71.8,81.6,950,Incidence,1241054,Non-Hispanic Black,76.5,Male and Female,Prostate,2018
45-49,5.6,7.6,174,Incidence,2648026,Non-Hispanic Black,6.6,Male and Female,Stomach,2018
45-49,1.0,2.6,21,Incidence,1241054,Non-Hispanic Black,1.7,Male and Female,Testis,2018
45-49,11.7,14.4,344,Incidence,2648026,Non-Hispanic Black,13.0,Male and Female,Thyroid,2018
45-49,2.8,4.3,93,Incidence,2648026,Non-Hispanic Black,3.5,Male and Female,Urinary Bladder,2018
5-9,9.1,11.4,316,Incidence,3089591,Non-Hispanic Black,10.2,Male and Female,All Cancer Sites Combined,2018
5-9,2.4,3.7,93,Incidence,3089591,Non-Hispanic Black,3.0,Male and Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,Cervix,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Esophagus,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,Female Breast,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
5-9,0.7,1.4,31,Incidence,3089591,Non-Hispanic Black,1.0,Male and Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Larynx,2018
5-9,1.9,3.1,76,Incidence,3089591,Non-Hispanic Black,2.5,Male and Female,Leukemias,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Myeloma,2018
5-9,0.6,1.3,29,Incidence,3089591,Non-Hispanic Black,0.9,Male and Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,1519565,Non-Hispanic Black,~,Male and Female,Ovary,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Pancreas,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male and Female,Prostate,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Stomach,2018
5-9,~,~,~,Incidence,1570026,Non-Hispanic Black,~,Male and Female,Testis,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Thyroid,2018
5-9,~,~,~,Incidence,3089591,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
50-54,603.0,621.9,16161,Incidence,2639052,Non-Hispanic Black,612.4,Male and Female,All Cancer Sites Combined,2018
50-54,4.7,6.5,146,Incidence,2639052,Non-Hispanic Black,5.5,Male and Female,Brain and Other Nervous System,2018
50-54,12.5,16.6,203,Incidence,1405345,Non-Hispanic Black,14.4,Male and Female,Cervix,2018
50-54,72.6,79.3,2002,Incidence,2639052,Non-Hispanic Black,75.9,Male and Female,Colon and Rectum,2018
50-54,34.6,41.1,531,Incidence,1405345,Non-Hispanic Black,37.8,Male and Female,"Corpus and Uterus, NOS",2018
50-54,3.3,4.9,107,Incidence,2639052,Non-Hispanic Black,4.1,Male and Female,Esophagus,2018
50-54,222.6,238.6,3239,Incidence,1405345,Non-Hispanic Black,230.5,Male and Female,Female Breast,2018
50-54,59.8,68.2,898,Incidence,1405345,Non-Hispanic Black,63.9,Male and Female,"Female Breast, <i>in situ</i>",2018
50-54,2.6,4.0,85,Incidence,2639052,Non-Hispanic Black,3.2,Male and Female,Hodgkin Lymphoma,2018
50-54,0.8,1.6,30,Incidence,2639052,Non-Hispanic Black,1.1,Male and Female,Kaposi Sarcoma,2018
50-54,26.0,30.1,738,Incidence,2639052,Non-Hispanic Black,28.0,Male and Female,Kidney and Renal Pelvis,2018
50-54,4.6,6.5,145,Incidence,2639052,Non-Hispanic Black,5.5,Male and Female,Larynx,2018
50-54,10.1,12.7,299,Incidence,2639052,Non-Hispanic Black,11.3,Male and Female,Leukemias,2018
50-54,7.5,9.8,226,Incidence,2639052,Non-Hispanic Black,8.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
50-54,42.2,47.3,1179,Incidence,2639052,Non-Hispanic Black,44.7,Male and Female,Lung and Bronchus,2018
50-54,222.6,238.6,3239,Incidence,1405345,Non-Hispanic Black,230.5,Male and Female,Male and Female Breast,2018
50-54,59.8,68.2,898,Incidence,1405345,Non-Hispanic Black,63.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
50-54,0.6,1.4,25,Incidence,2639052,Non-Hispanic Black,0.9,Male and Female,Melanomas of the Skin,2018
50-54,~,~,~,Incidence,2639052,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
50-54,16.6,19.9,479,Incidence,2639052,Non-Hispanic Black,18.2,Male and Female,Myeloma,2018
50-54,19.8,23.3,567,Incidence,2639052,Non-Hispanic Black,21.5,Male and Female,Non-Hodgkin Lymphoma,2018
50-54,13.6,16.6,397,Incidence,2639052,Non-Hispanic Black,15.0,Male and Female,Oral Cavity and Pharynx,2018
50-54,11.5,15.4,188,Incidence,1405345,Non-Hispanic Black,13.4,Male and Female,Ovary,2018
50-54,14.8,17.9,431,Incidence,2639052,Non-Hispanic Black,16.3,Male and Female,Pancreas,2018
50-54,235.1,252.6,3007,Incidence,1233707,Non-Hispanic Black,243.7,Male and Female,Prostate,2018
50-54,9.8,12.4,292,Incidence,2639052,Non-Hispanic Black,11.1,Male and Female,Stomach,2018
50-54,~,~,~,Incidence,1233707,Non-Hispanic Black,~,Male and Female,Testis,2018
50-54,12.8,15.7,375,Incidence,2639052,Non-Hispanic Black,14.2,Male and Female,Thyroid,2018
50-54,7.3,9.6,221,Incidence,2639052,Non-Hispanic Black,8.4,Male and Female,Urinary Bladder,2018
55-59,944.1,967.6,25352,Incidence,2652477,Non-Hispanic Black,955.8,Male and Female,All Cancer Sites Combined,2018
55-59,5.1,7.0,160,Incidence,2652477,Non-Hispanic Black,6.0,Male and Female,Brain and Other Nervous System,2018
55-59,13.7,17.9,224,Incidence,1425957,Non-Hispanic Black,15.7,Male and Female,Cervix,2018
55-59,82.5,89.6,2281,Incidence,2652477,Non-Hispanic Black,86.0,Male and Female,Colon and Rectum,2018
55-59,66.7,75.5,1012,Incidence,1425957,Non-Hispanic Black,71.0,Male and Female,"Corpus and Uterus, NOS",2018
55-59,7.7,10.0,234,Incidence,2652477,Non-Hispanic Black,8.8,Male and Female,Esophagus,2018
55-59,268.8,286.1,3955,Incidence,1425957,Non-Hispanic Black,277.4,Male and Female,Female Breast,2018
55-59,67.5,76.4,1025,Incidence,1425957,Non-Hispanic Black,71.9,Male and Female,"Female Breast, <i>in situ</i>",2018
55-59,2.6,4.0,85,Incidence,2652477,Non-Hispanic Black,3.2,Male and Female,Hodgkin Lymphoma,2018
55-59,0.5,1.2,21,Incidence,2652477,Non-Hispanic Black,0.8,Male and Female,Kaposi Sarcoma,2018
55-59,38.6,43.5,1088,Incidence,2652477,Non-Hispanic Black,41.0,Male and Female,Kidney and Renal Pelvis,2018
55-59,11.0,13.7,327,Incidence,2652477,Non-Hispanic Black,12.3,Male and Female,Larynx,2018
55-59,15.4,18.6,449,Incidence,2652477,Non-Hispanic Black,16.9,Male and Female,Leukemias,2018
55-59,23.4,27.2,670,Incidence,2652477,Non-Hispanic Black,25.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
55-59,104.4,112.3,2872,Incidence,2652477,Non-Hispanic Black,108.3,Male and Female,Lung and Bronchus,2018
55-59,268.8,286.1,3955,Incidence,1425957,Non-Hispanic Black,277.4,Male and Female,Male and Female Breast,2018
55-59,67.5,76.4,1025,Incidence,1425957,Non-Hispanic Black,71.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
55-59,1.1,2.1,42,Incidence,2652477,Non-Hispanic Black,1.6,Male and Female,Melanomas of the Skin,2018
55-59,0.3,1.0,16,Incidence,2652477,Non-Hispanic Black,0.6,Male and Female,Mesothelioma,2018
55-59,23.8,27.7,681,Incidence,2652477,Non-Hispanic Black,25.7,Male and Female,Myeloma,2018
55-59,25.2,29.2,719,Incidence,2652477,Non-Hispanic Black,27.1,Male and Female,Non-Hodgkin Lymphoma,2018
55-59,22.6,26.4,648,Incidence,2652477,Non-Hispanic Black,24.4,Male and Female,Oral Cavity and Pharynx,2018
55-59,14.7,19.0,239,Incidence,1425957,Non-Hispanic Black,16.8,Male and Female,Ovary,2018
55-59,29.0,33.3,824,Incidence,2652477,Non-Hispanic Black,31.1,Male and Female,Pancreas,2018
55-59,457.2,481.5,5755,Incidence,1226520,Non-Hispanic Black,469.2,Male and Female,Prostate,2018
55-59,15.3,18.4,446,Incidence,2652477,Non-Hispanic Black,16.8,Male and Female,Stomach,2018
55-59,~,~,~,Incidence,1226520,Non-Hispanic Black,~,Male and Female,Testis,2018
55-59,14.5,17.6,424,Incidence,2652477,Non-Hispanic Black,16.0,Male and Female,Thyroid,2018
55-59,14.8,17.9,431,Incidence,2652477,Non-Hispanic Black,16.2,Male and Female,Urinary Bladder,2018
60-64,1385.0,1415.5,32476,Incidence,2319454,Non-Hispanic Black,1400.2,Male and Female,All Cancer Sites Combined,2018
60-64,6.3,8.6,172,Incidence,2319454,Non-Hispanic Black,7.4,Male and Female,Brain and Other Nervous System,2018
60-64,13.1,17.5,193,Incidence,1271822,Non-Hispanic Black,15.2,Male and Female,Cervix,2018
60-64,108.1,116.8,2606,Incidence,2319454,Non-Hispanic Black,112.4,Male and Female,Colon and Rectum,2018
60-64,115.9,128.1,1550,Incidence,1271822,Non-Hispanic Black,121.9,Male and Female,"Corpus and Uterus, NOS",2018
60-64,11.4,14.3,297,Incidence,2319454,Non-Hispanic Black,12.8,Male and Female,Esophagus,2018
60-64,326.8,347.1,4284,Incidence,1271822,Non-Hispanic Black,336.8,Male and Female,Female Breast,2018
60-64,93.2,104.2,1254,Incidence,1271822,Non-Hispanic Black,98.6,Male and Female,"Female Breast, <i>in situ</i>",2018
60-64,2.0,3.3,60,Incidence,2319454,Non-Hispanic Black,2.6,Male and Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,2319454,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
60-64,59.9,66.4,1463,Incidence,2319454,Non-Hispanic Black,63.1,Male and Female,Kidney and Renal Pelvis,2018
60-64,13.0,16.1,336,Incidence,2319454,Non-Hispanic Black,14.5,Male and Female,Larynx,2018
60-64,22.2,26.2,560,Incidence,2319454,Non-Hispanic Black,24.1,Male and Female,Leukemias,2018
60-64,50.0,56.0,1228,Incidence,2319454,Non-Hispanic Black,52.9,Male and Female,Liver and Intrahepatic Bile Duct,2018
60-64,181.8,192.9,4344,Incidence,2319454,Non-Hispanic Black,187.3,Male and Female,Lung and Bronchus,2018
60-64,326.8,347.1,4284,Incidence,1271822,Non-Hispanic Black,336.8,Male and Female,Male and Female Breast,2018
60-64,93.2,104.2,1254,Incidence,1271822,Non-Hispanic Black,98.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
60-64,1.6,2.8,49,Incidence,2319454,Non-Hispanic Black,2.1,Male and Female,Melanomas of the Skin,2018
60-64,0.4,1.1,16,Incidence,2319454,Non-Hispanic Black,0.7,Male and Female,Mesothelioma,2018
60-64,36.2,41.3,897,Incidence,2319454,Non-Hispanic Black,38.7,Male and Female,Myeloma,2018
60-64,28.7,33.3,718,Incidence,2319454,Non-Hispanic Black,31.0,Male and Female,Non-Hodgkin Lymphoma,2018
60-64,27.1,31.6,679,Incidence,2319454,Non-Hispanic Black,29.3,Male and Female,Oral Cavity and Pharynx,2018
60-64,18.8,24.0,271,Incidence,1271822,Non-Hispanic Black,21.3,Male and Female,Ovary,2018
60-64,42.7,48.2,1053,Incidence,2319454,Non-Hispanic Black,45.4,Male and Female,Pancreas,2018
60-64,743.0,776.5,7958,Incidence,1047632,Non-Hispanic Black,759.6,Male and Female,Prostate,2018
60-64,23.1,27.2,582,Incidence,2319454,Non-Hispanic Black,25.1,Male and Female,Stomach,2018
60-64,~,~,~,Incidence,1047632,Non-Hispanic Black,~,Male and Female,Testis,2018
60-64,15.6,19.1,401,Incidence,2319454,Non-Hispanic Black,17.3,Male and Female,Thyroid,2018
60-64,25.6,30.0,643,Incidence,2319454,Non-Hispanic Black,27.7,Male and Female,Urinary Bladder,2018
65-69,1826.8,1866.8,32872,Incidence,1780053,Non-Hispanic Black,1846.7,Male and Female,All Cancer Sites Combined,2018
65-69,8.5,11.5,177,Incidence,1780053,Non-Hispanic Black,9.9,Male and Female,Brain and Other Nervous System,2018
65-69,15.4,20.7,180,Incidence,1007069,Non-Hispanic Black,17.9,Male and Female,Cervix,2018
65-69,139.3,150.6,2579,Incidence,1780053,Non-Hispanic Black,144.9,Male and Female,Colon and Rectum,2018
65-69,141.1,156.3,1496,Incidence,1007069,Non-Hispanic Black,148.5,Male and Female,"Corpus and Uterus, NOS",2018
65-69,13.1,16.7,264,Incidence,1780053,Non-Hispanic Black,14.8,Male and Female,Esophagus,2018
65-69,407.0,432.4,4225,Incidence,1007069,Non-Hispanic Black,419.5,Male and Female,Female Breast,2018
65-69,116.4,130.2,1240,Incidence,1007069,Non-Hispanic Black,123.1,Male and Female,"Female Breast, <i>in situ</i>",2018
65-69,1.8,3.4,45,Incidence,1780053,Non-Hispanic Black,2.5,Male and Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,1780053,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
65-69,73.9,82.2,1388,Incidence,1780053,Non-Hispanic Black,78.0,Male and Female,Kidney and Renal Pelvis,2018
65-69,16.2,20.2,322,Incidence,1780053,Non-Hispanic Black,18.1,Male and Female,Larynx,2018
65-69,30.6,36.0,592,Incidence,1780053,Non-Hispanic Black,33.3,Male and Female,Leukemias,2018
65-69,63.8,71.5,1202,Incidence,1780053,Non-Hispanic Black,67.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
65-69,237.6,252.1,4357,Incidence,1780053,Non-Hispanic Black,244.8,Male and Female,Lung and Bronchus,2018
65-69,407.0,432.4,4225,Incidence,1007069,Non-Hispanic Black,419.5,Male and Female,Male and Female Breast,2018
65-69,116.4,130.2,1240,Incidence,1007069,Non-Hispanic Black,123.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
65-69,2.2,3.8,52,Incidence,1780053,Non-Hispanic Black,2.9,Male and Female,Melanomas of the Skin,2018
65-69,0.9,2.1,25,Incidence,1780053,Non-Hispanic Black,1.4,Male and Female,Mesothelioma,2018
65-69,54.1,61.2,1025,Incidence,1780053,Non-Hispanic Black,57.6,Male and Female,Myeloma,2018
65-69,39.3,45.4,752,Incidence,1780053,Non-Hispanic Black,42.2,Male and Female,Non-Hodgkin Lymphoma,2018
65-69,29.6,34.9,573,Incidence,1780053,Non-Hispanic Black,32.2,Male and Female,Oral Cavity and Pharynx,2018
65-69,24.4,30.9,277,Incidence,1007069,Non-Hispanic Black,27.5,Male and Female,Ovary,2018
65-69,63.5,71.2,1197,Incidence,1780053,Non-Hispanic Black,67.2,Male and Female,Pancreas,2018
65-69,1044.8,1091.0,8253,Incidence,772984,Non-Hispanic Black,1067.7,Male and Female,Prostate,2018
65-69,29.5,34.8,571,Incidence,1780053,Non-Hispanic Black,32.1,Male and Female,Stomach,2018
65-69,~,~,~,Incidence,772984,Non-Hispanic Black,~,Male and Female,Testis,2018
65-69,17.3,21.5,344,Incidence,1780053,Non-Hispanic Black,19.3,Male and Female,Thyroid,2018
65-69,41.5,47.8,793,Incidence,1780053,Non-Hispanic Black,44.5,Male and Female,Urinary Bladder,2018
70-74,1950.5,2000.4,24168,Incidence,1223505,Non-Hispanic Black,1975.3,Male and Female,All Cancer Sites Combined,2018
70-74,9.1,12.9,133,Incidence,1223505,Non-Hispanic Black,10.9,Male and Female,Brain and Other Nervous System,2018
70-74,14.0,20.3,120,Incidence,708287,Non-Hispanic Black,16.9,Male and Female,Cervix,2018
70-74,159.1,173.6,2034,Incidence,1223505,Non-Hispanic Black,166.2,Male and Female,Colon and Rectum,2018
70-74,125.0,142.2,945,Incidence,708287,Non-Hispanic Black,133.4,Male and Female,"Corpus and Uterus, NOS",2018
70-74,14.8,19.5,208,Incidence,1223505,Non-Hispanic Black,17.0,Male and Female,Esophagus,2018
70-74,429.3,460.5,3150,Incidence,708287,Non-Hispanic Black,444.7,Male and Female,Female Breast,2018
70-74,116.6,133.2,883,Incidence,708287,Non-Hispanic Black,124.7,Male and Female,"Female Breast, <i>in situ</i>",2018
70-74,2.1,4.1,36,Incidence,1223505,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,1223505,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
70-74,71.8,81.6,937,Incidence,1223505,Non-Hispanic Black,76.6,Male and Female,Kidney and Renal Pelvis,2018
70-74,15.8,20.7,222,Incidence,1223505,Non-Hispanic Black,18.1,Male and Female,Larynx,2018
70-74,37.4,44.7,501,Incidence,1223505,Non-Hispanic Black,40.9,Male and Female,Leukemias,2018
70-74,42.6,50.3,567,Incidence,1223505,Non-Hispanic Black,46.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
70-74,319.5,339.9,4032,Incidence,1223505,Non-Hispanic Black,329.5,Male and Female,Lung and Bronchus,2018
70-74,429.3,460.5,3150,Incidence,708287,Non-Hispanic Black,444.7,Male and Female,Male and Female Breast,2018
70-74,116.6,133.2,883,Incidence,708287,Non-Hispanic Black,124.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
70-74,2.6,4.8,44,Incidence,1223505,Non-Hispanic Black,3.6,Male and Female,Melanomas of the Skin,2018
70-74,1.9,3.8,33,Incidence,1223505,Non-Hispanic Black,2.7,Male and Female,Mesothelioma,2018
70-74,64.6,74.0,846,Incidence,1223505,Non-Hispanic Black,69.1,Male and Female,Myeloma,2018
70-74,46.2,54.2,613,Incidence,1223505,Non-Hispanic Black,50.1,Male and Female,Non-Hodgkin Lymphoma,2018
70-74,26.2,32.3,356,Incidence,1223505,Non-Hispanic Black,29.1,Male and Female,Oral Cavity and Pharynx,2018
70-74,21.8,29.4,180,Incidence,708287,Non-Hispanic Black,25.4,Male and Female,Ovary,2018
70-74,78.3,88.6,1020,Incidence,1223505,Non-Hispanic Black,83.4,Male and Female,Pancreas,2018
70-74,936.9,990.7,4964,Incidence,515218,Non-Hispanic Black,963.5,Male and Female,Prostate,2018
70-74,34.9,41.9,468,Incidence,1223505,Non-Hispanic Black,38.3,Male and Female,Stomach,2018
70-74,~,~,~,Incidence,515218,Non-Hispanic Black,~,Male and Female,Testis,2018
70-74,17.0,22.0,237,Incidence,1223505,Non-Hispanic Black,19.4,Male and Female,Thyroid,2018
70-74,52.3,60.8,690,Incidence,1223505,Non-Hispanic Black,56.4,Male and Female,Urinary Bladder,2018
75-79,2016.9,2079.4,16563,Incidence,808739,Non-Hispanic Black,2048.0,Male and Female,All Cancer Sites Combined,2018
75-79,8.5,13.1,86,Incidence,808739,Non-Hispanic Black,10.6,Male and Female,Brain and Other Nervous System,2018
75-79,13.8,21.4,84,Incidence,486851,Non-Hispanic Black,17.3,Male and Female,Cervix,2018
75-79,182.0,201.2,1548,Incidence,808739,Non-Hispanic Black,191.4,Male and Female,Colon and Rectum,2018
75-79,99.0,117.7,526,Incidence,486851,Non-Hispanic Black,108.0,Male and Female,"Corpus and Uterus, NOS",2018
75-79,12.6,18.1,123,Incidence,808739,Non-Hispanic Black,15.2,Male and Female,Esophagus,2018
75-79,404.6,441.4,2058,Incidence,486851,Non-Hispanic Black,422.7,Male and Female,Female Breast,2018
75-79,93.7,111.9,499,Incidence,486851,Non-Hispanic Black,102.5,Male and Female,"Female Breast, <i>in situ</i>",2018
75-79,1.6,4.0,21,Incidence,808739,Non-Hispanic Black,2.6,Male and Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,808739,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
75-79,73.4,85.8,642,Incidence,808739,Non-Hispanic Black,79.4,Male and Female,Kidney and Renal Pelvis,2018
75-79,14.2,20.0,137,Incidence,808739,Non-Hispanic Black,16.9,Male and Female,Larynx,2018
75-79,43.1,52.7,386,Incidence,808739,Non-Hispanic Black,47.7,Male and Female,Leukemias,2018
75-79,33.4,41.9,303,Incidence,808739,Non-Hispanic Black,37.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
75-79,368.8,395.9,3091,Incidence,808739,Non-Hispanic Black,382.2,Male and Female,Lung and Bronchus,2018
75-79,404.6,441.4,2058,Incidence,486851,Non-Hispanic Black,422.7,Male and Female,Male and Female Breast,2018
75-79,93.7,111.9,499,Incidence,486851,Non-Hispanic Black,102.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
75-79,3.1,6.2,36,Incidence,808739,Non-Hispanic Black,4.5,Male and Female,Melanomas of the Skin,2018
75-79,1.5,3.8,20,Incidence,808739,Non-Hispanic Black,2.5,Male and Female,Mesothelioma,2018
75-79,74.8,87.3,654,Incidence,808739,Non-Hispanic Black,80.9,Male and Female,Myeloma,2018
75-79,51.2,61.7,455,Incidence,808739,Non-Hispanic Black,56.3,Male and Female,Non-Hodgkin Lymphoma,2018
75-79,25.5,33.0,235,Incidence,808739,Non-Hispanic Black,29.1,Male and Female,Oral Cavity and Pharynx,2018
75-79,29.3,39.9,167,Incidence,486851,Non-Hispanic Black,34.3,Male and Female,Ovary,2018
75-79,93.1,107.0,808,Incidence,808739,Non-Hispanic Black,99.9,Male and Female,Pancreas,2018
75-79,759.6,821.3,2543,Incidence,321888,Non-Hispanic Black,790.0,Male and Female,Prostate,2018
75-79,48.3,58.4,430,Incidence,808739,Non-Hispanic Black,53.2,Male and Female,Stomach,2018
75-79,~,~,~,Incidence,321888,Non-Hispanic Black,~,Male and Female,Testis,2018
75-79,12.3,17.7,120,Incidence,808739,Non-Hispanic Black,14.8,Male and Female,Thyroid,2018
75-79,66.4,78.2,583,Incidence,808739,Non-Hispanic Black,72.1,Male and Female,Urinary Bladder,2018
80-84,2015.9,2093.6,10818,Incidence,526557,Non-Hispanic Black,2054.5,Male and Female,All Cancer Sites Combined,2018
80-84,10.2,16.6,69,Incidence,526557,Non-Hispanic Black,13.1,Male and Female,Brain and Other Nervous System,2018
80-84,12.2,21.2,54,Incidence,332756,Non-Hispanic Black,16.2,Male and Female,Cervix,2018
80-84,213.9,239.8,1193,Incidence,526557,Non-Hispanic Black,226.6,Male and Female,Colon and Rectum,2018
80-84,90.5,112.4,336,Incidence,332756,Non-Hispanic Black,101.0,Male and Female,"Corpus and Uterus, NOS",2018
80-84,14.1,21.4,92,Incidence,526557,Non-Hispanic Black,17.5,Male and Female,Esophagus,2018
80-84,372.9,415.9,1311,Incidence,332756,Non-Hispanic Black,394.0,Male and Female,Female Breast,2018
80-84,58.2,76.1,222,Incidence,332756,Non-Hispanic Black,66.7,Male and Female,"Female Breast, <i>in situ</i>",2018
80-84,~,~,~,Incidence,526557,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,526557,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
80-84,58.4,72.4,343,Incidence,526557,Non-Hispanic Black,65.1,Male and Female,Kidney and Renal Pelvis,2018
80-84,13.1,20.2,86,Incidence,526557,Non-Hispanic Black,16.3,Male and Female,Larynx,2018
80-84,45.5,58.0,271,Incidence,526557,Non-Hispanic Black,51.5,Male and Female,Leukemias,2018
80-84,26.9,36.7,166,Incidence,526557,Non-Hispanic Black,31.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
80-84,344.0,376.7,1896,Incidence,526557,Non-Hispanic Black,360.1,Male and Female,Lung and Bronchus,2018
80-84,372.9,415.9,1311,Incidence,332756,Non-Hispanic Black,394.0,Male and Female,Male and Female Breast,2018
80-84,58.2,76.1,222,Incidence,332756,Non-Hispanic Black,66.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
80-84,3.8,8.1,30,Incidence,526557,Non-Hispanic Black,5.7,Male and Female,Melanomas of the Skin,2018
80-84,~,~,~,Incidence,526557,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
80-84,84.1,100.7,485,Incidence,526557,Non-Hispanic Black,92.1,Male and Female,Myeloma,2018
80-84,58.2,72.2,342,Incidence,526557,Non-Hispanic Black,65.0,Male and Female,Non-Hodgkin Lymphoma,2018
80-84,23.4,32.6,146,Incidence,526557,Non-Hispanic Black,27.7,Male and Female,Oral Cavity and Pharynx,2018
80-84,24.7,36.9,101,Incidence,332756,Non-Hispanic Black,30.4,Male and Female,Ovary,2018
80-84,107.6,126.2,614,Incidence,526557,Non-Hispanic Black,116.6,Male and Female,Pancreas,2018
80-84,565.6,635.1,1162,Incidence,193801,Non-Hispanic Black,599.6,Male and Female,Prostate,2018
80-84,57.3,71.2,337,Incidence,526557,Non-Hispanic Black,64.0,Male and Female,Stomach,2018
80-84,~,~,~,Incidence,193801,Non-Hispanic Black,~,Male and Female,Testis,2018
80-84,8.9,14.9,61,Incidence,526557,Non-Hispanic Black,11.6,Male and Female,Thyroid,2018
80-84,88.1,105.0,507,Incidence,526557,Non-Hispanic Black,96.3,Male and Female,Urinary Bladder,2018
85+,1719.6,1793.1,8826,Incidence,502609,Non-Hispanic Black,1756.0,Male and Female,All Cancer Sites Combined,2018
85+,6.9,12.4,47,Incidence,502609,Non-Hispanic Black,9.4,Male and Female,Brain and Other Nervous System,2018
85+,10.6,18.8,50,Incidence,350704,Non-Hispanic Black,14.3,Male and Female,Cervix,2018
85+,202.4,228.3,1081,Incidence,502609,Non-Hispanic Black,215.1,Male and Female,Colon and Rectum,2018
85+,55.5,72.5,223,Incidence,350704,Non-Hispanic Black,63.6,Male and Female,"Corpus and Uterus, NOS",2018
85+,10.7,17.4,69,Incidence,502609,Non-Hispanic Black,13.7,Male and Female,Esophagus,2018
85+,310.9,349.2,1156,Incidence,350704,Non-Hispanic Black,329.6,Male and Female,Female Breast,2018
85+,27.9,40.3,118,Incidence,350704,Non-Hispanic Black,33.6,Male and Female,"Female Breast, <i>in situ</i>",2018
85+,~,~,~,Incidence,502609,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,502609,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
85+,41.0,53.1,235,Incidence,502609,Non-Hispanic Black,46.8,Male and Female,Kidney and Renal Pelvis,2018
85+,8.4,14.5,56,Incidence,502609,Non-Hispanic Black,11.1,Male and Female,Larynx,2018
85+,52.0,65.6,294,Incidence,502609,Non-Hispanic Black,58.5,Male and Female,Leukemias,2018
85+,26.2,36.1,155,Incidence,502609,Non-Hispanic Black,30.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
85+,250.6,279.2,1330,Incidence,502609,Non-Hispanic Black,264.6,Male and Female,Lung and Bronchus,2018
85+,310.9,349.2,1156,Incidence,350704,Non-Hispanic Black,329.6,Male and Female,Male and Female Breast,2018
85+,27.9,40.3,118,Incidence,350704,Non-Hispanic Black,33.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
85+,4.0,8.5,30,Incidence,502609,Non-Hispanic Black,6.0,Male and Female,Melanomas of the Skin,2018
85+,~,~,~,Incidence,502609,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
85+,63.5,78.4,355,Incidence,502609,Non-Hispanic Black,70.6,Male and Female,Myeloma,2018
85+,49.0,62.2,278,Incidence,502609,Non-Hispanic Black,55.3,Male and Female,Non-Hodgkin Lymphoma,2018
85+,18.3,26.8,112,Incidence,502609,Non-Hispanic Black,22.3,Male and Female,Oral Cavity and Pharynx,2018
85+,26.0,38.1,111,Incidence,350704,Non-Hispanic Black,31.7,Male and Female,Ovary,2018
85+,92.1,109.8,506,Incidence,502609,Non-Hispanic Black,100.7,Male and Female,Pancreas,2018
85+,421.6,490.1,691,Incidence,151905,Non-Hispanic Black,454.9,Male and Female,Prostate,2018
85+,57.3,71.5,322,Incidence,502609,Non-Hispanic Black,64.1,Male and Female,Stomach,2018
85+,~,~,~,Incidence,151905,Non-Hispanic Black,~,Male and Female,Testis,2018
85+,4.2,8.8,31,Incidence,502609,Non-Hispanic Black,6.2,Male and Female,Thyroid,2018
85+,85.6,102.8,472,Incidence,502609,Non-Hispanic Black,93.9,Male and Female,Urinary Bladder,2018
<1,16.3,23.5,119,Incidence,605034,Non-Hispanic Black,19.7,Male and Female,All Cancer Sites Combined,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,Cervix,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Esophagus,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,Female Breast,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Larynx,2018
<1,1.8,4.7,18,Incidence,605034,Non-Hispanic Black,3.0,Male and Female,Leukemias,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Mesothelioma,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Myeloma,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,297609,Non-Hispanic Black,~,Male and Female,Ovary,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Pancreas,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male and Female,Prostate,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Stomach,2018
<1,~,~,~,Incidence,307425,Non-Hispanic Black,~,Male and Female,Testis,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Thyroid,2018
<1,~,~,~,Incidence,605034,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2018
1-4,20.6,23.5,877,Incidence,3987693,Non-Hispanic White,22.0,Female,All Cancer Sites Combined,2018
1-4,3.9,5.2,180,Incidence,3987693,Non-Hispanic White,4.5,Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Cervix,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Esophagus,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Female Breast,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
1-4,1.6,2.6,82,Incidence,3987693,Non-Hispanic White,2.1,Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Larynx,2018
1-4,8.1,10.0,360,Incidence,3987693,Non-Hispanic White,9.0,Female,Leukemias,2018
1-4,0.3,0.8,22,Incidence,3987693,Non-Hispanic White,0.6,Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Mesothelioma,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Myeloma,2018
1-4,0.2,0.7,17,Incidence,3987693,Non-Hispanic White,0.4,Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Ovary,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Pancreas,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Stomach,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Thyroid,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Female,Urinary Bladder,2018
10-14,15.2,17.4,872,Incidence,5363078,Non-Hispanic White,16.3,Female,All Cancer Sites Combined,2018
10-14,3.1,4.2,194,Incidence,5363078,Non-Hispanic White,3.6,Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Cervix,2018
10-14,0.9,1.5,65,Incidence,5363078,Non-Hispanic White,1.2,Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Esophagus,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Female Breast,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2018
10-14,0.9,1.5,65,Incidence,5363078,Non-Hispanic White,1.2,Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Larynx,2018
10-14,2.1,3.0,134,Incidence,5363078,Non-Hispanic White,2.5,Female,Leukemias,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Lung and Bronchus,2018
10-14,0.3,0.7,24,Incidence,5363078,Non-Hispanic White,0.4,Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Mesothelioma,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Myeloma,2018
10-14,0.8,1.4,57,Incidence,5363078,Non-Hispanic White,1.1,Female,Non-Hodgkin Lymphoma,2018
10-14,0.2,0.6,19,Incidence,5363078,Non-Hispanic White,0.4,Female,Oral Cavity and Pharynx,2018
10-14,0.4,0.8,32,Incidence,5363078,Non-Hispanic White,0.6,Female,Ovary,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Pancreas,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Stomach,2018
10-14,1.4,2.1,92,Incidence,5363078,Non-Hispanic White,1.7,Female,Thyroid,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Female,Urinary Bladder,2018
15-19,26.2,29.0,1538,Incidence,5582530,Non-Hispanic White,27.6,Female,All Cancer Sites Combined,2018
15-19,2.2,3.0,143,Incidence,5582530,Non-Hispanic White,2.6,Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Cervix,2018
15-19,1.7,2.5,117,Incidence,5582530,Non-Hispanic White,2.1,Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Esophagus,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Female Breast,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2018
15-19,3.5,4.6,225,Incidence,5582530,Non-Hispanic White,4.0,Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
15-19,0.2,0.5,17,Incidence,5582530,Non-Hispanic White,0.3,Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Larynx,2018
15-19,2.2,3.1,148,Incidence,5582530,Non-Hispanic White,2.7,Female,Leukemias,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Lung and Bronchus,2018
15-19,1.2,1.9,85,Incidence,5582530,Non-Hispanic White,1.5,Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Mesothelioma,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Myeloma,2018
15-19,1.0,1.6,72,Incidence,5582530,Non-Hispanic White,1.3,Female,Non-Hodgkin Lymphoma,2018
15-19,0.3,0.7,27,Incidence,5582530,Non-Hispanic White,0.5,Female,Oral Cavity and Pharynx,2018
15-19,0.9,1.5,68,Incidence,5582530,Non-Hispanic White,1.2,Female,Ovary,2018
15-19,0.2,0.5,16,Incidence,5582530,Non-Hispanic White,0.3,Female,Pancreas,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Stomach,2018
15-19,6.4,7.8,394,Incidence,5582530,Non-Hispanic White,7.1,Female,Thyroid,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Female,Urinary Bladder,2018
20-24,44.1,47.6,2679,Incidence,5841399,Non-Hispanic White,45.9,Female,All Cancer Sites Combined,2018
20-24,1.8,2.6,127,Incidence,5841399,Non-Hispanic White,2.2,Female,Brain and Other Nervous System,2018
20-24,0.4,0.8,31,Incidence,5841399,Non-Hispanic White,0.5,Female,Cervix,2018
20-24,2.0,2.8,141,Incidence,5841399,Non-Hispanic White,2.4,Female,Colon and Rectum,2018
20-24,0.3,0.7,27,Incidence,5841399,Non-Hispanic White,0.5,Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Esophagus,2018
20-24,1.4,2.1,102,Incidence,5841399,Non-Hispanic White,1.7,Female,Female Breast,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2018
20-24,4.7,5.8,305,Incidence,5841399,Non-Hispanic White,5.2,Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
20-24,0.4,0.9,36,Incidence,5841399,Non-Hispanic White,0.6,Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Larynx,2018
20-24,2.0,2.8,138,Incidence,5841399,Non-Hispanic White,2.4,Female,Leukemias,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Lung and Bronchus,2018
20-24,5.4,6.6,349,Incidence,5841399,Non-Hispanic White,6.0,Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Mesothelioma,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Myeloma,2018
20-24,1.8,2.5,123,Incidence,5841399,Non-Hispanic White,2.1,Female,Non-Hodgkin Lymphoma,2018
20-24,0.4,0.9,36,Incidence,5841399,Non-Hispanic White,0.6,Female,Oral Cavity and Pharynx,2018
20-24,1.5,2.2,108,Incidence,5841399,Non-Hispanic White,1.8,Female,Ovary,2018
20-24,0.2,0.5,21,Incidence,5841399,Non-Hispanic White,0.4,Female,Pancreas,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Stomach,2018
20-24,12.9,14.9,811,Incidence,5841399,Non-Hispanic White,13.9,Female,Thyroid,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Female,Urinary Bladder,2018
25-29,75.6,79.9,4963,Incidence,6384466,Non-Hispanic White,77.7,Female,All Cancer Sites Combined,2018
25-29,3.1,4.0,227,Incidence,6384466,Non-Hispanic White,3.6,Female,Brain and Other Nervous System,2018
25-29,4.1,5.2,296,Incidence,6384466,Non-Hispanic White,4.6,Female,Cervix,2018
25-29,3.3,4.2,239,Incidence,6384466,Non-Hispanic White,3.7,Female,Colon and Rectum,2018
25-29,1.6,2.3,125,Incidence,6384466,Non-Hispanic White,2.0,Female,"Corpus and Uterus, NOS",2018
25-29,~,~,~,Incidence,6384466,Non-Hispanic White,~,Female,Esophagus,2018
25-29,9.8,11.4,674,Incidence,6384466,Non-Hispanic White,10.6,Female,Female Breast,2018
25-29,0.5,0.9,44,Incidence,6384466,Non-Hispanic White,0.7,Female,"Female Breast, <i>in situ</i>",2018
25-29,4.0,5.1,291,Incidence,6384466,Non-Hispanic White,4.6,Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,6384466,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
25-29,1.0,1.6,82,Incidence,6384466,Non-Hispanic White,1.3,Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,6384466,Non-Hispanic White,~,Female,Larynx,2018
25-29,2.2,3.0,167,Incidence,6384466,Non-Hispanic White,2.6,Female,Leukemias,2018
25-29,0.2,0.4,18,Incidence,6384466,Non-Hispanic White,0.3,Female,Liver and Intrahepatic Bile Duct,2018
25-29,0.5,0.9,44,Incidence,6384466,Non-Hispanic White,0.7,Female,Lung and Bronchus,2018
25-29,10.0,11.6,686,Incidence,6384466,Non-Hispanic White,10.7,Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,6384466,Non-Hispanic White,~,Female,Mesothelioma,2018
25-29,~,~,~,Incidence,6384466,Non-Hispanic White,~,Female,Myeloma,2018
25-29,2.3,3.1,172,Incidence,6384466,Non-Hispanic White,2.7,Female,Non-Hodgkin Lymphoma,2018
25-29,0.6,1.1,53,Incidence,6384466,Non-Hispanic White,0.8,Female,Oral Cavity and Pharynx,2018
25-29,2.2,3.0,165,Incidence,6384466,Non-Hispanic White,2.6,Female,Ovary,2018
25-29,0.3,0.6,25,Incidence,6384466,Non-Hispanic White,0.4,Female,Pancreas,2018
25-29,0.2,0.5,23,Incidence,6384466,Non-Hispanic White,0.4,Female,Stomach,2018
25-29,18.8,21.0,1269,Incidence,6384466,Non-Hispanic White,19.9,Female,Thyroid,2018
25-29,0.2,0.4,17,Incidence,6384466,Non-Hispanic White,0.3,Female,Urinary Bladder,2018
30-34,137.1,143.0,8701,Incidence,6214227,Non-Hispanic White,140.0,Female,All Cancer Sites Combined,2018
30-34,3.4,4.4,241,Incidence,6214227,Non-Hispanic White,3.9,Female,Brain and Other Nervous System,2018
30-34,11.6,13.4,777,Incidence,6214227,Non-Hispanic White,12.5,Female,Cervix,2018
30-34,6.1,7.4,415,Incidence,6214227,Non-Hispanic White,6.7,Female,Colon and Rectum,2018
30-34,4.9,6.1,339,Incidence,6214227,Non-Hispanic White,5.5,Female,"Corpus and Uterus, NOS",2018
30-34,~,~,~,Incidence,6214227,Non-Hispanic White,~,Female,Esophagus,2018
30-34,31.0,33.9,2015,Incidence,6214227,Non-Hispanic White,32.4,Female,Female Breast,2018
30-34,2.4,3.2,171,Incidence,6214227,Non-Hispanic White,2.8,Female,"Female Breast, <i>in situ</i>",2018
30-34,3.3,4.3,234,Incidence,6214227,Non-Hispanic White,3.8,Female,Hodgkin Lymphoma,2018
30-34,~,~,~,Incidence,6214227,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
30-34,2.6,3.5,189,Incidence,6214227,Non-Hispanic White,3.0,Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,6214227,Non-Hispanic White,~,Female,Larynx,2018
30-34,2.6,3.5,187,Incidence,6214227,Non-Hispanic White,3.0,Female,Leukemias,2018
30-34,0.2,0.6,23,Incidence,6214227,Non-Hispanic White,0.4,Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.9,1.4,71,Incidence,6214227,Non-Hispanic White,1.1,Female,Lung and Bronchus,2018
30-34,18.7,20.9,1227,Incidence,6214227,Non-Hispanic White,19.7,Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,6214227,Non-Hispanic White,~,Female,Mesothelioma,2018
30-34,0.2,0.5,22,Incidence,6214227,Non-Hispanic White,0.4,Female,Myeloma,2018
30-34,3.3,4.2,232,Incidence,6214227,Non-Hispanic White,3.7,Female,Non-Hodgkin Lymphoma,2018
30-34,1.3,1.9,98,Incidence,6214227,Non-Hispanic White,1.6,Female,Oral Cavity and Pharynx,2018
30-34,2.9,3.9,210,Incidence,6214227,Non-Hispanic White,3.4,Female,Ovary,2018
30-34,0.7,1.2,57,Incidence,6214227,Non-Hispanic White,0.9,Female,Pancreas,2018
30-34,0.7,1.2,55,Incidence,6214227,Non-Hispanic White,0.9,Female,Stomach,2018
30-34,26.4,29.0,1721,Incidence,6214227,Non-Hispanic White,27.7,Female,Thyroid,2018
30-34,0.4,0.9,39,Incidence,6214227,Non-Hispanic White,0.6,Female,Urinary Bladder,2018
35-39,205.8,213.1,12822,Incidence,6122803,Non-Hispanic White,209.4,Female,All Cancer Sites Combined,2018
35-39,3.7,4.8,259,Incidence,6122803,Non-Hispanic White,4.2,Female,Brain and Other Nervous System,2018
35-39,13.1,15.0,857,Incidence,6122803,Non-Hispanic White,14.0,Female,Cervix,2018
35-39,10.6,12.3,701,Incidence,6122803,Non-Hispanic White,11.4,Female,Colon and Rectum,2018
35-39,8.9,10.4,589,Incidence,6122803,Non-Hispanic White,9.6,Female,"Corpus and Uterus, NOS",2018
35-39,~,~,~,Incidence,6122803,Non-Hispanic White,~,Female,Esophagus,2018
35-39,63.7,67.8,4023,Incidence,6122803,Non-Hispanic White,65.7,Female,Female Breast,2018
35-39,8.8,10.4,586,Incidence,6122803,Non-Hispanic White,9.6,Female,"Female Breast, <i>in situ</i>",2018
35-39,2.6,3.5,188,Incidence,6122803,Non-Hispanic White,3.1,Female,Hodgkin Lymphoma,2018
35-39,~,~,~,Incidence,6122803,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
35-39,5.3,6.6,364,Incidence,6122803,Non-Hispanic White,5.9,Female,Kidney and Renal Pelvis,2018
35-39,~,~,~,Incidence,6122803,Non-Hispanic White,~,Female,Larynx,2018
35-39,3.4,4.4,240,Incidence,6122803,Non-Hispanic White,3.9,Female,Leukemias,2018
35-39,0.5,0.9,41,Incidence,6122803,Non-Hispanic White,0.7,Female,Liver and Intrahepatic Bile Duct,2018
35-39,2.3,3.1,165,Incidence,6122803,Non-Hispanic White,2.7,Female,Lung and Bronchus,2018
35-39,23.5,26.1,1517,Incidence,6122803,Non-Hispanic White,24.8,Female,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,6122803,Non-Hispanic White,~,Female,Mesothelioma,2018
35-39,0.4,0.8,37,Incidence,6122803,Non-Hispanic White,0.6,Female,Myeloma,2018
35-39,4.7,5.9,323,Incidence,6122803,Non-Hispanic White,5.3,Female,Non-Hodgkin Lymphoma,2018
35-39,2.1,2.9,151,Incidence,6122803,Non-Hispanic White,2.5,Female,Oral Cavity and Pharynx,2018
35-39,4.7,5.8,321,Incidence,6122803,Non-Hispanic White,5.2,Female,Ovary,2018
35-39,1.3,1.9,95,Incidence,6122803,Non-Hispanic White,1.6,Female,Pancreas,2018
35-39,1.1,1.7,82,Incidence,6122803,Non-Hispanic White,1.3,Female,Stomach,2018
35-39,30.2,33.0,1932,Incidence,6122803,Non-Hispanic White,31.6,Female,Thyroid,2018
35-39,1.1,1.7,82,Incidence,6122803,Non-Hispanic White,1.3,Female,Urinary Bladder,2018
40-44,331.0,340.6,18908,Incidence,5630803,Non-Hispanic White,335.8,Female,All Cancer Sites Combined,2018
40-44,3.6,4.7,233,Incidence,5630803,Non-Hispanic White,4.1,Female,Brain and Other Nervous System,2018
40-44,14.3,16.3,859,Incidence,5630803,Non-Hispanic White,15.3,Female,Cervix,2018
40-44,18.5,20.8,1106,Incidence,5630803,Non-Hispanic White,19.6,Female,Colon and Rectum,2018
40-44,15.4,17.5,923,Incidence,5630803,Non-Hispanic White,16.4,Female,"Corpus and Uterus, NOS",2018
40-44,0.2,0.6,21,Incidence,5630803,Non-Hispanic White,0.4,Female,Esophagus,2018
40-44,136.3,142.4,7845,Incidence,5630803,Non-Hispanic White,139.3,Female,Female Breast,2018
40-44,39.9,43.3,2342,Incidence,5630803,Non-Hispanic White,41.6,Female,"Female Breast, <i>in situ</i>",2018
40-44,1.9,2.7,126,Incidence,5630803,Non-Hispanic White,2.2,Female,Hodgkin Lymphoma,2018
40-44,~,~,~,Incidence,5630803,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
40-44,8.8,10.5,542,Incidence,5630803,Non-Hispanic White,9.6,Female,Kidney and Renal Pelvis,2018
40-44,0.3,0.7,26,Incidence,5630803,Non-Hispanic White,0.5,Female,Larynx,2018
40-44,4.8,6.1,306,Incidence,5630803,Non-Hispanic White,5.4,Female,Leukemias,2018
40-44,1.2,1.8,82,Incidence,5630803,Non-Hispanic White,1.5,Female,Liver and Intrahepatic Bile Duct,2018
40-44,7.1,8.5,437,Incidence,5630803,Non-Hispanic White,7.8,Female,Lung and Bronchus,2018
40-44,27.9,30.8,1650,Incidence,5630803,Non-Hispanic White,29.3,Female,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,5630803,Non-Hispanic White,~,Female,Mesothelioma,2018
40-44,1.4,2.1,99,Incidence,5630803,Non-Hispanic White,1.8,Female,Myeloma,2018
40-44,7.4,8.9,458,Incidence,5630803,Non-Hispanic White,8.1,Female,Non-Hodgkin Lymphoma,2018
40-44,3.3,4.4,216,Incidence,5630803,Non-Hispanic White,3.8,Female,Oral Cavity and Pharynx,2018
40-44,7.8,9.4,484,Incidence,5630803,Non-Hispanic White,8.6,Female,Ovary,2018
40-44,2.5,3.4,163,Incidence,5630803,Non-Hispanic White,2.9,Female,Pancreas,2018
40-44,1.7,2.5,115,Incidence,5630803,Non-Hispanic White,2.0,Female,Stomach,2018
40-44,33.8,36.9,1990,Incidence,5630803,Non-Hispanic White,35.3,Female,Thyroid,2018
40-44,1.5,2.2,101,Incidence,5630803,Non-Hispanic White,1.8,Female,Urinary Bladder,2018
45-49,480.7,491.6,30735,Incidence,6322350,Non-Hispanic White,486.1,Female,All Cancer Sites Combined,2018
45-49,4.3,5.3,302,Incidence,6322350,Non-Hispanic White,4.8,Female,Brain and Other Nervous System,2018
45-49,12.7,14.5,858,Incidence,6322350,Non-Hispanic White,13.6,Female,Cervix,2018
45-49,31.3,34.1,2065,Incidence,6322350,Non-Hispanic White,32.7,Female,Colon and Rectum,2018
45-49,26.5,29.2,1759,Incidence,6322350,Non-Hispanic White,27.8,Female,"Corpus and Uterus, NOS",2018
45-49,0.7,1.2,59,Incidence,6322350,Non-Hispanic White,0.9,Female,Esophagus,2018
45-49,208.0,215.2,13378,Incidence,6322350,Non-Hispanic White,211.6,Female,Female Breast,2018
45-49,59.2,63.1,3863,Incidence,6322350,Non-Hispanic White,61.1,Female,"Female Breast, <i>in situ</i>",2018
45-49,1.6,2.3,122,Incidence,6322350,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2018
45-49,~,~,~,Incidence,6322350,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
45-49,12.9,14.8,873,Incidence,6322350,Non-Hispanic White,13.8,Female,Kidney and Renal Pelvis,2018
45-49,1.0,1.6,82,Incidence,6322350,Non-Hispanic White,1.3,Female,Larynx,2018
45-49,7.3,8.7,503,Incidence,6322350,Non-Hispanic White,8.0,Female,Leukemias,2018
45-49,1.6,2.3,119,Incidence,6322350,Non-Hispanic White,1.9,Female,Liver and Intrahepatic Bile Duct,2018
45-49,20.1,22.4,1342,Incidence,6322350,Non-Hispanic White,21.2,Female,Lung and Bronchus,2018
45-49,32.9,35.8,2171,Incidence,6322350,Non-Hispanic White,34.3,Female,Melanomas of the Skin,2018
45-49,0.2,0.5,20,Incidence,6322350,Non-Hispanic White,0.3,Female,Mesothelioma,2018
45-49,2.7,3.6,198,Incidence,6322350,Non-Hispanic White,3.1,Female,Myeloma,2018
45-49,11.5,13.2,779,Incidence,6322350,Non-Hispanic White,12.3,Female,Non-Hodgkin Lymphoma,2018
45-49,6.1,7.4,425,Incidence,6322350,Non-Hispanic White,6.7,Female,Oral Cavity and Pharynx,2018
45-49,12.1,13.9,819,Incidence,6322350,Non-Hispanic White,13.0,Female,Ovary,2018
45-49,5.0,6.1,349,Incidence,6322350,Non-Hispanic White,5.5,Female,Pancreas,2018
45-49,2.5,3.4,185,Incidence,6322350,Non-Hispanic White,2.9,Female,Stomach,2018
45-49,34.4,37.4,2270,Incidence,6322350,Non-Hispanic White,35.9,Female,Thyroid,2018
45-49,3.4,4.4,246,Incidence,6322350,Non-Hispanic White,3.9,Female,Urinary Bladder,2018
5-9,10.9,12.9,603,Incidence,5082371,Non-Hispanic White,11.9,Female,All Cancer Sites Combined,2018
5-9,3.2,4.2,186,Incidence,5082371,Non-Hispanic White,3.7,Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Cervix,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Esophagus,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Female Breast,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
5-9,0.5,1.0,36,Incidence,5082371,Non-Hispanic White,0.7,Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Larynx,2018
5-9,2.9,3.9,172,Incidence,5082371,Non-Hispanic White,3.4,Female,Leukemias,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Mesothelioma,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Myeloma,2018
5-9,0.3,0.7,22,Incidence,5082371,Non-Hispanic White,0.4,Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Ovary,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Pancreas,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Stomach,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Thyroid,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Female,Urinary Bladder,2018
50-54,644.3,656.4,44236,Incidence,6801821,Non-Hispanic White,650.4,Female,All Cancer Sites Combined,2018
50-54,5.5,6.7,412,Incidence,6801821,Non-Hispanic White,6.1,Female,Brain and Other Nervous System,2018
50-54,10.6,12.3,778,Incidence,6801821,Non-Hispanic White,11.4,Female,Cervix,2018
50-54,51.6,55.1,3628,Incidence,6801821,Non-Hispanic White,53.3,Female,Colon and Rectum,2018
50-54,48.3,51.7,3400,Incidence,6801821,Non-Hispanic White,50.0,Female,"Corpus and Uterus, NOS",2018
50-54,1.9,2.7,154,Incidence,6801821,Non-Hispanic White,2.3,Female,Esophagus,2018
50-54,242.6,250.0,16751,Incidence,6801821,Non-Hispanic White,246.3,Female,Female Breast,2018
50-54,66.0,69.9,4621,Incidence,6801821,Non-Hispanic White,67.9,Female,"Female Breast, <i>in situ</i>",2018
50-54,1.6,2.3,133,Incidence,6801821,Non-Hispanic White,2.0,Female,Hodgkin Lymphoma,2018
50-54,~,~,~,Incidence,6801821,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
50-54,16.9,18.9,1215,Incidence,6801821,Non-Hispanic White,17.9,Female,Kidney and Renal Pelvis,2018
50-54,2.4,3.3,192,Incidence,6801821,Non-Hispanic White,2.8,Female,Larynx,2018
50-54,9.9,11.5,726,Incidence,6801821,Non-Hispanic White,10.7,Female,Leukemias,2018
50-54,3.6,4.5,273,Incidence,6801821,Non-Hispanic White,4.0,Female,Liver and Intrahepatic Bile Duct,2018
50-54,49.8,53.2,3501,Incidence,6801821,Non-Hispanic White,51.5,Female,Lung and Bronchus,2018
50-54,38.6,41.6,2725,Incidence,6801821,Non-Hispanic White,40.1,Female,Melanomas of the Skin,2018
50-54,0.2,0.5,22,Incidence,6801821,Non-Hispanic White,0.3,Female,Mesothelioma,2018
50-54,4.6,5.7,349,Incidence,6801821,Non-Hispanic White,5.1,Female,Myeloma,2018
50-54,16.9,19.0,1220,Incidence,6801821,Non-Hispanic White,17.9,Female,Non-Hodgkin Lymphoma,2018
50-54,11.5,13.2,838,Incidence,6801821,Non-Hispanic White,12.3,Female,Oral Cavity and Pharynx,2018
50-54,16.7,18.7,1201,Incidence,6801821,Non-Hispanic White,17.7,Female,Ovary,2018
50-54,9.5,11.1,699,Incidence,6801821,Non-Hispanic White,10.3,Female,Pancreas,2018
50-54,3.6,4.6,275,Incidence,6801821,Non-Hispanic White,4.0,Female,Stomach,2018
50-54,32.1,34.8,2274,Incidence,6801821,Non-Hispanic White,33.4,Female,Thyroid,2018
50-54,7.3,8.7,544,Incidence,6801821,Non-Hispanic White,8.0,Female,Urinary Bladder,2018
55-59,840.3,853.3,65265,Incidence,7707609,Non-Hispanic White,846.8,Female,All Cancer Sites Combined,2018
55-59,8.7,10.1,723,Incidence,7707609,Non-Hispanic White,9.4,Female,Brain and Other Nervous System,2018
55-59,10.4,11.9,859,Incidence,7707609,Non-Hispanic White,11.1,Female,Cervix,2018
55-59,51.2,54.4,4067,Incidence,7707609,Non-Hispanic White,52.8,Female,Colon and Rectum,2018
55-59,77.5,81.4,6122,Incidence,7707609,Non-Hispanic White,79.4,Female,"Corpus and Uterus, NOS",2018
55-59,3.0,3.8,262,Incidence,7707609,Non-Hispanic White,3.4,Female,Esophagus,2018
55-59,278.5,286.0,21755,Incidence,7707609,Non-Hispanic White,282.3,Female,Female Breast,2018
55-59,64.9,68.5,5140,Incidence,7707609,Non-Hispanic White,66.7,Female,"Female Breast, <i>in situ</i>",2018
55-59,1.7,2.3,153,Incidence,7707609,Non-Hispanic White,2.0,Female,Hodgkin Lymphoma,2018
55-59,~,~,~,Incidence,7707609,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
55-59,22.6,24.8,1827,Incidence,7707609,Non-Hispanic White,23.7,Female,Kidney and Renal Pelvis,2018
55-59,4.2,5.1,357,Incidence,7707609,Non-Hispanic White,4.6,Female,Larynx,2018
55-59,15.3,17.1,1244,Incidence,7707609,Non-Hispanic White,16.1,Female,Leukemias,2018
55-59,7.0,8.3,590,Incidence,7707609,Non-Hispanic White,7.7,Female,Liver and Intrahepatic Bile Duct,2018
55-59,103.8,108.4,8179,Incidence,7707609,Non-Hispanic White,106.1,Female,Lung and Bronchus,2018
55-59,42.9,45.9,3418,Incidence,7707609,Non-Hispanic White,44.3,Female,Melanomas of the Skin,2018
55-59,0.3,0.6,36,Incidence,7707609,Non-Hispanic White,0.5,Female,Mesothelioma,2018
55-59,7.6,8.9,635,Incidence,7707609,Non-Hispanic White,8.2,Female,Myeloma,2018
55-59,25.9,28.2,2085,Incidence,7707609,Non-Hispanic White,27.1,Female,Non-Hodgkin Lymphoma,2018
55-59,16.5,18.3,1339,Incidence,7707609,Non-Hispanic White,17.4,Female,Oral Cavity and Pharynx,2018
55-59,20.4,22.5,1651,Incidence,7707609,Non-Hispanic White,21.4,Female,Ovary,2018
55-59,16.8,18.7,1370,Incidence,7707609,Non-Hispanic White,17.8,Female,Pancreas,2018
55-59,5.4,6.5,457,Incidence,7707609,Non-Hispanic White,5.9,Female,Stomach,2018
55-59,30.4,32.9,2436,Incidence,7707609,Non-Hispanic White,31.6,Female,Thyroid,2018
55-59,12.1,13.7,993,Incidence,7707609,Non-Hispanic White,12.9,Female,Urinary Bladder,2018
60-64,1074.9,1089.8,81512,Incidence,7531357,Non-Hispanic White,1082.3,Female,All Cancer Sites Combined,2018
60-64,10.3,11.9,835,Incidence,7531357,Non-Hispanic White,11.1,Female,Brain and Other Nervous System,2018
60-64,9.1,10.6,741,Incidence,7531357,Non-Hispanic White,9.8,Female,Cervix,2018
60-64,63.9,67.6,4952,Incidence,7531357,Non-Hispanic White,65.8,Female,Colon and Rectum,2018
60-64,100.1,104.6,7707,Incidence,7531357,Non-Hispanic White,102.3,Female,"Corpus and Uterus, NOS",2018
60-64,4.5,5.6,379,Incidence,7531357,Non-Hispanic White,5.0,Female,Esophagus,2018
60-64,343.4,351.9,26181,Incidence,7531357,Non-Hispanic White,347.6,Female,Female Breast,2018
60-64,77.4,81.4,5979,Incidence,7531357,Non-Hispanic White,79.4,Female,"Female Breast, <i>in situ</i>",2018
60-64,1.6,2.2,142,Incidence,7531357,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2018
60-64,~,~,~,Incidence,7531357,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
60-64,30.1,32.6,2358,Incidence,7531357,Non-Hispanic White,31.3,Female,Kidney and Renal Pelvis,2018
60-64,4.1,5.1,347,Incidence,7531357,Non-Hispanic White,4.6,Female,Larynx,2018
60-64,20.3,22.4,1610,Incidence,7531357,Non-Hispanic White,21.4,Female,Leukemias,2018
60-64,11.2,12.8,903,Incidence,7531357,Non-Hispanic White,12.0,Female,Liver and Intrahepatic Bile Duct,2018
60-64,153.4,159.0,11763,Incidence,7531357,Non-Hispanic White,156.2,Female,Lung and Bronchus,2018
60-64,49.5,52.8,3851,Incidence,7531357,Non-Hispanic White,51.1,Female,Melanomas of the Skin,2018
60-64,0.7,1.1,67,Incidence,7531357,Non-Hispanic White,0.9,Female,Mesothelioma,2018
60-64,11.1,12.6,890,Incidence,7531357,Non-Hispanic White,11.8,Female,Myeloma,2018
60-64,36.1,38.9,2823,Incidence,7531357,Non-Hispanic White,37.5,Female,Non-Hodgkin Lymphoma,2018
60-64,18.8,20.9,1494,Incidence,7531357,Non-Hispanic White,19.8,Female,Oral Cavity and Pharynx,2018
60-64,24.8,27.2,1957,Incidence,7531357,Non-Hispanic White,26.0,Female,Ovary,2018
60-64,25.9,28.3,2041,Incidence,7531357,Non-Hispanic White,27.1,Female,Pancreas,2018
60-64,7.3,8.6,598,Incidence,7531357,Non-Hispanic White,7.9,Female,Stomach,2018
60-64,27.7,30.2,2178,Incidence,7531357,Non-Hispanic White,28.9,Female,Thyroid,2018
60-64,19.5,21.6,1547,Incidence,7531357,Non-Hispanic White,20.5,Female,Urinary Bladder,2018
65-69,1403.8,1421.9,93782,Incidence,6637852,Non-Hispanic White,1412.8,Female,All Cancer Sites Combined,2018
65-69,13.6,15.5,965,Incidence,6637852,Non-Hispanic White,14.5,Female,Brain and Other Nervous System,2018
65-69,8.3,9.8,598,Incidence,6637852,Non-Hispanic White,9.0,Female,Cervix,2018
65-69,89.8,94.4,6112,Incidence,6637852,Non-Hispanic White,92.1,Female,Colon and Rectum,2018
65-69,114.4,119.6,7766,Incidence,6637852,Non-Hispanic White,117.0,Female,"Corpus and Uterus, NOS",2018
65-69,6.2,7.5,453,Incidence,6637852,Non-Hispanic White,6.8,Female,Esophagus,2018
65-69,437.6,447.7,29381,Incidence,6637852,Non-Hispanic White,442.6,Female,Female Breast,2018
65-69,93.6,98.3,6366,Incidence,6637852,Non-Hispanic White,95.9,Female,"Female Breast, <i>in situ</i>",2018
65-69,2.1,2.9,166,Incidence,6637852,Non-Hispanic White,2.5,Female,Hodgkin Lymphoma,2018
65-69,~,~,~,Incidence,6637852,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
65-69,39.8,42.9,2744,Incidence,6637852,Non-Hispanic White,41.3,Female,Kidney and Renal Pelvis,2018
65-69,4.4,5.5,329,Incidence,6637852,Non-Hispanic White,5.0,Female,Larynx,2018
65-69,31.0,33.8,2151,Incidence,6637852,Non-Hispanic White,32.4,Female,Leukemias,2018
65-69,15.4,17.3,1085,Incidence,6637852,Non-Hispanic White,16.3,Female,Liver and Intrahepatic Bile Duct,2018
65-69,217.4,224.6,14667,Incidence,6637852,Non-Hispanic White,221.0,Female,Lung and Bronchus,2018
65-69,57.3,61.0,3926,Incidence,6637852,Non-Hispanic White,59.1,Female,Melanomas of the Skin,2018
65-69,0.7,1.2,63,Incidence,6637852,Non-Hispanic White,0.9,Female,Mesothelioma,2018
65-69,17.3,19.3,1213,Incidence,6637852,Non-Hispanic White,18.3,Female,Myeloma,2018
65-69,53.4,56.9,3659,Incidence,6637852,Non-Hispanic White,55.1,Female,Non-Hodgkin Lymphoma,2018
65-69,22.7,25.0,1581,Incidence,6637852,Non-Hispanic White,23.8,Female,Oral Cavity and Pharynx,2018
65-69,28.5,31.2,1979,Incidence,6637852,Non-Hispanic White,29.8,Female,Ovary,2018
65-69,39.9,43.0,2752,Incidence,6637852,Non-Hispanic White,41.5,Female,Pancreas,2018
65-69,10.1,11.7,719,Incidence,6637852,Non-Hispanic White,10.8,Female,Stomach,2018
65-69,28.6,31.3,1986,Incidence,6637852,Non-Hispanic White,29.9,Female,Thyroid,2018
65-69,30.0,32.7,2081,Incidence,6637852,Non-Hispanic White,31.4,Female,Urinary Bladder,2018
70-74,1699.4,1721.4,93224,Incidence,5450588,Non-Hispanic White,1710.3,Female,All Cancer Sites Combined,2018
70-74,16.0,18.2,929,Incidence,5450588,Non-Hispanic White,17.0,Female,Brain and Other Nervous System,2018
70-74,8.0,9.6,479,Incidence,5450588,Non-Hispanic White,8.8,Female,Cervix,2018
70-74,114.5,120.2,6395,Incidence,5450588,Non-Hispanic White,117.3,Female,Colon and Rectum,2018
70-74,109.2,114.9,6105,Incidence,5450588,Non-Hispanic White,112.0,Female,"Corpus and Uterus, NOS",2018
70-74,8.0,9.6,479,Incidence,5450588,Non-Hispanic White,8.8,Female,Esophagus,2018
70-74,499.1,511.1,27529,Incidence,5450588,Non-Hispanic White,505.1,Female,Female Breast,2018
70-74,95.2,100.4,5330,Incidence,5450588,Non-Hispanic White,97.8,Female,"Female Breast, <i>in situ</i>",2018
70-74,2.8,3.8,178,Incidence,5450588,Non-Hispanic White,3.3,Female,Hodgkin Lymphoma,2018
70-74,~,~,~,Incidence,5450588,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
70-74,45.2,48.8,2560,Incidence,5450588,Non-Hispanic White,47.0,Female,Kidney and Renal Pelvis,2018
70-74,3.9,5.0,241,Incidence,5450588,Non-Hispanic White,4.4,Female,Larynx,2018
70-74,39.1,42.5,2224,Incidence,5450588,Non-Hispanic White,40.8,Female,Leukemias,2018
70-74,17.1,19.4,994,Incidence,5450588,Non-Hispanic White,18.2,Female,Liver and Intrahepatic Bile Duct,2018
70-74,311.0,320.5,17209,Incidence,5450588,Non-Hispanic White,315.7,Female,Lung and Bronchus,2018
70-74,62.2,66.5,3508,Incidence,5450588,Non-Hispanic White,64.4,Female,Melanomas of the Skin,2018
70-74,1.6,2.4,108,Incidence,5450588,Non-Hispanic White,2.0,Female,Mesothelioma,2018
70-74,21.2,23.8,1224,Incidence,5450588,Non-Hispanic White,22.5,Female,Myeloma,2018
70-74,67.8,72.2,3813,Incidence,5450588,Non-Hispanic White,70.0,Female,Non-Hodgkin Lymphoma,2018
70-74,24.9,27.6,1428,Incidence,5450588,Non-Hispanic White,26.2,Female,Oral Cavity and Pharynx,2018
70-74,34.1,37.3,1945,Incidence,5450588,Non-Hispanic White,35.7,Female,Ovary,2018
70-74,53.8,57.8,3041,Incidence,5450588,Non-Hispanic White,55.8,Female,Pancreas,2018
70-74,13.6,15.6,795,Incidence,5450588,Non-Hispanic White,14.6,Female,Stomach,2018
70-74,26.6,29.4,1526,Incidence,5450588,Non-Hispanic White,28.0,Female,Thyroid,2018
70-74,43.1,46.7,2445,Incidence,5450588,Non-Hispanic White,44.9,Female,Urinary Bladder,2018
75-79,1918.6,1946.1,75874,Incidence,3926577,Non-Hispanic White,1932.3,Female,All Cancer Sites Combined,2018
75-79,19.2,22.0,808,Incidence,3926577,Non-Hispanic White,20.6,Female,Brain and Other Nervous System,2018
75-79,7.2,9.0,316,Incidence,3926577,Non-Hispanic White,8.0,Female,Cervix,2018
75-79,153.3,161.2,6173,Incidence,3926577,Non-Hispanic White,157.2,Female,Colon and Rectum,2018
75-79,92.2,98.3,3739,Incidence,3926577,Non-Hispanic White,95.2,Female,"Corpus and Uterus, NOS",2018
75-79,10.1,12.2,436,Incidence,3926577,Non-Hispanic White,11.1,Female,Esophagus,2018
75-79,492.7,506.7,19620,Incidence,3926577,Non-Hispanic White,499.7,Female,Female Breast,2018
75-79,83.3,89.1,3384,Incidence,3926577,Non-Hispanic White,86.2,Female,"Female Breast, <i>in situ</i>",2018
75-79,2.6,3.8,125,Incidence,3926577,Non-Hispanic White,3.2,Female,Hodgkin Lymphoma,2018
75-79,~,~,~,Incidence,3926577,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
75-79,48.7,53.1,1997,Incidence,3926577,Non-Hispanic White,50.9,Female,Kidney and Renal Pelvis,2018
75-79,3.9,5.3,179,Incidence,3926577,Non-Hispanic White,4.6,Female,Larynx,2018
75-79,52.6,57.2,2155,Incidence,3926577,Non-Hispanic White,54.9,Female,Leukemias,2018
75-79,21.5,24.5,903,Incidence,3926577,Non-Hispanic White,23.0,Female,Liver and Intrahepatic Bile Duct,2018
75-79,374.9,387.1,14958,Incidence,3926577,Non-Hispanic White,380.9,Female,Lung and Bronchus,2018
75-79,66.1,71.3,2696,Incidence,3926577,Non-Hispanic White,68.7,Female,Melanomas of the Skin,2018
75-79,2.3,3.4,110,Incidence,3926577,Non-Hispanic White,2.8,Female,Mesothelioma,2018
75-79,28.5,32.0,1187,Incidence,3926577,Non-Hispanic White,30.2,Female,Myeloma,2018
75-79,86.7,92.7,3520,Incidence,3926577,Non-Hispanic White,89.6,Female,Non-Hodgkin Lymphoma,2018
75-79,28.4,31.8,1180,Incidence,3926577,Non-Hispanic White,30.1,Female,Oral Cavity and Pharynx,2018
75-79,36.9,40.8,1525,Incidence,3926577,Non-Hispanic White,38.8,Female,Ovary,2018
75-79,69.6,74.9,2835,Incidence,3926577,Non-Hispanic White,72.2,Female,Pancreas,2018
75-79,17.6,20.3,742,Incidence,3926577,Non-Hispanic White,18.9,Female,Stomach,2018
75-79,22.4,25.5,938,Incidence,3926577,Non-Hispanic White,23.9,Female,Thyroid,2018
75-79,58.4,63.3,2388,Incidence,3926577,Non-Hispanic White,60.8,Female,Urinary Bladder,2018
80-84,1969.2,2002.8,53978,Incidence,2718007,Non-Hispanic White,1985.9,Female,All Cancer Sites Combined,2018
80-84,17.8,21.2,529,Incidence,2718007,Non-Hispanic White,19.5,Female,Brain and Other Nervous System,2018
80-84,5.7,7.6,179,Incidence,2718007,Non-Hispanic White,6.6,Female,Cervix,2018
80-84,198.4,209.2,5537,Incidence,2718007,Non-Hispanic White,203.7,Female,Colon and Rectum,2018
80-84,75.7,82.4,2148,Incidence,2718007,Non-Hispanic White,79.0,Female,"Corpus and Uterus, NOS",2018
80-84,12.2,15.0,368,Incidence,2718007,Non-Hispanic White,13.5,Female,Esophagus,2018
80-84,435.8,451.7,12060,Incidence,2718007,Non-Hispanic White,443.7,Female,Female Breast,2018
80-84,51.4,57.0,1472,Incidence,2718007,Non-Hispanic White,54.2,Female,"Female Breast, <i>in situ</i>",2018
80-84,2.5,3.9,86,Incidence,2718007,Non-Hispanic White,3.2,Female,Hodgkin Lymphoma,2018
80-84,~,~,~,Incidence,2718007,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
80-84,46.1,51.3,1322,Incidence,2718007,Non-Hispanic White,48.6,Female,Kidney and Renal Pelvis,2018
80-84,2.9,4.4,98,Incidence,2718007,Non-Hispanic White,3.6,Female,Larynx,2018
80-84,62.3,68.5,1776,Incidence,2718007,Non-Hispanic White,65.3,Female,Leukemias,2018
80-84,22.5,26.2,660,Incidence,2718007,Non-Hispanic White,24.3,Female,Liver and Intrahepatic Bile Duct,2018
80-84,357.8,372.2,9918,Incidence,2718007,Non-Hispanic White,364.9,Female,Lung and Bronchus,2018
80-84,72.5,79.1,2058,Incidence,2718007,Non-Hispanic White,75.7,Female,Melanomas of the Skin,2018
80-84,3.1,4.6,104,Incidence,2718007,Non-Hispanic White,3.8,Female,Mesothelioma,2018
80-84,29.0,33.2,843,Incidence,2718007,Non-Hispanic White,31.0,Female,Myeloma,2018
80-84,93.4,100.9,2639,Incidence,2718007,Non-Hispanic White,97.1,Female,Non-Hodgkin Lymphoma,2018
80-84,30.8,35.2,896,Incidence,2718007,Non-Hispanic White,33.0,Female,Oral Cavity and Pharynx,2018
80-84,38.6,43.5,1114,Incidence,2718007,Non-Hispanic White,41.0,Female,Ovary,2018
80-84,81.8,88.8,2317,Incidence,2718007,Non-Hispanic White,85.2,Female,Pancreas,2018
80-84,18.4,21.8,544,Incidence,2718007,Non-Hispanic White,20.0,Female,Stomach,2018
80-84,15.6,18.7,465,Incidence,2718007,Non-Hispanic White,17.1,Female,Thyroid,2018
80-84,68.3,74.7,1941,Incidence,2718007,Non-Hispanic White,71.4,Female,Urinary Bladder,2018
85+,1730.8,1759.2,58253,Incidence,3338411,Non-Hispanic White,1744.9,Female,All Cancer Sites Combined,2018
85+,12.7,15.3,465,Incidence,3338411,Non-Hispanic White,13.9,Female,Brain and Other Nervous System,2018
85+,4.4,6.0,173,Incidence,3338411,Non-Hispanic White,5.2,Female,Cervix,2018
85+,223.3,233.6,7626,Incidence,3338411,Non-Hispanic White,228.4,Female,Colon and Rectum,2018
85+,48.1,52.9,1684,Incidence,3338411,Non-Hispanic White,50.4,Female,"Corpus and Uterus, NOS",2018
85+,11.3,13.7,416,Incidence,3338411,Non-Hispanic White,12.5,Female,Esophagus,2018
85+,326.9,339.3,11118,Incidence,3338411,Non-Hispanic White,333.0,Female,Female Breast,2018
85+,20.3,23.5,731,Incidence,3338411,Non-Hispanic White,21.9,Female,"Female Breast, <i>in situ</i>",2018
85+,1.8,2.8,75,Incidence,3338411,Non-Hispanic White,2.2,Female,Hodgkin Lymphoma,2018
85+,~,~,~,Incidence,3338411,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
85+,38.1,42.5,1344,Incidence,3338411,Non-Hispanic White,40.3,Female,Kidney and Renal Pelvis,2018
85+,2.0,3.1,85,Incidence,3338411,Non-Hispanic White,2.5,Female,Larynx,2018
85+,63.8,69.4,2221,Incidence,3338411,Non-Hispanic White,66.5,Female,Leukemias,2018
85+,20.1,23.3,723,Incidence,3338411,Non-Hispanic White,21.7,Female,Liver and Intrahepatic Bile Duct,2018
85+,245.3,256.1,8368,Incidence,3338411,Non-Hispanic White,250.7,Female,Lung and Bronchus,2018
85+,68.2,74.0,2372,Incidence,3338411,Non-Hispanic White,71.1,Female,Melanomas of the Skin,2018
85+,2.4,3.6,100,Incidence,3338411,Non-Hispanic White,3.0,Female,Mesothelioma,2018
85+,23.7,27.2,848,Incidence,3338411,Non-Hispanic White,25.4,Female,Myeloma,2018
85+,84.9,91.3,2939,Incidence,3338411,Non-Hispanic White,88.0,Female,Non-Hodgkin Lymphoma,2018
85+,31.5,35.4,1115,Incidence,3338411,Non-Hispanic White,33.4,Female,Oral Cavity and Pharynx,2018
85+,33.6,37.7,1190,Incidence,3338411,Non-Hispanic White,35.6,Female,Ovary,2018
85+,84.3,90.7,2919,Incidence,3338411,Non-Hispanic White,87.4,Female,Pancreas,2018
85+,20.0,23.2,721,Incidence,3338411,Non-Hispanic White,21.6,Female,Stomach,2018
85+,8.6,10.7,321,Incidence,3338411,Non-Hispanic White,9.6,Female,Thyroid,2018
85+,76.4,82.5,2652,Incidence,3338411,Non-Hispanic White,79.4,Female,Urinary Bladder,2018
<1,25.4,32.3,272,Incidence,948772,Non-Hispanic White,28.7,Female,All Cancer Sites Combined,2018
<1,2.2,4.6,31,Incidence,948772,Non-Hispanic White,3.3,Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Cervix,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Colon and Rectum,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Esophagus,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Female Breast,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Kaposi Sarcoma,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Larynx,2018
<1,3.4,6.2,44,Incidence,948772,Non-Hispanic White,4.6,Female,Leukemias,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Mesothelioma,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Myeloma,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Ovary,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Pancreas,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Stomach,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Thyroid,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Female,Urinary Bladder,2018
1-4,23.3,26.3,1039,Incidence,4198054,Non-Hispanic White,24.7,Male,All Cancer Sites Combined,2018
1-4,4.1,5.4,199,Incidence,4198054,Non-Hispanic White,4.7,Male,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Colon and Rectum,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Esophagus,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
1-4,1.4,2.3,77,Incidence,4198054,Non-Hispanic White,1.8,Male,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Larynx,2018
1-4,9.5,11.5,438,Incidence,4198054,Non-Hispanic White,10.4,Male,Leukemias,2018
1-4,0.6,1.1,34,Incidence,4198054,Non-Hispanic White,0.8,Male,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Lung and Bronchus,2018
1-4,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Mesothelioma,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Myeloma,2018
1-4,0.7,1.3,40,Incidence,4198054,Non-Hispanic White,1.0,Male,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Pancreas,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Prostate,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Stomach,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Testis,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Thyroid,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male,Urinary Bladder,2018
10-14,15.8,17.9,948,Incidence,5633173,Non-Hispanic White,16.8,Male,All Cancer Sites Combined,2018
10-14,3.2,4.2,208,Incidence,5633173,Non-Hispanic White,3.7,Male,Brain and Other Nervous System,2018
10-14,0.4,0.9,35,Incidence,5633173,Non-Hispanic White,0.6,Male,Colon and Rectum,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Esophagus,2018
10-14,1.3,1.9,88,Incidence,5633173,Non-Hispanic White,1.6,Male,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Larynx,2018
10-14,2.4,3.2,156,Incidence,5633173,Non-Hispanic White,2.8,Male,Leukemias,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Lung and Bronchus,2018
10-14,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
10-14,0.2,0.5,20,Incidence,5633173,Non-Hispanic White,0.4,Male,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Mesothelioma,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Myeloma,2018
10-14,1.5,2.3,106,Incidence,5633173,Non-Hispanic White,1.9,Male,Non-Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Pancreas,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Prostate,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Stomach,2018
10-14,0.3,0.7,25,Incidence,5633173,Non-Hispanic White,0.4,Male,Testis,2018
10-14,0.2,0.6,21,Incidence,5633173,Non-Hispanic White,0.4,Male,Thyroid,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male,Urinary Bladder,2018
15-19,24.7,27.3,1526,Incidence,5874991,Non-Hispanic White,26.0,Male,All Cancer Sites Combined,2018
15-19,2.6,3.5,180,Incidence,5874991,Non-Hispanic White,3.1,Male,Brain and Other Nervous System,2018
15-19,1.4,2.1,99,Incidence,5874991,Non-Hispanic White,1.7,Male,Colon and Rectum,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Esophagus,2018
15-19,3.1,4.1,209,Incidence,5874991,Non-Hispanic White,3.6,Male,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Larynx,2018
15-19,3.1,4.1,208,Incidence,5874991,Non-Hispanic White,3.5,Male,Leukemias,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Lung and Bronchus,2018
15-19,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
15-19,0.7,1.2,54,Incidence,5874991,Non-Hispanic White,0.9,Male,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Mesothelioma,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Myeloma,2018
15-19,2.0,2.8,138,Incidence,5874991,Non-Hispanic White,2.3,Male,Non-Hodgkin Lymphoma,2018
15-19,0.3,0.7,27,Incidence,5874991,Non-Hispanic White,0.5,Male,Oral Cavity and Pharynx,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Pancreas,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Prostate,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Stomach,2018
15-19,2.8,3.7,190,Incidence,5874991,Non-Hispanic White,3.2,Male,Testis,2018
15-19,1.4,2.1,103,Incidence,5874991,Non-Hispanic White,1.8,Male,Thyroid,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male,Urinary Bladder,2018
20-24,38.3,41.4,2451,Incidence,6154252,Non-Hispanic White,39.8,Male,All Cancer Sites Combined,2018
20-24,2.3,3.2,169,Incidence,6154252,Non-Hispanic White,2.7,Male,Brain and Other Nervous System,2018
20-24,1.9,2.7,139,Incidence,6154252,Non-Hispanic White,2.3,Male,Colon and Rectum,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Esophagus,2018
20-24,4.5,5.6,310,Incidence,6154252,Non-Hispanic White,5.0,Male,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
20-24,0.4,0.7,32,Incidence,6154252,Non-Hispanic White,0.5,Male,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Larynx,2018
20-24,2.1,2.9,150,Incidence,6154252,Non-Hispanic White,2.4,Male,Leukemias,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2018
20-24,0.2,0.5,22,Incidence,6154252,Non-Hispanic White,0.4,Male,Lung and Bronchus,2018
20-24,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
20-24,1.9,2.7,141,Incidence,6154252,Non-Hispanic White,2.3,Male,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Mesothelioma,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Myeloma,2018
20-24,2.4,3.2,172,Incidence,6154252,Non-Hispanic White,2.8,Male,Non-Hodgkin Lymphoma,2018
20-24,0.5,0.9,42,Incidence,6154252,Non-Hispanic White,0.7,Male,Oral Cavity and Pharynx,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Pancreas,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Prostate,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male,Stomach,2018
20-24,11.3,13.1,749,Incidence,6154252,Non-Hispanic White,12.2,Male,Testis,2018
20-24,2.2,3.1,162,Incidence,6154252,Non-Hispanic White,2.6,Male,Thyroid,2018
20-24,0.2,0.6,23,Incidence,6154252,Non-Hispanic White,0.4,Male,Urinary Bladder,2018
25-29,53.7,57.3,3683,Incidence,6643940,Non-Hispanic White,55.4,Male,All Cancer Sites Combined,2018
25-29,3.7,4.6,274,Incidence,6643940,Non-Hispanic White,4.1,Male,Brain and Other Nervous System,2018
25-29,3.0,3.9,227,Incidence,6643940,Non-Hispanic White,3.4,Male,Colon and Rectum,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Esophagus,2018
25-29,4.0,5.0,296,Incidence,6643940,Non-Hispanic White,4.5,Male,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
25-29,1.3,2.0,108,Incidence,6643940,Non-Hispanic White,1.6,Male,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Larynx,2018
25-29,2.6,3.4,198,Incidence,6643940,Non-Hispanic White,3.0,Male,Leukemias,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2018
25-29,0.5,0.9,46,Incidence,6643940,Non-Hispanic White,0.7,Male,Lung and Bronchus,2018
25-29,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
25-29,4.3,5.3,318,Incidence,6643940,Non-Hispanic White,4.8,Male,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Mesothelioma,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Myeloma,2018
25-29,3.3,4.3,251,Incidence,6643940,Non-Hispanic White,3.8,Male,Non-Hodgkin Lymphoma,2018
25-29,0.9,1.4,73,Incidence,6643940,Non-Hispanic White,1.1,Male,Oral Cavity and Pharynx,2018
25-29,0.2,0.4,19,Incidence,6643940,Non-Hispanic White,0.3,Male,Pancreas,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male,Prostate,2018
25-29,0.2,0.6,25,Incidence,6643940,Non-Hispanic White,0.4,Male,Stomach,2018
25-29,15.4,17.4,1090,Incidence,6643940,Non-Hispanic White,16.4,Male,Testis,2018
25-29,4.1,5.2,306,Incidence,6643940,Non-Hispanic White,4.6,Male,Thyroid,2018
25-29,0.4,0.8,39,Incidence,6643940,Non-Hispanic White,0.6,Male,Urinary Bladder,2018
30-34,76.7,81.1,5011,Incidence,6351171,Non-Hispanic White,78.9,Male,All Cancer Sites Combined,2018
30-34,4.5,5.7,323,Incidence,6351171,Non-Hispanic White,5.1,Male,Brain and Other Nervous System,2018
30-34,6.7,8.1,469,Incidence,6351171,Non-Hispanic White,7.4,Male,Colon and Rectum,2018
30-34,0.3,0.6,26,Incidence,6351171,Non-Hispanic White,0.4,Male,Esophagus,2018
30-34,3.6,4.6,261,Incidence,6351171,Non-Hispanic White,4.1,Male,Hodgkin Lymphoma,2018
30-34,0.2,0.5,21,Incidence,6351171,Non-Hispanic White,0.3,Male,Kaposi Sarcoma,2018
30-34,3.7,4.7,263,Incidence,6351171,Non-Hispanic White,4.1,Male,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,6351171,Non-Hispanic White,~,Male,Larynx,2018
30-34,2.9,3.8,212,Incidence,6351171,Non-Hispanic White,3.3,Male,Leukemias,2018
30-34,0.4,0.8,38,Incidence,6351171,Non-Hispanic White,0.6,Male,Liver and Intrahepatic Bile Duct,2018
30-34,0.7,1.2,60,Incidence,6351171,Non-Hispanic White,0.9,Male,Lung and Bronchus,2018
30-34,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
30-34,8.4,10.0,583,Incidence,6351171,Non-Hispanic White,9.2,Male,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,6351171,Non-Hispanic White,~,Male,Mesothelioma,2018
30-34,~,~,~,Incidence,6351171,Non-Hispanic White,~,Male,Myeloma,2018
30-34,4.9,6.1,347,Incidence,6351171,Non-Hispanic White,5.5,Male,Non-Hodgkin Lymphoma,2018
30-34,1.8,2.5,133,Incidence,6351171,Non-Hispanic White,2.1,Male,Oral Cavity and Pharynx,2018
30-34,0.5,0.9,41,Incidence,6351171,Non-Hispanic White,0.6,Male,Pancreas,2018
30-34,~,~,~,Incidence,6351171,Non-Hispanic White,~,Male,Prostate,2018
30-34,0.5,0.9,45,Incidence,6351171,Non-Hispanic White,0.7,Male,Stomach,2018
30-34,18.0,20.1,1209,Incidence,6351171,Non-Hispanic White,19.0,Male,Testis,2018
30-34,6.1,7.4,426,Incidence,6351171,Non-Hispanic White,6.7,Male,Thyroid,2018
30-34,0.9,1.4,73,Incidence,6351171,Non-Hispanic White,1.1,Male,Urinary Bladder,2018
35-39,110.4,115.7,7013,Incidence,6202347,Non-Hispanic White,113.1,Male,All Cancer Sites Combined,2018
35-39,4.9,6.1,341,Incidence,6202347,Non-Hispanic White,5.5,Male,Brain and Other Nervous System,2018
35-39,12.2,14.0,811,Incidence,6202347,Non-Hispanic White,13.1,Male,Colon and Rectum,2018
35-39,0.9,1.4,69,Incidence,6202347,Non-Hispanic White,1.1,Male,Esophagus,2018
35-39,3.3,4.3,235,Incidence,6202347,Non-Hispanic White,3.8,Male,Hodgkin Lymphoma,2018
35-39,0.5,0.9,40,Incidence,6202347,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2018
35-39,7.5,8.9,507,Incidence,6202347,Non-Hispanic White,8.2,Male,Kidney and Renal Pelvis,2018
35-39,0.3,0.6,26,Incidence,6202347,Non-Hispanic White,0.4,Male,Larynx,2018
35-39,5.1,6.3,350,Incidence,6202347,Non-Hispanic White,5.6,Male,Leukemias,2018
35-39,0.7,1.1,54,Incidence,6202347,Non-Hispanic White,0.9,Male,Liver and Intrahepatic Bile Duct,2018
35-39,2.2,3.0,158,Incidence,6202347,Non-Hispanic White,2.5,Male,Lung and Bronchus,2018
35-39,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
35-39,13.9,15.9,923,Incidence,6202347,Non-Hispanic White,14.9,Male,Melanomas of the Skin,2018
35-39,~,~,~,Incidence,6202347,Non-Hispanic White,~,Male,Mesothelioma,2018
35-39,0.7,1.2,55,Incidence,6202347,Non-Hispanic White,0.9,Male,Myeloma,2018
35-39,7.3,8.7,495,Incidence,6202347,Non-Hispanic White,8.0,Male,Non-Hodgkin Lymphoma,2018
35-39,3.1,4.1,222,Incidence,6202347,Non-Hispanic White,3.6,Male,Oral Cavity and Pharynx,2018
35-39,1.5,2.2,116,Incidence,6202347,Non-Hispanic White,1.9,Male,Pancreas,2018
35-39,0.3,0.7,29,Incidence,6202347,Non-Hispanic White,0.5,Male,Prostate,2018
35-39,1.2,1.8,91,Incidence,6202347,Non-Hispanic White,1.5,Male,Stomach,2018
35-39,15.5,17.5,1022,Incidence,6202347,Non-Hispanic White,16.5,Male,Testis,2018
35-39,8.2,9.7,555,Incidence,6202347,Non-Hispanic White,8.9,Male,Thyroid,2018
35-39,2.4,3.2,171,Incidence,6202347,Non-Hispanic White,2.8,Male,Urinary Bladder,2018
40-44,167.1,173.9,9689,Incidence,5684676,Non-Hispanic White,170.4,Male,All Cancer Sites Combined,2018
40-44,5.5,6.8,348,Incidence,5684676,Non-Hispanic White,6.1,Male,Brain and Other Nervous System,2018
40-44,23.3,25.9,1399,Incidence,5684676,Non-Hispanic White,24.6,Male,Colon and Rectum,2018
40-44,2.0,2.8,133,Incidence,5684676,Non-Hispanic White,2.3,Male,Esophagus,2018
40-44,2.9,3.8,188,Incidence,5684676,Non-Hispanic White,3.3,Male,Hodgkin Lymphoma,2018
40-44,0.3,0.6,23,Incidence,5684676,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2018
40-44,15.4,17.5,934,Incidence,5684676,Non-Hispanic White,16.4,Male,Kidney and Renal Pelvis,2018
40-44,1.1,1.8,81,Incidence,5684676,Non-Hispanic White,1.4,Male,Larynx,2018
40-44,6.7,8.1,418,Incidence,5684676,Non-Hispanic White,7.4,Male,Leukemias,2018
40-44,1.3,2.0,94,Incidence,5684676,Non-Hispanic White,1.7,Male,Liver and Intrahepatic Bile Duct,2018
40-44,6.4,7.8,403,Incidence,5684676,Non-Hispanic White,7.1,Male,Lung and Bronchus,2018
40-44,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
40-44,20.9,23.3,1254,Incidence,5684676,Non-Hispanic White,22.1,Male,Melanomas of the Skin,2018
40-44,~,~,~,Incidence,5684676,Non-Hispanic White,~,Male,Mesothelioma,2018
40-44,2.1,2.9,139,Incidence,5684676,Non-Hispanic White,2.4,Male,Myeloma,2018
40-44,10.0,11.7,615,Incidence,5684676,Non-Hispanic White,10.8,Male,Non-Hodgkin Lymphoma,2018
40-44,8.1,9.6,501,Incidence,5684676,Non-Hispanic White,8.8,Male,Oral Cavity and Pharynx,2018
40-44,3.1,4.2,206,Incidence,5684676,Non-Hispanic White,3.6,Male,Pancreas,2018
40-44,4.9,6.2,313,Incidence,5684676,Non-Hispanic White,5.5,Male,Prostate,2018
40-44,2.4,3.3,160,Incidence,5684676,Non-Hispanic White,2.8,Male,Stomach,2018
40-44,11.0,12.8,676,Incidence,5684676,Non-Hispanic White,11.9,Male,Testis,2018
40-44,9.6,11.3,590,Incidence,5684676,Non-Hispanic White,10.4,Male,Thyroid,2018
40-44,4.4,5.6,281,Incidence,5684676,Non-Hispanic White,4.9,Male,Urinary Bladder,2018
45-49,279.6,287.9,17979,Incidence,6336807,Non-Hispanic White,283.7,Male,All Cancer Sites Combined,2018
45-49,7.8,9.3,541,Incidence,6336807,Non-Hispanic White,8.5,Male,Brain and Other Nervous System,2018
45-49,39.7,42.9,2618,Incidence,6336807,Non-Hispanic White,41.3,Male,Colon and Rectum,2018
45-49,3.9,5.0,281,Incidence,6336807,Non-Hispanic White,4.4,Male,Esophagus,2018
45-49,2.4,3.3,178,Incidence,6336807,Non-Hispanic White,2.8,Male,Hodgkin Lymphoma,2018
45-49,0.4,0.8,38,Incidence,6336807,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2018
45-49,23.1,25.5,1540,Incidence,6336807,Non-Hispanic White,24.3,Male,Kidney and Renal Pelvis,2018
45-49,3.0,3.9,215,Incidence,6336807,Non-Hispanic White,3.4,Male,Larynx,2018
45-49,10.3,11.9,702,Incidence,6336807,Non-Hispanic White,11.1,Male,Leukemias,2018
45-49,3.1,4.1,227,Incidence,6336807,Non-Hispanic White,3.6,Male,Liver and Intrahepatic Bile Duct,2018
45-49,16.6,18.6,1114,Incidence,6336807,Non-Hispanic White,17.6,Male,Lung and Bronchus,2018
45-49,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
45-49,28.2,30.9,1871,Incidence,6336807,Non-Hispanic White,29.5,Male,Melanomas of the Skin,2018
45-49,0.2,0.5,21,Incidence,6336807,Non-Hispanic White,0.3,Male,Mesothelioma,2018
45-49,3.3,4.3,240,Incidence,6336807,Non-Hispanic White,3.8,Male,Myeloma,2018
45-49,14.6,16.6,989,Incidence,6336807,Non-Hispanic White,15.6,Male,Non-Hodgkin Lymphoma,2018
45-49,19.5,21.7,1303,Incidence,6336807,Non-Hispanic White,20.6,Male,Oral Cavity and Pharynx,2018
45-49,6.3,7.6,441,Incidence,6336807,Non-Hispanic White,7.0,Male,Pancreas,2018
45-49,25.8,28.4,1714,Incidence,6336807,Non-Hispanic White,27.0,Male,Prostate,2018
45-49,4.3,5.5,309,Incidence,6336807,Non-Hispanic White,4.9,Male,Stomach,2018
45-49,7.0,8.3,483,Incidence,6336807,Non-Hispanic White,7.6,Male,Testis,2018
45-49,12.0,13.8,817,Incidence,6336807,Non-Hispanic White,12.9,Male,Thyroid,2018
45-49,9.6,11.2,660,Incidence,6336807,Non-Hispanic White,10.4,Male,Urinary Bladder,2018
5-9,13.8,15.8,789,Incidence,5340882,Non-Hispanic White,14.8,Male,All Cancer Sites Combined,2018
5-9,3.3,4.3,201,Incidence,5340882,Non-Hispanic White,3.8,Male,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Colon and Rectum,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Esophagus,2018
5-9,0.4,0.8,29,Incidence,5340882,Non-Hispanic White,0.5,Male,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
5-9,0.4,0.9,33,Incidence,5340882,Non-Hispanic White,0.6,Male,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Larynx,2018
5-9,3.9,5.1,239,Incidence,5340882,Non-Hispanic White,4.5,Male,Leukemias,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Lung and Bronchus,2018
5-9,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Mesothelioma,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Myeloma,2018
5-9,1.2,1.9,82,Incidence,5340882,Non-Hispanic White,1.5,Male,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Pancreas,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Prostate,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Stomach,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Testis,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Thyroid,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male,Urinary Bladder,2018
50-54,535.8,547.0,36338,Incidence,6712156,Non-Hispanic White,541.4,Male,All Cancer Sites Combined,2018
50-54,9.0,10.5,655,Incidence,6712156,Non-Hispanic White,9.8,Male,Brain and Other Nervous System,2018
50-54,71.3,75.4,4919,Incidence,6712156,Non-Hispanic White,73.3,Male,Colon and Rectum,2018
50-54,9.9,11.5,715,Incidence,6712156,Non-Hispanic White,10.7,Male,Esophagus,2018
50-54,2.6,3.4,201,Incidence,6712156,Non-Hispanic White,3.0,Male,Hodgkin Lymphoma,2018
50-54,0.4,0.8,41,Incidence,6712156,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2018
50-54,36.1,39.0,2518,Incidence,6712156,Non-Hispanic White,37.5,Male,Kidney and Renal Pelvis,2018
50-54,6.9,8.2,505,Incidence,6712156,Non-Hispanic White,7.5,Male,Larynx,2018
50-54,15.8,17.8,1126,Incidence,6712156,Non-Hispanic White,16.8,Male,Leukemias,2018
50-54,10.7,12.4,774,Incidence,6712156,Non-Hispanic White,11.5,Male,Liver and Intrahepatic Bile Duct,2018
50-54,44.7,48.0,3109,Incidence,6712156,Non-Hispanic White,46.3,Male,Lung and Bronchus,2018
50-54,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
50-54,40.5,43.6,2822,Incidence,6712156,Non-Hispanic White,42.0,Male,Melanomas of the Skin,2018
50-54,0.5,0.9,44,Incidence,6712156,Non-Hispanic White,0.7,Male,Mesothelioma,2018
50-54,7.3,8.7,536,Incidence,6712156,Non-Hispanic White,8.0,Male,Myeloma,2018
50-54,23.9,26.4,1687,Incidence,6712156,Non-Hispanic White,25.1,Male,Non-Hodgkin Lymphoma,2018
50-54,37.7,40.7,2628,Incidence,6712156,Non-Hispanic White,39.2,Male,Oral Cavity and Pharynx,2018
50-54,13.1,14.9,935,Incidence,6712156,Non-Hispanic White,13.9,Male,Pancreas,2018
50-54,105.3,110.3,7235,Incidence,6712156,Non-Hispanic White,107.8,Male,Prostate,2018
50-54,7.1,8.4,518,Incidence,6712156,Non-Hispanic White,7.7,Male,Stomach,2018
50-54,5.0,6.2,373,Incidence,6712156,Non-Hispanic White,5.6,Male,Testis,2018
50-54,11.8,13.5,848,Incidence,6712156,Non-Hispanic White,12.6,Male,Thyroid,2018
50-54,21.1,23.4,1492,Incidence,6712156,Non-Hispanic White,22.2,Male,Urinary Bladder,2018
55-59,899.2,912.9,67444,Incidence,7443728,Non-Hispanic White,906.1,Male,All Cancer Sites Combined,2018
55-59,12.3,14.0,978,Incidence,7443728,Non-Hispanic White,13.1,Male,Brain and Other Nervous System,2018
55-59,76.5,80.5,5842,Incidence,7443728,Non-Hispanic White,78.5,Male,Colon and Rectum,2018
55-59,17.0,18.9,1335,Incidence,7443728,Non-Hispanic White,17.9,Male,Esophagus,2018
55-59,2.6,3.4,224,Incidence,7443728,Non-Hispanic White,3.0,Male,Hodgkin Lymphoma,2018
55-59,0.4,0.7,40,Incidence,7443728,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2018
55-59,50.4,53.7,3876,Incidence,7443728,Non-Hispanic White,52.1,Male,Kidney and Renal Pelvis,2018
55-59,13.1,14.8,1035,Incidence,7443728,Non-Hispanic White,13.9,Male,Larynx,2018
55-59,25.0,27.4,1948,Incidence,7443728,Non-Hispanic White,26.2,Male,Leukemias,2018
55-59,27.2,29.6,2111,Incidence,7443728,Non-Hispanic White,28.4,Male,Liver and Intrahepatic Bile Duct,2018
55-59,104.5,109.2,7955,Incidence,7443728,Non-Hispanic White,106.9,Male,Lung and Bronchus,2018
55-59,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
55-59,58.5,62.0,4483,Incidence,7443728,Non-Hispanic White,60.2,Male,Melanomas of the Skin,2018
55-59,0.6,1.1,62,Incidence,7443728,Non-Hispanic White,0.8,Male,Mesothelioma,2018
55-59,11.2,12.8,895,Incidence,7443728,Non-Hispanic White,12.0,Male,Myeloma,2018
55-59,36.3,39.1,2808,Incidence,7443728,Non-Hispanic White,37.7,Male,Non-Hodgkin Lymphoma,2018
55-59,55.9,59.4,4288,Incidence,7443728,Non-Hispanic White,57.6,Male,Oral Cavity and Pharynx,2018
55-59,25.6,27.9,1991,Incidence,7443728,Non-Hispanic White,26.7,Male,Pancreas,2018
55-59,232.4,239.4,17557,Incidence,7443728,Non-Hispanic White,235.9,Male,Prostate,2018
55-59,11.6,13.2,921,Incidence,7443728,Non-Hispanic White,12.4,Male,Stomach,2018
55-59,3.7,4.7,312,Incidence,7443728,Non-Hispanic White,4.2,Male,Testis,2018
55-59,14.1,15.9,1117,Incidence,7443728,Non-Hispanic White,15.0,Male,Thyroid,2018
55-59,41.6,44.6,3206,Incidence,7443728,Non-Hispanic White,43.1,Male,Urinary Bladder,2018
60-64,1373.0,1390.4,98016,Incidence,7093989,Non-Hispanic White,1381.7,Male,All Cancer Sites Combined,2018
60-64,16.5,18.4,1237,Incidence,7093989,Non-Hispanic White,17.4,Male,Brain and Other Nervous System,2018
60-64,99.8,104.5,7243,Incidence,7093989,Non-Hispanic White,102.1,Male,Colon and Rectum,2018
60-64,26.5,29.0,1969,Incidence,7093989,Non-Hispanic White,27.8,Male,Esophagus,2018
60-64,2.7,3.6,221,Incidence,7093989,Non-Hispanic White,3.1,Male,Hodgkin Lymphoma,2018
60-64,0.3,0.6,29,Incidence,7093989,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2018
60-64,65.5,69.3,4780,Incidence,7093989,Non-Hispanic White,67.4,Male,Kidney and Renal Pelvis,2018
60-64,18.9,20.9,1410,Incidence,7093989,Non-Hispanic White,19.9,Male,Larynx,2018
60-64,36.9,39.8,2721,Incidence,7093989,Non-Hispanic White,38.4,Male,Leukemias,2018
60-64,46.4,49.6,3403,Incidence,7093989,Non-Hispanic White,48.0,Male,Liver and Intrahepatic Bile Duct,2018
60-64,176.0,182.3,12708,Incidence,7093989,Non-Hispanic White,179.1,Male,Lung and Bronchus,2018
60-64,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
60-64,81.0,85.3,5896,Incidence,7093989,Non-Hispanic White,83.1,Male,Melanomas of the Skin,2018
60-64,1.2,1.8,105,Incidence,7093989,Non-Hispanic White,1.5,Male,Mesothelioma,2018
60-64,18.2,20.2,1360,Incidence,7093989,Non-Hispanic White,19.2,Male,Myeloma,2018
60-64,50.8,54.2,3723,Incidence,7093989,Non-Hispanic White,52.5,Male,Non-Hodgkin Lymphoma,2018
60-64,69.0,73.0,5035,Incidence,7093989,Non-Hispanic White,71.0,Male,Oral Cavity and Pharynx,2018
60-64,39.8,42.8,2927,Incidence,7093989,Non-Hispanic White,41.3,Male,Pancreas,2018
60-64,403.7,413.1,28969,Incidence,7093989,Non-Hispanic White,408.4,Male,Prostate,2018
60-64,16.6,18.6,1249,Incidence,7093989,Non-Hispanic White,17.6,Male,Stomach,2018
60-64,2.2,2.9,179,Incidence,7093989,Non-Hispanic White,2.5,Male,Testis,2018
60-64,16.3,18.2,1223,Incidence,7093989,Non-Hispanic White,17.2,Male,Thyroid,2018
60-64,73.9,78.0,5387,Incidence,7093989,Non-Hispanic White,75.9,Male,Urinary Bladder,2018
65-69,1961.6,1984.0,119889,Incidence,6077157,Non-Hispanic White,1972.8,Male,All Cancer Sites Combined,2018
65-69,20.8,23.1,1333,Incidence,6077157,Non-Hispanic White,21.9,Male,Brain and Other Nervous System,2018
65-69,128.7,134.4,7993,Incidence,6077157,Non-Hispanic White,131.5,Male,Colon and Rectum,2018
65-69,36.1,39.2,2287,Incidence,6077157,Non-Hispanic White,37.6,Male,Esophagus,2018
65-69,3.0,4.0,211,Incidence,6077157,Non-Hispanic White,3.5,Male,Hodgkin Lymphoma,2018
65-69,0.4,0.8,36,Incidence,6077157,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2018
65-69,85.1,89.8,5315,Incidence,6077157,Non-Hispanic White,87.5,Male,Kidney and Renal Pelvis,2018
65-69,19.8,22.1,1270,Incidence,6077157,Non-Hispanic White,20.9,Male,Larynx,2018
65-69,54.1,57.8,3399,Incidence,6077157,Non-Hispanic White,55.9,Male,Leukemias,2018
65-69,54.2,58.0,3409,Incidence,6077157,Non-Hispanic White,56.1,Male,Liver and Intrahepatic Bile Duct,2018
65-69,258.9,267.0,15979,Incidence,6077157,Non-Hispanic White,262.9,Male,Lung and Bronchus,2018
65-69,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
65-69,113.7,119.1,7071,Incidence,6077157,Non-Hispanic White,116.4,Male,Melanomas of the Skin,2018
65-69,3.2,4.2,224,Incidence,6077157,Non-Hispanic White,3.7,Male,Mesothelioma,2018
65-69,27.0,29.7,1721,Incidence,6077157,Non-Hispanic White,28.3,Male,Myeloma,2018
65-69,73.8,78.2,4619,Incidence,6077157,Non-Hispanic White,76.0,Male,Non-Hodgkin Lymphoma,2018
65-69,77.5,82.0,4843,Incidence,6077157,Non-Hispanic White,79.7,Male,Oral Cavity and Pharynx,2018
65-69,57.2,61.1,3595,Incidence,6077157,Non-Hispanic White,59.2,Male,Pancreas,2018
65-69,628.0,640.7,38550,Incidence,6077157,Non-Hispanic White,634.3,Male,Prostate,2018
65-69,23.5,26.0,1502,Incidence,6077157,Non-Hispanic White,24.7,Male,Stomach,2018
65-69,1.4,2.0,102,Incidence,6077157,Non-Hispanic White,1.7,Male,Testis,2018
65-69,17.8,20.0,1148,Incidence,6077157,Non-Hispanic White,18.9,Male,Thyroid,2018
65-69,121.9,127.6,7579,Incidence,6077157,Non-Hispanic White,124.7,Male,Urinary Bladder,2018
70-74,2369.1,2396.6,115763,Incidence,4858194,Non-Hispanic White,2382.8,Male,All Cancer Sites Combined,2018
70-74,23.4,26.2,1203,Incidence,4858194,Non-Hispanic White,24.8,Male,Brain and Other Nervous System,2018
70-74,152.2,159.2,7564,Incidence,4858194,Non-Hispanic White,155.7,Male,Colon and Rectum,2018
70-74,43.6,47.4,2210,Incidence,4858194,Non-Hispanic White,45.5,Male,Esophagus,2018
70-74,3.7,4.9,208,Incidence,4858194,Non-Hispanic White,4.3,Male,Hodgkin Lymphoma,2018
70-74,0.3,0.7,22,Incidence,4858194,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2018
70-74,99.0,104.7,4948,Incidence,4858194,Non-Hispanic White,101.8,Male,Kidney and Renal Pelvis,2018
70-74,22.2,25.0,1145,Incidence,4858194,Non-Hispanic White,23.6,Male,Larynx,2018
70-74,74.2,79.2,3724,Incidence,4858194,Non-Hispanic White,76.7,Male,Leukemias,2018
70-74,48.2,52.2,2437,Incidence,4858194,Non-Hispanic White,50.2,Male,Liver and Intrahepatic Bile Duct,2018
70-74,358.0,368.7,17650,Incidence,4858194,Non-Hispanic White,363.3,Male,Lung and Bronchus,2018
70-74,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
70-74,150.0,157.0,7455,Incidence,4858194,Non-Hispanic White,153.5,Male,Melanomas of the Skin,2018
70-74,5.8,7.2,315,Incidence,4858194,Non-Hispanic White,6.5,Male,Mesothelioma,2018
70-74,37.4,40.9,1899,Incidence,4858194,Non-Hispanic White,39.1,Male,Myeloma,2018
70-74,98.0,103.7,4898,Incidence,4858194,Non-Hispanic White,100.8,Male,Non-Hodgkin Lymphoma,2018
70-74,77.7,82.8,3896,Incidence,4858194,Non-Hispanic White,80.2,Male,Oral Cavity and Pharynx,2018
70-74,76.9,81.9,3857,Incidence,4858194,Non-Hispanic White,79.4,Male,Pancreas,2018
70-74,653.2,667.7,32084,Incidence,4858194,Non-Hispanic White,660.4,Male,Prostate,2018
70-74,31.9,35.2,1628,Incidence,4858194,Non-Hispanic White,33.5,Male,Stomach,2018
70-74,1.1,1.8,70,Incidence,4858194,Non-Hispanic White,1.4,Male,Testis,2018
70-74,17.3,19.7,896,Incidence,4858194,Non-Hispanic White,18.4,Male,Thyroid,2018
70-74,183.9,191.6,9121,Incidence,4858194,Non-Hispanic White,187.7,Male,Urinary Bladder,2018
75-79,2717.3,2753.1,89674,Incidence,3278602,Non-Hispanic White,2735.1,Male,All Cancer Sites Combined,2018
75-79,25.8,29.4,903,Incidence,3278602,Non-Hispanic White,27.5,Male,Brain and Other Nervous System,2018
75-79,190.5,200.0,6400,Incidence,3278602,Non-Hispanic White,195.2,Male,Colon and Rectum,2018
75-79,48.1,53.0,1655,Incidence,3278602,Non-Hispanic White,50.5,Male,Esophagus,2018
75-79,4.2,5.7,161,Incidence,3278602,Non-Hispanic White,4.9,Male,Hodgkin Lymphoma,2018
75-79,0.4,1.1,23,Incidence,3278602,Non-Hispanic White,0.7,Male,Kaposi Sarcoma,2018
75-79,106.8,114.1,3620,Incidence,3278602,Non-Hispanic White,110.4,Male,Kidney and Renal Pelvis,2018
75-79,23.5,27.0,827,Incidence,3278602,Non-Hispanic White,25.2,Male,Larynx,2018
75-79,101.8,108.9,3453,Incidence,3278602,Non-Hispanic White,105.3,Male,Leukemias,2018
75-79,52.6,57.7,1808,Incidence,3278602,Non-Hispanic White,55.1,Male,Liver and Intrahepatic Bile Duct,2018
75-79,458.2,473.0,15263,Incidence,3278602,Non-Hispanic White,465.5,Male,Lung and Bronchus,2018
75-79,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
75-79,180.7,190.0,6075,Incidence,3278602,Non-Hispanic White,185.3,Male,Melanomas of the Skin,2018
75-79,10.7,13.1,388,Incidence,3278602,Non-Hispanic White,11.8,Male,Mesothelioma,2018
75-79,49.5,54.5,1703,Incidence,3278602,Non-Hispanic White,51.9,Male,Myeloma,2018
75-79,128.1,136.0,4328,Incidence,3278602,Non-Hispanic White,132.0,Male,Non-Hodgkin Lymphoma,2018
75-79,68.4,74.2,2335,Incidence,3278602,Non-Hispanic White,71.2,Male,Oral Cavity and Pharynx,2018
75-79,92.3,99.0,3135,Incidence,3278602,Non-Hispanic White,95.6,Male,Pancreas,2018
75-79,579.3,595.9,19263,Incidence,3278602,Non-Hispanic White,587.5,Male,Prostate,2018
75-79,37.6,42.0,1304,Incidence,3278602,Non-Hispanic White,39.8,Male,Stomach,2018
75-79,0.6,1.3,31,Incidence,3278602,Non-Hispanic White,0.9,Male,Testis,2018
75-79,16.6,19.5,591,Incidence,3278602,Non-Hispanic White,18.0,Male,Thyroid,2018
75-79,259.1,270.3,8677,Incidence,3278602,Non-Hispanic White,264.7,Male,Urinary Bladder,2018
80-84,2887.3,2934.1,59592,Incidence,2047422,Non-Hispanic White,2910.6,Male,All Cancer Sites Combined,2018
80-84,27.4,32.2,608,Incidence,2047422,Non-Hispanic White,29.7,Male,Brain and Other Nervous System,2018
80-84,231.7,245.1,4880,Incidence,2047422,Non-Hispanic White,238.3,Male,Colon and Rectum,2018
80-84,47.4,53.6,1033,Incidence,2047422,Non-Hispanic White,50.5,Male,Esophagus,2018
80-84,4.5,6.5,111,Incidence,2047422,Non-Hispanic White,5.4,Male,Hodgkin Lymphoma,2018
80-84,0.5,1.3,17,Incidence,2047422,Non-Hispanic White,0.8,Male,Kaposi Sarcoma,2018
80-84,99.5,108.3,2126,Incidence,2047422,Non-Hispanic White,103.8,Male,Kidney and Renal Pelvis,2018
80-84,22.3,26.7,500,Incidence,2047422,Non-Hispanic White,24.4,Male,Larynx,2018
80-84,121.1,130.8,2577,Incidence,2047422,Non-Hispanic White,125.9,Male,Leukemias,2018
80-84,52.6,59.1,1142,Incidence,2047422,Non-Hispanic White,55.8,Male,Liver and Intrahepatic Bile Duct,2018
80-84,473.9,493.0,9897,Incidence,2047422,Non-Hispanic White,483.4,Male,Lung and Bronchus,2018
80-84,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
80-84,219.8,232.8,4632,Incidence,2047422,Non-Hispanic White,226.2,Male,Melanomas of the Skin,2018
80-84,15.3,18.9,348,Incidence,2047422,Non-Hispanic White,17.0,Male,Mesothelioma,2018
80-84,57.2,64.0,1239,Incidence,2047422,Non-Hispanic White,60.5,Male,Myeloma,2018
80-84,148.5,159.3,3150,Incidence,2047422,Non-Hispanic White,153.9,Male,Non-Hodgkin Lymphoma,2018
80-84,69.9,77.4,1507,Incidence,2047422,Non-Hispanic White,73.6,Male,Oral Cavity and Pharynx,2018
80-84,104.1,113.1,2222,Incidence,2047422,Non-Hispanic White,108.5,Male,Pancreas,2018
80-84,433.1,451.3,9052,Incidence,2047422,Non-Hispanic White,442.1,Male,Prostate,2018
80-84,44.6,50.6,973,Incidence,2047422,Non-Hispanic White,47.5,Male,Stomach,2018
80-84,~,~,~,Incidence,2047422,Non-Hispanic White,~,Male,Testis,2018
80-84,12.0,15.2,277,Incidence,2047422,Non-Hispanic White,13.5,Male,Thyroid,2018
80-84,321.1,336.9,6734,Incidence,2047422,Non-Hispanic White,328.9,Male,Urinary Bladder,2018
85+,2766.4,2814.2,52546,Incidence,1883228,Non-Hispanic White,2790.2,Male,All Cancer Sites Combined,2018
85+,22.0,26.5,455,Incidence,1883228,Non-Hispanic White,24.2,Male,Brain and Other Nervous System,2018
85+,257.7,272.4,4990,Incidence,1883228,Non-Hispanic White,265.0,Male,Colon and Rectum,2018
85+,40.9,46.9,825,Incidence,1883228,Non-Hispanic White,43.8,Male,Esophagus,2018
85+,2.8,4.5,67,Incidence,1883228,Non-Hispanic White,3.6,Male,Hodgkin Lymphoma,2018
85+,0.9,2.0,26,Incidence,1883228,Non-Hispanic White,1.4,Male,Kaposi Sarcoma,2018
85+,78.5,86.7,1554,Incidence,1883228,Non-Hispanic White,82.5,Male,Kidney and Renal Pelvis,2018
85+,19.4,23.6,404,Incidence,1883228,Non-Hispanic White,21.5,Male,Larynx,2018
85+,126.8,137.2,2485,Incidence,1883228,Non-Hispanic White,132.0,Male,Leukemias,2018
85+,41.8,47.9,843,Incidence,1883228,Non-Hispanic White,44.8,Male,Liver and Intrahepatic Bile Duct,2018
85+,401.0,419.3,7723,Incidence,1883228,Non-Hispanic White,410.1,Male,Lung and Bronchus,2018
85+,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
85+,227.0,240.9,4405,Incidence,1883228,Non-Hispanic White,233.9,Male,Melanomas of the Skin,2018
85+,14.9,18.7,315,Incidence,1883228,Non-Hispanic White,16.7,Male,Mesothelioma,2018
85+,48.4,55.0,972,Incidence,1883228,Non-Hispanic White,51.6,Male,Myeloma,2018
85+,142.6,153.6,2788,Incidence,1883228,Non-Hispanic White,148.0,Male,Non-Hodgkin Lymphoma,2018
85+,60.0,67.2,1196,Incidence,1883228,Non-Hispanic White,63.5,Male,Oral Cavity and Pharynx,2018
85+,99.6,108.8,1961,Incidence,1883228,Non-Hispanic White,104.1,Male,Pancreas,2018
85+,340.4,357.4,6569,Incidence,1883228,Non-Hispanic White,348.8,Male,Prostate,2018
85+,44.3,50.6,892,Incidence,1883228,Non-Hispanic White,47.4,Male,Stomach,2018
85+,0.7,1.7,21,Incidence,1883228,Non-Hispanic White,1.1,Male,Testis,2018
85+,9.2,12.2,200,Incidence,1883228,Non-Hispanic White,10.6,Male,Thyroid,2018
85+,359.4,376.8,6930,Incidence,1883228,Non-Hispanic White,368.0,Male,Urinary Bladder,2018
<1,27.4,34.4,307,Incidence,996803,Non-Hispanic White,30.8,Male,All Cancer Sites Combined,2018
<1,2.4,4.9,35,Incidence,996803,Non-Hispanic White,3.5,Male,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Colon and Rectum,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Esophagus,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Kaposi Sarcoma,2018
<1,1.1,2.9,18,Incidence,996803,Non-Hispanic White,1.8,Male,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Larynx,2018
<1,3.6,6.5,49,Incidence,996803,Non-Hispanic White,4.9,Male,Leukemias,2018
<1,1.1,3.0,19,Incidence,996803,Non-Hispanic White,1.9,Male,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Lung and Bronchus,2018
<1,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Melanomas of the Skin,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Mesothelioma,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Myeloma,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Pancreas,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Prostate,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Stomach,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Testis,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Thyroid,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male,Urinary Bladder,2018
1-4,22.4,24.5,1916,Incidence,8185747,Non-Hispanic White,23.4,Male and Female,All Cancer Sites Combined,2018
1-4,4.2,5.1,379,Incidence,8185747,Non-Hispanic White,4.6,Male and Female,Brain and Other Nervous System,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,Cervix,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Colon and Rectum,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Esophagus,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,Female Breast,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
1-4,1.7,2.3,159,Incidence,8185747,Non-Hispanic White,1.9,Male and Female,Kidney and Renal Pelvis,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Larynx,2018
1-4,9.1,10.4,798,Incidence,8185747,Non-Hispanic White,9.7,Male and Female,Leukemias,2018
1-4,0.5,0.9,56,Incidence,8185747,Non-Hispanic White,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,Male and Female Breast,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Myeloma,2018
1-4,0.5,0.9,57,Incidence,8185747,Non-Hispanic White,0.7,Male and Female,Non-Hodgkin Lymphoma,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2018
1-4,~,~,~,Incidence,3987693,Non-Hispanic White,~,Male and Female,Ovary,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Pancreas,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male and Female,Prostate,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Stomach,2018
1-4,~,~,~,Incidence,4198054,Non-Hispanic White,~,Male and Female,Testis,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Thyroid,2018
1-4,~,~,~,Incidence,8185747,Non-Hispanic White,~,Male and Female,Urinary Bladder,2018
10-14,15.8,17.3,1820,Incidence,10996251,Non-Hispanic White,16.6,Male and Female,All Cancer Sites Combined,2018
10-14,3.3,4.0,402,Incidence,10996251,Non-Hispanic White,3.7,Male and Female,Brain and Other Nervous System,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Male and Female,Cervix,2018
10-14,0.7,1.1,100,Incidence,10996251,Non-Hispanic White,0.9,Male and Female,Colon and Rectum,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Esophagus,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Male and Female,Female Breast,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2018
10-14,1.2,1.6,153,Incidence,10996251,Non-Hispanic White,1.4,Male and Female,Hodgkin Lymphoma,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
10-14,0.2,0.3,26,Incidence,10996251,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Larynx,2018
10-14,2.3,3.0,290,Incidence,10996251,Non-Hispanic White,2.6,Male and Female,Leukemias,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Male and Female,Male and Female Breast,2018
10-14,~,~,~,Incidence,5363078,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
10-14,0.3,0.5,44,Incidence,10996251,Non-Hispanic White,0.4,Male and Female,Melanomas of the Skin,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Myeloma,2018
10-14,1.3,1.7,163,Incidence,10996251,Non-Hispanic White,1.5,Male and Female,Non-Hodgkin Lymphoma,2018
10-14,0.2,0.3,26,Incidence,10996251,Non-Hispanic White,0.2,Male and Female,Oral Cavity and Pharynx,2018
10-14,0.4,0.8,32,Incidence,5363078,Non-Hispanic White,0.6,Male and Female,Ovary,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Pancreas,2018
10-14,~,~,~,Incidence,5633173,Non-Hispanic White,~,Male and Female,Prostate,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Stomach,2018
10-14,0.3,0.7,25,Incidence,5633173,Non-Hispanic White,0.4,Male and Female,Testis,2018
10-14,0.8,1.2,113,Incidence,10996251,Non-Hispanic White,1.0,Male and Female,Thyroid,2018
10-14,~,~,~,Incidence,10996251,Non-Hispanic White,~,Male and Female,Urinary Bladder,2018
15-19,25.8,27.7,3064,Incidence,11457521,Non-Hispanic White,26.7,Male and Female,All Cancer Sites Combined,2018
15-19,2.5,3.1,323,Incidence,11457521,Non-Hispanic White,2.8,Male and Female,Brain and Other Nervous System,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Male and Female,Cervix,2018
15-19,1.6,2.2,216,Incidence,11457521,Non-Hispanic White,1.9,Male and Female,Colon and Rectum,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2018
15-19,~,~,~,Incidence,11457521,Non-Hispanic White,~,Male and Female,Esophagus,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Male and Female,Female Breast,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2018
15-19,3.4,4.2,434,Incidence,11457521,Non-Hispanic White,3.8,Male and Female,Hodgkin Lymphoma,2018
15-19,~,~,~,Incidence,11457521,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
15-19,0.1,0.3,25,Incidence,11457521,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2018
15-19,~,~,~,Incidence,11457521,Non-Hispanic White,~,Male and Female,Larynx,2018
15-19,2.8,3.4,356,Incidence,11457521,Non-Hispanic White,3.1,Male and Female,Leukemias,2018
15-19,0.1,0.2,17,Incidence,11457521,Non-Hispanic White,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2018
15-19,0.1,0.2,17,Incidence,11457521,Non-Hispanic White,0.1,Male and Female,Lung and Bronchus,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Male and Female,Male and Female Breast,2018
15-19,~,~,~,Incidence,5582530,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
15-19,1.0,1.4,139,Incidence,11457521,Non-Hispanic White,1.2,Male and Female,Melanomas of the Skin,2018
15-19,~,~,~,Incidence,11457521,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
15-19,~,~,~,Incidence,11457521,Non-Hispanic White,~,Male and Female,Myeloma,2018
15-19,1.6,2.1,210,Incidence,11457521,Non-Hispanic White,1.8,Male and Female,Non-Hodgkin Lymphoma,2018
15-19,0.4,0.6,54,Incidence,11457521,Non-Hispanic White,0.5,Male and Female,Oral Cavity and Pharynx,2018
15-19,0.9,1.5,68,Incidence,5582530,Non-Hispanic White,1.2,Male and Female,Ovary,2018
15-19,0.1,0.3,23,Incidence,11457521,Non-Hispanic White,0.2,Male and Female,Pancreas,2018
15-19,~,~,~,Incidence,5874991,Non-Hispanic White,~,Male and Female,Prostate,2018
15-19,~,~,~,Incidence,11457521,Non-Hispanic White,~,Male and Female,Stomach,2018
15-19,2.8,3.7,190,Incidence,5874991,Non-Hispanic White,3.2,Male and Female,Testis,2018
15-19,4.0,4.7,497,Incidence,11457521,Non-Hispanic White,4.3,Male and Female,Thyroid,2018
15-19,0.1,0.2,17,Incidence,11457521,Non-Hispanic White,0.1,Male and Female,Urinary Bladder,2018
20-24,41.6,44.0,5130,Incidence,11995651,Non-Hispanic White,42.8,Male and Female,All Cancer Sites Combined,2018
20-24,2.2,2.8,296,Incidence,11995651,Non-Hispanic White,2.5,Male and Female,Brain and Other Nervous System,2018
20-24,0.4,0.8,31,Incidence,5841399,Non-Hispanic White,0.5,Male and Female,Cervix,2018
20-24,2.1,2.6,280,Incidence,11995651,Non-Hispanic White,2.3,Male and Female,Colon and Rectum,2018
20-24,0.3,0.7,27,Incidence,5841399,Non-Hispanic White,0.5,Male and Female,"Corpus and Uterus, NOS",2018
20-24,~,~,~,Incidence,11995651,Non-Hispanic White,~,Male and Female,Esophagus,2018
20-24,1.4,2.1,102,Incidence,5841399,Non-Hispanic White,1.7,Male and Female,Female Breast,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2018
20-24,4.7,5.5,615,Incidence,11995651,Non-Hispanic White,5.1,Male and Female,Hodgkin Lymphoma,2018
20-24,~,~,~,Incidence,11995651,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
20-24,0.4,0.7,68,Incidence,11995651,Non-Hispanic White,0.6,Male and Female,Kidney and Renal Pelvis,2018
20-24,~,~,~,Incidence,11995651,Non-Hispanic White,~,Male and Female,Larynx,2018
20-24,2.1,2.7,288,Incidence,11995651,Non-Hispanic White,2.4,Male and Female,Leukemias,2018
20-24,~,~,~,Incidence,11995651,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
20-24,0.2,0.4,36,Incidence,11995651,Non-Hispanic White,0.3,Male and Female,Lung and Bronchus,2018
20-24,1.4,2.1,102,Incidence,5841399,Non-Hispanic White,1.7,Male and Female,Male and Female Breast,2018
20-24,~,~,~,Incidence,5841399,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
20-24,3.7,4.5,490,Incidence,11995651,Non-Hispanic White,4.1,Male and Female,Melanomas of the Skin,2018
20-24,~,~,~,Incidence,11995651,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
20-24,~,~,~,Incidence,11995651,Non-Hispanic White,~,Male and Female,Myeloma,2018
20-24,2.2,2.8,295,Incidence,11995651,Non-Hispanic White,2.5,Male and Female,Non-Hodgkin Lymphoma,2018
20-24,0.5,0.8,78,Incidence,11995651,Non-Hispanic White,0.7,Male and Female,Oral Cavity and Pharynx,2018
20-24,1.5,2.2,108,Incidence,5841399,Non-Hispanic White,1.8,Male and Female,Ovary,2018
20-24,0.2,0.4,34,Incidence,11995651,Non-Hispanic White,0.3,Male and Female,Pancreas,2018
20-24,~,~,~,Incidence,6154252,Non-Hispanic White,~,Male and Female,Prostate,2018
20-24,0.1,0.3,23,Incidence,11995651,Non-Hispanic White,0.2,Male and Female,Stomach,2018
20-24,11.3,13.1,749,Incidence,6154252,Non-Hispanic White,12.2,Male and Female,Testis,2018
20-24,7.6,8.6,973,Incidence,11995651,Non-Hispanic White,8.1,Male and Female,Thyroid,2018
20-24,0.2,0.4,32,Incidence,11995651,Non-Hispanic White,0.3,Male and Female,Urinary Bladder,2018
25-29,65.0,67.8,8646,Incidence,13028406,Non-Hispanic White,66.4,Male and Female,All Cancer Sites Combined,2018
25-29,3.5,4.2,501,Incidence,13028406,Non-Hispanic White,3.8,Male and Female,Brain and Other Nervous System,2018
25-29,4.1,5.2,296,Incidence,6384466,Non-Hispanic White,4.6,Male and Female,Cervix,2018
25-29,3.3,3.9,466,Incidence,13028406,Non-Hispanic White,3.6,Male and Female,Colon and Rectum,2018
25-29,1.6,2.3,125,Incidence,6384466,Non-Hispanic White,2.0,Male and Female,"Corpus and Uterus, NOS",2018
25-29,0.1,0.2,17,Incidence,13028406,Non-Hispanic White,0.1,Male and Female,Esophagus,2018
25-29,9.8,11.4,674,Incidence,6384466,Non-Hispanic White,10.6,Male and Female,Female Breast,2018
25-29,0.5,0.9,44,Incidence,6384466,Non-Hispanic White,0.7,Male and Female,"Female Breast, <i>in situ</i>",2018
25-29,4.1,4.9,587,Incidence,13028406,Non-Hispanic White,4.5,Male and Female,Hodgkin Lymphoma,2018
25-29,~,~,~,Incidence,13028406,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
25-29,1.3,1.7,190,Incidence,13028406,Non-Hispanic White,1.5,Male and Female,Kidney and Renal Pelvis,2018
25-29,~,~,~,Incidence,13028406,Non-Hispanic White,~,Male and Female,Larynx,2018
25-29,2.5,3.1,365,Incidence,13028406,Non-Hispanic White,2.8,Male and Female,Leukemias,2018
25-29,0.1,0.3,28,Incidence,13028406,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2018
25-29,0.6,0.8,90,Incidence,13028406,Non-Hispanic White,0.7,Male and Female,Lung and Bronchus,2018
25-29,9.8,11.4,674,Incidence,6384466,Non-Hispanic White,10.6,Male and Female,Male and Female Breast,2018
25-29,0.5,0.9,44,Incidence,6384466,Non-Hispanic White,0.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
25-29,7.2,8.2,1004,Incidence,13028406,Non-Hispanic White,7.7,Male and Female,Melanomas of the Skin,2018
25-29,~,~,~,Incidence,13028406,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
25-29,~,~,~,Incidence,13028406,Non-Hispanic White,~,Male and Female,Myeloma,2018
25-29,2.9,3.6,423,Incidence,13028406,Non-Hispanic White,3.2,Male and Female,Non-Hodgkin Lymphoma,2018
25-29,0.8,1.2,126,Incidence,13028406,Non-Hispanic White,1.0,Male and Female,Oral Cavity and Pharynx,2018
25-29,2.2,3.0,165,Incidence,6384466,Non-Hispanic White,2.6,Male and Female,Ovary,2018
25-29,0.2,0.5,44,Incidence,13028406,Non-Hispanic White,0.3,Male and Female,Pancreas,2018
25-29,~,~,~,Incidence,6643940,Non-Hispanic White,~,Male and Female,Prostate,2018
25-29,0.3,0.5,48,Incidence,13028406,Non-Hispanic White,0.4,Male and Female,Stomach,2018
25-29,15.4,17.4,1090,Incidence,6643940,Non-Hispanic White,16.4,Male and Female,Testis,2018
25-29,11.5,12.7,1575,Incidence,13028406,Non-Hispanic White,12.1,Male and Female,Thyroid,2018
25-29,0.3,0.6,56,Incidence,13028406,Non-Hispanic White,0.4,Male and Female,Urinary Bladder,2018
30-34,107.3,111.0,13712,Incidence,12565398,Non-Hispanic White,109.1,Male and Female,All Cancer Sites Combined,2018
30-34,4.1,4.9,564,Incidence,12565398,Non-Hispanic White,4.5,Male and Female,Brain and Other Nervous System,2018
30-34,11.6,13.4,777,Incidence,6214227,Non-Hispanic White,12.5,Male and Female,Cervix,2018
30-34,6.6,7.5,884,Incidence,12565398,Non-Hispanic White,7.0,Male and Female,Colon and Rectum,2018
30-34,4.9,6.1,339,Incidence,6214227,Non-Hispanic White,5.5,Male and Female,"Corpus and Uterus, NOS",2018
30-34,0.2,0.3,30,Incidence,12565398,Non-Hispanic White,0.2,Male and Female,Esophagus,2018
30-34,31.0,33.9,2015,Incidence,6214227,Non-Hispanic White,32.4,Male and Female,Female Breast,2018
30-34,2.4,3.2,171,Incidence,6214227,Non-Hispanic White,2.8,Male and Female,"Female Breast, <i>in situ</i>",2018
30-34,3.6,4.3,495,Incidence,12565398,Non-Hispanic White,3.9,Male and Female,Hodgkin Lymphoma,2018
30-34,0.1,0.3,22,Incidence,12565398,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2018
30-34,3.3,3.9,452,Incidence,12565398,Non-Hispanic White,3.6,Male and Female,Kidney and Renal Pelvis,2018
30-34,~,~,~,Incidence,12565398,Non-Hispanic White,~,Male and Female,Larynx,2018
30-34,2.9,3.5,399,Incidence,12565398,Non-Hispanic White,3.2,Male and Female,Leukemias,2018
30-34,0.4,0.6,61,Incidence,12565398,Non-Hispanic White,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2018
30-34,0.9,1.2,131,Incidence,12565398,Non-Hispanic White,1.0,Male and Female,Lung and Bronchus,2018
30-34,31.0,33.9,2015,Incidence,6214227,Non-Hispanic White,32.4,Male and Female,Male and Female Breast,2018
30-34,2.4,3.2,171,Incidence,6214227,Non-Hispanic White,2.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
30-34,13.7,15.1,1810,Incidence,12565398,Non-Hispanic White,14.4,Male and Female,Melanomas of the Skin,2018
30-34,~,~,~,Incidence,12565398,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
30-34,0.2,0.4,34,Incidence,12565398,Non-Hispanic White,0.3,Male and Female,Myeloma,2018
30-34,4.2,5.0,579,Incidence,12565398,Non-Hispanic White,4.6,Male and Female,Non-Hodgkin Lymphoma,2018
30-34,1.6,2.1,231,Incidence,12565398,Non-Hispanic White,1.8,Male and Female,Oral Cavity and Pharynx,2018
30-34,2.9,3.9,210,Incidence,6214227,Non-Hispanic White,3.4,Male and Female,Ovary,2018
30-34,0.6,1.0,98,Incidence,12565398,Non-Hispanic White,0.8,Male and Female,Pancreas,2018
30-34,~,~,~,Incidence,6351171,Non-Hispanic White,~,Male and Female,Prostate,2018
30-34,0.6,1.0,100,Incidence,12565398,Non-Hispanic White,0.8,Male and Female,Stomach,2018
30-34,18.0,20.1,1209,Incidence,6351171,Non-Hispanic White,19.0,Male and Female,Testis,2018
30-34,16.4,17.8,2147,Incidence,12565398,Non-Hispanic White,17.1,Male and Female,Thyroid,2018
30-34,0.7,1.1,112,Incidence,12565398,Non-Hispanic White,0.9,Male and Female,Urinary Bladder,2018
35-39,158.7,163.2,19835,Incidence,12325150,Non-Hispanic White,160.9,Male and Female,All Cancer Sites Combined,2018
35-39,4.5,5.3,600,Incidence,12325150,Non-Hispanic White,4.9,Male and Female,Brain and Other Nervous System,2018
35-39,13.1,15.0,857,Incidence,6122803,Non-Hispanic White,14.0,Male and Female,Cervix,2018
35-39,11.7,12.9,1512,Incidence,12325150,Non-Hispanic White,12.3,Male and Female,Colon and Rectum,2018
35-39,8.9,10.4,589,Incidence,6122803,Non-Hispanic White,9.6,Male and Female,"Corpus and Uterus, NOS",2018
35-39,0.5,0.8,76,Incidence,12325150,Non-Hispanic White,0.6,Male and Female,Esophagus,2018
35-39,63.7,67.8,4023,Incidence,6122803,Non-Hispanic White,65.7,Male and Female,Female Breast,2018
35-39,8.8,10.4,586,Incidence,6122803,Non-Hispanic White,9.6,Male and Female,"Female Breast, <i>in situ</i>",2018
35-39,3.1,3.8,423,Incidence,12325150,Non-Hispanic White,3.4,Male and Female,Hodgkin Lymphoma,2018
35-39,0.2,0.5,41,Incidence,12325150,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2018
35-39,6.6,7.6,871,Incidence,12325150,Non-Hispanic White,7.1,Male and Female,Kidney and Renal Pelvis,2018
35-39,0.2,0.4,38,Incidence,12325150,Non-Hispanic White,0.3,Male and Female,Larynx,2018
35-39,4.4,5.2,590,Incidence,12325150,Non-Hispanic White,4.8,Male and Female,Leukemias,2018
35-39,0.6,0.9,95,Incidence,12325150,Non-Hispanic White,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
35-39,2.3,2.9,323,Incidence,12325150,Non-Hispanic White,2.6,Male and Female,Lung and Bronchus,2018
35-39,63.7,67.8,4023,Incidence,6122803,Non-Hispanic White,65.7,Male and Female,Male and Female Breast,2018
35-39,8.8,10.4,586,Incidence,6122803,Non-Hispanic White,9.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
35-39,19.0,20.6,2440,Incidence,12325150,Non-Hispanic White,19.8,Male and Female,Melanomas of the Skin,2018
35-39,0.1,0.2,16,Incidence,12325150,Non-Hispanic White,0.1,Male and Female,Mesothelioma,2018
35-39,0.6,0.9,92,Incidence,12325150,Non-Hispanic White,0.7,Male and Female,Myeloma,2018
35-39,6.2,7.1,818,Incidence,12325150,Non-Hispanic White,6.6,Male and Female,Non-Hodgkin Lymphoma,2018
35-39,2.7,3.3,373,Incidence,12325150,Non-Hispanic White,3.0,Male and Female,Oral Cavity and Pharynx,2018
35-39,4.7,5.8,321,Incidence,6122803,Non-Hispanic White,5.2,Male and Female,Ovary,2018
35-39,1.5,2.0,211,Incidence,12325150,Non-Hispanic White,1.7,Male and Female,Pancreas,2018
35-39,0.3,0.7,29,Incidence,6202347,Non-Hispanic White,0.5,Male and Female,Prostate,2018
35-39,1.2,1.6,173,Incidence,12325150,Non-Hispanic White,1.4,Male and Female,Stomach,2018
35-39,15.5,17.5,1022,Incidence,6202347,Non-Hispanic White,16.5,Male and Female,Testis,2018
35-39,19.4,21.0,2487,Incidence,12325150,Non-Hispanic White,20.2,Male and Female,Thyroid,2018
35-39,1.8,2.3,253,Incidence,12325150,Non-Hispanic White,2.1,Male and Female,Urinary Bladder,2018
40-44,249.8,255.7,28597,Incidence,11315479,Non-Hispanic White,252.7,Male and Female,All Cancer Sites Combined,2018
40-44,4.7,5.6,581,Incidence,11315479,Non-Hispanic White,5.1,Male and Female,Brain and Other Nervous System,2018
40-44,14.3,16.3,859,Incidence,5630803,Non-Hispanic White,15.3,Male and Female,Cervix,2018
40-44,21.3,23.0,2505,Incidence,11315479,Non-Hispanic White,22.1,Male and Female,Colon and Rectum,2018
40-44,15.4,17.5,923,Incidence,5630803,Non-Hispanic White,16.4,Male and Female,"Corpus and Uterus, NOS",2018
40-44,1.2,1.6,154,Incidence,11315479,Non-Hispanic White,1.4,Male and Female,Esophagus,2018
40-44,136.3,142.4,7845,Incidence,5630803,Non-Hispanic White,139.3,Male and Female,Female Breast,2018
40-44,39.9,43.3,2342,Incidence,5630803,Non-Hispanic White,41.6,Male and Female,"Female Breast, <i>in situ</i>",2018
40-44,2.5,3.1,314,Incidence,11315479,Non-Hispanic White,2.8,Male and Female,Hodgkin Lymphoma,2018
40-44,0.1,0.3,25,Incidence,11315479,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2018
40-44,12.4,13.7,1476,Incidence,11315479,Non-Hispanic White,13.0,Male and Female,Kidney and Renal Pelvis,2018
40-44,0.8,1.1,107,Incidence,11315479,Non-Hispanic White,0.9,Male and Female,Larynx,2018
40-44,5.9,6.9,724,Incidence,11315479,Non-Hispanic White,6.4,Male and Female,Leukemias,2018
40-44,1.3,1.8,176,Incidence,11315479,Non-Hispanic White,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
40-44,6.9,7.9,840,Incidence,11315479,Non-Hispanic White,7.4,Male and Female,Lung and Bronchus,2018
40-44,136.3,142.4,7845,Incidence,5630803,Non-Hispanic White,139.3,Male and Female,Male and Female Breast,2018
40-44,39.9,43.3,2342,Incidence,5630803,Non-Hispanic White,41.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
40-44,24.7,26.6,2904,Incidence,11315479,Non-Hispanic White,25.7,Male and Female,Melanomas of the Skin,2018
40-44,0.1,0.2,17,Incidence,11315479,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2018
40-44,1.8,2.4,238,Incidence,11315479,Non-Hispanic White,2.1,Male and Female,Myeloma,2018
40-44,8.9,10.1,1073,Incidence,11315479,Non-Hispanic White,9.5,Male and Female,Non-Hodgkin Lymphoma,2018
40-44,5.9,6.8,717,Incidence,11315479,Non-Hispanic White,6.3,Male and Female,Oral Cavity and Pharynx,2018
40-44,7.8,9.4,484,Incidence,5630803,Non-Hispanic White,8.6,Male and Female,Ovary,2018
40-44,2.9,3.6,369,Incidence,11315479,Non-Hispanic White,3.3,Male and Female,Pancreas,2018
40-44,4.9,6.2,313,Incidence,5684676,Non-Hispanic White,5.5,Male and Female,Prostate,2018
40-44,2.2,2.7,275,Incidence,11315479,Non-Hispanic White,2.4,Male and Female,Stomach,2018
40-44,11.0,12.8,676,Incidence,5684676,Non-Hispanic White,11.9,Male and Female,Testis,2018
40-44,21.9,23.7,2580,Incidence,11315479,Non-Hispanic White,22.8,Male and Female,Thyroid,2018
40-44,3.0,3.7,382,Incidence,11315479,Non-Hispanic White,3.4,Male and Female,Urinary Bladder,2018
45-49,381.4,388.2,48714,Incidence,12659157,Non-Hispanic White,384.8,Male and Female,All Cancer Sites Combined,2018
45-49,6.2,7.1,843,Incidence,12659157,Non-Hispanic White,6.7,Male and Female,Brain and Other Nervous System,2018
45-49,12.7,14.5,858,Incidence,6322350,Non-Hispanic White,13.6,Male and Female,Cervix,2018
45-49,35.9,38.1,4683,Incidence,12659157,Non-Hispanic White,37.0,Male and Female,Colon and Rectum,2018
45-49,26.5,29.2,1759,Incidence,6322350,Non-Hispanic White,27.8,Male and Female,"Corpus and Uterus, NOS",2018
45-49,2.4,3.0,340,Incidence,12659157,Non-Hispanic White,2.7,Male and Female,Esophagus,2018
45-49,208.0,215.2,13378,Incidence,6322350,Non-Hispanic White,211.6,Male and Female,Female Breast,2018
45-49,59.2,63.1,3863,Incidence,6322350,Non-Hispanic White,61.1,Male and Female,"Female Breast, <i>in situ</i>",2018
45-49,2.1,2.7,300,Incidence,12659157,Non-Hispanic White,2.4,Male and Female,Hodgkin Lymphoma,2018
45-49,0.2,0.4,38,Incidence,12659157,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2018
45-49,18.3,19.8,2413,Incidence,12659157,Non-Hispanic White,19.1,Male and Female,Kidney and Renal Pelvis,2018
45-49,2.1,2.6,297,Incidence,12659157,Non-Hispanic White,2.3,Male and Female,Larynx,2018
45-49,9.0,10.1,1205,Incidence,12659157,Non-Hispanic White,9.5,Male and Female,Leukemias,2018
45-49,2.5,3.0,346,Incidence,12659157,Non-Hispanic White,2.7,Male and Female,Liver and Intrahepatic Bile Duct,2018
45-49,18.6,20.2,2456,Incidence,12659157,Non-Hispanic White,19.4,Male and Female,Lung and Bronchus,2018
45-49,208.0,215.2,13378,Incidence,6322350,Non-Hispanic White,211.6,Male and Female,Male and Female Breast,2018
45-49,59.2,63.1,3863,Incidence,6322350,Non-Hispanic White,61.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
45-49,31.0,32.9,4042,Incidence,12659157,Non-Hispanic White,31.9,Male and Female,Melanomas of the Skin,2018
45-49,0.2,0.4,41,Incidence,12659157,Non-Hispanic White,0.3,Male and Female,Mesothelioma,2018
45-49,3.1,3.8,438,Incidence,12659157,Non-Hispanic White,3.5,Male and Female,Myeloma,2018
45-49,13.3,14.6,1768,Incidence,12659157,Non-Hispanic White,14.0,Male and Female,Non-Hodgkin Lymphoma,2018
45-49,13.0,14.3,1728,Incidence,12659157,Non-Hispanic White,13.7,Male and Female,Oral Cavity and Pharynx,2018
45-49,12.1,13.9,819,Incidence,6322350,Non-Hispanic White,13.0,Male and Female,Ovary,2018
45-49,5.8,6.7,790,Incidence,12659157,Non-Hispanic White,6.2,Male and Female,Pancreas,2018
45-49,25.8,28.4,1714,Incidence,6336807,Non-Hispanic White,27.0,Male and Female,Prostate,2018
45-49,3.6,4.3,494,Incidence,12659157,Non-Hispanic White,3.9,Male and Female,Stomach,2018
45-49,7.0,8.3,483,Incidence,6336807,Non-Hispanic White,7.6,Male and Female,Testis,2018
45-49,23.5,25.3,3087,Incidence,12659157,Non-Hispanic White,24.4,Male and Female,Thyroid,2018
45-49,6.7,7.6,906,Incidence,12659157,Non-Hispanic White,7.2,Male and Female,Urinary Bladder,2018
5-9,12.7,14.1,1392,Incidence,10423253,Non-Hispanic White,13.4,Male and Female,All Cancer Sites Combined,2018
5-9,3.4,4.1,387,Incidence,10423253,Non-Hispanic White,3.7,Male and Female,Brain and Other Nervous System,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,Cervix,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Colon and Rectum,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Esophagus,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,Female Breast,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2018
5-9,0.3,0.6,43,Incidence,10423253,Non-Hispanic White,0.4,Male and Female,Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
5-9,0.5,0.8,69,Incidence,10423253,Non-Hispanic White,0.7,Male and Female,Kidney and Renal Pelvis,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Larynx,2018
5-9,3.6,4.3,411,Incidence,10423253,Non-Hispanic White,3.9,Male and Female,Leukemias,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,Male and Female Breast,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Myeloma,2018
5-9,0.8,1.2,104,Incidence,10423253,Non-Hispanic White,1.0,Male and Female,Non-Hodgkin Lymphoma,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2018
5-9,~,~,~,Incidence,5082371,Non-Hispanic White,~,Male and Female,Ovary,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Pancreas,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male and Female,Prostate,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Stomach,2018
5-9,~,~,~,Incidence,5340882,Non-Hispanic White,~,Male and Female,Testis,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Thyroid,2018
5-9,~,~,~,Incidence,10423253,Non-Hispanic White,~,Male and Female,Urinary Bladder,2018
50-54,592.1,600.4,80574,Incidence,13513977,Non-Hispanic White,596.2,Male and Female,All Cancer Sites Combined,2018
50-54,7.4,8.4,1067,Incidence,13513977,Non-Hispanic White,7.9,Male and Female,Brain and Other Nervous System,2018
50-54,10.6,12.3,778,Incidence,6801821,Non-Hispanic White,11.4,Male and Female,Cervix,2018
50-54,61.9,64.6,8547,Incidence,13513977,Non-Hispanic White,63.2,Male and Female,Colon and Rectum,2018
50-54,48.3,51.7,3400,Incidence,6801821,Non-Hispanic White,50.0,Male and Female,"Corpus and Uterus, NOS",2018
50-54,6.0,6.9,869,Incidence,13513977,Non-Hispanic White,6.4,Male and Female,Esophagus,2018
50-54,242.6,250.0,16751,Incidence,6801821,Non-Hispanic White,246.3,Male and Female,Female Breast,2018
50-54,66.0,69.9,4621,Incidence,6801821,Non-Hispanic White,67.9,Male and Female,"Female Breast, <i>in situ</i>",2018
50-54,2.2,2.8,334,Incidence,13513977,Non-Hispanic White,2.5,Male and Female,Hodgkin Lymphoma,2018
50-54,0.2,0.4,44,Incidence,13513977,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2018
50-54,26.7,28.5,3733,Incidence,13513977,Non-Hispanic White,27.6,Male and Female,Kidney and Renal Pelvis,2018
50-54,4.8,5.6,697,Incidence,13513977,Non-Hispanic White,5.2,Male and Female,Larynx,2018
50-54,13.1,14.3,1852,Incidence,13513977,Non-Hispanic White,13.7,Male and Female,Leukemias,2018
50-54,7.3,8.2,1047,Incidence,13513977,Non-Hispanic White,7.7,Male and Female,Liver and Intrahepatic Bile Duct,2018
50-54,47.7,50.1,6610,Incidence,13513977,Non-Hispanic White,48.9,Male and Female,Lung and Bronchus,2018
50-54,242.6,250.0,16751,Incidence,6801821,Non-Hispanic White,246.3,Male and Female,Male and Female Breast,2018
50-54,66.0,69.9,4621,Incidence,6801821,Non-Hispanic White,67.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
50-54,40.0,42.1,5547,Incidence,13513977,Non-Hispanic White,41.0,Male and Female,Melanomas of the Skin,2018
50-54,0.4,0.6,66,Incidence,13513977,Non-Hispanic White,0.5,Male and Female,Mesothelioma,2018
50-54,6.1,7.0,885,Incidence,13513977,Non-Hispanic White,6.5,Male and Female,Myeloma,2018
50-54,20.7,22.3,2907,Incidence,13513977,Non-Hispanic White,21.5,Male and Female,Non-Hodgkin Lymphoma,2018
50-54,24.8,26.5,3466,Incidence,13513977,Non-Hispanic White,25.6,Male and Female,Oral Cavity and Pharynx,2018
50-54,16.7,18.7,1201,Incidence,6801821,Non-Hispanic White,17.7,Male and Female,Ovary,2018
50-54,11.5,12.7,1634,Incidence,13513977,Non-Hispanic White,12.1,Male and Female,Pancreas,2018
50-54,105.3,110.3,7235,Incidence,6712156,Non-Hispanic White,107.8,Male and Female,Prostate,2018
50-54,5.5,6.3,793,Incidence,13513977,Non-Hispanic White,5.9,Male and Female,Stomach,2018
50-54,5.0,6.2,373,Incidence,6712156,Non-Hispanic White,5.6,Male and Female,Testis,2018
50-54,22.3,23.9,3122,Incidence,13513977,Non-Hispanic White,23.1,Male and Female,Thyroid,2018
50-54,14.4,15.7,2036,Incidence,13513977,Non-Hispanic White,15.1,Male and Female,Urinary Bladder,2018
55-59,871.2,880.6,132709,Incidence,15151337,Non-Hispanic White,875.9,Male and Female,All Cancer Sites Combined,2018
55-59,10.7,11.8,1701,Incidence,15151337,Non-Hispanic White,11.2,Male and Female,Brain and Other Nervous System,2018
55-59,10.4,11.9,859,Incidence,7707609,Non-Hispanic White,11.1,Male and Female,Cervix,2018
55-59,64.1,66.7,9909,Incidence,15151337,Non-Hispanic White,65.4,Male and Female,Colon and Rectum,2018
55-59,77.5,81.4,6122,Incidence,7707609,Non-Hispanic White,79.4,Male and Female,"Corpus and Uterus, NOS",2018
55-59,10.0,11.1,1597,Incidence,15151337,Non-Hispanic White,10.5,Male and Female,Esophagus,2018
55-59,278.5,286.0,21755,Incidence,7707609,Non-Hispanic White,282.3,Male and Female,Female Breast,2018
55-59,64.9,68.5,5140,Incidence,7707609,Non-Hispanic White,66.7,Male and Female,"Female Breast, <i>in situ</i>",2018
55-59,2.2,2.8,377,Incidence,15151337,Non-Hispanic White,2.5,Male and Female,Hodgkin Lymphoma,2018
55-59,0.2,0.4,43,Incidence,15151337,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2018
55-59,36.7,38.6,5703,Incidence,15151337,Non-Hispanic White,37.6,Male and Female,Kidney and Renal Pelvis,2018
55-59,8.7,9.7,1392,Incidence,15151337,Non-Hispanic White,9.2,Male and Female,Larynx,2018
55-59,20.3,21.8,3192,Incidence,15151337,Non-Hispanic White,21.1,Male and Female,Leukemias,2018
55-59,17.2,18.5,2701,Incidence,15151337,Non-Hispanic White,17.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
55-59,104.8,108.1,16134,Incidence,15151337,Non-Hispanic White,106.5,Male and Female,Lung and Bronchus,2018
55-59,278.5,286.0,21755,Incidence,7707609,Non-Hispanic White,282.3,Male and Female,Male and Female Breast,2018
55-59,64.9,68.5,5140,Incidence,7707609,Non-Hispanic White,66.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
55-59,51.0,53.3,7901,Incidence,15151337,Non-Hispanic White,52.1,Male and Female,Melanomas of the Skin,2018
55-59,0.5,0.8,98,Incidence,15151337,Non-Hispanic White,0.6,Male and Female,Mesothelioma,2018
55-59,9.6,10.6,1530,Incidence,15151337,Non-Hispanic White,10.1,Male and Female,Myeloma,2018
55-59,31.4,33.2,4893,Incidence,15151337,Non-Hispanic White,32.3,Male and Female,Non-Hodgkin Lymphoma,2018
55-59,36.2,38.1,5627,Incidence,15151337,Non-Hispanic White,37.1,Male and Female,Oral Cavity and Pharynx,2018
55-59,20.4,22.5,1651,Incidence,7707609,Non-Hispanic White,21.4,Male and Female,Ovary,2018
55-59,21.4,22.9,3361,Incidence,15151337,Non-Hispanic White,22.2,Male and Female,Pancreas,2018
55-59,232.4,239.4,17557,Incidence,7443728,Non-Hispanic White,235.9,Male and Female,Prostate,2018
55-59,8.6,9.6,1378,Incidence,15151337,Non-Hispanic White,9.1,Male and Female,Stomach,2018
55-59,3.7,4.7,312,Incidence,7443728,Non-Hispanic White,4.2,Male and Female,Testis,2018
55-59,22.7,24.2,3553,Incidence,15151337,Non-Hispanic White,23.5,Male and Female,Thyroid,2018
55-59,26.9,28.6,4199,Incidence,15151337,Non-Hispanic White,27.7,Male and Female,Urinary Bladder,2018
60-64,1221.8,1233.2,179528,Incidence,14625346,Non-Hispanic White,1227.5,Male and Female,All Cancer Sites Combined,2018
60-64,13.6,14.8,2072,Incidence,14625346,Non-Hispanic White,14.2,Male and Female,Brain and Other Nervous System,2018
60-64,9.1,10.6,741,Incidence,7531357,Non-Hispanic White,9.8,Male and Female,Cervix,2018
60-64,81.9,84.9,12195,Incidence,14625346,Non-Hispanic White,83.4,Male and Female,Colon and Rectum,2018
60-64,100.1,104.6,7707,Incidence,7531357,Non-Hispanic White,102.3,Male and Female,"Corpus and Uterus, NOS",2018
60-64,15.4,16.7,2348,Incidence,14625346,Non-Hispanic White,16.1,Male and Female,Esophagus,2018
60-64,343.4,351.9,26181,Incidence,7531357,Non-Hispanic White,347.6,Male and Female,Female Breast,2018
60-64,77.4,81.4,5979,Incidence,7531357,Non-Hispanic White,79.4,Male and Female,"Female Breast, <i>in situ</i>",2018
60-64,2.2,2.8,363,Incidence,14625346,Non-Hispanic White,2.5,Male and Female,Hodgkin Lymphoma,2018
60-64,0.1,0.3,30,Incidence,14625346,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2018
60-64,47.7,50.0,7138,Incidence,14625346,Non-Hispanic White,48.8,Male and Female,Kidney and Renal Pelvis,2018
60-64,11.5,12.6,1757,Incidence,14625346,Non-Hispanic White,12.0,Male and Female,Larynx,2018
60-64,28.7,30.5,4331,Incidence,14625346,Non-Hispanic White,29.6,Male and Female,Leukemias,2018
60-64,28.6,30.3,4306,Incidence,14625346,Non-Hispanic White,29.4,Male and Female,Liver and Intrahepatic Bile Duct,2018
60-64,165.2,169.4,24471,Incidence,14625346,Non-Hispanic White,167.3,Male and Female,Lung and Bronchus,2018
60-64,343.4,351.9,26181,Incidence,7531357,Non-Hispanic White,347.6,Male and Female,Male and Female Breast,2018
60-64,77.4,81.4,5979,Incidence,7531357,Non-Hispanic White,79.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
60-64,65.3,68.0,9747,Incidence,14625346,Non-Hispanic White,66.6,Male and Female,Melanomas of the Skin,2018
60-64,1.0,1.4,172,Incidence,14625346,Non-Hispanic White,1.2,Male and Female,Mesothelioma,2018
60-64,14.8,16.0,2250,Incidence,14625346,Non-Hispanic White,15.4,Male and Female,Myeloma,2018
60-64,43.7,45.9,6546,Incidence,14625346,Non-Hispanic White,44.8,Male and Female,Non-Hodgkin Lymphoma,2018
60-64,43.6,45.7,6529,Incidence,14625346,Non-Hispanic White,44.6,Male and Female,Oral Cavity and Pharynx,2018
60-64,24.8,27.2,1957,Incidence,7531357,Non-Hispanic White,26.0,Male and Female,Ovary,2018
60-64,33.0,34.9,4968,Incidence,14625346,Non-Hispanic White,34.0,Male and Female,Pancreas,2018
60-64,403.7,413.1,28969,Incidence,7093989,Non-Hispanic White,408.4,Male and Female,Prostate,2018
60-64,12.1,13.2,1847,Incidence,14625346,Non-Hispanic White,12.6,Male and Female,Stomach,2018
60-64,2.2,2.9,179,Incidence,7093989,Non-Hispanic White,2.5,Male and Female,Testis,2018
60-64,22.5,24.0,3401,Incidence,14625346,Non-Hispanic White,23.3,Male and Female,Thyroid,2018
60-64,46.3,48.5,6934,Incidence,14625346,Non-Hispanic White,47.4,Male and Female,Urinary Bladder,2018
65-69,1673.3,1687.6,213671,Incidence,12715009,Non-Hispanic White,1680.5,Male and Female,All Cancer Sites Combined,2018
65-69,17.3,18.8,2298,Incidence,12715009,Non-Hispanic White,18.1,Male and Female,Brain and Other Nervous System,2018
65-69,8.3,9.8,598,Incidence,6637852,Non-Hispanic White,9.0,Male and Female,Cervix,2018
65-69,109.1,112.8,14105,Incidence,12715009,Non-Hispanic White,110.9,Male and Female,Colon and Rectum,2018
65-69,114.4,119.6,7766,Incidence,6637852,Non-Hispanic White,117.0,Male and Female,"Corpus and Uterus, NOS",2018
65-69,20.7,22.4,2740,Incidence,12715009,Non-Hispanic White,21.5,Male and Female,Esophagus,2018
65-69,437.6,447.7,29381,Incidence,6637852,Non-Hispanic White,442.6,Male and Female,Female Breast,2018
65-69,93.6,98.3,6366,Incidence,6637852,Non-Hispanic White,95.9,Male and Female,"Female Breast, <i>in situ</i>",2018
65-69,2.7,3.3,377,Incidence,12715009,Non-Hispanic White,3.0,Male and Female,Hodgkin Lymphoma,2018
65-69,0.2,0.4,39,Incidence,12715009,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2018
65-69,62.0,64.8,8059,Incidence,12715009,Non-Hispanic White,63.4,Male and Female,Kidney and Renal Pelvis,2018
65-69,12.0,13.2,1599,Incidence,12715009,Non-Hispanic White,12.6,Male and Female,Larynx,2018
65-69,42.5,44.8,5550,Incidence,12715009,Non-Hispanic White,43.6,Male and Female,Leukemias,2018
65-69,34.3,36.4,4494,Incidence,12715009,Non-Hispanic White,35.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
65-69,238.3,243.7,30646,Incidence,12715009,Non-Hispanic White,241.0,Male and Female,Lung and Bronchus,2018
65-69,437.6,447.7,29381,Incidence,6637852,Non-Hispanic White,442.6,Male and Female,Male and Female Breast,2018
65-69,93.6,98.3,6366,Incidence,6637852,Non-Hispanic White,95.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
65-69,84.9,88.1,10997,Incidence,12715009,Non-Hispanic White,86.5,Male and Female,Melanomas of the Skin,2018
65-69,2.0,2.5,287,Incidence,12715009,Non-Hispanic White,2.3,Male and Female,Mesothelioma,2018
65-69,22.2,23.9,2934,Incidence,12715009,Non-Hispanic White,23.1,Male and Female,Myeloma,2018
65-69,63.7,66.5,8278,Incidence,12715009,Non-Hispanic White,65.1,Male and Female,Non-Hodgkin Lymphoma,2018
65-69,49.3,51.8,6424,Incidence,12715009,Non-Hispanic White,50.5,Male and Female,Oral Cavity and Pharynx,2018
65-69,28.5,31.2,1979,Incidence,6637852,Non-Hispanic White,29.8,Male and Female,Ovary,2018
65-69,48.7,51.2,6347,Incidence,12715009,Non-Hispanic White,49.9,Male and Female,Pancreas,2018
65-69,628.0,640.7,38550,Incidence,6077157,Non-Hispanic White,634.3,Male and Female,Prostate,2018
65-69,16.7,18.2,2221,Incidence,12715009,Non-Hispanic White,17.5,Male and Female,Stomach,2018
65-69,1.4,2.0,102,Incidence,6077157,Non-Hispanic White,1.7,Male and Female,Testis,2018
65-69,23.8,25.5,3134,Incidence,12715009,Non-Hispanic White,24.6,Male and Female,Thyroid,2018
65-69,74.5,77.5,9660,Incidence,12715009,Non-Hispanic White,76.0,Male and Female,Urinary Bladder,2018
70-74,2018.6,2036.0,208987,Incidence,10308782,Non-Hispanic White,2027.3,Male and Female,All Cancer Sites Combined,2018
70-74,19.8,21.6,2132,Incidence,10308782,Non-Hispanic White,20.7,Male and Female,Brain and Other Nervous System,2018
70-74,8.0,9.6,479,Incidence,5450588,Non-Hispanic White,8.8,Male and Female,Cervix,2018
70-74,133.2,137.7,13959,Incidence,10308782,Non-Hispanic White,135.4,Male and Female,Colon and Rectum,2018
70-74,109.2,114.9,6105,Incidence,5450588,Non-Hispanic White,112.0,Male and Female,"Corpus and Uterus, NOS",2018
70-74,25.1,27.1,2689,Incidence,10308782,Non-Hispanic White,26.1,Male and Female,Esophagus,2018
70-74,499.1,511.1,27529,Incidence,5450588,Non-Hispanic White,505.1,Male and Female,Female Breast,2018
70-74,95.2,100.4,5330,Incidence,5450588,Non-Hispanic White,97.8,Male and Female,"Female Breast, <i>in situ</i>",2018
70-74,3.4,4.1,386,Incidence,10308782,Non-Hispanic White,3.7,Male and Female,Hodgkin Lymphoma,2018
70-74,0.2,0.4,28,Incidence,10308782,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2018
70-74,71.2,74.5,7508,Incidence,10308782,Non-Hispanic White,72.8,Male and Female,Kidney and Renal Pelvis,2018
70-74,12.7,14.2,1386,Incidence,10308782,Non-Hispanic White,13.4,Male and Female,Larynx,2018
70-74,56.2,59.2,5948,Incidence,10308782,Non-Hispanic White,57.7,Male and Female,Leukemias,2018
70-74,32.2,34.4,3431,Incidence,10308782,Non-Hispanic White,33.3,Male and Female,Liver and Intrahepatic Bile Duct,2018
70-74,334.6,341.7,34859,Incidence,10308782,Non-Hispanic White,338.1,Male and Female,Lung and Bronchus,2018
70-74,499.1,511.1,27529,Incidence,5450588,Non-Hispanic White,505.1,Male and Female,Male and Female Breast,2018
70-74,95.2,100.4,5330,Incidence,5450588,Non-Hispanic White,97.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
70-74,104.4,108.4,10963,Incidence,10308782,Non-Hispanic White,106.3,Male and Female,Melanomas of the Skin,2018
70-74,3.7,4.5,423,Incidence,10308782,Non-Hispanic White,4.1,Male and Female,Mesothelioma,2018
70-74,29.2,31.4,3123,Incidence,10308782,Non-Hispanic White,30.3,Male and Female,Myeloma,2018
70-74,82.7,86.3,8711,Incidence,10308782,Non-Hispanic White,84.5,Male and Female,Non-Hodgkin Lymphoma,2018
70-74,50.3,53.1,5324,Incidence,10308782,Non-Hispanic White,51.6,Male and Female,Oral Cavity and Pharynx,2018
70-74,34.1,37.3,1945,Incidence,5450588,Non-Hispanic White,35.7,Male and Female,Ovary,2018
70-74,65.3,68.5,6898,Incidence,10308782,Non-Hispanic White,66.9,Male and Female,Pancreas,2018
70-74,653.2,667.7,32084,Incidence,4858194,Non-Hispanic White,660.4,Male and Female,Prostate,2018
70-74,22.6,24.5,2423,Incidence,10308782,Non-Hispanic White,23.5,Male and Female,Stomach,2018
70-74,1.1,1.8,70,Incidence,4858194,Non-Hispanic White,1.4,Male and Female,Testis,2018
70-74,22.6,24.4,2422,Incidence,10308782,Non-Hispanic White,23.5,Male and Female,Thyroid,2018
70-74,110.2,114.3,11566,Incidence,10308782,Non-Hispanic White,112.2,Male and Female,Urinary Bladder,2018
75-79,2286.6,2308.7,165548,Incidence,7205179,Non-Hispanic White,2297.6,Male and Female,All Cancer Sites Combined,2018
75-79,22.6,24.9,1711,Incidence,7205179,Non-Hispanic White,23.7,Male and Female,Brain and Other Nervous System,2018
75-79,7.2,9.0,316,Incidence,3926577,Non-Hispanic White,8.0,Male and Female,Cervix,2018
75-79,171.5,177.6,12573,Incidence,7205179,Non-Hispanic White,174.5,Male and Female,Colon and Rectum,2018
75-79,92.2,98.3,3739,Incidence,3926577,Non-Hispanic White,95.2,Male and Female,"Corpus and Uterus, NOS",2018
75-79,27.8,30.3,2091,Incidence,7205179,Non-Hispanic White,29.0,Male and Female,Esophagus,2018
75-79,492.7,506.7,19620,Incidence,3926577,Non-Hispanic White,499.7,Male and Female,Female Breast,2018
75-79,83.3,89.1,3384,Incidence,3926577,Non-Hispanic White,86.2,Male and Female,"Female Breast, <i>in situ</i>",2018
75-79,3.5,4.5,286,Incidence,7205179,Non-Hispanic White,4.0,Male and Female,Hodgkin Lymphoma,2018
75-79,0.3,0.6,31,Incidence,7205179,Non-Hispanic White,0.4,Male and Female,Kaposi Sarcoma,2018
75-79,75.9,80.0,5617,Incidence,7205179,Non-Hispanic White,78.0,Male and Female,Kidney and Renal Pelvis,2018
75-79,13.1,14.9,1006,Incidence,7205179,Non-Hispanic White,14.0,Male and Female,Larynx,2018
75-79,75.8,79.9,5608,Incidence,7205179,Non-Hispanic White,77.8,Male and Female,Leukemias,2018
75-79,36.2,39.1,2711,Incidence,7205179,Non-Hispanic White,37.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
75-79,414.7,424.2,30221,Incidence,7205179,Non-Hispanic White,419.4,Male and Female,Lung and Bronchus,2018
75-79,492.7,506.7,19620,Incidence,3926577,Non-Hispanic White,499.7,Male and Female,Male and Female Breast,2018
75-79,83.3,89.1,3384,Incidence,3926577,Non-Hispanic White,86.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
75-79,119.2,124.3,8771,Incidence,7205179,Non-Hispanic White,121.7,Male and Female,Melanomas of the Skin,2018
75-79,6.3,7.5,498,Incidence,7205179,Non-Hispanic White,6.9,Male and Female,Mesothelioma,2018
75-79,38.7,41.6,2890,Incidence,7205179,Non-Hispanic White,40.1,Male and Female,Myeloma,2018
75-79,106.5,111.4,7848,Incidence,7205179,Non-Hispanic White,108.9,Male and Female,Non-Hodgkin Lymphoma,2018
75-79,47.2,50.4,3515,Incidence,7205179,Non-Hispanic White,48.8,Male and Female,Oral Cavity and Pharynx,2018
75-79,36.9,40.8,1525,Incidence,3926577,Non-Hispanic White,38.8,Male and Female,Ovary,2018
75-79,80.8,85.0,5970,Incidence,7205179,Non-Hispanic White,82.9,Male and Female,Pancreas,2018
75-79,579.3,595.9,19263,Incidence,3278602,Non-Hispanic White,587.5,Male and Female,Prostate,2018
75-79,27.2,29.7,2046,Incidence,7205179,Non-Hispanic White,28.4,Male and Female,Stomach,2018
75-79,0.6,1.3,31,Incidence,3278602,Non-Hispanic White,0.9,Male and Female,Testis,2018
75-79,20.2,22.3,1529,Incidence,7205179,Non-Hispanic White,21.2,Male and Female,Thyroid,2018
75-79,150.7,156.5,11065,Incidence,7205179,Non-Hispanic White,153.6,Male and Female,Urinary Bladder,2018
80-84,2369.4,2397.1,113570,Incidence,4765429,Non-Hispanic White,2383.2,Male and Female,All Cancer Sites Combined,2018
80-84,22.5,25.3,1137,Incidence,4765429,Non-Hispanic White,23.9,Male and Female,Brain and Other Nervous System,2018
80-84,5.7,7.6,179,Incidence,2718007,Non-Hispanic White,6.6,Male and Female,Cervix,2018
80-84,214.4,222.8,10417,Incidence,4765429,Non-Hispanic White,218.6,Male and Female,Colon and Rectum,2018
80-84,75.7,82.4,2148,Incidence,2718007,Non-Hispanic White,79.0,Male and Female,"Corpus and Uterus, NOS",2018
80-84,27.9,31.0,1401,Incidence,4765429,Non-Hispanic White,29.4,Male and Female,Esophagus,2018
80-84,435.8,451.7,12060,Incidence,2718007,Non-Hispanic White,443.7,Male and Female,Female Breast,2018
80-84,51.4,57.0,1472,Incidence,2718007,Non-Hispanic White,54.2,Male and Female,"Female Breast, <i>in situ</i>",2018
80-84,3.6,4.8,197,Incidence,4765429,Non-Hispanic White,4.1,Male and Female,Hodgkin Lymphoma,2018
80-84,0.3,0.8,25,Incidence,4765429,Non-Hispanic White,0.5,Male and Female,Kaposi Sarcoma,2018
80-84,70.0,74.8,3448,Incidence,4765429,Non-Hispanic White,72.4,Male and Female,Kidney and Renal Pelvis,2018
80-84,11.6,13.6,598,Incidence,4765429,Non-Hispanic White,12.5,Male and Female,Larynx,2018
80-84,88.7,94.1,4353,Incidence,4765429,Non-Hispanic White,91.3,Male and Female,Leukemias,2018
80-84,36.1,39.6,1802,Incidence,4765429,Non-Hispanic White,37.8,Male and Female,Liver and Intrahepatic Bile Duct,2018
80-84,410.0,421.6,19815,Incidence,4765429,Non-Hispanic White,415.8,Male and Female,Lung and Bronchus,2018
80-84,435.8,451.7,12060,Incidence,2718007,Non-Hispanic White,443.7,Male and Female,Male and Female Breast,2018
80-84,51.4,57.0,1472,Incidence,2718007,Non-Hispanic White,54.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
80-84,137.0,143.8,6690,Incidence,4765429,Non-Hispanic White,140.4,Male and Female,Melanomas of the Skin,2018
80-84,8.6,10.4,452,Incidence,4765429,Non-Hispanic White,9.5,Male and Female,Mesothelioma,2018
80-84,41.8,45.6,2082,Incidence,4765429,Non-Hispanic White,43.7,Male and Female,Myeloma,2018
80-84,118.4,124.6,5789,Incidence,4765429,Non-Hispanic White,121.5,Male and Female,Non-Hodgkin Lymphoma,2018
80-84,48.4,52.5,2403,Incidence,4765429,Non-Hispanic White,50.4,Male and Female,Oral Cavity and Pharynx,2018
80-84,38.6,43.5,1114,Incidence,2718007,Non-Hispanic White,41.0,Male and Female,Ovary,2018
80-84,92.5,98.1,4539,Incidence,4765429,Non-Hispanic White,95.2,Male and Female,Pancreas,2018
80-84,433.1,451.3,9052,Incidence,2047422,Non-Hispanic White,442.1,Male and Female,Prostate,2018
80-84,30.3,33.5,1517,Incidence,4765429,Non-Hispanic White,31.8,Male and Female,Stomach,2018
80-84,~,~,~,Incidence,2047422,Non-Hispanic White,~,Male and Female,Testis,2018
80-84,14.5,16.7,742,Incidence,4765429,Non-Hispanic White,15.6,Male and Female,Thyroid,2018
80-84,178.2,185.9,8675,Incidence,4765429,Non-Hispanic White,182.0,Male and Female,Urinary Bladder,2018
85+,2109.4,2134.5,110799,Incidence,5221639,Non-Hispanic White,2121.9,Male and Female,All Cancer Sites Combined,2018
85+,16.5,18.8,920,Incidence,5221639,Non-Hispanic White,17.6,Male and Female,Brain and Other Nervous System,2018
85+,4.4,6.0,173,Incidence,3338411,Non-Hispanic White,5.2,Male and Female,Cervix,2018
85+,237.4,245.9,12616,Incidence,5221639,Non-Hispanic White,241.6,Male and Female,Colon and Rectum,2018
85+,48.1,52.9,1684,Incidence,3338411,Non-Hispanic White,50.4,Male and Female,"Corpus and Uterus, NOS",2018
85+,22.5,25.1,1241,Incidence,5221639,Non-Hispanic White,23.8,Male and Female,Esophagus,2018
85+,326.9,339.3,11118,Incidence,3338411,Non-Hispanic White,333.0,Male and Female,Female Breast,2018
85+,20.3,23.5,731,Incidence,3338411,Non-Hispanic White,21.9,Male and Female,"Female Breast, <i>in situ</i>",2018
85+,2.3,3.2,142,Incidence,5221639,Non-Hispanic White,2.7,Male and Female,Hodgkin Lymphoma,2018
85+,0.6,1.1,41,Incidence,5221639,Non-Hispanic White,0.8,Male and Female,Kaposi Sarcoma,2018
85+,53.5,57.6,2898,Incidence,5221639,Non-Hispanic White,55.5,Male and Female,Kidney and Renal Pelvis,2018
85+,8.6,10.2,489,Incidence,5221639,Non-Hispanic White,9.4,Male and Female,Larynx,2018
85+,87.6,92.7,4706,Incidence,5221639,Non-Hispanic White,90.1,Male and Female,Leukemias,2018
85+,28.5,31.5,1566,Incidence,5221639,Non-Hispanic White,30.0,Male and Female,Liver and Intrahepatic Bile Duct,2018
85+,303.4,313.0,16091,Incidence,5221639,Non-Hispanic White,308.2,Male and Female,Lung and Bronchus,2018
85+,326.9,339.3,11118,Incidence,3338411,Non-Hispanic White,333.0,Male and Female,Male and Female Breast,2018
85+,20.3,23.5,731,Incidence,3338411,Non-Hispanic White,21.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
85+,126.7,132.9,6777,Incidence,5221639,Non-Hispanic White,129.8,Male and Female,Melanomas of the Skin,2018
85+,7.2,8.8,415,Incidence,5221639,Non-Hispanic White,7.9,Male and Female,Mesothelioma,2018
85+,33.3,36.5,1820,Incidence,5221639,Non-Hispanic White,34.9,Male and Female,Myeloma,2018
85+,106.9,112.6,5727,Incidence,5221639,Non-Hispanic White,109.7,Male and Female,Non-Hodgkin Lymphoma,2018
85+,42.5,46.1,2311,Incidence,5221639,Non-Hispanic White,44.3,Male and Female,Oral Cavity and Pharynx,2018
85+,33.6,37.7,1190,Incidence,3338411,Non-Hispanic White,35.6,Male and Female,Ovary,2018
85+,90.9,96.1,4880,Incidence,5221639,Non-Hispanic White,93.5,Male and Female,Pancreas,2018
85+,340.4,357.4,6569,Incidence,1883228,Non-Hispanic White,348.8,Male and Female,Prostate,2018
85+,29.4,32.4,1613,Incidence,5221639,Non-Hispanic White,30.9,Male and Female,Stomach,2018
85+,0.7,1.7,21,Incidence,1883228,Non-Hispanic White,1.1,Male and Female,Testis,2018
85+,9.1,10.9,521,Incidence,5221639,Non-Hispanic White,10.0,Male and Female,Thyroid,2018
85+,179.8,187.2,9582,Incidence,5221639,Non-Hispanic White,183.5,Male and Female,Urinary Bladder,2018
<1,27.4,32.3,579,Incidence,1945575,Non-Hispanic White,29.8,Male and Female,All Cancer Sites Combined,2018
<1,2.6,4.3,66,Incidence,1945575,Non-Hispanic White,3.4,Male and Female,Brain and Other Nervous System,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,Cervix,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Colon and Rectum,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Esophagus,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,Female Breast,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2018
<1,1.1,2.3,31,Incidence,1945575,Non-Hispanic White,1.6,Male and Female,Kidney and Renal Pelvis,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Larynx,2018
<1,3.9,5.9,93,Incidence,1945575,Non-Hispanic White,4.8,Male and Female,Leukemias,2018
<1,1.1,2.3,32,Incidence,1945575,Non-Hispanic White,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,Male and Female Breast,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Mesothelioma,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Myeloma,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Non-Hodgkin Lymphoma,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2018
<1,~,~,~,Incidence,948772,Non-Hispanic White,~,Male and Female,Ovary,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Pancreas,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male and Female,Prostate,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Stomach,2018
<1,~,~,~,Incidence,996803,Non-Hispanic White,~,Male and Female,Testis,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Thyroid,2018
<1,~,~,~,Incidence,1945575,Non-Hispanic White,~,Male and Female,Urinary Bladder,2018
1-4,19.3,21.3,1567,Incidence,7728847,All Races,20.3,Female,All Cancer Sites Combined,2019
1-4,3.2,4.1,279,Incidence,7728847,All Races,3.6,Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Cervix,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Esophagus,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Female Breast,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Kaposi Sarcoma,2019
1-4,1.8,2.5,163,Incidence,7728847,All Races,2.1,Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Larynx,2019
1-4,7.0,8.3,589,Incidence,7728847,All Races,7.6,Female,Leukemias,2019
1-4,0.4,0.7,39,Incidence,7728847,All Races,0.5,Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Mesothelioma,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Myeloma,2019
1-4,0.4,0.7,40,Incidence,7728847,All Races,0.5,Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Ovary,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Pancreas,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Stomach,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Thyroid,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Female,Urinary Bladder,2019
10-14,14.0,15.5,1506,Incidence,10190891,All Races,14.8,Female,All Cancer Sites Combined,2019
10-14,2.3,2.9,264,Incidence,10190891,All Races,2.6,Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Cervix,2019
10-14,0.4,0.7,58,Incidence,10190891,All Races,0.6,Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Esophagus,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Female Breast,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,"Female Breast, <i>in situ</i>",2019
10-14,0.8,1.2,104,Incidence,10190891,All Races,1.0,Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Kaposi Sarcoma,2019
10-14,0.1,0.3,20,Incidence,10190891,All Races,0.2,Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Larynx,2019
10-14,2.6,3.3,302,Incidence,10190891,All Races,3.0,Female,Leukemias,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Lung and Bronchus,2019
10-14,0.2,0.4,27,Incidence,10190891,All Races,0.3,Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Mesothelioma,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Myeloma,2019
10-14,0.6,1.0,81,Incidence,10190891,All Races,0.8,Female,Non-Hodgkin Lymphoma,2019
10-14,0.2,0.4,30,Incidence,10190891,All Races,0.3,Female,Oral Cavity and Pharynx,2019
10-14,0.5,0.9,69,Incidence,10190891,All Races,0.7,Female,Ovary,2019
10-14,0.1,0.3,18,Incidence,10190891,All Races,0.2,Female,Pancreas,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Stomach,2019
10-14,1.3,1.8,158,Incidence,10190891,All Races,1.6,Female,Thyroid,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Female,Urinary Bladder,2019
15-19,23.4,25.3,2514,Incidence,10313575,All Races,24.4,Female,All Cancer Sites Combined,2019
15-19,1.8,2.4,215,Incidence,10313575,All Races,2.1,Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Cervix,2019
15-19,1.3,1.8,160,Incidence,10313575,All Races,1.6,Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Esophagus,2019
15-19,0.1,0.3,24,Incidence,10313575,All Races,0.2,Female,Female Breast,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,"Female Breast, <i>in situ</i>",2019
15-19,2.9,3.6,336,Incidence,10313575,All Races,3.3,Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Kaposi Sarcoma,2019
15-19,0.1,0.3,24,Incidence,10313575,All Races,0.2,Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Larynx,2019
15-19,2.0,2.6,233,Incidence,10313575,All Races,2.3,Female,Leukemias,2019
15-19,0.1,0.3,16,Incidence,10313575,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2019
15-19,0.1,0.3,17,Incidence,10313575,All Races,0.2,Female,Lung and Bronchus,2019
15-19,0.8,1.2,98,Incidence,10313575,All Races,1.0,Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Mesothelioma,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Myeloma,2019
15-19,1.2,1.7,145,Incidence,10313575,All Races,1.4,Female,Non-Hodgkin Lymphoma,2019
15-19,0.3,0.6,42,Incidence,10313575,All Races,0.4,Female,Oral Cavity and Pharynx,2019
15-19,1.0,1.4,124,Incidence,10313575,All Races,1.2,Female,Ovary,2019
15-19,0.3,0.6,42,Incidence,10313575,All Races,0.4,Female,Pancreas,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Stomach,2019
15-19,5.7,6.7,635,Incidence,10313575,All Races,6.2,Female,Thyroid,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Female,Urinary Bladder,2019
20-24,37.0,39.4,4037,Incidence,10577124,All Races,38.2,Female,All Cancer Sites Combined,2019
20-24,1.6,2.1,194,Incidence,10577124,All Races,1.8,Female,Brain and Other Nervous System,2019
20-24,0.3,0.6,48,Incidence,10577124,All Races,0.5,Female,Cervix,2019
20-24,1.9,2.5,230,Incidence,10577124,All Races,2.2,Female,Colon and Rectum,2019
20-24,0.4,0.8,62,Incidence,10577124,All Races,0.6,Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,10577124,All Races,~,Female,Esophagus,2019
20-24,1.6,2.1,192,Incidence,10577124,All Races,1.8,Female,Female Breast,2019
20-24,0.1,0.3,24,Incidence,10577124,All Races,0.2,Female,"Female Breast, <i>in situ</i>",2019
20-24,3.9,4.7,453,Incidence,10577124,All Races,4.3,Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,10577124,All Races,~,Female,Kaposi Sarcoma,2019
20-24,0.4,0.8,62,Incidence,10577124,All Races,0.6,Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,10577124,All Races,~,Female,Larynx,2019
20-24,2.1,2.7,250,Incidence,10577124,All Races,2.4,Female,Leukemias,2019
20-24,0.2,0.4,30,Incidence,10577124,All Races,0.3,Female,Liver and Intrahepatic Bile Duct,2019
20-24,0.3,0.5,40,Incidence,10577124,All Races,0.4,Female,Lung and Bronchus,2019
20-24,2.8,3.5,328,Incidence,10577124,All Races,3.1,Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,10577124,All Races,~,Female,Mesothelioma,2019
20-24,~,~,~,Incidence,10577124,All Races,~,Female,Myeloma,2019
20-24,1.6,2.2,201,Incidence,10577124,All Races,1.9,Female,Non-Hodgkin Lymphoma,2019
20-24,0.5,0.9,73,Incidence,10577124,All Races,0.7,Female,Oral Cavity and Pharynx,2019
20-24,1.3,1.8,161,Incidence,10577124,All Races,1.5,Female,Ovary,2019
20-24,0.2,0.5,35,Incidence,10577124,All Races,0.3,Female,Pancreas,2019
20-24,0.2,0.3,25,Incidence,10577124,All Races,0.2,Female,Stomach,2019
20-24,10.6,11.9,1187,Incidence,10577124,All Races,11.2,Female,Thyroid,2019
20-24,~,~,~,Incidence,10577124,All Races,~,Female,Urinary Bladder,2019
25-29,67.6,70.7,7966,Incidence,11518714,All Races,69.2,Female,All Cancer Sites Combined,2019
25-29,2.0,2.5,260,Incidence,11518714,All Races,2.3,Female,Brain and Other Nervous System,2019
25-29,3.8,4.6,483,Incidence,11518714,All Races,4.2,Female,Cervix,2019
25-29,3.0,3.7,386,Incidence,11518714,All Races,3.4,Female,Colon and Rectum,2019
25-29,2.1,2.7,273,Incidence,11518714,All Races,2.4,Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,11518714,All Races,~,Female,Esophagus,2019
25-29,10.1,11.4,1237,Incidence,11518714,All Races,10.7,Female,Female Breast,2019
25-29,0.8,1.1,106,Incidence,11518714,All Races,0.9,Female,"Female Breast, <i>in situ</i>",2019
25-29,3.4,4.2,437,Incidence,11518714,All Races,3.8,Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,11518714,All Races,~,Female,Kaposi Sarcoma,2019
25-29,1.1,1.5,152,Incidence,11518714,All Races,1.3,Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,11518714,All Races,~,Female,Larynx,2019
25-29,2.3,2.9,298,Incidence,11518714,All Races,2.6,Female,Leukemias,2019
25-29,0.2,0.4,28,Incidence,11518714,All Races,0.2,Female,Liver and Intrahepatic Bile Duct,2019
25-29,0.5,0.8,69,Incidence,11518714,All Races,0.6,Female,Lung and Bronchus,2019
25-29,6.3,7.2,778,Incidence,11518714,All Races,6.8,Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,11518714,All Races,~,Female,Mesothelioma,2019
25-29,~,~,~,Incidence,11518714,All Races,~,Female,Myeloma,2019
25-29,2.6,3.2,333,Incidence,11518714,All Races,2.9,Female,Non-Hodgkin Lymphoma,2019
25-29,0.9,1.3,124,Incidence,11518714,All Races,1.1,Female,Oral Cavity and Pharynx,2019
25-29,2.3,2.9,301,Incidence,11518714,All Races,2.6,Female,Ovary,2019
25-29,0.4,0.7,64,Incidence,11518714,All Races,0.6,Female,Pancreas,2019
25-29,0.2,0.4,37,Incidence,11518714,All Races,0.3,Female,Stomach,2019
25-29,16.5,18.0,1988,Incidence,11518714,All Races,17.3,Female,Thyroid,2019
25-29,0.2,0.4,30,Incidence,11518714,All Races,0.3,Female,Urinary Bladder,2019
30-34,125.7,130.0,14181,Incidence,11093732,All Races,127.8,Female,All Cancer Sites Combined,2019
30-34,2.7,3.4,336,Incidence,11093732,All Races,3.0,Female,Brain and Other Nervous System,2019
30-34,11.3,12.6,1328,Incidence,11093732,All Races,12.0,Female,Cervix,2019
30-34,6.4,7.4,767,Incidence,11093732,All Races,6.9,Female,Colon and Rectum,2019
30-34,5.6,6.5,670,Incidence,11093732,All Races,6.0,Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,11093732,All Races,~,Female,Esophagus,2019
30-34,29.6,31.6,3392,Incidence,11093732,All Races,30.6,Female,Female Breast,2019
30-34,3.0,3.7,373,Incidence,11093732,All Races,3.4,Female,"Female Breast, <i>in situ</i>",2019
30-34,3.1,3.8,378,Incidence,11093732,All Races,3.4,Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,11093732,All Races,~,Female,Kaposi Sarcoma,2019
30-34,2.5,3.2,315,Incidence,11093732,All Races,2.8,Female,Kidney and Renal Pelvis,2019
30-34,0.1,0.3,19,Incidence,11093732,All Races,0.2,Female,Larynx,2019
30-34,2.8,3.4,342,Incidence,11093732,All Races,3.1,Female,Leukemias,2019
30-34,0.3,0.5,45,Incidence,11093732,All Races,0.4,Female,Liver and Intrahepatic Bile Duct,2019
30-34,1.0,1.4,133,Incidence,11093732,All Races,1.2,Female,Lung and Bronchus,2019
30-34,12.1,13.5,1417,Incidence,11093732,All Races,12.8,Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,11093732,All Races,~,Female,Mesothelioma,2019
30-34,0.2,0.4,36,Incidence,11093732,All Races,0.3,Female,Myeloma,2019
30-34,3.3,4.0,407,Incidence,11093732,All Races,3.7,Female,Non-Hodgkin Lymphoma,2019
30-34,1.5,2.0,189,Incidence,11093732,All Races,1.7,Female,Oral Cavity and Pharynx,2019
30-34,3.4,4.1,412,Incidence,11093732,All Races,3.7,Female,Ovary,2019
30-34,0.7,1.0,92,Incidence,11093732,All Races,0.8,Female,Pancreas,2019
30-34,0.7,1.1,99,Incidence,11093732,All Races,0.9,Female,Stomach,2019
30-34,24.2,26.1,2785,Incidence,11093732,All Races,25.1,Female,Thyroid,2019
30-34,0.4,0.6,53,Incidence,11093732,All Races,0.5,Female,Urinary Bladder,2019
35-39,197.6,202.9,21752,Incidence,10861340,All Races,200.3,Female,All Cancer Sites Combined,2019
35-39,3.1,3.8,374,Incidence,10861340,All Races,3.4,Female,Brain and Other Nervous System,2019
35-39,13.6,15.1,1559,Incidence,10861340,All Races,14.4,Female,Cervix,2019
35-39,10.9,12.2,1254,Incidence,10861340,All Races,11.5,Female,Colon and Rectum,2019
35-39,10.4,11.6,1192,Incidence,10861340,All Races,11.0,Female,"Corpus and Uterus, NOS",2019
35-39,0.1,0.3,22,Incidence,10861340,All Races,0.2,Female,Esophagus,2019
35-39,64.5,67.5,7168,Incidence,10861340,All Races,66.0,Female,Female Breast,2019
35-39,9.0,10.2,1044,Incidence,10861340,All Races,9.6,Female,"Female Breast, <i>in situ</i>",2019
35-39,2.6,3.3,322,Incidence,10861340,All Races,3.0,Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,10861340,All Races,~,Female,Kaposi Sarcoma,2019
35-39,5.4,6.3,637,Incidence,10861340,All Races,5.9,Female,Kidney and Renal Pelvis,2019
35-39,0.1,0.3,25,Incidence,10861340,All Races,0.2,Female,Larynx,2019
35-39,4.0,4.8,472,Incidence,10861340,All Races,4.3,Female,Leukemias,2019
35-39,0.7,1.0,91,Incidence,10861340,All Races,0.8,Female,Liver and Intrahepatic Bile Duct,2019
35-39,2.4,3.0,293,Incidence,10861340,All Races,2.7,Female,Lung and Bronchus,2019
35-39,15.2,16.7,1732,Incidence,10861340,All Races,15.9,Female,Melanomas of the Skin,2019
35-39,0.1,0.2,16,Incidence,10861340,All Races,0.1,Female,Mesothelioma,2019
35-39,0.9,1.3,118,Incidence,10861340,All Races,1.1,Female,Myeloma,2019
35-39,5.3,6.2,623,Incidence,10861340,All Races,5.7,Female,Non-Hodgkin Lymphoma,2019
35-39,2.1,2.7,264,Incidence,10861340,All Races,2.4,Female,Oral Cavity and Pharynx,2019
35-39,4.4,5.2,522,Incidence,10861340,All Races,4.8,Female,Ovary,2019
35-39,1.0,1.4,127,Incidence,10861340,All Races,1.2,Female,Pancreas,2019
35-39,1.7,2.2,211,Incidence,10861340,All Races,1.9,Female,Stomach,2019
35-39,28.9,30.9,3245,Incidence,10861340,All Races,29.9,Female,Thyroid,2019
35-39,0.7,1.1,99,Incidence,10861340,All Races,0.9,Female,Urinary Bladder,2019
40-44,313.3,320.3,31726,Incidence,10014341,All Races,316.8,Female,All Cancer Sites Combined,2019
40-44,3.4,4.1,374,Incidence,10014341,All Races,3.7,Female,Brain and Other Nervous System,2019
40-44,14.9,16.4,1566,Incidence,10014341,All Races,15.6,Female,Cervix,2019
40-44,18.8,20.6,1970,Incidence,10014341,All Races,19.7,Female,Colon and Rectum,2019
40-44,16.9,18.6,1778,Incidence,10014341,All Races,17.8,Female,"Corpus and Uterus, NOS",2019
40-44,0.3,0.6,42,Incidence,10014341,All Races,0.4,Female,Esophagus,2019
40-44,130.8,135.4,13328,Incidence,10014341,All Races,133.1,Female,Female Breast,2019
40-44,40.2,42.7,4148,Incidence,10014341,All Races,41.4,Female,"Female Breast, <i>in situ</i>",2019
40-44,1.9,2.5,218,Incidence,10014341,All Races,2.2,Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,10014341,All Races,~,Female,Kaposi Sarcoma,2019
40-44,8.8,10.0,940,Incidence,10014341,All Races,9.4,Female,Kidney and Renal Pelvis,2019
40-44,0.3,0.6,45,Incidence,10014341,All Races,0.4,Female,Larynx,2019
40-44,5.0,5.9,546,Incidence,10014341,All Races,5.5,Female,Leukemias,2019
40-44,1.1,1.5,127,Incidence,10014341,All Races,1.3,Female,Liver and Intrahepatic Bile Duct,2019
40-44,6.0,7.0,651,Incidence,10014341,All Races,6.5,Female,Lung and Bronchus,2019
40-44,19.0,20.7,1985,Incidence,10014341,All Races,19.8,Female,Melanomas of the Skin,2019
40-44,0.1,0.3,20,Incidence,10014341,All Races,0.2,Female,Mesothelioma,2019
40-44,1.8,2.4,209,Incidence,10014341,All Races,2.1,Female,Myeloma,2019
40-44,7.3,8.5,790,Incidence,10014341,All Races,7.9,Female,Non-Hodgkin Lymphoma,2019
40-44,3.2,3.9,355,Incidence,10014341,All Races,3.5,Female,Oral Cavity and Pharynx,2019
40-44,7.6,8.7,814,Incidence,10014341,All Races,8.1,Female,Ovary,2019
40-44,2.5,3.2,283,Incidence,10014341,All Races,2.8,Female,Pancreas,2019
40-44,2.7,3.4,304,Incidence,10014341,All Races,3.0,Female,Stomach,2019
40-44,32.4,34.7,3359,Incidence,10014341,All Races,33.5,Female,Thyroid,2019
40-44,1.4,1.9,166,Incidence,10014341,All Races,1.7,Female,Urinary Bladder,2019
45-49,458.6,467.0,47703,Incidence,10307804,All Races,462.8,Female,All Cancer Sites Combined,2019
45-49,4.2,5.0,472,Incidence,10307804,All Races,4.6,Female,Brain and Other Nervous System,2019
45-49,14.0,15.4,1514,Incidence,10307804,All Races,14.7,Female,Cervix,2019
45-49,32.4,34.6,3452,Incidence,10307804,All Races,33.5,Female,Colon and Rectum,2019
45-49,27.9,30.0,2980,Incidence,10307804,All Races,28.9,Female,"Corpus and Uterus, NOS",2019
45-49,0.8,1.2,101,Incidence,10307804,All Races,1.0,Female,Esophagus,2019
45-49,200.7,206.2,20968,Incidence,10307804,All Races,203.4,Female,Female Breast,2019
45-49,56.8,59.8,6010,Incidence,10307804,All Races,58.3,Female,"Female Breast, <i>in situ</i>",2019
45-49,1.8,2.4,218,Incidence,10307804,All Races,2.1,Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,10307804,All Races,~,Female,Kaposi Sarcoma,2019
45-49,12.2,13.6,1325,Incidence,10307804,All Races,12.9,Female,Kidney and Renal Pelvis,2019
45-49,0.7,1.1,90,Incidence,10307804,All Races,0.9,Female,Larynx,2019
45-49,7.4,8.5,817,Incidence,10307804,All Races,7.9,Female,Leukemias,2019
45-49,1.9,2.5,224,Incidence,10307804,All Races,2.2,Female,Liver and Intrahepatic Bile Duct,2019
45-49,15.5,17.1,1680,Incidence,10307804,All Races,16.3,Female,Lung and Bronchus,2019
45-49,23.9,25.8,2558,Incidence,10307804,All Races,24.8,Female,Melanomas of the Skin,2019
45-49,0.1,0.3,23,Incidence,10307804,All Races,0.2,Female,Mesothelioma,2019
45-49,3.8,4.6,429,Incidence,10307804,All Races,4.2,Female,Myeloma,2019
45-49,10.8,12.1,1178,Incidence,10307804,All Races,11.4,Female,Non-Hodgkin Lymphoma,2019
45-49,5.6,6.6,626,Incidence,10307804,All Races,6.1,Female,Oral Cavity and Pharynx,2019
45-49,11.3,12.6,1230,Incidence,10307804,All Races,11.9,Female,Ovary,2019
45-49,5.4,6.4,607,Incidence,10307804,All Races,5.9,Female,Pancreas,2019
45-49,4.5,5.4,509,Incidence,10307804,All Races,4.9,Female,Stomach,2019
45-49,32.8,35.1,3499,Incidence,10307804,All Races,33.9,Female,Thyroid,2019
45-49,2.7,3.4,312,Incidence,10307804,All Races,3.0,Female,Urinary Bladder,2019
5-9,11.0,12.3,1149,Incidence,9886447,All Races,11.6,Female,All Cancer Sites Combined,2019
5-9,2.8,3.5,313,Incidence,9886447,All Races,3.2,Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Cervix,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Esophagus,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Female Breast,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,"Female Breast, <i>in situ</i>",2019
5-9,0.2,0.4,25,Incidence,9886447,All Races,0.3,Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Kaposi Sarcoma,2019
5-9,0.4,0.7,53,Incidence,9886447,All Races,0.5,Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Larynx,2019
5-9,3.3,4.0,359,Incidence,9886447,All Races,3.6,Female,Leukemias,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Mesothelioma,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Myeloma,2019
5-9,0.5,0.8,60,Incidence,9886447,All Races,0.6,Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Oral Cavity and Pharynx,2019
5-9,0.2,0.5,34,Incidence,9886447,All Races,0.3,Female,Ovary,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Pancreas,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Stomach,2019
5-9,0.2,0.4,26,Incidence,9886447,All Races,0.3,Female,Thyroid,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Female,Urinary Bladder,2019
50-54,619.8,629.4,64879,Incidence,10387588,All Races,624.6,Female,All Cancer Sites Combined,2019
50-54,5.5,6.4,619,Incidence,10387588,All Races,6.0,Female,Brain and Other Nervous System,2019
50-54,12.7,14.2,1395,Incidence,10387588,All Races,13.4,Female,Cervix,2019
50-54,54.3,57.2,5792,Incidence,10387588,All Races,55.8,Female,Colon and Rectum,2019
50-54,47.3,50.0,5052,Incidence,10387588,All Races,48.6,Female,"Corpus and Uterus, NOS",2019
50-54,1.7,2.3,205,Incidence,10387588,All Races,2.0,Female,Esophagus,2019
50-54,240.5,246.5,25295,Incidence,10387588,All Races,243.5,Female,Female Breast,2019
50-54,65.7,68.9,6987,Incidence,10387588,All Races,67.3,Female,"Female Breast, <i>in situ</i>",2019
50-54,1.6,2.1,189,Incidence,10387588,All Races,1.8,Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,10387588,All Races,~,Female,Kaposi Sarcoma,2019
50-54,17.0,18.6,1848,Incidence,10387588,All Races,17.8,Female,Kidney and Renal Pelvis,2019
50-54,1.7,2.3,209,Incidence,10387588,All Races,2.0,Female,Larynx,2019
50-54,9.6,10.9,1064,Incidence,10387588,All Races,10.2,Female,Leukemias,2019
50-54,4.1,4.9,464,Incidence,10387588,All Races,4.5,Female,Liver and Intrahepatic Bile Duct,2019
50-54,39.6,42.0,4237,Incidence,10387588,All Races,40.8,Female,Lung and Bronchus,2019
50-54,29.3,31.4,3148,Incidence,10387588,All Races,30.3,Female,Melanomas of the Skin,2019
50-54,0.2,0.4,26,Incidence,10387588,All Races,0.3,Female,Mesothelioma,2019
50-54,6.2,7.2,690,Incidence,10387588,All Races,6.6,Female,Myeloma,2019
50-54,17.0,18.7,1854,Incidence,10387588,All Races,17.8,Female,Non-Hodgkin Lymphoma,2019
50-54,9.3,10.5,1024,Incidence,10387588,All Races,9.9,Female,Oral Cavity and Pharynx,2019
50-54,15.6,17.2,1700,Incidence,10387588,All Races,16.4,Female,Ovary,2019
50-54,9.4,10.7,1042,Incidence,10387588,All Races,10.0,Female,Pancreas,2019
50-54,6.1,7.1,680,Incidence,10387588,All Races,6.5,Female,Stomach,2019
50-54,32.3,34.5,3471,Incidence,10387588,All Races,33.4,Female,Thyroid,2019
50-54,5.7,6.6,638,Incidence,10387588,All Races,6.1,Female,Urinary Bladder,2019
55-59,804.4,815.0,90945,Incidence,11232044,All Races,809.7,Female,All Cancer Sites Combined,2019
55-59,7.4,8.4,887,Incidence,11232044,All Races,7.9,Female,Brain and Other Nervous System,2019
55-59,11.2,12.5,1334,Incidence,11232044,All Races,11.9,Female,Cervix,2019
55-59,54.5,57.3,6280,Incidence,11232044,All Races,55.9,Female,Colon and Rectum,2019
55-59,75.7,78.9,8680,Incidence,11232044,All Races,77.3,Female,"Corpus and Uterus, NOS",2019
55-59,3.5,4.2,428,Incidence,11232044,All Races,3.8,Female,Esophagus,2019
55-59,274.0,280.1,31117,Incidence,11232044,All Races,277.0,Female,Female Breast,2019
55-59,68.4,71.5,7853,Incidence,11232044,All Races,69.9,Female,"Female Breast, <i>in situ</i>",2019
55-59,1.6,2.1,203,Incidence,11232044,All Races,1.8,Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,11232044,All Races,~,Female,Kaposi Sarcoma,2019
55-59,23.3,25.2,2722,Incidence,11232044,All Races,24.2,Female,Kidney and Renal Pelvis,2019
55-59,3.3,4.0,405,Incidence,11232044,All Races,3.6,Female,Larynx,2019
55-59,14.5,15.9,1707,Incidence,11232044,All Races,15.2,Female,Leukemias,2019
55-59,8.5,9.6,1013,Incidence,11232044,All Races,9.0,Female,Liver and Intrahepatic Bile Duct,2019
55-59,88.9,92.5,10186,Incidence,11232044,All Races,90.7,Female,Lung and Bronchus,2019
55-59,33.0,35.2,3832,Incidence,11232044,All Races,34.1,Female,Melanomas of the Skin,2019
55-59,0.4,0.7,65,Incidence,11232044,All Races,0.6,Female,Mesothelioma,2019
55-59,9.2,10.3,1095,Incidence,11232044,All Races,9.7,Female,Myeloma,2019
55-59,24.6,26.5,2867,Incidence,11232044,All Races,25.5,Female,Non-Hodgkin Lymphoma,2019
55-59,13.9,15.4,1645,Incidence,11232044,All Races,14.6,Female,Oral Cavity and Pharynx,2019
55-59,19.5,21.2,2282,Incidence,11232044,All Races,20.3,Female,Ovary,2019
55-59,17.5,19.1,2059,Incidence,11232044,All Races,18.3,Female,Pancreas,2019
55-59,7.3,8.4,878,Incidence,11232044,All Races,7.8,Female,Stomach,2019
55-59,30.4,32.5,3533,Incidence,11232044,All Races,31.5,Female,Thyroid,2019
55-59,11.0,12.3,1309,Incidence,11232044,All Races,11.7,Female,Urinary Bladder,2019
60-64,1062.3,1074.6,114417,Incidence,10708826,All Races,1068.4,Female,All Cancer Sites Combined,2019
60-64,9.1,10.2,1032,Incidence,10708826,All Races,9.6,Female,Brain and Other Nervous System,2019
60-64,11.2,12.5,1269,Incidence,10708826,All Races,11.9,Female,Cervix,2019
60-64,67.7,70.9,7421,Incidence,10708826,All Races,69.3,Female,Colon and Rectum,2019
60-64,99.7,103.5,10882,Incidence,10708826,All Races,101.6,Female,"Corpus and Uterus, NOS",2019
60-64,5.1,6.0,594,Incidence,10708826,All Races,5.5,Female,Esophagus,2019
60-64,341.0,348.0,36888,Incidence,10708826,All Races,344.5,Female,Female Breast,2019
60-64,82.0,85.5,8971,Incidence,10708826,All Races,83.8,Female,"Female Breast, <i>in situ</i>",2019
60-64,1.7,2.2,207,Incidence,10708826,All Races,1.9,Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,10708826,All Races,~,Female,Kaposi Sarcoma,2019
60-64,31.7,33.9,3509,Incidence,10708826,All Races,32.8,Female,Kidney and Renal Pelvis,2019
60-64,4.4,5.2,512,Incidence,10708826,All Races,4.8,Female,Larynx,2019
60-64,19.9,21.7,2227,Incidence,10708826,All Races,20.8,Female,Leukemias,2019
60-64,14.5,16.0,1630,Incidence,10708826,All Races,15.2,Female,Liver and Intrahepatic Bile Duct,2019
60-64,142.3,146.8,15477,Incidence,10708826,All Races,144.5,Female,Lung and Bronchus,2019
60-64,41.9,44.4,4619,Incidence,10708826,All Races,43.1,Female,Melanomas of the Skin,2019
60-64,0.6,0.9,81,Incidence,10708826,All Races,0.8,Female,Mesothelioma,2019
60-64,14.3,15.8,1614,Incidence,10708826,All Races,15.1,Female,Myeloma,2019
60-64,35.0,37.3,3874,Incidence,10708826,All Races,36.2,Female,Non-Hodgkin Lymphoma,2019
60-64,17.7,19.4,1986,Incidence,10708826,All Races,18.5,Female,Oral Cavity and Pharynx,2019
60-64,24.5,26.4,2723,Incidence,10708826,All Races,25.4,Female,Ovary,2019
60-64,28.2,30.3,3134,Incidence,10708826,All Races,29.3,Female,Pancreas,2019
60-64,10.4,11.7,1185,Incidence,10708826,All Races,11.1,Female,Stomach,2019
60-64,28.5,30.5,3158,Incidence,10708826,All Races,29.5,Female,Thyroid,2019
60-64,17.4,19.0,1945,Incidence,10708826,All Races,18.2,Female,Urinary Bladder,2019
65-69,1354.8,1369.8,126045,Incidence,9252566,All Races,1362.3,Female,All Cancer Sites Combined,2019
65-69,12.0,13.5,1180,Incidence,9252566,All Races,12.8,Female,Brain and Other Nervous System,2019
65-69,9.3,10.6,916,Incidence,9252566,All Races,9.9,Female,Cervix,2019
65-69,90.8,94.8,8586,Incidence,9252566,All Races,92.8,Female,Colon and Rectum,2019
65-69,116.1,120.6,10951,Incidence,9252566,All Races,118.4,Female,"Corpus and Uterus, NOS",2019
65-69,6.3,7.4,635,Incidence,9252566,All Races,6.9,Female,Esophagus,2019
65-69,426.3,434.8,39838,Incidence,9252566,All Races,430.6,Female,Female Breast,2019
65-69,97.0,101.1,9161,Incidence,9252566,All Races,99.0,Female,"Female Breast, <i>in situ</i>",2019
65-69,2.1,2.8,226,Incidence,9252566,All Races,2.4,Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,9252566,All Races,~,Female,Kaposi Sarcoma,2019
65-69,40.7,43.4,3888,Incidence,9252566,All Races,42.0,Female,Kidney and Renal Pelvis,2019
65-69,4.1,4.9,415,Incidence,9252566,All Races,4.5,Female,Larynx,2019
65-69,26.9,29.1,2592,Incidence,9252566,All Races,28.0,Female,Leukemias,2019
65-69,20.5,22.4,1985,Incidence,9252566,All Races,21.5,Female,Liver and Intrahepatic Bile Duct,2019
65-69,195.9,201.6,18387,Incidence,9252566,All Races,198.7,Female,Lung and Bronchus,2019
65-69,48.7,51.6,4640,Incidence,9252566,All Races,50.1,Female,Melanomas of the Skin,2019
65-69,0.9,1.3,100,Incidence,9252566,All Races,1.1,Female,Mesothelioma,2019
65-69,21.3,23.2,2055,Incidence,9252566,All Races,22.2,Female,Myeloma,2019
65-69,48.0,50.9,4577,Incidence,9252566,All Races,49.5,Female,Non-Hodgkin Lymphoma,2019
65-69,21.2,23.2,2052,Incidence,9252566,All Races,22.2,Female,Oral Cavity and Pharynx,2019
65-69,26.3,28.5,2534,Incidence,9252566,All Races,27.4,Female,Ovary,2019
65-69,41.0,43.6,3911,Incidence,9252566,All Races,42.3,Female,Pancreas,2019
65-69,13.1,14.7,1285,Incidence,9252566,All Races,13.9,Female,Stomach,2019
65-69,28.9,31.2,2778,Incidence,9252566,All Races,30.0,Female,Thyroid,2019
65-69,27.0,29.2,2600,Incidence,9252566,All Races,28.1,Female,Urinary Bladder,2019
70-74,1621.8,1640.0,122771,Incidence,7527818,All Races,1630.9,Female,All Cancer Sites Combined,2019
70-74,14.2,16.0,1134,Incidence,7527818,All Races,15.1,Female,Brain and Other Nervous System,2019
70-74,8.6,10.0,700,Incidence,7527818,All Races,9.3,Female,Cervix,2019
70-74,112.5,117.4,8650,Incidence,7527818,All Races,114.9,Female,Colon and Rectum,2019
70-74,110.2,115.0,8473,Incidence,7527818,All Races,112.6,Female,"Corpus and Uterus, NOS",2019
70-74,7.8,9.1,637,Incidence,7527818,All Races,8.5,Female,Esophagus,2019
70-74,477.7,487.6,36333,Incidence,7527818,All Races,482.6,Female,Female Breast,2019
70-74,105.3,110.0,8102,Incidence,7527818,All Races,107.6,Female,"Female Breast, <i>in situ</i>",2019
70-74,2.0,2.7,172,Incidence,7527818,All Races,2.3,Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,7527818,All Races,~,Female,Kaposi Sarcoma,2019
70-74,46.9,50.0,3646,Incidence,7527818,All Races,48.4,Female,Kidney and Renal Pelvis,2019
70-74,4.0,5.0,338,Incidence,7527818,All Races,4.5,Female,Larynx,2019
70-74,37.0,39.8,2889,Incidence,7527818,All Races,38.4,Female,Leukemias,2019
70-74,22.4,24.6,1768,Incidence,7527818,All Races,23.5,Female,Liver and Intrahepatic Bile Duct,2019
70-74,275.4,283.0,21014,Incidence,7527818,All Races,279.2,Female,Lung and Bronchus,2019
70-74,54.2,57.5,4203,Incidence,7527818,All Races,55.8,Female,Melanomas of the Skin,2019
70-74,1.3,1.8,116,Incidence,7527818,All Races,1.5,Female,Mesothelioma,2019
70-74,27.2,29.7,2140,Incidence,7527818,All Races,28.4,Female,Myeloma,2019
70-74,61.7,65.3,4777,Incidence,7527818,All Races,63.5,Female,Non-Hodgkin Lymphoma,2019
70-74,23.1,25.3,1821,Incidence,7527818,All Races,24.2,Female,Oral Cavity and Pharynx,2019
70-74,32.0,34.6,2508,Incidence,7527818,All Races,33.3,Female,Ovary,2019
70-74,55.3,58.7,4292,Incidence,7527818,All Races,57.0,Female,Pancreas,2019
70-74,16.8,18.7,1333,Incidence,7527818,All Races,17.7,Female,Stomach,2019
70-74,27.1,29.5,2126,Incidence,7527818,All Races,28.2,Female,Thyroid,2019
70-74,38.8,41.6,3024,Incidence,7527818,All Races,40.2,Female,Urinary Bladder,2019
75-79,1815.2,1838.1,97417,Incidence,5333117,All Races,1826.6,Female,All Cancer Sites Combined,2019
75-79,15.3,17.5,875,Incidence,5333117,All Races,16.4,Female,Brain and Other Nervous System,2019
75-79,8.4,10.0,490,Incidence,5333117,All Races,9.2,Female,Cervix,2019
75-79,140.1,146.5,7642,Incidence,5333117,All Races,143.3,Female,Colon and Rectum,2019
75-79,91.4,96.6,5013,Incidence,5333117,All Races,94.0,Female,"Corpus and Uterus, NOS",2019
75-79,9.1,10.8,531,Incidence,5333117,All Races,10.0,Female,Esophagus,2019
75-79,467.7,479.4,25253,Incidence,5333117,All Races,473.5,Female,Female Breast,2019
75-79,82.3,87.3,4522,Incidence,5333117,All Races,84.8,Female,"Female Breast, <i>in situ</i>",2019
75-79,2.8,3.7,172,Incidence,5333117,All Races,3.2,Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,5333117,All Races,~,Female,Kaposi Sarcoma,2019
75-79,50.4,54.3,2788,Incidence,5333117,All Races,52.3,Female,Kidney and Renal Pelvis,2019
75-79,3.6,4.7,221,Incidence,5333117,All Races,4.1,Female,Larynx,2019
75-79,47.0,50.8,2607,Incidence,5333117,All Races,48.9,Female,Leukemias,2019
75-79,26.1,28.9,1465,Incidence,5333117,All Races,27.5,Female,Liver and Intrahepatic Bile Duct,2019
75-79,338.7,348.7,18330,Incidence,5333117,All Races,343.7,Female,Lung and Bronchus,2019
75-79,57.3,61.4,3163,Incidence,5333117,All Races,59.3,Female,Melanomas of the Skin,2019
75-79,2.1,3.0,133,Incidence,5333117,All Races,2.5,Female,Mesothelioma,2019
75-79,34.1,37.3,1903,Incidence,5333117,All Races,35.7,Female,Myeloma,2019
75-79,81.3,86.2,4464,Incidence,5333117,All Races,83.7,Female,Non-Hodgkin Lymphoma,2019
75-79,26.1,29.0,1468,Incidence,5333117,All Races,27.5,Female,Oral Cavity and Pharynx,2019
75-79,37.3,40.7,2078,Incidence,5333117,All Races,39.0,Female,Ovary,2019
75-79,72.8,77.5,4007,Incidence,5333117,All Races,75.1,Female,Pancreas,2019
75-79,20.6,23.2,1167,Incidence,5333117,All Races,21.9,Female,Stomach,2019
75-79,21.4,24.0,1210,Incidence,5333117,All Races,22.7,Female,Thyroid,2019
75-79,51.1,55.0,2826,Incidence,5333117,All Races,53.0,Female,Urinary Bladder,2019
80-84,1878.0,1906.3,68805,Incidence,3636357,All Races,1892.1,Female,All Cancer Sites Combined,2019
80-84,15.4,18.1,608,Incidence,3636357,All Races,16.7,Female,Brain and Other Nervous System,2019
80-84,7.2,9.0,293,Incidence,3636357,All Races,8.1,Female,Cervix,2019
80-84,186.8,195.9,6957,Incidence,3636357,All Races,191.3,Female,Colon and Rectum,2019
80-84,72.3,77.9,2730,Incidence,3636357,All Races,75.1,Female,"Corpus and Uterus, NOS",2019
80-84,9.9,12.1,398,Incidence,3636357,All Races,10.9,Female,Esophagus,2019
80-84,422.2,435.7,15597,Incidence,3636357,All Races,428.9,Female,Female Breast,2019
80-84,56.4,61.4,2140,Incidence,3636357,All Races,58.9,Female,"Female Breast, <i>in situ</i>",2019
80-84,2.8,4.0,122,Incidence,3636357,All Races,3.4,Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,3636357,All Races,~,Female,Kaposi Sarcoma,2019
80-84,48.7,53.4,1856,Incidence,3636357,All Races,51.0,Female,Kidney and Renal Pelvis,2019
80-84,3.4,4.7,145,Incidence,3636357,All Races,4.0,Female,Larynx,2019
80-84,54.7,59.7,2079,Incidence,3636357,All Races,57.2,Female,Leukemias,2019
80-84,28.8,32.4,1111,Incidence,3636357,All Races,30.6,Female,Liver and Intrahepatic Bile Duct,2019
80-84,332.4,344.4,12305,Incidence,3636357,All Races,338.4,Female,Lung and Bronchus,2019
80-84,59.3,64.5,2250,Incidence,3636357,All Races,61.9,Female,Melanomas of the Skin,2019
80-84,1.9,2.9,85,Incidence,3636357,All Races,2.3,Female,Mesothelioma,2019
80-84,37.2,41.3,1426,Incidence,3636357,All Races,39.2,Female,Myeloma,2019
80-84,89.9,96.2,3382,Incidence,3636357,All Races,93.0,Female,Non-Hodgkin Lymphoma,2019
80-84,28.3,31.9,1092,Incidence,3636357,All Races,30.0,Female,Oral Cavity and Pharynx,2019
80-84,36.2,40.3,1390,Incidence,3636357,All Races,38.2,Female,Ovary,2019
80-84,84.9,91.0,3198,Incidence,3636357,All Races,87.9,Female,Pancreas,2019
80-84,25.2,28.5,975,Incidence,3636357,All Races,26.8,Female,Stomach,2019
80-84,14.6,17.2,578,Incidence,3636357,All Races,15.9,Female,Thyroid,2019
80-84,63.9,69.3,2420,Incidence,3636357,All Races,66.6,Female,Urinary Bladder,2019
85+,1684.8,1709.7,71713,Incidence,4225260,All Races,1697.2,Female,All Cancer Sites Combined,2019
85+,13.7,16.0,627,Incidence,4225260,All Races,14.8,Female,Brain and Other Nervous System,2019
85+,6.9,8.6,326,Incidence,4225260,All Races,7.7,Female,Cervix,2019
85+,208.8,217.7,9009,Incidence,4225260,All Races,213.2,Female,Colon and Rectum,2019
85+,47.2,51.5,2084,Incidence,4225260,All Races,49.3,Female,"Corpus and Uterus, NOS",2019
85+,11.3,13.4,520,Incidence,4225260,All Races,12.3,Female,Esophagus,2019
85+,320.2,331.1,13760,Incidence,4225260,All Races,325.7,Female,Female Breast,2019
85+,22.3,25.3,1005,Incidence,4225260,All Races,23.8,Female,"Female Breast, <i>in situ</i>",2019
85+,1.9,2.9,100,Incidence,4225260,All Races,2.4,Female,Hodgkin Lymphoma,2019
85+,0.3,0.8,21,Incidence,4225260,All Races,0.5,Female,Kaposi Sarcoma,2019
85+,38.8,42.7,1721,Incidence,4225260,All Races,40.7,Female,Kidney and Renal Pelvis,2019
85+,1.8,2.7,93,Incidence,4225260,All Races,2.2,Female,Larynx,2019
85+,61.3,66.2,2692,Incidence,4225260,All Races,63.7,Female,Leukemias,2019
85+,26.0,29.2,1164,Incidence,4225260,All Races,27.5,Female,Liver and Intrahepatic Bile Duct,2019
85+,233.9,243.3,10080,Incidence,4225260,All Races,238.6,Female,Lung and Bronchus,2019
85+,60.4,65.2,2654,Incidence,4225260,All Races,62.8,Female,Melanomas of the Skin,2019
85+,2.3,3.4,119,Incidence,4225260,All Races,2.8,Female,Mesothelioma,2019
85+,28.3,31.6,1263,Incidence,4225260,All Races,29.9,Female,Myeloma,2019
85+,78.0,83.5,3410,Incidence,4225260,All Races,80.7,Female,Non-Hodgkin Lymphoma,2019
85+,27.2,30.4,1216,Incidence,4225260,All Races,28.8,Female,Oral Cavity and Pharynx,2019
85+,31.2,34.6,1389,Incidence,4225260,All Races,32.9,Female,Ovary,2019
85+,92.0,97.9,4009,Incidence,4225260,All Races,94.9,Female,Pancreas,2019
85+,24.4,27.5,1096,Incidence,4225260,All Races,25.9,Female,Stomach,2019
85+,8.7,10.5,404,Incidence,4225260,All Races,9.6,Female,Thyroid,2019
85+,71.6,76.8,3132,Incidence,4225260,All Races,74.1,Female,Urinary Bladder,2019
<1,23.1,27.8,467,Incidence,1841226,All Races,25.4,Female,All Cancer Sites Combined,2019
<1,2.6,4.3,62,Incidence,1841226,All Races,3.4,Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Cervix,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Colon and Rectum,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Esophagus,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Female Breast,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Kaposi Sarcoma,2019
<1,0.7,1.7,20,Incidence,1841226,All Races,1.1,Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Larynx,2019
<1,3.3,5.2,76,Incidence,1841226,All Races,4.1,Female,Leukemias,2019
<1,1.3,2.6,34,Incidence,1841226,All Races,1.8,Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Mesothelioma,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Myeloma,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Ovary,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Pancreas,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Stomach,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Thyroid,2019
<1,~,~,~,Incidence,1841226,All Races,~,Female,Urinary Bladder,2019
1-4,21.3,23.4,1802,Incidence,8080265,All Races,22.3,Male,All Cancer Sites Combined,2019
1-4,3.7,4.6,336,Incidence,8080265,All Races,4.2,Male,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Colon and Rectum,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Esophagus,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Kaposi Sarcoma,2019
1-4,1.4,2.0,137,Incidence,8080265,All Races,1.7,Male,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Larynx,2019
1-4,8.0,9.3,695,Incidence,8080265,All Races,8.6,Male,Leukemias,2019
1-4,0.6,1.0,66,Incidence,8080265,All Races,0.8,Male,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Lung and Bronchus,2019
1-4,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Mesothelioma,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Myeloma,2019
1-4,0.7,1.1,73,Incidence,8080265,All Races,0.9,Male,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Pancreas,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Prostate,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Stomach,2019
1-4,0.2,0.4,22,Incidence,8080265,All Races,0.3,Male,Testis,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Thyroid,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male,Urinary Bladder,2019
10-14,15.2,16.7,1696,Incidence,10629162,All Races,16.0,Male,All Cancer Sites Combined,2019
10-14,2.5,3.2,302,Incidence,10629162,All Races,2.8,Male,Brain and Other Nervous System,2019
10-14,0.6,0.9,76,Incidence,10629162,All Races,0.7,Male,Colon and Rectum,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Esophagus,2019
10-14,1.2,1.7,155,Incidence,10629162,All Races,1.5,Male,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Larynx,2019
10-14,3.4,4.2,405,Incidence,10629162,All Races,3.8,Male,Leukemias,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Lung and Bronchus,2019
10-14,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
10-14,0.1,0.3,21,Incidence,10629162,All Races,0.2,Male,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Mesothelioma,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Myeloma,2019
10-14,1.6,2.1,194,Incidence,10629162,All Races,1.8,Male,Non-Hodgkin Lymphoma,2019
10-14,0.2,0.4,27,Incidence,10629162,All Races,0.3,Male,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Pancreas,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Prostate,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Stomach,2019
10-14,0.2,0.4,27,Incidence,10629162,All Races,0.3,Male,Testis,2019
10-14,0.3,0.6,47,Incidence,10629162,All Races,0.4,Male,Thyroid,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male,Urinary Bladder,2019
15-19,23.7,25.6,2649,Incidence,10752848,All Races,24.6,Male,All Cancer Sites Combined,2019
15-19,2.1,2.7,255,Incidence,10752848,All Races,2.4,Male,Brain and Other Nervous System,2019
15-19,1.1,1.5,136,Incidence,10752848,All Races,1.3,Male,Colon and Rectum,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Esophagus,2019
15-19,3.0,3.7,355,Incidence,10752848,All Races,3.3,Male,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Kaposi Sarcoma,2019
15-19,0.2,0.4,29,Incidence,10752848,All Races,0.3,Male,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Larynx,2019
15-19,3.6,4.3,423,Incidence,10752848,All Races,3.9,Male,Leukemias,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Lung and Bronchus,2019
15-19,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
15-19,0.4,0.7,59,Incidence,10752848,All Races,0.5,Male,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Mesothelioma,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Myeloma,2019
15-19,2.1,2.7,255,Incidence,10752848,All Races,2.4,Male,Non-Hodgkin Lymphoma,2019
15-19,0.4,0.7,58,Incidence,10752848,All Races,0.5,Male,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Pancreas,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Prostate,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Stomach,2019
15-19,3.0,3.7,355,Incidence,10752848,All Races,3.3,Male,Testis,2019
15-19,1.0,1.4,123,Incidence,10752848,All Races,1.1,Male,Thyroid,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male,Urinary Bladder,2019
20-24,34.8,37.0,3972,Incidence,11066850,All Races,35.9,Male,All Cancer Sites Combined,2019
20-24,2.4,3.0,293,Incidence,11066850,All Races,2.6,Male,Brain and Other Nervous System,2019
20-24,1.6,2.1,207,Incidence,11066850,All Races,1.9,Male,Colon and Rectum,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male,Esophagus,2019
20-24,4.0,4.8,486,Incidence,11066850,All Races,4.4,Male,Hodgkin Lymphoma,2019
20-24,0.2,0.4,28,Incidence,11066850,All Races,0.3,Male,Kaposi Sarcoma,2019
20-24,0.7,1.0,95,Incidence,11066850,All Races,0.9,Male,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male,Larynx,2019
20-24,2.9,3.5,354,Incidence,11066850,All Races,3.2,Male,Leukemias,2019
20-24,0.1,0.2,17,Incidence,11066850,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2019
20-24,0.2,0.4,35,Incidence,11066850,All Races,0.3,Male,Lung and Bronchus,2019
20-24,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
20-24,1.3,1.7,166,Incidence,11066850,All Races,1.5,Male,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male,Mesothelioma,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male,Myeloma,2019
20-24,2.5,3.1,311,Incidence,11066850,All Races,2.8,Male,Non-Hodgkin Lymphoma,2019
20-24,0.5,0.9,77,Incidence,11066850,All Races,0.7,Male,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male,Pancreas,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male,Prostate,2019
20-24,0.1,0.3,22,Incidence,11066850,All Races,0.2,Male,Stomach,2019
20-24,9.4,10.6,1106,Incidence,11066850,All Races,10.0,Male,Testis,2019
20-24,2.0,2.5,246,Incidence,11066850,All Races,2.2,Male,Thyroid,2019
20-24,0.2,0.4,29,Incidence,11066850,All Races,0.3,Male,Urinary Bladder,2019
25-29,47.6,50.2,5877,Incidence,12020738,All Races,48.9,Male,All Cancer Sites Combined,2019
25-29,2.8,3.5,377,Incidence,12020738,All Races,3.1,Male,Brain and Other Nervous System,2019
25-29,2.9,3.6,387,Incidence,12020738,All Races,3.2,Male,Colon and Rectum,2019
25-29,~,~,~,Incidence,12020738,All Races,~,Male,Esophagus,2019
25-29,3.6,4.4,479,Incidence,12020738,All Races,4.0,Male,Hodgkin Lymphoma,2019
25-29,0.5,0.8,81,Incidence,12020738,All Races,0.7,Male,Kaposi Sarcoma,2019
25-29,1.3,1.8,183,Incidence,12020738,All Races,1.5,Male,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,12020738,All Races,~,Male,Larynx,2019
25-29,3.0,3.7,403,Incidence,12020738,All Races,3.4,Male,Leukemias,2019
25-29,0.3,0.5,48,Incidence,12020738,All Races,0.4,Male,Liver and Intrahepatic Bile Duct,2019
25-29,0.3,0.5,50,Incidence,12020738,All Races,0.4,Male,Lung and Bronchus,2019
25-29,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
25-29,2.6,3.2,345,Incidence,12020738,All Races,2.9,Male,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,12020738,All Races,~,Male,Mesothelioma,2019
25-29,~,~,~,Incidence,12020738,All Races,~,Male,Myeloma,2019
25-29,3.6,4.3,478,Incidence,12020738,All Races,4.0,Male,Non-Hodgkin Lymphoma,2019
25-29,0.8,1.1,113,Incidence,12020738,All Races,0.9,Male,Oral Cavity and Pharynx,2019
25-29,0.2,0.4,35,Incidence,12020738,All Races,0.3,Male,Pancreas,2019
25-29,~,~,~,Incidence,12020738,All Races,~,Male,Prostate,2019
25-29,0.5,0.8,73,Incidence,12020738,All Races,0.6,Male,Stomach,2019
25-29,13.1,14.4,1651,Incidence,12020738,All Races,13.7,Male,Testis,2019
25-29,3.7,4.5,492,Incidence,12020738,All Races,4.1,Male,Thyroid,2019
25-29,0.3,0.5,47,Incidence,12020738,All Races,0.4,Male,Urinary Bladder,2019
30-34,68.7,71.8,7991,Incidence,11370500,All Races,70.3,Male,All Cancer Sites Combined,2019
30-34,3.7,4.5,466,Incidence,11370500,All Races,4.1,Male,Brain and Other Nervous System,2019
30-34,6.0,7.0,738,Incidence,11370500,All Races,6.5,Male,Colon and Rectum,2019
30-34,0.3,0.5,45,Incidence,11370500,All Races,0.4,Male,Esophagus,2019
30-34,3.4,4.2,432,Incidence,11370500,All Races,3.8,Male,Hodgkin Lymphoma,2019
30-34,0.9,1.3,128,Incidence,11370500,All Races,1.1,Male,Kaposi Sarcoma,2019
30-34,3.3,4.0,410,Incidence,11370500,All Races,3.6,Male,Kidney and Renal Pelvis,2019
30-34,0.1,0.3,23,Incidence,11370500,All Races,0.2,Male,Larynx,2019
30-34,3.8,4.6,477,Incidence,11370500,All Races,4.2,Male,Leukemias,2019
30-34,0.7,1.1,98,Incidence,11370500,All Races,0.9,Male,Liver and Intrahepatic Bile Duct,2019
30-34,1.0,1.4,138,Incidence,11370500,All Races,1.2,Male,Lung and Bronchus,2019
30-34,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
30-34,6.0,6.9,732,Incidence,11370500,All Races,6.4,Male,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,11370500,All Races,~,Male,Mesothelioma,2019
30-34,0.3,0.5,44,Incidence,11370500,All Races,0.4,Male,Myeloma,2019
30-34,5.1,6.0,633,Incidence,11370500,All Races,5.6,Male,Non-Hodgkin Lymphoma,2019
30-34,1.7,2.2,222,Incidence,11370500,All Races,2.0,Male,Oral Cavity and Pharynx,2019
30-34,0.6,0.9,79,Incidence,11370500,All Races,0.7,Male,Pancreas,2019
30-34,~,~,~,Incidence,11370500,All Races,~,Male,Prostate,2019
30-34,0.8,1.1,105,Incidence,11370500,All Races,0.9,Male,Stomach,2019
30-34,14.0,15.4,1668,Incidence,11370500,All Races,14.7,Male,Testis,2019
30-34,4.6,5.4,569,Incidence,11370500,All Races,5.0,Male,Thyroid,2019
30-34,0.8,1.2,111,Incidence,11370500,All Races,1.0,Male,Urinary Bladder,2019
35-39,96.7,100.5,10739,Incidence,10892543,All Races,98.6,Male,All Cancer Sites Combined,2019
35-39,4.1,4.9,490,Incidence,10892543,All Races,4.5,Male,Brain and Other Nervous System,2019
35-39,11.6,12.9,1333,Incidence,10892543,All Races,12.2,Male,Colon and Rectum,2019
35-39,0.6,1.0,88,Incidence,10892543,All Races,0.8,Male,Esophagus,2019
35-39,2.6,3.3,319,Incidence,10892543,All Races,2.9,Male,Hodgkin Lymphoma,2019
35-39,0.6,1.0,88,Incidence,10892543,All Races,0.8,Male,Kaposi Sarcoma,2019
35-39,7.7,8.8,897,Incidence,10892543,All Races,8.2,Male,Kidney and Renal Pelvis,2019
35-39,0.2,0.5,36,Incidence,10892543,All Races,0.3,Male,Larynx,2019
35-39,4.9,5.8,585,Incidence,10892543,All Races,5.4,Male,Leukemias,2019
35-39,1.1,1.6,144,Incidence,10892543,All Races,1.3,Male,Liver and Intrahepatic Bile Duct,2019
35-39,2.5,3.1,300,Incidence,10892543,All Races,2.8,Male,Lung and Bronchus,2019
35-39,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
35-39,9.1,10.2,1050,Incidence,10892543,All Races,9.6,Male,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,10892543,All Races,~,Male,Mesothelioma,2019
35-39,0.9,1.3,116,Incidence,10892543,All Races,1.1,Male,Myeloma,2019
35-39,7.0,8.1,822,Incidence,10892543,All Races,7.5,Male,Non-Hodgkin Lymphoma,2019
35-39,3.5,4.3,421,Incidence,10892543,All Races,3.9,Male,Oral Cavity and Pharynx,2019
35-39,1.5,2.0,186,Incidence,10892543,All Races,1.7,Male,Pancreas,2019
35-39,0.5,0.8,65,Incidence,10892543,All Races,0.6,Male,Prostate,2019
35-39,1.8,2.3,223,Incidence,10892543,All Races,2.0,Male,Stomach,2019
35-39,11.7,13.0,1343,Incidence,10892543,All Races,12.3,Male,Testis,2019
35-39,7.1,8.1,826,Incidence,10892543,All Races,7.6,Male,Thyroid,2019
35-39,1.6,2.2,206,Incidence,10892543,All Races,1.9,Male,Urinary Bladder,2019
40-44,150.9,155.8,15194,Incidence,9906220,All Races,153.4,Male,All Cancer Sites Combined,2019
40-44,5.0,6.0,544,Incidence,9906220,All Races,5.5,Male,Brain and Other Nervous System,2019
40-44,21.8,23.7,2249,Incidence,9906220,All Races,22.7,Male,Colon and Rectum,2019
40-44,1.6,2.2,185,Incidence,9906220,All Races,1.9,Male,Esophagus,2019
40-44,2.7,3.4,302,Incidence,9906220,All Races,3.0,Male,Hodgkin Lymphoma,2019
40-44,0.6,1.0,80,Incidence,9906220,All Races,0.8,Male,Kaposi Sarcoma,2019
40-44,14.8,16.3,1539,Incidence,9906220,All Races,15.5,Male,Kidney and Renal Pelvis,2019
40-44,0.8,1.2,95,Incidence,9906220,All Races,1.0,Male,Larynx,2019
40-44,6.4,7.5,689,Incidence,9906220,All Races,7.0,Male,Leukemias,2019
40-44,1.9,2.5,219,Incidence,9906220,All Races,2.2,Male,Liver and Intrahepatic Bile Duct,2019
40-44,5.6,6.6,603,Incidence,9906220,All Races,6.1,Male,Lung and Bronchus,2019
40-44,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
40-44,13.3,14.8,1387,Incidence,9906220,All Races,14.0,Male,Melanomas of the Skin,2019
40-44,0.1,0.3,16,Incidence,9906220,All Races,0.2,Male,Mesothelioma,2019
40-44,2.3,3.0,262,Incidence,9906220,All Races,2.6,Male,Myeloma,2019
40-44,9.2,10.5,976,Incidence,9906220,All Races,9.9,Male,Non-Hodgkin Lymphoma,2019
40-44,7.6,8.8,812,Incidence,9906220,All Races,8.2,Male,Oral Cavity and Pharynx,2019
40-44,3.0,3.7,329,Incidence,9906220,All Races,3.3,Male,Pancreas,2019
40-44,5.6,6.6,604,Incidence,9906220,All Races,6.1,Male,Prostate,2019
40-44,3.0,3.8,334,Incidence,9906220,All Races,3.4,Male,Stomach,2019
40-44,8.9,10.1,942,Incidence,9906220,All Races,9.5,Male,Testis,2019
40-44,9.3,10.5,980,Incidence,9906220,All Races,9.9,Male,Thyroid,2019
40-44,3.6,4.4,393,Incidence,9906220,All Races,4.0,Male,Urinary Bladder,2019
45-49,263.6,270.0,26895,Incidence,10082635,All Races,266.7,Male,All Cancer Sites Combined,2019
45-49,6.1,7.1,660,Incidence,10082635,All Races,6.5,Male,Brain and Other Nervous System,2019
45-49,39.4,41.9,4096,Incidence,10082635,All Races,40.6,Male,Colon and Rectum,2019
45-49,3.7,4.4,407,Incidence,10082635,All Races,4.0,Male,Esophagus,2019
45-49,2.5,3.1,279,Incidence,10082635,All Races,2.8,Male,Hodgkin Lymphoma,2019
45-49,0.5,0.9,69,Incidence,10082635,All Races,0.7,Male,Kaposi Sarcoma,2019
45-49,24.9,26.9,2609,Incidence,10082635,All Races,25.9,Male,Kidney and Renal Pelvis,2019
45-49,2.4,3.1,278,Incidence,10082635,All Races,2.8,Male,Larynx,2019
45-49,10.1,11.3,1077,Incidence,10082635,All Races,10.7,Male,Leukemias,2019
45-49,4.5,5.3,493,Incidence,10082635,All Races,4.9,Male,Liver and Intrahepatic Bile Duct,2019
45-49,14.3,15.9,1520,Incidence,10082635,All Races,15.1,Male,Lung and Bronchus,2019
45-49,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
45-49,19.6,21.4,2065,Incidence,10082635,All Races,20.5,Male,Melanomas of the Skin,2019
45-49,0.1,0.3,17,Incidence,10082635,All Races,0.2,Male,Mesothelioma,2019
45-49,4.9,5.8,536,Incidence,10082635,All Races,5.3,Male,Myeloma,2019
45-49,15.1,16.6,1597,Incidence,10082635,All Races,15.8,Male,Non-Hodgkin Lymphoma,2019
45-49,16.4,18.0,1731,Incidence,10082635,All Races,17.2,Male,Oral Cavity and Pharynx,2019
45-49,7.5,8.6,812,Incidence,10082635,All Races,8.1,Male,Pancreas,2019
45-49,29.6,31.7,3088,Incidence,10082635,All Races,30.6,Male,Prostate,2019
45-49,5.1,6.1,564,Incidence,10082635,All Races,5.6,Male,Stomach,2019
45-49,5.6,6.6,615,Incidence,10082635,All Races,6.1,Male,Testis,2019
45-49,10.3,11.6,1104,Incidence,10082635,All Races,10.9,Male,Thyroid,2019
45-49,8.0,9.2,866,Incidence,10082635,All Races,8.6,Male,Urinary Bladder,2019
5-9,12.6,14.1,1379,Incidence,10335306,All Races,13.3,Male,All Cancer Sites Combined,2019
5-9,3.1,3.8,353,Incidence,10335306,All Races,3.4,Male,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Colon and Rectum,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Esophagus,2019
5-9,0.3,0.6,47,Incidence,10335306,All Races,0.5,Male,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Kaposi Sarcoma,2019
5-9,0.3,0.6,48,Incidence,10335306,All Races,0.5,Male,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Larynx,2019
5-9,4.1,5.0,468,Incidence,10335306,All Races,4.5,Male,Leukemias,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Lung and Bronchus,2019
5-9,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Mesothelioma,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Myeloma,2019
5-9,1.1,1.5,133,Incidence,10335306,All Races,1.3,Male,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Pancreas,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Prostate,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Stomach,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Testis,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Thyroid,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male,Urinary Bladder,2019
50-54,508.1,516.9,51669,Incidence,10082296,All Races,512.5,Male,All Cancer Sites Combined,2019
50-54,8.4,9.5,900,Incidence,10082296,All Races,8.9,Male,Brain and Other Nervous System,2019
50-54,73.6,77.0,7589,Incidence,10082296,All Races,75.3,Male,Colon and Rectum,2019
50-54,8.1,9.2,872,Incidence,10082296,All Races,8.6,Male,Esophagus,2019
50-54,2.5,3.1,279,Incidence,10082296,All Races,2.8,Male,Hodgkin Lymphoma,2019
50-54,0.7,1.0,83,Incidence,10082296,All Races,0.8,Male,Kaposi Sarcoma,2019
50-54,35.7,38.1,3717,Incidence,10082296,All Races,36.9,Male,Kidney and Renal Pelvis,2019
50-54,5.8,6.8,634,Incidence,10082296,All Races,6.3,Male,Larynx,2019
50-54,14.8,16.4,1570,Incidence,10082296,All Races,15.6,Male,Leukemias,2019
50-54,12.3,13.7,1310,Incidence,10082296,All Races,13.0,Male,Liver and Intrahepatic Bile Duct,2019
50-54,35.5,37.9,3700,Incidence,10082296,All Races,36.7,Male,Lung and Bronchus,2019
50-54,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
50-54,30.6,32.8,3191,Incidence,10082296,All Races,31.6,Male,Melanomas of the Skin,2019
50-54,0.4,0.7,55,Incidence,10082296,All Races,0.5,Male,Mesothelioma,2019
50-54,8.4,9.6,904,Incidence,10082296,All Races,9.0,Male,Myeloma,2019
50-54,22.4,24.3,2350,Incidence,10082296,All Races,23.3,Male,Non-Hodgkin Lymphoma,2019
50-54,31.8,34.0,3317,Incidence,10082296,All Races,32.9,Male,Oral Cavity and Pharynx,2019
50-54,14.2,15.7,1504,Incidence,10082296,All Races,14.9,Male,Pancreas,2019
50-54,112.6,116.8,11567,Incidence,10082296,All Races,114.7,Male,Prostate,2019
50-54,8.5,9.7,912,Incidence,10082296,All Races,9.0,Male,Stomach,2019
50-54,3.8,4.6,419,Incidence,10082296,All Races,4.2,Male,Testis,2019
50-54,12.2,13.6,1301,Incidence,10082296,All Races,12.9,Male,Thyroid,2019
50-54,16.6,18.2,1750,Incidence,10082296,All Races,17.4,Male,Urinary Bladder,2019
55-59,882.5,893.8,94488,Incidence,10639047,All Races,888.1,Male,All Cancer Sites Combined,2019
55-59,11.9,13.3,1341,Incidence,10639047,All Races,12.6,Male,Brain and Other Nervous System,2019
55-59,81.4,84.9,8845,Incidence,10639047,All Races,83.1,Male,Colon and Rectum,2019
55-59,14.5,16.0,1625,Incidence,10639047,All Races,15.3,Male,Esophagus,2019
55-59,3.0,3.7,357,Incidence,10639047,All Races,3.4,Male,Hodgkin Lymphoma,2019
55-59,0.7,1.0,88,Incidence,10639047,All Races,0.8,Male,Kaposi Sarcoma,2019
55-59,50.9,53.7,5560,Incidence,10639047,All Races,52.3,Male,Kidney and Renal Pelvis,2019
55-59,12.7,14.1,1427,Incidence,10639047,All Races,13.4,Male,Larynx,2019
55-59,23.0,24.9,2547,Incidence,10639047,All Races,23.9,Male,Leukemias,2019
55-59,30.5,32.6,3356,Incidence,10639047,All Races,31.5,Male,Liver and Intrahepatic Bile Duct,2019
55-59,90.8,94.5,9859,Incidence,10639047,All Races,92.7,Male,Lung and Bronchus,2019
55-59,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
55-59,45.9,48.5,5020,Incidence,10639047,All Races,47.2,Male,Melanomas of the Skin,2019
55-59,0.7,1.1,96,Incidence,10639047,All Races,0.9,Male,Mesothelioma,2019
55-59,14.1,15.6,1579,Incidence,10639047,All Races,14.8,Male,Myeloma,2019
55-59,33.4,35.7,3673,Incidence,10639047,All Races,34.5,Male,Non-Hodgkin Lymphoma,2019
55-59,49.6,52.3,5422,Incidence,10639047,All Races,51.0,Male,Oral Cavity and Pharynx,2019
55-59,24.5,26.5,2711,Incidence,10639047,All Races,25.5,Male,Pancreas,2019
55-59,257.9,264.0,27761,Incidence,10639047,All Races,260.9,Male,Prostate,2019
55-59,13.7,15.2,1535,Incidence,10639047,All Races,14.4,Male,Stomach,2019
55-59,3.1,3.8,367,Incidence,10639047,All Races,3.4,Male,Testis,2019
55-59,12.4,13.7,1387,Incidence,10639047,All Races,13.0,Male,Thyroid,2019
55-59,34.5,36.8,3791,Incidence,10639047,All Races,35.6,Male,Urinary Bladder,2019
60-64,1367.6,1382.3,135447,Incidence,9851308,All Races,1374.9,Male,All Cancer Sites Combined,2019
60-64,14.3,15.8,1481,Incidence,9851308,All Races,15.0,Male,Brain and Other Nervous System,2019
60-64,104.2,108.3,10465,Incidence,9851308,All Races,106.2,Male,Colon and Rectum,2019
60-64,24.5,26.5,2511,Incidence,9851308,All Races,25.5,Male,Esophagus,2019
60-64,3.1,3.8,340,Incidence,9851308,All Races,3.5,Male,Hodgkin Lymphoma,2019
60-64,0.4,0.8,58,Incidence,9851308,All Races,0.6,Male,Kaposi Sarcoma,2019
60-64,66.6,69.8,6717,Incidence,9851308,All Races,68.2,Male,Kidney and Renal Pelvis,2019
60-64,18.5,20.2,1903,Incidence,9851308,All Races,19.3,Male,Larynx,2019
60-64,32.6,34.9,3319,Incidence,9851308,All Races,33.7,Male,Leukemias,2019
60-64,51.7,54.5,5229,Incidence,9851308,All Races,53.1,Male,Liver and Intrahepatic Bile Duct,2019
60-64,164.2,169.4,16431,Incidence,9851308,All Races,166.8,Male,Lung and Bronchus,2019
60-64,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
60-64,65.9,69.2,6655,Incidence,9851308,All Races,67.6,Male,Melanomas of the Skin,2019
60-64,1.2,1.7,144,Incidence,9851308,All Races,1.5,Male,Mesothelioma,2019
60-64,21.3,23.2,2190,Incidence,9851308,All Races,22.2,Male,Myeloma,2019
60-64,48.8,51.6,4946,Incidence,9851308,All Races,50.2,Male,Non-Hodgkin Lymphoma,2019
60-64,62.8,66.0,6344,Incidence,9851308,All Races,64.4,Male,Oral Cavity and Pharynx,2019
60-64,39.6,42.2,4028,Incidence,9851308,All Races,40.9,Male,Pancreas,2019
60-64,444.1,452.5,44159,Incidence,9851308,All Races,448.3,Male,Prostate,2019
60-64,20.3,22.1,2084,Incidence,9851308,All Races,21.2,Male,Stomach,2019
60-64,1.9,2.5,213,Incidence,9851308,All Races,2.2,Male,Testis,2019
60-64,15.1,16.7,1569,Incidence,9851308,All Races,15.9,Male,Thyroid,2019
60-64,63.0,66.1,6358,Incidence,9851308,All Races,64.5,Male,Urinary Bladder,2019
65-69,1973.1,1992.4,162421,Incidence,8191801,All Races,1982.7,Male,All Cancer Sites Combined,2019
65-69,18.4,20.3,1583,Incidence,8191801,All Races,19.3,Male,Brain and Other Nervous System,2019
65-69,134.6,139.7,11233,Incidence,8191801,All Races,137.1,Male,Colon and Rectum,2019
65-69,33.4,36.0,2842,Incidence,8191801,All Races,34.7,Male,Esophagus,2019
65-69,3.5,4.3,317,Incidence,8191801,All Races,3.9,Male,Hodgkin Lymphoma,2019
65-69,0.5,0.8,51,Incidence,8191801,All Races,0.6,Male,Kaposi Sarcoma,2019
65-69,87.7,91.8,7349,Incidence,8191801,All Races,89.7,Male,Kidney and Renal Pelvis,2019
65-69,21.4,23.5,1836,Incidence,8191801,All Races,22.4,Male,Larynx,2019
65-69,47.7,50.8,4033,Incidence,8191801,All Races,49.2,Male,Leukemias,2019
65-69,67.0,70.6,5634,Incidence,8191801,All Races,68.8,Male,Liver and Intrahepatic Bile Duct,2019
65-69,248.5,255.4,20635,Incidence,8191801,All Races,251.9,Male,Lung and Bronchus,2019
65-69,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
65-69,94.2,98.5,7891,Incidence,8191801,All Races,96.3,Male,Melanomas of the Skin,2019
65-69,2.8,3.5,257,Incidence,8191801,All Races,3.1,Male,Mesothelioma,2019
65-69,30.7,33.2,2617,Incidence,8191801,All Races,31.9,Male,Myeloma,2019
65-69,70.6,74.3,5930,Incidence,8191801,All Races,72.4,Male,Non-Hodgkin Lymphoma,2019
65-69,70.8,74.5,5949,Incidence,8191801,All Races,72.6,Male,Oral Cavity and Pharynx,2019
65-69,58.6,62.0,4938,Incidence,8191801,All Races,60.3,Male,Pancreas,2019
65-69,680.7,692.0,56224,Incidence,8191801,All Races,686.3,Male,Prostate,2019
65-69,28.3,30.7,2414,Incidence,8191801,All Races,29.5,Male,Stomach,2019
65-69,1.7,2.3,159,Incidence,8191801,All Races,1.9,Male,Testis,2019
65-69,17.5,19.3,1507,Incidence,8191801,All Races,18.4,Male,Thyroid,2019
65-69,108.2,112.8,9050,Incidence,8191801,All Races,110.5,Male,Urinary Bladder,2019
70-74,2313.3,2336.8,151109,Incidence,6499159,All Races,2325.1,Male,All Cancer Sites Combined,2019
70-74,20.7,23.0,1419,Incidence,6499159,All Races,21.8,Male,Brain and Other Nervous System,2019
70-74,151.8,157.9,10062,Incidence,6499159,All Races,154.8,Male,Colon and Rectum,2019
70-74,39.4,42.5,2660,Incidence,6499159,All Races,40.9,Male,Esophagus,2019
70-74,3.9,4.9,284,Incidence,6499159,All Races,4.4,Male,Hodgkin Lymphoma,2019
70-74,0.6,1.0,49,Incidence,6499159,All Races,0.8,Male,Kaposi Sarcoma,2019
70-74,98.2,103.1,6543,Incidence,6499159,All Races,100.7,Male,Kidney and Renal Pelvis,2019
70-74,22.4,24.8,1531,Incidence,6499159,All Races,23.6,Male,Larynx,2019
70-74,67.3,71.3,4503,Incidence,6499159,All Races,69.3,Male,Leukemias,2019
70-74,57.8,61.6,3877,Incidence,6499159,All Races,59.7,Male,Liver and Intrahepatic Bile Duct,2019
70-74,340.3,349.3,22406,Incidence,6499159,All Races,344.8,Male,Lung and Bronchus,2019
70-74,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
70-74,127.0,132.5,8431,Incidence,6499159,All Races,129.7,Male,Melanomas of the Skin,2019
70-74,5.6,6.9,404,Incidence,6499159,All Races,6.2,Male,Mesothelioma,2019
70-74,41.0,44.2,2765,Incidence,6499159,All Races,42.5,Male,Myeloma,2019
70-74,92.3,97.0,6150,Incidence,6499159,All Races,94.6,Male,Non-Hodgkin Lymphoma,2019
70-74,70.8,75.0,4738,Incidence,6499159,All Races,72.9,Male,Oral Cavity and Pharynx,2019
70-74,74.9,79.2,5004,Incidence,6499159,All Races,77.0,Male,Pancreas,2019
70-74,691.5,704.3,45355,Incidence,6499159,All Races,697.9,Male,Prostate,2019
70-74,35.6,38.6,2411,Incidence,6499159,All Races,37.1,Male,Stomach,2019
70-74,0.9,1.4,72,Incidence,6499159,All Races,1.1,Male,Testis,2019
70-74,17.6,19.7,1212,Incidence,6499159,All Races,18.6,Male,Thyroid,2019
70-74,159.2,165.4,10544,Incidence,6499159,All Races,162.2,Male,Urinary Bladder,2019
75-79,2662.7,2693.6,115634,Incidence,4317707,All Races,2678.1,Male,All Cancer Sites Combined,2019
75-79,24.0,27.0,1100,Incidence,4317707,All Races,25.5,Male,Brain and Other Nervous System,2019
75-79,186.3,194.5,8219,Incidence,4317707,All Races,190.4,Male,Colon and Rectum,2019
75-79,42.4,46.4,1915,Incidence,4317707,All Races,44.4,Male,Esophagus,2019
75-79,4.3,5.6,212,Incidence,4317707,All Races,4.9,Male,Hodgkin Lymphoma,2019
75-79,0.7,1.3,43,Incidence,4317707,All Races,1.0,Male,Kaposi Sarcoma,2019
75-79,104.2,110.4,4630,Incidence,4317707,All Races,107.2,Male,Kidney and Renal Pelvis,2019
75-79,21.9,24.9,1009,Incidence,4317707,All Races,23.4,Male,Larynx,2019
75-79,90.4,96.1,4025,Incidence,4317707,All Races,93.2,Male,Leukemias,2019
75-79,59.0,63.7,2648,Incidence,4317707,All Races,61.3,Male,Liver and Intrahepatic Bile Duct,2019
75-79,430.2,442.6,18841,Incidence,4317707,All Races,436.4,Male,Lung and Bronchus,2019
75-79,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
75-79,161.6,169.2,7140,Incidence,4317707,All Races,165.4,Male,Melanomas of the Skin,2019
75-79,10.0,12.0,475,Incidence,4317707,All Races,11.0,Male,Mesothelioma,2019
75-79,50.6,54.9,2277,Incidence,4317707,All Races,52.7,Male,Myeloma,2019
75-79,123.0,129.7,5454,Incidence,4317707,All Races,126.3,Male,Non-Hodgkin Lymphoma,2019
75-79,66.9,71.9,2996,Incidence,4317707,All Races,69.4,Male,Oral Cavity and Pharynx,2019
75-79,92.1,97.9,4100,Incidence,4317707,All Races,95.0,Male,Pancreas,2019
75-79,622.7,637.7,27207,Incidence,4317707,All Races,630.1,Male,Prostate,2019
75-79,45.1,49.2,2034,Incidence,4317707,All Races,47.1,Male,Stomach,2019
75-79,0.6,1.2,38,Incidence,4317707,All Races,0.9,Male,Testis,2019
75-79,16.8,19.3,778,Incidence,4317707,All Races,18.0,Male,Thyroid,2019
75-79,236.4,245.7,10407,Incidence,4317707,All Races,241.0,Male,Urinary Bladder,2019
80-84,2762.8,2802.8,74543,Incidence,2678743,All Races,2782.8,Male,All Cancer Sites Combined,2019
80-84,24.9,28.9,719,Incidence,2678743,All Races,26.8,Male,Brain and Other Nervous System,2019
80-84,228.0,239.6,6261,Incidence,2678743,All Races,233.7,Male,Colon and Rectum,2019
80-84,43.0,48.1,1219,Incidence,2678743,All Races,45.5,Male,Esophagus,2019
80-84,4.0,5.7,129,Incidence,2678743,All Races,4.8,Male,Hodgkin Lymphoma,2019
80-84,1.2,2.2,43,Incidence,2678743,All Races,1.6,Male,Kaposi Sarcoma,2019
80-84,99.6,107.3,2770,Incidence,2678743,All Races,103.4,Male,Kidney and Renal Pelvis,2019
80-84,21.6,25.4,628,Incidence,2678743,All Races,23.4,Male,Larynx,2019
80-84,109.7,117.8,3045,Incidence,2678743,All Races,113.7,Male,Leukemias,2019
80-84,59.6,65.6,1675,Incidence,2678743,All Races,62.5,Male,Liver and Intrahepatic Bile Duct,2019
80-84,449.6,465.8,12259,Incidence,2678743,All Races,457.6,Male,Lung and Bronchus,2019
80-84,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
80-84,186.6,197.1,5137,Incidence,2678743,All Races,191.8,Male,Melanomas of the Skin,2019
80-84,12.9,15.8,384,Incidence,2678743,All Races,14.3,Male,Mesothelioma,2019
80-84,59.4,65.4,1669,Incidence,2678743,All Races,62.3,Male,Myeloma,2019
80-84,143.8,153.0,3974,Incidence,2678743,All Races,148.4,Male,Non-Hodgkin Lymphoma,2019
80-84,65.0,71.3,1824,Incidence,2678743,All Races,68.1,Male,Oral Cavity and Pharynx,2019
80-84,102.8,110.7,2858,Incidence,2678743,All Races,106.7,Male,Pancreas,2019
80-84,459.4,475.8,12525,Incidence,2678743,All Races,467.6,Male,Prostate,2019
80-84,50.0,55.5,1412,Incidence,2678743,All Races,52.7,Male,Stomach,2019
80-84,0.7,1.6,29,Incidence,2678743,All Races,1.1,Male,Testis,2019
80-84,13.0,15.9,386,Incidence,2678743,All Races,14.4,Male,Thyroid,2019
80-84,279.8,292.6,7665,Incidence,2678743,All Races,286.1,Male,Urinary Bladder,2019
85+,2639.8,2681.3,63165,Incidence,2374207,All Races,2660.5,Male,All Cancer Sites Combined,2019
85+,21.4,25.3,552,Incidence,2374207,All Races,23.2,Male,Brain and Other Nervous System,2019
85+,240.2,252.9,5853,Incidence,2374207,All Races,246.5,Male,Colon and Rectum,2019
85+,38.7,43.9,978,Incidence,2374207,All Races,41.2,Male,Esophagus,2019
85+,3.1,4.7,91,Incidence,2374207,All Races,3.8,Male,Hodgkin Lymphoma,2019
85+,1.0,2.1,35,Incidence,2374207,All Races,1.5,Male,Kaposi Sarcoma,2019
85+,76.1,83.4,1892,Incidence,2374207,All Races,79.7,Male,Kidney and Renal Pelvis,2019
85+,19.7,23.5,511,Incidence,2374207,All Races,21.5,Male,Larynx,2019
85+,110.8,119.5,2732,Incidence,2374207,All Races,115.1,Male,Leukemias,2019
85+,50.6,56.6,1271,Incidence,2374207,All Races,53.5,Male,Liver and Intrahepatic Bile Duct,2019
85+,375.7,391.5,9106,Incidence,2374207,All Races,383.5,Male,Lung and Bronchus,2019
85+,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
85+,197.2,208.7,4816,Incidence,2374207,All Races,202.8,Male,Melanomas of the Skin,2019
85+,13.5,16.7,357,Incidence,2374207,All Races,15.0,Male,Mesothelioma,2019
85+,51.7,57.7,1297,Incidence,2374207,All Races,54.6,Male,Myeloma,2019
85+,133.1,142.6,3271,Incidence,2374207,All Races,137.8,Male,Non-Hodgkin Lymphoma,2019
85+,56.9,63.1,1423,Incidence,2374207,All Races,59.9,Male,Oral Cavity and Pharynx,2019
85+,97.7,105.9,2415,Incidence,2374207,All Races,101.7,Male,Pancreas,2019
85+,353.5,368.9,8574,Incidence,2374207,All Races,361.1,Male,Prostate,2019
85+,48.3,54.1,1215,Incidence,2374207,All Races,51.2,Male,Stomach,2019
85+,0.6,1.4,22,Incidence,2374207,All Races,0.9,Male,Testis,2019
85+,9.0,11.7,244,Incidence,2374207,All Races,10.3,Male,Thyroid,2019
85+,320.7,335.4,7787,Incidence,2374207,All Races,328.0,Male,Urinary Bladder,2019
<1,24.2,28.9,509,Incidence,1921001,All Races,26.5,Male,All Cancer Sites Combined,2019
<1,2.2,3.8,57,Incidence,1921001,All Races,3.0,Male,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Colon and Rectum,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Esophagus,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Kaposi Sarcoma,2019
<1,1.4,2.7,37,Incidence,1921001,All Races,1.9,Male,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Larynx,2019
<1,2.8,4.6,70,Incidence,1921001,All Races,3.6,Male,Leukemias,2019
<1,0.9,2.0,26,Incidence,1921001,All Races,1.4,Male,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Lung and Bronchus,2019
<1,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Melanomas of the Skin,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Mesothelioma,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Myeloma,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Pancreas,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Prostate,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Stomach,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Testis,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Thyroid,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male,Urinary Bladder,2019
1-4,20.6,22.0,3369,Incidence,15809112,All Races,21.3,Male and Female,All Cancer Sites Combined,2019
1-4,3.6,4.2,615,Incidence,15809112,All Races,3.9,Male and Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,Cervix,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Esophagus,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,Female Breast,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Kaposi Sarcoma,2019
1-4,1.7,2.1,300,Incidence,15809112,All Races,1.9,Male and Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Larynx,2019
1-4,7.7,8.6,1284,Incidence,15809112,All Races,8.1,Male and Female,Leukemias,2019
1-4,0.5,0.8,105,Incidence,15809112,All Races,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
1-4,0.1,0.2,16,Incidence,15809112,All Races,0.1,Male and Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,Male and Female Breast,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
1-4,0.1,0.2,18,Incidence,15809112,All Races,0.1,Male and Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Mesothelioma,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Myeloma,2019
1-4,0.6,0.9,113,Incidence,15809112,All Races,0.7,Male and Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,7728847,All Races,~,Male and Female,Ovary,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Pancreas,2019
1-4,~,~,~,Incidence,8080265,All Races,~,Male and Female,Prostate,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Stomach,2019
1-4,0.2,0.4,22,Incidence,8080265,All Races,0.3,Male and Female,Testis,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Thyroid,2019
1-4,~,~,~,Incidence,15809112,All Races,~,Male and Female,Urinary Bladder,2019
10-14,14.9,15.9,3202,Incidence,20820053,All Races,15.4,Male and Female,All Cancer Sites Combined,2019
10-14,2.5,3.0,566,Incidence,20820053,All Races,2.7,Male and Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Male and Female,Cervix,2019
10-14,0.5,0.8,134,Incidence,20820053,All Races,0.6,Male and Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Male and Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Esophagus,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Male and Female,Female Breast,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2019
10-14,1.1,1.4,259,Incidence,20820053,All Races,1.2,Male and Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Kaposi Sarcoma,2019
10-14,0.1,0.2,28,Incidence,20820053,All Races,0.1,Male and Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Larynx,2019
10-14,3.2,3.7,707,Incidence,20820053,All Races,3.4,Male and Female,Leukemias,2019
10-14,0.1,0.2,25,Incidence,20820053,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
10-14,0.0,0.1,16,Incidence,20820053,All Races,0.1,Male and Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Male and Female,Male and Female Breast,2019
10-14,~,~,~,Incidence,10190891,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
10-14,0.2,0.3,48,Incidence,20820053,All Races,0.2,Male and Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Mesothelioma,2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Myeloma,2019
10-14,1.2,1.5,275,Incidence,20820053,All Races,1.3,Male and Female,Non-Hodgkin Lymphoma,2019
10-14,0.2,0.4,57,Incidence,20820053,All Races,0.3,Male and Female,Oral Cavity and Pharynx,2019
10-14,0.5,0.9,69,Incidence,10190891,All Races,0.7,Male and Female,Ovary,2019
10-14,0.1,0.2,22,Incidence,20820053,All Races,0.1,Male and Female,Pancreas,2019
10-14,~,~,~,Incidence,10629162,All Races,~,Male and Female,Prostate,2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Stomach,2019
10-14,0.2,0.4,27,Incidence,10629162,All Races,0.3,Male and Female,Testis,2019
10-14,0.9,1.1,205,Incidence,20820053,All Races,1.0,Male and Female,Thyroid,2019
10-14,~,~,~,Incidence,20820053,All Races,~,Male and Female,Urinary Bladder,2019
15-19,23.8,25.2,5163,Incidence,21066423,All Races,24.5,Male and Female,All Cancer Sites Combined,2019
15-19,2.0,2.4,470,Incidence,21066423,All Races,2.2,Male and Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Male and Female,Cervix,2019
15-19,1.2,1.6,296,Incidence,21066423,All Races,1.4,Male and Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Male and Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,21066423,All Races,~,Male and Female,Esophagus,2019
15-19,0.1,0.3,24,Incidence,10313575,All Races,0.2,Male and Female,Female Breast,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2019
15-19,3.0,3.5,691,Incidence,21066423,All Races,3.3,Male and Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,21066423,All Races,~,Male and Female,Kaposi Sarcoma,2019
15-19,0.2,0.3,53,Incidence,21066423,All Races,0.3,Male and Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,21066423,All Races,~,Male and Female,Larynx,2019
15-19,2.9,3.4,656,Incidence,21066423,All Races,3.1,Male and Female,Leukemias,2019
15-19,0.1,0.2,29,Incidence,21066423,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
15-19,0.1,0.2,31,Incidence,21066423,All Races,0.1,Male and Female,Lung and Bronchus,2019
15-19,0.1,0.3,24,Incidence,10313575,All Races,0.2,Male and Female,Male and Female Breast,2019
15-19,~,~,~,Incidence,10313575,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
15-19,0.6,0.9,157,Incidence,21066423,All Races,0.7,Male and Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,21066423,All Races,~,Male and Female,Mesothelioma,2019
15-19,~,~,~,Incidence,21066423,All Races,~,Male and Female,Myeloma,2019
15-19,1.7,2.1,400,Incidence,21066423,All Races,1.9,Male and Female,Non-Hodgkin Lymphoma,2019
15-19,0.4,0.6,100,Incidence,21066423,All Races,0.5,Male and Female,Oral Cavity and Pharynx,2019
15-19,1.0,1.4,124,Incidence,10313575,All Races,1.2,Male and Female,Ovary,2019
15-19,0.2,0.3,53,Incidence,21066423,All Races,0.3,Male and Female,Pancreas,2019
15-19,~,~,~,Incidence,10752848,All Races,~,Male and Female,Prostate,2019
15-19,~,~,~,Incidence,21066423,All Races,~,Male and Female,Stomach,2019
15-19,3.0,3.7,355,Incidence,10752848,All Races,3.3,Male and Female,Testis,2019
15-19,3.3,3.9,758,Incidence,21066423,All Races,3.6,Male and Female,Thyroid,2019
15-19,0.0,0.1,16,Incidence,21066423,All Races,0.1,Male and Female,Urinary Bladder,2019
20-24,36.2,37.8,8009,Incidence,21643974,All Races,37.0,Male and Female,All Cancer Sites Combined,2019
20-24,2.1,2.5,487,Incidence,21643974,All Races,2.3,Male and Female,Brain and Other Nervous System,2019
20-24,0.3,0.6,48,Incidence,10577124,All Races,0.5,Male and Female,Cervix,2019
20-24,1.8,2.2,437,Incidence,21643974,All Races,2.0,Male and Female,Colon and Rectum,2019
20-24,0.4,0.8,62,Incidence,10577124,All Races,0.6,Male and Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,21643974,All Races,~,Male and Female,Esophagus,2019
20-24,1.6,2.1,192,Incidence,10577124,All Races,1.8,Male and Female,Female Breast,2019
20-24,0.1,0.3,24,Incidence,10577124,All Races,0.2,Male and Female,"Female Breast, <i>in situ</i>",2019
20-24,4.1,4.6,939,Incidence,21643974,All Races,4.3,Male and Female,Hodgkin Lymphoma,2019
20-24,0.1,0.2,29,Incidence,21643974,All Races,0.1,Male and Female,Kaposi Sarcoma,2019
20-24,0.6,0.8,157,Incidence,21643974,All Races,0.7,Male and Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,21643974,All Races,~,Male and Female,Larynx,2019
20-24,2.6,3.0,604,Incidence,21643974,All Races,2.8,Male and Female,Leukemias,2019
20-24,0.2,0.3,47,Incidence,21643974,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2019
20-24,0.3,0.4,75,Incidence,21643974,All Races,0.3,Male and Female,Lung and Bronchus,2019
20-24,1.6,2.1,192,Incidence,10577124,All Races,1.8,Male and Female,Male and Female Breast,2019
20-24,0.1,0.3,24,Incidence,10577124,All Races,0.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
20-24,2.1,2.5,494,Incidence,21643974,All Races,2.3,Male and Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,21643974,All Races,~,Male and Female,Mesothelioma,2019
20-24,~,~,~,Incidence,21643974,All Races,~,Male and Female,Myeloma,2019
20-24,2.2,2.6,512,Incidence,21643974,All Races,2.4,Male and Female,Non-Hodgkin Lymphoma,2019
20-24,0.6,0.8,150,Incidence,21643974,All Races,0.7,Male and Female,Oral Cavity and Pharynx,2019
20-24,1.3,1.8,161,Incidence,10577124,All Races,1.5,Male and Female,Ovary,2019
20-24,0.1,0.3,44,Incidence,21643974,All Races,0.2,Male and Female,Pancreas,2019
20-24,~,~,~,Incidence,11066850,All Races,~,Male and Female,Prostate,2019
20-24,0.2,0.3,47,Incidence,21643974,All Races,0.2,Male and Female,Stomach,2019
20-24,9.4,10.6,1106,Incidence,11066850,All Races,10.0,Male and Female,Testis,2019
20-24,6.3,7.0,1433,Incidence,21643974,All Races,6.6,Male and Female,Thyroid,2019
20-24,0.1,0.3,40,Incidence,21643974,All Races,0.2,Male and Female,Urinary Bladder,2019
25-29,57.8,59.8,13843,Incidence,23539452,All Races,58.8,Male and Female,All Cancer Sites Combined,2019
25-29,2.5,2.9,637,Incidence,23539452,All Races,2.7,Male and Female,Brain and Other Nervous System,2019
25-29,3.8,4.6,483,Incidence,11518714,All Races,4.2,Male and Female,Cervix,2019
25-29,3.1,3.5,773,Incidence,23539452,All Races,3.3,Male and Female,Colon and Rectum,2019
25-29,2.1,2.7,273,Incidence,11518714,All Races,2.4,Male and Female,"Corpus and Uterus, NOS",2019
25-29,0.0,0.1,17,Incidence,23539452,All Races,0.1,Male and Female,Esophagus,2019
25-29,10.1,11.4,1237,Incidence,11518714,All Races,10.7,Male and Female,Female Breast,2019
25-29,0.8,1.1,106,Incidence,11518714,All Races,0.9,Male and Female,"Female Breast, <i>in situ</i>",2019
25-29,3.6,4.2,916,Incidence,23539452,All Races,3.9,Male and Female,Hodgkin Lymphoma,2019
25-29,0.3,0.4,82,Incidence,23539452,All Races,0.3,Male and Female,Kaposi Sarcoma,2019
25-29,1.3,1.6,335,Incidence,23539452,All Races,1.4,Male and Female,Kidney and Renal Pelvis,2019
25-29,0.0,0.1,16,Incidence,23539452,All Races,0.1,Male and Female,Larynx,2019
25-29,2.8,3.2,701,Incidence,23539452,All Races,3.0,Male and Female,Leukemias,2019
25-29,0.3,0.4,76,Incidence,23539452,All Races,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
25-29,0.4,0.6,119,Incidence,23539452,All Races,0.5,Male and Female,Lung and Bronchus,2019
25-29,10.1,11.4,1237,Incidence,11518714,All Races,10.7,Male and Female,Male and Female Breast,2019
25-29,0.8,1.1,106,Incidence,11518714,All Races,0.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
25-29,4.5,5.1,1123,Incidence,23539452,All Races,4.8,Male and Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,23539452,All Races,~,Male and Female,Mesothelioma,2019
25-29,0.0,0.1,18,Incidence,23539452,All Races,0.1,Male and Female,Myeloma,2019
25-29,3.2,3.7,811,Incidence,23539452,All Races,3.4,Male and Female,Non-Hodgkin Lymphoma,2019
25-29,0.9,1.1,237,Incidence,23539452,All Races,1.0,Male and Female,Oral Cavity and Pharynx,2019
25-29,2.3,2.9,301,Incidence,11518714,All Races,2.6,Male and Female,Ovary,2019
25-29,0.3,0.5,99,Incidence,23539452,All Races,0.4,Male and Female,Pancreas,2019
25-29,~,~,~,Incidence,12020738,All Races,~,Male and Female,Prostate,2019
25-29,0.4,0.6,110,Incidence,23539452,All Races,0.5,Male and Female,Stomach,2019
25-29,13.1,14.4,1651,Incidence,12020738,All Races,13.7,Male and Female,Testis,2019
25-29,10.1,11.0,2480,Incidence,23539452,All Races,10.5,Male and Female,Thyroid,2019
25-29,0.3,0.4,77,Incidence,23539452,All Races,0.3,Male and Female,Urinary Bladder,2019
30-34,97.4,100.0,22172,Incidence,22464232,All Races,98.7,Male and Female,All Cancer Sites Combined,2019
30-34,3.3,3.8,802,Incidence,22464232,All Races,3.6,Male and Female,Brain and Other Nervous System,2019
30-34,11.3,12.6,1328,Incidence,11093732,All Races,12.0,Male and Female,Cervix,2019
30-34,6.4,7.0,1505,Incidence,22464232,All Races,6.7,Male and Female,Colon and Rectum,2019
30-34,5.6,6.5,670,Incidence,11093732,All Races,6.0,Male and Female,"Corpus and Uterus, NOS",2019
30-34,0.2,0.3,58,Incidence,22464232,All Races,0.3,Male and Female,Esophagus,2019
30-34,29.6,31.6,3392,Incidence,11093732,All Races,30.6,Male and Female,Female Breast,2019
30-34,3.0,3.7,373,Incidence,11093732,All Races,3.4,Male and Female,"Female Breast, <i>in situ</i>",2019
30-34,3.4,3.9,810,Incidence,22464232,All Races,3.6,Male and Female,Hodgkin Lymphoma,2019
30-34,0.5,0.7,133,Incidence,22464232,All Races,0.6,Male and Female,Kaposi Sarcoma,2019
30-34,3.0,3.5,725,Incidence,22464232,All Races,3.2,Male and Female,Kidney and Renal Pelvis,2019
30-34,0.1,0.3,42,Incidence,22464232,All Races,0.2,Male and Female,Larynx,2019
30-34,3.4,3.9,819,Incidence,22464232,All Races,3.6,Male and Female,Leukemias,2019
30-34,0.5,0.7,143,Incidence,22464232,All Races,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
30-34,1.1,1.4,271,Incidence,22464232,All Races,1.2,Male and Female,Lung and Bronchus,2019
30-34,29.6,31.6,3392,Incidence,11093732,All Races,30.6,Male and Female,Male and Female Breast,2019
30-34,3.0,3.7,373,Incidence,11093732,All Races,3.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
30-34,9.2,10.0,2149,Incidence,22464232,All Races,9.6,Male and Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,22464232,All Races,~,Male and Female,Mesothelioma,2019
30-34,0.3,0.4,80,Incidence,22464232,All Races,0.4,Male and Female,Myeloma,2019
30-34,4.4,4.9,1040,Incidence,22464232,All Races,4.6,Male and Female,Non-Hodgkin Lymphoma,2019
30-34,1.7,2.0,411,Incidence,22464232,All Races,1.8,Male and Female,Oral Cavity and Pharynx,2019
30-34,3.4,4.1,412,Incidence,11093732,All Races,3.7,Male and Female,Ovary,2019
30-34,0.7,0.9,171,Incidence,22464232,All Races,0.8,Male and Female,Pancreas,2019
30-34,~,~,~,Incidence,11370500,All Races,~,Male and Female,Prostate,2019
30-34,0.8,1.0,204,Incidence,22464232,All Races,0.9,Male and Female,Stomach,2019
30-34,14.0,15.4,1668,Incidence,11370500,All Races,14.7,Male and Female,Testis,2019
30-34,14.4,15.4,3354,Incidence,22464232,All Races,14.9,Male and Female,Thyroid,2019
30-34,0.6,0.9,164,Incidence,22464232,All Races,0.7,Male and Female,Urinary Bladder,2019
35-39,147.7,151.0,32491,Incidence,21753883,All Races,149.4,Male and Female,All Cancer Sites Combined,2019
35-39,3.7,4.2,864,Incidence,21753883,All Races,4.0,Male and Female,Brain and Other Nervous System,2019
35-39,13.6,15.1,1559,Incidence,10861340,All Races,14.4,Male and Female,Cervix,2019
35-39,11.4,12.4,2587,Incidence,21753883,All Races,11.9,Male and Female,Colon and Rectum,2019
35-39,10.4,11.6,1192,Incidence,10861340,All Races,11.0,Male and Female,"Corpus and Uterus, NOS",2019
35-39,0.4,0.6,110,Incidence,21753883,All Races,0.5,Male and Female,Esophagus,2019
35-39,64.5,67.5,7168,Incidence,10861340,All Races,66.0,Male and Female,Female Breast,2019
35-39,9.0,10.2,1044,Incidence,10861340,All Races,9.6,Male and Female,"Female Breast, <i>in situ</i>",2019
35-39,2.7,3.2,641,Incidence,21753883,All Races,2.9,Male and Female,Hodgkin Lymphoma,2019
35-39,0.3,0.5,90,Incidence,21753883,All Races,0.4,Male and Female,Kaposi Sarcoma,2019
35-39,6.7,7.4,1534,Incidence,21753883,All Races,7.1,Male and Female,Kidney and Renal Pelvis,2019
35-39,0.2,0.4,61,Incidence,21753883,All Races,0.3,Male and Female,Larynx,2019
35-39,4.6,5.2,1057,Incidence,21753883,All Races,4.9,Male and Female,Leukemias,2019
35-39,0.9,1.2,235,Incidence,21753883,All Races,1.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
35-39,2.5,3.0,593,Incidence,21753883,All Races,2.7,Male and Female,Lung and Bronchus,2019
35-39,64.5,67.5,7168,Incidence,10861340,All Races,66.0,Male and Female,Male and Female Breast,2019
35-39,9.0,10.2,1044,Incidence,10861340,All Races,9.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
35-39,12.3,13.3,2782,Incidence,21753883,All Races,12.8,Male and Female,Melanomas of the Skin,2019
35-39,0.1,0.2,27,Incidence,21753883,All Races,0.1,Male and Female,Mesothelioma,2019
35-39,0.9,1.2,234,Incidence,21753883,All Races,1.1,Male and Female,Myeloma,2019
35-39,6.3,7.0,1445,Incidence,21753883,All Races,6.6,Male and Female,Non-Hodgkin Lymphoma,2019
35-39,2.9,3.4,685,Incidence,21753883,All Races,3.1,Male and Female,Oral Cavity and Pharynx,2019
35-39,4.4,5.2,522,Incidence,10861340,All Races,4.8,Male and Female,Ovary,2019
35-39,1.3,1.6,313,Incidence,21753883,All Races,1.4,Male and Female,Pancreas,2019
35-39,0.5,0.8,65,Incidence,10892543,All Races,0.6,Male and Female,Prostate,2019
35-39,1.8,2.2,434,Incidence,21753883,All Races,2.0,Male and Female,Stomach,2019
35-39,11.7,13.0,1343,Incidence,10892543,All Races,12.3,Male and Female,Testis,2019
35-39,18.1,19.3,4071,Incidence,21753883,All Races,18.7,Male and Female,Thyroid,2019
35-39,1.2,1.6,305,Incidence,21753883,All Races,1.4,Male and Female,Urinary Bladder,2019
40-44,233.4,237.7,46920,Incidence,19920561,All Races,235.5,Male and Female,All Cancer Sites Combined,2019
40-44,4.3,4.9,918,Incidence,19920561,All Races,4.6,Male and Female,Brain and Other Nervous System,2019
40-44,14.9,16.4,1566,Incidence,10014341,All Races,15.6,Male and Female,Cervix,2019
40-44,20.5,21.8,4219,Incidence,19920561,All Races,21.2,Male and Female,Colon and Rectum,2019
40-44,16.9,18.6,1778,Incidence,10014341,All Races,17.8,Male and Female,"Corpus and Uterus, NOS",2019
40-44,1.0,1.3,227,Incidence,19920561,All Races,1.1,Male and Female,Esophagus,2019
40-44,130.8,135.4,13328,Incidence,10014341,All Races,133.1,Male and Female,Female Breast,2019
40-44,40.2,42.7,4148,Incidence,10014341,All Races,41.4,Male and Female,"Female Breast, <i>in situ</i>",2019
40-44,2.4,2.8,520,Incidence,19920561,All Races,2.6,Male and Female,Hodgkin Lymphoma,2019
40-44,0.3,0.5,83,Incidence,19920561,All Races,0.4,Male and Female,Kaposi Sarcoma,2019
40-44,12.0,12.9,2479,Incidence,19920561,All Races,12.4,Male and Female,Kidney and Renal Pelvis,2019
40-44,0.6,0.8,140,Incidence,19920561,All Races,0.7,Male and Female,Larynx,2019
40-44,5.9,6.6,1235,Incidence,19920561,All Races,6.2,Male and Female,Leukemias,2019
40-44,1.6,1.9,346,Incidence,19920561,All Races,1.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
40-44,6.0,6.7,1254,Incidence,19920561,All Races,6.3,Male and Female,Lung and Bronchus,2019
40-44,130.8,135.4,13328,Incidence,10014341,All Races,133.1,Male and Female,Male and Female Breast,2019
40-44,40.2,42.7,4148,Incidence,10014341,All Races,41.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
40-44,16.4,17.5,3372,Incidence,19920561,All Races,16.9,Male and Female,Melanomas of the Skin,2019
40-44,0.1,0.3,36,Incidence,19920561,All Races,0.2,Male and Female,Mesothelioma,2019
40-44,2.2,2.6,471,Incidence,19920561,All Races,2.4,Male and Female,Myeloma,2019
40-44,8.5,9.3,1766,Incidence,19920561,All Races,8.9,Male and Female,Non-Hodgkin Lymphoma,2019
40-44,5.5,6.2,1167,Incidence,19920561,All Races,5.9,Male and Female,Oral Cavity and Pharynx,2019
40-44,7.6,8.7,814,Incidence,10014341,All Races,8.1,Male and Female,Ovary,2019
40-44,2.8,3.3,612,Incidence,19920561,All Races,3.1,Male and Female,Pancreas,2019
40-44,5.6,6.6,604,Incidence,9906220,All Races,6.1,Male and Female,Prostate,2019
40-44,3.0,3.5,638,Incidence,19920561,All Races,3.2,Male and Female,Stomach,2019
40-44,8.9,10.1,942,Incidence,9906220,All Races,9.5,Male and Female,Testis,2019
40-44,21.1,22.4,4339,Incidence,19920561,All Races,21.8,Male and Female,Thyroid,2019
40-44,2.6,3.0,559,Incidence,19920561,All Races,2.8,Male and Female,Urinary Bladder,2019
45-49,363.2,368.5,74598,Incidence,20390439,All Races,365.8,Male and Female,All Cancer Sites Combined,2019
45-49,5.2,5.9,1132,Incidence,20390439,All Races,5.6,Male and Female,Brain and Other Nervous System,2019
45-49,14.0,15.4,1514,Incidence,10307804,All Races,14.7,Male and Female,Cervix,2019
45-49,36.2,37.9,7548,Incidence,20390439,All Races,37.0,Male and Female,Colon and Rectum,2019
45-49,27.9,30.0,2980,Incidence,10307804,All Races,28.9,Male and Female,"Corpus and Uterus, NOS",2019
45-49,2.3,2.7,508,Incidence,20390439,All Races,2.5,Male and Female,Esophagus,2019
45-49,200.7,206.2,20968,Incidence,10307804,All Races,203.4,Male and Female,Female Breast,2019
45-49,56.8,59.8,6010,Incidence,10307804,All Races,58.3,Male and Female,"Female Breast, <i>in situ</i>",2019
45-49,2.2,2.7,497,Incidence,20390439,All Races,2.4,Male and Female,Hodgkin Lymphoma,2019
45-49,0.3,0.4,72,Incidence,20390439,All Races,0.4,Male and Female,Kaposi Sarcoma,2019
45-49,18.7,19.9,3934,Incidence,20390439,All Races,19.3,Male and Female,Kidney and Renal Pelvis,2019
45-49,1.6,2.0,368,Incidence,20390439,All Races,1.8,Male and Female,Larynx,2019
45-49,8.9,9.7,1894,Incidence,20390439,All Races,9.3,Male and Female,Leukemias,2019
45-49,3.3,3.8,717,Incidence,20390439,All Races,3.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
45-49,15.2,16.2,3200,Incidence,20390439,All Races,15.7,Male and Female,Lung and Bronchus,2019
45-49,200.7,206.2,20968,Incidence,10307804,All Races,203.4,Male and Female,Male and Female Breast,2019
45-49,56.8,59.8,6010,Incidence,10307804,All Races,58.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
45-49,22.0,23.3,4623,Incidence,20390439,All Races,22.7,Male and Female,Melanomas of the Skin,2019
45-49,0.1,0.3,40,Incidence,20390439,All Races,0.2,Male and Female,Mesothelioma,2019
45-49,4.4,5.0,965,Incidence,20390439,All Races,4.7,Male and Female,Myeloma,2019
45-49,13.1,14.1,2775,Incidence,20390439,All Races,13.6,Male and Female,Non-Hodgkin Lymphoma,2019
45-49,11.1,12.0,2357,Incidence,20390439,All Races,11.6,Male and Female,Oral Cavity and Pharynx,2019
45-49,11.3,12.6,1230,Incidence,10307804,All Races,11.9,Male and Female,Ovary,2019
45-49,6.6,7.3,1419,Incidence,20390439,All Races,7.0,Male and Female,Pancreas,2019
45-49,29.6,31.7,3088,Incidence,10082635,All Races,30.6,Male and Female,Prostate,2019
45-49,5.0,5.6,1073,Incidence,20390439,All Races,5.3,Male and Female,Stomach,2019
45-49,5.6,6.6,615,Incidence,10082635,All Races,6.1,Male and Female,Testis,2019
45-49,21.9,23.2,4603,Incidence,20390439,All Races,22.6,Male and Female,Thyroid,2019
45-49,5.5,6.1,1178,Incidence,20390439,All Races,5.8,Male and Female,Urinary Bladder,2019
5-9,12.0,13.0,2528,Incidence,20221753,All Races,12.5,Male and Female,All Cancer Sites Combined,2019
5-9,3.0,3.6,666,Incidence,20221753,All Races,3.3,Male and Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Male and Female,Cervix,2019
5-9,0.1,0.2,21,Incidence,20221753,All Races,0.1,Male and Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Male and Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Esophagus,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Male and Female,Female Breast,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2019
5-9,0.3,0.4,72,Incidence,20221753,All Races,0.4,Male and Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Kaposi Sarcoma,2019
5-9,0.4,0.6,101,Incidence,20221753,All Races,0.5,Male and Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Larynx,2019
5-9,3.8,4.4,827,Incidence,20221753,All Races,4.1,Male and Female,Leukemias,2019
5-9,0.1,0.2,27,Incidence,20221753,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Male and Female,Male and Female Breast,2019
5-9,~,~,~,Incidence,9886447,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
5-9,0.1,0.2,21,Incidence,20221753,All Races,0.1,Male and Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Mesothelioma,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Myeloma,2019
5-9,0.8,1.1,193,Incidence,20221753,All Races,1.0,Male and Female,Non-Hodgkin Lymphoma,2019
5-9,0.1,0.1,19,Incidence,20221753,All Races,0.1,Male and Female,Oral Cavity and Pharynx,2019
5-9,0.2,0.5,34,Incidence,9886447,All Races,0.3,Male and Female,Ovary,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Pancreas,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male and Female,Prostate,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Stomach,2019
5-9,~,~,~,Incidence,10335306,All Races,~,Male and Female,Testis,2019
5-9,0.1,0.2,36,Incidence,20221753,All Races,0.2,Male and Female,Thyroid,2019
5-9,~,~,~,Incidence,20221753,All Races,~,Male and Female,Urinary Bladder,2019
50-54,566.1,572.6,116548,Incidence,20469884,All Races,569.4,Male and Female,All Cancer Sites Combined,2019
50-54,7.1,7.8,1519,Incidence,20469884,All Races,7.4,Male and Female,Brain and Other Nervous System,2019
50-54,12.7,14.2,1395,Incidence,10387588,All Races,13.4,Male and Female,Cervix,2019
50-54,64.3,66.5,13381,Incidence,20469884,All Races,65.4,Male and Female,Colon and Rectum,2019
50-54,47.3,50.0,5052,Incidence,10387588,All Races,48.6,Male and Female,"Corpus and Uterus, NOS",2019
50-54,5.0,5.6,1077,Incidence,20469884,All Races,5.3,Male and Female,Esophagus,2019
50-54,240.5,246.5,25295,Incidence,10387588,All Races,243.5,Male and Female,Female Breast,2019
50-54,65.7,68.9,6987,Incidence,10387588,All Races,67.3,Male and Female,"Female Breast, <i>in situ</i>",2019
50-54,2.1,2.5,468,Incidence,20469884,All Races,2.3,Male and Female,Hodgkin Lymphoma,2019
50-54,0.3,0.5,87,Incidence,20469884,All Races,0.4,Male and Female,Kaposi Sarcoma,2019
50-54,26.5,27.9,5565,Incidence,20469884,All Races,27.2,Male and Female,Kidney and Renal Pelvis,2019
50-54,3.8,4.4,843,Incidence,20469884,All Races,4.1,Male and Female,Larynx,2019
50-54,12.4,13.4,2634,Incidence,20469884,All Races,12.9,Male and Female,Leukemias,2019
50-54,8.3,9.1,1774,Incidence,20469884,All Races,8.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
50-54,37.9,39.6,7937,Incidence,20469884,All Races,38.8,Male and Female,Lung and Bronchus,2019
50-54,240.5,246.5,25295,Incidence,10387588,All Races,243.5,Male and Female,Male and Female Breast,2019
50-54,65.7,68.9,6987,Incidence,10387588,All Races,67.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
50-54,30.2,31.7,6339,Incidence,20469884,All Races,31.0,Male and Female,Melanomas of the Skin,2019
50-54,0.3,0.5,81,Incidence,20469884,All Races,0.4,Male and Female,Mesothelioma,2019
50-54,7.4,8.2,1594,Incidence,20469884,All Races,7.8,Male and Female,Myeloma,2019
50-54,19.9,21.2,4204,Incidence,20469884,All Races,20.5,Male and Female,Non-Hodgkin Lymphoma,2019
50-54,20.6,21.8,4341,Incidence,20469884,All Races,21.2,Male and Female,Oral Cavity and Pharynx,2019
50-54,15.6,17.2,1700,Incidence,10387588,All Races,16.4,Male and Female,Ovary,2019
50-54,12.0,12.9,2546,Incidence,20469884,All Races,12.4,Male and Female,Pancreas,2019
50-54,112.6,116.8,11567,Incidence,10082296,All Races,114.7,Male and Female,Prostate,2019
50-54,7.4,8.2,1592,Incidence,20469884,All Races,7.8,Male and Female,Stomach,2019
50-54,3.8,4.6,419,Incidence,10082296,All Races,4.2,Male and Female,Testis,2019
50-54,22.7,24.0,4772,Incidence,20469884,All Races,23.3,Male and Female,Thyroid,2019
50-54,11.2,12.1,2388,Incidence,20469884,All Races,11.7,Male and Female,Urinary Bladder,2019
55-59,844.0,851.7,185433,Incidence,21871091,All Races,847.8,Male and Female,All Cancer Sites Combined,2019
55-59,9.8,10.6,2228,Incidence,21871091,All Races,10.2,Male and Female,Brain and Other Nervous System,2019
55-59,11.2,12.5,1334,Incidence,11232044,All Races,11.9,Male and Female,Cervix,2019
55-59,68.1,70.3,15125,Incidence,21871091,All Races,69.2,Male and Female,Colon and Rectum,2019
55-59,75.7,78.9,8680,Incidence,11232044,All Races,77.3,Male and Female,"Corpus and Uterus, NOS",2019
55-59,9.0,9.8,2053,Incidence,21871091,All Races,9.4,Male and Female,Esophagus,2019
55-59,274.0,280.1,31117,Incidence,11232044,All Races,277.0,Male and Female,Female Breast,2019
55-59,68.4,71.5,7853,Incidence,11232044,All Races,69.9,Male and Female,"Female Breast, <i>in situ</i>",2019
55-59,2.4,2.8,560,Incidence,21871091,All Races,2.6,Male and Female,Hodgkin Lymphoma,2019
55-59,0.3,0.5,93,Incidence,21871091,All Races,0.4,Male and Female,Kaposi Sarcoma,2019
55-59,37.1,38.7,8282,Incidence,21871091,All Races,37.9,Male and Female,Kidney and Renal Pelvis,2019
55-59,8.0,8.8,1832,Incidence,21871091,All Races,8.4,Male and Female,Larynx,2019
55-59,18.9,20.0,4254,Incidence,21871091,All Races,19.5,Male and Female,Leukemias,2019
55-59,19.4,20.6,4369,Incidence,21871091,All Races,20.0,Male and Female,Liver and Intrahepatic Bile Duct,2019
55-59,90.4,92.9,20045,Incidence,21871091,All Races,91.7,Male and Female,Lung and Bronchus,2019
55-59,274.0,280.1,31117,Incidence,11232044,All Races,277.0,Male and Female,Male and Female Breast,2019
55-59,68.4,71.5,7853,Incidence,11232044,All Races,69.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
55-59,39.6,41.3,8852,Incidence,21871091,All Races,40.5,Male and Female,Melanomas of the Skin,2019
55-59,0.6,0.9,161,Incidence,21871091,All Races,0.7,Male and Female,Mesothelioma,2019
55-59,11.8,12.7,2674,Incidence,21871091,All Races,12.2,Male and Female,Myeloma,2019
55-59,29.2,30.6,6540,Incidence,21871091,All Races,29.9,Male and Female,Non-Hodgkin Lymphoma,2019
55-59,31.6,33.1,7067,Incidence,21871091,All Races,32.3,Male and Female,Oral Cavity and Pharynx,2019
55-59,19.5,21.2,2282,Incidence,11232044,All Races,20.3,Male and Female,Ovary,2019
55-59,21.2,22.4,4770,Incidence,21871091,All Races,21.8,Male and Female,Pancreas,2019
55-59,257.9,264.0,27761,Incidence,10639047,All Races,260.9,Male and Female,Prostate,2019
55-59,10.6,11.5,2413,Incidence,21871091,All Races,11.0,Male and Female,Stomach,2019
55-59,3.1,3.8,367,Incidence,10639047,All Races,3.4,Male and Female,Testis,2019
55-59,21.9,23.1,4920,Incidence,21871091,All Races,22.5,Male and Female,Thyroid,2019
55-59,22.7,24.0,5100,Incidence,21871091,All Races,23.3,Male and Female,Urinary Bladder,2019
60-64,1210.5,1220.1,249864,Incidence,20560134,All Races,1215.3,Male and Female,All Cancer Sites Combined,2019
60-64,11.7,12.7,2513,Incidence,20560134,All Races,12.2,Male and Female,Brain and Other Nervous System,2019
60-64,11.2,12.5,1269,Incidence,10708826,All Races,11.9,Male and Female,Cervix,2019
60-64,85.7,88.3,17886,Incidence,20560134,All Races,87.0,Male and Female,Colon and Rectum,2019
60-64,99.7,103.5,10882,Incidence,10708826,All Races,101.6,Male and Female,"Corpus and Uterus, NOS",2019
60-64,14.6,15.6,3105,Incidence,20560134,All Races,15.1,Male and Female,Esophagus,2019
60-64,341.0,348.0,36888,Incidence,10708826,All Races,344.5,Male and Female,Female Breast,2019
60-64,82.0,85.5,8971,Incidence,10708826,All Races,83.8,Male and Female,"Female Breast, <i>in situ</i>",2019
60-64,2.4,2.9,547,Incidence,20560134,All Races,2.7,Male and Female,Hodgkin Lymphoma,2019
60-64,0.2,0.4,63,Incidence,20560134,All Races,0.3,Male and Female,Kaposi Sarcoma,2019
60-64,48.8,50.7,10226,Incidence,20560134,All Races,49.7,Male and Female,Kidney and Renal Pelvis,2019
60-64,11.3,12.2,2415,Incidence,20560134,All Races,11.7,Male and Female,Larynx,2019
60-64,26.3,27.7,5546,Incidence,20560134,All Races,27.0,Male and Female,Leukemias,2019
60-64,32.6,34.2,6859,Incidence,20560134,All Races,33.4,Male and Female,Liver and Intrahepatic Bile Duct,2019
60-64,153.5,156.9,31908,Incidence,20560134,All Races,155.2,Male and Female,Lung and Bronchus,2019
60-64,341.0,348.0,36888,Incidence,10708826,All Races,344.5,Male and Female,Male and Female Breast,2019
60-64,82.0,85.5,8971,Incidence,10708826,All Races,83.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
60-64,53.8,55.9,11274,Incidence,20560134,All Races,54.8,Male and Female,Melanomas of the Skin,2019
60-64,1.0,1.2,225,Incidence,20560134,All Races,1.1,Male and Female,Mesothelioma,2019
60-64,17.9,19.1,3804,Incidence,20560134,All Races,18.5,Male and Female,Myeloma,2019
60-64,42.0,43.8,8820,Incidence,20560134,All Races,42.9,Male and Female,Non-Hodgkin Lymphoma,2019
60-64,39.6,41.4,8330,Incidence,20560134,All Races,40.5,Male and Female,Oral Cavity and Pharynx,2019
60-64,24.5,26.4,2723,Incidence,10708826,All Races,25.4,Male and Female,Ovary,2019
60-64,34.0,35.7,7162,Incidence,20560134,All Races,34.8,Male and Female,Pancreas,2019
60-64,444.1,452.5,44159,Incidence,9851308,All Races,448.3,Male and Female,Prostate,2019
60-64,15.4,16.5,3269,Incidence,20560134,All Races,15.9,Male and Female,Stomach,2019
60-64,1.9,2.5,213,Incidence,9851308,All Races,2.2,Male and Female,Testis,2019
60-64,22.3,23.7,4727,Incidence,20560134,All Races,23.0,Male and Female,Thyroid,2019
60-64,39.5,41.3,8303,Incidence,20560134,All Races,40.4,Male and Female,Urinary Bladder,2019
65-69,1647.6,1659.7,288466,Incidence,17444367,All Races,1653.6,Male and Female,All Cancer Sites Combined,2019
65-69,15.3,16.4,2763,Incidence,17444367,All Races,15.8,Male and Female,Brain and Other Nervous System,2019
65-69,9.3,10.6,916,Incidence,9252566,All Races,9.9,Male and Female,Cervix,2019
65-69,112.0,115.2,19819,Incidence,17444367,All Races,113.6,Male and Female,Colon and Rectum,2019
65-69,116.1,120.6,10951,Incidence,9252566,All Races,118.4,Male and Female,"Corpus and Uterus, NOS",2019
65-69,19.3,20.6,3477,Incidence,17444367,All Races,19.9,Male and Female,Esophagus,2019
65-69,426.3,434.8,39838,Incidence,9252566,All Races,430.6,Male and Female,Female Breast,2019
65-69,97.0,101.1,9161,Incidence,9252566,All Races,99.0,Male and Female,"Female Breast, <i>in situ</i>",2019
65-69,2.9,3.4,543,Incidence,17444367,All Races,3.1,Male and Female,Hodgkin Lymphoma,2019
65-69,0.2,0.4,57,Incidence,17444367,All Races,0.3,Male and Female,Kaposi Sarcoma,2019
65-69,63.2,65.6,11237,Incidence,17444367,All Races,64.4,Male and Female,Kidney and Renal Pelvis,2019
65-69,12.4,13.4,2251,Incidence,17444367,All Races,12.9,Male and Female,Larynx,2019
65-69,37.1,38.9,6625,Incidence,17444367,All Races,38.0,Male and Female,Leukemias,2019
65-69,42.7,44.7,7619,Incidence,17444367,All Races,43.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
65-69,221.5,225.9,39022,Incidence,17444367,All Races,223.7,Male and Female,Lung and Bronchus,2019
65-69,426.3,434.8,39838,Incidence,9252566,All Races,430.6,Male and Female,Male and Female Breast,2019
65-69,97.0,101.1,9161,Incidence,9252566,All Races,99.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
65-69,70.6,73.1,12531,Incidence,17444367,All Races,71.8,Male and Female,Melanomas of the Skin,2019
65-69,1.8,2.3,357,Incidence,17444367,All Races,2.0,Male and Female,Mesothelioma,2019
65-69,26.0,27.6,4672,Incidence,17444367,All Races,26.8,Male and Female,Myeloma,2019
65-69,59.1,61.4,10507,Incidence,17444367,All Races,60.2,Male and Female,Non-Hodgkin Lymphoma,2019
65-69,44.9,46.9,8001,Incidence,17444367,All Races,45.9,Male and Female,Oral Cavity and Pharynx,2019
65-69,26.3,28.5,2534,Incidence,9252566,All Races,27.4,Male and Female,Ovary,2019
65-69,49.7,51.8,8849,Incidence,17444367,All Races,50.7,Male and Female,Pancreas,2019
65-69,680.7,692.0,56224,Incidence,8191801,All Races,686.3,Male and Female,Prostate,2019
65-69,20.5,21.9,3699,Incidence,17444367,All Races,21.2,Male and Female,Stomach,2019
65-69,1.7,2.3,159,Incidence,8191801,All Races,1.9,Male and Female,Testis,2019
65-69,23.8,25.3,4285,Incidence,17444367,All Races,24.6,Male and Female,Thyroid,2019
65-69,65.6,68.0,11650,Incidence,17444367,All Races,66.8,Male and Female,Urinary Bladder,2019
70-74,1945.2,1959.8,273880,Incidence,14026977,All Races,1952.5,Male and Female,All Cancer Sites Combined,2019
70-74,17.5,18.9,2553,Incidence,14026977,All Races,18.2,Male and Female,Brain and Other Nervous System,2019
70-74,8.6,10.0,700,Incidence,7527818,All Races,9.3,Male and Female,Cervix,2019
70-74,131.5,135.3,18712,Incidence,14026977,All Races,133.4,Male and Female,Colon and Rectum,2019
70-74,110.2,115.0,8473,Incidence,7527818,All Races,112.6,Male and Female,"Corpus and Uterus, NOS",2019
70-74,22.7,24.3,3297,Incidence,14026977,All Races,23.5,Male and Female,Esophagus,2019
70-74,477.7,487.6,36333,Incidence,7527818,All Races,482.6,Male and Female,Female Breast,2019
70-74,105.3,110.0,8102,Incidence,7527818,All Races,107.6,Male and Female,"Female Breast, <i>in situ</i>",2019
70-74,3.0,3.6,456,Incidence,14026977,All Races,3.3,Male and Female,Hodgkin Lymphoma,2019
70-74,0.3,0.5,58,Incidence,14026977,All Races,0.4,Male and Female,Kaposi Sarcoma,2019
70-74,71.2,74.1,10189,Incidence,14026977,All Races,72.6,Male and Female,Kidney and Renal Pelvis,2019
70-74,12.7,13.9,1869,Incidence,14026977,All Races,13.3,Male and Female,Larynx,2019
70-74,51.5,53.9,7392,Incidence,14026977,All Races,52.7,Male and Female,Leukemias,2019
70-74,39.2,41.3,5645,Incidence,14026977,All Races,40.2,Male and Female,Liver and Intrahepatic Bile Duct,2019
70-74,306.6,312.5,43420,Incidence,14026977,All Races,309.5,Male and Female,Lung and Bronchus,2019
70-74,477.7,487.6,36333,Incidence,7527818,All Races,482.6,Male and Female,Male and Female Breast,2019
70-74,105.3,110.0,8102,Incidence,7527818,All Races,107.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
70-74,88.5,91.7,12634,Incidence,14026977,All Races,90.1,Male and Female,Melanomas of the Skin,2019
70-74,3.4,4.0,520,Incidence,14026977,All Races,3.7,Male and Female,Mesothelioma,2019
70-74,34.0,36.0,4905,Incidence,14026977,All Races,35.0,Male and Female,Myeloma,2019
70-74,76.4,79.4,10927,Incidence,14026977,All Races,77.9,Male and Female,Non-Hodgkin Lymphoma,2019
70-74,45.6,47.9,6559,Incidence,14026977,All Races,46.8,Male and Female,Oral Cavity and Pharynx,2019
70-74,32.0,34.6,2508,Incidence,7527818,All Races,33.3,Male and Female,Ovary,2019
70-74,64.9,67.6,9296,Incidence,14026977,All Races,66.3,Male and Female,Pancreas,2019
70-74,691.5,704.3,45355,Incidence,6499159,All Races,697.9,Male and Female,Prostate,2019
70-74,25.8,27.6,3744,Incidence,14026977,All Races,26.7,Male and Female,Stomach,2019
70-74,0.9,1.4,72,Incidence,6499159,All Races,1.1,Male and Female,Testis,2019
70-74,23.0,24.6,3338,Incidence,14026977,All Races,23.8,Male and Female,Thyroid,2019
70-74,95.1,98.4,13568,Incidence,14026977,All Races,96.7,Male and Female,Urinary Bladder,2019
75-79,2198.2,2217.0,213051,Incidence,9650824,All Races,2207.6,Male and Female,All Cancer Sites Combined,2019
75-79,19.6,21.4,1975,Incidence,9650824,All Races,20.5,Male and Female,Brain and Other Nervous System,2019
75-79,8.4,10.0,490,Incidence,5333117,All Races,9.2,Male and Female,Cervix,2019
75-79,161.8,166.9,15861,Incidence,9650824,All Races,164.3,Male and Female,Colon and Rectum,2019
75-79,91.4,96.6,5013,Incidence,5333117,All Races,94.0,Male and Female,"Corpus and Uterus, NOS",2019
75-79,24.4,26.4,2446,Incidence,9650824,All Races,25.3,Male and Female,Esophagus,2019
75-79,467.7,479.4,25253,Incidence,5333117,All Races,473.5,Male and Female,Female Breast,2019
75-79,82.3,87.3,4522,Incidence,5333117,All Races,84.8,Male and Female,"Female Breast, <i>in situ</i>",2019
75-79,3.6,4.4,384,Incidence,9650824,All Races,4.0,Male and Female,Hodgkin Lymphoma,2019
75-79,0.4,0.7,49,Incidence,9650824,All Races,0.5,Male and Female,Kaposi Sarcoma,2019
75-79,75.1,78.6,7418,Incidence,9650824,All Races,76.9,Male and Female,Kidney and Renal Pelvis,2019
75-79,12.0,13.5,1230,Incidence,9650824,All Races,12.7,Male and Female,Larynx,2019
75-79,67.1,70.4,6632,Incidence,9650824,All Races,68.7,Male and Female,Leukemias,2019
75-79,41.3,43.9,4113,Incidence,9650824,All Races,42.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
75-79,381.3,389.1,37171,Incidence,9650824,All Races,385.2,Male and Female,Lung and Bronchus,2019
75-79,467.7,479.4,25253,Incidence,5333117,All Races,473.5,Male and Female,Male and Female Breast,2019
75-79,82.3,87.3,4522,Incidence,5333117,All Races,84.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
75-79,104.7,108.8,10303,Incidence,9650824,All Races,106.8,Male and Female,Melanomas of the Skin,2019
75-79,5.8,6.8,608,Incidence,9650824,All Races,6.3,Male and Female,Mesothelioma,2019
75-79,42.0,44.6,4180,Incidence,9650824,All Races,43.3,Male and Female,Myeloma,2019
75-79,100.8,104.8,9918,Incidence,9650824,All Races,102.8,Male and Female,Non-Hodgkin Lymphoma,2019
75-79,44.9,47.6,4464,Incidence,9650824,All Races,46.3,Male and Female,Oral Cavity and Pharynx,2019
75-79,37.3,40.7,2078,Incidence,5333117,All Races,39.0,Male and Female,Ovary,2019
75-79,82.2,85.9,8107,Incidence,9650824,All Races,84.0,Male and Female,Pancreas,2019
75-79,622.7,637.7,27207,Incidence,4317707,All Races,630.1,Male and Female,Prostate,2019
75-79,32.0,34.3,3201,Incidence,9650824,All Races,33.2,Male and Female,Stomach,2019
75-79,0.6,1.2,38,Incidence,4317707,All Races,0.9,Male and Female,Testis,2019
75-79,19.7,21.5,1988,Incidence,9650824,All Races,20.6,Male and Female,Thyroid,2019
75-79,134.8,139.5,13233,Incidence,9650824,All Races,137.1,Male and Female,Urinary Bladder,2019
80-84,2258.2,2281.7,143348,Incidence,6315100,All Races,2269.9,Male and Female,All Cancer Sites Combined,2019
80-84,19.9,22.2,1327,Incidence,6315100,All Races,21.0,Male and Female,Brain and Other Nervous System,2019
80-84,7.2,9.0,293,Incidence,3636357,All Races,8.1,Male and Female,Cervix,2019
80-84,205.8,212.9,13218,Incidence,6315100,All Races,209.3,Male and Female,Colon and Rectum,2019
80-84,72.3,77.9,2730,Incidence,3636357,All Races,75.1,Male and Female,"Corpus and Uterus, NOS",2019
80-84,24.4,26.9,1617,Incidence,6315100,All Races,25.6,Male and Female,Esophagus,2019
80-84,422.2,435.7,15597,Incidence,3636357,All Races,428.9,Male and Female,Female Breast,2019
80-84,56.4,61.4,2140,Incidence,3636357,All Races,58.9,Male and Female,"Female Breast, <i>in situ</i>",2019
80-84,3.5,4.5,251,Incidence,6315100,All Races,4.0,Male and Female,Hodgkin Lymphoma,2019
80-84,0.6,1.1,52,Incidence,6315100,All Races,0.8,Male and Female,Kaposi Sarcoma,2019
80-84,71.2,75.4,4626,Incidence,6315100,All Races,73.3,Male and Female,Kidney and Renal Pelvis,2019
80-84,11.4,13.1,773,Incidence,6315100,All Races,12.2,Male and Female,Larynx,2019
80-84,78.9,83.4,5124,Incidence,6315100,All Races,81.1,Male and Female,Leukemias,2019
80-84,42.5,45.8,2786,Incidence,6315100,All Races,44.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
80-84,384.1,393.9,24564,Incidence,6315100,All Races,389.0,Male and Female,Lung and Bronchus,2019
80-84,422.2,435.7,15597,Incidence,3636357,All Races,428.9,Male and Female,Male and Female Breast,2019
80-84,56.4,61.4,2140,Incidence,3636357,All Races,58.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
80-84,114.3,119.7,7387,Incidence,6315100,All Races,117.0,Male and Female,Melanomas of the Skin,2019
80-84,6.8,8.1,469,Incidence,6315100,All Races,7.4,Male and Female,Mesothelioma,2019
80-84,47.3,50.8,3095,Incidence,6315100,All Races,49.0,Male and Female,Myeloma,2019
80-84,113.8,119.2,7356,Incidence,6315100,All Races,116.5,Male and Female,Non-Hodgkin Lymphoma,2019
80-84,44.5,47.9,2916,Incidence,6315100,All Races,46.2,Male and Female,Oral Cavity and Pharynx,2019
80-84,36.2,40.3,1390,Incidence,3636357,All Races,38.2,Male and Female,Ovary,2019
80-84,93.5,98.3,6056,Incidence,6315100,All Races,95.9,Male and Female,Pancreas,2019
80-84,459.4,475.8,12525,Incidence,2678743,All Races,467.6,Male and Female,Prostate,2019
80-84,36.3,39.3,2387,Incidence,6315100,All Races,37.8,Male and Female,Stomach,2019
80-84,0.7,1.6,29,Incidence,2678743,All Races,1.1,Male and Female,Testis,2019
80-84,14.3,16.3,964,Incidence,6315100,All Races,15.3,Male and Female,Thyroid,2019
80-84,156.6,162.8,10085,Incidence,6315100,All Races,159.7,Male and Female,Urinary Bladder,2019
85+,2032.9,2054.7,134878,Incidence,6599467,All Races,2043.8,Male and Female,All Cancer Sites Combined,2019
85+,16.9,18.9,1179,Incidence,6599467,All Races,17.9,Male and Female,Brain and Other Nervous System,2019
85+,6.9,8.6,326,Incidence,4225260,All Races,7.7,Male and Female,Cervix,2019
85+,221.6,228.9,14862,Incidence,6599467,All Races,225.2,Male and Female,Colon and Rectum,2019
85+,47.2,51.5,2084,Incidence,4225260,All Races,49.3,Male and Female,"Corpus and Uterus, NOS",2019
85+,21.6,23.9,1498,Incidence,6599467,All Races,22.7,Male and Female,Esophagus,2019
85+,320.2,331.1,13760,Incidence,4225260,All Races,325.7,Male and Female,Female Breast,2019
85+,22.3,25.3,1005,Incidence,4225260,All Races,23.8,Male and Female,"Female Breast, <i>in situ</i>",2019
85+,2.5,3.3,191,Incidence,6599467,All Races,2.9,Male and Female,Hodgkin Lymphoma,2019
85+,0.6,1.1,56,Incidence,6599467,All Races,0.8,Male and Female,Kaposi Sarcoma,2019
85+,53.0,56.6,3613,Incidence,6599467,All Races,54.7,Male and Female,Kidney and Renal Pelvis,2019
85+,8.4,9.9,604,Incidence,6599467,All Races,9.2,Male and Female,Larynx,2019
85+,80.0,84.4,5424,Incidence,6599467,All Races,82.2,Male and Female,Leukemias,2019
85+,35.4,38.4,2435,Incidence,6599467,All Races,36.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
85+,286.6,294.9,19186,Incidence,6599467,All Races,290.7,Male and Female,Lung and Bronchus,2019
85+,320.2,331.1,13760,Incidence,4225260,All Races,325.7,Male and Female,Male and Female Breast,2019
85+,22.3,25.3,1005,Incidence,4225260,All Races,23.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
85+,110.6,115.8,7470,Incidence,6599467,All Races,113.2,Male and Female,Melanomas of the Skin,2019
85+,6.6,7.9,476,Incidence,6599467,All Races,7.2,Male and Female,Mesothelioma,2019
85+,37.3,40.3,2560,Incidence,6599467,All Races,38.8,Male and Female,Myeloma,2019
85+,98.8,103.7,6681,Incidence,6599467,All Races,101.2,Male and Female,Non-Hodgkin Lymphoma,2019
85+,38.5,41.5,2639,Incidence,6599467,All Races,40.0,Male and Female,Oral Cavity and Pharynx,2019
85+,31.2,34.6,1389,Incidence,4225260,All Races,32.9,Male and Female,Ovary,2019
85+,95.0,99.8,6424,Incidence,6599467,All Races,97.3,Male and Female,Pancreas,2019
85+,353.5,368.9,8574,Incidence,2374207,All Races,361.1,Male and Female,Prostate,2019
85+,33.6,36.5,2311,Incidence,6599467,All Races,35.0,Male and Female,Stomach,2019
85+,0.6,1.4,22,Incidence,2374207,All Races,0.9,Male and Female,Testis,2019
85+,9.1,10.6,648,Incidence,6599467,All Races,9.8,Male and Female,Thyroid,2019
85+,162.4,168.6,10919,Incidence,6599467,All Races,165.5,Male and Female,Urinary Bladder,2019
<1,24.3,27.6,976,Incidence,3762227,All Races,25.9,Male and Female,All Cancer Sites Combined,2019
<1,2.6,3.8,119,Incidence,3762227,All Races,3.2,Male and Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,Cervix,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Colon and Rectum,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Esophagus,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,Female Breast,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Kaposi Sarcoma,2019
<1,1.1,2.0,57,Incidence,3762227,All Races,1.5,Male and Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Larynx,2019
<1,3.3,4.6,146,Incidence,3762227,All Races,3.9,Male and Female,Leukemias,2019
<1,1.2,2.1,60,Incidence,3762227,All Races,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,Male and Female Breast,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Mesothelioma,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Myeloma,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,1841226,All Races,~,Male and Female,Ovary,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Pancreas,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male and Female,Prostate,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Stomach,2019
<1,~,~,~,Incidence,1921001,All Races,~,Male and Female,Testis,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Thyroid,2019
<1,~,~,~,Incidence,3762227,All Races,~,Male and Female,Urinary Bladder,2019
1-4,19.2,23.3,421,Incidence,1991876,Hispanic of any race,21.1,Female,All Cancer Sites Combined,2019
1-4,2.8,4.6,72,Incidence,1991876,Hispanic of any race,3.6,Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Cervix,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Esophagus,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Female Breast,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
1-4,1.5,2.8,41,Incidence,1991876,Hispanic of any race,2.1,Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Larynx,2019
1-4,7.6,10.2,176,Incidence,1991876,Hispanic of any race,8.8,Female,Leukemias,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Mesothelioma,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Myeloma,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Ovary,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Pancreas,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Stomach,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Thyroid,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Female,Urinary Bladder,2019
10-14,13.9,17.0,402,Incidence,2611522,Hispanic of any race,15.4,Female,All Cancer Sites Combined,2019
10-14,1.4,2.5,49,Incidence,2611522,Hispanic of any race,1.9,Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Cervix,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Esophagus,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Female Breast,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2019
10-14,0.5,1.3,22,Incidence,2611522,Hispanic of any race,0.8,Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Larynx,2019
10-14,3.2,4.8,103,Incidence,2611522,Hispanic of any race,3.9,Female,Leukemias,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Mesothelioma,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Myeloma,2019
10-14,0.5,1.2,20,Incidence,2611522,Hispanic of any race,0.8,Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
10-14,0.6,1.4,25,Incidence,2611522,Hispanic of any race,1.0,Female,Ovary,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Pancreas,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Stomach,2019
10-14,1.5,2.7,53,Incidence,2611522,Hispanic of any race,2.0,Female,Thyroid,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Female,Urinary Bladder,2019
15-19,20.6,24.4,555,Incidence,2471628,Hispanic of any race,22.5,Female,All Cancer Sites Combined,2019
15-19,1.2,2.3,41,Incidence,2471628,Hispanic of any race,1.7,Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Cervix,2019
15-19,0.8,1.7,29,Incidence,2471628,Hispanic of any race,1.2,Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Esophagus,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Female Breast,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2019
15-19,1.7,3.0,57,Incidence,2471628,Hispanic of any race,2.3,Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Larynx,2019
15-19,2.7,4.3,85,Incidence,2471628,Hispanic of any race,3.4,Female,Leukemias,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Mesothelioma,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Myeloma,2019
15-19,0.9,1.9,33,Incidence,2471628,Hispanic of any race,1.3,Female,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
15-19,1.0,2.0,36,Incidence,2471628,Hispanic of any race,1.5,Female,Ovary,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Pancreas,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Stomach,2019
15-19,4.8,6.7,141,Incidence,2471628,Hispanic of any race,5.7,Female,Thyroid,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Female,Urinary Bladder,2019
20-24,31.2,35.9,790,Incidence,2360414,Hispanic of any race,33.5,Female,All Cancer Sites Combined,2019
20-24,1.0,2.0,34,Incidence,2360414,Hispanic of any race,1.4,Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Cervix,2019
20-24,1.3,2.5,43,Incidence,2360414,Hispanic of any race,1.8,Female,Colon and Rectum,2019
20-24,0.7,1.6,25,Incidence,2360414,Hispanic of any race,1.1,Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Esophagus,2019
20-24,1.2,2.4,41,Incidence,2360414,Hispanic of any race,1.7,Female,Female Breast,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2019
20-24,2.3,3.8,71,Incidence,2360414,Hispanic of any race,3.0,Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
20-24,0.5,1.3,19,Incidence,2360414,Hispanic of any race,0.8,Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Larynx,2019
20-24,2.4,3.9,73,Incidence,2360414,Hispanic of any race,3.1,Female,Leukemias,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Lung and Bronchus,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Mesothelioma,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Myeloma,2019
20-24,1.0,2.0,34,Incidence,2360414,Hispanic of any race,1.4,Female,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
20-24,1.4,2.6,46,Incidence,2360414,Hispanic of any race,1.9,Female,Ovary,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Pancreas,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Stomach,2019
20-24,9.6,12.3,256,Incidence,2360414,Hispanic of any race,10.8,Female,Thyroid,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Female,Urinary Bladder,2019
25-29,58.4,64.7,1462,Incidence,2378138,Hispanic of any race,61.5,Female,All Cancer Sites Combined,2019
25-29,1.2,2.3,40,Incidence,2378138,Hispanic of any race,1.7,Female,Brain and Other Nervous System,2019
25-29,3.7,5.4,107,Incidence,2378138,Hispanic of any race,4.5,Female,Cervix,2019
25-29,2.3,3.8,71,Incidence,2378138,Hispanic of any race,3.0,Female,Colon and Rectum,2019
25-29,3.0,4.6,88,Incidence,2378138,Hispanic of any race,3.7,Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Esophagus,2019
25-29,7.3,9.7,201,Incidence,2378138,Hispanic of any race,8.5,Female,Female Breast,2019
25-29,0.4,1.1,16,Incidence,2378138,Hispanic of any race,0.7,Female,"Female Breast, <i>in situ</i>",2019
25-29,2.1,3.5,66,Incidence,2378138,Hispanic of any race,2.8,Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
25-29,0.7,1.7,27,Incidence,2378138,Hispanic of any race,1.1,Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Larynx,2019
25-29,2.5,4.0,76,Incidence,2378138,Hispanic of any race,3.2,Female,Leukemias,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Lung and Bronchus,2019
25-29,1.1,2.2,38,Incidence,2378138,Hispanic of any race,1.6,Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Mesothelioma,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Myeloma,2019
25-29,2.1,3.4,64,Incidence,2378138,Hispanic of any race,2.7,Female,Non-Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
25-29,2.3,3.7,69,Incidence,2378138,Hispanic of any race,2.9,Female,Ovary,2019
25-29,0.6,1.5,24,Incidence,2378138,Hispanic of any race,1.0,Female,Pancreas,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Stomach,2019
25-29,15.3,18.7,403,Incidence,2378138,Hispanic of any race,16.9,Female,Thyroid,2019
25-29,~,~,~,Incidence,2378138,Hispanic of any race,~,Female,Urinary Bladder,2019
30-34,109.4,118.4,2476,Incidence,2174331,Hispanic of any race,113.9,Female,All Cancer Sites Combined,2019
30-34,2.4,4.0,68,Incidence,2174331,Hispanic of any race,3.1,Female,Brain and Other Nervous System,2019
30-34,12.1,15.3,297,Incidence,2174331,Hispanic of any race,13.7,Female,Cervix,2019
30-34,4.7,6.7,122,Incidence,2174331,Hispanic of any race,5.6,Female,Colon and Rectum,2019
30-34,8.0,10.6,201,Incidence,2174331,Hispanic of any race,9.2,Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Esophagus,2019
30-34,23.5,27.8,556,Incidence,2174331,Hispanic of any race,25.6,Female,Female Breast,2019
30-34,2.0,3.4,57,Incidence,2174331,Hispanic of any race,2.6,Female,"Female Breast, <i>in situ</i>",2019
30-34,1.6,2.9,47,Incidence,2174331,Hispanic of any race,2.2,Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
30-34,2.5,4.1,70,Incidence,2174331,Hispanic of any race,3.2,Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Larynx,2019
30-34,3.2,5.0,88,Incidence,2174331,Hispanic of any race,4.0,Female,Leukemias,2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
30-34,0.6,1.4,20,Incidence,2174331,Hispanic of any race,0.9,Female,Lung and Bronchus,2019
30-34,2.0,3.4,58,Incidence,2174331,Hispanic of any race,2.7,Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Mesothelioma,2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Myeloma,2019
30-34,2.6,4.2,72,Incidence,2174331,Hispanic of any race,3.3,Female,Non-Hodgkin Lymphoma,2019
30-34,0.8,1.8,26,Incidence,2174331,Hispanic of any race,1.2,Female,Oral Cavity and Pharynx,2019
30-34,3.4,5.2,92,Incidence,2174331,Hispanic of any race,4.2,Female,Ovary,2019
30-34,0.6,1.5,21,Incidence,2174331,Hispanic of any race,1.0,Female,Pancreas,2019
30-34,1.1,2.2,35,Incidence,2174331,Hispanic of any race,1.6,Female,Stomach,2019
30-34,22.0,26.2,523,Incidence,2174331,Hispanic of any race,24.1,Female,Thyroid,2019
30-34,~,~,~,Incidence,2174331,Hispanic of any race,~,Female,Urinary Bladder,2019
35-39,166.6,177.7,3726,Incidence,2165426,Hispanic of any race,172.1,Female,All Cancer Sites Combined,2019
35-39,1.5,2.8,45,Incidence,2165426,Hispanic of any race,2.1,Female,Brain and Other Nervous System,2019
35-39,15.3,18.9,369,Incidence,2165426,Hispanic of any race,17.0,Female,Cervix,2019
35-39,8.2,10.8,204,Incidence,2165426,Hispanic of any race,9.4,Female,Colon and Rectum,2019
35-39,12.8,16.0,310,Incidence,2165426,Hispanic of any race,14.3,Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,2165426,Hispanic of any race,~,Female,Esophagus,2019
35-39,49.5,55.6,1136,Incidence,2165426,Hispanic of any race,52.5,Female,Female Breast,2019
35-39,4.8,6.9,125,Incidence,2165426,Hispanic of any race,5.8,Female,"Female Breast, <i>in situ</i>",2019
35-39,0.8,1.8,27,Incidence,2165426,Hispanic of any race,1.2,Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,2165426,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
35-39,4.9,7.0,128,Incidence,2165426,Hispanic of any race,5.9,Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,2165426,Hispanic of any race,~,Female,Larynx,2019
35-39,3.6,5.4,96,Incidence,2165426,Hispanic of any race,4.4,Female,Leukemias,2019
35-39,0.5,1.4,19,Incidence,2165426,Hispanic of any race,0.9,Female,Liver and Intrahepatic Bile Duct,2019
35-39,0.9,2.0,30,Incidence,2165426,Hispanic of any race,1.4,Female,Lung and Bronchus,2019
35-39,3.1,4.8,84,Incidence,2165426,Hispanic of any race,3.9,Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,2165426,Hispanic of any race,~,Female,Mesothelioma,2019
35-39,0.6,1.5,21,Incidence,2165426,Hispanic of any race,1.0,Female,Myeloma,2019
35-39,4.7,6.7,122,Incidence,2165426,Hispanic of any race,5.6,Female,Non-Hodgkin Lymphoma,2019
35-39,0.8,1.8,26,Incidence,2165426,Hispanic of any race,1.2,Female,Oral Cavity and Pharynx,2019
35-39,3.8,5.6,100,Incidence,2165426,Hispanic of any race,4.6,Female,Ovary,2019
35-39,0.7,1.7,25,Incidence,2165426,Hispanic of any race,1.2,Female,Pancreas,2019
35-39,3.1,4.9,85,Incidence,2165426,Hispanic of any race,3.9,Female,Stomach,2019
35-39,27.6,32.3,647,Incidence,2165426,Hispanic of any race,29.9,Female,Thyroid,2019
35-39,~,~,~,Incidence,2165426,Hispanic of any race,~,Female,Urinary Bladder,2019
40-44,264.0,278.4,5482,Incidence,2021836,Hispanic of any race,271.1,Female,All Cancer Sites Combined,2019
40-44,2.4,4.0,64,Incidence,2021836,Hispanic of any race,3.2,Female,Brain and Other Nervous System,2019
40-44,17.6,21.5,394,Incidence,2021836,Hispanic of any race,19.5,Female,Cervix,2019
40-44,15.1,18.7,340,Incidence,2021836,Hispanic of any race,16.8,Female,Colon and Rectum,2019
40-44,18.7,22.7,417,Incidence,2021836,Hispanic of any race,20.6,Female,"Corpus and Uterus, NOS",2019
40-44,~,~,~,Incidence,2021836,Hispanic of any race,~,Female,Esophagus,2019
40-44,100.2,109.2,2116,Incidence,2021836,Hispanic of any race,104.7,Female,Female Breast,2019
40-44,24.7,29.3,544,Incidence,2021836,Hispanic of any race,26.9,Female,"Female Breast, <i>in situ</i>",2019
40-44,1.0,2.1,30,Incidence,2021836,Hispanic of any race,1.5,Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,2021836,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
40-44,8.9,11.7,207,Incidence,2021836,Hispanic of any race,10.2,Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,2021836,Hispanic of any race,~,Female,Larynx,2019
40-44,5.2,7.4,126,Incidence,2021836,Hispanic of any race,6.2,Female,Leukemias,2019
40-44,1.0,2.2,31,Incidence,2021836,Hispanic of any race,1.5,Female,Liver and Intrahepatic Bile Duct,2019
40-44,3.1,4.9,79,Incidence,2021836,Hispanic of any race,3.9,Female,Lung and Bronchus,2019
40-44,3.8,5.7,95,Incidence,2021836,Hispanic of any race,4.7,Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,2021836,Hispanic of any race,~,Female,Mesothelioma,2019
40-44,0.9,2.0,28,Incidence,2021836,Hispanic of any race,1.4,Female,Myeloma,2019
40-44,5.9,8.2,141,Incidence,2021836,Hispanic of any race,7.0,Female,Non-Hodgkin Lymphoma,2019
40-44,1.8,3.1,48,Incidence,2021836,Hispanic of any race,2.4,Female,Oral Cavity and Pharynx,2019
40-44,6.7,9.2,159,Incidence,2021836,Hispanic of any race,7.9,Female,Ovary,2019
40-44,1.8,3.2,49,Incidence,2021836,Hispanic of any race,2.4,Female,Pancreas,2019
40-44,4.9,7.0,119,Incidence,2021836,Hispanic of any race,5.9,Female,Stomach,2019
40-44,32.4,37.6,706,Incidence,2021836,Hispanic of any race,34.9,Female,Thyroid,2019
40-44,0.8,1.8,25,Incidence,2021836,Hispanic of any race,1.2,Female,Urinary Bladder,2019
45-49,364.2,381.7,7036,Incidence,1887047,Hispanic of any race,372.9,Female,All Cancer Sites Combined,2019
45-49,3.0,4.8,72,Incidence,1887047,Hispanic of any race,3.8,Female,Brain and Other Nervous System,2019
45-49,14.9,18.6,315,Incidence,1887047,Hispanic of any race,16.7,Female,Cervix,2019
45-49,23.9,28.6,494,Incidence,1887047,Hispanic of any race,26.2,Female,Colon and Rectum,2019
45-49,28.2,33.2,578,Incidence,1887047,Hispanic of any race,30.6,Female,"Corpus and Uterus, NOS",2019
45-49,~,~,~,Incidence,1887047,Hispanic of any race,~,Female,Esophagus,2019
45-49,150.3,161.6,2941,Incidence,1887047,Hispanic of any race,155.9,Female,Female Breast,2019
45-49,40.9,46.9,827,Incidence,1887047,Hispanic of any race,43.8,Female,"Female Breast, <i>in situ</i>",2019
45-49,1.2,2.5,33,Incidence,1887047,Hispanic of any race,1.7,Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,1887047,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
45-49,11.5,14.8,247,Incidence,1887047,Hispanic of any race,13.1,Female,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,1887047,Hispanic of any race,~,Female,Larynx,2019
45-49,6.2,8.7,139,Incidence,1887047,Hispanic of any race,7.4,Female,Leukemias,2019
45-49,1.3,2.6,35,Incidence,1887047,Hispanic of any race,1.9,Female,Liver and Intrahepatic Bile Duct,2019
45-49,6.1,8.6,138,Incidence,1887047,Hispanic of any race,7.3,Female,Lung and Bronchus,2019
45-49,4.8,7.1,111,Incidence,1887047,Hispanic of any race,5.9,Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,1887047,Hispanic of any race,~,Female,Mesothelioma,2019
45-49,2.8,4.6,68,Incidence,1887047,Hispanic of any race,3.6,Female,Myeloma,2019
45-49,8.8,11.7,192,Incidence,1887047,Hispanic of any race,10.2,Female,Non-Hodgkin Lymphoma,2019
45-49,2.2,3.9,56,Incidence,1887047,Hispanic of any race,3.0,Female,Oral Cavity and Pharynx,2019
45-49,9.7,12.8,211,Incidence,1887047,Hispanic of any race,11.2,Female,Ovary,2019
45-49,3.5,5.5,83,Incidence,1887047,Hispanic of any race,4.4,Female,Pancreas,2019
45-49,6.9,9.5,153,Incidence,1887047,Hispanic of any race,8.1,Female,Stomach,2019
45-49,33.2,38.6,676,Incidence,1887047,Hispanic of any race,35.8,Female,Thyroid,2019
45-49,1.2,2.4,32,Incidence,1887047,Hispanic of any race,1.7,Female,Urinary Bladder,2019
5-9,10.4,13.1,296,Incidence,2540710,Hispanic of any race,11.7,Female,All Cancer Sites Combined,2019
5-9,1.8,3.0,59,Incidence,2540710,Hispanic of any race,2.3,Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Cervix,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Esophagus,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Female Breast,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
5-9,0.4,1.0,16,Incidence,2540710,Hispanic of any race,0.6,Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Larynx,2019
5-9,3.6,5.3,111,Incidence,2540710,Hispanic of any race,4.4,Female,Leukemias,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Mesothelioma,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Myeloma,2019
5-9,0.4,1.1,18,Incidence,2540710,Hispanic of any race,0.7,Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Ovary,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Pancreas,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Stomach,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Thyroid,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Female,Urinary Bladder,2019
50-54,484.9,506.5,8106,Incidence,1635599,Hispanic of any race,495.6,Female,All Cancer Sites Combined,2019
50-54,4.4,6.7,89,Incidence,1635599,Hispanic of any race,5.4,Female,Brain and Other Nervous System,2019
50-54,13.7,17.6,255,Incidence,1635599,Hispanic of any race,15.6,Female,Cervix,2019
50-54,40.6,47.1,716,Incidence,1635599,Hispanic of any race,43.8,Female,Colon and Rectum,2019
50-54,43.2,49.9,760,Incidence,1635599,Hispanic of any race,46.5,Female,"Corpus and Uterus, NOS",2019
50-54,~,~,~,Incidence,1635599,Hispanic of any race,~,Female,Esophagus,2019
50-54,180.8,194.1,3064,Incidence,1635599,Hispanic of any race,187.3,Female,Female Breast,2019
50-54,47.5,54.4,832,Incidence,1635599,Hispanic of any race,50.9,Female,"Female Breast, <i>in situ</i>",2019
50-54,0.9,2.2,24,Incidence,1635599,Hispanic of any race,1.5,Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,1635599,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
50-54,17.5,21.8,320,Incidence,1635599,Hispanic of any race,19.6,Female,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,1635599,Hispanic of any race,~,Female,Larynx,2019
50-54,6.8,9.6,132,Incidence,1635599,Hispanic of any race,8.1,Female,Leukemias,2019
50-54,4.6,7.0,93,Incidence,1635599,Hispanic of any race,5.7,Female,Liver and Intrahepatic Bile Duct,2019
50-54,12.6,16.4,236,Incidence,1635599,Hispanic of any race,14.4,Female,Lung and Bronchus,2019
50-54,4.6,7.0,93,Incidence,1635599,Hispanic of any race,5.7,Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,1635599,Hispanic of any race,~,Female,Mesothelioma,2019
50-54,5.0,7.5,101,Incidence,1635599,Hispanic of any race,6.2,Female,Myeloma,2019
50-54,15.8,20.0,291,Incidence,1635599,Hispanic of any race,17.8,Female,Non-Hodgkin Lymphoma,2019
50-54,5.0,7.4,100,Incidence,1635599,Hispanic of any race,6.1,Female,Oral Cavity and Pharynx,2019
50-54,15.0,19.1,277,Incidence,1635599,Hispanic of any race,16.9,Female,Ovary,2019
50-54,6.1,8.8,121,Incidence,1635599,Hispanic of any race,7.4,Female,Pancreas,2019
50-54,10.3,13.7,194,Incidence,1635599,Hispanic of any race,11.9,Female,Stomach,2019
50-54,34.1,40.1,605,Incidence,1635599,Hispanic of any race,37.0,Female,Thyroid,2019
50-54,2.1,3.8,46,Incidence,1635599,Hispanic of any race,2.8,Female,Urinary Bladder,2019
55-59,632.1,658.5,9261,Incidence,1435404,Hispanic of any race,645.2,Female,All Cancer Sites Combined,2019
55-59,5.7,8.5,101,Incidence,1435404,Hispanic of any race,7.0,Female,Brain and Other Nervous System,2019
55-59,13.5,17.6,222,Incidence,1435404,Hispanic of any race,15.5,Female,Cervix,2019
55-59,47.4,54.8,732,Incidence,1435404,Hispanic of any race,51.0,Female,Colon and Rectum,2019
55-59,70.9,79.9,1081,Incidence,1435404,Hispanic of any race,75.3,Female,"Corpus and Uterus, NOS",2019
55-59,0.9,2.2,20,Incidence,1435404,Hispanic of any race,1.4,Female,Esophagus,2019
55-59,208.6,223.9,3103,Incidence,1435404,Hispanic of any race,216.2,Female,Female Breast,2019
55-59,48.8,56.4,754,Incidence,1435404,Hispanic of any race,52.5,Female,"Female Breast, <i>in situ</i>",2019
55-59,1.2,2.7,26,Incidence,1435404,Hispanic of any race,1.8,Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,1435404,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
55-59,25.1,30.6,398,Incidence,1435404,Hispanic of any race,27.7,Female,Kidney and Renal Pelvis,2019
55-59,1.1,2.5,24,Incidence,1435404,Hispanic of any race,1.7,Female,Larynx,2019
55-59,9.2,12.7,156,Incidence,1435404,Hispanic of any race,10.9,Female,Leukemias,2019
55-59,11.4,15.3,190,Incidence,1435404,Hispanic of any race,13.2,Female,Liver and Intrahepatic Bile Duct,2019
55-59,31.3,37.4,492,Incidence,1435404,Hispanic of any race,34.3,Female,Lung and Bronchus,2019
55-59,7.3,10.5,126,Incidence,1435404,Hispanic of any race,8.8,Female,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,1435404,Hispanic of any race,~,Female,Mesothelioma,2019
55-59,8.5,11.8,144,Incidence,1435404,Hispanic of any race,10.0,Female,Myeloma,2019
55-59,22.4,27.6,357,Incidence,1435404,Hispanic of any race,24.9,Female,Non-Hodgkin Lymphoma,2019
55-59,6.4,9.3,111,Incidence,1435404,Hispanic of any race,7.7,Female,Oral Cavity and Pharynx,2019
55-59,18.0,22.7,291,Incidence,1435404,Hispanic of any race,20.3,Female,Ovary,2019
55-59,13.8,18.0,227,Incidence,1435404,Hispanic of any race,15.8,Female,Pancreas,2019
55-59,11.4,15.3,190,Incidence,1435404,Hispanic of any race,13.2,Female,Stomach,2019
55-59,33.1,39.4,519,Incidence,1435404,Hispanic of any race,36.2,Female,Thyroid,2019
55-59,4.9,7.5,87,Incidence,1435404,Hispanic of any race,6.1,Female,Urinary Bladder,2019
60-64,822.6,856.1,9673,Incidence,1152602,Hispanic of any race,839.2,Female,All Cancer Sites Combined,2019
60-64,5.9,9.1,85,Incidence,1152602,Hispanic of any race,7.4,Female,Brain and Other Nervous System,2019
60-64,12.5,17.0,169,Incidence,1152602,Hispanic of any race,14.7,Female,Cervix,2019
60-64,56.8,65.9,706,Incidence,1152602,Hispanic of any race,61.3,Female,Colon and Rectum,2019
60-64,85.9,97.0,1053,Incidence,1152602,Hispanic of any race,91.4,Female,"Corpus and Uterus, NOS",2019
60-64,1.5,3.3,26,Incidence,1152602,Hispanic of any race,2.3,Female,Esophagus,2019
60-64,267.1,286.4,3188,Incidence,1152602,Hispanic of any race,276.6,Female,Female Breast,2019
60-64,60.1,69.4,745,Incidence,1152602,Hispanic of any race,64.6,Female,"Female Breast, <i>in situ</i>",2019
60-64,1.8,3.7,30,Incidence,1152602,Hispanic of any race,2.6,Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,1152602,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
60-64,33.3,40.4,423,Incidence,1152602,Hispanic of any race,36.7,Female,Kidney and Renal Pelvis,2019
60-64,1.6,3.5,28,Incidence,1152602,Hispanic of any race,2.4,Female,Larynx,2019
60-64,12.5,17.0,169,Incidence,1152602,Hispanic of any race,14.7,Female,Leukemias,2019
60-64,18.9,24.4,248,Incidence,1152602,Hispanic of any race,21.5,Female,Liver and Intrahepatic Bile Duct,2019
60-64,57.4,66.6,713,Incidence,1152602,Hispanic of any race,61.9,Female,Lung and Bronchus,2019
60-64,8.0,11.7,112,Incidence,1152602,Hispanic of any race,9.7,Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,1152602,Hispanic of any race,~,Female,Mesothelioma,2019
60-64,12.9,17.5,174,Incidence,1152602,Hispanic of any race,15.1,Female,Myeloma,2019
60-64,30.7,37.5,392,Incidence,1152602,Hispanic of any race,34.0,Female,Non-Hodgkin Lymphoma,2019
60-64,9.7,13.8,134,Incidence,1152602,Hispanic of any race,11.6,Female,Oral Cavity and Pharynx,2019
60-64,21.1,26.9,275,Incidence,1152602,Hispanic of any race,23.9,Female,Ovary,2019
60-64,22.7,28.6,294,Incidence,1152602,Hispanic of any race,25.5,Female,Pancreas,2019
60-64,13.3,18.0,179,Incidence,1152602,Hispanic of any race,15.5,Female,Stomach,2019
60-64,32.5,39.6,414,Incidence,1152602,Hispanic of any race,35.9,Female,Thyroid,2019
60-64,7.5,11.0,105,Incidence,1152602,Hispanic of any race,9.1,Female,Urinary Bladder,2019
65-69,1083.4,1127.6,9673,Incidence,875129,Hispanic of any race,1105.3,Female,All Cancer Sites Combined,2019
65-69,9.8,14.5,105,Incidence,875129,Hispanic of any race,12.0,Female,Brain and Other Nervous System,2019
65-69,10.7,15.6,114,Incidence,875129,Hispanic of any race,13.0,Female,Cervix,2019
65-69,78.6,90.9,740,Incidence,875129,Hispanic of any race,84.6,Female,Colon and Rectum,2019
65-69,97.4,111.1,911,Incidence,875129,Hispanic of any race,104.1,Female,"Corpus and Uterus, NOS",2019
65-69,2.4,5.0,31,Incidence,875129,Hispanic of any race,3.5,Female,Esophagus,2019
65-69,333.0,357.7,3021,Incidence,875129,Hispanic of any race,345.2,Female,Female Breast,2019
65-69,76.3,88.4,719,Incidence,875129,Hispanic of any race,82.2,Female,"Female Breast, <i>in situ</i>",2019
65-69,1.7,3.9,23,Incidence,875129,Hispanic of any race,2.6,Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,875129,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
65-69,41.1,50.2,398,Incidence,875129,Hispanic of any race,45.5,Female,Kidney and Renal Pelvis,2019
65-69,1.4,3.5,20,Incidence,875129,Hispanic of any race,2.3,Female,Larynx,2019
65-69,17.1,23.2,175,Incidence,875129,Hispanic of any race,20.0,Female,Leukemias,2019
65-69,37.3,46.0,363,Incidence,875129,Hispanic of any race,41.5,Female,Liver and Intrahepatic Bile Duct,2019
65-69,85.9,98.7,806,Incidence,875129,Hispanic of any race,92.1,Female,Lung and Bronchus,2019
65-69,11.0,15.9,116,Incidence,875129,Hispanic of any race,13.3,Female,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,875129,Hispanic of any race,~,Female,Mesothelioma,2019
65-69,18.7,25.0,190,Incidence,875129,Hispanic of any race,21.7,Female,Myeloma,2019
65-69,45.4,54.8,437,Incidence,875129,Hispanic of any race,49.9,Female,Non-Hodgkin Lymphoma,2019
65-69,14.2,19.7,147,Incidence,875129,Hispanic of any race,16.8,Female,Oral Cavity and Pharynx,2019
65-69,23.1,30.0,231,Incidence,875129,Hispanic of any race,26.4,Female,Ovary,2019
65-69,37.1,45.7,361,Incidence,875129,Hispanic of any race,41.3,Female,Pancreas,2019
65-69,20.4,27.0,206,Incidence,875129,Hispanic of any race,23.5,Female,Stomach,2019
65-69,34.2,42.5,334,Incidence,875129,Hispanic of any race,38.2,Female,Thyroid,2019
65-69,14.6,20.2,151,Incidence,875129,Hispanic of any race,17.3,Female,Urinary Bladder,2019
70-74,1277.8,1333.6,8453,Incidence,647491,Hispanic of any race,1305.5,Female,All Cancer Sites Combined,2019
70-74,9.9,15.5,81,Incidence,647491,Hispanic of any race,12.5,Female,Brain and Other Nervous System,2019
70-74,13.0,19.3,103,Incidence,647491,Hispanic of any race,15.9,Female,Cervix,2019
70-74,94.3,110.0,660,Incidence,647491,Hispanic of any race,101.9,Female,Colon and Rectum,2019
70-74,91.9,107.4,644,Incidence,647491,Hispanic of any race,99.5,Female,"Corpus and Uterus, NOS",2019
70-74,4.0,7.9,37,Incidence,647491,Hispanic of any race,5.7,Female,Esophagus,2019
70-74,351.3,380.9,2369,Incidence,647491,Hispanic of any race,365.9,Female,Female Breast,2019
70-74,75.0,89.1,530,Incidence,647491,Hispanic of any race,81.9,Female,"Female Breast, <i>in situ</i>",2019
70-74,2.0,5.0,21,Incidence,647491,Hispanic of any race,3.2,Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,647491,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
70-74,47.4,58.7,342,Incidence,647491,Hispanic of any race,52.8,Female,Kidney and Renal Pelvis,2019
70-74,1.5,4.2,17,Incidence,647491,Hispanic of any race,2.6,Female,Larynx,2019
70-74,23.0,31.2,174,Incidence,647491,Hispanic of any race,26.9,Female,Leukemias,2019
70-74,39.5,49.9,288,Incidence,647491,Hispanic of any race,44.5,Female,Liver and Intrahepatic Bile Duct,2019
70-74,131.6,150.0,910,Incidence,647491,Hispanic of any race,140.5,Female,Lung and Bronchus,2019
70-74,10.5,16.2,85,Incidence,647491,Hispanic of any race,13.1,Female,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,647491,Hispanic of any race,~,Female,Mesothelioma,2019
70-74,23.3,31.5,176,Incidence,647491,Hispanic of any race,27.2,Female,Myeloma,2019
70-74,56.9,69.3,407,Incidence,647491,Hispanic of any race,62.9,Female,Non-Hodgkin Lymphoma,2019
70-74,14.7,21.3,115,Incidence,647491,Hispanic of any race,17.8,Female,Oral Cavity and Pharynx,2019
70-74,27.0,35.8,202,Incidence,647491,Hispanic of any race,31.2,Female,Ovary,2019
70-74,49.6,61.2,357,Incidence,647491,Hispanic of any race,55.1,Female,Pancreas,2019
70-74,27.5,36.3,205,Incidence,647491,Hispanic of any race,31.7,Female,Stomach,2019
70-74,33.8,43.5,249,Incidence,647491,Hispanic of any race,38.5,Female,Thyroid,2019
70-74,20.2,27.9,154,Incidence,647491,Hispanic of any race,23.8,Female,Urinary Bladder,2019
75-79,1388.3,1458.5,6357,Incidence,446721,Hispanic of any race,1423.0,Female,All Cancer Sites Combined,2019
75-79,12.4,20.0,71,Incidence,446721,Hispanic of any race,15.9,Female,Brain and Other Nervous System,2019
75-79,13.4,21.3,76,Incidence,446721,Hispanic of any race,17.0,Female,Cervix,2019
75-79,109.0,129.4,531,Incidence,446721,Hispanic of any race,118.9,Female,Colon and Rectum,2019
75-79,68.7,85.1,342,Incidence,446721,Hispanic of any race,76.6,Female,"Corpus and Uterus, NOS",2019
75-79,4.2,9.1,28,Incidence,446721,Hispanic of any race,6.3,Female,Esophagus,2019
75-79,305.7,339.2,1439,Incidence,446721,Hispanic of any race,322.1,Female,Female Breast,2019
75-79,56.8,71.9,286,Incidence,446721,Hispanic of any race,64.0,Female,"Female Breast, <i>in situ</i>",2019
75-79,3.1,7.5,22,Incidence,446721,Hispanic of any race,4.9,Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,446721,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
75-79,48.0,61.9,244,Incidence,446721,Hispanic of any race,54.6,Female,Kidney and Renal Pelvis,2019
75-79,~,~,~,Incidence,446721,Hispanic of any race,~,Female,Larynx,2019
75-79,31.7,43.3,166,Incidence,446721,Hispanic of any race,37.2,Female,Leukemias,2019
75-79,47.6,61.4,242,Incidence,446721,Hispanic of any race,54.2,Female,Liver and Intrahepatic Bile Duct,2019
75-79,163.9,188.7,786,Incidence,446721,Hispanic of any race,175.9,Female,Lung and Bronchus,2019
75-79,14.8,23.0,83,Incidence,446721,Hispanic of any race,18.6,Female,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,446721,Hispanic of any race,~,Female,Mesothelioma,2019
75-79,27.8,38.7,147,Incidence,446721,Hispanic of any race,32.9,Female,Myeloma,2019
75-79,74.4,91.5,369,Incidence,446721,Hispanic of any race,82.6,Female,Non-Hodgkin Lymphoma,2019
75-79,14.6,22.8,82,Incidence,446721,Hispanic of any race,18.4,Female,Oral Cavity and Pharynx,2019
75-79,34.2,46.1,178,Incidence,446721,Hispanic of any race,39.8,Female,Ovary,2019
75-79,74.0,91.0,367,Incidence,446721,Hispanic of any race,82.2,Female,Pancreas,2019
75-79,33.0,44.7,172,Incidence,446721,Hispanic of any race,38.5,Female,Stomach,2019
75-79,16.8,25.5,93,Incidence,446721,Hispanic of any race,20.8,Female,Thyroid,2019
75-79,27.6,38.4,146,Incidence,446721,Hispanic of any race,32.7,Female,Urinary Bladder,2019
80-84,1433.8,1519.4,4604,Incidence,311898,Hispanic of any race,1476.1,Female,All Cancer Sites Combined,2019
80-84,15.2,25.5,62,Incidence,311898,Hispanic of any race,19.9,Female,Brain and Other Nervous System,2019
80-84,11.3,20.4,48,Incidence,311898,Hispanic of any race,15.4,Female,Cervix,2019
80-84,141.4,169.3,483,Incidence,311898,Hispanic of any race,154.9,Female,Colon and Rectum,2019
80-84,56.1,74.3,202,Incidence,311898,Hispanic of any race,64.8,Female,"Corpus and Uterus, NOS",2019
80-84,4.7,11.1,23,Incidence,311898,Hispanic of any race,7.4,Female,Esophagus,2019
80-84,277.1,315.7,923,Incidence,311898,Hispanic of any race,295.9,Female,Female Breast,2019
80-84,31.9,46.0,120,Incidence,311898,Hispanic of any race,38.5,Female,"Female Breast, <i>in situ</i>",2019
80-84,4.2,10.3,21,Incidence,311898,Hispanic of any race,6.7,Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,311898,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
80-84,57.6,76.1,207,Incidence,311898,Hispanic of any race,66.4,Female,Kidney and Renal Pelvis,2019
80-84,~,~,~,Incidence,311898,Hispanic of any race,~,Female,Larynx,2019
80-84,37.8,53.0,140,Incidence,311898,Hispanic of any race,44.9,Female,Leukemias,2019
80-84,47.2,64.0,172,Incidence,311898,Hispanic of any race,55.1,Female,Liver and Intrahepatic Bile Duct,2019
80-84,161.0,190.7,547,Incidence,311898,Hispanic of any race,175.4,Female,Lung and Bronchus,2019
80-84,10.8,19.7,46,Incidence,311898,Hispanic of any race,14.7,Female,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,311898,Hispanic of any race,~,Female,Mesothelioma,2019
80-84,29.6,43.2,112,Incidence,311898,Hispanic of any race,35.9,Female,Myeloma,2019
80-84,70.5,90.7,250,Incidence,311898,Hispanic of any race,80.2,Female,Non-Hodgkin Lymphoma,2019
80-84,18.3,29.4,73,Incidence,311898,Hispanic of any race,23.4,Female,Oral Cavity and Pharynx,2019
80-84,29.9,43.6,113,Incidence,311898,Hispanic of any race,36.2,Female,Ovary,2019
80-84,73.8,94.5,261,Incidence,311898,Hispanic of any race,83.7,Female,Pancreas,2019
80-84,38.6,54.0,143,Incidence,311898,Hispanic of any race,45.8,Female,Stomach,2019
80-84,20.1,31.6,79,Incidence,311898,Hispanic of any race,25.3,Female,Thyroid,2019
80-84,35.7,50.5,133,Incidence,311898,Hispanic of any race,42.6,Female,Urinary Bladder,2019
85+,1343.9,1425.4,4461,Incidence,322282,Hispanic of any race,1384.2,Female,All Cancer Sites Combined,2019
85+,10.2,18.7,45,Incidence,322282,Hispanic of any race,14.0,Female,Brain and Other Nervous System,2019
85+,13.1,22.6,56,Incidence,322282,Hispanic of any race,17.4,Female,Cervix,2019
85+,146.9,174.9,517,Incidence,322282,Hispanic of any race,160.4,Female,Colon and Rectum,2019
85+,33.4,47.6,129,Incidence,322282,Hispanic of any race,40.0,Female,"Corpus and Uterus, NOS",2019
85+,8.6,16.5,39,Incidence,322282,Hispanic of any race,12.1,Female,Esophagus,2019
85+,216.4,250.0,750,Incidence,322282,Hispanic of any race,232.7,Female,Female Breast,2019
85+,15.3,25.4,64,Incidence,322282,Hispanic of any race,19.9,Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,322282,Hispanic of any race,~,Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,322282,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
85+,36.3,50.9,139,Incidence,322282,Hispanic of any race,43.1,Female,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,322282,Hispanic of any race,~,Female,Larynx,2019
85+,41.1,56.6,156,Incidence,322282,Hispanic of any race,48.4,Female,Leukemias,2019
85+,37.1,51.9,142,Incidence,322282,Hispanic of any race,44.1,Female,Liver and Intrahepatic Bile Duct,2019
85+,132.1,158.7,467,Incidence,322282,Hispanic of any race,144.9,Female,Lung and Bronchus,2019
85+,12.9,22.2,55,Incidence,322282,Hispanic of any race,17.1,Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,322282,Hispanic of any race,~,Female,Mesothelioma,2019
85+,23.6,35.7,94,Incidence,322282,Hispanic of any race,29.2,Female,Myeloma,2019
85+,63.0,81.9,232,Incidence,322282,Hispanic of any race,72.0,Female,Non-Hodgkin Lymphoma,2019
85+,18.0,28.8,74,Incidence,322282,Hispanic of any race,23.0,Female,Oral Cavity and Pharynx,2019
85+,24.4,36.7,97,Incidence,322282,Hispanic of any race,30.1,Female,Ovary,2019
85+,84.3,105.9,305,Incidence,322282,Hispanic of any race,94.6,Female,Pancreas,2019
85+,36.0,50.6,138,Incidence,322282,Hispanic of any race,42.8,Female,Stomach,2019
85+,12.3,21.5,53,Incidence,322282,Hispanic of any race,16.4,Female,Thyroid,2019
85+,43.7,59.6,165,Incidence,322282,Hispanic of any race,51.2,Female,Urinary Bladder,2019
<1,14.7,22.5,88,Incidence,481522,Hispanic of any race,18.3,Female,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Cervix,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Colon and Rectum,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Esophagus,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Female Breast,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Larynx,2019
<1,2.9,6.9,22,Incidence,481522,Hispanic of any race,4.6,Female,Leukemias,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Mesothelioma,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Myeloma,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Ovary,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Pancreas,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Stomach,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Thyroid,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Female,Urinary Bladder,2019
1-4,21.4,25.6,484,Incidence,2067279,Hispanic of any race,23.4,Male,All Cancer Sites Combined,2019
1-4,3.2,5.0,84,Incidence,2067279,Hispanic of any race,4.1,Male,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Colon and Rectum,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Esophagus,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
1-4,1.2,2.4,35,Incidence,2067279,Hispanic of any race,1.7,Male,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Larynx,2019
1-4,8.6,11.3,204,Incidence,2067279,Hispanic of any race,9.9,Male,Leukemias,2019
1-4,0.7,1.7,23,Incidence,2067279,Hispanic of any race,1.1,Male,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Lung and Bronchus,2019
1-4,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Mesothelioma,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Myeloma,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Pancreas,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Prostate,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Stomach,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Testis,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Thyroid,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male,Urinary Bladder,2019
10-14,13.9,16.8,416,Incidence,2718311,Hispanic of any race,15.3,Male,All Cancer Sites Combined,2019
10-14,1.5,2.6,55,Incidence,2718311,Hispanic of any race,2.0,Male,Brain and Other Nervous System,2019
10-14,0.4,1.0,18,Incidence,2718311,Hispanic of any race,0.7,Male,Colon and Rectum,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Esophagus,2019
10-14,0.9,1.8,36,Incidence,2718311,Hispanic of any race,1.3,Male,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Larynx,2019
10-14,4.3,6.0,139,Incidence,2718311,Hispanic of any race,5.1,Male,Leukemias,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Lung and Bronchus,2019
10-14,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Mesothelioma,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Myeloma,2019
10-14,1.2,2.2,45,Incidence,2718311,Hispanic of any race,1.7,Male,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Pancreas,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Prostate,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Stomach,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Testis,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Thyroid,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male,Urinary Bladder,2019
15-19,26.3,30.5,728,Incidence,2569693,Hispanic of any race,28.3,Male,All Cancer Sites Combined,2019
15-19,1.2,2.3,43,Incidence,2569693,Hispanic of any race,1.7,Male,Brain and Other Nervous System,2019
15-19,0.9,1.8,34,Incidence,2569693,Hispanic of any race,1.3,Male,Colon and Rectum,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Esophagus,2019
15-19,2.5,3.9,80,Incidence,2569693,Hispanic of any race,3.1,Male,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Larynx,2019
15-19,5.5,7.5,165,Incidence,2569693,Hispanic of any race,6.4,Male,Leukemias,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Lung and Bronchus,2019
15-19,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Mesothelioma,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Myeloma,2019
15-19,1.3,2.4,46,Incidence,2569693,Hispanic of any race,1.8,Male,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Pancreas,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Prostate,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Stomach,2019
15-19,4.9,6.8,149,Incidence,2569693,Hispanic of any race,5.8,Male,Testis,2019
15-19,1.1,2.1,39,Incidence,2569693,Hispanic of any race,1.5,Male,Thyroid,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male,Urinary Bladder,2019
20-24,34.4,39.2,911,Incidence,2482553,Hispanic of any race,36.7,Male,All Cancer Sites Combined,2019
20-24,1.5,2.7,51,Incidence,2482553,Hispanic of any race,2.1,Male,Brain and Other Nervous System,2019
20-24,1.3,2.3,43,Incidence,2482553,Hispanic of any race,1.7,Male,Colon and Rectum,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Esophagus,2019
20-24,2.0,3.3,64,Incidence,2482553,Hispanic of any race,2.6,Male,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
20-24,0.6,1.3,22,Incidence,2482553,Hispanic of any race,0.9,Male,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Larynx,2019
20-24,3.2,4.8,98,Incidence,2482553,Hispanic of any race,3.9,Male,Leukemias,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Lung and Bronchus,2019
20-24,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Mesothelioma,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Myeloma,2019
20-24,1.8,3.1,59,Incidence,2482553,Hispanic of any race,2.4,Male,Non-Hodgkin Lymphoma,2019
20-24,0.5,1.2,19,Incidence,2482553,Hispanic of any race,0.8,Male,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Pancreas,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Prostate,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Stomach,2019
20-24,12.7,15.7,350,Incidence,2482553,Hispanic of any race,14.1,Male,Testis,2019
20-24,1.3,2.3,43,Incidence,2482553,Hispanic of any race,1.7,Male,Thyroid,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male,Urinary Bladder,2019
25-29,44.4,49.8,1207,Incidence,2565338,Hispanic of any race,47.1,Male,All Cancer Sites Combined,2019
25-29,2.0,3.3,67,Incidence,2565338,Hispanic of any race,2.6,Male,Brain and Other Nervous System,2019
25-29,2.1,3.4,68,Incidence,2565338,Hispanic of any race,2.7,Male,Colon and Rectum,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Esophagus,2019
25-29,2.2,3.5,71,Incidence,2565338,Hispanic of any race,2.8,Male,Hodgkin Lymphoma,2019
25-29,0.5,1.3,21,Incidence,2565338,Hispanic of any race,0.8,Male,Kaposi Sarcoma,2019
25-29,1.3,2.3,45,Incidence,2565338,Hispanic of any race,1.8,Male,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Larynx,2019
25-29,4.0,5.8,124,Incidence,2565338,Hispanic of any race,4.8,Male,Leukemias,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Lung and Bronchus,2019
25-29,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Mesothelioma,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Myeloma,2019
25-29,3.2,4.8,102,Incidence,2565338,Hispanic of any race,4.0,Male,Non-Hodgkin Lymphoma,2019
25-29,0.4,1.0,16,Incidence,2565338,Hispanic of any race,0.6,Male,Oral Cavity and Pharynx,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Pancreas,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Prostate,2019
25-29,0.5,1.2,20,Incidence,2565338,Hispanic of any race,0.8,Male,Stomach,2019
25-29,14.7,17.8,415,Incidence,2565338,Hispanic of any race,16.2,Male,Testis,2019
25-29,2.9,4.4,93,Incidence,2565338,Hispanic of any race,3.6,Male,Thyroid,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male,Urinary Bladder,2019
30-34,54.2,60.3,1380,Incidence,2412946,Hispanic of any race,57.2,Male,All Cancer Sites Combined,2019
30-34,2.4,3.9,74,Incidence,2412946,Hispanic of any race,3.1,Male,Brain and Other Nervous System,2019
30-34,4.7,6.6,135,Incidence,2412946,Hispanic of any race,5.6,Male,Colon and Rectum,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male,Esophagus,2019
30-34,2.3,3.7,70,Incidence,2412946,Hispanic of any race,2.9,Male,Hodgkin Lymphoma,2019
30-34,1.1,2.2,38,Incidence,2412946,Hispanic of any race,1.6,Male,Kaposi Sarcoma,2019
30-34,3.1,4.7,93,Incidence,2412946,Hispanic of any race,3.9,Male,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male,Larynx,2019
30-34,3.7,5.5,110,Incidence,2412946,Hispanic of any race,4.6,Male,Leukemias,2019
30-34,0.6,1.4,22,Incidence,2412946,Hispanic of any race,0.9,Male,Liver and Intrahepatic Bile Duct,2019
30-34,0.9,1.8,31,Incidence,2412946,Hispanic of any race,1.3,Male,Lung and Bronchus,2019
30-34,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
30-34,0.7,1.5,25,Incidence,2412946,Hispanic of any race,1.0,Male,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male,Mesothelioma,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male,Myeloma,2019
30-34,4.0,5.8,117,Incidence,2412946,Hispanic of any race,4.8,Male,Non-Hodgkin Lymphoma,2019
30-34,0.6,1.4,22,Incidence,2412946,Hispanic of any race,0.9,Male,Oral Cavity and Pharynx,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male,Pancreas,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male,Prostate,2019
30-34,0.8,1.7,28,Incidence,2412946,Hispanic of any race,1.2,Male,Stomach,2019
30-34,11.3,14.2,306,Incidence,2412946,Hispanic of any race,12.7,Male,Testis,2019
30-34,3.2,4.8,95,Incidence,2412946,Hispanic of any race,3.9,Male,Thyroid,2019
30-34,0.5,1.2,19,Incidence,2412946,Hispanic of any race,0.8,Male,Urinary Bladder,2019
35-39,70.1,77.1,1719,Incidence,2337649,Hispanic of any race,73.5,Male,All Cancer Sites Combined,2019
35-39,2.3,3.7,69,Incidence,2337649,Hispanic of any race,3.0,Male,Brain and Other Nervous System,2019
35-39,9.6,12.3,255,Incidence,2337649,Hispanic of any race,10.9,Male,Colon and Rectum,2019
35-39,~,~,~,Incidence,2337649,Hispanic of any race,~,Male,Esophagus,2019
35-39,1.5,2.7,47,Incidence,2337649,Hispanic of any race,2.0,Male,Hodgkin Lymphoma,2019
35-39,0.7,1.6,25,Incidence,2337649,Hispanic of any race,1.1,Male,Kaposi Sarcoma,2019
35-39,6.7,9.0,183,Incidence,2337649,Hispanic of any race,7.8,Male,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,2337649,Hispanic of any race,~,Male,Larynx,2019
35-39,4.3,6.2,121,Incidence,2337649,Hispanic of any race,5.2,Male,Leukemias,2019
35-39,0.9,1.8,30,Incidence,2337649,Hispanic of any race,1.3,Male,Liver and Intrahepatic Bile Duct,2019
35-39,0.7,1.6,25,Incidence,2337649,Hispanic of any race,1.1,Male,Lung and Bronchus,2019
35-39,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
35-39,1.1,2.1,36,Incidence,2337649,Hispanic of any race,1.5,Male,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,2337649,Hispanic of any race,~,Male,Mesothelioma,2019
35-39,0.8,1.7,27,Incidence,2337649,Hispanic of any race,1.2,Male,Myeloma,2019
35-39,5.0,7.0,139,Incidence,2337649,Hispanic of any race,5.9,Male,Non-Hodgkin Lymphoma,2019
35-39,1.4,2.6,46,Incidence,2337649,Hispanic of any race,2.0,Male,Oral Cavity and Pharynx,2019
35-39,1.0,2.0,34,Incidence,2337649,Hispanic of any race,1.5,Male,Pancreas,2019
35-39,~,~,~,Incidence,2337649,Hispanic of any race,~,Male,Prostate,2019
35-39,2.7,4.2,79,Incidence,2337649,Hispanic of any race,3.4,Male,Stomach,2019
35-39,8.4,11.0,226,Incidence,2337649,Hispanic of any race,9.7,Male,Testis,2019
35-39,4.6,6.6,130,Incidence,2337649,Hispanic of any race,5.6,Male,Thyroid,2019
35-39,0.8,1.7,28,Incidence,2337649,Hispanic of any race,1.2,Male,Urinary Bladder,2019
40-44,104.0,112.9,2288,Incidence,2110784,Hispanic of any race,108.4,Male,All Cancer Sites Combined,2019
40-44,3.0,4.7,80,Incidence,2110784,Hispanic of any race,3.8,Male,Brain and Other Nervous System,2019
40-44,16.6,20.3,388,Incidence,2110784,Hispanic of any race,18.4,Male,Colon and Rectum,2019
40-44,0.7,1.6,23,Incidence,2110784,Hispanic of any race,1.1,Male,Esophagus,2019
40-44,1.2,2.4,37,Incidence,2110784,Hispanic of any race,1.8,Male,Hodgkin Lymphoma,2019
40-44,0.4,1.2,16,Incidence,2110784,Hispanic of any race,0.8,Male,Kaposi Sarcoma,2019
40-44,12.0,15.2,286,Incidence,2110784,Hispanic of any race,13.5,Male,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,2110784,Hispanic of any race,~,Male,Larynx,2019
40-44,5.7,7.9,142,Incidence,2110784,Hispanic of any race,6.7,Male,Leukemias,2019
40-44,1.7,3.0,48,Incidence,2110784,Hispanic of any race,2.3,Male,Liver and Intrahepatic Bile Duct,2019
40-44,2.2,3.7,60,Incidence,2110784,Hispanic of any race,2.8,Male,Lung and Bronchus,2019
40-44,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
40-44,1.6,2.9,46,Incidence,2110784,Hispanic of any race,2.2,Male,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,2110784,Hispanic of any race,~,Male,Mesothelioma,2019
40-44,1.5,2.7,43,Incidence,2110784,Hispanic of any race,2.0,Male,Myeloma,2019
40-44,7.9,10.5,192,Incidence,2110784,Hispanic of any race,9.1,Male,Non-Hodgkin Lymphoma,2019
40-44,3.4,5.2,90,Incidence,2110784,Hispanic of any race,4.3,Male,Oral Cavity and Pharynx,2019
40-44,2.1,3.6,58,Incidence,2110784,Hispanic of any race,2.7,Male,Pancreas,2019
40-44,2.5,4.1,69,Incidence,2110784,Hispanic of any race,3.3,Male,Prostate,2019
40-44,4.6,6.6,117,Incidence,2110784,Hispanic of any race,5.5,Male,Stomach,2019
40-44,4.8,7.0,123,Incidence,2110784,Hispanic of any race,5.8,Male,Testis,2019
40-44,6.2,8.6,155,Incidence,2110784,Hispanic of any race,7.3,Male,Thyroid,2019
40-44,1.5,2.8,44,Incidence,2110784,Hispanic of any race,2.1,Male,Urinary Bladder,2019
45-49,174.3,186.4,3450,Incidence,1913772,Hispanic of any race,180.3,Male,All Cancer Sites Combined,2019
45-49,4.3,6.4,100,Incidence,1913772,Hispanic of any race,5.2,Male,Brain and Other Nervous System,2019
45-49,26.7,31.6,557,Incidence,1913772,Hispanic of any race,29.1,Male,Colon and Rectum,2019
45-49,1.1,2.2,30,Incidence,1913772,Hispanic of any race,1.6,Male,Esophagus,2019
45-49,1.4,2.8,39,Incidence,1913772,Hispanic of any race,2.0,Male,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,1913772,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
45-49,21.2,25.6,447,Incidence,1913772,Hispanic of any race,23.4,Male,Kidney and Renal Pelvis,2019
45-49,1.1,2.4,32,Incidence,1913772,Hispanic of any race,1.7,Male,Larynx,2019
45-49,7.7,10.5,173,Incidence,1913772,Hispanic of any race,9.0,Male,Leukemias,2019
45-49,6.2,8.6,140,Incidence,1913772,Hispanic of any race,7.3,Male,Liver and Intrahepatic Bile Duct,2019
45-49,4.3,6.5,102,Incidence,1913772,Hispanic of any race,5.3,Male,Lung and Bronchus,2019
45-49,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
45-49,2.2,3.7,55,Incidence,1913772,Hispanic of any race,2.9,Male,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,1913772,Hispanic of any race,~,Male,Mesothelioma,2019
45-49,3.5,5.5,85,Incidence,1913772,Hispanic of any race,4.4,Male,Myeloma,2019
45-49,12.2,15.6,264,Incidence,1913772,Hispanic of any race,13.8,Male,Non-Hodgkin Lymphoma,2019
45-49,7.1,9.7,159,Incidence,1913772,Hispanic of any race,8.3,Male,Oral Cavity and Pharynx,2019
45-49,6.0,8.5,137,Incidence,1913772,Hispanic of any race,7.2,Male,Pancreas,2019
45-49,12.8,16.3,277,Incidence,1913772,Hispanic of any race,14.5,Male,Prostate,2019
45-49,6.5,9.0,147,Incidence,1913772,Hispanic of any race,7.7,Male,Stomach,2019
45-49,3.0,4.8,73,Incidence,1913772,Hispanic of any race,3.8,Male,Testis,2019
45-49,7.9,10.7,177,Incidence,1913772,Hispanic of any race,9.2,Male,Thyroid,2019
45-49,3.0,4.8,73,Incidence,1913772,Hispanic of any race,3.8,Male,Urinary Bladder,2019
5-9,13.5,16.5,393,Incidence,2636313,Hispanic of any race,14.9,Male,All Cancer Sites Combined,2019
5-9,2.5,3.9,84,Incidence,2636313,Hispanic of any race,3.2,Male,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Colon and Rectum,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Esophagus,2019
5-9,0.3,1.0,16,Incidence,2636313,Hispanic of any race,0.6,Male,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Larynx,2019
5-9,5.1,7.0,158,Incidence,2636313,Hispanic of any race,6.0,Male,Leukemias,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Lung and Bronchus,2019
5-9,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Mesothelioma,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Myeloma,2019
5-9,0.8,1.6,30,Incidence,2636313,Hispanic of any race,1.1,Male,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Pancreas,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Prostate,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Stomach,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Testis,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Thyroid,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male,Urinary Bladder,2019
50-54,333.7,351.5,5692,Incidence,1661932,Hispanic of any race,342.5,Male,All Cancer Sites Combined,2019
50-54,5.9,8.6,119,Incidence,1661932,Hispanic of any race,7.2,Male,Brain and Other Nervous System,2019
50-54,53.2,60.5,943,Incidence,1661932,Hispanic of any race,56.7,Male,Colon and Rectum,2019
50-54,4.1,6.3,85,Incidence,1661932,Hispanic of any race,5.1,Male,Esophagus,2019
50-54,2.7,4.5,58,Incidence,1661932,Hispanic of any race,3.5,Male,Hodgkin Lymphoma,2019
50-54,0.7,1.9,20,Incidence,1661932,Hispanic of any race,1.2,Male,Kaposi Sarcoma,2019
50-54,29.6,35.2,537,Incidence,1661932,Hispanic of any race,32.3,Male,Kidney and Renal Pelvis,2019
50-54,2.5,4.4,56,Incidence,1661932,Hispanic of any race,3.4,Male,Larynx,2019
50-54,9.6,12.9,185,Incidence,1661932,Hispanic of any race,11.1,Male,Leukemias,2019
50-54,20.5,25.2,378,Incidence,1661932,Hispanic of any race,22.7,Male,Liver and Intrahepatic Bile Duct,2019
50-54,10.9,14.4,209,Incidence,1661932,Hispanic of any race,12.6,Male,Lung and Bronchus,2019
50-54,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
50-54,4.7,7.1,97,Incidence,1661932,Hispanic of any race,5.8,Male,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,1661932,Hispanic of any race,~,Male,Mesothelioma,2019
50-54,5.7,8.2,114,Incidence,1661932,Hispanic of any race,6.9,Male,Myeloma,2019
50-54,19.5,24.0,360,Incidence,1661932,Hispanic of any race,21.7,Male,Non-Hodgkin Lymphoma,2019
50-54,13.9,17.8,262,Incidence,1661932,Hispanic of any race,15.8,Male,Oral Cavity and Pharynx,2019
50-54,9.9,13.2,191,Incidence,1661932,Hispanic of any race,11.5,Male,Pancreas,2019
50-54,62.6,70.5,1104,Incidence,1661932,Hispanic of any race,66.4,Male,Prostate,2019
50-54,8.9,12.0,172,Incidence,1661932,Hispanic of any race,10.3,Male,Stomach,2019
50-54,1.7,3.2,39,Incidence,1661932,Hispanic of any race,2.3,Male,Testis,2019
50-54,9.3,12.5,179,Incidence,1661932,Hispanic of any race,10.8,Male,Thyroid,2019
50-54,6.2,8.9,124,Incidence,1661932,Hispanic of any race,7.5,Male,Urinary Bladder,2019
55-59,593.7,619.6,8500,Incidence,1401308,Hispanic of any race,606.6,Male,All Cancer Sites Combined,2019
55-59,7.4,10.6,124,Incidence,1401308,Hispanic of any race,8.8,Male,Brain and Other Nervous System,2019
55-59,74.6,84.0,1110,Incidence,1401308,Hispanic of any race,79.2,Male,Colon and Rectum,2019
55-59,7.0,10.1,118,Incidence,1401308,Hispanic of any race,8.4,Male,Esophagus,2019
55-59,2.8,4.9,53,Incidence,1401308,Hispanic of any race,3.8,Male,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,1401308,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
55-59,42.4,49.6,643,Incidence,1401308,Hispanic of any race,45.9,Male,Kidney and Renal Pelvis,2019
55-59,6.0,8.9,103,Incidence,1401308,Hispanic of any race,7.4,Male,Larynx,2019
55-59,14.8,19.2,237,Incidence,1401308,Hispanic of any race,16.9,Male,Leukemias,2019
55-59,44.2,51.5,669,Incidence,1401308,Hispanic of any race,47.7,Male,Liver and Intrahepatic Bile Duct,2019
55-59,31.5,37.8,484,Incidence,1401308,Hispanic of any race,34.5,Male,Lung and Bronchus,2019
55-59,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
55-59,6.6,9.6,112,Incidence,1401308,Hispanic of any race,8.0,Male,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,1401308,Hispanic of any race,~,Male,Mesothelioma,2019
55-59,12.9,17.0,208,Incidence,1401308,Hispanic of any race,14.8,Male,Myeloma,2019
55-59,30.0,36.0,461,Incidence,1401308,Hispanic of any race,32.9,Male,Non-Hodgkin Lymphoma,2019
55-59,21.5,26.8,337,Incidence,1401308,Hispanic of any race,24.0,Male,Oral Cavity and Pharynx,2019
55-59,15.8,20.3,251,Incidence,1401308,Hispanic of any race,17.9,Male,Pancreas,2019
55-59,157.6,171.1,2302,Incidence,1401308,Hispanic of any race,164.3,Male,Prostate,2019
55-59,14.7,19.1,235,Incidence,1401308,Hispanic of any race,16.8,Male,Stomach,2019
55-59,1.2,2.6,25,Incidence,1401308,Hispanic of any race,1.8,Male,Testis,2019
55-59,10.0,13.7,165,Incidence,1401308,Hispanic of any race,11.8,Male,Thyroid,2019
55-59,14.2,18.5,228,Incidence,1401308,Hispanic of any race,16.3,Male,Urinary Bladder,2019
60-64,922.1,959.0,10019,Incidence,1065409,Hispanic of any race,940.4,Male,All Cancer Sites Combined,2019
60-64,8.5,12.4,110,Incidence,1065409,Hispanic of any race,10.3,Male,Brain and Other Nervous System,2019
60-64,95.1,107.3,1077,Incidence,1065409,Hispanic of any race,101.1,Male,Colon and Rectum,2019
60-64,11.9,16.5,150,Incidence,1065409,Hispanic of any race,14.1,Male,Esophagus,2019
60-64,2.7,5.1,40,Incidence,1065409,Hispanic of any race,3.8,Male,Hodgkin Lymphoma,2019
60-64,1.0,2.7,18,Incidence,1065409,Hispanic of any race,1.7,Male,Kaposi Sarcoma,2019
60-64,60.5,70.3,695,Incidence,1065409,Hispanic of any race,65.2,Male,Kidney and Renal Pelvis,2019
60-64,10.2,14.5,130,Incidence,1065409,Hispanic of any race,12.2,Male,Larynx,2019
60-64,17.7,23.3,217,Incidence,1065409,Hispanic of any race,20.4,Male,Leukemias,2019
60-64,69.6,80.1,796,Incidence,1065409,Hispanic of any race,74.7,Male,Liver and Intrahepatic Bile Duct,2019
60-64,59.9,69.7,689,Incidence,1065409,Hispanic of any race,64.7,Male,Lung and Bronchus,2019
60-64,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
60-64,7.7,11.5,101,Incidence,1065409,Hispanic of any race,9.5,Male,Melanomas of the Skin,2019
60-64,1.1,2.9,20,Incidence,1065409,Hispanic of any race,1.9,Male,Mesothelioma,2019
60-64,17.2,22.7,211,Incidence,1065409,Hispanic of any race,19.8,Male,Myeloma,2019
60-64,39.9,48.0,467,Incidence,1065409,Hispanic of any race,43.8,Male,Non-Hodgkin Lymphoma,2019
60-64,29.6,36.6,351,Incidence,1065409,Hispanic of any race,32.9,Male,Oral Cavity and Pharynx,2019
60-64,29.3,36.3,348,Incidence,1065409,Hispanic of any race,32.7,Male,Pancreas,2019
60-64,281.8,302.4,3111,Incidence,1065409,Hispanic of any race,292.0,Male,Prostate,2019
60-64,21.0,27.0,254,Incidence,1065409,Hispanic of any race,23.8,Male,Stomach,2019
60-64,~,~,~,Incidence,1065409,Hispanic of any race,~,Male,Testis,2019
60-64,10.5,14.9,134,Incidence,1065409,Hispanic of any race,12.6,Male,Thyroid,2019
60-64,30.5,37.6,361,Incidence,1065409,Hispanic of any race,33.9,Male,Urinary Bladder,2019
65-69,1433.3,1487.9,11056,Incidence,757033,Hispanic of any race,1460.4,Male,All Cancer Sites Combined,2019
65-69,14.3,20.4,130,Incidence,757033,Hispanic of any race,17.2,Male,Brain and Other Nervous System,2019
65-69,123.3,139.7,994,Incidence,757033,Hispanic of any race,131.3,Male,Colon and Rectum,2019
65-69,17.5,24.1,156,Incidence,757033,Hispanic of any race,20.6,Male,Esophagus,2019
65-69,3.6,6.9,38,Incidence,757033,Hispanic of any race,5.0,Male,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,757033,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
65-69,81.4,94.9,666,Incidence,757033,Hispanic of any race,88.0,Male,Kidney and Renal Pelvis,2019
65-69,13.0,18.8,119,Incidence,757033,Hispanic of any race,15.7,Male,Larynx,2019
65-69,27.0,35.0,233,Incidence,757033,Hispanic of any race,30.8,Male,Leukemias,2019
65-69,87.4,101.4,713,Incidence,757033,Hispanic of any race,94.2,Male,Liver and Intrahepatic Bile Duct,2019
65-69,123.1,139.6,993,Incidence,757033,Hispanic of any race,131.2,Male,Lung and Bronchus,2019
65-69,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
65-69,11.9,17.5,110,Incidence,757033,Hispanic of any race,14.5,Male,Melanomas of the Skin,2019
65-69,1.8,4.4,22,Incidence,757033,Hispanic of any race,2.9,Male,Mesothelioma,2019
65-69,27.3,35.4,236,Incidence,757033,Hispanic of any race,31.2,Male,Myeloma,2019
65-69,61.8,73.6,511,Incidence,757033,Hispanic of any race,67.5,Male,Non-Hodgkin Lymphoma,2019
65-69,37.1,46.5,315,Incidence,757033,Hispanic of any race,41.6,Male,Oral Cavity and Pharynx,2019
65-69,47.7,58.1,399,Incidence,757033,Hispanic of any race,52.7,Male,Pancreas,2019
65-69,487.4,519.5,3810,Incidence,757033,Hispanic of any race,503.3,Male,Prostate,2019
65-69,37.3,46.6,316,Incidence,757033,Hispanic of any race,41.7,Male,Stomach,2019
65-69,~,~,~,Incidence,757033,Hispanic of any race,~,Male,Testis,2019
65-69,14.8,21.0,134,Incidence,757033,Hispanic of any race,17.7,Male,Thyroid,2019
65-69,49.3,59.9,412,Incidence,757033,Hispanic of any race,54.4,Male,Urinary Bladder,2019
70-74,1765.0,1837.5,9529,Incidence,529092,Hispanic of any race,1801.0,Male,All Cancer Sites Combined,2019
70-74,16.1,23.8,104,Incidence,529092,Hispanic of any race,19.7,Male,Brain and Other Nervous System,2019
70-74,148.4,170.1,841,Incidence,529092,Hispanic of any race,159.0,Male,Colon and Rectum,2019
70-74,21.7,30.6,137,Incidence,529092,Hispanic of any race,25.9,Male,Esophagus,2019
70-74,6.5,11.8,47,Incidence,529092,Hispanic of any race,8.9,Male,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,529092,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
70-74,94.5,112.0,545,Incidence,529092,Hispanic of any race,103.0,Male,Kidney and Renal Pelvis,2019
70-74,19.0,27.3,121,Incidence,529092,Hispanic of any race,22.9,Male,Larynx,2019
70-74,36.1,47.3,219,Incidence,529092,Hispanic of any race,41.4,Male,Leukemias,2019
70-74,91.3,108.5,527,Incidence,529092,Hispanic of any race,99.6,Male,Liver and Intrahepatic Bile Duct,2019
70-74,191.8,216.3,1078,Incidence,529092,Hispanic of any race,203.7,Male,Lung and Bronchus,2019
70-74,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
70-74,17.9,26.1,115,Incidence,529092,Hispanic of any race,21.7,Male,Melanomas of the Skin,2019
70-74,3.1,7.0,25,Incidence,529092,Hispanic of any race,4.7,Male,Mesothelioma,2019
70-74,31.3,41.8,192,Incidence,529092,Hispanic of any race,36.3,Male,Myeloma,2019
70-74,72.9,88.3,425,Incidence,529092,Hispanic of any race,80.3,Male,Non-Hodgkin Lymphoma,2019
70-74,47.4,60.1,283,Incidence,529092,Hispanic of any race,53.5,Male,Oral Cavity and Pharynx,2019
70-74,54.2,67.7,321,Incidence,529092,Hispanic of any race,60.7,Male,Pancreas,2019
70-74,538.0,578.4,2952,Incidence,529092,Hispanic of any race,557.9,Male,Prostate,2019
70-74,42.6,54.7,256,Incidence,529092,Hispanic of any race,48.4,Male,Stomach,2019
70-74,~,~,~,Incidence,529092,Hispanic of any race,~,Male,Testis,2019
70-74,14.0,21.3,92,Incidence,529092,Hispanic of any race,17.4,Male,Thyroid,2019
70-74,89.5,106.5,517,Incidence,529092,Hispanic of any race,97.7,Male,Urinary Bladder,2019
75-79,2054.2,2153.5,6934,Incidence,329652,Hispanic of any race,2103.4,Male,All Cancer Sites Combined,2019
75-79,17.4,27.8,73,Incidence,329652,Hispanic of any race,22.1,Male,Brain and Other Nervous System,2019
75-79,173.9,203.8,621,Incidence,329652,Hispanic of any race,188.4,Male,Colon and Rectum,2019
75-79,26.3,38.9,106,Incidence,329652,Hispanic of any race,32.2,Male,Esophagus,2019
75-79,4.7,10.8,24,Incidence,329652,Hispanic of any race,7.3,Male,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,329652,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
75-79,104.3,127.8,381,Incidence,329652,Hispanic of any race,115.6,Male,Kidney and Renal Pelvis,2019
75-79,20.6,31.9,85,Incidence,329652,Hispanic of any race,25.8,Male,Larynx,2019
75-79,51.7,68.7,197,Incidence,329652,Hispanic of any race,59.8,Male,Leukemias,2019
75-79,97.6,120.5,358,Incidence,329652,Hispanic of any race,108.6,Male,Liver and Intrahepatic Bile Duct,2019
75-79,244.3,279.5,862,Incidence,329652,Hispanic of any race,261.5,Male,Lung and Bronchus,2019
75-79,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
75-79,20.6,31.9,85,Incidence,329652,Hispanic of any race,25.8,Male,Melanomas of the Skin,2019
75-79,5.4,11.9,27,Incidence,329652,Hispanic of any race,8.2,Male,Mesothelioma,2019
75-79,43.3,59.0,167,Incidence,329652,Hispanic of any race,50.7,Male,Myeloma,2019
75-79,97.1,119.8,356,Incidence,329652,Hispanic of any race,108.0,Male,Non-Hodgkin Lymphoma,2019
75-79,39.3,54.4,153,Incidence,329652,Hispanic of any race,46.4,Male,Oral Cavity and Pharynx,2019
75-79,72.1,92.0,269,Incidence,329652,Hispanic of any race,81.6,Male,Pancreas,2019
75-79,519.0,569.7,1793,Incidence,329652,Hispanic of any race,543.9,Male,Prostate,2019
75-79,59.1,77.1,223,Incidence,329652,Hispanic of any race,67.6,Male,Stomach,2019
75-79,~,~,~,Incidence,329652,Hispanic of any race,~,Male,Testis,2019
75-79,12.8,22.1,56,Incidence,329652,Hispanic of any race,17.0,Male,Thyroid,2019
75-79,124.5,150.0,451,Incidence,329652,Hispanic of any race,136.8,Male,Urinary Bladder,2019
80-84,2078.4,2203.0,4568,Incidence,213459,Hispanic of any race,2140.0,Male,All Cancer Sites Combined,2019
80-84,18.2,31.9,52,Incidence,213459,Hispanic of any race,24.4,Male,Brain and Other Nervous System,2019
80-84,183.7,222.4,432,Incidence,213459,Hispanic of any race,202.4,Male,Colon and Rectum,2019
80-84,25.6,41.4,70,Incidence,213459,Hispanic of any race,32.8,Male,Esophagus,2019
80-84,~,~,~,Incidence,213459,Hispanic of any race,~,Male,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,213459,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
80-84,80.3,106.6,198,Incidence,213459,Hispanic of any race,92.8,Male,Kidney and Renal Pelvis,2019
80-84,19.4,33.5,55,Incidence,213459,Hispanic of any race,25.8,Male,Larynx,2019
80-84,75.1,100.6,186,Incidence,213459,Hispanic of any race,87.1,Male,Leukemias,2019
80-84,81.6,108.1,201,Incidence,213459,Hispanic of any race,94.2,Male,Liver and Intrahepatic Bile Duct,2019
80-84,275.2,322.0,636,Incidence,213459,Hispanic of any race,297.9,Male,Lung and Bronchus,2019
80-84,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
80-84,17.8,31.4,51,Incidence,213459,Hispanic of any race,23.9,Male,Melanomas of the Skin,2019
80-84,11.0,22.3,34,Incidence,213459,Hispanic of any race,15.9,Male,Mesothelioma,2019
80-84,56.9,79.4,144,Incidence,213459,Hispanic of any race,67.5,Male,Myeloma,2019
80-84,114.5,145.5,276,Incidence,213459,Hispanic of any race,129.3,Male,Non-Hodgkin Lymphoma,2019
80-84,41.5,61.1,108,Incidence,213459,Hispanic of any race,50.6,Male,Oral Cavity and Pharynx,2019
80-84,80.7,107.1,199,Incidence,213459,Hispanic of any race,93.2,Male,Pancreas,2019
80-84,389.5,444.8,889,Incidence,213459,Hispanic of any race,416.5,Male,Prostate,2019
80-84,56.9,79.4,144,Incidence,213459,Hispanic of any race,67.5,Male,Stomach,2019
80-84,~,~,~,Incidence,213459,Hispanic of any race,~,Male,Testis,2019
80-84,7.2,16.7,24,Incidence,213459,Hispanic of any race,11.2,Male,Thyroid,2019
80-84,143.2,177.6,341,Incidence,213459,Hispanic of any race,159.7,Male,Urinary Bladder,2019
85+,2080.8,2215.3,3949,Incidence,183907,Hispanic of any race,2147.3,Male,All Cancer Sites Combined,2019
85+,16.5,30.9,42,Incidence,183907,Hispanic of any race,22.8,Male,Brain and Other Nervous System,2019
85+,195.7,238.8,398,Incidence,183907,Hispanic of any race,216.4,Male,Colon and Rectum,2019
85+,25.8,43.2,62,Incidence,183907,Hispanic of any race,33.7,Male,Esophagus,2019
85+,~,~,~,Incidence,183907,Hispanic of any race,~,Male,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,183907,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
85+,67.0,93.4,146,Incidence,183907,Hispanic of any race,79.4,Male,Kidney and Renal Pelvis,2019
85+,23.0,39.5,56,Incidence,183907,Hispanic of any race,30.5,Male,Larynx,2019
85+,55.1,79.2,122,Incidence,183907,Hispanic of any race,66.3,Male,Leukemias,2019
85+,80.6,109.2,173,Incidence,183907,Hispanic of any race,94.1,Male,Liver and Intrahepatic Bile Duct,2019
85+,269.9,320.0,541,Incidence,183907,Hispanic of any race,294.2,Male,Lung and Bronchus,2019
85+,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
85+,34.0,53.5,79,Incidence,183907,Hispanic of any race,43.0,Male,Melanomas of the Skin,2019
85+,6.2,16.1,19,Incidence,183907,Hispanic of any race,10.3,Male,Mesothelioma,2019
85+,35.5,55.3,82,Incidence,183907,Hispanic of any race,44.6,Male,Myeloma,2019
85+,124.2,159.1,259,Incidence,183907,Hispanic of any race,140.8,Male,Non-Hodgkin Lymphoma,2019
85+,34.0,53.5,79,Incidence,183907,Hispanic of any race,43.0,Male,Oral Cavity and Pharynx,2019
85+,79.1,107.4,170,Incidence,183907,Hispanic of any race,92.4,Male,Pancreas,2019
85+,308.5,361.9,615,Incidence,183907,Hispanic of any race,334.4,Male,Prostate,2019
85+,57.6,82.2,127,Incidence,183907,Hispanic of any race,69.1,Male,Stomach,2019
85+,~,~,~,Incidence,183907,Hispanic of any race,~,Male,Testis,2019
85+,9.7,21.4,27,Incidence,183907,Hispanic of any race,14.7,Male,Thyroid,2019
85+,178.1,219.3,364,Incidence,183907,Hispanic of any race,197.9,Male,Urinary Bladder,2019
<1,20.1,29.0,121,Incidence,498367,Hispanic of any race,24.3,Male,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Colon and Rectum,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Esophagus,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Larynx,2019
<1,2.0,5.5,17,Incidence,498367,Hispanic of any race,3.4,Male,Leukemias,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Lung and Bronchus,2019
<1,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Melanomas of the Skin,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Mesothelioma,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Myeloma,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Pancreas,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Prostate,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Stomach,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Testis,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Thyroid,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male,Urinary Bladder,2019
1-4,20.9,23.8,905,Incidence,4059155,Hispanic of any race,22.3,Male and Female,All Cancer Sites Combined,2019
1-4,3.3,4.5,156,Incidence,4059155,Hispanic of any race,3.8,Male and Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,Cervix,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Esophagus,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,Female Breast,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
1-4,1.5,2.3,76,Incidence,4059155,Hispanic of any race,1.9,Male and Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Larynx,2019
1-4,8.4,10.4,380,Incidence,4059155,Hispanic of any race,9.4,Male and Female,Leukemias,2019
1-4,0.6,1.3,37,Incidence,4059155,Hispanic of any race,0.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,Male and Female Breast,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Mesothelioma,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Myeloma,2019
1-4,0.4,0.9,25,Incidence,4059155,Hispanic of any race,0.6,Male and Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,1991876,Hispanic of any race,~,Male and Female,Ovary,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Pancreas,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male and Female,Prostate,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Stomach,2019
1-4,~,~,~,Incidence,2067279,Hispanic of any race,~,Male and Female,Testis,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Thyroid,2019
1-4,~,~,~,Incidence,4059155,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
10-14,14.3,16.4,818,Incidence,5329833,Hispanic of any race,15.3,Male and Female,All Cancer Sites Combined,2019
10-14,1.6,2.4,104,Incidence,5329833,Hispanic of any race,2.0,Male and Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Male and Female,Cervix,2019
10-14,0.4,0.8,31,Incidence,5329833,Hispanic of any race,0.6,Male and Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Esophagus,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Male and Female,Female Breast,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2019
10-14,0.8,1.4,58,Incidence,5329833,Hispanic of any race,1.1,Male and Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Larynx,2019
10-14,4.0,5.2,242,Incidence,5329833,Hispanic of any race,4.5,Male and Female,Leukemias,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Male and Female,Male and Female Breast,2019
10-14,~,~,~,Incidence,2611522,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Mesothelioma,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Myeloma,2019
10-14,0.9,1.6,65,Incidence,5329833,Hispanic of any race,1.2,Male and Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2019
10-14,0.6,1.4,25,Incidence,2611522,Hispanic of any race,1.0,Male and Female,Ovary,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Pancreas,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male and Female,Prostate,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Stomach,2019
10-14,~,~,~,Incidence,2718311,Hispanic of any race,~,Male and Female,Testis,2019
10-14,0.9,1.5,62,Incidence,5329833,Hispanic of any race,1.2,Male and Female,Thyroid,2019
10-14,~,~,~,Incidence,5329833,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
15-19,24.1,26.9,1283,Incidence,5041321,Hispanic of any race,25.4,Male and Female,All Cancer Sites Combined,2019
15-19,1.3,2.1,84,Incidence,5041321,Hispanic of any race,1.7,Male and Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Male and Female,Cervix,2019
15-19,1.0,1.6,63,Incidence,5041321,Hispanic of any race,1.2,Male and Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Esophagus,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Male and Female,Female Breast,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2019
15-19,2.3,3.2,137,Incidence,5041321,Hispanic of any race,2.7,Male and Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Larynx,2019
15-19,4.4,5.6,250,Incidence,5041321,Hispanic of any race,5.0,Male and Female,Leukemias,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Male and Female,Male and Female Breast,2019
15-19,~,~,~,Incidence,2471628,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Mesothelioma,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Myeloma,2019
15-19,1.2,2.0,79,Incidence,5041321,Hispanic of any race,1.6,Male and Female,Non-Hodgkin Lymphoma,2019
15-19,0.3,0.7,22,Incidence,5041321,Hispanic of any race,0.4,Male and Female,Oral Cavity and Pharynx,2019
15-19,1.0,2.0,36,Incidence,2471628,Hispanic of any race,1.5,Male and Female,Ovary,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Pancreas,2019
15-19,~,~,~,Incidence,2569693,Hispanic of any race,~,Male and Female,Prostate,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Stomach,2019
15-19,4.9,6.8,149,Incidence,2569693,Hispanic of any race,5.8,Male and Female,Testis,2019
15-19,3.1,4.1,180,Incidence,5041321,Hispanic of any race,3.6,Male and Female,Thyroid,2019
15-19,~,~,~,Incidence,5041321,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
20-24,33.5,36.8,1701,Incidence,4842967,Hispanic of any race,35.1,Male and Female,All Cancer Sites Combined,2019
20-24,1.4,2.2,85,Incidence,4842967,Hispanic of any race,1.8,Male and Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Male and Female,Cervix,2019
20-24,1.4,2.2,86,Incidence,4842967,Hispanic of any race,1.8,Male and Female,Colon and Rectum,2019
20-24,0.7,1.6,25,Incidence,2360414,Hispanic of any race,1.1,Male and Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Esophagus,2019
20-24,1.2,2.4,41,Incidence,2360414,Hispanic of any race,1.7,Male and Female,Female Breast,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2019
20-24,2.3,3.3,135,Incidence,4842967,Hispanic of any race,2.8,Male and Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
20-24,0.6,1.1,41,Incidence,4842967,Hispanic of any race,0.8,Male and Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Larynx,2019
20-24,3.0,4.1,171,Incidence,4842967,Hispanic of any race,3.5,Male and Female,Leukemias,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Lung and Bronchus,2019
20-24,1.2,2.4,41,Incidence,2360414,Hispanic of any race,1.7,Male and Female,Male and Female Breast,2019
20-24,~,~,~,Incidence,2360414,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
20-24,0.2,0.5,16,Incidence,4842967,Hispanic of any race,0.3,Male and Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Mesothelioma,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Myeloma,2019
20-24,1.5,2.4,93,Incidence,4842967,Hispanic of any race,1.9,Male and Female,Non-Hodgkin Lymphoma,2019
20-24,0.4,0.9,30,Incidence,4842967,Hispanic of any race,0.6,Male and Female,Oral Cavity and Pharynx,2019
20-24,1.4,2.6,46,Incidence,2360414,Hispanic of any race,1.9,Male and Female,Ovary,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Pancreas,2019
20-24,~,~,~,Incidence,2482553,Hispanic of any race,~,Male and Female,Prostate,2019
20-24,0.2,0.6,18,Incidence,4842967,Hispanic of any race,0.4,Male and Female,Stomach,2019
20-24,12.7,15.7,350,Incidence,2482553,Hispanic of any race,14.1,Male and Female,Testis,2019
20-24,5.5,6.9,299,Incidence,4842967,Hispanic of any race,6.2,Male and Female,Thyroid,2019
20-24,~,~,~,Incidence,4842967,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
25-29,52.0,56.1,2669,Incidence,4943476,Hispanic of any race,54.0,Male and Female,All Cancer Sites Combined,2019
25-29,1.8,2.6,107,Incidence,4943476,Hispanic of any race,2.2,Male and Female,Brain and Other Nervous System,2019
25-29,3.7,5.4,107,Incidence,2378138,Hispanic of any race,4.5,Male and Female,Cervix,2019
25-29,2.4,3.3,139,Incidence,4943476,Hispanic of any race,2.8,Male and Female,Colon and Rectum,2019
25-29,3.0,4.6,88,Incidence,2378138,Hispanic of any race,3.7,Male and Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,4943476,Hispanic of any race,~,Male and Female,Esophagus,2019
25-29,7.3,9.7,201,Incidence,2378138,Hispanic of any race,8.5,Male and Female,Female Breast,2019
25-29,0.4,1.1,16,Incidence,2378138,Hispanic of any race,0.7,Male and Female,"Female Breast, <i>in situ</i>",2019
25-29,2.3,3.3,137,Incidence,4943476,Hispanic of any race,2.8,Male and Female,Hodgkin Lymphoma,2019
25-29,0.3,0.6,21,Incidence,4943476,Hispanic of any race,0.4,Male and Female,Kaposi Sarcoma,2019
25-29,1.1,1.8,72,Incidence,4943476,Hispanic of any race,1.5,Male and Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,4943476,Hispanic of any race,~,Male and Female,Larynx,2019
25-29,3.5,4.6,200,Incidence,4943476,Hispanic of any race,4.0,Male and Female,Leukemias,2019
25-29,~,~,~,Incidence,4943476,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
25-29,0.2,0.6,19,Incidence,4943476,Hispanic of any race,0.4,Male and Female,Lung and Bronchus,2019
25-29,7.3,9.7,201,Incidence,2378138,Hispanic of any race,8.5,Male and Female,Male and Female Breast,2019
25-29,0.4,1.1,16,Incidence,2378138,Hispanic of any race,0.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
25-29,0.7,1.3,48,Incidence,4943476,Hispanic of any race,1.0,Male and Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,4943476,Hispanic of any race,~,Male and Female,Mesothelioma,2019
25-29,~,~,~,Incidence,4943476,Hispanic of any race,~,Male and Female,Myeloma,2019
25-29,2.9,3.9,166,Incidence,4943476,Hispanic of any race,3.4,Male and Female,Non-Hodgkin Lymphoma,2019
25-29,0.4,0.9,31,Incidence,4943476,Hispanic of any race,0.6,Male and Female,Oral Cavity and Pharynx,2019
25-29,2.3,3.7,69,Incidence,2378138,Hispanic of any race,2.9,Male and Female,Ovary,2019
25-29,0.4,0.9,32,Incidence,4943476,Hispanic of any race,0.6,Male and Female,Pancreas,2019
25-29,~,~,~,Incidence,2565338,Hispanic of any race,~,Male and Female,Prostate,2019
25-29,0.5,1.0,34,Incidence,4943476,Hispanic of any race,0.7,Male and Female,Stomach,2019
25-29,14.7,17.8,415,Incidence,2565338,Hispanic of any race,16.2,Male and Female,Testis,2019
25-29,9.2,11.0,496,Incidence,4943476,Hispanic of any race,10.0,Male and Female,Thyroid,2019
25-29,~,~,~,Incidence,4943476,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
30-34,81.4,86.8,3856,Incidence,4587277,Hispanic of any race,84.1,Male and Female,All Cancer Sites Combined,2019
30-34,2.6,3.6,142,Incidence,4587277,Hispanic of any race,3.1,Male and Female,Brain and Other Nervous System,2019
30-34,12.1,15.3,297,Incidence,2174331,Hispanic of any race,13.7,Male and Female,Cervix,2019
30-34,4.9,6.3,257,Incidence,4587277,Hispanic of any race,5.6,Male and Female,Colon and Rectum,2019
30-34,8.0,10.6,201,Incidence,2174331,Hispanic of any race,9.2,Male and Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,4587277,Hispanic of any race,~,Male and Female,Esophagus,2019
30-34,23.5,27.8,556,Incidence,2174331,Hispanic of any race,25.6,Male and Female,Female Breast,2019
30-34,2.0,3.4,57,Incidence,2174331,Hispanic of any race,2.6,Male and Female,"Female Breast, <i>in situ</i>",2019
30-34,2.1,3.1,117,Incidence,4587277,Hispanic of any race,2.6,Male and Female,Hodgkin Lymphoma,2019
30-34,0.6,1.1,38,Incidence,4587277,Hispanic of any race,0.8,Male and Female,Kaposi Sarcoma,2019
30-34,3.0,4.1,163,Incidence,4587277,Hispanic of any race,3.6,Male and Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,4587277,Hispanic of any race,~,Male and Female,Larynx,2019
30-34,3.7,5.0,198,Incidence,4587277,Hispanic of any race,4.3,Male and Female,Leukemias,2019
30-34,0.4,0.9,29,Incidence,4587277,Hispanic of any race,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
30-34,0.8,1.5,51,Incidence,4587277,Hispanic of any race,1.1,Male and Female,Lung and Bronchus,2019
30-34,23.5,27.8,556,Incidence,2174331,Hispanic of any race,25.6,Male and Female,Male and Female Breast,2019
30-34,2.0,3.4,57,Incidence,2174331,Hispanic of any race,2.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
30-34,1.4,2.2,83,Incidence,4587277,Hispanic of any race,1.8,Male and Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,4587277,Hispanic of any race,~,Male and Female,Mesothelioma,2019
30-34,~,~,~,Incidence,4587277,Hispanic of any race,~,Male and Female,Myeloma,2019
30-34,3.6,4.8,189,Incidence,4587277,Hispanic of any race,4.1,Male and Female,Non-Hodgkin Lymphoma,2019
30-34,0.8,1.4,48,Incidence,4587277,Hispanic of any race,1.0,Male and Female,Oral Cavity and Pharynx,2019
30-34,3.4,5.2,92,Incidence,2174331,Hispanic of any race,4.2,Male and Female,Ovary,2019
30-34,0.5,1.0,34,Incidence,4587277,Hispanic of any race,0.7,Male and Female,Pancreas,2019
30-34,~,~,~,Incidence,2412946,Hispanic of any race,~,Male and Female,Prostate,2019
30-34,1.1,1.8,63,Incidence,4587277,Hispanic of any race,1.4,Male and Female,Stomach,2019
30-34,11.3,14.2,306,Incidence,2412946,Hispanic of any race,12.7,Male and Female,Testis,2019
30-34,12.4,14.6,618,Incidence,4587277,Hispanic of any race,13.5,Male and Female,Thyroid,2019
30-34,0.3,0.8,24,Incidence,4587277,Hispanic of any race,0.5,Male and Female,Urinary Bladder,2019
35-39,117.7,124.2,5445,Incidence,4503075,Hispanic of any race,120.9,Male and Female,All Cancer Sites Combined,2019
35-39,2.1,3.0,114,Incidence,4503075,Hispanic of any race,2.5,Male and Female,Brain and Other Nervous System,2019
35-39,15.3,18.9,369,Incidence,2165426,Hispanic of any race,17.0,Male and Female,Cervix,2019
35-39,9.3,11.2,459,Incidence,4503075,Hispanic of any race,10.2,Male and Female,Colon and Rectum,2019
35-39,12.8,16.0,310,Incidence,2165426,Hispanic of any race,14.3,Male and Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,4503075,Hispanic of any race,~,Male and Female,Esophagus,2019
35-39,49.5,55.6,1136,Incidence,2165426,Hispanic of any race,52.5,Male and Female,Female Breast,2019
35-39,4.8,6.9,125,Incidence,2165426,Hispanic of any race,5.8,Male and Female,"Female Breast, <i>in situ</i>",2019
35-39,1.3,2.1,74,Incidence,4503075,Hispanic of any race,1.6,Male and Female,Hodgkin Lymphoma,2019
35-39,0.4,0.8,25,Incidence,4503075,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2019
35-39,6.2,7.7,311,Incidence,4503075,Hispanic of any race,6.9,Male and Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,4503075,Hispanic of any race,~,Male and Female,Larynx,2019
35-39,4.2,5.5,217,Incidence,4503075,Hispanic of any race,4.8,Male and Female,Leukemias,2019
35-39,0.8,1.4,49,Incidence,4503075,Hispanic of any race,1.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
35-39,0.9,1.6,55,Incidence,4503075,Hispanic of any race,1.2,Male and Female,Lung and Bronchus,2019
35-39,49.5,55.6,1136,Incidence,2165426,Hispanic of any race,52.5,Male and Female,Male and Female Breast,2019
35-39,4.8,6.9,125,Incidence,2165426,Hispanic of any race,5.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
35-39,2.2,3.2,120,Incidence,4503075,Hispanic of any race,2.7,Male and Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,4503075,Hispanic of any race,~,Male and Female,Mesothelioma,2019
35-39,0.8,1.4,48,Incidence,4503075,Hispanic of any race,1.1,Male and Female,Myeloma,2019
35-39,5.1,6.5,261,Incidence,4503075,Hispanic of any race,5.8,Male and Female,Non-Hodgkin Lymphoma,2019
35-39,1.3,2.0,72,Incidence,4503075,Hispanic of any race,1.6,Male and Female,Oral Cavity and Pharynx,2019
35-39,3.8,5.6,100,Incidence,2165426,Hispanic of any race,4.6,Male and Female,Ovary,2019
35-39,1.0,1.7,59,Incidence,4503075,Hispanic of any race,1.3,Male and Female,Pancreas,2019
35-39,~,~,~,Incidence,2337649,Hispanic of any race,~,Male and Female,Prostate,2019
35-39,3.1,4.2,164,Incidence,4503075,Hispanic of any race,3.6,Male and Female,Stomach,2019
35-39,8.4,11.0,226,Incidence,2337649,Hispanic of any race,9.7,Male and Female,Testis,2019
35-39,16.1,18.5,777,Incidence,4503075,Hispanic of any race,17.3,Male and Female,Thyroid,2019
35-39,0.7,1.3,43,Incidence,4503075,Hispanic of any race,1.0,Male and Female,Urinary Bladder,2019
40-44,183.9,192.2,7770,Incidence,4132620,Hispanic of any race,188.0,Male and Female,All Cancer Sites Combined,2019
40-44,2.9,4.1,144,Incidence,4132620,Hispanic of any race,3.5,Male and Female,Brain and Other Nervous System,2019
40-44,17.6,21.5,394,Incidence,2021836,Hispanic of any race,19.5,Male and Female,Cervix,2019
40-44,16.4,18.9,728,Incidence,4132620,Hispanic of any race,17.6,Male and Female,Colon and Rectum,2019
40-44,18.7,22.7,417,Incidence,2021836,Hispanic of any race,20.6,Male and Female,"Corpus and Uterus, NOS",2019
40-44,0.5,1.0,30,Incidence,4132620,Hispanic of any race,0.7,Male and Female,Esophagus,2019
40-44,100.2,109.2,2116,Incidence,2021836,Hispanic of any race,104.7,Male and Female,Female Breast,2019
40-44,24.7,29.3,544,Incidence,2021836,Hispanic of any race,26.9,Male and Female,"Female Breast, <i>in situ</i>",2019
40-44,1.3,2.1,67,Incidence,4132620,Hispanic of any race,1.6,Male and Female,Hodgkin Lymphoma,2019
40-44,0.2,0.6,16,Incidence,4132620,Hispanic of any race,0.4,Male and Female,Kaposi Sarcoma,2019
40-44,10.9,13.0,493,Incidence,4132620,Hispanic of any race,11.9,Male and Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,4132620,Hispanic of any race,~,Male and Female,Larynx,2019
40-44,5.7,7.3,268,Incidence,4132620,Hispanic of any race,6.5,Male and Female,Leukemias,2019
40-44,1.5,2.4,79,Incidence,4132620,Hispanic of any race,1.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
40-44,2.8,4.0,139,Incidence,4132620,Hispanic of any race,3.4,Male and Female,Lung and Bronchus,2019
40-44,100.2,109.2,2116,Incidence,2021836,Hispanic of any race,104.7,Male and Female,Male and Female Breast,2019
40-44,24.7,29.3,544,Incidence,2021836,Hispanic of any race,26.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
40-44,2.9,4.0,141,Incidence,4132620,Hispanic of any race,3.4,Male and Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,4132620,Hispanic of any race,~,Male and Female,Mesothelioma,2019
40-44,1.3,2.2,71,Incidence,4132620,Hispanic of any race,1.7,Male and Female,Myeloma,2019
40-44,7.2,9.0,333,Incidence,4132620,Hispanic of any race,8.1,Male and Female,Non-Hodgkin Lymphoma,2019
40-44,2.8,3.9,138,Incidence,4132620,Hispanic of any race,3.3,Male and Female,Oral Cavity and Pharynx,2019
40-44,6.7,9.2,159,Incidence,2021836,Hispanic of any race,7.9,Male and Female,Ovary,2019
40-44,2.1,3.1,107,Incidence,4132620,Hispanic of any race,2.6,Male and Female,Pancreas,2019
40-44,2.5,4.1,69,Incidence,2110784,Hispanic of any race,3.3,Male and Female,Prostate,2019
40-44,5.0,6.5,236,Incidence,4132620,Hispanic of any race,5.7,Male and Female,Stomach,2019
40-44,4.8,7.0,123,Incidence,2110784,Hispanic of any race,5.8,Male and Female,Testis,2019
40-44,19.5,22.3,861,Incidence,4132620,Hispanic of any race,20.8,Male and Female,Thyroid,2019
40-44,1.3,2.1,69,Incidence,4132620,Hispanic of any race,1.7,Male and Female,Urinary Bladder,2019
45-49,270.6,281.2,10486,Incidence,3800819,Hispanic of any race,275.9,Male and Female,All Cancer Sites Combined,2019
45-49,3.9,5.3,172,Incidence,3800819,Hispanic of any race,4.5,Male and Female,Brain and Other Nervous System,2019
45-49,14.9,18.6,315,Incidence,1887047,Hispanic of any race,16.7,Male and Female,Cervix,2019
45-49,26.0,29.4,1051,Incidence,3800819,Hispanic of any race,27.7,Male and Female,Colon and Rectum,2019
45-49,28.2,33.2,578,Incidence,1887047,Hispanic of any race,30.6,Male and Female,"Corpus and Uterus, NOS",2019
45-49,0.8,1.5,42,Incidence,3800819,Hispanic of any race,1.1,Male and Female,Esophagus,2019
45-49,150.3,161.6,2941,Incidence,1887047,Hispanic of any race,155.9,Male and Female,Female Breast,2019
45-49,40.9,46.9,827,Incidence,1887047,Hispanic of any race,43.8,Male and Female,"Female Breast, <i>in situ</i>",2019
45-49,1.5,2.4,72,Incidence,3800819,Hispanic of any race,1.9,Male and Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,3800819,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
45-49,16.9,19.7,694,Incidence,3800819,Hispanic of any race,18.3,Male and Female,Kidney and Renal Pelvis,2019
45-49,0.7,1.4,38,Incidence,3800819,Hispanic of any race,1.0,Male and Female,Larynx,2019
45-49,7.3,9.2,312,Incidence,3800819,Hispanic of any race,8.2,Male and Female,Leukemias,2019
45-49,3.9,5.3,175,Incidence,3800819,Hispanic of any race,4.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
45-49,5.5,7.2,240,Incidence,3800819,Hispanic of any race,6.3,Male and Female,Lung and Bronchus,2019
45-49,150.3,161.6,2941,Incidence,1887047,Hispanic of any race,155.9,Male and Female,Male and Female Breast,2019
45-49,40.9,46.9,827,Incidence,1887047,Hispanic of any race,43.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
45-49,3.7,5.1,166,Incidence,3800819,Hispanic of any race,4.4,Male and Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,3800819,Hispanic of any race,~,Male and Female,Mesothelioma,2019
45-49,3.4,4.7,153,Incidence,3800819,Hispanic of any race,4.0,Male and Female,Myeloma,2019
45-49,10.9,13.2,456,Incidence,3800819,Hispanic of any race,12.0,Male and Female,Non-Hodgkin Lymphoma,2019
45-49,4.9,6.5,215,Incidence,3800819,Hispanic of any race,5.7,Male and Female,Oral Cavity and Pharynx,2019
45-49,9.7,12.8,211,Incidence,1887047,Hispanic of any race,11.2,Male and Female,Ovary,2019
45-49,5.0,6.6,220,Incidence,3800819,Hispanic of any race,5.8,Male and Female,Pancreas,2019
45-49,12.8,16.3,277,Incidence,1913772,Hispanic of any race,14.5,Male and Female,Prostate,2019
45-49,7.0,8.8,300,Incidence,3800819,Hispanic of any race,7.9,Male and Female,Stomach,2019
45-49,3.0,4.8,73,Incidence,1913772,Hispanic of any race,3.8,Male and Female,Testis,2019
45-49,21.0,24.0,853,Incidence,3800819,Hispanic of any race,22.4,Male and Female,Thyroid,2019
45-49,2.3,3.3,105,Incidence,3800819,Hispanic of any race,2.8,Male and Female,Urinary Bladder,2019
5-9,12.3,14.3,689,Incidence,5177023,Hispanic of any race,13.3,Male and Female,All Cancer Sites Combined,2019
5-9,2.3,3.3,143,Incidence,5177023,Hispanic of any race,2.8,Male and Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,Cervix,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Esophagus,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,Female Breast,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2019
5-9,0.3,0.6,21,Incidence,5177023,Hispanic of any race,0.4,Male and Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
5-9,0.3,0.7,25,Incidence,5177023,Hispanic of any race,0.5,Male and Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Larynx,2019
5-9,4.6,5.9,269,Incidence,5177023,Hispanic of any race,5.2,Male and Female,Leukemias,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,Male and Female Breast,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Mesothelioma,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Myeloma,2019
5-9,0.7,1.2,48,Incidence,5177023,Hispanic of any race,0.9,Male and Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,2540710,Hispanic of any race,~,Male and Female,Ovary,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Pancreas,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male and Female,Prostate,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Stomach,2019
5-9,~,~,~,Incidence,2636313,Hispanic of any race,~,Male and Female,Testis,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Thyroid,2019
5-9,~,~,~,Incidence,5177023,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
50-54,411.5,425.5,13798,Incidence,3297531,Hispanic of any race,418.4,Male and Female,All Cancer Sites Combined,2019
50-54,5.5,7.2,208,Incidence,3297531,Hispanic of any race,6.3,Male and Female,Brain and Other Nervous System,2019
50-54,13.7,17.6,255,Incidence,1635599,Hispanic of any race,15.6,Male and Female,Cervix,2019
50-54,47.9,52.8,1659,Incidence,3297531,Hispanic of any race,50.3,Male and Female,Colon and Rectum,2019
50-54,43.2,49.9,760,Incidence,1635599,Hispanic of any race,46.5,Male and Female,"Corpus and Uterus, NOS",2019
50-54,2.3,3.5,95,Incidence,3297531,Hispanic of any race,2.9,Male and Female,Esophagus,2019
50-54,180.8,194.1,3064,Incidence,1635599,Hispanic of any race,187.3,Male and Female,Female Breast,2019
50-54,47.5,54.4,832,Incidence,1635599,Hispanic of any race,50.9,Male and Female,"Female Breast, <i>in situ</i>",2019
50-54,2.0,3.1,82,Incidence,3297531,Hispanic of any race,2.5,Male and Female,Hodgkin Lymphoma,2019
50-54,0.4,0.9,20,Incidence,3297531,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2019
50-54,24.3,27.8,857,Incidence,3297531,Hispanic of any race,26.0,Male and Female,Kidney and Renal Pelvis,2019
50-54,1.5,2.5,64,Incidence,3297531,Hispanic of any race,1.9,Male and Female,Larynx,2019
50-54,8.6,10.7,317,Incidence,3297531,Hispanic of any race,9.6,Male and Female,Leukemias,2019
50-54,13.0,15.6,471,Incidence,3297531,Hispanic of any race,14.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
50-54,12.3,14.8,445,Incidence,3297531,Hispanic of any race,13.5,Male and Female,Lung and Bronchus,2019
50-54,180.8,194.1,3064,Incidence,1635599,Hispanic of any race,187.3,Male and Female,Male and Female Breast,2019
50-54,47.5,54.4,832,Incidence,1635599,Hispanic of any race,50.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
50-54,5.0,6.6,190,Incidence,3297531,Hispanic of any race,5.8,Male and Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,3297531,Hispanic of any race,~,Male and Female,Mesothelioma,2019
50-54,5.7,7.5,215,Incidence,3297531,Hispanic of any race,6.5,Male and Female,Myeloma,2019
50-54,18.3,21.3,651,Incidence,3297531,Hispanic of any race,19.7,Male and Female,Non-Hodgkin Lymphoma,2019
50-54,9.9,12.2,362,Incidence,3297531,Hispanic of any race,11.0,Male and Female,Oral Cavity and Pharynx,2019
50-54,15.0,19.1,277,Incidence,1635599,Hispanic of any race,16.9,Male and Female,Ovary,2019
50-54,8.4,10.6,312,Incidence,3297531,Hispanic of any race,9.5,Male and Female,Pancreas,2019
50-54,62.6,70.5,1104,Incidence,1661932,Hispanic of any race,66.4,Male and Female,Prostate,2019
50-54,10.0,12.3,366,Incidence,3297531,Hispanic of any race,11.1,Male and Female,Stomach,2019
50-54,1.7,3.2,39,Incidence,1661932,Hispanic of any race,2.3,Male and Female,Testis,2019
50-54,22.1,25.5,784,Incidence,3297531,Hispanic of any race,23.8,Male and Female,Thyroid,2019
50-54,4.4,6.0,170,Incidence,3297531,Hispanic of any race,5.2,Male and Female,Urinary Bladder,2019
55-59,616.9,635.4,17761,Incidence,2836712,Hispanic of any race,626.1,Male and Female,All Cancer Sites Combined,2019
55-59,6.9,9.0,225,Incidence,2836712,Hispanic of any race,7.9,Male and Female,Brain and Other Nervous System,2019
55-59,13.5,17.6,222,Incidence,1435404,Hispanic of any race,15.5,Male and Female,Cervix,2019
55-59,62.0,68.0,1842,Incidence,2836712,Hispanic of any race,64.9,Male and Female,Colon and Rectum,2019
55-59,70.9,79.9,1081,Incidence,1435404,Hispanic of any race,75.3,Male and Female,"Corpus and Uterus, NOS",2019
55-59,4.1,5.7,138,Incidence,2836712,Hispanic of any race,4.9,Male and Female,Esophagus,2019
55-59,208.6,223.9,3103,Incidence,1435404,Hispanic of any race,216.2,Male and Female,Female Breast,2019
55-59,48.8,56.4,754,Incidence,1435404,Hispanic of any race,52.5,Male and Female,"Female Breast, <i>in situ</i>",2019
55-59,2.2,3.5,79,Incidence,2836712,Hispanic of any race,2.8,Male and Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,2836712,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
55-59,34.5,39.0,1041,Incidence,2836712,Hispanic of any race,36.7,Male and Female,Kidney and Renal Pelvis,2019
55-59,3.7,5.3,127,Incidence,2836712,Hispanic of any race,4.5,Male and Female,Larynx,2019
55-59,12.5,15.3,393,Incidence,2836712,Hispanic of any race,13.9,Male and Female,Leukemias,2019
55-59,28.3,32.4,859,Incidence,2836712,Hispanic of any race,30.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
55-59,32.3,36.6,976,Incidence,2836712,Hispanic of any race,34.4,Male and Female,Lung and Bronchus,2019
55-59,208.6,223.9,3103,Incidence,1435404,Hispanic of any race,216.2,Male and Female,Male and Female Breast,2019
55-59,48.8,56.4,754,Incidence,1435404,Hispanic of any race,52.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
55-59,7.4,9.5,238,Incidence,2836712,Hispanic of any race,8.4,Male and Female,Melanomas of the Skin,2019
55-59,0.6,1.3,25,Incidence,2836712,Hispanic of any race,0.9,Male and Female,Mesothelioma,2019
55-59,11.1,13.8,352,Incidence,2836712,Hispanic of any race,12.4,Male and Female,Myeloma,2019
55-59,26.9,30.9,818,Incidence,2836712,Hispanic of any race,28.8,Male and Female,Non-Hodgkin Lymphoma,2019
55-59,14.4,17.3,448,Incidence,2836712,Hispanic of any race,15.8,Male and Female,Oral Cavity and Pharynx,2019
55-59,18.0,22.7,291,Incidence,1435404,Hispanic of any race,20.3,Male and Female,Ovary,2019
55-59,15.4,18.4,478,Incidence,2836712,Hispanic of any race,16.9,Male and Female,Pancreas,2019
55-59,157.6,171.1,2302,Incidence,1401308,Hispanic of any race,164.3,Male and Female,Prostate,2019
55-59,13.6,16.5,425,Incidence,2836712,Hispanic of any race,15.0,Male and Female,Stomach,2019
55-59,1.2,2.6,25,Incidence,1401308,Hispanic of any race,1.8,Male and Female,Testis,2019
55-59,22.3,26.0,684,Incidence,2836712,Hispanic of any race,24.1,Male and Female,Thyroid,2019
55-59,9.9,12.4,315,Incidence,2836712,Hispanic of any race,11.1,Male and Female,Urinary Bladder,2019
60-64,875.5,900.3,19692,Incidence,2218011,Hispanic of any race,887.8,Male and Female,All Cancer Sites Combined,2019
60-64,7.6,10.1,195,Incidence,2218011,Hispanic of any race,8.8,Male and Female,Brain and Other Nervous System,2019
60-64,12.5,17.0,169,Incidence,1152602,Hispanic of any race,14.7,Male and Female,Cervix,2019
60-64,76.7,84.2,1783,Incidence,2218011,Hispanic of any race,80.4,Male and Female,Colon and Rectum,2019
60-64,85.9,97.0,1053,Incidence,1152602,Hispanic of any race,91.4,Male and Female,"Corpus and Uterus, NOS",2019
60-64,6.8,9.2,176,Incidence,2218011,Hispanic of any race,7.9,Male and Female,Esophagus,2019
60-64,267.1,286.4,3188,Incidence,1152602,Hispanic of any race,276.6,Male and Female,Female Breast,2019
60-64,60.1,69.4,745,Incidence,1152602,Hispanic of any race,64.6,Male and Female,"Female Breast, <i>in situ</i>",2019
60-64,2.5,4.0,70,Incidence,2218011,Hispanic of any race,3.2,Male and Female,Hodgkin Lymphoma,2019
60-64,0.6,1.4,20,Incidence,2218011,Hispanic of any race,0.9,Male and Female,Kaposi Sarcoma,2019
60-64,47.5,53.4,1118,Incidence,2218011,Hispanic of any race,50.4,Male and Female,Kidney and Renal Pelvis,2019
60-64,6.1,8.3,158,Incidence,2218011,Hispanic of any race,7.1,Male and Female,Larynx,2019
60-64,15.7,19.2,386,Incidence,2218011,Hispanic of any race,17.4,Male and Female,Leukemias,2019
60-64,44.3,50.0,1044,Incidence,2218011,Hispanic of any race,47.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
60-64,59.9,66.6,1402,Incidence,2218011,Hispanic of any race,63.2,Male and Female,Lung and Bronchus,2019
60-64,267.1,286.4,3188,Incidence,1152602,Hispanic of any race,276.6,Male and Female,Male and Female Breast,2019
60-64,60.1,69.4,745,Incidence,1152602,Hispanic of any race,64.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
60-64,8.4,11.0,213,Incidence,2218011,Hispanic of any race,9.6,Male and Female,Melanomas of the Skin,2019
60-64,0.9,1.9,30,Incidence,2218011,Hispanic of any race,1.4,Male and Female,Mesothelioma,2019
60-64,15.7,19.2,385,Incidence,2218011,Hispanic of any race,17.4,Male and Female,Myeloma,2019
60-64,36.2,41.4,859,Incidence,2218011,Hispanic of any race,38.7,Male and Female,Non-Hodgkin Lymphoma,2019
60-64,20.0,23.9,485,Incidence,2218011,Hispanic of any race,21.9,Male and Female,Oral Cavity and Pharynx,2019
60-64,21.1,26.9,275,Incidence,1152602,Hispanic of any race,23.9,Male and Female,Ovary,2019
60-64,26.7,31.3,642,Incidence,2218011,Hispanic of any race,28.9,Male and Female,Pancreas,2019
60-64,281.8,302.4,3111,Incidence,1065409,Hispanic of any race,292.0,Male and Female,Prostate,2019
60-64,17.7,21.5,433,Incidence,2218011,Hispanic of any race,19.5,Male and Female,Stomach,2019
60-64,~,~,~,Incidence,1065409,Hispanic of any race,~,Male and Female,Testis,2019
60-64,22.7,26.9,548,Incidence,2218011,Hispanic of any race,24.7,Male and Female,Thyroid,2019
60-64,19.1,23.0,466,Incidence,2218011,Hispanic of any race,21.0,Male and Female,Urinary Bladder,2019
65-69,1252.8,1287.4,20729,Incidence,1632162,Hispanic of any race,1270.0,Male and Female,All Cancer Sites Combined,2019
65-69,12.6,16.4,235,Incidence,1632162,Hispanic of any race,14.4,Male and Female,Brain and Other Nervous System,2019
65-69,10.7,15.6,114,Incidence,875129,Hispanic of any race,13.0,Male and Female,Cervix,2019
65-69,101.3,111.4,1734,Incidence,1632162,Hispanic of any race,106.2,Male and Female,Colon and Rectum,2019
65-69,97.4,111.1,911,Incidence,875129,Hispanic of any race,104.1,Male and Female,"Corpus and Uterus, NOS",2019
65-69,9.9,13.2,187,Incidence,1632162,Hispanic of any race,11.5,Male and Female,Esophagus,2019
65-69,333.0,357.7,3021,Incidence,875129,Hispanic of any race,345.2,Male and Female,Female Breast,2019
65-69,76.3,88.4,719,Incidence,875129,Hispanic of any race,82.2,Male and Female,"Female Breast, <i>in situ</i>",2019
65-69,2.9,4.8,61,Incidence,1632162,Hispanic of any race,3.7,Male and Female,Hodgkin Lymphoma,2019
65-69,0.6,1.7,17,Incidence,1632162,Hispanic of any race,1.0,Male and Female,Kaposi Sarcoma,2019
65-69,61.3,69.2,1064,Incidence,1632162,Hispanic of any race,65.2,Male and Female,Kidney and Renal Pelvis,2019
65-69,7.2,10.1,139,Incidence,1632162,Hispanic of any race,8.5,Male and Female,Larynx,2019
65-69,22.6,27.5,408,Incidence,1632162,Hispanic of any race,25.0,Male and Female,Leukemias,2019
65-69,62.0,70.0,1076,Incidence,1632162,Hispanic of any race,65.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
65-69,105.2,115.4,1799,Incidence,1632162,Hispanic of any race,110.2,Male and Female,Lung and Bronchus,2019
65-69,333.0,357.7,3021,Incidence,875129,Hispanic of any race,345.2,Male and Female,Male and Female Breast,2019
65-69,76.3,88.4,719,Incidence,875129,Hispanic of any race,82.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
65-69,12.1,15.8,226,Incidence,1632162,Hispanic of any race,13.8,Male and Female,Melanomas of the Skin,2019
65-69,1.4,2.8,33,Incidence,1632162,Hispanic of any race,2.0,Male and Female,Mesothelioma,2019
65-69,23.7,28.7,426,Incidence,1632162,Hispanic of any race,26.1,Male and Female,Myeloma,2019
65-69,54.4,61.9,948,Incidence,1632162,Hispanic of any race,58.1,Male and Female,Non-Hodgkin Lymphoma,2019
65-69,25.8,31.0,462,Incidence,1632162,Hispanic of any race,28.3,Male and Female,Oral Cavity and Pharynx,2019
65-69,23.1,30.0,231,Incidence,875129,Hispanic of any race,26.4,Male and Female,Ovary,2019
65-69,43.3,50.0,760,Incidence,1632162,Hispanic of any race,46.6,Male and Female,Pancreas,2019
65-69,487.4,519.5,3810,Incidence,757033,Hispanic of any race,503.3,Male and Female,Prostate,2019
65-69,29.3,34.8,522,Incidence,1632162,Hispanic of any race,32.0,Male and Female,Stomach,2019
65-69,~,~,~,Incidence,757033,Hispanic of any race,~,Male and Female,Testis,2019
65-69,26.1,31.4,468,Incidence,1632162,Hispanic of any race,28.7,Male and Female,Thyroid,2019
65-69,31.7,37.5,563,Incidence,1632162,Hispanic of any race,34.5,Male and Female,Urinary Bladder,2019
70-74,1506.1,1550.8,17982,Incidence,1176583,Hispanic of any race,1528.3,Male and Female,All Cancer Sites Combined,2019
70-74,13.5,18.2,185,Incidence,1176583,Hispanic of any race,15.7,Male and Female,Brain and Other Nervous System,2019
70-74,13.0,19.3,103,Incidence,647491,Hispanic of any race,15.9,Male and Female,Cervix,2019
70-74,121.2,134.2,1501,Incidence,1176583,Hispanic of any race,127.6,Male and Female,Colon and Rectum,2019
70-74,91.9,107.4,644,Incidence,647491,Hispanic of any race,99.5,Male and Female,"Corpus and Uterus, NOS",2019
70-74,12.7,17.2,174,Incidence,1176583,Hispanic of any race,14.8,Male and Female,Esophagus,2019
70-74,351.3,380.9,2369,Incidence,647491,Hispanic of any race,365.9,Male and Female,Female Breast,2019
70-74,75.0,89.1,530,Incidence,647491,Hispanic of any race,81.9,Male and Female,"Female Breast, <i>in situ</i>",2019
70-74,4.5,7.3,68,Incidence,1176583,Hispanic of any race,5.8,Male and Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,1176583,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
70-74,70.5,80.5,887,Incidence,1176583,Hispanic of any race,75.4,Male and Female,Kidney and Renal Pelvis,2019
70-74,9.9,13.9,138,Incidence,1176583,Hispanic of any race,11.7,Male and Female,Larynx,2019
70-74,30.2,36.9,393,Incidence,1176583,Hispanic of any race,33.4,Male and Female,Leukemias,2019
70-74,64.6,74.2,815,Incidence,1176583,Hispanic of any race,69.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
70-74,161.6,176.6,1988,Incidence,1176583,Hispanic of any race,169.0,Male and Female,Lung and Bronchus,2019
70-74,351.3,380.9,2369,Incidence,647491,Hispanic of any race,365.9,Male and Female,Male and Female Breast,2019
70-74,75.0,89.1,530,Incidence,647491,Hispanic of any race,81.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
70-74,14.7,19.5,200,Incidence,1176583,Hispanic of any race,17.0,Male and Female,Melanomas of the Skin,2019
70-74,2.2,4.3,37,Incidence,1176583,Hispanic of any race,3.1,Male and Female,Mesothelioma,2019
70-74,28.2,34.6,368,Incidence,1176583,Hispanic of any race,31.3,Male and Female,Myeloma,2019
70-74,66.0,75.7,832,Incidence,1176583,Hispanic of any race,70.7,Male and Female,Non-Hodgkin Lymphoma,2019
70-74,30.6,37.3,398,Incidence,1176583,Hispanic of any race,33.8,Male and Female,Oral Cavity and Pharynx,2019
70-74,27.0,35.8,202,Incidence,647491,Hispanic of any race,31.2,Male and Female,Ovary,2019
70-74,53.4,62.1,678,Incidence,1176583,Hispanic of any race,57.6,Male and Female,Pancreas,2019
70-74,538.0,578.4,2952,Incidence,529092,Hispanic of any race,557.9,Male and Female,Prostate,2019
70-74,35.7,42.9,461,Incidence,1176583,Hispanic of any race,39.2,Male and Female,Stomach,2019
70-74,~,~,~,Incidence,529092,Hispanic of any race,~,Male and Female,Testis,2019
70-74,26.0,32.2,341,Incidence,1176583,Hispanic of any race,29.0,Male and Female,Thyroid,2019
70-74,52.8,61.5,671,Incidence,1176583,Hispanic of any race,57.0,Male and Female,Urinary Bladder,2019
75-79,1683.0,1741.3,13291,Incidence,776373,Hispanic of any race,1711.9,Male and Female,All Cancer Sites Combined,2019
75-79,15.6,21.8,144,Incidence,776373,Hispanic of any race,18.5,Male and Female,Brain and Other Nervous System,2019
75-79,13.4,21.3,76,Incidence,446721,Hispanic of any race,17.0,Male and Female,Cervix,2019
75-79,139.9,157.2,1152,Incidence,776373,Hispanic of any race,148.4,Male and Female,Colon and Rectum,2019
75-79,68.7,85.1,342,Incidence,446721,Hispanic of any race,76.6,Male and Female,"Corpus and Uterus, NOS",2019
75-79,14.5,20.4,134,Incidence,776373,Hispanic of any race,17.3,Male and Female,Esophagus,2019
75-79,305.7,339.2,1439,Incidence,446721,Hispanic of any race,322.1,Male and Female,Female Breast,2019
75-79,56.8,71.9,286,Incidence,446721,Hispanic of any race,64.0,Male and Female,"Female Breast, <i>in situ</i>",2019
75-79,4.3,7.9,46,Incidence,776373,Hispanic of any race,5.9,Male and Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,776373,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
75-79,74.3,87.1,625,Incidence,776373,Hispanic of any race,80.5,Male and Female,Kidney and Renal Pelvis,2019
75-79,9.4,14.4,91,Incidence,776373,Hispanic of any race,11.7,Male and Female,Larynx,2019
75-79,42.1,51.8,363,Incidence,776373,Hispanic of any race,46.8,Male and Female,Leukemias,2019
75-79,71.2,83.7,600,Incidence,776373,Hispanic of any race,77.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
75-79,202.1,222.8,1648,Incidence,776373,Hispanic of any race,212.3,Male and Female,Lung and Bronchus,2019
75-79,305.7,339.2,1439,Incidence,446721,Hispanic of any race,322.1,Male and Female,Male and Female Breast,2019
75-79,56.8,71.9,286,Incidence,446721,Hispanic of any race,64.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
75-79,18.5,25.2,168,Incidence,776373,Hispanic of any race,21.6,Male and Female,Melanomas of the Skin,2019
75-79,3.7,7.0,40,Incidence,776373,Hispanic of any race,5.2,Male and Female,Mesothelioma,2019
75-79,36.1,45.2,314,Incidence,776373,Hispanic of any race,40.4,Male and Female,Myeloma,2019
75-79,86.7,100.4,725,Incidence,776373,Hispanic of any race,93.4,Male and Female,Non-Hodgkin Lymphoma,2019
75-79,26.5,34.4,235,Incidence,776373,Hispanic of any race,30.3,Male and Female,Oral Cavity and Pharynx,2019
75-79,34.2,46.1,178,Incidence,446721,Hispanic of any race,39.8,Male and Female,Ovary,2019
75-79,75.7,88.5,636,Incidence,776373,Hispanic of any race,81.9,Male and Female,Pancreas,2019
75-79,519.0,569.7,1793,Incidence,329652,Hispanic of any race,543.9,Male and Female,Prostate,2019
75-79,46.0,56.2,395,Incidence,776373,Hispanic of any race,50.9,Male and Female,Stomach,2019
75-79,~,~,~,Incidence,329652,Hispanic of any race,~,Male and Female,Testis,2019
75-79,16.2,22.5,149,Incidence,776373,Hispanic of any race,19.2,Male and Female,Thyroid,2019
75-79,70.9,83.3,597,Incidence,776373,Hispanic of any race,76.9,Male and Female,Urinary Bladder,2019
80-84,1710.3,1782.0,9172,Incidence,525357,Hispanic of any race,1745.9,Male and Female,All Cancer Sites Combined,2019
80-84,17.9,26.1,114,Incidence,525357,Hispanic of any race,21.7,Male and Female,Brain and Other Nervous System,2019
80-84,11.3,20.4,48,Incidence,311898,Hispanic of any race,15.4,Male and Female,Cervix,2019
80-84,163.1,185.8,915,Incidence,525357,Hispanic of any race,174.2,Male and Female,Colon and Rectum,2019
80-84,56.1,74.3,202,Incidence,311898,Hispanic of any race,64.8,Male and Female,"Corpus and Uterus, NOS",2019
80-84,14.3,21.7,93,Incidence,525357,Hispanic of any race,17.7,Male and Female,Esophagus,2019
80-84,277.1,315.7,923,Incidence,311898,Hispanic of any race,295.9,Male and Female,Female Breast,2019
80-84,31.9,46.0,120,Incidence,311898,Hispanic of any race,38.5,Male and Female,"Female Breast, <i>in situ</i>",2019
80-84,4.5,9.0,34,Incidence,525357,Hispanic of any race,6.5,Male and Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,525357,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
80-84,69.8,85.0,405,Incidence,525357,Hispanic of any race,77.1,Male and Female,Kidney and Renal Pelvis,2019
80-84,8.9,14.9,61,Incidence,525357,Hispanic of any race,11.6,Male and Female,Larynx,2019
80-84,55.5,69.2,326,Incidence,525357,Hispanic of any race,62.1,Male and Female,Leukemias,2019
80-84,64.0,78.6,373,Incidence,525357,Hispanic of any race,71.0,Male and Female,Liver and Intrahepatic Bile Duct,2019
80-84,212.5,238.4,1183,Incidence,525357,Hispanic of any race,225.2,Male and Female,Lung and Bronchus,2019
80-84,277.1,315.7,923,Incidence,311898,Hispanic of any race,295.9,Male and Female,Male and Female Breast,2019
80-84,31.9,46.0,120,Incidence,311898,Hispanic of any race,38.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
80-84,15.0,22.5,97,Incidence,525357,Hispanic of any race,18.5,Male and Female,Melanomas of the Skin,2019
80-84,5.1,9.9,38,Incidence,525357,Hispanic of any race,7.2,Male and Female,Mesothelioma,2019
80-84,42.9,55.1,256,Incidence,525357,Hispanic of any race,48.7,Male and Female,Myeloma,2019
80-84,91.7,109.1,526,Incidence,525357,Hispanic of any race,100.1,Male and Female,Non-Hodgkin Lymphoma,2019
80-84,29.6,39.9,181,Incidence,525357,Hispanic of any race,34.5,Male and Female,Oral Cavity and Pharynx,2019
80-84,29.9,43.6,113,Incidence,311898,Hispanic of any race,36.2,Male and Female,Ovary,2019
80-84,79.7,95.9,460,Incidence,525357,Hispanic of any race,87.6,Male and Female,Pancreas,2019
80-84,389.5,444.8,889,Incidence,213459,Hispanic of any race,416.5,Male and Female,Prostate,2019
80-84,48.5,61.3,287,Incidence,525357,Hispanic of any race,54.6,Male and Female,Stomach,2019
80-84,~,~,~,Incidence,213459,Hispanic of any race,~,Male and Female,Testis,2019
80-84,16.0,23.8,103,Incidence,525357,Hispanic of any race,19.6,Male and Female,Thyroid,2019
80-84,82.3,98.7,474,Incidence,525357,Hispanic of any race,90.2,Male and Female,Urinary Bladder,2019
85+,1626.1,1697.3,8410,Incidence,506189,Hispanic of any race,1661.4,Male and Female,All Cancer Sites Combined,2019
85+,13.8,21.2,87,Incidence,506189,Hispanic of any race,17.2,Male and Female,Brain and Other Nervous System,2019
85+,13.1,22.6,56,Incidence,322282,Hispanic of any race,17.4,Male and Female,Cervix,2019
85+,169.2,192.9,915,Incidence,506189,Hispanic of any race,180.8,Male and Female,Colon and Rectum,2019
85+,33.4,47.6,129,Incidence,322282,Hispanic of any race,40.0,Male and Female,"Corpus and Uterus, NOS",2019
85+,16.3,24.2,101,Incidence,506189,Hispanic of any race,20.0,Male and Female,Esophagus,2019
85+,216.4,250.0,750,Incidence,322282,Hispanic of any race,232.7,Male and Female,Female Breast,2019
85+,15.3,25.4,64,Incidence,322282,Hispanic of any race,19.9,Male and Female,"Female Breast, <i>in situ</i>",2019
85+,2.4,6.1,20,Incidence,506189,Hispanic of any race,4.0,Male and Female,Hodgkin Lymphoma,2019
85+,2.6,6.3,21,Incidence,506189,Hispanic of any race,4.1,Male and Female,Kaposi Sarcoma,2019
85+,50.0,63.2,285,Incidence,506189,Hispanic of any race,56.3,Male and Female,Kidney and Renal Pelvis,2019
85+,10.3,16.8,67,Incidence,506189,Hispanic of any race,13.2,Male and Female,Larynx,2019
85+,48.7,61.8,278,Incidence,506189,Hispanic of any race,54.9,Male and Female,Leukemias,2019
85+,55.5,69.5,315,Incidence,506189,Hispanic of any race,62.2,Male and Female,Liver and Intrahepatic Bile Duct,2019
85+,187.0,211.8,1008,Incidence,506189,Hispanic of any race,199.1,Male and Female,Lung and Bronchus,2019
85+,216.4,250.0,750,Incidence,322282,Hispanic of any race,232.7,Male and Female,Male and Female Breast,2019
85+,15.3,25.4,64,Incidence,322282,Hispanic of any race,19.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
85+,22.2,31.4,134,Incidence,506189,Hispanic of any race,26.5,Male and Female,Melanomas of the Skin,2019
85+,3.5,7.8,27,Incidence,506189,Hispanic of any race,5.3,Male and Female,Mesothelioma,2019
85+,29.8,40.3,176,Incidence,506189,Hispanic of any race,34.8,Male and Female,Myeloma,2019
85+,88.6,106.0,491,Incidence,506189,Hispanic of any race,97.0,Male and Female,Non-Hodgkin Lymphoma,2019
85+,25.6,35.4,153,Incidence,506189,Hispanic of any race,30.2,Male and Female,Oral Cavity and Pharynx,2019
85+,24.4,36.7,97,Incidence,322282,Hispanic of any race,30.1,Male and Female,Ovary,2019
85+,85.6,102.7,475,Incidence,506189,Hispanic of any race,93.8,Male and Female,Pancreas,2019
85+,308.5,361.9,615,Incidence,183907,Hispanic of any race,334.4,Male and Female,Prostate,2019
85+,46.2,59.0,265,Incidence,506189,Hispanic of any race,52.4,Male and Female,Stomach,2019
85+,~,~,~,Incidence,183907,Hispanic of any race,~,Male and Female,Testis,2019
85+,12.5,19.7,80,Incidence,506189,Hispanic of any race,15.8,Male and Female,Thyroid,2019
85+,95.8,113.8,529,Incidence,506189,Hispanic of any race,104.5,Male and Female,Urinary Bladder,2019
<1,18.5,24.4,209,Incidence,979889,Hispanic of any race,21.3,Male and Female,All Cancer Sites Combined,2019
<1,1.7,3.8,25,Incidence,979889,Hispanic of any race,2.6,Male and Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,Cervix,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Colon and Rectum,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Esophagus,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,Female Breast,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Larynx,2019
<1,2.8,5.4,39,Incidence,979889,Hispanic of any race,4.0,Male and Female,Leukemias,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,Male and Female Breast,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Mesothelioma,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Myeloma,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,481522,Hispanic of any race,~,Male and Female,Ovary,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Pancreas,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male and Female,Prostate,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Stomach,2019
<1,~,~,~,Incidence,498367,Hispanic of any race,~,Male and Female,Testis,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Thyroid,2019
<1,~,~,~,Incidence,979889,Hispanic of any race,~,Male and Female,Urinary Bladder,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
15-19,13.9,33.6,22,Incidence,99269,Non-Hispanic American Indian/Alaska Native,22.2,Female,All Cancer Sites Combined,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
20-24,12.7,31.5,21,Incidence,101992,Non-Hispanic American Indian/Alaska Native,20.6,Female,All Cancer Sites Combined,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
25-29,38.9,66.6,57,Incidence,110905,Non-Hispanic American Indian/Alaska Native,51.4,Female,All Cancer Sites Combined,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
30-34,96.1,140.2,113,Incidence,96880,Non-Hispanic American Indian/Alaska Native,116.6,Female,All Cancer Sites Combined,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
30-34,9.4,26.8,16,Incidence,96880,Non-Hispanic American Indian/Alaska Native,16.5,Female,Cervix,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
30-34,16.7,38.1,25,Incidence,96880,Non-Hispanic American Indian/Alaska Native,25.8,Female,Female Breast,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
30-34,12.6,31.9,20,Incidence,96880,Non-Hispanic American Indian/Alaska Native,20.6,Female,Thyroid,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
35-39,228.5,296.5,234,Incidence,89698,Non-Hispanic American Indian/Alaska Native,260.9,Female,All Cancer Sites Combined,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
35-39,17.1,39.8,24,Incidence,89698,Non-Hispanic American Indian/Alaska Native,26.8,Female,Cervix,2019
35-39,11.0,30.3,17,Incidence,89698,Non-Hispanic American Indian/Alaska Native,19.0,Female,Colon and Rectum,2019
35-39,17.1,39.8,24,Incidence,89698,Non-Hispanic American Indian/Alaska Native,26.8,Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
35-39,45.2,78.6,54,Incidence,89698,Non-Hispanic American Indian/Alaska Native,60.2,Female,Female Breast,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
35-39,29.0,56.9,37,Incidence,89698,Non-Hispanic American Indian/Alaska Native,41.2,Female,Thyroid,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
40-44,270.6,348.9,246,Incidence,79899,Non-Hispanic American Indian/Alaska Native,307.9,Female,All Cancer Sites Combined,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
40-44,14.3,37.1,19,Incidence,79899,Non-Hispanic American Indian/Alaska Native,23.8,Female,Colon and Rectum,2019
40-44,21.3,47.7,26,Incidence,79899,Non-Hispanic American Indian/Alaska Native,32.5,Female,"Corpus and Uterus, NOS",2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
40-44,88.3,135.7,88,Incidence,79899,Non-Hispanic American Indian/Alaska Native,110.1,Female,Female Breast,2019
40-44,12.4,34.1,17,Incidence,79899,Non-Hispanic American Indian/Alaska Native,21.3,Female,"Female Breast, <i>in situ</i>",2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
40-44,12.4,34.1,17,Incidence,79899,Non-Hispanic American Indian/Alaska Native,21.3,Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
40-44,24.3,52.1,29,Incidence,79899,Non-Hispanic American Indian/Alaska Native,36.3,Female,Thyroid,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
45-49,458.2,557.7,408,Incidence,80619,Non-Hispanic American Indian/Alaska Native,506.1,Female,All Cancer Sites Combined,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
45-49,32.3,63.3,37,Incidence,80619,Non-Hispanic American Indian/Alaska Native,45.9,Female,Colon and Rectum,2019
45-49,25.1,53.1,30,Incidence,80619,Non-Hispanic American Indian/Alaska Native,37.2,Female,"Corpus and Uterus, NOS",2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
45-49,155.2,215.7,148,Incidence,80619,Non-Hispanic American Indian/Alaska Native,183.6,Female,Female Breast,2019
45-49,21.1,47.3,26,Incidence,80619,Non-Hispanic American Indian/Alaska Native,32.3,Female,"Female Breast, <i>in situ</i>",2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
45-49,18.1,42.8,23,Incidence,80619,Non-Hispanic American Indian/Alaska Native,28.5,Female,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
45-49,11.3,32.2,16,Incidence,80619,Non-Hispanic American Indian/Alaska Native,19.8,Female,Lung and Bronchus,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
45-49,27.1,56.0,32,Incidence,80619,Non-Hispanic American Indian/Alaska Native,39.7,Female,Thyroid,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
50-54,523.0,627.7,473,Incidence,82465,Non-Hispanic American Indian/Alaska Native,573.6,Female,All Cancer Sites Combined,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
50-54,41.9,75.8,47,Incidence,82465,Non-Hispanic American Indian/Alaska Native,57.0,Female,Colon and Rectum,2019
50-54,32.6,63.2,38,Incidence,82465,Non-Hispanic American Indian/Alaska Native,46.1,Female,"Corpus and Uterus, NOS",2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
50-54,167.4,229.1,162,Incidence,82465,Non-Hispanic American Indian/Alaska Native,196.4,Female,Female Breast,2019
50-54,21.6,47.6,27,Incidence,82465,Non-Hispanic American Indian/Alaska Native,32.7,Female,"Female Breast, <i>in situ</i>",2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
50-54,22.6,49.1,28,Incidence,82465,Non-Hispanic American Indian/Alaska Native,34.0,Female,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
50-54,32.6,63.2,38,Incidence,82465,Non-Hispanic American Indian/Alaska Native,46.1,Female,Lung and Bronchus,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
50-54,13.9,36.0,19,Incidence,82465,Non-Hispanic American Indian/Alaska Native,23.0,Female,Thyroid,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
55-59,685.5,798.7,671,Incidence,90616,Non-Hispanic American Indian/Alaska Native,740.5,Female,All Cancer Sites Combined,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
55-59,36.2,66.4,45,Incidence,90616,Non-Hispanic American Indian/Alaska Native,49.7,Female,Colon and Rectum,2019
55-59,54.4,90.2,64,Incidence,90616,Non-Hispanic American Indian/Alaska Native,70.6,Female,"Corpus and Uterus, NOS",2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
55-59,193.2,255.9,202,Incidence,90616,Non-Hispanic American Indian/Alaska Native,222.9,Female,Female Breast,2019
55-59,21.4,46.0,29,Incidence,90616,Non-Hispanic American Indian/Alaska Native,32.0,Female,"Female Breast, <i>in situ</i>",2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
55-59,28.7,56.3,37,Incidence,90616,Non-Hispanic American Indian/Alaska Native,40.8,Female,Kidney and Renal Pelvis,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
55-59,10.1,28.7,16,Incidence,90616,Non-Hispanic American Indian/Alaska Native,17.7,Female,Leukemias,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
55-59,79.9,122.1,90,Incidence,90616,Non-Hispanic American Indian/Alaska Native,99.3,Female,Lung and Bronchus,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
55-59,15.2,36.8,22,Incidence,90616,Non-Hispanic American Indian/Alaska Native,24.3,Female,Non-Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
55-59,14.3,35.4,21,Incidence,90616,Non-Hispanic American Indian/Alaska Native,23.2,Female,Ovary,2019
55-59,14.3,35.4,21,Incidence,90616,Non-Hispanic American Indian/Alaska Native,23.2,Female,Pancreas,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
55-59,17.0,39.4,24,Incidence,90616,Non-Hispanic American Indian/Alaska Native,26.5,Female,Thyroid,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
60-64,877.5,1010.6,784,Incidence,83204,Non-Hispanic American Indian/Alaska Native,942.3,Female,All Cancer Sites Combined,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
60-64,66.6,107.6,71,Incidence,83204,Non-Hispanic American Indian/Alaska Native,85.3,Female,Colon and Rectum,2019
60-64,39.4,72.4,45,Incidence,83204,Non-Hispanic American Indian/Alaska Native,54.1,Female,"Corpus and Uterus, NOS",2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
60-64,240.7,313.3,229,Incidence,83204,Non-Hispanic American Indian/Alaska Native,275.2,Female,Female Breast,2019
60-64,32.3,62.7,38,Incidence,83204,Non-Hispanic American Indian/Alaska Native,45.7,Female,"Female Breast, <i>in situ</i>",2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
60-64,26.3,54.3,32,Incidence,83204,Non-Hispanic American Indian/Alaska Native,38.5,Female,Kidney and Renal Pelvis,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
60-64,15.6,38.6,21,Incidence,83204,Non-Hispanic American Indian/Alaska Native,25.2,Female,Liver and Intrahepatic Bile Duct,2019
60-64,127.2,181.6,127,Incidence,83204,Non-Hispanic American Indian/Alaska Native,152.6,Female,Lung and Bronchus,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
60-64,25.3,52.9,31,Incidence,83204,Non-Hispanic American Indian/Alaska Native,37.3,Female,Non-Hodgkin Lymphoma,2019
60-64,11.9,32.7,17,Incidence,83204,Non-Hispanic American Indian/Alaska Native,20.4,Female,Oral Cavity and Pharynx,2019
60-64,12.8,34.2,18,Incidence,83204,Non-Hispanic American Indian/Alaska Native,21.6,Female,Ovary,2019
60-64,20.4,45.8,26,Incidence,83204,Non-Hispanic American Indian/Alaska Native,31.2,Female,Pancreas,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
60-64,12.8,34.2,18,Incidence,83204,Non-Hispanic American Indian/Alaska Native,21.6,Female,Thyroid,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
65-69,1119.7,1289.1,789,Incidence,65632,Non-Hispanic American Indian/Alaska Native,1202.2,Female,All Cancer Sites Combined,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
65-69,77.8,127.9,66,Incidence,65632,Non-Hispanic American Indian/Alaska Native,100.6,Female,Colon and Rectum,2019
65-69,69.8,117.7,60,Incidence,65632,Non-Hispanic American Indian/Alaska Native,91.4,Female,"Corpus and Uterus, NOS",2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
65-69,336.6,432.8,251,Incidence,65632,Non-Hispanic American Indian/Alaska Native,382.4,Female,Female Breast,2019
65-69,51.3,93.5,46,Incidence,65632,Non-Hispanic American Indian/Alaska Native,70.1,Female,"Female Breast, <i>in situ</i>",2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
65-69,41.0,79.5,38,Incidence,65632,Non-Hispanic American Indian/Alaska Native,57.9,Female,Kidney and Renal Pelvis,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
65-69,18.6,47.1,20,Incidence,65632,Non-Hispanic American Indian/Alaska Native,30.5,Female,Liver and Intrahepatic Bile Duct,2019
65-69,143.3,208.7,114,Incidence,65632,Non-Hispanic American Indian/Alaska Native,173.7,Female,Lung and Bronchus,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
65-69,33.3,68.8,32,Incidence,65632,Non-Hispanic American Indian/Alaska Native,48.8,Female,Non-Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
65-69,29.6,63.5,29,Incidence,65632,Non-Hispanic American Indian/Alaska Native,44.2,Female,Pancreas,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
70-74,1247.8,1457.8,648,Incidence,48008,Non-Hispanic American Indian/Alaska Native,1349.8,Female,All Cancer Sites Combined,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
70-74,68.4,125.4,45,Incidence,48008,Non-Hispanic American Indian/Alaska Native,93.7,Female,Colon and Rectum,2019
70-74,52.5,103.8,36,Incidence,48008,Non-Hispanic American Indian/Alaska Native,75.0,Female,"Corpus and Uterus, NOS",2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
70-74,320.2,431.7,179,Incidence,48008,Non-Hispanic American Indian/Alaska Native,372.9,Female,Female Breast,2019
70-74,37.1,81.8,27,Incidence,48008,Non-Hispanic American Indian/Alaska Native,56.2,Female,"Female Breast, <i>in situ</i>",2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
70-74,30.4,71.9,23,Incidence,48008,Non-Hispanic American Indian/Alaska Native,47.9,Female,Kidney and Renal Pelvis,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
70-74,37.1,81.8,27,Incidence,48008,Non-Hispanic American Indian/Alaska Native,56.2,Female,Liver and Intrahepatic Bile Duct,2019
70-74,232.0,328.3,133,Incidence,48008,Non-Hispanic American Indian/Alaska Native,277.0,Female,Lung and Bronchus,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
70-74,27.1,66.9,21,Incidence,48008,Non-Hispanic American Indian/Alaska Native,43.7,Female,Non-Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
70-74,32.0,74.4,24,Incidence,48008,Non-Hispanic American Indian/Alaska Native,50.0,Female,Pancreas,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
75-79,1401.5,1681.8,473,Incidence,30777,Non-Hispanic American Indian/Alaska Native,1536.9,Female,All Cancer Sites Combined,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
75-79,112.2,203.1,47,Incidence,30777,Non-Hispanic American Indian/Alaska Native,152.7,Female,Colon and Rectum,2019
75-79,37.2,96.4,19,Incidence,30777,Non-Hispanic American Indian/Alaska Native,61.7,Female,"Corpus and Uterus, NOS",2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
75-79,261.4,391.6,99,Incidence,30777,Non-Hispanic American Indian/Alaska Native,321.7,Female,Female Breast,2019
75-79,42.2,104.3,21,Incidence,30777,Non-Hispanic American Indian/Alaska Native,68.2,Female,"Female Breast, <i>in situ</i>",2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
75-79,32.2,88.4,17,Incidence,30777,Non-Hispanic American Indian/Alaska Native,55.2,Female,Kidney and Renal Pelvis,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
75-79,29.7,84.4,16,Incidence,30777,Non-Hispanic American Indian/Alaska Native,52.0,Female,Liver and Intrahepatic Bile Duct,2019
75-79,261.4,391.6,99,Incidence,30777,Non-Hispanic American Indian/Alaska Native,321.7,Female,Lung and Bronchus,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
75-79,55.2,123.8,26,Incidence,30777,Non-Hispanic American Indian/Alaska Native,84.5,Female,Non-Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
75-79,52.6,119.9,25,Incidence,30777,Non-Hispanic American Indian/Alaska Native,81.2,Female,Pancreas,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
80-84,1351.2,1703.4,295,Incidence,19412,Non-Hispanic American Indian/Alaska Native,1519.7,Female,All Cancer Sites Combined,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
80-84,112.8,232.7,32,Incidence,19412,Non-Hispanic American Indian/Alaska Native,164.8,Female,Colon and Rectum,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
80-84,231.4,392.1,59,Incidence,19412,Non-Hispanic American Indian/Alaska Native,303.9,Female,Female Breast,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
80-84,182.3,327.8,48,Incidence,19412,Non-Hispanic American Indian/Alaska Native,247.3,Female,Lung and Bronchus,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
80-84,47.1,133.9,16,Incidence,19412,Non-Hispanic American Indian/Alaska Native,82.4,Female,Non-Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
85+,1180.7,1515.1,255,Incidence,19028,Non-Hispanic American Indian/Alaska Native,1340.1,Female,All Cancer Sites Combined,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
85+,128.1,255.8,35,Incidence,19028,Non-Hispanic American Indian/Alaska Native,183.9,Female,Colon and Rectum,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
85+,172.5,316.4,45,Incidence,19028,Non-Hispanic American Indian/Alaska Native,236.5,Female,Female Breast,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
85+,123.7,249.7,34,Incidence,19028,Non-Hispanic American Indian/Alaska Native,178.7,Female,Lung and Bronchus,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
85+,52.0,143.0,17,Incidence,19028,Non-Hispanic American Indian/Alaska Native,89.3,Female,Pancreas,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
1-4,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
10-14,12.7,31.5,21,Incidence,101980,Non-Hispanic American Indian/Alaska Native,20.6,Male,All Cancer Sites Combined,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
10-14,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
15-19,12.0,30.3,20,Incidence,102078,Non-Hispanic American Indian/Alaska Native,19.6,Male,All Cancer Sites Combined,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
15-19,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
20-24,23.4,46.7,35,Incidence,104329,Non-Hispanic American Indian/Alaska Native,33.5,Male,All Cancer Sites Combined,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
20-24,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
25-29,33.9,59.6,52,Incidence,114481,Non-Hispanic American Indian/Alaska Native,45.4,Male,All Cancer Sites Combined,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
25-29,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
25-29,8.7,23.8,17,Incidence,114481,Non-Hispanic American Indian/Alaska Native,14.8,Male,Testis,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
30-34,46.2,78.4,59,Incidence,97119,Non-Hispanic American Indian/Alaska Native,60.8,Male,All Cancer Sites Combined,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
30-34,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
35-39,92.7,138.8,99,Incidence,86811,Non-Hispanic American Indian/Alaska Native,114.0,Male,All Cancer Sites Combined,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
35-39,14.1,35.6,20,Incidence,86811,Non-Hispanic American Indian/Alaska Native,23.0,Male,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
35-39,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
35-39,14.1,35.6,20,Incidence,86811,Non-Hispanic American Indian/Alaska Native,23.0,Male,Testis,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
40-44,137.2,195.9,127,Incidence,77142,Non-Hispanic American Indian/Alaska Native,164.6,Male,All Cancer Sites Combined,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
40-44,28.4,58.6,32,Incidence,77142,Non-Hispanic American Indian/Alaska Native,41.5,Male,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
40-44,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
45-49,238.5,314.4,209,Incidence,76137,Non-Hispanic American Indian/Alaska Native,274.5,Male,All Cancer Sites Combined,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
45-49,32.0,63.9,35,Incidence,76137,Non-Hispanic American Indian/Alaska Native,46.0,Male,Colon and Rectum,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
45-49,25.5,54.7,29,Incidence,76137,Non-Hispanic American Indian/Alaska Native,38.1,Male,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
45-49,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
45-49,14.0,37.4,18,Incidence,76137,Non-Hispanic American Indian/Alaska Native,23.6,Male,Oral Cavity and Pharynx,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
45-49,16.0,40.6,20,Incidence,76137,Non-Hispanic American Indian/Alaska Native,26.3,Male,Prostate,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
5-9,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
50-54,390.7,485.6,334,Incidence,76571,Non-Hispanic American Indian/Alaska Native,436.2,Male,All Cancer Sites Combined,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
50-54,60.9,102.3,61,Incidence,76571,Non-Hispanic American Indian/Alaska Native,79.7,Male,Colon and Rectum,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
50-54,44.0,80.1,46,Incidence,76571,Non-Hispanic American Indian/Alaska Native,60.1,Male,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
50-54,17.0,41.9,21,Incidence,76571,Non-Hispanic American Indian/Alaska Native,27.4,Male,Liver and Intrahepatic Bile Duct,2019
50-54,21.1,48.2,25,Incidence,76571,Non-Hispanic American Indian/Alaska Native,32.6,Male,Lung and Bronchus,2019
50-54,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
50-54,22.2,49.8,26,Incidence,76571,Non-Hispanic American Indian/Alaska Native,34.0,Male,Oral Cavity and Pharynx,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
50-54,51.8,90.5,53,Incidence,76571,Non-Hispanic American Indian/Alaska Native,69.2,Male,Prostate,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
55-59,727.1,849.9,643,Incidence,81733,Non-Hispanic American Indian/Alaska Native,786.7,Male,All Cancer Sites Combined,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
55-59,80.9,125.9,83,Incidence,81733,Non-Hispanic American Indian/Alaska Native,101.6,Male,Colon and Rectum,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
55-59,63.5,104.1,67,Incidence,81733,Non-Hispanic American Indian/Alaska Native,82.0,Male,Kidney and Renal Pelvis,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
55-59,41.2,75.1,46,Incidence,81733,Non-Hispanic American Indian/Alaska Native,56.3,Male,Liver and Intrahepatic Bile Duct,2019
55-59,68.9,110.9,72,Incidence,81733,Non-Hispanic American Indian/Alaska Native,88.1,Male,Lung and Bronchus,2019
55-59,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
55-59,17.8,42.2,23,Incidence,81733,Non-Hispanic American Indian/Alaska Native,28.1,Male,Non-Hodgkin Lymphoma,2019
55-59,32.9,63.8,38,Incidence,81733,Non-Hispanic American Indian/Alaska Native,46.5,Male,Oral Cavity and Pharynx,2019
55-59,15.9,39.3,21,Incidence,81733,Non-Hispanic American Indian/Alaska Native,25.7,Male,Pancreas,2019
55-59,137.4,194.2,134,Incidence,81733,Non-Hispanic American Indian/Alaska Native,163.9,Male,Prostate,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
55-59,12.1,33.3,17,Incidence,81733,Non-Hispanic American Indian/Alaska Native,20.8,Male,Urinary Bladder,2019
60-64,1142.7,1305.7,879,Incidence,71922,Non-Hispanic American Indian/Alaska Native,1222.2,Male,All Cancer Sites Combined,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
60-64,120.7,178.3,106,Incidence,71922,Non-Hispanic American Indian/Alaska Native,147.4,Male,Colon and Rectum,2019
60-64,18.1,44.6,21,Incidence,71922,Non-Hispanic American Indian/Alaska Native,29.2,Male,Esophagus,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
60-64,82.0,130.7,75,Incidence,71922,Non-Hispanic American Indian/Alaska Native,104.3,Male,Kidney and Renal Pelvis,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
60-64,22.5,51.3,25,Incidence,71922,Non-Hispanic American Indian/Alaska Native,34.8,Male,Leukemias,2019
60-64,71.0,116.7,66,Incidence,71922,Non-Hispanic American Indian/Alaska Native,91.8,Male,Liver and Intrahepatic Bile Duct,2019
60-64,151.0,214.6,130,Incidence,71922,Non-Hispanic American Indian/Alaska Native,180.8,Male,Lung and Bronchus,2019
60-64,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
60-64,35.1,69.3,36,Incidence,71922,Non-Hispanic American Indian/Alaska Native,50.1,Male,Non-Hodgkin Lymphoma,2019
60-64,44.5,82.1,44,Incidence,71922,Non-Hispanic American Indian/Alaska Native,61.2,Male,Oral Cavity and Pharynx,2019
60-64,30.4,62.8,32,Incidence,71922,Non-Hispanic American Indian/Alaska Native,44.5,Male,Pancreas,2019
60-64,246.1,325.3,204,Incidence,71922,Non-Hispanic American Indian/Alaska Native,283.6,Male,Prostate,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
60-64,23.6,53.0,26,Incidence,71922,Non-Hispanic American Indian/Alaska Native,36.2,Male,Urinary Bladder,2019
65-69,1492.1,1703.2,892,Incidence,55924,Non-Hispanic American Indian/Alaska Native,1595.0,Male,All Cancer Sites Combined,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
65-69,113.4,178.0,80,Incidence,55924,Non-Hispanic American Indian/Alaska Native,143.1,Male,Colon and Rectum,2019
65-69,19.1,50.9,18,Incidence,55924,Non-Hispanic American Indian/Alaska Native,32.2,Male,Esophagus,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
65-69,85.0,142.1,62,Incidence,55924,Non-Hispanic American Indian/Alaska Native,110.9,Male,Kidney and Renal Pelvis,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
65-69,89.7,148.1,65,Incidence,55924,Non-Hispanic American Indian/Alaska Native,116.2,Male,Liver and Intrahepatic Bile Duct,2019
65-69,184.4,264.4,124,Incidence,55924,Non-Hispanic American Indian/Alaska Native,221.7,Male,Lung and Bronchus,2019
65-69,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
65-69,19.1,50.9,18,Incidence,55924,Non-Hispanic American Indian/Alaska Native,32.2,Male,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
65-69,21.8,55.2,20,Incidence,55924,Non-Hispanic American Indian/Alaska Native,35.8,Male,Myeloma,2019
65-69,42.1,85.0,34,Incidence,55924,Non-Hispanic American Indian/Alaska Native,60.8,Male,Non-Hodgkin Lymphoma,2019
65-69,45.1,89.1,36,Incidence,55924,Non-Hispanic American Indian/Alaska Native,64.4,Male,Oral Cavity and Pharynx,2019
65-69,34.7,74.5,29,Incidence,55924,Non-Hispanic American Indian/Alaska Native,51.9,Male,Pancreas,2019
65-69,374.9,485.1,239,Incidence,55924,Non-Hispanic American Indian/Alaska Native,427.4,Male,Prostate,2019
65-69,17.7,48.7,17,Incidence,55924,Non-Hispanic American Indian/Alaska Native,30.4,Male,Stomach,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
65-69,46.6,91.2,37,Incidence,55924,Non-Hispanic American Indian/Alaska Native,66.2,Male,Urinary Bladder,2019
70-74,1736.6,2002.9,769,Incidence,41206,Non-Hispanic American Indian/Alaska Native,1866.2,Male,All Cancer Sites Combined,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
70-74,109.0,184.7,59,Incidence,41206,Non-Hispanic American Indian/Alaska Native,143.2,Male,Colon and Rectum,2019
70-74,24.0,66.1,17,Incidence,41206,Non-Hispanic American Indian/Alaska Native,41.3,Male,Esophagus,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
70-74,75.5,140.6,43,Incidence,41206,Non-Hispanic American Indian/Alaska Native,104.4,Male,Kidney and Renal Pelvis,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
70-74,37.3,86.7,24,Incidence,41206,Non-Hispanic American Indian/Alaska Native,58.2,Male,Leukemias,2019
70-74,73.5,137.8,42,Incidence,41206,Non-Hispanic American Indian/Alaska Native,101.9,Male,Liver and Intrahepatic Bile Duct,2019
70-74,281.4,395.7,138,Incidence,41206,Non-Hispanic American Indian/Alaska Native,334.9,Male,Lung and Bronchus,2019
70-74,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
70-74,47.1,101.1,29,Incidence,41206,Non-Hispanic American Indian/Alaska Native,70.4,Male,Non-Hodgkin Lymphoma,2019
70-74,35.4,83.8,23,Incidence,41206,Non-Hispanic American Indian/Alaska Native,55.8,Male,Oral Cavity and Pharynx,2019
70-74,43.2,95.3,27,Incidence,41206,Non-Hispanic American Indian/Alaska Native,65.5,Male,Pancreas,2019
70-74,420.4,557.5,200,Incidence,41206,Non-Hispanic American Indian/Alaska Native,485.4,Male,Prostate,2019
70-74,27.8,72.0,19,Incidence,41206,Non-Hispanic American Indian/Alaska Native,46.1,Male,Stomach,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
70-74,47.1,101.1,29,Incidence,41206,Non-Hispanic American Indian/Alaska Native,70.4,Male,Urinary Bladder,2019
75-79,1891.3,2250.4,520,Incidence,25181,Non-Hispanic American Indian/Alaska Native,2065.0,Male,All Cancer Sites Combined,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
75-79,144.0,257.3,49,Incidence,25181,Non-Hispanic American Indian/Alaska Native,194.6,Male,Colon and Rectum,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
75-79,73.9,160.7,28,Incidence,25181,Non-Hispanic American Indian/Alaska Native,111.2,Male,Kidney and Renal Pelvis,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
75-79,36.3,103.2,16,Incidence,25181,Non-Hispanic American Indian/Alaska Native,63.5,Male,Leukemias,2019
75-79,51.6,127.5,21,Incidence,25181,Non-Hispanic American Indian/Alaska Native,83.4,Male,Liver and Intrahepatic Bile Duct,2019
75-79,319.5,478.7,99,Incidence,25181,Non-Hispanic American Indian/Alaska Native,393.2,Male,Lung and Bronchus,2019
75-79,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
75-79,54.8,132.3,22,Incidence,25181,Non-Hispanic American Indian/Alaska Native,87.4,Male,Non-Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
75-79,39.3,108.1,17,Incidence,25181,Non-Hispanic American Indian/Alaska Native,67.5,Male,Pancreas,2019
75-79,359.0,526.5,110,Incidence,25181,Non-Hispanic American Indian/Alaska Native,436.8,Male,Prostate,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
75-79,96.8,193.3,35,Incidence,25181,Non-Hispanic American Indian/Alaska Native,139.0,Male,Urinary Bladder,2019
80-84,1878.0,2361.9,301,Incidence,14268,Non-Hispanic American Indian/Alaska Native,2109.6,Male,All Cancer Sites Combined,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
80-84,119.0,267.0,26,Incidence,14268,Non-Hispanic American Indian/Alaska Native,182.2,Male,Colon and Rectum,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
80-84,394.8,635.5,72,Incidence,14268,Non-Hispanic American Indian/Alaska Native,504.6,Male,Lung and Bronchus,2019
80-84,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
80-84,69.4,190.8,17,Incidence,14268,Non-Hispanic American Indian/Alaska Native,119.1,Male,Non-Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
80-84,224.1,414.0,44,Incidence,14268,Non-Hispanic American Indian/Alaska Native,308.4,Male,Prostate,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
80-84,124.7,275.3,27,Incidence,14268,Non-Hispanic American Indian/Alaska Native,189.2,Male,Urinary Bladder,2019
85+,1493.9,1991.2,193,Incidence,11161,Non-Hispanic American Indian/Alaska Native,1729.2,Male,All Cancer Sites Combined,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
85+,145.0,330.7,25,Incidence,11161,Non-Hispanic American Indian/Alaska Native,224.0,Male,Colon and Rectum,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
85+,196.1,404.8,32,Incidence,11161,Non-Hispanic American Indian/Alaska Native,286.7,Male,Lung and Bronchus,2019
85+,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
85+,218.4,436.1,35,Incidence,11161,Non-Hispanic American Indian/Alaska Native,313.6,Male,Prostate,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
85+,102.5,265.8,19,Incidence,11161,Non-Hispanic American Indian/Alaska Native,170.2,Male,Urinary Bladder,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2019
<1,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2019
1-4,9.5,22.9,22,Incidence,145355,Non-Hispanic American Indian/Alaska Native,15.1,Male and Female,All Cancer Sites Combined,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,71459,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
1-4,~,~,~,Incidence,73896,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
1-4,~,~,~,Incidence,145355,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
10-14,12.5,24.7,36,Incidence,201877,Non-Hispanic American Indian/Alaska Native,17.8,Male and Female,All Cancer Sites Combined,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,99897,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
10-14,~,~,~,Incidence,101980,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
10-14,~,~,~,Incidence,201877,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
15-19,15.0,28.2,42,Incidence,201347,Non-Hispanic American Indian/Alaska Native,20.9,Male and Female,All Cancer Sites Combined,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,99269,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
15-19,~,~,~,Incidence,102078,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
15-19,~,~,~,Incidence,201347,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
20-24,20.5,35.2,56,Incidence,206321,Non-Hispanic American Indian/Alaska Native,27.1,Male and Female,All Cancer Sites Combined,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,101992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
20-24,~,~,~,Incidence,104329,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
20-24,~,~,~,Incidence,206321,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
25-29,39.7,58.3,109,Incidence,225386,Non-Hispanic American Indian/Alaska Native,48.4,Male and Female,All Cancer Sites Combined,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
25-29,~,~,~,Incidence,110905,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
25-29,~,~,~,Incidence,114481,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
25-29,8.7,23.8,17,Incidence,114481,Non-Hispanic American Indian/Alaska Native,14.8,Male and Female,Testis,2019
25-29,5.1,13.2,19,Incidence,225386,Non-Hispanic American Indian/Alaska Native,8.4,Male and Female,Thyroid,2019
25-29,~,~,~,Incidence,225386,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
30-34,75.9,102.9,172,Incidence,193999,Non-Hispanic American Indian/Alaska Native,88.7,Male and Female,All Cancer Sites Combined,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
30-34,9.4,26.8,16,Incidence,96880,Non-Hispanic American Indian/Alaska Native,16.5,Male and Female,Cervix,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
30-34,16.7,38.1,25,Incidence,96880,Non-Hispanic American Indian/Alaska Native,25.8,Male and Female,Female Breast,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
30-34,16.7,38.1,25,Incidence,96880,Non-Hispanic American Indian/Alaska Native,25.8,Male and Female,Male and Female Breast,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
30-34,~,~,~,Incidence,96880,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
30-34,~,~,~,Incidence,97119,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
30-34,7.5,17.8,23,Incidence,193999,Non-Hispanic American Indian/Alaska Native,11.9,Male and Female,Thyroid,2019
30-34,~,~,~,Incidence,193999,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
35-39,168.9,210.1,333,Incidence,176509,Non-Hispanic American Indian/Alaska Native,188.7,Male and Female,All Cancer Sites Combined,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
35-39,17.1,39.8,24,Incidence,89698,Non-Hispanic American Indian/Alaska Native,26.8,Male and Female,Cervix,2019
35-39,8.7,20.2,24,Incidence,176509,Non-Hispanic American Indian/Alaska Native,13.6,Male and Female,Colon and Rectum,2019
35-39,17.1,39.8,24,Incidence,89698,Non-Hispanic American Indian/Alaska Native,26.8,Male and Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
35-39,45.2,78.6,54,Incidence,89698,Non-Hispanic American Indian/Alaska Native,60.2,Male and Female,Female Breast,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
35-39,11.5,24.3,30,Incidence,176509,Non-Hispanic American Indian/Alaska Native,17.0,Male and Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
35-39,6.0,16.1,18,Incidence,176509,Non-Hispanic American Indian/Alaska Native,10.2,Male and Female,Leukemias,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
35-39,45.2,78.6,54,Incidence,89698,Non-Hispanic American Indian/Alaska Native,60.2,Male and Female,Male and Female Breast,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
35-39,5.6,15.4,17,Incidence,176509,Non-Hispanic American Indian/Alaska Native,9.6,Male and Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
35-39,~,~,~,Incidence,89698,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
35-39,~,~,~,Incidence,86811,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
35-39,14.1,35.6,20,Incidence,86811,Non-Hispanic American Indian/Alaska Native,23.0,Male and Female,Testis,2019
35-39,17.6,32.8,43,Incidence,176509,Non-Hispanic American Indian/Alaska Native,24.4,Male and Female,Thyroid,2019
35-39,~,~,~,Incidence,176509,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
40-44,214.0,262.9,373,Incidence,157041,Non-Hispanic American Indian/Alaska Native,237.5,Male and Female,All Cancer Sites Combined,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
40-44,12.4,26.5,29,Incidence,157041,Non-Hispanic American Indian/Alaska Native,18.5,Male and Female,Colon and Rectum,2019
40-44,21.3,47.7,26,Incidence,79899,Non-Hispanic American Indian/Alaska Native,32.5,Male and Female,"Corpus and Uterus, NOS",2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
40-44,88.3,135.7,88,Incidence,79899,Non-Hispanic American Indian/Alaska Native,110.1,Male and Female,Female Breast,2019
40-44,12.4,34.1,17,Incidence,79899,Non-Hispanic American Indian/Alaska Native,21.3,Male and Female,"Female Breast, <i>in situ</i>",2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
40-44,23.1,41.3,49,Incidence,157041,Non-Hispanic American Indian/Alaska Native,31.2,Male and Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
40-44,88.3,135.7,88,Incidence,79899,Non-Hispanic American Indian/Alaska Native,110.1,Male and Female,Male and Female Breast,2019
40-44,12.4,34.1,17,Incidence,79899,Non-Hispanic American Indian/Alaska Native,21.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
40-44,~,~,~,Incidence,79899,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
40-44,~,~,~,Incidence,77142,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
40-44,15.5,31.0,35,Incidence,157041,Non-Hispanic American Indian/Alaska Native,22.3,Male and Female,Thyroid,2019
40-44,~,~,~,Incidence,157041,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
45-49,363.2,425.9,617,Incidence,156756,Non-Hispanic American Indian/Alaska Native,393.6,Male and Female,All Cancer Sites Combined,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
45-49,35.9,57.8,72,Incidence,156756,Non-Hispanic American Indian/Alaska Native,45.9,Male and Female,Colon and Rectum,2019
45-49,25.1,53.1,30,Incidence,80619,Non-Hispanic American Indian/Alaska Native,37.2,Male and Female,"Corpus and Uterus, NOS",2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
45-49,155.2,215.7,148,Incidence,80619,Non-Hispanic American Indian/Alaska Native,183.6,Male and Female,Female Breast,2019
45-49,21.1,47.3,26,Incidence,80619,Non-Hispanic American Indian/Alaska Native,32.3,Male and Female,"Female Breast, <i>in situ</i>",2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
45-49,24.8,43.5,52,Incidence,156756,Non-Hispanic American Indian/Alaska Native,33.2,Male and Female,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
45-49,11.9,25.8,28,Incidence,156756,Non-Hispanic American Indian/Alaska Native,17.9,Male and Female,Lung and Bronchus,2019
45-49,155.2,215.7,148,Incidence,80619,Non-Hispanic American Indian/Alaska Native,183.6,Male and Female,Male and Female Breast,2019
45-49,21.1,47.3,26,Incidence,80619,Non-Hispanic American Indian/Alaska Native,32.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
45-49,6.3,17.4,17,Incidence,156756,Non-Hispanic American Indian/Alaska Native,10.8,Male and Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
45-49,8.8,21.2,22,Incidence,156756,Non-Hispanic American Indian/Alaska Native,14.0,Male and Female,Oral Cavity and Pharynx,2019
45-49,~,~,~,Incidence,80619,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
45-49,7.8,19.7,20,Incidence,156756,Non-Hispanic American Indian/Alaska Native,12.8,Male and Female,Pancreas,2019
45-49,16.0,40.6,20,Incidence,76137,Non-Hispanic American Indian/Alaska Native,26.3,Male and Female,Prostate,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
45-49,~,~,~,Incidence,76137,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
45-49,16.6,32.5,37,Incidence,156756,Non-Hispanic American Indian/Alaska Native,23.6,Male and Female,Thyroid,2019
45-49,~,~,~,Incidence,156756,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
5-9,7.9,18.3,24,Incidence,195520,Non-Hispanic American Indian/Alaska Native,12.3,Male and Female,All Cancer Sites Combined,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,96264,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
5-9,~,~,~,Incidence,99256,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
5-9,~,~,~,Incidence,195520,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
50-54,473.0,543.7,807,Incidence,159036,Non-Hispanic American Indian/Alaska Native,507.4,Male and Female,All Cancer Sites Combined,2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
50-54,55.7,82.0,108,Incidence,159036,Non-Hispanic American Indian/Alaska Native,67.9,Male and Female,Colon and Rectum,2019
50-54,32.6,63.2,38,Incidence,82465,Non-Hispanic American Indian/Alaska Native,46.1,Male and Female,"Corpus and Uterus, NOS",2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
50-54,167.4,229.1,162,Incidence,82465,Non-Hispanic American Indian/Alaska Native,196.4,Male and Female,Female Breast,2019
50-54,21.6,47.6,27,Incidence,82465,Non-Hispanic American Indian/Alaska Native,32.7,Male and Female,"Female Breast, <i>in situ</i>",2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
50-54,36.5,58.4,74,Incidence,159036,Non-Hispanic American Indian/Alaska Native,46.5,Male and Female,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
50-54,6.2,17.1,17,Incidence,159036,Non-Hispanic American Indian/Alaska Native,10.7,Male and Female,Leukemias,2019
50-54,11.7,25.4,28,Incidence,159036,Non-Hispanic American Indian/Alaska Native,17.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
50-54,30.4,50.7,63,Incidence,159036,Non-Hispanic American Indian/Alaska Native,39.6,Male and Female,Lung and Bronchus,2019
50-54,167.4,229.1,162,Incidence,82465,Non-Hispanic American Indian/Alaska Native,196.4,Male and Female,Male and Female Breast,2019
50-54,21.6,47.6,27,Incidence,82465,Non-Hispanic American Indian/Alaska Native,32.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
50-54,6.2,17.1,17,Incidence,159036,Non-Hispanic American Indian/Alaska Native,10.7,Male and Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
50-54,8.7,20.9,22,Incidence,159036,Non-Hispanic American Indian/Alaska Native,13.8,Male and Female,Non-Hodgkin Lymphoma,2019
50-54,14.8,29.9,34,Incidence,159036,Non-Hispanic American Indian/Alaska Native,21.4,Male and Female,Oral Cavity and Pharynx,2019
50-54,~,~,~,Incidence,82465,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
50-54,~,~,~,Incidence,159036,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
50-54,51.8,90.5,53,Incidence,76571,Non-Hispanic American Indian/Alaska Native,69.2,Male and Female,Prostate,2019
50-54,6.7,17.9,18,Incidence,159036,Non-Hispanic American Indian/Alaska Native,11.3,Male and Female,Stomach,2019
50-54,~,~,~,Incidence,76571,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
50-54,11.2,24.7,27,Incidence,159036,Non-Hispanic American Indian/Alaska Native,17.0,Male and Female,Thyroid,2019
50-54,8.7,20.9,22,Incidence,159036,Non-Hispanic American Indian/Alaska Native,13.8,Male and Female,Urinary Bladder,2019
55-59,721.7,804.8,1314,Incidence,172349,Non-Hispanic American Indian/Alaska Native,762.4,Male and Female,All Cancer Sites Combined,2019
55-59,~,~,~,Incidence,172349,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
55-59,~,~,~,Incidence,90616,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
55-59,62.0,88.3,128,Incidence,172349,Non-Hispanic American Indian/Alaska Native,74.3,Male and Female,Colon and Rectum,2019
55-59,54.4,90.2,64,Incidence,90616,Non-Hispanic American Indian/Alaska Native,70.6,Male and Female,"Corpus and Uterus, NOS",2019
55-59,5.7,15.8,17,Incidence,172349,Non-Hispanic American Indian/Alaska Native,9.9,Male and Female,Esophagus,2019
55-59,193.2,255.9,202,Incidence,90616,Non-Hispanic American Indian/Alaska Native,222.9,Male and Female,Female Breast,2019
55-59,21.4,46.0,29,Incidence,90616,Non-Hispanic American Indian/Alaska Native,32.0,Male and Female,"Female Breast, <i>in situ</i>",2019
55-59,~,~,~,Incidence,172349,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,172349,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
55-59,49.3,73.1,104,Incidence,172349,Non-Hispanic American Indian/Alaska Native,60.3,Male and Female,Kidney and Renal Pelvis,2019
55-59,~,~,~,Incidence,172349,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
55-59,10.3,22.8,27,Incidence,172349,Non-Hispanic American Indian/Alaska Native,15.7,Male and Female,Leukemias,2019
55-59,27.1,45.5,61,Incidence,172349,Non-Hispanic American Indian/Alaska Native,35.4,Male and Female,Liver and Intrahepatic Bile Duct,2019
55-59,80.1,109.6,162,Incidence,172349,Non-Hispanic American Indian/Alaska Native,94.0,Male and Female,Lung and Bronchus,2019
55-59,193.2,255.9,202,Incidence,90616,Non-Hispanic American Indian/Alaska Native,222.9,Male and Female,Male and Female Breast,2019
55-59,21.4,46.0,29,Incidence,90616,Non-Hispanic American Indian/Alaska Native,32.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
55-59,9.9,22.1,26,Incidence,172349,Non-Hispanic American Indian/Alaska Native,15.1,Male and Female,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,172349,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
55-59,8.0,19.3,22,Incidence,172349,Non-Hispanic American Indian/Alaska Native,12.8,Male and Female,Myeloma,2019
55-59,19.0,34.9,45,Incidence,172349,Non-Hispanic American Indian/Alaska Native,26.1,Male and Female,Non-Hodgkin Lymphoma,2019
55-59,21.5,38.2,50,Incidence,172349,Non-Hispanic American Indian/Alaska Native,29.0,Male and Female,Oral Cavity and Pharynx,2019
55-59,14.3,35.4,21,Incidence,90616,Non-Hispanic American Indian/Alaska Native,23.2,Male and Female,Ovary,2019
55-59,17.6,32.9,42,Incidence,172349,Non-Hispanic American Indian/Alaska Native,24.4,Male and Female,Pancreas,2019
55-59,137.4,194.2,134,Incidence,81733,Non-Hispanic American Indian/Alaska Native,163.9,Male and Female,Prostate,2019
55-59,7.5,18.6,21,Incidence,172349,Non-Hispanic American Indian/Alaska Native,12.2,Male and Female,Stomach,2019
55-59,~,~,~,Incidence,81733,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
55-59,13.7,27.6,34,Incidence,172349,Non-Hispanic American Indian/Alaska Native,19.7,Male and Female,Thyroid,2019
55-59,8.9,20.7,24,Incidence,172349,Non-Hispanic American Indian/Alaska Native,13.9,Male and Female,Urinary Bladder,2019
60-64,1021.1,1124.8,1663,Incidence,155126,Non-Hispanic American Indian/Alaska Native,1072.0,Male and Female,All Cancer Sites Combined,2019
60-64,5.9,16.7,16,Incidence,155126,Non-Hispanic American Indian/Alaska Native,10.3,Male and Female,Brain and Other Nervous System,2019
60-64,~,~,~,Incidence,83204,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
60-64,97.9,132.2,177,Incidence,155126,Non-Hispanic American Indian/Alaska Native,114.1,Male and Female,Colon and Rectum,2019
60-64,39.4,72.4,45,Incidence,83204,Non-Hispanic American Indian/Alaska Native,54.1,Male and Female,"Corpus and Uterus, NOS",2019
60-64,13.6,28.4,31,Incidence,155126,Non-Hispanic American Indian/Alaska Native,20.0,Male and Female,Esophagus,2019
60-64,240.7,313.3,229,Incidence,83204,Non-Hispanic American Indian/Alaska Native,275.2,Male and Female,Female Breast,2019
60-64,32.3,62.7,38,Incidence,83204,Non-Hispanic American Indian/Alaska Native,45.7,Male and Female,"Female Breast, <i>in situ</i>",2019
60-64,~,~,~,Incidence,155126,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,155126,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
60-64,56.5,83.4,107,Incidence,155126,Non-Hispanic American Indian/Alaska Native,69.0,Male and Female,Kidney and Renal Pelvis,2019
60-64,~,~,~,Incidence,155126,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
60-64,14.1,29.1,32,Incidence,155126,Non-Hispanic American Indian/Alaska Native,20.6,Male and Female,Leukemias,2019
60-64,44.9,69.2,87,Incidence,155126,Non-Hispanic American Indian/Alaska Native,56.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
60-64,146.0,187.2,257,Incidence,155126,Non-Hispanic American Indian/Alaska Native,165.7,Male and Female,Lung and Bronchus,2019
60-64,240.7,313.3,229,Incidence,83204,Non-Hispanic American Indian/Alaska Native,275.2,Male and Female,Male and Female Breast,2019
60-64,32.3,62.7,38,Incidence,83204,Non-Hispanic American Indian/Alaska Native,45.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
60-64,9.9,23.0,24,Incidence,155126,Non-Hispanic American Indian/Alaska Native,15.5,Male and Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,155126,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
60-64,8.4,20.7,21,Incidence,155126,Non-Hispanic American Indian/Alaska Native,13.5,Male and Female,Myeloma,2019
60-64,33.5,54.9,67,Incidence,155126,Non-Hispanic American Indian/Alaska Native,43.2,Male and Female,Non-Hodgkin Lymphoma,2019
60-64,30.1,50.5,61,Incidence,155126,Non-Hispanic American Indian/Alaska Native,39.3,Male and Female,Oral Cavity and Pharynx,2019
60-64,12.8,34.2,18,Incidence,83204,Non-Hispanic American Indian/Alaska Native,21.6,Male and Female,Ovary,2019
60-64,28.4,48.3,58,Incidence,155126,Non-Hispanic American Indian/Alaska Native,37.4,Male and Female,Pancreas,2019
60-64,246.1,325.3,204,Incidence,71922,Non-Hispanic American Indian/Alaska Native,283.6,Male and Female,Prostate,2019
60-64,10.4,23.8,25,Incidence,155126,Non-Hispanic American Indian/Alaska Native,16.1,Male and Female,Stomach,2019
60-64,~,~,~,Incidence,71922,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
60-64,8.9,21.5,22,Incidence,155126,Non-Hispanic American Indian/Alaska Native,14.2,Male and Female,Thyroid,2019
60-64,15.7,31.4,35,Incidence,155126,Non-Hispanic American Indian/Alaska Native,22.6,Male and Female,Urinary Bladder,2019
65-69,1317.6,1450.6,1681,Incidence,121556,Non-Hispanic American Indian/Alaska Native,1382.9,Male and Female,All Cancer Sites Combined,2019
65-69,~,~,~,Incidence,121556,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
65-69,101.4,141.2,146,Incidence,121556,Non-Hispanic American Indian/Alaska Native,120.1,Male and Female,Colon and Rectum,2019
65-69,69.8,117.7,60,Incidence,65632,Non-Hispanic American Indian/Alaska Native,91.4,Male and Female,"Corpus and Uterus, NOS",2019
65-69,10.1,25.4,20,Incidence,121556,Non-Hispanic American Indian/Alaska Native,16.5,Male and Female,Esophagus,2019
65-69,336.6,432.8,251,Incidence,65632,Non-Hispanic American Indian/Alaska Native,382.4,Male and Female,Female Breast,2019
65-69,51.3,93.5,46,Incidence,65632,Non-Hispanic American Indian/Alaska Native,70.1,Male and Female,"Female Breast, <i>in situ</i>",2019
65-69,~,~,~,Incidence,121556,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,121556,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
65-69,66.9,100.1,100,Incidence,121556,Non-Hispanic American Indian/Alaska Native,82.3,Male and Female,Kidney and Renal Pelvis,2019
65-69,8.1,22.4,17,Incidence,121556,Non-Hispanic American Indian/Alaska Native,14.0,Male and Female,Larynx,2019
65-69,14.6,32.3,27,Incidence,121556,Non-Hispanic American Indian/Alaska Native,22.2,Male and Female,Leukemias,2019
65-69,55.9,86.5,85,Incidence,121556,Non-Hispanic American Indian/Alaska Native,69.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
65-69,171.7,222.3,238,Incidence,121556,Non-Hispanic American Indian/Alaska Native,195.8,Male and Female,Lung and Bronchus,2019
65-69,336.6,432.8,251,Incidence,65632,Non-Hispanic American Indian/Alaska Native,382.4,Male and Female,Male and Female Breast,2019
65-69,51.3,93.5,46,Incidence,65632,Non-Hispanic American Indian/Alaska Native,70.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
65-69,17.3,36.2,31,Incidence,121556,Non-Hispanic American Indian/Alaska Native,25.5,Male and Female,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,121556,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
65-69,20.1,40.0,35,Incidence,121556,Non-Hispanic American Indian/Alaska Native,28.8,Male and Female,Myeloma,2019
65-69,42.0,69.1,66,Incidence,121556,Non-Hispanic American Indian/Alaska Native,54.3,Male and Female,Non-Hodgkin Lymphoma,2019
65-69,27.0,49.5,45,Incidence,121556,Non-Hispanic American Indian/Alaska Native,37.0,Male and Female,Oral Cavity and Pharynx,2019
65-69,~,~,~,Incidence,65632,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
65-69,36.2,61.7,58,Incidence,121556,Non-Hispanic American Indian/Alaska Native,47.7,Male and Female,Pancreas,2019
65-69,374.9,485.1,239,Incidence,55924,Non-Hispanic American Indian/Alaska Native,427.4,Male and Female,Prostate,2019
65-69,12.7,29.4,24,Incidence,121556,Non-Hispanic American Indian/Alaska Native,19.7,Male and Female,Stomach,2019
65-69,~,~,~,Incidence,55924,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
65-69,9.4,24.4,19,Incidence,121556,Non-Hispanic American Indian/Alaska Native,15.6,Male and Female,Thyroid,2019
65-69,31.9,56.1,52,Incidence,121556,Non-Hispanic American Indian/Alaska Native,42.8,Male and Female,Urinary Bladder,2019
70-74,1506.7,1673.2,1417,Incidence,89214,Non-Hispanic American Indian/Alaska Native,1588.3,Male and Female,All Cancer Sites Combined,2019
70-74,~,~,~,Incidence,89214,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
70-74,95.2,141.2,104,Incidence,89214,Non-Hispanic American Indian/Alaska Native,116.6,Male and Female,Colon and Rectum,2019
70-74,52.5,103.8,36,Incidence,48008,Non-Hispanic American Indian/Alaska Native,75.0,Male and Female,"Corpus and Uterus, NOS",2019
70-74,16.3,38.7,23,Incidence,89214,Non-Hispanic American Indian/Alaska Native,25.8,Male and Female,Esophagus,2019
70-74,320.2,431.7,179,Incidence,48008,Non-Hispanic American Indian/Alaska Native,372.9,Male and Female,Female Breast,2019
70-74,37.1,81.8,27,Incidence,48008,Non-Hispanic American Indian/Alaska Native,56.2,Male and Female,"Female Breast, <i>in situ</i>",2019
70-74,~,~,~,Incidence,89214,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,89214,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
70-74,57.2,94.1,66,Incidence,89214,Non-Hispanic American Indian/Alaska Native,74.0,Male and Female,Kidney and Renal Pelvis,2019
70-74,11.1,30.5,17,Incidence,89214,Non-Hispanic American Indian/Alaska Native,19.1,Male and Female,Larynx,2019
70-74,24.5,50.6,32,Incidence,89214,Non-Hispanic American Indian/Alaska Native,35.9,Male and Female,Leukemias,2019
70-74,60.2,97.9,69,Incidence,89214,Non-Hispanic American Indian/Alaska Native,77.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
70-74,268.7,342.2,271,Incidence,89214,Non-Hispanic American Indian/Alaska Native,303.8,Male and Female,Lung and Bronchus,2019
70-74,320.2,431.7,179,Incidence,48008,Non-Hispanic American Indian/Alaska Native,372.9,Male and Female,Male and Female Breast,2019
70-74,37.1,81.8,27,Incidence,48008,Non-Hispanic American Indian/Alaska Native,56.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
70-74,18.1,41.4,25,Incidence,89214,Non-Hispanic American Indian/Alaska Native,28.0,Male and Female,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,89214,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
70-74,16.3,38.7,23,Incidence,89214,Non-Hispanic American Indian/Alaska Native,25.8,Male and Female,Myeloma,2019
70-74,41.6,73.9,50,Incidence,89214,Non-Hispanic American Indian/Alaska Native,56.0,Male and Female,Non-Hodgkin Lymphoma,2019
70-74,23.6,49.3,31,Incidence,89214,Non-Hispanic American Indian/Alaska Native,34.7,Male and Female,Oral Cavity and Pharynx,2019
70-74,~,~,~,Incidence,48008,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
70-74,42.6,75.2,51,Incidence,89214,Non-Hispanic American Indian/Alaska Native,57.2,Male and Female,Pancreas,2019
70-74,420.4,557.5,200,Incidence,41206,Non-Hispanic American Indian/Alaska Native,485.4,Male and Female,Prostate,2019
70-74,20.9,45.4,28,Incidence,89214,Non-Hispanic American Indian/Alaska Native,31.4,Male and Female,Stomach,2019
70-74,~,~,~,Incidence,41206,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
70-74,~,~,~,Incidence,89214,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
70-74,33.9,63.6,42,Incidence,89214,Non-Hispanic American Indian/Alaska Native,47.1,Male and Female,Urinary Bladder,2019
75-79,1665.9,1888.4,993,Incidence,55958,Non-Hispanic American Indian/Alaska Native,1774.5,Male and Female,All Cancer Sites Combined,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
75-79,139.0,209.5,96,Incidence,55958,Non-Hispanic American Indian/Alaska Native,171.6,Male and Female,Colon and Rectum,2019
75-79,37.2,96.4,19,Incidence,30777,Non-Hispanic American Indian/Alaska Native,61.7,Male and Female,"Corpus and Uterus, NOS",2019
75-79,16.3,46.4,16,Incidence,55958,Non-Hispanic American Indian/Alaska Native,28.6,Male and Female,Esophagus,2019
75-79,261.4,391.6,99,Incidence,30777,Non-Hispanic American Indian/Alaska Native,321.7,Male and Female,Female Breast,2019
75-79,42.2,104.3,21,Incidence,30777,Non-Hispanic American Indian/Alaska Native,68.2,Male and Female,"Female Breast, <i>in situ</i>",2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
75-79,58.7,107.6,45,Incidence,55958,Non-Hispanic American Indian/Alaska Native,80.4,Male and Female,Kidney and Renal Pelvis,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
75-79,30.4,68.1,26,Incidence,55958,Non-Hispanic American Indian/Alaska Native,46.5,Male and Female,Leukemias,2019
75-79,46.6,91.1,37,Incidence,55958,Non-Hispanic American Indian/Alaska Native,66.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
75-79,306.3,406.7,198,Incidence,55958,Non-Hispanic American Indian/Alaska Native,353.8,Male and Female,Lung and Bronchus,2019
75-79,261.4,391.6,99,Incidence,30777,Non-Hispanic American Indian/Alaska Native,321.7,Male and Female,Male and Female Breast,2019
75-79,42.2,104.3,21,Incidence,30777,Non-Hispanic American Indian/Alaska Native,68.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
75-79,63.2,113.7,48,Incidence,55958,Non-Hispanic American Indian/Alaska Native,85.8,Male and Female,Non-Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
75-79,~,~,~,Incidence,30777,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
75-79,54.1,101.5,42,Incidence,55958,Non-Hispanic American Indian/Alaska Native,75.1,Male and Female,Pancreas,2019
75-79,359.0,526.5,110,Incidence,25181,Non-Hispanic American Indian/Alaska Native,436.8,Male and Female,Prostate,2019
75-79,20.4,53.0,19,Incidence,55958,Non-Hispanic American Indian/Alaska Native,34.0,Male and Female,Stomach,2019
75-79,~,~,~,Incidence,25181,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
75-79,~,~,~,Incidence,55958,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
75-79,54.1,101.5,42,Incidence,55958,Non-Hispanic American Indian/Alaska Native,75.1,Male and Female,Urinary Bladder,2019
80-84,1630.4,1917.5,596,Incidence,33680,Non-Hispanic American Indian/Alaska Native,1769.6,Male and Female,All Cancer Sites Combined,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
80-84,130.8,222.6,58,Incidence,33680,Non-Hispanic American Indian/Alaska Native,172.2,Male and Female,Colon and Rectum,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
80-84,231.4,392.1,59,Incidence,19412,Non-Hispanic American Indian/Alaska Native,303.9,Male and Female,Female Breast,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
80-84,36.3,91.7,20,Incidence,33680,Non-Hispanic American Indian/Alaska Native,59.4,Male and Female,Kidney and Renal Pelvis,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
80-84,29.4,80.8,17,Incidence,33680,Non-Hispanic American Indian/Alaska Native,50.5,Male and Female,Leukemias,2019
80-84,40.9,98.9,22,Incidence,33680,Non-Hispanic American Indian/Alaska Native,65.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
80-84,295.4,426.0,120,Incidence,33680,Non-Hispanic American Indian/Alaska Native,356.3,Male and Female,Lung and Bronchus,2019
80-84,231.4,392.1,59,Incidence,19412,Non-Hispanic American Indian/Alaska Native,303.9,Male and Female,Male and Female Breast,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
80-84,67.4,137.6,33,Incidence,33680,Non-Hispanic American Indian/Alaska Native,98.0,Male and Female,Non-Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
80-84,~,~,~,Incidence,19412,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
80-84,31.7,84.5,18,Incidence,33680,Non-Hispanic American Indian/Alaska Native,53.4,Male and Female,Pancreas,2019
80-84,224.1,414.0,44,Incidence,14268,Non-Hispanic American Indian/Alaska Native,308.4,Male and Female,Prostate,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
80-84,~,~,~,Incidence,14268,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
80-84,~,~,~,Incidence,33680,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
80-84,69.9,141.1,34,Incidence,33680,Non-Hispanic American Indian/Alaska Native,101.0,Male and Female,Urinary Bladder,2019
85+,1349.7,1628.0,448,Incidence,30189,Non-Hispanic American Indian/Alaska Native,1484.0,Male and Female,All Cancer Sites Combined,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
85+,151.7,255.8,60,Incidence,30189,Non-Hispanic American Indian/Alaska Native,198.7,Male and Female,Colon and Rectum,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
85+,172.5,316.4,45,Incidence,19028,Non-Hispanic American Indian/Alaska Native,236.5,Male and Female,Female Breast,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
85+,37.9,98.3,19,Incidence,30189,Non-Hispanic American Indian/Alaska Native,62.9,Male and Female,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
85+,32.8,90.2,17,Incidence,30189,Non-Hispanic American Indian/Alaska Native,56.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
85+,169.1,278.1,66,Incidence,30189,Non-Hispanic American Indian/Alaska Native,218.6,Male and Female,Lung and Bronchus,2019
85+,172.5,316.4,45,Incidence,19028,Non-Hispanic American Indian/Alaska Native,236.5,Male and Female,Male and Female Breast,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
85+,45.7,110.3,22,Incidence,30189,Non-Hispanic American Indian/Alaska Native,72.9,Male and Female,Non-Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
85+,~,~,~,Incidence,19028,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
85+,45.7,110.3,22,Incidence,30189,Non-Hispanic American Indian/Alaska Native,72.9,Male and Female,Pancreas,2019
85+,218.4,436.1,35,Incidence,11161,Non-Hispanic American Indian/Alaska Native,313.6,Male and Female,Prostate,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
85+,~,~,~,Incidence,11161,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
85+,~,~,~,Incidence,30189,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
85+,56.3,126.2,26,Incidence,30189,Non-Hispanic American Indian/Alaska Native,86.1,Male and Female,Urinary Bladder,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,16803,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2019
<1,~,~,~,Incidence,17217,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2019
<1,~,~,~,Incidence,34020,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2019
1-4,11.7,18.6,76,Incidence,512157,Non-Hispanic Asian/Pacific Islander,14.8,Female,All Cancer Sites Combined,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
1-4,3.6,7.9,28,Incidence,512157,Non-Hispanic Asian/Pacific Islander,5.5,Female,Leukemias,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
10-14,8.1,13.5,64,Incidence,607475,Non-Hispanic Asian/Pacific Islander,10.5,Female,All Cancer Sites Combined,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
15-19,17.4,24.6,131,Incidence,630634,Non-Hispanic Asian/Pacific Islander,20.8,Female,All Cancer Sites Combined,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
15-19,4.9,9.2,43,Incidence,630634,Non-Hispanic Asian/Pacific Islander,6.8,Female,Thyroid,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
20-24,27.7,36.2,219,Incidence,690547,Non-Hispanic Asian/Pacific Islander,31.7,Female,All Cancer Sites Combined,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
20-24,1.3,3.8,16,Incidence,690547,Non-Hispanic Asian/Pacific Islander,2.3,Female,Female Breast,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
20-24,1.9,4.6,21,Incidence,690547,Non-Hispanic Asian/Pacific Islander,3.0,Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
20-24,9.3,14.6,81,Incidence,690547,Non-Hispanic Asian/Pacific Islander,11.7,Female,Thyroid,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
25-29,51.4,61.6,486,Incidence,862785,Non-Hispanic Asian/Pacific Islander,56.3,Female,All Cancer Sites Combined,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
25-29,1.2,3.3,18,Incidence,862785,Non-Hispanic Asian/Pacific Islander,2.1,Female,Colon and Rectum,2019
25-29,1.5,3.7,21,Incidence,862785,Non-Hispanic Asian/Pacific Islander,2.4,Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
25-29,6.3,10.3,70,Incidence,862785,Non-Hispanic Asian/Pacific Islander,8.1,Female,Female Breast,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
25-29,1.4,3.6,20,Incidence,862785,Non-Hispanic Asian/Pacific Islander,2.3,Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
25-29,1.3,3.4,19,Incidence,862785,Non-Hispanic Asian/Pacific Islander,2.2,Female,Leukemias,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
25-29,1.4,3.6,20,Incidence,862785,Non-Hispanic Asian/Pacific Islander,2.3,Female,Non-Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
25-29,3.0,5.9,37,Incidence,862785,Non-Hispanic Asian/Pacific Islander,4.3,Female,Ovary,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
25-29,17.9,24.1,180,Incidence,862785,Non-Hispanic Asian/Pacific Islander,20.9,Female,Thyroid,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
30-34,92.8,105.8,921,Incidence,928958,Non-Hispanic Asian/Pacific Islander,99.1,Female,All Cancer Sites Combined,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
30-34,4.2,7.3,52,Incidence,928958,Non-Hispanic Asian/Pacific Islander,5.6,Female,Cervix,2019
30-34,3.3,6.2,43,Incidence,928958,Non-Hispanic Asian/Pacific Islander,4.6,Female,Colon and Rectum,2019
30-34,6.0,9.6,71,Incidence,928958,Non-Hispanic Asian/Pacific Islander,7.6,Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
30-34,21.9,28.4,232,Incidence,928958,Non-Hispanic Asian/Pacific Islander,25.0,Female,Female Breast,2019
30-34,2.0,4.4,28,Incidence,928958,Non-Hispanic Asian/Pacific Islander,3.0,Female,"Female Breast, <i>in situ</i>",2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
30-34,1.4,3.5,21,Incidence,928958,Non-Hispanic Asian/Pacific Islander,2.3,Female,Leukemias,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
30-34,2.9,5.6,38,Incidence,928958,Non-Hispanic Asian/Pacific Islander,4.1,Female,Non-Hodgkin Lymphoma,2019
30-34,1.5,3.6,22,Incidence,928958,Non-Hispanic Asian/Pacific Islander,2.4,Female,Oral Cavity and Pharynx,2019
30-34,2.4,5.0,33,Incidence,928958,Non-Hispanic Asian/Pacific Islander,3.6,Female,Ovary,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
30-34,25.0,31.9,263,Incidence,928958,Non-Hispanic Asian/Pacific Islander,28.3,Female,Thyroid,2019
30-34,~,~,~,Incidence,928958,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
35-39,153.5,170.1,1478,Incidence,914305,Non-Hispanic Asian/Pacific Islander,161.7,Female,All Cancer Sites Combined,2019
35-39,1.7,3.9,24,Incidence,914305,Non-Hispanic Asian/Pacific Islander,2.6,Female,Brain and Other Nervous System,2019
35-39,6.5,10.4,76,Incidence,914305,Non-Hispanic Asian/Pacific Islander,8.3,Female,Cervix,2019
35-39,7.0,11.0,81,Incidence,914305,Non-Hispanic Asian/Pacific Islander,8.9,Female,Colon and Rectum,2019
35-39,9.7,14.3,108,Incidence,914305,Non-Hispanic Asian/Pacific Islander,11.8,Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
35-39,55.8,66.0,555,Incidence,914305,Non-Hispanic Asian/Pacific Islander,60.7,Female,Female Breast,2019
35-39,8.7,13.1,98,Incidence,914305,Non-Hispanic Asian/Pacific Islander,10.7,Female,"Female Breast, <i>in situ</i>",2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
35-39,1.9,4.3,27,Incidence,914305,Non-Hispanic Asian/Pacific Islander,3.0,Female,Leukemias,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
35-39,1.5,3.6,22,Incidence,914305,Non-Hispanic Asian/Pacific Islander,2.4,Female,Lung and Bronchus,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
35-39,3.7,6.7,46,Incidence,914305,Non-Hispanic Asian/Pacific Islander,5.0,Female,Non-Hodgkin Lymphoma,2019
35-39,2.2,4.7,30,Incidence,914305,Non-Hispanic Asian/Pacific Islander,3.3,Female,Oral Cavity and Pharynx,2019
35-39,2.5,5.1,33,Incidence,914305,Non-Hispanic Asian/Pacific Islander,3.6,Female,Ovary,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
35-39,1.2,3.1,18,Incidence,914305,Non-Hispanic Asian/Pacific Islander,2.0,Female,Stomach,2019
35-39,30.6,38.4,314,Incidence,914305,Non-Hispanic Asian/Pacific Islander,34.3,Female,Thyroid,2019
35-39,~,~,~,Incidence,914305,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
40-44,262.5,285.1,2268,Incidence,828955,Non-Hispanic Asian/Pacific Islander,273.6,Female,All Cancer Sites Combined,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
40-44,7.1,11.3,75,Incidence,828955,Non-Hispanic Asian/Pacific Islander,9.0,Female,Cervix,2019
40-44,15.1,21.0,148,Incidence,828955,Non-Hispanic Asian/Pacific Islander,17.9,Female,Colon and Rectum,2019
40-44,15.3,21.2,150,Incidence,828955,Non-Hispanic Asian/Pacific Islander,18.1,Female,"Corpus and Uterus, NOS",2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
40-44,124.2,139.9,1093,Incidence,828955,Non-Hispanic Asian/Pacific Islander,131.9,Female,Female Breast,2019
40-44,42.7,52.2,392,Incidence,828955,Non-Hispanic Asian/Pacific Islander,47.3,Female,"Female Breast, <i>in situ</i>",2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
40-44,3.2,6.3,38,Incidence,828955,Non-Hispanic Asian/Pacific Islander,4.6,Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
40-44,1.5,3.7,20,Incidence,828955,Non-Hispanic Asian/Pacific Islander,2.4,Female,Leukemias,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
40-44,6.1,10.0,65,Incidence,828955,Non-Hispanic Asian/Pacific Islander,7.8,Female,Lung and Bronchus,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
40-44,4.3,7.7,48,Incidence,828955,Non-Hispanic Asian/Pacific Islander,5.8,Female,Non-Hodgkin Lymphoma,2019
40-44,3.5,6.7,41,Incidence,828955,Non-Hispanic Asian/Pacific Islander,4.9,Female,Oral Cavity and Pharynx,2019
40-44,7.2,11.5,76,Incidence,828955,Non-Hispanic Asian/Pacific Islander,9.2,Female,Ovary,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
40-44,1.9,4.3,24,Incidence,828955,Non-Hispanic Asian/Pacific Islander,2.9,Female,Stomach,2019
40-44,33.8,42.3,314,Incidence,828955,Non-Hispanic Asian/Pacific Islander,37.9,Female,Thyroid,2019
40-44,~,~,~,Incidence,828955,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
45-49,400.3,428.6,3326,Incidence,802835,Non-Hispanic Asian/Pacific Islander,414.3,Female,All Cancer Sites Combined,2019
45-49,1.8,4.3,23,Incidence,802835,Non-Hispanic Asian/Pacific Islander,2.9,Female,Brain and Other Nervous System,2019
45-49,10.1,15.1,100,Incidence,802835,Non-Hispanic Asian/Pacific Islander,12.5,Female,Cervix,2019
45-49,20.1,26.9,187,Incidence,802835,Non-Hispanic Asian/Pacific Islander,23.3,Female,Colon and Rectum,2019
45-49,28.8,36.8,262,Incidence,802835,Non-Hispanic Asian/Pacific Islander,32.6,Female,"Corpus and Uterus, NOS",2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
45-49,204.2,224.6,1720,Incidence,802835,Non-Hispanic Asian/Pacific Islander,214.2,Female,Female Breast,2019
45-49,64.9,76.7,567,Incidence,802835,Non-Hispanic Asian/Pacific Islander,70.6,Female,"Female Breast, <i>in situ</i>",2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
45-49,4.5,8.1,49,Incidence,802835,Non-Hispanic Asian/Pacific Islander,6.1,Female,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
45-49,3.3,6.5,38,Incidence,802835,Non-Hispanic Asian/Pacific Islander,4.7,Female,Leukemias,2019
45-49,1.5,3.8,20,Incidence,802835,Non-Hispanic Asian/Pacific Islander,2.5,Female,Liver and Intrahepatic Bile Duct,2019
45-49,12.7,18.3,123,Incidence,802835,Non-Hispanic Asian/Pacific Islander,15.3,Female,Lung and Bronchus,2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
45-49,1.3,3.5,18,Incidence,802835,Non-Hispanic Asian/Pacific Islander,2.2,Female,Myeloma,2019
45-49,5.9,9.9,62,Incidence,802835,Non-Hispanic Asian/Pacific Islander,7.7,Female,Non-Hodgkin Lymphoma,2019
45-49,5.4,9.2,57,Incidence,802835,Non-Hispanic Asian/Pacific Islander,7.1,Female,Oral Cavity and Pharynx,2019
45-49,13.1,18.7,126,Incidence,802835,Non-Hispanic Asian/Pacific Islander,15.7,Female,Ovary,2019
45-49,2.8,5.8,33,Incidence,802835,Non-Hispanic Asian/Pacific Islander,4.1,Female,Pancreas,2019
45-49,4.4,7.9,48,Incidence,802835,Non-Hispanic Asian/Pacific Islander,6.0,Female,Stomach,2019
45-49,32.6,41.1,294,Incidence,802835,Non-Hispanic Asian/Pacific Islander,36.6,Female,Thyroid,2019
45-49,~,~,~,Incidence,802835,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
5-9,8.5,13.8,69,Incidence,633257,Non-Hispanic Asian/Pacific Islander,10.9,Female,All Cancer Sites Combined,2019
5-9,1.4,4.1,16,Incidence,633257,Non-Hispanic Asian/Pacific Islander,2.5,Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
5-9,2.1,5.1,21,Incidence,633257,Non-Hispanic Asian/Pacific Islander,3.3,Female,Leukemias,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
50-54,504.1,538.4,3576,Incidence,686382,Non-Hispanic Asian/Pacific Islander,521.0,Female,All Cancer Sites Combined,2019
50-54,1.7,4.3,19,Incidence,686382,Non-Hispanic Asian/Pacific Islander,2.8,Female,Brain and Other Nervous System,2019
50-54,8.7,13.9,76,Incidence,686382,Non-Hispanic Asian/Pacific Islander,11.1,Female,Cervix,2019
50-54,44.7,55.4,342,Incidence,686382,Non-Hispanic Asian/Pacific Islander,49.8,Female,Colon and Rectum,2019
50-54,47.2,58.2,360,Incidence,686382,Non-Hispanic Asian/Pacific Islander,52.4,Female,"Corpus and Uterus, NOS",2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
50-54,217.6,240.3,1570,Incidence,686382,Non-Hispanic Asian/Pacific Islander,228.7,Female,Female Breast,2019
50-54,70.2,83.5,526,Incidence,686382,Non-Hispanic Asian/Pacific Islander,76.6,Female,"Female Breast, <i>in situ</i>",2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
50-54,6.5,11.1,59,Incidence,686382,Non-Hispanic Asian/Pacific Islander,8.6,Female,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
50-54,5.0,9.1,47,Incidence,686382,Non-Hispanic Asian/Pacific Islander,6.8,Female,Leukemias,2019
50-54,2.2,5.2,24,Incidence,686382,Non-Hispanic Asian/Pacific Islander,3.5,Female,Liver and Intrahepatic Bile Duct,2019
50-54,23.2,31.1,185,Incidence,686382,Non-Hispanic Asian/Pacific Islander,27.0,Female,Lung and Bronchus,2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
50-54,2.4,5.4,25,Incidence,686382,Non-Hispanic Asian/Pacific Islander,3.6,Female,Myeloma,2019
50-54,8.2,13.2,72,Incidence,686382,Non-Hispanic Asian/Pacific Islander,10.5,Female,Non-Hodgkin Lymphoma,2019
50-54,7.2,11.9,64,Incidence,686382,Non-Hispanic Asian/Pacific Islander,9.3,Female,Oral Cavity and Pharynx,2019
50-54,18.1,25.2,147,Incidence,686382,Non-Hispanic Asian/Pacific Islander,21.4,Female,Ovary,2019
50-54,5.3,9.4,49,Incidence,686382,Non-Hispanic Asian/Pacific Islander,7.1,Female,Pancreas,2019
50-54,7.3,12.1,65,Incidence,686382,Non-Hispanic Asian/Pacific Islander,9.5,Female,Stomach,2019
50-54,37.1,46.9,287,Incidence,686382,Non-Hispanic Asian/Pacific Islander,41.8,Female,Thyroid,2019
50-54,~,~,~,Incidence,686382,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
55-59,595.7,634.2,3957,Incidence,643697,Non-Hispanic Asian/Pacific Islander,614.7,Female,All Cancer Sites Combined,2019
55-59,2.4,5.5,24,Incidence,643697,Non-Hispanic Asian/Pacific Islander,3.7,Female,Brain and Other Nervous System,2019
55-59,9.6,15.1,78,Incidence,643697,Non-Hispanic Asian/Pacific Islander,12.1,Female,Cervix,2019
55-59,39.0,49.4,283,Incidence,643697,Non-Hispanic Asian/Pacific Islander,44.0,Female,Colon and Rectum,2019
55-59,63.4,76.5,449,Incidence,643697,Non-Hispanic Asian/Pacific Islander,69.8,Female,"Corpus and Uterus, NOS",2019
55-59,~,~,~,Incidence,643697,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
55-59,227.4,251.5,1540,Incidence,643697,Non-Hispanic Asian/Pacific Islander,239.2,Female,Female Breast,2019
55-59,67.5,80.9,476,Incidence,643697,Non-Hispanic Asian/Pacific Islander,73.9,Female,"Female Breast, <i>in situ</i>",2019
55-59,~,~,~,Incidence,643697,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,643697,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
55-59,9.0,14.4,74,Incidence,643697,Non-Hispanic Asian/Pacific Islander,11.5,Female,Kidney and Renal Pelvis,2019
55-59,~,~,~,Incidence,643697,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
55-59,7.4,12.3,62,Incidence,643697,Non-Hispanic Asian/Pacific Islander,9.6,Female,Leukemias,2019
55-59,5.8,10.2,50,Incidence,643697,Non-Hispanic Asian/Pacific Islander,7.8,Female,Liver and Intrahepatic Bile Duct,2019
55-59,41.3,52.0,299,Incidence,643697,Non-Hispanic Asian/Pacific Islander,46.5,Female,Lung and Bronchus,2019
55-59,~,~,~,Incidence,643697,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,643697,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
55-59,4.4,8.5,40,Incidence,643697,Non-Hispanic Asian/Pacific Islander,6.2,Female,Myeloma,2019
55-59,14.6,21.3,114,Incidence,643697,Non-Hispanic Asian/Pacific Islander,17.7,Female,Non-Hodgkin Lymphoma,2019
55-59,10.4,16.2,84,Incidence,643697,Non-Hispanic Asian/Pacific Islander,13.0,Female,Oral Cavity and Pharynx,2019
55-59,22.0,30.0,166,Incidence,643697,Non-Hispanic Asian/Pacific Islander,25.8,Female,Ovary,2019
55-59,8.6,13.9,71,Incidence,643697,Non-Hispanic Asian/Pacific Islander,11.0,Female,Pancreas,2019
55-59,10.8,16.7,87,Incidence,643697,Non-Hispanic Asian/Pacific Islander,13.5,Female,Stomach,2019
55-59,32.7,42.3,240,Incidence,643697,Non-Hispanic Asian/Pacific Islander,37.3,Female,Thyroid,2019
55-59,1.9,4.8,20,Incidence,643697,Non-Hispanic Asian/Pacific Islander,3.1,Female,Urinary Bladder,2019
60-64,711.1,755.2,4272,Incidence,582918,Non-Hispanic Asian/Pacific Islander,732.9,Female,All Cancer Sites Combined,2019
60-64,3.3,7.1,29,Incidence,582918,Non-Hispanic Asian/Pacific Islander,5.0,Female,Brain and Other Nervous System,2019
60-64,9.1,14.8,68,Incidence,582918,Non-Hispanic Asian/Pacific Islander,11.7,Female,Cervix,2019
60-64,46.9,58.9,307,Incidence,582918,Non-Hispanic Asian/Pacific Islander,52.7,Female,Colon and Rectum,2019
60-64,64.3,78.2,414,Incidence,582918,Non-Hispanic Asian/Pacific Islander,71.0,Female,"Corpus and Uterus, NOS",2019
60-64,1.6,4.5,16,Incidence,582918,Non-Hispanic Asian/Pacific Islander,2.7,Female,Esophagus,2019
60-64,263.7,290.9,1615,Incidence,582918,Non-Hispanic Asian/Pacific Islander,277.1,Female,Female Breast,2019
60-64,89.4,105.6,567,Incidence,582918,Non-Hispanic Asian/Pacific Islander,97.3,Female,"Female Breast, <i>in situ</i>",2019
60-64,~,~,~,Incidence,582918,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,582918,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
60-64,9.2,15.0,69,Incidence,582918,Non-Hispanic Asian/Pacific Islander,11.8,Female,Kidney and Renal Pelvis,2019
60-64,~,~,~,Incidence,582918,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
60-64,10.9,17.1,80,Incidence,582918,Non-Hispanic Asian/Pacific Islander,13.7,Female,Leukemias,2019
60-64,12.1,18.6,88,Incidence,582918,Non-Hispanic Asian/Pacific Islander,15.1,Female,Liver and Intrahepatic Bile Duct,2019
60-64,67.4,81.6,433,Incidence,582918,Non-Hispanic Asian/Pacific Islander,74.3,Female,Lung and Bronchus,2019
60-64,~,~,~,Incidence,582918,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,582918,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
60-64,5.0,9.5,41,Incidence,582918,Non-Hispanic Asian/Pacific Islander,7.0,Female,Myeloma,2019
60-64,22.7,31.3,156,Incidence,582918,Non-Hispanic Asian/Pacific Islander,26.8,Female,Non-Hodgkin Lymphoma,2019
60-64,11.3,17.7,83,Incidence,582918,Non-Hispanic Asian/Pacific Islander,14.2,Female,Oral Cavity and Pharynx,2019
60-64,18.0,25.7,126,Incidence,582918,Non-Hispanic Asian/Pacific Islander,21.6,Female,Ovary,2019
60-64,14.1,21.1,101,Incidence,582918,Non-Hispanic Asian/Pacific Islander,17.3,Female,Pancreas,2019
60-64,12.4,19.0,90,Incidence,582918,Non-Hispanic Asian/Pacific Islander,15.4,Female,Stomach,2019
60-64,29.7,39.4,200,Incidence,582918,Non-Hispanic Asian/Pacific Islander,34.3,Female,Thyroid,2019
60-64,6.2,11.1,49,Incidence,582918,Non-Hispanic Asian/Pacific Islander,8.4,Female,Urinary Bladder,2019
65-69,861.3,913.7,4430,Incidence,499315,Non-Hispanic Asian/Pacific Islander,887.2,Female,All Cancer Sites Combined,2019
65-69,4.7,9.5,34,Incidence,499315,Non-Hispanic Asian/Pacific Islander,6.8,Female,Brain and Other Nervous System,2019
65-69,7.4,13.2,50,Incidence,499315,Non-Hispanic Asian/Pacific Islander,10.0,Female,Cervix,2019
65-69,63.1,78.0,351,Incidence,499315,Non-Hispanic Asian/Pacific Islander,70.3,Female,Colon and Rectum,2019
65-69,64.8,79.9,360,Incidence,499315,Non-Hispanic Asian/Pacific Islander,72.1,Female,"Corpus and Uterus, NOS",2019
65-69,2.6,6.4,21,Incidence,499315,Non-Hispanic Asian/Pacific Islander,4.2,Female,Esophagus,2019
65-69,298.9,330.2,1569,Incidence,499315,Non-Hispanic Asian/Pacific Islander,314.2,Female,Female Breast,2019
65-69,92.9,110.8,507,Incidence,499315,Non-Hispanic Asian/Pacific Islander,101.5,Female,"Female Breast, <i>in situ</i>",2019
65-69,~,~,~,Incidence,499315,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,499315,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
65-69,12.7,19.9,80,Incidence,499315,Non-Hispanic Asian/Pacific Islander,16.0,Female,Kidney and Renal Pelvis,2019
65-69,~,~,~,Incidence,499315,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
65-69,10.9,17.7,70,Incidence,499315,Non-Hispanic Asian/Pacific Islander,14.0,Female,Leukemias,2019
65-69,21.2,30.3,127,Incidence,499315,Non-Hispanic Asian/Pacific Islander,25.4,Female,Liver and Intrahepatic Bile Duct,2019
65-69,98.5,116.8,536,Incidence,499315,Non-Hispanic Asian/Pacific Islander,107.3,Female,Lung and Bronchus,2019
65-69,1.8,5.2,16,Incidence,499315,Non-Hispanic Asian/Pacific Islander,3.2,Female,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,499315,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
65-69,8.0,13.9,53,Incidence,499315,Non-Hispanic Asian/Pacific Islander,10.6,Female,Myeloma,2019
65-69,34.9,46.2,201,Incidence,499315,Non-Hispanic Asian/Pacific Islander,40.3,Female,Non-Hodgkin Lymphoma,2019
65-69,8.5,14.6,56,Incidence,499315,Non-Hispanic Asian/Pacific Islander,11.2,Female,Oral Cavity and Pharynx,2019
65-69,15.2,23.0,94,Incidence,499315,Non-Hispanic Asian/Pacific Islander,18.8,Female,Ovary,2019
65-69,27.8,38.1,163,Incidence,499315,Non-Hispanic Asian/Pacific Islander,32.6,Female,Pancreas,2019
65-69,17.7,26.1,108,Incidence,499315,Non-Hispanic Asian/Pacific Islander,21.6,Female,Stomach,2019
65-69,27.8,38.1,163,Incidence,499315,Non-Hispanic Asian/Pacific Islander,32.6,Female,Thyroid,2019
65-69,8.6,14.8,57,Incidence,499315,Non-Hispanic Asian/Pacific Islander,11.4,Female,Urinary Bladder,2019
70-74,979.9,1044.1,3847,Incidence,380277,Non-Hispanic Asian/Pacific Islander,1011.6,Female,All Cancer Sites Combined,2019
70-74,4.3,9.7,25,Incidence,380277,Non-Hispanic Asian/Pacific Islander,6.6,Female,Brain and Other Nervous System,2019
70-74,6.9,13.4,37,Incidence,380277,Non-Hispanic Asian/Pacific Islander,9.7,Female,Cervix,2019
70-74,75.2,93.9,320,Incidence,380277,Non-Hispanic Asian/Pacific Islander,84.1,Female,Colon and Rectum,2019
70-74,62.0,79.2,267,Incidence,380277,Non-Hispanic Asian/Pacific Islander,70.2,Female,"Corpus and Uterus, NOS",2019
70-74,~,~,~,Incidence,380277,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
70-74,301.0,337.2,1212,Incidence,380277,Non-Hispanic Asian/Pacific Islander,318.7,Female,Female Breast,2019
70-74,102.4,124.0,429,Incidence,380277,Non-Hispanic Asian/Pacific Islander,112.8,Female,"Female Breast, <i>in situ</i>",2019
70-74,~,~,~,Incidence,380277,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,380277,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
70-74,17.4,27.1,83,Incidence,380277,Non-Hispanic Asian/Pacific Islander,21.8,Female,Kidney and Renal Pelvis,2019
70-74,~,~,~,Incidence,380277,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
70-74,11.6,19.7,58,Incidence,380277,Non-Hispanic Asian/Pacific Islander,15.3,Female,Leukemias,2019
70-74,29.0,41.2,132,Incidence,380277,Non-Hispanic Asian/Pacific Islander,34.7,Female,Liver and Intrahepatic Bile Duct,2019
70-74,130.5,154.8,541,Incidence,380277,Non-Hispanic Asian/Pacific Islander,142.3,Female,Lung and Bronchus,2019
70-74,3.2,8.1,20,Incidence,380277,Non-Hispanic Asian/Pacific Islander,5.3,Female,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,380277,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
70-74,14.1,23.0,69,Incidence,380277,Non-Hispanic Asian/Pacific Islander,18.1,Female,Myeloma,2019
70-74,35.3,48.6,158,Incidence,380277,Non-Hispanic Asian/Pacific Islander,41.5,Female,Non-Hodgkin Lymphoma,2019
70-74,15.3,24.4,74,Incidence,380277,Non-Hispanic Asian/Pacific Islander,19.5,Female,Oral Cavity and Pharynx,2019
70-74,16.4,25.9,79,Incidence,380277,Non-Hispanic Asian/Pacific Islander,20.8,Female,Ovary,2019
70-74,34.8,48.0,156,Incidence,380277,Non-Hispanic Asian/Pacific Islander,41.0,Female,Pancreas,2019
70-74,23.5,34.6,109,Incidence,380277,Non-Hispanic Asian/Pacific Islander,28.7,Female,Stomach,2019
70-74,24.5,35.7,113,Incidence,380277,Non-Hispanic Asian/Pacific Islander,29.7,Female,Thyroid,2019
70-74,9.3,16.7,48,Incidence,380277,Non-Hispanic Asian/Pacific Islander,12.6,Female,Urinary Bladder,2019
75-79,1073.4,1156.2,2811,Incidence,252278,Non-Hispanic Asian/Pacific Islander,1114.2,Female,All Cancer Sites Combined,2019
75-79,4.8,12.2,20,Incidence,252278,Non-Hispanic Asian/Pacific Islander,7.9,Female,Brain and Other Nervous System,2019
75-79,8.0,17.0,30,Incidence,252278,Non-Hispanic Asian/Pacific Islander,11.9,Female,Cervix,2019
75-79,83.5,108.0,240,Incidence,252278,Non-Hispanic Asian/Pacific Islander,95.1,Female,Colon and Rectum,2019
75-79,41.6,59.5,126,Incidence,252278,Non-Hispanic Asian/Pacific Islander,49.9,Female,"Corpus and Uterus, NOS",2019
75-79,~,~,~,Incidence,252278,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
75-79,264.2,306.2,718,Incidence,252278,Non-Hispanic Asian/Pacific Islander,284.6,Female,Female Breast,2019
75-79,63.1,84.7,185,Incidence,252278,Non-Hispanic Asian/Pacific Islander,73.3,Female,"Female Breast, <i>in situ</i>",2019
75-79,~,~,~,Incidence,252278,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,252278,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
75-79,17.8,30.2,59,Incidence,252278,Non-Hispanic Asian/Pacific Islander,23.4,Female,Kidney and Renal Pelvis,2019
75-79,~,~,~,Incidence,252278,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
75-79,20.9,34.2,68,Incidence,252278,Non-Hispanic Asian/Pacific Islander,27.0,Female,Leukemias,2019
75-79,32.6,48.6,101,Incidence,252278,Non-Hispanic Asian/Pacific Islander,40.0,Female,Liver and Intrahepatic Bile Duct,2019
75-79,176.7,211.4,488,Incidence,252278,Non-Hispanic Asian/Pacific Islander,193.4,Female,Lung and Bronchus,2019
75-79,~,~,~,Incidence,252278,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,252278,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
75-79,9.7,19.3,35,Incidence,252278,Non-Hispanic Asian/Pacific Islander,13.9,Female,Myeloma,2019
75-79,52.1,71.9,155,Incidence,252278,Non-Hispanic Asian/Pacific Islander,61.4,Female,Non-Hodgkin Lymphoma,2019
75-79,12.3,23.0,43,Incidence,252278,Non-Hispanic Asian/Pacific Islander,17.0,Female,Oral Cavity and Pharynx,2019
75-79,19.5,32.4,64,Incidence,252278,Non-Hispanic Asian/Pacific Islander,25.4,Female,Ovary,2019
75-79,47.0,65.9,141,Incidence,252278,Non-Hispanic Asian/Pacific Islander,55.9,Female,Pancreas,2019
75-79,26.9,41.7,85,Incidence,252278,Non-Hispanic Asian/Pacific Islander,33.7,Female,Stomach,2019
75-79,22.3,35.9,72,Incidence,252278,Non-Hispanic Asian/Pacific Islander,28.5,Female,Thyroid,2019
75-79,10.7,20.7,38,Incidence,252278,Non-Hispanic Asian/Pacific Islander,15.1,Female,Urinary Bladder,2019
80-84,1136.0,1240.1,2020,Incidence,170150,Non-Hispanic Asian/Pacific Islander,1187.2,Female,All Cancer Sites Combined,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
80-84,116.1,151.3,226,Incidence,170150,Non-Hispanic Asian/Pacific Islander,132.8,Female,Colon and Rectum,2019
80-84,33.6,53.9,73,Incidence,170150,Non-Hispanic Asian/Pacific Islander,42.9,Female,"Corpus and Uterus, NOS",2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
80-84,223.2,271.0,419,Incidence,170150,Non-Hispanic Asian/Pacific Islander,246.3,Female,Female Breast,2019
80-84,42.5,65.0,90,Incidence,170150,Non-Hispanic Asian/Pacific Islander,52.9,Female,"Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
80-84,21.8,38.7,50,Incidence,170150,Non-Hispanic Asian/Pacific Islander,29.4,Female,Kidney and Renal Pelvis,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
80-84,18.3,34.0,43,Incidence,170150,Non-Hispanic Asian/Pacific Islander,25.3,Female,Leukemias,2019
80-84,46.2,69.5,97,Incidence,170150,Non-Hispanic Asian/Pacific Islander,57.0,Female,Liver and Intrahepatic Bile Duct,2019
80-84,188.1,232.1,356,Incidence,170150,Non-Hispanic Asian/Pacific Islander,209.2,Female,Lung and Bronchus,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
80-84,20.8,37.4,48,Incidence,170150,Non-Hispanic Asian/Pacific Islander,28.2,Female,Myeloma,2019
80-84,41.5,63.7,88,Incidence,170150,Non-Hispanic Asian/Pacific Islander,51.7,Female,Non-Hodgkin Lymphoma,2019
80-84,15.3,30.0,37,Incidence,170150,Non-Hispanic Asian/Pacific Islander,21.7,Female,Oral Cavity and Pharynx,2019
80-84,15.3,30.0,37,Incidence,170150,Non-Hispanic Asian/Pacific Islander,21.7,Female,Ovary,2019
80-84,57.9,83.7,119,Incidence,170150,Non-Hispanic Asian/Pacific Islander,69.9,Female,Pancreas,2019
80-84,31.0,50.7,68,Incidence,170150,Non-Hispanic Asian/Pacific Islander,40.0,Female,Stomach,2019
80-84,11.4,24.5,29,Incidence,170150,Non-Hispanic Asian/Pacific Islander,17.0,Female,Thyroid,2019
80-84,18.8,34.7,44,Incidence,170150,Non-Hispanic Asian/Pacific Islander,25.9,Female,Urinary Bladder,2019
85+,1164.1,1263.6,2308,Incidence,190260,Non-Hispanic Asian/Pacific Islander,1213.1,Female,All Cancer Sites Combined,2019
85+,~,~,~,Incidence,190260,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
85+,6.4,16.2,20,Incidence,190260,Non-Hispanic Asian/Pacific Islander,10.5,Female,Cervix,2019
85+,168.2,207.6,356,Incidence,190260,Non-Hispanic Asian/Pacific Islander,187.1,Female,Colon and Rectum,2019
85+,20.9,36.4,53,Incidence,190260,Non-Hispanic Asian/Pacific Islander,27.9,Female,"Corpus and Uterus, NOS",2019
85+,4.8,13.7,16,Incidence,190260,Non-Hispanic Asian/Pacific Islander,8.4,Female,Esophagus,2019
85+,165.2,204.3,350,Incidence,190260,Non-Hispanic Asian/Pacific Islander,184.0,Female,Female Breast,2019
85+,13.3,26.2,36,Incidence,190260,Non-Hispanic Asian/Pacific Islander,18.9,Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,190260,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,190260,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
85+,14.6,28.0,39,Incidence,190260,Non-Hispanic Asian/Pacific Islander,20.5,Female,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,190260,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
85+,21.3,37.0,54,Incidence,190260,Non-Hispanic Asian/Pacific Islander,28.4,Female,Leukemias,2019
85+,43.2,64.5,101,Incidence,190260,Non-Hispanic Asian/Pacific Islander,53.1,Female,Liver and Intrahepatic Bile Duct,2019
85+,181.6,222.5,383,Incidence,190260,Non-Hispanic Asian/Pacific Islander,201.3,Female,Lung and Bronchus,2019
85+,~,~,~,Incidence,190260,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,190260,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
85+,11.5,23.7,32,Incidence,190260,Non-Hispanic Asian/Pacific Islander,16.8,Female,Myeloma,2019
85+,41.3,62.2,97,Incidence,190260,Non-Hispanic Asian/Pacific Islander,51.0,Female,Non-Hodgkin Lymphoma,2019
85+,20.0,35.2,51,Incidence,190260,Non-Hispanic Asian/Pacific Islander,26.8,Female,Oral Cavity and Pharynx,2019
85+,11.9,24.4,33,Incidence,190260,Non-Hispanic Asian/Pacific Islander,17.3,Female,Ovary,2019
85+,70.1,96.5,157,Incidence,190260,Non-Hispanic Asian/Pacific Islander,82.5,Female,Pancreas,2019
85+,45.1,66.8,105,Incidence,190260,Non-Hispanic Asian/Pacific Islander,55.2,Female,Stomach,2019
85+,5.6,15.0,18,Incidence,190260,Non-Hispanic Asian/Pacific Islander,9.5,Female,Thyroid,2019
85+,31.5,50.0,76,Incidence,190260,Non-Hispanic Asian/Pacific Islander,39.9,Female,Urinary Bladder,2019
<1,18.1,37.8,31,Incidence,116326,Non-Hispanic Asian/Pacific Islander,26.6,Female,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2019
1-4,14.1,21.3,95,Incidence,545131,Non-Hispanic Asian/Pacific Islander,17.4,Male,All Cancer Sites Combined,2019
1-4,1.8,5.0,17,Incidence,545131,Non-Hispanic Asian/Pacific Islander,3.1,Male,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
1-4,6.0,11.0,45,Incidence,545131,Non-Hispanic Asian/Pacific Islander,8.3,Male,Leukemias,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
1-4,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
10-14,9.8,15.6,78,Incidence,625982,Non-Hispanic Asian/Pacific Islander,12.5,Male,All Cancer Sites Combined,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
10-14,1.5,4.2,16,Incidence,625982,Non-Hispanic Asian/Pacific Islander,2.6,Male,Leukemias,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
10-14,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
15-19,17.5,24.8,133,Incidence,636316,Non-Hispanic Asian/Pacific Islander,20.9,Male,All Cancer Sites Combined,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
15-19,1.6,4.3,17,Incidence,636316,Non-Hispanic Asian/Pacific Islander,2.7,Male,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
15-19,2.3,5.4,23,Incidence,636316,Non-Hispanic Asian/Pacific Islander,3.6,Male,Leukemias,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
15-19,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
15-19,1.6,4.3,17,Incidence,636316,Non-Hispanic Asian/Pacific Islander,2.7,Male,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
20-24,29.6,38.4,239,Incidence,707319,Non-Hispanic Asian/Pacific Islander,33.8,Male,All Cancer Sites Combined,2019
20-24,1.5,4.0,18,Incidence,707319,Non-Hispanic Asian/Pacific Islander,2.5,Male,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
20-24,3.1,6.4,32,Incidence,707319,Non-Hispanic Asian/Pacific Islander,4.5,Male,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
20-24,3.4,6.9,35,Incidence,707319,Non-Hispanic Asian/Pacific Islander,4.9,Male,Leukemias,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
20-24,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
20-24,2.1,4.9,23,Incidence,707319,Non-Hispanic Asian/Pacific Islander,3.3,Male,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
20-24,4.0,7.7,40,Incidence,707319,Non-Hispanic Asian/Pacific Islander,5.7,Male,Testis,2019
20-24,2.7,5.9,29,Incidence,707319,Non-Hispanic Asian/Pacific Islander,4.1,Male,Thyroid,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
25-29,28.2,35.8,273,Incidence,857639,Non-Hispanic Asian/Pacific Islander,31.8,Male,All Cancer Sites Combined,2019
25-29,1.1,3.0,16,Incidence,857639,Non-Hispanic Asian/Pacific Islander,1.9,Male,Brain and Other Nervous System,2019
25-29,1.9,4.3,25,Incidence,857639,Non-Hispanic Asian/Pacific Islander,2.9,Male,Colon and Rectum,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
25-29,1.5,3.7,21,Incidence,857639,Non-Hispanic Asian/Pacific Islander,2.4,Male,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
25-29,1.1,3.0,16,Incidence,857639,Non-Hispanic Asian/Pacific Islander,1.9,Male,Leukemias,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
25-29,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
25-29,2.0,4.4,26,Incidence,857639,Non-Hispanic Asian/Pacific Islander,3.0,Male,Non-Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
25-29,3.9,7.2,46,Incidence,857639,Non-Hispanic Asian/Pacific Islander,5.4,Male,Testis,2019
25-29,4.3,7.7,50,Incidence,857639,Non-Hispanic Asian/Pacific Islander,5.8,Male,Thyroid,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
30-34,46.5,56.0,447,Incidence,875160,Non-Hispanic Asian/Pacific Islander,51.1,Male,All Cancer Sites Combined,2019
30-34,2.0,4.5,27,Incidence,875160,Non-Hispanic Asian/Pacific Islander,3.1,Male,Brain and Other Nervous System,2019
30-34,4.6,8.1,54,Incidence,875160,Non-Hispanic Asian/Pacific Islander,6.2,Male,Colon and Rectum,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
30-34,1.9,4.4,26,Incidence,875160,Non-Hispanic Asian/Pacific Islander,3.0,Male,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
30-34,1.9,4.4,26,Incidence,875160,Non-Hispanic Asian/Pacific Islander,3.0,Male,Leukemias,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
30-34,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
30-34,3.2,6.1,39,Incidence,875160,Non-Hispanic Asian/Pacific Islander,4.5,Male,Non-Hodgkin Lymphoma,2019
30-34,2.9,5.7,36,Incidence,875160,Non-Hispanic Asian/Pacific Islander,4.1,Male,Oral Cavity and Pharynx,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
30-34,4.4,7.8,52,Incidence,875160,Non-Hispanic Asian/Pacific Islander,5.9,Male,Testis,2019
30-34,4.9,8.4,57,Incidence,875160,Non-Hispanic Asian/Pacific Islander,6.5,Male,Thyroid,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
35-39,57.4,68.4,517,Incidence,824406,Non-Hispanic Asian/Pacific Islander,62.7,Male,All Cancer Sites Combined,2019
35-39,1.2,3.3,17,Incidence,824406,Non-Hispanic Asian/Pacific Islander,2.1,Male,Brain and Other Nervous System,2019
35-39,6.6,10.7,70,Incidence,824406,Non-Hispanic Asian/Pacific Islander,8.5,Male,Colon and Rectum,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
35-39,2.9,5.8,34,Incidence,824406,Non-Hispanic Asian/Pacific Islander,4.1,Male,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
35-39,3.4,6.5,39,Incidence,824406,Non-Hispanic Asian/Pacific Islander,4.7,Male,Leukemias,2019
35-39,2.1,4.6,26,Incidence,824406,Non-Hispanic Asian/Pacific Islander,3.2,Male,Liver and Intrahepatic Bile Duct,2019
35-39,2.1,4.6,26,Incidence,824406,Non-Hispanic Asian/Pacific Islander,3.2,Male,Lung and Bronchus,2019
35-39,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
35-39,4.2,7.6,47,Incidence,824406,Non-Hispanic Asian/Pacific Islander,5.7,Male,Non-Hodgkin Lymphoma,2019
35-39,3.2,6.2,37,Incidence,824406,Non-Hispanic Asian/Pacific Islander,4.5,Male,Oral Cavity and Pharynx,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
35-39,2.3,4.9,28,Incidence,824406,Non-Hispanic Asian/Pacific Islander,3.4,Male,Testis,2019
35-39,6.7,10.9,71,Incidence,824406,Non-Hispanic Asian/Pacific Islander,8.6,Male,Thyroid,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
40-44,90.0,104.5,705,Incidence,726540,Non-Hispanic Asian/Pacific Islander,97.0,Male,All Cancer Sites Combined,2019
40-44,2.4,5.4,27,Incidence,726540,Non-Hispanic Asian/Pacific Islander,3.7,Male,Brain and Other Nervous System,2019
40-44,14.4,20.6,126,Incidence,726540,Non-Hispanic Asian/Pacific Islander,17.3,Male,Colon and Rectum,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
40-44,5.0,8.9,49,Incidence,726540,Non-Hispanic Asian/Pacific Islander,6.7,Male,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
40-44,2.6,5.6,28,Incidence,726540,Non-Hispanic Asian/Pacific Islander,3.9,Male,Leukemias,2019
40-44,4.5,8.3,45,Incidence,726540,Non-Hispanic Asian/Pacific Islander,6.2,Male,Liver and Intrahepatic Bile Duct,2019
40-44,3.0,6.2,32,Incidence,726540,Non-Hispanic Asian/Pacific Islander,4.4,Male,Lung and Bronchus,2019
40-44,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
40-44,4.3,8.0,43,Incidence,726540,Non-Hispanic Asian/Pacific Islander,5.9,Male,Non-Hodgkin Lymphoma,2019
40-44,6.1,10.3,58,Incidence,726540,Non-Hispanic Asian/Pacific Islander,8.0,Male,Oral Cavity and Pharynx,2019
40-44,1.3,3.6,16,Incidence,726540,Non-Hispanic Asian/Pacific Islander,2.2,Male,Pancreas,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
40-44,2.3,5.2,26,Incidence,726540,Non-Hispanic Asian/Pacific Islander,3.6,Male,Stomach,2019
40-44,2.1,4.9,24,Incidence,726540,Non-Hispanic Asian/Pacific Islander,3.3,Male,Testis,2019
40-44,7.5,12.2,70,Incidence,726540,Non-Hispanic Asian/Pacific Islander,9.6,Male,Thyroid,2019
40-44,2.1,4.9,24,Incidence,726540,Non-Hispanic Asian/Pacific Islander,3.3,Male,Urinary Bladder,2019
45-49,150.0,168.7,1125,Incidence,706939,Non-Hispanic Asian/Pacific Islander,159.1,Male,All Cancer Sites Combined,2019
45-49,3.0,6.2,31,Incidence,706939,Non-Hispanic Asian/Pacific Islander,4.4,Male,Brain and Other Nervous System,2019
45-49,26.6,34.9,216,Incidence,706939,Non-Hispanic Asian/Pacific Islander,30.6,Male,Colon and Rectum,2019
45-49,~,~,~,Incidence,706939,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
45-49,~,~,~,Incidence,706939,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,706939,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
45-49,9.5,14.7,84,Incidence,706939,Non-Hispanic Asian/Pacific Islander,11.9,Male,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,706939,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
45-49,5.4,9.5,51,Incidence,706939,Non-Hispanic Asian/Pacific Islander,7.2,Male,Leukemias,2019
45-49,6.1,10.4,57,Incidence,706939,Non-Hispanic Asian/Pacific Islander,8.1,Male,Liver and Intrahepatic Bile Duct,2019
45-49,9.0,14.1,80,Incidence,706939,Non-Hispanic Asian/Pacific Islander,11.3,Male,Lung and Bronchus,2019
45-49,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
45-49,~,~,~,Incidence,706939,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,706939,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
45-49,1.7,4.4,20,Incidence,706939,Non-Hispanic Asian/Pacific Islander,2.8,Male,Myeloma,2019
45-49,7.2,11.9,66,Incidence,706939,Non-Hispanic Asian/Pacific Islander,9.3,Male,Non-Hodgkin Lymphoma,2019
45-49,12.8,18.8,110,Incidence,706939,Non-Hispanic Asian/Pacific Islander,15.6,Male,Oral Cavity and Pharynx,2019
45-49,4.8,8.7,46,Incidence,706939,Non-Hispanic Asian/Pacific Islander,6.5,Male,Pancreas,2019
45-49,7.0,11.6,64,Incidence,706939,Non-Hispanic Asian/Pacific Islander,9.1,Male,Prostate,2019
45-49,3.0,6.2,31,Incidence,706939,Non-Hispanic Asian/Pacific Islander,4.4,Male,Stomach,2019
45-49,1.5,4.0,18,Incidence,706939,Non-Hispanic Asian/Pacific Islander,2.5,Male,Testis,2019
45-49,10.0,15.3,88,Incidence,706939,Non-Hispanic Asian/Pacific Islander,12.4,Male,Thyroid,2019
45-49,3.0,6.2,31,Incidence,706939,Non-Hispanic Asian/Pacific Islander,4.4,Male,Urinary Bladder,2019
5-9,9.0,14.3,76,Incidence,666541,Non-Hispanic Asian/Pacific Islander,11.4,Male,All Cancer Sites Combined,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
5-9,2.7,5.9,27,Incidence,666541,Non-Hispanic Asian/Pacific Islander,4.1,Male,Leukemias,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
5-9,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
50-54,275.2,302.6,1735,Incidence,601055,Non-Hispanic Asian/Pacific Islander,288.7,Male,All Cancer Sites Combined,2019
50-54,3.8,7.7,33,Incidence,601055,Non-Hispanic Asian/Pacific Islander,5.5,Male,Brain and Other Nervous System,2019
50-54,60.7,73.9,403,Incidence,601055,Non-Hispanic Asian/Pacific Islander,67.0,Male,Colon and Rectum,2019
50-54,2.2,5.3,21,Incidence,601055,Non-Hispanic Asian/Pacific Islander,3.5,Male,Esophagus,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
50-54,11.1,17.3,84,Incidence,601055,Non-Hispanic Asian/Pacific Islander,14.0,Male,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
50-54,6.7,11.7,54,Incidence,601055,Non-Hispanic Asian/Pacific Islander,9.0,Male,Leukemias,2019
50-54,14.3,21.1,105,Incidence,601055,Non-Hispanic Asian/Pacific Islander,17.5,Male,Liver and Intrahepatic Bile Duct,2019
50-54,20.7,28.7,147,Incidence,601055,Non-Hispanic Asian/Pacific Islander,24.5,Male,Lung and Bronchus,2019
50-54,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
50-54,3.8,7.7,33,Incidence,601055,Non-Hispanic Asian/Pacific Islander,5.5,Male,Myeloma,2019
50-54,13.1,19.7,97,Incidence,601055,Non-Hispanic Asian/Pacific Islander,16.1,Male,Non-Hodgkin Lymphoma,2019
50-54,17.5,25.0,126,Incidence,601055,Non-Hispanic Asian/Pacific Islander,21.0,Male,Oral Cavity and Pharynx,2019
50-54,7.9,13.2,62,Incidence,601055,Non-Hispanic Asian/Pacific Islander,10.3,Male,Pancreas,2019
50-54,35.7,46.0,244,Incidence,601055,Non-Hispanic Asian/Pacific Islander,40.6,Male,Prostate,2019
50-54,7.0,12.1,56,Incidence,601055,Non-Hispanic Asian/Pacific Islander,9.3,Male,Stomach,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
50-54,8.8,14.3,68,Incidence,601055,Non-Hispanic Asian/Pacific Islander,11.3,Male,Thyroid,2019
50-54,6.7,11.7,54,Incidence,601055,Non-Hispanic Asian/Pacific Islander,9.0,Male,Urinary Bladder,2019
55-59,466.8,503.7,2676,Incidence,551754,Non-Hispanic Asian/Pacific Islander,485.0,Male,All Cancer Sites Combined,2019
55-59,4.7,9.2,37,Incidence,551754,Non-Hispanic Asian/Pacific Islander,6.7,Male,Brain and Other Nervous System,2019
55-59,65.2,79.6,398,Incidence,551754,Non-Hispanic Asian/Pacific Islander,72.1,Male,Colon and Rectum,2019
55-59,4.1,8.4,33,Incidence,551754,Non-Hispanic Asian/Pacific Islander,6.0,Male,Esophagus,2019
55-59,~,~,~,Incidence,551754,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,551754,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
55-59,22.7,31.5,148,Incidence,551754,Non-Hispanic Asian/Pacific Islander,26.8,Male,Kidney and Renal Pelvis,2019
55-59,3.1,6.9,26,Incidence,551754,Non-Hispanic Asian/Pacific Islander,4.7,Male,Larynx,2019
55-59,10.9,17.2,76,Incidence,551754,Non-Hispanic Asian/Pacific Islander,13.8,Male,Leukemias,2019
55-59,31.7,42.0,202,Incidence,551754,Non-Hispanic Asian/Pacific Islander,36.6,Male,Liver and Intrahepatic Bile Duct,2019
55-59,48.9,61.5,303,Incidence,551754,Non-Hispanic Asian/Pacific Islander,54.9,Male,Lung and Bronchus,2019
55-59,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
55-59,~,~,~,Incidence,551754,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,551754,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
55-59,7.0,12.4,52,Incidence,551754,Non-Hispanic Asian/Pacific Islander,9.4,Male,Myeloma,2019
55-59,21.5,30.1,141,Incidence,551754,Non-Hispanic Asian/Pacific Islander,25.6,Male,Non-Hodgkin Lymphoma,2019
55-59,22.7,31.5,148,Incidence,551754,Non-Hispanic Asian/Pacific Islander,26.8,Male,Oral Cavity and Pharynx,2019
55-59,10.4,16.6,73,Incidence,551754,Non-Hispanic Asian/Pacific Islander,13.2,Male,Pancreas,2019
55-59,96.6,113.8,579,Incidence,551754,Non-Hispanic Asian/Pacific Islander,104.9,Male,Prostate,2019
55-59,13.8,20.8,94,Incidence,551754,Non-Hispanic Asian/Pacific Islander,17.0,Male,Stomach,2019
55-59,~,~,~,Incidence,551754,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
55-59,9.6,15.6,68,Incidence,551754,Non-Hispanic Asian/Pacific Islander,12.3,Male,Thyroid,2019
55-59,10.7,17.0,75,Incidence,551754,Non-Hispanic Asian/Pacific Islander,13.6,Male,Urinary Bladder,2019
60-64,744.5,794.4,3688,Incidence,479498,Non-Hispanic Asian/Pacific Islander,769.1,Male,All Cancer Sites Combined,2019
60-64,5.3,10.4,36,Incidence,479498,Non-Hispanic Asian/Pacific Islander,7.5,Male,Brain and Other Nervous System,2019
60-64,84.8,102.3,447,Incidence,479498,Non-Hispanic Asian/Pacific Islander,93.2,Male,Colon and Rectum,2019
60-64,7.6,13.5,49,Incidence,479498,Non-Hispanic Asian/Pacific Islander,10.2,Male,Esophagus,2019
60-64,~,~,~,Incidence,479498,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,479498,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
60-64,29.6,40.3,166,Incidence,479498,Non-Hispanic Asian/Pacific Islander,34.6,Male,Kidney and Renal Pelvis,2019
60-64,2.9,6.9,22,Incidence,479498,Non-Hispanic Asian/Pacific Islander,4.6,Male,Larynx,2019
60-64,13.8,21.5,83,Incidence,479498,Non-Hispanic Asian/Pacific Islander,17.3,Male,Leukemias,2019
60-64,60.6,75.6,325,Incidence,479498,Non-Hispanic Asian/Pacific Islander,67.8,Male,Liver and Intrahepatic Bile Duct,2019
60-64,93.3,111.7,490,Incidence,479498,Non-Hispanic Asian/Pacific Islander,102.2,Male,Lung and Bronchus,2019
60-64,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
60-64,~,~,~,Incidence,479498,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,479498,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
60-64,10.3,17.0,64,Incidence,479498,Non-Hispanic Asian/Pacific Islander,13.3,Male,Myeloma,2019
60-64,30.3,41.2,170,Incidence,479498,Non-Hispanic Asian/Pacific Islander,35.5,Male,Non-Hodgkin Lymphoma,2019
60-64,26.3,36.5,149,Incidence,479498,Non-Hispanic Asian/Pacific Islander,31.1,Male,Oral Cavity and Pharynx,2019
60-64,20.0,29.0,116,Incidence,479498,Non-Hispanic Asian/Pacific Islander,24.2,Male,Pancreas,2019
60-64,192.0,217.8,981,Incidence,479498,Non-Hispanic Asian/Pacific Islander,204.6,Male,Prostate,2019
60-64,25.3,35.4,144,Incidence,479498,Non-Hispanic Asian/Pacific Islander,30.0,Male,Stomach,2019
60-64,~,~,~,Incidence,479498,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
60-64,9.5,16.1,60,Incidence,479498,Non-Hispanic Asian/Pacific Islander,12.5,Male,Thyroid,2019
60-64,17.9,26.5,105,Incidence,479498,Non-Hispanic Asian/Pacific Islander,21.9,Male,Urinary Bladder,2019
65-69,1126.0,1193.5,4562,Incidence,393477,Non-Hispanic Asian/Pacific Islander,1159.4,Male,All Cancer Sites Combined,2019
65-69,6.0,12.1,34,Incidence,393477,Non-Hispanic Asian/Pacific Islander,8.6,Male,Brain and Other Nervous System,2019
65-69,101.9,123.0,441,Incidence,393477,Non-Hispanic Asian/Pacific Islander,112.1,Male,Colon and Rectum,2019
65-69,12.7,21.1,65,Incidence,393477,Non-Hispanic Asian/Pacific Islander,16.5,Male,Esophagus,2019
65-69,~,~,~,Incidence,393477,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,393477,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
65-69,43.1,57.3,196,Incidence,393477,Non-Hispanic Asian/Pacific Islander,49.8,Male,Kidney and Renal Pelvis,2019
65-69,6.2,12.4,35,Incidence,393477,Non-Hispanic Asian/Pacific Islander,8.9,Male,Larynx,2019
65-69,20.4,30.6,99,Incidence,393477,Non-Hispanic Asian/Pacific Islander,25.2,Male,Leukemias,2019
65-69,72.4,90.5,319,Incidence,393477,Non-Hispanic Asian/Pacific Islander,81.1,Male,Liver and Intrahepatic Bile Duct,2019
65-69,150.0,175.5,639,Incidence,393477,Non-Hispanic Asian/Pacific Islander,162.4,Male,Lung and Bronchus,2019
65-69,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
65-69,~,~,~,Incidence,393477,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,393477,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
65-69,15.7,24.7,78,Incidence,393477,Non-Hispanic Asian/Pacific Islander,19.8,Male,Myeloma,2019
65-69,42.4,56.5,193,Incidence,393477,Non-Hispanic Asian/Pacific Islander,49.0,Male,Non-Hodgkin Lymphoma,2019
65-69,34.1,46.9,158,Incidence,393477,Non-Hispanic Asian/Pacific Islander,40.2,Male,Oral Cavity and Pharynx,2019
65-69,32.5,45.0,151,Incidence,393477,Non-Hispanic Asian/Pacific Islander,38.4,Male,Pancreas,2019
65-69,333.2,370.5,1383,Incidence,393477,Non-Hispanic Asian/Pacific Islander,351.5,Male,Prostate,2019
65-69,38.1,51.6,175,Incidence,393477,Non-Hispanic Asian/Pacific Islander,44.5,Male,Stomach,2019
65-69,~,~,~,Incidence,393477,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
65-69,10.8,18.5,56,Incidence,393477,Non-Hispanic Asian/Pacific Islander,14.2,Male,Thyroid,2019
65-69,42.4,56.5,193,Incidence,393477,Non-Hispanic Asian/Pacific Islander,49.0,Male,Urinary Bladder,2019
70-74,1313.6,1397.2,4068,Incidence,300232,Non-Hispanic Asian/Pacific Islander,1355.0,Male,All Cancer Sites Combined,2019
70-74,4.9,11.5,23,Incidence,300232,Non-Hispanic Asian/Pacific Islander,7.7,Male,Brain and Other Nervous System,2019
70-74,114.5,140.3,381,Incidence,300232,Non-Hispanic Asian/Pacific Islander,126.9,Male,Colon and Rectum,2019
70-74,10.1,18.9,42,Incidence,300232,Non-Hispanic Asian/Pacific Islander,14.0,Male,Esophagus,2019
70-74,~,~,~,Incidence,300232,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,300232,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
70-74,38.0,53.6,136,Incidence,300232,Non-Hispanic Asian/Pacific Islander,45.3,Male,Kidney and Renal Pelvis,2019
70-74,8.1,16.2,35,Incidence,300232,Non-Hispanic Asian/Pacific Islander,11.7,Male,Larynx,2019
70-74,28.3,42.0,104,Incidence,300232,Non-Hispanic Asian/Pacific Islander,34.6,Male,Leukemias,2019
70-74,65.2,85.0,224,Incidence,300232,Non-Hispanic Asian/Pacific Islander,74.6,Male,Liver and Intrahepatic Bile Duct,2019
70-74,206.6,240.7,670,Incidence,300232,Non-Hispanic Asian/Pacific Islander,223.2,Male,Lung and Bronchus,2019
70-74,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
70-74,4.6,11.1,22,Incidence,300232,Non-Hispanic Asian/Pacific Islander,7.3,Male,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,300232,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
70-74,17.9,29.1,69,Incidence,300232,Non-Hispanic Asian/Pacific Islander,23.0,Male,Myeloma,2019
70-74,52.1,70.1,182,Incidence,300232,Non-Hispanic Asian/Pacific Islander,60.6,Male,Non-Hodgkin Lymphoma,2019
70-74,33.1,47.8,120,Incidence,300232,Non-Hispanic Asian/Pacific Islander,40.0,Male,Oral Cavity and Pharynx,2019
70-74,41.1,57.2,146,Incidence,300232,Non-Hispanic Asian/Pacific Islander,48.6,Male,Pancreas,2019
70-74,369.3,414.4,1175,Incidence,300232,Non-Hispanic Asian/Pacific Islander,391.4,Male,Prostate,2019
70-74,47.2,64.4,166,Incidence,300232,Non-Hispanic Asian/Pacific Islander,55.3,Male,Stomach,2019
70-74,~,~,~,Incidence,300232,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
70-74,12.4,22.0,50,Incidence,300232,Non-Hispanic Asian/Pacific Islander,16.7,Male,Thyroid,2019
70-74,59.9,79.0,207,Incidence,300232,Non-Hispanic Asian/Pacific Islander,68.9,Male,Urinary Bladder,2019
75-79,1563.9,1676.2,3225,Incidence,199153,Non-Hispanic Asian/Pacific Islander,1619.4,Male,All Cancer Sites Combined,2019
75-79,11.8,23.9,34,Incidence,199153,Non-Hispanic Asian/Pacific Islander,17.1,Male,Brain and Other Nervous System,2019
75-79,123.2,156.5,277,Incidence,199153,Non-Hispanic Asian/Pacific Islander,139.1,Male,Colon and Rectum,2019
75-79,12.2,24.4,35,Incidence,199153,Non-Hispanic Asian/Pacific Islander,17.6,Male,Esophagus,2019
75-79,~,~,~,Incidence,199153,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,199153,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
75-79,38.6,58.3,95,Incidence,199153,Non-Hispanic Asian/Pacific Islander,47.7,Male,Kidney and Renal Pelvis,2019
75-79,7.3,17.3,23,Incidence,199153,Non-Hispanic Asian/Pacific Islander,11.5,Male,Larynx,2019
75-79,25.2,41.6,65,Incidence,199153,Non-Hispanic Asian/Pacific Islander,32.6,Male,Leukemias,2019
75-79,76.7,103.5,178,Incidence,199153,Non-Hispanic Asian/Pacific Islander,89.4,Male,Liver and Intrahepatic Bile Duct,2019
75-79,259.3,306.5,562,Incidence,199153,Non-Hispanic Asian/Pacific Islander,282.2,Male,Lung and Bronchus,2019
75-79,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
75-79,~,~,~,Incidence,199153,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,199153,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
75-79,24.7,41.0,64,Incidence,199153,Non-Hispanic Asian/Pacific Islander,32.1,Male,Myeloma,2019
75-79,67.0,92.2,157,Incidence,199153,Non-Hispanic Asian/Pacific Islander,78.8,Male,Non-Hodgkin Lymphoma,2019
75-79,28.7,46.1,73,Incidence,199153,Non-Hispanic Asian/Pacific Islander,36.7,Male,Oral Cavity and Pharynx,2019
75-79,67.0,92.2,157,Incidence,199153,Non-Hispanic Asian/Pacific Islander,78.8,Male,Pancreas,2019
75-79,370.5,426.4,792,Incidence,199153,Non-Hispanic Asian/Pacific Islander,397.7,Male,Prostate,2019
75-79,61.9,86.2,146,Incidence,199153,Non-Hispanic Asian/Pacific Islander,73.3,Male,Stomach,2019
75-79,~,~,~,Incidence,199153,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
75-79,9.8,20.9,29,Incidence,199153,Non-Hispanic Asian/Pacific Islander,14.6,Male,Thyroid,2019
75-79,89.3,118.0,205,Incidence,199153,Non-Hispanic Asian/Pacific Islander,102.9,Male,Urinary Bladder,2019
80-84,1733.7,1881.1,2333,Incidence,129163,Non-Hispanic Asian/Pacific Islander,1806.2,Male,All Cancer Sites Combined,2019
80-84,8.3,22.0,18,Incidence,129163,Non-Hispanic Asian/Pacific Islander,13.9,Male,Brain and Other Nervous System,2019
80-84,157.2,204.3,232,Incidence,129163,Non-Hispanic Asian/Pacific Islander,179.6,Male,Colon and Rectum,2019
80-84,11.9,27.6,24,Incidence,129163,Non-Hispanic Asian/Pacific Islander,18.6,Male,Esophagus,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
80-84,44.3,71.1,73,Incidence,129163,Non-Hispanic Asian/Pacific Islander,56.5,Male,Kidney and Renal Pelvis,2019
80-84,7.7,21.1,17,Incidence,129163,Non-Hispanic Asian/Pacific Islander,13.2,Male,Larynx,2019
80-84,41.6,67.6,69,Incidence,129163,Non-Hispanic Asian/Pacific Islander,53.4,Male,Leukemias,2019
80-84,98.3,136.3,150,Incidence,129163,Non-Hispanic Asian/Pacific Islander,116.1,Male,Liver and Intrahepatic Bile Duct,2019
80-84,293.3,356.2,418,Incidence,129163,Non-Hispanic Asian/Pacific Islander,323.6,Male,Lung and Bronchus,2019
80-84,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
80-84,32.1,55.4,55,Incidence,129163,Non-Hispanic Asian/Pacific Islander,42.6,Male,Myeloma,2019
80-84,80.6,115.3,125,Incidence,129163,Non-Hispanic Asian/Pacific Islander,96.8,Male,Non-Hodgkin Lymphoma,2019
80-84,32.1,55.4,55,Incidence,129163,Non-Hispanic Asian/Pacific Islander,42.6,Male,Oral Cavity and Pharynx,2019
80-84,62.3,93.3,99,Incidence,129163,Non-Hispanic Asian/Pacific Islander,76.6,Male,Pancreas,2019
80-84,280.8,342.4,401,Incidence,129163,Non-Hispanic Asian/Pacific Islander,310.5,Male,Prostate,2019
80-84,78.4,112.8,122,Incidence,129163,Non-Hispanic Asian/Pacific Islander,94.5,Male,Stomach,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
80-84,118.3,159.6,178,Incidence,129163,Non-Hispanic Asian/Pacific Islander,137.8,Male,Urinary Bladder,2019
85+,1595.9,1746.7,1909,Incidence,114310,Non-Hispanic Asian/Pacific Islander,1670.0,Male,All Cancer Sites Combined,2019
85+,12.8,30.2,23,Incidence,114310,Non-Hispanic Asian/Pacific Islander,20.1,Male,Brain and Other Nervous System,2019
85+,156.4,206.6,206,Incidence,114310,Non-Hispanic Asian/Pacific Islander,180.2,Male,Colon and Rectum,2019
85+,16.3,35.4,28,Incidence,114310,Non-Hispanic Asian/Pacific Islander,24.5,Male,Esophagus,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
85+,21.3,42.6,35,Incidence,114310,Non-Hispanic Asian/Pacific Islander,30.6,Male,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
85+,40.1,67.6,60,Incidence,114310,Non-Hispanic Asian/Pacific Islander,52.5,Male,Leukemias,2019
85+,87.0,125.5,120,Incidence,114310,Non-Hispanic Asian/Pacific Islander,105.0,Male,Liver and Intrahepatic Bile Duct,2019
85+,255.1,317.9,326,Incidence,114310,Non-Hispanic Asian/Pacific Islander,285.2,Male,Lung and Bronchus,2019
85+,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
85+,22.8,44.6,37,Incidence,114310,Non-Hispanic Asian/Pacific Islander,32.4,Male,Myeloma,2019
85+,86.2,124.6,119,Incidence,114310,Non-Hispanic Asian/Pacific Islander,104.1,Male,Non-Hodgkin Lymphoma,2019
85+,25.7,48.7,41,Incidence,114310,Non-Hispanic Asian/Pacific Islander,35.9,Male,Oral Cavity and Pharynx,2019
85+,69.6,104.5,98,Incidence,114310,Non-Hispanic Asian/Pacific Islander,85.7,Male,Pancreas,2019
85+,192.4,247.6,250,Incidence,114310,Non-Hispanic Asian/Pacific Islander,218.7,Male,Prostate,2019
85+,64.9,98.7,92,Incidence,114310,Non-Hispanic Asian/Pacific Islander,80.5,Male,Stomach,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
85+,119.9,164.4,161,Incidence,114310,Non-Hispanic Asian/Pacific Islander,140.8,Male,Urinary Bladder,2019
<1,10.6,26.1,21,Incidence,123138,Non-Hispanic Asian/Pacific Islander,17.1,Male,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2019
<1,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2019
1-4,13.8,18.8,171,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,16.2,Male and Female,All Cancer Sites Combined,2019
1-4,1.7,3.7,27,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
1-4,5.4,8.7,73,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,6.9,Male and Female,Leukemias,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,512157,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
1-4,~,~,~,Incidence,545131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2019
1-4,~,~,~,Incidence,1057288,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
10-14,9.7,13.6,142,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,11.5,Male and Female,All Cancer Sites Combined,2019
10-14,1.1,2.6,21,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
10-14,1.3,3.0,25,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Leukemias,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,607475,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
10-14,~,~,~,Incidence,625982,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
10-14,0.8,2.2,17,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Thyroid,2019
10-14,~,~,~,Incidence,1233457,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
15-19,18.4,23.5,264,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,20.8,Male and Female,All Cancer Sites Combined,2019
15-19,1.3,3.0,26,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
15-19,1.5,3.2,28,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
15-19,1.9,3.8,34,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Leukemias,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
15-19,1.4,3.1,27,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,630634,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
15-19,~,~,~,Incidence,636316,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
15-19,3.2,5.6,54,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Thyroid,2019
15-19,~,~,~,Incidence,1266950,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
20-24,29.8,35.9,458,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,32.8,Male and Female,All Cancer Sites Combined,2019
20-24,1.0,2.5,23,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
20-24,1.3,3.8,16,Incidence,690547,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Female Breast,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
20-24,2.8,5.0,53,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
20-24,2.7,4.7,50,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Leukemias,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
20-24,1.3,3.8,16,Incidence,690547,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Male and Female Breast,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
20-24,1.6,3.2,32,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,690547,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
20-24,~,~,~,Incidence,707319,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
20-24,4.0,7.7,40,Incidence,707319,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,Testis,2019
20-24,6.5,9.5,110,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Thyroid,2019
20-24,~,~,~,Incidence,1397866,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
25-29,41.0,47.4,759,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,44.1,Male and Female,All Cancer Sites Combined,2019
25-29,1.1,2.4,29,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Brain and Other Nervous System,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
25-29,1.8,3.4,43,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Colon and Rectum,2019
25-29,1.5,3.7,21,Incidence,862785,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
25-29,6.3,10.3,70,Incidence,862785,Non-Hispanic Asian/Pacific Islander,8.1,Male and Female,Female Breast,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
25-29,1.7,3.2,41,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
25-29,0.6,1.6,17,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,1.0,Male and Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
25-29,1.4,2.8,35,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Leukemias,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
25-29,6.3,10.3,70,Incidence,862785,Non-Hispanic Asian/Pacific Islander,8.1,Male and Female,Male and Female Breast,2019
25-29,~,~,~,Incidence,862785,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
25-29,2.0,3.6,46,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Non-Hodgkin Lymphoma,2019
25-29,0.7,1.8,20,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Oral Cavity and Pharynx,2019
25-29,3.0,5.9,37,Incidence,862785,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Ovary,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
25-29,~,~,~,Incidence,857639,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
25-29,3.9,7.2,46,Incidence,857639,Non-Hispanic Asian/Pacific Islander,5.4,Male and Female,Testis,2019
25-29,11.7,15.2,230,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,13.4,Male and Female,Thyroid,2019
25-29,~,~,~,Incidence,1720424,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
30-34,71.9,80.0,1368,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,75.8,Male and Female,All Cancer Sites Combined,2019
30-34,1.6,3.1,41,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Brain and Other Nervous System,2019
30-34,4.2,7.3,52,Incidence,928958,Non-Hispanic Asian/Pacific Islander,5.6,Male and Female,Cervix,2019
30-34,4.4,6.6,97,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,5.4,Male and Female,Colon and Rectum,2019
30-34,6.0,9.6,71,Incidence,928958,Non-Hispanic Asian/Pacific Islander,7.6,Male and Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
30-34,21.9,28.4,232,Incidence,928958,Non-Hispanic Asian/Pacific Islander,25.0,Male and Female,Female Breast,2019
30-34,2.0,4.4,28,Incidence,928958,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,"Female Breast, <i>in situ</i>",2019
30-34,1.5,3.0,39,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
30-34,0.9,2.0,25,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
30-34,1.9,3.5,47,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Leukemias,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
30-34,0.9,2.1,26,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Lung and Bronchus,2019
30-34,21.9,28.4,232,Incidence,928958,Non-Hispanic Asian/Pacific Islander,25.0,Male and Female,Male and Female Breast,2019
30-34,2.0,4.4,28,Incidence,928958,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
30-34,3.4,5.3,77,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Non-Hodgkin Lymphoma,2019
30-34,2.4,4.2,58,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,3.2,Male and Female,Oral Cavity and Pharynx,2019
30-34,2.4,5.0,33,Incidence,928958,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Ovary,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
30-34,~,~,~,Incidence,875160,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
30-34,0.7,1.8,21,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Stomach,2019
30-34,4.4,7.8,52,Incidence,875160,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Testis,2019
30-34,15.8,19.8,320,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,17.7,Male and Female,Thyroid,2019
30-34,~,~,~,Incidence,1804118,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
35-39,109.8,119.9,1995,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,114.7,Male and Female,All Cancer Sites Combined,2019
35-39,1.7,3.2,41,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Brain and Other Nervous System,2019
35-39,6.5,10.4,76,Incidence,914305,Non-Hispanic Asian/Pacific Islander,8.3,Male and Female,Cervix,2019
35-39,7.4,10.2,151,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,8.7,Male and Female,Colon and Rectum,2019
35-39,9.7,14.3,108,Incidence,914305,Non-Hispanic Asian/Pacific Islander,11.8,Male and Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
35-39,55.8,66.0,555,Incidence,914305,Non-Hispanic Asian/Pacific Islander,60.7,Male and Female,Female Breast,2019
35-39,8.7,13.1,98,Incidence,914305,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,"Female Breast, <i>in situ</i>",2019
35-39,0.9,2.1,24,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
35-39,2.0,3.7,48,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
35-39,2.9,4.8,66,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Leukemias,2019
35-39,1.5,2.9,37,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
35-39,2.0,3.7,48,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Lung and Bronchus,2019
35-39,55.8,66.0,555,Incidence,914305,Non-Hispanic Asian/Pacific Islander,60.7,Male and Female,Male and Female Breast,2019
35-39,8.7,13.1,98,Incidence,914305,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
35-39,4.3,6.6,93,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,5.3,Male and Female,Non-Hodgkin Lymphoma,2019
35-39,3.0,4.9,67,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,3.9,Male and Female,Oral Cavity and Pharynx,2019
35-39,2.5,5.1,33,Incidence,914305,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Ovary,2019
35-39,~,~,~,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
35-39,~,~,~,Incidence,824406,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
35-39,1.1,2.4,29,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Stomach,2019
35-39,2.3,4.9,28,Incidence,824406,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Testis,2019
35-39,20.0,24.5,385,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,22.1,Male and Female,Thyroid,2019
35-39,0.6,1.6,18,Incidence,1738711,Non-Hispanic Asian/Pacific Islander,1.0,Male and Female,Urinary Bladder,2019
40-44,184.3,198.1,2973,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,191.1,Male and Female,All Cancer Sites Combined,2019
40-44,1.9,3.6,41,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Brain and Other Nervous System,2019
40-44,7.1,11.3,75,Incidence,828955,Non-Hispanic Asian/Pacific Islander,9.0,Male and Female,Cervix,2019
40-44,15.6,19.8,274,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,17.6,Male and Female,Colon and Rectum,2019
40-44,15.3,21.2,150,Incidence,828955,Non-Hispanic Asian/Pacific Islander,18.1,Male and Female,"Corpus and Uterus, NOS",2019
40-44,~,~,~,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
40-44,124.2,139.9,1093,Incidence,828955,Non-Hispanic Asian/Pacific Islander,131.9,Male and Female,Female Breast,2019
40-44,42.7,52.2,392,Incidence,828955,Non-Hispanic Asian/Pacific Islander,47.3,Male and Female,"Female Breast, <i>in situ</i>",2019
40-44,0.6,1.7,16,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,1.0,Male and Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
40-44,4.5,6.9,87,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,5.6,Male and Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
40-44,2.3,4.1,48,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,3.1,Male and Female,Leukemias,2019
40-44,2.8,4.7,57,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
40-44,5.1,7.6,97,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,6.2,Male and Female,Lung and Bronchus,2019
40-44,124.2,139.9,1093,Incidence,828955,Non-Hispanic Asian/Pacific Islander,131.9,Male and Female,Male and Female Breast,2019
40-44,42.7,52.2,392,Incidence,828955,Non-Hispanic Asian/Pacific Islander,47.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
40-44,~,~,~,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
40-44,1.0,2.3,24,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,1.5,Male and Female,Myeloma,2019
40-44,4.7,7.2,91,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Non-Hodgkin Lymphoma,2019
40-44,5.2,7.7,99,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,6.4,Male and Female,Oral Cavity and Pharynx,2019
40-44,7.2,11.5,76,Incidence,828955,Non-Hispanic Asian/Pacific Islander,9.2,Male and Female,Ovary,2019
40-44,1.4,2.8,31,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,2.0,Male and Female,Pancreas,2019
40-44,~,~,~,Incidence,726540,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
40-44,2.4,4.2,50,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,3.2,Male and Female,Stomach,2019
40-44,2.1,4.9,24,Incidence,726540,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,Testis,2019
40-44,22.3,27.3,384,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,24.7,Male and Female,Thyroid,2019
40-44,1.2,2.7,29,Incidence,1555495,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Urinary Bladder,2019
45-49,286.2,303.6,4451,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,294.8,Male and Female,All Cancer Sites Combined,2019
45-49,2.7,4.7,54,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Brain and Other Nervous System,2019
45-49,10.1,15.1,100,Incidence,802835,Non-Hispanic Asian/Pacific Islander,12.5,Male and Female,Cervix,2019
45-49,24.1,29.4,403,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,26.7,Male and Female,Colon and Rectum,2019
45-49,28.8,36.8,262,Incidence,802835,Non-Hispanic Asian/Pacific Islander,32.6,Male and Female,"Corpus and Uterus, NOS",2019
45-49,0.7,1.9,18,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Esophagus,2019
45-49,204.2,224.6,1720,Incidence,802835,Non-Hispanic Asian/Pacific Islander,214.2,Male and Female,Female Breast,2019
45-49,64.9,76.7,567,Incidence,802835,Non-Hispanic Asian/Pacific Islander,70.6,Male and Female,"Female Breast, <i>in situ</i>",2019
45-49,~,~,~,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
45-49,7.4,10.4,133,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,8.8,Male and Female,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
45-49,4.7,7.3,89,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Leukemias,2019
45-49,4.0,6.4,77,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,5.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
45-49,11.7,15.4,203,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,13.4,Male and Female,Lung and Bronchus,2019
45-49,204.2,224.6,1720,Incidence,802835,Non-Hispanic Asian/Pacific Islander,214.2,Male and Female,Male and Female Breast,2019
45-49,64.9,76.7,567,Incidence,802835,Non-Hispanic Asian/Pacific Islander,70.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
45-49,~,~,~,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
45-49,1.8,3.5,38,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Myeloma,2019
45-49,7.1,10.1,128,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Non-Hodgkin Lymphoma,2019
45-49,9.4,12.9,167,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Oral Cavity and Pharynx,2019
45-49,13.1,18.7,126,Incidence,802835,Non-Hispanic Asian/Pacific Islander,15.7,Male and Female,Ovary,2019
45-49,4.1,6.5,79,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,5.2,Male and Female,Pancreas,2019
45-49,7.0,11.6,64,Incidence,706939,Non-Hispanic Asian/Pacific Islander,9.1,Male and Female,Prostate,2019
45-49,4.1,6.5,79,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,5.2,Male and Female,Stomach,2019
45-49,1.5,4.0,18,Incidence,706939,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Testis,2019
45-49,22.8,28.0,382,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,25.3,Male and Female,Thyroid,2019
45-49,1.7,3.3,36,Incidence,1509774,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Urinary Bladder,2019
5-9,9.4,13.1,145,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,11.2,Male and Female,All Cancer Sites Combined,2019
5-9,1.6,3.3,30,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
5-9,2.7,4.9,48,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Leukemias,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
5-9,0.8,2.1,17,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,633257,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
5-9,~,~,~,Incidence,666541,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2019
5-9,~,~,~,Incidence,1299798,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
50-54,401.5,423.8,5311,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,412.5,Male and Female,All Cancer Sites Combined,2019
50-54,3.0,5.3,52,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Brain and Other Nervous System,2019
50-54,8.7,13.9,76,Incidence,686382,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Cervix,2019
50-54,53.8,62.2,745,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,57.9,Male and Female,Colon and Rectum,2019
50-54,47.2,58.2,360,Incidence,686382,Non-Hispanic Asian/Pacific Islander,52.4,Male and Female,"Corpus and Uterus, NOS",2019
50-54,1.5,3.2,29,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Esophagus,2019
50-54,217.6,240.3,1570,Incidence,686382,Non-Hispanic Asian/Pacific Islander,228.7,Male and Female,Female Breast,2019
50-54,70.2,83.5,526,Incidence,686382,Non-Hispanic Asian/Pacific Islander,76.6,Male and Female,"Female Breast, <i>in situ</i>",2019
50-54,0.8,2.2,18,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,1.4,Male and Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
50-54,9.4,13.1,143,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Kidney and Renal Pelvis,2019
50-54,~,~,~,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
50-54,6.4,9.5,101,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,7.8,Male and Female,Leukemias,2019
50-54,8.4,11.9,129,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,10.0,Male and Female,Liver and Intrahepatic Bile Duct,2019
50-54,23.1,28.7,332,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,25.8,Male and Female,Lung and Bronchus,2019
50-54,217.6,240.3,1570,Incidence,686382,Non-Hispanic Asian/Pacific Islander,228.7,Male and Female,Male and Female Breast,2019
50-54,70.2,83.5,526,Incidence,686382,Non-Hispanic Asian/Pacific Islander,76.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
50-54,0.7,2.0,16,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,1.2,Male and Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
50-54,3.4,5.8,58,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,4.5,Male and Female,Myeloma,2019
50-54,11.2,15.3,169,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,13.1,Male and Female,Non-Hodgkin Lymphoma,2019
50-54,12.7,17.0,190,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,14.8,Male and Female,Oral Cavity and Pharynx,2019
50-54,18.1,25.2,147,Incidence,686382,Non-Hispanic Asian/Pacific Islander,21.4,Male and Female,Ovary,2019
50-54,7.1,10.4,111,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Pancreas,2019
50-54,35.7,46.0,244,Incidence,601055,Non-Hispanic Asian/Pacific Islander,40.6,Male and Female,Prostate,2019
50-54,7.8,11.2,121,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,9.4,Male and Female,Stomach,2019
50-54,~,~,~,Incidence,601055,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
50-54,24.8,30.6,355,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,27.6,Male and Female,Thyroid,2019
50-54,3.9,6.4,65,Incidence,1287437,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Urinary Bladder,2019
55-59,541.6,568.4,6633,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,554.9,Male and Female,All Cancer Sites Combined,2019
55-59,3.9,6.6,61,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,5.1,Male and Female,Brain and Other Nervous System,2019
55-59,9.6,15.1,78,Incidence,643697,Non-Hispanic Asian/Pacific Islander,12.1,Male and Female,Cervix,2019
55-59,52.8,61.4,681,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,57.0,Male and Female,Colon and Rectum,2019
55-59,63.4,76.5,449,Incidence,643697,Non-Hispanic Asian/Pacific Islander,69.8,Male and Female,"Corpus and Uterus, NOS",2019
55-59,2.8,5.1,46,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Esophagus,2019
55-59,227.4,251.5,1540,Incidence,643697,Non-Hispanic Asian/Pacific Islander,239.2,Male and Female,Female Breast,2019
55-59,67.5,80.9,476,Incidence,643697,Non-Hispanic Asian/Pacific Islander,73.9,Male and Female,"Female Breast, <i>in situ</i>",2019
55-59,~,~,~,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
55-59,16.2,21.2,222,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,18.6,Male and Female,Kidney and Renal Pelvis,2019
55-59,1.6,3.5,29,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Larynx,2019
55-59,9.7,13.6,138,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,11.5,Male and Female,Leukemias,2019
55-59,18.6,23.8,252,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
55-59,46.4,54.5,602,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,50.4,Male and Female,Lung and Bronchus,2019
55-59,227.4,251.5,1540,Incidence,643697,Non-Hispanic Asian/Pacific Islander,239.2,Male and Female,Male and Female Breast,2019
55-59,67.5,80.9,476,Incidence,643697,Non-Hispanic Asian/Pacific Islander,73.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
55-59,1.5,3.3,27,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
55-59,6.2,9.4,92,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,7.7,Male and Female,Myeloma,2019
55-59,18.8,24.1,255,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,21.3,Male and Female,Non-Hodgkin Lymphoma,2019
55-59,17.0,22.1,232,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,19.4,Male and Female,Oral Cavity and Pharynx,2019
55-59,22.0,30.0,166,Incidence,643697,Non-Hispanic Asian/Pacific Islander,25.8,Male and Female,Ovary,2019
55-59,10.2,14.2,144,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,12.0,Male and Female,Pancreas,2019
55-59,96.6,113.8,579,Incidence,551754,Non-Hispanic Asian/Pacific Islander,104.9,Male and Female,Prostate,2019
55-59,13.0,17.5,181,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,15.1,Male and Female,Stomach,2019
55-59,~,~,~,Incidence,551754,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
55-59,23.0,28.8,308,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,25.8,Male and Female,Thyroid,2019
55-59,6.4,9.7,95,Incidence,1195451,Non-Hispanic Asian/Pacific Islander,7.9,Male and Female,Urinary Bladder,2019
60-64,732.9,765.9,7960,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,749.2,Male and Female,All Cancer Sites Combined,2019
60-64,4.7,7.8,65,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,6.1,Male and Female,Brain and Other Nervous System,2019
60-64,9.1,14.8,68,Incidence,582918,Non-Hispanic Asian/Pacific Islander,11.7,Male and Female,Cervix,2019
60-64,66.0,76.2,754,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,71.0,Male and Female,Colon and Rectum,2019
60-64,64.3,78.2,414,Incidence,582918,Non-Hispanic Asian/Pacific Islander,71.0,Male and Female,"Corpus and Uterus, NOS",2019
60-64,4.7,7.8,65,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,6.1,Male and Female,Esophagus,2019
60-64,263.7,290.9,1615,Incidence,582918,Non-Hispanic Asian/Pacific Islander,277.1,Male and Female,Female Breast,2019
60-64,89.4,105.6,567,Incidence,582918,Non-Hispanic Asian/Pacific Islander,97.3,Male and Female,"Female Breast, <i>in situ</i>",2019
60-64,~,~,~,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
60-64,19.4,25.1,235,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,22.1,Male and Female,Kidney and Renal Pelvis,2019
60-64,1.6,3.6,26,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Larynx,2019
60-64,13.1,17.9,163,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,15.3,Male and Female,Leukemias,2019
60-64,35.2,42.8,413,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,38.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
60-64,81.4,92.7,923,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,86.9,Male and Female,Lung and Bronchus,2019
60-64,263.7,290.9,1615,Incidence,582918,Non-Hispanic Asian/Pacific Islander,277.1,Male and Female,Male and Female Breast,2019
60-64,89.4,105.6,567,Incidence,582918,Non-Hispanic Asian/Pacific Islander,97.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
60-64,1.8,3.8,28,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
60-64,8.1,12.0,105,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,9.9,Male and Female,Myeloma,2019
60-64,27.4,34.2,326,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,30.7,Male and Female,Non-Hodgkin Lymphoma,2019
60-64,19.1,24.8,232,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,21.8,Male and Female,Oral Cavity and Pharynx,2019
60-64,18.0,25.7,126,Incidence,582918,Non-Hispanic Asian/Pacific Islander,21.6,Male and Female,Ovary,2019
60-64,17.8,23.3,217,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,20.4,Male and Female,Pancreas,2019
60-64,192.0,217.8,981,Incidence,479498,Non-Hispanic Asian/Pacific Islander,204.6,Male and Female,Prostate,2019
60-64,19.3,25.0,234,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,22.0,Male and Female,Stomach,2019
60-64,~,~,~,Incidence,479498,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
60-64,21.6,27.6,260,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,24.5,Male and Female,Thyroid,2019
60-64,12.3,17.0,154,Incidence,1062416,Non-Hispanic Asian/Pacific Islander,14.5,Male and Female,Urinary Bladder,2019
65-69,986.5,1028.2,8992,Incidence,892792,Non-Hispanic Asian/Pacific Islander,1007.2,Male and Female,All Cancer Sites Combined,2019
65-69,5.9,9.7,68,Incidence,892792,Non-Hispanic Asian/Pacific Islander,7.6,Male and Female,Brain and Other Nervous System,2019
65-69,7.4,13.2,50,Incidence,499315,Non-Hispanic Asian/Pacific Islander,10.0,Male and Female,Cervix,2019
65-69,82.6,95.1,792,Incidence,892792,Non-Hispanic Asian/Pacific Islander,88.7,Male and Female,Colon and Rectum,2019
65-69,64.8,79.9,360,Incidence,499315,Non-Hispanic Asian/Pacific Islander,72.1,Male and Female,"Corpus and Uterus, NOS",2019
65-69,7.7,11.9,86,Incidence,892792,Non-Hispanic Asian/Pacific Islander,9.6,Male and Female,Esophagus,2019
65-69,298.9,330.2,1569,Incidence,499315,Non-Hispanic Asian/Pacific Islander,314.2,Male and Female,Female Breast,2019
65-69,92.9,110.8,507,Incidence,499315,Non-Hispanic Asian/Pacific Islander,101.5,Male and Female,"Female Breast, <i>in situ</i>",2019
65-69,~,~,~,Incidence,892792,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,892792,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
65-69,27.4,34.8,276,Incidence,892792,Non-Hispanic Asian/Pacific Islander,30.9,Male and Female,Kidney and Renal Pelvis,2019
65-69,3.1,6.0,39,Incidence,892792,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Larynx,2019
65-69,16.2,22.0,169,Incidence,892792,Non-Hispanic Asian/Pacific Islander,18.9,Male and Female,Leukemias,2019
65-69,45.4,54.8,446,Incidence,892792,Non-Hispanic Asian/Pacific Islander,50.0,Male and Female,Liver and Intrahepatic Bile Duct,2019
65-69,124.2,139.4,1175,Incidence,892792,Non-Hispanic Asian/Pacific Islander,131.6,Male and Female,Lung and Bronchus,2019
65-69,298.9,330.2,1569,Incidence,499315,Non-Hispanic Asian/Pacific Islander,314.2,Male and Female,Male and Female Breast,2019
65-69,92.9,110.8,507,Incidence,499315,Non-Hispanic Asian/Pacific Islander,101.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
65-69,2.0,4.4,27,Incidence,892792,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,892792,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
65-69,12.3,17.4,131,Incidence,892792,Non-Hispanic Asian/Pacific Islander,14.7,Male and Female,Myeloma,2019
65-69,39.9,48.7,394,Incidence,892792,Non-Hispanic Asian/Pacific Islander,44.1,Male and Female,Non-Hodgkin Lymphoma,2019
65-69,20.9,27.4,214,Incidence,892792,Non-Hispanic Asian/Pacific Islander,24.0,Male and Female,Oral Cavity and Pharynx,2019
65-69,15.2,23.0,94,Incidence,499315,Non-Hispanic Asian/Pacific Islander,18.8,Male and Female,Ovary,2019
65-69,31.4,39.3,314,Incidence,892792,Non-Hispanic Asian/Pacific Islander,35.2,Male and Female,Pancreas,2019
65-69,333.2,370.5,1383,Incidence,393477,Non-Hispanic Asian/Pacific Islander,351.5,Male and Female,Prostate,2019
65-69,28.1,35.6,283,Incidence,892792,Non-Hispanic Asian/Pacific Islander,31.7,Male and Female,Stomach,2019
65-69,~,~,~,Incidence,393477,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
65-69,21.4,28.0,219,Incidence,892792,Non-Hispanic Asian/Pacific Islander,24.5,Male and Female,Thyroid,2019
65-69,24.6,31.7,250,Incidence,892792,Non-Hispanic Asian/Pacific Islander,28.0,Male and Female,Urinary Bladder,2019
70-74,1137.6,1189.0,7915,Incidence,680509,Non-Hispanic Asian/Pacific Islander,1163.1,Male and Female,All Cancer Sites Combined,2019
70-74,5.2,9.4,48,Incidence,680509,Non-Hispanic Asian/Pacific Islander,7.1,Male and Female,Brain and Other Nervous System,2019
70-74,6.9,13.4,37,Incidence,380277,Non-Hispanic Asian/Pacific Islander,9.7,Male and Female,Cervix,2019
70-74,95.5,110.9,701,Incidence,680509,Non-Hispanic Asian/Pacific Islander,103.0,Male and Female,Colon and Rectum,2019
70-74,62.0,79.2,267,Incidence,380277,Non-Hispanic Asian/Pacific Islander,70.2,Male and Female,"Corpus and Uterus, NOS",2019
70-74,6.1,10.5,55,Incidence,680509,Non-Hispanic Asian/Pacific Islander,8.1,Male and Female,Esophagus,2019
70-74,301.0,337.2,1212,Incidence,380277,Non-Hispanic Asian/Pacific Islander,318.7,Male and Female,Female Breast,2019
70-74,102.4,124.0,429,Incidence,380277,Non-Hispanic Asian/Pacific Islander,112.8,Male and Female,"Female Breast, <i>in situ</i>",2019
70-74,~,~,~,Incidence,680509,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,680509,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
70-74,28.1,36.7,219,Incidence,680509,Non-Hispanic Asian/Pacific Islander,32.2,Male and Female,Kidney and Renal Pelvis,2019
70-74,4.2,8.0,40,Incidence,680509,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Larynx,2019
70-74,20.3,27.8,162,Incidence,680509,Non-Hispanic Asian/Pacific Islander,23.8,Male and Female,Leukemias,2019
70-74,47.0,58.0,356,Incidence,680509,Non-Hispanic Asian/Pacific Islander,52.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
70-74,168.1,188.3,1211,Incidence,680509,Non-Hispanic Asian/Pacific Islander,178.0,Male and Female,Lung and Bronchus,2019
70-74,301.0,337.2,1212,Incidence,380277,Non-Hispanic Asian/Pacific Islander,318.7,Male and Female,Male and Female Breast,2019
70-74,102.4,124.0,429,Incidence,380277,Non-Hispanic Asian/Pacific Islander,112.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
70-74,4.4,8.3,42,Incidence,680509,Non-Hispanic Asian/Pacific Islander,6.2,Male and Female,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,680509,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
70-74,17.0,24.0,138,Incidence,680509,Non-Hispanic Asian/Pacific Islander,20.3,Male and Female,Myeloma,2019
70-74,44.8,55.6,340,Incidence,680509,Non-Hispanic Asian/Pacific Islander,50.0,Male and Female,Non-Hodgkin Lymphoma,2019
70-74,24.6,32.8,194,Incidence,680509,Non-Hispanic Asian/Pacific Islander,28.5,Male and Female,Oral Cavity and Pharynx,2019
70-74,16.4,25.9,79,Incidence,380277,Non-Hispanic Asian/Pacific Islander,20.8,Male and Female,Ovary,2019
70-74,39.5,49.7,302,Incidence,680509,Non-Hispanic Asian/Pacific Islander,44.4,Male and Female,Pancreas,2019
70-74,369.3,414.4,1175,Incidence,300232,Non-Hispanic Asian/Pacific Islander,391.4,Male and Female,Prostate,2019
70-74,35.8,45.5,275,Incidence,680509,Non-Hispanic Asian/Pacific Islander,40.4,Male and Female,Stomach,2019
70-74,~,~,~,Incidence,300232,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
70-74,20.4,27.9,163,Incidence,680509,Non-Hispanic Asian/Pacific Islander,24.0,Male and Female,Thyroid,2019
70-74,33.0,42.4,255,Incidence,680509,Non-Hispanic Asian/Pacific Islander,37.5,Male and Female,Urinary Bladder,2019
75-79,1303.6,1371.2,6036,Incidence,451431,Non-Hispanic Asian/Pacific Islander,1337.1,Male and Female,All Cancer Sites Combined,2019
75-79,9.0,15.6,54,Incidence,451431,Non-Hispanic Asian/Pacific Islander,12.0,Male and Female,Brain and Other Nervous System,2019
75-79,8.0,17.0,30,Incidence,252278,Non-Hispanic Asian/Pacific Islander,11.9,Male and Female,Cervix,2019
75-79,104.9,124.8,517,Incidence,451431,Non-Hispanic Asian/Pacific Islander,114.5,Male and Female,Colon and Rectum,2019
75-79,41.6,59.5,126,Incidence,252278,Non-Hispanic Asian/Pacific Islander,49.9,Male and Female,"Corpus and Uterus, NOS",2019
75-79,7.6,13.8,47,Incidence,451431,Non-Hispanic Asian/Pacific Islander,10.4,Male and Female,Esophagus,2019
75-79,264.2,306.2,718,Incidence,252278,Non-Hispanic Asian/Pacific Islander,284.6,Male and Female,Female Breast,2019
75-79,63.1,84.7,185,Incidence,252278,Non-Hispanic Asian/Pacific Islander,73.3,Male and Female,"Female Breast, <i>in situ</i>",2019
75-79,~,~,~,Incidence,451431,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,451431,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
75-79,28.9,39.9,154,Incidence,451431,Non-Hispanic Asian/Pacific Islander,34.1,Male and Female,Kidney and Renal Pelvis,2019
75-79,3.9,8.7,27,Incidence,451431,Non-Hispanic Asian/Pacific Islander,6.0,Male and Female,Larynx,2019
75-79,24.7,34.9,133,Incidence,451431,Non-Hispanic Asian/Pacific Islander,29.5,Male and Female,Leukemias,2019
75-79,54.8,69.5,279,Incidence,451431,Non-Hispanic Asian/Pacific Islander,61.8,Male and Female,Liver and Intrahepatic Bile Duct,2019
75-79,218.7,247.1,1050,Incidence,451431,Non-Hispanic Asian/Pacific Islander,232.6,Male and Female,Lung and Bronchus,2019
75-79,264.2,306.2,718,Incidence,252278,Non-Hispanic Asian/Pacific Islander,284.6,Male and Female,Male and Female Breast,2019
75-79,63.1,84.7,185,Incidence,252278,Non-Hispanic Asian/Pacific Islander,73.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
75-79,3.6,8.2,25,Incidence,451431,Non-Hispanic Asian/Pacific Islander,5.5,Male and Female,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,451431,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
75-79,17.8,26.7,99,Incidence,451431,Non-Hispanic Asian/Pacific Islander,21.9,Male and Female,Myeloma,2019
75-79,61.7,77.2,312,Incidence,451431,Non-Hispanic Asian/Pacific Islander,69.1,Male and Female,Non-Hodgkin Lymphoma,2019
75-79,21.2,30.8,116,Incidence,451431,Non-Hispanic Asian/Pacific Islander,25.7,Male and Female,Oral Cavity and Pharynx,2019
75-79,19.5,32.4,64,Incidence,252278,Non-Hispanic Asian/Pacific Islander,25.4,Male and Female,Ovary,2019
75-79,58.7,73.9,298,Incidence,451431,Non-Hispanic Asian/Pacific Islander,66.0,Male and Female,Pancreas,2019
75-79,370.5,426.4,792,Incidence,199153,Non-Hispanic Asian/Pacific Islander,397.7,Male and Female,Prostate,2019
75-79,44.8,58.2,231,Incidence,451431,Non-Hispanic Asian/Pacific Islander,51.2,Male and Female,Stomach,2019
75-79,~,~,~,Incidence,199153,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
75-79,18.2,27.2,101,Incidence,451431,Non-Hispanic Asian/Pacific Islander,22.4,Male and Female,Thyroid,2019
75-79,47.3,61.0,243,Incidence,451431,Non-Hispanic Asian/Pacific Islander,53.8,Male and Female,Urinary Bladder,2019
80-84,1411.4,1498.2,4353,Incidence,299313,Non-Hispanic Asian/Pacific Islander,1454.3,Male and Female,All Cancer Sites Combined,2019
80-84,6.8,14.3,30,Incidence,299313,Non-Hispanic Asian/Pacific Islander,10.0,Male and Female,Brain and Other Nervous System,2019
80-84,~,~,~,Incidence,170150,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
80-84,139.3,167.7,458,Incidence,299313,Non-Hispanic Asian/Pacific Islander,153.0,Male and Female,Colon and Rectum,2019
80-84,33.6,53.9,73,Incidence,170150,Non-Hispanic Asian/Pacific Islander,42.9,Male and Female,"Corpus and Uterus, NOS",2019
80-84,7.3,15.1,32,Incidence,299313,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,Esophagus,2019
80-84,223.2,271.0,419,Incidence,170150,Non-Hispanic Asian/Pacific Islander,246.3,Male and Female,Female Breast,2019
80-84,42.5,65.0,90,Incidence,170150,Non-Hispanic Asian/Pacific Islander,52.9,Male and Female,"Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,299313,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,299313,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
80-84,34.2,49.0,123,Incidence,299313,Non-Hispanic Asian/Pacific Islander,41.1,Male and Female,Kidney and Renal Pelvis,2019
80-84,3.6,9.5,18,Incidence,299313,Non-Hispanic Asian/Pacific Islander,6.0,Male and Female,Larynx,2019
80-84,30.8,45.0,112,Incidence,299313,Non-Hispanic Asian/Pacific Islander,37.4,Male and Female,Leukemias,2019
80-84,72.6,93.5,247,Incidence,299313,Non-Hispanic Asian/Pacific Islander,82.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
80-84,240.7,277.5,774,Incidence,299313,Non-Hispanic Asian/Pacific Islander,258.6,Male and Female,Lung and Bronchus,2019
80-84,223.2,271.0,419,Incidence,170150,Non-Hispanic Asian/Pacific Islander,246.3,Male and Female,Male and Female Breast,2019
80-84,42.5,65.0,90,Incidence,170150,Non-Hispanic Asian/Pacific Islander,52.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,299313,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,299313,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
80-84,28.1,41.7,103,Incidence,299313,Non-Hispanic Asian/Pacific Islander,34.4,Male and Female,Myeloma,2019
80-84,61.9,81.4,213,Incidence,299313,Non-Hispanic Asian/Pacific Islander,71.2,Male and Female,Non-Hodgkin Lymphoma,2019
80-84,24.8,37.7,92,Incidence,299313,Non-Hispanic Asian/Pacific Islander,30.7,Male and Female,Oral Cavity and Pharynx,2019
80-84,15.3,30.0,37,Incidence,170150,Non-Hispanic Asian/Pacific Islander,21.7,Male and Female,Ovary,2019
80-84,63.5,83.2,218,Incidence,299313,Non-Hispanic Asian/Pacific Islander,72.8,Male and Female,Pancreas,2019
80-84,280.8,342.4,401,Incidence,129163,Non-Hispanic Asian/Pacific Islander,310.5,Male and Female,Prostate,2019
80-84,54.8,73.2,190,Incidence,299313,Non-Hispanic Asian/Pacific Islander,63.5,Male and Female,Stomach,2019
80-84,~,~,~,Incidence,129163,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
80-84,9.8,18.6,41,Incidence,299313,Non-Hispanic Asian/Pacific Islander,13.7,Male and Female,Thyroid,2019
80-84,64.7,84.6,222,Incidence,299313,Non-Hispanic Asian/Pacific Islander,74.2,Male and Female,Urinary Bladder,2019
85+,1343.1,1427.0,4217,Incidence,304570,Non-Hispanic Asian/Pacific Islander,1384.6,Male and Female,All Cancer Sites Combined,2019
85+,8.8,17.1,38,Incidence,304570,Non-Hispanic Asian/Pacific Islander,12.5,Male and Female,Brain and Other Nervous System,2019
85+,6.4,16.2,20,Incidence,190260,Non-Hispanic Asian/Pacific Islander,10.5,Male and Female,Cervix,2019
85+,169.6,200.4,562,Incidence,304570,Non-Hispanic Asian/Pacific Islander,184.5,Male and Female,Colon and Rectum,2019
85+,20.9,36.4,53,Incidence,190260,Non-Hispanic Asian/Pacific Islander,27.9,Male and Female,"Corpus and Uterus, NOS",2019
85+,10.5,19.4,44,Incidence,304570,Non-Hispanic Asian/Pacific Islander,14.4,Male and Female,Esophagus,2019
85+,165.2,204.3,350,Incidence,190260,Non-Hispanic Asian/Pacific Islander,184.0,Male and Female,Female Breast,2019
85+,13.3,26.2,36,Incidence,190260,Non-Hispanic Asian/Pacific Islander,18.9,Male and Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,304570,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,304570,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
85+,19.1,30.5,74,Incidence,304570,Non-Hispanic Asian/Pacific Islander,24.3,Male and Female,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,304570,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
85+,30.9,45.0,114,Incidence,304570,Non-Hispanic Asian/Pacific Islander,37.4,Male and Female,Leukemias,2019
85+,63.3,82.8,221,Incidence,304570,Non-Hispanic Asian/Pacific Islander,72.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
85+,216.0,250.6,709,Incidence,304570,Non-Hispanic Asian/Pacific Islander,232.8,Male and Female,Lung and Bronchus,2019
85+,165.2,204.3,350,Incidence,190260,Non-Hispanic Asian/Pacific Islander,184.0,Male and Female,Male and Female Breast,2019
85+,13.3,26.2,36,Incidence,190260,Non-Hispanic Asian/Pacific Islander,18.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
85+,3.0,8.5,16,Incidence,304570,Non-Hispanic Asian/Pacific Islander,5.3,Male and Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,304570,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
85+,17.6,28.7,69,Incidence,304570,Non-Hispanic Asian/Pacific Islander,22.7,Male and Female,Myeloma,2019
85+,61.8,81.0,216,Incidence,304570,Non-Hispanic Asian/Pacific Islander,70.9,Male and Female,Non-Hodgkin Lymphoma,2019
85+,24.4,37.0,92,Incidence,304570,Non-Hispanic Asian/Pacific Islander,30.2,Male and Female,Oral Cavity and Pharynx,2019
85+,11.9,24.4,33,Incidence,190260,Non-Hispanic Asian/Pacific Islander,17.3,Male and Female,Ovary,2019
85+,73.8,94.7,255,Incidence,304570,Non-Hispanic Asian/Pacific Islander,83.7,Male and Female,Pancreas,2019
85+,192.4,247.6,250,Incidence,114310,Non-Hispanic Asian/Pacific Islander,218.7,Male and Female,Prostate,2019
85+,56.0,74.4,197,Incidence,304570,Non-Hispanic Asian/Pacific Islander,64.7,Male and Female,Stomach,2019
85+,~,~,~,Incidence,114310,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
85+,5.6,12.5,26,Incidence,304570,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Thyroid,2019
85+,68.2,88.4,237,Incidence,304570,Non-Hispanic Asian/Pacific Islander,77.8,Male and Female,Urinary Bladder,2019
<1,16.2,28.5,52,Incidence,239464,Non-Hispanic Asian/Pacific Islander,21.7,Male and Female,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Leukemias,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,116326,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2019
<1,~,~,~,Incidence,123138,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2019
<1,~,~,~,Incidence,239464,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2019
1-4,13.7,18.3,191,Incidence,1203197,Non-Hispanic Black,15.9,Female,All Cancer Sites Combined,2019
1-4,2.7,4.9,44,Incidence,1203197,Non-Hispanic Black,3.7,Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Cervix,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Esophagus,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Female Breast,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
1-4,1.5,3.3,27,Incidence,1203197,Non-Hispanic Black,2.2,Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Larynx,2019
1-4,2.5,4.7,42,Incidence,1203197,Non-Hispanic Black,3.5,Female,Leukemias,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Mesothelioma,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Myeloma,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Ovary,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Pancreas,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Stomach,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Thyroid,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Female,Urinary Bladder,2019
10-14,10.0,13.4,180,Incidence,1552128,Non-Hispanic Black,11.6,Female,All Cancer Sites Combined,2019
10-14,1.8,3.4,39,Incidence,1552128,Non-Hispanic Black,2.5,Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Cervix,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Esophagus,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Female Breast,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Larynx,2019
10-14,1.2,2.6,28,Incidence,1552128,Non-Hispanic Black,1.8,Female,Leukemias,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Mesothelioma,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Myeloma,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2019
10-14,0.6,1.7,16,Incidence,1552128,Non-Hispanic Black,1.0,Female,Ovary,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Pancreas,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Stomach,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Thyroid,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Female,Urinary Bladder,2019
15-19,14.8,19.0,260,Incidence,1548518,Non-Hispanic Black,16.8,Female,All Cancer Sites Combined,2019
15-19,0.8,2.1,21,Incidence,1548518,Non-Hispanic Black,1.4,Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Cervix,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Esophagus,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Female Breast,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2019
15-19,1.7,3.4,38,Incidence,1548518,Non-Hispanic Black,2.5,Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Larynx,2019
15-19,0.9,2.2,23,Incidence,1548518,Non-Hispanic Black,1.5,Female,Leukemias,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Mesothelioma,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Myeloma,2019
15-19,0.7,1.8,18,Incidence,1548518,Non-Hispanic Black,1.2,Female,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2019
15-19,0.6,1.7,16,Incidence,1548518,Non-Hispanic Black,1.0,Female,Ovary,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Pancreas,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Stomach,2019
15-19,1.5,3.1,34,Incidence,1548518,Non-Hispanic Black,2.2,Female,Thyroid,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Female,Urinary Bladder,2019
20-24,23.3,28.3,415,Incidence,1615594,Non-Hispanic Black,25.7,Female,All Cancer Sites Combined,2019
20-24,1.1,2.4,26,Incidence,1615594,Non-Hispanic Black,1.6,Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Cervix,2019
20-24,1.0,2.2,24,Incidence,1615594,Non-Hispanic Black,1.5,Female,Colon and Rectum,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Esophagus,2019
20-24,2.1,3.8,46,Incidence,1615594,Non-Hispanic Black,2.8,Female,Female Breast,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2019
20-24,2.4,4.2,51,Incidence,1615594,Non-Hispanic Black,3.2,Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Larynx,2019
20-24,1.3,2.7,31,Incidence,1615594,Non-Hispanic Black,1.9,Female,Leukemias,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Mesothelioma,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Myeloma,2019
20-24,1.8,3.4,41,Incidence,1615594,Non-Hispanic Black,2.5,Female,Non-Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Ovary,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Pancreas,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Stomach,2019
20-24,2.1,3.9,47,Incidence,1615594,Non-Hispanic Black,2.9,Female,Thyroid,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Female,Urinary Bladder,2019
25-29,51.8,58.7,1003,Incidence,1817610,Non-Hispanic Black,55.2,Female,All Cancer Sites Combined,2019
25-29,0.7,1.7,20,Incidence,1817610,Non-Hispanic Black,1.1,Female,Brain and Other Nervous System,2019
25-29,3.6,5.6,82,Incidence,1817610,Non-Hispanic Black,4.5,Female,Cervix,2019
25-29,2.6,4.4,62,Incidence,1817610,Non-Hispanic Black,3.4,Female,Colon and Rectum,2019
25-29,1.5,2.9,38,Incidence,1817610,Non-Hispanic Black,2.1,Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Esophagus,2019
25-29,12.7,16.2,261,Incidence,1817610,Non-Hispanic Black,14.4,Female,Female Breast,2019
25-29,1.0,2.2,27,Incidence,1817610,Non-Hispanic Black,1.5,Female,"Female Breast, <i>in situ</i>",2019
25-29,2.3,4.0,56,Incidence,1817610,Non-Hispanic Black,3.1,Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
25-29,0.8,2.0,24,Incidence,1817610,Non-Hispanic Black,1.3,Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Larynx,2019
25-29,1.6,3.0,40,Incidence,1817610,Non-Hispanic Black,2.2,Female,Leukemias,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Mesothelioma,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Myeloma,2019
25-29,3.3,5.2,76,Incidence,1817610,Non-Hispanic Black,4.2,Female,Non-Hodgkin Lymphoma,2019
25-29,0.6,1.6,19,Incidence,1817610,Non-Hispanic Black,1.0,Female,Oral Cavity and Pharynx,2019
25-29,1.6,3.0,40,Incidence,1817610,Non-Hispanic Black,2.2,Female,Ovary,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Pancreas,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Stomach,2019
25-29,5.9,8.4,128,Incidence,1817610,Non-Hispanic Black,7.0,Female,Thyroid,2019
25-29,~,~,~,Incidence,1817610,Non-Hispanic Black,~,Female,Urinary Bladder,2019
30-34,99.1,109.1,1669,Incidence,1604608,Non-Hispanic Black,104.0,Female,All Cancer Sites Combined,2019
30-34,1.0,2.2,24,Incidence,1604608,Non-Hispanic Black,1.5,Female,Brain and Other Nervous System,2019
30-34,7.7,10.8,147,Incidence,1604608,Non-Hispanic Black,9.2,Female,Cervix,2019
30-34,5.3,7.9,104,Incidence,1604608,Non-Hispanic Black,6.5,Female,Colon and Rectum,2019
30-34,3.2,5.3,67,Incidence,1604608,Non-Hispanic Black,4.2,Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Esophagus,2019
30-34,34.3,40.4,598,Incidence,1604608,Non-Hispanic Black,37.3,Female,Female Breast,2019
30-34,3.0,5.0,63,Incidence,1604608,Non-Hispanic Black,3.9,Female,"Female Breast, <i>in situ</i>",2019
30-34,2.9,4.9,61,Incidence,1604608,Non-Hispanic Black,3.8,Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
30-34,2.0,3.8,45,Incidence,1604608,Non-Hispanic Black,2.8,Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Larynx,2019
30-34,2.5,4.3,53,Incidence,1604608,Non-Hispanic Black,3.3,Female,Leukemias,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
30-34,0.8,1.9,20,Incidence,1604608,Non-Hispanic Black,1.2,Female,Lung and Bronchus,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Mesothelioma,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Myeloma,2019
30-34,3.7,5.9,76,Incidence,1604608,Non-Hispanic Black,4.7,Female,Non-Hodgkin Lymphoma,2019
30-34,1.1,2.4,27,Incidence,1604608,Non-Hispanic Black,1.7,Female,Oral Cavity and Pharynx,2019
30-34,2.2,4.0,48,Incidence,1604608,Non-Hispanic Black,3.0,Female,Ovary,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Pancreas,2019
30-34,0.7,1.8,18,Incidence,1604608,Non-Hispanic Black,1.1,Female,Stomach,2019
30-34,8.9,12.1,167,Incidence,1604608,Non-Hispanic Black,10.4,Female,Thyroid,2019
30-34,~,~,~,Incidence,1604608,Non-Hispanic Black,~,Female,Urinary Bladder,2019
35-39,171.5,185.1,2677,Incidence,1502140,Non-Hispanic Black,178.2,Female,All Cancer Sites Combined,2019
35-39,1.4,2.9,31,Incidence,1502140,Non-Hispanic Black,2.1,Female,Brain and Other Nervous System,2019
35-39,11.3,15.0,196,Incidence,1502140,Non-Hispanic Black,13.0,Female,Cervix,2019
35-39,9.8,13.3,172,Incidence,1502140,Non-Hispanic Black,11.5,Female,Colon and Rectum,2019
35-39,7.0,10.1,127,Incidence,1502140,Non-Hispanic Black,8.5,Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Esophagus,2019
35-39,69.1,77.8,1102,Incidence,1502140,Non-Hispanic Black,73.4,Female,Female Breast,2019
35-39,8.2,11.4,146,Incidence,1502140,Non-Hispanic Black,9.7,Female,"Female Breast, <i>in situ</i>",2019
35-39,2.8,4.8,55,Incidence,1502140,Non-Hispanic Black,3.7,Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
35-39,4.6,7.1,86,Incidence,1502140,Non-Hispanic Black,5.7,Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Larynx,2019
35-39,3.4,5.6,66,Incidence,1502140,Non-Hispanic Black,4.4,Female,Leukemias,2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
35-39,2.3,4.2,47,Incidence,1502140,Non-Hispanic Black,3.1,Female,Lung and Bronchus,2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Mesothelioma,2019
35-39,1.5,3.1,33,Incidence,1502140,Non-Hispanic Black,2.2,Female,Myeloma,2019
35-39,5.4,8.1,100,Incidence,1502140,Non-Hispanic Black,6.7,Female,Non-Hodgkin Lymphoma,2019
35-39,1.7,3.3,36,Incidence,1502140,Non-Hispanic Black,2.4,Female,Oral Cavity and Pharynx,2019
35-39,3.1,5.2,61,Incidence,1502140,Non-Hispanic Black,4.1,Female,Ovary,2019
35-39,1.0,2.4,24,Incidence,1502140,Non-Hispanic Black,1.6,Female,Pancreas,2019
35-39,1.3,2.8,29,Incidence,1502140,Non-Hispanic Black,1.9,Female,Stomach,2019
35-39,12.9,16.9,222,Incidence,1502140,Non-Hispanic Black,14.8,Female,Thyroid,2019
35-39,~,~,~,Incidence,1502140,Non-Hispanic Black,~,Female,Urinary Bladder,2019
40-44,268.1,285.8,3816,Incidence,1378352,Non-Hispanic Black,276.9,Female,All Cancer Sites Combined,2019
40-44,2.1,4.0,41,Incidence,1378352,Non-Hispanic Black,3.0,Female,Brain and Other Nervous System,2019
40-44,11.9,15.9,190,Incidence,1378352,Non-Hispanic Black,13.8,Female,Cervix,2019
40-44,17.5,22.2,272,Incidence,1378352,Non-Hispanic Black,19.7,Female,Colon and Rectum,2019
40-44,10.0,13.7,162,Incidence,1378352,Non-Hispanic Black,11.8,Female,"Corpus and Uterus, NOS",2019
40-44,~,~,~,Incidence,1378352,Non-Hispanic Black,~,Female,Esophagus,2019
40-44,125.8,138.0,1817,Incidence,1378352,Non-Hispanic Black,131.8,Female,Female Breast,2019
40-44,33.2,39.6,500,Incidence,1378352,Non-Hispanic Black,36.3,Female,"Female Breast, <i>in situ</i>",2019
40-44,1.8,3.6,36,Incidence,1378352,Non-Hispanic Black,2.6,Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,1378352,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
40-44,6.4,9.5,108,Incidence,1378352,Non-Hispanic Black,7.8,Female,Kidney and Renal Pelvis,2019
40-44,~,~,~,Incidence,1378352,Non-Hispanic Black,~,Female,Larynx,2019
40-44,4.0,6.5,71,Incidence,1378352,Non-Hispanic Black,5.2,Female,Leukemias,2019
40-44,0.7,1.9,16,Incidence,1378352,Non-Hispanic Black,1.2,Female,Liver and Intrahepatic Bile Duct,2019
40-44,4.4,7.0,77,Incidence,1378352,Non-Hispanic Black,5.6,Female,Lung and Bronchus,2019
40-44,~,~,~,Incidence,1378352,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,1378352,Non-Hispanic Black,~,Female,Mesothelioma,2019
40-44,4.4,7.0,77,Incidence,1378352,Non-Hispanic Black,5.6,Female,Myeloma,2019
40-44,6.8,9.9,114,Incidence,1378352,Non-Hispanic Black,8.3,Female,Non-Hodgkin Lymphoma,2019
40-44,2.6,4.6,48,Incidence,1378352,Non-Hispanic Black,3.5,Female,Oral Cavity and Pharynx,2019
40-44,4.3,6.9,76,Incidence,1378352,Non-Hispanic Black,5.5,Female,Ovary,2019
40-44,3.1,5.3,56,Incidence,1378352,Non-Hispanic Black,4.1,Female,Pancreas,2019
40-44,2.7,4.8,50,Incidence,1378352,Non-Hispanic Black,3.6,Female,Stomach,2019
40-44,15.6,20.1,245,Incidence,1378352,Non-Hispanic Black,17.8,Female,Thyroid,2019
40-44,~,~,~,Incidence,1378352,Non-Hispanic Black,~,Female,Urinary Bladder,2019
45-49,411.5,433.1,5900,Incidence,1397512,Non-Hispanic Black,422.2,Female,All Cancer Sites Combined,2019
45-49,1.9,3.6,37,Incidence,1397512,Non-Hispanic Black,2.6,Female,Brain and Other Nervous System,2019
45-49,12.4,16.4,200,Incidence,1397512,Non-Hispanic Black,14.3,Female,Cervix,2019
45-49,34.2,40.7,522,Incidence,1397512,Non-Hispanic Black,37.4,Female,Colon and Rectum,2019
45-49,18.8,23.7,295,Incidence,1397512,Non-Hispanic Black,21.1,Female,"Corpus and Uterus, NOS",2019
45-49,0.7,1.9,16,Incidence,1397512,Non-Hispanic Black,1.1,Female,Esophagus,2019
45-49,189.4,204.2,2749,Incidence,1397512,Non-Hispanic Black,196.7,Female,Female Breast,2019
45-49,45.8,53.2,690,Incidence,1397512,Non-Hispanic Black,49.4,Female,"Female Breast, <i>in situ</i>",2019
45-49,2.0,3.8,39,Incidence,1397512,Non-Hispanic Black,2.8,Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,1397512,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
45-49,10.3,14.1,169,Incidence,1397512,Non-Hispanic Black,12.1,Female,Kidney and Renal Pelvis,2019
45-49,~,~,~,Incidence,1397512,Non-Hispanic Black,~,Female,Larynx,2019
45-49,6.3,9.3,107,Incidence,1397512,Non-Hispanic Black,7.7,Female,Leukemias,2019
45-49,1.6,3.3,33,Incidence,1397512,Non-Hispanic Black,2.4,Female,Liver and Intrahepatic Bile Duct,2019
45-49,11.9,15.9,193,Incidence,1397512,Non-Hispanic Black,13.8,Female,Lung and Bronchus,2019
45-49,0.7,1.9,17,Incidence,1397512,Non-Hispanic Black,1.2,Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,1397512,Non-Hispanic Black,~,Female,Mesothelioma,2019
45-49,8.5,11.9,141,Incidence,1397512,Non-Hispanic Black,10.1,Female,Myeloma,2019
45-49,11.6,15.5,188,Incidence,1397512,Non-Hispanic Black,13.5,Female,Non-Hodgkin Lymphoma,2019
45-49,3.9,6.3,70,Incidence,1397512,Non-Hispanic Black,5.0,Female,Oral Cavity and Pharynx,2019
45-49,8.4,11.8,140,Incidence,1397512,Non-Hispanic Black,10.0,Female,Ovary,2019
45-49,7.1,10.3,120,Incidence,1397512,Non-Hispanic Black,8.6,Female,Pancreas,2019
45-49,5.4,8.2,93,Incidence,1397512,Non-Hispanic Black,6.7,Female,Stomach,2019
45-49,18.0,22.8,284,Incidence,1397512,Non-Hispanic Black,20.3,Female,Thyroid,2019
45-49,1.4,3.1,30,Incidence,1397512,Non-Hispanic Black,2.1,Female,Urinary Bladder,2019
5-9,8.6,11.9,155,Incidence,1520994,Non-Hispanic Black,10.2,Female,All Cancer Sites Combined,2019
5-9,1.9,3.6,40,Incidence,1520994,Non-Hispanic Black,2.6,Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Cervix,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Esophagus,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Female Breast,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Larynx,2019
5-9,1.7,3.4,37,Incidence,1520994,Non-Hispanic Black,2.4,Female,Leukemias,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Mesothelioma,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Myeloma,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Ovary,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Pancreas,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Stomach,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Thyroid,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Female,Urinary Bladder,2019
50-54,582.2,608.0,8198,Incidence,1377812,Non-Hispanic Black,595.0,Female,All Cancer Sites Combined,2019
50-54,2.7,4.8,50,Incidence,1377812,Non-Hispanic Black,3.6,Female,Brain and Other Nervous System,2019
50-54,13.3,17.5,211,Incidence,1377812,Non-Hispanic Black,15.3,Female,Cervix,2019
50-54,64.6,73.4,949,Incidence,1377812,Non-Hispanic Black,68.9,Female,Colon and Rectum,2019
50-54,33.8,40.3,509,Incidence,1377812,Non-Hispanic Black,36.9,Female,"Corpus and Uterus, NOS",2019
50-54,2.6,4.6,48,Incidence,1377812,Non-Hispanic Black,3.5,Female,Esophagus,2019
50-54,235.0,251.5,3350,Incidence,1377812,Non-Hispanic Black,243.1,Female,Female Breast,2019
50-54,56.6,64.9,835,Incidence,1377812,Non-Hispanic Black,60.6,Female,"Female Breast, <i>in situ</i>",2019
50-54,2.4,4.4,45,Incidence,1377812,Non-Hispanic Black,3.3,Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,1377812,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
50-54,18.3,23.2,284,Incidence,1377812,Non-Hispanic Black,20.6,Female,Kidney and Renal Pelvis,2019
50-54,1.2,2.8,26,Incidence,1377812,Non-Hispanic Black,1.9,Female,Larynx,2019
50-54,9.1,12.7,149,Incidence,1377812,Non-Hispanic Black,10.8,Female,Leukemias,2019
50-54,3.7,6.1,66,Incidence,1377812,Non-Hispanic Black,4.8,Female,Liver and Intrahepatic Bile Duct,2019
50-54,32.3,38.6,487,Incidence,1377812,Non-Hispanic Black,35.3,Female,Lung and Bronchus,2019
50-54,0.9,2.3,21,Incidence,1377812,Non-Hispanic Black,1.5,Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,1377812,Non-Hispanic Black,~,Female,Mesothelioma,2019
50-54,13.7,18.0,217,Incidence,1377812,Non-Hispanic Black,15.7,Female,Myeloma,2019
50-54,13.7,17.9,216,Incidence,1377812,Non-Hispanic Black,15.7,Female,Non-Hodgkin Lymphoma,2019
50-54,7.1,10.3,118,Incidence,1377812,Non-Hispanic Black,8.6,Female,Oral Cavity and Pharynx,2019
50-54,9.3,12.9,152,Incidence,1377812,Non-Hispanic Black,11.0,Female,Ovary,2019
50-54,11.8,15.7,188,Incidence,1377812,Non-Hispanic Black,13.6,Female,Pancreas,2019
50-54,7.5,10.7,124,Incidence,1377812,Non-Hispanic Black,9.0,Female,Stomach,2019
50-54,17.3,22.1,270,Incidence,1377812,Non-Hispanic Black,19.6,Female,Thyroid,2019
50-54,2.5,4.5,47,Incidence,1377812,Non-Hispanic Black,3.4,Female,Urinary Bladder,2019
55-59,792.6,822.1,11539,Incidence,1429413,Non-Hispanic Black,807.3,Female,All Cancer Sites Combined,2019
55-59,4.3,6.8,78,Incidence,1429413,Non-Hispanic Black,5.5,Female,Brain and Other Nervous System,2019
55-59,14.0,18.2,229,Incidence,1429413,Non-Hispanic Black,16.0,Female,Cervix,2019
55-59,65.1,73.9,992,Incidence,1429413,Non-Hispanic Black,69.4,Female,Colon and Rectum,2019
55-59,65.8,74.6,1002,Incidence,1429413,Non-Hispanic Black,70.1,Female,"Corpus and Uterus, NOS",2019
55-59,4.4,7.0,80,Incidence,1429413,Non-Hispanic Black,5.6,Female,Esophagus,2019
55-59,281.8,299.5,4153,Incidence,1429413,Non-Hispanic Black,290.5,Female,Female Breast,2019
55-59,72.9,82.1,1106,Incidence,1429413,Non-Hispanic Black,77.4,Female,"Female Breast, <i>in situ</i>",2019
55-59,1.3,2.8,28,Incidence,1429413,Non-Hispanic Black,2.0,Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,1429413,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
55-59,24.1,29.5,382,Incidence,1429413,Non-Hispanic Black,26.7,Female,Kidney and Renal Pelvis,2019
55-59,3.4,5.6,63,Incidence,1429413,Non-Hispanic Black,4.4,Female,Larynx,2019
55-59,11.8,15.7,195,Incidence,1429413,Non-Hispanic Black,13.6,Female,Leukemias,2019
55-59,9.5,13.0,159,Incidence,1429413,Non-Hispanic Black,11.1,Female,Liver and Intrahepatic Bile Duct,2019
55-59,86.5,96.5,1306,Incidence,1429413,Non-Hispanic Black,91.4,Female,Lung and Bronchus,2019
55-59,0.7,2.0,18,Incidence,1429413,Non-Hispanic Black,1.3,Female,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,1429413,Non-Hispanic Black,~,Female,Mesothelioma,2019
55-59,19.7,24.6,315,Incidence,1429413,Non-Hispanic Black,22.0,Female,Myeloma,2019
55-59,17.5,22.2,282,Incidence,1429413,Non-Hispanic Black,19.7,Female,Non-Hodgkin Lymphoma,2019
55-59,10.0,13.6,167,Incidence,1429413,Non-Hispanic Black,11.7,Female,Oral Cavity and Pharynx,2019
55-59,15.1,19.5,246,Incidence,1429413,Non-Hispanic Black,17.2,Female,Ovary,2019
55-59,23.2,28.5,368,Incidence,1429413,Non-Hispanic Black,25.7,Female,Pancreas,2019
55-59,10.9,14.6,181,Incidence,1429413,Non-Hispanic Black,12.7,Female,Stomach,2019
55-59,19.7,24.7,316,Incidence,1429413,Non-Hispanic Black,22.1,Female,Thyroid,2019
55-59,6.8,9.8,117,Incidence,1429413,Non-Hispanic Black,8.2,Female,Urinary Bladder,2019
60-64,1077.2,1113.2,14251,Incidence,1301332,Non-Hispanic Black,1095.1,Female,All Cancer Sites Combined,2019
60-64,4.3,6.9,71,Incidence,1301332,Non-Hispanic Black,5.5,Female,Brain and Other Nervous System,2019
60-64,15.2,19.9,227,Incidence,1301332,Non-Hispanic Black,17.4,Female,Cervix,2019
60-64,80.2,90.3,1108,Incidence,1301332,Non-Hispanic Black,85.1,Female,Colon and Rectum,2019
60-64,117.3,129.4,1604,Incidence,1301332,Non-Hispanic Black,123.3,Female,"Corpus and Uterus, NOS",2019
60-64,5.5,8.4,89,Incidence,1301332,Non-Hispanic Black,6.8,Female,Esophagus,2019
60-64,331.2,351.4,4440,Incidence,1301332,Non-Hispanic Black,341.2,Female,Female Breast,2019
60-64,93.8,104.7,1290,Incidence,1301332,Non-Hispanic Black,99.1,Female,"Female Breast, <i>in situ</i>",2019
60-64,0.9,2.3,19,Incidence,1301332,Non-Hispanic Black,1.5,Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,1301332,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
60-64,38.7,45.8,548,Incidence,1301332,Non-Hispanic Black,42.1,Female,Kidney and Renal Pelvis,2019
60-64,5.2,8.1,85,Incidence,1301332,Non-Hispanic Black,6.5,Female,Larynx,2019
60-64,16.4,21.2,243,Incidence,1301332,Non-Hispanic Black,18.7,Female,Leukemias,2019
60-64,21.0,26.4,307,Incidence,1301332,Non-Hispanic Black,23.6,Female,Liver and Intrahepatic Bile Duct,2019
60-64,143.3,156.6,1950,Incidence,1301332,Non-Hispanic Black,149.8,Female,Lung and Bronchus,2019
60-64,1.1,2.7,23,Incidence,1301332,Non-Hispanic Black,1.8,Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,1301332,Non-Hispanic Black,~,Female,Mesothelioma,2019
60-64,30.1,36.5,432,Incidence,1301332,Non-Hispanic Black,33.2,Female,Myeloma,2019
60-64,23.8,29.5,345,Incidence,1301332,Non-Hispanic Black,26.5,Female,Non-Hodgkin Lymphoma,2019
60-64,12.7,17.0,192,Incidence,1301332,Non-Hispanic Black,14.8,Female,Oral Cavity and Pharynx,2019
60-64,21.4,26.8,312,Incidence,1301332,Non-Hispanic Black,24.0,Female,Ovary,2019
60-64,35.3,42.1,502,Incidence,1301332,Non-Hispanic Black,38.6,Female,Pancreas,2019
60-64,16.5,21.3,245,Incidence,1301332,Non-Hispanic Black,18.8,Female,Stomach,2019
60-64,19.3,24.4,283,Incidence,1301332,Non-Hispanic Black,21.7,Female,Thyroid,2019
60-64,12.8,17.1,193,Incidence,1301332,Non-Hispanic Black,14.8,Female,Urinary Bladder,2019
65-69,1380.3,1425.8,14634,Incidence,1043131,Non-Hispanic Black,1402.9,Female,All Cancer Sites Combined,2019
65-69,5.1,8.4,69,Incidence,1043131,Non-Hispanic Black,6.6,Female,Brain and Other Nervous System,2019
65-69,15.2,20.4,184,Incidence,1043131,Non-Hispanic Black,17.6,Female,Cervix,2019
65-69,109.5,122.6,1209,Incidence,1043131,Non-Hispanic Black,115.9,Female,Colon and Rectum,2019
65-69,138.9,153.7,1525,Incidence,1043131,Non-Hispanic Black,146.2,Female,"Corpus and Uterus, NOS",2019
65-69,5.5,8.8,73,Incidence,1043131,Non-Hispanic Black,7.0,Female,Esophagus,2019
65-69,405.1,430.0,4354,Incidence,1043131,Non-Hispanic Black,417.4,Female,Female Breast,2019
65-69,119.5,133.3,1317,Incidence,1043131,Non-Hispanic Black,126.3,Female,"Female Breast, <i>in situ</i>",2019
65-69,1.9,4.1,30,Incidence,1043131,Non-Hispanic Black,2.9,Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,1043131,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
65-69,49.5,58.5,562,Incidence,1043131,Non-Hispanic Black,53.9,Female,Kidney and Renal Pelvis,2019
65-69,4.5,7.5,61,Incidence,1043131,Non-Hispanic Black,5.8,Female,Larynx,2019
65-69,20.3,26.2,241,Incidence,1043131,Non-Hispanic Black,23.1,Female,Leukemias,2019
65-69,23.5,29.9,277,Incidence,1043131,Non-Hispanic Black,26.6,Female,Liver and Intrahepatic Bile Duct,2019
65-69,191.6,208.8,2087,Incidence,1043131,Non-Hispanic Black,200.1,Female,Lung and Bronchus,2019
65-69,1.2,3.1,21,Incidence,1043131,Non-Hispanic Black,2.0,Female,Melanomas of the Skin,2019
65-69,~,~,~,Incidence,1043131,Non-Hispanic Black,~,Female,Mesothelioma,2019
65-69,44.6,53.2,509,Incidence,1043131,Non-Hispanic Black,48.8,Female,Myeloma,2019
65-69,34.7,42.3,400,Incidence,1043131,Non-Hispanic Black,38.3,Female,Non-Hodgkin Lymphoma,2019
65-69,14.3,19.4,174,Incidence,1043131,Non-Hispanic Black,16.7,Female,Oral Cavity and Pharynx,2019
65-69,22.4,28.7,265,Incidence,1043131,Non-Hispanic Black,25.4,Female,Ovary,2019
65-69,53.4,62.7,604,Incidence,1043131,Non-Hispanic Black,57.9,Female,Pancreas,2019
65-69,19.6,25.4,233,Incidence,1043131,Non-Hispanic Black,22.3,Female,Stomach,2019
65-69,24.5,31.0,288,Incidence,1043131,Non-Hispanic Black,27.6,Female,Thyroid,2019
65-69,20.8,26.8,247,Incidence,1043131,Non-Hispanic Black,23.7,Female,Urinary Bladder,2019
70-74,1560.0,1616.9,12009,Incidence,756104,Non-Hispanic Black,1588.3,Female,All Cancer Sites Combined,2019
70-74,6.9,11.3,67,Incidence,756104,Non-Hispanic Black,8.9,Female,Brain and Other Nervous System,2019
70-74,12.1,17.7,111,Incidence,756104,Non-Hispanic Black,14.7,Female,Cervix,2019
70-74,123.8,140.3,997,Incidence,756104,Non-Hispanic Black,131.9,Female,Colon and Rectum,2019
70-74,130.6,147.5,1050,Incidence,756104,Non-Hispanic Black,138.9,Female,"Corpus and Uterus, NOS",2019
70-74,6.2,10.4,61,Incidence,756104,Non-Hispanic Black,8.1,Female,Esophagus,2019
70-74,439.6,470.2,3438,Incidence,756104,Non-Hispanic Black,454.7,Female,Female Breast,2019
70-74,131.0,147.9,1053,Incidence,756104,Non-Hispanic Black,139.3,Female,"Female Breast, <i>in situ</i>",2019
70-74,~,~,~,Incidence,756104,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,756104,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
70-74,54.4,65.6,452,Incidence,756104,Non-Hispanic Black,59.8,Female,Kidney and Renal Pelvis,2019
70-74,4.3,8.0,45,Incidence,756104,Non-Hispanic Black,6.0,Female,Larynx,2019
70-74,26.9,34.9,232,Incidence,756104,Non-Hispanic Black,30.7,Female,Leukemias,2019
70-74,22.9,30.4,200,Incidence,756104,Non-Hispanic Black,26.5,Female,Liver and Intrahepatic Bile Duct,2019
70-74,248.5,271.6,1965,Incidence,756104,Non-Hispanic Black,259.9,Female,Lung and Bronchus,2019
70-74,2.7,5.7,30,Incidence,756104,Non-Hispanic Black,4.0,Female,Melanomas of the Skin,2019
70-74,~,~,~,Incidence,756104,Non-Hispanic Black,~,Female,Mesothelioma,2019
70-74,57.0,68.5,473,Incidence,756104,Non-Hispanic Black,62.6,Female,Myeloma,2019
70-74,35.4,44.6,301,Incidence,756104,Non-Hispanic Black,39.8,Female,Non-Hodgkin Lymphoma,2019
70-74,13.4,19.3,122,Incidence,756104,Non-Hispanic Black,16.1,Female,Oral Cavity and Pharynx,2019
70-74,25.4,33.2,220,Incidence,756104,Non-Hispanic Black,29.1,Female,Ovary,2019
70-74,60.3,72.0,499,Incidence,756104,Non-Hispanic Black,66.0,Female,Pancreas,2019
70-74,26.7,34.8,231,Incidence,756104,Non-Hispanic Black,30.6,Female,Stomach,2019
70-74,21.7,29.0,190,Incidence,756104,Non-Hispanic Black,25.1,Female,Thyroid,2019
70-74,24.0,31.7,209,Incidence,756104,Non-Hispanic Black,27.6,Female,Urinary Bladder,2019
75-79,1682.5,1754.8,8727,Incidence,507855,Non-Hispanic Black,1718.4,Female,All Cancer Sites Combined,2019
75-79,3.7,8.0,28,Incidence,507855,Non-Hispanic Black,5.5,Female,Brain and Other Nervous System,2019
75-79,14.8,22.4,93,Incidence,507855,Non-Hispanic Black,18.3,Female,Cervix,2019
75-79,142.0,163.7,775,Incidence,507855,Non-Hispanic Black,152.6,Female,Colon and Rectum,2019
75-79,107.7,126.8,594,Incidence,507855,Non-Hispanic Black,117.0,Female,"Corpus and Uterus, NOS",2019
75-79,4.6,9.4,34,Incidence,507855,Non-Hispanic Black,6.7,Female,Esophagus,2019
75-79,438.4,475.8,2320,Incidence,507855,Non-Hispanic Black,456.8,Female,Female Breast,2019
75-79,95.1,113.0,527,Incidence,507855,Non-Hispanic Black,103.8,Female,"Female Breast, <i>in situ</i>",2019
75-79,~,~,~,Incidence,507855,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,507855,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
75-79,52.9,66.6,302,Incidence,507855,Non-Hispanic Black,59.5,Female,Kidney and Renal Pelvis,2019
75-79,4.0,8.4,30,Incidence,507855,Non-Hispanic Black,5.9,Female,Larynx,2019
75-79,32.6,43.5,192,Incidence,507855,Non-Hispanic Black,37.8,Female,Leukemias,2019
75-79,17.3,25.5,107,Incidence,507855,Non-Hispanic Black,21.1,Female,Liver and Intrahepatic Bile Duct,2019
75-79,292.1,322.8,1560,Incidence,507855,Non-Hispanic Black,307.2,Female,Lung and Bronchus,2019
75-79,2.1,5.6,18,Incidence,507855,Non-Hispanic Black,3.5,Female,Melanomas of the Skin,2019
75-79,~,~,~,Incidence,507855,Non-Hispanic Black,~,Female,Mesothelioma,2019
75-79,68.8,84.2,387,Incidence,507855,Non-Hispanic Black,76.2,Female,Myeloma,2019
75-79,40.7,52.8,236,Incidence,507855,Non-Hispanic Black,46.5,Female,Non-Hodgkin Lymphoma,2019
75-79,12.8,20.0,82,Incidence,507855,Non-Hispanic Black,16.1,Female,Oral Cavity and Pharynx,2019
75-79,23.6,33.0,142,Incidence,507855,Non-Hispanic Black,28.0,Female,Ovary,2019
75-79,74.6,90.6,418,Incidence,507855,Non-Hispanic Black,82.3,Female,Pancreas,2019
75-79,31.6,42.3,186,Incidence,507855,Non-Hispanic Black,36.6,Female,Stomach,2019
75-79,16.0,23.9,100,Incidence,507855,Non-Hispanic Black,19.7,Female,Thyroid,2019
75-79,35.2,46.5,206,Incidence,507855,Non-Hispanic Black,40.6,Female,Urinary Bladder,2019
80-84,1677.4,1765.7,5878,Incidence,341516,Non-Hispanic Black,1721.1,Female,All Cancer Sites Combined,2019
80-84,8.6,16.3,41,Incidence,341516,Non-Hispanic Black,12.0,Female,Brain and Other Nervous System,2019
80-84,8.9,16.6,42,Incidence,341516,Non-Hispanic Black,12.3,Female,Cervix,2019
80-84,163.9,192.5,607,Incidence,341516,Non-Hispanic Black,177.7,Female,Colon and Rectum,2019
80-84,74.0,93.7,285,Incidence,341516,Non-Hispanic Black,83.5,Female,"Corpus and Uterus, NOS",2019
80-84,7.6,14.9,37,Incidence,341516,Non-Hispanic Black,10.8,Female,Esophagus,2019
80-84,397.3,441.0,1430,Incidence,341516,Non-Hispanic Black,418.7,Female,Female Breast,2019
80-84,60.6,78.5,236,Incidence,341516,Non-Hispanic Black,69.1,Female,"Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,341516,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,341516,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
80-84,46.4,62.2,184,Incidence,341516,Non-Hispanic Black,53.9,Female,Kidney and Renal Pelvis,2019
80-84,2.9,8.0,17,Incidence,341516,Non-Hispanic Black,5.0,Female,Larynx,2019
80-84,34.2,48.1,139,Incidence,341516,Non-Hispanic Black,40.7,Female,Leukemias,2019
80-84,18.8,29.5,81,Incidence,341516,Non-Hispanic Black,23.7,Female,Liver and Intrahepatic Bile Duct,2019
80-84,271.5,307.9,988,Incidence,341516,Non-Hispanic Black,289.3,Female,Lung and Bronchus,2019
80-84,~,~,~,Incidence,341516,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,341516,Non-Hispanic Black,~,Female,Mesothelioma,2019
80-84,67.7,86.6,262,Incidence,341516,Non-Hispanic Black,76.7,Female,Myeloma,2019
80-84,47.2,63.2,187,Incidence,341516,Non-Hispanic Black,54.8,Female,Non-Hodgkin Lymphoma,2019
80-84,11.4,20.0,52,Incidence,341516,Non-Hispanic Black,15.2,Female,Oral Cavity and Pharynx,2019
80-84,30.5,43.6,125,Incidence,341516,Non-Hispanic Black,36.6,Female,Ovary,2019
80-84,94.5,116.6,359,Incidence,341516,Non-Hispanic Black,105.1,Female,Pancreas,2019
80-84,42.6,57.8,170,Incidence,341516,Non-Hispanic Black,49.8,Female,Stomach,2019
80-84,9.6,17.6,45,Incidence,341516,Non-Hispanic Black,13.2,Female,Thyroid,2019
80-84,44.2,59.7,176,Incidence,341516,Non-Hispanic Black,51.5,Female,Urinary Bladder,2019
85+,1539.7,1622.1,5693,Incidence,360197,Non-Hispanic Black,1580.5,Female,All Cancer Sites Combined,2019
85+,8.4,15.8,42,Incidence,360197,Non-Hispanic Black,11.7,Female,Brain and Other Nervous System,2019
85+,9.8,17.7,48,Incidence,360197,Non-Hispanic Black,13.3,Female,Cervix,2019
85+,179.7,208.7,698,Incidence,360197,Non-Hispanic Black,193.8,Female,Colon and Rectum,2019
85+,47.1,62.6,196,Incidence,360197,Non-Hispanic Black,54.4,Female,"Corpus and Uterus, NOS",2019
85+,7.0,13.8,36,Incidence,360197,Non-Hispanic Black,10.0,Female,Esophagus,2019
85+,314.3,352.3,1199,Incidence,360197,Non-Hispanic Black,332.9,Female,Female Breast,2019
85+,28.6,41.0,124,Incidence,360197,Non-Hispanic Black,34.4,Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,360197,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,360197,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
85+,36.0,49.8,153,Incidence,360197,Non-Hispanic Black,42.5,Female,Kidney and Renal Pelvis,2019
85+,~,~,~,Incidence,360197,Non-Hispanic Black,~,Female,Larynx,2019
85+,44.2,59.3,185,Incidence,360197,Non-Hispanic Black,51.4,Female,Leukemias,2019
85+,21.6,32.5,96,Incidence,360197,Non-Hispanic Black,26.7,Female,Liver and Intrahepatic Bile Duct,2019
85+,206.4,237.5,798,Incidence,360197,Non-Hispanic Black,221.5,Female,Lung and Bronchus,2019
85+,4.5,10.2,25,Incidence,360197,Non-Hispanic Black,6.9,Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,360197,Non-Hispanic Black,~,Female,Mesothelioma,2019
85+,48.6,64.4,202,Incidence,360197,Non-Hispanic Black,56.1,Female,Myeloma,2019
85+,38.8,53.1,164,Incidence,360197,Non-Hispanic Black,45.5,Female,Non-Hodgkin Lymphoma,2019
85+,7.7,14.8,39,Incidence,360197,Non-Hispanic Black,10.8,Female,Oral Cavity and Pharynx,2019
85+,21.8,32.9,97,Incidence,360197,Non-Hispanic Black,26.9,Female,Ovary,2019
85+,103.3,125.7,411,Incidence,360197,Non-Hispanic Black,114.1,Female,Pancreas,2019
85+,42.9,57.8,180,Incidence,360197,Non-Hispanic Black,50.0,Female,Stomach,2019
85+,3.8,9.2,22,Incidence,360197,Non-Hispanic Black,6.1,Female,Thyroid,2019
85+,57.9,75.0,238,Incidence,360197,Non-Hispanic Black,66.1,Female,Urinary Bladder,2019
<1,19.0,30.7,71,Incidence,291867,Non-Hispanic Black,24.3,Female,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Cervix,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Colon and Rectum,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Esophagus,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Female Breast,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Larynx,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Leukemias,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Mesothelioma,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Myeloma,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Ovary,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Pancreas,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Stomach,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Thyroid,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Female,Urinary Bladder,2019
1-4,16.1,20.9,228,Incidence,1240065,Non-Hispanic Black,18.4,Male,All Cancer Sites Combined,2019
1-4,2.5,4.7,43,Incidence,1240065,Non-Hispanic Black,3.5,Male,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Colon and Rectum,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Esophagus,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
1-4,2.0,4.0,36,Incidence,1240065,Non-Hispanic Black,2.9,Male,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Larynx,2019
1-4,3.6,6.1,59,Incidence,1240065,Non-Hispanic Black,4.8,Male,Leukemias,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
1-4,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Mesothelioma,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Myeloma,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Pancreas,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Prostate,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Stomach,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Testis,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Thyroid,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male,Urinary Bladder,2019
10-14,11.0,14.6,203,Incidence,1599454,Non-Hispanic Black,12.7,Male,All Cancer Sites Combined,2019
10-14,1.5,3.0,35,Incidence,1599454,Non-Hispanic Black,2.2,Male,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Colon and Rectum,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Esophagus,2019
10-14,0.7,1.9,19,Incidence,1599454,Non-Hispanic Black,1.2,Male,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Larynx,2019
10-14,1.6,3.1,36,Incidence,1599454,Non-Hispanic Black,2.3,Male,Leukemias,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
10-14,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Mesothelioma,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Myeloma,2019
10-14,0.9,2.1,22,Incidence,1599454,Non-Hispanic Black,1.4,Male,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Pancreas,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Prostate,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Stomach,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Testis,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Thyroid,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male,Urinary Bladder,2019
15-19,13.6,17.6,247,Incidence,1592681,Non-Hispanic Black,15.5,Male,All Cancer Sites Combined,2019
15-19,1.1,2.5,27,Incidence,1592681,Non-Hispanic Black,1.7,Male,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Colon and Rectum,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Esophagus,2019
15-19,1.5,3.0,34,Incidence,1592681,Non-Hispanic Black,2.1,Male,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Larynx,2019
15-19,1.6,3.2,37,Incidence,1592681,Non-Hispanic Black,2.3,Male,Leukemias,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
15-19,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Mesothelioma,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Myeloma,2019
15-19,1.5,3.0,34,Incidence,1592681,Non-Hispanic Black,2.1,Male,Non-Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Pancreas,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Prostate,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Stomach,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Testis,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Thyroid,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male,Urinary Bladder,2019
20-24,20.0,24.6,368,Incidence,1659163,Non-Hispanic Black,22.2,Male,All Cancer Sites Combined,2019
20-24,1.0,2.3,26,Incidence,1659163,Non-Hispanic Black,1.6,Male,Brain and Other Nervous System,2019
20-24,0.8,2.0,22,Incidence,1659163,Non-Hispanic Black,1.3,Male,Colon and Rectum,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Esophagus,2019
20-24,3.6,5.7,76,Incidence,1659163,Non-Hispanic Black,4.6,Male,Hodgkin Lymphoma,2019
20-24,0.6,1.6,17,Incidence,1659163,Non-Hispanic Black,1.0,Male,Kaposi Sarcoma,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Larynx,2019
20-24,1.6,3.1,38,Incidence,1659163,Non-Hispanic Black,2.3,Male,Leukemias,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
20-24,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Mesothelioma,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Myeloma,2019
20-24,2.0,3.7,46,Incidence,1659163,Non-Hispanic Black,2.8,Male,Non-Hodgkin Lymphoma,2019
20-24,0.7,1.8,19,Incidence,1659163,Non-Hispanic Black,1.1,Male,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Pancreas,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Prostate,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Stomach,2019
20-24,1.2,2.5,29,Incidence,1659163,Non-Hispanic Black,1.7,Male,Testis,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Thyroid,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male,Urinary Bladder,2019
25-29,29.9,35.1,599,Incidence,1847366,Non-Hispanic Black,32.4,Male,All Cancer Sites Combined,2019
25-29,1.3,2.6,35,Incidence,1847366,Non-Hispanic Black,1.9,Male,Brain and Other Nervous System,2019
25-29,2.2,3.8,54,Incidence,1847366,Non-Hispanic Black,2.9,Male,Colon and Rectum,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Esophagus,2019
25-29,3.1,5.0,73,Incidence,1847366,Non-Hispanic Black,4.0,Male,Hodgkin Lymphoma,2019
25-29,1.8,3.3,46,Incidence,1847366,Non-Hispanic Black,2.5,Male,Kaposi Sarcoma,2019
25-29,1.1,2.3,30,Incidence,1847366,Non-Hispanic Black,1.6,Male,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Larynx,2019
25-29,2.3,4.0,57,Incidence,1847366,Non-Hispanic Black,3.1,Male,Leukemias,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
25-29,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Mesothelioma,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Myeloma,2019
25-29,3.6,5.6,84,Incidence,1847366,Non-Hispanic Black,4.5,Male,Non-Hodgkin Lymphoma,2019
25-29,0.5,1.5,17,Incidence,1847366,Non-Hispanic Black,0.9,Male,Oral Cavity and Pharynx,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Pancreas,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Prostate,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Stomach,2019
25-29,2.0,3.5,49,Incidence,1847366,Non-Hispanic Black,2.7,Male,Testis,2019
25-29,0.7,1.7,21,Incidence,1847366,Non-Hispanic Black,1.1,Male,Thyroid,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male,Urinary Bladder,2019
30-34,46.0,53.1,761,Incidence,1539338,Non-Hispanic Black,49.4,Male,All Cancer Sites Combined,2019
30-34,1.0,2.3,24,Incidence,1539338,Non-Hispanic Black,1.6,Male,Brain and Other Nervous System,2019
30-34,4.0,6.3,78,Incidence,1539338,Non-Hispanic Black,5.1,Male,Colon and Rectum,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Esophagus,2019
30-34,2.9,4.9,58,Incidence,1539338,Non-Hispanic Black,3.8,Male,Hodgkin Lymphoma,2019
30-34,2.6,4.6,54,Incidence,1539338,Non-Hispanic Black,3.5,Male,Kaposi Sarcoma,2019
30-34,2.7,4.7,55,Incidence,1539338,Non-Hispanic Black,3.6,Male,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Larynx,2019
30-34,2.6,4.6,54,Incidence,1539338,Non-Hispanic Black,3.5,Male,Leukemias,2019
30-34,1.1,2.5,26,Incidence,1539338,Non-Hispanic Black,1.7,Male,Liver and Intrahepatic Bile Duct,2019
30-34,0.6,1.8,17,Incidence,1539338,Non-Hispanic Black,1.1,Male,Lung and Bronchus,2019
30-34,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Mesothelioma,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Myeloma,2019
30-34,5.6,8.3,106,Incidence,1539338,Non-Hispanic Black,6.9,Male,Non-Hodgkin Lymphoma,2019
30-34,0.9,2.2,23,Incidence,1539338,Non-Hispanic Black,1.5,Male,Oral Cavity and Pharynx,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Pancreas,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Prostate,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Stomach,2019
30-34,2.5,4.4,52,Incidence,1539338,Non-Hispanic Black,3.4,Male,Testis,2019
30-34,0.8,2.0,20,Incidence,1539338,Non-Hispanic Black,1.3,Male,Thyroid,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male,Urinary Bladder,2019
35-39,85.4,95.5,1242,Incidence,1374552,Non-Hispanic Black,90.4,Male,All Cancer Sites Combined,2019
35-39,1.6,3.3,32,Incidence,1374552,Non-Hispanic Black,2.3,Male,Brain and Other Nervous System,2019
35-39,10.9,14.8,175,Incidence,1374552,Non-Hispanic Black,12.7,Male,Colon and Rectum,2019
35-39,~,~,~,Incidence,1374552,Non-Hispanic Black,~,Male,Esophagus,2019
35-39,3.3,5.6,60,Incidence,1374552,Non-Hispanic Black,4.4,Male,Hodgkin Lymphoma,2019
35-39,1.5,3.2,31,Incidence,1374552,Non-Hispanic Black,2.3,Male,Kaposi Sarcoma,2019
35-39,6.7,9.8,112,Incidence,1374552,Non-Hispanic Black,8.1,Male,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,1374552,Non-Hispanic Black,~,Male,Larynx,2019
35-39,3.9,6.4,69,Incidence,1374552,Non-Hispanic Black,5.0,Male,Leukemias,2019
35-39,1.2,2.7,25,Incidence,1374552,Non-Hispanic Black,1.8,Male,Liver and Intrahepatic Bile Duct,2019
35-39,3.8,6.2,67,Incidence,1374552,Non-Hispanic Black,4.9,Male,Lung and Bronchus,2019
35-39,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
35-39,~,~,~,Incidence,1374552,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,1374552,Non-Hispanic Black,~,Male,Mesothelioma,2019
35-39,1.5,3.2,31,Incidence,1374552,Non-Hispanic Black,2.3,Male,Myeloma,2019
35-39,8.8,12.3,143,Incidence,1374552,Non-Hispanic Black,10.4,Male,Non-Hodgkin Lymphoma,2019
35-39,2.9,5.0,53,Incidence,1374552,Non-Hispanic Black,3.9,Male,Oral Cavity and Pharynx,2019
35-39,1.8,3.6,36,Incidence,1374552,Non-Hispanic Black,2.6,Male,Pancreas,2019
35-39,0.9,2.3,21,Incidence,1374552,Non-Hispanic Black,1.5,Male,Prostate,2019
35-39,2.5,4.5,47,Incidence,1374552,Non-Hispanic Black,3.4,Male,Stomach,2019
35-39,2.9,5.0,53,Incidence,1374552,Non-Hispanic Black,3.9,Male,Testis,2019
35-39,1.6,3.3,32,Incidence,1374552,Non-Hispanic Black,2.3,Male,Thyroid,2019
35-39,0.7,2.0,17,Incidence,1374552,Non-Hispanic Black,1.2,Male,Urinary Bladder,2019
40-44,152.0,166.2,1953,Incidence,1228464,Non-Hispanic Black,159.0,Male,All Cancer Sites Combined,2019
40-44,3.8,6.4,61,Incidence,1228464,Non-Hispanic Black,5.0,Male,Brain and Other Nervous System,2019
40-44,20.1,25.5,279,Incidence,1228464,Non-Hispanic Black,22.7,Male,Colon and Rectum,2019
40-44,~,~,~,Incidence,1228464,Non-Hispanic Black,~,Male,Esophagus,2019
40-44,3.7,6.3,60,Incidence,1228464,Non-Hispanic Black,4.9,Male,Hodgkin Lymphoma,2019
40-44,2.1,4.1,36,Incidence,1228464,Non-Hispanic Black,2.9,Male,Kaposi Sarcoma,2019
40-44,14.2,18.8,201,Incidence,1228464,Non-Hispanic Black,16.4,Male,Kidney and Renal Pelvis,2019
40-44,1.0,2.5,20,Incidence,1228464,Non-Hispanic Black,1.6,Male,Larynx,2019
40-44,6.1,9.3,93,Incidence,1228464,Non-Hispanic Black,7.6,Male,Leukemias,2019
40-44,1.7,3.6,31,Incidence,1228464,Non-Hispanic Black,2.5,Male,Liver and Intrahepatic Bile Duct,2019
40-44,9.4,13.2,137,Incidence,1228464,Non-Hispanic Black,11.2,Male,Lung and Bronchus,2019
40-44,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
40-44,~,~,~,Incidence,1228464,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,1228464,Non-Hispanic Black,~,Male,Mesothelioma,2019
40-44,4.9,7.8,77,Incidence,1228464,Non-Hispanic Black,6.3,Male,Myeloma,2019
40-44,7.3,10.7,109,Incidence,1228464,Non-Hispanic Black,8.9,Male,Non-Hodgkin Lymphoma,2019
40-44,6.2,9.4,94,Incidence,1228464,Non-Hispanic Black,7.7,Male,Oral Cavity and Pharynx,2019
40-44,3.5,6.0,57,Incidence,1228464,Non-Hispanic Black,4.6,Male,Pancreas,2019
40-44,15.4,20.2,217,Incidence,1228464,Non-Hispanic Black,17.7,Male,Prostate,2019
40-44,2.6,4.8,44,Incidence,1228464,Non-Hispanic Black,3.6,Male,Stomach,2019
40-44,1.8,3.7,32,Incidence,1228464,Non-Hispanic Black,2.6,Male,Testis,2019
40-44,3.4,5.9,56,Incidence,1228464,Non-Hispanic Black,4.6,Male,Thyroid,2019
40-44,1.7,3.6,31,Incidence,1228464,Non-Hispanic Black,2.5,Male,Urinary Bladder,2019
45-49,302.3,322.1,3836,Incidence,1229089,Non-Hispanic Black,312.1,Male,All Cancer Sites Combined,2019
45-49,3.6,6.1,58,Incidence,1229089,Non-Hispanic Black,4.7,Male,Brain and Other Nervous System,2019
45-49,42.3,49.9,565,Incidence,1229089,Non-Hispanic Black,46.0,Male,Colon and Rectum,2019
45-49,2.9,5.2,48,Incidence,1229089,Non-Hispanic Black,3.9,Male,Esophagus,2019
45-49,2.9,5.3,49,Incidence,1229089,Non-Hispanic Black,4.0,Male,Hodgkin Lymphoma,2019
45-49,1.1,2.7,22,Incidence,1229089,Non-Hispanic Black,1.8,Male,Kaposi Sarcoma,2019
45-49,26.3,32.5,360,Incidence,1229089,Non-Hispanic Black,29.3,Male,Kidney and Renal Pelvis,2019
45-49,3.0,5.4,50,Incidence,1229089,Non-Hispanic Black,4.1,Male,Larynx,2019
45-49,9.1,12.9,134,Incidence,1229089,Non-Hispanic Black,10.9,Male,Leukemias,2019
45-49,3.2,5.5,52,Incidence,1229089,Non-Hispanic Black,4.2,Male,Liver and Intrahepatic Bile Duct,2019
45-49,18.1,23.3,253,Incidence,1229089,Non-Hispanic Black,20.6,Male,Lung and Bronchus,2019
45-49,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
45-49,~,~,~,Incidence,1229089,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,1229089,Non-Hispanic Black,~,Male,Mesothelioma,2019
45-49,10.3,14.3,150,Incidence,1229089,Non-Hispanic Black,12.2,Male,Myeloma,2019
45-49,14.7,19.4,208,Incidence,1229089,Non-Hispanic Black,16.9,Male,Non-Hodgkin Lymphoma,2019
45-49,11.2,15.4,162,Incidence,1229089,Non-Hispanic Black,13.2,Male,Oral Cavity and Pharynx,2019
45-49,7.7,11.2,115,Incidence,1229089,Non-Hispanic Black,9.4,Male,Pancreas,2019
45-49,74.3,84.4,974,Incidence,1229089,Non-Hispanic Black,79.2,Male,Prostate,2019
45-49,6.2,9.4,94,Incidence,1229089,Non-Hispanic Black,7.6,Male,Stomach,2019
45-49,1.6,3.5,30,Incidence,1229089,Non-Hispanic Black,2.4,Male,Testis,2019
45-49,3.9,6.5,62,Incidence,1229089,Non-Hispanic Black,5.0,Male,Thyroid,2019
45-49,4.5,7.3,71,Incidence,1229089,Non-Hispanic Black,5.8,Male,Urinary Bladder,2019
5-9,8.2,11.3,152,Incidence,1571843,Non-Hispanic Black,9.7,Male,All Cancer Sites Combined,2019
5-9,1.5,3.0,34,Incidence,1571843,Non-Hispanic Black,2.2,Male,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Colon and Rectum,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Esophagus,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Larynx,2019
5-9,2.2,4.0,47,Incidence,1571843,Non-Hispanic Black,3.0,Male,Leukemias,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
5-9,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Mesothelioma,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Myeloma,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Pancreas,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Prostate,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Stomach,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Testis,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Thyroid,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male,Urinary Bladder,2019
50-54,618.2,646.6,7641,Incidence,1208545,Non-Hispanic Black,632.2,Male,All Cancer Sites Combined,2019
50-54,6.3,9.5,94,Incidence,1208545,Non-Hispanic Black,7.8,Male,Brain and Other Nervous System,2019
50-54,81.2,91.8,1044,Incidence,1208545,Non-Hispanic Black,86.4,Male,Colon and Rectum,2019
50-54,4.4,7.1,68,Incidence,1208545,Non-Hispanic Black,5.6,Male,Esophagus,2019
50-54,1.9,3.9,34,Incidence,1208545,Non-Hispanic Black,2.8,Male,Hodgkin Lymphoma,2019
50-54,0.8,2.3,17,Incidence,1208545,Non-Hispanic Black,1.4,Male,Kaposi Sarcoma,2019
50-54,41.1,48.7,541,Incidence,1208545,Non-Hispanic Black,44.8,Male,Kidney and Renal Pelvis,2019
50-54,6.1,9.2,91,Incidence,1208545,Non-Hispanic Black,7.5,Male,Larynx,2019
50-54,11.4,15.6,162,Incidence,1208545,Non-Hispanic Black,13.4,Male,Leukemias,2019
50-54,8.8,12.5,127,Incidence,1208545,Non-Hispanic Black,10.5,Male,Liver and Intrahepatic Bile Duct,2019
50-54,40.0,47.6,528,Incidence,1208545,Non-Hispanic Black,43.7,Male,Lung and Bronchus,2019
50-54,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
50-54,~,~,~,Incidence,1208545,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,1208545,Non-Hispanic Black,~,Male,Mesothelioma,2019
50-54,17.0,22.1,235,Incidence,1208545,Non-Hispanic Black,19.4,Male,Myeloma,2019
50-54,21.0,26.6,286,Incidence,1208545,Non-Hispanic Black,23.7,Male,Non-Hodgkin Lymphoma,2019
50-54,20.5,26.0,280,Incidence,1208545,Non-Hispanic Black,23.2,Male,Oral Cavity and Pharynx,2019
50-54,17.1,22.2,236,Incidence,1208545,Non-Hispanic Black,19.5,Male,Pancreas,2019
50-54,232.8,250.5,2919,Incidence,1208545,Non-Hispanic Black,241.5,Male,Prostate,2019
50-54,13.2,17.7,185,Incidence,1208545,Non-Hispanic Black,15.3,Male,Stomach,2019
50-54,0.8,2.3,17,Incidence,1208545,Non-Hispanic Black,1.4,Male,Testis,2019
50-54,5.0,8.0,77,Incidence,1208545,Non-Hispanic Black,6.4,Male,Thyroid,2019
50-54,10.4,14.4,148,Incidence,1208545,Non-Hispanic Black,12.2,Male,Urinary Bladder,2019
55-59,1116.6,1154.3,13949,Incidence,1228643,Non-Hispanic Black,1135.3,Male,All Cancer Sites Combined,2019
55-59,8.7,12.4,128,Incidence,1228643,Non-Hispanic Black,10.4,Male,Brain and Other Nervous System,2019
55-59,95.8,107.1,1245,Incidence,1228643,Non-Hispanic Black,101.3,Male,Colon and Rectum,2019
55-59,10.0,14.0,146,Incidence,1228643,Non-Hispanic Black,11.9,Male,Esophagus,2019
55-59,2.7,4.9,45,Incidence,1228643,Non-Hispanic Black,3.7,Male,Hodgkin Lymphoma,2019
55-59,1.2,2.8,23,Incidence,1228643,Non-Hispanic Black,1.9,Male,Kaposi Sarcoma,2019
55-59,59.3,68.4,783,Incidence,1228643,Non-Hispanic Black,63.7,Male,Kidney and Renal Pelvis,2019
55-59,16.1,21.0,226,Incidence,1228643,Non-Hispanic Black,18.4,Male,Larynx,2019
55-59,17.4,22.5,244,Incidence,1228643,Non-Hispanic Black,19.9,Male,Leukemias,2019
55-59,35.0,42.0,471,Incidence,1228643,Non-Hispanic Black,38.3,Male,Liver and Intrahepatic Bile Duct,2019
55-59,119.0,131.6,1538,Incidence,1228643,Non-Hispanic Black,125.2,Male,Lung and Bronchus,2019
55-59,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
55-59,0.8,2.2,17,Incidence,1228643,Non-Hispanic Black,1.4,Male,Melanomas of the Skin,2019
55-59,~,~,~,Incidence,1228643,Non-Hispanic Black,~,Male,Mesothelioma,2019
55-59,26.2,32.3,358,Incidence,1228643,Non-Hispanic Black,29.1,Male,Myeloma,2019
55-59,27.7,34.0,378,Incidence,1228643,Non-Hispanic Black,30.8,Male,Non-Hodgkin Lymphoma,2019
55-59,32.4,39.1,438,Incidence,1228643,Non-Hispanic Black,35.6,Male,Oral Cavity and Pharynx,2019
55-59,31.8,38.5,430,Incidence,1228643,Non-Hispanic Black,35.0,Male,Pancreas,2019
55-59,478.7,503.6,6033,Incidence,1228643,Non-Hispanic Black,491.0,Male,Prostate,2019
55-59,17.1,22.2,240,Incidence,1228643,Non-Hispanic Black,19.5,Male,Stomach,2019
55-59,0.7,2.1,16,Incidence,1228643,Non-Hispanic Black,1.3,Male,Testis,2019
55-59,4.5,7.3,71,Incidence,1228643,Non-Hispanic Black,5.8,Male,Thyroid,2019
55-59,19.3,24.6,268,Incidence,1228643,Non-Hispanic Black,21.8,Male,Urinary Bladder,2019
60-64,1693.6,1743.2,18502,Incidence,1076764,Non-Hispanic Black,1718.3,Male,All Cancer Sites Combined,2019
60-64,6.9,10.5,92,Incidence,1076764,Non-Hispanic Black,8.5,Male,Brain and Other Nervous System,2019
60-64,130.0,144.1,1474,Incidence,1076764,Non-Hispanic Black,136.9,Male,Colon and Rectum,2019
60-64,20.3,26.2,249,Incidence,1076764,Non-Hispanic Black,23.1,Male,Esophagus,2019
60-64,2.8,5.3,42,Incidence,1076764,Non-Hispanic Black,3.9,Male,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,1076764,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
60-64,74.5,85.3,859,Incidence,1076764,Non-Hispanic Black,79.8,Male,Kidney and Renal Pelvis,2019
60-64,23.0,29.1,279,Incidence,1076764,Non-Hispanic Black,25.9,Male,Larynx,2019
60-64,21.4,27.4,261,Incidence,1076764,Non-Hispanic Black,24.2,Male,Leukemias,2019
60-64,70.8,81.3,817,Incidence,1076764,Non-Hispanic Black,75.9,Male,Liver and Intrahepatic Bile Duct,2019
60-64,200.4,217.8,2250,Incidence,1076764,Non-Hispanic Black,209.0,Male,Lung and Bronchus,2019
60-64,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
60-64,1.2,3.0,21,Incidence,1076764,Non-Hispanic Black,2.0,Male,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,1076764,Non-Hispanic Black,~,Male,Mesothelioma,2019
60-64,43.1,51.4,507,Incidence,1076764,Non-Hispanic Black,47.1,Male,Myeloma,2019
60-64,35.0,42.5,416,Incidence,1076764,Non-Hispanic Black,38.6,Male,Non-Hodgkin Lymphoma,2019
60-64,40.9,49.0,483,Incidence,1076764,Non-Hispanic Black,44.9,Male,Oral Cavity and Pharynx,2019
60-64,49.2,58.0,576,Incidence,1076764,Non-Hispanic Black,53.5,Male,Pancreas,2019
60-64,749.0,782.1,8242,Incidence,1076764,Non-Hispanic Black,765.4,Male,Prostate,2019
60-64,28.5,35.3,342,Incidence,1076764,Non-Hispanic Black,31.8,Male,Stomach,2019
60-64,~,~,~,Incidence,1076764,Non-Hispanic Black,~,Male,Testis,2019
60-64,7.5,11.2,99,Incidence,1076764,Non-Hispanic Black,9.2,Male,Thyroid,2019
60-64,38.0,45.8,450,Incidence,1076764,Non-Hispanic Black,41.8,Male,Urinary Bladder,2019
65-69,2389.4,2457.7,19376,Incidence,799553,Non-Hispanic Black,2423.4,Male,All Cancer Sites Combined,2019
65-69,9.7,14.7,96,Incidence,799553,Non-Hispanic Black,12.0,Male,Brain and Other Nervous System,2019
65-69,170.2,188.9,1434,Incidence,799553,Non-Hispanic Black,179.4,Male,Colon and Rectum,2019
65-69,22.7,29.9,209,Incidence,799553,Non-Hispanic Black,26.1,Male,Esophagus,2019
65-69,1.8,4.3,23,Incidence,799553,Non-Hispanic Black,2.9,Male,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,799553,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
65-69,103.5,118.2,885,Incidence,799553,Non-Hispanic Black,110.7,Male,Kidney and Renal Pelvis,2019
65-69,32.9,41.5,296,Incidence,799553,Non-Hispanic Black,37.0,Male,Larynx,2019
65-69,32.7,41.2,294,Incidence,799553,Non-Hispanic Black,36.8,Male,Leukemias,2019
65-69,113.9,129.3,971,Incidence,799553,Non-Hispanic Black,121.4,Male,Liver and Intrahepatic Bile Duct,2019
65-69,305.6,330.4,2541,Incidence,799553,Non-Hispanic Black,317.8,Male,Lung and Bronchus,2019
65-69,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
65-69,~,~,~,Incidence,799553,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
65-69,1.3,3.6,18,Incidence,799553,Non-Hispanic Black,2.3,Male,Mesothelioma,2019
65-69,59.6,70.9,520,Incidence,799553,Non-Hispanic Black,65.0,Male,Myeloma,2019
65-69,48.2,58.5,425,Incidence,799553,Non-Hispanic Black,53.2,Male,Non-Hodgkin Lymphoma,2019
65-69,47.5,57.7,419,Incidence,799553,Non-Hispanic Black,52.4,Male,Oral Cavity and Pharynx,2019
65-69,70.4,82.6,610,Incidence,799553,Non-Hispanic Black,76.3,Male,Pancreas,2019
65-69,1051.7,1097.3,8590,Incidence,799553,Non-Hispanic Black,1074.4,Male,Prostate,2019
65-69,38.1,47.3,340,Incidence,799553,Non-Hispanic Black,42.5,Male,Stomach,2019
65-69,~,~,~,Incidence,799553,Non-Hispanic Black,~,Male,Testis,2019
65-69,7.7,12.2,78,Incidence,799553,Non-Hispanic Black,9.8,Male,Thyroid,2019
65-69,67.5,79.5,586,Incidence,799553,Non-Hispanic Black,73.3,Male,Urinary Bladder,2019
70-74,2485.0,2569.3,13891,Incidence,549728,Non-Hispanic Black,2526.9,Male,All Cancer Sites Combined,2019
70-74,8.5,14.3,61,Incidence,549728,Non-Hispanic Black,11.1,Male,Brain and Other Nervous System,2019
70-74,187.4,211.2,1094,Incidence,549728,Non-Hispanic Black,199.0,Male,Colon and Rectum,2019
70-74,26.6,36.1,171,Incidence,549728,Non-Hispanic Black,31.1,Male,Esophagus,2019
70-74,1.7,4.7,16,Incidence,549728,Non-Hispanic Black,2.9,Male,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,549728,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
70-74,109.7,128.1,652,Incidence,549728,Non-Hispanic Black,118.6,Male,Kidney and Renal Pelvis,2019
70-74,30.2,40.2,192,Incidence,549728,Non-Hispanic Black,34.9,Male,Larynx,2019
70-74,49.9,62.6,308,Incidence,549728,Non-Hispanic Black,56.0,Male,Leukemias,2019
70-74,76.2,91.7,460,Incidence,549728,Non-Hispanic Black,83.7,Male,Liver and Intrahepatic Bile Duct,2019
70-74,384.9,418.6,2207,Incidence,549728,Non-Hispanic Black,401.5,Male,Lung and Bronchus,2019
70-74,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
70-74,2.5,6.1,22,Incidence,549728,Non-Hispanic Black,4.0,Male,Melanomas of the Skin,2019
70-74,2.5,6.1,22,Incidence,549728,Non-Hispanic Black,4.0,Male,Mesothelioma,2019
70-74,77.4,93.0,467,Incidence,549728,Non-Hispanic Black,85.0,Male,Myeloma,2019
70-74,54.1,67.3,332,Incidence,549728,Non-Hispanic Black,60.4,Male,Non-Hodgkin Lymphoma,2019
70-74,44.5,56.5,276,Incidence,549728,Non-Hispanic Black,50.2,Male,Oral Cavity and Pharynx,2019
70-74,84.4,100.6,507,Incidence,549728,Non-Hispanic Black,92.2,Male,Pancreas,2019
70-74,945.3,997.6,5339,Incidence,549728,Non-Hispanic Black,971.2,Male,Prostate,2019
70-74,46.7,59.0,289,Incidence,549728,Non-Hispanic Black,52.6,Male,Stomach,2019
70-74,~,~,~,Incidence,549728,Non-Hispanic Black,~,Male,Testis,2019
70-74,8.3,14.0,60,Incidence,549728,Non-Hispanic Black,10.9,Male,Thyroid,2019
70-74,81.4,97.4,490,Incidence,549728,Non-Hispanic Black,89.1,Male,Urinary Bladder,2019
75-79,2510.9,2619.5,8621,Incidence,336133,Non-Hispanic Black,2564.8,Male,All Cancer Sites Combined,2019
75-79,11.0,19.6,50,Incidence,336133,Non-Hispanic Black,14.9,Male,Brain and Other Nervous System,2019
75-79,224.1,257.5,808,Incidence,336133,Non-Hispanic Black,240.4,Male,Colon and Rectum,2019
75-79,25.0,37.2,103,Incidence,336133,Non-Hispanic Black,30.6,Male,Esophagus,2019
75-79,~,~,~,Incidence,336133,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,336133,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
75-79,98.0,120.6,366,Incidence,336133,Non-Hispanic Black,108.9,Male,Kidney and Renal Pelvis,2019
75-79,27.7,40.4,113,Incidence,336133,Non-Hispanic Black,33.6,Male,Larynx,2019
75-79,53.5,70.6,207,Incidence,336133,Non-Hispanic Black,61.6,Male,Leukemias,2019
75-79,49.6,66.1,193,Incidence,336133,Non-Hispanic Black,57.4,Male,Liver and Intrahepatic Bile Duct,2019
75-79,433.8,479.8,1534,Incidence,336133,Non-Hispanic Black,456.4,Male,Lung and Bronchus,2019
75-79,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
75-79,3.9,9.6,21,Incidence,336133,Non-Hispanic Black,6.2,Male,Melanomas of the Skin,2019
75-79,3.4,8.8,19,Incidence,336133,Non-Hispanic Black,5.7,Male,Mesothelioma,2019
75-79,91.5,113.4,343,Incidence,336133,Non-Hispanic Black,102.0,Male,Myeloma,2019
75-79,63.2,81.7,242,Incidence,336133,Non-Hispanic Black,72.0,Male,Non-Hodgkin Lymphoma,2019
75-79,43.3,58.8,170,Incidence,336133,Non-Hispanic Black,50.6,Male,Oral Cavity and Pharynx,2019
75-79,87.0,108.4,327,Incidence,336133,Non-Hispanic Black,97.3,Male,Pancreas,2019
75-79,776.2,837.2,2710,Incidence,336133,Non-Hispanic Black,806.2,Male,Prostate,2019
75-79,63.2,81.7,242,Incidence,336133,Non-Hispanic Black,72.0,Male,Stomach,2019
75-79,~,~,~,Incidence,336133,Non-Hispanic Black,~,Male,Testis,2019
75-79,10.3,18.6,47,Incidence,336133,Non-Hispanic Black,14.0,Male,Thyroid,2019
75-79,117.8,142.5,436,Incidence,336133,Non-Hispanic Black,129.7,Male,Urinary Bladder,2019
80-84,2418.2,2556.6,4994,Incidence,200828,Non-Hispanic Black,2486.7,Male,All Cancer Sites Combined,2019
80-84,13.0,25.4,37,Incidence,200828,Non-Hispanic Black,18.4,Male,Brain and Other Nervous System,2019
80-84,226.7,270.7,498,Incidence,200828,Non-Hispanic Black,248.0,Male,Colon and Rectum,2019
80-84,22.8,38.5,60,Incidence,200828,Non-Hispanic Black,29.9,Male,Esophagus,2019
80-84,~,~,~,Incidence,200828,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,200828,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
80-84,93.7,122.9,216,Incidence,200828,Non-Hispanic Black,107.6,Male,Kidney and Renal Pelvis,2019
80-84,25.0,41.3,65,Incidence,200828,Non-Hispanic Black,32.4,Male,Larynx,2019
80-84,61.4,85.5,146,Incidence,200828,Non-Hispanic Black,72.7,Male,Leukemias,2019
80-84,44.6,65.5,109,Incidence,200828,Non-Hispanic Black,54.3,Male,Liver and Intrahepatic Bile Duct,2019
80-84,446.3,507.2,956,Incidence,200828,Non-Hispanic Black,476.0,Male,Lung and Bronchus,2019
80-84,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
80-84,~,~,~,Incidence,200828,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
80-84,~,~,~,Incidence,200828,Non-Hispanic Black,~,Male,Mesothelioma,2019
80-84,95.1,124.5,219,Incidence,200828,Non-Hispanic Black,109.0,Male,Myeloma,2019
80-84,66.0,90.9,156,Incidence,200828,Non-Hispanic Black,77.7,Male,Non-Hodgkin Lymphoma,2019
80-84,37.8,57.3,94,Incidence,200828,Non-Hispanic Black,46.8,Male,Oral Cavity and Pharynx,2019
80-84,92.8,121.8,214,Incidence,200828,Non-Hispanic Black,106.6,Male,Pancreas,2019
80-84,553.5,621.0,1178,Incidence,200828,Non-Hispanic Black,586.6,Male,Prostate,2019
80-84,71.0,96.8,167,Incidence,200828,Non-Hispanic Black,83.2,Male,Stomach,2019
80-84,~,~,~,Incidence,200828,Non-Hispanic Black,~,Male,Testis,2019
80-84,4.6,12.9,16,Incidence,200828,Non-Hispanic Black,8.0,Male,Thyroid,2019
80-84,143.3,178.8,322,Incidence,200828,Non-Hispanic Black,160.3,Male,Urinary Bladder,2019
85+,2213.7,2363.5,3612,Incidence,157889,Non-Hispanic Black,2287.7,Male,All Cancer Sites Combined,2019
85+,7.7,19.6,20,Incidence,157889,Non-Hispanic Black,12.7,Male,Brain and Other Nervous System,2019
85+,250.8,303.3,436,Incidence,157889,Non-Hispanic Black,276.1,Male,Colon and Rectum,2019
85+,18.6,35.2,41,Incidence,157889,Non-Hispanic Black,26.0,Male,Esophagus,2019
85+,~,~,~,Incidence,157889,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,157889,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
85+,52.7,78.4,102,Incidence,157889,Non-Hispanic Black,64.6,Male,Kidney and Renal Pelvis,2019
85+,21.3,38.9,46,Incidence,157889,Non-Hispanic Black,29.1,Male,Larynx,2019
85+,67.6,96.4,128,Incidence,157889,Non-Hispanic Black,81.1,Male,Leukemias,2019
85+,30.1,50.3,62,Incidence,157889,Non-Hispanic Black,39.3,Male,Liver and Intrahepatic Bile Duct,2019
85+,372.1,435.4,636,Incidence,157889,Non-Hispanic Black,402.8,Male,Lung and Bronchus,2019
85+,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
85+,7.2,18.8,19,Incidence,157889,Non-Hispanic Black,12.0,Male,Melanomas of the Skin,2019
85+,~,~,~,Incidence,157889,Non-Hispanic Black,~,Male,Mesothelioma,2019
85+,78.7,109.4,147,Incidence,157889,Non-Hispanic Black,93.1,Male,Myeloma,2019
85+,57.3,84.0,110,Incidence,157889,Non-Hispanic Black,69.7,Male,Non-Hodgkin Lymphoma,2019
85+,20.8,38.1,45,Incidence,157889,Non-Hispanic Black,28.5,Male,Oral Cavity and Pharynx,2019
85+,78.7,109.4,147,Incidence,157889,Non-Hispanic Black,93.1,Male,Pancreas,2019
85+,461.2,531.2,782,Incidence,157889,Non-Hispanic Black,495.3,Male,Prostate,2019
85+,73.4,103.3,138,Incidence,157889,Non-Hispanic Black,87.4,Male,Stomach,2019
85+,~,~,~,Incidence,157889,Non-Hispanic Black,~,Male,Testis,2019
85+,~,~,~,Incidence,157889,Non-Hispanic Black,~,Male,Thyroid,2019
85+,159.6,202.1,284,Incidence,157889,Non-Hispanic Black,179.9,Male,Urinary Bladder,2019
<1,17.5,28.6,68,Incidence,301209,Non-Hispanic Black,22.6,Male,All Cancer Sites Combined,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Colon and Rectum,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Esophagus,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Larynx,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Leukemias,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Lung and Bronchus,2019
<1,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Melanomas of the Skin,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Mesothelioma,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Myeloma,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Pancreas,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Prostate,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Stomach,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Testis,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Thyroid,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male,Urinary Bladder,2019
1-4,15.5,18.9,419,Incidence,2443262,Non-Hispanic Black,17.1,Male and Female,All Cancer Sites Combined,2019
1-4,2.9,4.4,87,Incidence,2443262,Non-Hispanic Black,3.6,Male and Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,Cervix,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Esophagus,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,Female Breast,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
1-4,2.0,3.3,63,Incidence,2443262,Non-Hispanic Black,2.6,Male and Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Larynx,2019
1-4,3.4,5.0,101,Incidence,2443262,Non-Hispanic Black,4.1,Male and Female,Leukemias,2019
1-4,0.5,1.3,21,Incidence,2443262,Non-Hispanic Black,0.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Myeloma,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,1203197,Non-Hispanic Black,~,Male and Female,Ovary,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Pancreas,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male and Female,Prostate,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Stomach,2019
1-4,~,~,~,Incidence,1240065,Non-Hispanic Black,~,Male and Female,Testis,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Thyroid,2019
1-4,~,~,~,Incidence,2443262,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
10-14,11.0,13.4,383,Incidence,3151582,Non-Hispanic Black,12.2,Male and Female,All Cancer Sites Combined,2019
10-14,1.8,2.9,74,Incidence,3151582,Non-Hispanic Black,2.3,Male and Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Male and Female,Cervix,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Esophagus,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Male and Female,Female Breast,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2019
10-14,0.7,1.4,31,Incidence,3151582,Non-Hispanic Black,1.0,Male and Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Larynx,2019
10-14,1.6,2.6,64,Incidence,3151582,Non-Hispanic Black,2.0,Male and Female,Leukemias,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2019
10-14,~,~,~,Incidence,1552128,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Myeloma,2019
10-14,0.6,1.3,29,Incidence,3151582,Non-Hispanic Black,0.9,Male and Female,Non-Hodgkin Lymphoma,2019
10-14,0.3,0.8,16,Incidence,3151582,Non-Hispanic Black,0.5,Male and Female,Oral Cavity and Pharynx,2019
10-14,0.6,1.7,16,Incidence,1552128,Non-Hispanic Black,1.0,Male and Female,Ovary,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Pancreas,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male and Female,Prostate,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Stomach,2019
10-14,~,~,~,Incidence,1599454,Non-Hispanic Black,~,Male and Female,Testis,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Thyroid,2019
10-14,~,~,~,Incidence,3151582,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
15-19,14.8,17.6,507,Incidence,3141199,Non-Hispanic Black,16.1,Male and Female,All Cancer Sites Combined,2019
15-19,1.1,2.0,48,Incidence,3141199,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Male and Female,Cervix,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Esophagus,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Male and Female,Female Breast,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2019
15-19,1.8,2.9,72,Incidence,3141199,Non-Hispanic Black,2.3,Male and Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Larynx,2019
15-19,1.5,2.5,60,Incidence,3141199,Non-Hispanic Black,1.9,Male and Female,Leukemias,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2019
15-19,~,~,~,Incidence,1548518,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Myeloma,2019
15-19,1.2,2.2,52,Incidence,3141199,Non-Hispanic Black,1.7,Male and Female,Non-Hodgkin Lymphoma,2019
15-19,0.4,1.0,20,Incidence,3141199,Non-Hispanic Black,0.6,Male and Female,Oral Cavity and Pharynx,2019
15-19,0.6,1.7,16,Incidence,1548518,Non-Hispanic Black,1.0,Male and Female,Ovary,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Pancreas,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male and Female,Prostate,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Stomach,2019
15-19,~,~,~,Incidence,1592681,Non-Hispanic Black,~,Male and Female,Testis,2019
15-19,0.8,1.6,37,Incidence,3141199,Non-Hispanic Black,1.2,Male and Female,Thyroid,2019
15-19,~,~,~,Incidence,3141199,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
20-24,22.3,25.6,783,Incidence,3274757,Non-Hispanic Black,23.9,Male and Female,All Cancer Sites Combined,2019
20-24,1.2,2.1,52,Incidence,3274757,Non-Hispanic Black,1.6,Male and Female,Brain and Other Nervous System,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Male and Female,Cervix,2019
20-24,1.0,1.9,46,Incidence,3274757,Non-Hispanic Black,1.4,Male and Female,Colon and Rectum,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Esophagus,2019
20-24,2.1,3.8,46,Incidence,1615594,Non-Hispanic Black,2.8,Male and Female,Female Breast,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2019
20-24,3.2,4.6,127,Incidence,3274757,Non-Hispanic Black,3.9,Male and Female,Hodgkin Lymphoma,2019
20-24,0.3,0.8,17,Incidence,3274757,Non-Hispanic Black,0.5,Male and Female,Kaposi Sarcoma,2019
20-24,0.3,0.9,18,Incidence,3274757,Non-Hispanic Black,0.5,Male and Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Larynx,2019
20-24,1.6,2.7,69,Incidence,3274757,Non-Hispanic Black,2.1,Male and Female,Leukemias,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
20-24,0.3,0.9,18,Incidence,3274757,Non-Hispanic Black,0.5,Male and Female,Lung and Bronchus,2019
20-24,2.1,3.8,46,Incidence,1615594,Non-Hispanic Black,2.8,Male and Female,Male and Female Breast,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Myeloma,2019
20-24,2.1,3.3,87,Incidence,3274757,Non-Hispanic Black,2.7,Male and Female,Non-Hodgkin Lymphoma,2019
20-24,0.6,1.3,31,Incidence,3274757,Non-Hispanic Black,0.9,Male and Female,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,1615594,Non-Hispanic Black,~,Male and Female,Ovary,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Pancreas,2019
20-24,~,~,~,Incidence,1659163,Non-Hispanic Black,~,Male and Female,Prostate,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Stomach,2019
20-24,1.2,2.5,29,Incidence,1659163,Non-Hispanic Black,1.7,Male and Female,Testis,2019
20-24,1.2,2.1,52,Incidence,3274757,Non-Hispanic Black,1.6,Male and Female,Thyroid,2019
20-24,~,~,~,Incidence,3274757,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
25-29,41.6,45.9,1602,Incidence,3664976,Non-Hispanic Black,43.7,Male and Female,All Cancer Sites Combined,2019
25-29,1.1,2.0,55,Incidence,3664976,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2019
25-29,3.6,5.6,82,Incidence,1817610,Non-Hispanic Black,4.5,Male and Female,Cervix,2019
25-29,2.6,3.8,116,Incidence,3664976,Non-Hispanic Black,3.2,Male and Female,Colon and Rectum,2019
25-29,1.5,2.9,38,Incidence,1817610,Non-Hispanic Black,2.1,Male and Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Esophagus,2019
25-29,12.7,16.2,261,Incidence,1817610,Non-Hispanic Black,14.4,Male and Female,Female Breast,2019
25-29,1.0,2.2,27,Incidence,1817610,Non-Hispanic Black,1.5,Male and Female,"Female Breast, <i>in situ</i>",2019
25-29,2.9,4.2,129,Incidence,3664976,Non-Hispanic Black,3.5,Male and Female,Hodgkin Lymphoma,2019
25-29,0.9,1.7,47,Incidence,3664976,Non-Hispanic Black,1.3,Male and Female,Kaposi Sarcoma,2019
25-29,1.1,1.9,54,Incidence,3664976,Non-Hispanic Black,1.5,Male and Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Larynx,2019
25-29,2.1,3.2,97,Incidence,3664976,Non-Hispanic Black,2.6,Male and Female,Leukemias,2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2019
25-29,12.7,16.2,261,Incidence,1817610,Non-Hispanic Black,14.4,Male and Female,Male and Female Breast,2019
25-29,1.0,2.2,27,Incidence,1817610,Non-Hispanic Black,1.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Myeloma,2019
25-29,3.7,5.1,160,Incidence,3664976,Non-Hispanic Black,4.4,Male and Female,Non-Hodgkin Lymphoma,2019
25-29,0.7,1.4,36,Incidence,3664976,Non-Hispanic Black,1.0,Male and Female,Oral Cavity and Pharynx,2019
25-29,1.6,3.0,40,Incidence,1817610,Non-Hispanic Black,2.2,Male and Female,Ovary,2019
25-29,0.2,0.7,16,Incidence,3664976,Non-Hispanic Black,0.4,Male and Female,Pancreas,2019
25-29,~,~,~,Incidence,1847366,Non-Hispanic Black,~,Male and Female,Prostate,2019
25-29,0.3,0.8,18,Incidence,3664976,Non-Hispanic Black,0.5,Male and Female,Stomach,2019
25-29,2.0,3.5,49,Incidence,1847366,Non-Hispanic Black,2.7,Male and Female,Testis,2019
25-29,3.4,4.8,149,Incidence,3664976,Non-Hispanic Black,4.1,Male and Female,Thyroid,2019
25-29,~,~,~,Incidence,3664976,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
30-34,74.2,80.4,2430,Incidence,3143946,Non-Hispanic Black,77.3,Male and Female,All Cancer Sites Combined,2019
30-34,1.1,2.0,48,Incidence,3143946,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2019
30-34,7.7,10.8,147,Incidence,1604608,Non-Hispanic Black,9.2,Male and Female,Cervix,2019
30-34,5.0,6.7,182,Incidence,3143946,Non-Hispanic Black,5.8,Male and Female,Colon and Rectum,2019
30-34,3.2,5.3,67,Incidence,1604608,Non-Hispanic Black,4.2,Male and Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,3143946,Non-Hispanic Black,~,Male and Female,Esophagus,2019
30-34,34.3,40.4,598,Incidence,1604608,Non-Hispanic Black,37.3,Male and Female,Female Breast,2019
30-34,3.0,5.0,63,Incidence,1604608,Non-Hispanic Black,3.9,Male and Female,"Female Breast, <i>in situ</i>",2019
30-34,3.1,4.5,119,Incidence,3143946,Non-Hispanic Black,3.8,Male and Female,Hodgkin Lymphoma,2019
30-34,1.4,2.4,59,Incidence,3143946,Non-Hispanic Black,1.9,Male and Female,Kaposi Sarcoma,2019
30-34,2.6,3.9,100,Incidence,3143946,Non-Hispanic Black,3.2,Male and Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,3143946,Non-Hispanic Black,~,Male and Female,Larynx,2019
30-34,2.8,4.1,107,Incidence,3143946,Non-Hispanic Black,3.4,Male and Female,Leukemias,2019
30-34,0.8,1.6,36,Incidence,3143946,Non-Hispanic Black,1.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
30-34,0.8,1.6,37,Incidence,3143946,Non-Hispanic Black,1.2,Male and Female,Lung and Bronchus,2019
30-34,34.3,40.4,598,Incidence,1604608,Non-Hispanic Black,37.3,Male and Female,Male and Female Breast,2019
30-34,3.0,5.0,63,Incidence,1604608,Non-Hispanic Black,3.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
30-34,~,~,~,Incidence,3143946,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,3143946,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
30-34,0.6,1.2,27,Incidence,3143946,Non-Hispanic Black,0.9,Male and Female,Myeloma,2019
30-34,5.0,6.7,182,Incidence,3143946,Non-Hispanic Black,5.8,Male and Female,Non-Hodgkin Lymphoma,2019
30-34,1.2,2.1,50,Incidence,3143946,Non-Hispanic Black,1.6,Male and Female,Oral Cavity and Pharynx,2019
30-34,2.2,4.0,48,Incidence,1604608,Non-Hispanic Black,3.0,Male and Female,Ovary,2019
30-34,0.4,0.9,19,Incidence,3143946,Non-Hispanic Black,0.6,Male and Female,Pancreas,2019
30-34,~,~,~,Incidence,1539338,Non-Hispanic Black,~,Male and Female,Prostate,2019
30-34,0.7,1.4,32,Incidence,3143946,Non-Hispanic Black,1.0,Male and Female,Stomach,2019
30-34,2.5,4.4,52,Incidence,1539338,Non-Hispanic Black,3.4,Male and Female,Testis,2019
30-34,5.1,6.9,187,Incidence,3143946,Non-Hispanic Black,5.9,Male and Female,Thyroid,2019
30-34,~,~,~,Incidence,3143946,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
35-39,132.0,140.6,3919,Incidence,2876692,Non-Hispanic Black,136.2,Male and Female,All Cancer Sites Combined,2019
35-39,1.7,2.8,63,Incidence,2876692,Non-Hispanic Black,2.2,Male and Female,Brain and Other Nervous System,2019
35-39,11.3,15.0,196,Incidence,1502140,Non-Hispanic Black,13.0,Male and Female,Cervix,2019
35-39,10.8,13.4,347,Incidence,2876692,Non-Hispanic Black,12.1,Male and Female,Colon and Rectum,2019
35-39,7.0,10.1,127,Incidence,1502140,Non-Hispanic Black,8.5,Male and Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,2876692,Non-Hispanic Black,~,Male and Female,Esophagus,2019
35-39,69.1,77.8,1102,Incidence,1502140,Non-Hispanic Black,73.4,Male and Female,Female Breast,2019
35-39,8.2,11.4,146,Incidence,1502140,Non-Hispanic Black,9.7,Male and Female,"Female Breast, <i>in situ</i>",2019
35-39,3.3,4.8,115,Incidence,2876692,Non-Hispanic Black,4.0,Male and Female,Hodgkin Lymphoma,2019
35-39,0.7,1.5,31,Incidence,2876692,Non-Hispanic Black,1.1,Male and Female,Kaposi Sarcoma,2019
35-39,6.0,7.9,198,Incidence,2876692,Non-Hispanic Black,6.9,Male and Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,2876692,Non-Hispanic Black,~,Male and Female,Larynx,2019
35-39,3.9,5.6,135,Incidence,2876692,Non-Hispanic Black,4.7,Male and Female,Leukemias,2019
35-39,0.9,1.8,37,Incidence,2876692,Non-Hispanic Black,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
35-39,3.3,4.8,114,Incidence,2876692,Non-Hispanic Black,4.0,Male and Female,Lung and Bronchus,2019
35-39,69.1,77.8,1102,Incidence,1502140,Non-Hispanic Black,73.4,Male and Female,Male and Female Breast,2019
35-39,8.2,11.4,146,Incidence,1502140,Non-Hispanic Black,9.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
35-39,~,~,~,Incidence,2876692,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,2876692,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
35-39,1.7,2.8,64,Incidence,2876692,Non-Hispanic Black,2.2,Male and Female,Myeloma,2019
35-39,7.4,9.6,243,Incidence,2876692,Non-Hispanic Black,8.4,Male and Female,Non-Hodgkin Lymphoma,2019
35-39,2.5,3.8,89,Incidence,2876692,Non-Hispanic Black,3.1,Male and Female,Oral Cavity and Pharynx,2019
35-39,3.1,5.2,61,Incidence,1502140,Non-Hispanic Black,4.1,Male and Female,Ovary,2019
35-39,1.6,2.7,60,Incidence,2876692,Non-Hispanic Black,2.1,Male and Female,Pancreas,2019
35-39,0.9,2.3,21,Incidence,1374552,Non-Hispanic Black,1.5,Male and Female,Prostate,2019
35-39,2.1,3.3,76,Incidence,2876692,Non-Hispanic Black,2.6,Male and Female,Stomach,2019
35-39,2.9,5.0,53,Incidence,1374552,Non-Hispanic Black,3.9,Male and Female,Testis,2019
35-39,7.8,10.0,254,Incidence,2876692,Non-Hispanic Black,8.8,Male and Female,Thyroid,2019
35-39,0.6,1.4,27,Incidence,2876692,Non-Hispanic Black,0.9,Male and Female,Urinary Bladder,2019
40-44,215.6,227.1,5769,Incidence,2606816,Non-Hispanic Black,221.3,Male and Female,All Cancer Sites Combined,2019
40-44,3.2,4.7,102,Incidence,2606816,Non-Hispanic Black,3.9,Male and Female,Brain and Other Nervous System,2019
40-44,11.9,15.9,190,Incidence,1378352,Non-Hispanic Black,13.8,Male and Female,Cervix,2019
40-44,19.4,23.0,551,Incidence,2606816,Non-Hispanic Black,21.1,Male and Female,Colon and Rectum,2019
40-44,10.0,13.7,162,Incidence,1378352,Non-Hispanic Black,11.8,Male and Female,"Corpus and Uterus, NOS",2019
40-44,0.4,1.1,19,Incidence,2606816,Non-Hispanic Black,0.7,Male and Female,Esophagus,2019
40-44,125.8,138.0,1817,Incidence,1378352,Non-Hispanic Black,131.8,Male and Female,Female Breast,2019
40-44,33.2,39.6,500,Incidence,1378352,Non-Hispanic Black,36.3,Male and Female,"Female Breast, <i>in situ</i>",2019
40-44,3.0,4.5,96,Incidence,2606816,Non-Hispanic Black,3.7,Male and Female,Hodgkin Lymphoma,2019
40-44,1.0,2.0,37,Incidence,2606816,Non-Hispanic Black,1.4,Male and Female,Kaposi Sarcoma,2019
40-44,10.6,13.3,309,Incidence,2606816,Non-Hispanic Black,11.9,Male and Female,Kidney and Renal Pelvis,2019
40-44,0.6,1.4,24,Incidence,2606816,Non-Hispanic Black,0.9,Male and Female,Larynx,2019
40-44,5.4,7.3,164,Incidence,2606816,Non-Hispanic Black,6.3,Male and Female,Leukemias,2019
40-44,1.3,2.4,47,Incidence,2606816,Non-Hispanic Black,1.8,Male and Female,Liver and Intrahepatic Bile Duct,2019
40-44,7.1,9.4,214,Incidence,2606816,Non-Hispanic Black,8.2,Male and Female,Lung and Bronchus,2019
40-44,125.8,138.0,1817,Incidence,1378352,Non-Hispanic Black,131.8,Male and Female,Male and Female Breast,2019
40-44,33.2,39.6,500,Incidence,1378352,Non-Hispanic Black,36.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
40-44,0.5,1.3,22,Incidence,2606816,Non-Hispanic Black,0.8,Male and Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,2606816,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
40-44,5.0,6.9,154,Incidence,2606816,Non-Hispanic Black,5.9,Male and Female,Myeloma,2019
40-44,7.5,9.8,223,Incidence,2606816,Non-Hispanic Black,8.6,Male and Female,Non-Hodgkin Lymphoma,2019
40-44,4.6,6.4,142,Incidence,2606816,Non-Hispanic Black,5.4,Male and Female,Oral Cavity and Pharynx,2019
40-44,4.3,6.9,76,Incidence,1378352,Non-Hispanic Black,5.5,Male and Female,Ovary,2019
40-44,3.6,5.2,113,Incidence,2606816,Non-Hispanic Black,4.3,Male and Female,Pancreas,2019
40-44,15.4,20.2,217,Incidence,1228464,Non-Hispanic Black,17.7,Male and Female,Prostate,2019
40-44,2.9,4.4,94,Incidence,2606816,Non-Hispanic Black,3.6,Male and Female,Stomach,2019
40-44,1.8,3.7,32,Incidence,1228464,Non-Hispanic Black,2.6,Male and Female,Testis,2019
40-44,10.3,12.9,301,Incidence,2606816,Non-Hispanic Black,11.5,Male and Female,Thyroid,2019
40-44,1.3,2.4,46,Incidence,2606816,Non-Hispanic Black,1.8,Male and Female,Urinary Bladder,2019
45-49,363.3,378.1,9736,Incidence,2626601,Non-Hispanic Black,370.7,Male and Female,All Cancer Sites Combined,2019
45-49,2.9,4.4,95,Incidence,2626601,Non-Hispanic Black,3.6,Male and Female,Brain and Other Nervous System,2019
45-49,12.4,16.4,200,Incidence,1397512,Non-Hispanic Black,14.3,Male and Female,Cervix,2019
45-49,39.0,43.9,1087,Incidence,2626601,Non-Hispanic Black,41.4,Male and Female,Colon and Rectum,2019
45-49,18.8,23.7,295,Incidence,1397512,Non-Hispanic Black,21.1,Male and Female,"Corpus and Uterus, NOS",2019
45-49,1.9,3.1,64,Incidence,2626601,Non-Hispanic Black,2.4,Male and Female,Esophagus,2019
45-49,189.4,204.2,2749,Incidence,1397512,Non-Hispanic Black,196.7,Male and Female,Female Breast,2019
45-49,45.8,53.2,690,Incidence,1397512,Non-Hispanic Black,49.4,Male and Female,"Female Breast, <i>in situ</i>",2019
45-49,2.7,4.1,88,Incidence,2626601,Non-Hispanic Black,3.4,Male and Female,Hodgkin Lymphoma,2019
45-49,0.6,1.3,23,Incidence,2626601,Non-Hispanic Black,0.9,Male and Female,Kaposi Sarcoma,2019
45-49,18.5,21.9,529,Incidence,2626601,Non-Hispanic Black,20.1,Male and Female,Kidney and Renal Pelvis,2019
45-49,1.7,2.9,60,Incidence,2626601,Non-Hispanic Black,2.3,Male and Female,Larynx,2019
45-49,8.1,10.4,241,Incidence,2626601,Non-Hispanic Black,9.2,Male and Female,Leukemias,2019
45-49,2.6,4.0,85,Incidence,2626601,Non-Hispanic Black,3.2,Male and Female,Liver and Intrahepatic Bile Duct,2019
45-49,15.4,18.6,446,Incidence,2626601,Non-Hispanic Black,17.0,Male and Female,Lung and Bronchus,2019
45-49,189.4,204.2,2749,Incidence,1397512,Non-Hispanic Black,196.7,Male and Female,Male and Female Breast,2019
45-49,45.8,53.2,690,Incidence,1397512,Non-Hispanic Black,49.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
45-49,0.7,1.5,28,Incidence,2626601,Non-Hispanic Black,1.1,Male and Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,2626601,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
45-49,9.8,12.4,291,Incidence,2626601,Non-Hispanic Black,11.1,Male and Female,Myeloma,2019
45-49,13.6,16.6,396,Incidence,2626601,Non-Hispanic Black,15.1,Male and Female,Non-Hodgkin Lymphoma,2019
45-49,7.7,10.0,232,Incidence,2626601,Non-Hispanic Black,8.8,Male and Female,Oral Cavity and Pharynx,2019
45-49,8.4,11.8,140,Incidence,1397512,Non-Hispanic Black,10.0,Male and Female,Ovary,2019
45-49,7.8,10.2,235,Incidence,2626601,Non-Hispanic Black,8.9,Male and Female,Pancreas,2019
45-49,74.3,84.4,974,Incidence,1229089,Non-Hispanic Black,79.2,Male and Female,Prostate,2019
45-49,6.1,8.2,187,Incidence,2626601,Non-Hispanic Black,7.1,Male and Female,Stomach,2019
45-49,1.6,3.5,30,Incidence,1229089,Non-Hispanic Black,2.4,Male and Female,Testis,2019
45-49,11.8,14.6,346,Incidence,2626601,Non-Hispanic Black,13.2,Male and Female,Thyroid,2019
45-49,3.1,4.7,101,Incidence,2626601,Non-Hispanic Black,3.8,Male and Female,Urinary Bladder,2019
5-9,8.8,11.1,307,Incidence,3092837,Non-Hispanic Black,9.9,Male and Female,All Cancer Sites Combined,2019
5-9,1.9,3.0,74,Incidence,3092837,Non-Hispanic Black,2.4,Male and Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,Cervix,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Esophagus,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,Female Breast,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
5-9,0.5,1.2,26,Incidence,3092837,Non-Hispanic Black,0.8,Male and Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Larynx,2019
5-9,2.2,3.4,84,Incidence,3092837,Non-Hispanic Black,2.7,Male and Female,Leukemias,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Myeloma,2019
5-9,0.5,1.2,26,Incidence,3092837,Non-Hispanic Black,0.8,Male and Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,1520994,Non-Hispanic Black,~,Male and Female,Ovary,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Pancreas,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male and Female,Prostate,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Stomach,2019
5-9,~,~,~,Incidence,1571843,Non-Hispanic Black,~,Male and Female,Testis,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Thyroid,2019
5-9,~,~,~,Incidence,3092837,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
50-54,602.9,622.0,15839,Incidence,2586357,Non-Hispanic Black,612.4,Male and Female,All Cancer Sites Combined,2019
50-54,4.7,6.6,144,Incidence,2586357,Non-Hispanic Black,5.6,Male and Female,Brain and Other Nervous System,2019
50-54,13.3,17.5,211,Incidence,1377812,Non-Hispanic Black,15.3,Male and Female,Cervix,2019
50-54,73.7,80.5,1993,Incidence,2586357,Non-Hispanic Black,77.1,Male and Female,Colon and Rectum,2019
50-54,33.8,40.3,509,Incidence,1377812,Non-Hispanic Black,36.9,Male and Female,"Corpus and Uterus, NOS",2019
50-54,3.7,5.4,116,Incidence,2586357,Non-Hispanic Black,4.5,Male and Female,Esophagus,2019
50-54,235.0,251.5,3350,Incidence,1377812,Non-Hispanic Black,243.1,Male and Female,Female Breast,2019
50-54,56.6,64.9,835,Incidence,1377812,Non-Hispanic Black,60.6,Male and Female,"Female Breast, <i>in situ</i>",2019
50-54,2.4,3.8,79,Incidence,2586357,Non-Hispanic Black,3.1,Male and Female,Hodgkin Lymphoma,2019
50-54,0.4,1.1,19,Incidence,2586357,Non-Hispanic Black,0.7,Male and Female,Kaposi Sarcoma,2019
50-54,29.8,34.2,825,Incidence,2586357,Non-Hispanic Black,31.9,Male and Female,Kidney and Renal Pelvis,2019
50-54,3.7,5.4,117,Incidence,2586357,Non-Hispanic Black,4.5,Male and Female,Larynx,2019
50-54,10.7,13.4,311,Incidence,2586357,Non-Hispanic Black,12.0,Male and Female,Leukemias,2019
50-54,6.4,8.6,193,Incidence,2586357,Non-Hispanic Black,7.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
50-54,36.9,41.7,1015,Incidence,2586357,Non-Hispanic Black,39.2,Male and Female,Lung and Bronchus,2019
50-54,235.0,251.5,3350,Incidence,1377812,Non-Hispanic Black,243.1,Male and Female,Male and Female Breast,2019
50-54,56.6,64.9,835,Incidence,1377812,Non-Hispanic Black,60.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
50-54,0.9,1.8,33,Incidence,2586357,Non-Hispanic Black,1.3,Male and Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,2586357,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
50-54,15.9,19.2,452,Incidence,2586357,Non-Hispanic Black,17.5,Male and Female,Myeloma,2019
50-54,17.7,21.2,502,Incidence,2586357,Non-Hispanic Black,19.4,Male and Female,Non-Hodgkin Lymphoma,2019
50-54,13.9,17.0,398,Incidence,2586357,Non-Hispanic Black,15.4,Male and Female,Oral Cavity and Pharynx,2019
50-54,9.3,12.9,152,Incidence,1377812,Non-Hispanic Black,11.0,Male and Female,Ovary,2019
50-54,14.9,18.0,424,Incidence,2586357,Non-Hispanic Black,16.4,Male and Female,Pancreas,2019
50-54,232.8,250.5,2919,Incidence,1208545,Non-Hispanic Black,241.5,Male and Female,Prostate,2019
50-54,10.7,13.4,309,Incidence,2586357,Non-Hispanic Black,11.9,Male and Female,Stomach,2019
50-54,0.8,2.3,17,Incidence,1208545,Non-Hispanic Black,1.4,Male and Female,Testis,2019
50-54,12.0,14.9,347,Incidence,2586357,Non-Hispanic Black,13.4,Male and Female,Thyroid,2019
50-54,6.5,8.7,195,Incidence,2586357,Non-Hispanic Black,7.5,Male and Female,Urinary Bladder,2019
55-59,947.2,970.7,25488,Incidence,2658056,Non-Hispanic Black,958.9,Male and Female,All Cancer Sites Combined,2019
55-59,6.7,8.9,206,Incidence,2658056,Non-Hispanic Black,7.8,Male and Female,Brain and Other Nervous System,2019
55-59,14.0,18.2,229,Incidence,1429413,Non-Hispanic Black,16.0,Male and Female,Cervix,2019
55-59,80.7,87.7,2237,Incidence,2658056,Non-Hispanic Black,84.2,Male and Female,Colon and Rectum,2019
55-59,65.8,74.6,1002,Incidence,1429413,Non-Hispanic Black,70.1,Male and Female,"Corpus and Uterus, NOS",2019
55-59,7.4,9.7,226,Incidence,2658056,Non-Hispanic Black,8.5,Male and Female,Esophagus,2019
55-59,281.8,299.5,4153,Incidence,1429413,Non-Hispanic Black,290.5,Male and Female,Female Breast,2019
55-59,72.9,82.1,1106,Incidence,1429413,Non-Hispanic Black,77.4,Male and Female,"Female Breast, <i>in situ</i>",2019
55-59,2.2,3.5,73,Incidence,2658056,Non-Hispanic Black,2.7,Male and Female,Hodgkin Lymphoma,2019
55-59,0.6,1.4,26,Incidence,2658056,Non-Hispanic Black,1.0,Male and Female,Kaposi Sarcoma,2019
55-59,41.3,46.4,1165,Incidence,2658056,Non-Hispanic Black,43.8,Male and Female,Kidney and Renal Pelvis,2019
55-59,9.7,12.2,289,Incidence,2658056,Non-Hispanic Black,10.9,Male and Female,Larynx,2019
55-59,15.0,18.1,439,Incidence,2658056,Non-Hispanic Black,16.5,Male and Female,Leukemias,2019
55-59,21.9,25.6,630,Incidence,2658056,Non-Hispanic Black,23.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
55-59,103.1,111.0,2844,Incidence,2658056,Non-Hispanic Black,107.0,Male and Female,Lung and Bronchus,2019
55-59,281.8,299.5,4153,Incidence,1429413,Non-Hispanic Black,290.5,Male and Female,Male and Female Breast,2019
55-59,72.9,82.1,1106,Incidence,1429413,Non-Hispanic Black,77.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
55-59,0.9,1.8,35,Incidence,2658056,Non-Hispanic Black,1.3,Male and Female,Melanomas of the Skin,2019
55-59,0.5,1.3,22,Incidence,2658056,Non-Hispanic Black,0.8,Male and Female,Mesothelioma,2019
55-59,23.4,27.3,673,Incidence,2658056,Non-Hispanic Black,25.3,Male and Female,Myeloma,2019
55-59,23.0,26.8,660,Incidence,2658056,Non-Hispanic Black,24.8,Male and Female,Non-Hodgkin Lymphoma,2019
55-59,21.0,24.6,605,Incidence,2658056,Non-Hispanic Black,22.8,Male and Female,Oral Cavity and Pharynx,2019
55-59,15.1,19.5,246,Incidence,1429413,Non-Hispanic Black,17.2,Male and Female,Ovary,2019
55-59,28.0,32.2,798,Incidence,2658056,Non-Hispanic Black,30.0,Male and Female,Pancreas,2019
55-59,478.7,503.6,6033,Incidence,1228643,Non-Hispanic Black,491.0,Male and Female,Prostate,2019
55-59,14.4,17.4,421,Incidence,2658056,Non-Hispanic Black,15.8,Male and Female,Stomach,2019
55-59,0.7,2.1,16,Incidence,1228643,Non-Hispanic Black,1.3,Male and Female,Testis,2019
55-59,13.1,16.1,387,Incidence,2658056,Non-Hispanic Black,14.6,Male and Female,Thyroid,2019
55-59,13.1,16.0,385,Incidence,2658056,Non-Hispanic Black,14.5,Male and Female,Urinary Bladder,2019
60-64,1362.4,1392.3,32753,Incidence,2378096,Non-Hispanic Black,1377.3,Male and Female,All Cancer Sites Combined,2019
60-64,5.8,8.0,163,Incidence,2378096,Non-Hispanic Black,6.9,Male and Female,Brain and Other Nervous System,2019
60-64,15.2,19.9,227,Incidence,1301332,Non-Hispanic Black,17.4,Male and Female,Cervix,2019
60-64,104.4,112.8,2582,Incidence,2378096,Non-Hispanic Black,108.6,Male and Female,Colon and Rectum,2019
60-64,117.3,129.4,1604,Incidence,1301332,Non-Hispanic Black,123.3,Male and Female,"Corpus and Uterus, NOS",2019
60-64,12.7,15.8,338,Incidence,2378096,Non-Hispanic Black,14.2,Male and Female,Esophagus,2019
60-64,331.2,351.4,4440,Incidence,1301332,Non-Hispanic Black,341.2,Male and Female,Female Breast,2019
60-64,93.8,104.7,1290,Incidence,1301332,Non-Hispanic Black,99.1,Male and Female,"Female Breast, <i>in situ</i>",2019
60-64,2.0,3.3,61,Incidence,2378096,Non-Hispanic Black,2.6,Male and Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,2378096,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
60-64,56.1,62.3,1407,Incidence,2378096,Non-Hispanic Black,59.2,Male and Female,Kidney and Renal Pelvis,2019
60-64,13.8,17.0,364,Incidence,2378096,Non-Hispanic Black,15.3,Male and Female,Larynx,2019
60-64,19.4,23.1,504,Incidence,2378096,Non-Hispanic Black,21.2,Male and Female,Leukemias,2019
60-64,44.5,50.1,1124,Incidence,2378096,Non-Hispanic Black,47.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
60-64,171.3,182.0,4200,Incidence,2378096,Non-Hispanic Black,176.6,Male and Female,Lung and Bronchus,2019
60-64,331.2,351.4,4440,Incidence,1301332,Non-Hispanic Black,341.2,Male and Female,Male and Female Breast,2019
60-64,93.8,104.7,1290,Incidence,1301332,Non-Hispanic Black,99.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
60-64,1.3,2.5,44,Incidence,2378096,Non-Hispanic Black,1.9,Male and Female,Melanomas of the Skin,2019
60-64,~,~,~,Incidence,2378096,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
60-64,37.0,42.1,939,Incidence,2378096,Non-Hispanic Black,39.5,Male and Female,Myeloma,2019
60-64,29.8,34.4,761,Incidence,2378096,Non-Hispanic Black,32.0,Male and Female,Non-Hodgkin Lymphoma,2019
60-64,26.3,30.6,675,Incidence,2378096,Non-Hispanic Black,28.4,Male and Female,Oral Cavity and Pharynx,2019
60-64,21.4,26.8,312,Incidence,1301332,Non-Hispanic Black,24.0,Male and Female,Ovary,2019
60-64,42.7,48.1,1078,Incidence,2378096,Non-Hispanic Black,45.3,Male and Female,Pancreas,2019
60-64,749.0,782.1,8242,Incidence,1076764,Non-Hispanic Black,765.4,Male and Female,Prostate,2019
60-64,22.7,26.8,587,Incidence,2378096,Non-Hispanic Black,24.7,Male and Female,Stomach,2019
60-64,~,~,~,Incidence,1076764,Non-Hispanic Black,~,Male and Female,Testis,2019
60-64,14.5,17.8,382,Incidence,2378096,Non-Hispanic Black,16.1,Male and Female,Thyroid,2019
60-64,25.0,29.2,643,Incidence,2378096,Non-Hispanic Black,27.0,Male and Female,Urinary Bladder,2019
65-69,1826.1,1865.4,34010,Incidence,1842684,Non-Hispanic Black,1845.7,Male and Female,All Cancer Sites Combined,2019
65-69,7.6,10.4,165,Incidence,1842684,Non-Hispanic Black,9.0,Male and Female,Brain and Other Nervous System,2019
65-69,15.2,20.4,184,Incidence,1043131,Non-Hispanic Black,17.6,Male and Female,Cervix,2019
65-69,138.0,149.0,2643,Incidence,1842684,Non-Hispanic Black,143.4,Male and Female,Colon and Rectum,2019
65-69,138.9,153.7,1525,Incidence,1043131,Non-Hispanic Black,146.2,Male and Female,"Corpus and Uterus, NOS",2019
65-69,13.6,17.2,282,Incidence,1842684,Non-Hispanic Black,15.3,Male and Female,Esophagus,2019
65-69,405.1,430.0,4354,Incidence,1043131,Non-Hispanic Black,417.4,Male and Female,Female Breast,2019
65-69,119.5,133.3,1317,Incidence,1043131,Non-Hispanic Black,126.3,Male and Female,"Female Breast, <i>in situ</i>",2019
65-69,2.2,3.8,53,Incidence,1842684,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,1842684,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
65-69,74.5,82.7,1447,Incidence,1842684,Non-Hispanic Black,78.5,Male and Female,Kidney and Renal Pelvis,2019
65-69,17.4,21.5,357,Incidence,1842684,Non-Hispanic Black,19.4,Male and Female,Larynx,2019
65-69,26.6,31.6,535,Incidence,1842684,Non-Hispanic Black,29.0,Male and Female,Leukemias,2019
65-69,64.0,71.6,1248,Incidence,1842684,Non-Hispanic Black,67.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
65-69,244.0,258.5,4628,Incidence,1842684,Non-Hispanic Black,251.2,Male and Female,Lung and Bronchus,2019
65-69,405.1,430.0,4354,Incidence,1043131,Non-Hispanic Black,417.4,Male and Female,Male and Female Breast,2019
65-69,119.5,133.3,1317,Incidence,1043131,Non-Hispanic Black,126.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
65-69,1.4,2.7,36,Incidence,1842684,Non-Hispanic Black,2.0,Male and Female,Melanomas of the Skin,2019
65-69,1.0,2.1,27,Incidence,1842684,Non-Hispanic Black,1.5,Male and Female,Mesothelioma,2019
65-69,52.5,59.4,1029,Incidence,1842684,Non-Hispanic Black,55.8,Male and Female,Myeloma,2019
65-69,41.8,47.9,825,Incidence,1842684,Non-Hispanic Black,44.8,Male and Female,Non-Hodgkin Lymphoma,2019
65-69,29.6,34.9,593,Incidence,1842684,Non-Hispanic Black,32.2,Male and Female,Oral Cavity and Pharynx,2019
65-69,22.4,28.7,265,Incidence,1043131,Non-Hispanic Black,25.4,Male and Female,Ovary,2019
65-69,62.2,69.7,1214,Incidence,1842684,Non-Hispanic Black,65.9,Male and Female,Pancreas,2019
65-69,1051.7,1097.3,8590,Incidence,799553,Non-Hispanic Black,1074.4,Male and Female,Prostate,2019
65-69,28.6,33.7,573,Incidence,1842684,Non-Hispanic Black,31.1,Male and Female,Stomach,2019
65-69,~,~,~,Incidence,799553,Non-Hispanic Black,~,Male and Female,Testis,2019
65-69,17.9,22.0,366,Incidence,1842684,Non-Hispanic Black,19.9,Male and Female,Thyroid,2019
65-69,42.2,48.4,833,Incidence,1842684,Non-Hispanic Black,45.2,Male and Female,Urinary Bladder,2019
70-74,1959.3,2007.7,25900,Incidence,1305832,Non-Hispanic Black,1983.4,Male and Female,All Cancer Sites Combined,2019
70-74,8.2,11.7,128,Incidence,1305832,Non-Hispanic Black,9.8,Male and Female,Brain and Other Nervous System,2019
70-74,12.1,17.7,111,Incidence,756104,Non-Hispanic Black,14.7,Male and Female,Cervix,2019
70-74,153.3,167.1,2091,Incidence,1305832,Non-Hispanic Black,160.1,Male and Female,Colon and Rectum,2019
70-74,130.6,147.5,1050,Incidence,756104,Non-Hispanic Black,138.9,Male and Female,"Corpus and Uterus, NOS",2019
70-74,15.6,20.2,232,Incidence,1305832,Non-Hispanic Black,17.8,Male and Female,Esophagus,2019
70-74,439.6,470.2,3438,Incidence,756104,Non-Hispanic Black,454.7,Male and Female,Female Breast,2019
70-74,131.0,147.9,1053,Incidence,756104,Non-Hispanic Black,139.3,Male and Female,"Female Breast, <i>in situ</i>",2019
70-74,1.6,3.3,30,Incidence,1305832,Non-Hispanic Black,2.3,Male and Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,1305832,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
70-74,79.6,89.7,1104,Incidence,1305832,Non-Hispanic Black,84.5,Male and Female,Kidney and Renal Pelvis,2019
70-74,15.9,20.6,237,Incidence,1305832,Non-Hispanic Black,18.1,Male and Female,Larynx,2019
70-74,37.9,45.0,540,Incidence,1305832,Non-Hispanic Black,41.4,Male and Female,Leukemias,2019
70-74,46.8,54.5,660,Incidence,1305832,Non-Hispanic Black,50.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
70-74,309.9,329.3,4172,Incidence,1305832,Non-Hispanic Black,319.5,Male and Female,Lung and Bronchus,2019
70-74,439.6,470.2,3438,Incidence,756104,Non-Hispanic Black,454.7,Male and Female,Male and Female Breast,2019
70-74,131.0,147.9,1053,Incidence,756104,Non-Hispanic Black,139.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
70-74,3.0,5.2,52,Incidence,1305832,Non-Hispanic Black,4.0,Male and Female,Melanomas of the Skin,2019
70-74,1.4,3.0,27,Incidence,1305832,Non-Hispanic Black,2.1,Male and Female,Mesothelioma,2019
70-74,67.5,76.7,940,Incidence,1305832,Non-Hispanic Black,72.0,Male and Female,Myeloma,2019
70-74,44.8,52.4,633,Incidence,1305832,Non-Hispanic Black,48.5,Male and Female,Non-Hodgkin Lymphoma,2019
70-74,27.6,33.6,398,Incidence,1305832,Non-Hispanic Black,30.5,Male and Female,Oral Cavity and Pharynx,2019
70-74,25.4,33.2,220,Incidence,756104,Non-Hispanic Black,29.1,Male and Female,Ovary,2019
70-74,72.4,82.0,1006,Incidence,1305832,Non-Hispanic Black,77.0,Male and Female,Pancreas,2019
70-74,945.3,997.6,5339,Incidence,549728,Non-Hispanic Black,971.2,Male and Female,Prostate,2019
70-74,36.5,43.4,520,Incidence,1305832,Non-Hispanic Black,39.8,Male and Female,Stomach,2019
70-74,~,~,~,Incidence,549728,Non-Hispanic Black,~,Male and Female,Testis,2019
70-74,16.8,21.7,250,Incidence,1305832,Non-Hispanic Black,19.1,Male and Female,Thyroid,2019
70-74,49.6,57.6,699,Incidence,1305832,Non-Hispanic Black,53.5,Male and Female,Urinary Bladder,2019
75-79,2025.0,2086.3,17348,Incidence,843988,Non-Hispanic Black,2055.5,Male and Female,All Cancer Sites Combined,2019
75-79,7.3,11.5,78,Incidence,843988,Non-Hispanic Black,9.2,Male and Female,Brain and Other Nervous System,2019
75-79,14.8,22.4,93,Incidence,507855,Non-Hispanic Black,18.3,Male and Female,Cervix,2019
75-79,178.4,197.0,1583,Incidence,843988,Non-Hispanic Black,187.6,Male and Female,Colon and Rectum,2019
75-79,107.7,126.8,594,Incidence,507855,Non-Hispanic Black,117.0,Male and Female,"Corpus and Uterus, NOS",2019
75-79,13.6,19.2,137,Incidence,843988,Non-Hispanic Black,16.2,Male and Female,Esophagus,2019
75-79,438.4,475.8,2320,Incidence,507855,Non-Hispanic Black,456.8,Male and Female,Female Breast,2019
75-79,95.1,113.0,527,Incidence,507855,Non-Hispanic Black,103.8,Male and Female,"Female Breast, <i>in situ</i>",2019
75-79,2.0,4.5,26,Incidence,843988,Non-Hispanic Black,3.1,Male and Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,843988,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
75-79,73.3,85.4,668,Incidence,843988,Non-Hispanic Black,79.1,Male and Female,Kidney and Renal Pelvis,2019
75-79,14.3,20.0,143,Incidence,843988,Non-Hispanic Black,16.9,Male and Female,Larynx,2019
75-79,42.8,52.1,399,Incidence,843988,Non-Hispanic Black,47.3,Male and Female,Leukemias,2019
75-79,31.6,39.8,300,Incidence,843988,Non-Hispanic Black,35.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
75-79,353.8,379.7,3094,Incidence,843988,Non-Hispanic Black,366.6,Male and Female,Lung and Bronchus,2019
75-79,438.4,475.8,2320,Incidence,507855,Non-Hispanic Black,456.8,Male and Female,Male and Female Breast,2019
75-79,95.1,113.0,527,Incidence,507855,Non-Hispanic Black,103.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
75-79,3.3,6.3,39,Incidence,843988,Non-Hispanic Black,4.6,Male and Female,Melanomas of the Skin,2019
75-79,1.9,4.4,25,Incidence,843988,Non-Hispanic Black,3.0,Male and Female,Mesothelioma,2019
75-79,80.3,93.0,730,Incidence,843988,Non-Hispanic Black,86.5,Male and Female,Myeloma,2019
75-79,51.7,61.9,478,Incidence,843988,Non-Hispanic Black,56.6,Male and Female,Non-Hodgkin Lymphoma,2019
75-79,26.3,33.8,252,Incidence,843988,Non-Hispanic Black,29.9,Male and Female,Oral Cavity and Pharynx,2019
75-79,23.6,33.0,142,Incidence,507855,Non-Hispanic Black,28.0,Male and Female,Ovary,2019
75-79,82.0,94.8,745,Incidence,843988,Non-Hispanic Black,88.3,Male and Female,Pancreas,2019
75-79,776.2,837.2,2710,Incidence,336133,Non-Hispanic Black,806.2,Male and Female,Prostate,2019
75-79,46.0,55.8,428,Incidence,843988,Non-Hispanic Black,50.7,Male and Female,Stomach,2019
75-79,~,~,~,Incidence,336133,Non-Hispanic Black,~,Male and Female,Testis,2019
75-79,14.7,20.5,147,Incidence,843988,Non-Hispanic Black,17.4,Male and Female,Thyroid,2019
75-79,70.3,82.2,642,Incidence,843988,Non-Hispanic Black,76.1,Male and Female,Urinary Bladder,2019
80-84,1967.1,2042.7,10872,Incidence,542344,Non-Hispanic Black,2004.6,Male and Female,All Cancer Sites Combined,2019
80-84,11.4,17.9,78,Incidence,542344,Non-Hispanic Black,14.4,Male and Female,Brain and Other Nervous System,2019
80-84,8.9,16.6,42,Incidence,341516,Non-Hispanic Black,12.3,Male and Female,Cervix,2019
80-84,191.9,216.1,1105,Incidence,542344,Non-Hispanic Black,203.7,Male and Female,Colon and Rectum,2019
80-84,74.0,93.7,285,Incidence,341516,Non-Hispanic Black,83.5,Male and Female,"Corpus and Uterus, NOS",2019
80-84,14.5,21.8,97,Incidence,542344,Non-Hispanic Black,17.9,Male and Female,Esophagus,2019
80-84,397.3,441.0,1430,Incidence,341516,Non-Hispanic Black,418.7,Male and Female,Female Breast,2019
80-84,60.6,78.5,236,Incidence,341516,Non-Hispanic Black,69.1,Male and Female,"Female Breast, <i>in situ</i>",2019
80-84,~,~,~,Incidence,542344,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,542344,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
80-84,66.7,81.3,400,Incidence,542344,Non-Hispanic Black,73.8,Male and Female,Kidney and Renal Pelvis,2019
80-84,12.0,18.8,82,Incidence,542344,Non-Hispanic Black,15.1,Male and Female,Larynx,2019
80-84,46.6,59.0,285,Incidence,542344,Non-Hispanic Black,52.5,Male and Female,Leukemias,2019
80-84,30.2,40.4,190,Incidence,542344,Non-Hispanic Black,35.0,Male and Female,Liver and Intrahepatic Bile Duct,2019
80-84,342.7,374.7,1944,Incidence,542344,Non-Hispanic Black,358.4,Male and Female,Lung and Bronchus,2019
80-84,397.3,441.0,1430,Incidence,341516,Non-Hispanic Black,418.7,Male and Female,Male and Female Breast,2019
80-84,60.6,78.5,236,Incidence,341516,Non-Hispanic Black,69.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
80-84,3.6,7.7,29,Incidence,542344,Non-Hispanic Black,5.3,Male and Female,Melanomas of the Skin,2019
80-84,1.7,4.8,16,Incidence,542344,Non-Hispanic Black,3.0,Male and Female,Mesothelioma,2019
80-84,80.9,97.0,481,Incidence,542344,Non-Hispanic Black,88.7,Male and Female,Myeloma,2019
80-84,56.7,70.3,343,Incidence,542344,Non-Hispanic Black,63.2,Male and Female,Non-Hodgkin Lymphoma,2019
80-84,22.7,31.7,146,Incidence,542344,Non-Hispanic Black,26.9,Male and Female,Oral Cavity and Pharynx,2019
80-84,30.5,43.6,125,Incidence,341516,Non-Hispanic Black,36.6,Male and Female,Ovary,2019
80-84,97.2,114.7,573,Incidence,542344,Non-Hispanic Black,105.7,Male and Female,Pancreas,2019
80-84,553.5,621.0,1178,Incidence,200828,Non-Hispanic Black,586.6,Male and Female,Prostate,2019
80-84,55.7,69.1,337,Incidence,542344,Non-Hispanic Black,62.1,Male and Female,Stomach,2019
80-84,~,~,~,Incidence,200828,Non-Hispanic Black,~,Male and Female,Testis,2019
80-84,8.6,14.4,61,Incidence,542344,Non-Hispanic Black,11.2,Male and Female,Thyroid,2019
80-84,83.9,100.3,498,Incidence,542344,Non-Hispanic Black,91.8,Male and Female,Urinary Bladder,2019
85+,1759.7,1832.9,9305,Incidence,518086,Non-Hispanic Black,1796.0,Male and Female,All Cancer Sites Combined,2019
85+,9.2,15.3,62,Incidence,518086,Non-Hispanic Black,12.0,Male and Female,Brain and Other Nervous System,2019
85+,9.8,17.7,48,Incidence,360197,Non-Hispanic Black,13.3,Male and Female,Cervix,2019
85+,206.3,232.0,1134,Incidence,518086,Non-Hispanic Black,218.9,Male and Female,Colon and Rectum,2019
85+,47.1,62.6,196,Incidence,360197,Non-Hispanic Black,54.4,Male and Female,"Corpus and Uterus, NOS",2019
85+,11.7,18.6,77,Incidence,518086,Non-Hispanic Black,14.9,Male and Female,Esophagus,2019
85+,314.3,352.3,1199,Incidence,360197,Non-Hispanic Black,332.9,Male and Female,Female Breast,2019
85+,28.6,41.0,124,Incidence,360197,Non-Hispanic Black,34.4,Male and Female,"Female Breast, <i>in situ</i>",2019
85+,~,~,~,Incidence,518086,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,518086,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
85+,43.4,55.6,255,Incidence,518086,Non-Hispanic Black,49.2,Male and Female,Kidney and Renal Pelvis,2019
85+,8.7,14.7,59,Incidence,518086,Non-Hispanic Black,11.4,Male and Female,Larynx,2019
85+,53.9,67.5,313,Incidence,518086,Non-Hispanic Black,60.4,Male and Female,Leukemias,2019
85+,25.9,35.6,158,Incidence,518086,Non-Hispanic Black,30.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
85+,262.6,291.5,1434,Incidence,518086,Non-Hispanic Black,276.8,Male and Female,Lung and Bronchus,2019
85+,314.3,352.3,1199,Incidence,360197,Non-Hispanic Black,332.9,Male and Female,Male and Female Breast,2019
85+,28.6,41.0,124,Incidence,360197,Non-Hispanic Black,34.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
85+,6.2,11.4,44,Incidence,518086,Non-Hispanic Black,8.5,Male and Female,Melanomas of the Skin,2019
85+,~,~,~,Incidence,518086,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
85+,60.5,74.8,349,Incidence,518086,Non-Hispanic Black,67.4,Male and Female,Myeloma,2019
85+,46.8,59.5,274,Incidence,518086,Non-Hispanic Black,52.9,Male and Female,Non-Hodgkin Lymphoma,2019
85+,12.9,20.1,84,Incidence,518086,Non-Hispanic Black,16.2,Male and Female,Oral Cavity and Pharynx,2019
85+,21.8,32.9,97,Incidence,360197,Non-Hispanic Black,26.9,Male and Female,Ovary,2019
85+,99.0,117.0,558,Incidence,518086,Non-Hispanic Black,107.7,Male and Female,Pancreas,2019
85+,461.2,531.2,782,Incidence,157889,Non-Hispanic Black,495.3,Male and Female,Prostate,2019
85+,54.8,68.5,318,Incidence,518086,Non-Hispanic Black,61.4,Male and Female,Stomach,2019
85+,~,~,~,Incidence,157889,Non-Hispanic Black,~,Male and Female,Testis,2019
85+,4.4,8.9,33,Incidence,518086,Non-Hispanic Black,6.4,Male and Female,Thyroid,2019
85+,92.3,109.8,522,Incidence,518086,Non-Hispanic Black,100.8,Male and Female,Urinary Bladder,2019
<1,19.7,27.7,139,Incidence,593076,Non-Hispanic Black,23.4,Male and Female,All Cancer Sites Combined,2019
<1,1.5,4.4,16,Incidence,593076,Non-Hispanic Black,2.7,Male and Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,Cervix,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Esophagus,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,Female Breast,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Larynx,2019
<1,2.2,5.4,21,Incidence,593076,Non-Hispanic Black,3.5,Male and Female,Leukemias,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Mesothelioma,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Myeloma,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,291867,Non-Hispanic Black,~,Male and Female,Ovary,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Pancreas,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male and Female,Prostate,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Stomach,2019
<1,~,~,~,Incidence,301209,Non-Hispanic Black,~,Male and Female,Testis,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Thyroid,2019
<1,~,~,~,Incidence,593076,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2019
1-4,19.5,22.4,821,Incidence,3928988,Non-Hispanic White,20.9,Female,All Cancer Sites Combined,2019
1-4,3.1,4.3,144,Incidence,3928988,Non-Hispanic White,3.7,Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Cervix,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Esophagus,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Female Breast,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
1-4,1.7,2.6,82,Incidence,3928988,Non-Hispanic White,2.1,Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Larynx,2019
1-4,7.2,9.0,317,Incidence,3928988,Non-Hispanic White,8.1,Female,Leukemias,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Mesothelioma,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Myeloma,2019
1-4,0.3,0.8,19,Incidence,3928988,Non-Hispanic White,0.5,Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Ovary,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Pancreas,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Stomach,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Thyroid,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Female,Urinary Bladder,2019
10-14,14.3,16.4,813,Incidence,5296092,Non-Hispanic White,15.4,Female,All Cancer Sites Combined,2019
10-14,2.6,3.6,162,Incidence,5296092,Non-Hispanic White,3.1,Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Cervix,2019
10-14,0.5,1.0,37,Incidence,5296092,Non-Hispanic White,0.7,Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Esophagus,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Female Breast,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2019
10-14,0.9,1.5,61,Incidence,5296092,Non-Hispanic White,1.2,Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Larynx,2019
10-14,2.5,3.4,156,Incidence,5296092,Non-Hispanic White,2.9,Female,Leukemias,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Lung and Bronchus,2019
10-14,0.2,0.6,21,Incidence,5296092,Non-Hispanic White,0.4,Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Mesothelioma,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Myeloma,2019
10-14,0.7,1.2,48,Incidence,5296092,Non-Hispanic White,0.9,Female,Non-Hodgkin Lymphoma,2019
10-14,0.2,0.5,16,Incidence,5296092,Non-Hispanic White,0.3,Female,Oral Cavity and Pharynx,2019
10-14,0.3,0.7,23,Incidence,5296092,Non-Hispanic White,0.4,Female,Ovary,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Pancreas,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Stomach,2019
10-14,1.2,1.9,81,Incidence,5296092,Non-Hispanic White,1.5,Female,Thyroid,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Female,Urinary Bladder,2019
15-19,25.6,28.4,1496,Incidence,5540622,Non-Hispanic White,27.0,Female,All Cancer Sites Combined,2019
15-19,2.0,2.9,134,Incidence,5540622,Non-Hispanic White,2.4,Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Cervix,2019
15-19,1.7,2.5,117,Incidence,5540622,Non-Hispanic White,2.1,Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Esophagus,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Female Breast,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2019
15-19,3.5,4.6,225,Incidence,5540622,Non-Hispanic White,4.1,Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Larynx,2019
15-19,1.6,2.4,110,Incidence,5540622,Non-Hispanic White,2.0,Female,Leukemias,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Lung and Bronchus,2019
15-19,1.2,1.9,84,Incidence,5540622,Non-Hispanic White,1.5,Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Mesothelioma,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Myeloma,2019
15-19,1.2,1.8,82,Incidence,5540622,Non-Hispanic White,1.5,Female,Non-Hodgkin Lymphoma,2019
15-19,0.2,0.6,20,Incidence,5540622,Non-Hispanic White,0.4,Female,Oral Cavity and Pharynx,2019
15-19,0.8,1.4,58,Incidence,5540622,Non-Hispanic White,1.0,Female,Ovary,2019
15-19,0.2,0.6,21,Incidence,5540622,Non-Hispanic White,0.4,Female,Pancreas,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Stomach,2019
15-19,6.5,7.9,399,Incidence,5540622,Non-Hispanic White,7.2,Female,Thyroid,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Female,Urinary Bladder,2019
20-24,41.4,44.8,2490,Incidence,5778949,Non-Hispanic White,43.1,Female,All Cancer Sites Combined,2019
20-24,1.8,2.6,124,Incidence,5778949,Non-Hispanic White,2.1,Female,Brain and Other Nervous System,2019
20-24,0.3,0.7,27,Incidence,5778949,Non-Hispanic White,0.5,Female,Cervix,2019
20-24,2.1,3.0,145,Incidence,5778949,Non-Hispanic White,2.5,Female,Colon and Rectum,2019
20-24,0.3,0.6,24,Incidence,5778949,Non-Hispanic White,0.4,Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Esophagus,2019
20-24,1.2,1.8,85,Incidence,5778949,Non-Hispanic White,1.5,Female,Female Breast,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2019
20-24,4.6,5.8,300,Incidence,5778949,Non-Hispanic White,5.2,Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
20-24,0.4,0.7,30,Incidence,5778949,Non-Hispanic White,0.5,Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Larynx,2019
20-24,1.8,2.6,126,Incidence,5778949,Non-Hispanic White,2.2,Female,Leukemias,2019
20-24,0.2,0.5,20,Incidence,5778949,Non-Hispanic White,0.3,Female,Liver and Intrahepatic Bile Duct,2019
20-24,0.2,0.5,18,Incidence,5778949,Non-Hispanic White,0.3,Female,Lung and Bronchus,2019
20-24,4.5,5.7,294,Incidence,5778949,Non-Hispanic White,5.1,Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Mesothelioma,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Myeloma,2019
20-24,1.5,2.3,109,Incidence,5778949,Non-Hispanic White,1.9,Female,Non-Hodgkin Lymphoma,2019
20-24,0.5,0.9,39,Incidence,5778949,Non-Hispanic White,0.7,Female,Oral Cavity and Pharynx,2019
20-24,1.1,1.7,81,Incidence,5778949,Non-Hispanic White,1.4,Female,Ovary,2019
20-24,0.2,0.5,19,Incidence,5778949,Non-Hispanic White,0.3,Female,Pancreas,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Stomach,2019
20-24,12.5,14.4,775,Incidence,5778949,Non-Hispanic White,13.4,Female,Thyroid,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Female,Urinary Bladder,2019
25-29,73.2,77.5,4762,Incidence,6321538,Non-Hispanic White,75.3,Female,All Cancer Sites Combined,2019
25-29,2.5,3.3,183,Incidence,6321538,Non-Hispanic White,2.9,Female,Brain and Other Nervous System,2019
25-29,3.8,4.8,270,Incidence,6321538,Non-Hispanic White,4.3,Female,Cervix,2019
25-29,3.2,4.1,228,Incidence,6321538,Non-Hispanic White,3.6,Female,Colon and Rectum,2019
25-29,1.5,2.2,118,Incidence,6321538,Non-Hispanic White,1.9,Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,6321538,Non-Hispanic White,~,Female,Esophagus,2019
25-29,9.9,11.5,676,Incidence,6321538,Non-Hispanic White,10.7,Female,Female Breast,2019
25-29,0.6,1.1,51,Incidence,6321538,Non-Hispanic White,0.8,Female,"Female Breast, <i>in situ</i>",2019
25-29,4.0,5.1,285,Incidence,6321538,Non-Hispanic White,4.5,Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,6321538,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
25-29,1.1,1.7,86,Incidence,6321538,Non-Hispanic White,1.4,Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,6321538,Non-Hispanic White,~,Female,Larynx,2019
25-29,2.1,2.8,153,Incidence,6321538,Non-Hispanic White,2.4,Female,Leukemias,2019
25-29,0.1,0.4,16,Incidence,6321538,Non-Hispanic White,0.3,Female,Liver and Intrahepatic Bile Duct,2019
25-29,0.5,0.9,41,Incidence,6321538,Non-Hispanic White,0.6,Female,Lung and Bronchus,2019
25-29,10.1,11.7,688,Incidence,6321538,Non-Hispanic White,10.9,Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,6321538,Non-Hispanic White,~,Female,Mesothelioma,2019
25-29,~,~,~,Incidence,6321538,Non-Hispanic White,~,Female,Myeloma,2019
25-29,2.2,3.0,160,Incidence,6321538,Non-Hispanic White,2.5,Female,Non-Hodgkin Lymphoma,2019
25-29,0.9,1.5,76,Incidence,6321538,Non-Hispanic White,1.2,Female,Oral Cavity and Pharynx,2019
25-29,2.0,2.8,149,Incidence,6321538,Non-Hispanic White,2.4,Female,Ovary,2019
25-29,0.3,0.6,25,Incidence,6321538,Non-Hispanic White,0.4,Female,Pancreas,2019
25-29,~,~,~,Incidence,6321538,Non-Hispanic White,~,Female,Stomach,2019
25-29,18.1,20.3,1210,Incidence,6321538,Non-Hispanic White,19.1,Female,Thyroid,2019
25-29,0.2,0.5,21,Incidence,6321538,Non-Hispanic White,0.3,Female,Urinary Bladder,2019
30-34,135.4,141.3,8665,Incidence,6263960,Non-Hispanic White,138.3,Female,All Cancer Sites Combined,2019
30-34,3.0,4.0,218,Incidence,6263960,Non-Hispanic White,3.5,Female,Brain and Other Nervous System,2019
30-34,11.7,13.5,787,Incidence,6263960,Non-Hispanic White,12.6,Female,Cervix,2019
30-34,7.0,8.4,479,Incidence,6263960,Non-Hispanic White,7.6,Female,Colon and Rectum,2019
30-34,4.5,5.6,313,Incidence,6263960,Non-Hispanic White,5.0,Female,"Corpus and Uterus, NOS",2019
30-34,~,~,~,Incidence,6263960,Non-Hispanic White,~,Female,Esophagus,2019
30-34,29.7,32.4,1943,Incidence,6263960,Non-Hispanic White,31.0,Female,Female Breast,2019
30-34,3.0,4.0,217,Incidence,6263960,Non-Hispanic White,3.5,Female,"Female Breast, <i>in situ</i>",2019
30-34,3.5,4.5,251,Incidence,6263960,Non-Hispanic White,4.0,Female,Hodgkin Lymphoma,2019
30-34,~,~,~,Incidence,6263960,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
30-34,2.5,3.4,182,Incidence,6263960,Non-Hispanic White,2.9,Female,Kidney and Renal Pelvis,2019
30-34,~,~,~,Incidence,6263960,Non-Hispanic White,~,Female,Larynx,2019
30-34,2.4,3.2,174,Incidence,6263960,Non-Hispanic White,2.8,Female,Leukemias,2019
30-34,0.2,0.6,23,Incidence,6263960,Non-Hispanic White,0.4,Female,Liver and Intrahepatic Bile Duct,2019
30-34,1.0,1.6,79,Incidence,6263960,Non-Hispanic White,1.3,Female,Lung and Bronchus,2019
30-34,18.8,21.0,1245,Incidence,6263960,Non-Hispanic White,19.9,Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,6263960,Non-Hispanic White,~,Female,Mesothelioma,2019
30-34,~,~,~,Incidence,6263960,Non-Hispanic White,~,Female,Myeloma,2019
30-34,3.0,3.9,215,Incidence,6263960,Non-Hispanic White,3.4,Female,Non-Hodgkin Lymphoma,2019
30-34,1.4,2.1,109,Incidence,6263960,Non-Hispanic White,1.7,Female,Oral Cavity and Pharynx,2019
30-34,3.1,4.1,224,Incidence,6263960,Non-Hispanic White,3.6,Female,Ovary,2019
30-34,0.7,1.2,57,Incidence,6263960,Non-Hispanic White,0.9,Female,Pancreas,2019
30-34,0.4,0.7,33,Incidence,6263960,Non-Hispanic White,0.5,Female,Stomach,2019
30-34,26.6,29.2,1745,Incidence,6263960,Non-Hispanic White,27.9,Female,Thyroid,2019
30-34,0.4,0.8,37,Incidence,6263960,Non-Hispanic White,0.6,Female,Urinary Bladder,2019
35-39,209.5,216.8,13142,Incidence,6165902,Non-Hispanic White,213.1,Female,All Cancer Sites Combined,2019
35-39,3.8,4.9,268,Incidence,6165902,Non-Hispanic White,4.3,Female,Brain and Other Nervous System,2019
35-39,13.1,15.0,863,Incidence,6165902,Non-Hispanic White,14.0,Female,Cervix,2019
35-39,11.4,13.2,759,Incidence,6165902,Non-Hispanic White,12.3,Female,Colon and Rectum,2019
35-39,9.0,10.6,604,Incidence,6165902,Non-Hispanic White,9.8,Female,"Corpus and Uterus, NOS",2019
35-39,~,~,~,Incidence,6165902,Non-Hispanic White,~,Female,Esophagus,2019
35-39,66.3,70.4,4212,Incidence,6165902,Non-Hispanic White,68.3,Female,Female Breast,2019
35-39,9.8,11.4,653,Incidence,6165902,Non-Hispanic White,10.6,Female,"Female Breast, <i>in situ</i>",2019
35-39,3.1,4.0,216,Incidence,6165902,Non-Hispanic White,3.5,Female,Hodgkin Lymphoma,2019
35-39,~,~,~,Incidence,6165902,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
35-39,5.7,7.0,392,Incidence,6165902,Non-Hispanic White,6.4,Female,Kidney and Renal Pelvis,2019
35-39,~,~,~,Incidence,6165902,Non-Hispanic White,~,Female,Larynx,2019
35-39,3.8,4.8,264,Incidence,6165902,Non-Hispanic White,4.3,Female,Leukemias,2019
35-39,0.5,1.0,45,Incidence,6165902,Non-Hispanic White,0.7,Female,Liver and Intrahepatic Bile Duct,2019
35-39,2.7,3.6,190,Incidence,6165902,Non-Hispanic White,3.1,Female,Lung and Bronchus,2019
35-39,23.0,25.5,1495,Incidence,6165902,Non-Hispanic White,24.2,Female,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,6165902,Non-Hispanic White,~,Female,Mesothelioma,2019
35-39,0.6,1.1,53,Incidence,6165902,Non-Hispanic White,0.9,Female,Myeloma,2019
35-39,4.8,6.0,331,Incidence,6165902,Non-Hispanic White,5.4,Female,Non-Hodgkin Lymphoma,2019
35-39,2.3,3.2,167,Incidence,6165902,Non-Hispanic White,2.7,Female,Oral Cavity and Pharynx,2019
35-39,4.5,5.7,313,Incidence,6165902,Non-Hispanic White,5.1,Female,Ovary,2019
35-39,0.9,1.4,68,Incidence,6165902,Non-Hispanic White,1.1,Female,Pancreas,2019
35-39,1.0,1.5,75,Incidence,6165902,Non-Hispanic White,1.2,Female,Stomach,2019
35-39,30.2,33.0,1948,Incidence,6165902,Non-Hispanic White,31.6,Female,Thyroid,2019
35-39,0.9,1.4,68,Incidence,6165902,Non-Hispanic White,1.1,Female,Urinary Bladder,2019
40-44,335.0,344.6,19318,Incidence,5685622,Non-Hispanic White,339.8,Female,All Cancer Sites Combined,2019
40-44,3.9,5.0,250,Incidence,5685622,Non-Hispanic White,4.4,Female,Brain and Other Nervous System,2019
40-44,14.4,16.5,877,Incidence,5685622,Non-Hispanic White,15.4,Female,Cervix,2019
40-44,19.3,21.7,1165,Incidence,5685622,Non-Hispanic White,20.5,Female,Colon and Rectum,2019
40-44,16.4,18.5,991,Incidence,5685622,Non-Hispanic White,17.4,Female,"Corpus and Uterus, NOS",2019
40-44,0.3,0.6,25,Incidence,5685622,Non-Hispanic White,0.4,Female,Esophagus,2019
40-44,138.4,144.6,8042,Incidence,5685622,Non-Hispanic White,141.4,Female,Female Breast,2019
40-44,44.3,47.9,2620,Incidence,5685622,Non-Hispanic White,46.1,Female,"Female Breast, <i>in situ</i>",2019
40-44,2.0,2.9,138,Incidence,5685622,Non-Hispanic White,2.4,Female,Hodgkin Lymphoma,2019
40-44,~,~,~,Incidence,5685622,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
40-44,9.0,10.7,558,Incidence,5685622,Non-Hispanic White,9.8,Female,Kidney and Renal Pelvis,2019
40-44,0.4,0.8,33,Incidence,5685622,Non-Hispanic White,0.6,Female,Larynx,2019
40-44,4.9,6.2,314,Incidence,5685622,Non-Hispanic White,5.5,Female,Leukemias,2019
40-44,0.9,1.4,63,Incidence,5685622,Non-Hispanic White,1.1,Female,Liver and Intrahepatic Bile Duct,2019
40-44,6.6,8.0,415,Incidence,5685622,Non-Hispanic White,7.3,Female,Lung and Bronchus,2019
40-44,29.0,31.9,1728,Incidence,5685622,Non-Hispanic White,30.4,Female,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,5685622,Non-Hispanic White,~,Female,Mesothelioma,2019
40-44,1.2,1.9,86,Incidence,5685622,Non-Hispanic White,1.5,Female,Myeloma,2019
40-44,7.5,9.0,469,Incidence,5685622,Non-Hispanic White,8.2,Female,Non-Hodgkin Lymphoma,2019
40-44,3.3,4.3,213,Incidence,5685622,Non-Hispanic White,3.7,Female,Oral Cavity and Pharynx,2019
40-44,7.8,9.4,487,Incidence,5685622,Non-Hispanic White,8.6,Female,Ovary,2019
40-44,2.3,3.2,154,Incidence,5685622,Non-Hispanic White,2.7,Female,Pancreas,2019
40-44,1.5,2.2,103,Incidence,5685622,Non-Hispanic White,1.8,Female,Stomach,2019
40-44,33.3,36.4,1978,Incidence,5685622,Non-Hispanic White,34.8,Female,Thyroid,2019
40-44,1.7,2.4,115,Incidence,5685622,Non-Hispanic White,2.0,Female,Urinary Bladder,2019
45-49,489.5,500.7,30303,Incidence,6121242,Non-Hispanic White,495.0,Female,All Cancer Sites Combined,2019
45-49,4.9,6.1,336,Incidence,6121242,Non-Hispanic White,5.5,Female,Brain and Other Nervous System,2019
45-49,13.3,15.2,870,Incidence,6121242,Non-Hispanic White,14.2,Female,Cervix,2019
45-49,33.7,36.7,2153,Incidence,6121242,Non-Hispanic White,35.2,Female,Colon and Rectum,2019
45-49,27.7,30.4,1777,Incidence,6121242,Non-Hispanic White,29.0,Female,"Corpus and Uterus, NOS",2019
45-49,0.8,1.3,64,Incidence,6121242,Non-Hispanic White,1.0,Female,Esophagus,2019
45-49,211.7,219.1,13183,Incidence,6121242,Non-Hispanic White,215.4,Female,Female Breast,2019
45-49,60.3,64.3,3814,Incidence,6121242,Non-Hispanic White,62.3,Female,"Female Breast, <i>in situ</i>",2019
45-49,1.8,2.6,133,Incidence,6121242,Non-Hispanic White,2.2,Female,Hodgkin Lymphoma,2019
45-49,~,~,~,Incidence,6121242,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
45-49,12.5,14.4,821,Incidence,6121242,Non-Hispanic White,13.4,Female,Kidney and Renal Pelvis,2019
45-49,0.9,1.5,71,Incidence,6121242,Non-Hispanic White,1.2,Female,Larynx,2019
45-49,7.7,9.2,514,Incidence,6121242,Non-Hispanic White,8.4,Female,Leukemias,2019
45-49,1.6,2.4,121,Incidence,6121242,Non-Hispanic White,2.0,Female,Liver and Intrahepatic Bile Duct,2019
45-49,18.5,20.7,1198,Incidence,6121242,Non-Hispanic White,19.6,Female,Lung and Bronchus,2019
45-49,35.3,38.3,2250,Incidence,6121242,Non-Hispanic White,36.8,Female,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,6121242,Non-Hispanic White,~,Female,Mesothelioma,2019
45-49,2.7,3.6,190,Incidence,6121242,Non-Hispanic White,3.1,Female,Myeloma,2019
45-49,10.8,12.5,710,Incidence,6121242,Non-Hispanic White,11.6,Female,Non-Hodgkin Lymphoma,2019
45-49,6.3,7.7,428,Incidence,6121242,Non-Hispanic White,7.0,Female,Oral Cavity and Pharynx,2019
45-49,11.0,12.8,727,Incidence,6121242,Non-Hispanic White,11.9,Female,Ovary,2019
45-49,5.2,6.4,354,Incidence,6121242,Non-Hispanic White,5.8,Female,Pancreas,2019
45-49,2.9,3.8,203,Incidence,6121242,Non-Hispanic White,3.3,Female,Stomach,2019
45-49,33.7,36.7,2152,Incidence,6121242,Non-Hispanic White,35.2,Female,Thyroid,2019
45-49,3.4,4.4,239,Incidence,6121242,Non-Hispanic White,3.9,Female,Urinary Bladder,2019
5-9,10.7,12.6,590,Incidence,5070171,Non-Hispanic White,11.6,Female,All Cancer Sites Combined,2019
5-9,3.3,4.3,191,Incidence,5070171,Non-Hispanic White,3.8,Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Cervix,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Esophagus,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Female Breast,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
5-9,0.2,0.6,19,Incidence,5070171,Non-Hispanic White,0.4,Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Larynx,2019
5-9,2.9,3.9,172,Incidence,5070171,Non-Hispanic White,3.4,Female,Leukemias,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Mesothelioma,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Myeloma,2019
5-9,0.3,0.7,25,Incidence,5070171,Non-Hispanic White,0.5,Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Ovary,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Pancreas,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Stomach,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Thyroid,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Female,Urinary Bladder,2019
50-54,655.3,667.7,43565,Incidence,6586058,Non-Hispanic White,661.5,Female,All Cancer Sites Combined,2019
50-54,6.2,7.4,446,Incidence,6586058,Non-Hispanic White,6.8,Female,Brain and Other Nervous System,2019
50-54,11.6,13.3,820,Incidence,6586058,Non-Hispanic White,12.5,Female,Cervix,2019
50-54,53.5,57.2,3644,Incidence,6586058,Non-Hispanic White,55.3,Female,Colon and Rectum,2019
50-54,48.7,52.1,3317,Incidence,6586058,Non-Hispanic White,50.4,Female,"Corpus and Uterus, NOS",2019
50-54,1.8,2.5,138,Incidence,6586058,Non-Hispanic White,2.1,Female,Esophagus,2019
50-54,252.9,260.7,16911,Incidence,6586058,Non-Hispanic White,256.8,Female,Female Breast,2019
50-54,68.9,73.0,4671,Incidence,6586058,Non-Hispanic White,70.9,Female,"Female Breast, <i>in situ</i>",2019
50-54,1.4,2.0,111,Incidence,6586058,Non-Hispanic White,1.7,Female,Hodgkin Lymphoma,2019
50-54,~,~,~,Incidence,6586058,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
50-54,16.3,18.3,1136,Incidence,6586058,Non-Hispanic White,17.2,Female,Kidney and Renal Pelvis,2019
50-54,2.2,3.0,171,Incidence,6586058,Non-Hispanic White,2.6,Female,Larynx,2019
50-54,10.0,11.6,712,Incidence,6586058,Non-Hispanic White,10.8,Female,Leukemias,2019
50-54,3.6,4.6,271,Incidence,6586058,Non-Hispanic White,4.1,Female,Liver and Intrahepatic Bile Duct,2019
50-54,47.8,51.3,3262,Incidence,6586058,Non-Hispanic White,49.5,Female,Lung and Bronchus,2019
50-54,40.9,44.1,2797,Incidence,6586058,Non-Hispanic White,42.5,Female,Melanomas of the Skin,2019
50-54,~,~,~,Incidence,6586058,Non-Hispanic White,~,Female,Mesothelioma,2019
50-54,4.5,5.6,333,Incidence,6586058,Non-Hispanic White,5.1,Female,Myeloma,2019
50-54,17.8,20.0,1243,Incidence,6586058,Non-Hispanic White,18.9,Female,Non-Hodgkin Lymphoma,2019
50-54,10.1,11.7,715,Incidence,6586058,Non-Hispanic White,10.9,Female,Oral Cavity and Pharynx,2019
50-54,15.7,17.7,1096,Incidence,6586058,Non-Hispanic White,16.6,Female,Ovary,2019
50-54,9.3,10.9,663,Incidence,6586058,Non-Hispanic White,10.1,Female,Pancreas,2019
50-54,3.7,4.7,277,Incidence,6586058,Non-Hispanic White,4.2,Female,Stomach,2019
50-54,32.3,35.1,2220,Incidence,6586058,Non-Hispanic White,33.7,Female,Thyroid,2019
50-54,7.0,8.4,506,Incidence,6586058,Non-Hispanic White,7.7,Female,Urinary Bladder,2019
55-59,838.0,851.1,64265,Incidence,7609697,Non-Hispanic White,844.5,Female,All Cancer Sites Combined,2019
55-59,8.2,9.5,673,Incidence,7609697,Non-Hispanic White,8.8,Female,Brain and Other Nervous System,2019
55-59,9.5,11.0,777,Incidence,7609697,Non-Hispanic White,10.2,Female,Cervix,2019
55-59,52.6,56.0,4130,Incidence,7609697,Non-Hispanic White,54.3,Female,Colon and Rectum,2019
55-59,76.7,80.7,5989,Incidence,7609697,Non-Hispanic White,78.7,Female,"Corpus and Uterus, NOS",2019
55-59,3.6,4.6,310,Incidence,7609697,Non-Hispanic White,4.1,Female,Esophagus,2019
55-59,282.7,290.3,21801,Incidence,7609697,Non-Hispanic White,286.5,Female,Female Breast,2019
55-59,69.0,72.8,5391,Incidence,7609697,Non-Hispanic White,70.8,Female,"Female Breast, <i>in situ</i>",2019
55-59,1.6,2.2,143,Incidence,7609697,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2019
55-59,~,~,~,Incidence,7609697,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
55-59,22.5,24.7,1794,Incidence,7609697,Non-Hispanic White,23.6,Female,Kidney and Renal Pelvis,2019
55-59,3.6,4.6,310,Incidence,7609697,Non-Hispanic White,4.1,Female,Larynx,2019
55-59,15.5,17.4,1251,Incidence,7609697,Non-Hispanic White,16.4,Female,Leukemias,2019
55-59,7.2,8.4,592,Incidence,7609697,Non-Hispanic White,7.8,Female,Liver and Intrahepatic Bile Duct,2019
55-59,102.1,106.7,7941,Incidence,7609697,Non-Hispanic White,104.4,Female,Lung and Bronchus,2019
55-59,43.2,46.2,3397,Incidence,7609697,Non-Hispanic White,44.6,Female,Melanomas of the Skin,2019
55-59,0.4,0.7,40,Incidence,7609697,Non-Hispanic White,0.5,Female,Mesothelioma,2019
55-59,6.9,8.1,571,Incidence,7609697,Non-Hispanic White,7.5,Female,Myeloma,2019
55-59,25.7,28.1,2044,Incidence,7609697,Non-Hispanic White,26.9,Female,Non-Hodgkin Lymphoma,2019
55-59,15.4,17.3,1242,Incidence,7609697,Non-Hispanic White,16.3,Female,Oral Cavity and Pharynx,2019
55-59,19.2,21.2,1537,Incidence,7609697,Non-Hispanic White,20.2,Female,Ovary,2019
55-59,16.9,18.8,1356,Incidence,7609697,Non-Hispanic White,17.8,Female,Pancreas,2019
55-59,4.8,5.9,407,Incidence,7609697,Non-Hispanic White,5.3,Female,Stomach,2019
55-59,29.9,32.4,2366,Incidence,7609697,Non-Hispanic White,31.1,Female,Thyroid,2019
55-59,13.1,14.8,1058,Incidence,7609697,Non-Hispanic White,13.9,Female,Urinary Bladder,2019
60-64,1102.1,1117.1,83944,Incidence,7565566,Non-Hispanic White,1109.6,Female,All Cancer Sites Combined,2019
60-64,10.2,11.7,828,Incidence,7565566,Non-Hispanic White,10.9,Female,Brain and Other Nervous System,2019
60-64,9.6,11.0,779,Incidence,7565566,Non-Hispanic White,10.3,Female,Cervix,2019
60-64,66.0,69.7,5132,Incidence,7565566,Non-Hispanic White,67.8,Female,Colon and Rectum,2019
60-64,98.7,103.2,7638,Incidence,7565566,Non-Hispanic White,101.0,Female,"Corpus and Uterus, NOS",2019
60-64,5.4,6.5,448,Incidence,7565566,Non-Hispanic White,5.9,Female,Esophagus,2019
60-64,353.0,361.5,27029,Incidence,7565566,Non-Hispanic White,357.3,Female,Female Breast,2019
60-64,80.6,84.7,6249,Incidence,7565566,Non-Hispanic White,82.6,Female,"Female Breast, <i>in situ</i>",2019
60-64,1.6,2.3,146,Incidence,7565566,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2019
60-64,~,~,~,Incidence,7565566,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
60-64,30.5,33.1,2405,Incidence,7565566,Non-Hispanic White,31.8,Female,Kidney and Renal Pelvis,2019
60-64,4.6,5.6,385,Incidence,7565566,Non-Hispanic White,5.1,Female,Larynx,2019
60-64,21.1,23.2,1676,Incidence,7565566,Non-Hispanic White,22.2,Female,Leukemias,2019
60-64,11.8,13.4,952,Incidence,7565566,Non-Hispanic White,12.6,Female,Liver and Intrahepatic Bile Duct,2019
60-64,157.9,163.6,12160,Incidence,7565566,Non-Hispanic White,160.7,Female,Lung and Bronchus,2019
60-64,53.1,56.4,4142,Incidence,7565566,Non-Hispanic White,54.7,Female,Melanomas of the Skin,2019
60-64,0.7,1.1,67,Incidence,7565566,Non-Hispanic White,0.9,Female,Mesothelioma,2019
60-64,11.6,13.2,934,Incidence,7565566,Non-Hispanic White,12.3,Female,Myeloma,2019
60-64,36.8,39.6,2892,Incidence,7565566,Non-Hispanic White,38.2,Female,Non-Hodgkin Lymphoma,2019
60-64,19.3,21.3,1536,Incidence,7565566,Non-Hispanic White,20.3,Female,Oral Cavity and Pharynx,2019
60-64,24.8,27.1,1959,Incidence,7565566,Non-Hispanic White,25.9,Female,Ovary,2019
60-64,27.8,30.2,2193,Incidence,7565566,Non-Hispanic White,29.0,Female,Pancreas,2019
60-64,7.9,9.3,648,Incidence,7565566,Non-Hispanic White,8.6,Female,Stomach,2019
60-64,27.8,30.2,2191,Incidence,7565566,Non-Hispanic White,29.0,Female,Thyroid,2019
60-64,19.6,21.6,1558,Incidence,7565566,Non-Hispanic White,20.6,Female,Urinary Bladder,2019
65-69,1399.3,1417.2,95060,Incidence,6750308,Non-Hispanic White,1408.2,Female,All Cancer Sites Combined,2019
65-69,13.3,15.1,958,Incidence,6750308,Non-Hispanic White,14.2,Female,Brain and Other Nervous System,2019
65-69,7.4,8.8,545,Incidence,6750308,Non-Hispanic White,8.1,Female,Cervix,2019
65-69,88.2,92.8,6107,Incidence,6750308,Non-Hispanic White,90.5,Female,Colon and Rectum,2019
65-69,115.3,120.5,7960,Incidence,6750308,Non-Hispanic White,117.9,Female,"Corpus and Uterus, NOS",2019
65-69,6.8,8.1,503,Incidence,6750308,Non-Hispanic White,7.5,Female,Esophagus,2019
65-69,443.9,454.0,30302,Incidence,6750308,Non-Hispanic White,448.9,Female,Female Breast,2019
65-69,93.8,98.5,6491,Incidence,6750308,Non-Hispanic White,96.2,Female,"Female Breast, <i>in situ</i>",2019
65-69,2.1,2.8,164,Incidence,6750308,Non-Hispanic White,2.4,Female,Hodgkin Lymphoma,2019
65-69,~,~,~,Incidence,6750308,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
65-69,39.6,42.7,2776,Incidence,6750308,Non-Hispanic White,41.1,Female,Kidney and Renal Pelvis,2019
65-69,4.2,5.3,319,Incidence,6750308,Non-Hispanic White,4.7,Female,Larynx,2019
65-69,29.0,31.7,2048,Incidence,6750308,Non-Hispanic White,30.3,Female,Leukemias,2019
65-69,16.6,18.6,1185,Incidence,6750308,Non-Hispanic White,17.6,Female,Liver and Intrahepatic Bile Duct,2019
65-69,214.8,221.9,14739,Incidence,6750308,Non-Hispanic White,218.3,Female,Lung and Bronchus,2019
65-69,60.7,64.5,4224,Incidence,6750308,Non-Hispanic White,62.6,Female,Melanomas of the Skin,2019
65-69,0.8,1.3,72,Incidence,6750308,Non-Hispanic White,1.1,Female,Mesothelioma,2019
65-69,17.6,19.7,1260,Incidence,6750308,Non-Hispanic White,18.7,Female,Myeloma,2019
65-69,49.3,52.7,3439,Incidence,6750308,Non-Hispanic White,50.9,Female,Non-Hodgkin Lymphoma,2019
65-69,23.0,25.4,1633,Incidence,6750308,Non-Hispanic White,24.2,Female,Oral Cavity and Pharynx,2019
65-69,27.1,29.7,1915,Incidence,6750308,Non-Hispanic White,28.4,Female,Ovary,2019
65-69,39.1,42.1,2739,Incidence,6750308,Non-Hispanic White,40.6,Female,Pancreas,2019
65-69,9.9,11.5,719,Incidence,6750308,Non-Hispanic White,10.7,Female,Stomach,2019
65-69,27.4,29.9,1933,Incidence,6750308,Non-Hispanic White,28.6,Female,Thyroid,2019
65-69,29.6,32.3,2086,Incidence,6750308,Non-Hispanic White,30.9,Female,Urinary Bladder,2019
70-74,1686.9,1708.3,96450,Incidence,5681614,Non-Hispanic White,1697.6,Female,All Cancer Sites Combined,2019
70-74,15.7,17.9,953,Incidence,5681614,Non-Hispanic White,16.8,Female,Brain and Other Nervous System,2019
70-74,6.9,8.3,431,Incidence,5681614,Non-Hispanic White,7.6,Female,Cervix,2019
70-74,112.1,117.7,6529,Incidence,5681614,Non-Hispanic White,114.9,Female,Colon and Rectum,2019
70-74,110.0,115.5,6405,Incidence,5681614,Non-Hispanic White,112.7,Female,"Corpus and Uterus, NOS",2019
70-74,8.3,9.9,517,Incidence,5681614,Non-Hispanic White,9.1,Female,Esophagus,2019
70-74,501.1,512.8,28801,Incidence,5681614,Non-Hispanic White,506.9,Female,Female Breast,2019
70-74,103.0,108.4,6003,Incidence,5681614,Non-Hispanic White,105.7,Female,"Female Breast, <i>in situ</i>",2019
70-74,2.0,2.8,133,Incidence,5681614,Non-Hispanic White,2.3,Female,Hodgkin Lymphoma,2019
70-74,~,~,~,Incidence,5681614,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
70-74,46.1,49.7,2721,Incidence,5681614,Non-Hispanic White,47.9,Female,Kidney and Renal Pelvis,2019
70-74,4.1,5.3,266,Incidence,5681614,Non-Hispanic White,4.7,Female,Larynx,2019
70-74,39.8,43.2,2358,Incidence,5681614,Non-Hispanic White,41.5,Female,Leukemias,2019
70-74,18.3,20.6,1106,Incidence,5681614,Non-Hispanic White,19.5,Female,Liver and Intrahepatic Bile Duct,2019
70-74,300.5,309.6,17330,Incidence,5681614,Non-Hispanic White,305.0,Female,Lung and Bronchus,2019
70-74,65.5,69.8,3841,Incidence,5681614,Non-Hispanic White,67.6,Female,Melanomas of the Skin,2019
70-74,1.3,2.0,94,Incidence,5681614,Non-Hispanic White,1.7,Female,Mesothelioma,2019
70-74,23.2,25.7,1388,Incidence,5681614,Non-Hispanic White,24.4,Female,Myeloma,2019
70-74,65.1,69.4,3821,Incidence,5681614,Non-Hispanic White,67.3,Female,Non-Hodgkin Lymphoma,2019
70-74,24.8,27.4,1481,Incidence,5681614,Non-Hispanic White,26.1,Female,Oral Cavity and Pharynx,2019
70-74,33.3,36.4,1978,Incidence,5681614,Non-Hispanic White,34.8,Female,Ovary,2019
70-74,54.9,58.9,3231,Incidence,5681614,Non-Hispanic White,56.9,Female,Pancreas,2019
70-74,12.5,14.5,766,Incidence,5681614,Non-Hispanic White,13.5,Female,Stomach,2019
70-74,25.6,28.3,1528,Incidence,5681614,Non-Hispanic White,26.9,Female,Thyroid,2019
70-74,43.3,46.8,2557,Incidence,5681614,Non-Hispanic White,45.0,Female,Urinary Bladder,2019
75-79,1898.8,1925.7,78116,Incidence,4085124,Non-Hispanic White,1912.2,Female,All Cancer Sites Combined,2019
75-79,17.0,19.6,747,Incidence,4085124,Non-Hispanic White,18.3,Female,Brain and Other Nervous System,2019
75-79,6.2,7.9,286,Incidence,4085124,Non-Hispanic White,7.0,Female,Cervix,2019
75-79,142.8,150.2,5983,Incidence,4085124,Non-Hispanic White,146.5,Female,Colon and Rectum,2019
75-79,91.9,97.9,3874,Incidence,4085124,Non-Hispanic White,94.8,Female,"Corpus and Uterus, NOS",2019
75-79,10.0,12.1,450,Incidence,4085124,Non-Hispanic White,11.0,Female,Esophagus,2019
75-79,494.0,507.7,20459,Incidence,4085124,Non-Hispanic White,500.8,Female,Female Breast,2019
75-79,81.8,87.5,3457,Incidence,4085124,Non-Hispanic White,84.6,Female,"Female Breast, <i>in situ</i>",2019
75-79,2.6,3.7,127,Incidence,4085124,Non-Hispanic White,3.1,Female,Hodgkin Lymphoma,2019
75-79,~,~,~,Incidence,4085124,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
75-79,50.4,54.9,2150,Incidence,4085124,Non-Hispanic White,52.6,Female,Kidney and Renal Pelvis,2019
75-79,3.8,5.1,179,Incidence,4085124,Non-Hispanic White,4.4,Female,Larynx,2019
75-79,50.0,54.4,2131,Incidence,4085124,Non-Hispanic White,52.2,Female,Leukemias,2019
75-79,22.8,25.9,994,Incidence,4085124,Non-Hispanic White,24.3,Female,Liver and Intrahepatic Bile Duct,2019
75-79,368.5,380.4,15297,Incidence,4085124,Non-Hispanic White,374.5,Female,Lung and Bronchus,2019
75-79,68.5,73.7,2904,Incidence,4085124,Non-Hispanic White,71.1,Female,Melanomas of the Skin,2019
75-79,2.2,3.3,111,Incidence,4085124,Non-Hispanic White,2.7,Female,Mesothelioma,2019
75-79,30.2,33.7,1305,Incidence,4085124,Non-Hispanic White,31.9,Female,Myeloma,2019
75-79,86.0,91.8,3630,Incidence,4085124,Non-Hispanic White,88.9,Female,Non-Hodgkin Lymphoma,2019
75-79,28.5,31.9,1231,Incidence,4085124,Non-Hispanic White,30.1,Female,Oral Cavity and Pharynx,2019
75-79,39.1,43.0,1675,Incidence,4085124,Non-Hispanic White,41.0,Female,Ovary,2019
75-79,71.6,76.9,3030,Incidence,4085124,Non-Hispanic White,74.2,Female,Pancreas,2019
75-79,16.2,18.8,714,Incidence,4085124,Non-Hispanic White,17.5,Female,Stomach,2019
75-79,21.3,24.2,928,Incidence,4085124,Non-Hispanic White,22.7,Female,Thyroid,2019
75-79,56.4,61.1,2398,Incidence,4085124,Non-Hispanic White,58.7,Female,Urinary Bladder,2019
80-84,1969.8,2003.0,55318,Incidence,2784914,Non-Hispanic White,1986.3,Female,All Cancer Sites Combined,2019
80-84,15.9,19.0,485,Incidence,2784914,Non-Hispanic White,17.4,Female,Brain and Other Nervous System,2019
80-84,5.7,7.6,183,Incidence,2784914,Non-Hispanic White,6.6,Female,Cervix,2019
80-84,194.0,204.5,5548,Incidence,2784914,Non-Hispanic White,199.2,Female,Colon and Rectum,2019
80-84,73.6,80.2,2140,Incidence,2784914,Non-Hispanic White,76.8,Female,"Corpus and Uterus, NOS",2019
80-84,10.5,13.0,326,Incidence,2784914,Non-Hispanic White,11.7,Female,Esophagus,2019
80-84,446.1,462.0,12644,Incidence,2784914,Non-Hispanic White,454.0,Female,Female Breast,2019
80-84,57.4,63.2,1677,Incidence,2784914,Non-Hispanic White,60.2,Female,"Female Breast, <i>in situ</i>",2019
80-84,2.7,4.1,94,Incidence,2784914,Non-Hispanic White,3.4,Female,Hodgkin Lymphoma,2019
80-84,~,~,~,Incidence,2784914,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
80-84,47.3,52.6,1390,Incidence,2784914,Non-Hispanic White,49.9,Female,Kidney and Renal Pelvis,2019
80-84,3.5,5.1,118,Incidence,2784914,Non-Hispanic White,4.2,Female,Larynx,2019
80-84,58.6,64.5,1712,Incidence,2784914,Non-Hispanic White,61.5,Female,Leukemias,2019
80-84,24.7,28.6,740,Incidence,2784914,Non-Hispanic White,26.6,Female,Liver and Intrahepatic Bile Duct,2019
80-84,362.4,376.7,10289,Incidence,2784914,Non-Hispanic White,369.5,Female,Lung and Bronchus,2019
80-84,71.1,77.5,2068,Incidence,2784914,Non-Hispanic White,74.3,Female,Melanomas of the Skin,2019
80-84,2.2,3.4,76,Incidence,2784914,Non-Hispanic White,2.7,Female,Mesothelioma,2019
80-84,33.0,37.5,980,Incidence,2784914,Non-Hispanic White,35.2,Female,Myeloma,2019
80-84,96.8,104.3,2798,Incidence,2784914,Non-Hispanic White,100.5,Female,Non-Hodgkin Lymphoma,2019
80-84,30.7,35.0,914,Incidence,2784914,Non-Hispanic White,32.8,Female,Oral Cavity and Pharynx,2019
80-84,37.2,41.9,1100,Incidence,2784914,Non-Hispanic White,39.5,Female,Ovary,2019
80-84,83.8,90.8,2429,Incidence,2784914,Non-Hispanic White,87.2,Female,Pancreas,2019
80-84,18.9,22.3,573,Incidence,2784914,Non-Hispanic White,20.6,Female,Stomach,2019
80-84,13.5,16.4,416,Incidence,2784914,Non-Hispanic White,14.9,Female,Thyroid,2019
80-84,70.0,76.4,2036,Incidence,2784914,Non-Hispanic White,73.1,Female,Urinary Bladder,2019
85+,1742.3,1770.8,58336,Incidence,3321123,Non-Hispanic White,1756.5,Female,All Cancer Sites Combined,2019
85+,14.3,17.0,519,Incidence,3321123,Non-Hispanic White,15.6,Female,Brain and Other Nervous System,2019
85+,5.2,6.9,198,Incidence,3321123,Non-Hispanic White,6.0,Female,Cervix,2019
85+,216.1,226.2,7343,Incidence,3321123,Non-Hispanic White,221.1,Female,Colon and Rectum,2019
85+,48.3,53.2,1684,Incidence,3321123,Non-Hispanic White,50.7,Female,"Corpus and Uterus, NOS",2019
85+,11.5,14.0,422,Incidence,3321123,Non-Hispanic White,12.7,Female,Esophagus,2019
85+,332.9,345.5,11264,Incidence,3321123,Non-Hispanic White,339.2,Female,Female Breast,2019
85+,21.6,24.9,772,Incidence,3321123,Non-Hispanic White,23.2,Female,"Female Breast, <i>in situ</i>",2019
85+,2.1,3.2,86,Incidence,3321123,Non-Hispanic White,2.6,Female,Hodgkin Lymphoma,2019
85+,~,~,~,Incidence,3321123,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
85+,39.1,43.5,1370,Incidence,3321123,Non-Hispanic White,41.3,Female,Kidney and Renal Pelvis,2019
85+,1.5,2.5,66,Incidence,3321123,Non-Hispanic White,2.0,Female,Larynx,2019
85+,65.2,70.8,2257,Incidence,3321123,Non-Hispanic White,68.0,Female,Leukemias,2019
85+,22.7,26.1,808,Incidence,3321123,Non-Hispanic White,24.3,Female,Liver and Intrahepatic Bile Duct,2019
85+,245.9,256.7,8345,Incidence,3321123,Non-Hispanic White,251.3,Female,Lung and Bronchus,2019
85+,71.4,77.3,2467,Incidence,3321123,Non-Hispanic White,74.3,Female,Melanomas of the Skin,2019
85+,2.5,3.7,101,Incidence,3321123,Non-Hispanic White,3.0,Female,Mesothelioma,2019
85+,26.1,29.8,927,Incidence,3321123,Non-Hispanic White,27.9,Female,Myeloma,2019
85+,83.5,89.9,2877,Incidence,3321123,Non-Hispanic White,86.6,Female,Non-Hodgkin Lymphoma,2019
85+,29.0,32.8,1026,Incidence,3321123,Non-Hispanic White,30.9,Female,Oral Cavity and Pharynx,2019
85+,32.6,36.6,1148,Incidence,3321123,Non-Hispanic White,34.6,Female,Ovary,2019
85+,90.1,96.7,3101,Incidence,3321123,Non-Hispanic White,93.4,Female,Pancreas,2019
85+,18.5,21.5,663,Incidence,3321123,Non-Hispanic White,20.0,Female,Stomach,2019
85+,8.2,10.3,306,Incidence,3321123,Non-Hispanic White,9.2,Female,Thyroid,2019
85+,75.8,81.9,2617,Incidence,3321123,Non-Hispanic White,78.8,Female,Urinary Bladder,2019
<1,24.8,31.7,261,Incidence,929655,Non-Hispanic White,28.1,Female,All Cancer Sites Combined,2019
<1,2.6,5.2,35,Incidence,929655,Non-Hispanic White,3.8,Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Cervix,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Colon and Rectum,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Esophagus,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Female Breast,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Kaposi Sarcoma,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Larynx,2019
<1,2.8,5.5,37,Incidence,929655,Non-Hispanic White,4.0,Female,Leukemias,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Mesothelioma,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Myeloma,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Ovary,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Pancreas,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Stomach,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Thyroid,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Female,Urinary Bladder,2019
1-4,21.2,24.2,936,Incidence,4131424,Non-Hispanic White,22.7,Male,All Cancer Sites Combined,2019
1-4,3.7,5.0,178,Incidence,4131424,Non-Hispanic White,4.3,Male,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Colon and Rectum,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Esophagus,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
1-4,1.0,1.8,56,Incidence,4131424,Non-Hispanic White,1.4,Male,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Larynx,2019
1-4,7.9,9.7,362,Incidence,4131424,Non-Hispanic White,8.8,Male,Leukemias,2019
1-4,0.4,0.9,26,Incidence,4131424,Non-Hispanic White,0.6,Male,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Lung and Bronchus,2019
1-4,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Mesothelioma,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Myeloma,2019
1-4,0.8,1.5,47,Incidence,4131424,Non-Hispanic White,1.1,Male,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Pancreas,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Prostate,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Stomach,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Testis,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Thyroid,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male,Urinary Bladder,2019
10-14,15.9,18.1,943,Incidence,5558531,Non-Hispanic White,17.0,Male,All Cancer Sites Combined,2019
10-14,2.9,3.8,185,Incidence,5558531,Non-Hispanic White,3.3,Male,Brain and Other Nervous System,2019
10-14,0.6,1.1,47,Incidence,5558531,Non-Hispanic White,0.8,Male,Colon and Rectum,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Esophagus,2019
10-14,1.3,2.0,90,Incidence,5558531,Non-Hispanic White,1.6,Male,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Larynx,2019
10-14,3.2,4.2,205,Incidence,5558531,Non-Hispanic White,3.7,Male,Leukemias,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Lung and Bronchus,2019
10-14,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
10-14,0.2,0.5,16,Incidence,5558531,Non-Hispanic White,0.3,Male,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Mesothelioma,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Myeloma,2019
10-14,1.6,2.4,111,Incidence,5558531,Non-Hispanic White,2.0,Male,Non-Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Pancreas,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Prostate,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Stomach,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Testis,2019
10-14,0.3,0.6,24,Incidence,5558531,Non-Hispanic White,0.4,Male,Thyroid,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male,Urinary Bladder,2019
15-19,24.0,26.5,1470,Incidence,5827490,Non-Hispanic White,25.2,Male,All Cancer Sites Combined,2019
15-19,2.4,3.3,165,Incidence,5827490,Non-Hispanic White,2.8,Male,Brain and Other Nervous System,2019
15-19,1.1,1.8,84,Incidence,5827490,Non-Hispanic White,1.4,Male,Colon and Rectum,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Esophagus,2019
15-19,3.2,4.2,216,Incidence,5827490,Non-Hispanic White,3.7,Male,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Larynx,2019
15-19,2.8,3.7,188,Incidence,5827490,Non-Hispanic White,3.2,Male,Leukemias,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Lung and Bronchus,2019
15-19,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
15-19,0.7,1.2,54,Incidence,5827490,Non-Hispanic White,0.9,Male,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Mesothelioma,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Myeloma,2019
15-19,2.2,3.0,151,Incidence,5827490,Non-Hispanic White,2.6,Male,Non-Hodgkin Lymphoma,2019
15-19,0.3,0.6,24,Incidence,5827490,Non-Hispanic White,0.4,Male,Oral Cavity and Pharynx,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Pancreas,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Prostate,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Stomach,2019
15-19,2.7,3.6,181,Incidence,5827490,Non-Hispanic White,3.1,Male,Testis,2019
15-19,0.9,1.5,67,Incidence,5827490,Non-Hispanic White,1.1,Male,Thyroid,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male,Urinary Bladder,2019
20-24,36.9,40.1,2340,Incidence,6080321,Non-Hispanic White,38.5,Male,All Cancer Sites Combined,2019
20-24,2.7,3.7,193,Incidence,6080321,Non-Hispanic White,3.2,Male,Brain and Other Nervous System,2019
20-24,1.8,2.6,132,Incidence,6080321,Non-Hispanic White,2.2,Male,Colon and Rectum,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Esophagus,2019
20-24,4.5,5.7,308,Incidence,6080321,Non-Hispanic White,5.1,Male,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
20-24,0.7,1.2,56,Incidence,6080321,Non-Hispanic White,0.9,Male,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Larynx,2019
20-24,2.5,3.3,174,Incidence,6080321,Non-Hispanic White,2.9,Male,Leukemias,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2019
20-24,0.2,0.5,19,Incidence,6080321,Non-Hispanic White,0.3,Male,Lung and Bronchus,2019
20-24,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
20-24,2.0,2.8,144,Incidence,6080321,Non-Hispanic White,2.4,Male,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Mesothelioma,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Myeloma,2019
20-24,2.5,3.4,177,Incidence,6080321,Non-Hispanic White,2.9,Male,Non-Hodgkin Lymphoma,2019
20-24,0.3,0.6,27,Incidence,6080321,Non-Hispanic White,0.4,Male,Oral Cavity and Pharynx,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Pancreas,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Prostate,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male,Stomach,2019
20-24,9.9,11.6,654,Incidence,6080321,Non-Hispanic White,10.8,Male,Testis,2019
20-24,2.2,3.1,160,Incidence,6080321,Non-Hispanic White,2.6,Male,Thyroid,2019
20-24,0.2,0.4,16,Incidence,6080321,Non-Hispanic White,0.3,Male,Urinary Bladder,2019
25-29,52.8,56.3,3600,Incidence,6603379,Non-Hispanic White,54.5,Male,All Cancer Sites Combined,2019
25-29,3.3,4.3,249,Incidence,6603379,Non-Hispanic White,3.8,Male,Brain and Other Nervous System,2019
25-29,3.0,3.9,229,Incidence,6603379,Non-Hispanic White,3.5,Male,Colon and Rectum,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male,Esophagus,2019
25-29,4.0,5.1,299,Incidence,6603379,Non-Hispanic White,4.5,Male,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
25-29,1.2,1.8,96,Incidence,6603379,Non-Hispanic White,1.5,Male,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male,Larynx,2019
25-29,2.6,3.4,196,Incidence,6603379,Non-Hispanic White,3.0,Male,Leukemias,2019
25-29,0.2,0.5,23,Incidence,6603379,Non-Hispanic White,0.3,Male,Liver and Intrahepatic Bile Duct,2019
25-29,0.4,0.8,38,Incidence,6603379,Non-Hispanic White,0.6,Male,Lung and Bronchus,2019
25-29,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
25-29,4.0,5.1,300,Incidence,6603379,Non-Hispanic White,4.5,Male,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male,Mesothelioma,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male,Myeloma,2019
25-29,3.4,4.4,258,Incidence,6603379,Non-Hispanic White,3.9,Male,Non-Hodgkin Lymphoma,2019
25-29,0.7,1.2,63,Incidence,6603379,Non-Hispanic White,1.0,Male,Oral Cavity and Pharynx,2019
25-29,0.2,0.5,21,Incidence,6603379,Non-Hispanic White,0.3,Male,Pancreas,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male,Prostate,2019
25-29,0.3,0.7,31,Incidence,6603379,Non-Hispanic White,0.5,Male,Stomach,2019
25-29,15.5,17.5,1086,Incidence,6603379,Non-Hispanic White,16.4,Male,Testis,2019
25-29,4.2,5.3,314,Incidence,6603379,Non-Hispanic White,4.8,Male,Thyroid,2019
25-29,0.4,0.8,39,Incidence,6603379,Non-Hispanic White,0.6,Male,Urinary Bladder,2019
30-34,77.5,81.8,5109,Incidence,6416438,Non-Hispanic White,79.6,Male,All Cancer Sites Combined,2019
30-34,4.6,5.8,333,Incidence,6416438,Non-Hispanic White,5.2,Male,Brain and Other Nervous System,2019
30-34,6.3,7.6,447,Incidence,6416438,Non-Hispanic White,7.0,Male,Colon and Rectum,2019
30-34,0.3,0.7,32,Incidence,6416438,Non-Hispanic White,0.5,Male,Esophagus,2019
30-34,3.7,4.7,266,Incidence,6416438,Non-Hispanic White,4.1,Male,Hodgkin Lymphoma,2019
30-34,0.3,0.6,26,Incidence,6416438,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2019
30-34,3.2,4.1,233,Incidence,6416438,Non-Hispanic White,3.6,Male,Kidney and Renal Pelvis,2019
30-34,0.1,0.4,16,Incidence,6416438,Non-Hispanic White,0.2,Male,Larynx,2019
30-34,3.8,4.8,272,Incidence,6416438,Non-Hispanic White,4.2,Male,Leukemias,2019
30-34,0.4,0.8,40,Incidence,6416438,Non-Hispanic White,0.6,Male,Liver and Intrahepatic Bile Duct,2019
30-34,0.9,1.4,72,Incidence,6416438,Non-Hispanic White,1.1,Male,Lung and Bronchus,2019
30-34,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
30-34,9.3,10.9,647,Incidence,6416438,Non-Hispanic White,10.1,Male,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,6416438,Non-Hispanic White,~,Male,Mesothelioma,2019
30-34,~,~,~,Incidence,6416438,Non-Hispanic White,~,Male,Myeloma,2019
30-34,4.8,6.0,346,Incidence,6416438,Non-Hispanic White,5.4,Male,Non-Hodgkin Lymphoma,2019
30-34,1.7,2.4,132,Incidence,6416438,Non-Hispanic White,2.1,Male,Oral Cavity and Pharynx,2019
30-34,0.6,1.0,49,Incidence,6416438,Non-Hispanic White,0.8,Male,Pancreas,2019
30-34,~,~,~,Incidence,6416438,Non-Hispanic White,~,Male,Prostate,2019
30-34,0.5,0.9,45,Incidence,6416438,Non-Hispanic White,0.7,Male,Stomach,2019
30-34,17.6,19.7,1197,Incidence,6416438,Non-Hispanic White,18.7,Male,Testis,2019
30-34,5.3,6.5,377,Incidence,6416438,Non-Hispanic White,5.9,Male,Thyroid,2019
30-34,1.0,1.5,78,Incidence,6416438,Non-Hispanic White,1.2,Male,Urinary Bladder,2019
35-39,107.9,113.1,6894,Incidence,6242047,Non-Hispanic White,110.4,Male,All Cancer Sites Combined,2019
35-39,5.2,6.4,362,Incidence,6242047,Non-Hispanic White,5.8,Male,Brain and Other Nervous System,2019
35-39,12.0,13.8,801,Incidence,6242047,Non-Hispanic White,12.8,Male,Colon and Rectum,2019
35-39,0.8,1.3,63,Incidence,6242047,Non-Hispanic White,1.0,Male,Esophagus,2019
35-39,2.7,3.6,195,Incidence,6242047,Non-Hispanic White,3.1,Male,Hodgkin Lymphoma,2019
35-39,0.2,0.5,22,Incidence,6242047,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2019
35-39,7.8,9.3,533,Incidence,6242047,Non-Hispanic White,8.5,Male,Kidney and Renal Pelvis,2019
35-39,0.3,0.6,25,Incidence,6242047,Non-Hispanic White,0.4,Male,Larynx,2019
35-39,4.8,6.0,335,Incidence,6242047,Non-Hispanic White,5.4,Male,Leukemias,2019
35-39,0.7,1.2,58,Incidence,6242047,Non-Hispanic White,0.9,Male,Liver and Intrahepatic Bile Duct,2019
35-39,2.5,3.3,180,Incidence,6242047,Non-Hispanic White,2.9,Male,Lung and Bronchus,2019
35-39,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
35-39,13.9,15.8,927,Incidence,6242047,Non-Hispanic White,14.9,Male,Melanomas of the Skin,2019
35-39,~,~,~,Incidence,6242047,Non-Hispanic White,~,Male,Mesothelioma,2019
35-39,0.6,1.1,52,Incidence,6242047,Non-Hispanic White,0.8,Male,Myeloma,2019
35-39,6.9,8.2,470,Incidence,6242047,Non-Hispanic White,7.5,Male,Non-Hodgkin Lymphoma,2019
35-39,3.9,5.0,276,Incidence,6242047,Non-Hispanic White,4.4,Male,Oral Cavity and Pharynx,2019
35-39,1.4,2.1,109,Incidence,6242047,Non-Hispanic White,1.7,Male,Pancreas,2019
35-39,0.3,0.7,30,Incidence,6242047,Non-Hispanic White,0.5,Male,Prostate,2019
35-39,1.0,1.6,79,Incidence,6242047,Non-Hispanic White,1.3,Male,Stomach,2019
35-39,14.7,16.7,981,Incidence,6242047,Non-Hispanic White,15.7,Male,Testis,2019
35-39,8.4,9.9,569,Incidence,6242047,Non-Hispanic White,9.1,Male,Thyroid,2019
35-39,1.9,2.6,138,Incidence,6242047,Non-Hispanic White,2.2,Male,Urinary Bladder,2019
40-44,166.3,173.0,9738,Incidence,5741161,Non-Hispanic White,169.6,Male,All Cancer Sites Combined,2019
40-44,5.6,7.0,360,Incidence,5741161,Non-Hispanic White,6.3,Male,Brain and Other Nervous System,2019
40-44,23.3,25.9,1409,Incidence,5741161,Non-Hispanic White,24.5,Male,Colon and Rectum,2019
40-44,2.0,2.9,139,Incidence,5741161,Non-Hispanic White,2.4,Male,Esophagus,2019
40-44,2.8,3.8,188,Incidence,5741161,Non-Hispanic White,3.3,Male,Hodgkin Lymphoma,2019
40-44,0.3,0.6,23,Incidence,5741161,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2019
40-44,15.5,17.6,948,Incidence,5741161,Non-Hispanic White,16.5,Male,Kidney and Renal Pelvis,2019
40-44,0.9,1.4,65,Incidence,5741161,Non-Hispanic White,1.1,Male,Larynx,2019
40-44,6.3,7.7,402,Incidence,5741161,Non-Hispanic White,7.0,Male,Leukemias,2019
40-44,1.2,1.8,84,Incidence,5741161,Non-Hispanic White,1.5,Male,Liver and Intrahepatic Bile Duct,2019
40-44,5.7,7.1,366,Incidence,5741161,Non-Hispanic White,6.4,Male,Lung and Bronchus,2019
40-44,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
40-44,20.0,22.4,1214,Incidence,5741161,Non-Hispanic White,21.1,Male,Melanomas of the Skin,2019
40-44,~,~,~,Incidence,5741161,Non-Hispanic White,~,Male,Mesothelioma,2019
40-44,1.8,2.6,123,Incidence,5741161,Non-Hispanic White,2.1,Male,Myeloma,2019
40-44,9.7,11.4,604,Incidence,5741161,Non-Hispanic White,10.5,Male,Non-Hodgkin Lymphoma,2019
40-44,8.7,10.3,545,Incidence,5741161,Non-Hispanic White,9.5,Male,Oral Cavity and Pharynx,2019
40-44,2.9,3.9,192,Incidence,5741161,Non-Hispanic White,3.3,Male,Pancreas,2019
40-44,4.5,5.7,290,Incidence,5741161,Non-Hispanic White,5.1,Male,Prostate,2019
40-44,2.1,2.9,140,Incidence,5741161,Non-Hispanic White,2.4,Male,Stomach,2019
40-44,11.8,13.6,727,Incidence,5741161,Non-Hispanic White,12.7,Male,Testis,2019
40-44,10.8,12.6,668,Incidence,5741161,Non-Hispanic White,11.6,Male,Thyroid,2019
40-44,4.4,5.5,283,Incidence,5741161,Non-Hispanic White,4.9,Male,Urinary Bladder,2019
45-49,284.4,293.0,17715,Incidence,6136494,Non-Hispanic White,288.7,Male,All Cancer Sites Combined,2019
45-49,6.8,8.1,456,Incidence,6136494,Non-Hispanic White,7.4,Male,Brain and Other Nervous System,2019
45-49,41.9,45.2,2670,Incidence,6136494,Non-Hispanic White,43.5,Male,Colon and Rectum,2019
45-49,4.4,5.6,306,Incidence,6136494,Non-Hispanic White,5.0,Male,Esophagus,2019
45-49,2.6,3.4,183,Incidence,6136494,Non-Hispanic White,3.0,Male,Hodgkin Lymphoma,2019
45-49,0.3,0.7,28,Incidence,6136494,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2019
45-49,25.7,28.4,1658,Incidence,6136494,Non-Hispanic White,27.0,Male,Kidney and Renal Pelvis,2019
45-49,2.6,3.5,186,Incidence,6136494,Non-Hispanic White,3.0,Male,Larynx,2019
45-49,10.5,12.2,696,Incidence,6136494,Non-Hispanic White,11.3,Male,Leukemias,2019
45-49,3.2,4.2,226,Incidence,6136494,Non-Hispanic White,3.7,Male,Liver and Intrahepatic Bile Duct,2019
45-49,16.3,18.4,1061,Incidence,6136494,Non-Hispanic White,17.3,Male,Lung and Bronchus,2019
45-49,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
45-49,28.6,31.3,1836,Incidence,6136494,Non-Hispanic White,29.9,Male,Melanomas of the Skin,2019
45-49,~,~,~,Incidence,6136494,Non-Hispanic White,~,Male,Mesothelioma,2019
45-49,3.9,5.0,271,Incidence,6136494,Non-Hispanic White,4.4,Male,Myeloma,2019
45-49,15.6,17.6,1018,Incidence,6136494,Non-Hispanic White,16.6,Male,Non-Hodgkin Lymphoma,2019
45-49,19.5,21.8,1264,Incidence,6136494,Non-Hispanic White,20.6,Male,Oral Cavity and Pharynx,2019
45-49,7.4,8.9,500,Incidence,6136494,Non-Hispanic White,8.1,Male,Pancreas,2019
45-49,26.0,28.6,1675,Incidence,6136494,Non-Hispanic White,27.3,Male,Prostate,2019
45-49,4.0,5.1,279,Incidence,6136494,Non-Hispanic White,4.5,Male,Stomach,2019
45-49,7.1,8.5,475,Incidence,6136494,Non-Hispanic White,7.7,Male,Testis,2019
45-49,11.4,13.2,752,Incidence,6136494,Non-Hispanic White,12.3,Male,Thyroid,2019
45-49,10.0,11.6,661,Incidence,6136494,Non-Hispanic White,10.8,Male,Urinary Bladder,2019
5-9,12.4,14.4,712,Incidence,5335225,Non-Hispanic White,13.3,Male,All Cancer Sites Combined,2019
5-9,3.3,4.4,205,Incidence,5335225,Non-Hispanic White,3.8,Male,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Colon and Rectum,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Esophagus,2019
5-9,0.2,0.5,17,Incidence,5335225,Non-Hispanic White,0.3,Male,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
5-9,0.3,0.7,25,Incidence,5335225,Non-Hispanic White,0.5,Male,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Larynx,2019
5-9,3.7,4.8,227,Incidence,5335225,Non-Hispanic White,4.3,Male,Leukemias,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Lung and Bronchus,2019
5-9,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Mesothelioma,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Myeloma,2019
5-9,1.0,1.6,69,Incidence,5335225,Non-Hispanic White,1.3,Male,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Pancreas,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Prostate,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Stomach,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Testis,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Thyroid,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male,Urinary Bladder,2019
50-54,533.7,545.0,35133,Incidence,6514008,Non-Hispanic White,539.3,Male,All Cancer Sites Combined,2019
50-54,9.1,10.6,641,Incidence,6514008,Non-Hispanic White,9.8,Male,Brain and Other Nervous System,2019
50-54,74.7,78.9,5001,Incidence,6514008,Non-Hispanic White,76.8,Male,Colon and Rectum,2019
50-54,9.8,11.4,688,Incidence,6514008,Non-Hispanic White,10.6,Male,Esophagus,2019
50-54,2.2,3.0,170,Incidence,6514008,Non-Hispanic White,2.6,Male,Hodgkin Lymphoma,2019
50-54,0.4,0.8,38,Incidence,6514008,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2019
50-54,36.3,39.3,2461,Incidence,6514008,Non-Hispanic White,37.8,Male,Kidney and Renal Pelvis,2019
50-54,6.6,7.9,469,Incidence,6514008,Non-Hispanic White,7.2,Male,Larynx,2019
50-54,16.2,18.3,1123,Incidence,6514008,Non-Hispanic White,17.2,Male,Leukemias,2019
50-54,9.5,11.1,671,Incidence,6514008,Non-Hispanic White,10.3,Male,Liver and Intrahepatic Bile Duct,2019
50-54,40.9,44.1,2765,Incidence,6514008,Non-Hispanic White,42.4,Male,Lung and Bronchus,2019
50-54,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
50-54,41.8,45.0,2826,Incidence,6514008,Non-Hispanic White,43.4,Male,Melanomas of the Skin,2019
50-54,0.5,0.9,42,Incidence,6514008,Non-Hispanic White,0.6,Male,Mesothelioma,2019
50-54,7.0,8.4,502,Incidence,6514008,Non-Hispanic White,7.7,Male,Myeloma,2019
50-54,22.5,24.8,1539,Incidence,6514008,Non-Hispanic White,23.6,Male,Non-Hodgkin Lymphoma,2019
50-54,38.2,41.2,2584,Incidence,6514008,Non-Hispanic White,39.7,Male,Oral Cavity and Pharynx,2019
50-54,14.4,16.3,996,Incidence,6514008,Non-Hispanic White,15.3,Male,Pancreas,2019
50-54,103.6,108.6,6911,Incidence,6514008,Non-Hispanic White,106.1,Male,Prostate,2019
50-54,6.7,8.0,477,Incidence,6514008,Non-Hispanic White,7.3,Male,Stomach,2019
50-54,4.7,5.9,343,Incidence,6514008,Non-Hispanic White,5.3,Male,Testis,2019
50-54,13.7,15.6,952,Incidence,6514008,Non-Hispanic White,14.6,Male,Thyroid,2019
50-54,20.1,22.3,1379,Incidence,6514008,Non-Hispanic White,21.2,Male,Urinary Bladder,2019
55-59,900.2,914.0,66686,Incidence,7351783,Non-Hispanic White,907.1,Male,All Cancer Sites Combined,2019
55-59,13.3,15.0,1037,Incidence,7351783,Non-Hispanic White,14.1,Male,Brain and Other Nervous System,2019
55-59,78.0,82.1,5885,Incidence,7351783,Non-Hispanic White,80.0,Male,Colon and Rectum,2019
55-59,16.7,18.7,1301,Incidence,7351783,Non-Hispanic White,17.7,Male,Esophagus,2019
55-59,3.0,3.8,248,Incidence,7351783,Non-Hispanic White,3.4,Male,Hodgkin Lymphoma,2019
55-59,0.4,0.8,42,Incidence,7351783,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2019
55-59,50.7,54.0,3850,Incidence,7351783,Non-Hispanic White,52.4,Male,Kidney and Renal Pelvis,2019
55-59,13.4,15.1,1048,Incidence,7351783,Non-Hispanic White,14.3,Male,Larynx,2019
55-59,24.7,27.1,1904,Incidence,7351783,Non-Hispanic White,25.9,Male,Leukemias,2019
55-59,25.2,27.6,1941,Incidence,7351783,Non-Hispanic White,26.4,Male,Liver and Intrahepatic Bile Duct,2019
55-59,98.4,103.0,7399,Incidence,7351783,Non-Hispanic White,100.6,Male,Lung and Bronchus,2019
55-59,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
55-59,59.9,63.5,4532,Incidence,7351783,Non-Hispanic White,61.6,Male,Melanomas of the Skin,2019
55-59,0.7,1.1,65,Incidence,7351783,Non-Hispanic White,0.9,Male,Mesothelioma,2019
55-59,11.9,13.6,935,Incidence,7351783,Non-Hispanic White,12.7,Male,Myeloma,2019
55-59,34.3,37.0,2620,Incidence,7351783,Non-Hispanic White,35.6,Male,Non-Hodgkin Lymphoma,2019
55-59,57.9,61.5,4388,Incidence,7351783,Non-Hispanic White,59.7,Male,Oral Cavity and Pharynx,2019
55-59,25.0,27.3,1920,Incidence,7351783,Non-Hispanic White,26.1,Male,Pancreas,2019
55-59,238.6,245.7,17801,Incidence,7351783,Non-Hispanic White,242.1,Male,Prostate,2019
55-59,11.9,13.6,936,Incidence,7351783,Non-Hispanic White,12.7,Male,Stomach,2019
55-59,3.7,4.7,309,Incidence,7351783,Non-Hispanic White,4.2,Male,Testis,2019
55-59,13.4,15.2,1050,Incidence,7351783,Non-Hispanic White,14.3,Male,Thyroid,2019
55-59,41.1,44.1,3130,Incidence,7351783,Non-Hispanic White,42.6,Male,Urinary Bladder,2019
60-64,1387.1,1404.4,99576,Incidence,7134246,Non-Hispanic White,1395.7,Male,All Cancer Sites Combined,2019
60-64,16.2,18.2,1227,Incidence,7134246,Non-Hispanic White,17.2,Male,Brain and Other Nervous System,2019
60-64,98.8,103.5,7213,Incidence,7134246,Non-Hispanic White,101.1,Male,Colon and Rectum,2019
60-64,27.2,29.6,2025,Incidence,7134246,Non-Hispanic White,28.4,Male,Esophagus,2019
60-64,3.1,4.0,249,Incidence,7134246,Non-Hispanic White,3.5,Male,Hodgkin Lymphoma,2019
60-64,0.2,0.5,25,Incidence,7134246,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2019
60-64,65.9,69.7,4837,Incidence,7134246,Non-Hispanic White,67.8,Male,Kidney and Renal Pelvis,2019
60-64,19.1,21.2,1439,Incidence,7134246,Non-Hispanic White,20.2,Male,Larynx,2019
60-64,35.9,38.8,2663,Incidence,7134246,Non-Hispanic White,37.3,Male,Leukemias,2019
60-64,43.2,46.3,3189,Incidence,7134246,Non-Hispanic White,44.7,Male,Liver and Intrahepatic Bile Duct,2019
60-64,175.6,181.9,12751,Incidence,7134246,Non-Hispanic White,178.7,Male,Lung and Bronchus,2019
60-64,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
60-64,83.8,88.1,6130,Incidence,7134246,Non-Hispanic White,85.9,Male,Melanomas of the Skin,2019
60-64,1.2,1.8,108,Incidence,7134246,Non-Hispanic White,1.5,Male,Mesothelioma,2019
60-64,18.3,20.3,1375,Incidence,7134246,Non-Hispanic White,19.3,Male,Myeloma,2019
60-64,51.4,54.8,3788,Incidence,7134246,Non-Hispanic White,53.1,Male,Non-Hodgkin Lymphoma,2019
60-64,71.3,75.3,5230,Incidence,7134246,Non-Hispanic White,73.3,Male,Oral Cavity and Pharynx,2019
60-64,39.5,42.5,2924,Incidence,7134246,Non-Hispanic White,41.0,Male,Pancreas,2019
60-64,419.1,428.6,30236,Incidence,7134246,Non-Hispanic White,423.8,Male,Prostate,2019
60-64,17.3,19.3,1301,Incidence,7134246,Non-Hispanic White,18.2,Male,Stomach,2019
60-64,2.2,3.0,184,Incidence,7134246,Non-Hispanic White,2.6,Male,Testis,2019
60-64,16.5,18.4,1243,Incidence,7134246,Non-Hispanic White,17.4,Male,Thyroid,2019
60-64,72.4,76.4,5308,Incidence,7134246,Non-Hispanic White,74.4,Male,Urinary Bladder,2019
65-69,1987.9,2010.2,123264,Incidence,6166269,Non-Hispanic White,1999.0,Male,All Cancer Sites Combined,2019
65-69,20.1,22.4,1307,Incidence,6166269,Non-Hispanic White,21.2,Male,Brain and Other Nervous System,2019
65-69,129.2,135.0,8145,Incidence,6166269,Non-Hispanic White,132.1,Male,Colon and Rectum,2019
65-69,37.0,40.1,2378,Incidence,6166269,Non-Hispanic White,38.6,Male,Esophagus,2019
65-69,3.5,4.6,248,Incidence,6166269,Non-Hispanic White,4.0,Male,Hodgkin Lymphoma,2019
65-69,0.3,0.6,26,Incidence,6166269,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2019
65-69,86.5,91.2,5478,Incidence,6166269,Non-Hispanic White,88.8,Male,Kidney and Renal Pelvis,2019
65-69,20.8,23.1,1353,Incidence,6166269,Non-Hispanic White,21.9,Male,Larynx,2019
65-69,51.9,55.6,3313,Incidence,6166269,Non-Hispanic White,53.7,Male,Leukemias,2019
65-69,55.2,59.0,3517,Incidence,6166269,Non-Hispanic White,57.0,Male,Liver and Intrahepatic Bile Duct,2019
65-69,258.5,266.6,16190,Incidence,6166269,Non-Hispanic White,262.6,Male,Lung and Bronchus,2019
65-69,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
65-69,116.1,121.5,7325,Incidence,6166269,Non-Hispanic White,118.8,Male,Melanomas of the Skin,2019
65-69,2.9,3.8,204,Incidence,6166269,Non-Hispanic White,3.3,Male,Mesothelioma,2019
65-69,26.8,29.5,1733,Incidence,6166269,Non-Hispanic White,28.1,Male,Myeloma,2019
65-69,73.8,78.2,4687,Incidence,6166269,Non-Hispanic White,76.0,Male,Non-Hodgkin Lymphoma,2019
65-69,78.1,82.6,4953,Incidence,6166269,Non-Hispanic White,80.3,Male,Oral Cavity and Pharynx,2019
65-69,58.4,62.2,3717,Incidence,6166269,Non-Hispanic White,60.3,Male,Pancreas,2019
65-69,649.4,662.2,40437,Incidence,6166269,Non-Hispanic White,655.8,Male,Prostate,2019
65-69,23.8,26.3,1544,Incidence,6166269,Non-Hispanic White,25.0,Male,Stomach,2019
65-69,2.0,2.7,144,Incidence,6166269,Non-Hispanic White,2.3,Male,Testis,2019
65-69,18.6,20.8,1213,Incidence,6166269,Non-Hispanic White,19.7,Male,Thyroid,2019
65-69,121.7,127.2,7672,Incidence,6166269,Non-Hispanic White,124.4,Male,Urinary Bladder,2019
70-74,2357.6,2384.4,120090,Incidence,5064990,Non-Hispanic White,2371.0,Male,All Cancer Sites Combined,2019
70-74,22.8,25.5,1221,Incidence,5064990,Non-Hispanic White,24.1,Male,Brain and Other Nervous System,2019
70-74,146.6,153.4,7596,Incidence,5064990,Non-Hispanic White,150.0,Male,Colon and Rectum,2019
70-74,43.1,46.8,2274,Incidence,5064990,Non-Hispanic White,44.9,Male,Esophagus,2019
70-74,3.6,4.7,210,Incidence,5064990,Non-Hispanic White,4.1,Male,Hodgkin Lymphoma,2019
70-74,0.3,0.6,21,Incidence,5064990,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2019
70-74,98.3,103.9,5119,Incidence,5064990,Non-Hispanic White,101.1,Male,Kidney and Renal Pelvis,2019
70-74,21.5,24.2,1157,Incidence,5064990,Non-Hispanic White,22.8,Male,Larynx,2019
70-74,72.1,76.9,3771,Incidence,5064990,Non-Hispanic White,74.5,Male,Leukemias,2019
70-74,49.4,53.3,2600,Incidence,5064990,Non-Hispanic White,51.3,Male,Liver and Intrahepatic Bile Duct,2019
70-74,353.5,363.9,18167,Incidence,5064990,Non-Hispanic White,358.7,Male,Lung and Bronchus,2019
70-74,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
70-74,152.0,158.9,7873,Incidence,5064990,Non-Hispanic White,155.4,Male,Melanomas of the Skin,2019
70-74,6.1,7.6,347,Incidence,5064990,Non-Hispanic White,6.9,Male,Mesothelioma,2019
70-74,37.8,41.2,1999,Incidence,5064990,Non-Hispanic White,39.5,Male,Myeloma,2019
70-74,98.2,103.7,5111,Incidence,5064990,Non-Hispanic White,100.9,Male,Non-Hodgkin Lymphoma,2019
70-74,76.4,81.3,3991,Incidence,5064990,Non-Hispanic White,78.8,Male,Oral Cavity and Pharynx,2019
70-74,75.9,80.8,3969,Incidence,5064990,Non-Hispanic White,78.4,Male,Pancreas,2019
70-74,668.5,682.8,34221,Incidence,5064990,Non-Hispanic White,675.6,Male,Prostate,2019
70-74,31.4,34.5,1667,Incidence,5064990,Non-Hispanic White,32.9,Male,Stomach,2019
70-74,0.9,1.5,59,Incidence,5064990,Non-Hispanic White,1.2,Male,Testis,2019
70-74,18.3,20.8,988,Incidence,5064990,Non-Hispanic White,19.5,Male,Thyroid,2019
70-74,177.2,184.6,9161,Incidence,5064990,Non-Hispanic White,180.9,Male,Urinary Bladder,2019
75-79,2744.4,2779.7,94416,Incidence,3418373,Non-Hispanic White,2762.0,Male,All Cancer Sites Combined,2019
75-79,25.5,29.1,932,Incidence,3418373,Non-Hispanic White,27.3,Male,Brain and Other Nervous System,2019
75-79,182.5,191.7,6393,Incidence,3418373,Non-Hispanic White,187.0,Male,Colon and Rectum,2019
75-79,46.0,50.7,1651,Incidence,3418373,Non-Hispanic White,48.3,Male,Esophagus,2019
75-79,4.3,5.8,170,Incidence,3418373,Non-Hispanic White,5.0,Male,Hodgkin Lymphoma,2019
75-79,0.4,0.9,20,Incidence,3418373,Non-Hispanic White,0.6,Male,Kaposi Sarcoma,2019
75-79,105.5,112.6,3726,Incidence,3418373,Non-Hispanic White,109.0,Male,Kidney and Renal Pelvis,2019
75-79,21.0,24.2,771,Incidence,3418373,Non-Hispanic White,22.6,Male,Larynx,2019
75-79,98.4,105.2,3477,Incidence,3418373,Non-Hispanic White,101.7,Male,Leukemias,2019
75-79,52.7,57.7,1884,Incidence,3418373,Non-Hispanic White,55.1,Male,Liver and Intrahepatic Bile Duct,2019
75-79,452.0,466.4,15695,Incidence,3418373,Non-Hispanic White,459.1,Male,Lung and Bronchus,2019
75-79,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
75-79,192.4,201.8,6736,Incidence,3418373,Non-Hispanic White,197.1,Male,Melanomas of the Skin,2019
75-79,11.2,13.6,423,Incidence,3418373,Non-Hispanic White,12.4,Male,Mesothelioma,2019
75-79,46.5,51.2,1667,Incidence,3418373,Non-Hispanic White,48.8,Male,Myeloma,2019
75-79,131.4,139.2,4623,Incidence,3418373,Non-Hispanic White,135.2,Male,Non-Hodgkin Lymphoma,2019
75-79,72.0,77.8,2560,Incidence,3418373,Non-Hispanic White,74.9,Male,Oral Cavity and Pharynx,2019
75-79,93.5,100.1,3308,Incidence,3418373,Non-Hispanic White,96.8,Male,Pancreas,2019
75-79,602.8,619.4,20888,Incidence,3418373,Non-Hispanic White,611.1,Male,Prostate,2019
75-79,38.6,42.9,1392,Incidence,3418373,Non-Hispanic White,40.7,Male,Stomach,2019
75-79,0.6,1.3,32,Incidence,3418373,Non-Hispanic White,0.9,Male,Testis,2019
75-79,17.2,20.1,635,Incidence,3418373,Non-Hispanic White,18.6,Male,Thyroid,2019
75-79,262.2,273.2,9148,Incidence,3418373,Non-Hispanic White,267.6,Male,Urinary Bladder,2019
80-84,2876.8,2922.8,61323,Incidence,2114781,Non-Hispanic White,2899.7,Male,All Cancer Sites Combined,2019
80-84,26.2,30.8,602,Incidence,2114781,Non-Hispanic White,28.5,Male,Brain and Other Nervous System,2019
80-84,231.0,244.2,5023,Incidence,2114781,Non-Hispanic White,237.5,Male,Colon and Rectum,2019
80-84,46.8,52.9,1053,Incidence,2114781,Non-Hispanic White,49.8,Male,Esophagus,2019
80-84,3.9,5.8,101,Incidence,2114781,Non-Hispanic White,4.8,Male,Hodgkin Lymphoma,2019
80-84,0.7,1.7,24,Incidence,2114781,Non-Hispanic White,1.1,Male,Kaposi Sarcoma,2019
80-84,102.4,111.2,2257,Incidence,2114781,Non-Hispanic White,106.7,Male,Kidney and Renal Pelvis,2019
80-84,20.8,24.9,482,Incidence,2114781,Non-Hispanic White,22.8,Male,Larynx,2019
80-84,117.9,127.4,2593,Incidence,2114781,Non-Hispanic White,122.6,Male,Leukemias,2019
80-84,53.5,59.9,1198,Incidence,2114781,Non-Hispanic White,56.6,Male,Liver and Intrahepatic Bile Duct,2019
80-84,469.4,488.0,10122,Incidence,2114781,Non-Hispanic White,478.6,Male,Lung and Bronchus,2019
80-84,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
80-84,224.5,237.5,4883,Incidence,2114781,Non-Hispanic White,230.9,Male,Melanomas of the Skin,2019
80-84,13.8,17.2,327,Incidence,2114781,Non-Hispanic White,15.5,Male,Mesothelioma,2019
80-84,54.8,61.3,1226,Incidence,2114781,Non-Hispanic White,58.0,Male,Myeloma,2019
80-84,153.4,164.2,3356,Incidence,2114781,Non-Hispanic White,158.7,Male,Non-Hodgkin Lymphoma,2019
80-84,69.0,76.3,1534,Incidence,2114781,Non-Hispanic White,72.5,Male,Oral Cavity and Pharynx,2019
80-84,105.6,114.6,2327,Incidence,2114781,Non-Hispanic White,110.0,Male,Pancreas,2019
80-84,447.2,465.4,9648,Incidence,2114781,Non-Hispanic White,456.2,Male,Prostate,2019
80-84,42.6,48.4,961,Incidence,2114781,Non-Hispanic White,45.4,Male,Stomach,2019
80-84,0.8,1.7,25,Incidence,2114781,Non-Hispanic White,1.2,Male,Testis,2019
80-84,13.9,17.3,329,Incidence,2114781,Non-Hispanic White,15.6,Male,Thyroid,2019
80-84,309.8,325.0,6711,Incidence,2114781,Non-Hispanic White,317.3,Male,Urinary Bladder,2019
85+,2751.4,2798.8,52737,Incidence,1900401,Non-Hispanic White,2775.0,Male,All Cancer Sites Combined,2019
85+,22.2,26.7,463,Incidence,1900401,Non-Hispanic White,24.4,Male,Brain and Other Nervous System,2019
85+,243.1,257.4,4754,Incidence,1900401,Non-Hispanic White,250.2,Male,Colon and Rectum,2019
85+,41.3,47.3,841,Incidence,1900401,Non-Hispanic White,44.3,Male,Esophagus,2019
85+,3.2,5.0,76,Incidence,1900401,Non-Hispanic White,4.0,Male,Hodgkin Lymphoma,2019
85+,0.6,1.6,19,Incidence,1900401,Non-Hispanic White,1.0,Male,Kaposi Sarcoma,2019
85+,79.6,87.9,1590,Incidence,1900401,Non-Hispanic White,83.7,Male,Kidney and Renal Pelvis,2019
85+,18.7,22.9,394,Incidence,1900401,Non-Hispanic White,20.7,Male,Larynx,2019
85+,120.2,130.3,2379,Incidence,1900401,Non-Hispanic White,125.2,Male,Leukemias,2019
85+,44.3,50.6,900,Incidence,1900401,Non-Hispanic White,47.4,Male,Liver and Intrahepatic Bile Duct,2019
85+,387.0,405.0,7524,Incidence,1900401,Non-Hispanic White,395.9,Male,Lung and Bronchus,2019
85+,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
85+,232.4,246.3,4547,Incidence,1900401,Non-Hispanic White,239.3,Male,Melanomas of the Skin,2019
85+,15.3,19.1,326,Incidence,1900401,Non-Hispanic White,17.2,Male,Mesothelioma,2019
85+,50.2,56.8,1015,Incidence,1900401,Non-Hispanic White,53.4,Male,Myeloma,2019
85+,138.8,149.7,2740,Incidence,1900401,Non-Hispanic White,144.2,Male,Non-Hodgkin Lymphoma,2019
85+,61.5,68.8,1236,Incidence,1900401,Non-Hispanic White,65.0,Male,Oral Cavity and Pharynx,2019
85+,99.8,109.0,1982,Incidence,1900401,Non-Hispanic White,104.3,Male,Pancreas,2019
85+,343.9,360.8,6694,Incidence,1900401,Non-Hispanic White,352.2,Male,Prostate,2019
85+,41.5,47.6,845,Incidence,1900401,Non-Hispanic White,44.5,Male,Stomach,2019
85+,0.6,1.5,18,Incidence,1900401,Non-Hispanic White,0.9,Male,Testis,2019
85+,8.8,11.8,194,Incidence,1900401,Non-Hispanic White,10.2,Male,Thyroid,2019
85+,353.4,370.5,6877,Incidence,1900401,Non-Hispanic White,361.9,Male,Urinary Bladder,2019
<1,24.3,31.0,268,Incidence,975660,Non-Hispanic White,27.5,Male,All Cancer Sites Combined,2019
<1,2.4,4.9,34,Incidence,975660,Non-Hispanic White,3.5,Male,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Colon and Rectum,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Esophagus,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Kaposi Sarcoma,2019
<1,1.2,3.0,19,Incidence,975660,Non-Hispanic White,1.9,Male,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Larynx,2019
<1,2.7,5.2,37,Incidence,975660,Non-Hispanic White,3.8,Male,Leukemias,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Lung and Bronchus,2019
<1,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Melanomas of the Skin,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Mesothelioma,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Myeloma,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Pancreas,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Prostate,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Stomach,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Testis,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Thyroid,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male,Urinary Bladder,2019
1-4,20.8,22.8,1757,Incidence,8060412,Non-Hispanic White,21.8,Male and Female,All Cancer Sites Combined,2019
1-4,3.6,4.5,322,Incidence,8060412,Non-Hispanic White,4.0,Male and Female,Brain and Other Nervous System,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,Cervix,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Colon and Rectum,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Esophagus,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,Female Breast,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
1-4,1.4,2.0,138,Incidence,8060412,Non-Hispanic White,1.7,Male and Female,Kidney and Renal Pelvis,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Larynx,2019
1-4,7.8,9.1,679,Incidence,8060412,Non-Hispanic White,8.4,Male and Female,Leukemias,2019
1-4,0.3,0.6,37,Incidence,8060412,Non-Hispanic White,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,Male and Female Breast,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Myeloma,2019
1-4,0.6,1.0,66,Incidence,8060412,Non-Hispanic White,0.8,Male and Female,Non-Hodgkin Lymphoma,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2019
1-4,~,~,~,Incidence,3928988,Non-Hispanic White,~,Male and Female,Ovary,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Pancreas,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male and Female,Prostate,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Stomach,2019
1-4,~,~,~,Incidence,4131424,Non-Hispanic White,~,Male and Female,Testis,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Thyroid,2019
1-4,~,~,~,Incidence,8060412,Non-Hispanic White,~,Male and Female,Urinary Bladder,2019
10-14,15.4,17.0,1756,Incidence,10854623,Non-Hispanic White,16.2,Male and Female,All Cancer Sites Combined,2019
10-14,2.9,3.6,347,Incidence,10854623,Non-Hispanic White,3.2,Male and Female,Brain and Other Nervous System,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Male and Female,Cervix,2019
10-14,0.6,1.0,84,Incidence,10854623,Non-Hispanic White,0.8,Male and Female,Colon and Rectum,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Esophagus,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Male and Female,Female Breast,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2019
10-14,1.2,1.6,151,Incidence,10854623,Non-Hispanic White,1.4,Male and Female,Hodgkin Lymphoma,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Kidney and Renal Pelvis,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Larynx,2019
10-14,3.0,3.7,361,Incidence,10854623,Non-Hispanic White,3.3,Male and Female,Leukemias,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Male and Female,Male and Female Breast,2019
10-14,~,~,~,Incidence,5296092,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
10-14,0.2,0.5,37,Incidence,10854623,Non-Hispanic White,0.3,Male and Female,Melanomas of the Skin,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Myeloma,2019
10-14,1.2,1.7,159,Incidence,10854623,Non-Hispanic White,1.5,Male and Female,Non-Hodgkin Lymphoma,2019
10-14,0.2,0.4,30,Incidence,10854623,Non-Hispanic White,0.3,Male and Female,Oral Cavity and Pharynx,2019
10-14,0.3,0.7,23,Incidence,5296092,Non-Hispanic White,0.4,Male and Female,Ovary,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Pancreas,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male and Female,Prostate,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Stomach,2019
10-14,~,~,~,Incidence,5558531,Non-Hispanic White,~,Male and Female,Testis,2019
10-14,0.8,1.2,105,Incidence,10854623,Non-Hispanic White,1.0,Male and Female,Thyroid,2019
10-14,~,~,~,Incidence,10854623,Non-Hispanic White,~,Male and Female,Urinary Bladder,2019
15-19,25.2,27.0,2966,Incidence,11368112,Non-Hispanic White,26.1,Male and Female,All Cancer Sites Combined,2019
15-19,2.3,2.9,299,Incidence,11368112,Non-Hispanic White,2.6,Male and Female,Brain and Other Nervous System,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Male and Female,Cervix,2019
15-19,1.5,2.0,201,Incidence,11368112,Non-Hispanic White,1.8,Male and Female,Colon and Rectum,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Esophagus,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Male and Female,Female Breast,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2019
15-19,3.5,4.3,441,Incidence,11368112,Non-Hispanic White,3.9,Male and Female,Hodgkin Lymphoma,2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
15-19,0.1,0.3,24,Incidence,11368112,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Larynx,2019
15-19,2.3,2.9,298,Incidence,11368112,Non-Hispanic White,2.6,Male and Female,Leukemias,2019
15-19,0.1,0.2,16,Incidence,11368112,Non-Hispanic White,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2019
15-19,0.1,0.3,19,Incidence,11368112,Non-Hispanic White,0.2,Male and Female,Lung and Bronchus,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Male and Female,Male and Female Breast,2019
15-19,~,~,~,Incidence,5540622,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
15-19,1.0,1.4,138,Incidence,11368112,Non-Hispanic White,1.2,Male and Female,Melanomas of the Skin,2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Myeloma,2019
15-19,1.8,2.3,233,Incidence,11368112,Non-Hispanic White,2.0,Male and Female,Non-Hodgkin Lymphoma,2019
15-19,0.3,0.5,44,Incidence,11368112,Non-Hispanic White,0.4,Male and Female,Oral Cavity and Pharynx,2019
15-19,0.8,1.4,58,Incidence,5540622,Non-Hispanic White,1.0,Male and Female,Ovary,2019
15-19,0.2,0.3,27,Incidence,11368112,Non-Hispanic White,0.2,Male and Female,Pancreas,2019
15-19,~,~,~,Incidence,5827490,Non-Hispanic White,~,Male and Female,Prostate,2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Stomach,2019
15-19,2.7,3.6,181,Incidence,5827490,Non-Hispanic White,3.1,Male and Female,Testis,2019
15-19,3.7,4.5,466,Incidence,11368112,Non-Hispanic White,4.1,Male and Female,Thyroid,2019
15-19,~,~,~,Incidence,11368112,Non-Hispanic White,~,Male and Female,Urinary Bladder,2019
20-24,39.6,41.9,4830,Incidence,11859270,Non-Hispanic White,40.7,Male and Female,All Cancer Sites Combined,2019
20-24,2.4,3.0,317,Incidence,11859270,Non-Hispanic White,2.7,Male and Female,Brain and Other Nervous System,2019
20-24,0.3,0.7,27,Incidence,5778949,Non-Hispanic White,0.5,Male and Female,Cervix,2019
20-24,2.1,2.6,277,Incidence,11859270,Non-Hispanic White,2.3,Male and Female,Colon and Rectum,2019
20-24,0.3,0.6,24,Incidence,5778949,Non-Hispanic White,0.4,Male and Female,"Corpus and Uterus, NOS",2019
20-24,~,~,~,Incidence,11859270,Non-Hispanic White,~,Male and Female,Esophagus,2019
20-24,1.2,1.8,85,Incidence,5778949,Non-Hispanic White,1.5,Male and Female,Female Breast,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2019
20-24,4.7,5.6,608,Incidence,11859270,Non-Hispanic White,5.1,Male and Female,Hodgkin Lymphoma,2019
20-24,~,~,~,Incidence,11859270,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
20-24,0.6,0.9,86,Incidence,11859270,Non-Hispanic White,0.7,Male and Female,Kidney and Renal Pelvis,2019
20-24,~,~,~,Incidence,11859270,Non-Hispanic White,~,Male and Female,Larynx,2019
20-24,2.3,2.8,300,Incidence,11859270,Non-Hispanic White,2.5,Male and Female,Leukemias,2019
20-24,0.2,0.4,30,Incidence,11859270,Non-Hispanic White,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
20-24,0.2,0.4,37,Incidence,11859270,Non-Hispanic White,0.3,Male and Female,Lung and Bronchus,2019
20-24,1.2,1.8,85,Incidence,5778949,Non-Hispanic White,1.5,Male and Female,Male and Female Breast,2019
20-24,~,~,~,Incidence,5778949,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
20-24,3.4,4.1,438,Incidence,11859270,Non-Hispanic White,3.7,Male and Female,Melanomas of the Skin,2019
20-24,~,~,~,Incidence,11859270,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
20-24,~,~,~,Incidence,11859270,Non-Hispanic White,~,Male and Female,Myeloma,2019
20-24,2.1,2.7,286,Incidence,11859270,Non-Hispanic White,2.4,Male and Female,Non-Hodgkin Lymphoma,2019
20-24,0.4,0.7,66,Incidence,11859270,Non-Hispanic White,0.6,Male and Female,Oral Cavity and Pharynx,2019
20-24,1.1,1.7,81,Incidence,5778949,Non-Hispanic White,1.4,Male and Female,Ovary,2019
20-24,0.1,0.3,24,Incidence,11859270,Non-Hispanic White,0.2,Male and Female,Pancreas,2019
20-24,~,~,~,Incidence,6080321,Non-Hispanic White,~,Male and Female,Prostate,2019
20-24,0.1,0.2,17,Incidence,11859270,Non-Hispanic White,0.1,Male and Female,Stomach,2019
20-24,9.9,11.6,654,Incidence,6080321,Non-Hispanic White,10.8,Male and Female,Testis,2019
20-24,7.4,8.4,935,Incidence,11859270,Non-Hispanic White,7.9,Male and Female,Thyroid,2019
20-24,0.1,0.3,22,Incidence,11859270,Non-Hispanic White,0.2,Male and Female,Urinary Bladder,2019
25-29,63.3,66.1,8362,Incidence,12924917,Non-Hispanic White,64.7,Male and Female,All Cancer Sites Combined,2019
25-29,3.0,3.7,432,Incidence,12924917,Non-Hispanic White,3.3,Male and Female,Brain and Other Nervous System,2019
25-29,3.8,4.8,270,Incidence,6321538,Non-Hispanic White,4.3,Male and Female,Cervix,2019
25-29,3.2,3.9,457,Incidence,12924917,Non-Hispanic White,3.5,Male and Female,Colon and Rectum,2019
25-29,1.5,2.2,118,Incidence,6321538,Non-Hispanic White,1.9,Male and Female,"Corpus and Uterus, NOS",2019
25-29,~,~,~,Incidence,12924917,Non-Hispanic White,~,Male and Female,Esophagus,2019
25-29,9.9,11.5,676,Incidence,6321538,Non-Hispanic White,10.7,Male and Female,Female Breast,2019
25-29,0.6,1.1,51,Incidence,6321538,Non-Hispanic White,0.8,Male and Female,"Female Breast, <i>in situ</i>",2019
25-29,4.2,4.9,584,Incidence,12924917,Non-Hispanic White,4.5,Male and Female,Hodgkin Lymphoma,2019
25-29,~,~,~,Incidence,12924917,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
25-29,1.2,1.6,182,Incidence,12924917,Non-Hispanic White,1.4,Male and Female,Kidney and Renal Pelvis,2019
25-29,~,~,~,Incidence,12924917,Non-Hispanic White,~,Male and Female,Larynx,2019
25-29,2.4,3.0,349,Incidence,12924917,Non-Hispanic White,2.7,Male and Female,Leukemias,2019
25-29,0.2,0.4,39,Incidence,12924917,Non-Hispanic White,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
25-29,0.5,0.8,79,Incidence,12924917,Non-Hispanic White,0.6,Male and Female,Lung and Bronchus,2019
25-29,9.9,11.5,676,Incidence,6321538,Non-Hispanic White,10.7,Male and Female,Male and Female Breast,2019
25-29,0.6,1.1,51,Incidence,6321538,Non-Hispanic White,0.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
25-29,7.2,8.1,988,Incidence,12924917,Non-Hispanic White,7.6,Male and Female,Melanomas of the Skin,2019
25-29,~,~,~,Incidence,12924917,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
25-29,~,~,~,Incidence,12924917,Non-Hispanic White,~,Male and Female,Myeloma,2019
25-29,2.9,3.6,418,Incidence,12924917,Non-Hispanic White,3.2,Male and Female,Non-Hodgkin Lymphoma,2019
25-29,0.9,1.3,139,Incidence,12924917,Non-Hispanic White,1.1,Male and Female,Oral Cavity and Pharynx,2019
25-29,2.0,2.8,149,Incidence,6321538,Non-Hispanic White,2.4,Male and Female,Ovary,2019
25-29,0.3,0.5,46,Incidence,12924917,Non-Hispanic White,0.4,Male and Female,Pancreas,2019
25-29,~,~,~,Incidence,6603379,Non-Hispanic White,~,Male and Female,Prostate,2019
25-29,0.2,0.5,44,Incidence,12924917,Non-Hispanic White,0.3,Male and Female,Stomach,2019
25-29,15.5,17.5,1086,Incidence,6603379,Non-Hispanic White,16.4,Male and Female,Testis,2019
25-29,11.2,12.4,1524,Incidence,12924917,Non-Hispanic White,11.8,Male and Female,Thyroid,2019
25-29,0.4,0.6,60,Incidence,12924917,Non-Hispanic White,0.5,Male and Female,Urinary Bladder,2019
30-34,106.8,110.5,13774,Incidence,12680398,Non-Hispanic White,108.6,Male and Female,All Cancer Sites Combined,2019
30-34,4.0,4.7,551,Incidence,12680398,Non-Hispanic White,4.3,Male and Female,Brain and Other Nervous System,2019
30-34,11.7,13.5,787,Incidence,6263960,Non-Hispanic White,12.6,Male and Female,Cervix,2019
30-34,6.8,7.8,926,Incidence,12680398,Non-Hispanic White,7.3,Male and Female,Colon and Rectum,2019
30-34,4.5,5.6,313,Incidence,6263960,Non-Hispanic White,5.0,Male and Female,"Corpus and Uterus, NOS",2019
30-34,0.2,0.4,40,Incidence,12680398,Non-Hispanic White,0.3,Male and Female,Esophagus,2019
30-34,29.7,32.4,1943,Incidence,6263960,Non-Hispanic White,31.0,Male and Female,Female Breast,2019
30-34,3.0,4.0,217,Incidence,6263960,Non-Hispanic White,3.5,Male and Female,"Female Breast, <i>in situ</i>",2019
30-34,3.7,4.4,517,Incidence,12680398,Non-Hispanic White,4.1,Male and Female,Hodgkin Lymphoma,2019
30-34,0.1,0.3,26,Incidence,12680398,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2019
30-34,3.0,3.6,415,Incidence,12680398,Non-Hispanic White,3.3,Male and Female,Kidney and Renal Pelvis,2019
30-34,0.2,0.3,29,Incidence,12680398,Non-Hispanic White,0.2,Male and Female,Larynx,2019
30-34,3.2,3.9,446,Incidence,12680398,Non-Hispanic White,3.5,Male and Female,Leukemias,2019
30-34,0.4,0.6,63,Incidence,12680398,Non-Hispanic White,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
30-34,1.0,1.4,151,Incidence,12680398,Non-Hispanic White,1.2,Male and Female,Lung and Bronchus,2019
30-34,29.7,32.4,1943,Incidence,6263960,Non-Hispanic White,31.0,Male and Female,Male and Female Breast,2019
30-34,3.0,4.0,217,Incidence,6263960,Non-Hispanic White,3.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
30-34,14.3,15.6,1892,Incidence,12680398,Non-Hispanic White,14.9,Male and Female,Melanomas of the Skin,2019
30-34,~,~,~,Incidence,12680398,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
30-34,0.2,0.3,30,Incidence,12680398,Non-Hispanic White,0.2,Male and Female,Myeloma,2019
30-34,4.1,4.8,561,Incidence,12680398,Non-Hispanic White,4.4,Male and Female,Non-Hodgkin Lymphoma,2019
30-34,1.7,2.2,241,Incidence,12680398,Non-Hispanic White,1.9,Male and Female,Oral Cavity and Pharynx,2019
30-34,3.1,4.1,224,Incidence,6263960,Non-Hispanic White,3.6,Male and Female,Ovary,2019
30-34,0.7,1.0,106,Incidence,12680398,Non-Hispanic White,0.8,Male and Female,Pancreas,2019
30-34,~,~,~,Incidence,6416438,Non-Hispanic White,~,Male and Female,Prostate,2019
30-34,0.5,0.8,78,Incidence,12680398,Non-Hispanic White,0.6,Male and Female,Stomach,2019
30-34,17.6,19.7,1197,Incidence,6416438,Non-Hispanic White,18.7,Male and Female,Testis,2019
30-34,16.0,17.5,2122,Incidence,12680398,Non-Hispanic White,16.7,Male and Female,Thyroid,2019
30-34,0.7,1.1,115,Incidence,12680398,Non-Hispanic White,0.9,Male and Female,Urinary Bladder,2019
35-39,159.2,163.7,20036,Incidence,12407949,Non-Hispanic White,161.5,Male and Female,All Cancer Sites Combined,2019
35-39,4.7,5.5,630,Incidence,12407949,Non-Hispanic White,5.1,Male and Female,Brain and Other Nervous System,2019
35-39,13.1,15.0,863,Incidence,6165902,Non-Hispanic White,14.0,Male and Female,Cervix,2019
35-39,12.0,13.2,1560,Incidence,12407949,Non-Hispanic White,12.6,Male and Female,Colon and Rectum,2019
35-39,9.0,10.6,604,Incidence,6165902,Non-Hispanic White,9.8,Male and Female,"Corpus and Uterus, NOS",2019
35-39,0.5,0.7,73,Incidence,12407949,Non-Hispanic White,0.6,Male and Female,Esophagus,2019
35-39,66.3,70.4,4212,Incidence,6165902,Non-Hispanic White,68.3,Male and Female,Female Breast,2019
35-39,9.8,11.4,653,Incidence,6165902,Non-Hispanic White,10.6,Male and Female,"Female Breast, <i>in situ</i>",2019
35-39,3.0,3.6,411,Incidence,12407949,Non-Hispanic White,3.3,Male and Female,Hodgkin Lymphoma,2019
35-39,0.1,0.3,23,Incidence,12407949,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2019
35-39,7.0,8.0,925,Incidence,12407949,Non-Hispanic White,7.5,Male and Female,Kidney and Renal Pelvis,2019
35-39,0.2,0.4,40,Incidence,12407949,Non-Hispanic White,0.3,Male and Female,Larynx,2019
35-39,4.4,5.2,599,Incidence,12407949,Non-Hispanic White,4.8,Male and Female,Leukemias,2019
35-39,0.7,1.0,103,Incidence,12407949,Non-Hispanic White,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2019
35-39,2.7,3.3,370,Incidence,12407949,Non-Hispanic White,3.0,Male and Female,Lung and Bronchus,2019
35-39,66.3,70.4,4212,Incidence,6165902,Non-Hispanic White,68.3,Male and Female,Male and Female Breast,2019
35-39,9.8,11.4,653,Incidence,6165902,Non-Hispanic White,10.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
35-39,18.8,20.3,2422,Incidence,12407949,Non-Hispanic White,19.5,Male and Female,Melanomas of the Skin,2019
35-39,0.1,0.2,16,Incidence,12407949,Non-Hispanic White,0.1,Male and Female,Mesothelioma,2019
35-39,0.7,1.0,105,Incidence,12407949,Non-Hispanic White,0.8,Male and Female,Myeloma,2019
35-39,6.0,6.9,801,Incidence,12407949,Non-Hispanic White,6.5,Male and Female,Non-Hodgkin Lymphoma,2019
35-39,3.2,3.9,443,Incidence,12407949,Non-Hispanic White,3.6,Male and Female,Oral Cavity and Pharynx,2019
35-39,4.5,5.7,313,Incidence,6165902,Non-Hispanic White,5.1,Male and Female,Ovary,2019
35-39,1.2,1.7,177,Incidence,12407949,Non-Hispanic White,1.4,Male and Female,Pancreas,2019
35-39,0.3,0.7,30,Incidence,6242047,Non-Hispanic White,0.5,Male and Female,Prostate,2019
35-39,1.1,1.5,154,Incidence,12407949,Non-Hispanic White,1.2,Male and Female,Stomach,2019
35-39,14.7,16.7,981,Incidence,6242047,Non-Hispanic White,15.7,Male and Female,Testis,2019
35-39,19.5,21.1,2517,Incidence,12407949,Non-Hispanic White,20.3,Male and Female,Thyroid,2019
35-39,1.4,1.9,206,Incidence,12407949,Non-Hispanic White,1.7,Male and Female,Urinary Bladder,2019
40-44,251.4,257.2,29056,Incidence,11426783,Non-Hispanic White,254.3,Male and Female,All Cancer Sites Combined,2019
40-44,4.9,5.8,610,Incidence,11426783,Non-Hispanic White,5.3,Male and Female,Brain and Other Nervous System,2019
40-44,14.4,16.5,877,Incidence,5685622,Non-Hispanic White,15.4,Male and Female,Cervix,2019
40-44,21.7,23.4,2574,Incidence,11426783,Non-Hispanic White,22.5,Male and Female,Colon and Rectum,2019
40-44,16.4,18.5,991,Incidence,5685622,Non-Hispanic White,17.4,Male and Female,"Corpus and Uterus, NOS",2019
40-44,1.2,1.7,164,Incidence,11426783,Non-Hispanic White,1.4,Male and Female,Esophagus,2019
40-44,138.4,144.6,8042,Incidence,5685622,Non-Hispanic White,141.4,Male and Female,Female Breast,2019
40-44,44.3,47.9,2620,Incidence,5685622,Non-Hispanic White,46.1,Male and Female,"Female Breast, <i>in situ</i>",2019
40-44,2.6,3.2,326,Incidence,11426783,Non-Hispanic White,2.9,Male and Female,Hodgkin Lymphoma,2019
40-44,0.1,0.3,25,Incidence,11426783,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2019
40-44,12.5,13.9,1506,Incidence,11426783,Non-Hispanic White,13.2,Male and Female,Kidney and Renal Pelvis,2019
40-44,0.7,1.0,98,Incidence,11426783,Non-Hispanic White,0.9,Male and Female,Larynx,2019
40-44,5.8,6.7,716,Incidence,11426783,Non-Hispanic White,6.3,Male and Female,Leukemias,2019
40-44,1.1,1.5,147,Incidence,11426783,Non-Hispanic White,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
40-44,6.4,7.3,781,Incidence,11426783,Non-Hispanic White,6.8,Male and Female,Lung and Bronchus,2019
40-44,138.4,144.6,8042,Incidence,5685622,Non-Hispanic White,141.4,Male and Female,Male and Female Breast,2019
40-44,44.3,47.9,2620,Incidence,5685622,Non-Hispanic White,46.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
40-44,24.8,26.7,2942,Incidence,11426783,Non-Hispanic White,25.7,Male and Female,Melanomas of the Skin,2019
40-44,0.1,0.3,22,Incidence,11426783,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2019
40-44,1.6,2.1,209,Incidence,11426783,Non-Hispanic White,1.8,Male and Female,Myeloma,2019
40-44,8.8,10.0,1073,Incidence,11426783,Non-Hispanic White,9.4,Male and Female,Non-Hodgkin Lymphoma,2019
40-44,6.2,7.1,758,Incidence,11426783,Non-Hispanic White,6.6,Male and Female,Oral Cavity and Pharynx,2019
40-44,7.8,9.4,487,Incidence,5685622,Non-Hispanic White,8.6,Male and Female,Ovary,2019
40-44,2.7,3.4,346,Incidence,11426783,Non-Hispanic White,3.0,Male and Female,Pancreas,2019
40-44,4.5,5.7,290,Incidence,5741161,Non-Hispanic White,5.1,Male and Female,Prostate,2019
40-44,1.9,2.4,243,Incidence,11426783,Non-Hispanic White,2.1,Male and Female,Stomach,2019
40-44,11.8,13.6,727,Incidence,5741161,Non-Hispanic White,12.7,Male and Female,Testis,2019
40-44,22.3,24.1,2646,Incidence,11426783,Non-Hispanic White,23.2,Male and Female,Thyroid,2019
40-44,3.1,3.8,398,Incidence,11426783,Non-Hispanic White,3.5,Male and Female,Urinary Bladder,2019
45-49,388.2,395.3,48018,Incidence,12257736,Non-Hispanic White,391.7,Male and Female,All Cancer Sites Combined,2019
45-49,6.0,6.9,792,Incidence,12257736,Non-Hispanic White,6.5,Male and Female,Brain and Other Nervous System,2019
45-49,13.3,15.2,870,Incidence,6121242,Non-Hispanic White,14.2,Male and Female,Cervix,2019
45-49,38.2,40.5,4823,Incidence,12257736,Non-Hispanic White,39.3,Male and Female,Colon and Rectum,2019
45-49,27.7,30.4,1777,Incidence,6121242,Non-Hispanic White,29.0,Male and Female,"Corpus and Uterus, NOS",2019
45-49,2.7,3.3,370,Incidence,12257736,Non-Hispanic White,3.0,Male and Female,Esophagus,2019
45-49,211.7,219.1,13183,Incidence,6121242,Non-Hispanic White,215.4,Male and Female,Female Breast,2019
45-49,60.3,64.3,3814,Incidence,6121242,Non-Hispanic White,62.3,Male and Female,"Female Breast, <i>in situ</i>",2019
45-49,2.3,2.9,316,Incidence,12257736,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2019
45-49,0.2,0.3,29,Incidence,12257736,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2019
45-49,19.4,21.0,2479,Incidence,12257736,Non-Hispanic White,20.2,Male and Female,Kidney and Renal Pelvis,2019
45-49,1.8,2.4,257,Incidence,12257736,Non-Hispanic White,2.1,Male and Female,Larynx,2019
45-49,9.3,10.4,1210,Incidence,12257736,Non-Hispanic White,9.9,Male and Female,Leukemias,2019
45-49,2.5,3.1,347,Incidence,12257736,Non-Hispanic White,2.8,Male and Female,Liver and Intrahepatic Bile Duct,2019
45-49,17.7,19.2,2259,Incidence,12257736,Non-Hispanic White,18.4,Male and Female,Lung and Bronchus,2019
45-49,211.7,219.1,13183,Incidence,6121242,Non-Hispanic White,215.4,Male and Female,Male and Female Breast,2019
45-49,60.3,64.3,3814,Incidence,6121242,Non-Hispanic White,62.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
45-49,32.3,34.4,4086,Incidence,12257736,Non-Hispanic White,33.3,Male and Female,Melanomas of the Skin,2019
45-49,0.1,0.3,26,Incidence,12257736,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2019
45-49,3.4,4.1,461,Incidence,12257736,Non-Hispanic White,3.8,Male and Female,Myeloma,2019
45-49,13.4,14.8,1728,Incidence,12257736,Non-Hispanic White,14.1,Male and Female,Non-Hodgkin Lymphoma,2019
45-49,13.2,14.5,1692,Incidence,12257736,Non-Hispanic White,13.8,Male and Female,Oral Cavity and Pharynx,2019
45-49,11.0,12.8,727,Incidence,6121242,Non-Hispanic White,11.9,Male and Female,Ovary,2019
45-49,6.5,7.5,854,Incidence,12257736,Non-Hispanic White,7.0,Male and Female,Pancreas,2019
45-49,26.0,28.6,1675,Incidence,6136494,Non-Hispanic White,27.3,Male and Female,Prostate,2019
45-49,3.6,4.3,482,Incidence,12257736,Non-Hispanic White,3.9,Male and Female,Stomach,2019
45-49,7.1,8.5,475,Incidence,6136494,Non-Hispanic White,7.7,Male and Female,Testis,2019
45-49,22.8,24.6,2904,Incidence,12257736,Non-Hispanic White,23.7,Male and Female,Thyroid,2019
45-49,6.9,7.8,900,Incidence,12257736,Non-Hispanic White,7.3,Male and Female,Urinary Bladder,2019
5-9,11.8,13.2,1302,Incidence,10405396,Non-Hispanic White,12.5,Male and Female,All Cancer Sites Combined,2019
5-9,3.4,4.2,396,Incidence,10405396,Non-Hispanic White,3.8,Male and Female,Brain and Other Nervous System,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,Cervix,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Colon and Rectum,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Esophagus,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,Female Breast,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2019
5-9,0.2,0.4,26,Incidence,10405396,Non-Hispanic White,0.2,Male and Female,Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
5-9,0.3,0.6,44,Incidence,10405396,Non-Hispanic White,0.4,Male and Female,Kidney and Renal Pelvis,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Larynx,2019
5-9,3.5,4.2,399,Incidence,10405396,Non-Hispanic White,3.8,Male and Female,Leukemias,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,Male and Female Breast,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Myeloma,2019
5-9,0.7,1.1,94,Incidence,10405396,Non-Hispanic White,0.9,Male and Female,Non-Hodgkin Lymphoma,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2019
5-9,~,~,~,Incidence,5070171,Non-Hispanic White,~,Male and Female,Ovary,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Pancreas,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male and Female,Prostate,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Stomach,2019
5-9,~,~,~,Incidence,5335225,Non-Hispanic White,~,Male and Female,Testis,2019
5-9,0.1,0.3,17,Incidence,10405396,Non-Hispanic White,0.2,Male and Female,Thyroid,2019
5-9,~,~,~,Incidence,10405396,Non-Hispanic White,~,Male and Female,Urinary Bladder,2019
50-54,596.6,605.0,78698,Incidence,13100066,Non-Hispanic White,600.7,Male and Female,All Cancer Sites Combined,2019
50-54,7.8,8.8,1087,Incidence,13100066,Non-Hispanic White,8.3,Male and Female,Brain and Other Nervous System,2019
50-54,11.6,13.3,820,Incidence,6586058,Non-Hispanic White,12.5,Male and Female,Cervix,2019
50-54,64.6,67.4,8645,Incidence,13100066,Non-Hispanic White,66.0,Male and Female,Colon and Rectum,2019
50-54,48.7,52.1,3317,Incidence,6586058,Non-Hispanic White,50.4,Male and Female,"Corpus and Uterus, NOS",2019
50-54,5.9,6.8,826,Incidence,13100066,Non-Hispanic White,6.3,Male and Female,Esophagus,2019
50-54,252.9,260.7,16911,Incidence,6586058,Non-Hispanic White,256.8,Male and Female,Female Breast,2019
50-54,68.9,73.0,4671,Incidence,6586058,Non-Hispanic White,70.9,Male and Female,"Female Breast, <i>in situ</i>",2019
50-54,1.9,2.4,281,Incidence,13100066,Non-Hispanic White,2.1,Male and Female,Hodgkin Lymphoma,2019
50-54,0.2,0.4,39,Incidence,13100066,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2019
50-54,26.6,28.4,3597,Incidence,13100066,Non-Hispanic White,27.5,Male and Female,Kidney and Renal Pelvis,2019
50-54,4.5,5.3,640,Incidence,13100066,Non-Hispanic White,4.9,Male and Female,Larynx,2019
50-54,13.4,14.7,1835,Incidence,13100066,Non-Hispanic White,14.0,Male and Female,Leukemias,2019
50-54,6.7,7.7,942,Incidence,13100066,Non-Hispanic White,7.2,Male and Female,Liver and Intrahepatic Bile Duct,2019
50-54,44.9,47.2,6027,Incidence,13100066,Non-Hispanic White,46.0,Male and Female,Lung and Bronchus,2019
50-54,252.9,260.7,16911,Incidence,6586058,Non-Hispanic White,256.8,Male and Female,Male and Female Breast,2019
50-54,68.9,73.0,4671,Incidence,6586058,Non-Hispanic White,70.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
50-54,41.8,44.1,5623,Incidence,13100066,Non-Hispanic White,42.9,Male and Female,Melanomas of the Skin,2019
50-54,0.3,0.6,57,Incidence,13100066,Non-Hispanic White,0.4,Male and Female,Mesothelioma,2019
50-54,5.9,6.8,835,Incidence,13100066,Non-Hispanic White,6.4,Male and Female,Myeloma,2019
50-54,20.5,22.0,2782,Incidence,13100066,Non-Hispanic White,21.2,Male and Female,Non-Hodgkin Lymphoma,2019
50-54,24.3,26.1,3299,Incidence,13100066,Non-Hispanic White,25.2,Male and Female,Oral Cavity and Pharynx,2019
50-54,15.7,17.7,1096,Incidence,6586058,Non-Hispanic White,16.6,Male and Female,Ovary,2019
50-54,12.1,13.3,1659,Incidence,13100066,Non-Hispanic White,12.7,Male and Female,Pancreas,2019
50-54,103.6,108.6,6911,Incidence,6514008,Non-Hispanic White,106.1,Male and Female,Prostate,2019
50-54,5.4,6.2,754,Incidence,13100066,Non-Hispanic White,5.8,Male and Female,Stomach,2019
50-54,4.7,5.9,343,Incidence,6514008,Non-Hispanic White,5.3,Male and Female,Testis,2019
50-54,23.4,25.1,3172,Incidence,13100066,Non-Hispanic White,24.2,Male and Female,Thyroid,2019
50-54,13.7,15.1,1885,Incidence,13100066,Non-Hispanic White,14.4,Male and Female,Urinary Bladder,2019
55-59,870.5,880.0,130951,Incidence,14961480,Non-Hispanic White,875.3,Male and Female,All Cancer Sites Combined,2019
55-59,10.9,12.0,1710,Incidence,14961480,Non-Hispanic White,11.4,Male and Female,Brain and Other Nervous System,2019
55-59,9.5,11.0,777,Incidence,7609697,Non-Hispanic White,10.2,Male and Female,Cervix,2019
55-59,65.6,68.3,10015,Incidence,14961480,Non-Hispanic White,66.9,Male and Female,Colon and Rectum,2019
55-59,76.7,80.7,5989,Incidence,7609697,Non-Hispanic White,78.7,Male and Female,"Corpus and Uterus, NOS",2019
55-59,10.2,11.3,1611,Incidence,14961480,Non-Hispanic White,10.8,Male and Female,Esophagus,2019
55-59,282.7,290.3,21801,Incidence,7609697,Non-Hispanic White,286.5,Male and Female,Female Breast,2019
55-59,69.0,72.8,5391,Incidence,7609697,Non-Hispanic White,70.8,Male and Female,"Female Breast, <i>in situ</i>",2019
55-59,2.4,2.9,391,Incidence,14961480,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2019
55-59,0.2,0.4,42,Incidence,14961480,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2019
55-59,36.7,38.7,5644,Incidence,14961480,Non-Hispanic White,37.7,Male and Female,Kidney and Renal Pelvis,2019
55-59,8.6,9.6,1358,Incidence,14961480,Non-Hispanic White,9.1,Male and Female,Larynx,2019
55-59,20.4,21.8,3155,Incidence,14961480,Non-Hispanic White,21.1,Male and Female,Leukemias,2019
55-59,16.3,17.6,2533,Incidence,14961480,Non-Hispanic White,16.9,Male and Female,Liver and Intrahepatic Bile Duct,2019
55-59,100.9,104.2,15340,Incidence,14961480,Non-Hispanic White,102.5,Male and Female,Lung and Bronchus,2019
55-59,282.7,290.3,21801,Incidence,7609697,Non-Hispanic White,286.5,Male and Female,Male and Female Breast,2019
55-59,69.0,72.8,5391,Incidence,7609697,Non-Hispanic White,70.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
55-59,51.8,54.2,7929,Incidence,14961480,Non-Hispanic White,53.0,Male and Female,Melanomas of the Skin,2019
55-59,0.6,0.8,105,Incidence,14961480,Non-Hispanic White,0.7,Male and Female,Mesothelioma,2019
55-59,9.6,10.6,1506,Incidence,14961480,Non-Hispanic White,10.1,Male and Female,Myeloma,2019
55-59,30.3,32.1,4664,Incidence,14961480,Non-Hispanic White,31.2,Male and Female,Non-Hodgkin Lymphoma,2019
55-59,36.7,38.6,5630,Incidence,14961480,Non-Hispanic White,37.6,Male and Female,Oral Cavity and Pharynx,2019
55-59,19.2,21.2,1537,Incidence,7609697,Non-Hispanic White,20.2,Male and Female,Ovary,2019
55-59,21.2,22.7,3276,Incidence,14961480,Non-Hispanic White,21.9,Male and Female,Pancreas,2019
55-59,238.6,245.7,17801,Incidence,7351783,Non-Hispanic White,242.1,Male and Female,Prostate,2019
55-59,8.5,9.5,1343,Incidence,14961480,Non-Hispanic White,9.0,Male and Female,Stomach,2019
55-59,3.7,4.7,309,Incidence,7351783,Non-Hispanic White,4.2,Male and Female,Testis,2019
55-59,22.1,23.6,3416,Incidence,14961480,Non-Hispanic White,22.8,Male and Female,Thyroid,2019
55-59,27.2,28.9,4188,Incidence,14961480,Non-Hispanic White,28.0,Male and Female,Urinary Bladder,2019
60-64,1242.7,1254.2,183520,Incidence,14699812,Non-Hispanic White,1248.5,Male and Female,All Cancer Sites Combined,2019
60-64,13.4,14.6,2055,Incidence,14699812,Non-Hispanic White,14.0,Male and Female,Brain and Other Nervous System,2019
60-64,9.6,11.0,779,Incidence,7565566,Non-Hispanic White,10.3,Male and Female,Cervix,2019
60-64,82.5,85.5,12345,Incidence,14699812,Non-Hispanic White,84.0,Male and Female,Colon and Rectum,2019
60-64,98.7,103.2,7638,Incidence,7565566,Non-Hispanic White,101.0,Male and Female,"Corpus and Uterus, NOS",2019
60-64,16.2,17.5,2473,Incidence,14699812,Non-Hispanic White,16.8,Male and Female,Esophagus,2019
60-64,353.0,361.5,27029,Incidence,7565566,Non-Hispanic White,357.3,Male and Female,Female Breast,2019
60-64,80.6,84.7,6249,Incidence,7565566,Non-Hispanic White,82.6,Male and Female,"Female Breast, <i>in situ</i>",2019
60-64,2.4,3.0,395,Incidence,14699812,Non-Hispanic White,2.7,Male and Female,Hodgkin Lymphoma,2019
60-64,0.1,0.3,27,Incidence,14699812,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2019
60-64,48.1,50.4,7242,Incidence,14699812,Non-Hispanic White,49.3,Male and Female,Kidney and Renal Pelvis,2019
60-64,11.8,13.0,1824,Incidence,14699812,Non-Hispanic White,12.4,Male and Female,Larynx,2019
60-64,28.6,30.4,4339,Incidence,14699812,Non-Hispanic White,29.5,Male and Female,Leukemias,2019
60-64,27.3,29.0,4141,Incidence,14699812,Non-Hispanic White,28.2,Male and Female,Liver and Intrahepatic Bile Duct,2019
60-64,167.4,171.6,24911,Incidence,14699812,Non-Hispanic White,169.5,Male and Female,Lung and Bronchus,2019
60-64,353.0,361.5,27029,Incidence,7565566,Non-Hispanic White,357.3,Male and Female,Male and Female Breast,2019
60-64,80.6,84.7,6249,Incidence,7565566,Non-Hispanic White,82.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
60-64,68.5,71.2,10272,Incidence,14699812,Non-Hispanic White,69.9,Male and Female,Melanomas of the Skin,2019
60-64,1.0,1.4,175,Incidence,14699812,Non-Hispanic White,1.2,Male and Female,Mesothelioma,2019
60-64,15.1,16.4,2309,Incidence,14699812,Non-Hispanic White,15.7,Male and Female,Myeloma,2019
60-64,44.4,46.5,6680,Incidence,14699812,Non-Hispanic White,45.4,Male and Female,Non-Hodgkin Lymphoma,2019
60-64,44.9,47.1,6766,Incidence,14699812,Non-Hispanic White,46.0,Male and Female,Oral Cavity and Pharynx,2019
60-64,24.8,27.1,1959,Incidence,7565566,Non-Hispanic White,25.9,Male and Female,Ovary,2019
60-64,33.9,35.8,5117,Incidence,14699812,Non-Hispanic White,34.8,Male and Female,Pancreas,2019
60-64,419.1,428.6,30236,Incidence,7134246,Non-Hispanic White,423.8,Male and Female,Prostate,2019
60-64,12.7,13.9,1949,Incidence,14699812,Non-Hispanic White,13.3,Male and Female,Stomach,2019
60-64,2.2,3.0,184,Incidence,7134246,Non-Hispanic White,2.6,Male and Female,Testis,2019
60-64,22.6,24.2,3434,Incidence,14699812,Non-Hispanic White,23.4,Male and Female,Thyroid,2019
60-64,45.6,47.8,6866,Incidence,14699812,Non-Hispanic White,46.7,Male and Female,Urinary Bladder,2019
65-69,1683.2,1697.4,218324,Incidence,12916577,Non-Hispanic White,1690.3,Male and Female,All Cancer Sites Combined,2019
65-69,16.8,18.3,2265,Incidence,12916577,Non-Hispanic White,17.5,Male and Female,Brain and Other Nervous System,2019
65-69,7.4,8.8,545,Incidence,6750308,Non-Hispanic White,8.1,Male and Female,Cervix,2019
65-69,108.5,112.2,14252,Incidence,12916577,Non-Hispanic White,110.3,Male and Female,Colon and Rectum,2019
65-69,115.3,120.5,7960,Incidence,6750308,Non-Hispanic White,117.9,Male and Female,"Corpus and Uterus, NOS",2019
65-69,21.5,23.1,2881,Incidence,12916577,Non-Hispanic White,22.3,Male and Female,Esophagus,2019
65-69,443.9,454.0,30302,Incidence,6750308,Non-Hispanic White,448.9,Male and Female,Female Breast,2019
65-69,93.8,98.5,6491,Incidence,6750308,Non-Hispanic White,96.2,Male and Female,"Female Breast, <i>in situ</i>",2019
65-69,2.9,3.5,412,Incidence,12916577,Non-Hispanic White,3.2,Male and Female,Hodgkin Lymphoma,2019
65-69,0.1,0.3,28,Incidence,12916577,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2019
65-69,62.5,65.3,8254,Incidence,12916577,Non-Hispanic White,63.9,Male and Female,Kidney and Renal Pelvis,2019
65-69,12.3,13.6,1672,Incidence,12916577,Non-Hispanic White,12.9,Male and Female,Larynx,2019
65-69,40.4,42.6,5361,Incidence,12916577,Non-Hispanic White,41.5,Male and Female,Leukemias,2019
65-69,35.4,37.5,4702,Incidence,12916577,Non-Hispanic White,36.4,Male and Female,Liver and Intrahepatic Bile Duct,2019
65-69,236.8,242.1,30929,Incidence,12916577,Non-Hispanic White,239.5,Male and Female,Lung and Bronchus,2019
65-69,443.9,454.0,30302,Incidence,6750308,Non-Hispanic White,448.9,Male and Female,Male and Female Breast,2019
65-69,93.8,98.5,6491,Incidence,6750308,Non-Hispanic White,96.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
65-69,87.8,91.1,11549,Incidence,12916577,Non-Hispanic White,89.4,Male and Female,Melanomas of the Skin,2019
65-69,1.9,2.4,276,Incidence,12916577,Non-Hispanic White,2.1,Male and Female,Mesothelioma,2019
65-69,22.3,24.0,2993,Incidence,12916577,Non-Hispanic White,23.2,Male and Female,Myeloma,2019
65-69,61.6,64.3,8126,Incidence,12916577,Non-Hispanic White,62.9,Male and Female,Non-Hodgkin Lymphoma,2019
65-69,49.8,52.2,6586,Incidence,12916577,Non-Hispanic White,51.0,Male and Female,Oral Cavity and Pharynx,2019
65-69,27.1,29.7,1915,Incidence,6750308,Non-Hispanic White,28.4,Male and Female,Ovary,2019
65-69,48.8,51.2,6456,Incidence,12916577,Non-Hispanic White,50.0,Male and Female,Pancreas,2019
65-69,649.4,662.2,40437,Incidence,6166269,Non-Hispanic White,655.8,Male and Female,Prostate,2019
65-69,16.8,18.3,2263,Incidence,12916577,Non-Hispanic White,17.5,Male and Female,Stomach,2019
65-69,2.0,2.7,144,Incidence,6166269,Non-Hispanic White,2.3,Male and Female,Testis,2019
65-69,23.5,25.2,3146,Incidence,12916577,Non-Hispanic White,24.4,Male and Female,Thyroid,2019
65-69,74.1,77.1,9758,Incidence,12916577,Non-Hispanic White,75.5,Male and Female,Urinary Bladder,2019
70-74,2006.5,2023.5,216540,Incidence,10746604,Non-Hispanic White,2015.0,Male and Female,All Cancer Sites Combined,2019
70-74,19.4,21.1,2174,Incidence,10746604,Non-Hispanic White,20.2,Male and Female,Brain and Other Nervous System,2019
70-74,6.9,8.3,431,Incidence,5681614,Non-Hispanic White,7.6,Male and Female,Cervix,2019
70-74,129.3,133.6,14125,Incidence,10746604,Non-Hispanic White,131.4,Male and Female,Colon and Rectum,2019
70-74,110.0,115.5,6405,Incidence,5681614,Non-Hispanic White,112.7,Male and Female,"Corpus and Uterus, NOS",2019
70-74,25.0,27.0,2791,Incidence,10746604,Non-Hispanic White,26.0,Male and Female,Esophagus,2019
70-74,501.1,512.8,28801,Incidence,5681614,Non-Hispanic White,506.9,Male and Female,Female Breast,2019
70-74,103.0,108.4,6003,Incidence,5681614,Non-Hispanic White,105.7,Male and Female,"Female Breast, <i>in situ</i>",2019
70-74,2.9,3.5,343,Incidence,10746604,Non-Hispanic White,3.2,Male and Female,Hodgkin Lymphoma,2019
70-74,0.2,0.4,27,Incidence,10746604,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2019
70-74,71.3,74.6,7840,Incidence,10746604,Non-Hispanic White,73.0,Male and Female,Kidney and Renal Pelvis,2019
70-74,12.6,13.9,1423,Incidence,10746604,Non-Hispanic White,13.2,Male and Female,Larynx,2019
70-74,55.6,58.5,6129,Incidence,10746604,Non-Hispanic White,57.0,Male and Female,Leukemias,2019
70-74,33.4,35.6,3706,Incidence,10746604,Non-Hispanic White,34.5,Male and Female,Liver and Intrahepatic Bile Duct,2019
70-74,326.9,333.8,35497,Incidence,10746604,Non-Hispanic White,330.3,Male and Female,Lung and Bronchus,2019
70-74,501.1,512.8,28801,Incidence,5681614,Non-Hispanic White,506.9,Male and Female,Male and Female Breast,2019
70-74,103.0,108.4,6003,Incidence,5681614,Non-Hispanic White,105.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
70-74,107.0,111.0,11714,Incidence,10746604,Non-Hispanic White,109.0,Male and Female,Melanomas of the Skin,2019
70-74,3.7,4.5,441,Incidence,10746604,Non-Hispanic White,4.1,Male and Female,Mesothelioma,2019
70-74,30.5,32.6,3387,Incidence,10746604,Non-Hispanic White,31.5,Male and Female,Myeloma,2019
70-74,81.4,84.9,8932,Incidence,10746604,Non-Hispanic White,83.1,Male and Female,Non-Hodgkin Lymphoma,2019
70-74,49.6,52.3,5472,Incidence,10746604,Non-Hispanic White,50.9,Male and Female,Oral Cavity and Pharynx,2019
70-74,33.3,36.4,1978,Incidence,5681614,Non-Hispanic White,34.8,Male and Female,Ovary,2019
70-74,65.5,68.6,7200,Incidence,10746604,Non-Hispanic White,67.0,Male and Female,Pancreas,2019
70-74,668.5,682.8,34221,Incidence,5064990,Non-Hispanic White,675.6,Male and Female,Prostate,2019
70-74,21.7,23.6,2433,Incidence,10746604,Non-Hispanic White,22.6,Male and Female,Stomach,2019
70-74,0.9,1.5,59,Incidence,5064990,Non-Hispanic White,1.2,Male and Female,Testis,2019
70-74,22.5,24.3,2516,Incidence,10746604,Non-Hispanic White,23.4,Male and Female,Thyroid,2019
70-74,107.1,111.0,11718,Incidence,10746604,Non-Hispanic White,109.0,Male and Female,Urinary Bladder,2019
75-79,2288.5,2310.2,172532,Incidence,7503497,Non-Hispanic White,2299.4,Male and Female,All Cancer Sites Combined,2019
75-79,21.3,23.5,1679,Incidence,7503497,Non-Hispanic White,22.4,Male and Female,Brain and Other Nervous System,2019
75-79,6.2,7.9,286,Incidence,4085124,Non-Hispanic White,7.0,Male and Female,Cervix,2019
75-79,162.0,167.9,12376,Incidence,7503497,Non-Hispanic White,164.9,Male and Female,Colon and Rectum,2019
75-79,91.9,97.9,3874,Incidence,4085124,Non-Hispanic White,94.8,Male and Female,"Corpus and Uterus, NOS",2019
75-79,26.8,29.2,2101,Incidence,7503497,Non-Hispanic White,28.0,Male and Female,Esophagus,2019
75-79,494.0,507.7,20459,Incidence,4085124,Non-Hispanic White,500.8,Male and Female,Female Breast,2019
75-79,81.8,87.5,3457,Incidence,4085124,Non-Hispanic White,84.6,Male and Female,"Female Breast, <i>in situ</i>",2019
75-79,3.5,4.4,297,Incidence,7503497,Non-Hispanic White,4.0,Male and Female,Hodgkin Lymphoma,2019
75-79,0.2,0.5,23,Incidence,7503497,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2019
75-79,76.3,80.3,5876,Incidence,7503497,Non-Hispanic White,78.3,Male and Female,Kidney and Renal Pelvis,2019
75-79,11.9,13.5,950,Incidence,7503497,Non-Hispanic White,12.7,Male and Female,Larynx,2019
75-79,72.8,76.7,5608,Incidence,7503497,Non-Hispanic White,74.7,Male and Female,Leukemias,2019
75-79,37.0,39.8,2878,Incidence,7503497,Non-Hispanic White,38.4,Male and Female,Liver and Intrahepatic Bile Duct,2019
75-79,408.4,417.7,30992,Incidence,7503497,Non-Hispanic White,413.0,Male and Female,Lung and Bronchus,2019
75-79,494.0,507.7,20459,Incidence,4085124,Non-Hispanic White,500.8,Male and Female,Male and Female Breast,2019
75-79,81.8,87.5,3457,Incidence,4085124,Non-Hispanic White,84.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
75-79,125.9,131.1,9640,Incidence,7503497,Non-Hispanic White,128.5,Male and Female,Melanomas of the Skin,2019
75-79,6.5,7.7,534,Incidence,7503497,Non-Hispanic White,7.1,Male and Female,Mesothelioma,2019
75-79,38.2,41.1,2972,Incidence,7503497,Non-Hispanic White,39.6,Male and Female,Myeloma,2019
75-79,107.6,112.4,8253,Incidence,7503497,Non-Hispanic White,110.0,Male and Female,Non-Hodgkin Lymphoma,2019
75-79,48.9,52.2,3791,Incidence,7503497,Non-Hispanic White,50.5,Male and Female,Oral Cavity and Pharynx,2019
75-79,39.1,43.0,1675,Incidence,4085124,Non-Hispanic White,41.0,Male and Female,Ovary,2019
75-79,82.4,86.6,6338,Incidence,7503497,Non-Hispanic White,84.5,Male and Female,Pancreas,2019
75-79,602.8,619.4,20888,Incidence,3418373,Non-Hispanic White,611.1,Male and Female,Prostate,2019
75-79,26.9,29.3,2106,Incidence,7503497,Non-Hispanic White,28.1,Male and Female,Stomach,2019
75-79,0.6,1.3,32,Incidence,3418373,Non-Hispanic White,0.9,Male and Female,Testis,2019
75-79,19.8,21.9,1563,Incidence,7503497,Non-Hispanic White,20.8,Male and Female,Thyroid,2019
75-79,151.1,156.7,11546,Incidence,7503497,Non-Hispanic White,153.9,Male and Female,Urinary Bladder,2019
80-84,2366.9,2394.3,116641,Incidence,4899695,Non-Hispanic White,2380.6,Male and Female,All Cancer Sites Combined,2019
80-84,20.9,23.5,1087,Incidence,4899695,Non-Hispanic White,22.2,Male and Female,Brain and Other Nervous System,2019
80-84,5.7,7.6,183,Incidence,2784914,Non-Hispanic White,6.6,Male and Female,Cervix,2019
80-84,211.7,219.9,10571,Incidence,4899695,Non-Hispanic White,215.7,Male and Female,Colon and Rectum,2019
80-84,73.6,80.2,2140,Incidence,2784914,Non-Hispanic White,76.8,Male and Female,"Corpus and Uterus, NOS",2019
80-84,26.7,29.7,1379,Incidence,4899695,Non-Hispanic White,28.1,Male and Female,Esophagus,2019
80-84,446.1,462.0,12644,Incidence,2784914,Non-Hispanic White,454.0,Male and Female,Female Breast,2019
80-84,57.4,63.2,1677,Incidence,2784914,Non-Hispanic White,60.2,Male and Female,"Female Breast, <i>in situ</i>",2019
80-84,3.4,4.6,195,Incidence,4899695,Non-Hispanic White,4.0,Male and Female,Hodgkin Lymphoma,2019
80-84,0.3,0.8,26,Incidence,4899695,Non-Hispanic White,0.5,Male and Female,Kaposi Sarcoma,2019
80-84,72.0,76.9,3647,Incidence,4899695,Non-Hispanic White,74.4,Male and Female,Kidney and Renal Pelvis,2019
80-84,11.3,13.3,600,Incidence,4899695,Non-Hispanic White,12.2,Male and Female,Larynx,2019
80-84,85.3,90.5,4305,Incidence,4899695,Non-Hispanic White,87.9,Male and Female,Leukemias,2019
80-84,37.8,41.4,1938,Incidence,4899695,Non-Hispanic White,39.6,Male and Female,Liver and Intrahepatic Bile Duct,2019
80-84,410.9,422.3,20411,Incidence,4899695,Non-Hispanic White,416.6,Male and Female,Lung and Bronchus,2019
80-84,446.1,462.0,12644,Incidence,2784914,Non-Hispanic White,454.0,Male and Female,Male and Female Breast,2019
80-84,57.4,63.2,1677,Incidence,2784914,Non-Hispanic White,60.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
80-84,138.6,145.2,6951,Incidence,4899695,Non-Hispanic White,141.9,Male and Female,Melanomas of the Skin,2019
80-84,7.4,9.1,403,Incidence,4899695,Non-Hispanic White,8.2,Male and Female,Mesothelioma,2019
80-84,43.2,46.9,2206,Incidence,4899695,Non-Hispanic White,45.0,Male and Female,Myeloma,2019
80-84,122.5,128.8,6154,Incidence,4899695,Non-Hispanic White,125.6,Male and Female,Non-Hodgkin Lymphoma,2019
80-84,48.0,52.0,2448,Incidence,4899695,Non-Hispanic White,50.0,Male and Female,Oral Cavity and Pharynx,2019
80-84,37.2,41.9,1100,Incidence,2784914,Non-Hispanic White,39.5,Male and Female,Ovary,2019
80-84,94.3,99.9,4756,Incidence,4899695,Non-Hispanic White,97.1,Male and Female,Pancreas,2019
80-84,447.2,465.4,9648,Incidence,2114781,Non-Hispanic White,456.2,Male and Female,Prostate,2019
80-84,29.8,32.9,1534,Incidence,4899695,Non-Hispanic White,31.3,Male and Female,Stomach,2019
80-84,0.8,1.7,25,Incidence,2114781,Non-Hispanic White,1.2,Male and Female,Testis,2019
80-84,14.1,16.3,745,Incidence,4899695,Non-Hispanic White,15.2,Male and Female,Thyroid,2019
80-84,174.8,182.3,8747,Incidence,4899695,Non-Hispanic White,178.5,Male and Female,Urinary Bladder,2019
85+,2114.7,2139.8,111073,Incidence,5221524,Non-Hispanic White,2127.2,Male and Female,All Cancer Sites Combined,2019
85+,17.6,20.0,982,Incidence,5221524,Non-Hispanic White,18.8,Male and Female,Brain and Other Nervous System,2019
85+,5.2,6.9,198,Incidence,3321123,Non-Hispanic White,6.0,Male and Female,Cervix,2019
85+,227.6,235.8,12097,Incidence,5221524,Non-Hispanic White,231.7,Male and Female,Colon and Rectum,2019
85+,48.3,53.2,1684,Incidence,3321123,Non-Hispanic White,50.7,Male and Female,"Corpus and Uterus, NOS",2019
85+,22.9,25.6,1263,Incidence,5221524,Non-Hispanic White,24.2,Male and Female,Esophagus,2019
85+,332.9,345.5,11264,Incidence,3321123,Non-Hispanic White,339.2,Male and Female,Female Breast,2019
85+,21.6,24.9,772,Incidence,3321123,Non-Hispanic White,23.2,Male and Female,"Female Breast, <i>in situ</i>",2019
85+,2.6,3.6,162,Incidence,5221524,Non-Hispanic White,3.1,Male and Female,Hodgkin Lymphoma,2019
85+,0.4,0.8,30,Incidence,5221524,Non-Hispanic White,0.6,Male and Female,Kaposi Sarcoma,2019
85+,54.7,58.8,2960,Incidence,5221524,Non-Hispanic White,56.7,Male and Female,Kidney and Renal Pelvis,2019
85+,8.0,9.7,460,Incidence,5221524,Non-Hispanic White,8.8,Male and Female,Larynx,2019
85+,86.2,91.4,4636,Incidence,5221524,Non-Hispanic White,88.8,Male and Female,Leukemias,2019
85+,31.2,34.3,1708,Incidence,5221524,Non-Hispanic White,32.7,Male and Female,Liver and Intrahepatic Bile Duct,2019
85+,299.2,308.7,15869,Incidence,5221524,Non-Hispanic White,303.9,Male and Female,Lung and Bronchus,2019
85+,332.9,345.5,11264,Incidence,3321123,Non-Hispanic White,339.2,Male and Female,Male and Female Breast,2019
85+,21.6,24.9,772,Incidence,3321123,Non-Hispanic White,23.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
85+,131.2,137.5,7014,Incidence,5221524,Non-Hispanic White,134.3,Male and Female,Melanomas of the Skin,2019
85+,7.4,9.0,427,Incidence,5221524,Non-Hispanic White,8.2,Male and Female,Mesothelioma,2019
85+,35.6,38.9,1942,Incidence,5221524,Non-Hispanic White,37.2,Male and Female,Myeloma,2019
85+,104.8,110.4,5617,Incidence,5221524,Non-Hispanic White,107.6,Male and Female,Non-Hodgkin Lymphoma,2019
85+,41.6,45.1,2262,Incidence,5221524,Non-Hispanic White,43.3,Male and Female,Oral Cavity and Pharynx,2019
85+,32.6,36.6,1148,Incidence,3321123,Non-Hispanic White,34.6,Male and Female,Ovary,2019
85+,94.7,100.1,5083,Incidence,5221524,Non-Hispanic White,97.3,Male and Female,Pancreas,2019
85+,343.9,360.8,6694,Incidence,1900401,Non-Hispanic White,352.2,Male and Female,Prostate,2019
85+,27.4,30.4,1508,Incidence,5221524,Non-Hispanic White,28.9,Male and Female,Stomach,2019
85+,0.6,1.5,18,Incidence,1900401,Non-Hispanic White,0.9,Male and Female,Testis,2019
85+,8.8,10.5,500,Incidence,5221524,Non-Hispanic White,9.6,Male and Female,Thyroid,2019
85+,178.2,185.5,9494,Incidence,5221524,Non-Hispanic White,181.8,Male and Female,Urinary Bladder,2019
<1,25.4,30.2,529,Incidence,1905315,Non-Hispanic White,27.8,Male and Female,All Cancer Sites Combined,2019
<1,2.8,4.6,69,Incidence,1905315,Non-Hispanic White,3.6,Male and Female,Brain and Other Nervous System,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,Cervix,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Colon and Rectum,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Esophagus,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,Female Breast,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2019
<1,1.1,2.3,31,Incidence,1905315,Non-Hispanic White,1.6,Male and Female,Kidney and Renal Pelvis,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Larynx,2019
<1,3.0,4.9,74,Incidence,1905315,Non-Hispanic White,3.9,Male and Female,Leukemias,2019
<1,0.8,1.9,25,Incidence,1905315,Non-Hispanic White,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,Male and Female Breast,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Mesothelioma,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Myeloma,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Non-Hodgkin Lymphoma,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2019
<1,~,~,~,Incidence,929655,Non-Hispanic White,~,Male and Female,Ovary,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Pancreas,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male and Female,Prostate,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Stomach,2019
<1,~,~,~,Incidence,975660,Non-Hispanic White,~,Male and Female,Testis,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Thyroid,2019
<1,~,~,~,Incidence,1905315,Non-Hispanic White,~,Male and Female,Urinary Bladder,2019
1-4,18.4,20.4,1430,Incidence,7377169,All Races,19.4,Female,All Cancer Sites Combined,2020
1-4,2.8,3.6,234,Incidence,7377169,All Races,3.2,Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Cervix,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Esophagus,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Female Breast,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Kaposi Sarcoma,2020
1-4,1.9,2.6,166,Incidence,7377169,All Races,2.3,Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Larynx,2020
1-4,7.0,8.3,561,Incidence,7377169,All Races,7.6,Female,Leukemias,2020
1-4,0.4,0.8,41,Incidence,7377169,All Races,0.6,Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Mesothelioma,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Myeloma,2020
1-4,0.3,0.6,33,Incidence,7377169,All Races,0.4,Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Ovary,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Pancreas,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Stomach,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Thyroid,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Female,Urinary Bladder,2020
10-14,13.2,14.6,1367,Incidence,9842471,All Races,13.9,Female,All Cancer Sites Combined,2020
10-14,2.2,2.8,242,Incidence,9842471,All Races,2.5,Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Cervix,2020
10-14,0.6,0.9,73,Incidence,9842471,All Races,0.7,Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Esophagus,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Female Breast,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,"Female Breast, <i>in situ</i>",2020
10-14,0.8,1.2,100,Incidence,9842471,All Races,1.0,Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Kaposi Sarcoma,2020
10-14,0.1,0.3,20,Incidence,9842471,All Races,0.2,Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Larynx,2020
10-14,2.4,3.1,267,Incidence,9842471,All Races,2.7,Female,Leukemias,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Lung and Bronchus,2020
10-14,0.1,0.3,20,Incidence,9842471,All Races,0.2,Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Mesothelioma,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Myeloma,2020
10-14,0.7,1.0,81,Incidence,9842471,All Races,0.8,Female,Non-Hodgkin Lymphoma,2020
10-14,0.1,0.3,17,Incidence,9842471,All Races,0.2,Female,Oral Cavity and Pharynx,2020
10-14,0.8,1.2,94,Incidence,9842471,All Races,1.0,Female,Ovary,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Pancreas,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Stomach,2020
10-14,1.1,1.6,131,Incidence,9842471,All Races,1.3,Female,Thyroid,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Female,Urinary Bladder,2020
15-19,20.8,22.6,2160,Incidence,9955751,All Races,21.7,Female,All Cancer Sites Combined,2020
15-19,1.8,2.3,203,Incidence,9955751,All Races,2.0,Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Cervix,2020
15-19,1.2,1.7,145,Incidence,9955751,All Races,1.5,Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Esophagus,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Female Breast,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,"Female Breast, <i>in situ</i>",2020
15-19,2.8,3.5,310,Incidence,9955751,All Races,3.1,Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Kaposi Sarcoma,2020
15-19,0.1,0.3,23,Incidence,9955751,All Races,0.2,Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Larynx,2020
15-19,1.9,2.5,220,Incidence,9955751,All Races,2.2,Female,Leukemias,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Lung and Bronchus,2020
15-19,0.6,1.0,78,Incidence,9955751,All Races,0.8,Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Mesothelioma,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Myeloma,2020
15-19,1.0,1.4,120,Incidence,9955751,All Races,1.2,Female,Non-Hodgkin Lymphoma,2020
15-19,0.3,0.6,44,Incidence,9955751,All Races,0.4,Female,Oral Cavity and Pharynx,2020
15-19,1.1,1.5,128,Incidence,9955751,All Races,1.3,Female,Ovary,2020
15-19,0.2,0.4,27,Incidence,9955751,All Races,0.3,Female,Pancreas,2020
15-19,0.1,0.3,16,Incidence,9955751,All Races,0.2,Female,Stomach,2020
15-19,4.2,5.0,457,Incidence,9955751,All Races,4.6,Female,Thyroid,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Female,Urinary Bladder,2020
20-24,34.9,37.3,3696,Incidence,10239813,All Races,36.1,Female,All Cancer Sites Combined,2020
20-24,1.5,2.1,182,Incidence,10239813,All Races,1.8,Female,Brain and Other Nervous System,2020
20-24,0.3,0.5,38,Incidence,10239813,All Races,0.4,Female,Cervix,2020
20-24,1.9,2.5,227,Incidence,10239813,All Races,2.2,Female,Colon and Rectum,2020
20-24,0.4,0.7,53,Incidence,10239813,All Races,0.5,Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Esophagus,2020
20-24,1.5,2.0,174,Incidence,10239813,All Races,1.7,Female,Female Breast,2020
20-24,0.1,0.3,19,Incidence,10239813,All Races,0.2,Female,"Female Breast, <i>in situ</i>",2020
20-24,3.9,4.7,436,Incidence,10239813,All Races,4.3,Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Kaposi Sarcoma,2020
20-24,0.4,0.7,57,Incidence,10239813,All Races,0.6,Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Larynx,2020
20-24,2.0,2.6,237,Incidence,10239813,All Races,2.3,Female,Leukemias,2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Liver and Intrahepatic Bile Duct,2020
20-24,0.2,0.4,31,Incidence,10239813,All Races,0.3,Female,Lung and Bronchus,2020
20-24,2.7,3.4,311,Incidence,10239813,All Races,3.0,Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Mesothelioma,2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Myeloma,2020
20-24,1.7,2.3,205,Incidence,10239813,All Races,2.0,Female,Non-Hodgkin Lymphoma,2020
20-24,0.5,0.8,61,Incidence,10239813,All Races,0.6,Female,Oral Cavity and Pharynx,2020
20-24,1.8,2.4,212,Incidence,10239813,All Races,2.1,Female,Ovary,2020
20-24,0.2,0.5,36,Incidence,10239813,All Races,0.4,Female,Pancreas,2020
20-24,0.2,0.4,27,Incidence,10239813,All Races,0.3,Female,Stomach,2020
20-24,8.8,10.0,963,Incidence,10239813,All Races,9.4,Female,Thyroid,2020
20-24,~,~,~,Incidence,10239813,All Races,~,Female,Urinary Bladder,2020
25-29,62.1,65.0,7000,Incidence,11016549,All Races,63.5,Female,All Cancer Sites Combined,2020
25-29,1.9,2.5,244,Incidence,11016549,All Races,2.2,Female,Brain and Other Nervous System,2020
25-29,2.9,3.6,354,Incidence,11016549,All Races,3.2,Female,Cervix,2020
25-29,3.0,3.7,363,Incidence,11016549,All Races,3.3,Female,Colon and Rectum,2020
25-29,1.8,2.3,227,Incidence,11016549,All Races,2.1,Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,11016549,All Races,~,Female,Esophagus,2020
25-29,9.8,11.0,1146,Incidence,11016549,All Races,10.4,Female,Female Breast,2020
25-29,0.7,1.1,98,Incidence,11016549,All Races,0.9,Female,"Female Breast, <i>in situ</i>",2020
25-29,3.5,4.2,421,Incidence,11016549,All Races,3.8,Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,11016549,All Races,~,Female,Kaposi Sarcoma,2020
25-29,1.0,1.4,128,Incidence,11016549,All Races,1.2,Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,11016549,All Races,~,Female,Larynx,2020
25-29,2.1,2.7,265,Incidence,11016549,All Races,2.4,Female,Leukemias,2020
25-29,0.2,0.4,35,Incidence,11016549,All Races,0.3,Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.5,0.8,66,Incidence,11016549,All Races,0.6,Female,Lung and Bronchus,2020
25-29,5.3,6.2,633,Incidence,11016549,All Races,5.7,Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,11016549,All Races,~,Female,Mesothelioma,2020
25-29,~,~,~,Incidence,11016549,All Races,~,Female,Myeloma,2020
25-29,2.3,3.0,291,Incidence,11016549,All Races,2.6,Female,Non-Hodgkin Lymphoma,2020
25-29,1.0,1.4,127,Incidence,11016549,All Races,1.2,Female,Oral Cavity and Pharynx,2020
25-29,1.8,2.3,222,Incidence,11016549,All Races,2.0,Female,Ovary,2020
25-29,0.4,0.7,56,Incidence,11016549,All Races,0.5,Female,Pancreas,2020
25-29,0.3,0.6,47,Incidence,11016549,All Races,0.4,Female,Stomach,2020
25-29,14.8,16.2,1705,Incidence,11016549,All Races,15.5,Female,Thyroid,2020
25-29,0.1,0.3,25,Incidence,11016549,All Races,0.2,Female,Urinary Bladder,2020
30-34,116.1,120.2,12926,Incidence,10939868,All Races,118.2,Female,All Cancer Sites Combined,2020
30-34,2.4,3.0,294,Incidence,10939868,All Races,2.7,Female,Brain and Other Nervous System,2020
30-34,9.8,11.0,1137,Incidence,10939868,All Races,10.4,Female,Cervix,2020
30-34,6.0,7.0,713,Incidence,10939868,All Races,6.5,Female,Colon and Rectum,2020
30-34,5.1,6.0,609,Incidence,10939868,All Races,5.6,Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,10939868,All Races,~,Female,Esophagus,2020
30-34,29.4,31.5,3332,Incidence,10939868,All Races,30.5,Female,Female Breast,2020
30-34,2.8,3.5,346,Incidence,10939868,All Races,3.2,Female,"Female Breast, <i>in situ</i>",2020
30-34,3.1,3.8,372,Incidence,10939868,All Races,3.4,Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,10939868,All Races,~,Female,Kaposi Sarcoma,2020
30-34,2.5,3.1,302,Incidence,10939868,All Races,2.8,Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,10939868,All Races,~,Female,Larynx,2020
30-34,2.7,3.3,327,Incidence,10939868,All Races,3.0,Female,Leukemias,2020
30-34,0.4,0.6,53,Incidence,10939868,All Races,0.5,Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.7,1.1,96,Incidence,10939868,All Races,0.9,Female,Lung and Bronchus,2020
30-34,9.8,11.1,1141,Incidence,10939868,All Races,10.4,Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,10939868,All Races,~,Female,Mesothelioma,2020
30-34,0.2,0.4,34,Incidence,10939868,All Races,0.3,Female,Myeloma,2020
30-34,3.0,3.7,363,Incidence,10939868,All Races,3.3,Female,Non-Hodgkin Lymphoma,2020
30-34,1.5,2.0,194,Incidence,10939868,All Races,1.8,Female,Oral Cavity and Pharynx,2020
30-34,3.0,3.7,362,Incidence,10939868,All Races,3.3,Female,Ovary,2020
30-34,0.6,1.0,86,Incidence,10939868,All Races,0.8,Female,Pancreas,2020
30-34,0.9,1.2,113,Incidence,10939868,All Races,1.0,Female,Stomach,2020
30-34,21.5,23.3,2446,Incidence,10939868,All Races,22.4,Female,Thyroid,2020
30-34,0.2,0.5,38,Incidence,10939868,All Races,0.3,Female,Urinary Bladder,2020
35-39,182.5,187.7,19567,Incidence,10569058,All Races,185.1,Female,All Cancer Sites Combined,2020
35-39,2.9,3.6,338,Incidence,10569058,All Races,3.2,Female,Brain and Other Nervous System,2020
35-39,12.3,13.7,1369,Incidence,10569058,All Races,13.0,Female,Cervix,2020
35-39,10.8,12.1,1209,Incidence,10569058,All Races,11.4,Female,Colon and Rectum,2020
35-39,9.6,10.8,1075,Incidence,10569058,All Races,10.2,Female,"Corpus and Uterus, NOS",2020
35-39,0.1,0.3,21,Incidence,10569058,All Races,0.2,Female,Esophagus,2020
35-39,62.0,65.1,6716,Incidence,10569058,All Races,63.5,Female,Female Breast,2020
35-39,7.6,8.7,859,Incidence,10569058,All Races,8.1,Female,"Female Breast, <i>in situ</i>",2020
35-39,2.2,2.8,267,Incidence,10569058,All Races,2.5,Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,10569058,All Races,~,Female,Kaposi Sarcoma,2020
35-39,4.5,5.4,521,Incidence,10569058,All Races,4.9,Female,Kidney and Renal Pelvis,2020
35-39,0.1,0.3,23,Incidence,10569058,All Races,0.2,Female,Larynx,2020
35-39,3.8,4.6,445,Incidence,10569058,All Races,4.2,Female,Leukemias,2020
35-39,0.5,0.8,71,Incidence,10569058,All Races,0.7,Female,Liver and Intrahepatic Bile Duct,2020
35-39,2.2,2.8,264,Incidence,10569058,All Races,2.5,Female,Lung and Bronchus,2020
35-39,13.3,14.8,1482,Incidence,10569058,All Races,14.0,Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,10569058,All Races,~,Female,Mesothelioma,2020
35-39,0.6,1.0,85,Incidence,10569058,All Races,0.8,Female,Myeloma,2020
35-39,5.0,5.9,577,Incidence,10569058,All Races,5.5,Female,Non-Hodgkin Lymphoma,2020
35-39,2.1,2.7,250,Incidence,10569058,All Races,2.4,Female,Oral Cavity and Pharynx,2020
35-39,4.5,5.3,516,Incidence,10569058,All Races,4.9,Female,Ovary,2020
35-39,1.2,1.6,148,Incidence,10569058,All Races,1.4,Female,Pancreas,2020
35-39,1.5,2.0,181,Incidence,10569058,All Races,1.7,Female,Stomach,2020
35-39,24.6,26.5,2697,Incidence,10569058,All Races,25.5,Female,Thyroid,2020
35-39,0.5,0.8,65,Incidence,10569058,All Races,0.6,Female,Urinary Bladder,2020
40-44,287.3,294.1,28764,Incidence,9894900,All Races,290.7,Female,All Cancer Sites Combined,2020
40-44,3.1,3.8,339,Incidence,9894900,All Races,3.4,Female,Brain and Other Nervous System,2020
40-44,13.5,15.0,1410,Incidence,9894900,All Races,14.2,Female,Cervix,2020
40-44,17.5,19.2,1811,Incidence,9894900,All Races,18.3,Female,Colon and Rectum,2020
40-44,15.0,16.6,1562,Incidence,9894900,All Races,15.8,Female,"Corpus and Uterus, NOS",2020
40-44,0.4,0.6,48,Incidence,9894900,All Races,0.5,Female,Esophagus,2020
40-44,122.9,127.3,12377,Incidence,9894900,All Races,125.1,Female,Female Breast,2020
40-44,33.5,35.9,3433,Incidence,9894900,All Races,34.7,Female,"Female Breast, <i>in situ</i>",2020
40-44,1.7,2.2,192,Incidence,9894900,All Races,1.9,Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,9894900,All Races,~,Female,Kaposi Sarcoma,2020
40-44,7.2,8.3,766,Incidence,9894900,All Races,7.7,Female,Kidney and Renal Pelvis,2020
40-44,0.2,0.5,32,Incidence,9894900,All Races,0.3,Female,Larynx,2020
40-44,4.6,5.5,503,Incidence,9894900,All Races,5.1,Female,Leukemias,2020
40-44,1.2,1.7,140,Incidence,9894900,All Races,1.4,Female,Liver and Intrahepatic Bile Duct,2020
40-44,5.0,5.9,540,Incidence,9894900,All Races,5.5,Female,Lung and Bronchus,2020
40-44,17.2,18.9,1782,Incidence,9894900,All Races,18.0,Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,9894900,All Races,~,Female,Mesothelioma,2020
40-44,1.9,2.5,212,Incidence,9894900,All Races,2.1,Female,Myeloma,2020
40-44,6.6,7.6,699,Incidence,9894900,All Races,7.1,Female,Non-Hodgkin Lymphoma,2020
40-44,2.9,3.6,322,Incidence,9894900,All Races,3.3,Female,Oral Cavity and Pharynx,2020
40-44,7.0,8.1,742,Incidence,9894900,All Races,7.5,Female,Ovary,2020
40-44,2.6,3.2,286,Incidence,9894900,All Races,2.9,Female,Pancreas,2020
40-44,2.5,3.2,282,Incidence,9894900,All Races,2.8,Female,Stomach,2020
40-44,27.0,29.1,2776,Incidence,9894900,All Races,28.1,Female,Thyroid,2020
40-44,1.1,1.6,131,Incidence,9894900,All Races,1.3,Female,Urinary Bladder,2020
45-49,417.2,425.3,41259,Incidence,9795351,All Races,421.2,Female,All Cancer Sites Combined,2020
45-49,3.7,4.5,402,Incidence,9795351,All Races,4.1,Female,Brain and Other Nervous System,2020
45-49,12.2,13.6,1259,Incidence,9795351,All Races,12.9,Female,Cervix,2020
45-49,30.7,33.0,3120,Incidence,9795351,All Races,31.9,Female,Colon and Rectum,2020
45-49,24.2,26.2,2467,Incidence,9795351,All Races,25.2,Female,"Corpus and Uterus, NOS",2020
45-49,0.6,1.0,79,Incidence,9795351,All Races,0.8,Female,Esophagus,2020
45-49,187.6,193.0,18638,Incidence,9795351,All Races,190.3,Female,Female Breast,2020
45-49,51.4,54.2,5170,Incidence,9795351,All Races,52.8,Female,"Female Breast, <i>in situ</i>",2020
45-49,1.5,2.0,170,Incidence,9795351,All Races,1.7,Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,9795351,All Races,~,Female,Kaposi Sarcoma,2020
45-49,10.9,12.2,1131,Incidence,9795351,All Races,11.5,Female,Kidney and Renal Pelvis,2020
45-49,0.6,1.0,79,Incidence,9795351,All Races,0.8,Female,Larynx,2020
45-49,6.8,7.9,718,Incidence,9795351,All Races,7.3,Female,Leukemias,2020
45-49,1.6,2.2,185,Incidence,9795351,All Races,1.9,Female,Liver and Intrahepatic Bile Duct,2020
45-49,14.0,15.5,1441,Incidence,9795351,All Races,14.7,Female,Lung and Bronchus,2020
45-49,20.3,22.2,2079,Incidence,9795351,All Races,21.2,Female,Melanomas of the Skin,2020
45-49,0.2,0.4,29,Incidence,9795351,All Races,0.3,Female,Mesothelioma,2020
45-49,3.6,4.4,392,Incidence,9795351,All Races,4.0,Female,Myeloma,2020
45-49,9.6,10.9,1000,Incidence,9795351,All Races,10.2,Female,Non-Hodgkin Lymphoma,2020
45-49,5.0,5.9,533,Incidence,9795351,All Races,5.4,Female,Oral Cavity and Pharynx,2020
45-49,10.5,11.8,1090,Incidence,9795351,All Races,11.1,Female,Ovary,2020
45-49,5.1,6.0,543,Incidence,9795351,All Races,5.5,Female,Pancreas,2020
45-49,3.6,4.4,386,Incidence,9795351,All Races,3.9,Female,Stomach,2020
45-49,26.6,28.7,2710,Incidence,9795351,All Races,27.7,Female,Thyroid,2020
45-49,2.2,2.8,244,Incidence,9795351,All Races,2.5,Female,Urinary Bladder,2020
5-9,10.6,11.9,1075,Incidence,9584236,All Races,11.2,Female,All Cancer Sites Combined,2020
5-9,2.7,3.4,288,Incidence,9584236,All Races,3.0,Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Cervix,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Esophagus,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Female Breast,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Kaposi Sarcoma,2020
5-9,0.6,1.0,75,Incidence,9584236,All Races,0.8,Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Larynx,2020
5-9,3.7,4.5,391,Incidence,9584236,All Races,4.1,Female,Leukemias,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Mesothelioma,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Myeloma,2020
5-9,0.4,0.7,49,Incidence,9584236,All Races,0.5,Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Oral Cavity and Pharynx,2020
5-9,0.1,0.3,16,Incidence,9584236,All Races,0.2,Female,Ovary,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Pancreas,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Stomach,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Thyroid,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Female,Urinary Bladder,2020
50-54,559.5,568.8,56649,Incidence,10041181,All Races,564.2,Female,All Cancer Sites Combined,2020
50-54,5.4,6.4,594,Incidence,10041181,All Races,5.9,Female,Brain and Other Nervous System,2020
50-54,10.8,12.2,1154,Incidence,10041181,All Races,11.5,Female,Cervix,2020
50-54,48.6,51.4,5022,Incidence,10041181,All Races,50.0,Female,Colon and Rectum,2020
50-54,42.2,44.8,4366,Incidence,10041181,All Races,43.5,Female,"Corpus and Uterus, NOS",2020
50-54,1.5,2.0,175,Incidence,10041181,All Races,1.7,Female,Esophagus,2020
50-54,218.5,224.3,22230,Incidence,10041181,All Races,221.4,Female,Female Breast,2020
50-54,57.9,60.9,5962,Incidence,10041181,All Races,59.4,Female,"Female Breast, <i>in situ</i>",2020
50-54,1.4,1.9,165,Incidence,10041181,All Races,1.6,Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,10041181,All Races,~,Female,Kaposi Sarcoma,2020
50-54,15.6,17.2,1641,Incidence,10041181,All Races,16.3,Female,Kidney and Renal Pelvis,2020
50-54,1.7,2.2,195,Incidence,10041181,All Races,1.9,Female,Larynx,2020
50-54,9.2,10.4,985,Incidence,10041181,All Races,9.8,Female,Leukemias,2020
50-54,3.9,4.7,432,Incidence,10041181,All Races,4.3,Female,Liver and Intrahepatic Bile Duct,2020
50-54,32.5,34.8,3378,Incidence,10041181,All Races,33.6,Female,Lung and Bronchus,2020
50-54,24.9,26.9,2601,Incidence,10041181,All Races,25.9,Female,Melanomas of the Skin,2020
50-54,0.3,0.5,38,Incidence,10041181,All Races,0.4,Female,Mesothelioma,2020
50-54,6.2,7.3,676,Incidence,10041181,All Races,6.7,Female,Myeloma,2020
50-54,15.2,16.7,1599,Incidence,10041181,All Races,15.9,Female,Non-Hodgkin Lymphoma,2020
50-54,8.9,10.1,954,Incidence,10041181,All Races,9.5,Female,Oral Cavity and Pharynx,2020
50-54,15.0,16.5,1579,Incidence,10041181,All Races,15.7,Female,Ovary,2020
50-54,9.6,10.9,1026,Incidence,10041181,All Races,10.2,Female,Pancreas,2020
50-54,5.3,6.3,582,Incidence,10041181,All Races,5.8,Female,Stomach,2020
50-54,27.3,29.4,2842,Incidence,10041181,All Races,28.3,Female,Thyroid,2020
50-54,4.9,5.9,541,Incidence,10041181,All Races,5.4,Female,Urinary Bladder,2020
55-59,730.4,740.6,79185,Incidence,10766098,All Races,735.5,Female,All Cancer Sites Combined,2020
55-59,7.2,8.3,836,Incidence,10766098,All Races,7.8,Female,Brain and Other Nervous System,2020
55-59,10.3,11.6,1179,Incidence,10766098,All Races,11.0,Female,Cervix,2020
55-59,47.6,50.2,5265,Incidence,10766098,All Races,48.9,Female,Colon and Rectum,2020
55-59,70.4,73.6,7754,Incidence,10766098,All Races,72.0,Female,"Corpus and Uterus, NOS",2020
55-59,3.0,3.7,358,Incidence,10766098,All Races,3.3,Female,Esophagus,2020
55-59,250.7,256.7,27310,Incidence,10766098,All Races,253.7,Female,Female Breast,2020
55-59,59.8,62.8,6598,Incidence,10766098,All Races,61.3,Female,"Female Breast, <i>in situ</i>",2020
55-59,1.6,2.1,196,Incidence,10766098,All Races,1.8,Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,10766098,All Races,~,Female,Kaposi Sarcoma,2020
55-59,21.0,22.8,2354,Incidence,10766098,All Races,21.9,Female,Kidney and Renal Pelvis,2020
55-59,3.1,3.8,374,Incidence,10766098,All Races,3.5,Female,Larynx,2020
55-59,13.1,14.5,1481,Incidence,10766098,All Races,13.8,Female,Leukemias,2020
55-59,7.8,8.9,899,Incidence,10766098,All Races,8.4,Female,Liver and Intrahepatic Bile Duct,2020
55-59,77.4,80.8,8513,Incidence,10766098,All Races,79.1,Female,Lung and Bronchus,2020
55-59,29.5,31.5,3282,Incidence,10766098,All Races,30.5,Female,Melanomas of the Skin,2020
55-59,0.4,0.6,53,Incidence,10766098,All Races,0.5,Female,Mesothelioma,2020
55-59,8.8,10.0,1013,Incidence,10766098,All Races,9.4,Female,Myeloma,2020
55-59,21.9,23.7,2451,Incidence,10766098,All Races,22.8,Female,Non-Hodgkin Lymphoma,2020
55-59,13.5,14.9,1528,Incidence,10766098,All Races,14.2,Female,Oral Cavity and Pharynx,2020
55-59,18.6,20.2,2087,Incidence,10766098,All Races,19.4,Female,Ovary,2020
55-59,17.0,18.6,1916,Incidence,10766098,All Races,17.8,Female,Pancreas,2020
55-59,6.5,7.6,758,Incidence,10766098,All Races,7.0,Female,Stomach,2020
55-59,24.8,26.8,2776,Incidence,10766098,All Races,25.8,Female,Thyroid,2020
55-59,9.7,10.9,1108,Incidence,10766098,All Races,10.3,Female,Urinary Bladder,2020
60-64,958.5,970.4,101308,Incidence,10504315,All Races,964.4,Female,All Cancer Sites Combined,2020
60-64,9.9,11.2,1107,Incidence,10504315,All Races,10.5,Female,Brain and Other Nervous System,2020
60-64,9.9,11.1,1103,Incidence,10504315,All Races,10.5,Female,Cervix,2020
60-64,59.8,62.8,6434,Incidence,10504315,All Races,61.3,Female,Colon and Rectum,2020
60-64,90.5,94.2,9696,Incidence,10504315,All Races,92.3,Female,"Corpus and Uterus, NOS",2020
60-64,4.6,5.5,527,Incidence,10504315,All Races,5.0,Female,Esophagus,2020
60-64,304.7,311.5,32363,Incidence,10504315,All Races,308.1,Female,Female Breast,2020
60-64,69.6,72.9,7483,Incidence,10504315,All Races,71.2,Female,"Female Breast, <i>in situ</i>",2020
60-64,1.4,1.9,174,Incidence,10504315,All Races,1.7,Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,10504315,All Races,~,Female,Kaposi Sarcoma,2020
60-64,27.4,29.5,2986,Incidence,10504315,All Races,28.4,Female,Kidney and Renal Pelvis,2020
60-64,3.9,4.7,454,Incidence,10504315,All Races,4.3,Female,Larynx,2020
60-64,18.1,19.8,1988,Incidence,10504315,All Races,18.9,Female,Leukemias,2020
60-64,12.9,14.3,1431,Incidence,10504315,All Races,13.6,Female,Liver and Intrahepatic Bile Duct,2020
60-64,129.7,134.1,13854,Incidence,10504315,All Races,131.9,Female,Lung and Bronchus,2020
60-64,35.0,37.3,3798,Incidence,10504315,All Races,36.2,Female,Melanomas of the Skin,2020
60-64,0.5,0.9,73,Incidence,10504315,All Races,0.7,Female,Mesothelioma,2020
60-64,13.5,14.9,1489,Incidence,10504315,All Races,14.2,Female,Myeloma,2020
60-64,31.3,33.5,3406,Incidence,10504315,All Races,32.4,Female,Non-Hodgkin Lymphoma,2020
60-64,17.9,19.6,1967,Incidence,10504315,All Races,18.7,Female,Oral Cavity and Pharynx,2020
60-64,22.9,24.8,2502,Incidence,10504315,All Races,23.8,Female,Ovary,2020
60-64,26.5,28.5,2885,Incidence,10504315,All Races,27.5,Female,Pancreas,2020
60-64,9.3,10.5,1038,Incidence,10504315,All Races,9.9,Female,Stomach,2020
60-64,23.3,25.2,2547,Incidence,10504315,All Races,24.2,Female,Thyroid,2020
60-64,15.4,16.9,1696,Incidence,10504315,All Races,16.1,Female,Urinary Bladder,2020
65-69,1220.4,1234.7,112951,Incidence,9201195,All Races,1227.6,Female,All Cancer Sites Combined,2020
65-69,11.5,13.0,1126,Incidence,9201195,All Races,12.2,Female,Brain and Other Nervous System,2020
65-69,8.7,9.9,854,Incidence,9201195,All Races,9.3,Female,Cervix,2020
65-69,76.8,80.5,7236,Incidence,9201195,All Races,78.6,Female,Colon and Rectum,2020
65-69,104.0,108.3,9765,Incidence,9201195,All Races,106.1,Female,"Corpus and Uterus, NOS",2020
65-69,5.9,7.0,592,Incidence,9201195,All Races,6.4,Female,Esophagus,2020
65-69,378.4,386.4,35182,Incidence,9201195,All Races,382.4,Female,Female Breast,2020
65-69,85.8,89.6,8070,Incidence,9201195,All Races,87.7,Female,"Female Breast, <i>in situ</i>",2020
65-69,1.8,2.4,191,Incidence,9201195,All Races,2.1,Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,9201195,All Races,~,Female,Kaposi Sarcoma,2020
65-69,35.5,38.0,3379,Incidence,9201195,All Races,36.7,Female,Kidney and Renal Pelvis,2020
65-69,3.8,4.6,384,Incidence,9201195,All Races,4.2,Female,Larynx,2020
65-69,26.2,28.3,2508,Incidence,9201195,All Races,27.3,Female,Leukemias,2020
65-69,19.6,21.5,1888,Incidence,9201195,All Races,20.5,Female,Liver and Intrahepatic Bile Duct,2020
65-69,176.2,181.6,16459,Incidence,9201195,All Races,178.9,Female,Lung and Bronchus,2020
65-69,42.8,45.5,4058,Incidence,9201195,All Races,44.1,Female,Melanomas of the Skin,2020
65-69,1.0,1.5,115,Incidence,9201195,All Races,1.2,Female,Mesothelioma,2020
65-69,18.6,20.5,1798,Incidence,9201195,All Races,19.5,Female,Myeloma,2020
65-69,44.1,46.8,4179,Incidence,9201195,All Races,45.4,Female,Non-Hodgkin Lymphoma,2020
65-69,18.9,20.7,1821,Incidence,9201195,All Races,19.8,Female,Oral Cavity and Pharynx,2020
65-69,25.5,27.6,2439,Incidence,9201195,All Races,26.5,Female,Ovary,2020
65-69,40.0,42.6,3801,Incidence,9201195,All Races,41.3,Female,Pancreas,2020
65-69,12.4,13.9,1205,Incidence,9201195,All Races,13.1,Female,Stomach,2020
65-69,24.3,26.3,2325,Incidence,9201195,All Races,25.3,Female,Thyroid,2020
65-69,24.4,26.5,2338,Incidence,9201195,All Races,25.4,Female,Urinary Bladder,2020
70-74,1433.6,1450.6,110314,Incidence,7649636,All Races,1442.1,Female,All Cancer Sites Combined,2020
70-74,14.9,16.7,1207,Incidence,7649636,All Races,15.8,Female,Brain and Other Nervous System,2020
70-74,8.8,10.2,723,Incidence,7649636,All Races,9.5,Female,Cervix,2020
70-74,95.0,99.4,7435,Incidence,7649636,All Races,97.2,Female,Colon and Rectum,2020
70-74,101.8,106.4,7959,Incidence,7649636,All Races,104.0,Female,"Corpus and Uterus, NOS",2020
70-74,7.2,8.5,600,Incidence,7649636,All Races,7.8,Female,Esophagus,2020
70-74,417.6,426.8,32298,Incidence,7649636,All Races,422.2,Female,Female Breast,2020
70-74,89.7,94.0,7028,Incidence,7649636,All Races,91.9,Female,"Female Breast, <i>in situ</i>",2020
70-74,2.0,2.7,181,Incidence,7649636,All Races,2.4,Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,7649636,All Races,~,Female,Kaposi Sarcoma,2020
70-74,40.1,43.0,3174,Incidence,7649636,All Races,41.5,Female,Kidney and Renal Pelvis,2020
70-74,3.6,4.5,309,Incidence,7649636,All Races,4.0,Female,Larynx,2020
70-74,33.0,35.7,2625,Incidence,7649636,All Races,34.3,Female,Leukemias,2020
70-74,20.7,22.9,1666,Incidence,7649636,All Races,21.8,Female,Liver and Intrahepatic Bile Duct,2020
70-74,232.9,239.8,18080,Incidence,7649636,All Races,236.4,Female,Lung and Bronchus,2020
70-74,45.9,49.0,3631,Incidence,7649636,All Races,47.5,Female,Melanomas of the Skin,2020
70-74,1.3,1.8,117,Incidence,7649636,All Races,1.5,Female,Mesothelioma,2020
70-74,24.9,27.2,1992,Incidence,7649636,All Races,26.0,Female,Myeloma,2020
70-74,57.6,61.0,4535,Incidence,7649636,All Races,59.3,Female,Non-Hodgkin Lymphoma,2020
70-74,22.0,24.2,1764,Incidence,7649636,All Races,23.1,Female,Oral Cavity and Pharynx,2020
70-74,28.4,30.9,2265,Incidence,7649636,All Races,29.6,Female,Ovary,2020
70-74,53.2,56.5,4196,Incidence,7649636,All Races,54.9,Female,Pancreas,2020
70-74,14.2,16.0,1152,Incidence,7649636,All Races,15.1,Female,Stomach,2020
70-74,22.4,24.6,1795,Incidence,7649636,All Races,23.5,Female,Thyroid,2020
70-74,34.7,37.4,2756,Incidence,7649636,All Races,36.0,Female,Urinary Bladder,2020
75-79,1616.2,1637.8,87076,Incidence,5352056,All Races,1627.0,Female,All Cancer Sites Combined,2020
75-79,14.7,16.9,843,Incidence,5352056,All Races,15.8,Female,Brain and Other Nervous System,2020
75-79,7.3,8.8,429,Incidence,5352056,All Races,8.0,Female,Cervix,2020
75-79,119.9,125.9,6577,Incidence,5352056,All Races,122.9,Female,Colon and Rectum,2020
75-79,85.7,90.8,4723,Incidence,5352056,All Races,88.2,Female,"Corpus and Uterus, NOS",2020
75-79,8.0,9.6,471,Incidence,5352056,All Races,8.8,Female,Esophagus,2020
75-79,416.5,427.5,22583,Incidence,5352056,All Races,421.9,Female,Female Breast,2020
75-79,71.4,76.0,3945,Incidence,5352056,All Races,73.7,Female,"Female Breast, <i>in situ</i>",2020
75-79,2.7,3.6,167,Incidence,5352056,All Races,3.1,Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,5352056,All Races,~,Female,Kaposi Sarcoma,2020
75-79,42.6,46.1,2372,Incidence,5352056,All Races,44.3,Female,Kidney and Renal Pelvis,2020
75-79,3.1,4.2,193,Incidence,5352056,All Races,3.6,Female,Larynx,2020
75-79,43.9,47.6,2447,Incidence,5352056,All Races,45.7,Female,Leukemias,2020
75-79,22.7,25.3,1282,Incidence,5352056,All Races,24.0,Female,Liver and Intrahepatic Bile Duct,2020
75-79,290.9,300.1,15812,Incidence,5352056,All Races,295.4,Female,Lung and Bronchus,2020
75-79,50.2,54.1,2788,Incidence,5352056,All Races,52.1,Female,Melanomas of the Skin,2020
75-79,2.1,2.9,133,Incidence,5352056,All Races,2.5,Female,Mesothelioma,2020
75-79,29.9,32.9,1679,Incidence,5352056,All Races,31.4,Female,Myeloma,2020
75-79,72.2,76.8,3986,Incidence,5352056,All Races,74.5,Female,Non-Hodgkin Lymphoma,2020
75-79,25.2,28.0,1422,Incidence,5352056,All Races,26.6,Female,Oral Cavity and Pharynx,2020
75-79,31.8,34.9,1784,Incidence,5352056,All Races,33.3,Female,Ovary,2020
75-79,67.7,72.2,3742,Incidence,5352056,All Races,69.9,Female,Pancreas,2020
75-79,17.8,20.2,1016,Incidence,5352056,All Races,19.0,Female,Stomach,2020
75-79,17.9,20.2,1017,Incidence,5352056,All Races,19.0,Female,Thyroid,2020
75-79,48.1,51.9,2673,Incidence,5352056,All Races,49.9,Female,Urinary Bladder,2020
80-84,1680.6,1707.4,61138,Incidence,3609181,All Races,1694.0,Female,All Cancer Sites Combined,2020
80-84,15.8,18.5,617,Incidence,3609181,All Races,17.1,Female,Brain and Other Nervous System,2020
80-84,6.3,8.1,258,Incidence,3609181,All Races,7.1,Female,Cervix,2020
80-84,161.6,170.0,5983,Incidence,3609181,All Races,165.8,Female,Colon and Rectum,2020
80-84,69.7,75.3,2615,Incidence,3609181,All Races,72.5,Female,"Corpus and Uterus, NOS",2020
80-84,9.5,11.6,380,Incidence,3609181,All Races,10.5,Female,Esophagus,2020
80-84,373.1,385.8,13693,Incidence,3609181,All Races,379.4,Female,Female Breast,2020
80-84,48.1,52.8,1819,Incidence,3609181,All Races,50.4,Female,"Female Breast, <i>in situ</i>",2020
80-84,2.4,3.6,107,Incidence,3609181,All Races,3.0,Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,3609181,All Races,~,Female,Kaposi Sarcoma,2020
80-84,39.9,44.2,1517,Incidence,3609181,All Races,42.0,Female,Kidney and Renal Pelvis,2020
80-84,2.8,4.0,120,Incidence,3609181,All Races,3.3,Female,Larynx,2020
80-84,52.0,56.8,1962,Incidence,3609181,All Races,54.4,Female,Leukemias,2020
80-84,25.6,29.0,984,Incidence,3609181,All Races,27.3,Female,Liver and Intrahepatic Bile Duct,2020
80-84,280.4,291.5,10320,Incidence,3609181,All Races,285.9,Female,Lung and Bronchus,2020
80-84,53.5,58.4,2019,Incidence,3609181,All Races,55.9,Female,Melanomas of the Skin,2020
80-84,2.1,3.2,95,Incidence,3609181,All Races,2.6,Female,Mesothelioma,2020
80-84,32.8,36.7,1254,Incidence,3609181,All Races,34.7,Female,Myeloma,2020
80-84,81.2,87.2,3036,Incidence,3609181,All Races,84.1,Female,Non-Hodgkin Lymphoma,2020
80-84,26.5,30.0,1017,Incidence,3609181,All Races,28.2,Female,Oral Cavity and Pharynx,2020
80-84,33.3,37.1,1269,Incidence,3609181,All Races,35.2,Female,Ovary,2020
80-84,82.3,88.3,3077,Incidence,3609181,All Races,85.3,Female,Pancreas,2020
80-84,20.8,24.0,807,Incidence,3609181,All Races,22.4,Female,Stomach,2020
80-84,12.6,15.1,499,Incidence,3609181,All Races,13.8,Female,Thyroid,2020
80-84,55.1,60.1,2078,Incidence,3609181,All Races,57.6,Female,Urinary Bladder,2020
85+,1465.2,1488.7,61001,Incidence,4130366,All Races,1476.9,Female,All Cancer Sites Combined,2020
85+,12.6,14.9,567,Incidence,4130366,All Races,13.7,Female,Brain and Other Nervous System,2020
85+,5.6,7.1,261,Incidence,4130366,All Races,6.3,Female,Cervix,2020
85+,183.8,192.2,7765,Incidence,4130366,All Races,188.0,Female,Colon and Rectum,2020
85+,43.1,47.3,1865,Incidence,4130366,All Races,45.2,Female,"Corpus and Uterus, NOS",2020
85+,9.7,11.7,442,Incidence,4130366,All Races,10.7,Female,Esophagus,2020
85+,274.6,284.8,11552,Incidence,4130366,All Races,279.7,Female,Female Breast,2020
85+,19.1,21.8,843,Incidence,4130366,All Races,20.4,Female,"Female Breast, <i>in situ</i>",2020
85+,1.3,2.1,67,Incidence,4130366,All Races,1.6,Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,4130366,All Races,~,Female,Kaposi Sarcoma,2020
85+,31.5,35.0,1373,Incidence,4130366,All Races,33.2,Female,Kidney and Renal Pelvis,2020
85+,1.8,2.7,92,Incidence,4130366,All Races,2.2,Female,Larynx,2020
85+,54.8,59.4,2358,Incidence,4130366,All Races,57.1,Female,Leukemias,2020
85+,21.4,24.3,943,Incidence,4130366,All Races,22.8,Female,Liver and Intrahepatic Bile Duct,2020
85+,192.9,201.5,8143,Incidence,4130366,All Races,197.1,Female,Lung and Bronchus,2020
85+,51.7,56.2,2227,Incidence,4130366,All Races,53.9,Female,Melanomas of the Skin,2020
85+,1.8,2.7,90,Incidence,4130366,All Races,2.2,Female,Mesothelioma,2020
85+,23.4,26.4,1027,Incidence,4130366,All Races,24.9,Female,Myeloma,2020
85+,70.3,75.5,3009,Incidence,4130366,All Races,72.9,Female,Non-Hodgkin Lymphoma,2020
85+,25.3,28.5,1111,Incidence,4130366,All Races,26.9,Female,Oral Cavity and Pharynx,2020
85+,27.5,30.8,1203,Incidence,4130366,All Races,29.1,Female,Ovary,2020
85+,80.0,85.6,3419,Incidence,4130366,All Races,82.8,Female,Pancreas,2020
85+,23.2,26.2,1019,Incidence,4130366,All Races,24.7,Female,Stomach,2020
85+,8.0,9.9,369,Incidence,4130366,All Races,8.9,Female,Thyroid,2020
85+,61.5,66.4,2640,Incidence,4130366,All Races,63.9,Female,Urinary Bladder,2020
<1,22.2,26.9,433,Incidence,1770114,All Races,24.5,Female,All Cancer Sites Combined,2020
<1,3.1,5.0,70,Incidence,1770114,All Races,4.0,Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Cervix,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Colon and Rectum,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Esophagus,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Female Breast,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Kaposi Sarcoma,2020
<1,1.0,2.2,27,Incidence,1770114,All Races,1.5,Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Larynx,2020
<1,3.1,5.0,70,Incidence,1770114,All Races,4.0,Female,Leukemias,2020
<1,0.7,1.7,20,Incidence,1770114,All Races,1.1,Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Mesothelioma,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Myeloma,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Ovary,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Pancreas,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Stomach,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Thyroid,2020
<1,~,~,~,Incidence,1770114,All Races,~,Female,Urinary Bladder,2020
1-4,21.4,23.5,1727,Incidence,7705193,All Races,22.4,Male,All Cancer Sites Combined,2020
1-4,3.4,4.3,294,Incidence,7705193,All Races,3.8,Male,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Colon and Rectum,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Esophagus,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Kaposi Sarcoma,2020
1-4,1.6,2.3,150,Incidence,7705193,All Races,1.9,Male,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Larynx,2020
1-4,8.5,9.8,704,Incidence,7705193,All Races,9.1,Male,Leukemias,2020
1-4,0.7,1.1,65,Incidence,7705193,All Races,0.8,Male,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Lung and Bronchus,2020
1-4,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Mesothelioma,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Myeloma,2020
1-4,0.8,1.3,80,Incidence,7705193,All Races,1.0,Male,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Pancreas,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Prostate,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Stomach,2020
1-4,0.2,0.5,27,Incidence,7705193,All Races,0.4,Male,Testis,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Thyroid,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male,Urinary Bladder,2020
10-14,13.8,15.3,1490,Incidence,10265195,All Races,14.5,Male,All Cancer Sites Combined,2020
10-14,2.3,2.9,267,Incidence,10265195,All Races,2.6,Male,Brain and Other Nervous System,2020
10-14,0.4,0.7,57,Incidence,10265195,All Races,0.6,Male,Colon and Rectum,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Esophagus,2020
10-14,1.1,1.6,136,Incidence,10265195,All Races,1.3,Male,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Kaposi Sarcoma,2020
10-14,0.1,0.3,16,Incidence,10265195,All Races,0.2,Male,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Larynx,2020
10-14,3.5,4.2,393,Incidence,10265195,All Races,3.8,Male,Leukemias,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Lung and Bronchus,2020
10-14,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
10-14,0.1,0.3,17,Incidence,10265195,All Races,0.2,Male,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Mesothelioma,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Myeloma,2020
10-14,1.5,2.0,176,Incidence,10265195,All Races,1.7,Male,Non-Hodgkin Lymphoma,2020
10-14,0.1,0.3,22,Incidence,10265195,All Races,0.2,Male,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Pancreas,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Prostate,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Stomach,2020
10-14,0.2,0.4,25,Incidence,10265195,All Races,0.2,Male,Testis,2020
10-14,0.1,0.3,21,Incidence,10265195,All Races,0.2,Male,Thyroid,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male,Urinary Bladder,2020
15-19,22.9,24.8,2472,Incidence,10367095,All Races,23.8,Male,All Cancer Sites Combined,2020
15-19,2.2,2.9,263,Incidence,10367095,All Races,2.5,Male,Brain and Other Nervous System,2020
15-19,0.9,1.3,114,Incidence,10367095,All Races,1.1,Male,Colon and Rectum,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Esophagus,2020
15-19,2.7,3.3,309,Incidence,10367095,All Races,3.0,Male,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Kaposi Sarcoma,2020
15-19,0.1,0.3,21,Incidence,10367095,All Races,0.2,Male,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Larynx,2020
15-19,3.3,4.1,383,Incidence,10367095,All Races,3.7,Male,Leukemias,2020
15-19,0.1,0.3,17,Incidence,10367095,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2020
15-19,0.1,0.3,18,Incidence,10367095,All Races,0.2,Male,Lung and Bronchus,2020
15-19,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
15-19,0.4,0.7,52,Incidence,10367095,All Races,0.5,Male,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Mesothelioma,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Myeloma,2020
15-19,2.2,2.9,262,Incidence,10367095,All Races,2.5,Male,Non-Hodgkin Lymphoma,2020
15-19,0.3,0.5,37,Incidence,10367095,All Races,0.4,Male,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Pancreas,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Prostate,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Stomach,2020
15-19,3.1,3.9,361,Incidence,10367095,All Races,3.5,Male,Testis,2020
15-19,1.0,1.4,121,Incidence,10367095,All Races,1.2,Male,Thyroid,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male,Urinary Bladder,2020
20-24,32.9,35.1,3638,Incidence,10696126,All Races,34.0,Male,All Cancer Sites Combined,2020
20-24,1.9,2.5,236,Incidence,10696126,All Races,2.2,Male,Brain and Other Nervous System,2020
20-24,1.6,2.1,194,Incidence,10696126,All Races,1.8,Male,Colon and Rectum,2020
20-24,~,~,~,Incidence,10696126,All Races,~,Male,Esophagus,2020
20-24,3.5,4.2,411,Incidence,10696126,All Races,3.8,Male,Hodgkin Lymphoma,2020
20-24,0.1,0.3,22,Incidence,10696126,All Races,0.2,Male,Kaposi Sarcoma,2020
20-24,0.4,0.7,57,Incidence,10696126,All Races,0.5,Male,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,10696126,All Races,~,Male,Larynx,2020
20-24,2.6,3.3,317,Incidence,10696126,All Races,3.0,Male,Leukemias,2020
20-24,0.2,0.4,26,Incidence,10696126,All Races,0.2,Male,Liver and Intrahepatic Bile Duct,2020
20-24,0.2,0.4,33,Incidence,10696126,All Races,0.3,Male,Lung and Bronchus,2020
20-24,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
20-24,1.1,1.6,142,Incidence,10696126,All Races,1.3,Male,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,10696126,All Races,~,Male,Mesothelioma,2020
20-24,~,~,~,Incidence,10696126,All Races,~,Male,Myeloma,2020
20-24,2.7,3.4,323,Incidence,10696126,All Races,3.0,Male,Non-Hodgkin Lymphoma,2020
20-24,0.4,0.6,53,Incidence,10696126,All Races,0.5,Male,Oral Cavity and Pharynx,2020
20-24,0.1,0.3,19,Incidence,10696126,All Races,0.2,Male,Pancreas,2020
20-24,~,~,~,Incidence,10696126,All Races,~,Male,Prostate,2020
20-24,0.1,0.3,23,Incidence,10696126,All Races,0.2,Male,Stomach,2020
20-24,9.5,10.7,1075,Incidence,10696126,All Races,10.1,Male,Testis,2020
20-24,1.9,2.5,231,Incidence,10696126,All Races,2.2,Male,Thyroid,2020
20-24,0.2,0.4,30,Incidence,10696126,All Races,0.3,Male,Urinary Bladder,2020
25-29,43.6,46.1,5168,Incidence,11522082,All Races,44.9,Male,All Cancer Sites Combined,2020
25-29,2.7,3.3,345,Incidence,11522082,All Races,3.0,Male,Brain and Other Nervous System,2020
25-29,2.9,3.5,368,Incidence,11522082,All Races,3.2,Male,Colon and Rectum,2020
25-29,~,~,~,Incidence,11522082,All Races,~,Male,Esophagus,2020
25-29,3.1,3.7,391,Incidence,11522082,All Races,3.4,Male,Hodgkin Lymphoma,2020
25-29,0.4,0.7,65,Incidence,11522082,All Races,0.6,Male,Kaposi Sarcoma,2020
25-29,1.0,1.4,137,Incidence,11522082,All Races,1.2,Male,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,11522082,All Races,~,Male,Larynx,2020
25-29,2.6,3.2,335,Incidence,11522082,All Races,2.9,Male,Leukemias,2020
25-29,0.2,0.5,40,Incidence,11522082,All Races,0.3,Male,Liver and Intrahepatic Bile Duct,2020
25-29,0.4,0.6,57,Incidence,11522082,All Races,0.5,Male,Lung and Bronchus,2020
25-29,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
25-29,2.0,2.5,259,Incidence,11522082,All Races,2.2,Male,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,11522082,All Races,~,Male,Mesothelioma,2020
25-29,~,~,~,Incidence,11522082,All Races,~,Male,Myeloma,2020
25-29,3.1,3.8,399,Incidence,11522082,All Races,3.5,Male,Non-Hodgkin Lymphoma,2020
25-29,0.7,1.0,95,Incidence,11522082,All Races,0.8,Male,Oral Cavity and Pharynx,2020
25-29,0.3,0.5,42,Incidence,11522082,All Races,0.4,Male,Pancreas,2020
25-29,~,~,~,Incidence,11522082,All Races,~,Male,Prostate,2020
25-29,0.3,0.6,53,Incidence,11522082,All Races,0.5,Male,Stomach,2020
25-29,12.9,14.3,1563,Incidence,11522082,All Races,13.6,Male,Testis,2020
25-29,2.7,3.3,346,Incidence,11522082,All Races,3.0,Male,Thyroid,2020
25-29,0.4,0.7,66,Incidence,11522082,All Races,0.6,Male,Urinary Bladder,2020
30-34,62.5,65.4,7180,Incidence,11231713,All Races,63.9,Male,All Cancer Sites Combined,2020
30-34,3.2,3.9,395,Incidence,11231713,All Races,3.5,Male,Brain and Other Nervous System,2020
30-34,6.1,7.1,739,Incidence,11231713,All Races,6.6,Male,Colon and Rectum,2020
30-34,0.1,0.3,24,Incidence,11231713,All Races,0.2,Male,Esophagus,2020
30-34,2.8,3.5,353,Incidence,11231713,All Races,3.1,Male,Hodgkin Lymphoma,2020
30-34,0.8,1.1,106,Incidence,11231713,All Races,0.9,Male,Kaposi Sarcoma,2020
30-34,2.9,3.6,366,Incidence,11231713,All Races,3.3,Male,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,11231713,All Races,~,Male,Larynx,2020
30-34,3.3,4.0,405,Incidence,11231713,All Races,3.6,Male,Leukemias,2020
30-34,0.5,0.8,70,Incidence,11231713,All Races,0.6,Male,Liver and Intrahepatic Bile Duct,2020
30-34,0.9,1.3,126,Incidence,11231713,All Races,1.1,Male,Lung and Bronchus,2020
30-34,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
30-34,4.4,5.2,534,Incidence,11231713,All Races,4.8,Male,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,11231713,All Races,~,Male,Mesothelioma,2020
30-34,0.3,0.6,51,Incidence,11231713,All Races,0.5,Male,Myeloma,2020
30-34,4.3,5.1,524,Incidence,11231713,All Races,4.7,Male,Non-Hodgkin Lymphoma,2020
30-34,1.6,2.1,205,Incidence,11231713,All Races,1.8,Male,Oral Cavity and Pharynx,2020
30-34,0.4,0.7,64,Incidence,11231713,All Races,0.6,Male,Pancreas,2020
30-34,~,~,~,Incidence,11231713,All Races,~,Male,Prostate,2020
30-34,0.6,0.9,82,Incidence,11231713,All Races,0.7,Male,Stomach,2020
30-34,13.7,15.1,1620,Incidence,11231713,All Races,14.4,Male,Testis,2020
30-34,4.8,5.7,589,Incidence,11231713,All Races,5.2,Male,Thyroid,2020
30-34,0.6,1.0,88,Incidence,11231713,All Races,0.8,Male,Urinary Bladder,2020
35-39,89.2,92.8,9654,Incidence,10613469,All Races,91.0,Male,All Cancer Sites Combined,2020
35-39,4.0,4.8,470,Incidence,10613469,All Races,4.4,Male,Brain and Other Nervous System,2020
35-39,11.2,12.6,1262,Incidence,10613469,All Races,11.9,Male,Colon and Rectum,2020
35-39,0.6,0.9,76,Incidence,10613469,All Races,0.7,Male,Esophagus,2020
35-39,2.7,3.4,324,Incidence,10613469,All Races,3.1,Male,Hodgkin Lymphoma,2020
35-39,0.7,1.0,87,Incidence,10613469,All Races,0.8,Male,Kaposi Sarcoma,2020
35-39,7.1,8.2,810,Incidence,10613469,All Races,7.6,Male,Kidney and Renal Pelvis,2020
35-39,0.3,0.5,41,Incidence,10613469,All Races,0.4,Male,Larynx,2020
35-39,4.7,5.5,541,Incidence,10613469,All Races,5.1,Male,Leukemias,2020
35-39,1.0,1.4,124,Incidence,10613469,All Races,1.2,Male,Liver and Intrahepatic Bile Duct,2020
35-39,2.1,2.7,257,Incidence,10613469,All Races,2.4,Male,Lung and Bronchus,2020
35-39,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
35-39,7.6,8.7,863,Incidence,10613469,All Races,8.1,Male,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,10613469,All Races,~,Male,Mesothelioma,2020
35-39,0.7,1.1,98,Incidence,10613469,All Races,0.9,Male,Myeloma,2020
35-39,6.3,7.3,721,Incidence,10613469,All Races,6.8,Male,Non-Hodgkin Lymphoma,2020
35-39,2.8,3.5,331,Incidence,10613469,All Races,3.1,Male,Oral Cavity and Pharynx,2020
35-39,1.0,1.4,128,Incidence,10613469,All Races,1.2,Male,Pancreas,2020
35-39,0.2,0.5,36,Incidence,10613469,All Races,0.3,Male,Prostate,2020
35-39,1.7,2.2,206,Incidence,10613469,All Races,1.9,Male,Stomach,2020
35-39,11.2,12.5,1254,Incidence,10613469,All Races,11.8,Male,Testis,2020
35-39,6.2,7.2,709,Incidence,10613469,All Races,6.7,Male,Thyroid,2020
35-39,1.5,2.0,180,Incidence,10613469,All Races,1.7,Male,Urinary Bladder,2020
40-44,137.0,141.7,13659,Incidence,9802410,All Races,139.3,Male,All Cancer Sites Combined,2020
40-44,4.7,5.6,499,Incidence,9802410,All Races,5.1,Male,Brain and Other Nervous System,2020
40-44,20.9,22.8,2138,Incidence,9802410,All Races,21.8,Male,Colon and Rectum,2020
40-44,1.4,2.0,165,Incidence,9802410,All Races,1.7,Male,Esophagus,2020
40-44,2.5,3.2,275,Incidence,9802410,All Races,2.8,Male,Hodgkin Lymphoma,2020
40-44,0.6,0.9,73,Incidence,9802410,All Races,0.7,Male,Kaposi Sarcoma,2020
40-44,13.1,14.6,1360,Incidence,9802410,All Races,13.9,Male,Kidney and Renal Pelvis,2020
40-44,0.7,1.1,90,Incidence,9802410,All Races,0.9,Male,Larynx,2020
40-44,6.0,7.0,635,Incidence,9802410,All Races,6.5,Male,Leukemias,2020
40-44,1.9,2.5,211,Incidence,9802410,All Races,2.2,Male,Liver and Intrahepatic Bile Duct,2020
40-44,5.1,6.1,549,Incidence,9802410,All Races,5.6,Male,Lung and Bronchus,2020
40-44,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
40-44,11.4,12.7,1180,Incidence,9802410,All Races,12.0,Male,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,9802410,All Races,~,Male,Mesothelioma,2020
40-44,2.0,2.6,221,Incidence,9802410,All Races,2.3,Male,Myeloma,2020
40-44,8.8,10.0,922,Incidence,9802410,All Races,9.4,Male,Non-Hodgkin Lymphoma,2020
40-44,6.6,7.6,696,Incidence,9802410,All Races,7.1,Male,Oral Cavity and Pharynx,2020
40-44,3.2,3.9,347,Incidence,9802410,All Races,3.5,Male,Pancreas,2020
40-44,4.6,5.5,494,Incidence,9802410,All Races,5.0,Male,Prostate,2020
40-44,2.7,3.4,293,Incidence,9802410,All Races,3.0,Male,Stomach,2020
40-44,8.2,9.4,860,Incidence,9802410,All Races,8.8,Male,Testis,2020
40-44,7.7,8.9,814,Incidence,9802410,All Races,8.3,Male,Thyroid,2020
40-44,3.5,4.3,385,Incidence,9802410,All Races,3.9,Male,Urinary Bladder,2020
45-49,238.6,244.9,23138,Incidence,9571144,All Races,241.7,Male,All Cancer Sites Combined,2020
45-49,5.5,6.5,571,Incidence,9571144,All Races,6.0,Male,Brain and Other Nervous System,2020
45-49,37.8,40.4,3741,Incidence,9571144,All Races,39.1,Male,Colon and Rectum,2020
45-49,3.6,4.4,377,Incidence,9571144,All Races,3.9,Male,Esophagus,2020
45-49,2.1,2.8,232,Incidence,9571144,All Races,2.4,Male,Hodgkin Lymphoma,2020
45-49,0.5,0.9,66,Incidence,9571144,All Races,0.7,Male,Kaposi Sarcoma,2020
45-49,22.5,24.5,2246,Incidence,9571144,All Races,23.5,Male,Kidney and Renal Pelvis,2020
45-49,2.4,3.0,256,Incidence,9571144,All Races,2.7,Male,Larynx,2020
45-49,8.2,9.4,845,Incidence,9571144,All Races,8.8,Male,Leukemias,2020
45-49,4.0,4.9,425,Incidence,9571144,All Races,4.4,Male,Liver and Intrahepatic Bile Duct,2020
45-49,13.0,14.5,1314,Incidence,9571144,All Races,13.7,Male,Lung and Bronchus,2020
45-49,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
45-49,17.5,19.2,1755,Incidence,9571144,All Races,18.3,Male,Melanomas of the Skin,2020
45-49,0.1,0.3,20,Incidence,9571144,All Races,0.2,Male,Mesothelioma,2020
45-49,4.5,5.4,475,Incidence,9571144,All Races,5.0,Male,Myeloma,2020
45-49,13.1,14.7,1329,Incidence,9571144,All Races,13.9,Male,Non-Hodgkin Lymphoma,2020
45-49,15.8,17.4,1587,Incidence,9571144,All Races,16.6,Male,Oral Cavity and Pharynx,2020
45-49,6.6,7.7,684,Incidence,9571144,All Races,7.1,Male,Pancreas,2020
45-49,23.9,25.9,2384,Incidence,9571144,All Races,24.9,Male,Prostate,2020
45-49,5.1,6.0,528,Incidence,9571144,All Races,5.5,Male,Stomach,2020
45-49,5.6,6.6,583,Incidence,9571144,All Races,6.1,Male,Testis,2020
45-49,8.2,9.4,843,Incidence,9571144,All Races,8.8,Male,Thyroid,2020
45-49,7.5,8.6,767,Incidence,9571144,All Races,8.0,Male,Urinary Bladder,2020
5-9,12.3,13.7,1304,Incidence,10024258,All Races,13.0,Male,All Cancer Sites Combined,2020
5-9,2.7,3.4,306,Incidence,10024258,All Races,3.1,Male,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Colon and Rectum,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Esophagus,2020
5-9,0.4,0.7,55,Incidence,10024258,All Races,0.5,Male,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Kaposi Sarcoma,2020
5-9,0.4,0.7,53,Incidence,10024258,All Races,0.5,Male,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Larynx,2020
5-9,4.0,4.8,441,Incidence,10024258,All Races,4.4,Male,Leukemias,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Lung and Bronchus,2020
5-9,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Mesothelioma,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Myeloma,2020
5-9,1.2,1.7,146,Incidence,10024258,All Races,1.5,Male,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Pancreas,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Prostate,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Stomach,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Testis,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Thyroid,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male,Urinary Bladder,2020
50-54,444.2,452.6,43712,Incidence,9748896,All Races,448.4,Male,All Cancer Sites Combined,2020
50-54,7.9,9.1,825,Incidence,9748896,All Races,8.5,Male,Brain and Other Nervous System,2020
50-54,64.1,67.3,6407,Incidence,9748896,All Races,65.7,Male,Colon and Rectum,2020
50-54,7.3,8.4,761,Incidence,9748896,All Races,7.8,Male,Esophagus,2020
50-54,2.2,2.8,244,Incidence,9748896,All Races,2.5,Male,Hodgkin Lymphoma,2020
50-54,0.5,0.9,67,Incidence,9748896,All Races,0.7,Male,Kaposi Sarcoma,2020
50-54,31.8,34.1,3210,Incidence,9748896,All Races,32.9,Male,Kidney and Renal Pelvis,2020
50-54,5.2,6.2,553,Incidence,9748896,All Races,5.7,Male,Larynx,2020
50-54,12.5,13.9,1284,Incidence,9748896,All Races,13.2,Male,Leukemias,2020
50-54,9.8,11.1,1013,Incidence,9748896,All Races,10.4,Male,Liver and Intrahepatic Bile Duct,2020
50-54,31.6,33.9,3194,Incidence,9748896,All Races,32.8,Male,Lung and Bronchus,2020
50-54,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
50-54,25.2,27.2,2550,Incidence,9748896,All Races,26.2,Male,Melanomas of the Skin,2020
50-54,0.2,0.5,32,Incidence,9748896,All Races,0.3,Male,Mesothelioma,2020
50-54,7.3,8.4,761,Incidence,9748896,All Races,7.8,Male,Myeloma,2020
50-54,19.9,21.7,2024,Incidence,9748896,All Races,20.8,Male,Non-Hodgkin Lymphoma,2020
50-54,29.0,31.2,2936,Incidence,9748896,All Races,30.1,Male,Oral Cavity and Pharynx,2020
50-54,12.7,14.2,1311,Incidence,9748896,All Races,13.4,Male,Pancreas,2020
50-54,93.4,97.3,9296,Incidence,9748896,All Races,95.4,Male,Prostate,2020
50-54,7.2,8.4,759,Incidence,9748896,All Races,7.8,Male,Stomach,2020
50-54,3.7,4.5,395,Incidence,9748896,All Races,4.1,Male,Testis,2020
50-54,10.3,11.7,1071,Incidence,9748896,All Races,11.0,Male,Thyroid,2020
50-54,16.0,17.6,1639,Incidence,9748896,All Races,16.8,Male,Urinary Bladder,2020
55-59,773.8,784.6,79446,Incidence,10196269,All Races,779.2,Male,All Cancer Sites Combined,2020
55-59,11.7,13.0,1257,Incidence,10196269,All Races,12.3,Male,Brain and Other Nervous System,2020
55-59,70.0,73.2,7299,Incidence,10196269,All Races,71.6,Male,Colon and Rectum,2020
55-59,14.1,15.6,1509,Incidence,10196269,All Races,14.8,Male,Esophagus,2020
55-59,2.6,3.3,297,Incidence,10196269,All Races,2.9,Male,Hodgkin Lymphoma,2020
55-59,0.6,1.0,80,Incidence,10196269,All Races,0.8,Male,Kaposi Sarcoma,2020
55-59,45.7,48.4,4793,Incidence,10196269,All Races,47.0,Male,Kidney and Renal Pelvis,2020
55-59,10.8,12.1,1165,Incidence,10196269,All Races,11.4,Male,Larynx,2020
55-59,19.5,21.2,2074,Incidence,10196269,All Races,20.3,Male,Leukemias,2020
55-59,25.4,27.4,2687,Incidence,10196269,All Races,26.4,Male,Liver and Intrahepatic Bile Duct,2020
55-59,79.0,82.5,8234,Incidence,10196269,All Races,80.8,Male,Lung and Bronchus,2020
55-59,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
55-59,38.9,41.4,4094,Incidence,10196269,All Races,40.2,Male,Melanomas of the Skin,2020
55-59,0.6,1.0,81,Incidence,10196269,All Races,0.8,Male,Mesothelioma,2020
55-59,12.8,14.2,1378,Incidence,10196269,All Races,13.5,Male,Myeloma,2020
55-59,30.4,32.6,3214,Incidence,10196269,All Races,31.5,Male,Non-Hodgkin Lymphoma,2020
55-59,45.6,48.2,4781,Incidence,10196269,All Races,46.9,Male,Oral Cavity and Pharynx,2020
55-59,24.0,25.9,2540,Incidence,10196269,All Races,24.9,Male,Pancreas,2020
55-59,216.1,221.8,22325,Incidence,10196269,All Races,219.0,Male,Prostate,2020
55-59,12.4,13.8,1331,Incidence,10196269,All Races,13.1,Male,Stomach,2020
55-59,2.7,3.4,313,Incidence,10196269,All Races,3.1,Male,Testis,2020
55-59,11.2,12.5,1205,Incidence,10196269,All Races,11.8,Male,Thyroid,2020
55-59,31.1,33.3,3280,Incidence,10196269,All Races,32.2,Male,Urinary Bladder,2020
60-64,1211.2,1225.1,117876,Incidence,9676681,All Races,1218.1,Male,All Cancer Sites Combined,2020
60-64,14.5,16.0,1475,Incidence,9676681,All Races,15.2,Male,Brain and Other Nervous System,2020
60-64,91.5,95.4,9041,Incidence,9676681,All Races,93.4,Male,Colon and Rectum,2020
60-64,21.3,23.2,2149,Incidence,9676681,All Races,22.2,Male,Esophagus,2020
60-64,2.9,3.6,313,Incidence,9676681,All Races,3.2,Male,Hodgkin Lymphoma,2020
60-64,0.4,0.7,53,Incidence,9676681,All Races,0.5,Male,Kaposi Sarcoma,2020
60-64,61.6,64.7,6109,Incidence,9676681,All Races,63.1,Male,Kidney and Renal Pelvis,2020
60-64,16.5,18.2,1676,Incidence,9676681,All Races,17.3,Male,Larynx,2020
60-64,29.6,31.9,2974,Incidence,9676681,All Races,30.7,Male,Leukemias,2020
60-64,43.9,46.6,4374,Incidence,9676681,All Races,45.2,Male,Liver and Intrahepatic Bile Duct,2020
60-64,147.4,152.3,14501,Incidence,9676681,All Races,149.9,Male,Lung and Bronchus,2020
60-64,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
60-64,55.8,58.8,5544,Incidence,9676681,All Races,57.3,Male,Melanomas of the Skin,2020
60-64,1.2,1.6,134,Incidence,9676681,All Races,1.4,Male,Mesothelioma,2020
60-64,18.5,20.2,1870,Incidence,9676681,All Races,19.3,Male,Myeloma,2020
60-64,44.3,47.0,4419,Incidence,9676681,All Races,45.7,Male,Non-Hodgkin Lymphoma,2020
60-64,58.3,61.4,5790,Incidence,9676681,All Races,59.8,Male,Oral Cavity and Pharynx,2020
60-64,38.3,40.8,3826,Incidence,9676681,All Races,39.5,Male,Pancreas,2020
60-64,375.2,383.0,36686,Incidence,9676681,All Races,379.1,Male,Prostate,2020
60-64,18.6,20.4,1888,Incidence,9676681,All Races,19.5,Male,Stomach,2020
60-64,1.9,2.5,214,Incidence,9676681,All Races,2.2,Male,Testis,2020
60-64,12.8,14.2,1306,Incidence,9676681,All Races,13.5,Male,Thyroid,2020
60-64,58.9,62.1,5853,Incidence,9676681,All Races,60.5,Male,Urinary Bladder,2020
65-69,1736.4,1754.6,142007,Incidence,8135710,All Races,1745.5,Male,All Cancer Sites Combined,2020
65-69,17.3,19.2,1483,Incidence,8135710,All Races,18.2,Male,Brain and Other Nervous System,2020
65-69,115.3,120.0,9570,Incidence,8135710,All Races,117.6,Male,Colon and Rectum,2020
65-69,29.4,31.9,2492,Incidence,8135710,All Races,30.6,Male,Esophagus,2020
65-69,3.0,3.8,274,Incidence,8135710,All Races,3.4,Male,Hodgkin Lymphoma,2020
65-69,0.5,0.8,52,Incidence,8135710,All Races,0.6,Male,Kaposi Sarcoma,2020
65-69,78.9,82.8,6574,Incidence,8135710,All Races,80.8,Male,Kidney and Renal Pelvis,2020
65-69,19.1,21.0,1630,Incidence,8135710,All Races,20.0,Male,Larynx,2020
65-69,43.9,46.9,3692,Incidence,8135710,All Races,45.4,Male,Leukemias,2020
65-69,60.0,63.5,5023,Incidence,8135710,All Races,61.7,Male,Liver and Intrahepatic Bile Duct,2020
65-69,217.2,223.6,17930,Incidence,8135710,All Races,220.4,Male,Lung and Bronchus,2020
65-69,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
65-69,79.5,83.5,6630,Incidence,8135710,All Races,81.5,Male,Melanomas of the Skin,2020
65-69,2.0,2.7,193,Incidence,8135710,All Races,2.4,Male,Mesothelioma,2020
65-69,27.7,30.0,2347,Incidence,8135710,All Races,28.8,Male,Myeloma,2020
65-69,63.1,66.6,5272,Incidence,8135710,All Races,64.8,Male,Non-Hodgkin Lymphoma,2020
65-69,66.7,70.3,5573,Incidence,8135710,All Races,68.5,Male,Oral Cavity and Pharynx,2020
65-69,55.8,59.1,4676,Incidence,8135710,All Races,57.5,Male,Pancreas,2020
65-69,581.2,591.8,47713,Incidence,8135710,All Races,586.5,Male,Prostate,2020
65-69,24.9,27.1,2114,Incidence,8135710,All Races,26.0,Male,Stomach,2020
65-69,1.4,1.9,133,Incidence,8135710,All Races,1.6,Male,Testis,2020
65-69,14.4,16.1,1242,Incidence,8135710,All Races,15.3,Male,Thyroid,2020
65-69,96.8,101.1,8047,Incidence,8135710,All Races,98.9,Male,Urinary Bladder,2020
70-74,2052.3,2074.2,135924,Incidence,6587863,All Races,2063.2,Male,All Cancer Sites Combined,2020
70-74,21.3,23.6,1476,Incidence,6587863,All Races,22.4,Male,Brain and Other Nervous System,2020
70-74,128.3,133.9,8634,Incidence,6587863,All Races,131.1,Male,Colon and Rectum,2020
70-74,36.6,39.6,2508,Incidence,6587863,All Races,38.1,Male,Esophagus,2020
70-74,3.4,4.4,255,Incidence,6587863,All Races,3.9,Male,Hodgkin Lymphoma,2020
70-74,0.4,0.8,40,Incidence,6587863,All Races,0.6,Male,Kaposi Sarcoma,2020
70-74,90.2,94.8,6091,Incidence,6587863,All Races,92.5,Male,Kidney and Renal Pelvis,2020
70-74,19.8,22.0,1376,Incidence,6587863,All Races,20.9,Male,Larynx,2020
70-74,61.5,65.4,4178,Incidence,6587863,All Races,63.4,Male,Leukemias,2020
70-74,54.1,57.7,3679,Incidence,6587863,All Races,55.8,Male,Liver and Intrahepatic Bile Duct,2020
70-74,289.4,297.7,19336,Incidence,6587863,All Races,293.5,Male,Lung and Bronchus,2020
70-74,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
70-74,107.3,112.4,7233,Incidence,6587863,All Races,109.8,Male,Melanomas of the Skin,2020
70-74,4.7,5.8,342,Incidence,6587863,All Races,5.2,Male,Mesothelioma,2020
70-74,36.1,39.0,2473,Incidence,6587863,All Races,37.5,Male,Myeloma,2020
70-74,84.5,89.1,5717,Incidence,6587863,All Races,86.8,Male,Non-Hodgkin Lymphoma,2020
70-74,68.3,72.4,4634,Incidence,6587863,All Races,70.3,Male,Oral Cavity and Pharynx,2020
70-74,73.0,77.2,4946,Incidence,6587863,All Races,75.1,Male,Pancreas,2020
70-74,592.3,604.1,39406,Incidence,6587863,All Races,598.2,Male,Prostate,2020
70-74,31.4,34.2,2162,Incidence,6587863,All Races,32.8,Male,Stomach,2020
70-74,0.9,1.4,73,Incidence,6587863,All Races,1.1,Male,Testis,2020
70-74,15.7,17.7,1097,Incidence,6587863,All Races,16.7,Male,Thyroid,2020
70-74,147.0,152.9,9879,Incidence,6587863,All Races,150.0,Male,Urinary Bladder,2020
75-79,2370.0,2399.1,103483,Incidence,4339773,All Races,2384.5,Male,All Cancer Sites Combined,2020
75-79,22.8,25.8,1052,Incidence,4339773,All Races,24.2,Male,Brain and Other Nervous System,2020
75-79,155.8,163.4,6925,Incidence,4339773,All Races,159.6,Male,Colon and Rectum,2020
75-79,39.9,43.8,1815,Incidence,4339773,All Races,41.8,Male,Esophagus,2020
75-79,4.2,5.6,212,Incidence,4339773,All Races,4.9,Male,Hodgkin Lymphoma,2020
75-79,0.7,1.3,41,Incidence,4339773,All Races,0.9,Male,Kaposi Sarcoma,2020
75-79,93.9,99.8,4202,Incidence,4339773,All Races,96.8,Male,Kidney and Renal Pelvis,2020
75-79,20.2,22.9,934,Incidence,4339773,All Races,21.5,Male,Larynx,2020
75-79,82.7,88.3,3709,Incidence,4339773,All Races,85.5,Male,Leukemias,2020
75-79,51.5,55.9,2329,Incidence,4339773,All Races,53.7,Male,Liver and Intrahepatic Bile Duct,2020
75-79,377.4,389.1,16630,Incidence,4339773,All Races,383.2,Male,Lung and Bronchus,2020
75-79,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
75-79,137.5,144.6,6121,Incidence,4339773,All Races,141.0,Male,Melanomas of the Skin,2020
75-79,8.6,10.4,410,Incidence,4339773,All Races,9.4,Male,Mesothelioma,2020
75-79,45.0,49.1,2042,Incidence,4339773,All Races,47.1,Male,Myeloma,2020
75-79,113.3,119.8,5056,Incidence,4339773,All Races,116.5,Male,Non-Hodgkin Lymphoma,2020
75-79,64.3,69.2,2897,Incidence,4339773,All Races,66.8,Male,Oral Cavity and Pharynx,2020
75-79,87.6,93.3,3925,Incidence,4339773,All Races,90.4,Male,Pancreas,2020
75-79,540.0,554.0,23737,Incidence,4339773,All Races,547.0,Male,Prostate,2020
75-79,42.6,46.6,1936,Incidence,4339773,All Races,44.6,Male,Stomach,2020
75-79,0.7,1.3,40,Incidence,4339773,All Races,0.9,Male,Testis,2020
75-79,14.0,16.3,656,Incidence,4339773,All Races,15.1,Male,Thyroid,2020
75-79,213.7,222.5,9465,Incidence,4339773,All Races,218.1,Male,Urinary Bladder,2020
80-84,2475.6,2513.5,66579,Incidence,2669035,All Races,2494.5,Male,All Cancer Sites Combined,2020
80-84,23.4,27.2,674,Incidence,2669035,All Races,25.3,Male,Brain and Other Nervous System,2020
80-84,189.0,199.6,5185,Incidence,2669035,All Races,194.3,Male,Colon and Rectum,2020
80-84,40.5,45.5,1145,Incidence,2669035,All Races,42.9,Male,Esophagus,2020
80-84,5.0,6.9,157,Incidence,2669035,All Races,5.9,Male,Hodgkin Lymphoma,2020
80-84,0.9,1.7,33,Incidence,2669035,All Races,1.2,Male,Kaposi Sarcoma,2020
80-84,81.7,88.8,2274,Incidence,2669035,All Races,85.2,Male,Kidney and Renal Pelvis,2020
80-84,20.5,24.1,593,Incidence,2669035,All Races,22.2,Male,Larynx,2020
80-84,100.9,108.7,2796,Incidence,2669035,All Races,104.8,Male,Leukemias,2020
80-84,55.0,60.8,1545,Incidence,2669035,All Races,57.9,Male,Liver and Intrahepatic Bile Duct,2020
80-84,388.2,403.4,10563,Incidence,2669035,All Races,395.8,Male,Lung and Bronchus,2020
80-84,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
80-84,155.2,164.9,4270,Incidence,2669035,All Races,160.0,Male,Melanomas of the Skin,2020
80-84,11.2,13.9,333,Incidence,2669035,All Races,12.5,Male,Mesothelioma,2020
80-84,51.6,57.2,1450,Incidence,2669035,All Races,54.3,Male,Myeloma,2020
80-84,128.6,137.4,3549,Incidence,2669035,All Races,133.0,Male,Non-Hodgkin Lymphoma,2020
80-84,60.9,67.0,1706,Incidence,2669035,All Races,63.9,Male,Oral Cavity and Pharynx,2020
80-84,98.8,106.5,2738,Incidence,2669035,All Races,102.6,Male,Pancreas,2020
80-84,413.7,429.3,11249,Incidence,2669035,All Races,421.5,Male,Prostate,2020
80-84,46.0,51.4,1298,Incidence,2669035,All Races,48.6,Male,Stomach,2020
80-84,0.5,1.2,20,Incidence,2669035,All Races,0.7,Male,Testis,2020
80-84,11.1,13.9,332,Incidence,2669035,All Races,12.4,Male,Thyroid,2020
80-84,264.4,276.9,7223,Incidence,2669035,All Races,270.6,Male,Urinary Bladder,2020
85+,2346.9,2386.3,55613,Incidence,2349949,All Races,2366.6,Male,All Cancer Sites Combined,2020
85+,19.5,23.3,502,Incidence,2349949,All Races,21.4,Male,Brain and Other Nervous System,2020
85+,214.0,226.0,5168,Incidence,2349949,All Races,219.9,Male,Colon and Rectum,2020
85+,36.6,41.7,918,Incidence,2349949,All Races,39.1,Male,Esophagus,2020
85+,3.0,4.6,87,Incidence,2349949,All Races,3.7,Male,Hodgkin Lymphoma,2020
85+,0.9,1.9,32,Incidence,2349949,All Races,1.4,Male,Kaposi Sarcoma,2020
85+,70.0,77.0,1725,Incidence,2349949,All Races,73.4,Male,Kidney and Renal Pelvis,2020
85+,17.5,21.0,451,Incidence,2349949,All Races,19.2,Male,Larynx,2020
85+,99.0,107.3,2422,Incidence,2349949,All Races,103.1,Male,Leukemias,2020
85+,44.1,49.7,1100,Incidence,2349949,All Races,46.8,Male,Liver and Intrahepatic Bile Duct,2020
85+,319.5,334.1,7678,Incidence,2349949,All Races,326.7,Male,Lung and Bronchus,2020
85+,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
85+,166.2,176.8,4029,Incidence,2349949,All Races,171.5,Male,Melanomas of the Skin,2020
85+,12.1,15.1,319,Incidence,2349949,All Races,13.6,Male,Mesothelioma,2020
85+,44.2,49.8,1104,Incidence,2349949,All Races,47.0,Male,Myeloma,2020
85+,119.5,128.6,2914,Incidence,2349949,All Races,124.0,Male,Non-Hodgkin Lymphoma,2020
85+,48.3,54.1,1202,Incidence,2349949,All Races,51.2,Male,Oral Cavity and Pharynx,2020
85+,90.7,98.6,2222,Incidence,2349949,All Races,94.6,Male,Pancreas,2020
85+,321.9,336.6,7736,Incidence,2349949,All Races,329.2,Male,Prostate,2020
85+,44.6,50.2,1112,Incidence,2349949,All Races,47.3,Male,Stomach,2020
85+,~,~,~,Incidence,2349949,All Races,~,Male,Testis,2020
85+,7.4,9.8,201,Incidence,2349949,All Races,8.6,Male,Thyroid,2020
85+,291.7,305.8,7019,Incidence,2349949,All Races,298.7,Male,Urinary Bladder,2020
<1,23.4,28.1,475,Incidence,1848742,All Races,25.7,Male,All Cancer Sites Combined,2020
<1,2.7,4.5,65,Incidence,1848742,All Races,3.5,Male,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Colon and Rectum,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Esophagus,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Kaposi Sarcoma,2020
<1,0.9,2.1,26,Incidence,1848742,All Races,1.4,Male,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Larynx,2020
<1,2.9,4.7,68,Incidence,1848742,All Races,3.7,Male,Leukemias,2020
<1,1.1,2.3,30,Incidence,1848742,All Races,1.6,Male,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Lung and Bronchus,2020
<1,~,~,~,Incidence,0,All Races,~,Male,Male Breast,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Melanomas of the Skin,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Mesothelioma,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Myeloma,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Pancreas,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Prostate,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Stomach,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Testis,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Thyroid,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male,Urinary Bladder,2020
1-4,20.2,21.7,3157,Incidence,15082362,All Races,20.9,Male and Female,All Cancer Sites Combined,2020
1-4,3.2,3.8,528,Incidence,15082362,All Races,3.5,Male and Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,Cervix,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Esophagus,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,Female Breast,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Kaposi Sarcoma,2020
1-4,1.9,2.3,316,Incidence,15082362,All Races,2.1,Male and Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Larynx,2020
1-4,7.9,8.9,1265,Incidence,15082362,All Races,8.4,Male and Female,Leukemias,2020
1-4,0.6,0.9,106,Incidence,15082362,All Races,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,Male and Female Breast,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Mesothelioma,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Myeloma,2020
1-4,0.6,0.9,113,Incidence,15082362,All Races,0.7,Male and Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,7377169,All Races,~,Male and Female,Ovary,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Pancreas,2020
1-4,~,~,~,Incidence,7705193,All Races,~,Male and Female,Prostate,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Stomach,2020
1-4,0.2,0.5,27,Incidence,7705193,All Races,0.4,Male and Female,Testis,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Thyroid,2020
1-4,~,~,~,Incidence,15082362,All Races,~,Male and Female,Urinary Bladder,2020
10-14,13.7,14.7,2857,Incidence,20107666,All Races,14.2,Male and Female,All Cancer Sites Combined,2020
10-14,2.3,2.8,509,Incidence,20107666,All Races,2.5,Male and Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Male and Female,Cervix,2020
10-14,0.5,0.8,130,Incidence,20107666,All Races,0.6,Male and Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Male and Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Esophagus,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Male and Female,Female Breast,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2020
10-14,1.0,1.3,236,Incidence,20107666,All Races,1.2,Male and Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Kaposi Sarcoma,2020
10-14,0.1,0.2,36,Incidence,20107666,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Larynx,2020
10-14,3.0,3.5,660,Incidence,20107666,All Races,3.3,Male and Female,Leukemias,2020
10-14,0.1,0.2,22,Incidence,20107666,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Male and Female,Male and Female Breast,2020
10-14,~,~,~,Incidence,9842471,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
10-14,0.1,0.3,37,Incidence,20107666,All Races,0.2,Male and Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Mesothelioma,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Myeloma,2020
10-14,1.1,1.4,257,Incidence,20107666,All Races,1.3,Male and Female,Non-Hodgkin Lymphoma,2020
10-14,0.1,0.3,39,Incidence,20107666,All Races,0.2,Male and Female,Oral Cavity and Pharynx,2020
10-14,0.8,1.2,94,Incidence,9842471,All Races,1.0,Male and Female,Ovary,2020
10-14,0.0,0.1,17,Incidence,20107666,All Races,0.1,Male and Female,Pancreas,2020
10-14,~,~,~,Incidence,10265195,All Races,~,Male and Female,Prostate,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Stomach,2020
10-14,0.2,0.4,25,Incidence,10265195,All Races,0.2,Male and Female,Testis,2020
10-14,0.6,0.9,152,Incidence,20107666,All Races,0.8,Male and Female,Thyroid,2020
10-14,~,~,~,Incidence,20107666,All Races,~,Male and Female,Urinary Bladder,2020
15-19,22.1,23.5,4632,Incidence,20322846,All Races,22.8,Male and Female,All Cancer Sites Combined,2020
15-19,2.1,2.5,466,Incidence,20322846,All Races,2.3,Male and Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Male and Female,Cervix,2020
15-19,1.1,1.4,259,Incidence,20322846,All Races,1.3,Male and Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Male and Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,20322846,All Races,~,Male and Female,Esophagus,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Male and Female,Female Breast,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2020
15-19,2.8,3.3,619,Incidence,20322846,All Races,3.0,Male and Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,20322846,All Races,~,Male and Female,Kaposi Sarcoma,2020
15-19,0.2,0.3,44,Incidence,20322846,All Races,0.2,Male and Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,20322846,All Races,~,Male and Female,Larynx,2020
15-19,2.7,3.2,603,Incidence,20322846,All Races,3.0,Male and Female,Leukemias,2020
15-19,0.1,0.2,32,Incidence,20322846,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
15-19,0.1,0.2,28,Incidence,20322846,All Races,0.1,Male and Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Male and Female,Male and Female Breast,2020
15-19,~,~,~,Incidence,9955751,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
15-19,0.5,0.8,130,Incidence,20322846,All Races,0.6,Male and Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,20322846,All Races,~,Male and Female,Mesothelioma,2020
15-19,~,~,~,Incidence,20322846,All Races,~,Male and Female,Myeloma,2020
15-19,1.7,2.1,382,Incidence,20322846,All Races,1.9,Male and Female,Non-Hodgkin Lymphoma,2020
15-19,0.3,0.5,81,Incidence,20322846,All Races,0.4,Male and Female,Oral Cavity and Pharynx,2020
15-19,1.1,1.5,128,Incidence,9955751,All Races,1.3,Male and Female,Ovary,2020
15-19,0.1,0.2,35,Incidence,20322846,All Races,0.2,Male and Female,Pancreas,2020
15-19,~,~,~,Incidence,10367095,All Races,~,Male and Female,Prostate,2020
15-19,0.1,0.2,22,Incidence,20322846,All Races,0.1,Male and Female,Stomach,2020
15-19,3.1,3.9,361,Incidence,10367095,All Races,3.5,Male and Female,Testis,2020
15-19,2.6,3.1,578,Incidence,20322846,All Races,2.8,Male and Female,Thyroid,2020
15-19,0.1,0.1,19,Incidence,20322846,All Races,0.1,Male and Female,Urinary Bladder,2020
20-24,34.2,35.8,7334,Incidence,20935939,All Races,35.0,Male and Female,All Cancer Sites Combined,2020
20-24,1.8,2.2,418,Incidence,20935939,All Races,2.0,Male and Female,Brain and Other Nervous System,2020
20-24,0.3,0.5,38,Incidence,10239813,All Races,0.4,Male and Female,Cervix,2020
20-24,1.8,2.2,421,Incidence,20935939,All Races,2.0,Male and Female,Colon and Rectum,2020
20-24,0.4,0.7,53,Incidence,10239813,All Races,0.5,Male and Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,20935939,All Races,~,Male and Female,Esophagus,2020
20-24,1.5,2.0,174,Incidence,10239813,All Races,1.7,Male and Female,Female Breast,2020
20-24,0.1,0.3,19,Incidence,10239813,All Races,0.2,Male and Female,"Female Breast, <i>in situ</i>",2020
20-24,3.8,4.3,847,Incidence,20935939,All Races,4.0,Male and Female,Hodgkin Lymphoma,2020
20-24,0.1,0.2,22,Incidence,20935939,All Races,0.1,Male and Female,Kaposi Sarcoma,2020
20-24,0.4,0.7,114,Incidence,20935939,All Races,0.5,Male and Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,20935939,All Races,~,Male and Female,Larynx,2020
20-24,2.4,2.9,554,Incidence,20935939,All Races,2.6,Male and Female,Leukemias,2020
20-24,0.1,0.3,41,Incidence,20935939,All Races,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
20-24,0.2,0.4,64,Incidence,20935939,All Races,0.3,Male and Female,Lung and Bronchus,2020
20-24,1.5,2.0,174,Incidence,10239813,All Races,1.7,Male and Female,Male and Female Breast,2020
20-24,0.1,0.3,19,Incidence,10239813,All Races,0.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
20-24,2.0,2.4,453,Incidence,20935939,All Races,2.2,Male and Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,20935939,All Races,~,Male and Female,Mesothelioma,2020
20-24,~,~,~,Incidence,20935939,All Races,~,Male and Female,Myeloma,2020
20-24,2.3,2.7,528,Incidence,20935939,All Races,2.5,Male and Female,Non-Hodgkin Lymphoma,2020
20-24,0.4,0.7,114,Incidence,20935939,All Races,0.5,Male and Female,Oral Cavity and Pharynx,2020
20-24,1.8,2.4,212,Incidence,10239813,All Races,2.1,Male and Female,Ovary,2020
20-24,0.2,0.3,55,Incidence,20935939,All Races,0.3,Male and Female,Pancreas,2020
20-24,~,~,~,Incidence,10696126,All Races,~,Male and Female,Prostate,2020
20-24,0.2,0.3,50,Incidence,20935939,All Races,0.2,Male and Female,Stomach,2020
20-24,9.5,10.7,1075,Incidence,10696126,All Races,10.1,Male and Female,Testis,2020
20-24,5.4,6.0,1194,Incidence,20935939,All Races,5.7,Male and Female,Thyroid,2020
20-24,0.1,0.3,43,Incidence,20935939,All Races,0.2,Male and Female,Urinary Bladder,2020
25-29,53.0,55.0,12168,Incidence,22538631,All Races,54.0,Male and Female,All Cancer Sites Combined,2020
25-29,2.4,2.8,589,Incidence,22538631,All Races,2.6,Male and Female,Brain and Other Nervous System,2020
25-29,2.9,3.6,354,Incidence,11016549,All Races,3.2,Male and Female,Cervix,2020
25-29,3.0,3.5,731,Incidence,22538631,All Races,3.2,Male and Female,Colon and Rectum,2020
25-29,1.8,2.3,227,Incidence,11016549,All Races,2.1,Male and Female,"Corpus and Uterus, NOS",2020
25-29,0.0,0.1,16,Incidence,22538631,All Races,0.1,Male and Female,Esophagus,2020
25-29,9.8,11.0,1146,Incidence,11016549,All Races,10.4,Male and Female,Female Breast,2020
25-29,0.7,1.1,98,Incidence,11016549,All Races,0.9,Male and Female,"Female Breast, <i>in situ</i>",2020
25-29,3.4,3.9,812,Incidence,22538631,All Races,3.6,Male and Female,Hodgkin Lymphoma,2020
25-29,0.2,0.4,69,Incidence,22538631,All Races,0.3,Male and Female,Kaposi Sarcoma,2020
25-29,1.0,1.3,265,Incidence,22538631,All Races,1.2,Male and Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,22538631,All Races,~,Male and Female,Larynx,2020
25-29,2.5,2.9,600,Incidence,22538631,All Races,2.7,Male and Female,Leukemias,2020
25-29,0.3,0.4,75,Incidence,22538631,All Races,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.5,0.7,123,Incidence,22538631,All Races,0.5,Male and Female,Lung and Bronchus,2020
25-29,9.8,11.0,1146,Incidence,11016549,All Races,10.4,Male and Female,Male and Female Breast,2020
25-29,0.7,1.1,98,Incidence,11016549,All Races,0.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
25-29,3.7,4.2,892,Incidence,22538631,All Races,4.0,Male and Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,22538631,All Races,~,Male and Female,Mesothelioma,2020
25-29,0.1,0.1,20,Incidence,22538631,All Races,0.1,Male and Female,Myeloma,2020
25-29,2.8,3.3,690,Incidence,22538631,All Races,3.1,Male and Female,Non-Hodgkin Lymphoma,2020
25-29,0.9,1.1,222,Incidence,22538631,All Races,1.0,Male and Female,Oral Cavity and Pharynx,2020
25-29,1.8,2.3,222,Incidence,11016549,All Races,2.0,Male and Female,Ovary,2020
25-29,0.4,0.5,98,Incidence,22538631,All Races,0.4,Male and Female,Pancreas,2020
25-29,~,~,~,Incidence,11522082,All Races,~,Male and Female,Prostate,2020
25-29,0.4,0.5,100,Incidence,22538631,All Races,0.4,Male and Female,Stomach,2020
25-29,12.9,14.3,1563,Incidence,11522082,All Races,13.6,Male and Female,Testis,2020
25-29,8.7,9.5,2051,Incidence,22538631,All Races,9.1,Male and Female,Thyroid,2020
25-29,0.3,0.5,91,Incidence,22538631,All Races,0.4,Male and Female,Urinary Bladder,2020
30-34,89.4,91.9,20106,Incidence,22171581,All Races,90.7,Male and Female,All Cancer Sites Combined,2020
30-34,2.9,3.3,689,Incidence,22171581,All Races,3.1,Male and Female,Brain and Other Nervous System,2020
30-34,9.8,11.0,1137,Incidence,10939868,All Races,10.4,Male and Female,Cervix,2020
30-34,6.2,6.9,1452,Incidence,22171581,All Races,6.5,Male and Female,Colon and Rectum,2020
30-34,5.1,6.0,609,Incidence,10939868,All Races,5.6,Male and Female,"Corpus and Uterus, NOS",2020
30-34,0.1,0.2,29,Incidence,22171581,All Races,0.1,Male and Female,Esophagus,2020
30-34,29.4,31.5,3332,Incidence,10939868,All Races,30.5,Male and Female,Female Breast,2020
30-34,2.8,3.5,346,Incidence,10939868,All Races,3.2,Male and Female,"Female Breast, <i>in situ</i>",2020
30-34,3.0,3.5,725,Incidence,22171581,All Races,3.3,Male and Female,Hodgkin Lymphoma,2020
30-34,0.4,0.6,108,Incidence,22171581,All Races,0.5,Male and Female,Kaposi Sarcoma,2020
30-34,2.8,3.3,668,Incidence,22171581,All Races,3.0,Male and Female,Kidney and Renal Pelvis,2020
30-34,0.1,0.1,19,Incidence,22171581,All Races,0.1,Male and Female,Larynx,2020
30-34,3.1,3.5,732,Incidence,22171581,All Races,3.3,Male and Female,Leukemias,2020
30-34,0.5,0.7,123,Incidence,22171581,All Races,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.9,1.1,222,Incidence,22171581,All Races,1.0,Male and Female,Lung and Bronchus,2020
30-34,29.4,31.5,3332,Incidence,10939868,All Races,30.5,Male and Female,Male and Female Breast,2020
30-34,2.8,3.5,346,Incidence,10939868,All Races,3.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
30-34,7.2,7.9,1675,Incidence,22171581,All Races,7.6,Male and Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,22171581,All Races,~,Male and Female,Mesothelioma,2020
30-34,0.3,0.5,85,Incidence,22171581,All Races,0.4,Male and Female,Myeloma,2020
30-34,3.7,4.3,887,Incidence,22171581,All Races,4.0,Male and Female,Non-Hodgkin Lymphoma,2020
30-34,1.6,2.0,399,Incidence,22171581,All Races,1.8,Male and Female,Oral Cavity and Pharynx,2020
30-34,3.0,3.7,362,Incidence,10939868,All Races,3.3,Male and Female,Ovary,2020
30-34,0.6,0.8,150,Incidence,22171581,All Races,0.7,Male and Female,Pancreas,2020
30-34,~,~,~,Incidence,11231713,All Races,~,Male and Female,Prostate,2020
30-34,0.8,1.0,195,Incidence,22171581,All Races,0.9,Male and Female,Stomach,2020
30-34,13.7,15.1,1620,Incidence,11231713,All Races,14.4,Male and Female,Testis,2020
30-34,13.2,14.2,3035,Incidence,22171581,All Races,13.7,Male and Female,Thyroid,2020
30-34,0.5,0.7,126,Incidence,22171581,All Races,0.6,Male and Female,Urinary Bladder,2020
35-39,136.4,139.5,29221,Incidence,21182527,All Races,137.9,Male and Female,All Cancer Sites Combined,2020
35-39,3.6,4.1,808,Incidence,21182527,All Races,3.8,Male and Female,Brain and Other Nervous System,2020
35-39,12.3,13.7,1369,Incidence,10569058,All Races,13.0,Male and Female,Cervix,2020
35-39,11.2,12.1,2471,Incidence,21182527,All Races,11.7,Male and Female,Colon and Rectum,2020
35-39,9.6,10.8,1075,Incidence,10569058,All Races,10.2,Male and Female,"Corpus and Uterus, NOS",2020
35-39,0.4,0.6,97,Incidence,21182527,All Races,0.5,Male and Female,Esophagus,2020
35-39,62.0,65.1,6716,Incidence,10569058,All Races,63.5,Male and Female,Female Breast,2020
35-39,7.6,8.7,859,Incidence,10569058,All Races,8.1,Male and Female,"Female Breast, <i>in situ</i>",2020
35-39,2.6,3.0,591,Incidence,21182527,All Races,2.8,Male and Female,Hodgkin Lymphoma,2020
35-39,0.4,0.5,92,Incidence,21182527,All Races,0.4,Male and Female,Kaposi Sarcoma,2020
35-39,6.0,6.6,1331,Incidence,21182527,All Races,6.3,Male and Female,Kidney and Renal Pelvis,2020
35-39,0.2,0.4,64,Incidence,21182527,All Races,0.3,Male and Female,Larynx,2020
35-39,4.4,5.0,986,Incidence,21182527,All Races,4.7,Male and Female,Leukemias,2020
35-39,0.8,1.1,195,Incidence,21182527,All Races,0.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
35-39,2.3,2.7,521,Incidence,21182527,All Races,2.5,Male and Female,Lung and Bronchus,2020
35-39,62.0,65.1,6716,Incidence,10569058,All Races,63.5,Male and Female,Male and Female Breast,2020
35-39,7.6,8.7,859,Incidence,10569058,All Races,8.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
35-39,10.6,11.5,2345,Incidence,21182527,All Races,11.1,Male and Female,Melanomas of the Skin,2020
35-39,0.1,0.2,23,Incidence,21182527,All Races,0.1,Male and Female,Mesothelioma,2020
35-39,0.7,1.0,183,Incidence,21182527,All Races,0.9,Male and Female,Myeloma,2020
35-39,5.8,6.5,1298,Incidence,21182527,All Races,6.1,Male and Female,Non-Hodgkin Lymphoma,2020
35-39,2.5,3.0,581,Incidence,21182527,All Races,2.7,Male and Female,Oral Cavity and Pharynx,2020
35-39,4.5,5.3,516,Incidence,10569058,All Races,4.9,Male and Female,Ovary,2020
35-39,1.2,1.5,276,Incidence,21182527,All Races,1.3,Male and Female,Pancreas,2020
35-39,0.2,0.5,36,Incidence,10613469,All Races,0.3,Male and Female,Prostate,2020
35-39,1.6,2.0,387,Incidence,21182527,All Races,1.8,Male and Female,Stomach,2020
35-39,11.2,12.5,1254,Incidence,10613469,All Races,11.8,Male and Female,Testis,2020
35-39,15.5,16.6,3406,Incidence,21182527,All Races,16.1,Male and Female,Thyroid,2020
35-39,1.0,1.3,245,Incidence,21182527,All Races,1.2,Male and Female,Urinary Bladder,2020
40-44,213.3,217.4,42423,Incidence,19697310,All Races,215.4,Male and Female,All Cancer Sites Combined,2020
40-44,4.0,4.6,838,Incidence,19697310,All Races,4.3,Male and Female,Brain and Other Nervous System,2020
40-44,13.5,15.0,1410,Incidence,9894900,All Races,14.2,Male and Female,Cervix,2020
40-44,19.4,20.7,3949,Incidence,19697310,All Races,20.0,Male and Female,Colon and Rectum,2020
40-44,15.0,16.6,1562,Incidence,9894900,All Races,15.8,Male and Female,"Corpus and Uterus, NOS",2020
40-44,0.9,1.2,213,Incidence,19697310,All Races,1.1,Male and Female,Esophagus,2020
40-44,122.9,127.3,12377,Incidence,9894900,All Races,125.1,Male and Female,Female Breast,2020
40-44,33.5,35.9,3433,Incidence,9894900,All Races,34.7,Male and Female,"Female Breast, <i>in situ</i>",2020
40-44,2.2,2.6,467,Incidence,19697310,All Races,2.4,Male and Female,Hodgkin Lymphoma,2020
40-44,0.3,0.5,80,Incidence,19697310,All Races,0.4,Male and Female,Kaposi Sarcoma,2020
40-44,10.3,11.3,2126,Incidence,19697310,All Races,10.8,Male and Female,Kidney and Renal Pelvis,2020
40-44,0.5,0.7,122,Incidence,19697310,All Races,0.6,Male and Female,Larynx,2020
40-44,5.4,6.1,1138,Incidence,19697310,All Races,5.8,Male and Female,Leukemias,2020
40-44,1.6,2.0,351,Incidence,19697310,All Races,1.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
40-44,5.2,5.9,1089,Incidence,19697310,All Races,5.5,Male and Female,Lung and Bronchus,2020
40-44,122.9,127.3,12377,Incidence,9894900,All Races,125.1,Male and Female,Male and Female Breast,2020
40-44,33.5,35.9,3433,Incidence,9894900,All Races,34.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
40-44,14.5,15.6,2962,Incidence,19697310,All Races,15.0,Male and Female,Melanomas of the Skin,2020
40-44,0.1,0.2,25,Incidence,19697310,All Races,0.1,Male and Female,Mesothelioma,2020
40-44,2.0,2.4,433,Incidence,19697310,All Races,2.2,Male and Female,Myeloma,2020
40-44,7.8,8.6,1621,Incidence,19697310,All Races,8.2,Male and Female,Non-Hodgkin Lymphoma,2020
40-44,4.9,5.5,1018,Incidence,19697310,All Races,5.2,Male and Female,Oral Cavity and Pharynx,2020
40-44,7.0,8.1,742,Incidence,9894900,All Races,7.5,Male and Female,Ovary,2020
40-44,3.0,3.5,633,Incidence,19697310,All Races,3.2,Male and Female,Pancreas,2020
40-44,4.6,5.5,494,Incidence,9802410,All Races,5.0,Male and Female,Prostate,2020
40-44,2.7,3.2,575,Incidence,19697310,All Races,2.9,Male and Female,Stomach,2020
40-44,8.2,9.4,860,Incidence,9802410,All Races,8.8,Male and Female,Testis,2020
40-44,17.6,18.8,3590,Incidence,19697310,All Races,18.2,Male and Female,Thyroid,2020
40-44,2.4,2.9,516,Incidence,19697310,All Races,2.6,Male and Female,Urinary Bladder,2020
45-49,330.0,335.1,64397,Incidence,19366495,All Races,332.5,Male and Female,All Cancer Sites Combined,2020
45-49,4.7,5.4,973,Incidence,19366495,All Races,5.0,Male and Female,Brain and Other Nervous System,2020
45-49,12.2,13.6,1259,Incidence,9795351,All Races,12.9,Male and Female,Cervix,2020
45-49,34.6,36.3,6861,Incidence,19366495,All Races,35.4,Male and Female,Colon and Rectum,2020
45-49,24.2,26.2,2467,Incidence,9795351,All Races,25.2,Male and Female,"Corpus and Uterus, NOS",2020
45-49,2.1,2.6,456,Incidence,19366495,All Races,2.4,Male and Female,Esophagus,2020
45-49,187.6,193.0,18638,Incidence,9795351,All Races,190.3,Male and Female,Female Breast,2020
45-49,51.4,54.2,5170,Incidence,9795351,All Races,52.8,Male and Female,"Female Breast, <i>in situ</i>",2020
45-49,1.9,2.3,402,Incidence,19366495,All Races,2.1,Male and Female,Hodgkin Lymphoma,2020
45-49,0.3,0.5,70,Incidence,19366495,All Races,0.4,Male and Female,Kaposi Sarcoma,2020
45-49,16.9,18.0,3377,Incidence,19366495,All Races,17.4,Male and Female,Kidney and Renal Pelvis,2020
45-49,1.5,1.9,335,Incidence,19366495,All Races,1.7,Male and Female,Larynx,2020
45-49,7.7,8.5,1563,Incidence,19366495,All Races,8.1,Male and Female,Leukemias,2020
45-49,2.9,3.4,610,Incidence,19366495,All Races,3.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
45-49,13.7,14.8,2755,Incidence,19366495,All Races,14.2,Male and Female,Lung and Bronchus,2020
45-49,187.6,193.0,18638,Incidence,9795351,All Races,190.3,Male and Female,Male and Female Breast,2020
45-49,51.4,54.2,5170,Incidence,9795351,All Races,52.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
45-49,19.2,20.4,3834,Incidence,19366495,All Races,19.8,Male and Female,Melanomas of the Skin,2020
45-49,0.2,0.3,49,Incidence,19366495,All Races,0.3,Male and Female,Mesothelioma,2020
45-49,4.2,4.8,867,Incidence,19366495,All Races,4.5,Male and Female,Myeloma,2020
45-49,11.5,12.5,2329,Incidence,19366495,All Races,12.0,Male and Female,Non-Hodgkin Lymphoma,2020
45-49,10.5,11.4,2120,Incidence,19366495,All Races,10.9,Male and Female,Oral Cavity and Pharynx,2020
45-49,10.5,11.8,1090,Incidence,9795351,All Races,11.1,Male and Female,Ovary,2020
45-49,6.0,6.7,1227,Incidence,19366495,All Races,6.3,Male and Female,Pancreas,2020
45-49,23.9,25.9,2384,Incidence,9571144,All Races,24.9,Male and Female,Prostate,2020
45-49,4.4,5.0,914,Incidence,19366495,All Races,4.7,Male and Female,Stomach,2020
45-49,5.6,6.6,583,Incidence,9571144,All Races,6.1,Male and Female,Testis,2020
45-49,17.7,19.0,3553,Incidence,19366495,All Races,18.3,Male and Female,Thyroid,2020
45-49,4.9,5.6,1011,Incidence,19366495,All Races,5.2,Male and Female,Urinary Bladder,2020
5-9,11.6,12.6,2379,Incidence,19608494,All Races,12.1,Male and Female,All Cancer Sites Combined,2020
5-9,2.8,3.3,594,Incidence,19608494,All Races,3.0,Male and Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Male and Female,Cervix,2020
5-9,0.1,0.1,18,Incidence,19608494,All Races,0.1,Male and Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Male and Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Esophagus,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Male and Female,Female Breast,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2020
5-9,0.3,0.4,65,Incidence,19608494,All Races,0.3,Male and Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Kaposi Sarcoma,2020
5-9,0.5,0.8,128,Incidence,19608494,All Races,0.7,Male and Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Larynx,2020
5-9,4.0,4.5,832,Incidence,19608494,All Races,4.2,Male and Female,Leukemias,2020
5-9,0.1,0.2,25,Incidence,19608494,All Races,0.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Male and Female,Male and Female Breast,2020
5-9,~,~,~,Incidence,9584236,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Mesothelioma,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Myeloma,2020
5-9,0.9,1.1,195,Incidence,19608494,All Races,1.0,Male and Female,Non-Hodgkin Lymphoma,2020
5-9,0.1,0.2,21,Incidence,19608494,All Races,0.1,Male and Female,Oral Cavity and Pharynx,2020
5-9,0.1,0.3,16,Incidence,9584236,All Races,0.2,Male and Female,Ovary,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Pancreas,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male and Female,Prostate,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Stomach,2020
5-9,~,~,~,Incidence,10024258,All Races,~,Male and Female,Testis,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Thyroid,2020
5-9,~,~,~,Incidence,19608494,All Races,~,Male and Female,Urinary Bladder,2020
50-54,504.0,510.3,100361,Incidence,19790077,All Races,507.1,Male and Female,All Cancer Sites Combined,2020
50-54,6.8,7.6,1419,Incidence,19790077,All Races,7.2,Male and Female,Brain and Other Nervous System,2020
50-54,10.8,12.2,1154,Incidence,10041181,All Races,11.5,Male and Female,Cervix,2020
50-54,56.7,58.8,11429,Incidence,19790077,All Races,57.8,Male and Female,Colon and Rectum,2020
50-54,42.2,44.8,4366,Incidence,10041181,All Races,43.5,Male and Female,"Corpus and Uterus, NOS",2020
50-54,4.4,5.0,936,Incidence,19790077,All Races,4.7,Male and Female,Esophagus,2020
50-54,218.5,224.3,22230,Incidence,10041181,All Races,221.4,Male and Female,Female Breast,2020
50-54,57.9,60.9,5962,Incidence,10041181,All Races,59.4,Male and Female,"Female Breast, <i>in situ</i>",2020
50-54,1.9,2.3,409,Incidence,19790077,All Races,2.1,Male and Female,Hodgkin Lymphoma,2020
50-54,0.3,0.5,77,Incidence,19790077,All Races,0.4,Male and Female,Kaposi Sarcoma,2020
50-54,23.8,25.2,4851,Incidence,19790077,All Races,24.5,Male and Female,Kidney and Renal Pelvis,2020
50-54,3.5,4.1,748,Incidence,19790077,All Races,3.8,Male and Female,Larynx,2020
50-54,11.0,11.9,2269,Incidence,19790077,All Races,11.5,Male and Female,Leukemias,2020
50-54,6.9,7.7,1445,Incidence,19790077,All Races,7.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
50-54,32.4,34.0,6572,Incidence,19790077,All Races,33.2,Male and Female,Lung and Bronchus,2020
50-54,218.5,224.3,22230,Incidence,10041181,All Races,221.4,Male and Female,Male and Female Breast,2020
50-54,57.9,60.9,5962,Incidence,10041181,All Races,59.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
50-54,25.3,26.7,5151,Incidence,19790077,All Races,26.0,Male and Female,Melanomas of the Skin,2020
50-54,0.3,0.4,70,Incidence,19790077,All Races,0.4,Male and Female,Mesothelioma,2020
50-54,6.9,7.6,1437,Incidence,19790077,All Races,7.3,Male and Female,Myeloma,2020
50-54,17.7,18.9,3623,Incidence,19790077,All Races,18.3,Male and Female,Non-Hodgkin Lymphoma,2020
50-54,19.0,20.3,3890,Incidence,19790077,All Races,19.7,Male and Female,Oral Cavity and Pharynx,2020
50-54,15.0,16.5,1579,Incidence,10041181,All Races,15.7,Male and Female,Ovary,2020
50-54,11.3,12.3,2337,Incidence,19790077,All Races,11.8,Male and Female,Pancreas,2020
50-54,93.4,97.3,9296,Incidence,9748896,All Races,95.4,Male and Female,Prostate,2020
50-54,6.4,7.1,1341,Incidence,19790077,All Races,6.8,Male and Female,Stomach,2020
50-54,3.7,4.5,395,Incidence,9748896,All Races,4.1,Male and Female,Testis,2020
50-54,19.2,20.4,3913,Incidence,19790077,All Races,19.8,Male and Female,Thyroid,2020
50-54,10.6,11.5,2180,Incidence,19790077,All Races,11.0,Male and Female,Urinary Bladder,2020
55-59,753.0,760.5,158631,Incidence,20962367,All Races,756.7,Male and Female,All Cancer Sites Combined,2020
55-59,9.6,10.4,2093,Incidence,20962367,All Races,10.0,Male and Female,Brain and Other Nervous System,2020
55-59,10.3,11.6,1179,Incidence,10766098,All Races,11.0,Male and Female,Cervix,2020
55-59,58.9,61.0,12564,Incidence,20962367,All Races,59.9,Male and Female,Colon and Rectum,2020
55-59,70.4,73.6,7754,Incidence,10766098,All Races,72.0,Male and Female,"Corpus and Uterus, NOS",2020
55-59,8.5,9.3,1867,Incidence,20962367,All Races,8.9,Male and Female,Esophagus,2020
55-59,250.7,256.7,27310,Incidence,10766098,All Races,253.7,Male and Female,Female Breast,2020
55-59,59.8,62.8,6598,Incidence,10766098,All Races,61.3,Male and Female,"Female Breast, <i>in situ</i>",2020
55-59,2.1,2.6,493,Incidence,20962367,All Races,2.4,Male and Female,Hodgkin Lymphoma,2020
55-59,0.3,0.5,84,Incidence,20962367,All Races,0.4,Male and Female,Kaposi Sarcoma,2020
55-59,33.3,34.9,7147,Incidence,20962367,All Races,34.1,Male and Female,Kidney and Renal Pelvis,2020
55-59,7.0,7.7,1539,Incidence,20962367,All Races,7.3,Male and Female,Larynx,2020
55-59,16.4,17.5,3555,Incidence,20962367,All Races,17.0,Male and Female,Leukemias,2020
55-59,16.6,17.7,3586,Incidence,20962367,All Races,17.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
55-59,78.7,81.1,16747,Incidence,20962367,All Races,79.9,Male and Female,Lung and Bronchus,2020
55-59,250.7,256.7,27310,Incidence,10766098,All Races,253.7,Male and Female,Male and Female Breast,2020
55-59,59.8,62.8,6598,Incidence,10766098,All Races,61.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
55-59,34.4,36.0,7376,Incidence,20962367,All Races,35.2,Male and Female,Melanomas of the Skin,2020
55-59,0.5,0.8,134,Incidence,20962367,All Races,0.6,Male and Female,Mesothelioma,2020
55-59,11.0,11.9,2391,Incidence,20962367,All Races,11.4,Male and Female,Myeloma,2020
55-59,26.3,27.7,5665,Incidence,20962367,All Races,27.0,Male and Female,Non-Hodgkin Lymphoma,2020
55-59,29.4,30.8,6309,Incidence,20962367,All Races,30.1,Male and Female,Oral Cavity and Pharynx,2020
55-59,18.6,20.2,2087,Incidence,10766098,All Races,19.4,Male and Female,Ovary,2020
55-59,20.6,21.9,4456,Incidence,20962367,All Races,21.3,Male and Female,Pancreas,2020
55-59,216.1,221.8,22325,Incidence,10196269,All Races,219.0,Male and Female,Prostate,2020
55-59,9.5,10.4,2089,Incidence,20962367,All Races,10.0,Male and Female,Stomach,2020
55-59,2.7,3.4,313,Incidence,10196269,All Races,3.1,Male and Female,Testis,2020
55-59,18.4,19.6,3981,Incidence,20962367,All Races,19.0,Male and Female,Thyroid,2020
55-59,20.3,21.6,4388,Incidence,20962367,All Races,20.9,Male and Female,Urinary Bladder,2020
60-64,1081.5,1090.6,219184,Incidence,20180996,All Races,1086.1,Male and Female,All Cancer Sites Combined,2020
60-64,12.3,13.3,2582,Incidence,20180996,All Races,12.8,Male and Female,Brain and Other Nervous System,2020
60-64,9.9,11.1,1103,Incidence,10504315,All Races,10.5,Male and Female,Cervix,2020
60-64,75.5,77.9,15475,Incidence,20180996,All Races,76.7,Male and Female,Colon and Rectum,2020
60-64,90.5,94.2,9696,Incidence,10504315,All Races,92.3,Male and Female,"Corpus and Uterus, NOS",2020
60-64,12.8,13.8,2676,Incidence,20180996,All Races,13.3,Male and Female,Esophagus,2020
60-64,304.7,311.5,32363,Incidence,10504315,All Races,308.1,Male and Female,Female Breast,2020
60-64,69.6,72.9,7483,Incidence,10504315,All Races,71.2,Male and Female,"Female Breast, <i>in situ</i>",2020
60-64,2.2,2.6,487,Incidence,20180996,All Races,2.4,Male and Female,Hodgkin Lymphoma,2020
60-64,0.2,0.4,59,Incidence,20180996,All Races,0.3,Male and Female,Kaposi Sarcoma,2020
60-64,44.1,46.0,9095,Incidence,20180996,All Races,45.1,Male and Female,Kidney and Renal Pelvis,2020
60-64,10.1,11.0,2130,Incidence,20180996,All Races,10.6,Male and Female,Larynx,2020
60-64,23.9,25.3,4962,Incidence,20180996,All Races,24.6,Male and Female,Leukemias,2020
60-64,28.0,29.5,5805,Incidence,20180996,All Races,28.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
60-64,138.9,142.1,28355,Incidence,20180996,All Races,140.5,Male and Female,Lung and Bronchus,2020
60-64,304.7,311.5,32363,Incidence,10504315,All Races,308.1,Male and Female,Male and Female Breast,2020
60-64,69.6,72.9,7483,Incidence,10504315,All Races,71.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
60-64,45.4,47.2,9342,Incidence,20180996,All Races,46.3,Male and Female,Melanomas of the Skin,2020
60-64,0.9,1.2,207,Incidence,20180996,All Races,1.0,Male and Female,Mesothelioma,2020
60-64,16.1,17.2,3359,Incidence,20180996,All Races,16.6,Male and Female,Myeloma,2020
60-64,37.9,39.6,7825,Incidence,20180996,All Races,38.8,Male and Female,Non-Hodgkin Lymphoma,2020
60-64,37.6,39.3,7757,Incidence,20180996,All Races,38.4,Male and Female,Oral Cavity and Pharynx,2020
60-64,22.9,24.8,2502,Incidence,10504315,All Races,23.8,Male and Female,Ovary,2020
60-64,32.5,34.1,6711,Incidence,20180996,All Races,33.3,Male and Female,Pancreas,2020
60-64,375.2,383.0,36686,Incidence,9676681,All Races,379.1,Male and Female,Prostate,2020
60-64,14.0,15.0,2926,Incidence,20180996,All Races,14.5,Male and Female,Stomach,2020
60-64,1.9,2.5,214,Incidence,9676681,All Races,2.2,Male and Female,Testis,2020
60-64,18.5,19.7,3853,Incidence,20180996,All Races,19.1,Male and Female,Thyroid,2020
60-64,36.6,38.3,7549,Incidence,20180996,All Races,37.4,Male and Female,Urinary Bladder,2020
65-69,1464.9,1476.3,254958,Incidence,17336905,All Races,1470.6,Male and Female,All Cancer Sites Combined,2020
65-69,14.5,15.6,2609,Incidence,17336905,All Races,15.0,Male and Female,Brain and Other Nervous System,2020
65-69,8.7,9.9,854,Incidence,9201195,All Races,9.3,Male and Female,Cervix,2020
65-69,95.5,98.4,16806,Incidence,17336905,All Races,96.9,Male and Female,Colon and Rectum,2020
65-69,104.0,108.3,9765,Incidence,9201195,All Races,106.1,Male and Female,"Corpus and Uterus, NOS",2020
65-69,17.2,18.4,3084,Incidence,17336905,All Races,17.8,Male and Female,Esophagus,2020
65-69,378.4,386.4,35182,Incidence,9201195,All Races,382.4,Male and Female,Female Breast,2020
65-69,85.8,89.6,8070,Incidence,9201195,All Races,87.7,Male and Female,"Female Breast, <i>in situ</i>",2020
65-69,2.4,2.9,465,Incidence,17336905,All Races,2.7,Male and Female,Hodgkin Lymphoma,2020
65-69,0.3,0.4,58,Incidence,17336905,All Races,0.3,Male and Female,Kaposi Sarcoma,2020
65-69,56.3,58.5,9953,Incidence,17336905,All Races,57.4,Male and Female,Kidney and Renal Pelvis,2020
65-69,11.1,12.1,2014,Incidence,17336905,All Races,11.6,Male and Female,Larynx,2020
65-69,34.9,36.7,6200,Incidence,17336905,All Races,35.8,Male and Female,Leukemias,2020
65-69,38.9,40.8,6911,Incidence,17336905,All Races,39.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
65-69,196.3,200.5,34389,Incidence,17336905,All Races,198.4,Male and Female,Lung and Bronchus,2020
65-69,378.4,386.4,35182,Incidence,9201195,All Races,382.4,Male and Female,Male and Female Breast,2020
65-69,85.8,89.6,8070,Incidence,9201195,All Races,87.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
65-69,60.5,62.8,10688,Incidence,17336905,All Races,61.6,Male and Female,Melanomas of the Skin,2020
65-69,1.6,2.0,308,Incidence,17336905,All Races,1.8,Male and Female,Mesothelioma,2020
65-69,23.2,24.6,4145,Incidence,17336905,All Races,23.9,Male and Female,Myeloma,2020
65-69,53.4,55.6,9451,Incidence,17336905,All Races,54.5,Male and Female,Non-Hodgkin Lymphoma,2020
65-69,41.7,43.6,7394,Incidence,17336905,All Races,42.6,Male and Female,Oral Cavity and Pharynx,2020
65-69,25.5,27.6,2439,Incidence,9201195,All Races,26.5,Male and Female,Ovary,2020
65-69,47.9,49.9,8477,Incidence,17336905,All Races,48.9,Male and Female,Pancreas,2020
65-69,581.2,591.8,47713,Incidence,8135710,All Races,586.5,Male and Female,Prostate,2020
65-69,18.5,19.8,3319,Incidence,17336905,All Races,19.1,Male and Female,Stomach,2020
65-69,1.4,1.9,133,Incidence,8135710,All Races,1.6,Male and Female,Testis,2020
65-69,19.9,21.3,3567,Incidence,17336905,All Races,20.6,Male and Female,Thyroid,2020
65-69,58.8,61.1,10385,Incidence,17336905,All Races,59.9,Male and Female,Urinary Bladder,2020
70-74,1722.7,1736.3,246238,Incidence,14237499,All Races,1729.5,Male and Female,All Cancer Sites Combined,2020
70-74,18.1,19.6,2683,Incidence,14237499,All Races,18.8,Male and Female,Brain and Other Nervous System,2020
70-74,8.8,10.2,723,Incidence,7649636,All Races,9.5,Male and Female,Cervix,2020
70-74,111.1,114.6,16069,Incidence,14237499,All Races,112.9,Male and Female,Colon and Rectum,2020
70-74,101.8,106.4,7959,Incidence,7649636,All Races,104.0,Male and Female,"Corpus and Uterus, NOS",2020
70-74,21.1,22.6,3108,Incidence,14237499,All Races,21.8,Male and Female,Esophagus,2020
70-74,417.6,426.8,32298,Incidence,7649636,All Races,422.2,Male and Female,Female Breast,2020
70-74,89.7,94.0,7028,Incidence,7649636,All Races,91.9,Male and Female,"Female Breast, <i>in situ</i>",2020
70-74,2.8,3.4,436,Incidence,14237499,All Races,3.1,Male and Female,Hodgkin Lymphoma,2020
70-74,0.2,0.4,43,Incidence,14237499,All Races,0.3,Male and Female,Kaposi Sarcoma,2020
70-74,63.8,66.4,9265,Incidence,14237499,All Races,65.1,Male and Female,Kidney and Renal Pelvis,2020
70-74,11.3,12.4,1685,Incidence,14237499,All Races,11.8,Male and Female,Larynx,2020
70-74,46.7,48.9,6803,Incidence,14237499,All Races,47.8,Male and Female,Leukemias,2020
70-74,36.5,38.6,5345,Incidence,14237499,All Races,37.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
70-74,260.1,265.5,37416,Incidence,14237499,All Races,262.8,Male and Female,Lung and Bronchus,2020
70-74,417.6,426.8,32298,Incidence,7649636,All Races,422.2,Male and Female,Male and Female Breast,2020
70-74,89.7,94.0,7028,Incidence,7649636,All Races,91.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
70-74,74.9,77.8,10864,Incidence,14237499,All Races,76.3,Male and Female,Melanomas of the Skin,2020
70-74,2.9,3.5,459,Incidence,14237499,All Races,3.2,Male and Female,Mesothelioma,2020
70-74,30.4,32.3,4465,Incidence,14237499,All Races,31.4,Male and Female,Myeloma,2020
70-74,70.6,73.4,10252,Incidence,14237499,All Races,72.0,Male and Female,Non-Hodgkin Lymphoma,2020
70-74,43.8,46.1,6398,Incidence,14237499,All Races,44.9,Male and Female,Oral Cavity and Pharynx,2020
70-74,28.4,30.9,2265,Incidence,7649636,All Races,29.6,Male and Female,Ovary,2020
70-74,62.9,65.5,9142,Incidence,14237499,All Races,64.2,Male and Female,Pancreas,2020
70-74,592.3,604.1,39406,Incidence,6587863,All Races,598.2,Male and Female,Prostate,2020
70-74,22.5,24.1,3314,Incidence,14237499,All Races,23.3,Male and Female,Stomach,2020
70-74,0.9,1.4,73,Incidence,6587863,All Races,1.1,Male and Female,Testis,2020
70-74,19.6,21.1,2892,Incidence,14237499,All Races,20.3,Male and Female,Thyroid,2020
70-74,87.2,90.3,12635,Incidence,14237499,All Races,88.7,Male and Female,Urinary Bladder,2020
75-79,1957.4,1975.0,190559,Incidence,9691829,All Races,1966.2,Male and Female,All Cancer Sites Combined,2020
75-79,18.7,20.5,1895,Incidence,9691829,All Races,19.6,Male and Female,Brain and Other Nervous System,2020
75-79,7.3,8.8,429,Incidence,5352056,All Races,8.0,Male and Female,Cervix,2020
75-79,137.0,141.7,13502,Incidence,9691829,All Races,139.3,Male and Female,Colon and Rectum,2020
75-79,85.7,90.8,4723,Incidence,5352056,All Races,88.2,Male and Female,"Corpus and Uterus, NOS",2020
75-79,22.6,24.6,2286,Incidence,9691829,All Races,23.6,Male and Female,Esophagus,2020
75-79,416.5,427.5,22583,Incidence,5352056,All Races,421.9,Male and Female,Female Breast,2020
75-79,71.4,76.0,3945,Incidence,5352056,All Races,73.7,Male and Female,"Female Breast, <i>in situ</i>",2020
75-79,3.5,4.3,379,Incidence,9691829,All Races,3.9,Male and Female,Hodgkin Lymphoma,2020
75-79,0.4,0.7,48,Incidence,9691829,All Races,0.5,Male and Female,Kaposi Sarcoma,2020
75-79,66.2,69.5,6574,Incidence,9691829,All Races,67.8,Male and Female,Kidney and Renal Pelvis,2020
75-79,11.0,12.3,1127,Incidence,9691829,All Races,11.6,Male and Female,Larynx,2020
75-79,61.9,65.1,6156,Incidence,9691829,All Races,63.5,Male and Female,Leukemias,2020
75-79,36.1,38.5,3611,Incidence,9691829,All Races,37.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
75-79,331.1,338.4,32442,Incidence,9691829,All Races,334.7,Male and Female,Lung and Bronchus,2020
75-79,416.5,427.5,22583,Incidence,5352056,All Races,421.9,Male and Female,Male and Female Breast,2020
75-79,71.4,76.0,3945,Incidence,5352056,All Races,73.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
75-79,90.0,93.9,8909,Incidence,9691829,All Races,91.9,Male and Female,Melanomas of the Skin,2020
75-79,5.1,6.1,543,Incidence,9691829,All Races,5.6,Male and Female,Mesothelioma,2020
75-79,37.2,39.6,3721,Incidence,9691829,All Races,38.4,Male and Female,Myeloma,2020
75-79,91.4,95.2,9042,Incidence,9691829,All Races,93.3,Male and Female,Non-Hodgkin Lymphoma,2020
75-79,43.2,45.9,4319,Incidence,9691829,All Races,44.6,Male and Female,Oral Cavity and Pharynx,2020
75-79,31.8,34.9,1784,Incidence,5352056,All Races,33.3,Male and Female,Ovary,2020
75-79,77.3,80.9,7667,Incidence,9691829,All Races,79.1,Male and Female,Pancreas,2020
75-79,540.0,554.0,23737,Incidence,4339773,All Races,547.0,Male and Female,Prostate,2020
75-79,29.4,31.6,2952,Incidence,9691829,All Races,30.5,Male and Female,Stomach,2020
75-79,0.7,1.3,40,Incidence,4339773,All Races,0.9,Male and Female,Testis,2020
75-79,16.4,18.1,1673,Incidence,9691829,All Races,17.3,Male and Female,Thyroid,2020
75-79,123.0,127.5,12138,Incidence,9691829,All Races,125.2,Male and Female,Urinary Bladder,2020
80-84,2023.1,2045.5,127717,Incidence,6278216,All Races,2034.3,Male and Female,All Cancer Sites Combined,2020
80-84,19.5,21.7,1291,Incidence,6278216,All Races,20.6,Male and Female,Brain and Other Nervous System,2020
80-84,6.3,8.1,258,Incidence,3609181,All Races,7.1,Male and Female,Cervix,2020
80-84,174.6,181.2,11168,Incidence,6278216,All Races,177.9,Male and Female,Colon and Rectum,2020
80-84,69.7,75.3,2615,Incidence,3609181,All Races,72.5,Male and Female,"Corpus and Uterus, NOS",2020
80-84,23.1,25.5,1525,Incidence,6278216,All Races,24.3,Male and Female,Esophagus,2020
80-84,373.1,385.8,13693,Incidence,3609181,All Races,379.4,Male and Female,Female Breast,2020
80-84,48.1,52.8,1819,Incidence,3609181,All Races,50.4,Male and Female,"Female Breast, <i>in situ</i>",2020
80-84,3.7,4.7,264,Incidence,6278216,All Races,4.2,Male and Female,Hodgkin Lymphoma,2020
80-84,0.5,0.9,43,Incidence,6278216,All Races,0.7,Male and Female,Kaposi Sarcoma,2020
80-84,58.5,62.3,3791,Incidence,6278216,All Races,60.4,Male and Female,Kidney and Renal Pelvis,2020
80-84,10.5,12.2,713,Incidence,6278216,All Races,11.4,Male and Female,Larynx,2020
80-84,73.6,78.0,4758,Incidence,6278216,All Races,75.8,Male and Female,Leukemias,2020
80-84,38.7,41.9,2529,Incidence,6278216,All Races,40.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
80-84,328.1,337.2,20883,Incidence,6278216,All Races,332.6,Male and Female,Lung and Bronchus,2020
80-84,373.1,385.8,13693,Incidence,3609181,All Races,379.4,Male and Female,Male and Female Breast,2020
80-84,48.1,52.8,1819,Incidence,3609181,All Races,50.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
80-84,97.7,102.7,6289,Incidence,6278216,All Races,100.2,Male and Female,Melanomas of the Skin,2020
80-84,6.2,7.5,428,Incidence,6278216,All Races,6.8,Male and Female,Mesothelioma,2020
80-84,41.5,44.7,2704,Incidence,6278216,All Races,43.1,Male and Female,Myeloma,2020
80-84,102.4,107.5,6585,Incidence,6278216,All Races,104.9,Male and Female,Non-Hodgkin Lymphoma,2020
80-84,41.8,45.0,2723,Incidence,6278216,All Races,43.4,Male and Female,Oral Cavity and Pharynx,2020
80-84,33.3,37.1,1269,Incidence,3609181,All Races,35.2,Male and Female,Ovary,2020
80-84,90.3,95.0,5815,Incidence,6278216,All Races,92.6,Male and Female,Pancreas,2020
80-84,413.7,429.3,11249,Incidence,2669035,All Races,421.5,Male and Female,Prostate,2020
80-84,32.1,35.0,2105,Incidence,6278216,All Races,33.5,Male and Female,Stomach,2020
80-84,0.5,1.2,20,Incidence,2669035,All Races,0.7,Male and Female,Testis,2020
80-84,12.4,14.2,831,Incidence,6278216,All Races,13.2,Male and Female,Thyroid,2020
80-84,145.2,151.2,9301,Incidence,6278216,All Races,148.1,Male and Female,Urinary Bladder,2020
85+,1789.2,1809.9,116614,Incidence,6480315,All Races,1799.5,Male and Female,All Cancer Sites Combined,2020
85+,15.5,17.5,1069,Incidence,6480315,All Races,16.5,Male and Female,Brain and Other Nervous System,2020
85+,5.6,7.1,261,Incidence,4130366,All Races,6.3,Male and Female,Cervix,2020
85+,196.1,203.0,12933,Incidence,6480315,All Races,199.6,Male and Female,Colon and Rectum,2020
85+,43.1,47.3,1865,Incidence,4130366,All Races,45.2,Male and Female,"Corpus and Uterus, NOS",2020
85+,19.9,22.1,1360,Incidence,6480315,All Races,21.0,Male and Female,Esophagus,2020
85+,274.6,284.8,11552,Incidence,4130366,All Races,279.7,Male and Female,Female Breast,2020
85+,19.1,21.8,843,Incidence,4130366,All Races,20.4,Male and Female,"Female Breast, <i>in situ</i>",2020
85+,2.0,2.8,154,Incidence,6480315,All Races,2.4,Male and Female,Hodgkin Lymphoma,2020
85+,0.5,0.9,43,Incidence,6480315,All Races,0.7,Male and Female,Kaposi Sarcoma,2020
85+,46.1,49.5,3098,Incidence,6480315,All Races,47.8,Male and Female,Kidney and Renal Pelvis,2020
85+,7.7,9.1,543,Incidence,6480315,All Races,8.4,Male and Female,Larynx,2020
85+,71.7,75.9,4780,Incidence,6480315,All Races,73.8,Male and Female,Leukemias,2020
85+,30.2,32.9,2043,Incidence,6480315,All Races,31.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
85+,240.3,248.0,15821,Incidence,6480315,All Races,244.1,Male and Female,Lung and Bronchus,2020
85+,274.6,284.8,11552,Incidence,4130366,All Races,279.7,Male and Female,Male and Female Breast,2020
85+,19.1,21.8,843,Incidence,4130366,All Races,20.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
85+,94.2,99.0,6256,Incidence,6480315,All Races,96.5,Male and Female,Melanomas of the Skin,2020
85+,5.7,7.0,409,Incidence,6480315,All Races,6.3,Male and Female,Mesothelioma,2020
85+,31.5,34.3,2131,Incidence,6480315,All Races,32.9,Male and Female,Myeloma,2020
85+,89.1,93.8,5923,Incidence,6480315,All Races,91.4,Male and Female,Non-Hodgkin Lymphoma,2020
85+,34.3,37.2,2313,Incidence,6480315,All Races,35.7,Male and Female,Oral Cavity and Pharynx,2020
85+,27.5,30.8,1203,Incidence,4130366,All Races,29.1,Male and Female,Ovary,2020
85+,84.8,89.4,5641,Incidence,6480315,All Races,87.0,Male and Female,Pancreas,2020
85+,321.9,336.6,7736,Incidence,2349949,All Races,329.2,Male and Female,Prostate,2020
85+,31.5,34.3,2131,Incidence,6480315,All Races,32.9,Male and Female,Stomach,2020
85+,~,~,~,Incidence,2349949,All Races,~,Male and Female,Testis,2020
85+,8.1,9.5,570,Incidence,6480315,All Races,8.8,Male and Female,Thyroid,2020
85+,146.1,152.1,9659,Incidence,6480315,All Races,149.1,Male and Female,Urinary Bladder,2020
<1,23.5,26.8,908,Incidence,3618856,All Races,25.1,Male and Female,All Cancer Sites Combined,2020
<1,3.1,4.4,135,Incidence,3618856,All Races,3.7,Male and Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,Cervix,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Colon and Rectum,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Esophagus,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,Female Breast,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Kaposi Sarcoma,2020
<1,1.1,1.9,53,Incidence,3618856,All Races,1.5,Male and Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Larynx,2020
<1,3.2,4.5,138,Incidence,3618856,All Races,3.8,Male and Female,Leukemias,2020
<1,1.0,1.8,50,Incidence,3618856,All Races,1.4,Male and Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,Male and Female Breast,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Mesothelioma,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Myeloma,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,1770114,All Races,~,Male and Female,Ovary,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Pancreas,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male and Female,Prostate,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Stomach,2020
<1,~,~,~,Incidence,1848742,All Races,~,Male and Female,Testis,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Thyroid,2020
<1,~,~,~,Incidence,3618856,All Races,~,Male and Female,Urinary Bladder,2020
1-4,16.0,19.8,343,Incidence,1926812,Hispanic of any race,17.8,Female,All Cancer Sites Combined,2020
1-4,2.4,4.1,61,Incidence,1926812,Hispanic of any race,3.2,Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Cervix,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Esophagus,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Female Breast,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
1-4,1.4,2.6,37,Incidence,1926812,Hispanic of any race,1.9,Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Larynx,2020
1-4,6.5,9.0,148,Incidence,1926812,Hispanic of any race,7.7,Female,Leukemias,2020
1-4,0.6,1.5,18,Incidence,1926812,Hispanic of any race,0.9,Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Mesothelioma,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Myeloma,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Ovary,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Pancreas,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Stomach,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Thyroid,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Female,Urinary Bladder,2020
10-14,12.3,15.3,352,Incidence,2561755,Hispanic of any race,13.7,Female,All Cancer Sites Combined,2020
10-14,1.4,2.5,49,Incidence,2561755,Hispanic of any race,1.9,Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Cervix,2020
10-14,0.4,1.1,17,Incidence,2561755,Hispanic of any race,0.7,Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Esophagus,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Female Breast,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Larynx,2020
10-14,3.1,4.6,97,Incidence,2561755,Hispanic of any race,3.8,Female,Leukemias,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Mesothelioma,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Myeloma,2020
10-14,0.4,1.1,18,Incidence,2561755,Hispanic of any race,0.7,Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2020
10-14,0.9,1.9,34,Incidence,2561755,Hispanic of any race,1.3,Female,Ovary,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Pancreas,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Stomach,2020
10-14,1.1,2.1,39,Incidence,2561755,Hispanic of any race,1.5,Female,Thyroid,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Female,Urinary Bladder,2020
15-19,17.8,21.3,475,Incidence,2439012,Hispanic of any race,19.5,Female,All Cancer Sites Combined,2020
15-19,1.0,1.9,34,Incidence,2439012,Hispanic of any race,1.4,Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Cervix,2020
15-19,0.6,1.4,23,Incidence,2439012,Hispanic of any race,0.9,Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Esophagus,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Female Breast,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2020
15-19,2.1,3.4,66,Incidence,2439012,Hispanic of any race,2.7,Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Larynx,2020
15-19,2.0,3.3,63,Incidence,2439012,Hispanic of any race,2.6,Female,Leukemias,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Mesothelioma,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Myeloma,2020
15-19,0.8,1.7,28,Incidence,2439012,Hispanic of any race,1.1,Female,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2020
15-19,1.1,2.1,37,Incidence,2439012,Hispanic of any race,1.5,Female,Ovary,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Pancreas,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Stomach,2020
15-19,3.7,5.5,111,Incidence,2439012,Hispanic of any race,4.6,Female,Thyroid,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Female,Urinary Bladder,2020
20-24,27.8,32.2,699,Incidence,2334375,Hispanic of any race,29.9,Female,All Cancer Sites Combined,2020
20-24,1.1,2.2,37,Incidence,2334375,Hispanic of any race,1.6,Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Cervix,2020
20-24,1.4,2.5,44,Incidence,2334375,Hispanic of any race,1.9,Female,Colon and Rectum,2020
20-24,0.4,1.2,17,Incidence,2334375,Hispanic of any race,0.7,Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Esophagus,2020
20-24,1.2,2.3,40,Incidence,2334375,Hispanic of any race,1.7,Female,Female Breast,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2020
20-24,2.1,3.5,64,Incidence,2334375,Hispanic of any race,2.7,Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Larynx,2020
20-24,2.2,3.6,67,Incidence,2334375,Hispanic of any race,2.9,Female,Leukemias,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Lung and Bronchus,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Mesothelioma,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Myeloma,2020
20-24,1.5,2.7,47,Incidence,2334375,Hispanic of any race,2.0,Female,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2020
20-24,1.9,3.2,58,Incidence,2334375,Hispanic of any race,2.5,Female,Ovary,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Pancreas,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Stomach,2020
20-24,6.3,8.5,171,Incidence,2334375,Hispanic of any race,7.3,Female,Thyroid,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Female,Urinary Bladder,2020
25-29,53.9,60.0,1330,Incidence,2338367,Hispanic of any race,56.9,Female,All Cancer Sites Combined,2020
25-29,1.2,2.3,39,Incidence,2338367,Hispanic of any race,1.7,Female,Brain and Other Nervous System,2020
25-29,2.9,4.4,84,Incidence,2338367,Hispanic of any race,3.6,Female,Cervix,2020
25-29,2.0,3.4,61,Incidence,2338367,Hispanic of any race,2.6,Female,Colon and Rectum,2020
25-29,2.4,3.8,71,Incidence,2338367,Hispanic of any race,3.0,Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Esophagus,2020
25-29,8.7,11.3,233,Incidence,2338367,Hispanic of any race,10.0,Female,Female Breast,2020
25-29,0.4,1.1,16,Incidence,2338367,Hispanic of any race,0.7,Female,"Female Breast, <i>in situ</i>",2020
25-29,1.9,3.2,58,Incidence,2338367,Hispanic of any race,2.5,Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
25-29,1.0,2.0,34,Incidence,2338367,Hispanic of any race,1.5,Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Larynx,2020
25-29,2.4,3.8,71,Incidence,2338367,Hispanic of any race,3.0,Female,Leukemias,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Lung and Bronchus,2020
25-29,0.6,1.4,22,Incidence,2338367,Hispanic of any race,0.9,Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Mesothelioma,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Myeloma,2020
25-29,1.7,2.9,52,Incidence,2338367,Hispanic of any race,2.2,Female,Non-Hodgkin Lymphoma,2020
25-29,0.6,1.5,23,Incidence,2338367,Hispanic of any race,1.0,Female,Oral Cavity and Pharynx,2020
25-29,1.5,2.7,47,Incidence,2338367,Hispanic of any race,2.0,Female,Ovary,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Pancreas,2020
25-29,0.4,1.1,16,Incidence,2338367,Hispanic of any race,0.7,Female,Stomach,2020
25-29,14.0,17.2,363,Incidence,2338367,Hispanic of any race,15.5,Female,Thyroid,2020
25-29,~,~,~,Incidence,2338367,Hispanic of any race,~,Female,Urinary Bladder,2020
30-34,101.1,109.8,2280,Incidence,2163578,Hispanic of any race,105.4,Female,All Cancer Sites Combined,2020
30-34,1.4,2.6,42,Incidence,2163578,Hispanic of any race,1.9,Female,Brain and Other Nervous System,2020
30-34,10.9,13.9,266,Incidence,2163578,Hispanic of any race,12.3,Female,Cervix,2020
30-34,5.2,7.3,134,Incidence,2163578,Hispanic of any race,6.2,Female,Colon and Rectum,2020
30-34,6.5,8.8,164,Incidence,2163578,Hispanic of any race,7.6,Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Esophagus,2020
30-34,23.8,28.2,561,Incidence,2163578,Hispanic of any race,25.9,Female,Female Breast,2020
30-34,1.8,3.2,53,Incidence,2163578,Hispanic of any race,2.4,Female,"Female Breast, <i>in situ</i>",2020
30-34,1.5,2.8,45,Incidence,2163578,Hispanic of any race,2.1,Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
30-34,2.1,3.5,59,Incidence,2163578,Hispanic of any race,2.7,Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Larynx,2020
30-34,2.6,4.2,73,Incidence,2163578,Hispanic of any race,3.4,Female,Leukemias,2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.7,1.7,25,Incidence,2163578,Hispanic of any race,1.2,Female,Lung and Bronchus,2020
30-34,1.8,3.2,53,Incidence,2163578,Hispanic of any race,2.4,Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Mesothelioma,2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Myeloma,2020
30-34,1.4,2.6,42,Incidence,2163578,Hispanic of any race,1.9,Female,Non-Hodgkin Lymphoma,2020
30-34,0.9,1.9,29,Incidence,2163578,Hispanic of any race,1.3,Female,Oral Cavity and Pharynx,2020
30-34,2.1,3.6,60,Incidence,2163578,Hispanic of any race,2.8,Female,Ovary,2020
30-34,0.7,1.6,23,Incidence,2163578,Hispanic of any race,1.1,Female,Pancreas,2020
30-34,1.2,2.3,36,Incidence,2163578,Hispanic of any race,1.7,Female,Stomach,2020
30-34,20.6,24.6,487,Incidence,2163578,Hispanic of any race,22.5,Female,Thyroid,2020
30-34,~,~,~,Incidence,2163578,Hispanic of any race,~,Female,Urinary Bladder,2020
35-39,153.2,164.0,3354,Incidence,2115409,Hispanic of any race,158.6,Female,All Cancer Sites Combined,2020
35-39,1.8,3.2,51,Incidence,2115409,Hispanic of any race,2.4,Female,Brain and Other Nervous System,2020
35-39,13.8,17.2,327,Incidence,2115409,Hispanic of any race,15.5,Female,Cervix,2020
35-39,8.7,11.4,211,Incidence,2115409,Hispanic of any race,10.0,Female,Colon and Rectum,2020
35-39,10.8,13.9,260,Incidence,2115409,Hispanic of any race,12.3,Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Esophagus,2020
35-39,47.8,53.9,1075,Incidence,2115409,Hispanic of any race,50.8,Female,Female Breast,2020
35-39,4.7,6.7,119,Incidence,2115409,Hispanic of any race,5.6,Female,"Female Breast, <i>in situ</i>",2020
35-39,1.1,2.2,34,Incidence,2115409,Hispanic of any race,1.6,Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
35-39,4.1,6.1,107,Incidence,2115409,Hispanic of any race,5.1,Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Larynx,2020
35-39,3.8,5.7,100,Incidence,2115409,Hispanic of any race,4.7,Female,Leukemias,2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
35-39,1.3,2.5,39,Incidence,2115409,Hispanic of any race,1.8,Female,Lung and Bronchus,2020
35-39,2.5,4.1,68,Incidence,2115409,Hispanic of any race,3.2,Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Mesothelioma,2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Myeloma,2020
35-39,4.7,6.8,121,Incidence,2115409,Hispanic of any race,5.7,Female,Non-Hodgkin Lymphoma,2020
35-39,0.9,2.0,29,Incidence,2115409,Hispanic of any race,1.4,Female,Oral Cavity and Pharynx,2020
35-39,3.6,5.5,95,Incidence,2115409,Hispanic of any race,4.5,Female,Ovary,2020
35-39,0.6,1.5,20,Incidence,2115409,Hispanic of any race,0.9,Female,Pancreas,2020
35-39,2.3,3.9,64,Incidence,2115409,Hispanic of any race,3.0,Female,Stomach,2020
35-39,22.1,26.3,511,Incidence,2115409,Hispanic of any race,24.2,Female,Thyroid,2020
35-39,~,~,~,Incidence,2115409,Hispanic of any race,~,Female,Urinary Bladder,2020
40-44,234.1,247.7,4844,Incidence,2011626,Hispanic of any race,240.8,Female,All Cancer Sites Combined,2020
40-44,2.3,3.8,60,Incidence,2011626,Hispanic of any race,3.0,Female,Brain and Other Nervous System,2020
40-44,13.6,17.1,308,Incidence,2011626,Hispanic of any race,15.3,Female,Cervix,2020
40-44,14.2,17.7,320,Incidence,2011626,Hispanic of any race,15.9,Female,Colon and Rectum,2020
40-44,16.2,20.0,363,Incidence,2011626,Hispanic of any race,18.0,Female,"Corpus and Uterus, NOS",2020
40-44,~,~,~,Incidence,2011626,Hispanic of any race,~,Female,Esophagus,2020
40-44,88.9,97.4,1872,Incidence,2011626,Hispanic of any race,93.1,Female,Female Breast,2020
40-44,21.2,25.4,467,Incidence,2011626,Hispanic of any race,23.2,Female,"Female Breast, <i>in situ</i>",2020
40-44,0.6,1.6,21,Incidence,2011626,Hispanic of any race,1.0,Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,2011626,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
40-44,6.5,9.0,154,Incidence,2011626,Hispanic of any race,7.7,Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,2011626,Hispanic of any race,~,Female,Larynx,2020
40-44,4.7,6.8,114,Incidence,2011626,Hispanic of any race,5.7,Female,Leukemias,2020
40-44,0.9,2.0,28,Incidence,2011626,Hispanic of any race,1.4,Female,Liver and Intrahepatic Bile Duct,2020
40-44,3.2,5.0,81,Incidence,2011626,Hispanic of any race,4.0,Female,Lung and Bronchus,2020
40-44,2.5,4.2,66,Incidence,2011626,Hispanic of any race,3.3,Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,2011626,Hispanic of any race,~,Female,Mesothelioma,2020
40-44,1.6,3.0,45,Incidence,2011626,Hispanic of any race,2.2,Female,Myeloma,2020
40-44,6.6,9.1,156,Incidence,2011626,Hispanic of any race,7.8,Female,Non-Hodgkin Lymphoma,2020
40-44,1.5,2.8,42,Incidence,2011626,Hispanic of any race,2.1,Female,Oral Cavity and Pharynx,2020
40-44,5.9,8.2,140,Incidence,2011626,Hispanic of any race,7.0,Female,Ovary,2020
40-44,2.2,3.7,58,Incidence,2011626,Hispanic of any race,2.9,Female,Pancreas,2020
40-44,4.0,6.0,99,Incidence,2011626,Hispanic of any race,4.9,Female,Stomach,2020
40-44,25.4,30.1,557,Incidence,2011626,Hispanic of any race,27.7,Female,Thyroid,2020
40-44,~,~,~,Incidence,2011626,Hispanic of any race,~,Female,Urinary Bladder,2020
45-49,327.8,344.5,6295,Incidence,1873134,Hispanic of any race,336.1,Female,All Cancer Sites Combined,2020
45-49,2.2,3.8,54,Incidence,1873134,Hispanic of any race,2.9,Female,Brain and Other Nervous System,2020
45-49,12.7,16.2,270,Incidence,1873134,Hispanic of any race,14.4,Female,Cervix,2020
45-49,24.5,29.3,502,Incidence,1873134,Hispanic of any race,26.8,Female,Colon and Rectum,2020
45-49,23.8,28.5,488,Incidence,1873134,Hispanic of any race,26.1,Female,"Corpus and Uterus, NOS",2020
45-49,~,~,~,Incidence,1873134,Hispanic of any race,~,Female,Esophagus,2020
45-49,133.6,144.4,2602,Incidence,1873134,Hispanic of any race,138.9,Female,Female Breast,2020
45-49,34.3,39.9,693,Incidence,1873134,Hispanic of any race,37.0,Female,"Female Breast, <i>in situ</i>",2020
45-49,1.1,2.3,30,Incidence,1873134,Hispanic of any race,1.6,Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,1873134,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
45-49,10.2,13.3,219,Incidence,1873134,Hispanic of any race,11.7,Female,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,1873134,Hispanic of any race,~,Female,Larynx,2020
45-49,5.5,7.8,123,Incidence,1873134,Hispanic of any race,6.6,Female,Leukemias,2020
45-49,1.3,2.6,35,Incidence,1873134,Hispanic of any race,1.9,Female,Liver and Intrahepatic Bile Duct,2020
45-49,5.7,8.2,129,Incidence,1873134,Hispanic of any race,6.9,Female,Lung and Bronchus,2020
45-49,4.3,6.4,99,Incidence,1873134,Hispanic of any race,5.3,Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,1873134,Hispanic of any race,~,Female,Mesothelioma,2020
45-49,2.9,4.7,70,Incidence,1873134,Hispanic of any race,3.7,Female,Myeloma,2020
45-49,9.2,12.2,199,Incidence,1873134,Hispanic of any race,10.6,Female,Non-Hodgkin Lymphoma,2020
45-49,2.6,4.4,64,Incidence,1873134,Hispanic of any race,3.4,Female,Oral Cavity and Pharynx,2020
45-49,10.0,13.1,215,Incidence,1873134,Hispanic of any race,11.5,Female,Ovary,2020
45-49,3.8,5.8,88,Incidence,1873134,Hispanic of any race,4.7,Female,Pancreas,2020
45-49,5.2,7.5,117,Incidence,1873134,Hispanic of any race,6.2,Female,Stomach,2020
45-49,26.9,31.9,549,Incidence,1873134,Hispanic of any race,29.3,Female,Thyroid,2020
45-49,0.8,1.8,23,Incidence,1873134,Hispanic of any race,1.2,Female,Urinary Bladder,2020
5-9,10.6,13.4,296,Incidence,2474075,Hispanic of any race,12.0,Female,All Cancer Sites Combined,2020
5-9,2.0,3.3,63,Incidence,2474075,Hispanic of any race,2.5,Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Cervix,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Esophagus,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Female Breast,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
5-9,0.4,1.1,18,Incidence,2474075,Hispanic of any race,0.7,Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Larynx,2020
5-9,4.3,6.1,127,Incidence,2474075,Hispanic of any race,5.1,Female,Leukemias,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Mesothelioma,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Myeloma,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Ovary,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Pancreas,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Stomach,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Thyroid,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Female,Urinary Bladder,2020
50-54,444.3,465.0,7471,Incidence,1643443,Hispanic of any race,454.6,Female,All Cancer Sites Combined,2020
50-54,2.8,4.8,61,Incidence,1643443,Hispanic of any race,3.7,Female,Brain and Other Nervous System,2020
50-54,11.3,14.8,213,Incidence,1643443,Hispanic of any race,13.0,Female,Cervix,2020
50-54,38.6,44.9,684,Incidence,1643443,Hispanic of any race,41.6,Female,Colon and Rectum,2020
50-54,41.1,47.6,728,Incidence,1643443,Hispanic of any race,44.3,Female,"Corpus and Uterus, NOS",2020
50-54,~,~,~,Incidence,1643443,Hispanic of any race,~,Female,Esophagus,2020
50-54,165.8,178.5,2828,Incidence,1643443,Hispanic of any race,172.1,Female,Female Breast,2020
50-54,38.4,44.7,681,Incidence,1643443,Hispanic of any race,41.4,Female,"Female Breast, <i>in situ</i>",2020
50-54,1.1,2.4,27,Incidence,1643443,Hispanic of any race,1.6,Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,1643443,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
50-54,16.3,20.5,301,Incidence,1643443,Hispanic of any race,18.3,Female,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,1643443,Hispanic of any race,~,Female,Larynx,2020
50-54,6.5,9.3,128,Incidence,1643443,Hispanic of any race,7.8,Female,Leukemias,2020
50-54,4.2,6.5,87,Incidence,1643443,Hispanic of any race,5.3,Female,Liver and Intrahepatic Bile Duct,2020
50-54,12.8,16.6,240,Incidence,1643443,Hispanic of any race,14.6,Female,Lung and Bronchus,2020
50-54,4.3,6.6,88,Incidence,1643443,Hispanic of any race,5.4,Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,1643443,Hispanic of any race,~,Female,Mesothelioma,2020
50-54,5.1,7.6,103,Incidence,1643443,Hispanic of any race,6.3,Female,Myeloma,2020
50-54,13.5,17.3,252,Incidence,1643443,Hispanic of any race,15.3,Female,Non-Hodgkin Lymphoma,2020
50-54,4.8,7.3,98,Incidence,1643443,Hispanic of any race,6.0,Female,Oral Cavity and Pharynx,2020
50-54,14.2,18.2,265,Incidence,1643443,Hispanic of any race,16.1,Female,Ovary,2020
50-54,6.7,9.5,132,Incidence,1643443,Hispanic of any race,8.0,Female,Pancreas,2020
50-54,8.5,11.6,164,Incidence,1643443,Hispanic of any race,10.0,Female,Stomach,2020
50-54,27.5,32.9,495,Incidence,1643443,Hispanic of any race,30.1,Female,Thyroid,2020
50-54,1.7,3.3,40,Incidence,1643443,Hispanic of any race,2.4,Female,Urinary Bladder,2020
55-59,559.6,584.3,8278,Incidence,1447678,Hispanic of any race,571.8,Female,All Cancer Sites Combined,2020
55-59,4.8,7.3,86,Incidence,1447678,Hispanic of any race,5.9,Female,Brain and Other Nervous System,2020
55-59,11.5,15.3,192,Incidence,1447678,Hispanic of any race,13.3,Female,Cervix,2020
55-59,39.7,46.5,622,Incidence,1447678,Hispanic of any race,43.0,Female,Colon and Rectum,2020
55-59,61.6,70.0,951,Incidence,1447678,Hispanic of any race,65.7,Female,"Corpus and Uterus, NOS",2020
55-59,1.0,2.4,23,Incidence,1447678,Hispanic of any race,1.6,Female,Esophagus,2020
55-59,187.7,202.1,2820,Incidence,1447678,Hispanic of any race,194.8,Female,Female Breast,2020
55-59,40.7,47.6,637,Incidence,1447678,Hispanic of any race,44.0,Female,"Female Breast, <i>in situ</i>",2020
55-59,1.1,2.5,25,Incidence,1447678,Hispanic of any race,1.7,Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,1447678,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
55-59,20.5,25.5,331,Incidence,1447678,Hispanic of any race,22.9,Female,Kidney and Renal Pelvis,2020
55-59,~,~,~,Incidence,1447678,Hispanic of any race,~,Female,Larynx,2020
55-59,11.5,15.4,193,Incidence,1447678,Hispanic of any race,13.3,Female,Leukemias,2020
55-59,10.2,13.8,172,Incidence,1447678,Hispanic of any race,11.9,Female,Liver and Intrahepatic Bile Duct,2020
55-59,27.7,33.4,441,Incidence,1447678,Hispanic of any race,30.5,Female,Lung and Bronchus,2020
55-59,5.5,8.2,98,Incidence,1447678,Hispanic of any race,6.8,Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,1447678,Hispanic of any race,~,Female,Mesothelioma,2020
55-59,6.6,9.6,116,Incidence,1447678,Hispanic of any race,8.0,Female,Myeloma,2020
55-59,20.8,25.8,336,Incidence,1447678,Hispanic of any race,23.2,Female,Non-Hodgkin Lymphoma,2020
55-59,5.9,8.7,104,Incidence,1447678,Hispanic of any race,7.2,Female,Oral Cavity and Pharynx,2020
55-59,15.9,20.4,261,Incidence,1447678,Hispanic of any race,18.0,Female,Ovary,2020
55-59,12.6,16.6,210,Incidence,1447678,Hispanic of any race,14.5,Female,Pancreas,2020
55-59,7.6,10.8,132,Incidence,1447678,Hispanic of any race,9.1,Female,Stomach,2020
55-59,25.9,31.5,414,Incidence,1447678,Hispanic of any race,28.6,Female,Thyroid,2020
55-59,4.8,7.3,86,Incidence,1447678,Hispanic of any race,5.9,Female,Urinary Bladder,2020
60-64,729.1,760.3,8796,Incidence,1181327,Hispanic of any race,744.6,Female,All Cancer Sites Combined,2020
60-64,7.2,10.7,104,Incidence,1181327,Hispanic of any race,8.8,Female,Brain and Other Nervous System,2020
60-64,10.9,15.1,152,Incidence,1181327,Hispanic of any race,12.9,Female,Cervix,2020
60-64,49.2,57.6,629,Incidence,1181327,Hispanic of any race,53.2,Female,Colon and Rectum,2020
60-64,72.5,82.6,915,Incidence,1181327,Hispanic of any race,77.5,Female,"Corpus and Uterus, NOS",2020
60-64,2.0,4.0,34,Incidence,1181327,Hispanic of any race,2.9,Female,Esophagus,2020
60-64,226.7,244.2,2780,Incidence,1181327,Hispanic of any race,235.3,Female,Female Breast,2020
60-64,49.1,57.5,628,Incidence,1181327,Hispanic of any race,53.2,Female,"Female Breast, <i>in situ</i>",2020
60-64,1.6,3.5,29,Incidence,1181327,Hispanic of any race,2.5,Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,1181327,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
60-64,26.0,32.2,342,Incidence,1181327,Hispanic of any race,29.0,Female,Kidney and Renal Pelvis,2020
60-64,1.1,2.7,21,Incidence,1181327,Hispanic of any race,1.8,Female,Larynx,2020
60-64,11.4,15.6,158,Incidence,1181327,Hispanic of any race,13.4,Female,Leukemias,2020
60-64,17.6,22.8,237,Incidence,1181327,Hispanic of any race,20.1,Female,Liver and Intrahepatic Bile Duct,2020
60-64,52.7,61.4,672,Incidence,1181327,Hispanic of any race,56.9,Female,Lung and Bronchus,2020
60-64,8.3,12.0,118,Incidence,1181327,Hispanic of any race,10.0,Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,1181327,Hispanic of any race,~,Female,Mesothelioma,2020
60-64,11.0,15.2,153,Incidence,1181327,Hispanic of any race,13.0,Female,Myeloma,2020
60-64,30.0,36.6,392,Incidence,1181327,Hispanic of any race,33.2,Female,Non-Hodgkin Lymphoma,2020
60-64,10.1,14.2,142,Incidence,1181327,Hispanic of any race,12.0,Female,Oral Cavity and Pharynx,2020
60-64,19.3,24.7,258,Incidence,1181327,Hispanic of any race,21.8,Female,Ovary,2020
60-64,23.6,29.6,313,Incidence,1181327,Hispanic of any race,26.5,Female,Pancreas,2020
60-64,12.9,17.4,177,Incidence,1181327,Hispanic of any race,15.0,Female,Stomach,2020
60-64,24.0,30.0,317,Incidence,1181327,Hispanic of any race,26.8,Female,Thyroid,2020
60-64,5.1,8.1,77,Incidence,1181327,Hispanic of any race,6.5,Female,Urinary Bladder,2020
65-69,946.5,987.1,8743,Incidence,904481,Hispanic of any race,966.6,Female,All Cancer Sites Combined,2020
65-69,6.7,10.6,77,Incidence,904481,Hispanic of any race,8.5,Female,Brain and Other Nervous System,2020
65-69,11.1,16.0,121,Incidence,904481,Hispanic of any race,13.4,Female,Cervix,2020
65-69,67.8,79.1,663,Incidence,904481,Hispanic of any race,73.3,Female,Colon and Rectum,2020
65-69,78.9,91.0,767,Incidence,904481,Hispanic of any race,84.8,Female,"Corpus and Uterus, NOS",2020
65-69,1.9,4.2,26,Incidence,904481,Hispanic of any race,2.9,Female,Esophagus,2020
65-69,284.4,306.9,2673,Incidence,904481,Hispanic of any race,295.5,Female,Female Breast,2020
65-69,59.0,69.6,580,Incidence,904481,Hispanic of any race,64.1,Female,"Female Breast, <i>in situ</i>",2020
65-69,2.1,4.5,28,Incidence,904481,Hispanic of any race,3.1,Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,904481,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
65-69,38.1,46.7,382,Incidence,904481,Hispanic of any race,42.2,Female,Kidney and Renal Pelvis,2020
65-69,~,~,~,Incidence,904481,Hispanic of any race,~,Female,Larynx,2020
65-69,19.1,25.3,199,Incidence,904481,Hispanic of any race,22.0,Female,Leukemias,2020
65-69,29.2,36.8,297,Incidence,904481,Hispanic of any race,32.8,Female,Liver and Intrahepatic Bile Duct,2020
65-69,72.9,84.6,711,Incidence,904481,Hispanic of any race,78.6,Female,Lung and Bronchus,2020
65-69,9.3,13.8,103,Incidence,904481,Hispanic of any race,11.4,Female,Melanomas of the Skin,2020
65-69,1.4,3.5,21,Incidence,904481,Hispanic of any race,2.3,Female,Mesothelioma,2020
65-69,16.7,22.6,176,Incidence,904481,Hispanic of any race,19.5,Female,Myeloma,2020
65-69,44.1,53.3,439,Incidence,904481,Hispanic of any race,48.5,Female,Non-Hodgkin Lymphoma,2020
65-69,13.4,18.7,144,Incidence,904481,Hispanic of any race,15.9,Female,Oral Cavity and Pharynx,2020
65-69,19.7,26.0,205,Incidence,904481,Hispanic of any race,22.7,Female,Ovary,2020
65-69,31.3,39.1,317,Incidence,904481,Hispanic of any race,35.0,Female,Pancreas,2020
65-69,17.7,23.7,186,Incidence,904481,Hispanic of any race,20.6,Female,Stomach,2020
65-69,28.1,35.5,286,Incidence,904481,Hispanic of any race,31.6,Female,Thyroid,2020
65-69,11.2,16.1,122,Incidence,904481,Hispanic of any race,13.5,Female,Urinary Bladder,2020
70-74,1091.3,1141.8,7551,Incidence,676434,Hispanic of any race,1116.3,Female,All Cancer Sites Combined,2020
70-74,11.9,17.8,99,Incidence,676434,Hispanic of any race,14.6,Female,Brain and Other Nervous System,2020
70-74,14.3,20.7,117,Incidence,676434,Hispanic of any race,17.3,Female,Cervix,2020
70-74,77.6,91.6,571,Incidence,676434,Hispanic of any race,84.4,Female,Colon and Rectum,2020
70-74,81.3,95.6,597,Incidence,676434,Hispanic of any race,88.3,Female,"Corpus and Uterus, NOS",2020
70-74,2.6,5.8,27,Incidence,676434,Hispanic of any race,4.0,Female,Esophagus,2020
70-74,286.0,312.2,2022,Incidence,676434,Hispanic of any race,298.9,Female,Female Breast,2020
70-74,59.4,71.7,442,Incidence,676434,Hispanic of any race,65.3,Female,"Female Breast, <i>in situ</i>",2020
70-74,1.9,4.7,21,Incidence,676434,Hispanic of any race,3.1,Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,676434,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
70-74,36.4,46.2,278,Incidence,676434,Hispanic of any race,41.1,Female,Kidney and Renal Pelvis,2020
70-74,1.8,4.6,20,Incidence,676434,Hispanic of any race,3.0,Female,Larynx,2020
70-74,24.0,32.1,188,Incidence,676434,Hispanic of any race,27.8,Female,Leukemias,2020
70-74,33.9,43.4,260,Incidence,676434,Hispanic of any race,38.4,Female,Liver and Intrahepatic Bile Duct,2020
70-74,103.7,119.7,754,Incidence,676434,Hispanic of any race,111.5,Female,Lung and Bronchus,2020
70-74,8.3,13.4,72,Incidence,676434,Hispanic of any race,10.6,Female,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,676434,Hispanic of any race,~,Female,Mesothelioma,2020
70-74,23.6,31.6,185,Incidence,676434,Hispanic of any race,27.3,Female,Myeloma,2020
70-74,52.1,63.7,390,Incidence,676434,Hispanic of any race,57.7,Female,Non-Hodgkin Lymphoma,2020
70-74,12.3,18.3,102,Incidence,676434,Hispanic of any race,15.1,Female,Oral Cavity and Pharynx,2020
70-74,23.7,31.7,186,Incidence,676434,Hispanic of any race,27.5,Female,Ovary,2020
70-74,45.6,56.5,344,Incidence,676434,Hispanic of any race,50.9,Female,Pancreas,2020
70-74,22.6,30.5,178,Incidence,676434,Hispanic of any race,26.3,Female,Stomach,2020
70-74,24.2,32.4,190,Incidence,676434,Hispanic of any race,28.1,Female,Thyroid,2020
70-74,17.8,24.9,143,Incidence,676434,Hispanic of any race,21.1,Female,Urinary Bladder,2020
75-79,1179.6,1243.3,5595,Incidence,461971,Hispanic of any race,1211.1,Female,All Cancer Sites Combined,2020
75-79,10.7,17.7,64,Incidence,461971,Hispanic of any race,13.9,Female,Brain and Other Nervous System,2020
75-79,10.9,17.9,65,Incidence,461971,Hispanic of any race,14.1,Female,Cervix,2020
75-79,90.7,109.1,460,Incidence,461971,Hispanic of any race,99.6,Female,Colon and Rectum,2020
75-79,65.2,80.9,336,Incidence,461971,Hispanic of any race,72.7,Female,"Corpus and Uterus, NOS",2020
75-79,3.9,8.5,27,Incidence,461971,Hispanic of any race,5.8,Female,Esophagus,2020
75-79,264.0,294.7,1289,Incidence,461971,Hispanic of any race,279.0,Female,Female Breast,2020
75-79,42.8,55.7,226,Incidence,461971,Hispanic of any race,48.9,Female,"Female Breast, <i>in situ</i>",2020
75-79,2.3,6.2,18,Incidence,461971,Hispanic of any race,3.9,Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,461971,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
75-79,37.9,50.2,202,Incidence,461971,Hispanic of any race,43.7,Female,Kidney and Renal Pelvis,2020
75-79,~,~,~,Incidence,461971,Hispanic of any race,~,Female,Larynx,2020
75-79,27.1,37.6,148,Incidence,461971,Hispanic of any race,32.0,Female,Leukemias,2020
75-79,40.9,53.7,217,Incidence,461971,Hispanic of any race,47.0,Female,Liver and Intrahepatic Bile Duct,2020
75-79,128.8,150.6,644,Incidence,461971,Hispanic of any race,139.4,Female,Lung and Bronchus,2020
75-79,9.3,16.0,57,Incidence,461971,Hispanic of any race,12.3,Female,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,461971,Hispanic of any race,~,Female,Mesothelioma,2020
75-79,19.0,28.0,107,Incidence,461971,Hispanic of any race,23.2,Female,Myeloma,2020
75-79,64.1,79.8,331,Incidence,461971,Hispanic of any race,71.6,Female,Non-Hodgkin Lymphoma,2020
75-79,14.5,22.5,84,Incidence,461971,Hispanic of any race,18.2,Female,Oral Cavity and Pharynx,2020
75-79,20.2,29.4,113,Incidence,461971,Hispanic of any race,24.5,Female,Ovary,2020
75-79,62.7,78.2,324,Incidence,461971,Hispanic of any race,70.1,Female,Pancreas,2020
75-79,25.9,36.2,142,Incidence,461971,Hispanic of any race,30.7,Female,Stomach,2020
75-79,21.5,31.1,120,Incidence,461971,Hispanic of any race,26.0,Female,Thyroid,2020
75-79,24.7,34.8,136,Incidence,461971,Hispanic of any race,29.4,Female,Urinary Bladder,2020
80-84,1270.2,1349.9,4187,Incidence,319718,Hispanic of any race,1309.6,Female,All Cancer Sites Combined,2020
80-84,17.1,27.7,70,Incidence,319718,Hispanic of any race,21.9,Female,Brain and Other Nervous System,2020
80-84,8.7,16.7,39,Incidence,319718,Hispanic of any race,12.2,Female,Cervix,2020
80-84,118.2,143.6,417,Incidence,319718,Hispanic of any race,130.4,Female,Colon and Rectum,2020
80-84,47.5,64.1,177,Incidence,319718,Hispanic of any race,55.4,Female,"Corpus and Uterus, NOS",2020
80-84,3.3,8.9,18,Incidence,319718,Hispanic of any race,5.6,Female,Esophagus,2020
80-84,235.9,271.1,809,Incidence,319718,Hispanic of any race,253.0,Female,Female Breast,2020
80-84,25.7,38.4,101,Incidence,319718,Hispanic of any race,31.6,Female,"Female Breast, <i>in situ</i>",2020
80-84,3.3,8.9,18,Incidence,319718,Hispanic of any race,5.6,Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,319718,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
80-84,31.7,45.6,122,Incidence,319718,Hispanic of any race,38.2,Female,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,319718,Hispanic of any race,~,Female,Larynx,2020
80-84,37.1,52.0,141,Incidence,319718,Hispanic of any race,44.1,Female,Leukemias,2020
80-84,46.1,62.5,172,Incidence,319718,Hispanic of any race,53.8,Female,Liver and Intrahepatic Bile Duct,2020
80-84,144.8,172.7,506,Incidence,319718,Hispanic of any race,158.3,Female,Lung and Bronchus,2020
80-84,13.8,23.5,58,Incidence,319718,Hispanic of any race,18.1,Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,319718,Hispanic of any race,~,Female,Mesothelioma,2020
80-84,24.0,36.3,95,Incidence,319718,Hispanic of any race,29.7,Female,Myeloma,2020
80-84,67.3,86.9,245,Incidence,319718,Hispanic of any race,76.6,Female,Non-Hodgkin Lymphoma,2020
80-84,17.9,28.7,73,Incidence,319718,Hispanic of any race,22.8,Female,Oral Cavity and Pharynx,2020
80-84,24.6,37.0,97,Incidence,319718,Hispanic of any race,30.3,Female,Ovary,2020
80-84,68.2,87.8,248,Incidence,319718,Hispanic of any race,77.6,Female,Pancreas,2020
80-84,28.8,42.2,112,Incidence,319718,Hispanic of any race,35.0,Female,Stomach,2020
80-84,11.1,19.9,48,Incidence,319718,Hispanic of any race,15.0,Female,Thyroid,2020
80-84,31.7,45.6,122,Incidence,319718,Hispanic of any race,38.2,Female,Urinary Bladder,2020
85+,1166.2,1240.8,4029,Incidence,334903,Hispanic of any race,1203.0,Female,All Cancer Sites Combined,2020
85+,9.8,18.0,45,Incidence,334903,Hispanic of any race,13.4,Female,Brain and Other Nervous System,2020
85+,8.0,15.6,38,Incidence,334903,Hispanic of any race,11.3,Female,Cervix,2020
85+,133.9,160.2,491,Incidence,334903,Hispanic of any race,146.6,Female,Colon and Rectum,2020
85+,32.7,46.4,131,Incidence,334903,Hispanic of any race,39.1,Female,"Corpus and Uterus, NOS",2020
85+,5.3,11.7,27,Incidence,334903,Hispanic of any race,8.1,Female,Esophagus,2020
85+,164.8,193.8,599,Incidence,334903,Hispanic of any race,178.9,Female,Female Breast,2020
85+,8.8,16.6,41,Incidence,334903,Hispanic of any race,12.2,Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,334903,Hispanic of any race,~,Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,334903,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
85+,34.3,48.4,137,Incidence,334903,Hispanic of any race,40.9,Female,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,334903,Hispanic of any race,~,Female,Larynx,2020
85+,34.1,48.0,136,Incidence,334903,Hispanic of any race,40.6,Female,Leukemias,2020
85+,42.0,57.4,165,Incidence,334903,Hispanic of any race,49.3,Female,Liver and Intrahepatic Bile Duct,2020
85+,114.3,138.6,422,Incidence,334903,Hispanic of any race,126.0,Female,Lung and Bronchus,2020
85+,10.8,19.3,49,Incidence,334903,Hispanic of any race,14.6,Female,Melanomas of the Skin,2020
85+,~,~,~,Incidence,334903,Hispanic of any race,~,Female,Mesothelioma,2020
85+,23.0,34.7,95,Incidence,334903,Hispanic of any race,28.4,Female,Myeloma,2020
85+,56.7,74.3,218,Incidence,334903,Hispanic of any race,65.1,Female,Non-Hodgkin Lymphoma,2020
85+,14.7,24.4,64,Incidence,334903,Hispanic of any race,19.1,Female,Oral Cavity and Pharynx,2020
85+,19.7,30.7,83,Incidence,334903,Hispanic of any race,24.8,Female,Ovary,2020
85+,76.9,97.2,290,Incidence,334903,Hispanic of any race,86.6,Female,Pancreas,2020
85+,34.1,48.0,136,Incidence,334903,Hispanic of any race,40.6,Female,Stomach,2020
85+,6.8,13.8,33,Incidence,334903,Hispanic of any race,9.9,Female,Thyroid,2020
85+,33.0,46.7,132,Incidence,334903,Hispanic of any race,39.4,Female,Urinary Bladder,2020
<1,14.5,22.4,84,Incidence,463556,Hispanic of any race,18.1,Female,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Cervix,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Colon and Rectum,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Esophagus,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Female Breast,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Larynx,2020
<1,2.6,6.7,20,Incidence,463556,Hispanic of any race,4.3,Female,Leukemias,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Mesothelioma,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Myeloma,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Ovary,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Pancreas,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Stomach,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Thyroid,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Female,Urinary Bladder,2020
1-4,21.3,25.5,466,Incidence,1998024,Hispanic of any race,23.3,Male,All Cancer Sites Combined,2020
1-4,3.0,4.8,76,Incidence,1998024,Hispanic of any race,3.8,Male,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Colon and Rectum,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Esophagus,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
1-4,1.1,2.3,33,Incidence,1998024,Hispanic of any race,1.7,Male,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Larynx,2020
1-4,9.0,11.9,208,Incidence,1998024,Hispanic of any race,10.4,Male,Leukemias,2020
1-4,0.6,1.5,19,Incidence,1998024,Hispanic of any race,1.0,Male,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Lung and Bronchus,2020
1-4,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Mesothelioma,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Myeloma,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Pancreas,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Prostate,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Stomach,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Testis,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Thyroid,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male,Urinary Bladder,2020
10-14,13.9,17.0,410,Incidence,2663844,Hispanic of any race,15.4,Male,All Cancer Sites Combined,2020
10-14,1.7,2.9,60,Incidence,2663844,Hispanic of any race,2.3,Male,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Colon and Rectum,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Esophagus,2020
10-14,0.5,1.3,23,Incidence,2663844,Hispanic of any race,0.9,Male,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Larynx,2020
10-14,4.9,6.8,155,Incidence,2663844,Hispanic of any race,5.8,Male,Leukemias,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Lung and Bronchus,2020
10-14,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Mesothelioma,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Myeloma,2020
10-14,1.1,2.0,40,Incidence,2663844,Hispanic of any race,1.5,Male,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Pancreas,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Prostate,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Stomach,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Testis,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Thyroid,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male,Urinary Bladder,2020
15-19,23.3,27.2,639,Incidence,2536174,Hispanic of any race,25.2,Male,All Cancer Sites Combined,2020
15-19,1.5,2.7,52,Incidence,2536174,Hispanic of any race,2.1,Male,Brain and Other Nervous System,2020
15-19,0.4,1.0,16,Incidence,2536174,Hispanic of any race,0.6,Male,Colon and Rectum,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Esophagus,2020
15-19,1.7,2.9,56,Incidence,2536174,Hispanic of any race,2.2,Male,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Larynx,2020
15-19,5.2,7.2,155,Incidence,2536174,Hispanic of any race,6.1,Male,Leukemias,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Lung and Bronchus,2020
15-19,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Mesothelioma,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Myeloma,2020
15-19,1.6,2.7,53,Incidence,2536174,Hispanic of any race,2.1,Male,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Pancreas,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Prostate,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Stomach,2020
15-19,4.4,6.2,133,Incidence,2536174,Hispanic of any race,5.2,Male,Testis,2020
15-19,0.6,1.4,24,Incidence,2536174,Hispanic of any race,0.9,Male,Thyroid,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male,Urinary Bladder,2020
20-24,35.0,39.8,915,Incidence,2451030,Hispanic of any race,37.3,Male,All Cancer Sites Combined,2020
20-24,1.3,2.4,44,Incidence,2451030,Hispanic of any race,1.8,Male,Brain and Other Nervous System,2020
20-24,1.1,2.1,37,Incidence,2451030,Hispanic of any race,1.5,Male,Colon and Rectum,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Esophagus,2020
20-24,2.3,3.7,73,Incidence,2451030,Hispanic of any race,3.0,Male,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Larynx,2020
20-24,3.4,5.1,102,Incidence,2451030,Hispanic of any race,4.2,Male,Leukemias,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Lung and Bronchus,2020
20-24,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Mesothelioma,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Myeloma,2020
20-24,2.2,3.5,68,Incidence,2451030,Hispanic of any race,2.8,Male,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Pancreas,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Prostate,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Stomach,2020
20-24,13.4,16.5,364,Incidence,2451030,Hispanic of any race,14.9,Male,Testis,2020
20-24,1.4,2.5,47,Incidence,2451030,Hispanic of any race,1.9,Male,Thyroid,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male,Urinary Bladder,2020
25-29,41.8,47.0,1110,Incidence,2502178,Hispanic of any race,44.4,Male,All Cancer Sites Combined,2020
25-29,1.7,2.9,55,Incidence,2502178,Hispanic of any race,2.2,Male,Brain and Other Nervous System,2020
25-29,2.4,3.8,76,Incidence,2502178,Hispanic of any race,3.0,Male,Colon and Rectum,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Esophagus,2020
25-29,2.2,3.6,71,Incidence,2502178,Hispanic of any race,2.8,Male,Hodgkin Lymphoma,2020
25-29,0.5,1.2,19,Incidence,2502178,Hispanic of any race,0.8,Male,Kaposi Sarcoma,2020
25-29,0.8,1.7,29,Incidence,2502178,Hispanic of any race,1.2,Male,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Larynx,2020
25-29,3.3,4.9,100,Incidence,2502178,Hispanic of any race,4.0,Male,Leukemias,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Lung and Bronchus,2020
25-29,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Mesothelioma,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Myeloma,2020
25-29,2.5,3.9,79,Incidence,2502178,Hispanic of any race,3.2,Male,Non-Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Pancreas,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Prostate,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Stomach,2020
25-29,15.5,18.8,428,Incidence,2502178,Hispanic of any race,17.1,Male,Testis,2020
25-29,1.9,3.1,61,Incidence,2502178,Hispanic of any race,2.4,Male,Thyroid,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male,Urinary Bladder,2020
30-34,52.3,58.3,1320,Incidence,2389619,Hispanic of any race,55.2,Male,All Cancer Sites Combined,2020
30-34,2.0,3.4,63,Incidence,2389619,Hispanic of any race,2.6,Male,Brain and Other Nervous System,2020
30-34,4.1,5.9,118,Incidence,2389619,Hispanic of any race,4.9,Male,Colon and Rectum,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Esophagus,2020
30-34,1.8,3.1,58,Incidence,2389619,Hispanic of any race,2.4,Male,Hodgkin Lymphoma,2020
30-34,0.7,1.5,25,Incidence,2389619,Hispanic of any race,1.0,Male,Kaposi Sarcoma,2020
30-34,2.1,3.5,66,Incidence,2389619,Hispanic of any race,2.8,Male,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Larynx,2020
30-34,3.7,5.5,108,Incidence,2389619,Hispanic of any race,4.5,Male,Leukemias,2020
30-34,0.4,1.1,17,Incidence,2389619,Hispanic of any race,0.7,Male,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Lung and Bronchus,2020
30-34,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
30-34,0.7,1.5,25,Incidence,2389619,Hispanic of any race,1.0,Male,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Mesothelioma,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Myeloma,2020
30-34,3.9,5.7,114,Incidence,2389619,Hispanic of any race,4.8,Male,Non-Hodgkin Lymphoma,2020
30-34,0.9,1.8,31,Incidence,2389619,Hispanic of any race,1.3,Male,Oral Cavity and Pharynx,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Pancreas,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Prostate,2020
30-34,0.9,1.8,31,Incidence,2389619,Hispanic of any race,1.3,Male,Stomach,2020
30-34,13.9,17.1,368,Incidence,2389619,Hispanic of any race,15.4,Male,Testis,2020
30-34,3.1,4.7,91,Incidence,2389619,Hispanic of any race,3.8,Male,Thyroid,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male,Urinary Bladder,2020
35-39,66.4,73.3,1597,Incidence,2288875,Hispanic of any race,69.8,Male,All Cancer Sites Combined,2020
35-39,2.3,3.8,69,Incidence,2288875,Hispanic of any race,3.0,Male,Brain and Other Nervous System,2020
35-39,9.1,11.8,238,Incidence,2288875,Hispanic of any race,10.4,Male,Colon and Rectum,2020
35-39,~,~,~,Incidence,2288875,Hispanic of any race,~,Male,Esophagus,2020
35-39,1.3,2.5,42,Incidence,2288875,Hispanic of any race,1.8,Male,Hodgkin Lymphoma,2020
35-39,0.8,1.7,27,Incidence,2288875,Hispanic of any race,1.2,Male,Kaposi Sarcoma,2020
35-39,6.0,8.2,161,Incidence,2288875,Hispanic of any race,7.0,Male,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,2288875,Hispanic of any race,~,Male,Larynx,2020
35-39,4.8,6.8,132,Incidence,2288875,Hispanic of any race,5.8,Male,Leukemias,2020
35-39,0.7,1.7,26,Incidence,2288875,Hispanic of any race,1.1,Male,Liver and Intrahepatic Bile Duct,2020
35-39,0.7,1.7,26,Incidence,2288875,Hispanic of any race,1.1,Male,Lung and Bronchus,2020
35-39,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
35-39,1.0,2.1,34,Incidence,2288875,Hispanic of any race,1.5,Male,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,2288875,Hispanic of any race,~,Male,Mesothelioma,2020
35-39,~,~,~,Incidence,2288875,Hispanic of any race,~,Male,Myeloma,2020
35-39,4.7,6.7,129,Incidence,2288875,Hispanic of any race,5.6,Male,Non-Hodgkin Lymphoma,2020
35-39,1.0,2.0,33,Incidence,2288875,Hispanic of any race,1.4,Male,Oral Cavity and Pharynx,2020
35-39,0.6,1.4,21,Incidence,2288875,Hispanic of any race,0.9,Male,Pancreas,2020
35-39,~,~,~,Incidence,2288875,Hispanic of any race,~,Male,Prostate,2020
35-39,2.4,3.9,70,Incidence,2288875,Hispanic of any race,3.1,Male,Stomach,2020
35-39,8.5,11.1,223,Incidence,2288875,Hispanic of any race,9.7,Male,Testis,2020
35-39,4.0,5.9,112,Incidence,2288875,Hispanic of any race,4.9,Male,Thyroid,2020
35-39,0.6,1.5,22,Incidence,2288875,Hispanic of any race,1.0,Male,Urinary Bladder,2020
40-44,97.6,106.3,2156,Incidence,2116074,Hispanic of any race,101.9,Male,All Cancer Sites Combined,2020
40-44,2.9,4.5,77,Incidence,2116074,Hispanic of any race,3.6,Male,Brain and Other Nervous System,2020
40-44,14.9,18.4,351,Incidence,2116074,Hispanic of any race,16.6,Male,Colon and Rectum,2020
40-44,0.5,1.3,18,Incidence,2116074,Hispanic of any race,0.9,Male,Esophagus,2020
40-44,1.7,3.1,49,Incidence,2116074,Hispanic of any race,2.3,Male,Hodgkin Lymphoma,2020
40-44,0.8,1.7,25,Incidence,2116074,Hispanic of any race,1.2,Male,Kaposi Sarcoma,2020
40-44,11.6,14.7,277,Incidence,2116074,Hispanic of any race,13.1,Male,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,2116074,Hispanic of any race,~,Male,Larynx,2020
40-44,4.7,6.8,120,Incidence,2116074,Hispanic of any race,5.7,Male,Leukemias,2020
40-44,2.5,4.0,67,Incidence,2116074,Hispanic of any race,3.2,Male,Liver and Intrahepatic Bile Duct,2020
40-44,2.2,3.6,60,Incidence,2116074,Hispanic of any race,2.8,Male,Lung and Bronchus,2020
40-44,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
40-44,1.4,2.6,41,Incidence,2116074,Hispanic of any race,1.9,Male,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,2116074,Hispanic of any race,~,Male,Mesothelioma,2020
40-44,1.8,3.2,52,Incidence,2116074,Hispanic of any race,2.5,Male,Myeloma,2020
40-44,6.5,8.9,162,Incidence,2116074,Hispanic of any race,7.7,Male,Non-Hodgkin Lymphoma,2020
40-44,2.9,4.6,78,Incidence,2116074,Hispanic of any race,3.7,Male,Oral Cavity and Pharynx,2020
40-44,2.5,4.0,67,Incidence,2116074,Hispanic of any race,3.2,Male,Pancreas,2020
40-44,2.0,3.4,55,Incidence,2116074,Hispanic of any race,2.6,Male,Prostate,2020
40-44,4.1,6.0,105,Incidence,2116074,Hispanic of any race,5.0,Male,Stomach,2020
40-44,5.1,7.3,130,Incidence,2116074,Hispanic of any race,6.1,Male,Testis,2020
40-44,4.3,6.3,111,Incidence,2116074,Hispanic of any race,5.2,Male,Thyroid,2020
40-44,1.5,2.8,44,Incidence,2116074,Hispanic of any race,2.1,Male,Urinary Bladder,2020
45-49,157.0,168.5,3087,Incidence,1897723,Hispanic of any race,162.7,Male,All Cancer Sites Combined,2020
45-49,3.7,5.7,87,Incidence,1897723,Hispanic of any race,4.6,Male,Brain and Other Nervous System,2020
45-49,26.6,31.5,550,Incidence,1897723,Hispanic of any race,29.0,Male,Colon and Rectum,2020
45-49,1.5,2.8,39,Incidence,1897723,Hispanic of any race,2.1,Male,Esophagus,2020
45-49,0.9,2.0,26,Incidence,1897723,Hispanic of any race,1.4,Male,Hodgkin Lymphoma,2020
45-49,0.5,1.4,17,Incidence,1897723,Hispanic of any race,0.9,Male,Kaposi Sarcoma,2020
45-49,19.8,24.1,415,Incidence,1897723,Hispanic of any race,21.9,Male,Kidney and Renal Pelvis,2020
45-49,1.0,2.2,29,Incidence,1897723,Hispanic of any race,1.5,Male,Larynx,2020
45-49,6.2,8.6,139,Incidence,1897723,Hispanic of any race,7.3,Male,Leukemias,2020
45-49,4.5,6.6,104,Incidence,1897723,Hispanic of any race,5.5,Male,Liver and Intrahepatic Bile Duct,2020
45-49,4.1,6.2,97,Incidence,1897723,Hispanic of any race,5.1,Male,Lung and Bronchus,2020
45-49,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
45-49,2.0,3.5,50,Incidence,1897723,Hispanic of any race,2.6,Male,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,1897723,Hispanic of any race,~,Male,Mesothelioma,2020
45-49,3.8,5.8,90,Incidence,1897723,Hispanic of any race,4.7,Male,Myeloma,2020
45-49,10.3,13.5,224,Incidence,1897723,Hispanic of any race,11.8,Male,Non-Hodgkin Lymphoma,2020
45-49,6.6,9.2,149,Incidence,1897723,Hispanic of any race,7.9,Male,Oral Cavity and Pharynx,2020
45-49,4.5,6.6,104,Incidence,1897723,Hispanic of any race,5.5,Male,Pancreas,2020
45-49,10.0,13.1,218,Incidence,1897723,Hispanic of any race,11.5,Male,Prostate,2020
45-49,6.3,8.8,141,Incidence,1897723,Hispanic of any race,7.4,Male,Stomach,2020
45-49,3.0,4.8,73,Incidence,1897723,Hispanic of any race,3.8,Male,Testis,2020
45-49,5.2,7.6,120,Incidence,1897723,Hispanic of any race,6.3,Male,Thyroid,2020
45-49,3.5,5.5,84,Incidence,1897723,Hispanic of any race,4.4,Male,Urinary Bladder,2020
5-9,12.1,15.0,347,Incidence,2566788,Hispanic of any race,13.5,Male,All Cancer Sites Combined,2020
5-9,2.2,3.6,73,Incidence,2566788,Hispanic of any race,2.8,Male,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Colon and Rectum,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Esophagus,2020
5-9,0.4,1.1,17,Incidence,2566788,Hispanic of any race,0.7,Male,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Larynx,2020
5-9,4.2,6.0,129,Incidence,2566788,Hispanic of any race,5.0,Male,Leukemias,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Lung and Bronchus,2020
5-9,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Mesothelioma,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Myeloma,2020
5-9,0.9,1.9,34,Incidence,2566788,Hispanic of any race,1.3,Male,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Pancreas,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Prostate,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Stomach,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Testis,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Thyroid,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male,Urinary Bladder,2020
50-54,286.8,303.4,4921,Incidence,1667975,Hispanic of any race,295.0,Male,All Cancer Sites Combined,2020
50-54,5.8,8.4,117,Incidence,1667975,Hispanic of any race,7.0,Male,Brain and Other Nervous System,2020
50-54,44.5,51.2,796,Incidence,1667975,Hispanic of any race,47.7,Male,Colon and Rectum,2020
50-54,2.9,4.8,63,Incidence,1667975,Hispanic of any race,3.8,Male,Esophagus,2020
50-54,1.8,3.3,41,Incidence,1667975,Hispanic of any race,2.5,Male,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,1667975,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
50-54,27.2,32.5,496,Incidence,1667975,Hispanic of any race,29.7,Male,Kidney and Renal Pelvis,2020
50-54,2.7,4.6,59,Incidence,1667975,Hispanic of any race,3.5,Male,Larynx,2020
50-54,8.9,12.0,173,Incidence,1667975,Hispanic of any race,10.4,Male,Leukemias,2020
50-54,14.3,18.2,270,Incidence,1667975,Hispanic of any race,16.2,Male,Liver and Intrahepatic Bile Duct,2020
50-54,10.7,14.2,206,Incidence,1667975,Hispanic of any race,12.4,Male,Lung and Bronchus,2020
50-54,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
50-54,2.7,4.6,60,Incidence,1667975,Hispanic of any race,3.6,Male,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,1667975,Hispanic of any race,~,Male,Mesothelioma,2020
50-54,5.1,7.6,104,Incidence,1667975,Hispanic of any race,6.2,Male,Myeloma,2020
50-54,16.8,21.0,314,Incidence,1667975,Hispanic of any race,18.8,Male,Non-Hodgkin Lymphoma,2020
50-54,11.7,15.3,224,Incidence,1667975,Hispanic of any race,13.4,Male,Oral Cavity and Pharynx,2020
50-54,8.9,12.1,174,Incidence,1667975,Hispanic of any race,10.4,Male,Pancreas,2020
50-54,47.5,54.4,848,Incidence,1667975,Hispanic of any race,50.8,Male,Prostate,2020
50-54,8.3,11.4,163,Incidence,1667975,Hispanic of any race,9.8,Male,Stomach,2020
50-54,2.2,3.9,49,Incidence,1667975,Hispanic of any race,2.9,Male,Testis,2020
50-54,7.3,10.2,144,Incidence,1667975,Hispanic of any race,8.6,Male,Thyroid,2020
50-54,6.3,9.0,126,Incidence,1667975,Hispanic of any race,7.6,Male,Urinary Bladder,2020
55-59,515.8,539.7,7480,Incidence,1417613,Hispanic of any race,527.6,Male,All Cancer Sites Combined,2020
55-59,8.4,11.8,142,Incidence,1417613,Hispanic of any race,10.0,Male,Brain and Other Nervous System,2020
55-59,61.8,70.3,935,Incidence,1417613,Hispanic of any race,66.0,Male,Colon and Rectum,2020
55-59,7.0,10.0,119,Incidence,1417613,Hispanic of any race,8.4,Male,Esophagus,2020
55-59,2.7,4.8,52,Incidence,1417613,Hispanic of any race,3.7,Male,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,1417613,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
55-59,37.8,44.5,582,Incidence,1417613,Hispanic of any race,41.1,Male,Kidney and Renal Pelvis,2020
55-59,5.6,8.4,98,Incidence,1417613,Hispanic of any race,6.9,Male,Larynx,2020
55-59,12.8,16.9,209,Incidence,1417613,Hispanic of any race,14.7,Male,Leukemias,2020
55-59,36.5,43.1,563,Incidence,1417613,Hispanic of any race,39.7,Male,Liver and Intrahepatic Bile Duct,2020
55-59,26.3,31.9,411,Incidence,1417613,Hispanic of any race,29.0,Male,Lung and Bronchus,2020
55-59,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
55-59,5.4,8.2,95,Incidence,1417613,Hispanic of any race,6.7,Male,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,1417613,Hispanic of any race,~,Male,Mesothelioma,2020
55-59,10.1,13.7,167,Incidence,1417613,Hispanic of any race,11.8,Male,Myeloma,2020
55-59,24.5,30.0,385,Incidence,1417613,Hispanic of any race,27.2,Male,Non-Hodgkin Lymphoma,2020
55-59,21.0,26.1,332,Incidence,1417613,Hispanic of any race,23.4,Male,Oral Cavity and Pharynx,2020
55-59,16.6,21.2,267,Incidence,1417613,Hispanic of any race,18.8,Male,Pancreas,2020
55-59,123.4,135.4,1833,Incidence,1417613,Hispanic of any race,129.3,Male,Prostate,2020
55-59,15.6,20.0,251,Incidence,1417613,Hispanic of any race,17.7,Male,Stomach,2020
55-59,0.8,2.0,18,Incidence,1417613,Hispanic of any race,1.3,Male,Testis,2020
55-59,8.4,11.7,141,Incidence,1417613,Hispanic of any race,9.9,Male,Thyroid,2020
55-59,12.7,16.8,208,Incidence,1417613,Hispanic of any race,14.7,Male,Urinary Bladder,2020
60-64,811.1,845.2,9119,Incidence,1101260,Hispanic of any race,828.1,Male,All Cancer Sites Combined,2020
60-64,9.4,13.5,125,Incidence,1101260,Hispanic of any race,11.4,Male,Brain and Other Nervous System,2020
60-64,78.4,89.3,922,Incidence,1101260,Hispanic of any race,83.7,Male,Colon and Rectum,2020
60-64,11.0,15.4,144,Incidence,1101260,Hispanic of any race,13.1,Male,Esophagus,2020
60-64,2.5,4.8,39,Incidence,1101260,Hispanic of any race,3.5,Male,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,1101260,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
60-64,55.6,64.9,662,Incidence,1101260,Hispanic of any race,60.1,Male,Kidney and Renal Pelvis,2020
60-64,9.4,13.5,125,Incidence,1101260,Hispanic of any race,11.4,Male,Larynx,2020
60-64,19.0,24.5,238,Incidence,1101260,Hispanic of any race,21.6,Male,Leukemias,2020
60-64,61.9,71.7,734,Incidence,1101260,Hispanic of any race,66.7,Male,Liver and Intrahepatic Bile Duct,2020
60-64,53.5,62.6,638,Incidence,1101260,Hispanic of any race,57.9,Male,Lung and Bronchus,2020
60-64,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
60-64,8.0,11.7,107,Incidence,1101260,Hispanic of any race,9.7,Male,Melanomas of the Skin,2020
60-64,0.8,2.4,16,Incidence,1101260,Hispanic of any race,1.5,Male,Mesothelioma,2020
60-64,15.7,20.9,200,Incidence,1101260,Hispanic of any race,18.2,Male,Myeloma,2020
60-64,32.3,39.5,394,Incidence,1101260,Hispanic of any race,35.8,Male,Non-Hodgkin Lymphoma,2020
60-64,26.6,33.1,327,Incidence,1101260,Hispanic of any race,29.7,Male,Oral Cavity and Pharynx,2020
60-64,30.1,37.0,368,Incidence,1101260,Hispanic of any race,33.4,Male,Pancreas,2020
60-64,238.1,256.7,2723,Incidence,1101260,Hispanic of any race,247.3,Male,Prostate,2020
60-64,17.2,22.5,217,Incidence,1101260,Hispanic of any race,19.7,Male,Stomach,2020
60-64,~,~,~,Incidence,1101260,Hispanic of any race,~,Male,Testis,2020
60-64,10.3,14.5,135,Incidence,1101260,Hispanic of any race,12.3,Male,Thyroid,2020
60-64,24.2,30.5,300,Incidence,1101260,Hispanic of any race,27.2,Male,Urinary Bladder,2020
65-69,1244.8,1294.7,9988,Incidence,786708,Hispanic of any race,1269.6,Male,All Cancer Sites Combined,2020
65-69,12.3,17.8,117,Incidence,786708,Hispanic of any race,14.9,Male,Brain and Other Nervous System,2020
65-69,107.8,122.9,906,Incidence,786708,Hispanic of any race,115.2,Male,Colon and Rectum,2020
65-69,13.7,19.5,129,Incidence,786708,Hispanic of any race,16.4,Male,Esophagus,2020
65-69,2.8,5.7,32,Incidence,786708,Hispanic of any race,4.1,Male,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,786708,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
65-69,71.6,84.1,611,Incidence,786708,Hispanic of any race,77.7,Male,Kidney and Renal Pelvis,2020
65-69,11.4,16.7,109,Incidence,786708,Hispanic of any race,13.9,Male,Larynx,2020
65-69,24.2,31.6,218,Incidence,786708,Hispanic of any race,27.7,Male,Leukemias,2020
65-69,80.1,93.2,680,Incidence,786708,Hispanic of any race,86.4,Male,Liver and Intrahepatic Bile Duct,2020
65-69,98.2,112.7,828,Incidence,786708,Hispanic of any race,105.2,Male,Lung and Bronchus,2020
65-69,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
65-69,8.1,12.7,80,Incidence,786708,Hispanic of any race,10.2,Male,Melanomas of the Skin,2020
65-69,1.4,3.6,18,Incidence,786708,Hispanic of any race,2.3,Male,Mesothelioma,2020
65-69,22.8,30.2,207,Incidence,786708,Hispanic of any race,26.3,Male,Myeloma,2020
65-69,52.0,62.7,450,Incidence,786708,Hispanic of any race,57.2,Male,Non-Hodgkin Lymphoma,2020
65-69,37.1,46.2,326,Incidence,786708,Hispanic of any race,41.4,Male,Oral Cavity and Pharynx,2020
65-69,43.9,53.8,383,Incidence,786708,Hispanic of any race,48.7,Male,Pancreas,2020
65-69,405.5,434.3,3302,Incidence,786708,Hispanic of any race,419.7,Male,Prostate,2020
65-69,27.8,35.8,249,Incidence,786708,Hispanic of any race,31.7,Male,Stomach,2020
65-69,~,~,~,Incidence,786708,Hispanic of any race,~,Male,Testis,2020
65-69,14.0,19.9,132,Incidence,786708,Hispanic of any race,16.8,Male,Thyroid,2020
65-69,52.3,63.0,452,Incidence,786708,Hispanic of any race,57.5,Male,Urinary Bladder,2020
70-74,1463.4,1527.9,8285,Incidence,554040,Hispanic of any race,1495.4,Male,All Cancer Sites Combined,2020
70-74,13.5,20.6,93,Incidence,554040,Hispanic of any race,16.8,Male,Brain and Other Nervous System,2020
70-74,127.1,146.7,757,Incidence,554040,Hispanic of any race,136.6,Male,Colon and Rectum,2020
70-74,17.3,25.1,116,Incidence,554040,Hispanic of any race,20.9,Male,Esophagus,2020
70-74,3.8,7.9,31,Incidence,554040,Hispanic of any race,5.6,Male,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,554040,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
70-74,83.4,99.5,505,Incidence,554040,Hispanic of any race,91.1,Male,Kidney and Renal Pelvis,2020
70-74,15.2,22.5,103,Incidence,554040,Hispanic of any race,18.6,Male,Larynx,2020
70-74,36.0,46.9,228,Incidence,554040,Hispanic of any race,41.2,Male,Leukemias,2020
70-74,79.7,95.5,484,Incidence,554040,Hispanic of any race,87.4,Male,Liver and Intrahepatic Bile Duct,2020
70-74,154.3,175.8,913,Incidence,554040,Hispanic of any race,164.8,Male,Lung and Bronchus,2020
70-74,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
70-74,12.7,19.6,88,Incidence,554040,Hispanic of any race,15.9,Male,Melanomas of the Skin,2020
70-74,1.8,4.9,17,Incidence,554040,Hispanic of any race,3.1,Male,Mesothelioma,2020
70-74,33.8,44.4,215,Incidence,554040,Hispanic of any race,38.8,Male,Myeloma,2020
70-74,63.4,77.5,389,Incidence,554040,Hispanic of any race,70.2,Male,Non-Hodgkin Lymphoma,2020
70-74,36.7,47.6,232,Incidence,554040,Hispanic of any race,41.9,Male,Oral Cavity and Pharynx,2020
70-74,50.4,63.1,313,Incidence,554040,Hispanic of any race,56.5,Male,Pancreas,2020
70-74,409.5,444.1,2363,Incidence,554040,Hispanic of any race,426.5,Male,Prostate,2020
70-74,37.3,48.4,236,Incidence,554040,Hispanic of any race,42.6,Male,Stomach,2020
70-74,~,~,~,Incidence,554040,Hispanic of any race,~,Male,Testis,2020
70-74,11.1,17.6,78,Incidence,554040,Hispanic of any race,14.1,Male,Thyroid,2020
70-74,67.5,82.1,413,Incidence,554040,Hispanic of any race,74.5,Male,Urinary Bladder,2020
75-79,1769.6,1860.0,6236,Incidence,343700,Hispanic of any race,1814.4,Male,All Cancer Sites Combined,2020
75-79,16.1,26.1,71,Incidence,343700,Hispanic of any race,20.7,Male,Brain and Other Nervous System,2020
75-79,140.2,166.7,526,Incidence,343700,Hispanic of any race,153.0,Male,Colon and Rectum,2020
75-79,19.2,29.9,83,Incidence,343700,Hispanic of any race,24.1,Male,Esophagus,2020
75-79,5.9,12.5,30,Incidence,343700,Hispanic of any race,8.7,Male,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,343700,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
75-79,85.7,106.6,329,Incidence,343700,Hispanic of any race,95.7,Male,Kidney and Renal Pelvis,2020
75-79,16.4,26.4,72,Incidence,343700,Hispanic of any race,20.9,Male,Larynx,2020
75-79,43.4,58.7,174,Incidence,343700,Hispanic of any race,50.6,Male,Leukemias,2020
75-79,78.0,98.0,301,Incidence,343700,Hispanic of any race,87.6,Male,Liver and Intrahepatic Bile Duct,2020
75-79,209.0,241.0,772,Incidence,343700,Hispanic of any race,224.6,Male,Lung and Bronchus,2020
75-79,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
75-79,20.3,31.2,87,Incidence,343700,Hispanic of any race,25.3,Male,Melanomas of the Skin,2020
75-79,3.6,9.0,20,Incidence,343700,Hispanic of any race,5.8,Male,Mesothelioma,2020
75-79,35.3,49.3,144,Incidence,343700,Hispanic of any race,41.9,Male,Myeloma,2020
75-79,95.6,117.7,365,Incidence,343700,Hispanic of any race,106.2,Male,Non-Hodgkin Lymphoma,2020
75-79,36.9,51.2,150,Incidence,343700,Hispanic of any race,43.6,Male,Oral Cavity and Pharynx,2020
75-79,76.6,96.5,296,Incidence,343700,Hispanic of any race,86.1,Male,Pancreas,2020
75-79,403.6,447.4,1461,Incidence,343700,Hispanic of any race,425.1,Male,Prostate,2020
75-79,52.8,69.6,209,Incidence,343700,Hispanic of any race,60.8,Male,Stomach,2020
75-79,~,~,~,Incidence,343700,Hispanic of any race,~,Male,Testis,2020
75-79,10.8,19.2,50,Incidence,343700,Hispanic of any race,14.5,Male,Thyroid,2020
75-79,115.5,139.6,437,Incidence,343700,Hispanic of any race,127.1,Male,Urinary Bladder,2020
80-84,1792.5,1906.7,4059,Incidence,219531,Hispanic of any race,1848.9,Male,All Cancer Sites Combined,2020
80-84,15.3,27.9,46,Incidence,219531,Hispanic of any race,21.0,Male,Brain and Other Nervous System,2020
80-84,148.8,183.3,363,Incidence,219531,Hispanic of any race,165.4,Male,Colon and Rectum,2020
80-84,21.3,35.7,61,Incidence,219531,Hispanic of any race,27.8,Male,Esophagus,2020
80-84,~,~,~,Incidence,219531,Hispanic of any race,~,Male,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,219531,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
80-84,73.4,98.3,187,Incidence,219531,Hispanic of any race,85.2,Male,Kidney and Renal Pelvis,2020
80-84,14.2,26.4,43,Incidence,219531,Hispanic of any race,19.6,Male,Larynx,2020
80-84,57.8,80.2,150,Incidence,219531,Hispanic of any race,68.3,Male,Leukemias,2020
80-84,75.9,101.2,193,Incidence,219531,Hispanic of any race,87.9,Male,Liver and Intrahepatic Bile Duct,2020
80-84,227.4,269.5,544,Incidence,219531,Hispanic of any race,247.8,Male,Lung and Bronchus,2020
80-84,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
80-84,17.3,30.5,51,Incidence,219531,Hispanic of any race,23.2,Male,Melanomas of the Skin,2020
80-84,6.3,15.2,22,Incidence,219531,Hispanic of any race,10.0,Male,Mesothelioma,2020
80-84,44.5,64.4,118,Incidence,219531,Hispanic of any race,53.8,Male,Myeloma,2020
80-84,90.4,117.8,227,Incidence,219531,Hispanic of any race,103.4,Male,Non-Hodgkin Lymphoma,2020
80-84,37.9,56.4,102,Incidence,219531,Hispanic of any race,46.5,Male,Oral Cavity and Pharynx,2020
80-84,73.8,98.8,188,Incidence,219531,Hispanic of any race,85.6,Male,Pancreas,2020
80-84,333.0,383.5,785,Incidence,219531,Hispanic of any race,357.6,Male,Prostate,2020
80-84,57.0,79.2,148,Incidence,219531,Hispanic of any race,67.4,Male,Stomach,2020
80-84,~,~,~,Incidence,219531,Hispanic of any race,~,Male,Testis,2020
80-84,8.5,18.4,28,Incidence,219531,Hispanic of any race,12.8,Male,Thyroid,2020
80-84,119.5,150.6,295,Incidence,219531,Hispanic of any race,134.4,Male,Urinary Bladder,2020
85+,1701.3,1820.8,3368,Incidence,191332,Hispanic of any race,1760.3,Male,All Cancer Sites Combined,2020
85+,12.7,25.4,35,Incidence,191332,Hispanic of any race,18.3,Male,Brain and Other Nervous System,2020
85+,169.7,209.2,361,Incidence,191332,Hispanic of any race,188.7,Male,Colon and Rectum,2020
85+,16.3,30.3,43,Incidence,191332,Hispanic of any race,22.5,Male,Esophagus,2020
85+,~,~,~,Incidence,191332,Hispanic of any race,~,Male,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,191332,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
85+,60.6,85.2,138,Incidence,191332,Hispanic of any race,72.1,Male,Kidney and Renal Pelvis,2020
85+,12.7,25.4,35,Incidence,191332,Hispanic of any race,18.3,Male,Larynx,2020
85+,50.6,73.3,117,Incidence,191332,Hispanic of any race,61.2,Male,Leukemias,2020
85+,61.1,85.8,139,Incidence,191332,Hispanic of any race,72.6,Male,Liver and Intrahepatic Bile Duct,2020
85+,204.5,247.6,431,Incidence,191332,Hispanic of any race,225.3,Male,Lung and Bronchus,2020
85+,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
85+,24.8,41.5,62,Incidence,191332,Hispanic of any race,32.4,Male,Melanomas of the Skin,2020
85+,~,~,~,Incidence,191332,Hispanic of any race,~,Male,Mesothelioma,2020
85+,28.5,46.2,70,Incidence,191332,Hispanic of any race,36.6,Male,Myeloma,2020
85+,92.5,122.3,204,Incidence,191332,Hispanic of any race,106.6,Male,Non-Hodgkin Lymphoma,2020
85+,25.3,42.1,63,Incidence,191332,Hispanic of any race,32.9,Male,Oral Cavity and Pharynx,2020
85+,61.1,85.8,139,Incidence,191332,Hispanic of any race,72.6,Male,Pancreas,2020
85+,268.4,317.4,559,Incidence,191332,Hispanic of any race,292.2,Male,Prostate,2020
85+,53.9,77.3,124,Incidence,191332,Hispanic of any race,64.8,Male,Stomach,2020
85+,~,~,~,Incidence,191332,Hispanic of any race,~,Male,Testis,2020
85+,~,~,~,Incidence,191332,Hispanic of any race,~,Male,Thyroid,2020
85+,146.0,182.8,313,Incidence,191332,Hispanic of any race,163.6,Male,Urinary Bladder,2020
<1,17.6,26.1,104,Incidence,482262,Hispanic of any race,21.6,Male,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Colon and Rectum,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Esophagus,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Larynx,2020
<1,1.9,5.4,16,Incidence,482262,Hispanic of any race,3.3,Male,Leukemias,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Lung and Bronchus,2020
<1,~,~,~,Incidence,0,Hispanic of any race,~,Male,Male Breast,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Melanomas of the Skin,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Mesothelioma,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Myeloma,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Pancreas,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Prostate,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Stomach,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Testis,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Thyroid,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male,Urinary Bladder,2020
1-4,19.2,22.1,809,Incidence,3924836,Hispanic of any race,20.6,Male and Female,All Cancer Sites Combined,2020
1-4,2.9,4.1,137,Incidence,3924836,Hispanic of any race,3.5,Male and Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,Cervix,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Esophagus,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,Female Breast,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
1-4,1.4,2.3,70,Incidence,3924836,Hispanic of any race,1.8,Male and Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Larynx,2020
1-4,8.2,10.1,356,Incidence,3924836,Hispanic of any race,9.1,Male and Female,Leukemias,2020
1-4,0.7,1.3,37,Incidence,3924836,Hispanic of any race,0.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,Male and Female Breast,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Mesothelioma,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Myeloma,2020
1-4,0.3,0.8,21,Incidence,3924836,Hispanic of any race,0.5,Male and Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,1926812,Hispanic of any race,~,Male and Female,Ovary,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Pancreas,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male and Female,Prostate,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Stomach,2020
1-4,~,~,~,Incidence,1998024,Hispanic of any race,~,Male and Female,Testis,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Thyroid,2020
1-4,~,~,~,Incidence,3924836,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
10-14,13.6,15.7,762,Incidence,5225599,Hispanic of any race,14.6,Male and Female,All Cancer Sites Combined,2020
10-14,1.7,2.5,109,Incidence,5225599,Hispanic of any race,2.1,Male and Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Male and Female,Cervix,2020
10-14,0.4,0.8,30,Incidence,5225599,Hispanic of any race,0.6,Male and Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Esophagus,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Male and Female,Female Breast,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2020
10-14,0.5,1.0,38,Incidence,5225599,Hispanic of any race,0.7,Male and Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Larynx,2020
10-14,4.2,5.5,252,Incidence,5225599,Hispanic of any race,4.8,Male and Female,Leukemias,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Male and Female,Male and Female Breast,2020
10-14,~,~,~,Incidence,2561755,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Mesothelioma,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Myeloma,2020
10-14,0.8,1.4,58,Incidence,5225599,Hispanic of any race,1.1,Male and Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2020
10-14,0.9,1.9,34,Incidence,2561755,Hispanic of any race,1.3,Male and Female,Ovary,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Pancreas,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male and Female,Prostate,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Stomach,2020
10-14,~,~,~,Incidence,2663844,Hispanic of any race,~,Male and Female,Testis,2020
10-14,0.7,1.2,48,Incidence,5225599,Hispanic of any race,0.9,Male and Female,Thyroid,2020
10-14,~,~,~,Incidence,5225599,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
15-19,21.1,23.7,1114,Incidence,4975186,Hispanic of any race,22.4,Male and Female,All Cancer Sites Combined,2020
15-19,1.4,2.1,86,Incidence,4975186,Hispanic of any race,1.7,Male and Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Male and Female,Cervix,2020
15-19,0.6,1.1,39,Incidence,4975186,Hispanic of any race,0.8,Male and Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Esophagus,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Male and Female,Female Breast,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2020
15-19,2.0,2.9,122,Incidence,4975186,Hispanic of any race,2.5,Male and Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Larynx,2020
15-19,3.8,5.0,218,Incidence,4975186,Hispanic of any race,4.4,Male and Female,Leukemias,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Male and Female,Male and Female Breast,2020
15-19,~,~,~,Incidence,2439012,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Mesothelioma,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Myeloma,2020
15-19,1.3,2.0,81,Incidence,4975186,Hispanic of any race,1.6,Male and Female,Non-Hodgkin Lymphoma,2020
15-19,0.2,0.6,20,Incidence,4975186,Hispanic of any race,0.4,Male and Female,Oral Cavity and Pharynx,2020
15-19,1.1,2.1,37,Incidence,2439012,Hispanic of any race,1.5,Male and Female,Ovary,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Pancreas,2020
15-19,~,~,~,Incidence,2536174,Hispanic of any race,~,Male and Female,Prostate,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Stomach,2020
15-19,4.4,6.2,133,Incidence,2536174,Hispanic of any race,5.2,Male and Female,Testis,2020
15-19,2.3,3.2,135,Incidence,4975186,Hispanic of any race,2.7,Male and Female,Thyroid,2020
15-19,~,~,~,Incidence,4975186,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
20-24,32.1,35.4,1614,Incidence,4785405,Hispanic of any race,33.7,Male and Female,All Cancer Sites Combined,2020
20-24,1.3,2.1,81,Incidence,4785405,Hispanic of any race,1.7,Male and Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Male and Female,Cervix,2020
20-24,1.3,2.1,81,Incidence,4785405,Hispanic of any race,1.7,Male and Female,Colon and Rectum,2020
20-24,0.4,1.2,17,Incidence,2334375,Hispanic of any race,0.7,Male and Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Esophagus,2020
20-24,1.2,2.3,40,Incidence,2334375,Hispanic of any race,1.7,Male and Female,Female Breast,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2020
20-24,2.4,3.4,137,Incidence,4785405,Hispanic of any race,2.9,Male and Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
20-24,0.3,0.8,25,Incidence,4785405,Hispanic of any race,0.5,Male and Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Larynx,2020
20-24,3.0,4.1,169,Incidence,4785405,Hispanic of any race,3.5,Male and Female,Leukemias,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Lung and Bronchus,2020
20-24,1.2,2.3,40,Incidence,2334375,Hispanic of any race,1.7,Male and Female,Male and Female Breast,2020
20-24,~,~,~,Incidence,2334375,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
20-24,0.3,0.7,22,Incidence,4785405,Hispanic of any race,0.5,Male and Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Mesothelioma,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Myeloma,2020
20-24,2.0,2.9,115,Incidence,4785405,Hispanic of any race,2.4,Male and Female,Non-Hodgkin Lymphoma,2020
20-24,0.3,0.6,20,Incidence,4785405,Hispanic of any race,0.4,Male and Female,Oral Cavity and Pharynx,2020
20-24,1.9,3.2,58,Incidence,2334375,Hispanic of any race,2.5,Male and Female,Ovary,2020
20-24,0.2,0.6,17,Incidence,4785405,Hispanic of any race,0.4,Male and Female,Pancreas,2020
20-24,~,~,~,Incidence,2451030,Hispanic of any race,~,Male and Female,Prostate,2020
20-24,0.3,0.7,22,Incidence,4785405,Hispanic of any race,0.5,Male and Female,Stomach,2020
20-24,13.4,16.5,364,Incidence,2451030,Hispanic of any race,14.9,Male and Female,Testis,2020
20-24,4.0,5.2,218,Incidence,4785405,Hispanic of any race,4.6,Male and Female,Thyroid,2020
20-24,~,~,~,Incidence,4785405,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
25-29,48.4,52.4,2440,Incidence,4840545,Hispanic of any race,50.4,Male and Female,All Cancer Sites Combined,2020
25-29,1.6,2.4,94,Incidence,4840545,Hispanic of any race,1.9,Male and Female,Brain and Other Nervous System,2020
25-29,2.9,4.4,84,Incidence,2338367,Hispanic of any race,3.6,Male and Female,Cervix,2020
25-29,2.4,3.3,137,Incidence,4840545,Hispanic of any race,2.8,Male and Female,Colon and Rectum,2020
25-29,2.4,3.8,71,Incidence,2338367,Hispanic of any race,3.0,Male and Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,4840545,Hispanic of any race,~,Male and Female,Esophagus,2020
25-29,8.7,11.3,233,Incidence,2338367,Hispanic of any race,10.0,Male and Female,Female Breast,2020
25-29,0.4,1.1,16,Incidence,2338367,Hispanic of any race,0.7,Male and Female,"Female Breast, <i>in situ</i>",2020
25-29,2.2,3.2,129,Incidence,4840545,Hispanic of any race,2.7,Male and Female,Hodgkin Lymphoma,2020
25-29,0.3,0.6,20,Incidence,4840545,Hispanic of any race,0.4,Male and Female,Kaposi Sarcoma,2020
25-29,1.0,1.7,63,Incidence,4840545,Hispanic of any race,1.3,Male and Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,4840545,Hispanic of any race,~,Male and Female,Larynx,2020
25-29,3.0,4.1,171,Incidence,4840545,Hispanic of any race,3.5,Male and Female,Leukemias,2020
25-29,~,~,~,Incidence,4840545,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.3,0.7,23,Incidence,4840545,Hispanic of any race,0.5,Male and Female,Lung and Bronchus,2020
25-29,8.7,11.3,233,Incidence,2338367,Hispanic of any race,10.0,Male and Female,Male and Female Breast,2020
25-29,0.4,1.1,16,Incidence,2338367,Hispanic of any race,0.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
25-29,0.4,0.8,28,Incidence,4840545,Hispanic of any race,0.6,Male and Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,4840545,Hispanic of any race,~,Male and Female,Mesothelioma,2020
25-29,~,~,~,Incidence,4840545,Hispanic of any race,~,Male and Female,Myeloma,2020
25-29,2.3,3.2,131,Incidence,4840545,Hispanic of any race,2.7,Male and Female,Non-Hodgkin Lymphoma,2020
25-29,0.5,0.9,32,Incidence,4840545,Hispanic of any race,0.7,Male and Female,Oral Cavity and Pharynx,2020
25-29,1.5,2.7,47,Incidence,2338367,Hispanic of any race,2.0,Male and Female,Ovary,2020
25-29,0.2,0.6,19,Incidence,4840545,Hispanic of any race,0.4,Male and Female,Pancreas,2020
25-29,~,~,~,Incidence,2502178,Hispanic of any race,~,Male and Female,Prostate,2020
25-29,0.4,0.8,28,Incidence,4840545,Hispanic of any race,0.6,Male and Female,Stomach,2020
25-29,15.5,18.8,428,Incidence,2502178,Hispanic of any race,17.1,Male and Female,Testis,2020
25-29,7.9,9.6,424,Incidence,4840545,Hispanic of any race,8.8,Male and Female,Thyroid,2020
25-29,~,~,~,Incidence,4840545,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
30-34,76.5,81.7,3600,Incidence,4553197,Hispanic of any race,79.1,Male and Female,All Cancer Sites Combined,2020
30-34,1.9,2.8,105,Incidence,4553197,Hispanic of any race,2.3,Male and Female,Brain and Other Nervous System,2020
30-34,10.9,13.9,266,Incidence,2163578,Hispanic of any race,12.3,Male and Female,Cervix,2020
30-34,4.9,6.3,252,Incidence,4553197,Hispanic of any race,5.5,Male and Female,Colon and Rectum,2020
30-34,6.5,8.8,164,Incidence,2163578,Hispanic of any race,7.6,Male and Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,4553197,Hispanic of any race,~,Male and Female,Esophagus,2020
30-34,23.8,28.2,561,Incidence,2163578,Hispanic of any race,25.9,Male and Female,Female Breast,2020
30-34,1.8,3.2,53,Incidence,2163578,Hispanic of any race,2.4,Male and Female,"Female Breast, <i>in situ</i>",2020
30-34,1.8,2.7,103,Incidence,4553197,Hispanic of any race,2.3,Male and Female,Hodgkin Lymphoma,2020
30-34,0.4,0.8,26,Incidence,4553197,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2020
30-34,2.3,3.3,125,Incidence,4553197,Hispanic of any race,2.7,Male and Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,4553197,Hispanic of any race,~,Male and Female,Larynx,2020
30-34,3.4,4.6,181,Incidence,4553197,Hispanic of any race,4.0,Male and Female,Leukemias,2020
30-34,0.4,0.8,25,Incidence,4553197,Hispanic of any race,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.6,1.2,39,Incidence,4553197,Hispanic of any race,0.9,Male and Female,Lung and Bronchus,2020
30-34,23.8,28.2,561,Incidence,2163578,Hispanic of any race,25.9,Male and Female,Male and Female Breast,2020
30-34,1.8,3.2,53,Incidence,2163578,Hispanic of any race,2.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
30-34,1.4,2.1,78,Incidence,4553197,Hispanic of any race,1.7,Male and Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,4553197,Hispanic of any race,~,Male and Female,Mesothelioma,2020
30-34,0.2,0.6,16,Incidence,4553197,Hispanic of any race,0.4,Male and Female,Myeloma,2020
30-34,2.9,4.0,156,Incidence,4553197,Hispanic of any race,3.4,Male and Female,Non-Hodgkin Lymphoma,2020
30-34,1.0,1.7,60,Incidence,4553197,Hispanic of any race,1.3,Male and Female,Oral Cavity and Pharynx,2020
30-34,2.1,3.6,60,Incidence,2163578,Hispanic of any race,2.8,Male and Female,Ovary,2020
30-34,0.5,1.0,33,Incidence,4553197,Hispanic of any race,0.7,Male and Female,Pancreas,2020
30-34,~,~,~,Incidence,2389619,Hispanic of any race,~,Male and Female,Prostate,2020
30-34,1.1,1.9,67,Incidence,4553197,Hispanic of any race,1.5,Male and Female,Stomach,2020
30-34,13.9,17.1,368,Incidence,2389619,Hispanic of any race,15.4,Male and Female,Testis,2020
30-34,11.7,13.8,578,Incidence,4553197,Hispanic of any race,12.7,Male and Female,Thyroid,2020
30-34,0.2,0.6,16,Incidence,4553197,Hispanic of any race,0.4,Male and Female,Urinary Bladder,2020
35-39,109.3,115.6,4951,Incidence,4404284,Hispanic of any race,112.4,Male and Female,All Cancer Sites Combined,2020
35-39,2.3,3.3,120,Incidence,4404284,Hispanic of any race,2.7,Male and Female,Brain and Other Nervous System,2020
35-39,13.8,17.2,327,Incidence,2115409,Hispanic of any race,15.5,Male and Female,Cervix,2020
35-39,9.3,11.2,449,Incidence,4404284,Hispanic of any race,10.2,Male and Female,Colon and Rectum,2020
35-39,10.8,13.9,260,Incidence,2115409,Hispanic of any race,12.3,Male and Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,4404284,Hispanic of any race,~,Male and Female,Esophagus,2020
35-39,47.8,53.9,1075,Incidence,2115409,Hispanic of any race,50.8,Male and Female,Female Breast,2020
35-39,4.7,6.7,119,Incidence,2115409,Hispanic of any race,5.6,Male and Female,"Female Breast, <i>in situ</i>",2020
35-39,1.4,2.2,76,Incidence,4404284,Hispanic of any race,1.7,Male and Female,Hodgkin Lymphoma,2020
35-39,0.4,0.9,29,Incidence,4404284,Hispanic of any race,0.7,Male and Female,Kaposi Sarcoma,2020
35-39,5.4,6.9,268,Incidence,4404284,Hispanic of any race,6.1,Male and Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,4404284,Hispanic of any race,~,Male and Female,Larynx,2020
35-39,4.6,6.0,232,Incidence,4404284,Hispanic of any race,5.3,Male and Female,Leukemias,2020
35-39,0.6,1.1,36,Incidence,4404284,Hispanic of any race,0.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
35-39,1.1,1.9,65,Incidence,4404284,Hispanic of any race,1.5,Male and Female,Lung and Bronchus,2020
35-39,47.8,53.9,1075,Incidence,2115409,Hispanic of any race,50.8,Male and Female,Male and Female Breast,2020
35-39,4.7,6.7,119,Incidence,2115409,Hispanic of any race,5.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
35-39,1.9,2.8,102,Incidence,4404284,Hispanic of any race,2.3,Male and Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,4404284,Hispanic of any race,~,Male and Female,Mesothelioma,2020
35-39,0.3,0.8,22,Incidence,4404284,Hispanic of any race,0.5,Male and Female,Myeloma,2020
35-39,5.0,6.4,250,Incidence,4404284,Hispanic of any race,5.7,Male and Female,Non-Hodgkin Lymphoma,2020
35-39,1.1,1.8,62,Incidence,4404284,Hispanic of any race,1.4,Male and Female,Oral Cavity and Pharynx,2020
35-39,3.6,5.5,95,Incidence,2115409,Hispanic of any race,4.5,Male and Female,Ovary,2020
35-39,0.7,1.3,41,Incidence,4404284,Hispanic of any race,0.9,Male and Female,Pancreas,2020
35-39,~,~,~,Incidence,2288875,Hispanic of any race,~,Male and Female,Prostate,2020
35-39,2.5,3.6,134,Incidence,4404284,Hispanic of any race,3.0,Male and Female,Stomach,2020
35-39,8.5,11.1,223,Incidence,2288875,Hispanic of any race,9.7,Male and Female,Testis,2020
35-39,13.1,15.3,623,Incidence,4404284,Hispanic of any race,14.1,Male and Female,Thyroid,2020
35-39,0.5,1.0,32,Incidence,4404284,Hispanic of any race,0.7,Male and Female,Urinary Bladder,2020
40-44,165.6,173.6,7000,Incidence,4127700,Hispanic of any race,169.6,Male and Female,All Cancer Sites Combined,2020
40-44,2.8,3.9,137,Incidence,4127700,Hispanic of any race,3.3,Male and Female,Brain and Other Nervous System,2020
40-44,13.6,17.1,308,Incidence,2011626,Hispanic of any race,15.3,Male and Female,Cervix,2020
40-44,15.0,17.5,671,Incidence,4127700,Hispanic of any race,16.3,Male and Female,Colon and Rectum,2020
40-44,16.2,20.0,363,Incidence,2011626,Hispanic of any race,18.0,Male and Female,"Corpus and Uterus, NOS",2020
40-44,0.4,0.9,24,Incidence,4127700,Hispanic of any race,0.6,Male and Female,Esophagus,2020
40-44,88.9,97.4,1872,Incidence,2011626,Hispanic of any race,93.1,Male and Female,Female Breast,2020
40-44,21.2,25.4,467,Incidence,2011626,Hispanic of any race,23.2,Male and Female,"Female Breast, <i>in situ</i>",2020
40-44,1.3,2.1,70,Incidence,4127700,Hispanic of any race,1.7,Male and Female,Hodgkin Lymphoma,2020
40-44,0.4,0.9,26,Incidence,4127700,Hispanic of any race,0.6,Male and Female,Kaposi Sarcoma,2020
40-44,9.5,11.5,431,Incidence,4127700,Hispanic of any race,10.4,Male and Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,4127700,Hispanic of any race,~,Male and Female,Larynx,2020
40-44,5.0,6.4,234,Incidence,4127700,Hispanic of any race,5.7,Male and Female,Leukemias,2020
40-44,1.9,2.8,95,Incidence,4127700,Hispanic of any race,2.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
40-44,2.9,4.0,141,Incidence,4127700,Hispanic of any race,3.4,Male and Female,Lung and Bronchus,2020
40-44,88.9,97.4,1872,Incidence,2011626,Hispanic of any race,93.1,Male and Female,Male and Female Breast,2020
40-44,21.2,25.4,467,Incidence,2011626,Hispanic of any race,23.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
40-44,2.1,3.1,107,Incidence,4127700,Hispanic of any race,2.6,Male and Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,4127700,Hispanic of any race,~,Male and Female,Mesothelioma,2020
40-44,1.9,2.9,97,Incidence,4127700,Hispanic of any race,2.3,Male and Female,Myeloma,2020
40-44,6.9,8.6,318,Incidence,4127700,Hispanic of any race,7.7,Male and Female,Non-Hodgkin Lymphoma,2020
40-44,2.4,3.5,120,Incidence,4127700,Hispanic of any race,2.9,Male and Female,Oral Cavity and Pharynx,2020
40-44,5.9,8.2,140,Incidence,2011626,Hispanic of any race,7.0,Male and Female,Ovary,2020
40-44,2.5,3.6,125,Incidence,4127700,Hispanic of any race,3.0,Male and Female,Pancreas,2020
40-44,2.0,3.4,55,Incidence,2116074,Hispanic of any race,2.6,Male and Female,Prostate,2020
40-44,4.3,5.7,204,Incidence,4127700,Hispanic of any race,4.9,Male and Female,Stomach,2020
40-44,5.1,7.3,130,Incidence,2116074,Hispanic of any race,6.1,Male and Female,Testis,2020
40-44,15.0,17.5,668,Incidence,4127700,Hispanic of any race,16.2,Male and Female,Thyroid,2020
40-44,0.9,1.7,52,Incidence,4127700,Hispanic of any race,1.3,Male and Female,Urinary Bladder,2020
45-49,243.8,253.9,9382,Incidence,3770857,Hispanic of any race,248.8,Male and Female,All Cancer Sites Combined,2020
45-49,3.1,4.4,141,Incidence,3770857,Hispanic of any race,3.7,Male and Female,Brain and Other Nervous System,2020
45-49,12.7,16.2,270,Incidence,1873134,Hispanic of any race,14.4,Male and Female,Cervix,2020
45-49,26.2,29.6,1052,Incidence,3770857,Hispanic of any race,27.9,Male and Female,Colon and Rectum,2020
45-49,23.8,28.5,488,Incidence,1873134,Hispanic of any race,26.1,Male and Female,"Corpus and Uterus, NOS",2020
45-49,1.0,1.7,50,Incidence,3770857,Hispanic of any race,1.3,Male and Female,Esophagus,2020
45-49,133.6,144.4,2602,Incidence,1873134,Hispanic of any race,138.9,Male and Female,Female Breast,2020
45-49,34.3,39.9,693,Incidence,1873134,Hispanic of any race,37.0,Male and Female,"Female Breast, <i>in situ</i>",2020
45-49,1.1,1.9,56,Incidence,3770857,Hispanic of any race,1.5,Male and Female,Hodgkin Lymphoma,2020
45-49,0.3,0.7,17,Incidence,3770857,Hispanic of any race,0.5,Male and Female,Kaposi Sarcoma,2020
45-49,15.5,18.2,634,Incidence,3770857,Hispanic of any race,16.8,Male and Female,Kidney and Renal Pelvis,2020
45-49,0.6,1.3,34,Incidence,3770857,Hispanic of any race,0.9,Male and Female,Larynx,2020
45-49,6.1,7.8,262,Incidence,3770857,Hispanic of any race,6.9,Male and Female,Leukemias,2020
45-49,3.1,4.4,139,Incidence,3770857,Hispanic of any race,3.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
45-49,5.2,6.8,226,Incidence,3770857,Hispanic of any race,6.0,Male and Female,Lung and Bronchus,2020
45-49,133.6,144.4,2602,Incidence,1873134,Hispanic of any race,138.9,Male and Female,Male and Female Breast,2020
45-49,34.3,39.9,693,Incidence,1873134,Hispanic of any race,37.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
45-49,3.3,4.6,149,Incidence,3770857,Hispanic of any race,4.0,Male and Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,3770857,Hispanic of any race,~,Male and Female,Mesothelioma,2020
45-49,3.6,5.0,160,Incidence,3770857,Hispanic of any race,4.2,Male and Female,Myeloma,2020
45-49,10.2,12.3,423,Incidence,3770857,Hispanic of any race,11.2,Male and Female,Non-Hodgkin Lymphoma,2020
45-49,4.9,6.5,213,Incidence,3770857,Hispanic of any race,5.6,Male and Female,Oral Cavity and Pharynx,2020
45-49,10.0,13.1,215,Incidence,1873134,Hispanic of any race,11.5,Male and Female,Ovary,2020
45-49,4.4,5.9,192,Incidence,3770857,Hispanic of any race,5.1,Male and Female,Pancreas,2020
45-49,10.0,13.1,218,Incidence,1897723,Hispanic of any race,11.5,Male and Female,Prostate,2020
45-49,6.0,7.7,258,Incidence,3770857,Hispanic of any race,6.8,Male and Female,Stomach,2020
45-49,3.0,4.8,73,Incidence,1897723,Hispanic of any race,3.8,Male and Female,Testis,2020
45-49,16.4,19.1,669,Incidence,3770857,Hispanic of any race,17.7,Male and Female,Thyroid,2020
45-49,2.3,3.4,107,Incidence,3770857,Hispanic of any race,2.8,Male and Female,Urinary Bladder,2020
5-9,11.8,13.8,643,Incidence,5040863,Hispanic of any race,12.8,Male and Female,All Cancer Sites Combined,2020
5-9,2.3,3.2,136,Incidence,5040863,Hispanic of any race,2.7,Male and Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,Cervix,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Esophagus,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,Female Breast,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2020
5-9,0.3,0.7,23,Incidence,5040863,Hispanic of any race,0.5,Male and Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
5-9,0.3,0.7,25,Incidence,5040863,Hispanic of any race,0.5,Male and Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Larynx,2020
5-9,4.5,5.7,256,Incidence,5040863,Hispanic of any race,5.1,Male and Female,Leukemias,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,Male and Female Breast,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Mesothelioma,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Myeloma,2020
5-9,0.6,1.1,43,Incidence,5040863,Hispanic of any race,0.9,Male and Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,2474075,Hispanic of any race,~,Male and Female,Ovary,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Pancreas,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male and Female,Prostate,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Stomach,2020
5-9,~,~,~,Incidence,2566788,Hispanic of any race,~,Male and Female,Testis,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Thyroid,2020
5-9,~,~,~,Incidence,5040863,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
50-54,367.7,380.9,12392,Incidence,3311418,Hispanic of any race,374.2,Male and Female,All Cancer Sites Combined,2020
50-54,4.6,6.2,178,Incidence,3311418,Hispanic of any race,5.4,Male and Female,Brain and Other Nervous System,2020
50-54,11.3,14.8,213,Incidence,1643443,Hispanic of any race,13.0,Male and Female,Cervix,2020
50-54,42.4,47.0,1480,Incidence,3311418,Hispanic of any race,44.7,Male and Female,Colon and Rectum,2020
50-54,41.1,47.6,728,Incidence,1643443,Hispanic of any race,44.3,Male and Female,"Corpus and Uterus, NOS",2020
50-54,1.9,2.9,78,Incidence,3311418,Hispanic of any race,2.4,Male and Female,Esophagus,2020
50-54,165.8,178.5,2828,Incidence,1643443,Hispanic of any race,172.1,Male and Female,Female Breast,2020
50-54,38.4,44.7,681,Incidence,1643443,Hispanic of any race,41.4,Male and Female,"Female Breast, <i>in situ</i>",2020
50-54,1.6,2.6,68,Incidence,3311418,Hispanic of any race,2.1,Male and Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,3311418,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
50-54,22.4,25.8,797,Incidence,3311418,Hispanic of any race,24.1,Male and Female,Kidney and Renal Pelvis,2020
50-54,1.7,2.7,71,Incidence,3311418,Hispanic of any race,2.1,Male and Female,Larynx,2020
50-54,8.1,10.2,301,Incidence,3311418,Hispanic of any race,9.1,Male and Female,Leukemias,2020
50-54,9.7,12.0,357,Incidence,3311418,Hispanic of any race,10.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
50-54,12.2,14.8,446,Incidence,3311418,Hispanic of any race,13.5,Male and Female,Lung and Bronchus,2020
50-54,165.8,178.5,2828,Incidence,1643443,Hispanic of any race,172.1,Male and Female,Male and Female Breast,2020
50-54,38.4,44.7,681,Incidence,1643443,Hispanic of any race,41.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
50-54,3.8,5.3,148,Incidence,3311418,Hispanic of any race,4.5,Male and Female,Melanomas of the Skin,2020
50-54,0.3,0.8,16,Incidence,3311418,Hispanic of any race,0.5,Male and Female,Mesothelioma,2020
50-54,5.4,7.2,207,Incidence,3311418,Hispanic of any race,6.3,Male and Female,Myeloma,2020
50-54,15.7,18.6,566,Incidence,3311418,Hispanic of any race,17.1,Male and Female,Non-Hodgkin Lymphoma,2020
50-54,8.7,10.8,322,Incidence,3311418,Hispanic of any race,9.7,Male and Female,Oral Cavity and Pharynx,2020
50-54,14.2,18.2,265,Incidence,1643443,Hispanic of any race,16.1,Male and Female,Ovary,2020
50-54,8.2,10.3,306,Incidence,3311418,Hispanic of any race,9.2,Male and Female,Pancreas,2020
50-54,47.5,54.4,848,Incidence,1667975,Hispanic of any race,50.8,Male and Female,Prostate,2020
50-54,8.8,11.0,327,Incidence,3311418,Hispanic of any race,9.9,Male and Female,Stomach,2020
50-54,2.2,3.9,49,Incidence,1667975,Hispanic of any race,2.9,Male and Female,Testis,2020
50-54,17.8,20.9,639,Incidence,3311418,Hispanic of any race,19.3,Male and Female,Thyroid,2020
50-54,4.3,5.8,166,Incidence,3311418,Hispanic of any race,5.0,Male and Female,Urinary Bladder,2020
55-59,541.4,558.6,15758,Incidence,2865291,Hispanic of any race,550.0,Male and Female,All Cancer Sites Combined,2020
55-59,7.0,9.1,228,Incidence,2865291,Hispanic of any race,8.0,Male and Female,Brain and Other Nervous System,2020
55-59,11.5,15.3,192,Incidence,1447678,Hispanic of any race,13.3,Male and Female,Cervix,2020
55-59,51.7,57.1,1557,Incidence,2865291,Hispanic of any race,54.3,Male and Female,Colon and Rectum,2020
55-59,61.6,70.0,951,Incidence,1447678,Hispanic of any race,65.7,Male and Female,"Corpus and Uterus, NOS",2020
55-59,4.2,5.8,142,Incidence,2865291,Hispanic of any race,5.0,Male and Female,Esophagus,2020
55-59,187.7,202.1,2820,Incidence,1447678,Hispanic of any race,194.8,Male and Female,Female Breast,2020
55-59,40.7,47.6,637,Incidence,1447678,Hispanic of any race,44.0,Male and Female,"Female Breast, <i>in situ</i>",2020
55-59,2.1,3.4,77,Incidence,2865291,Hispanic of any race,2.7,Male and Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,2865291,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
55-59,29.8,34.0,913,Incidence,2865291,Hispanic of any race,31.9,Male and Female,Kidney and Renal Pelvis,2020
55-59,3.2,4.6,110,Incidence,2865291,Hispanic of any race,3.8,Male and Female,Larynx,2020
55-59,12.7,15.5,402,Incidence,2865291,Hispanic of any race,14.0,Male and Female,Leukemias,2020
55-59,23.8,27.6,735,Incidence,2865291,Hispanic of any race,25.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
55-59,27.8,31.8,852,Incidence,2865291,Hispanic of any race,29.7,Male and Female,Lung and Bronchus,2020
55-59,187.7,202.1,2820,Incidence,1447678,Hispanic of any race,194.8,Male and Female,Male and Female Breast,2020
55-59,40.7,47.6,637,Incidence,1447678,Hispanic of any race,44.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
55-59,5.8,7.8,193,Incidence,2865291,Hispanic of any race,6.7,Male and Female,Melanomas of the Skin,2020
55-59,0.4,1.0,18,Incidence,2865291,Hispanic of any race,0.6,Male and Female,Mesothelioma,2020
55-59,8.8,11.1,283,Incidence,2865291,Hispanic of any race,9.9,Male and Female,Myeloma,2020
55-59,23.4,27.1,721,Incidence,2865291,Hispanic of any race,25.2,Male and Female,Non-Hodgkin Lymphoma,2020
55-59,13.8,16.7,436,Incidence,2865291,Hispanic of any race,15.2,Male and Female,Oral Cavity and Pharynx,2020
55-59,15.9,20.4,261,Incidence,1447678,Hispanic of any race,18.0,Male and Female,Ovary,2020
55-59,15.2,18.2,477,Incidence,2865291,Hispanic of any race,16.6,Male and Female,Pancreas,2020
55-59,123.4,135.4,1833,Incidence,1417613,Hispanic of any race,129.3,Male and Female,Prostate,2020
55-59,12.1,14.8,383,Incidence,2865291,Hispanic of any race,13.4,Male and Female,Stomach,2020
55-59,0.8,2.0,18,Incidence,1417613,Hispanic of any race,1.3,Male and Female,Testis,2020
55-59,17.8,21.1,555,Incidence,2865291,Hispanic of any race,19.4,Male and Female,Thyroid,2020
55-59,9.1,11.5,294,Incidence,2865291,Hispanic of any race,10.3,Male and Female,Urinary Bladder,2020
60-64,773.4,796.4,17915,Incidence,2282587,Hispanic of any race,784.9,Male and Female,All Cancer Sites Combined,2020
60-64,8.8,11.4,229,Incidence,2282587,Hispanic of any race,10.0,Male and Female,Brain and Other Nervous System,2020
60-64,10.9,15.1,152,Incidence,1181327,Hispanic of any race,12.9,Male and Female,Cervix,2020
60-64,64.6,71.4,1551,Incidence,2282587,Hispanic of any race,67.9,Male and Female,Colon and Rectum,2020
60-64,72.5,82.6,915,Incidence,1181327,Hispanic of any race,77.5,Male and Female,"Corpus and Uterus, NOS",2020
60-64,6.7,9.0,178,Incidence,2282587,Hispanic of any race,7.8,Male and Female,Esophagus,2020
60-64,226.7,244.2,2780,Incidence,1181327,Hispanic of any race,235.3,Male and Female,Female Breast,2020
60-64,49.1,57.5,628,Incidence,1181327,Hispanic of any race,53.2,Male and Female,"Female Breast, <i>in situ</i>",2020
60-64,2.3,3.8,68,Incidence,2282587,Hispanic of any race,3.0,Male and Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,2282587,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
60-64,41.3,46.8,1004,Incidence,2282587,Hispanic of any race,44.0,Male and Female,Kidney and Renal Pelvis,2020
60-64,5.4,7.5,146,Incidence,2282587,Hispanic of any race,6.4,Male and Female,Larynx,2020
60-64,15.7,19.1,396,Incidence,2282587,Hispanic of any race,17.3,Male and Female,Leukemias,2020
60-64,39.9,45.3,971,Incidence,2282587,Hispanic of any race,42.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
60-64,54.3,60.6,1310,Incidence,2282587,Hispanic of any race,57.4,Male and Female,Lung and Bronchus,2020
60-64,226.7,244.2,2780,Incidence,1181327,Hispanic of any race,235.3,Male and Female,Male and Female Breast,2020
60-64,49.1,57.5,628,Incidence,1181327,Hispanic of any race,53.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
60-64,8.6,11.2,225,Incidence,2282587,Hispanic of any race,9.9,Male and Female,Melanomas of the Skin,2020
60-64,0.6,1.4,21,Incidence,2282587,Hispanic of any race,0.9,Male and Female,Mesothelioma,2020
60-64,13.9,17.2,353,Incidence,2282587,Hispanic of any race,15.5,Male and Female,Myeloma,2020
60-64,32.1,36.9,786,Incidence,2282587,Hispanic of any race,34.4,Male and Female,Non-Hodgkin Lymphoma,2020
60-64,18.7,22.5,469,Incidence,2282587,Hispanic of any race,20.5,Male and Female,Oral Cavity and Pharynx,2020
60-64,19.3,24.7,258,Incidence,1181327,Hispanic of any race,21.8,Male and Female,Ovary,2020
60-64,27.6,32.2,681,Incidence,2282587,Hispanic of any race,29.8,Male and Female,Pancreas,2020
60-64,238.1,256.7,2723,Incidence,1101260,Hispanic of any race,247.3,Male and Female,Prostate,2020
60-64,15.6,19.1,394,Incidence,2282587,Hispanic of any race,17.3,Male and Female,Stomach,2020
60-64,~,~,~,Incidence,1101260,Hispanic of any race,~,Male and Female,Testis,2020
60-64,18.0,21.7,452,Incidence,2282587,Hispanic of any race,19.8,Male and Female,Thyroid,2020
60-64,14.9,18.3,377,Incidence,2282587,Hispanic of any race,16.5,Male and Female,Urinary Bladder,2020
65-69,1091.8,1123.5,18731,Incidence,1691189,Hispanic of any race,1107.6,Male and Female,All Cancer Sites Combined,2020
65-69,9.9,13.2,194,Incidence,1691189,Hispanic of any race,11.5,Male and Female,Brain and Other Nervous System,2020
65-69,11.1,16.0,121,Incidence,904481,Hispanic of any race,13.4,Male and Female,Cervix,2020
65-69,88.2,97.5,1569,Incidence,1691189,Hispanic of any race,92.8,Male and Female,Colon and Rectum,2020
65-69,78.9,91.0,767,Incidence,904481,Hispanic of any race,84.8,Male and Female,"Corpus and Uterus, NOS",2020
65-69,7.8,10.7,155,Incidence,1691189,Hispanic of any race,9.2,Male and Female,Esophagus,2020
65-69,284.4,306.9,2673,Incidence,904481,Hispanic of any race,295.5,Male and Female,Female Breast,2020
65-69,59.0,69.6,580,Incidence,904481,Hispanic of any race,64.1,Male and Female,"Female Breast, <i>in situ</i>",2020
65-69,2.7,4.6,60,Incidence,1691189,Hispanic of any race,3.5,Male and Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,1691189,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
65-69,55.1,62.5,993,Incidence,1691189,Hispanic of any race,58.7,Male and Female,Kidney and Renal Pelvis,2020
65-69,5.8,8.4,119,Incidence,1691189,Hispanic of any race,7.0,Male and Female,Larynx,2020
65-69,22.3,27.1,417,Incidence,1691189,Hispanic of any race,24.7,Male and Female,Leukemias,2020
65-69,54.2,61.5,977,Incidence,1691189,Hispanic of any race,57.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
65-69,86.5,95.7,1539,Incidence,1691189,Hispanic of any race,91.0,Male and Female,Lung and Bronchus,2020
65-69,284.4,306.9,2673,Incidence,904481,Hispanic of any race,295.5,Male and Female,Male and Female Breast,2020
65-69,59.0,69.6,580,Incidence,904481,Hispanic of any race,64.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
65-69,9.3,12.5,183,Incidence,1691189,Hispanic of any race,10.8,Male and Female,Melanomas of the Skin,2020
65-69,1.6,3.2,39,Incidence,1691189,Hispanic of any race,2.3,Male and Female,Mesothelioma,2020
65-69,20.4,25.0,383,Incidence,1691189,Hispanic of any race,22.6,Male and Female,Myeloma,2020
65-69,49.2,56.1,889,Incidence,1691189,Hispanic of any race,52.6,Male and Female,Non-Hodgkin Lymphoma,2020
65-69,25.3,30.4,470,Incidence,1691189,Hispanic of any race,27.8,Male and Female,Oral Cavity and Pharynx,2020
65-69,19.7,26.0,205,Incidence,904481,Hispanic of any race,22.7,Male and Female,Ovary,2020
65-69,38.4,44.6,700,Incidence,1691189,Hispanic of any race,41.4,Male and Female,Pancreas,2020
65-69,405.5,434.3,3302,Incidence,786708,Hispanic of any race,419.7,Male and Female,Prostate,2020
65-69,23.4,28.3,435,Incidence,1691189,Hispanic of any race,25.7,Male and Female,Stomach,2020
65-69,~,~,~,Incidence,786708,Hispanic of any race,~,Male and Female,Testis,2020
65-69,22.4,27.2,418,Incidence,1691189,Hispanic of any race,24.7,Male and Female,Thyroid,2020
65-69,31.2,36.8,574,Incidence,1691189,Hispanic of any race,33.9,Male and Female,Urinary Bladder,2020
70-74,1267.0,1307.2,15836,Incidence,1230474,Hispanic of any race,1287.0,Male and Female,All Cancer Sites Combined,2020
70-74,13.5,18.0,192,Incidence,1230474,Hispanic of any race,15.6,Male and Female,Brain and Other Nervous System,2020
70-74,14.3,20.7,117,Incidence,676434,Hispanic of any race,17.3,Male and Female,Cervix,2020
70-74,102.2,113.9,1328,Incidence,1230474,Hispanic of any race,107.9,Male and Female,Colon and Rectum,2020
70-74,81.3,95.6,597,Incidence,676434,Hispanic of any race,88.3,Male and Female,"Corpus and Uterus, NOS",2020
70-74,9.8,13.7,143,Incidence,1230474,Hispanic of any race,11.6,Male and Female,Esophagus,2020
70-74,286.0,312.2,2022,Incidence,676434,Hispanic of any race,298.9,Male and Female,Female Breast,2020
70-74,59.4,71.7,442,Incidence,676434,Hispanic of any race,65.3,Male and Female,"Female Breast, <i>in situ</i>",2020
70-74,3.2,5.5,52,Incidence,1230474,Hispanic of any race,4.2,Male and Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,1230474,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
70-74,59.3,68.3,783,Incidence,1230474,Hispanic of any race,63.6,Male and Female,Kidney and Renal Pelvis,2020
70-74,8.3,11.9,123,Incidence,1230474,Hispanic of any race,10.0,Male and Female,Larynx,2020
70-74,30.6,37.2,416,Incidence,1230474,Hispanic of any race,33.8,Male and Female,Leukemias,2020
70-74,56.2,65.0,744,Incidence,1230474,Hispanic of any race,60.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
70-74,129.1,142.1,1667,Incidence,1230474,Hispanic of any race,135.5,Male and Female,Lung and Bronchus,2020
70-74,286.0,312.2,2022,Incidence,676434,Hispanic of any race,298.9,Male and Female,Male and Female Breast,2020
70-74,59.4,71.7,442,Incidence,676434,Hispanic of any race,65.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
70-74,11.1,15.2,160,Incidence,1230474,Hispanic of any race,13.0,Male and Female,Melanomas of the Skin,2020
70-74,1.3,3.0,25,Incidence,1230474,Hispanic of any race,2.0,Male and Female,Mesothelioma,2020
70-74,29.4,35.9,400,Incidence,1230474,Hispanic of any race,32.5,Male and Female,Myeloma,2020
70-74,58.9,67.9,779,Incidence,1230474,Hispanic of any race,63.3,Male and Female,Non-Hodgkin Lymphoma,2020
70-74,24.3,30.2,334,Incidence,1230474,Hispanic of any race,27.1,Male and Female,Oral Cavity and Pharynx,2020
70-74,23.7,31.7,186,Incidence,676434,Hispanic of any race,27.5,Male and Female,Ovary,2020
70-74,49.4,57.6,657,Incidence,1230474,Hispanic of any race,53.4,Male and Female,Pancreas,2020
70-74,409.5,444.1,2363,Incidence,554040,Hispanic of any race,426.5,Male and Female,Prostate,2020
70-74,30.5,37.0,414,Incidence,1230474,Hispanic of any race,33.6,Male and Female,Stomach,2020
70-74,~,~,~,Incidence,554040,Hispanic of any race,~,Male and Female,Testis,2020
70-74,19.3,24.6,268,Incidence,1230474,Hispanic of any race,21.8,Male and Female,Thyroid,2020
70-74,41.5,49.1,556,Incidence,1230474,Hispanic of any race,45.2,Male and Female,Urinary Bladder,2020
75-79,1442.1,1495.2,11831,Incidence,805671,Hispanic of any race,1468.5,Male and Female,All Cancer Sites Combined,2020
75-79,14.0,19.8,135,Incidence,805671,Hispanic of any race,16.8,Male and Female,Brain and Other Nervous System,2020
75-79,10.9,17.9,65,Incidence,461971,Hispanic of any race,14.1,Male and Female,Cervix,2020
75-79,114.9,130.3,986,Incidence,805671,Hispanic of any race,122.4,Male and Female,Colon and Rectum,2020
75-79,65.2,80.9,336,Incidence,461971,Hispanic of any race,72.7,Male and Female,"Corpus and Uterus, NOS",2020
75-79,11.2,16.5,110,Incidence,805671,Hispanic of any race,13.7,Male and Female,Esophagus,2020
75-79,264.0,294.7,1289,Incidence,461971,Hispanic of any race,279.0,Male and Female,Female Breast,2020
75-79,42.8,55.7,226,Incidence,461971,Hispanic of any race,48.9,Male and Female,"Female Breast, <i>in situ</i>",2020
75-79,4.4,7.9,48,Incidence,805671,Hispanic of any race,6.0,Male and Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,805671,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
75-79,60.4,71.8,531,Incidence,805671,Hispanic of any race,65.9,Male and Female,Kidney and Renal Pelvis,2020
75-79,7.9,12.4,80,Incidence,805671,Hispanic of any race,9.9,Male and Female,Larynx,2020
75-79,35.7,44.6,322,Incidence,805671,Hispanic of any race,40.0,Male and Female,Leukemias,2020
75-79,58.9,70.1,518,Incidence,805671,Hispanic of any race,64.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
75-79,166.7,185.2,1416,Incidence,805671,Hispanic of any race,175.8,Male and Female,Lung and Bronchus,2020
75-79,264.0,294.7,1289,Incidence,461971,Hispanic of any race,279.0,Male and Female,Male and Female Breast,2020
75-79,42.8,55.7,226,Incidence,461971,Hispanic of any race,48.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
75-79,15.1,21.0,144,Incidence,805671,Hispanic of any race,17.9,Male and Female,Melanomas of the Skin,2020
75-79,2.7,5.6,32,Incidence,805671,Hispanic of any race,4.0,Male and Female,Mesothelioma,2020
75-79,27.4,35.3,251,Incidence,805671,Hispanic of any race,31.2,Male and Female,Myeloma,2020
75-79,80.1,93.1,696,Incidence,805671,Hispanic of any race,86.4,Male and Female,Non-Hodgkin Lymphoma,2020
75-79,25.4,33.0,234,Incidence,805671,Hispanic of any race,29.0,Male and Female,Oral Cavity and Pharynx,2020
75-79,20.2,29.4,113,Incidence,461971,Hispanic of any race,24.5,Male and Female,Ovary,2020
75-79,71.0,83.3,620,Incidence,805671,Hispanic of any race,77.0,Male and Female,Pancreas,2020
75-79,403.6,447.4,1461,Incidence,343700,Hispanic of any race,425.1,Male and Female,Prostate,2020
75-79,39.1,48.4,351,Incidence,805671,Hispanic of any race,43.6,Male and Female,Stomach,2020
75-79,~,~,~,Incidence,343700,Hispanic of any race,~,Male and Female,Testis,2020
75-79,18.0,24.5,170,Incidence,805671,Hispanic of any race,21.1,Male and Female,Thyroid,2020
75-79,65.4,77.2,573,Incidence,805671,Hispanic of any race,71.1,Male and Female,Urinary Bladder,2020
80-84,1496.3,1562.5,8246,Incidence,539249,Hispanic of any race,1529.2,Male and Female,All Cancer Sites Combined,2020
80-84,17.8,25.8,116,Incidence,539249,Hispanic of any race,21.5,Male and Female,Brain and Other Nervous System,2020
80-84,8.7,16.7,39,Incidence,319718,Hispanic of any race,12.2,Male and Female,Cervix,2020
80-84,134.7,155.2,780,Incidence,539249,Hispanic of any race,144.6,Male and Female,Colon and Rectum,2020
80-84,47.5,64.1,177,Incidence,319718,Hispanic of any race,55.4,Male and Female,"Corpus and Uterus, NOS",2020
80-84,11.6,18.3,79,Incidence,539249,Hispanic of any race,14.7,Male and Female,Esophagus,2020
80-84,235.9,271.1,809,Incidence,319718,Hispanic of any race,253.0,Male and Female,Female Breast,2020
80-84,25.7,38.4,101,Incidence,319718,Hispanic of any race,31.6,Male and Female,"Female Breast, <i>in situ</i>",2020
80-84,4.2,8.6,33,Incidence,539249,Hispanic of any race,6.1,Male and Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,539249,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
80-84,51.1,64.1,309,Incidence,539249,Hispanic of any race,57.3,Male and Female,Kidney and Renal Pelvis,2020
80-84,7.0,12.4,51,Incidence,539249,Hispanic of any race,9.5,Male and Female,Larynx,2020
80-84,47.9,60.5,291,Incidence,539249,Hispanic of any race,54.0,Male and Female,Leukemias,2020
80-84,60.9,75.0,365,Incidence,539249,Hispanic of any race,67.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
80-84,183.1,206.9,1050,Incidence,539249,Hispanic of any race,194.7,Male and Female,Lung and Bronchus,2020
80-84,235.9,271.1,809,Incidence,319718,Hispanic of any race,253.0,Male and Female,Male and Female Breast,2020
80-84,25.7,38.4,101,Incidence,319718,Hispanic of any race,31.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
80-84,16.6,24.4,109,Incidence,539249,Hispanic of any race,20.2,Male and Female,Melanomas of the Skin,2020
80-84,3.5,7.5,28,Incidence,539249,Hispanic of any race,5.2,Male and Female,Mesothelioma,2020
80-84,34.4,45.2,213,Incidence,539249,Hispanic of any race,39.5,Male and Female,Myeloma,2020
80-84,79.8,95.8,472,Incidence,539249,Hispanic of any race,87.5,Male and Female,Non-Hodgkin Lymphoma,2020
80-84,27.8,37.6,175,Incidence,539249,Hispanic of any race,32.5,Male and Female,Oral Cavity and Pharynx,2020
80-84,24.6,37.0,97,Incidence,319718,Hispanic of any race,30.3,Male and Female,Ovary,2020
80-84,73.4,88.8,436,Incidence,539249,Hispanic of any race,80.9,Male and Female,Pancreas,2020
80-84,333.0,383.5,785,Incidence,219531,Hispanic of any race,357.6,Male and Female,Prostate,2020
80-84,42.5,54.4,260,Incidence,539249,Hispanic of any race,48.2,Male and Female,Stomach,2020
80-84,~,~,~,Incidence,219531,Hispanic of any race,~,Male and Female,Testis,2020
80-84,11.1,17.6,76,Incidence,539249,Hispanic of any race,14.1,Male and Female,Thyroid,2020
80-84,70.1,85.1,417,Incidence,539249,Hispanic of any race,77.3,Male and Female,Urinary Bladder,2020
85+,1373.8,1438.1,7397,Incidence,526235,Hispanic of any race,1405.6,Male and Female,All Cancer Sites Combined,2020
85+,12.1,18.9,80,Incidence,526235,Hispanic of any race,15.2,Male and Female,Brain and Other Nervous System,2020
85+,8.0,15.6,38,Incidence,334903,Hispanic of any race,11.3,Male and Female,Cervix,2020
85+,151.2,173.2,852,Incidence,526235,Hispanic of any race,161.9,Male and Female,Colon and Rectum,2020
85+,32.7,46.4,131,Incidence,334903,Hispanic of any race,39.1,Male and Female,"Corpus and Uterus, NOS",2020
85+,10.4,16.8,70,Incidence,526235,Hispanic of any race,13.3,Male and Female,Esophagus,2020
85+,164.8,193.8,599,Incidence,334903,Hispanic of any race,178.9,Male and Female,Female Breast,2020
85+,8.8,16.6,41,Incidence,334903,Hispanic of any race,12.2,Male and Female,"Female Breast, <i>in situ</i>",2020
85+,2.9,6.8,24,Incidence,526235,Hispanic of any race,4.6,Male and Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,526235,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
85+,46.3,58.8,275,Incidence,526235,Hispanic of any race,52.3,Male and Female,Kidney and Renal Pelvis,2020
85+,5.1,9.9,38,Incidence,526235,Hispanic of any race,7.2,Male and Female,Larynx,2020
85+,42.3,54.4,253,Incidence,526235,Hispanic of any race,48.1,Male and Female,Leukemias,2020
85+,51.5,64.6,304,Incidence,526235,Hispanic of any race,57.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
85+,151.4,173.3,853,Incidence,526235,Hispanic of any race,162.1,Male and Female,Lung and Bronchus,2020
85+,164.8,193.8,599,Incidence,334903,Hispanic of any race,178.9,Male and Female,Male and Female Breast,2020
85+,8.8,16.6,41,Incidence,334903,Hispanic of any race,12.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
85+,17.4,25.4,111,Incidence,526235,Hispanic of any race,21.1,Male and Female,Melanomas of the Skin,2020
85+,1.9,5.2,17,Incidence,526235,Hispanic of any race,3.2,Male and Female,Mesothelioma,2020
85+,26.8,36.5,165,Incidence,526235,Hispanic of any race,31.4,Male and Female,Myeloma,2020
85+,72.7,88.2,422,Incidence,526235,Hispanic of any race,80.2,Male and Female,Non-Hodgkin Lymphoma,2020
85+,20.1,28.7,127,Incidence,526235,Hispanic of any race,24.1,Male and Female,Oral Cavity and Pharynx,2020
85+,19.7,30.7,83,Incidence,334903,Hispanic of any race,24.8,Male and Female,Ovary,2020
85+,74.0,89.6,429,Incidence,526235,Hispanic of any race,81.5,Male and Female,Pancreas,2020
85+,268.4,317.4,559,Incidence,191332,Hispanic of any race,292.2,Male and Female,Prostate,2020
85+,43.6,55.8,260,Incidence,526235,Hispanic of any race,49.4,Male and Female,Stomach,2020
85+,~,~,~,Incidence,191332,Hispanic of any race,~,Male and Female,Testis,2020
85+,6.2,11.4,45,Incidence,526235,Hispanic of any race,8.6,Male and Female,Thyroid,2020
85+,76.9,92.8,445,Incidence,526235,Hispanic of any race,84.6,Male and Female,Urinary Bladder,2020
<1,17.1,22.9,188,Incidence,945818,Hispanic of any race,19.9,Male and Female,All Cancer Sites Combined,2020
<1,1.4,3.4,21,Incidence,945818,Hispanic of any race,2.2,Male and Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,Cervix,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Colon and Rectum,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Esophagus,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,Female Breast,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Larynx,2020
<1,2.7,5.3,36,Incidence,945818,Hispanic of any race,3.8,Male and Female,Leukemias,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,Male and Female Breast,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Mesothelioma,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Myeloma,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,463556,Hispanic of any race,~,Male and Female,Ovary,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Pancreas,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male and Female,Prostate,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Stomach,2020
<1,~,~,~,Incidence,482262,Hispanic of any race,~,Male and Female,Testis,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Thyroid,2020
<1,~,~,~,Incidence,945818,Hispanic of any race,~,Male and Female,Urinary Bladder,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
10-14,9.3,26.5,16,Incidence,98043,Non-Hispanic American Indian/Alaska Native,16.3,Female,All Cancer Sites Combined,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
20-24,19.4,41.6,29,Incidence,100073,Non-Hispanic American Indian/Alaska Native,29.0,Female,All Cancer Sites Combined,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
25-29,38.6,66.7,55,Incidence,107370,Non-Hispanic American Indian/Alaska Native,51.2,Female,All Cancer Sites Combined,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
25-29,9.2,25.4,17,Incidence,107370,Non-Hispanic American Indian/Alaska Native,15.8,Female,Thyroid,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
30-34,94.9,138.5,113,Incidence,98121,Non-Hispanic American Indian/Alaska Native,115.2,Female,All Cancer Sites Combined,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
30-34,12.5,31.5,20,Incidence,98121,Non-Hispanic American Indian/Alaska Native,20.4,Female,Female Breast,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
30-34,14.1,33.9,22,Incidence,98121,Non-Hispanic American Indian/Alaska Native,22.4,Female,Thyroid,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
35-39,186.1,248.4,191,Incidence,88603,Non-Hispanic American Indian/Alaska Native,215.6,Female,All Cancer Sites Combined,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
35-39,16.5,39.0,23,Incidence,88603,Non-Hispanic American Indian/Alaska Native,26.0,Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
35-39,36.1,66.7,44,Incidence,88603,Non-Hispanic American Indian/Alaska Native,49.7,Female,Female Breast,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
35-39,24.7,51.0,32,Incidence,88603,Non-Hispanic American Indian/Alaska Native,36.1,Female,Thyroid,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
40-44,275.4,354.1,251,Incidence,80226,Non-Hispanic American Indian/Alaska Native,312.9,Female,All Cancer Sites Combined,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
40-44,16.2,40.0,21,Incidence,80226,Non-Hispanic American Indian/Alaska Native,26.2,Female,Cervix,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
40-44,21.2,47.5,26,Incidence,80226,Non-Hispanic American Indian/Alaska Native,32.4,Female,"Corpus and Uterus, NOS",2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
40-44,86.9,133.8,87,Incidence,80226,Non-Hispanic American Indian/Alaska Native,108.4,Female,Female Breast,2020
40-44,17.2,41.5,22,Incidence,80226,Non-Hispanic American Indian/Alaska Native,27.4,Female,"Female Breast, <i>in situ</i>",2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
40-44,24.2,51.9,29,Incidence,80226,Non-Hispanic American Indian/Alaska Native,36.1,Female,Thyroid,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
45-49,411.1,507.6,355,Incidence,77598,Non-Hispanic American Indian/Alaska Native,457.5,Female,All Cancer Sites Combined,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
45-49,29.3,59.7,33,Incidence,77598,Non-Hispanic American Indian/Alaska Native,42.5,Female,Colon and Rectum,2020
45-49,33.6,65.7,37,Incidence,77598,Non-Hispanic American Indian/Alaska Native,47.7,Female,"Corpus and Uterus, NOS",2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
45-49,145.9,205.9,135,Incidence,77598,Non-Hispanic American Indian/Alaska Native,174.0,Female,Female Breast,2020
45-49,30.3,61.2,34,Incidence,77598,Non-Hispanic American Indian/Alaska Native,43.8,Female,"Female Breast, <i>in situ</i>",2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
45-49,12.8,35.1,17,Incidence,77598,Non-Hispanic American Indian/Alaska Native,21.9,Female,Thyroid,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
50-54,470.5,572.1,412,Incidence,79320,Non-Hispanic American Indian/Alaska Native,519.4,Female,All Cancer Sites Combined,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
50-54,36.0,68.7,40,Incidence,79320,Non-Hispanic American Indian/Alaska Native,50.4,Female,Colon and Rectum,2020
50-54,33.9,65.8,38,Incidence,79320,Non-Hispanic American Indian/Alaska Native,47.9,Female,"Corpus and Uterus, NOS",2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
50-54,141.5,200.1,134,Incidence,79320,Non-Hispanic American Indian/Alaska Native,168.9,Female,Female Breast,2020
50-54,23.5,51.0,28,Incidence,79320,Non-Hispanic American Indian/Alaska Native,35.3,Female,"Female Breast, <i>in situ</i>",2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
50-54,18.4,43.5,23,Incidence,79320,Non-Hispanic American Indian/Alaska Native,29.0,Female,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
50-54,16.4,40.5,21,Incidence,79320,Non-Hispanic American Indian/Alaska Native,26.5,Female,Lung and Bronchus,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
50-54,15.4,38.9,20,Incidence,79320,Non-Hispanic American Indian/Alaska Native,25.2,Female,Thyroid,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
55-59,636.9,748.1,605,Incidence,87577,Non-Hispanic American Indian/Alaska Native,690.8,Female,All Cancer Sites Combined,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
55-59,44.3,77.9,52,Incidence,87577,Non-Hispanic American Indian/Alaska Native,59.4,Female,Colon and Rectum,2020
55-59,39.4,71.4,47,Incidence,87577,Non-Hispanic American Indian/Alaska Native,53.7,Female,"Corpus and Uterus, NOS",2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
55-59,191.4,255.0,194,Incidence,87577,Non-Hispanic American Indian/Alaska Native,221.5,Female,Female Breast,2020
55-59,26.9,54.3,34,Incidence,87577,Non-Hispanic American Indian/Alaska Native,38.8,Female,"Female Breast, <i>in situ</i>",2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
55-59,24.1,50.2,31,Incidence,87577,Non-Hispanic American Indian/Alaska Native,35.4,Female,Kidney and Renal Pelvis,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
55-59,14.8,36.7,21,Incidence,87577,Non-Hispanic American Indian/Alaska Native,24.0,Female,Liver and Intrahepatic Bile Duct,2020
55-59,66.3,106.1,74,Incidence,87577,Non-Hispanic American Indian/Alaska Native,84.5,Female,Lung and Bronchus,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
60-64,783.5,909.6,704,Incidence,83333,Non-Hispanic American Indian/Alaska Native,844.8,Female,All Cancer Sites Combined,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
60-64,62.3,102.1,67,Incidence,83333,Non-Hispanic American Indian/Alaska Native,80.4,Female,Colon and Rectum,2020
60-64,66.5,107.5,71,Incidence,83333,Non-Hispanic American Indian/Alaska Native,85.2,Female,"Corpus and Uterus, NOS",2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
60-64,187.8,252.5,182,Incidence,83333,Non-Hispanic American Indian/Alaska Native,218.4,Female,Female Breast,2020
60-64,31.3,61.2,37,Incidence,83333,Non-Hispanic American Indian/Alaska Native,44.4,Female,"Female Breast, <i>in situ</i>",2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
60-64,32.3,62.6,38,Incidence,83333,Non-Hispanic American Indian/Alaska Native,45.6,Female,Kidney and Renal Pelvis,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
60-64,17.5,41.4,23,Incidence,83333,Non-Hispanic American Indian/Alaska Native,27.6,Female,Liver and Intrahepatic Bile Duct,2020
60-64,105.2,155.2,107,Incidence,83333,Non-Hispanic American Indian/Alaska Native,128.4,Female,Lung and Bronchus,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
60-64,23.3,50.0,29,Incidence,83333,Non-Hispanic American Indian/Alaska Native,34.8,Female,Non-Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
60-64,14.7,37.1,20,Incidence,83333,Non-Hispanic American Indian/Alaska Native,24.0,Female,Ovary,2020
60-64,12.8,34.1,18,Incidence,83333,Non-Hispanic American Indian/Alaska Native,21.6,Female,Pancreas,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
65-69,955.9,1111.5,689,Incidence,66796,Non-Hispanic American Indian/Alaska Native,1031.5,Female,All Cancer Sites Combined,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
65-69,64.6,110.6,57,Incidence,66796,Non-Hispanic American Indian/Alaska Native,85.3,Female,Colon and Rectum,2020
65-69,49.1,90.1,45,Incidence,66796,Non-Hispanic American Indian/Alaska Native,67.4,Female,"Corpus and Uterus, NOS",2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
65-69,242.7,324.7,188,Incidence,66796,Non-Hispanic American Indian/Alaska Native,281.5,Female,Female Breast,2020
65-69,39.0,76.4,37,Incidence,66796,Non-Hispanic American Indian/Alaska Native,55.4,Female,"Female Breast, <i>in situ</i>",2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
65-69,37.7,74.6,36,Incidence,66796,Non-Hispanic American Indian/Alaska Native,53.9,Female,Kidney and Renal Pelvis,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
65-69,24.2,55.3,25,Incidence,66796,Non-Hispanic American Indian/Alaska Native,37.4,Female,Liver and Intrahepatic Bile Duct,2020
65-69,125.9,187.0,103,Incidence,66796,Non-Hispanic American Indian/Alaska Native,154.2,Female,Lung and Bronchus,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
65-69,18.3,46.2,20,Incidence,66796,Non-Hispanic American Indian/Alaska Native,29.9,Female,Myeloma,2020
65-69,17.1,44.4,19,Incidence,66796,Non-Hispanic American Indian/Alaska Native,28.4,Female,Non-Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
65-69,16.0,42.6,18,Incidence,66796,Non-Hispanic American Indian/Alaska Native,26.9,Female,Ovary,2020
65-69,19.5,48.1,21,Incidence,66796,Non-Hispanic American Indian/Alaska Native,31.4,Female,Pancreas,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
70-74,1147.2,1344.5,623,Incidence,50123,Non-Hispanic American Indian/Alaska Native,1242.9,Female,All Cancer Sites Combined,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
70-74,68.9,124.7,47,Incidence,50123,Non-Hispanic American Indian/Alaska Native,93.8,Female,Colon and Rectum,2020
70-74,48.6,97.1,35,Incidence,50123,Non-Hispanic American Indian/Alaska Native,69.8,Female,"Corpus and Uterus, NOS",2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
70-74,279.0,381.3,164,Incidence,50123,Non-Hispanic American Indian/Alaska Native,327.2,Female,Female Breast,2020
70-74,45.3,92.5,33,Incidence,50123,Non-Hispanic American Indian/Alaska Native,65.8,Female,"Female Breast, <i>in situ</i>",2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
70-74,37.1,80.7,28,Incidence,50123,Non-Hispanic American Indian/Alaska Native,55.9,Female,Kidney and Renal Pelvis,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
70-74,24.4,61.6,20,Incidence,50123,Non-Hispanic American Indian/Alaska Native,39.9,Female,Liver and Intrahepatic Bile Duct,2020
70-74,193.0,279.8,117,Incidence,50123,Non-Hispanic American Indian/Alaska Native,233.4,Female,Lung and Bronchus,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
70-74,25.9,64.0,21,Incidence,50123,Non-Hispanic American Indian/Alaska Native,41.9,Female,Non-Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
70-74,19.8,54.3,17,Incidence,50123,Non-Hispanic American Indian/Alaska Native,33.9,Female,Ovary,2020
70-74,30.7,71.2,24,Incidence,50123,Non-Hispanic American Indian/Alaska Native,47.9,Female,Pancreas,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
75-79,1269.6,1532.7,444,Incidence,31793,Non-Hispanic American Indian/Alaska Native,1396.5,Female,All Cancer Sites Combined,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
75-79,97.9,182.2,43,Incidence,31793,Non-Hispanic American Indian/Alaska Native,135.2,Female,Colon and Rectum,2020
75-79,36.0,93.3,19,Incidence,31793,Non-Hispanic American Indian/Alaska Native,59.8,Female,"Corpus and Uterus, NOS",2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
75-79,227.6,348.0,90,Incidence,31793,Non-Hispanic American Indian/Alaska Native,283.1,Female,Female Breast,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
75-79,43.4,104.8,22,Incidence,31793,Non-Hispanic American Indian/Alaska Native,69.2,Female,Kidney and Renal Pelvis,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
75-79,230.5,351.4,91,Incidence,31793,Non-Hispanic American Indian/Alaska Native,286.2,Female,Lung and Bronchus,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
80-84,1175.0,1499.1,267,Incidence,20080,Non-Hispanic American Indian/Alaska Native,1329.7,Female,All Cancer Sites Combined,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
80-84,100.8,213.3,30,Incidence,20080,Non-Hispanic American Indian/Alaska Native,149.4,Female,Colon and Rectum,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
80-84,142.3,271.3,40,Incidence,20080,Non-Hispanic American Indian/Alaska Native,199.2,Female,Female Breast,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
80-84,219.3,373.4,58,Incidence,20080,Non-Hispanic American Indian/Alaska Native,288.8,Female,Lung and Bronchus,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
80-84,76.6,177.8,24,Incidence,20080,Non-Hispanic American Indian/Alaska Native,119.5,Female,Pancreas,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
85+,929.2,1223.6,210,Incidence,19647,Non-Hispanic American Indian/Alaska Native,1068.9,Female,All Cancer Sites Combined,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
85+,46.5,132.2,16,Incidence,19647,Non-Hispanic American Indian/Alaska Native,81.4,Female,Colon and Rectum,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
85+,149.8,283.1,41,Incidence,19647,Non-Hispanic American Indian/Alaska Native,208.7,Female,Female Breast,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
85+,111.4,229.9,32,Incidence,19647,Non-Hispanic American Indian/Alaska Native,162.9,Female,Lung and Bronchus,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Cervix,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Colon and Rectum,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Esophagus,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Female Breast,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Larynx,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Leukemias,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Mesothelioma,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Myeloma,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Ovary,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Pancreas,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Stomach,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Thyroid,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Female,Urinary Bladder,2020
1-4,15.1,40.2,18,Incidence,70731,Non-Hispanic American Indian/Alaska Native,25.4,Male,All Cancer Sites Combined,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
1-4,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
10-14,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
15-19,13.1,32.3,21,Incidence,99504,Non-Hispanic American Indian/Alaska Native,21.1,Male,All Cancer Sites Combined,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
15-19,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
20-24,27.1,52.1,39,Incidence,102419,Non-Hispanic American Indian/Alaska Native,38.1,Male,All Cancer Sites Combined,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
20-24,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
25-29,24.9,47.9,39,Incidence,111213,Non-Hispanic American Indian/Alaska Native,35.1,Male,All Cancer Sites Combined,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
25-29,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
30-34,48.8,81.2,63,Incidence,99283,Non-Hispanic American Indian/Alaska Native,63.5,Male,All Cancer Sites Combined,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
30-34,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
35-39,69.8,110.9,76,Incidence,85754,Non-Hispanic American Indian/Alaska Native,88.6,Male,All Cancer Sites Combined,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
35-39,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
40-44,132.0,189.5,123,Incidence,77458,Non-Hispanic American Indian/Alaska Native,158.8,Male,All Cancer Sites Combined,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
40-44,25.1,53.8,29,Incidence,77458,Non-Hispanic American Indian/Alaska Native,37.4,Male,Colon and Rectum,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
40-44,29.3,59.8,33,Incidence,77458,Non-Hispanic American Indian/Alaska Native,42.6,Male,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
40-44,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
45-49,209.2,282.0,179,Incidence,73497,Non-Hispanic American Indian/Alaska Native,243.5,Male,All Cancer Sites Combined,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
45-49,29.8,61.5,32,Incidence,73497,Non-Hispanic American Indian/Alaska Native,43.5,Male,Colon and Rectum,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
45-49,30.9,63.1,33,Incidence,73497,Non-Hispanic American Indian/Alaska Native,44.9,Male,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
45-49,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
45-49,12.4,35.4,16,Incidence,73497,Non-Hispanic American Indian/Alaska Native,21.8,Male,Prostate,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
5-9,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
50-54,364.1,457.8,302,Incidence,73845,Non-Hispanic American Indian/Alaska Native,409.0,Male,All Cancer Sites Combined,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
50-54,51.4,90.8,51,Incidence,73845,Non-Hispanic American Indian/Alaska Native,69.1,Male,Colon and Rectum,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
50-54,42.1,78.4,43,Incidence,73845,Non-Hispanic American Indian/Alaska Native,58.2,Male,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
50-54,16.5,41.8,20,Incidence,73845,Non-Hispanic American Indian/Alaska Native,27.1,Male,Liver and Intrahepatic Bile Duct,2020
50-54,19.7,46.7,23,Incidence,73845,Non-Hispanic American Indian/Alaska Native,31.1,Male,Lung and Bronchus,2020
50-54,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
50-54,17.6,43.5,21,Incidence,73845,Non-Hispanic American Indian/Alaska Native,28.4,Male,Oral Cavity and Pharynx,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
50-54,34.1,67.5,36,Incidence,73845,Non-Hispanic American Indian/Alaska Native,48.8,Male,Prostate,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
55-59,639.3,757.0,550,Incidence,78985,Non-Hispanic American Indian/Alaska Native,696.3,Male,All Cancer Sites Combined,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
55-59,62.4,103.5,64,Incidence,78985,Non-Hispanic American Indian/Alaska Native,81.0,Male,Colon and Rectum,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
55-59,50.3,87.8,53,Incidence,78985,Non-Hispanic American Indian/Alaska Native,67.1,Male,Kidney and Renal Pelvis,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
55-59,13.5,36.0,18,Incidence,78985,Non-Hispanic American Indian/Alaska Native,22.8,Male,Leukemias,2020
55-59,31.9,63.1,36,Incidence,78985,Non-Hispanic American Indian/Alaska Native,45.6,Male,Liver and Intrahepatic Bile Duct,2020
55-59,62.4,103.5,64,Incidence,78985,Non-Hispanic American Indian/Alaska Native,81.0,Male,Lung and Bronchus,2020
55-59,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
55-59,11.6,32.9,16,Incidence,78985,Non-Hispanic American Indian/Alaska Native,20.3,Male,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
55-59,11.6,32.9,16,Incidence,78985,Non-Hispanic American Indian/Alaska Native,20.3,Male,Non-Hodgkin Lymphoma,2020
55-59,39.4,73.3,43,Incidence,78985,Non-Hispanic American Indian/Alaska Native,54.4,Male,Oral Cavity and Pharynx,2020
55-59,11.6,32.9,16,Incidence,78985,Non-Hispanic American Indian/Alaska Native,20.3,Male,Pancreas,2020
55-59,114.5,167.9,110,Incidence,78985,Non-Hispanic American Indian/Alaska Native,139.3,Male,Prostate,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
55-59,12.5,34.5,17,Incidence,78985,Non-Hispanic American Indian/Alaska Native,21.5,Male,Urinary Bladder,2020
60-64,1010.1,1163.7,781,Incidence,71992,Non-Hispanic American Indian/Alaska Native,1084.8,Male,All Cancer Sites Combined,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
60-64,84.4,133.7,77,Incidence,71992,Non-Hispanic American Indian/Alaska Native,107.0,Male,Colon and Rectum,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
60-64,77.0,124.4,71,Incidence,71992,Non-Hispanic American Indian/Alaska Native,98.6,Male,Kidney and Renal Pelvis,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
60-64,13.8,37.8,17,Incidence,71992,Non-Hispanic American Indian/Alaska Native,23.6,Male,Leukemias,2020
60-64,62.4,105.7,59,Incidence,71992,Non-Hispanic American Indian/Alaska Native,82.0,Male,Liver and Intrahepatic Bile Duct,2020
60-64,104.3,158.3,93,Incidence,71992,Non-Hispanic American Indian/Alaska Native,129.2,Male,Lung and Bronchus,2020
60-64,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
60-64,12.7,36.1,16,Incidence,71992,Non-Hispanic American Indian/Alaska Native,22.2,Male,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
60-64,23.6,52.9,26,Incidence,71992,Non-Hispanic American Indian/Alaska Native,36.1,Male,Non-Hodgkin Lymphoma,2020
60-64,43.2,80.5,43,Incidence,71992,Non-Hispanic American Indian/Alaska Native,59.7,Male,Oral Cavity and Pharynx,2020
60-64,35.0,69.2,36,Incidence,71992,Non-Hispanic American Indian/Alaska Native,50.0,Male,Pancreas,2020
60-64,225.1,301.3,188,Incidence,71992,Non-Hispanic American Indian/Alaska Native,261.1,Male,Prostate,2020
60-64,18.1,44.6,21,Incidence,71992,Non-Hispanic American Indian/Alaska Native,29.2,Male,Stomach,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
60-64,35.0,69.2,36,Incidence,71992,Non-Hispanic American Indian/Alaska Native,50.0,Male,Urinary Bladder,2020
65-69,1329.9,1528.7,806,Incidence,56494,Non-Hispanic American Indian/Alaska Native,1426.7,Male,All Cancer Sites Combined,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
65-69,95.0,154.6,69,Incidence,56494,Non-Hispanic American Indian/Alaska Native,122.1,Male,Colon and Rectum,2020
65-69,16.2,46.0,16,Incidence,56494,Non-Hispanic American Indian/Alaska Native,28.3,Male,Esophagus,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
65-69,84.1,140.7,62,Incidence,56494,Non-Hispanic American Indian/Alaska Native,109.7,Male,Kidney and Renal Pelvis,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
65-69,17.5,48.2,17,Incidence,56494,Non-Hispanic American Indian/Alaska Native,30.1,Male,Leukemias,2020
65-69,70.3,122.7,53,Incidence,56494,Non-Hispanic American Indian/Alaska Native,93.8,Male,Liver and Intrahepatic Bile Duct,2020
65-69,187.4,267.5,127,Incidence,56494,Non-Hispanic American Indian/Alaska Native,224.8,Male,Lung and Bronchus,2020
65-69,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
65-69,16.2,46.0,16,Incidence,56494,Non-Hispanic American Indian/Alaska Native,28.3,Male,Myeloma,2020
65-69,35.8,75.8,30,Incidence,56494,Non-Hispanic American Indian/Alaska Native,53.1,Male,Non-Hodgkin Lymphoma,2020
65-69,44.6,88.2,36,Incidence,56494,Non-Hispanic American Indian/Alaska Native,63.7,Male,Oral Cavity and Pharynx,2020
65-69,34.4,73.7,29,Incidence,56494,Non-Hispanic American Indian/Alaska Native,51.3,Male,Pancreas,2020
65-69,305.0,404.7,199,Incidence,56494,Non-Hispanic American Indian/Alaska Native,352.2,Male,Prostate,2020
65-69,16.2,46.0,16,Incidence,56494,Non-Hispanic American Indian/Alaska Native,28.3,Male,Stomach,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
65-69,49.1,94.4,39,Incidence,56494,Non-Hispanic American Indian/Alaska Native,69.0,Male,Urinary Bladder,2020
70-74,1441.6,1680.4,667,Incidence,42822,Non-Hispanic American Indian/Alaska Native,1557.6,Male,All Cancer Sites Combined,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
70-74,100.8,172.5,57,Incidence,42822,Non-Hispanic American Indian/Alaska Native,133.1,Male,Colon and Rectum,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
70-74,64.8,124.5,39,Incidence,42822,Non-Hispanic American Indian/Alaska Native,91.1,Male,Kidney and Renal Pelvis,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
70-74,23.1,63.6,17,Incidence,42822,Non-Hispanic American Indian/Alaska Native,39.7,Male,Leukemias,2020
70-74,37.8,86.2,25,Incidence,42822,Non-Hispanic American Indian/Alaska Native,58.4,Male,Liver and Intrahepatic Bile Duct,2020
70-74,238.7,342.7,123,Incidence,42822,Non-Hispanic American Indian/Alaska Native,287.2,Male,Lung and Bronchus,2020
70-74,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
70-74,39.7,89.0,26,Incidence,42822,Non-Hispanic American Indian/Alaska Native,60.7,Male,Non-Hodgkin Lymphoma,2020
70-74,34.0,80.6,23,Incidence,42822,Non-Hispanic American Indian/Alaska Native,53.7,Male,Oral Cavity and Pharynx,2020
70-74,37.8,86.2,25,Incidence,42822,Non-Hispanic American Indian/Alaska Native,58.4,Male,Pancreas,2020
70-74,309.4,426.2,156,Incidence,42822,Non-Hispanic American Indian/Alaska Native,364.3,Male,Prostate,2020
70-74,30.4,75.0,21,Incidence,42822,Non-Hispanic American Indian/Alaska Native,49.0,Male,Stomach,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
70-74,49.2,102.8,31,Incidence,42822,Non-Hispanic American Indian/Alaska Native,72.4,Male,Urinary Bladder,2020
75-79,1736.9,2077.2,491,Incidence,25824,Non-Hispanic American Indian/Alaska Native,1901.3,Male,All Cancer Sites Combined,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
75-79,133.7,242.0,47,Incidence,25824,Non-Hispanic American Indian/Alaska Native,182.0,Male,Colon and Rectum,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
75-79,65.8,147.5,26,Incidence,25824,Non-Hispanic American Indian/Alaska Native,100.7,Male,Kidney and Renal Pelvis,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
75-79,38.3,105.4,17,Incidence,25824,Non-Hispanic American Indian/Alaska Native,65.8,Male,Leukemias,2020
75-79,50.3,124.3,21,Incidence,25824,Non-Hispanic American Indian/Alaska Native,81.3,Male,Liver and Intrahepatic Bile Duct,2020
75-79,308.1,462.5,98,Incidence,25824,Non-Hispanic American Indian/Alaska Native,379.5,Male,Lung and Bronchus,2020
75-79,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
75-79,56.5,133.6,23,Incidence,25824,Non-Hispanic American Indian/Alaska Native,89.1,Male,Non-Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
75-79,59.5,138.3,24,Incidence,25824,Non-Hispanic American Indian/Alaska Native,92.9,Male,Pancreas,2020
75-79,259.5,402.7,84,Incidence,25824,Non-Hispanic American Indian/Alaska Native,325.3,Male,Prostate,2020
75-79,35.4,100.6,16,Incidence,25824,Non-Hispanic American Indian/Alaska Native,62.0,Male,Stomach,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
75-79,78.4,165.8,30,Incidence,25824,Non-Hispanic American Indian/Alaska Native,116.2,Male,Urinary Bladder,2020
80-84,1745.9,2203.7,292,Incidence,14861,Non-Hispanic American Indian/Alaska Native,1964.9,Male,All Cancer Sites Combined,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
80-84,141.7,296.1,31,Incidence,14861,Non-Hispanic American Indian/Alaska Native,208.6,Male,Colon and Rectum,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
80-84,61.5,174.8,16,Incidence,14861,Non-Hispanic American Indian/Alaska Native,107.7,Male,Liver and Intrahepatic Bile Duct,2020
80-84,243.9,435.9,49,Incidence,14861,Non-Hispanic American Indian/Alaska Native,329.7,Male,Lung and Bronchus,2020
80-84,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
80-84,215.1,397.5,44,Incidence,14861,Non-Hispanic American Indian/Alaska Native,296.1,Male,Prostate,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
80-84,108.9,248.3,25,Incidence,14861,Non-Hispanic American Indian/Alaska Native,168.2,Male,Urinary Bladder,2020
85+,1368.3,1833.8,186,Incidence,11710,Non-Hispanic American Indian/Alaska Native,1588.4,Male,All Cancer Sites Combined,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
85+,244.0,465.1,40,Incidence,11710,Non-Hispanic American Indian/Alaska Native,341.6,Male,Lung and Bronchus,2020
85+,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
85+,258.5,484.8,42,Incidence,11710,Non-Hispanic American Indian/Alaska Native,358.7,Male,Prostate,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Colon and Rectum,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Esophagus,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Larynx,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Leukemias,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Lung and Bronchus,2020
<1,~,~,~,Incidence,0,Non-Hispanic American Indian/Alaska Native,~,Male,Male Breast,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Melanomas of the Skin,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Mesothelioma,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Myeloma,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Pancreas,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Prostate,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Stomach,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Testis,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Thyroid,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male,Urinary Bladder,2020
1-4,13.9,29.9,29,Incidence,139309,Non-Hispanic American Indian/Alaska Native,20.8,Male and Female,All Cancer Sites Combined,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
1-4,6.6,18.7,16,Incidence,139309,Non-Hispanic American Indian/Alaska Native,11.5,Male and Female,Leukemias,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,68578,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
1-4,~,~,~,Incidence,70731,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
1-4,~,~,~,Incidence,139309,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
10-14,9.4,20.4,28,Incidence,197941,Non-Hispanic American Indian/Alaska Native,14.1,Male and Female,All Cancer Sites Combined,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,98043,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
10-14,~,~,~,Incidence,99898,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
10-14,~,~,~,Incidence,197941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
15-19,12.4,24.8,35,Incidence,196586,Non-Hispanic American Indian/Alaska Native,17.8,Male and Female,All Cancer Sites Combined,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,97082,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
15-19,~,~,~,Incidence,99504,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
15-19,~,~,~,Incidence,196586,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
20-24,26.1,42.6,68,Incidence,202492,Non-Hispanic American Indian/Alaska Native,33.6,Male and Female,All Cancer Sites Combined,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,100073,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
20-24,~,~,~,Incidence,102419,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
20-24,~,~,~,Incidence,202492,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
25-29,34.8,52.6,94,Incidence,218583,Non-Hispanic American Indian/Alaska Native,43.0,Male and Female,All Cancer Sites Combined,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
25-29,~,~,~,Incidence,107370,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
25-29,~,~,~,Incidence,111213,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
25-29,5.9,14.7,21,Incidence,218583,Non-Hispanic American Indian/Alaska Native,9.6,Male and Female,Thyroid,2020
25-29,~,~,~,Incidence,218583,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
30-34,76.5,103.3,176,Incidence,197404,Non-Hispanic American Indian/Alaska Native,89.2,Male and Female,All Cancer Sites Combined,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
30-34,4.6,13.2,16,Incidence,197404,Non-Hispanic American Indian/Alaska Native,8.1,Male and Female,Colon and Rectum,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
30-34,12.5,31.5,20,Incidence,98121,Non-Hispanic American Indian/Alaska Native,20.4,Male and Female,Female Breast,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
30-34,12.5,31.5,20,Incidence,98121,Non-Hispanic American Indian/Alaska Native,20.4,Male and Female,Male and Female Breast,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
30-34,~,~,~,Incidence,98121,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
30-34,~,~,~,Incidence,99283,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
30-34,9.0,19.9,27,Incidence,197404,Non-Hispanic American Indian/Alaska Native,13.7,Male and Female,Thyroid,2020
30-34,~,~,~,Incidence,197404,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
35-39,135.3,172.6,267,Incidence,174357,Non-Hispanic American Indian/Alaska Native,153.1,Male and Female,All Cancer Sites Combined,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
35-39,10.2,22.5,27,Incidence,174357,Non-Hispanic American Indian/Alaska Native,15.5,Male and Female,Colon and Rectum,2020
35-39,16.5,39.0,23,Incidence,88603,Non-Hispanic American Indian/Alaska Native,26.0,Male and Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
35-39,36.1,66.7,44,Incidence,88603,Non-Hispanic American Indian/Alaska Native,49.7,Male and Female,Female Breast,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
35-39,6.1,16.3,18,Incidence,174357,Non-Hispanic American Indian/Alaska Native,10.3,Male and Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
35-39,36.1,66.7,44,Incidence,88603,Non-Hispanic American Indian/Alaska Native,49.7,Male and Female,Male and Female Breast,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
35-39,~,~,~,Incidence,88603,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
35-39,~,~,~,Incidence,85754,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
35-39,14.0,27.9,35,Incidence,174357,Non-Hispanic American Indian/Alaska Native,20.1,Male and Female,Thyroid,2020
35-39,~,~,~,Incidence,174357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
40-44,213.8,262.5,374,Incidence,157684,Non-Hispanic American Indian/Alaska Native,237.2,Male and Female,All Cancer Sites Combined,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
40-44,16.2,40.0,21,Incidence,80226,Non-Hispanic American Indian/Alaska Native,26.2,Male and Female,Cervix,2020
40-44,19.7,36.7,43,Incidence,157684,Non-Hispanic American Indian/Alaska Native,27.3,Male and Female,Colon and Rectum,2020
40-44,21.2,47.5,26,Incidence,80226,Non-Hispanic American Indian/Alaska Native,32.4,Male and Female,"Corpus and Uterus, NOS",2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
40-44,86.9,133.8,87,Incidence,80226,Non-Hispanic American Indian/Alaska Native,108.4,Male and Female,Female Breast,2020
40-44,17.2,41.5,22,Incidence,80226,Non-Hispanic American Indian/Alaska Native,27.4,Male and Female,"Female Breast, <i>in situ</i>",2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
40-44,21.4,38.9,46,Incidence,157684,Non-Hispanic American Indian/Alaska Native,29.2,Male and Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
40-44,86.9,133.8,87,Incidence,80226,Non-Hispanic American Indian/Alaska Native,108.4,Male and Female,Male and Female Breast,2020
40-44,17.2,41.5,22,Incidence,80226,Non-Hispanic American Indian/Alaska Native,27.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
40-44,~,~,~,Incidence,80226,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
40-44,~,~,~,Incidence,77458,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
40-44,14.4,29.4,33,Incidence,157684,Non-Hispanic American Indian/Alaska Native,20.9,Male and Female,Thyroid,2020
40-44,~,~,~,Incidence,157684,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
45-49,324.1,384.7,534,Incidence,151095,Non-Hispanic American Indian/Alaska Native,353.4,Male and Female,All Cancer Sites Combined,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
45-49,33.2,54.8,65,Incidence,151095,Non-Hispanic American Indian/Alaska Native,43.0,Male and Female,Colon and Rectum,2020
45-49,33.6,65.7,37,Incidence,77598,Non-Hispanic American Indian/Alaska Native,47.7,Male and Female,"Corpus and Uterus, NOS",2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
45-49,145.9,205.9,135,Incidence,77598,Non-Hispanic American Indian/Alaska Native,174.0,Male and Female,Female Breast,2020
45-49,30.3,61.2,34,Incidence,77598,Non-Hispanic American Indian/Alaska Native,43.8,Male and Female,"Female Breast, <i>in situ</i>",2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
45-49,21.7,39.9,45,Incidence,151095,Non-Hispanic American Indian/Alaska Native,29.8,Male and Female,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
45-49,10.2,23.6,24,Incidence,151095,Non-Hispanic American Indian/Alaska Native,15.9,Male and Female,Lung and Bronchus,2020
45-49,145.9,205.9,135,Incidence,77598,Non-Hispanic American Indian/Alaska Native,174.0,Male and Female,Male and Female Breast,2020
45-49,30.3,61.2,34,Incidence,77598,Non-Hispanic American Indian/Alaska Native,43.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
45-49,7.1,18.8,18,Incidence,151095,Non-Hispanic American Indian/Alaska Native,11.9,Male and Female,Non-Hodgkin Lymphoma,2020
45-49,7.6,19.6,19,Incidence,151095,Non-Hispanic American Indian/Alaska Native,12.6,Male and Female,Oral Cavity and Pharynx,2020
45-49,~,~,~,Incidence,77598,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
45-49,12.4,35.4,16,Incidence,73497,Non-Hispanic American Indian/Alaska Native,21.8,Male and Female,Prostate,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
45-49,~,~,~,Incidence,73497,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
45-49,7.6,19.6,19,Incidence,151095,Non-Hispanic American Indian/Alaska Native,12.6,Male and Female,Thyroid,2020
45-49,~,~,~,Incidence,151095,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
5-9,7.6,18.1,23,Incidence,190892,Non-Hispanic American Indian/Alaska Native,12.0,Male and Female,All Cancer Sites Combined,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,93651,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
5-9,~,~,~,Incidence,97241,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
5-9,~,~,~,Incidence,190892,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
50-54,432.6,501.6,714,Incidence,153165,Non-Hispanic American Indian/Alaska Native,466.2,Male and Female,All Cancer Sites Combined,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
50-54,47.8,72.9,91,Incidence,153165,Non-Hispanic American Indian/Alaska Native,59.4,Male and Female,Colon and Rectum,2020
50-54,33.9,65.8,38,Incidence,79320,Non-Hispanic American Indian/Alaska Native,47.9,Male and Female,"Corpus and Uterus, NOS",2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
50-54,141.5,200.1,134,Incidence,79320,Non-Hispanic American Indian/Alaska Native,168.9,Male and Female,Female Breast,2020
50-54,23.5,51.0,28,Incidence,79320,Non-Hispanic American Indian/Alaska Native,35.3,Male and Female,"Female Breast, <i>in situ</i>",2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
50-54,33.3,54.8,66,Incidence,153165,Non-Hispanic American Indian/Alaska Native,43.1,Male and Female,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
50-54,7.0,18.6,18,Incidence,153165,Non-Hispanic American Indian/Alaska Native,11.8,Male and Female,Leukemias,2020
50-54,12.7,27.2,29,Incidence,153165,Non-Hispanic American Indian/Alaska Native,18.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
50-54,20.9,38.6,44,Incidence,153165,Non-Hispanic American Indian/Alaska Native,28.7,Male and Female,Lung and Bronchus,2020
50-54,141.5,200.1,134,Incidence,79320,Non-Hispanic American Indian/Alaska Native,168.9,Male and Female,Male and Female Breast,2020
50-54,23.5,51.0,28,Incidence,79320,Non-Hispanic American Indian/Alaska Native,35.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
50-54,8.5,21.0,21,Incidence,153165,Non-Hispanic American Indian/Alaska Native,13.7,Male and Female,Non-Hodgkin Lymphoma,2020
50-54,15.9,31.8,35,Incidence,153165,Non-Hispanic American Indian/Alaska Native,22.9,Male and Female,Oral Cavity and Pharynx,2020
50-54,~,~,~,Incidence,79320,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
50-54,8.0,20.2,20,Incidence,153165,Non-Hispanic American Indian/Alaska Native,13.1,Male and Female,Pancreas,2020
50-54,34.1,67.5,36,Incidence,73845,Non-Hispanic American Indian/Alaska Native,48.8,Male and Female,Prostate,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
50-54,~,~,~,Incidence,73845,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
50-54,13.8,28.7,31,Incidence,153165,Non-Hispanic American Indian/Alaska Native,20.2,Male and Female,Thyroid,2020
50-54,~,~,~,Incidence,153165,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
55-59,654.0,734.6,1155,Incidence,166562,Non-Hispanic American Indian/Alaska Native,693.4,Male and Female,All Cancer Sites Combined,2020
55-59,~,~,~,Incidence,166562,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
55-59,57.5,83.5,116,Incidence,166562,Non-Hispanic American Indian/Alaska Native,69.6,Male and Female,Colon and Rectum,2020
55-59,39.4,71.4,47,Incidence,87577,Non-Hispanic American Indian/Alaska Native,53.7,Male and Female,"Corpus and Uterus, NOS",2020
55-59,~,~,~,Incidence,166562,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
55-59,191.4,255.0,194,Incidence,87577,Non-Hispanic American Indian/Alaska Native,221.5,Male and Female,Female Breast,2020
55-59,26.9,54.3,34,Incidence,87577,Non-Hispanic American Indian/Alaska Native,38.8,Male and Female,"Female Breast, <i>in situ</i>",2020
55-59,~,~,~,Incidence,166562,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,166562,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
55-59,40.2,62.4,84,Incidence,166562,Non-Hispanic American Indian/Alaska Native,50.4,Male and Female,Kidney and Renal Pelvis,2020
55-59,~,~,~,Incidence,166562,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
55-59,11.7,25.0,29,Incidence,166562,Non-Hispanic American Indian/Alaska Native,17.4,Male and Female,Leukemias,2020
55-59,25.9,44.3,57,Incidence,166562,Non-Hispanic American Indian/Alaska Native,34.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
55-59,69.6,97.9,138,Incidence,166562,Non-Hispanic American Indian/Alaska Native,82.9,Male and Female,Lung and Bronchus,2020
55-59,191.4,255.0,194,Incidence,87577,Non-Hispanic American Indian/Alaska Native,221.5,Male and Female,Male and Female Breast,2020
55-59,26.9,54.3,34,Incidence,87577,Non-Hispanic American Indian/Alaska Native,38.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
55-59,9.2,21.4,24,Incidence,166562,Non-Hispanic American Indian/Alaska Native,14.4,Male and Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,166562,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
55-59,7.8,19.3,21,Incidence,166562,Non-Hispanic American Indian/Alaska Native,12.6,Male and Female,Myeloma,2020
55-59,10.7,23.6,27,Incidence,166562,Non-Hispanic American Indian/Alaska Native,16.2,Male and Female,Non-Hodgkin Lymphoma,2020
55-59,22.3,39.6,50,Incidence,166562,Non-Hispanic American Indian/Alaska Native,30.0,Male and Female,Oral Cavity and Pharynx,2020
55-59,~,~,~,Incidence,87577,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
55-59,12.6,26.4,31,Incidence,166562,Non-Hispanic American Indian/Alaska Native,18.6,Male and Female,Pancreas,2020
55-59,114.5,167.9,110,Incidence,78985,Non-Hispanic American Indian/Alaska Native,139.3,Male and Female,Prostate,2020
55-59,7.3,18.5,20,Incidence,166562,Non-Hispanic American Indian/Alaska Native,12.0,Male and Female,Stomach,2020
55-59,~,~,~,Incidence,78985,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
55-59,6.9,17.8,19,Incidence,166562,Non-Hispanic American Indian/Alaska Native,11.4,Male and Female,Thyroid,2020
55-59,8.8,20.7,23,Incidence,166562,Non-Hispanic American Indian/Alaska Native,13.8,Male and Female,Urinary Bladder,2020
60-64,908.0,1006.0,1485,Incidence,155325,Non-Hispanic American Indian/Alaska Native,956.1,Male and Female,All Cancer Sites Combined,2020
60-64,~,~,~,Incidence,155325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
60-64,~,~,~,Incidence,83333,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
60-64,78.2,109.1,144,Incidence,155325,Non-Hispanic American Indian/Alaska Native,92.7,Male and Female,Colon and Rectum,2020
60-64,66.5,107.5,71,Incidence,83333,Non-Hispanic American Indian/Alaska Native,85.2,Male and Female,"Corpus and Uterus, NOS",2020
60-64,7.9,19.9,20,Incidence,155325,Non-Hispanic American Indian/Alaska Native,12.9,Male and Female,Esophagus,2020
60-64,187.8,252.5,182,Incidence,83333,Non-Hispanic American Indian/Alaska Native,218.4,Male and Female,Female Breast,2020
60-64,31.3,61.2,37,Incidence,83333,Non-Hispanic American Indian/Alaska Native,44.4,Male and Female,"Female Breast, <i>in situ</i>",2020
60-64,~,~,~,Incidence,155325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,155325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
60-64,57.6,84.7,109,Incidence,155325,Non-Hispanic American Indian/Alaska Native,70.2,Male and Female,Kidney and Renal Pelvis,2020
60-64,~,~,~,Incidence,155325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
60-64,11.5,25.3,27,Incidence,155325,Non-Hispanic American Indian/Alaska Native,17.4,Male and Female,Leukemias,2020
60-64,42.0,65.5,82,Incidence,155325,Non-Hispanic American Indian/Alaska Native,52.8,Male and Female,Liver and Intrahepatic Bile Duct,2020
60-64,111.5,147.9,200,Incidence,155325,Non-Hispanic American Indian/Alaska Native,128.8,Male and Female,Lung and Bronchus,2020
60-64,187.8,252.5,182,Incidence,83333,Non-Hispanic American Indian/Alaska Native,218.4,Male and Female,Male and Female Breast,2020
60-64,31.3,61.2,37,Incidence,83333,Non-Hispanic American Indian/Alaska Native,44.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
60-64,8.9,21.4,22,Incidence,155325,Non-Hispanic American Indian/Alaska Native,14.2,Male and Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,155325,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
60-64,8.4,20.7,21,Incidence,155325,Non-Hispanic American Indian/Alaska Native,13.5,Male and Female,Myeloma,2020
60-64,26.7,46.1,55,Incidence,155325,Non-Hispanic American Indian/Alaska Native,35.4,Male and Female,Non-Hodgkin Lymphoma,2020
60-64,24.4,43.2,51,Incidence,155325,Non-Hispanic American Indian/Alaska Native,32.8,Male and Female,Oral Cavity and Pharynx,2020
60-64,14.7,37.1,20,Incidence,83333,Non-Hispanic American Indian/Alaska Native,24.0,Male and Female,Ovary,2020
60-64,26.1,45.4,54,Incidence,155325,Non-Hispanic American Indian/Alaska Native,34.8,Male and Female,Pancreas,2020
60-64,225.1,301.3,188,Incidence,71992,Non-Hispanic American Indian/Alaska Native,261.1,Male and Female,Prostate,2020
60-64,11.5,25.3,27,Incidence,155325,Non-Hispanic American Indian/Alaska Native,17.4,Male and Female,Stomach,2020
60-64,~,~,~,Incidence,71992,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
60-64,6.4,17.5,17,Incidence,155325,Non-Hispanic American Indian/Alaska Native,10.9,Male and Female,Thyroid,2020
60-64,22.2,40.2,47,Incidence,155325,Non-Hispanic American Indian/Alaska Native,30.3,Male and Female,Urinary Bladder,2020
65-69,1151.9,1275.7,1495,Incidence,123290,Non-Hispanic American Indian/Alaska Native,1212.6,Male and Female,All Cancer Sites Combined,2020
65-69,~,~,~,Incidence,123290,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
65-69,~,~,~,Incidence,66796,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
65-69,85.1,121.7,126,Incidence,123290,Non-Hispanic American Indian/Alaska Native,102.2,Male and Female,Colon and Rectum,2020
65-69,49.1,90.1,45,Incidence,66796,Non-Hispanic American Indian/Alaska Native,67.4,Male and Female,"Corpus and Uterus, NOS",2020
65-69,12.5,29.0,24,Incidence,123290,Non-Hispanic American Indian/Alaska Native,19.5,Male and Female,Esophagus,2020
65-69,242.7,324.7,188,Incidence,66796,Non-Hispanic American Indian/Alaska Native,281.5,Male and Female,Female Breast,2020
65-69,39.0,76.4,37,Incidence,66796,Non-Hispanic American Indian/Alaska Native,55.4,Male and Female,"Female Breast, <i>in situ</i>",2020
65-69,~,~,~,Incidence,123290,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,123290,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
65-69,64.5,96.9,98,Incidence,123290,Non-Hispanic American Indian/Alaska Native,79.5,Male and Female,Kidney and Renal Pelvis,2020
65-69,7.4,21.1,16,Incidence,123290,Non-Hispanic American Indian/Alaska Native,13.0,Male and Female,Larynx,2020
65-69,15.8,33.8,29,Incidence,123290,Non-Hispanic American Indian/Alaska Native,23.5,Male and Female,Leukemias,2020
65-69,50.0,79.0,78,Incidence,123290,Non-Hispanic American Indian/Alaska Native,63.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
65-69,163.2,212.3,230,Incidence,123290,Non-Hispanic American Indian/Alaska Native,186.6,Male and Female,Lung and Bronchus,2020
65-69,242.7,324.7,188,Incidence,66796,Non-Hispanic American Indian/Alaska Native,281.5,Male and Female,Male and Female Breast,2020
65-69,39.0,76.4,37,Incidence,66796,Non-Hispanic American Indian/Alaska Native,55.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
65-69,11.2,27.0,22,Incidence,123290,Non-Hispanic American Indian/Alaska Native,17.8,Male and Female,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,123290,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
65-69,20.5,40.4,36,Incidence,123290,Non-Hispanic American Indian/Alaska Native,29.2,Male and Female,Myeloma,2020
65-69,29.4,52.5,49,Incidence,123290,Non-Hispanic American Indian/Alaska Native,39.7,Male and Female,Non-Hodgkin Lymphoma,2020
65-69,25.2,47.0,43,Incidence,123290,Non-Hispanic American Indian/Alaska Native,34.9,Male and Female,Oral Cavity and Pharynx,2020
65-69,16.0,42.6,18,Incidence,66796,Non-Hispanic American Indian/Alaska Native,26.9,Male and Female,Ovary,2020
65-69,30.1,53.5,50,Incidence,123290,Non-Hispanic American Indian/Alaska Native,40.6,Male and Female,Pancreas,2020
65-69,305.0,404.7,199,Incidence,56494,Non-Hispanic American Indian/Alaska Native,352.2,Male and Female,Prostate,2020
65-69,17.1,35.7,31,Incidence,123290,Non-Hispanic American Indian/Alaska Native,25.1,Male and Female,Stomach,2020
65-69,~,~,~,Incidence,56494,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
65-69,8.0,22.1,17,Incidence,123290,Non-Hispanic American Indian/Alaska Native,13.8,Male and Female,Thyroid,2020
65-69,28.7,51.6,48,Incidence,123290,Non-Hispanic American Indian/Alaska Native,38.9,Male and Female,Urinary Bladder,2020
70-74,1313.2,1465.8,1290,Incidence,92945,Non-Hispanic American Indian/Alaska Native,1387.9,Male and Female,All Cancer Sites Combined,2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
70-74,~,~,~,Incidence,50123,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
70-74,91.4,135.6,104,Incidence,92945,Non-Hispanic American Indian/Alaska Native,111.9,Male and Female,Colon and Rectum,2020
70-74,48.6,97.1,35,Incidence,50123,Non-Hispanic American Indian/Alaska Native,69.8,Male and Female,"Corpus and Uterus, NOS",2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
70-74,279.0,381.3,164,Incidence,50123,Non-Hispanic American Indian/Alaska Native,327.2,Male and Female,Female Breast,2020
70-74,45.3,92.5,33,Incidence,50123,Non-Hispanic American Indian/Alaska Native,65.8,Male and Female,"Female Breast, <i>in situ</i>",2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
70-74,55.9,91.5,67,Incidence,92945,Non-Hispanic American Indian/Alaska Native,72.1,Male and Female,Kidney and Renal Pelvis,2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
70-74,23.5,48.6,32,Incidence,92945,Non-Hispanic American Indian/Alaska Native,34.4,Male and Female,Leukemias,2020
70-74,35.3,64.8,45,Incidence,92945,Non-Hispanic American Indian/Alaska Native,48.4,Male and Female,Liver and Intrahepatic Bile Duct,2020
70-74,226.6,293.0,240,Incidence,92945,Non-Hispanic American Indian/Alaska Native,258.2,Male and Female,Lung and Bronchus,2020
70-74,279.0,381.3,164,Incidence,50123,Non-Hispanic American Indian/Alaska Native,327.2,Male and Female,Male and Female Breast,2020
70-74,45.3,92.5,33,Incidence,50123,Non-Hispanic American Indian/Alaska Native,65.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
70-74,14.8,35.8,22,Incidence,92945,Non-Hispanic American Indian/Alaska Native,23.7,Male and Female,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
70-74,15.7,37.1,23,Incidence,92945,Non-Hispanic American Indian/Alaska Native,24.7,Male and Female,Myeloma,2020
70-74,37.2,67.2,47,Incidence,92945,Non-Hispanic American Indian/Alaska Native,50.6,Male and Female,Non-Hodgkin Lymphoma,2020
70-74,23.5,48.6,32,Incidence,92945,Non-Hispanic American Indian/Alaska Native,34.4,Male and Female,Oral Cavity and Pharynx,2020
70-74,19.8,54.3,17,Incidence,50123,Non-Hispanic American Indian/Alaska Native,33.9,Male and Female,Ovary,2020
70-74,39.0,69.7,49,Incidence,92945,Non-Hispanic American Indian/Alaska Native,52.7,Male and Female,Pancreas,2020
70-74,309.4,426.2,156,Incidence,42822,Non-Hispanic American Indian/Alaska Native,364.3,Male and Female,Prostate,2020
70-74,24.4,49.9,33,Incidence,92945,Non-Hispanic American Indian/Alaska Native,35.5,Male and Female,Stomach,2020
70-74,~,~,~,Incidence,42822,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
70-74,~,~,~,Incidence,92945,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
70-74,34.4,63.6,44,Incidence,92945,Non-Hispanic American Indian/Alaska Native,47.3,Male and Female,Urinary Bladder,2020
75-79,1520.4,1730.2,935,Incidence,57617,Non-Hispanic American Indian/Alaska Native,1622.8,Male and Female,All Cancer Sites Combined,2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
75-79,125.6,192.0,90,Incidence,57617,Non-Hispanic American Indian/Alaska Native,156.2,Male and Female,Colon and Rectum,2020
75-79,36.0,93.3,19,Incidence,31793,Non-Hispanic American Indian/Alaska Native,59.8,Male and Female,"Corpus and Uterus, NOS",2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
75-79,227.6,348.0,90,Incidence,31793,Non-Hispanic American Indian/Alaska Native,283.1,Male and Female,Female Breast,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
75-79,61.4,110.5,48,Incidence,57617,Non-Hispanic American Indian/Alaska Native,83.3,Male and Female,Kidney and Renal Pelvis,2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
75-79,36.6,76.4,31,Incidence,57617,Non-Hispanic American Indian/Alaska Native,53.8,Male and Female,Leukemias,2020
75-79,39.4,80.4,33,Incidence,57617,Non-Hispanic American Indian/Alaska Native,57.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
75-79,282.9,378.3,189,Incidence,57617,Non-Hispanic American Indian/Alaska Native,328.0,Male and Female,Lung and Bronchus,2020
75-79,227.6,348.0,90,Incidence,31793,Non-Hispanic American Indian/Alaska Native,283.1,Male and Female,Male and Female Breast,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
75-79,21.2,53.6,20,Incidence,57617,Non-Hispanic American Indian/Alaska Native,34.7,Male and Female,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
75-79,22.6,55.7,21,Incidence,57617,Non-Hispanic American Indian/Alaska Native,36.4,Male and Female,Myeloma,2020
75-79,45.2,88.5,37,Incidence,57617,Non-Hispanic American Indian/Alaska Native,64.2,Male and Female,Non-Hodgkin Lymphoma,2020
75-79,15.9,45.1,16,Incidence,57617,Non-Hispanic American Indian/Alaska Native,27.8,Male and Female,Oral Cavity and Pharynx,2020
75-79,~,~,~,Incidence,31793,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
75-79,43.8,86.5,36,Incidence,57617,Non-Hispanic American Indian/Alaska Native,62.5,Male and Female,Pancreas,2020
75-79,259.5,402.7,84,Incidence,25824,Non-Hispanic American Indian/Alaska Native,325.3,Male and Female,Prostate,2020
75-79,29.5,66.1,26,Incidence,57617,Non-Hispanic American Indian/Alaska Native,45.1,Male and Female,Stomach,2020
75-79,~,~,~,Incidence,25824,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
75-79,~,~,~,Incidence,57617,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
75-79,45.2,88.5,37,Incidence,57617,Non-Hispanic American Indian/Alaska Native,64.2,Male and Female,Urinary Bladder,2020
80-84,1469.9,1738.1,559,Incidence,34941,Non-Hispanic American Indian/Alaska Native,1599.8,Male and Female,All Cancer Sites Combined,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
80-84,133.5,224.3,61,Incidence,34941,Non-Hispanic American Indian/Alaska Native,174.6,Male and Female,Colon and Rectum,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
80-84,142.3,271.3,40,Incidence,20080,Non-Hispanic American Indian/Alaska Native,199.2,Male and Female,Female Breast,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
80-84,30.5,81.4,18,Incidence,34941,Non-Hispanic American Indian/Alaska Native,51.5,Male and Female,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
80-84,44.0,102.2,24,Incidence,34941,Non-Hispanic American Indian/Alaska Native,68.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
80-84,251.0,370.0,107,Incidence,34941,Non-Hispanic American Indian/Alaska Native,306.2,Male and Female,Lung and Bronchus,2020
80-84,142.3,271.3,40,Incidence,20080,Non-Hispanic American Indian/Alaska Native,199.2,Male and Female,Male and Female Breast,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
80-84,41.7,98.8,23,Incidence,34941,Non-Hispanic American Indian/Alaska Native,65.8,Male and Female,Non-Hodgkin Lymphoma,2020
80-84,26.2,74.4,16,Incidence,34941,Non-Hispanic American Indian/Alaska Native,45.8,Male and Female,Oral Cavity and Pharynx,2020
80-84,~,~,~,Incidence,20080,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
80-84,74.6,146.0,37,Incidence,34941,Non-Hispanic American Indian/Alaska Native,105.9,Male and Female,Pancreas,2020
80-84,215.1,397.5,44,Incidence,14861,Non-Hispanic American Indian/Alaska Native,296.1,Male and Female,Prostate,2020
80-84,26.2,74.4,16,Incidence,34941,Non-Hispanic American Indian/Alaska Native,45.8,Male and Female,Stomach,2020
80-84,~,~,~,Incidence,14861,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
80-84,~,~,~,Incidence,34941,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
80-84,48.6,109.0,26,Incidence,34941,Non-Hispanic American Indian/Alaska Native,74.4,Male and Female,Urinary Bladder,2020
85+,1141.5,1393.6,396,Incidence,31357,Non-Hispanic American Indian/Alaska Native,1262.9,Male and Female,All Cancer Sites Combined,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
85+,61.9,132.8,29,Incidence,31357,Non-Hispanic American Indian/Alaska Native,92.5,Male and Female,Colon and Rectum,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
85+,149.8,283.1,41,Incidence,19647,Non-Hispanic American Indian/Alaska Native,208.7,Male and Female,Female Breast,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
85+,179.7,289.2,72,Incidence,31357,Non-Hispanic American Indian/Alaska Native,229.6,Male and Female,Lung and Bronchus,2020
85+,149.8,283.1,41,Incidence,19647,Non-Hispanic American Indian/Alaska Native,208.7,Male and Female,Male and Female Breast,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
85+,44.0,106.2,22,Incidence,31357,Non-Hispanic American Indian/Alaska Native,70.2,Male and Female,Non-Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
85+,~,~,~,Incidence,19647,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
85+,34.0,90.7,18,Incidence,31357,Non-Hispanic American Indian/Alaska Native,57.4,Male and Female,Pancreas,2020
85+,258.5,484.8,42,Incidence,11710,Non-Hispanic American Indian/Alaska Native,358.7,Male and Female,Prostate,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
85+,~,~,~,Incidence,11710,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
85+,~,~,~,Incidence,31357,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
85+,31.6,86.8,17,Incidence,31357,Non-Hispanic American Indian/Alaska Native,54.2,Male and Female,Urinary Bladder,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Cervix,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Colon and Rectum,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Esophagus,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Female Breast,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Larynx,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Leukemias,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Male and Female Breast,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Mesothelioma,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Myeloma,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,16351,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Ovary,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Pancreas,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Prostate,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Stomach,2020
<1,~,~,~,Incidence,16840,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Testis,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Thyroid,2020
<1,~,~,~,Incidence,33191,Non-Hispanic American Indian/Alaska Native,~,Male and Female,Urinary Bladder,2020
1-4,15.0,22.9,92,Incidence,493409,Non-Hispanic Asian/Pacific Islander,18.6,Female,All Cancer Sites Combined,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
1-4,4.9,9.9,35,Incidence,493409,Non-Hispanic Asian/Pacific Islander,7.1,Female,Leukemias,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
10-14,10.8,16.9,81,Incidence,594869,Non-Hispanic Asian/Pacific Islander,13.6,Female,All Cancer Sites Combined,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
10-14,1.9,5.0,19,Incidence,594869,Non-Hispanic Asian/Pacific Islander,3.2,Female,Leukemias,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
15-19,16.5,23.6,123,Incidence,621336,Non-Hispanic Asian/Pacific Islander,19.8,Female,All Cancer Sites Combined,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
15-19,5.0,9.3,43,Incidence,621336,Non-Hispanic Asian/Pacific Islander,6.9,Female,Thyroid,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
20-24,25.8,34.3,200,Incidence,670451,Non-Hispanic Asian/Pacific Islander,29.8,Female,All Cancer Sites Combined,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
20-24,2.3,5.3,24,Incidence,670451,Non-Hispanic Asian/Pacific Islander,3.6,Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
20-24,1.4,3.9,16,Incidence,670451,Non-Hispanic Asian/Pacific Islander,2.4,Female,Leukemias,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
20-24,1.4,3.9,16,Incidence,670451,Non-Hispanic Asian/Pacific Islander,2.4,Female,Ovary,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
20-24,8.1,13.2,70,Incidence,670451,Non-Hispanic Asian/Pacific Islander,10.4,Female,Thyroid,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
25-29,46.0,55.9,418,Incidence,823635,Non-Hispanic Asian/Pacific Islander,50.8,Female,All Cancer Sites Combined,2020
25-29,1.1,3.2,16,Incidence,823635,Non-Hispanic Asian/Pacific Islander,1.9,Female,Brain and Other Nervous System,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
25-29,1.8,4.2,23,Incidence,823635,Non-Hispanic Asian/Pacific Islander,2.8,Female,Colon and Rectum,2020
25-29,1.3,3.5,18,Incidence,823635,Non-Hispanic Asian/Pacific Islander,2.2,Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
25-29,6.7,10.9,71,Incidence,823635,Non-Hispanic Asian/Pacific Islander,8.6,Female,Female Breast,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
25-29,1.5,3.8,20,Incidence,823635,Non-Hispanic Asian/Pacific Islander,2.4,Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
25-29,2.3,4.9,28,Incidence,823635,Non-Hispanic Asian/Pacific Islander,3.4,Female,Non-Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
25-29,1.5,3.8,20,Incidence,823635,Non-Hispanic Asian/Pacific Islander,2.4,Female,Ovary,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
25-29,12.3,17.7,122,Incidence,823635,Non-Hispanic Asian/Pacific Islander,14.8,Female,Thyroid,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
30-34,84.0,96.4,829,Incidence,920697,Non-Hispanic Asian/Pacific Islander,90.0,Female,All Cancer Sites Combined,2020
30-34,1.2,3.2,19,Incidence,920697,Non-Hispanic Asian/Pacific Islander,2.1,Female,Brain and Other Nervous System,2020
30-34,4.7,8.0,57,Incidence,920697,Non-Hispanic Asian/Pacific Islander,6.2,Female,Cervix,2020
30-34,4.5,7.8,55,Incidence,920697,Non-Hispanic Asian/Pacific Islander,6.0,Female,Colon and Rectum,2020
30-34,3.8,6.9,48,Incidence,920697,Non-Hispanic Asian/Pacific Islander,5.2,Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
30-34,23.4,30.2,245,Incidence,920697,Non-Hispanic Asian/Pacific Islander,26.6,Female,Female Breast,2020
30-34,2.2,4.7,30,Incidence,920697,Non-Hispanic Asian/Pacific Islander,3.3,Female,"Female Breast, <i>in situ</i>",2020
30-34,1.1,3.0,17,Incidence,920697,Non-Hispanic Asian/Pacific Islander,1.8,Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
30-34,1.8,4.0,25,Incidence,920697,Non-Hispanic Asian/Pacific Islander,2.7,Female,Leukemias,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
30-34,2.4,4.9,32,Incidence,920697,Non-Hispanic Asian/Pacific Islander,3.5,Female,Non-Hodgkin Lymphoma,2020
30-34,1.1,3.0,17,Incidence,920697,Non-Hispanic Asian/Pacific Islander,1.8,Female,Oral Cavity and Pharynx,2020
30-34,2.5,5.0,33,Incidence,920697,Non-Hispanic Asian/Pacific Islander,3.6,Female,Ovary,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
30-34,18.0,24.0,192,Incidence,920697,Non-Hispanic Asian/Pacific Islander,20.9,Female,Thyroid,2020
30-34,~,~,~,Incidence,920697,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
35-39,128.8,144.1,1236,Incidence,906842,Non-Hispanic Asian/Pacific Islander,136.3,Female,All Cancer Sites Combined,2020
35-39,1.7,3.9,24,Incidence,906842,Non-Hispanic Asian/Pacific Islander,2.6,Female,Brain and Other Nervous System,2020
35-39,4.4,7.6,53,Incidence,906842,Non-Hispanic Asian/Pacific Islander,5.8,Female,Cervix,2020
35-39,5.0,8.4,59,Incidence,906842,Non-Hispanic Asian/Pacific Islander,6.5,Female,Colon and Rectum,2020
35-39,7.8,12.0,88,Incidence,906842,Non-Hispanic Asian/Pacific Islander,9.7,Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
35-39,50.9,60.8,505,Incidence,906842,Non-Hispanic Asian/Pacific Islander,55.7,Female,Female Breast,2020
35-39,6.1,9.9,71,Incidence,906842,Non-Hispanic Asian/Pacific Islander,7.8,Female,"Female Breast, <i>in situ</i>",2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
35-39,1.2,3.1,18,Incidence,906842,Non-Hispanic Asian/Pacific Islander,2.0,Female,Leukemias,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
35-39,3.8,6.9,47,Incidence,906842,Non-Hispanic Asian/Pacific Islander,5.2,Female,Non-Hodgkin Lymphoma,2020
35-39,1.9,4.2,26,Incidence,906842,Non-Hispanic Asian/Pacific Islander,2.9,Female,Oral Cavity and Pharynx,2020
35-39,3.5,6.5,44,Incidence,906842,Non-Hispanic Asian/Pacific Islander,4.9,Female,Ovary,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
35-39,22.7,29.4,235,Incidence,906842,Non-Hispanic Asian/Pacific Islander,25.9,Female,Thyroid,2020
35-39,~,~,~,Incidence,906842,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
40-44,227.2,248.4,1960,Incidence,824763,Non-Hispanic Asian/Pacific Islander,237.6,Female,All Cancer Sites Combined,2020
40-44,1.4,3.6,19,Incidence,824763,Non-Hispanic Asian/Pacific Islander,2.3,Female,Brain and Other Nervous System,2020
40-44,8.1,12.6,84,Incidence,824763,Non-Hispanic Asian/Pacific Islander,10.2,Female,Cervix,2020
40-44,9.9,14.7,100,Incidence,824763,Non-Hispanic Asian/Pacific Islander,12.1,Female,Colon and Rectum,2020
40-44,12.3,17.7,122,Incidence,824763,Non-Hispanic Asian/Pacific Islander,14.8,Female,"Corpus and Uterus, NOS",2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
40-44,116.6,131.9,1023,Incidence,824763,Non-Hispanic Asian/Pacific Islander,124.0,Female,Female Breast,2020
40-44,31.5,39.7,292,Incidence,824763,Non-Hispanic Asian/Pacific Islander,35.4,Female,"Female Breast, <i>in situ</i>",2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
40-44,1.8,4.2,23,Incidence,824763,Non-Hispanic Asian/Pacific Islander,2.8,Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
40-44,2.2,4.8,27,Incidence,824763,Non-Hispanic Asian/Pacific Islander,3.3,Female,Leukemias,2020
40-44,1.4,3.6,19,Incidence,824763,Non-Hispanic Asian/Pacific Islander,2.3,Female,Liver and Intrahepatic Bile Duct,2020
40-44,3.9,7.2,44,Incidence,824763,Non-Hispanic Asian/Pacific Islander,5.3,Female,Lung and Bronchus,2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
40-44,3.5,6.6,40,Incidence,824763,Non-Hispanic Asian/Pacific Islander,4.8,Female,Non-Hodgkin Lymphoma,2020
40-44,2.4,5.0,29,Incidence,824763,Non-Hispanic Asian/Pacific Islander,3.5,Female,Oral Cavity and Pharynx,2020
40-44,6.7,10.9,71,Incidence,824763,Non-Hispanic Asian/Pacific Islander,8.6,Female,Ovary,2020
40-44,1.1,3.2,16,Incidence,824763,Non-Hispanic Asian/Pacific Islander,1.9,Female,Pancreas,2020
40-44,1.8,4.2,23,Incidence,824763,Non-Hispanic Asian/Pacific Islander,2.8,Female,Stomach,2020
40-44,22.5,29.5,213,Incidence,824763,Non-Hispanic Asian/Pacific Islander,25.8,Female,Thyroid,2020
40-44,~,~,~,Incidence,824763,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
45-49,360.7,387.8,2964,Incidence,792432,Non-Hispanic Asian/Pacific Islander,374.0,Female,All Cancer Sites Combined,2020
45-49,1.7,4.2,22,Incidence,792432,Non-Hispanic Asian/Pacific Islander,2.8,Female,Brain and Other Nervous System,2020
45-49,7.7,12.1,77,Incidence,792432,Non-Hispanic Asian/Pacific Islander,9.7,Female,Cervix,2020
45-49,23.5,30.9,214,Incidence,792432,Non-Hispanic Asian/Pacific Islander,27.0,Female,Colon and Rectum,2020
45-49,26.9,34.8,243,Incidence,792432,Non-Hispanic Asian/Pacific Islander,30.7,Female,"Corpus and Uterus, NOS",2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
45-49,186.4,206.0,1553,Incidence,792432,Non-Hispanic Asian/Pacific Islander,196.0,Female,Female Breast,2020
45-49,63.7,75.5,550,Incidence,792432,Non-Hispanic Asian/Pacific Islander,69.4,Female,"Female Breast, <i>in situ</i>",2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
45-49,3.5,6.7,39,Incidence,792432,Non-Hispanic Asian/Pacific Islander,4.9,Female,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
45-49,4.5,8.0,48,Incidence,792432,Non-Hispanic Asian/Pacific Islander,6.1,Female,Leukemias,2020
45-49,1.9,4.5,24,Incidence,792432,Non-Hispanic Asian/Pacific Islander,3.0,Female,Liver and Intrahepatic Bile Duct,2020
45-49,10.0,15.1,98,Incidence,792432,Non-Hispanic Asian/Pacific Islander,12.4,Female,Lung and Bronchus,2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
45-49,6.9,11.2,70,Incidence,792432,Non-Hispanic Asian/Pacific Islander,8.8,Female,Non-Hodgkin Lymphoma,2020
45-49,3.9,7.3,43,Incidence,792432,Non-Hispanic Asian/Pacific Islander,5.4,Female,Oral Cavity and Pharynx,2020
45-49,8.9,13.7,88,Incidence,792432,Non-Hispanic Asian/Pacific Islander,11.1,Female,Ovary,2020
45-49,2.2,5.0,27,Incidence,792432,Non-Hispanic Asian/Pacific Islander,3.4,Female,Pancreas,2020
45-49,2.3,5.1,28,Incidence,792432,Non-Hispanic Asian/Pacific Islander,3.5,Female,Stomach,2020
45-49,25.4,33.0,230,Incidence,792432,Non-Hispanic Asian/Pacific Islander,29.0,Female,Thyroid,2020
45-49,~,~,~,Incidence,792432,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
5-9,8.6,14.0,70,Incidence,632753,Non-Hispanic Asian/Pacific Islander,11.1,Female,All Cancer Sites Combined,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
5-9,3.5,7.1,32,Incidence,632753,Non-Hispanic Asian/Pacific Islander,5.1,Female,Leukemias,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
50-54,452.8,485.1,3251,Incidence,693545,Non-Hispanic Asian/Pacific Islander,468.8,Female,All Cancer Sites Combined,2020
50-54,2.4,5.5,26,Incidence,693545,Non-Hispanic Asian/Pacific Islander,3.7,Female,Brain and Other Nervous System,2020
50-54,11.7,17.5,100,Incidence,693545,Non-Hispanic Asian/Pacific Islander,14.4,Female,Cervix,2020
50-54,34.3,43.7,269,Incidence,693545,Non-Hispanic Asian/Pacific Islander,38.8,Female,Colon and Rectum,2020
50-54,41.2,51.5,320,Incidence,693545,Non-Hispanic Asian/Pacific Islander,46.1,Female,"Corpus and Uterus, NOS",2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
50-54,199.1,220.9,1455,Incidence,693545,Non-Hispanic Asian/Pacific Islander,209.8,Female,Female Breast,2020
50-54,58.9,71.0,449,Incidence,693545,Non-Hispanic Asian/Pacific Islander,64.7,Female,"Female Breast, <i>in situ</i>",2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
50-54,4.9,8.8,46,Incidence,693545,Non-Hispanic Asian/Pacific Islander,6.6,Female,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
50-54,4.1,7.9,40,Incidence,693545,Non-Hispanic Asian/Pacific Islander,5.8,Female,Leukemias,2020
50-54,3.5,7.0,35,Incidence,693545,Non-Hispanic Asian/Pacific Islander,5.0,Female,Liver and Intrahepatic Bile Duct,2020
50-54,20.2,27.6,164,Incidence,693545,Non-Hispanic Asian/Pacific Islander,23.6,Female,Lung and Bronchus,2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
50-54,2.2,5.1,24,Incidence,693545,Non-Hispanic Asian/Pacific Islander,3.5,Female,Myeloma,2020
50-54,9.3,14.5,81,Incidence,693545,Non-Hispanic Asian/Pacific Islander,11.7,Female,Non-Hodgkin Lymphoma,2020
50-54,6.4,10.8,58,Incidence,693545,Non-Hispanic Asian/Pacific Islander,8.4,Female,Oral Cavity and Pharynx,2020
50-54,15.4,21.9,128,Incidence,693545,Non-Hispanic Asian/Pacific Islander,18.5,Female,Ovary,2020
50-54,4.5,8.4,43,Incidence,693545,Non-Hispanic Asian/Pacific Islander,6.2,Female,Pancreas,2020
50-54,5.8,10.2,54,Incidence,693545,Non-Hispanic Asian/Pacific Islander,7.8,Female,Stomach,2020
50-54,28.2,36.8,224,Incidence,693545,Non-Hispanic Asian/Pacific Islander,32.3,Female,Thyroid,2020
50-54,~,~,~,Incidence,693545,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
55-59,533.0,569.7,3489,Incidence,633085,Non-Hispanic Asian/Pacific Islander,551.1,Female,All Cancer Sites Combined,2020
55-59,3.5,7.1,32,Incidence,633085,Non-Hispanic Asian/Pacific Islander,5.1,Female,Brain and Other Nervous System,2020
55-59,9.6,15.2,77,Incidence,633085,Non-Hispanic Asian/Pacific Islander,12.2,Female,Cervix,2020
55-59,36.7,46.9,263,Incidence,633085,Non-Hispanic Asian/Pacific Islander,41.5,Female,Colon and Rectum,2020
55-59,60.4,73.3,422,Incidence,633085,Non-Hispanic Asian/Pacific Islander,66.7,Female,"Corpus and Uterus, NOS",2020
55-59,~,~,~,Incidence,633085,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
55-59,201.9,224.8,1349,Incidence,633085,Non-Hispanic Asian/Pacific Islander,213.1,Female,Female Breast,2020
55-59,54.9,67.2,385,Incidence,633085,Non-Hispanic Asian/Pacific Islander,60.8,Female,"Female Breast, <i>in situ</i>",2020
55-59,~,~,~,Incidence,633085,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,633085,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
55-59,6.5,11.3,55,Incidence,633085,Non-Hispanic Asian/Pacific Islander,8.7,Female,Kidney and Renal Pelvis,2020
55-59,~,~,~,Incidence,633085,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
55-59,5.6,10.1,48,Incidence,633085,Non-Hispanic Asian/Pacific Islander,7.6,Female,Leukemias,2020
55-59,4.5,8.6,40,Incidence,633085,Non-Hispanic Asian/Pacific Islander,6.3,Female,Liver and Intrahepatic Bile Duct,2020
55-59,36.8,47.0,264,Incidence,633085,Non-Hispanic Asian/Pacific Islander,41.7,Female,Lung and Bronchus,2020
55-59,1.8,4.7,19,Incidence,633085,Non-Hispanic Asian/Pacific Islander,3.0,Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,633085,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
55-59,3.7,7.5,34,Incidence,633085,Non-Hispanic Asian/Pacific Islander,5.4,Female,Myeloma,2020
55-59,13.6,20.1,105,Incidence,633085,Non-Hispanic Asian/Pacific Islander,16.6,Female,Non-Hodgkin Lymphoma,2020
55-59,7.6,12.7,63,Incidence,633085,Non-Hispanic Asian/Pacific Islander,10.0,Female,Oral Cavity and Pharynx,2020
55-59,20.3,28.1,152,Incidence,633085,Non-Hispanic Asian/Pacific Islander,24.0,Female,Ovary,2020
55-59,12.6,18.9,98,Incidence,633085,Non-Hispanic Asian/Pacific Islander,15.5,Female,Pancreas,2020
55-59,8.1,13.3,66,Incidence,633085,Non-Hispanic Asian/Pacific Islander,10.4,Female,Stomach,2020
55-59,24.9,33.4,183,Incidence,633085,Non-Hispanic Asian/Pacific Islander,28.9,Female,Thyroid,2020
55-59,2.4,5.6,24,Incidence,633085,Non-Hispanic Asian/Pacific Islander,3.8,Female,Urinary Bladder,2020
60-64,626.5,668.1,3749,Incidence,579396,Non-Hispanic Asian/Pacific Islander,647.1,Female,All Cancer Sites Combined,2020
60-64,4.1,8.2,34,Incidence,579396,Non-Hispanic Asian/Pacific Islander,5.9,Female,Brain and Other Nervous System,2020
60-64,6.3,11.2,49,Incidence,579396,Non-Hispanic Asian/Pacific Islander,8.5,Female,Cervix,2020
60-64,41.5,52.9,272,Incidence,579396,Non-Hispanic Asian/Pacific Islander,46.9,Female,Colon and Rectum,2020
60-64,59.0,72.3,379,Incidence,579396,Non-Hispanic Asian/Pacific Islander,65.4,Female,"Corpus and Uterus, NOS",2020
60-64,~,~,~,Incidence,579396,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
60-64,230.5,256.0,1408,Incidence,579396,Non-Hispanic Asian/Pacific Islander,243.0,Female,Female Breast,2020
60-64,65.6,79.6,419,Incidence,579396,Non-Hispanic Asian/Pacific Islander,72.3,Female,"Female Breast, <i>in situ</i>",2020
60-64,~,~,~,Incidence,579396,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,579396,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
60-64,10.3,16.4,76,Incidence,579396,Non-Hispanic Asian/Pacific Islander,13.1,Female,Kidney and Renal Pelvis,2020
60-64,~,~,~,Incidence,579396,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
60-64,7.5,12.7,57,Incidence,579396,Non-Hispanic Asian/Pacific Islander,9.8,Female,Leukemias,2020
60-64,8.7,14.3,65,Incidence,579396,Non-Hispanic Asian/Pacific Islander,11.2,Female,Liver and Intrahepatic Bile Duct,2020
60-64,53.9,66.7,348,Incidence,579396,Non-Hispanic Asian/Pacific Islander,60.1,Female,Lung and Bronchus,2020
60-64,2.7,6.2,24,Incidence,579396,Non-Hispanic Asian/Pacific Islander,4.1,Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,579396,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
60-64,5.2,9.8,42,Incidence,579396,Non-Hispanic Asian/Pacific Islander,7.2,Female,Myeloma,2020
60-64,21.1,29.4,145,Incidence,579396,Non-Hispanic Asian/Pacific Islander,25.0,Female,Non-Hodgkin Lymphoma,2020
60-64,9.6,15.5,71,Incidence,579396,Non-Hispanic Asian/Pacific Islander,12.3,Female,Oral Cavity and Pharynx,2020
60-64,18.9,26.8,131,Incidence,579396,Non-Hispanic Asian/Pacific Islander,22.6,Female,Ovary,2020
60-64,13.9,20.8,99,Incidence,579396,Non-Hispanic Asian/Pacific Islander,17.1,Female,Pancreas,2020
60-64,9.7,15.6,72,Incidence,579396,Non-Hispanic Asian/Pacific Islander,12.4,Female,Stomach,2020
60-64,22.9,31.5,156,Incidence,579396,Non-Hispanic Asian/Pacific Islander,26.9,Female,Thyroid,2020
60-64,3.8,7.8,32,Incidence,579396,Non-Hispanic Asian/Pacific Islander,5.5,Female,Urinary Bladder,2020
65-69,771.7,821.3,3983,Incidence,500236,Non-Hispanic Asian/Pacific Islander,796.2,Female,All Cancer Sites Combined,2020
65-69,4.0,8.6,30,Incidence,500236,Non-Hispanic Asian/Pacific Islander,6.0,Female,Brain and Other Nervous System,2020
65-69,7.8,13.6,52,Incidence,500236,Non-Hispanic Asian/Pacific Islander,10.4,Female,Cervix,2020
65-69,45.3,58.1,257,Incidence,500236,Non-Hispanic Asian/Pacific Islander,51.4,Female,Colon and Rectum,2020
65-69,61.1,75.8,341,Incidence,500236,Non-Hispanic Asian/Pacific Islander,68.2,Female,"Corpus and Uterus, NOS",2020
65-69,2.1,5.7,18,Incidence,500236,Non-Hispanic Asian/Pacific Islander,3.6,Female,Esophagus,2020
65-69,262.5,291.8,1385,Incidence,500236,Non-Hispanic Asian/Pacific Islander,276.9,Female,Female Breast,2020
65-69,84.3,101.4,463,Incidence,500236,Non-Hispanic Asian/Pacific Islander,92.6,Female,"Female Breast, <i>in situ</i>",2020
65-69,~,~,~,Incidence,500236,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,500236,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
65-69,12.7,19.9,80,Incidence,500236,Non-Hispanic Asian/Pacific Islander,16.0,Female,Kidney and Renal Pelvis,2020
65-69,~,~,~,Incidence,500236,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
65-69,12.5,19.7,79,Incidence,500236,Non-Hispanic Asian/Pacific Islander,15.8,Female,Leukemias,2020
65-69,18.3,26.7,111,Incidence,500236,Non-Hispanic Asian/Pacific Islander,22.2,Female,Liver and Intrahepatic Bile Duct,2020
65-69,92.0,109.7,503,Incidence,500236,Non-Hispanic Asian/Pacific Islander,100.6,Female,Lung and Bronchus,2020
65-69,1.8,5.2,16,Incidence,500236,Non-Hispanic Asian/Pacific Islander,3.2,Female,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,500236,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
65-69,7.9,13.9,53,Incidence,500236,Non-Hispanic Asian/Pacific Islander,10.6,Female,Myeloma,2020
65-69,30.4,41.0,177,Incidence,500236,Non-Hispanic Asian/Pacific Islander,35.4,Female,Non-Hodgkin Lymphoma,2020
65-69,9.0,15.2,59,Incidence,500236,Non-Hispanic Asian/Pacific Islander,11.8,Female,Oral Cavity and Pharynx,2020
65-69,15.9,23.9,98,Incidence,500236,Non-Hispanic Asian/Pacific Islander,19.6,Female,Ovary,2020
65-69,26.5,36.5,156,Incidence,500236,Non-Hispanic Asian/Pacific Islander,31.2,Female,Pancreas,2020
65-69,11.8,18.8,75,Incidence,500236,Non-Hispanic Asian/Pacific Islander,15.0,Female,Stomach,2020
65-69,23.7,33.2,141,Incidence,500236,Non-Hispanic Asian/Pacific Islander,28.2,Female,Thyroid,2020
65-69,7.9,13.9,53,Incidence,500236,Non-Hispanic Asian/Pacific Islander,10.6,Female,Urinary Bladder,2020
70-74,854.8,913.3,3533,Incidence,399799,Non-Hispanic Asian/Pacific Islander,883.7,Female,All Cancer Sites Combined,2020
70-74,5.9,11.9,34,Incidence,399799,Non-Hispanic Asian/Pacific Islander,8.5,Female,Brain and Other Nervous System,2020
70-74,8.2,15.1,45,Incidence,399799,Non-Hispanic Asian/Pacific Islander,11.3,Female,Cervix,2020
70-74,59.7,76.1,270,Incidence,399799,Non-Hispanic Asian/Pacific Islander,67.5,Female,Colon and Rectum,2020
70-74,54.3,70.0,247,Incidence,399799,Non-Hispanic Asian/Pacific Islander,61.8,Female,"Corpus and Uterus, NOS",2020
70-74,2.3,6.5,16,Incidence,399799,Non-Hispanic Asian/Pacific Islander,4.0,Female,Esophagus,2020
70-74,248.7,280.8,1057,Incidence,399799,Non-Hispanic Asian/Pacific Islander,264.4,Female,Female Breast,2020
70-74,72.0,89.8,322,Incidence,399799,Non-Hispanic Asian/Pacific Islander,80.5,Female,"Female Breast, <i>in situ</i>",2020
70-74,~,~,~,Incidence,399799,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,399799,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
70-74,14.8,23.5,75,Incidence,399799,Non-Hispanic Asian/Pacific Islander,18.8,Female,Kidney and Renal Pelvis,2020
70-74,~,~,~,Incidence,399799,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
70-74,13.9,22.4,71,Incidence,399799,Non-Hispanic Asian/Pacific Islander,17.8,Female,Leukemias,2020
70-74,26.9,38.3,129,Incidence,399799,Non-Hispanic Asian/Pacific Islander,32.3,Female,Liver and Intrahepatic Bile Duct,2020
70-74,102.2,123.2,449,Incidence,399799,Non-Hispanic Asian/Pacific Islander,112.3,Female,Lung and Bronchus,2020
70-74,~,~,~,Incidence,399799,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,399799,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
70-74,9.9,17.3,53,Incidence,399799,Non-Hispanic Asian/Pacific Islander,13.3,Female,Myeloma,2020
70-74,40.1,53.7,186,Incidence,399799,Non-Hispanic Asian/Pacific Islander,46.5,Female,Non-Hodgkin Lymphoma,2020
70-74,13.2,21.6,68,Incidence,399799,Non-Hispanic Asian/Pacific Islander,17.0,Female,Oral Cavity and Pharynx,2020
70-74,16.3,25.5,82,Incidence,399799,Non-Hispanic Asian/Pacific Islander,20.5,Female,Ovary,2020
70-74,36.4,49.4,170,Incidence,399799,Non-Hispanic Asian/Pacific Islander,42.5,Female,Pancreas,2020
70-74,15.2,24.1,77,Incidence,399799,Non-Hispanic Asian/Pacific Islander,19.3,Female,Stomach,2020
70-74,21.0,31.2,103,Incidence,399799,Non-Hispanic Asian/Pacific Islander,25.8,Female,Thyroid,2020
70-74,14.8,23.5,75,Incidence,399799,Non-Hispanic Asian/Pacific Islander,18.8,Female,Urinary Bladder,2020
75-79,922.4,998.1,2498,Incidence,260298,Non-Hispanic Asian/Pacific Islander,959.7,Female,All Cancer Sites Combined,2020
75-79,4.7,11.9,20,Incidence,260298,Non-Hispanic Asian/Pacific Islander,7.7,Female,Brain and Other Nervous System,2020
75-79,3.5,10.0,16,Incidence,260298,Non-Hispanic Asian/Pacific Islander,6.1,Female,Cervix,2020
75-79,77.7,101.0,231,Incidence,260298,Non-Hispanic Asian/Pacific Islander,88.7,Female,Colon and Rectum,2020
75-79,32.3,48.0,103,Incidence,260298,Non-Hispanic Asian/Pacific Islander,39.6,Female,"Corpus and Uterus, NOS",2020
75-79,~,~,~,Incidence,260298,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
75-79,216.5,254.1,611,Incidence,260298,Non-Hispanic Asian/Pacific Islander,234.7,Female,Female Breast,2020
75-79,53.4,73.0,163,Incidence,260298,Non-Hispanic Asian/Pacific Islander,62.6,Female,"Female Breast, <i>in situ</i>",2020
75-79,~,~,~,Incidence,260298,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,260298,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
75-79,15.6,27.1,54,Incidence,260298,Non-Hispanic Asian/Pacific Islander,20.7,Female,Kidney and Renal Pelvis,2020
75-79,~,~,~,Incidence,260298,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
75-79,17.3,29.2,59,Incidence,260298,Non-Hispanic Asian/Pacific Islander,22.7,Female,Leukemias,2020
75-79,30.6,45.9,98,Incidence,260298,Non-Hispanic Asian/Pacific Islander,37.6,Female,Liver and Intrahepatic Bile Duct,2020
75-79,130.9,160.6,378,Incidence,260298,Non-Hispanic Asian/Pacific Islander,145.2,Female,Lung and Bronchus,2020
75-79,~,~,~,Incidence,260298,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,260298,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
75-79,16.3,27.9,56,Incidence,260298,Non-Hispanic Asian/Pacific Islander,21.5,Female,Myeloma,2020
75-79,41.7,59.3,130,Incidence,260298,Non-Hispanic Asian/Pacific Islander,49.9,Female,Non-Hodgkin Lymphoma,2020
75-79,12.3,22.7,44,Incidence,260298,Non-Hispanic Asian/Pacific Islander,16.9,Female,Oral Cavity and Pharynx,2020
75-79,15.9,27.5,55,Incidence,260298,Non-Hispanic Asian/Pacific Islander,21.1,Female,Ovary,2020
75-79,47.7,66.4,147,Incidence,260298,Non-Hispanic Asian/Pacific Islander,56.5,Female,Pancreas,2020
75-79,26.8,41.2,87,Incidence,260298,Non-Hispanic Asian/Pacific Islander,33.4,Female,Stomach,2020
75-79,12.9,23.6,46,Incidence,260298,Non-Hispanic Asian/Pacific Islander,17.7,Female,Thyroid,2020
75-79,16.6,28.4,57,Incidence,260298,Non-Hispanic Asian/Pacific Islander,21.9,Female,Urinary Bladder,2020
80-84,1012.5,1109.3,1864,Incidence,175838,Non-Hispanic Asian/Pacific Islander,1060.1,Female,All Cancer Sites Combined,2020
80-84,6.9,17.6,20,Incidence,175838,Non-Hispanic Asian/Pacific Islander,11.4,Female,Brain and Other Nervous System,2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
80-84,100.1,132.5,203,Incidence,175838,Non-Hispanic Asian/Pacific Islander,115.4,Female,Colon and Rectum,2020
80-84,33.0,52.8,74,Incidence,175838,Non-Hispanic Asian/Pacific Islander,42.1,Female,"Corpus and Uterus, NOS",2020
80-84,5.2,14.8,16,Incidence,175838,Non-Hispanic Asian/Pacific Islander,9.1,Female,Esophagus,2020
80-84,189.5,233.0,370,Incidence,175838,Non-Hispanic Asian/Pacific Islander,210.4,Female,Female Breast,2020
80-84,28.0,46.5,64,Incidence,175838,Non-Hispanic Asian/Pacific Islander,36.4,Female,"Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
80-84,14.3,28.3,36,Incidence,175838,Non-Hispanic Asian/Pacific Islander,20.5,Female,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
80-84,21.1,37.5,50,Incidence,175838,Non-Hispanic Asian/Pacific Islander,28.4,Female,Leukemias,2020
80-84,32.0,51.6,72,Incidence,175838,Non-Hispanic Asian/Pacific Islander,40.9,Female,Liver and Intrahepatic Bile Duct,2020
80-84,153.5,192.9,303,Incidence,175838,Non-Hispanic Asian/Pacific Islander,172.3,Female,Lung and Bronchus,2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
80-84,15.3,29.7,38,Incidence,175838,Non-Hispanic Asian/Pacific Islander,21.6,Female,Myeloma,2020
80-84,45.8,68.5,99,Incidence,175838,Non-Hispanic Asian/Pacific Islander,56.3,Female,Non-Hodgkin Lymphoma,2020
80-84,12.4,25.7,32,Incidence,175838,Non-Hispanic Asian/Pacific Islander,18.2,Female,Oral Cavity and Pharynx,2020
80-84,12.9,26.4,33,Incidence,175838,Non-Hispanic Asian/Pacific Islander,18.8,Female,Ovary,2020
80-84,58.7,84.1,124,Incidence,175838,Non-Hispanic Asian/Pacific Islander,70.5,Female,Pancreas,2020
80-84,23.1,40.1,54,Incidence,175838,Non-Hispanic Asian/Pacific Islander,30.7,Female,Stomach,2020
80-84,6.9,17.6,20,Incidence,175838,Non-Hispanic Asian/Pacific Islander,11.4,Female,Thyroid,2020
80-84,26.0,43.9,60,Incidence,175838,Non-Hispanic Asian/Pacific Islander,34.1,Female,Urinary Bladder,2020
85+,920.8,1007.8,1906,Incidence,197808,Non-Hispanic Asian/Pacific Islander,963.6,Female,All Cancer Sites Combined,2020
85+,5.0,13.8,17,Incidence,197808,Non-Hispanic Asian/Pacific Islander,8.6,Female,Brain and Other Nervous System,2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
85+,116.9,149.5,262,Incidence,197808,Non-Hispanic Asian/Pacific Islander,132.5,Female,Colon and Rectum,2020
85+,20.1,35.0,53,Incidence,197808,Non-Hispanic Asian/Pacific Islander,26.8,Female,"Corpus and Uterus, NOS",2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
85+,124.5,158.1,278,Incidence,197808,Non-Hispanic Asian/Pacific Islander,140.5,Female,Female Breast,2020
85+,8.2,18.7,25,Incidence,197808,Non-Hispanic Asian/Pacific Islander,12.6,Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
85+,12.7,25.2,36,Incidence,197808,Non-Hispanic Asian/Pacific Islander,18.2,Female,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
85+,17.0,31.0,46,Incidence,197808,Non-Hispanic Asian/Pacific Islander,23.3,Female,Leukemias,2020
85+,28.5,45.8,72,Incidence,197808,Non-Hispanic Asian/Pacific Islander,36.4,Female,Liver and Intrahepatic Bile Duct,2020
85+,130.2,164.5,290,Incidence,197808,Non-Hispanic Asian/Pacific Islander,146.6,Female,Lung and Bronchus,2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
85+,5.0,13.8,17,Incidence,197808,Non-Hispanic Asian/Pacific Islander,8.6,Female,Myeloma,2020
85+,43.9,64.8,106,Incidence,197808,Non-Hispanic Asian/Pacific Islander,53.6,Female,Non-Hodgkin Lymphoma,2020
85+,19.2,33.9,51,Incidence,197808,Non-Hispanic Asian/Pacific Islander,25.8,Female,Oral Cavity and Pharynx,2020
85+,15.7,29.3,43,Incidence,197808,Non-Hispanic Asian/Pacific Islander,21.7,Female,Ovary,2020
85+,60.5,84.6,142,Incidence,197808,Non-Hispanic Asian/Pacific Islander,71.8,Female,Pancreas,2020
85+,45.7,67.0,110,Incidence,197808,Non-Hispanic Asian/Pacific Islander,55.6,Female,Stomach,2020
85+,8.6,19.3,26,Incidence,197808,Non-Hispanic Asian/Pacific Islander,13.1,Female,Thyroid,2020
85+,20.9,36.2,55,Incidence,197808,Non-Hispanic Asian/Pacific Islander,27.8,Female,Urinary Bladder,2020
<1,11.5,28.4,21,Incidence,113216,Non-Hispanic Asian/Pacific Islander,18.5,Female,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Cervix,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Colon and Rectum,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Esophagus,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Female Breast,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Larynx,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Leukemias,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Mesothelioma,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Myeloma,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Ovary,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Pancreas,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Stomach,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Thyroid,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Female,Urinary Bladder,2020
1-4,14.1,21.5,92,Incidence,524343,Non-Hispanic Asian/Pacific Islander,17.5,Male,All Cancer Sites Combined,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
1-4,6.4,11.7,46,Incidence,524343,Non-Hispanic Asian/Pacific Islander,8.8,Male,Leukemias,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
1-4,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
10-14,10.0,15.8,78,Incidence,617211,Non-Hispanic Asian/Pacific Islander,12.6,Male,All Cancer Sites Combined,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
10-14,2.4,5.6,23,Incidence,617211,Non-Hispanic Asian/Pacific Islander,3.7,Male,Leukemias,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
10-14,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
15-19,16.5,23.6,124,Incidence,625520,Non-Hispanic Asian/Pacific Islander,19.8,Male,All Cancer Sites Combined,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
15-19,3.2,6.8,30,Incidence,625520,Non-Hispanic Asian/Pacific Islander,4.8,Male,Leukemias,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
15-19,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
15-19,1.7,4.5,18,Incidence,625520,Non-Hispanic Asian/Pacific Islander,2.9,Male,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
20-24,21.3,29.0,170,Incidence,681874,Non-Hispanic Asian/Pacific Islander,24.9,Male,All Cancer Sites Combined,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
20-24,1.3,3.8,16,Incidence,681874,Non-Hispanic Asian/Pacific Islander,2.3,Male,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
20-24,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
20-24,1.7,4.4,19,Incidence,681874,Non-Hispanic Asian/Pacific Islander,2.8,Male,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
20-24,4.1,7.8,39,Incidence,681874,Non-Hispanic Asian/Pacific Islander,5.7,Male,Testis,2020
20-24,1.3,3.8,16,Incidence,681874,Non-Hispanic Asian/Pacific Islander,2.3,Male,Thyroid,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
25-29,27.6,35.4,258,Incidence,823777,Non-Hispanic Asian/Pacific Islander,31.3,Male,All Cancer Sites Combined,2020
25-29,1.8,4.2,23,Incidence,823777,Non-Hispanic Asian/Pacific Islander,2.8,Male,Brain and Other Nervous System,2020
25-29,1.2,3.3,17,Incidence,823777,Non-Hispanic Asian/Pacific Islander,2.1,Male,Colon and Rectum,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
25-29,1.5,3.7,20,Incidence,823777,Non-Hispanic Asian/Pacific Islander,2.4,Male,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
25-29,1.4,3.6,19,Incidence,823777,Non-Hispanic Asian/Pacific Islander,2.3,Male,Leukemias,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
25-29,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
25-29,1.5,3.7,20,Incidence,823777,Non-Hispanic Asian/Pacific Islander,2.4,Male,Non-Hodgkin Lymphoma,2020
25-29,1.1,3.2,16,Incidence,823777,Non-Hispanic Asian/Pacific Islander,1.9,Male,Oral Cavity and Pharynx,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
25-29,5.0,8.7,55,Incidence,823777,Non-Hispanic Asian/Pacific Islander,6.7,Male,Testis,2020
25-29,3.5,6.6,40,Incidence,823777,Non-Hispanic Asian/Pacific Islander,4.9,Male,Thyroid,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
30-34,39.4,48.2,382,Incidence,875434,Non-Hispanic Asian/Pacific Islander,43.6,Male,All Cancer Sites Combined,2020
30-34,1.2,3.2,18,Incidence,875434,Non-Hispanic Asian/Pacific Islander,2.1,Male,Brain and Other Nervous System,2020
30-34,3.7,6.9,45,Incidence,875434,Non-Hispanic Asian/Pacific Islander,5.1,Male,Colon and Rectum,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
30-34,1.8,4.2,25,Incidence,875434,Non-Hispanic Asian/Pacific Islander,2.9,Male,Leukemias,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
30-34,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
30-34,2.7,5.4,34,Incidence,875434,Non-Hispanic Asian/Pacific Islander,3.9,Male,Non-Hodgkin Lymphoma,2020
30-34,2.3,4.9,30,Incidence,875434,Non-Hispanic Asian/Pacific Islander,3.4,Male,Oral Cavity and Pharynx,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
30-34,5.1,8.7,59,Incidence,875434,Non-Hispanic Asian/Pacific Islander,6.7,Male,Testis,2020
30-34,4.8,8.3,56,Incidence,875434,Non-Hispanic Asian/Pacific Islander,6.4,Male,Thyroid,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
35-39,54.7,65.3,493,Incidence,824184,Non-Hispanic Asian/Pacific Islander,59.8,Male,All Cancer Sites Combined,2020
35-39,2.3,4.9,28,Incidence,824184,Non-Hispanic Asian/Pacific Islander,3.4,Male,Brain and Other Nervous System,2020
35-39,5.2,9.0,57,Incidence,824184,Non-Hispanic Asian/Pacific Islander,6.9,Male,Colon and Rectum,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
35-39,3.4,6.5,39,Incidence,824184,Non-Hispanic Asian/Pacific Islander,4.7,Male,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
35-39,2.4,5.1,29,Incidence,824184,Non-Hispanic Asian/Pacific Islander,3.5,Male,Leukemias,2020
35-39,2.6,5.3,31,Incidence,824184,Non-Hispanic Asian/Pacific Islander,3.8,Male,Liver and Intrahepatic Bile Duct,2020
35-39,1.2,3.3,17,Incidence,824184,Non-Hispanic Asian/Pacific Islander,2.1,Male,Lung and Bronchus,2020
35-39,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
35-39,3.1,6.0,36,Incidence,824184,Non-Hispanic Asian/Pacific Islander,4.4,Male,Non-Hodgkin Lymphoma,2020
35-39,2.9,5.8,34,Incidence,824184,Non-Hispanic Asian/Pacific Islander,4.1,Male,Oral Cavity and Pharynx,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
35-39,1.7,4.0,22,Incidence,824184,Non-Hispanic Asian/Pacific Islander,2.7,Male,Stomach,2020
35-39,2.6,5.3,31,Incidence,824184,Non-Hispanic Asian/Pacific Islander,3.8,Male,Testis,2020
35-39,6.2,10.2,66,Incidence,824184,Non-Hispanic Asian/Pacific Islander,8.0,Male,Thyroid,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
40-44,86.0,100.2,672,Incidence,723069,Non-Hispanic Asian/Pacific Islander,92.9,Male,All Cancer Sites Combined,2020
40-44,3.3,6.6,34,Incidence,723069,Non-Hispanic Asian/Pacific Islander,4.7,Male,Brain and Other Nervous System,2020
40-44,13.8,19.8,120,Incidence,723069,Non-Hispanic Asian/Pacific Islander,16.6,Male,Colon and Rectum,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
40-44,4.5,8.3,45,Incidence,723069,Non-Hispanic Asian/Pacific Islander,6.2,Male,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
40-44,4.0,7.5,40,Incidence,723069,Non-Hispanic Asian/Pacific Islander,5.5,Male,Leukemias,2020
40-44,3.4,6.7,35,Incidence,723069,Non-Hispanic Asian/Pacific Islander,4.8,Male,Liver and Intrahepatic Bile Duct,2020
40-44,3.6,7.1,37,Incidence,723069,Non-Hispanic Asian/Pacific Islander,5.1,Male,Lung and Bronchus,2020
40-44,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
40-44,5.3,9.3,51,Incidence,723069,Non-Hispanic Asian/Pacific Islander,7.1,Male,Non-Hodgkin Lymphoma,2020
40-44,6.1,10.4,58,Incidence,723069,Non-Hispanic Asian/Pacific Islander,8.0,Male,Oral Cavity and Pharynx,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
40-44,1.8,4.4,21,Incidence,723069,Non-Hispanic Asian/Pacific Islander,2.9,Male,Testis,2020
40-44,6.5,10.8,61,Incidence,723069,Non-Hispanic Asian/Pacific Islander,8.4,Male,Thyroid,2020
40-44,2.5,5.4,27,Incidence,723069,Non-Hispanic Asian/Pacific Islander,3.7,Male,Urinary Bladder,2020
45-49,136.9,154.9,1019,Incidence,699320,Non-Hispanic Asian/Pacific Islander,145.7,Male,All Cancer Sites Combined,2020
45-49,2.1,4.9,23,Incidence,699320,Non-Hispanic Asian/Pacific Islander,3.3,Male,Brain and Other Nervous System,2020
45-49,25.8,34.1,208,Incidence,699320,Non-Hispanic Asian/Pacific Islander,29.7,Male,Colon and Rectum,2020
45-49,1.6,4.2,19,Incidence,699320,Non-Hispanic Asian/Pacific Islander,2.7,Male,Esophagus,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
45-49,10.1,15.5,88,Incidence,699320,Non-Hispanic Asian/Pacific Islander,12.6,Male,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
45-49,4.1,7.8,40,Incidence,699320,Non-Hispanic Asian/Pacific Islander,5.7,Male,Leukemias,2020
45-49,8.2,13.1,73,Incidence,699320,Non-Hispanic Asian/Pacific Islander,10.4,Male,Liver and Intrahepatic Bile Duct,2020
45-49,6.8,11.4,62,Incidence,699320,Non-Hispanic Asian/Pacific Islander,8.9,Male,Lung and Bronchus,2020
45-49,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
45-49,2.1,4.9,23,Incidence,699320,Non-Hispanic Asian/Pacific Islander,3.3,Male,Myeloma,2020
45-49,7.0,11.7,64,Incidence,699320,Non-Hispanic Asian/Pacific Islander,9.2,Male,Non-Hodgkin Lymphoma,2020
45-49,10.7,16.3,93,Incidence,699320,Non-Hispanic Asian/Pacific Islander,13.3,Male,Oral Cavity and Pharynx,2020
45-49,3.8,7.5,38,Incidence,699320,Non-Hispanic Asian/Pacific Islander,5.4,Male,Pancreas,2020
45-49,4.2,8.0,41,Incidence,699320,Non-Hispanic Asian/Pacific Islander,5.9,Male,Prostate,2020
45-49,2.7,5.8,28,Incidence,699320,Non-Hispanic Asian/Pacific Islander,4.0,Male,Stomach,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
45-49,7.2,11.8,65,Incidence,699320,Non-Hispanic Asian/Pacific Islander,9.3,Male,Thyroid,2020
45-49,2.7,5.8,28,Incidence,699320,Non-Hispanic Asian/Pacific Islander,4.0,Male,Urinary Bladder,2020
5-9,8.9,14.2,76,Incidence,669147,Non-Hispanic Asian/Pacific Islander,11.4,Male,All Cancer Sites Combined,2020
5-9,1.6,4.3,18,Incidence,669147,Non-Hispanic Asian/Pacific Islander,2.7,Male,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
5-9,3.0,6.4,30,Incidence,669147,Non-Hispanic Asian/Pacific Islander,4.5,Male,Leukemias,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
5-9,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
50-54,234.5,259.7,1500,Incidence,607617,Non-Hispanic Asian/Pacific Islander,246.9,Male,All Cancer Sites Combined,2020
50-54,4.1,8.2,36,Incidence,607617,Non-Hispanic Asian/Pacific Islander,5.9,Male,Brain and Other Nervous System,2020
50-54,43.8,55.1,299,Incidence,607617,Non-Hispanic Asian/Pacific Islander,49.2,Male,Colon and Rectum,2020
50-54,2.5,5.9,24,Incidence,607617,Non-Hispanic Asian/Pacific Islander,3.9,Male,Esophagus,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
50-54,12.6,19.1,95,Incidence,607617,Non-Hispanic Asian/Pacific Islander,15.6,Male,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
50-54,3.9,7.8,34,Incidence,607617,Non-Hispanic Asian/Pacific Islander,5.6,Male,Leukemias,2020
50-54,14.0,20.7,104,Incidence,607617,Non-Hispanic Asian/Pacific Islander,17.1,Male,Liver and Intrahepatic Bile Duct,2020
50-54,20.4,28.4,147,Incidence,607617,Non-Hispanic Asian/Pacific Islander,24.2,Male,Lung and Bronchus,2020
50-54,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
50-54,1.6,4.5,17,Incidence,607617,Non-Hispanic Asian/Pacific Islander,2.8,Male,Myeloma,2020
50-54,11.2,17.3,85,Incidence,607617,Non-Hispanic Asian/Pacific Islander,14.0,Male,Non-Hodgkin Lymphoma,2020
50-54,17.0,24.3,124,Incidence,607617,Non-Hispanic Asian/Pacific Islander,20.4,Male,Oral Cavity and Pharynx,2020
50-54,7.2,12.3,58,Incidence,607617,Non-Hispanic Asian/Pacific Islander,9.5,Male,Pancreas,2020
50-54,24.4,33.0,173,Incidence,607617,Non-Hispanic Asian/Pacific Islander,28.5,Male,Prostate,2020
50-54,6.4,11.2,52,Incidence,607617,Non-Hispanic Asian/Pacific Islander,8.6,Male,Stomach,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
50-54,5.3,9.7,44,Incidence,607617,Non-Hispanic Asian/Pacific Islander,7.2,Male,Thyroid,2020
50-54,5.0,9.3,42,Incidence,607617,Non-Hispanic Asian/Pacific Islander,6.9,Male,Urinary Bladder,2020
55-59,399.7,434.1,2277,Incidence,546523,Non-Hispanic Asian/Pacific Islander,416.6,Male,All Cancer Sites Combined,2020
55-59,4.5,8.9,35,Incidence,546523,Non-Hispanic Asian/Pacific Islander,6.4,Male,Brain and Other Nervous System,2020
55-59,47.8,60.3,294,Incidence,546523,Non-Hispanic Asian/Pacific Islander,53.8,Male,Colon and Rectum,2020
55-59,4.5,8.9,35,Incidence,546523,Non-Hispanic Asian/Pacific Islander,6.4,Male,Esophagus,2020
55-59,~,~,~,Incidence,546523,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,546523,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
55-59,18.0,26.1,119,Incidence,546523,Non-Hispanic Asian/Pacific Islander,21.8,Male,Kidney and Renal Pelvis,2020
55-59,1.7,4.8,16,Incidence,546523,Non-Hispanic Asian/Pacific Islander,2.9,Male,Larynx,2020
55-59,9.5,15.6,67,Incidence,546523,Non-Hispanic Asian/Pacific Islander,12.3,Male,Leukemias,2020
55-59,27.8,37.5,177,Incidence,546523,Non-Hispanic Asian/Pacific Islander,32.4,Male,Liver and Intrahepatic Bile Duct,2020
55-59,42.3,54.1,262,Incidence,546523,Non-Hispanic Asian/Pacific Islander,47.9,Male,Lung and Bronchus,2020
55-59,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
55-59,1.8,5.0,17,Incidence,546523,Non-Hispanic Asian/Pacific Islander,3.1,Male,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,546523,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
55-59,5.2,10.0,40,Incidence,546523,Non-Hispanic Asian/Pacific Islander,7.3,Male,Myeloma,2020
55-59,20.4,28.8,133,Incidence,546523,Non-Hispanic Asian/Pacific Islander,24.3,Male,Non-Hodgkin Lymphoma,2020
55-59,26.6,36.1,170,Incidence,546523,Non-Hispanic Asian/Pacific Islander,31.1,Male,Oral Cavity and Pharynx,2020
55-59,10.1,16.4,71,Incidence,546523,Non-Hispanic Asian/Pacific Islander,13.0,Male,Pancreas,2020
55-59,75.3,90.7,452,Incidence,546523,Non-Hispanic Asian/Pacific Islander,82.7,Male,Prostate,2020
55-59,11.8,18.4,81,Incidence,546523,Non-Hispanic Asian/Pacific Islander,14.8,Male,Stomach,2020
55-59,~,~,~,Incidence,546523,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
55-59,7.1,12.5,52,Incidence,546523,Non-Hispanic Asian/Pacific Islander,9.5,Male,Thyroid,2020
55-59,10.0,16.2,70,Incidence,546523,Non-Hispanic Asian/Pacific Islander,12.8,Male,Urinary Bladder,2020
60-64,642.6,688.9,3202,Incidence,481211,Non-Hispanic Asian/Pacific Islander,665.4,Male,All Cancer Sites Combined,2020
60-64,7.5,13.5,49,Incidence,481211,Non-Hispanic Asian/Pacific Islander,10.2,Male,Brain and Other Nervous System,2020
60-64,69.1,84.9,369,Incidence,481211,Non-Hispanic Asian/Pacific Islander,76.7,Male,Colon and Rectum,2020
60-64,8.4,14.6,54,Incidence,481211,Non-Hispanic Asian/Pacific Islander,11.2,Male,Esophagus,2020
60-64,~,~,~,Incidence,481211,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,481211,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
60-64,26.2,36.4,149,Incidence,481211,Non-Hispanic Asian/Pacific Islander,31.0,Male,Kidney and Renal Pelvis,2020
60-64,3.4,7.7,25,Incidence,481211,Non-Hispanic Asian/Pacific Islander,5.2,Male,Larynx,2020
60-64,12.1,19.3,74,Incidence,481211,Non-Hispanic Asian/Pacific Islander,15.4,Male,Leukemias,2020
60-64,38.9,51.1,215,Incidence,481211,Non-Hispanic Asian/Pacific Islander,44.7,Male,Liver and Intrahepatic Bile Duct,2020
60-64,78.5,95.4,417,Incidence,481211,Non-Hispanic Asian/Pacific Islander,86.7,Male,Lung and Bronchus,2020
60-64,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
60-64,~,~,~,Incidence,481211,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,481211,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
60-64,10.6,17.4,66,Incidence,481211,Non-Hispanic Asian/Pacific Islander,13.7,Male,Myeloma,2020
60-64,29.8,40.6,168,Incidence,481211,Non-Hispanic Asian/Pacific Islander,34.9,Male,Non-Hodgkin Lymphoma,2020
60-64,28.1,38.6,159,Incidence,481211,Non-Hispanic Asian/Pacific Islander,33.0,Male,Oral Cavity and Pharynx,2020
60-64,21.4,30.7,124,Incidence,481211,Non-Hispanic Asian/Pacific Islander,25.8,Male,Pancreas,2020
60-64,142.7,165.1,739,Incidence,481211,Non-Hispanic Asian/Pacific Islander,153.6,Male,Prostate,2020
60-64,20.9,30.0,121,Incidence,481211,Non-Hispanic Asian/Pacific Islander,25.1,Male,Stomach,2020
60-64,~,~,~,Incidence,481211,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
60-64,10.2,17.0,64,Incidence,481211,Non-Hispanic Asian/Pacific Islander,13.3,Male,Thyroid,2020
60-64,23.1,32.8,133,Incidence,481211,Non-Hispanic Asian/Pacific Islander,27.6,Male,Urinary Bladder,2020
65-69,939.5,1001.1,3841,Incidence,396016,Non-Hispanic Asian/Pacific Islander,969.9,Male,All Cancer Sites Combined,2020
65-69,5.7,11.7,33,Incidence,396016,Non-Hispanic Asian/Pacific Islander,8.3,Male,Brain and Other Nervous System,2020
65-69,88.2,108.0,387,Incidence,396016,Non-Hispanic Asian/Pacific Islander,97.7,Male,Colon and Rectum,2020
65-69,12.7,20.9,65,Incidence,396016,Non-Hispanic Asian/Pacific Islander,16.4,Male,Esophagus,2020
65-69,~,~,~,Incidence,396016,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,396016,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
65-69,31.6,43.9,148,Incidence,396016,Non-Hispanic Asian/Pacific Islander,37.4,Male,Kidney and Renal Pelvis,2020
65-69,3.3,8.1,21,Incidence,396016,Non-Hispanic Asian/Pacific Islander,5.3,Male,Larynx,2020
65-69,17.4,26.8,86,Incidence,396016,Non-Hispanic Asian/Pacific Islander,21.7,Male,Leukemias,2020
65-69,51.3,66.6,232,Incidence,396016,Non-Hispanic Asian/Pacific Islander,58.6,Male,Liver and Intrahepatic Bile Duct,2020
65-69,121.2,144.1,524,Incidence,396016,Non-Hispanic Asian/Pacific Islander,132.3,Male,Lung and Bronchus,2020
65-69,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
65-69,~,~,~,Incidence,396016,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,396016,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
65-69,14.9,23.7,75,Incidence,396016,Non-Hispanic Asian/Pacific Islander,18.9,Male,Myeloma,2020
65-69,41.4,55.3,190,Incidence,396016,Non-Hispanic Asian/Pacific Islander,48.0,Male,Non-Hodgkin Lymphoma,2020
65-69,33.5,46.1,156,Incidence,396016,Non-Hispanic Asian/Pacific Islander,39.4,Male,Oral Cavity and Pharynx,2020
65-69,31.6,43.9,148,Incidence,396016,Non-Hispanic Asian/Pacific Islander,37.4,Male,Pancreas,2020
65-69,277.8,311.8,1166,Incidence,396016,Non-Hispanic Asian/Pacific Islander,294.4,Male,Prostate,2020
65-69,30.2,42.3,142,Incidence,396016,Non-Hispanic Asian/Pacific Islander,35.9,Male,Stomach,2020
65-69,~,~,~,Incidence,396016,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
65-69,7.9,14.6,43,Incidence,396016,Non-Hispanic Asian/Pacific Islander,10.9,Male,Thyroid,2020
65-69,30.9,43.1,145,Incidence,396016,Non-Hispanic Asian/Pacific Islander,36.6,Male,Urinary Bladder,2020
70-74,1163.0,1240.0,3770,Incidence,313899,Non-Hispanic Asian/Pacific Islander,1201.0,Male,All Cancer Sites Combined,2020
70-74,6.2,13.3,29,Incidence,313899,Non-Hispanic Asian/Pacific Islander,9.2,Male,Brain and Other Nervous System,2020
70-74,103.1,127.2,360,Incidence,313899,Non-Hispanic Asian/Pacific Islander,114.7,Male,Colon and Rectum,2020
70-74,13.5,23.2,56,Incidence,313899,Non-Hispanic Asian/Pacific Islander,17.8,Male,Esophagus,2020
70-74,~,~,~,Incidence,313899,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,313899,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
70-74,38.4,53.7,143,Incidence,313899,Non-Hispanic Asian/Pacific Islander,45.6,Male,Kidney and Renal Pelvis,2020
70-74,6.7,14.0,31,Incidence,313899,Non-Hispanic Asian/Pacific Islander,9.9,Male,Larynx,2020
70-74,23.9,36.3,93,Incidence,313899,Non-Hispanic Asian/Pacific Islander,29.6,Male,Leukemias,2020
70-74,55.2,73.2,200,Incidence,313899,Non-Hispanic Asian/Pacific Islander,63.7,Male,Liver and Intrahepatic Bile Duct,2020
70-74,175.8,206.7,599,Incidence,313899,Non-Hispanic Asian/Pacific Islander,190.8,Male,Lung and Bronchus,2020
70-74,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
70-74,3.4,9.1,18,Incidence,313899,Non-Hispanic Asian/Pacific Islander,5.7,Male,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,313899,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
70-74,16.0,26.4,65,Incidence,313899,Non-Hispanic Asian/Pacific Islander,20.7,Male,Myeloma,2020
70-74,50.5,67.7,184,Incidence,313899,Non-Hispanic Asian/Pacific Islander,58.6,Male,Non-Hodgkin Lymphoma,2020
70-74,27.6,40.8,106,Incidence,313899,Non-Hispanic Asian/Pacific Islander,33.8,Male,Oral Cavity and Pharynx,2020
70-74,42.5,58.5,157,Incidence,313899,Non-Hispanic Asian/Pacific Islander,50.0,Male,Pancreas,2020
70-74,320.1,361.3,1068,Incidence,313899,Non-Hispanic Asian/Pacific Islander,340.2,Male,Prostate,2020
70-74,39.6,55.0,147,Incidence,313899,Non-Hispanic Asian/Pacific Islander,46.8,Male,Stomach,2020
70-74,~,~,~,Incidence,313899,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
70-74,9.1,17.4,40,Incidence,313899,Non-Hispanic Asian/Pacific Islander,12.7,Male,Thyroid,2020
70-74,48.1,65.0,176,Incidence,313899,Non-Hispanic Asian/Pacific Islander,56.1,Male,Urinary Bladder,2020
75-79,1358.9,1462.4,2877,Incidence,204055,Non-Hispanic Asian/Pacific Islander,1409.9,Male,All Cancer Sites Combined,2020
75-79,9.9,21.0,30,Incidence,204055,Non-Hispanic Asian/Pacific Islander,14.7,Male,Brain and Other Nervous System,2020
75-79,102.3,132.4,238,Incidence,204055,Non-Hispanic Asian/Pacific Islander,116.6,Male,Colon and Rectum,2020
75-79,12.8,25.0,37,Incidence,204055,Non-Hispanic Asian/Pacific Islander,18.1,Male,Esophagus,2020
75-79,~,~,~,Incidence,204055,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,204055,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
75-79,40.3,60.1,101,Incidence,204055,Non-Hispanic Asian/Pacific Islander,49.5,Male,Kidney and Renal Pelvis,2020
75-79,6.8,16.3,22,Incidence,204055,Non-Hispanic Asian/Pacific Islander,10.8,Male,Larynx,2020
75-79,32.0,49.9,82,Incidence,204055,Non-Hispanic Asian/Pacific Islander,40.2,Male,Leukemias,2020
75-79,67.6,92.6,162,Incidence,204055,Non-Hispanic Asian/Pacific Islander,79.4,Male,Liver and Intrahepatic Bile Duct,2020
75-79,218.9,261.9,489,Incidence,204055,Non-Hispanic Asian/Pacific Islander,239.6,Male,Lung and Bronchus,2020
75-79,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
75-79,~,~,~,Incidence,204055,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,204055,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
75-79,15.3,28.4,43,Incidence,204055,Non-Hispanic Asian/Pacific Islander,21.1,Male,Myeloma,2020
75-79,59.5,83.1,144,Incidence,204055,Non-Hispanic Asian/Pacific Islander,70.6,Male,Non-Hodgkin Lymphoma,2020
75-79,31.5,49.3,81,Incidence,204055,Non-Hispanic Asian/Pacific Islander,39.7,Male,Oral Cavity and Pharynx,2020
75-79,47.0,68.2,116,Incidence,204055,Non-Hispanic Asian/Pacific Islander,56.8,Male,Pancreas,2020
75-79,323.8,375.5,712,Incidence,204055,Non-Hispanic Asian/Pacific Islander,348.9,Male,Prostate,2020
75-79,49.7,71.4,122,Incidence,204055,Non-Hispanic Asian/Pacific Islander,59.8,Male,Stomach,2020
75-79,~,~,~,Incidence,204055,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
75-79,6.0,15.1,20,Incidence,204055,Non-Hispanic Asian/Pacific Islander,9.8,Male,Thyroid,2020
75-79,72.6,98.4,173,Incidence,204055,Non-Hispanic Asian/Pacific Islander,84.8,Male,Urinary Bladder,2020
80-84,1443.1,1575.1,2029,Incidence,134546,Non-Hispanic Asian/Pacific Islander,1508.0,Male,All Cancer Sites Combined,2020
80-84,9.1,23.0,20,Incidence,134546,Non-Hispanic Asian/Pacific Islander,14.9,Male,Brain and Other Nervous System,2020
80-84,128.1,169.9,199,Incidence,134546,Non-Hispanic Asian/Pacific Islander,147.9,Male,Colon and Rectum,2020
80-84,12.6,28.3,26,Incidence,134546,Non-Hispanic Asian/Pacific Islander,19.3,Male,Esophagus,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
80-84,33.4,56.6,59,Incidence,134546,Non-Hispanic Asian/Pacific Islander,43.9,Male,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
80-84,30.2,52.4,54,Incidence,134546,Non-Hispanic Asian/Pacific Islander,40.1,Male,Leukemias,2020
80-84,78.7,112.3,127,Incidence,134546,Non-Hispanic Asian/Pacific Islander,94.4,Male,Liver and Intrahepatic Bile Duct,2020
80-84,248.4,305.3,371,Incidence,134546,Non-Hispanic Asian/Pacific Islander,275.7,Male,Lung and Bronchus,2020
80-84,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
80-84,25.0,45.6,46,Incidence,134546,Non-Hispanic Asian/Pacific Islander,34.2,Male,Myeloma,2020
80-84,72.6,105.0,118,Incidence,134546,Non-Hispanic Asian/Pacific Islander,87.7,Male,Non-Hodgkin Lymphoma,2020
80-84,25.0,45.6,46,Incidence,134546,Non-Hispanic Asian/Pacific Islander,34.2,Male,Oral Cavity and Pharynx,2020
80-84,66.5,97.7,109,Incidence,134546,Non-Hispanic Asian/Pacific Islander,81.0,Male,Pancreas,2020
80-84,223.7,277.9,336,Incidence,134546,Non-Hispanic Asian/Pacific Islander,249.7,Male,Prostate,2020
80-84,55.1,83.9,92,Incidence,134546,Non-Hispanic Asian/Pacific Islander,68.4,Male,Stomach,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
80-84,107.4,146.0,169,Incidence,134546,Non-Hispanic Asian/Pacific Islander,125.6,Male,Urinary Bladder,2020
85+,1288.8,1421.0,1631,Incidence,120486,Non-Hispanic Asian/Pacific Islander,1353.7,Male,All Cancer Sites Combined,2020
85+,11.4,27.6,22,Incidence,120486,Non-Hispanic Asian/Pacific Islander,18.3,Male,Brain and Other Nervous System,2020
85+,124.5,168.4,175,Incidence,120486,Non-Hispanic Asian/Pacific Islander,145.2,Male,Colon and Rectum,2020
85+,8.2,22.6,17,Incidence,120486,Non-Hispanic Asian/Pacific Islander,14.1,Male,Esophagus,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
85+,25.1,47.1,42,Incidence,120486,Non-Hispanic Asian/Pacific Islander,34.9,Male,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
85+,31.5,55.7,51,Incidence,120486,Non-Hispanic Asian/Pacific Islander,42.3,Male,Leukemias,2020
85+,60.8,92.7,91,Incidence,120486,Non-Hispanic Asian/Pacific Islander,75.5,Male,Liver and Intrahepatic Bile Duct,2020
85+,198.9,253.4,271,Incidence,120486,Non-Hispanic Asian/Pacific Islander,224.9,Male,Lung and Bronchus,2020
85+,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
85+,14.8,32.6,27,Incidence,120486,Non-Hispanic Asian/Pacific Islander,22.4,Male,Myeloma,2020
85+,51.9,81.7,79,Incidence,120486,Non-Hispanic Asian/Pacific Islander,65.6,Male,Non-Hodgkin Lymphoma,2020
85+,23.0,44.2,39,Incidence,120486,Non-Hispanic Asian/Pacific Islander,32.4,Male,Oral Cavity and Pharynx,2020
85+,56.4,87.2,85,Incidence,120486,Non-Hispanic Asian/Pacific Islander,70.5,Male,Pancreas,2020
85+,153.1,201.3,212,Incidence,120486,Non-Hispanic Asian/Pacific Islander,176.0,Male,Prostate,2020
85+,49.7,79.0,76,Incidence,120486,Non-Hispanic Asian/Pacific Islander,63.1,Male,Stomach,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
85+,123.8,167.5,174,Incidence,120486,Non-Hispanic Asian/Pacific Islander,144.4,Male,Urinary Bladder,2020
<1,18.4,37.9,32,Incidence,119266,Non-Hispanic Asian/Pacific Islander,26.8,Male,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Colon and Rectum,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Esophagus,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Larynx,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Leukemias,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Lung and Bronchus,2020
<1,~,~,~,Incidence,0,Non-Hispanic Asian/Pacific Islander,~,Male,Male Breast,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Melanomas of the Skin,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Mesothelioma,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Myeloma,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Pancreas,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Prostate,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Stomach,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Testis,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Thyroid,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male,Urinary Bladder,2020
1-4,15.6,20.9,184,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,18.1,Male and Female,All Cancer Sites Combined,2020
1-4,1.9,4.1,29,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
1-4,6.3,9.9,81,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,8.0,Male and Female,Leukemias,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,493409,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
1-4,~,~,~,Incidence,524343,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2020
1-4,~,~,~,Incidence,1017752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
10-14,11.2,15.3,159,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,13.1,Male and Female,All Cancer Sites Combined,2020
10-14,1.2,2.8,23,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
10-14,2.5,4.7,42,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Leukemias,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,594869,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
10-14,~,~,~,Incidence,617211,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2020
10-14,~,~,~,Incidence,1212080,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
15-19,17.4,22.4,247,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,19.8,Male and Female,All Cancer Sites Combined,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
15-19,1.4,3.2,27,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
15-19,2.6,4.7,44,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Leukemias,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
15-19,1.2,2.8,23,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,1.8,Male and Female,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,621336,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
15-19,~,~,~,Incidence,625520,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
15-19,3.0,5.3,50,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Thyroid,2020
15-19,~,~,~,Incidence,1246856,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
20-24,24.6,30.3,370,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,27.4,Male and Female,All Cancer Sites Combined,2020
20-24,0.8,2.1,18,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
20-24,1.0,2.4,21,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,1.6,Male and Female,Colon and Rectum,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
20-24,2.1,4.0,40,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
20-24,1.6,3.3,31,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Leukemias,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2020
20-24,~,~,~,Incidence,670451,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
20-24,1.6,3.3,31,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2020
20-24,1.4,3.9,16,Incidence,670451,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Ovary,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
20-24,~,~,~,Incidence,681874,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
20-24,4.1,7.8,39,Incidence,681874,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,Testis,2020
20-24,5.1,7.9,86,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,6.4,Male and Female,Thyroid,2020
20-24,~,~,~,Incidence,1352325,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
25-29,38.0,44.2,676,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,41.0,Male and Female,All Cancer Sites Combined,2020
25-29,1.7,3.2,39,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Brain and Other Nervous System,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
25-29,1.7,3.3,40,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Colon and Rectum,2020
25-29,1.3,3.5,18,Incidence,823635,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
25-29,6.7,10.9,71,Incidence,823635,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Female Breast,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
25-29,1.7,3.3,40,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
25-29,1.3,2.7,32,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Leukemias,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.6,1.6,16,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,1.0,Male and Female,Lung and Bronchus,2020
25-29,6.7,10.9,71,Incidence,823635,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Male and Female Breast,2020
25-29,~,~,~,Incidence,823635,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
25-29,2.1,3.9,48,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Non-Hodgkin Lymphoma,2020
25-29,1.2,2.6,30,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,1.8,Male and Female,Oral Cavity and Pharynx,2020
25-29,1.5,3.8,20,Incidence,823635,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Ovary,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
25-29,~,~,~,Incidence,823777,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
25-29,5.0,8.7,55,Incidence,823777,Non-Hispanic Asian/Pacific Islander,6.7,Male and Female,Testis,2020
25-29,8.4,11.5,162,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,9.8,Male and Female,Thyroid,2020
25-29,~,~,~,Incidence,1647412,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
30-34,63.7,71.3,1211,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,67.4,Male and Female,All Cancer Sites Combined,2020
30-34,1.5,2.8,37,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Brain and Other Nervous System,2020
30-34,4.7,8.0,57,Incidence,920697,Non-Hispanic Asian/Pacific Islander,6.2,Male and Female,Cervix,2020
30-34,4.5,6.8,100,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,5.6,Male and Female,Colon and Rectum,2020
30-34,3.8,6.9,48,Incidence,920697,Non-Hispanic Asian/Pacific Islander,5.2,Male and Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
30-34,23.4,30.2,245,Incidence,920697,Non-Hispanic Asian/Pacific Islander,26.6,Male and Female,Female Breast,2020
30-34,2.2,4.7,30,Incidence,920697,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,"Female Breast, <i>in situ</i>",2020
30-34,1.2,2.4,31,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
30-34,0.6,1.7,19,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
30-34,2.1,3.7,50,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Leukemias,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.6,1.5,17,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,0.9,Male and Female,Lung and Bronchus,2020
30-34,23.4,30.2,245,Incidence,920697,Non-Hispanic Asian/Pacific Islander,26.6,Male and Female,Male and Female Breast,2020
30-34,2.2,4.7,30,Incidence,920697,Non-Hispanic Asian/Pacific Islander,3.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
30-34,2.8,4.7,66,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Non-Hodgkin Lymphoma,2020
30-34,1.9,3.5,47,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Oral Cavity and Pharynx,2020
30-34,2.5,5.0,33,Incidence,920697,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Ovary,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
30-34,~,~,~,Incidence,875434,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
30-34,0.7,1.7,20,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Stomach,2020
30-34,5.1,8.7,59,Incidence,875434,Non-Hispanic Asian/Pacific Islander,6.7,Male and Female,Testis,2020
30-34,12.1,15.6,248,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,13.8,Male and Female,Thyroid,2020
30-34,~,~,~,Incidence,1796131,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
35-39,95.2,104.7,1729,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,99.9,Male and Female,All Cancer Sites Combined,2020
35-39,2.2,3.9,52,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Brain and Other Nervous System,2020
35-39,4.4,7.6,53,Incidence,906842,Non-Hispanic Asian/Pacific Islander,5.8,Male and Female,Cervix,2020
35-39,5.5,8.0,116,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,6.7,Male and Female,Colon and Rectum,2020
35-39,7.8,12.0,88,Incidence,906842,Non-Hispanic Asian/Pacific Islander,9.7,Male and Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
35-39,50.9,60.8,505,Incidence,906842,Non-Hispanic Asian/Pacific Islander,55.7,Male and Female,Female Breast,2020
35-39,6.1,9.9,71,Incidence,906842,Non-Hispanic Asian/Pacific Islander,7.8,Male and Female,"Female Breast, <i>in situ</i>",2020
35-39,0.8,2.0,23,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,1.3,Male and Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
35-39,2.0,3.7,48,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,2.8,Male and Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
35-39,2.0,3.6,47,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Leukemias,2020
35-39,1.5,2.9,36,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,2.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
35-39,1.3,2.6,32,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,1.8,Male and Female,Lung and Bronchus,2020
35-39,50.9,60.8,505,Incidence,906842,Non-Hispanic Asian/Pacific Islander,55.7,Male and Female,Male and Female Breast,2020
35-39,6.1,9.9,71,Incidence,906842,Non-Hispanic Asian/Pacific Islander,7.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
35-39,3.8,5.9,83,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,4.8,Male and Female,Non-Hodgkin Lymphoma,2020
35-39,2.6,4.5,60,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Oral Cavity and Pharynx,2020
35-39,3.5,6.5,44,Incidence,906842,Non-Hispanic Asian/Pacific Islander,4.9,Male and Female,Ovary,2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
35-39,~,~,~,Incidence,824184,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
35-39,1.3,2.7,33,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Stomach,2020
35-39,2.6,5.3,31,Incidence,824184,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Testis,2020
35-39,15.5,19.5,301,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,17.4,Male and Female,Thyroid,2020
35-39,~,~,~,Incidence,1731026,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
40-44,163.6,176.7,2632,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,170.0,Male and Female,All Cancer Sites Combined,2020
40-44,2.6,4.5,53,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Brain and Other Nervous System,2020
40-44,8.1,12.6,84,Incidence,824763,Non-Hispanic Asian/Pacific Islander,10.2,Male and Female,Cervix,2020
40-44,12.4,16.2,220,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,14.2,Male and Female,Colon and Rectum,2020
40-44,12.3,17.7,122,Incidence,824763,Non-Hispanic Asian/Pacific Islander,14.8,Male and Female,"Corpus and Uterus, NOS",2020
40-44,~,~,~,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
40-44,116.6,131.9,1023,Incidence,824763,Non-Hispanic Asian/Pacific Islander,124.0,Male and Female,Female Breast,2020
40-44,31.5,39.7,292,Incidence,824763,Non-Hispanic Asian/Pacific Islander,35.4,Male and Female,"Female Breast, <i>in situ</i>",2020
40-44,~,~,~,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
40-44,3.4,5.6,68,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
40-44,3.4,5.5,67,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,4.3,Male and Female,Leukemias,2020
40-44,2.6,4.6,54,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,3.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
40-44,4.2,6.5,81,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,5.2,Male and Female,Lung and Bronchus,2020
40-44,116.6,131.9,1023,Incidence,824763,Non-Hispanic Asian/Pacific Islander,124.0,Male and Female,Male and Female Breast,2020
40-44,31.5,39.7,292,Incidence,824763,Non-Hispanic Asian/Pacific Islander,35.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
40-44,0.6,1.8,17,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,1.1,Male and Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
40-44,~,~,~,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
40-44,4.7,7.2,91,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Non-Hodgkin Lymphoma,2020
40-44,4.5,6.9,87,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,5.6,Male and Female,Oral Cavity and Pharynx,2020
40-44,6.7,10.9,71,Incidence,824763,Non-Hispanic Asian/Pacific Islander,8.6,Male and Female,Ovary,2020
40-44,1.2,2.6,28,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,1.8,Male and Female,Pancreas,2020
40-44,~,~,~,Incidence,723069,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
40-44,1.7,3.3,37,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,2.4,Male and Female,Stomach,2020
40-44,1.8,4.4,21,Incidence,723069,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Testis,2020
40-44,15.7,19.9,274,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,17.7,Male and Female,Thyroid,2020
40-44,1.3,2.8,30,Incidence,1547832,Non-Hispanic Asian/Pacific Islander,1.9,Male and Female,Urinary Bladder,2020
45-49,258.8,275.4,3983,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,267.0,Male and Female,All Cancer Sites Combined,2020
45-49,2.2,4.0,45,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,3.0,Male and Female,Brain and Other Nervous System,2020
45-49,7.7,12.1,77,Incidence,792432,Non-Hispanic Asian/Pacific Islander,9.7,Male and Female,Cervix,2020
45-49,25.7,31.1,422,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,28.3,Male and Female,Colon and Rectum,2020
45-49,26.9,34.8,243,Incidence,792432,Non-Hispanic Asian/Pacific Islander,30.7,Male and Female,"Corpus and Uterus, NOS",2020
45-49,0.9,2.2,22,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,1.5,Male and Female,Esophagus,2020
45-49,186.4,206.0,1553,Incidence,792432,Non-Hispanic Asian/Pacific Islander,196.0,Male and Female,Female Breast,2020
45-49,63.7,75.5,550,Incidence,792432,Non-Hispanic Asian/Pacific Islander,69.4,Male and Female,"Female Breast, <i>in situ</i>",2020
45-49,~,~,~,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
45-49,7.1,10.1,127,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
45-49,4.7,7.3,88,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Leukemias,2020
45-49,5.3,7.9,97,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,6.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
45-49,9.1,12.5,160,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,Lung and Bronchus,2020
45-49,186.4,206.0,1553,Incidence,792432,Non-Hispanic Asian/Pacific Islander,196.0,Male and Female,Male and Female Breast,2020
45-49,63.7,75.5,550,Incidence,792432,Non-Hispanic Asian/Pacific Islander,69.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
45-49,~,~,~,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
45-49,1.7,3.4,37,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,2.5,Male and Female,Myeloma,2020
45-49,7.5,10.6,134,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,9.0,Male and Female,Non-Hodgkin Lymphoma,2020
45-49,7.6,10.8,136,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,9.1,Male and Female,Oral Cavity and Pharynx,2020
45-49,8.9,13.7,88,Incidence,792432,Non-Hispanic Asian/Pacific Islander,11.1,Male and Female,Ovary,2020
45-49,3.4,5.6,65,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,4.4,Male and Female,Pancreas,2020
45-49,4.2,8.0,41,Incidence,699320,Non-Hispanic Asian/Pacific Islander,5.9,Male and Female,Prostate,2020
45-49,2.8,4.9,56,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,3.8,Male and Female,Stomach,2020
45-49,~,~,~,Incidence,699320,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
45-49,17.6,22.2,295,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,19.8,Male and Female,Thyroid,2020
45-49,1.6,3.3,35,Incidence,1491752,Non-Hispanic Asian/Pacific Islander,2.3,Male and Female,Urinary Bladder,2020
5-9,9.5,13.2,146,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,11.2,Male and Female,All Cancer Sites Combined,2020
5-9,1.5,3.2,29,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
5-9,3.7,6.1,62,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,4.8,Male and Female,Leukemias,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,632753,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
5-9,~,~,~,Incidence,669147,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2020
5-9,~,~,~,Incidence,1301900,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
50-54,354.8,375.7,4751,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,365.1,Male and Female,All Cancer Sites Combined,2020
50-54,3.7,6.1,62,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,4.8,Male and Female,Brain and Other Nervous System,2020
50-54,11.7,17.5,100,Incidence,693545,Non-Hispanic Asian/Pacific Islander,14.4,Male and Female,Cervix,2020
50-54,40.1,47.4,568,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,43.7,Male and Female,Colon and Rectum,2020
50-54,41.2,51.5,320,Incidence,693545,Non-Hispanic Asian/Pacific Islander,46.1,Male and Female,"Corpus and Uterus, NOS",2020
50-54,1.4,3.1,28,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,2.2,Male and Female,Esophagus,2020
50-54,199.1,220.9,1455,Incidence,693545,Non-Hispanic Asian/Pacific Islander,209.8,Male and Female,Female Breast,2020
50-54,58.9,71.0,449,Incidence,693545,Non-Hispanic Asian/Pacific Islander,64.7,Male and Female,"Female Breast, <i>in situ</i>",2020
50-54,~,~,~,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
50-54,9.1,12.8,141,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,10.8,Male and Female,Kidney and Renal Pelvis,2020
50-54,~,~,~,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
50-54,4.5,7.1,74,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,Leukemias,2020
50-54,9.0,12.6,139,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,10.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
50-54,21.3,26.7,311,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,23.9,Male and Female,Lung and Bronchus,2020
50-54,199.1,220.9,1455,Incidence,693545,Non-Hispanic Asian/Pacific Islander,209.8,Male and Female,Male and Female Breast,2020
50-54,58.9,71.0,449,Incidence,693545,Non-Hispanic Asian/Pacific Islander,64.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
50-54,~,~,~,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
50-54,2.3,4.3,41,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,3.2,Male and Female,Myeloma,2020
50-54,10.9,14.9,166,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,12.8,Male and Female,Non-Hodgkin Lymphoma,2020
50-54,12.0,16.2,182,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,14.0,Male and Female,Oral Cavity and Pharynx,2020
50-54,15.4,21.9,128,Incidence,693545,Non-Hispanic Asian/Pacific Islander,18.5,Male and Female,Ovary,2020
50-54,6.3,9.4,101,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,7.8,Male and Female,Pancreas,2020
50-54,24.4,33.0,173,Incidence,607617,Non-Hispanic Asian/Pacific Islander,28.5,Male and Female,Prostate,2020
50-54,6.7,9.9,106,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,8.1,Male and Female,Stomach,2020
50-54,~,~,~,Incidence,607617,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
50-54,18.2,23.2,268,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,20.6,Male and Female,Thyroid,2020
50-54,3.0,5.2,52,Incidence,1301162,Non-Hispanic Asian/Pacific Islander,4.0,Male and Female,Urinary Bladder,2020
55-59,476.3,501.6,5766,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,488.8,Male and Female,All Cancer Sites Combined,2020
55-59,4.4,7.2,67,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,5.7,Male and Female,Brain and Other Nervous System,2020
55-59,9.6,15.2,77,Incidence,633085,Non-Hispanic Asian/Pacific Islander,12.2,Male and Female,Cervix,2020
55-59,43.4,51.3,557,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,47.2,Male and Female,Colon and Rectum,2020
55-59,60.4,73.3,422,Incidence,633085,Non-Hispanic Asian/Pacific Islander,66.7,Male and Female,"Corpus and Uterus, NOS",2020
55-59,2.7,5.0,44,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,3.7,Male and Female,Esophagus,2020
55-59,201.9,224.8,1349,Incidence,633085,Non-Hispanic Asian/Pacific Islander,213.1,Male and Female,Female Breast,2020
55-59,54.9,67.2,385,Incidence,633085,Non-Hispanic Asian/Pacific Islander,60.8,Male and Female,"Female Breast, <i>in situ</i>",2020
55-59,~,~,~,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
55-59,12.6,17.1,174,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,14.8,Male and Female,Kidney and Renal Pelvis,2020
55-59,1.0,2.6,20,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,1.7,Male and Female,Larynx,2020
55-59,8.0,11.7,115,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,9.7,Male and Female,Leukemias,2020
55-59,16.0,21.0,217,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,18.4,Male and Female,Liver and Intrahepatic Bile Duct,2020
55-59,40.9,48.6,526,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,44.6,Male and Female,Lung and Bronchus,2020
55-59,201.9,224.8,1349,Incidence,633085,Non-Hispanic Asian/Pacific Islander,213.1,Male and Female,Male and Female Breast,2020
55-59,54.9,67.2,385,Incidence,633085,Non-Hispanic Asian/Pacific Islander,60.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
55-59,2.1,4.2,36,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,3.1,Male and Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
55-59,4.9,7.9,74,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Myeloma,2020
55-59,17.7,22.9,238,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,20.2,Male and Female,Non-Hodgkin Lymphoma,2020
55-59,17.3,22.5,233,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,19.8,Male and Female,Oral Cavity and Pharynx,2020
55-59,20.3,28.1,152,Incidence,633085,Non-Hispanic Asian/Pacific Islander,24.0,Male and Female,Ovary,2020
55-59,12.2,16.7,169,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,14.3,Male and Female,Pancreas,2020
55-59,75.3,90.7,452,Incidence,546523,Non-Hispanic Asian/Pacific Islander,82.7,Male and Female,Prostate,2020
55-59,10.5,14.6,147,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,12.5,Male and Female,Stomach,2020
55-59,~,~,~,Incidence,546523,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
55-59,17.5,22.6,235,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,19.9,Male and Female,Thyroid,2020
55-59,6.4,9.8,94,Incidence,1179608,Non-Hispanic Asian/Pacific Islander,8.0,Male and Female,Urinary Bladder,2020
60-64,640.1,671.0,6951,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,655.4,Male and Female,All Cancer Sites Combined,2020
60-64,6.2,9.7,83,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,7.8,Male and Female,Brain and Other Nervous System,2020
60-64,6.3,11.2,49,Incidence,579396,Non-Hispanic Asian/Pacific Islander,8.5,Male and Female,Cervix,2020
60-64,55.8,65.3,641,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,60.4,Male and Female,Colon and Rectum,2020
60-64,59.0,72.3,379,Incidence,579396,Non-Hispanic Asian/Pacific Islander,65.4,Male and Female,"Corpus and Uterus, NOS",2020
60-64,4.9,8.0,67,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,6.3,Male and Female,Esophagus,2020
60-64,230.5,256.0,1408,Incidence,579396,Non-Hispanic Asian/Pacific Islander,243.0,Male and Female,Female Breast,2020
60-64,65.6,79.6,419,Incidence,579396,Non-Hispanic Asian/Pacific Islander,72.3,Male and Female,"Female Breast, <i>in situ</i>",2020
60-64,~,~,~,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
60-64,18.5,24.2,225,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,21.2,Male and Female,Kidney and Renal Pelvis,2020
60-64,2.0,4.1,31,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,2.9,Male and Female,Larynx,2020
60-64,10.3,14.7,131,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,12.4,Male and Female,Leukemias,2020
60-64,23.4,29.7,280,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,26.4,Male and Female,Liver and Intrahepatic Bile Duct,2020
60-64,67.1,77.4,765,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,72.1,Male and Female,Lung and Bronchus,2020
60-64,230.5,256.0,1408,Incidence,579396,Non-Hispanic Asian/Pacific Islander,243.0,Male and Female,Male and Female Breast,2020
60-64,65.6,79.6,419,Incidence,579396,Non-Hispanic Asian/Pacific Islander,72.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
60-64,2.4,4.7,36,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,3.4,Male and Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
60-64,8.4,12.3,108,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,10.2,Male and Female,Myeloma,2020
60-64,26.3,33.0,313,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,29.5,Male and Female,Non-Hodgkin Lymphoma,2020
60-64,19.0,24.7,230,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,21.7,Male and Female,Oral Cavity and Pharynx,2020
60-64,18.9,26.8,131,Incidence,579396,Non-Hispanic Asian/Pacific Islander,22.6,Male and Female,Ovary,2020
60-64,18.4,24.0,223,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,21.0,Male and Female,Pancreas,2020
60-64,142.7,165.1,739,Incidence,481211,Non-Hispanic Asian/Pacific Islander,153.6,Male and Female,Prostate,2020
60-64,15.7,21.0,193,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,18.2,Male and Female,Stomach,2020
60-64,~,~,~,Incidence,481211,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
60-64,18.1,23.7,220,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,20.7,Male and Female,Thyroid,2020
60-64,13.3,18.1,165,Incidence,1060607,Non-Hispanic Asian/Pacific Islander,15.6,Male and Female,Urinary Bladder,2020
65-69,853.7,892.5,7824,Incidence,896252,Non-Hispanic Asian/Pacific Islander,873.0,Male and Female,All Cancer Sites Combined,2020
65-69,5.4,9.0,63,Incidence,896252,Non-Hispanic Asian/Pacific Islander,7.0,Male and Female,Brain and Other Nervous System,2020
65-69,7.8,13.6,52,Incidence,500236,Non-Hispanic Asian/Pacific Islander,10.4,Male and Female,Cervix,2020
65-69,66.4,77.6,644,Incidence,896252,Non-Hispanic Asian/Pacific Islander,71.9,Male and Female,Colon and Rectum,2020
65-69,61.1,75.8,341,Incidence,500236,Non-Hispanic Asian/Pacific Islander,68.2,Male and Female,"Corpus and Uterus, NOS",2020
65-69,7.4,11.5,83,Incidence,896252,Non-Hispanic Asian/Pacific Islander,9.3,Male and Female,Esophagus,2020
65-69,262.5,291.8,1385,Incidence,500236,Non-Hispanic Asian/Pacific Islander,276.9,Male and Female,Female Breast,2020
65-69,84.3,101.4,463,Incidence,500236,Non-Hispanic Asian/Pacific Islander,92.6,Male and Female,"Female Breast, <i>in situ</i>",2020
65-69,~,~,~,Incidence,896252,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,896252,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
65-69,22.2,29.0,228,Incidence,896252,Non-Hispanic Asian/Pacific Islander,25.4,Male and Female,Kidney and Renal Pelvis,2020
65-69,1.7,4.0,24,Incidence,896252,Non-Hispanic Asian/Pacific Islander,2.7,Male and Female,Larynx,2020
65-69,15.7,21.4,165,Incidence,896252,Non-Hispanic Asian/Pacific Islander,18.4,Male and Female,Leukemias,2020
65-69,34.3,42.5,343,Incidence,896252,Non-Hispanic Asian/Pacific Islander,38.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
65-69,107.7,121.8,1027,Incidence,896252,Non-Hispanic Asian/Pacific Islander,114.6,Male and Female,Lung and Bronchus,2020
65-69,262.5,291.8,1385,Incidence,500236,Non-Hispanic Asian/Pacific Islander,276.9,Male and Female,Male and Female Breast,2020
65-69,84.3,101.4,463,Incidence,500236,Non-Hispanic Asian/Pacific Islander,92.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
65-69,1.6,3.9,23,Incidence,896252,Non-Hispanic Asian/Pacific Islander,2.6,Male and Female,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,896252,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
65-69,11.9,17.0,128,Incidence,896252,Non-Hispanic Asian/Pacific Islander,14.3,Male and Female,Myeloma,2020
65-69,36.9,45.4,367,Incidence,896252,Non-Hispanic Asian/Pacific Islander,40.9,Male and Female,Non-Hodgkin Lymphoma,2020
65-69,20.9,27.4,215,Incidence,896252,Non-Hispanic Asian/Pacific Islander,24.0,Male and Female,Oral Cavity and Pharynx,2020
65-69,15.9,23.9,98,Incidence,500236,Non-Hispanic Asian/Pacific Islander,19.6,Male and Female,Ovary,2020
65-69,30.2,38.0,304,Incidence,896252,Non-Hispanic Asian/Pacific Islander,33.9,Male and Female,Pancreas,2020
65-69,277.8,311.8,1166,Incidence,396016,Non-Hispanic Asian/Pacific Islander,294.4,Male and Female,Prostate,2020
65-69,21.1,27.7,217,Incidence,896252,Non-Hispanic Asian/Pacific Islander,24.2,Male and Female,Stomach,2020
65-69,~,~,~,Incidence,396016,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
65-69,17.7,23.7,184,Incidence,896252,Non-Hispanic Asian/Pacific Islander,20.5,Male and Female,Thyroid,2020
65-69,19.1,25.4,198,Incidence,896252,Non-Hispanic Asian/Pacific Islander,22.1,Male and Female,Urinary Bladder,2020
70-74,999.9,1047.0,7303,Incidence,713698,Non-Hispanic Asian/Pacific Islander,1023.3,Male and Female,All Cancer Sites Combined,2020
70-74,6.8,11.3,63,Incidence,713698,Non-Hispanic Asian/Pacific Islander,8.8,Male and Female,Brain and Other Nervous System,2020
70-74,8.2,15.1,45,Incidence,399799,Non-Hispanic Asian/Pacific Islander,11.3,Male and Female,Cervix,2020
70-74,81.5,95.4,630,Incidence,713698,Non-Hispanic Asian/Pacific Islander,88.3,Male and Female,Colon and Rectum,2020
70-74,54.3,70.0,247,Incidence,399799,Non-Hispanic Asian/Pacific Islander,61.8,Male and Female,"Corpus and Uterus, NOS",2020
70-74,7.9,12.7,72,Incidence,713698,Non-Hispanic Asian/Pacific Islander,10.1,Male and Female,Esophagus,2020
70-74,248.7,280.8,1057,Incidence,399799,Non-Hispanic Asian/Pacific Islander,264.4,Male and Female,Female Breast,2020
70-74,72.0,89.8,322,Incidence,399799,Non-Hispanic Asian/Pacific Islander,80.5,Male and Female,"Female Breast, <i>in situ</i>",2020
70-74,~,~,~,Incidence,713698,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,713698,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
70-74,26.6,34.9,218,Incidence,713698,Non-Hispanic Asian/Pacific Islander,30.5,Male and Female,Kidney and Renal Pelvis,2020
70-74,3.5,7.0,36,Incidence,713698,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Larynx,2020
70-74,19.6,26.8,164,Incidence,713698,Non-Hispanic Asian/Pacific Islander,23.0,Male and Female,Leukemias,2020
70-74,41.3,51.4,329,Incidence,713698,Non-Hispanic Asian/Pacific Islander,46.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
70-74,138.1,156.0,1048,Incidence,713698,Non-Hispanic Asian/Pacific Islander,146.8,Male and Female,Lung and Bronchus,2020
70-74,248.7,280.8,1057,Incidence,399799,Non-Hispanic Asian/Pacific Islander,264.4,Male and Female,Male and Female Breast,2020
70-74,72.0,89.8,322,Incidence,399799,Non-Hispanic Asian/Pacific Islander,80.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
70-74,2.4,5.3,26,Incidence,713698,Non-Hispanic Asian/Pacific Islander,3.6,Male and Female,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,713698,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
70-74,13.7,19.8,118,Incidence,713698,Non-Hispanic Asian/Pacific Islander,16.5,Male and Female,Myeloma,2020
70-74,46.7,57.4,370,Incidence,713698,Non-Hispanic Asian/Pacific Islander,51.8,Male and Female,Non-Hodgkin Lymphoma,2020
70-74,20.9,28.3,174,Incidence,713698,Non-Hispanic Asian/Pacific Islander,24.4,Male and Female,Oral Cavity and Pharynx,2020
70-74,16.3,25.5,82,Incidence,399799,Non-Hispanic Asian/Pacific Islander,20.5,Male and Female,Ovary,2020
70-74,41.0,51.1,327,Incidence,713698,Non-Hispanic Asian/Pacific Islander,45.8,Male and Female,Pancreas,2020
70-74,320.1,361.3,1068,Incidence,313899,Non-Hispanic Asian/Pacific Islander,340.2,Male and Female,Prostate,2020
70-74,27.4,35.8,224,Incidence,713698,Non-Hispanic Asian/Pacific Islander,31.4,Male and Female,Stomach,2020
70-74,~,~,~,Incidence,313899,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
70-74,16.9,23.6,143,Incidence,713698,Non-Hispanic Asian/Pacific Islander,20.0,Male and Female,Thyroid,2020
70-74,31.0,39.8,251,Incidence,713698,Non-Hispanic Asian/Pacific Islander,35.2,Male and Female,Urinary Bladder,2020
75-79,1126.8,1188.9,5375,Incidence,464353,Non-Hispanic Asian/Pacific Islander,1157.5,Male and Female,All Cancer Sites Combined,2020
75-79,8.0,14.2,50,Incidence,464353,Non-Hispanic Asian/Pacific Islander,10.8,Male and Female,Brain and Other Nervous System,2020
75-79,3.5,10.0,16,Incidence,260298,Non-Hispanic Asian/Pacific Islander,6.1,Male and Female,Cervix,2020
75-79,92.1,110.6,469,Incidence,464353,Non-Hispanic Asian/Pacific Islander,101.0,Male and Female,Colon and Rectum,2020
75-79,32.3,48.0,103,Incidence,260298,Non-Hispanic Asian/Pacific Islander,39.6,Male and Female,"Corpus and Uterus, NOS",2020
75-79,8.4,14.7,52,Incidence,464353,Non-Hispanic Asian/Pacific Islander,11.2,Male and Female,Esophagus,2020
75-79,216.5,254.1,611,Incidence,260298,Non-Hispanic Asian/Pacific Islander,234.7,Male and Female,Female Breast,2020
75-79,53.4,73.0,163,Incidence,260298,Non-Hispanic Asian/Pacific Islander,62.6,Male and Female,"Female Breast, <i>in situ</i>",2020
75-79,~,~,~,Incidence,464353,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,464353,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
75-79,28.3,39.1,155,Incidence,464353,Non-Hispanic Asian/Pacific Islander,33.4,Male and Female,Kidney and Renal Pelvis,2020
75-79,3.1,7.4,23,Incidence,464353,Non-Hispanic Asian/Pacific Islander,5.0,Male and Female,Larynx,2020
75-79,25.6,35.8,141,Incidence,464353,Non-Hispanic Asian/Pacific Islander,30.4,Male and Female,Leukemias,2020
75-79,49.4,63.2,260,Incidence,464353,Non-Hispanic Asian/Pacific Islander,56.0,Male and Female,Liver and Intrahepatic Bile Duct,2020
75-79,174.5,199.6,867,Incidence,464353,Non-Hispanic Asian/Pacific Islander,186.7,Male and Female,Lung and Bronchus,2020
75-79,216.5,254.1,611,Incidence,260298,Non-Hispanic Asian/Pacific Islander,234.7,Male and Female,Male and Female Breast,2020
75-79,53.4,73.0,163,Incidence,260298,Non-Hispanic Asian/Pacific Islander,62.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
75-79,3.5,7.9,25,Incidence,464353,Non-Hispanic Asian/Pacific Islander,5.4,Male and Female,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,464353,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
75-79,17.3,26.0,99,Incidence,464353,Non-Hispanic Asian/Pacific Islander,21.3,Male and Female,Myeloma,2020
75-79,52.2,66.4,274,Incidence,464353,Non-Hispanic Asian/Pacific Islander,59.0,Male and Female,Non-Hodgkin Lymphoma,2020
75-79,22.4,32.1,125,Incidence,464353,Non-Hispanic Asian/Pacific Islander,26.9,Male and Female,Oral Cavity and Pharynx,2020
75-79,15.9,27.5,55,Incidence,260298,Non-Hispanic Asian/Pacific Islander,21.1,Male and Female,Ovary,2020
75-79,50.0,63.9,263,Incidence,464353,Non-Hispanic Asian/Pacific Islander,56.6,Male and Female,Pancreas,2020
75-79,323.8,375.5,712,Incidence,204055,Non-Hispanic Asian/Pacific Islander,348.9,Male and Female,Prostate,2020
75-79,39.1,51.5,209,Incidence,464353,Non-Hispanic Asian/Pacific Islander,45.0,Male and Female,Stomach,2020
75-79,~,~,~,Incidence,204055,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
75-79,11.0,18.1,66,Incidence,464353,Non-Hispanic Asian/Pacific Islander,14.2,Male and Female,Thyroid,2020
75-79,43.3,56.4,230,Incidence,464353,Non-Hispanic Asian/Pacific Islander,49.5,Male and Female,Urinary Bladder,2020
80-84,1215.2,1294.3,3893,Incidence,310384,Non-Hispanic Asian/Pacific Islander,1254.3,Male and Female,All Cancer Sites Combined,2020
80-84,9.2,17.5,40,Incidence,310384,Non-Hispanic Asian/Pacific Islander,12.9,Male and Female,Brain and Other Nervous System,2020
80-84,~,~,~,Incidence,175838,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
80-84,117.2,142.8,402,Incidence,310384,Non-Hispanic Asian/Pacific Islander,129.5,Male and Female,Colon and Rectum,2020
80-84,33.0,52.8,74,Incidence,175838,Non-Hispanic Asian/Pacific Islander,42.1,Male and Female,"Corpus and Uterus, NOS",2020
80-84,9.8,18.3,42,Incidence,310384,Non-Hispanic Asian/Pacific Islander,13.5,Male and Female,Esophagus,2020
80-84,189.5,233.0,370,Incidence,175838,Non-Hispanic Asian/Pacific Islander,210.4,Male and Female,Female Breast,2020
80-84,28.0,46.5,64,Incidence,175838,Non-Hispanic Asian/Pacific Islander,36.4,Male and Female,"Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,310384,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,310384,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
80-84,24.8,37.4,95,Incidence,310384,Non-Hispanic Asian/Pacific Islander,30.6,Male and Female,Kidney and Renal Pelvis,2020
80-84,~,~,~,Incidence,310384,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
80-84,27.4,40.6,104,Incidence,310384,Non-Hispanic Asian/Pacific Islander,33.5,Male and Female,Leukemias,2020
80-84,55.5,73.7,199,Incidence,310384,Non-Hispanic Asian/Pacific Islander,64.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
80-84,201.1,234.2,674,Incidence,310384,Non-Hispanic Asian/Pacific Islander,217.2,Male and Female,Lung and Bronchus,2020
80-84,189.5,233.0,370,Incidence,175838,Non-Hispanic Asian/Pacific Islander,210.4,Male and Female,Male and Female Breast,2020
80-84,28.0,46.5,64,Incidence,175838,Non-Hispanic Asian/Pacific Islander,36.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,310384,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,310384,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
80-84,21.6,33.5,84,Incidence,310384,Non-Hispanic Asian/Pacific Islander,27.1,Male and Female,Myeloma,2020
80-84,60.9,79.9,217,Incidence,310384,Non-Hispanic Asian/Pacific Islander,69.9,Male and Female,Non-Hodgkin Lymphoma,2020
80-84,19.9,31.4,78,Incidence,310384,Non-Hispanic Asian/Pacific Islander,25.1,Male and Female,Oral Cavity and Pharynx,2020
80-84,12.9,26.4,33,Incidence,175838,Non-Hispanic Asian/Pacific Islander,18.8,Male and Female,Ovary,2020
80-84,65.7,85.4,233,Incidence,310384,Non-Hispanic Asian/Pacific Islander,75.1,Male and Female,Pancreas,2020
80-84,223.7,277.9,336,Incidence,134546,Non-Hispanic Asian/Pacific Islander,249.7,Male and Female,Prostate,2020
80-84,39.7,55.3,146,Incidence,310384,Non-Hispanic Asian/Pacific Islander,47.0,Male and Female,Stomach,2020
80-84,~,~,~,Incidence,134546,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
80-84,6.8,14.2,31,Incidence,310384,Non-Hispanic Asian/Pacific Islander,10.0,Male and Female,Thyroid,2020
80-84,64.5,84.0,229,Incidence,310384,Non-Hispanic Asian/Pacific Islander,73.8,Male and Female,Urinary Bladder,2020
85+,1074.9,1148.5,3537,Incidence,318294,Non-Hispanic Asian/Pacific Islander,1111.2,Male and Female,All Cancer Sites Combined,2020
85+,8.7,16.8,39,Incidence,318294,Non-Hispanic Asian/Pacific Islander,12.3,Male and Female,Brain and Other Nervous System,2020
85+,~,~,~,Incidence,197808,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
85+,124.7,150.8,437,Incidence,318294,Non-Hispanic Asian/Pacific Islander,137.3,Male and Female,Colon and Rectum,2020
85+,20.1,35.0,53,Incidence,197808,Non-Hispanic Asian/Pacific Islander,26.8,Male and Female,"Corpus and Uterus, NOS",2020
85+,6.6,13.8,31,Incidence,318294,Non-Hispanic Asian/Pacific Islander,9.7,Male and Female,Esophagus,2020
85+,124.5,158.1,278,Incidence,197808,Non-Hispanic Asian/Pacific Islander,140.5,Male and Female,Female Breast,2020
85+,8.2,18.7,25,Incidence,197808,Non-Hispanic Asian/Pacific Islander,12.6,Male and Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,318294,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,318294,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
85+,19.4,30.6,78,Incidence,318294,Non-Hispanic Asian/Pacific Islander,24.5,Male and Female,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,318294,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
85+,24.7,37.2,97,Incidence,318294,Non-Hispanic Asian/Pacific Islander,30.5,Male and Female,Leukemias,2020
85+,43.7,59.7,163,Incidence,318294,Non-Hispanic Asian/Pacific Islander,51.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
85+,162.0,191.5,561,Incidence,318294,Non-Hispanic Asian/Pacific Islander,176.3,Male and Female,Lung and Bronchus,2020
85+,124.5,158.1,278,Incidence,197808,Non-Hispanic Asian/Pacific Islander,140.5,Male and Female,Male and Female Breast,2020
85+,8.2,18.7,25,Incidence,197808,Non-Hispanic Asian/Pacific Islander,12.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,318294,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
85+,~,~,~,Incidence,318294,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
85+,10.0,18.6,44,Incidence,318294,Non-Hispanic Asian/Pacific Islander,13.8,Male and Female,Myeloma,2020
85+,50.0,67.1,185,Incidence,318294,Non-Hispanic Asian/Pacific Islander,58.1,Male and Female,Non-Hodgkin Lymphoma,2020
85+,22.7,34.8,90,Incidence,318294,Non-Hispanic Asian/Pacific Islander,28.3,Male and Female,Oral Cavity and Pharynx,2020
85+,15.7,29.3,43,Incidence,197808,Non-Hispanic Asian/Pacific Islander,21.7,Male and Female,Ovary,2020
85+,62.3,81.2,227,Incidence,318294,Non-Hispanic Asian/Pacific Islander,71.3,Male and Female,Pancreas,2020
85+,153.1,201.3,212,Incidence,120486,Non-Hispanic Asian/Pacific Islander,176.0,Male and Female,Prostate,2020
85+,50.3,67.5,186,Incidence,318294,Non-Hispanic Asian/Pacific Islander,58.4,Male and Female,Stomach,2020
85+,~,~,~,Incidence,120486,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
85+,6.9,14.2,32,Incidence,318294,Non-Hispanic Asian/Pacific Islander,10.1,Male and Female,Thyroid,2020
85+,62.9,81.9,229,Incidence,318294,Non-Hispanic Asian/Pacific Islander,71.9,Male and Female,Urinary Bladder,2020
<1,17.1,29.8,53,Incidence,232482,Non-Hispanic Asian/Pacific Islander,22.8,Male and Female,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Cervix,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Colon and Rectum,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Esophagus,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Female Breast,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Larynx,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Leukemias,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Male and Female Breast,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Mesothelioma,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Myeloma,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,113216,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Ovary,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Pancreas,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Prostate,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Stomach,2020
<1,~,~,~,Incidence,119266,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Testis,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Thyroid,2020
<1,~,~,~,Incidence,232482,Non-Hispanic Asian/Pacific Islander,~,Male and Female,Urinary Bladder,2020
1-4,13.9,18.6,187,Incidence,1159420,Non-Hispanic Black,16.1,Female,All Cancer Sites Combined,2020
1-4,1.2,2.9,22,Incidence,1159420,Non-Hispanic Black,1.9,Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Cervix,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Esophagus,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Female Breast,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
1-4,2.4,4.6,39,Incidence,1159420,Non-Hispanic Black,3.4,Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Larynx,2020
1-4,3.3,5.8,51,Incidence,1159420,Non-Hispanic Black,4.4,Female,Leukemias,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Mesothelioma,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Myeloma,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Ovary,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Pancreas,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Stomach,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Thyroid,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Female,Urinary Bladder,2020
10-14,10.1,13.7,179,Incidence,1515675,Non-Hispanic Black,11.8,Female,All Cancer Sites Combined,2020
10-14,1.0,2.4,24,Incidence,1515675,Non-Hispanic Black,1.6,Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Cervix,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Esophagus,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Female Breast,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
10-14,1.2,2.6,27,Incidence,1515675,Non-Hispanic Black,1.8,Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Larynx,2020
10-14,1.4,3.0,32,Incidence,1515675,Non-Hispanic Black,2.1,Female,Leukemias,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Mesothelioma,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Myeloma,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2020
10-14,0.7,1.9,18,Incidence,1515675,Non-Hispanic Black,1.2,Female,Ovary,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Pancreas,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Stomach,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Thyroid,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Female,Urinary Bladder,2020
15-19,14.7,18.9,250,Incidence,1493680,Non-Hispanic Black,16.7,Female,All Cancer Sites Combined,2020
15-19,1.1,2.6,26,Incidence,1493680,Non-Hispanic Black,1.7,Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Cervix,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Esophagus,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Female Breast,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
15-19,2.3,4.2,47,Incidence,1493680,Non-Hispanic Black,3.1,Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Larynx,2020
15-19,1.3,2.8,29,Incidence,1493680,Non-Hispanic Black,1.9,Female,Leukemias,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Mesothelioma,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Myeloma,2020
15-19,1.0,2.3,23,Incidence,1493680,Non-Hispanic Black,1.5,Female,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2020
15-19,0.6,1.7,16,Incidence,1493680,Non-Hispanic Black,1.1,Female,Ovary,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Pancreas,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Stomach,2020
15-19,1.1,2.5,25,Incidence,1493680,Non-Hispanic Black,1.7,Female,Thyroid,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Female,Urinary Bladder,2020
20-24,24.0,29.2,416,Incidence,1570857,Non-Hispanic Black,26.5,Female,All Cancer Sites Combined,2020
20-24,1.0,2.3,24,Incidence,1570857,Non-Hispanic Black,1.5,Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Cervix,2020
20-24,0.9,2.2,23,Incidence,1570857,Non-Hispanic Black,1.5,Female,Colon and Rectum,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Esophagus,2020
20-24,2.0,3.7,43,Incidence,1570857,Non-Hispanic Black,2.7,Female,Female Breast,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
20-24,3.1,5.1,63,Incidence,1570857,Non-Hispanic Black,4.0,Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Larynx,2020
20-24,1.0,2.3,24,Incidence,1570857,Non-Hispanic Black,1.5,Female,Leukemias,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Mesothelioma,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Myeloma,2020
20-24,1.1,2.4,26,Incidence,1570857,Non-Hispanic Black,1.7,Female,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2020
20-24,1.1,2.5,27,Incidence,1570857,Non-Hispanic Black,1.7,Female,Ovary,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Pancreas,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Stomach,2020
20-24,3.0,5.0,61,Incidence,1570857,Non-Hispanic Black,3.9,Female,Thyroid,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Female,Urinary Bladder,2020
25-29,46.6,53.3,869,Incidence,1743897,Non-Hispanic Black,49.8,Female,All Cancer Sites Combined,2020
25-29,0.9,2.1,25,Incidence,1743897,Non-Hispanic Black,1.4,Female,Brain and Other Nervous System,2020
25-29,2.1,3.7,49,Incidence,1743897,Non-Hispanic Black,2.8,Female,Cervix,2020
25-29,2.2,3.8,51,Incidence,1743897,Non-Hispanic Black,2.9,Female,Colon and Rectum,2020
25-29,1.4,2.7,34,Incidence,1743897,Non-Hispanic Black,1.9,Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Esophagus,2020
25-29,11.2,14.6,224,Incidence,1743897,Non-Hispanic Black,12.8,Female,Female Breast,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
25-29,3.1,5.1,70,Incidence,1743897,Non-Hispanic Black,4.0,Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
25-29,0.5,1.5,16,Incidence,1743897,Non-Hispanic Black,0.9,Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Larynx,2020
25-29,1.7,3.2,41,Incidence,1743897,Non-Hispanic Black,2.4,Female,Leukemias,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Mesothelioma,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Myeloma,2020
25-29,2.1,3.8,50,Incidence,1743897,Non-Hispanic Black,2.9,Female,Non-Hodgkin Lymphoma,2020
25-29,0.6,1.6,18,Incidence,1743897,Non-Hispanic Black,1.0,Female,Oral Cavity and Pharynx,2020
25-29,0.7,1.7,19,Incidence,1743897,Non-Hispanic Black,1.1,Female,Ovary,2020
25-29,0.5,1.5,16,Incidence,1743897,Non-Hispanic Black,0.9,Female,Pancreas,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Stomach,2020
25-29,4.8,7.2,103,Incidence,1743897,Non-Hispanic Black,5.9,Female,Thyroid,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Female,Urinary Bladder,2020
30-34,94.6,104.3,1617,Incidence,1627460,Non-Hispanic Black,99.4,Female,All Cancer Sites Combined,2020
30-34,1.7,3.2,38,Incidence,1627460,Non-Hispanic Black,2.3,Female,Brain and Other Nervous System,2020
30-34,7.1,10.0,138,Incidence,1627460,Non-Hispanic Black,8.5,Female,Cervix,2020
30-34,4.8,7.3,97,Incidence,1627460,Non-Hispanic Black,6.0,Female,Colon and Rectum,2020
30-34,3.4,5.4,70,Incidence,1627460,Non-Hispanic Black,4.3,Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Esophagus,2020
30-34,33.2,39.0,586,Incidence,1627460,Non-Hispanic Black,36.0,Female,Female Breast,2020
30-34,2.8,4.7,60,Incidence,1627460,Non-Hispanic Black,3.7,Female,"Female Breast, <i>in situ</i>",2020
30-34,2.5,4.3,54,Incidence,1627460,Non-Hispanic Black,3.3,Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
30-34,2.0,3.7,45,Incidence,1627460,Non-Hispanic Black,2.8,Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Larynx,2020
30-34,2.2,4.0,49,Incidence,1627460,Non-Hispanic Black,3.0,Female,Leukemias,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Mesothelioma,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Myeloma,2020
30-34,3.7,5.9,77,Incidence,1627460,Non-Hispanic Black,4.7,Female,Non-Hodgkin Lymphoma,2020
30-34,1.0,2.3,26,Incidence,1627460,Non-Hispanic Black,1.6,Female,Oral Cavity and Pharynx,2020
30-34,1.7,3.3,39,Incidence,1627460,Non-Hispanic Black,2.4,Female,Ovary,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Pancreas,2020
30-34,0.7,1.7,18,Incidence,1627460,Non-Hispanic Black,1.1,Female,Stomach,2020
30-34,8.8,12.0,168,Incidence,1627460,Non-Hispanic Black,10.3,Female,Thyroid,2020
30-34,~,~,~,Incidence,1627460,Non-Hispanic Black,~,Female,Urinary Bladder,2020
35-39,162.0,175.4,2473,Incidence,1466563,Non-Hispanic Black,168.6,Female,All Cancer Sites Combined,2020
35-39,1.0,2.4,24,Incidence,1466563,Non-Hispanic Black,1.6,Female,Brain and Other Nervous System,2020
35-39,10.4,14.0,177,Incidence,1466563,Non-Hispanic Black,12.1,Female,Cervix,2020
35-39,9.7,13.2,166,Incidence,1466563,Non-Hispanic Black,11.3,Female,Colon and Rectum,2020
35-39,6.4,9.3,113,Incidence,1466563,Non-Hispanic Black,7.7,Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Esophagus,2020
35-39,67.7,76.5,1056,Incidence,1466563,Non-Hispanic Black,72.0,Female,Female Breast,2020
35-39,7.3,10.5,129,Incidence,1466563,Non-Hispanic Black,8.8,Female,"Female Breast, <i>in situ</i>",2020
35-39,2.0,3.8,41,Incidence,1466563,Non-Hispanic Black,2.8,Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
35-39,3.7,6.0,69,Incidence,1466563,Non-Hispanic Black,4.7,Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Larynx,2020
35-39,3.2,5.3,61,Incidence,1466563,Non-Hispanic Black,4.2,Female,Leukemias,2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
35-39,2.1,3.9,43,Incidence,1466563,Non-Hispanic Black,2.9,Female,Lung and Bronchus,2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Mesothelioma,2020
35-39,1.3,2.8,28,Incidence,1466563,Non-Hispanic Black,1.9,Female,Myeloma,2020
35-39,4.7,7.2,86,Incidence,1466563,Non-Hispanic Black,5.9,Female,Non-Hodgkin Lymphoma,2020
35-39,1.5,3.1,32,Incidence,1466563,Non-Hispanic Black,2.2,Female,Oral Cavity and Pharynx,2020
35-39,2.9,5.0,56,Incidence,1466563,Non-Hispanic Black,3.8,Female,Ovary,2020
35-39,1.4,2.9,30,Incidence,1466563,Non-Hispanic Black,2.0,Female,Pancreas,2020
35-39,1.8,3.6,38,Incidence,1466563,Non-Hispanic Black,2.6,Female,Stomach,2020
35-39,12.1,16.0,204,Incidence,1466563,Non-Hispanic Black,13.9,Female,Thyroid,2020
35-39,~,~,~,Incidence,1466563,Non-Hispanic Black,~,Female,Urinary Bladder,2020
40-44,263.0,280.4,3752,Incidence,1381367,Non-Hispanic Black,271.6,Female,All Cancer Sites Combined,2020
40-44,1.5,3.2,31,Incidence,1381367,Non-Hispanic Black,2.2,Female,Brain and Other Nervous System,2020
40-44,11.9,15.9,190,Incidence,1381367,Non-Hispanic Black,13.8,Female,Cervix,2020
40-44,16.7,21.4,262,Incidence,1381367,Non-Hispanic Black,19.0,Female,Colon and Rectum,2020
40-44,11.5,15.5,185,Incidence,1381367,Non-Hispanic Black,13.4,Female,"Corpus and Uterus, NOS",2020
40-44,~,~,~,Incidence,1381367,Non-Hispanic Black,~,Female,Esophagus,2020
40-44,128.6,140.9,1860,Incidence,1381367,Non-Hispanic Black,134.6,Female,Female Breast,2020
40-44,26.7,32.5,407,Incidence,1381367,Non-Hispanic Black,29.5,Female,"Female Breast, <i>in situ</i>",2020
40-44,1.6,3.4,33,Incidence,1381367,Non-Hispanic Black,2.4,Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,1381367,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
40-44,6.0,8.9,101,Incidence,1381367,Non-Hispanic Black,7.3,Female,Kidney and Renal Pelvis,2020
40-44,~,~,~,Incidence,1381367,Non-Hispanic Black,~,Female,Larynx,2020
40-44,3.4,5.8,62,Incidence,1381367,Non-Hispanic Black,4.5,Female,Leukemias,2020
40-44,0.8,2.1,18,Incidence,1381367,Non-Hispanic Black,1.3,Female,Liver and Intrahepatic Bile Duct,2020
40-44,5.3,8.1,91,Incidence,1381367,Non-Hispanic Black,6.6,Female,Lung and Bronchus,2020
40-44,~,~,~,Incidence,1381367,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,1381367,Non-Hispanic Black,~,Female,Mesothelioma,2020
40-44,3.9,6.3,69,Incidence,1381367,Non-Hispanic Black,5.0,Female,Myeloma,2020
40-44,4.5,7.0,78,Incidence,1381367,Non-Hispanic Black,5.6,Female,Non-Hodgkin Lymphoma,2020
40-44,1.9,3.7,37,Incidence,1381367,Non-Hispanic Black,2.7,Female,Oral Cavity and Pharynx,2020
40-44,4.5,7.0,78,Incidence,1381367,Non-Hispanic Black,5.6,Female,Ovary,2020
40-44,2.7,4.8,50,Incidence,1381367,Non-Hispanic Black,3.6,Female,Pancreas,2020
40-44,2.3,4.3,44,Incidence,1381367,Non-Hispanic Black,3.2,Female,Stomach,2020
40-44,14.8,19.3,234,Incidence,1381367,Non-Hispanic Black,16.9,Female,Thyroid,2020
40-44,~,~,~,Incidence,1381367,Non-Hispanic Black,~,Female,Urinary Bladder,2020
45-49,370.5,391.5,5121,Incidence,1344415,Non-Hispanic Black,380.9,Female,All Cancer Sites Combined,2020
45-49,2.4,4.4,44,Incidence,1344415,Non-Hispanic Black,3.3,Female,Brain and Other Nervous System,2020
45-49,9.6,13.3,152,Incidence,1344415,Non-Hispanic Black,11.3,Female,Cervix,2020
45-49,34.9,41.5,512,Incidence,1344415,Non-Hispanic Black,38.1,Female,Colon and Rectum,2020
45-49,16.6,21.3,253,Incidence,1344415,Non-Hispanic Black,18.8,Female,"Corpus and Uterus, NOS",2020
45-49,~,~,~,Incidence,1344415,Non-Hispanic Black,~,Female,Esophagus,2020
45-49,168.2,182.4,2355,Incidence,1344415,Non-Hispanic Black,175.2,Female,Female Breast,2020
45-49,41.6,48.9,607,Incidence,1344415,Non-Hispanic Black,45.1,Female,"Female Breast, <i>in situ</i>",2020
45-49,1.4,3.1,29,Incidence,1344415,Non-Hispanic Black,2.2,Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,1344415,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
45-49,9.7,13.4,154,Incidence,1344415,Non-Hispanic Black,11.5,Female,Kidney and Renal Pelvis,2020
45-49,~,~,~,Incidence,1344415,Non-Hispanic Black,~,Female,Larynx,2020
45-49,5.9,8.8,97,Incidence,1344415,Non-Hispanic Black,7.2,Female,Leukemias,2020
45-49,1.8,3.6,35,Incidence,1344415,Non-Hispanic Black,2.6,Female,Liver and Intrahepatic Bile Duct,2020
45-49,10.7,14.5,168,Incidence,1344415,Non-Hispanic Black,12.5,Female,Lung and Bronchus,2020
45-49,~,~,~,Incidence,1344415,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,1344415,Non-Hispanic Black,~,Female,Mesothelioma,2020
45-49,8.7,12.2,139,Incidence,1344415,Non-Hispanic Black,10.3,Female,Myeloma,2020
45-49,7.4,10.7,120,Incidence,1344415,Non-Hispanic Black,8.9,Female,Non-Hodgkin Lymphoma,2020
45-49,3.9,6.4,68,Incidence,1344415,Non-Hispanic Black,5.1,Female,Oral Cavity and Pharynx,2020
45-49,7.9,11.2,127,Incidence,1344415,Non-Hispanic Black,9.4,Female,Ovary,2020
45-49,5.1,7.9,86,Incidence,1344415,Non-Hispanic Black,6.4,Female,Pancreas,2020
45-49,3.4,5.7,60,Incidence,1344415,Non-Hispanic Black,4.5,Female,Stomach,2020
45-49,15.8,20.4,242,Incidence,1344415,Non-Hispanic Black,18.0,Female,Thyroid,2020
45-49,1.1,2.7,24,Incidence,1344415,Non-Hispanic Black,1.8,Female,Urinary Bladder,2020
5-9,7.6,10.8,135,Incidence,1482112,Non-Hispanic Black,9.1,Female,All Cancer Sites Combined,2020
5-9,2.0,3.8,41,Incidence,1482112,Non-Hispanic Black,2.8,Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Cervix,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Esophagus,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Female Breast,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
5-9,0.7,1.8,17,Incidence,1482112,Non-Hispanic Black,1.1,Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Larynx,2020
5-9,1.9,3.6,39,Incidence,1482112,Non-Hispanic Black,2.6,Female,Leukemias,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Mesothelioma,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Myeloma,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Ovary,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Pancreas,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Stomach,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Thyroid,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Female,Urinary Bladder,2020
50-54,522.8,547.6,7178,Incidence,1341430,Non-Hispanic Black,535.1,Female,All Cancer Sites Combined,2020
50-54,3.5,5.8,61,Incidence,1341430,Non-Hispanic Black,4.5,Female,Brain and Other Nervous System,2020
50-54,10.5,14.3,165,Incidence,1341430,Non-Hispanic Black,12.3,Female,Cervix,2020
50-54,54.4,62.6,783,Incidence,1341430,Non-Hispanic Black,58.4,Female,Colon and Rectum,2020
50-54,30.2,36.5,446,Incidence,1341430,Non-Hispanic Black,33.2,Female,"Corpus and Uterus, NOS",2020
50-54,1.9,3.7,36,Incidence,1341430,Non-Hispanic Black,2.7,Female,Esophagus,2020
50-54,217.8,234.0,3029,Incidence,1341430,Non-Hispanic Black,225.8,Female,Female Breast,2020
50-54,53.6,61.8,772,Incidence,1341430,Non-Hispanic Black,57.6,Female,"Female Breast, <i>in situ</i>",2020
50-54,1.1,2.7,24,Incidence,1341430,Non-Hispanic Black,1.8,Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,1341430,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
50-54,12.9,17.1,200,Incidence,1341430,Non-Hispanic Black,14.9,Female,Kidney and Renal Pelvis,2020
50-54,2.5,4.6,46,Incidence,1341430,Non-Hispanic Black,3.4,Female,Larynx,2020
50-54,7.0,10.2,114,Incidence,1341430,Non-Hispanic Black,8.5,Female,Leukemias,2020
50-54,3.5,5.9,62,Incidence,1341430,Non-Hispanic Black,4.6,Female,Liver and Intrahepatic Bile Duct,2020
50-54,25.6,31.3,380,Incidence,1341430,Non-Hispanic Black,28.3,Female,Lung and Bronchus,2020
50-54,~,~,~,Incidence,1341430,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,1341430,Non-Hispanic Black,~,Female,Mesothelioma,2020
50-54,13.8,18.2,213,Incidence,1341430,Non-Hispanic Black,15.9,Female,Myeloma,2020
50-54,11.5,15.5,180,Incidence,1341430,Non-Hispanic Black,13.4,Female,Non-Hodgkin Lymphoma,2020
50-54,5.6,8.5,93,Incidence,1341430,Non-Hispanic Black,6.9,Female,Oral Cavity and Pharynx,2020
50-54,8.3,11.8,133,Incidence,1341430,Non-Hispanic Black,9.9,Female,Ovary,2020
50-54,12.6,16.8,196,Incidence,1341430,Non-Hispanic Black,14.6,Female,Pancreas,2020
50-54,6.2,9.2,102,Incidence,1341430,Non-Hispanic Black,7.6,Female,Stomach,2020
50-54,17.4,22.3,265,Incidence,1341430,Non-Hispanic Black,19.8,Female,Thyroid,2020
50-54,2.7,4.8,49,Incidence,1341430,Non-Hispanic Black,3.7,Female,Urinary Bladder,2020
55-59,730.0,758.8,10366,Incidence,1392742,Non-Hispanic Black,744.3,Female,All Cancer Sites Combined,2020
55-59,4.7,7.3,82,Incidence,1392742,Non-Hispanic Black,5.9,Female,Brain and Other Nervous System,2020
55-59,11.6,15.5,187,Incidence,1392742,Non-Hispanic Black,13.4,Female,Cervix,2020
55-59,54.6,62.8,816,Incidence,1392742,Non-Hispanic Black,58.6,Female,Colon and Rectum,2020
55-59,62.8,71.5,934,Incidence,1392742,Non-Hispanic Black,67.1,Female,"Corpus and Uterus, NOS",2020
55-59,3.9,6.3,69,Incidence,1392742,Non-Hispanic Black,5.0,Female,Esophagus,2020
55-59,266.8,284.3,3836,Incidence,1392742,Non-Hispanic Black,275.4,Female,Female Breast,2020
55-59,65.7,74.6,976,Incidence,1392742,Non-Hispanic Black,70.1,Female,"Female Breast, <i>in situ</i>",2020
55-59,1.5,3.2,31,Incidence,1392742,Non-Hispanic Black,2.2,Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,1392742,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
55-59,22.5,27.8,349,Incidence,1392742,Non-Hispanic Black,25.1,Female,Kidney and Renal Pelvis,2020
55-59,3.5,5.9,64,Incidence,1392742,Non-Hispanic Black,4.6,Female,Larynx,2020
55-59,11.0,14.8,178,Incidence,1392742,Non-Hispanic Black,12.8,Female,Leukemias,2020
55-59,7.9,11.2,132,Incidence,1392742,Non-Hispanic Black,9.5,Female,Liver and Intrahepatic Bile Duct,2020
55-59,71.2,80.5,1055,Incidence,1392742,Non-Hispanic Black,75.7,Female,Lung and Bronchus,2020
55-59,~,~,~,Incidence,1392742,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,1392742,Non-Hispanic Black,~,Female,Mesothelioma,2020
55-59,18.5,23.4,290,Incidence,1392742,Non-Hispanic Black,20.8,Female,Myeloma,2020
55-59,15.9,20.5,252,Incidence,1392742,Non-Hispanic Black,18.1,Female,Non-Hodgkin Lymphoma,2020
55-59,10.8,14.6,176,Incidence,1392742,Non-Hispanic Black,12.6,Female,Oral Cavity and Pharynx,2020
55-59,14.7,19.0,233,Incidence,1392742,Non-Hispanic Black,16.7,Female,Ovary,2020
55-59,20.9,26.1,326,Incidence,1392742,Non-Hispanic Black,23.4,Female,Pancreas,2020
55-59,10.2,14.0,167,Incidence,1392742,Non-Hispanic Black,12.0,Female,Stomach,2020
55-59,15.7,20.2,248,Incidence,1392742,Non-Hispanic Black,17.8,Female,Thyroid,2020
55-59,6.8,9.9,115,Incidence,1392742,Non-Hispanic Black,8.3,Female,Urinary Bladder,2020
60-64,973.3,1007.6,12890,Incidence,1301616,Non-Hispanic Black,990.3,Female,All Cancer Sites Combined,2020
60-64,7.1,10.4,112,Incidence,1301616,Non-Hispanic Black,8.6,Female,Brain and Other Nervous System,2020
60-64,11.6,15.7,176,Incidence,1301616,Non-Hispanic Black,13.5,Female,Cervix,2020
60-64,69.3,78.7,962,Incidence,1301616,Non-Hispanic Black,73.9,Female,Colon and Rectum,2020
60-64,106.1,117.7,1455,Incidence,1301616,Non-Hispanic Black,111.8,Female,"Corpus and Uterus, NOS",2020
60-64,3.9,6.4,65,Incidence,1301616,Non-Hispanic Black,5.0,Female,Esophagus,2020
60-64,305.0,324.4,4095,Incidence,1301616,Non-Hispanic Black,314.6,Female,Female Breast,2020
60-64,78.3,88.3,1083,Incidence,1301616,Non-Hispanic Black,83.2,Female,"Female Breast, <i>in situ</i>",2020
60-64,0.9,2.3,19,Incidence,1301616,Non-Hispanic Black,1.5,Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,1301616,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
60-64,29.8,36.1,427,Incidence,1301616,Non-Hispanic Black,32.8,Female,Kidney and Renal Pelvis,2020
60-64,4.5,7.1,74,Incidence,1301616,Non-Hispanic Black,5.7,Female,Larynx,2020
60-64,12.4,16.6,187,Incidence,1301616,Non-Hispanic Black,14.4,Female,Leukemias,2020
60-64,17.7,22.6,261,Incidence,1301616,Non-Hispanic Black,20.1,Female,Liver and Intrahepatic Bile Duct,2020
60-64,125.1,137.7,1709,Incidence,1301616,Non-Hispanic Black,131.3,Female,Lung and Bronchus,2020
60-64,1.0,2.5,21,Incidence,1301616,Non-Hispanic Black,1.6,Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,1301616,Non-Hispanic Black,~,Female,Mesothelioma,2020
60-64,28.2,34.3,405,Incidence,1301616,Non-Hispanic Black,31.1,Female,Myeloma,2020
60-64,21.3,26.7,311,Incidence,1301616,Non-Hispanic Black,23.9,Female,Non-Hodgkin Lymphoma,2020
60-64,13.2,17.6,199,Incidence,1301616,Non-Hispanic Black,15.3,Female,Oral Cavity and Pharynx,2020
60-64,19.4,24.5,284,Incidence,1301616,Non-Hispanic Black,21.8,Female,Ovary,2020
60-64,34.9,41.7,497,Incidence,1301616,Non-Hispanic Black,38.2,Female,Pancreas,2020
60-64,14.9,19.5,222,Incidence,1301616,Non-Hispanic Black,17.1,Female,Stomach,2020
60-64,16.3,21.0,241,Incidence,1301616,Non-Hispanic Black,18.5,Female,Thyroid,2020
60-64,11.4,15.4,173,Incidence,1301616,Non-Hispanic Black,13.3,Female,Urinary Bladder,2020
65-69,1241.8,1284.8,13330,Incidence,1055272,Non-Hispanic Black,1263.2,Female,All Cancer Sites Combined,2020
65-69,6.3,9.9,84,Incidence,1055272,Non-Hispanic Black,8.0,Female,Brain and Other Nervous System,2020
65-69,11.9,16.5,148,Incidence,1055272,Non-Hispanic Black,14.0,Female,Cervix,2020
65-69,90.3,102.2,1014,Incidence,1055272,Non-Hispanic Black,96.1,Female,Colon and Rectum,2020
65-69,133.6,148.0,1484,Incidence,1055272,Non-Hispanic Black,140.6,Female,"Corpus and Uterus, NOS",2020
65-69,5.7,9.0,76,Incidence,1055272,Non-Hispanic Black,7.2,Female,Esophagus,2020
65-69,367.3,390.9,3999,Incidence,1055272,Non-Hispanic Black,379.0,Female,Female Breast,2020
65-69,100.8,113.4,1129,Incidence,1055272,Non-Hispanic Black,107.0,Female,"Female Breast, <i>in situ</i>",2020
65-69,1.6,3.6,26,Incidence,1055272,Non-Hispanic Black,2.5,Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,1055272,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
65-69,42.2,50.5,488,Incidence,1055272,Non-Hispanic Black,46.2,Female,Kidney and Renal Pelvis,2020
65-69,4.7,7.7,64,Incidence,1055272,Non-Hispanic Black,6.1,Female,Larynx,2020
65-69,21.0,27.0,252,Incidence,1055272,Non-Hispanic Black,23.9,Female,Leukemias,2020
65-69,24.1,30.5,287,Incidence,1055272,Non-Hispanic Black,27.2,Female,Liver and Intrahepatic Bile Duct,2020
65-69,174.6,191.0,1928,Incidence,1055272,Non-Hispanic Black,182.7,Female,Lung and Bronchus,2020
65-69,2.0,4.2,31,Incidence,1055272,Non-Hispanic Black,2.9,Female,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,1055272,Non-Hispanic Black,~,Female,Mesothelioma,2020
65-69,32.7,40.1,383,Incidence,1055272,Non-Hispanic Black,36.3,Female,Myeloma,2020
65-69,27.9,34.7,329,Incidence,1055272,Non-Hispanic Black,31.2,Female,Non-Hodgkin Lymphoma,2020
65-69,10.3,14.6,130,Incidence,1055272,Non-Hispanic Black,12.3,Female,Oral Cavity and Pharynx,2020
65-69,24.1,30.5,287,Incidence,1055272,Non-Hispanic Black,27.2,Female,Ovary,2020
65-69,50.5,59.5,579,Incidence,1055272,Non-Hispanic Black,54.9,Female,Pancreas,2020
65-69,19.8,25.6,238,Incidence,1055272,Non-Hispanic Black,22.6,Female,Stomach,2020
65-69,15.1,20.2,185,Incidence,1055272,Non-Hispanic Black,17.5,Female,Thyroid,2020
65-69,16.9,22.4,206,Incidence,1055272,Non-Hispanic Black,19.5,Female,Urinary Bladder,2020
70-74,1367.1,1419.3,11013,Incidence,790600,Non-Hispanic Black,1393.0,Female,All Cancer Sites Combined,2020
70-74,7.7,12.2,77,Incidence,790600,Non-Hispanic Black,9.7,Female,Brain and Other Nervous System,2020
70-74,9.9,15.0,97,Incidence,790600,Non-Hispanic Black,12.3,Female,Cervix,2020
70-74,102.1,116.8,864,Incidence,790600,Non-Hispanic Black,109.3,Female,Colon and Rectum,2020
70-74,120.2,136.1,1012,Incidence,790600,Non-Hispanic Black,128.0,Female,"Corpus and Uterus, NOS",2020
70-74,5.5,9.3,57,Incidence,790600,Non-Hispanic Black,7.2,Female,Esophagus,2020
70-74,388.1,416.2,3178,Incidence,790600,Non-Hispanic Black,402.0,Female,Female Breast,2020
70-74,108.7,123.9,918,Incidence,790600,Non-Hispanic Black,116.1,Female,"Female Breast, <i>in situ</i>",2020
70-74,~,~,~,Incidence,790600,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,790600,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
70-74,48.4,58.7,422,Incidence,790600,Non-Hispanic Black,53.4,Female,Kidney and Renal Pelvis,2020
70-74,3.9,7.3,43,Incidence,790600,Non-Hispanic Black,5.4,Female,Larynx,2020
70-74,22.7,30.0,207,Incidence,790600,Non-Hispanic Black,26.2,Female,Leukemias,2020
70-74,19.9,26.8,183,Incidence,790600,Non-Hispanic Black,23.1,Female,Liver and Intrahepatic Bile Duct,2020
70-74,198.1,218.4,1645,Incidence,790600,Non-Hispanic Black,208.1,Female,Lung and Bronchus,2020
70-74,~,~,~,Incidence,790600,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
70-74,~,~,~,Incidence,790600,Non-Hispanic Black,~,Female,Mesothelioma,2020
70-74,49.2,59.6,429,Incidence,790600,Non-Hispanic Black,54.3,Female,Myeloma,2020
70-74,35.0,43.8,310,Incidence,790600,Non-Hispanic Black,39.2,Female,Non-Hodgkin Lymphoma,2020
70-74,11.2,16.5,108,Incidence,790600,Non-Hispanic Black,13.7,Female,Oral Cavity and Pharynx,2020
70-74,23.2,30.5,211,Incidence,790600,Non-Hispanic Black,26.7,Female,Ovary,2020
70-74,65.8,77.7,566,Incidence,790600,Non-Hispanic Black,71.6,Female,Pancreas,2020
70-74,23.4,30.8,213,Incidence,790600,Non-Hispanic Black,26.9,Female,Stomach,2020
70-74,16.9,23.2,157,Incidence,790600,Non-Hispanic Black,19.9,Female,Thyroid,2020
70-74,24.2,31.6,219,Incidence,790600,Non-Hispanic Black,27.7,Female,Urinary Bladder,2020
75-79,1461.1,1528.0,7706,Incidence,515696,Non-Hispanic Black,1494.3,Female,All Cancer Sites Combined,2020
75-79,7.5,13.2,52,Incidence,515696,Non-Hispanic Black,10.1,Female,Brain and Other Nervous System,2020
75-79,8.7,14.8,59,Incidence,515696,Non-Hispanic Black,11.4,Female,Cervix,2020
75-79,121.0,140.9,674,Incidence,515696,Non-Hispanic Black,130.7,Female,Colon and Rectum,2020
75-79,97.4,115.3,547,Incidence,515696,Non-Hispanic Black,106.1,Female,"Corpus and Uterus, NOS",2020
75-79,6.4,11.7,45,Incidence,515696,Non-Hispanic Black,8.7,Female,Esophagus,2020
75-79,375.8,410.2,2025,Incidence,515696,Non-Hispanic Black,392.7,Female,Female Breast,2020
75-79,79.2,95.5,449,Incidence,515696,Non-Hispanic Black,87.1,Female,"Female Breast, <i>in situ</i>",2020
75-79,~,~,~,Incidence,515696,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,515696,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
75-79,43.9,56.3,257,Incidence,515696,Non-Hispanic Black,49.8,Female,Kidney and Renal Pelvis,2020
75-79,2.5,6.2,21,Incidence,515696,Non-Hispanic Black,4.1,Female,Larynx,2020
75-79,27.3,37.3,165,Incidence,515696,Non-Hispanic Black,32.0,Female,Leukemias,2020
75-79,15.4,23.2,98,Incidence,515696,Non-Hispanic Black,19.0,Female,Liver and Intrahepatic Bile Duct,2020
75-79,235.9,263.4,1286,Incidence,515696,Non-Hispanic Black,249.4,Female,Lung and Bronchus,2020
75-79,2.7,6.5,22,Incidence,515696,Non-Hispanic Black,4.3,Female,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,515696,Non-Hispanic Black,~,Female,Mesothelioma,2020
75-79,59.3,73.5,341,Incidence,515696,Non-Hispanic Black,66.1,Female,Myeloma,2020
75-79,38.7,50.3,228,Incidence,515696,Non-Hispanic Black,44.2,Female,Non-Hodgkin Lymphoma,2020
75-79,12.0,18.9,78,Incidence,515696,Non-Hispanic Black,15.1,Female,Oral Cavity and Pharynx,2020
75-79,27.1,37.1,164,Incidence,515696,Non-Hispanic Black,31.8,Female,Ovary,2020
75-79,73.3,89.0,417,Incidence,515696,Non-Hispanic Black,80.9,Female,Pancreas,2020
75-79,28.7,38.9,173,Incidence,515696,Non-Hispanic Black,33.5,Female,Stomach,2020
75-79,10.4,16.9,69,Incidence,515696,Non-Hispanic Black,13.4,Female,Thyroid,2020
75-79,36.5,47.9,216,Incidence,515696,Non-Hispanic Black,41.9,Female,Urinary Bladder,2020
80-84,1428.0,1509.1,5067,Incidence,345135,Non-Hispanic Black,1468.1,Female,All Cancer Sites Combined,2020
80-84,4.7,10.7,25,Incidence,345135,Non-Hispanic Black,7.2,Female,Brain and Other Nervous System,2020
80-84,7.5,14.8,37,Incidence,345135,Non-Hispanic Black,10.7,Female,Cervix,2020
80-84,136.1,162.1,513,Incidence,345135,Non-Hispanic Black,148.6,Female,Colon and Rectum,2020
80-84,65.4,83.8,256,Incidence,345135,Non-Hispanic Black,74.2,Female,"Corpus and Uterus, NOS",2020
80-84,4.7,10.7,25,Incidence,345135,Non-Hispanic Black,7.2,Female,Esophagus,2020
80-84,330.5,370.3,1208,Incidence,345135,Non-Hispanic Black,350.0,Female,Female Breast,2020
80-84,53.2,70.0,211,Incidence,345135,Non-Hispanic Black,61.1,Female,"Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,345135,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,345135,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
80-84,37.3,51.6,152,Incidence,345135,Non-Hispanic Black,44.0,Female,Kidney and Renal Pelvis,2020
80-84,2.6,7.5,16,Incidence,345135,Non-Hispanic Black,4.6,Female,Larynx,2020
80-84,33.9,47.6,139,Incidence,345135,Non-Hispanic Black,40.3,Female,Leukemias,2020
80-84,18.1,28.5,79,Incidence,345135,Non-Hispanic Black,22.9,Female,Liver and Intrahepatic Bile Duct,2020
80-84,216.8,249.3,803,Incidence,345135,Non-Hispanic Black,232.7,Female,Lung and Bronchus,2020
80-84,~,~,~,Incidence,345135,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,345135,Non-Hispanic Black,~,Female,Mesothelioma,2020
80-84,64.5,82.9,253,Incidence,345135,Non-Hispanic Black,73.3,Female,Myeloma,2020
80-84,36.5,50.7,149,Incidence,345135,Non-Hispanic Black,43.2,Female,Non-Hodgkin Lymphoma,2020
80-84,10.8,19.1,50,Incidence,345135,Non-Hispanic Black,14.5,Female,Oral Cavity and Pharynx,2020
80-84,26.5,38.7,111,Incidence,345135,Non-Hispanic Black,32.2,Female,Ovary,2020
80-84,79.8,100.1,309,Incidence,345135,Non-Hispanic Black,89.5,Female,Pancreas,2020
80-84,31.7,45.0,131,Incidence,345135,Non-Hispanic Black,38.0,Female,Stomach,2020
80-84,10.5,18.8,49,Incidence,345135,Non-Hispanic Black,14.2,Female,Thyroid,2020
80-84,34.9,48.8,143,Incidence,345135,Non-Hispanic Black,41.4,Female,Urinary Bladder,2020
85+,1313.4,1389.4,4895,Incidence,362317,Non-Hispanic Black,1351.0,Female,All Cancer Sites Combined,2020
85+,3.8,9.2,22,Incidence,362317,Non-Hispanic Black,6.1,Female,Brain and Other Nervous System,2020
85+,12.4,21.0,59,Incidence,362317,Non-Hispanic Black,16.3,Female,Cervix,2020
85+,150.0,176.5,590,Incidence,362317,Non-Hispanic Black,162.8,Female,Colon and Rectum,2020
85+,48.3,64.0,202,Incidence,362317,Non-Hispanic Black,55.8,Female,"Corpus and Uterus, NOS",2020
85+,6.0,12.5,32,Incidence,362317,Non-Hispanic Black,8.8,Female,Esophagus,2020
85+,258.6,293.1,998,Incidence,362317,Non-Hispanic Black,275.4,Female,Female Breast,2020
85+,25.7,37.5,113,Incidence,362317,Non-Hispanic Black,31.2,Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,362317,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,362317,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
85+,31.2,44.1,135,Incidence,362317,Non-Hispanic Black,37.3,Female,Kidney and Renal Pelvis,2020
85+,~,~,~,Incidence,362317,Non-Hispanic Black,~,Female,Larynx,2020
85+,39.6,53.9,168,Incidence,362317,Non-Hispanic Black,46.4,Female,Leukemias,2020
85+,12.9,21.6,61,Incidence,362317,Non-Hispanic Black,16.8,Female,Liver and Intrahepatic Bile Duct,2020
85+,156.6,183.7,615,Incidence,362317,Non-Hispanic Black,169.7,Female,Lung and Bronchus,2020
85+,4.5,10.2,25,Incidence,362317,Non-Hispanic Black,6.9,Female,Melanomas of the Skin,2020
85+,~,~,~,Incidence,362317,Non-Hispanic Black,~,Female,Mesothelioma,2020
85+,41.7,56.3,176,Incidence,362317,Non-Hispanic Black,48.6,Female,Myeloma,2020
85+,34.3,47.7,147,Incidence,362317,Non-Hispanic Black,40.6,Female,Non-Hodgkin Lymphoma,2020
85+,12.4,21.0,59,Incidence,362317,Non-Hispanic Black,16.3,Female,Oral Cavity and Pharynx,2020
85+,16.8,26.6,77,Incidence,362317,Non-Hispanic Black,21.3,Female,Ovary,2020
85+,89.1,109.9,359,Incidence,362317,Non-Hispanic Black,99.1,Female,Pancreas,2020
85+,40.6,55.1,172,Incidence,362317,Non-Hispanic Black,47.5,Female,Stomach,2020
85+,6.7,13.4,35,Incidence,362317,Non-Hispanic Black,9.7,Female,Thyroid,2020
85+,47.8,63.4,200,Incidence,362317,Non-Hispanic Black,55.2,Female,Urinary Bladder,2020
<1,16.6,27.9,61,Incidence,281093,Non-Hispanic Black,21.7,Female,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Cervix,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Colon and Rectum,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Esophagus,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Female Breast,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Larynx,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Leukemias,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Mesothelioma,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Myeloma,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Ovary,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Pancreas,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Stomach,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Thyroid,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Female,Urinary Bladder,2020
1-4,14.7,19.5,203,Incidence,1193865,Non-Hispanic Black,17.0,Male,All Cancer Sites Combined,2020
1-4,2.0,4.0,34,Incidence,1193865,Non-Hispanic Black,2.8,Male,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Colon and Rectum,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Esophagus,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
1-4,2.2,4.3,37,Incidence,1193865,Non-Hispanic Black,3.1,Male,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Larynx,2020
1-4,4.1,6.8,63,Incidence,1193865,Non-Hispanic Black,5.3,Male,Leukemias,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
1-4,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Mesothelioma,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Myeloma,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Pancreas,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Prostate,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Stomach,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Testis,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Thyroid,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male,Urinary Bladder,2020
10-14,10.5,14.0,190,Incidence,1561522,Non-Hispanic Black,12.2,Male,All Cancer Sites Combined,2020
10-14,1.5,3.0,34,Incidence,1561522,Non-Hispanic Black,2.2,Male,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Colon and Rectum,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Esophagus,2020
10-14,0.6,1.7,17,Incidence,1561522,Non-Hispanic Black,1.1,Male,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Larynx,2020
10-14,2.0,3.8,44,Incidence,1561522,Non-Hispanic Black,2.8,Male,Leukemias,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
10-14,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Mesothelioma,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Myeloma,2020
10-14,1.3,2.7,30,Incidence,1561522,Non-Hispanic Black,1.9,Male,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Pancreas,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Prostate,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Stomach,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Testis,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Thyroid,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male,Urinary Bladder,2020
15-19,14.8,18.9,257,Incidence,1533793,Non-Hispanic Black,16.8,Male,All Cancer Sites Combined,2020
15-19,1.4,2.9,32,Incidence,1533793,Non-Hispanic Black,2.1,Male,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Colon and Rectum,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Esophagus,2020
15-19,1.9,3.6,40,Incidence,1533793,Non-Hispanic Black,2.6,Male,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Larynx,2020
15-19,1.5,3.0,33,Incidence,1533793,Non-Hispanic Black,2.2,Male,Leukemias,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
15-19,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Mesothelioma,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Myeloma,2020
15-19,1.7,3.3,37,Incidence,1533793,Non-Hispanic Black,2.4,Male,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Pancreas,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Prostate,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Stomach,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Testis,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Thyroid,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male,Urinary Bladder,2020
20-24,17.8,22.2,321,Incidence,1609920,Non-Hispanic Black,19.9,Male,All Cancer Sites Combined,2020
20-24,0.7,1.8,19,Incidence,1609920,Non-Hispanic Black,1.2,Male,Brain and Other Nervous System,2020
20-24,1.0,2.2,24,Incidence,1609920,Non-Hispanic Black,1.5,Male,Colon and Rectum,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Esophagus,2020
20-24,2.2,4.0,48,Incidence,1609920,Non-Hispanic Black,3.0,Male,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Larynx,2020
20-24,1.6,3.2,37,Incidence,1609920,Non-Hispanic Black,2.3,Male,Leukemias,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
20-24,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Mesothelioma,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Myeloma,2020
20-24,2.0,3.7,45,Incidence,1609920,Non-Hispanic Black,2.8,Male,Non-Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Pancreas,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Prostate,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Stomach,2020
20-24,0.9,2.1,23,Incidence,1609920,Non-Hispanic Black,1.4,Male,Testis,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Thyroid,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male,Urinary Bladder,2020
25-29,25.8,30.8,503,Incidence,1783202,Non-Hispanic Black,28.2,Male,All Cancer Sites Combined,2020
25-29,1.0,2.2,27,Incidence,1783202,Non-Hispanic Black,1.5,Male,Brain and Other Nervous System,2020
25-29,2.1,3.7,50,Incidence,1783202,Non-Hispanic Black,2.8,Male,Colon and Rectum,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Esophagus,2020
25-29,1.6,3.1,41,Incidence,1783202,Non-Hispanic Black,2.3,Male,Hodgkin Lymphoma,2020
25-29,1.3,2.7,34,Incidence,1783202,Non-Hispanic Black,1.9,Male,Kaposi Sarcoma,2020
25-29,0.8,1.9,22,Incidence,1783202,Non-Hispanic Black,1.2,Male,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Larynx,2020
25-29,1.8,3.3,44,Incidence,1783202,Non-Hispanic Black,2.5,Male,Leukemias,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
25-29,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Mesothelioma,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Myeloma,2020
25-29,2.9,4.7,66,Incidence,1783202,Non-Hispanic Black,3.7,Male,Non-Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Pancreas,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Prostate,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Stomach,2020
25-29,2.4,4.1,56,Incidence,1783202,Non-Hispanic Black,3.1,Male,Testis,2020
25-29,0.6,1.5,17,Incidence,1783202,Non-Hispanic Black,1.0,Male,Thyroid,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male,Urinary Bladder,2020
30-34,41.4,48.0,703,Incidence,1575983,Non-Hispanic Black,44.6,Male,All Cancer Sites Combined,2020
30-34,1.0,2.3,25,Incidence,1575983,Non-Hispanic Black,1.6,Male,Brain and Other Nervous System,2020
30-34,4.9,7.4,96,Incidence,1575983,Non-Hispanic Black,6.1,Male,Colon and Rectum,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Esophagus,2020
30-34,2.5,4.4,53,Incidence,1575983,Non-Hispanic Black,3.4,Male,Hodgkin Lymphoma,2020
30-34,2.5,4.3,52,Incidence,1575983,Non-Hispanic Black,3.3,Male,Kaposi Sarcoma,2020
30-34,2.2,4.0,48,Incidence,1575983,Non-Hispanic Black,3.0,Male,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Larynx,2020
30-34,2.0,3.7,44,Incidence,1575983,Non-Hispanic Black,2.8,Male,Leukemias,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
30-34,0.7,1.8,18,Incidence,1575983,Non-Hispanic Black,1.1,Male,Lung and Bronchus,2020
30-34,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Mesothelioma,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Myeloma,2020
30-34,4.4,6.7,86,Incidence,1575983,Non-Hispanic Black,5.5,Male,Non-Hodgkin Lymphoma,2020
30-34,0.8,2.0,21,Incidence,1575983,Non-Hispanic Black,1.3,Male,Oral Cavity and Pharynx,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Pancreas,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Prostate,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Stomach,2020
30-34,2.2,4.0,47,Incidence,1575983,Non-Hispanic Black,3.0,Male,Testis,2020
30-34,0.9,2.2,23,Incidence,1575983,Non-Hispanic Black,1.5,Male,Thyroid,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male,Urinary Bladder,2020
35-39,74.5,84.1,1069,Incidence,1349441,Non-Hispanic Black,79.2,Male,All Cancer Sites Combined,2020
35-39,1.6,3.3,32,Incidence,1349441,Non-Hispanic Black,2.4,Male,Brain and Other Nervous System,2020
35-39,9.5,13.2,152,Incidence,1349441,Non-Hispanic Black,11.3,Male,Colon and Rectum,2020
35-39,~,~,~,Incidence,1349441,Non-Hispanic Black,~,Male,Esophagus,2020
35-39,3.0,5.2,54,Incidence,1349441,Non-Hispanic Black,4.0,Male,Hodgkin Lymphoma,2020
35-39,1.6,3.3,32,Incidence,1349441,Non-Hispanic Black,2.4,Male,Kaposi Sarcoma,2020
35-39,6.2,9.2,102,Incidence,1349441,Non-Hispanic Black,7.6,Male,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,1349441,Non-Hispanic Black,~,Male,Larynx,2020
35-39,3.0,5.2,54,Incidence,1349441,Non-Hispanic Black,4.0,Male,Leukemias,2020
35-39,1.3,2.9,27,Incidence,1349441,Non-Hispanic Black,2.0,Male,Liver and Intrahepatic Bile Duct,2020
35-39,3.0,5.2,54,Incidence,1349441,Non-Hispanic Black,4.0,Male,Lung and Bronchus,2020
35-39,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
35-39,~,~,~,Incidence,1349441,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,1349441,Non-Hispanic Black,~,Male,Mesothelioma,2020
35-39,1.5,3.2,30,Incidence,1349441,Non-Hispanic Black,2.2,Male,Myeloma,2020
35-39,7.0,10.1,114,Incidence,1349441,Non-Hispanic Black,8.4,Male,Non-Hodgkin Lymphoma,2020
35-39,2.2,4.1,41,Incidence,1349441,Non-Hispanic Black,3.0,Male,Oral Cavity and Pharynx,2020
35-39,1.0,2.4,21,Incidence,1349441,Non-Hispanic Black,1.6,Male,Pancreas,2020
35-39,~,~,~,Incidence,1349441,Non-Hispanic Black,~,Male,Prostate,2020
35-39,1.6,3.3,31,Incidence,1349441,Non-Hispanic Black,2.3,Male,Stomach,2020
35-39,2.8,5.0,51,Incidence,1349441,Non-Hispanic Black,3.8,Male,Testis,2020
35-39,1.7,3.4,33,Incidence,1349441,Non-Hispanic Black,2.4,Male,Thyroid,2020
35-39,0.7,1.9,16,Incidence,1349441,Non-Hispanic Black,1.2,Male,Urinary Bladder,2020
40-44,130.0,143.1,1684,Incidence,1234374,Non-Hispanic Black,136.4,Male,All Cancer Sites Combined,2020
40-44,1.7,3.6,31,Incidence,1234374,Non-Hispanic Black,2.5,Male,Brain and Other Nervous System,2020
40-44,20.0,25.3,278,Incidence,1234374,Non-Hispanic Black,22.5,Male,Colon and Rectum,2020
40-44,~,~,~,Incidence,1234374,Non-Hispanic Black,~,Male,Esophagus,2020
40-44,2.5,4.7,43,Incidence,1234374,Non-Hispanic Black,3.5,Male,Hodgkin Lymphoma,2020
40-44,1.0,2.5,20,Incidence,1234374,Non-Hispanic Black,1.6,Male,Kaposi Sarcoma,2020
40-44,12.2,16.5,176,Incidence,1234374,Non-Hispanic Black,14.3,Male,Kidney and Renal Pelvis,2020
40-44,0.9,2.3,18,Incidence,1234374,Non-Hispanic Black,1.5,Male,Larynx,2020
40-44,4.6,7.3,72,Incidence,1234374,Non-Hispanic Black,5.8,Male,Leukemias,2020
40-44,1.3,3.0,25,Incidence,1234374,Non-Hispanic Black,2.0,Male,Liver and Intrahepatic Bile Duct,2020
40-44,8.1,11.7,121,Incidence,1234374,Non-Hispanic Black,9.8,Male,Lung and Bronchus,2020
40-44,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
40-44,~,~,~,Incidence,1234374,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,1234374,Non-Hispanic Black,~,Male,Mesothelioma,2020
40-44,4.1,6.7,65,Incidence,1234374,Non-Hispanic Black,5.3,Male,Myeloma,2020
40-44,7.9,11.4,118,Incidence,1234374,Non-Hispanic Black,9.6,Male,Non-Hodgkin Lymphoma,2020
40-44,5.4,8.4,84,Incidence,1234374,Non-Hispanic Black,6.8,Male,Oral Cavity and Pharynx,2020
40-44,4.2,6.9,67,Incidence,1234374,Non-Hispanic Black,5.4,Male,Pancreas,2020
40-44,11.0,15.0,159,Incidence,1234374,Non-Hispanic Black,12.9,Male,Prostate,2020
40-44,2.0,4.0,36,Incidence,1234374,Non-Hispanic Black,2.9,Male,Stomach,2020
40-44,1.8,3.7,32,Incidence,1234374,Non-Hispanic Black,2.6,Male,Testis,2020
40-44,2.9,5.2,48,Incidence,1234374,Non-Hispanic Black,3.9,Male,Thyroid,2020
40-44,2.0,3.9,35,Incidence,1234374,Non-Hispanic Black,2.8,Male,Urinary Bladder,2020
45-49,276.3,295.7,3371,Incidence,1179038,Non-Hispanic Black,285.9,Male,All Cancer Sites Combined,2020
45-49,3.0,5.4,48,Incidence,1179038,Non-Hispanic Black,4.1,Male,Brain and Other Nervous System,2020
45-49,41.0,48.7,527,Incidence,1179038,Non-Hispanic Black,44.7,Male,Colon and Rectum,2020
45-49,2.0,4.0,34,Incidence,1179038,Non-Hispanic Black,2.9,Male,Esophagus,2020
45-49,2.8,5.1,45,Incidence,1179038,Non-Hispanic Black,3.8,Male,Hodgkin Lymphoma,2020
45-49,1.1,2.7,21,Incidence,1179038,Non-Hispanic Black,1.8,Male,Kaposi Sarcoma,2020
45-49,22.6,28.4,299,Incidence,1179038,Non-Hispanic Black,25.4,Male,Kidney and Renal Pelvis,2020
45-49,2.6,4.8,42,Incidence,1179038,Non-Hispanic Black,3.6,Male,Larynx,2020
45-49,7.4,10.9,106,Incidence,1179038,Non-Hispanic Black,9.0,Male,Leukemias,2020
45-49,2.7,5.0,44,Incidence,1179038,Non-Hispanic Black,3.7,Male,Liver and Intrahepatic Bile Duct,2020
45-49,16.0,20.9,216,Incidence,1179038,Non-Hispanic Black,18.3,Male,Lung and Bronchus,2020
45-49,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
45-49,~,~,~,Incidence,1179038,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,1179038,Non-Hispanic Black,~,Male,Mesothelioma,2020
45-49,9.4,13.4,133,Incidence,1179038,Non-Hispanic Black,11.3,Male,Myeloma,2020
45-49,13.6,18.2,186,Incidence,1179038,Non-Hispanic Black,15.8,Male,Non-Hodgkin Lymphoma,2020
45-49,12.6,17.0,173,Incidence,1179038,Non-Hispanic Black,14.7,Male,Oral Cavity and Pharynx,2020
45-49,7.7,11.2,110,Incidence,1179038,Non-Hispanic Black,9.3,Male,Pancreas,2020
45-49,63.5,73.0,803,Incidence,1179038,Non-Hispanic Black,68.1,Male,Prostate,2020
45-49,6.1,9.4,90,Incidence,1179038,Non-Hispanic Black,7.6,Male,Stomach,2020
45-49,1.6,3.4,28,Incidence,1179038,Non-Hispanic Black,2.4,Male,Testis,2020
45-49,4.3,7.0,65,Incidence,1179038,Non-Hispanic Black,5.5,Male,Thyroid,2020
45-49,4.2,6.9,64,Incidence,1179038,Non-Hispanic Black,5.4,Male,Urinary Bladder,2020
5-9,7.9,11.0,143,Incidence,1531309,Non-Hispanic Black,9.3,Male,All Cancer Sites Combined,2020
5-9,1.4,3.0,32,Incidence,1531309,Non-Hispanic Black,2.1,Male,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Colon and Rectum,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Esophagus,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Larynx,2020
5-9,2.4,4.3,50,Incidence,1531309,Non-Hispanic Black,3.3,Male,Leukemias,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
5-9,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Mesothelioma,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Myeloma,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Pancreas,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Prostate,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Stomach,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Testis,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Thyroid,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male,Urinary Bladder,2020
50-54,524.1,550.7,6308,Incidence,1174154,Non-Hispanic Black,537.2,Male,All Cancer Sites Combined,2020
50-54,4.2,7.0,64,Incidence,1174154,Non-Hispanic Black,5.5,Male,Brain and Other Nervous System,2020
50-54,68.3,78.1,858,Incidence,1174154,Non-Hispanic Black,73.1,Male,Colon and Rectum,2020
50-54,4.1,6.9,63,Incidence,1174154,Non-Hispanic Black,5.4,Male,Esophagus,2020
50-54,1.7,3.5,29,Incidence,1174154,Non-Hispanic Black,2.5,Male,Hodgkin Lymphoma,2020
50-54,0.8,2.3,17,Incidence,1174154,Non-Hispanic Black,1.4,Male,Kaposi Sarcoma,2020
50-54,33.2,40.2,429,Incidence,1174154,Non-Hispanic Black,36.5,Male,Kidney and Renal Pelvis,2020
50-54,5.9,9.1,87,Incidence,1174154,Non-Hispanic Black,7.4,Male,Larynx,2020
50-54,10.3,14.4,144,Incidence,1174154,Non-Hispanic Black,12.3,Male,Leukemias,2020
50-54,7.2,10.7,104,Incidence,1174154,Non-Hispanic Black,8.9,Male,Liver and Intrahepatic Bile Duct,2020
50-54,34.1,41.2,441,Incidence,1174154,Non-Hispanic Black,37.6,Male,Lung and Bronchus,2020
50-54,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
50-54,~,~,~,Incidence,1174154,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,1174154,Non-Hispanic Black,~,Male,Mesothelioma,2020
50-54,14.4,19.1,195,Incidence,1174154,Non-Hispanic Black,16.6,Male,Myeloma,2020
50-54,16.9,22.0,227,Incidence,1174154,Non-Hispanic Black,19.3,Male,Non-Hodgkin Lymphoma,2020
50-54,18.3,23.6,244,Incidence,1174154,Non-Hispanic Black,20.8,Male,Oral Cavity and Pharynx,2020
50-54,14.4,19.1,195,Incidence,1174154,Non-Hispanic Black,16.6,Male,Pancreas,2020
50-54,194.4,210.7,2377,Incidence,1174154,Non-Hispanic Black,202.4,Male,Prostate,2020
50-54,8.0,11.7,114,Incidence,1174154,Non-Hispanic Black,9.7,Male,Stomach,2020
50-54,0.9,2.4,18,Incidence,1174154,Non-Hispanic Black,1.5,Male,Testis,2020
50-54,3.5,6.1,55,Incidence,1174154,Non-Hispanic Black,4.7,Male,Thyroid,2020
50-54,9.7,13.7,136,Incidence,1174154,Non-Hispanic Black,11.6,Male,Urinary Bladder,2020
55-59,953.0,988.5,11597,Incidence,1194801,Non-Hispanic Black,970.6,Male,All Cancer Sites Combined,2020
55-59,7.4,10.9,108,Incidence,1194801,Non-Hispanic Black,9.0,Male,Brain and Other Nervous System,2020
55-59,83.4,94.1,1059,Incidence,1194801,Non-Hispanic Black,88.6,Male,Colon and Rectum,2020
55-59,9.4,13.3,134,Incidence,1194801,Non-Hispanic Black,11.2,Male,Esophagus,2020
55-59,2.6,4.8,43,Incidence,1194801,Non-Hispanic Black,3.6,Male,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,1194801,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
55-59,49.1,57.4,635,Incidence,1194801,Non-Hispanic Black,53.1,Male,Kidney and Renal Pelvis,2020
55-59,12.2,16.6,171,Incidence,1194801,Non-Hispanic Black,14.3,Male,Larynx,2020
55-59,14.8,19.6,204,Incidence,1194801,Non-Hispanic Black,17.1,Male,Leukemias,2020
55-59,23.5,29.4,314,Incidence,1194801,Non-Hispanic Black,26.3,Male,Liver and Intrahepatic Bile Duct,2020
55-59,93.6,105.0,1185,Incidence,1194801,Non-Hispanic Black,99.2,Male,Lung and Bronchus,2020
55-59,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
55-59,~,~,~,Incidence,1194801,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,1194801,Non-Hispanic Black,~,Male,Mesothelioma,2020
55-59,25.0,31.0,333,Incidence,1194801,Non-Hispanic Black,27.9,Male,Myeloma,2020
55-59,23.3,29.2,312,Incidence,1194801,Non-Hispanic Black,26.1,Male,Non-Hodgkin Lymphoma,2020
55-59,30.3,36.9,400,Incidence,1194801,Non-Hispanic Black,33.5,Male,Oral Cavity and Pharynx,2020
55-59,30.0,36.7,397,Incidence,1194801,Non-Hispanic Black,33.2,Male,Pancreas,2020
55-59,404.2,427.4,4967,Incidence,1194801,Non-Hispanic Black,415.7,Male,Prostate,2020
55-59,17.2,22.3,234,Incidence,1194801,Non-Hispanic Black,19.6,Male,Stomach,2020
55-59,0.9,2.4,18,Incidence,1194801,Non-Hispanic Black,1.5,Male,Testis,2020
55-59,3.3,5.8,53,Incidence,1194801,Non-Hispanic Black,4.4,Male,Thyroid,2020
55-59,18.6,24.0,253,Incidence,1194801,Non-Hispanic Black,21.2,Male,Urinary Bladder,2020
60-64,1471.8,1518.1,16130,Incidence,1079055,Non-Hispanic Black,1494.8,Male,All Cancer Sites Combined,2020
60-64,6.4,9.8,86,Incidence,1079055,Non-Hispanic Black,8.0,Male,Brain and Other Nervous System,2020
60-64,107.6,120.4,1229,Incidence,1079055,Non-Hispanic Black,113.9,Male,Colon and Rectum,2020
60-64,14.7,19.7,184,Incidence,1079055,Non-Hispanic Black,17.1,Male,Esophagus,2020
60-64,2.5,4.8,38,Incidence,1079055,Non-Hispanic Black,3.5,Male,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,1079055,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
60-64,64.9,75.0,753,Incidence,1079055,Non-Hispanic Black,69.8,Male,Kidney and Renal Pelvis,2020
60-64,20.6,26.5,253,Incidence,1079055,Non-Hispanic Black,23.4,Male,Larynx,2020
60-64,21.6,27.6,264,Incidence,1079055,Non-Hispanic Black,24.5,Male,Leukemias,2020
60-64,58.5,68.1,682,Incidence,1079055,Non-Hispanic Black,63.2,Male,Liver and Intrahepatic Bile Duct,2020
60-64,179.4,195.8,2023,Incidence,1079055,Non-Hispanic Black,187.5,Male,Lung and Bronchus,2020
60-64,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
60-64,1.0,2.6,18,Incidence,1079055,Non-Hispanic Black,1.7,Male,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,1079055,Non-Hispanic Black,~,Male,Mesothelioma,2020
60-64,32.5,39.7,388,Incidence,1079055,Non-Hispanic Black,36.0,Male,Myeloma,2020
60-64,32.6,39.8,389,Incidence,1079055,Non-Hispanic Black,36.1,Male,Non-Hodgkin Lymphoma,2020
60-64,38.1,45.9,452,Incidence,1079055,Non-Hispanic Black,41.9,Male,Oral Cavity and Pharynx,2020
60-64,47.1,55.7,553,Incidence,1079055,Non-Hispanic Black,51.2,Male,Pancreas,2020
60-64,633.1,663.6,6995,Incidence,1079055,Non-Hispanic Black,648.3,Male,Prostate,2020
60-64,26.3,32.9,318,Incidence,1079055,Non-Hispanic Black,29.5,Male,Stomach,2020
60-64,~,~,~,Incidence,1079055,Non-Hispanic Black,~,Male,Testis,2020
60-64,6.2,9.6,84,Incidence,1079055,Non-Hispanic Black,7.8,Male,Thyroid,2020
60-64,34.3,41.8,409,Incidence,1079055,Non-Hispanic Black,37.9,Male,Urinary Bladder,2020
65-69,2052.6,2115.6,16881,Incidence,810069,Non-Hispanic Black,2083.9,Male,All Cancer Sites Combined,2020
65-69,9.0,13.8,91,Incidence,810069,Non-Hispanic Black,11.2,Male,Brain and Other Nervous System,2020
65-69,147.0,164.2,1259,Incidence,810069,Non-Hispanic Black,155.4,Male,Colon and Rectum,2020
65-69,19.8,26.5,186,Incidence,810069,Non-Hispanic Black,23.0,Male,Esophagus,2020
65-69,1.8,4.3,23,Incidence,810069,Non-Hispanic Black,2.8,Male,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,810069,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
65-69,86.6,100.0,754,Incidence,810069,Non-Hispanic Black,93.1,Male,Kidney and Renal Pelvis,2020
65-69,25.9,33.5,239,Incidence,810069,Non-Hispanic Black,29.5,Male,Larynx,2020
65-69,28.8,36.8,264,Incidence,810069,Non-Hispanic Black,32.6,Male,Leukemias,2020
65-69,92.6,106.5,805,Incidence,810069,Non-Hispanic Black,99.4,Male,Liver and Intrahepatic Bile Duct,2020
65-69,265.9,289.0,2246,Incidence,810069,Non-Hispanic Black,277.3,Male,Lung and Bronchus,2020
65-69,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
65-69,1.8,4.3,23,Incidence,810069,Non-Hispanic Black,2.8,Male,Melanomas of the Skin,2020
65-69,~,~,~,Incidence,810069,Non-Hispanic Black,~,Male,Mesothelioma,2020
65-69,51.9,62.5,462,Incidence,810069,Non-Hispanic Black,57.0,Male,Myeloma,2020
65-69,38.2,47.3,345,Incidence,810069,Non-Hispanic Black,42.6,Male,Non-Hodgkin Lymphoma,2020
65-69,42.0,51.5,377,Incidence,810069,Non-Hispanic Black,46.5,Male,Oral Cavity and Pharynx,2020
65-69,68.3,80.2,600,Incidence,810069,Non-Hispanic Black,74.1,Male,Pancreas,2020
65-69,880.8,922.3,7302,Incidence,810069,Non-Hispanic Black,901.4,Male,Prostate,2020
65-69,34.4,43.0,312,Incidence,810069,Non-Hispanic Black,38.5,Male,Stomach,2020
65-69,~,~,~,Incidence,810069,Non-Hispanic Black,~,Male,Testis,2020
65-69,6.8,11.1,71,Incidence,810069,Non-Hispanic Black,8.8,Male,Thyroid,2020
65-69,55.4,66.2,491,Incidence,810069,Non-Hispanic Black,60.6,Male,Urinary Bladder,2020
70-74,2171.3,2248.3,12685,Incidence,574097,Non-Hispanic Black,2209.6,Male,All Cancer Sites Combined,2020
70-74,11.0,17.3,80,Incidence,574097,Non-Hispanic Black,13.9,Male,Brain and Other Nervous System,2020
70-74,157.8,179.2,966,Incidence,574097,Non-Hispanic Black,168.3,Male,Colon and Rectum,2020
70-74,19.1,27.1,131,Incidence,574097,Non-Hispanic Black,22.8,Male,Esophagus,2020
70-74,2.0,5.2,19,Incidence,574097,Non-Hispanic Black,3.3,Male,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,574097,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
70-74,92.6,109.2,578,Incidence,574097,Non-Hispanic Black,100.7,Male,Kidney and Renal Pelvis,2020
70-74,24.7,33.7,166,Incidence,574097,Non-Hispanic Black,28.9,Male,Larynx,2020
70-74,42.9,54.5,278,Incidence,574097,Non-Hispanic Black,48.4,Male,Leukemias,2020
70-74,77.6,92.9,488,Incidence,574097,Non-Hispanic Black,85.0,Male,Liver and Intrahepatic Bile Duct,2020
70-74,327.6,358.1,1967,Incidence,574097,Non-Hispanic Black,342.6,Male,Lung and Bronchus,2020
70-74,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
70-74,2.1,5.4,20,Incidence,574097,Non-Hispanic Black,3.5,Male,Melanomas of the Skin,2020
70-74,1.6,4.5,16,Incidence,574097,Non-Hispanic Black,2.8,Male,Mesothelioma,2020
70-74,61.2,74.8,389,Incidence,574097,Non-Hispanic Black,67.8,Male,Myeloma,2020
70-74,51.0,63.5,327,Incidence,574097,Non-Hispanic Black,57.0,Male,Non-Hodgkin Lymphoma,2020
70-74,44.7,56.5,289,Incidence,574097,Non-Hispanic Black,50.3,Male,Oral Cavity and Pharynx,2020
70-74,81.3,96.9,510,Incidence,574097,Non-Hispanic Black,88.8,Male,Pancreas,2020
70-74,784.3,830.9,4635,Incidence,574097,Non-Hispanic Black,807.4,Male,Prostate,2020
70-74,50.0,62.4,321,Incidence,574097,Non-Hispanic Black,55.9,Male,Stomach,2020
70-74,~,~,~,Incidence,574097,Non-Hispanic Black,~,Male,Testis,2020
70-74,9.8,15.8,72,Incidence,574097,Non-Hispanic Black,12.5,Male,Thyroid,2020
70-74,77.6,92.9,488,Incidence,574097,Non-Hispanic Black,85.0,Male,Urinary Bladder,2020
75-79,2212.5,2313.7,7731,Incidence,341672,Non-Hispanic Black,2262.7,Male,All Cancer Sites Combined,2020
75-79,11.1,19.6,51,Incidence,341672,Non-Hispanic Black,14.9,Male,Brain and Other Nervous System,2020
75-79,177.0,206.7,654,Incidence,341672,Non-Hispanic Black,191.4,Male,Colon and Rectum,2020
75-79,23.0,34.6,97,Incidence,341672,Non-Hispanic Black,28.4,Male,Esophagus,2020
75-79,2.7,7.6,16,Incidence,341672,Non-Hispanic Black,4.7,Male,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,341672,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
75-79,82.3,103.0,315,Incidence,341672,Non-Hispanic Black,92.2,Male,Kidney and Renal Pelvis,2020
75-79,25.7,37.8,107,Incidence,341672,Non-Hispanic Black,31.3,Male,Larynx,2020
75-79,52.6,69.4,207,Incidence,341672,Non-Hispanic Black,60.6,Male,Leukemias,2020
75-79,39.3,54.0,158,Incidence,341672,Non-Hispanic Black,46.2,Male,Liver and Intrahepatic Bile Duct,2020
75-79,403.1,447.1,1451,Incidence,341672,Non-Hispanic Black,424.7,Male,Lung and Bronchus,2020
75-79,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
75-79,3.1,8.3,18,Incidence,341672,Non-Hispanic Black,5.3,Male,Melanomas of the Skin,2020
75-79,~,~,~,Incidence,341672,Non-Hispanic Black,~,Male,Mesothelioma,2020
75-79,75.9,95.8,292,Incidence,341672,Non-Hispanic Black,85.5,Male,Myeloma,2020
75-79,57.3,74.7,224,Incidence,341672,Non-Hispanic Black,65.6,Male,Non-Hodgkin Lymphoma,2020
75-79,34.7,48.7,141,Incidence,341672,Non-Hispanic Black,41.3,Male,Oral Cavity and Pharynx,2020
75-79,81.2,101.7,311,Incidence,341672,Non-Hispanic Black,91.0,Male,Pancreas,2020
75-79,653.7,709.3,2327,Incidence,341672,Non-Hispanic Black,681.1,Male,Prostate,2020
75-79,64.7,83.1,251,Incidence,341672,Non-Hispanic Black,73.5,Male,Stomach,2020
75-79,~,~,~,Incidence,341672,Non-Hispanic Black,~,Male,Testis,2020
75-79,3.6,9.0,20,Incidence,341672,Non-Hispanic Black,5.9,Male,Thyroid,2020
75-79,108.7,132.2,410,Incidence,341672,Non-Hispanic Black,120.0,Male,Urinary Bladder,2020
80-84,2066.8,2194.1,4332,Incidence,203405,Non-Hispanic Black,2129.7,Male,All Cancer Sites Combined,2020
80-84,10.4,21.6,31,Incidence,203405,Non-Hispanic Black,15.2,Male,Brain and Other Nervous System,2020
80-84,191.4,231.8,429,Incidence,203405,Non-Hispanic Black,210.9,Male,Colon and Rectum,2020
80-84,24.2,40.2,64,Incidence,203405,Non-Hispanic Black,31.5,Male,Esophagus,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
80-84,58.4,81.8,141,Incidence,203405,Non-Hispanic Black,69.3,Male,Kidney and Renal Pelvis,2020
80-84,24.2,40.2,64,Incidence,203405,Non-Hispanic Black,31.5,Male,Larynx,2020
80-84,58.4,81.8,141,Incidence,203405,Non-Hispanic Black,69.3,Male,Leukemias,2020
80-84,35.1,53.8,89,Incidence,203405,Non-Hispanic Black,43.8,Male,Liver and Intrahepatic Bile Duct,2020
80-84,357.0,411.4,780,Incidence,203405,Non-Hispanic Black,383.5,Male,Lung and Bronchus,2020
80-84,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male,Mesothelioma,2020
80-84,78.8,105.6,186,Incidence,203405,Non-Hispanic Black,91.4,Male,Myeloma,2020
80-84,58.4,81.8,141,Incidence,203405,Non-Hispanic Black,69.3,Male,Non-Hodgkin Lymphoma,2020
80-84,32.5,50.6,83,Incidence,203405,Non-Hispanic Black,40.8,Male,Oral Cavity and Pharynx,2020
80-84,86.1,114.0,202,Incidence,203405,Non-Hispanic Black,99.3,Male,Pancreas,2020
80-84,478.8,541.3,1036,Incidence,203405,Non-Hispanic Black,509.3,Male,Prostate,2020
80-84,71.0,96.6,169,Incidence,203405,Non-Hispanic Black,83.1,Male,Stomach,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male,Testis,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male,Thyroid,2020
80-84,126.6,160.0,290,Incidence,203405,Non-Hispanic Black,142.6,Male,Urinary Bladder,2020
85+,1857.2,1993.7,3083,Incidence,160193,Non-Hispanic Black,1924.6,Male,All Cancer Sites Combined,2020
85+,5.7,16.2,16,Incidence,160193,Non-Hispanic Black,10.0,Male,Brain and Other Nervous System,2020
85+,203.9,251.2,363,Incidence,160193,Non-Hispanic Black,226.6,Male,Colon and Rectum,2020
85+,16.8,32.6,38,Incidence,160193,Non-Hispanic Black,23.7,Male,Esophagus,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
85+,48.0,72.5,95,Incidence,160193,Non-Hispanic Black,59.3,Male,Kidney and Renal Pelvis,2020
85+,24.8,43.3,53,Incidence,160193,Non-Hispanic Black,33.1,Male,Larynx,2020
85+,44.1,67.7,88,Incidence,160193,Non-Hispanic Black,54.9,Male,Leukemias,2020
85+,21.6,39.0,47,Incidence,160193,Non-Hispanic Black,29.3,Male,Liver and Intrahepatic Bile Duct,2020
85+,284.8,340.1,499,Incidence,160193,Non-Hispanic Black,311.5,Male,Lung and Bronchus,2020
85+,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male,Mesothelioma,2020
85+,73.5,103.1,140,Incidence,160193,Non-Hispanic Black,87.4,Male,Myeloma,2020
85+,44.6,68.4,89,Incidence,160193,Non-Hispanic Black,55.6,Male,Non-Hodgkin Lymphoma,2020
85+,15.2,30.4,35,Incidence,160193,Non-Hispanic Black,21.8,Male,Oral Cavity and Pharynx,2020
85+,87.3,119.3,164,Incidence,160193,Non-Hispanic Black,102.4,Male,Pancreas,2020
85+,400.4,465.4,692,Incidence,160193,Non-Hispanic Black,432.0,Male,Prostate,2020
85+,63.2,90.9,122,Incidence,160193,Non-Hispanic Black,76.2,Male,Stomach,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male,Testis,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male,Thyroid,2020
85+,138.5,178.0,252,Incidence,160193,Non-Hispanic Black,157.3,Male,Urinary Bladder,2020
<1,16.0,26.8,61,Incidence,292395,Non-Hispanic Black,20.9,Male,All Cancer Sites Combined,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Colon and Rectum,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Esophagus,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Larynx,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Leukemias,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Lung and Bronchus,2020
<1,~,~,~,Incidence,0,Non-Hispanic Black,~,Male,Male Breast,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Melanomas of the Skin,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Mesothelioma,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Myeloma,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Pancreas,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Prostate,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Stomach,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Testis,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Thyroid,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male,Urinary Bladder,2020
1-4,15.0,18.3,390,Incidence,2353285,Non-Hispanic Black,16.6,Male and Female,All Cancer Sites Combined,2020
1-4,1.8,3.1,56,Incidence,2353285,Non-Hispanic Black,2.4,Male and Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,Cervix,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Esophagus,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,Female Breast,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
1-4,2.5,4.0,76,Incidence,2353285,Non-Hispanic Black,3.2,Male and Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Larynx,2020
1-4,4.0,5.8,114,Incidence,2353285,Non-Hispanic Black,4.8,Male and Female,Leukemias,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Myeloma,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,1159420,Non-Hispanic Black,~,Male and Female,Ovary,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Pancreas,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male and Female,Prostate,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Stomach,2020
1-4,~,~,~,Incidence,1193865,Non-Hispanic Black,~,Male and Female,Testis,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Thyroid,2020
1-4,~,~,~,Incidence,2353285,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
10-14,10.8,13.3,369,Incidence,3077197,Non-Hispanic Black,12.0,Male and Female,All Cancer Sites Combined,2020
10-14,1.4,2.4,58,Incidence,3077197,Non-Hispanic Black,1.9,Male and Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Male and Female,Cervix,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Esophagus,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Male and Female,Female Breast,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
10-14,1.0,1.9,44,Incidence,3077197,Non-Hispanic Black,1.4,Male and Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Larynx,2020
10-14,1.9,3.1,76,Incidence,3077197,Non-Hispanic Black,2.5,Male and Female,Leukemias,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2020
10-14,~,~,~,Incidence,1515675,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Myeloma,2020
10-14,0.9,1.7,39,Incidence,3077197,Non-Hispanic Black,1.3,Male and Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2020
10-14,0.7,1.9,18,Incidence,1515675,Non-Hispanic Black,1.2,Male and Female,Ovary,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Pancreas,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male and Female,Prostate,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Stomach,2020
10-14,~,~,~,Incidence,1561522,Non-Hispanic Black,~,Male and Female,Testis,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Thyroid,2020
10-14,~,~,~,Incidence,3077197,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
15-19,15.3,18.3,507,Incidence,3027473,Non-Hispanic Black,16.7,Male and Female,All Cancer Sites Combined,2020
15-19,1.5,2.5,58,Incidence,3027473,Non-Hispanic Black,1.9,Male and Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Male and Female,Cervix,2020
15-19,0.3,0.9,17,Incidence,3027473,Non-Hispanic Black,0.6,Male and Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Esophagus,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Male and Female,Female Breast,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
15-19,2.3,3.5,87,Incidence,3027473,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Larynx,2020
15-19,1.6,2.6,62,Incidence,3027473,Non-Hispanic Black,2.0,Male and Female,Leukemias,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2020
15-19,~,~,~,Incidence,1493680,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Myeloma,2020
15-19,1.5,2.6,60,Incidence,3027473,Non-Hispanic Black,2.0,Male and Female,Non-Hodgkin Lymphoma,2020
15-19,0.4,1.0,19,Incidence,3027473,Non-Hispanic Black,0.6,Male and Female,Oral Cavity and Pharynx,2020
15-19,0.6,1.7,16,Incidence,1493680,Non-Hispanic Black,1.1,Male and Female,Ovary,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Pancreas,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male and Female,Prostate,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Stomach,2020
15-19,~,~,~,Incidence,1533793,Non-Hispanic Black,~,Male and Female,Testis,2020
15-19,0.8,1.6,36,Incidence,3027473,Non-Hispanic Black,1.2,Male and Female,Thyroid,2020
15-19,~,~,~,Incidence,3027473,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
20-24,21.5,24.9,737,Incidence,3180777,Non-Hispanic Black,23.2,Male and Female,All Cancer Sites Combined,2020
20-24,1.0,1.8,43,Incidence,3180777,Non-Hispanic Black,1.4,Male and Female,Brain and Other Nervous System,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Male and Female,Cervix,2020
20-24,1.1,2.0,47,Incidence,3180777,Non-Hispanic Black,1.5,Male and Female,Colon and Rectum,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Esophagus,2020
20-24,2.0,3.7,43,Incidence,1570857,Non-Hispanic Black,2.7,Male and Female,Female Breast,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
20-24,2.9,4.2,111,Incidence,3180777,Non-Hispanic Black,3.5,Male and Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
20-24,0.5,1.1,23,Incidence,3180777,Non-Hispanic Black,0.7,Male and Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Larynx,2020
20-24,1.5,2.5,61,Incidence,3180777,Non-Hispanic Black,1.9,Male and Female,Leukemias,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2020
20-24,2.0,3.7,43,Incidence,1570857,Non-Hispanic Black,2.7,Male and Female,Male and Female Breast,2020
20-24,~,~,~,Incidence,1570857,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Myeloma,2020
20-24,1.7,2.8,71,Incidence,3180777,Non-Hispanic Black,2.2,Male and Female,Non-Hodgkin Lymphoma,2020
20-24,0.5,1.1,24,Incidence,3180777,Non-Hispanic Black,0.8,Male and Female,Oral Cavity and Pharynx,2020
20-24,1.1,2.5,27,Incidence,1570857,Non-Hispanic Black,1.7,Male and Female,Ovary,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Pancreas,2020
20-24,~,~,~,Incidence,1609920,Non-Hispanic Black,~,Male and Female,Prostate,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Stomach,2020
20-24,0.9,2.1,23,Incidence,1609920,Non-Hispanic Black,1.4,Male and Female,Testis,2020
20-24,1.6,2.7,67,Incidence,3180777,Non-Hispanic Black,2.1,Male and Female,Thyroid,2020
20-24,~,~,~,Incidence,3180777,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
25-29,36.9,41.0,1372,Incidence,3527099,Non-Hispanic Black,38.9,Male and Female,All Cancer Sites Combined,2020
25-29,1.1,1.9,52,Incidence,3527099,Non-Hispanic Black,1.5,Male and Female,Brain and Other Nervous System,2020
25-29,2.1,3.7,49,Incidence,1743897,Non-Hispanic Black,2.8,Male and Female,Cervix,2020
25-29,2.3,3.5,101,Incidence,3527099,Non-Hispanic Black,2.9,Male and Female,Colon and Rectum,2020
25-29,1.4,2.7,34,Incidence,1743897,Non-Hispanic Black,1.9,Male and Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Esophagus,2020
25-29,11.2,14.6,224,Incidence,1743897,Non-Hispanic Black,12.8,Male and Female,Female Breast,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
25-29,2.6,3.8,111,Incidence,3527099,Non-Hispanic Black,3.1,Male and Female,Hodgkin Lymphoma,2020
25-29,0.7,1.4,36,Incidence,3527099,Non-Hispanic Black,1.0,Male and Female,Kaposi Sarcoma,2020
25-29,0.8,1.5,38,Incidence,3527099,Non-Hispanic Black,1.1,Male and Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Larynx,2020
25-29,1.9,3.0,85,Incidence,3527099,Non-Hispanic Black,2.4,Male and Female,Leukemias,2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.3,0.9,20,Incidence,3527099,Non-Hispanic Black,0.6,Male and Female,Lung and Bronchus,2020
25-29,11.2,14.6,224,Incidence,1743897,Non-Hispanic Black,12.8,Male and Female,Male and Female Breast,2020
25-29,~,~,~,Incidence,1743897,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Myeloma,2020
25-29,2.7,3.9,116,Incidence,3527099,Non-Hispanic Black,3.3,Male and Female,Non-Hodgkin Lymphoma,2020
25-29,0.6,1.3,32,Incidence,3527099,Non-Hispanic Black,0.9,Male and Female,Oral Cavity and Pharynx,2020
25-29,0.7,1.7,19,Incidence,1743897,Non-Hispanic Black,1.1,Male and Female,Ovary,2020
25-29,0.4,1.0,24,Incidence,3527099,Non-Hispanic Black,0.7,Male and Female,Pancreas,2020
25-29,~,~,~,Incidence,1783202,Non-Hispanic Black,~,Male and Female,Prostate,2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Stomach,2020
25-29,2.4,4.1,56,Incidence,1783202,Non-Hispanic Black,3.1,Male and Female,Testis,2020
25-29,2.8,4.1,120,Incidence,3527099,Non-Hispanic Black,3.4,Male and Female,Thyroid,2020
25-29,~,~,~,Incidence,3527099,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
30-34,69.5,75.4,2320,Incidence,3203443,Non-Hispanic Black,72.4,Male and Female,All Cancer Sites Combined,2020
30-34,1.5,2.5,63,Incidence,3203443,Non-Hispanic Black,2.0,Male and Female,Brain and Other Nervous System,2020
30-34,7.1,10.0,138,Incidence,1627460,Non-Hispanic Black,8.5,Male and Female,Cervix,2020
30-34,5.2,6.9,193,Incidence,3203443,Non-Hispanic Black,6.0,Male and Female,Colon and Rectum,2020
30-34,3.4,5.4,70,Incidence,1627460,Non-Hispanic Black,4.3,Male and Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,3203443,Non-Hispanic Black,~,Male and Female,Esophagus,2020
30-34,33.2,39.0,586,Incidence,1627460,Non-Hispanic Black,36.0,Male and Female,Female Breast,2020
30-34,2.8,4.7,60,Incidence,1627460,Non-Hispanic Black,3.7,Male and Female,"Female Breast, <i>in situ</i>",2020
30-34,2.7,4.0,107,Incidence,3203443,Non-Hispanic Black,3.3,Male and Female,Hodgkin Lymphoma,2020
30-34,1.2,2.1,52,Incidence,3203443,Non-Hispanic Black,1.6,Male and Female,Kaposi Sarcoma,2020
30-34,2.3,3.6,93,Incidence,3203443,Non-Hispanic Black,2.9,Male and Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,3203443,Non-Hispanic Black,~,Male and Female,Larynx,2020
30-34,2.3,3.6,93,Incidence,3203443,Non-Hispanic Black,2.9,Male and Female,Leukemias,2020
30-34,0.5,1.1,23,Incidence,3203443,Non-Hispanic Black,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.7,1.4,31,Incidence,3203443,Non-Hispanic Black,1.0,Male and Female,Lung and Bronchus,2020
30-34,33.2,39.0,586,Incidence,1627460,Non-Hispanic Black,36.0,Male and Female,Male and Female Breast,2020
30-34,2.8,4.7,60,Incidence,1627460,Non-Hispanic Black,3.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
30-34,~,~,~,Incidence,3203443,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,3203443,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
30-34,~,~,~,Incidence,3203443,Non-Hispanic Black,~,Male and Female,Myeloma,2020
30-34,4.3,5.9,163,Incidence,3203443,Non-Hispanic Black,5.1,Male and Female,Non-Hodgkin Lymphoma,2020
30-34,1.1,2.0,47,Incidence,3203443,Non-Hispanic Black,1.5,Male and Female,Oral Cavity and Pharynx,2020
30-34,1.7,3.3,39,Incidence,1627460,Non-Hispanic Black,2.4,Male and Female,Ovary,2020
30-34,0.5,1.2,26,Incidence,3203443,Non-Hispanic Black,0.8,Male and Female,Pancreas,2020
30-34,~,~,~,Incidence,1575983,Non-Hispanic Black,~,Male and Female,Prostate,2020
30-34,0.7,1.4,31,Incidence,3203443,Non-Hispanic Black,1.0,Male and Female,Stomach,2020
30-34,2.2,4.0,47,Incidence,1575983,Non-Hispanic Black,3.0,Male and Female,Testis,2020
30-34,5.1,6.9,191,Incidence,3203443,Non-Hispanic Black,6.0,Male and Female,Thyroid,2020
30-34,~,~,~,Incidence,3203443,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
35-39,121.7,130.0,3542,Incidence,2816004,Non-Hispanic Black,125.8,Male and Female,All Cancer Sites Combined,2020
35-39,1.5,2.6,56,Incidence,2816004,Non-Hispanic Black,2.0,Male and Female,Brain and Other Nervous System,2020
35-39,10.4,14.0,177,Incidence,1466563,Non-Hispanic Black,12.1,Male and Female,Cervix,2020
35-39,10.1,12.6,318,Incidence,2816004,Non-Hispanic Black,11.3,Male and Female,Colon and Rectum,2020
35-39,6.4,9.3,113,Incidence,1466563,Non-Hispanic Black,7.7,Male and Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,2816004,Non-Hispanic Black,~,Male and Female,Esophagus,2020
35-39,67.7,76.5,1056,Incidence,1466563,Non-Hispanic Black,72.0,Male and Female,Female Breast,2020
35-39,7.3,10.5,129,Incidence,1466563,Non-Hispanic Black,8.8,Male and Female,"Female Breast, <i>in situ</i>",2020
35-39,2.7,4.1,95,Incidence,2816004,Non-Hispanic Black,3.4,Male and Female,Hodgkin Lymphoma,2020
35-39,0.9,1.7,35,Incidence,2816004,Non-Hispanic Black,1.2,Male and Female,Kaposi Sarcoma,2020
35-39,5.2,7.1,171,Incidence,2816004,Non-Hispanic Black,6.1,Male and Female,Kidney and Renal Pelvis,2020
35-39,~,~,~,Incidence,2816004,Non-Hispanic Black,~,Male and Female,Larynx,2020
35-39,3.4,4.9,115,Incidence,2816004,Non-Hispanic Black,4.1,Male and Female,Leukemias,2020
35-39,0.9,1.8,36,Incidence,2816004,Non-Hispanic Black,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
35-39,2.8,4.2,97,Incidence,2816004,Non-Hispanic Black,3.4,Male and Female,Lung and Bronchus,2020
35-39,67.7,76.5,1056,Incidence,1466563,Non-Hispanic Black,72.0,Male and Female,Male and Female Breast,2020
35-39,7.3,10.5,129,Incidence,1466563,Non-Hispanic Black,8.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
35-39,~,~,~,Incidence,2816004,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,2816004,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
35-39,1.6,2.7,58,Incidence,2816004,Non-Hispanic Black,2.1,Male and Female,Myeloma,2020
35-39,6.2,8.2,200,Incidence,2816004,Non-Hispanic Black,7.1,Male and Female,Non-Hodgkin Lymphoma,2020
35-39,2.0,3.3,73,Incidence,2816004,Non-Hispanic Black,2.6,Male and Female,Oral Cavity and Pharynx,2020
35-39,2.9,5.0,56,Incidence,1466563,Non-Hispanic Black,3.8,Male and Female,Ovary,2020
35-39,1.3,2.4,51,Incidence,2816004,Non-Hispanic Black,1.8,Male and Female,Pancreas,2020
35-39,~,~,~,Incidence,1349441,Non-Hispanic Black,~,Male and Female,Prostate,2020
35-39,1.9,3.1,69,Incidence,2816004,Non-Hispanic Black,2.5,Male and Female,Stomach,2020
35-39,2.8,5.0,51,Incidence,1349441,Non-Hispanic Black,3.8,Male and Female,Testis,2020
35-39,7.4,9.6,237,Incidence,2816004,Non-Hispanic Black,8.4,Male and Female,Thyroid,2020
35-39,0.5,1.2,22,Incidence,2816004,Non-Hispanic Black,0.8,Male and Female,Urinary Bladder,2020
40-44,202.3,213.4,5436,Incidence,2615741,Non-Hispanic Black,207.8,Male and Female,All Cancer Sites Combined,2020
40-44,1.8,3.0,62,Incidence,2615741,Non-Hispanic Black,2.4,Male and Female,Brain and Other Nervous System,2020
40-44,11.9,15.9,190,Incidence,1381367,Non-Hispanic Black,13.8,Male and Female,Cervix,2020
40-44,18.9,22.5,540,Incidence,2615741,Non-Hispanic Black,20.6,Male and Female,Colon and Rectum,2020
40-44,11.5,15.5,185,Incidence,1381367,Non-Hispanic Black,13.4,Male and Female,"Corpus and Uterus, NOS",2020
40-44,0.4,1.1,18,Incidence,2615741,Non-Hispanic Black,0.7,Male and Female,Esophagus,2020
40-44,128.6,140.9,1860,Incidence,1381367,Non-Hispanic Black,134.6,Male and Female,Female Breast,2020
40-44,26.7,32.5,407,Incidence,1381367,Non-Hispanic Black,29.5,Male and Female,"Female Breast, <i>in situ</i>",2020
40-44,2.3,3.6,76,Incidence,2615741,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2020
40-44,0.6,1.4,25,Incidence,2615741,Non-Hispanic Black,1.0,Male and Female,Kaposi Sarcoma,2020
40-44,9.4,11.9,277,Incidence,2615741,Non-Hispanic Black,10.6,Male and Female,Kidney and Renal Pelvis,2020
40-44,0.6,1.4,24,Incidence,2615741,Non-Hispanic Black,0.9,Male and Female,Larynx,2020
40-44,4.3,6.1,134,Incidence,2615741,Non-Hispanic Black,5.1,Male and Female,Leukemias,2020
40-44,1.2,2.2,43,Incidence,2615741,Non-Hispanic Black,1.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
40-44,7.1,9.3,212,Incidence,2615741,Non-Hispanic Black,8.1,Male and Female,Lung and Bronchus,2020
40-44,128.6,140.9,1860,Incidence,1381367,Non-Hispanic Black,134.6,Male and Female,Male and Female Breast,2020
40-44,26.7,32.5,407,Incidence,1381367,Non-Hispanic Black,29.5,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
40-44,~,~,~,Incidence,2615741,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,2615741,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
40-44,4.3,6.1,134,Incidence,2615741,Non-Hispanic Black,5.1,Male and Female,Myeloma,2020
40-44,6.5,8.6,196,Incidence,2615741,Non-Hispanic Black,7.5,Male and Female,Non-Hodgkin Lymphoma,2020
40-44,3.8,5.5,121,Incidence,2615741,Non-Hispanic Black,4.6,Male and Female,Oral Cavity and Pharynx,2020
40-44,4.5,7.0,78,Incidence,1381367,Non-Hispanic Black,5.6,Male and Female,Ovary,2020
40-44,3.7,5.4,117,Incidence,2615741,Non-Hispanic Black,4.5,Male and Female,Pancreas,2020
40-44,11.0,15.0,159,Incidence,1234374,Non-Hispanic Black,12.9,Male and Female,Prostate,2020
40-44,2.4,3.8,80,Incidence,2615741,Non-Hispanic Black,3.1,Male and Female,Stomach,2020
40-44,1.8,3.7,32,Incidence,1234374,Non-Hispanic Black,2.6,Male and Female,Testis,2020
40-44,9.6,12.1,282,Incidence,2615741,Non-Hispanic Black,10.8,Male and Female,Thyroid,2020
40-44,1.3,2.3,45,Incidence,2615741,Non-Hispanic Black,1.7,Male and Female,Urinary Bladder,2020
45-49,329.4,343.8,8492,Incidence,2523453,Non-Hispanic Black,336.5,Male and Female,All Cancer Sites Combined,2020
45-49,2.9,4.5,92,Incidence,2523453,Non-Hispanic Black,3.6,Male and Female,Brain and Other Nervous System,2020
45-49,9.6,13.3,152,Incidence,1344415,Non-Hispanic Black,11.3,Male and Female,Cervix,2020
45-49,38.7,43.8,1039,Incidence,2523453,Non-Hispanic Black,41.2,Male and Female,Colon and Rectum,2020
45-49,16.6,21.3,253,Incidence,1344415,Non-Hispanic Black,18.8,Male and Female,"Corpus and Uterus, NOS",2020
45-49,1.3,2.3,44,Incidence,2523453,Non-Hispanic Black,1.7,Male and Female,Esophagus,2020
45-49,168.2,182.4,2355,Incidence,1344415,Non-Hispanic Black,175.2,Male and Female,Female Breast,2020
45-49,41.6,48.9,607,Incidence,1344415,Non-Hispanic Black,45.1,Male and Female,"Female Breast, <i>in situ</i>",2020
45-49,2.3,3.7,74,Incidence,2523453,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2020
45-49,0.6,1.4,23,Incidence,2523453,Non-Hispanic Black,0.9,Male and Female,Kaposi Sarcoma,2020
45-49,16.3,19.7,453,Incidence,2523453,Non-Hispanic Black,18.0,Male and Female,Kidney and Renal Pelvis,2020
45-49,1.4,2.5,48,Incidence,2523453,Non-Hispanic Black,1.9,Male and Female,Larynx,2020
45-49,7.0,9.2,203,Incidence,2523453,Non-Hispanic Black,8.0,Male and Female,Leukemias,2020
45-49,2.5,3.9,79,Incidence,2523453,Non-Hispanic Black,3.1,Male and Female,Liver and Intrahepatic Bile Duct,2020
45-49,13.7,16.8,384,Incidence,2523453,Non-Hispanic Black,15.2,Male and Female,Lung and Bronchus,2020
45-49,168.2,182.4,2355,Incidence,1344415,Non-Hispanic Black,175.2,Male and Female,Male and Female Breast,2020
45-49,41.6,48.9,607,Incidence,1344415,Non-Hispanic Black,45.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
45-49,0.5,1.3,22,Incidence,2523453,Non-Hispanic Black,0.9,Male and Female,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,2523453,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
45-49,9.5,12.1,272,Incidence,2523453,Non-Hispanic Black,10.8,Male and Female,Myeloma,2020
45-49,10.8,13.6,306,Incidence,2523453,Non-Hispanic Black,12.1,Male and Female,Non-Hodgkin Lymphoma,2020
45-49,8.4,10.8,241,Incidence,2523453,Non-Hispanic Black,9.6,Male and Female,Oral Cavity and Pharynx,2020
45-49,7.9,11.2,127,Incidence,1344415,Non-Hispanic Black,9.4,Male and Female,Ovary,2020
45-49,6.7,8.9,196,Incidence,2523453,Non-Hispanic Black,7.8,Male and Female,Pancreas,2020
45-49,63.5,73.0,803,Incidence,1179038,Non-Hispanic Black,68.1,Male and Female,Prostate,2020
45-49,5.0,7.0,150,Incidence,2523453,Non-Hispanic Black,5.9,Male and Female,Stomach,2020
45-49,1.6,3.4,28,Incidence,1179038,Non-Hispanic Black,2.4,Male and Female,Testis,2020
45-49,10.8,13.6,307,Incidence,2523453,Non-Hispanic Black,12.2,Male and Female,Thyroid,2020
45-49,2.8,4.3,88,Incidence,2523453,Non-Hispanic Black,3.5,Male and Female,Urinary Bladder,2020
5-9,8.2,10.4,278,Incidence,3013421,Non-Hispanic Black,9.2,Male and Female,All Cancer Sites Combined,2020
5-9,1.9,3.0,73,Incidence,3013421,Non-Hispanic Black,2.4,Male and Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,Cervix,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Esophagus,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,Female Breast,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
5-9,0.7,1.4,30,Incidence,3013421,Non-Hispanic Black,1.0,Male and Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Larynx,2020
5-9,2.4,3.6,89,Incidence,3013421,Non-Hispanic Black,3.0,Male and Female,Leukemias,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Myeloma,2020
5-9,0.4,1.0,20,Incidence,3013421,Non-Hispanic Black,0.7,Male and Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,1482112,Non-Hispanic Black,~,Male and Female,Ovary,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Pancreas,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male and Female,Prostate,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Stomach,2020
5-9,~,~,~,Incidence,1531309,Non-Hispanic Black,~,Male and Female,Testis,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Thyroid,2020
5-9,~,~,~,Incidence,3013421,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
50-54,527.1,545.2,13486,Incidence,2515584,Non-Hispanic Black,536.1,Male and Female,All Cancer Sites Combined,2020
50-54,4.1,5.9,125,Incidence,2515584,Non-Hispanic Black,5.0,Male and Female,Brain and Other Nervous System,2020
50-54,10.5,14.3,165,Incidence,1341430,Non-Hispanic Black,12.3,Male and Female,Cervix,2020
50-54,62.1,68.5,1641,Incidence,2515584,Non-Hispanic Black,65.2,Male and Female,Colon and Rectum,2020
50-54,30.2,36.5,446,Incidence,1341430,Non-Hispanic Black,33.2,Male and Female,"Corpus and Uterus, NOS",2020
50-54,3.2,4.8,99,Incidence,2515584,Non-Hispanic Black,3.9,Male and Female,Esophagus,2020
50-54,217.8,234.0,3029,Incidence,1341430,Non-Hispanic Black,225.8,Male and Female,Female Breast,2020
50-54,53.6,61.8,772,Incidence,1341430,Non-Hispanic Black,57.6,Male and Female,"Female Breast, <i>in situ</i>",2020
50-54,1.6,2.8,53,Incidence,2515584,Non-Hispanic Black,2.1,Male and Female,Hodgkin Lymphoma,2020
50-54,0.6,1.4,23,Incidence,2515584,Non-Hispanic Black,0.9,Male and Female,Kaposi Sarcoma,2020
50-54,23.1,27.0,629,Incidence,2515584,Non-Hispanic Black,25.0,Male and Female,Kidney and Renal Pelvis,2020
50-54,4.4,6.3,133,Incidence,2515584,Non-Hispanic Black,5.3,Male and Female,Larynx,2020
50-54,9.0,11.6,258,Incidence,2515584,Non-Hispanic Black,10.3,Male and Female,Leukemias,2020
50-54,5.6,7.7,166,Incidence,2515584,Non-Hispanic Black,6.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
50-54,30.4,34.9,821,Incidence,2515584,Non-Hispanic Black,32.6,Male and Female,Lung and Bronchus,2020
50-54,217.8,234.0,3029,Incidence,1341430,Non-Hispanic Black,225.8,Male and Female,Male and Female Breast,2020
50-54,53.6,61.8,772,Incidence,1341430,Non-Hispanic Black,57.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
50-54,0.7,1.6,27,Incidence,2515584,Non-Hispanic Black,1.1,Male and Female,Melanomas of the Skin,2020
50-54,~,~,~,Incidence,2515584,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
50-54,14.7,17.9,408,Incidence,2515584,Non-Hispanic Black,16.2,Male and Female,Myeloma,2020
50-54,14.6,17.8,407,Incidence,2515584,Non-Hispanic Black,16.2,Male and Female,Non-Hodgkin Lymphoma,2020
50-54,12.0,14.9,337,Incidence,2515584,Non-Hispanic Black,13.4,Male and Female,Oral Cavity and Pharynx,2020
50-54,8.3,11.8,133,Incidence,1341430,Non-Hispanic Black,9.9,Male and Female,Ovary,2020
50-54,14.0,17.2,391,Incidence,2515584,Non-Hispanic Black,15.5,Male and Female,Pancreas,2020
50-54,194.4,210.7,2377,Incidence,1174154,Non-Hispanic Black,202.4,Male and Female,Prostate,2020
50-54,7.5,9.8,216,Incidence,2515584,Non-Hispanic Black,8.6,Male and Female,Stomach,2020
50-54,0.9,2.4,18,Incidence,1174154,Non-Hispanic Black,1.5,Male and Female,Testis,2020
50-54,11.4,14.2,320,Incidence,2515584,Non-Hispanic Black,12.7,Male and Female,Thyroid,2020
50-54,6.3,8.5,185,Incidence,2515584,Non-Hispanic Black,7.4,Male and Female,Urinary Bladder,2020
55-59,837.6,860.1,21963,Incidence,2587543,Non-Hispanic Black,848.8,Male and Female,All Cancer Sites Combined,2020
55-59,6.3,8.5,190,Incidence,2587543,Non-Hispanic Black,7.3,Male and Female,Brain and Other Nervous System,2020
55-59,11.6,15.5,187,Incidence,1392742,Non-Hispanic Black,13.4,Male and Female,Cervix,2020
55-59,69.2,75.8,1875,Incidence,2587543,Non-Hispanic Black,72.5,Male and Female,Colon and Rectum,2020
55-59,62.8,71.5,934,Incidence,1392742,Non-Hispanic Black,67.1,Male and Female,"Corpus and Uterus, NOS",2020
55-59,6.8,9.0,203,Incidence,2587543,Non-Hispanic Black,7.8,Male and Female,Esophagus,2020
55-59,266.8,284.3,3836,Incidence,1392742,Non-Hispanic Black,275.4,Male and Female,Female Breast,2020
55-59,65.7,74.6,976,Incidence,1392742,Non-Hispanic Black,70.1,Male and Female,"Female Breast, <i>in situ</i>",2020
55-59,2.2,3.6,74,Incidence,2587543,Non-Hispanic Black,2.9,Male and Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,2587543,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
55-59,35.7,40.5,984,Incidence,2587543,Non-Hispanic Black,38.0,Male and Female,Kidney and Renal Pelvis,2020
55-59,8.0,10.3,235,Incidence,2587543,Non-Hispanic Black,9.1,Male and Female,Larynx,2020
55-59,13.3,16.3,382,Incidence,2587543,Non-Hispanic Black,14.8,Male and Female,Leukemias,2020
55-59,15.7,18.9,446,Incidence,2587543,Non-Hispanic Black,17.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
55-59,83.0,90.2,2240,Incidence,2587543,Non-Hispanic Black,86.6,Male and Female,Lung and Bronchus,2020
55-59,266.8,284.3,3836,Incidence,1392742,Non-Hispanic Black,275.4,Male and Female,Male and Female Breast,2020
55-59,65.7,74.6,976,Incidence,1392742,Non-Hispanic Black,70.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
55-59,0.7,1.5,26,Incidence,2587543,Non-Hispanic Black,1.0,Male and Female,Melanomas of the Skin,2020
55-59,~,~,~,Incidence,2587543,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
55-59,22.2,26.0,623,Incidence,2587543,Non-Hispanic Black,24.1,Male and Female,Myeloma,2020
55-59,20.0,23.7,564,Incidence,2587543,Non-Hispanic Black,21.8,Male and Female,Non-Hodgkin Lymphoma,2020
55-59,20.5,24.2,576,Incidence,2587543,Non-Hispanic Black,22.3,Male and Female,Oral Cavity and Pharynx,2020
55-59,14.7,19.0,233,Incidence,1392742,Non-Hispanic Black,16.7,Male and Female,Ovary,2020
55-59,25.9,30.1,723,Incidence,2587543,Non-Hispanic Black,27.9,Male and Female,Pancreas,2020
55-59,404.2,427.4,4967,Incidence,1194801,Non-Hispanic Black,415.7,Male and Female,Prostate,2020
55-59,14.0,17.1,401,Incidence,2587543,Non-Hispanic Black,15.5,Male and Female,Stomach,2020
55-59,0.9,2.4,18,Incidence,1194801,Non-Hispanic Black,1.5,Male and Female,Testis,2020
55-59,10.4,13.0,301,Incidence,2587543,Non-Hispanic Black,11.6,Male and Female,Thyroid,2020
55-59,12.8,15.8,368,Incidence,2587543,Non-Hispanic Black,14.2,Male and Female,Urinary Bladder,2020
60-64,1205.0,1233.1,29020,Incidence,2380671,Non-Hispanic Black,1219.0,Male and Female,All Cancer Sites Combined,2020
60-64,7.2,9.6,198,Incidence,2380671,Non-Hispanic Black,8.3,Male and Female,Brain and Other Nervous System,2020
60-64,11.6,15.7,176,Incidence,1301616,Non-Hispanic Black,13.5,Male and Female,Cervix,2020
60-64,88.2,96.0,2191,Incidence,2380671,Non-Hispanic Black,92.0,Male and Female,Colon and Rectum,2020
60-64,106.1,117.7,1455,Incidence,1301616,Non-Hispanic Black,111.8,Male and Female,"Corpus and Uterus, NOS",2020
60-64,9.2,11.8,249,Incidence,2380671,Non-Hispanic Black,10.5,Male and Female,Esophagus,2020
60-64,305.0,324.4,4095,Incidence,1301616,Non-Hispanic Black,314.6,Male and Female,Female Breast,2020
60-64,78.3,88.3,1083,Incidence,1301616,Non-Hispanic Black,83.2,Male and Female,"Female Breast, <i>in situ</i>",2020
60-64,1.8,3.1,57,Incidence,2380671,Non-Hispanic Black,2.4,Male and Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,2380671,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
60-64,46.8,52.5,1180,Incidence,2380671,Non-Hispanic Black,49.6,Male and Female,Kidney and Renal Pelvis,2020
60-64,12.3,15.3,327,Incidence,2380671,Non-Hispanic Black,13.7,Male and Female,Larynx,2020
60-64,17.2,20.8,451,Incidence,2380671,Non-Hispanic Black,18.9,Male and Female,Leukemias,2020
60-64,37.1,42.2,943,Incidence,2380671,Non-Hispanic Black,39.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
60-64,151.8,161.9,3732,Incidence,2380671,Non-Hispanic Black,156.8,Male and Female,Lung and Bronchus,2020
60-64,305.0,324.4,4095,Incidence,1301616,Non-Hispanic Black,314.6,Male and Female,Male and Female Breast,2020
60-64,78.3,88.3,1083,Incidence,1301616,Non-Hispanic Black,83.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
60-64,1.2,2.2,39,Incidence,2380671,Non-Hispanic Black,1.6,Male and Female,Melanomas of the Skin,2020
60-64,~,~,~,Incidence,2380671,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
60-64,31.0,35.7,793,Incidence,2380671,Non-Hispanic Black,33.3,Male and Female,Myeloma,2020
60-64,27.3,31.7,700,Incidence,2380671,Non-Hispanic Black,29.4,Male and Female,Non-Hodgkin Lymphoma,2020
60-64,25.3,29.5,651,Incidence,2380671,Non-Hispanic Black,27.3,Male and Female,Oral Cavity and Pharynx,2020
60-64,19.4,24.5,284,Incidence,1301616,Non-Hispanic Black,21.8,Male and Female,Ovary,2020
60-64,41.5,46.9,1050,Incidence,2380671,Non-Hispanic Black,44.1,Male and Female,Pancreas,2020
60-64,633.1,663.6,6995,Incidence,1079055,Non-Hispanic Black,648.3,Male and Female,Prostate,2020
60-64,20.8,24.7,540,Incidence,2380671,Non-Hispanic Black,22.7,Male and Female,Stomach,2020
60-64,~,~,~,Incidence,1079055,Non-Hispanic Black,~,Male and Female,Testis,2020
60-64,12.2,15.2,325,Incidence,2380671,Non-Hispanic Black,13.7,Male and Female,Thyroid,2020
60-64,22.5,26.5,582,Incidence,2380671,Non-Hispanic Black,24.4,Male and Female,Urinary Bladder,2020
65-69,1601.4,1638.0,30211,Incidence,1865341,Non-Hispanic Black,1619.6,Male and Female,All Cancer Sites Combined,2020
65-69,8.0,10.9,175,Incidence,1865341,Non-Hispanic Black,9.4,Male and Female,Brain and Other Nervous System,2020
65-69,11.9,16.5,148,Incidence,1055272,Non-Hispanic Black,14.0,Male and Female,Cervix,2020
65-69,116.9,127.0,2273,Incidence,1865341,Non-Hispanic Black,121.9,Male and Female,Colon and Rectum,2020
65-69,133.6,148.0,1484,Incidence,1055272,Non-Hispanic Black,140.6,Male and Female,"Corpus and Uterus, NOS",2020
65-69,12.4,15.9,262,Incidence,1865341,Non-Hispanic Black,14.0,Male and Female,Esophagus,2020
65-69,367.3,390.9,3999,Incidence,1055272,Non-Hispanic Black,379.0,Male and Female,Female Breast,2020
65-69,100.8,113.4,1129,Incidence,1055272,Non-Hispanic Black,107.0,Male and Female,"Female Breast, <i>in situ</i>",2020
65-69,1.9,3.5,49,Incidence,1865341,Non-Hispanic Black,2.6,Male and Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,1865341,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
65-69,62.9,70.4,1242,Incidence,1865341,Non-Hispanic Black,66.6,Male and Female,Kidney and Renal Pelvis,2020
65-69,14.5,18.2,303,Incidence,1865341,Non-Hispanic Black,16.2,Male and Female,Larynx,2020
65-69,25.3,30.2,516,Incidence,1865341,Non-Hispanic Black,27.7,Male and Female,Leukemias,2020
65-69,55.1,62.1,1092,Incidence,1865341,Non-Hispanic Black,58.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
65-69,217.0,230.7,4174,Incidence,1865341,Non-Hispanic Black,223.8,Male and Female,Lung and Bronchus,2020
65-69,367.3,390.9,3999,Incidence,1055272,Non-Hispanic Black,379.0,Male and Female,Male and Female Breast,2020
65-69,100.8,113.4,1129,Incidence,1055272,Non-Hispanic Black,107.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
65-69,2.2,3.8,54,Incidence,1865341,Non-Hispanic Black,2.9,Male and Female,Melanomas of the Skin,2020
65-69,0.8,1.9,24,Incidence,1865341,Non-Hispanic Black,1.3,Male and Female,Mesothelioma,2020
65-69,42.3,48.5,845,Incidence,1865341,Non-Hispanic Black,45.3,Male and Female,Myeloma,2020
65-69,33.5,39.0,674,Incidence,1865341,Non-Hispanic Black,36.1,Male and Female,Non-Hodgkin Lymphoma,2020
65-69,24.9,29.7,507,Incidence,1865341,Non-Hispanic Black,27.2,Male and Female,Oral Cavity and Pharynx,2020
65-69,24.1,30.5,287,Incidence,1055272,Non-Hispanic Black,27.2,Male and Female,Ovary,2020
65-69,59.6,66.9,1179,Incidence,1865341,Non-Hispanic Black,63.2,Male and Female,Pancreas,2020
65-69,880.8,922.3,7302,Incidence,810069,Non-Hispanic Black,901.4,Male and Female,Prostate,2020
65-69,27.1,32.1,550,Incidence,1865341,Non-Hispanic Black,29.5,Male and Female,Stomach,2020
65-69,~,~,~,Incidence,810069,Non-Hispanic Black,~,Male and Female,Testis,2020
65-69,12.1,15.5,256,Incidence,1865341,Non-Hispanic Black,13.7,Male and Female,Thyroid,2020
65-69,34.6,40.2,697,Incidence,1865341,Non-Hispanic Black,37.4,Male and Female,Urinary Bladder,2020
70-74,1714.5,1758.8,23698,Incidence,1364697,Non-Hispanic Black,1736.5,Male and Female,All Cancer Sites Combined,2020
70-74,9.8,13.5,157,Incidence,1364697,Non-Hispanic Black,11.5,Male and Female,Brain and Other Nervous System,2020
70-74,9.9,15.0,97,Incidence,790600,Non-Hispanic Black,12.3,Male and Female,Cervix,2020
70-74,128.0,140.4,1830,Incidence,1364697,Non-Hispanic Black,134.1,Male and Female,Colon and Rectum,2020
70-74,120.2,136.1,1012,Incidence,790600,Non-Hispanic Black,128.0,Male and Female,"Corpus and Uterus, NOS",2020
70-74,11.9,15.9,188,Incidence,1364697,Non-Hispanic Black,13.8,Male and Female,Esophagus,2020
70-74,388.1,416.2,3178,Incidence,790600,Non-Hispanic Black,402.0,Male and Female,Female Breast,2020
70-74,108.7,123.9,918,Incidence,790600,Non-Hispanic Black,116.1,Male and Female,"Female Breast, <i>in situ</i>",2020
70-74,1.7,3.5,34,Incidence,1364697,Non-Hispanic Black,2.5,Male and Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,1364697,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
70-74,68.8,78.0,1000,Incidence,1364697,Non-Hispanic Black,73.3,Male and Female,Kidney and Renal Pelvis,2020
70-74,13.3,17.5,209,Incidence,1364697,Non-Hispanic Black,15.3,Male and Female,Larynx,2020
70-74,32.4,38.8,485,Incidence,1364697,Non-Hispanic Black,35.5,Male and Female,Leukemias,2020
70-74,45.5,53.0,671,Incidence,1364697,Non-Hispanic Black,49.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
70-74,256.1,273.4,3612,Incidence,1364697,Non-Hispanic Black,264.7,Male and Female,Lung and Bronchus,2020
70-74,388.1,416.2,3178,Incidence,790600,Non-Hispanic Black,402.0,Male and Female,Male and Female Breast,2020
70-74,108.7,123.9,918,Incidence,790600,Non-Hispanic Black,116.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
70-74,1.7,3.5,34,Incidence,1364697,Non-Hispanic Black,2.5,Male and Female,Melanomas of the Skin,2020
70-74,1.1,2.5,23,Incidence,1364697,Non-Hispanic Black,1.7,Male and Female,Mesothelioma,2020
70-74,55.9,64.2,818,Incidence,1364697,Non-Hispanic Black,59.9,Male and Female,Myeloma,2020
70-74,43.1,50.4,637,Incidence,1364697,Non-Hispanic Black,46.7,Male and Female,Non-Hodgkin Lymphoma,2020
70-74,26.3,32.1,397,Incidence,1364697,Non-Hispanic Black,29.1,Male and Female,Oral Cavity and Pharynx,2020
70-74,23.2,30.5,211,Incidence,790600,Non-Hispanic Black,26.7,Male and Female,Ovary,2020
70-74,74.2,83.7,1076,Incidence,1364697,Non-Hispanic Black,78.8,Male and Female,Pancreas,2020
70-74,784.3,830.9,4635,Incidence,574097,Non-Hispanic Black,807.4,Male and Female,Prostate,2020
70-74,35.9,42.6,534,Incidence,1364697,Non-Hispanic Black,39.1,Male and Female,Stomach,2020
70-74,~,~,~,Incidence,574097,Non-Hispanic Black,~,Male and Female,Testis,2020
70-74,14.7,19.1,229,Incidence,1364697,Non-Hispanic Black,16.8,Male and Female,Thyroid,2020
70-74,48.1,55.8,707,Incidence,1364697,Non-Hispanic Black,51.8,Male and Female,Urinary Bladder,2020
75-79,1772.2,1829.1,15437,Incidence,857368,Non-Hispanic Black,1800.5,Male and Female,All Cancer Sites Combined,2020
75-79,9.8,14.6,103,Incidence,857368,Non-Hispanic Black,12.0,Male and Female,Brain and Other Nervous System,2020
75-79,8.7,14.8,59,Incidence,515696,Non-Hispanic Black,11.4,Male and Female,Cervix,2020
75-79,146.7,163.5,1328,Incidence,857368,Non-Hispanic Black,154.9,Male and Female,Colon and Rectum,2020
75-79,97.4,115.3,547,Incidence,515696,Non-Hispanic Black,106.1,Male and Female,"Corpus and Uterus, NOS",2020
75-79,14.0,19.5,142,Incidence,857368,Non-Hispanic Black,16.6,Male and Female,Esophagus,2020
75-79,375.8,410.2,2025,Incidence,515696,Non-Hispanic Black,392.7,Male and Female,Female Breast,2020
75-79,79.2,95.5,449,Incidence,515696,Non-Hispanic Black,87.1,Male and Female,"Female Breast, <i>in situ</i>",2020
75-79,1.7,4.0,23,Incidence,857368,Non-Hispanic Black,2.7,Male and Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,857368,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
75-79,61.4,72.4,572,Incidence,857368,Non-Hispanic Black,66.7,Male and Female,Kidney and Renal Pelvis,2020
75-79,12.5,17.8,128,Incidence,857368,Non-Hispanic Black,14.9,Male and Female,Larynx,2020
75-79,39.1,48.0,372,Incidence,857368,Non-Hispanic Black,43.4,Male and Female,Leukemias,2020
75-79,26.3,33.7,256,Incidence,857368,Non-Hispanic Black,29.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
75-79,307.4,331.4,2737,Incidence,857368,Non-Hispanic Black,319.2,Male and Female,Lung and Bronchus,2020
75-79,375.8,410.2,2025,Incidence,515696,Non-Hispanic Black,392.7,Male and Female,Male and Female Breast,2020
75-79,79.2,95.5,449,Incidence,515696,Non-Hispanic Black,87.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
75-79,3.3,6.4,40,Incidence,857368,Non-Hispanic Black,4.7,Male and Female,Melanomas of the Skin,2020
75-79,1.8,4.2,24,Incidence,857368,Non-Hispanic Black,2.8,Male and Female,Mesothelioma,2020
75-79,68.2,79.8,633,Incidence,857368,Non-Hispanic Black,73.8,Male and Female,Myeloma,2020
75-79,48.0,57.8,452,Incidence,857368,Non-Hispanic Black,52.7,Male and Female,Non-Hodgkin Lymphoma,2020
75-79,22.3,29.2,219,Incidence,857368,Non-Hispanic Black,25.5,Male and Female,Oral Cavity and Pharynx,2020
75-79,27.1,37.1,164,Incidence,515696,Non-Hispanic Black,31.8,Male and Female,Ovary,2020
75-79,78.9,91.3,728,Incidence,857368,Non-Hispanic Black,84.9,Male and Female,Pancreas,2020
75-79,653.7,709.3,2327,Incidence,341672,Non-Hispanic Black,681.1,Male and Female,Prostate,2020
75-79,44.9,54.4,424,Incidence,857368,Non-Hispanic Black,49.5,Male and Female,Stomach,2020
75-79,~,~,~,Incidence,341672,Non-Hispanic Black,~,Male and Female,Testis,2020
75-79,8.3,12.8,89,Incidence,857368,Non-Hispanic Black,10.4,Male and Female,Thyroid,2020
75-79,67.4,79.0,626,Incidence,857368,Non-Hispanic Black,73.0,Male and Female,Urinary Bladder,2020
80-84,1679.0,1748.5,9399,Incidence,548540,Non-Hispanic Black,1713.5,Male and Female,All Cancer Sites Combined,2020
80-84,7.7,13.3,56,Incidence,548540,Non-Hispanic Black,10.2,Male and Female,Brain and Other Nervous System,2020
80-84,7.5,14.8,37,Incidence,345135,Non-Hispanic Black,10.7,Male and Female,Cervix,2020
80-84,160.9,183.1,942,Incidence,548540,Non-Hispanic Black,171.7,Male and Female,Colon and Rectum,2020
80-84,65.4,83.8,256,Incidence,345135,Non-Hispanic Black,74.2,Male and Female,"Corpus and Uterus, NOS",2020
80-84,13.0,20.0,89,Incidence,548540,Non-Hispanic Black,16.2,Male and Female,Esophagus,2020
80-84,330.5,370.3,1208,Incidence,345135,Non-Hispanic Black,350.0,Male and Female,Female Breast,2020
80-84,53.2,70.0,211,Incidence,345135,Non-Hispanic Black,61.1,Male and Female,"Female Breast, <i>in situ</i>",2020
80-84,~,~,~,Incidence,548540,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,548540,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
80-84,47.5,59.9,293,Incidence,548540,Non-Hispanic Black,53.4,Male and Female,Kidney and Renal Pelvis,2020
80-84,11.6,18.2,80,Incidence,548540,Non-Hispanic Black,14.6,Male and Female,Larynx,2020
80-84,45.2,57.4,280,Incidence,548540,Non-Hispanic Black,51.0,Male and Female,Leukemias,2020
80-84,26.2,35.6,168,Incidence,548540,Non-Hispanic Black,30.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
80-84,274.5,303.2,1583,Incidence,548540,Non-Hispanic Black,288.6,Male and Female,Lung and Bronchus,2020
80-84,330.5,370.3,1208,Incidence,345135,Non-Hispanic Black,350.0,Male and Female,Male and Female Breast,2020
80-84,53.2,70.0,211,Incidence,345135,Non-Hispanic Black,61.1,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
80-84,3.2,7.2,27,Incidence,548540,Non-Hispanic Black,4.9,Male and Female,Melanomas of the Skin,2020
80-84,~,~,~,Incidence,548540,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
80-84,72.7,87.9,439,Incidence,548540,Non-Hispanic Black,80.0,Male and Female,Myeloma,2020
80-84,47.0,59.3,290,Incidence,548540,Non-Hispanic Black,52.9,Male and Female,Non-Hodgkin Lymphoma,2020
80-84,20.3,28.7,133,Incidence,548540,Non-Hispanic Black,24.2,Male and Female,Oral Cavity and Pharynx,2020
80-84,26.5,38.7,111,Incidence,345135,Non-Hispanic Black,32.2,Male and Female,Ovary,2020
80-84,85.3,101.6,511,Incidence,548540,Non-Hispanic Black,93.2,Male and Female,Pancreas,2020
80-84,478.8,541.3,1036,Incidence,203405,Non-Hispanic Black,509.3,Male and Female,Prostate,2020
80-84,48.7,61.2,300,Incidence,548540,Non-Hispanic Black,54.7,Male and Female,Stomach,2020
80-84,~,~,~,Incidence,203405,Non-Hispanic Black,~,Male and Female,Testis,2020
80-84,8.0,13.7,58,Incidence,548540,Non-Hispanic Black,10.6,Male and Female,Thyroid,2020
80-84,71.7,86.7,433,Incidence,548540,Non-Hispanic Black,78.9,Male and Female,Urinary Bladder,2020
85+,1493.5,1560.7,7978,Incidence,522510,Non-Hispanic Black,1526.9,Male and Female,All Cancer Sites Combined,2020
85+,5.1,10.0,38,Incidence,522510,Non-Hispanic Black,7.3,Male and Female,Brain and Other Nervous System,2020
85+,12.4,21.0,59,Incidence,362317,Non-Hispanic Black,16.3,Male and Female,Cervix,2020
85+,171.0,194.3,953,Incidence,522510,Non-Hispanic Black,182.4,Male and Female,Colon and Rectum,2020
85+,48.3,64.0,202,Incidence,362317,Non-Hispanic Black,55.8,Male and Female,"Corpus and Uterus, NOS",2020
85+,10.4,16.9,70,Incidence,522510,Non-Hispanic Black,13.4,Male and Female,Esophagus,2020
85+,258.6,293.1,998,Incidence,362317,Non-Hispanic Black,275.4,Male and Female,Female Breast,2020
85+,25.7,37.5,113,Incidence,362317,Non-Hispanic Black,31.2,Male and Female,"Female Breast, <i>in situ</i>",2020
85+,~,~,~,Incidence,522510,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,522510,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
85+,38.5,50.1,230,Incidence,522510,Non-Hispanic Black,44.0,Male and Female,Kidney and Renal Pelvis,2020
85+,10.1,16.5,68,Incidence,522510,Non-Hispanic Black,13.0,Male and Female,Larynx,2020
85+,43.2,55.4,256,Incidence,522510,Non-Hispanic Black,49.0,Male and Female,Leukemias,2020
85+,17.0,25.0,108,Incidence,522510,Non-Hispanic Black,20.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
85+,200.9,226.1,1114,Incidence,522510,Non-Hispanic Black,213.2,Male and Female,Lung and Bronchus,2020
85+,258.6,293.1,998,Incidence,362317,Non-Hispanic Black,275.4,Male and Female,Male and Female Breast,2020
85+,25.7,37.5,113,Incidence,362317,Non-Hispanic Black,31.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
85+,4.7,9.3,35,Incidence,522510,Non-Hispanic Black,6.7,Male and Female,Melanomas of the Skin,2020
85+,1.8,5.0,16,Incidence,522510,Non-Hispanic Black,3.1,Male and Female,Mesothelioma,2020
85+,54.0,67.5,316,Incidence,522510,Non-Hispanic Black,60.5,Male and Female,Myeloma,2020
85+,39.6,51.3,236,Incidence,522510,Non-Hispanic Black,45.2,Male and Female,Non-Hodgkin Lymphoma,2020
85+,14.5,22.0,94,Incidence,522510,Non-Hispanic Black,18.0,Male and Female,Oral Cavity and Pharynx,2020
85+,16.8,26.6,77,Incidence,362317,Non-Hispanic Black,21.3,Male and Female,Ovary,2020
85+,91.7,109.1,523,Incidence,522510,Non-Hispanic Black,100.1,Male and Female,Pancreas,2020
85+,400.4,465.4,692,Incidence,160193,Non-Hispanic Black,432.0,Male and Female,Prostate,2020
85+,50.0,63.1,294,Incidence,522510,Non-Hispanic Black,56.3,Male and Female,Stomach,2020
85+,~,~,~,Incidence,160193,Non-Hispanic Black,~,Male and Female,Testis,2020
85+,6.0,11.1,43,Incidence,522510,Non-Hispanic Black,8.2,Male and Female,Thyroid,2020
85+,78.7,94.9,452,Incidence,522510,Non-Hispanic Black,86.5,Male and Female,Urinary Bladder,2020
<1,17.7,25.4,122,Incidence,573488,Non-Hispanic Black,21.3,Male and Female,All Cancer Sites Combined,2020
<1,2.0,5.2,19,Incidence,573488,Non-Hispanic Black,3.3,Male and Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,Cervix,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Colon and Rectum,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Esophagus,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,Female Breast,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Larynx,2020
<1,1.7,4.7,17,Incidence,573488,Non-Hispanic Black,3.0,Male and Female,Leukemias,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,Male and Female Breast,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Mesothelioma,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Myeloma,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,281093,Non-Hispanic Black,~,Male and Female,Ovary,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Pancreas,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male and Female,Prostate,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Stomach,2020
<1,~,~,~,Incidence,292395,Non-Hispanic Black,~,Male and Female,Testis,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Thyroid,2020
<1,~,~,~,Incidence,573488,Non-Hispanic Black,~,Male and Female,Urinary Bladder,2020
1-4,19.3,22.3,770,Incidence,3708386,Non-Hispanic White,20.8,Female,All Cancer Sites Combined,2020
1-4,3.0,4.2,132,Incidence,3708386,Non-Hispanic White,3.6,Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Cervix,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Esophagus,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Female Breast,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
1-4,1.7,2.6,78,Incidence,3708386,Non-Hispanic White,2.1,Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Larynx,2020
1-4,7.4,9.3,309,Incidence,3708386,Non-Hispanic White,8.3,Female,Leukemias,2020
1-4,0.2,0.7,16,Incidence,3708386,Non-Hispanic White,0.4,Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Mesothelioma,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Myeloma,2020
1-4,0.3,0.8,19,Incidence,3708386,Non-Hispanic White,0.5,Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Ovary,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Pancreas,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Stomach,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Thyroid,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Female,Urinary Bladder,2020
10-14,12.8,14.9,699,Incidence,5047995,Non-Hispanic White,13.8,Female,All Cancer Sites Combined,2020
10-14,2.6,3.6,155,Incidence,5047995,Non-Hispanic White,3.1,Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Cervix,2020
10-14,0.7,1.2,47,Incidence,5047995,Non-Hispanic White,0.9,Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Esophagus,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Female Breast,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2020
10-14,0.8,1.4,56,Incidence,5047995,Non-Hispanic White,1.1,Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Larynx,2020
10-14,1.7,2.6,107,Incidence,5047995,Non-Hispanic White,2.1,Female,Leukemias,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Mesothelioma,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Myeloma,2020
10-14,0.7,1.2,46,Incidence,5047995,Non-Hispanic White,0.9,Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2020
10-14,0.4,0.8,28,Incidence,5047995,Non-Hispanic White,0.6,Female,Ovary,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Pancreas,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Stomach,2020
10-14,1.0,1.6,63,Incidence,5047995,Non-Hispanic White,1.2,Female,Thyroid,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Female,Urinary Bladder,2020
15-19,22.3,25.0,1248,Incidence,5281438,Non-Hispanic White,23.6,Female,All Cancer Sites Combined,2020
15-19,2.2,3.0,136,Incidence,5281438,Non-Hispanic White,2.6,Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Cervix,2020
15-19,1.6,2.4,105,Incidence,5281438,Non-Hispanic White,2.0,Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Esophagus,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Female Breast,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2020
15-19,2.9,3.9,179,Incidence,5281438,Non-Hispanic White,3.4,Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
15-19,0.2,0.5,16,Incidence,5281438,Non-Hispanic White,0.3,Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Larynx,2020
15-19,1.7,2.5,109,Incidence,5281438,Non-Hispanic White,2.1,Female,Leukemias,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Lung and Bronchus,2020
15-19,1.0,1.7,71,Incidence,5281438,Non-Hispanic White,1.3,Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Mesothelioma,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Myeloma,2020
15-19,0.9,1.5,60,Incidence,5281438,Non-Hispanic White,1.1,Female,Non-Hodgkin Lymphoma,2020
15-19,0.3,0.6,22,Incidence,5281438,Non-Hispanic White,0.4,Female,Oral Cavity and Pharynx,2020
15-19,0.8,1.4,56,Incidence,5281438,Non-Hispanic White,1.1,Female,Ovary,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Pancreas,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Stomach,2020
15-19,4.5,5.7,267,Incidence,5281438,Non-Hispanic White,5.1,Female,Thyroid,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Female,Urinary Bladder,2020
20-24,38.8,42.2,2239,Incidence,5534774,Non-Hispanic White,40.5,Female,All Cancer Sites Combined,2020
20-24,1.6,2.4,109,Incidence,5534774,Non-Hispanic White,2.0,Female,Brain and Other Nervous System,2020
20-24,0.2,0.6,21,Incidence,5534774,Non-Hispanic White,0.4,Female,Cervix,2020
20-24,2.2,3.1,145,Incidence,5534774,Non-Hispanic White,2.6,Female,Colon and Rectum,2020
20-24,0.2,0.6,21,Incidence,5534774,Non-Hispanic White,0.4,Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Esophagus,2020
20-24,1.2,1.9,84,Incidence,5534774,Non-Hispanic White,1.5,Female,Female Breast,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2020
20-24,4.4,5.6,276,Incidence,5534774,Non-Hispanic White,5.0,Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
20-24,0.4,0.8,29,Incidence,5534774,Non-Hispanic White,0.5,Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Larynx,2020
20-24,1.9,2.7,126,Incidence,5534774,Non-Hispanic White,2.3,Female,Leukemias,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Lung and Bronchus,2020
20-24,4.0,5.1,250,Incidence,5534774,Non-Hispanic White,4.5,Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Mesothelioma,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Myeloma,2020
20-24,1.7,2.5,113,Incidence,5534774,Non-Hispanic White,2.0,Female,Non-Hodgkin Lymphoma,2020
20-24,0.4,0.8,32,Incidence,5534774,Non-Hispanic White,0.6,Female,Oral Cavity and Pharynx,2020
20-24,1.5,2.2,101,Incidence,5534774,Non-Hispanic White,1.8,Female,Ovary,2020
20-24,0.2,0.5,17,Incidence,5534774,Non-Hispanic White,0.3,Female,Pancreas,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Stomach,2020
20-24,10.4,12.2,624,Incidence,5534774,Non-Hispanic White,11.3,Female,Thyroid,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Female,Urinary Bladder,2020
25-29,66.7,70.9,4109,Incidence,5976247,Non-Hispanic White,68.8,Female,All Cancer Sites Combined,2020
25-29,2.2,3.1,157,Incidence,5976247,Non-Hispanic White,2.6,Female,Brain and Other Nervous System,2020
25-29,2.8,3.7,194,Incidence,5976247,Non-Hispanic White,3.2,Female,Cervix,2020
25-29,3.1,4.1,216,Incidence,5976247,Non-Hispanic White,3.6,Female,Colon and Rectum,2020
25-29,1.2,1.9,92,Incidence,5976247,Non-Hispanic White,1.5,Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,5976247,Non-Hispanic White,~,Female,Esophagus,2020
25-29,9.1,10.7,590,Incidence,5976247,Non-Hispanic White,9.9,Female,Female Breast,2020
25-29,0.7,1.2,55,Incidence,5976247,Non-Hispanic White,0.9,Female,"Female Breast, <i>in situ</i>",2020
25-29,3.9,4.9,261,Incidence,5976247,Non-Hispanic White,4.4,Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,5976247,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
25-29,1.0,1.6,75,Incidence,5976247,Non-Hispanic White,1.3,Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,5976247,Non-Hispanic White,~,Female,Larynx,2020
25-29,1.8,2.6,129,Incidence,5976247,Non-Hispanic White,2.2,Female,Leukemias,2020
25-29,0.2,0.5,19,Incidence,5976247,Non-Hispanic White,0.3,Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.4,0.8,33,Incidence,5976247,Non-Hispanic White,0.6,Female,Lung and Bronchus,2020
25-29,8.4,9.9,545,Incidence,5976247,Non-Hispanic White,9.1,Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,5976247,Non-Hispanic White,~,Female,Mesothelioma,2020
25-29,~,~,~,Incidence,5976247,Non-Hispanic White,~,Female,Myeloma,2020
25-29,2.1,2.9,150,Incidence,5976247,Non-Hispanic White,2.5,Female,Non-Hodgkin Lymphoma,2020
25-29,0.9,1.4,66,Incidence,5976247,Non-Hispanic White,1.1,Female,Oral Cavity and Pharynx,2020
25-29,1.8,2.5,128,Incidence,5976247,Non-Hispanic White,2.1,Female,Ovary,2020
25-29,0.3,0.6,25,Incidence,5976247,Non-Hispanic White,0.4,Female,Pancreas,2020
25-29,~,~,~,Incidence,5976247,Non-Hispanic White,~,Female,Stomach,2020
25-29,16.7,18.8,1060,Incidence,5976247,Non-Hispanic White,17.7,Female,Thyroid,2020
25-29,0.2,0.4,16,Incidence,5976247,Non-Hispanic White,0.3,Female,Urinary Bladder,2020
30-34,124.0,129.7,7744,Incidence,6104776,Non-Hispanic White,126.9,Female,All Cancer Sites Combined,2020
30-34,2.7,3.6,189,Incidence,6104776,Non-Hispanic White,3.1,Female,Brain and Other Nervous System,2020
30-34,9.7,11.4,643,Incidence,6104776,Non-Hispanic White,10.5,Female,Cervix,2020
30-34,6.0,7.3,405,Incidence,6104776,Non-Hispanic White,6.6,Female,Colon and Rectum,2020
30-34,4.5,5.7,309,Incidence,6104776,Non-Hispanic White,5.1,Female,"Corpus and Uterus, NOS",2020
30-34,~,~,~,Incidence,6104776,Non-Hispanic White,~,Female,Esophagus,2020
30-34,29.3,32.1,1870,Incidence,6104776,Non-Hispanic White,30.6,Female,Female Breast,2020
30-34,2.7,3.6,193,Incidence,6104776,Non-Hispanic White,3.2,Female,"Female Breast, <i>in situ</i>",2020
30-34,3.5,4.5,243,Incidence,6104776,Non-Hispanic White,4.0,Female,Hodgkin Lymphoma,2020
30-34,~,~,~,Incidence,6104776,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
30-34,2.5,3.4,181,Incidence,6104776,Non-Hispanic White,3.0,Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,6104776,Non-Hispanic White,~,Female,Larynx,2020
30-34,2.4,3.3,172,Incidence,6104776,Non-Hispanic White,2.8,Female,Leukemias,2020
30-34,0.4,0.8,33,Incidence,6104776,Non-Hispanic White,0.5,Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.6,1.1,51,Incidence,6104776,Non-Hispanic White,0.8,Female,Lung and Bronchus,2020
30-34,15.0,17.0,977,Incidence,6104776,Non-Hispanic White,16.0,Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,6104776,Non-Hispanic White,~,Female,Mesothelioma,2020
30-34,0.2,0.5,18,Incidence,6104776,Non-Hispanic White,0.3,Female,Myeloma,2020
30-34,2.8,3.7,198,Incidence,6104776,Non-Hispanic White,3.2,Female,Non-Hodgkin Lymphoma,2020
30-34,1.5,2.2,114,Incidence,6104776,Non-Hispanic White,1.9,Female,Oral Cavity and Pharynx,2020
30-34,3.1,4.1,220,Incidence,6104776,Non-Hispanic White,3.6,Female,Ovary,2020
30-34,0.5,0.9,39,Incidence,6104776,Non-Hispanic White,0.6,Female,Pancreas,2020
30-34,0.5,0.9,43,Incidence,6104776,Non-Hispanic White,0.7,Female,Stomach,2020
30-34,23.4,25.9,1505,Incidence,6104776,Non-Hispanic White,24.7,Female,Thyroid,2020
30-34,0.3,0.6,24,Incidence,6104776,Non-Hispanic White,0.4,Female,Urinary Bladder,2020
35-39,194.3,201.4,11805,Incidence,5967417,Non-Hispanic White,197.8,Female,All Cancer Sites Combined,2020
35-39,3.4,4.5,234,Incidence,5967417,Non-Hispanic White,3.9,Female,Brain and Other Nervous System,2020
35-39,12.0,13.8,770,Incidence,5967417,Non-Hispanic White,12.9,Female,Cervix,2020
35-39,11.5,13.3,741,Incidence,5967417,Non-Hispanic White,12.4,Female,Colon and Rectum,2020
35-39,8.8,10.4,572,Incidence,5967417,Non-Hispanic White,9.6,Female,"Corpus and Uterus, NOS",2020
35-39,~,~,~,Incidence,5967417,Non-Hispanic White,~,Female,Esophagus,2020
35-39,63.8,67.9,3927,Incidence,5967417,Non-Hispanic White,65.8,Female,Female Breast,2020
35-39,8.0,9.5,520,Incidence,5967417,Non-Hispanic White,8.7,Female,"Female Breast, <i>in situ</i>",2020
35-39,2.5,3.4,174,Incidence,5967417,Non-Hispanic White,2.9,Female,Hodgkin Lymphoma,2020
35-39,~,~,~,Incidence,5967417,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
35-39,4.7,5.9,317,Incidence,5967417,Non-Hispanic White,5.3,Female,Kidney and Renal Pelvis,2020
35-39,0.2,0.5,17,Incidence,5967417,Non-Hispanic White,0.3,Female,Larynx,2020
35-39,3.6,4.7,245,Incidence,5967417,Non-Hispanic White,4.1,Female,Leukemias,2020
35-39,0.6,1.0,46,Incidence,5967417,Non-Hispanic White,0.8,Female,Liver and Intrahepatic Bile Duct,2020
35-39,2.3,3.1,161,Incidence,5967417,Non-Hispanic White,2.7,Female,Lung and Bronchus,2020
35-39,19.6,22.0,1240,Incidence,5967417,Non-Hispanic White,20.8,Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,5967417,Non-Hispanic White,~,Female,Mesothelioma,2020
35-39,0.4,0.8,36,Incidence,5967417,Non-Hispanic White,0.6,Female,Myeloma,2020
35-39,4.6,5.8,309,Incidence,5967417,Non-Hispanic White,5.2,Female,Non-Hodgkin Lymphoma,2020
35-39,2.2,3.0,153,Incidence,5967417,Non-Hispanic White,2.6,Female,Oral Cavity and Pharynx,2020
35-39,4.5,5.6,299,Incidence,5967417,Non-Hispanic White,5.0,Female,Ovary,2020
35-39,1.2,1.8,86,Incidence,5967417,Non-Hispanic White,1.4,Female,Pancreas,2020
35-39,0.8,1.3,59,Incidence,5967417,Non-Hispanic White,1.0,Female,Stomach,2020
35-39,26.2,28.8,1640,Incidence,5967417,Non-Hispanic White,27.5,Female,Thyroid,2020
35-39,0.5,0.9,41,Incidence,5967417,Non-Hispanic White,0.7,Female,Urinary Bladder,2020
40-44,305.4,314.7,17289,Incidence,5576675,Non-Hispanic White,310.0,Female,All Cancer Sites Combined,2020
40-44,3.5,4.6,224,Incidence,5576675,Non-Hispanic White,4.0,Female,Brain and Other Nervous System,2020
40-44,12.9,14.9,775,Incidence,5576675,Non-Hispanic White,13.9,Female,Cervix,2020
40-44,18.2,20.5,1077,Incidence,5576675,Non-Hispanic White,19.3,Female,Colon and Rectum,2020
40-44,13.9,16.0,832,Incidence,5576675,Non-Hispanic White,14.9,Female,"Corpus and Uterus, NOS",2020
40-44,0.4,0.8,30,Incidence,5576675,Non-Hispanic White,0.5,Female,Esophagus,2020
40-44,128.4,134.4,7328,Incidence,5576675,Non-Hispanic White,131.4,Female,Female Breast,2020
40-44,37.3,40.5,2168,Incidence,5576675,Non-Hispanic White,38.9,Female,"Female Breast, <i>in situ</i>",2020
40-44,1.9,2.7,127,Incidence,5576675,Non-Hispanic White,2.3,Female,Hodgkin Lymphoma,2020
40-44,~,~,~,Incidence,5576675,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
40-44,7.6,9.1,465,Incidence,5576675,Non-Hispanic White,8.3,Female,Kidney and Renal Pelvis,2020
40-44,0.3,0.7,25,Incidence,5576675,Non-Hispanic White,0.4,Female,Larynx,2020
40-44,4.6,5.8,288,Incidence,5576675,Non-Hispanic White,5.2,Female,Leukemias,2020
40-44,1.0,1.6,73,Incidence,5576675,Non-Hispanic White,1.3,Female,Liver and Intrahepatic Bile Duct,2020
40-44,5.1,6.4,318,Incidence,5576675,Non-Hispanic White,5.7,Female,Lung and Bronchus,2020
40-44,26.2,29.0,1536,Incidence,5576675,Non-Hispanic White,27.5,Female,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,5576675,Non-Hispanic White,~,Female,Mesothelioma,2020
40-44,1.2,1.9,87,Incidence,5576675,Non-Hispanic White,1.6,Female,Myeloma,2020
40-44,6.5,8.0,403,Incidence,5576675,Non-Hispanic White,7.2,Female,Non-Hodgkin Lymphoma,2020
40-44,3.1,4.2,202,Incidence,5576675,Non-Hispanic White,3.6,Female,Oral Cavity and Pharynx,2020
40-44,7.1,8.6,437,Incidence,5576675,Non-Hispanic White,7.8,Female,Ovary,2020
40-44,2.4,3.3,156,Incidence,5576675,Non-Hispanic White,2.8,Female,Pancreas,2020
40-44,1.6,2.4,109,Incidence,5576675,Non-Hispanic White,2.0,Female,Stomach,2020
40-44,28.4,31.2,1660,Incidence,5576675,Non-Hispanic White,29.8,Female,Thyroid,2020
40-44,1.5,2.3,105,Incidence,5576675,Non-Hispanic White,1.9,Female,Urinary Bladder,2020
45-49,446.4,457.4,25709,Incidence,5689420,Non-Hispanic White,451.9,Female,All Cancer Sites Combined,2020
45-49,4.2,5.4,271,Incidence,5689420,Non-Hispanic White,4.8,Female,Brain and Other Nervous System,2020
45-49,11.9,13.8,730,Incidence,5689420,Non-Hispanic White,12.8,Female,Cervix,2020
45-49,30.4,33.3,1810,Incidence,5689420,Non-Hispanic White,31.8,Female,Colon and Rectum,2020
45-49,23.3,25.9,1399,Incidence,5689420,Non-Hispanic White,24.6,Female,"Corpus and Uterus, NOS",2020
45-49,0.7,1.3,55,Incidence,5689420,Non-Hispanic White,1.0,Female,Esophagus,2020
45-49,202.0,209.5,11706,Incidence,5689420,Non-Hispanic White,205.8,Female,Female Breast,2020
45-49,53.9,57.8,3176,Incidence,5689420,Non-Hispanic White,55.8,Female,"Female Breast, <i>in situ</i>",2020
45-49,1.5,2.2,103,Incidence,5689420,Non-Hispanic White,1.8,Female,Hodgkin Lymphoma,2020
45-49,~,~,~,Incidence,5689420,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
45-49,11.2,13.1,690,Incidence,5689420,Non-Hispanic White,12.1,Female,Kidney and Renal Pelvis,2020
45-49,0.9,1.5,66,Incidence,5689420,Non-Hispanic White,1.2,Female,Larynx,2020
45-49,6.8,8.2,424,Incidence,5689420,Non-Hispanic White,7.5,Female,Leukemias,2020
45-49,1.2,1.9,86,Incidence,5689420,Non-Hispanic White,1.5,Female,Liver and Intrahepatic Bile Duct,2020
45-49,16.8,19.0,1019,Incidence,5689420,Non-Hispanic White,17.9,Female,Lung and Bronchus,2020
45-49,30.2,33.1,1800,Incidence,5689420,Non-Hispanic White,31.6,Female,Melanomas of the Skin,2020
45-49,0.2,0.5,19,Incidence,5689420,Non-Hispanic White,0.3,Female,Mesothelioma,2020
45-49,2.4,3.3,160,Incidence,5689420,Non-Hispanic White,2.8,Female,Myeloma,2020
45-49,9.5,11.2,585,Incidence,5689420,Non-Hispanic White,10.3,Female,Non-Hodgkin Lymphoma,2020
45-49,5.2,6.4,328,Incidence,5689420,Non-Hispanic White,5.8,Female,Oral Cavity and Pharynx,2020
45-49,10.3,12.1,637,Incidence,5689420,Non-Hispanic White,11.2,Female,Ovary,2020
45-49,5.2,6.5,333,Incidence,5689420,Non-Hispanic White,5.9,Female,Pancreas,2020
45-49,2.5,3.4,164,Incidence,5689420,Non-Hispanic White,2.9,Female,Stomach,2020
45-49,27.0,29.8,1616,Incidence,5689420,Non-Hispanic White,28.4,Female,Thyroid,2020
45-49,2.7,3.7,180,Incidence,5689420,Non-Hispanic White,3.2,Female,Urinary Bladder,2020
5-9,10.0,11.9,533,Incidence,4876090,Non-Hispanic White,10.9,Female,All Cancer Sites Combined,2020
5-9,2.8,3.9,163,Incidence,4876090,Non-Hispanic White,3.3,Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Cervix,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Esophagus,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Female Breast,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
5-9,0.5,1.0,33,Incidence,4876090,Non-Hispanic White,0.7,Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Larynx,2020
5-9,3.2,4.2,179,Incidence,4876090,Non-Hispanic White,3.7,Female,Leukemias,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Mesothelioma,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Myeloma,2020
5-9,0.4,0.8,28,Incidence,4876090,Non-Hispanic White,0.6,Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Ovary,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Pancreas,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Stomach,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Thyroid,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Female,Urinary Bladder,2020
50-54,589.4,601.5,37303,Incidence,6264647,Non-Hispanic White,595.5,Female,All Cancer Sites Combined,2020
50-54,6.3,7.6,432,Incidence,6264647,Non-Hispanic White,6.9,Female,Brain and Other Nervous System,2020
50-54,9.5,11.2,647,Incidence,6264647,Non-Hispanic White,10.3,Female,Cervix,2020
50-54,48.6,52.1,3152,Incidence,6264647,Non-Hispanic White,50.3,Female,Colon and Rectum,2020
50-54,42.6,45.9,2771,Incidence,6264647,Non-Hispanic White,44.2,Female,"Corpus and Uterus, NOS",2020
50-54,1.5,2.2,116,Incidence,6264647,Non-Hispanic White,1.9,Female,Esophagus,2020
50-54,227.2,234.7,14468,Incidence,6264647,Non-Hispanic White,230.9,Female,Female Breast,2020
50-54,60.6,64.5,3919,Incidence,6264647,Non-Hispanic White,62.6,Female,"Female Breast, <i>in situ</i>",2020
50-54,1.4,2.0,104,Incidence,6264647,Non-Hispanic White,1.7,Female,Hodgkin Lymphoma,2020
50-54,~,~,~,Incidence,6264647,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
50-54,15.8,17.9,1054,Incidence,6264647,Non-Hispanic White,16.8,Female,Kidney and Renal Pelvis,2020
50-54,1.7,2.5,130,Incidence,6264647,Non-Hispanic White,2.1,Female,Larynx,2020
50-54,10.0,11.7,678,Incidence,6264647,Non-Hispanic White,10.8,Female,Leukemias,2020
50-54,3.3,4.3,236,Incidence,6264647,Non-Hispanic White,3.8,Female,Liver and Intrahepatic Bile Duct,2020
50-54,39.2,42.3,2552,Incidence,6264647,Non-Hispanic White,40.7,Female,Lung and Bronchus,2020
50-54,34.7,37.7,2267,Incidence,6264647,Non-Hispanic White,36.2,Female,Melanomas of the Skin,2020
50-54,0.3,0.6,27,Incidence,6264647,Non-Hispanic White,0.4,Female,Mesothelioma,2020
50-54,4.7,5.8,326,Incidence,6264647,Non-Hispanic White,5.2,Female,Myeloma,2020
50-54,15.7,17.8,1047,Incidence,6264647,Non-Hispanic White,16.7,Female,Non-Hodgkin Lymphoma,2020
50-54,9.9,11.5,669,Incidence,6264647,Non-Hispanic White,10.7,Female,Oral Cavity and Pharynx,2020
50-54,15.3,17.3,1019,Incidence,6264647,Non-Hispanic White,16.3,Female,Ovary,2020
50-54,9.3,10.9,630,Incidence,6264647,Non-Hispanic White,10.1,Female,Pancreas,2020
50-54,3.5,4.5,250,Incidence,6264647,Non-Hispanic White,4.0,Female,Stomach,2020
50-54,27.1,29.8,1781,Incidence,6264647,Non-Hispanic White,28.4,Female,Thyroid,2020
50-54,6.1,7.4,423,Incidence,6264647,Non-Hispanic White,6.8,Female,Urinary Bladder,2020
55-59,761.4,774.3,55150,Incidence,7182650,Non-Hispanic White,767.8,Female,All Cancer Sites Combined,2020
55-59,8.0,9.4,623,Incidence,7182650,Non-Hispanic White,8.7,Female,Brain and Other Nervous System,2020
55-59,9.1,10.5,703,Incidence,7182650,Non-Hispanic White,9.8,Female,Cervix,2020
55-59,46.0,49.2,3417,Incidence,7182650,Non-Hispanic White,47.6,Female,Colon and Rectum,2020
55-59,71.6,75.6,5283,Incidence,7182650,Non-Hispanic White,73.6,Female,"Corpus and Uterus, NOS",2020
55-59,3.0,3.9,248,Incidence,7182650,Non-Hispanic White,3.5,Female,Esophagus,2020
55-59,257.8,265.3,18787,Incidence,7182650,Non-Hispanic White,261.6,Female,Female Breast,2020
55-59,60.4,64.1,4468,Incidence,7182650,Non-Hispanic White,62.2,Female,"Female Breast, <i>in situ</i>",2020
55-59,1.6,2.2,134,Incidence,7182650,Non-Hispanic White,1.9,Female,Hodgkin Lymphoma,2020
55-59,~,~,~,Incidence,7182650,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
55-59,20.6,22.8,1558,Incidence,7182650,Non-Hispanic White,21.7,Female,Kidney and Renal Pelvis,2020
55-59,3.6,4.5,290,Incidence,7182650,Non-Hispanic White,4.0,Female,Larynx,2020
55-59,13.3,15.1,1018,Incidence,7182650,Non-Hispanic White,14.2,Female,Leukemias,2020
55-59,6.7,8.0,525,Incidence,7182650,Non-Hispanic White,7.3,Female,Liver and Intrahepatic Bile Duct,2020
55-59,89.8,94.2,6608,Incidence,7182650,Non-Hispanic White,92.0,Female,Lung and Bronchus,2020
55-59,38.7,41.6,2884,Incidence,7182650,Non-Hispanic White,40.2,Female,Melanomas of the Skin,2020
55-59,0.4,0.7,36,Incidence,7182650,Non-Hispanic White,0.5,Female,Mesothelioma,2020
55-59,7.0,8.3,550,Incidence,7182650,Non-Hispanic White,7.7,Female,Myeloma,2020
55-59,22.5,24.7,1695,Incidence,7182650,Non-Hispanic White,23.6,Female,Non-Hodgkin Lymphoma,2020
55-59,15.0,16.8,1141,Incidence,7182650,Non-Hispanic White,15.9,Female,Oral Cavity and Pharynx,2020
55-59,18.6,20.7,1412,Incidence,7182650,Non-Hispanic White,19.7,Female,Ovary,2020
55-59,16.4,18.4,1248,Incidence,7182650,Non-Hispanic White,17.4,Female,Pancreas,2020
55-59,4.7,5.7,373,Incidence,7182650,Non-Hispanic White,5.2,Female,Stomach,2020
55-59,24.7,27.0,1855,Incidence,7182650,Non-Hispanic White,25.8,Female,Thyroid,2020
55-59,11.1,12.7,851,Incidence,7182650,Non-Hispanic White,11.8,Female,Urinary Bladder,2020
60-64,995.8,1010.3,73575,Incidence,7335341,Non-Hispanic White,1003.0,Female,All Cancer Sites Combined,2020
60-64,10.7,12.3,844,Incidence,7335341,Non-Hispanic White,11.5,Female,Brain and Other Nervous System,2020
60-64,8.8,10.2,694,Incidence,7335341,Non-Hispanic White,9.5,Female,Cervix,2020
60-64,58.3,61.8,4404,Incidence,7335341,Non-Hispanic White,60.0,Female,Colon and Rectum,2020
60-64,89.7,94.1,6739,Incidence,7335341,Non-Hispanic White,91.9,Female,"Corpus and Uterus, NOS",2020
60-64,5.0,6.1,407,Incidence,7335341,Non-Hispanic White,5.5,Female,Esophagus,2020
60-64,316.4,324.6,23506,Incidence,7335341,Non-Hispanic White,320.4,Female,Female Breast,2020
60-64,68.9,72.8,5196,Incidence,7335341,Non-Hispanic White,70.8,Female,"Female Breast, <i>in situ</i>",2020
60-64,1.3,1.9,116,Incidence,7335341,Non-Hispanic White,1.6,Female,Hodgkin Lymphoma,2020
60-64,~,~,~,Incidence,7335341,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
60-64,27.1,29.5,2074,Incidence,7335341,Non-Hispanic White,28.3,Female,Kidney and Renal Pelvis,2020
60-64,4.2,5.3,347,Incidence,7335341,Non-Hispanic White,4.7,Female,Larynx,2020
60-64,19.9,22.0,1535,Incidence,7335341,Non-Hispanic White,20.9,Female,Leukemias,2020
60-64,10.5,12.0,825,Incidence,7335341,Non-Hispanic White,11.2,Female,Liver and Intrahepatic Bile Duct,2020
60-64,145.8,151.4,10897,Incidence,7335341,Non-Hispanic White,148.6,Female,Lung and Bronchus,2020
60-64,44.0,47.1,3338,Incidence,7335341,Non-Hispanic White,45.5,Female,Melanomas of the Skin,2020
60-64,0.6,1.0,58,Incidence,7335341,Non-Hispanic White,0.8,Female,Mesothelioma,2020
60-64,11.0,12.6,863,Incidence,7335341,Non-Hispanic White,11.8,Female,Myeloma,2020
60-64,32.2,34.9,2461,Incidence,7335341,Non-Hispanic White,33.5,Female,Non-Hodgkin Lymphoma,2020
60-64,19.5,21.6,1507,Incidence,7335341,Non-Hispanic White,20.5,Female,Oral Cavity and Pharynx,2020
60-64,23.2,25.4,1781,Incidence,7335341,Non-Hispanic White,24.3,Female,Ovary,2020
60-64,25.2,27.5,1930,Incidence,7335341,Non-Hispanic White,26.3,Female,Pancreas,2020
60-64,6.8,8.0,542,Incidence,7335341,Non-Hispanic White,7.4,Female,Stomach,2020
60-64,23.1,25.4,1776,Incidence,7335341,Non-Hispanic White,24.2,Female,Thyroid,2020
60-64,17.7,19.7,1368,Incidence,7335341,Non-Hispanic White,18.6,Female,Urinary Bladder,2020
65-69,1262.3,1279.4,84568,Incidence,6654570,Non-Hispanic White,1270.8,Female,All Cancer Sites Combined,2020
65-69,13.0,14.8,922,Incidence,6654570,Non-Hispanic White,13.9,Female,Brain and Other Nervous System,2020
65-69,7.1,8.4,514,Incidence,6654570,Non-Hispanic White,7.7,Female,Cervix,2020
65-69,75.3,79.6,5152,Incidence,6654570,Non-Hispanic White,77.4,Female,Colon and Rectum,2020
65-69,102.7,107.6,6997,Incidence,6654570,Non-Hispanic White,105.1,Female,"Corpus and Uterus, NOS",2020
65-69,6.2,7.5,456,Incidence,6654570,Non-Hispanic White,6.9,Female,Esophagus,2020
65-69,393.7,403.3,26520,Incidence,6654570,Non-Hispanic White,398.5,Female,Female Breast,2020
65-69,83.8,88.2,5722,Incidence,6654570,Non-Hispanic White,86.0,Female,"Female Breast, <i>in situ</i>",2020
65-69,1.6,2.3,131,Incidence,6654570,Non-Hispanic White,2.0,Female,Hodgkin Lymphoma,2020
65-69,~,~,~,Incidence,6654570,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
65-69,33.9,36.8,2352,Incidence,6654570,Non-Hispanic White,35.3,Female,Kidney and Renal Pelvis,2020
65-69,4.0,5.1,301,Incidence,6654570,Non-Hispanic White,4.5,Female,Larynx,2020
65-69,27.6,30.2,1919,Incidence,6654570,Non-Hispanic White,28.8,Female,Leukemias,2020
65-69,16.4,18.5,1160,Incidence,6654570,Non-Hispanic White,17.4,Female,Liver and Intrahepatic Bile Duct,2020
65-69,193.2,200.0,13082,Incidence,6654570,Non-Hispanic White,196.6,Female,Lung and Bronchus,2020
65-69,52.7,56.2,3623,Incidence,6654570,Non-Hispanic White,54.4,Female,Melanomas of the Skin,2020
65-69,0.9,1.4,76,Incidence,6654570,Non-Hispanic White,1.1,Female,Mesothelioma,2020
65-69,16.2,18.2,1145,Incidence,6654570,Non-Hispanic White,17.2,Female,Myeloma,2020
65-69,45.7,49.0,3149,Incidence,6654570,Non-Hispanic White,47.3,Female,Non-Hodgkin Lymphoma,2020
65-69,20.5,22.8,1438,Incidence,6654570,Non-Hispanic White,21.6,Female,Oral Cavity and Pharynx,2020
65-69,25.8,28.3,1801,Incidence,6654570,Non-Hispanic White,27.1,Female,Ovary,2020
65-69,38.9,41.9,2687,Incidence,6654570,Non-Hispanic White,40.4,Female,Pancreas,2020
65-69,9.3,10.8,667,Incidence,6654570,Non-Hispanic White,10.0,Female,Stomach,2020
65-69,24.0,26.4,1674,Incidence,6654570,Non-Hispanic White,25.2,Female,Thyroid,2020
65-69,27.2,29.8,1893,Incidence,6654570,Non-Hispanic White,28.4,Female,Urinary Bladder,2020
70-74,1497.6,1517.7,86200,Incidence,5717654,Non-Hispanic White,1507.6,Female,All Cancer Sites Combined,2020
70-74,16.1,18.3,982,Incidence,5717654,Non-Hispanic White,17.2,Female,Brain and Other Nervous System,2020
70-74,7.2,8.6,450,Incidence,5717654,Non-Hispanic White,7.9,Female,Cervix,2020
70-74,95.4,100.5,5599,Incidence,5717654,Non-Hispanic White,97.9,Female,Colon and Rectum,2020
70-74,101.9,107.2,5977,Incidence,5717654,Non-Hispanic White,104.5,Female,"Corpus and Uterus, NOS",2020
70-74,7.8,9.4,490,Incidence,5717654,Non-Hispanic White,8.6,Female,Esophagus,2020
70-74,441.3,452.3,25547,Incidence,5717654,Non-Hispanic White,446.8,Female,Female Breast,2020
70-74,88.9,93.9,5225,Incidence,5717654,Non-Hispanic White,91.4,Female,"Female Breast, <i>in situ</i>",2020
70-74,2.0,2.9,138,Incidence,5717654,Non-Hispanic White,2.4,Female,Hodgkin Lymphoma,2020
70-74,~,~,~,Incidence,5717654,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
70-74,39.4,42.8,2349,Incidence,5717654,Non-Hispanic White,41.1,Female,Kidney and Renal Pelvis,2020
70-74,3.7,4.7,239,Incidence,5717654,Non-Hispanic White,4.2,Female,Larynx,2020
70-74,35.2,38.3,2100,Incidence,5717654,Non-Hispanic White,36.7,Female,Leukemias,2020
70-74,17.4,19.7,1058,Incidence,5717654,Non-Hispanic White,18.5,Female,Liver and Intrahepatic Bile Duct,2020
70-74,258.3,266.7,15007,Incidence,5717654,Non-Hispanic White,262.5,Female,Lung and Bronchus,2020
70-74,55.9,59.9,3310,Incidence,5717654,Non-Hispanic White,57.9,Female,Melanomas of the Skin,2020
70-74,1.3,2.0,93,Incidence,5717654,Non-Hispanic White,1.6,Female,Mesothelioma,2020
70-74,21.3,23.8,1289,Incidence,5717654,Non-Hispanic White,22.5,Female,Myeloma,2020
70-74,60.1,64.3,3555,Incidence,5717654,Non-Hispanic White,62.2,Female,Non-Hodgkin Lymphoma,2020
70-74,23.7,26.3,1430,Incidence,5717654,Non-Hispanic White,25.0,Female,Oral Cavity and Pharynx,2020
70-74,29.2,32.1,1750,Incidence,5717654,Non-Hispanic White,30.6,Female,Ovary,2020
70-74,51.8,55.6,3068,Incidence,5717654,Non-Hispanic White,53.7,Female,Pancreas,2020
70-74,10.5,12.3,650,Incidence,5717654,Non-Hispanic White,11.4,Female,Stomach,2020
70-74,21.7,24.2,1310,Incidence,5717654,Non-Hispanic White,22.9,Female,Thyroid,2020
70-74,37.5,40.8,2237,Incidence,5717654,Non-Hispanic White,39.1,Female,Urinary Bladder,2020
75-79,1701.3,1726.8,69786,Incidence,4071553,Non-Hispanic White,1714.0,Female,All Cancer Sites Combined,2020
75-79,15.8,18.4,695,Incidence,4071553,Non-Hispanic White,17.1,Female,Brain and Other Nervous System,2020
75-79,6.0,7.6,274,Incidence,4071553,Non-Hispanic White,6.7,Female,Cervix,2020
75-79,121.7,128.5,5092,Incidence,4071553,Non-Hispanic White,125.1,Female,Colon and Rectum,2020
75-79,87.1,93.0,3665,Incidence,4071553,Non-Hispanic White,90.0,Female,"Corpus and Uterus, NOS",2020
75-79,8.4,10.3,378,Incidence,4071553,Non-Hispanic White,9.3,Female,Esophagus,2020
75-79,444.2,457.3,18352,Incidence,4071553,Non-Hispanic White,450.7,Female,Female Breast,2020
75-79,72.3,77.7,3053,Incidence,4071553,Non-Hispanic White,75.0,Female,"Female Breast, <i>in situ</i>",2020
75-79,2.8,3.9,134,Incidence,4071553,Non-Hispanic White,3.3,Female,Hodgkin Lymphoma,2020
75-79,~,~,~,Incidence,4071553,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
75-79,42.7,46.9,1823,Incidence,4071553,Non-Hispanic White,44.8,Female,Kidney and Renal Pelvis,2020
75-79,3.3,4.5,157,Incidence,4071553,Non-Hispanic White,3.9,Female,Larynx,2020
75-79,47.0,51.3,2001,Incidence,4071553,Non-Hispanic White,49.1,Female,Leukemias,2020
75-79,19.5,22.3,849,Incidence,4071553,Non-Hispanic White,20.9,Female,Liver and Intrahepatic Bile Duct,2020
75-79,321.2,332.4,13304,Incidence,4071553,Non-Hispanic White,326.8,Female,Lung and Bronchus,2020
75-79,59.9,64.8,2536,Incidence,4071553,Non-Hispanic White,62.3,Female,Melanomas of the Skin,2020
75-79,2.1,3.1,103,Incidence,4071553,Non-Hispanic White,2.5,Female,Mesothelioma,2020
75-79,26.5,29.7,1143,Incidence,4071553,Non-Hispanic White,28.1,Female,Myeloma,2020
75-79,76.5,82.0,3226,Incidence,4071553,Non-Hispanic White,79.2,Female,Non-Hodgkin Lymphoma,2020
75-79,27.0,30.3,1166,Incidence,4071553,Non-Hispanic White,28.6,Female,Oral Cavity and Pharynx,2020
75-79,33.3,36.9,1427,Incidence,4071553,Non-Hispanic White,35.0,Female,Ovary,2020
75-79,66.9,72.0,2827,Incidence,4071553,Non-Hispanic White,69.4,Female,Pancreas,2020
75-79,13.5,15.8,595,Incidence,4071553,Non-Hispanic White,14.6,Female,Stomach,2020
75-79,17.4,20.1,762,Incidence,4071553,Non-Hispanic White,18.7,Female,Thyroid,2020
75-79,52.1,56.7,2213,Incidence,4071553,Non-Hispanic White,54.4,Female,Urinary Bladder,2020
80-84,1773.1,1804.8,49016,Incidence,2740042,Non-Hispanic White,1788.9,Female,All Cancer Sites Combined,2020
80-84,16.4,19.7,493,Incidence,2740042,Non-Hispanic White,18.0,Female,Brain and Other Nervous System,2020
80-84,5.1,7.0,165,Incidence,2740042,Non-Hispanic White,6.0,Female,Cervix,2020
80-84,168.6,178.5,4754,Incidence,2740042,Non-Hispanic White,173.5,Female,Colon and Rectum,2020
80-84,72.2,78.7,2066,Incidence,2740042,Non-Hispanic White,75.4,Female,"Corpus and Uterus, NOS",2020
80-84,10.4,13.0,318,Incidence,2740042,Non-Hispanic White,11.6,Female,Esophagus,2020
80-84,398.0,413.1,11111,Incidence,2740042,Non-Hispanic White,405.5,Female,Female Breast,2020
80-84,48.8,54.2,1409,Incidence,2740042,Non-Hispanic White,51.4,Female,"Female Breast, <i>in situ</i>",2020
80-84,2.3,3.6,80,Incidence,2740042,Non-Hispanic White,2.9,Female,Hodgkin Lymphoma,2020
80-84,~,~,~,Incidence,2740042,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
80-84,40.6,45.6,1179,Incidence,2740042,Non-Hispanic White,43.0,Female,Kidney and Renal Pelvis,2020
80-84,2.7,4.2,93,Incidence,2740042,Non-Hispanic White,3.4,Female,Larynx,2020
80-84,55.5,61.3,1598,Incidence,2740042,Non-Hispanic White,58.3,Female,Leukemias,2020
80-84,21.9,25.6,649,Incidence,2740042,Non-Hispanic White,23.7,Female,Liver and Intrahepatic Bile Duct,2020
80-84,307.0,320.3,8593,Incidence,2740042,Non-Hispanic White,313.6,Female,Lung and Bronchus,2020
80-84,64.2,70.4,1843,Incidence,2740042,Non-Hispanic White,67.3,Female,Melanomas of the Skin,2020
80-84,2.3,3.6,78,Incidence,2740042,Non-Hispanic White,2.8,Female,Mesothelioma,2020
80-84,29.0,33.2,851,Incidence,2740042,Non-Hispanic White,31.1,Female,Myeloma,2020
80-84,87.1,94.3,2483,Incidence,2740042,Non-Hispanic White,90.6,Female,Non-Hodgkin Lymphoma,2020
80-84,28.1,32.2,825,Incidence,2740042,Non-Hispanic White,30.1,Female,Oral Cavity and Pharynx,2020
80-84,34.9,39.5,1018,Incidence,2740042,Non-Hispanic White,37.2,Female,Ovary,2020
80-84,82.2,89.2,2346,Incidence,2740042,Non-Hispanic White,85.6,Female,Pancreas,2020
80-84,16.4,19.7,493,Incidence,2740042,Non-Hispanic White,18.0,Female,Stomach,2020
80-84,12.4,15.2,377,Incidence,2740042,Non-Hispanic White,13.8,Female,Thyroid,2020
80-84,60.1,66.1,1728,Incidence,2740042,Non-Hispanic White,63.1,Female,Urinary Bladder,2020
85+,1521.9,1549.0,49188,Incidence,3203568,Non-Hispanic White,1535.4,Female,All Cancer Sites Combined,2020
85+,13.5,16.2,474,Incidence,3203568,Non-Hispanic White,14.8,Female,Brain and Other Nervous System,2020
85+,4.0,5.6,153,Incidence,3203568,Non-Hispanic White,4.8,Female,Cervix,2020
85+,192.9,202.7,6336,Incidence,3203568,Non-Hispanic White,197.8,Female,Colon and Rectum,2020
85+,43.0,47.7,1451,Incidence,3203568,Non-Hispanic White,45.3,Female,"Corpus and Uterus, NOS",2020
85+,10.3,12.7,366,Incidence,3203568,Non-Hispanic White,11.4,Female,Esophagus,2020
85+,289.8,301.7,9473,Incidence,3203568,Non-Hispanic White,295.7,Female,Female Breast,2020
85+,18.8,21.9,650,Incidence,3203568,Non-Hispanic White,20.3,Female,"Female Breast, <i>in situ</i>",2020
85+,1.1,2.0,49,Incidence,3203568,Non-Hispanic White,1.5,Female,Hodgkin Lymphoma,2020
85+,~,~,~,Incidence,3203568,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
85+,30.8,34.8,1049,Incidence,3203568,Non-Hispanic White,32.7,Female,Kidney and Renal Pelvis,2020
85+,1.8,2.8,72,Incidence,3203568,Non-Hispanic White,2.2,Female,Larynx,2020
85+,58.8,64.2,1969,Incidence,3203568,Non-Hispanic White,61.5,Female,Leukemias,2020
85+,18.1,21.2,627,Incidence,3203568,Non-Hispanic White,19.6,Female,Liver and Intrahepatic Bile Duct,2020
85+,205.1,215.2,6730,Incidence,3203568,Non-Hispanic White,210.1,Female,Lung and Bronchus,2020
85+,60.7,66.2,2032,Incidence,3203568,Non-Hispanic White,63.4,Female,Melanomas of the Skin,2020
85+,1.8,2.9,74,Incidence,3203568,Non-Hispanic White,2.3,Female,Mesothelioma,2020
85+,20.9,24.2,720,Incidence,3203568,Non-Hispanic White,22.5,Female,Myeloma,2020
85+,74.4,80.5,2479,Incidence,3203568,Non-Hispanic White,77.4,Female,Non-Hodgkin Lymphoma,2020
85+,26.2,29.9,896,Incidence,3203568,Non-Hispanic White,28.0,Female,Oral Cavity and Pharynx,2020
85+,29.0,32.9,990,Incidence,3203568,Non-Hispanic White,30.9,Female,Ovary,2020
85+,77.8,84.1,2592,Incidence,3203568,Non-Hispanic White,80.9,Female,Pancreas,2020
85+,16.9,19.9,589,Incidence,3203568,Non-Hispanic White,18.4,Female,Stomach,2020
85+,7.5,9.5,271,Incidence,3203568,Non-Hispanic White,8.5,Female,Thyroid,2020
85+,66.5,72.3,2222,Incidence,3203568,Non-Hispanic White,69.4,Female,Urinary Bladder,2020
<1,24.2,31.2,245,Incidence,890797,Non-Hispanic White,27.5,Female,All Cancer Sites Combined,2020
<1,3.5,6.5,43,Incidence,890797,Non-Hispanic White,4.8,Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Cervix,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Colon and Rectum,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Esophagus,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Female Breast,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Kaposi Sarcoma,2020
<1,1.0,2.9,16,Incidence,890797,Non-Hispanic White,1.8,Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Larynx,2020
<1,3.0,5.9,38,Incidence,890797,Non-Hispanic White,4.3,Female,Leukemias,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Mesothelioma,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Myeloma,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Ovary,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Pancreas,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Stomach,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Thyroid,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Female,Urinary Bladder,2020
1-4,21.7,24.8,905,Incidence,3896174,Non-Hispanic White,23.2,Male,All Cancer Sites Combined,2020
1-4,3.4,4.6,154,Incidence,3896174,Non-Hispanic White,4.0,Male,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Colon and Rectum,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Esophagus,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
1-4,1.5,2.4,73,Incidence,3896174,Non-Hispanic White,1.9,Male,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Larynx,2020
1-4,8.4,10.4,365,Incidence,3896174,Non-Hispanic White,9.4,Male,Leukemias,2020
1-4,0.6,1.2,33,Incidence,3896174,Non-Hispanic White,0.8,Male,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Lung and Bronchus,2020
1-4,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Mesothelioma,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Myeloma,2020
1-4,0.9,1.6,46,Incidence,3896174,Non-Hispanic White,1.2,Male,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Pancreas,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Prostate,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Stomach,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Testis,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Thyroid,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male,Urinary Bladder,2020
10-14,13.6,15.6,772,Incidence,5297698,Non-Hispanic White,14.6,Male,All Cancer Sites Combined,2020
10-14,2.5,3.4,154,Incidence,5297698,Non-Hispanic White,2.9,Male,Brain and Other Nervous System,2020
10-14,0.5,0.9,36,Incidence,5297698,Non-Hispanic White,0.7,Male,Colon and Rectum,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Esophagus,2020
10-14,1.4,2.1,90,Incidence,5297698,Non-Hispanic White,1.7,Male,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Larynx,2020
10-14,2.6,3.6,162,Incidence,5297698,Non-Hispanic White,3.1,Male,Leukemias,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Lung and Bronchus,2020
10-14,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Mesothelioma,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Myeloma,2020
10-14,1.4,2.1,90,Incidence,5297698,Non-Hispanic White,1.7,Male,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Pancreas,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Prostate,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Stomach,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Testis,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Thyroid,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male,Urinary Bladder,2020
15-19,23.4,26.1,1371,Incidence,5547131,Non-Hispanic White,24.7,Male,All Cancer Sites Combined,2020
15-19,2.5,3.4,161,Incidence,5547131,Non-Hispanic White,2.9,Male,Brain and Other Nervous System,2020
15-19,1.2,1.8,82,Incidence,5547131,Non-Hispanic White,1.5,Male,Colon and Rectum,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Esophagus,2020
15-19,2.9,3.9,189,Incidence,5547131,Non-Hispanic White,3.4,Male,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Larynx,2020
15-19,2.5,3.4,161,Incidence,5547131,Non-Hispanic White,2.9,Male,Leukemias,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Lung and Bronchus,2020
15-19,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
15-19,0.6,1.0,43,Incidence,5547131,Non-Hispanic White,0.8,Male,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Mesothelioma,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Myeloma,2020
15-19,2.1,3.0,140,Incidence,5547131,Non-Hispanic White,2.5,Male,Non-Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Pancreas,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Prostate,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Stomach,2020
15-19,3.1,4.1,198,Incidence,5547131,Non-Hispanic White,3.6,Male,Testis,2020
15-19,1.0,1.7,74,Incidence,5547131,Non-Hispanic White,1.3,Male,Thyroid,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male,Urinary Bladder,2020
20-24,34.7,37.8,2110,Incidence,5817825,Non-Hispanic White,36.3,Male,All Cancer Sites Combined,2020
20-24,2.3,3.2,160,Incidence,5817825,Non-Hispanic White,2.8,Male,Brain and Other Nervous System,2020
20-24,1.6,2.3,113,Incidence,5817825,Non-Hispanic White,1.9,Male,Colon and Rectum,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Esophagus,2020
20-24,4.0,5.1,261,Incidence,5817825,Non-Hispanic White,4.5,Male,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
20-24,0.4,0.8,32,Incidence,5817825,Non-Hispanic White,0.6,Male,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Larynx,2020
20-24,2.3,3.1,156,Incidence,5817825,Non-Hispanic White,2.7,Male,Leukemias,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2020
20-24,0.2,0.6,22,Incidence,5817825,Non-Hispanic White,0.4,Male,Lung and Bronchus,2020
20-24,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
20-24,1.6,2.4,116,Incidence,5817825,Non-Hispanic White,2.0,Male,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Mesothelioma,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Myeloma,2020
20-24,2.8,3.7,186,Incidence,5817825,Non-Hispanic White,3.2,Male,Non-Hodgkin Lymphoma,2020
20-24,0.3,0.6,25,Incidence,5817825,Non-Hispanic White,0.4,Male,Oral Cavity and Pharynx,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Pancreas,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Prostate,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male,Stomach,2020
20-24,9.7,11.3,609,Incidence,5817825,Non-Hispanic White,10.5,Male,Testis,2020
20-24,2.3,3.2,157,Incidence,5817825,Non-Hispanic White,2.7,Male,Thyroid,2020
20-24,0.2,0.5,19,Incidence,5817825,Non-Hispanic White,0.3,Male,Urinary Bladder,2020
25-29,48.2,51.7,3128,Incidence,6270281,Non-Hispanic White,49.9,Male,All Cancer Sites Combined,2020
25-29,3.3,4.2,233,Incidence,6270281,Non-Hispanic White,3.7,Male,Brain and Other Nervous System,2020
25-29,2.9,3.9,212,Incidence,6270281,Non-Hispanic White,3.4,Male,Colon and Rectum,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male,Esophagus,2020
25-29,3.5,4.5,251,Incidence,6270281,Non-Hispanic White,4.0,Male,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
25-29,1.0,1.6,82,Incidence,6270281,Non-Hispanic White,1.3,Male,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male,Larynx,2020
25-29,2.1,2.9,158,Incidence,6270281,Non-Hispanic White,2.5,Male,Leukemias,2020
25-29,0.2,0.5,21,Incidence,6270281,Non-Hispanic White,0.3,Male,Liver and Intrahepatic Bile Duct,2020
25-29,0.3,0.7,29,Incidence,6270281,Non-Hispanic White,0.5,Male,Lung and Bronchus,2020
25-29,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
25-29,3.2,4.2,231,Incidence,6270281,Non-Hispanic White,3.7,Male,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male,Mesothelioma,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male,Myeloma,2020
25-29,3.1,4.1,223,Incidence,6270281,Non-Hispanic White,3.6,Male,Non-Hodgkin Lymphoma,2020
25-29,0.6,1.1,53,Incidence,6270281,Non-Hispanic White,0.8,Male,Oral Cavity and Pharynx,2020
25-29,0.3,0.6,26,Incidence,6270281,Non-Hispanic White,0.4,Male,Pancreas,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male,Prostate,2020
25-29,0.3,0.7,30,Incidence,6270281,Non-Hispanic White,0.5,Male,Stomach,2020
25-29,14.6,16.6,977,Incidence,6270281,Non-Hispanic White,15.6,Male,Testis,2020
25-29,3.0,4.0,217,Incidence,6270281,Non-Hispanic White,3.5,Male,Thyroid,2020
25-29,0.5,0.9,44,Incidence,6270281,Non-Hispanic White,0.7,Male,Urinary Bladder,2020
30-34,69.8,74.1,4504,Incidence,6261783,Non-Hispanic White,71.9,Male,All Cancer Sites Combined,2020
30-34,3.9,5.0,276,Incidence,6261783,Non-Hispanic White,4.4,Male,Brain and Other Nervous System,2020
30-34,6.6,8.0,457,Incidence,6261783,Non-Hispanic White,7.3,Male,Colon and Rectum,2020
30-34,0.2,0.4,17,Incidence,6261783,Non-Hispanic White,0.3,Male,Esophagus,2020
30-34,3.1,4.0,220,Incidence,6261783,Non-Hispanic White,3.5,Male,Hodgkin Lymphoma,2020
30-34,0.2,0.5,19,Incidence,6261783,Non-Hispanic White,0.3,Male,Kaposi Sarcoma,2020
30-34,3.2,4.2,229,Incidence,6261783,Non-Hispanic White,3.7,Male,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,6261783,Non-Hispanic White,~,Male,Larynx,2020
30-34,3.0,4.0,217,Incidence,6261783,Non-Hispanic White,3.5,Male,Leukemias,2020
30-34,0.3,0.7,29,Incidence,6261783,Non-Hispanic White,0.5,Male,Liver and Intrahepatic Bile Duct,2020
30-34,1.0,1.6,80,Incidence,6261783,Non-Hispanic White,1.3,Male,Lung and Bronchus,2020
30-34,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
30-34,6.7,8.1,463,Incidence,6261783,Non-Hispanic White,7.4,Male,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,6261783,Non-Hispanic White,~,Male,Mesothelioma,2020
30-34,0.4,0.7,33,Incidence,6261783,Non-Hispanic White,0.5,Male,Myeloma,2020
30-34,3.9,4.9,273,Incidence,6261783,Non-Hispanic White,4.4,Male,Non-Hodgkin Lymphoma,2020
30-34,1.5,2.2,117,Incidence,6261783,Non-Hispanic White,1.9,Male,Oral Cavity and Pharynx,2020
30-34,0.4,0.8,34,Incidence,6261783,Non-Hispanic White,0.5,Male,Pancreas,2020
30-34,~,~,~,Incidence,6261783,Non-Hispanic White,~,Male,Prostate,2020
30-34,0.3,0.7,31,Incidence,6261783,Non-Hispanic White,0.5,Male,Stomach,2020
30-34,16.3,18.4,1085,Incidence,6261783,Non-Hispanic White,17.3,Male,Testis,2020
30-34,5.7,7.0,396,Incidence,6261783,Non-Hispanic White,6.3,Male,Thyroid,2020
30-34,0.8,1.3,63,Incidence,6261783,Non-Hispanic White,1.0,Male,Urinary Bladder,2020
35-39,99.2,104.3,6140,Incidence,6037715,Non-Hispanic White,101.7,Male,All Cancer Sites Combined,2020
35-39,4.9,6.1,329,Incidence,6037715,Non-Hispanic White,5.4,Male,Brain and Other Nervous System,2020
35-39,12.0,13.8,779,Incidence,6037715,Non-Hispanic White,12.9,Male,Colon and Rectum,2020
35-39,0.6,1.1,50,Incidence,6037715,Non-Hispanic White,0.8,Male,Esophagus,2020
35-39,3.0,3.9,206,Incidence,6037715,Non-Hispanic White,3.4,Male,Hodgkin Lymphoma,2020
35-39,0.2,0.6,22,Incidence,6037715,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2020
35-39,7.5,8.9,493,Incidence,6037715,Non-Hispanic White,8.2,Male,Kidney and Renal Pelvis,2020
35-39,0.3,0.6,25,Incidence,6037715,Non-Hispanic White,0.4,Male,Larynx,2020
35-39,4.6,5.8,313,Incidence,6037715,Non-Hispanic White,5.2,Male,Leukemias,2020
35-39,0.5,0.9,39,Incidence,6037715,Non-Hispanic White,0.6,Male,Liver and Intrahepatic Bile Duct,2020
35-39,2.1,2.9,151,Incidence,6037715,Non-Hispanic White,2.5,Male,Lung and Bronchus,2020
35-39,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
35-39,11.5,13.3,745,Incidence,6037715,Non-Hispanic White,12.3,Male,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,6037715,Non-Hispanic White,~,Male,Mesothelioma,2020
35-39,0.7,1.1,53,Incidence,6037715,Non-Hispanic White,0.9,Male,Myeloma,2020
35-39,6.4,7.8,427,Incidence,6037715,Non-Hispanic White,7.1,Male,Non-Hodgkin Lymphoma,2020
35-39,2.9,3.9,203,Incidence,6037715,Non-Hispanic White,3.4,Male,Oral Cavity and Pharynx,2020
35-39,1.0,1.6,75,Incidence,6037715,Non-Hispanic White,1.2,Male,Pancreas,2020
35-39,0.2,0.5,18,Incidence,6037715,Non-Hispanic White,0.3,Male,Prostate,2020
35-39,1.0,1.6,79,Incidence,6037715,Non-Hispanic White,1.3,Male,Stomach,2020
35-39,13.9,15.9,900,Incidence,6037715,Non-Hispanic White,14.9,Male,Testis,2020
35-39,7.2,8.7,478,Incidence,6037715,Non-Hispanic White,7.9,Male,Thyroid,2020
35-39,1.7,2.4,124,Incidence,6037715,Non-Hispanic White,2.1,Male,Urinary Bladder,2020
40-44,149.6,156.1,8602,Incidence,5628513,Non-Hispanic White,152.8,Male,All Cancer Sites Combined,2020
40-44,5.5,6.8,343,Incidence,5628513,Non-Hispanic White,6.1,Male,Brain and Other Nervous System,2020
40-44,22.1,24.6,1314,Incidence,5628513,Non-Hispanic White,23.3,Male,Colon and Rectum,2020
40-44,1.9,2.7,126,Incidence,5628513,Non-Hispanic White,2.2,Male,Esophagus,2020
40-44,2.6,3.5,170,Incidence,5628513,Non-Hispanic White,3.0,Male,Hodgkin Lymphoma,2020
40-44,0.2,0.6,22,Incidence,5628513,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2020
40-44,13.3,15.3,804,Incidence,5628513,Non-Hispanic White,14.3,Male,Kidney and Renal Pelvis,2020
40-44,0.8,1.3,58,Incidence,5628513,Non-Hispanic White,1.0,Male,Larynx,2020
40-44,6.1,7.5,382,Incidence,5628513,Non-Hispanic White,6.8,Male,Leukemias,2020
40-44,1.1,1.7,76,Incidence,5628513,Non-Hispanic White,1.4,Male,Liver and Intrahepatic Bile Duct,2020
40-44,5.0,6.3,318,Incidence,5628513,Non-Hispanic White,5.6,Male,Lung and Bronchus,2020
40-44,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
40-44,16.8,19.0,1006,Incidence,5628513,Non-Hispanic White,17.9,Male,Melanomas of the Skin,2020
40-44,~,~,~,Incidence,5628513,Non-Hispanic White,~,Male,Mesothelioma,2020
40-44,1.4,2.1,96,Incidence,5628513,Non-Hispanic White,1.7,Male,Myeloma,2020
40-44,9.0,10.6,550,Incidence,5628513,Non-Hispanic White,9.8,Male,Non-Hodgkin Lymphoma,2020
40-44,7.4,8.9,455,Incidence,5628513,Non-Hispanic White,8.1,Male,Oral Cavity and Pharynx,2020
40-44,2.9,3.9,192,Incidence,5628513,Non-Hispanic White,3.4,Male,Pancreas,2020
40-44,4.0,5.1,254,Incidence,5628513,Non-Hispanic White,4.5,Male,Prostate,2020
40-44,1.9,2.8,131,Incidence,5628513,Non-Hispanic White,2.3,Male,Stomach,2020
40-44,10.5,12.3,642,Incidence,5628513,Non-Hispanic White,11.4,Male,Testis,2020
40-44,9.4,11.0,573,Incidence,5628513,Non-Hispanic White,10.2,Male,Thyroid,2020
40-44,4.1,5.3,264,Incidence,5628513,Non-Hispanic White,4.7,Male,Urinary Bladder,2020
45-49,256.3,264.7,14852,Incidence,5701532,Non-Hispanic White,260.5,Male,All Cancer Sites Combined,2020
45-49,6.4,7.8,404,Incidence,5701532,Non-Hispanic White,7.1,Male,Brain and Other Nervous System,2020
45-49,39.6,43.0,2353,Incidence,5701532,Non-Hispanic White,41.3,Male,Colon and Rectum,2020
45-49,4.3,5.4,275,Incidence,5701532,Non-Hispanic White,4.8,Male,Esophagus,2020
45-49,2.2,3.1,151,Incidence,5701532,Non-Hispanic White,2.6,Male,Hodgkin Lymphoma,2020
45-49,0.2,0.6,22,Incidence,5701532,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2020
45-49,22.8,25.4,1371,Incidence,5701532,Non-Hispanic White,24.0,Male,Kidney and Renal Pelvis,2020
45-49,2.6,3.6,175,Incidence,5701532,Non-Hispanic White,3.1,Male,Larynx,2020
45-49,8.6,10.2,533,Incidence,5701532,Non-Hispanic White,9.3,Male,Leukemias,2020
45-49,3.0,4.0,196,Incidence,5701532,Non-Hispanic White,3.4,Male,Liver and Intrahepatic Bile Duct,2020
45-49,15.0,17.1,914,Incidence,5701532,Non-Hispanic White,16.0,Male,Lung and Bronchus,2020
45-49,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
45-49,25.3,28.0,1516,Incidence,5701532,Non-Hispanic White,26.6,Male,Melanomas of the Skin,2020
45-49,~,~,~,Incidence,5701532,Non-Hispanic White,~,Male,Mesothelioma,2020
45-49,3.4,4.4,220,Incidence,5701532,Non-Hispanic White,3.9,Male,Myeloma,2020
45-49,13.5,15.5,827,Incidence,5701532,Non-Hispanic White,14.5,Male,Non-Hodgkin Lymphoma,2020
45-49,18.7,21.0,1131,Incidence,5701532,Non-Hispanic White,19.8,Male,Oral Cavity and Pharynx,2020
45-49,6.6,8.0,415,Incidence,5701532,Non-Hispanic White,7.3,Male,Pancreas,2020
45-49,20.1,22.5,1211,Incidence,5701532,Non-Hispanic White,21.2,Male,Prostate,2020
45-49,3.9,5.0,254,Incidence,5701532,Non-Hispanic White,4.5,Male,Stomach,2020
45-49,7.2,8.7,452,Incidence,5701532,Non-Hispanic White,7.9,Male,Testis,2020
45-49,9.2,10.8,568,Incidence,5701532,Non-Hispanic White,10.0,Male,Thyroid,2020
45-49,9.0,10.6,556,Incidence,5701532,Non-Hispanic White,9.8,Male,Urinary Bladder,2020
5-9,12.6,14.6,696,Incidence,5133322,Non-Hispanic White,13.6,Male,All Cancer Sites Combined,2020
5-9,2.9,4.0,176,Incidence,5133322,Non-Hispanic White,3.4,Male,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Colon and Rectum,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Esophagus,2020
5-9,0.4,0.9,31,Incidence,5133322,Non-Hispanic White,0.6,Male,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
5-9,0.4,0.9,31,Incidence,5133322,Non-Hispanic White,0.6,Male,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Larynx,2020
5-9,3.7,4.8,216,Incidence,5133322,Non-Hispanic White,4.2,Male,Leukemias,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Lung and Bronchus,2020
5-9,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Mesothelioma,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Myeloma,2020
5-9,1.3,2.0,82,Incidence,5133322,Non-Hispanic White,1.6,Male,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Pancreas,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Prostate,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Stomach,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Testis,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Thyroid,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male,Urinary Bladder,2020
50-54,468.9,479.8,29434,Incidence,6205326,Non-Hispanic White,474.3,Male,All Cancer Sites Combined,2020
50-54,8.9,10.4,598,Incidence,6205326,Non-Hispanic White,9.6,Male,Brain and Other Nervous System,2020
50-54,66.5,70.6,4251,Incidence,6205326,Non-Hispanic White,68.5,Male,Colon and Rectum,2020
50-54,8.8,10.4,596,Incidence,6205326,Non-Hispanic White,9.6,Male,Esophagus,2020
50-54,2.2,3.0,161,Incidence,6205326,Non-Hispanic White,2.6,Male,Hodgkin Lymphoma,2020
50-54,0.4,0.7,32,Incidence,6205326,Non-Hispanic White,0.5,Male,Kaposi Sarcoma,2020
50-54,32.3,35.2,2093,Incidence,6205326,Non-Hispanic White,33.7,Male,Kidney and Renal Pelvis,2020
50-54,5.6,6.9,385,Incidence,6205326,Non-Hispanic White,6.2,Male,Larynx,2020
50-54,13.5,15.4,896,Incidence,6205326,Non-Hispanic White,14.4,Male,Leukemias,2020
50-54,7.4,8.8,503,Incidence,6205326,Non-Hispanic White,8.1,Male,Liver and Intrahepatic Bile Duct,2020
50-54,36.4,39.5,2353,Incidence,6205326,Non-Hispanic White,37.9,Male,Lung and Bronchus,2020
50-54,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
50-54,34.8,37.8,2250,Incidence,6205326,Non-Hispanic White,36.3,Male,Melanomas of the Skin,2020
50-54,0.2,0.5,19,Incidence,6205326,Non-Hispanic White,0.3,Male,Mesothelioma,2020
50-54,6.2,7.5,422,Incidence,6205326,Non-Hispanic White,6.8,Male,Myeloma,2020
50-54,20.4,22.7,1334,Incidence,6205326,Non-Hispanic White,21.5,Male,Non-Hodgkin Lymphoma,2020
50-54,35.1,38.1,2268,Incidence,6205326,Non-Hispanic White,36.5,Male,Oral Cavity and Pharynx,2020
50-54,12.9,14.7,854,Incidence,6205326,Non-Hispanic White,13.8,Male,Pancreas,2020
50-54,85.3,89.9,5434,Incidence,6205326,Non-Hispanic White,87.6,Male,Prostate,2020
50-54,6.1,7.4,415,Incidence,6205326,Non-Hispanic White,6.7,Male,Stomach,2020
50-54,4.4,5.5,307,Incidence,6205326,Non-Hispanic White,4.9,Male,Testis,2020
50-54,12.0,13.8,801,Incidence,6205326,Non-Hispanic White,12.9,Male,Thyroid,2020
50-54,19.4,21.7,1273,Incidence,6205326,Non-Hispanic White,20.5,Male,Urinary Bladder,2020
55-59,794.4,807.7,55555,Incidence,6935516,Non-Hispanic White,801.0,Male,All Cancer Sites Combined,2020
55-59,12.8,14.6,949,Incidence,6935516,Non-Hispanic White,13.7,Male,Brain and Other Nervous System,2020
55-59,67.5,71.4,4816,Incidence,6935516,Non-Hispanic White,69.4,Male,Colon and Rectum,2020
55-59,16.2,18.2,1193,Incidence,6935516,Non-Hispanic White,17.2,Male,Esophagus,2020
55-59,2.4,3.2,194,Incidence,6935516,Non-Hispanic White,2.8,Male,Hodgkin Lymphoma,2020
55-59,0.5,0.9,47,Incidence,6935516,Non-Hispanic White,0.7,Male,Kaposi Sarcoma,2020
55-59,46.5,49.7,3335,Incidence,6935516,Non-Hispanic White,48.1,Male,Kidney and Renal Pelvis,2020
55-59,11.5,13.2,857,Incidence,6935516,Non-Hispanic White,12.4,Male,Larynx,2020
55-59,20.8,23.0,1518,Incidence,6935516,Non-Hispanic White,21.9,Male,Leukemias,2020
55-59,21.6,23.8,1574,Incidence,6935516,Non-Hispanic White,22.7,Male,Liver and Intrahepatic Bile Duct,2020
55-59,87.8,92.3,6242,Incidence,6935516,Non-Hispanic White,90.0,Male,Lung and Bronchus,2020
55-59,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
55-59,51.5,55.0,3693,Incidence,6935516,Non-Hispanic White,53.2,Male,Melanomas of the Skin,2020
55-59,0.7,1.2,67,Incidence,6935516,Non-Hispanic White,1.0,Male,Mesothelioma,2020
55-59,10.9,12.5,810,Incidence,6935516,Non-Hispanic White,11.7,Male,Myeloma,2020
55-59,31.9,34.6,2304,Incidence,6935516,Non-Hispanic White,33.2,Male,Non-Hodgkin Lymphoma,2020
55-59,52.5,56.0,3760,Incidence,6935516,Non-Hispanic White,54.2,Male,Oral Cavity and Pharynx,2020
55-59,24.3,26.7,1765,Incidence,6935516,Non-Hispanic White,25.4,Male,Pancreas,2020
55-59,199.7,206.4,14082,Incidence,6935516,Non-Hispanic White,203.0,Male,Prostate,2020
55-59,9.9,11.4,736,Incidence,6935516,Non-Hispanic White,10.6,Male,Stomach,2020
55-59,3.4,4.3,264,Incidence,6935516,Non-Hispanic White,3.8,Male,Testis,2020
55-59,12.5,14.3,927,Incidence,6935516,Non-Hispanic White,13.4,Male,Thyroid,2020
55-59,36.6,39.5,2640,Incidence,6935516,Non-Hispanic White,38.1,Male,Urinary Bladder,2020
60-64,1228.3,1244.9,85565,Incidence,6919613,Non-Hispanic White,1236.6,Male,All Cancer Sites Combined,2020
60-64,16.4,18.4,1200,Incidence,6919613,Non-Hispanic White,17.3,Male,Brain and Other Nervous System,2020
60-64,88.6,93.1,6282,Incidence,6919613,Non-Hispanic White,90.8,Male,Colon and Rectum,2020
60-64,23.8,26.1,1725,Incidence,6919613,Non-Hispanic White,24.9,Male,Esophagus,2020
60-64,2.9,3.8,228,Incidence,6919613,Non-Hispanic White,3.3,Male,Hodgkin Lymphoma,2020
60-64,0.3,0.6,30,Incidence,6919613,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2020
60-64,61.7,65.4,4396,Incidence,6919613,Non-Hispanic White,63.5,Male,Kidney and Renal Pelvis,2020
60-64,16.9,18.9,1235,Incidence,6919613,Non-Hispanic White,17.8,Male,Larynx,2020
60-64,32.0,34.7,2306,Incidence,6919613,Non-Hispanic White,33.3,Male,Leukemias,2020
60-64,36.7,39.7,2642,Incidence,6919613,Non-Hispanic White,38.2,Male,Liver and Intrahepatic Bile Duct,2020
60-64,158.7,164.7,11190,Incidence,6919613,Non-Hispanic White,161.7,Male,Lung and Bronchus,2020
60-64,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
60-64,70.0,74.0,4978,Incidence,6919613,Non-Hispanic White,71.9,Male,Melanomas of the Skin,2020
60-64,1.3,1.9,107,Incidence,6919613,Non-Hispanic White,1.5,Male,Mesothelioma,2020
60-64,16.1,18.0,1179,Incidence,6919613,Non-Hispanic White,17.0,Male,Myeloma,2020
60-64,47.1,50.4,3372,Incidence,6919613,Non-Hispanic White,48.7,Male,Non-Hodgkin Lymphoma,2020
60-64,66.2,70.1,4713,Incidence,6919613,Non-Hispanic White,68.1,Male,Oral Cavity and Pharynx,2020
60-64,37.8,40.8,2716,Incidence,6919613,Non-Hispanic White,39.3,Male,Pancreas,2020
60-64,349.5,358.4,24488,Incidence,6919613,Non-Hispanic White,353.9,Male,Prostate,2020
60-64,16.1,18.0,1177,Incidence,6919613,Non-Hispanic White,17.0,Male,Stomach,2020
60-64,2.3,3.1,184,Incidence,6919613,Non-Hispanic White,2.7,Male,Testis,2020
60-64,13.6,15.4,999,Incidence,6919613,Non-Hispanic White,14.4,Male,Thyroid,2020
60-64,68.0,71.9,4839,Incidence,6919613,Non-Hispanic White,69.9,Male,Urinary Bladder,2020
65-69,1752.9,1774.1,106977,Incidence,6066339,Non-Hispanic White,1763.5,Male,All Cancer Sites Combined,2020
65-69,19.0,21.3,1219,Incidence,6066339,Non-Hispanic White,20.1,Male,Brain and Other Nervous System,2020
65-69,109.3,114.7,6793,Incidence,6066339,Non-Hispanic White,112.0,Male,Colon and Rectum,2020
65-69,32.7,35.6,2071,Incidence,6066339,Non-Hispanic White,34.1,Male,Esophagus,2020
65-69,2.9,3.9,205,Incidence,6066339,Non-Hispanic White,3.4,Male,Hodgkin Lymphoma,2020
65-69,0.2,0.6,23,Incidence,6066339,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2020
65-69,79.1,83.6,4933,Incidence,6066339,Non-Hispanic White,81.3,Male,Kidney and Renal Pelvis,2020
65-69,19.2,21.4,1230,Incidence,6066339,Non-Hispanic White,20.3,Male,Larynx,2020
65-69,48.1,51.7,3027,Incidence,6066339,Non-Hispanic White,49.9,Male,Leukemias,2020
65-69,51.0,54.7,3203,Incidence,6066339,Non-Hispanic White,52.8,Male,Liver and Intrahepatic Bile Duct,2020
65-69,227.8,235.5,14050,Incidence,6066339,Non-Hispanic White,231.6,Male,Lung and Bronchus,2020
65-69,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
65-69,97.7,102.8,6080,Incidence,6066339,Non-Hispanic White,100.2,Male,Melanomas of the Skin,2020
65-69,2.3,3.1,161,Incidence,6066339,Non-Hispanic White,2.7,Male,Mesothelioma,2020
65-69,24.2,26.8,1547,Incidence,6066339,Non-Hispanic White,25.5,Male,Myeloma,2020
65-69,66.7,70.9,4173,Incidence,6066339,Non-Hispanic White,68.8,Male,Non-Hodgkin Lymphoma,2020
65-69,73.3,77.7,4579,Incidence,6066339,Non-Hispanic White,75.5,Male,Oral Cavity and Pharynx,2020
65-69,55.3,59.1,3468,Incidence,6066339,Non-Hispanic White,57.2,Male,Pancreas,2020
65-69,552.5,564.4,33876,Incidence,6066339,Non-Hispanic White,558.4,Male,Prostate,2020
65-69,21.4,23.8,1367,Incidence,6066339,Non-Hispanic White,22.5,Male,Stomach,2020
65-69,1.6,2.3,114,Incidence,6066339,Non-Hispanic White,1.9,Male,Testis,2020
65-69,15.0,17.1,972,Incidence,6066339,Non-Hispanic White,16.0,Male,Thyroid,2020
65-69,108.9,114.2,6767,Incidence,6066339,Non-Hispanic White,111.5,Male,Urinary Bladder,2020
70-74,2098.4,2123.6,107413,Incidence,5088297,Non-Hispanic White,2111.0,Male,All Cancer Sites Combined,2020
70-74,23.4,26.2,1260,Incidence,5088297,Non-Hispanic White,24.8,Male,Brain and Other Nervous System,2020
70-74,122.4,128.6,6383,Incidence,5088297,Non-Hispanic White,125.4,Male,Colon and Rectum,2020
70-74,40.8,44.4,2165,Incidence,5088297,Non-Hispanic White,42.5,Male,Esophagus,2020
70-74,3.2,4.3,191,Incidence,5088297,Non-Hispanic White,3.8,Male,Hodgkin Lymphoma,2020
70-74,0.2,0.6,20,Incidence,5088297,Non-Hispanic White,0.4,Male,Kaposi Sarcoma,2020
70-74,90.9,96.3,4762,Incidence,5088297,Non-Hispanic White,93.6,Male,Kidney and Renal Pelvis,2020
70-74,19.3,21.9,1047,Incidence,5088297,Non-Hispanic White,20.6,Male,Larynx,2020
70-74,66.4,71.0,3494,Incidence,5088297,Non-Hispanic White,68.7,Male,Leukemias,2020
70-74,46.5,50.3,2461,Incidence,5088297,Non-Hispanic White,48.4,Male,Liver and Intrahepatic Bile Duct,2020
70-74,301.8,311.4,15598,Incidence,5088297,Non-Hispanic White,306.5,Male,Lung and Bronchus,2020
70-74,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
70-74,128.6,134.9,6704,Incidence,5088297,Non-Hispanic White,131.8,Male,Melanomas of the Skin,2020
70-74,5.2,6.5,297,Incidence,5088297,Non-Hispanic White,5.8,Male,Mesothelioma,2020
70-74,33.2,36.4,1769,Incidence,5088297,Non-Hispanic White,34.8,Male,Myeloma,2020
70-74,89.4,94.7,4681,Incidence,5088297,Non-Hispanic White,92.0,Male,Non-Hodgkin Lymphoma,2020
70-74,74.5,79.3,3911,Incidence,5088297,Non-Hispanic White,76.9,Male,Oral Cavity and Pharynx,2020
70-74,74.5,79.3,3912,Incidence,5088297,Non-Hispanic White,76.9,Male,Pancreas,2020
70-74,574.7,588.0,29580,Incidence,5088297,Non-Hispanic White,581.3,Male,Prostate,2020
70-74,26.4,29.4,1418,Incidence,5088297,Non-Hispanic White,27.9,Male,Stomach,2020
70-74,1.0,1.6,65,Incidence,5088297,Non-Hispanic White,1.3,Male,Testis,2020
70-74,16.3,18.6,887,Incidence,5088297,Non-Hispanic White,17.4,Male,Thyroid,2020
70-74,165.2,172.3,8584,Incidence,5088297,Non-Hispanic White,168.7,Male,Urinary Bladder,2020
75-79,2440.7,2474.0,83915,Incidence,3414963,Non-Hispanic White,2457.3,Male,All Cancer Sites Combined,2020
75-79,24.3,27.7,886,Incidence,3414963,Non-Hispanic White,25.9,Male,Brain and Other Nervous System,2020
75-79,153.2,161.7,5376,Incidence,3414963,Non-Hispanic White,157.4,Male,Colon and Rectum,2020
75-79,43.8,48.3,1571,Incidence,3414963,Non-Hispanic White,46.0,Male,Esophagus,2020
75-79,4.0,5.5,161,Incidence,3414963,Non-Hispanic White,4.7,Male,Hodgkin Lymphoma,2020
75-79,0.4,1.0,23,Incidence,3414963,Non-Hispanic White,0.7,Male,Kaposi Sarcoma,2020
75-79,95.9,102.6,3387,Incidence,3414963,Non-Hispanic White,99.2,Male,Kidney and Renal Pelvis,2020
75-79,19.5,22.6,716,Incidence,3414963,Non-Hispanic White,21.0,Male,Larynx,2020
75-79,89.8,96.3,3176,Incidence,3414963,Non-Hispanic White,93.0,Male,Leukemias,2020
75-79,46.6,51.4,1672,Incidence,3414963,Non-Hispanic White,49.0,Male,Liver and Intrahepatic Bile Duct,2020
75-79,394.7,408.1,13706,Incidence,3414963,Non-Hispanic White,401.4,Male,Lung and Bronchus,2020
75-79,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
75-79,160.7,169.3,5634,Incidence,3414963,Non-Hispanic White,165.0,Male,Melanomas of the Skin,2020
75-79,9.5,11.7,361,Incidence,3414963,Non-Hispanic White,10.6,Male,Mesothelioma,2020
75-79,42.6,47.1,1529,Incidence,3414963,Non-Hispanic White,44.8,Male,Myeloma,2020
75-79,119.7,127.2,4215,Incidence,3414963,Non-Hispanic White,123.4,Male,Non-Hodgkin Lymphoma,2020
75-79,69.4,75.1,2466,Incidence,3414963,Non-Hispanic White,72.2,Male,Oral Cavity and Pharynx,2020
75-79,88.9,95.4,3146,Incidence,3414963,Non-Hispanic White,92.1,Male,Pancreas,2020
75-79,523.4,538.9,18136,Incidence,3414963,Non-Hispanic White,531.1,Male,Prostate,2020
75-79,36.7,40.9,1322,Incidence,3414963,Non-Hispanic White,38.7,Male,Stomach,2020
75-79,0.7,1.4,33,Incidence,3414963,Non-Hispanic White,1.0,Male,Testis,2020
75-79,15.1,17.8,561,Incidence,3414963,Non-Hispanic White,16.4,Male,Thyroid,2020
75-79,236.8,247.3,8264,Incidence,3414963,Non-Hispanic White,242.0,Male,Urinary Bladder,2020
80-84,2596.0,2639.9,54727,Incidence,2090514,Non-Hispanic White,2617.9,Male,All Cancer Sites Combined,2020
80-84,25.1,29.6,570,Incidence,2090514,Non-Hispanic White,27.3,Male,Brain and Other Nervous System,2020
80-84,190.2,202.2,4100,Incidence,2090514,Non-Hispanic White,196.1,Male,Colon and Rectum,2020
80-84,44.0,50.0,981,Incidence,2090514,Non-Hispanic White,46.9,Male,Esophagus,2020
80-84,5.0,7.1,125,Incidence,2090514,Non-Hispanic White,6.0,Male,Hodgkin Lymphoma,2020
80-84,0.7,1.6,22,Incidence,2090514,Non-Hispanic White,1.1,Male,Kaposi Sarcoma,2020
80-84,84.6,92.8,1853,Incidence,2090514,Non-Hispanic White,88.6,Male,Kidney and Renal Pelvis,2020
80-84,19.9,24.0,457,Incidence,2090514,Non-Hispanic White,21.9,Male,Larynx,2020
80-84,110.4,119.6,2402,Incidence,2090514,Non-Hispanic White,114.9,Male,Leukemias,2020
80-84,49.8,56.1,1105,Incidence,2090514,Non-Hispanic White,52.9,Male,Liver and Intrahepatic Bile Duct,2020
80-84,409.5,427.1,8743,Incidence,2090514,Non-Hispanic White,418.2,Male,Lung and Bronchus,2020
80-84,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
80-84,186.8,198.7,4028,Incidence,2090514,Non-Hispanic White,192.7,Male,Melanomas of the Skin,2020
80-84,12.7,16.0,298,Incidence,2090514,Non-Hispanic White,14.3,Male,Mesothelioma,2020
80-84,48.7,54.9,1081,Incidence,2090514,Non-Hispanic White,51.7,Male,Myeloma,2020
80-84,138.6,148.9,3003,Incidence,2090514,Non-Hispanic White,143.6,Male,Non-Hodgkin Lymphoma,2020
80-84,65.3,72.4,1438,Incidence,2090514,Non-Hispanic White,68.8,Male,Oral Cavity and Pharynx,2020
80-84,101.4,110.3,2212,Incidence,2090514,Non-Hispanic White,105.8,Male,Pancreas,2020
80-84,405.2,422.7,8652,Incidence,2090514,Non-Hispanic White,413.9,Male,Prostate,2020
80-84,38.8,44.4,868,Incidence,2090514,Non-Hispanic White,41.5,Male,Stomach,2020
80-84,0.5,1.4,18,Incidence,2090514,Non-Hispanic White,0.9,Male,Testis,2020
80-84,11.8,15.0,279,Incidence,2090514,Non-Hispanic White,13.3,Male,Thyroid,2020
80-84,295.9,310.9,6341,Incidence,2090514,Non-Hispanic White,303.3,Male,Urinary Bladder,2020
85+,2478.7,2524.2,46518,Incidence,1859718,Non-Hispanic White,2501.3,Male,All Cancer Sites Combined,2020
85+,20.5,24.9,421,Incidence,1859718,Non-Hispanic White,22.6,Male,Brain and Other Nervous System,2020
85+,220.2,233.9,4221,Incidence,1859718,Non-Hispanic White,227.0,Male,Colon and Rectum,2020
85+,40.7,46.7,811,Incidence,1859718,Non-Hispanic White,43.6,Male,Esophagus,2020
85+,2.8,4.6,68,Incidence,1859718,Non-Hispanic White,3.7,Male,Hodgkin Lymphoma,2020
85+,0.5,1.5,17,Incidence,1859718,Non-Hispanic White,0.9,Male,Kaposi Sarcoma,2020
85+,73.0,81.0,1431,Incidence,1859718,Non-Hispanic White,76.9,Male,Kidney and Renal Pelvis,2020
85+,16.5,20.4,342,Incidence,1859718,Non-Hispanic White,18.4,Male,Larynx,2020
85+,109.9,119.7,2134,Incidence,1859718,Non-Hispanic White,114.7,Male,Leukemias,2020
85+,40.6,46.7,810,Incidence,1859718,Non-Hispanic White,43.6,Male,Liver and Intrahepatic Bile Duct,2020
85+,335.3,352.2,6391,Incidence,1859718,Non-Hispanic White,343.7,Male,Lung and Bronchus,2020
85+,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
85+,197.0,210.1,3784,Incidence,1859718,Non-Hispanic White,203.5,Male,Melanomas of the Skin,2020
85+,13.9,17.5,290,Incidence,1859718,Non-Hispanic White,15.6,Male,Mesothelioma,2020
85+,42.6,48.8,848,Incidence,1859718,Non-Hispanic White,45.6,Male,Myeloma,2020
85+,129.3,139.9,2501,Incidence,1859718,Non-Hispanic White,134.5,Male,Non-Hodgkin Lymphoma,2020
85+,51.9,58.8,1028,Incidence,1859718,Non-Hispanic White,55.3,Male,Oral Cavity and Pharynx,2020
85+,93.1,102.1,1814,Incidence,1859718,Non-Hispanic White,97.5,Male,Pancreas,2020
85+,316.7,333.2,6042,Incidence,1859718,Non-Hispanic White,324.9,Male,Prostate,2020
85+,38.8,44.7,775,Incidence,1859718,Non-Hispanic White,41.7,Male,Stomach,2020
85+,~,~,~,Incidence,1859718,Non-Hispanic White,~,Male,Testis,2020
85+,8.0,10.8,173,Incidence,1859718,Non-Hispanic White,9.3,Male,Thyroid,2020
85+,323.9,340.5,6176,Incidence,1859718,Non-Hispanic White,332.1,Male,Urinary Bladder,2020
<1,24.2,31.0,256,Incidence,932621,Non-Hispanic White,27.4,Male,All Cancer Sites Combined,2020
<1,3.2,6.0,41,Incidence,932621,Non-Hispanic White,4.4,Male,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Colon and Rectum,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Esophagus,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Kaposi Sarcoma,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Larynx,2020
<1,2.3,4.7,31,Incidence,932621,Non-Hispanic White,3.3,Male,Leukemias,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Lung and Bronchus,2020
<1,~,~,~,Incidence,0,Non-Hispanic White,~,Male,Male Breast,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Melanomas of the Skin,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Mesothelioma,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Myeloma,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Pancreas,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Prostate,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Stomach,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Testis,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Thyroid,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male,Urinary Bladder,2020
1-4,21.0,23.1,1675,Incidence,7604560,Non-Hispanic White,22.0,Male and Female,All Cancer Sites Combined,2020
1-4,3.3,4.2,286,Incidence,7604560,Non-Hispanic White,3.8,Male and Female,Brain and Other Nervous System,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,Cervix,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Colon and Rectum,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Esophagus,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,Female Breast,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
1-4,1.7,2.3,151,Incidence,7604560,Non-Hispanic White,2.0,Male and Female,Kidney and Renal Pelvis,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Larynx,2020
1-4,8.2,9.6,674,Incidence,7604560,Non-Hispanic White,8.9,Male and Female,Leukemias,2020
1-4,0.5,0.9,49,Incidence,7604560,Non-Hispanic White,0.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,Male and Female Breast,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Myeloma,2020
1-4,0.7,1.1,65,Incidence,7604560,Non-Hispanic White,0.9,Male and Female,Non-Hodgkin Lymphoma,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2020
1-4,~,~,~,Incidence,3708386,Non-Hispanic White,~,Male and Female,Ovary,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Pancreas,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male and Female,Prostate,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Stomach,2020
1-4,~,~,~,Incidence,3896174,Non-Hispanic White,~,Male and Female,Testis,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Thyroid,2020
1-4,~,~,~,Incidence,7604560,Non-Hispanic White,~,Male and Female,Urinary Bladder,2020
10-14,13.5,15.0,1471,Incidence,10345693,Non-Hispanic White,14.2,Male and Female,All Cancer Sites Combined,2020
10-14,2.7,3.3,309,Incidence,10345693,Non-Hispanic White,3.0,Male and Female,Brain and Other Nervous System,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Male and Female,Cervix,2020
10-14,0.6,1.0,83,Incidence,10345693,Non-Hispanic White,0.8,Male and Female,Colon and Rectum,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Esophagus,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Male and Female,Female Breast,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2020
10-14,1.2,1.7,146,Incidence,10345693,Non-Hispanic White,1.4,Male and Female,Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
10-14,0.1,0.3,19,Incidence,10345693,Non-Hispanic White,0.2,Male and Female,Kidney and Renal Pelvis,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Larynx,2020
10-14,2.3,2.9,269,Incidence,10345693,Non-Hispanic White,2.6,Male and Female,Leukemias,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Male and Female,Male and Female Breast,2020
10-14,~,~,~,Incidence,5047995,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
10-14,0.2,0.4,28,Incidence,10345693,Non-Hispanic White,0.3,Male and Female,Melanomas of the Skin,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Myeloma,2020
10-14,1.1,1.6,136,Incidence,10345693,Non-Hispanic White,1.3,Male and Female,Non-Hodgkin Lymphoma,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2020
10-14,0.4,0.8,28,Incidence,5047995,Non-Hispanic White,0.6,Male and Female,Ovary,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Pancreas,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male and Female,Prostate,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Stomach,2020
10-14,~,~,~,Incidence,5297698,Non-Hispanic White,~,Male and Female,Testis,2020
10-14,0.5,0.9,72,Incidence,10345693,Non-Hispanic White,0.7,Male and Female,Thyroid,2020
10-14,~,~,~,Incidence,10345693,Non-Hispanic White,~,Male and Female,Urinary Bladder,2020
15-19,23.3,25.1,2619,Incidence,10828569,Non-Hispanic White,24.2,Male and Female,All Cancer Sites Combined,2020
15-19,2.4,3.1,297,Incidence,10828569,Non-Hispanic White,2.7,Male and Female,Brain and Other Nervous System,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Male and Female,Cervix,2020
15-19,1.5,2.0,187,Incidence,10828569,Non-Hispanic White,1.7,Male and Female,Colon and Rectum,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Esophagus,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Male and Female,Female Breast,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2020
15-19,3.1,3.8,368,Incidence,10828569,Non-Hispanic White,3.4,Male and Female,Hodgkin Lymphoma,2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
15-19,0.2,0.4,29,Incidence,10828569,Non-Hispanic White,0.3,Male and Female,Kidney and Renal Pelvis,2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Larynx,2020
15-19,2.2,2.8,270,Incidence,10828569,Non-Hispanic White,2.5,Male and Female,Leukemias,2020
15-19,0.1,0.3,23,Incidence,10828569,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
15-19,0.1,0.3,18,Incidence,10828569,Non-Hispanic White,0.2,Male and Female,Lung and Bronchus,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Male and Female,Male and Female Breast,2020
15-19,~,~,~,Incidence,5281438,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
15-19,0.9,1.3,114,Incidence,10828569,Non-Hispanic White,1.1,Male and Female,Melanomas of the Skin,2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Myeloma,2020
15-19,1.6,2.1,200,Incidence,10828569,Non-Hispanic White,1.8,Male and Female,Non-Hodgkin Lymphoma,2020
15-19,0.2,0.5,36,Incidence,10828569,Non-Hispanic White,0.3,Male and Female,Oral Cavity and Pharynx,2020
15-19,0.8,1.4,56,Incidence,5281438,Non-Hispanic White,1.1,Male and Female,Ovary,2020
15-19,0.1,0.3,18,Incidence,10828569,Non-Hispanic White,0.2,Male and Female,Pancreas,2020
15-19,~,~,~,Incidence,5547131,Non-Hispanic White,~,Male and Female,Prostate,2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Stomach,2020
15-19,3.1,4.1,198,Incidence,5547131,Non-Hispanic White,3.6,Male and Female,Testis,2020
15-19,2.8,3.5,341,Incidence,10828569,Non-Hispanic White,3.1,Male and Female,Thyroid,2020
15-19,~,~,~,Incidence,10828569,Non-Hispanic White,~,Male and Female,Urinary Bladder,2020
20-24,37.2,39.5,4349,Incidence,11352599,Non-Hispanic White,38.3,Male and Female,All Cancer Sites Combined,2020
20-24,2.1,2.7,269,Incidence,11352599,Non-Hispanic White,2.4,Male and Female,Brain and Other Nervous System,2020
20-24,0.2,0.6,21,Incidence,5534774,Non-Hispanic White,0.4,Male and Female,Cervix,2020
20-24,2.0,2.6,258,Incidence,11352599,Non-Hispanic White,2.3,Male and Female,Colon and Rectum,2020
20-24,0.2,0.6,21,Incidence,5534774,Non-Hispanic White,0.4,Male and Female,"Corpus and Uterus, NOS",2020
20-24,~,~,~,Incidence,11352599,Non-Hispanic White,~,Male and Female,Esophagus,2020
20-24,1.2,1.9,84,Incidence,5534774,Non-Hispanic White,1.5,Male and Female,Female Breast,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2020
20-24,4.3,5.1,537,Incidence,11352599,Non-Hispanic White,4.7,Male and Female,Hodgkin Lymphoma,2020
20-24,~,~,~,Incidence,11352599,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
20-24,0.4,0.7,61,Incidence,11352599,Non-Hispanic White,0.5,Male and Female,Kidney and Renal Pelvis,2020
20-24,~,~,~,Incidence,11352599,Non-Hispanic White,~,Male and Female,Larynx,2020
20-24,2.2,2.8,282,Incidence,11352599,Non-Hispanic White,2.5,Male and Female,Leukemias,2020
20-24,0.1,0.3,24,Incidence,11352599,Non-Hispanic White,0.2,Male and Female,Liver and Intrahepatic Bile Duct,2020
20-24,0.2,0.4,34,Incidence,11352599,Non-Hispanic White,0.3,Male and Female,Lung and Bronchus,2020
20-24,1.2,1.9,84,Incidence,5534774,Non-Hispanic White,1.5,Male and Female,Male and Female Breast,2020
20-24,~,~,~,Incidence,5534774,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
20-24,2.9,3.6,366,Incidence,11352599,Non-Hispanic White,3.2,Male and Female,Melanomas of the Skin,2020
20-24,~,~,~,Incidence,11352599,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
20-24,~,~,~,Incidence,11352599,Non-Hispanic White,~,Male and Female,Myeloma,2020
20-24,2.3,2.9,299,Incidence,11352599,Non-Hispanic White,2.6,Male and Female,Non-Hodgkin Lymphoma,2020
20-24,0.4,0.7,57,Incidence,11352599,Non-Hispanic White,0.5,Male and Female,Oral Cavity and Pharynx,2020
20-24,1.5,2.2,101,Incidence,5534774,Non-Hispanic White,1.8,Male and Female,Ovary,2020
20-24,0.2,0.3,27,Incidence,11352599,Non-Hispanic White,0.2,Male and Female,Pancreas,2020
20-24,~,~,~,Incidence,5817825,Non-Hispanic White,~,Male and Female,Prostate,2020
20-24,0.1,0.3,18,Incidence,11352599,Non-Hispanic White,0.2,Male and Female,Stomach,2020
20-24,9.7,11.3,609,Incidence,5817825,Non-Hispanic White,10.5,Male and Female,Testis,2020
20-24,6.4,7.4,781,Incidence,11352599,Non-Hispanic White,6.9,Male and Female,Thyroid,2020
20-24,0.2,0.4,29,Incidence,11352599,Non-Hispanic White,0.3,Male and Female,Urinary Bladder,2020
25-29,57.7,60.5,7237,Incidence,12246528,Non-Hispanic White,59.1,Male and Female,All Cancer Sites Combined,2020
25-29,2.9,3.5,390,Incidence,12246528,Non-Hispanic White,3.2,Male and Female,Brain and Other Nervous System,2020
25-29,2.8,3.7,194,Incidence,5976247,Non-Hispanic White,3.2,Male and Female,Cervix,2020
25-29,3.2,3.8,428,Incidence,12246528,Non-Hispanic White,3.5,Male and Female,Colon and Rectum,2020
25-29,1.2,1.9,92,Incidence,5976247,Non-Hispanic White,1.5,Male and Female,"Corpus and Uterus, NOS",2020
25-29,~,~,~,Incidence,12246528,Non-Hispanic White,~,Male and Female,Esophagus,2020
25-29,9.1,10.7,590,Incidence,5976247,Non-Hispanic White,9.9,Male and Female,Female Breast,2020
25-29,0.7,1.2,55,Incidence,5976247,Non-Hispanic White,0.9,Male and Female,"Female Breast, <i>in situ</i>",2020
25-29,3.8,4.6,512,Incidence,12246528,Non-Hispanic White,4.2,Male and Female,Hodgkin Lymphoma,2020
25-29,~,~,~,Incidence,12246528,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
25-29,1.1,1.5,157,Incidence,12246528,Non-Hispanic White,1.3,Male and Female,Kidney and Renal Pelvis,2020
25-29,~,~,~,Incidence,12246528,Non-Hispanic White,~,Male and Female,Larynx,2020
25-29,2.1,2.6,287,Incidence,12246528,Non-Hispanic White,2.3,Male and Female,Leukemias,2020
25-29,0.2,0.4,40,Incidence,12246528,Non-Hispanic White,0.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
25-29,0.4,0.6,62,Incidence,12246528,Non-Hispanic White,0.5,Male and Female,Lung and Bronchus,2020
25-29,9.1,10.7,590,Incidence,5976247,Non-Hispanic White,9.9,Male and Female,Male and Female Breast,2020
25-29,0.7,1.2,55,Incidence,5976247,Non-Hispanic White,0.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
25-29,5.9,6.8,776,Incidence,12246528,Non-Hispanic White,6.3,Male and Female,Melanomas of the Skin,2020
25-29,~,~,~,Incidence,12246528,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
25-29,~,~,~,Incidence,12246528,Non-Hispanic White,~,Male and Female,Myeloma,2020
25-29,2.7,3.4,373,Incidence,12246528,Non-Hispanic White,3.0,Male and Female,Non-Hodgkin Lymphoma,2020
25-29,0.8,1.2,119,Incidence,12246528,Non-Hispanic White,1.0,Male and Female,Oral Cavity and Pharynx,2020
25-29,1.8,2.5,128,Incidence,5976247,Non-Hispanic White,2.1,Male and Female,Ovary,2020
25-29,0.3,0.5,51,Incidence,12246528,Non-Hispanic White,0.4,Male and Female,Pancreas,2020
25-29,~,~,~,Incidence,6270281,Non-Hispanic White,~,Male and Female,Prostate,2020
25-29,0.3,0.5,44,Incidence,12246528,Non-Hispanic White,0.4,Male and Female,Stomach,2020
25-29,14.6,16.6,977,Incidence,6270281,Non-Hispanic White,15.6,Male and Female,Testis,2020
25-29,9.9,11.0,1277,Incidence,12246528,Non-Hispanic White,10.4,Male and Female,Thyroid,2020
25-29,0.4,0.6,60,Incidence,12246528,Non-Hispanic White,0.5,Male and Female,Urinary Bladder,2020
30-34,97.3,100.8,12248,Incidence,12366559,Non-Hispanic White,99.0,Male and Female,All Cancer Sites Combined,2020
30-34,3.4,4.1,465,Incidence,12366559,Non-Hispanic White,3.8,Male and Female,Brain and Other Nervous System,2020
30-34,9.7,11.4,643,Incidence,6104776,Non-Hispanic White,10.5,Male and Female,Cervix,2020
30-34,6.5,7.5,862,Incidence,12366559,Non-Hispanic White,7.0,Male and Female,Colon and Rectum,2020
30-34,4.5,5.7,309,Incidence,6104776,Non-Hispanic White,5.1,Male and Female,"Corpus and Uterus, NOS",2020
30-34,0.1,0.3,21,Incidence,12366559,Non-Hispanic White,0.2,Male and Female,Esophagus,2020
30-34,29.3,32.1,1870,Incidence,6104776,Non-Hispanic White,30.6,Male and Female,Female Breast,2020
30-34,2.7,3.6,193,Incidence,6104776,Non-Hispanic White,3.2,Male and Female,"Female Breast, <i>in situ</i>",2020
30-34,3.4,4.1,463,Incidence,12366559,Non-Hispanic White,3.7,Male and Female,Hodgkin Lymphoma,2020
30-34,0.1,0.2,20,Incidence,12366559,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
30-34,3.0,3.7,410,Incidence,12366559,Non-Hispanic White,3.3,Male and Female,Kidney and Renal Pelvis,2020
30-34,~,~,~,Incidence,12366559,Non-Hispanic White,~,Male and Female,Larynx,2020
30-34,2.8,3.5,389,Incidence,12366559,Non-Hispanic White,3.1,Male and Female,Leukemias,2020
30-34,0.4,0.6,62,Incidence,12366559,Non-Hispanic White,0.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
30-34,0.9,1.3,131,Incidence,12366559,Non-Hispanic White,1.1,Male and Female,Lung and Bronchus,2020
30-34,29.3,32.1,1870,Incidence,6104776,Non-Hispanic White,30.6,Male and Female,Male and Female Breast,2020
30-34,2.7,3.6,193,Incidence,6104776,Non-Hispanic White,3.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
30-34,11.1,12.3,1440,Incidence,12366559,Non-Hispanic White,11.6,Male and Female,Melanomas of the Skin,2020
30-34,~,~,~,Incidence,12366559,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
30-34,0.3,0.5,51,Incidence,12366559,Non-Hispanic White,0.4,Male and Female,Myeloma,2020
30-34,3.5,4.2,471,Incidence,12366559,Non-Hispanic White,3.8,Male and Female,Non-Hodgkin Lymphoma,2020
30-34,1.6,2.1,231,Incidence,12366559,Non-Hispanic White,1.9,Male and Female,Oral Cavity and Pharynx,2020
30-34,3.1,4.1,220,Incidence,6104776,Non-Hispanic White,3.6,Male and Female,Ovary,2020
30-34,0.5,0.7,73,Incidence,12366559,Non-Hispanic White,0.6,Male and Female,Pancreas,2020
30-34,~,~,~,Incidence,6261783,Non-Hispanic White,~,Male and Female,Prostate,2020
30-34,0.5,0.8,74,Incidence,12366559,Non-Hispanic White,0.6,Male and Female,Stomach,2020
30-34,16.3,18.4,1085,Incidence,6261783,Non-Hispanic White,17.3,Male and Female,Testis,2020
30-34,14.7,16.1,1901,Incidence,12366559,Non-Hispanic White,15.4,Male and Female,Thyroid,2020
30-34,0.6,0.9,87,Incidence,12366559,Non-Hispanic White,0.7,Male and Female,Urinary Bladder,2020
35-39,147.3,151.7,17945,Incidence,12005132,Non-Hispanic White,149.5,Male and Female,All Cancer Sites Combined,2020
35-39,4.3,5.1,563,Incidence,12005132,Non-Hispanic White,4.7,Male and Female,Brain and Other Nervous System,2020
35-39,12.0,13.8,770,Incidence,5967417,Non-Hispanic White,12.9,Male and Female,Cervix,2020
35-39,12.0,13.3,1520,Incidence,12005132,Non-Hispanic White,12.7,Male and Female,Colon and Rectum,2020
35-39,8.8,10.4,572,Incidence,5967417,Non-Hispanic White,9.6,Male and Female,"Corpus and Uterus, NOS",2020
35-39,0.4,0.7,63,Incidence,12005132,Non-Hispanic White,0.5,Male and Female,Esophagus,2020
35-39,63.8,67.9,3927,Incidence,5967417,Non-Hispanic White,65.8,Male and Female,Female Breast,2020
35-39,8.0,9.5,520,Incidence,5967417,Non-Hispanic White,8.7,Male and Female,"Female Breast, <i>in situ</i>",2020
35-39,2.9,3.5,380,Incidence,12005132,Non-Hispanic White,3.2,Male and Female,Hodgkin Lymphoma,2020
35-39,0.1,0.3,22,Incidence,12005132,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
35-39,6.3,7.2,810,Incidence,12005132,Non-Hispanic White,6.7,Male and Female,Kidney and Renal Pelvis,2020
35-39,0.3,0.5,42,Incidence,12005132,Non-Hispanic White,0.3,Male and Female,Larynx,2020
35-39,4.3,5.1,558,Incidence,12005132,Non-Hispanic White,4.6,Male and Female,Leukemias,2020
35-39,0.6,0.9,85,Incidence,12005132,Non-Hispanic White,0.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
35-39,2.3,2.9,312,Incidence,12005132,Non-Hispanic White,2.6,Male and Female,Lung and Bronchus,2020
35-39,63.8,67.9,3927,Incidence,5967417,Non-Hispanic White,65.8,Male and Female,Male and Female Breast,2020
35-39,8.0,9.5,520,Incidence,5967417,Non-Hispanic White,8.7,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
35-39,15.8,17.3,1985,Incidence,12005132,Non-Hispanic White,16.5,Male and Female,Melanomas of the Skin,2020
35-39,~,~,~,Incidence,12005132,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
35-39,0.6,0.9,89,Incidence,12005132,Non-Hispanic White,0.7,Male and Female,Myeloma,2020
35-39,5.7,6.6,736,Incidence,12005132,Non-Hispanic White,6.1,Male and Female,Non-Hodgkin Lymphoma,2020
35-39,2.7,3.3,356,Incidence,12005132,Non-Hispanic White,3.0,Male and Female,Oral Cavity and Pharynx,2020
35-39,4.5,5.6,299,Incidence,5967417,Non-Hispanic White,5.0,Male and Female,Ovary,2020
35-39,1.1,1.6,161,Incidence,12005132,Non-Hispanic White,1.3,Male and Female,Pancreas,2020
35-39,0.2,0.5,18,Incidence,6037715,Non-Hispanic White,0.3,Male and Female,Prostate,2020
35-39,1.0,1.4,138,Incidence,12005132,Non-Hispanic White,1.1,Male and Female,Stomach,2020
35-39,13.9,15.9,900,Incidence,6037715,Non-Hispanic White,14.9,Male and Female,Testis,2020
35-39,16.9,18.4,2118,Incidence,12005132,Non-Hispanic White,17.6,Male and Female,Thyroid,2020
35-39,1.2,1.6,165,Incidence,12005132,Non-Hispanic White,1.4,Male and Female,Urinary Bladder,2020
40-44,228.3,233.9,25891,Incidence,11205188,Non-Hispanic White,231.1,Male and Female,All Cancer Sites Combined,2020
40-44,4.7,5.5,567,Incidence,11205188,Non-Hispanic White,5.1,Male and Female,Brain and Other Nervous System,2020
40-44,12.9,14.9,775,Incidence,5576675,Non-Hispanic White,13.9,Male and Female,Cervix,2020
40-44,20.5,22.2,2391,Incidence,11205188,Non-Hispanic White,21.3,Male and Female,Colon and Rectum,2020
40-44,13.9,16.0,832,Incidence,5576675,Non-Hispanic White,14.9,Male and Female,"Corpus and Uterus, NOS",2020
40-44,1.2,1.6,156,Incidence,11205188,Non-Hispanic White,1.4,Male and Female,Esophagus,2020
40-44,128.4,134.4,7328,Incidence,5576675,Non-Hispanic White,131.4,Male and Female,Female Breast,2020
40-44,37.3,40.5,2168,Incidence,5576675,Non-Hispanic White,38.9,Male and Female,"Female Breast, <i>in situ</i>",2020
40-44,2.4,3.0,297,Incidence,11205188,Non-Hispanic White,2.7,Male and Female,Hodgkin Lymphoma,2020
40-44,0.1,0.3,22,Incidence,11205188,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
40-44,10.7,12.0,1269,Incidence,11205188,Non-Hispanic White,11.3,Male and Female,Kidney and Renal Pelvis,2020
40-44,0.6,0.9,83,Incidence,11205188,Non-Hispanic White,0.7,Male and Female,Larynx,2020
40-44,5.5,6.4,670,Incidence,11205188,Non-Hispanic White,6.0,Male and Female,Leukemias,2020
40-44,1.1,1.6,149,Incidence,11205188,Non-Hispanic White,1.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
40-44,5.2,6.1,636,Incidence,11205188,Non-Hispanic White,5.7,Male and Female,Lung and Bronchus,2020
40-44,128.4,134.4,7328,Incidence,5576675,Non-Hispanic White,131.4,Male and Female,Male and Female Breast,2020
40-44,37.3,40.5,2168,Incidence,5576675,Non-Hispanic White,38.9,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
40-44,21.8,23.6,2542,Incidence,11205188,Non-Hispanic White,22.7,Male and Female,Melanomas of the Skin,2020
40-44,0.1,0.3,18,Incidence,11205188,Non-Hispanic White,0.2,Male and Female,Mesothelioma,2020
40-44,1.4,1.9,183,Incidence,11205188,Non-Hispanic White,1.6,Male and Female,Myeloma,2020
40-44,8.0,9.1,953,Incidence,11205188,Non-Hispanic White,8.5,Male and Female,Non-Hodgkin Lymphoma,2020
40-44,5.4,6.3,657,Incidence,11205188,Non-Hispanic White,5.9,Male and Female,Oral Cavity and Pharynx,2020
40-44,7.1,8.6,437,Incidence,5576675,Non-Hispanic White,7.8,Male and Female,Ovary,2020
40-44,2.8,3.4,348,Incidence,11205188,Non-Hispanic White,3.1,Male and Female,Pancreas,2020
40-44,4.0,5.1,254,Incidence,5628513,Non-Hispanic White,4.5,Male and Female,Prostate,2020
40-44,1.9,2.4,240,Incidence,11205188,Non-Hispanic White,2.1,Male and Female,Stomach,2020
40-44,10.5,12.3,642,Incidence,5628513,Non-Hispanic White,11.4,Male and Female,Testis,2020
40-44,19.1,20.8,2233,Incidence,11205188,Non-Hispanic White,19.9,Male and Female,Thyroid,2020
40-44,3.0,3.6,369,Incidence,11205188,Non-Hispanic White,3.3,Male and Female,Urinary Bladder,2020
45-49,352.6,359.6,40561,Incidence,11390952,Non-Hispanic White,356.1,Male and Female,All Cancer Sites Combined,2020
45-49,5.5,6.4,675,Incidence,11390952,Non-Hispanic White,5.9,Male and Female,Brain and Other Nervous System,2020
45-49,11.9,13.8,730,Incidence,5689420,Non-Hispanic White,12.8,Male and Female,Cervix,2020
45-49,35.4,37.7,4163,Incidence,11390952,Non-Hispanic White,36.5,Male and Female,Colon and Rectum,2020
45-49,23.3,25.9,1399,Incidence,5689420,Non-Hispanic White,24.6,Male and Female,"Corpus and Uterus, NOS",2020
45-49,2.6,3.2,330,Incidence,11390952,Non-Hispanic White,2.9,Male and Female,Esophagus,2020
45-49,202.0,209.5,11706,Incidence,5689420,Non-Hispanic White,205.8,Male and Female,Female Breast,2020
45-49,53.9,57.8,3176,Incidence,5689420,Non-Hispanic White,55.8,Male and Female,"Female Breast, <i>in situ</i>",2020
45-49,2.0,2.5,254,Incidence,11390952,Non-Hispanic White,2.2,Male and Female,Hodgkin Lymphoma,2020
45-49,0.1,0.3,23,Incidence,11390952,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
45-49,17.3,18.9,2061,Incidence,11390952,Non-Hispanic White,18.1,Male and Female,Kidney and Renal Pelvis,2020
45-49,1.9,2.4,241,Incidence,11390952,Non-Hispanic White,2.1,Male and Female,Larynx,2020
45-49,7.9,9.0,957,Incidence,11390952,Non-Hispanic White,8.4,Male and Female,Leukemias,2020
45-49,2.2,2.8,282,Incidence,11390952,Non-Hispanic White,2.5,Male and Female,Liver and Intrahepatic Bile Duct,2020
45-49,16.2,17.7,1933,Incidence,11390952,Non-Hispanic White,17.0,Male and Female,Lung and Bronchus,2020
45-49,202.0,209.5,11706,Incidence,5689420,Non-Hispanic White,205.8,Male and Female,Male and Female Breast,2020
45-49,53.9,57.8,3176,Incidence,5689420,Non-Hispanic White,55.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
45-49,28.1,30.1,3316,Incidence,11390952,Non-Hispanic White,29.1,Male and Female,Melanomas of the Skin,2020
45-49,0.2,0.4,31,Incidence,11390952,Non-Hispanic White,0.3,Male and Female,Mesothelioma,2020
45-49,3.0,3.7,380,Incidence,11390952,Non-Hispanic White,3.3,Male and Female,Myeloma,2020
45-49,11.8,13.1,1412,Incidence,11390952,Non-Hispanic White,12.4,Male and Female,Non-Hodgkin Lymphoma,2020
45-49,12.2,13.5,1459,Incidence,11390952,Non-Hispanic White,12.8,Male and Female,Oral Cavity and Pharynx,2020
45-49,10.3,12.1,637,Incidence,5689420,Non-Hispanic White,11.2,Male and Female,Ovary,2020
45-49,6.1,7.1,748,Incidence,11390952,Non-Hispanic White,6.6,Male and Female,Pancreas,2020
45-49,20.1,22.5,1211,Incidence,5701532,Non-Hispanic White,21.2,Male and Female,Prostate,2020
45-49,3.3,4.0,418,Incidence,11390952,Non-Hispanic White,3.7,Male and Female,Stomach,2020
45-49,7.2,8.7,452,Incidence,5701532,Non-Hispanic White,7.9,Male and Female,Testis,2020
45-49,18.4,20.0,2184,Incidence,11390952,Non-Hispanic White,19.2,Male and Female,Thyroid,2020
45-49,6.0,6.9,736,Incidence,11390952,Non-Hispanic White,6.5,Male and Female,Urinary Bladder,2020
5-9,11.6,13.0,1229,Incidence,10009412,Non-Hispanic White,12.3,Male and Female,All Cancer Sites Combined,2020
5-9,3.0,3.8,339,Incidence,10009412,Non-Hispanic White,3.4,Male and Female,Brain and Other Nervous System,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,Cervix,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Colon and Rectum,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Esophagus,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,Female Breast,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2020
5-9,0.2,0.5,34,Incidence,10009412,Non-Hispanic White,0.3,Male and Female,Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
5-9,0.5,0.8,64,Incidence,10009412,Non-Hispanic White,0.6,Male and Female,Kidney and Renal Pelvis,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Larynx,2020
5-9,3.6,4.4,395,Incidence,10009412,Non-Hispanic White,3.9,Male and Female,Leukemias,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Liver and Intrahepatic Bile Duct,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,Male and Female Breast,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Myeloma,2020
5-9,0.9,1.3,110,Incidence,10009412,Non-Hispanic White,1.1,Male and Female,Non-Hodgkin Lymphoma,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2020
5-9,~,~,~,Incidence,4876090,Non-Hispanic White,~,Male and Female,Ovary,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Pancreas,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male and Female,Prostate,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Stomach,2020
5-9,~,~,~,Incidence,5133322,Non-Hispanic White,~,Male and Female,Testis,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Thyroid,2020
5-9,~,~,~,Incidence,10009412,Non-Hispanic White,~,Male and Female,Urinary Bladder,2020
50-54,531.1,539.3,66737,Incidence,12469973,Non-Hispanic White,535.2,Male and Female,All Cancer Sites Combined,2020
50-54,7.8,8.8,1030,Incidence,12469973,Non-Hispanic White,8.3,Male and Female,Brain and Other Nervous System,2020
50-54,9.5,11.2,647,Incidence,6264647,Non-Hispanic White,10.3,Male and Female,Cervix,2020
50-54,58.0,60.7,7403,Incidence,12469973,Non-Hispanic White,59.4,Male and Female,Colon and Rectum,2020
50-54,42.6,45.9,2771,Incidence,6264647,Non-Hispanic White,44.2,Male and Female,"Corpus and Uterus, NOS",2020
50-54,5.3,6.1,712,Incidence,12469973,Non-Hispanic White,5.7,Male and Female,Esophagus,2020
50-54,227.2,234.7,14468,Incidence,6264647,Non-Hispanic White,230.9,Male and Female,Female Breast,2020
50-54,60.6,64.5,3919,Incidence,6264647,Non-Hispanic White,62.6,Male and Female,"Female Breast, <i>in situ</i>",2020
50-54,1.9,2.4,265,Incidence,12469973,Non-Hispanic White,2.1,Male and Female,Hodgkin Lymphoma,2020
50-54,0.2,0.4,36,Incidence,12469973,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2020
50-54,24.4,26.1,3147,Incidence,12469973,Non-Hispanic White,25.2,Male and Female,Kidney and Renal Pelvis,2020
50-54,3.8,4.5,515,Incidence,12469973,Non-Hispanic White,4.1,Male and Female,Larynx,2020
50-54,12.0,13.3,1574,Incidence,12469973,Non-Hispanic White,12.6,Male and Female,Leukemias,2020
50-54,5.5,6.4,739,Incidence,12469973,Non-Hispanic White,5.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
50-54,38.2,40.5,4905,Incidence,12469973,Non-Hispanic White,39.3,Male and Female,Lung and Bronchus,2020
50-54,227.2,234.7,14468,Incidence,6264647,Non-Hispanic White,230.9,Male and Female,Male and Female Breast,2020
50-54,60.6,64.5,3919,Incidence,6264647,Non-Hispanic White,62.6,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
50-54,35.2,37.3,4517,Incidence,12469973,Non-Hispanic White,36.2,Male and Female,Melanomas of the Skin,2020
50-54,0.3,0.5,46,Incidence,12469973,Non-Hispanic White,0.4,Male and Female,Mesothelioma,2020
50-54,5.6,6.4,748,Incidence,12469973,Non-Hispanic White,6.0,Male and Female,Myeloma,2020
50-54,18.3,19.9,2381,Incidence,12469973,Non-Hispanic White,19.1,Male and Female,Non-Hodgkin Lymphoma,2020
50-54,22.7,24.4,2937,Incidence,12469973,Non-Hispanic White,23.6,Male and Female,Oral Cavity and Pharynx,2020
50-54,15.3,17.3,1019,Incidence,6264647,Non-Hispanic White,16.3,Male and Female,Ovary,2020
50-54,11.3,12.5,1484,Incidence,12469973,Non-Hispanic White,11.9,Male and Female,Pancreas,2020
50-54,85.3,89.9,5434,Incidence,6205326,Non-Hispanic White,87.6,Male and Female,Prostate,2020
50-54,4.9,5.8,665,Incidence,12469973,Non-Hispanic White,5.3,Male and Female,Stomach,2020
50-54,4.4,5.5,307,Incidence,6205326,Non-Hispanic White,4.9,Male and Female,Testis,2020
50-54,19.9,21.5,2582,Incidence,12469973,Non-Hispanic White,20.7,Male and Female,Thyroid,2020
50-54,13.0,14.3,1696,Incidence,12469973,Non-Hispanic White,13.6,Male and Female,Urinary Bladder,2020
55-59,779.5,788.8,110705,Incidence,14118166,Non-Hispanic White,784.1,Male and Female,All Cancer Sites Combined,2020
55-59,10.6,11.7,1572,Incidence,14118166,Non-Hispanic White,11.1,Male and Female,Brain and Other Nervous System,2020
55-59,9.1,10.5,703,Incidence,7182650,Non-Hispanic White,9.8,Male and Female,Cervix,2020
55-59,57.1,59.6,8233,Incidence,14118166,Non-Hispanic White,58.3,Male and Female,Colon and Rectum,2020
55-59,71.6,75.6,5283,Incidence,7182650,Non-Hispanic White,73.6,Male and Female,"Corpus and Uterus, NOS",2020
55-59,9.7,10.7,1441,Incidence,14118166,Non-Hispanic White,10.2,Male and Female,Esophagus,2020
55-59,257.8,265.3,18787,Incidence,7182650,Non-Hispanic White,261.6,Male and Female,Female Breast,2020
55-59,60.4,64.1,4468,Incidence,7182650,Non-Hispanic White,62.2,Male and Female,"Female Breast, <i>in situ</i>",2020
55-59,2.1,2.6,328,Incidence,14118166,Non-Hispanic White,2.3,Male and Female,Hodgkin Lymphoma,2020
55-59,0.3,0.5,49,Incidence,14118166,Non-Hispanic White,0.3,Male and Female,Kaposi Sarcoma,2020
55-59,33.7,35.6,4893,Incidence,14118166,Non-Hispanic White,34.7,Male and Female,Kidney and Renal Pelvis,2020
55-59,7.7,8.6,1147,Incidence,14118166,Non-Hispanic White,8.1,Male and Female,Larynx,2020
55-59,17.3,18.7,2536,Incidence,14118166,Non-Hispanic White,18.0,Male and Female,Leukemias,2020
55-59,14.2,15.5,2099,Incidence,14118166,Non-Hispanic White,14.9,Male and Female,Liver and Intrahepatic Bile Duct,2020
55-59,89.5,92.6,12850,Incidence,14118166,Non-Hispanic White,91.0,Male and Female,Lung and Bronchus,2020
55-59,257.8,265.3,18787,Incidence,7182650,Non-Hispanic White,261.6,Male and Female,Male and Female Breast,2020
55-59,60.4,64.1,4468,Incidence,7182650,Non-Hispanic White,62.2,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
55-59,45.5,47.7,6577,Incidence,14118166,Non-Hispanic White,46.6,Male and Female,Melanomas of the Skin,2020
55-59,0.6,0.9,103,Incidence,14118166,Non-Hispanic White,0.7,Male and Female,Mesothelioma,2020
55-59,9.1,10.2,1360,Incidence,14118166,Non-Hispanic White,9.6,Male and Female,Myeloma,2020
55-59,27.5,29.2,3999,Incidence,14118166,Non-Hispanic White,28.3,Male and Female,Non-Hodgkin Lymphoma,2020
55-59,33.7,35.7,4901,Incidence,14118166,Non-Hispanic White,34.7,Male and Female,Oral Cavity and Pharynx,2020
55-59,18.6,20.7,1412,Incidence,7182650,Non-Hispanic White,19.7,Male and Female,Ovary,2020
55-59,20.6,22.1,3013,Incidence,14118166,Non-Hispanic White,21.3,Male and Female,Pancreas,2020
55-59,199.7,206.4,14082,Incidence,6935516,Non-Hispanic White,203.0,Male and Female,Prostate,2020
55-59,7.4,8.3,1109,Incidence,14118166,Non-Hispanic White,7.9,Male and Female,Stomach,2020
55-59,3.4,4.3,264,Incidence,6935516,Non-Hispanic White,3.8,Male and Female,Testis,2020
55-59,19.0,20.5,2782,Incidence,14118166,Non-Hispanic White,19.7,Male and Female,Thyroid,2020
55-59,23.9,25.6,3491,Incidence,14118166,Non-Hispanic White,24.7,Male and Female,Urinary Bladder,2020
60-64,1110.9,1121.9,159140,Incidence,14254954,Non-Hispanic White,1116.4,Male and Female,All Cancer Sites Combined,2020
60-64,13.7,15.0,2044,Incidence,14254954,Non-Hispanic White,14.3,Male and Female,Brain and Other Nervous System,2020
60-64,8.8,10.2,694,Incidence,7335341,Non-Hispanic White,9.5,Male and Female,Cervix,2020
60-64,73.5,76.4,10686,Incidence,14254954,Non-Hispanic White,75.0,Male and Female,Colon and Rectum,2020
60-64,89.7,94.1,6739,Incidence,7335341,Non-Hispanic White,91.9,Male and Female,"Corpus and Uterus, NOS",2020
60-64,14.3,15.6,2132,Incidence,14254954,Non-Hispanic White,15.0,Male and Female,Esophagus,2020
60-64,316.4,324.6,23506,Incidence,7335341,Non-Hispanic White,320.4,Male and Female,Female Breast,2020
60-64,68.9,72.8,5196,Incidence,7335341,Non-Hispanic White,70.8,Male and Female,"Female Breast, <i>in situ</i>",2020
60-64,2.2,2.7,344,Incidence,14254954,Non-Hispanic White,2.4,Male and Female,Hodgkin Lymphoma,2020
60-64,0.1,0.3,31,Incidence,14254954,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
60-64,44.3,46.5,6470,Incidence,14254954,Non-Hispanic White,45.4,Male and Female,Kidney and Renal Pelvis,2020
60-64,10.6,11.7,1582,Incidence,14254954,Non-Hispanic White,11.1,Male and Female,Larynx,2020
60-64,26.1,27.8,3841,Incidence,14254954,Non-Hispanic White,26.9,Male and Female,Leukemias,2020
60-64,23.5,25.1,3467,Incidence,14254954,Non-Hispanic White,24.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
60-64,152.9,157.0,22087,Incidence,14254954,Non-Hispanic White,154.9,Male and Female,Lung and Bronchus,2020
60-64,316.4,324.6,23506,Incidence,7335341,Non-Hispanic White,320.4,Male and Female,Male and Female Breast,2020
60-64,68.9,72.8,5196,Incidence,7335341,Non-Hispanic White,70.8,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
60-64,57.1,59.6,8316,Incidence,14254954,Non-Hispanic White,58.3,Male and Female,Melanomas of the Skin,2020
60-64,1.0,1.3,165,Incidence,14254954,Non-Hispanic White,1.2,Male and Female,Mesothelioma,2020
60-64,13.7,15.0,2042,Incidence,14254954,Non-Hispanic White,14.3,Male and Female,Myeloma,2020
60-64,39.9,42.0,5833,Incidence,14254954,Non-Hispanic White,40.9,Male and Female,Non-Hodgkin Lymphoma,2020
60-64,42.6,44.7,6220,Incidence,14254954,Non-Hispanic White,43.6,Male and Female,Oral Cavity and Pharynx,2020
60-64,23.2,25.4,1781,Incidence,7335341,Non-Hispanic White,24.3,Male and Female,Ovary,2020
60-64,31.7,33.5,4646,Incidence,14254954,Non-Hispanic White,32.6,Male and Female,Pancreas,2020
60-64,349.5,358.4,24488,Incidence,6919613,Non-Hispanic White,353.9,Male and Female,Prostate,2020
60-64,11.5,12.6,1719,Incidence,14254954,Non-Hispanic White,12.1,Male and Female,Stomach,2020
60-64,2.3,3.1,184,Incidence,6919613,Non-Hispanic White,2.7,Male and Female,Testis,2020
60-64,18.7,20.2,2775,Incidence,14254954,Non-Hispanic White,19.5,Male and Female,Thyroid,2020
60-64,42.5,44.6,6207,Incidence,14254954,Non-Hispanic White,43.5,Male and Female,Urinary Bladder,2020
65-69,1499.0,1512.5,191545,Incidence,12720909,Non-Hispanic White,1505.7,Male and Female,All Cancer Sites Combined,2020
65-69,16.1,17.6,2141,Incidence,12720909,Non-Hispanic White,16.8,Male and Female,Brain and Other Nervous System,2020
65-69,7.1,8.4,514,Incidence,6654570,Non-Hispanic White,7.7,Male and Female,Cervix,2020
65-69,92.2,95.6,11945,Incidence,12720909,Non-Hispanic White,93.9,Male and Female,Colon and Rectum,2020
65-69,102.7,107.6,6997,Incidence,6654570,Non-Hispanic White,105.1,Male and Female,"Corpus and Uterus, NOS",2020
65-69,19.1,20.7,2527,Incidence,12720909,Non-Hispanic White,19.9,Male and Female,Esophagus,2020
65-69,393.7,403.3,26520,Incidence,6654570,Non-Hispanic White,398.5,Male and Female,Female Breast,2020
65-69,83.8,88.2,5722,Incidence,6654570,Non-Hispanic White,86.0,Male and Female,"Female Breast, <i>in situ</i>",2020
65-69,2.4,2.9,336,Incidence,12720909,Non-Hispanic White,2.6,Male and Female,Hodgkin Lymphoma,2020
65-69,0.1,0.3,26,Incidence,12720909,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
65-69,56.0,58.6,7285,Incidence,12720909,Non-Hispanic White,57.3,Male and Female,Kidney and Renal Pelvis,2020
65-69,11.4,12.7,1531,Incidence,12720909,Non-Hispanic White,12.0,Male and Female,Larynx,2020
65-69,37.8,40.0,4946,Incidence,12720909,Non-Hispanic White,38.9,Male and Female,Leukemias,2020
65-69,33.3,35.3,4363,Incidence,12720909,Non-Hispanic White,34.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
65-69,210.8,215.8,27132,Incidence,12720909,Non-Hispanic White,213.3,Male and Female,Lung and Bronchus,2020
65-69,393.7,403.3,26520,Incidence,6654570,Non-Hispanic White,398.5,Male and Female,Male and Female Breast,2020
65-69,83.8,88.2,5722,Incidence,6654570,Non-Hispanic White,86.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
65-69,74.8,77.8,9703,Incidence,12720909,Non-Hispanic White,76.3,Male and Female,Melanomas of the Skin,2020
65-69,1.6,2.1,237,Incidence,12720909,Non-Hispanic White,1.9,Male and Female,Mesothelioma,2020
65-69,20.4,22.0,2692,Incidence,12720909,Non-Hispanic White,21.2,Male and Female,Myeloma,2020
65-69,56.2,58.9,7322,Incidence,12720909,Non-Hispanic White,57.6,Male and Female,Non-Hodgkin Lymphoma,2020
65-69,46.1,48.5,6017,Incidence,12720909,Non-Hispanic White,47.3,Male and Female,Oral Cavity and Pharynx,2020
65-69,25.8,28.3,1801,Incidence,6654570,Non-Hispanic White,27.1,Male and Female,Ovary,2020
65-69,47.2,49.6,6155,Incidence,12720909,Non-Hispanic White,48.4,Male and Female,Pancreas,2020
65-69,552.5,564.4,33876,Incidence,6066339,Non-Hispanic White,558.4,Male and Female,Prostate,2020
65-69,15.3,16.7,2034,Incidence,12720909,Non-Hispanic White,16.0,Male and Female,Stomach,2020
65-69,1.6,2.3,114,Incidence,6066339,Non-Hispanic White,1.9,Male and Female,Testis,2020
65-69,20.0,21.6,2646,Incidence,12720909,Non-Hispanic White,20.8,Male and Female,Thyroid,2020
65-69,66.7,69.5,8660,Incidence,12720909,Non-Hispanic White,68.1,Male and Female,Urinary Bladder,2020
70-74,1783.8,1799.7,193613,Incidence,10805951,Non-Hispanic White,1791.7,Male and Female,All Cancer Sites Combined,2020
70-74,19.9,21.6,2242,Incidence,10805951,Non-Hispanic White,20.7,Male and Female,Brain and Other Nervous System,2020
70-74,7.2,8.6,450,Incidence,5717654,Non-Hispanic White,7.9,Male and Female,Cervix,2020
70-74,108.9,112.9,11982,Incidence,10805951,Non-Hispanic White,110.9,Male and Female,Colon and Rectum,2020
70-74,101.9,107.2,5977,Incidence,5717654,Non-Hispanic White,104.5,Male and Female,"Corpus and Uterus, NOS",2020
70-74,23.6,25.5,2655,Incidence,10805951,Non-Hispanic White,24.6,Male and Female,Esophagus,2020
70-74,441.3,452.3,25547,Incidence,5717654,Non-Hispanic White,446.8,Male and Female,Female Breast,2020
70-74,88.9,93.9,5225,Incidence,5717654,Non-Hispanic White,91.4,Male and Female,"Female Breast, <i>in situ</i>",2020
70-74,2.7,3.4,329,Incidence,10805951,Non-Hispanic White,3.0,Male and Female,Hodgkin Lymphoma,2020
70-74,0.1,0.3,21,Incidence,10805951,Non-Hispanic White,0.2,Male and Female,Kaposi Sarcoma,2020
70-74,64.3,67.4,7111,Incidence,10805951,Non-Hispanic White,65.8,Male and Female,Kidney and Renal Pelvis,2020
70-74,11.3,12.6,1286,Incidence,10805951,Non-Hispanic White,11.9,Male and Female,Larynx,2020
70-74,50.4,53.1,5594,Incidence,10805951,Non-Hispanic White,51.8,Male and Female,Leukemias,2020
70-74,31.5,33.7,3519,Incidence,10805951,Non-Hispanic White,32.6,Male and Female,Liver and Intrahepatic Bile Duct,2020
70-74,280.1,286.4,30605,Incidence,10805951,Non-Hispanic White,283.2,Male and Female,Lung and Bronchus,2020
70-74,441.3,452.3,25547,Incidence,5717654,Non-Hispanic White,446.8,Male and Female,Male and Female Breast,2020
70-74,88.9,93.9,5225,Incidence,5717654,Non-Hispanic White,91.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
70-74,90.9,94.5,10014,Incidence,10805951,Non-Hispanic White,92.7,Male and Female,Melanomas of the Skin,2020
70-74,3.3,4.0,390,Incidence,10805951,Non-Hispanic White,3.6,Male and Female,Mesothelioma,2020
70-74,27.3,29.3,3058,Incidence,10805951,Non-Hispanic White,28.3,Male and Female,Myeloma,2020
70-74,74.6,77.9,8236,Incidence,10805951,Non-Hispanic White,76.2,Male and Female,Non-Hodgkin Lymphoma,2020
70-74,48.1,50.8,5341,Incidence,10805951,Non-Hispanic White,49.4,Male and Female,Oral Cavity and Pharynx,2020
70-74,29.2,32.1,1750,Incidence,5717654,Non-Hispanic White,30.6,Male and Female,Ovary,2020
70-74,63.1,66.1,6980,Incidence,10805951,Non-Hispanic White,64.6,Male and Female,Pancreas,2020
70-74,574.7,588.0,29580,Incidence,5088297,Non-Hispanic White,581.3,Male and Female,Prostate,2020
70-74,18.3,20.0,2068,Incidence,10805951,Non-Hispanic White,19.1,Male and Female,Stomach,2020
70-74,1.0,1.6,65,Incidence,5088297,Non-Hispanic White,1.3,Male and Female,Testis,2020
70-74,19.5,21.2,2197,Incidence,10805951,Non-Hispanic White,20.3,Male and Female,Thyroid,2020
70-74,98.3,102.0,10821,Incidence,10805951,Non-Hispanic White,100.1,Male and Female,Urinary Bladder,2020
75-79,2042.8,2063.3,153701,Incidence,7486516,Non-Hispanic White,2053.0,Male and Female,All Cancer Sites Combined,2020
75-79,20.1,22.2,1581,Incidence,7486516,Non-Hispanic White,21.1,Male and Female,Brain and Other Nervous System,2020
75-79,6.0,7.6,274,Incidence,4071553,Non-Hispanic White,6.7,Male and Female,Cervix,2020
75-79,137.2,142.5,10468,Incidence,7486516,Non-Hispanic White,139.8,Male and Female,Colon and Rectum,2020
75-79,87.1,93.0,3665,Incidence,4071553,Non-Hispanic White,90.0,Male and Female,"Corpus and Uterus, NOS",2020
75-79,24.9,27.2,1949,Incidence,7486516,Non-Hispanic White,26.0,Male and Female,Esophagus,2020
75-79,444.2,457.3,18352,Incidence,4071553,Non-Hispanic White,450.7,Male and Female,Female Breast,2020
75-79,72.3,77.7,3053,Incidence,4071553,Non-Hispanic White,75.0,Male and Female,"Female Breast, <i>in situ</i>",2020
75-79,3.5,4.4,295,Incidence,7486516,Non-Hispanic White,3.9,Male and Female,Hodgkin Lymphoma,2020
75-79,0.2,0.5,28,Incidence,7486516,Non-Hispanic White,0.4,Male and Female,Kaposi Sarcoma,2020
75-79,67.7,71.5,5210,Incidence,7486516,Non-Hispanic White,69.6,Male and Female,Kidney and Renal Pelvis,2020
75-79,10.9,12.5,873,Incidence,7486516,Non-Hispanic White,11.7,Male and Female,Larynx,2020
75-79,67.3,71.1,5177,Incidence,7486516,Non-Hispanic White,69.2,Male and Female,Leukemias,2020
75-79,32.4,35.0,2521,Incidence,7486516,Non-Hispanic White,33.7,Male and Female,Liver and Intrahepatic Bile Duct,2020
75-79,356.5,365.1,27010,Incidence,7486516,Non-Hispanic White,360.8,Male and Female,Lung and Bronchus,2020
75-79,444.2,457.3,18352,Incidence,4071553,Non-Hispanic White,450.7,Male and Female,Male and Female Breast,2020
75-79,72.3,77.7,3053,Incidence,4071553,Non-Hispanic White,75.0,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
75-79,106.8,111.5,8170,Incidence,7486516,Non-Hispanic White,109.1,Male and Female,Melanomas of the Skin,2020
75-79,5.6,6.8,464,Incidence,7486516,Non-Hispanic White,6.2,Male and Female,Mesothelioma,2020
75-79,34.4,37.1,2672,Incidence,7486516,Non-Hispanic White,35.7,Male and Female,Myeloma,2020
75-79,97.1,101.7,7441,Incidence,7486516,Non-Hispanic White,99.4,Male and Female,Non-Hodgkin Lymphoma,2020
75-79,46.9,50.1,3632,Incidence,7486516,Non-Hispanic White,48.5,Male and Female,Oral Cavity and Pharynx,2020
75-79,33.3,36.9,1427,Incidence,4071553,Non-Hispanic White,35.0,Male and Female,Ovary,2020
75-79,77.8,81.8,5973,Incidence,7486516,Non-Hispanic White,79.8,Male and Female,Pancreas,2020
75-79,523.4,538.9,18136,Incidence,3414963,Non-Hispanic White,531.1,Male and Female,Prostate,2020
75-79,24.5,26.8,1917,Incidence,7486516,Non-Hispanic White,25.6,Male and Female,Stomach,2020
75-79,0.7,1.4,33,Incidence,3414963,Non-Hispanic White,1.0,Male and Female,Testis,2020
75-79,16.7,18.7,1323,Incidence,7486516,Non-Hispanic White,17.7,Male and Female,Thyroid,2020
75-79,137.3,142.7,10477,Incidence,7486516,Non-Hispanic White,139.9,Male and Female,Urinary Bladder,2020
80-84,2134.6,2160.7,103743,Incidence,4830556,Non-Hispanic White,2147.6,Male and Female,All Cancer Sites Combined,2020
80-84,20.7,23.4,1063,Incidence,4830556,Non-Hispanic White,22.0,Male and Female,Brain and Other Nervous System,2020
80-84,5.1,7.0,165,Incidence,2740042,Non-Hispanic White,6.0,Male and Female,Cervix,2020
80-84,179.5,187.1,8854,Incidence,4830556,Non-Hispanic White,183.3,Male and Female,Colon and Rectum,2020
80-84,72.2,78.7,2066,Incidence,2740042,Non-Hispanic White,75.4,Male and Female,"Corpus and Uterus, NOS",2020
80-84,25.4,28.4,1299,Incidence,4830556,Non-Hispanic White,26.9,Male and Female,Esophagus,2020
80-84,398.0,413.1,11111,Incidence,2740042,Non-Hispanic White,405.5,Male and Female,Female Breast,2020
80-84,48.8,54.2,1409,Incidence,2740042,Non-Hispanic White,51.4,Male and Female,"Female Breast, <i>in situ</i>",2020
80-84,3.7,4.9,205,Incidence,4830556,Non-Hispanic White,4.2,Male and Female,Hodgkin Lymphoma,2020
80-84,0.4,0.8,27,Incidence,4830556,Non-Hispanic White,0.6,Male and Female,Kaposi Sarcoma,2020
80-84,60.6,65.0,3032,Incidence,4830556,Non-Hispanic White,62.8,Male and Female,Kidney and Renal Pelvis,2020
80-84,10.5,12.4,550,Incidence,4830556,Non-Hispanic White,11.4,Male and Female,Larynx,2020
80-84,80.3,85.4,4000,Incidence,4830556,Non-Hispanic White,82.8,Male and Female,Leukemias,2020
80-84,34.6,38.1,1754,Incidence,4830556,Non-Hispanic White,36.3,Male and Female,Liver and Intrahepatic Bile Duct,2020
80-84,353.6,364.3,17336,Incidence,4830556,Non-Hispanic White,358.9,Male and Female,Lung and Bronchus,2020
80-84,398.0,413.1,11111,Incidence,2740042,Non-Hispanic White,405.5,Male and Female,Male and Female Breast,2020
80-84,48.8,54.2,1409,Incidence,2740042,Non-Hispanic White,51.4,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
80-84,118.4,124.7,5871,Incidence,4830556,Non-Hispanic White,121.5,Male and Female,Melanomas of the Skin,2020
80-84,7.0,8.6,376,Incidence,4830556,Non-Hispanic White,7.8,Male and Female,Mesothelioma,2020
80-84,38.2,41.8,1932,Incidence,4830556,Non-Hispanic White,40.0,Male and Female,Myeloma,2020
80-84,110.6,116.6,5486,Incidence,4830556,Non-Hispanic White,113.6,Male and Female,Non-Hodgkin Lymphoma,2020
80-84,44.9,48.8,2263,Incidence,4830556,Non-Hispanic White,46.8,Male and Female,Oral Cavity and Pharynx,2020
80-84,34.9,39.5,1018,Incidence,2740042,Non-Hispanic White,37.2,Male and Female,Ovary,2020
80-84,91.6,97.1,4558,Incidence,4830556,Non-Hispanic White,94.4,Male and Female,Pancreas,2020
80-84,405.2,422.7,8652,Incidence,2090514,Non-Hispanic White,413.9,Male and Female,Prostate,2020
80-84,26.7,29.7,1361,Incidence,4830556,Non-Hispanic White,28.2,Male and Female,Stomach,2020
80-84,0.5,1.4,18,Incidence,2090514,Non-Hispanic White,0.9,Male and Female,Testis,2020
80-84,12.6,14.7,656,Incidence,4830556,Non-Hispanic White,13.6,Male and Female,Thyroid,2020
80-84,163.4,170.7,8069,Incidence,4830556,Non-Hispanic White,167.0,Male and Female,Urinary Bladder,2020
85+,1878.2,1902.2,95706,Incidence,5063286,Non-Hispanic White,1890.2,Male and Female,All Cancer Sites Combined,2020
85+,16.5,18.9,895,Incidence,5063286,Non-Hispanic White,17.7,Male and Female,Brain and Other Nervous System,2020
85+,4.0,5.6,153,Incidence,3203568,Non-Hispanic White,4.8,Male and Female,Cervix,2020
85+,204.5,212.5,10557,Incidence,5063286,Non-Hispanic White,208.5,Male and Female,Colon and Rectum,2020
85+,43.0,47.7,1451,Incidence,3203568,Non-Hispanic White,45.3,Male and Female,"Corpus and Uterus, NOS",2020
85+,21.9,24.6,1177,Incidence,5063286,Non-Hispanic White,23.2,Male and Female,Esophagus,2020
85+,289.8,301.7,9473,Incidence,3203568,Non-Hispanic White,295.7,Male and Female,Female Breast,2020
85+,18.8,21.9,650,Incidence,3203568,Non-Hispanic White,20.3,Male and Female,"Female Breast, <i>in situ</i>",2020
85+,1.9,2.8,117,Incidence,5063286,Non-Hispanic White,2.3,Male and Female,Hodgkin Lymphoma,2020
85+,0.3,0.6,21,Incidence,5063286,Non-Hispanic White,0.4,Male and Female,Kaposi Sarcoma,2020
85+,47.1,50.9,2480,Incidence,5063286,Non-Hispanic White,49.0,Male and Female,Kidney and Renal Pelvis,2020
85+,7.4,9.0,414,Incidence,5063286,Non-Hispanic White,8.2,Male and Female,Larynx,2020
85+,78.6,83.6,4103,Incidence,5063286,Non-Hispanic White,81.0,Male and Female,Leukemias,2020
85+,26.9,29.9,1437,Incidence,5063286,Non-Hispanic White,28.4,Male and Female,Liver and Intrahepatic Bile Duct,2020
85+,254.7,263.6,13121,Incidence,5063286,Non-Hispanic White,259.1,Male and Female,Lung and Bronchus,2020
85+,289.8,301.7,9473,Incidence,3203568,Non-Hispanic White,295.7,Male and Female,Male and Female Breast,2020
85+,18.8,21.9,650,Incidence,3203568,Non-Hispanic White,20.3,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
85+,111.9,117.9,5816,Incidence,5063286,Non-Hispanic White,114.9,Male and Female,Melanomas of the Skin,2020
85+,6.5,8.0,364,Incidence,5063286,Non-Hispanic White,7.2,Male and Female,Mesothelioma,2020
85+,29.5,32.5,1568,Incidence,5063286,Non-Hispanic White,31.0,Male and Female,Myeloma,2020
85+,95.6,101.1,4980,Incidence,5063286,Non-Hispanic White,98.4,Male and Female,Non-Hodgkin Lymphoma,2020
85+,36.3,39.7,1924,Incidence,5063286,Non-Hispanic White,38.0,Male and Female,Oral Cavity and Pharynx,2020
85+,29.0,32.9,990,Incidence,3203568,Non-Hispanic White,30.9,Male and Female,Ovary,2020
85+,84.5,89.6,4406,Incidence,5063286,Non-Hispanic White,87.0,Male and Female,Pancreas,2020
85+,316.7,333.2,6042,Incidence,1859718,Non-Hispanic White,324.9,Male and Female,Prostate,2020
85+,25.5,28.4,1364,Incidence,5063286,Non-Hispanic White,26.9,Male and Female,Stomach,2020
85+,~,~,~,Incidence,1859718,Non-Hispanic White,~,Male and Female,Testis,2020
85+,8.0,9.6,444,Incidence,5063286,Non-Hispanic White,8.8,Male and Female,Thyroid,2020
85+,162.3,169.4,8398,Incidence,5063286,Non-Hispanic White,165.9,Male and Female,Urinary Bladder,2020
<1,25.1,30.0,501,Incidence,1823418,Non-Hispanic White,27.5,Male and Female,All Cancer Sites Combined,2020
<1,3.7,5.7,84,Incidence,1823418,Non-Hispanic White,4.6,Male and Female,Brain and Other Nervous System,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,Cervix,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Colon and Rectum,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,"Corpus and Uterus, NOS",2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Esophagus,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,Female Breast,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,"Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Kaposi Sarcoma,2020
<1,1.1,2.3,30,Incidence,1823418,Non-Hispanic White,1.6,Male and Female,Kidney and Renal Pelvis,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Larynx,2020
<1,2.9,4.8,69,Incidence,1823418,Non-Hispanic White,3.8,Male and Female,Leukemias,2020
<1,0.9,2.1,26,Incidence,1823418,Non-Hispanic White,1.4,Male and Female,Liver and Intrahepatic Bile Duct,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Lung and Bronchus,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,Male and Female Breast,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,"Male and Female Breast, <i>in situ</i>",2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Melanomas of the Skin,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Mesothelioma,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Myeloma,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Non-Hodgkin Lymphoma,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Oral Cavity and Pharynx,2020
<1,~,~,~,Incidence,890797,Non-Hispanic White,~,Male and Female,Ovary,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Pancreas,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male and Female,Prostate,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Stomach,2020
<1,~,~,~,Incidence,932621,Non-Hispanic White,~,Male and Female,Testis,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Thyroid,2020
<1,~,~,~,Incidence,1823418,Non-Hispanic White,~,Male and Female,Urinary Bladder,2020
